Wavefront-Guided LASIK|Completed||Phase 4|51|Actual|Stanford University||3|||f||||t||||||||||2017-02-18 13:07:38.260617|2017-02-18 13:07:38.260617
NCT00889928|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2011-11-01|2011-11-01||April 2009||2009-04-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|November 2010|Actual|2010-11-01||Interventional|NOTES||A Trial to Evaluate Natural Orifice Transvaginal Endoscopic Cholecystectomy With Laparoscopic Assistance|A Trial to Evaluate Natural Orifice Transvaginal Endoscopic Cholecystectomy With Laparoscopic Assistance|Completed||N/A|7|Actual|Ethicon Endo-Surgery|No significant limitations. Small sample size limits inference to a larger population, however it did allow to assess whether the procedure was feasible.|1|||f||||f||||||||||2017-02-18 13:07:38.352986|2017-02-18 13:07:38.352986
NCT00889915|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2013-07-30|2013-01-22||April 2009||2009-04-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)|A Randomized Controlled Trial of Methylphenidate Transdermal System (Daytrana), Lisdexamfetamine Dimesylate (Vyvanse), OROS MPH (Concerta), and Mixed Amphetamine Salts Extended Release (Adderall XR) in Children and Adolescents With ADHD|Completed||Phase 4|228|Actual|Duke University||4|||f||||t||||||||||2017-02-18 13:07:38.646455|2017-02-18 13:07:38.646455
NCT00889902|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-04-27|||April 2009||2009-04-01|April 2009|2009-04-01|July 2011|Anticipated|2011-07-01|June 2010|Anticipated|2010-06-01||Observational|||Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis|Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis|Unknown status|Not yet recruiting|N/A|200|Anticipated|Wuhan University|||1||f||||t||||||Samples With DNA|"~     Cervical exfoliated cells~   "|||2017-02-18 13:07:39.425982|2017-02-18 13:07:39.425982
NCT00889889|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2013-09-27||2012-01-24|May 2009||2009-05-01|September 2013|2013-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination|Randomized, Double-Blind, Placebo-Controlled Study to Assess the Immunogenicity and Safety of a Cell-Derived Trivalent Subunit Influenza Vaccine in Subjects Aged >= 18 Years and <= 64 Years During Two Consecutive Years.|Completed||Phase 2|1270|Actual|Abbott||2|||f||||f||||||||||2017-02-18 13:07:39.529976|2017-02-18 13:07:39.529976
NCT00889876|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2011-02-03|||February 2009||2009-02-01|February 2011|2011-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese Adolescents|Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for Cardiovascular Disease (CVD) Among Obese Adolescents|Unknown status|Recruiting|N/A|100|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 13:07:39.644846|2017-02-18 13:07:39.644846
NCT00889863|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2012-09-13|2012-09-12||July 2009||2009-07-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|β-SPECIFIC 2||Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)|A Randomized, Double-blind, Placebo Controlled, Withdrawal Study of Flare Prevention of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations|Completed||Phase 3|177|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:07:39.764726|2017-02-18 13:07:39.764726
NCT00889850|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2009-06-22|||April 2009||2009-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed Administration|Open, Randomised, Single-Dose, 2x2-Way Cross-Over Comparative Oral Bioavailability Study in Healthy Adult Male Subjects Under Fasted Conditions (Block I) and Under Fed Conditions (Block II); Comparison of 40 mg Esomeprazole Mepha Capsules (Test) With 40 mg Esomeprazole INexium MUPS Tablets (Reference)|Completed||Phase 1|100|Actual|Mepha Ltd.||4|||f||||f||||||||||2017-02-18 13:07:40.517867|2017-02-18 13:07:40.517867
NCT00889837|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-08-28|||June 2009||2009-06-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Staccato Loxapine Pulmonary Safety in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Pulmonary Safety of Staccato® Loxapine for Inhalation in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 1|53|Actual|Alexza Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 13:07:40.624386|2017-02-18 13:07:40.624386
NCT00889824|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2016-01-13|2013-06-12||February 2011||2011-02-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability|Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability|Completed||Phase 1|5|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 13:07:40.725701|2017-02-18 13:07:40.725701
NCT00889811|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2009-10-07|||March 2009||2009-03-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Remote Preconditioning in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery|Effect of Lower Limb Remote Preconditioning on Myocardial Injury in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery|Completed||Phase 1|68|Actual|Seoul National University Hospital||1|||f||||t||||||||||2017-02-18 13:07:40.948979|2017-02-18 13:07:40.948979
NCT00889798|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2016-06-27|||April 2009||2009-04-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|August 2019|Anticipated|2019-08-01||Observational|TLN-Registry||Tumor Registry of Lymphatic Neoplasia|Epidemiological Registry Describing Treatment Reality and Therapy Modalities of Patients With Malignant Lymphatic Systemic Diseases (Non-Hodgkin`s Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma) Requiring Therapy.|Active, not recruiting||N/A|3750|Anticipated|iOMEDICO AG|||1||f||||f||||||||No||2017-02-18 13:07:41.048746|2017-02-18 13:07:41.048746
NCT00889785|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2013-12-16|||June 2009||2009-06-01|December 2013|2013-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Situational Problem Solving in Adolescents With Type 2 Diabetes: Enhancing a Randomized Controlled Trial (RCT)|Situational Problem Solving in Adolescents With Type 2 Diabetes: Enhancing an RCT|Completed||N/A|43|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:07:41.143284|2017-02-18 13:07:41.143284
NCT00889772|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2015-09-22|||March 2009||2009-03-01|June 2012|2012-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|USCTG-LIPS1||Lung Injury Prediction Study|Identifying Patients at Risk of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) at the Time of Hospital Admission: External Validation of a Lung Injury Prediction Score (LIPS)|Completed||N/A|300|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 13:07:41.240456|2017-02-18 13:07:41.240456
NCT00889759|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2009-09-22|||December 2007||2007-12-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Observational|||The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak Investigation|The Role of Addition of High Resolution-CT in Outbreak Investigation of Tuberculosis|Completed||N/A|92|Actual|Armed Forces Capital Hospital, Republic of Korea|||1||f||||f||||||||||2017-02-18 13:07:41.332764|2017-02-18 13:07:41.332764
NCT00889746|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2009-05-05|||May 2008||2008-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:07:41.461216|2017-02-18 13:07:41.461216
NCT00889733|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2011-10-06|||February 2007||2007-02-01|October 2011|2011-10-01||||July 2009|Actual|2009-07-01||Interventional|OVHM-01||Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer|A Phase I/II Trial of Intraperitoneal (IP) Cisplatin Combined With IV Paclitaxel in Patients With Epithelial Ovarian Cancer Optimally Debulked at Their Initial Surgery Performed Following Neoadjuvant Intravenous Chemotherapy|Terminated||Phase 1/Phase 2|20|Anticipated|University Health Network, Toronto||1||Poor recruitment|f||||t||||||||||2017-02-18 13:07:41.50886|2017-02-18 13:07:41.50886
NCT00889720|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2011-10-12|2011-07-27||November 2009||2009-11-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery|A Multicenter, Open Label Study To Investigate The Feasibility And Efficacy Of A Smoking Cessation Program With Varenicline In Patients Undergoing Elective Surgery|Completed||Phase 4|16|Actual|Pfizer|This study was terminated after 16 of 100 planned subjects were enrolled due to slow recruitment and non-compliance with the protocol; only selected efficacy listings of the surgical population and key safety data were reported.|1|||f||||f||||||||||2017-02-18 13:07:41.595884|2017-02-18 13:07:41.595884
NCT00889707|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2013-08-19|2013-05-28||January 2009||2009-01-01|August 2013|2013-08-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Interventional|TRIUMPH-1|All randomized patients who received study drug.|Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia|A Randomized, Double-blind, Placebo-controlled Phase II Study of Transperineal Intraprostatic Injection of PRX302 for the Treatment of Benign Prostatic Hyperplasia|Completed||Phase 2|92|Actual|Sophiris Bio Corp||2|||f||||f||||||||||2017-02-18 13:07:42.260637|2017-02-18 13:07:42.260637
NCT00889694|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-04-27|||October 2008||2008-10-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|July 2009|Anticipated|2009-07-01||Interventional|||Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis|Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis: a 12-Week, Multiple Centers, Randomized Double-Blind, Positive Drug and Placebo Controlled Clinical Trial|Unknown status|Enrolling by invitation|Phase 2/Phase 3|80|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-02-18 13:07:42.7311|2017-02-18 13:07:42.7311
NCT00889681|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2014-03-26|2014-02-03||March 2009||2009-03-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|CAP-AF|All enrolled subjects|Continued Access Protocol|CAP-AF: Continued Access Protocol for the Evaluation of Catheter Cryoablation in the Treatment of Paroxysmal Atrial Fibrillation|Completed||N/A|81|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||t||||||||||2017-02-18 13:07:42.815256|2017-02-18 13:07:42.815256
NCT00889668|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2012-04-29|||May 2009||2009-05-01|April 2012|2012-04-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|CR-01-001||Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device|Evaluation of the Performance and Use of GlucoTrack Model DF-F Non-Invasive Glucose Monitoring Device.|Unknown status|Recruiting|Phase 1/Phase 2|180|Anticipated|Integrity Applications Ltd.||1|||f||||t||||||||||2017-02-18 13:07:43.13077|2017-02-18 13:07:43.13077
NCT00889655|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2009-04-28|||May 2009||2009-05-01|April 2009|2009-04-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus Golytely|A Prospective, Randomized Controlled Trial Comparing the Efficacy and Patient Tolerability of MiraLAX (PEG 3350) vs Golytely as Bowel Preparation for Screening Colonoscopy|Unknown status|Not yet recruiting|Phase 4|432|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 13:07:43.227776|2017-02-18 13:07:43.227776
NCT00889642|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-06-22|||May 2009||2009-05-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy Study of an Iontophoretic Patch Containing Lidocaine and Epinephrine for Venipuncture in Healthy Adult Volunteers|A Multicenter Double-Blind Randomized Placebo Controlled Two-Arm Study Evaluating the Safety and Efficacy of the Iontophoretic Administration of Lidocaine and Epinephrine Using Lidocaine Iontophoretic Drug Delivery System (IDDS) to Provide Local Anesthesia for Venipuncture in Healthy Adult Volunteer Subjects|Completed||Phase 2|90|Anticipated|Dharma Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 13:07:43.320421|2017-02-18 13:07:43.320421
NCT00889629|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2009-04-28|||November 2008||2008-11-01|April 2009|2009-04-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients|Pilot Study: Effects of Hectorol (Doxercalciferol) Vitamin D Replacement on Proteinuria, PTH Level and Bone Turnover in Stable Kidney Transplant Recipients: a Single-Blind, Placebo-Controlled Study in Patients Receiving 25-OH Vitamin D3|Unknown status|Recruiting|Phase 4|60|Anticipated|State University of New York - Downstate Medical Center||2|||f||||f||||||||||2017-02-18 13:07:43.414577|2017-02-18 13:07:43.414577
NCT00889616|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2017-01-24|||April 23, 2009||2009-04-23|July 18, 2012|2012-07-18|July 18, 2012|Actual|2012-07-18|||||Interventional|||Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali|Phase 1 Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and in Bancoumana, Mali|Completed||Phase 1|400|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:07:43.525092|2017-02-18 13:07:43.525092
NCT00889603|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2011-03-04|2011-01-26||May 2009||2009-05-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Non-Interventional Study With Aricept® Evess|Non-Interventional Study With Aricept® Evess In Patients Diagnosed With Mild And Moderate Alzheimer's Disease Or Vascular Dementia|Completed||N/A|370|Actual|Pfizer|FAQ Change from baseline not analyzed, a note to file was issued stating it was removed from protocol but erroneously remained in statistical analysis section. Patient Domain of Benefit, Week 24 LOCF not analyzed; endpoint only collected at Week 24.||1||f||||t||||||||||2017-02-18 13:07:43.634414|2017-02-18 13:07:43.634414
NCT00889590|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2016-01-25|||December 2008||2008-12-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|May 2015|Actual|2015-05-01||Interventional|HR-GCT||Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT)|Adjuvant Zoledronic Acid in 'High Risk' Giant Cell Tumour of Bone (GCT) - A Randomized Phase II Study|Terminated||Phase 2|15|Actual|Leiden University Medical Center||2||low recruitment with registration denosumab|f||||f||||||||||2017-02-18 13:07:44.055635|2017-02-18 13:07:44.055635
NCT00889577|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2015-05-06|||December 2008||2008-12-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|March 2010|Actual|2010-03-01||Observational|||Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons|Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons|Completed||N/A|233|Actual|Uniformed Services University of the Health Sciences|||1||f||||t||||||Samples With DNA|"~     Blood samples will be obtained~   "|||2017-02-18 13:07:44.170754|2017-02-18 13:07:44.170754
NCT00889564|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-04-28|||March 2006||2006-03-01|April 2009|2009-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||HeRO Vascular Access Device Bacteremia Study|HeRO Vascular Access Device Bacteremia Study|Completed||N/A|38|Actual|Hemosphere, Inc.||1|||f||||t||||||||||2017-02-18 13:07:44.25297|2017-02-18 13:07:44.25297
NCT00889551|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2009-04-28||||||April 2009|2009-04-01||||||||Observational|||Pregnancy and Growth of Adolescent Mothers and Their Child|Pregnancy and Growth of Adolescent Mothers and Their Child|Unknown status|Active, not recruiting|N/A|||University of Brasilia|||1||f||||||||||||||2017-02-18 13:07:44.336715|2017-02-18 13:07:44.336715
NCT00889538|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2016-12-06|||April 2009||2009-04-01|December 2016|2016-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems|Double-Blind, Placebo-Controlled, Crossover Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems|Completed||N/A|24|Actual|University of Louisville||3|||f||||f||||||||||2017-02-18 13:07:44.393097|2017-02-18 13:07:44.393097
NCT00889525|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-04-28|||November 2007||2007-11-01|April 2009|2009-04-01||||||||Interventional|||Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor|Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor|Completed||Phase 3|||Seth Gordhandas Sunderdas Medical College||1|||f||||||||||||||2017-02-18 13:07:44.505589|2017-02-18 13:07:44.505589
NCT00889512|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2014-10-22|2014-01-08||April 2009||2009-04-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||The Luveris In Vitro Fertilization Trial|The Luveris® In Vitro Fertilization Trial: The Effect of Recombinant Luteinizing Hormone on Follicular Response, Oocyte Quality, and Pregnancy in In-Vitro Fertilization Treatment Cycles in Women Without Endogenous LH Activity.|Terminated||Phase 4|14|Actual|University Reproductive Associates||2||Drug no longer available by manufacturer|f||||f||||||||||2017-02-18 13:07:44.652879|2017-02-18 13:07:44.652879
NCT00889499|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2011-03-23|||March 2009||2009-03-01|March 2011|2011-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron|Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron|Completed||Phase 2|30|Actual|University Hospital Inselspital, Berne||3|||f||||f||||||||||2017-02-18 13:07:45.102835|2017-02-18 13:07:45.102835
NCT00889486|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2012-12-07||2012-12-05|April 2009||2009-04-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Evaluation of the Safety and Efficacy of Once-Daily Administrations of TZP 102 for the Treatment of Symptomatic Gastroparesis in Patients With Diabetes Mellitus|Completed||Phase 2|92|Actual|Tranzyme, Inc.||4|||f||||f||||||||||2017-02-18 13:07:45.209856|2017-02-18 13:07:45.209856
NCT00889473|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2012-07-12|||April 2009||2009-04-01|January 2010|2010-01-01|April 2010|Actual|2010-04-01|November 2009|Actual|2009-11-01||Interventional|||Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease|A Phase IIb, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multicenter Study to Determine the Safety, Tolerance, and Efficacy of AT-1001 in Celiac Disease Subjects During a Gluten Challenge|Completed||Phase 2|42|Actual|Alba Therapeutics||2|||f||||f||||||||||2017-02-18 13:07:45.328283|2017-02-18 13:07:45.328283
NCT00889460|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-28|2009-04-28|||November 2007||2007-11-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Tolerability Study of rBet v1 SLIT Tablets|Phase I Study to re-Investigate the Safety, Tolerability and Pharmacodynamic Effects of SLIT(Tablets) With Recombinant Bet v1 Given in Single Rising Doses and in Multi Dose Regimens to Subjects Sensitised to Birch Pollen|Completed||Phase 1|55|Actual|Stallergenes||2|||f||||f||||||||||2017-02-18 13:07:45.450985|2017-02-18 13:07:45.450985
NCT00889447|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2013-04-01|||January 2008||2008-01-01|April 2013|2013-04-01||||July 2013|Anticipated|2013-07-01||Observational|||Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)|Screening Evaluation for Studies of COPD|Unknown status|Active, not recruiting|N/A|200|Anticipated|Johns Hopkins University|||1||f||||t||||||Samples Without DNA|"~     blood~   "|||2017-02-18 13:07:45.561577|2017-02-18 13:07:45.561577
NCT00889434|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-11-11|||September 2009||2009-09-01|November 2012|2012-11-01|June 2015|Anticipated|2015-06-01|October 2014|Anticipated|2014-10-01||Interventional|||Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)|Single-site, Open-label, Dose-ranging, Efficacy, and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated CF|Unknown status|Recruiting|N/A|18|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||||2017-02-18 13:07:45.640124|2017-02-18 13:07:45.640124
NCT00889239|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-25|2015-05-14|||May 2004||2004-05-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Clinical Performance and Wear Mechanism of Hot-Pressed Ceramic Crowns|Clinical Performance and Wear Mechanism of Hot-Pressed Ceramic Crowns|Completed||N/A|30|Actual|Mahidol University||1|||f||||f||||||||||2017-02-18 13:07:48.61534|2017-02-18 13:07:48.61534
NCT00889421|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2014-06-06|2014-06-06||November 2009||2009-11-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||patients with refractory uveitis|Apremilast in the Treatment of Uveitis|An Open-label Trial to Assess the Efficacy and Safety of Apremilast in the Management of Vision-threatening Uveitis That is Refractory to Other Modes of Systemic Immunosuppression.|Terminated||Phase 1/Phase 2|3|Actual|Oregon Health and Science University|Study was terminated prematurely due to inefficacy in the three initial patients enrolled. Endpoints were not analyzed as participants did not make it to the 6 month time frame before discontinuing the study.|1||Investigator discretion due to lack of efficacy in three subjects enrolled|f||||||||||||||2017-02-18 13:07:45.75131|2017-02-18 13:07:45.75131
NCT00889408|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-26|2017-02-09|||December 2, 2013|Actual|2013-12-02|February 2017|2017-02-01|July 21, 2014|Actual|2014-07-21|July 21, 2014|Actual|2014-07-21||Interventional|||DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma|A Phase I Study of DT2219ARL, A Bispecific Singe Chain Immunotoxin for the Treatment of Relapsed or Refractory CD19(+), CD22(+) B-Lineage Leukemia or Lymphoma|Completed||Phase 1|25|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 13:07:45.995489|2017-02-18 13:07:45.995489
NCT00889395|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-05-14|||September 2008||2008-09-01|April 2009|2009-04-01|June 2011|Anticipated|2011-06-01|April 2011|Anticipated|2011-04-01||Interventional|||Cognitive and Psychosocial Benefits of MISC Training for Ugandan Children|Cognitive and Psychosocial Benefits of Caregiver Training for Ugandan HIV Children|Unknown status|Recruiting|N/A|120|Anticipated|Makerere University||1|||f||||f||||||||||2017-02-18 13:07:46.105412|2017-02-18 13:07:46.105412
NCT00889382|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2014-09-22||2014-09-22|July 2009||2009-07-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|||A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)|A Phase 1/2 Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)|Completed||Phase 1/Phase 2|152|Actual|Astellas Pharma Inc||8|||f||||f||||||||||2017-02-18 13:07:46.212751|2017-02-18 13:07:46.212751
NCT00889369|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2012-02-07|||May 2009||2009-05-01|June 2009|2009-06-01|June 2012|Anticipated|2012-06-01|February 2012|Anticipated|2012-02-01||Interventional|||Duloxetine for Major Depression in Peri-/Postmenopausal Women|Duloxetine for the Treatment of Major Depression in Midlife Women: Effects on Brain Structure and Functioning, Mood, and Quality of Life|Unknown status|Recruiting|Phase 4|70|Anticipated|McMaster University||1|||f||||f||||||||||2017-02-18 13:07:46.382234|2017-02-18 13:07:46.382234
NCT00889356|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2009-04-27|||September 2009||2009-09-01|April 2009|2009-04-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis|Phase III, Open Label, Randomized, Multicenter Study to Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, Compared to Combination of Tetracycline 100mg and Amphotericin B 50mg in Vaginal Cream for the Treatment of Bacterial Vaginosis and Candidiasis Isolatedly or in Association (Mixed-Type Vaginosis)|Unknown status|Not yet recruiting|Phase 3|160|Anticipated|Zodiac Produtos Farmaceuticos S.A.||2|||f||||t||||||||||2017-02-18 13:07:46.492428|2017-02-18 13:07:46.492428
NCT00889343|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-03-01|||March 2009||2009-03-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|November 2011|Actual|2011-11-01||Interventional|FOSCO||Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer|A Controlled Randomized Double-blind Multi-center Phase II Study of FOLFOX6 or FOLFIRI Combined With Sorafenib Versus Placebo in Second-line Metastatic Colorectal Carcinoma|Terminated||Phase 2|101|Actual|AIO-Studien-gGmbH||2|||f||||t||||||||||2017-02-18 13:07:46.594383|2017-02-18 13:07:46.594383
NCT00889330|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2015-02-18|2011-06-24||April 2009||2009-04-01|February 2015|2015-02-01||||May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy Study of a Eye Drop for Eye Allergy||Completed||Phase 3|60|Actual|Vistakon Pharmaceuticals||2|||f||||||||||||||2017-02-18 13:07:46.776615|2017-02-18 13:07:46.776615
NCT00889317|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2013-01-15|||March 2009||2009-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|SPIM||Sensorimotor Maps of Vowel Perception and Production|Les Cartes Sensori-motrices De La Parole : Corrélats Neuroanatomiques Des Systèmes De Perception Et De Production Des Voyelles Du Français|Completed||N/A|54|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-02-18 13:07:47.369507|2017-02-18 13:07:47.369507
NCT00889304|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2011-07-21|||July 2007||2007-07-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|August 2009|Actual|2009-08-01||Observational|Position HTO||Position HTO Multicenter NIS|Study on Quality of Life in Patients With Unicompartmental Arthrosis After High Tibial Osteotomy With the Position HTO(R) System|Completed||N/A|221|Actual|Aesculap AG|||1||f||||f||||||||||2017-02-18 13:07:47.47401|2017-02-18 13:07:47.47401
NCT00889291|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2009-04-28|||December 2008||2008-12-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|PPS||HeRO Vascular Access Device Post Market Procedural Survey Protocol|HeRO Vascular Access Device Post Market Procedural Survey Protocol|Completed||N/A|77|Actual|Hemosphere, Inc.|||1||f||||f||||||||||2017-02-18 13:07:47.584475|2017-02-18 13:07:47.584475
NCT00889278|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-05-04|||February 2008||2008-02-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation|Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation|Active, not recruiting||N/A|42|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||Samples With DNA|"~     10cc Peripheral Blood~   "|||2017-02-18 13:07:47.677823|2017-02-18 13:07:47.677823
NCT00889265|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-26|2014-08-06|2014-05-05||June 2009||2009-06-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation|Prospective, Multi-Center Study of CopiOs® Pericardium Membrane With Puros® Cancellous Particulate Allograft for Localized Alveolar Ridge Augmentation|Completed||N/A|51|Actual|Zimmer Biomet||1|||f||||f||||||||||2017-02-18 13:07:47.762446|2017-02-18 13:07:47.762446
NCT00889252|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2015-02-18|2010-10-04||April 2009||2009-04-01|February 2015|2015-02-01||||July 2009|Actual|2009-07-01||Interventional|||Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers|A Single-Center, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study Evaluating the Safety of a Novel Contact Lens Used Daily in Healthy, Normal Volunteers|Completed||Phase 3|250|Actual|Vistakon Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:07:47.997066|2017-02-18 13:07:47.997066
NCT00889226|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2013-04-02|||April 2008||2008-04-01|April 2013|2013-04-01|January 2010|Actual|2010-01-01|May 2009|Actual|2009-05-01||Interventional|ESPRIT||Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia|A Randomized, Open Label, Dose Titration Study to Evaluate the Efficacy and Safety of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia|Completed||Phase 4|161|Actual|JW Pharmaceutical||2|||f||||t||||||||||2017-02-18 13:07:48.787582|2017-02-18 13:07:48.787582
NCT00889213|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2014-08-05|||August 2008||2008-08-01|August 2014|2014-08-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas|A Prospective Randomized Comparison of Pancreatic Stump Closure Techniques Utilizing an Autologous Falciform Patch and Fibrin Glue Compared to Standard Closure Following Distal Pancreatectomy With or Without Splenectomy|Unknown status|Recruiting|N/A|190|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 13:07:48.896547|2017-02-18 13:07:48.896547
NCT00889200|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-11-03|2013-08-21||May 2007||2007-05-01|November 2014|2014-11-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||Eszopiclone Treatment & Cortisol Responsivity|Eszopiclone Treatment & Cortisol Response to HPA Axis Tests|Completed||Phase 4|12|Actual|Butler Hospital||1|||f||||f||||||||||2017-02-18 13:07:49.14908|2017-02-18 13:07:49.14908
NCT00889187|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2012-08-15|||August 2009||2009-08-01|August 2012|2012-08-01||||September 2016|Anticipated|2016-09-01||Interventional|||Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer|Phase I/II Study of Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer|Terminated||Phase 1/Phase 2|10|Actual|Dana-Farber Cancer Institute||1||Excess toxicity was identified intraoperatively|f||||t||||||||||2017-02-18 13:07:49.397455|2017-02-18 13:07:49.397455
NCT00889174|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-25|2017-01-24|||April 23, 2009||2009-04-23|September 26, 2016|2016-09-26||||||||Observational|||The Nosology and Etiology of Leukodystrophies of Unknown Causes|Leukodystrophies of Unknown Cause|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:07:49.505562|2017-02-18 13:07:49.505562
NCT00889161|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2010-06-16|||May 2009||2009-05-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Curcumin in Pediatric Inflammatory Bowel Disease|Curcumin in Pediatric Inflammatory Bowel Disease: A Forced Dose Titration Study|Completed||Phase 1|11|Actual|Seattle Children's Hospital||1|||f||||||||||||||2017-02-18 13:07:49.612362|2017-02-18 13:07:49.612362
NCT00889148|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2011-02-28|||October 2007||2007-10-01|April 2009|2009-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|MOBILE||Morphine COnsumption in Joint Replacement Patients, With and Without GaBapentin Treatment, a RandomIzed ControlLEd Study|Multiple Doses of Gabapentin and Postoperative Morphine Consumption in Primary Hip Arthroplasty|Completed||N/A|103|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 13:07:49.709437|2017-02-18 13:07:49.709437
NCT00889135|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-10-14|||September 2004||2004-09-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Expanded Access|||Long Term Treatment With L-DOPS|Long Term Treatment With L-DOPS|Approved for marketing||N/A|||Vanderbilt University|||||||||||||||||||2017-02-18 13:07:49.830739|2017-02-18 13:07:49.830739
NCT00889122|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2010-08-03|||March 2009||2009-03-01|July 2010|2010-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Family Exergaming: A Research Study Testing a Videogame Intervention to Increase Physical Activity for Families|Family Exergaming: A Research Study Testing a Videogame Intervention to Increase Physical Activity for Families|Completed||N/A|213|Actual|Maine Medical Center||1|||f||||f||||||||||2017-02-18 13:07:49.919105|2017-02-18 13:07:49.919105
NCT00889109|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-26|2009-04-27|||July 2009||2009-07-01|April 2009|2009-04-01||||December 2009|Anticipated|2009-12-01||Observational|||Shoulder Proprioception Following Open and Arthroscopic Instability Repair|Proprioception of the Glenohumeral Joint Following Open and Arthroscopic Repair for Anterior Shoulder Instability|Unknown status|Not yet recruiting|N/A|45|Anticipated|Sheba Medical Center|||3||f||||t||||||||||2017-02-18 13:07:50.018384|2017-02-18 13:07:50.018384
NCT00889096|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2015-06-26||||||April 2009|2009-04-01||||||||Interventional|||Effects of Propranolol on the Encoding and Retrieval of Emotional Material After Single Dose Administration in Healthy Young Subjects|Effects of Propranolol on the Encoding and Retrieval of Emotional Material After Single Dose Administration in Healthy Young Subjects|Completed||Phase 1|46|Anticipated|University Medicine Greifswald||2|||f||||f||||||||||2017-02-18 13:07:50.121512|2017-02-18 13:07:50.121512
NCT00889083|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2011-06-30|||April 2009||2009-04-01|June 2011|2011-06-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Observational|||Hepatic Mitochondrial Function in Sepsis|Evaluation of Hepatic Mitochondrial Function in Sepsis|Unknown status|Recruiting|N/A|60|Anticipated|Institut d'Anesthesiologie des Alpes Maritimes|||2||f||||f||||||Samples With DNA|"~     Liver biopsies~   "|||2017-02-18 13:07:50.241126|2017-02-18 13:07:50.241126
NCT00889070|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2009-08-06|||November 2008||2008-11-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Respiratory Events Among Premature Infants|Respiratory Events Among Premature Infants (32-<36 w/GA) - Outcomes & Risk Tracking Study (The REPORT Study)|Completed||N/A|50|Anticipated|MedImmune LLC|||1||f||||f||||||||||2017-02-18 13:07:50.352074|2017-02-18 13:07:50.352074
NCT00889057|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2013-03-26|||January 2008||2008-01-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Sorafenib in Relapsed High Grade Osteosarcoma|Phase II, Open Label, Non-randomized Study of Second or Third Line Treatment With Sorafenib (BAY 43-9006) in Patients Affected by Relapsed High-grade Osteosarcoma.|Completed||Phase 2|35|Actual|Italian Sarcoma Group||1|||f||||||||||||||2017-02-18 13:07:50.455103|2017-02-18 13:07:50.455103
NCT00889044|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-26|2009-04-26|||April 2009||2009-04-01|April 2009|2009-04-01|June 2011|Anticipated|2011-06-01|December 2010|Anticipated|2010-12-01||Interventional|||Chewing Clopidogrel in Addition to Regular Oral Clopidogrel Treatment to Improve Platelets Aggregation in Patient With NON ST ELEVATION MI|Chewing Clopidogrel in Addition to Regular Oral Clopidogrel Treatment to Improve Platelets Aggregation in Patient With NON ST ELEVATION MI|Unknown status|Recruiting|Phase 3|30|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 13:07:50.574953|2017-02-18 13:07:50.574953
NCT00889031|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-05-04|||April 2009||2009-04-01|May 2016|2016-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Protocol to Obtain Blood Samples for Leukemia Research|Protocol to Obtain Blood Samples for Leukemia Research|Recruiting||N/A|50|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||Samples With DNA|"~     10cc of peripheral blood.~   "|||2017-02-18 13:07:50.676389|2017-02-18 13:07:50.676389
NCT00889018|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2012-02-07|||April 2009||2009-04-01|February 2012|2012-02-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma|Randomized Control Trial Comparing Carboplatin 560mg/m2 With 750mg/m2 for Ocular Salvage in Groups C and D Intraocular Retinoblastoma|Unknown status|Active, not recruiting|N/A|60|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 13:07:50.797592|2017-02-18 13:07:50.797592
NCT00889005|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-26|2012-12-03|||May 2009||2009-05-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Prevention of Post-traumatic Stress Disorder by Telephone Based Cognitive Behavioral Therapy|Prevention of Post-traumatic Stress Disorder by Telephone Based Cognitive Behavioral Therapy|Completed||N/A|200|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:07:50.911433|2017-02-18 13:07:50.911433
NCT00888992|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2015-04-02|||April 2010||2010-04-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|January 2013|Actual|2013-01-01||Interventional|TEQ||Technology-Enhanced Quitline Services to Prevent Smoking Relapse|Technology-Enhanced Quitline Services to Prevent Smoking Relapse|Completed||N/A|1785|Actual|Indiana University||3|||f||||f||||||||||2017-02-18 13:07:51.020237|2017-02-18 13:07:51.020237
NCT00888979|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-11-10|2015-07-10||April 2009||2009-04-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|May 2011|Actual|2011-05-01||Interventional|||Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy|Pilot Study of Nicotine Replacement for Smoking Cessation During Pregnancy|Completed||N/A|10|Actual|Hartford Hospital||1|||f||||f||||||||No||2017-02-18 13:07:51.124523|2017-02-18 13:07:51.124523
NCT00888966|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-25|2011-06-30|||April 2006||2006-04-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Observational|||Oxidative Stress and Cardiac Arrest|Evaluation of Oxidative Stress After Out of Hospital Cardiac Arrest Treated With Moderate Hypothermia|Completed||N/A|40|Anticipated|Institut d'Anesthesiologie des Alpes Maritimes|||1||f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 13:07:51.393475|2017-02-18 13:07:51.393475
NCT00888953|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2013-06-12|||May 2009||2009-05-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|EMERCOIR||Nursing Homes Study of Fall Risk Assessment Oriented to Intervention|Estudio de Medida Del Riesgo de Caídas Orientada a la Intervención en Residencias|Completed||N/A|331|Actual|Fundacio Salut i Envelliment UAB||2|||f||||f||||||||||2017-02-18 13:07:51.482068|2017-02-18 13:07:51.482068
NCT00888940|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-26|2015-07-21|2010-12-14||June 2009||2009-06-01|July 2015|2015-07-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|CONSERV-2||Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery|CONSERV - 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) - A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects Exposed to Cardio-pulmonary Bypass During Cardiac Surgery at High Risk of Bleeding|Completed||Phase 2|243|Actual|Cubist Pharmaceuticals LLC||2|||f||||t||||||||||2017-02-18 13:07:51.592461|2017-02-18 13:07:51.592461
NCT00888927|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2016-06-14||2013-08-26|May 2009||2009-05-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma|Open-Label, Multi-Center, Dose Escalation Phase 1/2 Study of Anti-CCR4 Monoclonal Antibody KW-0761 as Monotherapy in Subjects With Previously Treated Peripheral T-Cell Lymphoma|Completed||Phase 1/Phase 2|42|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||f||||||||||2017-02-18 13:07:52.236038|2017-02-18 13:07:52.236038
NCT00888914|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2013-10-25||2010-09-23|November 2008||2008-11-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines|A Phase 2, Double-Blind, Randomized, Parallel-Group, Controlled, Dose-Ranging, Multi-Center Study to Evaluate the Safety and Efficacy of RT001, a Botulinum Toxin Type A Topical Gel, to Treat Moderate to Severe Lateral Canthal Lines in Adults.|Completed||Phase 2|60|Actual|Revance Therapeutics, Inc.||5|||f||||f||||||||||2017-02-18 13:07:52.40669|2017-02-18 13:07:52.40669
NCT00888901|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2012-04-19|||May 2009||2009-05-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|PLATEFUN||Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag|Assessment of Platelet Function in Patients With Chronic Autoimmune Thrombocytopenic Purpura (cAITP) Treated With the Thrombopoietin Receptor (MPL) Agonist Eltrombopag.|Completed||Phase 4|30|Actual|Medical University of Vienna||3|||f||||f||||||||||2017-02-18 13:07:52.5077|2017-02-18 13:07:52.5077
NCT00888888|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2012-10-29|||April 2009||2009-04-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Colonic Resections in Patients With Suspected Appendicitis|Risk Factors for Colonic Resections in Patients With Suspected Acute Appendicitis|Completed||N/A|87|Actual|Cirujanos la Serena|||1||f||||f||||||||||2017-02-18 13:07:52.626321|2017-02-18 13:07:52.626321
NCT00888875|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2014-03-11|||July 2008||2008-07-01|March 2014|2014-03-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||ILMA Fastrach Versus I-gel for Fiberoptic Tracheal Intubation|Is Fiberoptic Intubation Through the I-gel™ Equal to Fiberoptic Intubation Through the Intubating Laryngeal Mask (Fastrach)™ ?|Completed||N/A|240|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 13:07:52.719156|2017-02-18 13:07:52.719156
NCT00888862|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2012-02-07|||June 2009||2009-06-01|April 2009|2009-04-01|October 2012|Anticipated|2012-10-01|June 2012|Anticipated|2012-06-01||Interventional|DVS||Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women|Desvenlafaxine Succinate in Major Depressive Disorder: Effects on Structural and Functional Imaging, Cognition, and Functional Outcomes in Midlife Women and Men|Unknown status|Recruiting|Phase 3|90|Anticipated|McMaster University||1|||f||||f||||||||||2017-02-18 13:07:52.822692|2017-02-18 13:07:52.822692
NCT00888849|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2011-11-30|2011-10-18||April 2009||2009-04-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|October 2010|Actual|2010-10-01||Interventional|Tiger||An Open-label, Randomized, Prospective Study of the Effectiveness, Safety, and Clinical Outcomes of Stapled Anastomoses Versus Hand-Sutured Anastomoses in Patients Undergoing Gastrointestinal End to End or Side to Side Anastomoses|An Open-label, Randomized, Prospective Study of the Effectiveness, Safety, and Clinical Outcomes of Stapled Anastomoses Versus Hand-Sutured Anastomoses in Patients Undergoing Gastrointestinal End to End or Side to Side Anastomoses|Completed||N/A|280|Actual|Ethicon Endo-Surgery||2|||f||||||||||||||2017-02-18 13:07:52.944517|2017-02-18 13:07:52.944517
NCT00888836|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2014-07-28|||April 2009||2009-04-01|July 2014|2014-07-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|DIBASY||Diet and Medical Therapy Versus Bariatric Surgery in Type 2 Diabetes|Prospective Randomized Controlled Trial on the Effect of Gastric Bypass and Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients With BMI > 35 vs. Medical Therapy|Completed||Phase 2/Phase 3|60|Actual|Catholic University of the Sacred Heart||3|||f||||f||||||||||2017-02-18 13:07:53.417853|2017-02-18 13:07:53.417853
NCT00888823|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2016-03-14|||March 2010||2010-03-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer|Multicentre, Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Early Stage Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|13|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 13:07:53.540102|2017-02-18 13:07:53.540102
NCT00888810|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-04-27|||March 2008||2008-03-01|April 2009|2009-04-01||||||||Interventional|TOPO-LAPA||Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer|A Phase II Study Evaluating the Association of Topotecan and Lapatinib in Early Recurrent (Less Than 12 Months)Ovarian or Peritoneal Cancer Patients After First Line of Platinum-Based Chemotherapy|Terminated||Phase 2|39|Actual|Centre Francois Baclesse||1||lack of efficacy (intermediate analysis)|f||||t||||||||||2017-02-18 13:07:53.636723|2017-02-18 13:07:53.636723
NCT00888797|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-26|2011-07-10|||January 2010||2010-01-01|July 2011|2011-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence|Perioperative β-adrenergic Blocker and a COX2 Inhibitor in Patients Undergoing Resection for Primary Colon and Rectal Cancer: Effect on Tumor Recurrence and Postoperative Immune Perturbations. A Multicenter Randomized Prospective Trial.|Unknown status|Recruiting|Phase 3|400|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 13:07:56.050713|2017-02-18 13:07:56.050713
NCT00888784|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-04-27|||August 2006||2006-08-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Secondary Prophylaxis Gastric Variceal Bleed|Endoscopic Cyanoacrylate Injection Versus Beta-Blockers for Secondary Prophylaxis of Gastric Variceal Bleed|Completed||N/A|64|Actual|Govind Ballabh Pant Hospital||2|||f||||f||||||||||2017-02-18 13:07:56.147618|2017-02-18 13:07:56.147618
NCT00888771|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2016-02-11|||August 2008||2008-08-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Observational|DISCARD||Discard:Characterisation of Colonic Polyps in Vivo|Characterisation of Small Colonic Polyps in Vivo|Completed||N/A|130|Actual|Imperial College London|||4||f||||f||||||||||2017-02-18 13:07:56.246821|2017-02-18 13:07:56.246821
NCT00888758|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2009-04-30|||May 2009||2009-05-01|April 2009|2009-04-01|May 2011|Anticipated|2011-05-01|January 2011|Anticipated|2011-01-01||Interventional|ROBUST||Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction|Randomized Comparison of Biolimus-Eluting and Everolimus-Eluting Stents With Optical Coherence Tomography Guided Stent Implantation in ST Elevation Myocardial Infarction.A 9-Month Angiographic and Optical Coherence Tomography Follow-up.|Unknown status|Not yet recruiting|Phase 4|400|Anticipated|Masaryk University||2|||f||||t||||||||||2017-02-18 13:07:56.333246|2017-02-18 13:07:56.333246
NCT00888745|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2010-11-29|||May 2009||2009-05-01|November 2010|2010-11-01||||June 2010|Actual|2010-06-01||Interventional|||A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis|Completed||Phase 1|65|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 13:07:56.446297|2017-02-18 13:07:56.446297
NCT00888732|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2011-04-27|||June 2009||2009-06-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin|A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 70 and 50 & Fast-acting Human Insulin in Patients With Type 1 Diabetes, A Randomised, Quadruple Crossover Trial|Completed||Phase 3|24|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 13:07:56.549636|2017-02-18 13:07:56.549636
NCT00888719|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2010-11-03|||February 2009||2009-02-01|November 2010|2010-11-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Therapeutic Exploratory Study of CWP-0403|A Prospective, Randomized, Double Blinded, Multicenter and Therapeutic Exploratory Study to Comparatively Assess Efficacy and Safety of CWP-0403 in Type 2 Diabetes Patients Who Are Insufficiently Controlled by Diet and Exercise.|Completed||Phase 2|145|Actual|JW Pharmaceutical||3|||f||||f||||||||||2017-02-18 13:07:56.673266|2017-02-18 13:07:56.673266
NCT00888706|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2009-04-27|||August 2002||2002-08-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Activities and Exercise on Sleep in Elderly Persons With Dementia|Effect of Activities and Exercise on Sleep in Dementia|Completed||Phase 2|355|Actual|National Institute of Nursing Research (NINR)||4|||f||||t||||||||||2017-02-18 13:07:56.778375|2017-02-18 13:07:56.778375
NCT00888693|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2010-12-05|||November 2008||2008-11-01|October 2010|2010-10-01||||December 2009|Actual|2009-12-01||Interventional|||A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia||Completed||Phase 1|81|Actual|Abbott||9|||f||||f||||||||||2017-02-18 13:07:57.069638|2017-02-18 13:07:57.069638
NCT00888680|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-27|2016-01-12||||||January 2016|2016-01-01||||||||Interventional|||Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine|A Multinational, Multi-centre, Randomised, Double-blind, Placebo-controlled, 3-way Crossover Study in Migraine Patients, Treated With Two Doses of BGC20-1531 and Placebo|Withdrawn||Phase 2|0|Actual|BTG International Inc.||3||No patients enrolled. Delay due to optimisation of drug product formulation.|f||||f||||||||||2017-02-18 13:07:57.173654|2017-02-18 13:07:57.173654
NCT00888667|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2013-06-07|||April 2009||2009-04-01|June 2013|2013-06-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Observational|SVT Morphology||Optimal EGM Configuration for Morphology Discrimination|Optimal EGM Configuration for Morphology Discrimination|Terminated||N/A|3|Actual|St. Jude Medical|||1|Patient population was not available|f||||f||||||||||2017-02-18 13:07:57.374174|2017-02-18 13:07:57.374174
NCT00888654|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2015-03-23|2015-03-23||August 2009||2009-08-01|March 2015|2015-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy|Phase II Trial of B-DIM (DIM: 3,3 Diindolylmethane) on Intermediate Endpoint Biomarkers in Patients With Prostate Cancer Who Are Undergoing Prostatectomy|Completed||Phase 2|39|Actual|Barbara Ann Karmanos Cancer Institute|There were no significant limitations.|1|||f||||f||||||||||2017-02-18 13:07:57.474882|2017-02-18 13:07:57.474882
NCT00888628|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-11-30|2015-05-13||May 2009||2009-05-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients|Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients|Completed||Phase 1/Phase 2|7|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-02-18 13:07:57.811984|2017-02-18 13:07:57.811984
NCT00888615|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2014-12-23|||December 2010||2010-12-01|December 2014|2014-12-01||||January 2016|Anticipated|2016-01-01||Interventional|||Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian,Fallopian Tube or Primary Peritoneal Cancer|Unknown status|Recruiting|Phase 2|55|Anticipated|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 13:07:58.144434|2017-02-18 13:07:58.144434
NCT00888602|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2012-12-19|||April 2009||2009-04-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study to Evaluate the Effects of Psyllium on Blood Glucose|An Open Label, Randomized, 4-Period Cross-over Study to Evaluate the Effects of Psyllium Taken Before a Meal on Postprandial Blood Glucose in Healthy Males|Completed||N/A|49|Actual|Procter and Gamble||4|||f||||f||||||||||2017-02-18 13:07:58.592058|2017-02-18 13:07:58.592058
NCT00888589|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2014-03-25|||May 2008||2008-05-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Detection of Aggressive Breast Tumors Using Tc-99m-NC100692|Improved Sensitivity for the Detection of Aggressive Breast Tumors Using 99mTc-NC100692 and a Dual-headed Small Field of View CZT Gamma Camera.|Completed||N/A|40|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 13:07:58.692371|2017-02-18 13:07:58.692371
NCT00888576|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2012-02-07|||December 2008||2008-12-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan|A Registry Study to Describe the Implications of Therapeutic Management of Etanercept in Patients With Rheumatoid Arthritis|Completed||N/A|441|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:07:58.777981|2017-02-18 13:07:58.777981
NCT00888563|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2017-01-24|||April 21, 2009||2009-04-21|July 22, 2016|2016-07-22||||||||Observational|||Fatigue in Healthy Individuals|Fatigue in Healthy Individuals|Completed||N/A|114|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:07:58.915453|2017-02-18 13:07:58.915453
NCT00888550|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2010-09-28|||August 2007||2007-08-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Splinting Versus Not Splinting of the Distal Lower Extremity After Intramedullary Nailing for Tibial Fractures|A Randomized Trial of Post-Operative Outcomes: Splinting Versus Not Splinting of the Distal Lower Extremity After Intramedullary Nailing for Tibial Fractures|Completed||N/A|20|Anticipated|Denver Health and Hospital Authority||2|||f||||||||||||||2017-02-18 13:07:59.008692|2017-02-18 13:07:59.008692
NCT00888537|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-03-18|||March 2009||2009-03-01|March 2016|2016-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Wiser Choices in Acute Myocardial Infarction|Wiser Choices in Acute Myocardial Infarction|Completed||N/A|107|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:07:59.09793|2017-02-18 13:07:59.09793
NCT00888524|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2009-04-24|||January 2006||2006-01-01|April 2009|2009-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|+DWR||Plus Deep Water Running on Low Back Pain|Evidence-Based Physiotherapy With and Without Deep Water Running on Non-Specific Low Back Pain. A Randomized Controlled Trial|Completed||N/A|46|Actual|University of Malaga||2|||f||||t||||||||||2017-02-18 13:07:59.199718|2017-02-18 13:07:59.199718
NCT00888511|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-05-19|||May 2009||2009-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|TARLAL||Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer|Concomitant Tarceva® and Irradiation in Patients in Local-regionally Advanced Non-small Cell Lung Cancer. A Phase II Study|Completed||Phase 2|15|Actual|Odense University Hospital||1|||f||||t||||||||||2017-02-18 13:07:59.304459|2017-02-18 13:07:59.304459
NCT00888498|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2015-07-01|||January 2009||2009-01-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|AMT||Ankle Manual Therapy for Ankle Sprains|Ankle Manual Therapy for Individuals With Post-Acute Ankle Sprains: A Randomized, Placebo-Controlled Trial|Suspended||Phase 2/Phase 3|189|Anticipated|University of the Pacific||3|||f||||f||||||||||2017-02-18 13:07:59.418253|2017-02-18 13:07:59.418253
NCT00888485|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2009-04-24|||May 1996||1996-05-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|SUPRIM||Randomized Trial of Behavioral Intervention Versus Standard Treatment|Secondary Prevention in Uppsala Primary Health Care After Myocardial Infarction, Coronary Artery CABG and PCI. Secondary Prevention After CHD (SUPRIM).|Completed||N/A|362|Actual|Uppsala University||2|||f||||f||||||||||2017-02-18 13:07:59.534531|2017-02-18 13:07:59.534531
NCT00888472|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2013-02-03|||November 2008||2008-11-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Efficacy of High-dose Leukocytapheresis Using a Large Filter in Refractory Asthma|Safety and Efficacy of High-dose Leukocytapheresis Using a Large Filter in Patients With Refractory Asthma|Completed||N/A|6|Actual|Gunma University||1|||f||||f||||||||||2017-02-18 13:07:59.627174|2017-02-18 13:07:59.627174
NCT00888459|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2011-07-14|2010-10-04||April 2008||2008-04-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Pilot Study Evaluating Nicotine Lozenges and Self Help|A Pilot Study to Assess the Effectiveness of the Nicotine Lozenge for Smokeless Tobacco Users|Completed||Phase 2|60|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:07:59.730353|2017-02-18 13:07:59.730353
NCT00888446|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-12-13|||October 2005||2005-10-01|December 2012|2012-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|TGC14F||Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid|Phase II, Placebo-controlled, Double-blind, Dose-escalation/Dose-optimization Trial to Evaluate Safety and Immunogenicity of tgAAC09, an HIV Vaccine Containing Clade C Gag-PR-ΔRT DNA in an Adeno-associated Virus (AAV) Capsid|Completed||Phase 2|91|Actual|International AIDS Vaccine Initiative||8|||f||||t||||||||||2017-02-18 13:08:00.066735|2017-02-18 13:08:00.066735
NCT00888433|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2015-05-04|2013-09-13||June 2009||2009-06-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|September 2010|Actual|2010-09-01||Interventional|HTN-2||Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)|Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)|Completed||N/A|106|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-02-18 13:08:00.208243|2017-02-18 13:08:00.208243
NCT00888420|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-10-19|||February 2008||2008-02-01|October 2015|2015-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||The Application of Performance Improvement Principles to the Patient Throughput Process in an Adult Outpatient Pain Treatment Clinic|The Application of Performance Improvement Principles to the Patient Throughput Process in an Adult Outpatient Pain Treatment Clinic|Completed||N/A|1221|Actual|University of Alabama at Birmingham|||2||f||||||||||||||2017-02-18 13:08:00.742705|2017-02-18 13:08:00.742705
NCT00888407|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-12-08|||September 2006||2006-09-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Community-based Hepatitis B Interventions for Hmong Adults|Community-based Hepatitis B Interventions for Hmong Adults|Completed||N/A|1500|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 13:08:00.83569|2017-02-18 13:08:00.83569
NCT00888394|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-07-23|||September 2009||2009-09-01|January 2013|2013-01-01|February 2013|Actual|2013-02-01|May 2010|Actual|2010-05-01||Interventional|EPOPLAPAIN||Effectiveness of Podiatry on Plantar Pain|Clinical Effectiveness of Quiropodiatry and Orthesis on Heel and Plantar Pain: Randomized Control Trial|Completed||Phase 4|312|Actual|University of Malaga||4|||f||||t||||||||||2017-02-18 13:08:00.949175|2017-02-18 13:08:00.949175
NCT00888381|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-07-17|2012-06-13||May 2009||2009-05-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers|A Phase IV, Single-centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2009/2010 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: 'Adults' (Aged ≥ 18 to < 60 Years) and 'Older Adults' (Aged ≥ 60 Years).|Completed||Phase 4|120|Actual|Seqirus||2|||f||||||||||||||2017-02-18 13:08:01.253345|2017-02-18 13:08:01.253345
NCT00888368|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-07-11|||January 2008||2008-01-01|July 2012|2012-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Accuracy of the Transpatellar Tendon Approach to Knee Arthrocentesis||Completed||N/A|20|Actual|Denver Health and Hospital Authority||2|||f||||||||||||||2017-02-18 13:08:01.697963|2017-02-18 13:08:01.697963
NCT00888355|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2009-07-02|2009-05-07||May 1992||1992-05-01|July 2009|2009-07-01|February 1993|Actual|1993-02-01|January 1993|Actual|1993-01-01||Interventional|||MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension|A Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Investigate the Antihypertensive Efficacy and Safety of Losartan Given Once or Twice Daily in Patients With Mild to Moderate Hypertension|Completed||Phase 3|428|Actual|Merck Sharp & Dohme Corp.|"Note that deaths are not entered under drop reasons in the participant flow panel because the patients who died are already counted as dropped due to adverse event."|4|||f||||||||||||||2017-02-18 13:08:01.786483|2017-02-18 13:08:01.786483
NCT00888342|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2012-05-15|||May 2009||2009-05-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD Patients|A Study of Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in Patients With COPD in Different Stages of the Disease, and the Effect of Alcohol, Supplementary Oxygen and Zopiclone on These Changes.|Completed||N/A|150|Actual|LHL Helse||3|||f||||f||||||||||2017-02-18 13:08:02.812362|2017-02-18 13:08:02.812362
NCT00888329|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2012-03-05|2012-02-01||July 2007||2007-07-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy|Prevention of Postoperative Nausea and Vomiting in a Gynecologic Surgery Population: A Randomized Placebo Controlled Trial of Aprepitant NK-1-receptor Antagonist|Terminated||Phase 4|256|Actual|Mayo Clinic|Results might have been influenced by selection bias.|2||Slow accrual.|f||||f||||||||||2017-02-18 13:08:02.925844|2017-02-18 13:08:02.925844
NCT00888316|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2013-06-11|||December 2008||2008-12-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Iron Overload in Patients Undergoing Donor Stem Cell Transplant|Iron Overload in Allogeneic Hematopoietic Cell Transplantation|Completed||Phase 1|112|Actual|Masonic Cancer Center, University of Minnesota|||2||f||||t||||||||||2017-02-18 13:08:03.2565|2017-02-18 13:08:03.2565
NCT00888303|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-09-01|||January 2009||2009-01-01|September 2012|2012-09-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Single Dose Steroid Before Thyroidectomy for Benign Disease to Improve Postoperative Nausea, Pain, and Vocal Function|Randomized Controlled Trial on Efficacy of Preemptive 8 mg of Dexamethasone for Reducing Pain and Postoperative Nausea and Vomit After Thyroidectomy for Benign Disease.|Unknown status|Recruiting|Phase 2|80|Anticipated|Ospedale Misericordia e Dolce||2|||f||||t||||||||||2017-02-18 13:08:03.376346|2017-02-18 13:08:03.376346
NCT00888290|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-02-12|||March 2009||2009-03-01|February 2015|2015-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects|Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects|Completed||Phase 2/Phase 3|20|Actual|Albert Einstein College of Medicine, Inc.||1|||f||||f||||||||||2017-02-18 13:08:03.482476|2017-02-18 13:08:03.482476
NCT00888277|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-10-31|||May 2009||2009-05-01|October 2013|2013-10-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Observational|||Bayer/Cognitive Assessments With Multiple Sclerosis Subjects|Neuropsychological Assessments in the Multiple Sclerosis Clinic|Completed||N/A|74|Actual|University of Louisville|||1||f||||f||||||||||2017-02-18 13:08:03.593382|2017-02-18 13:08:03.593382
NCT00888264|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2010-12-21|||May 2009||2009-05-01|December 2010|2010-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|HARMONY||A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder|A 6 Month Observational Multicentric Prospective Study Observing the Use of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder, in the Course of a Major Depressive Episode|Completed||N/A|152|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:08:03.68016|2017-02-18 13:08:03.68016
NCT00888251|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2011-09-21|||March 2009||2009-03-01|September 2011|2011-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Evaluation of a Weight Management Program|A Multicenter, Retrospective Study to Evaluate the Effectiveness of the OPTIFAST Weight Management Program|Completed||N/A|153|Actual|Nestlé|||1||f||||f||||||||||2017-02-18 13:08:03.804034|2017-02-18 13:08:03.804034
NCT00888238|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2015-04-24|2010-05-24||May 2009||2009-05-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)|A Randomized Clinical Trial to Evaluate Glucose-Dependent Insulinotropic Effects of a Single Dose of a DPP-4 Inhibitor in Lean Healthy Males|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:08:03.895748|2017-02-18 13:08:03.895748
NCT00888225|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2009-04-24|||October 2003||2003-10-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|January 2008|Actual|2008-01-01||Interventional|Epi-X||Tennis Elbow Trial|Chronic Lateral Epicondylitis. A Randomized Controlled Clinical Trial of Two Physical Training Concepts With Special Reference to Etiology and Treatment Effect|Completed||N/A|205|Actual|Uppsala University||2|||f||||f||||||||||2017-02-18 13:08:04.182795|2017-02-18 13:08:04.182795
NCT00888212|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2009-06-19|||June 2008||2008-06-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|MITOSIS||Minimally Invasive Techniques Or Surgery In the Diagnosis of Sarcoidosis|Minimally Invasive Techniques Or Surgery In the Diagnosis of Sarcoidosis (MITOSIS-Trial)|Completed||N/A|100|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 13:08:04.290643|2017-02-18 13:08:04.290643
NCT00888199|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2009-04-24|||January 2010||2010-01-01|April 2009|2009-04-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Clinical Trial of Tensegrity Prosthetics K3 Promoter Foot Prosthesis|Clinical Trial of Tensegrity Prosthetics K3 Promoter Foot Prosthesis|Unknown status|Not yet recruiting|Phase 2/Phase 3|80|Anticipated|Tensegrity Prosthetics||2|||f||||t||||||||||2017-02-18 13:08:04.586554|2017-02-18 13:08:04.586554
NCT00888186|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2009-04-24|||February 2008||2008-02-01|April 2009|2009-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|DYSK-PD-2007||Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics|Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics|Completed||Phase 4|5|Actual|Uppsala University||5|||f||||t||||||||||2017-02-18 13:08:04.695766|2017-02-18 13:08:04.695766
NCT00888173|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-03-16|||July 2009||2009-07-01|March 2016|2016-03-01||||January 2014|Actual|2014-01-01||Interventional|||Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Brivanib (BMS582664), an Oral, Multitargeted Growth Factor Tyrosine Kinase Inhibitor in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Active, not recruiting||Phase 2|45|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 13:08:04.820951|2017-02-18 13:08:04.820951
NCT00888160|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2016-03-15|||September 2010||2010-09-01|March 2016|2016-03-01||||September 2030|Anticipated|2030-09-01||Observational|||Timing of Orthopaedic Surgery in the Multiply-injured Patient: Development of a Protocol for Early Appropriate Care|Timing of Orthopaedic Surgery in the Multiply-injured Patient: Development of a Protocol for Early Appropriate Care|Active, not recruiting||N/A|500|Anticipated|MetroHealth Medical Center|||1||f||||f||||||||||2017-02-18 13:08:04.967206|2017-02-18 13:08:04.967206
NCT00888147|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-24|2011-09-23|||April 2009||2009-04-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Fiber Formula Study Among Radiation Oncology Patients|"Pilot Study: Does Using a Fiber Containing Enteral Tube Feeding Formula Increase Constipation and the Use of Stool Softeners in Patients Undergoing Radiation Therapy and Have a Percutaneous Endoscopic Gastrostomy (PEG) Placed?"|Completed||N/A|19|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 13:08:05.04108|2017-02-18 13:08:05.04108
NCT00888134|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-12-10|2015-12-10||July 2009||2009-07-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Selumetinib in Cancers With BRAF Mutations|Phase II Clinical Trial of the MEK 1/2 Inhibitor AZD6244 in Cancers With BRAF Mutations Identified by Prospective Genotypic Analysis|Completed||Phase 2|28|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 13:08:05.157655|2017-02-18 13:08:05.157655
NCT00888108|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-05-18|||July 2009||2009-07-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer|A Phase 1 Safety and Pharmacokinetic Study of ABT-263 in Combination With Taxotere® (Docetaxel) in the Treatment of Subjects With Solid Tumors|Completed||Phase 1|41|Actual|Abbott||1|||f||||||||||||||2017-02-18 13:08:05.622583|2017-02-18 13:08:05.622583
NCT00888095|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2009-07-21|||July 2010||2010-07-01|July 2009|2009-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Deep Brain Stimulation (DBS) For Parkinson's Disease: Caudal Zona Incerta Versus Subthalamic Nucleus|The Clinical Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus (STN-DBS) Versus Bilateral Deep Brain Stimulation of the Caudal Zona Incerta (cZI-DBS) in Patients With Idiopathic Parkinson's Disease|Unknown status|Not yet recruiting|N/A|70|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 13:08:05.729016|2017-02-18 13:08:05.729016
NCT00888082|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2010-12-09||||||December 2010|2010-12-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|PROOF||Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy|Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study|Withdrawn||Phase 3|102|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:08:05.836234|2017-02-18 13:08:05.836234
NCT00888069|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-09-29|||May 2009||2009-05-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects|A Randomized, Open-Label, Single-Dose Pilot Study of Oral and i.v. CTAP101 Evaluating PK and Safety in Stage 3 and 4 CKD Subjects With Vitamin D Insufficiency and SHPT|Completed||Phase 1|28|Actual|OPKO Health, Inc.||3|||f||||f||||||||||2017-02-18 13:08:05.952846|2017-02-18 13:08:05.952846
NCT00888056|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-06-26|||June 2009||2009-06-01|April 2009|2009-04-01||||||||Interventional|||Chronic Electrical Stimulation of Hypothalamus/Fornix in Alzheimer's Disease|Effect of Deep Brain Stimulation of the Hypothalamus/ Fornix on Memory Impairment in Patients With Alzheimer's Disease|Unknown status|Recruiting|Phase 1/Phase 2|5|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||t||||||||||2017-02-18 13:08:06.073107|2017-02-18 13:08:06.073107
NCT00888043|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-03-10|||March 2009||2009-03-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|CNTO95/Avastin||Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors|A Phase I/Biomarker Study of Bevacizumab in Combination With CNTO 95 in Patients With Refractory Solid Tumors|Completed||Phase 1|13|Actual|Duke University||1|||f||||f||||||||||2017-02-18 13:08:06.16658|2017-02-18 13:08:06.16658
NCT00888030|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2012-09-05|||May 2006||2006-05-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||P-cresol: Correlation With Glomerular Filtration Rate and Outcome in Chronic Kidney Disease||Completed||N/A|300|Actual|Chang Gung Memorial Hospital|||4||f||||t||||||Samples Without DNA|"~     Serum level of p-cresol and indoxyl sulfate~   "|||2017-02-18 13:08:06.275654|2017-02-18 13:08:06.275654
NCT00888017|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2013-01-22|||April 2009||2009-04-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|PPI||Proton Pump Inhibitor Therapy and Bone Density in Premature Infants|Proton Pump Inhibitor Therapy and Bone Density in Premature Infants|Terminated||N/A|10|Actual|University of Utah|||2|Slow enrollment|f||||f||||||||||2017-02-18 13:08:06.377427|2017-02-18 13:08:06.377427
NCT00888004|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-04-15|||March 2009||2009-03-01|April 2016|2016-04-01||||August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients|A Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multiple Oral Dose Study to Assess the Efficacy and Tolerability of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Patients With Severe L-dopa Induced Dyskinesias|Completed||Phase 2|28|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:08:06.485805|2017-02-18 13:08:06.485805
NCT00887991|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2009-04-23|||February 2009||2009-02-01|April 2009|2009-04-01|February 2010|Anticipated|2010-02-01|July 2009|Anticipated|2009-07-01||Observational|||A Trial Comparing Two Breast Pumps in Mothers Expressing Milk for Their Preterm Infants|Randomised Trial Comparing the Efficacy of the ISIS Duo iQ Electric Breast Pump and the Medela Symphony Electric Breast Pump in Mothers Expressing Breast Milk for Preterm Infants|Unknown status|Recruiting|N/A|176|Anticipated|Institute of Child Health|||2||f||||||||||||||2017-02-18 13:08:06.59715|2017-02-18 13:08:06.59715
NCT00887978|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-12-07|2012-11-02||June 2009||2009-06-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|FREEDOM-C2||Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension|A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 3|310|Actual|United Therapeutics||2|||f||||t||||||||||2017-02-18 13:08:06.70404|2017-02-18 13:08:06.70404
NCT00887965|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2013-10-23|2011-06-30||June 2009||2009-06-01|October 2013|2013-10-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab|A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab|Completed||Phase 2|15|Actual|Amgen||1|||f||||f||||||||||2017-02-18 13:08:08.044575|2017-02-18 13:08:08.044575
NCT00887952|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2009-12-29|||August 2005||2005-08-01|April 2009|2009-04-01|November 2010|Anticipated|2010-11-01|November 2008|Actual|2008-11-01||Interventional|PRCD||Partial Removal of Caries Dentines|Alternative Treatment of Deep Caries Lesions Based on Biological Evidences|Unknown status|Active, not recruiting|N/A|329|Actual|Federal University of Rio Grande do Sul||2|||f||||f||||||||||2017-02-18 13:08:08.532178|2017-02-18 13:08:08.532178
NCT00887939|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2017-01-24|||April 21, 2009||2009-04-21|May 16, 2016|2016-05-16||||||||Observational|||Pathogenesis of Physical Induced Urticarial Syndromes|Pathogenesis of Physical Induced Urticarial Syndromes|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:08:08.653801|2017-02-18 13:08:08.653801
NCT00887926|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-02-24|||June 2009||2009-06-01|February 2012|2012-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Study of EB10 in Patients With Leukemia|An Open-label, Dose Escalation, Phase I Study of IMC-EB10 in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Terminated||Phase 1|26|Actual|ImClone LLC||1||Lack of efficacy|f||||f||||||||||2017-02-18 13:08:08.761801|2017-02-18 13:08:08.761801
NCT00887913|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2010-11-02|2010-10-06||April 2008||2008-04-01|November 2010|2010-11-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction|Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction|Completed||N/A|69|Actual|Syneron Medical||1|||f||||f||||||||||2017-02-18 13:08:08.877394|2017-02-18 13:08:08.877394
NCT00887900|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2009-04-23|||January 2006||2006-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|DALK||Deep Anterior Lamellar Keratoplasty (DALK)|Deep Anterior Lamellar Keratoplasty by Big-Bubble Technique: Results and Complications|Completed||Phase 3|40|Actual|Hospital Oftalmologico de Brasilia||2|||f||||t||||||||||2017-02-18 13:08:09.116939|2017-02-18 13:08:09.116939
NCT00887887|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-10-13|||January 2008||2008-01-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|June 2010|Actual|2010-06-01||Observational|||The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery|The Association Between Gene Polymorphisms in the Innate Immune Response and the Risk of Infectious Complications and Liver Failure After Partial Hepatic Resection|Completed||N/A|100|Actual|Maastricht University Medical Center|||1||f||||t||||||Samples With DNA|"~     whole blood, fresh frozen liver tissue~   "|||2017-02-18 13:08:09.264149|2017-02-18 13:08:09.264149
NCT00887874|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-11-21|||May 2009||2009-05-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|DiabCare Asia||A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan|DiabCare Asia 2008. A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Asia.|Completed||N/A|2370|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"~     Capillary or venous blood will be drawn for analysing HbA1c.~   "|||2017-02-18 13:08:09.366544|2017-02-18 13:08:09.366544
NCT00887861|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2011-02-22|||March 2009||2009-03-01|February 2011|2011-02-01||||August 2010|Actual|2010-08-01||Interventional|||Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery|A Multicenter, Double-blind, Randomized, Placebo-controlled, Two-arm Parallel-group Study of BGG492 as Monotherapy in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery|Completed||Phase 2|37|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:08:09.476679|2017-02-18 13:08:09.476679
NCT00887848|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-09-16|||May 2009||2009-05-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|PeLoGAIT||Effectiveness of Robotic Assisted Gait Training in Children With Cerebral Palsy|Effectiveness of Robotic Assisted Gait Training in Children With Cerebral Palsy: A Randomized Controlled Clinical Trial Including 3D Gait Analysis|Recruiting||N/A|34|Anticipated|University Children's Hospital, Zurich||2|||f||||f||||||||Undecided||2017-02-18 13:08:09.588454|2017-02-18 13:08:09.588454
NCT00887835|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-04-25|||April 2009||2009-04-01|April 2009|2009-04-01||||October 2010|Anticipated|2010-10-01||Interventional|||A Post-Market Study of Transfacet Lumbar Spine Fixation and Fusion Utilizing the PERPOS™ PLS System|A Post-Market Study of Transfacet Lumbar Spine Fixation and Fusion Utilizing the PERPOS™ PLS System|Withdrawn||N/A|0|Actual|Interventional Spine, Inc.||1|||f||||f||||||||||2017-02-18 13:08:09.715564|2017-02-18 13:08:09.715564
NCT00887822|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-09-01|||March 2009||2009-03-01|September 2016|2016-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer|A Double-blind, Randomised, Multicenter, Phase III Study of Bevacizumab in Combination With Capecitabine and Cisplatin Versus Placebo in Combination With Capecitabine and Cisplatin, as First-line Therapy in Chinese Patients With Advanced Gastric Cancer.|Completed||Phase 3|202|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:08:09.81189|2017-02-18 13:08:09.81189
NCT00887809|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-12-21|2015-12-21||April 2009||2009-04-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes|Phase II Trial Of Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes|Completed||Phase 2|47|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:08:09.936394|2017-02-18 13:08:09.936394
NCT00887783|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-05-19|||May 2009||2009-05-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|August 2012|Actual|2012-08-01||Interventional|NARLAL||Navelbine And Radiotherapy in Locally Advanced Lung Cancer|Induction Chemotherapy With Carboplatin and Navelbine Oral(R) Followed by Concomitant Navelbine Oral(R) and Irradiation in Local-regionally Advanced Non-small Cell Lung Cancer. A Randomized Phase II Study.|Active, not recruiting||Phase 2|114|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-02-18 13:08:10.369667|2017-02-18 13:08:10.369667
NCT00887770|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2009-07-15|||April 2009||2009-04-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|||||Interventional|||A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart|A Single-centre, Double-blind, Double-dummy, Randomised, Placebo-controlled, Four-period Crossover Study to Assess the Effect of Single Oral Doses of AZD5672 (600 mg and 150 mg) on QT/QTc Interval, Compared to Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers|Completed||Phase 1|64|Anticipated|AstraZeneca||4|||f||||f||||||||||2017-02-18 13:08:10.492805|2017-02-18 13:08:10.492805
NCT00887757|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2011-12-21|||September 2009||2009-09-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors|A Phase 1 Safety and Pharmacokinetic Study of ABT-263 in Combination With Gemzar® (Gemcitabine) in the Treatment of Subjects With Solid Tumors|Completed||Phase 1|46|Actual|Abbott||1|||f||||||||||||||2017-02-18 13:08:10.606168|2017-02-18 13:08:10.606168
NCT00887744|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-01-26|2011-04-11||November 2006||2006-11-01|January 2016|2016-01-01|March 2010|Actual|2010-03-01|May 2009|Actual|2009-05-01||Interventional|INCA||Intermittent Neurogenic Claudication Treatment With APERIUS®|A Multicenter, Post Marketing Clinical Follow-up Study to Evaluate the Safety and Effectiveness of the Minimally Invasive Device APERIUS® in Degenerative Lumbar Spinal Stenosis With Symptomatic Neurogenic Intermittent Claudication|Completed||Phase 4|162|Actual|Medtronic Spinal and Biologics||1|||f||||f||||||||||2017-02-18 13:08:10.719368|2017-02-18 13:08:10.719368
NCT00887731|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-09-10|||August 2009||2009-08-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care|Clinical Evaluation of a Closed Loop Oxygen Controller for Neonatal Respiratory Care|Terminated||N/A|20|Actual|University of Utah|||3|slow enrollment|f||||f||||||||||2017-02-18 13:08:11.118062|2017-02-18 13:08:11.118062
NCT00887718|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-12-17|||August 2007||2007-08-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Positron Emission Tomography(PET) in Lymphoma Assessment|Positron Emission Tomography for Staging, and Treatment Assessment of Response in Lymphomas (the Pet-star Lymphoma Study)|Completed||N/A|103|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 13:08:11.212041|2017-02-18 13:08:11.212041
NCT00887705|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2010-06-22|||May 2009||2009-05-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Activities of Daily Living (ADL)-Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|24|Actual|LHL Helse||2|||f||||f||||||||||2017-02-18 13:08:11.312952|2017-02-18 13:08:11.312952
NCT00887692|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2010-10-18|||July 2009||2009-07-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy|Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy|Completed||N/A|10|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 13:08:11.413524|2017-02-18 13:08:11.413524
NCT00887679|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-10-23|2012-11-19||May 2009||2009-05-01|March 2014|2014-03-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS|Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder, Adherence to Antiretroviral Therapy,Cognition, and Immune Status Among Patients With HIV and AIDS: A 6-week Open-label, Prospective, Pilot Trial.|Completed||Phase 3|30|Actual|Duke University||1|||f||||f||||||||||2017-02-18 13:08:11.506291|2017-02-18 13:08:11.506291
NCT00887666|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2009-04-23|||October 2007||2007-10-01|April 2009|2009-04-01||||||||Observational|||Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure|Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure|Unknown status|Recruiting|N/A|40|Anticipated|State University of New York - Downstate Medical Center|||1||f||||f||||||||||2017-02-18 13:08:11.78852|2017-02-18 13:08:11.78852
NCT00887653|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-10-08|2014-09-19||May 2009||2009-05-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|June 2012|Actual|2012-06-01||Interventional|||Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy|Changes in Lipid Profiles and Safety of Raltegravir Based Antiretroviral Therapy in HIV-1-infected Patients With Hyperlipidemia While on Current Standard Therapy|Completed||Phase 3|20|Actual|The Miriam Hospital||1|||f||||t||||||||||2017-02-18 13:08:12.05853|2017-02-18 13:08:12.05853
NCT00887640|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-01-24|2013-09-04||July 2009||2009-07-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer|Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer|Terminated||Phase 2|11|Actual|Duke University||1|||f||||t||||||||||2017-02-18 13:08:12.360741|2017-02-18 13:08:12.360741
NCT00887627|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-04-30|||April 2009||2009-04-01|April 2014|2014-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function|A Phase 1, Open-Label Study to Assess the Effects of Renal Impairment on the Pharmacokinetics of Intravenous Conivaptan|Completed||Phase 1|25|Actual|Cumberland Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:08:12.764686|2017-02-18 13:08:12.764686
NCT00887614|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2011-10-01|||July 2009||2009-07-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Mindfulness, Emotional Well-being, and Sleep Quality|Mechanisms of Mindfulness: Effects on Sleep Quality, Stress Physiology and CVD Risk|Completed||N/A|372|Actual|Duke University||1|||f||||t||||||||||2017-02-18 13:08:12.882375|2017-02-18 13:08:12.882375
NCT00887601|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-07-29|||August 2007||2007-08-01|July 2015|2015-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)|A 4-Period, Placebo-Controlled, Crossover Study to Evaluate the Utility and Feasibility of BOLD fMRI and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (Donepezil and MK3134)|Completed||Phase 1|32|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:08:12.999433|2017-02-18 13:08:12.999433
NCT00887588|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2015-08-12|2015-07-16||November 2009||2009-11-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction|A 36-week, Randomized, Double-blind, Multi-center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction|Completed||Phase 2|307|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:08:13.119782|2017-02-18 13:08:13.119782
NCT00887575|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-09-02|2014-11-21||June 2009||2009-06-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|July 2013|Actual|2013-07-01||Interventional||Between June 2009 and July 2012, 54 patients were enrolled (15 in phase I and 39 additional patients in phase II). Three patients were later found to be ineligible and were excluded from the analysis. An additional patient did not receive any study treatment and is also excluded from the analysis.|Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer|Phase I/II Trial of Neoadjuvant Sunitinib Administered With Weekly Paclitaxel/Carboplatin in Patients With Locally Advanced Triple-Negative Breast Cancer|Completed||Phase 1/Phase 2|54|Actual|SCRI Development Innovations, LLC||3|||f||||f||||||||||2017-02-18 13:08:14.249013|2017-02-18 13:08:14.249013
NCT00887562|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-09-20|2015-12-17||May 2009||2009-05-01|September 2016|2016-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|MELAS||Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes|A Phase IIa Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like Episodes|Completed||Phase 2|27|Actual|Columbia University|Clinical variability in severity of disease among participants|3|||f||||f||||||||No||2017-02-18 13:08:14.780857|2017-02-18 13:08:14.780857
NCT00887549|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2012-06-07|2011-07-29||April 2009||2009-04-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|||A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer|An Exploratory, Prospective Phase II Study to Investigate Progression-Free Survival, Response and Overall Survival Seen With Pemetrexed/Cisplatin and the Role of Thymidylate Synthase Expression|Completed||Phase 2|70|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 13:08:15.553101|2017-02-18 13:08:15.553101
NCT00887536|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-06-24|||May 2009||2009-05-01|June 2015|2015-06-01|January 2022|Anticipated|2022-01-01|December 2017|Anticipated|2017-12-01||Interventional|||A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer|A Phase III Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer|Active, not recruiting||Phase 3|3900|Anticipated|NSABP Foundation Inc||3|||f||||t||||||||||2017-02-18 13:08:18.328792|2017-02-18 13:08:18.328792
NCT00887523|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-06-02|||July 2009||2009-07-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis|Randomized Controlled Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis|Recruiting||N/A|84|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:08:19.391064|2017-02-18 13:08:19.391064
NCT00887510|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-06-12|2013-06-10||May 2007||2007-05-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|MEAD||Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)|Metabolic Effects of Antihypertensive Drugs|Completed||Phase 4|24|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 13:08:19.499101|2017-02-18 13:08:19.499101
NCT00887497|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2011-09-26|||April 2009||2009-04-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Ischemic Conditioning (Delay Phenomenon) in Colorectal Surgery|Ischemic Conditioning (Delay Phenomenon) in Colorectal Surgery|Terminated||Phase 4|10|Anticipated|University of California, Irvine||1||terminated due to failure to enroll patients after two years of approval|f||||t||||||||||2017-02-18 13:08:20.029238|2017-02-18 13:08:20.029238
NCT00887484|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-10-28|2010-09-22||February 2009||2009-02-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne|A Single-blind, Randomized, Comparative Pilot Study Evaluating the Tolerability of Two Topical Combination Therapies in the Treatment of Acne Vulgaris|Completed||Phase 4|50|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:08:20.13703|2017-02-18 13:08:20.13703
NCT00887471|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2013-12-20|2012-06-06||August 2006||2006-08-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Observational|||Comparison of Sleep Study Results After Partial Intracapsular Tonsillectomy Versus Total Tonsillectomy|Comparison of Polysomnography Outcomes for Microdebrider-assisted Partial Intracapsular Tonsillectomy Versus Total Tonsillectomy|Completed||N/A|30|Actual|State University of New York - Downstate Medical Center|Selection bias, sample size limitation as it the study was not powered to detect small differences between the groups, and the use of unattended home PSG instead of laboratory-based PSG.||2||f||||f||||||||||2017-02-18 13:08:21.398916|2017-02-18 13:08:21.398916
NCT00887458|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2014-01-28|2013-12-11||July 2009||2009-07-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|May 2011|Actual|2011-05-01||Interventional|||A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy|A Randomized Phase II Clinical Trial of Two Dose-levels of Itraconazole in Patients With Metastatic Castration-resistant Prostate Cancer|Completed||Phase 2|46|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 13:08:21.810748|2017-02-18 13:08:21.810748
NCT00887445|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2010-04-27|||July 2008||2008-07-01|April 2010|2010-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||First in Man Study With SLV341|A Double-blind, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SLV341 in Young Healthy Male Subjects|Terminated||Phase 1|87|Actual|Solvay Pharmaceuticals||2||The study was terminated on June 25th, 2009 due to strategic decision|f||||f||||||||||2017-02-18 13:08:22.397908|2017-02-18 13:08:22.397908
NCT00887432|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-10-11|||April 2009||2009-04-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation|Randomized Placebo-Controlled, Double-Blind Study of Cholecalciferol Replacement in Patients on Expectant Management for Localized Prostate Cancer|Recruiting||N/A|100|Anticipated|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-02-18 13:08:22.503687|2017-02-18 13:08:22.503687
NCT00887419|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2015-03-24|||November 2008||2008-11-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|SCS||Spinal Cord Stimulator Implant Study|Pain Coping Skills Training for Spinal Cord Stimulator Implant Candidates|Completed||N/A|101|Actual|Duke University||3|||f||||f||||||||||2017-02-18 13:08:22.643236|2017-02-18 13:08:22.643236
NCT00887406|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-10-24|||November 2005||2005-11-01|October 2016|2016-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of GSK961081 in Healthy Volunteer Subjects|A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetic Profile and Pharmacodynamics of Single and Repeat Inhaled Doses of GSK961081 in Healthy Subjects|Completed||Phase 1|46|Actual|GlaxoSmithKline||10|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:08:22.756379|2017-02-18 13:08:22.756379
NCT00887393|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-06-17|||April 2009||2009-04-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates|Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates|Completed||N/A|31|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 13:08:22.890765|2017-02-18 13:08:22.890765
NCT00887380|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2017-01-22|||September 2009||2009-09-01|January 2017|2017-01-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|STARS||STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)|A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-oestrogen Therapy Delayed Until After Radiotherapy.|Active, not recruiting||Phase 3|2023|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||t||||||||||2017-02-18 13:08:22.989277|2017-02-18 13:08:22.989277
NCT00887367|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2010-09-03|||September 2008||2008-09-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||EtOH Interaction Study|A Study to Investigate Potential Interactions Between GSK598809 and Ethanol in Healthy Subjects|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 13:08:23.140304|2017-02-18 13:08:23.140304
NCT00887354|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-23|2016-11-11|2016-07-15||April 2009||2009-04-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MOVE|Full Analysis Set (FAS): All randomized participants who received at least one dose of study drug and with at least one post-baseline efficacy measure.|A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture|Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine BMD (Bone Mineral Density) in Men and Postmenopausal Women With Low Bone Mass and a Recent Pertrochanteric Hip Fracture|Completed||Phase 4|224|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 13:08:23.25892|2017-02-18 13:08:23.25892
NCT00887341|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2014-10-20|2014-06-26||May 2009||2009-05-01|October 2014|2014-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||Intent-to-treat (ITT) Population: all participants enrolled in the study who had been randomly assigned to one of the two study treatments and received at least one dose of study drug.|A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis|Phase II Multi-centre, Randomized, Parallel Group, Pilot Trial to Compare the Incidence of Tocilizumab Related Infusion Reactions in Moderate to Severe RA Patients When Infusion is Made Over 1 Hour Against 31 Minutes|Completed||Phase 2|76|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:08:24.601369|2017-02-18 13:08:24.601369
NCT00887328|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-09-21|||June 2010||2010-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|EXTEND||Extending the Time for Thrombolysis in Emergency Neurological Deficits|Extending the Time for Thrombolysis in Emergency Neurological Deficits|Recruiting||Phase 3|400|Anticipated|Neuroscience Trials Australia||2|||f||||t||||||||||2017-02-18 13:08:25.499621|2017-02-18 13:08:25.499621
NCT00882648|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2013-02-19|||April 2009||2009-04-01|February 2013|2013-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||The Effect of Fetal Gender on Maternal Substance Abuse Treatment|The Effect of Fetal Gender on Maternal Substance Abuse Treatment|Completed||N/A|850|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 13:10:07.213951|2017-02-18 13:10:07.213951
NCT00887315|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-11-13|2013-06-24||April 2009||2009-04-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|SMART||The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)|A Randomized Phase II Trial of Docetaxel, Cisplatin, and Hypofractionated Radiotherapy Versus Docetaxel and Cisplatin for Limited Volume Stage IV Non-small Cell Lung Cancer: The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial|Terminated||Phase 2|11|Actual|University of Chicago|Funding was withdrawn before conclusions were reached so the study was terminated and no data was collected and analyzed.|2||Slow accrual and loss of sponsor|f||||t||||||||||2017-02-18 13:08:25.677951|2017-02-18 13:08:25.677951
NCT00887302|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2009-04-22|||May 2009||2009-05-01|April 2009|2009-04-01||||June 2010|Anticipated|2010-06-01||Observational|J&J Ethicon||Metabolics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy|Johnson and Johnson Ethicon Metabolics of RYGB With Gastrostomy|Unknown status|Not yet recruiting|N/A|120|Anticipated|East Carolina University|||3||f||||f||||||||||2017-02-18 13:08:26.017038|2017-02-18 13:08:26.017038
NCT00887289|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2014-06-17|2010-10-12||April 2009||2009-04-01|March 2014|2014-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Non-interventional Observational Study on the Influence of Pramipexole on Sensory Symptoms of Restless Legs Syndrome (RLS)|Non-interventional Observational Study on the Influence of Pramipexole (PPX) on Sensory Symptoms of Restless Legs Syndrome (RLS)|Completed||N/A|1504|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 13:08:26.11766|2017-02-18 13:08:26.11766
NCT00887276|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2014-12-16|||November 2008||2008-11-01|January 2010|2010-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|PENCAP||Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia|Prospective, Doubleblind, Randomized Multicenter Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia|Terminated||Phase 4|290|Actual|University of Ulm||2|||f||||f||||||||||2017-02-18 13:08:27.644325|2017-02-18 13:08:27.644325
NCT00887263|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-01-20|||March 2009||2009-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)|Double-blind, Randomised, Placebo-controlled Multicentre Phase III Clinical Study Followed by Open-label Phase on the Efficacy and Tolerability of Budesonide 3 mg Effervescent Tablet in Patients With Resistant Oral Chronic GvHD|Completed||Phase 3|186|Actual|Dr. Falk Pharma GmbH||2|||f||||t||||||||||2017-02-18 13:08:27.767988|2017-02-18 13:08:27.767988
NCT00887250|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2009-07-08|2009-05-07||December 1991||1991-12-01|July 2009|2009-07-01|November 1992|Actual|1992-11-01|August 1992|Actual|1992-08-01||Interventional|||A Study to Investigate the Antihypertensive Efficacy of MK0954|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan (MK954, DuP753) in Patients With Mild to|Completed||Phase 3|366|Actual|Merck Sharp & Dohme Corp.|Safety has been reported in the literature.|3|||f||||||||||||||2017-02-18 13:08:27.951298|2017-02-18 13:08:27.951298
NCT00887237|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-07-03|||May 2009||2009-05-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|TRIV||Triple Site Ventricular Stimulation for Cardiac Resynchronization Therapy (CRT) Candidates|Triple Site Ventricular Stimulation for CRT Candidates|Completed||Phase 3|76|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||t||||||||||2017-02-18 13:08:28.547372|2017-02-18 13:08:28.547372
NCT00887224|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2014-11-06|2012-03-06||June 2009||2009-06-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder|A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal, Parallel Group Study To Evaluate The Efficacy And Safety Of 50 mg/Day Of DVS SR In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|874|Actual|Pfizer|P-value from the primary analysis is different from the one testing equality of relapse rates on Double-blind day 185. Estimated percentages were provided as representative descriptive measures. Medians were not estimable due to low relapse rates.|2|||f||||f||||||||||2017-02-18 13:08:28.675592|2017-02-18 13:08:28.675592
NCT00887211|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-29|||October 2008||2008-10-01|April 2009|2009-04-01|March 2010|Anticipated|2010-03-01|February 2010|Anticipated|2010-02-01||Interventional|Prostent||ProStent Coronary Drug-Eluting Stent|Clinical Trial Program of a Medical Instrument Product|Unknown status|Recruiting|N/A|290|Anticipated|CCRF Consulting Co., Ltd.||2|||f||||t||||||||||2017-02-18 13:08:30.447659|2017-02-18 13:08:30.447659
NCT00887198|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2016-09-30|2015-03-30||April 2009||2009-04-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|March 2014|Actual|2014-03-01||Interventional||Analysis population included all the randomized participants who were classified according to their assigned treatment group, regardless of the actual treatment received.|Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer|A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 3|1088|Actual|Janssen Research & Development, LLC|These results are up to clinical cutoff (CCO) date (that is, 31 March 2014).|2|||f||||t||||||||||2017-02-18 13:08:30.569778|2017-02-18 13:08:30.569778
NCT00887185|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2011-09-26|||October 2006||2006-10-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Validation/Dissemination Of A Temporal Bone Dissection Simulator|Validation/Dissemination Of A Temporal Bone Dissection Simulator|Completed||Phase 2|100|Anticipated|Ohio State University||2|||f||||t||||||||||2017-02-18 13:08:32.727774|2017-02-18 13:08:32.727774
NCT00887172|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-22|||June 2005||2005-06-01|April 2009|2009-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs)|A Randomized Double Blind, Placebo-Controlled Clinical Trial of Chinese Herbal Medicine (CHM) in the Treatment of Acute Upper Respiratory Tract Infections|Completed||Phase 4|327|Actual|The University of Hong Kong||4|||f||||t||||||||||2017-02-18 13:08:32.840521|2017-02-18 13:08:32.840521
NCT00887159|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-11-04|2015-07-01||July 2009||2009-07-01|November 2016|2016-11-01||||September 2014|Actual|2014-09-01||Interventional||Eligible and treated patients.|A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage|A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Small Cell Lung Cancer|Active, not recruiting||Phase 2|168|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 13:08:32.972488|2017-02-18 13:08:32.972488
NCT00887146|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-09-23|||September 2009||2009-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma|Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma|Recruiting||Phase 3|360|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 13:08:34.446898|2017-02-18 13:08:34.446898
NCT00887133|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-22|||November 2005||2005-11-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Effectiveness of Western Medicine Outpatient Consultations in Primary Care|Effectiveness of Western Medicine Outpatient Consultations in Primary Care - A Comparison With Chinese Medicine Consultations|Completed||N/A|1469|Actual|The University of Hong Kong|||1||f||||f||||||||||2017-02-18 13:08:35.400662|2017-02-18 13:08:35.400662
NCT00887120|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-22|||April 2007||2007-04-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Dose Reduction of Lopinavir in Children|Pharmacokinetics and Efficacy of Low- or Standard-Dose of Lopinavir/Ritonavir (Kaletra®) in PI-naïve HIV-1 Infected Children|Completed||Phase 2|24|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||f||||||||||2017-02-18 13:08:35.496245|2017-02-18 13:08:35.496245
NCT00887107|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2009-04-22|||October 2007||2007-10-01|April 2009|2009-04-01||||||||Interventional|||Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma|Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma|Completed||Phase 2|32|Actual|Leiden University Medical Center||1|||f||||f||||||||||2017-02-18 13:08:35.635898|2017-02-18 13:08:35.635898
NCT00887094|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2011-08-03|||June 2009||2009-06-01|August 2011|2011-08-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|CGMSexercise||Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 Diabetes|Acute and Subacute Effects of Aerobic Training vs Aerobic/Resistance Training Upon Glucose Profile Evaluated Through Continuous Glucose Monitoring System in Type 2 Diabetes|Completed||N/A|14|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-02-18 13:08:35.742403|2017-02-18 13:08:35.742403
NCT00887081|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-22|||January 2009||2009-01-01|April 2009|2009-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|IFNRIBAHE||Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies|Phase IV Study of Effectiveness of Interferon and Ribavirin Treatment in Thalassemia Major Patients With Chronic Viral Hepatitis C|Unknown status|Recruiting|Phase 4|150|Anticipated|Azienda Ospedaliera V. Cervello||1|||f||||t||||||||||2017-02-18 13:08:35.849118|2017-02-18 13:08:35.849118
NCT00887068|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-10-06|||April 2009||2009-04-01|October 2016|2016-10-01||||April 2018|Anticipated|2018-04-01||Interventional|||Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)|Randomized Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)|Recruiting||Phase 3|246|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 13:08:36.166058|2017-02-18 13:08:36.166058
NCT00887055|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2015-06-26||||||June 2015|2015-06-01||||||||Observational|||OPTIMA Bi-ventricular Capture Verification Study|Bi-ventricular Capture Verification Study|Withdrawn||Phase 4|0|Actual|Guidant Corporation|||1|never started|f||||||||||||||2017-02-18 13:08:36.29378|2017-02-18 13:08:36.29378
NCT00887042|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2012-03-23|||June 2006||2006-06-01|March 2012|2012-03-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML|Phase II Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric Acute Myeloid Leukemia|Unknown status|Active, not recruiting|Phase 1/Phase 2|35|Anticipated|The Korean Society of Pediatric Hematology Oncology||1|||f||||f||||||||||2017-02-18 13:08:36.372704|2017-02-18 13:08:36.372704
NCT00887029|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2015-04-20|||January 2009||2009-01-01|April 2015|2015-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|DVX||A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma|A 12 Week Comparison of DuoTrav and Xalacom at 24 Hours Post-Dose in the Treatment of Open-Angle Glaucoma (the DVX Study)|Completed||Phase 4|54|Actual|Ophthalmic Consultants Centres, Canada||2|||f||||t||||||||||2017-02-18 13:08:36.473072|2017-02-18 13:08:36.473072
NCT00887003|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2012-02-07|||May 2005||2005-05-01|July 2011|2011-07-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Epidural Study of Patients With Chronic Lower Back Pain|Effects of Volume and Dose of Local Anaesthetic Solution in Epidural Steroidal Injections for Patients With Chronic Lower Back Pain|Completed||N/A|252|Actual|McMaster University||4|||f||||f||||||||||2017-02-18 13:08:36.594753|2017-02-18 13:08:36.594753
NCT00886990|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2009-05-14|||October 2007||2007-10-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens|Comparing the Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens for Children Failing Non Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Treatment|Completed||N/A|240|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||2||f||||f||||||||||2017-02-18 13:08:36.709858|2017-02-18 13:08:36.709858
NCT00886977|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2010-10-22|||April 2009||2009-04-01|April 2009|2009-04-01||||December 2010|Anticipated|2010-12-01||Interventional|||Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS)|Pilot-Study of YAM80 in Amyotrophic Lateral Sclerosis. Evaluation of the Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS)|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|Yoshino Neurology Clinic||1|||f||||f||||||||||2017-02-18 13:08:36.835122|2017-02-18 13:08:36.835122
NCT00886964|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2010-06-04|||April 2009||2009-04-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Hepatitis B Vaccination (HBV) in HIV Infected Children|Immunogenicity and Safety of Intradermal Compare to Intramuscular Hepatitis B Vaccination in HIV Children|Completed||Phase 2|80|Anticipated|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||f||||||||||2017-02-18 13:08:36.924656|2017-02-18 13:08:36.924656
NCT00886431|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2014-11-26|||May 2009||2009-05-01|November 2014|2014-11-01||||May 2012|Actual|2012-05-01||Interventional|||Vitrification Versus Slow Cooling of Human Cleavage Stage Embryos|A Double Blinded, Randomised Controlled Trial Comparing the Effectiveness of Vitrification to Slow Cooling in Cryopreserving Human Preimplantation Embryos|Terminated||N/A|146|Actual|UMC Utrecht||2|||f||||f||||||||||2017-02-18 13:08:49.401577|2017-02-18 13:08:49.401577
NCT00886951|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2010-09-20|||March 2009||2009-03-01|September 2010|2010-09-01||||March 2011|Anticipated|2011-03-01||Interventional|||Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease|Evaluation of [123I] MNI-388 and 123-I MNI-390 and SPECT as Markers of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Terminated||Phase 1|2|Actual|Institute for Neurodegenerative Disorders||1||"There did not appear to be uptake of the ligand in the areas of the brain expected for~   individuals with amyloid."|f||||f||||||||||2017-02-18 13:08:37.035255|2017-02-18 13:08:37.035255
NCT00886938|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2014-05-07|2012-03-07||June 2009||2009-06-01|May 2014|2014-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||rTMS To The Dorsolateral Prefrontal Cortex For Patients With Subjective Idiopathic Tinnitus. A Pilot Study|rTMS To The Dorsolateral Prefrontal Cortex For Patients With Subjective Idiopathic Tinnitus. A Pilot Study|Completed||Phase 2|12|Actual|Washington University School of Medicine|Open label study.|1|||f||||t||||||||||2017-02-18 13:08:39.301945|2017-02-18 13:08:39.301945
NCT00886925|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2012-12-14|||March 2009||2009-03-01|April 2012|2012-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|ALFAE||Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis|Effects of the Administration of Albumin in Patients With Cirrhosis and Acute Hepatic Encephalopathy.|Completed||Phase 4|56|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||f||||||||||2017-02-18 13:08:39.538394|2017-02-18 13:08:39.538394
NCT00886912|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2010-06-24|||June 2008||2008-06-01|April 2009|2009-04-01|October 2009|Anticipated|2009-10-01|August 2008|Actual|2008-08-01||Interventional|||Training in Hypoxia to Prevent Acute Mountain Sickness|Prevention of Acute Mountain Sickness (AMS) by Intermittent Hypoxic Training|Unknown status|Recruiting|N/A|50|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-02-18 13:08:39.646438|2017-02-18 13:08:39.646438
NCT00886899|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2012-03-15|2012-02-21||March 2009||2009-03-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|FAST-CTOs||Facilitated Antegrade Steering Technique in Chronic Total Occlusions (FAST-CTOs)|Facilitated Antegrade Steering Technique in Chronic Total Occlusions|Completed||Phase 2|147|Actual|BridgePoint Medical||1|||f||||t||||||||||2017-02-18 13:08:39.753021|2017-02-18 13:08:39.753021
NCT00886886|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-01-24|||April 2009||2009-04-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)|Pharmacological Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy): Pharmacological Effects and Pharmacokinetics|Completed||Phase 1|16|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-02-18 13:08:40.000044|2017-02-18 13:08:40.000044
NCT00886873|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2014-10-16|||May 2008||2008-05-01|October 2014|2014-10-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|Mifemyo_2||Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids|Mifepristone 5 mg Versus 10 mg During 6 Months for the Treatment of Uterine Leiomyomata. A Randomized, Double Blinded Clinical Trial.|Completed||Phase 2/Phase 3|100|Actual|Mediterranea Medica S. L.||2|||f||||t||||||||||2017-02-18 13:08:40.12606|2017-02-18 13:08:40.12606
NCT00886860|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2010-07-12|||May 2009||2009-05-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol|The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral Misoprostol|Completed||Phase 4|64|Actual|Mahidol University||2|||f||||t||||||||||2017-02-18 13:08:42.342151|2017-02-18 13:08:42.342151
NCT00886847|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2016-02-17|||April 2009||2009-04-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Endobronchial Ultrasound-Guided Biopsy Using Fine Needle Aspiration Versus Fine Needle Capillary Sampling|Specimen Adequacy and Diagnostic Agreement of Fine Needle Aspiration (FNA) VS. Fine Needle Capillary Sampling (FNC) of Endobronchial Ultrasound-Guided Biopsy of Mediastinal Lymph Nodes|Completed||N/A|120|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:08:42.440484|2017-02-18 13:08:42.440484
NCT00886834|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2014-12-04|2011-08-05||April 2009||2009-04-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|MPIIN||Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women|A Randomized Control Trial of Misoprostol vs. Placebo Prior to IUD Insertion in Nulliparous Women|Completed||N/A|108|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 13:08:42.548408|2017-02-18 13:08:42.548408
NCT00886821|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2015-07-30|||October 2008||2008-10-01|July 2015|2015-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics|A Phase 1, Placebo-Controlled, Randomized Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Following Escalating Subcutaneous Doses Of CVX-096 In Type 2 Diabetic Adult Subjects|Completed||Phase 1|114|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:08:42.947555|2017-02-18 13:08:42.947555
NCT00886808|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2012-03-21|||February 2008||2008-02-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema|A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of iCo-007 Intravitreal Injection in Subjects With Diffuse Diabetic Macular Edema|Completed||Phase 1|15|Actual|iCo Therapeutics Inc.||4|||f||||t||||||||||2017-02-18 13:08:43.04921|2017-02-18 13:08:43.04921
NCT00886795|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2015-12-17|2015-08-31||May 2009||2009-05-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|TAHOE||Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy|A Phase I/II Open-label Study to Evaluate The Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy.|Completed||Phase 1/Phase 2|4|Actual|Johns Hopkins University|Open Label study. Small number of patients. Outcome measures for urticaria not standardized.|1|||f||||t||||||||||2017-02-18 13:08:43.142864|2017-02-18 13:08:43.142864
NCT00886782|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2015-09-23||2012-04-25|May 2009||2009-05-01|September 2015|2015-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors|A Phase 1/2 Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-863233 in Subjects With Advanced and/or Metastatic Solid Tumors|Terminated||Phase 1/Phase 2|11|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 13:08:43.364586|2017-02-18 13:08:43.364586
NCT00886769|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2012-03-13|2011-11-21||July 2009||2009-07-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|β-SPECIFIC 1||Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)|A Randomized, Double-blind, Placebo Controlled, Single-dose Study to Assess the Initial Efficacy of Canakinumab (ACZ885) With Respect to the Adapted ACR Pediatric 30 Criteria in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations|Terminated||Phase 3|84|Actual|Novartis||2||recommendation by Data Monitoring Committee|f||||||||||||||2017-02-18 13:08:43.666901|2017-02-18 13:08:43.666901
NCT00886756|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-08-18|||April 2009||2009-04-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|||||Interventional|JSAD||AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects|A Phase I, Single-Centre, Randomised, Double-Blind, Placebo Controlled Single-Ascending Dose, Study to Assess the Safety, Tolerability, Pharmacokinetics of AZD8529 in Healthy Male Japanese Subjects|Completed||Phase 1|48|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:08:44.287018|2017-02-18 13:08:44.287018
NCT00886743|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-02-05|||September 2009||2009-09-01|February 2016|2016-02-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia|Study Of The Effects Of Oprelvekin On Cardiac Repolarization In Subjects At Risk Of Severe Thrombocytopenia After Myelosuppressive Chemotherapy|Terminated||Phase 2|19|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:08:44.375457|2017-02-18 13:08:44.375457
NCT00886730|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2012-12-13|||October 2008||2008-10-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|September 2009|Actual|2009-09-01||Interventional|Psychobabble||Primary Care Patients With Depression for Internet-Based Social Support|Feasibility Study of Methods of Referral Primary Care Patients With Depression for Internet-Based Social Support|Completed||Phase 1/Phase 2|49|Actual|University of Chicago||3|||f||||t||||||||||2017-02-18 13:08:44.482428|2017-02-18 13:08:44.482428
NCT00886717|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-08-01|||May 2008||2008-05-01|December 2009|2009-12-01||||||||Interventional|||Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer|Open-label, Multicenter, Phase I/II Trial to Evaluate Efficacy Safety of the Combination Therapy of Genexol-PM and Carboplatin as a Firstline Treatment in Subjects With Advanced Ovarian Cancer|Unknown status|Recruiting|Phase 1/Phase 2|74|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:08:44.586094|2017-02-18 13:08:44.586094
NCT00886704|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2011-09-29|2011-06-15||April 2009||2009-04-01|July 2009|2009-07-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis|Influence of Dietary Omega-3 Fatty Acids in a Convenience Drink (Smartfish) on the Omega-3 Index in Patients With Atherosclerotic Disease|Completed||N/A|50|Actual|Ludwig-Maximilians - University of Munich|Single center study, too small to detect rare side effects, 8 week intervention period relatively short.|2|||f||||f||||||||||2017-02-18 13:08:44.682982|2017-02-18 13:08:44.682982
NCT00886691|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-05-28|||December 2010||2010-12-01|May 2013|2013-05-01||||June 2014|Anticipated|2014-06-01||Interventional|||Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase II Randomized, Double-Blinded Evaluation of Oral Everolimus (RAD001) Plus Bevacizumab vs. Oral Placebo Plus Bevacizumab in the Treatment of Recurrent or Persistent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|Gynecologic Oncology Group||2|||f||||t||||||||||2017-02-18 13:08:45.09794|2017-02-18 13:08:45.09794
NCT00886678|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2011-02-23|||July 2008||2008-07-01|March 2010|2010-03-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|NSCLC||A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)|A Phase II Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|63|Anticipated|Zhejiang Cancer Hospital||1|||f||||t||||||||||2017-02-18 13:08:45.434115|2017-02-18 13:08:45.434115
NCT00886665|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-06-17|||July 2008||2008-07-01|April 2009|2009-04-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Interventional|||The Evaluation of Safety and Efficacy of JWHGWT on Diabetic Neuropathy|The Evaluation of Safety and Efficacy of JWHGWT on Diabetic Neuropathy|Unknown status|Recruiting|Phase 3|120|Anticipated|Taichung Veterans General Hospital||2|||f||||t||||||||||2017-02-18 13:08:45.540223|2017-02-18 13:08:45.540223
NCT00886652|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-02-25|||January 2008||2008-01-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||An Aerobic Exercising Program on Respiratory Muscle Strength in Patients With Adolescent Idiopathic Scoliosis|Results of an Aerobic Exercising Program on Respiratory Muscle Strength in Patients With Adolescent Idiopathic Scoliosis: a Randomized, Controlled Trial|Completed||N/A|90|Actual|Irmandade da Santa Casa de Misericordia de Sao Paulo||2|||f||||f||||||||||2017-02-18 13:08:45.655409|2017-02-18 13:08:45.655409
NCT00886639|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2011-11-02|2011-06-22||December 2008||2008-12-01|November 2011|2011-11-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Oxygen-supply on 6-Minute-Walking-Distance of COPD III/IV-patients|Effect Of Oxygen-Supply On The 6-Minute-Walking-Distance in Patients With Chronic Obstructive Pulmonary Disease (COPD) GOLD Stage III/IV Before And After A Multimodal Rehabilitation|Completed||N/A|127|Actual|Klinikum Berchtesgadener Land der Schön-Kliniken||2|||f||||f||||||||||2017-02-18 13:08:45.762822|2017-02-18 13:08:45.762822
NCT00886626|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2012-10-22|2012-04-25||May 2009||2009-05-01|October 2012|2012-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children|GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children: A Randomized, Controlled, Pilot Study|Completed||Phase 2|12|Actual|University of Minnesota - Clinical and Translational Science Institute|Small sample size; un-blinded; crossover study design|2|||f||||t||||||||||2017-02-18 13:08:46.012976|2017-02-18 13:08:46.012976
NCT00886613|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2015-10-05|2011-03-22||March 2009||2009-03-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)|A Double-Blind, Randomized, Placebo Controlled, Parallel Group Study to Evaluate Biomarkers of Immunity to Varicella Zoster Virus Following Immunization With V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine or With ZOSTAVAX in Healthy Volunteers|Completed||Phase 1|120|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:08:46.293095|2017-02-18 13:08:46.293095
NCT00886600|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2015-08-17|2009-05-21||May 1991||1991-05-01|August 2015|2015-08-01|August 1992|Actual|1992-08-01|May 1992|Actual|1992-05-01||Interventional|||A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)|A Double-blind, Randomized, Parallel-group, Placebo-controlled Pilot Study to Investigate the Magnitude and Duration of Response and the Safety of MK0954 (50 mg Given Once or Twice Daily, or 100 mg Given Once Daily) Compared to Placebo Using Ambulatory Blood Pressure Monitoring|Completed||Phase 3|122|Actual|Merck Sharp & Dohme Corp.|Safety has been reported in the literature.|4|||f||||||||||||||2017-02-18 13:08:46.817941|2017-02-18 13:08:46.817941
NCT00886587|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2014-06-04||2014-06-04|April 2009||2009-04-01|June 2014|2014-06-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children|A Double-Blind, Randomized, Active-Controlled Clinical Trial To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children|Completed||N/A|108|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-02-18 13:08:47.502353|2017-02-18 13:08:47.502353
NCT00886574|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2010-06-03|||April 2009||2009-04-01|May 2010|2010-05-01|February 2014|Anticipated|2014-02-01|February 2011|Anticipated|2011-02-01||Interventional|CAPPA||Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events|Multi-Center, Randomized, Open Label Study of the Efficacy of Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events With Korean Type 2 DM Patients|Unknown status|Active, not recruiting|Phase 4|400|Anticipated|Hanyang University||2|||f||||t||||||||||2017-02-18 13:08:47.612107|2017-02-18 13:08:47.612107
NCT00886561|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2013-11-21|||July 2007||2007-07-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||HIV- Risk Reduction Behavioral Intervention for Commercial Sex Workers in Yerevan Armenia|HIV- Risk Reduction Behavioral Intervention for Commercial Sex Workers in Yerevan Armenia|Completed||Phase 2|120|Actual|Emory University||2|||f||||f||||||||||2017-02-18 13:08:47.722606|2017-02-18 13:08:47.722606
NCT00886548|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2016-01-11|||April 2009||2009-04-01|May 2009|2009-05-01|May 2010||2010-05-01|May 2010||2010-05-01||Observational|||Echocardiographic Examination Performed by Nurses in Cardiac Intensive Care Unit|Echocardiographic Examination Performed by Nurses in Cardiac Intensive Care Unit. Is it Clinical Useful?|Withdrawn||N/A|0|Actual|Levanger Hospital|||1|Delayed inclusion|f||||f||||||||||2017-02-18 13:08:47.819751|2017-02-18 13:08:47.819751
NCT00886535|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2017-01-26|||February 2010|Actual|2010-02-01|January 2017|2017-01-01|July 27, 2017|Anticipated|2017-07-27|December 2013|Actual|2013-12-01||Observational|||Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity|An Observational Trial of the Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity|Active, not recruiting||N/A|41|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||Undecided|After determining if data is valuable|2017-02-18 13:08:47.91643|2017-02-18 13:08:47.91643
NCT00886522|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-04-14|||April 2009||2009-04-01|April 2016|2016-04-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|IBCB||Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies|Intrabone Infusion of Cord Blood Hemopoietic Stem Cells in Adult Patients With High Risk Haematological Malignancies.|Completed||Phase 2|23|Actual|St. Orsola Hospital||1|||f||||f||||||||Undecided||2017-02-18 13:08:48.009746|2017-02-18 13:08:48.009746
NCT00886509|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2015-12-15|||March 2009||2009-03-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Peg-Granulocyte-Colony Stimulating Factor (GCSF) for Coronary Collateral Growth in Coronary Artery Disease Patients|Subcutaneous Administration of Pegylated Granulocyte-Colony Stimulating Factor for Long-Term Promotion of Collateral Growth in Patients With Coronary Artery Disease|Completed||N/A|50|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-02-18 13:08:48.136717|2017-02-18 13:08:48.136717
NCT00886496|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2012-06-19|||November 2006||2006-11-01|August 2007|2007-08-01|April 2011|Actual|2011-04-01|||||Interventional|||Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia|A Multi-Center Study of the Safety, Tolerability, Pharmacokinetics and Dose Escalation of Intravenous Recombinant Human Mannose-Binding-Lectin (rhMBL) in MBL Deficient Pediatric Hematology/Oncology Patients With Fever and Neutropenia|Withdrawn||Phase 1|0|Actual|Enzon Pharmaceuticals, Inc.||||No participants enrolled. IND withdrawn.|||||||||||||||2017-02-18 13:08:48.442111|2017-02-18 13:08:48.442111
NCT00886483|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-10-05|2012-07-02||August 2008||2008-08-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Interventional|||Pilot Feasibility Study of Neurofeedback for Attention Deficit Hyperactivity Disorder (ADHD)|Pilot Explorations of Neurofeedback Issues in ADHD|Completed||N/A|39|Actual|Ohio State University|"Small sample.~Self-selection families willing to stop/delay meds.~Failure to select for high TBR.~Small/medium pre-post ES suggests particular Tx technology may not have been the most effective.~Sham NF may not have been inert."|2|||f||||f||||||||||2017-02-18 13:08:48.560071|2017-02-18 13:08:48.560071
NCT00886470|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-22|2016-12-05||2016-12-05|June 2009||2009-06-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns|Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns|Terminated||Phase 1/Phase 2|16|Actual|Noveome Biotherapeutics, formerly Stemnion||3||This study was terminated early due to slow accrual of patients.|f||||t||||||||||2017-02-18 13:08:49.091667|2017-02-18 13:08:49.091667
NCT00886457|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2011-07-19|||April 2009||2009-04-01|July 2011|2011-07-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates|Inhibition of DNA Methylation by 1-hr Infusion of 5-aza-2'-Deoxycytidine (Decitabine) x 10 Days (M-F) With Escalating Doses of Sub-Q Pegylated (PEG) Interferon-alfa 2B (PEG-Intron): A Phase I Study With Molecular Correlates|Terminated||Phase 1|3|Actual|Nevada Cancer Institute||1||low accrual|f||||t||||||||||2017-02-18 13:08:49.209466|2017-02-18 13:08:49.209466
NCT00886444|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2014-11-06|||March 2009||2009-03-01|November 2014|2014-11-01||||March 2010|Actual|2010-03-01||Interventional|||Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran|Comparative Evaluation of Various CMR Pulse-Sequences for Macrophage Imaging Using Ferucarbotran as Molecular Contrast Agent in Human Myocardial Infarction|Completed||Phase 2/Phase 3|20|Actual|Robert Bosch Gesellschaft für Medizinische Forschung mbH||1|||f||||f||||||||||2017-02-18 13:08:49.306479|2017-02-18 13:08:49.306479
NCT00886418|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-19|2016-09-22|||December 2009||2009-12-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Drone-Curare||Influence of Muscle Relaxation on a Closed-loop Anesthesia System|Effect of Continuous Myorelaxation on the Need for Hypnotic Agent During Surgical Procedures Which do Not Require it (Multicenter, Randomized and Prospective Study)|Completed||Phase 3|140|Actual|Hopital Foch||2|||f||||f||||||||||2017-02-18 13:08:49.525723|2017-02-18 13:08:49.525723
NCT00886405|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-21|||July 2006||2006-07-01|April 2009|2009-04-01|January 2010|Anticipated|2010-01-01|April 2009|Actual|2009-04-01||Interventional|||Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer|Phase II Study That Evaluates Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|40|Anticipated|National Institute of Cancerología||1|||f||||f||||||||||2017-02-18 13:08:49.621618|2017-02-18 13:08:49.621618
NCT00886392|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-21|||June 2006||2006-06-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Observational|||Diabetic Macular Edema Severity at Diagnosis|Distribution of Macular Edema Severity Level at the Moment of Diagnosis|Completed||N/A|118|Actual|Hospital Juarez de Mexico|||1||f||||f||||||||||2017-02-18 13:08:49.725512|2017-02-18 13:08:49.725512
NCT00886379|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-21|||January 2009||2009-01-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|BSS||Blue Sky Study: Impact of Milk and Vitamin D for Child Growth and Health|Blue Sky Study: Impact of Milk and Vitamin D for Child Growth and Health|Completed||Phase 2|744|Actual|Brigham and Women's Hospital||6|||f||||f||||||||||2017-02-18 13:08:49.821375|2017-02-18 13:08:49.821375
NCT00886366|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2010-12-06|||April 2009||2009-04-01|December 2010|2010-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients|A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction After Single Ascending Oral Doses of AZD6714 in Healthy Male Volunteers and Male Type II Diabetic Patients|Terminated||Phase 1|26|Anticipated|AstraZeneca||3||"Part A reached a predefined stopping criteria. Relevant doses for part B could not be~   established based on A and subsequently study was stopped."|f||||||||||||||2017-02-18 13:08:49.926661|2017-02-18 13:08:49.926661
NCT00886353|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-12-30|||April 2009||2009-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)|Double-blind, Placebo-controlled Dose-escalation Phase I Study With Recombinant Human Soluble Angiotensin Converting Enzyme 2 (rhACE2) APN01 in Healthy Volunteers|Completed||Phase 1|22|Anticipated|Apeiron Biologics||2|||f||||t||||||||||2017-02-18 13:08:50.026546|2017-02-18 13:08:50.026546
NCT00886340|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-04-04|2009-01-22||September 2005||2005-09-01|April 2012|2012-04-01|August 2008|Actual|2008-08-01|September 2007|Actual|2007-09-01||Interventional|||A Lifestyle Change Program to Prevent Type 2 Diabetes|A Lifestyle Change Program to Prevent Type 2 Diabetes|Completed||Phase 2|58|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 13:08:50.138503|2017-02-18 13:08:50.138503
NCT00886327|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2012-05-30|||May 2009||2009-05-01|April 2009|2009-04-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Observational|||Detecting Postoperative Recurrence in Crohn's Disease|Detection of Postoperative Recurrence of Crohn's Disease by Colonic Capsule-Endoscopy|Unknown status|Recruiting|N/A|70|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||t||||||||||2017-02-18 13:08:50.483927|2017-02-18 13:08:50.483927
NCT00886314|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-10-18|||June 2009||2009-06-01|February 2009|2009-02-01||||September 2009|Anticipated|2009-09-01||Interventional|||Clown Doctors and a Sedative Premedicant for Children Undergoing Surgery||Unknown status|Not yet recruiting|N/A|80|Anticipated|Shaare Zedek Medical Center||2|||f||||||||||||||2017-02-18 13:08:50.586616|2017-02-18 13:08:50.586616
NCT00886301|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-03-29|||March 2010||2010-03-01|March 2010|2010-03-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Fatty Liver and Ectopic Fat in Overweight and Obese Patients|Fatty Liver and Ectopic Fat in Overweight and Obese Patients|Unknown status|Recruiting|N/A|100|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:08:50.685299|2017-02-18 13:08:50.685299
NCT00886288|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2014-06-12|2009-08-27||September 2006||2006-09-01|June 2014|2014-06-01||||April 2007|Actual|2007-04-01||Observational||Baseline characteristics are presented for patients with available information on albuminuria at baseline. Respective data were not collected for patients without information on albuminuria at baseline.|TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in Belgium|A Comparison of Telmisartan Effectiveness in Hypertensive Patients With and Without Albuminuria.|Completed||N/A|2874|Actual|Boehringer Ingelheim|Observational study of daily medical practice, a lot of patients did not return to their GP for the second visit during the time period of 10 to 14 weeks after the first visit||2||f||||||||||||||2017-02-18 13:08:50.818301|2017-02-18 13:08:50.818301
NCT00886275|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-11-15|||July 2010||2010-07-01|November 2012|2012-11-01||||April 2011|Actual|2011-04-01||Interventional|||Comparing the Effect of Dexmedetomidine With Midazolam on Sedation, Oxidative Stress, and Microcirculation in Intensive Care Unit|Comparing the Effect of Dexmedetomidine With Midazolam on Sedation, Oxidative Stress, and Microcirculation in Intensive Care Unit|Completed||Phase 4|33|Actual|National Taiwan University Hospital||3|||f||||||||||||||2017-02-18 13:08:52.64867|2017-02-18 13:08:52.64867
NCT00886262|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-21|||July 2007||2007-07-01|April 2009|2009-04-01|January 2010|Anticipated|2010-01-01|July 2009|Anticipated|2009-07-01||Interventional|||Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant|Low Dose Vasopressin for Renal Protection During Liver Transplantation|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 13:08:52.745039|2017-02-18 13:08:52.745039
NCT00886249|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-10-09|||March 2009||2009-03-01|October 2009|2009-10-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Observational|||Depth of Focus Comparison Between Acrysof IQ and Acrysof Natural IOLs|Depth of Focus Comparison Between Acrysof IQ and Acrysof Natural IOLs|Withdrawn||N/A|50|Anticipated|Medical University of South Carolina|||1|The PI has determined not to continue the study.|f||||f||||||||||2017-02-18 13:08:52.854103|2017-02-18 13:08:52.854103
NCT00881335|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-06-25|2009-06-17||April 2009||2009-04-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function|Implemental Flutter Mucus Clearance Devices on Geriatric Lung Function|Completed||N/A|60|Actual|Tongji University||2|||f||||t||||||||||2017-02-18 13:10:32.172703|2017-02-18 13:10:32.172703
NCT00886236|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-21|||July 2008||2008-07-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting|The Effect of Gabapentin on Acute Pain and PONV in Bariatric Surgical Patients|Unknown status|Enrolling by invitation|N/A|150|Anticipated|Medical University of South Carolina||3|||f||||f||||||||||2017-02-18 13:08:52.952797|2017-02-18 13:08:52.952797
NCT00886223|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-06-23|||April 2009||2009-04-01|June 2009|2009-06-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|RobPex||Laparoscopic Sacropexy With Robot-Assisted Surgical System|Laparoscopic Sacropexy: Clinical Prospective Study With Robot-Assisted Technique(da Vinci®-System)|Unknown status|Recruiting|N/A|30|Anticipated|Kantonsspital Aarau||1|||f||||f||||||||||2017-02-18 13:08:53.166161|2017-02-18 13:08:53.166161
NCT00886210|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-21|||October 2006||2006-10-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Clinical Impact of Routine Abdominal Drainage After Laparoscopic Cholecystectomy|Clinical Impact of Routine Abdominal Drainage After Laparoscopic Cholecystectomy. A Prospective Randomized Study|Completed||N/A|100|Actual|Mansoura University||2|||f||||t||||||||||2017-02-18 13:08:53.278915|2017-02-18 13:08:53.278915
NCT00886197|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-21|||September 2007||2007-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux Disease|Diagnostic Efficacy of Narrow Band Imaging (NBI) in Patients With Gastroesophageal Reflux Disease (GERD)|Completed||N/A|80|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:08:53.39829|2017-02-18 13:08:53.39829
NCT00886184|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-01-29|||February 2009||2009-02-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|HITUPPAC-BIO||Intra-arrest Therapeutic Hypothermia in Prehospital Cardiac Arrest|Intra-arrest Therapeutic Hypothermia in Prehospital Cardiac Arrest. Impact on Biomarker of Brain Damage.|Completed||N/A|244|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-02-18 13:08:53.488827|2017-02-18 13:08:53.488827
NCT00886171|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2011-09-28|||September 2007||2007-09-01|September 2011|2011-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effects of Social Skills and Physical Activity Training on Recreational Activities in Youth|Effects of Social Skills and Physical Activity Training on Recreational Activities in Youth|Completed||N/A|35|Actual|University at Buffalo||2|||f||||f||||||||||2017-02-18 13:08:53.5911|2017-02-18 13:08:53.5911
NCT00886158|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2011-07-20|||June 2001||2001-06-01|July 2011|2011-07-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Observational|||Virus Surveillance in Pediatric Solid Organ Transplant Recipients|Virus Surveillance in Pediatric Solid Organ Transplant Recipients: Identifying Risk Factors for PTLD and Other Complications Post-Transplant|Unknown status|Recruiting|N/A|100|Anticipated|Seattle Children's Hospital|||1||f||||f||||||Samples With DNA|"~     blood, urine, kidney biopsy tissue~   "|||2017-02-18 13:08:53.680671|2017-02-18 13:08:53.680671
NCT00886145|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2016-03-28|2016-02-24||June 2009||2009-06-01|February 2016|2016-02-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Vibration Therapy on Bone in Persons With Sub-acute Spinal Cord Injury|Effect of Using Low-magnitude High Frequency Mechanical Stimulation of Bone in Persons With Subacute SCI|Completed||N/A|1|Actual|James J. Peters Veterans Affairs Medical Center|Subject recruitment was untenable due to the physiological and psychological healing necessary during the sub-acute phase of spinal cord injury.|1|||f||||f||||||||No||2017-02-18 13:08:53.762745|2017-02-18 13:08:53.762745
NCT00886132|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-07-22|||January 2007||2007-01-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|A Phase 2 Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|Completed||Phase 2|14|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 13:08:53.993958|2017-02-18 13:08:53.993958
NCT00886119|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2012-06-26|2010-09-14||April 2009||2009-04-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of a Multifocal Contact Lens to a Traditional Multifocal Contact Lens|Lotrafilcon B Multifocal Evaluations - Comparison to a Traditional Multifocal in Higher Spectacle Adds|Completed||N/A|48|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 13:08:54.100318|2017-02-18 13:08:54.100318
NCT00886106|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-11-17|||June 2009||2009-06-01|November 2009|2009-11-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|RemiAnes 1||The Effect of High-dose Remifentanil on Established Capsaicin-induced Hyperalgesia in Human Volunteers|The Effect of High-dose Remifentanil on Established Capsaicin-induced Hyperalgesia in Human Volunteers|Unknown status|Recruiting|Phase 4|24|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:08:54.449549|2017-02-18 13:08:54.449549
NCT00886093|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-06-29|||April 2009||2009-04-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants|A Phase 1, Open Label, Randomized, Single Dose, Cross-Over Study To Evaluate The Effect Of Food On PF-04447943 Pharmacokinetics In Healthy Adult Subjects|Completed||Phase 1|10|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:08:54.561699|2017-02-18 13:08:54.561699
NCT00886080|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-21|||October 2002||2002-10-01|April 2009|2009-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||The Effect of Arrhythmia Surgery on Quality of Life in Patients With Atrial Fibrillation Undergoing Cardiac Surgery|A Prospective Randomised Multicentre Comparison on Health Related Quality of Life: the Value of Add-on Arrhythmia Surgery in Patients With Atrial Fibrillation Undergoing Valvular and/or Coronary Bypass Surgery|Completed||N/A|150|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 13:08:54.660682|2017-02-18 13:08:54.660682
NCT00886067|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-09-09|||April 2009||2009-04-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Positron Emission Tomography (PET) Study|An Open-label Positron Emission Tomography (PET) Study Using 2 [18F] F A85380 to Determine α4β2 Neuronal Nicotinic Receptor (NNR) Occupancy of AZD1446 After Oral Administration to Male and Non-fertile Female (Non-nicotine Users) Healthy Volunteers|Completed||Phase 1|11|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:08:54.76878|2017-02-18 13:08:54.76878
NCT00885872|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2010-05-26|||March 2009||2009-03-01|April 2009|2009-04-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|REACH||Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)|A 104-week, Open-label, Single-group Study: Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)|Unknown status|Recruiting|Phase 4|60|Anticipated|Chinese PLA General Hospital||1|||f||||f||||||||||2017-02-18 13:08:56.277344|2017-02-18 13:08:56.277344
NCT00886054|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-12-20|||December 2009||2009-12-01|December 2009|2009-12-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||The Prediction of Intracranial Pressure and Clinical Outcome by Transcranial Doppler in Neurocritical Patients|The Prediction of Intracranial Pressure and Clinical Outcome by Transcranial Doppler in Neurocritical Patients|Unknown status|Active, not recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:08:54.86163|2017-02-18 13:08:54.86163
NCT00886041|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-21|||January 2003||2003-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Role of Laparoscopy in Unexplained Infertility|Role of Laparoscopy in Unexplained Infertility|Completed||Phase 4|512|Actual|Mansoura University||2|||f||||f||||||||||2017-02-18 13:08:54.965481|2017-02-18 13:08:54.965481
NCT00886028|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-21|||September 2006||2006-09-01|April 2009|2009-04-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Interventional|||Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma|"Phase II Study: Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma "|Unknown status|Active, not recruiting|Phase 2|31|Actual|National Institute of Cancerología||1|||f||||||||||||||2017-02-18 13:08:55.073163|2017-02-18 13:08:55.073163
NCT00886015|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2011-10-20|||May 2009||2009-05-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|November 2011|Anticipated|2011-11-01||Interventional|||Modified Instrumentation for Surgery to Correct Trichiasis|PRET Clinical Trial of Evaluation of Modified Instrumentation for Surgery to Correct Trichiasis|Unknown status|Active, not recruiting|Phase 3|1876|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 13:08:55.188039|2017-02-18 13:08:55.188039
NCT00886002|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-06-18|||November 2004||2004-11-01|June 2010|2010-06-01|January 2005|Actual|2005-01-01|||||Interventional|||Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers.|Explorative, Double-blind Study on Dose Effectiveness of DUROGESIC D-Trans 12 Mcg/h and 25mcg/h Compared to Transtec and Placebo in Acute Pain Models in Healthy Volunteers.|Completed||Phase 1|20|Actual|Janssen-Cilag A.G., Switzerland|||||f||||||||||||||2017-02-18 13:08:55.29062|2017-02-18 13:08:55.29062
NCT00885989|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2010-01-28|||May 2009||2009-05-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers|A Placebo-Controlled, Combined Single and Multiple Rising Dose Study to Determine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SLV338 After Intravenous Administration in Healthy Male Subjects|Completed||Phase 1|42|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:08:55.379142|2017-02-18 13:08:55.379142
NCT00885976|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-06-25|||September 2011||2011-09-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain|The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain|Completed||N/A|99|Actual|University of Alabama at Birmingham|||1||f||||||||||||||2017-02-18 13:08:55.480506|2017-02-18 13:08:55.480506
NCT00885963|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-02-07|||December 2008||2008-12-01|February 2014|2014-02-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer|A Phase II Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer|Terminated||Phase 2|62|Actual|Cyclacel Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:08:55.568398|2017-02-18 13:08:55.568398
NCT00885950|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2014-02-03|||January 2008||2008-01-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Observational|||Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants|Prevention of the Hepatic Sinusoidal Obstruction Syndrome Secondary to Oxaliplatin-based Neoadjuvant Chemotherapy for Colorectal Liver Metastases by Means of Anticoagulants|Completed||N/A|80|Actual|Maastricht University Medical Center|||1||f||||t||||||Samples Without DNA|"~     Paraffin embedded liver tissue~   "|||2017-02-18 13:08:55.66135|2017-02-18 13:08:55.66135
NCT00885937|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2014-06-20|||April 2009||2009-04-01|June 2014|2014-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparative Safety Study of New Sinecort Formulation Versus Positive Control|Single-blind, Randomized, Controlled, Single Center Trial to Evaluate the Skin Irritation Potential of a New Topical Formulation by Means of an Occlusive Patch Test in Healthy Subjects.|Completed||Phase 1|33|Actual|Bayer||3|||f||||f||||||||||2017-02-18 13:08:55.772183|2017-02-18 13:08:55.772183
NCT00885924|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-04-07|||March 2009||2009-03-01|April 2015|2015-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery|Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery|Terminated||Phase 4|17|Actual|St. Olavs Hospital||2||to include required number of patients took too much time|f||||f||||||||||2017-02-18 13:08:55.871336|2017-02-18 13:08:55.871336
NCT00885911|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-09-27|||March 2009||2009-03-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Evaluation of the Intubating Laryngeal Airway in Children|Evaluation of the Intubating Laryngeal Airway in Children - Phase 1|Completed||N/A|110|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 13:08:55.970799|2017-02-18 13:08:55.970799
NCT00885898|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-21|||March 2005||2005-03-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|January 2007|Actual|2007-01-01||Interventional|NIV||Out-of-Hospital Non-Invasive Ventilation for Patients With Acute Respiratory Failure|Out-of-Hospital Non-Invasive Ventilation in Patients With Acute Respiratory Insufficiency|Completed||N/A|51|Actual|University of Göttingen||2|||f||||f||||||||||2017-02-18 13:08:56.058989|2017-02-18 13:08:56.058989
NCT00885885|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2015-09-14|||May 2009||2009-05-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|PLANET||Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases|An Open Label Randomized, Multi-Centre Exploratory Phase II Study to Evaluate the Efficacy and Safety of the Combination of Panitumumab With FOLFOX 4 Chemotherapy or Panitumumab With FOLFIRI Chemotherapy in Subjects With Wild- Type KRAS Colorectal Cancer and Liver-only Metastases.|Completed||Phase 2|80|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||2|||f||||f||||||||||2017-02-18 13:08:56.167297|2017-02-18 13:08:56.167297
NCT00885131|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2017-01-24|||April 15, 2009||2009-04-15|January 22, 2013|2013-01-22|January 22, 2013||2013-01-22|||||Observational|||Effect of Reward on Learning in Motor Cortex|Effects of Reward on Learning in the Motor Cortex|Completed||N/A|64|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:09:10.195436|2017-02-18 13:09:10.195436
NCT00885859|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2009-04-21|||June 2009||2009-06-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Transcutaneous Electrical Nerve Stimulation (TENS) in Chronic Pain, Responders and Non-Responders?|Is Transcutaneous Electrical Nerve Stimulation (TENS) an Effective Method to Modulate Pain Transmission and Pain Perception in Patients Suffering From Chronic Non-Specific Pain Syndromes?|Unknown status|Not yet recruiting|N/A|62|Anticipated|Maastricht University Medical Center|||2||f||||f||||||||||2017-02-18 13:08:56.389376|2017-02-18 13:08:56.389376
NCT00885846|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2015-10-23|2009-02-05||June 2007||2007-06-01|April 2015|2015-04-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Qigong on Type 2 Diabetic Patients|A Pilot Study: The Effects of Qigong Therapy on Type 2 Diabetic Patients|Completed||N/A|32|Actual|Bastyr University|Limitations to this study include high withdrawal rate from PRT group, especially during the first cohort. Also, participants from both Qigong and PRT group changed or discontinued medications. Consequently, their results were excluded from analysis.|3|||f||||||||||||||2017-02-18 13:08:56.504809|2017-02-18 13:08:56.504809
NCT00885833|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2014-07-11|||February 2007||2007-02-01|July 2014|2014-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)|Phase I/II Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome|Completed||Phase 1/Phase 2|5|Anticipated|The Korean Society of Pediatric Hematology Oncology||1|||f||||f||||||||||2017-02-18 13:08:56.976166|2017-02-18 13:08:56.976166
NCT00885820|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2014-09-17|||September 2001||2001-09-01|September 2014|2014-09-01|January 2006|Actual|2006-01-01|July 2004|Actual|2004-07-01||Interventional|||Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection|The Effects of Treatment of Subclinical Rejection on Renal Histology and Graft Function in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil|Completed||Phase 4|240|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 13:08:57.076094|2017-02-18 13:08:57.076094
NCT00885807|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2011-06-17|||July 2006||2006-07-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment Rating Scale)|Psychometric Validation of the Weiss Functional Impairment Rating Scale and the Weiss Symptom Record in Patients With Attention-Deficit Hyperactivity Disorder|Completed||N/A|220|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 13:08:57.193892|2017-02-18 13:08:57.193892
NCT00885794|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2011-06-23|||May 2008||2008-05-01|June 2011|2011-06-01|May 2012|Anticipated|2012-05-01|May 2011|Actual|2011-05-01||Interventional|MORE||Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)|Microperimetry and High-Definition-OCT in Ranibizumab Treatment for Diabetic Macular Edema (MORE-Study)|Unknown status|Active, not recruiting|Phase 2/Phase 3|40|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||2|||f||||f||||||||||2017-02-18 13:08:57.28475|2017-02-18 13:08:57.28475
NCT00885781|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2011-10-13|||November 2008||2008-11-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety Comparison Between SMOFlipid and Lipovenoes MCT|Clinical Study Comparing Safety and Efficacy of SMOFlipid, the New Generation Fat Emulsion, in Comparison With the Current Fat Emulsion Lipovenoes MCT at the Hospital|Completed||Phase 4|40|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 13:08:57.394731|2017-02-18 13:08:57.394731
NCT00885768|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2011-05-11|2010-03-09||July 2008||2008-07-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|September 2008|Actual|2008-09-01||Observational|RAS||Prevalence of Renal Artery Stenosis in Patients Referred for Cardiac Catheterization|Prevalence of Renal Artery Stenosis in Patients Refered for Cardiac Catheterization to Heart Center Hospital in July-September 2008|Completed||Phase 3|146|Actual|Imam Khomeini Hospital|||1||f||||t||||||||||2017-02-18 13:08:57.593939|2017-02-18 13:08:57.593939
NCT00885755|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-07-01|2015-09-01||August 2009||2009-08-01|July 2016|2016-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Intent-to-treat (ITT) population: All registered participants were included in the ITT population.|A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer|A Prospective Study to Evaluate Alterations in Molecular Biomarkers in HER2 Neu Positive Metastatic Breast Cancer Together With Assessment of Trastuzumab Use Beyond Progression After Initial Response to Trastuzumab-taxane Based Treatment|Completed||Phase 2|33|Actual|Hoffmann-La Roche|The study was prematurely terminated on December 31, 2012. The end of study follow-up was February 18, 2013.|1|||f||||||||||||||2017-02-18 13:08:57.831568|2017-02-18 13:08:57.831568
NCT00885742|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2012-07-10|2012-04-30||August 2009||2009-08-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency|A Prospective, Multicenter, Open-label, Phase 3b Study of Human Plasma-Derived Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency|Completed||Phase 3|41|Actual|CSL Behring||1|||f||||f||||||||||2017-02-18 13:08:59.293252|2017-02-18 13:08:59.293252
NCT00885729|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2015-10-14|||April 2009||2009-04-01|October 2015|2015-10-01|July 2018|Anticipated|2018-07-01|July 2011|Actual|2011-07-01||Interventional|||Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects|Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects|Active, not recruiting||Phase 1|50|Anticipated|University Hospital, Akershus||2|||f||||f||||||||||2017-02-18 13:08:59.656714|2017-02-18 13:08:59.656714
NCT00885716|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-04-07|||May 2009||2009-05-01|April 2010|2010-04-01||||||||Interventional|||A Shared Decision Making Training for Inpatients With Schizophrenia|Shared Decision Making: Ein Kommunikationstraining für Patienten Mit Schizophrenie|Unknown status|Recruiting|N/A|80|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-02-18 13:08:59.760212|2017-02-18 13:08:59.760212
NCT00885703|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2016-10-17|||February 2010||2010-02-01|October 2016|2016-10-01||||February 2017|Anticipated|2017-02-01||Interventional|||High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals|A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis|Active, not recruiting||Phase 1/Phase 2|168|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 13:08:59.858972|2017-02-18 13:08:59.858972
NCT00885690|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-09-03|||April 2009||2009-04-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|SEROLA||Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)|A Multicentre Double-blinded Randomized Head-to-head Study|Terminated||N/A|11|Actual|University of Aarhus||2||Due to recruitment problems|f||||t||||||||||2017-02-18 13:09:00.010911|2017-02-18 13:09:00.010911
NCT00885677|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2016-01-11|||June 2009||2009-06-01|January 2016|2016-01-01|April 2016|Anticipated|2016-04-01|December 2015|Actual|2015-12-01||Interventional|MORE-CARE||MOnitoring REsynchronization deviCes and cARdiac patiEnts|MOnitoring REsynchronization deviCes and cARdiac patiEnts|Terminated||N/A|918|Actual|Medtronic Bakken Research Center||2||Low enrollment rate|f||||t||||||||||2017-02-18 13:09:00.138748|2017-02-18 13:09:00.138748
NCT00885664|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-05-14|||October 2005||2005-10-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection|Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection|Unknown status|Active, not recruiting|Phase 4|60|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 13:09:00.318401|2017-02-18 13:09:00.318401
NCT00885651|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-21|||September 2008||2008-09-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|MEXICHO||Ability of Metoprolol to Alter the Exercise Induced Elevation of Catecholamines|A Randomised, Double Blinded, Crossover Study of the Influence of Metoprolol on Exercise Induced Elevation of Catecholamines in Healthy Subjects.|Unknown status|Enrolling by invitation|Phase 4|30|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:09:00.452312|2017-02-18 13:09:00.452312
NCT00885638|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2013-12-25|2012-09-21||August 2009||2009-08-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|May 2011|Actual|2011-05-01||Interventional|||Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion|Study of the Effect of Sitagliptin on the Hormonal Responses to Macronutrient Ingestion in Healthy Volunteers|Completed||Phase 4|12|Actual|Lund University||2|||f||||f||||||||||2017-02-18 13:09:00.545292|2017-02-18 13:09:00.545292
NCT00885625|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-07-14|||March 2009||2009-03-01|June 2010|2010-06-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|PCV||7-valent Pneumococcal Conjugated Vaccination|1-Year Longitudinal Follow-up Study of Serologic Responses to 7-valent Pneumococcal Conjugated Vaccination and Opsonophagocytic Activities for Streptococcus Pneumoniae Among Patients With Human Immunodeficiency Virus Infection|Unknown status|Recruiting|Phase 4|350|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 13:09:00.81576|2017-02-18 13:09:00.81576
NCT00885612|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2010-06-28|||May 2009||2009-05-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)|10-year CHD Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer Patients Taking Aromatase Inhibitors|Completed||N/A|1114|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:09:01.008285|2017-02-18 13:09:01.008285
NCT00885599|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-07-16|||June 2009||2009-06-01|July 2012|2012-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy of a Naturally-derived Mouthrinse for Gingival Inflammation|A Randomized Multi-treatment/Controlled Double-blinded Study to Evaluate the Efficacy of a Naturally-derived Mouthrinse in the Treatment of Gingival Inflammation.|Completed||Phase 1/Phase 2|94|Actual|Shaare Zedek Medical Center||4|||f||||f||||||||||2017-02-18 13:09:01.131012|2017-02-18 13:09:01.131012
NCT00885586|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2017-02-03|||November 2008||2008-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Interventional|ACUZoster||Acupuncture in Herpes Zoster Neuralgia (ACUZoster)|Analgetic Effectiveness of Acupuncture When Compared to a Standardised Analgesic Regimen in the Treatment of Herpes Zoster Neuralgia|Recruiting||Phase 4|336|Anticipated|Ludwig-Maximilians - University of Munich||3|||f||||t||||||||||2017-02-18 13:09:01.235191|2017-02-18 13:09:01.235191
NCT00885573|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2014-05-02|||December 2008||2008-12-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SENSITEST||Pharyngeal Sensitivity in Diagnosis Algorithm for Sleep Apnea Syndrome|Measurement of Pharyngeal Sensitivity With the SENSITEST Device: Validation of the Diagnosis Algorithm for Sleep Disordered Breathing|Completed||N/A|52|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-02-18 13:09:01.343657|2017-02-18 13:09:01.343657
NCT00885560|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-09-14|||July 2006||2006-07-01|September 2012|2012-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||SNAP 25 Gene Study|Do People With ADHD, Who Respond Well to Amphetamine Medication But Not to Methylphenidate, Have Allelic Variants of the SNAP 25 Gene?|Terminated||N/A|19|Actual|University of British Columbia|||1|"Collecting data for the population involved was very difficult. Over 3 years, only 19~   participants were recruited."|f||||f||||||Samples With DNA|"~     Whole blood for genetic analysis.~   "|||2017-02-18 13:09:01.4576|2017-02-18 13:09:01.4576
NCT00885547|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-03-31|||March 2009||2009-03-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis|Prospective Clinical Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis.|Terminated||N/A|90|Actual|Nanjing University School of Medicine||1||low-rate of enrollment|f||||f||||||||||2017-02-18 13:09:01.544071|2017-02-18 13:09:01.544071
NCT00885534|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2015-04-21|2015-04-07||April 2009||2009-04-01|April 2015|2015-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma|Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma|Completed||Phase 2|7|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:09:01.639602|2017-02-18 13:09:01.639602
NCT00885521|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2014-03-10|||February 2009||2009-02-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis|Exercise Training in Patients With Non-CF Bronchiectasis - a Multi-centre Randomized Controlled Trial|Completed||Phase 1|39|Actual|Bayside Health||2|||f||||t||||||||||2017-02-18 13:09:02.029046|2017-02-18 13:09:02.029046
NCT00885508|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2015-04-23|||February 2009||2009-02-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|GFM-Chimio-Rev||A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q|A Phase II Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk MDS and AML With Del 5q|Active, not recruiting||Phase 2|85|Actual|Groupe Francophone des Myelodysplasies||1|||f||||t||||||||||2017-02-18 13:09:02.137703|2017-02-18 13:09:02.137703
NCT00885495|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-21|||January 2009||2009-01-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Interventional|||Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study|The Effects of Darunavir Plus Ritonavir on the Pharmacokinetics and Pharmacodynamics of Rosuvastatin|Unknown status|Active, not recruiting|Phase 1/Phase 2|12|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 13:09:02.280017|2017-02-18 13:09:02.280017
NCT00885482|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-02-23|2015-02-04||May 2009||2009-05-01|February 2015|2015-02-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|AtLaS||Atazanavir and Lamivudine for Treatment Simplification|Pilot Study for the Evaluation of the Safety and the Feasibility of Treatment Simplification to Atazanavir/Ritonavir + Lamivudine in Patients Stably Treated With Two NRTIs + Atazanavir/Ritonavir With Optimal Virologic Response.|Completed||Phase 4|40|Actual|Catholic University of the Sacred Heart||1|||f||||f||||||||||2017-02-18 13:09:02.422621|2017-02-18 13:09:02.422621
NCT00885469|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-08-03|||December 2007||2007-12-01|August 2009|2009-08-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Observational|MA-76||PillCam® ESO 2 in Esophageal Pathologies|Evaluation of PillCam® ESO 2 in Patients With Suspected Esophageal Pathologies|Completed||N/A|101|Actual|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 13:09:02.687976|2017-02-18 13:09:02.687976
NCT00885456|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2014-10-29|||December 2009||2009-12-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PREVENT||Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT|Effectiveness of a Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke: A Multi-site RCT|Unknown status|Enrolling by invitation|Phase 2|250|Anticipated|Nova Scotia Health Authority||2|||f||||t||||||||||2017-02-18 13:09:02.796689|2017-02-18 13:09:02.796689
NCT00885443|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-09-25|||February 2009||2009-02-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Emergence Delirium in Children: Total Intravenous Anesthesia With Propofol and Remifentanil Versus Inhalational Sevoflurane Anesthesia|Emergence Delirium in Children: Total Intravenous Anesthesia With Propofol and Remifentanil Versus Inhalational Sevoflurane Anesthesia|Completed||N/A|112|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:09:02.913827|2017-02-18 13:09:02.913827
NCT00885430|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-09-18|||July 2008||2008-07-01|September 2015|2015-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes|Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes|Completed||Phase 4|20|Actual|Queen's University||1|||f||||f||||||||||2017-02-18 13:09:03.034502|2017-02-18 13:09:03.034502
NCT00885417|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2011-04-21|||April 2009||2009-04-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study|The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study|Completed||Phase 4|142|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 13:09:03.135548|2017-02-18 13:09:03.135548
NCT00885404|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2010-02-24|||February 2009||2009-02-01|February 2010|2010-02-01|August 2010|Anticipated|2010-08-01|August 2009|Anticipated|2009-08-01||Interventional|CHLORIDE||Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation|A Prospective, Before and After Study of the Impact of Lower Chloride Intravenous Fluid Management on Patients' Acid-base Status, Renal Profile,Length of Stay and Mortality.|Unknown status|Active, not recruiting|Phase 4|7000|Anticipated|Austin Health||1|||f||||f||||||||||2017-02-18 13:09:03.242282|2017-02-18 13:09:03.242282
NCT00885391|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2014-12-09|||January 2007||2007-01-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|DCCV||QT Variability Pre and Post Cardioversion|QT Variability Pre & Post Cardioversion in Patient's With Atrial Fibrillation|Completed||N/A|219|Actual|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     Blood sample~   "|||2017-02-18 13:09:03.372325|2017-02-18 13:09:03.372325
NCT00885378|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-21|2015-05-08|2011-11-02||May 2009||2009-05-01|May 2015|2015-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2.5 mg Saxagliptin, Twice Daily, in Combination With Metformin IR in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin IR Alone|Completed||Phase 3|166|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:09:03.474789|2017-02-18 13:09:03.474789
NCT00885365|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2014-06-19|2014-05-14||April 2009||2009-04-01|June 2014|2014-06-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|CT03 Core|Safety Population|A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®|A Multicentre, Multinational, Open-Label, Randomised, Parallel Group Clinical Trial of Tobrineb®/Actitob®/Bramitob® (Tobramycin Solution for Nebulisation, 300mg Twice Daily in 4mL Unit Dose Vials) Compared to TOBI® in the Treatment of Patients With Cystic Fibrosis and Chronic Infection With Pseudomonas Aeruginosa|Completed||Phase 3|324|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-02-18 13:09:04.567307|2017-02-18 13:09:04.567307
NCT00885352|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-07-27|2011-11-04||April 2009||2009-04-01|July 2015|2015-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)|A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin (MK-0431) in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Metformin and Pioglitazone|Completed||Phase 3|313|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:09:05.641095|2017-02-18 13:09:05.641095
NCT00885339|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-03-10|||February 2008||2008-02-01|March 2010|2010-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure|Evaluation of the PillCam Colon Capsule Endoscopy Preparation and Procedure|Completed||N/A|100|Anticipated|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 13:09:06.047842|2017-02-18 13:09:06.047842
NCT00885326|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2015-12-11|||December 2009||2009-12-01|December 2015|2015-12-01|May 2016|Anticipated|2016-05-01|April 2014|Actual|2014-04-01||Interventional|||N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma|A Phase I Study of Bevacizumab With Bolus and Metronomic Cyclophosphamide and Zoledronic Acid in Children With Recurrent or Refractory Neuroblastoma|Active, not recruiting||Phase 1|36|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-02-18 13:09:06.146132|2017-02-18 13:09:06.146132
NCT00885313|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2011-05-12|||March 2009||2009-03-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|April 2010|Actual|2010-04-01||Interventional|EDACN||Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)|Study of Efficacy and Tolerability of Docosahexaenoic Acid (DHA) on Children Affected by Nonalcoholic Fatty Liver Disease (NAFLD).|Completed||Phase 1/Phase 2|60|Actual|Bambino Gesù Hospital and Research Institute||3|||f||||t||||||||||2017-02-18 13:09:06.27412|2017-02-18 13:09:06.27412
NCT00885300|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-20|||January 2008||2008-01-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients|Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients|Completed||N/A|100|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-02-18 13:09:06.399161|2017-02-18 13:09:06.399161
NCT00885287|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-01-15|||July 2009||2009-07-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|InterACT||Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania|Study of Therapeutic Efficacy, Safety and Pharmacokinetic Interactions Between Artemether-lumefantrine and Nevirapine-based Antiretrovirals in HIV-infected Patients With Uncomplicated Falciparum-malaria in Muheza, Northeastern Tanzania|Completed||Phase 4|830|Actual|University of Copenhagen||3|||f||||t||||||||||2017-02-18 13:09:08.763976|2017-02-18 13:09:08.763976
NCT00885274|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-08-27|||November 2008||2008-11-01|August 2015|2015-08-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Interventional|||A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy|A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy.|Completed||Phase 4|250|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 13:09:08.871714|2017-02-18 13:09:08.871714
NCT00885261|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-19|2014-03-26|||May 2009||2009-05-01|April 2009|2009-04-01|April 2012|Actual|2012-04-01|||||Observational|||The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic Pain|The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic Pain|Completed||N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-02-18 13:09:08.969636|2017-02-18 13:09:08.969636
NCT00885248|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-20|||January 2009||2009-01-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Observational|||Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer|Clinical Implication of Integrated PET-CT in the Patients With Pancreatic Cancer|Unknown status|Active, not recruiting|N/A|70|Anticipated|Asan Medical Center|||1||f||||t||||||||||2017-02-18 13:09:09.057816|2017-02-18 13:09:09.057816
NCT00885235|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-08-02|||October 2008||2008-10-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|||Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure|Evaluation of the PillCam Colon Capsule Endoscopy Preparation and Procedure|Completed||N/A|40|Anticipated|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 13:09:09.136221|2017-02-18 13:09:09.136221
NCT00885222|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-06-02|||May 2009||2009-05-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease Patients|Antidepressant Effect of Deep Brain Stimulation (DBS) in Parkinson's Disease (PD) Patients: Relationship of Stimulation Parameters to Improvement in the Clinical Features of Depression in PD Patients.|Completed||N/A|20|Anticipated|Hadassah Medical Organization||3|||f||||||||||||||2017-02-18 13:09:09.232175|2017-02-18 13:09:09.232175
NCT00885209|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-03-10|||February 2008||2008-02-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Observational|||Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure|Evaluation of the PillCam Colon Capsule Endoscopy Preparation and Procedure|Completed||N/A|127|Actual|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 13:09:09.338808|2017-02-18 13:09:09.338808
NCT00885196|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2016-11-15|||April 2009||2009-04-01|April 2016|2016-04-01||||August 2011|Actual|2011-08-01||Interventional|||A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis|A Double Blind, Randomized, Placebo Controlled, Multicenter, Dose Finding Study of Oral AEB071 Assessing Psoriasis Area and Severity Index (PASI) Response and a Function of Dose and Treatment Duration (Primary Outcome) in Patients With Plaque Psoriasis|Completed||Phase 2|336|Actual|Novartis||4|||f||||||||||||||2017-02-18 13:09:09.430713|2017-02-18 13:09:09.430713
NCT00885183|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-19|2012-05-11|||April 2009||2009-04-01|May 2012|2012-05-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|Acubreast||Adjuvant Acupuncture Care for Breast Cancer Patients Experiencing Side Effects From Chemotherapy|Adjuvant Acupuncture Care for Breast Cancer Patients Experiencing Side Effects From Chemotherapy. A Randomised Controlled Pilot and Feasibility Study|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital of North Norway||1|||f||||f||||||||||2017-02-18 13:09:09.784048|2017-02-18 13:09:09.784048
NCT00885170|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-02-12|||April 2009||2009-04-01|February 2015|2015-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (0822-042)(COMPLETED)|A Phase IIa Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of Odanacatib (MK0822) on Bone Mineral Density (BMD) and Overall Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate|Completed||Phase 2|247|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 13:09:09.881348|2017-02-18 13:09:09.881348
NCT00885157|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2014-01-20|||April 2009||2009-04-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly|Immunogenicity and Safety of Fractional Booster Dose of Sanofi Pasteur's Inactivated Poliomyelitis Vaccine (IMOVAX Polio) Administered Intradermally Versus Full Booster Dose of Inactivated Poliomyelitis Vaccine (IMOVAX Polio) Administered Intramuscularly at 15 to 18 Months of Age in Healthy Toddlers in The Philippines|Completed||Phase 2|225|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:09:09.986051|2017-02-18 13:09:09.986051
NCT00885144|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-06-23|||April 2009||2009-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|iLiNS-ACCEPT-M||Trial on the Acceptability of Modified Lipid Based Nutrient Supplements Among Malawian Infants|Differential Acceptability of New Lipid Based Nutrient Supplement (LNS) Formulations for Prevention of Moderate Malnutrition|Completed||Phase 1|19|Actual|University of Tampere||1|||f||||f||||||||||2017-02-18 13:09:10.090533|2017-02-18 13:09:10.090533
NCT00885118|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2014-11-13|2014-05-16||April 2009||2009-04-01|November 2014|2014-11-01||||October 2009|Actual|2009-10-01||Interventional|||4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)|A Phase II, Randomised, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Once Daily Oral Administration of BI 10773 (1 mg, 5 mg, 10 mg, and 25 mg) for 28 Days in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|100|Actual|Boehringer Ingelheim|Additional secondary endpoints were listed in the original protocol. Those endpoints are of exploratory nature only and were not considered relevant for trial conclusions. For more information see tab “Full Text Review”, section “More Information”.|5|||f||||||||||||||2017-02-18 13:09:10.295686|2017-02-18 13:09:10.295686
NCT00885105|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2016-04-12|2009-09-02||October 2005||2005-10-01|April 2016|2016-04-01|September 2007|Actual|2007-09-01|January 2006|Actual|2006-01-01||Interventional|||Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age|Evaluation of Serologic Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® Vaccine at 2 Months of Age|Completed||Phase 3|242|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:09:12.153678|2017-02-18 13:09:12.153678
NCT00885092|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-03-21|2012-02-24||March 2009||2009-03-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Single Site Study of the Wettability of Contact Lenses With an Investigational Multi-Purpose Disinfecting Solution vs. a Marketed Multi-Purpose Solution|Wettability of Silicone Hydrogel Lenses With SiH MPDS FID 114675A vs. A Marketed Multi-Purpose Solution|Completed||N/A|40|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:09:12.86657|2017-02-18 13:09:12.86657
NCT00885079|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-19|2013-11-18|2013-09-12||May 2009||2009-05-01|November 2013|2013-11-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Confirmatory Study of OPC-12759 Ophthalmic Suspension|Confirmatory Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients|Completed||Phase 3|188|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 13:09:13.177569|2017-02-18 13:09:13.177569
NCT00885066|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2015-02-08|||May 2008||2008-05-01|February 2015|2015-02-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer|Phase I Study of Gemcitabine, Capecitabine, and Erlotinib Together in Advanced Pancreatic Cancers|Completed||Phase 1|30|Actual|Centre Antoine Lacassagne||1|||f||||||||||||||2017-02-18 13:09:13.649975|2017-02-18 13:09:13.649975
NCT00885053|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-01-25|||April 2009||2009-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ADIPOMEGA||Fish Oil and Inflammation in Overweight Subjects|The Effect of Acute and Short-term Intervention With Fish Oil on Overweight Subjects - Focus on Inflammation|Completed||N/A|50|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-02-18 13:09:13.755294|2017-02-18 13:09:13.755294
NCT00885040|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2017-01-24|||April 7, 2009||2009-04-07|December 22, 2016|2016-12-22||||||||Observational|||Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement Disorders|Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement Disorders|Recruiting||N/A|110|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:09:13.866963|2017-02-18 13:09:13.866963
NCT00885027|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-11-13|||March 2009||2009-03-01|November 2013|2013-11-01||||April 2009|Actual|2009-04-01||Observational|||MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment|Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment|Completed||N/A|1342|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 13:09:13.97865|2017-02-18 13:09:13.97865
NCT00885014|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-03-15|||April 2009||2009-04-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|||Telephone Cognitive-Behavioral Therapy (CBT) for Subthreshold Depression and Presenteeism in Workplace|Telephone Cognitive-behavioral Therapy for Subthreshold Depression and Presenteeism in Workplace: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|118|Actual|Kyoto University||2|||f||||t||||||||||2017-02-18 13:09:14.272838|2017-02-18 13:09:14.272838
NCT00885001|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-04-20|||April 2009||2009-04-01|April 2009|2009-04-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||The Effects of Short Arc Banding|The Effects of Short Arc Banding: A Novel Exercise Intervention in Patients With Chronic Low Back Pain|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Logan College of Chiropractic||1|||f||||f||||||||||2017-02-18 13:09:14.375376|2017-02-18 13:09:14.375376
NCT00884988|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-19|2012-02-19|||February 2010||2010-02-01|February 2012|2012-02-01||||December 2012|Anticipated|2012-12-01||Interventional|||Lymphomyosot for Ankle Edema Following Fracture|The Efficacy of Lymphomyosot in the Treatment of Posttraumatic Edema Following Ankle Fracture, Pending Surgery: a Randomized, Double-blind, Placebo-controlled Study.|Suspended||Phase 2|60|Anticipated|Shaare Zedek Medical Center||2||Study recruiter withdrew from study. Suspended until replacement found.|f||||f||||||||||2017-02-18 13:09:14.472055|2017-02-18 13:09:14.472055
NCT00884975|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-20|||May 2002||2002-05-01|April 2009|2009-04-01|June 2009|Anticipated|2009-06-01|March 2009|Actual|2009-03-01||Observational|||Exacerbations and Health Related Quality of Life in Chronic Obstructive Pulmonary Disease|Exacerbations and Health Related Quality of Life in Chronic Obstructive Pulmonary Disease: CRECOPD Study|Unknown status|Active, not recruiting|N/A|102|Actual|University of Thessaly|||1||f||||t||||||||||2017-02-18 13:09:14.570254|2017-02-18 13:09:14.570254
NCT00884962|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2011-10-20|||December 2008||2008-12-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema||Completed||Phase 1|25|Actual|Aeris Therapeutics||1|||f||||||||||||||2017-02-18 13:09:14.646538|2017-02-18 13:09:14.646538
NCT00884949|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2014-05-28|2014-03-13||April 2009||2009-04-01|May 2014|2014-05-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA|A Phase 1/2, Multicenter, Open-label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)|Completed||Phase 1/Phase 2|20|Actual|BioMarin Pharmaceutical||1|||f||||f||||||||||2017-02-18 13:09:14.759058|2017-02-18 13:09:14.759058
NCT00884936|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-03-30|||August 2008||2008-08-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Observational|||Identification of Gene Biomarkers in Aging Skin|Identification of Gene Biomarkers in Aging Skin; a Blinded, Prospective, Single-center, Clinical Study|Completed||N/A|121|Actual|Interleukin Genetics, Inc.|||3||f||||t||||||Samples With DNA|"~     A 4 mm punch biopsy taken from exposed and unexposed skin.~   "|||2017-02-18 13:09:15.911984|2017-02-18 13:09:15.911984
NCT00884910|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-07-12|2010-08-02||February 2008||2008-02-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Long Term Use of the Provox Vega 22.5|"Amendment on Phase 1 Trial N07VEG Assessment of a Next Generation Indwelling Provox Voice Rehabilitation System (Vega). Amendment 3: Long-term Use of the Provox Vega"|Completed||Phase 2|33|Actual|Atos Medical AB||1|||f||||f||||||||||2017-02-18 13:09:16.012474|2017-02-18 13:09:16.012474
NCT00884897|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-04-02|||January 2010||2010-01-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Oxytocin and Social Cognition in Schizophrenia|Oxytocin and Social Cognition in Schizophrenia|Completed||Phase 2|28|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 13:09:16.246887|2017-02-18 13:09:16.246887
NCT00884884|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-10-05|||September 2007||2007-09-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|AT||Aripiprazole and Topiramate on Free-Choice Alcohol Use|Aripiprazole and Topiramate on Free-Choice Alcohol Use|Completed||Phase 2/Phase 3|90|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||9|||f||||f||||||||||2017-02-18 13:09:16.351187|2017-02-18 13:09:16.351187
NCT00884871|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-11-10|||September 2007||2007-09-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders|A Prospective Cohort Study of the Impact of Surgically-Induced Weight Loss on Pelvic Floor Disorders|Completed||N/A|100|Anticipated|University of California, San Diego|||1||f||||f||||||||||2017-02-18 13:09:16.47675|2017-02-18 13:09:16.47675
NCT00884858|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-04-29|||April 2009||2009-04-01|April 2013|2013-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects|Use of Maraviroc (MVC) in Immunological Non-responder HIV-1-infected Patients.|Completed||Phase 4|100|Actual|Ospedale L. Sacco – Polo Universitario||2|||f||||f||||||||||2017-02-18 13:09:16.570226|2017-02-18 13:09:16.570226
NCT00884845|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-03-25|||January 2009||2009-01-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid Tumors|Phase I Multicenter, Open-label, Dose-escalating Clinical and Pharmacokinetic Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid Tumors|Completed||Phase 1|35|Actual|PharmaMar||1|||f||||f||||||||||2017-02-18 13:09:16.691305|2017-02-18 13:09:16.691305
NCT00884832|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2014-01-20|2013-10-16||October 2008||2008-10-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Placebo-Controlled Study of Clonidine for Fecal Incontinence.|A Placebo-Controlled Study of Clonidine for Fecal Incontinence.|Completed||Phase 2|44|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:09:16.987265|2017-02-18 13:09:16.987265
NCT00884819|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2015-04-01|||December 2008||2008-12-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome|Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome. A Randomized, Double-Blind, Placebo-Controlled Trial|Terminated||N/A|4|Actual|Lawson Health Research Institute||2||Poor recruitment|f||||f||||||||||2017-02-18 13:09:17.685826|2017-02-18 13:09:17.685826
NCT00884806|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-03-21|2012-02-20||March 2009||2009-03-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||7-Day, Multi-Site Study of an Investigational Multi-Purpose Disinfecting Solution for Contact Lens Wearers|Corneal Staining Evaluation of SiH MPDS FID 114675A|Completed||N/A|110|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:09:17.798431|2017-02-18 13:09:17.798431
NCT00884793|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2012-06-18|2011-08-08||September 2008||2008-09-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|PLUS||Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut|A Prospective Longitudinal Pilot Study to Measure the Effect of Intensification With Raltegravir +/- a Protease Inhibitor (PI) or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) on HIV-1 Levels in the Gut|Completed||N/A|8|Actual|University of California, San Francisco|1) relatively small number of participants; 2) intensification may have been too short; 3)the biopsies themselves can cause inflammation/microbial leakage; 4) sampling may miss viral replication if it occurs in temporally and spatially-discrete foci|1|||f||||t||||||||||2017-02-18 13:09:17.990853|2017-02-18 13:09:17.990853
NCT00884780|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-07-30|||April 2009||2009-04-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||Development of a New Electronic Measure of Pediatric Pain: A Pilot Study|Development of a New Electronic Measure of Pediatric Pain: A Pilot Study|Completed||N/A|20|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-02-18 13:09:18.265299|2017-02-18 13:09:18.265299
NCT00884767|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2009-07-07|||September 2007||2007-09-01|July 2009|2009-07-01||||August 2009|Anticipated|2009-08-01||Interventional|||Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin|Characterization and Research of Predictive Markers of Neurotoxicity During Treatment With Oxaliplatin in Colorectal Carcinoma: a Genetic and Proteomic Approach. Phase II Multicenter Study|Unknown status|Recruiting|Phase 2|206|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:09:18.353267|2017-02-18 13:09:18.353267
NCT00884754|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-12-13|2010-12-13||March 2009||2009-03-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Comparison of GlideScope-Specific Rigid Stylet to Standard Malleable Stylet for GlideScope Intubation by Novice Operators|Comparison of GlideScope-Specific Rigid Stylet to Standard Malleable Stylet for GlideScope Intubation by Novice Operators|Completed||N/A|60|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 13:09:18.452758|2017-02-18 13:09:18.452758
NCT00884741|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2016-11-14|2015-12-18||April 2009||2009-04-01|November 2016|2016-11-01||||March 2013|Actual|2013-03-01||Interventional||All eligible patients. Note that the Pre-Randomization TMZ+RT arm only includes eligible patients that did not continue to randomization.|Temozolomide (TMZ) and Radiation Therapy (RT) With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)|Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma|Active, not recruiting||Phase 3|637|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 13:09:18.740178|2017-02-18 13:09:18.740178
NCT00884351|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2017-01-24|||April 15, 2009||2009-04-15|June 15, 2011|2011-06-15|June 15, 2011||2011-06-15|||||Observational|||Magnetoencephalography in Absence Seizures|Magnetoencephalography in Absence Seizures|Completed||N/A|5|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:09:25.029964|2017-02-18 13:09:25.029964
NCT00884728|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2009-04-20|||September 2004||2004-09-01|April 2009|2009-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|EAHSP||Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory|East Arnhem Healthy Skin Project: A Regional Collaboration to Reduce Scabies, Skin Sores and Associated Chronic Diseases, Including Rheumatic Fever and Renal Disease, Among Australian Aboriginal Communities|Completed||N/A|2329|Actual|Menzies School of Health Research|||1||f||||f||||||Samples Without DNA|"~     throat swabs, pyoderma swabs and skin scrapings for tinea where individual consent was~     obtained within selected participating communities~   "|||2017-02-18 13:09:20.501819|2017-02-18 13:09:20.501819
NCT00884715|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-09-17||2013-09-09|July 2009||2009-07-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome|Open Label Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Two Doses of an Octreotide Implant in Patients With Carcinoid Syndrome|Terminated||Phase 1/Phase 2|10|Actual|Endo Pharmaceuticals||2||Program was terminated for business reasons|f||||f||||||||||2017-02-18 13:09:20.598257|2017-02-18 13:09:20.598257
NCT00884702|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2017-01-24|||April 16, 2009||2009-04-16|May 2, 2016|2016-05-02||||||||Observational|||Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation|Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation|Recruiting||N/A|580|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:09:20.703057|2017-02-18 13:09:20.703057
NCT00884689|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2011-03-30|||April 2009||2009-04-01|March 2011|2011-03-01|June 2010|Actual|2010-06-01|||||Observational|||A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®|A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART® 1-2 Inhalations b.i.d. as Maintenance Therapy Plus Additional Inhalations As-needed, Compared to Patients Treated With a Free Combination of an Inhaled Glucocorticosteroid and an Inhaled Long Acting ß2-agonist Plus as Needed Inhalations of a Short Acting ß2 Agonist.|Completed||N/A|500|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:09:20.808551|2017-02-18 13:09:20.808551
NCT00884676|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2015-10-08|||November 2008||2008-11-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|November 2013|Actual|2013-11-01||Interventional|||Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors|A Phase I Trial of Weekly and Every Three Weeks Ixabepilone and Sunitinib in Solid Tumor Patients|Completed||Phase 1|36|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 13:09:20.930855|2017-02-18 13:09:20.930855
NCT00884663|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2013-12-22|||April 2009||2009-04-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Candesartan Versus Propranolol for Migraine Prevention|Candesartan vs Propranolol for Migraine Prevention: A Double Blind, Placebo Controlled, Double Dummy, Triple Cross-over Study|Completed||Phase 2/Phase 3|72|Actual|Norwegian University of Science and Technology||3|||f||||t||||||||||2017-02-18 13:09:21.118552|2017-02-18 13:09:21.118552
NCT00884650|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2011-06-20|||June 2005||2005-06-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Managing Post-operative Pain in Children With Cerebral Palsy Using a Pain Pump|Comparing the Effectiveness of an Anesthetic Continuous-infusion Device to Oral Analgesia in Orthopedic Postoperative Pain Control of Children With Cerebral Palsy|Completed||N/A|54|Actual|Children's Hospital Colorado||2|||f||||f||||||||||2017-02-18 13:09:21.232824|2017-02-18 13:09:21.232824
NCT00884637|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2014-10-02|||June 2009||2009-06-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Observational|||Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects|Correlation Between Visual Field Defects on Home Macular Perimeter (FORESEE HOME) and on OCT in Eyes of Patients With CNV Before and After Treatment|Completed||N/A|15|Actual|Notal Vision Ltd|||1||f||||f||||||||||2017-02-18 13:09:21.341707|2017-02-18 13:09:21.341707
NCT00884624|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-20|2010-03-10|||March 2009||2009-03-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Evaluation of the PillCam™ Colon Capsule -2 System|Evaluation of the PillCam™ Colon Capsule -2 System|Completed||N/A|255|Actual|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 13:09:21.443468|2017-02-18 13:09:21.443468
NCT00884611|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2015-03-05|||May 2007||2007-05-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Development of Algorithms for a Hypoglycemic Prevention Alarm: Closed Loop Study|Development of Algorithms for a Hypoglycemic Prevention Alarm|Completed||N/A|28|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 13:09:21.544827|2017-02-18 13:09:21.544827
NCT00884598|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-18|2010-04-27|||December 2008||2008-12-01|April 2010|2010-04-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|CIRAB||Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer|Cilengitide (EMD121974) in Combination With Whole Brain Radiotherapy in Patients With Brain Metastases From Lung Cancer - a Single-center, Open-label Phase I Study|Unknown status|Recruiting|Phase 1|21|Anticipated|Universitätsmedizin Mannheim||1|||f||||t||||||||||2017-02-18 13:09:21.655376|2017-02-18 13:09:21.655376
NCT00884585|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-11-02|2012-09-27||May 2009||2009-05-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis||Completed||Phase 3|176|Actual|Allergan||2|||f||||f||||||||||2017-02-18 13:09:21.76437|2017-02-18 13:09:21.76437
NCT00884559|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-08-24|||November 2005||2005-11-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Leadership Instructions Improve Cardiopulmonary Resuscitation in a High Fidelity Simulation|Brief Leadership Instructions Improve Cardiopulmonary Resuscitation in a High Fidelity Simulation: a Randomised Controlled Trial|Completed||N/A|237|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 13:09:22.356433|2017-02-18 13:09:22.356433
NCT00884546|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2016-09-28|||July 2009||2009-07-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma|A Phase Ib Multiple Ascending Dose Study of BMS-833923 Alone or in Combination With Lenalidomide (Revlimid) Plus Dexamethasone or in Combination With Bortezomib (Velcade) in Subjects With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|27|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 13:09:22.459004|2017-02-18 13:09:22.459004
NCT00884533|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2015-04-15|||June 2009||2009-06-01|April 2015|2015-04-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|Rosi XR||QTc Study of Rosi XR in Healthy Volunteers|A Study to Evaluate the Effect of Extended Release Rosiglitazone (RSG XR) on Cardiac Conduction as Compared to Placebo and a Single Oral Dose of Moxifloxacin|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||3||The whole project was terminated|f||||||||||||||2017-02-18 13:09:22.578237|2017-02-18 13:09:22.578237
NCT00884520|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2010-03-15|||April 2009||2009-04-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|VM4-037||An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037|An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037|Completed||Early Phase 1|16|Anticipated|Siemens Molecular Imaging||1|||f||||f||||||||||2017-02-18 13:09:22.686183|2017-02-18 13:09:22.686183
NCT00884507|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2016-11-01||2016-07-08|May 2009||2009-05-01|November 2016|2016-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease|A Dose-ranging, Randomized, Double-blind , Placebo-controlled Study of the Effect of RO5313534, Used as add-on Therapy to Donepezil, on Cognitive Function in Patients With Mild to Moderate Symptoms of Alzheimer's Disease|Completed||Phase 2|389|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 13:09:22.794069|2017-02-18 13:09:22.794069
NCT00884494|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2017-01-18|||August 2011||2011-08-01|January 2017|2017-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Ghrelin and Insulin Resistance|Role of Ghrelin in the Improvement of Insulin Resistance After Roux-en-Y Gastric Bypass Surgery|Completed||Phase 1|20|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-02-18 13:09:22.959415|2017-02-18 13:09:22.959415
NCT00884481|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2015-07-09|||March 2009||2009-03-01|July 2015|2015-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|TYNERGY||Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS|A Multi-centre and Prospective Trial to Evaluate the Effects on Multiple Sclerosis Related Fatigue During Treatment With Tysabri in Patients With Relapsing Remitting Multiple Sclerosis Over the Course of 12 Months|Completed||N/A|200|Actual|Biogen|||1||f||||f||||||||||2017-02-18 13:09:23.062973|2017-02-18 13:09:23.062973
NCT00884468|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-05-26|||May 2008||2008-05-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis|Anxiety and Depression in Patients With Psoriatic Arthritis: Prevalence and Characteristics|Completed||N/A|384|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 13:09:23.172399|2017-02-18 13:09:23.172399
NCT00884455|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2016-05-31|||December 2002||2002-12-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Alpha-1 Foundation DNA and Tissue Bank|Alpha-1 Foundation DNA and Tissue Bank|Enrolling by invitation||N/A|5000|Anticipated|University of Florida|||1||f||||f||||||Samples With DNA|"~     blood, liver and lung~   "|||2017-02-18 13:09:23.260055|2017-02-18 13:09:23.260055
NCT00884442|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-10-20|||April 2009||2009-04-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions|Randomized, Non-blind, 4-fold Crossover Study on Safety, Tolerability and Pharmacokinetics of Nifedipine After Single Oral Doses of Adalat® LA 60 mg or of a Marketed Generic Version of Nifedipine Retard 60 mg After an Overnight Fasting or Immediately After a High-fat American Breakfast in Healthy Male Volunteers|Completed||Phase 1|28|Actual|SocraTec R&D GmbH||4|||f||||f||||||||||2017-02-18 13:09:23.351114|2017-02-18 13:09:23.351114
NCT00884429|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-08-28|||April 2009||2009-04-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|ECPAVB||Effectiveness of Chest Physiotherapy in Infants With Acute Viral Bronchiolitis|Effectiveness of Chest Physiotherapy Actual Versus Conventional Techniques in Infants With Acute Viral Bronchiolitis. Random Clinical Trial|Completed||N/A|33|Actual|Hospital Sirio-Libanes||3|||f||||t||||||||||2017-02-18 13:09:23.459542|2017-02-18 13:09:23.459542
NCT00884416|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2014-10-31|||March 2009||2009-03-01|October 2014|2014-10-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Sorafenib in Newly Diagnosed High Grade Glioma|Phase I Dose Finding Study of Sorafenib in Combination With Radiation Therapy and Temozolomide as a First Line Treatment of Patients With High Grade Glioma|Completed||Phase 1|17|Actual|University Hospital, Geneva||1|||f||||t||||||||||2017-02-18 13:09:23.562133|2017-02-18 13:09:23.562133
NCT00884403|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2014-03-14|||September 2008||2008-09-01|March 2014|2014-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Gestational Age is Underestimated by Menstrual Dating Compared to Ultrasound Dating in Those Undergoing Abortion up to 20 Weeks|Gestational Age is Underestimated by Menstrual Dating Compared to Ultrasound Dating in Those Undergoing Abortion up to 20 Weeks|Completed||N/A|415|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 13:09:23.854103|2017-02-18 13:09:23.854103
NCT00884390|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-08-20|2014-03-20||May 2009||2009-05-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings|A Postauthorization Safety Surveillance Study Of Patients Switching To ReFacto AF From ReFacto Or Other Factor VIII Products In Usual Care Settings|Terminated||Phase 4|208|Actual|Pfizer|The study was terminated early by agreement with the EMA before full recruitment was attained, but this is not considered to affect the overall results and the ability of the study to address its objectives.|1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:09:23.962431|2017-02-18 13:09:23.962431
NCT00884377|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-04-17|||February 2004||2004-02-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis|A Phase I/II Randomized Comparison of Localized Heat Therapy Versus Sodium Stibogluconate (Pentostam) for the Treatment of Old World Cutaneous Leishmaniasis (HSRRB Log No. A-12364)|Completed||Phase 2|60|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-02-18 13:09:24.67996|2017-02-18 13:09:24.67996
NCT00884364|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-12-21|||May 2009||2009-05-01|December 2009|2009-12-01|September 2011|Anticipated|2011-09-01|April 2011|Anticipated|2011-04-01||Interventional|||Exercise During Chemotherapy for Patients With Hematological Malignancies|Exercise During Chemotherapy for Patients With Hematological Malignancies|Unknown status|Recruiting|Phase 3|60|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:09:24.930666|2017-02-18 13:09:24.930666
NCT00884338|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-12-18|||May 2009||2009-05-01|December 2009|2009-12-01|September 2011|Anticipated|2011-09-01|August 2011|Anticipated|2011-08-01||Interventional|||Cognitive Function After Stem Cell Transplantation|Evaluation of the Cognitive Function of Patients After Stem Cell Transplantation|Unknown status|Recruiting|Phase 3|60|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:09:25.10885|2017-02-18 13:09:25.10885
NCT00884325|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-08-14|2013-04-23||February 2009||2009-02-01|August 2013|2013-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Management of Pruritus With Xyzal in Atopic Dermatitis|Management of Pruritus With Xyzal in Atopic Dermatitis in a Randomized, Double-Blind, Placebo Controlled Study|Completed||Phase 4|40|Actual|Derm Research, PLLC|Small number of subjects. Of 40 subjects enrolled, only 33 completed the 4 week study.|2|||f||||f||||||||||2017-02-18 13:09:25.220247|2017-02-18 13:09:25.220247
NCT00884312|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2017-01-03|||April 2009||2009-04-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||A Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols|An Open-Label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols|Active, not recruiting||Phase 2|100|Anticipated|Onyx Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:09:25.626496|2017-02-18 13:09:25.626496
NCT00884299|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-20|||January 2004||2004-01-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|March 2008|Actual|2008-03-01||Interventional|||Nutritional Enhancement in Chronic Obstructive Pulmonary Disease (COPD)|Nutritional Enhancement in COPD: Randomized, Controlled Trial|Completed||N/A|120|Actual|University of Thessaly||2|||f||||t||||||||||2017-02-18 13:09:25.759484|2017-02-18 13:09:25.759484
NCT00884286|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2011-02-10|||December 2004||2004-12-01|February 2011|2011-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma|A Phase II Multicenter, Open-Label, Clinical And Pharmacokinetic Study of Aplidin® As A 1-Hour Weekly IV Infusion, in Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|67|Actual|PharmaMar||1|||f||||f||||||||||2017-02-18 13:09:25.858357|2017-02-18 13:09:25.858357
NCT00884273|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-10-21|2012-02-01||August 2009||2009-08-01|October 2013|2013-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients|A Randomised, Parallel-arm, Open-label Trial Comparing Degarelix With Goserelin Plus Anti-androgen Flare Protection (Bicalutamide), in Terms of Volume Reduction of the Prostate in Patients With Prostate Cancer Being Candidates for Medical Castration|Completed||Phase 3|182|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:09:25.98969|2017-02-18 13:09:25.98969
NCT00884260|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-08-20|||April 2009||2009-04-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China|Multi-center, Open Label, Single Arm Study to Assess Efficacy, Safety, Bleeding Pattern and Pharmacokinetics of the Ultra Low Dose Levonorgestrel Intrauterine Contraceptive System (LCS) for a Maximum of 3 Years in Women 18 to 40 Years of Age|Completed||Phase 3|918|Actual|Bayer||1|||f||||f||||||||||2017-02-18 13:09:27.221714|2017-02-18 13:09:27.221714
NCT00884247|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2010-12-06|||April 2009||2009-04-01|December 2010|2010-12-01|June 2009|Actual|2009-06-01|||||Observational|||Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity|A Prospective, Non Interventional Study to Evaluate the Effects on Quality of Life, Symptoms and Productivity in Patients With Gastroesophageal Reflux Disease (GERD) After 6 Weeks Structured Treatment in a Company Health Care Setting|Completed||N/A|36|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:09:27.339538|2017-02-18 13:09:27.339538
NCT00884234|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-10-25||2010-09-23|February 2009||2009-02-01|October 2013|2013-10-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines|A Phase 2, Double-Blind, Randomized, Parallel-Group, Controlled, Repeat Dose, Single Center Study to Evaluate the Safety and Efficacy of RT001, a Botulinum Toxin Type A Topical Gel, for the Treatment of Moderate to Severe Lateral Canthal Lines In Adults|Completed||Phase 2|30|Actual|Revance Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 13:09:27.509165|2017-02-18 13:09:27.509165
NCT00884221|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-04-18|2012-02-14||July 2009||2009-07-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01||Interventional|MEGASET||MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer|A Randomized, Open-label, Assessor-blind, Parallel Groups, Multicentre Trial Comparing the Efficacy of MENOPUR Versus Recombinant FSH in Controlled Ovarian Stimulation Following a GnRH Antagonist Protocol and Single Embryo Transfer|Completed||Phase 3|749|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:09:27.62701|2017-02-18 13:09:27.62701
NCT00884208|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-04-17|||April 2009||2009-04-01|April 2009|2009-04-01||||||||Observational|||Fall Risk Prediction and Reduction in Community Ambulators 65 Years of Age or Older|Fall Risk Prediction and Reduction in Community Ambulators 65 Years of Age or Older|Unknown status|Recruiting|N/A|50|Anticipated|Guthrie Healthcare System|||2||f||||f||||||||||2017-02-18 13:09:28.679077|2017-02-18 13:09:28.679077
NCT00884195|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2011-05-25|||January 2009||2009-01-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|September 2011|Anticipated|2011-09-01||Interventional|||Journaling and Weight Loss|Journaling and Weight Loss|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-02-18 13:09:28.753503|2017-02-18 13:09:28.753503
NCT00884182|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-01-10|||April 2009||2009-04-01|January 2014|2014-01-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children|Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in European Children|Completed||Phase 2|350|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 13:09:28.856643|2017-02-18 13:09:28.856643
NCT00884169|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2010-11-02|||July 2009||2009-07-01|November 2010|2010-11-01|December 2009||2009-12-01|||||Interventional|||Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients||Completed||Phase 2|||Maruho Co., Ltd.|||||f||||||||||||||2017-02-18 13:09:28.976448|2017-02-18 13:09:28.976448
NCT00884143|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2010-04-19|||July 2009||2009-07-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|TIME 2 CHANGE||Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer|Retrospective Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer in Two Successive Time Periods|Completed||N/A|515|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:09:29.060904|2017-02-18 13:09:29.060904
NCT00884117|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-10-18|2016-06-08||January 2009||2009-01-01|October 2016|2016-10-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|IRIS|All Enrolled Healthy Participants (AEHP) Population: All otherwise healthy participants who entered the study. Due to the imbalance between healthy (n=4553) and immunocompromised participants (n=8), results from immunocompromised participants were not included in any analyses, and data obtained from healthy participants were the focus of the study.|Influenza Resistance Information Study|Influenza Resistance Information Study (IRIS)|Completed||N/A|4561|Actual|Hoffmann-La Roche|This was a non-randomized, observational study and many comparisons were not powered to detect a true statistically significant difference between groups. Inferential analyses should be interpreted with caution.||1||f||||||||||||||2017-02-18 13:09:29.242743|2017-02-18 13:09:29.242743
NCT00884104|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-01-06|||March 2009||2009-03-01|January 2016|2016-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks|A Prospective, Open-label, Observational, Multi-center Study for the Identification of Predictive Factors for the Solifenacin Treatment in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks and Evaluation of Efficacy and Persistency of Add on Solifenacin in Men With Residual Overactive Bladder Symptoms After Previous Monotherapy With Tamsulosin.|Completed||Phase 4|307|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-02-18 13:09:30.131166|2017-02-18 13:09:30.131166
NCT00884091|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2011-12-05|||April 2009||2009-04-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|IC-1-V1||A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects|A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects|Completed||N/A|21|Actual|Taipei Veterans General Hospital, Taiwan|||1||f||||f||||||Samples Without DNA|"~     Plasma samples retained, with no potential for DNA extraction from any retained samples. The~     retained samples will be destroyed after the results published.~   "|||2017-02-18 13:09:30.255578|2017-02-18 13:09:30.255578
NCT00884078|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-04-17|||May 2009||2009-05-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Self Harm in Females of South Asian Family Origin|Exploratory RCT of Culturally Adapted Manual Assisted Problem Solving Training (C-MAP) for Self Harm in Females of South Asian Family Origin|Unknown status|Not yet recruiting|N/A|20|Anticipated|Lancashire Care NHS Foundation Trust||2|||f||||||||||||||2017-02-18 13:09:30.346091|2017-02-18 13:09:30.346091
NCT00884065|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2015-03-03|2009-02-09||June 2007||2007-06-01|March 2015|2015-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effectiveness of Diacutaneous Fibrolysis in Painful Shoulder|Effectiveness of Diacutaneous Fibrolysis on Pain and Mobility in Patients Suffering From Painful Shoulder. A Randomized Pilot Study.|Completed||N/A|50|Actual|Jordi Gol i Gurina Foundation||2|||f||||||||||||||2017-02-18 13:09:30.452784|2017-02-18 13:09:30.452784
NCT00884052|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-10-21|||April 2007||2007-04-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|March 2011|Actual|2011-03-01||Interventional|Keppra||Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures|Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures|Completed||Phase 1/Phase 2|18|Actual|University of California, San Diego||1|||f||||t||||||||||2017-02-18 13:09:30.940541|2017-02-18 13:09:30.940541
NCT00884039|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2014-08-04|2010-09-20||May 2009||2009-05-01|August 2014|2014-08-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients|Compassionate Use of Anecortave Acetate: Clinical Protocol for the Treatment of Corticosteroid-induced Intraocular Pressure (IOP) Increases After Corneal Transplantation|Terminated||N/A|7|Actual|Cornea Research Foundation of America||2||Preliminary data analysis showed insufficient efficacy to justify continuation.|f||||t||||||||||2017-02-18 13:09:31.049757|2017-02-18 13:09:31.049757
NCT00884026|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-01-22|||March 2009||2009-03-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Can Augmentation Index (AIx) be Used to Predict Hypotension After Spinal Anesthesia?|Pulse Wave Analysis and Augmentation Index Changes Associated With Neuraxial Anesthesia in the Parturient|Completed||N/A|56|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:09:31.501754|2017-02-18 13:09:31.501754
NCT00884013|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-17|||January 2009||2009-01-01|April 2009|2009-04-01||||||||Observational|ehearts||New York City (NYC) Health eHearts Pay for Quality Pilot|Program Evaluation of New York City Health eHearts Pay for Quality Program|Completed||N/A|84|Anticipated|New York City Department of Health and Mental Hygiene|||6||f||||f||||||||||2017-02-18 13:09:31.613133|2017-02-18 13:09:31.613133
NCT00884000|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-07-16|||January 2010||2010-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||A Study of Zomacton in Children With Growth Hormone Deficiency|A Randomised, Open-label, Parallel-group, Multi-centre Trial to Compare the Efficacy and Safety for 12 Months of Zomacton to Genotropin in Children With Idiopathic Growth Hormone Deficiency|Completed||Phase 3|165|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:09:31.709781|2017-02-18 13:09:31.709781
NCT00883987|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-03-05|||June 2009||2009-06-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Osteopathic Treatment of Low Back Pain|A Pilot Project to Study the Effect of Four Osteopathic Treatments on Trunk Muscle Firing Patterns and Temporospatial Parameters of Gait in Persons With Chronic Low Back Pain|Completed||N/A|10|Actual|Nova Scotia Health Authority|||1||f||||f||||||||||2017-02-18 13:09:31.853255|2017-02-18 13:09:31.853255
NCT00883974|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-10-28|||April 2004||2004-04-01|October 2009|2009-10-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||Sensitivity Training For Parents of Preterm Infants|Early Sensitivity Training for Parents of Preterm Infants: Impact on the Developing Brain|Completed||N/A|45|Actual|University of Melbourne||2|||f||||f||||||||||2017-02-18 13:09:31.942037|2017-02-18 13:09:31.942037
NCT00883961|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-12-21|||December 2009||2009-12-01|December 2009|2009-12-01|September 2011|Anticipated|2011-09-01|April 2011|Anticipated|2011-04-01||Interventional|||Exercise Following Autologous Peripheral Blood Stem Cell Transplantation||Unknown status|Recruiting|Phase 3|60|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:09:32.058556|2017-02-18 13:09:32.058556
NCT00883610|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-12-09|||April 2009||2009-04-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Effects Rapid Atrial Pacing Has on the Electrocardiogram (ECG) in Patients With Dual Chamber Pacemakers|Modulation of QT Interval by Rapid Atrial Pacing in Patients With Dual Chamber Pacemakers|Completed||N/A|12|Actual|Vanderbilt University|||1||f||||t||||||||||2017-02-18 13:09:42.953956|2017-02-18 13:09:42.953956
NCT00883948|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2016-04-12|||December 2007||2007-12-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|EDEN||Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study)|Prospective, Randomized, Multi-Center Trial of Initial Trophic Enteral Feeding Followed by Advancement to Full-Calorie Enteral Feeding vs. Early Advancement to Full-Calorie Enteral Feeding in Patients With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)|Completed||Phase 3|1000|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 13:09:32.305072|2017-02-18 13:09:32.305072
NCT00883935|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-06-18|||April 2009||2009-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||GSK1349572 Drug Interaction Study With Atazanavir/Ritonavir and Atazanavir|Phase I, Open Label, Randomized, Drug-Drug Interaction Study in Healthy Subjects to Investigate the Effects of Co-Administered Atazanavir/Ritonavir (300mg/100mg) or Atazanavir 400mg Administered Once Daily on the Steady-State Plasma Pharmacokinetics of GSK1349572 30mg Administered Once Daily|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 13:09:32.469713|2017-02-18 13:09:32.469713
NCT00883922|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-04-17|||January 2007||2007-01-01|April 2009|2009-04-01||||||||Observational|||Central Venous Saturation (ScvO2) Monitoring in Pediatric Patients Undergoing Cardiac Surgery|Central Venous Saturation (ScvO2) Monitoring in Pediatric Patients Undergoing Cardiac Surgery|Unknown status|Recruiting|N/A|100|Anticipated|University of California, Los Angeles|||1||f||||f||||||||||2017-02-18 13:09:32.602037|2017-02-18 13:09:32.602037
NCT00883909|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2016-11-30|||April 2009||2009-04-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||ARI103094-Follow-Up Study for REDUCE Study Subjects|ARI103094-Follow-Up Study for REDUCE Study Subjects|Completed||N/A|2795|Actual|GlaxoSmithKline|||1||f||||f||||||Samples With DNA|"~     PART B: Collection of tissue blocks or unstained slides from positive biopsies.~   "|Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:09:32.695372|2017-02-18 13:09:32.695372
NCT00883896|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-11-12||2012-11-12|June 2009||2009-06-01|November 2012|2012-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis|A Randomized, Parallel, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of ILV-094 Administered Subcutaneously To Subjects With Active Rheumatoid Arthritis On A Stable Background Of Methotrexate|Completed||Phase 2|195|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 13:09:33.130613|2017-02-18 13:09:33.130613
NCT00883883|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-17|||April 2005||2005-04-01|April 2009|2009-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed Conditions|A Single Center, Open, Randomized, 2-Way, 2-Period, 2-Sequence Crossover Study of the Bioequivalence of 250mg/5 ml Cefdinir (Test Formulation) and Omnicel 250mg/5 ml Powder For Oral Suspension (Reference Formulation) Each Given as a Single Oral Dose to Forty Healthy Male and/or Female Volunteers in the Fed State|Completed||Phase 1|40|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:09:33.283595|2017-02-18 13:09:33.283595
NCT00883870|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-03-04|||April 2009||2009-04-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|February 2010|Actual|2010-02-01||Interventional|||Mesenchymal Stem Cells in Critical Limb Ischemia|A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intramuscular ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Critical Limb Ischemia (Cli)|Completed||Phase 1/Phase 2|20|Actual|Stempeutics Research Pvt Ltd||2|||f||||t||||||||||2017-02-18 13:09:33.371647|2017-02-18 13:09:33.371647
NCT00883857|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-04-17|||October 2007||2007-10-01|April 2009|2009-04-01||||||||Observational|||Comparison Endotracheal Cardiac Output Monitor (ECOM) to a Standard Device in Measuring Heart Blood Volume|Comparison Endotracheal Cardiac Output Monitor (ECOM) to a Standard Device in Measuring Heart Blood Volume|Unknown status|Recruiting|N/A|100|Anticipated|University of California, Los Angeles|||1||f||||f||||||||||2017-02-18 13:09:33.474675|2017-02-18 13:09:33.474675
NCT00883844|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-04-18|||April 2009||2009-04-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|PADD||PEG-IFN in HBV Patients With Incomplete Response to NA|Lowering Viral Load With Nucleos(t)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B - a Pilot Study|Completed||Phase 4|11|Actual|Foundation for Liver Research||2|||f||||f||||||||||2017-02-18 13:09:33.544878|2017-02-18 13:09:33.544878
NCT00883831|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2010-01-22|||April 2009||2009-04-01|April 2009|2009-04-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||The Effectiveness and the Safety of Acupuncture for Symptomatic Care of Hemodialysis Patients: A Case-series|Acupuncture for Symptomatic Care of Hemodialysis Patients: a Case-series|Completed||N/A|20|Anticipated|Korea Institute of Oriental Medicine||1|||f||||f||||||||||2017-02-18 13:09:33.643306|2017-02-18 13:09:33.643306
NCT00883818|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-07-05|||January 2007||2007-01-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Microorganism in Overactive Bladder Patients|Detection and Treatment Benefit of Microorganism (Chlamydia Trachomatis, Mycoplasma Hominis, Ureaplasma Urealyticum) in Overactive Bladder Patients|Completed||Phase 4|84|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-02-18 13:09:33.740081|2017-02-18 13:09:33.740081
NCT00883805|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2015-09-16|||April 2009||2009-04-01|September 2015|2015-09-01||||April 2014|Actual|2014-04-01||Observational|||Investigation of Systemic Metal Ion Concentration Following a Ceramic-on-metal Total Hip Arthroplasty|Investigation of Systemic Metal Ion Concentration Following a Ceramic-on-metal Total Hip Arthroplasty|Withdrawn||N/A|0|Actual|Northwell Health|||2|PI moved|f||||f||||||||||2017-02-18 13:09:33.849445|2017-02-18 13:09:33.849445
NCT00883792|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2011-06-09|||May 2009||2009-05-01|June 2011|2011-06-01|July 2036|Anticipated|2036-07-01|June 2026|Anticipated|2026-06-01||Interventional|NordICC||The Northern-European Initiative on Colorectal Cancer|NordICC The Northern-European Initiative on Colorectal Cancer|Recruiting||Phase 3|66000|Anticipated|Norwegian Department of Health and Social Affairs||2|||f||||t||||||||||2017-02-18 13:09:34.044918|2017-02-18 13:09:34.044918
NCT00883597|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2017-01-30|||November 2011||2011-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Sidestream Dark-Field (SDF) Imaging of the Intestinal Microcirculation|Sidestream Dark-Field Imaging of the Intestinal Microcirculation in Clinical Sepsis: The Impact of Activated Protein C Therapy|Active, not recruiting||N/A|36|Anticipated|Nova Scotia Health Authority|||2||f||||f||||||||||2017-02-18 13:09:43.040504|2017-02-18 13:09:43.040504
NCT00883779|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2015-11-10|2015-11-10||April 2009||2009-04-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Full analysis set (FAS) population (Included all enrolled participants).|A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|A Randomized, Placebo-controlled, Double-blind Phase III Study of the Effect of First-line Treatment With Intercalated Tarceva Versus Placebo in Combination With Gemcitabine/Platinum on Progression-free Survival in Patients With Stage IIIB/IV Non-small Cell Lung Cancer|Completed||Phase 3|451|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:09:34.186442|2017-02-18 13:09:34.186442
NCT00883766|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-07-19|||April 2009||2009-04-01|October 2010|2010-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1|PCOS and IVF: A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1|Terminated||N/A|172|Anticipated|Institut Universitari Dexeus||2|||f||||f||||||||||2017-02-18 13:09:35.178203|2017-02-18 13:09:35.178203
NCT00883753|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2014-08-04|2014-06-18||March 2009||2009-03-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy|An Extension Phase of the Multi-National Open-Label Study (MA21573) to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have an Inadequate Response to Current Non-biologic DMARD and/or Anti-TNF Therapy.|Completed||Phase 3|934|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:09:37.502141|2017-02-18 13:09:37.502141
NCT00883740|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2011-07-14|2011-05-16||June 2009||2009-06-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia|Effects Of Pregabalin On Sleep Maintenance In Subjects With Fibromyalgia Syndrome And Sleep Maintenance Disturbance: A Randomized Placebo-Controlled 2-Way Crossover Polysomnography Study|Completed||Phase 3|119|Actual|Pfizer|The protocol specified analyses of secondary outcome measures (OMs) indicated OMs would use PP population; however all secondary OMs were analyzed using the ITT population in accordance with the statistical analysis plan.|2|||f||||t||||||||||2017-02-18 13:09:40.824659|2017-02-18 13:09:40.824659
NCT00883727|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-03-04|||April 2009||2009-04-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|May 2010|Actual|2010-05-01||Interventional|||Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI|A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intravenous ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With st Elevated Acute Myocardial Infarction (Stemi)|Completed||Phase 1/Phase 2|20|Actual|Stempeutics Research Pvt Ltd||2|||f||||t||||||||||2017-02-18 13:09:41.868413|2017-02-18 13:09:41.868413
NCT00883714|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2009-12-21|||May 2009||2009-05-01|December 2009|2009-12-01|August 2011|Anticipated|2011-08-01|April 2011|Anticipated|2011-04-01||Interventional|||Exercise During the Allogeneic Stem Cell Transplantation|Exercise During the Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|Phase 3|60|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:09:41.969589|2017-02-18 13:09:41.969589
NCT00883701|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2010-04-28|||December 2002||2002-12-01|August 2009|2009-08-01|September 2009|Actual|2009-09-01|August 2008|Actual|2008-08-01||Observational|||Granzymes and Perforin at the Onset of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations|Granzymes and Perforin at the Onset of COPD Exacerbations|Completed||N/A|30|Anticipated|University of Thessaly|||2||f||||t||||||Samples Without DNA|"~     sputum cells and supernatant~   "|||2017-02-18 13:09:42.064566|2017-02-18 13:09:42.064566
NCT00883688|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2015-11-17|||July 2009||2009-07-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma|A Phase II Study of Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma|Completed||Phase 2|24|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:09:42.155759|2017-02-18 13:09:42.155759
NCT00883675|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-10-29|2013-10-29||May 2009||2009-05-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer|Multicenter Exploratory Trial of the Safety and Efficacy of Adjuvant Docetaxel and Carboplatin in Patients With Resected Non-small Cell Lung Cancer|Completed||Phase 4|133|Actual|Maestro Clinical, Inc.||1|||f||||t||||||||||2017-02-18 13:09:42.279338|2017-02-18 13:09:42.279338
NCT00883662|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2016-09-29|||May 2009||2009-05-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|April 2014|Actual|2014-04-01||Observational|||Mirena Observational Program|Mirena Observational Program|Completed||N/A|2725|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a~   "|||2017-02-18 13:09:42.53927|2017-02-18 13:09:42.53927
NCT00883649|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2012-02-16|||September 2008||2008-09-01|February 2012|2012-02-01||||December 2011|Actual|2011-12-01||Interventional|||Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye|A Randomized, Parallel-Group, Placebo-Control, Double-Blind Trial Comparing the Efficacy and Safety of Nutritional Supplementation Containing Omega 3 Fatty Acids and Gamma Linoleic Acid, for Treatment of Keratoconjunctivitis Sicca in Post-Menopausal Females|Completed||N/A|62|Actual|Virginia Eye Consultants||2|||f||||||||||||||2017-02-18 13:09:42.63548|2017-02-18 13:09:42.63548
NCT00883636|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-17|2013-06-18|||October 2008||2008-10-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Observational|||Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis|Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis|Terminated||N/A|4|Actual|Northwell Health|||2|study stopped due to lack of activity|f||||f||||||Samples With DNA|"~     Blood Serum, plasma~   "|||2017-02-18 13:09:42.744341|2017-02-18 13:09:42.744341
NCT00883623|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2013-11-21|||April 2009||2009-04-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|LEOMEX||A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis|A Prospective Single Center Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With AL Amyloidosis|Completed||Phase 2|50|Actual|Heidelberg University||1|||f||||t||||||||||2017-02-18 13:09:42.845263|2017-02-18 13:09:42.845263
NCT00883389|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-12-01|2011-07-31||May 2008||2008-05-01|December 2014|2014-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Med-alert Bracelet in Chronic Kidney Disease|Safe Kidney Care Med-Alert Bracelet/Keytag|Completed||N/A|26|Actual|University of Maryland|||1||f||||f||||||||||2017-02-18 13:09:45.877511|2017-02-18 13:09:45.877511
NCT00883584|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-22|||July 2008||2008-07-01|April 2009|2009-04-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|COPD||IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study|A Phase IIa, Proof of Concept Study to Evaluate the Reduction in Inflammatory Biomarkers and Assess Airway Function Following Administration of IMD-1041 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Institute of Medicinal Molecular Design, Inc.||2|||f||||f||||||||||2017-02-18 13:09:43.120938|2017-02-18 13:09:43.120938
NCT00883571|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-12-28|||April 2002||2002-04-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparative Study of the House Advancement Flap, Rhomboid Flap, and Y-V Anoplasty|Comparative Study of the House Advancement Flap, Rhomboid Flap, and Y-V Anoplasty in Treatment of Anal Stenosis: A Prospective Randomized Study|Completed||N/A|60|Actual|Mansoura University||3|||f||||t||||||||||2017-02-18 13:09:43.232005|2017-02-18 13:09:43.232005
NCT00883558|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2014-08-28|2014-08-28||May 2009||2009-05-01|August 2014|2014-08-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional||Participants who were randomized and received at least 1 dose of study drug.|Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus|A Phase II, Randomized, Open Label, 2-Way Crossover, Safety Study of Subcutaneously Injected Prandial INSULIN-PH20 NP Compared to Insulin Analog Injection in Patients With Type 1 Diabetes|Completed||Phase 2|48|Actual|Halozyme Therapeutics||1|||f||||f||||||||||2017-02-18 13:09:43.349305|2017-02-18 13:09:43.349305
NCT00883545|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2013-01-03|||October 2008||2008-10-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of Adherence to Colonoscopy in Women|The Effect of a Woman Endoscopist on Adherence to Screening Colonoscopy in Women|Completed||N/A|625|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 13:09:43.940371|2017-02-18 13:09:43.940371
NCT00883532|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-08-07|||April 2009||2009-04-01|April 2009|2009-04-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|||Prevention of Chronic Lung Disease (CLD) in Preterm Infants|Prevention of Chronic Lung Disease (CLD) in Preterm Infants -A New Therapeutic Regimen|Unknown status|Recruiting|Phase 4|300|Anticipated|China Medical University, China||2|||f||||t||||||||||2017-02-18 13:09:44.048712|2017-02-18 13:09:44.048712
NCT00883519|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2012-04-12|||January 2009||2009-01-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Efficacy of Parent Involvement in the Treatment of Adolescent Depression|The Efficacy of Parent Involvement in the Treatment of Adolescent Depression|Completed||Phase 1/Phase 2|15|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 13:09:44.174327|2017-02-18 13:09:44.174327
NCT00883506|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||May 2000||2000-05-01|March 2009|2009-03-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed|Randomized, 3-Way Crossover, Bioequivalence Study of Eon Labs Manufacturing Inc. (USA) and Zeneca (USA) (Zestril) 40 mg Lisinopril Tablet Administered as a 1 x 40 mg Tablet in Health Adult Males Under Fasting Conditions Under Fasting and Fed Conditions.|Completed||Phase 1|24|Actual|Sandoz||3|||f||||||||||||||2017-02-18 13:09:44.270646|2017-02-18 13:09:44.270646
NCT00883493|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2012-07-02|2012-02-29||April 2009||2009-04-01|July 2012|2012-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|QUALITY||Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression|A Randomised, Multi-Centre Study to Compare the Efficacy and Safety of Extended Release Quetiapine Fumarate (Seroquel XR TM) Tablets as Mono-Therapy or in Combination With Lithium in the Treatment of Patients With Acute Bipolar Depression|Completed||Phase 3|421|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:09:44.366235|2017-02-18 13:09:44.366235
NCT00883480|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2009-04-16|||June 2005||2005-06-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|SLAT||Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma|Tratamiento Individualizado en función de Las Mutaciones en EGFR y Del Nivel de expresión de BRCA1 en Pacientes Con Adenocarcinoma de pulmón Avanzado|Completed||N/A|153|Actual|Spanish Lung Cancer Group||1|||f||||f||||||||||2017-02-18 13:09:44.959738|2017-02-18 13:09:44.959738
NCT00883467|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||May 2008||2008-05-01|April 2009|2009-04-01||||June 2009|Anticipated|2009-06-01||Interventional|IPC in MRI||The Effects of Preconditioning on Intramuscular High-Energy Phosphate Levels During Ischemia|The Effects of Preconditioning on Intramuscular High-Energy Phosphate Levels During Ischemia|Unknown status|Active, not recruiting|N/A|16|Anticipated|Medical University of Vienna||4|||f||||||||||||||2017-02-18 13:09:45.08051|2017-02-18 13:09:45.08051
NCT00883454|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16||||||April 2009|2009-04-01||||||||Observational|||Estimation of Functional Liver Reserve Using Cholinesterases|Estimation of Functional Liver Reserve in Patients With Hepatocellular Carcinoma in Cirrhosis: the Value of Preoperative Cholinesterases|Completed||N/A|181|Actual|University of Milan|||1||f||||f||||||||||2017-02-18 13:09:45.189737|2017-02-18 13:09:45.189737
NCT00883441|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2013-01-07|||July 2006||2006-07-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|||Implementation Research of New Dengue Vector Control Tools|Implementation Research of New Dengue Vector Control Tools|Completed||N/A|22|Actual|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||||2017-02-18 13:09:45.265095|2017-02-18 13:09:45.265095
NCT00883428|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-03-11|||June 2009||2009-06-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Observational|||Prevalence of Low Back and Pelvic Pain in Pregnant Women|Prevalence of Low Back and Pelvic Pain in Pregnant Women and Factors Associated With a Greater Risk of Having it|Completed||N/A|1158|Actual|Kovacs Foundation|||1||f||||t||||||||||2017-02-18 13:09:45.358195|2017-02-18 13:09:45.358195
NCT00883415|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-12-01|||May 2008||2008-05-01|December 2014|2014-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease|A Study to Evaluate the Effect of the Treatment of Anemia on Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease|Completed||Phase 4|20|Actual|University of Maryland|||1||f||||f||||||||||2017-02-18 13:09:45.483673|2017-02-18 13:09:45.483673
NCT00883402|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2017-01-19|||January 2008||2008-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|ACST-2||Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients|Asymptomatic Carotid Surgery Trial-2 (ACST-2): an International Randomised Trial to Compare Carotid Endarterectomy With Carotid Artery Stenting to Prevent Stroke|Recruiting||N/A|3600|Anticipated|University of Oxford||2|||f||||t||||||||||2017-02-18 13:09:45.604253|2017-02-18 13:09:45.604253
NCT00883376|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||January 2007||2007-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Observational|StanforAIH||Classification of Stanford for Snore as Factor of Aggravation of the Apnea Hypopnea Index (AIH) in Patients With Obstructive Sleep Apnea Syndrome (OSAS)|Classification of Stanford for Snore as Factor of Aggravation of the AIH in Patients With OSAS.|Completed||N/A|159|Actual|Irmandade da Santa Casa de Misericoridia de Limeira|||2||f||||f||||||||||2017-02-18 13:09:46.097406|2017-02-18 13:09:46.097406
NCT00883363|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2015-01-12|||April 2009||2009-04-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PreconRAAA||Reduction of Myocardial Infarction by Preconditioning in Patients With Ruptured Abdominal Aortic Aneurysm|Reduction of Myocardial Infarction by Preconditioning in Patients With Ruptured Abdominal Aortic Aneurysm|Completed||N/A|200|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-02-18 13:09:46.179029|2017-02-18 13:09:46.179029
NCT00883350|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-01-15|||May 2009||2009-05-01|January 2016|2016-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|RIDE||Evaluation of the Remote Intervention for Diet and Exercise (RIDE)|Design and Evaluation of the Remote Intervention for Diet and Exercise (RIDE)|Completed||N/A|40|Actual|Pennington Biomedical Research Center||2|||f||||t||||||||||2017-02-18 13:09:46.327305|2017-02-18 13:09:46.327305
NCT00883337|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2016-05-04|2012-10-03||April 2009||2009-04-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|September 2011|Actual|2011-09-01||Interventional|TENERE||A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis|A Multi-center, Randomized, Parallel-group, Rater-blinded Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis Plus a Long Term Extension Period|Completed||Phase 3|324|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 13:09:46.602463|2017-02-18 13:09:46.602463
NCT00883324|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2011-06-16|||March 2009||2009-03-01|June 2011|2011-06-01||||||||Observational|SpecOp||Comparison of Fetal Fibronectin (fFN) Specimen Collection Methodologies: With Speculum Versus Without Speculum|A Phase IIIB Comparison of Fetal Fibronectin (fFN) Specimen Collection Methodologies: With Speculum Versus Without Speculum|Completed||N/A|329|Anticipated|Hologic, Inc.|||2||f||||f||||||||||2017-02-18 13:09:48.202007|2017-02-18 13:09:48.202007
NCT00883311|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2010-08-29||2010-08-26|January 2009||2009-01-01|August 2010|2010-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis|A Clinical Usage Study to Evaluate the Safety and Efficacy of BRT-FC-83C in the Management of Mild to Moderate Atopic Dermatitis|Completed||Phase 2|32|Actual|Biomed Research & Technologies, Inc.||1|||f||||t||||||||||2017-02-18 13:09:48.301244|2017-02-18 13:09:48.301244
NCT00883298|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-04-01|||April 2009||2009-04-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme|Phase II Study of Bi-Weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Center for Neurosciences, Tucson||1|||f||||t||||||||||2017-02-18 13:09:48.399769|2017-02-18 13:09:48.399769
NCT00883285|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-01-31|||April 2009||2009-04-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Incidence and Severity of Silent and Apparent Cerebral Embolism After Conventional and Minimal-invasive Transfemoral Aortic Valve Replacement|Incidence and Severity of Silent and Apparent Cerebral Embolism After Conventional and Minimal-invasive Transfemoral Aortic Valve Replacement|Completed||N/A|60|Anticipated|University Hospital, Bonn|||3||f||||f||||||||||2017-02-18 13:09:48.510271|2017-02-18 13:09:48.510271
NCT00883272|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2015-10-20|||January 2007||2007-01-01|October 2015|2015-10-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Observational|||Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal Women|Assessment of Femarelle (DT56a), a Novel SERM, Effect on the Clotting Time in Normal and Thrombophililic Postmenopausal Women|Completed||N/A|32|Actual|New York University School of Medicine|||2||f||||f||||||Samples Without DNA|"~     Blood samples were collected in evacuated tubes (Vacutainer, Becton Dickinson) at baseline,~     eight weeks, and one year.~   "|||2017-02-18 13:09:48.597763|2017-02-18 13:09:48.597763
NCT00883259|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2013-04-05|||September 2013||2013-09-01|April 2013|2013-04-01||||December 2013|Anticipated|2013-12-01||Interventional|||Metformin and Gestational Diabetes in High-risk Patients: a RCTs|Metformin Treatment for Preventing Gestational Diabetes in High-risk Patients|Unknown status|Not yet recruiting|Phase 4|80|Anticipated|University Magna Graecia||2|||f||||t||||||||||2017-02-18 13:09:48.702525|2017-02-18 13:09:48.702525
NCT00883246|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2016-01-28|2015-01-23||April 2009||2009-04-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||800 patients were enrolled, but 1 subject’s data were excluded from all analyses due to an invalid informed consent, yielding a cohort of 799 analyzable subjects.|Study of SilverHawk®/TurboHawk® in Lower Extremity Vessels (DEFINITIVE™ LE)|Determination of Effectiveness of SilverHawk Peripheral Plaque Excision (SilverHawk Device) for the Treatment of Infrainguinal Vessels/Lower Extremities|Completed||Phase 4|800|Actual|Medtronic Endovascular|The study’s principal limitations include a lack of randomization and follow-up beyond 12 months.|1|||f||||t||||||||||2017-02-18 13:09:48.812727|2017-02-18 13:09:48.812727
NCT00883233|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2010-11-11|2010-10-11||April 2009||2009-04-01|November 2010|2010-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|FREE||Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris|Efficacy and Safety Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris|Completed||Phase 3|123|Actual|Galderma||4|||f||||f||||||||||2017-02-18 13:09:49.394305|2017-02-18 13:09:49.394305
NCT00883220|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-09-17|||June 2009||2009-06-01|July 2011|2011-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Self Management in Urinary Catheter Users|Self-management of Urine Flow in Long-term Urinary Catheter Users|Completed||Phase 2|202|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 13:09:49.993422|2017-02-18 13:09:49.993422
NCT00883207|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||February 2006||2006-02-01|April 2009|2009-04-01|October 2009|Anticipated|2009-10-01|July 2007|Actual|2007-07-01||Interventional|DINADEP||Dialogical and Narrative Processes in Couple Therapy for Depression|Dialogical and Narrative Processes in Couple Therapy for Depression. Two Year Follow-up Study of the Effectiveness and Processes in Couple Therapy|Unknown status|Recruiting|Phase 2/Phase 3|65|Anticipated|University of Jyvaskyla||1|||f||||f||||||||||2017-02-18 13:09:50.317406|2017-02-18 13:09:50.317406
NCT00883194|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2013-09-12|||October 2010||2010-10-01|September 2013|2013-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Safety and Effectiveness Pilot Study of PRF-108 and PRF-110 in Healthy Volunteers|A Single-center, Randomized, Placebo-controlled, Double-blind, Single-dose, Efficacy of PRF-108 4% and PRF-110 4% Versus Ropivacaine Solution 0.5% in an Experimental Pain Model|Completed||Phase 1/Phase 2|15|Actual|PainReform LTD||4|||f||||f||||||||||2017-02-18 13:09:50.411131|2017-02-18 13:09:50.411131
NCT00883181|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2016-05-06|2016-03-10||December 2007||2007-12-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|January 2010|Actual|2010-01-01||Observational|||A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy|A Prospective Observational Study of Neutropenia and Anemia Management in Subjects With Solid Tumors Receiving Myelotoxic Chemotherapy|Completed||N/A|1370|Actual|Amgen|||1||f||||f||||||None Retained|"~     This is an observational study. No bio-specimens are being collected.~   "|||2017-02-18 13:09:50.539721|2017-02-18 13:09:50.539721
NCT00883168|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2013-06-17|2012-05-21||April 2009||2009-04-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies|Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Azelastine Hydrochloride Nasal Spray and Fluticasone Propionate Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis|Completed||Phase 3|1791|Actual|Meda Pharmaceuticals||4|||f||||f||||||||||2017-02-18 13:09:52.983124|2017-02-18 13:09:52.983124
NCT00883155|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||October 1998||1998-10-01|April 2009|2009-04-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions|To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions.|Completed||Phase 1|36|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:09:53.608522|2017-02-18 13:09:53.608522
NCT00883142|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2013-06-10|||October 2006||2006-10-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|August 2012|Actual|2012-08-01||Observational|||Functional and Physiological Responses to Lokomat Therapy (Pilot Study)|Functional and Physiological Responses to Lokomat Therapy (Pilot Study)|Completed||N/A|27|Actual|VA Office of Research and Development|||1||f||||f||||||Samples With DNA|"~     Serum, plasma and for some muscle biopsy samples~   "|||2017-02-18 13:09:53.69486|2017-02-18 13:09:53.69486
NCT00883129|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2017-02-06|2016-11-06||September 2009||2009-09-01|February 2017|2017-02-01|November 2015|Actual|2015-11-01|January 2015|Actual|2015-01-01||Interventional|SLSII||Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)|Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)|Completed||Phase 2|142|Actual|University of California, Los Angeles|While the rate of premature withdrawal from taking study drug was significant, this was anticipated in the study design and addressed by the sample size and the use of the mixed model statistical analysis.|2|||f||||t||||||||No||2017-02-18 13:09:53.966614|2017-02-18 13:09:53.966614
NCT00883116|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2016-09-21|2013-12-06||August 2009||2009-08-01|September 2016|2016-09-01|February 2014|Actual|2014-02-01|June 2012|Actual|2012-06-01||Interventional|IXAMPLE2|Baseline analyses are for randomized participants.|A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer|A Phase III, Open Label, Randomized, 2 Arm Study of Ixabepilone Administered Every 21 Days Versus Paclitaxel or Doxorubicin Administered Every 21 Days in Women With Advanced Endometrial Cancer Who Have Previously Been Treated With Chemotherapy|Terminated||Phase 3|551|Actual|Bristol-Myers Squibb|This study was terminated per Data Monitoring Committee. Results from an interim analysis showed that there was no favorable benefit/risk ratio with ixabepilone and that ixabepilone did not improve survival compared with control chemotherapies.|2||"Interim analysis results showed that ixabepilone did not improve survival compared with~   control chemotherapies."|f||||t||||||||||2017-02-18 13:09:55.26527|2017-02-18 13:09:55.26527
NCT00883103|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2011-08-10|2011-07-18||November 2007||2007-11-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Double Blinded Randomized Trial Between Lidocaine And Plain Gel For Urethral Straight Catheterization And The Q-Tip Test|Double Blinded Randomized Trial Between Lidocaine Jelly And Plain Aqueous Gel For Urethral Straight Catheterization And The Q-Tip Test|Completed||Phase 4|137|Actual|Baystate Medical Center||2|||f||||t||||||||||2017-02-18 13:09:56.591734|2017-02-18 13:09:56.591734
NCT00883090|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2011-12-07|2011-12-07||May 2009||2009-05-01|December 2011|2011-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency|A 12 Week, Multicenter, Pharmacokinetic and Safety Study of Human Plasma-Derived Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency|Completed||Phase 2|15|Actual|CSL Behring||1|||f||||f||||||||||2017-02-18 13:09:57.323676|2017-02-18 13:09:57.323676
NCT00883077|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-10-13|||April 2009||2009-04-01|October 2009|2009-10-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Observational|||Assessment of Colonic Permeability by Confocal Laser Endomicroscopy|Combined Assessment of Colonic Permeability by Real Time Confocal Laser Endomicroscopy and Sucralose Absorption Test|Unknown status|Recruiting|N/A|30|Anticipated|Shandong University|||3||f||||t||||||Samples With DNA|"~     Biopsies during colonoscopy.~   "|||2017-02-18 13:09:57.660157|2017-02-18 13:09:57.660157
NCT00883064|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||March 2000||2000-03-01|March 2009|2009-03-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Eon Labs Manufacturing Inc. (USA) and Zeneca (USA) (Zestril) 40 mg Lisinopril Tablet Administered as a 1 x 40 mg Tablet in Health Adult Males Under Fasting Conditions.|Completed||Phase 1|32|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:09:57.753731|2017-02-18 13:09:57.753731
NCT00883051|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2010-04-22|||July 2009||2009-07-01|April 2010|2010-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment|A Double Blind Randomized Placebo-Controlled Parallel Group Dose-Ranging Study of Oral COL-144 in the Acute Treatment of Migraine|Completed||Phase 2|450|Anticipated|CoLucid Pharmaceuticals||5|||f||||f||||||||||2017-02-18 13:09:57.83547|2017-02-18 13:09:57.83547
NCT00883038|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2009-04-15|||July 2008||2008-07-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||Does a Low-Fat Vegetarian Diet Improve Insulin Resistance in Individuals With Type 2 Diabetes?|Does a Low-Fat Vegetarian Diet Improve Insulin Resistance in Individuals With Type 2 Diabetes?|Completed||Phase 1|70|Actual|Institute for Clinical and Experimental Medicine||2|||f||||t||||||||||2017-02-18 13:09:58.158645|2017-02-18 13:09:58.158645
NCT00883025|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||February 2007||2007-02-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Observational|FriedmAIH||Correlation Between Friedman Classification and the Apnea Hypopnea Index (AIH) in a Population With Obstructive Sleep Apnea Syndrome (OSAS)|Correlation Between Friedman Classification Ande ApneaHypopnea Index in a Population With OSAS|Completed||N/A|147|Anticipated|Irmandade da Santa Casa de Misericoridia de Limeira|||2||f||||f||||||||||2017-02-18 13:09:58.274376|2017-02-18 13:09:58.274376
NCT00883012|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-04-02|||February 2009||2009-02-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Influenza Vaccine in HIV Infected Children|Immunogenicity, Safety and Efficacy of Influenza Vaccine in HIV Infected Children|Completed||Phase 4|412|Actual|University of Witwatersrand, South Africa||2|||f||||f||||||||||2017-02-18 13:09:58.358614|2017-02-18 13:09:58.358614
NCT00882999|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2012-06-22||2011-06-13|April 2009||2009-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|February 2011|Actual|2011-02-01||Interventional|||A Study of Patients With Relapsing Remitting Multiple Sclerosis|Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|245|Anticipated|Eli Lilly and Company||7|||f||||t||||||||||2017-02-18 13:09:58.486342|2017-02-18 13:09:58.486342
NCT00882986|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2015-09-22|||January 2009||2009-01-01|September 2015|2015-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Cardiovascular and Metabolic Responses to a Mixed Meal|Role of Exercise Training and Body Weight on Cardiovascular and Metabolic Responses to a Mixed Meal Tolerance Test|Completed||N/A|20|Actual|University of Kansas Medical Center|||2||f||||f||||||||||2017-02-18 13:09:58.683503|2017-02-18 13:09:58.683503
NCT00882973|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16||||||April 2009|2009-04-01||||||||Interventional|||Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer||Unknown status|Active, not recruiting|Phase 1/Phase 2|||Samyang Biopharmaceuticals Corporation|||||f||||||||||||||2017-02-18 13:09:58.783118|2017-02-18 13:09:58.783118
NCT00882960|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2011-05-03|||April 2009||2009-04-01|May 2009|2009-05-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Intranasal Fentanyl for Pain Management|Atomization of Fentanyl: A Randomized Comparison Study of Intranasal Versus Intravenous Fentanyl for Pre-hospital Pain Management|Unknown status|Recruiting|Phase 4|500|Anticipated|Genesys||2|||f||||||||||||||2017-02-18 13:09:58.860973|2017-02-18 13:09:58.860973
NCT00882947|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||February 2006||2006-02-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)|Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)|Completed||Phase 4|38|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a.~   "|||2017-02-18 13:09:58.963846|2017-02-18 13:09:58.963846
NCT00882934|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-04-15|||October 2006||2006-10-01|April 2009|2009-04-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|DAFA06||The Management of Erectile Dysfunction With Placebo Only|A Single-Blind, Controlled, Randomized, Parallel-Group Study of the Efficacy of Patients' Awareness on the Composition of the Experimental Drug in the Treatment of Erectile Dysfunction.|Completed||N/A|123|Actual|Rio de Janeiro State University||3|||f||||t||||||||||2017-02-18 13:09:59.073762|2017-02-18 13:09:59.073762
NCT00882921|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-08-04|2014-06-23||October 2008||2008-10-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients|A Multi-Center Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Enrolled in the Hunter Outcome Survey (HOS) Receiving Idursulfase Enzyme Replacement Therapy|Completed||N/A|26|Actual|Shire|||1||f||||f||||||Samples Without DNA|"~     Blood and urine~   "|||2017-02-18 13:09:59.181768|2017-02-18 13:09:59.181768
NCT00882908|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2014-05-19|2013-12-18||June 2009||2009-06-01|May 2014|2014-05-01|April 2011|Actual|2011-04-01|April 2010|Actual|2010-04-01||Interventional|PILLAR||A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment|A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial to Investigate the Efficacy, Tolerability, Safety and Pharmacokinetics of TMC435 as Part of a Treatment Regimen Including Peginterferon Alfa-2a and Ribavirin In Treatment-Naive Genotype 1 Hepatitis C-Infected Subjects|Completed||Phase 2|386|Actual|Tibotec Pharmaceuticals, Ireland||5|||f||||t||||||||||2017-02-18 13:09:59.612241|2017-02-18 13:09:59.612241
NCT00882895|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2017-02-14|||May 5, 2009|Actual|2009-05-05|February 2017|2017-02-01|January 31, 2029|Anticipated|2029-01-31|January 31, 2029|Anticipated|2029-01-31||Interventional|||Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma|Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma|Recruiting||Phase 2|25|Anticipated|Washington University School of Medicine||1|||f||||t|t|f|||f|||No||2017-02-18 13:10:01.388417|2017-02-18 13:10:01.388417
NCT00882882|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||June 2001||2001-06-01|April 2009|2009-04-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions|A Relative Bioavailability Study of Metformin HCL 500 mg XR Tablets Under Fasting Conditions|Completed||Phase 1|16|Actual|Sandoz||4|||f||||||||||||||2017-02-18 13:10:01.571993|2017-02-18 13:10:01.571993
NCT00882869|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2011-07-12|||March 2009||2009-03-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)|A Phase 1-2, Open-Label Study of The X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)|Completed||Phase 1/Phase 2|75|Anticipated|Aegera Therapeutics||1|||f||||f||||||||||2017-02-18 13:10:01.670065|2017-02-18 13:10:01.670065
NCT00882856|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2017-01-06|||April 2009||2009-04-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|Biscloz||Treating Clozapine-induced Sinustachycardia With Bisoprolol|Treating Clozapine-induced Sinustachycardia With Bisoprolol - a Double Blinded Placebo Controlled Cross Over Study|Completed||N/A|21|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 13:10:01.782104|2017-02-18 13:10:01.782104
NCT00882843|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2012-06-21|||September 2006||2006-09-01|June 2012|2012-06-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Observational|||Feasibility Study for the Use of Low-magnitude, High Frequency Mechanical Stimulation of Bone in Persons With Spinal Cord Injury (SCI)|Feasibility Study for the Use of Low-magnitude, High Frequency Mechanical Stimulation of Bone in Persons With SCI|Completed||N/A|22|Actual|VA Office of Research and Development|||2||f||||f||||||||||2017-02-18 13:10:01.893247|2017-02-18 13:10:01.893247
NCT00882830|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2015-03-12|||September 2007||2007-09-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|June 2009|Actual|2009-06-01||Interventional|||Electrical Muscle Stimulation (EMS), a Preventive and Therapeutic Tool for Critical Illness Polyneuromyopathy (CIPNM)|Electrical Muscle Stimulation (EMS), a Preventive and Therapeutic Tool for Critical Illness Polyneuromyopathy (CIPNM)- A Randomized Controlled Parallel Intervention Trial.|Active, not recruiting||Phase 2|52|Actual|University of Athens||2|||f||||f||||||||||2017-02-18 13:10:01.988109|2017-02-18 13:10:01.988109
NCT00882817|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2013-07-31|||April 2009||2009-04-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Pulmonary Rehabilitation in Interstitial Lung Diseases|Effects of Pulmonary Rehabilitation in Interstitial Lung Diseases: a Prospective Randomized Controlled Trial|Completed||Phase 4|60|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-02-18 13:10:02.117466|2017-02-18 13:10:02.117466
NCT00882804|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2009-04-16|||February 2009||2009-02-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Hemin in Healthy Subjects|Effect of Hemin on Heme-Oxygenase-1 Activity in Healthy Subjects|Completed||Phase 1|10|Actual|Mayo Clinic||2|||f||||||||||||||2017-02-18 13:10:02.215201|2017-02-18 13:10:02.215201
NCT00882791|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-16|2012-09-14|||May 2008||2008-05-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Basal Cell Carcinoma Recurrence After Mohs Surgery|Basal Cell Carcinoma Recurrence|Completed||N/A|115|Actual|Northwestern University|||2||f||||f||||||||||2017-02-18 13:10:02.340215|2017-02-18 13:10:02.340215
NCT00882778|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2016-11-17|2011-05-11||April 2009||2009-04-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|PROPACT||PROPACT: Retrospective Prophylaxis Patient Case Collection|Prophylactic Treatment With Recombinant Factor VIIa (rFVIIa, NovoSeven®) in Haemophilia Patients With Inhibitors|Completed||N/A|86|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:10:02.44187|2017-02-18 13:10:02.44187
NCT00882765|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2015-10-28|||May 2009||2009-05-01|July 2012|2012-07-01||||January 2011|Actual|2011-01-01||Interventional|||Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery|A Pre-Surgical, Randomized Clinical Trial of Genistein in Resectable Pancreatic Adenocarcinoma|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||2||Study has been closed due to no accrual.|f||||t||||||||||2017-02-18 13:10:05.8544|2017-02-18 13:10:05.8544
NCT00882752|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2011-09-06|||January 2008||2008-01-01|September 2011|2011-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Report of a New Method Used to Identify the Bacteria Present in a Human Colon Biopsy Sample|Retrospective Study Protocol: Report of a New Method Used to Identify the Bacteria Present in a Human Colon Biopsy|Completed||N/A|1|Actual|Southwest Regional Wound Care Center|||1||f||||t||||||Samples With DNA|"~     colon biopsy~   "|||2017-02-18 13:10:05.961332|2017-02-18 13:10:05.961332
NCT00882739|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-01-25|||April 2009||2009-04-01|January 2012|2012-01-01||||July 2011|Actual|2011-07-01||Interventional|Load & Go||Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction|Safety and Efficacy of Three Different Loading Doses of Clopidogrel, Administered at First Medical Contact in Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty. The LOAD & GO Trial|Completed||Phase 4|168|Actual|Ospedale San Donato||3|||f||||f||||||||||2017-02-18 13:10:06.052786|2017-02-18 13:10:06.052786
NCT00882726|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2013-12-13|||February 2009||2009-02-01|December 2013|2013-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus|A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Intravenous and Subcutaneous Single-Dose Study in Healthy Subjects and Ascending Subcutaneous Multiple-Dose Study in Subjects With Type 2 Diabetes Mellitus to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immune Response of CNTO 3649|Completed||Phase 1|133|Actual|Centocor, Inc.||3|||f||||f||||||||||2017-02-18 13:10:06.172828|2017-02-18 13:10:06.172828
NCT00882713|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-08-12|2016-07-02||February 2009||2009-02-01|August 2016|2016-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||Safety population included all participants who have been treated with at least one dose of the study drug and a safety follow-up, whether withdrawn prematurely or not.|A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia|A Single Arm, Open Label Study to Assess the Efficacy, Safety and Tolerability of Once- Monthly Administration of Subcutaneous CERA for the Maintenance of Haemoglobin Levels in Dialysis Patients With Chronic Renal Anemia|Completed||Phase 3|202|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:10:06.296698|2017-02-18 13:10:06.296698
NCT00882700|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-12-30|||April 2005||2005-04-01|April 2009|2009-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions|A Single Center, Open, Randomized, 2-Way, 2-Period, 2-Sequence Crossover Study of the Bioequivalence of 300 mg Cefdinir (Test Formulation) and Omnicel 300 mg Capsule (Reference Formulation) Each Given as a Single Oral Dose to Twenty-Eight Healthy Male and/or Female Volunteers in the Fasting State|Completed||Phase 1|28|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:06.846247|2017-02-18 13:10:06.846247
NCT00882687|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2014-04-25||2013-07-02|April 2009||2009-04-01|April 2014|2014-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis|A Phase 2, Single Center, Randomized, Double-Masked and Placebo Controlled Study Evaluating the Efficacy of Three Different Concentrations (0.1, 1.0, 5.0%) of SAR 1118 Ophthalmic Solution in a Modified Conjunctival Allergen Challenge (CAC) Model|Completed||Phase 2|60|Actual|Shire||4|||f||||f||||||||||2017-02-18 13:10:06.937646|2017-02-18 13:10:06.937646
NCT00882674|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-11-01|||July 2009||2009-07-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer|An Exploratory Study to Evaluate the Biological Activity of R1507, a Human Monoclonal Antibody Antagonist of the Insulin-like Growth Factor Receptor (IGF-1R) in Women With Operable Breast Cancer|Completed||Phase 1|8|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:10:07.035273|2017-02-18 13:10:07.035273
NCT00882661|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2013-05-10|||July 2005||2005-07-01|May 2013|2013-05-01|September 2015|Anticipated|2015-09-01|April 2010|Actual|2010-04-01||Interventional|||SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study|A Prospective Randomized Clinical Investigation of the SECURE-C Cervical Artificial Disc: A Pivotal Study/ SECURE-C Cervical Artificial Disc Postmarket Approval Study|Unknown status|Active, not recruiting|Phase 3|380|Actual|Globus Medical Inc||1|||f||||||||||||||2017-02-18 13:10:07.13768|2017-02-18 13:10:07.13768
NCT00882635|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-06-28|||October 2008||2008-10-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study|The STrategic Reperfusion Early After Myocardial Infarction (STREAM) Anticoagulation With Enoxaparin vs. Unfractionated Heparin in Primary PCI Sub-study.|Completed||Phase 3|44|Actual|University of Alberta||2|||f||||f||||||||||2017-02-18 13:10:07.295831|2017-02-18 13:10:07.295831
NCT00882622|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-01-17|||February 2009||2009-02-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery|Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery|Withdrawn||Phase 1|0|Actual|University of Schleswig-Holstein||2||Endpoints were investigated in parallel in NCT00877305|f||||f||||||||||2017-02-18 13:10:07.585972|2017-02-18 13:10:07.585972
NCT00882609|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-11-28|||January 2009||2009-01-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets|18F-Fluoride PET/CT Versus 99mTc-MDP Scanning for Detecting Bone Metastases: A Randomized, Multi-Center Trial to Compare Two Bone Imaging Techniques|Unknown status|Recruiting|Phase 3|550|Anticipated|American College of Radiology - Image Metrix||2|||f||||f||||||||||2017-02-18 13:10:07.698181|2017-02-18 13:10:07.698181
NCT00882596|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-01-26|||May 2008||2008-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|||"Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to Low-risk Breast Cancer Patients"|A Multi-Site, Prospective, Non-Randomized Study of the Contura™ Multi-Lumen Balloon (MLB) Catheter to Deliver Accelerated Partial Breast Irradiation: Analysis of Dosimetry, Local Tumor Control, Cosmetic Outcome, and Toxicity|Completed||Phase 4|30|Actual|Cancer Center of Irvine||1|||f||||t||||||||||2017-02-18 13:10:07.828405|2017-02-18 13:10:07.828405
NCT00882583|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-10-12|||July 2009||2009-07-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|Dasatinib||A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC|A Phase I/II Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in Locally Advanced Squamous Cell Carcinoma of Head and Neck (HNSCC)|Terminated||Phase 1/Phase 2|20|Actual|Sidney Kimmel Comprehensive Cancer Center||2||Low accrual|f||||t||||||||||2017-02-18 13:10:07.950222|2017-02-18 13:10:07.950222
NCT00882570|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-04-15|||April 2005||2005-04-01|April 2009|2009-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions|A Single Center, Open, Randomized, 2-Way, 2-Period, 2-Sequence Crossover Study of the Bioequivalence of 250mg/5 ml Cefdinir (Test Formulation) and Omnicel 250mg/5 ml Powder For Oral Suspension (Reference Formulation) Each Given as a Single Oral Dose to Forty Healthy Male and/or Female Volunteers in the Fasting State|Completed||Phase 1|40|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:08.072275|2017-02-18 13:10:08.072275
NCT00882557|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2011-09-16|2011-07-19||May 2009||2009-05-01|September 2011|2011-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study to Evaluate Daptomycin Given During Dialysis and After Dialysis|A Prospective, Randomized, Crossover-design Study to Evaluate the Pharmacokinetics and Safety of Daptomycin Administered at 9 mg/kg During and 6 mg/kg After Hemodialysis|Completed||Phase 1/Phase 2|16|Actual|Cubist Pharmaceuticals LLC||2|||f||||f||||||||||2017-02-18 13:10:08.194185|2017-02-18 13:10:08.194185
NCT00882544|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-02-09|||March 2009||2009-03-01|February 2012|2012-02-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Observational|||Prospective Pediatric Pyeloplasty Robotic Surgical Database|Prospective Pediatric Pyeloplasty Robotic Surgical Database|Unknown status|Recruiting|N/A|200|Anticipated|Connecticut Children's Medical Center|||1||f||||f||||||||||2017-02-18 13:10:08.612465|2017-02-18 13:10:08.612465
NCT00882531|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-11-16|||February 2007||2007-02-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|ISOROS||Isotretinoin in Papular-Pustular Rosacea|Evaluation of the Efficacy of Isotretinoin Versus Placebo in Terms of Response Rate Among Patients Presenting Papular-pustular Rosacea Resistant to Standard Therapy|Completed||Phase 3|156|Actual|Laboratoires Bailleul-Biorga||2|||f||||t||||||||||2017-02-18 13:10:08.72032|2017-02-18 13:10:08.72032
NCT00882518|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-04-16|2011-03-07||April 2009||2009-04-01|April 2012|2012-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|ESPRIT||Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients|A 6-Week, Multi-centre, Double-blind, Double-dummy, Chlorpromazine-Controlled Randomised Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Extended-Release in the Treatment of Schizophrenic Patients With Acute Episode|Completed||Phase 3|388|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:10:08.818733|2017-02-18 13:10:08.818733
NCT00882505|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-09-14|||April 2009||2009-04-01|September 2012|2012-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Comparison of 25-hydroxy Vitamin D Level in Caucasian Women Receiving Vitamin D Supplementation and Not Receiving Supplementation: a Randomized Controlled Trial.|Comparison of 25-hydroxy Vitamin D Level in Caucasian Women Receiving Vitamin D Supplementation and Not Receiving Supplementation: a Randomized Controlled Trial.|Completed||N/A|67|Actual|Northwestern University||3|||f||||f||||||||||2017-02-18 13:10:09.31258|2017-02-18 13:10:09.31258
NCT00882492|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-02-14|||December 2008||2008-12-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|GLP||GLP 1 for Intraoperative Glycemic Control|Identifying a Novel Mechanism for Perioperative Hyperglycemia Identifying a Novel Mechanism for Perioperative Hyperglycemia in Cardiac Surgery: A Role for Incretins|Completed||Phase 1|80|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 13:10:09.425476|2017-02-18 13:10:09.425476
NCT00882479|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-06-12|||April 2009||2009-04-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Formalizing a Conceptual Framework of Work Domain Knowledge|Formalizing a Conceptual Framework of Work Domain Knowledge|Completed||N/A|51|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-02-18 13:10:09.526763|2017-02-18 13:10:09.526763
NCT00882466|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-04-16|||May 2008||2008-05-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction|Phase 4 Study of the Effect of Human Recombinant Erythropoietin at the Time of Reperfusion in Patients With Acute Myocardial Infarction|Completed||Phase 4|58|Actual|Seoul National University Bundang Hospital||2|||f||||t||||||||||2017-02-18 13:10:09.609833|2017-02-18 13:10:09.609833
NCT00882453|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-05-28|||August 2006||2006-08-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|BEGIN||Physical Activity and Fatigue in Early Multiple Sclerosis (MS)|Betaferon Treatment and Exercise Data Gathering IN Early MS|Completed||N/A|1739|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a~   "|||2017-02-18 13:10:09.704505|2017-02-18 13:10:09.704505
NCT00882440|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2015-08-17|2009-04-17||December 1990||1990-12-01|August 2015|2015-08-01|January 1992|Actual|1992-01-01|August 1991|Actual|1991-08-01||Interventional|||A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)|A Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Investigate the Antihypertensive Efficacy and Safety of Different Doses of DuP 753 (MK0954)|Completed||Phase 3|576|Actual|Merck Sharp & Dohme Corp.||7|||f||||||||||||||2017-02-18 13:10:09.852443|2017-02-18 13:10:09.852443
NCT00882427|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2010-02-04|||March 2009||2009-03-01|February 2010|2010-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|Aldea_02||Blood Glucose Control Over an Extended Glucose Control Range in Postoperative Cardiac Surgery Patients in the Intensive Care Unit|Single-center, Open Study on the Performance of the Software eMPC Algorithm Used for Blood Glucose Control Over an Extended Glucose Control Range (4.4 to 8.3 mmol/L) for a Maximum of 48 Hours in Postoperative Cardiac Surgery Patients in the Intensive Care Unit|Completed||N/A|20|Actual|B. Braun Melsungen AG||1|||f||||f||||||||||2017-02-18 13:10:10.74218|2017-02-18 13:10:10.74218
NCT00882414|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2010-04-07|||December 2006||2006-12-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)|A Multi-centre, Randomized, Controlled, Single-blinded, Phase II Study to Investigate the Safety and Efficacy of Intravenous Infusions of FERINJECT® Versus Placebo in Patients With Thrombocytosis Secondary to Iron Deficiency and Chronic Inflammatory Bowel Disease|Terminated||Phase 2|26|Actual|Vifor Inc.||4||Main objective of study was met. Further recruitment was difficult.|f||||f||||||||||2017-02-18 13:10:11.03635|2017-02-18 13:10:11.03635
NCT00882401|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2011-03-21|||April 2009||2009-04-01|March 2011|2011-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Vitamin D, Chronic Kidney Disease (CKD) and the Microcirculation|The Effect of Vitamin D on the Microcirculation of Patients With Chronic Kidney Disease (CKD) and Vitamin D Deficiency|Completed||Phase 4|64|Anticipated|Barts & The London NHS Trust||2|||f||||f||||||||||2017-02-18 13:10:11.173645|2017-02-18 13:10:11.173645
NCT00882388|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2013-12-15|||March 2005||2005-03-01|December 2013|2013-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers|Phase 4 Study of the Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel|Completed||Phase 4|40|Actual|Seoul National University Hospital||5|||f||||t||||||||||2017-02-18 13:10:11.279191|2017-02-18 13:10:11.279191
NCT00882375|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-06-28|||March 2009||2009-03-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy|Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy. A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, 52 Week Study in Smokers Motivated to Quit.|Completed||N/A|479|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-02-18 13:10:11.393955|2017-02-18 13:10:11.393955
NCT00882362|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2013-12-20|2013-12-20||March 2009||2009-03-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder|Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder|Completed||Phase 3|155|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 13:10:11.510782|2017-02-18 13:10:11.510782
NCT00882336|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-10-28|||May 2009||2009-05-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|||||Observational|EURIKA||European Study of Cardiovascular Risk|Epidemiological Study of European Cardiovascular Risk Patients: Disease Prevention and Management in Usual Daily Practice|Completed||N/A|7200|Anticipated|AstraZeneca|||1||f||||f||||||Samples Without DNA|"~     Whole blood Serum~   "|||2017-02-18 13:10:11.968427|2017-02-18 13:10:11.968427
NCT00882323|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-03-23|||November 2008||2008-11-01|March 2012|2012-03-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)|Reduced Toxicity Fludarabine, Cyclophosphamide Plus Thymoglobulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia|Unknown status|Recruiting|Phase 2|33|Anticipated|The Korean Society of Pediatric Hematology Oncology||1|||f||||t||||||||||2017-02-18 13:10:13.181635|2017-02-18 13:10:13.181635
NCT00882310|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-06-22|2016-04-26||September 2006||2006-09-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer|A Phase II Study of Gemzar, Taxotere, and Xeloda (GTX) for Adjuvant Pancreatic Cancer|Completed||Phase 2|37|Actual|Columbia University||1|||f||||t||||||||Undecided||2017-02-18 13:10:13.282459|2017-02-18 13:10:13.282459
NCT00882297|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2010-01-20|||April 2009||2009-04-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|CATETEL||Subclavian Vein Ultrasound Guided Cannulation in Adult|Subclavian Vein Ultrasound Guided Cannulation in Adult: Transversal and Longitudinal Approach Comparison|Completed||N/A|100|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 13:10:13.819705|2017-02-18 13:10:13.819705
NCT00882284|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-07-21|||April 2009||2009-04-01|July 2015|2015-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Hypotension in Neonates|Hydrocortisone Treatment of Hypotension in Term and Late Preterm Infants: An Observational Study|Completed||N/A|820|Actual|NICHD Neonatal Research Network|||1||f||||f||||||||||2017-02-18 13:10:13.926138|2017-02-18 13:10:13.926138
NCT00882271|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2011-11-16|||January 2008||2008-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Fibromyalgia Acupuncture Study|Efficacy of Acupuncture to Improve Symptoms and Functionality for People With Fibromyalgia|Completed||N/A|50|Actual|Southern California University of Health Sciences||2|||f||||t||||||||||2017-02-18 13:10:14.059092|2017-02-18 13:10:14.059092
NCT00882258|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2014-07-03|||March 2006||2006-03-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids|A Phase II, Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Selective Progesterone Receptor Modulator Proellex (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata|Completed||Phase 2|144|Actual|Repros Therapeutics Inc.||3|||f||||t||||||||||2017-02-18 13:10:14.171613|2017-02-18 13:10:14.171613
NCT00882245|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-10-29|||April 2009||2009-04-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis|A Phase II, Double-Blind, Vehicle Controlled Study to Determine the Efficacy, Safety and Toleration of SRD441 Ointment in Patients With Atopic Dermatitis|Completed||Phase 2|93|Actual|Serentis Ltd.||2|||f||||f||||||||||2017-02-18 13:10:14.310104|2017-02-18 13:10:14.310104
NCT00882232|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2013-02-14|||September 2008||2008-09-01|February 2013|2013-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer|Transperineal Injection of Cross-linked Hyaluronan Gel Into Anterior Perirectal Fat to Reduce Rectal Toxicity From High Dose Rate Brachytherapy and/or Intensity-Modulated Radiation Therapy for Prostate Cancer|Completed||Phase 1|10|Actual|Cancer Center of Irvine||1|||f||||t||||||||||2017-02-18 13:10:14.417074|2017-02-18 13:10:14.417074
NCT00882219|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-09-05|||March 2009||2009-03-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|March 2011|Actual|2011-03-01||Interventional|XERES||Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period|"XERES Trial: Clinical Evaluation of Patients With Everolimus-eluting Stent  Xience V®  Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period"|Completed||Phase 3|102|Actual|Abbott Vascular||1|||f||||f||||||||||2017-02-18 13:10:14.537808|2017-02-18 13:10:14.537808
NCT00882206|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-09-08|2015-04-10||April 2009||2009-04-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia|A Therapeutic Trial of Decitabine and Vorinostat in Combination With Chemotherapy (Vincristine, Prednisone, Doxorubicin and PEG-Asparaginase) for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)|Terminated||Phase 2|15|Actual|Masonic Cancer Center, University of Minnesota||1||Slow accrual|f||||t||||||||||2017-02-18 13:10:14.649885|2017-02-18 13:10:14.649885
NCT00882193|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2011-08-08|||May 2009||2009-05-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers|Pilot Therapy Using Betaine in Combination With Peginterferon Alpha-2a Plus Ribavirin in Subjects With Genotype 1 Hepatitis C Who Have Not Achieved a Sustained Viral Response With a Prior Course of Pegylated Interferon and Ribavirin|Terminated||Early Phase 1|30|Anticipated|University of Nebraska||1||new medications with improved response released, nonaccrual|f||||t||||||||||2017-02-18 13:10:14.996158|2017-02-18 13:10:14.996158
NCT00882180|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2011-08-23|||March 2009||2009-03-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement|A Multi-Center, Open Label, Phase 1 Dose-Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 in Patients With Advanced Solid Tumors With Liver Involvement|Completed||Phase 1|41|Actual|Alnylam Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:10:15.12558|2017-02-18 13:10:15.12558
NCT00882167|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-11-23|||April 2009||2009-04-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Cine-magnetic Resonance Imaging (MRI) Detecting Intra Abdominal Adhesions|Sensitivity and Predictive Value of Functional Cine Magnetic Resonance Imaging (MRI) Detecting Intra-abdominal Adhesions|Recruiting||N/A|100|Anticipated|Radboud University|||1||f||||f||||||||||2017-02-18 13:10:15.240404|2017-02-18 13:10:15.240404
NCT00882154|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-15|||April 2005||2005-04-01|April 2009|2009-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions|A Single Center, Open, Randomized, 2-Way, 2-Period, 2-Sequence Crossover Study of the Bioequivalence of 300 mg Cefdinir (Test Formulation) and Omnicel 300 mg Capsule (Reference Formulation) Each Given as a Single Oral Dose to Twenty-Eight Healthy Male and/or Female Volunteers in the Fed State|Completed||Phase 1|28|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:15.356668|2017-02-18 13:10:15.356668
NCT00882141|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2010-01-11|||March 2002||2002-03-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Race, Menopause and Metabolism After Exercise and Diet|Menopause, Genes and Metabolism After Weight Loss and Exercise|Completed||N/A|103|Actual|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 13:10:15.443403|2017-02-18 13:10:15.443403
NCT00882128|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-11-13|||May 2009||2009-05-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|||||Observational|SAISON||Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)|Evaluation of the Control Level (GINA) of Asthmatic Patients Consulting Their General Practitioner for a Seasonal Increase of Respiratory Symptoms (High and / or Low), Whether an Inhaled Corticotherapy is Taken or Not|Completed||N/A|3300|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:10:15.692339|2017-02-18 13:10:15.692339
NCT00882115|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2014-06-12|||August 2009||2009-08-01|June 2014|2014-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose|Broccoli Sprout Extract Effects on the Inflammatory Response to Diesel Exhaust Particles in the Nose|Completed||N/A|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 13:10:17.226304|2017-02-18 13:10:17.226304
NCT00882102|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2013-09-03|2013-06-06||April 2009||2009-04-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)|Phase II Study of Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndrome|Completed||Phase 2|43|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:10:17.331148|2017-02-18 13:10:17.331148
NCT00882089|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-01-26|||October 2007||2007-10-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients|Registry Study of the Contura™ Multi-Lumen Balloon (MLB) Applicator for Accelerated Partial Breast Irradiation in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients|Completed||Phase 4|13|Actual|Cancer Center of Irvine||1|||f||||t||||||||||2017-02-18 13:10:17.632124|2017-02-18 13:10:17.632124
NCT00882076|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2014-12-04|||March 2009||2009-03-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias|Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias|Completed||Phase 1|22|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-02-18 13:10:17.743098|2017-02-18 13:10:17.743098
NCT00882063|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2012-11-20|||January 2008||2008-01-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|November 2009|Actual|2009-11-01||Interventional|||Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma|An Open Label, Multicenter Phase I/II Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Relapsed and/or Relapsed/Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|19|Actual|Piramal Enterprises Limited||1|||f||||t||||||||||2017-02-18 13:10:17.860298|2017-02-18 13:10:17.860298
NCT00882050|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2016-08-17|||March 2009||2009-03-01|August 2016|2016-08-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Intravenous Exenatide (Byetta) During Surgery|Intravenous Exenatide (Byetta) for the Treatment of Perioperative Hyperglycemia: Rollover Phase I/II Trial|Completed||Phase 1/Phase 2|12|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 13:10:17.96714|2017-02-18 13:10:17.96714
NCT00882037|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2009-04-15|||August 2008||2008-08-01|April 2009|2009-04-01|July 2010|Anticipated|2010-07-01|August 2009|Anticipated|2009-08-01||Observational|||Risk and Protective Factors for Rural Methamphetamine Dependence|Risk and Protective Factors for Rural Methamphetamine Dependence|Unknown status|Enrolling by invitation|N/A|150|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-02-18 13:10:18.076457|2017-02-18 13:10:18.076457
NCT00882024|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2011-01-05|||March 2009||2009-03-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)|A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast With Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients With Active Rheumatoid Arthritis (RA)|Completed||Phase 2|250|Anticipated|Nuon Therapeutics, Inc.||3|||f||||t||||||||||2017-02-18 13:10:18.16632|2017-02-18 13:10:18.16632
NCT00882011|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-15|2011-10-12|||April 2009||2009-04-01|October 2011|2011-10-01|April 2019|Anticipated|2019-04-01|April 2014|Anticipated|2014-04-01||Observational|||Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters|Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy-pathological Parameters|Recruiting||N/A|100|Anticipated|Fondazione Italiana Linfomi ONLUS|||1||f||||f||||||Samples With DNA|"~     Involved lymph nodes biopsy; biopsies performed in other areas affected by lymphoma; bone~     marrow blood; peripheral blood.~   "|||2017-02-18 13:10:18.299855|2017-02-18 13:10:18.299855
NCT00881998|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-15||||||April 2009|2009-04-01||||||||Interventional|||Study of Two Surgical Approaches for Total Hip Arthroplasty|Prospective, Randomized Study of Two Surgical Approaches for Total Hip Arthroplasty|Completed||N/A|100|Actual|Rothman Institute Orthopaedics||2|||f||||f||||||||||2017-02-18 13:10:18.587042|2017-02-18 13:10:18.587042
NCT00881985|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2016-01-17|||March 2009||2009-03-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Resistant Hypertension|Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Drug-resistant Hypertension : A Randomized Controlled Trial|Recruiting||N/A|64|Anticipated|The University of Hong Kong||2|||f||||||||||||||2017-02-18 13:10:18.683931|2017-02-18 13:10:18.683931
NCT00881972|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2015-09-23|||February 2009||2009-02-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|||Physical Activity and Glycemic Control|Physical Activity and Glycemic Control|Completed||N/A|12|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 13:10:18.82589|2017-02-18 13:10:18.82589
NCT00881959|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2015-05-07|2015-05-07||August 2009||2009-08-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Study of Root Coverage With Acellular Dermal Matrix: Puros® Dermis Versus Alloderm®|Multi-center, Post-market, Prospective, Randomized, Examiner-Only-Masked Study of Root Coverage With Acellular Dermal Matrix: Puros® Dermis Versus Alloderm®|Completed||N/A|80|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:10:18.926507|2017-02-18 13:10:18.926507
NCT00881946|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2012-04-03|||July 2009||2009-07-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Repeat Dose Safety Study for Compound to Treat Hematologic Cancer|A Phase I, Open-Label, Two-Stage Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral AKT Inhibitor GSK2110183 in Subjects With Any Hematologic Malignancy|Completed||Phase 1/Phase 2|73|Actual|Accenture||1|||f||||f||||||||||2017-02-18 13:10:19.320091|2017-02-18 13:10:19.320091
NCT00881933|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-03-23|||November 2008||2008-11-01|March 2012|2012-03-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)|Phase I/II Study of Fludarabine, Cyclophosphamide Plus TBI Conditioning Regimen for Double Units Cord Blood Transplantation in Severe Aplastic Anemia|Unknown status|Recruiting|Phase 1/Phase 2|5|Anticipated|The Korean Society of Pediatric Hematology Oncology||1|||f||||t||||||||||2017-02-18 13:10:19.428341|2017-02-18 13:10:19.428341
NCT00881920|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2016-12-01|||July 2009||2009-07-01|December 2016|2016-12-01|July 2034|Anticipated|2034-07-01|July 2019|Anticipated|2019-07-01||Interventional|CHARKALL||Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL|Phase I Study of Adoptive Transfer of Autologous T Lymphocytes Engrafted With a Chimeric Antigen Receptor Targeting the Kappa Light Chain of Immunoglobulin Expressed in Patients With CLL, B-Cell Lymphoma or Multiple Myeloma|Recruiting||Phase 1|54|Anticipated|Baylor College of Medicine||3|||f||||t||||||||||2017-02-18 13:10:19.528896|2017-02-18 13:10:19.528896
NCT00881907|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2016-02-04|||March 2010||2010-03-01|February 2016|2016-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Tissue Characterization in Teeth Treated With a Regeneration Protocol|Tissue Characterization in Teeth Treated With a Regeneration Protocol|Completed||Early Phase 1|1|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-02-18 13:10:19.644721|2017-02-18 13:10:19.644721
NCT00881894|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2014-10-17|2009-11-20||October 2008||2008-10-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.|Single-site, Open-label, Randomized, Cross-over Trial to Evaluate the Bioequivalence of Single Dose Rotigotine Transdermal Patch (4.5mg/10cm^2) From 2 Different Manufacturing Processes|Completed||Phase 1|52|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 13:10:19.760173|2017-02-18 13:10:19.760173
NCT00881881|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-14|||December 2006||2006-12-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain|Clinical and Therapeutic Management of the Rheumatoid Arthritis in Spain|Completed||N/A|360|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 13:10:20.37572|2017-02-18 13:10:20.37572
NCT00881868|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2012-09-21|2010-12-16||April 2009||2009-04-01|September 2012|2012-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp|A Multi-Center, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Clobetasol Propionate Spray Versus Vehicle for the Management of Moderate to Severe Plaque Psoriasis of the Scalp|Completed||Phase 4|81|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||||2017-02-18 13:10:20.449573|2017-02-18 13:10:20.449573
NCT00881855|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-14|||March 2004||2004-03-01|April 2009|2009-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Sandoz GmbH and Bristol-Myers Squibb (Cefzil) 500 mg Cefprozil Tablets In Healthy Adults Volunteers Under Fed Conditions.|Completed||Phase 1|35|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:20.954214|2017-02-18 13:10:20.954214
NCT00881842|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2011-08-24|||June 2009||2009-06-01|August 2011|2011-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season|Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2009/2010. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects and Elderly Subjects|Completed||Phase 3|120|Actual|Abbott||1|||f||||f||||||||||2017-02-18 13:10:21.042312|2017-02-18 13:10:21.042312
NCT00881829|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2016-08-10|||August 2016||2016-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Oxitone Blood Validation|Accuracy Validation of the Oxitone SpO2 System|Recruiting||N/A|10000|Anticipated|Clinimark, LLC|||1||f||||t||||||||||2017-02-18 13:10:21.144455|2017-02-18 13:10:21.144455
NCT00881816|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-14|||April 2009||2009-04-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma|Phase I Clinical Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|Nanjing Sike Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 13:10:21.255234|2017-02-18 13:10:21.255234
NCT00881803|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2012-05-21|||June 2008||2008-06-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Observational|||Iron & Vitamin C Study|Implications of Concurrent Iron and Ascorbic Acid Supplementation on Iron Status in Persons With Spinal Cord Injury|Completed||N/A|60|Anticipated|VA Office of Research and Development|||3||f||||f||||||Samples With DNA|"~     Blood samples will be obtained for analysis.~   "|||2017-02-18 13:10:21.35397|2017-02-18 13:10:21.35397
NCT00881790|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2013-01-09|||April 2009||2009-04-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Observational|BEHAVE||The Behaviour of Dental Nurses Applying Fluoride Varnish to Young Children|The Behavioural Engagement of Dental Nurses Applying the Fluoride Varnish to Young Children: the BEHAVE Study|Completed||N/A|509|Actual|University of St Andrews|||1||f||||t||||||||||2017-02-18 13:10:21.454356|2017-02-18 13:10:21.454356
NCT00881777|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2011-07-12|||September 2009||2009-09-01|July 2011|2011-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|RECOVER||Feasibility Study of Radiofrequency Heating of Cardiac Infarction Scar to Treat Heart Failure|Radiofrequency Energy Use in Cardiomyopathy and Ventricular Enlargement (RECOVER)|Terminated||Phase 1/Phase 2|3|Actual|CoRepair, Inc.||2||Unable to recruit suitable subjects within a reasonable time period.|f||||f||||||||||2017-02-18 13:10:21.568472|2017-02-18 13:10:21.568472
NCT00881764|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2016-02-01|||May 2009||2009-05-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|April 2015|Actual|2015-04-01||Observational|||PANDA (Pediatric Anesthesia & NeuroDevelopment Assessment) Study|Anesthesia Exposure and Neurodevelopment in Infants and Children: Pediatric Anesthesia & NeuroDevelopment (PANDA) Study|Completed||N/A|369|Actual|Columbia University|||2||f||||f||||||||Undecided||2017-02-18 13:10:21.679652|2017-02-18 13:10:21.679652
NCT00881751|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2015-10-14|||March 2009||2009-03-01|October 2015|2015-10-01||||June 2016|Anticipated|2016-06-01||Interventional|||Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer|A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)|Active, not recruiting||Phase 2|120|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 13:10:21.797284|2017-02-18 13:10:21.797284
NCT00881738|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-04-15|||June 2002||2002-06-01|April 2009|2009-04-01|July 2002|Actual|2002-07-01|June 2002|Actual|2002-06-01||Interventional|||To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting Conditions|A Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:21.90817|2017-02-18 13:10:21.90817
NCT00881725|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-06-18|||June 2009||2009-06-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|March 2011|Actual|2011-03-01||Interventional|ANIMATE||A Study of Pre-operative Metformin in Prostate Cancer|A Phase II, Open Label Assessment of Neoadjuvant Intervention With Metformin Against Tumour Expression of Signaling|Terminated||Phase 2|24|Actual|University Health Network, Toronto||1||Slow Accrual|f||||t||||||||||2017-02-18 13:10:22.004952|2017-02-18 13:10:22.004952
NCT00881712|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2016-12-08|2015-05-28||June 2009||2009-06-01|December 2016|2016-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|LU02||Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)|A Phase II Trial of 3 Dimensional Proton Radiotherapy With Concomitant Chemotherapy for Patients With Initially Unresectable Stage III Non-Small Cell Lung Cancer|Terminated||Phase 2|15|Actual|University of Florida||3||projected enrollment rate not feasible|f||||t||||||||||2017-02-18 13:10:22.116365|2017-02-18 13:10:22.116365
NCT00881699|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-03-08|||September 2006||2006-09-01|March 2012|2012-03-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil|Randomized Clinical Trial of a Brazilian HIV Prevention Intervention for the Severely Mentally Ill|Completed||Phase 3|460|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 13:10:22.612745|2017-02-18 13:10:22.612745
NCT00881686|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-14|||June 2008||2008-06-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Myocardial Protection With Adenosine Preconditioning|Study of Myocardial Protection in Pediatric Cardiac Surgery With Adenosine Preconditioning|Completed||Phase 1/Phase 2|238|Actual|Xijing Hospital||1|||f||||t||||||||||2017-02-18 13:10:22.729678|2017-02-18 13:10:22.729678
NCT00881673|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-03-03|||May 2009||2009-05-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge|A Single-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge (CAC)|Withdrawn||Phase 2|0|Actual|Alcon Research||3||Management decision|f||||t||||||||||2017-02-18 13:10:22.881633|2017-02-18 13:10:22.881633
NCT00881660|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2016-07-19|||March 2010||2010-03-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|FETO||Fetal Endotracheal Occlusion (FETO) in Severe and Extremely Severe Congenital Diaphragmatic Hernia|A Prospective Study of the Effectiveness of Fetal Endotracheal Occlusion (FETO) in the Management of Severe and Extremely Severe Congenital Diaphragmatic Hernia|Recruiting||N/A|15|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 13:10:22.983864|2017-02-18 13:10:22.983864
NCT00881647|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2014-02-20|2014-01-07||November 2008||2008-11-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||per protocol|Treating People With Post-Traumatic Stress Disorder With Cognitive Behavioral Therapy for Insomnia|Cognitive Behavioral Treatment of Insomnia in Posttraumatic Stress Disorder|Completed||N/A|45|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 13:10:23.109924|2017-02-18 13:10:23.109924
NCT00881634|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-04-14|||June 2005||2005-06-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions|A Single-Dose Comparative Bioavailability Study of Two Formulations of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release Tablets Under Fed Conditions|Completed||Phase 1|40|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:26.119969|2017-02-18 13:10:26.119969
NCT00881621|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2014-03-23|||August 2009||2009-08-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer|Phase II Study of Lapatinib and Capecitabine in 2nd Line Treatment of Locally Advanced/Metastatic Pancreatic Cancer|Terminated||Phase 2|17|Actual|Georgetown University||1||slow enrollment|f||||t||||||||||2017-02-18 13:10:26.215021|2017-02-18 13:10:26.215021
NCT00881608|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2014-08-08|2014-06-26||February 2009||2009-02-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Study prematurely terminated, no data available|Study to Evaluate Menses Induction in Women Administered Proellex|An Open-Label, Escalating Dose, Single Center, Cross-over Design, Phase I Study to Evaluate Menses Induction in Women Administered Proellex|Terminated||Phase 1|11|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with any study data.|5||Repros stopped study for safety and the FDA put the study on hold for safety.|f||||f||||||||||2017-02-18 13:10:26.326988|2017-02-18 13:10:26.326988
NCT00881595|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2017-02-09|||February 2009||2009-02-01|February 2017|2017-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|SA02||Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas|A Pilot Study Investigating Neoadjuvant Temozolomide-based Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas|Withdrawn||Phase 2|0|Actual|University of Florida||3||No patients accrued since study opened|f||||t|f|f|||f|||||2017-02-18 13:10:26.661048|2017-02-18 13:10:26.661048
NCT00881582|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-09-13|||January 2009||2009-01-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients|Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients|Completed||Phase 4|32|Actual|King Abdulaziz Medical City||1|||f||||t||||||||||2017-02-18 13:10:26.802513|2017-02-18 13:10:26.802513
NCT00881569|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-09-05|||March 2009||2009-03-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Interventional|||Extended Use Protocol for Subjects With Cancer to Receive Continued Treatment With CS-7017|Extended Use of CS 7017 Upon Completion of Participation in a Clinical Study of CS-7017 in Subjects With Cancer|Completed||Phase 1|2|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 13:10:26.909343|2017-02-18 13:10:26.909343
NCT00881556|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-02-14|||March 2009||2009-03-01|February 2012|2012-02-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|RDEB||Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)|A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB)|Unknown status|Active, not recruiting|Early Phase 1|20|Anticipated|Columbia University||1|||f||||t||||||||||2017-02-18 13:10:27.202134|2017-02-18 13:10:27.202134
NCT00881543|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-05-24|||June 2009||2009-06-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|June 2010|Actual|2010-06-01||Interventional|||"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"|"Effect of Dipeptidyl Peptidase IV Inhibitors on Glycemia, Insulin, Glucagon, C Peptide, Glp 1 and Lipids After Isocaloric Meals With Different Nutritional Composition in Patients With Type 2 Diabetes näive of Treatment"|Completed||N/A|45|Actual|University of Sao Paulo General Hospital||2|||f||||f||||||||||2017-02-18 13:10:27.313862|2017-02-18 13:10:27.313862
NCT00881530|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2014-05-16|2014-05-16||March 2009||2009-03-01|May 2014|2014-05-01||||May 2011|Actual|2011-05-01||Interventional||Treated set including all patients treated with at least 1 dose of study drug.|Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension|A 78 Week Open Label Extension to Trials Assessing the Safety and Efficacy of BI 10773 as Monotherapy or in Combination With Metformin in Type 2 Diabetic Patients|Completed||Phase 2|660|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 13:10:27.44468|2017-02-18 13:10:27.44468
NCT00881517|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2011-12-07|||June 2009||2009-06-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|CHIP||Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection|Prevention of Human Cytomegalovirus (HCMV) Mother-to-fetus Transmission by Administration of Virus-specific Hyperimmune Globulin to Pregnant Women With Primary HCMV Infection|Completed||Phase 2/Phase 3|124|Actual|IRCCS Policlinico S. Matteo||2|||f||||f||||||||||2017-02-18 13:10:29.411345|2017-02-18 13:10:29.411345
NCT00881504|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2014-10-16|2014-09-05||June 2009||2009-06-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|February 2011|Actual|2011-02-01||Interventional||3 males; 5 females. Average age, 68.1 years.|A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma|A Single-Center, Open-Labeled, Phase II Trial of Modified FOLFOX6 With Bevacizumab in Patients With Advanced Biliary System Carcinoma|Terminated||Phase 2|9|Actual|Georgetown University||1||It was not possible to get insurance companies to cover bevacizumab.|f||||t||||||||||2017-02-18 13:10:29.542834|2017-02-18 13:10:29.542834
NCT00881491|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2016-02-04|||April 2009||2009-04-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste|Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste|Completed||Early Phase 1|10|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||No|No data to be shared|2017-02-18 13:10:29.781|2017-02-18 13:10:29.781
NCT00881478|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2014-08-29|||August 2009||2009-08-01|October 2011|2011-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|FOCUS||Family Intervention for Obese Children Using Portion Control Strategy for Weight Control|Family Intervention for Obese Children Using Portion Control Strategy (F.O.C.U.S.) for Weight Control- A Randomized Controlled Trial|Completed||N/A|102|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 13:10:29.890446|2017-02-18 13:10:29.890446
NCT00881465|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2015-05-15|2015-04-07||March 2009||2009-03-01|May 2015|2015-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder|Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder|Completed||Phase 2|31|Actual|University of South Florida|Use of a non-active control condition.|2|||f||||f||||||||||2017-02-18 13:10:30.003306|2017-02-18 13:10:30.003306
NCT00881452|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2017-01-23||2013-03-04|May 2009||2009-05-01|January 2017|2017-01-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|CM-AT||A Trial of CM-AT in Children With Autism|A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism|Completed||Phase 3|182|Actual|Curemark||2|||f||||f||||||||||2017-02-18 13:10:30.446421|2017-02-18 13:10:30.446421
NCT00881439|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2013-05-16|||April 2009||2009-04-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|ARIANA-CHF-RD||Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment|A Double-blind, Placebo-controlled, Randomized Trial Investigating the Safety and Efficacy of Additive Renin Inhibition With Aliskiren on Renal Blood Flow and Neurohormonal Activation in Patients With Chronic Heart Failure and Renal Dysfunction|Terminated||Phase 2|41|Actual|University Medical Center Groningen||2||Futility|f||||t||||||||||2017-02-18 13:10:30.572517|2017-02-18 13:10:30.572517
NCT00881426|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-15|||March 2004||2004-03-01|April 2009|2009-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Sandoz GmbH and Bristol-Myers Squibb (Cefzil) 500 mg Cefprozil Tablets In Healthy Adults Volunteers Under Fasting Conditions|Completed||Phase 1|26|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:30.678|2017-02-18 13:10:30.678
NCT00881413|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2015-04-07||||||April 2009|2009-04-01||||||||Interventional|||Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding|Clinical Effectiveness of Intravenous Esomeprazole Versus Pantoprazole in Preventing Peptic Ulcer Recurrent Bleeding: a Double-Blind Randomized Trial|Withdrawn||Phase 4|0|Actual|Lotung Poh-Ai Hospital||2||problems in funding|f||||f||||||||||2017-02-18 13:10:30.767054|2017-02-18 13:10:30.767054
NCT00881400|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-15|||June 2004||2004-06-01|April 2009|2009-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Sandoz GmbH and Bristol-Myers Squibb Company (Cefzil) 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose In Healthy Adults Volunteers Under Fed Conditions|Completed||Phase 1|24|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:30.877925|2017-02-18 13:10:30.877925
NCT00881387|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2016-12-14|||February 2009||2009-02-01|December 2016|2016-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment|A Pilot Study of Rituximab-Gemcitabine-Navelbine for Relapsed/Refractory Hodgkin's Lymphoma|Withdrawn||Phase 2|0|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 13:10:31.146045|2017-02-18 13:10:31.146045
NCT00881374|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2009-04-14|||February 2009||2009-02-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dermacyd Infantile (Lactic Acid)- Compatibility.|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermic Irritability, Dermic Sensitivity) of Dermacyd Infantile (Lactic Acid).|Completed||Phase 4|50|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:10:31.26|2017-02-18 13:10:31.26
NCT00881361|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2016-07-01|||July 2009||2009-07-01|July 2016|2016-07-01||||March 2020|Anticipated|2020-03-01||Interventional|||Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer|A Phase II Study Evaluating the Role of Sentinel Lymph Node Surgery and Axillary Lymph Node Dissection Following Preoperative Chemotherapy in Women With Node Positive Breast Cancer (T1-4, N1-2, M0) at Initial Diagnosis|Active, not recruiting||Phase 2|756|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 13:10:31.363078|2017-02-18 13:10:31.363078
NCT00881348|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2009-04-14|||February 2009||2009-02-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dermacyd Infantile (Lactic Acid) - Photo Evaluation.|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Infantile (Lactic Acid).|Completed||Phase 4|25|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:10:32.084722|2017-02-18 13:10:32.084722
NCT00881322|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-09-29|||June 2008||2008-06-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study on Intestinal Gas Symptoms to Evaluate the Effects of Gas Defense in Otherwise Healthy Adult|A Prospective, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Clinical Trial to Evaluate the Effects of Gas Defense On Intestinal Gas Symptoms in Otherwise Healthy Adults|Completed||N/A|61|Actual|Miami Research Associates||2|||f||||f||||||||||2017-02-18 13:10:32.64372|2017-02-18 13:10:32.64372
NCT00881309|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2011-05-17|||March 2009||2009-03-01|April 2009|2009-04-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis|To Compare the Efficacy and Safety of Tripterygium (TW) vs Aza in the Maintenance Therapy for Lupus Nephritis|Completed||N/A|94|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 13:10:32.742238|2017-02-18 13:10:32.742238
NCT00881296|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2011-09-05|||March 2008||2008-03-01|May 2010|2010-05-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|GEEP||Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer|Randomized Phase II Study of Biweekly Chemotherapy With Gemcitabine and Carboplatin in Elder Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|60|Actual|Hamamatsu University||2|||f||||t||||||||||2017-02-18 13:10:32.835824|2017-02-18 13:10:32.835824
NCT00881283|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2017-01-19|||September 8, 2008|Actual|2008-09-08|April 2015|2015-04-01|March 30, 2010|Actual|2010-03-30|March 30, 2010|Actual|2010-03-30||Observational|||Long-term Cardiovascular Risk in Cured Cushing's Patients|Role of Adipokines in Long-term Cardiovascular Risk in Cured Cushing's Patients|Terminated||N/A|1|Actual|Massachusetts General Hospital|||1|Decision made to close study early.|f||||f||||||Samples With DNA|"~     serum, urine~   "|||2017-02-18 13:10:32.936175|2017-02-18 13:10:32.936175
NCT00881270|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2009-09-25|||March 2009||2009-03-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dermacyd Infantile - Acceptability.|Safety Dermatological Evaluation: Acceptability With Paediatric Follow up Dermacyd Infantile (Lactic Acid).|Completed||Phase 4|31|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:10:33.019312|2017-02-18 13:10:33.019312
NCT00881257|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2013-06-19|||August 2007||2007-08-01|June 2013|2013-06-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional|||Multicenter Assessment of the Safety and Efficacy of the Minnow Medical GRST™ Peripheral Catheter System|Multicenter Assessment of the Safety and Efficacy of the Minnow Medical GRST™ Peripheral Catheter System|Terminated||Phase 2/Phase 3|78|Actual|Vessix Vascular, Inc||1||Data was inconclusive|f||||t||||||||||2017-02-18 13:10:33.105777|2017-02-18 13:10:33.105777
NCT00881244|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-14|||September 2003||2003-09-01|April 2009|2009-04-01|February 2007|Actual|2007-02-01|June 2006|Actual|2006-06-01||Interventional|||Study of AS1411 in Advanced Solid Tumours|Phase I Open Label Study of AS1411 in Advanced Solid Tumours|Completed||Phase 1|30|Actual|Antisoma Research||1|||||||t||||||||||2017-02-18 13:10:33.200588|2017-02-18 13:10:33.200588
NCT00881231|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-04-14|||January 2004||2004-01-01|April 2009|2009-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Eon and Otsuka (Pletal) 50 mg Cilostazol Tablets In Healthy Adults Volunteers Under Fasting Conditions|Completed||Phase 1|26|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:33.276018|2017-02-18 13:10:33.276018
NCT00881218|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2012-04-08|||June 2009||2009-06-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson|Feasibility of Detecting Myocardial Ischemia by First-pass Contrast MRI Using Regadenoson|Completed||Early Phase 1|50|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 13:10:33.356911|2017-02-18 13:10:33.356911
NCT00881205|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-03-08|2012-01-20||April 2009||2009-04-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|EXCITING||Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment|A 16-week, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy of Rivastigmine Patch (10 cm²) on Cognitive Deficits in Patients With Multiple Sclerosis, Followed by a 1-year Open-label Treatment Phase|Terminated||Phase 4|86|Actual|Novartis|This study was terminated early due to low recruitment numbers. This study did not have the anticipated 80% power.|2||Termination of study due to low enrollment|f||||||||||||||2017-02-18 13:10:33.475699|2017-02-18 13:10:33.475699
NCT00881192|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-05-09|||April 2009||2009-04-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Perioperative Intra-Aortic Balloon Pump (IABP) in Coronary Artery Bypass Grafting (CABG) Operations in Patients With Severely Depressed Left Ventricular Function|Perioperative IABP in CABG Operations in Patients With Severely Depressed Left Ventricular Function: a Randomized, Controlled Trial|Completed||N/A|160|Actual|IRCCS Policlinico S. Donato||2|||f||||f||||||||||2017-02-18 13:10:33.976211|2017-02-18 13:10:33.976211
NCT00881179|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-04-15|||May 2002||2002-05-01|April 2009|2009-04-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions|A Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|24|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:34.08715|2017-02-18 13:10:34.08715
NCT00881166|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2012-10-31|||November 2007||2007-11-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|SGI-0470-02||Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors|Safety and Dose Finding Study of Oral MP470, a Multi-targeted Tyrosine Kinase Inhibitor, in Combination With Standard-of-Care Chemotherapy Regimens|Completed||Phase 1|101|Actual|Astex Pharmaceuticals||5|||f||||f||||||||||2017-02-18 13:10:34.170374|2017-02-18 13:10:34.170374
NCT00881153|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-14|||May 2004||2004-05-01|April 2009|2009-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Sandoz GmbH and Bristol-Myers Squibb Company (Cefzil) 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose In Healthy Adults Volunteers Under Fasting Conditions.|Completed||Phase 1|20|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:34.276669|2017-02-18 13:10:34.276669
NCT00879164|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2014-10-15|||April 2009||2009-04-01|October 2014|2014-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Stellate Ganglion Nerve Block in Treating Women With Hot Flashes|Pilot Evaluation of a Stellate Ganglion Block for the Treatment of Hot Flashes|Completed||Early Phase 1|10|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 13:11:18.94558|2017-02-18 13:11:18.94558
NCT00881140|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2012-12-18|||April 2009||2009-04-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids|The Effect of Vaginal Mifepristone on Reduction of Uterine Fibroids Size and the Symptoms Associated With the Fibroids - Pilot Study (Phase IIa)|Completed||Phase 2|30|Actual|BioPro Medical Ltd||1|||f||||f||||||||||2017-02-18 13:10:34.364464|2017-02-18 13:10:34.364464
NCT00881127|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-04-14|||July 2005||2005-07-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions|A Single-Dose Comparative Bioavailability Study of Two Formulations of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release Tablets Under Fasting Conditions|Completed||Phase 1|40|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:10:34.629264|2017-02-18 13:10:34.629264
NCT00881114|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2015-03-26|||April 2009||2009-04-01|April 2009|2009-04-01|June 2013|Anticipated|2013-06-01|June 2009|Actual|2009-06-01||Interventional|PGx-SELECT||Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer|A Prospective Phase II Clinical Trial to Use Pharmacogenetics (PGx) to Select Erbitux or Cisplatin to Treat Head and Neck Cancer|Withdrawn||Phase 2|0|Actual|Georgetown University||2||Investigator decided it was not feasible to conduct this study|f||||t||||||||||2017-02-18 13:10:34.715582|2017-02-18 13:10:34.715582
NCT00881101|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2009-04-14|||April 2009||2009-04-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Clinical Study of Liposomal Paclitaxel in Chinese Patients|Dose Escalation Study of Liposomal Paclitaxel in Chinese Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|Nanjing Sike Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 13:10:34.824936|2017-02-18 13:10:34.824936
NCT00881088|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2012-12-15|||April 2009||2009-04-01|May 2009|2009-05-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|PROTECT||Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures|Prophylaxis of Venous Thromboembolism in Patients With a Nonsurgical Fracture of the Lower Extremity Immobilised in a Below-Knee Plaster Cast|Unknown status|Recruiting|Phase 2/Phase 3|669|Anticipated|Red Cross Hospital Beverwijk||3|||f||||f||||||||||2017-02-18 13:10:34.921266|2017-02-18 13:10:34.921266
NCT00881075|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2016-02-03|||June 2008||2008-06-01|February 2016|2016-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Efficacy of SeeMore (TM) in Heart Patients|An Open-label, Baseline-Controlled Study of the Safety and Efficacy of SeeMore (TM) (EVP 1001-1 Injection) in Heart Patients|Completed||Phase 2|24|Actual|Eagle Vision Pharmaceutical Corp.||1|||f||||f||||||||||2017-02-18 13:10:35.048013|2017-02-18 13:10:35.048013
NCT00881062|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-14|2014-07-03|||April 2009||2009-04-01|July 2014|2014-07-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females|A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose Administration in Healthy Female Subjects|Completed||Phase 1|6|Actual|Repros Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 13:10:35.160616|2017-02-18 13:10:35.160616
NCT00881049|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2011-01-14|||December 2008||2008-12-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma|Phase II Trial of Imatinib(Gleevec®) in Selected Patients With Metastatic Melanoma|Completed||Phase 2|1|Anticipated|Peking University||1|||f||||f||||||||||2017-02-18 13:10:35.260073|2017-02-18 13:10:35.260073
NCT00881036|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2015-09-02|||August 2006||2006-08-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients|Activation of HBV Under Immunosuppression in HBsAg-negative But Anti-HBc-positive Patients With Hematological Malignancies|Completed||N/A|33|Actual|Kyoto University|||1||f||||f||||||||||2017-02-18 13:10:35.345452|2017-02-18 13:10:35.345452
NCT00881023|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2016-08-01||2016-02-25|July 2010||2010-07-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CAIS||Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration|A Multicenter, Randomized, Pivotal Study to Evaluate the Safety and Efficacy of the Cartilage Autograft Implantation System (CAIS) for the Surgical Treatment of Articular Cartilage Lesions of the Knee|Terminated||N/A|75|Actual|DePuy Mitek||3||Study was terminated because of very low enrollment rate.|f||||f||||||||No|These data will not be used in support of an FDA submission, and the product will not be commercialized. As such, there is no plan to share the IPD.|2017-02-18 13:10:35.424655|2017-02-18 13:10:35.424655
NCT00881010|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2016-11-28|||February 2009||2009-02-01|November 2016|2016-11-01||||February 2018|Anticipated|2018-02-01||Observational|||Automated Pain Intervention for Underserved Minority Breast Cancer Patients|Automated Pain Intervention for Underserved Minority Breast Cancer Patients|Active, not recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center|||2||f||||t||||||||||2017-02-18 13:10:35.567614|2017-02-18 13:10:35.567614
NCT00880997|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2012-10-22|||September 2009||2009-09-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|||The Efficacy of Doxazosin for Cocaine Users|Doxazosin, An Alpha-1 Adrenergic Antagonist, for Cocaine Dependence: Pilot Study|Completed||Phase 1|35|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 13:10:35.67823|2017-02-18 13:10:35.67823
NCT00880984|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2010-01-06|||June 2008||2008-06-01|July 2009|2009-07-01||||September 2009|Actual|2009-09-01||Interventional|||Compression Anastomosis Using the Compression Anastomosis Ring (CAR™ 27)|Compression Anastomosis Using the CAR™ 27|Completed||N/A|15|Anticipated|Aristotle University Of Thessaloniki||1|||f||||f||||||||||2017-02-18 13:10:35.79523|2017-02-18 13:10:35.79523
NCT00880971|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2011-12-15|||January 2009||2009-01-01|December 2011|2011-12-01|July 2012|Anticipated|2012-07-01|April 2012|Anticipated|2012-04-01||Interventional|||To Evaluate Postoperative 3D Conform Radiotherapy in Patients With IIIA (N2) Non-small Cell Lung Cancer|Phase III Comparison of Postoperative 3D Conform Radiotherapy After Chemotherapy and Chemotherapy Alone in Patients With Completely Resected Stage IIIA(N2) Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 3|500|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-02-18 13:10:35.889605|2017-02-18 13:10:35.889605
NCT00879151|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-05-21|||January 2009||2009-01-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study of Treatment for Adolescents With Bulimia Nervosa|Treatment of Bulimic Adolescents|Completed||N/A|130|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 13:11:19.057337|2017-02-18 13:11:19.057337
NCT00880958|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-10-28|||March 2009||2009-03-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|||||Interventional|||Effects of Supplement Containing Various Probiotics and Fermentation Products on Obesity|Effects of Supplement Containing Various Probiotics and Fermentation Products on Obesity: a Double-Blind, Randomized Controlled Trial|Completed||N/A|30|Anticipated|Hiroshima University||2|||f||||f||||||||||2017-02-18 13:10:36.011061|2017-02-18 13:10:36.011061
NCT00880945|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-04-13|||May 2009||2009-05-01|April 2009|2009-04-01|May 2010|Anticipated|2010-05-01|April 2010|Anticipated|2010-04-01||Observational|||Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions|Comparison of the Electromagnetic Navigation System and Rapid on Site Evaluation Versus Conventional Bronchoscopy and Rapid on Site Evaluation: Improved Yield in Small Peripheral Lung Lesions(Original Investigation)|Unknown status|Not yet recruiting|N/A|40|Anticipated|Azienda Ospedaliero Universitaria Maggiore della Carita|||1||f||||f||||||||||2017-02-18 13:10:36.100222|2017-02-18 13:10:36.100222
NCT00880932|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-04-13|||August 2006||2006-08-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert|The Effect of Customized Alerts Versus Generic Alerts for the Prescription of Warfarin and NSAID|Completed||N/A|1865|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 13:10:36.188928|2017-02-18 13:10:36.188928
NCT00880919|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2016-11-01|2014-04-16||June 2008||2008-06-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD)|Seroquel XR for the Management of Borderline Personality Disorder (BPD)|Completed||Phase 3|95|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||No||2017-02-18 13:10:36.287394|2017-02-18 13:10:36.287394
NCT00880906|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-04-29|2014-03-27||August 2008||2008-08-01|July 2013|2013-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EOE||Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis|Prospective, Single-Blinded, Randomized Controlled Trial With Sham Comparing Standard Therapy With or Without Esophageal Dilatation in Patients With Eosinophilic Esophagitis|Completed||N/A|50|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:10:36.987388|2017-02-18 13:10:36.987388
NCT00880893|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2015-08-17|||April 2009||2009-04-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|||Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore|Immunogenicity and Large-Scale Safety of Tetravalent Dengue Vaccine in Healthy Subjects Aged 2 to 45 Years in Singapore|Completed||Phase 2|1198|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:10:37.35265|2017-02-18 13:10:37.35265
NCT00880880|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2015-10-01|||August 2007||2007-08-01|April 2009|2009-04-01||||August 2008|Actual|2008-08-01||Interventional|||Improving Women's Health by Using an Electronic Pelvic Floor Questionnaire|Improving the Assessment of Women's Health Through the Use of a Computerized Pelvic Floor Questionnaire|Completed||N/A|284|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 13:10:37.576667|2017-02-18 13:10:37.576667
NCT00880867|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2011-07-19|||April 2009||2009-04-01|July 2011|2011-07-01|April 2011|Actual|2011-04-01|May 2010|Actual|2010-05-01||Interventional|||Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma|A Phase I Study of Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma|Terminated||Phase 1|3|Actual|Nevada Cancer Institute||1||Low enrollment|f||||t||||||||||2017-02-18 13:10:37.686933|2017-02-18 13:10:37.686933
NCT00880854|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2015-09-30|||June 2009||2009-06-01|September 2015|2015-09-01||||February 2011|Actual|2011-02-01||Interventional|||Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer|Phase I Dose-escalation Trial of CP-675,206 (Tremelimumab, Anti-CTLA-4 Monoclonal Antibody) for Patients With BCG-resistant Localized Transitional Cell Carcinoma of the Bladder|Withdrawn||Phase 1|0|Actual|University of Wisconsin, Madison||1||Lack of accrual|f||||t||||||||||2017-02-18 13:10:37.796648|2017-02-18 13:10:37.796648
NCT00880841|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2016-04-11|||April 2009||2009-04-01|April 2016|2016-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone|A Single-Dose, 1-Period, 1-Treatment Pilot Study of an Investigational Capsule Formulation of 2 mg/.05 mg Buprenorphine/Naloxone Under Fasting Conditions|Completed||N/A|6|Actual|Nanotherapeutics, Inc.|||1||f||||f||||||||||2017-02-18 13:10:37.907663|2017-02-18 13:10:37.907663
NCT00880828|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2010-09-23|||August 2010||2010-08-01|September 2010|2010-09-01|October 2011|Anticipated|2011-10-01|April 2011|Anticipated|2011-04-01||Interventional|||Comparing Two Different Cervical Collars for the Treatment in Patient With Cervical Radiculopathy and Radicular Pain|A Single-Center, Prospective, Randomized, Active Controlled, Single Blind, Parallel Design, Three Arms Trial Comparing Two Different Cervical Collar Combine With Acetaminophen and Acetaminophen Along for the Treatment in Patient With Cervical Radiculopathy and Radicular Pain|Unknown status|Active, not recruiting|N/A|72|Anticipated|Taipei Medical University WanFang Hospital||3|||f||||f||||||||||2017-02-18 13:10:38.006044|2017-02-18 13:10:38.006044
NCT00880815|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2015-10-05|||February 2009||2009-02-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies|Fludarabine, Bendamustine and Rituximab (FBR) Non-myeloablative Allogeneic Conditioning for Patients With Lymphoid Malignancies|Completed||Phase 1|60|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:10:38.117843|2017-02-18 13:10:38.117843
NCT00880802|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-11|2010-01-08|||December 2008||2008-12-01|January 2010|2010-01-01|March 2011|Anticipated|2011-03-01|January 2011|Anticipated|2011-01-01||Observational|FAST-TRAC||Finding Acute Coronary Syndromes (ACS) With Serial Troponin Testing for Rapid Assessment of Cardiac Ischemic Symptoms|Finding ACS With Serial Troponin Testing for Rapid Assessment of Cardiac Ischemic Symptoms|Unknown status|Active, not recruiting|N/A|1500|Anticipated|Nanosphere, Inc.|||1||f||||f||||||Samples Without DNA|"~     Plasma samples.~   "|||2017-02-18 13:10:38.241077|2017-02-18 13:10:38.241077
NCT00880789|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2014-10-13|||May 2009||2009-05-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|August 2013|Actual|2013-08-01||Interventional|ACT-CAT||Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus|Adoptive Transfer of Cord Blood T Cells To Prevent and Treat CMV and Adenovirus Infections After Transplantation|Completed||Phase 1|9|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 13:10:38.338149|2017-02-18 13:10:38.338149
NCT00880763|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2015-12-22|2014-09-26||April 2009||2009-04-01|December 2015|2015-12-01|February 2012|Actual|2012-02-01|June 2010|Actual|2010-06-01||Interventional||All randomized participants|A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)|A Phase II Randomized Placebo-controlled Study to Evaluate the Safety and Efficacy of MK-7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Japanese Treatment-Experienced Patients With Chronic Hepatitis C Infection|Completed||Phase 2|90|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:10:38.595465|2017-02-18 13:10:38.595465
NCT00880750|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2015-03-03|2010-02-19||April 2009||2009-04-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults|A Phase I Pharmacodynamic Equivalence Study Comparing Urinary Phosphate Excretion and Plasma Lanthanum Pharmacokinetics for a Lanthanum Carbonate Granule Formulation and Chewable Tablets Administered to Healthy Adult Subjects|Completed||Phase 1|72|Actual|Shire||2|||f||||f||||||||||2017-02-18 13:10:39.517236|2017-02-18 13:10:39.517236
NCT00880737|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2011-06-14|||February 2009||2009-02-01|February 2010|2010-02-01||||June 2011|Actual|2011-06-01||Observational|PROTECT||Prognostic Value of Computed Tomography (CT) Scan in Hemodynamically Stable Patients With Acute Symptomatic Pulmonary Embolism||Completed||N/A|850|Anticipated|Carlos III Health Institute|||1||f||||t||||||||||2017-02-18 13:10:40.005734|2017-02-18 13:10:40.005734
NCT00880724|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2009-06-25|||March 2007||2007-03-01|June 2009|2009-06-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|IBV||European Multi-Center Post Market Study of the IBV Valve System|European Post Market Study: A Prospective, Randomized, Controlled, Multicenter Study to Evaluate the Performance of the IBV Valve System for the Treatment of Severe Emphysema|Unknown status|Active, not recruiting|N/A|100|Anticipated|Spiration, Inc.||1|||f||||f||||||||||2017-02-18 13:10:40.098159|2017-02-18 13:10:40.098159
NCT00880711|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2011-11-29|||April 2009||2009-04-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Observational|FIONA||Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)|Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer|Completed||N/A|57|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:10:40.211283|2017-02-18 13:10:40.211283
NCT00880698|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2015-07-17|2015-06-22||December 2009||2009-12-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Includes all participants 'as randomized'|Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers|Safety and Immunogenicity of a Live, Attenuated Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1-Infected Mothers|Completed||Phase 2|202|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The study was closed to enrollment prematurely so statistical power to detect differences was reduced.|4|||f||||t||||||||||2017-02-18 13:10:40.318962|2017-02-18 13:10:40.318962
NCT00880685|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2014-01-17|2013-08-19||March 2009||2009-03-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Memantine in the Treatment of Kleptomania|Memantine Treatment of Kleptomania: An Open-Label Study|Completed||Phase 2|12|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 13:10:41.412132|2017-02-18 13:10:41.412132
NCT00880672|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2013-06-10|||January 2008||2008-01-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate|Apoptosis and Expression of Neovascularization-related Factors in Human Prostate Tissue After Administration of Dutasteride|Completed||Phase 4|40|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 13:10:41.696963|2017-02-18 13:10:41.696963
NCT00880659|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-11|2010-12-29|||June 2009||2009-06-01|May 2010|2010-05-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Bangladesh Secondary Transmission Handwashing Protocol|Prevention of Secondary Transmission of Human Influenza by Promoting Handwashing With Soap: The Bangladesh Interruption of Secondary Transmission of Influenza Study (BISTIS)|Completed||Phase 2|6600|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-02-18 13:10:41.879867|2017-02-18 13:10:41.879867
NCT00880646|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2009-10-28|||March 2009||2009-03-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|||||Interventional|||Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity|Effects of the Combination of L-Arabinose and Indigestible Dextrin on Obesity: a Double-Blind, Randomized Controlled Trial|Completed||N/A|70|Anticipated|Hiroshima University||2|||f||||f||||||||||2017-02-18 13:10:41.976906|2017-02-18 13:10:41.976906
NCT00880633|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2011-02-16|||April 2007||2007-04-01|February 2011|2011-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Observational|||Endoscopic Ultrasound Staging of Periampullary Neoplasms: Retrospective|EUS Staging Accuracy of Periampullary Neoplasms: a Retrospective Review|Completed||N/A|||Indiana University|||1||f||||f||||||||||2017-02-18 13:10:42.068614|2017-02-18 13:10:42.068614
NCT00880620|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-01-25|2015-12-07||April 2009||2009-04-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|APEX-PD|Baseline Analysis Population is all treated|A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease|A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease|Completed||Phase 3|381|Actual|IMPAX Laboratories, Inc.||4|||f||||f||||||||No||2017-02-18 13:10:42.150922|2017-02-18 13:10:42.150922
NCT00880607|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2015-05-26|||December 2008||2008-12-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|April 2011|Actual|2011-04-01||Interventional|IT Morphine||The Use of Intraoperative Intrathecal Morphine Versus Epidural Extended Release Morphine for Postoperative Pain Control in Pediatric Patients Undergoing Posterior Spinal Fusion|The Use of Intraoperative Intrathecal Morphine Versus Epidural Extended Release Morphine for Postoperative Pain Control in Pediatric Patients Undergoing Posterior Spinal Fusion|Completed||Phase 4|70|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 13:10:43.538459|2017-02-18 13:10:43.538459
NCT00880594|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-13|2010-03-15|||February 2009||2009-02-01|March 2010|2010-03-01||||February 2012|Anticipated|2012-02-01||Interventional|||Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine|The Modulation of Cerebral Pain Responses Using Desipramine in the Treatment of Irritable Bowel Syndrome (IBS)|Unknown status|Recruiting|N/A|200|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 13:10:43.650279|2017-02-18 13:10:43.650279
NCT00880581|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2012-12-30|||January 2009||2009-01-01|December 2012|2012-12-01|September 2013|Anticipated|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||A Phase II Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas|A Phase II Study of Intratumoral Injection PF-3512676 in Combination With Local Radiation in Low-Grade B-Cell Lymphomas|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Stanford University||1|||f||||t||||||||||2017-02-18 13:10:43.748979|2017-02-18 13:10:43.748979
NCT00880568|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2015-02-02|2012-09-25||April 2009||2009-04-01|February 2015|2015-02-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Interventional|||Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED)|A Phase I Dose Escalation Study of MK1496 in Patients With Advanced Solid Tumor|Completed||Phase 1|27|Actual|Merck Sharp & Dohme Corp.||9|||f||||f||||||||||2017-02-18 13:10:43.861791|2017-02-18 13:10:43.861791
NCT00880555|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2016-02-24|2015-11-10||April 2009||2009-04-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|CASL|Seventy-eight individuals underwent the baseline assessment, but four were removed from the analysis and were not asked to follow up because the consensus panel did not feel that they met criteria for any of the three arms (MCI, control, mild AD). This left 74 individuals at baseline who were eligible to continue in the study.|Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)|Semantic Memory, Financial Capacity and Brain Perfusion in MCI|Completed||N/A|78|Actual|VA Office of Research and Development|This trial did not involve an intervention. Technical problems limited the analysis of the MRI scans. Lack of a designated rater for the study negatively impacted participant retention.||3||f||||f||||||None Retained|"~     N/A- no biospecimens~   "|No||2017-02-18 13:10:45.204223|2017-02-18 13:10:45.204223
NCT00880542|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2015-10-28|2011-04-13||August 2008||2008-08-01|July 2012|2012-07-01||||November 2010|Actual|2010-11-01||Interventional|||Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery|A Phase II Study of Sorafenib and Ifosfamide as a Treatment for Patients With Sarcoma|Terminated||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center|This study lost funding and was not able to enroll enough participants to do a complete review.|1||The study lost funding.|f||||t||||||||||2017-02-18 13:10:46.268961|2017-02-18 13:10:46.268961
NCT00880529|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2013-02-26|||February 2009||2009-02-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|ON-Q||Pain Relief for Ventilated Patients With Multiple Rib Fractures Using the ON-Q Pain Relief System|Does Continuous Subcutaneous Paravertebral Infusion of Bupivicaine With the ON-Q Pain Relief System vs. Standard IV Pain Management Decrease Ventilator Dependence in Trauma Patients With Multiple Rib Fractures|Terminated||Phase 4|2|Actual|The Cooper Health System||2||low enrollment, 2 pts enrolled no data every analyzed investigator left the institution|f||||f||||||||||2017-02-18 13:10:46.600078|2017-02-18 13:10:46.600078
NCT00880516|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2016-08-25|||April 2009||2009-04-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Genetic Factors in Chronic Sinusitis|Genetic Factors in Chronic Sinusitis|Recruiting||N/A|1200|Anticipated|University of Chicago|||2||f||||f||||||Samples With DNA|"~     peripheral blood for DNA~   "|||2017-02-18 13:10:46.711373|2017-02-18 13:10:46.711373
NCT00880503|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2017-01-24|||December 19, 2003||2003-12-19|February 17, 2016|2016-02-17||||||||Observational|||Collection of Tissue Samples for Study of Multidrug Resistance|Multidrug Resistance Molecular Target Analysis of Human Samples Collected in Clinical Trials Performed Outside of the Intramural National Cancer Institute|Completed||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:10:46.822555|2017-02-18 13:10:46.822555
NCT00880490|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2010-10-11||2010-10-05|November 2008||2008-11-01|October 2010|2010-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study to Evaluate the Safety and Efficacy of Inhaled PT005 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Five-period, Placebo and Active-controlled,Cross-over, Multi-centre, Study Evaluating Single Administration of Three Doses of Inhaled PT005 in Patients With Moderate-to-Severe COPD, Compared to Open- Label Marketed Formoterol (FORADIL® AEROLIZER®) as an Active Control|Completed||Phase 1/Phase 2|34|Actual|Pearl Therapeutics, Inc.||5|||f||||f||||||||||2017-02-18 13:10:46.919173|2017-02-18 13:10:46.919173
NCT00880477|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2016-09-06|||January 2001||2001-01-01|September 2016|2016-09-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine|Immunogenicity and Safety of GSK Biological's DTPa-HBV-IPV/Hib Vaccine or DTPa-IPV/Hib Co-administered With HBV Vaccine as Primary and Booster Vaccination in Healthy Infants Born to Hepatitis B Surface Antigen Negative Mothers|Completed||Phase 3|140|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:10:47.045368|2017-02-18 13:10:47.045368
NCT00880464|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2016-05-25|||April 2009||2009-04-01|May 2016|2016-05-01|July 2017|Anticipated|2017-07-01|April 2017|Anticipated|2017-04-01||Interventional|||Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer|A Phase Ib Study of Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete GM-CSF Following Preoperative Chemotherapy in Women With Operable Breast Cancer|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:10:47.232721|2017-02-18 13:10:47.232721
NCT00880451|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2009-04-10|||March 2009||2009-03-01|October 2008|2008-10-01||||||||Observational|||Development and Decline of Brain and Cognition Through the Life Span|Development and Decline of Brain and Cognition Through the Life Span|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:10:47.35575|2017-02-18 13:10:47.35575
NCT00880425|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2011-01-04|2010-10-22||April 2009||2009-04-01|January 2011|2011-01-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?|Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?|Completed||N/A|45|Actual|Thomas Jefferson University|||2||f||||f||||||||||2017-02-18 13:10:47.431988|2017-02-18 13:10:47.431988
NCT00879905|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2012-10-18|||May 2009||2009-05-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors|A Phase I Dose Escalation, Multi-center, Open-label Study of HSP990 Administered Orally in Adult Patients With Advanced Solid Malignancies|Completed||Phase 1|64|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:10:59.783924|2017-02-18 13:10:59.783924
NCT00880412|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2009-09-18|||April 2008||2008-04-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|EHT0202/002||A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease|A Pilot, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase IIA Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 (40 and 80 mg Bid) as Adjunctive Therapy to Acetylcholinesterase Inhibitor Over a 3-month Period in Ambulatory Patients Suffering From Mild to Moderate Alzheimer's Disease (EHT 0202/002 Protocol)|Completed||Phase 2|197|Actual|Exonhit||3|||f||||t||||||||||2017-02-18 13:10:47.6745|2017-02-18 13:10:47.6745
NCT00880399|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2013-09-12||2012-02-23|March 2009||2009-03-01|September 2013|2013-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|orvepitant MDD||A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder|Terminated||Phase 2|328|Actual|GlaxoSmithKline||3||To allow assessment of isolated events of seizure during program|f||||t||||||||||2017-02-18 13:10:47.808601|2017-02-18 13:10:47.808601
NCT00880386|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2013-05-21|||March 2009||2009-03-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer|A Pilot Project to Determine the Effect of Losartan (Cozaar) on Radiation-Induced Pulmonary Fibrosis in Patients With Non-Small Cell Lung Cancer|Withdrawn||N/A|0|Actual|University of South Florida||1||Study concept was not approved by NCI. Study was never activated. No enrollment|f||||f||||||||||2017-02-18 13:10:47.936583|2017-02-18 13:10:47.936583
NCT00880373|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2012-12-03|||March 2011||2011-03-01|December 2012|2012-12-01|August 2014|Anticipated|2014-08-01|March 2014|Anticipated|2014-03-01||Interventional|SWIM||Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease - Sickle With Ibuprofen & Morphine|An Evaluation of the Effectiveness of Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease: a Double-blind, Placebo-controlled Randomised Trial|Terminated||Phase 4|320|Anticipated|London North West Healthcare NHS Trust||2||"The funding withdrawal and early termination of the trial is based upon lack of suitable~   recruitment figures in order to reach the required trial endpoints."|f||||t||||||||||2017-02-18 13:10:48.188856|2017-02-18 13:10:48.188856
NCT00880360|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2013-01-07|2012-08-13||February 2007||2007-02-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|ONTAK||A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer|A Phase II Trial of Intravenous Ontak to Treat Epithelial Ovarian Cancer FIGO Stage III or Stage IV, or Extraovarian Peritoneal Carcinoma, of Fallopian Tube Carcinoma Failing or Ineligible for First-Line Therapy|Completed||Phase 2|19|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 13:10:48.305025|2017-02-18 13:10:48.305025
NCT00880347|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2011-03-30|||February 2008||2008-02-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia|Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia : A Prospective Study for a Blood Diagnostic Test in Alzheimer's Disease - (Protocol n° EHTAD/002).|Completed||N/A|550|Anticipated|Exonhit||3|||f||||f||||||||||2017-02-18 13:10:48.543271|2017-02-18 13:10:48.543271
NCT00880334|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2016-10-24|2014-04-15||September 2006||2006-09-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|December 2013|Actual|2013-12-01||Interventional||The analysis dataset is comprised of all eligible and treated patients.|Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC|Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC|Completed||Phase 2|149|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 13:10:48.673854|2017-02-18 13:10:48.673854
NCT00880321|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2014-04-10|||June 2009||2009-06-01|June 2013|2013-06-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors|A Phase I, Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of the BRAF Inhibitor GSK2118436 in Subjects With Solid Tumors|Completed||Phase 1|184|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:10:49.682935|2017-02-18 13:10:49.682935
NCT00880308|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2014-12-27|||March 2009||2009-03-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors|A Phase I, Multicenter, Open-label, Dose-escalation Study of Oral LDE225 in Patients With Advanced Solid Tumors|Completed||Phase 1|103|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:10:49.81004|2017-02-18 13:10:49.81004
NCT00880295|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2010-08-04||||||April 2009|2009-04-01||||||||Interventional|||Patient Outcomes With Endoscopic Versus Open Carpal Tunnel Release|Endoscopic vs Open Carpal Tunnel Release: Comparison of Patient Satisfaction, Outcomes, and Complications|Unknown status|Recruiting|Phase 2|68|Anticipated|Penn State University||2|||f||||t||||||||||2017-02-18 13:10:49.916641|2017-02-18 13:10:49.916641
NCT00880282|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2014-04-28|||April 2009||2009-04-01|April 2013|2013-04-01||||October 2012|Actual|2012-10-01||Interventional|||Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment|A Phase I Study of IMC-A12 (Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody) in Combination With CCI-779 (Temsirolimus) in Pediatric Patients With Recurrent or Refractory Solid Tumors|Completed||Phase 1|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:10:50.013664|2017-02-18 13:10:50.013664
NCT00880269|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-10-23|2016-07-21||August 2009||2009-08-01|September 2016|2016-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)|A Phase II Study of Oral Single Agent Panobinostat in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)|Completed||Phase 2|59|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:10:50.165688|2017-02-18 13:10:50.165688
NCT00880256|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2012-01-20|2011-11-25||September 2008||2008-09-01|January 2012|2012-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data|Mindfulness-Based Stress Reduction for Bowel Symptoms: Collection of Pilot Survey Data|Completed||N/A|93|Actual|Seattle Institute for Biomedical and Clinical Research||1|||f||||f||||||||||2017-02-18 13:10:50.999544|2017-02-18 13:10:50.999544
NCT00880243|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-04-10|||March 1999||1999-03-01|April 2009|2009-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)|Effect of Priming With Granulocyte-Macrophage Colony-Stimulating Factor During Chemotherapy and Comparison of Timed Sequential Chemotherapy vs 4 Courses of High Dose Cytarabine as Consolidation in Younger Adults With Newly Diagnosed AML|Completed||Phase 3|473|Actual|Acute Leukemia French Association||4|||f||||t||||||||||2017-02-18 13:10:51.202746|2017-02-18 13:10:51.202746
NCT00880230|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2016-01-28|2013-02-01||March 2009||2009-03-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|June 2011|Actual|2011-06-01||Interventional|INTENSE||Iliac Artery Treatment With The Invatec Scuba™ Cobalt Chromium Stent (INTENSE)|INTENSE: Iliac Artery Treatment With The Invatec Scuba™ Cobalt Chromium Stent|Completed||N/A|141|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-02-18 13:10:51.312648|2017-02-18 13:10:51.312648
NCT00880217|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2013-02-27||2011-08-22|May 2009||2009-05-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study of 3 Dosages of JNJ-31001074 in the Treatment of Adult Subjects With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 2|430|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||6|||f||||t||||||||||2017-02-18 13:10:52.142312|2017-02-18 13:10:52.142312
NCT00880204|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2009-05-13|||May 2009||2009-05-01|May 2009|2009-05-01|November 2009|Anticipated|2009-11-01|August 2009|Anticipated|2009-08-01||Interventional|||Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health (ESS-EMCH) Training by Assessing the Doctors' Practices|Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health (ESS-EMCH) Training by Assessing the Doctors' Practices in Pakistan|Unknown status|Recruiting|N/A|24|Anticipated|Child Advocacy International||2|||f||||t||||||||||2017-02-18 13:10:52.296829|2017-02-18 13:10:52.296829
NCT00880191|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2016-07-01|2015-04-13||April 2009||2009-04-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|March 2011|Actual|2011-03-01||Interventional|||Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy|Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy|Completed||Phase 3|430|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 13:10:52.421872|2017-02-18 13:10:52.421872
NCT00880178|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2012-12-18|||May 2008||2008-05-01|December 2012|2012-12-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Observational|HDL Proteomics||Plaque Inflammation and Dysfunctional HDL Cholesterol in Participants Receiving Niacin and Statins in the AIM-HIGH Study (The HDL Proteomics Study)|Plaque Inflammation and Dysfunctional HDL in AIM-HIGH|Completed||N/A|324|Actual|University of Washington|||2||f||||t||||||Samples Without DNA|"~     Plasma for HDL isolation~   "|||2017-02-18 13:10:53.477662|2017-02-18 13:10:53.477662
NCT00880165|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2014-03-18|2014-01-08||November 2006||2006-11-01|March 2014|2014-03-01|January 2010|Actual|2010-01-01|July 2009|Actual|2009-07-01||Interventional|VSATT|Veterans referred to the participating sleep centers for evaluation of obstructive sleep apnea|Cost Effectiveness of Ambulatory Management for Veterans With Sleep Apnea|Cost Effective Strategy to Evaluate Veterans With Sleep Apnea|Completed||N/A|296|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:10:53.622006|2017-02-18 13:10:53.622006
NCT00880152|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2010-09-23|||September 2008||2008-09-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|MBSRforPTSD||Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study|Mindfulness-Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study|Completed||N/A|50|Anticipated|Seattle Institute for Biomedical and Clinical Research||2|||f||||f||||||||||2017-02-18 13:10:54.050529|2017-02-18 13:10:54.050529
NCT00880139|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-11-13|||June 2009||2009-06-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Observational|||Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 Diabetes|A Cross-sectional Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 Diabetes|Terminated||N/A|33|Actual|Medical University of Vienna|||1||f||||||||||||||2017-02-18 13:10:54.149099|2017-02-18 13:10:54.149099
NCT00880126|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2009-04-10|||September 2006||2006-09-01|February 2009|2009-02-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Community Development Teams to Scale-Up Multidimensional Treatment Foster Care (MTFC) in California|Community Development Teams to Scale-Up MTFC in California|Unknown status|Enrolling by invitation|Phase 2/Phase 3|350|Anticipated|Center for Research to Practice||1|||f||||t||||||||||2017-02-18 13:10:54.25748|2017-02-18 13:10:54.25748
NCT00880113|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2012-06-04|||May 2009||2009-05-01|June 2012|2012-06-01||||December 2013|Anticipated|2013-12-01||Observational|DUST||The Dutch Acute Stroke Trial (DUST): Prediction of Outcome With Computed Tomography (CT) - Perfusion and CT-angiography|The Dutch Acute Stroke Trial (DUST): Prediction of Outcome With CT-perfusion and CT-angiography|Unknown status|Recruiting|N/A|1500|Anticipated|UMC Utrecht|||1||f||||||||||||||2017-02-18 13:10:54.345814|2017-02-18 13:10:54.345814
NCT00880100|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2015-02-17|2014-03-05||April 2009||2009-04-01|February 2015|2015-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||Safety population included patients who signed an informed consent form (ICF), completed the baseline phase and started the treatment phase by taking at least one dose of the study treatment.|Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)|Efficacy and Safety of Ultrase MT12 in the Control of Steatorrhea in Cystic Fibrosis (CF) and Pancreatic Insufficient (PI) Children Aged 2 to 6 Years Old|Completed||Phase 3|49|Actual|Forest Laboratories||1|||f||||t||||||||||2017-02-18 13:10:54.455075|2017-02-18 13:10:54.455075
NCT00880087|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2016-05-11|||September 2009||2009-09-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|THAPCA-IH||Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial|Therapeutic Hypothermia After Pediatric Cardiac Arrest (In Hospital)|Completed||Phase 3|329|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 13:10:54.817415|2017-02-18 13:10:54.817415
NCT00880074|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2016-05-16|||April 2009||2009-04-01|May 2016|2016-05-01||||April 2018|Anticipated|2018-04-01||Interventional|||Clinical Response to Chemotherapy With Fluoro-L-Thymidine With Positron Emission Tomography (FLT-PET)|Early Prediction of Clinical Response to Chemotherapy With FLT-PET {[F-18]-Fluoro-L-thymidine (FLT) With Positron Emission Tomography (PET)}|Active, not recruiting||N/A|16|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:10:54.979164|2017-02-18 13:10:54.979164
NCT00880061|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2017-01-24|||April 7, 2009||2009-04-07|June 5, 2015|2015-06-05|June 5, 2015|Actual|2015-06-05|June 5, 2015|Actual|2015-06-05||Interventional|||An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma|An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma|Terminated||Phase 1|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:10:55.101155|2017-02-18 13:10:55.101155
NCT00880048|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2012-09-13||2012-02-23|March 2009||2009-03-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|Orvepitant MDD||A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder|A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder|Terminated||Phase 2|346|Actual|GlaxoSmithKline||3||To allow assessment of isolated events of seizure during program|f||||t||||||||||2017-02-18 13:10:55.207077|2017-02-18 13:10:55.207077
NCT00880035|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2009-04-20|||December 2008||2008-12-01|April 2009|2009-04-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|MUSIC||Efficacy of Music on Reduction of Sedative Drugs in Mechanically Ventilated Intensive Care Unit Patients|M.U.S.I.C (MUSicotherapy in the Intensive Care) Interventional, Pilot, Cross-Over, in Mechanically-Ventilated Patients on ICU Ward|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Université de Sherbrooke||2|||f||||t||||||||||2017-02-18 13:10:55.349051|2017-02-18 13:10:55.349051
NCT00880022|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2012-09-12|2012-08-14||May 2009||2009-05-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer|Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer|Completed||Phase 4|47|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:10:55.450775|2017-02-18 13:10:55.450775
NCT00880009|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2012-10-04|2012-10-04||July 2009||2009-07-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer|A Phase 2, Randomized, Open-Label Study Of Bosutinib Administered In Combination With Letrozole Versus Letrozole Alone As First Line Therapy In Post-Menopausal Women With Locally Advanced Or Metastatic ER+/PgR+/ErbB2- Breast Cancer|Terminated||Phase 2|16|Actual|Pfizer|Results are not provided because the study was terminated prior to part 2 due to unfavorable risk benefit ratio of the study treatment.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:10:55.830219|2017-02-18 13:10:55.830219
NCT00879996|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2012-08-03|2012-03-21||April 2009||2009-04-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients|A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients|Completed||Phase 4|54|Actual|State University of New York at Buffalo|small subject number not a double-blind study|2|||f||||f||||||||||2017-02-18 13:10:56.356401|2017-02-18 13:10:56.356401
NCT00879983|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2010-06-11|||May 2009||2009-05-01|June 2010|2010-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects|An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:10:56.85795|2017-02-18 13:10:56.85795
NCT00879970|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-11-23|2011-11-10||May 2009||2009-05-01|November 2016|2016-11-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|TIDE||Thiazolidinedione Intervention With Vitamin D Evaluation|AVANDIA CV Outcomes Study: Thiazolidinedione Intervention With Vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People With Type 2 Diabetes at Risk For Cardiovascular Disease|Terminated||Phase 4|1332|Actual|GlaxoSmithKline|The intended duration of this study was approximately 5.5 years. However, the trial was stopped prematurely because of regulatory concerns after a mean of 162 days without consideration of the accrued data.|5||FDA has placed the trial on full clinical hold.|f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:10:56.996612|2017-02-18 13:10:56.996612
NCT00879957|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-04-14|||January 2010||2010-01-01|April 2015|2015-04-01|May 2011|Actual|2011-05-01|March 2011|Anticipated|2011-03-01||Interventional|||Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates|Comparison of Heparin vs. no Heparin on Duration of Peripherally Inserted Central Catheter Patency in Neonates|Withdrawn||N/A|0|Actual|The University of Texas Health Science Center at San Antonio||2||A study was published regarding the same question this study had.|f||||t||||||||||2017-02-18 13:10:59.336689|2017-02-18 13:10:59.336689
NCT00879944|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2015-04-10|||May 2009||2009-05-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|||Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index|Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis|Completed||N/A|409|Actual|Northwestern University|||3||f||||t||||||||||2017-02-18 13:10:59.449027|2017-02-18 13:10:59.449027
NCT00879931|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2014-12-04|||January 2013||2013-01-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Influence of Corticoids on Renal Function in Cardiac Surgery|Influence of Corticoids on Renal Function in Cardiac Surgery|Unknown status|Recruiting|Phase 2|80|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:10:59.579273|2017-02-18 13:10:59.579273
NCT00879918|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2013-05-23|||December 2008||2008-12-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|5075-AAPK1||Pharmacogenetics of Nicotine Metabolism in African-Americans|Pharmacogenetics of Nicotine Metabolism in African-Americans|Completed||Phase 1|70|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 13:10:59.68083|2017-02-18 13:10:59.68083
NCT00879892|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2015-01-16|||May 2009||2009-05-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|Xe-hypotheca||Effect of Xenon and Therapeutic Hypothermia, on the Brain and on Neurological Outcome Following Brain Ischemia in Cardiac Arrest Patients|Phase 2 Study of Effect of Xenon, in Combination With Therapeutic Hypothermia, on the Brain and on Neurological Outcome Following Brain Ischemia in Cardiac Arrest Patients|Completed||Phase 2|110|Actual|Turku University Hospital||2|||f||||t||||||||||2017-02-18 13:10:59.894111|2017-02-18 13:10:59.894111
NCT00879879|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2013-08-09|2013-08-09||March 2009||2009-03-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis|Treatment of Idiopathic Pulmonary Fibrosis With Losartan: A Pilot Project|Completed||N/A|20|Actual|University of South Florida||1|||f||||t||||||||||2017-02-18 13:11:00.033217|2017-02-18 13:11:00.033217
NCT00879866|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2014-06-20|||April 2009||2009-04-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|February 2011|Actual|2011-02-01||Interventional|||EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)|An Open-label, Phase Ib, Dose-escalation Trial on the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Biological Effects and Antitumor Activity of EMD 521873 in Combination With Local Irradiation (20 Gy) of Primary Tumors or Metastases in Subjects With Non-small Cell Lung Cancer Stage IIIb With Malignant Pleural Effusion or Stage IV With Disease Control (Partial Response or Stable Disease) After Application of 4 Cycles of Platinum-based, First-line Chemotherapy|Completed||Phase 1|15|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 13:11:00.299911|2017-02-18 13:11:00.299911
NCT00879853|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2009-04-10||||||April 2009|2009-04-01||||||||Interventional|||Trial of Mental Health Treatment for Darfur Refugees in Cairo|Randomized Controlled Trial of Mental Health Treatment for Darfur Refugees in Cairo|Completed||N/A|||University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:11:00.410744|2017-02-18 13:11:00.410744
NCT00879840|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2017-01-24|||April 7, 2009||2009-04-07|October 28, 2016|2016-10-28||||||||Observational|||Assessment of Screening Modalities for Gynecologic Cancers|Assessment of Screening Modalities for Gynecologic Cancers|Active, not recruiting||N/A|170|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:11:00.503928|2017-02-18 13:11:00.503928
NCT00879827|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2016-09-06|||September 2000||2000-09-01|September 2016|2016-09-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants|Immunogenicity and Reactogenicity of GSK Biologicals' DTPa-HBV-IPV and Hib Vaccines When Administered Concomitantly to Healthy Infants Administered as a Three-dose Primary Vaccination Course at the Age of 1.5, 3.5 and 6 Months|Completed||Phase 3|60|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:11:00.604689|2017-02-18 13:11:00.604689
NCT00879814|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-10|2015-07-15|2014-11-17||April 2009||2009-04-01|July 2015|2015-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Safety population included all randomized participants who received at least 1 vaccination.|Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults|A Phase 1 Randomized, Open-label, Parallel-group, Active- And Placebo-controlled Study To Assess Safety And Tolerability Of 60, 120, And 200 Mcg Meningococcal Group B Rlp2086 Vaccine In Healthy Adult Subjects|Completed||Phase 1|48|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:11:00.723699|2017-02-18 13:11:00.723699
NCT00879801|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2009-04-09|||January 2003||2003-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|GENFIEV||Genetic Physiopathology and Evolution of Type 2 Diabetes|Evaluation of Genetic, Biochemical and Clinical Determinants of Type 2 Diabetes Progression in Subjects at High Risk|Completed||N/A|1017|Actual|University of Pisa|||1||f||||t||||||Samples With DNA|"~     Serum and plasma sample, DNA~   "|||2017-02-18 13:11:06.52799|2017-02-18 13:11:06.52799
NCT00879788|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2009-04-09|||October 2006||2006-10-01|April 2009|2009-04-01|March 2007|Actual|2007-03-01|November 2006|Actual|2006-11-01||Interventional|||Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions|An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Bioavailability Study Comparing Ramipril 10 mg Capsules of Ohm Laboratories Inc. (A Subsidiary of Ranbaxy Pharmaceuticals Inc.), With Altace® Capsule 10 mg (Containing Ramipril 10 mg) of Monarch Pharmaceuticals Inc, USA in Healthy, Adult, Male, Human Subjects Under Fed Conditions.|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:11:06.6177|2017-02-18 13:11:06.6177
NCT00879775|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2011-03-03|2011-01-11||April 2009||2009-04-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain|Efficacy of Caffeine as an Adjuvant to Opioid Therapy in Cancer Pain: a Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 2|41|Actual|Korea Research Foundation||2|||f||||f||||||||||2017-02-18 13:11:06.717623|2017-02-18 13:11:06.717623
NCT00879762|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2012-12-06||2012-10-17|May 2009||2009-05-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||High Dose IMVAMUNE® in Vaccinia-Naive Individuals|Comparison of Safety and Immunogenicity of a High Dose (5 x 10^8 TCID50) and a Standard Dose (1 x 10^8 TCID50) of IMVAMUNE® in Healthy Vaccinia-Naive Individuals|Completed||Phase 2|91|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 13:11:07.393983|2017-02-18 13:11:07.393983
NCT00879749|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2011-04-05|||April 2009||2009-04-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Safety Study of Nexvax2 in Subjects With Coeliac Disease|A Phase I Study to Determine Safety, Tolerability and Bioactivity of Nexvax2 in HLA DQ2+ Volunteers With Coeliac Disease Following a Long-term, Strict Gluten-free Diet|Completed||Phase 1|34|Actual|Nexpep Pty Ltd||2|||f||||f||||||||||2017-02-18 13:11:07.506029|2017-02-18 13:11:07.506029
NCT00879736|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2011-08-19|||March 2009||2009-03-01|October 2010|2010-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study of the Effect of Patient Education (Talking Health Together) in Improving Doctor-patient Communication|A Multi-centre, Randomised Trial in Ontario to Evaluate the Efficacy of Talking Health Together T.M. (T.H.T. in Practice), a Communication Education Intervention for Primary Care Patients With Chronic Disease.|Completed||N/A|322|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 13:11:07.601744|2017-02-18 13:11:07.601744
NCT00879723|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2015-08-25|||August 2010||2010-08-01|August 2015|2015-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Burn Micronutrient Repletion Pilot Study|Burn Micronutrient Repletion Pilot Study: Characterizing Relationships Between Vitamin and Mineral Supplementation and Health Outcomes of Adult Burn Patients|Completed||Phase 1|28|Actual|Southern Illinois University||2|||f||||f||||||||||2017-02-18 13:11:07.908194|2017-02-18 13:11:07.908194
NCT00879710|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2016-03-16|2015-08-25||August 2008||2008-08-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Diabetes Mellitus on Cholesterol Metabolism|Effect of Diabetes Mellitus on Cholesterol Absorption, Synthesis and Statin Efficacy|Completed||N/A|57|Actual|Medical College of Wisconsin|"Smaller than desirable sample size due to difficulty in recruitment.~Could not evaluate the effect of duration of the diabetes mellitus as independent confirmation of the duration could not be done.~Apolipoprotein levels were not measured."|2|||f||||f||||||||||2017-02-18 13:11:08.032178|2017-02-18 13:11:08.032178
NCT00879697|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-10-24|2009-01-27||July 2005||2005-07-01|October 2016|2016-10-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Strength Training in Walking Tolerance in Intermittent Claudication Patients|Effects of Strength Training and Walking Training on Physical Fitness of Patients With Intermittent Claudication|Completed||Phase 3|34|Actual|University of Sao Paulo|Our sample was composed of patients with many diseases and taking different medications.|2|||f||||t||||||||No||2017-02-18 13:11:08.509165|2017-02-18 13:11:08.509165
NCT00879684|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2015-01-15|2015-01-15||January 2008||2008-01-01|January 2015|2015-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional||Safety population included all enrolled participants in the study who received any study medication.|Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors|A Phase 1, Multicenter, Open-label, Dose-escalation, Safety, Pharmacokinetic, And Pharmacodynamic Trial Of Cvx-060, A Selective Angiopoietin-2 (Ang-2) Binding, Anti-angiogenic Covx-body, In Patients With Advanced Solid Tumors|Completed||Phase 1|34|Actual|Pfizer|Designation of outcomes as primary, secondary was based on study team’s input as study did not specify them as primary or secondary.|1|||f||||f||||||||||2017-02-18 13:11:08.955938|2017-02-18 13:11:08.955938
NCT00879671|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2014-11-13|||November 2006||2006-11-01|November 2014|2014-11-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients With Age-related Macular Degeneration|Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients With Age-related Macular Degeneration|Completed||N/A|126|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 13:11:10.633791|2017-02-18 13:11:10.633791
NCT00879658|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2012-09-19||2012-07-24|March 2009||2009-03-01|September 2012|2012-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis|A Phase II, Double-blind, Randomized, Multi-center, Adaptive Dose-ranging, Placebo-controlled, Parallel-group Study Evaluating Safety, Tolerability and Efficacy on MRI Lesion Parameters and Determining the Dose Response Curve of BAF312 Given Orally Once Daily in Patients With Relapsing-remitting Multiple Sclerosis.|Completed||Phase 2|296|Actual|Novartis||6|||f||||||||||||||2017-02-18 13:11:10.746824|2017-02-18 13:11:10.746824
NCT00879645|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2016-10-18|2010-10-07||August 2009||2009-08-01|October 2016|2016-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function|A Phase I Study to Assess the Pharmacokinetics of IK-1001 (Sodium Sulfide) in Subjects With Impaired Renal Function Following a Continuous 3-hour Intravenous Infusion|Terminated||Phase 1|28|Actual|Mallinckrodt||4||unable to develop a rapid & reliable assay to detect sulfide concentrations|f||||t||||||||||2017-02-18 13:11:10.937416|2017-02-18 13:11:10.937416
NCT00879632|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2011-02-15|||March 2009||2009-03-01|February 2011|2011-02-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|||Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania|Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up Study|Unknown status|Recruiting|N/A|200|Anticipated|Hospital de Clinicas de Porto Alegre|||2||f||||f||||||Samples With DNA|"~     SERUM, DNA, PLASMA~   "|||2017-02-18 13:11:11.622796|2017-02-18 13:11:11.622796
NCT00879619|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2016-12-06|2013-04-19||July 2009||2009-07-01|April 2013|2013-04-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients|A Pilot Phase I/II Study to Evaluate the Effects of Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients With Biochemical Relapse|Terminated||Phase 1/Phase 2|4|Actual|University of California, Irvine|The study was terminated due to slow accrual. Zero subjects were analyzed.|1||Terminated due to slow accrual.|f||||t||||||||||2017-02-18 13:11:11.71107|2017-02-18 13:11:11.71107
NCT00879606|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2015-03-20||2014-01-14|April 2009||2009-04-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome|Efficacy and Safety Evaluation of ALT-836 in Patients With Sepsis and Acute Lung Injury/Acute Respiratory Distress Syndrome|Completed||Phase 2|150|Actual|Altor Bioscience Corporation||2|||f||||t||||||||||2017-02-18 13:11:11.983012|2017-02-18 13:11:11.983012
NCT00879593|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2017-01-25|||April 2009||2009-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|June 2014|Actual|2014-06-01||Interventional|||Nocturnal PtcCO2 Monitoring in Patients With Amyotrophic Lateral Sclerosis (ALS)|Potential Role for Nocturnal PtcCO2 Monitoring in the Close Follow up of ALS Patients.|Completed||N/A|66|Actual|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche||1|||f||||f||||||||||2017-02-18 13:11:12.121027|2017-02-18 13:11:12.121027
NCT00879580|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-10-10|||February 2009||2009-02-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|ESAT||Enterprise Stent Aneurysm Treatment (ESAT) Study - France|"Prospective Multicenter Observational Study for the Evaluation of the Efficacy of the Cordis Enterprise(TM) Self-expanding Intracranial Stent: Enterprise Stent Aneurysm Treatment (ESAT) Study"|Completed||N/A|133|Actual|Codman & Shurtleff|||2||f||||f||||||||||2017-02-18 13:11:12.414886|2017-02-18 13:11:12.414886
NCT00879554|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2010-12-10|||February 2007||2007-02-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|March 2009|Actual|2009-03-01||Interventional|CVX-045-101||A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors|A Multicenter, Open-Label, 2-Stage, Phase 1, Clinical Safety, Pharmacokinetic, And Pharmacodynamic Study Of CVX-045, A Thrombospondin-1 Mimetic, Anti-Angiogenic Agent, In Patients With Advanced Solid Tumors|Completed||Phase 1|40|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:11:12.519278|2017-02-18 13:11:12.519278
NCT00879541|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2011-02-10|||February 2009||2009-02-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia A|A Phase II, Multicentre, Double-blinded, Randomised, Cross-over Study to Evaluate Efficacy, Safety and Pharmacokinetics of Biostate® in Subjects With Haemophilia A.|Completed||Phase 2|81|Actual|CSL Behring||3|||f||||t||||||||||2017-02-18 13:11:12.625866|2017-02-18 13:11:12.625866
NCT00879528|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2016-08-16|||May 2009||2009-05-01|August 2016|2016-08-01|September 2015|Actual|2015-09-01|May 2010|Actual|2010-05-01||Observational|||Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory|Consolidation PET-based and Donor-based After Salvage Therapy in Patients With Hodgkin Lymphoma in Relapse or Refractory|Terminated||N/A|264|Actual|Fondazione Italiana Linfomi ONLUS|||1|Failure of accrual achievement|f||||f||||||||||2017-02-18 13:11:12.754142|2017-02-18 13:11:12.754142
NCT00879515|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2013-03-05|||October 2005||2005-10-01|March 2013|2013-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Examining Social, Emotional, and Cognitive Functioning in People With Fragile X and Down Syndromes|Genetics and Physiology of Social Anxiety in Fragile X|Completed||N/A|511|Actual|University of California, Davis|||4||f||||t||||||Samples With DNA|"~     Saliva samples collected at four time periods~   "|||2017-02-18 13:11:12.941086|2017-02-18 13:11:12.941086
NCT00879502|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2013-03-05|||June 2007||2007-06-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Examining Physiology and Brain Function in People With the Fragile X Premutation|Limbic System Function in Carriers of the Fragile X Premutation|Completed||N/A|110|Actual|University of California, Davis|||3||f||||t||||||Samples With DNA|"~     Saliva and blood samples~   "|||2017-02-18 13:11:13.181186|2017-02-18 13:11:13.181186
NCT00879489|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2011-02-23|||May 2008||2008-05-01|April 2009|2009-04-01|September 2011|Anticipated|2011-09-01|March 2011|Anticipated|2011-03-01||Interventional|||Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer|Phase I/II Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|24|Anticipated|Quantum Immunologics, Inc.||1|||f||||f||||||||||2017-02-18 13:11:13.277923|2017-02-18 13:11:13.277923
NCT00879476|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2009-04-09|||January 2007||2007-01-01|April 2009|2009-04-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions|An Open Label, Balanced, Randomised, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioavailability Study Comparing Ramipril 10 mg Capsules of OHM Laboratories Inc (a Subsidiary of Ranbaxy Pharmaceuticals Inc) With ALTACE® 10 mg Capsules (Containing Ramipril 10 mg) of King Pharmaceuticals Inc, in Healthy, Adult, Male Human Subjects Under Fasting Condition.|Completed||N/A|68|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:11:13.375788|2017-02-18 13:11:13.375788
NCT00879463|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2012-07-24|||June 2009||2009-06-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|December 2010|Actual|2010-12-01||Interventional|INVOS||Brain Tissue Oxygen Saturation and Blood Transfusion in Cardiac Surgery|The Impact of Brain Tissue Oxygen Saturation Monitoring in Reducing the Use of Red Blood Cells in Cardiac Surgery|Completed||N/A|150|Actual|Larissa University Hospital||2|||f||||f||||||||||2017-02-18 13:11:13.48877|2017-02-18 13:11:13.48877
NCT00879450|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2011-07-19|||May 2009||2009-05-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Evaluating the Impact of a New Complement to Physiotherapy Intervention for Positional Torticollis in Infants|Evaluating the Impact of a New Complement to Physiotherapy Intervention for Positional Torticollis in Infants|Terminated||N/A|160|Anticipated|McGill University Health Center||2||Clinical department where study was held was unable to continue collaboration|f||||t||||||||||2017-02-18 13:11:13.603386|2017-02-18 13:11:13.603386
NCT00879437|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2016-06-20|||July 2009||2009-07-01|June 2016|2016-06-01|May 2019|Anticipated|2019-05-01|November 2016|Anticipated|2016-11-01||Interventional|||Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma|A Phase 2 Study of Valproic Acid and Radiation, Followed by Maintenance Valproic Acid and Bevacizumab in Children With Newly Diagnosed High-grade Gliomas or Brainstem Gliomas|Active, not recruiting||Phase 2|38|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 13:11:13.711426|2017-02-18 13:11:13.711426
NCT00879424|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2016-12-20|||February 2009||2009-02-01|December 2016|2016-12-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Vitamin D Supplementation in Childhood Atopic Dermatitis|Randomized Trial of Vitamin D Supplementation in Winter-related, Childhood Atopic Dermatitis|Completed||N/A|107|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:11:13.83313|2017-02-18 13:11:13.83313
NCT00879411|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2014-02-28|2012-01-18||April 2009||2009-04-01|February 2014|2014-02-01||||January 2010|Actual|2010-01-01||Observational|||Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients|24h BP Under Micardis in Daily Practice|Completed||N/A|670|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 13:11:13.944489|2017-02-18 13:11:13.944489
NCT00879398|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2015-09-30|2015-08-06||November 2009||2009-11-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational||Safety Analysis Set: regardless of treatment period, all participants who received study drug once or more, including dropouts due to adverse event (AE), were included in the safety analysis set. Participants who started Toviaz prior to the contract date or violated usage of maximum daily dose of 8 mg were excluded from the safety analysis set.|Toviaz Post Marketing Surveillance Study|Post Marketing Surveillance Study To Observe Safety And Efficacy Of Toviaz (Registered)|Completed||N/A|3000|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:11:14.168996|2017-02-18 13:11:14.168996
NCT00879385|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2014-10-29|||December 2009||2009-12-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||KRAS Wild-type Metastatic Colorectal Cancer Trial|Targeted Demethylation to Enhance Response or Overcome Resistance to EGFR Blocking Agents in KRAS Wild-type Metastatic Colorectal Cancer Patients Using Sequential Decitabine and Panitumumab|Completed||Phase 1|21|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 13:11:14.680573|2017-02-18 13:11:14.680573
NCT00879372|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2013-10-05|||March 2009||2009-03-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy of Adjunctive Tianeptine in the Treatment of Bipolar Depression|Double Blind,Randomized, Placebo Controlled Trial of Adjunctive Tianeptine in the Treatment of Bipolar Depression|Unknown status|Active, not recruiting|Phase 3|13|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 13:11:14.791925|2017-02-18 13:11:14.791925
NCT00879359|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2013-01-09|||December 2007||2007-12-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer|A Phase II Trial of a Vascular Endothelial Growth Factor (VEGF) Monoclonal Antibody, AVASTIN, in Combination With Cytotoxic Chemotherapy CARBOPLATIN and PACLITAXEL for Recurrent/Advanced Endometrial Cancer|Completed||Phase 2|15|Actual|The Cleveland Clinic||1|||f||||t||||||||||2017-02-18 13:11:14.899612|2017-02-18 13:11:14.899612
NCT00879346|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-10-22|||March 2009||2009-03-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|||||Interventional|||A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets|A Randomised, Open-label, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets in Healthy Subjects|Completed||Phase 1|24|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:11:15.00465|2017-02-18 13:11:15.00465
NCT00879333|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2015-10-08|2015-01-28||July 2009||2009-07-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|GRANITE-1||Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)|A Randomized, Double-blind, Multi-center Phase III Study Comparing Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Gastric Cancer After Progression on 1 or 2 Prior Systemic Chemotherapy|Completed||Phase 3|656|Actual|Novartis|4 randomized patients, 2 patients each from the everolimus and placebo arms were excluded from the safety analyses as they did not receive any dose of study treatment.|2|||f||||t||||||||||2017-02-18 13:11:15.112915|2017-02-18 13:11:15.112915
NCT00879320|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2013-10-21|||February 2009||2009-02-01|October 2013|2013-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder|Healthy Lifestyle in Adults With ADHD|Completed||N/A|253|Actual|Massachusetts General Hospital|||2||f||||f||||||||||2017-02-18 13:11:16.571716|2017-02-18 13:11:16.571716
NCT00879307|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2011-02-15|||March 2009||2009-03-01|February 2011|2011-02-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR|Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR|Unknown status|Recruiting|Phase 3|100|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||f||||||||||2017-02-18 13:11:16.661626|2017-02-18 13:11:16.661626
NCT00879294|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-09|2010-06-24||||||June 2010|2010-06-01||||June 2010|Anticipated|2010-06-01||Interventional|||The Effect of Gum Chewing on Postoperative Ileus|The Effect of Gum Chewing on Postoperative Ileus|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Wake Forest University Health Sciences||3|||f||||f||||||||||2017-02-18 13:11:16.764366|2017-02-18 13:11:16.764366
NCT00879281|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2011-02-23|||December 2008||2008-12-01|April 2009|2009-04-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|ACZiE||Action Plan to Enhance Self-management and Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients|Action Plan to Enhance Self-management and Early Detection of Exacerbations in COPD Patients; A Multicenter RCT (ACZiE)|Completed||N/A|233|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 13:11:16.866849|2017-02-18 13:11:16.866849
NCT00879268|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-04-07|||July 2004||2004-07-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System|Phase 1 Study of Liver Machine Preservation With Vasosol Solution|Completed||Phase 1|20|Actual|Polyak, Maximilian||1|||f||||||||||||||2017-02-18 13:11:16.979527|2017-02-18 13:11:16.979527
NCT00879255|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-04-23|2014-11-12||October 2008||2008-10-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|CPTVTEL|Male combat veterans with posttraumatic stress disorder (PTSD).|Telemental Health and Cognitive Processing Therapy for Rural Combat Veterans With Posttraumatic Stress Disorder|Telemental Health and Cognitive Processing Therapy for Rural Combat Veterans With PTSD|Completed||Phase 3|125|Actual|VA Office of Research and Development|For patients in rural areas, their local mental health facilities may not have access to videoteleconferencing technology.There were no women veterans as study participants. Participants with acute safety concerns or current substances were excluded.|2|||f||||f||||||||||2017-02-18 13:11:17.058714|2017-02-18 13:11:17.058714
NCT00879242|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2016-12-08|||February 2009||2009-02-01|November 2011|2011-11-01||||May 2011|Actual|2011-05-01||Interventional|||Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec|Multicenter, Open Label, Prospective Study to Evaluate the Efficacy and Safety of Deferasirox 30 mg/kg/Day for 52 Weeks, in Transfusion-dependent Beta-thalassemic Patients With Cardiac MRI T2* < 20 Msec|Completed||Phase 2|20|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:11:17.429893|2017-02-18 13:11:17.429893
NCT00879229|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2014-05-05|2013-08-09||July 2009||2009-07-01|May 2014|2014-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|ARTEMIS-PH|Full Analysis Set: participants who were randomized and received at least one dose of study drug|ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension|Terminated||Phase 3|40|Actual|Gilead Sciences|Study GS-US-300-0128 was terminated early with enrollment of 40 of 225 planned subjects.|2|||f||||t||||||||||2017-02-18 13:11:17.541911|2017-02-18 13:11:17.541911
NCT00879216|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-11-24|||April 2009||2009-04-01|November 2009|2009-11-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||VA106483 and Alpha Blocker Interaction Study in Elderly Males|A Single Centre, Double-blind, Placebo Controlled Crossover Study in Elderly Male Subjects to Investigate the Plarmacodynamic Interaction of VA106483 Administered Concomitanctly With Alpha-blocker Therapy|Completed||Phase 1|12|Actual|Vantia Ltd||2|||f||||f||||||||||2017-02-18 13:11:18.527751|2017-02-18 13:11:18.527751
NCT00879203|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-10-31|||November 2008||2008-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|November 2013|Actual|2013-11-01||Observational|LO5/HY5||Glycemic Control, Brain Structure and Cognition in Youth With Type 1 Diabetes (T1DM)|Glycemic Control, Brain Structure and Cognition in Youth With T1DM|Completed||N/A|230|Actual|Washington University School of Medicine|||2||f||||f||||||||||2017-02-18 13:11:18.634422|2017-02-18 13:11:18.634422
NCT00879190|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-10-13|||May 2009||2009-05-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|September 2014|Actual|2014-09-01||Interventional|||Comparison of Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Intrapartum Chorioamnionitis: a Randomized Controlled Trial|Comparison of Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Intrapartum Chorioamnionitis: a Randomized Controlled Trial|Active, not recruiting||Phase 2/Phase 3|92|Actual|Stanford University||2|||f||||f||||||||No||2017-02-18 13:11:18.723272|2017-02-18 13:11:18.723272
NCT00879177|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2013-12-09|||April 2009||2009-04-01|December 2013|2013-12-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|VANQUISH||Smoking Study With Behavioral Therapy for Hypertensive Patients|Contingency Management for Initiating Smoking Abstinence in Patients With Hypertension|Unknown status|Active, not recruiting|Phase 4|260|Anticipated|UConn Health||2|||f||||f||||||||||2017-02-18 13:11:18.834193|2017-02-18 13:11:18.834193
NCT00879138|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-04-08|||August 2008||2008-08-01|April 2009|2009-04-01||||||||Interventional|||Efficacy and Safety of VA106483 in Elderly Males|A Double-Blind, Placebo-Controlled Dose Response Study to Investigate Pharmacodynamics and Pharmacokinetics of Single and Repeated Oral Doses of VA106483 in Elderly Male Subjects|Completed||Phase 1/Phase 2|27|Actual|Vantia Ltd||2|||f||||f||||||||||2017-02-18 13:11:19.172115|2017-02-18 13:11:19.172115
NCT00879125|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-09-10|||November 1999||1999-11-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia|Effect of Gastric Bypass on Type 2 Diabetes and/or Dyslipidemia|Completed||N/A|219|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 13:11:19.256263|2017-02-18 13:11:19.256263
NCT00879112|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2011-08-10|||April 2009||2009-04-01|August 2011|2011-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study of MB07811 in Subjects With Hypercholesterolemia|Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of MB07811 for 12 Weeks Followed by a 6-Week Off Drug Phase in Subjects With Primary Hypercholesterolemia|Withdrawn||Phase 2|80|Anticipated|Ligand Pharmaceuticals||4||Study terminated prior to initiation|f||||f||||||||||2017-02-18 13:11:19.349131|2017-02-18 13:11:19.349131
NCT00879099|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2010-01-27|||April 2009||2009-04-01|July 2009|2009-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Interaction Study of Timolol Eye Drops and Paroxetine Capsules|The Effect of Paroxetine on the Plasma Levels of Timolol Using Ophthalmic 0.5% Timolol Eye Drops and 0.1% Timolol Eye Gel in Healthy Volunteers|Completed||Phase 1|12|Anticipated|Santen Oy||4|||f||||f||||||||||2017-02-18 13:11:19.46627|2017-02-18 13:11:19.46627
NCT00879086|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2014-07-22|||March 2009||2009-03-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer|A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer|Completed||Phase 2|104|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 13:11:19.573687|2017-02-18 13:11:19.573687
NCT00879073|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2012-12-17|||April 2009||2009-04-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors|Phase I Study of Bendamustine With Concurrent Whole Brain Radiation Therapy in Patients With Brain Metastases From Solid Tumors|Terminated||Phase 1|12|Actual|H. Lee Moffitt Cancer Center and Research Institute||3||Principal Investigator is leaving Moffitt|f||||t||||||||||2017-02-18 13:11:19.727218|2017-02-18 13:11:19.727218
NCT00879060|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-04-08|||November 2007||2007-11-01|April 2009|2009-04-01|November 2012|Anticipated|2012-11-01|November 2011|Anticipated|2011-11-01||Interventional|||Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy|Clinical and Therapeutic Implications of Fibrosis in Hypertrophic|Unknown status|Recruiting|Phase 4|95|Anticipated|Tufts Medical Center||1|||f||||t||||||||||2017-02-18 13:11:19.840458|2017-02-18 13:11:19.840458
NCT00879047|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2014-05-02|||April 2009||2009-04-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection|Interaction of Alcohol & HAART in HIV/AIDS and HIV/AIDS With HCV Co-Infection|Completed||Phase 1|30|Actual|University of California, San Francisco||5|||f||||t||||||||||2017-02-18 13:11:19.934021|2017-02-18 13:11:19.934021
NCT00879034|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2010-04-20|||March 2009||2009-03-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria|A Phase II Pilot Study of Zoledronic Acid, Pravastatin, and Lonafarnib (SCH66336) for Patients With Hutchinson-Gilford Progeria Syndrome (HGPS) and Progeroid Laminopathies|Completed||Phase 2|5|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 13:11:20.063039|2017-02-18 13:11:20.063039
NCT00879021|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2013-07-29|||September 2009||2009-09-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of Pregabalin in the Prevention of Central Neuropathic Pain in Acute Spinal Cord Injury|Can Pregabalin Prevent the Development of Neuropathic Pain Following Spinal Cord Injury? A Double-Blind, Randomized, Placebo Controlled Trial.|Terminated||Phase 3|5|Actual|Nova Scotia Health Authority||2||lack of funding and patients|f||||f||||||||||2017-02-18 13:11:20.159306|2017-02-18 13:11:20.159306
NCT00879008|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2014-06-20|||December 2009||2009-12-01|June 2014|2014-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|SYMPROVE III||SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB)|SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe AECB|Completed||N/A|345|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a.~   "|||2017-02-18 13:11:20.26933|2017-02-18 13:11:20.26933
NCT00878995|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2017-01-12|||April 2008||2008-04-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|June 2014|Actual|2014-06-01||Interventional|||Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma|Nutrition and Anabolic Interventions in Squamous Cell Carcinoma|Completed||Phase 1|29|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-02-18 13:11:20.377982|2017-02-18 13:11:20.377982
NCT00878982|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2013-02-06|||February 2009||2009-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:11:20.62747|2017-02-18 13:11:20.62747
NCT00878969|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2016-01-18|2015-11-20||January 2010||2010-01-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3|Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3|Terminated||Phase 3|78|Actual|Vanderbilt University||3||insufficient enrollment and retention|f||||t||||||||||2017-02-18 13:11:20.690298|2017-02-18 13:11:20.690298
NCT00878956|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2012-07-31|||April 2009||2009-04-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|June 2011|Actual|2011-06-01||Interventional|||Bicarbonate in Cardiac Surgery|A Phase IIb Multiple Blind Randomized Controlled Trial of Sodium Bicarbonate in Cardiac Surgery at High-risk of Acute Kidney Injury|Terminated||Phase 2|427|Actual|Austin Health||2|||f||||t||||||||||2017-02-18 13:11:21.422157|2017-02-18 13:11:21.422157
NCT00877981|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-04-07|||February 2003||2003-02-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|April 2007|Actual|2007-04-01||Interventional|||Open Versus Video-Assisted Minimal-Invasive Parathyroid Surgery|Open Compared to Video-Assisted Minimal-Invasive Parathyroid Surgery in Primary Hyperparathyroidism|Completed||N/A|143|Actual|Uppsala University||2|||f||||f||||||||||2017-02-18 13:11:39.129444|2017-02-18 13:11:39.129444
NCT00878943|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2016-04-14|||April 2009||2009-04-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Expanded Access|UK 92480||Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study|A Local, Multi-centre, Open Label Access Study, To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study In India Or Ongoing In A1481269 Study Who Continue To Receive Benefit From Sildenafil Therapy.|Temporarily not available||Phase 4|||Pfizer|||||f||||||||||||||2017-02-18 13:11:21.531797|2017-02-18 13:11:21.531797
NCT00878930|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2011-01-04|||April 2009||2009-04-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|FRAME||Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer|Non-interventional Report on Parameters of Acceptability, Efficacy and Compliance of Fulvestrant in Post-menopausal Patients With Advanced Breast Cancer HR Positive Who Progresses to One Prior Endocrine Therapy With Antiestrogens|Completed||N/A|500|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:11:21.636595|2017-02-18 13:11:21.636595
NCT00878917|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2010-02-11|||April 2009||2009-04-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Equivalence Study of Dorzolamide 2% Eye Drops Solution|Randomized, Double-Masked, Active Controlled, Crossover Phase III Equivalence Study of Dorzolamide 2% Eye Drops Solution In Subjects With Open Angle Glaucoma Or Ocular Hypertension|Completed||Phase 3|32|Actual|Alfred E. Tiefenbacher (GmbH & Co. KG)||1|||f||||t||||||||||2017-02-18 13:11:21.735244|2017-02-18 13:11:21.735244
NCT00878904|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2015-01-15|||June 2009||2009-06-01|January 2015|2015-01-01|April 2015|Anticipated|2015-04-01|May 2013|Actual|2013-05-01||Interventional|||Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors|A Phase I Trial of Panobinostat (LBH589) and Epirubicin in Patients With Solid Tumor Malignancies|Unknown status|Active, not recruiting|Phase 1|40|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 13:11:21.987036|2017-02-18 13:11:21.987036
NCT00878891|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2015-07-30|||April 2009||2009-04-01|July 2015|2015-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|MARGE||Real-time Continuous Glucose Monitoring in Diabetic Cardiothoracic Surgery Patients|Real Time Continuous Glucose Monitoring With Glucoday® as an Assistant for Intensive Insulin Therapy in Diabetic Cardiothoracic Surgery Patients: a Randomized Study Comparing Blood Glucose Measurements Alone or Associated to Continue Glucose Monitoring|Terminated||N/A|45|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 13:11:22.104096|2017-02-18 13:11:22.104096
NCT00878878|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2012-07-19|2012-04-04||March 2009||2009-03-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).|A Phase 4, Placebo Controlled, Single-blind, Cross-over Safety Study to Evaluate the Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR) as Measured by Right Heart Catheterization|Completed||Phase 4|30|Actual|GE Healthcare||2|||f||||t||||||||||2017-02-18 13:11:22.222873|2017-02-18 13:11:22.222873
NCT00878865|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-11-23|||April 2009||2009-04-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets|Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets; an Open, Randomised, Single Centre, Single Dose Study With Crossover Design in Healthy Subjects|Completed||Phase 1|18|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-02-18 13:11:22.640575|2017-02-18 13:11:22.640575
NCT00878852|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-05-20|||April 2009||2009-04-01|May 2009|2009-05-01||||December 2010|Anticipated|2010-12-01||Interventional|||Efficacy of Contingency Management in the Treatment of Adolescents With Cannabis Use Disorders|Efficacy of a Contingency Management Program in the Treatment of Adolescents With Cannabis Use Disorders in a Child and Adolescent Psychiatry and Psychology Department|Unknown status|Recruiting|N/A|30|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 13:11:22.757065|2017-02-18 13:11:22.757065
NCT00878839|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2012-07-31|||March 2009||2009-03-01|June 2012|2012-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Investigation of Corneal Aberrations and Visual Outcomes in Patients Implanted With an AcrySof Toric Intraocular Lens (IOL)||Withdrawn||N/A|0|Actual|Alcon Research||1||Product availability|f||||f||||||||||2017-02-18 13:11:22.861039|2017-02-18 13:11:22.861039
NCT00878826|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-10-24|2013-06-21||May 2009||2009-05-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|August 2011|Actual|2011-08-01||Interventional||All participants in study.|Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.|Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.|Completed||Phase 2/Phase 3|11|Actual|Stanford University|Small numbers of subjects|3|||f||||f||||||||No||2017-02-18 13:11:22.96819|2017-02-18 13:11:22.96819
NCT00878813|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-11-09|||March 2009||2009-03-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|April 2011|Actual|2011-04-01||Observational|CoRisk||Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study|Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk-study|Completed||N/A|1102|Actual|University Hospital Inselspital, Berne|||4||f||||f||||||Samples Without DNA|"~     In all patients: 5 ml serum~      In patients undergoing intra-arterial revascularisation: 10 ml serum~   "|||2017-02-18 13:11:23.920965|2017-02-18 13:11:23.920965
NCT00878800|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-07-07|2014-07-07||December 2006||2006-12-01|July 2015|2015-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas|A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas|Completed||Phase 1/Phase 2|41|Actual|Onxeo||1|||f||||||||||||||2017-02-18 13:11:24.056152|2017-02-18 13:11:24.056152
NCT00878787|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2014-05-28|||January 2008||2008-01-01|May 2014|2014-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Theta-burst Transcranial Magnetic Stimulation|Theta-burst Transcranial Magnetic Stimulation for the Treatment of Childhood Dystonia and Spasticity|Completed||N/A|5|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 13:11:25.47738|2017-02-18 13:11:25.47738
NCT00878774|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2010-11-09|||April 2009||2009-04-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis|An Escalating, Multiple-dose Study in Ragweed Allergic Subjects to Assess the Safety of Intradermal Injection of ToleroMune Ragweed|Completed||Phase 2|50|Anticipated|Circassia Limited||5|||f||||f||||||||||2017-02-18 13:11:25.581308|2017-02-18 13:11:25.581308
NCT00878761|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2011-05-20|||September 2010||2010-09-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|||Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)|Randomized Double-Blind, Placebo-Controlled, Single and Multiple Dose, Dose-Escalation Study of STX 100 in Renal Transplant Patients With Biopsy Proven Interstitial Fibrosis and Tubular Atrophy (IF/TA)|Withdrawn||Phase 2|48|Anticipated|Stromedix, Inc.||4|||f||||t||||||||||2017-02-18 13:11:25.696413|2017-02-18 13:11:25.696413
NCT00878748|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2010-09-21|||April 2009||2009-04-01|September 2010|2010-09-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder|An Open Label, Prospective and Multi-center Recurrence Prevention Study With Effexor XR in MDD Patients in China|Withdrawn||Phase 4|0|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||t||||||||||2017-02-18 13:11:25.796317|2017-02-18 13:11:25.796317
NCT00878735|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2014-06-06|||January 2008||2008-01-01|June 2014|2014-06-01||||January 2009|Actual|2009-01-01||Interventional|Sesshin||The Effects of a Meditation Retreat on Healthy Volunteers and Cancer Patients: an fMRI Study|The Effects of an Intensive Mindfulness Practice (Sesshin) on Neural Systems: an fMRI Evaluation of Healthy Volunteers and Cancer Patients|Completed||N/A|96|Actual|Hospital Israelita Albert Einstein||2|||f||||t||||||||||2017-02-18 13:11:25.890173|2017-02-18 13:11:25.890173
NCT00878722|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-07-06|2014-06-27||August 2007||2007-08-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|May 2009|Actual|2009-05-01||Interventional|||Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy|A Phase I/II Clinical Trial of PXD101 in Combination With Idarubicin in Patients With AML Not Suitable for Standard Intensive Therapy|Completed||Phase 1/Phase 2|41|Actual|Onxeo||2|||f||||||||||||||2017-02-18 13:11:26.034793|2017-02-18 13:11:26.034793
NCT00878709|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2016-09-30||2013-11-12|July 2009||2009-07-01|September 2016|2016-09-01|November 2020|Anticipated|2020-11-01|November 2013|Actual|2013-11-01||Interventional|ExteNET||Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled Trial Of Neratinib (HKI-272) After Trastuzumab In Women With Early-Stage HER-2/Neu Overexpressed/Amplified Breast Cancer|Active, not recruiting||Phase 3|2840|Actual|Puma Biotechnology, Inc.||2|||f||||t||||||||||2017-02-18 13:11:28.910718|2017-02-18 13:11:28.910718
NCT00878696|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-04-08|||January 2007||2007-01-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|September 2007|Actual|2007-09-01||Observational|||Influence of Tonic and Burst Transcranial Magnetic Stimulation (TMS) Characteristics on Acute Inhibition of Subjective Tinnitus|Influence of Tonic and Burst TMS Characteristics on Acute Inhibition of Subjective Tinnitus|Completed||N/A|64|Actual|University Hospital, Antwerp|||1||f||||f||||||||||2017-02-18 13:11:30.274597|2017-02-18 13:11:30.274597
NCT00878683|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-05-01|||July 2009||2009-07-01|May 2015|2015-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Novel Device for Reducing Catheter-Related Infections|Exploring the Use of a Novel Device for Reducing Catheter-Related Bloodstream Infections|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||2||Never received IRB approval; Withdrawn before enrollment ever started|f||||f||||||||||2017-02-18 13:11:30.365811|2017-02-18 13:11:30.365811
NCT00878670|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2012-01-25|||March 2009||2009-03-01|January 2012|2012-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Investigation of Efficacy and Safety of EPOGAM|Prospective Clinical Trial to Assess the Efficacy and Safety of EPOGAM 1000 in Patients With Atopic Dermatitis (Explorative Pilot Study)|Completed||Phase 4|23|Actual|Max Zeller Soehne AG||1|||f||||f||||||||||2017-02-18 13:11:30.452642|2017-02-18 13:11:30.452642
NCT00878657|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2014-05-01|||April 2009||2009-04-01|May 2014|2014-05-01|October 2013|Actual|2013-10-01|October 2012|Actual|2012-10-01||Interventional|||Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer|Phase I/II Radiotherapy Dose Escalation Study in Locally Advanced Pancreatic Cancer, Using a Simultaneous Intensity Modulated Boost With Concurrent Gemcitabine|Terminated||Phase 1|8|Actual|Rutgers, The State University of New Jersey||1||Slow accrual|f||||f||||||||||2017-02-18 13:11:30.564997|2017-02-18 13:11:30.564997
NCT00878644|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2015-12-02|||September 2009||2009-09-01|December 2015|2015-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|THAPCA-OH||Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial|Therapeutic Hypothermia After Pediatric Cardiac Arrest (Out of Hospital)|Completed||Phase 3|295|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 13:11:30.68024|2017-02-18 13:11:30.68024
NCT00878631|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-04-08|||September 2004||2004-09-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|January 2006|Actual|2006-01-01||Interventional|TOPHR HIT||Feasibility Trial of Traumatic Brain Injured Patients Randomized in the Prehospital Setting to Either Hypertonic Saline and Dextran Versus Normal Saline|The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial|Completed||Phase 2/Phase 3|113|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 13:11:30.81397|2017-02-18 13:11:30.81397
NCT00878618|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-06-02|||April 2009||2009-04-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|||||Interventional|||Pharmacokinetics of Extended-Release Test- and Reference Formulations of AZD0837|A Phase I, Single-Centre, Open, Randomized, Two-Way Crossover Study to Evaluate the Pharmacokinetics of the Extended-Release Test Formulation of AZD0837 Compared to the Extended-Release AZD0837 Reference Formulation After Repeated Dosing in Healthy Volunteers|Completed||Phase 1|36|Anticipated|AstraZeneca||4|||f||||f||||||||||2017-02-18 13:11:30.928099|2017-02-18 13:11:30.928099
NCT00878605|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-01-26|2014-12-17||April 2010||2010-04-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Development of A Novel Anti-Hyperglycemic Agent|Development of A Novel Anti-Hyperglycemic Agent|Terminated||Phase 2|38|Actual|VA Office of Research and Development|This subject was terminated early and data was not analyzed due to inability to recruit and therefore small numbers of subjects to analyze leading to uninterpretable data.|4||Unable to reach accrual target.|f||||t||||||||||2017-02-18 13:11:31.030704|2017-02-18 13:11:31.030704
NCT00878592|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-04-08|||October 2008||2008-10-01|April 2009|2009-04-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity|Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity|Unknown status|Recruiting|Phase 4|116|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:11:31.913427|2017-02-18 13:11:31.913427
NCT00878579|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2013-02-19|||March 2009||2009-03-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Percutaneous Dynamic Stabilization (PDS) System Versus Fusion for Treating Degenerative Disc Disease|A Study to Evaluate the Safety and Effectiveness of the PDS System to Treat Back Pain Associated With Degenerative Disc Disease|Terminated||Phase 2|20|Actual|Interventional Spine, Inc.||2||Sponsor Termination|f||||f||||||||||2017-02-18 13:11:32.038198|2017-02-18 13:11:32.038198
NCT00878566|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2015-04-25|||November 2009||2009-11-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|RxAction||Alberta Clinical Trial in Optimizing Hypertension|Alberta Clinical Trial in Optimizing Hypertension: The RxAction Study|Completed||N/A|248|Actual|University of Alberta||2|||f||||f||||||||||2017-02-18 13:11:32.144001|2017-02-18 13:11:32.144001
NCT00878553|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-01-30|2013-01-07||May 2010||2010-05-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|December 2010|Actual|2010-12-01||Interventional|||Study of Sleep-maintenance Activity of 3 Doses of SKP-1041|A Phase 2, Double-Blind, Placebo-Controlled, Double-Dummy, Cross-Over Study to Investigate the Hypnotic Activity of Three Doses (10mg, 15mg, 20mg) of a New Zaleplon Prototype, SKP-1041, in Adults With Primary Insomnia|Completed||Phase 2|67|Actual|Somnus Therapeutics, Inc.|Questionnaires focused on initial insomnia as opposed to middle of the night awakening, short exposure to each dose, and lengthy washout periods between doses, may not allow for ideal assessment of subjective response to treatment.|4|||f||||f||||||||||2017-02-18 13:11:32.269836|2017-02-18 13:11:32.269836
NCT00878540|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2010-09-15|||September 2008||2008-09-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SMMS||Short-term Metabolic Effects of Mirtazapine in Healthy Subjects|Phase 1 Study of Mirtazapine in Healthy Subjects|Completed||Phase 1|12|Anticipated|Max-Planck-Institute of Psychiatry||1|||f||||f||||||||||2017-02-18 13:11:33.582588|2017-02-18 13:11:33.582588
NCT00878527|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2016-04-30|||June 2007||2007-06-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety and Performance Evaluation of CircuLite Synergy|Safety and Performance Evaluation of the CircuLite Synergy Pocket Circulatory Assist Device|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|HeartWare, Inc.||1|||f||||t||||||||||2017-02-18 13:11:33.69105|2017-02-18 13:11:33.69105
NCT00878514|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-11-23|||May 2009||2009-05-01|November 2009|2009-11-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions|Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions; an Open, Randomised, Single Centre, Single Dose Study With Crossover Design in Healthy Subjects|Completed||Phase 1|18|Anticipated|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-02-18 13:11:33.825975|2017-02-18 13:11:33.825975
NCT00878501|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2012-05-28|2011-01-27||March 2009||2009-03-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|OA19||Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee|A Phase II Randomised, Double-blind, Parallel Group, 4-week Treatment, Adaptive Dose Finding, Multi-centre Study Evaluating the Efficacy, Safety, Tolerability and Pharmacokinetics of up to Three Different Oral Doses of AZD1386 and Placebo in Patients With Osteoarthritis of the Knee|Terminated||Phase 2|241|Actual|AstraZeneca||3||The study was terminated after the planned interim analysis.|f||||f||||||||||2017-02-18 13:11:33.947094|2017-02-18 13:11:33.947094
NCT00878475|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2009-04-08|||January 2005||2005-01-01|April 2009|2009-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Dyspnea and Biomarkers in a Prehospital Setting|Quantitative Capnometry and Nt-proBNP in Differentiating of Acute Dyspnea in Pre-Hospital Emergency Setting|Completed||N/A|546|Actual|Health Care Center Maribor|||2||f||||f||||||||||2017-02-18 13:11:34.471461|2017-02-18 13:11:34.471461
NCT00878462|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2015-05-13|||June 2005||2005-06-01|May 2015|2015-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)|A Randomized, Crossover Study Evaluating the Acceptability of Unflavored Asenapine and Raspberry Flavored Asenapine in Stable Subjects With A Psychotic Disorder|Completed||Phase 2|174|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 13:11:34.568904|2017-02-18 13:11:34.568904
NCT00878449|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2013-01-24|||October 2009||2009-10-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer|A Phase 1 Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer|Completed||Phase 1|12|Actual|AbbVie||1|||f||||||||||||||2017-02-18 13:11:34.676408|2017-02-18 13:11:34.676408
NCT00878436|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2015-08-21|||June 2009||2009-06-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Interventional|||Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration|Phase I/II Randomized Trial of LBH589 (Panobinostat) at Two Dose Levels Combined With Bicalutamide (Casodex) in Men With Castration-resistant Prostate Cancer|Completed||Phase 1/Phase 2|57|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-02-18 13:11:34.776126|2017-02-18 13:11:34.776126
NCT00878423|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-08|2014-05-07|||May 2008||2008-05-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|May 2013|Actual|2013-05-01||Interventional|||Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors|A Phase I Open-label Dose Escalation Study of AT13387 in Patients With Metastatic Solid Tumors|Completed||Phase 1|62|Actual|Astex Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:11:34.904088|2017-02-18 13:11:34.904088
NCT00878397|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2014-04-09|||May 2009||2009-05-01|April 2014|2014-04-01|November 2010|Actual|2010-11-01|July 2010|Actual|2010-07-01||Interventional|||Impact of School-based Delivery of Long Lasting Insecticide Nets|Evaluating the Impact of Delivering Long Lasting Insecticide Nets Through Schools on Household Access and the Health of School Children in North Eastern Kenya|Completed||N/A|5113|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-02-18 13:11:34.999857|2017-02-18 13:11:34.999857
NCT00878384|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2012-07-11|||April 2009||2009-04-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|ARC-HF||Catheter Ablation Versus Medical Rate Control for Atrial Fibrillation in Patients With Heart Failure|A Randomised Trial to Assess Catheter Ablation Versus Rate-Control in the Management of Persistent Atrial Fibrillation in Chronic Heart Failure|Completed||N/A|52|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 13:11:35.205185|2017-02-18 13:11:35.205185
NCT00878371|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-06-22|||May 2009||2009-05-01|June 2016|2016-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Effects of a Surgery-induced Peripheral Inflammatory Response on the Blood Brain Barrier|Identification and Quantification of the Effects of a Surgery-induced Peripheral Inflammatory Response on Changes in Drug Efflux Transporter Function in the Brain|Completed||Phase 4|35|Actual|Nova Scotia Health Authority||1|||f||||f||||||||Yes|publication in process|2017-02-18 13:11:35.325528|2017-02-18 13:11:35.325528
NCT00878358|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2011-04-27|||June 2009||2009-06-01|April 2009|2009-04-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Hydrotherapy Versus Physiotherapy for Short-term Rehabilitation After Primary TKR|Hydrotherapy Versus Physiotherapy for Short-term Rehabilitation After Primary TKR|Completed||N/A|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:11:35.437535|2017-02-18 13:11:35.437535
NCT00878345|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-11-06||||||November 2009|2009-11-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Dexmedetomidine Versus Pentobarbital for Pediatric Procedural Sedation|Dexmedetomidine Versus Pentobarbital Sedation Protocol for Non-painful Procedural Sedation in Pediatrics|Withdrawn||N/A|120|Anticipated|Washington University School of Medicine||2||Study was never opened|f||||t||||||||||2017-02-18 13:11:35.533649|2017-02-18 13:11:35.533649
NCT00878332|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-04-07|||February 2009||2009-02-01|March 2009|2009-03-01|April 2011|Anticipated|2011-04-01|April 2010|Anticipated|2010-04-01||Observational|||"Histologic Evaluation of Bone Formation After Alveolar Augmentation by Sandwich Osteotomy Procedure for Dental Implants Insertion"|"Sandwich Osteotomy Histologic Evaluation"|Unknown status|Active, not recruiting|N/A|10|Anticipated|Hadassah Medical Organization|||1||f||||t||||||Samples Without DNA|"~     Histologic slides~   "|||2017-02-18 13:11:35.661498|2017-02-18 13:11:35.661498
NCT00878319|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-09-14|||August 2009||2009-08-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|May 2019|Anticipated|2019-05-01||Interventional|||Operative and Nonoperative Treatment of Humeral Shaft Fractures|A Randomized Prospective Trial Comparing Operative and Nonoperative Treatment of Humeral Shaft Fractures|Recruiting||Phase 3|180|Anticipated|McGill University Health Center||2|||f||||f||||||||No||2017-02-18 13:11:35.773853|2017-02-18 13:11:35.773853
NCT00878306|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2014-05-04|||November 2008||2008-11-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Disulfiram Interactions With HIV Medications: Clinical Implications|Disulfiram Interactions With HIV Medications: Clinical Implications|Completed||Phase 1|40|Actual|University of California, San Francisco||4|||f||||f||||||||||2017-02-18 13:11:35.891724|2017-02-18 13:11:35.891724
NCT00878293|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-08-19|||April 2009||2009-04-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic|A Randomized Phase IIa Trial Evaluating the Safety and Efficacy of a New Centrally Acting Analgesic in Subjects With Pain Due to Diabetic Polyneuropathy|Completed||Phase 2|90|Actual|Grünenthal GmbH||9|||f||||f||||||||||2017-02-18 13:11:36.007065|2017-02-18 13:11:36.007065
NCT00878280|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2011-04-21|||August 2008||2008-08-01|April 2011|2011-04-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Observational|||Copy Number Variations, Inflammatory Cytokines and the Risk of Dementia|Copy Number Variations, Expression of Inflammatory Cytokines and the Risk of Dementia - A Two-stage Genome-wide Association Study|Unknown status|Recruiting|N/A|700|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-02-18 13:11:36.118109|2017-02-18 13:11:36.118109
NCT00878267|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2011-09-20|||March 2009||2009-03-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study|A Qualitative Study of Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: Integrating PROs and Decision Support Into an Electronic Record|Completed||N/A|9|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:11:36.218613|2017-02-18 13:11:36.218613
NCT00878254|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-12-20|||March 2009||2009-03-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma|Phase II Study of Rituximab in Combination With Methotrexate, Doxorubicin, Cyclophosphamide, Leucovorin, Vincristine, Ifosfamide, Etoposide, Cytarabine and Mesna (R-MACLO/VAM) in Patients With Previously Untreated Mantle Cell Lymphoma|Recruiting||Phase 2|22|Anticipated|University of Miami||1|||f||||t||||||||||2017-02-18 13:11:36.480794|2017-02-18 13:11:36.480794
NCT00878241|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2011-02-23|||June 2008||2008-06-01|April 2009|2009-04-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Compression Anastomosis Using the CAR™ 27||Completed||N/A|14|Actual|Bnai Zion Medical Center||1|||f||||f||||||||||2017-02-18 13:11:36.643397|2017-02-18 13:11:36.643397
NCT00878228|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2013-01-28|2012-07-23||April 2009||2009-04-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|PDNV||Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy|Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy|Completed||Phase 4|98|Actual|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-02-18 13:11:36.727177|2017-02-18 13:11:36.727177
NCT00878215|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2013-09-10|||December 2002||2002-12-01|September 2013|2013-09-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Clinical Application of Image Guided Liver Surgery|Clinical Application of Image Guided Liver Surgery|Unknown status|Recruiting|N/A|66|Anticipated|Washington University School of Medicine||4|||f||||t||||||||||2017-02-18 13:11:37.092298|2017-02-18 13:11:37.092298
NCT00878202|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2013-02-19|||March 2009||2009-03-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|SEDIC||Therapeutic Education by Telemedicine in Chronic Heart Failure|Impact of Clinical Follow-up and Therapeutic Education by Telemedicine in Chronic Heart Failure: a Randomized Multicenter Study.|Terminated||Phase 4|100|Actual|University Hospital, Caen||2||Insufficient recruitment|f||||t||||||||||2017-02-18 13:11:37.218843|2017-02-18 13:11:37.218843
NCT00878189|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-11-30|||June 2009||2009-06-01|November 2016|2016-11-01|November 2016|Anticipated|2016-11-01|January 2013|Actual|2013-01-01||Interventional|||A Trial In Patients With Advanced Cancer And Leukemia|A Phase I Trial Of Pf-03084014 In Patients With Advanced Solid Tumor Malignancy And T-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma|Active, not recruiting||Phase 1|100|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 13:11:37.330245|2017-02-18 13:11:37.330245
NCT00877968|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-04-07|||March 2008||2008-03-01|April 2009|2009-04-01||||May 2008|Actual|2008-05-01||Interventional|||Glycemic Responses and Sensory Characteristics of Whole Yellow Pea Flour Added to Novel Functional Foods|Glycemic Responses and Sensory Characteristics of Whole Yellow Pea Flour Added to Novel Functional Foods|Completed||Phase 2|23|Actual|University of Manitoba||8|||f||||f||||||||||2017-02-18 13:11:39.250457|2017-02-18 13:11:39.250457
NCT00878176|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-09-17|||June 2009||2009-06-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Interventional|||Sacral Neuromodulation Test With Bilateral First Stage Tined Lead Procedure in Patients With Non-obstructive Urinary Retention: A Pilot Study|Sacral Neuromodulation Test With Bilateral First Stage Tined Lead Procedure in Patients With Non-obstructive Urinary Retention: A Pilot Study|Unknown status|Recruiting|N/A|12|Anticipated|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 13:11:37.448316|2017-02-18 13:11:37.448316
NCT00878163|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2017-01-31|||March 2009||2009-03-01|November 2016|2016-11-01||||April 2012|Actual|2012-04-01||Interventional|||GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery|Phase I Trial of the Combination of Vismodegib GDC-0449 and Erlotinib +/- Gemcitabine|Active, not recruiting||Phase 1|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:11:37.553926|2017-02-18 13:11:37.553926
NCT00878150|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2013-10-16|||September 2007||2007-09-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional|LIFT||Life Improvement Following Traumatic Brain Injury|Cognitive Behavioral Therapy for Depression After Traumatic Brain Injury|Completed||N/A|100|Actual|University of Washington||3|||f||||f||||||||||2017-02-18 13:11:37.679285|2017-02-18 13:11:37.679285
NCT00878137|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2012-10-12|||March 2009||2009-03-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin|INR Determined by Plasma-based Methods Versus Newer Point-of-care Instruments in Patients With Antiphospholipid-antibody Syndrome Treated With Anticoagulants|Completed||N/A|63|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-02-18 13:11:37.820808|2017-02-18 13:11:37.820808
NCT00878124|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2010-01-11|||June 2009||2009-06-01|January 2010|2010-01-01||||||||Interventional|CoQ10||How Dose Coenzyme Q10 Supplementation During Infertility Treatment Effects Pregnancy Outcome|The Influence of Concomitant Co Enzyme Q10 Use on Pregnancy Outcome in Intrauterine Insemination|Terminated||N/A|100|Anticipated|University of Toronto||2||Very low recruitment rate|f||||f||||||||||2017-02-18 13:11:37.918379|2017-02-18 13:11:37.918379
NCT00878111|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-10-08|||April 2009||2009-04-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour|NGR013: Phase I and Pharmacodynamic Study of NGR-hTNF Administered at High Doses in Patients With Advanced or Metastatic Solid Tumour|Active, not recruiting||Phase 1|48|Anticipated|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 13:11:38.04218|2017-02-18 13:11:38.04218
NCT00878098|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2017-01-24|||April 2, 2009||2009-04-02|August 8, 2016|2016-08-08||||||||Observational|||Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa|Study of DDT and Loss of Clinically Recognized Pregnancies in South Africa|Completed||N/A|2805|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:11:38.153295|2017-02-18 13:11:38.153295
NCT00878085|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2014-02-03|||November 2008||2008-11-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living|fMRI and Robot-Assisted Practice of Activities of Daily Living|Completed||Phase 1|61|Anticipated|Medical College of Wisconsin||2|||f||||t||||||||||2017-02-18 13:11:38.25303|2017-02-18 13:11:38.25303
NCT00878072|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2012-05-01|||March 2009||2009-03-01|May 2012|2012-05-01||||June 2010|Actual|2010-06-01||Interventional|||Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis|A Multicenter, Open-label, Single-arm Study to Evaluate the Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis|Completed||Phase 2/Phase 3|53|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:11:38.376793|2017-02-18 13:11:38.376793
NCT00878059|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2013-10-14|||July 2008||2008-07-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Alzheimer's Family Research|Proxy Decision Making for Alzheimer Disease Research|Completed||N/A|165|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:11:38.501363|2017-02-18 13:11:38.501363
NCT00878046|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-04-20|||May 2005||2005-05-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|March 2009|Actual|2009-03-01||Interventional|||Multi-centre Study to Assess Long-term Safety and Efficacy of the Silent™ Hip Prosthesis in Primary THR|A Non-comparative, Multi-centre Study to Evaluate the Safety and Efficacy of the DePuy Silent™ Hip Prosthesis in Primary Total Hip Replacement|Terminated||N/A|108|Actual|DePuy International||1||The Silent Hip has been rationalized for business reasons only|f||||f||||||||||2017-02-18 13:11:38.583994|2017-02-18 13:11:38.583994
NCT00878033|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2012-01-17|||April 2009||2009-04-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Observational|||Autonomic Dysfunction and Inflammation in Chronic Hemodialysis Patients|Autonomic Dysfunction and Inflammation in Chronic Hemodialysis Patients|Completed||N/A|45|Actual|Martin-Luther-Universität Halle-Wittenberg|||3||f||||f||||||Samples Without DNA|"~     Serum Samples will be frozen for later Cytokine Sampling.~   "|||2017-02-18 13:11:38.709859|2017-02-18 13:11:38.709859
NCT00878020|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2011-02-22|||May 2009||2009-05-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety Study to Evaluate BMS-830216 in Healthy Subjects|Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BMS-830216 (Pro-Drug of BMS-819881) in Healthy Subjects|Completed||Phase 1|48|Actual|Bristol-Myers Squibb||6|||f||||f||||||||||2017-02-18 13:11:38.795294|2017-02-18 13:11:38.795294
NCT00878007|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2014-02-14|||January 2010||2010-01-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Impact of Malaria Prevention on Health and Education in Kenyan Schoolchildren|Impact of Malaria Prevention on Health and Education in Kenyan Schoolchildren|Completed||N/A|5177|Actual|London School of Hygiene and Tropical Medicine||4|||f||||t||||||||||2017-02-18 13:11:38.901342|2017-02-18 13:11:38.901342
NCT00877994|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-05-17|||April 2008||2008-04-01|May 2016|2016-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Nurture: A Program for Mothers With Histories of Disordered Eating|Breaking the Cycle of Risk: Intervention for Mothers With Eating Disorders|Completed||N/A|28|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 13:11:39.014846|2017-02-18 13:11:39.014846
NCT00877955|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-03-11|||September 2012||2012-09-01|March 2015|2015-03-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation|Open-label, Randomized, Single-dose, 2-way Crossover Bioequivalence Study Comparing A New Alprazolam Sublingual Tablet Formulation To A Reference Alprazolam Sublingual Tablet|Withdrawn||Phase 1|0|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:11:39.361375|2017-02-18 13:11:39.361375
NCT00877942|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2014-05-01|||October 2006||2006-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Sex Differences in Early Brain Development; Brain Development in Turner Syndrome|Sex Differences in Early Brain Development; Brain Development in Turner Syndrome|Completed||N/A|295|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"~     For participating children with Turner Syndrome, subjects may participate in an optional~     blood draw for DNA extraction and hormone assays.~   "|||2017-02-18 13:11:39.464933|2017-02-18 13:11:39.464933
NCT00877929|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2014-02-10|2011-05-13||February 2009||2009-02-01|February 2014|2014-02-01||||May 2010|Actual|2010-05-01||Interventional|||Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus|An 8-week Randomised, Double-blind Study to Compare the Fixed-dose Combination of Telmisartan 80 + Amlodipine 10mg Versus Amlodipine 10 mg Monotherapy as First Line Therapy in Type 2 Diabetes Patients With Hypertension.|Completed||Phase 3|706|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:11:39.568675|2017-02-18 13:11:39.568675
NCT00877916|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2010-06-15|||April 2009||2009-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:11:41.836869|2017-02-18 13:11:41.836869
NCT00877903|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-09-19|||March 2009||2009-03-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|December 2011|Actual|2011-12-01||Interventional|||Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)|A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL® (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction|Completed||Phase 2|220|Actual|Mesoblast, Ltd.||2|||f||||t||||||||||2017-02-18 13:11:41.899094|2017-02-18 13:11:41.899094
NCT00877890|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2015-03-19|2012-02-14||March 2009||2009-03-01|March 2015|2015-03-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)|A Randomized, Open-Label, Parallel-Group, Comparator-Controlled, Multicenter Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|254|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:11:42.067075|2017-02-18 13:11:42.067075
NCT00877877|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-09-22|2011-03-31||May 2009||2009-05-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.|Follow-up Study to Evaluate the Long-term Immunogenicity and Safety of a HPV Vaccine (GSK 580299) in Healthy Female Subjects|Completed||Phase 3|632|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:11:43.016723|2017-02-18 13:11:43.016723
NCT00877864|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2011-08-04|||February 2010||2010-02-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|DEAL||Diabetes Exercise and Lifestyle Trial|Diabetes Exercise and Lifestyle Trial|Unknown status|Active, not recruiting|Early Phase 1|26|Actual|University of Calgary||6|||f||||f||||||||||2017-02-18 13:11:44.120398|2017-02-18 13:11:44.120398
NCT00877851|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2011-08-19|||April 2009||2009-04-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|LWD||Evaluation of an Interactive CD-ROM for People With Type 2 Diabetes|Development and Evaluation of an Interactive CD-ROM for People With Type 2 Diabetes (Evaluation Phase)|Completed||N/A|100|Anticipated|Queen's University, Belfast||2|||f||||f||||||||||2017-02-18 13:11:44.229907|2017-02-18 13:11:44.229907
NCT00877838|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-07-27|||May 2009||2009-05-01|July 2009|2009-07-01|December 2010|Anticipated|2010-12-01|March 2010|Anticipated|2010-03-01||Interventional|||Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura|A Phase 2a Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura|Unknown status|Recruiting|Phase 2|40|Anticipated|Danish Headache Center||1|||f||||t||||||||||2017-02-18 13:11:44.320722|2017-02-18 13:11:44.320722
NCT00877825|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-07||||||April 2009|2009-04-01|April 2000|Actual|2000-04-01|||||Interventional|||The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy|The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy|Completed||Phase 2|||University of Toronto|||||f||||||||||||||2017-02-18 13:11:44.421401|2017-02-18 13:11:44.421401
NCT00877812|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-03-25|||January 2008||2008-01-01|March 2013|2013-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Vitamin B6 Dependence of One-Carbon Metabolism|Vitamin B6 Dependence of One-Carbon Metabolism|Completed||N/A|45|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 13:11:44.493141|2017-02-18 13:11:44.493141
NCT00877799|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2015-04-23|2012-07-24||March 2009||2009-03-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate the Analgesic Efficacy and Safety of Intravenous CR845 During the Post-Operative Period in Subjects Undergoing Laparoscopic-Assisted Hysterectomy|Completed||Phase 2|114|Actual|Cara Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 13:11:44.621702|2017-02-18 13:11:44.621702
NCT00877786|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-06-20|||April 2008||2008-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|CBT4BN||Online Cognitive Behavioral Therapy for Bulimia Nervosa|Optimizing Technology in the Treatment of Bulimia Nervosa|Completed||N/A|196|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 13:11:47.69251|2017-02-18 13:11:47.69251
NCT00877773|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-07-15|2016-07-15||April 2009||2009-04-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients|Histology-Independent Study of the mTOR Inhibitor, Temsirolimus, in Patients With Advanced Cancer|Terminated||Phase 1/Phase 2|44|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f||||||||||2017-02-18 13:11:47.798204|2017-02-18 13:11:47.798204
NCT00877760|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2014-03-27|||August 2009||2009-08-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|ARES||Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B|Augmenting Response to Entecavir Using a Temporary Peginterferon Alpha-2a add-on Strategy for the Treatment of HBeAg-positive Chronic Hepatitis B|Completed||Phase 4|184|Actual|Foundation for Liver Research||2|||f||||f||||||||||2017-02-18 13:11:48.050996|2017-02-18 13:11:48.050996
NCT00877747|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-10-16|||January 2006||2006-01-01|October 2015|2015-10-01|October 2015|Anticipated|2015-10-01|November 2014|Actual|2014-11-01||Observational|||Early Chemotherapy Intensification in Interim-Positron Emission Tomography (PET) Positive Hodgkin Lymphoma|Early Chemotherapy Intensification With BEACOPP in High-risk, Interim-PET Positive Advanced-stage Hodgkin Lymphoma:a GITIL Retrospective Multicenter Clinical Study|Active, not recruiting||N/A|160|Actual|Ospedale Santa Croce-Carle Cuneo|||2||f||||f||||||||||2017-02-18 13:11:48.167092|2017-02-18 13:11:48.167092
NCT00877734|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2012-09-13|||April 2005||2005-04-01|April 2011|2011-04-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Tolerability of Baclofen for Alcohol Dependence|Phase IIIa Trial of Baclofen for Alcohol Dependence|Completed||Phase 2/Phase 3|80|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 13:11:48.253871|2017-02-18 13:11:48.253871
NCT00877721|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2010-09-19|||April 2010||2010-04-01|April 2009|2009-04-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Self Mobility Improvement in the Elderly by Counteracting Falls (SMILING)||Completed||N/A|30|Actual|Soroka University Medical Center||1|||f||||t||||||||||2017-02-18 13:11:48.363476|2017-02-18 13:11:48.363476
NCT00877708|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2015-12-16|||March 2009||2009-03-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol|Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol|Active, not recruiting||N/A|150|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     Biologic samples (isolates) will be under the control of the principal investigator of this~     research project. All samples provided to the investigator are de-identified by the honest~     broker and will be coded with numbers. The information linking these code numbers to the~     corresponding subjects' identities will be kept in a separate, secure location that only the~     honest broker has access to. The investigator on this study will keep the samples~     indefinitely. Samples will be kept in the investigator's laboratory located in Scaife Hall,~     room 839, 3550 Terrace Street. At no time with the research investigators have access to any~     patient identifers. Medical record information and bacteria samples from facilities outside~     of UPMC will be provided to the PI de-identified. At not time will anyone on the research~     team have access to patient identifiers. All information and bacteria are collected as part~     of the patient's clinical treatment.~   "|||2017-02-18 13:11:48.449217|2017-02-18 13:11:48.449217
NCT00877695|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2013-03-01|||August 2010||2010-08-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|Motiv82Change||Motiv82Change: an HIV Prevention Study for Young Latino Men|"Young Hispanic Men Entre Culturas: Navigating Culture, Identity and HIV Risk"|Completed||N/A|200|Actual|Nova Southeastern University||4|||f||||t||||||||||2017-02-18 13:11:48.72092|2017-02-18 13:11:48.72092
NCT00877682|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2017-02-13|||April 2009|Actual|2009-04-01|February 2017|2017-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Prostate Conformal Cryotherapy|Regional Cryoablation for Localized Adenocarcinoma of the Prostate|Active, not recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:11:48.828107|2017-02-18 13:11:48.828107
NCT00877669|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2015-02-12|||October 2008||2008-10-01|January 2014|2014-01-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH|The Comparison of Efficacy Between Holmium Laser Enucleation of the Prostate (HoLEP) and Transurethral Resection of the Prostate (TURP) on the Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostate Hyperplasia (BPH)|Unknown status|Recruiting|Phase 2|116|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 13:11:48.935132|2017-02-18 13:11:48.935132
NCT00877656|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2012-11-20|||August 2005||2005-08-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|January 2006|Actual|2006-01-01||Interventional|||HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma|An Open-Label Therapeutic Exploratory Clinical Trial of HuMax-CD4, a Fully Human Monoclonal Anti-CD4 Antibody, in Patients With Refractory or Relapsed Non-Cutaneous CD4+ T-Cell Lymphoma|Completed||Phase 2/Phase 3|21|Actual|Emergent BioSolutions||1|||f||||f||||||||||2017-02-18 13:11:49.03646|2017-02-18 13:11:49.03646
NCT00877643|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2016-05-12|||May 2009||2009-05-01|May 2016|2016-05-01|January 2021|Anticipated|2021-01-01|January 2017|Anticipated|2017-01-01||Interventional|RACE 3||Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure|Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure: RACE 3|Active, not recruiting||N/A|250|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-02-18 13:11:49.137135|2017-02-18 13:11:49.137135
NCT00877630|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-04-09|||September 2006||2006-09-01|April 2009|2009-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Minimal Invasiveness of Endoscopic Thyroidectomy|Minimal Invasiveness of Endoscopic Thyroidectomy|Completed||N/A|||Second Military Medical University|||2||f||||||||||||||2017-02-18 13:11:49.256485|2017-02-18 13:11:49.256485
NCT00877617|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2012-07-26|||May 2006||2006-05-01|July 2012|2012-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Quality of Life in Men With High Risk Localized Prostate Cancer|Assessment of Quality of Life in Men With High Risk Localized Prostate Cancer Undergoing Neoadjuvant Investigational Therapy|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||1|Slow accrual|f||||f||||||||||2017-02-18 13:11:49.342496|2017-02-18 13:11:49.342496
NCT00877604|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2014-11-19|2014-10-31||June 2008||2008-06-01|November 2014|2014-11-01|April 2012|Actual|2012-04-01|July 2011|Actual|2011-07-01||Interventional|TUDCA-ALS||Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis|A Randomized, Double-blind Multicenter Pilot Study vs. Placebo for the Evaluation of Efficacy and Tolerability of Tauroursodeoxycholic Acid Administered by Oral Route as Add on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis|Completed||Phase 2|34|Actual|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta||2|||f||||t||||||||||2017-02-18 13:11:49.450126|2017-02-18 13:11:49.450126
NCT00872911|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-12-08|||March 2009||2009-03-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|December 2014|Actual|2014-12-01||Interventional|||Nutrition and Exercise for Sarcopenia|Nutrition and Exercise to Improve Protein Metabolism and Prevent Sarcopenia in Aging|Completed||Phase 1|108|Actual|The University of Texas Medical Branch, Galveston||4|||f||||f||||||||||2017-02-18 13:13:21.878435|2017-02-18 13:13:21.878435
NCT00877591|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2014-05-02|||April 2008||2008-04-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications|Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications|Completed||Phase 1|63|Actual|University of California, San Francisco||6|||f||||f||||||||||2017-02-18 13:11:49.786617|2017-02-18 13:11:49.786617
NCT00877578|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2013-10-15|||April 2009||2009-04-01|October 2013|2013-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|Nutri-PA||Efficacy of a Special Oral Nutritional Supplement on Nutritional Status of Malnourished Elderly Patients|Efficacy of a Special Oral Nutritional Supplement on Nutritional Status of Malnourished Elderly Patients|Completed||N/A|40|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-02-18 13:11:49.910871|2017-02-18 13:11:49.910871
NCT00877565|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-07|2009-04-07|||February 2009||2009-02-01|April 2009|2009-04-01||||||||Observational|2DSonTOEcho||Global Longitudinal Peak Systolic Strain (GLPSS) Derived From Transesophageal Echocardiography - A Reliable Measure of Systolic Function?|Is Global Longitudinal Peak Systolic Strain (GLPSS) Derived From Transesophageal Echocardiography a Reliable Measure of Systolic Function? A Multicenter-Study to Compare GLPSS With Ejection Fraction Derived From Biplane Simpson´s Method on TTE and TEE in Patients Undergoing Elective Cardiac and Non-Cardiac Surgery|Unknown status|Recruiting|Phase 4|400|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-02-18 13:11:50.021555|2017-02-18 13:11:50.021555
NCT00877552|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2015-12-03|||August 2002||2002-08-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Prospective Studies of the Pathogenesis of Schizophrenia|Prospective Studies of the Pathogenesis of Schizophrenia (Center Title) Early Brain Development in High Risk Children (Project Title) Early Brain Development in One and Two Year Olds (Associated Grant Title)|Active, not recruiting||N/A|600|Anticipated|University of North Carolina, Chapel Hill|||4||f||||f||||||Samples With DNA|"~     MRIs, buccal swabs, prenatal ultrasounds~   "|||2017-02-18 13:11:50.092015|2017-02-18 13:11:50.092015
NCT00877539|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2010-09-27|||June 2009||2009-06-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|||A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects|A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, 3-Way Crossover Study To Determine The Effects Of Inhaled Doses Of PF-03526299 On Allergen-Induced Airway Responses In Mild Asthmatic Subjects.|Completed||Phase 1|29|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:11:50.188467|2017-02-18 13:11:50.188467
NCT00877526|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-11-21|||May 2009||2009-05-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|DiabCare Asia||A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Malaysia|DiabCare Asia 2008 (Malaysia): A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Asia|Completed||N/A|1670|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"~     Capillary or venous blood will be drawn for analysing HbA1c.~   "|||2017-02-18 13:11:50.301019|2017-02-18 13:11:50.301019
NCT00877513|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-02-07|||February 2009||2009-02-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Insulin Resistance in Smokers Undergoing Smoking Cessation|Insulin Resistance in Smokers Undergoing Smoking Cessation|Terminated||N/A|103|Actual|Charles Drew University of Medicine and Science||1||Funding expired|f||||t||||||||||2017-02-18 13:11:50.399672|2017-02-18 13:11:50.399672
NCT00877500|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-07-28|||April 2009||2009-04-01|July 2016|2016-07-01||||April 2020|Anticipated|2020-04-01||Interventional|||Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease|A Phase II Randomized Study of Ixabepilone vs. Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2/Neu-negative Breast Cancer|Active, not recruiting||Phase 2|116|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 13:11:50.761412|2017-02-18 13:11:50.761412
NCT00877487|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2012-07-31|2011-07-06||April 2009||2009-04-01|July 2012|2012-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder|A Phase 4, Double-Blind, Multi-Center, Placebo-Controlled, Randomized Withdrawal, Safety and Efficacy Study of SPD489 in Adults Aged 18-55 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 4|123|Actual|Shire||2|||f||||||||||||||2017-02-18 13:11:50.882313|2017-02-18 13:11:50.882313
NCT00877474|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2015-11-03|||March 2009||2009-03-01|November 2015|2015-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors|Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors|Completed||Phase 1|30|Actual|PharmaMar||1|||f||||f||||||||||2017-02-18 13:11:51.488738|2017-02-18 13:11:51.488738
NCT00877461|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-07|||May 2005||2005-05-01|April 2009|2009-04-01|December 2005|Actual|2005-12-01|November 2005|Actual|2005-11-01||Observational|||Glucose Monitor Accuracy Investigation (Ⅰ)|Glucose Monitor Accuracy Investigation (Ⅰ)|Completed||N/A|308|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:11:51.593748|2017-02-18 13:11:51.593748
NCT00877448|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2013-02-20|2012-08-01||June 2009||2009-06-01|February 2013|2013-02-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)|A Phase I/II, Randomized, Single-Blind, Placebo-Controlled Escalating Double-Dose Safety Study of an Intramuscular Influenza Vaccine (Multimeric-001) Injected to Healthy Volunteers|Completed||Phase 1/Phase 2|63|Actual|BiondVax Pharmaceuticals ltd.||7|||f||||t||||||||||2017-02-18 13:11:51.680576|2017-02-18 13:11:51.680576
NCT00877435|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2015-01-28|||September 2008||2008-09-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|August 2013|Actual|2013-08-01||Interventional|||Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial|Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial|Completed||N/A|60|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 13:11:52.591464|2017-02-18 13:11:52.591464
NCT00877422|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-07|||August 2008||2008-08-01|April 2009|2009-04-01||||||||Interventional|||Vitamin D Supplementation Prevents Elderly Pneumonia|Vitamin D Supplementation Prevents Pneumonia in Institutionalized Elderly Subjects|Completed||N/A|100|Actual|Tohoku University||3|||f||||f||||||||||2017-02-18 13:11:52.70319|2017-02-18 13:11:52.70319
NCT00877409|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-06|||April 2009||2009-04-01|April 2009|2009-04-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|ACNASE||Safety and Efficacy Study of Acnase Creme in the Treatment of Acne Vulgaris I and II|A Monocentric, Single-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of the Topical Drug Acnase Creme in the Treatment of Acne Vulgaris I and II|Unknown status|Not yet recruiting|Phase 3|80|Anticipated|Zurita Laboratorio Farmaceutico Ltda.||2|||f||||f||||||||||2017-02-18 13:11:52.814622|2017-02-18 13:11:52.814622
NCT00877396|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2011-09-27|||September 2008||2008-09-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Hutterite Influenza Prevention Study|Does Vaccinating Health Hutterite Children Against Influenza Prevent Influenza in Other Hutterite Colony Members: A Randomized Cluster Trial|Completed||Phase 4|4771|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 13:11:52.930537|2017-02-18 13:11:52.930537
NCT00877383|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2011-08-23|2011-07-22||April 2009||2009-04-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|INTRUST2||Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease|A Randomized, Double-blind, Controlled, Parallel-group, 12-week Study to Compare the Efficacy and Safety of the Combination of Indacaterol 150 µg Once Daily With Open Label Tiotropium 18 µg Once Daily Versus Open Label Tiotropium 18 µg Once Daily in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease|Completed||Phase 3|1142|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:11:53.137192|2017-02-18 13:11:53.137192
NCT00877370|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-08-29|2012-08-29||February 2009||2009-02-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis|Pharmacokinetics of Invanz® (Ertapenem) in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis|Completed||Phase 4|8|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 13:11:53.989746|2017-02-18 13:11:53.989746
NCT00877357|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-05-05|||January 2009||2009-01-01|April 2009|2009-04-01|February 2013|Anticipated|2013-02-01|December 2012|Anticipated|2012-12-01||Interventional|||Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine|Open Label Multicentric Randomized Phase IV Post Marketing Safety, Immunogenicity and Lot-to-Lot Consistency Analysis of Shan 5 [DTPwHB-Hib (Liquid) Pentavalent Combination Vaccine] in Indian Infants|Unknown status|Recruiting|Phase 4|3000|Anticipated|Shantha Biotechnics Limited||3|||f||||f||||||||||2017-02-18 13:11:54.23869|2017-02-18 13:11:54.23869
NCT00877344|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-11-15|||June 2009||2009-06-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion|Better Contraceptive Choices: Immediate vs. Delayed Insertion of Intrauterine Contraception After Second Trimester Abortion|Active, not recruiting||Phase 4|534|Actual|University of British Columbia||2|||f||||f||||||||No||2017-02-18 13:11:54.346354|2017-02-18 13:11:54.346354
NCT00877331|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2014-10-17|||April 2009||2009-04-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|October 2013|Actual|2013-10-01||Interventional|||Brief Intervention in Primary Care for Problem Drug Use and Abuse|Brief Intervention in Primary Care for Problem Drug Use and Abuse|Completed||N/A|868|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 13:11:54.458846|2017-02-18 13:11:54.458846
NCT00877318|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-03-17|||March 2009||2009-03-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|READ||Cardiac Rehabilitation of Heart Failure Patients by Telemedicine|Cardiac Rehabilitation of Heart Failure Patients by Telemedicine: a Randomized Multicenter Study.|Terminated||Phase 4|64|Actual|University Hospital, Caen||2||insufficient recruitment|f||||t||||||||||2017-02-18 13:11:54.571358|2017-02-18 13:11:54.571358
NCT00877305|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2012-01-17|||October 2008||2008-10-01|January 2012|2012-01-01||||November 2010|Actual|2010-11-01||Interventional|||Effect of Remote Ischemic Preconditioning on Cognitive Function After Cardiac Surgery||Completed||Phase 1|180|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-02-18 13:11:54.683688|2017-02-18 13:11:54.683688
NCT00877292|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2015-06-01|||February 2009||2009-02-01|June 2015|2015-06-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Observational|RNA||A New Prenatal Blood Test for Down Syndrome|The RNA (RNA-Based Noninvasive Aneuploidy) Study|Completed||N/A|4664|Actual|Women and Infants Hospital of Rhode Island|||1||f||||f||||||Samples With DNA|"~     Fetal RNA and DNA in maternal plasma~   "|||2017-02-18 13:11:54.777847|2017-02-18 13:11:54.777847
NCT00877279|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-10-23||2011-10-12|November 2007||2007-11-01|October 2013|2013-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft|A Randomized,Blinded,Controlled,Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero® Soft, After Superficial to Mid Dermal Implantation for Correction of Mild Facial Wrinkles Over 4 Weeks.|Completed||Phase 3|64|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-02-18 13:11:54.923058|2017-02-18 13:11:54.923058
NCT00877266|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-06|||August 2007||2007-08-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Ultrasound Guidance Versus Electrical Stimulation for Perineural Catheter Insertion|Ultrasound Guidance vs. Electrical Stimulation for Perineural Catheter Insertion: A Randomized, Controlled Trial|Completed||Phase 4|180|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 13:11:55.03325|2017-02-18 13:11:55.03325
NCT00877253|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-06-11|||May 2008||2008-05-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer|Open-label, Multicenter, Phase I Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin as a Firstline Treatment in Subjects With Advanced Ovarian Cancer|Completed||Phase 1|18|Actual|Samyang Biopharmaceuticals Corporation||3|||f||||f||||||||||2017-02-18 13:11:55.14541|2017-02-18 13:11:55.14541
NCT00877240|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-03-15|||August 2008||2008-08-01|March 2016|2016-03-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||The Influence of an Intervention Program on Altering Health Behavioral Patterns Among IDF's Staff||Withdrawn||N/A|0|Actual|Medical Corps, Israel Defense Force||1||lack of complaince|f||||||||||||||2017-02-18 13:11:55.242352|2017-02-18 13:11:55.242352
NCT00877227|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-05-05|||January 2003||2003-01-01|April 2009|2009-04-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Does B Vitamin Supplementation Decrease Homocysteine Concentrations in Newborns|Does Folinic Acid Supplementation Decrease Homocysteine Concentrations in Newborns|Completed||Phase 1|37|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 13:11:55.327959|2017-02-18 13:11:55.327959
NCT00877214|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-10-25|||April 2009||2009-04-01|October 2016|2016-10-01|April 2022|Anticipated|2022-04-01|April 2017|Anticipated|2017-04-01||Interventional|MAINTAIN||Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas|Prospective Randomized Multicenter Study in First-line Treatment of Advanced progredIeNT Follicular And Other IndoleNt and Mantle Cell Lymphomas|Recruiting||Phase 3|1272|Anticipated|University of Giessen||2|||f||||t||||||||No||2017-02-18 13:11:55.446523|2017-02-18 13:11:55.446523
NCT00876213|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-03|||March 2007||2007-03-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|||||Observational|||Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans|Amylin and GLP-1: Influence on Gastric Emptying, Appetite and Food Intake in Humans.|Completed||N/A|23|Actual|Hvidovre University Hospital|||2||f||||f||||||||||2017-02-18 13:11:55.589907|2017-02-18 13:11:55.589907
NCT00876200|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-01-20|||March 2009||2009-03-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|Williams||Efficacy of Minoxidil in Children With Williams-Beuren Syndrome|The Efficacy of Minoxidil in Children With Williams-Beuren Syndrome: a Randomized Clinical Trial.|Completed||Phase 2|21|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 13:11:55.675978|2017-02-18 13:11:55.675978
NCT00876187|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2011-07-19||2011-07-19|June 2009||2009-06-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||A Study of Tanezumab in Adults With Chronic Low Back Pain|A Randomized, Double-Blind, Multi-Dose, Active- and Placebo-Controlled, Multi-Center, Parallel Group Study of the Analgesic Effects of Tanezumab in Adult Patients With Chronic Low Back Pain|Completed||Phase 2|1359|Actual|Pfizer||5|||f||||t||||||||||2017-02-18 13:11:55.801717|2017-02-18 13:11:55.801717
NCT00876174|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2010-01-11|||May 2009||2009-05-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|||||Observational|||Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C|Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C|Terminated||N/A|30|Anticipated|University of Nebraska|||2|no accrual|f||||f||||||Samples Without DNA|"~     20 ml blood for peripheral mononuclear cells~   "|||2017-02-18 13:11:56.208999|2017-02-18 13:11:56.208999
NCT00876161|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-02-02|||April 2009||2009-04-01|February 2010|2010-02-01||||December 2009|Actual|2009-12-01||Interventional|||DAS181 Single Dose Escalation Study in Healthy Adults|Phase 1 Clinical Study With DAS181: Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalation Study in Healthy Adults|Completed||Phase 1|45|Actual|Ansun Biopharma, Inc.||2|||f||||t||||||||||2017-02-18 13:11:56.325157|2017-02-18 13:11:56.325157
NCT00875147|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-10-24|||April 2009||2009-04-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Observational|||Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases|Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases A Case Matched Control Study|Completed||N/A|163|Actual|University of Zurich|||2||f||||t||||||||||2017-02-18 13:11:56.415992|2017-02-18 13:11:56.415992
NCT00875134|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-04-02|||March 2009||2009-03-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Testing of the Apnea Prevention Device|Testing of the Apnea Prevention Device|Unknown status|Active, not recruiting|Phase 1/Phase 2|35|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 13:11:56.522228|2017-02-18 13:11:56.522228
NCT00875121|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-05-11|||October 2007||2007-10-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Peer Interactions and Food Are Substitutable in Youth|Peer Interactions and Food Are Substitutable in Youth|Completed||N/A|||University at Buffalo|||1||f||||f||||||||||2017-02-18 13:11:56.607823|2017-02-18 13:11:56.607823
NCT00875108|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-07-28||2015-07-28|July 2007||2007-07-01|July 2015|2015-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes Mellitus||Completed||Phase 3|116|Actual|Biodel||1|||f||||f||||||||||2017-02-18 13:11:56.689241|2017-02-18 13:11:56.689241
NCT00875095|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-09-07|||October 2007||2007-10-01|September 2016|2016-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)|Impact of Sperm DNA Integrity on ART Treatment|Terminated||N/A|8|Actual|Northwell Health|||2|"Study funding was withdrawn by the sponsor following agreement that slow patient recruitment~   warranted a new approach."|f||||f||||||Samples Without DNA|"~     Smears of semen samples will be stained and stored.~   "|||2017-02-18 13:11:56.771465|2017-02-18 13:11:56.771465
NCT00875082|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2013-06-18|||February 2010||2010-02-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|September 2011|Actual|2011-09-01||Interventional|MORACH||Effect of Montelukast on Remodelling Markers in Asthmatic Children|Effect of Montelukast on Metalloproteinase (MMP)-9, MMP-12, Tissue Inhibitor Metalloproteinase-1 (TIMP-1), Procollagen Type I C-terminal Peptide (PICP) and TGF-beta1 Levels in Sputum From Mild Intermittent Asthmatic Children: a Pilot Study|Completed||Phase 4|30|Actual|Universita di Verona||2|||f||||f||||||||||2017-02-18 13:11:56.865581|2017-02-18 13:11:56.865581
NCT00875069|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2014-06-13|||April 2009||2009-04-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|June 2011|Actual|2011-06-01||Interventional|ELVIS||Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical Trial|Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical Trial.|Completed||Phase 3|1460|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-02-18 13:11:56.962512|2017-02-18 13:11:56.962512
NCT00875056|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2017-02-13|||April 2009||2009-04-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|February 2011|Actual|2011-02-01||Interventional|||Study of Vorinostat (MK0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) or Mantle Cell Lymphoma (MCL) Patients (MK-0683-103)|A Phase II Study of MK0683 in Patients With Relapsed / Refractory Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) or Mantle Cell Lymphoma (MCL)|Active, not recruiting||Phase 2|54|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:11:57.070575|2017-02-18 13:11:57.070575
NCT00876889|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-07-29|||April 2010||2010-04-01|July 2013|2013-07-01|April 2012|Actual|2012-04-01|June 2011|Actual|2011-06-01||Observational|||Safety of Riluzole in Patients With Acute Spinal Cord Injury|Safety and Pharmacokinetics of Riluzole in Patients With Traumatic Acute Spinal Cord Injury|Completed||N/A|36|Actual|The Methodist Hospital System|||1||f||||f||||||Samples Without DNA|"~     plasma and cerebral spinal fluid~   "|||2017-02-18 13:12:06.32972|2017-02-18 13:12:06.32972
NCT00875043|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2016-10-13|||March 2008||2008-03-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||Determine the Effect of Intraocular Pressure (IOP), Optic Nerve Imaging, Venous Congestion in Volunteers Prone Position 5 Hours|A Pilot Study to Determine the Effect on Intraocular Pressure, Optic Nerve Imaging and Other Markers of Venous Congestion of Volunteer Subjects in the Prone Position for a Period of Five Hours|Completed||N/A|10|Actual|Rutgers, The State University of New Jersey|||2||f||||f||||||||No||2017-02-18 13:11:57.17004|2017-02-18 13:11:57.17004
NCT00875030|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2010-06-07|||June 2009||2009-06-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects|A Single-Dose Bioequivalence Study Comparing Artesunate Sachets (Pfizer) To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects|Completed||Phase 4|40|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:11:57.25792|2017-02-18 13:11:57.25792
NCT00875017|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2013-12-04|2010-03-03||April 2009||2009-04-01|December 2013|2013-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers|An Open-label, Phase I, One-dose, One-meal, Balance Study Comparing the Absorption of Dietary Phosphorus When Administering FOSRENOL® (Lanthanum Carbonate) or RENVELA® (Sevelamer Carbonate) in Healthy Adult Volunteers|Completed||Phase 1|31|Actual|Shire||4|||f||||f||||||||||2017-02-18 13:11:57.374237|2017-02-18 13:11:57.374237
NCT00877201|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-07|||March 2007||2007-03-01|April 2009|2009-04-01||||||||Interventional|||Improvement of Accommodation With Anti-Oxidant Supplementation in Visual Display Terminal Users||Completed||N/A|||Ryogoku Eye Clinic|||||f||||t||||||||||2017-02-18 13:11:58.255364|2017-02-18 13:11:58.255364
NCT00877188|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2012-12-20|||January 2009||2009-01-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Effect of Combined Aerobic and Resisted Exercise in Breast Cancer Survivors|Effect of Combined Aerobic and Resisted Exercise in Breast Cancer Survivors: Upper Extremity Function, Quality of Life and Fitness Outcomes|Completed||N/A|34|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:11:58.328877|2017-02-18 13:11:58.328877
NCT00877175|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2012-03-07|||March 2009||2009-03-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of Instillation and Packing in Mydriasis for Premature Infants|Comparison of Conventional Instillation and Lower Conjunctival Fornix Packing in Mydriasis for Premature Infants|Completed||Phase 4|25|Actual|Khon Kaen University||2|||f||||t||||||||||2017-02-18 13:11:58.426245|2017-02-18 13:11:58.426245
NCT00877162|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-06-18|||June 2009||2009-06-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|May 2011|Actual|2011-05-01||Interventional|||The Rocky Sleep Study|Night Waking Reduction in Canadian Infants: A Randomized Controlled Clinical Trial of a Parent-based Cognitive and Behavioural Intervention in Community Health Units.|Completed||N/A|235|Actual|University of British Columbia||1|||f||||t||||||||||2017-02-18 13:11:58.540308|2017-02-18 13:11:58.540308
NCT00877149|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2012-05-03|||March 2009||2009-03-01|May 2012|2012-05-01||||April 2011|Actual|2011-04-01||Interventional|||Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B|A Single-arm, Multicenter, Open-label, 52-week Treatment, Extension Study to CLDT600ACN04 Study to Evaluate the Efficacy (Including Histological Improvement) and Safety in Fourth to Sixth Year of Telbivudine Treatment in Patients With Chronic Hepatitis B|Completed||Phase 4|80|Anticipated|Novartis||1|||f||||||||||||||2017-02-18 13:11:58.652511|2017-02-18 13:11:58.652511
NCT00877136|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2014-10-14|||February 2009||2009-02-01|October 2014|2014-10-01|February 2016|Anticipated|2016-02-01|February 2015|Anticipated|2015-02-01||Observational|||A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®|A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®|Unknown status|Recruiting|N/A|50|Anticipated|St. Joseph Hospital of Orange|||1||f||||f||||||||||2017-02-18 13:11:58.752843|2017-02-18 13:11:58.752843
NCT00877123|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2011-11-09|||June 2009||2009-06-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effect of Vitamin D Supplementation on Fasting Glucose and Interleukin-10 (IL-10) in Arab Women With Impaired Fasting Glucose|Prospective, Randomized, Double Blind Placebo Controled Clinical Trial to Assess the Effect of Vitamin D Supplementation on Fasting Glucose and IL-10 in Arab Women With Impaired Fasting Glucose.|Completed||Phase 4|74|Actual|Clalit Health Services||2|||f||||f||||||||||2017-02-18 13:11:58.849867|2017-02-18 13:11:58.849867
NCT00877110|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2017-02-01|||April 2, 2009||2009-04-02|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma|Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma|Active, not recruiting||Phase 1|71|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:11:58.957346|2017-02-18 13:11:58.957346
NCT00877097|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-04-06|||July 1996||1996-07-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|December 2002|Actual|2002-12-01||Interventional|Osteo||Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women|Randomized Clinical Trial on the Effectts of Estradiol 2 mg + NETA 1 mg With or Without Clodronate on Bone Mineral Density and Bone Markers of Osteoporotic Postmenopausal 167 Finnish Women.|Completed||N/A|167|Actual|Kuopio University Hospital||3|||f||||f||||||||||2017-02-18 13:11:59.063344|2017-02-18 13:11:59.063344
NCT00877084|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-06|||January 2004||2004-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2005|Actual|2005-12-01||Interventional|EXTRA||Exacerbation and Training in Patients With Chronic Obstructive Pulmonary Disease|Exacerbation and Training - Study; a Randomized Controlled Study of the Effect of Resistance Training in Acute Exacerbations of COPD|Completed||N/A|40|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-02-18 13:11:59.155618|2017-02-18 13:11:59.155618
NCT00877071|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-04|2016-02-08|2016-01-08||November 2008||2008-11-01|February 2016|2016-02-01|April 2012|Actual|2012-04-01|May 2011|Actual|2011-05-01||Interventional|HCC||LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed|LC Drug Eluting Bead for Regional Chemoembolization to Downstage Unresectable Hepatocellular Carcinoma (HCC) to Liver Transplantation|Completed||Phase 2|2|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:11:59.26434|2017-02-18 13:11:59.26434
NCT00876499|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2015-01-07|||January 2009||2009-01-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients|Relationship Among Fatigue, Symptoms, Melatonin and Sleep in PBT Patients Undergoing Radiation Therapy|Completed||N/A|20|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:12:14.045908|2017-02-18 13:12:14.045908
NCT00877058|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2014-06-11|2013-10-30||January 2008||2008-01-01|June 2014|2014-06-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|||SUPPORT FOR FRAIL ELDERLY PERSONS - From Prevention to Palliation|Elderly Persons at the Risk Zone - a Randomized Controlled Trial of a Community Based Preventive Multiprofessional Program for Old Persons at Risk of Frailty|Completed||N/A|459|Actual|Vardalinstitutet The Swedish Institute for Health Sciences||3|||f||||f||||||||||2017-02-18 13:11:59.504386|2017-02-18 13:11:59.504386
NCT00877045|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-08-03|||January 2008||2008-01-01|August 2010|2010-08-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Observational|||Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting|Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting|Completed||N/A|200|Actual|SCRI Development Innovations, LLC|||1||f||||f||||||||||2017-02-18 13:11:59.990262|2017-02-18 13:11:59.990262
NCT00877032|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2015-03-20|2015-03-20||April 2009||2009-04-01|March 2015|2015-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Safety analysis population included all participants who received any amount of the single dose of either study drug or placebo.|Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration|A Phase I, Double-masked, Placebo-controlled Study Evaluating The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Immunogenicity Of Single Escalating Doses Of Rn6g In Patients With Dry, Age-related Macular Degeneration (Amd)|Completed||Phase 1|57|Actual|Pfizer|Results for pharmacodynamic parameters [Cmax, Tmax and AUC (0-65d) of A beta(1-X)], are presented as absolute values at specified time points and not as change from baseline as planned.|1|||f||||f||||||||||2017-02-18 13:12:00.094338|2017-02-18 13:12:00.094338
NCT00877019|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-06|||August 2007||2007-08-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|timebrush||Time Dependent Professional Toothbrushing Study|Time Dependent Professional Toothbrushing Study Comparing Sonicare With Manual Toothbrushes|Completed||N/A|90|Actual|University of Erlangen-Nürnberg Medical School|||||f||||f||||||||||2017-02-18 13:12:02.358427|2017-02-18 13:12:02.358427
NCT00877006|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-11-14|2014-03-25||April 2009||2009-04-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2012|Actual|2012-03-01||Interventional|||Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study|An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)|Active, not recruiting||Phase 3|447|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-02-18 13:12:02.447171|2017-02-18 13:12:02.447171
NCT00876993|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-06-10|||September 2008||2008-09-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors|A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors|Completed||Phase 1|26|Actual|Johns Hopkins All Children's Hospital||5|||f||||t||||||||||2017-02-18 13:12:03.978637|2017-02-18 13:12:03.978637
NCT00876980|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2013-10-15|||May 2008||2008-05-01|October 2013|2013-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Obstructive Sleep Apnea and Diabetes Mellitus|The Effect of Nasal Continuous Positive Airway Pressure Treatment on Glycemic Control and Vascular Function in Patients With Obstructive Sleep Apnea and Type II Diabetes Mellitus.|Completed||N/A|64|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-02-18 13:12:04.092479|2017-02-18 13:12:04.092479
NCT00876967|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2010-03-30|||January 2008||2008-01-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|Laryngotest||Comparison of Three Laryngoscope Blades for Orotracheal Intubation in the Operating Room|Comparison of Performance of Three Laryngoscope Blades: Plastic Single Use, Metallic Single Use and Metallic Reusable Blades.|Completed||Phase 4|1040|Anticipated|University Hospital, Caen||3|||f||||t||||||||||2017-02-18 13:12:04.211274|2017-02-18 13:12:04.211274
NCT00876954|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2016-01-20|||April 2009||2009-04-01|January 2016|2016-01-01|July 2011|Actual|2011-07-01|October 2010|Actual|2010-10-01||Interventional|||Preoperative Hyperthermia in Major Abdominal Surgery Patients|Preoperative Whole-Body Hyperthermia in Patients Undergoing Major Abdominal Cancer Surgery: A Randomized Pilot Study|Completed||Phase 1/Phase 2|20|Actual|Medical University of Vienna||2|||f||||f||||||||Undecided|on request|2017-02-18 13:12:04.320662|2017-02-18 13:12:04.320662
NCT00876941|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2014-10-01|||April 2009||2009-04-01|February 2012|2012-02-01|September 2014|Actual|2014-09-01|October 2012|Actual|2012-10-01||Interventional|ASPIRE||Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use|Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models|Completed||Phase 3|589|Actual|Boston Medical Center||3|||f||||f||||||||||2017-02-18 13:12:04.424279|2017-02-18 13:12:04.424279
NCT00876928|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2013-04-17|2012-07-03||March 2009||2009-03-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Vitamin D in Minorities With Prediabetes|Effect of Vitamin D Supplementation on Pre-Diabetes in a Minority Population|Completed||N/A|117|Actual|Charles Drew University of Medicine and Science||2|||f||||t||||||||||2017-02-18 13:12:04.539943|2017-02-18 13:12:04.539943
NCT00876915|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-10-28|2015-07-24||July 2009||2009-07-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|PHACS||A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients|A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients|Terminated||Phase 3|218|Actual|University of Rochester||3||slow enrollment and lack of continuing funds|f||||t||||||||||2017-02-18 13:12:04.967484|2017-02-18 13:12:04.967484
NCT00876902|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-06|||May 2008||2008-05-01|April 2009|2009-04-01|October 2009|Anticipated|2009-10-01|March 2009|Actual|2009-03-01||Interventional|YSPSL||YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation|A Controlled, Prospective, Blinded, Randomized, Single-Center, Study of YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation|Unknown status|Active, not recruiting|Phase 2|36|Actual|Y's Therapeutics, Inc.||2|||f||||t||||||||||2017-02-18 13:12:06.206345|2017-02-18 13:12:06.206345
NCT00875706|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-04-06|2014-10-10||October 2009||2009-10-01|August 2014|2014-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Training and Coaching to Promote High Performance in Veteran Affairs (VA) Nursing Home Care|Training and Coaching to Promote High Performance in VA Nursing Home Care|Completed||N/A|45|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 13:12:34.095087|2017-02-18 13:12:34.095087
NCT00876876|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-11-19|||July 2009||2009-07-01|November 2010|2010-11-01|December 2010|Anticipated|2010-12-01|August 2010|Anticipated|2010-08-01||Interventional|||International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia|International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic Hyponatremia|Withdrawn||Phase 3|300|Anticipated|CardioKine Inc.||2||Created Extension study - This study was no longer feasible|f||||||||||||||2017-02-18 13:12:06.445723|2017-02-18 13:12:06.445723
NCT00876863|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2017-01-06|||September 2009||2009-09-01|January 2017|2017-01-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Interventional|||Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease|A Double-Blind, Placebo-Controlled (Sham Surgery), Randomized, Multicenter Study Evaluating CERE-110 Gene Delivery in Subjects With Mild to Moderate Alzheimer's Disease|Active, not recruiting||Phase 2|50|Anticipated|Sangamo Therapeutics||2|||f||||t||||||||||2017-02-18 13:12:06.536624|2017-02-18 13:12:06.536624
NCT00876850|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2012-05-08|||July 2009||2009-07-01|May 2012|2012-05-01|August 2010|Anticipated|2010-08-01|July 2010|Anticipated|2010-07-01||Interventional|||Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)|A Randomized, Evaluator-Blinded, Phase 3 Study to Compare the Safety and Efficacy of PTK 0796 With Linezolid in the Treatment of Adults With Complicated Skin and Skin Structure Infection|Withdrawn||Phase 3|0|Actual|Paratek Pharmaceuticals Inc||2||Terminated|f||||f||||||||||2017-02-18 13:12:06.64097|2017-02-18 13:12:06.64097
NCT00876837|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-11-01|||March 1998||1998-03-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|||Long-term Outcomes and Life Satisfaction of Adults With Pediatric-Onset Spinal Cord Injuries|Long-term Outcomes and Life Satisfaction of Adults With Pediatric-Onset Spinal Cord Injuries|Recruiting||N/A|600|Anticipated|Shriners Hospitals for Children|||1||f||||f||||||||||2017-02-18 13:12:06.742542|2017-02-18 13:12:06.742542
NCT00876824|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2011-06-01|||July 2009||2009-07-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar|A Prospective, Multicentric, Randomized, Two Arm, Open Label Phase III Study To Assess Efficacy And Safety Of Infusion Of Amphomul® (Amphotericin B Emulsion) As Compared To Liposomal Amphotericin In Patients Of Visceral Leishmaniasis (Kala Azar)|Completed||Phase 3|500|Actual|Bharat Serums and Vaccines Limited||2|||f||||t||||||||||2017-02-18 13:12:06.853446|2017-02-18 13:12:06.853446
NCT00876811|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-10-28|||March 2009||2009-03-01|October 2010|2010-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Red Raspberry Consumption on Fasting Oxidative Stress Biomarkers|Raspberries and Human Health: A Short-term Intervention Trial Investigating the Effect of Daily Red Raspberry Consumption on Fasting Oxidative Stress Biomarkers|Completed||Phase 1|24|Actual|University of Toronto||3|||f||||f||||||||||2017-02-18 13:12:06.96438|2017-02-18 13:12:06.96438
NCT00876798|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2011-06-20||2011-06-20|June 2009||2009-06-01|November 2010|2010-11-01||||November 2010|Actual|2010-11-01||Interventional|||A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia|Completed||Phase 3|206|Actual|CardioKine Inc.||2|||f||||t||||||||||2017-02-18 13:12:07.078678|2017-02-18 13:12:07.078678
NCT00876785|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-13|||September 2007||2007-09-01|April 2009|2009-04-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Rye Bread Breakfasts on Eight Hour Satiety Ratings|Effect of Rye Bread Breakfasts on Subjective Hunger and Satiety|Completed||N/A|32|Actual|Swedish University of Agricultural Sciences||2|||f||||f||||||||||2017-02-18 13:12:07.45598|2017-02-18 13:12:07.45598
NCT00876772|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2011-03-23|||March 2011||2011-03-01|March 2011|2011-03-01||||July 2012|Anticipated|2012-07-01||Interventional|||Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)|Randomized, Placebo-controlled Parallel Group Study for the Evaluation of an Oral Dose of 10mg Olanzapine in Combination With Riluzole for the Treatment of Loss of Appetite in Patients With Amyotrophic Lateral Sclerosis (ALS)|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-02-18 13:12:07.567906|2017-02-18 13:12:07.567906
NCT00876759|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-06|||April 2009||2009-04-01|April 2009|2009-04-01|July 2013|Anticipated|2013-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Whole-Brain Radiotherapy (WBRT) Versus WBRT and Integrated Boost Using Helical Tomotherapy for Multiple Brain Metastases|Whole-Brain Radiotherapy (WBRT) vs. WBRT and Integrated Boost Using Helical Tomotherapy for Patients With Multiple Brain Metastases - a Multicentre Randomized Phase II Trial|Unknown status|Recruiting|Phase 2|160|Anticipated|University Hospital, Essen||2|||f||||t||||||||||2017-02-18 13:12:07.687989|2017-02-18 13:12:07.687989
NCT00876746|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-06-14|||December 2008||2008-12-01|April 2009|2009-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Optimization of Catheter Insertion Site for Continuous Peripheral Nerve Blocks|Optimization of Catheter Insertion Site for Continuous Peripheral Nerve Blocks|Completed||Phase 4|60|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-02-18 13:12:07.799305|2017-02-18 13:12:07.799305
NCT00876733|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2015-01-14|2014-12-27||March 2009||2009-03-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational||Treated set (TS): This patient set includes all HIV-1 infected patients who were dispensed Viramune® and were documented to have taken at least one dose of Viramune®and of a antiretroviral combination partner.|Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients|Non-Interventional Observational Study With Viramune Plus ARV in HIV Infected Patients|Completed||N/A|605|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 13:12:07.925026|2017-02-18 13:12:07.925026
NCT00876720|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2010-11-12|||April 2009||2009-04-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effectiveness Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Chronic Tinnitus|Effectiveness of Combined Frontal and Temporal Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Chronic Tinnitus|Completed||N/A|100|Anticipated|University of Regensburg||2|||f||||f||||||||||2017-02-18 13:12:09.516553|2017-02-18 13:12:09.516553
NCT00876707|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-07-01|||March 2009||2009-03-01|April 2009|2009-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|IOL||Wavefront Analyzes and Visual Performance of Three Multifocal Intra-ocular Lenses|Phase 1 Study of Ocular Aberrations and Visual Performance of Eyes Implanted With Three Multifocal Intra-ocular Lenses|Completed||Phase 1/Phase 2|60|Anticipated|University of Sao Paulo||3|||f||||||||||||||2017-02-18 13:12:09.622725|2017-02-18 13:12:09.622725
NCT00876694|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2011-10-04|2011-10-04||March 2009||2009-03-01|October 2011|2011-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A 52-week Treatment, Multi-center, Randomized, Open Label, Parallel Group Study to Assess the Long Term Safety and Efficacy of Indacaterol (300 µg o.d.) Using Salmeterol (50 µg b.i.d.) as an Active Control in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|186|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:12:09.733096|2017-02-18 13:12:09.733096
NCT00876681|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-10-07|||April 2008||2008-04-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Ultrasound Guidance Versus Electrical Stimulation for Continuous Popliteal-Sciatic Nerve Blocks|Ultrasound Guidance Versus Electrical Stimulation for Continuous Popliteal-Sciatic Nerve Blocks: A Randomized, Controlled Trial|Completed||Phase 4|80|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-02-18 13:12:10.325379|2017-02-18 13:12:10.325379
NCT00876668|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2009-04-06|||June 2007||2007-06-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|December 2008|Actual|2008-12-01||Observational|||Evaluation of the Clinical Significance of Fluorescence Videoangiography With Indocyanine-Green|Pilot-Study to Evaluate the Clinical Significance of the Fluorescence Videoangiography With Indocyanine-Green in Patients With PAD, Rutherford Classification II-V, and Relation to Common Diagnostics.|Unknown status|Active, not recruiting|N/A|25|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-02-18 13:12:10.438205|2017-02-18 13:12:10.438205
NCT00876655|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-05-02|||February 2009||2009-02-01|May 2016|2016-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate|An Open-Label, Randomized, Single-Dose, 2-Treatment, 2-Sequence, Crossover, Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of TR-701 (Torezolid Phosphate) in Normal Healthy Adults|Completed||Phase 1|12|Actual|Trius Therapeutics LLC||2|||f||||f||||||||||2017-02-18 13:12:10.525821|2017-02-18 13:12:10.525821
NCT00876642|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-05|2009-04-06|||March 2007||2007-03-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Trial Comparing Best Supportive Care to Aloe Vera Gel|Phase III Trial Comparing Best Supportive Care to Aloe Vera Gel as a Prophylactic Agent for Radiation Induced Skin Toxicity|Completed||Phase 3|137|Actual|Marilia Medicine School||2|||f||||t||||||||||2017-02-18 13:12:10.619132|2017-02-18 13:12:10.619132
NCT00876629|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-08-18|||March 2009||2009-03-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|MRE_Rénale||Renal Magnetic Resonance (MR) Elastography in Healthy Volunteers|Renal MR Elastography: Normal Findings and Variability of Stiffness Measurements|Completed||N/A|10|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-02-18 13:12:10.714011|2017-02-18 13:12:10.714011
NCT00876616|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2013-08-28|||April 2009||2009-04-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|May 2011|Actual|2011-05-01||Interventional|||Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis|An Multi-site, Open, Prospective Study to Assess the Efficacy and Safety of Multi-target Therapy in the Treatment of Class Ⅲ,Ⅳ,Ⅴ,Ⅲ+Ⅴand Ⅳ+Ⅴ Lupus Nephritis|Completed||N/A|362|Actual|Nanjing University School of Medicine||2|||f||||t||||||||||2017-02-18 13:12:10.795307|2017-02-18 13:12:10.795307
NCT00876603|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2010-01-12|||May 2001||2001-05-01|January 2010|2010-01-01|December 2020|Anticipated|2020-12-01|December 2010|Anticipated|2010-12-01||Observational|CSM||Anterior Vs Posterior Procedures for Cervical Spondylotic Myelopathy: Prospective Randomized Clinical Trial|A Comparison of Anterior and Posterior Procedures for the Surgical Management of Cervical Spondylotic Myelopathy: Prospective Randomized Clinical Trial|Recruiting||N/A|100|Anticipated|The University of Hong Kong|||4||f||||t||||||||||2017-02-18 13:12:10.905909|2017-02-18 13:12:10.905909
NCT00876590|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-06|2009-04-07|||April 2006||2006-04-01|April 2009|2009-04-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Observational|||Glucose Monitor Accuracy Investigation (Ⅱ)|Glucose Monitor Accuracy Investigation (Ⅱ)|Completed||N/A|319|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:12:11.020747|2017-02-18 13:12:11.020747
NCT00876577|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-09-07|||May 2009||2009-05-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|VICTOR||VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis|VICTOR - Avelox® i.v. in Acute Exacerbations of Chronic Bronchitis|Completed||N/A|1206|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a~   "|||2017-02-18 13:12:11.106854|2017-02-18 13:12:11.106854
NCT00876564|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-05-07|||February 2009||2009-02-01|May 2013|2013-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|RTSS||Rogaland Trauma System Study|Trauma System Evolution. A Quality Improvement Study of the Trauma System at Stavanger University Hospital, Norway.|Completed||N/A|1812|Actual|Norwegian Air Ambulance Foundation||1|||f||||f||||||||||2017-02-18 13:12:11.217981|2017-02-18 13:12:11.217981
NCT00876551|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-05-25|||January 2008||2008-01-01|April 2009|2009-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|EVACoIL||Endoscopic-vacuum Assisted Closure of Intrathoracic Postsurgical Leaks|Endoscopic - Vacuum Assisted Closure of Intrathoracic Postsurgical Leaks|Unknown status|Recruiting|N/A|30|Anticipated|Hannover Medical School||1|||f||||f||||||||||2017-02-18 13:12:11.313014|2017-02-18 13:12:11.313014
NCT00876538|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-11-21|||March 2009||2009-03-01|November 2016|2016-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|CIPN||Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy|A Double Blind, Placebo Controlled Study of the Effect of 330 mg QD of TRO19622 in the Treatment of Chemotherapy Induced Peripheral Neuropathy|Completed||Phase 2|17|Actual|Hoffmann-La Roche||2|||f||||f||||||||||2017-02-18 13:12:13.734344|2017-02-18 13:12:13.734344
NCT00876525|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-11-30|||March 2009||2009-03-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|December 2013|Actual|2013-12-01||Interventional|||Clinical Investigation of the Freedom SOLO Stentless Heart Valve|Clinical Investigation of the Freedom SOLO Stentless Heart Valve|Active, not recruiting||N/A|700|Anticipated|LivaNova||1|||f||||t||||||||||2017-02-18 13:12:13.84646|2017-02-18 13:12:13.84646
NCT00876512|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2014-09-08|||December 2008||2008-12-01|September 2014|2014-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|CALDERA-PCI||CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study|CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study|Completed||N/A|104|Actual|Kumamoto University|||1||f||||f||||||Samples With DNA|"~     CYP2C19 gene alteration is measured by using whole blood in patients with stable effort~     angina undergoing PCI.~   "|||2017-02-18 13:12:13.96153|2017-02-18 13:12:13.96153
NCT00876486|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-06-10|||December 2008||2008-12-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer|A Open-label, Randomized, Parallel, Phase III Trial to Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol®(Conventional Paclitaxel With Cremorphor EL) in Subjects With Recurrent or Metastatic Breast Cancer|Unknown status|Recruiting|Phase 3|212|Anticipated|Samyang Biopharmaceuticals Corporation||2|||f||||f||||||||||2017-02-18 13:12:14.15236|2017-02-18 13:12:14.15236
NCT00876473|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2015-04-27|||April 2009||2009-04-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Evaluation of Different Continuous Positive Airway Pressure (CPAP) Systems in Patients With Acute Respiratory Failure|The CPAP in Patients Affected by Acute Respiratory Failure|Completed||N/A|30|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-02-18 13:12:14.248133|2017-02-18 13:12:14.248133
NCT00876460|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-09-27|2014-11-14||March 2009||2009-03-01|September 2016|2016-09-01|July 2015|Actual|2015-07-01|September 2012|Actual|2012-09-01||Interventional||Treated set: all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment|BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I|A Phase I Study of Continuous, Concomitant Oral Treatment With BIBF 1120 and Docetaxel - a Phase I, Open-label, Dose-escalation Study in Japanese Patients With Stage IIIB/IV or Recurrent Non-small-cell Lung Cancer After Failure of Chemotherapy|Completed||Phase 1|43|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-02-18 13:12:14.377613|2017-02-18 13:12:14.377613
NCT00876447|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2014-06-12|2014-06-12||January 2009||2009-01-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional||BOTOX-Treated population includes all patients who enrolled in this study and who received at least one BOTOX treatment, regardless of which study they received it in (study 191622-094 or their preceding study 191622-515 or 191622-516). The treatment groups are based on the first BOTOX dose that patients received.|A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis||Completed||Phase 3|397|Actual|Allergan||2|||f||||f||||||||||2017-02-18 13:12:17.110957|2017-02-18 13:12:17.110957
NCT00876434|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2017-01-24|||April 1, 2009||2009-04-01|February 10, 2011|2011-02-10|February 10, 2011|Actual|2011-02-10|February 10, 2011|Actual|2011-02-10||Interventional|||Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti|Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveitis|Completed||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:12:23.387318|2017-02-18 13:12:23.387318
NCT00876421|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2012-06-12|||April 2009||2009-04-01|June 2012|2012-06-01||||April 2010|Actual|2010-04-01||Interventional|||Study of ONO-8539 in Patients With Overactive Bladder|A Randomised, Multi-Centre, Double-Blind, Placebo and Active-Controlled, 5-Way Parallel Group Study to Investigate the Efficacy, Safety and Tolerability of ONO-8539 in Patients With Overactive Bladder|Completed||Phase 2|435|Actual|Ono Pharmaceutical Co. Ltd||5|||f||||||||||||||2017-02-18 13:12:23.501405|2017-02-18 13:12:23.501405
NCT00876408|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-12-03|||May 2009||2009-05-01|December 2013|2013-12-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Observational|||Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer|Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer: Role in Clinical Management and Primary Site Prediction|Completed||N/A|30|Actual|SCRI Development Innovations, LLC|||1||f||||f||||||||||2017-02-18 13:12:23.707881|2017-02-18 13:12:23.707881
NCT00876395|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-11-15|||September 2009||2009-09-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|BOLERO-1||Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer|A Randomized Phase III, Double-Blind, Placebo-Controlled Multicenter Trial of Everolimus in Combination With Trastuzumab and Paclitaxel, as First Line Therapy in Women With HER2 Positive Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 3|719|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:12:23.800196|2017-02-18 13:12:23.800196
NCT00876382|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-11-12|||May 2009||2009-05-01|November 2013|2013-11-01|August 2011|Actual|2011-08-01|February 2011|Actual|2011-02-01||Observational|||Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma|Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma|Completed||N/A|47|Actual|SCRI Development Innovations, LLC|||1||f||||f||||||||||2017-02-18 13:12:26.409947|2017-02-18 13:12:26.409947
NCT00876369|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-12-17|||September 2009||2009-09-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema|Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema|Completed||N/A|50|Anticipated|University of Nebraska|||2||f||||f||||||||||2017-02-18 13:12:26.520986|2017-02-18 13:12:26.520986
NCT00876356|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-03|||May 2002||2002-05-01|April 2009|2009-04-01|September 2004|Actual|2004-09-01|May 2002|Actual|2002-05-01||Interventional|||The Health Benefits of Conjugated Linoleic Acid (CLA) for Asthma & Allergy|Conjugated Linoleic Acid (CLA) as Adjunctive Therapy in Mild Asthmatics: A Pilot Study.|Completed||N/A|40|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:12:26.626167|2017-02-18 13:12:26.626167
NCT00876343|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2013-12-20|2013-12-20||March 2009||2009-03-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder|Placebo-Controlled, Double-Blind, Parallel Group-Comparison Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder|Completed||Phase 3|586|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-02-18 13:12:26.742638|2017-02-18 13:12:26.742638
NCT00876330|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-09-19|||May 2009||2009-05-01|September 2012|2012-09-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|CERT2||Improving Antihypertensive and Lipid-Lowering Therapy|CERT-HIT: A Multimodal Intervention to Improve Antihypertensive and Lipid-lowering Therapy|Unknown status|Active, not recruiting|N/A|6000|Anticipated|VA Boston Healthcare System||2|||f||||f||||||||||2017-02-18 13:12:27.570256|2017-02-18 13:12:27.570256
NCT00876317|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2012-06-29|||November 2009||2009-11-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder|Efficacy and Safety of Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder|Terminated||Phase 3|45|Actual|Clinica Virgen Milagrosa||2||Change in current areas of research interest of the collaborator|f||||t||||||||||2017-02-18 13:12:27.671926|2017-02-18 13:12:27.671926
NCT00876304|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-03-17|||April 2009||2009-04-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia|Phase 1, Investigator And Subject-Blind, Placebo-Controlled, Randomized, Sequential Group, Multiple Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04802540 In Patients With Schizophrenia|Completed||Phase 1|39|Actual|Taisho Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 13:12:27.785684|2017-02-18 13:12:27.785684
NCT00876291|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2011-01-31|||December 2004||2004-12-01|April 2009|2009-04-01|August 2008|Actual|2008-08-01|December 2007|Actual|2007-12-01||Interventional|LGGDAR||Efficacy of Lactobacillus GG (LGG) in Children With Abdominal Pain|The Use of Lactobacillus gg in Functional Abdominal Pain in Children: a Double-blind Randomized Control Trial|Completed||N/A|140|Actual|University of Bari||2|||f||||t||||||||||2017-02-18 13:12:27.883839|2017-02-18 13:12:27.883839
NCT00876278|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-11-27|||June 2009||2009-06-01|November 2013|2013-11-01|February 2010|Anticipated|2010-02-01|October 2009|Anticipated|2009-10-01||Interventional|||Night Driving Pilot|Prospective Clinical Study to Evaluate Usability of Mesotest II for Assessment of Night Driving Capacity of Pseudophakic Patients Implanted With Monofocal IOL *AT.Smart 46LC|Withdrawn||Phase 4|0|Actual|Carl Zeiss Meditec AG||1||Due to internal reasons study was not performed.|f||||f||||||||||2017-02-18 13:12:27.978607|2017-02-18 13:12:27.978607
NCT00876265|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-04-19|2011-12-13||December 2006||2006-12-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|July 2007|Actual|2007-07-01||Interventional|||Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.|A Randomized, Blinded, Controlled, Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®, After Mid-to-Deep Dermal Implantation for Correction of Moderate to Severe Facial Wrinkles|Completed||Phase 3|118|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-02-18 13:12:28.079977|2017-02-18 13:12:28.079977
NCT00876252|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-10-18|||December 2008||2008-12-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients|A Phase 2 Pilot Study Assessing Immunogenicity and Safety of IC43 in Intensive Care Patients|Completed||Phase 2|400|Actual|Valneva Austria GmbH||4|||f||||t||||||||||2017-02-18 13:12:28.332972|2017-02-18 13:12:28.332972
NCT00876226|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2014-05-19|||May 2010||2010-05-01|May 2014|2014-05-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|||Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome|Study to Determine Steady-state Level of Citalopram Pharmacokinetic Parameters in Patients With Short Bowel Syndrome|Withdrawn||N/A|0|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 13:12:28.447074|2017-02-18 13:12:28.447074
NCT00876148|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-03||||||April 2009|2009-04-01||||||||Observational|||Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting|Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting|Completed||N/A|||Azienda Ospedaliera San Giovanni Battista|||1||f||||||||||||||2017-02-18 13:12:28.54855|2017-02-18 13:12:28.54855
NCT00876135|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-05-09|||December 2008||2008-12-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Role of Airway Hyperresponsiveness on Performance in Elite Swimmers.|Role of Airway Hyperresponsiveness on Performance in Elite Swimmers: Efficiency of a Bronchodilator to Prevent an Exercise-induced Bronchoconstriction|Completed||N/A|57|Actual|Laval University||1|||f||||t||||||||||2017-02-18 13:12:28.635174|2017-02-18 13:12:28.635174
NCT00876122|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2016-11-01|||March 2008||2008-03-01|November 2016|2016-11-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable|An Open-Label, Phase I, Dose-Escalation Study of PI3-Kinase Inhibitor (GDC-0941) in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable|Completed||Phase 1|60|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 13:12:28.747144|2017-02-18 13:12:28.747144
NCT00876109|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2016-11-01|||October 2007||2007-10-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|June 2012|Actual|2012-06-01||Interventional|||A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable|An Open-Label, Phase I, Dose-Escalation Study Evaluating Two Dosing Schedules of PI3-Kinase Inhibitor (GDC-0941) in Patients With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable|Completed||Phase 1|108|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 13:12:28.858325|2017-02-18 13:12:28.858325
NCT00876096|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-03|||February 2007||2007-02-01|April 2009|2009-04-01|March 2010|Anticipated|2010-03-01|July 2009|Anticipated|2009-07-01||Interventional|||Interest of Real-Time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections|Development and Validation of Fungal Extraction and Real -Time PCR Assay for the Diagnosis of Medically Important Fungal Infections in Blood Samples.|Unknown status|Enrolling by invitation|N/A|480|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:12:28.969398|2017-02-18 13:12:28.969398
NCT00876083|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2011-02-25|||March 2008||2008-03-01|February 2011|2011-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|IMAGE||PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination|Post-marketing Surveillance Study Ultravist®-IMAGE IoproMide (UltrAvist®) to Gain Further Information on Tolerability and Safety in X-ray Examination|Completed||N/A|44920|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:12:29.081833|2017-02-18 13:12:29.081833
NCT00876070|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2011-11-18|||November 2008||2008-11-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|November 2009|Actual|2009-11-01||Observational|||Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer|Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer|Completed||N/A|198|Actual|SCRI Development Innovations, LLC|||1||f||||f||||||||||2017-02-18 13:12:29.212167|2017-02-18 13:12:29.212167
NCT00876057|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-06-08|||March 1998||1998-03-01|June 2012|2012-06-01|April 2005|Actual|2005-04-01|April 2004|Actual|2004-04-01||Interventional|||Psychological Well-being, Recovery and Sexuality After Total and Subtotal Hysterectomy|Subtotal Versus Total Abdominal Hysterectomy- a Prospective Randomised Comparison of Medical , Psychological and Sexual Effects.|Completed||Phase 4|200|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-02-18 13:12:29.498789|2017-02-18 13:12:29.498789
NCT00876044|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-05-04|||April 2009||2009-04-01|May 2016|2016-05-01|November 2010|Actual|2010-11-01|February 2010|Actual|2010-02-01||Interventional|QUTIE||A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients|A Randomized, Double-Blind, Placebo-controlled Study Comparing Aflibercept Versus Placebo on the QTc Interval in Cancer Patients Treated With Docetaxel|Completed||Phase 1|88|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:12:29.611015|2017-02-18 13:12:29.611015
NCT00876031|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-05-13|||July 2009||2009-07-01|May 2016|2016-05-01|July 2024|Anticipated|2024-07-01|July 2019|Anticipated|2019-07-01||Interventional|CWS-2007-HR||Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma|A Randomised Phase-III Trial of the Cooperative Weichteilsarkom Study Group (CWS) for Localised High-risk Rhabdomyosarcoma and Localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in Children, Adolescents, and Young Adults|Recruiting||Phase 3|320|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-02-18 13:12:29.723916|2017-02-18 13:12:29.723916
NCT00876018|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2012-07-25|||July 2008||2008-07-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Nutrition, Physical Performance & Fitness in Indian School Children|A Double Blind Randomized Controlled Trial in School Going Children, to Evaluate the Impact of a Multiple Micronutrient Fortified Nutritional Powder on Physical Performance Measures|Completed||Phase 4|300|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 13:12:29.952185|2017-02-18 13:12:29.952185
NCT00876005|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-10-12|||August 2006||2006-08-01|May 2016|2016-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|PORSSI||Supplemental Oxygen and the Risk of Surgical Site Infection|Perioperative Supplemental Oxygen and the Risk of Surgical Site Infection|Completed||Phase 4|1202|Anticipated|Santa Clara Valley Health & Hospital System||2|||f||||t||||||||||2017-02-18 13:12:30.055149|2017-02-18 13:12:30.055149
NCT00875992|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2013-01-22|||June 2009||2009-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Trial to Evaluate the Effectiveness of Angular Stable Locking System (ASLS) in Patients With Distal Tibial Fractures|A Randomized Controlled Trial to Evaluate the Effectiveness of Angular Stable Locking System (ASLS) in Patients With Distal Tibial Fractures Treated With Expert Tibial Nails (ETN)|Completed||N/A|141|Actual|AO Clinical Investigation and Documentation||2|||f||||f||||||||||2017-02-18 13:12:30.162957|2017-02-18 13:12:30.162957
NCT00875979|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2013-12-20|2013-02-22||May 2009||2009-05-01|December 2013|2013-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||Treated population: All patients who received at least 1 dose of study drug and had at least 1 follow-up tumor assessment.|A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab|A Phase Ib/II, Open-label Study of the Safety, Tolerability, and Efficacy of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab|Completed||Phase 1/Phase 2|67|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:12:30.282683|2017-02-18 13:12:30.282683
NCT00875966|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-03|||August 2004||2004-08-01|April 2009|2009-04-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Eon and Pfizer Inc. (ZITHROMAX) 200mg/5mL Azithromycin Suspension Following a 600mg Dose in Healthy Adult Volunteers Under Fed Conditions|Completed||Phase 1|42|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:12:30.838965|2017-02-18 13:12:30.838965
NCT00875953|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2010-12-13|||January 2009||2009-01-01|April 2009|2009-04-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Use of the Harmonic Scalpel in Neck Dissection|Harmonic Scalpel vs. Electrocautery in Modified Radical Neck Dissection: A Single Blinded Prospective Randomized Trial|Completed||N/A|34|Anticipated|University of Calgary||2|||f||||f||||||||||2017-02-18 13:12:30.91713|2017-02-18 13:12:30.91713
NCT00875940|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2009-04-03|||February 2008||2008-02-01|April 2009|2009-04-01||||January 2009|Actual|2009-01-01||Observational|||Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis|Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis Between Tc-99m Tetrofosmin SPECT Adn Echocardiography|Completed||N/A|||University of Cincinnati|||1||f||||t||||||||||2017-02-18 13:12:31.018658|2017-02-18 13:12:31.018658
NCT00875927|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-04-05|||May 2009||2009-05-01|April 2009|2009-04-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Interventional|BCHS||Effects of Breezy Candy on Halitosis|Breezy Candy Halitosis Study|Unknown status|Not yet recruiting|Phase 1/Phase 2|75|Anticipated|Breezy Industries Ltd.||5|||f||||f||||||||||2017-02-18 13:12:31.111028|2017-02-18 13:12:31.111028
NCT00875914|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2016-06-24|||April 2009||2009-04-01|June 2016|2016-06-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Interventional|MAGMA-AVNRT||Magnetically Navigated vs. Manually Guided Radiofrequency in Atrioventricular-node-reentry-tachycardia|Randomized Comparison Between Magnetically Navigated vs Manually Guided Radiofrequency in AV-node-reentry-tachycardia|Completed||Phase 4|300|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||f||||||||||2017-02-18 13:12:31.21808|2017-02-18 13:12:31.21808
NCT00875901|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2017-02-09|||September 2009||2009-09-01|February 2017|2017-02-01|April 2032|Anticipated|2032-04-01|June 2021|Anticipated|2021-06-01||Interventional|LU03||Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)|Hypofractionated, Image-Guided Radiation Therapy With Proton Therapy for Stage I Non-Small Cell Lung Cancer|Recruiting||N/A|23|Anticipated|University of Florida||2|||f||||t|f|f||||||Undecided||2017-02-18 13:12:31.327593|2017-02-18 13:12:31.327593
NCT00875888|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-08-23|||February 2004||2004-02-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|HICOSS||High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic Shock|High Cut-off Continuous Venovenous Hemodialysis (CVVHD) to Improve Hemodynamic Stability and Organ Function Scores in Patients Treated for Acute Renal Failure After Systemic Inflammatory Response Syndrome (SIRS)/Septic Shock|Terminated||N/A|80|Actual|Gambro Dialysatoren GmbH||2||"based on interim analysis statistical significance in primary endpoint cannot be achieved with~   planned sample size, no safety concerns"|f||||f||||||||||2017-02-18 13:12:31.46292|2017-02-18 13:12:31.46292
NCT00869934|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2013-06-28|||April 2008||2008-04-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Cognitive-Behavior Therapy for Insomnia|Cognitive-Behavior Therapy for Insomnia: Component Analysis and Treatment|Completed||Phase 4|186|Actual|Laval University||3|||f||||f||||||||||2017-02-18 13:14:12.710527|2017-02-18 13:14:12.710527
NCT00875875|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2015-06-08|||June 2009||2009-06-01|June 2015|2015-06-01|June 2009|Anticipated|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Rifaximin 600||Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea|Single Daily Dose Rifaximin vs. Standard Thrice Daily Dosing for the 3-Day Treatment of Travelers' Diarrhea|Withdrawn||Phase 4|0|Actual|The University of Texas Health Science Center, Houston||2||No study population in Mexico (H1N1). Study withdrawn from IRB consideration.|f||||f||||||||||2017-02-18 13:12:31.575687|2017-02-18 13:12:31.575687
NCT00875862|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-03|2011-04-21|||September 2008||2008-09-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks|Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks: A Randomized, Triple-Masked, Placebo-Controlled Study|Terminated||Phase 4|4|Actual|University of California, San Diego||2||procedure no longer being done|f||||f||||||||||2017-02-18 13:12:31.723316|2017-02-18 13:12:31.723316
NCT00875849|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2014-11-20|||March 2008||2008-03-01|August 2012|2012-08-01|December 2013|Actual|2013-12-01|February 2010|Actual|2010-02-01||Interventional|||Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer|Phase II Study Evaluating Radiotherapy-chemotherapy and Cetuximab in Patients With Histologically Proven Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx, or Larynx and With a Poor Prognosis After Complete Surgical Resection|Completed||Phase 2|53|Actual|Centre Antoine Lacassagne||1|||f||||t||||||||||2017-02-18 13:12:31.988621|2017-02-18 13:12:31.988621
NCT00875836|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-07-08|2015-09-21||September 2009||2009-09-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|June 2014|Actual|2014-06-01||Interventional|||Buspirone Treatment for Marijuana Dependence|Buspirone Treatment for Marijuana Dependence|Completed||Phase 4|175|Actual|Medical University of South Carolina|Limitations included significant attrition during the course of the 12-week trial, difficulty with UCT interpretation due to the long excretion half-life of marijuana in urine, and likelihood that the genetic analysis was underpowered.|2|||f||||t||||||||||2017-02-18 13:12:32.101902|2017-02-18 13:12:32.101902
NCT00875823|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-04-06|||September 2003||2003-09-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||International Registry for Primary Hyperoxaluria|International Registry for Hereditary Calcium Stone Diseases|Withdrawn||N/A|0|Actual|Mayo Clinic|||1|Study was combined with Mayo protocol 07-003476|f||||t||||||||||2017-02-18 13:12:32.507629|2017-02-18 13:12:32.507629
NCT00875810|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2016-01-26|2014-12-19||April 2008||2008-04-01|January 2016|2016-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||PRESTIGE Observational Study|PRESTIGE Observational Study|Completed||N/A|194|Actual|Medtronic Spinal and Biologics|Low patient compliance at the 6 and 12 months follow up visits||1||f||||f||||||||||2017-02-18 13:12:32.621844|2017-02-18 13:12:32.621844
NCT00875797|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2013-12-01|2013-06-27||October 2004||2004-10-01|December 2013|2013-12-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional||mixed surgical ICU population|Enteral Versus Parenteral Glutamine Supplement|Comparison of Effect of Enteral Versus Parenteral Glutamine Supplement on Intestinal Permeability and Outcome of Critically Ill Patients|Terminated||Phase 4|90|Actual|University Medical Centre Ljubljana|Termination due to small sample size for nutritional pilot study.|2||Termination due to interim analysis results, inclusion problems in small ICUs.|f||||t||||||||||2017-02-18 13:12:32.958105|2017-02-18 13:12:32.958105
NCT00875784|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-11-03|||May 2008||2008-05-01|November 2016|2016-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)|An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate) Injection 4mg Administered Using the IMITREX STATdose System® and a TREXIMA Tablet Followed by IMI|Completed||Phase 1|30|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:12:33.390075|2017-02-18 13:12:33.390075
NCT00875771|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-02-19|||April 2009||2009-04-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|AVAXIRI||Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients|Phase II Study of Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients|Completed||Phase 2|80|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1|||f||||f||||||||||2017-02-18 13:12:33.50962|2017-02-18 13:12:33.50962
NCT00875758|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-12-07|||May 2009||2009-05-01|December 2015|2015-12-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|LETAP||Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants|Phase II Study of Late- Versus Early Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants.|Active, not recruiting||Phase 2|50|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 13:12:33.630561|2017-02-18 13:12:33.630561
NCT00875745|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2014-09-17|||April 2009||2009-04-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|May 2010|Actual|2010-05-01||Interventional|||Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)|Phase I, Open-label, Dose-escalation Study of the Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)|Completed||Phase 1|15|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 13:12:33.762026|2017-02-18 13:12:33.762026
NCT00875732|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2010-06-24|||September 2009||2009-09-01|March 2009|2009-03-01||||||||Interventional|CHOICE||Choosing the Right Pacing Mode in Heart Failure - The CHOICE Trial|CHOosing the rIght paCing Mode in Heart failurE : Should Heart Failure Patients With Bradycardia Receive Biventricular Pacemakers Rather Than Conventional Pacemakers?|Unknown status|Recruiting|N/A|40|Anticipated|University of Dundee||2|||f||||f||||||||||2017-02-18 13:12:33.88496|2017-02-18 13:12:33.88496
NCT00875719|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2011-02-15|||February 2009||2009-02-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Oxygen Portable Concentrator During Exercises in Patients With COPD|Comparing Effectiveness of Oxygen Supplementation From a Portable Concentrator and a Liquid Oxygen Source During Walking Test in COPD Patients With Respiratory Failure|Completed||N/A|19|Actual|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche||1|||f||||t||||||||||2017-02-18 13:12:33.982542|2017-02-18 13:12:33.982542
NCT00875693|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2011-01-03|||June 2009||2009-06-01|January 2011|2011-01-01||||March 2011|Anticipated|2011-03-01||Interventional|||A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)|A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT)for Primary Refractory and Relapsed Acute Myelogenous Leukemia|Unknown status|Recruiting|Phase 1|30|Anticipated|Weill Medical College of Cornell University||6|||f||||||||||||||2017-02-18 13:12:34.720382|2017-02-18 13:12:34.720382
NCT00875680|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2012-02-09|||May 2009||2009-05-01|February 2012|2012-02-01|June 2014|Anticipated|2014-06-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy of autoPPC for the Treatment of Obstructive Sleep Apnea Syndrome (OSAS)|Evaluation of the Efficacy of Autoadjusted Positive Pressure Devices for the Treatment of Obstructive Sleep Apnea Syndrome|Unknown status|Recruiting|N/A|20|Anticipated|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche||1|||f||||f||||||||||2017-02-18 13:12:34.817084|2017-02-18 13:12:34.817084
NCT00875667|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2017-01-30|||April 2009||2009-04-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|Sprint||A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)|A Phase 2, Multicenter, Randomized Open-Label Study To Determine the Efficacy of Lenalidomide (Revlimid®) Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma|Active, not recruiting||Phase 2|254|Actual|Celgene||2|||f||||t||||||||||2017-02-18 13:12:34.907005|2017-02-18 13:12:34.907005
NCT00875654|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-02-12|||August 2010||2010-08-01|February 2015|2015-02-01|July 2016|Anticipated|2016-07-01|July 2014|Actual|2014-07-01||Interventional|ISIS||Intravenous Stem Cells After Ischemic Stroke|Cell Therapy by Intravenous Injection of Mesenchymal Stem Cells After Stroke|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|University Hospital, Grenoble||3|||f||||t||||||||||2017-02-18 13:12:35.111438|2017-02-18 13:12:35.111438
NCT00875641|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2017-02-07|||April 2009||2009-04-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States|Safety Study of GSK Biologicals' Rotarix® (Rotavirus Vaccine, Live, Oral) Administered to a Birth Cohort in United States Health Insurance Plans|Completed||N/A|127120|Actual|GlaxoSmithKline|||3||f||||||||||||||2017-02-18 13:12:35.222953|2017-02-18 13:12:35.222953
NCT00875628|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-10-21|||April 2009||2009-04-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers|A Phase 1, Randomized, Double Blind (Sponsor-Open), Placebo Controlled, Dose Escalation, Multiple Dose Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers|Terminated||Phase 1|24|Actual|Pfizer||3||See Detailed Description|f||||f||||||||||2017-02-18 13:12:35.521124|2017-02-18 13:12:35.521124
NCT00875615|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-12-14|2013-07-18||December 2008||2008-12-01|December 2016|2016-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery|Phase II Trial of Intrahepatic Artery Chemotherapy With Nexavar in Hepatocellular Carcinoma Patients|Completed||Phase 2|11|Actual|University of Miami||1|||f||||||||||||||2017-02-18 13:12:35.625366|2017-02-18 13:12:35.625366
NCT00875602|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-12-05|||April 2009||2009-04-01|October 2012|2012-10-01||||||||Interventional|||Evaluation of EverOn™ - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion|Evaluation of EverOn™ - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion|Withdrawn||N/A|0|Actual|EarlySense Ltd.||2||NO need|f||||f||||||||||2017-02-18 13:12:35.87827|2017-02-18 13:12:35.87827
NCT00875589|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-10-15|2015-09-10||April 2011||2011-04-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|||Eye Movement Recordings in the Diagnosis of Traumatic Brain Injury|Eye-movement Recordings in the Diagnosis of Traumatic Brain Injury|Completed||Phase 1|26|Actual|VA Office of Research and Development|||2||f||||f||||||||||2017-02-18 13:12:35.973976|2017-02-18 13:12:35.973976
NCT00875576|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2010-06-25|||January 2009||2009-01-01|April 2009|2009-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Influence of Parents and Friends on Children and Adolescents|Influence of Parents and Friends on Children and Adolescents|Completed||N/A|40|Anticipated|University at Buffalo|||1||f||||f||||||||||2017-02-18 13:12:36.279565|2017-02-18 13:12:36.279565
NCT00875563|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-11-20|2015-06-30||January 2005||2005-01-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|February 2011|Actual|2011-02-01||Interventional|||Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study|Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft|Completed||N/A|42|Actual|Cook||1|||t||||||||||||||2017-02-18 13:12:36.357247|2017-02-18 13:12:36.357247
NCT00875550|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-07-23|2014-05-30||January 2010||2010-01-01|July 2015|2015-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study Evaluating Safety and Efficacy of Dexmedetomidine (DEX) in Intubated and Mechanically Ventilated Pediatric Intensive Care Unit (PICU) Subjects|A Phase III Randomized, Double-blind, Dose-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Dexmedetomidine in Intubated and Mechanically Ventilated Pediatric Intensive Care Unit Subjects|Completed||Phase 3|175|Actual|Hospira, Inc.||2|||f||||t||||||||||2017-02-18 13:12:36.594452|2017-02-18 13:12:36.594452
NCT00875537|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2011-02-22|||January 2009||2009-01-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|BMS17||Neurogenic Mechanisms in Burning Mouth Syndrome|Neurogenic Mechanisms in Burning Mouth Syndrome With Focus on Localization and Desensibilization of Vanilloid Receptor TRPV1|Completed||Early Phase 1|26|Anticipated|University of Copenhagen||2|||f||||t||||||||||2017-02-18 13:12:37.502714|2017-02-18 13:12:37.502714
NCT00875524|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-01-09|||March 2009||2009-03-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects|Immunogenicity and Safety of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects Aged 2 to 45 Years in Viet Nam|Completed||Phase 2|180|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:12:37.60598|2017-02-18 13:12:37.60598
NCT00875511|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2010-06-25|||November 2008||2008-11-01|April 2009|2009-04-01|September 2009|Actual|2009-09-01|||||Observational|||Effects of a Computer Game on Activity Choices||Completed||N/A|40|Anticipated|University at Buffalo|||1||f||||f||||||||||2017-02-18 13:12:37.711371|2017-02-18 13:12:37.711371
NCT00875498|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-01-26|||November 2008||2008-11-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia|Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia|Completed||N/A|22|Actual|Hôpital le Vinatier||2|||f||||t||||||||||2017-02-18 13:12:37.794492|2017-02-18 13:12:37.794492
NCT00875485|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-10-04|2010-05-27||May 2009||2009-05-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™|An Open Multicentre, Multicountry Study to Evaluate Long-term Antibody Persistence and Immune Memory Between Years 11 and 15 After the Primary Study HAB-084 in Which Healthy Adolescents Were Vaccinated With Twinrix™ Adult Following a Two-dose Schedule or Twinrix™ Junior Following a Three-dose Schedule.|Completed||Phase 4|210|Actual|GlaxoSmithKline|A decrease in the specificity of the anti-HB ELISA assay had been observed in some studies for low levels of antibody (10-100 mIU/mL).The table shows updated results following complete retesting and reanalysis.|2|||f||||||||||||||2017-02-18 13:12:37.913763|2017-02-18 13:12:37.913763
NCT00875472|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-04-02|||June 2008||2008-06-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Social Influences on Adolescents' Snack Purchases|Social Influences on Adolescents' Snack Purchases|Completed||N/A|||University at Buffalo|||1||f||||f||||||||||2017-02-18 13:12:38.939724|2017-02-18 13:12:38.939724
NCT00875459|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-07-28||2015-07-28|April 2007||2007-04-01|July 2015|2015-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 1 Diabetes Mellitus||Completed||Phase 3|233|Actual|Biodel||1|||f||||f||||||||||2017-02-18 13:12:39.018307|2017-02-18 13:12:39.018307
NCT00875446|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2011-11-10|||May 2009||2009-05-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis|A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in Patients With ALS.|Completed||Phase 1|76|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:12:39.104043|2017-02-18 13:12:39.104043
NCT00875433|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2013-12-05|2013-08-08||March 2009||2009-03-01|October 2013|2013-10-01||||April 2011|Actual|2011-04-01||Interventional|||Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours|Phase II Open Label Trial to Assess the Efficacy and the Impact on QTcF of Continuous Oral BIBW 2992 at a Daily Dose of 50mg in Patients With Relapsed or Refractory Solid Tumours Including Patients With Brain Metastases and Those With Glioblastoma Not Amenable to Other Therapy|Completed||Phase 2|60|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-02-18 13:12:39.224526|2017-02-18 13:12:39.224526
NCT00875420|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2012-02-22|2011-02-16||March 2009||2009-03-01|October 2011|2011-10-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women|A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2, Multi-Center, Dose-Finding Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 2|100|Actual|Radius Health, Inc.||5|||f||||f||||||||||2017-02-18 13:12:39.952482|2017-02-18 13:12:39.952482
NCT00875407|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2014-02-24|||February 2009||2009-02-01|February 2014|2014-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot||Completed||N/A|10|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 13:12:41.075644|2017-02-18 13:12:41.075644
NCT00875394|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-08-26|2009-06-12||February 2007||2007-02-01|August 2015|2015-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)|A Multicenter, Randomized, Open-label Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With T2 DM With Inadequate Glycemic Control on Metformin|Completed||N/A|68|Actual|Merck Sharp & Dohme Corp.|"A limited number of participants were recruited into this open-label study. This study was conducted at a single site.~Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data."|3|||f||||f||||||||||2017-02-18 13:12:41.16153|2017-02-18 13:12:41.16153
NCT00875381|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2011-03-14|||September 2007||2007-09-01|March 2011|2011-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin|Immunohistochemical Analysis of Melanocytes in Sun-Exposed Skin|Completed||N/A|100|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"~     The proposed dog-ears excised, that were to be discarded during reconstruction, were~     evaluated for the presence of any visible lesions (i.e. ephelid, lentigo, seborrheic~     keratosis, nevi). Dog-ears with any skin lesions were excluded. The specimens were inked by~     the surgeon on the side to be cut by the histotechnician. The specimens were placed in~     formalin bottles and submitted to the pathology department at Mayo Clinic Rochester for~     processing. The tissue was cut (4 microns) along its long access and stained with routine H&~     E and Mart-1 (MelanA) immunostains.~   "|||2017-02-18 13:12:41.589213|2017-02-18 13:12:41.589213
NCT00875368|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2013-09-06|||February 2009||2009-02-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|December 2011|Actual|2011-12-01||Interventional|MIRS||Maraviroc Immune Recovery Study|Maraviroc Immune Recovery Study, A Multicenter, Randomized, Placebo-controlled, Exploratory Mechanistic Study Into the Role of Maraviroc on Immune Recovery|Completed||Phase 4|85|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 13:12:41.667513|2017-02-18 13:12:41.667513
NCT00875355|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-08-25|||November 2007||2007-11-01|July 2009|2009-07-01||||November 2009|Anticipated|2009-11-01||Interventional|||Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer|Phase II Randomized Multicenter Study Comparing Brain Radiation in Combination With Temozolomide or Radiation Alone in Patients With Brain Metastases From Breast Cancer|Unknown status|Recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:12:41.77506|2017-02-18 13:12:41.77506
NCT00875342|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-11-03|||May 2008||2008-05-01|November 2016|2016-11-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)|D-cycloserine Enhanced Imaginal ExposureTherapy for Posttraumatic Stress Disorder (PTSD)|Recruiting||N/A|124|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 13:12:41.869812|2017-02-18 13:12:41.869812
NCT00875329|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-06-04|2014-06-10||September 2010||2010-09-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|June 2012|Actual|2012-06-01||Observational|||Traumatic Brain Injury (TBI) Screening Instruments|TBI Screening Instruments and Processes for Clinical Follow-Up|Completed||N/A|97|Actual|VA Office of Research and Development|||1||f||||f||||||None Retained|"~     As there are no biospecimans, there is no biospeciman description.~   "|||2017-02-18 13:12:41.994521|2017-02-18 13:12:41.994521
NCT00875316|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-08-20|||April 2009||2009-04-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Tolerability Study of Cogane™ in Healthy Volunteers and Parkinson's Disease Patients|A Randomised, Double-blind, Multiple Dose-ascending, Placebo-controlled Study in Healthy Volunteers and Parkinson's Disease Patients to Assess the Safety, Tolerability and PK of Daily Oral Administration of Cogane™ Over One Month|Completed||Phase 1|36|Anticipated|Phytopharm||4|||f||||f||||||||||2017-02-18 13:12:42.176142|2017-02-18 13:12:42.176142
NCT00875303|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-10-27|||June 2008||2008-06-01|October 2011|2011-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Brief Primary Care Intervention Helps Parents With Discipline|Brief Primary Care Intervention Helps Parents With Discipline|Completed||N/A|258|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:12:42.272394|2017-02-18 13:12:42.272394
NCT00875290|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2011-08-04|||November 2008||2008-11-01|August 2011|2011-08-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|Gerber RTSA||The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children|Gerber Pump Trial: Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Real-Time Sensor Augmentation (RTSA) in 0-3 Years Old Diabetes Patients; A One Year Randomized Controlled Clinical Trial.|Unknown status|Recruiting|Phase 3|40|Anticipated|Seattle Children's Hospital||2|||f||||f||||||||||2017-02-18 13:12:42.366201|2017-02-18 13:12:42.366201
NCT00875277|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2013-10-24|||April 2009||2009-04-01|October 2013|2013-10-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products|A Psoriasis Plaque Test Comparing LEO 29102 Cream and Its Different Combinations to Daivobet® Ointment and a Vehicle Control for the Treatment of Psoriasis Vulgaris|Completed||Phase 2|24|Actual|LEO Pharma||1|||f||||f||||||||||2017-02-18 13:12:42.46195|2017-02-18 13:12:42.46195
NCT00875264|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2012-07-24|||September 2007||2007-09-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer|An Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer|Completed||Phase 1|43|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 13:12:42.600655|2017-02-18 13:12:42.600655
NCT00875251|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-07-21|||April 2009||2009-04-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|Crescer||Growth and Body Composition in Preterm Infants|Growth and Body Composition of Very Low Birth Weight Infants Compared With Infants Birth at Term|Recruiting||N/A|60|Anticipated|Oswaldo Cruz Foundation|||2||f||||t||||||||||2017-02-18 13:12:42.919185|2017-02-18 13:12:42.919185
NCT00875238|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2014-12-01|||June 2008||2008-06-01|December 2014|2014-12-01||||January 2015|Anticipated|2015-01-01||Observational|PACE in BC||Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab|Predicting Adverse Cardiac Events in Breast Cancer Therapy (PACE in Breast Cancer)|Unknown status|Recruiting|N/A|200|Anticipated|Vanderbilt University|||1||f||||t||||||Samples With DNA|"~     Serum, Plasma, Mononuclear Cells~   "|||2017-02-18 13:12:43.037337|2017-02-18 13:12:43.037337
NCT00875225|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-04-02|||December 2006||2006-12-01|April 2009|2009-04-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|CSI Birmingham||Using Multimedia Technology for Hypertension Control for Low-Income African Americans|Culturally Sensitive Intervention: CSI Birmingham|Unknown status|Active, not recruiting|N/A|300|Actual|Cooper Green Mercy Hospital||2|||f||||t||||||||||2017-02-18 13:12:43.141825|2017-02-18 13:12:43.141825
NCT00875212|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-10-13|2009-04-02||January 2006||2006-01-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|CAGP-F||Effect of Calcium Glycerophosphate (CaGP) - Fluoride Dentifrice on Dental Biofilm pH|Effect of a Dentifrice Containing Calcium Glycerophosphate and Fluoride on the pH of Dental Biofilm in Vivo|Completed||Phase 1|12|Actual|Federal University of Paraíba|pH measurements of dental biofilms were difficult after continuous use of dentifrice because of reduced biofilm mass in contrast to baseline measurements.|1|||f||||f||||||||||2017-02-18 13:12:43.237294|2017-02-18 13:12:43.237294
NCT00875199|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2011-11-17|||March 2009||2009-03-01|November 2011|2011-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Contingency Management to Promote Weight Loss in Low Income Adults|Contingency Management to Promote Weight Loss in Low Income Adults|Completed||Phase 2|30|Actual|UConn Health||2|||f||||f||||||||||2017-02-18 13:12:43.549844|2017-02-18 13:12:43.549844
NCT00875186|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-04-02|||October 2006||2006-10-01|April 2009|2009-04-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|AET||The Influence of Aerobic Endurance Training After Roux-en-Y-Gastric Bypass|Impact of Aerobic Physical Exercising on Body Composition and co-Morbidities in Patients After Laparoscopic Roux-en-Y Gastric Bypass|Unknown status|Recruiting|N/A|60|Anticipated|Universitätsmedizin Mannheim|||2||f||||f||||||||||2017-02-18 13:12:43.660388|2017-02-18 13:12:43.660388
NCT00875173|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-11-09|||October 2008||2008-10-01|November 2015|2015-11-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Interventional|STCC||Selenium Treatment and Chagasic Cardiopathy (STCC)|Selenium Treatment and Chagasic Cardiopathy (STCC): A Prospective Randomized Trial in Patients With Chagas Disease|Recruiting||Phase 3|130|Anticipated|Oswaldo Cruz Foundation||2|||f||||t||||||||||2017-02-18 13:12:43.772609|2017-02-18 13:12:43.772609
NCT00875160|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2010-08-17||2010-08-17|April 2009||2009-04-01|August 2010|2010-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101|An Open-Label Study to Assess the Pharmacokinetics, Safety, and Pharmacodynamics of Repeated Doses of Orally Administered AT2101 in Adult Patients With Type 1 Gaucher Disease|Terminated||Phase 1|1|Actual|Amicus Therapeutics||1||Subject Recruitment|f||||f||||||||||2017-02-18 13:12:46.130555|2017-02-18 13:12:46.130555
NCT00875004|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-12-13|||December 2007||2007-12-01|July 2009|2009-07-01||||November 2009|Anticipated|2009-11-01||Interventional|||Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors|Research Factors Predictive of Treatment Failure With Erythropoietin Beta (NeoRecormon®) in Patients With Solid Tumors Treated With Chemotherapy|Unknown status|Recruiting|N/A|300|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:12:46.258503|2017-02-18 13:12:46.258503
NCT00874991|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-07-07|||June 2008||2008-06-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Cardiac Deformation: Correlation With Conventional Echocardiographic Hemodynamic Variables (An Intraoperative Study)|Cardiac Deformation: Correlation With Conventional Echocardiographic Hemodynamic Variables. An Intraoperative Study.|Completed||N/A|198|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No|There is no plan to share IPD|2017-02-18 13:12:46.349841|2017-02-18 13:12:46.349841
NCT00874978|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-09-01|||January 2005||2005-01-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality|The Efficacy and Safety of Lenalidomide (Revlimid®) Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome Associated With Del (5q) Cytogenetic Abnormality|Active, not recruiting||Phase 2|36|Anticipated|King's College Hospital NHS Trust||1|||f||||f||||||||||2017-02-18 13:12:46.440189|2017-02-18 13:12:46.440189
NCT00874965|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2012-10-09|||December 2006||2006-12-01|October 2012|2012-10-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|ESTIM||Electrostimulation, Skeletal Muscle Function, and Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD)|Study of the Benefits of Lower Limb Electrostimulation Training on Muscular Parameters and Minute Ventilation During Exercise in Severe and Deconditioned COPD Patients.|Completed||N/A|23|Actual|Laval University||2|||f||||f||||||||||2017-02-18 13:12:46.550418|2017-02-18 13:12:46.550418
NCT00874952|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2010-02-16|||March 2009||2009-03-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|ORSA||Regional Observation of the Metabolic Syndrome|Regional Observation of the Metabolic Syndrome|Completed||N/A|1600|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:12:46.661353|2017-02-18 13:12:46.661353
NCT00874939|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-05-26|2015-05-26||April 2009||2009-04-01|May 2015|2015-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)|A Randomized Clinical Trial To Evaluate the Single Dose Acute Effects of MK-0249 and Donepezil On Cognitive Function In Adult Patients With Alzheimer's Disease|Terminated||Phase 1|4|Actual|Merck Sharp & Dohme Corp.||12|||f||||f||||||||||2017-02-18 13:12:46.740449|2017-02-18 13:12:46.740449
NCT00874926|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2014-01-28|||June 2008||2008-06-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Observational|||EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS|Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS|Completed||N/A|405|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:12:47.021543|2017-02-18 13:12:47.021543
NCT00874913|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2012-10-08|||September 2006||2006-09-01|October 2012|2012-10-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Study of Ocular Blood Flow in Patients With Glaucoma and/or Obstructive Sleep Apnea Syndrome (OSAS)|Study of Ocular Blood Flow Using Laser Doppler Flowmetry in Patients With Glaucoma and/or OSAS|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-02-18 13:12:47.332177|2017-02-18 13:12:47.332177
NCT00874900|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-07-07|||December 2008||2008-12-01|July 2011|2011-07-01|May 2013|Anticipated|2013-05-01|January 2013|Anticipated|2013-01-01||Interventional|ALP||Asthma Learning Project|Asthma Learning Project: Randomized Trial of a Computerized Asthma Game in a Pediatric Emergency Department|Unknown status|Recruiting|N/A|120|Anticipated|Seattle Children's Hospital||4|||f||||f||||||||||2017-02-18 13:12:47.446632|2017-02-18 13:12:47.446632
NCT00874887|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-11-16|2011-11-16||March 2009||2009-03-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms||Completed||Phase 4|66|Actual|Allergan|Only a small number of resistant species were obtained at the study endpoints. Therefore, some outcome measures were not able to be analyzed.|2|||f||||||||||||||2017-02-18 13:12:47.556942|2017-02-18 13:12:47.556942
NCT00874874|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2009-12-23|||May 2008||2008-05-01|July 2009|2009-07-01||||May 2011|Anticipated|2011-05-01||Interventional|||Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery|Phase II Multicenter Stratified Study Evaluating the Efficacy and Toxicity of Sorafenib in Treating Locally Advanced or Metastatic Angiosarcomas That Are Not Accessible to Curative Surgery|Unknown status|Recruiting|Phase 2|96|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:12:47.932381|2017-02-18 13:12:47.932381
NCT00874861|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-12-04|||April 2009||2009-04-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|May 2012|Actual|2012-05-01||Interventional|||HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas|A Pilot Study to Evaluate the Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With Recurrent WHO Grade II Gliomas|Completed||Early Phase 1|10|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:12:48.024283|2017-02-18 13:12:48.024283
NCT00874848|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2016-10-06|2016-07-15||August 2009||2009-08-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|November 2012|Actual|2012-11-01||Interventional||The safety population comprised all randomized participants who received any amount of Imprime PGG, cetuximab, paclitaxel or carboplatin.|Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer|Efficacy and Safety Study of Imprime PGG® Injection in Combination With Cetuximab and Concomitant Paclitaxel and Carboplatin Therapy in Patients With Previously Untreated Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer|Completed||Phase 2|90|Actual|Biothera||2|||f||||t||||||||No||2017-02-18 13:12:48.139631|2017-02-18 13:12:48.139631
NCT00874835|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2010-05-06|||March 2009||2009-03-01|May 2010|2010-05-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|||Corneal Endothelium Delivery Instrument|Endothelial Graft Injector Versus Folding Forceps Insertion During Descemet's Stripping Endothelial Keratoplasty (DSEK)|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Ocular Systems, Inc.||1|||f||||t||||||||||2017-02-18 13:12:49.112834|2017-02-18 13:12:49.112834
NCT00874822|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-01-18|2011-10-27||September 2008||2008-09-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Prevalence of Sleep Apnea in Patients Presenting for Hip or Knee Replacement Surgery|Prevalence of Sleep Apnea in Patients Presenting for Hip or Knee Replacement Surgery|Completed||N/A|216|Actual|University of Nebraska|Obstructive sleep apnea was diagnosed in only four patients due to a high rate of failure to undergo PSG by patients for whom it was indicated. A second major weakness is the use of a literature control group.||1||f||||f||||||||||2017-02-18 13:12:49.225003|2017-02-18 13:12:49.225003
NCT00874809|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-08-23|||March 2009||2009-03-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study|A Pilot Study to Explore Basal Insulin Dosing Requirements in Patients With Type 2 Diabetes Treated With Insulin Pump Therapy|Completed||N/A|30|Actual|Diabetes Care Center||1|||f||||f||||||||||2017-02-18 13:12:49.633509|2017-02-18 13:12:49.633509
NCT00874796|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2014-01-03||2014-01-03|May 2009||2009-05-01|January 2014|2014-01-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection|A Phase 2b, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of GS 9450 in Adults With Chronic Hepatitis C Virus Infection (GS-US-227-0106)|Terminated||Phase 2|307|Actual|Gilead Sciences||3||"Reports of significant laboratory abnormalities and adverse events in a number of clinical~   study participants."|f||||t||||||||||2017-02-18 13:12:49.744962|2017-02-18 13:12:49.744962
NCT00874783|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2016-09-01|||April 2009||2009-04-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases|Derivation of Induced Pluripotent Stem Cells From Somatic Cells Donated by Patients With Neurological Diseases for the Study of the Pathogenesis of the Disorders and Development of Novel Therapies|Recruiting||N/A|120|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"~     donation of a skin specimen of up to 10mm in diameter from skin which will be removed in a~     surgical operation from a patient who is scheduled to undergo an operation for medical~     reasons and with no relation to the study at hand.~   "|||2017-02-18 13:12:49.913111|2017-02-18 13:12:49.913111
NCT00874770|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-02|2015-09-23|2015-08-06||June 2009||2009-06-01|September 2015|2015-09-01|January 2011|Actual|2011-01-01|November 2009|Actual|2009-11-01||Interventional||The analysis was performed in the treated population defined as all participants who received at least 1 dose of study therapy.|Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)|A Phase 2a Study of BMS-790052 in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype 1|Completed||Phase 2|74|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 13:12:50.02286|2017-02-18 13:12:50.02286
NCT00874757|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-08-02|||July 2009||2009-07-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of Anti-inflammatory Effects|Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of|Unknown status|Recruiting|N/A|20|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-02-18 13:12:51.134731|2017-02-18 13:12:51.134731
NCT00874744|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-03-31|||March 2008||2008-03-01|March 2009|2009-03-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|Tribeva-DME||Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema|Phase 2 Study of Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema.|Completed||Phase 2|13|Actual|Universidade Federal de Goias||2|||f||||f||||||||||2017-02-18 13:12:51.215248|2017-02-18 13:12:51.215248
NCT00874731|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-02-18|||April 2009||2009-04-01|February 2015|2015-02-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Evaluate the Effect of MK-8669 (Ridaforolimus) on QTc Interval in Participants With Advanced Cancer (MK-8669-037 AM1)|A Clinical Trial to Assess the Effect of Deforolimus (AP23573; MK-8669) on QTc Interval in Patients (Protocol 037)|Completed||Phase 1|23|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:12:51.319496|2017-02-18 13:12:51.319496
NCT00874718|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-04-01|||October 2007||2007-10-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Interventional|||Impact in Life Quality of a Educational Program for Prevention of Occupational Musculoskeletal Disorders in Workers|Impact in Life Quality of a Educational Program for Prevention of Occupational Musculoskeletal Disorders in Workers.|Completed||N/A|64|Anticipated|Federal University of Rio Grande do Sul||2|||f||||t||||||||||2017-02-18 13:12:51.426019|2017-02-18 13:12:51.426019
NCT00874692|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2010-06-01|||April 2009||2009-04-01|June 2010|2010-06-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Health and Environmental Effects of Boiler Management Systems in Social Housing|Randomised Controlled Trial of Boiler Management Systems in Social Housing in Camden: An Assessment of Health, Environmental and Economic Outcomes|Completed||N/A|150|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-02-18 13:12:51.534198|2017-02-18 13:12:51.534198
NCT00874679|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-11-09|||March 2007||2007-03-01|November 2011|2011-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||REPEAT - Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra Therapy|REal-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra® Therapy|Completed||N/A|7293|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:12:51.637876|2017-02-18 13:12:51.637876
NCT00874666|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-11-18|||April 2009||2009-04-01|November 2009|2009-11-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|||Allicin Bioavailability From Garlic Supplements and Garlic Foods|Allicin Bioavailability of Garlic Products|Unknown status|Active, not recruiting|Early Phase 1|12|Anticipated|Silliker, Inc.||2|||f||||t||||||||||2017-02-18 13:12:51.751707|2017-02-18 13:12:51.751707
NCT00874653|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2014-06-20|||April 2008||2008-04-01|June 2014|2014-06-01|December 2008|Actual|2008-12-01|||||Observational|||Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding|Levonorgestrel Releasing Intrauterine System (MIRENA) in Idiopathic Menorrhagia|Completed||N/A|78|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:12:51.878408|2017-02-18 13:12:51.878408
NCT00874640|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-02-19|||March 2009||2009-03-01|February 2014|2014-02-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Observational|||Patient Characteristics in Daily Radiological Practice of Gadovist® Application (PATRON)|Patient Characteristics in Daily Radiological Practice of Gadovist® Application (PATRON)|Completed||N/A|3711|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:12:52.155796|2017-02-18 13:12:52.155796
NCT00874627|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2012-12-10|||September 2008||2008-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|Lactaide||Sublingual Milk Immunotherapy in Children|Sublingual Milk Immunotherapy in Children With IgE-mediated Cow Milk Protein Allergy|Completed||N/A|51|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:12:52.260403|2017-02-18 13:12:52.260403
NCT00874614|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2016-11-17|||June 2009||2009-06-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|January 2017|Anticipated|2017-01-01||Interventional|||A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma|A Phase II Study Evaluating the Efficacy and Safety of Ultratrace Iobenguane I 131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma|Active, not recruiting||Phase 2|75|Anticipated|Molecular Insight Pharmaceuticals, Inc.||1|||t||||t||||||||No||2017-02-18 13:12:52.383548|2017-02-18 13:12:52.383548
NCT00874601|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-10-04|||October 2008||2008-10-01|October 2011|2011-10-01|July 2012|Anticipated|2012-07-01|July 2011|Actual|2011-07-01||Interventional|VENTURE||Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke|Prospective, Randomized, Open-label, Blinded Endpoints, Multi-center Study to Evaluate the Efficacy of Modest Blood Pressure Reduction With Diovan® (Valsartan) in Acute Ischemic Stroke|Unknown status|Recruiting|Phase 4|578|Anticipated|Hallym University Medical Center||2|||f||||t||||||||||2017-02-18 13:12:52.510306|2017-02-18 13:12:52.510306
NCT00874588|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-08-13|||March 2009||2009-03-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer|Phase I Trial in Studying Peptide Vaccine Therapy Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer|Completed||Phase 1|6|Actual|Fukushima Medical University||1|||f||||t||||||||||2017-02-18 13:12:52.622017|2017-02-18 13:12:52.622017
NCT00874575|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-09-16|||November 2008||2008-11-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Nutritional Intervention for Age-related Muscular Function and Strength Losses|A Double Blind Study on the Efficacy of a Combination of Beta-hydroxy-beta-methylbutyrate and Vitamin D on Muscular Strength and Functionality in Older Adults.|Completed||Phase 1|76|Actual|Metabolic Technologies Inc.||4|||f||||t||||||||||2017-02-18 13:12:52.73695|2017-02-18 13:12:52.73695
NCT00874562|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2016-11-21|||July 2007||2007-07-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|November 2009|Actual|2009-11-01||Interventional|||Rapamycin in Relapsed Acute Lymphoblastic Leukemia|Rapamycin in Relapsed Acute Lymphoblastic Leukemia|Completed||Phase 1|6|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 13:12:52.85702|2017-02-18 13:12:52.85702
NCT00874549|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-09-12|2010-03-08||October 2007||2007-10-01|September 2013|2013-09-01|October 2008|Actual|2008-10-01|January 2008|Actual|2008-01-01||Interventional|||Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years|A Safety and Immunogenicity Evaluation of a Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) and a Meningococcal Polysaccharide Vaccine Groups A, C, Y, and W-135 Combined (Menomune® - A/C/Y/W-135) in Subjects 56 Years of Age or Older|Completed||Phase 1/Phase 2|216|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 13:12:52.987304|2017-02-18 13:12:52.987304
NCT00874536|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-07-29|||April 2009||2009-04-01|July 2013|2013-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Omega-3 Supplementation and Attention-deficit-hyperactivity Disorder (ADHD)|The Effect of Omega-3 Fatty Acid Supplementation on Behavior of Children With ADHD|Completed||N/A|40|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:12:54.373914|2017-02-18 13:12:54.373914
NCT00874523|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2012-04-10|||July 2009||2009-07-01|April 2010|2010-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|SPARTA||Raltegravir and Atazanavir Dosing Strategy Study|A Randomised, Open-label, Cross-over Study to Examine the Pharmacokinetics and Short-term Safety and Efficacy of Two Dosing Strategies of Raltegravir Plus Atazanavir in HIV-infected Patients|Completed||Phase 3|26|Actual|Kirby Institute||2|||f||||f||||||||||2017-02-18 13:12:54.463939|2017-02-18 13:12:54.463939
NCT00874510|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2016-01-22|2014-09-15||June 2009||2009-06-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|June 2011|Actual|2011-06-01||Interventional||Characteristics of control and intervention groups comprised of medicine interns participating in a randomized trial of a Year 1 5-hour and Year 2 3-hour protected nap period at the Philadelphia Veterans Administration Medical Center ( PVAMC) and the Hospital of the University of Pennsylvania|A Randomized Controlled Trial of Mandatory Naps for Physicians in Training|Interventions to Improve Fatigue Management Among Physician Trainees|Completed||Phase 3|352|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:12:54.588996|2017-02-18 13:12:54.588996
NCT00874497|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2016-06-24||2016-06-24|March 2009||2009-03-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|EMPHASIS||Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema|A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES|Terminated||Phase 2|84|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2||Sponsor Terminated|f||||||||||||||2017-02-18 13:12:54.962717|2017-02-18 13:12:54.962717
NCT00874484|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2011-10-17|||March 2009||2009-03-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Enoxaparin as Treatment for Vulvodynia|Enoxaparin as Treatment for Vulvar Vestibulitis Syndrome - Vulvodynia|Completed||Phase 2|40|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||f||||||||||2017-02-18 13:12:55.072414|2017-02-18 13:12:55.072414
NCT00874471|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2014-04-07|||June 2005||2005-06-01|April 2014|2014-04-01||||July 2010|Actual|2010-07-01||Observational|||Uveitis Gene-Expression Profiling||Completed||N/A|280|Actual|Oregon Health and Science University|||10||f||||f||||||||||2017-02-18 13:12:55.157242|2017-02-18 13:12:55.157242
NCT00874458|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2014-11-20|||April 2007||2007-04-01|July 2009|2009-07-01|December 2013|Actual|2013-12-01|May 2011|Actual|2011-05-01||Interventional|||MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ|Ductal Carcinoma in Situ: Protocol Evaluating the Assessment of Extension of Disease by MRI|Completed||N/A|40|Actual|Centre Antoine Lacassagne||1|||f||||f||||||||||2017-02-18 13:12:55.245186|2017-02-18 13:12:55.245186
NCT00874445|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-06-03|||March 2009||2009-03-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|PROMISE||Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configuration|Prospective Comparison of 50/50% Tilt and Tuned Defibrillation Waveforms in a Single Coil Active Can Configuration|Completed||N/A|77|Actual|St. Jude Medical|||2||f||||f||||||||||2017-02-18 13:12:55.348593|2017-02-18 13:12:55.348593
NCT00874432|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-10-06|||March 2009||2009-03-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|||||Interventional|||Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease|Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease|Completed||N/A|90|Anticipated|University of Wisconsin, Madison||4|||f||||t||||||||||2017-02-18 13:12:55.444377|2017-02-18 13:12:55.444377
NCT00874419|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2014-09-23|||August 2008||2008-08-01|September 2014|2014-09-01|July 2012|Actual|2012-07-01|July 2010|Actual|2010-07-01||Interventional|ML20981||Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation|A Randomized, Open-label, Multi-center Phase III Study of Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With EGFR Exon 19 or 21 Mutation (Optimal)|Completed||Phase 3|165|Actual|Tongji University||2|||f||||t||||||||||2017-02-18 13:12:55.571719|2017-02-18 13:12:55.571719
NCT00874406|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-04-01|||January 2008||2008-01-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer|Preoperative Transhepatic Arterial Chemotherapy in the Treatment of Liver Metastasis of Resectable Colorectal Cancer|Unknown status|Recruiting|Phase 4|100|Anticipated|Fudan University||2|||f||||t||||||||||2017-02-18 13:12:55.683103|2017-02-18 13:12:55.683103
NCT00874393|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2017-01-06|||July 2009||2009-07-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|ELGAN BP||Early Blood Pressure Management in Extremely Premature Infants|Early Blood Pressure Management in Extremely Preterm Infants Feasibility Pilot Study|Completed||Phase 1/Phase 2|10|Actual|NICHD Neonatal Research Network||4|||f||||t||||||||||2017-02-18 13:12:55.794135|2017-02-18 13:12:55.794135
NCT00874380|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-05-14|||October 2008||2008-10-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Fiber Intake in an End Stage Renal Disease (ESRD) Population Followed Over 2 Years|Fiber Content of Hemodialysis Patients' Diet and it's Cardiovascular Implications.|Completed||N/A|70|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 13:12:56.116211|2017-02-18 13:12:56.116211
NCT00874367|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-11-06|||February 2006||2006-02-01|October 2015|2015-10-01|May 2011|Actual|2011-05-01|December 2009|Actual|2009-12-01||Observational|EOS||Early-Onset Sepsis Surveillance Study|Early-Onset Sepsis: an NICHD/CDC Surveillance Study|Completed||N/A|615|Actual|NICHD Neonatal Research Network|||1||f||||t||||||Samples Without DNA|"~     Samples of the isolated pathogens~   "|||2017-02-18 13:12:56.211808|2017-02-18 13:12:56.211808
NCT00874354|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-02-01|||July 2005||2005-07-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|REVITALIZE||Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction|REVITALIZE: Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction|Completed||Phase 1|27|Actual|Cedars-Sinai Medical Center||1|||f||||t||||||||No||2017-02-18 13:12:56.353168|2017-02-18 13:12:56.353168
NCT00874341|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-05-07|||January 2009||2009-01-01|May 2015|2015-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|FIRST||Effect of Fruit and Vegetables on Insulin Resistance|Dose−Response Effect of Fruit and Vegetables on Insulin Resistance in Healthy People Who Are Overweight and at High Risk of Cardiovascular Disease|Completed||Phase 1|105|Actual|Queen's University, Belfast||3|||f||||f||||||||||2017-02-18 13:12:56.465197|2017-02-18 13:12:56.465197
NCT00874328|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2010-10-22|||October 2008||2008-10-01|July 2010|2010-07-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)|A Phase I/II Study of TS-1, Irinotecan and Cisplatin for Patients With Advanced or Metastatic NSLC|Unknown status|Recruiting|Phase 1/Phase 2|74|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-02-18 13:12:56.575829|2017-02-18 13:12:56.575829
NCT00874315|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-10-14|||September 2008||2008-09-01|October 2015|2015-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.|A Multicenter Pilot Study of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation With In-vivo T-cell Depletion to Evaluate the Role of NK Cells and KIR Mis-matches in Relapsed or Refractory High-risk Neuroblastoma.|Withdrawn||Phase 2|0|Actual|Nationwide Children's Hospital||1||lack of accrual|f||||t||||||||||2017-02-18 13:12:56.690376|2017-02-18 13:12:56.690376
NCT00874302|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-06-26||||||June 2014|2014-06-01||||||||Interventional|||Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms|A Phase III, Open Label, Randomized, Multicenter Study Evaluating the Safety and Efficacy of 25 mg and 50 mg Doses of Proellex to Assess Recurrence of Symptoms in the Treatment of Symptomatic Uterine Fibroids|Withdrawn||Phase 3|0|Actual|Repros Therapeutics Inc.||2||Study terminated for safety and the FDA put the study on hold for safety.|f||||t||||||||||2017-02-18 13:12:56.802423|2017-02-18 13:12:56.802423
NCT00874289|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-01-20|||December 2008||2008-12-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|ANGLE-HF||Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Renal Impairment, Further Decompensation and Rehospitalization in Acutely Decompensated and Chronic Heart Failure Patients|Utility of NGAL in Predicting Renal Impairment, Further Decompensation & Rehospitalization in Acutely Decompensated & Chronic Heart Failure Patients|Completed||N/A|106|Actual|The Alfred|||2||f||||f||||||Samples Without DNA|"~     Blood and urine samples are being collected.~   "|||2017-02-18 13:12:56.922838|2017-02-18 13:12:56.922838
NCT00874276|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-06-03|2013-03-11||August 2009||2009-08-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pharmacotoxicology of Trichloroethylene Metabolites|Pharmacotoxicology of Trichloroethylene Metabolites|Completed||N/A|21|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 13:12:57.023486|2017-02-18 13:12:57.023486
NCT00874263|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2012-06-21|||March 2008||2008-03-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Observational|ASGE-FNDT-1||Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies|The Role of Endoscopic Confocal Microscopy in Diagnosing Colorectal Cancer and Other Gastrointestinal Pathologies in Vivo|Completed||N/A|225|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 13:12:57.466999|2017-02-18 13:12:57.466999
NCT00873691|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2015-06-03|||March 2009||2009-03-01|June 2015|2015-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|Tilt & Tune||Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants|Prospective Comparison of 50/50% Tilt and Tuned Defibrillation Waveforms in Right-Sided Implants|Completed||Phase 4|129|Actual|St. Jude Medical|||2||f||||f||||||||||2017-02-18 13:13:06.059864|2017-02-18 13:13:06.059864
NCT00874250|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2016-05-24|2011-09-22||June 2009||2009-06-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|January 2011|Actual|2011-01-01||Interventional|||Thoracic Endoprosthesis for Treatment of Aneurysm of the Descending Thoracic Aortic|An Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for the Primary Treatment of Aneurysm of the Descending Thoracic Aortic|Active, not recruiting||N/A|51|Actual|W.L.Gore & Associates||1|||f||||t||||||||||2017-02-18 13:12:57.562016|2017-02-18 13:12:57.562016
NCT00874237|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-06-18|||April 2009||2009-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Staccato Loxapine Thorough QT/QTc|Thorough QT/QTc Study of Staccato® Loxapine for Inhalation in Healthy Volunteers|Completed||Phase 1|46|Actual|Alexza Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 13:12:57.885416|2017-02-18 13:12:57.885416
NCT00874224|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2016-03-08|||January 2010||2010-01-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ORANGE II||Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery.|The ORANGE II Trial: An International Multicenter Randomised Controlled Trial of Optimised Surgical Recovery After Left Lateral Hepatic Sectionectomy: Open Versus Laparoscopic Surgery Within an Enhanced Recovery Programme|Completed||N/A|110|Anticipated|Maastricht University Medical Center||3|||f||||t||||||||||2017-02-18 13:12:57.986202|2017-02-18 13:12:57.986202
NCT00874211|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2017-01-04|||December 2008||2008-12-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases|S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment|Active, not recruiting||N/A|3500|Anticipated|Southwest Oncology Group|||1||f||||t||||||Samples With DNA|"~     Serum for banking & whole blood for DNA analysis and banking.~   "|||2017-02-18 13:12:58.113101|2017-02-18 13:12:58.113101
NCT00874198|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-04-02|||October 2004||2004-10-01|April 2009|2009-04-01|June 2009|Anticipated|2009-06-01|March 2008|Actual|2008-03-01||Interventional|||European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus|European Multicenter Study on the Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus|Unknown status|Active, not recruiting|N/A|156|Anticipated|International Neuroscience Institute Hannover||1|||f||||f||||||||||2017-02-18 13:12:58.930919|2017-02-18 13:12:58.930919
NCT00874185|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-02-12|||December 2007||2007-12-01|February 2013|2013-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|TIERRA||Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk|Satisfaction With Treatment In Patients With Erectile Dysfunction And Cardiovascular Risk And/Or Previous Cardiovascular Event.|Completed||Phase 4|720|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:12:59.04286|2017-02-18 13:12:59.04286
NCT00874172|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2012-12-17|||October 2009||2009-10-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|DREPANOX||Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy|New Analgesic Strategy Combining Nitrous Oxide, Nefopam, Acetaminophen and Morphine Compared to the Usal Antalgic Strategy (Acetaminophen and Morphine) for the Treatment of Acute Sickle Cell Disease Pain in the Emergency Room|Completed||N/A|176|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:12:59.136696|2017-02-18 13:12:59.136696
NCT00874159|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-08-12|||April 2009||2009-04-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|DiabCare Asia||A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in Philippines|DiabCare Asia 2008 Philippines A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Philippines & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Philippines|Completed||N/A|770|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"~     Capillary or venous blood will be drawn for analysing HbA1c.~   "|||2017-02-18 13:12:59.252116|2017-02-18 13:12:59.252116
NCT00874146|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-09-01|||March 2009||2009-03-01|September 2010|2010-09-01|December 2009|Anticipated|2009-12-01|September 2009|Actual|2009-09-01||Observational|||Level of HER2-neu Gene Amplification an Response to Trastuzumab|Retrospective Study of the Level of HER2-neu Gene Amplification as Predictive Factor of Response in Patients With HER2-positive Advanced Breast Cancer Treated With Trastuzumab Containing Regimens.|Unknown status|Recruiting|N/A|100|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples With DNA|"~     FISH test performed on paraffine embedded tumor sections.~   "|||2017-02-18 13:12:59.360352|2017-02-18 13:12:59.360352
NCT00874133|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-12-05|||March 2009||2009-03-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis|The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis|Terminated||N/A|8|Actual|Rabin Medical Center||2||Completed due to low number of eligible patients|f||||t||||||||||2017-02-18 13:12:59.468602|2017-02-18 13:12:59.468602
NCT00874120|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-02-20|2010-06-02||December 2008||2008-12-01|February 2015|2015-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED)|Randomized, Placebo-Controlled, Double-Blind, Two-Way Crossover Study to Evaluate the Effects of Phenylephrine HCl Extended-Release Tablets 30 mg Compared to Placebo on Ambulatory Blood Pressure|Completed||Phase 3|116|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:12:59.581211|2017-02-18 13:12:59.581211
NCT00874107|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-05-05|||June 2009||2009-06-01|May 2015|2015-05-01|June 2016|Anticipated|2016-06-01|March 2016|Anticipated|2016-03-01||Interventional|||Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase 2, Randomized, Efficacy and Safety Study of Imprime PGG® Injection in Combination With Bevacizumab and Concomitant Paclitaxel and Carboplatin Therapy in Patients With Previously Untreated Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|90|Anticipated|Biothera||2|||f||||t||||||||||2017-02-18 13:12:59.879267|2017-02-18 13:12:59.879267
NCT00874094|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-07-10|2011-07-18||April 2008||2008-04-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds|Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds|Completed||Phase 1/Phase 2|15|Actual|The New York Eye & Ear Infirmary||1|||f||||f||||||||||2017-02-18 13:13:00.016651|2017-02-18 13:13:00.016651
NCT00874068|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2011-02-23|||February 2009||2009-02-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|InFat_002||The Effects of Dietary Palmitic Acid Triacylglyceride Position on Bone Strength Parameters in Infants|The Effects of Dietary Palmitic Acid Triacylglyceride Position on Anthropometric Measures, Bone Strength Parameters, Stool Characteristics and Stool Biochemistry in Preterm and Term Infants|Completed||N/A|94|Actual|Enzymotec||3|||f||||f||||||||||2017-02-18 13:13:00.292593|2017-02-18 13:13:00.292593
NCT00874055|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-04-01|||October 2007||2007-10-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||The Presence of Friends Increases Food Intake in Youth|The Presence of Friends Increases Food Intake in Youth|Completed||N/A|72|Actual|University at Buffalo|||1||f||||f||||||||||2017-02-18 13:13:00.414111|2017-02-18 13:13:00.414111
NCT00874042|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2012-07-20|||March 2009||2009-03-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors|A Phase 1 Dose Escalation Study of ARQ 197 Administered in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|74|Actual|ArQule||1|||f||||f||||||||||2017-02-18 13:13:00.492542|2017-02-18 13:13:00.492542
NCT00874029|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2014-06-03|2013-10-24||March 2009||2009-03-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|January 2012|Actual|2012-01-01||Interventional|Halt|Subjects who met the initial inclusion exclusion criteria were enrolled and treated. Two subjects were later found to have baseline bleeding volumes outside of the protocol inclusion limits. All 137 Subjects comprised the Safety Set. The Full Analysis Set excluded the two subjects that did not meet the baseline bleeding criteria.|Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids|Evaluation of the Halt System for Laparoscopic Treatment of Symptomatic Uterine Fibroids With Radiofrequency Ablation|Completed||N/A|137|Actual|Halt Medical, Inc||1|||f||||t||||||||||2017-02-18 13:13:00.5936|2017-02-18 13:13:00.5936
NCT00874016|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2010-12-15|||April 2009||2009-04-01|April 2009|2009-04-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Airtraq Versus Standard Direct Laryngoscopy in the Pediatric Airway|A Comparison of the Airtraq and Standard Direct Laryngoscopy in the Pediatric Airway - A Randomized Trial.|Completed||N/A|50|Actual|IWK Health Centre||2|||f||||t||||||||||2017-02-18 13:13:00.969071|2017-02-18 13:13:00.969071
NCT00874003|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-04-01|||April 2004||2004-04-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|July 2006|Actual|2006-07-01||Interventional|||The Effects of Mirtazapine Versus Placebo on Alcohol Consumption in Male Alcohol High Consumers|The Effects of Mirtazapine vs Placebo on Alcohol Consumption in Male Alcohol High Consumers; a Randomized Controlled Trial|Completed||Phase 2|59|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-02-18 13:13:01.071074|2017-02-18 13:13:01.071074
NCT00873990|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-04-01|||January 2009||2009-01-01|March 2009|2009-03-01|October 2009|Anticipated|2009-10-01|July 2009|Anticipated|2009-07-01||Interventional|FSRT||Fissure Sealant Retention Trial|Split Mouth Clinical Trial of Fissure Sealant Retention With Self Etching and Total Etch Bonding Agent|Unknown status|Recruiting|Phase 2/Phase 3|93|Anticipated|Aga Khan University||2|||f||||t||||||||||2017-02-18 13:13:01.16764|2017-02-18 13:13:01.16764
NCT00873977|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-11-30|||April 2009||2009-04-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|||Treatment Adherence and Outcomes in Three Modalities of Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea|Comparison of Three Modalities of Continuous Positive Pressure Airway Treatment for Obstructive Sleep Apnea Syndrome|Completed||N/A|93|Actual|Kyoto University, Graduate School of Medicine||3|||f||||t||||||||||2017-02-18 13:13:01.359336|2017-02-18 13:13:01.359336
NCT00873964|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2012-04-26|||March 2009||2009-03-01|April 2012|2012-04-01|July 2013|Anticipated|2013-07-01|April 2013|Anticipated|2013-04-01||Observational|||Metabolic Syndrome in an Elderly Population is More Linked to Insulin Resistance Than to Obesity|Metabolic Syndrome in an Elderly Population is More Linked to Insulin Resistance Than to Obesity|Unknown status|Active, not recruiting|N/A|156|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||Samples Without DNA|"~     Serum collected.~   "|||2017-02-18 13:13:01.477049|2017-02-18 13:13:01.477049
NCT00873951|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-04-01|||January 2006||2006-01-01|March 2009|2009-03-01|January 2008|Actual|2008-01-01|November 2006|Actual|2006-11-01||Interventional|||Influence of Protein Hydrolysis on Dietary Protein Digestibility and Metabolism in Healthy Subjects|Influence of Protein Hydrolysis on Dietary Protein Digestibility and Metabolism in Healthy Subjects|Completed||N/A|26|Actual|Institut National de la Recherche Agronomique||3|||f||||t||||||||||2017-02-18 13:13:01.558534|2017-02-18 13:13:01.558534
NCT00873938|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2010-04-29|||October 2005||2005-10-01|April 2009|2009-04-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Observational|Compliance||Compliance to Artesunate-Amodiaquine Therapy for Uncomplicated Malaria in Rural Ghana||Completed||N/A|411|Actual|Kintampo Health Research Centre, Ghana|||2||f||||f||||||||||2017-02-18 13:13:01.667166|2017-02-18 13:13:01.667166
NCT00873925|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-04-01|||March 2009||2009-03-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|March 2012|Actual|2012-03-01||Interventional|||Cord Blood Plus Vitamin D and Omega 3s in T1D|Transfusion of Autologous Umbilical Cord Blood Plus Vitamin D and Omega 3 Fatty Acids to Preserve Beta Cell Function in Children With Recent Onset Type 1 Diabetes - A Pilot Study|Completed||Phase 1|15|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 13:13:01.780511|2017-02-18 13:13:01.780511
NCT00873912|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2011-07-12|2010-10-08||May 2009||2009-05-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|MI-MA205||A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a New 6:2 Influenza Virus Reassortant in Healthy Adults|Completed||Phase 4|300|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 13:13:01.918914|2017-02-18 13:13:01.918914
NCT00873899|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-04-01|||May 2008||2008-05-01|April 2009|2009-04-01|September 2010|Anticipated|2010-09-01|||||Observational|EVOLVO||Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators||Unknown status|Recruiting|N/A|200|Anticipated|Regione Lombardia|||2||f||||f||||||||||2017-02-18 13:13:02.738111|2017-02-18 13:13:02.738111
NCT00873886|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-09-28|||April 2009||2009-04-01|September 2015|2015-09-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy|A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy|Withdrawn||Phase 1|0|Actual|University of Pittsburgh||2||We will focus on other Tamiflu research studies. No subjects were enrolled.|f||||t||||||||||2017-02-18 13:13:02.860095|2017-02-18 13:13:02.860095
NCT00873873|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2014-09-28|2011-11-27||September 2008||2008-09-01|September 2014|2014-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Progression of Airway Obstruction in Childhood Asthma|Progression of Airway Obstruction in Childhood Asthma|Completed||N/A|55|Actual|National Jewish Health|We had planned to extend invitations to the remaining 55 participants in a streamlined version of this protocol after analyzing the preliminary data and an additional cycle of CAMP was funded in 2007.||4||f||||t||||||Samples Without DNA|"~     Induced sputum, urine, blood, and exhaled breath condensates~   "|||2017-02-18 13:13:02.987623|2017-02-18 13:13:02.987623
NCT00873860|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2012-08-29|||June 2009||2009-06-01|August 2012|2012-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Study to Evaluate the Safety and Efficacy of CAT-354|A Phase 2a, Randomized, Double-blind, Placebo-Controlled, Parallel-Arm, Multicenter Study to Evaluate the Efficacy and Safety of CAT-354, on Asthma Control in Adults|Completed||Phase 2|194|Actual|MedImmune LLC||3|||f||||f||||||||||2017-02-18 13:13:03.601268|2017-02-18 13:13:03.601268
NCT00873847|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-07-27|||July 2009||2009-07-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|June 2010|Actual|2010-06-01||Observational|||Cerebral Function Monitoring in Premature Infants|Cerebral Function Monitoring and Brain Injury in Preterm Infants: Correlation With Neuroimaging Abnormalities and Neurodevelopmental Impairment - a Pilot Study|Completed||N/A|102|Actual|NICHD Neonatal Research Network|||1||f||||t||||||||||2017-02-18 13:13:03.754725|2017-02-18 13:13:03.754725
NCT00873834|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2012-01-09|||September 2009||2009-09-01|April 2009|2009-04-01|November 2011|Anticipated|2011-11-01|November 2010|Anticipated|2010-11-01||Interventional|FAIR||Fluoxetine Essay in Children With Autism|Fluoxetine : Clinical and Anatomy-functional Therapeutic Effects in Children With Autism|Withdrawn||Phase 2|0|Actual|Assistance Publique - Hôpitaux de Paris||2||Withdrawn for problem of logistics with the associated laboratories|f||||t||||||||||2017-02-18 13:13:03.882355|2017-02-18 13:13:03.882355
NCT00873821|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-02-24|2012-04-10||December 2008||2008-12-01|February 2015|2015-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)|A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK0941 After Multiple Daily Administration in Subjects With Type 2 Diabetes|Completed||Phase 1|44|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:13:03.99773|2017-02-18 13:13:03.99773
NCT00873808|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2013-04-09|||October 2008||2008-10-01|April 2013|2013-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307|Long-Term Bone Quality in Women With Breast Cancer (A Companion Study to S0307)|Withdrawn||N/A|0|Actual|Southwest Oncology Group||||lack of accrual|f||||t||||||||||2017-02-18 13:13:04.347092|2017-02-18 13:13:04.347092
NCT00873795|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-04-01|||April 2007||2007-04-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression|Efficacy and Safety of Aripiprazole 2.5mg Combine Sertraline 50mg in Major Depression|Completed||N/A|41|Actual|Chimei Medical Center||2|||f||||t||||||||||2017-02-18 13:13:04.456443|2017-02-18 13:13:04.456443
NCT00873782|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2015-02-27|2015-01-22||March 2009||2009-03-01|January 2015|2015-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy|Safety and Feasibility of Transvenous Limb Perfusion With Normal Saline in Human Muscular Dystrophy|Completed||Phase 1|16|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-02-18 13:13:04.569506|2017-02-18 13:13:04.569506
NCT00873769|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-06-18|||April 2009||2009-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Staccato Loxapine PK in Smokers and Nonsmokers|Pharmacokinetics of Staccato® Loxapine for Inhalation in Smokers Compared to Nonsmokers|Completed||Phase 1|35|Actual|Alexza Pharmaceuticals, Inc.||2|||t||||f||||||||||2017-02-18 13:13:04.792028|2017-02-18 13:13:04.792028
NCT00873756|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-11-01|||May 2009||2009-05-01|November 2016|2016-11-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer|A Phase Ib Study of the Safety and Pharmacokinetics of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer|Completed||Phase 1|23|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 13:13:04.885181|2017-02-18 13:13:04.885181
NCT00873743|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2009-04-01|||October 2008||2008-10-01|April 2009|2009-04-01|October 2009|Anticipated|2009-10-01|May 2009|Anticipated|2009-05-01||Observational|||Analgesia and Antihyperalgesia of Tramadol and Acetaminophen Per Oral After Caesarean Section|Postoperative Analgesia and Antihyperalgesia of Tramadol and Acetaminophen Per Oral After Caesarean Section -A Randomised Controlled Trial in Female O-Desmethyl 1 Metabolizers Identified by the Respective Gene-|Suspended||N/A|120|Anticipated|Medical University of Vienna|||2|Study was stopped because of ineffectiveness of one investigated Drug|f||||t||||||Samples With DNA|"~     CYP P450 2D6 metabolizer status~   "|||2017-02-18 13:13:04.995019|2017-02-18 13:13:04.995019
NCT00873730|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2010-04-23|2009-06-30||December 2006||2006-12-01|April 2010|2010-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|Loadet||Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain|A 12-week Randomized, Double-blind, Multicenter Pilot Study to Evaluate the Effect of Etanercept 100 mg and 50 mg Weekly in Subjects With Ankylosing Spondylitis|Completed||Phase 4|108|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:13:05.097261|2017-02-18 13:13:05.097261
NCT00873717|ClinicalTrials.gov processed this data on February 17, 2017|2009-04-01|2012-07-25|||January 2009||2009-01-01|April 2009|2009-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|Nutrident||Improvement of Nutritional Status in Elderly Residents of Long-term Facilities|Improvement of Nutritional Status in Elderly Residents of Long-term Facilities: Impact of Two Strategies (Oral Care and Dietary Control)|Completed||N/A|114|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||||2017-02-18 13:13:05.869087|2017-02-18 13:13:05.869087
NCT00873704|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-10-11|||March 2009||2009-03-01|October 2015|2015-10-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Supplemental Oxygen in Vascular Surgery|Supplemental Postoperative Oxygen and the Risk of Surgical Wound Infection in a Vascular Surgery Population: A Randomized Controlled Trial|Completed||N/A|274|Actual|North Karelia Central Hospital||2|||f||||f||||||||||2017-02-18 13:13:05.975187|2017-02-18 13:13:05.975187
NCT00873678|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2010-06-02|||March 2007||2007-03-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|JSCORS||Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome|Assessment of the Prevalence and Mutational Spectrum of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome and Cerebello-oculo-renal Syndromes|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"~     Whole blood sample (10 ml)~   "|||2017-02-18 13:13:06.159976|2017-02-18 13:13:06.159976
NCT00873665|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-10-25|||December 2008||2008-12-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Erectile Dysfunction Study|Exercise Training, Erectile Dysfunction, and Prostate Cancer Study.|Completed||N/A|64|Actual|Duke University||2|||f||||f||||||||||2017-02-18 13:13:06.265365|2017-02-18 13:13:06.265365
NCT00873652|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-05-07|||February 2009||2009-02-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Observational Study of Immune Response to Hepatitis B Childhood Booster|An Observational Study of Children Immunised in Infancy Against Hepatitis B Virus, Evaluating the Persistence of Immunity and the Immune Response to a Scheduled Booster Dose of Hepatitis B Vaccine|Completed||N/A|28|Actual|University of Oxford|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:13:06.365113|2017-02-18 13:13:06.365113
NCT00873639|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2016-10-13|||April 2009||2009-04-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues|A Prospective, Multicentre, Open Label, Non-controlled, Observational, 24-week Study in Patients Using NovoRapid® (Insulin Aspart) and Levemir® (Insulin Detemir) in a Basal-bolus Regimen for Treatment of Type 1 Diabetes Mellitus in Romania|Completed||N/A|417|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:13:06.476268|2017-02-18 13:13:06.476268
NCT00873626|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-11-05|||June 2009||2009-06-01|June 2011|2011-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|DTP||Treatment's Duration of Acute Uncomplicated Pyelonephritis|Randomized Controled Multicentric Trial, of Non Inferiority, Comparing Two Durations of Antibiotherapy (5 Days Versus 10 Days) in COMMUNAUTARY Acute Uncomplicated Pyelonephritis.|Completed||Phase 4|310|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:13:06.587097|2017-02-18 13:13:06.587097
NCT00873613|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-11-07|||April 2009||2009-04-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|August 2011|Actual|2011-08-01||Interventional|||Digital Ocular Fundus Photography in the Emergency Department: A New Application for Telemedicine?|Digital Ocular Fundus Photography in the Emergency Department: A New Application for Telemedicine?|Completed||N/A|705|Actual|Emory University||2|||f||||f||||||||||2017-02-18 13:13:06.699152|2017-02-18 13:13:06.699152
NCT00873600|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-03-17|||October 2007||2007-10-01|March 2015|2015-03-01||||||||Observational|||Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer|A Randomized Controlled Trial of Outpatient Geriatric Evaluation and Management Among Older Patients With Breast and Colon Cancer|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center|||1|No accrual|f||||t||||||||||2017-02-18 13:13:06.800713|2017-02-18 13:13:06.800713
NCT00873587|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2015-10-11|||March 2009||2009-03-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||Clinical Trial Evaluating the Optimal Technique for Chest Tube Removal|Randomized Clinical Trial Evaluating the Optimal Technique for Chest Tube Removal|Completed||N/A|342|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 13:13:06.892085|2017-02-18 13:13:06.892085
NCT00873574|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-03-07|||September 2008||2008-09-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|May 2011|Actual|2011-05-01||Observational|SMP||JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders|Molecular Study of Factors Involved in JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders|Completed||N/A|234|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"~     Peripheral blood samples (35 ml) and buccal swabs~   "|||2017-02-18 13:13:06.980173|2017-02-18 13:13:06.980173
NCT00873561|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-03-30|||December 2001||2001-12-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|April 2006|Actual|2006-04-01||Interventional|||A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel, Dose-Ranging Study to Evaluate The Efficacy, Safety, Tolerability, and Pharmacodynamics of NBI-6024 In Adult and Adolescent Patients With New Onset Type 1 Diabetes Mellitus|Completed||Phase 1|188|Actual|Neurocrine Biosciences||4|||f||||t||||||||||2017-02-18 13:13:07.082864|2017-02-18 13:13:07.082864
NCT00873548|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-01-24|||November 2007||2007-11-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Observational|||Treatment of Unstable Trochanteric Fractures With the Proximal Femoral Nail - Antirotation (PFNA)-Asia|Treatment of Unstable Trochanteric Fractures With the Proximal Femoral Nail - Antirotation Asia - A Prospective Multicenter Case Series|Completed||N/A|245|Actual|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-02-18 13:13:09.448648|2017-02-18 13:13:09.448648
NCT00873535|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-09-03|||October 2008||2008-10-01|September 2015|2015-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of Varenicline on Reactivity to Smoking and Drinking Cues|Effect of Varenicline on Reactivity to Smoking and Drinking Cues in Individuals With Concurrent Tobacco Dependence and Alcohol Use|Completed||N/A|48|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 13:13:09.589817|2017-02-18 13:13:09.589817
NCT00873522|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-03-31|||March 2008||2008-03-01|March 2009|2009-03-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Observational|||Microbiology and Clinical Outcome of Pneumonia|Microbiology and Clinical Outcome of Community Acquired Pneumonia and Health-Care-Associated Pneumonia in Taiwan: a Multi-Center Study|Unknown status|Recruiting|N/A|2600|Anticipated|Taichung Veterans General Hospital|||2||f||||f||||||||||2017-02-18 13:13:09.712368|2017-02-18 13:13:09.712368
NCT00873509|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-07-25|||May 2009||2009-05-01|July 2016|2016-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|B-ACE||Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder|A Randomized, Placebo-controlled, Double-masked Clinical Trial of Buspirone in the Treatment of 2- 6 Year Old Children With Autistic Disorder|Completed||Phase 2/Phase 3|166|Actual|Chugani, Diane C.||3|||f||||t||||||||||2017-02-18 13:13:09.816213|2017-02-18 13:13:09.816213
NCT00873496|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-03-31|||January 2005||2005-01-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Observational|||Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients|Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients: a Prospective Sample Study.|Completed||N/A|30|Actual|Ege University|||1||f||||f||||||||||2017-02-18 13:13:09.927659|2017-02-18 13:13:09.927659
NCT00873483|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-09-30|||April 2009||2009-04-01|September 2014|2014-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||US Ovulation Inhibition Study in Obese Women|Multicenter, Open-Label, Uncontrolled Study to Investigate the Impact of Weight and BMI on Inhibition of Ovulation of a Transdermal Patch Formulation Containing 0.55 mg Ethinylestradiol and 2.1 mg Gestodene in Young Female Volunteers Stratified by BMI Over a Period of 3 Treatment Cycles|Completed||Phase 2|173|Actual|Bayer||1|||f||||f||||||||||2017-02-18 13:13:10.223911|2017-02-18 13:13:10.223911
NCT00873470|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-02-07|||February 2009||2009-02-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|WPW||Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory Duct|Long Term Evolution of the Anterograde Refractory Period of Accessory Duct in the Wolff-Parkinson-White Syndrome|Terminated||N/A|13|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-02-18 13:13:10.326049|2017-02-18 13:13:10.326049
NCT00873457|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-05-19|2012-12-15||August 2009||2009-08-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|October 2011|Actual|2011-10-01||Interventional|||Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Phase II Trial of Perifosine in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Completed||Phase 2|16|Actual|Duke University|Early termination leading to small numbers of subjects analyzed. All patients were heavily pretreated and had aggressive disease.|1|||f||||f||||||||||2017-02-18 13:13:10.417373|2017-02-18 13:13:10.417373
NCT00873444|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-05-09|||July 2006||2006-07-01|March 2016|2016-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Randomised Study to Compare Metal Ion Release and Long-term Performance of the Pinnacle™ Cup With a Ceramic-on-Metal or a Metal-on-Metal Bearing|Randomised, Controlled, Prospective, Multi-Centre, Post Market Surveillance Study Comparing a Ceramic-on-Metal Bearing and a Metal-on-Metal Bearing in Subjects Requiring Primary Total Hip Arthroplasty for Non-Inflammatory Degenerative Joint Disease|Terminated||Phase 4|5|Actual|DePuy International||2||"Study progress very slow therefore terminated as other projects underway to investigate the~   same research question which will deliver results earlier"|f||||f||||||||||2017-02-18 13:13:10.948974|2017-02-18 13:13:10.948974
NCT00873431|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2012-10-18|||March 2009||2009-03-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47|An Open-Label Phase 1 Study Assessing the Safety, Immunogenicity and Dose Response of IC47, a New Vaccine Against Streptococcus Pneumoniae, in Healthy Subjects.|Completed||Phase 1|32|Actual|Valneva Austria GmbH||4|||f||||t||||||||||2017-02-18 13:13:11.054131|2017-02-18 13:13:11.054131
NCT00873418|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-03-16|||March 2009||2009-03-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|COPE-HF||Coping Skills and Heart Failure: Outcomes and Mechanisms|Coping Skills Training in Heart Failure: Outcomes and Mechanisms|Completed||N/A|190|Actual|Duke University||2|||f||||t||||||||||2017-02-18 13:13:11.159161|2017-02-18 13:13:11.159161
NCT00873405|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-03-31|||June 2006||2006-06-01|March 2009|2009-03-01||||June 2009|Anticipated|2009-06-01||Interventional|||Banded Sleeve Gastrectomy Versus Banded Ring Gastric Bypass in Morbidly Obese Patients|Banded Sleeve Gastrectomy Versus Banded Ring Gastric Bypass in Morbidly Obese Patients: a Prospective Controlled Trial.|Unknown status|Active, not recruiting|N/A|65|Anticipated|Federal University of Espirito Santo||2|||f||||t||||||||||2017-02-18 13:13:11.265029|2017-02-18 13:13:11.265029
NCT00873392|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-12-29|||February 2009||2009-02-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|NICOPARK2||Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease|Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease(One Daily Administration).A Controlled Randomised Study, in Two Parallel Groups and Single Blind in 40 Patients.|Completed||Phase 2|40|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:13:11.37562|2017-02-18 13:13:11.37562
NCT00873379|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-07-06|||October 2007||2007-10-01|July 2009|2009-07-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly|Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly: a Randomized, Double Blind, Placebo-Controlled Trial|Completed||Phase 3|122|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-02-18 13:13:11.490508|2017-02-18 13:13:11.490508
NCT00873366|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-03-23|||May 2009||2009-05-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer|¹³C - Dextromethorphan (DM) Breath Test for Determination of CYP2D6 Enzyme Activity in Patients Receiving Tamoxifen|Terminated||N/A|210|Anticipated|Mayo Clinic||1||Funding issues|f||||t||||||||||2017-02-18 13:13:11.597302|2017-02-18 13:13:11.597302
NCT00873353|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2010-08-17|||March 2008||2008-03-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|August 2008|Actual|2008-08-01||Interventional|XELTA||Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients|An Open Non-randomized Multicenter Phase II Trial to Evaluate the Efficacy and Safety of Tarceva in Combination With Capecitabine in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|32|Actual|Grupo Gallego de Investigaciones Oncologicas||1|||f||||f||||||||||2017-02-18 13:13:11.710341|2017-02-18 13:13:11.710341
NCT00873340|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-06-25|||October 2007||2007-10-01|June 2014|2014-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Physical Disability in Patients Treated With Betaferon|Physical Disability Observational Study in Patients Treated With Betaferon in Daily Practice|Completed||N/A|83|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a~   "|||2017-02-18 13:13:11.820596|2017-02-18 13:13:11.820596
NCT00873327|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-05-29|2012-11-25||October 2009||2009-10-01|May 2013|2013-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates|Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates|Completed||Phase 1|32|Actual|Duke University||1|||f||||f||||||||||2017-02-18 13:13:11.935198|2017-02-18 13:13:11.935198
NCT00873314|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-31|||July 2006||2006-07-01|March 2009|2009-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Bed Rest for Threatened Preterm Labor. Pilot Study|Bed Rest for Arrested Threatened Preterm Labor. Pilot Study for the Design of a Randomized Controlled Clinical Trial.|Completed||N/A|46|Actual|Institute for Clinical Effectiveness and Health Policy||2|||f||||f||||||||||2017-02-18 13:13:12.156256|2017-02-18 13:13:12.156256
NCT00873301|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2012-03-29|||January 2009||2009-01-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||The Effectiveness of Vestibulectomy||Completed||N/A|40|Actual|Western Galilee Hospital-Nahariya||1|||f||||f||||||||||2017-02-18 13:13:12.268302|2017-02-18 13:13:12.268302
NCT00873288|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2010-01-27|||October 2006||2006-10-01|March 2009|2009-03-01||||September 2009|Anticipated|2009-09-01||Interventional|||Personalized Letter With Cancer Information Service Support or a Standard Reminder Letter in Women Scheduled for Colposcopy After an Abnormal Pap Test|Activating Collaborative CIS Support Via Targeted Provider Mailing|Unknown status|Recruiting|N/A|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:13:12.350685|2017-02-18 13:13:12.350685
NCT00873275|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2017-02-10|||March 2009||2009-03-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer|Phase I Study of Ursodeoxycholic Acid (Ursodiol)in Combination With 5-Fluorouracil, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 1|30|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:13:12.436899|2017-02-18 13:13:12.436899
NCT00873262|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2010-06-15|||April 2009||2009-04-01|February 2010|2010-02-01|November 2010|Anticipated|2010-11-01|May 2010|Anticipated|2010-05-01||Interventional|||Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)|A Phase II Randomized, Two-arms, Single-blind, Cross Controlled Study for Evaluation the Safety and Efficacy of Diagnosis and Treatment of Premenstrual Syndrome by Detecting Skin Reactions Followed by Desensitization to Sex Hormones|Unknown status|Recruiting|Phase 2|20|Anticipated|EVE Medical Systems Ltd.||2|||f||||t||||||||||2017-02-18 13:13:12.556255|2017-02-18 13:13:12.556255
NCT00873249|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2010-03-23|||April 2009||2009-04-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|SMS||Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia|Effect of Daily SMS Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia|Completed||N/A|339|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:13:12.870634|2017-02-18 13:13:12.870634
NCT00873236|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-08-09|||April 2008||2008-04-01|March 2009|2009-03-01||||||||Interventional|||MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer|Dynamic Contrast Enhanced MRI (DCE-MRI) Assessment of the Vascular Changes Induced With Bevacizumab Alone and in Combination With Interferon-α in Patients With Advanced Renal Cell Carcinoma|Unknown status|Recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 13:13:12.9761|2017-02-18 13:13:12.9761
NCT00873223|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2017-01-25|||March 2009||2009-03-01|January 2017|2017-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir|Insulin Detemir Co-administered With Liraglutide: An Open Label Trial to Assess Insulin Detemir and Liraglutide Pharmacokinetics and Pharmacodynamics Following Liraglutide Therapy in Subjects With Type 2 Diabetes|Completed||Phase 1|33|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 13:13:13.085557|2017-02-18 13:13:13.085557
NCT00873210|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2012-11-07|||May 2009||2009-05-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Study In Patients With Kidney Cancer Treated With Sutent|Non-Interventional Study In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With Sutent|Completed||N/A|121|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:13:13.188655|2017-02-18 13:13:13.188655
NCT00873197|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2009-05-01|||April 2009||2009-04-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||PK, Tolerability and Safety of the co-Administration of Sancuso® (Transdermal Granisetron) and IV Granisetron|A Study to Assess the Pharmacokinetics, Tolerability and Safety of the co-Administration of Sancuso® (Transdermal Granisetron) and Intravenous Granisetron in Healthy Subjects|Completed||Phase 1|12|Actual|Prostrakan Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:13:13.311686|2017-02-18 13:13:13.311686
NCT00873184|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-05-29|||September 2008||2008-09-01|March 2012|2012-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Study of Massage Therapy Within a Brain Tumor Setting|Feasibility Study of Massage Therapy Within a Brain Tumor Setting|Completed||N/A|10|Actual|Duke University||1|||f||||t||||||||||2017-02-18 13:13:13.417401|2017-02-18 13:13:13.417401
NCT00873171|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2010-04-15|||January 2009||2009-01-01|April 2010|2010-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis|Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis|Completed||N/A|24|Actual|CAMC Health System|||3||f||||f||||||||||2017-02-18 13:13:13.517102|2017-02-18 13:13:13.517102
NCT00873158|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-08-08|||January 2006||2006-01-01|August 2013|2013-08-01||||January 2014|Anticipated|2014-01-01||Interventional|DS-SDH||Dynamic Splinting for Patients With Adhesive Capsulitis|Outcomes Following Dynamic Splinting and/or Physical Therapy for Patients With Adhesive Capsulitis|Terminated||N/A|10|Actual|Dynasplint Systems, Inc.||2||Unrelated to trial|f||||t||||||||||2017-02-18 13:13:13.611972|2017-02-18 13:13:13.611972
NCT00873145|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-04-14|||December 2008||2008-12-01|March 2009|2009-03-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Observational|||Management of Bone Defects Around the Elbow|Modular Prosthetic Reconstruction of Major Bone Defects of the Distal Humerus.|Completed||N/A|50|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-02-18 13:13:13.730925|2017-02-18 13:13:13.730925
NCT00873132|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-06-17|||April 2009||2009-04-01|June 2013|2013-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||BTC Neuropsychological Database|BTC Neuropsychological Database:Prospective Study|Withdrawn||N/A|0|Actual|Duke University|||1|No Funding|f||||f||||||||||2017-02-18 13:13:13.829243|2017-02-18 13:13:13.829243
NCT00873119|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-07-07|2014-07-01||February 2009||2009-02-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary|An Open-label Randomized Phase II Trial of Belinostat (PXD101) in Combination With Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Previously Untreated Carcinoma of Unknown Primary|Completed||Phase 2|89|Actual|Onxeo||2|||f||||||||||||||2017-02-18 13:13:13.920548|2017-02-18 13:13:13.920548
NCT00873106|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-09-05|||February 2009||2009-02-01|September 2012|2012-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography|Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography|Completed||N/A|20|Actual|Glostrup University Hospital, Copenhagen|||1||f||||f||||||||||2017-02-18 13:13:14.564113|2017-02-18 13:13:14.564113
NCT00873093|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2016-11-30|2016-02-09||March 2009||2009-03-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|A Phase II Pilot Trial of Bortezomib (PS-341, Velcade) in Combination With Intensive Re-Induction Therapy for Children With Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)|Completed||Phase 2|148|Actual|National Cancer Institute (NCI)||5|||f||||t||||||||||2017-02-18 13:13:14.66507|2017-02-18 13:13:14.66507
NCT00873080|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||April 2008||2008-04-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|SAPO||Reliability of the Angle Measurement of the Software for Photogrammetry Postural Assessment (SAPO)|Reliability of the Angle Measurement of the Software for Photogrammetry Postural Assessment|Completed||N/A|24|Actual|Universidade Federal de Santa Maria|||1||f||||f||||||||||2017-02-18 13:13:17.464525|2017-02-18 13:13:17.464525
NCT00873067|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-02-26|||January 2009||2009-01-01|September 2011|2011-09-01|September 2013|Actual|2013-09-01|February 2012|Actual|2012-02-01||Interventional|||Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation|Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation|Completed||Phase 3|142|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 13:13:17.547365|2017-02-18 13:13:17.547365
NCT00873054|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2014-01-30|||October 2008||2008-10-01|January 2014|2014-01-01|January 2011|Actual|2011-01-01|October 2010|Actual|2010-10-01||Observational|||Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy|Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy|Completed||N/A|32|Actual|CAMC Health System|||2||f||||f||||||||||2017-02-18 13:13:17.648946|2017-02-18 13:13:17.648946
NCT00873041|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-05-20|2012-06-20||November 2008||2008-11-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|THALASSA||Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study|A Randomized, Double-blind, Placebo-controlled, Phase II Study to Evaluate Efficacy and Safety of Deferasirox in Non-transfusion-dependent Thalassemia Patients With Iron Overload|Completed||Phase 2|166|Actual|Novartis||4|||f||||||||||||||2017-02-18 13:13:17.744308|2017-02-18 13:13:17.744308
NCT00873028|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-31|||August 2004||2004-08-01|March 2009|2009-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Evaluation of Inspiratory Muscle Strength Early After Coronary Artery Bypass|Inspiratory Muscle Strength as a Determinant of Functional Capacity Early After Coronary Artery Bypass Graft Surgery|Completed||Phase 3|20|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 13:13:19.03519|2017-02-18 13:13:19.03519
NCT00873015|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-07-28|2013-01-26||April 2010||2010-04-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|November 2010|Actual|2010-11-01||Interventional|||Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm|Safety and Pharmacokinetic Evaluation of Sodium Nitrite Injection for the Prevention of Post-Subarachnoid Hemorrhage Induced Vasospasm|Completed||Phase 2|19|Actual|Hope Pharmaceuticals||2|||f||||t||||||||||2017-02-18 13:13:19.144026|2017-02-18 13:13:19.144026
NCT00873002|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2012-03-16|||March 2009||2009-03-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery|Phase I Study of Combination of Sorafenib and LBH589 in Hepatocellular Carcinoma|Terminated||Phase 1|3|Actual|Case Comprehensive Cancer Center||1||Dose Limiting Toxicity|f||||t||||||||||2017-02-18 13:13:19.654653|2017-02-18 13:13:19.654653
NCT00872989|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2016-10-26|2015-09-28||March 2010||2010-03-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional|||S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|Randomized Phase II Study of Docetaxel Followed by Vandetanib (ZD6474) vs. Docetaxel Plus Vandetanib in Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|129|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 13:13:19.785732|2017-02-18 13:13:19.785732
NCT00872976|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2013-07-19|||May 2009||2009-05-01|July 2013|2013-07-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia|Phase 1 Trial of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||2||Business Objectives Changed|f||||f||||||||||2017-02-18 13:13:21.20345|2017-02-18 13:13:21.20345
NCT00872963|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-31|2015-12-04|||February 2009||2009-02-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|February 2016|Anticipated|2016-02-01||Observational|MAL059||An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial|An Extended Follow up of a Phase 2b Vaccine Trial With RTS,S/AS01E in Kilifi District, Kenya.|Active, not recruiting||Phase 2/Phase 3|450|Anticipated|KEMRI-Wellcome Trust Collaborative Research Program|||2||f||||t||||||Samples Without DNA|"~     Yearly cross sectional bleeds to collect blood samples.~   "|||2017-02-18 13:13:21.315238|2017-02-18 13:13:21.315238
NCT00872950|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-06-22|||June 2001||2001-06-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|LEMS||3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)|Open Label Trial Of 3,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenic Syndromes (CMS)|Recruiting||N/A|25|Anticipated|Lahey Clinic||1|||f||||f||||||||||2017-02-18 13:13:21.569701|2017-02-18 13:13:21.569701
NCT00872937|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2012-05-16|||March 2009||2009-03-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|March 2009|Actual|2009-03-01||Observational|||Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions|Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions|Unknown status|Recruiting|N/A|800|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:13:21.695072|2017-02-18 13:13:21.695072
NCT00872924|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-03-30|||July 2008||2008-07-01|March 2009|2009-03-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions|An Open Label, Bioequivalence Study of Sumatriptan Succinate 100 mg Tablets (Containing 140 mg of Sumatriptan Succinate Equivalent to 100 mg Sumatriptan) Under Fasting Conditions|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:13:21.772849|2017-02-18 13:13:21.772849
NCT00872898|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-11-26|2013-08-01||April 2009||2009-04-01|November 2013|2013-11-01||||August 2012|Actual|2012-08-01||Interventional||Part One of the study enrolled 4 patients to determine a safe dosing regimen for Part Two along with data collected for 14 patients enrolled in study MEM-PK-21. One patient from Part One of the study also enrolled in Part Two. The 121 patients enrolled in Part Two were randomized after two weeks of single-blind placebo treatment.|Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism|An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism|Completed||Phase 2|124|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 13:13:22.006648|2017-02-18 13:13:22.006648
NCT00872885|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-06-21||2010-06-11|March 2009||2009-03-01|June 2010|2010-06-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Bunionectomy Trial With GRT6005|A Randomized, Phase IIa Trial Evaluating the Safety and Efficacy of a New Centrally Acting Analgesic in Subjects With Moderate to Severe Pain Following Bunionectomy.|Completed||Phase 2|258|Actual|Grünenthal GmbH||5|||f||||f||||||||||2017-02-18 13:13:22.782814|2017-02-18 13:13:22.782814
NCT00872872|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2017-01-17|||May 2008||2008-05-01|April 2016|2016-04-01|April 2025|Anticipated|2025-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)|Nevirapine Plasma Level After Discontinuation of Short-term Antiretroviral Treatment for the Prevention of Mother-to-child Transmission of HIV and Development of Drug Resistant HIV-1 Variants With 1 or 2 Weeks Continuation of Zidovudine/Lamivudine in Women After Delivery|Active, not recruiting||N/A|30|Actual|Thai Red Cross AIDS Research Centre||2|||f||||f||||||||||2017-02-18 13:13:22.902676|2017-02-18 13:13:22.902676
NCT00872859|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2012-06-01|||October 2008||2008-10-01|June 2012|2012-06-01|October 2013|Anticipated|2013-10-01|May 2011|Actual|2011-05-01||Interventional|||The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial|The BREASTrial: Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial|Unknown status|Active, not recruiting|Phase 4|196|Anticipated|University of Utah||4|||f||||t||||||||||2017-02-18 13:13:22.994991|2017-02-18 13:13:22.994991
NCT00872846|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-28|2012-01-23|||February 2009||2009-02-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Balance System Study in Type 2 Diabetic Patients|Evaluation of the BALANCE System in Type 2 Diabetic Patients|Completed||Phase 1|20|Actual|Beta-Stim Ltd.||1|||f||||t||||||||||2017-02-18 13:13:23.103057|2017-02-18 13:13:23.103057
NCT00872833|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2015-10-05|2014-04-09||July 2009||2009-07-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions|Assessment of Pain in Transfusion Dependent Patients With Thalassemia During Transfusion Cycles|Completed||N/A|32|Actual|New England Research Institutes|||2||f||||t||||||||||2017-02-18 13:13:23.202665|2017-02-18 13:13:23.202665
NCT00872820|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2014-12-09|||October 2008||2008-10-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Examining Long-Term Effects and Neural Mediators of Behavioral Treatments for Social Anxiety Disorder|Neural Mediators of Behavior Therapy for Anxiety|Completed||N/A|50|Actual|University of California, Los Angeles||3|||f||||f||||||||||2017-02-18 13:13:23.501181|2017-02-18 13:13:23.501181
NCT00872807|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2014-12-11|||April 2009||2009-04-01|December 2012|2012-12-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||The Activity School in Finnmark for Overweight Children|The Activity School in Finnmark for Overweight and Obese Children and Their Families|Completed||N/A|97|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-02-18 13:13:23.606703|2017-02-18 13:13:23.606703
NCT00872794|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-08-03|||November 2003||2003-11-01|July 2016|2016-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Single Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery|Prospective Single-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of the DePuy ASR™ Hip in Subjects With Suitable Indications for a Primary Resurfacing Hip Arthroplasty|Terminated||Phase 4|50|Actual|DePuy International||1||"DePuy discontinued this product in 4Q 2009.At the time of this decision DePuy reviewed all~   clinical studies for this product and decided to close this Study."|f||||f||||||||||2017-02-18 13:13:23.710965|2017-02-18 13:13:23.710965
NCT00872781|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||October 2007||2007-10-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Bioavailability Study Comparing Fixed Dose Combination of Quinapril HCl 20 mg and Hydrochlorothiazide 25 mg Tablets of OHM Laboratories Inc (a Subsidiary of Ranbaxy Pharmaceuticals Inc) With ACCURETICTM Tablets (Containing Fixed Dose Combination of Quinapril HCl 20 mg and Hydrochlorothiazide 25 mg) of Parke Davis, in Healthy, Adult, Human, Male Subjects Under Fasting Condition.|Completed||N/A|64|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:13:23.806101|2017-02-18 13:13:23.806101
NCT00872755|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||January 2002||2002-01-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD)|Laparoscopic Nissen Fundoplication Combined With Posterior Gastropexy in Surgical Treatment of Gastroesophageal Reflux Disease|Completed||Phase 4|90|Actual|G. Hatzikosta General Hospital||2|||f||||f||||||||||2017-02-18 13:13:23.910074|2017-02-18 13:13:23.910074
NCT00872742|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2014-04-08|||March 2009||2009-03-01|April 2014|2014-04-01|October 2014|Anticipated|2014-10-01|October 2013|Actual|2013-10-01||Interventional|||Testing a New Therapy for Trichotillomania|Acceptance Enhanced Behavior Therapy for Trichotillomania|Unknown status|Active, not recruiting|Phase 2|84|Anticipated|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-02-18 13:13:24.011122|2017-02-18 13:13:24.011122
NCT00872729|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2017-01-13|2012-10-05||May 2009||2009-05-01|January 2017|2017-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis|A Pilot Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cysteamine Bitartrate Delayed-release Capsules (RP103), Compared to Cysteamine Bitartrate (Cystagon®) in Patients With Nephropathic Cystinosis|Completed||Phase 1/Phase 2|9|Actual|Horizon Orphan LLC||2|||f||||f||||||||||2017-02-18 13:13:24.129286|2017-02-18 13:13:24.129286
NCT00872716|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2011-03-30|||April 2009||2009-04-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|QUISS||Quetiapine in Specific Phobia|Anxiolytic Effects of Single-dose Quetiapine XR Administration on Clinical Symptoms and Amygdala Activation During Exposure in Patients With Simple Phobia|Completed||Phase 2|60|Actual|University Hospital Muenster||2|||f||||f||||||||||2017-02-18 13:13:24.609571|2017-02-18 13:13:24.609571
NCT00872703|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||January 2008||2008-01-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Observational|||Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection?|Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection?|Completed||N/A|42|Actual|Wolfson Medical Center|||2||f||||f||||||||||2017-02-18 13:13:24.722717|2017-02-18 13:13:24.722717
NCT00872690|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-03-13|||October 2010||2010-10-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Observational|||Factors Affecting Return to Work Among OEF/OIF Veterans With Polytrauma|Factors Affecting Return to Work Among OEF/OIF Veterans With Polytrauma|Completed||N/A|7|Actual|VA Office of Research and Development|||2||f||||f||||||||||2017-02-18 13:13:24.822763|2017-02-18 13:13:24.822763
NCT00872677|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-28|2013-04-25|||May 2004||2004-05-01|April 2013|2013-04-01|November 2008|Actual|2008-11-01|October 2006|Actual|2006-10-01||Observational|||Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors|A Culturally-Tailored Weight Loss Program|Completed||N/A|31|Actual|Barbara Ann Karmanos Cancer Institute|||2||f||||f||||||||||2017-02-18 13:13:24.932358|2017-02-18 13:13:24.932358
NCT00872664|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-12-03|||September 2009||2009-09-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids|Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids|Completed||N/A|36|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 13:13:25.042655|2017-02-18 13:13:25.042655
NCT00872651|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2013-03-27|||January 2010||2010-01-01|March 2013|2013-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 3|242|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:13:25.154234|2017-02-18 13:13:25.154234
NCT00872638|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-28|2015-05-28|||January 2008||2008-01-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Interventional|||The Effect of Wound Edge Eversion on Cosmesis|The Effect of Wound Edge Eversion on Cosmesis|Withdrawn||N/A|0|Actual|Stony Brook University||2||lack of participation|f||||f||||||||||2017-02-18 13:13:25.250588|2017-02-18 13:13:25.250588
NCT00872625|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-28|2015-02-08|||April 2007||2007-04-01|February 2015|2015-02-01|December 2010|Actual|2010-12-01|April 2009|Actual|2009-04-01||Interventional|||Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer|Phase I Study - Hypofractionated Cyberknife Radiotherapy Combined With Neoadjuvant Chemotherapy for Breast Tumors|Completed||Phase 1|26|Actual|Centre Antoine Lacassagne||1|||f||||||||||||||2017-02-18 13:13:25.351135|2017-02-18 13:13:25.351135
NCT00872612|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2015-12-04|||March 2009||2009-03-01|December 2015|2015-12-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Interventional|GRANULOMA||Trial for the Diagnosis of Sarcoidosis|Endosonography (EUS and EBUS) vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis: a Randomized Trial|Completed||Phase 3|304|Actual|Leiden University Medical Center||2|||f||||t||||||||||2017-02-18 13:13:25.549236|2017-02-18 13:13:25.549236
NCT00872599|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-06-19|2013-02-26||September 2009||2009-09-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||Total number who completed the screening and low salt diet and were randomized.|The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans|The Effect of a PPAR Alpha Agonist on CYP Monooxygenase Activity in Humans|Completed||Phase 4|75|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 13:13:25.675713|2017-02-18 13:13:25.675713
NCT00872586|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2010-09-28|||August 2006||2006-08-01|September 2010|2010-09-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension|A Randomized, Double-blind, Double-dummy, Multicenter Clinical Trial to Evaluate the Additional Efficacy and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension, Who Fail to Attain the Blood Pressure Goals With Olmesartan Medoxomil 20mg Monotherapy|Completed||Phase 3|304|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:13:25.991037|2017-02-18 13:13:25.991037
NCT00872573|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-07-01|||July 2006||2006-07-01|June 2016|2016-06-01|October 2007||2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Two Centre Study to Assess the Stability and Long-term Performance of the C-Stem™ AMT in a Total Primary Hip Replacement|Prospective, Uncontrolled, Two-centre, RSA, Post-market Surveillance Study to Evaluate the Stability of the C-Stem™ AMT Femoral Component in Primary Total Hip Arthroplasty.|Terminated||Phase 4|5|Actual|DePuy International||1||Technical issues with RSA at main site and departure of Principal Investigator|f||||f||||||||||2017-02-18 13:13:26.118781|2017-02-18 13:13:26.118781
NCT00872560|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2012-01-23|||January 1998||1998-01-01|January 2012|2012-01-01|July 1998|Actual|1998-07-01|July 1998|Actual|1998-07-01||Interventional|||Comparison of 2 NovoFine® Needles on the Reflux of Insulin|Insulin Leakage and Pain Perception in IDDM Children or Adolescents, Where the Injections Are Performed With NovoFine™ 6 x 0.30 mm Needles and NovoFine® 8 x 0.30 mm Needles: An Open, Randomized, Two-period Cross-over, Multi-centre, Phase IIIb Trial at 4 Centres|Completed||Phase 3|60|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 13:13:26.206129|2017-02-18 13:13:26.206129
NCT00872547|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-08-03|||September 2006||2006-09-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip Replacement|Prospective, International Multi-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of a Large Metal-on-Metal (MoM) Bearing Comprising a DePuy ASR™ Cup in Conjunction With Either a DePuy ASR™ Hip Resurfacing Femoral Component or a DePuy ASR™ XL Head in Subjects With Indications Suitable for Either a Primary Resurfacing Arthroplasty or Primary Total Hip Arthroplasty|Terminated||Phase 4|329|Actual|DePuy International||2||"DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all~   clinical studies for this product and decided to close this Study"|f||||f||||||||||2017-02-18 13:13:26.307864|2017-02-18 13:13:26.307864
NCT00872534|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2015-08-05|2015-06-22||January 2009||2009-01-01|August 2015|2015-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers|A Randomized, Single-Blind, Endoscopic Evaluation Of Upper GI Mucosal Damage Induced By PL-2200 Versus Aspirin In Healthy Volunteers|Completed||Phase 1/Phase 2|204|Actual|PLx Pharma||2|||f||||f||||||||||2017-02-18 13:13:26.570339|2017-02-18 13:13:26.570339
NCT00872521|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2014-05-07|2012-12-14||January 2009||2009-01-01|May 2014|2014-05-01|November 2011|Actual|2011-11-01|March 2011|Actual|2011-03-01||Interventional|||A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma|A Phase II Trial of Bortezomib, Doxorubicin and Dexamethasone (PAD) Induction Therapy in Patients With Untreated Multiple Myeloma (MM), Stratified for Markers of Bortezomib Resistance|Completed||Phase 2|107|Actual|Janssen-Cilag Pty Ltd||1|||f||||f||||||||||2017-02-18 13:13:26.884343|2017-02-18 13:13:26.884343
NCT00872495|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-09-06|||September 2002||2002-09-01|September 2016|2016-09-01|November 2025|Anticipated|2025-11-01|October 2025|Anticipated|2025-10-01||Observational|||Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer|Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney|Recruiting||N/A|500|Anticipated|Lahey Clinic|||2||f||||f||||||Samples With DNA|"~     Urine~   "|||2017-02-18 13:13:28.425276|2017-02-18 13:13:28.425276
NCT00872482|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2011-06-30|||April 2009||2009-04-01|June 2011|2011-06-01|July 2011|Anticipated|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases|A Randomized, Phase II, Double-Blind Study of Nimotuzumab Plus Whole-Brain Radiation Therapy (WBRT) Compared With WBRT Alone in Patients With Brain Metastases From Non-Small Cell Lung Cancer|Terminated||Phase 2|21|Actual|YM BioSciences||2||Study closed due to low enrollment|f||||f||||||||||2017-02-18 13:13:28.531828|2017-02-18 13:13:28.531828
NCT00872469|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-09-08|||May 2009||2009-05-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|June 2016|Actual|2016-06-01||Interventional|WOMAN||World Maternal Antifibrinolytic Trial|Tranexamic Acid for the Treatment of Postpartum Haemorrhage: An International Randomised, Double Blind, Placebo Controlled Trial|Active, not recruiting||Phase 3|20060|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||Yes|Will be available at https://ctu-app.lshtm.ac.uk/freebird/ in the future|2017-02-18 13:13:28.651041|2017-02-18 13:13:28.651041
NCT00872456|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-07-25|||March 2005||2005-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|ADHOC||Associations Between Diabetes Care and Haptoglobin Genotype On outComes|The ADHOC Project: Associations Between Diabetes Care and Haptoglobin Genotype On outComes|Active, not recruiting||N/A|3054|Actual|Clalit Health Services|||1||f||||t||||||||||2017-02-18 13:13:28.771409|2017-02-18 13:13:28.771409
NCT00872443|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2010-04-27|||November 2008||2008-11-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|FOPasa||Interest of Occlusion of Permeable Foramen Ovale After a Cryptogenic Cerebrovascular Accident (CVA)|Interest of Occlusion of Permeable Foramen Ovale After a Cryptogenic Cerebrovacular Accident.|Completed||N/A|72|Actual|Nantes University Hospital|||1||f||||f||||||||||2017-02-18 13:13:28.842368|2017-02-18 13:13:28.842368
NCT00872430|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2009-06-16|2008-11-06||July 2002||2002-07-01|June 2009|2009-06-01|June 2003|Actual|2003-06-01|December 2002|Actual|2002-12-01||Interventional|||Laxative Effectiveness of a Phytotherapeutic Tea|Laxative Effectiveness of a Phytotherapeutic Tea: A Randomized Placebo-Controlled Clinical Trial|Completed||Phase 2|20|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-02-18 13:13:28.923054|2017-02-18 13:13:28.923054
NCT00872417|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||March 2009||2009-03-01|March 2009|2009-03-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients|Research on the Antiretroviral Therapy and Immune Reconstitution on Chinese HIV/AIDS Patients|Unknown status|Not yet recruiting|Phase 4|750|Anticipated|Peking Union Medical College||3|||f||||t||||||||||2017-02-18 13:13:29.365202|2017-02-18 13:13:29.365202
NCT00872404|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-04-19|||January 2009||2009-01-01|April 2016|2016-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma|A Phase II Study of CP-751,871 in Patients With Recurrent and/or Metastatic Squamous Head and Neck Carcinoma|Terminated||Phase 2|37|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1||lack of efficacy|f||||f||||||||||2017-02-18 13:13:29.489826|2017-02-18 13:13:29.489826
NCT00872391|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||March 2009||2009-03-01|March 2009|2009-03-01||||March 2024|Anticipated|2024-03-01||Interventional|||Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma|Safety and Efficacy of Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Malignant Melanoma of the Uvea|Recruiting||N/A|155|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-02-18 13:13:29.601145|2017-02-18 13:13:29.601145
NCT00872378|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-03-30|||February 2009||2009-02-01|March 2009|2009-03-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|AGREE||The Effects of Exenatide After Gastric Restriction|A Pilot Study of the Effects of BYETTA® (Exenatide) on Weight Loss in Morbidly Obese Non Diabetic Patients Following Adjustable Gastric Banding|Unknown status|Recruiting|Phase 2/Phase 3|28|Anticipated|Advanced Specialty Care||2|||f||||t||||||||||2017-02-18 13:13:29.713386|2017-02-18 13:13:29.713386
NCT00872365|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2011-01-08|||March 2011||2011-03-01|January 2011|2011-01-01|May 2012|Anticipated|2012-05-01|November 2011|Anticipated|2011-11-01||Interventional|||Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases|Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases|Unknown status|Not yet recruiting|Phase 2/Phase 3|320|Anticipated|Universidad del Valle, Colombia||4|||f||||t||||||||||2017-02-18 13:13:29.824708|2017-02-18 13:13:29.824708
NCT00872352|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||April 2009||2009-04-01|March 2009|2009-03-01|August 2009|Anticipated|2009-08-01|July 2009|Anticipated|2009-07-01||Interventional|||Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients|Phase 3 Study to Evaluate Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients.|Unknown status|Not yet recruiting|Phase 3|30|Anticipated|Wolfson Medical Center||1|||f||||f||||||||||2017-02-18 13:13:29.946677|2017-02-18 13:13:29.946677
NCT00872339|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2014-05-27|2014-01-02||March 2009||2009-03-01|January 2014|2014-01-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Observational|Pain||Assessment of Pain in People With Thalassemia|Assessment of Pain in People With Thalassemia|Completed||N/A|252|Actual|New England Research Institutes|||3||f||||t||||||||||2017-02-18 13:13:30.048861|2017-02-18 13:13:30.048861
NCT00872326|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2014-11-13|||December 2007||2007-12-01|November 2014|2014-11-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia|Phase I/II Study of Regenerative Cell Therapy in Treating Diabetic Patients With Critical Limb Ischemia|Completed||Phase 1/Phase 2|20|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||1|||f||||f||||||||||2017-02-18 13:13:30.432226|2017-02-18 13:13:30.432226
NCT00872313|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2014-01-11|||February 2009||2009-02-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|RIFPP||Risk Factors for Postpartum Psychosis|Potential Risk Factors for Postpartum Psychosis|Completed||N/A|4000|Actual|Nanjing Medical University|||2||f||||t||||||||||2017-02-18 13:13:30.534671|2017-02-18 13:13:30.534671
NCT00872300|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2014-05-13||2014-05-13|October 2008||2008-10-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||PHA-739358 for the Treatment of Multiple Myeloma|An Exploratory Phase II Study of PHA-739358 in Patients With Multiple Myeloma Harbouring the t(4;14) Translocation With or Without FGFR3 Expression|Terminated||Phase 2|7|Actual|Nerviano Medical Sciences||1||Low recruitment rate|f||||||||||||||2017-02-18 13:13:30.619739|2017-02-18 13:13:30.619739
NCT00872287|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||September 2008||2008-09-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pain in Single Incision Laparoscopic Surgery Cholecystectomy|Randomized Controlled Study of Different Pain Scores in Single Transumbilical Incision Laparoscopic Cholecystectomy Versus Classic Laparoscopic Cholecystectomy|Completed||Phase 4|40|Actual|G. Hatzikosta General Hospital||2|||f||||f||||||||||2017-02-18 13:13:30.715822|2017-02-18 13:13:30.715822
NCT00872274|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-03-30|||July 2008||2008-07-01|March 2009|2009-03-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions|An Open Label, Bioequivalence Study of Sumatriptan Succinate 100 mg Tablets (Containing 140 mg of Sumatriptan Succinate Equivalent to 100 mg Sumatriptan) Under Fed Conditions|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:13:30.813358|2017-02-18 13:13:30.813358
NCT00872261|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2013-04-29|||March 2010||2010-03-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|||Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation|Adolescent Women & Microbicide Trials: Assessing the Challenges & Opportunities to Their Participation|Completed||N/A|135|Actual|FHI 360|||1||f||||f||||||||||2017-02-18 13:13:30.911021|2017-02-18 13:13:30.911021
NCT00872248|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2011-07-26|||February 2009||2009-02-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|NARELESS||Neuraxial Anesthesia and Restless Leg Syndromes in Cesarean|Correlation of Neuraxial Anesthesia and Restless Leg Syndromes in Cesarean Delivery|Completed||N/A|350|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 13:13:31.009368|2017-02-18 13:13:31.009368
NCT00872235|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||June 2005||2005-06-01|March 2009|2009-03-01|November 2005|Actual|2005-11-01|July 2005|Actual|2005-07-01||Interventional|||Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions|An Open Label, Balanced, Randomised, Two-Treatment, Four-Period, Two-Sequence, Single-Dose, Crossover, Fully Replicated Bioavailability Study on Fixed-Dose Combination of Quinapril 20 mg and Hydrochlorothiazide 25 mg Tablets of OHM Laboratories Inc.(Division of Ranbaxy Laboratories Limited) With Accuretic 20-25 mg Tablets (Fixed Dose Combination of Quinapril 20 mg and Hydrochlorothiazide 25 mg) of Parke-Davis (Division of Pfizer Inc.) in Healthy, Adult, Human, Male Subjects Under Fed Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||4|||f||||t||||||||||2017-02-18 13:13:31.115073|2017-02-18 13:13:31.115073
NCT00872222|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-10-06|||January 2007||2007-01-01|September 2016|2016-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Single Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Ceramic-on-ceramic Bearing in Primary Total Hip Replacement|Uncontrolled Prospective Multi-Centre Post Marketing Surveillance Study to Monitor the Long Term Survivorship of Pinnacle™ Acetabular Cup Prosthesis With a Ceramic-on-ceramic Bearing in Subjects With Aetiologies Requiring a Primary Total Hip Replacement|Terminated||Phase 4|98|Actual|DePuy International||1||Study terminated early due to business reasons|f||||f||||||||||2017-02-18 13:13:33.536815|2017-02-18 13:13:33.536815
NCT00872209|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-29|2009-12-23|||May 2009||2009-05-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa|Bioequivalence of Ciprofloxacin 0.3%: a Randomized, Multicenter, Parallel, Comparative Study on the Safety and Efficacy of Ciprofloxacin 0.3% in a Standard Solution or Foam Solution, in Patients With Acute External Otitis.|Completed||Phase 1/Phase 2|100|Anticipated|Otic Pharma||2|||f||||t||||||||||2017-02-18 13:13:33.64224|2017-02-18 13:13:33.64224
NCT00872196|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2013-03-22||2011-09-06|April 2009||2009-04-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies|A Follow-up Study to Assess the Evolution and Persistence of Resistance to ABT-072 After Discontinuation of ABT-072 Therapy in HCV Genotype-1 Infected Subjects Who Participated in Phase 1, 2, or 3 ABT-072 Clinical Studies|Completed||Phase 2|5|Actual|AbbVie||1|||f||||||||||||||2017-02-18 13:13:33.752817|2017-02-18 13:13:33.752817
NCT00872183|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-28|2017-01-24|||March 25, 2009||2009-03-25|May 3, 2012|2012-05-03|May 3, 2012||2012-05-03|||||Observational|||Exploring a Motor Learning Technique Based on the Mirror Motor Neuron System|Exploring a Motor Learning Technique Based on the Mirror Motor Neuron System|Completed||N/A|76|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:13:33.843243|2017-02-18 13:13:33.843243
NCT00872170|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2014-01-02|2013-04-24||March 2009||2009-03-01|January 2014|2014-01-01|November 2010|Actual|2010-11-01|June 2010|Actual|2010-06-01||Interventional||All 27 patients (14 in the Sildenafil group and 13 in the control group) who completed the baseline visit were used.|Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension|Pilot of Oral Sildenafil for the Treatment of Pulmonary Hypertension in Thalassemia With Comparison to Controls|Completed||Phase 2/Phase 3|27|Actual|New England Research Institutes|Of 14 patients in the Sildenafil arm, 4 patients with discrepant TRVs between the local site, core lab and NHLBI readings were excluded for the main analyses.|2|||f||||t||||||||||2017-02-18 13:13:33.923269|2017-02-18 13:13:33.923269
NCT00872157|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2015-10-22|||March 2009||2009-03-01|October 2015|2015-10-01||||October 2015|Actual|2015-10-01||Interventional|||BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets|A Limited, First-in-Man, Phase IB Evaluation of BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With High-Volume Osseous Metastases and no Standard Treatment Options|Completed||Phase 1|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:13:34.491502|2017-02-18 13:13:34.491502
NCT00872144|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-03-05|||June 2010||2010-06-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Sativex for Treatment of Chemotherapy Induced Neuropathic Pain|A Double Blind Placebo Controlled Crossover Pilot Trial of Sativex With Open Label Extension for Treatment of Chemotherapy Induced Neuropathic Pain|Completed||Phase 3|16|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-02-18 13:13:34.745591|2017-02-18 13:13:34.745591
NCT00872131|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2011-11-21|||March 2008||2008-03-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Observational|||Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder|Neuro-Genetic Markers of SSRI Treatment Response in Social Anxiety Disorder|Completed||Phase 4|200|Actual|University of Michigan|||2||f||||f||||||Samples With DNA|"~     Saliva samples~   "|||2017-02-18 13:13:34.847391|2017-02-18 13:13:34.847391
NCT00872118|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2010-09-15|||April 2004||2004-04-01|September 2010|2010-09-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|BISAD||Brief Intervention for Socially Anxious College Drinkers|Brief Intervention for Socially Anxious Alcohol Abusers|Completed||Phase 1|53|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 13:13:34.960771|2017-02-18 13:13:34.960771
NCT00872105|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-10-24|||March 2009||2009-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Conservative Treatment Versus Operative Plate Fixation for Acute, Displaced Fractures of the Distal Clavicle|A Multicentre, Randomized Trial of Conservative Treatment Versus Operative Plate Fixation for Acute, Displaced Fractures of the Distal Clavicle|Active, not recruiting||N/A|59|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 13:13:35.072312|2017-02-18 13:13:35.072312
NCT00872092|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||October 1997||1997-10-01|March 2009|2009-03-01|September 1998|Actual|1998-09-01|September 1998|Actual|1998-09-01||Observational|BTO||Validation of Breath Tests in Diagnosing Small Bowel Bacterial Overgrowth|Validation of Breath Tests in Diagnosing Small Bowel Bacterial Overgrowth|Completed||N/A|22|Actual|University Hospital, Bonn|||1||f||||f||||||Samples Without DNA|"~     Breath samples~   "|||2017-02-18 13:13:35.177458|2017-02-18 13:13:35.177458
NCT00872079|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2014-02-21|2014-02-21||September 2008||2008-09-01|February 2014|2014-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Personalized Warfarin Dosing by Genomics and Computational Intelligence|Personalized Warfarin Dosing Using Genomics and Computational Intelligence|Terminated||N/A|175|Actual|VA Office of Research and Development||1||Lack of Funding|f||||f||||||||||2017-02-18 13:13:35.290873|2017-02-18 13:13:35.290873
NCT00872066|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-08-12|||March 2006||2006-03-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement|A Prospective, Randomised, Uncontrolled, Single-Centre, Post-Market Surveillance Study To Evaluate The Performance Of SmartSet® HV and SmartSet® GHV Bone Cements In Primary Cemented Total Hip Arthroplasty(THA)|Active, not recruiting||Phase 4|243|Actual|DePuy International||2|||f||||f||||||||||2017-02-18 13:13:35.57291|2017-02-18 13:13:35.57291
NCT00872053|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2013-09-18|||February 2009||2009-02-01|September 2013|2013-09-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis|Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis|Completed||Phase 1/Phase 2|18|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 13:13:35.685604|2017-02-18 13:13:35.685604
NCT00872040|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2009-03-30|||October 2008||2008-10-01|March 2009|2009-03-01|October 2011|Anticipated|2011-10-01|October 2010|Anticipated|2010-10-01||Observational|||The Effect of Delivery Mode on Inter - Couple Relationship, Sexual Function and Pelvic Floor Activity|Observational Study on the Effect of Delivery Mode on Inter Personal Relationship, Sexual Function and Pelvic Floor Activity|Unknown status|Recruiting|N/A|300|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 13:13:35.786034|2017-02-18 13:13:35.786034
NCT00872027|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-30|2016-06-23|||April 2009||2009-04-01|June 2016|2016-06-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|||Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit|Feasibility Study to Prevent Post-ICU Depression|Completed||Phase 4|37|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 13:13:35.888564|2017-02-18 13:13:35.888564
NCT00872014|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-03-07||2015-10-22|August 2009||2009-08-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|October 2011|Actual|2011-10-01||Interventional|||A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer|Phase 2 Open-label Multi-Center Study to Evaluate the Efficacy and Safety of AMG 386 and Sorafenib as First Line Therapy for Subjects With Advanced or Inoperable Hepatocellular Carcinoma|Completed||Phase 2|60|Actual|Amgen||2|||f||||||||||||||2017-02-18 13:13:36.013608|2017-02-18 13:13:36.013608
NCT00872001|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-10-28|2012-11-20||April 2009||2009-04-01|October 2015|2015-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|RED-CABG||The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)|The Effect Of Acadesine On Clinically Significant Adverse Cardiovascular and Cerebrovascular Events In High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonary Bypass (Protocol No. P05633): RED-CABG Trial (Reduction in Cardiovascular Events by AcaDesine in Subjects Undergoing CABG)|Terminated||Phase 3|3080|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 13:13:36.130845|2017-02-18 13:13:36.130845
NCT00871975|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-06-07|2015-09-01||April 2009||2009-04-01|June 2016|2016-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Includes both male patients suffering from LUTS, and female patients suffering from OAB.|Tetra-NIRS Clinical Study|Diagnostic Utility of Tetra-NIRS in Conjunction With Urodynamic Studies|Terminated||Phase 4|155|Actual|Laborie Medical Technologies Inc.|Early termination was due to slow recruitment exceeding trial deadlines. Technical issues resulted in several studies being excluded (8).|1||Low enrollment exceeding trial deadlines|f||||f||||||||No|Data are highly reliant on expert interpretation on a case-by-case basis.|2017-02-18 13:13:37.262804|2017-02-18 13:13:37.262804
NCT00871962|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-06-22|||June 2009||2009-06-01|June 2015|2015-06-01|May 2016|Anticipated|2016-05-01|December 2015|Anticipated|2015-12-01||Observational|||Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival|Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival: Survival Factors in COPD Treated by Long-term Oxygen Therapy|Active, not recruiting||N/A|750|Anticipated|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche|||1||f||||t||||||Samples Without DNA|"~     Blood gaz analysis~   "|||2017-02-18 13:13:37.518063|2017-02-18 13:13:37.518063
NCT00871949|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2013-08-26|||April 2009||2009-04-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults|A Phase 1 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PNU-100480 (PF-02341272) After First Time Administration Of Ascending Oral Doses To Healthy Adult Subjects Under Fed And Fasted Conditions|Completed||Phase 1|19|Actual|Sequella, Inc.||6|||f||||f||||||||||2017-02-18 13:13:37.63158|2017-02-18 13:13:37.63158
NCT00871936|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-02-02||2014-12-09|April 2009||2009-04-01|February 2015|2015-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of SLx-4090 in Combination With Metformin in Subjects With Type 2 Diabetes|Completed||Phase 2|82|Actual|Kadmon Corporation, LLC||2|||f||||f||||||||||2017-02-18 13:13:37.788516|2017-02-18 13:13:37.788516
NCT00871923|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-11-04|||March 2009||2009-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer|A Phase II Study to Determine the Efficacy of Tarceva® (Erlotinib Hydrochloride) With Concurrent Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:13:37.909012|2017-02-18 13:13:37.909012
NCT00871910|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-06-05|||October 2006||2006-10-01|June 2015|2015-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Cyclin-Dependent Kinase (CDK) Inhibitor SCH 727965 Administered Every 3 Weeks in Subjects With Advanced Malignancies|Completed||Phase 1|81|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 13:13:38.03459|2017-02-18 13:13:38.03459
NCT00871897|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-07-28|||April 2009||2009-04-01|December 2009|2009-12-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Observational|CHF CaRe||Examining the Cognitive Benefits of Cardiac Rehabilitation in People With Heart Failure (The CHF CaRe Study)|Cognitive Benefits of Cardiac Rehabilitation in Heart Failure|Unknown status|Enrolling by invitation|N/A|200|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||2||f||||f||||||||||2017-02-18 13:13:38.140937|2017-02-18 13:13:38.140937
NCT00871884|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2014-01-21|||April 2008||2008-04-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Evaluation of Two Treatments for Chronic Post Concussion Syndrome|The Role of Anxiety Sensitivity in the Maintenance of Chronic Post Concussion Symptoms|Terminated||Phase 1/Phase 2|10|Actual|Simon Fraser University||2||Poor enrollment, low recruitment.|f||||t||||||||||2017-02-18 13:13:38.224848|2017-02-18 13:13:38.224848
NCT00871871|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-07-22|2011-02-22||March 2009||2009-03-01|July 2015|2015-07-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)|A Randomized, Double-Blind, Placebo-Controlled, 2-Part Study to Evaluate the Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis in Obese Patients With Hypertension|Completed||Phase 1|64|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:13:38.350723|2017-02-18 13:13:38.350723
NCT00871858|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2011-01-07|||January 2008||2008-01-01|July 2009|2009-07-01||||September 2009|Anticipated|2009-09-01||Interventional|||Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer|Response to Neoadjuvant Treatment With Anti-aromatase Anastrozole and Anti-estrogen Fulvestrant: a Randomized Phase II Study in Postmenopausal Patients With Hormone-sensitive Nonmetastatic Breast Cancer and an Exploratory Study of Molecular Signatures of Response|Unknown status|Recruiting|Phase 2|114|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:13:39.194476|2017-02-18 13:13:39.194476
NCT00871845|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-03-26|||September 2008||2008-09-01|March 2009|2009-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients|Effects of Dietary and Behavioral Intervention and Orlistat for Management of Obesity and Metabolic Syndrome on Response to Hepatitis C Therapy|Unknown status|Recruiting|Phase 4|222|Anticipated|University of Pittsburgh||6|||f||||t||||||||||2017-02-18 13:13:39.309498|2017-02-18 13:13:39.309498
NCT00871832|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-06-05|||May 2007||2007-05-01|June 2013|2013-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality|To Evaluate if Pre-admission Hyperglycemia Measured by Glycosylated Hemoglobin Level Affects the Morbidity and Mortality of Patients in a Mixed Medical and Surgical Intensive Care Unit|Completed||N/A|200|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 13:13:39.429001|2017-02-18 13:13:39.429001
NCT00871819|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2013-11-05|2012-02-13||March 2009||2009-03-01|November 2013|2013-11-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|OP||Optimized Programming in Spinal Cord Stimulation (SCS) System|Optimized Programming in a Multiple-Independent Current Sources Spinal Cord Stimulation (SCS) System|Completed||Phase 4|20|Actual|Boston Scientific Corporation|Small number of subjects; technical outcomes not necessarily predictive of therapeutic effectiveness.|1|||f||||f||||||||||2017-02-18 13:13:39.511848|2017-02-18 13:13:39.511848
NCT00871806|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-04-22|||April 2009||2009-04-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water|Phase 1, Open-Label, Randomized, Single-Dose, 5-Way Crossover Pilot Bioavailability Study Comparing Eletriptan Oral Disintegrating Tablet Formulations A And B Administered With Or Without Water To Relpax® Commercial Tablets Administered With Water|Completed||Phase 1|20|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 13:13:39.736053|2017-02-18 13:13:39.736053
NCT00871793|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2012-06-28|||March 2009||2009-03-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Occupational Therapy on the Function and Mobility of Elbow Fractures|Effect of Occupational Therapy on the Function and Mobility in Supracondylar Humerus Fractures: A Randomized Controlled Trial|Completed||N/A|61|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-02-18 13:13:39.843826|2017-02-18 13:13:39.843826
NCT00871780|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2014-11-11|2014-11-11||August 2009||2009-08-01|November 2014|2014-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|TIMER|Efficacy Analysis Population (participants who had at least 1 infusion of natalizumab and completed at least 1 on-treatment evaluation)|A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients|"A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients TIMER Study"|Completed||Phase 4|224|Actual|Biogen||1|||f||||f||||||||||2017-02-18 13:13:39.939279|2017-02-18 13:13:39.939279
NCT00871767|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-06-29|||March 2009||2009-03-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|||||Interventional|||AZD5672 Bioavailability Study in Healthy Male and Female Subjects|An Open-Label, Randomized, 4 Period Crossover, Replicate Study to Assess the Relative Bioavailability of the Phase III and Phase IIb Formulations of AZD5672 in Healthy Male and Female Subjects|Completed||Phase 1|24|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:13:40.498255|2017-02-18 13:13:40.498255
NCT00871754|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-03-02|||April 1988||1988-04-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Molecular Analysis Of Bladder Cancer|Molecular Analysis Of Bladder Cancer|Active, not recruiting||N/A|5000|Anticipated|Lahey Clinic|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 13:13:40.599627|2017-02-18 13:13:40.599627
NCT00871741|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-10-11||2012-11-16|April 2009||2009-04-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.|Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.|Terminated||Phase 2|16|Actual|GlaxoSmithKline||2||"Study stopped due to non-approval of IEC to proposed change in locations. Study~   discontinuation not due to safety/efficacy reasons related to the vaccine."|f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:13:40.679753|2017-02-18 13:13:40.679753
NCT00871728|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2013-06-24|2013-04-29||January 2007||2007-01-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules|Change in SCIO (Scoring Clinical Index For Onychomycosis) in Toenail Onychomycosis Treating With Itraconazole Capsules|Completed||Phase 4|132|Actual|Janssen Korea, Ltd., Korea|Initially it was planned to assess clinical cure rate but analysis for clinical cure rate following the administration of the study drug was replaced by change in SCIO scores which was the primary endpoint.|1|||f||||f||||||||||2017-02-18 13:13:40.79911|2017-02-18 13:13:40.79911
NCT00871715|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-03-23|2016-02-17||June 2009||2009-06-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ICARE||Arm Rehabilitation Study After Stroke|Interdisciplinary Comprehensive Arm Rehab Evaluation (ICARE) Stroke Initiative|Completed||Phase 3|361|Actual|University of Southern California||3|||f||||t||||||||||2017-02-18 13:13:41.127124|2017-02-18 13:13:41.127124
NCT00871702|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2013-07-09|||October 2010||2010-10-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease|Infusion of Genetically Modified T Cells: A Pilot Study of Tracking and Toxicity|Completed||Phase 1|12|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 13:13:43.22195|2017-02-18 13:13:43.22195
NCT00871689|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2012-07-18|2012-06-11||January 2009||2009-01-01|July 2012|2012-07-01|October 2011|Actual|2011-10-01|March 2010|Actual|2010-03-01||Interventional|||Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML|Haploidentical Donor NK Cell Adoptive Therapy and Double T Cell Depleted Umbilical Cord Blood Transplantation With Post-Transplant IL-2 Immune Therapy For Refractory Acute Myeloid Leukemia|Terminated||Phase 2|2|Actual|Masonic Cancer Center, University of Minnesota|Quantitative, phenotypic and functional assessment of the in vivo expanded UCB-derived NK cells on Day 72 were not performed. Patients were not well enough to provide research samples.|1||Due to graft failure.|f||||t||||||||||2017-02-18 13:13:43.338575|2017-02-18 13:13:43.338575
NCT00871676|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-08-15|||May 2006||2006-05-01|March 2009|2009-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Use of Chewing Gum to Facilitate Appetite Control and Weight Loss|Use of Chewing Gum to Facilitate Appetite Control and Weight Loss in Overweight Individuals Treated by Lifestyle Modification|Completed||N/A|146|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 13:13:43.674842|2017-02-18 13:13:43.674842
NCT00871663|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-04-17|||August 2006||2006-08-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Cyclin-Dependent Kinase (CDK) Inhibitor SCH 727965 Administered Weekly in Subjects With Advanced Malignancies|Completed||Phase 1|123|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:13:43.776777|2017-02-18 13:13:43.776777
NCT00871650|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-01-14|||March 2009||2009-03-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|March 2011|Actual|2011-03-01||Observational|REM-P||Neurobiological Correlates of Post Traumatic Stress Disorder (PTSD) During Rapid Eye Movement (REM) Sleep|Neurobiological Correlates of PTSD During REM Sleep (REM-P)|Completed||N/A|24|Anticipated|University of Pittsburgh|||2||f||||t||||||||||2017-02-18 13:13:43.861924|2017-02-18 13:13:43.861924
NCT00871637|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-03-26|||August 2008||2008-08-01|March 2009|2009-03-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Observational|||Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction|Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction|Unknown status|Recruiting|N/A|30|Anticipated|University of Nebraska|||3||f||||t||||||||||2017-02-18 13:13:43.974049|2017-02-18 13:13:43.974049
NCT00871624|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-11-03|2014-04-07||March 2009||2009-03-01|November 2015|2015-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation|Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation for Patients With Acute Respiratory Failure: A Randomized, Double-blind, Placebo-controlled Pilot Study|Completed||Phase 2|36|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-02-18 13:13:44.077263|2017-02-18 13:13:44.077263
NCT00871611|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2011-07-27|||January 2009||2009-01-01|July 2011|2011-07-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Observational|VIEPAF||Viennese Prevalence Study of Anderson-Fabry Disease|Prevalence of Anderson - Fabry Disease in Patients With Left Ventricular Hypertrophy|Unknown status|Active, not recruiting|N/A|4000|Anticipated|Medical University of Vienna|||1||f||||f||||||Samples Without DNA|"~     Urine~   "|||2017-02-18 13:13:44.392912|2017-02-18 13:13:44.392912
NCT00871598|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2010-11-15|||March 2009||2009-03-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||BTT1023 in Psoriasis|A Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of Repeated Intravenous Doses of BTT-1023 in Patients With Plaque Psoriasis - a Double-blind Randomized Placebo-controlled Sequential Group Trial|Completed||Phase 1|26|Actual|Biotie Therapies Corp.||6|||f||||f||||||||||2017-02-18 13:13:44.483043|2017-02-18 13:13:44.483043
NCT00871585|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2010-04-14|||March 2009||2009-03-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide|Non-interventional Observational Study to Evaluate Change of PSA Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide in Combination With Medical or Surgical Castration|Completed||N/A|340|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:13:44.592575|2017-02-18 13:13:44.592575
NCT00871572|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-12-09||2010-12-09|March 2009||2009-03-01|December 2010|2010-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study for Patients With Type 2 Diabetes Mellitus|A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of LY2409021 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|87|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 13:13:44.6978|2017-02-18 13:13:44.6978
NCT00871559|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-03-24|||June 2009||2009-06-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies|A Phase 1, Multiple-Dose Study of the Safety and Tolerability of Single Agent REGN421 Administered Every 2 or 3 Weeks in Patients With Advanced Solid Malignancies|Completed||Phase 1|83|Actual|Regeneron Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:13:44.819364|2017-02-18 13:13:44.819364
NCT00871546|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-08-06|||March 2009||2009-03-01|August 2015|2015-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)|A Randomized Phase 2 Study of SCH 727965 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) or B-Cell Chronic Lymphocytic Leukemia (B-CLL)|Terminated||Phase 2|8|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 13:13:44.914968|2017-02-18 13:13:44.914968
NCT00871533|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2017-01-18|||September 2009||2009-09-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Interventional|||Pilot Study of IFN α2b for Melanoma Patients|Pilot Analysis of the Effects of IFN α2b Upon the Molecular Profile of Regional Lymph Nodes in Melanoma Patients With and Without Tumor-Involved Sentinel Lymph Nodes|Recruiting||Early Phase 1|60|Anticipated|University of Pittsburgh||5|||f||||t||||||||||2017-02-18 13:13:45.01484|2017-02-18 13:13:45.01484
NCT00871520|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-08-22|||April 2008||2008-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|December 2011|Actual|2011-12-01||Observational|||Prognosis and Survival Estimates in Palliative Therapy|Prognosis in Palliative Therapy - a Prospective Study on Survival Prognostication in Advanced Stage Cancer Patients|Completed||N/A|612|Actual|Heinrich-Heine University, Duesseldorf|||1||f||||f||||||||||2017-02-18 13:13:45.130234|2017-02-18 13:13:45.130234
NCT00871507|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2014-05-21|||April 2009||2009-04-01|May 2014|2014-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus|SD in Subjects With T2DM|Completed||Phase 1|25|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||f||||||||||2017-02-18 13:13:45.231417|2017-02-18 13:13:45.231417
NCT00871494|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2011-09-28|2011-09-28||May 2009||2009-05-01|September 2011|2011-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan|A Multicenter, Non-Randomized, Open Label Study Of Azithromycin Intravenous Followed By Oral Administration In Japanese Adult Subjects With Pelvic Inflammatory Disease (PID) Requiring Initial Intravenous Therapy|Completed||Phase 3|76|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:13:45.346251|2017-02-18 13:13:45.346251
NCT00871481|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2013-12-17|||February 2009||2009-02-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma|Phase I/II Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4 For Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|10|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 13:13:45.797534|2017-02-18 13:13:45.797534
NCT00871468|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-12-27|||October 2008||2008-10-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Plating Clavicle Fractures|Does Anterior-Inferior Clavicle Plating Have a Lower Rate of Soft Tissue Irritation Compared to Superior Plating? A Prospective Randomized Trial|Active, not recruiting||N/A|90|Anticipated|United States Army Institute of Surgical Research||2|||f||||f||||||||||2017-02-18 13:13:45.91456|2017-02-18 13:13:45.91456
NCT00871455|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-03-29|||April 2003||2003-04-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study|Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study|Completed||N/A|20|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 13:13:46.016181|2017-02-18 13:13:46.016181
NCT00869921|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-06-21|||March 2009||2009-03-01|June 2016|2016-06-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Model 4195 Left Ventricular (LV) Lead Chronic Performance Study|Attain StarFix® Model 4195 Left Ventricular Lead Chronic Performance Post Approval Study|Active, not recruiting||N/A|1322|Actual|Medtronic|||1||f||||f||||||||||2017-02-18 13:14:12.81659|2017-02-18 13:14:12.81659
NCT00871442|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-11-17|||May 2009||2009-05-01|July 2009|2009-07-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Parturient Controlled Epidural Analgesia (PCEA) With or Without a Basal Infusion for Early Labor|Parturient Controlled Epidural Analgesia (PCEA) With or Without a Basal Infusion for Early Labor|Withdrawn||Phase 3|0|Actual|Baystate Medical Center||2||would not substantially add to existing contributions in the literature|f||||f||||||||||2017-02-18 13:13:46.112936|2017-02-18 13:13:46.112936
NCT00871429|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-02-24|2010-05-05||March 2009||2009-03-01|February 2015|2015-02-01|August 2010|Actual|2010-08-01|November 2009|Actual|2009-11-01||Interventional|||Skin Care for Cancer Patients: A Product Satisfaction Survey|Selected Skin Products for Cancer Patients: A Product Satisfaction Survey|Completed||N/A|99|Actual|Northwestern University|No limitations of the trial identified.|1|||f||||f||||||||||2017-02-18 13:13:46.238949|2017-02-18 13:13:46.238949
NCT00871416|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2012-06-28|||April 1997||1997-04-01|June 2012|2012-06-01|July 1997|Actual|1997-07-01|July 1997|Actual|1997-07-01||Interventional|||Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles|Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles. Furthermore, the Thickness of Cutis/Subcutis Is Measured on Recommended Insulin Injection Sites|Completed||Phase 3|48|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 13:13:46.490156|2017-02-18 13:13:46.490156
NCT00871403|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-06-12|2012-01-26||July 2009||2009-07-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer|An Open-label, Multicentre, Randomised Phase II Study of Pazopanib in Combination With Pemetrexed in First-line Treatment of Subjects With Predominantly Non-squamous Cell Stage IIIBwet/IV Non-small Cell Lung Cancer|Completed||Phase 2|107|Actual|GlaxoSmithKline|Efficacy data were only summarized for the pazopanib (pazo.) 800 mg + pemetrexed (peme.) 500 mg/m^2 and the cisplatin 75 mg/m^2 + peme. 500 mg/m^2 arms due to the small sample size/short treatment duration in the pazo. 600 mg + peme. 500 mg/m^2 arm.|2|||f||||f||||||||||2017-02-18 13:13:46.590395|2017-02-18 13:13:46.590395
NCT00871390|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-08-06|||September 2006||2006-09-01|August 2009|2009-08-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Observational|||Organization of Excitation in People With Atrial Fibrillation|Complex Electrograms in Atrial Fibrillation: Spatiotemporal Organization and Mechanistic Insights and Organization in Acute Atrial Fibrillation Post Open Heart Surgery|Unknown status|Active, not recruiting|Phase 1|101|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||||||2017-02-18 13:13:47.49096|2017-02-18 13:13:47.49096
NCT00871377|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2014-01-09|2013-10-31||May 2008||2008-05-01|January 2014|2014-01-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|FOS|16 Female, 8 Male|Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures|Pilot Randomized Double Blind Crossover Study Of Fish Oil [Eicosapentaenoic Acid (EPA) And Docosahexaenoic Acid (DHA)] For Intractable Partial Seizures|Completed||Phase 2|24|Actual|National Center for Complementary and Integrative Health (NCCIH)||3|||f||||t||||||||||2017-02-18 13:13:47.585994|2017-02-18 13:13:47.585994
NCT00871364|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-08-13|||April 2006||2006-04-01|August 2010|2010-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Actavis Group hf 50 mg Venlafaxine Hydrochloride Tablets and Wyeth Pharmaceuticals (Effexor®) 50 mg Venlafaxine Hydrochloride Tablets|Completed||Phase 1|30|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:13:47.916424|2017-02-18 13:13:47.916424
NCT00871351|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-09-28|2011-05-16||February 2009||2009-02-01|September 2015|2015-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)|Ezetimibe Phase IV Clinical Study in Patients With Hypercholesterolemia|Completed||Phase 4|125|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:13:48.038926|2017-02-18 13:13:48.038926
NCT00871338|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-09-22|2014-06-26||June 2009||2009-06-01|September 2016|2016-09-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants|Study in Healthy Children of GSK Biologicals' DTPa-IPV/Hib-MenC-TT Vaccine, GSK2197870A, Co-administered With Prevenar™ as a Three-dose Primary Vaccination Course in Infancy Followed by a Booster Dose of Menitorix™ at 12 Months of Age|Completed||Phase 2|284|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:13:48.602503|2017-02-18 13:13:48.602503
NCT00871325|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-01-08||2012-12-27|June 2009||2009-06-01|January 2013|2013-01-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans|Effect of Gastrointestinal Nerve Modulation With DAIKENCHUTO (TU-100) on Gastrointestinal and Colonic Transit in Humans|Completed||Phase 1/Phase 2|60|Actual|Tsumura USA||3|||f||||f||||||||||2017-02-18 13:13:49.978191|2017-02-18 13:13:49.978191
NCT00871312|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2014-01-08|||May 2007||2007-05-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation of Topical Wound Oxygen (two2) Therapy|A Randomized, Double-blinded, Parallel Group, Placebo-Controlled, Multi-Center Trial of Topical Wound Oxygen Therapy in the Treatment of Diabetic Lower Extremity Ulcers|Terminated||N/A|21|Actual|AOTI Ltd.||2||Low recruitment rate meaning unable to complete the study in a timely manner|f||||t||||||||||2017-02-18 13:13:50.091209|2017-02-18 13:13:50.091209
NCT00871299|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2014-12-01|||September 2009||2009-09-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|PATH-D||Practicing Alternative Techniques to Heal From Depression: The PATH-D Study|Applying Mindfulness-Based Cognitive Therapy to Treatment Resistant Depression|Completed||N/A|173|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 13:13:50.200177|2017-02-18 13:13:50.200177
NCT00871286|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-01-17|2011-08-29||March 2009||2009-03-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Point-of-Care Computed Tomography (CT) Chronic Rhinosinusitis Study|Role of Point-of-Care CT Scanning in Patients Presenting With Symptoms of Chronic Rhinosinusitis|Completed||N/A|40|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 13:13:50.313266|2017-02-18 13:13:50.313266
NCT00869193|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-08-27|||March 2009||2009-03-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Grape Seed Extract on Blood Pressure|Effect of Grape Seed Extract High in Polyphenols on Blood Pressure in Subjects With Elevated Blood Pressure Levels|Completed||N/A|70|Actual|Unilever R&D||2|||f||||f||||||||||2017-02-18 13:14:26.939013|2017-02-18 13:14:26.939013
NCT00871273|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-07-18|||November 2009||2009-11-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|||Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma|A Pharmacokinetic Study of Capecitabine in Patients Undergoing Peri-operative Chemotherapy and a Total Gastrectomy for Adenocarcinoma of the Stomach|Terminated||Phase 4|13|Actual|Cambridge University Hospitals NHS Foundation Trust||1||"1. Slow recruitment; 2. Change to clinical environment reducing the pool of potentially~   eligible patients; 3. Availability of data from another similar study"|f||||f||||||||||2017-02-18 13:13:50.707625|2017-02-18 13:13:50.707625
NCT00871260|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-08-23|||April 2009||2009-04-01|August 2016|2016-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Stress Testing and Cardiac Magnetic Resonance|Stress Testing and Cardiac Magnetic Resonance|Recruiting||N/A|525|Anticipated|University of Chicago||1|||f||||f||||||||||2017-02-18 13:13:50.817904|2017-02-18 13:13:50.817904
NCT00871247|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-08-13|||November 2004||2004-11-01|August 2010|2010-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions|Randomized, 2-Way Crossover Bioequivalence Study Finasteride 5 mg Tablet and Proscar Administrated as 1 x 5 mg Tablet in Healthy Subjects Under Fed Conditions|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:13:50.951255|2017-02-18 13:13:50.951255
NCT00871234|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2011-01-05|2010-12-07||April 2009||2009-04-01|December 2010|2010-12-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study|Effects of Etravirine (INTELENCETM) on Endothelial Function in HIV-uninfected Adults: A Pilot Study|Completed||Phase 1|28|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 13:13:51.069596|2017-02-18 13:13:51.069596
NCT00871208|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-05-11|||May 2009||2009-05-01|May 2015|2015-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy|Randomized, Placebo-Controlled Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids vs. Low-Potency Corticosteroid Mono-therapy|Withdrawn||Phase 4|0|Actual|St. Luke's-Roosevelt Hospital Center||2||Funding withdrawn|f||||t||||||||||2017-02-18 13:13:51.332232|2017-02-18 13:13:51.332232
NCT00871195|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-05-09|||April 2009||2009-04-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|November 2011|Actual|2011-11-01||Observational|NAFTnet RHD||A Noninvasive Test for Fetal RHD Genotype|Evaluation Of The Performance Of A Noninvasive Test For Fetal RHD Genotype On The Sequenom MassARRAY System|Completed||N/A|520|Actual|Sequenom, Inc.|||1||f||||f||||||Samples With DNA|"~     Plasma and buffy coat.~   "|||2017-02-18 13:13:51.454101|2017-02-18 13:13:51.454101
NCT00871182|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-06-12||2010-08-24|March 2009||2009-03-01|June 2013|2013-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Single Dose, Four-period, Six-treatment, Placebo-controlled, Balanced, Incomplete Block, Cross-over, Study of Four Doses of Inhaled PT001 in Patients With Mild to Moderate COPD, Compared to Open Label Tiotropium|Completed||Phase 1/Phase 2|33|Actual|Pearl Therapeutics, Inc.||6|||f||||f||||||||||2017-02-18 13:13:51.563518|2017-02-18 13:13:51.563518
NCT00871169|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-05-06|2016-05-06||October 2008||2008-10-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||These enrolled patients received study treatment according to the protocol.|Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer|INST 0802: Phase II Trial of Combination Irinotecan, Oxaliplatin and Cetuximab for Patients With Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|61|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||No||2017-02-18 13:13:51.694548|2017-02-18 13:13:51.694548
NCT00871156|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-10-15|||March 2009||2009-03-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Tafenoquine/Chloroquine DDI Study|Safety, Tolerability, and Pharmacokinetic Study of Concomitant Chloroquine and Tafenoquine in Healthy Volunteers|Completed||Phase 1|68|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 13:13:52.165996|2017-02-18 13:13:52.165996
NCT00871143|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2015-09-04|2015-04-15||April 2009||2009-04-01|September 2015|2015-09-01|September 2012|Actual|2012-09-01|May 2011|Actual|2011-05-01||Interventional||"Inclusion criteria:~Diagnosis of BDD according to the DSM-IV diagnostic criterion~Total of >24 on the Yale-Brown Obsessive Compulsive Scale modified for BDD~>18 years old~Willing to travel to the treatment centre for weekly sessions~Not on psychotropic medication or on a dose that's been stable for at least 12 weeks"|Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD)|Efficacy of Cognitive Behaviour Therapy -v- Anxiety Management for Body Dysmorphic Disorder: a Randomised Controlled Trial|Completed||N/A|46|Actual|Institute of Psychiatry, London|"Small sample size: may have led to difficulty in identifying predictors of outcome.~Investigator bias: but testing blinding would be biased as it may be influenced by her rating of the outcome.~Treatment too brief to achieve sig. changes in BDD."|2|||f||||f||||||||||2017-02-18 13:13:52.288635|2017-02-18 13:13:52.288635
NCT00871130|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-27|||January 1998||1998-01-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||The Effect of Bariatric Surgery on Thyroid Function and Morphology|The Effect of Bariatric Surgery on Thyroid Function and Morphology, a Retrospective Study|Completed||N/A|300|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-02-18 13:13:53.161947|2017-02-18 13:13:53.161947
NCT00871117|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-09-26|2011-01-13||March 2009||2009-03-01|September 2016|2016-09-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years|Immunogenicity and Safety Study of Kinrix® Co-administered With Varivax®|Completed||Phase 3|478|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:13:53.263049|2017-02-18 13:13:53.263049
NCT00871104|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2013-02-21|||July 2009||2009-07-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis|Evaluation of the Efficacy and Safety of Fosfomycin Plus Imipenem for the Treatment of Methicillin-resistant Staphylococcus Aureus (MRSA) Infective Endocarditis.|Unknown status|Recruiting|Phase 4|50|Anticipated|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 13:13:53.842534|2017-02-18 13:13:53.842534
NCT00871091|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-03-27|||January 2007||2007-01-01|March 2009|2009-03-01|June 2009|Anticipated|2009-06-01|May 2009|Anticipated|2009-05-01||Interventional|||Study Investigating Tooth Movements With Conventional and Computer-Aided Design/Computer-Aided Manufacturing (CAD/CAM) Supported Fixed Appliances|Pilot Study Investigating Tooth Movements With Conventional and CAD/CAM Supported Fixed Appliances|Unknown status|Active, not recruiting|N/A|32|Anticipated|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-02-18 13:13:53.953464|2017-02-18 13:13:53.953464
NCT00871078|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-09-28|||June 2008||2008-06-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients|Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients Using Optical Coherence Tomography and Frequency Doubling Technology Perimetry|Completed||N/A|90|Anticipated|Federal University of São Paulo|||3||f||||f||||||||||2017-02-18 13:13:54.065074|2017-02-18 13:13:54.065074
NCT00871065|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-03-26|||July 2009||2009-07-01|March 2009|2009-03-01|January 2011|Anticipated|2011-01-01|July 2010|Anticipated|2010-07-01||Interventional|||Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm|Safety and Efficacy Trial of Sildenafil Citrate in Attenuation of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage|Withdrawn||Phase 2|45|Anticipated|University of Nebraska||1||PI decision|f||||t||||||||||2017-02-18 13:13:56.415235|2017-02-18 13:13:56.415235
NCT00871052|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-10-02|||March 2009||2009-03-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Calcipotriol and Polymorphic Light Eruption|Calcipotriol in the Prevention of Polymorphic Light Eruption|Completed||N/A|13|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 13:13:56.525696|2017-02-18 13:13:56.525696
NCT00871039|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-02-29|||March 2009||2009-03-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pilot Study Evaluating Stress Response and Immune Function in Mechanically Ventilated Patients With Alcohol Use Disorders Treated With Propofol or Midazolam|Randomized Clinical Trial Comparing Propofol and Midazolam in Mechanically Ventilated Critically Ill Patients With Alcohol Use Disorders: An Open Label Pilot Study|Withdrawn||Phase 4|0|Actual|Virginia Commonwealth University||2||Due to logistical purposes|f||||f||||||||No||2017-02-18 13:13:56.637862|2017-02-18 13:13:56.637862
NCT00871026|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2009-03-27|||March 2007||2007-03-01|March 2009|2009-03-01|October 2010|Anticipated|2010-10-01|March 2010|Anticipated|2010-03-01||Interventional|||Computer-Aided Design/Computer-Aided Manufacturing (CAD/CAM) - Based Planning and Creation of Orthodontic Appliances|Randomized Controlled Clinical Study Comparing Conventional and CAD/CAM-Based Treatment With Fixed Orthodontic Appliances|Unknown status|Active, not recruiting|N/A|160|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:13:56.750657|2017-02-18 13:13:56.750657
NCT00871013|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-10-11|||March 2009||2009-03-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||UARK 2008-03 Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)|Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)|Recruiting||Phase 2|100|Anticipated|University of Arkansas||1|||f||||t||||||||||2017-02-18 13:13:56.850173|2017-02-18 13:13:56.850173
NCT00871000|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-10-06||2010-07-02|April 2009||2009-04-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.|Immunogenicity and Safety of GSK Biologicals' dTpa-IPV Vaccine (Boostrix Polio) as a Booster Dose in 5 to 6-year-old Children.|Completed||Phase 3|303|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:13:56.988765|2017-02-18 13:13:56.988765
NCT00870987|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-27|2016-08-24|||May 2009||2009-05-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2016|Anticipated|2016-11-01||Interventional|DNA-Ad||Clinical Trial for Malaria Vaccines to Test for Safety, Immune Response and Protection Against Malaria|Clinical Trial on Safety, Immunogenicity, and Efficacy of a Prime Boost Regimen of DNA- and Adenovirus-vectored Malaria Vaccines Encoding Plasmodium Falciparum Circumsporozoite Protein and Apical Membrane Antigen 1 in Healthy Malaria-Naïve Adults in the US|Active, not recruiting||Phase 1/Phase 2|26|Anticipated|U.S. Army Medical Research and Materiel Command||2|||f||||f||||||||||2017-02-18 13:13:57.108747|2017-02-18 13:13:57.108747
NCT00870974|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2017-01-05|||March 2009||2009-03-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|October 2016|Actual|2016-10-01||Interventional|FPEB||A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions|Evaluation of [18F]PEB and Positron Emission Tomography (PET) as a Marker of mGluR5 in Subjects w/ Neuropsychiatric Conditions|Completed||Phase 1|48|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 13:13:57.212248|2017-02-18 13:13:57.212248
NCT00870961|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-09-13|||February 2009||2009-02-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps|Vitamin D Intervention For Colon Cancer Prevention In African-Americans-A Pilot Study|Terminated||N/A|22|Actual|Northwestern University||2||PI changed institutions and accrual was not completed.|f||||||||||||||2017-02-18 13:13:57.319288|2017-02-18 13:13:57.319288
NCT00870948|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-11-04|||January 2009||2009-01-01|September 2010|2010-09-01||||April 2009|Actual|2009-04-01||Interventional|||Phase 1 BA Study, Single Center With Healthy Volunteers||Completed||Phase 1|75|Actual|Abbott||5|||f||||f||||||||||2017-02-18 13:13:57.620205|2017-02-18 13:13:57.620205
NCT00870935|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-12-02|||August 2007||2007-08-01|March 2009|2009-03-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||A Trial to Compare Three Methods of Performing Hysterosalpingography|A Prospective, Randomized Study to Compare the Efficacy and the Tolerability of Three Methods of Performing Hysterosalpingography|Completed||N/A|222|Anticipated|IRCCS Burlo Garofolo||3|||f||||f||||||||||2017-02-18 13:13:57.718345|2017-02-18 13:13:57.718345
NCT00870922|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-03-25|||March 2009||2009-03-01|March 2009|2009-03-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||Effects of Masseter Manual Therapy on Temporomandibular Dysfunction|Effects of Masseter Manual Therapy on Temporomandibular Dysfunction: A Pilot Study|Unknown status|Recruiting|Phase 1|45|Anticipated|Logan College of Chiropractic||1|||f||||f||||||||||2017-02-18 13:13:57.830486|2017-02-18 13:13:57.830486
NCT00870909|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2014-10-03|||January 2009||2009-01-01|October 2014|2014-10-01|November 2015|Anticipated|2015-11-01|September 2015|Anticipated|2015-09-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia|Anodal & Cathodal tDCS for Treatment of Resistant Auditory Hallucinations in Schizophrenia|Unknown status|Recruiting|N/A|60|Anticipated|Hôpital le Vinatier||2|||f||||f||||||||||2017-02-18 13:13:57.927905|2017-02-18 13:13:57.927905
NCT00870896|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-09-29|2012-06-13||February 2008||2008-02-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|February 2009|Actual|2009-02-01||Interventional||Twenty male subjects between 40-80 years of age with COPD will be recruited from the USF and James A. Haley medical clinics, word of mouth, newspaper and radio advertising. We are restricting the study to men because woman have a more sensitive cough reflex and analysis of data will be more difficult when comparing as a group.|The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)|The Effects of Tiotropium on the Cough Reflex in Patients With COPD|Completed||Early Phase 1|5|Actual|University of South Florida||1|||f||||t||||||||||2017-02-18 13:13:58.040043|2017-02-18 13:13:58.040043
NCT00870883|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2015-05-27|||March 2009||2009-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||N-acetylcysteine Plus Deferoxamine for Patients With Hypotension|Prospective, Randomized, Double-blinded, Placebo-controlled Study of N-acetylcysteine Plus Deferoxamine for Patients With Hypotension as Prophylaxis for Acute Renal Failure|Completed||Phase 2|81|Actual|Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude||1|||f||||t||||||||||2017-02-18 13:13:58.317008|2017-02-18 13:13:58.317008
NCT00870870|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-06-12||2010-09-03|March 2009||2009-03-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Patients With Lung Cancer Who Have Not Received Chemotherapy Before|Randomized, Open Label, Stratified Phase 2 Trial of Gemcitabine, Carboplatin, and Cetuximab With Vs. Without IMC-A12 in Chemotherapy-Naive Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|64|Actual|ImClone LLC||2|||f||||f||||||||||2017-02-18 13:13:58.414883|2017-02-18 13:13:58.414883
NCT00870857|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-10-24|||January 2009||2009-01-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|October 2013|Actual|2013-10-01||Observational|MACS||Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center|Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center|Completed||N/A|407|Actual|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     blood oral wash sputum BAL~   "|||2017-02-18 13:13:58.562607|2017-02-18 13:13:58.562607
NCT00870844|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2011-04-19|||May 2009||2009-05-01|April 2011|2011-04-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke|A Randomised, Double-blind, Placebo-controlled, Multiple-dose, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of Lu AA24493 in Patients With Acute Ischemic Stroke|Completed||Phase 1|24|Actual|H. Lundbeck A/S||4|||f||||t||||||||||2017-02-18 13:13:58.659177|2017-02-18 13:13:58.659177
NCT00870831|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2014-12-08|||October 2000||2000-10-01|December 2014|2014-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|Islet OGTT||Islet Function and Clinical Analyses of Transplant Recipients|Islet Function and Clinical Analyses if Transplant Recipients (Project 2 of JDFI Washington University Center For Islet Transplantation) (Please Note That the JDRFI Funded Has Ended|Terminated||N/A|8|Actual|Washington University School of Medicine|||2|PI left University|f||||f||||||Samples Without DNA|"~     Serum samples are obtained during the OGTT and stored in a -20degree freezer. They are~     tested for Insulin C-peptide and glucose.~   "|||2017-02-18 13:13:58.773574|2017-02-18 13:13:58.773574
NCT00870818|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-03-05||2012-03-01|February 2009||2009-02-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|||Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)|An Extension of Study CP-MGA031-01 to Evaluate the Long-Term Efficacy and Safety of Teplizumab (MGA031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Patients With Recent-Onset Type 1 Diabetes Mellitus|Terminated||Phase 2/Phase 3|219|Actual|MacroGenics||4|||f||||f||||||||||2017-02-18 13:13:58.873544|2017-02-18 13:13:58.873544
NCT00870805|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-02-26|||January 2009||2009-01-01|September 2011|2011-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|UB ECT||Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT)|A Controlled Study of Ultrabrief Pulsewidth ECT (Electroconvulsive Therapy)|Completed||Phase 4|150|Actual|The University of New South Wales||4|||f||||t||||||||||2017-02-18 13:13:58.987019|2017-02-18 13:13:58.987019
NCT00870792|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2017-01-10|||November 2002||2002-11-01|March 2009|2009-03-01|February 2005|Actual|2005-02-01|January 2005|Actual|2005-01-01||Interventional|MAP||Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals|Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals|Completed||N/A|156|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 13:13:59.097988|2017-02-18 13:13:59.097988
NCT00870779|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-08-28|||May 2007||2007-05-01|August 2014|2014-08-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|FGR||Fluorescence Guided Resection of Brain Tumors|Co-registered Fluorescence-Enhanced Resection of Brain Tumors Stage I: Correlation With MR and Biopsy|Unknown status|Active, not recruiting|Phase 1|234|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 13:13:59.196106|2017-02-18 13:13:59.196106
NCT00870766|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-09-13|||January 2009||2009-01-01|September 2010|2010-09-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|PRACTA||Computer Tomography (CT) Trial of Acute Abdomen||Completed||N/A|250|Anticipated|Kuopio University Hospital||2|||f||||||||||||||2017-02-18 13:13:59.302486|2017-02-18 13:13:59.302486
NCT00870753|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-03-26|||March 2009||2009-03-01|March 2009|2009-03-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Yoga in Treatment of Eating Disorders|Yoga in Treatment of Eating Disorders|Unknown status|Recruiting|Phase 1|50|Anticipated|Norwegian School of Sport Sciences||2|||f||||f||||||||||2017-02-18 13:13:59.384125|2017-02-18 13:13:59.384125
NCT00870740|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-07-19|2016-05-31||February 2009||2009-02-01|July 2016|2016-07-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional|SELECTION||Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis|A Double-Blind, Multicenter, Extension Study to Evaluate the Safety and Efficacy of DAC HYP in Subjects With Multiple Sclerosis Who Have Completed Treatment in Study 205MS201 (SELECT)|Completed||Phase 2|517|Actual|Biogen||6|||f||||t||||||||||2017-02-18 13:13:59.496461|2017-02-18 13:13:59.496461
NCT00870727|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-05-14|||February 2009||2009-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Interventional|||Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders|Pharmacotherapy of Pervasive Developmental Disorders|Completed||Phase 3|33|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 13:14:01.765974|2017-02-18 13:14:01.765974
NCT00870714|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2009-03-25|||September 2004||2004-09-01|March 2009|2009-03-01||||September 2010|Anticipated|2010-09-01||Interventional|IST 16167||Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study|Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study|Unknown status|Active, not recruiting|N/A|20|Anticipated|Kansas City Veteran Affairs Medical Center||1|||f||||t||||||||||2017-02-18 13:14:01.890504|2017-02-18 13:14:01.890504
NCT00870701|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-03-26|||March 2009||2009-03-01|March 2015|2015-03-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma|Randomised Multicentric Phase III Study Comparing Observation Versus Post-surgery Radiotherapy After Complete Exeresis With Margins Greater Than or Equal to 1 cm in Soft Tissues Members Sarcoma.|Recruiting||Phase 3|570|Anticipated|Institut Claudius Regaud||2|||f||||t||||||||||2017-02-18 13:14:02.003147|2017-02-18 13:14:02.003147
NCT00870688|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-05-19|2009-01-09||January 2005||2005-01-01|February 2009|2009-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening|Non Interventional Trial of Valproate Sustained Release Minitablets Once Daily in the Evening|Completed||N/A|82|Actual|Desitin Arzneimittel GmbH|||1||f||||f||||||||||2017-02-18 13:14:02.37121|2017-02-18 13:14:02.37121
NCT00870675|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2014-09-23|||January 1996||1996-01-01|September 2014|2014-09-01|June 2011|Actual|2011-06-01|May 2009|Actual|2009-05-01||Observational|||Magnetic Resonance Imaging (MRI) of Ventriculomegaly: Morphology and Outcome|MRI of Ventriculomegaly: Morphology and Outcome|Completed||N/A|434|Actual|National Institute for Biomedical Imaging and Bioengineering (NIBIB)|||1||f||||f||||||||||2017-02-18 13:14:02.584845|2017-02-18 13:14:02.584845
NCT00870662|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2011-12-16|||December 2008||2008-12-01|December 2011|2011-12-01||||December 2009|Actual|2009-12-01||Interventional|||A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal|A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal|Completed||N/A|7|Actual|NovaShunt AG||1|||f||||f||||||||||2017-02-18 13:14:02.689763|2017-02-18 13:14:02.689763
NCT00870649|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-11-07|||February 2009||2009-02-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|Bilhvax3||Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium|Efficacy and Safety Evaluation of the Therapeutic Vaccine Candidate Sh28GST in Association With Praziquantel (PZQ) for Prevention of Clinical and Parasitological Recurrences of S. Haematobium Infection in Children|Completed||Phase 3|250|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||No||2017-02-18 13:14:02.784818|2017-02-18 13:14:02.784818
NCT00870636|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-03-27||||||March 2009|2009-03-01||||||||Expanded Access|||Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)|Compassionate Use Pan-VEGF Blockade for the Treatment of ROP (Compassionate Use BLOCK-ROP) Trial|Temporarily not available||N/A|||Children's Hospital Los Angeles|||||||||||||||||||2017-02-18 13:14:02.894622|2017-02-18 13:14:02.894622
NCT00870623|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2011-03-01|||June 2009||2009-06-01|March 2011|2011-03-01||||June 2011|Anticipated|2011-06-01||Observational|||Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections|Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections|Unknown status|Recruiting|N/A|136|Anticipated|University of Nebraska|||1||f||||f||||||Samples Without DNA|"~     Blood (maximum 40mL) will be collected for future use or for purposes that are not integral~     to the current research.~   "|||2017-02-18 13:14:02.990955|2017-02-18 13:14:02.990955
NCT00870610|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2015-04-27|||November 2011||2011-11-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|SjO2||Jugular Venous Oxygen Saturation During Therapeutic Hypothermia After Cardiac Arrest|Cerebral Metabolism During Therapeutic Hypothermia for Cardiac Arrest|Completed||N/A|15|Actual|Policlinico Hospital|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:14:03.084657|2017-02-18 13:14:03.084657
NCT00870597|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-03-26|||January 2007||2007-01-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|TSV-25G||Transconjunctival Sutureless 25-Gauge Vitrectomy|Transconjunctival Sutureless 25-Gauge Vitrectomy for Visually Significant Vitreous Floaters in Patients With Multifocal Intraocular Lens|Completed||Phase 3|14|Actual|Hospital Oftalmologico de Brasilia||2|||f||||t||||||||||2017-02-18 13:14:03.179652|2017-02-18 13:14:03.179652
NCT00870584|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2011-10-12|2011-10-12||March 2009||2009-03-01|October 2011|2011-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma|A 26-week Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma|Completed||Phase 4|271|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:14:03.289763|2017-02-18 13:14:03.289763
NCT00870571|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-08-13|||April 2005||2005-04-01|August 2010|2010-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions|Comparative, Randomized, Single Dose, 2-way Crossover Bioavailability Study of Actavis Group hf and Pfizer Inc. (Norvasc®)10 mg Amlodipine Besylate Tablets in Healthy Adult Volunteers Under Fed Conditions.|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:14:03.913438|2017-02-18 13:14:03.913438
NCT00870558|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2011-08-13|||June 2005||2005-06-01|April 2009|2009-04-01||||May 2011|Actual|2011-05-01||Interventional|||Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer|Adjuvant Treatment by Intra-arterial Injection of Lipiodol-labeled Iodine-131 in Preventing Recurrence of Hepatocellular Carcinoma After Curative Treatment|Completed||Phase 3|120|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:14:04.023927|2017-02-18 13:14:04.023927
NCT00870545|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-06-03|2013-04-04||September 2009||2009-09-01|June 2013|2013-06-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|||Reintegration: The Role of Spouse Telephone BATTLEMIND Pilot Study|Reintegration: The Role of Spouse Telephone BATTLEMIND Pilot Study|Completed||N/A|86|Actual|Memphis VA Medical Center|Small sample size, some of the Wounded Warrior Project spouses knew each other, pilot feasibility study and not a randomized controlled trial.|1|||f||||f||||||||||2017-02-18 13:14:04.130989|2017-02-18 13:14:04.130989
NCT00870532|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2013-11-01|||June 2008||2008-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer|A Prospective Study of Metronomic Oral Vinorelbine in Combination With Sorafenib in Advanced Non-small Cell Lung Cancer a) A Phase I Dose-finding Study of the Combination of Metronomic Oral Vinorelbine and Sorafenib b) Pharmacokinetics Profiling of the Combination of Metronomic Oral Vinorelbine and Sorafenib at MTD|Completed||Phase 1|52|Actual|National Cancer Centre, Singapore||3|||f||||f||||||||||2017-02-18 13:14:04.422725|2017-02-18 13:14:04.422725
NCT00870519|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2011-02-24|||January 2009||2009-01-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Evaluation of [123I] MNI-168 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Terminated||Phase 1|2|Actual|Institute for Neurodegenerative Disorders||2||"Assessment of data shows inadequate brain uptake, suggesting the tracer is inadequate as an~   imaging biomarker of brain amyloid."|f||||f||||||||||2017-02-18 13:14:04.629896|2017-02-18 13:14:04.629896
NCT00870506|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-07-09|||March 2009||2009-03-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Community Trial to Enhance Organ Donation|Community-based Intervention to Enhance Signing of Organ Donor Cards|Completed||N/A|973|Actual|Case Western Reserve University||2|||f||||f||||||||||2017-02-18 13:14:04.724344|2017-02-18 13:14:04.724344
NCT00870493|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-12-03|||April 2009||2009-04-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||Aliskiren for Immunoglobulin A (IgA) Nephropathy|The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy - A Randomized Cross-Over Study|Completed||Phase 3|22|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 13:14:04.817957|2017-02-18 13:14:04.817957
NCT00870480|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-08-13|||November 2004||2004-11-01|August 2010|2010-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions|Randomized, 2-Way Crossover Bioequivalence Study Finasteride 5 mg Tablet and Proscar Administrated as 1 x 5 mg Tablet in Healthy Subjects Under Fasting Conditions.|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:14:04.912048|2017-02-18 13:14:04.912048
NCT00870467|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-08-01|2012-03-09||March 2009||2009-03-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Interventional|||A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis|A Phase 3 Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Comparing Adalimumab and Placebo in Adult Japanese Subjects With Rheumatoid Arthritis|Completed||Phase 3|334|Actual|Abbott||6|||f||||||||||||||2017-02-18 13:14:05.02924|2017-02-18 13:14:05.02924
NCT00870454|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-01-15||2013-01-15|May 2009||2009-05-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||An Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in Diabetics|A Randomized, Double-Blind, Placebo- and Active-Controlled Study of Carisbamate in the Treatment of Neuropathic Pain in Diabetic Peripheral Neuropathy Followed by a Blinded Extension Phase|Completed||Phase 2|386|Actual|SK Life Science||4|||f||||||||||||||2017-02-18 13:14:06.166097|2017-02-18 13:14:06.166097
NCT00870441|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-02-27|||March 2009||2009-03-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Multiple Dose, Multi-Center Study to Compare the Safety of ASP2151 to Valacylcovir and Placebo in Healthy Male and Female Subjects|Terminated||Phase 1|442|Actual|Astellas Pharma Inc||3||Study terminated due to treatment-emergent serious adverse events|f||||f||||||||||2017-02-18 13:14:06.277785|2017-02-18 13:14:06.277785
NCT00870428|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-03-26|||March 2009||2009-03-01|March 2009|2009-03-01||||||||Observational|||Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia|The Predictive Use of Spot Urine Protein/Creatinine Ratios and Decreased Sample Collection Time in the Diagnosis of Preeclampsia|Unknown status|Recruiting|N/A|117|Anticipated|MemorialCare|||1||f||||f||||||||||2017-02-18 13:14:06.38525|2017-02-18 13:14:06.38525
NCT00870415|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2011-01-07|||April 2007||2007-04-01|July 2009|2009-07-01||||April 2009|Anticipated|2009-04-01||Interventional|||Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer|Multicenter (Phase II) Study of Oncoplastic Surgical Techniques for Breast Conservation in Breast Cancers|Unknown status|Recruiting|Phase 2|352|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:14:06.479122|2017-02-18 13:14:06.479122
NCT00870402|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-03-25|||March 2009||2009-03-01|March 2009|2009-03-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|ALDODN||Aldosterone in Diabetic Nephropathy|Effect of Aldosterone Antagonism in the Reduction of Albuminuria and Diastolic Disfunction of Patients With Diabetic Nephropathy.|Unknown status|Recruiting|Phase 4|160|Anticipated|Universidad Los Andes, Chile||2|||f||||t||||||||||2017-02-18 13:14:06.566686|2017-02-18 13:14:06.566686
NCT00870376|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2017-02-09|||April 2009|Actual|2009-04-01|July 2015|2015-07-01|April 23, 2009|Actual|2009-04-23|April 2009|Actual|2009-04-01||Observational|||Studies of Biomarkers in Different Urodynamic Diagnoses of Female Patients With Lower Urinary Tract Symptoms|Studies of Biomarkers in Different Urodynamic Diagnoses of Female Patients With Lower Urinary Tract Symptoms|Withdrawn||N/A|0|Actual|Far Eastern Memorial Hospital|||1|no budget|f||||||||||||||2017-02-18 13:14:06.664142|2017-02-18 13:14:06.664142
NCT00870363|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2017-02-09|2017-01-12||April 2009||2009-04-01|January 2017|2017-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy|A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy|Completed||Phase 4|44|Actual|University of California, Davis||4|||f||||f||||||||||2017-02-18 13:14:06.757977|2017-02-18 13:14:06.757977
NCT00870350|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-06-04|||April 2009||2009-04-01|March 2009|2009-03-01|June 2010|Anticipated|2010-06-01|October 2009|Actual|2009-10-01||Interventional|Tdap Booster||An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster|An Immunogenicity and Safety Study of Combined Adsorbed Tetanus, Low Dose Diphtheria and Acellular Pertussis Vaccine (Td5ap and Td1aP) Given as a School-leaving Booster to 14-15-year-old Children Primed With a Five Component Acellular Pertussis Vaccine at 3, 5 and 12 Months of Age, and a Booster Dose at 5½ Years of Age|Unknown status|Active, not recruiting|Phase 4|400|Anticipated|Swedish Institute for Infectious Disease Control||2|||f||||t||||||||||2017-02-18 13:14:07.625033|2017-02-18 13:14:07.625033
NCT00870337|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2014-10-28|||March 2008||2008-03-01|October 2014|2014-10-01||||May 2011|Actual|2011-05-01||Interventional|ENDORAD||Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer|Phase II Multicenter Study Evaluating the Tolerability and Efficacy of RAD001 (Everolimus) in Patients With Relapsed or Metastatic Endometrial Cancer|Completed||Phase 2|44|Actual|ARCAGY/ GINECO GROUP||1|||f||||t||||||||||2017-02-18 13:14:07.75226|2017-02-18 13:14:07.75226
NCT00870324|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2015-06-03|||March 2009||2009-03-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|SENSE-AF||OptiSense™ Performance in Detecting Atrial Episodes|OptiSense Performance in Detecting Atrial Episodes in CRMD Device Patient Population|Completed||Phase 4|50|Actual|St. Jude Medical|||2||f||||t||||||||||2017-02-18 13:14:07.851758|2017-02-18 13:14:07.851758
NCT00870311|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-03-25|||March 1996||1996-03-01|March 2009|2009-03-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Investigation of Lithium on Signal Transduction, Gene Expression and Brain Myo-Inositol Levels in Manic Patients|Investigation of Lithium on Signal Transduction, Gene Expression and Brain Myo-Inositol Levels in Manic Patients|Completed||Phase 4|28|Actual|Wayne State University||1|||f||||f||||||||||2017-02-18 13:14:07.938582|2017-02-18 13:14:07.938582
NCT00870298|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2015-12-07|||August 2006||2006-08-01|December 2015|2015-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|warf-tmp/smx||Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin|Randomized Controlled Study of a Computer Stop Order Versus Routine Practice When Trimethoprim/Sulfamethoxazole is Ordered Concurrently With Warfarin|Terminated||N/A|1971|Actual|University of Pennsylvania||2||four adverse events encountered|f||||f||||||||||2017-02-18 13:14:08.059273|2017-02-18 13:14:08.059273
NCT00870285|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2012-03-15|||March 2009||2009-03-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Ustekinumab Plus UVB-311nm in Psoriasis|Ustekinumab Plus UVB-311nm Half-side Phototherapy in Patients With Psoriasis|Completed||N/A|10|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 13:14:08.136428|2017-02-18 13:14:08.136428
NCT00870272|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-03-26|||July 2007||2007-07-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)|A Randomized Study of Sublingual and Buccal Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation|Completed||N/A|550|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-02-18 13:14:08.234692|2017-02-18 13:14:08.234692
NCT00870259|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2014-12-03|||February 2008||2008-02-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Investigating Physiological Adaptations to Weight Loss|An Investigation of Physiological Adaptations Contributing to Weight Regain After Weight Loss|Completed||N/A|50|Actual|University of Melbourne||1|||f||||f||||||||||2017-02-18 13:14:08.330666|2017-02-18 13:14:08.330666
NCT00870246|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2009-05-05|||February 2008||2008-02-01|May 2009|2009-05-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Observational|DMCOPD||Diaphragmatic Mobility and Chronic Obstructive Pulmonary Disease|Influence of Diaphragmatic Mobility on the Exercise Capacity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|50|Actual|University of Sao Paulo|||2||f||||f||||||||||2017-02-18 13:14:08.492711|2017-02-18 13:14:08.492711
NCT00870233|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-03-11|||March 2009||2009-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life|Electronic Patient-Reported Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life|Active, not recruiting||N/A|120|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 13:14:08.576047|2017-02-18 13:14:08.576047
NCT00870220|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2014-03-10|||April 2009||2009-04-01|March 2014|2014-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Initiating Transdermal Estradiol Therapy in Turner's Syndrome|Initiating Transdermal Estradiol Therapy in Turner's Syndrome|Terminated||Phase 1|1|Actual|University of Chicago||1||Poor accrual|f||||t||||||||||2017-02-18 13:14:08.682119|2017-02-18 13:14:08.682119
NCT00870207|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2011-04-29|||November 2010||2010-11-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|TSSC Worksite||Tu Salud Si Cuenta Worksite: Pilot Intervention Study|Tu Salud Si Cuenta Worksite: Pilot Intervention Study|Completed||N/A|150|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 13:14:08.792159|2017-02-18 13:14:08.792159
NCT00870194|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2015-03-20|2011-04-11||March 2009||2009-03-01|March 2015|2015-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin|A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin|Completed||Phase 4|255|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:14:08.900378|2017-02-18 13:14:08.900378
NCT00870181|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2013-06-22|||January 2008||2008-01-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|HGG-01||ADV-TK Improves Outcome of Recurrent High-Grade Glioma|Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Recurrent High-Grade Glioma|Completed||Phase 2|47|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-02-18 13:14:09.837456|2017-02-18 13:14:09.837456
NCT00870168|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2011-05-13|||January 2006||2006-01-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer|Modifications of Hormone Receptors and Biological Parameters of Metastatic Breast Cancer Treated With First-line Chemotherapy. Prospective Biological Study.|Completed||N/A|60|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:14:09.943975|2017-02-18 13:14:09.943975
NCT00870155|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-09-07||2010-09-07|February 2007||2007-02-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|MAESTRO-02||A Study for Patients With Multiple Sclerosis|An Open Label Follow-On Study to Assess the Ongoing Safety of MBP8298 In Subjects With Secondary Progressive Multiple Sclerosis|Terminated||Phase 2/Phase 3|546|Anticipated|Eli Lilly and Company||1||Negative efficacy results of the MAESTRO-01 trial|f||||f||||||||||2017-02-18 13:14:10.031271|2017-02-18 13:14:10.031271
NCT00870142|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2010-08-13|||April 2005||2005-04-01|August 2010|2010-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions|Comparative, Randomized, Single Dose, 2-way Crossover Bioavailability Study of Actavis Group hf and Pfizer Inc. (Norvasc®)10 mg Amlodipine Besylate Tablets in Healthy Adult Volunteers Under Fasting Conditions.|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:14:10.14233|2017-02-18 13:14:10.14233
NCT00870129|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-26|2016-11-10|||March 2009||2009-03-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors|Using Advanced MR Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans: A Pilot Study, and to Examine Metabolite Changes in Gliomas and Other Solid Tumors|Recruiting||N/A|150|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:14:10.252621|2017-02-18 13:14:10.252621
NCT00870116|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-03-05|||April 2009||2009-04-01|February 2013|2013-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|SBRT-NSCLC||Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)|SBRT Radiotherapy for Non-operated Non-small-cell Lung Cancer (NSCLC), T1-T2, N0, M0|Unknown status|Active, not recruiting|N/A|120|Anticipated|Centre Leon Berard||3|||f||||t||||||||||2017-02-18 13:14:10.365091|2017-02-18 13:14:10.365091
NCT00870103|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-03-03|2010-01-14||September 2008||2008-09-01|March 2010|2010-03-01||||February 2009|Actual|2009-02-01||Interventional|||Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery|An Evaluation of the Prophylactic Efficacy and Safety of the Administration of the Combination Formulation of Moxifloxacin 0.5% and Dexamethasone 0.1% Eye Drops in Inflammation and Infection Post-cataract Surgery|Completed||Phase 4|64|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:14:10.48998|2017-02-18 13:14:10.48998
NCT00870077|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2012-02-23|||April 2009||2009-04-01|February 2012|2012-02-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|PROTOB||A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease|Effect of a Whey Protein Supplementation on Intrahepatic Lipids in Obese Patients With Non-alcoholic Fatty Liver Disease|Completed||N/A|11|Actual|University of Lausanne||1|||f||||f||||||||||2017-02-18 13:14:10.727267|2017-02-18 13:14:10.727267
NCT00870064|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2015-07-29|||March 2010||2010-03-01|July 2015|2015-07-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PROOF||The Treatment of Type I Open Fractures in Pediatrics|The Treatment of Type I Open Fractures in Pediatrics: Evaluating the Necessity of Formal Irrigation and Debridement|Recruiting||Phase 1/Phase 2|300|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-02-18 13:14:10.841392|2017-02-18 13:14:10.841392
NCT00870051|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2017-02-01|||March 2009||2009-03-01|January 2017|2017-01-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Observational|ENGAGE||Endurant Stent Graft Natural Selection Global Postmarket Registry|Endurant Stent Graft Natural Selection Global Postmarket Registry|Active, not recruiting||N/A|1200|Anticipated|Medtronic Endovascular|||1||f||||f||||||||Undecided||2017-02-18 13:14:10.985529|2017-02-18 13:14:10.985529
NCT00870038|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2010-07-21|||December 2010||2010-12-01|March 2009|2009-03-01|January 2012|Anticipated|2012-01-01|August 2011|Anticipated|2011-08-01||Interventional|EREMUS||To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study|Early Re-Endothelialization Might Not be the Unique Solution to Prevent Restenosis. The EREMUS Study|Unknown status|Not yet recruiting|Phase 4|75|Anticipated|Ospedale della Misericordia||3|||f||||f||||||||||2017-02-18 13:14:11.126898|2017-02-18 13:14:11.126898
NCT00870025|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-25|2015-04-21|||October 2008||2008-10-01|April 2015|2015-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|APPE||Human Chorionic Gonadotropin (hCG) Priming Prior to Controlled Ovarian Hyperstimulation (COH) in Poor Responder In Vitro Fertilization (IVF) Patients|hCG Priming Prior to COH in Poor Responder IVF Patients|Completed||Phase 4|60|Actual|IVI Madrid||2|||f||||||||||||||2017-02-18 13:14:11.242597|2017-02-18 13:14:11.242597
NCT00870012|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-02-20|||February 2009||2009-02-01|February 2014|2014-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics||Completed||N/A|20|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 13:14:11.352835|2017-02-18 13:14:11.352835
NCT00869999|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-10-23|2013-10-25||May 2009||2009-05-01|October 2013|2013-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||26 patients enrolled, 24 evaluable|Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma|Everolimus in Combination With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma|Completed||Phase 2|26|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 13:14:11.464352|2017-02-18 13:14:11.464352
NCT00869986|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-09-07||2010-09-07|November 2006||2006-11-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|MINDSET01||A Study for Patients With Relapsing Remitting Multiple Sclerosis|A Double Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of MBP8298 in Relapsing Remitting Multiple Sclerosis|Completed||Phase 2/Phase 3|218|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 13:14:11.734689|2017-02-18 13:14:11.734689
NCT00869973|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-01-22|||September 2009||2009-09-01|October 2009|2009-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients|Aprepitant in the Prevention of Delayed Emesis Induced by Moderately Emetogenic Chemotherapy (Cyclophosphamide Plus Anthracyclines) in Breast Cancer Patients: a Double-blind Randomized Study|Terminated||Phase 3|580|Actual|S. Maria Hospital, Terni||2||We terminated the study after enrolling 580/900 patients due to a slow accrual|f||||f||||||||||2017-02-18 13:14:11.849063|2017-02-18 13:14:11.849063
NCT00869960|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-08-17|2012-03-15||March 2009||2009-03-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women|Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women|Completed||Phase 4|24|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 13:14:11.974495|2017-02-18 13:14:11.974495
NCT00869947|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2014-01-07|2013-09-18||March 2009||2009-03-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|June 2011|Actual|2011-06-01||Interventional|||Effects of Wearing a Powered Ankle-Foot Prosthesis on Amputee Walking|Effects of Wearing a Powered Ankle-Foot Prosthesis on Amputee Walking|Completed||N/A|16|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 13:14:12.312893|2017-02-18 13:14:12.312893
NCT00869908|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2017-01-18|||November 2008||2008-11-01|January 2017|2017-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|A1chieve®||Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication|The Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or in Combination) in Subjects With Type 2 Diabetes Previously Treated With Other Anti-diabetic Medication. A 24-week, International, Prospective, Multi-centre, Open-labelled, Non-interventional Study|Completed||N/A|66726|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:14:13.047842|2017-02-18 13:14:13.047842
NCT00869895|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-01-27|||March 2009||2009-03-01|November 2012|2012-11-01||||August 2012|Actual|2012-08-01||Interventional|||A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors|A Phase I Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors|Completed||Phase 1|60|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 13:14:13.191364|2017-02-18 13:14:13.191364
NCT00869882|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-10-29|||June 2009||2009-06-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|SPONGIT||SPONGIT: Comparison of Two Surgical Approaches in the Treatment of Degenerative Spondylolysthesis|Comparison of 2 Surgical Approaches in the Treatment of Degenerative Spondylolysthesis: Posterolateral Fusion With Instrumentation (GPLI) Plus or Minus Transforaminal Lumbar Interbody Fusion (TLIF)|Completed||N/A|60|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 13:14:13.432387|2017-02-18 13:14:13.432387
NCT00869869|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2011-06-27|||March 2009||2009-03-01|June 2011|2011-06-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Melatonin Supplementation to Improve Sleep in Patients With Heart Failure|Restoration of Sleep in Heart Failure Patients|Withdrawn||Phase 2|16|Anticipated|Brigham and Women's Hospital||2||No subjects were enrolled in this study. Funding ran out.|f||||f||||||||||2017-02-18 13:14:13.581431|2017-02-18 13:14:13.581431
NCT00869856|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2015-06-01|||April 2009||2009-04-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|SWEEP||Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)|An Open Label, Single-arm, Baseline-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 Administered Once a Week (qw) and Once Every Two Weeks (q2w) in the Treatment of Anemia Associated With Chronic Kidney Disease in Pre-dialysis and Dialysis Subjects|Withdrawn||Phase 3|0|Actual|Sandoz||1||investigation of adverse events in a related clinical study|f||||t||||||||||2017-02-18 13:14:13.706889|2017-02-18 13:14:13.706889
NCT00869843|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-04-22|||October 2002||2002-10-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|October 2007|Actual|2007-10-01||Interventional|||Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors|Phase I Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors|Completed||Phase 1|28|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 13:14:13.841185|2017-02-18 13:14:13.841185
NCT00869830|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-03-25|||January 2007||2007-01-01|March 2009|2009-03-01||||August 2008|Actual|2008-08-01||Interventional|||The Effectiveness of Biofeedback Treatment in Constipated Patients With Idiopathic Parkinson's Disease|The Effectiveness of Biofeedback Treatment in Constipated Patients With Idiopathic Parkinson's Disease|Completed||N/A|30|Actual|Asan Medical Center||1|||f||||t||||||||||2017-02-18 13:14:13.953595|2017-02-18 13:14:13.953595
NCT00869817|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-06-08|||January 2009||2009-01-01|June 2016|2016-06-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|DIAN||Dominantly Inherited Alzheimer Network (DIAN)|Dominantly Inherited Alzheimer Network (DIAN)|Recruiting||N/A|600|Anticipated|Washington University School of Medicine|||2||f||||t||||||Samples With DNA|"~     serum, plasma, cerebral spinal fluid~   "|||2017-02-18 13:14:14.066118|2017-02-18 13:14:14.066118
NCT00869804|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-03-25|||April 2009||2009-04-01|March 2009|2009-03-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|HOPE||Heading Off Peripheral Neuropathy With Exercise|Pilot Randomized Study of Aerobic and Resistance Exercise for Women Undergoing Treatment for Breast Cancer With Taxanes.|Unknown status|Not yet recruiting|N/A|200|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-02-18 13:14:14.235227|2017-02-18 13:14:14.235227
NCT00869791|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-10-29||2010-10-29|February 2009||2009-02-01|October 2010|2010-10-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa|A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa|Completed||Phase 1/Phase 2|27|Actual|IMPAX Laboratories, Inc.||2|||f||||f||||||||||2017-02-18 13:14:14.345476|2017-02-18 13:14:14.345476
NCT00869778|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-11-20|2016-11-20||June 2009||2009-06-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||FAS|Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B|A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine (Mimogen-based) in Treating Chronic Hepatitis B Patients|Completed||Phase 2|360|Actual|Chongqing Jiachen Biotechnology Ltd.||3|||f||||t||||||||Undecided||2017-02-18 13:14:14.465013|2017-02-18 13:14:14.465013
NCT00869765|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2010-09-09|||April 2009||2009-04-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression|An Open Pilot Trial of Transcranial Direct Current Stimulation (tDCS) Augmented by D-Cycloserine as a Treatment for Depression.|Completed||Phase 2|5|Actual|The University of New South Wales||1|||f||||t||||||||||2017-02-18 13:14:15.359003|2017-02-18 13:14:15.359003
NCT00869752|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-03-06|||January 2009||2009-01-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase I-II Trial of MK-0646, a Monoclonal Antibody Against Insulin-Like Growth Factor-1 Receptor, in Combination With Etoposide and Cisplatin in Extensive Stage Small Cell Lung Cancer|Completed||Phase 1/Phase 2|12|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 13:14:15.463919|2017-02-18 13:14:15.463919
NCT00869739|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-02-21|||August 2008||2008-08-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer|Prostate Cancer Recovery Enhancement for African American Men and Their Intimate Partners|Completed||N/A|112|Actual|East Carolina University|||||f||||||||||||||2017-02-18 13:14:15.579202|2017-02-18 13:14:15.579202
NCT00869726|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-05-27||2010-05-27|December 2004||2004-12-01|May 2010|2010-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|MAESTRO-01||A Study for Patients With Secondary Progressive Multiple Sclerosis|A Double-Blind, Placebo Controlled Multicentre Study To Evaluate The Efficacy And Safety Of MBP8298 In Subjects With Secondary Progressive Multiple Sclerosis|Completed||Phase 2/Phase 3|596|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 13:14:15.680458|2017-02-18 13:14:15.680458
NCT00869713|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-11-09|||June 2009||2009-06-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|RVF||Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated|Long-Term Open-Label Primary Vaccination and Booster Dose Study of the Safety and Immunogenicity of Rift Valley Fever Vaccine, Inactivated, Dried (TSI-GSD 200) in At-Risk Adults|Enrolling by invitation||Phase 2|500|Anticipated|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 13:14:15.789985|2017-02-18 13:14:15.789985
NCT00869700|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2010-06-25|||June 2009||2009-06-01|June 2010|2010-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|SEACAT 2_4_2||Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults|Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults|Completed||Phase 4|18|Actual|University of Cape Town||1|||f||||t||||||||||2017-02-18 13:14:15.895797|2017-02-18 13:14:15.895797
NCT00869687|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2012-06-22|||March 2009||2009-03-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Biopsy Study for Sculptra (Poly-L-Lactic Acid)|A Single Group Study for the Characterization of Human Tissue Response to Injectable Poly-L-Lactic Acid (Sculptra) in Healthy Volunteers|Completed||Phase 2|14|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:14:16.063241|2017-02-18 13:14:16.063241
NCT00869674|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-05-29|||February 2009||2009-02-01|June 2009|2009-06-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study|一项比较GeneSearch 乳腺淋巴结（BLN）检测试剂盒和永久病理切片检测乳腺癌患者腋窝前哨淋巴结转移的前瞻性、多中心临床试验 A Prospective and Multi-center Clinical Trial By Comparing GeneSearch™ Breast Lymph Node (BLN) Test Kit To Permanent Pathological Section On Detecting Axillary Sentinel Lymph Node Metastases In Breast Cancer Patients|Terminated||Phase 3|540|Actual|Johnson & Johnson Medical, China||2||Investigational products has been suspended from the US market|f||||f||||||||||2017-02-18 13:14:16.144004|2017-02-18 13:14:16.144004
NCT00869661|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-11-01||2016-07-07|February 2001||2001-02-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4|A Randomized, Double-blind, Multicenter, Dose and Duration Finding Study to Evaluate the Sustained Virologic Response of the HCV Polymerase Inhibitor Prodrug (RO5024048) in Combination With Pegasys® and Ribavirin® (SOC) Versus SOC in Treatment-Naïve Patients With HCV Genotype 1 or 4 Infection|Completed||Phase 2|413|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-02-18 13:14:16.267259|2017-02-18 13:14:16.267259
NCT00869648|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-09-29|||April 2009||2009-04-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Head Positions to Open the Upper Airway|Head Positions to Open the Upper Airway- a Pilot Study|Completed||N/A|60|Anticipated|Medical University Innsbruck||3|||f||||f||||||||||2017-02-18 13:14:16.441301|2017-02-18 13:14:16.441301
NCT00869635|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-02-05|||February 2009||2009-02-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Interventional|||S-1 and Photodynamic Therapy in Cholangiocarcinoma|Photodynamic Therapy With S-1 in the Patients With Unresectable Type III or IV Cholangiocarcinoma: A Prospective Randomized Trial With Open Label Control|Completed||Phase 3|43|Actual|Asan Medical Center||3|||f||||t||||||||||2017-02-18 13:14:16.525768|2017-02-18 13:14:16.525768
NCT00869622|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2015-07-23|2015-01-28||June 2006||2006-06-01|July 2015|2015-07-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|ADOPT||Antiepileptic Drugs and Osteoporotic Prevention Trial|Antiepileptic Drugs and Osteoporotic Prevention Trial|Completed||Phase 4|80|Actual|Boston VA Research Institute, Inc.||2|||f||||t||||||||||2017-02-18 13:14:16.640378|2017-02-18 13:14:16.640378
NCT00869609|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-05-19|2016-01-11||March 2009||2009-03-01|May 2016|2016-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Evaluation of Group Lifestyle Balance Maintenance Strategies|Evaluation of Group Lifestyle Balance Maintenance Strategies|Completed||N/A|60|Actual|University of Pittsburgh|The sample size was small and included primarily white individuals, so these results may not be generalizable to other groups. The CPC was not carbohydrate restricted and may not be directly comparable to studies that focus on carbohydrate reduction.|2|||f||||f||||||||No||2017-02-18 13:14:17.169299|2017-02-18 13:14:17.169299
NCT00869596|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2015-07-22|||March 2009||2009-03-01|July 2015|2015-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of Biomarkers of Airway Inflammation (0000-128)|A Randomized Clinical Trial to Assess the Effects of Inhaled Fluticasone on Sputum Neutrophils After Low-dose Inhaled Endotoxin Challenge in Healthy Subjects|Completed||Phase 1|22|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:14:17.611563|2017-02-18 13:14:17.611563
NCT00869583|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-01-06|||August 2009||2009-08-01|January 2014|2014-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Increasing Physical Activity Among Mexican American Women (The Enlace Study)|Enlace: A Partnership to Promote Physical Activity Among Mexican Immigrant Women|Completed||Phase 1/Phase 2|117|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-02-18 13:14:17.710431|2017-02-18 13:14:17.710431
NCT00869570|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-12-28|||March 2009||2009-03-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|May 2013|Actual|2013-05-01||Interventional|||External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer|Neoadjuvant Radiotherapy Combined With Capecitabine and Sorafenib in Patients With Advanced, K-ras Mutated Rectal Cancer. A Multicenter Phase I/IIa Trial.|Completed||Phase 1/Phase 2|54|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||No||2017-02-18 13:14:20.092712|2017-02-18 13:14:20.092712
NCT00869180|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-01-26|||February 2009||2009-02-01|January 2010|2010-01-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|SUPPORT 2||Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Diclofenac Sodium Patch for the Topical Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain|Completed||Phase 3|219|Actual|Cerimon Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:14:27.053652|2017-02-18 13:14:27.053652
NCT00869557|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2014-05-22|2012-09-20||April 2009||2009-04-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|November 2009|Actual|2009-11-01||Interventional||Safety Analysis Set: participants were randomized and received at least 1 dose of study medication.|Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults|A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Atripla® (Efavirenz 600 mg/Emtricitabine 200 mg/Tenofovir Disoproxil Fumarate 300 mg) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults|Completed||Phase 2|71|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 13:14:20.242511|2017-02-18 13:14:20.242511
NCT00869544|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-09-04|||August 2007||2007-08-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|September 2010|Actual|2010-09-01||Observational|PACT||Pneumocystis in Pathogenesis of HIV-associated Emphysema|Pneumocystis in Pathogenesis of HIV-associated Emphysema|Completed||N/A|250|Actual|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     oral wash blood sputum BAL~   "|||2017-02-18 13:14:21.458993|2017-02-18 13:14:21.458993
NCT00869531|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-03-25|||August 2007||2007-08-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|HEALTHGRAIN||Effect of Wholegrain Wheat on Body Weight and Composition and Cardiovascular Risk|Healthgrain WP 4.4.3: Effects of Whole Grain on Weight Maintenance/Weight Reduction in Overweight Subjects|Completed||N/A|85|Actual|University of Copenhagen||2|||f||||f||||||||||2017-02-18 13:14:21.552901|2017-02-18 13:14:21.552901
NCT00869518|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2014-04-23|2014-03-13||July 2009||2009-07-01|April 2014|2014-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected Adults|Randomized, Double-Blinded Evaluation of Rifabutin Based Therapy for Eradication of Staphylococcus Aureus Carriage in HIV Infected Individuals With Prior Skin and Skin Structure Infections|Terminated||Phase 2|12|Actual|University of California, San Francisco||2||Poor enrollment|f||||f||||||||||2017-02-18 13:14:21.660873|2017-02-18 13:14:21.660873
NCT00869505|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-03-25|||March 2008||2008-03-01|March 2009|2009-03-01||||||||Observational|||Study of Memantine Augmentation in Severe Obsessive-Compulsive Disorder|A Chart Review of Memantine Use in the Treatment of Obsessive-Compulsive Disorder at the OCD Institute|Completed||N/A|||Massachusetts General Hospital|||2||f||||f||||||||||2017-02-18 13:14:22.031397|2017-02-18 13:14:22.031397
NCT00869492|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||August 2008||2008-08-01|March 2009|2009-03-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Comparison of Nadifloxacin Cream Alone and With Benzoyl Peroxide Solution in the Treatment of Acne|A Double Blind Randomised Comparison of Nadifloxacin 1% Cream Alone and Nadifloxacine %1 Cream With Benzoyl Peroxide 5% Solution in the Treatment of Mild to Moderate Facial Acne Vulgaris|Unknown status|Active, not recruiting|Phase 3|90|Anticipated|Marmara University||2|||f||||f||||||||||2017-02-18 13:14:22.129457|2017-02-18 13:14:22.129457
NCT00869479|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-12-14|||March 2009||2009-03-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis|Validation of a Questionnaire as a Screening Tool to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis|Completed||N/A|60|Anticipated|Massachusetts General Hospital|||4||f||||t||||||||||2017-02-18 13:14:22.242003|2017-02-18 13:14:22.242003
NCT00869466|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-04-02|||August 2008||2008-08-01|March 2009|2009-03-01|February 2011|Actual|2011-02-01|||||Observational|||Weight Control Programs in Women Who Have Undergone Surgery for Early Stage Breast Cancer|B- AHEAD Study (Breast - Activity & Healthy Eating After Diagnosis) Randomised Comparison of 3 Weight Control Programmes During Adjuvant Treatment for Early Breast Cancer.|Completed||N/A|409|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:14:22.436277|2017-02-18 13:14:22.436277
NCT00869453|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2012-06-29|||March 2009||2009-03-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Observational|||Gut Hormone Secretion and Macronutrients|Gut Hormone Secretion Pattern in Response to Different Macronutrients in Healthy Volunteers|Completed||N/A|8|Actual|University of Lausanne|||1||f||||f||||||||||2017-02-18 13:14:22.534044|2017-02-18 13:14:22.534044
NCT00869440|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2010-09-08||2010-09-08|March 2009||2009-03-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Dose-Finding Safety Study Evaluating CNS 7056 in Patients Undergoing Diagnostic Upper GI Endoscopy|A Phase IIa, Randomized, Controlled, Double-Blind, Dose-Finding Study Evaluating the Safety and Pharmacodynamics of CNS 7056 in Patients Undergoing Diagnostic Upper GI Endoscopy|Completed||Phase 2|102|Actual|Paion UK Ltd.||4|||f||||t||||||||||2017-02-18 13:14:22.658875|2017-02-18 13:14:22.658875
NCT00869427|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2010-07-02|||March 2009||2009-03-01|January 2010|2010-01-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|||Vitamin C for Prevention of Urinary Tract Infections in the Spinal Cord Injured|Vitamin C for Prevention of Urinary Tract Infections in the Spinal Cord Injured|Terminated||Phase 4|40|Anticipated|Sunnaas Rehabilitation Hospital||2||Inability to recruit sufficient number of patients|f||||f||||||||||2017-02-18 13:14:22.793556|2017-02-18 13:14:22.793556
NCT00869414|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2009-03-25|||March 2009||2009-03-01|March 2009|2009-03-01|May 2010|Anticipated|2010-05-01|March 2010|Anticipated|2010-03-01||Interventional|||Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes|Comparison of Glycemic Response to Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes Using Continuous Glucose Monitoring|Unknown status|Not yet recruiting|N/A|25|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 13:14:22.908125|2017-02-18 13:14:22.908125
NCT00869401|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-06-24|||June 2009||2009-06-01|June 2016|2016-06-01||||October 2014|Actual|2014-10-01||Interventional|||Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I/Randomized Phase II Trial of Either Dasatinib or Placebo Combined With Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM)|Active, not recruiting||Phase 1/Phase 2|217|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 13:14:23.047331|2017-02-18 13:14:23.047331
NCT00869388|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-07-12|||October 2008||2008-10-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors|A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors|Completed||Phase 1|12|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-02-18 13:14:23.550387|2017-02-18 13:14:23.550387
NCT00869375|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-06-26|2014-04-04||April 2009||2009-04-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia|Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia: A Randomized Controlled Trial|Terminated||N/A|6|Actual|University of Oklahoma|The main limitation of this trial was slow enrollment. This led to early termination leading to small numbers of subjects analyzed. This makes the results uninterpretable.|2||very low enrollment due to low access to study population|f||||t||||||||||2017-02-18 13:14:23.656007|2017-02-18 13:14:23.656007
NCT00869362|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2014-10-27|2012-10-03||March 2009||2009-03-01|October 2014|2014-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Inpatient Diabetes Management on Outpatient Glycemic Control|Effect of Inpatient Diabetes Management on Outpatient Glycemic Control|Completed||N/A|31|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 13:14:24.058002|2017-02-18 13:14:24.058002
NCT00869349|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2013-02-04|||September 2008||2008-09-01|February 2013|2013-02-01|December 2014|Anticipated|2014-12-01|December 2010|Actual|2010-12-01||Interventional|||Living Well With Rheumatoid Arthritis|Brigham Rheumatoid Arthritis Sequential Study B.R.A.S.S.|Unknown status|Active, not recruiting|N/A|100|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:14:24.466767|2017-02-18 13:14:24.466767
NCT00869336|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2011-06-06||2011-06-06|March 2009||2009-03-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)|Phase 2 Study - A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Duration Finding Study Evaluating the Efficacy and Safety of Two Week and Four Week Once Daily Treatment of Luliconazole Cream 1% in Patients With Tinea Pedis|Completed||Phase 2|147|Actual|Tinea Pharmaceuticals||4|||f||||f||||||||||2017-02-18 13:14:24.587632|2017-02-18 13:14:24.587632
NCT00869323|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-25|2016-02-18|||March 2009||2009-03-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|March 2013|Actual|2013-03-01||Interventional|||Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders|Phase II Trial of Bortezomib and Rituximab for Patients With Post Transplant Lymphoproliferative Disorders (PTLD)|Terminated||Phase 2|3|Actual|Masonic Cancer Center, University of Minnesota||1||Funding unavailable|f||||t||||||||||2017-02-18 13:14:24.699556|2017-02-18 13:14:24.699556
NCT00869310|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2014-01-03|||September 2009||2009-09-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis|Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis: a Double-blind Randomized Trial|Terminated||Phase 3|303|Actual|S. Maria Hospital, Terni||2||we terminated the study before enrolling 303/560 due to a slow accrual|f||||f||||||||||2017-02-18 13:14:24.812639|2017-02-18 13:14:24.812639
NCT00869297|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2011-04-18|||March 2009||2009-03-01|April 2011|2011-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Goal Directed Fluid Therapy in Free Flap Patients|Goal Directed Fluid Therapy for Microvascular Free Flap Reconstruction Following Mastectomy: A Pilot Study|Completed||N/A|20|Actual|University of Manitoba||2|||f||||f||||||||||2017-02-18 13:14:24.927577|2017-02-18 13:14:24.927577
NCT00869284|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-03-24|||October 1994||1994-10-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|July 1999|Actual|1999-07-01||Interventional|073||Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas|Phase II Study Treatment of High Risk Non-Hodgkin's Lymphomas|Completed||Phase 2|45|Actual|French Innovative Leukemia Organisation||1|||f||||t||||||||||2017-02-18 13:14:25.011408|2017-02-18 13:14:25.011408
NCT00869271|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||January 2005||2005-01-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer|Postoperative folfox4 Only vs folfox4 Plus TAC in the Treatment Unresectable Liver Metastasis of Colorectal Cancer: a Randomized,Prospective,Control Trial|Completed||Phase 4|200|Actual|Fudan University||2|||f||||f||||||||||2017-02-18 13:14:25.10136|2017-02-18 13:14:25.10136
NCT00869258|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-05-16|2016-04-19||June 2005||2005-06-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar|Phase II Study for Inoperable Non-Metastatic Pancreatic Cancer (Stage IVA) With Neoadjuvant Gemzar, Taxotere and Xeloda (GTX), and Radiation With Gemzar|Completed||Phase 2|32|Actual|Columbia University||1|||f||||t||||||||Undecided|Unknown.|2017-02-18 13:14:25.391418|2017-02-18 13:14:25.391418
NCT00869245|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2012-02-15|||March 2009||2009-03-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy Evaluation of Observation Unit Cardiac Magnetic Resonance Imaging (MRI) in Patients With Intermediate Risk Acute Chest Pain|Efficacy Evaluation of Observation Unit Cardiac Magnetic Resonance Imaging (MRI) in Patients With Intermediate Risk Acute Chest Pain|Completed||N/A|124|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 13:14:25.682531|2017-02-18 13:14:25.682531
NCT00869232|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-10-11|||October 2008||2008-10-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission|UARK 2008-02, A Phase II Trial for High-risk Myeloma Evaluation Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-host-exhausting and Timely Dose-reduced MEL-80-VRD-PACE Tandem Transplants|Enrolling by invitation||Phase 2|90|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 13:14:25.820488|2017-02-18 13:14:25.820488
NCT00869219|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-03-25|||March 2009||2009-03-01|March 2009|2009-03-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)|Phase 4 Study of Topical NSAID for Ophthalmologic Use: Pain Measurement After First Drop.|Unknown status|Recruiting|Phase 4|40|Anticipated|Santa Casa de Misericordia de Santos||2|||f||||f||||||||||2017-02-18 13:14:25.943966|2017-02-18 13:14:25.943966
NCT00869206|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-10-04|||March 2009||2009-03-01|October 2016|2016-10-01||||June 2014|Actual|2014-06-01||Interventional|||Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement|A Randomized, Phase III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer|Active, not recruiting||Phase 3|1758|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 13:14:26.068286|2017-02-18 13:14:26.068286
NCT00869167|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-04-26|2011-06-28||March 2008||2008-03-01|April 2013|2013-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Ramelteon for Insomnia Comorbid With Asthma|Ramelteon for Insomnia Comorbid With Asthma|Terminated||Phase 3|2|Actual|Northwestern University|Recruitment difficulties led to only 3 participants in the study. Only 2 participants finished the study.|2|||f||||f||||||||||2017-02-18 13:14:27.163145|2017-02-18 13:14:27.163145
NCT00869154|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2015-12-01|||March 2009||2009-03-01|December 2015|2015-12-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Multidisciplinary Treatment in Patients With Mild Traumatic Brain Injury|Effect of Multidisciplinary Treatment in Patients With Mild Traumatic Brain Injury - a Randomized Controlled Trial|Active, not recruiting||Phase 2|151|Actual|Haukeland University Hospital||2|||f||||t||||||||||2017-02-18 13:14:27.614688|2017-02-18 13:14:27.614688
NCT00869141|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2015-11-30|2015-06-01||March 2009||2009-03-01|July 2015|2015-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma|Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma|Completed||Phase 4|52|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 13:14:27.737603|2017-02-18 13:14:27.737603
NCT00869128|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2009-03-30|2008-12-08||November 1995||1995-11-01|March 2009|2009-03-01|March 1997|Actual|1997-03-01|March 1997|Actual|1997-03-01||Interventional|||A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia|A Randomized Double-Blind, Crossover Study Comparing the Efficacy of Prolonged-Release Melatonin Versus Placebo in a 3 Week Treatment of Diabetic Patients Suffering From Insomnia|Completed||Phase 2|36|Actual|Neurim Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 13:14:28.285393|2017-02-18 13:14:28.285393
NCT00869115|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2014-10-21|||June 2009||2009-06-01|October 2014|2014-10-01||||||||Interventional|||Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure|A Randomized, Double-blind, Placebo-controlled Escalating Dose Phase I Interaction Study to Evaluate the Pharmacokinetics, Tolerability and Pharmacodynamics of Three Dose Levels of Debio 0614 (Istaroxime) as a 24-hour Constant Rate IV Infusion in Combination With Chronic Oral Digoxin Treatment in Patients With Controlled Cardiac Failure and Decreased Left Ventricular Systolic Function|Withdrawn||Phase 1|0|Actual|Debiopharm International SA||4||The study was not started due to a re-evaluation of the istaroxime development program|f||||t||||||||||2017-02-18 13:14:28.516905|2017-02-18 13:14:28.516905
NCT00869102|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2014-07-30|||May 2009||2009-05-01|March 2009|2009-03-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Characterization of Beta Cell Failure||Withdrawn||N/A|0|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-02-18 13:14:28.62541|2017-02-18 13:14:28.62541
NCT00869089|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-09-27|2014-05-20||September 2008||2008-09-01|September 2016|2016-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||Number of subjects enrolled in the study.|Safety and Efficacy of CC-10004 for Prurigo Nodularis|An Open Label, Single Center Study to Assess the Safety and Efficacy of a 24 Week Treatment Course of CC-10004 in Adults With Recalcitrant Nodularis|Completed||Phase 2|5|Actual|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-02-18 13:14:28.724588|2017-02-18 13:14:28.724588
NCT00869076|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-03-24|||May 2006||2006-05-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pharmacists Management of Diabetes|Pharmacist Management of Diabetes Mellitus: A Randomized Controlled Trial.|Completed||Phase 4|102|Actual|Advantage Health Physician Network||2|||f||||f||||||||||2017-02-18 13:14:29.016609|2017-02-18 13:14:29.016609
NCT00869063|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-01-26|||February 2009||2009-02-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|WIND||Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Diclofenac Sodium Patch for the Topical Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion|Completed||Phase 3|214|Actual|Cerimon Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:14:29.113416|2017-02-18 13:14:29.113416
NCT00869050|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-06-22|2016-05-03||August 2005||2005-08-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|||Capecitabine and Temozolomide for Neuroendocrine Cancers|Phase II Study of Capecitabine and Temozolomide for Progressive, Differentiated, Metastatic Neuroendocrine Cancers|Completed||Phase 2|41|Actual|Columbia University||1|||f||||t||||||||No||2017-02-18 13:14:29.223713|2017-02-18 13:14:29.223713
NCT00869037|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2011-03-23|||March 2009||2009-03-01|January 2010|2010-01-01|February 2012|Anticipated|2012-02-01|July 2011|Anticipated|2011-07-01||Interventional|||Analgesia After Total Knee Arthroplasty|Analgesia After Total Knee Arthroplasty: Randomized Controlled Trial Comparing (a) Periarticular Multimodal Technique With (B) Continuous Femoral Nerve Block + Posterior Capsular Injection|Unknown status|Recruiting|Phase 4|90|Anticipated|University of Manitoba||2|||f||||||||||||||2017-02-18 13:14:29.572721|2017-02-18 13:14:29.572721
NCT00869024|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2017-02-07|||November 10, 2011|Actual|2011-11-10|February 2017|2017-02-01|March 29, 2016|Actual|2016-03-29|March 29, 2016|Actual|2016-03-29||Interventional|ASSURANCE||Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement|AsseSsment of Efficacy, Safety and Utility of intRa myocardiAl iNjection of Stem Cells in Patients With End Stage Heart Failure Undergoing LVAD Implantation (ASSURANCE)|Completed||Phase 1/Phase 2|25|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 13:14:29.675855|2017-02-18 13:14:29.675855
NCT00869011|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-12-21|||December 2009||2009-12-01|December 2009|2009-12-01||||June 2011|Anticipated|2011-06-01||Interventional|||Exercise for Patients With Renal Cell Cancer Receiving Sunitinib|Effects of Physical Activity on the Endothelial and Cardiac Function of Patients With Renal Cell Carcinoma Receiving a Thyrosine Kinase Inhibitor (Sunitinib)|Unknown status|Recruiting|Phase 3|70|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:14:29.933546|2017-02-18 13:14:29.933546
NCT00868998|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-05-16|2016-04-21||August 2005||2005-08-01|May 2016|2016-05-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||GTX Regimen for Biliary Cancers|Phase II Study of the Gemzar, Taxotere and Xeloda Regimen (GTX) for Inoperable or Metastatic Adenocarcinoma of the Biliary System|Terminated||Phase 2|4|Actual|Columbia University||1||Poor patient accrual|f||||t||||||||Undecided||2017-02-18 13:14:30.047998|2017-02-18 13:14:30.047998
NCT00868985|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||January 2008||2008-01-01|March 2009|2009-03-01||||August 2008|Actual|2008-08-01||Interventional|||Effects of Oral PEG 3350 on Electrolyte Balance|Effects of Oral PEG 3350 on the Electrolyte Balance in Patient Volunteers With Chronic Constipation:Pharmacokinetic Evaluation|Completed||Phase 1|114|Actual|Norgine||2|||f||||f||||||||||2017-02-18 13:14:30.363451|2017-02-18 13:14:30.363451
NCT00868972|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-01-22|||March 2009||2009-03-01|January 2010|2010-01-01|September 2011|Anticipated|2011-09-01|March 2011|Anticipated|2011-03-01||Interventional|||Renal Stenting With Distal Atheroembolic Protection|Percutaneous Renal Stenting in Renovascular Disease With or Without Distal Atheroembolic Protection|Unknown status|Recruiting|Phase 2/Phase 3|150|Anticipated|Universita di Verona||2|||f||||f||||||||||2017-02-18 13:14:30.470652|2017-02-18 13:14:30.470652
NCT00868959|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-03-15|2014-02-17||April 2009||2009-04-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Safety population - received at least one dose of study medication|Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression|A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression|Completed||Phase 3|817|Actual|Sunovion||1|||f||||t||||||||||2017-02-18 13:14:30.585367|2017-02-18 13:14:30.585367
NCT00868946|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-10-11|||October 2009||2009-10-01|August 2016|2016-08-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|HFRS||Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany|A Phase 2 Treatment Protocol of Intravenous Ribavirin in Adult Subjects With Hemorrhagic Fever With Renal Syndrome (HFRS) in Landstuhl Regional Medical Center (Landstuhl, Germany) IND 16,666|Withdrawn||Phase 2|0|Actual|U.S. Army Medical Research and Materiel Command||1||Lack of enrollment|f||||f||||||||||2017-02-18 13:14:31.096774|2017-02-18 13:14:31.096774
NCT00868933|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2014-02-20|||February 2009||2009-02-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease|Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease - A Randomized Controlled Trial|Completed||N/A|159|Actual|Chinese University of Hong Kong||2|||f||||||||||||||2017-02-18 13:14:31.207289|2017-02-18 13:14:31.207289
NCT00868920|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||January 2008||2008-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Patient-Controlled Sedation Versus Anesthesiologist-Administered Sedation|A Phase IV, Randomized, Double-Blind, Controlled Study of the Effects of Patient-Controlled Sedation vs. Anesthesiologist-Administered Sedation With Propofol and Remifentanil on Rate of Disordered Breathing in Subjects Undergoing Elective Colonoscopy|Completed||Phase 4|50|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 13:14:31.306897|2017-02-18 13:14:31.306897
NCT00868907|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-10-07|||March 2009||2009-03-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food|A Crossover Study to Assess the Relative BA of Delayed-release Risedronate Compared When Dosed With Either Dinner, Breakfast or Breakfast Plus a Calcium/Vitamin D Tablet|Completed||Phase 1|101|Actual|Warner Chilcott||3|||f||||f||||||||||2017-02-18 13:14:31.391774|2017-02-18 13:14:31.391774
NCT00868894|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-11-01|||March 2009||2009-03-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension|A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension|Completed||Phase 1/Phase 2|49|Actual|Santen Inc.||4|||f||||||||||||||2017-02-18 13:14:31.489664|2017-02-18 13:14:31.489664
NCT00868881|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-07-10|||March 2009||2009-03-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|||||Observational|TAPAS||Treatment of Hypertension in Primary Care in Spain|Treatment of Hypertension in Primary Care in Spain|Completed||N/A|2160|Anticipated|AstraZeneca|||6||f||||f||||||||||2017-02-18 13:14:31.693231|2017-02-18 13:14:31.693231
NCT00868868|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||June 2008||2008-06-01|March 2009|2009-03-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|||Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy|Pedometer and Exercise Study: A Randomized Trial Evaluating the Use of a Pedometer and Brief Exercise Coaching in Prostate Cancer Patients Treated With Androgen Deprivation Therapy.|Unknown status|Recruiting|N/A|400|Anticipated|Groupe de recherche en Urologie de la Mauricie|||1||f||||f||||||||||2017-02-18 13:14:32.079707|2017-02-18 13:14:32.079707
NCT00868855|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-11-18|||December 2003||2003-12-01|November 2016|2016-11-01||||December 2010|Actual|2010-12-01||Interventional|||Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease|The Intracoronary Tissue-type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events in Patients With Non-critical Coronary Artery Disease|Enrolling by invitation||Phase 1|16|Actual|Vanderbilt University||1|||f||||t||||||||||2017-02-18 13:14:32.162243|2017-02-18 13:14:32.162243
NCT00868842|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2014-04-10|||January 2009||2009-01-01|April 2014|2014-04-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Observational|||Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis|Open-label, Single-center Study of Whether Oral Penicillin Desensitization of Healthy Sensitive Subjects Results in Allergen Cross-desensitization of Mast Cells by Skin Testing and Desensitization of Peripheral Blood Basophils.|Completed||N/A|10|Actual|Virginia Commonwealth University|||1||f||||t||||||||||2017-02-18 13:14:32.273975|2017-02-18 13:14:32.273975
NCT00868829|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-08-09|||April 2009||2009-04-01|August 2011|2011-08-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|FOCUS||Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial|Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial|Unknown status|Recruiting|N/A|5000|Anticipated|Shanghai MicroPort Medical (Group) Co., Ltd.||1|||f||||t||||||||||2017-02-18 13:14:32.358843|2017-02-18 13:14:32.358843
NCT00868816|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||January 2005||2005-01-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 Cycles|A Prospective, Randomized, Control Trial of Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles vs 12 Cycles|Completed||Phase 4|400|Actual|Fudan University||2|||f||||t||||||||||2017-02-18 13:14:32.47832|2017-02-18 13:14:32.47832
NCT00868634|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-08-29|||February 2009||2009-02-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|March 2014|Actual|2014-03-01||Interventional|CARIN||Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer|Capecitabine and Bevacizumab ± Vinorelbine as 1st Line Treatment in HER-2 Negative Metastatic or Locally Advanced Inoperable Breast Cancer Patients|Completed||Phase 3|600|Actual|iOMEDICO AG||2|||f||||f||||||||No||2017-02-18 13:14:35.942115|2017-02-18 13:14:35.942115
NCT00868803|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-09-06|||April 1995||1995-04-01|September 2016|2016-09-01|April 2025|Anticipated|2025-04-01|April 2020|Anticipated|2020-04-01||Observational|||Aberrant Gene Expression Prostate Carcinoma|Identification of Aberant Gene Expression in Human Prostatic Carcinoma|Active, not recruiting||N/A|5000|Anticipated|Lahey Clinic|||1||f||||f||||||Samples With DNA|"~     Surplus tissue following pathologic review requirements will be snap frozen and processed~     for extraction of RNA. mRNA will be reversed transcribed to make cDNA with the prime~     5'TCCTTAGAAC, followed by 40 cycles of palindromic PCR using the sam eprimer. Amplified cDNA~     (35 S-labled) will be analysed on a 4% polyacrylamide gel. Comparative analysis of cDNA~     amplified products will serve to identify aberrantly expressed candidate genes. Such~     products will be isolated, sequenced and evaluated as to their role in establishing the~     neoplastic pheotype and the potential utility as a marker of prostatic neoplastic~     progression.~   "|||2017-02-18 13:14:32.602318|2017-02-18 13:14:32.602318
NCT00868790|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-11-14|2016-11-14||March 2009||2009-03-01|November 2016|2016-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)|A Phase IIa, Multicenter, Randomized, Placebo- and Active-Comparator Controlled, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK-3577 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Terminated||Phase 2|118|Actual|Merck Sharp & Dohme Corp.|A pre-specified interim analysis of the efficacy and safety data for the initial cohort of participants in this study (Cohort 1) determined that sufficient data had been accrued to assess the study hypotheses, thus the study was discontinued.|14||Upon interim analysis, sufficient data was accrued to assess study hypotheses.|f||||t||||||||||2017-02-18 13:14:32.700643|2017-02-18 13:14:32.700643
NCT00868777|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-09-24|||January 2008||2008-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||The Influence of Dimensional Anatomic Variables on the Outcomes of Maxillary Sinus Grafting Procedures|The Influence of Dimensional Anatomic Variables on the Outcomes of Maxillary Sinus Grafting Procedures|Completed||Phase 4|25|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 13:14:33.55425|2017-02-18 13:14:33.55425
NCT00868764|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-10-05|||April 2009||2009-04-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron|An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron|Completed||Phase 1|60|Anticipated|Prostrakan Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:14:33.661241|2017-02-18 13:14:33.661241
NCT00868751|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2012-12-06|||March 2009||2009-03-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis|Single Patient Use of Tocilizumab for Treatment of Steroid Dependent, Active Systemic Onset Juvenile Idiopathic Arthritis|Terminated||N/A|1|Actual|Tufts Medical Center||1||Hyperintensities of unclear etiology on brain MRI. Follow up revealed no progression.|f||||f||||||||||2017-02-18 13:14:33.762903|2017-02-18 13:14:33.762903
NCT00868738|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2011-11-01|||March 2009||2009-03-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||Evaluation of Calcium, Vitamin D, Magnesium, and Zinc Absorption in Children|Evaluation of Calcium, Vitamin D, Magnesium, and Zinc Absorption in Healthy Children 4 to 8 Years of Age|Completed||N/A|60|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 13:14:33.873178|2017-02-18 13:14:33.873178
NCT00868725|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-09-30|||April 2009||2009-04-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Detecting Lesions in the Oral Cavity With Thermal Imaging|Detecting Lesions in the Oral Cavity With Thermal Imaging|Completed||N/A|50|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 13:14:33.987453|2017-02-18 13:14:33.987453
NCT00868712|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2012-08-23|2010-02-02||May 2004||2004-05-01|August 2012|2012-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|WACC||Warfarin and Coronary Calcification Project|Warfarin and Coronary Calcification Project|Completed||N/A|70|Actual|Walter Reed Army Medical Center|Cross-sectional nature, small sample size. Initially powered for sample size of 100 subjects, our trial was stopped early after an interim analysis at 70 subjects demonstrated no trend for effect of warfarin after adjusting for standard risk factors.||3||f||||t||||||||||2017-02-18 13:14:34.092086|2017-02-18 13:14:34.092086
NCT00868699|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2014-03-31|2013-02-14||April 2009||2009-04-01|March 2014|2014-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Intent-to-treat population is analyzed.|Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)|A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression|Completed||Phase 3|505|Actual|Sunovion||3|||f||||t||||||||||2017-02-18 13:14:34.540411|2017-02-18 13:14:34.540411
NCT00868686|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||October 2005||2005-10-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Clinical Trial Comparing Volar, Dorsal, and Custom Thermoplastic Splinting in the Treatment of Acute Mallet Finger|Blinded, Prospective, Randomized Clinical Trial Comparing Volar, Dorsal, and Custom Thermoplastic Splinting in the Treatment of Acute Mallet Finger|Completed||Phase 3|77|Actual|St. Paul's Hospital, Canada||3|||f||||||||||||||2017-02-18 13:14:35.413089|2017-02-18 13:14:35.413089
NCT00868673|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-07-08|||March 2009||2009-03-01|November 2009|2009-11-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional|||The Role Of Fructose and Uric Acid In the Development of Obesity and Metabolic Syndrome|The Role Of Fructose and Uric Acid In the Development of Obesity and Metabolic Syndrome|Completed||N/A|120|Actual|Instituto Nacional de Cardiologia Ignacio Chavez||2|||f||||f||||||||||2017-02-18 13:14:35.505774|2017-02-18 13:14:35.505774
NCT00868660|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2010-11-01|||January 2009||2009-01-01|November 2010|2010-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose|A Phase I, Double Blind, Placebo-Controlled Study of ZP1848 Administered as Subcutaneous Bolus Injections in Healthy Subjects Followed by Multiple Doses in Patients With Crohn's Disease in Remission|Completed||Phase 1|66|Actual|Zealand Pharma||2|||f||||t||||||||||2017-02-18 13:14:35.612056|2017-02-18 13:14:35.612056
NCT00868647|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-08-28|||June 2007||2007-06-01|August 2009|2009-08-01||||June 2012|Anticipated|2012-06-01||Interventional|||Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood|Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood: A Phase II Study|Suspended||Phase 2|60|Anticipated|Seattle Children's Hospital||1|||f||||t||||||||||2017-02-18 13:14:35.708695|2017-02-18 13:14:35.708695
NCT00868621|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-03-23|||March 2007||2007-03-01|March 2009|2009-03-01|June 2009|Anticipated|2009-06-01|September 2008|Actual|2008-09-01||Observational|||Urinary Cytokines in Patients With Overactive Bladder (OAB)|Identification of Urinary Cytokines in Patients With Overactive Bladder (OAB)|Unknown status|Active, not recruiting|N/A|56|Actual|Cleveland Clinic Florida|||3||f||||t||||||||||2017-02-18 13:14:36.055469|2017-02-18 13:14:36.055469
NCT00868608|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2013-07-17||2013-04-18|July 2009||2009-07-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|January 2012|Actual|2012-01-01||Interventional|||Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma|A Phase 2 Study Of Inotuzumab Ozogamicin (CMC-544) In Subjects With Indolent Non-Hodgkin's Lymphoma (NHL) That Is Refractory To Or Has Relapsed After Rituximab And Chemotherapy Or Radioimmunotherapy|Completed||Phase 2|81|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:14:36.155732|2017-02-18 13:14:36.155732
NCT00868595|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-11-04|||April 2009||2009-04-01|March 2016|2016-03-01|March 2012|Actual|2012-03-01|July 2011|Actual|2011-07-01||Interventional|||MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer|A Phase I, Non-randomized, Multiple Dose, Dose Escalation Study of the Safety, PK, PD and Efficacy of Therapeutic Vaccine, BP-GMAX-CD1, Plus Activating Agent, AP1903, in Patients With Castrate Resistant Prostate Cancer|Completed||Phase 1|18|Actual|Bellicum Pharmaceuticals||1|||f||||t||||||||Undecided||2017-02-18 13:14:36.29188|2017-02-18 13:14:36.29188
NCT00868582|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-01-15|||May 2006||2006-05-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|March 2016|Anticipated|2016-03-01||Observational|NOPR||The National Oncologic PET Registry|The National Oncologic PET Registry|Recruiting||N/A|333000|Anticipated|American College of Radiology Imaging Network|||2||f||||f||||||||||2017-02-18 13:14:36.408773|2017-02-18 13:14:36.408773
NCT00868569|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||January 2008||2008-01-01|March 2009|2009-03-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer|TAC vs TACE Plus folfox4 as the Treatment of Unresectalbe Liver Metastasis of Colorectal Cancer With Resection of the Primary Tumor: a Prospective, Randomized, Control Trial|Unknown status|Recruiting|Phase 4|200|Anticipated|Fudan University||2|||f||||t||||||||||2017-02-18 13:14:36.53496|2017-02-18 13:14:36.53496
NCT00868556|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-01-04|||January 2009||2009-01-01|March 2009|2009-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease?|fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease?|Completed||N/A|33|Actual|The Cleveland Clinic|||3||f||||f||||||||||2017-02-18 13:14:36.659515|2017-02-18 13:14:36.659515
NCT00868543|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-03-24|||July 2008||2008-07-01|March 2009|2009-03-01|December 2015|Anticipated|2015-12-01|July 2013|Anticipated|2013-07-01||Interventional|||Long or Very Long-Limb Gastric Bypass in Superobese|Long or Very Long-Limb Gastric Bypass in Superobese|Unknown status|Recruiting|Phase 3|150|Anticipated|Kaunas University of Medicine||2|||f||||f||||||||||2017-02-18 13:14:36.758981|2017-02-18 13:14:36.758981
NCT00868530|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2011-04-01|2010-12-03||September 2008||2008-09-01|April 2011|2011-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects|An Evaluation Of The Safety And Efficacy Of On-Demand Treatment With Xyntha (B Domain Deleted Recombinant Factor VIII, Albumin Free) In Chinese Subjects With Hemophilia A|Completed||Phase 3|53|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:14:36.869439|2017-02-18 13:14:36.869439
NCT00868517|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2015-04-06|2014-09-22||October 2009||2009-10-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional||OEF/OIF Veterans with PTSD-related insomnia.|Examining the Effect of Acupuncture on Sleep Difficulties Related to Post Traumatic Stress Disorder|The Effect of Acupuncture on PTSD-Related Insomnia|Completed||N/A|35|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 13:14:37.182331|2017-02-18 13:14:37.182331
NCT00868504|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-09-29|||April 2009||2009-04-01|September 2009|2009-09-01|November 2009|Anticipated|2009-11-01|October 2009|Anticipated|2009-10-01||Observational|||Measuring Temperatures of Tissues During Endoscopy|Measuring Temperatures of Tumors and Normal Tissues in the GI Tract, Using a Thermocouple Sheathed in a Catheter, in the Work Canal of an Endoscope|Unknown status|Recruiting|N/A|50|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 13:14:37.958656|2017-02-18 13:14:37.958656
NCT00868491|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2011-10-23|||March 2008||2008-03-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|December 2009|Actual|2009-12-01||Interventional|||Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer|Induction Chemotherapy Followed by Chemoradiation With Cetuximab and Cisplatin for Inoperable Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|30|Anticipated|Institute of Oncology Ljubljana||1|||f||||t||||||||||2017-02-18 13:14:38.061565|2017-02-18 13:14:38.061565
NCT00868478|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-06-01|||April 2009||2009-04-01|September 2009|2009-09-01|April 2012|Anticipated|2012-04-01|April 2011|Anticipated|2011-04-01||Interventional|||The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)|Phase I-II Trial of the Anti CD74 Monoclonal Antibody-Milatuzumab as a Single Agent in Refractory Chronic Lymphocytic Leukemia|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|Kaplan Medical Center||1|||f||||f||||||||||2017-02-18 13:14:38.163278|2017-02-18 13:14:38.163278
NCT00868465|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2010-06-04|||April 2009||2009-04-01|April 2009|2009-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|TRANSACT||Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)||Completed||N/A|600|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 13:14:38.272849|2017-02-18 13:14:38.272849
NCT00868452|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2014-03-31|2013-01-11||April 2009||2009-04-01|March 2014|2014-03-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional||Data for full analysis set is provided (intent-to-treat population)|Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)|A Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression|Completed||Phase 3|348|Actual|Sunovion||2|||f||||t||||||||||2017-02-18 13:14:38.394384|2017-02-18 13:14:38.394384
NCT00868088|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-07-05|||July 2009||2009-07-01|July 2011|2011-07-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip|A Clinical Trial of ALA Photodynamic Therapy for Treatment of Actinic Cheilitis in Patients With Squamous Cell Carcinoma of the Lip.|Completed||Phase 4|34|Anticipated|Tufts Medical Center||2|||f||||f||||||||||2017-02-18 13:14:48.704193|2017-02-18 13:14:48.704193
NCT00868439|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-01-25|2015-11-11||April 2009||2009-04-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|PEARL-HF|One participant received one dose of patiromer and did not return to the clinic in a timely manner; the participant was terminated from the study for protocol noncompliance, and because the participant did not have post-treatment efficacy data, the participant was excluded from the Full Analysis Set but retained in the Safety Analysis Set.|Evaluation of Patiromer in Heart Failure Patients|A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Study to Evaluate the Effects of Patiromer in Heart Failure Patients|Completed||Phase 2|120|Actual|Relypsa, Inc.||2|||f||||f||||||||||2017-02-18 13:14:39.090897|2017-02-18 13:14:39.090897
NCT00868426|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-08-12|||April 2009||2009-04-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler|Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler, Symbicort Turbuhaler; an Open, Single Center, Single Dose Study With 3-way Crossover Design in Healthy Subjects|Completed||Phase 1|12|Actual|Orion Corporation, Orion Pharma||3|||f||||f||||||||||2017-02-18 13:14:39.710918|2017-02-18 13:14:39.710918
NCT00868413|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2013-06-05|||November 2009||2009-11-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia|A Phase 1 Study Evaluating the Safety of ABT-263 in Combination With Either Fludarabine/Cyclophosphamide/Rituximab (FCR) or Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 1|32|Actual|AbbVie||2|||f||||||||||||||2017-02-18 13:14:39.820869|2017-02-18 13:14:39.820869
NCT00868400|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2015-03-09|||May 2009||2009-05-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery|Multi-centre Double-blind Randomized Trial of the Clinical Value of Preoperative Oral Carbohydrate Loading in Colorectal Surgery.|Completed||N/A|215|Actual|Gulhane School of Medicine||3|||f||||f||||||||||2017-02-18 13:14:39.93127|2017-02-18 13:14:39.93127
NCT00868387|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2013-12-12|||November 2005||2005-11-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|November 2006|Actual|2006-11-01||Interventional|||Macronutrient Relations and Weight Loss in Obese Subjects|Effects of Macronutrient Relations on Body Weight, Body Composition, and Cardiovascular Risk Markers in Overweight Patients Attending a Telemedically Guided Weight Loss Program|Completed||N/A|200|Actual|Heart and Diabetes Center North-Rhine Westfalia||2|||f||||f||||||||||2017-02-18 13:14:40.029929|2017-02-18 13:14:40.029929
NCT00868374|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2016-11-09|2013-11-01||June 2008||2008-06-01|November 2016|2016-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|MDD/GAD||Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder|Quetiapine XR Monotherapy or Adjunctive Therapy to Antidepressants in the Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder|Terminated||Phase 3|23|Actual|University Hospitals Cleveland Medical Center||2||Study terminated due to low enrollment|f||||t||||||||||2017-02-18 13:14:40.128576|2017-02-18 13:14:40.128576
NCT00868361|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2009-09-15|||May 2009||2009-05-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel|A Phase 1 Open-label Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-Talampanel Following Oral Administration to Healthy Male|Terminated||Phase 1|10|Anticipated|Teva Pharmaceutical Industries||1||Poor recruitment of fast and slow acetylators|f||||f||||||||||2017-02-18 13:14:40.744143|2017-02-18 13:14:40.744143
NCT00868348|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-24|2014-01-22|2013-07-10||May 2009||2009-05-01|July 2013|2013-07-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional||Gender, Age,|A Comparison of Naropin and Ketorolac for Postoperative Analgesia After Total Knee Arthroplasty|Local Infiltration Analgesia for Total Knee Arthroplasty: Should Ketorolac be Added|Completed||Phase 4|60|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 13:14:40.849946|2017-02-18 13:14:40.849946
NCT00868335|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-03-20|||December 2007||2007-12-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Cervical Spine; Movement Before and After Anterior Cervical Discectomy, With or Without a Cervical Disc Prosthesis|Cervical Spine; Movement Before and After Anterior Cervical Discectomy, With or Without an Activ-C Cervical Disc Prosthesis.|Completed||N/A|24|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 13:14:41.330128|2017-02-18 13:14:41.330128
NCT00868309|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2016-03-18|2008-11-06||January 2005||2005-01-01|March 2016|2016-03-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Interventional|||A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,|A Comparison of Anavip and CroFab in the Treatment of Subjects With Crotalinae (Pit Viper) Envenomation: A Randomized, Prospective, Open-Label, Controlled, Comparative, Multicenter Study|Completed||Phase 2|12|Actual|Instituto Bioclon S.A. de C.V.||2|||f||||f||||||||Undecided||2017-02-18 13:14:41.44769|2017-02-18 13:14:41.44769
NCT00868296|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2010-04-29|2009-11-30||March 2006||2006-03-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)|A Muliticenter, Open Label Safety Study of 2 Doses of Pantoprazole Sodium Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed GERD|Completed||Phase 3|58|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 13:14:41.902394|2017-02-18 13:14:41.902394
NCT00868283|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-07-06|||September 2006||2006-09-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|October 2010|Actual|2010-10-01||Interventional|CASTA||The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke|A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke|Completed||Phase 4|1071|Actual|Ever Neuro Pharma GmbH||2|||f||||t||||||||||2017-02-18 13:14:42.412374|2017-02-18 13:14:42.412374
NCT00868270|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2009-03-22|||May 2009||2009-05-01|March 2009|2009-03-01||||||||Observational|||Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis||Unknown status|Not yet recruiting|N/A|35|Anticipated|Hillel Yaffe Medical Center|||1||f||||||||||||||2017-02-18 13:14:42.632024|2017-02-18 13:14:42.632024
NCT00868075|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2011-11-04|||March 2009||2009-03-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Pulmonary Rehabilitation in Non Cystic Fibrosis Bronchiectasis|Pulmonary Rehabilitation in Non Cystic Fibrosis Bronchiectasis|Completed||Phase 4|27|Actual|NHS Lothian||2|||f||||f||||||||||2017-02-18 13:14:48.823439|2017-02-18 13:14:48.823439
NCT00868257|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2012-01-11|||July 2008||2008-07-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Measurement of Adherence to ART in HIV-Infected Children in Uganda (The CHARTA Study)|Measurement of Adherence to ART in HIV-Infected School-Aged Children in Uganda|Completed||N/A|120|Actual|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"~     Plasma samples to repeat HIV viral load testing, in the case of processing errors. If these~     samples are not needed, they may be used for immunologic or viral resistance testing at a~     future date.~   "|||2017-02-18 13:14:42.708581|2017-02-18 13:14:42.708581
NCT00868244|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-03-23|||June 2008||2008-06-01|March 2009|2009-03-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Observational|BRUXISM||Relationship of Facial Pattern With Bruxism|Relationship of Facial Pattern With Bruxism|Unknown status|Recruiting|N/A|300|Anticipated|Universidad de Guanajuato|||1||f||||t||||||||||2017-02-18 13:14:42.817604|2017-02-18 13:14:42.817604
NCT00868231|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-11-16|2012-08-14||March 2009||2009-03-01|September 2016|2016-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients||Completed||Phase 2|30|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 13:14:42.889964|2017-02-18 13:14:42.889964
NCT00868218|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-10-19|2015-06-06||March 2009||2009-03-01|October 2016|2016-10-01|November 2013|Actual|2013-11-01|July 2010|Actual|2010-07-01||Interventional|PANFLUVAC|Healthy adults willing to join phase I trial|Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults|Preparing for an Influenza Pandemic: A Phase I Study of a Parenterally Administered H5N1 Influenza Vaccine in Healthy Adults|Completed||Phase 1|60|Actual|University of Bergen||4|||f||||f||||||||||2017-02-18 13:14:43.479306|2017-02-18 13:14:43.479306
NCT00868205|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2012-02-27|||March 2009||2009-03-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|July 2009|Actual|2009-07-01||Interventional|||Coffee and In-vivo Oxidative Stress|The Relationship Between Short- and Mid-term Intake of Coffee on in Vivo Levels of Oxidative Stress Parameters in Healthy Adults.|Completed||Phase 2|180|Anticipated|TNO||3|||f||||f||||||||||2017-02-18 13:14:44.058995|2017-02-18 13:14:44.058995
NCT00868192|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2014-10-10|2014-10-02||May 2008||2008-05-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma|Phase II Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian and Primary Peritoneal Carcinoma|Completed||Phase 2|38|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 13:14:44.165442|2017-02-18 13:14:44.165442
NCT00868179|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2015-05-14|||April 2009||2009-04-01|May 2009|2009-05-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten Days|A Cohort (Follow Up) Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax (Tablet) Post Discharge for Ten Days, Without the Need for Routine Coagulation Monitoring and Dose Adjustment|Withdrawn||Phase 4|0|Actual|Nova Scotia Health Authority||1||study never started|f||||t||||||||||2017-02-18 13:14:44.65722|2017-02-18 13:14:44.65722
NCT00868166|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2012-03-27|||April 2009||2009-04-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|MITOTARGET||Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)|Phase II/III, Multicenter, Randomized, Parallel Group, Double-blind, Placebo Controlled Study to Assess Safety and Efficacy of TRO19622 in Amyotrophic Lateral Sclerosis (ALS) Patients Treated With Riluzole|Completed||Phase 2/Phase 3|512|Actual|Trophos||2|||f||||t||||||||||2017-02-18 13:14:44.763658|2017-02-18 13:14:44.763658
NCT00868153|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2015-02-16|||August 2004||2004-08-01|February 2015|2015-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Mirena in Idiopathic Menorrhagia|Levonorgestrel Releasing Intrauterine Device (Mirena) in Idiopathic Menorrhagia|Completed||N/A|1125|Actual|Bayer|||1||f||||f||||||None Retained|"~     Serum~   "|||2017-02-18 13:14:47.166418|2017-02-18 13:14:47.166418
NCT00868140|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2016-05-02|2016-02-19||February 2009||2009-02-01|May 2016|2016-05-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|PCOS|A total of 32 obese (body mass index, BMI, greater than or equal to 30 kg/m2 PCOS women, between 18-40 years old, were studied during the equivalent of the follicular phase of the menstrual cycle, as documented by a serum progesterone of less than or equal to 2 ng/ml.|Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)|Determination if Indirectly Reducing Circulating Insulin by Improving Insulin Sensitivity With Pioglitazone Reduces Renal Clearance of D-chiro-inositol (DCI) Increases the Circulating Concentration of DCI and Enhances Insulin-stimulated Release of the D-chiro-inositol-containing Inositolphosphoglycan (DCI-IPG) Mediator in Obese Women With PCOS|Terminated||N/A|51|Actual|Virginia Commonwealth University||2||Lack of recruitment|f||||t||||||||No|individual data kept confidential, secured and not shared beyond authorized study staff|2017-02-18 13:14:47.282258|2017-02-18 13:14:47.282258
NCT00868127|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-05-23|||December 2005||2005-12-01|May 2012|2012-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia|An Open-Label Extension Study to Evaluate the Safety and Tolerability of Lapaquistat Acetate in Subjects With Hypercholesterolemia|Completed||Phase 3|574|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:14:47.873722|2017-02-18 13:14:47.873722
NCT00868114|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2014-10-23|||July 2006||2006-07-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|July 2013|Actual|2013-07-01||Interventional|||Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer|A Phase II Study of Apoptosis Induction Through Direct Tumor Injection of TNFerade(TM)or Radiation Alone Followed by KLH-Pulsed Autologous Dendritic Cells in Patients With Unresectable Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|Leo W. Jenkins Cancer Center||2|||f||||t||||||||||2017-02-18 13:14:47.978676|2017-02-18 13:14:47.978676
NCT00868101|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-12-02|2011-08-03||January 2008||2008-01-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||The Effect of Remote Ischemic Preconditioning Applied in Children the Day Before Open Heart Surgery|The Use of Remote Ischemic Preconditioning Applied in Child the Day Before Open Heart Surgery With Extracorporeal Circulation to Correct Congenital Heart Diseases (the Second Window Effect)|Completed||Phase 1/Phase 2|22|Actual|University of Sao Paulo|Small number of subjects|2|||f||||t||||||||||2017-02-18 13:14:48.099079|2017-02-18 13:14:48.099079
NCT00866125|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-03-19|||April 2002||2002-04-01|March 2009|2009-03-01|August 2002|Actual|2002-08-01|||||Observational|||Hand Function in Patients With Poly- or Dermatomyositis|Hand Function, Health Related Quality of Life and Activity Performance in Patients With Polymyositis or Dermatomyositis.|Completed||N/A|31|Actual|Karolinska Institutet|||1||f||||f||||||||||2017-02-18 13:15:22.652689|2017-02-18 13:15:22.652689
NCT00868062|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-11-15|||April 2009||2009-04-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Responses to Colloid Infusions|Do 100 kiloDaltons Matter? A Prospective Randomised Double-blind Study on the Blood Volume Expanding Effects of Two Different Colloids in Patients Undergoing Laparoscopic Cholecystectomy|Completed||Phase 3|24|Actual|University of Nottingham||1|||f||||f||||||||||2017-02-18 13:14:48.926323|2017-02-18 13:14:48.926323
NCT00868049|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-03-23|||May 2007||2007-05-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Observational|SSSCDFO||Study of Stomatognathic System of the Obese Subjects|Study of Stomatognathic System,Chewing and Deglutition Functions in the Obese Subjects|Completed||N/A|40|Actual|University of Sao Paulo|||2||f||||f||||||||||2017-02-18 13:14:49.036775|2017-02-18 13:14:49.036775
NCT00868036|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2010-02-01|||December 2008||2008-12-01|February 2010|2010-02-01|March 2011|Anticipated|2011-03-01|December 2010|Anticipated|2010-12-01||Interventional|||Evaluating for Contact Allergies in Patients With Chronic Urticaria|Contact Allergens Causing Chronic Urticaria in a New England-Area Population|Unknown status|Recruiting|N/A|60|Anticipated|Tufts Medical Center||1|||f||||f||||||||||2017-02-18 13:14:49.124848|2017-02-18 13:14:49.124848
NCT00868023|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2010-12-22|||February 2009||2009-02-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients|A Phase II, Multinational, Multicentre, Double Blind, Double Dummy, Randomised, 5-way Cross-over, Placebo and Active Controlled Clinical Study to Test the Non-inferiority of a Single Dose of CHF 1535 (Fixed Combination of Beclomethasone Dipropionate 100 µg Plus Formoterol Fumarate 6 µg Dry Powder) Via NEXT™ DPI 1 or 4 Inhalations Versus CHF 1535 (Beclomethasone Dipropionate 100 µg Plus Formoterol Fumarate 6 µg) pMDI With HFA-134a Propellant 1 or 4 Puffs on FEV1 AUC0-12h in Partly Controlled Adult Asthmatic Patients|Completed||Phase 2|69|Actual|Chiesi Farmaceutici S.p.A.||5|||f||||f||||||||||2017-02-18 13:14:49.236342|2017-02-18 13:14:49.236342
NCT00868010|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2013-03-04|||March 2009||2009-03-01|March 2013|2013-03-01|November 2013|Anticipated|2013-11-01|August 2013|Anticipated|2013-08-01||Interventional|Enhance||Enhancing Rehabilitation After Stroke|Donepezil to Promote Functional Recovery Post-stroke|Unknown status|Recruiting|Phase 3|200|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 13:14:49.339839|2017-02-18 13:14:49.339839
NCT00867997|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2012-02-27|||March 2009||2009-03-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Interventional|||Noncarious Cervical Lesion Treatment Outcomes|Noncarious Cervical Lesion Treatment Outcomes: Randomized Clinical Trial|Completed||Phase 3|304|Actual|Pearl Network||3|||f||||t||||||||||2017-02-18 13:14:49.459398|2017-02-18 13:14:49.459398
NCT00867984|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2015-11-20|||March 2009||2009-03-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|TORSION||Torsion Optimization to Reduce Symptoms and Improve Outcomes in Non-responders|Torsion Optimization to Reduce Symptoms and Improve Outcomes in Non-responders (TORSION). A Randomized Comparison of Torsion-imaging Guided Optimization vs. Usual Settings.|Active, not recruiting||Phase 3|60|Anticipated|University of Calgary||2|||f||||t||||||||||2017-02-18 13:14:49.593003|2017-02-18 13:14:49.593003
NCT00867971|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2009-03-22|||February 2009||2009-02-01|February 2009|2009-02-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Observational|||Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?||Unknown status|Active, not recruiting|N/A|100|Anticipated|Assaf-Harofeh Medical Center|||2||f||||||||||||||2017-02-18 13:14:49.702777|2017-02-18 13:14:49.702777
NCT00867958|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2011-02-20|||September 2008||2008-09-01|May 2009|2009-05-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|||Compression Anastomosis Using the CAR™ 27|Compression Anastomosis Using the CAR™ 27|Completed||N/A|15|Anticipated|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-02-18 13:14:49.78486|2017-02-18 13:14:49.78486
NCT00867945|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2013-06-17|||March 2009||2009-03-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Pregnancy-Induced Analgesia - A Longitudinal Study of DNIC|Pregnancy-Induced Analgesia - A Longitudinal Study of DNIC|Unknown status|Recruiting|N/A|60|Anticipated|University of Washington|||3||f||||f||||||||||2017-02-18 13:14:49.869741|2017-02-18 13:14:49.869741
NCT00867932|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2017-02-15|||May 2009||2009-05-01|February 2017|2017-02-01|November 2011|Actual|2011-11-01|May 2011|Actual|2011-05-01||Interventional|||Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent PNH Subjects|An Open Label Multi Center Study of Eculizumab in Children and Adolescents With Diagnosis of Paroxysmal Nocturnal Hemoglobinuria|Completed||Phase 1/Phase 2|7|Actual|Alexion Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:14:49.97027|2017-02-18 13:14:49.97027
NCT00867919|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2013-04-16|||April 2009||2009-04-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Designing and Testing a Family Therapy for Adolescent Depression|Family Therapy for Adolescent Depression: Deployment Focused Development, Phase 1|Completed||Phase 1|56|Anticipated|Oregon Research Institute||2|||f||||f||||||||||2017-02-18 13:14:50.079737|2017-02-18 13:14:50.079737
NCT00867906|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-05-05|||March 2009||2009-03-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma|A Double-blind, Randomised, Placebo-controlled Study to Assess the Safety of Cat-PAD in Cat Allergic Subjects With Controlled Asthma|Completed||Phase 2|48|Anticipated|Circassia Limited||3|||f||||f||||||||||2017-02-18 13:14:50.175135|2017-02-18 13:14:50.175135
NCT00867893|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2012-08-13|||February 2009||2009-02-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Suggested Immobilization Test (SIT) Test for Early Detection of Restless Legs Syndrome (RLS) Augmentation - Proof of Concept|d Immobilization Test (SIT) Test for Early Detection of Restless Legs Syndrome (RLS) Augmentation - Proof of Concept|Completed||N/A|68|Actual|Johns Hopkins University|||2||f||||f||||||||||2017-02-18 13:14:50.468204|2017-02-18 13:14:50.468204
NCT00867880|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2014-12-12|||March 2009||2009-03-01|December 2014|2014-12-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single Dose, Crossover Study of the Pharmacokinetics, Safety and Tolerability of Ibuprofen Inejction (IVIb) In Healthy Adult Volunteers|Completed||Phase 1|12|Actual|Cumberland Pharmaceuticals||2|||f||||t||||||||||2017-02-18 13:14:50.563642|2017-02-18 13:14:50.563642
NCT00866112|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2012-06-13|||May 2008||2008-05-01|April 2010|2010-04-01|June 2012|Actual|2012-06-01|February 2011|Actual|2011-02-01||Interventional|||A Randomized Exercise Trial for Wheelchair Users|A Randomized Exercise Trial for Wheelchair Users|Completed||N/A|135|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 13:15:22.724384|2017-02-18 13:15:22.724384
NCT00867867|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2013-07-13|||October 2003||2003-10-01|March 2009|2009-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries|The Usefulness of Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries|Completed||Phase 1|235|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||t||||||||||2017-02-18 13:14:50.658773|2017-02-18 13:14:50.658773
NCT00867854|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2016-03-01|||February 2009||2009-02-01|March 2016|2016-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Treatment De-Intensification and Residual HIV-1 in Youth|Treatment De-Intensification and Residual HIV-1 in Adolescents and Young Adults: A Sub-Study of ATN 061 and ATN 071.|Completed||N/A|34|Actual|Westat|||2||f||||t||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:14:50.760997|2017-02-18 13:14:50.760997
NCT00867841|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-02-24||||||February 2016|2016-02-01||||||||Observational|||A Polymerase Chain Reaction (PCR) - Based Method to Improve Antibiotic Prescribing for Pneumonia|A Polymerase Chain Reaction-based Method to Improve Antibiotic Prescribing for Children and Adolescents With Community-Acquired Pneumonia - a Pilot Study|Withdrawn||N/A|0|Actual|Children's Hospital of Eastern Ontario|||1|funding issues and procedural problems|f||||f||||||Samples With DNA|"~     nasopharyngeal swabs blood samples (for pneumococcal PCR)~   "|||2017-02-18 13:14:50.886255|2017-02-18 13:14:50.886255
NCT00867828|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-09-30|||May 2009||2009-05-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01||Interventional|MNEMOSYNE||Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)|Multi-Center, Double-Blind, Placebo-Controlled, Monotherapy Study of Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease|Completed||Phase 4|175|Actual|NeuroBioPharm Inc.||3|||f||||f||||||||||2017-02-18 13:14:50.991731|2017-02-18 13:14:50.991731
NCT00867815|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2017-01-30|||July 2009||2009-07-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)|Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men With Erectile Dysfunction Increases the Risk for the Development of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)|Recruiting||Phase 4|284|Anticipated|Bayer||1|||f||||f||||||||||2017-02-18 13:14:51.106102|2017-02-18 13:14:51.106102
NCT00867802|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2009-03-20|||May 2007||2007-05-01|March 2009|2009-03-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|MICAS||Mindfulness Intervention For Child Abuse Survivors (MICAS)|Mindfulness Intervention For Child Abuse Survivors|Unknown status|Active, not recruiting|N/A|20|Anticipated|University of Maryland||1|||f||||f||||||||||2017-02-18 13:14:51.310866|2017-02-18 13:14:51.310866
NCT00867789|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-06-21|||March 2009||2009-03-01|June 2011|2011-06-01|October 2012|Anticipated|2012-10-01|September 2012|Anticipated|2012-09-01||Interventional|||Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department|Trimethoprim-sulfamethoxazole Versus Placebo in the Treatment of Cutaneous Abscesses in the Emergency Department|Unknown status|Recruiting|N/A|200|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-02-18 13:14:51.406527|2017-02-18 13:14:51.406527
NCT00867776|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2015-10-30|||June 2009||2009-06-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Creating African-American Wellness Through Exercise|Creating African-American Wellness Through Exercise: Community Driven Strategies to Improve Health|Terminated||N/A|22|Actual|Oregon Health and Science University||1||We decided to alter the intervention.|f||||f||||||||||2017-02-18 13:14:51.522646|2017-02-18 13:14:51.522646
NCT00867763|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2010-08-10|||March 2009||2009-03-01|March 2009|2009-03-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Interventional|IVM vs IVF||In Vitro Maturation With in Vitro Fertilization (IVF) Compared to Mild in Vitro Fertilization|Clinical Research Study on in Vitro Maturation With IVF Compared to Mild Stimulation IVF|Suspended||N/A|1440|Anticipated|Batzofin Fertility Services||2||investigator changed location, requires new training effort|f||||t||||||||||2017-02-18 13:14:51.632136|2017-02-18 13:14:51.632136
NCT00867750|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-05-04|||March 2006||2006-03-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|SIRTACE||SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma|Radioembolisation (RE) With SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation (TACE) in Patients With Unresectable Hepatocellular Carcinoma (HCC). A Comparative, Prospective, Randomised, Open, Pilot Study.|Completed||Phase 2|28|Actual|Sirtex Medical||2|||f||||t||||||||||2017-02-18 13:14:51.73994|2017-02-18 13:14:51.73994
NCT00867737|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-03-23|||September 2008||2008-09-01|March 2009|2009-03-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)|Onset of Action of Advair HFA 115/21 in Comparison to Symbicort pMDI 160/4.5 Measured by Impulse Oscillometry, IOS.|Unknown status|Recruiting|Phase 4|30|Anticipated|Allergy and Asthma Center of El Paso||2|||f||||f||||||||||2017-02-18 13:14:51.839468|2017-02-18 13:14:51.839468
NCT00867724|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2011-06-09|||September 2009||2009-09-01|June 2011|2011-06-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||"Clinical Study-evaluate Performance&Safety Aer-O-Scope in Colon of Low Risk Patients"|"A Clinical Study to Evaluate the Performance & Safety of the Aer-O-Scope Traveling Through the Colon in Low Risk Subjects"|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|GI View Ltd.||1|||f||||f||||||||||2017-02-18 13:14:51.943912|2017-02-18 13:14:51.943912
NCT00867711|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2014-12-01|||January 2009||2009-01-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients|Pharmacogenetics of Pemetrexed and Carboplatin in Malignant Pleural Mesothelioma Patients|Completed||N/A|121|Actual|Istituto Clinico Humanitas|||1||f||||f||||||Samples With DNA|"~     The paraffin-embedded tumor specimens of patients will be collected. The tumor RNA and DNA~     will be extracted and genotyping, gene expression and gene copy number analyses will be~     performed with validated PCR and array-CGH techniques.~   "|||2017-02-18 13:14:52.042036|2017-02-18 13:14:52.042036
NCT00867698|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2014-06-02||2013-07-26|March 2009||2009-03-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|ASTUTE||AST-120 Used to Treat Mild Hepatic Encephalopathy|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy, Safety and Tolerability of AST-120 (Spherical Carbon Adsorbent) for 8 Weeks in the Treatment of Mild Hepatic Encephalopathy|Completed||Phase 2|148|Actual|Ocera Therapeutics||4|||f||||f||||||||||2017-02-18 13:14:52.130258|2017-02-18 13:14:52.130258
NCT00867685|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-04-29|||March 2009||2009-03-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|||||Interventional|||Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation|A Phase I, Randomized, Open Label, 2-Way Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of AZD2624 (Tablet Versus Liquid Suspension) Followed by an Additional Period to Assess the Food Effect on the Tablet|Completed||Phase 1|16|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 13:14:52.282235|2017-02-18 13:14:52.282235
NCT00867672|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-08-30|||August 2011||2011-08-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2015|Actual|2015-02-01||Interventional|DECIDER||Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia|Prospective Randomized Multicenter Phase II Trial of Low-dose Decitabine (DAC) Administered Alone or in Combination With the Histone Deacetylase Inhibitor Valproic Acid (VPA) and All-trans Retinoic Acid (ATRA) in Patients > 60 Years With Acute Myeloid Leukemia Who Are Ineligible for Induction Chemotherapy|Completed||Phase 2|204|Actual|University Hospital Freiburg||4|||f||||t||||||||||2017-02-18 13:14:52.386336|2017-02-18 13:14:52.386336
NCT00867659|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-21|2013-03-26|2012-12-27||March 2009||2009-03-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors|The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome in Oocyte Donors|Completed||N/A|20|Actual|Virginia Center for Reproductive Medicine|Only 20 donors were recruited because this was a pilot study to assess the benefit of Cetrotide acetate in oocyte donors in the prevention of ovarian hyperstimulation syndrome.|1|||f||||t||||||||||2017-02-18 13:14:52.736288|2017-02-18 13:14:52.736288
NCT00867646|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2009-12-14|||May 2008||2008-05-01|December 2009|2009-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Comparison Study of CoaguChek XS PT and Laboratory Innovin PT by NTUH Lab Medicine|Comparison Study of CoaguChek XS Prothrombin Time and Laboratory Innovin PT by NTUH Lab Medicine|Completed||N/A|70|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:14:52.990852|2017-02-18 13:14:52.990852
NCT00867633|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2012-02-20|||March 2009||2009-03-01|February 2012|2012-02-01|March 2012|Anticipated|2012-03-01|||||Observational|||Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan|Observational Study of Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||3||f||||f||||||Samples With DNA|"~     DNA extracted from the resected tissue samples~   "|||2017-02-18 13:14:53.079751|2017-02-18 13:14:53.079751
NCT00867620|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2009-03-22|||August 2008||2008-08-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|||||Observational|||Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma|Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma|Unknown status|Enrolling by invitation|N/A|82|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples With DNA|"~     These biospecimens will be keep in low-temperature (-80 degree)and then genomic DNA will be~     extracted from blood/urine samples until the detection of DNA methylation profiles.~   "|||2017-02-18 13:14:53.164839|2017-02-18 13:14:53.164839
NCT00867607|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2015-04-19|||March 2011||2011-03-01|March 2012|2012-03-01|March 2014|Actual|2014-03-01|April 2013|Actual|2013-04-01||Interventional|||Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis|A Double-blind, Vehicle-controlled Study to Assess the Safety, Tolerability, and Efficacy of Three Weeks of Daily Dermal Application of MRX-6 (2% HyPE) on the Treatment of Mild to Moderate Contact Dermatitis of the Hand and Forearm|Completed||Phase 1/Phase 2|13|Actual|Hadassah Medical Organization||4|||f||||t||||||||||2017-02-18 13:14:53.239254|2017-02-18 13:14:53.239254
NCT00867594|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2011-08-10|||July 2008||2008-07-01|March 2008|2008-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effectiveness of Oral Insulin in Unstable Type 1 Diabetes Patients|A Single Blind, Open-Label Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral Insulin Formulation in Type 1 Subjects|Completed||Phase 2|12|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-02-18 13:14:53.352881|2017-02-18 13:14:53.352881
NCT00867581|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-03-23|||September 2008||2008-09-01|March 2009|2009-03-01||||July 2009|Anticipated|2009-07-01||Observational|||Magnetic Resonance Imaging (MRI) Study of the Hippocampus After Infarction in the Territory of the Middle Cerebral Artery|To Observe Delayed Neuronal Death of Hippocampus After Middle Cerebral Artery Infarction Through Magnetic Resonance Imaging(MRI) Volume Measurement and Magnetic Resonance Spectroscopy(MRS) Study of Hippocampus|Unknown status|Recruiting|N/A|80|Anticipated|Huazhong University of Science and Technology|||2||f||||t||||||||||2017-02-18 13:14:53.437593|2017-02-18 13:14:53.437593
NCT00867568|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2016-09-09|2016-05-11||March 2009||2009-03-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|September 2011|Actual|2011-09-01||Interventional|||TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma|A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma|Completed||Phase 1|18|Actual|Spectrum Health Hospitals||1|||f||||t||||||||Undecided||2017-02-18 13:14:53.528336|2017-02-18 13:14:53.528336
NCT00867555|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-23|2009-09-17|||October 2008||2008-10-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation|Effects of the Green Tea Extract TEAVIGO High in EGCG, on Postprandial Fat Oxidation in Overweight Volunteers|Completed||N/A|24|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 13:14:53.883768|2017-02-18 13:14:53.883768
NCT00867542|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-22|2009-03-23|||June 2009||2009-06-01|March 2009|2009-03-01|February 2010|Anticipated|2010-02-01|December 2009|Anticipated|2009-12-01||Observational|||Dental and Oral Finding in Israeli Children With Past Intrauterine Growth Retardation (IUGR)|Dental and Oral Findings in Israeli Children With Past IUGR - a Comprehensive Study|Unknown status|Not yet recruiting|N/A|45|Anticipated|Hadassah Medical Organization|||2||f||||f||||||||||2017-02-18 13:14:53.981811|2017-02-18 13:14:53.981811
NCT00867529|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2016-11-21|||February 2009||2009-02-01|November 2016|2016-11-01||||March 2015|Actual|2015-03-01||Interventional|||Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma|Addition of Pre- and Post-Transplant Rituximab for Patients Undergoing Non-myeloablative Allogeneic Hematopoietic Cell Transplantation With Relapsed or Refractory CD20+ B-Cell Malignancies|Active, not recruiting||Phase 2|100|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 13:14:54.084582|2017-02-18 13:14:54.084582
NCT00867516|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2010-09-10|||October 2008||2008-10-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|ALD518-003||Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis|A Study to Determine the Safety, Efficacy, and Pharmacokinetics of 80,160 and 320mg ALD518 Versus Placebo Administered as Multiple IV Infusions to Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate|Completed||Phase 2|127|Actual|Alder Biopharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 13:14:54.219782|2017-02-18 13:14:54.219782
NCT00867503|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2015-12-02|2012-10-01||February 2009||2009-02-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|January 2012|Actual|2012-01-01||Interventional|||Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer|Open Label Phase II Trial of Bendamustine Hydrochloride (HCL) in Women With Advanced Ovarian Cancer|Completed||Phase 2|10|Actual|University of Arizona|The team was not able to collect fresh tumor tissue at the time of the study, so we could not examine patient tumors to determine their DNA repair capabilities.|1|||f||||t||||||||||2017-02-18 13:14:54.352063|2017-02-18 13:14:54.352063
NCT00867490|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2011-05-04|2011-01-07||March 2009||2009-03-01|May 2011|2011-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|AMAZING||Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension|An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of a 4 Week Therapy With Aliskiren 300 mg Plus Hydrochlorothiazide 25 mg in Hypertensive Patients Not Adequately Responding to a 4 Week Therapy With Candesartan 32 mg Plus Hydrochlorothiazide 25 mg|Completed||Phase 3|186|Actual|Novartis|The Phases of this study were entered in separate tables for outcomes and the Phases for SAEs and the AEs were entered all in one table.|1|||f||||||||||||||2017-02-18 13:14:54.755354|2017-02-18 13:14:54.755354
NCT00867477|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2014-08-27|||March 2009||2009-03-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide|A Biomarker Study Comparing the Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide in Patients Who Receive Thoracic Radiotherapy|Completed||Phase 2|163|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 13:14:55.150673|2017-02-18 13:14:55.150673
NCT00867464|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2017-01-24|||March 17, 2009||2009-03-17|May 27, 2016|2016-05-27||||||||Observational|||Extended Follow-Up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls|Extended Follow-up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls|Active, not recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:14:55.272225|2017-02-18 13:14:55.272225
NCT00867451|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2012-03-15|2011-09-28||January 2010||2010-01-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD)|A Pilot Study Designed To Improve Sleep and Subsequent Daytime Functioning in Children Diagnosed With ADHD|Completed||Phase 1/Phase 2|8|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-02-18 13:14:55.372426|2017-02-18 13:14:55.372426
NCT00867438|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2009-03-24|||January 2007||2007-01-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy|Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium (CB-01-05-MMX™), Administered as Add-on Therapy to Oral Mesalazine or Other 5-ASA Derivatives, in Patients With Active, Left-Sided, Mild to Moderate Ulcerative Colitis. A Multicentre Randomized, Double-Blind, Comparative Study Versus Placebo.|Completed||Phase 2|133|Actual|Cosmo Technologies Ltd||2|||f||||f||||||||||2017-02-18 13:14:55.850902|2017-02-18 13:14:55.850902
NCT00867425|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2012-04-26|||April 2009||2009-04-01|April 2012|2012-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Translating the Diabetes Prevention Program Into a Virtual Lifestyle Management Program|Translating the Diabetes Prevention Program Into a Virtual Lifestyle Management Program: A Pilot Study in a Military Community|Completed||N/A|30|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:14:55.932957|2017-02-18 13:14:55.932957
NCT00867412|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2009-03-20|||January 2002||2002-01-01|March 2009|2009-03-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Observational|||Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer|Randomized Study of PET/CT in Pre-Operative Staging of Lung Cancer|Completed||N/A|189|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-02-18 13:14:56.229255|2017-02-18 13:14:56.229255
NCT00867399|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-10-31|||March 2009||2009-03-01|September 2010|2010-09-01||||May 2009|Actual|2009-05-01||Interventional|||A Safety and Tolerability Study of ABT-126 in Elderly|A Multiple Dose Study of Safety, Tolerability and Pharmacokinetics of ABT-126 in Elderly Subjects|Completed||Phase 1|30|Actual|Abbott||2|||f||||||||||||||2017-02-18 13:14:56.32205|2017-02-18 13:14:56.32205
NCT00867386|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2014-03-11|||December 2006||2006-12-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Observational|||Desensitization for Highly Sensitized Recipients of Pancreas Transplantation|Desensitization for Highly Sensitized Recipients of Pancreas Transplantation|Completed||N/A|7|Actual|Northwestern University|||1||f||||f||||||||||2017-02-18 13:14:56.410787|2017-02-18 13:14:56.410787
NCT00867373|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-04-24|||May 2007||2007-05-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Parent Perceptions of Weight Status: Impact of a Pilot Intervention|Parent Perceptions of Weight Status: Impact of a Pilot Intervention to Enhance Awareness of Risk for Overweight Parents and Their Children|Completed||N/A|222|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 13:14:56.495131|2017-02-18 13:14:56.495131
NCT00867360|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2009-06-10|||August 2005||2005-08-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Treatment of Psychotic Major Depression With Mifepristone|Hypothalamic-Pituitary-Adrenal (HPA)/Dopamine Axis in Psychotic Depression|Terminated||Phase 3|50|Anticipated|Stanford University||2|||f||||||||||||||2017-02-18 13:14:56.601521|2017-02-18 13:14:56.601521
NCT00867347|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2011-07-09|||December 2006||2006-12-01|March 2009|2009-03-01||||March 2014|Anticipated|2014-03-01||Interventional|||Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer|Randomised Trial of Selective Bladder Preservation Against Radical Excision (Cystectomy) in Muscle Invasive T2/T3 Transitional Cell Carcinoma of the Bladder - Feasibility Study|Unknown status|Active, not recruiting|Phase 3|1015|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:14:56.701018|2017-02-18 13:14:56.701018
NCT00867334|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2014-03-11|||June 2009||2009-06-01|March 2014|2014-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|NITMEC||New Individualized Therapy Trial for Metastatic Colorectal Cancer|A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay|Completed||Phase 1/Phase 2|10|Actual|Inova Health Care Services||2|||f||||f||||||||||2017-02-18 13:14:56.813806|2017-02-18 13:14:56.813806
NCT00867321|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2016-08-12|||April 2009||2009-04-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|April 2012|Actual|2012-04-01||Interventional|||Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer|Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|24|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 13:14:56.930714|2017-02-18 13:14:56.930714
NCT00867308|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-10-14|||March 2009||2009-03-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Trial of High Dose Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Trilineage Dysplasia (AML-TLD)|Protocol Title: Phase II Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia (AML-TLD)|Active, not recruiting||Phase 2|48|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 13:14:57.213101|2017-02-18 13:14:57.213101
NCT00867295|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2010-06-01|||September 2008||2008-09-01|March 2009|2009-03-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|TIVAD||Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device|A Randomized, Double-blind, Placebo-controlled Trial to Determine Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device.|Completed||Phase 3|150|Anticipated|Istanbul University||2|||f||||t||||||||||2017-02-18 13:14:57.30906|2017-02-18 13:14:57.30906
NCT00867282|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2009-07-27|||June 2009||2009-06-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|B0871003||A Study to Estimate the Time Course of PF-00241939 Concentration in the Blood Following Dosing by Oral Inhalation From Dry Powder Inhalers|An Open Study To Estimate The Plasma Pharmacokinetics Of PF-00241939 Administered Via Oral Inhalation Using Dry Powder Inhalers.|Completed||Phase 1|36|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 13:14:57.406044|2017-02-18 13:14:57.406044
NCT00867269|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2017-01-27|||March 17, 2009||2009-03-17|January 26, 2017|2017-01-26||||||||Observational|||Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia|Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia|Recruiting||N/A|450|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:14:57.503643|2017-02-18 13:14:57.503643
NCT00867256|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2009-03-19|||March 2004||2004-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:14:57.605046|2017-02-18 13:14:57.605046
NCT00867243|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-06-10|||October 2005||2005-10-01|June 2013|2013-06-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Observational|||Prediction of Hepatitis C Recurrence in Liver Transplant Recipients|Prediction of Hepatitis C Recurrence in Liver Transplant Recipients|Terminated||N/A|24|Actual|Northwestern University|||2|This project is no longer being adequately supported to allow completion|f||||f||||||Samples With DNA|"~     Recipient specimens: Peripheral blood draws at baseline and follow-up clinic visits.~      Donor specimens: Donor cells will be isolated from lymph nodes obtained at time of harvest;~     if living donor - blood taken at time of liver resection surgery.~   "|||2017-02-18 13:14:57.650499|2017-02-18 13:14:57.650499
NCT00867230|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2012-07-31|||May 2006||2006-05-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||FTS Study in Patients With Advanced Hematologic Malignancies|A Phase I Open-Label Study of S-Trans, Trans-Farnesylthiosalicylic Acid (FTS) Administered on Days 1 to 21 of a 28 Day Cycle in Patients With Advanced Hematologic Malignancies|Completed||Phase 1|18|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:14:57.746079|2017-02-18 13:14:57.746079
NCT00867217|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2010-08-17|||March 2009||2009-03-01|August 2010|2010-08-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|VITAL||Vitamin D3 for Aromatase Inhibitor Induced Arthralgias|A Randomized Trial to Evaluate the Benefit of High Dose Vitamin D3 on Aromatase Inhibitor Letrozole-Associated Musculoskeletal Symptoms and Fatigue (The VITAL Trial).|Unknown status|Active, not recruiting|Phase 2|160|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 13:14:57.864688|2017-02-18 13:14:57.864688
NCT00867204|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2011-09-16|||October 2004||2004-10-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|February 2008|Actual|2008-02-01||Observational|ERCP systems||Short Versus Long Wire ERCP Systems|Prospective Randomized Blinded Comparison of a Short-wire ERCP System to Traditional Long-wire Devices|Completed||N/A|71|Actual|University of Florida|||2||f||||f||||||||||2017-02-18 13:14:57.96489|2017-02-18 13:14:57.96489
NCT00867191|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2015-04-20|||February 2002||2002-02-01|April 2015|2015-04-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)|A Multi-Centre, Double-Blind, Randomised Comparison Of The Effects Of Desloratadine (Aerius®) And Placebo In The Relief Of Nasal Symptom Scores In Subjects With Seasonal Allergic Rhinitis (Sar) To Cypress Pollen|Completed||Phase 4|233|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:14:58.05267|2017-02-18 13:14:58.05267
NCT00867178|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2017-01-31|||February 2009||2009-02-01|January 2017|2017-01-01||||January 2017|Anticipated|2017-01-01||Interventional|||Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System|A Feasibility Study of Vorinostat (SAHA) Combined With Isotretinoin and Chemotherapy in Infants With Embryonal Tumors of the Central Nervous System|Active, not recruiting||N/A|62|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:14:58.152941|2017-02-18 13:14:58.152941
NCT00867165|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2015-04-20|2013-04-10||May 2009||2009-05-01|April 2015|2015-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Efficacy and Safety Study of Ezetimibe Monotherapy in Children (Ages 6 to 10 Years) With Primary Hypercholesterolemia (Heterozygous Familial and Nonfamilial) (Phase 3, Protocol No. P05522)|Completed||Phase 3|138|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 13:14:58.347678|2017-02-18 13:14:58.347678
NCT00867152|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2012-02-20|||April 2009||2009-04-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir|A Phase I, Open Label, Randomized, Three Period, One-way, Two Cohort, Adaptive Crossover Study to Evaluate the Effect of Darunavir/Ritonavir Plus Etravirine and Lopinavir/Ritonavir Plus Etravirine on GSK1349572 Pharmacokinetics in Healthy Adult Subjects (ING112934)|Completed||Phase 1|17|Actual|ViiV Healthcare||2|||f||||||||||||||2017-02-18 13:14:59.873073|2017-02-18 13:14:59.873073
NCT00867139|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2013-08-08|2012-12-21||March 2009||2009-03-01|August 2013|2013-08-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients|A Pilot, Randomized Study Comparing the Safety, Tolerability and Pharmacokinetics of Combination Therapy (Amantadine, Ribavirin, Oseltamivir) Versus Neuraminidase Inhibitor Monotherapy to Influenza Virus Infected Immunocompromised Patients|Completed||Phase 1/Phase 2|7|Actual|Fred Hutchinson Cancer Research Center|Study was terminated. Limitations of this study include: small sample size pilot study; inability to enroll the projected number of patients for full analysis before the study was terminated.|3|||f||||t||||||||||2017-02-18 13:14:59.999136|2017-02-18 13:14:59.999136
NCT00867126|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2009-04-02|||February 2009||2009-02-01|March 2009|2009-03-01||||February 2013|Anticipated|2013-02-01||Interventional|||Pioglitazone as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Treatment With Gemcitabine|A Pilot Study of Pioglitazone as Second Line Therapy for Patients With Previously Treated Metastatic Adenocarcinoma of the Pancreas With Disease Progression After Gemcitabine Based Chemotherapy|Unknown status|Recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:15:00.855021|2017-02-18 13:15:00.855021
NCT00867113|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2016-08-08|||July 2009||2009-07-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)|A Phase II, Non-Randomized, Open-Label Multicenter Study of 5 Year Adjuvant Imatinib Mesylate (Gleevec®) in Patients at Significant Risk for Recurrence Following Complete Resection of Primary Gastrointestinal Stromal Tumor (GIST)|Active, not recruiting||Phase 2|91|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:15:00.96563|2017-02-18 13:15:00.96563
NCT00867100|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2010-08-19|||December 2007||2007-12-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis|A Randomized, Double-blind, Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis|Completed||Phase 1|84|Actual|Amgen||1|||f||||||||||||||2017-02-18 13:15:01.106354|2017-02-18 13:15:01.106354
NCT00867087|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2013-12-04||2013-11-07|June 2009||2009-06-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma|An Open-Label, Single-Arm, Phase 2 Study Of Inotuzumab Ozogamicin Plus Rituximab In Subjects With Relapsed/Refractory CD22-Positive Diffuse Large B-Cell Lymphoma, Eligible For Autologous Stem Cell Transplantation|Completed||Phase 2|65|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:15:01.200694|2017-02-18 13:15:01.200694
NCT00867061|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2012-11-27|||March 2009||2009-03-01|November 2012|2012-11-01|September 2010|Anticipated|2010-09-01|June 2010|Anticipated|2010-06-01||Interventional|||Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)|A Phase 1/2, Single-Arm Study To Assess The Efficacy and Safety Of 5-day Continuous Intravenous Dosing Of ON 01910.Na Administered Every 2 Weeks in Patients With Intermediate-1, Intermediate-2, or High Risk Myelodysplastic Syndrome (MDS)|Withdrawn||Phase 1/Phase 2|0|Actual|Onconova Therapeutics, Inc.||1||Mutual decision by site and sponsor because of difficulty recruiting Patients.|f||||f||||||||||2017-02-18 13:15:01.349151|2017-02-18 13:15:01.349151
NCT00867048|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2016-10-28|||March 2009||2009-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|START||Strategic Timing of Antiretroviral Treatment|Strategic Timing of AntiRetroviral Treatment|Active, not recruiting||Phase 4|4688|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 13:15:01.467323|2017-02-18 13:15:01.467323
NCT00867035|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2013-05-15|2009-07-01||March 2008||2008-03-01|May 2013|2013-05-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Bad Breath Response to Tongue Scraper and Rinses|Bad Breath Response to Tongue Scraper and Rinses, a Double-blind, Randomized, Parallel Group Clinical Trial.|Completed||N/A|22|Actual|University of California, San Francisco|Total number of subjects is less than the desired 50 persons; dimethyl sulfide measures distorted by materials in syringes; accuracy of portable gas chromatograph a concern.|2|||f||||t||||||||||2017-02-18 13:15:04.094899|2017-02-18 13:15:04.094899
NCT00867022|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2009-03-20|||August 2004||2004-08-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|November 2007|Actual|2007-11-01||Observational|||Autonomic Nervous Activity in Women With Gestational Diabetes|Autonomic Nervous Activity in Women With Gestational Diabetes|Completed||N/A|80|Actual|Helsinki University|||4||f||||f||||||||||2017-02-18 13:15:04.937974|2017-02-18 13:15:04.937974
NCT00867009|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2015-05-20|2012-04-10||April 2009||2009-04-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|May 2011|Actual|2011-05-01||Interventional|||A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer|A Phase 2 Study of Pemetrexed and Cisplatin Plus Cetuximab Followed by Pemetrexed and Cetuximab Maintenance Therapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB or IV) Other Than Predominantly Squamous Cell Histology|Completed||Phase 2|113|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 13:15:05.034918|2017-02-18 13:15:05.034918
NCT00866996|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2011-05-20||||||March 2010|2010-03-01|December 2003|Actual|2003-12-01|||||Interventional|||Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder|A Multi-center Randomized Parallel Group Study Evaluating Treatment Outcomes of Concerta (Extended Release Methylphenidate) and Strattera (Atomoxetine) in Children With Attention-deficit/Hyperactivity Disorder|Completed||Phase 4|1323|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||f||||||||||||||2017-02-18 13:15:05.737769|2017-02-18 13:15:05.737769
NCT00865124|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-07-31|||September 2008||2008-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|January 2013|Actual|2013-01-01||Interventional|||Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease|Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease|Completed||N/A|93|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-02-18 13:15:38.205135|2017-02-18 13:15:38.205135
NCT00866983|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2013-02-11|||October 2009||2009-10-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Expanded Access|||Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil|A Local, Multi-Centre, Extension, Open Label Access Study, To Provide Sildenafil Therapy For Patients Who Completed A1481244 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil , Prior To Reimbursement And Availability For Patients In Brazil.|No longer available||Phase 4|||Pfizer|||||f||||f||||||||||2017-02-18 13:15:05.827823|2017-02-18 13:15:05.827823
NCT00866970|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2010-09-10|||September 2008||2008-09-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia|A Phase II Study to Determine the Safety, Efficacy, and Pharmacokinetics of Multiple Intravenous Doses of ALD518 80 mg, 160 mg, and 320 mg Versus Placebo Administered to Patients With Non-Small Cell Lung Cancer-Related Fatigue and Cachexia|Completed||Phase 2|124|Actual|Alder Biopharmaceuticals, Inc.||4|||f||||t||||||||||2017-02-18 13:15:05.924441|2017-02-18 13:15:05.924441
NCT00866957|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-09-13|||February 2006||2006-02-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)|Human Liver Explants for HIF-1 Alpha- Analysis/Comparison|Recruiting||N/A|500|Anticipated|Northwestern University|||1||f||||f||||||Samples With DNA|"~     Both, samples with DNA and without: serum, plasma, genomic samples, & liver biopsy specimens~   "|||2017-02-18 13:15:06.262283|2017-02-18 13:15:06.262283
NCT00866944|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2011-11-10|||March 2009||2009-03-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|MT201-204||Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases|A Randomized, Open-label, Controlled, Multi-center Phase II Study to Evaluate the Efficacy and Safety of Adecatumumab Alone or Sequentially to FOLFOX Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases|Completed||Phase 2|35|Actual|Amgen Research (Munich) GmbH||3|||f||||t||||||||||2017-02-18 13:15:06.386512|2017-02-18 13:15:06.386512
NCT00866918|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2016-10-19|||March 2009||2009-03-01|October 2016|2016-10-01||||June 2015|Actual|2015-06-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia|Risk Adapted Treatment of Newly Diagnosed Childhood Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide (Trisenox® IND# 103, 331) During Consolidation|Active, not recruiting||Phase 3|108|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 13:15:06.525704|2017-02-18 13:15:06.525704
NCT00866905|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2014-12-05|2014-11-21||April 2009||2009-04-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer|Phase II Study of Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER2-Negative Breast Cancer|Completed||Phase 2|168|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 13:15:06.777708|2017-02-18 13:15:06.777708
NCT00866892|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-07-13|||April 2009||2009-04-01|July 2015|2015-07-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Pediatric Pilot Study: Irrigation and Scrubbing in Facial and Scalp Wounds|A Pilot Study of Noncontaminated Facial and Scalp Wounds in the Pediatric Population: Getting Away Without Irrigation and Scrubbing|Withdrawn||N/A|0|Actual|Children's Hospitals and Clinics of Minnesota||2||PI left the institution|f||||f||||||||||2017-02-18 13:15:07.077659|2017-02-18 13:15:07.077659
NCT00866879|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2017-01-18|||June 2007||2007-06-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients|Randomized Conversion of Calcineurin-Inhibitors(Tacrolimus to Sirolimus),6-24 Months Post Transplant Prednisone-Free Immunosuppression Regimen: Impact of Incidence of Acute Cellular Rejection,Renal Allograft Function & Lymphocytes Function|Active, not recruiting||Phase 4|275|Actual|Northwestern University||3|||f||||f||||||||||2017-02-18 13:15:07.175916|2017-02-18 13:15:07.175916
NCT00866866|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2009-03-20|||March 2009||2009-03-01|March 2009|2009-03-01|May 2010|Anticipated|2010-05-01|December 2009|Anticipated|2009-12-01||Interventional|||The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal Symptoms|The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial|Unknown status|Recruiting|Phase 4|60|Anticipated|University of Calgary||2|||f||||f||||||||||2017-02-18 13:15:07.303642|2017-02-18 13:15:07.303642
NCT00866853|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-04-26|||March 2009||2009-03-01|April 2010|2010-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins.|A Phase I, Open Label, 2-period, Randomized, Crossover Trial in 16 Healthy Subjects to Assess the Drug Interaction Potential of TMC435 With Oral Midazolam and With a Drug Cocktail Representative of CYP1A2, CYP2C9, CYP2D6, CYP3A4, and CYP2C19 Substrates.|Completed||Phase 1|16|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:15:07.411591|2017-02-18 13:15:07.411591
NCT00866840|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2013-11-18|||April 2009||2009-04-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery|A Phase II Trial of Riluzole in Patients With Advanced Melanoma|Completed||Phase 2|13|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 13:15:07.508517|2017-02-18 13:15:07.508517
NCT00866827|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2017-01-26|||December 2002||2002-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Airway Vascular Lesions|Airway Vascular Lesions|Active, not recruiting||N/A|75|Anticipated|University of Arkansas|||1||f||||||||||||||2017-02-18 13:15:07.609502|2017-02-18 13:15:07.609502
NCT00866814|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2012-10-10|2012-04-19||March 2009||2009-03-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch|A Prospective, Single Arm, Multi-Center Study Of Open Ventral Hernia Repair Utilizing The Bard Ventrio Hernia Patch|Completed||N/A|119|Actual|C. R. Bard|This study was designed as a single arm observational trial without predefined statistical hypotheses (theories) to test; therefore, data can only be described and no treatment comparisons or conclusions can be made.||1||f||||f||||||||||2017-02-18 13:15:07.688207|2017-02-18 13:15:07.688207
NCT00866801|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2015-10-12|||April 2009||2009-04-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Observational|||Coronary Blood Flow Regulation During General Anesthesia|Cardiac Sympathetic Innervation and Coronary Blood Flow Regulation During General Anesthesia|Completed||N/A|45|Actual|VU University Medical Center|||4||f||||f||||||Samples Without DNA|"~     Frozen plasma will be retained~   "|||2017-02-18 13:15:08.175789|2017-02-18 13:15:08.175789
NCT00866788|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-20|2016-05-09|2011-07-01||March 2009||2009-03-01|May 2016|2016-05-01||||January 2010|Actual|2010-01-01||Interventional||Intent-to-Treat population|A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)|Completed||Phase 2|90|Actual|Genentech, Inc.||4|||f||||||||||||||2017-02-18 13:15:08.28727|2017-02-18 13:15:08.28727
NCT00866775|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2016-02-09|2015-10-06||April 2009||2009-04-01|February 2016|2016-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs|Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs|Completed||Phase 3|193|Actual|Sunovion|The comparison of active treatment to control which was used in this trial is based on a pooled analysis of comparator groups from 8 earlier trials of similar design. Limitations related to use of historical control groups are applicable.|2|||f||||f||||||||||2017-02-18 13:15:09.214353|2017-02-18 13:15:09.214353
NCT00866762|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2011-12-09|||February 2009||2009-02-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Interventional|||A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia|A Phase II Study of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia.|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Copenhagen University Hospital at Herlev||1|||f||||t||||||||||2017-02-18 13:15:10.263919|2017-02-18 13:15:10.263919
NCT00866749|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-11-07|||September 2006||2006-09-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|||Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma|Augmented Berlin-Frankfurt-Munster Therapy for Adolescents/Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|Active, not recruiting||Phase 2|125|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:15:10.562712|2017-02-18 13:15:10.562712
NCT00866736|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2015-09-14|||March 2009||2009-03-01|December 2010|2010-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia|A Phase II Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia|Completed||Phase 2|65|Actual|Kanto CML Study Group||1|||f||||t||||||||||2017-02-18 13:15:10.700106|2017-02-18 13:15:10.700106
NCT00866723|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-04-12|2014-11-19||March 2009||2009-03-01|April 2016|2016-04-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional||The analysis dataset is comprised of all treated patients.|Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer|Phase II Study of Single-Agent Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous, Papillary Serous Endometrial or Fallopian Tube Cancer Who Have Recurred After Prior Therapy With Maintenance Avastin|Terminated||Phase 2|5|Actual|Dana-Farber Cancer Institute|Early termination leading to small numbers of subjects analyzed.|1||Recruitment has been terminated prematurely because of poor enrollment.|f||||t||||||||||2017-02-18 13:15:10.809836|2017-02-18 13:15:10.809836
NCT00866710|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2012-01-10|||October 2008||2008-10-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|BETTUR PD||Behavioral Therapy to Treat Urinary Incontinence in Parkinson's Disease|Behavioral Therapy to Treat Urinary Incontinence in Parkinson's Disease|Completed||N/A|28|Actual|Atlanta VA Medical Center||1|||f||||f||||||||||2017-02-18 13:15:11.075888|2017-02-18 13:15:11.075888
NCT00866697|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-04-03|2013-07-03||May 2009||2009-05-01|April 2016|2016-04-01|November 2017|Anticipated|2017-11-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have Not Progressed After First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Active, not recruiting||Phase 3|940|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:15:11.183349|2017-02-18 13:15:11.183349
NCT00866684|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-09-01|||January 2007||2007-01-01|September 2015|2015-09-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Interventional|PROSKIN||Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol|Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol|Terminated||Phase 4|44|Actual|Charite University, Berlin, Germany||2||Insufficient patient recruitment|f||||f||||||||||2017-02-18 13:15:13.235383|2017-02-18 13:15:13.235383
NCT00866671|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-01-12|||February 2009||2009-02-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Observational Study of Nelarabine in Children and Young Adults|A Multicentre, Single Arm, Observational Phase IV Study to Assess the Safety and Efficacy of Nelarabine in Children and Young Adults (up to 21 Years of Age) With Relapsed or Refractory T-Lineage Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma|Completed||N/A|28|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 13:15:13.445311|2017-02-18 13:15:13.445311
NCT00866658|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-08-18|2016-08-18||March 2009||2009-03-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|GETGOAL-L-ASIA|Safety population included all randomized patients who were exposed to at least 1 dose of study drug, regardless of the amount of treatment administered.|GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)|A Randomized, Double-Blind, Placebo-Controlled, 2-arm Parallel-group, Multicenter Study With a 24-Week Treatment Period Assessing the Efficacy and Safety of AVE0010 in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin With or Without Sulfonylurea|Completed||Phase 3|311|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:15:13.581144|2017-02-18 13:15:13.581144
NCT00866645|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-12-02|||February 2009||2009-02-01|December 2010|2010-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia|A Randomized Blind Parallel Intramuscular Haloperidol-Controlled Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Intramuscular Levosulpiride in the Treatment of Chinese Patients With Agitation Of Schizophrenia|Completed||Phase 2/Phase 3|240|Anticipated|Shanghai Mental Health Center||2|||f||||f||||||||||2017-02-18 13:15:14.69017|2017-02-18 13:15:14.69017
NCT00866632|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-09-09|||June 2008||2008-06-01|September 2010|2010-09-01||||December 2010|Anticipated|2010-12-01||Interventional|||Improving Psychological Wellness After Acquired Brain Injury|Improving Mood, Adjustment and Coping in People With Acquired Brain Injury: A Randomized Controlled Trial to Examine the Efficacy of a Cognitive Behaviour Therapy Protocol Adapted for Brain Injury and Remote Administration of Services.|Unknown status|Recruiting|N/A|75|Anticipated|Toronto Rehabilitation Institute||4|||f||||f||||||||||2017-02-18 13:15:14.812122|2017-02-18 13:15:14.812122
NCT00866619|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-10-05|||March 2009||2009-03-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|March 2011|Actual|2011-03-01||Interventional|||Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa|Efficacy of GSK Biologicals' Candidate Malaria Vaccine (257049) Against Malaria Disease Caused by P. Falciparum Infection in Infants and Children in Africa|Completed||Phase 3|15459|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-02-18 13:15:14.921731|2017-02-18 13:15:14.921731
NCT00866606|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2011-04-01|2010-12-14||February 2009||2009-02-01|April 2011|2011-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects|An Evaluation Of The Safety And Efficacy Of On-Demand Treatment With BeneFIX (Nonacog Alfa, Recombinant Factor IX) In Chinese Subjects With Hemophilia B|Completed||Phase 3|35|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:15:15.069489|2017-02-18 13:15:15.069489
NCT00866593|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2013-04-01|||March 2009||2009-03-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression|A Randomized Double-blind Parallel Innovator-Controlled Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram Oxalate Tablets in the Treatment of Chinese Patients With Depression|Completed||Phase 2/Phase 3|260|Actual|Shanghai Mental Health Center||2|||f||||f||||||||||2017-02-18 13:15:15.38|2017-02-18 13:15:15.38
NCT00866580|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-03-19|||May 2010||2010-05-01|March 2015|2015-03-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine|Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine GSK 1562902A.|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||2||Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.|f||||||||||||||2017-02-18 13:15:15.511156|2017-02-18 13:15:15.511156
NCT00866567|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-02-02|||October 2008||2008-10-01|March 2009|2009-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Defects in Opsonophagocytosis in Premature Infants|Defects in Opsonophagocytosis in Premature Infants as a Factor for the Development of Neonatal Sepsis|Completed||N/A|80|Anticipated|University Hospital, Geneva|||4||f||||f||||||Samples With DNA|"~     Serum cDNA~   "|||2017-02-18 13:15:15.622876|2017-02-18 13:15:15.622876
NCT00866554|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-04-14|||March 2009||2009-03-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy|Phase II Study of Bicalutamide and Dutasteride for Prostate Cytoreduction Prior to Permanent Implant I-125 Prostate Brachytherapy|Active, not recruiting||Phase 2|88|Anticipated|Centre Hospitalier Universitaire de Québec, CHU de Québec||2|||f||||f||||||||||2017-02-18 13:15:15.715724|2017-02-18 13:15:15.715724
NCT00866541|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-03-19|||January 2009||2009-01-01|March 2009|2009-03-01||||December 2009|Anticipated|2009-12-01||Interventional|||Flow Proportional Pressure Support in Volunteers|Flow Proportional Pressure Support as a New Mode of Spontaneous Breathing Assist - Evaluation of Objective and Subjective Measured Data in Volunteers|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital Freiburg||1|||f||||f||||||||||2017-02-18 13:15:15.823698|2017-02-18 13:15:15.823698
NCT00866528|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-02-12|||July 2009||2009-07-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Interventional|||Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer|An Open-label, Multicenter, Phase I/II Study of Pazopanib in Combination With Paclitaxel in First-line Treatment of Subjects With Stage IIIBwet/IV Non-small Cell Lung Cancer|Completed||Phase 1|30|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 13:15:15.916757|2017-02-18 13:15:15.916757
NCT00866515|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-10-26|||December 2008||2008-12-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole|A Double-blind, Placebo-controlled, Randomised, 2-way Crossover Drug Interaction Study to Investigate the Pharmacokinetic and Pharmacodynamic Effects Following Co-administration of GW642444M With Ketoconazole|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:15:16.029553|2017-02-18 13:15:16.029553
NCT00866502|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2015-01-09|||March 2009||2009-03-01|January 2015|2015-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease|A Randomized, Double-blind, Placebo Controlled, Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Idiopathic Parkinson's Disease (PD) of Moderate Severity, Using an Implanted Catheter and a SynchroMed® II Pump.|Completed||Phase 1/Phase 2|12|Actual|Newron Sweden AB||2|||f||||t||||||||||2017-02-18 13:15:16.145987|2017-02-18 13:15:16.145987
NCT00866489|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-12-26|||September 2008||2008-09-01|March 2009|2009-03-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||The Neuroprotective Effects of RPC on the Neurosurgery|Clinical Trial Cencer, Xijing Hospital, Fourth Military Medical University|Completed||Phase 1|70|Actual|Xijing Hospital||2|||f||||t||||||||||2017-02-18 13:15:16.267306|2017-02-18 13:15:16.267306
NCT00866099|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-04-16|||July 2009||2009-07-01|March 2009|2009-03-01|September 2012|Anticipated|2012-09-01|May 2011|Anticipated|2011-05-01||Interventional|EVIDEM-ED||Dementia Early Recognition and Response in Primary Care|Evidence-based Interventions In Dementia EVIDEM-ED: Early Recognition and Response in Primary Care|Unknown status|Recruiting|Phase 2/Phase 3|125|Anticipated|University College, London||2|||f||||t||||||||||2017-02-18 13:15:22.83507|2017-02-18 13:15:22.83507
NCT00866476|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-01-16|||January 2010||2010-01-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa|Safety, Immunogenicity, and Efficacy Following Experimental Challenge of CVD 1208S, a Delta guaBA, Delta Sen, Delta Set Shigella Flexneri 2a Live, Oral Vaccine: Phase IIa Vaccination Study|Terminated||Phase 2|20|Actual|University of Maryland||2||Reactogenicity met study halting criteria|f||||t||||||||||2017-02-18 13:15:16.361074|2017-02-18 13:15:16.361074
NCT00866463|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-02-12|||October 2008||2008-10-01|February 2013|2013-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects|An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of An Experimental Tablet Of Sildenafil With Or Without Water Relative To Viagra® Conventional Oral Tablet With Water.|Completed||Phase 1|18|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:15:16.465508|2017-02-18 13:15:16.465508
NCT00866450|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2012-01-10|||February 2009||2009-02-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Effects of a Western-type Diet on Colorectal Inflammation|Effects of a Western-type Diet on Colorectal Inflammation, Gut Permeability and Systemic Endotoxemia|Completed||Early Phase 1|5|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 13:15:16.569883|2017-02-18 13:15:16.569883
NCT00866437|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-06-15|||April 2009||2009-04-01|February 2010|2010-02-01|November 2010|Anticipated|2010-11-01|May 2010|Anticipated|2010-05-01||Interventional|||Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel|Prospective, Controlled, Single-blinded, Longitudinal, Two-arms, Clinical Study Evaluation of Efficacy/Safety of EVE-PMS Skin-Test Panel -Detecting Sensitivity to Sex Hormones in Women With Premenstrual Syndrome|Unknown status|Recruiting|Phase 2|40|Anticipated|EVE Medical Systems Ltd.||2|||f||||t||||||||||2017-02-18 13:15:16.678957|2017-02-18 13:15:16.678957
NCT00866424|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-03-19|||April 2008||2008-04-01|January 2009|2009-01-01|April 2009|Anticipated|2009-04-01|January 2009|Anticipated|2009-01-01||Interventional|||Clinical Trial of Hyperbaric Oxygen Treatment in Trigeminal Neuralgia Patients|A Prospective Study on Efficacy of Hyperbaric Oxygenation Treatment for Patients With Trigeminal Neuralgia: a Randomized, Double-Blind, Mock Hyperbaric Chamber -Controlled, Parallel-Group Trial|Unknown status|Enrolling by invitation|Phase 1/Phase 2|30|Anticipated|Xijing Hospital||1|||f||||t||||||||||2017-02-18 13:15:16.790485|2017-02-18 13:15:16.790485
NCT00866411|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-03-19|||May 2007||2007-05-01|March 2009|2009-03-01|January 2010|Anticipated|2010-01-01|May 2009|Anticipated|2009-05-01||Interventional|CES||Cranial Electrotherapy Stimulation (CES) for Soldiers With Combat-Related Symptoms|Outcomes of Cranial Electrotherapy Stimulation (CES) With Soldiers for Combat-Related Symptoms|Unknown status|Recruiting|N/A|100|Anticipated|Brooke Army Medical Center||1|||f||||t||||||||||2017-02-18 13:15:16.901227|2017-02-18 13:15:16.901227
NCT00866398|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2011-01-14|||December 2005||2005-12-01|January 2011|2011-01-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Observational|||Economic Evaluation German Drug-Eluting Stent Registry|Economic Evaluation German Drug-Eluting Stent Registry|Completed||N/A|3973|Actual|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-02-18 13:15:16.997733|2017-02-18 13:15:16.997733
NCT00866385|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-06-08|||March 2009||2009-03-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||AZD8566 Food Effect/Microtracer Study|An Open, Randomised, Phase I, 2-Period Crossover Trial to Investigate the Absolute Bioavailability and the Effect of Food on the Oral Bioavailability of AZD8566 in Healthy Volunteers|Completed||Phase 1|21|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:15:17.193187|2017-02-18 13:15:17.193187
NCT00866359|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2016-06-14|2014-04-22||October 2009||2009-10-01|June 2016|2016-06-01|July 2013|Actual|2013-07-01|May 2012|Actual|2012-05-01||Interventional||The intent to treat (ITT) population was defined as all randomized participants with at least one oral ulcer evaluation (including the baseline evaluation)|A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease|A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Followed by an Active-Treatment Extension to Evaluate the Efficacy and Safety of Apremilast(CC-10004) in the Treatment of Behçet Disease|Completed||Phase 2|111|Actual|Celgene Corporation|Planned sample size not reached; slow enrollment|2|||f||||t||||||||||2017-02-18 13:15:17.289815|2017-02-18 13:15:17.289815
NCT00866346|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2014-03-03|||March 2008||2008-03-01|March 2014|2014-03-01||||March 2015|Anticipated|2015-03-01||Interventional|||PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation|A Phase I Study of PR1-Specific Cytotoxic T-Lymphocyte Infusion for Patients With Recurrent CML After Allogeneic Hematopoietic Transplantation|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1||"Study failed to accrue any patients due to regulatory issues with PR1 vaccine and T cell~   production."|f||||f||||||||||2017-02-18 13:15:18.297116|2017-02-18 13:15:18.297116
NCT00866333|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-06-29|||March 2009||2009-03-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma|A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patients With Relapsed or Refractory Hodgkin's Lymphoma|Completed||Phase 2|49|Actual|Syndax Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:15:18.408422|2017-02-18 13:15:18.408422
NCT00866320|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2014-07-14|2011-12-27||February 2006||2006-02-01|July 2014|2014-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab|A Phase II Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma (RCC) Refractory to SU11248 or Bevacizumab Therapy|Completed||Phase 2|49|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:15:18.524102|2017-02-18 13:15:18.524102
NCT00866307|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-10-13|2016-08-01||February 2009||2009-02-01|August 2016|2016-08-01||||June 2013|Actual|2013-06-01||Interventional|||Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)|Intensified PEG-Asparaginase in High Risk Acute Lymphoblastic Leukemia (ALL): A Pilot Study|Completed||N/A|104|Actual|Children's Oncology Group|The COG SDC reviewed the NLM notification related to ct.gov AE/SAE reporting. The information in ‘Additional Description’ is accurate with respect to data supplied to ct.gov.COG plans to submit data AE/SAE data consistent with the text in this field.|2|||f||||||||||||||2017-02-18 13:15:18.823597|2017-02-18 13:15:18.823597
NCT00866294|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-12-01|2010-10-14||April 2009||2009-04-01|December 2016|2016-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)|A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Clinical Effects of Controlled Release Paroxetine in the Treatment of Major Depressive Disorder|Completed||Phase 3|416|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:15:19.663666|2017-02-18 13:15:19.663666
NCT00866281|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-11-18|2015-09-08||September 2009||2009-09-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||The analysis was performed in full analysis set (FAS) population, defined as all participants to whom study treatment was assigned.|A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia|A Phase I/II, Open-label, Dose-escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Twice Daily Oral Midostaurin and to Evaluate the Preliminary Clinical and Pharmacodynamic Response in Pediatric Patients With Relapsed or Refractory Leukemia|Terminated||Phase 1/Phase 2|22|Actual|Novartis|The study was terminated early since despite considerable efforts to boost recruitment, no new participants were enrolled in the final year of this study.|2||"Despite considerable efforts to boost recruitment during the final year of the study, no new~   patients were enrolled."|f||||||||||||||2017-02-18 13:15:20.552207|2017-02-18 13:15:20.552207
NCT00866268|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-03-19|||May 2006||2006-05-01|March 2009|2009-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Low Versus High Pressure Suction Drainage After Total Knee Arthroplasty|"Low Versus High Pressure Suction Drainage After Total Knee Arthroplasty: a Double Blind Randomized Controlled Trial"|Completed||Phase 3|169|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-02-18 13:15:21.413776|2017-02-18 13:15:21.413776
NCT00866255|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2010-02-01|||January 2008||2008-01-01|March 2009|2009-03-01||||May 2009|Actual|2009-05-01||Interventional|||Continuous Measurement of Intratracheal Pressure|Continuous Measurement of Intratracheal Pressure in Mechanically Ventilated Infants|Completed||N/A|50|Anticipated|University Hospital Freiburg||1|||f||||f||||||||||2017-02-18 13:15:21.526513|2017-02-18 13:15:21.526513
NCT00866242|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-01-16|||January 2010||2010-01-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb|Safety, Immunogenicity, and Efficacy Following Experimental Challenge of CVD 1208S, a Delta guaBA, Delta Sen, Delta Set Shigella Flexneri 2a Live, Oral Vaccine: Phase IIb Challenge Study|Terminated||Phase 2|20|Actual|University of Maryland||1||Reactogenicity met study halting criteria|f||||t||||||||||2017-02-18 13:15:21.61035|2017-02-18 13:15:21.61035
NCT00866229|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-03-19|||April 2008||2008-04-01|March 2009|2009-03-01|June 2010|Anticipated|2010-06-01|March 2010|Anticipated|2010-03-01||Interventional|||Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level|Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in SLE Patients With Corticosteroid Therapy and High LDL Cholesterol Level|Unknown status|Recruiting|Phase 4|140|Anticipated|Ramathibodi Hospital||2|||f||||t||||||||||2017-02-18 13:15:21.717912|2017-02-18 13:15:21.717912
NCT00866216|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-19|||August 2003||2003-08-01|March 2009|2009-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Geneva 600mg Azithromycin Monohydrate Tablets and Pfizer Inc. (Zithromax) 600mg Azithromycin Dihydrate Tablets in Healthy Adult Volunteers Under Fasting Conditions|Completed||Phase 1|38|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:15:21.806925|2017-02-18 13:15:21.806925
NCT00866203|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2009-03-19|||October 2000||2000-10-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|||||Interventional|||HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy|A Prospective, Randomized, Multicenter Trial Comparing a Modified HDS Therapy Supported by PBPC Transplant With Additional 4 Courses of Front-Line Therapy in Adult Aggressive NHL With PR After Short Course of Up-Front Chemotherapy|Completed||Phase 3|441|Actual|Gruppo Italiano Studio Linfomi||2|||f||||f||||||||||2017-02-18 13:15:21.893598|2017-02-18 13:15:21.893598
NCT00866190|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2011-11-03|||April 2009||2009-04-01|October 2009|2009-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Dose Escalation Study of SQ109 in Healthy Adult Volunteers|A Phase 1B, Randomized, Placebo-Controlled, Double-Blinded, Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single-Daily Doses of SQ109 in Normal, Healthy Male and Female Volunteers|Completed||Phase 1|10|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 13:15:21.987469|2017-02-18 13:15:21.987469
NCT00866177|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2015-07-16|2015-07-16||March 2009||2009-03-01|June 2013|2013-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma|Phase II Trial of Hyd-sulfate AZD6244 [NSC 748727] in Patients With BRAF or NRAS Mutated Melanomas|Completed||Phase 2|167|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:15:22.088496|2017-02-18 13:15:22.088496
NCT00866164|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-03-02||||||March 2012|2012-03-01||||||||Expanded Access|(PUMP 2)||Prometra's Utilization in Mitigating Pain II|Prometra's Utilization in Mitigating Pain II|Approved for marketing||N/A|||Flowonix Medical|||||||||||||||||||2017-02-18 13:15:22.384196|2017-02-18 13:15:22.384196
NCT00866151|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-03-19|||August 2008||2008-08-01|March 2009|2009-03-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Observational|||A to Z Study Follow-up: Collection of DNA Data From Buccal Swabs|A to Z Study Follow-up: Collection of DNA Data From Buccal Swabs|Unknown status|Enrolling by invitation|N/A|150|Anticipated|Interleukin Genetics, Inc.|||1||f||||f||||||Samples With DNA|"~     Buccal swabs are collected by Stanford and sent to Interleukin Genetics for genotyping.~   "|||2017-02-18 13:15:22.468602|2017-02-18 13:15:22.468602
NCT00866138|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-08-13|||February 2005||2005-02-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|January 2011|Actual|2011-01-01||Interventional|||A Phase 2 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3|Phase II Study of AB1010 in Patients With Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not Expressing FGFR3|Unknown status|Active, not recruiting|Phase 2|24|Actual|AB Science||1|||f||||f||||||||||2017-02-18 13:15:22.56966|2017-02-18 13:15:22.56966
NCT00866086|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-04-18|||February 2009||2009-02-01|March 2009|2009-03-01||||February 2010|Anticipated|2010-02-01||Interventional|||Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors|Study of Automated Abdominal Compression Device and Screw Based Abdominal Compression Devices During Stereotactic Body Radiation Therapy of Lung Tumors|Unknown status|Recruiting|Phase 1|10|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:15:22.947451|2017-02-18 13:15:22.947451
NCT00866073|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-03-19|||April 2003||2003-04-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia|Phase II Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia Who Are Not Eligible for Standard Induction Chemotherapy|Completed||Phase 2|238|Actual|University Hospital Freiburg||1|||f||||f||||||||||2017-02-18 13:15:23.039417|2017-02-18 13:15:23.039417
NCT00866060|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-03-19|||February 2008||2008-02-01|March 2009|2009-03-01|June 2013|Anticipated|2013-06-01|February 2012|Anticipated|2012-02-01||Interventional|DOMINO-AD||Donepezil and Memantine in Moderate to Severe Alzheimer's Disease|Donepezil and Memantine in Moderate to Severe Alzheimer's Disease|Unknown status|Recruiting|Phase 4|800|Anticipated|King's College London||4|||f||||t||||||||||2017-02-18 13:15:23.151246|2017-02-18 13:15:23.151246
NCT00866047|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2016-08-12|2011-09-15||March 2009||2009-03-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|August 2010|Actual|2010-08-01||Interventional|||A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma|A Phase 2 Study of SGN-35 in Treatment of Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma (ALCL)|Completed||Phase 2|58|Actual|Seattle Genetics, Inc.|Maximum duration of follow-up was 17.5 months; 9 participants were continuing on treatment and 31 participants remained in survival follow-up at the time of the efficacy analyses.|1|||f||||t||||||||||2017-02-18 13:15:23.276513|2017-02-18 13:15:23.276513
NCT00866034|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2014-02-04|2013-10-17||February 2009||2009-02-01|February 2014|2014-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Cetrotide Treatment Optimization|Prospective, Multicenter,Randomized Controlled Trial Towards Identifying the Optimal GnRH Antagonist Treatment Protocol|Terminated||Phase 4|617|Actual|UMC Utrecht|The study was terminated prematurely because no significant difference was observed in clinical outcome after 617 inclusions. A much larger population would be needed to detect a small significant difference in favour of either study arm.|2||Due to limited rate of patient inclusion|f||||t||||||||||2017-02-18 13:15:23.975836|2017-02-18 13:15:23.975836
NCT00866021|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2013-03-21|||February 2008||2008-02-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|PEKARI||Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r|A Multicenter, Randomized, Open Label, Pilot Study to Assess the Possibility of Concomitant Treatment of HCV/HIV co Infection With Peg-interferon + Ribavirin, and Lopinavir/r as a Single Antiretroviral Agent.|Completed||Phase 4|68|Actual|Fundacion SEIMC-GESIDA||2|||f||||f||||||||||2017-02-18 13:15:24.366013|2017-02-18 13:15:24.366013
NCT00866008|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-07-19|||October 2008||2008-10-01|July 2013|2013-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)|The Impact of the Heterogeneity of the Recruited Cohort of Follicles During Ovarian Hyperstimulation for IVF on Aneuploidy Rates of Generated Embryos.|Terminated||Phase 4|34|Actual|UMC Utrecht||2||Due to a very slow inclusion rate.|f||||f||||||||||2017-02-18 13:15:24.491016|2017-02-18 13:15:24.491016
NCT00865995|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2013-10-22|||February 2008||2008-02-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Pepsin As A Biomarker For Aspiration|Pepsin as a Biomarker for Aspiration Due to Gastroesophageal Reflux|Completed||N/A|76|Actual|Medical College of Wisconsin|||3||f||||f||||||Samples Without DNA|"~     Tracheal fluid~   "|||2017-02-18 13:15:24.588767|2017-02-18 13:15:24.588767
NCT00865982|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2011-08-04|||September 2008||2008-09-01|August 2011|2011-08-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|DCXAIOCHARITE||Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer|Multicenter, Open Lable Phase II Study to Evaluate the Safety and Efficacy of a Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine in Patients With Gastric Adenocarcinoma, Adenocarcinoma of the Gastro-esophageal Junction or the Distal Esophagus|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-02-18 13:15:24.696354|2017-02-18 13:15:24.696354
NCT00865969|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2014-12-04|||December 2008||2008-12-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PTCL||Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma|A Multicenter, Open-Label Trial of Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma|Completed||Phase 2|129|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||t||||||||||2017-02-18 13:15:24.957339|2017-02-18 13:15:24.957339
NCT00865956|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-19|2009-11-03|||March 2008||2008-03-01|November 2009|2009-11-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||A Comprehensive Disease Management Program for Medically-Complex Substance Users|A Comprehensive Disease Management Program for Medically-Complex Substance Users|Unknown status|Recruiting|N/A|100|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 13:15:25.203915|2017-02-18 13:15:25.203915
NCT00865943|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||July 2003||2003-07-01|August 2010|2010-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting Conditions|A Relative Bioavailability of 10 mg Citalopram Hydrobromide Tablets Under Fasting Conditions|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:25.310127|2017-02-18 13:15:25.310127
NCT00865930|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-18|||November 2008||2008-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:15:25.424003|2017-02-18 13:15:25.424003
NCT00865917|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||November 2008||2008-11-01|March 2009|2009-03-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Interventional|||Cardiovascular Effects of Selective I(f)-Channel Blockade|Einfluss Selektiver I(f)-Blockade Auf Orthostase-Toleranz Und Sympathikusaktivität Bei Gesunden|Unknown status|Recruiting|Phase 2|40|Anticipated|Hannover Medical School||3|||f||||f||||||||||2017-02-18 13:15:25.473021|2017-02-18 13:15:25.473021
NCT00865904|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2015-08-01|2015-08-01||March 2009||2009-03-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||Full Analysis Set (FAS) included all randomized participants who received at least 1 dose of study drug.|Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation|Completed||Phase 2|93|Actual|Vertex Pharmaceuticals Incorporated||5|||f||||t||||||||||2017-02-18 13:15:25.601398|2017-02-18 13:15:25.601398
NCT00865891|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||July 2005||2005-07-01|August 2010|2010-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions|A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions|Completed||Phase 1|96|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:26.976075|2017-02-18 13:15:26.976075
NCT00865878|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2011-10-20|||May 2009||2009-05-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients|A Randomized, Evaluator-Blinded, Parallel Group Comparison of PDT With Levulan Topical Solution + Blue Light vs Levulan Topical Solution Vehicle + Blue Light for the Treatment of AK and Reduction of New NMSC in Organ Transplant Recipients|Terminated||Phase 2|6|Actual|DUSA Pharmaceuticals, Inc.||2||Orphan Drug Designation for this indication not granted|f||||f||||||||||2017-02-18 13:15:27.086307|2017-02-18 13:15:27.086307
NCT00865865|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-18|||May 2006||2006-05-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Computer Aided Gap Balancing Improves Sagittal Stability and Outcomes for Cruciate-Retaining Total Knee Arthroplasty|Computer Aided Gap Balancing Improves Sagittal Stability and Outcomes for Cruciate-Retaining Total Knee Arthroplasty- 2-Year Results of a Prospective Randomised Trial|Completed||N/A|140|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-02-18 13:15:27.198713|2017-02-18 13:15:27.198713
NCT00865852|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||August 2003||2003-08-01|August 2010|2010-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Non-fasting Conditions|A Relative Bioavailability Study of 750 mg Metformin Hydrochloride Extended Release Tablets Under Non-Fasting Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:27.290899|2017-02-18 13:15:27.290899
NCT00865839|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||March 2002||2002-03-01|August 2010|2010-08-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions|A Relative Bioavailability Study of 500 mg Metformin Hydrochloride Extended Release Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:27.397773|2017-02-18 13:15:27.397773
NCT00865826|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-03-17|||December 2009||2009-12-01|March 2015|2015-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals|Sensitivity and Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals|Completed||N/A|801|Actual|AIDS Clinical Trials Group|||1||f||||||||||Samples With DNA|"~     Sputum samples and blood collection~   "|||2017-02-18 13:15:27.507451|2017-02-18 13:15:27.507451
NCT00865813|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||December 2008||2008-12-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Biopsy Incisional With Trepan in Periocular Lesions|Biopsy Incisional With Trepan in Periocular Lesions|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-02-18 13:15:27.626367|2017-02-18 13:15:27.626367
NCT00865787|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2011-08-10|||February 2008||2008-02-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Effects of EGCG-Enhanced Extra Virgin Olive Oil on Endothelial Function|Effects of EGCG-Enhanced Extra Virgin Olive Oil on Endothelial Function|Completed||N/A|83|Actual|Mayo Clinic|||2||f||||f||||||Samples Without DNA|"~     blood~   "|||2017-02-18 13:15:27.816596|2017-02-18 13:15:27.816596
NCT00865774|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-06-28|||January 2009||2009-01-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|TM||The Teachable Moment: Screening and Brief Intervention for Admitted Trauma Patients|The Teachable Moment: Screening and Brief Intervention for Admitted Trauma Patients|Completed||Phase 2|333|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 13:15:27.904257|2017-02-18 13:15:27.904257
NCT00865761|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||September 2005||2005-09-01|August 2010|2010-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions|A Relative Bioavailability Study of 3 mg Alprazolam Extended Release Tablets Under Fasting Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:28.013732|2017-02-18 13:15:28.013732
NCT00865748|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||January 2004||2004-01-01|August 2010|2010-08-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions|A Relative Bioavailability Study of 500 mg Metformin Hydrochloride Extended Release Tablets Under Fasting Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:28.135806|2017-02-18 13:15:28.135806
NCT00865735|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-04-16|||January 1993||1993-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:15:28.244351|2017-02-18 13:15:28.244351
NCT00865722|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-08-16|||March 2009||2009-03-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|RemPostCon||Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI)|Pilot Study to Test Feasibility, Safety, Molecular Mediators and Preliminary Efficacy of Remote Myocardial Postconditioning Provided With Extrinsic Cuff Compression of Lower Limb During Primary PCI|Completed||Phase 2/Phase 3|96|Anticipated|IRCCS Policlinico S. Matteo||2|||f||||f||||||||||2017-02-18 13:15:28.294055|2017-02-18 13:15:28.294055
NCT00865709|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2014-11-25|2012-01-31||March 2009||2009-03-01|November 2014|2014-11-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Interventional|||Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects|Phase 2b, DB, Randomized Study Evaluating Efficacy & Safety of Sorafenib Compared With Placebo When Administered in Combination With Modified FOLFOX6 for the Treatment of Metastatic CRC Subjects Previously Untreated for Stage IV Disease|Completed||Phase 2|198|Actual|Bayer||2|||f||||t||||||||||2017-02-18 13:15:28.410963|2017-02-18 13:15:28.410963
NCT00865696|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||September 2001||2001-09-01|August 2010|2010-08-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 15 mg Mirtazapine Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:30.059998|2017-02-18 13:15:30.059998
NCT00865683|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-07-14|||April 2009||2009-04-01|July 2009|2009-07-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)|DHA, Inflammation, and Insulin Sensitivity|Unknown status|Recruiting|Phase 1|90|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||f||||||||||2017-02-18 13:15:30.170175|2017-02-18 13:15:30.170175
NCT00865670|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||August 2003||2003-08-01|March 2009|2009-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Geneva 600 mg Azithromycin Monohydrate Tablets and Pfizer Inc. (Zithromax) 600 mg Azithromycin Dihydrate Tablets in Healthy Adult Volunteers Under Fed Conditions|Completed||Phase 1|38|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:15:30.29299|2017-02-18 13:15:30.29299
NCT00865657|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||September 2005||2005-09-01|August 2010|2010-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions|A Relative Bioavailability Study of 3 mg Alprazolam Extended Release Tablets Under Non-Fasting Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:30.386657|2017-02-18 13:15:30.386657
NCT00865644|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2017-01-09|||March 2009||2009-03-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|April 2010|Actual|2010-04-01||Interventional|||Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1|Pilot Study of Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1|Completed||Phase 1|11|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 13:15:30.498868|2017-02-18 13:15:30.498868
NCT00865631|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||June 1999||1999-06-01|August 2010|2010-08-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||A Limited Food Effect Study of Gabapentin 800 mg Tablets|A Limited Food Effect Study of 800 mg Gabapentin Tablets Versus 400 mg Gabapentin Capsules|Completed||Phase 1|18|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:30.602054|2017-02-18 13:15:30.602054
NCT00865618|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||June 2006||2006-06-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions|Comparative Bioavailability Study of Eplerenone 50 mg Tablets (Sandoz Inc., USA) and Inspra 50 mg Tablets (GD Searle LLC, USA) in Healthy Male and/or Female Volunteers Under Fed Conditions.|Completed||Phase 1|60|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:15:30.718376|2017-02-18 13:15:30.718376
NCT00865605|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||December 2003||2003-12-01|August 2010|2010-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects|A Single-blind, Single Exposure Study, to Evaluate the Vasoconstriction Activity of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects: Pivotal Bioequivalence Study|Completed||Phase 1|71|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:30.803862|2017-02-18 13:15:30.803862
NCT00865592|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-10|||March 2009||2009-03-01|August 2010|2010-08-01|March 2011|Anticipated|2011-03-01|January 2011|Anticipated|2011-01-01||Interventional|||Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus|An Open Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety of PHX1149T/Dutogliptin in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 3|450|Anticipated|Phenomix||1|||f||||f||||||||||2017-02-18 13:15:30.916692|2017-02-18 13:15:30.916692
NCT00865579|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2013-03-28|||March 2009||2009-03-01|July 2012|2012-07-01||||July 2012|Actual|2012-07-01||Interventional|||Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients|Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients|Completed||Phase 3|965|Actual|Newron||1|||f||||||||||||||2017-02-18 13:15:31.15599|2017-02-18 13:15:31.15599
NCT00865566|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2016-09-21|||May 2009||2009-05-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men|Phase 2b, Randomized, Placebo-Controlled Test-of-Concept Trial to Evaluate the Safety and Efficacy of a Multiclade HIV-1 DNA Plasmid Vaccine Followed by a Multiclade HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Adenovirus Type 5 Neutralizing Antibody Negative, Circumcised Men and Male-to-Female (MTF) Transgender Persons, Who Have Sex With Men|Active, not recruiting||Phase 2|2504|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:15:31.259147|2017-02-18 13:15:31.259147
NCT00865553|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2013-09-19|||March 2009||2009-03-01|March 2011|2011-03-01||||August 2010|Anticipated|2010-08-01||Interventional|||Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes|Clinical Testing of a Decision Support System for Tobacco Use Treatment|Unknown status|Recruiting|Phase 2|630|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:15:31.399757|2017-02-18 13:15:31.399757
NCT00865540|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2011-05-23|||March 2009||2009-03-01|March 2009|2009-03-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies|Effect of Anti-inflammatory Topical Prednisolone Acetate 1%, Nepafenac of 0.1% and Ketorolac Tromethamine 0.4% in Intra-operative Mydriasis in Facetectomies|Unknown status|Active, not recruiting|Phase 4|30|Actual|Clinica Oftamologica Zona Sul||4|||f||||t||||||||||2017-02-18 13:15:31.494591|2017-02-18 13:15:31.494591
NCT00865527|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2016-03-29|||March 2010||2010-03-01|March 2016|2016-03-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Interventional|||Pilot Study of Colon Cancer Screening Tests|Randomized Comparison of Virtual Colonoscopy, Optical Colonoscopy, and Fecal Occult Blood Testing for Colorectal Cancer Screening: a Pilot Study|Terminated||N/A|198|Actual|McMaster University||3||Lack of ongoing funding|f||||f||||||||||2017-02-18 13:15:31.601404|2017-02-18 13:15:31.601404
NCT00865514|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-06-02|2013-03-21||August 2011||2011-08-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Pharmacotoxicology of Trichloroethylene Metabolites|Pharmacotoxicology of Trichloroethylene Metabolites: Short-term Effect of DCA on in Vivo Tyrosine Catabolism and MAAI Expression|Terminated||N/A|2|Actual|University of Florida||1||"Difficulty in obtaining the solution from the compounding pharmacies caused a two year delay~   in start-up; the funding ended prior to study completion."|f||||f||||||||||2017-02-18 13:15:31.712864|2017-02-18 13:15:31.712864
NCT00865501|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-07-06|||March 2008||2008-03-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease|Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease|Completed||Phase 3|50|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-02-18 13:15:31.991954|2017-02-18 13:15:31.991954
NCT00865488|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-12-20|||May 2009||2009-05-01|December 2009|2009-12-01|April 2010|Anticipated|2010-04-01|February 2010|Anticipated|2010-02-01||Interventional|||Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery|A Prospective, Controlled, Randomized, Multi-Center, Pivotal Study Evaluating the Safety and Efficacy of AdhexilTM in Prevention And/Or Reduction of Adhesions in Gynecology Surgery|Suspended||Phase 3|80|Anticipated|OMRIX Biopharmaceuticals||2|||f||||t||||||||||2017-02-18 13:15:32.104521|2017-02-18 13:15:32.104521
NCT00865475|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2013-09-11|||December 2008||2008-12-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|KALIPO||Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC|A Randomized Comparative Clinical Trial of ZDV + 3TC + ABC (Trizivir) vs Monotherapy With Lopinavir/R (Kaletra) in Patients With Viral Suppression on Previous Treatment With ZDV + 3TC + ABC (Trizivir) for Preventing Lipoatrophy|Completed||Phase 4|38|Actual|Fundacion SEIMC-GESIDA||2|||f||||f||||||||||2017-02-18 13:15:32.216369|2017-02-18 13:15:32.216369
NCT00865462|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||July 2004||2004-07-01|August 2010|2010-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions|A Randomized, Single Dose Two -Way Crossover Relative Bioavailability Study of Bupropion XL Tablets Formulation in Normal, Healthy Man Following a Standard Meal|Completed||Phase 1|30|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:32.334686|2017-02-18 13:15:32.334686
NCT00865449|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-10-23|||July 2008||2008-07-01|March 2009|2009-03-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis|Role of Renin Angiotensin Blockade in Peritoneal Fibrosis in Peritoneal Dialysis Patients|Completed||Phase 3|20|Actual|Instituto Nacional de Cardiologia Ignacio Chavez||2|||f||||f||||||||||2017-02-18 13:15:32.44431|2017-02-18 13:15:32.44431
NCT00865436|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||April 2004||2004-04-01|August 2010|2010-08-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 5 mg Glyburide/500 mg Metformin HCl Tablets Under Fasting Conditions|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:32.551159|2017-02-18 13:15:32.551159
NCT00865423|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||February 2001||2001-02-01|August 2010|2010-08-01|March 2001|Actual|2001-03-01|February 2001|Actual|2001-02-01||Interventional|||A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Fasting Conditions|A Relative Bioavailability Study of 800 mg Gabapentin Tablets Under Fasting Conditions|Completed||Phase 1|28|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:32.664007|2017-02-18 13:15:32.664007
NCT00865410|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||August 2004||2004-08-01|August 2010|2010-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions|A Randomized, Single Dose Two -Way Crossover Relative Bioavailability Study of Bupropion Extended-Released Tablets Formulation in Fasted, Normal, Healthy Subjects.|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:35.090997|2017-02-18 13:15:35.090997
NCT00865397|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2016-11-22|||February 2009||2009-02-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|HA-BOT||Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment|Observational Study of Glycaemic Control in Type 2 Diabetic Patients Uncontrolled on Oral Antidiabetic Agents and Starting With Once Daily Levemir® (Insulin Detemir) - 24 Weeks, Prospective, Multicentre Observational Study in Hungary|Completed||N/A|1032|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:15:35.201644|2017-02-18 13:15:35.201644
NCT00865384|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||September 2001||2001-09-01|August 2010|2010-08-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Non-fasting Conditions|A Relative Bioavailability Study of 15 mg Mirtazapine Tablets Under Non-Fasting Conditions|Completed||Phase 1|24|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:35.306734|2017-02-18 13:15:35.306734
NCT00865371|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||September 2004||2004-09-01|August 2010|2010-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions|A Randomized, Single Dose Two -Way Crossover Relative Bioavailability Study of Bupropion Extended-Released Tablets Formulation in Normal, Healthy Man Following a Standard Meal|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:35.414055|2017-02-18 13:15:35.414055
NCT00865358|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-12-04|||February 2007||2007-02-01|December 2012|2012-12-01|January 2008|Actual|2008-01-01|July 2007|Actual|2007-07-01||Interventional|||Yoga for Chronic Low Back Pain|Yoga for Chronic Low Back Pain in a Predominantly Minority Population: A Pilot Randomized Controlled Trial|Completed||Phase 2|30|Actual|Boston Medical Center||2|||f||||f||||||||||2017-02-18 13:15:35.517392|2017-02-18 13:15:35.517392
NCT00865345|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-11-05|2011-04-19||March 2009||2009-03-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|6-DayFU||An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance|An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance|Completed||N/A|63|Actual|Medtronic Diabetes||1|||f||||t||||||||||2017-02-18 13:15:35.626098|2017-02-18 13:15:35.626098
NCT00865332|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2017-01-24|||December 12, 2007||2007-12-12|December 21, 2010|2010-12-21|December 21, 2010||2010-12-21|||||Observational|||Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates|Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:15:35.851277|2017-02-18 13:15:35.851277
NCT00865319|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2013-03-20|||June 2009||2009-06-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)|A Multicenter Phase 2 Study Comparing 99m Tc EC-DG SPECT/CT With 18F FDG PET/CT in the Evaluation of Patients With Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|22|Actual|Cell>Point LLC||2|||f||||t||||||||||2017-02-18 13:15:35.935969|2017-02-18 13:15:35.935969
NCT00865306|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-09-22|2010-07-20||March 1998||1998-03-01|September 2010|2010-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Early Intervention for Children at Risk for Anxiety|Early Intervention for Children at Risk for Anxiety|Completed||N/A|65|Actual|Massachusetts General Hospital|Wait-list control condition Use of parent report in diagnostic interviews (necessary in this young age range) Small sample size|2|||f||||f||||||||||2017-02-18 13:15:36.244617|2017-02-18 13:15:36.244617
NCT00865293|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-07-13|||July 2008||2008-07-01|July 2009|2009-07-01||||||||Observational|EFL||Expiratory Airflow Limitation in Subjects With Obesity|Obesity and Expiratory Flow Limitation (EFL)|Unknown status|Active, not recruiting|N/A|30|Anticipated|Medical Center Alkmaar|||2||f||||f||||||||||2017-02-18 13:15:36.662194|2017-02-18 13:15:36.662194
NCT00865280|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-05-20||2013-05-20|March 2009||2009-03-01|May 2013|2013-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|CSSI||Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)|A Randomized, Evaluator-Blinded, Phase 3 Study to Compare the Safety and Efficacy of PTK 0796 With Linezolid in the Treatment of Adults With Complicated Skin and Skin Structure Infection|Terminated||Phase 3|143|Actual|Paratek Pharmaceuticals Inc||2||Terminated|f||||f||||||||||2017-02-18 13:15:36.743642|2017-02-18 13:15:36.743642
NCT00865267|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||December 2003||2003-12-01|August 2010|2010-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects|A Single-blind, Single Exposure Study, to Evaluate the Vasoconstriction Activity of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects: Dose Ranging Study|Completed||Phase 1|20|Actual|Actavis Inc.||1|||f||||f||||||||||2017-02-18 13:15:36.863299|2017-02-18 13:15:36.863299
NCT00865254|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-06-27|||August 2007||2007-08-01|June 2013|2013-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Prize Reinforcement for Smoking Cessation|Prize Reinforcement for Smoking Cessation|Completed||N/A|84|Actual|Wayne State University||3|||f||||t||||||||||2017-02-18 13:15:36.973772|2017-02-18 13:15:36.973772
NCT00865241|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||November 2002||2002-11-01|August 2010|2010-08-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 5 mg Glyburide/500 mg Metformin HCl Tablets Under Fasting Conditions|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:37.075957|2017-02-18 13:15:37.075957
NCT00865228|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-05-23|||July 2007||2007-07-01|May 2012|2012-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia|A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 100 mg in the Morning vs Lapaquistat Acetate 100 mg in the Evening vs Lapaquistat Acetate 50 mg Twice Daily vs Placebo in Subjects With Hypercholesterolemia|Terminated||Phase 2|224|Actual|Takeda||4||"Overall profile of the compound does not offer significant clinical advantage to patients over~   currently available lipid lowering agents"|f||||f||||||||||2017-02-18 13:15:37.193016|2017-02-18 13:15:37.193016
NCT00865215|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||April 2005||2005-04-01|August 2010|2010-08-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 160 mg Propranolol Hydrochloride Extended Release Capsules Under Fasting Conditions|Completed||Phase 1|60|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:37.328208|2017-02-18 13:15:37.328208
NCT00865202|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-03-27|||December 2008||2008-12-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Placebo Controlled Trial Of L-Tryptophan In Post-Operative Delirium|A Placebo Controlled Trial Of L-Tryptophan In Post-Operative Delirium|Completed||Phase 3|325|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 13:15:37.439772|2017-02-18 13:15:37.439772
NCT00865189|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2016-11-01|||November 2007||2007-11-01|November 2016|2016-11-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study of Avastin (Bevacizumab) in Patients With Newly Diagnosed Locally Advanced Rectal Cancer.|A Randomized, Open-label Study to Assess the Effect on Tumor Response, and the Safety, of Two Neo-adjuvant Approaches With Avastin in Newly-diagnosed Patients With High Risk Locally-advanced Rectal Cancer|Completed||Phase 2|91|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:15:37.551541|2017-02-18 13:15:37.551541
NCT00865176|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||June 2006||2006-06-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions|Comparative Bioavailability Study of Eplerenone 50 mg Tablets (Sandoz Inc., USA) and Inspra 50 mg Tablets (GD Searle LLC, USA) in Healthy Male and/or Female Volunteers Under Fasting Conditions.|Completed||Phase 1|60|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:15:37.662117|2017-02-18 13:15:37.662117
NCT00865163|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2016-06-16|||November 2008||2008-11-01|June 2016|2016-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|LASER||LASER: Real Life Antithrombotic Stent Evaluation Registry|LASER: Real Life Antithrombotic Stent Evaluation Registry|Completed||N/A|915|Actual|Stiftung Institut fuer Herzinfarktforschung|||1||f||||f||||||||No||2017-02-18 13:15:37.743527|2017-02-18 13:15:37.743527
NCT00865150|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-02-28|||April 2009||2009-04-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|August 2011|Actual|2011-08-01||Observational|||Amino Acid and Acylcarnitine Profiles in Premature Neonates|How Illness and Nutritional Support Influence Amino Acid and Acylcarnitine Profiles in Premature Neonates|Completed||N/A|1003|Actual|Mednax Center for Research, Education and Quality|||1||f||||t||||||||||2017-02-18 13:15:37.820318|2017-02-18 13:15:37.820318
NCT00865137|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2014-07-17|||September 2007||2007-09-01|July 2014|2014-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients|An Open-label, Single-centre Study to Assess the Effect of Food on the Relative Bioavailability of Orally Administered Tacrolimus Modified Release Formulation, FK506E (MR4), in Stable Kidney Transplant Recipients|Completed||Phase 3|27|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-02-18 13:15:37.909057|2017-02-18 13:15:37.909057
NCT00865111|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||March 2006||2006-03-01|August 2010|2010-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions|A Randomized, Single Dose Two -Way Crossover Relative Bioavailability Study of Bupropion Sustained Release Tablets in Fasted, Normal, Healthy Men.|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:38.52065|2017-02-18 13:15:38.52065
NCT00865098|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2014-02-10|2011-06-23||March 2009||2009-03-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Open-label, Non-randomized, Non-controlled, Multicenter Phase II Study Investigating Cetuximab in Combination With Concomitant-boost Radiotherapy as First-line Treatment for Japanese Patients With Newly Diagnosed Locally Advanced SCCHN.|Completed||Phase 2|27|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 13:15:38.634484|2017-02-18 13:15:38.634484
NCT00865085|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||June 2003||2003-06-01|August 2010|2010-08-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting Conditions|Single Dose Crossover Comparative Bioavailability Study of Citalopram 40 mg Tablets in Healthy Male Volunteers/Fasting State|Completed||Phase 1|28|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:38.973702|2017-02-18 13:15:38.973702
NCT00865072|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||August 2003||2003-08-01|August 2010|2010-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions|A Relative Bioavailability Study of 750 mg Metformin Hydrochloride Extended Release Tablets Under Fasting Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:39.084621|2017-02-18 13:15:39.084621
NCT00865059|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||February 2001||2001-02-01|August 2010|2010-08-01|March 2001|Actual|2001-03-01|February 2001|Actual|2001-02-01||Interventional|||A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions|A Relative Bioavailability Study of 800 mg Gabapentin Tablets Under Non-Fasting Conditions|Completed||Phase 1|24|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:39.196758|2017-02-18 13:15:39.196758
NCT00865046|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-01-22|2014-12-10||November 2009||2009-11-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|PST|Community dwelling adults with advanced knee osteoarthritis and chronic pain|Periosteal Stimulation for Knee Osteoarthritis|Efficacy of Periosteal Stimulation and Boosters for Advanced Knee OA Pain|Completed||N/A|190|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 13:15:39.307293|2017-02-18 13:15:39.307293
NCT00865033|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2009-03-18|||November 2005||2005-11-01|March 2009|2009-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions|A Relative Bioavailability Study of Metformin HCL 1000 mg Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:15:40.29983|2017-02-18 13:15:40.29983
NCT00865020|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2011-06-22|2011-06-22||March 2009||2009-03-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|ASSERTIVE||Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal|A Twelve-week, Randomized, Double-blind, Parallel Group Study to Evaluate the Prolonged Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg in Mild to Moderate Hypertensive Patients With the 24-hour Ambulatory Blood Pressure Measurement After 1 Week of Treatment Withdrawal Study Acronym: ASSERTIVE - AliSkiren Study of Profound antihypERtensive Efficacy in hyperTensIVE Patients|Completed||Phase 4|822|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:15:40.384142|2017-02-18 13:15:40.384142
NCT00865007|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2013-03-21|||December 2008||2008-12-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|KRETA||Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy|A Phase IV-III Comparative, Randomized, Open-label Study to Evaluate the Efficacy for the Recovery of Peripheral Fat (or of the Extremities) of Lopinavir/Ritonavir in Monotherapy Versus Abacavir/Lamivudine and Lopinavir/Ritonavir|Completed||Phase 4|88|Actual|Fundacion SEIMC-GESIDA||2|||f||||f||||||||||2017-02-18 13:15:40.779571|2017-02-18 13:15:40.779571
NCT00864994|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-03-26|||September 2010||2010-09-01|September 2010|2010-09-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Multiorgan Pathology in Chronic Obstructive Pulmonary Disease (COPD)|COPD: Transition of Systemic Inflammation Into Multiorgan Pathology (Study 3). (De Effecten Van Ontsteking op Skeletspieren Bij COPD)|Unknown status|Not yet recruiting|N/A|60|Anticipated|Top Institute Pharma|||2||f||||t||||||Samples With DNA|"~     Blood will be retained to investigate differences in candidate genes (SNPs) for COPD and CVD~     between the different groups.~   "|||2017-02-18 13:15:40.894058|2017-02-18 13:15:40.894058
NCT00864981|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2009-03-18|||September 2005||2005-09-01|March 2009|2009-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions|A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:15:40.984158|2017-02-18 13:15:40.984158
NCT00864968|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||February 2007||2007-02-01|August 2010|2010-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers|Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:41.065716|2017-02-18 13:15:41.065716
NCT00864955|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-09-02|||March 2009||2009-03-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|DIMUVA||Cutaneous DNA Damage Caused by UV-A Irradiation|Damage to DNA Caused by UV-A Irradiation: Photochemical Mechanism and Cutaneous Parameters Involved in the Formation of Cyclobutane Pyrimidine Dimers|Completed||N/A|24|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-02-18 13:15:41.357647|2017-02-18 13:15:41.357647
NCT00864942|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-03-12|||February 2009||2009-02-01|June 2014|2014-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Phase I BLR||Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)|Phase I Clinical Trial of Bendamustine, Lenalidomide and Rituximab in B-Cell Lymphoid Malignancies|Completed||Phase 1|28|Actual|Georgetown University||4|||f||||t||||||||||2017-02-18 13:15:41.476722|2017-02-18 13:15:41.476722
NCT00864929|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2011-02-15|||November 2009||2009-11-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice|An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice|Completed||N/A|1500|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:15:41.599058|2017-02-18 13:15:41.599058
NCT00864916|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2014-04-28|2014-03-10||March 2009||2009-03-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Completed enrollment visit|Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People|A Randomized, Placebo-Controlled Trial of Pentoxifylline Plus Combination ART vs. Combination ART Alone to Improve Endothelial Dysfunction in HIV-Infected Patients|Completed||Phase 2|19|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 13:15:41.699188|2017-02-18 13:15:41.699188
NCT00864903|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-09-17|||April 2009||2009-04-01|March 2009|2009-03-01|November 2009|Anticipated|2009-11-01|October 2009|Anticipated|2009-10-01||Observational|||A New Enzymatic Assay for Rapid Diagnosing of Central Nervous System Enteroviral Infection|A Comparison Between a New Experimental Enzymatic Assay to Real Time PCR for the Diagnosing of Central Nervous System Enteroviral Infection|Unknown status|Active, not recruiting|N/A|200|Anticipated|Shaare Zedek Medical Center|||1||f||||f||||||Samples With DNA|"~     Cerebrospinal Fluid~   "|||2017-02-18 13:15:42.018596|2017-02-18 13:15:42.018596
NCT00864890|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||June 2003||2003-06-01|August 2010|2010-08-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed Conditions|Single Dose Crossover Comparative Bioavailability Study of Citalopram 40 mg Tablets in Healthy Male Volunteers/Fed State|Completed||Phase 1|32|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:42.116843|2017-02-18 13:15:42.116843
NCT00864877|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||May 2009||2009-05-01|March 2009|2009-03-01||||April 2012|Anticipated|2012-04-01||Interventional|||Comparison of Biodegradable & Metal Plates for Fixing Ankle Fracture|A Randomised, Prospective Clinical Investigation to Compare Post-Operative Fracture Healing and Complication Rate After the Fixation of Ankle Fractures Using the Inion OTPS FreedomPlate Biodegradable Fixation System Versus Conventional Metal Screws and Plates.|Unknown status|Not yet recruiting|N/A|||Inion Oy|||||f||||f||||||||||2017-02-18 13:15:42.228263|2017-02-18 13:15:42.228263
NCT00864864|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2016-07-06|||May 2007||2007-05-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|May 2011|Actual|2011-05-01||Interventional|||Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma|Pilot Study of Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma|Completed||Early Phase 1|8|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 13:15:42.319043|2017-02-18 13:15:42.319043
NCT00864851|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2015-03-03|2014-01-30||December 2008||2008-12-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease|A Multi-Center, Open-Label, Randomized Study Evaluating the Safety and Efficacy of Three Dosing Regimens of Replagal Enzyme Replacement Therapy in Adult Patients With Fabry Disease|Completed||Phase 3|44|Actual|Shire||3|||f||||t||||||||||2017-02-18 13:15:42.446674|2017-02-18 13:15:42.446674
NCT00864838|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||June 2008||2008-06-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab|Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab Injection|Completed||Phase 2|56|Actual|University of Sao Paulo||4|||f||||t||||||||||2017-02-18 13:15:44.320724|2017-02-18 13:15:44.320724
NCT00864825|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-05-06|||August 2009||2009-08-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia|Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia|Completed||Phase 4|248|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 13:15:44.422128|2017-02-18 13:15:44.422128
NCT00864812|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-03-29|||March 2009||2009-03-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea|A Randomized, Open Label, Multicenter, Phase 4 Study for the Comparison of Efficacy of Tiotropium Plus Salmeterol/ Fluticasone Propionate Compared With Tiotropium Alone in COPD Patients|Completed||Phase 4|509|Actual|The Korean Academy of Tuberculosis and Respiratory Diseases||2|||f||||f||||||||||2017-02-18 13:15:44.56522|2017-02-18 13:15:44.56522
NCT00864799|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2013-07-23|||April 2009||2009-04-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Techniques to Improve Efficacy of Second Trimester Medical Termination|Comparison of 3 Regimens Using Mifepristone and Misoprostol for Second Trimester Pregnancy Interruption.|Completed||N/A|302|Actual|King Edward Memorial Hospital||3|||f||||f||||||||||2017-02-18 13:15:44.884691|2017-02-18 13:15:44.884691
NCT00864786|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2009-03-20|||September 2008||2008-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Multiple Dose Healthy Volunteer Safety Pharmacokinetics Study|A Double Blind (3rd Party Open), Randomised, Placebo Controlled, Dose Escalating Study To Investigate The Safety, Toleration, Pharmacokinetics, And Pharmacodynamics Of Multiple Inhaled Doses Of PF-03635659 In Healthy Male Subjects.|Completed||Phase 1|50|Anticipated|Pfizer||5|||f||||f||||||||||2017-02-18 13:15:44.991161|2017-02-18 13:15:44.991161
NCT00864773|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||March 2009||2009-03-01|March 2009|2009-03-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy|Intraocular Concentrations of Growth Factors and Cytokines in Chronic Central Serous Chorioretinopathy And the Effect of Therapy With Bevacizumab|Unknown status|Enrolling by invitation|N/A|10|Anticipated|Hallym University Medical Center||1|||f||||t||||||||||2017-02-18 13:15:45.10634|2017-02-18 13:15:45.10634
NCT00864760|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||June 1999||1999-06-01|August 2010|2010-08-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||A Relative Bioavailability Study of Gabapentin 800 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 800 mg Gabapentin Tablets Versus 400 mg Gabapentin Capsules Under Fasting Conditions|Completed||Phase 1|30|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:45.186713|2017-02-18 13:15:45.186713
NCT00864747|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||May 2005||2005-05-01|August 2010|2010-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Relative Bioavailability Study of Propranolol HCl 160 mg Tablets Under Non-fasting Conditions|A Relative Bioavailability Study of 160 mg Propranolol Hydrochloride Extended Release Capsules Under Non-Fasting Conditions|Completed||Phase 1|60|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:45.326911|2017-02-18 13:15:45.326911
NCT00864734|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||November 2002||2002-11-01|August 2010|2010-08-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions|A Relative Bioavailability Study of 5 mg Glyburide/500 mg Metformin HCl Tablets Under Non-Fasting Conditions|Completed||Phase 1|24|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:45.437792|2017-02-18 13:15:45.437792
NCT00864721|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2014-05-19|||February 2009||2009-02-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Sunitinib Non Small Cell Lung Cancer Patients Over 70|Phase II Trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70|Completed||Phase 2|63|Actual|US Oncology Research||1|||f||||f||||||||||2017-02-18 13:15:45.552444|2017-02-18 13:15:45.552444
NCT00864708|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2014-05-07|2013-11-25||December 2008||2008-12-01|May 2014|2014-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||This was a feasibility study to test an RFM Gait System for re-training gait coordination. Number of participants was limited to sponsor timeline.|Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008|Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008|Terminated||N/A|1|Actual|VA Office of Research and Development|Study sponsor, Alfred Mann foundation (AMF) stopped study because “enrollment period/study duration has exceeded the AMF’s timeline”.|1||The enrollment period/study duration had exceeded The Alfred Mann Foundation's timeline.|f||||t||||||||||2017-02-18 13:15:45.682847|2017-02-18 13:15:45.682847
NCT00864695|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2009-03-18|||May 2007||2007-05-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Role of Anesthesiologist-Patient Relationship|Role of Anesthesiologist-Patient Relationship in Changing Postoperative Perception of Patients Admitted to a Teaching Hospital|Completed||N/A|1137|Actual|UPECLIN HC FM Botucatu Unesp|||1||f||||t||||||||||2017-02-18 13:15:45.960019|2017-02-18 13:15:45.960019
NCT00864682|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-02-04|2009-03-24||January 2008||2008-01-01|February 2012|2012-02-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Preventing Propofol-associated Injection Pain|Propofol Mixed With Lidocaine Versus Lidocaine Pretreatment With Tourniquet for Alleviation of Pain Associated With Propofol Injection|Completed||Phase 4|156|Actual|Benaroya Research Institute||3|||f||||t||||||||||2017-02-18 13:15:46.064502|2017-02-18 13:15:46.064502
NCT00864669|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||March 2002||2002-03-01|August 2010|2010-08-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting Conditions|A Relative Bioavailability Study of 500 mg Metformin Hydrochloride Extended Release Tablets Under Non-Fasting Conditions|Completed||Phase 1|32|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:46.555553|2017-02-18 13:15:46.555553
NCT00864656|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-18|||September 2006||2006-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Eyelid Position Interdependence in Involutional Ptosis Patients Submitted to 10% Phenylephrine|Comparative Study of Eyelid Position Interdependence in Involutional Ptosis Patients Submitted to 1, 2 or 4 Drops of 10% Phenylephrine|Completed||N/A|60|Actual|University of Sao Paulo|||3||f||||t||||||||||2017-02-18 13:15:46.663612|2017-02-18 13:15:46.663612
NCT00864643|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2012-05-23|||September 2004||2004-09-01|May 2012|2012-05-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia|A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 (100 mg) Vs Placebo When Coadministered With Atorvastatin (10 or 20 mg) in Subjects With Primary Hypercholesterolemia|Completed||Phase 2|172|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:15:46.77961|2017-02-18 13:15:46.77961
NCT00864630|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2011-05-23|||September 2010||2010-09-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|||Neuroimaging for Depression|Objective Detection, Evaluation and Countermeasures for In-flight Depression|Terminated||N/A|68|Anticipated|Massachusetts General Hospital||2||"The study upon which this project depended for subjects and the intervention was terminated~   prematurely due to lack of funds."|f||||f||||||||||2017-02-18 13:15:46.887179|2017-02-18 13:15:46.887179
NCT00864617|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||May 2005||2005-05-01|August 2010|2010-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Relative Bioavailability Study of 60 mg Nifedipine ER Tablets Under Non-fasting Conditions|A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Non-Fasting Conditions|Completed||Phase 1|84|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:46.987047|2017-02-18 13:15:46.987047
NCT00864604|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-18|2010-08-13|||April 2007||2007-04-01|August 2010|2010-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers|Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers|Completed||Phase 1|30|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:47.096619|2017-02-18 13:15:47.096619
NCT00864591|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-17|||April 2009||2009-04-01|March 2009|2009-03-01|October 2010|Anticipated|2010-10-01|April 2010|Anticipated|2010-04-01||Observational|||Stress Adenosine Cardiac Magnetic Resonance (MR) Comparison With Single Photon Emission Computed Tomography (SPECT) Imaging|Stress Adenosine Cardiac MR Comparison With SPECT Imaging|Unknown status|Not yet recruiting|N/A|50|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 13:15:47.20895|2017-02-18 13:15:47.20895
NCT00864578|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-06-05|||April 2009||2009-04-01|June 2012|2012-06-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Observational|||Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy|Effects of the Oral Administration of an Association of Forskolin With Rutin and Vitamins B on Intraocular Pressure (IOP) in Patients Affected by Primary Open Angle Glaucoma (POAG) Under Maximun Tolerated Medical Therapy (MTMT)|Withdrawn||N/A|0|Actual|Sooft Italia|||1|loss of interest before enrolment started|f||||t||||||||||2017-02-18 13:15:47.304269|2017-02-18 13:15:47.304269
NCT00863395|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2014-03-28|||December 2008||2008-12-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CTCL||Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma|Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma|Terminated||Phase 1/Phase 2|6|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-02-18 13:16:11.870461|2017-02-18 13:16:11.870461
NCT00864565|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||June 2003||2003-06-01|August 2010|2010-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System|Randomized, 2-way Crossover, Bioequivalence Study of Fentanyl 25 μg/h Transdermal System and Duragesic 25 μg/h Transdermal System Administrated as 1 x 25 μg/h Single Application in the Healthy Subjects|Completed||Phase 1|48|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:47.402337|2017-02-18 13:15:47.402337
NCT00864552|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-06-29|||December 2002||2002-12-01|June 2009|2009-06-01|December 2005|Actual|2005-12-01|||||Observational|||International PMS Study - KOGENATE Bayer|International PMS Study - KOGENATE Bayer|Completed||N/A|200|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:15:47.509637|2017-02-18 13:15:47.509637
NCT00864539|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2011-11-12|2010-07-27||November 2007||2007-11-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|February 2009|Actual|2009-02-01||Interventional|||Comparison of the Efficacy of Calcium-cholecalciferol Foodstuffs and Calcium-cholecalciferol Supplement|The Prevalence of Vitamin D Insufficiency in Primary School Children and Comparison of the Effect of Calcium-Vitamin D-Fortified Milk, -Orange Juice and Calcium-Vitamin D Supplement|Completed||Phase 2/Phase 3|585|Actual|National Nutrition and Food Technology Institute|Because of very cold winter, it was not possible to extend the intervention period to 12 weeks or longer. Moreover, it was impossible to fortify the foodstuffs with more than 50% of RDA(recommended daily allowance) because of legal problems.|6|||f||||f||||||||||2017-02-18 13:15:47.621935|2017-02-18 13:15:47.621935
NCT00864526|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||October 2006||2006-10-01|August 2010|2010-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Fasting Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:48.356087|2017-02-18 13:15:48.356087
NCT00864513|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-12-07|2011-03-24||October 2007||2007-10-01|December 2015|2015-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study of Pemetrexed for Second-Line Pancreas Cancer|A Phase II Study of Pemetrexed as Second-Line Treatment in Patients With Pancreatic Cancer Progressing Despite Therapy With Gemcitabine|Terminated||Phase 2|17|Actual|Georgetown University|study was closed at interim analysis so only 12 subjects were evaluable for response, 15 subjects received treatment and were evaluable for adverse events|1||At interim analysis the study did not meet the response criteria to continue|f||||t||||||||||2017-02-18 13:15:48.469606|2017-02-18 13:15:48.469606
NCT00864500|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||November 2005||2005-11-01|August 2010|2010-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects|Bioequivalence of Two Clobetasol Propionate 0.05% Topical Lotions|Completed||Phase 1|224|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:48.941331|2017-02-18 13:15:48.941331
NCT00864487|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-05-10|||April 2009||2009-04-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib|A Study to Examine the Potential Effect of Rifampin on the Pharmacokinetics of Neratinib When Administered Concomitantly to Healthy Subjects|Completed||Phase 1|24|Actual|Puma Biotechnology, Inc.||2|||f||||f||||||||||2017-02-18 13:15:49.048705|2017-02-18 13:15:49.048705
NCT00864474|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2016-12-05|||March 2010||2010-03-01|December 2016|2016-12-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Observational|||Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)|Drug Use Investigation For Hiv Infection Patients Of Maraviroc (Regulatory Post Marketing Commitment Plan).|Active, not recruiting||N/A|50|Anticipated|ViiV Healthcare|||1||f||||f||||||||||2017-02-18 13:15:49.20222|2017-02-18 13:15:49.20222
NCT00864461|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||May 2009||2009-05-01|March 2009|2009-03-01|July 2009|Anticipated|2009-07-01|May 2009|Anticipated|2009-05-01||Observational|||Frequency of Metabolic Syndrome in Down Syndrome Patients||Unknown status|Not yet recruiting|N/A|96|Anticipated|Universidad de Guanajuato|||2||f||||||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:15:49.29983|2017-02-18 13:15:49.29983
NCT00864448|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||October 2004||2004-10-01|August 2010|2010-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalence Study of Ramipril10 mg Capsules Under Fasting Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:49.380045|2017-02-18 13:15:49.380045
NCT00864435|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||October 2005||2005-10-01|August 2010|2010-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions|A Two-Way Crossover, Open-Label, Single Dose, Fasting, Bioequivalence Study of Carvedilol 12.5 mg Tablets Versus Coreg® 12.5 mg Tablets in Normal, Healthy, Non-Smoking Male and Female Subjects|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:49.485732|2017-02-18 13:15:49.485732
NCT00864422|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||October 2006||2006-10-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Changes in Motor Cortex Following Exercises for Chronic Low Back Pain|Driving Plasticity in the Motor Brain in Chronic Back Pain|Completed||Phase 1|20|Actual|The University of Queensland||2|||f||||f||||||||||2017-02-18 13:15:49.594707|2017-02-18 13:15:49.594707
NCT00864409|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17||||||March 2009|2009-03-01||||||||Interventional|||Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Hip Arthroplasty||Unknown status|Recruiting|Phase 4|12|Anticipated|Hvidovre University Hospital||2|||f||||||||||||||2017-02-18 13:15:49.69669|2017-02-18 13:15:49.69669
NCT00864396|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||July 2005||2005-07-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux|Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux: A Double-Blind, Placebo Controlled, Randomized Clinical Trial|Completed||Phase 1|59|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 13:15:49.787446|2017-02-18 13:15:49.787446
NCT00864201|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||April 2009||2009-04-01|March 2009|2009-03-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease|A Pilot Study to Evaluate the Effect of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease|Unknown status|Not yet recruiting|Phase 3|10|Anticipated|McMaster University||1|||f||||f||||||||||2017-02-18 13:15:58.573059|2017-02-18 13:15:58.573059
NCT00864383|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-05-07|2015-03-10||January 2008||2008-01-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional|REMoxTB|Per protocol population|Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis|A Randomised Placebo - Controlled Double Blind Trial Comparing 1) a Two Month Intensive Phase of Ethambutol, Moxifloxacin, Rifampicin, Pyrazinamide Versus the Standard Regimen (Ethambutol, Isoniazid, Rifampicin, Pyrazinamide) and 2) a Treatment Shortening Regimen Comparing Two Months Moxifloxacin, Isoniazid, Rifampicin, Pyrazinamide Followed by Two Months Moxifloxacin, Isoniazid, Rifampicin Versus the Standard Regimen (Two Months Ethambutol, Isoniazid, Rifampicin, Pyrazinamide Followed by Four Months Isoniazid and Rifampicin) for the Treatment of Adults With Pulmonary Tuberculosis|Completed||Phase 3|1931|Actual|Global Alliance for TB Drug Development||3|||f||||t||||||||||2017-02-18 13:15:50.044895|2017-02-18 13:15:50.044895
NCT00864370|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2013-11-12|||May 2005||2005-05-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|January 2011|Actual|2011-01-01||Observational|||Bipolar Disorder (BPD) in Pregnancy: Predictors of Morbidity|Bipolar Disorder in Pregnancy: Predictors of Morbidity|Completed||N/A|237|Actual|Emory University|||1||f||||t||||||Samples With DNA|"~     Plasma, serum and urine samples are processed and stored at each research visit.~   "|||2017-02-18 13:15:52.786182|2017-02-18 13:15:52.786182
NCT00864357|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||October 2006||2006-10-01|August 2010|2010-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions|A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:52.888489|2017-02-18 13:15:52.888489
NCT00864344|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||August 2004||2004-08-01|August 2010|2010-08-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalence Study of Sertraline 100 mg Tablets Under Fasting Conditions|Completed||Phase 1|30|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:53.005376|2017-02-18 13:15:53.005376
NCT00864331|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-08-06|||February 2008||2008-02-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy|Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy|Completed||Phase 3|251|Actual|International Atomic Energy Agency||4|||f||||t||||||||||2017-02-18 13:15:53.11206|2017-02-18 13:15:53.11206
NCT00864318|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-03-26|||March 2009||2009-03-01|March 2015|2015-03-01|September 2029|Anticipated|2029-09-01|September 2021|Anticipated|2021-09-01||Interventional|TICE||Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis|Dose Intensification Phase II Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis. TICE Protocol : Paclitaxel and Ifosfamide Followed by Carboplatine and Etoposide Intensification With Individual Carboplatine Dose Adjustment.|Recruiting||Phase 2|93|Anticipated|Institut Claudius Regaud||1|||f||||t||||||||||2017-02-18 13:15:53.228013|2017-02-18 13:15:53.228013
NCT00864305|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||December 1997||1997-12-01|August 2010|2010-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions|A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Non-fasting Conditions|Completed||Phase 1|18|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:53.371809|2017-02-18 13:15:53.371809
NCT00864292|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2011-05-02|||August 2007||2007-08-01|March 2009|2009-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Predictors of Neuro-cognitive Decline and Survival in HIV-infected Subjects||Completed||N/A|60|Actual|South East Asia Research Collaboration with Hawaii|||2||f||||f||||||||||2017-02-18 13:15:53.481784|2017-02-18 13:15:53.481784
NCT00864279|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||August 2006||2006-08-01|August 2010|2010-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions|Single Dose Two-Way Crossover Fasted Bioequivalence Study of Cetirizine Hydrochloride 10 mg Tablets in Healthy Volunteers|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:53.558023|2017-02-18 13:15:53.558023
NCT00864266|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-08-09|||March 2009||2009-03-01|August 2016|2016-08-01|March 2021|Anticipated|2021-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer|Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer : a Prospective Study|Recruiting||N/A|70|Anticipated|European Lung Cancer Working Party||1|||f||||t||||||||Undecided||2017-02-18 13:15:53.671407|2017-02-18 13:15:53.671407
NCT00864253|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-12-14|2014-04-16||April 2009||2009-04-01|December 2016|2016-12-01|February 2014|Actual|2014-02-01|June 2012|Actual|2012-06-01||Interventional||Intent-to-Treat (ITT) Population: The ITT population consisted of all randomized participants regardless of whether the participant received any study drug or had any efficacy assessments collected.|A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma|An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma|Completed||Phase 3|529|Actual|Celgene Corporation|Participation in the PK sampling for participants randomized to the ABI-007 arm was optional; too few samples were available to support the analysis|2|||f||||t||||||||||2017-02-18 13:15:56.095044|2017-02-18 13:15:56.095044
NCT00864240|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||October 2005||2005-10-01|August 2010|2010-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||"The Dose-response Pilot Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects"|Dose Response of Clobex 0.05% Lotion|Completed||Phase 1|15|Actual|Actavis Inc.||1|||f||||f||||||||||2017-02-18 13:15:57.583205|2017-02-18 13:15:57.583205
NCT00864227|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2016-08-01|2015-05-20||December 2008||2008-12-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|April 2011|Actual|2011-04-01||Interventional|||Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)|A Multi-Center, Phase II Trial of Non-Myeloablative Conditioning (NST) and Transplantation of Umbilical Cord Blood (UCB) From Unrelated Donors in Patients With Hematologic Malignancies (BMT CTN #0604)|Completed||Phase 2|54|Actual|Medical College of Wisconsin||1|||f||||t||||||||Yes|Findings will be published in a manuscript.|2017-02-18 13:15:57.693284|2017-02-18 13:15:57.693284
NCT00864214|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-01-12|||June 2008||2008-06-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|HRT||A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone|A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone|Completed||Phase 1|40|Actual|Mayo Clinic||4|||f||||t||||||||||2017-02-18 13:15:58.465015|2017-02-18 13:15:58.465015
NCT00864175|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-01-20||2010-06-18|July 2007||2007-07-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer|A Phase 1/2, Modified Dose Escalation, Open Label Trial to Determine the Therapeutic Effect and Safety of INCB007839 Combined With Trastuzumab in Patients With Previously Untreated HER2 Positive Metastatic Breast Cancer|Terminated||Phase 1/Phase 2|68|Actual|Incyte Corporation||4||Incyte suspended development of the compound.|f||||f||||||||||2017-02-18 13:15:58.783716|2017-02-18 13:15:58.783716
NCT00864162|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||September 2004||2004-09-01|August 2010|2010-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalence Study of Ramipril10 mg Capsules Under Fed Conditions|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:58.894682|2017-02-18 13:15:58.894682
NCT00864149|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||October 2005||2005-10-01|August 2010|2010-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions|A Two-Way Crossover, Open-Label, Single Dose, Fed, Bioequivalence Study of Carvedilol 12.5 mg Tablets Versus Coreg® 12.5 mg Tablets in Normal, Healthy, Non-Smoking Male and Female Subjects|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:15:59.006954|2017-02-18 13:15:59.006954
NCT00864136|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-06-30|||November 2008||2008-11-01|June 2015|2015-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Mirena or Conventional Medical Treatment for Menorrhagia|MiCo - Mirena or Conventional Medical Treatment for Menorrhagia|Completed||N/A|647|Actual|Bayer|||3||f||||f||||||None Retained|"~     n.a~   "|||2017-02-18 13:15:59.11995|2017-02-18 13:15:59.11995
NCT00864123|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-09-14|2012-06-26||January 2008||2008-01-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder|D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder|Completed||Phase 2|30|Actual|University of South Florida||2|||f||||f||||||||||2017-02-18 13:15:59.241632|2017-02-18 13:15:59.241632
NCT00864110|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-03-20|||April 2010||2010-04-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)|A Multi-Center Phase 1b Pharmacokinetic and Radiation Dosimetry Study Evaluating 99mTc-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1|4|Actual|Cell>Point LLC||2|||f||||t||||||||||2017-02-18 13:15:59.674758|2017-02-18 13:15:59.674758
NCT00864097|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-03-04||2012-01-26|August 2009||2009-08-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip|A Phase 3, Randomized, Double-Blind, Controlled, Multi-Center Study Of The Analgesic Efficacy And Safety Of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip|Terminated||Phase 3|607|Actual|Pfizer||4||See termination reason in detailed description.|f||||t||||||||||2017-02-18 13:15:59.794418|2017-02-18 13:15:59.794418
NCT00864084|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2014-08-26|2013-09-30||April 2009||2009-04-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Does Pulmonary Rehabilitation Improve Balance in People With Respiratory Disease?|Does a Pulmonary Rehabilitation Program Improve Balance in Individuals With Respiratory Disease?|Completed||Phase 1|14|Actual|University of Manitoba|This sample size in this study was small. Study participants received an individualised exercise program which means that exercises given and number of pulmonary rehabilitation sessions attended were not standardized between study participants.|1|||f||||f||||||||||2017-02-18 13:15:59.989806|2017-02-18 13:15:59.989806
NCT00864071|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||November 2005||2005-11-01|August 2010|2010-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions|A Two-Way Crossover, Open-Label, Single-Dose, Fed, Bioequivalence Study Of Griseofulvin 125 mg/5 mL Suspension Versus Grifulvin V® 125 mg/5 mL Suspension In Normal, Healthy, Non-Smoking Male And Female Subjects|Completed||Phase 1|50|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:16:00.607196|2017-02-18 13:16:00.607196
NCT00864058|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||January 1998||1998-01-01|August 2010|2010-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions|A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions|Completed||Phase 1|30|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:16:00.72261|2017-02-18 13:16:00.72261
NCT00864045|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-09-19|||March 2007||2007-03-01|September 2013|2013-09-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Sertindole in Asian Patients With Schizophrenia|A Randomised, Double-blind, Parallel-group, Flexible-dose Trial Evaluating the Efficacy and Safety of 12 Weeks of Treatment With Sertindole or Olanzapine in Patients With Schizophrenia in Asia|Completed||Phase 3|394|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:16:00.837775|2017-02-18 13:16:00.837775
NCT00864032|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-04-09|2013-01-15||March 2009||2009-03-01|April 2013|2013-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall|Phase I/II Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall|Completed||Phase 1/Phase 2|8|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 13:16:00.943078|2017-02-18 13:16:00.943078
NCT00864019|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||August 2004||2004-08-01|August 2010|2010-08-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalence Study of Sertraline 100 mg Tablets Under Fed Conditions|Completed||Phase 1|30|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:16:01.215061|2017-02-18 13:16:01.215061
NCT00864006|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||October 2006||2006-10-01|March 2009|2009-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions|A Single-Dose, Comparative Bioavailability Study of Two Formulations of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions|Completed||Phase 1|28|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:16:01.327255|2017-02-18 13:16:01.327255
NCT00863980|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-09-01|||April 2009||2009-04-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|KCPS||Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients|Effects of Telmisartan Compared With Candesartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients: a Multi-center, Prospective, Randomized, Open-labeled, Blinded Endpoints Trial|Terminated||N/A|1500|Actual|Kyoto Prefectural University of Medicine||2||Principle investigator resigned in 2013|f||||t||||||||||2017-02-18 13:16:01.497132|2017-02-18 13:16:01.497132
NCT00863967|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||October 2003||2003-10-01|March 2009|2009-03-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Early Detection of Arteriosclerosis|Prospective Observational Cohort Study for Early Detection of Arteriosclerosis|Unknown status|Active, not recruiting|N/A|269|Actual|Kantonsspital Baselland Bruderholz|||3||f||||f||||||Samples With DNA|"~     Whole blood / serum / white cells / plasma~   "|||2017-02-18 13:16:01.64336|2017-02-18 13:16:01.64336
NCT00863954|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-12-14|||January 2009||2009-01-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes|A Controlled Pilot Study of the Application of Magnetic Fields Using the Resonator in Adjunctive Management of Type 2 Diabetes|Completed||Phase 1|60|Anticipated|pico-tesla Magnetic Therapies, LLC||6|||f||||t||||||||||2017-02-18 13:16:01.743813|2017-02-18 13:16:01.743813
NCT00863941|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-19|||June 2004||2004-06-01|August 2010|2010-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions|A Randomized, Single Dose Two -Way Crossover Relative Bioavailability Study of Bupropion XL Tablets Formulation in Fasted, Normal, Healthy Subjects.|Completed||Phase 1|28|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:16:01.843868|2017-02-18 13:16:01.843868
NCT00863928|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-05-25||||||May 2010|2010-05-01||||||||Interventional|||Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain and Morphine Consumption on Patients After Robotic Assisted Laparoscopic Radical Prostatectomy|Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain and Morphine Consumption on Patients After Robotic Assisted Laparoscopic Radical Prostatectomy|Completed||N/A|||Benaroya Research Institute|||||f||||||||||||||2017-02-18 13:16:01.962135|2017-02-18 13:16:01.962135
NCT00863915|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||October 2004||2004-10-01|August 2010|2010-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalence Study of Ramipril10 mg Capsules Administered Orally as a Sprinkle on Applesauce|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:16:02.057043|2017-02-18 13:16:02.057043
NCT00863902|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||August 2006||2006-08-01|August 2010|2010-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Non-fasting Conditions|Single Dose Two-Way Crossover Fed Bioequivalence Study of Cetirizine Hydrochloride 10 mg Tablets in Healthy Volunteers|Completed||Phase 1|26|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:16:02.17576|2017-02-18 13:16:02.17576
NCT00863889|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-09-19|||March 2009||2009-03-01|September 2013|2013-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome|Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome: A Randomized Controlled Trial|Withdrawn||Phase 4|0|Actual|Emory University||2|||f||||f||||||||||2017-02-18 13:16:02.290558|2017-02-18 13:16:02.290558
NCT00863876|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-06-28|||March 2009||2009-03-01|June 2010|2010-06-01||||||||Observational|||Comparison of WaveLight Analyzer and Alcon LadarWave||Completed||N/A|144|Anticipated|WaveLight AG|||9||f||||t||||||||||2017-02-18 13:16:02.410825|2017-02-18 13:16:02.410825
NCT00863863|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-08-13|||January 2006||2006-01-01|August 2010|2010-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions|A Two-Way Crossover, Open-Label, Single-Dose, Fed, Bioequivalence Study Of Griseofulvin 125 mg/5 mL Suspension Versus Grifulvin V® 125 mg/5 mL Suspension In Normal, Healthy, Non-Smoking Male And Female Subjects|Completed||Phase 1|40|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:16:02.498616|2017-02-18 13:16:02.498616
NCT00863850|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-04-20|||May 2009||2009-05-01|April 2012|2012-04-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy|Open-Label Study to Investigate the Pharmacokinetics of Bendamustine Hydrochloride Following Intravenous Infusion of [14C] Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy|Completed||Phase 1|6|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 13:16:02.618483|2017-02-18 13:16:02.618483
NCT00863837|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2009-03-17|||December 2006||2006-12-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|||Prevention of Esophageal Variceal Rebleeding||Unknown status|Enrolling by invitation|Phase 4|120|Anticipated|National Science Council, Taiwan||2|||f||||f||||||||||2017-02-18 13:16:02.717449|2017-02-18 13:16:02.717449
NCT00863824|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||July 2009||2009-07-01|March 2009|2009-03-01|June 2010|Anticipated|2010-06-01|May 2010|Anticipated|2010-05-01||Observational|NNAL||NNAL Clearance in Hair and Urine|Elimination of NNAL and Cotinine From Hair and Urine|Unknown status|Not yet recruiting|N/A|40|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-02-18 13:16:02.82674|2017-02-18 13:16:02.82674
NCT00863811|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-06-05|||April 2009||2009-04-01|June 2012|2012-06-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Observational|||Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops|Effects of the Oral Administration of an Association of Forskolin With Rutin and Vitamins B on Intraocular Pressure in Patients Affected by Primary Open Angle Glaucoma and Treated With Either Beta-blockers or Prostaglandin Eye Drops|Withdrawn||N/A|0|Actual|Sooft Italia|||2|loss of interest before enrolment started|f||||t||||||||||2017-02-18 13:16:02.911622|2017-02-18 13:16:02.911622
NCT00863798|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2011-04-07|2011-03-08||April 2009||2009-04-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy And Safety Of 2 Fixed Doses (10 And 50 mg/Day) Of DVS SR Tablets In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|682|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 13:16:03.047191|2017-02-18 13:16:03.047191
NCT00863785|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-10-19|||April 2004||2004-04-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|HAA-NAC||Treatment of Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone|Treatment of Acute Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone: a French Multicentre Randomized Controlled Study.|Completed||Phase 3|174|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||t||||||||||2017-02-18 13:16:05.136893|2017-02-18 13:16:05.136893
NCT00863772|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2012-08-20||2012-01-27|May 2009||2009-05-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Tanezumab and Nerve Function In Arthritis Patients|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Of Tanezumab On Peripheral Nerve Function In Patients With Osteoarthritis|Terminated||Phase 3|220|Actual|Pfizer||3||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:16:05.262241|2017-02-18 13:16:05.262241
NCT00863759|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2010-07-01|||March 2009||2009-03-01|March 2009|2009-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos Advanced Optics Intraocular Lens Implantation|Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos AO Intraocular Lens Implantation: Clinical Comparative Study|Completed||N/A|25|Anticipated|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 13:16:05.375475|2017-02-18 13:16:05.375475
NCT00863746|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2015-01-07|2013-04-10||April 2009||2009-04-01|January 2015|2015-01-01|April 2013|Actual|2013-04-01|March 2012|Actual|2012-03-01||Interventional|MISSION||A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).|A Phase III, Multi-center, Placebo-Controlled Trial of Sorafenib (BAY43-9006) in Patients With Relapsed or Refractory Advanced Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC) After 2 or 3 Previous Treatment Regimens for Advanced Disease|Completed||Phase 3|703|Actual|Bayer||2|||f||||t||||||||||2017-02-18 13:16:05.506117|2017-02-18 13:16:05.506117
NCT00863733|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||May 1996||1996-05-01|March 2009|2009-03-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|DMXAA||Study of DMXAA (Now Known as ASA404) in Solid Tumors|Phase I Trial of 5,6 Dimethylxanthenone - 4 - Acetic Acid (DMXAA) in Solid Tumors|Completed||Phase 1|63|Actual|Cancer Research UK||1|||f||||f||||||||||2017-02-18 13:16:07.061714|2017-02-18 13:16:07.061714
NCT00863707|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-05-11|2010-12-28||April 2009||2009-04-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment|A Phase 4, Multicenter, Double-Blind, Randomized, Placebo-controlled Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment|Completed||Phase 4|511|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||f||||||||||2017-02-18 13:16:07.164685|2017-02-18 13:16:07.164685
NCT00863694|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2013-12-12|||February 2009||2009-02-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Fecal Calprotectin in Cystic Fibrosis|Fecal Calprotectin in Cystic Fibrosis|Completed||N/A|106|Actual|Medical College of Wisconsin|||1||f||||f||||||Samples Without DNA|"~     stool~   "|||2017-02-18 13:16:07.645564|2017-02-18 13:16:07.645564
NCT00863681|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2017-01-06|||March 2009||2009-03-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|March 2019|Anticipated|2019-03-01||Interventional|PATENT-2||BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension|Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)|Active, not recruiting||Phase 3|396|Actual|Bayer||1|||f||||t||||||||||2017-02-18 13:16:07.737607|2017-02-18 13:16:07.737607
NCT00863668|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-05-14|||March 2009||2009-03-01|May 2015|2015-05-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Raltegravir Activity In Lymphoid Tissues|Decay Kinetics of HIV With the Integrase Inhibitor Raltegravir|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 13:16:08.289874|2017-02-18 13:16:08.289874
NCT00863655|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-11-25|2012-07-31||June 2009||2009-06-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|BOLERO-2||Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole|A Randomized Double-Blind, Placebo-Controlled Study of Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole|Completed||Phase 3|724|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:16:08.437947|2017-02-18 13:16:08.437947
NCT00863642|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2011-09-25|||November 2007||2007-11-01|September 2011|2011-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Early Versus Delayed Surgery for Gallstone Pancreatitis|Early Versus Delayed Surgery for Gallstone Pancreatitis: A Prospective Randomized|Completed||N/A|100|Anticipated|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-02-18 13:16:09.407699|2017-02-18 13:16:09.407699
NCT00863629|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2009-03-17|||January 2001||2001-01-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction|Tight Glycemic Control Increases Cardiac Stem Cells and Reduces Heart Remodeling During Acute Myocardial Infarction in Hyperglycemic Patients|Completed||Phase 4|65|Actual|Second University of Naples||3|||f||||t||||||||||2017-02-18 13:16:09.518979|2017-02-18 13:16:09.518979
NCT00863616|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-03-17|||August 2006||2006-08-01|March 2009|2009-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||High Frequency Chest Wall Oscillation in Chronic Obstructive Pulmonary Disease (COPD)|Self-Administered High Frequency Chest Wall Oscillation Technique for Mucus Clearance in COPD: An Exploratory Pilot Project Using the SMARTVEST Device|Completed||N/A|32|Actual|East and North Hertfordshire NHS Trust||2|||f||||t||||||||||2017-02-18 13:16:09.629934|2017-02-18 13:16:09.629934
NCT00863603|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-05-23|||January 2005||2005-01-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||"The Effect of Oxygen on Healing an Artery From the Injury of Surgery"|Artery Wall Hypoxia and Intimal Hyperplasia|Terminated||N/A|46|Actual|University of Minnesota - Clinical and Translational Science Institute||2||"Clinical changes: graft to fistula first; enrollment of 46/132 planned. NIH approved animal~   model: supplemental oxygen/AV fistula."|f||||f||||||||||2017-02-18 13:16:09.73788|2017-02-18 13:16:09.73788
NCT00863590|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-08-18|||June 2004||2004-06-01|August 2015|2015-08-01|August 2008|Actual|2008-08-01|February 2005|Actual|2005-02-01||Interventional|||A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers|A Double-Blind, Randomized, Placebo-Controlled, Multi-Panel, Single Oral Rising-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of MK0822 in Healthy Volunteers|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 13:16:09.927783|2017-02-18 13:16:09.927783
NCT00863577|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-03-17|||March 2009||2009-03-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Pharmacokinetic Study of Two Oral Bemiparin Formulations||Completed||Phase 1|102|Actual|Rovi Pharmaceuticals Laboratories|||||f||||f||||||||||2017-02-18 13:16:10.019809|2017-02-18 13:16:10.019809
NCT00863564|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2009-11-09|||March 2009||2009-03-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects|Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects|Completed||N/A|12|Anticipated|Aarhus University Hospital||4|||f||||f||||||||||2017-02-18 13:16:10.125706|2017-02-18 13:16:10.125706
NCT00863551|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-01-28|2011-11-16||April 2009||2009-04-01|January 2016|2016-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial||Completed||Phase 4|12|Actual|Allergan|Due to technical problems associated with the administration of the BVMT-R test, the results were invalid, therefore, results for Outcome Measures 4 and 5 are not presented.|1|||f||||||||||||||2017-02-18 13:16:10.233189|2017-02-18 13:16:10.233189
NCT00863538|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2010-02-01||||||February 2010|2010-02-01||||||||Interventional|||Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)|An Open-label, Phase II Study of KPS-0373 in Patients With SCD|Completed||Phase 2|40|Anticipated|Kissei Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 13:16:10.489592|2017-02-18 13:16:10.489592
NCT00863525|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-08-18|||November 2004||2004-11-01|August 2015|2015-08-01|June 2006|Actual|2006-06-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822)|A Double-Blind, Randomized, 2-Period Crossover, Placebo Controlled Study to Asses the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Single Oral Dose of MK0822|Completed||Phase 1|8|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:16:10.582513|2017-02-18 13:16:10.582513
NCT00863512|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2016-08-11|||March 2009||2009-03-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|November 2011|Actual|2011-11-01||Interventional|||Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer|A Randomized Phase III Trial of Adjuvant Chemotherapy in Patients With Early Stage Non-Small Cell Lung Cancer Associated With Banking of Frozen Tumor Specimens and Collection of Gene Expression Profile Data|Completed||Phase 3|34|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 13:16:10.672686|2017-02-18 13:16:10.672686
NCT00863499|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2016-07-20|||October 2009||2009-10-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|June 2017|Anticipated|2017-06-01||Interventional|||International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder|International Study to Predict Optimised Treatment Response to Short or Long Acting Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder.|Recruiting||Phase 4|1344|Anticipated|BRC Operations Pty. Ltd.||3|||f||||f||||||||||2017-02-18 13:16:11.036189|2017-02-18 13:16:11.036189
NCT00863486|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-02-22|||July 2007||2007-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:16:11.20055|2017-02-18 13:16:11.20055
NCT00863473|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-04-22|||May 2003||2003-05-01|April 2015|2015-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Comminuted Proximal Humeral Fractures. A Randomised Study of Surgical Versus Conservative Treatment|Health and Cost Consequenses of Surgical Versus Conservative Treatment for a Comminuted Humerus Fracture. Do Interlocking Plate Surgery Benefit Displaced Proximal Humerus Fractures? A Randomized Clinical Trial|Completed||Phase 2|50|Actual|Oslo University Hospital||2|||f||||||||||||||2017-02-18 13:16:11.252581|2017-02-18 13:16:11.252581
NCT00863460|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2017-01-23|||October 2008||2008-10-01|January 2017|2017-01-01|February 2025|Anticipated|2025-02-01|August 2017|Anticipated|2017-08-01||Interventional|PRECIS||Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients|Prospective , Multicentric, Randomized Phase II Study, Evaluating the Role of Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue After Conventional Chemotherapy for Primary Central Nervous System in Young Patients (< 60 y)|Active, not recruiting||Phase 2|140|Anticipated|Institut Curie||2|||f||||t||||||||||2017-02-18 13:16:11.361638|2017-02-18 13:16:11.361638
NCT00863447|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2009-03-16|||March 2009||2009-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:16:11.512476|2017-02-18 13:16:11.512476
NCT00863434|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2013-05-07|||February 2009||2009-02-01|May 2013|2013-05-01||||February 2011|Actual|2011-02-01||Interventional|||Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease|A Phase II Trial of Clofarabine and Cytarabine to Treat Minimal Residual Disease (MRD) in Acute Myeloid Leukemia|Terminated||Phase 2|2|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 13:16:11.564001|2017-02-18 13:16:11.564001
NCT00863421|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2011-06-15|||September 2008||2008-09-01|June 2011|2011-06-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Observational|VISIFA||Sleep Disordered Breathing in Patients With Chronic Heart Failure|Prevalence, Incidence and Clinical Characteristics of Sleep Disordered Breathing in Patients With Stable Chronic Heart Failure|Unknown status|Recruiting|N/A|200|Anticipated|LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology|||1||f||||t||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 13:16:11.683048|2017-02-18 13:16:11.683048
NCT00863408|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2017-01-24|||March 3, 2009||2009-03-03|March 10, 2010|2010-03-10|March 10, 2010||2010-03-10|||||Observational|||Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali|Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali (Village of Thierola in the District of Banamba)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:16:11.779722|2017-02-18 13:16:11.779722
NCT00863382|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-05-04|||January 2009||2009-01-01|May 2012|2012-05-01|January 2012|Anticipated|2012-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Comparison of External Event Recorders for Atrial Fibrillation Monitoring|Comparison of External Event Recorders With Implantable Monitor for Post Atrial Fibrillation Monitoring: Assessment of Cost and Efficacy|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 13:16:11.978447|2017-02-18 13:16:11.978447
NCT00863369|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2016-10-05|||June 2005||2005-06-01|October 2016|2016-10-01||||August 2017|Anticipated|2017-08-01||Interventional|||Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma|A Phase I/II Study of VELCADE in Combination With Gemcitabine in Relapsed B-Cell Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1/Phase 2|56|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:16:12.088393|2017-02-18 13:16:12.088393
NCT00863356|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-10-29|2012-10-29||March 2009||2009-03-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis|Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis|Completed||N/A|20|Actual|HemCon Medical Technologies, Inc||1|||f||||f||||||||||2017-02-18 13:16:12.216339|2017-02-18 13:16:12.216339
NCT00863343|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-01-30|2011-08-05||March 2010||2010-03-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Observational|||Clinical Validation of the Point-of-Care MSD Influenza Test|Clinical Validation of the Point-of-Care MSD Influenza Test|Terminated||N/A|391|Actual|Meso Scale Diagnostics, LLC.|||1|Funding of study was exhausted prior to completion of study|f||||f||||||Samples With DNA|"~     Viral transport media containing nasal swab extract.~   "|||2017-02-18 13:16:12.458451|2017-02-18 13:16:12.458451
NCT00863330|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-17|2014-12-16|2014-12-03||February 2009||2009-02-01|December 2014|2014-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma|A Phase II Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen in Metastatic Melanoma|Terminated||Phase 2|14|Actual|Aurora Health Care|Study was ended early, before substantial data could be collected, due to Investigators retiring/leaving the institution.|1||administrative decision- PI retired and treating physician left the institution|f||||t||||||||||2017-02-18 13:16:12.834778|2017-02-18 13:16:12.834778
NCT00863317|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-06-19|2015-06-02||December 2008||2008-12-01|June 2015|2015-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Trial of Montelukast for Treatment of Acute Bronchiolitis|A Randomized, Double Blind, Placebo Controlled Trial of Daily Montelukast for the Treatment of Viral Bronchiolitis|Completed||N/A|141|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-02-18 13:16:13.056413|2017-02-18 13:16:13.056413
NCT00863304|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2011-05-02||2011-05-02|May 2009||2009-05-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Tanezumab in Osteoarthritis of the Hip or Knee (2)|A Phase 3 Randomized, Double Blind Placebo And Naproxen Controlled Multicenter Study of the Analgesic Efficacy And Study of Tanezumab in Patients With Osteoarthritis Of The Hip or Knee|Completed||Phase 3|849|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 13:16:13.408372|2017-02-18 13:16:13.408372
NCT00863291|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2009-03-16|||November 2007||2007-11-01|March 2009|2009-03-01|November 2008|Anticipated|2008-11-01|||||Interventional|||A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality|Phase 3 Study of the Effects of Buprenophine as Add-on Treatment to Antidepressants in Treating Acutely Suicidal Depressed Inpatients|Unknown status|Active, not recruiting|Phase 3|40|Anticipated|Abarbanel Mental Health Center||2|||f||||t||||||||||2017-02-18 13:16:13.685242|2017-02-18 13:16:13.685242
NCT00863278|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-03-23|||March 2009||2009-03-01|June 2009|2009-06-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser|Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser; a Comparative Prospective Study|Terminated||Phase 4|20|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:16:13.792396|2017-02-18 13:16:13.792396
NCT00863265|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-05-02|||June 2009||2009-06-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|Phyteaux-III||Phytosterols, Ezetimibe, and Cholesterol Metabolism|Regulation of Cholesterol Absorption: LDL Cholesterol Response to a Combination of Phytosterols and Ezetimibe (Phyto-3)|Completed||N/A|22|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 13:16:13.886419|2017-02-18 13:16:13.886419
NCT00863252|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2009-03-16|||March 2002||2002-03-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|June 2004|Actual|2004-06-01||Interventional|||Mycophenolate Mofetil for IgA Nephropathy|A Prospective, Randomized, Open Label, Case-Controlled Study on the Efficacy of Mycophenolate Mofetil for IgA Nephropathy Patients With Heavy Proteinuria Despite Angiotensin Blockade|Completed||Phase 4|40|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-02-18 13:16:13.989983|2017-02-18 13:16:13.989983
NCT00863239|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-02-01|||March 2009||2009-03-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|SELECT-2||Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV|Phase 2B, Partially Blinded, Randomized Study in Treatment Naive HCV G1 to Compare the Efficacy, Safety, and Tolerability of Three Doses of Locteron Plus Ribavirin Given Bi-weekly in Comparison With PEG-Intron Plus Ribavirin Given Weekly|Completed||Phase 2|116|Actual|Biolex Therapeutics, Inc.||4|||f||||t||||||||||2017-02-18 13:16:14.101043|2017-02-18 13:16:14.101043
NCT00863226|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2011-12-13|||March 2009||2009-03-01|December 2011|2011-12-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease|A Randomized, Double-Blind, Sham-Stimulation Controlled Study of the Application of Magnetic Fields Using the Resonator Device for the Treatment of Parkinson's Disease: Phase Three Clinical Trial Protocol|Unknown status|Active, not recruiting|Phase 3|72|Anticipated|pico-tesla Magnetic Therapies, LLC||1|||f||||||||||||||2017-02-18 13:16:14.250998|2017-02-18 13:16:14.250998
NCT00863213|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2013-04-25|||March 2009||2009-03-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|March 2011|Actual|2011-03-01||Interventional|SARA||Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation|Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation|Completed||Phase 4|152|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 13:16:14.349895|2017-02-18 13:16:14.349895
NCT00863200|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-11-15|||March 2009||2009-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Observational|||Identification and Treatment of Depression|Identification and Treatment of Depression in Underserved African American and Latino Patients With Cancer|Active, not recruiting||N/A|166|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 13:16:14.460767|2017-02-18 13:16:14.460767
NCT00863187|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2009-03-16|||February 2009||2009-02-01|February 2009|2009-02-01||||February 2010|Anticipated|2010-02-01||Interventional|||Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab||Unknown status|Not yet recruiting|N/A|100|Anticipated|Rambam Health Care Campus||1|||f||||f||||||||||2017-02-18 13:16:14.569633|2017-02-18 13:16:14.569633
NCT00863174|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-03-08|||November 2010||2010-11-01|March 2016|2016-03-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma|A Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single Dose, Crossover, Bioequivalence Study of SPARC_147709- Test and Reference, 2mg/ml (30 mg/m2 Dose) in Patients With Multiple Myeloma|Completed||Phase 1|24|Actual|Sun Pharma Advanced Research Company Limited||2|||f||||f||||||||||2017-02-18 13:16:14.656555|2017-02-18 13:16:14.656555
NCT00863161|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2011-01-21|||March 2009||2009-03-01|January 2011|2011-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Renal Impairment Study|A Phase I, Open Label, Non-randomized, Parallel Group, Pharmacokinetic Study in Subjects With Normal Renal Function, Moderate or Severe Renal Impairment Receiving a Single Dose of Oral 130 mg AZD3355|Completed||Phase 1|23|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:16:14.753757|2017-02-18 13:16:14.753757
NCT00863148|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2013-09-19|||October 2009||2009-10-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Cloric||Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)|A Phase II Open-label, Multicenter, Non Randomized Study Evaluating the Efficacy and the Safety of Clofarabine in Combination With IV Busulfan and Thymoglobulin (CBT) as a Reduced Intensity Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Adult Patients With High-risk AML, MDS or ALL.|Completed||Phase 2|30|Actual|Nantes University Hospital||1|||f||||t||||||||||2017-02-18 13:16:14.864986|2017-02-18 13:16:14.864986
NCT00863135|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2017-02-07|||December 2008||2008-12-01|February 2017|2017-02-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effect of CPAP on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension|Effect of Continuous Positive Airway Pressure (CPAP) Treatment on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension|Completed||N/A|68|Actual|Corporacion Parc Tauli||2|||f||||f||||||||No||2017-02-18 13:16:17.228562|2017-02-18 13:16:17.228562
NCT00863122|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2013-08-05|||June 2009||2009-06-01|August 2013|2013-08-01||||December 2013|Anticipated|2013-12-01||Interventional|||Concentration and Activity of Lapatinib in Vestibular Schwannomas|Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas|Unknown status|Recruiting|Early Phase 1|26|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||||2017-02-18 13:16:17.366574|2017-02-18 13:16:17.366574
NCT00863109|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2015-04-15|2014-05-14||April 2009||2009-04-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|VIDA|Of 133 enrolled participants, Baseline Characteristics were reported for 130 evaluable participants. 3 enrolled participants who failed screening did not have Baseline Characteristics reported.|Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)|Evaluation of the Health-Related Quality of Life During Combined Treatment of Chronic Hepatitis Due to Hepatitis C Virus Under Habitual Clinical Practise Conditions.|Completed||N/A|133|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:16:17.494746|2017-02-18 13:16:17.494746
NCT00863096|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2011-03-02|||June 2009||2009-06-01|March 2009|2009-03-01|December 2010|Anticipated|2010-12-01|June 2010|Actual|2010-06-01||Observational|||Human Papillomavirus Screening and Vaccine Readiness Program|Human Papillomavirus Screening and Vaccine Readiness Program|Withdrawn||N/A|450|Anticipated|Public Health Research Institute, India|||1|Unable to get the vaccine on time to offer it to the study population.|f||||f||||||||||2017-02-18 13:16:18.125235|2017-02-18 13:16:18.125235
NCT00863083|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2010-06-17|||February 2009||2009-02-01|June 2010|2010-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Reducing Barriers to Behavior Change Among Youth With Pediatric Overweight and Obesity|Reducing Barriers to Behavior Change Among Youth With Pediatric Overweight and Obesity|Terminated||N/A|12|Actual|Medical College of Wisconsin||2||Study was terminated due to poor enrollment.|f||||f||||||||||2017-02-18 13:16:18.235899|2017-02-18 13:16:18.235899
NCT00863070|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2011-06-14|||April 2009||2009-04-01|June 2011|2011-06-01|June 2012|Anticipated|2012-06-01|April 2012|Anticipated|2012-04-01||Observational|Gait||Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy|Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy|Unknown status|Recruiting|N/A|8|Anticipated|Connecticut Children's Medical Center|||1||f||||f||||||||||2017-02-18 13:16:18.346089|2017-02-18 13:16:18.346089
NCT00863057|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2014-09-03|2011-12-14||May 2009||2009-05-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Combination Pain Therapy in HIV Neuropathy|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Duloxetine and Methadone for the Treatment of HIV-Associated Painful Peripheral Neuropathy|Completed||Phase 2|15|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The results should be interpreted with caution since the total sample size was much lower than planned.|4|||f||||t||||||||||2017-02-18 13:16:18.451727|2017-02-18 13:16:18.451727
NCT00863044|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-03-15|||November 2009||2009-11-01|March 2016|2016-03-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|VHF||High Frequency Ventilation During Off Pump Coronary Artery Bypass Graft (CABG)|Impact of High Frequency Ventilation During Coronary Anastomosis in Off Pump Coronary Artery Bypass.|Completed||Phase 4|80|Actual|Montreal Heart Institute||2|||f||||f||||||||||2017-02-18 13:16:19.923241|2017-02-18 13:16:19.923241
NCT00863031|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2009-03-16|||November 2002||2002-11-01|March 2009|2009-03-01|June 2006|Actual|2006-06-01|December 2005|Actual|2005-12-01||Interventional|||A Trial on the Effectiveness of Screening and Brief Problem-Solving Therapy (PST) for Elderly Patients With Psychological Problems|A Randomised Controlled Trail on the Effectiveness of Screening and Brief Counselling (Problem-Solving Therapy) for Elderly Patients With Psychological Problems in Primary Care.|Completed||N/A|299|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-02-18 13:16:20.04251|2017-02-18 13:16:20.04251
NCT00863018|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-07-27|||August 2003||2003-08-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Observational|||Corneal Endothelium After Glaucoma Surgery|Change in Corneal Endothelium After Glaucoma Surgery; Trabeculectomy and Glaucoma Implant Surgery|Completed||N/A|61|Actual|Chungnam National University|||3||f||||t||||||||||2017-02-18 13:16:20.142489|2017-02-18 13:16:20.142489
NCT00863005|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-11-05||||||November 2009|2009-11-01||||||||Interventional|||Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study||Completed||Phase 1/Phase 2|||Moberg Pharma AB||2|||f||||f||||||||||2017-02-18 13:16:20.246217|2017-02-18 13:16:20.246217
NCT00862992|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2009-09-08|||April 2008||2008-04-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia|Phase II Study of MP-214 in Patients With Schizophrenia (Exploratory Study)|Completed||Phase 2|30|Anticipated|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-02-18 13:16:20.33156|2017-02-18 13:16:20.33156
NCT00862979|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-08-02|||February 2009||2009-02-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|MANDELA||A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients|A 15-month, Multi-center, Randomized, Open-label, Parallel Group Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Regimen (Everolimus and Mycophenolic Acid) Versus a Standard Regimen (Cyclosporine A and Everolimus) in de Novo Heart Transplant Recipients|Active, not recruiting||Phase 4|178|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:16:20.61729|2017-02-18 13:16:20.61729
NCT00862966|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2009-03-13|||April 2009||2009-04-01|March 2009|2009-03-01||||April 2010|Anticipated|2010-04-01||Interventional|CVCLS||Central Venous Catheter Lock Solution|Randomized Control Trial on Citrate as the Central Venous Catheter Lock Solution|Unknown status|Not yet recruiting|N/A|40|Anticipated|University Medical Center, Tuzla||2|||f||||f||||||||||2017-02-18 13:16:20.732317|2017-02-18 13:16:20.732317
NCT00862953|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-02-19|||July 2008||2008-07-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|May 2010|Actual|2010-05-01||Interventional|LOWER||Study to Assess the Effects of High Protein Diet in Obesity, the LOWER Study|The Lifestyle, OverWeight, Energy Restriction Study|Completed||N/A|317|Actual|University Medical Center Groningen||4|||f||||f||||||||||2017-02-18 13:16:20.824256|2017-02-18 13:16:20.824256
NCT00862940|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-08-29|2010-11-23||September 2005||2005-09-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease|A 1-year Randomised, Double-blind Placebo-controlled Study to Evaluate the Effects of Memantine on Rate of Brain Atrophy in Patients With Alzheimer's Disease|Completed||Phase 4|277|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:16:20.92771|2017-02-18 13:16:20.92771
NCT00862927|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-06-19|||March 2009||2009-03-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Cue Reactivity in Virtual Reality: The Role of Context|Cue Reactivity in Virtual Reality: The Role of Context|Terminated||N/A|21|Actual|M.D. Anderson Cancer Center|||1|Slow accrual.|f||||f||||||||||2017-02-18 13:16:21.604805|2017-02-18 13:16:21.604805
NCT00862914|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-10-15|||July 2008||2008-07-01|October 2012|2012-10-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Observational|||Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi||Completed||N/A|30|Actual|Ruhr University of Bochum|||3||f||||f||||||Samples With DNA|"~     Paraffin embedded melanocytic skin lesion~   "|||2017-02-18 13:16:21.711514|2017-02-18 13:16:21.711514
NCT00862901|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2011-09-23|||January 2009||2009-01-01|September 2011|2011-09-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|CLIPT||Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma|A Phase I Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) for Patients Failing Radiation Therapy|Completed||Phase 1|48|Anticipated|Tufts Medical Center||4|||f||||t||||||||||2017-02-18 13:16:21.814525|2017-02-18 13:16:21.814525
NCT00862888|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2009-04-07|||July 2007||2007-07-01|April 2009|2009-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction|A 2-Cohort, Multi-Centre, Randomised, Double Blind, Placebo Controlled 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses Of PF-00446687 On Erectile Function In Men Suffering From Erectile Dysfunction, Using 100 Mg Sildenafil As A Positive Control.|Completed||Phase 2|39|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:16:21.933604|2017-02-18 13:16:21.933604
NCT00862875|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2014-05-06|||March 2009||2009-03-01|May 2014|2014-05-01||||April 2014|Actual|2014-04-01||Interventional|||Levemir-Body Composition and Energy Metabolism|Effects of Basal Insulin Analogue Detemir on Body Composition, Epicardial Fat and Energy Metabolism|Completed||Phase 4|42|Actual|Institut de Recherches Cliniques de Montreal||2|||f||||f||||||||||2017-02-18 13:16:22.048865|2017-02-18 13:16:22.048865
NCT00862862|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2015-05-27|||April 2009||2009-04-01|May 2015|2015-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus|Evaluation of Pharmacodynamic Target Attainment With Vancomycin Treatment of Infections Due to Staphylococcus Aureus|Terminated||N/A|250|Actual|University of Nebraska|||1|lack of enrollment|f||||f||||||||||2017-02-18 13:16:22.159596|2017-02-18 13:16:22.159596
NCT00862849|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2014-07-11|2014-06-10||March 2009||2009-03-01|July 2014|2014-07-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional||Participants who received at least one dose of insulin lispro, regular human insulin, or recombinant human hyaluronidase (rHuPH20).|Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone|Phase 1, Randomized, Double-Blind, Pharmacokinetic and Glucodynamic 6-Way Crossover Study of SC Administered Insulin Lispro With Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin With Recombinant Human Hyaluronidase (rHuPH20) Compared to Insulin Lispro Alone in Healthy Volunteers|Completed||Phase 1|22|Actual|Halozyme Therapeutics||1|||f||||f||||||||||2017-02-18 13:16:22.267968|2017-02-18 13:16:22.267968
NCT00862446|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2016-10-31|||March 2009||2009-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease|Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease|Recruiting||Phase 4|20|Anticipated|Vanderbilt University||1|||f||||t||||||||||2017-02-18 13:16:35.100664|2017-02-18 13:16:35.100664
NCT00862836|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-08-29|2011-11-02||April 2009||2009-04-01|August 2016|2016-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|ZACFAST||Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD)|Addition of Vandetanib to Standard Therapy (Pegliposomal Doxorubicin) in Patients With Recurrent Ovarian Cancer. A Multicentre Phase I / Randomized Phase II Study|Terminated||Phase 1/Phase 2|15|Actual|Sanofi||1||Lack of efficacy|f||||f||||||||||2017-02-18 13:16:22.935131|2017-02-18 13:16:22.935131
NCT00862823|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-08-16|2012-02-16||February 2009||2009-02-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers|The Stability and Bioequivalence of Tenofovir, Emtricitabine and Efavirenz (Atripla) in an Extemporaneously Prepared Oral Liquid Formulation Compared With the Commercially Available Tablet Formulation|Completed||Phase 4|14|Actual|University of Alabama at Birmingham|Efavirenz exposure was highly variable and relative bioequivalence for efavirenz may have been more appropriately assessed with a larger sample size.|2|||f||||||||||||||2017-02-18 13:16:23.500814|2017-02-18 13:16:23.500814
NCT00862810|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2014-11-19|2014-09-17||March 2009||2009-03-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|ADS||Alternate Dosing Schedules Study for HPV Vaccine|Alternate Dosing Schedules Study for HPV Vaccine|Completed||Phase 4|72|Actual|Duke University||2|||f||||f||||||||||2017-02-18 13:16:23.803842|2017-02-18 13:16:23.803842
NCT00862797|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2010-02-01|||January 2008||2008-01-01|March 2009|2009-03-01||||May 2009|Actual|2009-05-01||Observational|||Pressure Course in the Tube Cuff During Swallowing|Pressure Course in the Tube Cuff During Swallowing|Completed||N/A|20|Anticipated|University Hospital Freiburg|||1||f||||f||||||||||2017-02-18 13:16:24.142695|2017-02-18 13:16:24.142695
NCT00862784|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2014-05-16|2014-05-16||April 2009||2009-04-01|May 2014|2014-05-01|August 2011|Actual|2011-08-01|April 2011|Actual|2011-04-01||Interventional||All participants who received any amount of study drug.|A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer|An Open Label, Multicenter, Phase 2 Study Evaluating the Safety and Efficacy of IMC-1121B in Combination With 5-FU/FA and Oxaliplatin (Modified FOLFOX-6) as First-line Therapy in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|48|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 13:16:24.246297|2017-02-18 13:16:24.246297
NCT00862758|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2013-12-09|||February 2009||2009-02-01|December 2013|2013-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Expanded Access|||Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab|Emergency IND for Provision of Tocilizumab|No longer available||N/A|||University of Oklahoma|||||||||f||||||||||2017-02-18 13:16:24.802523|2017-02-18 13:16:24.802523
NCT00862745|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2011-10-19|2011-09-14||January 2009||2009-01-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|BRIDGES||Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES)|A Multi-center, Randomized, Placebo-controlled Clinical Trial Comparing Fesoterodine to Placebo in Women Diagnosed With Urge Urinary Incontinence by the 3 Incontinence Questions (3IQ). Followed by a Multi-center Open Label Clinical Cohort Study of Long-term Effects of Treatment With Fesoterodine.|Completed||Phase 4|645|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 13:16:24.891897|2017-02-18 13:16:24.891897
NCT00862732|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2009-03-16|||March 2009||2009-03-01|March 2009|2009-03-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Study to Prevent Negative Thoughts of Life|A Randomised Controlled Trial With Cognitive Behavioural Therapy for Persons With Active Suicidal Ideations|Unknown status|Not yet recruiting|N/A|68|Anticipated|Institute for Research & Development Sri Lanka||2|||f||||f||||||||||2017-02-18 13:16:25.302972|2017-02-18 13:16:25.302972
NCT00862719|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-08-25|2016-06-22||March 2009||2009-03-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|November 2012|Actual|2012-11-01||Interventional|||Sitagliptin Umbilical Cord Blood Transplant Study|A Phase II Trial of Inhibition of CD26 Peptidase Using Sitagliptin to Enhance Engraftment After Umbilical Cord Blood Transplantation for Adults With Hematological Malignancies|Completed||Phase 2|29|Actual|Indiana University||3|||f||||t||||||||||2017-02-18 13:16:25.412108|2017-02-18 13:16:25.412108
NCT00862706|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-09-22|||April 2009||2009-04-01|September 2016|2016-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks|An Open-label, Single-arm, Multicenter, Study of Telbivudine in Nucleos(t)Ide-naïve Subjects of Black/African American or Hispanic/Latino Origin With Compensated Chronic Hepatitis B Virus (HBV) Infection|Withdrawn||Phase 4|0|Actual|Novartis||1||Stopped with Patients|f||||||||||||||2017-02-18 13:16:27.023949|2017-02-18 13:16:27.023949
NCT00862693|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2011-02-16|||March 2009||2009-03-01|March 2009|2009-03-01|March 2011|Anticipated|2011-03-01|August 2010|Anticipated|2010-08-01||Interventional|||Calcitriol in the Treatment of Immunoglobulin A Nephropathy||Unknown status|Recruiting|Phase 4|40|Anticipated|Peking University First Hospital||2|||f||||||||||||||2017-02-18 13:16:27.313678|2017-02-18 13:16:27.313678
NCT00862680|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2017-01-23|||March 12, 2009|Actual|2009-03-12|January 2017|2017-01-01|March 1, 2019|Anticipated|2019-03-01|March 1, 2019|Anticipated|2019-03-01||Interventional|||4D PET/CT Imaging in Lung and Colorectal Cancer With Liver Metastasis|4D PET/CT Imaging in Lung and Colorectal Cancer With Liver Metastasis|Active, not recruiting||N/A|59|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:16:27.6038|2017-02-18 13:16:27.6038
NCT00862667|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-06-23|||May 2009||2009-05-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|B0871002||A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers.|An Open Study To Estimate The Plasma Pharmacokinetics Of PF-00241939 Administered Via Oral Inhalation Using Dry Powder Inhalers.|Completed||Phase 1|36|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:16:27.719323|2017-02-18 13:16:27.719323
NCT00862654|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2011-08-31|2011-06-15||March 2009||2009-03-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|Escape||Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis|Efficacy and Safety of Clobetasol Propionate Shampoo 0.05% Used in Association With an Antifungal Shampoo in the Treatment of Moderate to Severe Scalp Seborrheic Dermatitis|Completed||Phase 3|326|Actual|Galderma||4|||f||||f||||||||||2017-02-18 13:16:27.823644|2017-02-18 13:16:27.823644
NCT00862433|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2017-01-24|||March 11, 2009||2009-03-11|November 7, 2016|2016-11-07|December 31, 2019|Anticipated|2019-12-31|December 30, 2018|Anticipated|2018-12-30||Interventional|||Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women|Vitamin E Pharmacokinetics and Biomarkers in Women|Recruiting||Phase 1|326|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 13:16:35.209724|2017-02-18 13:16:35.209724
NCT00862641|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2012-09-12|2010-11-15||April 2009||2009-04-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease|A Phase 4, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 4|1009|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|4|||f||||f||||||||||2017-02-18 13:16:28.595492|2017-02-18 13:16:28.595492
NCT00862628|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2009-09-18|||October 2009||2009-10-01|September 2009|2009-09-01|October 2010|Anticipated|2010-10-01|June 2010|Anticipated|2010-06-01||Interventional|||The Effect of Rebamipide for Non-steroidal Anti-inflammatory Drugs (NSAID) - Induced Small-intestinal Injuries||Unknown status|Not yet recruiting|N/A|60|Anticipated|Nagoya University||1|||f||||||||||||||2017-02-18 13:16:29.727361|2017-02-18 13:16:29.727361
NCT00862615|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2010-09-28|||January 2009||2009-01-01|September 2010|2010-09-01|January 2011|Anticipated|2011-01-01|July 2010|Anticipated|2010-07-01||Interventional|Compalimage||Relationships Between Quality of Ageing and Age-related Degenerated Disease (Compalimage)|Chronic Micro-inflammation and Bone and Muscular Status in Elderly|Unknown status|Recruiting|N/A|32|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:16:29.816472|2017-02-18 13:16:29.816472
NCT00862602|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2010-09-09|||July 2009||2009-07-01|September 2010|2010-09-01|April 2011|Anticipated|2011-04-01|November 2010|Anticipated|2010-11-01||Interventional|PEG||Pedometers for Gestational Diabetes|Type 2 Diabetes Risk in Women With Gestational Diabetes|Unknown status|Active, not recruiting|N/A|60|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 13:16:29.901688|2017-02-18 13:16:29.901688
NCT00862589|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2009-03-17|||October 2006||2006-10-01|March 2009|2009-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)|GLP-1 Suppression of Alpha Cell Secretion in T2DM|Completed||N/A|20|Actual|University Hospital, Gentofte, Copenhagen|||||f||||f||||||||||2017-02-18 13:16:29.992294|2017-02-18 13:16:29.992294
NCT00862576|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2009-03-16|||June 2006||2006-06-01|March 2009|2009-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome|A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome|Completed||N/A|55|Actual|University of California, San Francisco|||2||f||||f||||||||||2017-02-18 13:16:30.073612|2017-02-18 13:16:30.073612
NCT00862563|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2015-04-06|2015-03-06||May 2009||2009-05-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism|A Double-Blind, Placebo-Controlled, Parallel Group Design Trial of; Levetiracetam, Zonisamide, Topiramate, and Placebo Control for the Treatment of Alcohol Dependent Subjects.|Terminated||Phase 2|85|Actual|Boston Medical Center|Early termination lead to a small number of subjects in each group being analyzed.|4||Recruitment goals could not be met before ending of funding for this project.|f||||t||||||||||2017-02-18 13:16:30.16827|2017-02-18 13:16:30.16827
NCT00862550|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-04-08|||March 2009||2009-03-01|April 2016|2016-04-01||||March 2018|Anticipated|2018-03-01||Interventional|||Xerostomia Pilot Fudan: Acupuncture for Prevention of Radiation-Induced Xerostomia|Randomized Pilot Trial of Acupuncture for Prevention of Radiation-Induced Xerostomia|Active, not recruiting||N/A|23|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 13:16:31.245031|2017-02-18 13:16:31.245031
NCT00862537|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2011-06-09|2011-05-13||April 2008||2008-04-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)|An Open-label Extension Study for Subjects Previously Treated Either in Pilot I or Pilot II Studies of the Application of Magnetic Fields Using the Resonator for the Treatment of Parkinson's Disease.|Completed||N/A|18|Actual|pico-tesla Magnetic Therapies, LLC|||1||f||||t||||||||||2017-02-18 13:16:31.56191|2017-02-18 13:16:31.56191
NCT00862524|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-09-28||2012-01-23|March 2009||2009-03-01|September 2012|2012-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer||Completed||Phase 1/Phase 2|20|Actual|Array BioPharma||1|||f||||||||||||||2017-02-18 13:16:31.746169|2017-02-18 13:16:31.746169
NCT00862511|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2017-01-24|||March 2009|Actual|2009-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|December 2012|Actual|2012-12-01||Interventional|||Serum Metal Ion Concentration After Total Knee Arthroplasty (TKA)|A Prospective Randomized Comparison of Serum Metal Ion Levels After Implantation of Coated and Uncoated Knee Prostheses|Completed||N/A|120|Actual|Technische Universität Dresden||2|||f||||f|f|f||||||No||2017-02-18 13:16:31.88694|2017-02-18 13:16:31.88694
NCT00862498|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2016-08-11|||August 2008||2008-08-01|August 2016|2016-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Examining Written Disclosure as a Treatment for Post-Traumatic Stress Disorder|Examining Written Disclosure as an Intervention for Posttraumatic Stress Disorder|Completed||N/A|48|Actual|Boston University||3|||f||||f||||||||||2017-02-18 13:16:31.997507|2017-02-18 13:16:31.997507
NCT00862485|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-15|2016-04-04|||March 2009||2009-03-01|April 2016|2016-04-01||||December 2013|Actual|2013-12-01||Observational|||MCA Doppler Studies in Neborns Following Exchange Transfusion||Completed||N/A|50|Actual|Rambam Health Care Campus|||1||f||||||||||||||2017-02-18 13:16:32.260128|2017-02-18 13:16:32.260128
NCT00862472|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-16|2012-01-13|||March 2009||2009-03-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy Study of DuoTrav APS Versus DuoTrav||Withdrawn||Phase 3|0|Actual|Alcon Research||2||Management decision not to conduct an additional efficacy study.|f||||f||||||||||2017-02-18 13:16:32.344131|2017-02-18 13:16:32.344131
NCT00862459|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-12-11|2011-09-14||August 2005||2005-08-01|December 2013|2013-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)|Multi-center, Double-blind, Randomized, Controlled, Parallel Group, Dose Comparison Study With Corresponding Blinded Image Evaluation Following a Single Intravenous Injection of Three Different Doses of Gadobutrol 1.0 Molar (Gadavist) in Patients With Known or Suspected Focal Blood Brain Barrier Disturbances and/or Abnormal Vascularity of the Central Nervous System|Completed||Phase 2|237|Actual|Bayer|OptiMARK was used as a standard of reference in this study. A formal comparison of the efficacy of gadobutrol and OptiMARK was not specified prospectively in the statistical analysis plan. For completeness, the safety data of OptiMARK is presented.|3|||f||||f||||||||||2017-02-18 13:16:32.463311|2017-02-18 13:16:32.463311
NCT00862420|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-07-16|||February 2009||2009-02-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease|A Randomized, Double Blind, Parallel Group Study to Investigate the Safety of 12 Weeks of Clopidogrel 75 mg/Day Versus Ticlopidine 200 mg/Day in Patients With Peripheral Arterial Disease - With Extended Treatment of Clopidogrel 75 mg/Day for 40 Weeks|Completed||Phase 3|431|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:16:35.339681|2017-02-18 13:16:35.339681
NCT00862407|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-05-08|||October 2008||2008-10-01|May 2012|2012-05-01||||||||Observational|||Impact of Pulsatile Cardio-Pulmonary Bypass (CPB) on Vital Organ Recovery|Impact of Pulsatile CPB on Vital Organ Recovery|Unknown status|Recruiting|N/A|300|Anticipated|Penn State University|||2||f||||t||||||Samples Without DNA|"~     Blood and plasma samples~   "|||2017-02-18 13:16:35.435851|2017-02-18 13:16:35.435851
NCT00862394|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-08-24|||February 2009||2009-02-01|October 2009|2009-10-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma|A 12-week, Multinational, Randomised, Double Blind, Double Dummy, 4-arm Parallel-group Study Comparing the Efficacy and Safety of CHF 1535 (Fixed Combination of Beclomethasone Dipropionate + Formoterol Fumarate) 100 + 6 μg/Actuation Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (Fixed Combination of Beclomethasone Dipropionate + Formoterol Fumarate) 100 + 6 μg/Actuation, Via HFA Pressurised Inhalation Solution, in Moderate to Severe Symptomatic Asthmatic Patients Aged ≥ 12 Years Under Treatment With Inhaled Corticosteroids|Completed||Phase 3|783|Actual|Chiesi Farmaceutici S.p.A.||4|||f||||f||||||||||2017-02-18 13:16:35.511892|2017-02-18 13:16:35.511892
NCT00862381|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2010-07-23|||October 2008||2008-10-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Hydrocortisone Use After Etomidate in Intensive Care|Opothérapie Par Hydrocortisone après Injection Unique d'Etomidate Chez le Patient de réanimation|Completed||Phase 3|106|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-02-18 13:16:35.604779|2017-02-18 13:16:35.604779
NCT00862368|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-04-24|||October 2005||2005-10-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|PAQS2||Sustaining Smoking Cessation in Smokers With Kids With Asthma|Sustaining Cessation in Smokers With Kids With Asthma|Completed||Phase 3|573|Actual|The Miriam Hospital||3|||f||||t||||||||||2017-02-18 13:16:35.711356|2017-02-18 13:16:35.711356
NCT00862355|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2016-03-08|||March 2010||2010-03-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer||Completed||Phase 1|24|Actual|Sun Pharma Advanced Research Company Limited||2|||f||||f||||||||||2017-02-18 13:16:35.838067|2017-02-18 13:16:35.838067
NCT00862342|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-07-16|||January 2009||2009-01-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Interventional|SAFE||Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC)|Efficacy and Safety of Second-line Combination Chemotherapy With Avastin in Patients With Metastatic Colorectal Cancer Who Have Received First-line Chemotherapy Plus Avastin|Completed||Phase 2|78|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 13:16:35.9472|2017-02-18 13:16:35.9472
NCT00862329|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-03-21|||March 2008||2008-03-01|March 2012|2012-03-01|November 2010|Actual|2010-11-01|June 2009|Actual|2009-06-01||Interventional|||Influence of Protein Source on Satiety and Metabolism||Completed||N/A|120|Actual|Institut National de la Recherche Agronomique||4|||f||||t||||||||||2017-02-18 13:16:38.381962|2017-02-18 13:16:38.381962
NCT00862316|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-02-11|||May 2009||2009-05-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Oxford Unicompartmental Knee Arthroplasty With and Without Navigational Unit|Outcome Analysis of the Oxford Unicompartmental Knee Arthroplasty With and Without the Assistance of a Computer Navigational Unit|Completed||N/A|48|Actual|Zimmer Biomet||2|||f||||||||||||||2017-02-18 13:16:38.476271|2017-02-18 13:16:38.476271
NCT00862303|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2011-03-07|||March 2009||2009-03-01|March 2009|2009-03-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma|Study of Autologous Dendritic Cells (DC) Loaded With Autologous Tumor Lysate (DC-Vaccine) in Combination With Cytokine-Induced Killer Cell (CIK) in Patients With Renal Cell Cancer|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Fuzhou General Hospital||2|||f||||t||||||||||2017-02-18 13:16:38.586658|2017-02-18 13:16:38.586658
NCT00862290|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2013-05-02|||August 2008||2008-08-01|May 2013|2013-05-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Observational|||Circulating microRNAs as Biomarkers of Sepsis|Diagnostic and Predictive Value of Circulating microRNAs During Sepsis|Completed||N/A|100|Actual|Changhai Hospital|||3||f||||t||||||Samples Without DNA|"~     Blood of septic patients is collected on the second day when they are diagnosed with sepsis~     in ICU. Blood of SIRS patients is collected on the second day when they are diagnozed with~     SIRS after cardiac surgery with cardiopulmonary bypass.~   "|||2017-02-18 13:16:38.698163|2017-02-18 13:16:38.698163
NCT00862277|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2016-04-12|2010-12-11||December 2008||2008-12-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Observational|||Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine|Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier|Completed||N/A|763|Actual|Sanofi|||3||f||||f||||||||||2017-02-18 13:16:38.788383|2017-02-18 13:16:38.788383
NCT00862264|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-02-14|||August 2004||2004-08-01|February 2012|2012-02-01|September 2005|Actual|2005-09-01|||||Interventional|||Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma|A 12-week Phase III Study to Evaluate the Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler HFA 134a-pMDI in Adult Patients With Mild to Moderate Persistent Asthma|Completed||Phase 3|286|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-02-18 13:16:39.292091|2017-02-18 13:16:39.292091
NCT00862251|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2015-10-12|2012-02-23||April 2009||2009-04-01|October 2015|2015-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)|A Randomized, Double-Blind, Active-Controlled Study of Patients With Cardiovascular Disease and Diabetes Mellitus Not Adequately Controlled With Simvastatin or Atorvastatin: Comparison of Switching to Combination Tablet Ezetimibe/Simvastatin Versus Switching to Rosuvastatin or Doubling the Statin Dose|Completed||Phase 3|808|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:16:39.5954|2017-02-18 13:16:39.5954
NCT00862225|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-01-25|||January 2008||2008-01-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|PETRA||MOA Study of Ze 339 in Seasonal Allergic Rhinitis|Randomized, Double-blind Prospective Clinical Study to Examine the Mechanism of Action of IG-RD-001 (Ze-339) Compared to Desloratadine and Placebo in Patients With Seasonal Allergic Rhinitis Who Are Sensitized to Grasses|Completed||Phase 2|18|Actual|Max Zeller Soehne AG||3|||f||||f||||||||||2017-02-18 13:16:40.563662|2017-02-18 13:16:40.563662
NCT00862212|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2013-04-22|||January 2009||2009-01-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting|Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting|Completed||N/A|83|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 13:16:40.670683|2017-02-18 13:16:40.670683
NCT00862186|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-01-11|2012-04-11||April 2009||2009-04-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Self-Management of Cancer-Related Fatigue by Adolescents|Self-Management of Cancer-Related Fatigue by Adolescents: Pilot Study of an Evidence Based Educational Resource|Completed||N/A|15|Actual|Seattle Children's Hospital|Slow enrollment resulting in low accrual - only 15 participants rather than the 60 planned - therefore unable to complete analysis.|1|||f||||f||||||||||2017-02-18 13:16:40.78222|2017-02-18 13:16:40.78222
NCT00862173|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2012-06-11|||March 2008||2008-03-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer|Gene-expression Profile as Predictor of Central Nervous System Metastasis Development in Non-small Cell Lung Cancer: a Prospective Study|Unknown status|Recruiting|N/A|120|Anticipated|National Institute of Cancerología|||2||f||||f||||||Samples With DNA|"~     NSCLC Biopsy.~   "|||2017-02-18 13:16:41.019707|2017-02-18 13:16:41.019707
NCT00862160|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2009-10-06|||April 2009||2009-04-01|October 2009|2009-10-01|October 2010|Anticipated|2010-10-01|April 2010|Anticipated|2010-04-01||Interventional|ROCsafeTM||Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit|Acute Cerebrovascular Events During Extracorporeal Circulation a Comparison of New Minimized Perfusion Circuit to Standard Cardiopulmonary Bypass|Unknown status|Recruiting|Phase 4|64|Anticipated|Hannover Medical School||2|||f||||t||||||||||2017-02-18 13:16:41.120437|2017-02-18 13:16:41.120437
NCT00862147|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2017-02-13|||January 2007|Actual|2007-01-01|February 2017|2017-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effectiveness Study of the International Child Development Program|The Effect of the International Child Development Program - A Randomised Controlled Trial|Terminated||N/A|35|Actual|Norwegian University of Science and Technology||2||the study was stopped due to failure to recruit sufficient participants|f||||t||||||||||2017-02-18 13:16:41.226476|2017-02-18 13:16:41.226476
NCT00862134|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-01-08|2011-05-31||March 2009||2009-03-01|January 2013|2013-01-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)|A Randomized Phase II, Multi-Center, Open-Label Trial of PR104 and Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|42|Actual|Proacta, Incorporated||2||Interim analysis indicated low probability of clinically significant result|f||||||||||||||2017-02-18 13:16:41.325371|2017-02-18 13:16:41.325371
NCT00862121|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-03-15|2011-10-03||April 2009||2009-04-01|March 2012|2012-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|PEACE||A Study With Pentasa in Patients With Active Crohn's Disease|PENTASA in Active Crohn's Disease: A 10-week, Double-blind, Multi-centre Trial Comparing PENTASA Sachet 6 g/Day (Mesalazine, Mesalamine) With Placebo.|Terminated||Phase 3|20|Actual|Ferring Pharmaceuticals|Early termination led to small number of participants (20/510; actual/planned). Only the primary efficacy outcome was subject to formal statistical analysis. No conclusions could be drawn on primary and secondary efficacy analyses.|2||Terminated due to poor recruitment|f||||f||||||||||2017-02-18 13:16:42.091367|2017-02-18 13:16:42.091367
NCT00862108|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-09-20|||September 2008||2008-09-01|September 2009|2009-09-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)|Functional Brain Markers and Predictors of Treatment Response Associated With Norepinephrine System Genes in ADHD|Unknown status|Recruiting|Phase 4|50|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-02-18 13:16:42.723432|2017-02-18 13:16:42.723432
NCT00862095|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-04-22|||June 2008||2008-06-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Medical Therapies for Chronic Post-Traumatic Headaches|A Randomized Controlled Trial of Medical Therapies for Chronic Post-Traumatic Headaches|Terminated||Phase 4|64|Actual|Madigan Army Medical Center||4||inadequate enrollment, insufficient funds to continue enrollment|f||||t||||||||||2017-02-18 13:16:42.837325|2017-02-18 13:16:42.837325
NCT00862082|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-07-19|2011-05-31||March 2009||2009-03-01|July 2013|2013-07-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)|A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Terminated||Phase 1/Phase 2|14|Actual|Proacta, Incorporated|Early termination leading to small numbers of subjects analyzed. Phase II part of study never initiated.|1||PR104 plus sorafenib was poorly tolerated in patients with advanced HCC|f||||||||||||||2017-02-18 13:16:42.95297|2017-02-18 13:16:42.95297
NCT00862056|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2014-04-14|||January 2009||2009-01-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Observational|Decide CTA||Detection of Subclinical Atherosclerosis in Asymptomatic Individuals|Prospective Detection of Subclinical Atherosclerosis in Asymptomatic Individuals With High Likelihood of Coronary Artery Disease With a Novel, Low-Radiation Volumetric Computed Tomography Approach|Unknown status|Recruiting|Early Phase 1|300|Anticipated|Piedmont Healthcare|||1||f||||f||||||Samples With DNA|"~     Whole blood for DNA and RNA analysis for genetics and genomics~   "|||2017-02-18 13:16:43.780148|2017-02-18 13:16:43.780148
NCT00862043|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2016-09-22|||April 2009||2009-04-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|SIOVAC||Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease|Sildenafil for Improving Outcomes After Valvular Correction|Completed||Phase 4|200|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||t||||||||||2017-02-18 13:16:43.872035|2017-02-18 13:16:43.872035
NCT00862030|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2011-08-04|||April 2009||2009-04-01|August 2011|2011-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer|Comparison of Two-versus Three-Dimensional Treatment Planning for Patients Receiving Chest Radiotherapy for Symptom Control|Completed||N/A|20|Anticipated|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 13:16:43.997218|2017-02-18 13:16:43.997218
NCT00862017|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2009-03-13|||April 2008||2008-04-01|March 2009|2009-03-01||||||||Interventional|||Effect of Monosodium Glutamate Supplementation on Gastric Emptying and Postprandial Nitrogen Kinetics|Effect of Monosodium Glutamate on Gastric Emptying and Postprandial Nitrogen in Healthy Volunteers|Completed||N/A|13|Actual|Institut National de la Recherche Agronomique||2|||f||||t||||||||||2017-02-18 13:16:44.092282|2017-02-18 13:16:44.092282
NCT00862004|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2010-02-01|||December 2008||2008-12-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Video-assisted Thoracoscopic Surgery for Stage IIIA Non-Small Cell Lung Cancer|Feasibility of Video-Assisted Thoracoscopic Surgery for Clinical Stage IIIA Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|The First Affiliated Hospital of Guangzhou Medical University||1|||f||||t||||||||||2017-02-18 13:16:44.171371|2017-02-18 13:16:44.171371
NCT00861991|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2009-03-13|||June 2006||2006-06-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Enhancing Empathy in Medical Communication Through Perspective-Taking|Enhancing Empathy in Medical Communication Through Perspective-Taking|Completed||N/A|608|Actual|George Washington University||2|||f||||t||||||||||2017-02-18 13:16:44.26999|2017-02-18 13:16:44.26999
NCT00861978|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2009-03-13|||December 2002||2002-12-01|March 2009|2009-03-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||St. John's Wort Extract LI 160 for the Treatment of Atypical Depression||Completed||Phase 3|201|Actual|Cassella-med GmbH & Co. KG||2|||f||||t||||||||||2017-02-18 13:16:44.54448|2017-02-18 13:16:44.54448
NCT00861965|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2015-04-01|||January 2010||2010-01-01|April 2015|2015-04-01||||November 2012|Actual|2012-11-01||Interventional|||Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match Alternative to Allogeneic Transplant for Blood Cancers|A Phase I/II Study of Polyclonally Activated, Intentionally Mis-Matched, Allogeneic Th1 Memory Cells (AlloStimTM) in Patients With Relapsed or Refractory Hematological Malignancy Without Prior Conditioning|Withdrawn||Phase 1/Phase 2|0|Actual|Immunovative Therapies, Ltd.||1||withdrawn due to poor recruitment|f||||f||||||||||2017-02-18 13:16:44.628494|2017-02-18 13:16:44.628494
NCT00861952|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2015-03-10|||January 2010||2010-01-01|March 2015|2015-03-01||||||||Interventional|||Neuragen for Peripheral Diabetic Neuropathy|The Safety and Efficacy of Neuragen in Diabetic Peripheral Neuropathy: A Double-blind Randomized Placebo Controlled Trial|Withdrawn||Phase 3|0|Actual|The Canadian College of Naturopathic Medicine||2||"Study has received ethics approval, however funding limitations have resulted in suspending~   date of commencement."|f||||t||||||||||2017-02-18 13:16:44.740788|2017-02-18 13:16:44.740788
NCT00861939|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-13|||March 2004||2004-03-01|March 2009|2009-03-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions|A Relative Bioavailability Study of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions|Completed||Phase 1|28|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:16:44.853036|2017-02-18 13:16:44.853036
NCT00861926|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2012-02-14|||March 2009||2009-03-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics|48-week,Multinational,Randomized,Double-blind,2-parallel Groups,Comparing the Efficacy of Foster for Maintenance and Reliever Versus Fixed-dose Foster for Maintenance Plus Salbutamol as Reliever in Asthmatics >=18 Years of Age|Completed||Phase 3|2079|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-02-18 13:16:44.940545|2017-02-18 13:16:44.940545
NCT00861913|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2016-12-29|2013-11-07||April 2009||2009-04-01|December 2016|2016-12-01||||September 2010|Actual|2010-09-01||Interventional|||Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery|Phase II Trial of Pazopanib (GW786034) in Pre-Treated and Untreated Metastatic Melanoma Patients|Active, not recruiting||Phase 2|13|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:16:45.07027|2017-02-18 13:16:45.07027
NCT00861900|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2009-07-14|||January 1998||1998-01-01|July 2009|2009-07-01||||||||Observational|||Immune Mechanisms of Rejection in Human Lung Allografts|Immune Mechanisms of Rejection in Human Lung Allografts|Unknown status|Enrolling by invitation|N/A|360|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 13:16:45.372327|2017-02-18 13:16:45.372327
NCT00861887|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-13|2016-12-13|||February 2009||2009-02-01|January 2010|2010-01-01|January 2010|Anticipated|2010-01-01|November 2009|Anticipated|2009-11-01||Interventional|||Extended Treatment With Vancomycin for Clostridium Difficile Colitis|Comparative Study of 2 Weeks Versus 4 Weeks Treatment With Vancomycin for Clostridium Difficile Colitis|Withdrawn||N/A|0|Actual|William Beaumont Hospitals||2||Difficult enrollment|f||||t||||||||No||2017-02-18 13:16:45.440869|2017-02-18 13:16:45.440869
NCT00861874|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2012-10-08|||January 2010||2010-01-01|October 2012|2012-10-01||||September 2012|Actual|2012-09-01||Interventional|||A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase I Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Completed||Phase 1|13|Actual|University of Rochester||1|||f||||t||||||||||2017-02-18 13:16:45.543043|2017-02-18 13:16:45.543043
NCT00861861|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-10-11|||September 2008||2008-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|COMPACT-CAD||Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)|Comparison of Pitavastatin With Atorvastatin in Increasing HDL-C and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease.|Completed||Phase 4|129|Actual|Kumamoto University||2|||f||||f||||||||||2017-02-18 13:16:45.634205|2017-02-18 13:16:45.634205
NCT00861848|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-09-17|||April 2009||2009-04-01|September 2009|2009-09-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Observational|ECHOBIKE||Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging|Quantification of Ventricular Mechanics and Myocardial Blood Flow Reserve in Adolescents and Adults Ages 13-40 With Congenital or Acquired Heart Disease Using Supine Bicycle Stress With Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging|Unknown status|Enrolling by invitation|Phase 1|80|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-02-18 13:16:45.740333|2017-02-18 13:16:45.740333
NCT00861835|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||November 2004||2004-11-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Trial of Rapid On-Site Evaluation of Transbronchial Needle Aspirate (TBNA)|A Randomized Prospective Trial of Rapid On-Site Evaluation of Transbronchial Needle Aspirate Specimens|Completed||N/A|||Maine Medical Center||2|||f||||t||||||||||2017-02-18 13:16:45.846746|2017-02-18 13:16:45.846746
NCT00861822|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-02-22|||July 2009||2009-07-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|||Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection: A Proof of Concept Pilot Study|Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection: A Proof of Concept Pilot Study|Completed||Phase 1|60|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 13:16:45.922158|2017-02-18 13:16:45.922158
NCT00861809|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2017-01-27||2012-03-22|June 2009||2009-06-01|January 2017|2017-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis|A Multicenter, Double-Blind, Randomized Placebo-Controlled Phase II Study to Evaluate the Pharmacodynamics, Safety, Tolerability, and PK of Single Doses of the Oral Motilin Receptor Agonist GSK962040, in Type 1 Diabetic Male and Female Patients With Gastroparesis|Completed||Phase 2|11|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:16:46.017123|2017-02-18 13:16:46.017123
NCT00861796|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2011-06-06|||March 2008||2008-03-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Study of CYR-101 in Patients With Schizophrenia|A Multi-center, Inpatient and Ambulatory, Phase 2, Double Blind, Randomized, Placebo-controlled Proof of Concept Study of CYR-101 in Patients With DSM-IV Schizophrenia|Completed||Phase 2|100|Anticipated|Cyrenaic Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:16:46.135045|2017-02-18 13:16:46.135045
NCT00861783|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2011-12-29|||June 2008||2008-06-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma|A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Hepatoma and Other Advanced Solid Tumors|Completed||Phase 1|16|Actual|Onconova Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 13:16:46.226235|2017-02-18 13:16:46.226235
NCT00861770|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2014-03-20|||November 2008||2008-11-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|TEAM UF||Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients|Prospective Protocol for Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients|Completed||N/A|50|Anticipated|Christiana Care Health Services||2|||f||||t||||||||||2017-02-18 13:16:46.349929|2017-02-18 13:16:46.349929
NCT00861757|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2011-06-23|2011-05-10||March 2009||2009-03-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia|A Phase 3, Randomized, Double Blind, Placebo and Tamsulosin Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Tadalafil Once a Day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|612|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 13:16:46.472545|2017-02-18 13:16:46.472545
NCT00861744|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-08-29|2011-07-14||June 2009||2009-06-01|August 2016|2016-08-01|June 2012|Actual|2012-06-01|July 2010|Actual|2010-07-01||Interventional|||Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age|A Phase II, Randomized, Observer Blind, Controlled, Multicenter Study to Assess Immunogenicity and Antibody Persistence Following Vaccination With GSK's Candidate Combined Measles, Mumps, and Rubella Vaccine (MMR) Versus M-M-R® II as a First Dose, Both Administered Subcutaneously at 12-15 Months of Age, Concomitantly With Hepatitis A Vaccine (HAV), Varicella Vaccine (VV) and Pneumococcal Conjugate Vaccine (PCV) But at Separate Sites.|Completed||Phase 2|1259|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:16:48.797321|2017-02-18 13:16:48.797321
NCT00861731|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-04-27|||November 2008||2008-11-01|April 2009|2009-04-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|VICTORY||Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy|The Metabolic and Anti-Inflammatory Effects of Combined Ezetimibe and Simvastin Therapy, as Compared to Simvastatin Alone, in Patients With Chronic Proteinuric Nephropathy|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Azienda Ospedaliero Universitaria di Sassari||3|||f||||t||||||||||2017-02-18 13:16:51.045241|2017-02-18 13:16:51.045241
NCT00861718|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-12-09|||April 2009||2009-04-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|||||Interventional|||Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers|A Phase I, Single-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 When Given in Multiple Ascending Oral Doses in Healthy Subjects|Completed||Phase 1|40|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:16:51.187516|2017-02-18 13:16:51.187516
NCT00861705|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2015-09-28|2015-01-12||May 2009||2009-05-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Using a modified intent-to-treat approach only patients who began protocol treatment (n=443) were included in analyses for neoadjuvant treatment and toxicity. Analyses for surgical endpoints excluded 10 patients who withdrew consent prior to surgery (n=433). All analyses considered patients according to treatment assignment.|Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery|Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer|Completed||Phase 2|454|Actual|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 13:16:51.313133|2017-02-18 13:16:51.313133
NCT00861692|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-07-01|2015-11-17||April 2009||2009-04-01|July 2016|2016-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II|An Open-label, Multi-centre, Clinical Study to Collect Information on the Clinical Use of Argatroban in Patients With Heparin Induced Thrombocytopenia (HIT) Type II Who Require Parenteral Antithrombotic Therapy|Completed||Phase 2|20|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-02-18 13:16:54.701819|2017-02-18 13:16:54.701819
NCT00861679|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-15|||January 2007||2007-01-01|March 2009|2009-03-01|September 2014|Anticipated|2014-09-01|September 2009|Anticipated|2009-09-01||Interventional|ALL SCT BFM||Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International|Therapy Protocol ALL SCT BFM International-Open, Multicenter, Controlled, Prospective Study for Therapy and Therapy Optimisation in Patients With Acute Lymphoblastic Leukemia (ALL) and an Indication for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|Unknown status|Recruiting|Phase 1/Phase 2|552|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 13:16:55.231823|2017-02-18 13:16:55.231823
NCT00861666|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-06-01|||October 2008||2008-10-01|June 2009|2009-06-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Forgiveness-Based Writing to Prevent Post-Traumatic Stress Disorder (PTSD) in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans|Forgiveness-Based Writing to Prevent Posttraumatic Stress Disorder in OEF/OIF Veterans|Unknown status|Recruiting|N/A|20|Anticipated|South Central VA Mental Illness Research, Education & Clinical Center||1|||f||||f||||||||||2017-02-18 13:16:55.325812|2017-02-18 13:16:55.325812
NCT00861653|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2014-04-14|||October 2006||2006-10-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|August 2011|Actual|2011-08-01||Observational|APC||Atherosclerotic Plaque Characterization|Atherosclerotic Plaque Characterization Using Multispectral, Multicontrast High Resolution Cardiovascular Magnetic Resonance Imaging|Completed||N/A|50|Actual|Piedmont Healthcare|||1||f||||f||||||Samples With DNA|"~     Serum and tissue samples are collected for markers of inflammation and gene chip analysis~   "|||2017-02-18 13:16:55.431363|2017-02-18 13:16:55.431363
NCT00861640|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-07-14|||March 2009||2009-03-01|July 2009|2009-07-01|April 2010|Anticipated|2010-04-01|March 2010|Anticipated|2010-03-01||Interventional|||Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding|The Comparison of Oral Rabeprazole vs. Intravenous Omeprazole in the Treatment of Patients With Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding|Unknown status|Recruiting|Phase 4|200|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-02-18 13:16:55.530692|2017-02-18 13:16:55.530692
NCT00861627|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2015-12-01|||March 2009||2009-03-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|September 2015|Actual|2015-09-01||Interventional|||Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation|Phase 2 Study of Intravenous Administration of Reovirus Serotype 3 - Dearing Strain (REOLYSIN®) in Combination With Paclitaxel and Carboplatin in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer Who Have KRAS or EGFR Activated Tumors|Completed||Phase 2|37|Actual|Oncolytics Biotech||1|||f||||f||||||||||2017-02-18 13:16:55.64344|2017-02-18 13:16:55.64344
NCT00861614|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-08-04|2016-03-15||May 2009||2009-05-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|November 2012|Actual|2012-11-01||Interventional|||Study of Immunotherapy to Treat Advanced Prostate Cancer|A Randomized, Double-Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects With Castration Resistant Prostate Cancer That Have Received Prior Treatment With Docetaxel|Completed||Phase 3|988|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:16:55.772456|2017-02-18 13:16:55.772456
NCT00861601|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2015-04-23|2010-05-11||January 2009||2009-01-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease|TPL111913, a Multi-centre, Open Label, Dose Ranging Phase II Study to Assess Efficacy, Safety and Pharmacokinetics of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease|Completed||Phase 2|38|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 13:16:57.547765|2017-02-18 13:16:57.547765
NCT00861588|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||February 2006||2006-02-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia||Completed||N/A|176|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 13:16:58.597057|2017-02-18 13:16:58.597057
NCT00861575|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-09-04|||February 2006||2006-02-01|August 2013|2013-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|CGR||Cardiogenomics Registry|CAD Genotype and Phenotype Cardiac Catheterization Laboratory Registry|Suspended||N/A|10000|Anticipated|Piedmont Healthcare|||1|Staffing resources currently being restructured|f||||f||||||Samples With DNA|"~     20 mL of blood are collected and aliquots of whole blood, plasma, serum and buffy coat are~     stored.~   "|||2017-02-18 13:16:58.702348|2017-02-18 13:16:58.702348
NCT00861562|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||April 2008||2008-04-01|March 2009|2009-03-01|April 2009|Anticipated|2009-04-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Efficacy and Safety Evaluation of the Drug Imescard Compound Water Smartweed Pills|Clinical Efficacy and Safety Evaluation of the Drug Imescard Compound Water Smartweed Pills|Unknown status|Active, not recruiting|Phase 3|56|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 13:16:58.789528|2017-02-18 13:16:58.789528
NCT00861549|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2011-09-13|||August 2008||2008-08-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Bioavailability, Pharmacokinetics and Safety Evaluation of Phencynonate Hydrochloride in Healthy Volunteers|Bioavailability, Pharmacokinetics and Safety Evaluation of Phencynonate Hydrochloride in Healthy Volunteers|Completed||Phase 1|30|Anticipated|PhytoHealth Corporation||3|||f||||f||||||||||2017-02-18 13:16:58.894743|2017-02-18 13:16:58.894743
NCT00861536|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2015-04-13|||January 2009||2009-01-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Comparison of ATG to Thymoglobuline in Renal Transplantation|An Open, Multicenter, Randomised, Parallel Group Pilot Study to Investigate Two Different Polyclonal Rabbit Immunoglobulin Preparations for Safety and Efficacy:A Comparison of ATG-Fresenius S to Thymoglobulin in Prophylaxis for Immunological High Risk Patients Following Renal Transplantation|Completed||Phase 4|40|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 13:16:58.991015|2017-02-18 13:16:58.991015
NCT00861523|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-06-21|||February 2009||2009-02-01|June 2015|2015-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Does Thiamine Help Vomiting and Nausea in Pregnancy?|Comparison Between the Treatment of Thiamine and Promethazine for Improving Vomiting and Nausea in Pregnancy|Terminated||Phase 3|50|Actual|HaEmek Medical Center, Israel||2||Difficulties in recruiting patients|f||||||||||||||2017-02-18 13:16:59.095494|2017-02-18 13:16:59.095494
NCT00860977|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2016-10-27|||March 2010||2010-03-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|March 2017|Anticipated|2017-03-01||Interventional|VALIDATE||Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?|VALacyclovir In Delaying Antiretroviral Treatment Entry|Active, not recruiting||Phase 3|202|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 13:17:05.170695|2017-02-18 13:17:05.170695
NCT00861510|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2017-01-24|||March 5, 2009||2009-03-05|September 4, 2014|2014-09-04|October 19, 2012|Actual|2012-10-19|October 19, 2012|Actual|2012-10-19||Interventional|||A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies|A Pilot Study of the Safety and Efficacy of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies|Completed||Phase 1|16|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:16:59.208384|2017-02-18 13:16:59.208384
NCT00861497|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-09-13|||January 2006||2006-01-01|September 2013|2013-09-01|July 2009|Actual|2009-07-01|January 2008|Actual|2008-01-01||Interventional|||Bifeprunox Extension to Extension Study in Patients With Schizophrenia|An Open-label Safety Study of Bifeprunox Investigating Flexible Doses of 20, 30, or 40mg/Day in Patients With Schizophrenia Who Have Completed Studies 10206 or 10265|Terminated||Phase 3|11|Actual|H. Lundbeck A/S||1||The study stopped after been paused (the patients were switched in the meantime)|f||||f||||||||||2017-02-18 13:16:59.319031|2017-02-18 13:16:59.319031
NCT00861484|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-10-11|||November 2008||2008-11-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|PoM||Proof of Mechanism in ELT|A Double Blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of a Single Oral Dose of GSK958108 on Ejaculatory Latency Time (ELT) in Male Patient Suffering From Premature Ejaculation|Completed||Phase 1|33|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:16:59.430629|2017-02-18 13:16:59.430629
NCT00861471|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-05-31|2011-04-29||May 2005||2005-05-01|May 2016|2016-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer|Phase I/II, Open Label Study of Sequential Taxotere® (Docetaxel) and Gleevec® (Imatinib Mesylate) in Hormone Refractory Prostate Cancer|Terminated||Phase 1/Phase 2|24|Actual|New York University School of Medicine|This study was terminated before it reached the target accrual number due to slow accrual, leading to small number of subjects analyzed (12 out of the target number of 37).|1||due to slow accrual|f||||t||||||||||2017-02-18 13:16:59.680058|2017-02-18 13:16:59.680058
NCT00861458|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-07-06|||April 2009||2009-04-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State|A Phase 1, Open-Label, Randomized, 3-Way Crossover Study In Healthy Subjects To Estimate The Pharmacokinetics Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State|Completed||Phase 1|14|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:17:00.021412|2017-02-18 13:17:00.021412
NCT00861445|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2014-10-17|||June 2001||2001-06-01|July 2010|2010-07-01|February 2003|Actual|2003-02-01|January 2003|Actual|2003-01-01||Interventional|||A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy|A Randomized, Double-Blind Placebo Controlled Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy|Completed||Phase 2|119|Actual|UCB Pharma||2|||f||||t||||||||||2017-02-18 13:17:00.130429|2017-02-18 13:17:00.130429
NCT00861432|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-09-12|||December 2008||2008-12-01|September 2016|2016-09-01|April 2011|Actual|2011-04-01|July 2010|Actual|2010-07-01||Interventional|||Evaluation of Questionnaires of Tumor Patients With and Without Additive Homeopathic Therapy|Evaluation of Quality of Life of Tumor Patients With and Without Additive Homeopathy.|Completed||Phase 2|400|Actual|Medical University of Vienna||2|||f||||f||||||||No||2017-02-18 13:17:00.266916|2017-02-18 13:17:00.266916
NCT00861419|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2017-02-07|||December 2005||2005-12-01|February 2017|2017-02-01||||||||Interventional|||To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.|An Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 386 With AMG 706, AMG 386 With Bevacizumab, AMG 386 With Sorafenib, and AMG 386 With Sunitinib in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|88|Anticipated|Amgen||8|||f||||||||||||||2017-02-18 13:17:00.379767|2017-02-18 13:17:00.379767
NCT00861406|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-05-09|||March 2009||2009-03-01|May 2016|2016-05-01||||March 2018|Anticipated|2018-03-01||Interventional|||Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine|An Exploratory Study of Adjuvant Therapy of Pegylated Interferon-Alfa 2b Plus Melanoma Peptide Vaccine in Patients With Resected, Intermediate-Thickness, Node-Negative Melanoma|Active, not recruiting||Phase 1|30|Anticipated|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-02-18 13:17:00.504915|2017-02-18 13:17:00.504915
NCT00861393|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||February 2009||2009-02-01|March 2009|2009-03-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|CBT||Cognitive Behavioural Therapy (CBT) For Improving Emotional Well Being in Spinal Cord Injuries (SCI)|The Impact of a Brief Cognitive Behavior Therapy Intervention Aimed at Improving Emotional Well-Being and Quality of Life for Individuals With Spinal Cord Injuries|Unknown status|Active, not recruiting|N/A|50|Anticipated|Toronto Rehabilitation Institute||2|||f||||f||||||||||2017-02-18 13:17:00.628125|2017-02-18 13:17:00.628125
NCT00861380|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-08-08||2013-02-14|May 2009||2009-05-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|January 2012|Actual|2012-01-01||Interventional|FinIP||Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease|Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease|Completed||Phase 3|41188|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:17:00.724252|2017-02-18 13:17:00.724252
NCT00861367|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-11-17|||September 2008||2008-09-01|November 2016|2016-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate|Prospektive Doppel-Blind-randomisierte Studie Zur Verwendung Von Aspirin Bei Transurethralen Operationen|Withdrawn||N/A|0|Actual|University Hospital, Basel, Switzerland||2||difficult enrollment, focus of study no longer of interest|f||||f||||||||||2017-02-18 13:17:00.854573|2017-02-18 13:17:00.854573
NCT00860964|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-16|||February 1998||1998-02-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|February 2003|Actual|2003-02-01||Interventional|||A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women|A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women|Completed||Phase 4|221|Actual|Peking Union Medical College||2|||f||||f||||||||||2017-02-18 13:17:05.327675|2017-02-18 13:17:05.327675
NCT00861354|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2010-01-06|||March 2009||2009-03-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|TRIPPS||Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor|Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor: Trial of Regular vs Irregualr Pulse for the Prevention of Stroke (TRIPPS 2.0)|Completed||N/A|150|Anticipated|Microlife|||1||f||||f||||||||||2017-02-18 13:17:00.960819|2017-02-18 13:17:00.960819
NCT00861341|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2015-12-23|2011-06-21||December 2008||2008-12-01|December 2015|2015-12-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|UHEM08014||Effects of Pioglitazone on Platelet Function|Effects of Pioglitazone on Platelet Function|Completed||Phase 2|40|Actual|University of Rochester||1|||f||||t||||||||||2017-02-18 13:17:01.053047|2017-02-18 13:17:01.053047
NCT00861328|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2011-12-29|||February 2008||2008-02-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin|A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|18|Actual|Onconova Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 13:17:01.330714|2017-02-18 13:17:01.330714
NCT00861315|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-13|||January 2009||2009-01-01|March 2009|2009-03-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|DARTAGNAN||Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation|Phase II Study of High Dose Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation|Unknown status|Recruiting|Phase 2/Phase 3|24|Anticipated|Association Pour La Promotion A Tours De La Reanimation Medicale||2|||f||||t||||||||||2017-02-18 13:17:01.459089|2017-02-18 13:17:01.459089
NCT00861302|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2012-06-18|||September 2008||2008-09-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Evaluating a Chronic Pain Treatment Program|Evaluating Outcomes and Response Profiles of a Psychological Treatment for People With Chronic Pain|Completed||Phase 1|72|Actual|Wayne State University||1|||f||||f||||||||||2017-02-18 13:17:01.572585|2017-02-18 13:17:01.572585
NCT00861276|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||June 2000||2000-06-01|March 2009|2009-03-01|December 2001|Actual|2001-12-01|July 2001|Actual|2001-07-01||Interventional|SUNIC||Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit|Use of Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit: a Randomized Controlled Trial|Completed||Phase 4|50|Actual|University of Lausanne||2|||f||||f||||||||||2017-02-18 13:17:01.671349|2017-02-18 13:17:01.671349
NCT00861263|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2014-03-07|2013-11-12||June 2007||2007-06-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|Spirus||The Clinical Utility of Overtube Use at the Time of Endoscopy|The Clinical Utility of Overtube Use at the Time of Endoscopy|Completed||N/A|193|Actual|University of Florida|No limitations were found|1|||f||||f||||||||||2017-02-18 13:17:01.780031|2017-02-18 13:17:01.780031
NCT00861250|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-06-15|||March 2009||2009-03-01|December 2014|2014-12-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|||Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT|Assessment of Molecular Remission by ASO-RQ-PCR Technique After Induction Treatment With Bortezomib-dexamethasone (Vel/Dex) Followed by HDT With ASCT|Completed||Phase 2/Phase 3|47|Actual|Tampere University Hospital||1|||f||||t||||||||||2017-02-18 13:17:02.006574|2017-02-18 13:17:02.006574
NCT00861237|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2016-09-12|||July 2008||2008-07-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|October 2016|Anticipated|2016-10-01||Interventional|||Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery|Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery|Terminated||Phase 4|12|Actual|Medical University of Vienna||2||Number of patients recruited to small, no cooperation of study members|f||||f||||||||No||2017-02-18 13:17:02.119987|2017-02-18 13:17:02.119987
NCT00861224|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2010-07-15|||August 2005||2005-08-01|July 2010|2010-07-01|May 2007|Actual|2007-05-01|October 2006|Actual|2006-10-01||Observational|||Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology|The Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology in Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|Completed||N/A|10|Actual|Amgen|||1||f||||||||||None Retained|"~     No biospecimen samples were retained.~   "|||2017-02-18 13:17:02.225908|2017-02-18 13:17:02.225908
NCT00861211|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2011-07-08||2011-07-07|October 2008||2008-10-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess The Safety and Efficacy of Two Weeks of Oral Senicapoc Administration on Allergen Challenge in Atopic Asthmatic Subjects|Completed||Phase 2|34|Actual|Icagen||2|||f||||f||||||||||2017-02-18 13:17:02.333256|2017-02-18 13:17:02.333256
NCT00861198|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2015-06-29|2015-06-29||November 2006||2006-11-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders|The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders|Completed||N/A|88|Actual|University of Florida|||1||f||||f||||||||||2017-02-18 13:17:02.444104|2017-02-18 13:17:02.444104
NCT00861185|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2011-07-08||2011-07-07|March 2009||2009-03-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Safety and Efficacy of Four Weeks of Oral Senicapoc Administration on Exercise-Induced Asthma|Completed||Phase 2|69|Actual|Icagen||2|||f||||f||||||||||2017-02-18 13:17:02.780669|2017-02-18 13:17:02.780669
NCT00861172|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2013-06-20|||February 2009||2009-02-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|IRM 3T-SEP||Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy|Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy|Completed||N/A|6|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-02-18 13:17:02.901132|2017-02-18 13:17:02.901132
NCT00860951|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-06-10|2015-05-27||September 2008||2008-09-01|May 2015|2015-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Participants who completed the protocol.|P300 Brain Computer Interface Keyboard to Operate Assistive Technology||Completed||Phase 1/Phase 2|29|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 13:17:05.425455|2017-02-18 13:17:05.425455
NCT00861159|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2011-01-11|||September 2011||2011-09-01|January 2011|2011-01-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|||RLIP76 in Human Serum in Adults With Rheumatologic Diseases|Measurement Of RLIP76 Auto Antibodies in Human Serum In Adults With Rheumatologic Diseases.|Withdrawn||N/A|100|Anticipated|University of North Texas Health Science Center|||1|Study withdrawn due to lack of staffing resources and subject interest|f||||t||||||||||2017-02-18 13:17:03.007188|2017-02-18 13:17:03.007188
NCT00861146|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2014-02-27|2014-01-15||April 2009||2009-04-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk|Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk|Completed||Phase 2|151|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:17:03.115828|2017-02-18 13:17:03.115828
NCT00861133|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-05-04|||March 2009||2009-03-01|May 2009|2009-05-01|May 2011|Anticipated|2011-05-01|April 2011|Anticipated|2011-04-01||Interventional|||Cryptogenic Stroke Study|Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation After Cryptogenic Stroke|Unknown status|Recruiting|N/A|100|Anticipated|Transoma Medical||1|||f||||t||||||||||2017-02-18 13:17:03.668138|2017-02-18 13:17:03.668138
NCT00861120|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2012-10-25|||April 2009||2009-04-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|PaLiDo||Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type|Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Wild-type|Completed||Phase 2|33|Anticipated|Vejle Hospital||1|||f||||t||||||||||2017-02-18 13:17:03.753581|2017-02-18 13:17:03.753581
NCT00861107|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2011-06-06|||August 2009||2009-08-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation|Phase I/II Study of a Therapeutic Cancer Vacccine Created In-situ in Patients With Refractory or Metastatic Cancer|Completed||Phase 1/Phase 2|50|Anticipated|Immunovative Therapies, Ltd.||1|||f||||f||||||||||2017-02-18 13:17:04.016805|2017-02-18 13:17:04.016805
NCT00861094|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2015-12-17|||March 2008||2008-03-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|September 2011|Actual|2011-09-01||Interventional|||Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer|Phase II-III Study Comparing Radiochemotherapy With the FOLFOX Regimen Versus Radiochemotherapy With 5FU-cisplatin (Herskovic Regimen) in First Line Treatment of Patients With Inoperable Oesophageal Cancer.|Completed||Phase 2/Phase 3|266|Actual|UNICANCER||2|||f||||t||||||||||2017-02-18 13:17:04.139851|2017-02-18 13:17:04.139851
NCT00861081|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2014-01-06|||January 2010||2010-01-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|SUSTAIN||"Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to Stay Within the Guidelines"|"RCT of an Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to Stay Within the Guidelines (SUSTAIN)"|Completed||N/A|410|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 13:17:04.292055|2017-02-18 13:17:04.292055
NCT00861068|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2014-10-17|||February 2002||2002-02-01|March 2009|2009-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).|A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).|Completed||Phase 2|44|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 13:17:04.406933|2017-02-18 13:17:04.406933
NCT00861055|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2010-01-22|||March 2009||2009-03-01|January 2010|2010-01-01|December 2011|Anticipated|2011-12-01|February 2011|Anticipated|2011-02-01||Observational|NSS||Neonatal Sepsis and GBS Carriage Study|A Clinical and Microbiological Study of Early Onset Neonatal Sepsis in Refugee Infants and Group B Streptococcal Carriage in Expectant Refugee Mothers Living on the Thai-Burmese Border|Unknown status|Recruiting|N/A|160|Anticipated|University of Oxford|||2||f||||f||||||||||2017-02-18 13:17:04.519609|2017-02-18 13:17:04.519609
NCT00861042|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2014-09-19|||April 2002||2002-04-01|July 2010|2010-07-01|March 2005|Actual|2005-03-01|December 2004|Actual|2004-12-01||Interventional|||An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy|An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy|Completed||Phase 2|69|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 13:17:04.612667|2017-02-18 13:17:04.612667
NCT00861029|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2011-01-22|||March 2009||2009-03-01|November 2010|2010-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||VEG111485: A QTc Study of Pazopanib|VEG111485: A Phase I, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effect of Repeat Oral Doses ofPazopanib (GW786034) on Cardiac Conduction in Subjects withSolid Tumors|Completed||Phase 1|96|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:17:04.739313|2017-02-18 13:17:04.739313
NCT00861016|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||October 2005||2005-10-01|March 2009|2009-03-01|May 2006|Actual|2006-05-01|April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension|An Open-Label, Non-Comparative, Multi-Centre Study to Evaluate the Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet (Betaloc Zok) in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 4|310|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:17:04.875546|2017-02-18 13:17:04.875546
NCT00861003|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||April 2009||2009-04-01|March 2009|2009-03-01|August 2010|Anticipated|2010-08-01|December 2009|Anticipated|2009-12-01||Observational|MEMS-SPR||An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder|An Exploratory Study on Comparison of Electronic Monitoring and Other Measures of Adherence to Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder|Unknown status|Not yet recruiting|N/A|57|Anticipated|Korea University Guro Hospital|||1||f||||f||||||||||2017-02-18 13:17:04.976706|2017-02-18 13:17:04.976706
NCT00860990|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2015-06-25|||April 2007||2007-04-01|June 2015|2015-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|VA GI QOL||VA Gastrointestinal (GI) Quality of Life Survey|VA GI Quality of Life Survey|Terminated||N/A|100|Anticipated|VA Office of Research and Development|||2|Outcome measures are included in another, similar study.|f||||f||||||||||2017-02-18 13:17:05.073328|2017-02-18 13:17:05.073328
NCT00860561|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2014-10-09|||January 2009||2009-01-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Faslodex Post Marketing Surveillance|Faslodex Post Marketing Surveillance|Completed||N/A|42|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:17:10.845556|2017-02-18 13:17:10.845556
NCT00860938|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||April 2007||2007-04-01|March 2009|2009-03-01|May 2010|Anticipated|2010-05-01|June 2009|Anticipated|2009-06-01||Interventional|||Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD|Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Recruiting|Phase 4|100|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 13:17:05.650246|2017-02-18 13:17:05.650246
NCT00860925|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2010-03-08|||May 2009||2009-05-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|POISE2-pilot||PeriOperative ISchemic Evaluation-2 Pilot|PeriOperative ISchemic Evaluation-2 (POISE-2) Trial: A Pilot|Completed||Phase 4|90|Actual|McMaster University||4|||f||||f||||||||||2017-02-18 13:17:05.766403|2017-02-18 13:17:05.766403
NCT00860912|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-12|2009-03-12|||December 2001||2001-12-01|March 2009|2009-03-01||||May 2007|Actual|2007-05-01||Interventional|||Veritas Collagen Matrix Cystocele Repair Study - Postmarketing|Veritas Collagen Matrix Cystocele Repair Study - Postmarketing Protocol #CP1004|Completed||Phase 4|60|Anticipated|Cleveland Clinic Florida||2|||f||||f||||||||||2017-02-18 13:17:05.897978|2017-02-18 13:17:05.897978
NCT00860899|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2011-11-16|||December 2007||2007-12-01|November 2011|2011-11-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|PPSAPACL||Postoperative Pain and SIRS After Preoperative Analgesia With Clonidine or Levobupivacaine|Postoperative Pain and Systemic Inflammatory Stress Response (SIRS) After Preoperative Analgesia With Clonidine or Levobupivacaine|Completed||Phase 4|42|Actual|University Hospital Dubrava||2|||f||||f||||||||||2017-02-18 13:17:05.989332|2017-02-18 13:17:05.989332
NCT00860886|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2017-01-24|||February 26, 2009||2009-02-26|March 15, 2016|2016-03-15||||||||Observational|||Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast Cancer|Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast Cancer|Completed||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:17:06.104034|2017-02-18 13:17:06.104034
NCT00860873|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-02-22|||October 2009||2009-10-01|February 2013|2013-02-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Interventional|||Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis|"Randomized Study of Two Dosage Forms (Oral Powder and Capsule) of Chondroitin + Glucosamine Sulfate Produced by the Laboratory EMS When Compared to the Product Condroflex (Oral Powder and Capsules) Produced by Laboratory Zodiac in the Treatment of Osteoarthrosis."|Completed||Phase 3|280|Actual|Azidus Brasil||4|||f||||f||||||||||2017-02-18 13:17:06.217159|2017-02-18 13:17:06.217159
NCT00860860|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2012-03-16|||July 2009||2009-07-01|August 2010|2010-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|PRIT2008||Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer|Phase I Clinical Study of the Feasibility of Pretargeted Radioimmunotherapy of an Anti-CEA Bispecific Antibody and Lu-177-labeled Peptide in Patients With Advanced Colorectal Cancer|Completed||Phase 1|20|Actual|Radboud University||1|||f||||t||||||||||2017-02-18 13:17:06.326487|2017-02-18 13:17:06.326487
NCT00860847|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-02-28|2013-01-27||May 2009||2009-05-01|February 2015|2015-02-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)|Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)|Completed||Phase 3|65|Actual|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-02-18 13:17:06.457179|2017-02-18 13:17:06.457179
NCT00860834|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2014-03-28|||August 2008||2008-08-01|March 2014|2014-03-01|May 2014|Anticipated|2014-05-01|May 2013|Actual|2013-05-01||Interventional|PARTNER||Parents, Pediatricians, and Asthma Telephone Coaches Partner to Improve Control of Asthma in Children (The PARTNER Study)|Parents, Pediatricians, and Telephone Coaches Partner to Improve Control of Asthma|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 13:17:06.843616|2017-02-18 13:17:06.843616
NCT00860821|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-10-27|||March 2009||2009-03-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|||||Interventional|||A Methodology Study in Healthy Subjects to Evaluate the Effect of AZD8309 After Nasal Administration of Lipopolysaccharide (LPS)|A Randomised, Double-blind, Placebo-controlled, Two-way Crossover, Single-centre Methodologhy Study in Healthy Subjects to Evaluate the Effect of Oral Dosing With AZD8309 on Cells and Inflammatory Biomarkers in Nasal Lavage and Blood After Nasal Challenge With Lipopolysaccharide (LPS).|Completed||N/A|20|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:17:06.955208|2017-02-18 13:17:06.955208
NCT00860808|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2013-02-12|||March 2009||2009-03-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus|Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus: A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Multiple Dose, Group Comparison Phase II Study|Completed||Phase 2|248|Actual|Auris Medical, Inc.||3|||f||||t||||||||||2017-02-18 13:17:07.048222|2017-02-18 13:17:07.048222
NCT00860795|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2010-10-20|2010-09-28||March 2009||2009-03-01|October 2010|2010-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Immunologic Effects of Echinacea|Study of the Immunologic Effects of Echinacea Purpurea in Adults|Completed||N/A|20|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 13:17:07.152695|2017-02-18 13:17:07.152695
NCT00860782|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2016-06-29|||August 2008||2008-08-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|May 2016|Actual|2016-05-01||Interventional|||Parent Educational Program for Children With Sickle Cell Disease|Parent Intervention to Improve Academic Success in Children With Sickle Cell Disease|Active, not recruiting||N/A|160|Anticipated|University of Miami||2|||f||||t||||||||Undecided||2017-02-18 13:17:07.688356|2017-02-18 13:17:07.688356
NCT00860769|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2016-09-26|||September 2008||2008-09-01|September 2016|2016-09-01|June 2012|Actual|2012-06-01|March 2011|Actual|2011-03-01||Interventional|||Asha HIV Health Promotion Intervention in India|ASHA HIV Health Promotion Intervention in India|Completed||Phase 1/Phase 2|68|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 13:17:07.914036|2017-02-18 13:17:07.914036
NCT00860756|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-03-11|||September 2007||2007-09-01|March 2009|2009-03-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Sleep Disturbance in Deployed Soldiers|Sleep Disturbance in Deployed Soldiers|Unknown status|Recruiting|Early Phase 1|150|Anticipated|Brooke Army Medical Center||1|||f||||f||||||||||2017-02-18 13:17:08.018299|2017-02-18 13:17:08.018299
NCT00859989|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2013-12-17|||July 2004||2004-07-01|March 2009|2009-03-01||||April 2009|Anticipated|2009-04-01||Interventional|||A Weight-Loss Program in Helping Obese Black Women Lose Weight|Obesity Reduction Black Intervention Trial (ORBIT)|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:17:27.362022|2017-02-18 13:17:27.362022
NCT00860743|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2015-02-23|2014-12-10||September 2009||2009-09-01|February 2015|2015-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|RAP-IH|Overall 40 participants were enrolled in Aim 1. One OSA male and two healthy male participants were enrolled but withdrew from the study. Thus, the total number that completed Aim 1 was 37 participants.|Respiratory and Autonomic Plasticity Following Intermittent Hypoxia|Respiratory and Autonomic Plasticity Following Intermittent Hypoxia|Completed||Early Phase 1|63|Actual|VA Office of Research and Development|The primary limitation of this trial was the number of participants that required screening to recruit the participants that met the inclusion criteria for the study. However, once the participants were recruited few withdrew.|2|||f||||t||||||||||2017-02-18 13:17:08.136244|2017-02-18 13:17:08.136244
NCT00860730|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-05-21|||January 2009||2009-01-01|May 2014|2014-05-01|September 2015|Anticipated|2015-09-01|October 2009|Actual|2009-10-01||Interventional|||PERCEVAL Pivotal Trial|PERCEVAL Pivotal Trial|Unknown status|Active, not recruiting|N/A|150|Actual|LivaNova||1|||f||||t||||||||||2017-02-18 13:17:09.101502|2017-02-18 13:17:09.101502
NCT00860717|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-12-12|||November 2006||2006-11-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients|Clinic-Epidemiological Evaluation of Ulcers in Leprosy Patients and the Use of Low Level Laser Therapy: a Randomized Clinical Trial|Completed||N/A|25|Actual|Para Federal University||2|||f||||f||||||||||2017-02-18 13:17:09.214664|2017-02-18 13:17:09.214664
NCT00860704|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-04-06|||November 2007||2007-11-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|FLO1||Goal Directed Fluid Therapy|Intraoperative Goal Directed Fluid Therapy in Lean and Obese Patients|Completed||Phase 4|90|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:17:09.327618|2017-02-18 13:17:09.327618
NCT00860691|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2010-03-24|||January 2008||2008-01-01|March 2010|2010-03-01|June 2010|Anticipated|2010-06-01|July 2009|Actual|2009-07-01||Interventional|||Double Blinded Randomized Clinical Trial of the Effect of Open Versus Laparoscopic Colectomy on Neutrophils in Patients With Colon Cancer|Double Blinded Randomized Clinical Trial of the Effect of Open Versus Laparoscopic Colectomy on Neutrophils in Patients With Colon Cancer|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital Dubrava||3|||f||||t||||||||||2017-02-18 13:17:09.572418|2017-02-18 13:17:09.572418
NCT00860678|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-03-11||||||March 2009|2009-03-01||||||||Interventional|||Physical Activity in Patients After Aortic Valve Replacement (Valve-ex)|Influence of Regular Physical Activity on Exercise Capacity, Cardiac Remodeling and Endothelial Function in Patients After Aortic Valve Replacement|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Technische Universität München||2|||f||||||||||||||2017-02-18 13:17:09.701675|2017-02-18 13:17:09.701675
NCT00860665|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-03-11|||October 2006||2006-10-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Observational|||Case Volume and Adenoma Rate During Screening Colonoscopy|Case Volume and Adenoma Detection Rates During Screening Colonoscopy|Completed||N/A|12134|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-02-18 13:17:09.806897|2017-02-18 13:17:09.806897
NCT00860652|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2017-01-23|||March 2009||2009-03-01|January 2017|2017-01-01|December 2026|Anticipated|2026-12-01|December 2021|Anticipated|2021-12-01||Interventional|RAVES||Radiotherapy - Adjuvant Versus Early Salvage|Radiotherapy - Adjuvant Versus Early Salvage. A Phase III Multi-centre Randomised Trial Comparing Adjuvant Radiotherapy (RT) With Early Salvage RT in Patients With Positive Margins or Extraprostatic Disease Following Radical Prostatectomy.|Active, not recruiting||Phase 3|333|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||t||||||||||2017-02-18 13:17:09.917491|2017-02-18 13:17:09.917491
NCT00860639|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2017-01-26|||October 2007||2007-10-01|January 2017|2017-01-01|September 26, 2016|Actual|2016-09-26|September 26, 2016|Actual|2016-09-26||Interventional|LAM2006IR||Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk|Randomized Open Phase III Trial Testing Efficacy of Gemtuzumab Ozogamycin (MYLOTARG) Associated to Intensive Chemotherapy for Patients Aged Between 18-60 Years and Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk|Completed||Phase 3|327|Actual|Nantes University Hospital||2|||f||||t||||||||||2017-02-18 13:17:10.102273|2017-02-18 13:17:10.102273
NCT00860626|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-03-11|||January 2008||2008-01-01|March 2009|2009-03-01|February 2010|Anticipated|2010-02-01|December 2009|Anticipated|2009-12-01||Interventional|||Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B|Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B|Unknown status|Recruiting|N/A|50|Anticipated|Sun Yat-sen University||3|||f||||f||||||||||2017-02-18 13:17:10.260075|2017-02-18 13:17:10.260075
NCT00860613|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-03-11|||February 2004||2004-02-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|June 2007|Actual|2007-06-01||Interventional|||Medical Nutrition Therapy Program for Pregnant Women With Diabetes|Medical Nutrition Therapy Program for Pregnant Women With Diabetes: Evaluation of Two Different Dietary Strategies on Metabolic Control, Maternal and Fetal Nutritional Status and Cost Effectiveness.|Completed||N/A|162|Actual|Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes||3|||f||||f||||||||||2017-02-18 13:17:10.365595|2017-02-18 13:17:10.365595
NCT00860600|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2015-11-03|||September 2008||2008-09-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients|The Clinical Trial of PG2 in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)|Completed||Phase 2|14|Actual|PhytoHealth Corporation||2|||f||||f||||||||||2017-02-18 13:17:10.475905|2017-02-18 13:17:10.475905
NCT00860587|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-03-11|||February 2006||2006-02-01|March 2009|2009-03-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Observational|Bakki||Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections|Risk Factors for Colonization and Infection With Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections (IAI). An Open Observational Study|Unknown status|Active, not recruiting|N/A|200|Anticipated|University Hospital, Linkoeping|||1||f||||f||||||||||2017-02-18 13:17:10.607808|2017-02-18 13:17:10.607808
NCT00860574|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2013-10-29|||February 2009||2009-02-01|October 2013|2013-10-01||||February 2013|Actual|2013-02-01||Interventional|||Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia|A Multi-Center Study of Conditioning With Treosulfan, Fludarabine and Escalating Doses of TBI for Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome (MDS), and Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2|96|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 13:17:10.698384|2017-02-18 13:17:10.698384
NCT00860548|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2016-05-16|||June 2005||2005-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||SCOT Scleroderma Treatment Alternative Registry (STAR Registry)|An Observational, Long-term Follow-up Study of Eligible Individuals Declining To Participate in the Scleroderma Cyclophosphamide or Transplantation (SCOT) Study (SCSSc-02)|Completed||N/A|19|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||||||2017-02-18 13:17:10.946284|2017-02-18 13:17:10.946284
NCT00860535|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2015-09-28|2011-06-28||June 2009||2009-06-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)|A Multicenter Phase Ib Trial to Determine Whether a Gene Expression Signature Changes in Response to Treatment With Bcr-Abl Inhibitors in Patients With Blast Phase Philadelphia Chromosome Positive Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphocytic Leukemia|Terminated||Phase 1|9|Actual|Merck Sharp & Dohme Corp.|Part I aimed to have 10 evaluable patients. Due to slow enrollment, 9 patients who met the inclusion/exclusion criteria were enrolled over a period of 9 months. Part I was terminated early and Part II was cancelled due to slow enrollment.|1|||f||||f||||||||||2017-02-18 13:17:11.055282|2017-02-18 13:17:11.055282
NCT00860522|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2017-01-26|||March 2009|Actual|2009-03-01|January 2017|2017-01-01|October 19, 2017|Anticipated|2017-10-19|October 31, 2014|Actual|2014-10-31||Interventional|||JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia|A Phase I Trial of the Immunostimulant JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia|Active, not recruiting||Phase 1|23|Anticipated|Milton S. Hershey Medical Center||2|||f||||t||||||||Undecided|To determine if data is valuable|2017-02-18 13:17:11.266513|2017-02-18 13:17:11.266513
NCT00860509|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2012-05-02|||November 2006||2006-11-01|May 2012|2012-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|Phyteaux-II||Comparison of Low and High Phytosterol Diets With Respect to Cholesterol Metabolism|Phyteaux-II- Regulation of Cholesterol Absorption: Response of LDL to Low and Naturally High Phytosterol Diets|Completed||N/A|20|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:17:11.373334|2017-02-18 13:17:11.373334
NCT00860496|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-08-12|||June 2009||2009-06-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers|A Phase I, Open Label, Fixed-Sequence Study to Estimate the Effect of Tacrolimus and Cyclosporine on the Pharmacokinetics of CP-690,550 in Healthy Volunteers|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:17:11.475735|2017-02-18 13:17:11.475735
NCT00860483|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2012-12-03|||February 2008||2008-02-01|December 2012|2012-12-01|November 2009|Actual|2009-11-01|February 2009|Actual|2009-02-01||Interventional|||Correlation of Laparoscopic Experience and Functional Brain Activation: A PET Scan Study|GAC 0201 Correlation of Laparoscopic Experience and Functional Brain Activation: A Pet Scan Study|Completed||N/A|10|Anticipated|Northwell Health||1|||f||||f||||||||||2017-02-18 13:17:11.579899|2017-02-18 13:17:11.579899
NCT00860470|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-05-07|2015-05-07||January 2008||2008-01-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|JiVitA-3||Antenatal Micronutrient Supplementation and Infant Survival|Antenatal Multiple Micronutrient Supplementation to Improve Infant Survival and Health in Bangladesh|Completed||Phase 3|44567|Actual|Johns Hopkins Bloomberg School of Public Health|The study was run in an area where iron deficiency rates were low.|2|||f||||t||||||||||2017-02-18 13:17:11.679694|2017-02-18 13:17:11.679694
NCT00860457|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2014-08-04|2014-02-24||February 2008||2008-02-01|August 2014|2014-08-01|February 2012|Actual|2012-02-01|March 2011|Actual|2011-03-01||Interventional|||Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)|Lenalidomide Following Rituximab and Fludarabine in Untreated Chronic Lymphocytic Leukemia|Completed||Phase 2|22|Actual|Georgetown University||1|||f||||t||||||||||2017-02-18 13:17:12.389171|2017-02-18 13:17:12.389171
NCT00860444|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2014-01-06|||May 2005||2005-05-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|HHER||Cardiovascular Risk Reduction Program Aimed at African American Women (The HHER Lifestyle Program)|The Heart Healthy and Ethnically Relevant (HHER) Lifestyle Program for Cardiovascular Risk Reduction|Completed||Phase 3|266|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-02-18 13:17:12.939306|2017-02-18 13:17:12.939306
NCT00860431|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2014-03-17|||March 2009||2009-03-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|K-STAR||Kremezin Study Against Renal Disease Progression in Korea|K-STAR (Kremezin STudy Against Renal Disease Progression in Korea) Randomized, Open-label, Controlled Study|Completed||Phase 4|578|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 13:17:13.039969|2017-02-18 13:17:13.039969
NCT00860418|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-08-31|||September 2008||2008-09-01|June 2011|2011-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PAAL||Pediatric Asthma Alert Intervention for Minority Children With Asthma|Pediatric Asthma Alert Intervention for Minority Children|Completed||Phase 2|350|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 13:17:13.137744|2017-02-18 13:17:13.137744
NCT00860405|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2011-11-01|2011-08-12||March 2009||2009-03-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Voluven® in Paediatric Patients|Efficacy and Safety of 6 % Hydroxyethyl Starch 130/0.4 (Voluven®) vs. 5% HSA in Volume Replacement Therapy During Elective Open-heart Surgery in Paediatric Patients|Completed||Phase 4|61|Actual|Fresenius Kabi||2|||f||||||||||||||2017-02-18 13:17:13.257832|2017-02-18 13:17:13.257832
NCT00860392|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-02-24|||March 2009||2009-03-01|February 2015|2015-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Comparison of Measurements of Ketone Body Flux Versus Ketone Body Concentration as a Pharmacodynamic Marker of Hepatic Fatty Acid Oxidation (0000-110)|A Comparison of Measurements of Ketone Body Flux Versus Ketone Body Concentration as a Pharmacodynamic Marker of Hepatic Fatty Acid Oxidation|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:17:13.995099|2017-02-18 13:17:13.995099
NCT00860379|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2017-01-03|||January 2009||2009-01-01|January 2017|2017-01-01|January 2019|Anticipated|2019-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Effect of Selenium Supplementation Among Pediatric Patients With Burns|The Effect of Selenium Supplementation Among Pediatric Patients With Burns|Active, not recruiting||Phase 4|14|Actual|Shriners Hospitals for Children||3|||f||||t||||||||No||2017-02-18 13:17:14.074399|2017-02-18 13:17:14.074399
NCT00860366|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-03-09|||June 2011||2011-06-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|August 2013|Actual|2013-08-01||Interventional|Urico-Ictus||Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke|Randomized, Double Blind Study Assessing the Clinical Efficacy of Combined Treatment With Uric Acid and rtPA Administered Intravenously in Acute Ischemic Stroke Patients Within the First 4.5 Hours of Symptoms Onset|Completed||Phase 2/Phase 3|421|Actual|Fundacion Clinic per a la Recerca Biomédica||2|||f||||t||||||||||2017-02-18 13:17:14.176089|2017-02-18 13:17:14.176089
NCT00860353|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2010-12-02|||February 2009||2009-02-01|December 2010|2010-12-01|May 2009|Actual|2009-05-01|||||Interventional|||Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551|A Double Blind, Randomised, Placebo-controlled, Phase I Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single, Ascending, Oral Doses of AZD2551 in Healthy Male Subjects|Terminated||Phase 1|90|Anticipated|AstraZeneca||2||"Due to portfolio and logistical issues, this study will not be re-started at the present time.~   The study is not being terminated for safety reasons."|f||||f||||||||||2017-02-18 13:17:14.294615|2017-02-18 13:17:14.294615
NCT00860340|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2014-12-09|||February 2003||2003-02-01|December 2014|2014-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Hemodynamic Effects of Spironolactone in Patients With Heart Failure|Hemodynamic Effects of Spironolactone in Patients With Heart Failure|Completed||N/A|18|Actual|University of Toledo Health Science Campus||1|||f||||f||||||||||2017-02-18 13:17:14.388936|2017-02-18 13:17:14.388936
NCT00860327|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2016-08-19|||December 2007||2007-12-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Examining Developmental Changes in Heart Contractions of Children With Congenital Heart Defects|Excitation-contraction Coupling in Human Ventricle Development|Terminated||N/A|375|Actual|Emory University|||2||f||||f||||||Samples Without DNA|"~     Ventricular tissue, that would have been discarded, and was removed during surgery as part~     of the necessary repair for congenital heart defects~   "|||2017-02-18 13:17:14.481756|2017-02-18 13:17:14.481756
NCT00860314|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-08-17|2008-11-10||January 2005||2005-01-01|August 2015|2015-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|APOVERSAL||Antero-posterior Versus Antero-lateral Electrode Position for Electrical Cardioversion of Typical Atrial Flutter|Prospective, Randomized Single-center Study for Efficacy of Antero-posterior and Antero-lateral Electrode Position for External Electrical Cardioversion of Typical Atrial Flutter|Terminated||N/A|96|Actual|Universitätsklinikum Hamburg-Eppendorf||2||Statistical interim analysis showed valid and significant results|f||||f||||||||||2017-02-18 13:17:14.585255|2017-02-18 13:17:14.585255
NCT00860301|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-03-11|||December 2006||2006-12-01|March 2009|2009-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Acupuncture in Infantile Colic|Acupuncture in Infantile Colic - a Randomised Controlled Double Blind Clinical Study|Completed||N/A|90|Actual|Lund University||2|||f||||f||||||||||2017-02-18 13:17:17.157548|2017-02-18 13:17:17.157548
NCT00860288|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2013-01-03||2013-01-02|February 2009||2009-02-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes||Completed||Phase 2/Phase 3|1988|Actual|Novartis||4|||f||||||||||||||2017-02-18 13:17:17.271697|2017-02-18 13:17:17.271697
NCT00860275|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2011-01-24|||April 2009||2009-04-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole|A Study of the Effect of Concomitant Administration of Ketoconazole or Fluconazole on the Pharmacokinetics of BMS-708163 in Healthy Subjects|Completed||Phase 1|30|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 13:17:19.660249|2017-02-18 13:17:19.660249
NCT00860262|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2014-05-16|2010-12-10||March 2009||2009-03-01|May 2014|2014-05-01||||December 2009|Actual|2009-12-01||Interventional|||Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension|An 8-week Randomised, Double-blind Study to Compare the Fixed-dose Combination of Telmisartan 80 mg & Amlodipine 10mg Versus Telmisartan 80 mg Monotherapy or Amlodipine 10 mg Monotherapy as First Line Therapy in Patients With Severe Hypertension (Grade 3).|Completed||Phase 3|858|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 13:17:19.782124|2017-02-18 13:17:19.782124
NCT00860249|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2011-11-30|2011-09-02||March 2009||2009-03-01|November 2011|2011-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|UPQUAL||Outreach for Patients That Are Newly Eligible for Colorectal Cancer Screening|Using Precision Performance Measurement To Conduct Focused Quality Improvement. Sub-study 2|Terminated||N/A|60|Actual|Northwestern University|Early termination prior to collection of primary or secondary outcome measures, hence no analyses of the primary or secondary outcomes were performed.Thus, the only results reported are baseline characteristics of enrolled participants.|3||"Lack of sufficient participants meeting the eligibility criteria to complete study in proposed~   and acceptable time frame."|f||||f||||||||||2017-02-18 13:17:22.354822|2017-02-18 13:17:22.354822
NCT00860236|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2009-04-22|||March 2009||2009-03-01|April 2009|2009-04-01|December 2010|Anticipated|2010-12-01|May 2010|Anticipated|2010-05-01||Interventional|GIFF||Giardia Induced Fatigue and Functional Gastrointestinal Diseases|Chronic Fatigue Syndrome and Abdominal Symptoms After Giardia Infection: Clinical Evaluation, Biomarkers, Risk Factors and the Effect of Intervention|Unknown status|Enrolling by invitation|Phase 4|40|Anticipated|University of Bergen||2|||f||||f||||||||||2017-02-18 13:17:22.802449|2017-02-18 13:17:22.802449
NCT00860223|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2012-05-10|||April 2009||2009-04-01|May 2012|2012-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin|An Open-Label, Nonrandomized, Crossover Study to Evaluate the Potential Effect of Multiple Doses of Neratinib on the Pharmacokinetics of a Single Dose of Digoxin When Administered Orally to Healthy Adult Subjects|Completed||Phase 1|27|Actual|Puma Biotechnology, Inc.||2|||f||||f||||||||||2017-02-18 13:17:22.90255|2017-02-18 13:17:22.90255
NCT00860210|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2010-04-09|||October 2007||2007-10-01|April 2010|2010-04-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|||Pilot Study Assessing the Feasibility of Treating Foot Drop With the Neurostep™ System.|Pilot Feasibility Study of the Neurostep™ System in Subjects With Gait Disorder Secondary to CNS Lesion.|Completed||Phase 1|14|Actual|Neurostream Technologies G.P.||1|||f||||t||||||||||2017-02-18 13:17:23.004379|2017-02-18 13:17:23.004379
NCT00860197|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2015-11-30|||March 2009||2009-03-01|November 2015|2015-11-01|February 2010|Actual|2010-02-01|May 2009|Actual|2009-05-01||Interventional|||Immune Benefits of Coffee|Effect of Coffee Consumption on Immune and Inflammatory Status in Elderly|Completed||N/A|116|Actual|University of Chile||3|||f||||f||||||||||2017-02-18 13:17:23.099588|2017-02-18 13:17:23.099588
NCT00860184|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2011-04-13|||November 2009||2009-11-01|April 2011|2011-04-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|SmartRisk||SmartRisk Stroke Prediction by MRI of Carotid Disease|Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals|Unknown status|Recruiting|N/A|300|Anticipated|VPDiagnostics|||1||f||||t||||||||||2017-02-18 13:17:23.421127|2017-02-18 13:17:23.421127
NCT00860171|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2016-06-10|||February 2009||2009-02-01|June 2016|2016-06-01||||March 2015|Actual|2015-03-01||Interventional|||Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma|A Study Evaluating Escalating Doses of 131I-BC8 (Anti-CD45) Antibody Followed by Autologous Stem Cell Transplantation for Relapsed or Refractory Lymphoid Malignancies|Active, not recruiting||Phase 1|16|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 13:17:23.531015|2017-02-18 13:17:23.531015
NCT00860158|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2016-02-04|2016-01-07||March 2009||2009-03-01|February 2016|2016-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer|A Phase II Study of Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer|Terminated||Phase 2|1|Actual|Hoosier Cancer Research Network|This study was terminated due to slow accrual and no results were analyzed.|1||Slow accrual; closed by funder|f||||t||||||||No||2017-02-18 13:17:23.641193|2017-02-18 13:17:23.641193
NCT00860145|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-11|2016-05-12|||September 2009||2009-09-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|ROSE||Radiosurgery or Open Surgery for Epilepsy Trial|Radiosurgery Versus Lobectomy for Temporal Lobe Epilepsy|Active, not recruiting||Phase 3|61|Actual|University of California, San Francisco||2|||f||||t||||||||Yes|Preliminary report 12/2016 at the American Epilepsy Society meeting. Full paper to follow.|2017-02-18 13:17:24.090523|2017-02-18 13:17:24.090523
NCT00860132|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-03-10|||May 2009||2009-05-01|March 2009|2009-03-01||||||||Observational|||Economic Aspects Associated With the Implementation of an Orthogeriatric Setting in a General Hospital|Economic Aspects Associated With the Implementation of an Orthogeriatric Setting in a General Hospital|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 13:17:24.225176|2017-02-18 13:17:24.225176
NCT00860119|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-11-11|||August 2009||2009-08-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Bioequivalence of Alprazolam Sublingual vs Oral Tablets|Open-Label, Randomized, Single-Dose, 2-Way Crossover Pivotal Bioequivalence Study Comparing Alprazolam Immediate Release (IR) Tablets (Administered Orally) And Alprazolam Sublingual (SL) Tablets (Administered Sublingually)|Completed||Phase 1|23|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:17:24.299952|2017-02-18 13:17:24.299952
NCT00860106|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2011-10-10|||March 2005||2005-03-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|VAPRED||Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation|Study of Predictive Echo Doppler Score and D-dimer Level in Evaluation of the Thromboembolic Event Recurrence After Anticoagulant Treatment Cessation.|Completed||Phase 4|222|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-02-18 13:17:24.411608|2017-02-18 13:17:24.411608
NCT00860093|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2011-01-25|||April 2010||2010-04-01|January 2011|2011-01-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Interventional|||Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy|A Multi-Site Placebo-Controlled Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Using MPC-5971 as Adjuvant Therapy in Subjects Undergoing Shock Wave Lithotripsy|Terminated||Phase 2|135|Anticipated|Mission Pharmacal||2||Sponsor Corporate Business Decision|f||||t||||||||||2017-02-18 13:17:24.544168|2017-02-18 13:17:24.544168
NCT00860080|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2010-04-22|||March 2009||2009-03-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety Study Investigating Local Tolerability and Pharmacokinetics of PXL01 in Healthy Volunteers|A First in Man, Phase I, Single-blind, Placebo-controlled Study Investigating the Local Tolerability, Safety and Pharmacokinetics in Three Doses of PXL01 and Placebo in 15 Healthy Volunteers|Completed||Phase 1|15|Actual|PharmaSurgics AB||2|||f||||t||||||||||2017-02-18 13:17:24.65846|2017-02-18 13:17:24.65846
NCT00860067|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2011-11-30|2011-06-10||March 2009||2009-03-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Interventional|MI-CP185||A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age|A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of MEDI3250 in Adults 18 to 49 Years of Age|Completed||Phase 2/Phase 3|1800|Actual|MedImmune LLC||3|||f||||t||||||||||2017-02-18 13:17:24.776512|2017-02-18 13:17:24.776512
NCT00860054|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2012-04-17|||March 2006||2006-03-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|September 2006|Actual|2006-09-01||Interventional|phyteaux-I||Addition of Phytosterols to a Low Phytosterol Diet|Regulation of Cholesterol Absorption: Dose Response of LDL to Phytosterols Added to a Phytosterol-Poor Diet|Completed||N/A|18|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-02-18 13:17:26.000913|2017-02-18 13:17:26.000913
NCT00860041|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2016-07-12|||February 2009||2009-02-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|April 2011|Actual|2011-04-01||Observational|||Acute Pain Caused by Paclitaxel in Patients With Cancer|Paclitaxel-Associated Acute Pain Syndrome Natural History Study|Completed||N/A|306|Actual|Alliance for Clinical Trials in Oncology|||4||f||||f||||||||||2017-02-18 13:17:26.11134|2017-02-18 13:17:26.11134
NCT00860028|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2013-01-28|2012-01-03||October 2008||2008-10-01|January 2013|2013-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Varenicline for Smoking Cessation in Heavy Drinking Smokers|Varenicline for Smoking Cessation in Heavy Drinking Smokers|Completed||Phase 2|30|Actual|Yale University||2|||f||||t||||||||||2017-02-18 13:17:26.699452|2017-02-18 13:17:26.699452
NCT00860015|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-11-01|||August 2005||2005-08-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|August 2009|Actual|2009-08-01||Interventional|||Alimta Plus Gemcitabine for Advanced Sarcoma|Alimta Plus Gemcitabine as Chemotherapy for Patients With Advanced Sarcoma: A Phase II Clinical|Completed||Phase 2|12|Actual|Columbia University||1|||f||||t||||||||||2017-02-18 13:17:27.177561|2017-02-18 13:17:27.177561
NCT00860002|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2010-06-06|||January 2009||2009-01-01|June 2010|2010-06-01|December 2014|Anticipated|2014-12-01|December 2010|Anticipated|2010-12-01||Observational|||The Benefits and Limits of Laparoscopic Surgery for Uterine Fibroids|The Benefits and Limits of Laparoscopic Surgery for Uterine Fibroids|Unknown status|Recruiting|N/A|1200|Anticipated|Taipei Veterans General Hospital, Taiwan|||17||f||||f||||||||||2017-02-18 13:17:27.276128|2017-02-18 13:17:27.276128
NCT00859976|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2016-07-28|||March 2009||2009-03-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|June 2012|Actual|2012-06-01||Interventional|||Study Comparing BoneMaster Hydroxyapatite Coating With Plasma-sprayed Hydroxyapatite Coating on Acetabular Cups|Prospective Randomised Control Trial to Compare the Effect Upon Bone Density and Clinical Outcomes When Using BoneMaster HA Coated Acetabular Cups Compared With Plasma Sprayed HA Coated Cups in Patients With Total Hip Replacements|Completed||N/A|193|Actual|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-02-18 13:17:27.459303|2017-02-18 13:17:27.459303
NCT00859963|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2016-09-23|||March 2009||2009-03-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Regenerex Tibial Tray Multi-Center Data Collection|Regenerex Tibial Tray Multi-Center Data Collection|Enrolling by invitation||N/A|200|Anticipated|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-02-18 13:17:27.563669|2017-02-18 13:17:27.563669
NCT00859950|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2015-12-29|||April 2009||2009-04-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea|Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea|Completed||N/A|70|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 13:17:27.65174|2017-02-18 13:17:27.65174
NCT00859937|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2016-11-01|2014-06-19||March 2009||2009-03-01|November 2016|2016-11-01||||January 2013|Actual|2013-01-01||Interventional|||Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors|Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and Non-Adenoid Cystic Malignant Salivary Tumors|Active, not recruiting||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:17:27.757539|2017-02-18 13:17:27.757539
NCT00859911|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2009-03-09|||March 2008||2008-03-01|March 2009|2009-03-01|October 2011|Anticipated|2011-10-01|March 2011|Anticipated|2011-03-01||Interventional|||The Effectiveness of Micronutrient Supplements on Growth and Educational Achievement of Schoolchildren in Bangladesh|The Effectiveness of Multiple Micronutrient Supplements Given by Teachers to School-Age Children on Growth and Educational Achievement|Unknown status|Active, not recruiting|N/A|2300|Actual|Save the Children||2|||f||||f||||||||||2017-02-18 13:17:28.324081|2017-02-18 13:17:28.324081
NCT00859898|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2016-05-30|2014-02-04||April 2009||2009-04-01|May 2016|2016-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||All randomized participants who took at least one dose of double-blind study medication.|Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin 10 mg in Combination With Metformin as Initial Therapy as Compared With Dapagliflozin 10 mg Monotherapy and Metformin Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|Completed||Phase 3|1093|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 13:17:28.446253|2017-02-18 13:17:28.446253
NCT00859885|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2014-09-08|||January 2009||2009-01-01|September 2014|2014-09-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Observational|||International PFO Consortium|Secondary Stroke Prevention In Patients With Patent Foramen Ovale: International PFO Consortium|Unknown status|Recruiting|N/A|1500|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-02-18 13:17:30.235239|2017-02-18 13:17:30.235239
NCT00859872|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-07-31|||August 2008||2008-08-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia|Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol IM Injection for Treatment of Acute Psychotic Agitation in Schizophrenia|Completed||Phase 4|198|Actual|Central South University||2|||f||||t||||||||||2017-02-18 13:17:30.378938|2017-02-18 13:17:30.378938
NCT00859859|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2011-07-19|||October 2006||2006-10-01|July 2011|2011-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Vagus Nerve Stimulation in Rheumatoid Arthritis|Vagus Nerve Stimulation in Rheumatoid Arthritis|Terminated||Phase 1|23|Actual|Northwell Health||1||"The protocol was terminated early (prior to complete enrollment) after interim analysis proved~   data to be statistically insignificant"|f||||f||||||||||2017-02-18 13:17:30.500186|2017-02-18 13:17:30.500186
NCT00859846|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2014-12-03|||March 2009||2009-03-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Ultrasound Guided Arterial Line Placement in Long Axis Versus Short Axis in Pediatric Patients|Comparison of Ultrasound Guided Arterial Line Placement in Long Axis Versus Short Axis in Pediatric Patients.|Unknown status|Recruiting|N/A|74|Anticipated|University of Oklahoma||1|||f||||t||||||||||2017-02-18 13:17:30.584027|2017-02-18 13:17:30.584027
NCT00859833|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2011-05-20|2010-11-01||February 2009||2009-02-01|May 2011|2011-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Body Mass Index on the Hyperemic Response to Regadenoson|Effects of Body Mass Index on the Hyperemic Response to Regadenoson|Completed||N/A|30|Actual|University of Utah|Due to technical problems, data from two of the 30 subjects was not usable.|1|||f||||f||||||||||2017-02-18 13:17:30.690595|2017-02-18 13:17:30.690595
NCT00859807|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2010-04-20|||May 2009||2009-05-01|April 2010|2010-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects|A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects|Completed||Phase 4|38|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:17:30.927286|2017-02-18 13:17:30.927286
NCT00859794|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2017-01-13|||November 2007||2007-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||An Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy|An Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy Using Electrophysiology, Cortical Mapping, and fMRI|Enrolling by invitation||N/A|200|Anticipated|Northwell Health|||1||f||||t||||||||||2017-02-18 13:17:31.034423|2017-02-18 13:17:31.034423
NCT00859781|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2017-02-01|||June 2009|Actual|2009-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer|A Randomized Phase 2 Trial of 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With High-Risk Castrate Biochemically Relapsed Prostate Cancer After Local Therapy|Recruiting||Phase 2|140|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||No||2017-02-18 13:17:31.130402|2017-02-18 13:17:31.130402
NCT00859768|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2011-03-07|||April 2008||2008-04-01|March 2009|2009-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients|The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients Treated With Radiotherapy.|Completed||N/A|568|Actual|Netherlands Open University||4|||f||||f||||||||||2017-02-18 13:17:31.297162|2017-02-18 13:17:31.297162
NCT00859755|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2012-08-29|||March 2009||2009-03-01|August 2012|2012-08-01||||July 2009|Actual|2009-07-01||Interventional|||A Safety Study of ARRY-403 in Patients With Type 2 Diabetes||Completed||Phase 1|41|Actual|Array BioPharma||2|||f||||||||||||||2017-02-18 13:17:31.432323|2017-02-18 13:17:31.432323
NCT00859742|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-03-10|||March 2009||2009-03-01|March 2009|2009-03-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) for Mediastinal Re-Staging of Non-Small Cell Lung Cancer (NSCLC)|Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for the Mediastinal Re-Staging After Induction Therapy in Non-Small Cell Lung Cancer. A Prospective Study|Unknown status|Active, not recruiting|N/A|40|Anticipated|National Cancer Center, Korea||1|||f||||t||||||||||2017-02-18 13:17:31.525541|2017-02-18 13:17:31.525541
NCT00859729|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2014-03-14|||December 2008||2008-12-01|March 2014|2014-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer|DNA Vaccine Coding for the Rhesus Prostate Specific Antigen (rhPSA) and Electroporation in Patients With Relapsed Prostate Cancer. A Phase I/II Study|Completed||Phase 1/Phase 2|15|Actual|Uppsala University||5|||f||||t||||||||||2017-02-18 13:17:31.663895|2017-02-18 13:17:31.663895
NCT00859716|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-03-10|||October 2008||2008-10-01|March 2009|2009-03-01|July 2009|Anticipated|2009-07-01|March 2009|Anticipated|2009-03-01||Interventional|ACE393-103VC||ACE393-103 Vaccination Challenge Study|A Randomized, Double-Blind, Placebo Controlled Vaccination-Challenge Study of ACE393 to Determine Efficacy Against the Symptoms of Moderate to Severe Campylobacter Jejuni Infection in Normal Healthy Volunteers|Unknown status|Active, not recruiting|Phase 2|72|Anticipated|TD Vaccines A/S||2|||f||||t||||||||||2017-02-18 13:17:31.788695|2017-02-18 13:17:31.788695
NCT00859703|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2013-10-30|||November 2009||2009-11-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|RISAROS||Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer|Randomized, Double-blinded, Placebo Controlled Study to Assess Efficacy of Oral 35 mg Per Week Risedronate in Preventing Bone Loss in Postmenopausal Women With Aromatase Inhibitor Therapy for Breast Cancer.|Completed||Phase 3|20|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-02-18 13:17:31.911464|2017-02-18 13:17:31.911464
NCT00859690|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2013-07-25|||March 2009||2009-03-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Regulation of Vascular Thrombosis in Sleep Apnea|Regulation of Vascular Thrombosis in Sleep Apnea|Completed||N/A|14|Actual|Weill Medical College of Cornell University|||2||f||||f||||||Samples With DNA|"~     A total of 15ml (approximately 1 tablespoon) of whole blood will be collected from each~     subject during his or her out-patient office visit. This sample will be retained for genomic~     analysis~   "|||2017-02-18 13:17:32.013476|2017-02-18 13:17:32.013476
NCT00859677|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2016-06-14|||March 2009||2009-03-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|November 2010|Actual|2010-11-01||Observational|MRSA-2||Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection|Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection|Suspended||N/A|52|Actual|Uniformed Services University of the Health Sciences|||6|Enrollment was stopped due to staffing issues.|f||||t||||||Samples With DNA|"~     Skin biopsy will be obtained.~   "|||2017-02-18 13:17:32.104495|2017-02-18 13:17:32.104495
NCT00859664|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-03-10|||March 2009||2009-03-01|March 2009|2009-03-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Observational|||Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders||Unknown status|Recruiting|N/A|500|Anticipated|Assaf-Harofeh Medical Center|||1||f||||||||||||||2017-02-18 13:17:32.203432|2017-02-18 13:17:32.203432
NCT00859651|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2015-06-30|||June 2009||2009-06-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Vitamin D in Postmenopausal Women at High Risk for Breast Cancer|Effects of High-Dose Vitamin D on Circulating Vitamin D Levels and Breast Density in Postmenopausal Women at High Risk for Breast Cancer Development|Completed||Phase 2|20|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 13:17:32.299799|2017-02-18 13:17:32.299799
NCT00859638|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2010-06-17|2009-09-29||May 2008||2008-05-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||I Am Able: Population Based Rehabilitation in a Family Health Team|I Am Able: Population Based Rehabilitation in a Family Health Team|Completed||N/A|124|Actual|McMaster University|The limited duration of the study period may not allow sufficient time to show the difference in outcome measures such as self-rated health and health care utilization.|2|||f||||f||||||||||2017-02-18 13:17:32.418373|2017-02-18 13:17:32.418373
NCT00859625|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2015-01-20|||November 2008||2008-11-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||The Impact of Active Nurse Participation on Adenoma Detection During Routine Colonoscopy|The Impact of Active Nurse Participation on Adenoma Detection During Routine Colonoscopy|Completed||N/A|500|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:17:32.791899|2017-02-18 13:17:32.791899
NCT00859612|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2015-06-03|||March 2009||2009-03-01|June 2015|2015-06-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Renal Osteodystrophy: A Fresh Approach|Renal Osteodystrophy: A Fresh Approach|Completed||N/A|464|Actual|University of Kentucky|||1||f||||f||||||Samples Without DNA|"~     blood samples and bone biopsy samples~   "|||2017-02-18 13:17:35.145413|2017-02-18 13:17:35.145413
NCT00859599|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2011-06-07|||August 2008||2008-08-01|June 2011|2011-06-01|April 2012|Anticipated|2012-04-01|December 2011|Anticipated|2011-12-01||Interventional|||Monochromatic Phototherapy on Diabetic Foot Ulcers|Monochromatic Phototherapy on Diabetic Foot Ulcers. A Twenty Weeks Prospective, Randomised, Double Blind, Multi-centre, Placebo Controlled Study|Unknown status|Recruiting|Phase 3|107|Anticipated|Biolight AB||2|||f||||f||||||||||2017-02-18 13:17:35.224421|2017-02-18 13:17:35.224421
NCT00859586|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2015-10-05|2015-10-05||February 2009||2009-02-01|August 2014|2014-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation|Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation|Completed||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 13:17:35.349024|2017-02-18 13:17:35.349024
NCT00859573|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2011-06-17|2011-04-15||April 2009||2009-04-01|June 2011|2011-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Modafinil for Methamphetamine Dependence|Clinical Efficacy of Modafinil in Recently-Abstinent Methamphetamine-Dependent Volunteers|Terminated||Phase 2|9|Actual|University of Arkansas|Early termination leading to small numbers of subjects analyzed. Small number of completers leading to small numbers of subjects analyzed.|2||Terminated due to lack of funding.|f||||t||||||||||2017-02-18 13:17:35.607209|2017-02-18 13:17:35.607209
NCT00859560|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-03-10|||January 2008||2008-01-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|||||Observational|||Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg|Retrospective Survey of Bone Fracture in Post-Menopausal Breast Cancer Patients With Arimidex 1 mg as Adjuvant Therapy|Completed||N/A|2205|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 13:17:35.96234|2017-02-18 13:17:35.96234
NCT00859547|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-01-25|2011-11-03||March 2009||2009-03-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants|A Phase 4, Open-Label, Single-Group Safety and Immunogenicity Study of RECOTHROM® (rThrombin) in Pediatric Subjects Undergoing Synchronous Burn Wound Excision and Skin Grafting|Completed||Phase 4|30|Actual|ZymoGenetics||1|||f||||t||||||||||2017-02-18 13:17:36.048335|2017-02-18 13:17:36.048335
NCT00859534|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-09-13|||December 2008||2008-12-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Phase II Solar Urticaria (SU) Pilot Study|A Phase II, Open Label Pilot Study to Evaluate the Safety and Efficacy of A Bioresorbable Subcutaneous Implant of CUV1647 in Patients With Solar Urticaria (SU)|Completed||Phase 2|5|Actual|Clinuvel Pharmaceuticals Limited||1|||f||||f||||||||||2017-02-18 13:17:36.631278|2017-02-18 13:17:36.631278
NCT00859521|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2009-07-09|2009-07-09||January 2007||2007-01-01|July 2009|2009-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Levetiracetam 1000 mg Under Fasting Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalence Study of Levetiracetam 1000 mg Tablet Under Fasting Conditions|Completed||Phase 1|30|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:17:36.728706|2017-02-18 13:17:36.728706
NCT00859508|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2012-03-06|2012-02-03||February 2006||2006-02-01|March 2012|2012-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of SyntheCelTM Dura Replacement to Other Dura Replacements|A Prospective, Multi-Center, Randomized, Controlled Clinical Study Comparing SyntheCelTM Dura Replacement to Other Dura Replacements in Patients Requiring Dura Repair Following Cranial Surgery|Completed||N/A|99|Actual|Synthes USA HQ, Inc.||2|||f||||||||||||||2017-02-18 13:17:37.187605|2017-02-18 13:17:37.187605
NCT00859495|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2011-10-28|||February 2008||2008-02-01|October 2011|2011-10-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Trimodal Lung-Sparing Treatment of Pleural Mesothelioma|Phase II, A Study of Lung-Sparing Combined Modality Protocol for the Treatment for Malignant Pleural Mesothelioma: The Columbia Protocol|Unknown status|Recruiting|Phase 2|25|Anticipated|Columbia University||1|||f||||t||||||||||2017-02-18 13:17:37.670886|2017-02-18 13:17:37.670886
NCT00859482|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-03-10|||July 2006||2006-07-01|March 2009|2009-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Differential Immune Effects of Natalizumab|A Phase IV Study to Investigate Differential Immune Effects of Natalizumab|Completed||N/A|27|Actual|Cantonal Hospital of St. Gallen|||1||f||||f||||||Samples Without DNA|"~     full blodd~   "|||2017-02-18 13:17:37.768358|2017-02-18 13:17:37.768358
NCT00859469|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-01-20|2012-01-20||April 2004||2004-04-01|January 2012|2012-01-01|March 2013|Anticipated|2013-03-01|March 2009|Actual|2009-03-01||Interventional|||Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma|Oxaliplatin (Eloxatin®) Plus Gemcitabine as First or Second-line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma: A Phase II Clinical Trial|Unknown status|Active, not recruiting|Phase 2|29|Actual|Columbia University||1|||f||||t||||||||||2017-02-18 13:17:37.851896|2017-02-18 13:17:37.851896
NCT00859456|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-11-02|||April 2007||2007-04-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Sunitinib in Soft Tissue Sarcoma|A Phase II, Open-label, Non-randomized Trial of Sunitinib in Certain Subtypes of Soft Tissue Sarcomas|Unknown status|Active, not recruiting|Phase 2|17|Anticipated|Columbia University||1|||f||||f||||||||||2017-02-18 13:17:38.161823|2017-02-18 13:17:38.161823
NCT00859430|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2009-07-09|2009-07-09||January 2007||2007-01-01|July 2009|2009-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Levetiracetam 1000 mg Under Non-Fasting Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalence Study of Levetiracetam 1000 mg Tablet Under Fed Conditions|Completed||Phase 1|22|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:17:38.440248|2017-02-18 13:17:38.440248
NCT00859417|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2013-11-29|||September 2008||2008-09-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Study Evaluating the Effectiveness of the Use of Prosthesis With Trans-Obturator Way for the Correction of Anterior Prolapse|PERIGEE :Randomized Study Evaluating the Effectiveness of the Use of Prosthesis With Trans-obturator Way for the Correction of Anterior Prolapse.|Completed||N/A|78|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 13:17:38.926584|2017-02-18 13:17:38.926584
NCT00859404|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-09-23|||October 2008||2008-10-01|September 2009|2009-09-01|January 2010|Anticipated|2010-01-01|December 2009|Anticipated|2009-12-01||Interventional|||A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma|A 12-week Randomized, Double-blind, Parallel Group, Placebo-controlled Dose Range Finding Study to Evaluate the Efficacy of Oglemilast in the Treatment of Stable Mild to Moderate Persistent Asthma|Unknown status|Active, not recruiting|Phase 2|282|Anticipated|Glenmark Pharmaceuticals Europe Ltd. (R&D)||4|||f||||t||||||||||2017-02-18 13:17:39.038667|2017-02-18 13:17:39.038667
NCT00859391|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2009-06-09|||May 2008||2008-05-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|0801||Effects of Gluten Digestion With ALV003|A Phase 0 Study in Subjects With Well Controlled Celiac Disease to Assess the Effects of Gluten Digestion With ALV003 (a Protease Enzyme) in Vitro|Completed||Early Phase 1|20|Actual|Alvine Pharmaceuticals Inc.|||2||f||||f||||||Samples With DNA|"~     The enzyme linked immunospot (ELISPOT) assay is used in vaccine development, cancer~     research, infectious disease diagnosis and monitoring, autoimmune disease studies and~     allergy and transplantation research. The ELISPOT enables determination of the frequency of~     cytokine secreting cells. The ELISPOT is a combination of both immunoassay and bioassay~     because live cells are cultured in plates. This enables a very high sensitivity to detect~     cytokine secretion at a single cell level as secreted cytokine does not diffuse into media~     but is immediately membrane bound.~   "|||2017-02-18 13:17:39.135763|2017-02-18 13:17:39.135763
NCT00859378|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2015-04-03|||October 2008||2008-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Cemented vs Non-cemented Semiendoprosthesis in the Treatment of Proximal Femoral Fractures|A Prospective, Randomized Study Comparing Cemented and Non-cemented Semiendoprostheses in the Treatment of Proximal Femoral Fractures in the Elderly Patients|Active, not recruiting||N/A|400|Anticipated|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 13:17:39.227852|2017-02-18 13:17:39.227852
NCT00859365|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2012-01-27|||January 2009||2009-01-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ABNP||Acupuncture for Back and Neck Pain in an Emergency Room Setting|Efficacy of an Integrative Approach Utilizing Acupuncture as an add-on Therapy for the Treatment of Back and Neck Pain in an Emergency Department Setting - A Comparative Randomized Controlled Trial|Completed||Phase 1/Phase 2|65|Actual|Assaf-Harofeh Medical Center||3|||f||||t||||||||||2017-02-18 13:17:39.323317|2017-02-18 13:17:39.323317
NCT00859352|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-04-09|||March 2009||2009-03-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|||||Interventional|||AZD1981 Midazolam CYP4503A Induction Study|A Phase I, Open, Randomised, Non-Comparative, Parallel Group Study of a Potential Cytochrome P450 3A Induction After Repeat Twice Daily Oral Dosing With 100 and 500 mg AZD1981 Tablets for 14 Days to Healthy Male Volunteers With Single Oral Doses of Midazolam 7.5 mg.|Completed||Phase 1|28|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:17:39.435013|2017-02-18 13:17:39.435013
NCT00859339|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-03-15|2016-03-15||March 2009||2009-03-01|March 2016|2016-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC|A Phase II Trial of Neoadjuvant Cisplatin, Gemcitabine and Sunitinib Malate Followed by Radical Cystectomy for Transitional Cell Carcinoma (TCC) of the Bladder: Hoosier Oncology Group GU07-123|Terminated||Phase 2|9|Actual|Hoosier Cancer Research Network|Study was terminated due to pre-defined stopping rules (patient toxicities)|1||Patient Toxicities|f||||t||||||||No||2017-02-18 13:17:39.534053|2017-02-18 13:17:39.534053
NCT00859313|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-02-28|2012-01-25||April 2009||2009-04-01|February 2012|2012-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||An Open-Label Functionality, Safety and Efficacy Study in Patients Undergoing Elective Unilateral Knee Replacement|An Open-Label Functionality, Safety, and Efficacy Study of the NanoTab® Delivery System/ARX-F01 15 Mcg in Patients Undergoing Elective Unilateral Knee Replacement|Completed||Phase 2|30|Actual|AcelRx Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:17:39.88078|2017-02-18 13:17:39.88078
NCT00859300|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-03-15|||December 2007||2007-12-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|MAP-IDM||MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction|MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction. A Case Control Study|Completed||N/A|1011|Actual|Hospices Civils de Lyon|||2||f||||f||||||||||2017-02-18 13:17:40.11558|2017-02-18 13:17:40.11558
NCT00859287|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-07-14|||June 2007||2007-06-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|||||Observational|OMAREE||Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis|Omepral® Tablets Mega-study to Investigate the Efficacy on Various Type of Acid Reflux Related Symptoms and QOL, and Epidemiology in Patients With Erosive Esophagitis in Daily Medical Practice|Completed||N/A|10703|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:17:40.216703|2017-02-18 13:17:40.216703
NCT00859274|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2013-10-09|||March 2009||2009-03-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Saline Challenge in Monitoring Asthma Control|Saline Challenge in Monitoring Asthma Control|Completed||N/A|40|Actual|Kuopio University Hospital||1|||f||||f||||||||||2017-02-18 13:17:40.293206|2017-02-18 13:17:40.293206
NCT00859261|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-05-03|||March 2009||2009-03-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound|2D Silicon Transducer-Compression Plates for Breast Ultrasound|Completed||N/A|21|Actual|University of Michigan||1|||f||||t||||||||No||2017-02-18 13:17:40.38258|2017-02-18 13:17:40.38258
NCT00859235|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-10|2009-03-10|||May 2009||2009-05-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|PEG||The Influence of Oral Hygiene on Local Wound and Systemic Infection in Patients With Percutaneous Endoscopic Gastrostomy Placement|Predicting Oral Care Before Percutaneous Endoscopic Gastrostomy (PEG). The Influence of Oral Hygiene on Local Wound and Systemic Infection in Patients With PEG Placement|Unknown status|Not yet recruiting|Phase 3|50|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-02-18 13:17:40.495765|2017-02-18 13:17:40.495765
NCT00859222|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-10-06|2016-03-29||March 2009||2009-03-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|September 2013|Actual|2013-09-01||Interventional||The analysis dataset is comprised of all enrolled patients.|LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma|Phase I/II Study of LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma|Completed||Phase 1/Phase 2|51|Actual|Dana-Farber Cancer Institute||7|||f||||t||||||||No||2017-02-18 13:17:40.600565|2017-02-18 13:17:40.600565
NCT00859209|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2015-08-11|||December 2008||2008-12-01|March 2009|2009-03-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Capnography in Infants Ventilated With High Frequency Ventilation|Capnography in Infants Ventilated With High Frequency Ventilation: Prospective, Observational, Multi-Center Study|Completed||N/A|24|Actual|Bnai Zion Medical Center|||1||f||||f||||||||||2017-02-18 13:17:42.003418|2017-02-18 13:17:42.003418
NCT00859196|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2014-12-08|||February 2009||2009-02-01|December 2014|2014-12-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries|A Randomized, Double-blind, Single Centre, Placebo-controlled Pilot Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Previously Injured Skin by Investigation of Skin Biopsies|Completed||Phase 4|15|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:17:42.096164|2017-02-18 13:17:42.096164
NCT00859183|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2009-03-09|||October 2001||2001-10-01|March 2009|2009-03-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Interventional|OSIRIS||Oral Sirolimus for In-Stent Restenosis|A Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Impact of Oral Sirolimus on Restenosis Prevention in Patients With In-Stent Restenosis.|Completed||Phase 4|300|Actual|Deutsches Herzzentrum Muenchen||3|||f||||t||||||||||2017-02-18 13:17:42.219109|2017-02-18 13:17:42.219109
NCT00859170|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2010-01-06|||February 2009||2009-02-01|January 2010|2010-01-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Interventional|||Use of Antiretropulsion Device in Laser Lithotripsy|Use of the Accordion Stone Management Device in Laser Lithotripsy|Terminated||N/A|100|Anticipated|Percutaneous Systems, Inc.||2||Change in priorities occurred|f||||f||||||||||2017-02-18 13:17:42.342371|2017-02-18 13:17:42.342371
NCT00859157|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-07|2013-01-15|||October 2008||2008-10-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer|Tumescent Mastectomy: A Prospective Comparison to Standard Mastectomy Technique|Unknown status|Recruiting|N/A|74|Anticipated|University of California, Davis|||2||f||||f||||||||||2017-02-18 13:17:42.456514|2017-02-18 13:17:42.456514
NCT00859144|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2012-03-07|||March 2009||2009-03-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Training Community Members to Deliver HIV Prevention Programs to Urban Youth|Community Partnerships to Prevent Urban Youth Health Risks (CHAMPions)|Completed||Phase 3|901|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||f||||||||||2017-02-18 13:17:42.564797|2017-02-18 13:17:42.564797
NCT00859131|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2016-03-23|2015-05-14||March 2009||2009-03-01|February 2014|2014-02-01|July 2014|Actual|2014-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists|Rabbit Anti-thymocyte Globulin Versus IL2 Receptor Antagonists in Combination With Tacrolimus, Corticosteroids and Mycophenolate Mofetil in a Predominantly High Risk Kidney Transplant Population.|Completed||N/A|200|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 13:17:42.688213|2017-02-18 13:17:42.688213
NCT00859118|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2015-03-04|||February 2009||2009-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|May 2013|Actual|2013-05-01||Interventional|||Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies|Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies|Completed||Phase 1|30|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 13:17:43.088957|2017-02-18 13:17:43.088957
NCT00859105|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2009-03-09|||February 2008||2008-02-01|March 2009|2009-03-01||||November 2008|Actual|2008-11-01||Interventional|||A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis|A Multicenter, Double-Blind, Vehical-Controlled Study Comparing Imiquimod Cream, 5% (Apotex Inc.) to Aldara™ Cream, 5%(3M Pharmaceutials, U.S.) and Aldara™ Cream, 5%(3M Pharmaceuticals, Canada) in the Treatments of Actinic Keratosis.|Completed||Phase 3|497|Actual|Apotex Inc.||4|||f||||t||||||||||2017-02-18 13:17:43.188144|2017-02-18 13:17:43.188144
NCT00859092|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-03-07|||March 2008||2008-03-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|||Promotion of Thickened Feeds to Manage Newborns With Feeding Difficulties|Promotion of Thickened Feeds to Manage Newborns With Feeding Difficulties|Completed||Phase 2|15|Anticipated|Eastern Virginia Medical School||2|||f||||f||||||||||2017-02-18 13:17:43.282698|2017-02-18 13:17:43.282698
NCT00859079|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-07|2009-03-09|||June 2006||2006-06-01|March 2009|2009-03-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients|Efficacy of a Continuous GLP-1 Infusion in Comparison to a Structured Insulin Infusion Protocol to Reach Normoglycemia in Non-Fasted Type 2 Diabetic Patients|Completed||Phase 4|8|Actual|Medical University of Graz||2|||f||||t||||||||||2017-02-18 13:17:43.390211|2017-02-18 13:17:43.390211
NCT00859066|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-04-26|||January 2009||2009-01-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Observational|||Evaluation of Radiology Resident Anxiety When Beginning Emergency Room (ER) Call|Evaluation of Radiology Resident Anxiety When Beginning ER Call|Terminated||N/A|19|Actual|University of Michigan|||2|Original Principal Investigator (Andrew Trout M.D.) left the University.|f||||t||||||||||2017-02-18 13:17:43.504878|2017-02-18 13:17:43.504878
NCT00859053|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2015-09-09|2015-08-10||March 2009||2009-03-01|September 2015|2015-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||Analysis was done in safety population, defined as all the participants who received study medication.|Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment|Single-Dose Pharmacokinetics of BMS-790052 in Subjects With Hepatic Impairment Compared to Healthy Subjects|Completed||Phase 1|46|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 13:17:43.59974|2017-02-18 13:17:43.59974
NCT00859040|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-06-24|2014-02-14||March 2009||2009-03-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|December 2011|Actual|2011-12-01||Interventional|||Monthly SOM230C for Recurrent or Progressive Meningioma|Phase II Study of Monthly SOM230C for Recurrent or Progressive Meningioma|Completed||Phase 2|34|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:17:44.34759|2017-02-18 13:17:44.34759
NCT00859027|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-07|2013-06-28|2012-08-22||January 2003||2003-01-01|June 2013|2013-06-01|February 2009|Actual|2009-02-01|March 2008|Actual|2008-03-01||Interventional|||Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer|The Effect Of Risedronate On Bone Turnover And Bone Mass In Older Men|Completed||Phase 4|50|Actual|UConn Health|Small number but otherwise no limitations.|2|||f||||f||||||||||2017-02-18 13:17:44.909512|2017-02-18 13:17:44.909512
NCT00859014|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2014-12-31|2014-12-18||January 2009||2009-01-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Total number of study participants|Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients|Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients|Completed||Phase 1|25|Actual|The University of Texas Health Science Center, Houston|This is a Phase I safety and feasibility study, designed without a control group. Small sample size and inclusion of selected patients warrants caution in interpretation of findings. A randomized controlled study is needed.|1|||f||||t||||||||||2017-02-18 13:17:45.269107|2017-02-18 13:17:45.269107
NCT00859001|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2009-03-10||||||March 2009|2009-03-01||||||||Interventional|FM+R-Z||Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy|A Phase II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy.|Completed||Phase 2|55|Actual|University of Bologna||1|||f||||||||||||||2017-02-18 13:17:45.728783|2017-02-18 13:17:45.728783
NCT00858988|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2009-03-09||||||March 2009|2009-03-01||||||||Interventional|||Trial of Rifaximin in the Treatment of Tropical Enteropathy|A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin, a Non-Absorbable Antibiotic, in the Treatment of Tropical Enteropathy|Completed||N/A|||Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:17:45.820592|2017-02-18 13:17:45.820592
NCT00858975|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2013-08-12|||October 2007||2007-10-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Study of Cryotherapy for Renal Tumors|Study of Cryotherapy for Renal Tumors|Withdrawn||N/A|0|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 13:17:45.907512|2017-02-18 13:17:45.907512
NCT00858962|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2012-10-19|2012-05-31||March 2009||2009-03-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Buprenorphine/Raltegravir Pharmacokinetic Interaction Study|A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Raltegravir (Isentress) and Buprenorphine|Completed||N/A|12|Actual|Yale University|The sample size was small, though within the range of similar drug-drug interaction studies. This study utilized a within-subject design with patients acting as their own controls (thereby resulting in less intra-patient variability).|1|||f||||f||||||||||2017-02-18 13:17:45.99519|2017-02-18 13:17:45.99519
NCT00858949|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-07-18|||August 2008||2008-08-01|July 2016|2016-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Costs of Postoperative Nausea and Vomiting in Ambulatory Surgery Patients|Time-Motion Study of PONV Costs in Ambulatory Surgery|Completed||N/A|100|Actual|The Cleveland Clinic|||1||f||||f||||||||||2017-02-18 13:17:46.202065|2017-02-18 13:17:46.202065
NCT00858936|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-10-18|||May 2009||2009-05-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of IK-1001 to Evaluate Safety, Pharmacokinetics and Proof-of-concept Efficacy for Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft(CABG)Surgery|Terminated||Phase 2|6|Actual|Mallinckrodt||2||Study Terminated - Company decision|f||||t||||||||||2017-02-18 13:17:46.308035|2017-02-18 13:17:46.308035
NCT00858923|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2009-04-07|||July 2008||2008-07-01|March 2009|2009-03-01|November 2009|Anticipated|2009-11-01|July 2009|Anticipated|2009-07-01||Interventional|||Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)|Phase 1 Study of the HemoModulator System for the Treatment of Human Immunodeficiency Virus (HIV)|Unknown status|Enrolling by invitation|Phase 1|10|Actual|Energex Systems, Inc.||1|||f||||t||||||||||2017-02-18 13:17:46.423116|2017-02-18 13:17:46.423116
NCT00858910|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2013-10-24|||March 2009||2009-03-01|July 2010|2010-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Comparison of Embedded and Added Motor Imagery Training in Patients After Stroke|Comparison of Embedded and Added Motor Imagery Training to Improve a Motor Skill in Patients After Stroke: a Pilot Randomised Controlled Trial Using a Mixed Methods Approach|Completed||Phase 2|90|Anticipated|Reha Rheinfelden||3|||f||||f||||||||||2017-02-18 13:17:46.531384|2017-02-18 13:17:46.531384
NCT00858897|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2009-07-14|||June 2007||2007-06-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A|Regulation of Glutathione Homeostasis in Adolescents With Type 1 Diabetes - Study A|Completed||N/A|10|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-02-18 13:17:46.642518|2017-02-18 13:17:46.642518
NCT00858884|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2013-06-25|||August 2006||2006-08-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus|Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus|Completed||N/A|68|Actual|University of New Mexico||1|||f||||f||||||||||2017-02-18 13:17:46.754119|2017-02-18 13:17:46.754119
NCT00858871|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-10-14||2015-09-23|May 2009||2009-05-01|October 2016|2016-10-01|September 2013|Actual|2013-09-01|June 2012|Actual|2012-06-01||Interventional|BRISK FL||First Line Hepato Cellular Carcinoma (HCC)|A Randomized, Double-blind, Multi-center Phase III Study of Brivanib Versus Sorafenib as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 3|1714|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:17:46.872241|2017-02-18 13:17:46.872241
NCT00858858|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2015-04-15|2014-11-07||March 2009||2009-03-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|March 2013|Actual|2013-03-01||Interventional|||Clinical Studies on Bile Acids in Barrett's Esophagus|Clinical Studies on Bile Acids in Barrett's Esophagus|Completed||N/A|60|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 13:17:47.296613|2017-02-18 13:17:47.296613
NCT00858845|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2013-09-04|2013-06-19||May 2008||2008-05-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|March 2011|Actual|2011-03-01||Interventional|||Using Clonidine to Improve Leg Weakness in People With Heart Failure|Clonidine and the Skeletal Myopathy of Heart Failure|Completed||Phase 4|11|Actual|University of California, Los Angeles|This is a small trial, but it was not terminated early, and there were no technical issues.|1|||f||||t||||||||||2017-02-18 13:17:47.515186|2017-02-18 13:17:47.515186
NCT00858832|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-09-17|2012-07-05||December 2008||2008-12-01|September 2012|2012-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine|Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine|Completed||N/A|44|Actual|University of South Florida|Early termination due to lack of feasibility in completing project; full analysis was not conducted;|2|||f||||f||||||||||2017-02-18 13:17:47.763922|2017-02-18 13:17:47.763922
NCT00858819|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2015-05-28|||March 2009||2009-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|May 2012|Actual|2012-05-01||Observational|||Clinical Trial of Osteoporosis in Ankylosing Spondylitis|Clinical Trial of Osteoporosis in Ankylosing Spondylitis|Completed||N/A|250|Anticipated|Göteborg University|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:17:48.067119|2017-02-18 13:17:48.067119
NCT00858806|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2014-12-02|||April 2008||2008-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2010|Actual|2010-12-01||Interventional|INTERIM0407||Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy|Phase II Explorative Study of Intermittent Imatinib (IM) Treatment (INTERIM) in Elderly Patients With Ph+ Chronic Myeloid Leukemia (CML) Who Achieved a Stable Complete Cytogenetic Response (CCgR) With Standard IM Therapy|Completed||Phase 2|78|Actual|Università degli Studi di Brescia||1|||f||||t||||||||||2017-02-18 13:17:48.326715|2017-02-18 13:17:48.326715
NCT00858793|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2015-05-12|||October 2008||2008-10-01|May 2015|2015-05-01|October 2017|Anticipated|2017-10-01|December 2016|Anticipated|2016-12-01||Interventional|||High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT|High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT|Suspended||Phase 1/Phase 2|10|Anticipated|Universitätsklinikum Hamburg-Eppendorf||1||"A leukaemia case was reported in patient treated with a similar vector. For safety risk we~   stopped recruitment"|f||||t||||||||||2017-02-18 13:17:48.439164|2017-02-18 13:17:48.439164
NCT00858780|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2013-08-30|2013-06-06||January 2009||2009-01-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|DOSERA||Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA|Dose Reduction or Discontinuation of Etanercept in Methotrexate-Treated Rheumatoid Arthritis Subjects Who Have Achieved a Stable Low Disease Activity-state (DOSERA)|Completed||Phase 4|91|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:17:48.566374|2017-02-18 13:17:48.566374
NCT00858767|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2010-12-15|||October 2008||2008-10-01|December 2010|2010-12-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|||Arabic Gum-Absorption Study|Comparison of Absorption and Efficacy of 3 Different Menaquinone-7 Delivery Systems; Casein Powder, Arabic Gum Powder, or Linseed Oil|Completed||N/A|69|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-02-18 13:17:50.363079|2017-02-18 13:17:50.363079
NCT00858754|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2011-07-22|||March 2009||2009-03-01|July 2011|2011-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects|A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Subjects With Cancer-Related Pain|Withdrawn||Phase 4|340|Anticipated|Valeant Pharmaceuticals International, Inc.||2||"Withdrawn [This study was terminated early by Wyeth, prior to dosing any subjects, for~   business reasons not related to safety."|f||||f||||||||||2017-02-18 13:17:50.478068|2017-02-18 13:17:50.478068
NCT00858741|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2009-03-09||||||March 2009|2009-03-01||||||||Interventional|||Palliative Radiotherapy for Bone Metastases: Single Versus Multiple Fractions.|Phase III Study of Palliative Radiotherapy for Bone Metastases Comparing Single to Multiple Fractions.|Completed||Phase 3|148|Actual|Marilia Medicine School||2|||f||||f||||||||||2017-02-18 13:17:50.597182|2017-02-18 13:17:50.597182
NCT00858728|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2010-07-22|||October 2006||2006-10-01|July 2010|2010-07-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Interventional|ADIT||Effect of Fruit and Vegetable Consumption on Immune Function in the Elderly|Effect of Fruit and Vegetable Consumption on Immune Function in the Elderly: a Randomised Controlled Trial|Completed||Phase 3|83|Actual|Queen's University, Belfast||2|||f||||f||||||||||2017-02-18 13:17:50.695443|2017-02-18 13:17:50.695443
NCT00858715|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-12-11|||May 2008||2008-05-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|Vienna REACT||Resistance to Antithrombotic Therapy|Resistance to Antithrombotic Therapy in Patients Undergoing Angioplasty and Stenting for Cardiovascular Disease - Vienna REACT|Completed||N/A|46|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:17:50.789169|2017-02-18 13:17:50.789169
NCT00858702|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2009-09-18|2009-07-16||February 2005||2005-02-01|September 2009|2009-09-01|November 2005|Actual|2005-11-01|July 2005|Actual|2005-07-01||Interventional|||Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension|Add-on Study of CCBs or Diuretics in Essential Hypertension Not Achieving Target Blood Pressure on Olmesartan Medoxomil Alone|Completed||Phase 4|105|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:17:50.890968|2017-02-18 13:17:50.890968
NCT00858689|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-02-16|2013-09-01||October 2007||2007-10-01|February 2016|2016-02-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Add-on Pilot Trial of Minocycline to Treat Fragile X Syndrome|Add-on Pilot Trial of Minocycline in Fragile X Syndrome|Completed||N/A|20|Actual|FRAXA Research Foundation|This was an open-label trial. Further study in a randomized controlled trial is warranted.|1|||f||||f||||||||||2017-02-18 13:17:51.256794|2017-02-18 13:17:51.256794
NCT00858676|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-07-17|||April 2009||2009-04-01|July 2012|2012-07-01|March 2013|Anticipated|2013-03-01|March 2012|Actual|2012-03-01||Interventional|||Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)|Multicenter Trial on Clinical Utility of Acarbose in Patients With Ischemic Heart Disease Accompanied by Abnormal Glucose Regulation|Unknown status|Recruiting|Phase 4|150|Anticipated|Aichi Gakuin University||1|||f||||t||||||||||2017-02-18 13:17:51.701461|2017-02-18 13:17:51.701461
NCT00858663|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2013-07-23|||March 2009||2009-03-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer|A Phase I Study of Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer|Completed||Phase 1|13|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:17:51.81836|2017-02-18 13:17:51.81836
NCT00858650|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2016-08-22|||March 2009||2009-03-01|April 2016|2016-04-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|RHyMe||Registry of Hypogonadism in Men|Registry of Hypogonadism in Men|Completed||N/A|999|Actual|New England Research Institutes|||1||f||||f||||||||||2017-02-18 13:17:51.937939|2017-02-18 13:17:51.937939
NCT00858637|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2014-12-08|2014-09-08||March 2009||2009-03-01|December 2014|2014-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis|A Phase III, Multicentre, Double-blind, Double-dummy, Randomised, Flexible-dose, Comparative Study of MCI-196 Versus Simvastatin for the Treatment of Dyslipidaemia in Subjects With Chronic Kidney Disease on Dialysis (Incorporating a Placebo-controlled Withdrawal Phase)|Completed||Phase 3|260|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||f||||||||||2017-02-18 13:17:52.071119|2017-02-18 13:17:52.071119
NCT00858624|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2013-06-17|||February 2008||2008-02-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Neurophysiology and Pharmacology of Cough Reflex Hypersensitivity|Neurophysiology and Pharmacology of Cough Reflex Hypersensitivity|Completed||N/A|24|Actual|University of Manchester||2|||f||||f||||||||||2017-02-18 13:17:52.764278|2017-02-18 13:17:52.764278
NCT00857714|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2015-06-16|2015-06-16||April 2009||2009-04-01|June 2015|2015-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast|Lapatinib in the Treatment of Ductal Carcinoma in Situ of the Breast|Terminated||N/A|1|Actual|Indiana University||1||Terminated due to low accrual|f||||t||||||||||2017-02-18 13:18:10.737759|2017-02-18 13:18:10.737759
NCT00858611|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-07|2017-01-24|||March 3, 2009||2009-03-03|June 21, 2010|2010-06-21|June 21, 2010|Actual|2010-06-21|June 21, 2010|Actual|2010-06-21||Interventional|||VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...|VRC 307: A D/B Randomized Ph. I Study of Safety/Immunogenicity of a Prime-Boost Schedule of an Investigational DNA Influenza Vaccine, Followed by the Seasonal Influenza Trivalent Inactivated Vaccine (TIV), Compared to TIV Alone in Healthy Adults|Completed||Phase 1|51|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:17:52.863176|2017-02-18 13:17:52.863176
NCT00858598|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2012-02-29|||December 2009||2009-12-01|February 2012|2012-02-01|January 2014|Anticipated|2014-01-01|July 2013|Anticipated|2013-07-01||Observational|PO||Pro Osteon Bone Void Filler Study|Pro Osteon Bone Void Filler Data Collection|Withdrawn||N/A|0|Actual|Zimmer Biomet|||1|Study never started. Study suspended indefinitely.|f||||f||||||||||2017-02-18 13:17:52.984815|2017-02-18 13:17:52.984815
NCT00858585|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-07|2016-03-10|||March 2009||2009-03-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|May 2011|Actual|2011-05-01||Observational|||Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study|Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study|Active, not recruiting||N/A|120|Anticipated|University of Michigan Cancer Center|||1||f||||t||||||Samples With DNA|"~     Retained samples will consist of a portion of the specimens collected for this concordance~     study: peripheral blood leukocytes, lymph nodes, and tumor tissue. All retained samples will~     be completely de-identified and re-numbered.~   "|||2017-02-18 13:17:53.074554|2017-02-18 13:17:53.074554
NCT00858572|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2014-09-17|||March 2009||2009-03-01|September 2014|2014-09-01|February 2013|Actual|2013-02-01|May 2011|Actual|2011-05-01||Interventional|||STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders|A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice Weekly in Subjects With Hematologic Malignancies|Completed||Phase 1|31|Actual|Synta Pharmaceuticals Corp.||1|||f||||f||||||||||2017-02-18 13:17:53.172677|2017-02-18 13:17:53.172677
NCT00858559|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2011-05-19|||March 2009||2009-03-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|September 2011|Anticipated|2011-09-01||Interventional|ANVITE||Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE)|Follow-up of Patients With Implantable Cardioverter Defibrillators by Home Monitoring (ANVITE)|Terminated||N/A|110|Actual|Biotronik SE & Co. KG||2||Stopped due to low enrollment. Patients will be followed up for 3 months.|f||||f||||||||||2017-02-18 13:17:53.281224|2017-02-18 13:17:53.281224
NCT00858546|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-08|2009-10-15|||May 2009||2009-05-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) Treatment on Motor and Cognitive Measurements in Patients With Parkinson's Disease|The Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) Treatment on Motor and Cognitive Measurements in Patients With Parkinson's Disease|Completed||N/A|10|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 13:17:53.420602|2017-02-18 13:17:53.420602
NCT00858533|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2010-07-26|||June 2008||2008-06-01|January 2010|2010-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|H@W||Trial of Health at Work Workplace Health Intervention|A Pilot Controlled Feasibility Trial of Early Health at Work Workplace Intervention|Completed||N/A|63|Actual|University of Liverpool||2|||f||||t||||||||||2017-02-18 13:17:53.511161|2017-02-18 13:17:53.511161
NCT00858520|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-09|2013-09-02|||October 2007||2007-10-01|September 2013|2013-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer|Serum, Plasma, DNA and Tissue Bank of Patients With Chronic Obstructive Pulmonary Disease, Lung Cancer and Smoking Controls.|Recruiting||N/A|2000|Anticipated|Katholieke Universiteit Leuven|||3||f||||f||||||Samples With DNA|"~     Germline DNA, serum and plasma, Peripheral blood mononuclear cells, Lung tissue biopsies~   "|||2017-02-18 13:17:53.610784|2017-02-18 13:17:53.610784
NCT00858507|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-06-09|2014-12-10||October 2009||2009-10-01|June 2016|2016-06-01|March 2014|Actual|2014-03-01|October 2012|Actual|2012-10-01||Interventional|||Engaging Homeless Veterans in Primary Care|Engaging Homeless Veterans in Primary Care|Completed||N/A|221|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 13:17:53.716505|2017-02-18 13:17:53.716505
NCT00858494|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2011-03-01|2010-12-27||March 2009||2009-03-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Homeopathic Cold Medicine for Children|Homeopathic Cold Medicine for Children|Completed||N/A|50|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 13:17:54.067463|2017-02-18 13:17:54.067463
NCT00858481|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2015-10-19|||September 2005||2005-09-01|October 2015|2015-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Pilot Dose Ranging Study of Spinosad Creme Rinse|Efficacy and Safety of Different Strengths of Spinosad Topical Creme (0%, 0.5%, 1.0% or 2%) in Subjects With Pediculosis Capitis - a Dose Ranging Study|Completed||Phase 2|36|Actual|ParaPRO LLC||4|||f||||f||||||||||2017-02-18 13:17:54.29484|2017-02-18 13:17:54.29484
NCT00858468|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-04-12|2009-04-20||April 2005||2005-04-01|April 2016|2016-04-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age|Proof of Concept Study of the Safety and Immunogenicity of Influenza Virus Vaccine Fluzone® 2004-2005 Among Healthy Children 2 Months vs 6 Months of Age|Completed||Phase 1/Phase 2|394|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:17:54.404278|2017-02-18 13:17:54.404278
NCT00858455|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-06-04|||January 2009||2009-01-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|DDI||A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572|A Phase I, Open Label, Randomized, Four-Period Crossover Study to Evaluate the Effects of Maalox® Advanced Maximum Strength and One A Day® Maximum on Pharmacokinetics of GSK1349572 in Healthy Adult Subjects|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:17:55.108115|2017-02-18 13:17:55.108115
NCT00858442|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2015-01-28|2013-04-18||March 2009||2009-03-01|January 2015|2015-01-01|November 2012|Actual|2012-11-01|October 2011|Actual|2011-10-01||Interventional||Some patients received more than one graft, as it is shown in result section.|Platelet-Rich Plasma (PRP) in Reconstructive Surgery on Children With Retractable Burn Sequelae on Extremities|PRP on Children With Retractable Burn Sequelae Who Have Submitted Release of Burn Contractures and Skin Graft on Their Limbs. A Double-Blind Randomized Clinical Trial|Completed||N/A|44|Actual|Corporation for the Aid of Burned Children|Loss cases: PRP group: 3/23 and group without PRP: 1/21|2|||f||||f||||||||||2017-02-18 13:17:55.206622|2017-02-18 13:17:55.206622
NCT00858429|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2016-10-10|||March 2009||2009-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases|Dose Escalating Study of Yttrium 90 Microspheres (TheraSphere) With Capecitabine (Xeloda) for Intrahepatic Cholangiocarcinoma or Metastatic Disease to the Liver|Active, not recruiting||Phase 1|30|Anticipated|Northwestern University||4|||f||||t||||||||||2017-02-18 13:17:55.571017|2017-02-18 13:17:55.571017
NCT00858416|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-06|||April 2006||2006-04-01|March 2009|2009-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|KC-01||Combined Vibrations, Passive Motion and Thermotherapy for Knee Osteoarthritis|Efficacy of Combined Local Mechanical Vibrations, Continuous Passive Motion and Thermotherapy in the Management of Osteoarthritis of the Knee|Completed||Phase 4|71|Actual|Kineticure||2|||f||||f||||||||||2017-02-18 13:17:55.83099|2017-02-18 13:17:55.83099
NCT00858403|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2013-12-13|2011-07-12||March 2009||2009-03-01|December 2013|2013-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation|Phase II Study of Dasatinib in Advanced Non-small Cell Lung Cancer With Ex Vivo and In Vivo Assessment of Tumor Target Modulation|Terminated||Phase 2|7|Actual|H. Lee Moffitt Cancer Center and Research Institute|The low accrual of 7 participants prevented us from completing the planned analysis. Target accrual was 40.|1||Slow Accrual|f||||t||||||||||2017-02-18 13:17:55.946743|2017-02-18 13:17:55.946743
NCT00858390|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2014-06-13|2014-05-15||February 2009||2009-02-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|August 2012|Actual|2012-08-01||Interventional|HRSA Nutrition||Nutritional Status and Enteral Absorption Capability After Brain Death|Clinical Interventions to Increase Organ Procurement Nutritional Status and Enteral Absorption Capability After Brain Death (R38OT10585)|Completed||N/A|36|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-02-18 13:17:56.306895|2017-02-18 13:17:56.306895
NCT00858377|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2017-02-01|||August 2009||2009-08-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|December 2014|Actual|2014-12-01||Interventional|||A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors|A Phase 1, First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered AMG 900 in Adult Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|95|Actual|Amgen||2|||f||||t||||||||||2017-02-18 13:17:56.981929|2017-02-18 13:17:56.981929
NCT00858364|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2017-02-15|||July 2009||2009-07-01|February 2017|2017-02-01|April 2021|Anticipated|2021-04-01|April 2021|Anticipated|2021-04-01||Interventional|||Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemotherapy|Recruiting||Phase 3|3000|Anticipated|Amgen||2|||f||||t||||||||||2017-02-18 13:17:57.146801|2017-02-18 13:17:57.146801
NCT00858351|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2015-05-08|||November 2007||2007-11-01|May 2015|2015-05-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|||Thermal Biofeedback for the Treatment of Diabetic Neuropathy|A Placebo-Controlled Trial of Thermal Biofeedback Assisted Relaxation for the Treatment of Diabetic Neuropathy: An Evaluation of Outcomes and Mechanisms|Completed||N/A|32|Actual|Rosalind Franklin University of Medicine and Science||2|||f||||f||||||||||2017-02-18 13:18:00.26492|2017-02-18 13:18:00.26492
NCT00858338|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2016-03-10|||December 2002||2002-12-01|March 2016|2016-03-01|February 2012|Actual|2012-02-01|March 2007|Actual|2007-03-01||Interventional|||Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer|Phase-II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma (R0 Resection and at Least D1 Lymph-node Dissection)|Completed||Phase 2|28|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 13:18:00.373566|2017-02-18 13:18:00.373566
NCT00858325|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2010-01-21|||February 2009||2009-02-01|January 2010|2010-01-01|March 2009|Actual|2009-03-01|||||Interventional|||Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China|A Two Cohort, Open Label, Single and Multiple Dose Pharmacokinetic Study of 4mg/Kg and 6mg/Kg Doses of Daptomycin in Healthy Chinese Subjects Living in China|Completed||Phase 1|24|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:18:00.488124|2017-02-18 13:18:00.488124
NCT00858312|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-10-22|||October 2006||2006-10-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Dairy Foods and Weight Loss|Role of Dairy Foods to Enhance Central Fat and Weight Loss With Moderate Energy Restriction in Overweight and Obesity Individuals|Completed||Phase 2/Phase 3|72|Anticipated|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-02-18 13:18:00.596197|2017-02-18 13:18:00.596197
NCT00858299|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-06|||March 2009||2009-03-01|March 2009|2009-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria|The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Chronic Kidney Diseases Patients With Persistent Proteinuria|Unknown status|Not yet recruiting|Phase 4|500|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 13:18:00.707327|2017-02-18 13:18:00.707327
NCT00858286|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2014-08-11|||February 2009||2009-02-01|August 2014|2014-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.|Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.|Completed||Phase 4|56|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:18:00.819206|2017-02-18 13:18:00.819206
NCT00858273|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2012-05-02|||March 2008||2008-03-01|May 2012|2012-05-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Interventional|||Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B|Regulation of Glutathione Homeostasis in Adolescents With Type 1 Diabetes - Study B|Completed||N/A|40|Anticipated|Nemours Children's Clinic||2|||f||||f||||||||||2017-02-18 13:18:01.10942|2017-02-18 13:18:01.10942
NCT00858260|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2009-09-03|||November 2008||2008-11-01|September 2009|2009-09-01|February 2009|Actual|2009-02-01|||||Observational|ARNOGENE||Arnogene: A Phosphocalcic Study in Dialysis|Genetic Determinants of Phosphocalcic Metabolism in Hemodialysis Patients|Completed||N/A|1200|Anticipated|Hospices Civils de Lyon|||1||f||||f||||||Samples With DNA|"~     Searching for high morbi-mortality risk Klotho variants~   "|||2017-02-18 13:18:01.223486|2017-02-18 13:18:01.223486
NCT00858247|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2014-05-13|2013-12-16||April 2009||2009-04-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||47 Subjects started the study, but one subject in the Vitamin D3-high dose arm only completed one visit. The baseline characteristics are reported on the 47 subjects who started the study.|Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in Obese Adolescents|Significance of Vitamin D Status in Obese Adolescents- A Pilot Study to Examine the Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors|Completed||Phase 2|51|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 13:18:01.330049|2017-02-18 13:18:01.330049
NCT00858234|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2016-01-21|||March 2009||2009-03-01|January 2016|2016-01-01|April 2012|Actual|2012-04-01|June 2010|Actual|2010-06-01||Interventional|||Phase I Study of MK0683 in Combination With Bortezomib in Multiple Myeloma Patients (0683-098)|A Multicenter, Open-Label, Phase I Study of MK0683 in Combination With Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma|Completed||Phase 1|9|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:18:01.77425|2017-02-18 13:18:01.77425
NCT00858221|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-10-19|||August 2008||2008-08-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Observational|||Association of Genes to Resistance to Weight Loss in Obese Patients|Association of Genetic Variants in Obesity Genes to Resistance to Weight Loss and Susceptibility to Metabolic Syndrome in Morbidly Obese Patients: A Single Center, Blinded, Retrospective Clinical Study|Completed||N/A|824|Actual|Interleukin Genetics, Inc.|||1||f||||f||||||Samples With DNA|"~     DNA to be analyzed by genotyping~   "|||2017-02-18 13:18:01.881146|2017-02-18 13:18:01.881146
NCT00858208|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-03-14|2012-03-14||March 2008||2008-03-01|September 2011|2011-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|MACULA||Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.|Long-Term Non-Interventional Study To Investigate The Efficacy And Safety Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice.|Completed||N/A|86|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:18:01.991462|2017-02-18 13:18:01.991462
NCT00858195|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-06|||June 2006||2006-06-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules|A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules Under Fasting Conditions|Completed||Phase 1|36|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:18:02.667202|2017-02-18 13:18:02.667202
NCT00858182|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2013-03-25|||May 2009||2009-05-01|March 2013|2013-03-01|January 2013|Anticipated|2013-01-01|October 2012|Anticipated|2012-10-01||Interventional|||Study of Safety and Efficacy on New Peritoneal Dialysis Solutions|Evaluation of a New Peritoneal Dialysis Solutions Containing Glucose, Xylitol and L-carnitine Compared to Standard PD Solutions in End-stage Renal Disease (ESRD) Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)|Withdrawn||Phase 2|0|Actual|Iperboreal Pharma Srl||2|||f||||f||||||||||2017-02-18 13:18:02.893664|2017-02-18 13:18:02.893664
NCT00858169|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2015-02-12|||March 2009||2009-03-01|February 2015|2015-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|3D sono in RA||Assessment of Wrist Joint and Knee Joint Inflammation in Patients With Rheumatoid Arthritis by Quantitative Three Dimensional Power Doppler Ultrasonography|Taichung Veterans General Hospital|Completed||N/A|49|Actual|Taichung Veterans General Hospital|||1||f||||f||||||||||2017-02-18 13:18:02.988628|2017-02-18 13:18:02.988628
NCT00858156|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2010-01-26|||April 2009||2009-04-01|January 2010|2010-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||BG9928 in Subjects With Hepatic Impairment|An Open-Label, Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Oral BG9928 in Subjects With Mild and Moderate Hepatic Impairment and in Healthy Subjects|Completed||Phase 1|23|Actual|Biogen||1|||f||||f||||||||||2017-02-18 13:18:03.063935|2017-02-18 13:18:03.063935
NCT00858143|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2009-08-24|2009-06-25||January 2004||2004-01-01|March 2009|2009-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|GPOS||Non Interventional Study For Patients Treated With Somavert®|German Non Interventional Study For Patients Treated With Somavert®|Completed||Phase 4|311|Actual|Pfizer|||1||f||||t||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:18:03.174481|2017-02-18 13:18:03.174481
NCT00858130|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-02-02|||March 2009||2009-03-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|VeinoPlus||Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome|Optimal Intensity and Frequency of a Portable Electrical Muscle Stimulator (VeinoPlus) to Improve Symptoms of Postthrombotic Syndrome|Completed||Phase 2|12|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-02-18 13:18:04.408092|2017-02-18 13:18:04.408092
NCT00858117|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2017-01-10|||March 2005||2005-03-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL|A Phase II Trial of Alemtuzumab (Campath-1H) and Rituximab (Rituxan) in Patients With Previously Untreated CLL|Active, not recruiting||Phase 2|30|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 13:18:04.697546|2017-02-18 13:18:04.697546
NCT00858104|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2014-05-23|||November 2008||2008-11-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|March 2010|Actual|2010-03-01||Interventional|||Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results|Multicentric Randomized Controlled Study of Percutaneous Laser Ablation Versus Follow Up in Benign Thyroid Nodules. Long Term Results|Completed||Phase 4|200|Actual|Elesta S.R.L.||2|||f||||t||||||||||2017-02-18 13:18:04.818256|2017-02-18 13:18:04.818256
NCT00858091|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2015-04-06|||February 2009||2009-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:18:04.92904|2017-02-18 13:18:04.92904
NCT00858078|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2017-02-02|||January 26, 2009||2009-01-26|February 25, 2016|2016-02-25||||||||Observational|||A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women|A Qualitative Exploration of the Impact of Positive BRCA 1/2 Mutation Status on the Lives of Young Women|Completed||N/A|126|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:18:04.981475|2017-02-18 13:18:04.981475
NCT00858065|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2012-12-14|||April 2005||2005-04-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Adolescent Family-Based Alcohol Prevention|Adolescent Family-Based Alcohol Prevention|Completed||Phase 4|1228|Actual|Pacific Institute for Research and Evaluation||5|||f||||t||||||||||2017-02-18 13:18:05.080294|2017-02-18 13:18:05.080294
NCT00858052|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2014-09-04||2014-03-11|February 2009||2009-02-01|September 2014|2014-09-01|February 2020|Anticipated|2020-02-01|February 2012|Actual|2012-02-01||Interventional|||Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-filled Breast Implants|Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-filled Breast Implants in Women Who Are Undergoing Primary Breast Augmentation or Replacement of Existing Augmentation Implants|Active, not recruiting||N/A|500|Anticipated|Ideal Implant Incorporated||1|||f||||f||||||||||2017-02-18 13:18:05.202287|2017-02-18 13:18:05.202287
NCT00858039|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2014-11-04|||February 2009||2009-02-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|July 2013|Actual|2013-07-01||Observational|CATS||Cardiotoxicity of Adjuvant Trastuzumab|Prediction of Cardiotoxicity Using Serum N-terminal Pro-B-type Natriuretic Peptide in Breast Cancer Patients Receiving Adjuvant Trastuzumab|Completed||N/A|220|Actual|Royal Prince Alfred Hospital, Sydney, Australia|||1||f||||f||||||Samples With DNA|"~     Human serum Human whole blood~   "|||2017-02-18 13:18:05.325573|2017-02-18 13:18:05.325573
NCT00858026|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2009-03-06|||April 2006||2006-04-01|March 2009|2009-03-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Impact of a Fermented Infant Formula in Weaning Babies|Impact of a Fermented Infant Formula in Weaning Babies|Completed||N/A|91|Actual|Bledina||3|||f||||f||||||||||2017-02-18 13:18:05.42516|2017-02-18 13:18:05.42516
NCT00858013|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2011-06-24|||April 2009||2009-04-01|June 2011|2011-06-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Study of the Durability of Glycemic Control With Nateglinide|Multi-center, Randomized, Open Label Study of the Durability of Glycemic Control With Nateglinide Versus Glimepiride as Monotherapy in Type 2 Diabetic Patients|Unknown status|Recruiting|Phase 4|200|Anticipated|Ajou University School of Medicine||2|||f||||t||||||||||2017-02-18 13:18:05.537867|2017-02-18 13:18:05.537867
NCT00858000|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-12-23|||July 2009||2009-07-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Analysis of Expression of Specific Markers in Hepatocellular Carcinoma|Analysis of the Incidence of Expression of a Specific Set of Genes and of Tumor Antigens in Cancer Tissue From Patients With Hepatocellular Carcinoma|Completed||N/A|30|Actual|GlaxoSmithKline|||1||f||||||||||None Retained|"~     This retrospective study is based upon the analysis of archived samples and patient-related~     data already available at the investigational site~   "|||2017-02-18 13:18:05.65913|2017-02-18 13:18:05.65913
NCT00857987|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2011-01-27|||April 2010||2010-04-01|January 2011|2011-01-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|||Effectiveness and Safety of the of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improvement of Symptoms Resulting From Acute Respiratory Infections.|Randomized , Placebo-controlled, Clinical Trial of Efficacy and Safety Evaluation of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improving the Signs and Symptoms of Infections of Way Upper (URI)|Unknown status|Recruiting|Phase 3|174|Anticipated|Azidus Brasil||2|||f||||t||||||||||2017-02-18 13:18:05.754848|2017-02-18 13:18:05.754848
NCT00857974|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2017-01-23|||July 2007||2007-07-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|PART||Physical Activity Program for Older Renal Transplant Candidates|Impact of a Physical Activity Intervention on Physical Function and Quality of Life in Aging Candidates for Renal Transplantation: The PART Study|Completed||N/A|25|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 13:18:05.866989|2017-02-18 13:18:05.866989
NCT00857961|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2011-01-06|2010-12-15||October 2007||2007-10-01|January 2011|2011-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations|A Phase II, Randomised, Four-way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered Dose (MD) Lotion® Formulations and Doses in Hypogonadal Men|Completed||Phase 2|21|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 13:18:05.982224|2017-02-18 13:18:05.982224
NCT00857948|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2012-03-01|2012-03-01||March 2009||2009-03-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation|A Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of 3 Strengths of Ivermectin Treatment Conditioner and Placebo in Subjects With Pediculus Humanus Capitis (Head Lice) Infestation|Completed||Phase 2|78|Actual|Topaz Pharmaceuticals Inc||4|||f||||f||||||||||2017-02-18 13:18:06.652351|2017-02-18 13:18:06.652351
NCT00857935|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-06|||March 2007||2007-03-01|March 2009|2009-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse|A Pilot Study to Test the Operational Elements of an Actual Use Study Designed to Compare the Safety and Efficacy of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months of Age or Older With Pediculosis Capitis|Completed||Phase 2|24|Actual|ParaPRO LLC||2|||f||||f||||||||||2017-02-18 13:18:07.388303|2017-02-18 13:18:07.388303
NCT00857922|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2017-01-16|||March 2009||2009-03-01|January 2017|2017-01-01|August 2029|Anticipated|2029-08-01|March 2020|Anticipated|2020-03-01||Observational|NRR||Neurosciences Research Repository|Neurosciences Research Repository|Recruiting||N/A|5000|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||t||||||Samples With DNA|"~     whole blood, plasma, white cells, saliva, tissue, CSF~   "|||2017-02-18 13:18:07.489821|2017-02-18 13:18:07.489821
NCT00857909|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2011-07-07|||January 2009||2009-01-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SPAS||The Effect of Amiloride and Spironolactone in Healthy Persons|The Effect of Amiloride and Spironolactone Measured on Cardiovascular and Kidney Related Variables in Healthy Subjects in a Double-blinded, Randomised, Placebo-controlled, Cross-over Study|Completed||Phase 1|30|Actual|Regional Hospital Holstebro||3|||f||||t||||||||||2017-02-18 13:18:07.587254|2017-02-18 13:18:07.587254
NCT00857896|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2011-11-20|2011-10-04||March 2009||2009-03-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years|An Open-Label, Dose-Escalating Study Of The Pharmacokinetics, Safety And Tolerability Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years.|Completed||Phase 2|21|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 13:18:07.692137|2017-02-18 13:18:07.692137
NCT00857727|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2015-03-03|||August 2009||2009-08-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|DexPeds||Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children|Use of Dexmedetomidine for Emergence Delirium in Children Undergoing General Anesthesia for Endovascular Interventional Neuroradiologic Procedures|Completed||Phase 3|128|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||t||||||||||2017-02-18 13:18:10.616263|2017-02-18 13:18:10.616263
NCT00857883|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-10-11|||November 2008||2008-11-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|FTIH||A First-Time-In-Human Study in Healthy Subjects|A First-Time-In-Human, Three-Part, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1521498 in Healthy Subjects|Completed||Phase 1|56|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:18:07.99887|2017-02-18 13:18:07.99887
NCT00857870|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2012-01-10|||March 2009||2009-03-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|GLORY||Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects|Comparative Investigation of Efficacy and Safety of Insulin Glargine Versus Metformin as First Line Drug in Treatment of Early Type 2 Diabetes|Completed||Phase 4|96|Actual|GWT-TUD GmbH||2|||f||||||||||||||2017-02-18 13:18:08.107822|2017-02-18 13:18:08.107822
NCT00857857|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-10-11|||February 2009||2009-02-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics|A Randomised, Placebo-controlled, Incomplete Block, Three-way Cross-over Study to Evaluate the Effect of Treatment With Repeat Inhaled Doses of GW870086X on the Allergen-induced Early and Late Asthmatic Response in Subjects With Mild Asthma|Completed||Phase 2|24|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:18:08.396099|2017-02-18 13:18:08.396099
NCT00857844|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2013-05-01|||July 2007||2007-07-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|October 2008|Actual|2008-10-01||Observational|||Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers|Genetic Predisposition of Chronic Nephrotoxicity From Calcineurin Inhibitors in Liver Transplant Recipients, Potential Correlation With Urinary Biomarkers|Completed||N/A|207|Actual|Northwestern University|||3||f||||f||||||Samples With DNA|"~     -  Urine will be collected from all patients in the 3 groups and analyzed for biomarkers~          of interstitial fibrosis and proximal tubule injury. Specific biomarkers that will be~          tested are: urinary TGF-beta1, kidney injury molecule-1 and angiotensinogen. Urinary~          biomarkers will be normalized to creatinine and analyzed using an ELISA assay.~        -  An additional 18mls of blood will be collected. This blood will be used to study organ~          transplant tolerance in subjects who are currently using immunosuppressant medications.~   "|||2017-02-18 13:18:08.524197|2017-02-18 13:18:08.524197
NCT00857831|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2012-10-02|||January 2008||2008-01-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||Vitamin D and Calcium Study|Vitamin D and Calcium Replacement/Supplementation in Subjects With Chronic Spinal Cord Injury|Completed||N/A|10|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 13:18:08.637648|2017-02-18 13:18:08.637648
NCT00857818|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2013-11-07|2011-05-17||April 2009||2009-04-01|July 2011|2011-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome|A 16-Week, Randomized, Controlled Trial of the Effect of Aripiprazole Versus Standard of Care on Non-HDL Cholesterol Among Patients With Schizophrenia and Bipolar I Disorder Who Have Pre-existing Metabolic Syndrome|Terminated||Phase 3|64|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|The study terminated early due to low enrollment. Mean changes from baseline in: the Clinical Global Impression-Severity Scale and the Impact of Weight on Quality of Life scores were not analyzed due to insufficient data for meaningful conclusions.|2||Slow Accrual|f||||f||||||||||2017-02-18 13:18:08.748709|2017-02-18 13:18:08.748709
NCT00857805|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-11-02|||January 2009||2009-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma|Randomized Controlled Trial of Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma|Recruiting||N/A|220|Anticipated|Loma Linda University||2|||f||||f||||||||||2017-02-18 13:18:09.458643|2017-02-18 13:18:09.458643
NCT00857792|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-05-09|2014-11-18||March 2009||2009-03-01|May 2016|2016-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging|Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging|Completed||N/A|120|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 13:18:09.569304|2017-02-18 13:18:09.569304
NCT00857779|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2013-02-07|||February 2009||2009-02-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients|A Multicentre Randomised Phase II Clinical Trial to Demonstrate Equivalent Pharmacodynamic Efficacy and Tolerability of Two Updosing Schedules for ALK-Flex SQ|Completed||Phase 2|473|Actual|ALK-Abelló A/S||2|||f||||t||||||||||2017-02-18 13:18:09.814032|2017-02-18 13:18:09.814032
NCT00857766|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-12-01|2010-12-16||March 2009||2009-03-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-Blind, Parallel-Group, 16-Week Study to Evaluate the Effect of Fluticasone Propionate/Salmeterol DISKUS® 250/50mcg BID and Placebo on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|249|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:18:09.923265|2017-02-18 13:18:09.923265
NCT00857753|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-06|||September 2006||2006-09-01|March 2009|2009-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Relative Bioavailability of a Fentanyl Patch|A Study to Evaluate the Relative Bioavailability of a Fentanyl PAtch Transdermal Delivery System (25 ug/hr) (Sandoz) Compared to Duragesic (Fentanyl Transdermal SYstem 25 ug/hr Patches (Alza)|Completed||Phase 1|40|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:18:10.447462|2017-02-18 13:18:10.447462
NCT00857740|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2010-07-07|||March 2009||2009-03-01|March 2009|2009-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Influence of Painphysiolgy Education on the Pain Inhibition in Fibromyalgia|Influence of Painphysiolgy Education on the Pain Inhibition in Fibromyalgia|Completed||Early Phase 1|50|Anticipated|Vrije Universiteit Brussel||1|||f||||||||||||||2017-02-18 13:18:10.5308|2017-02-18 13:18:10.5308
NCT00857701|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2013-08-08|||January 2009||2009-01-01|August 2013|2013-08-01||||May 2015|Anticipated|2015-05-01||Interventional|||Dynamic Splinting After Total Knee Arthroplasty|Dynamic Splinting After Total Knee Arthroplasty: a Randomized, Controlled Trial|Terminated||N/A|25|Actual|Dynasplint Systems, Inc.||2||Unrelated to trial|f||||t||||||||||2017-02-18 13:18:11.011738|2017-02-18 13:18:11.011738
NCT00857688|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-06|2013-02-22|||May 2011||2011-05-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration|Randomized Clinical Study to Evaluate the Effectiveness and Safety of the Drug Topic Bismu-Jet ® (Bismuth Tartrate, Neomycin Sulphate and Procaine Hydrochloride) Compared to Placebo in Improvement of Signs and Symptoms of Ulcerations Caused Disease.|Completed||Phase 3|100|Actual|Azidus Brasil||2|||f||||t||||||||||2017-02-18 13:18:11.116333|2017-02-18 13:18:11.116333
NCT00857675|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-04-02|||December 2002||2002-12-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B|A Multi-Centre, Double-Blind , Randomized, Placebo-Controlled Phase II/III Study of Adefovir Dipivoxil for the Treatment of Chinese Patients With HBeAg Positive Chronic Hepatitis B Followed by Long-Term (5 Years Total) Adefovir Dipivoxil Treatment. (Report on Year 1 and Year 2 Data)|Completed||Phase 3|480|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 13:18:11.215767|2017-02-18 13:18:11.215767
NCT00857662|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-06|||May 2001||2001-05-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|April 2003|Actual|2003-04-01||Interventional|||Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)|U.S. Multicenter, Randomized Controlled Study Comparing the Performance fo Onyx(EVOH) and TRUFILL® (n-BCA)in Presurgical Embolization of Brain Arteriovenous Malformations (BAVMs)|Completed||Phase 2|117|Actual|ev3||2|||f||||t||||||||||2017-02-18 13:18:11.340188|2017-02-18 13:18:11.340188
NCT00857649|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2013-11-12|2011-10-26||December 2003||2003-12-01|November 2013|2013-11-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease|A Randomised, Double-Blind, Parallel-Group Study Examining the Efficacy and Safety of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type|Terminated||Phase 3|369|Actual|H. Lundbeck A/S|Long recruitment, premature termination, substantial protocol changes; baseline imbalances (concomitant medication and severity of agitation). Variability across sites in reported events frequency (50% of agitation reports from a single site)|2|||f||||f||||||||||2017-02-18 13:18:11.457223|2017-02-18 13:18:11.457223
NCT00857636|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2015-03-31|||November 2009||2009-11-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2011|Actual|2011-11-01||Interventional|||Behavioral Intervention Study for Better Breast and Cervical Cancer Control for Korean American Women|Better Breast and Cervical Cancer Control for Korean American Women|Completed||N/A|560|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 13:18:12.069569|2017-02-18 13:18:12.069569
NCT00857623|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-11-08|2012-09-28||February 2009||2009-02-01|November 2012|2012-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy|A Phase IIa, Double-Blind, Randomised, Parallel-Group, Multi-Centre Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy|Completed||Phase 2|127|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 13:18:12.176865|2017-02-18 13:18:12.176865
NCT00857610|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-10-17|||April 2009||2009-04-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Retinol-induced Dermatitis in Aged Skin|Molecular Analyses of Retinoid-induced Dermatitis in Aged/Photoaged Human Skin|Recruiting||N/A|200|Anticipated|University of Michigan|||6||f||||f||||||Samples With DNA|"~     Skin biopsies will be taken; however, they are not intended to be used for DNA extraction.~   "|||2017-02-18 13:18:12.836267|2017-02-18 13:18:12.836267
NCT00857597|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-04-17|||March 2009||2009-03-01|April 2009|2009-04-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Interventional|TvP||Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment|A Randomized Controlled Trial of Transoral Incisionless Fundoplication (TIF) Versus Proton Pump Inhibitors (PPIs) for Treatment of GERD: The TIF vs. PPIs Study|Unknown status|Recruiting|Phase 3|120|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:18:12.950378|2017-02-18 13:18:12.950378
NCT00857584|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2012-04-16|2012-02-06||May 2009||2009-05-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy|Effectiveness of Quetiapine XR Versus Sertraline in Acute Depression as add-on Therapy to Previous Mood Stabilizer Treatment: a Pilot Study|Completed||Phase 3|27|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:18:13.08821|2017-02-18 13:18:13.08821
NCT00857571|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2010-10-22|||April 2009||2009-04-01|October 2010|2010-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.|An Open-Label Randomized Incomplete Block Four-Way Crossover Study To Evaluate The Dose Response Of PF-02413873 Tablets And PF-02413873 Suspension.|Terminated||Phase 1|30|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 13:18:13.82133|2017-02-18 13:18:13.82133
NCT00857558|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2014-01-06|||January 2009||2009-01-01|January 2014|2014-01-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes|A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes|Completed||Phase 2|280|Anticipated|Kyowa Hakko Kirin Co., Ltd||4|||f||||f||||||||||2017-02-18 13:18:13.934744|2017-02-18 13:18:13.934744
NCT00857545|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-03-16|||July 2010||2010-07-01|March 2016|2016-03-01||||February 2015|Actual|2015-02-01||Interventional|||OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission|A Phase II Randomized, Double-Blind Trial of a Polyvalent Vaccine-KLH Conjugate (NSC 748933 ) + OPT-821 Versus OPT-821 in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Who Are in Second or Third Complete Remission|Active, not recruiting||Phase 2|163|Actual|Gynecologic Oncology Group||2|||f||||t||||||||||2017-02-18 13:18:14.045902|2017-02-18 13:18:14.045902
NCT00857532|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2013-02-01|2012-11-30||January 2009||2009-01-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients|A Phase 2 Trial of Florbetapir F18 PET Imaging of β-amyloid in Parkinson's Disease Patients With Cognitive Impairment|Completed||Phase 2|31|Actual|Avid Radiopharmaceuticals||3|||f||||f||||||||||2017-02-18 13:18:14.23171|2017-02-18 13:18:14.23171
NCT00857519|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2016-12-09|||January 2009||2009-01-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|IAC-RB||A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma|Intra-arterial (Ophthalmic Artery) Chemotherapy for Retinoblastoma|Completed||N/A|10|Actual|Wills Eye||1|||f||||f||||||||No||2017-02-18 13:18:14.512475|2017-02-18 13:18:14.512475
NCT00857506|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2013-03-26|2012-12-31||January 2009||2009-01-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)|Longitudinal Study of Long-term (36 Month) Cognitive Outcomes in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) Who Have Previously Had PET Imaging With 18F-AV-45 Injection.|Completed||Phase 2|152|Actual|Avid Radiopharmaceuticals||1|||f||||f||||||||||2017-02-18 13:18:14.625453|2017-02-18 13:18:14.625453
NCT00857493|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2015-01-28|||June 2009||2009-06-01|January 2015|2015-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects|A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects|Completed||Phase 2|120|Actual|Bavarian Nordic||2|||f||||t||||||||||2017-02-18 13:18:15.188169|2017-02-18 13:18:15.188169
NCT00857480|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-06|||June 2006||2006-06-01|March 2009|2009-03-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin|A Single-Centre, Open, Controlled, Randomised Cross-Over Study in Healthy Male and Female Volunteers to Evaluate the Pharmacokinetics of Cholyl-Lysyl-Fluorescein (NRL972) in the Presence of Medication-Induced Changes in Cytochrome P450 or Biliary Transporter Proteins. Part B: Interaction With Ursodeoxycholic Acid and Cloxacillin|Completed||Phase 1|12|Actual|Norgine||3|||f||||f||||||||||2017-02-18 13:18:15.287848|2017-02-18 13:18:15.287848
NCT00857467|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-12-21|||February 2009||2009-02-01|December 2009|2009-12-01||||December 2009|Actual|2009-12-01||Interventional|||Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001.|Randomised, Double-blind, Single Dose, Three-way, Cross-over Study to Investigate the Safety and Response to 1g or 2g Rectal Suppositories Containing 5 mg or 10 mg 1R,2S-methoxamine Hydrochloride [NRL001] or Matching Placebo|Completed||Phase 1|36|Anticipated|Norgine||2|||f||||f||||||||||2017-02-18 13:18:15.383068|2017-02-18 13:18:15.383068
NCT00857454|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2010-12-15|2010-12-15||October 2008||2008-10-01|December 2010|2010-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations|A Phase III Open-label Extension of the MTE08 Trial (A Phase III Open-label Titration Trial to Evaluate the Effectiveness and Safety of Different Doses of a Dermal Application of Testosterone MD-Lotion® (Cutaneous Solution) in Hypogonadal Men) to Evaluate Skin-safety|Completed||Phase 3|71|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 13:18:15.474309|2017-02-18 13:18:15.474309
NCT00857441|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2015-07-16|||January 2008||2008-01-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|September 2009|Actual|2009-09-01||Interventional|DEBIUT||Drug-eluting Balloon in Bifurcations Trial|A Prospective Three-arm Multi-center Study to Investigate Procedural, Clinical and Angiographic Outcomes Using a Drug Eluting Balloon Versus a Standard Balloon in Combination With a Bare Metal Stent and a DES Stent, Following the Provisional Side Branch T-stenting Approach, in Patients With Complex Lesions|Completed||Phase 2/Phase 3|120|Actual|UMC Utrecht||3|||f||||t||||||||||2017-02-18 13:18:15.877585|2017-02-18 13:18:15.877585
NCT00857428|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-05|||November 2007||2007-11-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions|A Study to Evaluate the Relative Bioavailability of Oxymorphone 40 mg Extended-Release Tablets (Sandoz, Inc.) Compared to Opana ER (Oxymorphone Hydrochloride) Extended-Release Tablets, 40 mg (Endo Pharmaceuticals, Inc.) in Healthy Volunteers Under Fasted Conditions|Completed||Phase 1|50|Actual|Sandoz||2|||f||||f||||||||||2017-02-18 13:18:15.988323|2017-02-18 13:18:15.988323
NCT00857415|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2012-05-17|2012-04-06||December 2008||2008-12-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain|A Phase III Study of the Correlation Between Florbetapir F 18 (18F-AV-45) PET Imaging and Amyloid Pathology|Completed||Phase 3|226|Actual|Avid Radiopharmaceuticals||2|||f||||f||||||||||2017-02-18 13:18:16.090377|2017-02-18 13:18:16.090377
NCT00857402|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-05|||February 2004||2004-02-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Arginine as an Adjuvant Treatment Against Tuberculosis|Arginine Rich Food Supplementation as an Adjuvant Treatment Against Tuberculosis|Completed||N/A|180|Actual|Linkoeping University||2|||f||||f||||||||||2017-02-18 13:18:18.77933|2017-02-18 13:18:18.77933
NCT00857389|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-11-22|||March 2009||2009-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies|Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies|Active, not recruiting||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:18:18.886044|2017-02-18 13:18:18.886044
NCT00857376|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2012-09-27|||March 2008||2008-03-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|Alpha||Dose Ranging Study of the Effects of Alpha Lipoic Acid on Oxidative Stress|Dose Ranging Study of the Effects of Alpha Lipoic Acid on Oxidative Stress|Completed||Phase 2|77|Actual|Johns Hopkins University||4|||f||||f||||||||||2017-02-18 13:18:19.008614|2017-02-18 13:18:19.008614
NCT00857363|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2010-01-14|||March 2009||2009-03-01|January 2010|2010-01-01|June 2009|Anticipated|2009-06-01|May 2009|Anticipated|2009-05-01||Observational|CTT||Colonic Transit Time Validation Study|SmartPill Colonic Transit Time Validation Study in Patients With Chronic Constipation|Unknown status|Recruiting|N/A|210|Anticipated|The SmartPill Corporation|||1||f||||f||||||||||2017-02-18 13:18:19.107281|2017-02-18 13:18:19.107281
NCT00857350|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-07-19|||June 2008||2008-06-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|June 2010|Actual|2010-06-01||Observational|||The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment|The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment|Completed||N/A|60|Actual|Yale University|||1||f||||f||||||||||2017-02-18 13:18:19.211826|2017-02-18 13:18:19.211826
NCT00857324|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2016-05-09|||March 2009||2009-03-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2012|Actual|2012-03-01||Interventional|||Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients|A Phase I/II, Multi-Center, Open Label Study of Vorinostat Plus Melphalan and Prednisone (ZMP) in Advanced, Refractory Multiple Myeloma Patients|Terminated||Phase 1/Phase 2|18|Actual|University of Turin, Italy||1||The Phase I of the study was completed, but Phase 2 has not been activated|f||||t||||||||||2017-02-18 13:18:19.307411|2017-02-18 13:18:19.307411
NCT00857311|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2015-08-11|2011-06-09||May 2004||2004-05-01|August 2015|2015-08-01|May 2010|Actual|2010-05-01|January 2006|Actual|2006-01-01||Interventional|||MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Probe Study With an Additional Open-Label Control Arm to Evaluate the Safety and Immunogenicity of a 3-Dose Regimen of the MRKAd5 HIV-1 Gag Vaccine in Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 1|17|Actual|Merck Sharp & Dohme Corp.|An interim analysis of a related study, V520 Protocol 023 (NCT00095576), showed that the MRKAd5 vaccine used in Protocol 022 (NCT00857311) was not efficacious; therefore, only a high level summary of the safety data was performed.|4|||f||||t||||||||||2017-02-18 13:18:19.41773|2017-02-18 13:18:19.41773
NCT00857298|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2015-02-13|||February 2009||2009-02-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome|Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome|Completed||N/A|20|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:18:20.103734|2017-02-18 13:18:20.103734
NCT00857285|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-07-22|2009-05-28||May 2002||2002-05-01|July 2009|2009-07-01|September 2003|Actual|2003-09-01|August 2003|Actual|2003-08-01||Interventional|||Olmesartan Medoxomil Versus Losartan in Patients With Hypertension|"A Multi-center, Double Blind, Efficacy, and Safety Study of the Oral Angiotensin II Receptor Blocker Olmesartan Medoxomil Versus Losartan in Patients With Mild to Moderate Essential Hypertension"|Completed||Phase 3|130|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:18:20.214406|2017-02-18 13:18:20.214406
NCT00857272|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2010-09-29|2010-08-09||February 2009||2009-02-01|September 2010|2010-09-01||||May 2009|Actual|2009-05-01||Interventional|||F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects|F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects|Completed||Phase 4|308|Actual|Braintree Laboratories|Total number of patients experiencing a non-serious adverse event is based on all adverse events, not just those events above the reporting threshold of 3%|2|||f||||f||||||||||2017-02-18 13:18:20.527253|2017-02-18 13:18:20.527253
NCT00857259|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2011-07-22|2011-07-22||February 2009||2009-02-01|July 2011|2011-07-01||||July 2010|Actual|2010-07-01||Interventional|||The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration|A Randomized, Double-masked, Parallel Group Study to Assess the Efficacy of Oral Everolimus, Either Alone or Added to Lucentis, in Patients With Neovascular Age-related Macular Degeneration|Terminated||Phase 2|16|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:18:20.931293|2017-02-18 13:18:20.931293
NCT00857246|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2015-11-06|2015-03-02||July 2005||2005-07-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|September 2011|Actual|2011-09-01||Interventional|||Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer|Neoadjuvant Therapy of Gastric Cancer With Irinotecan, Cisplatin and Cetuximab Followed by Surgical Resection and Adjuvant Chemoradiation|Completed||Phase 2|30|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 13:18:21.353412|2017-02-18 13:18:21.353412
NCT00857233|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2012-07-26|2012-07-26||June 2004||2004-06-01|July 2012|2012-07-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease|An Open-label Extension Study Examining the Safety and Tolerability of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type Having Completed Study 10158|Terminated||Phase 3|297|Actual|H. Lundbeck A/S|Long recruitment, premature termination.|1||Please see explanation in the Detailed Description field.|f||||f||||||||||2017-02-18 13:18:22.013675|2017-02-18 13:18:22.013675
NCT00857220|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-06-18|2012-11-02||May 2009||2009-05-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia|A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia|Completed||Phase 3|304|Actual|Sunovion|Designed to assess safety/tolerability. Efficacy endpoints evaluated w/ descriptive stats only, w/ no placebo group against which to assess the impact of therapy. ~40% completion rate typical for one year studies but limits interpretation of results.|1|||f||||t||||||||||2017-02-18 13:18:22.399601|2017-02-18 13:18:22.399601
NCT00857207|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-11-30|||October 2013||2013-10-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|January 2018|Anticipated|2018-01-01||Interventional|||Metacognitive Training to Enhance Strategy Use in Blast-Related TBI|Metacognitive Training to Enhance Strategy Use in Blast Related TBI|Recruiting||Phase 1/Phase 2|54|Anticipated|VA Office of Research and Development||2|||f||||f||||||||Undecided||2017-02-18 13:18:22.946309|2017-02-18 13:18:22.946309
NCT00857194|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-12-07|||March 2007||2007-03-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Cardiovascular Disease Study|Risk Factors for Coronary Heart Disease in Spinal Cord Injury: Conventional and Emerging|Recruiting||N/A|200|Anticipated|VA Office of Research and Development|||1||f||||f||||||Samples Without DNA|"~     serum and plasma~   "|Undecided||2017-02-18 13:18:23.069074|2017-02-18 13:18:23.069074
NCT00857181|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2012-03-02|||March 2009||2009-03-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|CLC-2009||Cytokines and the Risk of Infection in Liver Cirrhosis|A Single-center, Open Study to Investigate Cytokine Levels in Patients With Hepatic Cirrhosis Before the Development of Significant Infection|Terminated||N/A|150|Actual|Medical University of Graz|||1|Finding to be unable to reach the primary endpoint|f||||f||||||Samples Without DNA|"~     Serum and plasma samples.~   "|||2017-02-18 13:18:23.185187|2017-02-18 13:18:23.185187
NCT00857168|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-10-12|||January 2009||2009-01-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|MTE10||To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion|A Phase I Trial to Determine the Impact of Application of Antiperspirant and Deodorant as Well as Washing the Application Site, on the Pharmacokinetics of Testosterone Following Single Dose Applications of 2% Testosterone MD-Lotion® (Cutaneous Solution)|Completed||Phase 1|36|Anticipated|Acrux DDS Pty Ltd||6|||f||||f||||||||||2017-02-18 13:18:23.27956|2017-02-18 13:18:23.27956
NCT00857155|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-05|||January 2009||2009-01-01|March 2009|2009-03-01|February 2011|Anticipated|2011-02-01|January 2011|Anticipated|2011-01-01||Interventional|TARGET-CABG||Time Based Strategy to Reduce Clopidogrel Associated Bleeding Related to Coronary Artery Bypass Graft (CABG)||Unknown status|Recruiting|N/A|200|Anticipated|LifeBridge Health||2|||f||||f||||||||||2017-02-18 13:18:23.378394|2017-02-18 13:18:23.378394
NCT00857142|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-05|||November 2007||2007-11-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions|A Study to Evaluate the Relative Bioavaility of Oxymorphone Hydrochloride 40 mg Extended-Release Tablets(Sandoz, Inc. Compared to Opana ER (Oxymorphone Hydrochloride) Extended-Release Tablets, 40 mg (Edo Pharmaceuticals Inc.) in Healthy Volunteers Under Non-Fasted COnditions|Completed||Phase 1|32|Actual|Sandoz||2|||f||||||||||||||2017-02-18 13:18:23.502028|2017-02-18 13:18:23.502028
NCT00857129|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2014-10-17|||September 2006||2006-09-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|March 2010|Actual|2010-03-01||Interventional|||Can Differentiated Birth Care Improve the Service?|Differentiated Birth Service- an Improvement?|Completed||N/A|1111|Actual|Ostfold Hospital Trust||3|||f||||f||||||||||2017-02-18 13:18:23.765976|2017-02-18 13:18:23.765976
NCT00857116|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2013-08-28|||March 2009||2009-03-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Deworming Against Tuberculosis|The Impact of Deworming on Host Immunity and Clinical Outcome in Patients With Pulmonary Tuberculosis|Completed||N/A|140|Actual|Linkoeping University||2|||f||||t||||||||||2017-02-18 13:18:23.875685|2017-02-18 13:18:23.875685
NCT00857103|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2013-06-14|||August 2006||2006-08-01|June 2013|2013-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Interactive Tailored Assessment on Patient-provider Communication|Improving Patient-Provider Communication in Cancer Care|Completed||N/A|200|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 13:18:23.990069|2017-02-18 13:18:23.990069
NCT00857090|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2012-10-10||2012-10-10|March 2009||2009-03-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones|Double-Blind, Placebo-Controlled, Concentration-Escalating, Pharmacokinetic Study Evaluating the Systemic Absorption, Safety, and Efficacy of OMS201 in Subjects Undergoing Ureteroscopic Treatment of Ureteral- or Renal Collecting System-Located Stones|Completed||Phase 1/Phase 2|18|Actual|Omeros Corporation||2|||f||||f||||||||||2017-02-18 13:18:24.103716|2017-02-18 13:18:24.103716
NCT00857077|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2017-01-25|||September 2000||2000-09-01|January 2017|2017-01-01|June 2004|Actual|2004-06-01|||||Interventional|||Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana|Evaluation of the Safety and Effectiveness of EPI-linked Malaria Intermittent Chemotherapy and Iron Supplementation|Completed||N/A|2485|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 13:18:24.220073|2017-02-18 13:18:24.220073
NCT00857064|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2010-12-07|||March 2009||2009-03-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|AURA||Subjective Well Being of Schizophrenic Patients in Greece|Subjective Well Being of Schizophrenic Patients in Greece|Completed||N/A|600|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:18:24.341071|2017-02-18 13:18:24.341071
NCT00857051|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-09-24|||March 2009||2009-03-01|March 2009|2009-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Postpartum Support: Can we Facilitate the Transition to Motherhood?|Postpartum Support: Can we Facilitate the Transition to Motherhood?|Completed||N/A|552|Anticipated|American University of Beirut Medical Center||4|||f||||f||||||||||2017-02-18 13:18:24.452284|2017-02-18 13:18:24.452284
NCT00857038|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-05|||April 2009||2009-04-01|March 2009|2009-03-01|January 2010|Anticipated|2010-01-01|August 2009|Anticipated|2009-08-01||Interventional|||Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)|Doxycycline and Airway Inflammation in COPD: A Randomised Placebo Controlled Trial Studying the Effects of Doxycycline on Airway Inflammation in Patients With Moderate and Severe Stable COPD.|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Medical Center Alkmaar||2|||f||||f||||||||||2017-02-18 13:18:24.560337|2017-02-18 13:18:24.560337
NCT00857025|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-09-16|||November 2008||2008-11-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase I Study of MM-10-001 In Advanced Non Small Lung Cancer|Active, not recruiting||Phase 1|20|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:18:24.670768|2017-02-18 13:18:24.670768
NCT00857012|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2012-11-09|||April 2009||2009-04-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|||||Observational|COMPACT||Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT)|Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT): An in Practice Assessment of Arthralgias and Related Costs as Well as Compliance in the First Year of Anastrozole Therapy|Completed||N/A|2313|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:18:24.799841|2017-02-18 13:18:24.799841
NCT00856999|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-04||||||March 2009|2009-03-01||||||||Interventional|||Botox Cosmetic and the Young Patient With Glabellar Furrows|Botox Cosmetic and the Young Patient With Glabellar Furrows|Completed||Phase 4|||Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 13:18:25.486571|2017-02-18 13:18:25.486571
NCT00856986|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2014-11-17|2011-04-19||March 2009||2009-03-01|November 2014|2014-11-01|November 2010|Actual|2010-11-01|April 2010|Actual|2010-04-01||Interventional|||The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes|The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes. A 26 Week, Randomised, Open-label, Parallel-group, Multicentre, Multinational Trial With a 26 Week Extension|Completed||Phase 3|987|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-02-18 13:18:25.600694|2017-02-18 13:18:25.600694
NCT00856973|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-06-07|2012-11-02||May 2009||2009-05-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia|A Randomized, Placebo Controlled, Double Blind, Fixed Dose Study of the Efficacy and Safety of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia|Completed||Phase 3|486|Actual|Sunovion|Per protocol, study did not have PSG adaptation nights at baseline and contained one PSG assessment post randomization visit|3|||f||||t||||||||||2017-02-18 13:18:28.831997|2017-02-18 13:18:28.831997
NCT00856960|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-01-21|||January 2010||2010-01-01|January 2016|2016-01-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)|A Randomized, Double-Blind, Placebo-Controlled, 4-Treatment, 3-Period, Incomplete Block, Balanced Crossover Study to Evaluate the Effects of a Single Dose of Aliskiren and Losartan on Renal Blood Flow Measurements in Healthy Male Subjects|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:18:29.896987|2017-02-18 13:18:29.896987
NCT00856947|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2015-07-27|||March 2009||2009-03-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|ABCvitaminD||Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood|Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood: An Interventional Trial in the ABC (Asthma Begins in Childhood) Cohort|Active, not recruiting||Phase 2/Phase 3|600|Anticipated|Copenhagen Studies on Asthma in Childhood||2|||f||||t||||||||||2017-02-18 13:18:29.988346|2017-02-18 13:18:29.988346
NCT00856934|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-02-05|2009-01-02||June 2005||2005-06-01|February 2009|2009-02-01||||March 2006|Actual|2006-03-01||Interventional|||Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing|A New Model to Enhance Wound Healing Using Autologous Keratinocytes in Platelet Concentrates - a Prospective Randomized Trial.|Completed||Phase 1|45|Actual|Centre Hospitalier Universitaire Vaudois||3|||f||||f||||||||||2017-02-18 13:18:30.102258|2017-02-18 13:18:30.102258
NCT00856921|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-05|||April 2008||2008-04-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Observational|AAAS||Genetic Evaluation of AAAS Gene in Early-Onset Achalasia and Alacrima Patients|To Find Out the Genetic Relationship Between the Early-Onset Achalasia and AAAS Gene|Completed||N/A|19|Actual|Asan Medical Center|||||f||||t||||||Samples With DNA|"~     DNA and genetic analysis~   "|||2017-02-18 13:18:30.526895|2017-02-18 13:18:30.526895
NCT00856908|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2012-11-27|2012-07-24||February 2009||2009-02-01|November 2012|2012-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes|A Randomised, Single-Blind, Placebo-Controlled, Phase IIa Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 During Four Weeks in T2DM Subjects Treated With Insulin|Completed||Phase 2|20|Actual|AstraZeneca|"The primary objective of the study was to assess safety and tolerability and hence the study was not sized based on statistical considerations. The most import outcome, no safety or tolerability concerns were identified, is not a numerical variable"|2|||f||||f||||||||||2017-02-18 13:18:30.600281|2017-02-18 13:18:30.600281
NCT00856895|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-06-30|||October 2007||2007-10-01|June 2016|2016-06-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Observational|QOL||Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients|Evaluation of Quality of Life Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients|Enrolling by invitation||N/A|1200|Anticipated|Northwestern University|||2||f||||f||||||||||2017-02-18 13:18:31.085701|2017-02-18 13:18:31.085701
NCT00856882|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-05|||October 2007||2007-10-01|March 2009|2009-03-01||||April 2008|Actual|2008-04-01||Interventional|||The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors|The Effects of Soy Protein and/or Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors-a Six Months RCT Among Postmenopausal Women|Completed||N/A|||Chinese University of Hong Kong||3|||f||||t||||||||||2017-02-18 13:18:31.176618|2017-02-18 13:18:31.176618
NCT00856869|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-05|||August 2004||2004-08-01|March 2009|2009-03-01|April 2005|Actual|2005-04-01|February 2005|Actual|2005-02-01||Interventional|||Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers|A Study in Healthy Volunteers and Patients With Liver Cirrhosis and Non-Alcoholic Steatohepatitis (NASH) to Assess the Effects of Age, Gender, Chronic Liver Disease, and Prandial Effects on the Clearance of Cholyl-Lysyl-Fluorescein (NRL972) an an in-Vivo Marker of Liver Function in Man.|Completed||Phase 1/Phase 2|52|Actual|Norgine||7|||f||||f||||||||||2017-02-18 13:18:31.247831|2017-02-18 13:18:31.247831
NCT00856856|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-02-24|||March 2009||2009-03-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|October 2015|Actual|2015-10-01||Interventional|ABSORB B||ABSORB Clinical Investigation, Cohort B|A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System (BVS EECSS) in the Treatment of Patients With de Novo Native Coronary Artery Lesions.|Active, not recruiting||Phase 1/Phase 2|101|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 13:18:31.356214|2017-02-18 13:18:31.356214
NCT00856843|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2010-10-15|2010-09-03||February 2009||2009-02-01|October 2010|2010-10-01||||May 2009|Actual|2009-05-01||Interventional|||BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects|BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects|Completed||Phase 3|136|Actual|Braintree Laboratories|As prespecified in the study protocol, expected prep related side effects (nausea, vomiting, cramping, bloating and overall discomfort) were only documented as AEs if patients rated them severely distressing on the study questionnaire.|2|||f||||f||||||||||2017-02-18 13:18:31.513131|2017-02-18 13:18:31.513131
NCT00856830|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-07-07|||March 2009||2009-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2015|Actual|2015-05-01||Interventional|||Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer|Phase I/IIa Study of the Novel Combination of Bendamustine With Irinotecan Followed by Etoposide/Carboplatin in Chemonaive Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 1/Phase 2|30|Actual|University of Alabama at Birmingham||1|||f||||t||||||||No||2017-02-18 13:18:32.48846|2017-02-18 13:18:32.48846
NCT00856817|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2011-08-10|||March 2009||2009-03-01|January 2010|2010-01-01||||||||Interventional|||Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation||Terminated||Phase 4|6|Anticipated|Radboud University||2||Recruitment faillure. Similar study published by others. Not yet entered treatment phase.|f||||||||||||||2017-02-18 13:18:32.610948|2017-02-18 13:18:32.610948
NCT00856804|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2009-03-05|||March 2009||2009-03-01|March 2009|2009-03-01|June 2012|Anticipated|2012-06-01|June 2009|Anticipated|2009-06-01||Interventional|TRITAL||Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance|Usefulness of Adding Thalidomide to Peginterferon and Ribavirin in Patients With Hepatitis C and Resistance to Interferon. Phase II|Unknown status|Recruiting|Phase 2|10|Anticipated|Valme University Hospital||1|||f||||f||||||||||2017-02-18 13:18:32.711111|2017-02-18 13:18:32.711111
NCT00856791|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-01-07|2012-11-27||March 2009||2009-03-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients|Phase II Single-arm Study of ON 01910.Na by 2-hr Infusion in Patients With Recurring Platinum-resistant Ovarian Cancer|Completed||Phase 2|1|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-02-18 13:18:32.826587|2017-02-18 13:18:32.826587
NCT00856765|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-06-03|||March 2009||2009-03-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|June 2011|Actual|2011-06-01||Interventional|DEB-AMI||Drug-eluting Balloon in Acute Myocardial Infarction|Randomized Comparison of Drug Eluting Balloon/Bare Metal Stent Versus Drug Eluting Stent Versus Bare Metal Stent for the Treatment of Patients With Acute ST-elevation Myocardial Infarction|Active, not recruiting||Phase 2/Phase 3|150|Actual|UMC Utrecht||3|||f||||t||||||||||2017-02-18 13:18:33.484032|2017-02-18 13:18:33.484032
NCT00856752|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-03-05|||June 2006||2006-06-01|March 2009|2009-03-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine|A Single-Centre, Open, Controlled, Randomised Cross-Over Study in Healthy Male and Female Volunteers to Evaluate the Pharmacokinetics of Cholyl-Lysyl-Fluorescein (NRL972) in the Presence of Medication-Induced Changes in Cytochrome P450 or Biliary Transporter Proteins. Part A: Interaction With Rifampicin and Cyclosporine|Completed||Phase 1|12|Actual|Norgine||3|||f||||f||||||||||2017-02-18 13:18:33.602714|2017-02-18 13:18:33.602714
NCT00856739|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2014-12-10|2014-12-02||March 2009||2009-03-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational||no self-reported chronic pain or significant injury in any of the lower extremity joints or lower back|Obesity and the Initiation of Knee Osteoarthritis|Obesity and Initiation of Osteoarthritis|Completed||N/A|177|Actual|VA Office of Research and Development|||1||f||||f||||||Samples Without DNA|"~     One tube of blood identified with a unique number.~   "|||2017-02-18 13:18:33.702021|2017-02-18 13:18:33.702021
NCT00856726|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2011-06-30|||February 2009||2009-02-01|September 2010|2010-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Racial Differences in Phosphorus Metabolism|Racial Differences in Phosphorus Metabolism|Completed||N/A|40|Anticipated|University of Miami||1|||f||||f||||||||||2017-02-18 13:18:34.063165|2017-02-18 13:18:34.063165
NCT00856713|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-05|||March 2006||2006-03-01|March 2009|2009-03-01||||August 2006|Actual|2006-08-01||Interventional|||Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers|A Study in Healthy Volunteers and Patients With Liver Cirrhosis to Assess the Effects of Age, Gender, and Stable Liver Disease on the Clearance of Cholyl-Lysyl-Fluorescein (NRL972) as an in-Vivo Marker of Liver Function in Man|Completed||Phase 1|72|Actual|Norgine||6|||f||||f||||||||||2017-02-18 13:18:34.143518|2017-02-18 13:18:34.143518
NCT00856700|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2013-12-10|||November 2008||2008-11-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome|Effect of GLP-1 on Endothelial Function and Glucose Uptake in Patients With Metabolic Syndrome|Completed||N/A|20|Actual|University of Rome Tor Vergata||1|||f||||t||||||||||2017-02-18 13:18:34.245609|2017-02-18 13:18:34.245609
NCT00856687|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2010-01-21|||April 2009||2009-04-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects|A Randomized, Double-Blind (3rd Party Open), Double-Dummy, Placebo- And Active Controlled, 3-Way Crossover Study To Determine The Effects Of Oral PF-03893787 On Allergen-Induced Airway Responses In Mild Asthmatic Subjects.|Completed||Phase 1|12|Anticipated|Pfizer||3|||f||||f||||||||||2017-02-18 13:18:34.359194|2017-02-18 13:18:34.359194
NCT00856674|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2010-06-01|||March 2009||2009-03-01|June 2010|2010-06-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy|A Dose-Escalating Phase I Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous OPL-CCL2-LPM in Patients With IgA Nephropathy|Terminated||Phase 1|30|Anticipated|Osprey Pharmaceuticals USA, Inc.||1||Study terminated due to resources and slow enrollment; not due to safety|f||||f||||||||||2017-02-18 13:18:34.461912|2017-02-18 13:18:34.461912
NCT00856661|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2016-12-12|2015-10-06||April 2009||2009-04-01|December 2016|2016-12-01||||October 2014|Actual|2014-10-01||Interventional|||Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)|A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke|Terminated||Phase 3|270|Actual|H. Lundbeck A/S||2||"The recruitment into DIAS4 has been stopped as the result of DIAS 3 indicates that the study~   is unlikely to reach its primary endpoint with the current protocol"|f||||t||||||||||2017-02-18 13:18:34.586152|2017-02-18 13:18:34.586152
NCT00856648|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2012-05-21|||April 2009||2009-04-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Observational|||SmartPill Monitoring for Assessment of GI Function in SCI|SmartPill Monitoring for Assessment of GI Function in SCI|Completed||N/A|40|Anticipated|VA Office of Research and Development|||2||f||||f||||||None Retained|"~     No Biospecimens will be collected.~   "|||2017-02-18 13:18:35.462006|2017-02-18 13:18:35.462006
NCT00856635|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-09-20|2013-07-11||February 2009||2009-02-01|September 2013|2013-09-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional||The safety analysis set included all patients who had been randomized to the study and received at least one dose of study drug.|A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)|A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON)|Completed||Phase 3|44|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 13:18:35.62745|2017-02-18 13:18:35.62745
NCT00856622|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-06-03|||August 1997||1997-08-01|June 2009|2009-06-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients|A 6-Month, Randomized, Double-Masked Comparison Of Fixed Combination Of Latanoprost And Timolol With The Individual Components, Continuing Into A 6-Month Open Label Safety Study Of Fixed Combination In Patients With Glaucoma Or Ocular Hypertension.|Completed||Phase 3|436|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:18:36.006758|2017-02-18 13:18:36.006758
NCT00856609|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2017-01-24|||March 3, 2009||2009-03-03|September 19, 2016|2016-09-19|September 19, 2016|Actual|2016-09-19|September 19, 2016|Actual|2016-09-19||Interventional|||The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects|The Effects of Exenatide (Byetta) on Energy Expenditure and Weight Loss in Non-Diabetic Obese Subjects|Completed||Phase 3|180|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 13:18:36.302213|2017-02-18 13:18:36.302213
NCT00856596|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2009-08-03|||March 2009||2009-03-01|August 2009|2009-08-01|September 2009|Anticipated|2009-09-01|August 2009|Anticipated|2009-08-01||Interventional|||Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females|Efficacy Of Sertaconazole 2% (ERTACZO) in the Treatment of Interdigital Tinea Pedis With Once a Day Treatment for 4 Weeks|Unknown status|Recruiting|Phase 3|30|Anticipated|Jamaica Hospital Medical Center||1|||f||||t||||||||||2017-02-18 13:18:36.418608|2017-02-18 13:18:36.418608
NCT00856583|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-05|2011-08-18|2011-05-04||July 2002||2002-07-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|SCoP||Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use|Sertindole Versus Risperidone Safety Outcome Study: a Randomised, Partially-blinded, Parallel-group, Active-controlled, Post-marketing Study|Completed||Phase 3|9809|Actual|H. Lundbeck A/S||2|||f||||t||||||||||2017-02-18 13:18:36.5545|2017-02-18 13:18:36.5545
NCT00856570|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-07-01|||September 2008||2008-09-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects|An Open-label, One-sequence Crossover Study to Evaluate the Effect of Multiple Doses of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 13:18:38.201722|2017-02-18 13:18:38.201722
NCT00856557|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-04-06|2014-10-27||October 2009||2009-10-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional||Resident physicians in primary care.|Intervening to Prevent Contextual Errors in Medical Decision Making|Intervening to Prevent Contextual Errors in Medical Decision Making|Completed||N/A|138|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 13:18:38.298883|2017-02-18 13:18:38.298883
NCT00856544|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2012-12-06|2012-12-06||May 2009||2009-05-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications|Phase 3, Randomized, Double Blind, Placebo Controlled Study Of The Safety And Efficacy Of 2 Doses Of CP 690,550 In Patients With Active Rheumatoid Arthritis On Background DMARDS|Completed||Phase 3|795|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 13:18:38.84872|2017-02-18 13:18:38.84872
NCT00856531|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-04|||January 2002||2002-01-01|March 2009|2009-03-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|Mobius||Impairments of Oral Language in Mobius Syndrome|Impairments of Oral Language in Subjects With the Möbius Sequence|Completed||N/A|||Fortaleza University|||15||f||||f||||||||||2017-02-18 13:18:45.754723|2017-02-18 13:18:45.754723
NCT00856518|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-12-19|2016-02-26||March 2009||2009-03-01|December 2016|2016-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|EMST||Expiratory Muscle Training for Persons With Neurodegenerative Disease|Expiratory Muscle Training for Persons With Neurodegenerative Disease|Completed||Phase 2/Phase 3|42|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-02-18 13:18:45.834331|2017-02-18 13:18:45.834331
NCT00856505|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-04|||March 2008||2008-03-01|March 2009|2009-03-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation|Everolimus and Mycophenolate Sodium as GvHD Prophylaxis in Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|Phase 1/Phase 2|38|Anticipated|University Hospital Freiburg||1|||f||||t||||||||||2017-02-18 13:18:46.450272|2017-02-18 13:18:46.450272
NCT00856492|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2015-05-08|||April 2010||2010-04-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|August 2015|Anticipated|2015-08-01||Interventional|||S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer|A Randomized Phase II Trial of Weekly Nanoparticle Albumin Bound Paclitaxel (Nab-Paclitaxel) (NSC-736631) With or Without Bevacizumab, Either Preceded by or Followed by Q 2 Week Doxorubicin (A)and Cyclophosphamide (C) Plus Pegfilgrastim (PEG-G) as Neoadjuvant Therapy For Inflammatory and Locally Advanced HER-2/NEU Negative Breast Cancer|Active, not recruiting||Phase 2|200|Anticipated|Southwest Oncology Group||3|||f||||t||||||||||2017-02-18 13:18:46.56614|2017-02-18 13:18:46.56614
NCT00856479|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-05-14|||March 2009||2009-03-01|February 2009|2009-02-01|March 2013|Anticipated|2013-03-01|March 2010|Anticipated|2010-03-01||Interventional|Infuse||A Randomized Controlled Cost Study of Infuse BMP 2 vs Iliac Crest Autograft for Non Union of Long Bone Fractures|A Randomized Controlled Cost Study of Infuse BMP 2 vs Iliac Crest Autograft for Non Union of Long Bone Fractures|Withdrawn||Phase 4|0|Actual|Nova Scotia Health Authority||2||Study never started|f||||t||||||||||2017-02-18 13:18:47.337864|2017-02-18 13:18:47.337864
NCT00856453|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-02-27|||May 2009||2009-05-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer|Restorative Yoga for Women With Ovarian Cancer Undergoing Chemotherapy|Terminated||N/A|2|Actual|Wake Forest University Health Sciences||2||slow accrual|f||||f||||||||||2017-02-18 13:18:47.438161|2017-02-18 13:18:47.438161
NCT00856440|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2010-07-15|||June 2006||2006-06-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Safety and Efficacy of Routine Colonoscopy Preparations|Safety and Efficacy of Routine Colonoscopy Preparations|Completed||N/A|330|Actual|VA Office of Research and Development|||2||f||||f||||||Samples Without DNA|"~     Serum and urine samples~   "|||2017-02-18 13:18:47.541815|2017-02-18 13:18:47.541815
NCT00856427|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-12-18|||February 2008||2008-02-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||Implantation of Markers for the Radiotherapy of Lung Cancer Patients|Implantation of Markers for the Radiotherapy of Lung Cancer Patients|Terminated||Phase 1|6|Actual|Virginia Commonwealth University||1||Slow accrual|f||||t||||||||||2017-02-18 13:18:47.645148|2017-02-18 13:18:47.645148
NCT00856414|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2011-11-08|2011-09-22||March 2009||2009-03-01|November 2011|2011-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines||Completed||Phase 4|45|Actual|Allergan||1|||f||||||||||||||2017-02-18 13:18:47.753095|2017-02-18 13:18:47.753095
NCT00856401|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2014-06-12|||September 2010||2010-09-01|June 2014|2014-06-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|||ADD-ON Study to Existing Hypoparathyroidism Studies|Phase II Trial of Parathyroid Hormone for the Treatment of Hypoparathyroidism|Unknown status|Active, not recruiting|Phase 3|62|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 13:18:48.001515|2017-02-18 13:18:48.001515
NCT00856388|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2016-11-28|2016-05-05||January 2009||2009-01-01|November 2016|2016-11-01||||August 2012|Actual|2012-08-01||Interventional|||Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders|A Pilot Trial Of Reduced Intensity Allogeneic Stem Cell Transplantation With Fludarabine, Melphalan, And Low Dose Total Body Irradiation|Active, not recruiting||N/A|62|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 13:18:48.118568|2017-02-18 13:18:48.118568
NCT00856375|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-02-06||2014-08-13|December 2008||2008-12-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Interventional|||NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer|A Multicenter, Open-Label, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naive, KRAS-Mutant, Metastatic Colorectal Cancer (mCRC)|Completed||Phase 2|83|Actual|Nektar Therapeutics||2|||f||||t||||||||||2017-02-18 13:18:48.580209|2017-02-18 13:18:48.580209
NCT00856362|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2010-09-15|||April 2009||2009-04-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study Evaluating The Co-Administration Of Moxidectin And Midazolam In Healthy Subjects|An Open-label, Single-Dose, 4-Period, Sequential Study to Determine the Effect of Moxidectin on CYP3A4 Activity in Healthy Subjects Using Midazolam as a Probe Substrate|Completed||Phase 1|38|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:18:48.704827|2017-02-18 13:18:48.704827
NCT00856349|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2014-07-01|2014-05-22||April 2009||2009-04-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational||Enrolled subjects who met study eligibility criteria and contributed data toward study endpoints.|Medtronic Shock-Less Study on Physician Utilization of Shock Reduction Programming|Medtronic Shock-Less Study on Physician Utilization of Shock Reduction Programming|Completed||N/A|4384|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-02-18 13:18:48.823221|2017-02-18 13:18:48.823221
NCT00856336|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-04|||May 2003||2003-05-01|March 2009|2009-03-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|DART||Phase I Safety Study of DMXAA in Refractory Tumors|5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA) in the Treatment of Refractory Tumors: A Phase I Multicentre Doubleblind Randomized Six-Way Intrapatient Dose-Ranging Crossover Safety Study.|Completed||Phase 1|15|Actual|Antisoma Research|||||f||||t||||||||||2017-02-18 13:18:49.533675|2017-02-18 13:18:49.533675
NCT00856323|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-08-12|2012-08-27||January 2009||2009-01-01|August 2016|2016-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men|Biobehavioral Interventions for HIV-negative Methamphetamine-using MSM|Completed||Phase 2|53|Actual|Friends Research Institute, Inc.||1|||f||||t||||||||No||2017-02-18 13:18:49.623618|2017-02-18 13:18:49.623618
NCT00856310|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-05-09|||February 2009||2009-02-01|May 2012|2012-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study of the Safety and Tolerability of REGN475 in Healthy Subjects|Completed||Phase 1|56|Actual|Regeneron Pharmaceuticals||7|||f||||f||||||||||2017-02-18 13:18:49.910486|2017-02-18 13:18:49.910486
NCT00856297|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2013-12-17|2013-10-24||February 2009||2009-02-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||Enrolled population|Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine|An Open-Label, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Adolescents Who Previously Received Novartis MenACWY Conjugate Vaccine or Commercially Available MenACWY Conjugate Vaccine|Completed||Phase 3|389|Actual|Novartis||5|||f||||||||||||||2017-02-18 13:18:50.015134|2017-02-18 13:18:50.015134
NCT00856284|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-09-25|2013-09-25||March 2009||2009-03-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|ENDURE|The Randomized Set included all enrolled subjects who were subsequently randomized.|Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus|A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination With Metformin in Subjects With Type 2 Diabetes|Completed||Phase 3|2639|Actual|Takeda|The Week 52 results summarized in herein differ from the Week 52 results summarized in an interim analysis, because the per protocol set (PPS) defined for the final analysis included fewer subjects than the PPS defined for the interim analysis.|3|||f||||t||||||||||2017-02-18 13:18:51.068017|2017-02-18 13:18:51.068017
NCT00856271|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2010-09-28|||August 2004||2004-08-01|September 2010|2010-09-01|April 2005|Actual|2005-04-01|February 2005|Actual|2005-02-01||Interventional|||Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension|A Randomized, Double-blind, Double-dummy, Multi-center Study to Investigate the Safety and Efficacy of Olmesartan Medoxomil Compared With Losartan Potassium in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 3|287|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:18:53.547049|2017-02-18 13:18:53.547049
NCT00856258|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2009-12-22|||March 2009||2009-03-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Multiple Dose Study in Healthy Volunteers to Assess Safety, Pharmacokinetics and Pharmacodynamics of PF 03882845|A Phase 1, Double Blind (Sponsor Open), Randomized, Placebo Controlled, Parallel Group, Oral Multiple Dose Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF 03882845 In Healthy Volunteers|Terminated||Phase 1|10|Actual|Pfizer||4||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:18:53.65492|2017-02-18 13:18:53.65492
NCT00856245|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-03-31|||February 2009||2009-02-01|December 2013|2013-12-01|January 2016|Anticipated|2016-01-01|September 2015|Anticipated|2015-09-01||Interventional|||Evaluate Rituximab in Obtaining PCR Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma|Role of Rituximab Containing Salvage Chemotherapy and in Vivo Purging in Obtaining PCR Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma or Transplant Eligible Mantle Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|21|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-02-18 13:18:53.759439|2017-02-18 13:18:53.759439
NCT00855673|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||January 2001||2001-01-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|FM-S1||Intermittent Mechanical Compression For Peripheral Arterial Disease|Intermittent Mechanical Compression For Peripheral Arterial Disease|Completed||Phase 4|30|Actual|Hospital Universitario Getafe||2|||f||||f||||||||||2017-02-18 13:19:06.346676|2017-02-18 13:19:06.346676
NCT00856232|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2016-03-23|2012-06-12||January 2009||2009-01-01|March 2016|2016-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Oxygen Therapy for the Treatment of Undifferentiated Headache in the Emergency Department|Oxygen Therapy for the Treatment of Undifferentiated Headache in the Emergency Department|Completed||N/A|91|Actual|Rutgers, The State University of New Jersey|Limited number of subjects due to difficulty with recruitment|3|||f||||f||||||||||2017-02-18 13:18:53.871353|2017-02-18 13:18:53.871353
NCT00856219|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2015-05-20|||February 2009||2009-02-01|May 2015|2015-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|Feeding||Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects|Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects|Completed||Phase 1|12|Actual|Rutgers, The State University of New Jersey||3|||f||||f||||||||||2017-02-18 13:18:54.317072|2017-02-18 13:18:54.317072
NCT00856206|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-21|2011-12-01||2011-01-05|March 2009||2009-03-01|December 2011|2011-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)|A Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial of the Safety of Rilonacept for the Prophylaxis of Gout Flares in Patients on Urate- Lowering Therapy|Completed||Phase 3|1274|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-02-18 13:18:54.418616|2017-02-18 13:18:54.418616
NCT00856193|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2016-08-02|2011-01-20||February 2009||2009-02-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Placebo-controlled, Multi-center, Two-period Crossover Study to Investigate the Bronchodilatory Effect of 50 µg NVA237 Inhaled Once Daily in Patient With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 2|33|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:18:54.739614|2017-02-18 13:18:54.739614
NCT00856180|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-04-13|2016-04-13||February 2009||2009-02-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|April 2010|Actual|2010-04-01||Interventional|||Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies|Pilot Study of Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies|Completed||Phase 2|20|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 13:18:55.20964|2017-02-18 13:18:55.20964
NCT00856167|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-05-26|||September 2006||2006-09-01|May 2015|2015-05-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|TCM-TMD||Traditional Chinese Medicine (TCM) for Temporomandibular Dysfunction (TMD): A Whole Systems Multi-site Trial|TCM for TMD: A Multi-Site Whole Systems Trial|Completed||Phase 2|160|Actual|University of Arizona||2|||f||||t||||||||||2017-02-18 13:18:55.558628|2017-02-18 13:18:55.558628
NCT00856154|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2009-04-07|||January 2007||2007-01-01|March 2009|2009-03-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|HIVDCVac||Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection|Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection. Phase I Trial|Completed||Phase 1|12|Actual|Statens Serum Institut||1|||f||||t||||||||||2017-02-18 13:18:55.668465|2017-02-18 13:18:55.668465
NCT00856141|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-04|||January 2006||2006-01-01|March 2009|2009-03-01|May 2006|Actual|2006-05-01|March 2006|Actual|2006-03-01||Interventional|||Set up for in-Vivo Measurement of Dynamic Intraocular Pressure (IOP)|In Vivo Evaluation of Dynamic IOP Measuring Device During Phacoemulsifcation: A Prospective Randomised Clinical Trial|Completed||N/A|20|Actual|Iladevi Cataract and IOL Research Center||2|||f||||t||||||||||2017-02-18 13:18:55.786162|2017-02-18 13:18:55.786162
NCT00856115|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2014-07-14|||November 2008||2008-11-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|October 2010|Actual|2010-10-01||Observational|||Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer|Appraisal Delay and Disparities in Timely Cancer Diagnosis|Completed||Phase 1|84|Actual|Case Comprehensive Cancer Center|||4||f||||t||||||||||2017-02-18 13:18:55.911049|2017-02-18 13:18:55.911049
NCT00856102|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2011-01-31|||March 2009||2009-03-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy|Efficacy of Exercise in Promotion Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy|Completed||N/A|30|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-02-18 13:18:56.044238|2017-02-18 13:18:56.044238
NCT00856089|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-05-28|||May 2009||2009-05-01|April 2011|2011-04-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization|Prevalence of Methicillin-resistant Staphylococcus Aureus (MRSA) in a Medical Center and Efficacy of Altabax in Clearing MRSA Nasal Colonization|Withdrawn||Phase 4|0|Actual|Ochsner Health System||1||Study is withdrawn and no one enrolled due to changes in personnel|f||||t||||||||||2017-02-18 13:18:56.151394|2017-02-18 13:18:56.151394
NCT00856076|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2011-10-17|||January 2005||2005-01-01|March 2009|2009-03-01|December 2023|Anticipated|2023-12-01|December 2010|Actual|2010-12-01||Observational|VIP||Venous Thromboembolism in Pregnancy Study|Venous Thromboembolism and Intrauterine Fetal Death in Pregnancy - Epidemiology and Pathogenic Mechanisms|Recruiting||N/A|1200|Anticipated|Oslo University Hospital|||10||f||||f||||||Samples With DNA|"~     Serum, EDTA and citrated plasma, whole blood and processed DNA~   "|||2017-02-18 13:18:56.264177|2017-02-18 13:18:56.264177
NCT00856063|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2012-07-05|||March 2009||2009-03-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)|Feasibility and Utility of Autonomic Correlates of Impulsivity in Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD): Extending Translational Research Skills|Completed||Phase 4|5|Actual|University of Arizona||1|||f||||f||||||||||2017-02-18 13:18:56.392763|2017-02-18 13:18:56.392763
NCT00856050|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2016-09-12|2014-01-09||February 2009||2009-02-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|January 2013|Actual|2013-01-01||Interventional||27 patients were enrolled, and 26 patients received at least one dose of study medication and were included in the analysis.|Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma|Phase 2 Clinical Study of Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma|Completed||Phase 2|27|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:18:56.494967|2017-02-18 13:18:56.494967
NCT00856037|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2016-06-15|||February 2009||2009-02-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer|A Phase I Study of Weekly Doxorubicin and Oral Topotecan for Patients With Relapsed or Refractory Small Cell Lung Cancer (SCLC)|Recruiting||Phase 1|30|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 13:18:56.719738|2017-02-18 13:18:56.719738
NCT00856024|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2015-06-04|2011-10-14||July 2008||2008-07-01|June 2015|2015-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|ATHENAS||ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632)|ATHENAS - Retrospective Analysis of Compliance to Treatment of Chronic Hepatitis C With Pegylated Interferon Alpha 2b Associated to Ribavirin Until Week 12 and Correlation With Virological Response in Brazil Health Centers|Terminated||N/A|902|Actual|Merck Sharp & Dohme Corp.|||3||f||||f||||||||||2017-02-18 13:18:56.847399|2017-02-18 13:18:56.847399
NCT00856011|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-04|||December 2003||2003-12-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|||||Observational|||Nerve Morphology in Diabetic Patients|Posterior Interosseous Nerve Pathology May Provide Novel Insights Into Both Predisposition and Potential Vascular Basis for the Development of Carpal Tunnel Syndrome in Diabetic Patients.|Completed||N/A|46|Actual|Skane University Hospital|||2||f||||f||||||Samples Without DNA|"~     Biopsies of the posterior interosseous nerve~   "|||2017-02-18 13:18:57.146185|2017-02-18 13:18:57.146185
NCT00855998|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-22|2010-06-02|||March 2009||2009-03-01|March 2009|2009-03-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Observational|||Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer|Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer|Unknown status|Recruiting|N/A|300|Anticipated|Hadassah Medical Organization|||2||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:18:57.23456|2017-02-18 13:18:57.23456
NCT00855985|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2011-09-24|||July 2004||2004-07-01|September 2011|2011-09-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|PG/PJ||Anastomotic Techniques in Pancreaticoduodenectomy|A Randomised Controlled Trial of Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Pancreaticoduodenectomy for Cancer|Unknown status|Active, not recruiting|N/A|312|Actual|Lakeshore Hospital||2|||f||||f||||||||||2017-02-18 13:18:57.326529|2017-02-18 13:18:57.326529
NCT00855972|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-12-09|||August 2010||2010-08-01|December 2015|2015-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome|Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome|Withdrawn||N/A|0|Actual|Stanford University||1||"The FDA IND application is paused due to additional required testing. The IRB protocol was~   closed prior to research starting."|f||||||||||||||2017-02-18 13:18:57.428675|2017-02-18 13:18:57.428675
NCT00855959|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2011-02-16|2010-08-17||February 2009||2009-02-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients|An Evaluation of Efficacy and Safety of Corresponding Doses of Pulmicort Turbuhaler® and Pulmicort Respules® in Japanese Asthmatic Adult Patients (Open, Multicenter, Phase III Study)|Completed||Phase 3|108|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:18:57.512405|2017-02-18 13:18:57.512405
NCT00855946|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-05-07|||May 2009||2009-05-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|PROTEORECTUM||Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy|Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy|Completed||N/A|46|Actual|University Hospital, Bordeaux|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:18:57.826509|2017-02-18 13:18:57.826509
NCT00855933|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2013-01-07|2012-12-03||January 2009||2009-01-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Controlled Clinical Study to Determine the Gingivitis Benefit of Flossing|A Controlled Clinical Study to Determine the Gingivitis Benefit of Flossing|Completed||Phase 4|60|Actual|Procter and Gamble||2|||f||||f||||||||||2017-02-18 13:18:57.930137|2017-02-18 13:18:57.930137
NCT00855920|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2013-09-27||2011-01-05|March 2009||2009-03-01|June 2011|2011-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|SURGE||Study Utilizing Rilonacept in Gout Exacerbations|A Multi-Center, Randomized, Double-Blind, Active-Controlled Study of the Safety and Efficacy of Rilonacept Administered Subcutaneously for the Treatment of an Acute Gout Flare|Completed||Phase 3|225|Actual|Regeneron Pharmaceuticals||3|||f||||t||||||||||2017-02-18 13:18:58.338714|2017-02-18 13:18:58.338714
NCT00855907|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2009-03-04|||March 2009||2009-03-01|March 2009|2009-03-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Observational|||Fatty Liver in Inflammatory Bowel Disease (IBD) Patients|Prevalence of Fatty Liver in Inflammatory Bowel Disease (IBD) Patients and Mechanisms Related to Inflammation and Fatty Liver|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"~     Blood count and biochemistry tests (such as: Liver and thyroid enzimes,cholesterol,~     immunology, glucose)~   "|||2017-02-18 13:18:58.573035|2017-02-18 13:18:58.573035
NCT00855894|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2013-05-14|2013-03-14||March 2009||2009-03-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|PENGUIN||A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer|An Open-label Phase II Multicenter Study of the Safety and Activity (as Measured by FDG-PET Imaging Changes) of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer|Completed||Phase 2|41|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 13:18:58.673058|2017-02-18 13:18:58.673058
NCT00855881|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-04|2011-07-25|||December 2008||2008-12-01|August 2010|2010-08-01|December 2016|Anticipated|2016-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma|A Trial of Metronomic Chemotherapy With Tegafur/Uracil for Patients With Locally Advanced (Stage III~IVB) Head and Neck Squamous Cell Carcinoma (HNSCC)|Unknown status|Recruiting|Phase 2|115|Anticipated|Mackay Memorial Hospital||1|||f||||t||||||||||2017-02-18 13:18:59.025456|2017-02-18 13:18:59.025456
NCT00855660|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-01-07|||March 2009||2009-03-01|January 2016|2016-01-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Riociguat on Bone Metabolism|Investigation of the Effect of Riociguat, Administered as 2.5 mg IR-tablets TID Over 14 Days, on Bone Metabolism in a Randomized, Placebo-controlled, Double-blind, 2-fold Cross-over Design in Healthy Male Subjects|Completed||Phase 1|17|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:19:06.451001|2017-02-18 13:19:06.451001
NCT00855868|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2012-06-19|2012-05-04||March 2009||2009-03-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals|Evaluation of the Ability of a Novel [18F] Amyloid Ligand ([18F]-AV-45) to Distinguish Patients With a Clinical Diagnosis of Alzheimer's Disease From Cognitively Normal Elderly Individuals|Completed||Phase 2|28|Actual|Avid Radiopharmaceuticals||1|||f||||t||||||||||2017-02-18 13:18:59.15309|2017-02-18 13:18:59.15309
NCT00855855|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-04-12|||February 2009||2009-02-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|June 2015|Actual|2015-06-01||Observational|||Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease|Surveillance for Rates of Hib Disease Among Persons 0 Through 59 Months of Age Receiving Pentacel® or Other Hib Vaccines|Active, not recruiting||N/A|520000|Anticipated|Sanofi|||1||f||||f||||||||||2017-02-18 13:18:59.490607|2017-02-18 13:18:59.490607
NCT00855842|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-06-10|2011-04-04||March 2009||2009-03-01|June 2011|2011-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|DAIS||Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion|Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion|Terminated||N/A|4|Actual|Boston University|The study was terminated early because the clinical facility changed and eligible patients were not seen at the facility.|1||inadequate enrollment|f||||f||||||||||2017-02-18 13:18:59.667723|2017-02-18 13:18:59.667723
NCT00855829|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2013-11-10|||May 2010||2010-05-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|||A Feasibility Study Designed to Assess the Efficacy of the ActiLady Device in Adult Female Subjects With Dysmenorrhea|A Single-Center, Randomized, Controlled, Double-Blind Feasibility Study Designed to Assess the Safety Performance of ActiLady Prototype in Adult Female Subjects With Dysmenorrhea.|Completed||Phase 1|24|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:18:59.908798|2017-02-18 13:18:59.908798
NCT00855816|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2014-10-14|2014-10-07||February 2010||2010-02-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|BaRT||Post Traumatic Stress Disorder (PTSD) Hyperarousal Symptoms Treated With Physiological Stress Management|PTSD Hyperarousal Symptoms Treated With Physiological Stress Management|Completed||Phase 2/Phase 3|80|Actual|VA Office of Research and Development|Higher than anticipated withdrawal rate limited power of statistical analyses.|2|||f||||t||||||||||2017-02-18 13:19:00.010123|2017-02-18 13:19:00.010123
NCT00855803|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-03-02|||February 2009||2009-02-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Stereotactic Body Radiation Therapy and Vertebroplasty in Treating Patients With Localized Spinal Metastasis|Phase II Study of Stereotactic Body Radiation Therapy and Vertebroplasty for Localized Spinal Metastasis (SBRT Spine)|Recruiting||Phase 2|42|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||No||2017-02-18 13:19:02.632395|2017-02-18 13:19:02.632395
NCT00855790|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2015-07-22|||December 2008||2008-12-01|July 2015|2015-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Comparison of Two Types of Biopsy Forceps for Obtaining Cold Biopsy Polypectomy for Small Sessile Colorectal Polyps Less Than 6 mm in Diameter|Comparison of Two Types of Biopsy Forceps for Obtaining Cold Biopsy Polypectomy for Small Sessile Colorectal Polyps Less Than 6 mm in Diameter|Completed||N/A|125|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 13:19:02.745502|2017-02-18 13:19:02.745502
NCT00855777|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2009-03-03|||April 2009||2009-04-01|March 2009|2009-03-01|April 2010|Anticipated|2010-04-01|December 2009|Anticipated|2009-12-01||Interventional|||Etoricoxib Versus Ibuprofen in Third Molar Extraction Pain|Evaluation of Analgesic Efficacy of Etoricoxib Compared With Ibuprofen in Third Molar Extraction Pain.|Unknown status|Not yet recruiting|Phase 4|110|Anticipated|Universita di Verona||2|||f||||f||||||||||2017-02-18 13:19:02.847681|2017-02-18 13:19:02.847681
NCT00855764|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2010-02-02||2010-02-02|October 2005||2005-10-01|October 2009|2009-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer|Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer|Completed||Phase 2|36|Anticipated|Bristol-Myers Squibb||1|||f||||t||||||||||2017-02-18 13:19:02.949897|2017-02-18 13:19:02.949897
NCT00855738|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2010-11-23|2010-06-23||May 2007||2007-05-01|November 2010|2010-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice|Liceo Study: A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice|Completed||Phase 4|111|Actual|Pfizer|This study was cancelled with 111 patients enrolled due to lack of recruitment, and inability to analyze the study by treatment groups. Seizures were analyzed by 3 month data instead of 2 month data as originally planned.|1|||f||||t||||||||||2017-02-18 13:19:03.07158|2017-02-18 13:19:03.07158
NCT00855725|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2009-07-08|||June 2008||2008-06-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Affective Processing in Depression and Epilepsy|Affective Processing in Depression and Epilepsy; An fMRI Study|Terminated||N/A|14|Actual|Northwell Health|||1|PI wanted to discontinue study.|f||||f||||||||||2017-02-18 13:19:05.720818|2017-02-18 13:19:05.720818
NCT00855712|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-05-11||2015-05-11|March 2009||2009-03-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|PROCEEDII||Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation|Prospective, Multicenter, Randomized, Clinical Investigation of TransMedics Organ Care System (OCS) for Cardiac Use|Completed||Phase 2/Phase 3|128|Actual|TransMedics||2|||f||||t||||||||||2017-02-18 13:19:05.813088|2017-02-18 13:19:05.813088
NCT00855699|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2011-01-18|||November 2009||2009-11-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|July 2010|Actual|2010-07-01||Interventional|ADEPT||Alcohol Detoxification in Primary Care Treatment (ADEPT)|Alcohol Detoxification in Primary Care Treatment (ADEPT) - a Feasibility Study of Conducting a Randomised Trial in Primary Care Comparing Two Pharmacological Regimens.|Completed||Phase 4|36|Actual|University of Bristol||1|||f||||f||||||||||2017-02-18 13:19:05.927058|2017-02-18 13:19:05.927058
NCT00855686|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2013-09-19|||January 2007||2007-01-01|September 2013|2013-09-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies|A Randomised, Double-blind, Placebo-controlled, 6-month Study of the Efficacy and Safety of Memantine in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies|Completed||Phase 4|199|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:19:06.032059|2017-02-18 13:19:06.032059
NCT00855647|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2010-06-01|||August 2003||2003-08-01|June 2010|2010-06-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)|Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)|Completed||Phase 2|99999|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 13:19:06.574883|2017-02-18 13:19:06.574883
NCT00855634|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2012-09-05|||August 2009||2009-08-01|July 2009|2009-07-01|March 2012|Actual|2012-03-01|||||Interventional|PaMeViTUM||Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München|Extended Versus Standard Resection in Two Cohorts of Patients With Adenocarcinoma of the Pancreas: Minimal Metastatic Disease or Venous Infiltration - a Randomized Trial|Terminated||N/A|355|Anticipated|Technische Universität München||2||"Protocol planned interim analysis after two years showed very low recruitment in cohort 1 and~   low recruitment in cohort 2."|f||||t||||||||||2017-02-18 13:19:06.659643|2017-02-18 13:19:06.659643
NCT00855621|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-11-18|||March 2009||2009-03-01|November 2016|2016-11-01|December 2023|Anticipated|2023-12-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Deep Brain Stimulation in Parkinson's Disease|Prognostic Factors in Parkinson's Disease Patients Treated With Deep Brain Stimulation of the Subthalamic Nucleus (STN-DBS) - a Prospective Randomized Double-blind Study (The NORSTIM Study)|Active, not recruiting||N/A|70|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 13:19:06.769686|2017-02-18 13:19:06.769686
NCT00855608|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-07-20|||March 2009||2009-03-01|September 2009|2009-09-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|ADA01||Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study|The Safety and Tolerability of Intravitreal Adalimumab in Patients With Refractory Diabetic Macular Retinopathy or Choroidal Neovascularization or Uveitis: A Pilot Study|Unknown status|Recruiting|Phase 1|15|Anticipated|Rafic Hariri University Hospital||1|||f||||t||||||||||2017-02-18 13:19:06.892165|2017-02-18 13:19:06.892165
NCT00855595|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2014-01-29|2012-07-25||February 2009||2009-02-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea|An Exploratory, Multicenter, Investigator-blinded, Active-controlled Study to Investigate the Efficacy of Topical Azelaic Acid (AzA)15% Gel Twice Daily or Metronidazole Topical Gel 1% Once Daily, Plus Anti-inflammatory Dose Doxycycline (40mg) Once Daily in Subjects With Moderate Papulopustular Rosacea|Completed||Phase 4|207|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:19:07.023584|2017-02-18 13:19:07.023584
NCT00855582|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2011-07-26|2011-06-01||March 2009||2009-03-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|COMORBID©||A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia|A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Tadalafil 2.5 and 5 mg Once Daily Dosing for 12 Weeks for the Treatment of Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia in Men With Both Erectile Dysfunction and Benign Prostatic Hyperplasia|Completed||Phase 3|606|Actual|Eli Lilly and Company|P-values for the peak urine flow rate outcome were corrected in this record after an error was identified.|3|||f||||f||||||||||2017-02-18 13:19:08.181469|2017-02-18 13:19:08.181469
NCT00855569|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2012-06-15|||June 2008||2008-06-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Observational|Stasilon||Hemostatic Textile to Control Bleeding at Donor Graft Sites|Use of a HemostaticTextile (StasilonTM) to Control Bleeding at Skin Graft Donor Sites (Randomized, Single-Blind)|Completed||Phase 4|20|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 13:19:10.87004|2017-02-18 13:19:10.87004
NCT00855556|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2015-09-15|||February 2008||2008-02-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Parkinson's Disease Genetics Database|Parkinson's Disease Genetics Database|Terminated||N/A|16|Actual|Northwell Health|||1|"Enrollment into this registry was not as robust as investigator envisioned. Thus, the registry~   was closed."|f||||f||||||Samples With DNA|"~     DNA stored in TE buffer solution~   "|||2017-02-18 13:19:10.955531|2017-02-18 13:19:10.955531
NCT00855543|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2011-07-14|||August 2009||2009-08-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Phospholipase A2 Producing Bacteria and Pre-Term Labor|Phospholipase A2 Producing Bacteria, Age at Gestation, Cervical Length Measurement and the Incidence of Pre-Term Labor|Completed||N/A|60|Anticipated|CAMC Health System|||1||f||||f||||||||||2017-02-18 13:19:11.039309|2017-02-18 13:19:11.039309
NCT00855530|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2009-03-24|||September 2005||2005-09-01|March 2009|2009-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder|A Fifty-Two-Week Multicenter, Open-Label, Study Evaluating the Long-Term Safety and Tolerability of SR58611A 350 mg q12 in Patients With Major Depressive Disorder.|Completed||Phase 3|527|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:19:11.126945|2017-02-18 13:19:11.126945
NCT00855517|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2013-09-16|||March 2009||2009-03-01|September 2013|2013-09-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma|A Partially Masked, Phase 2 Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)|Withdrawn||Phase 2|0|Actual|Mati Therapeutics Inc.||1||Sponsor's decision|f||||f||||||||||2017-02-18 13:19:11.253858|2017-02-18 13:19:11.253858
NCT00855504|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2015-04-10|||February 2009||2009-02-01|April 2015|2015-04-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Observational|||Association of Periodontitis and Preeclampsia During Pregnancy|Role of Cytokines in Association Between Periodontitis and Preeclampsia During Pregnancy|Completed||N/A|528|Actual|Maulana Azad Medical College|||1||f||||f||||||||||2017-02-18 13:19:11.347422|2017-02-18 13:19:11.347422
NCT00855491|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2009-03-03|||July 2003||2003-07-01|March 2009|2009-03-01|November 2008|Actual|2008-11-01|September 2004|Actual|2004-09-01||Interventional|||Posterior Capsule Opacification (PCO) With AcrySof Single-Piece IOL|Prospective Evaluation of Posterior Capsule Opacification in Myopic Eyes 4 Years After AcrySof Single-Piece IOL Implantation|Completed||N/A|100|Actual|Iladevi Cataract and IOL Research Center||2|||f||||t||||||||||2017-02-18 13:19:11.458867|2017-02-18 13:19:11.458867
NCT00855478|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2010-11-25|||May 2006||2006-05-01|November 2010|2010-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|FR E-REGISTRY||French Post-Marketing Surveillance Survey|French Post-Marketing Surveillance Survey|Terminated||Phase 4|4080|Actual|Cordis Corporation||1||Early termination of patient enrollment based on business decision|f||||t||||||||||2017-02-18 13:19:11.573218|2017-02-18 13:19:11.573218
NCT00855465|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-10-14|2013-11-04||February 2009||2009-02-01|October 2016|2016-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|CHEST-1||A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.|Randomized, Double-blind, Placebo-controlled, Multi-centre, Multi-national Study to Evaluate the Efficacy and Safety of Oral BAY63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg Tid) in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|Completed||Phase 3|262|Actual|Bayer||2|||f||||t||||||||||2017-02-18 13:19:11.702526|2017-02-18 13:19:11.702526
NCT00855452|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-06-10|||January 2009||2009-01-01|October 2008|2008-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|rIL-2(LAK)||Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors|rIL-2 Activated Allogeneic Lymphocytes for the Induction of Graft Versus Tumor Effect (GVT) in Metastatic Solid Tumors|Completed||Phase 2|20|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-02-18 13:19:13.74272|2017-02-18 13:19:13.74272
NCT00855439|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-04-23|2015-04-23||June 2008||2008-06-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Evaluation of Exenatide in Patients With Diabetic Neuropathy|A Single-center,Proof of Concept,Randomized,Controlled Parallel Group Clinical Trial of the Effects of Exenatide vs. a Long Acting Insulin Analog to Evaluate the Efficacy of Exenatide in Patients With Diabetic Neuropathy and Type 2 Diabetes|Completed||N/A|46|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 13:19:13.83852|2017-02-18 13:19:13.83852
NCT00855426|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2010-11-28||||||October 2010|2010-10-01||||||||Observational|||Diagnostic Protocol Of Painful Hip||Suspended||N/A|||Hadassah Medical Organization|||1|the research is on susoension beacause the lack of manpower|f||||f||||||||||2017-02-18 13:19:14.315049|2017-02-18 13:19:14.315049
NCT00855413|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2014-10-14|||March 2009||2009-03-01|October 2014|2014-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Naïve Patients Treated With Darunavir/Ritonavir and Etravirine|CID 0821 - Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine|Completed||Phase 4|15|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-02-18 13:19:14.381413|2017-02-18 13:19:14.381413
NCT00855400|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2010-12-01|||February 2007||2007-02-01|December 2010|2010-12-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|CMN/ELA||Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis|Phase I/II Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis|Completed||Phase 1/Phase 2|11|Actual|Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia||1|||f||||t||||||||||2017-02-18 13:19:14.499043|2017-02-18 13:19:14.499043
NCT00855387|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2009-11-25|||March 2009||2009-03-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Observational|||Severe Complications Triplicate the Costs of Major Surgical Procedures|Surgical Complications Dramatically Influence Overall Cost of Major Surgical Procedures|Completed||N/A|1235|Actual|University of Zurich|||1||f||||f||||||||||2017-02-18 13:19:14.609346|2017-02-18 13:19:14.609346
NCT00855374|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-06-29|||June 2008||2008-06-01|June 2011|2011-06-01|June 2013|Anticipated|2013-06-01|||||Observational|||PAR Regulation of Platelet Function in Diabetic Patients|PAR Regulation of Platelet Function in Diabetic Patients|Unknown status|Recruiting|N/A|200|Anticipated|Vanderbilt University|||1||f||||t||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:19:14.709347|2017-02-18 13:19:14.709347
NCT00855361|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2013-04-26|||July 2009||2009-07-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)|A Pharmacokinetic, Pharmacodynamic and Short-term Safety Study of Single and Multiple Day Doses of Rabeprazole Sodium in Neonates and Pre-term Infants With a Corrected Age of Less Than 44 Weeks With a Presumptive Diagnosis of GERD|Completed||Phase 1|69|Actual|Janssen Research & Development, LLC||1|||f||||||||||||||2017-02-18 13:19:14.79532|2017-02-18 13:19:14.79532
NCT00855348|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2014-08-01|||June 2008||2008-06-01|August 2014|2014-08-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Observational|PRESEPT||PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening|PRESEPT Study: Prospective Evaluation of Septin 9 Performance for Colorectal Cancer Screening|Completed||N/A|7929|Actual|Epigenomics, Inc|||1||f||||t||||||Samples With DNA|"~     Eligible consented Subjects meeting inclusion / exclusion criteria will have 40 ml of blood~     drawn prior to undergoing bowel cleansing in preparation for screening colonoscopy. Subject~     blood specimens will be processed according to Epigenomics' plasma preparation procedure~     (Blood Collection and Plasma Preparation SOP.~   "|||2017-02-18 13:19:14.934213|2017-02-18 13:19:14.934213
NCT00855335|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2017-02-14|||April 2009||2009-04-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women|A Single Arm, Open Label Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women|Completed||Phase 3|77|Actual|Janssen Scientific Affairs, LLC||5|||f||||f||||||||||2017-02-18 13:19:15.067303|2017-02-18 13:19:15.067303
NCT00855322|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||January 2008||2008-01-01|February 2009|2009-02-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication|Randomized Controlled Trial Examining The Effect Of Exercise In People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication|Unknown status|Active, not recruiting|Phase 2|51|Anticipated|University College Dublin||3|||f||||f||||||||||2017-02-18 13:19:15.203017|2017-02-18 13:19:15.203017
NCT00855309|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-10-22|2013-09-24||November 2008||2008-11-01|September 2014|2014-09-01||||November 2013|Actual|2013-11-01||Interventional|||Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia|Low Dose Versus Weight-based Intravenous Acyclovir for Herpes Simplex Virus Prophylaxis in the Neutropenic Patient|Completed||Phase 3|112|Actual|Wake Forest University Health Sciences|per the protocol, only nephrotoxicities (as measured by Creatinine increase over baseline were observed.|2|||f||||t||||||||||2017-02-18 13:19:15.318276|2017-02-18 13:19:15.318276
NCT00855296|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-06-29|||September 2006||2006-09-01|June 2011|2011-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||Thrombin Regulated Platelet Activation|Thrombin Regulated Platelet Activation|Unknown status|Recruiting|N/A|200|Anticipated|Vanderbilt University|||1||f||||t||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:19:15.670903|2017-02-18 13:19:15.670903
NCT00855283|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2013-07-23|||September 2012||2012-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|IN NEO||Intranasal Administration of a Prokinetic for Bowel Evacuation in Persons With SCI|Intranasal Administration of Neostigmine and Glycopyrrolate for Bowel Evacuation|Completed||Phase 2|20|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 13:19:15.749742|2017-02-18 13:19:15.749742
NCT00855270|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-05-22|||April 2009||2009-04-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|||Efficacy of Single Dose IV Hydrocortisone in Post Traumatic Stress Disorder (PTSD) Prevention|The Efficacy of a Single Dose IV Hydrocortisone Given Within 6 Hours of Exposure to a Traumatic Event in PTSD Prevention|Recruiting||N/A|120|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 13:19:15.850613|2017-02-18 13:19:15.850613
NCT00855257|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-07-08|||June 2007||2007-06-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|EVANACS||Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome|Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Patients Presenting a Recent Acute Coronary Syndrome.|Completed||Phase 3|93|Actual|French Cardiology Society||2|||f||||t||||||||||2017-02-18 13:19:15.98135|2017-02-18 13:19:15.98135
NCT00855244|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-05-14|||March 2009||2009-03-01|May 2015|2015-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Metabolic Syndrome in Bone Marrow Transplant Survivors|Metabolic Syndrome in Bone Marrow Transplant Survivors|Terminated||N/A|5|Actual|Nationwide Children's Hospital||1||Principal Investigator left the institution|f||||f||||||||||2017-02-18 13:19:16.093315|2017-02-18 13:19:16.093315
NCT00855231|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2011-09-09|||July 2006||2006-07-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Observational|ACUTE CT||Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain|Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain - Assessment of Chest Pain Utilizing a Triple Rule Out Evaluation With Computed Tomography (ACUTE CT) Trial|Completed||N/A|102|Actual|University of Washington|||1||f||||f||||||||||2017-02-18 13:19:16.205536|2017-02-18 13:19:16.205536
NCT00855218|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2014-07-15|2012-08-23||March 2009||2009-03-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|July 2011|Actual|2011-07-01||Interventional|||A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).|A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).|Completed||Phase 2|307|Actual|Bayer||2|||f||||t||||||||||2017-02-18 13:19:16.315097|2017-02-18 13:19:16.315097
NCT00855205|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2013-12-09|||July 2009||2009-07-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|RIPS||Rituximab for Pulmonary Sarcoidosis|Rituximab as a Novel Therapy in Refractory Sarcoidosis: A Prospective Open-|Completed||Phase 2|10|Actual|University of Cincinnati||1|||f||||t||||||||||2017-02-18 13:19:17.949593|2017-02-18 13:19:17.949593
NCT00855192|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2010-03-17|||October 2008||2008-10-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|ARG||Antenatal Relaxation Group for Anxiety and Depression Management|Antenatal Depression Group Research Project: The Effectiveness of Mindfulness-based Relaxation and Interpersonal Therapy to Relieve Anxiety and Depression Symptoms in Pregnant Women.|Unknown status|Enrolling by invitation|N/A|20|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-02-18 13:19:18.062383|2017-02-18 13:19:18.062383
NCT00855179|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2014-04-30||2014-04-30|March 2009||2009-03-01|April 2014|2014-04-01||||November 2009|Actual|2009-11-01||Interventional|||Assess the Efficacy and Tolerability of Antistax Film-coated Tablets in Patients With Chronic Venous Insufficiency|A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial to Evaluate Efficacy and Tolerability of Antistax® Film Coated Tablets, 720 mg/Day Orally, in Male and Female Patients Suffering From Chronic Venous Insufficiency|Completed||Phase 3|250|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:19:18.173554|2017-02-18 13:19:18.173554
NCT00855166|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2013-08-09|2013-01-21||February 2009||2009-02-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Interventional||Full Analysis Set defined as all randomized participants (as randomized) who received at least one dose of double-blind study medication, who have a non-missing baseline value and at least one post-baseline efficacy value for at least one efficacy variable during double-blind treatment period.|Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes|A 24-week,Multi-centre,Int.,Double-blind,Rand.,Parallel-group,Plac.-Controlled,Phase III Study With a 78-week Ext.Per. to Evaluate the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone|Completed||Phase 3|182|Actual|AstraZeneca|For participants who did not complete 24 weeks, last observation carried forward (LOCF) was used.|2|||f||||t||||||||||2017-02-18 13:19:18.300554|2017-02-18 13:19:18.300554
NCT00855153|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2011-12-19|||May 2009||2009-05-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Virtual Reality and D-Cycloserine in Combat Related Psycological Trauma in Burn Service Members|A Pilot Study Using Gradual Virtual Reality Exposure Therapy and D-Cycloserine (DCS) for Treatment of Combat Related Psychological Trauma in Burn Service Members|Withdrawn||N/A|0|Actual|United States Army Institute of Surgical Research||1||Investigator was not able to maintain IRB approval. Study never accrued subjects.|f||||f||||||||||2017-02-18 13:19:18.89444|2017-02-18 13:19:18.89444
NCT00855140|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2016-01-07|||March 2009||2009-03-01|January 2016|2016-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Acupuncture for the Treatment of Insomnia|Acupuncture for the Treatment of Insomnia - A Pilot Study|Completed||Phase 2|56|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:19:19.022709|2017-02-18 13:19:19.022709
NCT00855127|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2015-05-28|||January 2009||2009-01-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Observational|||New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients|Early Biomarkers of Acute Kidney Injury in Liver Transplant Patients|Withdrawn||N/A|0|Actual|University of Colorado, Denver|||1|no enrollment|f||||f||||||Samples Without DNA|"~     Urine supernatent Serum~   "|||2017-02-18 13:19:19.134922|2017-02-18 13:19:19.134922
NCT00851201|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-09-15|||August 2009||2009-08-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Family Weight Management Study|Comprehensive Approach to Family Weight Management|Completed||N/A|506|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 13:20:54.082138|2017-02-18 13:20:54.082138
NCT00855114|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-03|2016-02-18|||July 2008||2008-07-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery|A Phase II Trial of Short-Term Everolimus (RAD001) to Predict Response in Women With Operable Breast Cancer|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||1||Withdrawn due to no accrual|f||||t||||||||||2017-02-18 13:19:19.24738|2017-02-18 13:19:19.24738
NCT00855101|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2010-06-11|||April 2009||2009-04-01|June 2010|2010-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults|An Open-Label, Intravenous (6/4 Mg/Kg Q12h) To Oral Switch (200 Mg Q12h), Multiple Dose Study To Evaluate The Pharmacokinetics, Safety And Tolerability Of Voriconazole In Healthy Male And Female Adults|Completed||Phase 1|35|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:19:19.358186|2017-02-18 13:19:19.358186
NCT00855088|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-05-11|||July 2009||2009-07-01|May 2011|2011-05-01|February 2011|Actual|2011-02-01|February 2010|Actual|2010-02-01||Interventional|DESeRT||Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue|A Phase IV, Open Label Study in Healthy Male Subjects to Investigate the Extent of Darunavir/Ritonavir and Etravirine Exposure in Blood, Seminal Fluid, and Rectal Mucosal Tissue Following Single and Multiple Dosing of Darunavir/Ritonavir and Etravirine|Completed||Phase 1|13|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 13:19:19.470209|2017-02-18 13:19:19.470209
NCT00855075|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-07-27|||May 2008||2008-05-01|July 2015|2015-07-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Observational|||Correlation of Cerebral State Index With the Richmond Agitation-Sedation Scale in Mechanically Ventilated ICU Patients|Correlation of the Cerebral State Index With the Richmond Agitation-Sedation Scale in ICU Patients Who Are Sedated and Mechanically Ventilated: A Pilot Study|Terminated||Phase 4|3|Actual|CAMC Health System|||1|Technology used to obtain/measure cerebral state index is no longer manufactured|f||||f||||||||||2017-02-18 13:19:19.581698|2017-02-18 13:19:19.581698
NCT00855062|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-01-28|2010-12-17||April 2008||2008-04-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Minocycline for HIV+ Cognitive Impairment in Uganda|Minocycline in the Treatment of HIV-Associated Cognitive Impairment in Uganda|Terminated||Phase 1/Phase 2|73|Actual|Johns Hopkins University|The estimated sample size was 100; however, due to early termination of the study, the total number of randomized participants was 73.|2||"The Neurologic AIDS Research Consortium Data Safety and Monitoring Board committee recommended~   to terminate the study early due to futility on 11/6/2009."|f||||t||||||||||2017-02-18 13:19:19.698917|2017-02-18 13:19:19.698917
NCT00855049|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2010-09-23|||April 2009||2009-04-01|September 2010|2010-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||A Randomized Crossover Study to Determine the Pharmacokinetics of Intranasally Administered Acetaminophen in Healthy Adults|A Randomized Crossover Study to Determine the Pharmacokinetics of Intranasally Administered Acetaminophen in Healthy Adults|Withdrawn||N/A|10|Anticipated|University of Texas Southwestern Medical Center||2||Unable to obtain FDA approval|f||||f||||||||||2017-02-18 13:19:20.77596|2017-02-18 13:19:20.77596
NCT00855036|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2017-01-23|||August 2008||2008-08-01|January 2017|2017-01-01|August 2019|Anticipated|2019-08-01|January 2018|Anticipated|2018-01-01||Observational|||Prospective Evaluation of Blunt Renal Injury in Children|Prospective Evaluation of Blunt Renal Injury in Children|Recruiting||N/A|100|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-02-18 13:19:20.875083|2017-02-18 13:19:20.875083
NCT00855023|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||November 2007||2007-11-01|March 2009|2009-03-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Observational|||Knee Alignment Contributions to Anterior Cruciate Ligament (ACL) Injury|Tibiofemoral Alignment: Contributing Factors to Noncontact Anterior Cruciate Ligament Injury|Suspended||N/A|25|Actual|The Orthopaedic Center, Maryland|||1|May continue recruiting only if required by journal reviewers|f||||f||||||||||2017-02-18 13:19:20.979589|2017-02-18 13:19:20.979589
NCT00855010|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-06-23|||February 2009||2009-02-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Pioglitazone on Pancreatic Steatosis and Bone Health|Effect of Pioglitazone on Pancreatic Steatosis and Bone Health|Completed||N/A|40|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 13:19:21.253201|2017-02-18 13:19:21.253201
NCT00854997|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-03-01|||January 2009||2009-01-01|February 2009|2009-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||The Impact of Obstructive Sleep Apnea on the Outcomes in Patients of First-Time Acute Myocardial Infarction|The Impact of Obstructive Sleep Apnea on the Outcomes in Patients of First-Time Acute Myocardial Infarction|Unknown status|Recruiting|N/A|120|Anticipated|National Taiwan University Hospital|||2||f||||t||||||Samples With DNA|"~     serum, plasma, RNA, DNA~   "|||2017-02-18 13:19:21.370426|2017-02-18 13:19:21.370426
NCT00854984|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2010-04-07|||February 2009||2009-02-01|April 2010|2010-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Pilot Study of a Self-help Intervention for Depression in Patients With a Chronic Disease|Pilot Study of a Practice Nurse Supported Psychological Self-help Intervention for Patients With Diabetes or Coronary Heart Disease and Co-morbid Depression|Unknown status|Recruiting|N/A|49|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-02-18 13:19:21.473859|2017-02-18 13:19:21.473859
NCT00854971|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-28|2009-05-15|||January 2009||2009-01-01|March 2009|2009-03-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Efficacy Study of TKcell in Advanced Colorectal Cancer|Evaluating the Safety and Efficacy of Combination Therapy With FOLFOX-4 and TKcell Therapy Versus FOLFOX-4 Alone in Patients With Recurrent, Unresectable and Advanced Colorectal Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|86|Anticipated|Binex||2|||f||||f||||||||||2017-02-18 13:19:21.587124|2017-02-18 13:19:21.587124
NCT00854958|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||May 2005||2005-05-01|February 2009|2009-02-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Observational|||The Diagnosis of Oral Allergy Syndrome Through the Use of a Structured Questionnaire|The Diagnosis of Oral Allergy Syndrome Through the Use of a Structured Questionnaire|Completed||N/A|123|Actual|Royal Brompton & Harefield NHS Foundation Trust|||1||f||||f||||||||||2017-02-18 13:19:21.697111|2017-02-18 13:19:21.697111
NCT00854945|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2016-08-02||2014-10-03|January 2009||2009-01-01|August 2016|2016-08-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML|A Phase 1/2, Single-Arm Study To Assess The Efficacy and Safety Of 72-Hour Continuous Intravenous Dosing Of ON 01910.Na Administered Every Other Week in Patients With Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)|Completed||Phase 1/Phase 2|36|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-02-18 13:19:21.782541|2017-02-18 13:19:21.782541
NCT00854932|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2016-03-04|||June 2009||2009-06-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|May 2015|Actual|2015-05-01||Interventional|NeoPInS||Neonatal Procalcitonin Intervention Study|Effect of Procalcitonin-guided Decision Making on Duration of Antibiotic Therapy in Suspected Neonatal Early-onset Sepsis: Multicenter Prospective Randomized Intervention Study|Active, not recruiting||N/A|1600|Anticipated|Luzerner Kantonsspital||2|||f||||t||||||||||2017-02-18 13:19:21.928137|2017-02-18 13:19:21.928137
NCT00854919|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||January 2006||2006-01-01|December 2005|2005-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|OCDDRUG||Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder|An Long Term Trial on Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder|Completed||Phase 4|||Osaka City University||3|||f||||||||||||||2017-02-18 13:19:22.054326|2017-02-18 13:19:22.054326
NCT00854906|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2014-10-22|2010-07-07||February 2009||2009-02-01|October 2014|2014-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Keratometric Tear Breakup Time and Fluorescein Tear Breakup Time|Comparison of Keratometric Tear Break Up Time (KTBUT) to Fluorescein Tear Break Up Time (FTBUT)|Completed||N/A|26|Actual|University of Arkansas|||2||f||||f||||||||||2017-02-18 13:19:22.158386|2017-02-18 13:19:22.158386
NCT00854893|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-03-18|||October 2009||2009-10-01|March 2011|2011-03-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Interventional|||Enhance of Language Learning With Neurostimulation|Enhance of Language Learning With Neurostimulation (Transcranial Direct Current Stimulation)|Unknown status|Recruiting|N/A|70|Anticipated|Universitätsklinikum Hamburg-Eppendorf||3|||f||||t||||||||||2017-02-18 13:19:22.424654|2017-02-18 13:19:22.424654
NCT00854880|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-03-02|||March 2005||2005-03-01|March 2005|2005-03-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||A Clinical Trial to Evaluate the Efficacy and Safety of PDC-339 for the Treatment of Acute Erosive Gastritis|A Randomized, Double-Blind, Placebo-Controlled, Parallel Comparative Phase II Clinical Trial to Evaluate the Efficacy and Safety of PDC-339 for the Treatment of Acute Erosive Gastritis|Completed||Phase 2|69|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 13:19:22.534451|2017-02-18 13:19:22.534451
NCT00854867|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2014-02-21|||February 2011||2011-02-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.|Phase I Randomised Multi-centre Study to Demonstrate the Safety of WBRT Concomitant to Intrathecal Liposomal Cytarabine (DepoCyte®) Versus WBRT & Sequential Intrathecal Liposomal Cytarabine (DepoCyte®) for Treatment of STNM With or Without Brain Metastasis.|Completed||Phase 1|18|Actual|Mundipharma Research Limited||2|||f||||t||||||||||2017-02-18 13:19:22.644391|2017-02-18 13:19:22.644391
NCT00854854|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2009-05-15|||January 2009||2009-01-01|March 2009|2009-03-01|July 2010|Anticipated|2010-07-01|January 2010|Anticipated|2010-01-01||Interventional|||Efficacy Study of TKcell in Advanced Gastric Cancer|Evaluating the Safety and Efficacy of Combination Therapy With FOLFOX-4 and TKcell Therapy Versus FOLFOX-4 Alone in Patients With Recurrent, Unresectable and Advanced Gastric Cancer|Unknown status|Enrolling by invitation|Phase 1/Phase 2|94|Actual|Binex||2|||f||||f||||||||||2017-02-18 13:19:22.771092|2017-02-18 13:19:22.771092
NCT00854841|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02||||||March 2009|2009-03-01||||||||Expanded Access|||The Randomized Study of Dasatinib and High-Dose Imatinib (600mg) in Suboptimal Responder|Randomized, Open Label Study of Dasatinib (100mg qd) vs. High-Dose Imatinib (600mg) in Patients With Chronic Phase CML Who Have Had Suboptimal Response After 3-18 Months of Therapy With Imatinib (400mg)|Available||N/A|||Pusan National University Hospital|||||f||||||||||||||2017-02-18 13:19:22.876294|2017-02-18 13:19:22.876294
NCT00854828|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2016-10-31|||January 2010||2010-01-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|ASLS||A Multicenter Prospective Study of Quality of Life in Adult Scoliosis|A Multicenter Prospective Study of Quality of Life in Adult Scoliosis|Active, not recruiting||N/A|300|Anticipated|Washington University School of Medicine||2|||f||||t||||||||Undecided||2017-02-18 13:19:22.982607|2017-02-18 13:19:22.982607
NCT00854815|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2012-07-31|||December 2008||2008-12-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Irrigation Versus No Irrigation for Perforated Appendicitis|Irrigation Versus No Irrigation for Perforated Appendicitis|Completed||N/A|220|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-02-18 13:19:23.107981|2017-02-18 13:19:23.107981
NCT00854802|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2016-02-12|||January 2009||2009-01-01|February 2016|2016-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients|A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel-group Phase II Study on the Efficacy and Safety of Debio 025 Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients|Completed||N/A|290|Actual|Debiopharm International SA||4|||f||||t||||||||||2017-02-18 13:19:23.228247|2017-02-18 13:19:23.228247
NCT00854789|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2014-06-02|||December 2002||2002-12-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|May 2012|Actual|2012-05-01||Interventional|||Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer|Phase Ib Trial of HER2/Neu Peptide (E75) Vaccine in Node Negative Breast Cancer Patients|Completed||Phase 1/Phase 2|95|Actual|Walter Reed Army Medical Center||2|||f||||f||||||||||2017-02-18 13:19:23.408609|2017-02-18 13:19:23.408609
NCT00854776|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2010-06-06|||January 2009||2009-01-01|June 2010|2010-06-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor|The Occurrence of Peptic Ulcer Disease and Its Complications in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Co-prescription of Proton Pump Inhibitor|Unknown status|Recruiting|N/A|300|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-02-18 13:19:23.529486|2017-02-18 13:19:23.529486
NCT00854763|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2009-03-01|||April 2009||2009-04-01|February 2009|2009-02-01||||||||Observational|||Olmesartan on Ambulatory Blood Pressure Change|Phase 4 Study on Olmesartan, an Angiotensin Receptor Blocker, on Ambulatory Blood Pressure Change, Vitamin D Levels and Urinary Sodium Excretion of Patients With Hypertension|Unknown status|Not yet recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:19:23.636319|2017-02-18 13:19:23.636319
NCT00854750|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2013-04-19|||May 2009||2009-05-01|April 2013|2013-04-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|||Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis|Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis|Terminated||Phase 4|1|Actual|University of Texas Southwestern Medical Center||4||Poor Enrollment- schedule of assessments too complex and time-consuming.|f||||t||||||||||2017-02-18 13:19:23.738202|2017-02-18 13:19:23.738202
NCT00854737|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-04-19|||July 2004||2004-07-01|April 2012|2012-04-01|July 2010|Actual|2010-07-01|August 2007|Actual|2007-08-01||Interventional|||Cytidine and Omega-3 Fatty Acids in Bipolar Disorder|A Combination of Cytidine and Omega-3 Fatty Acids in Bipolar Disorder: Are There Additive or Synergistic Mood Stabilizing Effects?|Completed||Phase 2|90|Actual|Mclean Hospital||3|||f||||f||||||||||2017-02-18 13:19:23.852132|2017-02-18 13:19:23.852132
NCT00854724|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2011-09-01|2011-07-19||February 2009||2009-02-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Interventional|PAD||Puerarin Effects on Alcohol Drinking|Puerarin (NPI-031G) Effects on Alcohol Drinking - A Natural Settings Study|Completed||Phase 2|16|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 13:19:23.974985|2017-02-18 13:19:23.974985
NCT00854711|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2016-07-06|||August 2009||2009-08-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|October 2011|Actual|2011-10-01||Interventional|ENAMOR||Randomized Placebo-controlled Trial of Inhaled iNO in Acute ST-segment Elevation MI Treated by Primary Angioplasty|Randomized Placebo-controlled Trial of Inhaled iNO in Acute ST-segment Elevation MI Treated by Primary Angioplasty|Completed||Phase 2|7|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||No||2017-02-18 13:19:24.3703|2017-02-18 13:19:24.3703
NCT00854698|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2014-06-20|||June 2009||2009-06-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Long-Term Effects of Aortic Valve Mismatch|Long-Term Effects of Aortic Valve Mismatch on Functional Ability and Remodeling the Left Ventricular After Aortic Valve Replacement Mechanics|Completed||N/A|77|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 13:19:24.480921|2017-02-18 13:19:24.480921
NCT00854685|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2010-01-04|||February 2009||2009-02-01|March 2009|2009-03-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate|A Factorial-design, Randomised, Double-blind, Placebo-controlled, Dose Optimisation Study to Investigate the Safety, Efficacy, Immunogenicity and Pharmacokinetics of ART621 Following Multiple Dose Administration in Subjects Diagnosed With Rheumatoid Arthritis Concomitantly Taking Methotrexate|Completed||Phase 2|27|Actual|Arana Therapeutics Ltd||6|||f||||t||||||||||2017-02-18 13:19:24.57764|2017-02-18 13:19:24.57764
NCT00854672|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-04-05|||January 2009||2009-01-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|August 2009|Actual|2009-08-01||Observational|||Muscle Strength and Exercise Capacity in Sarcoidosis Patients|Exercise Capacity, Muscle Strength and Fatigue in Sarcoidosis: a Two-year Follow-up Study|Completed||N/A|124|Actual|Maastricht University Medical Center|||1||f||||t||||||||||2017-02-18 13:19:24.683147|2017-02-18 13:19:24.683147
NCT00854659|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2010-11-01|||March 2009||2009-03-01|September 2010|2010-09-01||||June 2009|Actual|2009-06-01||Interventional|||A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study of the Safety, Tolerability and Pharmacokinetics of ABT-102 in Healthy Subjects|Completed||Phase 1|36|Actual|Abbott||4|||f||||f||||||||||2017-02-18 13:19:24.779702|2017-02-18 13:19:24.779702
NCT00854646|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2016-08-01|||October 2008||2008-10-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional|||Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)|Phase I Dose Escalation Study of ON 01910.Na With Increasing Duration of an Initial 3-Day Continuous Infusion in Patients With Refractory Leukemia or MDS|Completed||Phase 1|22|Actual|Onconova Therapeutics, Inc.||1|||f||||f||||||||||2017-02-18 13:19:24.861617|2017-02-18 13:19:24.861617
NCT00854633|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2012-03-13|||June 2009||2009-06-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|March 2012|Anticipated|2012-03-01||Interventional|||Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants|Phase 1/2 Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants|Unknown status|Recruiting|Phase 1/Phase 2|120|Anticipated|Agennix||2|||f||||t||||||||||2017-02-18 13:19:24.982407|2017-02-18 13:19:24.982407
NCT00854620|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2015-05-20|2015-01-06||December 2007||2007-12-01|May 2015|2015-05-01|January 2011|Actual|2011-01-01|July 2009|Actual|2009-07-01||Interventional||All subjects enrolled were included in the analysis|Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer|A Phase 2 Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma at Stanford University|Completed||Phase 2|9|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 13:19:25.134209|2017-02-18 13:19:25.134209
NCT00854607|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2015-08-04|2012-07-24||March 2009||2009-03-01|August 2015|2015-08-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Observational|||An Observational Study of Fungal Biomarkers (MK-0000-089)|A Prospective, Non-Intervention, Observational Assessment of the Correlation Between Circulating Biomarkers of Fungal Bioburden and Clinical Outcome in the Setting of Invasive Aspergillosis|Completed||N/A|116|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||Samples With DNA|"~     Blood samples are collected for 12 weeks to evaluate levels of fungal biomarkers.~   "|||2017-02-18 13:19:25.356602|2017-02-18 13:19:25.356602
NCT00854594|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2015-09-02|2015-06-11||September 2010||2010-09-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|ReSPECT|For providers who completed the survey once, using demographics reported; for providers who completed the survey twice, using demographics from earlier survey completion.|Interprofessional Training to Improve Diabetes Care: The ReSPECT Trial|Interprofessional Training for Improving Diabetes Care|Completed||N/A|117|Actual|VA Office of Research and Development|IRB-related delays were so significant that aspects of the research plan could not be completed. Delays have also been experienced in the collection and analysis of clinical endpoints.|2|||f||||f||||||||||2017-02-18 13:19:25.838449|2017-02-18 13:19:25.838449
NCT00854581|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-28|2015-11-23|2014-12-22||November 2007||2007-11-01|November 2015|2015-11-01||||November 2011|Actual|2011-11-01||Interventional|||Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma|Prospective Study of the Molecular Characteristics of Sensitive and Resistant Disease in Patients With HTLV-I Associated Adult T Cell Leukemia Treated With Zidovudine (AZT) Plus Interferon Alpha-2b|Terminated||Phase 1/Phase 2|13|Actual|University of Miami||2||Investigator Decision|f||||t||||||||||2017-02-18 13:19:28.556016|2017-02-18 13:19:28.556016
NCT00854568|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2014-08-19|||March 2009||2009-03-01|August 2014|2014-08-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL|A Randomized Phase III Study Comparing CHOP Versus CEOP-induced Cardiotoxicity in Patients With Aggressive B-cell Lymphoma|Completed||Phase 3|398|Actual|Fudan University||2|||f||||f||||||||||2017-02-18 13:19:28.939929|2017-02-18 13:19:28.939929
NCT00854555|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2016-09-06|||August 2008||2008-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|ATLET||The ATLET Study: Can Subjects With Incomplete Spinal Cord Injury Learn to Walk?|The ATLET Study: Can Subjects With Incomplete Spinal Cord Injury Learn to Walk? A Randomized Clinical Trial|Recruiting||N/A|60|Anticipated|North Norway Rehabilitation Center||2|||f||||f||||||||||2017-02-18 13:19:29.055627|2017-02-18 13:19:29.055627
NCT00854542|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-11-30|||January 2009||2009-01-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|January 2014|Actual|2014-01-01||Interventional|||Effectiveness of Telepsychiatry-based Culturally Sensitive Collaborative Treatment of Depressed Chinese Americans|Effectiveness of Telepsychiatry-based Culturally Sensitive Collaborative Treatment of Depressed Chinese Americans|Completed||N/A|241|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 13:19:29.18355|2017-02-18 13:19:29.18355
NCT00854529|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2009-03-02|||April 2009||2009-04-01|February 2009|2009-02-01|October 2011|Anticipated|2011-10-01|April 2011|Anticipated|2011-04-01||Interventional|||Subconjunctival Bevacizumab Effect on Bleb Vascularity|Subconjunctival Bevacizumab Injection for the Prevention of Bleb Vascularization Post Trabeculectomy|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Rabin Medical Center||3|||f||||t||||||||||2017-02-18 13:19:29.283991|2017-02-18 13:19:29.283991
NCT00854516|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-01-20|||February 2009||2009-02-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Open Label Clinical Study to Assess the Clinical Safety of a New Compression Device in Subjects With Peripheral Arterial Vascular Disease|Open Label Clinical Study to Assess the Clinical Safety of a New Compression Procedure in Subjects With Peripheral Arterial Vascular Disease|Completed||N/A|15|Actual|3M||1|||f||||t||||||||||2017-02-18 13:19:29.586967|2017-02-18 13:19:29.586967
NCT00854503|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-05-11|||September 2008||2008-09-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients||Completed||Phase 3|30|Actual|University of Rome Tor Vergata||2|||f||||||||||||||2017-02-18 13:19:29.694636|2017-02-18 13:19:29.694636
NCT00854490|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-09-18|||October 2009||2009-10-01|September 2009|2009-09-01||||||||Observational|||Follow-up Study of Small-intestinal Mucosal Injuries in Chronic Non-steroidal Anti-inflammatory Drugs (NSAIDs)-Users||Unknown status|Not yet recruiting|N/A|100|Anticipated|Nagoya University|||1||f||||||||||||||2017-02-18 13:19:29.805839|2017-02-18 13:19:29.805839
NCT00854477|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2013-02-15|||November 2009||2009-11-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma|A Pharmacokinetic Study of Adjuvant Capecitabine in Patients Who Have Undergone Proximal Pancreatico-duodenectomy for Resection of Pancreatic Adenocarcinoma|Completed||Phase 4|13|Actual|Cambridge University Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 13:19:29.883236|2017-02-18 13:19:29.883236
NCT00854464|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2009-03-02|||August 2008||2008-08-01|March 2009|2009-03-01||||July 2011|Anticipated|2011-07-01||Observational|||Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma|Arsenic Methylation, Cigarette Smoking Exposure, Individual DNA Susceptibility Factors and Urothelial Carcinoma|Unknown status|Recruiting|N/A|420|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:19:29.990906|2017-02-18 13:19:29.990906
NCT00854451|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-03-01|||August 1996||1996-08-01|July 1996|1996-07-01|February 1998|Actual|1998-02-01|December 1997|Actual|1997-12-01||Interventional|||Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection|Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection - A Combination of Clinical and Pharmacogenetic Study|Completed||Phase 4|128|Actual|National Taiwan University Hospital||4|||f||||f||||||||||2017-02-18 13:19:30.08336|2017-02-18 13:19:30.08336
NCT00854438|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-06-18|||September 2008||2008-09-01|June 2015|2015-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|PRADA||Reduction of Adverse Events of Anticholinergic Drugs by Multidisciplinary Medical Reviews in Norwegian Nursing Homes|Pharmacist-initiated Reduction of Anticholinergic Drug Activity|Completed||N/A|87|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 13:19:30.189507|2017-02-18 13:19:30.189507
NCT00854425|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2012-02-16|||June 2008||2008-06-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma|Phase II Study of L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma|Completed||Phase 2|40|Actual|Fudan University||1|||f||||f||||||||||2017-02-18 13:19:30.298802|2017-02-18 13:19:30.298802
NCT00854412|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||March 1995||1995-03-01|March 2009|2009-03-01|June 1995|Actual|1995-06-01|June 1995|Actual|1995-06-01||Interventional|WLMBL||The Effect of Weight Loss on Serum Mannose-Binding Lectin(MBL) Levels|The Effect of Weight Loss on Serum Mannose-Binding Lectin (MBL) Levels|Completed||N/A|36|Actual|University of Aarhus|||||f||||f||||||||||2017-02-18 13:19:30.405237|2017-02-18 13:19:30.405237
NCT00854399|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2009-03-02|||January 2006||2006-01-01|March 2009|2009-03-01|December 2011|Anticipated|2011-12-01|January 2006|Anticipated|2006-01-01||Interventional|||Screening and Identification of Ovarian Cancers|Screening and Identification of Novel Diagnostic and Prognostic Biomarkers on Ovarian Cancers|Unknown status|Recruiting|N/A|250|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 13:19:30.47824|2017-02-18 13:19:30.47824
NCT00854386|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-10-14|||May 2009||2009-05-01|October 2009|2009-10-01|September 2011|Anticipated|2011-09-01|May 2011|Anticipated|2011-05-01||Interventional|||Effect of Intraoperative Fluid Restriction on Postoperative Outcomes in Video-assisted Thoracic Surgery (VATS)|The Effect of Intraoperative Fluid Restriction on Postoperative Outcomes in Video-assisted Thoracic Surgery (VATS) for Lung Resection|Unknown status|Recruiting|N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-02-18 13:19:30.564912|2017-02-18 13:19:30.564912
NCT00854191|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2009-03-02|||July 2007||2007-07-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Simulator Practice on Trainees' Endoscopic Retrograde Cholangiopancreatography (ERCP) Performance in the Early Learning Period|A RCT of Mechanical Simulator Practice and Usual Training vs. Usual Training on Novice Trainee Clinical ERCP Performance|Completed||N/A|8|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:19:33.741648|2017-02-18 13:19:33.741648
NCT00854373|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2013-08-01|2013-05-29||June 2006||2006-06-01|August 2013|2013-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial|Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial|Completed||Phase 4|232|Actual|University of California, San Francisco|This study was powered to detect difference in fertilization instead of pregnancy outcomes, because the number of patients required to detect a 10% absolute difference in pregnancy rates was too large to be completed at our center (n=387 per group).|2|||f||||t||||||||||2017-02-18 13:19:30.6837|2017-02-18 13:19:30.6837
NCT00854360|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2012-04-23|2012-04-23||March 2009||2009-03-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR|Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center, Dose-Range-Finding Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Adult and Adolescent Patients (12 Years and Older) With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 2|487|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-02-18 13:19:31.066429|2017-02-18 13:19:31.066429
NCT00854347|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||November 2005||2005-11-01|November 2008|2008-11-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Observational|||Hyperglycemia in the Intensive Care Unit, a Prevalence Study|Hyperglycemia in the Intensive Care Unit Marker of Diabetes or Pre-Diabetes ?|Completed||N/A|100|Actual|Université de Montréal|||1||f||||f||||||||||2017-02-18 13:19:32.157473|2017-02-18 13:19:32.157473
NCT00854334|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-07-18|||September 2010||2010-09-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|September 2011|Anticipated|2011-09-01||Observational|||Co-existent Obstructive Sleep Apnea (OSA) and Obesity: Finding Non-exercise Activity Thermogenesis (NEAT) Targets for Intervention|Co-existent OSA and Obesity: Finding NEAT Targets for Intervention|Unknown status|Recruiting|N/A|40|Anticipated|Katz, Sherri Lynne, M.D.|||2||f||||f||||||Samples Without DNA|"~     urine~   "|||2017-02-18 13:19:32.238176|2017-02-18 13:19:32.238176
NCT00854321|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||November 2004||2004-11-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|KuoRituxi1||Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital|One Centre Follow-up Study on Safety and Efficacy|Completed||N/A|49|Actual|Kuopio University Hospital|||1||f||||f||||||||||2017-02-18 13:19:32.325456|2017-02-18 13:19:32.325456
NCT00854308|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-11-14|2011-09-09||April 2009||2009-04-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|November 2010|Actual|2010-11-01||Interventional|||A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)|A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Activity of MetMAb, a Monovalent Antagonist Antibody to the Receptor Met, Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)|Completed||Phase 2|137|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 13:19:32.444184|2017-02-18 13:19:32.444184
NCT00854295|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-01-04|||April 2009||2009-04-01|January 2016|2016-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee|Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee|Active, not recruiting||N/A|400|Anticipated|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:19:33.005679|2017-02-18 13:19:33.005679
NCT00854282|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2009-03-02|||January 2009||2009-01-01|March 2009|2009-03-01|December 2012|Anticipated|2012-12-01|January 2009|Anticipated|2009-01-01||Interventional|Tregs||The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression|The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 13:19:33.1279|2017-02-18 13:19:33.1279
NCT00854269|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2009-03-22|||January 2007||2007-01-01|March 2009|2009-03-01|January 2011|Anticipated|2011-01-01|May 2008|Anticipated|2008-05-01||Interventional|||Screening and Identification of Biomarkers on Cervical Cancers|Screening and Identification of Novel Diagnostic and Prognosis Biomarkers on Cervical Cancers|Unknown status|Recruiting|N/A|250|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 13:19:33.206664|2017-02-18 13:19:33.206664
NCT00854256|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2013-04-12|||April 2009||2009-04-01|April 2013|2013-04-01|May 2014|Anticipated|2014-05-01|December 2013|Anticipated|2013-12-01||Interventional|||Trabeculectomy Versus Canaloplasty to Treat Glaucoma|Comparison of Canaloplasty and Trabeculectomy in Patients With Open Angle Glaucoma and Inadequate Local Eye Pressure Lowering Therapy - a Prospective, Randomized Study|Unknown status|Recruiting|N/A|60|Anticipated|University of Cologne||2|||f||||f||||||||||2017-02-18 13:19:33.287076|2017-02-18 13:19:33.287076
NCT00854243|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2009-03-02|||April 2009||2009-04-01|March 2009|2009-03-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Observational|||Role of Greyscale and Power Doppler Sonography in Therapy Monitoring in Early Rheumatoid Arthritis (RA)|Therapy Monitoring in Early Rheumatoid Arthritis: The Role of Greyscale and Power Doppler Sonography A Prospective Study Of 20 Egyptian Rheumatoid Arthritis Patients|Unknown status|Not yet recruiting|N/A|20|Anticipated|Cairo University|||1||f||||f||||||||||2017-02-18 13:19:33.397428|2017-02-18 13:19:33.397428
NCT00854230|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2012-03-27|||January 2009||2009-01-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Pharmacotherapy for HIV Infected Patients With Alcohol Problems|Pharmacotherapy for HIV Infected Patients With Alcohol Problems|Withdrawn||Phase 4|0|Actual|VA Connecticut Healthcare System||2||We expanded to a bigger, multi-site study & decided to close this study.|f||||t||||||||||2017-02-18 13:19:33.467364|2017-02-18 13:19:33.467364
NCT00854217|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2011-03-02|||March 2009||2009-03-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Cardioprotective Effects of Endogenous Erythropoietin in Patients Undergoing Coronary Artery Bypass Surgery||Completed||N/A|40|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||||||||||||2017-02-18 13:19:33.57128|2017-02-18 13:19:33.57128
NCT00854204|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2010-04-26|||November 2008||2008-11-01|April 2010|2010-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629|Phase I, Open-label, 3-way Crossover Trial in Healthy Male Volunteers to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629|Completed||Phase 1|12|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:19:33.663079|2017-02-18 13:19:33.663079
NCT00854178|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-02|2010-01-05|||March 2008||2008-03-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery|Toxicogenomic and Immunocytotoxic Effects of Propofol and Isoflurane Anesthetics in Patients Undergoing Elective Surgery|Completed||Phase 4|26|Anticipated|UPECLIN HC FM Botucatu Unesp||1|||f||||f||||||||||2017-02-18 13:19:33.837682|2017-02-18 13:19:33.837682
NCT00854165|ClinicalTrials.gov processed this data on February 17, 2017|2009-03-01|2009-03-02|||February 2009||2009-02-01|March 2009|2009-03-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Observational|||Lung Transplantation in Respiratory Failure Patients|Extracorporeal Membrane Oxygenation Support for Bilateral Sequential Lung Transplantation in Respiratory Failure Patients.|Unknown status|Active, not recruiting|N/A|10|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:19:33.949546|2017-02-18 13:19:33.949546
NCT00854152|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-11-01|||March 2009||2009-03-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma|An Open-label, Phase I, Dose-Escalation Study Evaluating the Safety, Tolerability, and Maximally Tolerated Dose of GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors and Non-Hodgkin's Lymphoma|Completed||Phase 1|121|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 13:19:34.036193|2017-02-18 13:19:34.036193
NCT00854139|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2015-04-13|||August 2001||2001-08-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)|Combined HLA-matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With Renal Failure|Completed||Phase 1|10|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 13:19:34.135182|2017-02-18 13:19:34.135182
NCT00854126|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-11-01|||May 2009||2009-05-01|November 2016|2016-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma|An Open-label, Phase I, Dose-escalation Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors and Non-hodgkin's Lymphoma|Completed||Phase 1|38|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 13:19:34.247776|2017-02-18 13:19:34.247776
NCT00854113|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2011-07-18|2010-10-25||February 2009||2009-02-01|July 2011|2011-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers|A Phase I , Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of EGT0001474 In Healthy Volunteers|Completed||Phase 1|78|Actual|Theracos||2|||f||||f||||||||||2017-02-18 13:19:34.352696|2017-02-18 13:19:34.352696
NCT00854100|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-02-06||2012-02-06|June 2009||2009-06-01|February 2012|2012-02-01||||December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder|A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) As Adjunctive Therapy In Major Depressive Disorder|Completed||Phase 2|232|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 13:19:37.033132|2017-02-18 13:19:37.033132
NCT00854087|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2014-06-18|2014-05-19||August 2010||2010-08-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis|A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis|Completed||Phase 2|118|Actual|SCTI Research Foundation||2|||f||||t||||||||||2017-02-18 13:19:37.192505|2017-02-18 13:19:37.192505
NCT00854074|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-02-15|||July 2009||2009-07-01|February 2016|2016-02-01|January 2010|Anticipated|2010-01-01|December 2009|Anticipated|2009-12-01||Interventional|||Neurostimulation for the Treatment of Post-Operative Ileus|Neurostimulation for the Treatment of Post-Operative Ileus|Withdrawn||Phase 2|0|Actual|ElectroCore LLC||2||Withdrawn: study halted prematurely, prior to enrollment of first participant|f||||f||||||||||2017-02-18 13:19:37.717198|2017-02-18 13:19:37.717198
NCT00854061|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2014-04-04||2011-09-02|February 2009||2009-02-01|April 2014|2014-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of T-PRED(TM) Compared to Pred Forte(R) II||Completed||Phase 3|135|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 13:19:37.818103|2017-02-18 13:19:37.818103
NCT00854048|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-11-29|||December 2007||2007-12-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||The Performance of Pulse Oximeters in Pediatric Patients With Low Oxygen Saturation Levels|The Performance of Nellcor OxiMax N-560 and Masimo SET Radical Pulse Oximeters in Pediatric Patients With Low Oxygen Saturation Levels|Completed||N/A|66|Actual|Medtronic - MITG|||1||f||||t||||||||||2017-02-18 13:19:37.915604|2017-02-18 13:19:37.915604
NCT00854035|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-06-12|||February 2009||2009-02-01|June 2012|2012-06-01||||June 2010|Actual|2010-06-01||Interventional|||MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus|A Phase III, Randomized, Placebo-Controlled, Double-Blind Clinical Trial and Subsequent Open-Label, Extension Clinical Trial to Study the Efficacy and Safety of Addition of MK-0431/ONO-5435 in Japansese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy and Insulin Monotherapy|Completed||Phase 3|266|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||||||||||||2017-02-18 13:19:37.987724|2017-02-18 13:19:37.987724
NCT00854022|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2010-12-02|||July 2008||2008-07-01|December 2010|2010-12-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Observational|||Genetic Susceptibility to Kidney Cancer|Genetic Susceptibility to Renal Cell Carcinoma|Unknown status|Recruiting|N/A|1600|Anticipated|Baylor College of Medicine|||2||f||||f||||||Samples With DNA|"~     We will utilize the blood collected to run several laboratory analyses that will assess DNA~     damage/repair, telomere length, telomerase activity, and other genetic instability as~     predictors of RCC risk. All information linking this unique identifier to the participant~     will be kept in a secure location under lock-and-key password protected.~      In addition, RCC tumor and adjacent normal tissue samples may be obtained from the MDACC~     Institutional Tissue Bank (ITB) for cases only. The samples obtained will be left over from~     surgical procedures, so as to prevent any additional distress to the patient.~   "|||2017-02-18 13:19:38.089582|2017-02-18 13:19:38.089582
NCT00853489|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2017-01-10|||August 2011||2011-08-01|June 2016|2016-06-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||rhBMP-2 Versus Autograft in Critical Size Tibial Defects|RhBMP-2 vs. Autograft for Critical Size Tibial Defects: A Multicenter Randomized Trial|Terminated||Phase 4|33|Actual|St. Louis University||2||Enrollment too slow|f||||t||||||||||2017-02-18 13:20:00.225355|2017-02-18 13:20:00.225355
NCT00854009|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-10-07|||February 2009||2009-02-01|October 2009|2009-10-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects|Ascending Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of BLI-489 Administered Intravenously to Healthy Japanese Male Subjects|Terminated||Phase 1|56|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:19:38.161968|2017-02-18 13:19:38.161968
NCT00853996|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2013-05-31|||February 2009||2009-02-01|May 2013|2013-05-01||||August 2010|Actual|2010-08-01||Interventional|||Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer|Phase II Study of Acolbifene in Pre-Menopausal Women at High Risk for Breast Cancer|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 13:19:38.253697|2017-02-18 13:19:38.253697
NCT00853983|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2009-05-20|||March 2009||2009-03-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|||||Interventional|||Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers|An Open-Label, Phase I Study to Assess Absorption, Metabolism and Excretion of a Single Oral Dose of [14C]AZD0530 in Healthy Male Volunteers|Completed||Phase 1|6|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:19:38.352213|2017-02-18 13:19:38.352213
NCT00853970|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2013-01-11|2010-11-15||February 2009||2009-02-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery||Completed||Phase 3|299|Actual|Bausch & Lomb Incorporated||2|||f||||||||||||||2017-02-18 13:19:38.436889|2017-02-18 13:19:38.436889
NCT00853957|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-04-26|2010-12-06||February 2009||2009-02-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|AACESS||Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension|An 8-week Multicenter, Randomized, Double-blind, Active Control, Parallel Group Study to Evaluate the Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine (150/5 mg, 300/10 mg) Versus Amlodipine Alone (5 mg, 10 mg) in African American Patients With Stage 2 Hypertension|Completed||Phase 4|443|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:19:38.942842|2017-02-18 13:19:38.942842
NCT00853944|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2011-02-15|||July 2009||2009-07-01|February 2011|2011-02-01|July 2011|Anticipated|2011-07-01|||||Interventional|||Effect of Sitagliptin on Graft Function Following Islet Transplantation|A Randomized Controlled Trial to Determine if Sitagliptin Will Enhance Islet Graft Function When Given for 1 Year Following Transplantation|Unknown status|Recruiting|Phase 3|12|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:19:39.377175|2017-02-18 13:19:39.377175
NCT00853931|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-11-27|||October 2009||2009-10-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Biomarker - Panitumumab Response With KRAS Wild Type MCC|An Exploratory Trial of Biomarkers for Panitumumab Response Among Previously Treated Patients With KRAS Wild Type Metastatic Colorectal Cancer.|Completed||N/A|52|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-02-18 13:19:39.485431|2017-02-18 13:19:39.485431
NCT00853918|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2010-06-04|||June 2009||2009-06-01|June 2010|2010-06-01|December 2010|Anticipated|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Clinical Practice Intensity: Comparing Veterans Affairs (VA) to Private Sector Physicians|Clinical Practice Intensity: Comparing VA to Private Sector Physicians|Unknown status|Active, not recruiting|N/A|1000|Anticipated|White River Junction VAMC||4|||f||||f||||||||||2017-02-18 13:19:39.593832|2017-02-18 13:19:39.593832
NCT00853905|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-11-20|2015-02-12||February 2009||2009-02-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?|The Effect of Intracameral Triesence (Triamcinolone Acetonide Injectable Suspension) on Ocular Inflammation After Trabeculectomy, Tube Shunt Implantation or Combined Trabeculectomy With Cataract Surgery|Completed||Phase 2/Phase 3|77|Actual|Wills Eye||2|||f||||f||||||||No||2017-02-18 13:19:39.697253|2017-02-18 13:19:39.697253
NCT00853892|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-09-08|||April 2005||2005-04-01|September 2016|2016-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets|An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate the Relative Bioavailability of a Controlled-Release Test Tablet Formulation of Oxycodone Hydrochloride (40 mg) Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (OxyContin® 40 mg, Purdue Pharma L.P.) in Normal Human Subjects Under Fasting Conditions|Completed||Phase 1|34|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 13:19:40.246216|2017-02-18 13:19:40.246216
NCT00853879|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-05-13|||December 2006||2006-12-01|May 2015|2015-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's Disease|An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's Disease|Terminated||N/A|150|Actual|Northwell Health||3|||f||||f||||||||||2017-02-18 13:19:40.337933|2017-02-18 13:19:40.337933
NCT00853866|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2010-12-01|||January 2009||2009-01-01|December 2010|2010-12-01|June 2010|Anticipated|2010-06-01|November 2009|Anticipated|2009-11-01||Interventional|STIMBOX||Enhancement of Motor Function With Reboxetine and Transcranial Direct Current Stimulation|Entwicklung Neuronaler Repräsentationen Nach Schlaganfall: Verbesserung Motorischer Leistungen Durch Transkranielle Gleichstromstimulation Und Noradrenerge Co-Stimulation|Unknown status|Recruiting|Phase 4|12|Anticipated|Universitätsklinikum Hamburg-Eppendorf||4|||f||||t||||||||||2017-02-18 13:19:40.449332|2017-02-18 13:19:40.449332
NCT00853853|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-11-19|||March 2009||2009-03-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||EnSeal Device Versus Ferguson Technique in Hemorrhoidectomy|Randomized Trial Comparing Standard Ferguson Technique With the EnSeal Device During Hemorrhoidectomy|Unknown status|Active, not recruiting|N/A|100|Anticipated|The Miriam Hospital||2|||f||||t||||||||||2017-02-18 13:19:40.579706|2017-02-18 13:19:40.579706
NCT00853840|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2013-01-16|2009-05-05||April 2008||2008-04-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc|A Randomized, Single-Blinded, Placebo-Controlled Two-Way Crossover Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc|Completed||Phase 4|18|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-02-18 13:19:40.690288|2017-02-18 13:19:40.690288
NCT00853827|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2014-05-20|2014-01-23||March 2009||2009-03-01|May 2014|2014-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|AQUARIUS|Randomized - All patients who received a randomization number, regardless of whether or not the patient received the trial medication|Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients|A 104 Week, Randomized, Double Blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy of Aliskiren on the Progression of Atherosclerosis in Patients With Coronary Artery Disease When Added to Optimal Background Therapy|Completed||Phase 3|613|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:19:41.550075|2017-02-18 13:19:41.550075
NCT00853814|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-02-27|||September 2007||2007-09-01|February 2009|2009-02-01|September 2011|Anticipated|2011-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Increasing Youth Physical Activity: Neighborhood Environment Influences|Increasing Youth Physical Activity: Neighborhood Environment Influences|Unknown status|Recruiting|N/A|100|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||4|||f||||f||||||||||2017-02-18 13:19:42.475706|2017-02-18 13:19:42.475706
NCT00853801|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2014-09-30|||February 2006||2006-02-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|November 2007|Actual|2007-11-01||Interventional|||Integrating Lifestyle Therapy for Diabetes Prevention Into Primary Care|Detecting and Managing Metabolic Syndrome and Pre-Diabetes in General Medicine Clinic (Feasibility)|Completed||N/A|112|Anticipated|John H. Stroger Hospital||1|||f||||t||||||||||2017-02-18 13:19:42.576523|2017-02-18 13:19:42.576523
NCT00853788|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-02-15|||November 2008||2008-11-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil|Genomic and Histological Analysis of Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil|Completed||N/A|40|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||Samples Without DNA|"~     skin biopsy samples~   "|||2017-02-18 13:19:42.676293|2017-02-18 13:19:42.676293
NCT00853775|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2015-02-06|||February 2009||2009-02-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Observational|||Family Research Study: Metabolism of Fats and Proteins in Specific Ethnic Groups|Regulation of Lipoprotein(a) Metabolism in Humans With Reference to Ethnicity|Completed||N/A|325|Actual|University of California, Davis|||2||f||||t||||||Samples With DNA|"~     plasma, DNA, white blood cell~   "|||2017-02-18 13:19:42.770321|2017-02-18 13:19:42.770321
NCT00853762|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-08-24|2016-04-15||March 2009||2009-03-01|August 2016|2016-08-01|February 2011|Actual|2011-02-01|September 2009|Actual|2009-09-01||Interventional|ATAMS ext|Intent-to-treat (ITT) population included all randomized subjects.|Atacicept in Multiple Sclerosis Extension Study, Phase II|An Open-label, Multicenter Phase II Extension of Study 28063 (ATAMS) to Obtain Long-term Follow-up Data in Subjects With Relapsing Multiple Sclerosis Treated With Atacicept for up to 5 Years (ATAMS-Extension)|Terminated||Phase 2|74|Actual|EMD Serono|Sponsor voluntarily decided to terminate this trial after observing increased MS disease activity in trial 28063 ATAMS.|2||"EMD Serono voluntarily decided to terminate this trial after observing increased MS disease~   activity in trial 28063 ATAMS [Please refer to ATAMS]"|f||||t||||||||||2017-02-18 13:19:42.890983|2017-02-18 13:19:42.890983
NCT00853749|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-12-16|2010-12-16||May 2009||2009-05-01|December 2010|2010-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|REPLAY||Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine|Revaccination With Pneumococcal Conjugate Vaccine - Characterization Of The Immune Response After Polysaccharide|Completed||Phase 3|89|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|In protocol, primary analysis based on All Available Immunogenicity Population and later modified to Evaluable Immunogenicity Population in Statistical Analysis Plan based on subsequent similar studies and suitability for primary objective.|1|||f||||f||||||||||2017-02-18 13:19:44.352301|2017-02-18 13:19:44.352301
NCT00853736|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-18|||February 2003||2003-02-01|October 2016|2016-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets|An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate the Relative Bioavailability of an Immediate Release Test Tablet Formulation of Oxycodone Hydrochloride (30 mg) Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Roxicodone™, 30 mg Tablet, Roxane Laboratories, Inc.) in Normal Human Subjects Under Fed Conditions|Completed||Phase 1|23|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 13:19:45.164186|2017-02-18 13:19:45.164186
NCT00853723|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-02-24|2015-07-15||May 2009||2009-05-01|February 2016|2016-02-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional||Postmenopausal women age 45-75 with osteoporosis or low bone density|Comparison Study of PTHrP and PTH to Treat Osteoporosis|Comparison of 3 Month PTHrP(1-36) and PTH(1-34) on Post-Menopausal Osteoporosis|Completed||Phase 2|105|Actual|University of Pittsburgh|This study was not double-blinded. There was no placebo group in this study. Subjects had higher than anticipated calcium intake and baseline vitamin D levels.|3|||f||||t||||||||No||2017-02-18 13:19:45.266801|2017-02-18 13:19:45.266801
NCT00853710|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-08-04|||March 2009||2009-03-01|June 2009|2009-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Test Semiquantitative Prostate Specific Antigen (PSA)|Validation of a Semiquantitative Screening Assay for PSA|Completed||N/A|94|Actual|Institut Curie||1|||f||||f||||||||||2017-02-18 13:19:46.206056|2017-02-18 13:19:46.206056
NCT00853697|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-10-28|||March 2009||2009-03-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer|Phase II Trial of Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer|Completed||Phase 2|6|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:19:46.316909|2017-02-18 13:19:46.316909
NCT00853684|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-09-17|||February 2009||2009-02-01|September 2009|2009-09-01|March 2011|Anticipated|2011-03-01|December 2010|Anticipated|2010-12-01||Interventional|OXCE||Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer|Phase II Study of Oxaliplatin, Capecitabine and Endostar as First Line Treatment for Patients With Advanced Colorectal Cancer|Unknown status|Recruiting|Phase 2|44|Anticipated|Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||||2017-02-18 13:19:46.43107|2017-02-18 13:19:46.43107
NCT00853671|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2010-04-30|||April 2008||2008-04-01|April 2010|2010-04-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Myocardial Stress Perfusion Imaging With Dual Source CT|Myocardial Stress Perfusion Imaging With Dual Source CT|Unknown status|Recruiting|N/A|60|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:19:46.558319|2017-02-18 13:19:46.558319
NCT00853658|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-03|2016-10-03||March 2009||2009-03-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ATMOSPHERE|Full Analysis Set (FAS) - included all randomized patients but excluded 48 patients (22 mis-randomized but took no double blind and 26 patients due to GCP violations)|Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure|A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV). The Study is Also Known as Aliskiren Trial of Minimizing OutcomeS in Patients With HEart Failure (ATMOSPHERE).|Completed||Phase 3|7064|Actual|Novartis||3|||f||||t||||||||||2017-02-18 13:19:46.809668|2017-02-18 13:19:46.809668
NCT00853645|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2017-02-14|||July 2008||2008-07-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|Chronic II||Initial Chronic Human Validation Study: Subcutaneous Implantable (S-ICD) System|Initial Chronic Human Validation Study: Subcutaneous Implantable (S-ICD) System|Completed||N/A|6|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 13:19:57.522103|2017-02-18 13:19:57.522103
NCT00853632|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-09-20|||August 2007||2007-08-01|September 2016|2016-09-01|December 2023|Anticipated|2023-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol|Carpentier-Edwards® Perimount Magna® Mitral Pericardial Bioprostheses Models 7000/7000 TFX and Carpentier-Edwards® Perimount Magna® Mitral Ease™ Pericardial Bioprostheses Models 7200TFX and 7300/7300TFX|Active, not recruiting||N/A|250|Anticipated|Edwards Lifesciences||1|||f||||f||||||||||2017-02-18 13:19:57.610833|2017-02-18 13:19:57.610833
NCT00853619|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-02-27|||March 2008||2008-03-01|February 2012|2012-02-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|CDSC||Clinical Decision Support Consortium|Clinical Decision Support Consortium for AHRQ CDS Research|Unknown status|Enrolling by invitation|N/A|70|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:19:57.738382|2017-02-18 13:19:57.738382
NCT00853606|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-08-10|2012-05-25||March 2009||2009-03-01|August 2012|2012-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction|An Open-Label, Long-Term Evaluation of the Safety and Efficacy of Avanafil in Men With Erectile Dysfunction|Completed||Phase 3|712|Actual|VIVUS, Inc.||1|||f||||f||||||||||2017-02-18 13:19:57.931345|2017-02-18 13:19:57.931345
NCT00853593|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-02-01|2011-08-25||March 2009||2009-03-01|February 2012|2012-02-01|August 2010|Actual|2010-08-01|July 2009|Actual|2009-07-01||Interventional|4396||Model 4396 Left Ventricular (LV) Lead Study|Model 4396 Left Ventricular Lead Study|Completed||Phase 3|197|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-02-18 13:19:58.364622|2017-02-18 13:19:58.364622
NCT00853580|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-12-02|||July 2009||2009-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|STARS||A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1|A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1|Active, not recruiting||Phase 2|142|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 13:19:59.106576|2017-02-18 13:19:59.106576
NCT00853567|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2014-08-05|2014-06-25||February 2009||2009-02-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Study prematurely terminated|Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids|A Phase III, Three-Arm, Parallel Design, Placebo-Controlled, Randomized, Double-Blind, Multicenter Study Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in the Treatment of Premenopausal Women With Symptomatic Uterine Fibroids|Terminated||Phase 3|71|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with any study data.|3||Repros stopped the study for safety and FDA put the study on hold for safety.|f||||t||||||||||2017-02-18 13:19:59.405444|2017-02-18 13:19:59.405444
NCT00853554|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-18|||December 2002||2002-12-01|October 2016|2016-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets|An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate the Relative Bioavailability of a Test Tablet Formulation of Hydromorphone Hydrochloride (8 mg) Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (DILAUDID®, 8 mg Tablet, Knoll Pharmaceutical Company) in Normal Human Subjects Under Fasting Conditions|Completed||Phase 1|24|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 13:19:59.669301|2017-02-18 13:19:59.669301
NCT00853541|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-09-22|||March 2009||2009-03-01|September 2015|2015-09-01|October 2011|Anticipated|2011-10-01|October 2010|Anticipated|2010-10-01||Observational|CAPRICORN||Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study|Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||1|No patients enrolled.|f||||f||||||Samples Without DNA|"~     blood samples are taken~   "|||2017-02-18 13:19:59.772185|2017-02-18 13:19:59.772185
NCT00853528|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-09-01|||January 2009||2009-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2013|Actual|2013-06-01||Interventional|||Stereotactic Radiosurgery in Treating Patients With Spinal Metastases|Cyberknife Radiosurgery for Improving Palliation of Metastatic Tumors of the Spine|Active, not recruiting||Phase 1|36|Anticipated|Boston Medical Center||1|||f||||t||||||||No|There is no plan to share individual participant data.|2017-02-18 13:19:59.866926|2017-02-18 13:19:59.866926
NCT00853515|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-12-08|||March 2009||2009-03-01|December 2016|2016-12-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||Goal-directed Fluid Resuscitation in Acute Pancreatitis|A Randomized-controlled Trial of a Targeted Approach to Fluid Resuscitation in Acute Pancreatitis|Terminated||N/A|40|Actual|Brigham and Women's Hospital||4||"interim analysis incidence primary endpoint lower than anticipated. Sigicant finding based on~   secondary endpoint."|f||||t||||||||||2017-02-18 13:19:59.995325|2017-02-18 13:19:59.995325
NCT00853502|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-26|||December 2008||2008-12-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||The Effect of Testosterone Replacement on Bone Mineral Density in Boys and Men With Anorexia Nervosa|The Effect of Testosterone Replacement on Bone Mineral Density and Bone Microarchitecture in Teenage Boys and Young Adult Men With Anorexia Nervosa|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||2||No recruitment|f||||t||||||||||2017-02-18 13:20:00.106947|2017-02-18 13:20:00.106947
NCT00853476|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2011-02-16|||March 2009||2009-03-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||The Standard Concentration of Morphine as a Positive Control for Intradermal Skin Test|The Standard Concentration of Morphine as a Positive Control for Intradermal Skin Test|Completed||N/A|25|Actual|Chulalongkorn University|||1||f||||f||||||||||2017-02-18 13:20:00.352235|2017-02-18 13:20:00.352235
NCT00853463|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2011-05-31|||April 2009||2009-04-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|March 2010|Actual|2010-03-01||Interventional|Discharge||Discharge ALERT: Quality Improvement Initiative|Multi-centered Discharge Alert to Prevent DVT and PE at Hospital Discharge|Completed||N/A|2515|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:20:00.590231|2017-02-18 13:20:00.590231
NCT00853450|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2009-08-18|||February 2009||2009-02-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|||||Interventional|||Bleeding Time Study With AZD6482, Clopidogrel and ASA|A Randomised, Open-label, Single-Centre, Phase I, Crossover Study to Evaluate the Effect of AZD6482, Compared With Clopidogrel, on Bleeding Time in Healthy Volunteers Receiving Low-Dose ASA|Completed||Phase 1|28|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:20:00.746372|2017-02-18 13:20:00.746372
NCT00853437|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-05-25|||January 2009||2009-01-01|May 2016|2016-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|GCH||Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients|Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients|Completed||N/A|7|Actual|Transonic Systems Inc.|||1||f||||f||||||||||2017-02-18 13:20:00.861386|2017-02-18 13:20:00.861386
NCT00853424|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2014-03-14|||December 2009||2009-12-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease|A Comparison of Islet Cell Transplantation With Medical Therapy on the Risk of Progression of Diabetic Retinopathy and Diabetic Macular Edema|Withdrawn||Phase 3|0|Actual|University of British Columbia||2||"We were unable to enroll any subjects in this study due to lack of interest."|f||||f||||||||||2017-02-18 13:20:00.954698|2017-02-18 13:20:00.954698
NCT00853411|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-03-21|||December 2008||2008-12-01|March 2016|2016-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Asthma Exacerbation Study|Th2 Effects on Eicosanoid Pathways: Implications for Altered Innate Responses in Asthma|Withdrawn||N/A|0|Actual|University of Pittsburgh||1||Terminated by Investigator due to lack of eligible subjects.|f||||||||||||||2017-02-18 13:20:01.066605|2017-02-18 13:20:01.066605
NCT00853398|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2014-05-22|||October 2004||2004-10-01|May 2014|2014-05-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|MIS GEN II||MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty|A Prospective (Non)-Randomized Controlled Multicenter Clinical Study Of the Genesis ii Total Knee System in Minimally Invasive Total Knee Arthroplasty|Terminated||Phase 4|||Smith & Nephew, Inc.||2||"The results obtained 1 year after surgery were clearly indicative of the outcome and the~   investigators decided to terminate follow-up at that point."|f||||||||||||||2017-02-18 13:20:01.152959|2017-02-18 13:20:01.152959
NCT00853385|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2013-01-10|2012-12-04||May 2009||2009-05-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis|Phase 3 Randomized, Double-Blind, Active Comparator, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of CP 690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate|Completed||Phase 3|717|Actual|Pfizer||5|||f||||t||||||||||2017-02-18 13:20:01.314756|2017-02-18 13:20:01.314756
NCT00853372|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2017-02-01||2015-11-02|May 2009||2009-05-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|August 2011|Actual|2011-08-01||Interventional|||AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib|Phase 2 Open-Label, Multi-Center Study to Evaluate the Safety and Efficacy of Sunitinib Malate in Combination With AMG 386 as First Line or Second Line Therapy for Subjects With Metastatic Renal Cell Carcinoma|Active, not recruiting||Phase 2|85|Actual|Amgen||2|||f||||f||||||||||2017-02-18 13:20:06.648933|2017-02-18 13:20:06.648933
NCT00853346|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-11-15|||April 2007||2007-04-01|November 2012|2012-11-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Psychosocial Treatment of Depression in Parkinson's Disease|Psychosocial Treatment of Depression in Parkinson's Disease|Unknown status|Active, not recruiting|N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 13:20:06.759535|2017-02-18 13:20:06.759535
NCT00853333|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2014-06-24|2013-08-23||November 2008||2008-11-01|June 2014|2014-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Sedation and Pain (The Effect of IV Sedation on Pain Perception)|Sedation and Pain (The Effect of IV Sedation on Pain Perception)|Completed||N/A|86|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-02-18 13:20:06.868169|2017-02-18 13:20:06.868169
NCT00853320|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-18|||February 2003||2003-02-01|October 2016|2016-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets|An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate the Relative Bioavailability of an Immediate Release Test Tablet Formulation of Oxycodone Hydrochloride (15 mg) Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Roxicodone™, 15 mg Tablet, Roxane Laboratories, Inc.) in Normal Human Subjects Under Fasting Conditions|Completed||Phase 1|38|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 13:20:07.256409|2017-02-18 13:20:07.256409
NCT00853307|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2013-11-15||2012-01-27|March 2009||2009-03-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|April 2010|Actual|2010-04-01||Interventional|||MLN8237 for Treatment of Patients With Ovarian, Fallopian Tube, or Peritoneal Carcinoma|A Phase 2 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in the Treatment of Patients With Platinum-Refractory or Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|31|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:20:07.350198|2017-02-18 13:20:07.350198
NCT00853294|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-18|||September 2003||2003-09-01|October 2016|2016-10-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension|An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate the Bioequivalence of an Extended Release Test Capsule Formulation of Chlorpheniramine Polistirex and Hydrocodone Polistirex Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Tussionex® Pennkinetic® Extended Release Oral Suspension, Celltech Pharmaceuticals, Inc.) in Normal Human Subjects Under Fasting Conditions|Completed||Phase 1|42|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 13:20:07.444429|2017-02-18 13:20:07.444429
NCT00853281|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2010-09-12|||March 2004||2004-03-01|September 2010|2010-09-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||A Cluster Randomized Trial to Evaluate Long Lasting Insecticidal Hammocks to Prevent Forest Malaria in Vietnam|A Cluster Randomized Trial to Evaluate the Effectiveness of Long Lasting Insecticidal Hammocks for Controlling Forest Malaria in Central Vietnam|Completed||N/A|18646|Actual|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||||2017-02-18 13:20:07.536954|2017-02-18 13:20:07.536954
NCT00853268|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-09-08|||April 2005||2005-04-01|September 2016|2016-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Fed Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets|An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate the Relative Bioavailability of a Controlled-Release Test Tablet Formulation of Oxycodone Hydrochloride (40 mg) Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (OxyContin® 40 mg, Purdue Pharma L.P.) in Normal Human Subjects Under Fed Conditions|Completed||Phase 1|34|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 13:20:07.663964|2017-02-18 13:20:07.663964
NCT00853255|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-12-31|||July 2010||2010-07-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults|Phase 1 Inpatient Study of the Safety and Immunogenicity of One Dose of Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/Chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H7N3 Infection in the Event of a Pandemic|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||f||||||||||2017-02-18 13:20:07.761758|2017-02-18 13:20:07.761758
NCT00853242|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2015-04-15|2015-04-15||February 2009||2009-02-01|April 2015|2015-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|LEAP|Safety Set included all randomized participants who received at least one dose of study drug.|Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Using Genz-644470 and Sevelamer Carbonate in Hyperphosphatemic Chronic Kidney Disease Patients on Hemodialysis|Completed||Phase 2|349|Actual|Sanofi||7|||f||||f||||||||||2017-02-18 13:20:07.885608|2017-02-18 13:20:07.885608
NCT00853229|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2013-08-22|||February 2009||2009-02-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Pregabalin for the Treatment of Vulvodynia|Pregabalin (Lyrica) for the Treatment of Vulvodynia: A Randomized, Double-blinded, Placebo-controlled Cross-over Study|Terminated||Phase 2|16|Actual|The Cleveland Clinic||2||Not feasible due to low accrual|f||||f||||||||||2017-02-18 13:20:10.160838|2017-02-18 13:20:10.160838
NCT00853216|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-18|||January 2003||2003-01-01|October 2016|2016-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets|An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate the Relative Bioavailability of an Immediate Release Test Tablet Formulation of Oxycodone Hydrochloride (30 mg) Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Roxicodone™, 30 mg Tablet, Roxane Laboratories, Inc.) in Normal Human Subjects Under Fasting Conditions|Completed||Phase 1|38|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 13:20:10.275943|2017-02-18 13:20:10.275943
NCT00853203|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-11-02|||January 2009||2009-01-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Observational|||Expressive Disclosure and Colorectal Cancer|Expressive Disclosure Program for Colorectal Cancer Patients|Active, not recruiting||N/A|174|Anticipated|M.D. Anderson Cancer Center|||3||f||||t||||||||||2017-02-18 13:20:10.384765|2017-02-18 13:20:10.384765
NCT00853190|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-18|||September 2003||2003-09-01|October 2016|2016-10-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension|An Open-Label, Randomized, Two-Period, Crossover Study to Evaluate the Bioequivalence of an Extended Release Test Capsule Formulation of Chlorpheniramine Polistirex and Hydrocodone Polistirex Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Tussionex® Pennkinetic® Extended Release Oral Suspension, Celltech Pharmaceuticals, Inc.) in Normal Human Subjects Under Fed Conditions|Completed||Phase 1|43|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 13:20:10.502848|2017-02-18 13:20:10.502848
NCT00853177|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-09-15|||November 2008||2008-11-01|May 2011|2011-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|KALOVAL||MEOPA Breathing Analgesia for Oocyte Retrieval(KALOVAL)|MEOPA Breathing Analgesia vs Local Anesthesia for Oocyte Retrieval in ART: a Prospective, Randomized Controlled Study|Completed||Phase 4|77|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:20:10.607801|2017-02-18 13:20:10.607801
NCT00853164|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2009-11-17|||July 2008||2008-07-01|November 2009|2009-11-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|MAP-P||A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)|A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy|Unknown status|Active, not recruiting|N/A|60|Anticipated|Washington University School of Medicine||3|||f||||f||||||||||2017-02-18 13:20:10.72786|2017-02-18 13:20:10.72786
NCT00853151|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-03-19|2011-09-15||February 2009||2009-02-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes|A Proof of Concept Study to Evaluate the Coadministration of TT223 Given Daily and LY2428757 Given Once-Weekly for Four Weeks in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|131|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 13:20:10.84823|2017-02-18 13:20:10.84823
NCT00853138|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-05-26|||May 2007||2007-05-01|May 2015|2015-05-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Web-based CBT for Children With Chronic Pain|Web-based CBT for Children With Chronic Pain|Completed||Phase 2|48|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-02-18 13:20:13.235915|2017-02-18 13:20:13.235915
NCT00853125|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2017-02-13|||February 2009||2009-02-01|May 2015|2015-05-01|February 22, 2014|Actual|2014-02-22|February 22, 2014|Actual|2014-02-22||Interventional|||Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer|Phase II Study of Sunitinib Plus Extended Courses of Irradiated Allogeneic Lymphocytes for Patients With Renal Cell Carcinoma (SPECIAL Trial)|Terminated||Phase 2|10|Actual|Rutgers, The State University of New Jersey||1||Slow accrual|f||||t||||||||||2017-02-18 13:20:13.336493|2017-02-18 13:20:13.336493
NCT00853112|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2012-03-27||2012-03-27|April 2009||2009-04-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension|A Phase 2a, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study Investigating The Dose-Response Of PF-00489791 On Acute Hemodynamics In Subjects With Idiopathic And Familial Pulmonary Hypertension|Terminated||Phase 2|44|Actual|Pfizer||7||See termination reason in detailed description.|f||||t||||||||||2017-02-18 13:20:13.454545|2017-02-18 13:20:13.454545
NCT00853099|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2014-09-03|2012-10-26||February 2009||2009-02-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|May 2011|Actual|2011-05-01||Interventional||1 participant in the adalimumab 160 mg/80 mg arm was incorrectly treated with open-label (rescue) study drug at Week 0, and was not included in Baseline Characteristics.|A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis|A Multi-Center, Randomized, Double-Blind, Placebo-controlled Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis.|Completed||Phase 3|274|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 13:20:13.638014|2017-02-18 13:20:13.638014
NCT00853086|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-27|2016-11-15|||January 2008||2008-01-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database|United Kingdom Haemophilia Centre Doctor's Organisation (UKHCDO) - Novo Nordisk Collaboration on NovoSeven® Post Marketing Follow-up Measures|Completed||N/A|139|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:20:14.99029|2017-02-18 13:20:14.99029
NCT00853073|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-11-20|2015-01-30||February 2009||2009-02-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|Avastin||Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?|Does a New Add on (or Adjunctive) Therapy Used in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?|Completed||Phase 2/Phase 3|63|Actual|Wills Eye||2|||f||||f||||||||No||2017-02-18 13:20:15.098291|2017-02-18 13:20:15.098291
NCT00853060|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-26|||March 2006||2006-03-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Observational|||Energy Expenditure in Weaning From Mechanical Ventilation|Energy Expenditure During Weaning From Mechanical Ventilation: Is There Any Difference Between Pressure Support and T-Tube?|Completed||N/A|40|Actual|Hospital de Clinicas de Porto Alegre|||1||f||||f||||||||||2017-02-18 13:20:15.524154|2017-02-18 13:20:15.524154
NCT00853047|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-04-01||2016-02-04|March 2009||2009-03-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy||Completed||Phase 2|23|Actual|Lexicon Pharmaceuticals||6|||f||||f||||||||||2017-02-18 13:20:15.605974|2017-02-18 13:20:15.605974
NCT00853034|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-26|||October 2006||2006-10-01|February 2009|2009-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Effects of Arabinoxylan-Oligosaccharides Compared to Other Prebiotics in Healthy Subjects|Effects of Arabinoxylan-Oligosaccharides on Colonic Metabolism and Microbial Composition Compared to Other Prebiotics in Healthy Subjects|Completed||Phase 4|20|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-02-18 13:20:15.873184|2017-02-18 13:20:15.873184
NCT00853021|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-07-28|2015-07-28||December 2005||2005-12-01|July 2015|2015-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney|Phase II Open Label Trial of rIL-2 and Bevacizumab Combination in Patients With Metastatic Clear Cell Renal Carcinoma|Completed||Phase 2|26|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:20:15.975942|2017-02-18 13:20:15.975942
NCT00853008|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2017-01-11|||January 2003||2003-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|LAL-AR/2003||Treatment of High Risk Adult Acute Lymphoblastic Leukemia|Treatment of High Risk Adult Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 4|100|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 13:20:16.388372|2017-02-18 13:20:16.388372
NCT00852995|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-09-13|2016-02-15||February 2009||2009-02-01|September 2016|2016-09-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|||Dose Finding Study of HP802-247 in Venous Leg Ulcers|A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers|Completed||Phase 2|228|Actual|Healthpoint||5|||f||||f||||||||||2017-02-18 13:20:16.545474|2017-02-18 13:20:16.545474
NCT00852982|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-02-27|||April 2006||2006-04-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|SMIDIG||Exercise Effects on Cardiovascular Risk Factors, Quality of Life, Muscle Function in Type 2 Diabetes and Healthy Persons|Exercise - Effects on Health Related Quality of Life, Cardiovascular Risk Factors, and Cellular Functions With Respect to Glucose Metabolism, in Type 2 Diabetes Mellitus, Impaired Glucose Tolerance and in Healthy Individuals.|Unknown status|Active, not recruiting|N/A|213|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 13:20:18.890458|2017-02-18 13:20:18.890458
NCT00852969|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2014-04-03|2013-11-27||August 2008||2008-08-01|April 2014|2014-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||These were the number of individuals who agreed to be randomized for the study|Niacin and Endothelial Function in Early CKD|Does Raising HDL-C With Niacin Improve Endothelial Function in Early CKD?|Completed||Phase 4|30|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-02-18 13:20:18.997725|2017-02-18 13:20:18.997725
NCT00852956|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-05-03|||February 2009||2009-02-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects|Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects|Completed||Phase 1|50|Anticipated|OBEcure Ltd.||2|||f||||f||||||||||2017-02-18 13:20:19.559461|2017-02-18 13:20:19.559461
NCT00852943|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2017-01-24|||February 24, 2009||2009-02-24|January 10, 2017|2017-01-10||||||||Observational|||Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation|Screening Protocol for Genetic Diseases of Allergic Inflammation and Mast Cell Homeostasis and Activation|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:20:19.659531|2017-02-18 13:20:19.659531
NCT00851955|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-01-11|||May 2007||2007-05-01|January 2016|2016-01-01|November 2011|Actual|2011-11-01|December 2009|Actual|2009-12-01||Observational|||Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer|Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer|Completed||N/A|150|Actual|Mayo Clinic|||3||f||||||||||||||2017-02-18 13:20:44.201782|2017-02-18 13:20:44.201782
NCT00852930|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-11-30|2015-07-17||September 2009||2009-09-01|November 2015|2015-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||breast cancer survivors with known lymphedema|Low Level Laser Treatment and Breast Cancer Related Lymphedema|Low Level Laser Treatment and Breast Cancer Related Lymphedema|Completed||Phase 4|50|Actual|Vanderbilt University||3|||f||||f||||||||||2017-02-18 13:20:19.773497|2017-02-18 13:20:19.773497
NCT00852917|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-04-25|2009-04-08||January 2003||2003-01-01|April 2012|2012-04-01||||August 2003|Actual|2003-08-01||Interventional|||A Four-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol Once a Day 100, 200 and 300 mg Versus Placebo for the Treatment of Pain Due to Osteoarthritis of the Knee (With 7-Day Follow-up)||Completed||Phase 3|552|Actual|Labopharm Inc.||4|||f||||||||||||||2017-02-18 13:20:20.589214|2017-02-18 13:20:20.589214
NCT00852904|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2017-01-24|||February 24, 2009||2009-02-24|August 23, 2016|2016-08-23||||||||Observational|||National Children s Health Study|Vanguard Phase of the National Children s Study|Completed||N/A|13700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:20:21.41345|2017-02-18 13:20:21.41345
NCT00852891|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-02-26|||December 2005||2005-12-01|February 2009|2009-02-01|August 2007|Actual|2007-08-01|||||Observational|||Cardiorespiratory Changes in Patients Being Weaned Off Mechanical Ventilation|Cardiorespiratory Changes in Patients Being Weaned Off Mechanical Ventilation: a Randomized Crossover Clinical Trial|Completed||N/A|24|Actual|Hospital de Clinicas de Porto Alegre|||1||f||||f||||||||||2017-02-18 13:20:21.506372|2017-02-18 13:20:21.506372
NCT00852878|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-06-19|||March 2009||2009-03-01|December 2010|2010-12-01||||January 2010|Anticipated|2010-01-01||Interventional|||The Treatment of Recurrent Abdominal Pain in Children|The Treatment of Recurrent Abdominal Pain in Children: A Comparison of Biofeedback and Behavioral Intervention|Withdrawn||N/A|0|Actual|Kaiser Permanente||2||Not enough interested participants|f||||f||||||||||2017-02-18 13:20:21.584902|2017-02-18 13:20:21.584902
NCT00852865|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-04-30|||February 2009||2009-02-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Lactobacillus Farciminis and Hyperalgesia|Effect of a Dialy Consumption of a Probiotic (Lactobacillus Farciminis) on Hyperalgesia in Response to Thermal Stimulation|Completed||Phase 1|48|Actual|Lallemand SAS||2|||f||||f||||||||||2017-02-18 13:20:21.686715|2017-02-18 13:20:21.686715
NCT00852852|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-04-30|||October 2008||2008-10-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|July 2011|Actual|2011-07-01||Interventional|ESRA-C_II||Computerized Assessment for Patients With Cancer|Computerized Assessment for Patients With Cancer-ESRA-C II|Completed||Phase 3|779|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 13:20:21.784201|2017-02-18 13:20:21.784201
NCT00852839|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2014-07-11||2011-08-04|February 2009||2009-02-01|July 2014|2014-07-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome|A Randomized, Double-Blind, Vehicle-Controlled, Parallel Arm Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome|Completed||Phase 2|140|Actual|Parion Sciences||2|||f||||f||||||||||2017-02-18 13:20:21.876439|2017-02-18 13:20:21.876439
NCT00852826|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-02-26|||January 2008||2008-01-01|February 2009|2009-02-01|November 2008||2008-11-01|||||Interventional|||Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy|Value of a Hemostatic and Sealing Agent for Preventing Seroma After Axillary Lymphadenectomy|Completed||Phase 4|60|Actual|Hospital Universitario Virgen de la Arrixaca||2|||f||||||||||||||2017-02-18 13:20:21.991424|2017-02-18 13:20:21.991424
NCT00852813|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-02-26|||October 2007||2007-10-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|||||Interventional|||Tolerance and Prebiotic Activity of Arabinoxylan-Oligosaccharides in Healthy Subjects|Tolerance and Prebiotic Activity of Arabinoxylan-Oligosaccharides in Healthy Subjects: a Randomized, Placebo-Controlled Cross-Over Study|Completed||Phase 4|20|Actual|Katholieke Universiteit Leuven|||||f||||t||||||||||2017-02-18 13:20:22.085221|2017-02-18 13:20:22.085221
NCT00852800|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2010-06-04|||March 2006||2006-03-01|June 2010|2010-06-01|March 2011|Anticipated|2011-03-01|August 2009|Actual|2009-08-01||Interventional|ALTERNATE||Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot Study|Effect of Intravenous Albumin (Standard vs Dose Reduced Regimen) On Renal Impairment and Mortality in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis: A Double Blind Randomized Clinical Trial|Unknown status|Enrolling by invitation|Phase 2|43|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 13:20:22.174118|2017-02-18 13:20:22.174118
NCT00852787|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-05-23|||April 2009||2009-04-01|December 2009|2009-12-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease|Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|National Institute on Aging (NIA)||4|||f||||f||||||||||2017-02-18 13:20:22.285842|2017-02-18 13:20:22.285842
NCT00852774|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2014-07-25|||May 2009||2009-05-01|July 2014|2014-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Steep Trendelenburg Positioning on Intra-Ocular Pressure During Surgery for Endometrial Robotics Versus Laparotomy|Effects of Steep Trendelenburg Positioning on Intra-Ocular Pressure During Surgery For Endometrial Cancer: Robotics Versus Laparotomy|Withdrawn||N/A|0|Actual|Ohio State University Comprehensive Cancer Center|||2|terminated due to low staffing|f||||f||||||||||2017-02-18 13:20:22.406083|2017-02-18 13:20:22.406083
NCT00852761|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-04-19|2010-11-04||March 2009||2009-03-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis|A Study to Evaluate Safety and Efficacy of Clobetasol Propionate for Treatment of Plaque-Type Psoriasis in Adult Subjects.|Completed||Phase 4|34|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:20:22.493755|2017-02-18 13:20:22.493755
NCT00851786|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2015-11-18|2012-09-07||April 2009||2009-04-01|November 2015|2015-11-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy|A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function|Completed||Phase 2|395|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:20:23.527976|2017-02-18 13:20:23.527976
NCT00851188|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2012-06-12|||January 2009||2009-01-01|June 2012|2012-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Internet Delivered Self-help for Insomnia||Completed||N/A|626|Actual|Utrecht University||3|||f||||t||||||||||2017-02-18 13:20:54.170341|2017-02-18 13:20:54.170341
NCT00851773|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2015-02-20|||February 2009||2009-02-01|February 2015|2015-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects|A Randomised, Double Blind, Placebo-controlled, Parallel-group, Multiple Doses, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics Profiles of NN9535 in Healthy Male Japanese and Caucasian Subjects After Weekly Subcutaneous Injections.|Completed||Phase 1|84|Actual|Novo Nordisk A/S||10|||f||||f||||||||||2017-02-18 13:20:24.696446|2017-02-18 13:20:24.696446
NCT00851760|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-08-03|||January 2005||2005-01-01|August 2009|2009-08-01|September 2007|Actual|2007-09-01|December 2006|Actual|2006-12-01||Interventional|||Epiretinal Macular Membrane and Cataract Extraction|Idiopathic Epiretinal Macular Membrane and Cataract Extraction : Combined vs Consecutive Surgery|Completed||N/A|174|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||t||||||||||2017-02-18 13:20:24.810279|2017-02-18 13:20:24.810279
NCT00851747|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2010-01-15|||February 2009||2009-02-01|January 2010|2010-01-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal||Terminated||N/A|25|Anticipated|The Cleveland Clinic||2|||f||||||||||||||2017-02-18 13:20:24.902692|2017-02-18 13:20:24.902692
NCT00851734|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2012-06-21|||February 2009||2009-02-01|June 2012|2012-06-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)|A Phase 1 Dose-Escalation Study To Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed By an Open-Label Evaluation of LX214 Ophthalmic Solution in Patients With Keratoconjunctivitis Sicca|Completed||Phase 1|35|Actual|Lux Biosciences, Inc.||3|||f||||f||||||||||2017-02-18 13:20:24.995467|2017-02-18 13:20:24.995467
NCT00851721|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-10-28|2014-01-30||March 2009||2009-03-01|October 2016|2016-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor|FEIBA NF: A Prospective, Open-label, Randomized, Parallel Study to Evaluate the Efficacy and Safety of Prophylactic Versus On-Demand Treatment in Subjects With Hemophilia A or B and a High Titer Inhibitor|Completed||Phase 3|52|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-02-18 13:20:25.131732|2017-02-18 13:20:25.131732
NCT00851708|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-27||||||February 2009|2009-02-01||||||||Interventional|||Impact of N-Acetylcysteine on Oxidative Stress and Renal Function in Deceased Kidney Transplant Recipients|Oxidative Stress and Postoperatory Renal Function in Deceased Kidney Transplantation|Completed||N/A|||University of Sao Paulo||2|||f||||f||||||||||2017-02-18 13:20:27.606552|2017-02-18 13:20:27.606552
NCT00851695|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2012-08-10|||July 2007||2007-07-01|August 2012|2012-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Examining the Role of Vitamin D in Asthma and Chronic Obstructive Pulmonary Disease (COPD)|Vitamin D in Obstructive Lung Diseases|Completed||N/A|2266|Actual|Brigham and Women's Hospital|||3||f||||f||||||Samples With DNA|"~     Serum samples~   "|||2017-02-18 13:20:27.696843|2017-02-18 13:20:27.696843
NCT00851682|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2015-10-14|2015-09-08||January 2009||2009-01-01|October 2015|2015-10-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma|Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma|Terminated||N/A|65|Actual|Washington University School of Medicine||2||Enrollment was stopped and will not resume. Participants are no longer being examined.|f||||f||||||||||2017-02-18 13:20:27.787097|2017-02-18 13:20:27.787097
NCT00851669|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2013-07-12|||April 2009||2009-04-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|MEADOW/Bridge||The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)|Behavioral Treatment for Alcohol Dependent Women With Co-occurring Depression|Completed||Phase 2|91|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 13:20:28.163952|2017-02-18 13:20:28.163952
NCT00851656|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-25|||May 2008||2008-05-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||MilkScreen Home Test for Alcohol in Breast Milk|MilkScreen Home Test for Alcohol in Breast Milk Clinical Study|Completed||N/A|48|Actual|UpSpring Baby, Ltd.|||1||f||||f||||||||||2017-02-18 13:20:28.274661|2017-02-18 13:20:28.274661
NCT00851643|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-02-02|2011-02-10||April 2006||2006-04-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|December 2007|Actual|2007-12-01||Interventional|||Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)|A Randomized, Double-Blind, Multicenter, Biphasic, Controlled With GARDASIL™ Dose-Escalation Study of Octavalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Adjuvanted With Amorphous Aluminum Hydroxyphosphate Sulfate (AAHS) and ISCOMATRIX™ (IMX)|Completed||Phase 1|158|Actual|Merck Sharp & Dohme Corp.||6|||f||||t||||||||||2017-02-18 13:20:28.350918|2017-02-18 13:20:28.350918
NCT00851630|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2010-05-02|2009-03-15||June 2004||2004-06-01|May 2010|2010-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|THIRST||Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)|A Pilot Study Of Open-Label Fixed Dose Combination Zidovudine/Lamivudine/Abacavir In HIV-Infected Persons With Tuberculosis In Moshi, Tanzania; Tuberculosis And HIV Immune Reconstitution Syndrome Trial (THIRST)|Completed||Phase 4|70|Actual|Duke University||2|||f||||t||||||||||2017-02-18 13:20:29.176918|2017-02-18 13:20:29.176918
NCT00852748|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2010-10-07|||January 2009||2009-01-01|February 2009|2009-02-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Observational|||Validation of Venogenic Hypothesis for Cough, Exertional and Sexual Headaches||Completed||N/A|50|Anticipated|French Society for the Study of Migraine Headache|||1||f||||f||||||||||2017-02-18 13:20:29.73507|2017-02-18 13:20:29.73507
NCT00852735|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2010-03-09|||December 2008||2008-12-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of the Antioxidant Micronutrients of Rapeseed Oil on the Prevention of Cardiovascular Diseases (Optim'Oils)|Effect of the Antioxidant Micronutrients of Rapeseed Oil on the Prevention of Cardiovascular Diseases|Completed||N/A|60|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:20:29.803685|2017-02-18 13:20:29.803685
NCT00852722|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-02-02|||February 2009||2009-02-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|MS||Low Fat Diet and Multiple Sclerosis|A Randomized, Controlled Study of Diet and Multiple Sclerosis|Completed||Phase 1|61|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 13:20:29.904698|2017-02-18 13:20:29.904698
NCT00852709|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2010-09-21|||September 2007||2007-09-01|September 2010|2010-09-01||||January 2010|Anticipated|2010-01-01||Interventional|POE07-01||Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias|Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 13:20:30.014211|2017-02-18 13:20:30.014211
NCT00852696|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-02-08|||February 2008||2008-02-01|February 2012|2012-02-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|||Over Active Bladder Patients Having Sling Surgery|A Double Blind, Randomized Placebo Controlled Trial of the Perioperative Use of Solifenacin in the Management of Postoperative Overactive Bladder Symptoms in Patients With Mixed Incontinence Undergoing Suburethral Sling Procedures.|Completed||Phase 4|11|Actual|Cleveland Clinic Florida||2|||f||||f||||||||||2017-02-18 13:20:30.129954|2017-02-18 13:20:30.129954
NCT00852683|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2014-03-05|||May 2008||2008-05-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional|||The Effects of Peri-Operative Pregabalin on Post-Operative Pain Following Breast Cancer Surgery With Axillary Node Dissection: A Pilot Study||Completed||Phase 3|70|Anticipated|Nova Scotia Health Authority||2|||f||||||||||||||2017-02-18 13:20:30.228457|2017-02-18 13:20:30.228457
NCT00852670|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-11-11|||October 2008||2008-10-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||ACT-128800 in Psoriasis|Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IIa Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800, an S1P1 Receptor Agonist, Administered for 6 Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|66|Actual|Actelion||2|||f||||t||||||||||2017-02-18 13:20:30.333044|2017-02-18 13:20:30.333044
NCT00852657|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2017-02-07|||September 2004||2004-09-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Comparison of Tendon Repair and Physiotherapy in the Treatment of Small and Medium-sized Tears of the Rotator Cuff|Comparison of Surgical Treatment by Tendon Repair and Physiotherapy in the Treatment of Small and Medium-sized Tears of the Rotator Cuff|Active, not recruiting||N/A|103|Actual|Martina Hansen's Hospital||2|||f||||f||||||||||2017-02-18 13:20:30.442306|2017-02-18 13:20:30.442306
NCT00852644|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-03-16|||January 2009||2009-01-01|March 2016|2016-03-01|March 2018|Anticipated|2018-03-01|June 2013|Actual|2013-06-01||Interventional|||Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer|Feasibility and Outcome of Cyberknife® Precision Hypofractionated Radiosurgery for the Curative Management of Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1|36|Anticipated|Boston Medical Center||1|||f||||t||||||||||2017-02-18 13:20:30.54386|2017-02-18 13:20:30.54386
NCT00852631|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-06-12|2011-05-18||February 2009||2009-02-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Seroquel XR in Adults With Schizophrenia|Open-label Multicentre Study on Efficacy and Safety of Oral Quetiapine (Seroquel XR) in Adults With Schizophrenia|Terminated||Phase 3|28|Actual|AstraZeneca||1||The study was prematurely terminated due to insufficient recruitment.|f||||f||||||||||2017-02-18 13:20:30.810074|2017-02-18 13:20:30.810074
NCT00852618|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-06-08|||May 2008||2008-05-01|June 2015|2015-06-01|September 2008|Actual|2008-09-01|||||Observational|||Intensive Viral Dynamics Substudy of A5248|Intensive Viral Dynamics Substudy of A5248|Completed||N/A|11|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples Without DNA|"~     Plasma samples will be collected throughout the study~   "|||2017-02-18 13:20:31.063527|2017-02-18 13:20:31.063527
NCT00852605|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-02-26|||December 2001||2001-12-01|February 2009|2009-02-01||||August 2005|Actual|2005-08-01||Interventional|||Acute Lung Injury After Allogeneic Transplantation - Diagnosis and Early Treatment|A Randomized Clinical Trial on the Use of Early Intermittent Non-Invasive Ventilation in Patients Suffering From Acute Lung Injury After Allogeneic Transplantation|Completed||Phase 1/Phase 2|86|Actual|Technische Universität Dresden||2|||f||||||||||||||2017-02-18 13:20:31.174438|2017-02-18 13:20:31.174438
NCT00852592|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-09-20|2016-02-19||May 2009||2009-05-01|September 2016|2016-09-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial|Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial|Completed||Phase 3|46|Actual|Northwestern University||2|||f||||t||||||||Undecided|We can share data if approached by other investigators|2017-02-18 13:20:31.26063|2017-02-18 13:20:31.26063
NCT00852579|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2011-10-18|||March 2009||2009-03-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effects of Macrolides on Asthma Control|Effects of Macrolides on Asthma Control, Airway Inflammation and Bacterial Colonisation in Smokers With Asthma.|Completed||Phase 3|77|Actual|University of Glasgow||2|||f||||t||||||||||2017-02-18 13:20:31.715379|2017-02-18 13:20:31.715379
NCT00852566|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-02-04|||March 2009||2009-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|February 2011|Actual|2011-02-01||Interventional|NordCML006||Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia|An Open-Label, Randomized, Multicenter Phase II Trial Comparing the Depletion of Malignant Stem Cells With Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid|Completed||Phase 2|46|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 13:20:31.818596|2017-02-18 13:20:31.818596
NCT00852553|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-07-23|||February 2003||2003-02-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Neurohumoral Control of Intestinal Electrical and Mechanical Activity|Neurohumoral Control of Intestinal Electrical and Mechanical Activity|Completed||N/A|45|Actual|University of California, Davis|||1||f||||f||||||Samples Without DNA|"~     jejunum~   "|||2017-02-18 13:20:31.938131|2017-02-18 13:20:31.938131
NCT00852540|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-11-30|2011-07-28||April 2009||2009-04-01|November 2016|2016-11-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA|A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 3|410|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:20:32.044944|2017-02-18 13:20:32.044944
NCT00852527|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2015-04-06|2014-11-04||June 2009||2009-06-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|TBI|Number of participants consented and enrolled.|Evaluation of VA's Traumatic Brain Injury (TBI) Clinical Reminder and Comprehensive TBI Evaluation (CTBIE)|Evaluation of VA's TBI Clinical Reminder And Secondary Level Evaluation|Completed||N/A|456|Actual|VA Office of Research and Development|||2||f||||f||||||||||2017-02-18 13:20:32.941899|2017-02-18 13:20:32.941899
NCT00852514|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-02-26|||September 2006||2006-09-01|February 2009|2009-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis|The Optimization of Blood Pressure and Fluid Status Control With Eight-Polar Bioelectrical Impedance Analysis|Completed||Phase 4|132|Actual|Taipei Veterans General Hospital, Taiwan||1|||f||||t||||||||||2017-02-18 13:20:33.220558|2017-02-18 13:20:33.220558
NCT00852501|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2013-04-08|||March 2006||2006-03-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Characterization of Receptors in Non-functioning Pituitary Macroadenomas|Characterization of Receptors Present in Non-functioning Pituitary Macroadenomas by Reverse Transcriptase- Polymerase Chain Reaction (RT-PCR)|Unknown status|Recruiting|Phase 4|100|Anticipated|John H. Stroger Hospital|||1||f||||f||||||Samples Without DNA|"~     A small piece of the pituitary macradenoma removed at surgery will be frozen to perform~     RT-PCR~   "|||2017-02-18 13:20:33.435687|2017-02-18 13:20:33.435687
NCT00852488|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2010-02-12|||March 2009||2009-03-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Medium-term Venous Access in Congenital Heart Surgery|A Medium-term Venous Access Alternative in Infants Undergoing Congenital Heart Surgery|Completed||N/A|50|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 13:20:33.554844|2017-02-18 13:20:33.554844
NCT00852475|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-12-07|2014-12-22||February 2010||2010-02-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MUFAPUFA||Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome|Comparative Effects of Two Popular Diets in Veterans With the Metabolic Syndrome|Completed||N/A|46|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 13:20:33.66413|2017-02-18 13:20:33.66413
NCT00852462|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-10-19|||May 2008||2008-05-01|October 2016|2016-10-01|June 2016|Actual|2016-06-01|August 2012|Actual|2012-08-01||Interventional|||Lung Cancer Symptom Assessment and Management Intervention|Lung Cancer Symptom Assessment and Management Intervention|Completed||Phase 2|179|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 13:20:34.05289|2017-02-18 13:20:34.05289
NCT00852449|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2012-10-04|||May 2008||2008-05-01|October 2012|2012-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Intraoperative Hypovolemia and Fluid Therapy|Restrictive Versus Liberal Intraoperative Goal-directed Fluid Management During Major Abdominal Surgery:a Prospective Randomized Study|Terminated||Phase 4|70|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-02-18 13:20:34.166474|2017-02-18 13:20:34.166474
NCT00852436|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-06-01|||February 2009||2009-02-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|Pregabalin-Dao||Pregabalin and Orofacial Neuropathic Pain|Efficacy of Pregabalin in the Treatment of Orofacial Neuropathic Pain|Terminated||Phase 2|1|Actual|University of Toronto||2||difficulty to recruit patients|f||||f||||||||||2017-02-18 13:20:34.257081|2017-02-18 13:20:34.257081
NCT00852423|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-03-11|||June 2010||2010-06-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|October 2013|Actual|2013-10-01||Interventional|PREGACT||Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria|Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria|Completed||Phase 3|3428|Actual|Institute of Tropical Medicine, Belgium||4|||f||||t||||||||||2017-02-18 13:20:34.373214|2017-02-18 13:20:34.373214
NCT00852410|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2010-06-29|||March 2009||2009-03-01|June 2010|2010-06-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||The Hemostatic and Hemodynamic Effects of Adrenaline During Endoscopic Sinus Surgery|The Hemostatic and Hemodynamic Effects of Adrenaline During Endoscopic Sinus Surgery: Randomized Clinical Trial|Unknown status|Not yet recruiting|Phase 3|140|Anticipated|University of Toronto||2|||f||||f||||||||||2017-02-18 13:20:34.50419|2017-02-18 13:20:34.50419
NCT00852397|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2013-08-27|2013-06-04||April 2009||2009-04-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients|A Phase 2, Placebo-Controlled, Randomized, Double-Blinded, Multicenter, Study To Evaluate The Bleeding Profile Of 2.5 Mg And 5.0 Mg BID Apixaban In Combination With Standard Therapy In Patients With Recent (≤7 Days) Acute Coronary Syndrome (ACS)|Terminated||Phase 2|151|Actual|Pfizer||3||See termination reason in detailed description.|f||||t||||||||||2017-02-18 13:20:34.615328|2017-02-18 13:20:34.615328
NCT00852384|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2009-08-27|||February 2009||2009-02-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Non Invasive Pressure Support Ventilation (NIPPV) Versus Recruitment Maneuver (RM) and Preoxygenation|Non Invasive Pressure Support Ventilation (NIPPV) Versus Conventionnal Approach and Early Recruitment Maneuver (RM) for Preoxygenation of Morbidly Obese Patient|Completed||Phase 4|60|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:20:35.291976|2017-02-18 13:20:35.291976
NCT00852371|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2017-01-25|||February 2008||2008-02-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Intermittent Preventive Treatment of Malaria in Schoolchildren|IPT in Schoolchildren: Comparison of the Efficacy, Safety, and Tolerability of Antimalarial Regimens in Uganda|Completed||Phase 3|760|Anticipated|London School of Hygiene and Tropical Medicine||4|||f||||t||||||||||2017-02-18 13:20:35.385156|2017-02-18 13:20:35.385156
NCT00852358|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-01-22|||June 2009||2009-06-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I|A Study of Intrathecal Enzyme Replacement for Cognitive Decline in Mucopolysaccharidosis I|Completed||N/A|9|Actual|Dickson, Patricia I., M.D.||2|||f||||t||||||||No||2017-02-18 13:20:35.50108|2017-02-18 13:20:35.50108
NCT00852345|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2015-04-02||||||March 2015|2015-03-01||||||||Expanded Access|||Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy|Clofazamine in the Long Term Treatment of Leprosy, Phase III|No longer available||N/A|||Kaiser Permanente|||||||||||||||||||2017-02-18 13:20:37.909832|2017-02-18 13:20:37.909832
NCT00851175|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-09-30|||March 2009||2009-03-01|March 2009|2009-03-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?|Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?|Completed||Phase 4|8|Anticipated|Radboud University||4|||f||||f||||||||||2017-02-18 13:20:54.262533|2017-02-18 13:20:54.262533
NCT00852332|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-26|2016-07-28|||August 2009||2009-08-01|July 2016|2016-07-01||||January 2017|Anticipated|2017-01-01||Interventional|||Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer|An Open-label, Randomised, Phase II Study of Docetaxel in Combination With a Dietary Phytonutrient in First or Second Line Treatment for Patients With HER2 Negative Locally Advanced or Metastatic Breast Cancer, or Loco-regional Recurrence Not Amenable to Treatment by Surgery or Radiotherapy.|Recruiting||Phase 2|100|Anticipated|Centre Jean Perrin||2|||f||||||||||||||2017-02-18 13:20:38.026361|2017-02-18 13:20:38.026361
NCT00852319|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-01-13|||February 2009||2009-02-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|IPC-M||Interpregnancy Care Project-Mississippi (IPC-M)|Interpregnancy Care Project-Mississippi|Completed||N/A|264|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-02-18 13:20:38.139977|2017-02-18 13:20:38.139977
NCT00852306|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-10-08|||February 2009||2009-02-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|February 2011|Actual|2011-02-01||Interventional|||A Comparison of Two Freezing Techniques|A Comparison of Two Freezing Techniques|Completed||N/A|18|Actual|Northwell Health||2|||f||||f||||||||||2017-02-18 13:20:38.253108|2017-02-18 13:20:38.253108
NCT00852293|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-25|||March 2009||2009-03-01|February 2009|2009-02-01|March 2014|Anticipated|2014-03-01|March 2010|Anticipated|2010-03-01||Observational|||The Connection Between Liver Disease and Chitinase Proteins|The Connection Between Liver Disease and Chitinase Proteins|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||||||||Samples Without DNA|"~     Blood tests are taken to determin Chitinase 3 like-1 protein levels.~   "|||2017-02-18 13:20:38.372824|2017-02-18 13:20:38.372824
NCT00852280|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-06-06|||December 2008||2008-12-01|July 2010|2010-07-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Effects of Pulsed-Dyed Laser on Scar Formation|Effects of Pulsed-Dyed Laser on Scar Formation|Completed||N/A|17|Actual|Shriners Hospitals for Children||1|||f||||f||||||||||2017-02-18 13:20:38.47149|2017-02-18 13:20:38.47149
NCT00852267|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2011-10-04|||January 2008||2008-01-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Lipoprotein Effects of Substituting Beef Protein for Carbohydrate|Lipoprotein Effects of Substituting Beef Protein for Carbohydrate|Completed||N/A|40|Anticipated|Children's Hospital & Research Center Oakland||3|||f||||f||||||||||2017-02-18 13:20:38.556934|2017-02-18 13:20:38.556934
NCT00852254|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-05-25|||June 2008||2008-06-01|May 2016|2016-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children|Validation of a Novel, Minimally Invasive Ultrasound Indicator Dilution Technique for Measuring Cardiac Index in Critically Ill Children|Completed||N/A|9|Actual|Transonic Systems Inc.|||1||f||||f||||||||No||2017-02-18 13:20:38.664615|2017-02-18 13:20:38.664615
NCT00852241|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2010-01-15|||February 2009||2009-02-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study||Completed||N/A|25|Anticipated|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 13:20:38.750427|2017-02-18 13:20:38.750427
NCT00852228|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2013-12-10|||July 2008||2008-07-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|March 2012|Actual|2012-03-01||Interventional|OPTILIV||Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy|Optimal Control of Liver Metastases With Intravenous Cetuximab and Hepatic Artery Infusion of Three-drug Chemotherapy in Patients With Liver-only Metastases From Colorectal Cancer. A European Multicenter Phase II Trial|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Association pour la Recherche sur le Temps Biologique et la Chronothérapie||2|||f||||t||||||||||2017-02-18 13:20:38.833397|2017-02-18 13:20:38.833397
NCT00852215|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-25|||August 2008||2008-08-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|July 2009|Anticipated|2009-07-01||Interventional|COPE||Do Cobalt Chrome Stent and Paclitaxel-Eluting Stent Have Equivalent Clinical Result in Non-Complex Lesion?|Do Cobalt Chrome Stent and Paclitaxel-Eluting Stent Have Equivalent Clinical Result in Non-Complex Lesion? (COPE Study): Long-Term Follow-up Study|Unknown status|Recruiting|Phase 4|500|Anticipated|Samsung Medical Center||2|||f||||||||||||||2017-02-18 13:20:41.080012|2017-02-18 13:20:41.080012
NCT00852202|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2011-07-06||2011-07-06|June 2009||2009-06-01|July 2011|2011-07-01||||June 2010|Actual|2010-06-01||Interventional|||Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression|A Double-blind, Placebo-controlled Study of RGH-188 (Cariprazine) in Bipolar Depression|Completed||Phase 2|234|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 13:20:41.190636|2017-02-18 13:20:41.190636
NCT00852189|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-08-07|||April 2009||2009-04-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Study of EC0489 for the Treatment of Refractory or Metastatic Tumors|A Phase I Study of EC0489 Administered Weeks 1 and 3 of a 4-Week Cycle|Completed||Phase 1|65|Actual|Endocyte||1|||f||||f||||||||||2017-02-18 13:20:41.307971|2017-02-18 13:20:41.307971
NCT00852176|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2017-02-06|||May 2009||2009-05-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|May 2020|Anticipated|2020-05-01||Observational|||Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System|Best Vascular P000018 Post-approval Study: Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System|Recruiting||N/A|200|Anticipated|Best Vascular, Inc.|||1||f||||t||||||||Undecided||2017-02-18 13:20:41.406777|2017-02-18 13:20:41.406777
NCT00852163|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2013-04-01|||March 2007||2007-03-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen|Phase II Trial of Clofarabine With Parenteral Busulfan (Busulfex®) Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases|Completed||Phase 2|20|Actual|Baylor Research Institute||1|||f||||t||||||||||2017-02-18 13:20:41.501862|2017-02-18 13:20:41.501862
NCT00852150|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-06-05|||March 2009||2009-03-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Is a Reporting System for Gastritis or Duodenitis (Modified Lanza Scale) Reproducible?|Reproducibility of Modified Lanza Scale for the Reporting of Gastritis and Duodenitis|Completed||Phase 4|200|Anticipated|Ruttonjee Hospital|||1||f||||f||||||||||2017-02-18 13:20:41.613022|2017-02-18 13:20:41.613022
NCT00851942|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2010-02-24|||September 2008||2008-09-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test|Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test|Unknown status|Active, not recruiting|Phase 4|240|Anticipated|Cardiff University||1|||f||||f||||||||||2017-02-18 13:20:44.295989|2017-02-18 13:20:44.295989
NCT00852137|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-22|2015-02-18|2012-02-21||March 2009||2009-03-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis|A Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis|Completed||Phase 2|16|Actual|Peplin||2|||f||||f||||||||||2017-02-18 13:20:41.693764|2017-02-18 13:20:41.693764
NCT00852124|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-06-22|2014-12-02||February 2007||2007-02-01|June 2015|2015-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Zero participants analyzed for the primary outcome due to early termination of study|Safety of VSL#3 in Adult Asthmatics|Safety of VSL#3 for Adult Asthmatics|Terminated||Phase 1/Phase 2|3|Actual|University of Maryland|Early termination due to small number of persons recruited before PI relocated.|2||Inadequate recruitment|f||||t||||||||||2017-02-18 13:20:42.387226|2017-02-18 13:20:42.387226
NCT00852111|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2017-01-24|||February 23, 2009||2009-02-23|August 12, 2016|2016-08-12||||||||Observational|||Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy|Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy|Recruiting||N/A|292|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:20:42.785507|2017-02-18 13:20:42.785507
NCT00852098|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-25|||November 1997||1997-11-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|January 2000|Actual|2000-01-01||Interventional|||Laparoscopic Nissen Fundoplication Comparing Division Versus Non-Division of Short Gastric Vessels|Randomized Clinic Trial of Total Fundoplication and Fundal Mobilization With or Without Division of Short Gastric Vessels: Long-Term Endoscopic Evaluation|Completed||N/A|2|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 13:20:42.896431|2017-02-18 13:20:42.896431
NCT00852085|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-25|||October 2005||2005-10-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|RYDD||Reducing Youthful Dangerous Driving||Unknown status|Active, not recruiting|Phase 1/Phase 2|482|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-02-18 13:20:43.012617|2017-02-18 13:20:43.012617
NCT00852072|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2017-02-13|||March 2016||2016-03-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|March 2018|Anticipated|2018-03-01||Interventional|||Randomized Trial Comparing Sphincteroplasty and Lithotripsy for Extraction of Large Bile Duct Stones|Randomized Trial Comparing the Use of Single-operator Peroral Cholangioscopy-guided Laser Lithotripsy (POC-LL) Versus Endoscopic Balloon Sphincteroplasty (EBS) for Removal of Difficult Bile Duct Stones|Recruiting||N/A|82|Anticipated|Florida Hospital||2|||f||||f||||||||Yes|A manuscript will be developed when the study is complete.|2017-02-18 13:20:43.095584|2017-02-18 13:20:43.095584
NCT00852059|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2014-05-06|||March 2009||2009-03-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ASTA||Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA)|Effect of Methylphenidate Formulation on ADHD-patients` Adherence to Medical Treatment. A Comparison of Medikinet Retard® (ER) Once Daily and Medikinet® (IR) Twice Daily in Children and Adolescents Diagnosed With ADHD|Terminated||Phase 4|32|Actual|Johannes Gutenberg University Mainz||2||Diffculties to recruit anticipated study size, now analysis|f||||f||||||||||2017-02-18 13:20:43.204598|2017-02-18 13:20:43.204598
NCT00852046|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2011-10-05|||February 2009||2009-02-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement|Adjunct Dexmedetomidine Therapy Impact on Sedative and Analgesic|Withdrawn||Phase 4|0|Actual|Avera McKennan Hospital & University Health Center||3||PI resigned.|f||||t||||||||||2017-02-18 13:20:43.31102|2017-02-18 13:20:43.31102
NCT00852033|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-24|||January 2004||2004-01-01|February 2009|2009-02-01|July 2009|Anticipated|2009-07-01|June 2007|Actual|2007-06-01||Interventional|Transitions||Alcohol Early Intervention for Freshmen|Alcohol Early Intervention for Freshmen|Unknown status|Active, not recruiting|N/A|1014|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||4|||f||||t||||||||||2017-02-18 13:20:43.406393|2017-02-18 13:20:43.406393
NCT00852020|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2017-01-30|||April 2009||2009-04-01|January 2017|2017-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients|Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in CHF and COPD Patients. A Randomised, Double-blind and Controlled Pilot Study.|Completed||N/A|60|Actual|Fresenius Kabi||2|||f||||||||||||||2017-02-18 13:20:43.514419|2017-02-18 13:20:43.514419
NCT00852007|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-09-13|||February 2009||2009-02-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2014|Actual|2014-02-01||Interventional|MUC1||A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1|A Phase I/II Study Evaluating the Safety and Efficacy of Vaccination With Autologous Dendritic Cells Loaded With Tn-MUC1 Peptide in Patients With Non-Metastatic Androgen Independent Prostatic Adenocarcinoma.|Completed||Phase 1/Phase 2|20|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 13:20:43.616012|2017-02-18 13:20:43.616012
NCT00851994|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-10-31|||July 2008||2008-07-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Urine Proteome of Patients Having Surgery|Urine Proteome of Patients Undergoing Surgery|Completed||N/A|274|Actual|Washington University School of Medicine|||1||f||||f||||||Samples With DNA|"~     We are collecting urine and blood samples.~   "|||2017-02-18 13:20:43.715507|2017-02-18 13:20:43.715507
NCT00851981|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2010-09-09|||October 2008||2008-10-01|September 2010|2010-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|RCT SAMe||Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver Disease|Effect of Oral S-Adenosylmethionine Administration on Abnormalities of Hepatic Methionine Metabolism and Disease Progression in Alcoholic Liver Disease. A Randomized, Double Blind, Placebo-controlled Trial|Completed||Phase 2|60|Anticipated|Loma Linda University||2|||f||||f||||||||||2017-02-18 13:20:43.791126|2017-02-18 13:20:43.791126
NCT00851968|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-03-30|||December 2008||2008-12-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy|A Prospective Randomized Controlled Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy|Completed||N/A|320|Actual|Eastern Hepatobiliary Surgery Hospital||3|||f||||t||||||||||2017-02-18 13:20:43.900003|2017-02-18 13:20:43.900003
NCT00851929|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-25|||November 2008||2008-11-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension|Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension|Unknown status|Recruiting|Phase 2/Phase 3|24|Anticipated|Medical University of South Carolina||1|||f||||f||||||||||2017-02-18 13:20:44.399977|2017-02-18 13:20:44.399977
NCT00851916|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2014-03-13|||February 2009||2009-02-01|March 2014|2014-03-01||||February 2020|Anticipated|2020-02-01||Interventional|||CyberKnife Radiosurgery for Locally Recurrent Prostate CA|VIRTUAL HDR CYBERKNIFE RADIOSURGERY FOR LOCALLY RECURRENT PROSTATIC CARCINOMA: A PHASE II STUDY|Recruiting||Phase 2|20|Anticipated|CyberKnife Centers of San Diego||1|||f||||f||||||||||2017-02-18 13:20:44.510824|2017-02-18 13:20:44.510824
NCT00851903|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-09-03|2012-09-03||June 2009||2009-06-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial|Combination Therapy of Insulin Glargine and Sitagliptin in Patients With Type 2 Diabetes Not Adequately Controlled by a Previous Treatment With Metformin and Either Insulin Glargine or Sitagliptin|Completed||Phase 3|112|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:20:44.619173|2017-02-18 13:20:44.619173
NCT00851890|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2014-12-29|2014-12-29||March 2009||2009-03-01|December 2014|2014-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||Baseline characteristics were summarized by treatment group for all participants who received at least 1 dose of study drug. The treatment groups were compared with 1-way analysis of variance (ANOVA).|A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection|A Blinded, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection|Completed||Phase 2|30|Actual|AbbVie||4|||f||||f||||||||||2017-02-18 13:20:44.999727|2017-02-18 13:20:44.999727
NCT00851877|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2015-05-29|||March 2009||2009-03-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Cisplatin, and Cetuximab Given Together With Radiation Therapy in Treating Patients With Locally Advanced Stage III or Stage IV Head and Neck Cancer|A Phase I/II Study of Nab-paclitaxel, Cisplatin and Cetuximab With Concurrent Radiation Therapy for Local-regionally Advanced Head-and-neck Squamous Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|80|Anticipated|University of Texas Southwestern Medical Center||1|||f||||||||||||||2017-02-18 13:20:46.093944|2017-02-18 13:20:46.093944
NCT00851864|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2013-08-14|||October 2007||2007-10-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|October 2010|Actual|2010-10-01||Interventional|||Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing|Weight-Adjusted Dosing of Tinzaparin in Pregnancy|Completed||Phase 4|13|Actual|University of Calgary||1|||f||||t||||||||||2017-02-18 13:20:46.214301|2017-02-18 13:20:46.214301
NCT00851851|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-07-18|||January 2009||2009-01-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Observational|RTMKF||New Non-invasive Methods for Real-time Monitoring of Organ Function.|New Non-invasive Methods for Real-time Monitoring of Organ Function.|Completed||N/A|641|Actual|Washington University School of Medicine|||1||f||||f||||||Samples With DNA|"~     Urine and blood samples~   "|||2017-02-18 13:20:46.330222|2017-02-18 13:20:46.330222
NCT00851838|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2013-03-25|||June 2009||2009-06-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis|Phase 2 Study of Dialysis Efficiency and Tolerability of Peritoneal Dialysis Solution Containing Glucose Plus L-Carnitine in APD (Automated Peritoneal Dialysis) Treated Uremic Patients|Completed||Phase 2|5|Actual|Iperboreal Pharma Srl||1|||f||||f||||||||||2017-02-18 13:20:46.605998|2017-02-18 13:20:46.605998
NCT00851825|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-05-07|||March 2003||2003-03-01|May 2009|2009-05-01|June 2007|Actual|2007-06-01|||||Observational|||Heart Rate Variability During Weaning From Mechanical Ventilation|The Effect of T-Tube and Pressure Support on Cardiorespiratory Variables and Heart Rate Variability During Weaning From Mechanical Ventilation|Completed||N/A|30|Actual|Hospital de Clinicas de Porto Alegre|||1||f||||f||||||||||2017-02-18 13:20:46.714249|2017-02-18 13:20:46.714249
NCT00851812|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-05-10|||May 2007||2007-05-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Exercise for Breast Cancer Patients (EXCAP)|Aerobic and Resistance Exercise for Cancer Treatment-Related Fatigue|Active, not recruiting||N/A|114|Anticipated|University of Rochester||2|||f||||t||||||||||2017-02-18 13:20:46.801145|2017-02-18 13:20:46.801145
NCT00851799|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2015-12-09|2015-11-04||June 2009||2009-06-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational||All eligible participants were included in the baseline characteristics.|Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters|Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257|Completed||N/A|334|Actual|AIDS Clinical Trials Group|||3||f||||||||||Samples Without DNA|"~     Blood and urine samples will be collected and stored~   "|||2017-02-18 13:20:46.928231|2017-02-18 13:20:46.928231
NCT00851617|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-03-05|||August 2004||2004-08-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|March 2005|Actual|2005-03-01||Interventional|||Does Threshold IMT Influence Weaning?|Is Threshold IMT Useful To Accelerate Weaning From Mechanical Ventilation?|Completed||N/A|92|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 13:20:48.441107|2017-02-18 13:20:48.441107
NCT00851604|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2010-06-02|||March 2009||2009-03-01|May 2010|2010-05-01|January 2011|Anticipated|2011-01-01|March 2010|Anticipated|2010-03-01||Observational|||ProGRP, CgA, NSE and TUM2-PK in in Patients With Neuroendocrine Tumors|Evaluation of Serological Markers ProGRP, CgA, NSE and TUM2-PK in Patients With Malignant Neuroendocrine Tumors|Unknown status|Recruiting|N/A|40|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples Without DNA|"~     Serum and plasma~   "|||2017-02-18 13:20:48.544733|2017-02-18 13:20:48.544733
NCT00851591|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2014-06-30|2014-01-24||September 2008||2008-09-01|June 2014|2014-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|fenugreek||Effect of Fenugreek on Milk Production|Effect of Fenugreek on Milk Production|Terminated||Phase 2/Phase 3|3|Actual|Texas Tech University Health Sciences Center||2||Low enrollment; investigator chose not to continue study|f||||t||||||||||2017-02-18 13:20:48.638544|2017-02-18 13:20:48.638544
NCT00851578|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2015-01-26|||January 2009||2009-01-01|September 2013|2013-09-01|December 2013|Actual|2013-12-01|February 2012|Actual|2012-02-01||Interventional|ASAP||ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology|ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology|Completed||N/A|150|Anticipated|Boston Scientific Corporation||1|||f||||t||||||||||2017-02-18 13:20:48.974362|2017-02-18 13:20:48.974362
NCT00851565|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2011-11-24|||June 2009||2009-06-01|November 2011|2011-11-01|February 2014|Anticipated|2014-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy|Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-02-18 13:20:49.068909|2017-02-18 13:20:49.068909
NCT00851552|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2014-06-23|2014-06-23||January 2009||2009-01-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||All treated and eligible patients|Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment|A Phase II Study of VDR (VELCADE™, DOXIL® and RITUXAN™) in Relapsed/Refractory Diffuse Large B-cell Lymphoma|Terminated||Phase 2|9|Actual|Roswell Park Cancer Institute|Due to the study’s early termination and inadequate number of patients, no patients were analyzed.|1||Lack of sponsor support|f||||t||||||||||2017-02-18 13:20:49.184155|2017-02-18 13:20:49.184155
NCT00851539|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2014-12-09|||June 2008||2008-06-01|December 2014|2014-12-01|April 2011|Actual|2011-04-01|November 2008|Actual|2008-11-01||Interventional|Control||Evaluating Post-test HIV Counseling Videos for Teens|Educational Effectiveness of an HIV Pretest Video for Adolescents: A Randomized Controlled Trial|Completed||N/A|200|Actual|North Bronx Healthcare Network||2|||f||||t||||||||||2017-02-18 13:20:49.61732|2017-02-18 13:20:49.61732
NCT00851526|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-07-15|||January 2004||2004-01-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|COBIS||Coronary Bifurcation Stenting (COBIS) Registry in South Korea|Coronary Bifurcation Stenting (COBIS) Registry in South Korea|Completed||N/A|1919|Actual|Samsung Medical Center|||1||f||||||||||||||2017-02-18 13:20:49.727929|2017-02-18 13:20:49.727929
NCT00851513|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2013-09-02|||November 2008||2008-11-01|September 2013|2013-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|INFILTHERA||Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia||Completed||Phase 4|202|Actual|Nantes University Hospital||3|||f||||||||||||||2017-02-18 13:20:49.805416|2017-02-18 13:20:49.805416
NCT00851500|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2011-08-15|||February 2009||2009-02-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis||Completed||Phase 2|210|Anticipated|Kowa Research Institute, Inc.||3|||f||||f||||||||||2017-02-18 13:20:49.917418|2017-02-18 13:20:49.917418
NCT00851487|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-02-25|||January 2006||2006-01-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Trial of Amoxicillin Compared With Placebo for Pneumonia in Children Aged 2-59 Months|A Randomized Multicentre Double Blind Trial of Amoxicillin Compared With Placebo for Treatment of WHO Defined Non-Severe Pneumonia in Children Aged 2-59 Months: NARIMA Study Group|Completed||N/A|900|Actual|Pakistan Institute of Medical Sciences||2|||f||||t||||||||||2017-02-18 13:20:50.036858|2017-02-18 13:20:50.036858
NCT00851474|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2016-05-25|||March 2009||2009-03-01|May 2016|2016-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|WSU||Measurement of Cardiac Output and Blood Volumes|Measurement of Cardiac Output and Blood Volumes|Withdrawn||N/A|0|Actual|Transonic Systems Inc.|||1|Protocol not renewed|f||||f||||||||||2017-02-18 13:20:50.15808|2017-02-18 13:20:50.15808
NCT00851461|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2015-05-20|||April 2008||2008-04-01|February 2009|2009-02-01|November 2013|Actual|2013-11-01|November 2011|Actual|2011-11-01||Interventional|||Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy|Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy in Thai Patients|Completed||Phase 4|10|Actual|Ramathibodi Hospital||1|||f||||f||||||||||2017-02-18 13:20:50.251103|2017-02-18 13:20:50.251103
NCT00851448|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-06-01|||October 2009||2009-10-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients|Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients. A Randomised, Double-blind, Controlled Pilot Study|Terminated||N/A|17|Actual|Fresenius Kabi||2|||f||||||||||||||2017-02-18 13:20:50.363454|2017-02-18 13:20:50.363454
NCT00851435|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2009-07-29|||February 2008||2008-02-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa|A Non-comparative Open Pilot Trial to Assess the Safety and Pharmacokinetics of up to Three Single Doses of AERUMAB 11 (KBPA-101) in Patients With Hospital Acquired Pneumonia Caused by Serotype O11 P. Aeruginosa|Completed||Phase 1/Phase 2|15|Anticipated|Kenta Biotech Ltd||1|||f||||f||||||||||2017-02-18 13:20:50.474413|2017-02-18 13:20:50.474413
NCT00851422|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-05-30|||February 2008||2008-02-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|BCM||Accurate Measurement of Cardiac Output Using the Ultrasound Dilution Technique|Accurate Measurement of Cardiac Output Using the Ultrasound Dilution Technique|Completed||Phase 2/Phase 3|28|Actual|Transonic Systems Inc.|||1||f||||f||||||||||2017-02-18 13:20:50.58501|2017-02-18 13:20:50.58501
NCT00851409|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-25|2012-12-20|2012-11-09||June 2009||2009-06-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|OPERA||A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration|"An Open-label Exploratory Phase II Study of the Safety and Immunogenicity of Repeated rhC1INH Administration of 50 U/Kg in Patients With Hereditary C1 Inhibitor Deficiency (HAE)"|Completed||Phase 2|25|Actual|Pharming Technologies B.V.||1|||f||||f||||||||||2017-02-18 13:20:50.67054|2017-02-18 13:20:50.67054
NCT00851396|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2011-09-09|||April 2008||2008-04-01|September 2011|2011-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Assessment of Influence of Vitamin D on Insulin Secretion and Sensitivity in Obese Teenage Girls|Assessment of Influence of Vitamin D on Insulin Secretion and Sensitivity in Obese Teenage Girls (Assessment of Prevalence of Vitamin D Deficiency in Obese Teenage Girls and Influence of Vitamin D on Insulin Secretion and Sensitivity)|Completed||N/A|30|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 13:20:50.896907|2017-02-18 13:20:50.896907
NCT00851383|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2012-04-23|||March 2009||2009-03-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers|A Phase I Placebo-controlled, Double-blinded (in Terms of Vaccine or Placebo), Randomized Dose-escalation Trial to Evaluate the Safety and Immunogenicity of Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers. (IAVI B001)|Completed||Phase 1|56|Actual|International AIDS Vaccine Initiative||4|||f||||t||||||||||2017-02-18 13:20:50.989143|2017-02-18 13:20:50.989143
NCT00851370|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2015-04-14|||January 2009||2009-01-01|April 2015|2015-04-01|February 2011|Anticipated|2011-02-01|February 2011|Anticipated|2011-02-01||Interventional|||Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels|Exploratory Study of Xolair (Omalizumab)to Improve Outcomes in Patients With COPD and Elevated IgE Levels, and Positive RAST or Skin Prick Tests|Withdrawn||Phase 2|0|Actual|National Jewish Health||2||Unable to find eligible subjects- study closed|f||||t||||||||||2017-02-18 13:20:51.097509|2017-02-18 13:20:51.097509
NCT00851357|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-10-27|||February 2009||2009-02-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|October 2010|Actual|2010-10-01||Interventional|||Telephone Counseling and the Distribution of Nicotine Patches to Smokers|The Efficacy of Telephone Counseling and the Centralized Distribution of Nicotine Replacement Therapy Through a Smoking Cessation Quitline|Completed||Phase 3|4200|Actual|University of California, San Diego||6|||f||||f||||||||No||2017-02-18 13:20:51.201461|2017-02-18 13:20:51.201461
NCT00851344|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-11-04|||September 2008||2008-09-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo|A Randomised, Double-blind, Placebo-controlled, 4-period Incomplete Block Crossover Study of Single Oral Dose GSK835726 (100mg, 50mg, 10mg), Cetirizine (10mg) and Placebo to Evaluate the Efficacy and Safety Using an Environmental Challenge Chamber in Male Subjects With Seasonal Allergic Rhinitis|Completed||Phase 2|54|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:20:51.310223|2017-02-18 13:20:51.310223
NCT00851331|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-24||||||February 2009|2009-02-01||||||||Interventional|||Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits|Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits|Unknown status|Not yet recruiting|N/A|||University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 13:20:51.414291|2017-02-18 13:20:51.414291
NCT00851318|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-10-27|2014-09-09||March 2009||2009-03-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients|A Multicenter, Open-label, Long-term Safety Study of CDP870 to Evaluate the Safety and Efficacy of CDP870 Administered in Combination With Methotrexate (MTX) Over the Long Term in Patients With Active Rheumatoid Arthritis Transferred From the Efficacy Confirmatory Study (Study 275-08-001)|Completed||Phase 3|285|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 13:20:51.508959|2017-02-18 13:20:51.508959
NCT00851305|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2012-07-16|||August 2008||2008-08-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|CLE||Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy|Comparison Confocal Laser Endomicroscopy With Conventional Endoscopy for the Detection of Early Gastric Cancers|Completed||N/A|1786|Actual|Shandong University||2|||f||||t||||||||||2017-02-18 13:20:53.052119|2017-02-18 13:20:53.052119
NCT00851292|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2011-06-21|||October 2009||2009-10-01|June 2011|2011-06-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|BIOPRES||The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing|The BIOPRES Trial; Transrectal BIOpsies of the PRostate: End Versus Side-firing|Unknown status|Recruiting|Phase 3|800|Anticipated|Amphia Hospital||2|||f||||f||||||||||2017-02-18 13:20:53.15826|2017-02-18 13:20:53.15826
NCT00851279|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2015-07-27|2013-12-02||June 2009||2009-06-01|July 2015|2015-07-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|STOP-VT||Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia|Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia: Data Collection of Clinical Scar-related VT Cases|Completed||Phase 4|53|Actual|Stereotaxis||1|||f||||f||||||||||2017-02-18 13:20:53.26563|2017-02-18 13:20:53.26563
NCT00851266|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-02-11|||October 2006||2006-10-01|February 2015|2015-02-01|January 2009|Actual|2009-01-01|August 2007|Actual|2007-08-01||Interventional|||A Study of a Bivalent Influenza Peptide Conjugate Vaccine in Healthy Adults|A Dose-Escalation, Dose-Ranging Study of the Safety, Tolerability, and Immunogenicity of a Bivalent Influenza Peptide Conjugate Vaccine Formulated With Aluminum- and ISCOMATRIX(TM) Containing Adjuvants (BIPCV/IMX) Evaluated in Healthy Adults 18 to 35 Years of Age|Completed||Phase 1|187|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:20:53.573464|2017-02-18 13:20:53.573464
NCT00851253|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-06-14|||January 2009||2009-01-01|June 2016|2016-06-01|February 2018|Anticipated|2018-02-01|December 2014|Actual|2014-12-01||Interventional|||Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer|The Feasibility and Outcome of Cyberknife® Stereotactic Radiosurgical Boost and Salvage Therapy for Head and Neck Cancer|Active, not recruiting||Phase 1|30|Anticipated|Boston Medical Center||2|||f||||t||||||||||2017-02-18 13:20:53.658436|2017-02-18 13:20:53.658436
NCT00851240|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2012-02-02|||February 2009||2009-02-01|February 2012|2012-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||BTT-1023 in Rheumatoid Arthritis|A Multiple Ascending Dose Study to Assess the Safety and Pharmacokinetics of Repeated Intravenous Doses of BTT-1023 in Patients With Rheumatoid Arthritis - a Double-blind Randomized Placebo-controlled Sequential Group Trial|Completed||Phase 1|24|Actual|Biotie Therapies Corp.||2|||f||||||||||||||2017-02-18 13:20:53.768284|2017-02-18 13:20:53.768284
NCT00851227|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-04-30|||February 2009||2009-02-01|April 2014|2014-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function|A Phase 1, Open-Label Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan|Completed||Phase 1|26|Actual|Cumberland Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:20:53.862211|2017-02-18 13:20:53.862211
NCT00851214|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2010-02-17|||March 2009||2009-03-01|March 2009|2009-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Use of Non Invasive Hemodynamic Cardiovascular Monitoring to Evaluate Emergency Department Patients|Assessments of Early Hemodynamics in Emergency Department Patients and Evaluation of Trends and Variability in Prediction of Life-saving Interventions|Completed||N/A|40|Actual|Henry Ford Health System|||4||f||||f||||||||||2017-02-18 13:20:53.971655|2017-02-18 13:20:53.971655
NCT00851162|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2012-11-27|||March 2009||2009-03-01|November 2012|2012-11-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions|Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions|Withdrawn||Phase 2/Phase 3|0|Actual|Emory University||2||Study was not continued due to lack of enrollment.|f||||f||||||||||2017-02-18 13:20:54.368889|2017-02-18 13:20:54.368889
NCT00851149|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2010-06-10|||November 2009||2009-11-01|June 2010|2010-06-01|May 2010|Anticipated|2010-05-01|February 2010|Anticipated|2010-02-01||Observational|KEEP-HB||Pro-inflammatory Cytokines in Blood From Orthopedic Surgery Compared to Abdominal Aneurysm Repair|Pro-inflammatory Cytokines (IL-1beta,IL-6, IL-8 and TNF-α) and Complement Activation (C3a) in Blood Collected From Surgery Field From Patients Undergoing Orthopedic Surgery Compared to Patients Undergoing Abdominal Aneurysm Repair.|Unknown status|Active, not recruiting|N/A|20|Anticipated|Sykehuset i Vestfold HF|||2||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 13:20:54.481456|2017-02-18 13:20:54.481456
NCT00851136|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2010-06-29|||May 2009||2009-05-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|||||Interventional|||A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)|A Phase Ib Study of the Safety and Pharmacokinetics of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer|Completed||Phase 1|9|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 13:20:54.593216|2017-02-18 13:20:54.593216
NCT00851123|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-01-03|||February 2009||2009-02-01|January 2014|2014-01-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Modified Constrained - Induced Movement Therapy Compared to Intensive Bimanual Training|Modified Constrained - Induced Movement Therapy Compared to Intensive Bimanual Training for Subacute Stroke Patients. A Randomized Controlled Trial|Terminated||N/A|30|Actual|University of Bergen||2||"Due to recruitment difficulties the trial was stopped after an interim analysis at 30~   patients."|f||||t||||||||||2017-02-18 13:20:54.688209|2017-02-18 13:20:54.688209
NCT00851110|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-02-24|||October 2004||2004-10-01|February 2009|2009-02-01||||||||Interventional|||Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors|A Prospective Randomized Feasibility and Phase II Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors.|Terminated||Phase 2|50|Anticipated|University Medical Center Groningen|||||f||||||||||||||2017-02-18 13:20:54.790169|2017-02-18 13:20:54.790169
NCT00851084|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-05-04|2013-02-19||February 2009||2009-02-01|May 2016|2016-05-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional|AFFIRM||Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer|Randomized, Multinational, Study Of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer|Completed||Phase 2|268|Actual|Sanofi|The overall survival (OS) data are severely limited due to the low number of events (<50%) in both arms, therefore median OS cannot be accurately estimated due to limitations of available data.|2|||f||||t||||||||||2017-02-18 13:20:54.920889|2017-02-18 13:20:54.920889
NCT00851071|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2017-01-24|||February 2009|Actual|2009-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2011|Actual|2011-12-01||Interventional|||Interventional Study of Anxiety Symptoms in the Implantable Cardioverter Defibrillator (ICD) Patient|"Bakken Heart Brain Institute's An Observational and Interventional Study of Anxiety Symptoms in the Implantable Cardioverter Defibrillator (ICD) Patient."|Active, not recruiting||N/A|28|Actual|The Cleveland Clinic||2|||f||||f|f|f||||||No||2017-02-18 13:20:55.981446|2017-02-18 13:20:55.981446
NCT00851058|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2011-02-24|||May 2007||2007-05-01|February 2011|2011-02-01|April 2012|Anticipated|2012-04-01|March 2010|Anticipated|2010-03-01||Interventional|ROAD||Reducing Driving Offenses of Adolescent Drinkers|A Randomized Control Trial of the Effectiveness of of Group Motivational Counseling and an Emergency Department Experience in Reducing Risky Alcohol Use and Driving Behaviors.|Unknown status|Active, not recruiting|Phase 1/Phase 2|786|Anticipated|Rhode Island Hospital||3|||f||||t||||||||||2017-02-18 13:20:56.087006|2017-02-18 13:20:56.087006
NCT00851045|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-09-23||2015-09-23|October 2009||2009-10-01|September 2015|2015-09-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer|A Randomized, Double-Blind, Phase II Trial of CT-322 (BMS-844203) Plus Irinotecan, 5-FU and Leucovorin (FOLFIRI) Versus Bevacizumab Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer|Completed||Phase 2|17|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:20:56.199611|2017-02-18 13:20:56.199611
NCT00851032|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-07-27|||February 2009||2009-02-01|July 2016|2016-07-01||||February 2018|Anticipated|2018-02-01||Observational|||Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol|An Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial. A Molecular Profile-Based Study in Patients With Advanced Cancer Treated in the Investigational Cancer Therapeutics Program|Recruiting||N/A|5000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Specimen obtained from MDACC Tissue Bank.~   "|||2017-02-18 13:20:56.32894|2017-02-18 13:20:56.32894
NCT00851019|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2013-03-25|||February 2009||2009-02-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Dance Dance Revolution (DDR) in Type 2 Diabetes|Dance Dance Revolution (DDR) Exergaming in Adults With Type 2 Diabetes Mellitus|Completed||N/A|76|Actual|Charles Drew University of Medicine and Science||2|||f||||t||||||||||2017-02-18 13:20:56.442674|2017-02-18 13:20:56.442674
NCT00851006|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-01-08|2014-12-09||April 2009||2009-04-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram|Adjunctive Creatine Treatment for Adolescent Females With Major Depressive Disorder Who Are Non-Responders to Fluoxetine or Escitalopram: A Magnetic Resonance Spectroscopy Study|Completed||Phase 2|13|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 13:20:56.603415|2017-02-18 13:20:56.603415
NCT00850811|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-09-07|||February 2009||2009-02-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers|A 4-Day, Randomized, Controlled, Open Application Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers, Using a Phototoxicity Test Design|Completed||Phase 1|30|Anticipated|Peplin||1|||f||||f||||||||||2017-02-18 13:20:59.285386|2017-02-18 13:20:59.285386
NCT00850993|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2014-08-19|2013-12-06||August 2008||2008-08-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|June 2011|Actual|2011-06-01||Interventional|||A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia|A Phase 2b, Multicenter, Single-dose, Blinded, Randomized, Placebo-controlled, Dose-escalation, Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia|Terminated||Phase 2|63|Actual|InfaCare Pharmaceuticals Corporation|It should be noted that the study was discontinued before enrollment of the full 4.5 mg/kg cohort,and therefore, the stannsoporfin 4.5 mg/kg treatment group included 8 patients and the placebo group included 15 patients.|2||To redefine study population|f||||t||||||||||2017-02-18 13:20:57.068679|2017-02-18 13:20:57.068679
NCT00850980|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2017-02-09|||February 2009|Actual|2009-02-01|February 2017|2017-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Selective AV Nodal Vagal Stimulation For Reduction of the Ventricular Rate During Atrial Fibrillation|Selective AV Nodal Vagal Stimulation For Reduction of the Ventricular Rate During Atrial Fibrillation|Withdrawn||N/A|0|Actual|The Cleveland Clinic|||1|unable to recruit|f||||f|f|f||||||No||2017-02-18 13:20:57.76572|2017-02-18 13:20:57.76572
NCT00850954|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-09-14|||August 2006||2006-08-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Observational|||Project CASA: Promoting Smoke-Free Indoor Air Policy in Mexican American Households|Project CASA: Promoting Smoke-Free Indoor Air Policy in Mexican American Households|Recruiting||N/A|250|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 13:20:57.880147|2017-02-18 13:20:57.880147
NCT00850941|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-08-04|||January 2009||2009-01-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Observational|||Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy|Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy|Recruiting||N/A|500|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Leftover tissue from prostate surgery to be used for biomarker research.~   "|||2017-02-18 13:20:57.995654|2017-02-18 13:20:57.995654
NCT00850928|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-03-15|||December 2008||2008-12-01|March 2016|2016-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloids|Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloids.|Completed||N/A|41|Actual|New York University School of Medicine|||1||f||||f||||||Samples With DNA|"~     Serum and plasma will be collected and stored at baseline, intra-operatively, and one day~     post-operative for analysis of markers of inflammation. Plasma will be collected and stored~     at baseline, three months, and six months for analysis of Beta Amyloid levels. DNA will be~     collected and stored at baseline for analysis of Apolipoprotein E.~   "|No||2017-02-18 13:20:58.11938|2017-02-18 13:20:58.11938
NCT00850915|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2013-05-17|||April 2009||2009-04-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|IPT||Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya|Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya|Completed||Phase 4|1259|Actual|KNCV Tuberculosis Foundation||2|||f||||f||||||||||2017-02-18 13:20:58.217237|2017-02-18 13:20:58.217237
NCT00850902|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-03-09|||March 2009||2009-03-01|March 2009|2009-03-01|April 2010|Anticipated|2010-04-01|March 2010|Anticipated|2010-03-01||Interventional|||Humidity Strategy to Decrease Morbidity and Mortality in Extremely Low Birth Weight Infants|Application of a Different Incubator Humidity Strategy at Birth to Decrease Morbidity and Mortality in Extremely Low Birth (1000 g or Less) Infants|Unknown status|Not yet recruiting|N/A|700|Anticipated|King Fahad Medical City||2|||f||||t||||||||||2017-02-18 13:20:58.349082|2017-02-18 13:20:58.349082
NCT00850889|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-10-06|2011-02-24||November 2008||2008-11-01|December 2013|2013-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds||Completed||Phase 4|32|Actual|Allergan||2|||f||||||||||||||2017-02-18 13:20:58.439332|2017-02-18 13:20:58.439332
NCT00850876|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2010-04-08|||September 2008||2008-09-01|April 2010|2010-04-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Observational|||Heated Humidified Continuous Positive Airway Pressure and Nasal Physiology|Randomized Cross-over Trials of the Effect of Heated Humidified CPAP Versus Non-humidified CPAP on Nasal Physiology|Completed||N/A|20|Actual|University of Athens|||1||f||||f||||||Samples Without DNA|"~     Nasal wash will be performed using a technique adapted by Hurst et al. Briefly, a 12-French~     Foley catheter (Bard, Crawley, UK), modified by removal of the tip distal to the balloon,~     was inserted into the nostril and inflated with sufficient air to form a comfortable seal~     (typically 7-10ml). With the patients head flexed 45o forward, 7ml of warmed 0.9% saline~     will be instilled through the catheter and washed in and out of the nasal cavity three~     times. A portion of the pooled wash from both nostrils will be centrifuged to yield a~     supernatant for analysis of inflammatory cytokines (IL-6, IL-8, TNF-a, IL-10).~   "|||2017-02-18 13:20:58.731797|2017-02-18 13:20:58.731797
NCT00850863|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-24|||February 2009||2009-02-01|February 2009|2009-02-01|January 2015|Anticipated|2015-01-01|January 2013|Anticipated|2013-01-01||Observational|||Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)|Acute and Chronic Inflammatory Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPD: From Specific Disease Phenotyping Towards Novel Therapy (Study 2).|Unknown status|Recruiting|N/A|240|Anticipated|Top Institute Pharma|||9||f||||t||||||||||2017-02-18 13:20:58.841313|2017-02-18 13:20:58.841313
NCT00850850|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2010-05-26|||December 2009||2009-12-01|May 2010|2010-05-01|May 2011|Anticipated|2011-05-01|March 2011|Anticipated|2011-03-01||Interventional|||Physostigmine After General Anesthesia|The Use of Physostigmine in Elderly Patients in the Postoperative Recovery-phase After General Anesthesia|Unknown status|Recruiting|N/A|50|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||||2017-02-18 13:20:58.941045|2017-02-18 13:20:58.941045
NCT00850837|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2013-12-02|||February 2009||2009-02-01|December 2013|2013-12-01||||||||Interventional|||Safety of Acidform Lubricant in HIV-Uninfected Women|Safety of Acidform Lubricant (Amphora) in Women at Low Risk for HIV-1 Infection|Completed||Phase 1|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:20:59.075202|2017-02-18 13:20:59.075202
NCT00850824|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-10-05|||October 2007||2007-10-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|June 2011|Actual|2011-06-01||Interventional|DCAS||Community Health Workers in Diabetes Care in American Samoa|Diabetes Care in American Samoa|Completed||N/A|268|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 13:20:59.181315|2017-02-18 13:20:59.181315
NCT00850785|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-09-26|||January 2009||2009-01-01|September 2016|2016-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|DRibble||Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer|A Pilot Study of Autologous Tumor DRibble Vaccine With Docetaxel in Stage IIIB and IV Non-Small Cell Lung Cancer|Completed||Phase 1|6|Actual|Providence Health & Services||1|||f||||f||||||||No||2017-02-18 13:20:59.536821|2017-02-18 13:20:59.536821
NCT00850772|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-06-10|||January 2009||2009-01-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|OPEN||Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer|Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer|Completed||Phase 3|109|Actual|Queensland Centre for Gynaecological Cancer||2|||f||||t||||||||||2017-02-18 13:20:59.633112|2017-02-18 13:20:59.633112
NCT00850759|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2014-12-01|2013-06-17||October 2009||2009-10-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|May 2012|Actual|2012-05-01||Interventional|||Using Virtual Reality to Train Children in Pedestrian Safety|Using Virtual Reality to Train Children in Pedestrian Safety|Completed||Phase 3|240|Actual|University of Alabama at Birmingham||4|||f||||t||||||||||2017-02-18 13:20:59.741067|2017-02-18 13:20:59.741067
NCT00850746|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-03-21|||February 2009||2009-02-01|March 2014|2014-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults|A Phase 1, Randomized, Double-Blind, Placebo- and Active- Controlled, Crossover Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Male and Female Adult Subjects|Completed||Phase 1|80|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-02-18 13:21:00.293066|2017-02-18 13:21:00.293066
NCT00850733|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-09-15|||August 2008||2008-08-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||516-BOTOX Urinary Incontinence Detrusor|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of Safety and Efficacy of a Single Treatment With 2 Dose Levels of BOTOX Purified Neurotoxin Complex Followed by a Treatment With BOTOX in Patients With…|Completed||N/A|||Veterans Medical Research Foundation|||1||f||||t||||||||||2017-02-18 13:21:00.614014|2017-02-18 13:21:00.614014
NCT00850720|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2013-11-18|2010-01-15||March 2009||2009-03-01|November 2013|2013-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants|Prevalence of Neuroendocrine Dysfunction in the Pediatric Cardiopulmonary Bypass Patient|Terminated||N/A|3|Actual|Emory University|Early termination of study; Technical problems with measurement leading to unreliable or uninterpretable data.||1|Inability to recruit / logistic problems.|f||||f||||||||||2017-02-18 13:21:00.67946|2017-02-18 13:21:00.67946
NCT00850707|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-26|||January 2000||2000-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2006|Actual|2006-12-01||Observational|||Vascular Access for Hemodialysis and Inflammation|Artero-Venous Fistula, Prosthetic Polytetrafluoroethylene Grafts (AVG), Tunneled Cuffed Catheter (TCC): Impact of Vascular Access on HD Inflammation and Monocyte Activation|Completed||N/A|458|Actual|St. Orsola Hospital|||4||f||||t||||||||||2017-02-18 13:21:00.851772|2017-02-18 13:21:00.851772
NCT00850694|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2011-09-09|||February 2007||2007-02-01|September 2011|2011-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Vitamin D Deficiency in Obese Adolescent Girls and Influence of Vitamin D on Insulin Secretion and Sensitivity|Assessment of Prevalence of Vitamin D Deficiency in Obese Adolescent Girls and Influence of Vitamin D on Insulin Secretion and Sensitivity|Completed||N/A|114|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 13:21:00.950709|2017-02-18 13:21:00.950709
NCT00850681|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-09-07|||February 2009||2009-02-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers|A Randomized, Controlled Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers Using an Open Application Photoallergic Test Design|Completed||Phase 1|50|Anticipated|Peplin||1|||f||||f||||||||||2017-02-18 13:21:01.054286|2017-02-18 13:21:01.054286
NCT00850668|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2013-05-23|||October 2009||2009-10-01|May 2013|2013-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults|A Phase 1 Study of Heat/Phenol-Killed, E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP 123) in Healthy Volunteers Followed by Subjects Allergic to Peanuts (CoFAR 1)|Completed||Phase 1|15|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:21:01.148053|2017-02-18 13:21:01.148053
NCT00850655|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-10-25|||March 2008||2008-03-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae|Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae|Completed||N/A|20|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||No||2017-02-18 13:21:03.534562|2017-02-18 13:21:03.534562
NCT00850642|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-11-30|||June 2009||2009-06-01|November 2016|2016-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||GSK2190915 Moderate to Severe Asthma Study|The Efficacy of Orally Administered GSK2190915 as an add-on to Current Therapy in Subjects With Moderate to Severe Asthma Who Have Elevated Sputum Neutrophils|Terminated||Phase 2|7|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:21:03.62084|2017-02-18 13:21:03.62084
NCT00850629|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-01-30|||October 2009||2009-10-01|January 2012|2012-01-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||Hormonal Regulation of Body Weight Maintenance|Hormonal Regulation of Body Weight Maintenance|Unknown status|Active, not recruiting|N/A|320|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 13:21:03.731426|2017-02-18 13:21:03.731426
NCT00850616|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2015-10-30|||April 2005||2005-04-01|October 2015|2015-10-01|March 2011|Actual|2011-03-01|August 2006|Actual|2006-08-01||Interventional|||Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED)|A Phase I Dose Ranging Study of the Safety, Tolerability, and Immunogenicity of a 3-Dose Regimen of the MRKAd5 HIV-1 Trigene and the MRKAd6 HIV-1 Trigene Vaccines Alone and in Combination in Healthy Adults|Completed||Phase 1|147|Actual|Merck Sharp & Dohme Corp.||8|||f||||||||||||||2017-02-18 13:21:03.822961|2017-02-18 13:21:03.822961
NCT00850603|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2016-04-12|2009-03-13||October 2002||2002-10-01|April 2016|2016-04-01|November 2004|Actual|2004-11-01|May 2003|Actual|2003-05-01||Interventional|||Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®|Safety and Immunogenicity of Intradermal, and Low-dose Subcutaneous vs Subcutaneous Administration of Menomune® - A/C/Y/W-135|Completed||Phase 4|170|Actual|Sanofi||5|||f||||f||||||||||2017-02-18 13:21:03.92905|2017-02-18 13:21:03.92905
NCT00850590|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-12-21|||February 2009||2009-02-01|December 2009|2009-12-01||||April 2009|Actual|2009-04-01||Interventional|||Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights|A Randomised, Placebo-controlled, Double-blind, Dose Escalation Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of Rectal Suppositories Containing Between 5 and 15 mg NRL001 or Matching Placebo for Two Different Sized Suppositories (1 g and 2 g).|Completed||Phase 1|48|Anticipated|Norgine||2|||f||||t||||||||||2017-02-18 13:21:05.074754|2017-02-18 13:21:05.074754
NCT00850577|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-09-23||2015-09-23|June 2009||2009-06-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer|A Randomized Double-Blinded Phase II Study of Carboplatin/Paclitaxel/CT-322 Versus Carboplatin/Paclitaxel/Bevacizumab as First-Line Treatment for Recurrent or Advanced Non-Small Cell Lung Cancer With Non-Squamous Histology|Terminated||Phase 2|255|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:21:05.163871|2017-02-18 13:21:05.163871
NCT00850564|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2011-04-15|2011-03-03||February 2009||2009-02-01|April 2011|2011-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men|Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men|Completed||N/A|15|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:21:05.348829|2017-02-18 13:21:05.348829
NCT00850551|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-11-30|||January 2009||2009-01-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis|Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis|Completed||N/A|42|Actual|University of Washington||2|||f||||f||||||||No|There is no IPD|2017-02-18 13:21:05.616318|2017-02-18 13:21:05.616318
NCT00850538|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-11-02|2013-05-15||July 2008||2008-07-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Role of Bone in Knee Osteoarthritis (OA)|The Role of Bone and Its Measurement in Knee Osteoarthritis|Completed||N/A|101|Actual|The New England Baptist Hospital|||1||f||||f||||||Samples Without DNA|"~     Tibial plateau patella fat pad synovial fluid and synovium~   "|||2017-02-18 13:21:05.730859|2017-02-18 13:21:05.730859
NCT00850512|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-24||||||February 2009|2009-02-01||||||||Interventional|CHOP21+R-Z||Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy||Completed||Phase 2|55|Actual|University of Bologna||1|||f||||||||||||||2017-02-18 13:21:05.965527|2017-02-18 13:21:05.965527
NCT00850499|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2012-12-10|2012-10-03||September 2009||2009-09-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab|A Randomized, Open-Label, Multicenter Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab|Terminated||Phase 2|12|Actual|Millennium Pharmaceuticals, Inc.|Early termination leading to small numbers of subjects analyzed|2|||f||||f||||||||||2017-02-18 13:21:06.060587|2017-02-18 13:21:06.060587
NCT00850486|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-24|||August 2008||2008-08-01|February 2009|2009-02-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|||Diagnostic Benefits of HyperQTM vs. Conventional ECG Stress Test. Comparison of HyperQ vs. Stress ECG in Women Before Angiography|The Diagnostic Benefits of HyperQTM vs. Conventional ECG During Stress Test. A Comparison Study in Women Referred to Angiography.|Unknown status|Recruiting|Phase 4|200|Anticipated|BSP Biological Signal Processing Ltd.||1|||f||||f||||||||||2017-02-18 13:21:06.863983|2017-02-18 13:21:06.863983
NCT00850473|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2014-05-02|||October 2007||2007-10-01|May 2014|2014-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|PET/CT||PET/CT Study in the Diagnosis of Coronary Plaque|x Comparison of Cardiac Positron Emission Tomography/Computed Tomography (PET/CT) With Coronary Angiography (CA) in the Diagnosis and Characterization of Coronary Artery Plaque|Completed||N/A|3|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 13:21:06.968616|2017-02-18 13:21:06.968616
NCT00850460|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-09-21|2016-02-12||February 2009||2009-02-01|September 2016|2016-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Males and females 30-60 years old, taking a statin, experiencing muscle pain, weakness, cramping and not at high risk for a cardiovascular event|Quality of Life in Patients With Statin-Associated Myopathy|Quality of Life and Metabolic Alterations in Patients With Statin-Associated Myopathy|Terminated||Phase 4|14|Actual|Rockefeller University||2||Investigator left institution and no PI has been found to continue the study|f||||f||||||||||2017-02-18 13:21:07.088504|2017-02-18 13:21:07.088504
NCT00850447|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2012-02-01|||October 2008||2008-10-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Cognitive Remediation in Posttraumatic Stress Disorder (PTSD)|Cognitive Remediation in PTSD|Completed||N/A|2|Actual|Bronx VA Medical Center||2|||f||||f||||||||||2017-02-18 13:21:07.617853|2017-02-18 13:21:07.617853
NCT00849602|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-02-23|||February 2008||2008-02-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|May 2008|Anticipated|2008-05-01||Interventional|||The Effect of Chloroquine in the Treatment of Patients With Dengue|The Effect of Chloroquine in the Treatment of Patients With Dengue|Unknown status|Active, not recruiting|Phase 1/Phase 2|132|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:21:07.717839|2017-02-18 13:21:07.717839
NCT00849589|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-10-06|||January 2010||2010-01-01|October 2016|2016-10-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Interventional|||Computerized Screening and Brief Physician Advice to Reduce Teen Drinking|Computerized Screening and Brief Physician Advice to Reduce Teen Drinking|Withdrawn||N/A|0|Actual|Boston Children’s Hospital||3||Grant application was not funded|f||||t||||||||No||2017-02-18 13:21:07.809916|2017-02-18 13:21:07.809916
NCT00849576|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2015-07-30||2015-07-30|April 2008||2008-04-01|July 2015|2015-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.||Completed||Phase 3|15|Actual|Biodel||4|||f||||f||||||||||2017-02-18 13:21:07.923744|2017-02-18 13:21:07.923744
NCT00849563|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-22|2014-04-09|||April 2009||2009-04-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|September 2011|Actual|2011-09-01||Interventional|TDE||Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes|Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes|Completed||N/A|450|Actual|Duke University||3|||f||||f||||||||||2017-02-18 13:21:08.026408|2017-02-18 13:21:08.026408
NCT00849550|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-22|2012-12-21|||July 2009||2009-07-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|COBRA||Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.|A Phase I Study of Capecitabine, Oxaliplatin, Bevacizumab, and RAD001 (XELOX-A-Ev) for Subjects With Advanced Solid Tumors|Completed||Phase 1|32|Actual|Duke University||1|||f||||t||||||||||2017-02-18 13:21:08.137252|2017-02-18 13:21:08.137252
NCT00849537|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-02-23|||April 2008||2008-04-01|February 2009|2009-02-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy||Unknown status|Recruiting|Phase 1/Phase 2|||Shahid Beheshti University of Medical Sciences||1|||f||||||||||||||2017-02-18 13:21:08.248702|2017-02-18 13:21:08.248702
NCT00849524|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2015-11-30|2015-08-24||January 2009||2009-01-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2009|Actual|2009-07-01||Interventional|||Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|A Phase II Study of Repeat Intranodal Injections of Adenovirus-CD 154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma|Terminated||Phase 2|6|Actual|University of California, San Diego||1||drug supply became unavailable|f||||t||||||||||2017-02-18 13:21:08.361974|2017-02-18 13:21:08.361974
NCT00849511|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-09-24|||February 2009||2009-02-01|September 2014|2014-09-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|MMP||Melatonin for Migraine Prevention|Melatonin for Migraine Prevention (The MMP-study): A Randomized, Double-blind, Cross-over, Placebo-controlled Study of Melatonin in Prophylactic Treatment of Migraine|Completed||Phase 2|48|Actual|Nordlandssykehuset HF||2|||f||||f||||||||||2017-02-18 13:21:08.598306|2017-02-18 13:21:08.598306
NCT00849485|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-09-01|2009-06-30||November 2005||2005-11-01|September 2009|2009-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Levetiracetam 750 mg Tablets Under Non-Fasting Conditions|Randomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Levetiracetam 750 mg Tablet and Keppra® (Reference) Following a 750 mg Dose in Healthy Subjects Under Fed Conditions|Completed||Phase 1|22|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:21:08.705025|2017-02-18 13:21:08.705025
NCT00850434|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-24|||November 2005||2005-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:21:09.093692|2017-02-18 13:21:09.093692
NCT00850421|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2015-11-25|2013-07-10||April 2004||2004-04-01|July 2013|2013-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Pilot Study of BOTOX for Migraine Headaches|A Single-Center Pharmacoeconomic Pilot Study of BOTOX® (Botulinum Toxin Type A) for the Prophylactic Treatment of Migraine Headaches|Terminated||N/A|35|Actual|HealthPartners Institute||1||Recently published BOTOX efficacy data and study design deficits.|f||||f||||||||||2017-02-18 13:21:09.144384|2017-02-18 13:21:09.144384
NCT00850408|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2013-04-22|||June 2008||2008-06-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Enhancing the Response to Rehabilitation After Stroke Using Repetitive Transcranial Magnetic Stimulation (rTMS)|Enhancing the Response to Rehabilitative Interventions After Stroke Using Transcranial Magnetic Stimulation|Terminated||Phase 2|11|Actual|McGill University Health Center||2|||f||||t||||||||||2017-02-18 13:21:09.351901|2017-02-18 13:21:09.351901
NCT00850395|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2012-11-05|2012-09-11||July 2009||2009-07-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-Infection|Non-Interventional Study Of Celsentri® In Treatment Experienced Patients Infected With CCR5 Tropic HIV-1|Completed||N/A|79|Actual|ViiV Healthcare|Designation of outcomes as primary and secondary was based on study team input as study did not specify primary or secondary outcome measures.||1||f||||f||||||||||2017-02-18 13:21:09.511173|2017-02-18 13:21:09.511173
NCT00850382|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-02-29|||June 2009||2009-06-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)|Open-Label, Multicenter Phase Ib/IIa Study For the Evaluation of Dasatinib (Sprycel™) Following Induction and Consolida-tion Therapy as Well as in Maintenance Therapy in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)|Completed||Phase 1/Phase 2|89|Actual|University of Ulm||1|||f||||f||||||||||2017-02-18 13:21:10.137413|2017-02-18 13:21:10.137413
NCT00850369|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-22|2013-07-26|||February 2005||2005-02-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension|A Pilot Study of the Effects of Chronic Red Blood Cell Transfusion in Sickle Cell Disease On Pulmonary Hypertension in Patients With Sickle Cell Disease|Withdrawn||Phase 2|0|Actual|University of North Carolina, Chapel Hill||1||Slow accrual onto the study|f||||t||||||||||2017-02-18 13:21:10.296109|2017-02-18 13:21:10.296109
NCT00850356|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2013-05-17|||November 2008||2008-11-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Quality of Life Outcomes and Economic Impacts of Bariatric Surgery|Alberta Population-based, Prospective Evaluation of the Quality of Life Outcomes and Economic Impacts of Bariatric Surgery|Completed||N/A|500|Actual|University of Alberta|||3||f||||||||||||||2017-02-18 13:21:10.390104|2017-02-18 13:21:10.390104
NCT00850343|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-10-27|2014-09-09||March 2009||2009-03-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients|A Multicenter, Open-label, Long-term Safety Study of CDP870 to Evaluate the Safety and Efficacy of CDP870 Administered Without Coadministration of Methotrexate (MTX) Over the Long Term in Patients With Active Rheumatoid Arthritis Transferred From the Efficacy Confirmatory Study (Study 275-08-003)|Completed||Phase 3|208|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 13:21:10.511678|2017-02-18 13:21:10.511678
NCT00850330|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-08-03|||June 2009||2009-06-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|SEDDI||Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software|Transversal, Multicentric Study for Early Detection of Drug Interactions in Older Hospitalized Patients Using on Line Software in Córdoba, Argentina|Unknown status|Recruiting|N/A|3000|Anticipated|Universidad Nacional de Córdoba|||1||f||||f||||||||||2017-02-18 13:21:11.874741|2017-02-18 13:21:11.874741
NCT00850317|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-24|2009-02-24|||April 2009||2009-04-01|February 2009|2009-02-01||||April 2012|Anticipated|2012-04-01||Interventional|||Fanconi Anemia Transplant Lacking Genotypically Identical Donor|Multicenter Phase II Trial-Hematopoietic Stem Cell Transplantation for Treatment of Patients With FA Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine|Unknown status|Not yet recruiting|Phase 2|25|Anticipated|Boston Children’s Hospital||1|||f||||f||||||||||2017-02-18 13:21:11.988609|2017-02-18 13:21:11.988609
NCT00850304|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-21|2009-02-21|||October 2007||2007-10-01|February 2009|2009-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide|Feasibility Study of Treatment of Non Promyelocytic Acute Myeloid Leukaemia on Elderly Patients by Low Dose Cytosar Plus Arsenic Trioxide on Ambulatory Schedule|Completed||Phase 2|10|Actual|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-02-18 13:21:12.150424|2017-02-18 13:21:12.150424
NCT00850291|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2010-12-30|||May 2008||2008-05-01|December 2010|2010-12-01|October 2010|Actual|2010-10-01|February 2010|Actual|2010-02-01||Observational|SEAL||Economisation of Whipple Resection Using Electrosurgical Sealing Device|Prospective, Controlled, Randomized Study of Economisation of the Preparation in Partial Duodenopancreatectomy Using an Electrosurgical Sealing Device Versus Traditional Methods|Completed||N/A|89|Actual|Universitätsklinikum Hamburg-Eppendorf|||2||f||||f||||||||||2017-02-18 13:21:12.269473|2017-02-18 13:21:12.269473
NCT00850278|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2012-08-31|||October 2008||2008-10-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|FLT||Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors|Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors|Completed||N/A|50|Actual|University Hospital, Caen||1|||f||||t||||||||||2017-02-18 13:21:12.496845|2017-02-18 13:21:12.496845
NCT00850265|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-03-26|||March 2008||2008-03-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Spacer in Extrafine Formoterol-Beclomethasone Treatment to Asthma|Rol of Spacer in the Combined Treatment With Extrafine Beclomethasone-Formoterol in Stable Asthma|Completed||N/A|40|Actual|Hospital General de Requena||2|||f||||f||||||||||2017-02-18 13:21:12.602833|2017-02-18 13:21:12.602833
NCT00850252|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2013-07-15|||September 2004||2004-09-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|||Use of a Lifeline Graft in the A-V Shunt Model|Use of a Completely Autologous and Completely Biological Tissue Engineered Blood Vessel Lifeline as an Arteriovenous Fistula in Hemodialysis Patients - Safety and Efficacy Study.|Completed||Phase 1/Phase 2|||Cytograft Tissue Engineering||1|||f||||t||||||||||2017-02-18 13:21:12.691595|2017-02-18 13:21:12.691595
NCT00850239|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2010-08-10|||May 2009||2009-05-01|August 2010|2010-08-01|December 2010|Anticipated|2010-12-01|October 2010|Anticipated|2010-10-01||Interventional|||Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin|Terminated||Phase 3|700|Anticipated|Phenomix||2|||f||||f||||||||||2017-02-18 13:21:12.791243|2017-02-18 13:21:12.791243
NCT00850226|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2010-05-28|||February 2009||2009-02-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Comparing Acceptance and Commitment Therapy (ACT) and Cognitive Therapy (CT) for Test Anxiety|Comparing Acceptance and Commitment Therapy Strategies to Cognitive Therapy Strategies in Reduction of Test Anxiety|Completed||N/A|50|Anticipated|Drexel University||2|||f||||f||||||||||2017-02-18 13:21:12.99425|2017-02-18 13:21:12.99425
NCT00850213|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2012-02-14|||February 2009||2009-02-01|February 2012|2012-02-01|February 2011|Actual|2011-02-01|||||Observational|REDES||"Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent in Real Life in Spain."|"Registro Redes - Evaluación Del Comportamiento clínico y Del Coste Del Stent Coronario Endeavor Resolute de Medtronic en el Mundo Real en España"|Completed||N/A|448|Actual|Medtronic Bakken Research Center|||1||f||||t||||||||||2017-02-18 13:21:13.100402|2017-02-18 13:21:13.100402
NCT00850200|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2016-09-13|2013-12-13||August 2009||2009-08-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|May 2013|Actual|2013-05-01||Interventional|HL01|20 patients were enrolled. One decided to withdrawal after being enrolled, but prior to any treatment plans being performed.|Proton Therapy for Hodgkin Lymphoma|Improving the Therapeutic Ratio by Using Proton Beam Radiation Therapy for Patients With Stage IA-IIIBX (Bulky/Non-bulky) Hodgkin Lymphoma Involving the Mediastinum Following Standard Chemotherapy|Active, not recruiting||Phase 2|20|Actual|University of Florida||3|||f||||t||||||||||2017-02-18 13:21:13.212215|2017-02-18 13:21:13.212215
NCT00850187|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-21|2012-01-02|||August 2008||2008-08-01|April 2010|2010-04-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage|Treatment of Full-thickness Articular Cartilage Defects in the Knee of Patients With Autologous Bone-marrow Mesenchymal Stem Cells and Scaffold|Completed||Phase 1|6|Actual|Royan Institute||1|||f||||t||||||||||2017-02-18 13:21:13.493972|2017-02-18 13:21:13.493972
NCT00850174|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-09-09|2009-07-02||April 2005||2005-04-01|September 2009|2009-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Oxcarbazepine 600 mg Tablets Under Fasting Conditions|A Single-Dose, Comparative Bioavailability Study of Two Formulations of Oxcarbazepine 600 mg Tablets Under Fasting Conditions|Completed||Phase 1|60|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:21:13.609983|2017-02-18 13:21:13.609983
NCT00850161|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-02-12|||July 2009||2009-07-01|February 2016|2016-02-01|September 2010|Anticipated|2010-09-01|August 2009|Anticipated|2009-08-01||Interventional|||Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin|Intranasal Insulin and Its Effect on Postprandial Glucose Metabolism in Comparison to Subcutaneous Insulin|Withdrawn||Phase 2|0|Actual|CPEX Pharmaceuticals Inc.||2||Business purposes.|f||||f||||||||No|There is no data; study never initiated.|2017-02-18 13:21:14.122101|2017-02-18 13:21:14.122101
NCT00850135|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2016-04-13|2016-04-13||February 2009||2009-02-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|July 2014|Actual|2014-07-01||Interventional||A total of 57 patients were enrolled from two clinical sites. One patient had no CGM data. One patient transferred care after completing the CGM study period, and thus did not have delivery data. Two patients who had an existing diagnosis of diabetes were excluded.The remaining 53 patients were analyzed.|Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes|Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes|Completed||Phase 1/Phase 2|57|Actual|Stanford University|Limited monitoring period between 24 and 28 weeks’ gestation. Sample size was under powered to detect differences in secondary outcomes of interest.|1|||f||||f||||||||No||2017-02-18 13:21:14.322042|2017-02-18 13:21:14.322042
NCT00850122|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-10-18|||July 2013||2013-07-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|July 2017|Anticipated|2017-07-01||Interventional|||An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates|An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates|Active, not recruiting||Phase 1|9|Actual|Duke University||1|||f||||f||||||||||2017-02-18 13:21:14.787439|2017-02-18 13:21:14.787439
NCT00850109|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-22|2012-04-25|||February 2009||2009-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:21:14.876046|2017-02-18 13:21:14.876046
NCT00850096|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2013-11-25|2012-02-14||January 2009||2009-01-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|CPEX-011||Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus|Effects of Nasulin v.Placebo on Blood Glucose Control in Patients With Type 2 DM Treated With Basal Insulin & Oral Antidiabetic Meds, Excluding Secretagogues in Phase 2A, Randomized, Parallel, Double-Blind, Placebo-Controlled, Multi-Center Study|Completed||Phase 2|94|Actual|CPEX Pharmaceuticals Inc.||2|||f||||f||||||||||2017-02-18 13:21:14.923777|2017-02-18 13:21:14.923777
NCT00850083|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-02-23|||March 2009||2009-03-01|February 2009|2009-02-01||||December 2009|Anticipated|2009-12-01||Observational|||Accuracy of Measurement of Surface Body Temperature Using the Health e Pod Device (Card Guard) Compared to Gold Standard Equipment|Accuracy of Measurement of Surface Body Temperature Using the Health e Pod Device (Card Guard) Compared to Gold Standard Equipment|Unknown status|Not yet recruiting|N/A|400|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-02-18 13:21:15.39343|2017-02-18 13:21:15.39343
NCT00850070|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2014-01-27|2012-08-31||March 2009||2009-03-01|January 2014|2014-01-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||Sapropterin as a Treatment for Autistic Disorder|Sapropterin as a Treatment for Autistic Disorder: A Phase II Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|46|Actual|The Children's Health Council||2|||f||||t||||||||||2017-02-18 13:21:15.473098|2017-02-18 13:21:15.473098
NCT00850057|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2011-03-31|||February 2006||2006-02-01|September 2010|2010-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Pharmacodynamic (PD) Study of Intranodal Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)|A Phase 1, Open Label, Dose-escalation, Pharmacodynamic Study of Intranodal Injection of Adenovirus-CD154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Completed||Phase 1|16|Actual|University of California, San Diego||1|||f||||t||||||||||2017-02-18 13:21:16.06198|2017-02-18 13:21:16.06198
NCT00850044|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2010-10-14|||February 2009||2009-02-01|September 2010|2010-09-01||||July 2009|Actual|2009-07-01||Interventional|||Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1|A Double-Blind, Randomized, Placebo-Controlled, Nonfasting Study in Healthy Adults to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Single Doses of ABT-450 With and Without Ritonavir|Completed||Phase 1|87|Actual|Abbott||4|||f||||f||||||||||2017-02-18 13:21:16.148785|2017-02-18 13:21:16.148785
NCT00850031|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2016-12-13|2016-07-20||January 2009||2009-01-01|December 2016|2016-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|ACI|Patients between 45 and 60 years of age with presbyopia|Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes|A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the AcuFocus Corneal Inlay (ACI)™ ACI 7000PDT in Presbyopic Subjects (OUS Study)|Completed||N/A|119|Actual|AcuFocus, Inc.||1|||f||||f||||||||No||2017-02-18 13:21:16.40018|2017-02-18 13:21:16.40018
NCT00850018|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2017-02-14|||December 2004||2004-12-01|February 2017|2017-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study|Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Disease - A Pilot Intervention Study|Completed||Phase 1|36|Anticipated|Children's Hospital & Research Center Oakland||2|||f||||t||||||||||2017-02-18 13:21:16.735441|2017-02-18 13:21:16.735441
NCT00850005|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-23|||February 2009||2009-02-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|||Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic Pain|IVIG for Treatment of Resistant Neuropathic Pain: a Preliminary Study|Unknown status|Recruiting|Phase 2|12|Anticipated|University of Calgary||2|||f||||f||||||||||2017-02-18 13:21:16.85857|2017-02-18 13:21:16.85857
NCT00849992|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-08-11|||March 2009||2009-03-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|March 2013|Actual|2013-03-01||Interventional|||Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy|Randomized Prospective Study Comparing 5% Imiquimod and Photodynamic Therapy for Actinic Cheilitis|Completed||Phase 4|53|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 13:21:16.965008|2017-02-18 13:21:16.965008
NCT00849979|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2012-07-26|||July 2008||2008-07-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy|M.D. Anderson Symptom Inventory (MDASI-GI) Validation and Clinical Utility in Patients With Gastrointestinal Cancers Being Treated or Followed by GI Medical Oncology|Completed||N/A|184|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 13:21:17.079956|2017-02-18 13:21:17.079956
NCT00849966|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2013-04-17|||August 2009||2009-08-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Celecoxib for Pediatric Adenotonsillectomy|Celecoxib for Pediatric Adenotonsillectomy: A Randomized Controlled Double Blinded Study|Completed||Phase 2|282|Actual|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-02-18 13:21:17.190778|2017-02-18 13:21:17.190778
NCT00849940|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-12-20|2015-11-09||February 2009||2009-02-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Validation of Brain Oxygenation Monitor on Pediatric Patients|Validation of the CAS Medical System, Inc. FORE-SIGHT Near-Infrared Spectroscopy (NIRS) Monitor in Pediatric Subjects for Viscerosomatic Applications|Terminated||N/A|72|Actual|Duke University|Blood samples collected from pediatric patients undergoing cardiac catheterization. Venous blood samples taken from within IVC as close to the tissue of interest.|1|||f||||f||||||||||2017-02-18 13:21:17.421544|2017-02-18 13:21:17.421544
NCT00849927|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-21|||January 2003||2003-01-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Circumferential Lesions of the Glenoid Labrum|Circumferential Lesions of the Glenoid Labrum: A Prospective Cohort Study of Arthroscopic Repair With Minimum 2-Year Follow-up: A Multi-Center Study.|Completed||N/A|39|Actual|Society of Military Orthopedic Surgeons|||1||f||||f||||||||||2017-02-18 13:21:17.697435|2017-02-18 13:21:17.697435
NCT00849914|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2012-10-15|||July 2008||2008-07-01|October 2012|2012-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Expression Levels of microRNA Processing Enzymes Dicer and Drosha in Epithelial Skin Cancer|Expression Levels of microRNA Processing Enzymes Dicer and Drosha in Epithelial Skin Cancer|Completed||N/A|28|Actual|Ruhr University of Bochum|||3||f||||f||||||Samples With DNA|"~     Punch biopsy from tumour, punch biopsy from healthy skin~   "|||2017-02-18 13:21:17.798884|2017-02-18 13:21:17.798884
NCT00849901|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2012-03-18|2012-02-22||March 2009||2009-03-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|March 2011|Actual|2011-03-01||Interventional|||A Study in the Treatment of Children and Adolescents With Major Depressive Disorder|A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder|Completed||Phase 3|337|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 13:21:17.904258|2017-02-18 13:21:17.904258
NCT00849888|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-22|2014-10-27|||April 2008||2008-04-01|October 2014|2014-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|SerumFree||Serum-Free Thymus Transplantation in DiGeorge Anomaly|Phase I Serum-Free Cultured Thymus Transplantation in DiGeorge Anomaly, IND9836|Terminated||Phase 1|2|Actual|Duke University||2||The sponsor decided to withdraw the study.|f||||t||||||||||2017-02-18 13:21:19.462131|2017-02-18 13:21:19.462131
NCT00849875|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-09-24||2015-03-12|May 2009||2009-05-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients|Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Association With Chemotherapy in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma|Terminated||Phase 2|48|Actual|GlaxoSmithKline||1||"Early end of trial notification after termination of long term follow up due to lack of~   scientific justification to continue collect information."|f||||||||||||||2017-02-18 13:21:19.580317|2017-02-18 13:21:19.580317
NCT00849862|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-09-01|2009-06-30||October 2005||2005-10-01|September 2009|2009-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Levetiracetam 750 mg Tablets Under Fasting Conditions|Randomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Levetiracetam 750 mg Tablet and Keppra® (Reference) Following a 750 mg Dose in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|22|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:21:19.788897|2017-02-18 13:21:19.788897
NCT00849849|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2014-12-17|||July 2011||2011-07-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|COPSS-GDM||Comprehensive Postpartum Screening Strategies for Women With Gestational Diabetes Mellitus (GDM)|Comprehensive Postpartum Screening Strategies for Women With Prior Gestational Diabetes (COPSS - GDM): Now is the Time for a Paradigm Shift in Clinical Practice|Completed||N/A|214|Actual|Woman's|||1||f||||t||||||Samples Without DNA|"~     Blood samples for diabetes testing~   "|||2017-02-18 13:21:20.20186|2017-02-18 13:21:20.20186
NCT00849836|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2009-02-23|||February 2009||2009-02-01|February 2009|2009-02-01|January 2010|Anticipated|2010-01-01|||||Observational|||Novel Biomarkers in Chronic Airway Diseases|The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders|Unknown status|Recruiting|N/A|30|Anticipated|Chonbuk National University|||3||f||||||||||||||2017-02-18 13:21:20.501486|2017-02-18 13:21:20.501486
NCT00849823|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2013-12-13|||February 2009||2009-02-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||HIV Prevention Program for African American Teen Males|A Brief, Clinic-Based, HIV Prevention Program for African American Teen Males|Completed||N/A|840|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-02-18 13:21:20.716817|2017-02-18 13:21:20.716817
NCT00849810|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-03-18|2013-03-18||January 2009||2009-01-01|March 2013|2013-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate|Comparative Effects of Nebivolol Versus Metoprolol on 24-hour Blood Pressures and Basal Metabolic Rate: An Open-Label Study|Terminated||N/A|1|Actual|University of Mississippi Medical Center||1||Difficulty with recruiting willing participants.|f||||t||||||||||2017-02-18 13:21:20.823859|2017-02-18 13:21:20.823859
NCT00849797|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-09-09|2009-07-02||July 2005||2005-07-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions|Randomized, Open-Label, 2-Way Crossover, Bioequivalence Study of Oxcarbazepine 600 mg Tablet and Trileptal® Following a 600 mg Dose in Healthy Subjects Under Fed Conditions|Completed||Phase 1|120|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:21:21.046146|2017-02-18 13:21:21.046146
NCT00849771|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2015-11-10|||March 2008||2008-03-01|November 2015|2015-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Operative Versus Nonoperative Treatment for Scapula Fractures|Multicenter Prospective Study of Operative and Non-operative Treatment for Scapula Fractures|Withdrawn||N/A|0|Actual|Vanderbilt University|||2|Joined another larger group of same study|f||||f||||||||||2017-02-18 13:21:21.57036|2017-02-18 13:21:21.57036
NCT00849758|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2014-12-08|||May 2009||2009-05-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2012|Actual|2012-09-01||Observational|EBS||Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients|Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients.|Completed||N/A|110|Actual|Universitaire Ziekenhuizen Leuven|||2||f||||f||||||Samples With DNA|"~     peripheral blood is collected for DNA, RNA, serum plasma, and lymphocytes~   "|||2017-02-18 13:21:21.665301|2017-02-18 13:21:21.665301
NCT00849745|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-22|2016-06-21|||January 2003||2003-01-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases|Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Autoimmune Diseases|Terminated||Phase 1|4|Actual|Duke University||2||low accrual|f||||t||||||||||2017-02-18 13:21:21.764457|2017-02-18 13:21:21.764457
NCT00849732|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2015-02-26|||June 2003||2003-06-01|February 2015|2015-02-01|February 2011|Actual|2011-02-01|October 2006|Actual|2006-10-01||Interventional|||A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018)|A Worldwide, Phase I, Dose-Escalating Study of Safety, Tolerability, and Immunogenicity of a 3-Dose Regimen of the MRKAd5 HIV-1 Gag Vaccine in Healthy Adults|Completed||Phase 1|360|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:21:21.885304|2017-02-18 13:21:21.885304
NCT00849719|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-23|||April 2009||2009-04-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|April 2010|Anticipated|2010-04-01||Interventional|||Effects of a Combination of IV-PCA With Continuous IV Infusion of MO, Versus IV-PCA MO on Postoperative Pain|Effects of Combination of Continuous Intravenous (IV) Infusion Plus Patient-Controlled Analgesia (PCA) of Morphine (MO) vs. IV-PCA MO on Postoperative Pain Control|Unknown status|Not yet recruiting|N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-02-18 13:21:21.987343|2017-02-18 13:21:21.987343
NCT00849706|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-23|||March 2009||2009-03-01|February 2009|2009-02-01||||March 2010|Anticipated|2010-03-01||Observational|||Effect of Work Load and Sleep Deprivation on Medical Staff's Driving Skills|Effect of Work Load and Sleep Deprivation on Medical Staff's Driving Skills|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 13:21:22.09976|2017-02-18 13:21:22.09976
NCT00849693|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2012-03-26|2012-02-22||March 2009||2009-03-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|February 2011|Actual|2011-02-01||Interventional|||A Study in the Treatment of Children and Adolescents With Major Depressive Disorder|A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder|Completed||Phase 3|463|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 13:21:22.213441|2017-02-18 13:21:22.213441
NCT00849680|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2015-01-21|2011-06-09||April 2003||2003-04-01|January 2015|2015-01-01|February 2010|Actual|2010-02-01|March 2005|Actual|2005-03-01||Interventional|||A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)|A Phase I Dose-Ranging Study of the Safety, Tolerability, and Immunogenicity of the Merck Trivalent Adenovirus Serotype 5 HIV-1 Gag/Pol/Nef Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in a Prime-Boost Regimen in Healthy Adults|Completed||Phase 1|317|Actual|Merck Sharp & Dohme Corp.|An interim analysis of a related study, V520 Protocol 023 (NCT00095576), showed that the MRKAd5 vaccine used in Protocol 016 (NCT00849680) was not efficacious; therefore, only a high level summary of the safety data was performed.|8|||f||||f||||||||||2017-02-18 13:21:23.971823|2017-02-18 13:21:23.971823
NCT00849667|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-06-25||2015-06-25|April 2009||2009-04-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse|A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Weekly MORAb-003 in Combination With Carboplatin and Taxane in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse|Completed||Phase 3|1100|Actual|Morphotek||3|||f||||t||||||||||2017-02-18 13:21:25.778549|2017-02-18 13:21:25.778549
NCT00849654|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2013-05-21|||February 2009||2009-02-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|PCYC-04753||Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma|Phase I Dose-Escalation Study of Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Recurrent B Cell Lymphoma|Completed||Phase 1|66|Actual|Pharmacyclics LLC.||1|||f||||f||||||||||2017-02-18 13:21:26.289304|2017-02-18 13:21:26.289304
NCT00849641|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-02-20|||March 2009||2009-03-01|February 2009|2009-02-01|March 2011|Anticipated|2011-03-01|October 2010|Anticipated|2010-10-01||Observational|||Muscle Tissue Oxygenation in Patients With Decompensated Liver Cirrhosis|Muscle Tissue Oxygenation in Patients With Decompensated Liver Cirrhosis|Unknown status|Not yet recruiting|N/A|90|Anticipated|University of Regensburg|||3||f||||f||||||||||2017-02-18 13:21:26.397239|2017-02-18 13:21:26.397239
NCT00849628|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-07-18|||June 2008||2008-06-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Observational|||Use of Drugs and Constipation in Nursing Homes|Use of Drugs and Constipation in Nursing Homes|Completed||N/A|267|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 13:21:26.483631|2017-02-18 13:21:26.483631
NCT00849615|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-23|2016-04-05|||February 2009||2009-02-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2012|Actual|2012-01-01||Interventional|FLOT3||Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction|A Prospective Multicenter Study With 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction|Completed||Phase 2|252|Actual|Krankenhaus Nordwest||1|||f||||t||||||||||2017-02-18 13:21:26.582647|2017-02-18 13:21:26.582647
NCT00849472|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-01-30|2012-12-06||July 2009||2009-07-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|December 2011|Actual|2011-12-01||Interventional|||Treatment With Pazopanib for Neoadjuvant Breast Cancer|A Phase II Clinical Trial of Four Cycles of Doxorubicin and Cyclophosphamide Followed by Weekly Paclitaxel Given Concurrently With Pazopanib as Neoadjuvant Therapy Followed by Postoperative Pazopanib for Women With Locally Advanced Breast Cancer|Completed||Phase 2|101|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 13:21:26.720263|2017-02-18 13:21:26.720263
NCT00849459|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2017-01-10|||August 2008||2008-08-01|January 2017|2017-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Gene Therapy in Treating Women With Metastatic Breast Cancer|Phase I Trial of Adenoviral Vector Delivery of the Human Interleukin-12 cDNA by Intratumoral Injection in Patents With Metastatic Breast Cancer|Completed||Phase 1|3|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-02-18 13:21:27.719087|2017-02-18 13:21:27.719087
NCT00849446|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2011-08-23|||February 2009||2009-02-01|February 2011|2011-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Validity and Reliability of an Activity Monitor in Persons With a Cerebrovascular Accident||Completed||N/A|30|Anticipated|University College of Antwerp|||2||f||||f||||||||||2017-02-18 13:21:27.864178|2017-02-18 13:21:27.864178
NCT00849433|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2015-01-15|||April 2009||2009-04-01|January 2015|2015-01-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Observational|||Effects of Smoking on Bronchial Epithelium|Effects of Smoking on Airway Remodeling and Phenotypic Changes of the Airway Epithelium in Asthma and COPD: Strategies to Restore the Epithelial Barrier, Repair and Steroid Sensitivity.|Completed||N/A|60|Anticipated|University Medical Center Groningen|||2||f||||f||||||Samples With DNA|"~     Bronchial biopsies Bronchial brushes Blood~   "|||2017-02-18 13:21:27.982265|2017-02-18 13:21:27.982265
NCT00849407|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2013-04-23|||October 2008||2008-10-01|April 2013|2013-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|M3||Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma|Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma|Recruiting||N/A|2000|Anticipated|Medical University of Vienna|||2||f||||f||||||||||2017-02-18 13:21:28.069346|2017-02-18 13:21:28.069346
NCT00849394|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2012-10-31|||November 2007||2007-11-01|February 2009|2009-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Evaluation of Protein in the Urine in Patients Receiving Bevacizumab|An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab|Completed||N/A|106|Actual|North Texas Veterans Healthcare System|||1||f||||f||||||||||2017-02-18 13:21:28.155924|2017-02-18 13:21:28.155924
NCT00849381|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2014-09-04|2013-11-27||April 2009||2009-04-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand|Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK580299) in Female Brazilian, Taiwanese and Thai Subjects Who Had Received Control Vaccine in Study 580299/008|Completed||Phase 3|1239|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 13:21:28.26605|2017-02-18 13:21:28.26605
NCT00849368|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2012-02-06|||January 2009||2009-01-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients|Dose-effect Relationship Between Allopurinol, Azathioprine and 6-thioguanine Nucleotide Levels (6-TGN) in Inflammatory Bowel Disease Patients.|Completed||Phase 1|6|Actual|University of Zurich||1|||f||||t||||||||||2017-02-18 13:21:28.565641|2017-02-18 13:21:28.565641
NCT00849355|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-02-20|||August 2008||2008-08-01|February 2009|2009-02-01|November 2010|Anticipated|2010-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Ciclophosphamide, Vincristine, Myocet and Prednisone, With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) Risk|Phase II, Multicenter Trial to Evaluate the Efficacy and Safety of the Following Treatment Squeme:Ciclophosphamide, Vincristine, Lyposomal Doxorrubicine, Myocet and Prednisone,Combined With Rituximab in First Line Treatment for Patients With Aggresive No Hodgkin B Lymphoma and Cardiovascular Risk|Unknown status|Recruiting|Phase 2|44|Anticipated|Asociacion Doctor Peset Para el Estudio de la Hematología||1|||f||||f||||||||||2017-02-18 13:21:28.665046|2017-02-18 13:21:28.665046
NCT00849342|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2014-08-13|||December 2008||2008-12-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|April 2011|Actual|2011-04-01||Observational|KILOS||Observational Study on Levemir® in Obese Diabetic Patients|A Prospective, Multicentre, Non-controlled, Observational, 52-weeks Study: the Evaluation of the Body Weight Progress During the Treatment With Insulin Detemir in Type 1 or 2 Diabetes Patients, Previously Treated With Other Basal Insulins|Completed||N/A|580|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:21:28.76947|2017-02-18 13:21:28.76947
NCT00849329|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-05-17|||March 2009||2009-03-01|March 2011|2011-03-01|February 2010|Actual|2010-02-01|November 2009|Actual|2009-11-01||Interventional|||A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer|An Open-Label, Single Sequence Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 13:21:28.868287|2017-02-18 13:21:28.868287
NCT00849316|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2013-01-18|||February 2009||2009-02-01|January 2013|2013-01-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Observational|||Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease|A Multicenter, Open Label, Nonrandomized, Non Interventional, Observational, Safety and Efficacy Study of NovoRapid™(Insulin Aspart) in Patients With Coexisting Diabetes and Kidney Disease in India. The NovoRapid™ Nephropathy Study|Withdrawn||N/A|0|Actual|Novo Nordisk A/S|||1|"Due to company decision to focus resources on the finalisation of three ongoing studies in the~   region"|f||||f||||||||||2017-02-18 13:21:28.973425|2017-02-18 13:21:28.973425
NCT00849303|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-02-20|||January 2009||2009-01-01|February 2009|2009-02-01||||December 2011|Anticipated|2011-12-01||Interventional|||Multicenter Rehabilitation Study in Acute Stroke|Gait-Oriented Rehabilitation at Different Phases in Patients With Acute Stroke - Multicenter Randomized Controlled Trial.|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|University of Jyvaskyla||2|||f||||f||||||||||2017-02-18 13:21:29.172601|2017-02-18 13:21:29.172601
NCT00849290|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2013-03-12|2010-05-28||April 2004||2004-04-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)||Completed||Phase 2|113|Actual|Dendreon||1|||f||||f||||||||||2017-02-18 13:21:29.280022|2017-02-18 13:21:29.280022
NCT00849277|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-02-20|||October 2006||2006-10-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of the Effect of Probiotics on Respiratory Morbidity After Influenza Vaccination of Elderly in Nursing Homes|An RCT in Nursing Homes: the Effect of a Probiotic Treatment With Lactobacillus Casei Shirota on Respiratory Morbidity After Influenza Vaccination of Elderly.|Completed||Phase 4|737|Actual|Universiteit Antwerpen||2|||f||||||||||||||2017-02-18 13:21:29.605518|2017-02-18 13:21:29.605518
NCT00849264|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-03-30|||December 2008||2008-12-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients|a Randomized Controlled Study of Surgical Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients|Completed||Phase 2|120|Actual|Eastern Hepatobiliary Surgery Hospital||3|||f||||t||||||||||2017-02-18 13:21:29.696894|2017-02-18 13:21:29.696894
NCT00848913|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-06-02|||October 2013||2013-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Strength Training After Hip Fracture Surgery|Effect of Rehabilitation With Versus Without Progressive Strength Training Implemented in the Acute Ward After Hip Fracture Surgery: A Randomized Controlled Trial|Completed||N/A|90|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-02-18 13:21:40.944863|2017-02-18 13:21:40.944863
NCT00849251|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2015-09-17|||November 2008||2008-11-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|December 2011|Actual|2011-12-01||Interventional|||Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma|Combination Pegylated Liposomal Doxorubicin, Bortezomib, Cyclophosphamide, and Dexamethasone for Multiple Myeloma (PLD-BCD)|Terminated||Phase 1/Phase 2|31|Actual|University of Washington||1||One of the study drugs is not available.|f||||t||||||||||2017-02-18 13:21:29.819312|2017-02-18 13:21:29.819312
NCT00849238|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-10-06||||||October 2015|2015-10-01||||||||Interventional|||Mycophenolate Mofetil Maintenance Therapy for Liver Transplantation|Mycophenolate Mofetil Maintenance Therapy for Liver Transplantation Following Campath-1H Induction|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison||||feasibility issues|f||||||||||||||2017-02-18 13:21:29.941001|2017-02-18 13:21:29.941001
NCT00849212|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2013-01-03|2012-10-26||April 2009||2009-04-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)|A Phase II, Open-label, Ascending High-dose, add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)|Completed||Phase 2|30|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 13:21:30.009167|2017-02-18 13:21:30.009167
NCT00849199|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2016-08-05|||July 2001||2001-07-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Cancer Screening and Prevention Program for High Risk Women|Cancer Screening and Prevention Program for High Risk Women|Recruiting||N/A|2062|Anticipated|New York University School of Medicine|||1||f||||f||||||||||2017-02-18 13:21:30.237485|2017-02-18 13:21:30.237485
NCT00849186|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2015-01-22|2015-01-22||August 2007||2007-08-01|January 2015|2015-01-01|April 2010|Actual|2010-04-01|July 2009|Actual|2009-07-01||Interventional||All treated and eligible patients|Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer|A Pilot Study of Neoadjuvant SUNITINIB MALATE (Sunitinib) in Patients With Renal Cell Carcinoma Undergoing Nephrectomy|Completed||N/A|20|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 13:21:30.342289|2017-02-18 13:21:30.342289
NCT00849173|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2017-01-24|||February 17, 2009||2009-02-17|November 26, 2012|2012-11-26|November 26, 2012||2012-11-26|||||Observational|||Global Study of Women's Health|Global Study of Women's Health|Completed||N/A|7|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:21:32.881868|2017-02-18 13:21:32.881868
NCT00849160|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2014-01-21|||May 2009||2009-05-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|RADAR||Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.|Non-comparative, Opened Study, Evaluating in HIV-1 Infected Patients With Undetectable Viral Load, Treated by an Antiretroviral Combination Including a Protease Inhibitor Boosted With Ritonavir and Administered by Oral Route Twice a Day, the Substitutability of the Current Protease Inhibitor Regimen by the Association Darunavir/Ritonavir 800/100 mg Once a Day to Maintain the Viral Load Under the 50 Copies/ml Limit of Detection After 24 Weeks of Treatment.|Completed||Phase 3|100|Actual|Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida||1|||f||||f||||||||||2017-02-18 13:21:32.969014|2017-02-18 13:21:32.969014
NCT00849147|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2016-08-01|2015-05-20||October 2008||2008-10-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|June 2011|Actual|2011-06-01||Interventional||Received transplant.|Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)|A Multi-Center, Phase II Trial of Nonmyeloablative Conditioning (NST) and Transplantation of Partially HLA-Mismatched Bone Marrow From Related Donors for Patients With Hematologic Malignancies (BMT CTN #0603)|Completed||Phase 2|55|Actual|Medical College of Wisconsin||1|||f||||t||||||||Yes||2017-02-18 13:21:33.090089|2017-02-18 13:21:33.090089
NCT00849134|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-10-26|||November 2008||2008-11-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.|A First-Time-in-Human Randomised, Single Blind Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics, of Single Escalating Doses of GSK1482160, in Male and Female Healthy Subjects, and to Make a Preliminary Assessment of the Effect of Food.|Completed||Phase 1|25|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:21:33.883157|2017-02-18 13:21:33.883157
NCT00849121|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-10-10|2014-08-29||March 2009||2009-03-01|October 2016|2016-10-01|July 2019|Anticipated|2019-07-01|February 2014|Actual|2014-02-01||Interventional|||Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer|A Pilot Randomized Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer|Active, not recruiting||Phase 2|17|Actual|University of Wisconsin, Madison|Of the 17 participants enrolled, 16 received at least 6 initial immunizations with pTVG-HP vaccine and were deemed evaluable to be assessed for outcome measure 3.|2|||f||||t||||||||||2017-02-18 13:21:34.001192|2017-02-18 13:21:34.001192
NCT00849108|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-10-12|2014-10-30||January 2009||2009-01-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||Intent to treat population Cohort 1 N=33; Cohort 2 N=125 Safety population; Cohort 1 N=33; Cohort 2 N=143|Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158|A Phase 2, Open-Label, Randomized Multicenter Study for the Development of One-Day Rest/Stress Cardiac Positron Emission Tomography (PET) Perfusion Imaging Protocols of BMS747158|Completed||Phase 2|176|Actual|Lantheus Medical Imaging||2|||f||||t||||||||||2017-02-18 13:21:34.538066|2017-02-18 13:21:34.538066
NCT00849095|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2014-05-29|||April 2009||2009-04-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma|As Needed Budesonide/Formoterol Combination Versus Regular Budesonide/Formoterol Combination Plus as Needed Terbutaline in Mild-Moderate Persistent Asthma|Completed||Phase 3|860|Actual|Università degli Studi di Ferrara||2|||f||||t||||||||||2017-02-18 13:21:35.078219|2017-02-18 13:21:35.078219
NCT00845351|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2011-05-26|||November 2008||2008-11-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Preoperative Bexarotene Treatment for Cushing's Disease|Preoperative Bexarotene Treatment for Cushing's Disease|Unknown status|Recruiting|Phase 1/Phase 2|6|Anticipated|University of Virginia||1|||f||||f||||||||||2017-02-18 13:22:59.655044|2017-02-18 13:22:59.655044
NCT00849082|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2012-07-10|||May 1987||1987-05-01|July 2012|2012-07-01||||November 1995|Actual|1995-11-01||Interventional|||Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer|Phase III Randomized Comparison of Pelvic Radiotherapy Alone vs Pelvic Radiotherapy Plus the LHRH Analogue Goserelin and Cyproterone Acetate in Carcinoma of the Prostate at High Risk for Metastasis|Completed||Phase 3|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 13:21:35.221223|2017-02-18 13:21:35.221223
NCT00849069|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-10-19|||March 2009||2009-03-01|October 2015|2015-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine|An Observer-blind, Safety Study of GSK Biologicals' Haemophilus Influenzae and Streptococcus Pneumoniae Candidate Vaccine in Adults.|Terminated||Phase 1|30|Anticipated|GlaxoSmithKline||2||"The study has been stopped for logistic reasons not related to the safety or efficacy of the~   vaccine."|f||||||||||||||2017-02-18 13:21:35.316327|2017-02-18 13:21:35.316327
NCT00849056|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-11-18|2014-04-24||January 2009||2009-01-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|November 2011|Actual|2011-11-01||Interventional|||Safety and Efficacy of Albiglutide in Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Pioglitazone With or Without Metformin in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|310|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:21:35.649988|2017-02-18 13:21:35.649988
NCT00849043|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2011-01-25|||February 2009||2009-02-01|January 2011|2011-01-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Observational|AERO C009E||Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea|A Single Arm, Open-label Extension Study to Evaluate the Long-term Durability of Treatment Response and and Safety of the Provent Professional Sleep Apnea Therapy Device for the Non-invasive Treatment of Obstructive Sleep Apnea-hypopnea|Completed||Phase 3|65|Anticipated|Ventus Medical, Inc.|||1||f||||f||||||||||2017-02-18 13:21:37.107952|2017-02-18 13:21:37.107952
NCT00849030|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2012-06-05|||July 1996||1996-07-01|June 2012|2012-06-01|April 2010|Actual|2010-04-01|June 2001|Actual|2001-06-01||Interventional|||ATAC - Arimidex, Tamoxifen Alone or in Combination|A Randomised, Double Blind Trial Comparing Arimidex Alone With Nolvadex Alone With Arimidex and Nolvadex in Combination, as Adjuvant Treatment in Post-Menopausal Women With Breast Cancer|Completed||Phase 3|9358|Actual|AstraZeneca||3|||f||||t||||||||||2017-02-18 13:21:37.220171|2017-02-18 13:21:37.220171
NCT00849017|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-11-18|2014-04-24||January 2009||2009-01-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|November 2011|Actual|2011-11-01||Interventional|||Safety and Efficacy Study of Albiglutide in Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|309|Actual|GlaxoSmithKline||3|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:21:37.356276|2017-02-18 13:21:37.356276
NCT00849004|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2012-10-19|||March 2009||2009-03-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|RCT||Prevention of Hypertrophic Scars or Keloids|Comparison of the Effectiveness in Prevention of Hypertrophic Scars or Keloids Between Silicone Sheet, Silicone Gel and Paper Steri-strip-A Randomised Controlled Trial.|Unknown status|Active, not recruiting|N/A|75|Anticipated|Kaohsiung Veterans General Hospital.||3|||f||||f||||||||||2017-02-18 13:21:39.183395|2017-02-18 13:21:39.183395
NCT00848991|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-02-09|||February 2009||2009-02-01|February 2009|2009-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Comparison of Propofol to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy Surgery|Comparison of Propofol Standard Anesthetic to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy Surgery|Completed||Phase 3|15|Actual|The Cooper Health System||2|||f||||f||||||||||2017-02-18 13:21:39.304154|2017-02-18 13:21:39.304154
NCT00848978|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2009-02-20|||March 2009||2009-03-01|February 2009|2009-02-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|STRONG||Strength Training in Nonagenarians|Health Enhancing Strength Training in Nonagenarians|Unknown status|Enrolling by invitation|N/A|60|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||t||||||||||2017-02-18 13:21:39.412354|2017-02-18 13:21:39.412354
NCT00848965|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-08-23|2012-08-23||October 2007||2007-10-01|February 2011|2011-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber|A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study to Assess the Dose-response Curve of Intranasal Fluticasone Propionate (25, 50, 100 and 200 μg, Once Daily for 8 Days) in the Vienna Challenge Chamber for the Purpose of Investigating the Sensitivity|Completed||Phase 4|59|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-02-18 13:21:39.522056|2017-02-18 13:21:39.522056
NCT00848952|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-20|2010-02-03|||March 2009||2009-03-01|February 2009|2009-02-01||||March 2010|Anticipated|2010-03-01||Interventional|CHIC||Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis|Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis|Unknown status|Not yet recruiting|N/A|450|Anticipated|University Hospital, Angers||1|||f||||||||||||||2017-02-18 13:21:40.147002|2017-02-18 13:21:40.147002
NCT00848939|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2012-10-19|||December 2008||2008-12-01|October 2012|2012-10-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|DISTOL-PK||Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis|An Evaluation of the Pharmacokinetics and Safety of Fixed and Escalating Doses of Oral Treprostinil Diethanolamine (UT-15C) Sustained Release Tablets in Patients With Systemic Sclerosis|Completed||Phase 1|28|Actual|United Therapeutics||1|||f||||f||||||||||2017-02-18 13:21:40.251613|2017-02-18 13:21:40.251613
NCT00848926|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-11-06|2011-09-15||February 2009||2009-02-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|August 2010|Actual|2010-08-01||Interventional|||A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma|A Pivotal Study of SGN-35 in Treatment of Patients With Relapsed or Refractory Hodgkin Lymphoma (HL)|Completed||Phase 2|102|Actual|Seattle Genetics, Inc.||1|||f||||t||||||||||2017-02-18 13:21:40.356791|2017-02-18 13:21:40.356791
NCT00848900|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-11-19|||April 2009||2009-04-01|October 2010|2010-10-01|July 2012|Anticipated|2012-07-01|April 2012|Anticipated|2012-04-01||Interventional|||Guangzhou Outdoor Activity Longitudinal Study|A Controlled Clinical Trial of the Effect of Increases Time Outdoors in the Prevention of Juvenile-onset Myopia in Chinese Children|Unknown status|Enrolling by invitation|N/A|2000|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:21:41.196475|2017-02-18 13:21:41.196475
NCT00848887|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2014-01-23|||October 2008||2008-10-01|January 2014|2014-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age|A Phase Ib, Randomized, Observer-Blind, Multicenter, Factorial-Design Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Injections of Trivalent Inactivated Influenza Vaccine With or Without a Second Influenza B Strain in Combination With or Without One of Three Different Doses of Adjuvant in Healthy Children, Aged 6 to <36 Months|Completed||Phase 1|410|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:21:41.299189|2017-02-18 13:21:41.299189
NCT00848874|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2009-02-19|||September 2008||2008-09-01|February 2009|2009-02-01|April 2010|Anticipated|2010-04-01|June 2009|Anticipated|2009-06-01||Interventional|PVGS-II||Portable Visual Guidance System Phase II|Phase II Study of a Portable Visual Guidance System for Use by AS/HFA Students in Inclusion Settings|Unknown status|Enrolling by invitation|N/A|50|Anticipated|SymTrend Inc.||1|||f||||f||||||||||2017-02-18 13:21:41.411031|2017-02-18 13:21:41.411031
NCT00848861|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||February 2006||2006-02-01|February 2009|2009-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Trial Comparing Propofol to Midazolam Plus Meperidine Sedation for Outpatient Colonoscopy||Completed||N/A|92|Actual|University of Alberta||2|||f||||f||||||||||2017-02-18 13:21:41.506513|2017-02-18 13:21:41.506513
NCT00848848|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-05-05|||October 2008||2008-10-01|May 2016|2016-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older|A Phase Ib, Multi-Center, Randomized, Observer-Blind, Proof of Concept, Dose- and Formulation-Ranging Study to Evaluate Safety, Tolerability, and Immunogenicity of One Dose of Trivalent Inactivated Influenza Vaccine in Different Presentations (Intramuscular and Intradermal Delivery), Dosages (Regular or Higher A/H3N2 Content) and Doses of Adjuvant Administered to Healthy Elderly Aged ≥ 65 Years|Completed||Phase 1|450|Actual|Seqirus||10|||f||||||||||||||2017-02-18 13:21:41.633019|2017-02-18 13:21:41.633019
NCT00848835|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-08-30|||March 2002||2002-03-01|August 2010|2010-08-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Observational|LEAD LIFE||Long Term Integrity Follow-up Evaluation|Long Term Integrity Follow-up Evaluation|Completed||Phase 4|372|Actual|Guidant Corporation|||1||f||||f||||||||||2017-02-18 13:21:41.753199|2017-02-18 13:21:41.753199
NCT00848822|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-04-14|||February 2009||2009-02-01|April 2011|2011-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Sleep and Glucose Regulation in Youth With Type 1 Diabetes Mellitus|Sleep and Glucose Regulation in Youth With Type 1 Diabetes Mellitus|Completed||N/A|50|Actual|University of Arizona|||1||f||||f||||||||||2017-02-18 13:21:41.857324|2017-02-18 13:21:41.857324
NCT00848809|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-04-21|||December 2008||2008-12-01|April 2015|2015-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Pharmacokinetics of Vancomycin in the ICU in Renal Replacement Therapy|Pharmacokinetics of Vancomycin in Various Modalities of Renal Replacement Therapy in the Intensive Care Unit|Withdrawn||N/A|0|Actual|Avera McKennan Hospital & University Health Center|||2|PI had difficult enrollment.|f||||f||||||None Retained|"~     Whole blood~   "|||2017-02-18 13:21:41.948989|2017-02-18 13:21:41.948989
NCT00848796|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||September 2006||2006-09-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparative Study of Two Brands of Heparin Already on the Market|Do Different Heparin Brands Influence Bleeding in Coronary Surgery|Completed||N/A|100|Actual|Southlake Regional Health Centre||1|||f||||f||||||||||2017-02-18 13:21:42.063106|2017-02-18 13:21:42.063106
NCT00848783|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-06-17|2012-11-09||May 2008||2008-05-01|June 2016|2016-06-01|September 2012|Actual|2012-09-01|August 2011|Actual|2011-08-01||Interventional|||Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers|A Randomized Phase-II Study of Patients With Locally Advanced Gastric of Gastro-Esophageal Adenocarcinoma Treated With Induction Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Adjuvant Intraperitoneal Floxuridine, Followed by Prolonged Administration of Capecitabine|Terminated||Phase 2|8|Actual|New York University School of Medicine|Early termination leading to small numbers of subjects analyzed.|2||Due to slow accrual|f||||t||||||||||2017-02-18 13:21:42.167903|2017-02-18 13:21:42.167903
NCT00848770|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-12-30|||January 2008||2008-01-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|MAPAS||Manipulation of Arterial Pressure in Acute Ischemic Stroke|Manipulation of Arterial Pressure Early in Non Thrombolysed Acute Ischemic Stroke: Effects on Death and Neurological Disability|Unknown status|Recruiting|N/A|240|Anticipated|Hospital de Clinicas de Porto Alegre||3|||f||||f||||||||||2017-02-18 13:21:42.649335|2017-02-18 13:21:42.649335
NCT00848757|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-07-20|||March 2009||2009-03-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Changing Lifestyles for Better Health|Changing Lifestyles for Better Health: A Model Program for Community Health Centers|Completed||N/A|130|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:21:42.775433|2017-02-18 13:21:42.775433
NCT00848744|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-05-15|2009-11-10||February 2008||2008-02-01|May 2015|2015-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Two Salicylic Acid Formulations|A Split-Face, Paired-Comparison, Pilot Study to Evaluate Safety and Efficacy of Two Topical Salicylic Acid 1.0% Creams for Mild to Moderate Acne Vulgaris|Completed||N/A|10|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 13:21:42.878648|2017-02-18 13:21:42.878648
NCT00848731|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2011-06-23|||February 2009||2009-02-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism|Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism|Completed||Phase 1|25|Anticipated|Carolinas Healthcare System||1|||f||||f||||||||||2017-02-18 13:21:43.104981|2017-02-18 13:21:43.104981
NCT00848523|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-07-15|||November 2008||2008-11-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors|Phase II Trial of LBH589 (Panobinostat) in Adult Patients With Recurrent Malignant Gliomas|Terminated||Phase 2|6|Actual|Neurological Surgery, P.C.||1||insufficient accrual|f||||t||||||||||2017-02-18 13:21:45.889907|2017-02-18 13:21:45.889907
NCT00848718|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-01-21|||March 2009||2009-03-01|January 2015|2015-01-01|May 2012|Actual|2012-05-01|May 2011|Actual|2011-05-01||Interventional|||A Phase I Study of MK2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (2206-003 AM5)|A Phase I Dose Escalation Study of MK-2206 in Combination With Standard Doses of Selected Chemotherapies or Targeted Agents in Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|72|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:21:43.204916|2017-02-18 13:21:43.204916
NCT00848705|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2011-01-31|||October 2007||2007-10-01|January 2011|2011-01-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|YourWay||Adolescent Self-Management of Type 1 Diabetes: an Intervention (Completed)|Adolescent Self-Management of Type 1 Diabetes: an Intervention|Completed||Early Phase 1|72|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 13:21:43.304249|2017-02-18 13:21:43.304249
NCT00848692|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2011-06-01|||June 2008||2008-06-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|KTS-1-2008||Drug Intervention in Chronic Fatigue Syndrome|B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-blind, Placebo-controlled Study.|Completed||Phase 2/Phase 3|30|Anticipated|Haukeland University Hospital||2|||f||||f||||||||||2017-02-18 13:21:43.394441|2017-02-18 13:21:43.394441
NCT00848679|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||March 2009||2009-03-01|February 2009|2009-02-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Investigating the Novel Observation of Right-Left Difference in Uterine Artery Vascular Resistance in Pre-Eclampsia|Investigating the Novel Observation of Right-Left Difference in Uterine Artery Vascular Resistance in Pre-Eclampsia: A Double-Blinded, Randomized, Placebo-Controlled Study to Assess the Dose-Dependent Effect of Epidural Lidocaine on Right-Left Uterine Artery Blood Flow Differences in Pre-Eclampsia, With Healthy Term Pregnant and Non-Pregnant Controls|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:21:43.497423|2017-02-18 13:21:43.497423
NCT00848666|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2009-02-23|||April 2009||2009-04-01|February 2009|2009-02-01||||April 2010|Anticipated|2010-04-01||Interventional|||Safety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot)||Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-02-18 13:21:43.594783|2017-02-18 13:21:43.594783
NCT00848653|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||November 2004||2004-11-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Observational|ELECTION||ELECTION - The Electrode Configuration Cardiac Resynchronization Therapy (CRT) Study (ELECTION)|The Electrode Configuration (ELECTION) CRT Study Including ELECTION Phrenic Nerve Stimulation (PNS) Sub-Study|Completed||Phase 4|260|Actual|Guidant Corporation|||1||f||||f||||||||||2017-02-18 13:21:43.684951|2017-02-18 13:21:43.684951
NCT00848640|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-05-25|||October 2008||2008-10-01|September 2009|2009-09-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|MERITS||Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma|Multi-center,Middle East, Phase-II Study, Non-comparative, of the RAF-Kinase Inhibitor Sorafenib in Patients With Advanced Renal Cell Carcinoma to Evaluate The Efficacy and Tolerability of the Drug|Completed||Phase 2|75|Actual|Egyptian Foundation For Cancer Research||1|||f||||t||||||||||2017-02-18 13:21:43.76751|2017-02-18 13:21:43.76751
NCT00848627|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-12-09|||March 2007||2007-03-01|December 2010|2010-12-01|February 2015|Anticipated|2015-02-01|February 2012|Anticipated|2012-02-01||Observational|||Screening for Bladder Cancer|Screening for Bladder Cancer|Unknown status|Recruiting|N/A|1500|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-02-18 13:21:43.990682|2017-02-18 13:21:43.990682
NCT00848601|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2011-12-01|||February 2009||2009-02-01|December 2011|2011-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma|Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of SGI-1776, a PIM Kinase Inhibitor, in Subjects With Hormone and Docetaxel Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma|Terminated||Phase 1|14|Actual|Astex Pharmaceuticals||1||"The dose limiting toxicity of cardiac QTc prolongation was identifiedin the phase 1 study in~   patients with refractory prostate and lymphoma"|f||||f||||||||||2017-02-18 13:21:44.104759|2017-02-18 13:21:44.104759
NCT00848588|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2012-03-01|||June 2009||2009-06-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Observational|||A Survey of Factors Associated With the Successful Recognition of Agonal Breathing and Cardiac Arrest.|A Survey of Factors Associated With the Successful Recognition of Agonal Breathing and Cardiac Arrest by 9-1-1 Call Takers.|Completed||N/A|409|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 13:21:44.194239|2017-02-18 13:21:44.194239
NCT00848575|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2013-09-13|||February 2009||2009-02-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|Culdo||A Preliminary Study Utilizing a Flexible Endoscope for Pelvic Culdoscopy|A Preliminary Study Utilizing a Flexible Endoscope for Pelvic Culdoscopy|Terminated||N/A|2|Actual|University of Arkansas|||1|Low enrollment|f||||f||||||||||2017-02-18 13:21:44.271671|2017-02-18 13:21:44.271671
NCT00848562|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||January 2002||2002-01-01|February 2009|2009-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients|Oral Nicorandil to Reduce Cardiac Death After Coronary Revascularization in Hemodialysis Patients: A Randomized Trial|Completed||N/A|129|Actual|Toujinkai Hospital||1|||f||||t||||||||||2017-02-18 13:21:44.355886|2017-02-18 13:21:44.355886
NCT00848549|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-12-21|2012-11-12||October 2008||2008-10-01|November 2015|2015-11-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures|A Randomized, Double-Blind Extension Study To Assess The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures|Completed||Phase 3|295|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 13:21:44.457403|2017-02-18 13:21:44.457403
NCT00848536|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2012-04-04|2011-02-14||March 2009||2009-03-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy Study of Travoprost APS Versus TRAVATAN|A Multi-Center, Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|371|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:21:45.509791|2017-02-18 13:21:45.509791
NCT00848510|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-11-09|2015-07-24||February 2009||2009-02-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||All subjects analysis set included all subjects who entered the trial (that is, all subjects who signed informed consent).|EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases|A Phase I, Open-label, Dose-escalation Study to Investigate the Safety, Tolerability, PD and PK of EMD 525797 Using DCE-MRI as a PK Measure of Response in Colorectal and Ovarian Cancer Patients With Liver Metastases After Failure of Standard Therapy|Completed||Phase 1|41|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 13:21:45.999602|2017-02-18 13:21:45.999602
NCT00848497|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-06-02|2013-03-18||November 2007||2007-11-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Arm 1 = 2 Arm 2 = 1|Testosterone for Penile Rehabilitation After Radical Prostatectomy|Efficacy of Testosterone Replacement Therapy in Penile Rehabilitation Following Radical Prostatectomy (#: 04-07-30-01)|Terminated||Early Phase 1|3|Actual|Baylor College of Medicine|The subject that completed the study reported no adverse reactions or events.|2||Lack of volunteers who would consent to participate and lack of funding|f||||t||||||||||2017-02-18 13:21:47.281603|2017-02-18 13:21:47.281603
NCT00848484|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-10-30|2010-06-11||October 2008||2008-10-01|October 2015|2015-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, Add-On Therapy, 2-Period Cross-Over Clinical Trial to Evaluate the Safety and Efficacy of MK5757 for the Treatment of Cognitive Impairment in Men With Schizophrenia|Completed||Phase 2|54|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:21:47.7011|2017-02-18 13:21:47.7011
NCT00848471|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-08-18|||January 2009||2009-01-01|August 2009|2009-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|Protocol Quark||Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems)|Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems) for Measuring Energy Expenditure at Rest and in Dynamic Phase After a Meal in Adult Healthy and Obese Volunteers|Unknown status|Recruiting|N/A|30|Anticipated|Hospices Civils de Lyon||2|||f||||f||||||||||2017-02-18 13:21:48.298224|2017-02-18 13:21:48.298224
NCT00848458|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-07-14|||January 2009||2009-01-01|July 2010|2010-07-01||||December 2010|Anticipated|2010-12-01||Interventional|AAI||Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream in the Treatment of Melasma|Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream in the Treatment of Melasma - An Open Randomized, Controlled, Prospective, Single Blinded Clinical Trial|Unknown status|Recruiting|Phase 2/Phase 3|70|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 13:21:48.394398|2017-02-18 13:21:48.394398
NCT00848445|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||October 2002||2002-10-01|February 2009|2009-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|CAFE||Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study -|the Use of Atrial Fibrillation Pacing Therapies in Patients With no Previous History of Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study -|Completed||Phase 4|270|Actual|Guidant Corporation||2|||f||||f||||||||||2017-02-18 13:21:48.659902|2017-02-18 13:21:48.659902
NCT00848432|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-23|||December 2002||2002-12-01|February 2009|2009-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Risperidone Maintenance Treatment in Schizophrenia|Risperidone Maintenance Treatment for Relapse Prevention in Schizophrenia|Completed||Phase 4|404|Actual|Capital Medical University||3|||f||||t||||||||||2017-02-18 13:21:48.755613|2017-02-18 13:21:48.755613
NCT00848419|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||April 2009||2009-04-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||A Prospective Randomized Comparison of Fentanyl, Methadone and Morphine for Epidural Analgesia in an Experimental Pain Model|A Prospective Randomized Comparison of Fentanyl, Methadone and Morphine for Epidural Analgesia in an Experimental Pain Model|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Hadassah Medical Organization||4|||f||||f||||||||||2017-02-18 13:21:48.867514|2017-02-18 13:21:48.867514
NCT00848406|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-01-15|||April 2009||2009-04-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|April 2014|Actual|2014-04-01||Observational|NORM||A Study to Obtain Normal Values of Inflammatory Variables From Healthy Subjects|An Observational Study to Obtain Normal Values of Inflammatory Variables in Induced Sputum, Exhaled Breath, and Bronchial Biopsies From Healthy Smoking and Non-smoking Individuals|Completed||N/A|120|Anticipated|University Medical Center Groningen|||4||f||||f||||||Samples With DNA|"~     Blood, induced sputum, bronchial biopsies, brush and lining fluid, urine~   "|||2017-02-18 13:21:48.963816|2017-02-18 13:21:48.963816
NCT00848393|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-06-26|||November 2008||2008-11-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Measures to Lower the Stress Response in Pediatric Cardiac Surgery|Stress Response in Children Undergoing Cardiac Surgery: a Prospective Randomized Comparison Between Low Dose Fentanyl, Low Dose Fentanyl Plus Dexmedetomidine and High Dose Fentanyl.|Completed||N/A|52|Actual|Nationwide Children's Hospital||3|||f||||t||||||||||2017-02-18 13:21:49.052774|2017-02-18 13:21:49.052774
NCT00848380|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-11-15|||February 2009||2009-02-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Management of Cardiovascular Risk Factors|Management of Cardiovascular Risk Factors|Completed||N/A|1492|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:21:49.190021|2017-02-18 13:21:49.190021
NCT00848367|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2014-01-10|2013-06-04||April 2007||2007-04-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Binge Eating Disorder Treatment Study|Optimizing Outcomes for Binge Eating, Depression and Weight Loss for Obese Women With Binge Eating Disorder by Matching to Group Psychological Treatments Based on Level of Attachment Anxiety|Completed||N/A|102|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 13:21:49.307732|2017-02-18 13:21:49.307732
NCT00848354|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-12-11|2012-02-02||June 2009||2009-06-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||The safety population included all randomized participant with documented use of at least 1 dose of test article - Baseline characteristics from Phase 1 CSR are provided.|Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy|A Randomized, Open-label Study In The Latin America Region Comparing The Safety And Efficacy Of Etanercept With Conventional Dmard Therapy In Subjects With Rheumatoid Arthritis.|Completed||Phase 4|429|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:21:49.746185|2017-02-18 13:21:49.746185
NCT00848328|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-12-20|||March 2008||2008-03-01|December 2016|2016-12-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma|A Phase II Trial of the Combination of Lenalidomide and Rituximab in Patients With Relapsed/Refractory Follicular NHL (RV 0163)|Active, not recruiting||Phase 2|30|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-02-18 13:21:53.346118|2017-02-18 13:21:53.346118
NCT00848315|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||July 2004||2004-07-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Diabetes Management in Low-Income Hispanic Patients|Diabetes Management in Low-Income Hispanic Patients|Completed||Phase 2|252|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-02-18 13:21:53.470835|2017-02-18 13:21:53.470835
NCT00848302|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-06-21|||September 2009||2009-09-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Endothelial Function in Human Arteries|Endothelial Function in Human Arteries|Completed||Phase 1|25|Actual|The Cleveland Clinic||1|||f||||t||||||||||2017-02-18 13:21:53.699177|2017-02-18 13:21:53.699177
NCT00848289|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||July 2008||2008-07-01|February 2009|2009-02-01|January 2014|Anticipated|2014-01-01|June 2013|Anticipated|2013-06-01||Observational|||Genetic Susceptibility to Bladder Cancer|H-8577:Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach|Unknown status|Recruiting|N/A|2200|Anticipated|Baylor College of Medicine|||2||f||||f||||||Samples Without DNA|"~     blood (about 40 cc or 8 teaspoons), urine~   "|||2017-02-18 13:21:53.808695|2017-02-18 13:21:53.808695
NCT00848276|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-12-07|||July 2008||2008-07-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Sex Hormones and Blood PCSK9 Levels|Human Studies On Gender Differences In PCSK9 Function In Lipoprotein Metabolism|Completed||N/A|61|Actual|Ottawa Hospital Research Institute|||2||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:21:53.913398|2017-02-18 13:21:53.913398
NCT00848263|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2014-11-17|||February 2009||2009-02-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|RADIUS||Unstable Fractures of the Distal Radius: Trial of Volar Plate Versus Dorsal Nail Plate Fixation|Unstable Fractures of the Distal Radius: Randomised Controlled Trial of Volar Plate Versus Dorsal Nail Plate Fixation.|Completed||N/A|120|Actual|Sykehuset Asker og Baerum||2|||f||||f||||||||||2017-02-18 13:21:54.014586|2017-02-18 13:21:54.014586
NCT00848250|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2010-10-25|||September 2008||2008-09-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children|Effects of Angiotensin Converting Enzyme Inhibition During and After Cardiopulmonary Bypass in Infants and Children With Congenital Heart Defects|Completed||N/A|21|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:21:54.123654|2017-02-18 13:21:54.123654
NCT00848237|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-01-05|2015-09-11||July 2007||2007-07-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||HALO Patient Registry: Ablation of Barrett's Esophagus|HALO Patient Registry: Ablation of Barrett's Esophagus, A Multi-Center Patient Registry|Completed||N/A|5521|Actual|Medtronic - MITG|Endoscopic clearance rate for Barrett's esophagus-Percentage of patients with no endoscopically visible Barrett's esophagus at 1 year follow-up: This endpoint is a visual and not reliable or accurate.|1|||f||||f||||||||||2017-02-18 13:21:54.238368|2017-02-18 13:21:54.238368
NCT00848224|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-19|||September 2000||2000-09-01|February 2009|2009-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|PACT||Improving Adherence to Pharmacological Treatment|Improving Adherence to Pharmacological Treatment|Completed||N/A|689|Actual|University of Massachusetts, Worcester||1|||f||||f||||||||||2017-02-18 13:21:54.549845|2017-02-18 13:21:54.549845
NCT00848211|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-02-17|2010-06-12||February 2009||2009-02-01|February 2011|2011-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|THYMON-08001||Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects|Phase I/IIA Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects|Completed||Phase 1/Phase 2|24|Actual|Thymon, LLC||4|||f||||f||||||||||2017-02-18 13:21:54.799338|2017-02-18 13:21:54.799338
NCT00848198|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2016-04-13|2011-04-05||February 2009||2009-02-01|April 2016|2016-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|CVS||TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease|A Prospective Study to Establish Normative Values, Demographic Variations, Referent Diagnostic Values and Disease Severity Correlations for Dry Eye Disease and TearLab Osmometry.|Completed||N/A|314|Actual|TearLab Corporation|95/299 subjects were using topical medication at the time of measurement, potentially lowering the diagnostic performance of osmolarity (osmolarity is lowered and responds before the other tests during therapy) and compressing the referent spread.||2||f||||f||||||||Yes|Data was published in AJO May 2011 and IOVS Dec.2010.|2017-02-18 13:21:55.471082|2017-02-18 13:21:55.471082
NCT00848185|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2015-05-04|||June 2008||2008-06-01|May 2015|2015-05-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Observational|||Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors|Differential Regulation of VEGF, Cadherin and Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors: Try to Explain the Lower OHSS Incidence|Completed||N/A|60|Actual|IVI Madrid|||3||f||||t||||||Samples With DNA|"~     follicular fluid~   "|||2017-02-18 13:21:56.119779|2017-02-18 13:21:56.119779
NCT00848172|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2012-11-22|2012-08-06||February 2009||2009-02-01|November 2012|2012-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor|Double-Blind, Placebo Controlled Pilot-Study of Octanoic Acid in Essential Tremor|Completed||Phase 1/Phase 2|29|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 13:21:56.199419|2017-02-18 13:21:56.199419
NCT00848159|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||April 2007||2007-04-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|November 2007|Actual|2007-11-01||Observational|||Postural Assessment by Photogrammetry|Evaluation of Thoracic Kyphosis in Elderly Women Affected by Osteoporosis Through Computerized Photogrammetry|Completed||N/A|12||Universidade de Franca|||2||f||||t|||||||"~     The two groups were photographed in the sagittal plane with right column markers fixed on~     two anatomical points. The selected images were quantified by computerized photogrametry,~     using the program Autocad-2006~   "|||2017-02-18 13:21:56.689988|2017-02-18 13:21:56.689988
NCT00848146|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2012-07-03|||February 2009||2009-02-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|TAS-NOTES||NOTES-Assisted Laparoscopic Cholecystectomy Surgery|Natural Orifice Translumenal Endoscopic Surgery (NOTES)-Assisted Laparoscopic Cholecystectomy Surgery|Completed||N/A|4|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 13:21:56.790011|2017-02-18 13:21:56.790011
NCT00848133|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||July 2004||2004-07-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty|A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty|Completed||Phase 4|51|Actual|Sinai Hospital of Baltimore||2|||f||||f||||||||||2017-02-18 13:21:56.903177|2017-02-18 13:21:56.903177
NCT00848120|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2014-12-23|2014-05-05||December 2008||2008-12-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||"The safety population included all participants who received any part of an infusion of study drug.~Intent to Treat (ITT) Population was used for efficacy analyses. All participants who have received any part of an infusion of study medication were included in this population."|A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid Arthritis|An Open Label Study to Evaluate the Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis|Completed||Phase 3|29|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:21:57.000899|2017-02-18 13:21:57.000899
NCT00848107|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2014-01-08|2013-07-12||September 2009||2009-09-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|DISTOL-EXT|Efficacy was assessed using data obtained at each visit, if available, from all subjects enrolled in this study. Assessments performed after discontinuation of study drug were excluded from the summaries. All subjects who had at least one dose of study drug documented were included in the safety analysis population.|Open-Label Study of Oral Treprostinil in Digital Ulcers|Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-label Multicenter Extension Study|Terminated||Phase 2|115|Actual|United Therapeutics|Interpretation of the change in digital ulcer status was limited by the lack of a control group and the discontinuation of the study prior to subjects completing all scheduled visits.|1||"The TDE-DU-202 extension study was discontinued after the randomized, placebo-controlled~   TDE-DU-201 study did not meet its primary efficacy objective."|f||||f||||||||||2017-02-18 13:21:57.319164|2017-02-18 13:21:57.319164
NCT00848094|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2009-02-19|||April 2005||2005-04-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Radiation Dose Escalation Study for Advanced Liver Cancer|Phase I Trial of Radiation Dose Escalation for Locally Advanced Hepatocellular Carcinoma|Completed||Phase 1|40|Actual|Fudan University||2|||f||||t||||||||||2017-02-18 13:21:57.813636|2017-02-18 13:21:57.813636
NCT00848081|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2010-08-16|2010-08-16||March 2009||2009-03-01|August 2010|2010-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Evaluate the Safety and Efficacy of Daily Tadalafil for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant Alpha1-Adrenergic Blocker Therapy|Completed||Phase 3|318|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:21:57.917525|2017-02-18 13:21:57.917525
NCT00848068|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2012-02-01|||January 2009||2009-01-01|February 2012|2012-02-01||||March 2009|Actual|2009-03-01||Interventional|||Evaluation of FID 114657 on Tear Film Lipid Layer Thickness||Completed||N/A|40|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:21:58.780283|2017-02-18 13:21:58.780283
NCT00848055|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-10-31|||December 2008||2008-12-01|October 2013|2013-10-01||||October 2010|Actual|2010-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single Rising, Open-label Doses of AbGn-168 Administered by Intravenous Infusion (1 Mcg/kg, 5 Mcg/kg, 25 Mcg/kg, 125 Mcg/kg, 625 Mcg/kg, 3 mg/kg, or 10 mg/kg) or Subcutaneous Injection (625 Mcg/kg) to Patients With Chronic Plaque Psoriasis|Completed||Phase 1|40|Actual|Boehringer Ingelheim||8|||f||||||||||||||2017-02-18 13:21:58.866604|2017-02-18 13:21:58.866604
NCT00848042|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-12-19|2016-06-07||April 2008||2008-04-01|December 2016|2016-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck|A Pilot Study of AuroLase(tm) Therapy in Patients With Refractory and/or Recurrent Tumors of the Head and Neck|Completed||N/A|11|Actual|Nanospectra Biosciences, Inc.||3|||f||||t||||||||||2017-02-18 13:21:58.977426|2017-02-18 13:21:58.977426
NCT00848029|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2016-11-30|||November 2008||2008-11-01|December 2011|2011-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules||Completed||Phase 3|240|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:22:02.058146|2017-02-18 13:22:02.058146
NCT00848016|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-19|2014-04-17|2014-01-06||February 2009||2009-02-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery|A Phase II Study of the Orally Administered Negative Enantiomer of Gossypol (AT-101) in Patients With Advanced Adrenocortical Carcinoma (ACC)|Completed||Phase 2|29|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:22:02.212268|2017-02-18 13:22:02.212268
NCT00848003|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-05-17|||October 2009||2009-10-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|PHASE||Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Adults on Antibiotics|Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Adults on Antibiotics|Completed||Phase 1|40|Actual|Georgetown University||2|||f||||t||||||||||2017-02-18 13:22:02.506182|2017-02-18 13:22:02.506182
NCT00847990|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-09-01|||March 2009||2009-03-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|April 2011|Actual|2011-04-01||Observational|||Non-Invasive Screening for Fetal Aneuploidy|Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker|Completed||N/A|5000|Anticipated|Sequenom, Inc.|||1||f||||f||||||Samples With DNA|"~     plasma, PBMCs~   "|||2017-02-18 13:22:02.640457|2017-02-18 13:22:02.640457
NCT00847977|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-01-30|||October 2008||2008-10-01|January 2013|2013-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|IsoTC||Interest of Using Balanced Fluid for Infusion at the Early Phase of an Acute Cranial Trauma for Limiting Hyperchloremic Acidosis|Intérêt d'Utiliser Des solutés de Remplissage équilibrés à la Phase précoce d'un Traumatisme crânien Grave Pour Limiter l'Acidose hyperchlorémique|Terminated||Phase 3|42|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-02-18 13:22:02.757371|2017-02-18 13:22:02.757371
NCT00847964|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-11-29|||February 2009||2009-02-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery|SYM-08-001: A Pilot Study to Evaluate the Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With Dilated Cardiomyopathy Undergoing Open-heart Surgery|Completed||Phase 2|11|Actual|LoneStar Heart, Inc.||1|||f||||f||||||||||2017-02-18 13:22:03.050399|2017-02-18 13:22:03.050399
NCT00847951|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-06-20||||||June 2012|2012-06-01||||||||Interventional|||Ultrasound for Perfusion in Neonates|3D Ultrasound for Perfusion in Neonates|Withdrawn||N/A|0|Actual|University of Michigan||1||Study terminated at this time by investigator. Will create new protocol.|f||||f||||||||||2017-02-18 13:22:03.162353|2017-02-18 13:22:03.162353
NCT00847938|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-11-30|||March 2009||2009-03-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|NEODEC||Comparision of Different Dose of Neostigmine at Advanced Decurarization|Randomized, Controlled, Double-blind, Prospective Study, Comparing Different Doses of Neostigmine at Advanced Decurarization .|Completed||Phase 3|72|Anticipated|Centre Hospitalier Departemental Vendee||4|||f||||f||||||||||2017-02-18 13:22:03.267846|2017-02-18 13:22:03.267846
NCT00847925|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-18|||November 2001||2001-11-01|February 2009|2009-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects|A Double Blind, Placebo and Standard Care Controlled, Randomised Study to Investigate the Clinical Safety and Toleration, Wound Healing and Antiscarring Potential of Two Applications of Intradermal RN1001 (Avotermin) in Healthy Male Subjects|Completed||Phase 1/Phase 2|103|Actual|Renovo||9|||f||||f||||||||||2017-02-18 13:22:03.377397|2017-02-18 13:22:03.377397
NCT00847912|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2016-03-29||2014-08-11|June 2009||2009-06-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|June 2013|Actual|2013-06-01||Interventional|VAKCCT||CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial|CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial|Active, not recruiting||Phase 4|1000|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:22:03.498167|2017-02-18 13:22:03.498167
NCT00847899|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-11-18|||January 2009||2009-01-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Exploratory, 28-Day Study to Examine the Effects of AR9281 on Blood Pressure and Glucose Tolerance in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance|Completed||Phase 2|150|Anticipated|Arete Therapeutics||4|||f||||f||||||||||2017-02-18 13:22:03.636052|2017-02-18 13:22:03.636052
NCT00847886|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2010-06-01|2010-04-19||February 2009||2009-02-01|June 2010|2010-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Determine the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis|Completed||Phase 1|15|Actual|Lexicon Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:22:03.778175|2017-02-18 13:22:03.778175
NCT00847873|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-11-03|||October 2009||2009-10-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Treatment of Intimate Partner Violence and Substance Abuse in a Substance Abuse Treatment Facility|Treatment of Intimate Partner Violence and Substance Abuse in a Substance Abuse: a Randomized Controlled Trial|Completed||N/A|100|Anticipated|VU University of Amsterdam||2|||f||||f||||||||||2017-02-18 13:22:04.294969|2017-02-18 13:22:04.294969
NCT00847860|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2015-05-05|||March 2008||2008-03-01|December 2009|2009-12-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|CAVAD||Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions|Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White|Completed||Phase 4|200|Actual|Peking University First Hospital||2|||f||||t||||||||||2017-02-18 13:22:04.424497|2017-02-18 13:22:04.424497
NCT00847847|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2012-11-16|||March 2009||2009-03-01|December 2009|2009-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|NETALS||Neuromuscular Transmission in Amyotrophic Lateral Sclerosis|Neuromuscular Transmission in Amyotrophic Lateral Sclerosis|Completed||N/A|14|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:22:04.525857|2017-02-18 13:22:04.525857
NCT00847834|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-09-14|||December 2003||2003-12-01|September 2009|2009-09-01||||June 2004|Actual|2004-06-01||Interventional|||Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population|Multi-center Open Label, Non-comparative Observational Study of Irbesartan-Hydrochlorothiazide in the Treatment of Hypertension in Chinese Population|Completed||Phase 4|968|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:22:04.638693|2017-02-18 13:22:04.638693
NCT00847821|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2010-09-03|||May 2009||2009-05-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene|RNA Expression Analysis Of Endometrial Biopsies Comparing Placebo, Bazedoxifene/ Conjugated Estrogens And Raloxifene|Terminated||Phase 3|185|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||8|See termination reason in detailed description.|f||||f||||||Samples With DNA|"~     Endometrial biopsy blocks~   "|||2017-02-18 13:22:04.960962|2017-02-18 13:22:04.960962
NCT00847808|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2012-02-01|2011-04-05||February 2009||2009-02-01|February 2012|2012-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy|A Phase 3b Multicenter, Single-Blind Trial to Evaluate the Efficacy of Dexlansoprazole MR 30 mg in Maintaining Control of Gastroesophageal Reflux Disease Symptoms in Subjects on Prior Twice Daily Proton Pump Inhibitor Therapy|Completed||Phase 3|178|Actual|Takeda||1|||f||||f||||||||||2017-02-18 13:22:05.113682|2017-02-18 13:22:05.113682
NCT00847795|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-18|||September 2002||2002-09-01|February 2009|2009-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.|A Trial to Investigate the Accelerated Wound Healing and Antiscarring Potential, Safety, Toleration and Systemic Exposure of Intradermal RN1001 (Avotermin) in Male and Female Subjects Aged 60 Years and Over.|Completed||Phase 1/Phase 2|42|Actual|Renovo||5|||f||||f||||||||||2017-02-18 13:22:05.555873|2017-02-18 13:22:05.555873
NCT00847782|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-11-04|||March 2009||2009-03-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||An Experimental Medicine Study to Evaluate Serum Biomarkers of Lipid Metabolism|An Experimental Medicine Study to Quantify PCSK9 Serum Concentrations and LDL Receptor Expression in Peripheral Blood Cells in Normal and Hypercholesterolemic Subjects|Completed||N/A|150|Anticipated|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 13:22:05.660919|2017-02-18 13:22:05.660919
NCT00847769|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-02-17|||December 2008||2008-12-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|ACE||Ankle Sprains and Corticospinal Excitability|Effect of Manual Therapy Intervention on Corticospinal Excitability in Individuals With Post-Acute Ankle Sprains|Unknown status|Recruiting|Phase 1/Phase 2|27|Anticipated|University of Southern California||3|||f||||f||||||||||2017-02-18 13:22:05.758887|2017-02-18 13:22:05.758887
NCT00847756|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-07-19|||April 2008||2008-04-01|December 2010|2010-12-01|July 2011|Anticipated|2011-07-01|September 2009|Actual|2009-09-01||Observational|OMVac||Host-pathogen Interaction in Otitis Media|Thorough Clinical Investigation of the Host-pathogen Interaction in Chronic and Recurrent Otitis Media|Unknown status|Active, not recruiting|N/A|179|Actual|Radboud University|||3||f||||f||||||Samples With DNA|"~     blood nasopharyngeal swab middle ear fluid~   "|||2017-02-18 13:22:05.867885|2017-02-18 13:22:05.867885
NCT00847743|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-18|||October 2007||2007-10-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study on Whether Tart Cherry Juice Can Reduce Oxidative Stress and Inflammation|Effects of Tart Cherry Juice on Oxidative Stress and Inflammation in Older Men and Women|Completed||N/A|12|Actual|Kronos Longevity Research Institute||1|||f||||f||||||||||2017-02-18 13:22:05.974774|2017-02-18 13:22:05.974774
NCT00847730|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2011-09-08|||February 2009||2009-02-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negatvie Pressure Wound Therapy|A Single Arm, Prospective Clinical Trial Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabectic Foot Ulcers Receiving VAC Negative Pressure Therapy|Completed||Phase 2|75|Anticipated|KCI USA, Inc.||1|||f||||f||||||||||2017-02-18 13:22:06.072193|2017-02-18 13:22:06.072193
NCT00847717|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-08-10|||August 2007||2007-08-01|August 2009|2009-08-01||||September 2009|Anticipated|2009-09-01||Interventional|||Trial of IIb Preserving Neck Dissection|Randomized Controlled Trial of IIb Preserving Neck Dissection VS Neck Dissections Involving IIb Removal (Selective/Functional) in Patients With N0 Neck With Oral Cavity Malignancies|Unknown status|Recruiting|Phase 3|100|Anticipated|Banaras Hindu University||2|||f||||f||||||||||2017-02-18 13:22:06.165483|2017-02-18 13:22:06.165483
NCT00847704|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2016-11-23|2014-12-17||April 2008||2008-04-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||Stroke >1 yr prior to enrollment Able to stand independently <50% normal strength in affected leg Functioning proprioception in affected leg|Clinic-Based AMES Treatment of Stroke|Clinic-Based Ames Treatment of the Lower Extremity in Chronic Stroke Subjects|Terminated||Phase 1/Phase 2|3|Actual|Oregon Health and Science University|Early termination due to lack of funding lead to only 2 subjects treated and analyzed.|1||Funding not available.|f||||t||||||||||2017-02-18 13:22:06.277076|2017-02-18 13:22:06.277076
NCT00847691|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2012-12-17|||March 2009||2009-03-01|February 2009|2009-02-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Observational|GENSARC||GENSARC 2008 : Medical Economic Evaluation of the Molecular Detection by FISH (Fluorescent in Situ Hybridization) and by PCR (Polymerase Chain Reaction) of Sarcomas Specific Translocations and Amplifications .|GENSARC 2008 : Medical Economic Evaluation of the Molecular Detection by FISH (Fluorescent in Situ Hybridization) and by PCR (Polymerase Chain Reaction) of Sarcomas Specific Translocations and Amplifications .|Completed||N/A|350|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||Samples With DNA|"~     sarcoma biopsy~   "|||2017-02-18 13:22:06.555479|2017-02-18 13:22:06.555479
NCT00847678|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-18|||August 2006||2006-08-01|February 2009|2009-02-01||||November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS|A Multicenter, Randomized Study to Assess the Efficacy and Safety of Mycograb® as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS|Terminated||Phase 2|38|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:22:06.640053|2017-02-18 13:22:06.640053
NCT00847665|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-03-09|2012-06-28||February 2009||2009-02-01|March 2013|2013-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|PUPPAS||Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens|Comparison of Two Turning Regimens (2 Versus Every 4 Hours) in the Prevention of Pressure Ulcers in Patients on Mechanical Ventilation That Use Alternating-pressure Air Mattresses.|Completed||Phase 3|330|Actual|University Hospital Virgen de las Nieves||2|||f||||t||||||||||2017-02-18 13:22:06.74178|2017-02-18 13:22:06.74178
NCT00847639|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-04-02|||February 2009||2009-02-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|January 2013|Actual|2013-01-01||Interventional|07-REV||Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma|Evaluation of Lenalidomide as Maintenance Therapy Post Allogeneic Hematopoietic Cell Transplantation for High-risk Multiple Myeloma|Completed||Phase 2|30|Actual|Center for International Blood and Marrow Transplant Research||1|||f||||t||||||||||2017-02-18 13:22:07.355798|2017-02-18 13:22:07.355798
NCT00847626|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2012-01-04|2012-01-04||January 2009||2009-01-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension|A Phase 3, Double-Blind, Randomized, Factorial, Efficacy and Safety Study of TAK 491 Plus Chlorthalidone Fixed-Dose Combination in Participants With Moderate to Severe Hypertension|Completed||Phase 3|1711|Actual|Takeda||11|||f||||f||||||||||2017-02-18 13:22:07.499799|2017-02-18 13:22:07.499799
NCT00847613|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-01-14|2012-12-05||March 2009||2009-03-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|April 2011|Actual|2011-04-01||Interventional|||A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate|Phase 3 Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Of 2 Doses Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate|Completed||Phase 3|800|Actual|Pfizer|Results include data of 1-year analysis.|4|||f||||t||||||||||2017-02-18 13:22:13.118483|2017-02-18 13:22:13.118483
NCT00847236|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-12-15|||January 2009||2009-01-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|||Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica|Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica|Active, not recruiting||N/A|150|Anticipated|Lahey Clinic|||3||f||||f||||||||||2017-02-18 13:22:23.671037|2017-02-18 13:22:23.671037
NCT00847600|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2010-12-14|||March 2009||2009-03-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|PREG-2008||Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia|Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia: an 8-week, Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 4|60|Anticipated|Sha’ar Menashe Mental Health Center||2|||f||||f||||||||||2017-02-18 13:22:18.179291|2017-02-18 13:22:18.179291
NCT00847587|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2016-03-18|2011-03-10||January 2009||2009-01-01|March 2016|2016-03-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant|Randomized Controlled Trial of Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant|Completed||Phase 4|69|Actual|University of Utah|Limitations:Study was not blinded & early insertion was allowed as late as 3 days postpartum. Insertion on postpartum days 1-3 was allowed so long as lactogenesis had not already occurred to mimic normal clinical practice & improve generalizability.|2|||f||||t||||||||||2017-02-18 13:22:18.292328|2017-02-18 13:22:18.292328
NCT00847574|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-11-30|||March 2006||2006-03-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|June 2008|Actual|2008-06-01||Interventional|WORLD||The WORLD (Weight Optimization: Revamping Lifestyles Using the Dietary Guidelines) Study - Developing, Implementing, and Testing an Education Program|Development, Implementation, & Testing and Education Program to Teach Weight Loss Using the 2005 Dietary Guidelines to Pre-Menopausal Women|Completed||N/A|101|Actual|Penn State University||2|||f||||f||||||||||2017-02-18 13:22:18.624179|2017-02-18 13:22:18.624179
NCT00847561|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2014-05-05|2014-05-05||August 2008||2008-08-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Effectiveness of a Family-Based Treatment for Preventing Anxiety Disorders in At-Risk Children|Family-Based Prevention for Childhood Anxiety|Completed||N/A|136|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 13:22:18.735783|2017-02-18 13:22:18.735783
NCT00847548|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-09-16|||September 2010||2010-09-01|September 2013|2013-09-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting|Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting|Unknown status|Active, not recruiting|N/A|100|Anticipated|VU University of Amsterdam||2|||f||||f||||||||||2017-02-18 13:22:19.068216|2017-02-18 13:22:19.068216
NCT00847535|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-07-29|2013-11-12||September 2008||2008-09-01|July 2015|2015-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence|Muscle Cell Mediated Therapy for Stress Urinary Incontinence: An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells.|Completed||Phase 2|66|Actual|Cook||2|||f||||||||||||||2017-02-18 13:22:19.163333|2017-02-18 13:22:19.163333
NCT00847522|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-07-26|||February 2009||2009-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Fluorescein for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Stage I and II Malignant Melanoma|Fluorescein for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Stage I and II Malignant Melanoma|Completed||Phase 1/Phase 2|90|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 13:22:19.44345|2017-02-18 13:22:19.44345
NCT00847509|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-07-26|2013-07-26||February 2009||2009-02-01|July 2013|2013-07-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|FLT101|A total of 49 patients were enrolled and 38 patients received investiational product.|A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation|A Phase II/III, Open Label, Non-Randomized, Multi - Center Study Of Positron Emission Tomography (PET) Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation|Completed||N/A|49|Actual|Siemens Molecular Imaging||1|||f||||f||||||||||2017-02-18 13:22:19.552406|2017-02-18 13:22:19.552406
NCT00847496|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-12-10|||December 2009||2009-12-01|December 2012|2012-12-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|Awbat||Awbat Versus Biobrane in Partial Thickness Burns|The Treatment of Partial Thickness Burns: Awbat(r) Versus Biobrane(r)|Withdrawn||Phase 2|0|Actual|The University of Texas Medical Branch, Galveston||2||Company went out of business|f||||f||||||||||2017-02-18 13:22:19.790758|2017-02-18 13:22:19.790758
NCT00847483|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2009-02-17|||January 2002||2002-01-01|February 2009|2009-02-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|XLT||Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-Weeks, Masked Evaluator, Phase IV Multi-Center Study in the US|A Comparison of Latanoprost (Xalatan) With Travoprost (Travatan) and Bimatoprost (Lumigan) in Patients With Elevated Intraocular Pressure. A Twelve-Week, Masked Evaluator, Phase IV, Multicenter Study in the United States. (Xalatan vs Travatan vs Lumigan).|Completed||Phase 4|375|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:22:20.056798|2017-02-18 13:22:20.056798
NCT00847470|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-11-17|||June 2006||2006-06-01|November 2014|2014-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||DPBRN Reasons for Placing the First Restoration on Permanent Tooth Surfaces|Reasons for Placing the First Restoration on Permanent Tooth Surfaces|Completed||N/A|5810|Actual|Dental Practice-Based Research Network|||1||f||||f||||||||||2017-02-18 13:22:20.203508|2017-02-18 13:22:20.203508
NCT00847457|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-06-26|||January 2009||2009-01-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Depressed Adolescents Treated With Exercise (The DATE Study)|Exercise Treatment for Depressed Youth|Completed||N/A|40|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 13:22:20.29858|2017-02-18 13:22:20.29858
NCT00847444|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-04-17|||February 2009||2009-02-01|April 2013|2013-04-01|September 2016|Anticipated|2016-09-01|September 2011|Actual|2011-09-01||Interventional|SUCCESS-C||Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention|Simultaneous Study of Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention Strategies|Unknown status|Active, not recruiting|Phase 3|3547|Anticipated|Ludwig-Maximilians - University of Munich||3|||f||||t||||||||||2017-02-18 13:22:20.403566|2017-02-18 13:22:20.403566
NCT00847431|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-05-03|||December 2008||2008-12-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Observational|MOOD-D||Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)|Mapping Mood in the Subthalamic Nucleus in PD|Completed||N/A|81|Actual|Washington University School of Medicine|||2||f||||f||||||||||2017-02-18 13:22:20.515604|2017-02-18 13:22:20.515604
NCT00847405|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-09-01|2009-07-06||March 2003||2003-03-01|September 2009|2009-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions|A Two-Way Crossover, Open-Label, Single-Dose, Fasting Bioequivalence Study of Sumatriptan Succinate 100 mg Tablets Versus Imitrex® 100 mg Tablets in Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|28|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:22:20.689279|2017-02-18 13:22:20.689279
NCT00847392|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-09-16|||March 2009||2009-03-01|September 2016|2016-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|PV-BUS||Study to Determine Pediatric Bladder Volume Prior to Catheterization|Pediatric Volumetric Bladder Ultrasound Study|Withdrawn||N/A|0|Actual|McMaster University||2||Inability to obtain grant funding|f||||f||||||||||2017-02-18 13:22:21.294605|2017-02-18 13:22:21.294605
NCT00847379|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2013-08-28|||January 2009||2009-01-01|August 2013|2013-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Phase 2b Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)|A Phase 2b Extension Study of Ataluren (PTC124) in Subjects With Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy|Terminated||Phase 2/Phase 3|173|Actual|PTC Therapeutics||1|||f||||t||||||||||2017-02-18 13:22:21.408055|2017-02-18 13:22:21.408055
NCT00847366|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-05-28|||May 2008||2008-05-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma|An Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma|Unknown status|Active, not recruiting|N/A|50|Anticipated|AEterna Zentaris||5|||f||||f||||||||||2017-02-18 13:22:21.564816|2017-02-18 13:22:21.564816
NCT00847353|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2010-02-03|||February 2009||2009-02-01|February 2010|2010-02-01|June 2010|Anticipated|2010-06-01|February 2010|Anticipated|2010-02-01||Observational|||Normal Values of High Frequency ECG (HyperQ™) in Apparently Healthy Individuals and in Young and Masters Athletes|Normal Values of High Frequency ECG (HyperQ™) in Asymptomatic, Apparently Healthy Normal Weight vs. Obese Individuals and in Young and Masters Athletes|Unknown status|Recruiting|N/A|300|Anticipated|BSP Biological Signal Processing Ltd.|||1||f||||f||||||||||2017-02-18 13:22:21.658428|2017-02-18 13:22:21.658428
NCT00847340|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-03-19|||December 2009||2009-12-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|GWprofamilia||Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population|Prevalence of HPV Genotypes in Genital Warts in Colombian Male and Female Population Attending Medical Services.|Completed||N/A|342|Actual|La Fundacion para la Investigacion y el Desarrollo|||1||f||||t||||||Samples With DNA|"~     Biopsies from genital warts will be taken through an excisional procedure. Homeostasis will~     be obtained by using topications of Monssell solution. Biopsy sample will be splinted in~     order to obtain two pieces, one of them will be frozen (liquid Nitrogen) and designated to~     the HPV DNA PCR test (GP5, GP6) to be performed at the immunology lab at the National Cancer~     Institute in Bogotá. The other one will be kept in Formalin solution (10%) and sent to the~     pathology laboratory for haematoxiline - eosine paint and lecture.~   "|||2017-02-18 13:22:21.73738|2017-02-18 13:22:21.73738
NCT00847327|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2011-02-01|||April 2008||2008-04-01|February 2011|2011-02-01|March 2013|Anticipated|2013-03-01|November 2012|Anticipated|2012-11-01||Interventional|YCP||Parental Management of Young Children's Diabetes|Parenting and Control Among Young Children With Type 1 Diabetes|Unknown status|Recruiting|Phase 1|135|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 13:22:21.817517|2017-02-18 13:22:21.817517
NCT00847314|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-06-19|||June 2007||2007-06-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients|Efficacy and Tolerability of Testogel® / Nebido in Combination With a Standardised Exercise and Diet Programme in Hypogonadal Male Patients With Abdominal Obesity Compared With Exercise and Diet Programme|Completed||N/A|30|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:22:21.93116|2017-02-18 13:22:21.93116
NCT00847301|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-08-25|2015-06-30||April 2009||2009-04-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational||The Treated set with moderate renal impairment: this patient set included all patients with CrCl (Creatinine clearance) 30 - 50 mL/min who received at least one 1 of dabigatran etexilate.|Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery|Observational Cohort Study to Evaluate Safety and Efficacy of Pradaxa (Dabigatran Etexilate) in Patients With Moderate Renal Impairment (Creatinine Clearance 30-50 ml/Min) Undergoing Elective Total Hip Replacement Surgery or Total Knee Replacement Surgery|Completed||N/A|472|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 13:22:22.038242|2017-02-18 13:22:22.038242
NCT00847288|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2013-04-30|2012-06-05||March 2009||2009-03-01|April 2013|2013-04-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||OptiVol® Care Pathway|OptiVol® Care Pathway|Completed||Phase 4|1682|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f||||||||||2017-02-18 13:22:22.368733|2017-02-18 13:22:22.368733
NCT00847275|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2010-01-25|||July 2008||2008-07-01|January 2010|2010-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|BCDE||Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE)|Behaviour and Cognitive Evaluation for Dialysis Elderly Patients|Unknown status|Recruiting|N/A|500|Anticipated|Nantes University Hospital||2|||f||||t||||||||||2017-02-18 13:22:23.210958|2017-02-18 13:22:23.210958
NCT00847262|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-12-15|||June 2008||2008-06-01|December 2013|2013-12-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|HOT-DM||Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes|Hypertension With Obesity Trial: Diabetes Mellitus Branch|Completed||Phase 4|120|Actual|Third Military Medical University||2|||f||||t||||||||||2017-02-18 13:22:23.319313|2017-02-18 13:22:23.319313
NCT00847249|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-09-22|||February 2009||2009-02-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|||||Interventional|||AZD9164 Single Ascending Dose Study in Healthy Male Subjects|A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled AZD9164 After Single Ascending Doses in Healthy Male Subjects|Completed||Phase 1|65|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:22:23.421449|2017-02-18 13:22:23.421449
NCT00847002|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2016-09-06|2012-05-31||September 2007||2007-09-01|September 2016|2016-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Flexitouch Treatment for Venous Ulcers|A Pilot Randomized Trial of Flexitouch as an Adjunctive Treatment for Venous Ulcers|Terminated||Phase 4|8|Actual|Tactile Medical||2||Lack of Enrollment|f||||f||||||||||2017-02-18 13:22:30.497424|2017-02-18 13:22:30.497424
NCT00847223|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-03-03|||June 2007||2007-06-01|March 2011|2011-03-01||||March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma|A Phase II Study Evaluating the Efficacy and Safety of the Farnesyl-transferase Inhibitor ZARNESTRA® in Patients With Relapsed, Refractory or Progressive Mantle Cell Lymphoma Not Appropriate for Autologous Bone Marrow Transplantation|Terminated||Phase 2|11|Actual|Lymphoma Study Association||1||Inefficiency of treatment|f||||t||||||||||2017-02-18 13:22:23.77611|2017-02-18 13:22:23.77611
NCT00847210|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2012-01-31|2010-09-08||May 2009||2009-05-01|January 2012|2012-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease|A Phase 1, Randomized, Open-Label, Parallel Group, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole Modified Release Capsules (30 mg and 60 mg) in Adolescents With Symptomatic Gastroesophageal Reflux Disease|Completed||Phase 1|36|Actual|Takeda|For outcome measures #4, 5, 6, 7 and 8, outcomes could not be estimated for one participant in the 30 mg dose group.|2|||f||||f||||||||||2017-02-18 13:22:23.883667|2017-02-18 13:22:23.883667
NCT00847197|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-11-19|2010-08-27||June 2008||2008-06-01|November 2015|2015-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Lipid-Modifying Effect and Tolerability of MK1903 in Patients With Dyslipidemia|Completed||Phase 2|191|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:22:24.381787|2017-02-18 13:22:24.381787
NCT00847184|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-18|||February 2009||2009-02-01|February 2009|2009-02-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Comparison of Airtraq Versus MacIntosh Intubation Via Nasal Approach|Comparison of Airtraq vs. MacIntosh Intubation Via Nasal Approach|Unknown status|Recruiting|N/A|200|Anticipated|Kliniken Essen-Mitte||2|||f||||f||||||||||2017-02-18 13:22:25.108033|2017-02-18 13:22:25.108033
NCT00847171|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-05-24|||December 2008||2008-12-01|May 2013|2013-05-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer|A Safety and Bioactivity Study of Combination Therapy With Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-Secreting Breast Tumor Vaccine for the Treatment of Patients With High Risk/ Metastatic HER-2/Neu- Overexpressing Breast Cancer With No Evidence of Disease|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 13:22:25.217347|2017-02-18 13:22:25.217347
NCT00847158|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-18|||December 2006||2006-12-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Clinical Trial of Phacoemulsification Versus Phacoemulsification & the iStent Implantation in POAG Patients|A Randomized, Double-Masked Clinical Trial of Phacoemulsification Compared With Phacoemulsification and Micro-Bypass Stent Implantation in Patients With POAG|Completed||N/A|36|Actual|University of Turin, Italy||2|||f||||t||||||||||2017-02-18 13:22:25.328208|2017-02-18 13:22:25.328208
NCT00847145|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-03-02|2015-02-03||February 2009||2009-02-01|March 2015|2015-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers|A Phase 3, Open Label, Multi-Center, Extension Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster at 12 Months of Age or as a Two-dose Catch-up to Healthy Toddlers Who Participated in Study V72P13|Completed||Phase 3|2249|Actual|Novartis|None reported.|8|||f||||||||||||||2017-02-18 13:22:25.451988|2017-02-18 13:22:25.451988
NCT00847132|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2010-11-29|||July 2007||2007-07-01|November 2010|2010-11-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||A Collaborative Care Program to Improve Depression Treatment in Cardiac Patients|A Collaborative Care Program to Improve Depression Treatment in Cardiac Patients|Completed||N/A|175|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:22:27.418433|2017-02-18 13:22:27.418433
NCT00847119|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-06-19|||September 2007||2007-09-01|June 2013|2013-06-01|September 2013|Anticipated|2013-09-01|June 2011|Actual|2011-06-01||Interventional|xeberecto||Xeloda and Bevacizumab to Treat Rectal Cancer|ESTUDIO FASE II DE BEVACIZUMAB EN COMBINACIÓN CON CAPECITABINA Y RADIOTERAPIA COMO TRATAMIENTO PREOPERATORIO EN PACIENTES CON CÁNCER RECTAL LOCALMENTE AVANZADO RESECABLE|Unknown status|Active, not recruiting|Phase 2|43|Anticipated|Institut Català d'Oncologia||1|||f||||f||||||||||2017-02-18 13:22:27.677633|2017-02-18 13:22:27.677633
NCT00847106|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-18|||March 2004||2004-03-01|February 2009|2009-02-01|October 2005||2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients|Augmentation of Dendritic Cell Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells With an Anti-CD25 Monoclonal Antibody (Daclizumab). A Clinical Study.|Completed||Phase 1/Phase 2|15||Radboud University|||||f||||||||||||||2017-02-18 13:22:27.814725|2017-02-18 13:22:27.814725
NCT00847093|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-06-30|||September 2008||2008-09-01|February 2009|2009-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|LMX-4||LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery|Post-Operative Pain Control in Children and Infants Undergoing Penoplasty: A Randomized Control Trial of a Local Anesthetic Cream Placebo.|Completed||Phase 4|50|Actual|Ferndale Laboratories, Inc.||1|||f||||f||||||||||2017-02-18 13:22:27.918144|2017-02-18 13:22:27.918144
NCT00847080|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-04-22|||December 2008||2008-12-01|February 2009|2009-02-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism|Treatment With Sitagliptin Phosphate in Patients With Reactive Hypoglycemia Secondary to Dysinsulinism. A Controlled, Randomized, Double-blind, Clinical Trial|Completed||Phase 4|20|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2|||f||||t||||||||||2017-02-18 13:22:28.042235|2017-02-18 13:22:28.042235
NCT00847067|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2010-06-10|||February 2009||2009-02-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Chronic Post Breast Surgery Pain|A Prospective, Single-blinded, Randomized, Trial Evaluating the Use of Paravertebral Block to Decrease Chronic Post Breast Surgery Pain.|Terminated||N/A|40|Actual|Mayo Clinic||2||Funding not renewed|f||||f||||||||||2017-02-18 13:22:28.384985|2017-02-18 13:22:28.384985
NCT00847054|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2014-07-15|||March 2009||2009-03-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||A Study of of MORAb-004 in Subjects With Solid Tumors|A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-004, a Humanized Monoclonal Antibody, in Subjects With Solid Tumors|Completed||Phase 1|80|Actual|Morphotek||1|||f||||f||||||||||2017-02-18 13:22:28.478496|2017-02-18 13:22:28.478496
NCT00845598|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-06-11|||August 2010||2010-08-01|June 2012|2012-06-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Azelastine Fluticasone Combination vs. Fluticasone|A Proof of Concept Study to Evaluate Comparative Efficacy of an Azelastine/Fluticasone Combination Nasal Spray vs. Twice the Dose of Fluticasone in Persistent Allergic Rhinitis|Withdrawn||Phase 4|0|Actual|University of Dundee||2||Could not get IMP|f||||f||||||||||2017-02-18 13:22:28.603141|2017-02-18 13:22:28.603141
NCT00845585|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2015-07-16|||January 2009||2009-01-01|November 2010|2010-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Ovine Graft (Omniflow II) Versus PTFE in Below Knee Arterial Reconstruction|Ovine Graft (Omniflow II) Versus PTFE in Below Knee Arterial Reconstruction: A Prospective Randomized Multi Centre Study|Withdrawn||N/A|0|Actual|University Hospital Inselspital, Berne||2||found not enough centers for recruitment|f||||f||||||||||2017-02-18 13:22:28.741788|2017-02-18 13:22:28.741788
NCT00845572|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-09-17|||January 2007||2007-01-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center|The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center|Completed||N/A|30|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 13:22:28.894264|2017-02-18 13:22:28.894264
NCT00845559|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2012-12-10|||August 2008||2008-08-01|December 2012|2012-12-01||||March 2010|Anticipated|2010-03-01||Interventional|||The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults|The Effects of Exenatide on Post-Prandial Glucose Excursions and Vascular Health in Obese/Pre-Diabetic Young Adults|Withdrawn||Phase 4|0|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:22:29.016781|2017-02-18 13:22:29.016781
NCT00845546|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-02-16|||June 2002||2002-06-01|February 2009|2009-02-01|November 2002|Actual|2002-11-01|August 2002|Actual|2002-08-01||Interventional|||Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions|Comparative, Randomized, Single-Dose, Fully Replicated, 4-Way Crossover Bioavailability Study of Ranbaxy and Schering (Claritin_D® 24 Hour) 10 mg Loratadine/240 mg Pseudoephedrine Sulfate Extended-Release Tablets, in Healthy Adult Volunteers Under Fed Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:22:29.133196|2017-02-18 13:22:29.133196
NCT00845533|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-01-15|||August 2007||2007-08-01|January 2014|2014-01-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso||Completed||Phase 4|||University of California, San Francisco|||||f||||||||||||||2017-02-18 13:22:29.235221|2017-02-18 13:22:29.235221
NCT00845494|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||February 2009||2009-02-01|February 2009|2009-02-01|October 2010|Anticipated|2010-10-01|February 2010|Anticipated|2010-02-01||Interventional|||Efficacy of a Behavioral Based Education Intervention to Decrease Medication History Errors Among Professional Nurses.|Efficacy of a Behavioral Based Education Intervention to Decrease Medication History Errors Among Professional Nurses.|Unknown status|Not yet recruiting|Early Phase 1|140|Anticipated|Waukesha Memorial Hospital||1|||f||||t||||||||||2017-02-18 13:22:29.319052|2017-02-18 13:22:29.319052
NCT00845481|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2015-03-25|2011-01-13||January 2009||2009-01-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris|A Plaque Test Comparing 4 Steroids With Daivobet® Ointment and a Vehicle Control for the Treatment of Psoriasis Vulgaris|Completed||Phase 2|24|Actual|LEO Pharma||1|||f||||f||||||||||2017-02-18 13:22:29.424049|2017-02-18 13:22:29.424049
NCT00845468|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||January 2006||2006-01-01|February 2009|2009-02-01||||August 2008|Actual|2008-08-01||Observational|||Coronary Flow Reserve and Glucometabolic State|Coronary Flow Velocity Reserve According to Glucometabolic State in Acute Myocardial Infarction; Relation to Ventricular Systolic and Diastolic Function|Completed||N/A|190|Actual|Medicinsk Forsknings Afdeling|||1||f||||f||||||||||2017-02-18 13:22:29.709272|2017-02-18 13:22:29.709272
NCT00845455|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2011-10-24|||November 2007||2007-11-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|TPQ BDI SSQOL||Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.|Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.|Completed||N/A|85|Actual|Rambam Health Care Campus|||3||f||||f||||||||||2017-02-18 13:22:29.794132|2017-02-18 13:22:29.794132
NCT00845442|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2010-01-12|||January 2006||2006-01-01|January 2010|2010-01-01|November 2010|Anticipated|2010-11-01|January 2009|Anticipated|2009-01-01||Interventional|||Dynamic Laryngeal Opening for Bilateral Vocal Fold Paralysis by an Implanted Stimulator|Dynamic Vocal Fold Abduction for Bilateral Paralysis|Unknown status|Recruiting|Phase 1|6|Anticipated|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-02-18 13:22:29.87026|2017-02-18 13:22:29.87026
NCT00847041|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-18||||||February 2009|2009-02-01||||||||Observational|||Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis.|Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis.|Completed||N/A|||University of California, San Francisco|||||f||||f||||||||||2017-02-18 13:22:29.959987|2017-02-18 13:22:29.959987
NCT00847028|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||November 2007||2007-11-01|February 2009|2009-02-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Oral Glucose Solution as Pain Relief in Newborns: Results of a Clinical Trial|Oral Glucose Solution as Pain Relief in Newborns: Results of a Clinical Trial|Unknown status|Active, not recruiting|N/A|304|Actual|Universiteit Antwerpen||4|||f||||t||||||||||2017-02-18 13:22:30.033036|2017-02-18 13:22:30.033036
NCT00847015|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2016-02-01|2015-10-19||February 2009||2009-02-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer|Phase II Study of Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer|Completed||Phase 2|18|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:22:30.223178|2017-02-18 13:22:30.223178
NCT00846989|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2013-02-11||2012-05-02|January 2009||2009-01-01|February 2013|2013-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension|A 4-week Multi-center, Single-masked, Randomized, Latanoprost-controlled, Parallel Group Study to Assess the Efficacy, Tolerability and Safety of RKI983 (0.05% and 0.10%) Ophthalmic Solution Given Twice a Day Versus Once Daily Latanoprost 0.005%, in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.|Completed||Phase 1/Phase 2|276|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:22:30.993935|2017-02-18 13:22:30.993935
NCT00846976|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-01-20|||December 1994||1994-12-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer|A Treatment Protocol to Monitor the Safety of a 200 mg Daily Dose of Bicalutamide (Casodex) in Patients With Advanced Prostate Cancer|Completed||Phase 3|101|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:22:31.120403|2017-02-18 13:22:31.120403
NCT00846963|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-09-16|||October 2008||2008-10-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|URSONEONAT||Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates|Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates|Completed||Phase 2/Phase 3|26|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-02-18 13:22:31.219968|2017-02-18 13:22:31.219968
NCT00846950|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-18|||December 2006||2006-12-01|February 2009|2009-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effects of H1-Antagonist on Cognition|Effects of H1-Antagonist on Stages of Human Information Processing|Completed||N/A|18|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 13:22:31.334936|2017-02-18 13:22:31.334936
NCT00846937|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-02-09|||February 2009||2009-02-01|February 2009|2009-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|STOMA||Plant Stanol Ester Beverage and Ileostoma Patients|Effects of a Plant Stanolester Beverage on Cholesterol Metabolism Among Human Subjects With Ileostoma|Completed||N/A|10|Actual|Helsinki University||1|||f||||f||||||||||2017-02-18 13:22:31.437263|2017-02-18 13:22:31.437263
NCT00846924|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2016-04-12|||May 2009||2009-05-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|April 2014|Actual|2014-04-01||Interventional|EMBRACE||30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event|30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event: A Randomized Controlled Trial|Active, not recruiting||N/A|564|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 13:22:31.525499|2017-02-18 13:22:31.525499
NCT00846911|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2012-07-05|||April 2008||2008-04-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs|AVANTI - Avelox® in Acute Exacerbations of Chronic Bronchitis|Completed||N/A|2672|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:22:31.648345|2017-02-18 13:22:31.648345
NCT00846898|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-11-11|||March 2008||2008-03-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|cinnamon||Is There a Metabolic Effect of Cinnamon on HbA1c, Blood Pressure and Serum Lipids in Type 2 Diabetes Mellitus?|The Effect of Dietary Supplementation of Cinnamon (Cinnamon Cassia) on HbA1c, Blood Pressure and Serum Lipid Measurements in Patients With Type 2 Diabetes Mellitus: a Randomised Placebo Controlled, Double Blind Clinical Trial|Completed||Phase 2|58|Actual|Thames Valley University||2|||f||||t||||||||||2017-02-18 13:22:31.757092|2017-02-18 13:22:31.757092
NCT00846885|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-09-01|2009-07-06||August 2004||2004-08-01|September 2009|2009-09-01|October 2004|Actual|2004-10-01|September 2004|Actual|2004-09-01||Interventional|||Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions|A Randomized, Two-Way, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Sumatriptan Succinate, (100mg), Compared to and Equivalent Dose of a Commercially Available Reference Drug Product (Imitrex®, GlaxoSmithKline, USA) in 28 Fed, Healthy, Adult Subjects.|Completed||Phase 1|28|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:22:31.869225|2017-02-18 13:22:31.869225
NCT00846872|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-12-01|||July 2008||2008-07-01|December 2016|2016-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance|Effect of Continuous Subcutaneous GHRP-3 Infusion at 2 Dose Levels on the Physiological Secretion of the GH-IGF-I System, Blood Pressure, Glucose, Inflammatory Markers and Endothelial Function in Subjects With Insulin Resistance|Withdrawn||Phase 1/Phase 2|0|Actual|Tulane University||3||Inadequate subject recruitment|f||||t||||||||||2017-02-18 13:22:32.317328|2017-02-18 13:22:32.317328
NCT00846859|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2011-07-20|||March 2009||2009-03-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|August 2010|Actual|2010-08-01||Interventional|||Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?|Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?|Completed||Phase 2|162|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-02-18 13:22:32.434463|2017-02-18 13:22:32.434463
NCT00846846|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-04-13|2014-05-30||January 2009||2009-01-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2013|Actual|2013-03-01||Interventional|PROTECT-CA||PROTECT Continued Access Post Marketing Surveillance Trial|Patient Related OuTcomes With Endeavor Versus Cypher Stenting Trial: PROTECT Continued Access Post Marketing Surveillance Trial|Completed||Phase 4|1018|Actual|Medtronic Vascular||1|||f||||f||||||||||2017-02-18 13:22:32.553017|2017-02-18 13:22:32.553017
NCT00846833|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-06-06|||February 2009||2009-02-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|February 2011|Actual|2011-02-01||Interventional|||Haploidentical NK Cell Infusion in Malignant Melanoma|Phase I/II Study of Haploidentical Natural Killer Cell Infusion in Patients With Refractory or Relapsed Malignant Melanoma|Completed||Phase 1/Phase 2|12|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-02-18 13:22:35.189602|2017-02-18 13:22:35.189602
NCT00846820|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2014-11-21|||February 2009||2009-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:22:35.294796|2017-02-18 13:22:35.294796
NCT00846807|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-09-13|2012-07-25||February 2009||2009-02-01|September 2012|2012-09-01||||July 2011|Actual|2011-07-01||Observational|||Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery|Observational Cohort Study to Evaluate the Safety and Efficacy of Pradaxa (Dabigatran Etexilate) for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery or Total Knee Replacement Surgery in a Routine Clinical Setting.|Completed||N/A|5476|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 13:22:35.346675|2017-02-18 13:22:35.346675
NCT00846781|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2015-10-15||2011-05-20|February 2009||2009-02-01|October 2015|2015-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|DEFY||Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)||Terminated||Phase 3|308|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 13:22:36.110894|2017-02-18 13:22:36.110894
NCT00846768|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2014-05-29|2014-03-28||February 2009||2009-02-01|May 2014|2014-05-01||||July 2009|Actual|2009-07-01||Interventional||Treated set, includes all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPD|Randomised, Double-Blind, Cross-over Study to Determine the 24-hour FEV1-time Profile of Orally Inhaled BI 1744 CL, Delivered With the Respimat Inhaler, After 3 Weeks of Once Daily or Twice Daily Administration in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|47|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 13:22:36.221421|2017-02-18 13:22:36.221421
NCT00846755|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2011-09-26|||March 2005||2005-03-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening|Impact of Treating Thyroid Hormone Dysfunction During Pregnancy: A Randomized Controlled Trial of Universal Screening Versus Case Finding|Completed||N/A|4657|Actual|Ospedale V. Fazzi||2|||f||||f||||||||||2017-02-18 13:22:37.300167|2017-02-18 13:22:37.300167
NCT00846742|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-08-17|||February 2009||2009-02-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma|Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma|Recruiting||Phase 2|80|Anticipated|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 13:22:37.40546|2017-02-18 13:22:37.40546
NCT00846729|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2010-09-03|||March 2003||2003-03-01|September 2010|2010-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Comparative Renal Function of Young (18-45 Years) and Ageing (55 Years and Above) Kidney Donors|Preserving Renal Longevity in Living Kidney Donors|Unknown status|Recruiting|N/A|120|Anticipated|Stanford University|||2||f||||||||||Samples With DNA|"~     1. Blood samples are obtained throughout the kidney function study. These samples are~          analyzed for Iothalamate and PAH (markers of kidney function) only.~        2. Kidney tissue obtained by biopsy at the time of surgery are used to analyze the~          structure of the kidney.~      No Tissue or Blood is used for genetic analysis.~   "|||2017-02-18 13:22:37.542892|2017-02-18 13:22:37.542892
NCT00846716|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2009-02-18|||March 2008||2008-03-01|February 2009|2009-02-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|SHIP-DINER||Shiga Progression of Diabetes, Nephropathy and Retinopathy|Exploratory Study to Investigate the Suppressive Effect of Oral Anti-Diabetic Drug (TZD) on Progression of Diabetic Nephropathy on|Unknown status|Recruiting|N/A|400|Anticipated|Shiga University||2|||f||||t||||||||||2017-02-18 13:22:37.63504|2017-02-18 13:22:37.63504
NCT00846703|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2010-03-05|||July 2008||2008-07-01|March 2010|2010-03-01|December 2018|Anticipated|2018-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia|Clinical Study of GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia in Guangdong Province|Recruiting||Phase 4|600|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:22:37.750067|2017-02-18 13:22:37.750067
NCT00846690|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2009-02-18|||January 2009||2009-01-01|February 2009|2009-02-01|May 2009|Anticipated|2009-05-01|March 2009|Anticipated|2009-03-01||Interventional|||Comparative Efficacy of 20% Benzocaine Versus TAC Alternate Gel|Comparative Efficacy of 20% Benzocaine Versus TAC Alternate Gel for Control of Pain of Dental Needle Insertion in the Palate|Unknown status|Recruiting|Phase 4|20|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 13:22:37.876335|2017-02-18 13:22:37.876335
NCT00846677|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-03-01|||January 2009||2009-01-01|March 2012|2012-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study Comparing Two Vitamin D Supplements for Infants: Liquid Versus D-Strips|A Randomized, Open-label, Cross-over Study Comparing Two Vitamin D Supplements for Infants: Liquid Versus D-Strips.|Completed||Phase 4|50|Actual|McGill University||2|||f||||f||||||||||2017-02-18 13:22:37.988352|2017-02-18 13:22:37.988352
NCT00846664|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||February 2009||2009-02-01|February 2009|2009-02-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Short Arc Multifidus Study|Increase in Multifidus Size By Short Arc Banding on the ATM Machine as Measure by Diagnostic Ultrasound|Unknown status|Recruiting|Early Phase 1|20|Anticipated|Logan College of Chiropractic||1|||f||||f||||||||||2017-02-18 13:22:38.098678|2017-02-18 13:22:38.098678
NCT00846651|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2016-03-17|2013-02-04||February 2009||2009-02-01|March 2016|2016-03-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Spinal Anesthesia Induced Hypotension During Cesarean Section|Comparison of Phenylephrine Infusion With Colloids vs. Crystalloids for Reduction of Spinal-induced Hypotension During Cesarean Section|Completed||Phase 4|82|Actual|Milton S. Hershey Medical Center|technical problems for analysing fetal pH in all newborns|2|||f||||f||||||||||2017-02-18 13:22:38.194274|2017-02-18 13:22:38.194274
NCT00846638|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2010-05-06|||January 2005||2005-01-01|May 2010|2010-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|WHHS||Women's Health Habits Study|Screening and Brief Intervention for Problem Drinking Women|Completed||Phase 3|611|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:22:38.619401|2017-02-18 13:22:38.619401
NCT00846625|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2014-12-09|||November 2009||2009-11-01|December 2014|2014-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|SURFING||Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids|Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids Following a Periocular Steroid Injections in Patients on Steroid Sparing Agents or Low Dose Steroids|Withdrawn||Phase 2|0|Actual|University of Utah||2||Insufficient enrollment (no subjects were enrolled)|f||||t||||||||||2017-02-18 13:22:38.708226|2017-02-18 13:22:38.708226
NCT00846612|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-18|2012-10-18|||January 2008||2008-01-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|September 2010|Actual|2010-09-01||Interventional|||Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer|Phase II and Pharmacokinetic Study of Avastin and Doxil in the Treatment of Platinum-resistant or Refractory Ovarian Cancer|Completed||Phase 1|15|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 13:22:38.81864|2017-02-18 13:22:38.81864
NCT00846599|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-12-02|||January 2008||2008-01-01|December 2009|2009-12-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|PERTH||Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men|Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men|Unknown status|Recruiting|N/A|50|Anticipated|Tufts University|||2||f||||f||||||||||2017-02-18 13:22:38.941325|2017-02-18 13:22:38.941325
NCT00846586|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2011-07-22|2011-07-22||March 2009||2009-03-01|July 2011|2011-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|INTRUST1||Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease|A Randomized, Double-blind, Controlled, Parallel-group, 12-week Study to Compare the Efficacy and Safety of the Combination of Indacaterol 150 µg Once Daily With Open Label Tiotropium 18 µg Once Daily Versus Open Label Tiotropium 18 µg Once Daily in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease|Completed||Phase 3|1134|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:22:39.049262|2017-02-18 13:22:39.049262
NCT00846573|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2012-11-08|2012-08-21||November 2008||2008-11-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders|Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders|Terminated||N/A|14|Actual|University of Massachusetts, Worcester||4||The study was halted prematurely as the PI was no longer an employee of UMass Medical School.|f||||f||||||||||2017-02-18 13:22:39.895957|2017-02-18 13:22:39.895957
NCT00845520|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-02-02|||January 2009||2009-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:22:40.371931|2017-02-18 13:22:40.371931
NCT00845507|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2015-08-03|||December 2008||2008-12-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults|A Double-Blind Placebo-Controlled Study of Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults With Bipolar Disorder, Major Depressive Disorder, Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|60|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 13:22:40.420261|2017-02-18 13:22:40.420261
NCT00846560|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2009-02-17|||August 2008||2008-08-01|February 2009|2009-02-01||||December 2010|Anticipated|2010-12-01||Observational|||Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)|Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Rambam Health Care Campus|||2||f||||f||||||||||2017-02-18 13:22:40.523885|2017-02-18 13:22:40.523885
NCT00846547|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-05-10|2013-02-14||February 2009||2009-02-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders|An Open-Label, Flexible-Dose Evaluation of the Safety and Tolerability of STX209 for Treatment of Irritability in Subjects With Autism Spectrum Disorders|Completed||Phase 2|32|Actual|Seaside Therapeutics, Inc.||1|||f||||t||||||||||2017-02-18 13:22:40.596876|2017-02-18 13:22:40.596876
NCT00846534|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2014-04-21|||April 2008||2008-04-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|POAF||The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery|The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery|Terminated||N/A|100|Anticipated|University of Illinois at Chicago|||1|Insufficient patient volume|f||||f||||||Samples Without DNA|"~     Approximately 10- 15 ml of blood will be drawn from subjects. Blood samples will be~     separated into plasma and serum to measure the oxidative stress markers.~   "|||2017-02-18 13:22:40.829972|2017-02-18 13:22:40.829972
NCT00846521|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2013-04-29|2013-03-07||September 2006||2006-09-01|April 2013|2013-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Baseline analysis was only done on subjects who completed the study|Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity|Postprandial Glycemia in Association With Vascular Disease in Childhood Obesity|Terminated||Phase 4|23|Actual|Yale University||1|||f||||f||||||||||2017-02-18 13:22:40.921699|2017-02-18 13:22:40.921699
NCT00846508|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-12-31|||February 2009||2009-02-01|February 2009|2009-02-01|January 2013|Anticipated|2013-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Cisplatin Based Chemoradiation v.s Radiotherapy for Cervical Cancer and With Clinically Defined Good Prognosis|Phase III Randomized Trial of Comparing CCRT vs. RT Alone for Cervical Cancer Patients Primarily Treated by Radiotherapy and With Clinically Defined Good-prognosis|Unknown status|Enrolling by invitation|Phase 3|208|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-02-18 13:22:41.143564|2017-02-18 13:22:41.143564
NCT00846495|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-01-11|2011-06-09||August 2009||2009-08-01|January 2012|2012-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine|A Randomized, Single-Blind Pilot Study to Compare the Efficacy and Cost-Effectiveness of Frovatriptan vs. Topiramate for the Prevention of Migraine|Completed||Phase 4|55|Actual|Cady, Roger, M.D.||2|||f||||f||||||||||2017-02-18 13:22:41.26036|2017-02-18 13:22:41.26036
NCT00846482|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2009-02-17|||February 2008||2008-02-01|February 2009|2009-02-01|August 2010|Anticipated|2010-08-01|February 2010|Anticipated|2010-02-01||Observational|||Exploratory Study Of The ERCC-1 Gene|Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer|Unknown status|Recruiting|N/A|40|Anticipated|Montefiore Medical Center|||1||f||||t||||||Samples With DNA|"~     Biospecimens include blood and tumor samples.~   "|||2017-02-18 13:22:41.816579|2017-02-18 13:22:41.816579
NCT00846469|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-12-04|||July 2009||2009-07-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Coronary Computed Tomography (CT) Angiography Versus Standard Therapy in the Emergency Room|64 Slice Coronary CT Angiography vs. Standard Therapy in the Emergency Room: Determining Cost-effectiveness and Predicting Clinical Outcome in Patients With Low and Moderate Risk for Acute Coronary Syndrome.|Completed||N/A|43|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 13:22:41.928107|2017-02-18 13:22:41.928107
NCT00846456|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2015-10-19|||January 2009||2009-01-01|October 2015|2015-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma|Phase I/II Trial of Vaccine Therapy With Tumor Stem Cell Derived mRNA- Transfected Dendritic Cells in Patients Receiving Standard Therapy for Glioblastoma|Completed||Phase 1/Phase 2|20|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-02-18 13:22:42.020774|2017-02-18 13:22:42.020774
NCT00846443|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||January 2009||2009-01-01|February 2009|2009-02-01||||January 2010|Anticipated|2010-01-01||Interventional|||Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer|A Phase I Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer.|Unknown status|Recruiting|Phase 1|12|Anticipated|Fudan University||4|||f||||t||||||||||2017-02-18 13:22:42.191607|2017-02-18 13:22:42.191607
NCT00846430|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2015-05-20|||October 2008||2008-10-01|May 2015|2015-05-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||"Medical Treatment of High-Risk Neurofibromas"|"Medical Treatment of High-Risk Neurofibromas in Patients With Type 1 Neurofibromatosis: A Clinical Trial of Sequential Medical Therapies"|Active, not recruiting||Phase 2|20|Anticipated|Spectrum Health Hospitals||1|||f||||f||||||||||2017-02-18 13:22:42.290806|2017-02-18 13:22:42.290806
NCT00846417|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2013-09-10|||July 2008||2008-07-01|September 2013|2013-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Implantable Cardioverter Defibrillator (ICD) Support Groups and Veterans|Impact of ICD Support Groups in Veterans Receiving Internal Cardioverter Defibrillators|Terminated||N/A|3|Actual|Emory University|||2|No funding, lost support staff, no data collected/processed|f||||t||||||||||2017-02-18 13:22:42.398026|2017-02-18 13:22:42.398026
NCT00846404|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2009-02-17|||July 2006||2006-07-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|May 2007|Anticipated|2007-05-01||Observational|ODDS||Markers of Oxidative Stress Diastolic Dysfunction|Markers of Oxidative Stress Present in Blood in Patients With Diastolic Dysfunction|Unknown status|Active, not recruiting|N/A|50|Anticipated|Emory University|||2||f||||f||||||||||2017-02-18 13:22:42.48823|2017-02-18 13:22:42.48823
NCT00846391|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-02-04|2010-08-26||December 2008||2008-12-01|February 2016|2016-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)|A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK8245 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control|Terminated||Phase 2|14|Actual|Merck Sharp & Dohme Corp.|This study was terminated due to the continuing inability to recruit patients. No efficacy analysis was performed because of insufficient sample size for meaningful analysis due to early study termination and insufficient sample size.|3||Study was terminated due to inability to recruit patients.|f||||||||||||||2017-02-18 13:22:42.581825|2017-02-18 13:22:42.581825
NCT00846378|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2014-01-31|||March 2008||2008-03-01|January 2014|2014-01-01||||May 2010|Actual|2010-05-01||Interventional|PCinAMI||Minimizing Reperfusion Injury in Patients With Acute Myocardial Infarction|The Mechanism of Ischemic Post-conditioning in Humans: Minimizing Reperfusion Injury in Patients With Acute Myocardial Infarction|Suspended||Phase 1|30|Anticipated|University of Cincinnati||2||Suspended for potential change in protocol to include different imaging modalities|f||||t||||||||||2017-02-18 13:22:43.082334|2017-02-18 13:22:43.082334
NCT00846365|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-02-09|2012-01-04||March 2009||2009-03-01|February 2012|2012-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension|A Phase 3, Double-Blind, Randomized, Efficacy and Safety Study Comparing the TAK-491 Plus Chlorthalidone Fixed-Dose Combination vs Benicar HCT® (Olmesartan Medoxomil-Hydrochlorothiazide) in Subjects With Moderate to Severe Essential Hypertension|Completed||Phase 3|1085|Actual|Takeda||3|||f||||f||||||||||2017-02-18 13:22:43.337659|2017-02-18 13:22:43.337659
NCT00846352|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-08-05|||January 2009||2009-01-01|August 2009|2009-08-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients|Randomized Trial Comparing Early Versus Late Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates.|Unknown status|Recruiting|Phase 4|100|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 13:22:45.148238|2017-02-18 13:22:45.148238
NCT00846339|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-14|2011-02-19|||November 2008||2008-11-01|February 2011|2011-02-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration|[11C] Raclopride PET Imaging Study That Investigates Relation Between Occupancy of Dopamine D2 Receptors and Genotypes of DRD2 After Bupropion Administration|Completed||Phase 4|12|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-02-18 13:22:45.280947|2017-02-18 13:22:45.280947
NCT00846326|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-10-24||||||October 2016|2016-10-01||||||||Interventional|||Preventing Tolerance to Oxymetazoline in Allergic Rhinitis|A Proof of Concept Study to Evaluate if Concomitant Topical Intranasal Steroid Prevents Tolerance and Rebound Congestion Due to Regular Oxymetazoline in Persistent Allergic Rhinitis.|Withdrawn||Phase 4|0|Actual|University of Dundee||2||The suppliers were unable to provide the investigational medicinal product (IMP)|f||||f||||||||||2017-02-18 13:22:45.392003|2017-02-18 13:22:45.392003
NCT00846313|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2015-04-07|||December 2003||2003-12-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|ColErn||Can Malnutrition be Prevented in Patient With Colorectal Cancer Stage Dukes D?|A Randomised Study of Dietary Counseling for Patients With Colorectal Cancer.|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||2||Study was stopped due to lack of resources (clinical dietitians)|f||||f||||||||||2017-02-18 13:22:45.511143|2017-02-18 13:22:45.511143
NCT00846300|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2015-10-07|||August 2001||2001-08-01|October 2015|2015-10-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas|An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.|Completed||N/A|150|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||||2017-02-18 13:22:45.602028|2017-02-18 13:22:45.602028
NCT00846287|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2012-10-03|2012-06-19||November 2008||2008-11-01|October 2012|2012-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI|Assessment of Arformoterol for COPD Using Hyperpolarized 3He MRI|Completed||N/A|16|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-02-18 13:22:45.699124|2017-02-18 13:22:45.699124
NCT00846274|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2009-02-17|||October 2008||2008-10-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III|"Single-Dose, Open Label, Randomized Comparative Clinical Trial to Evaluate the Tolerability, Safety and PK/PD of Human ATIII Products, SKATIII Injection andATIII Injection in Healthy Male Subjects"|Completed||Phase 1|20|Anticipated|SK Chemicals Co.,Ltd.||2|||f||||||||||||||2017-02-18 13:22:46.214262|2017-02-18 13:22:46.214262
NCT00846261|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-03-03|||January 2002||2002-01-01|March 2009|2009-03-01|January 2008|Actual|2008-01-01|December 2006|Actual|2006-12-01||Interventional|||The Infected Bone Nonunion and Soft Tissue Defect of Long Bone Treated Simultaneously With Ilizarov Technique|The Infected Bone Nonunion and Soft Tissue Defect of Long Bone Treated Simultaneously With Ilizarov Technique|Completed||Phase 4|22|Actual|Zhejiang University||1|||f||||t||||||||||2017-02-18 13:22:46.305923|2017-02-18 13:22:46.305923
NCT00846248|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-08-30|||January 2006||2006-01-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|July 2009|Actual|2009-07-01||Interventional|||Chromium and Insulin Resistance|Chromium and Insulin Resistance|Completed||N/A|75|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:22:46.405377|2017-02-18 13:22:46.405377
NCT00846235|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-10-07|||December 2008||2008-12-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis|Clinical Evaluation of the Effect of Moisturising Cream on Skin Moisture in Atopic Dermatitis|Completed||Phase 4|24|Actual|Orion Corporation, Orion Pharma||1|||f||||f||||||||||2017-02-18 13:22:46.505651|2017-02-18 13:22:46.505651
NCT00846222|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2009-02-17|||February 2009||2009-02-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|April 2010|Anticipated|2010-04-01||Interventional|||Adjunctive Mild Hypothermia Therapy to Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated With Shock: A Feasibility Study||Unknown status|Active, not recruiting|Phase 3|10|Anticipated|Assaf-Harofeh Medical Center||1|||f||||f||||||||||2017-02-18 13:22:46.602799|2017-02-18 13:22:46.602799
NCT00846209|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-17|||June 2007||2007-06-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Improving Prescription Drug Warning Labels||Completed||Phase 4|500|Actual|Northwestern University|||||f||||f||||||||||2017-02-18 13:22:46.695043|2017-02-18 13:22:46.695043
NCT00846196|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-10-07|||January 2009||2009-01-01|October 2011|2011-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects|A Crossover Study to Assess the Bioequivalence of the Phase III and Commercial Risedronate 35 mg Delayed Release Formulations.|Completed||Phase 1|538|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 13:22:46.776266|2017-02-18 13:22:46.776266
NCT00846183|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-12-20|||June 2008||2008-06-01|December 2013|2013-12-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Effect of Local Injury on Implantation|Effect of Local Injury to Endometrium on the Day of Oocyte Retrieval in First IVF Cycle on Implantation Rate.|Completed||Phase 2|156|Actual|Yazd Research & Clinical Center for Infertility||2|||f||||t||||||||||2017-02-18 13:22:46.887094|2017-02-18 13:22:46.887094
NCT00846170|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2015-03-08|||September 2010||2010-09-01|May 2011|2011-05-01||||March 2012|Anticipated|2012-03-01||Interventional|||Probiotics in Irritable Bowel Syndrome|"Double Blind Placebo Controlled Study of the Effect of Probiotics Co-Biotic (TM)on Symptoms and Fecal Bacterial Composition in IBS Patients"|Withdrawn||Phase 3|0|Actual|Meir Medical Center||2||sponsor decided they are not interested in the study due to finacial reasons|f||||f||||||||||2017-02-18 13:22:46.99802|2017-02-18 13:22:46.99802
NCT00846157|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2011-06-26|||September 2007||2007-09-01|February 2009|2009-02-01|September 2014|Anticipated|2014-09-01|September 2011|Anticipated|2011-09-01||Interventional|NKCell||Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients|R-CHOP Therapy Compared With R-CHOP Plus Biocell Natural Killer Mixture in Patients With DLBCL (Diffuse Large B Cell Lymphoma);A Randomized, Open-label,Multi-center Trail|Unknown status|Enrolling by invitation|Phase 3|276|Anticipated|NKBio Co.Ltd.||2|||f||||f||||||||||2017-02-18 13:22:47.090558|2017-02-18 13:22:47.090558
NCT00846144|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||September 2009||2009-09-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|September 2010|Anticipated|2010-09-01||Interventional|||The Reduction in Glucose Stimulated Insulin Secretion Induced by Cytokines May be Prevented by Copper Addition - Studies in Diabetic Patients|This Study is a Small Preliminary Study to Evaluate the Possibility of Performing a Phase 1 Study.|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 13:22:47.331722|2017-02-18 13:22:47.331722
NCT00846131|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2016-09-13|||February 2009||2009-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2015|Actual|2015-07-01||Interventional|||Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma|A Single-Center Proof of Concept Pilot Study to Evaluate the Safety, Efficacy, and Tolerability of Sorafenib Combined With Therasphere in Subjects With Hepatocellular Carcinoma Awaiting Liver Transplantation.|Completed||Phase 1|24|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 13:22:47.429666|2017-02-18 13:22:47.429666
NCT00846118|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-09-24|||February 2009||2009-02-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|July 2014|Actual|2014-07-01||Interventional|||Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)|Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis.|Unknown status|Active, not recruiting|N/A|1550|Anticipated|Juntendo University Hospital||2|||f||||t||||||||||2017-02-18 13:22:47.554422|2017-02-18 13:22:47.554422
NCT00846105|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2010-06-14|||February 2009||2009-02-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)|Two-Center Intervention Study to Evaluate the Impact of Rapid Molecular Screening on Nosocomial Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA).|Completed||N/A|7400|Anticipated|Erasme University Hospital||2|||f||||f||||||||||2017-02-18 13:22:47.666385|2017-02-18 13:22:47.666385
NCT00846092|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2013-09-20|||November 2007||2007-11-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|NIR||Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study|Phase 1 Study To Determine the Effects of Short Term Near-infrared Light (NIR) Therapy on Anatomic and Functional Abnormalities of Diabetic Macular Edema, and Assess Safety of Short Term Near-infrared Light Therapy in Eyes With Diabetic Macular Edema.|Completed||Phase 1|4|Actual|Medical College of Wisconsin||1|||f||||f||||||||||2017-02-18 13:22:47.788925|2017-02-18 13:22:47.788925
NCT00846079|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||February 2009||2009-02-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Myocardial Perfusion Assessment With Multidetector Computed Tomography|Myocardial Perfusion Assessment With Multidetector Computed Tomography|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|Tennessee Heart and Vascular Institute, P.C.||1|||f||||f||||||||||2017-02-18 13:22:47.907259|2017-02-18 13:22:47.907259
NCT00846066|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-07-27|2009-02-19||January 2007||2007-01-01|July 2015|2015-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Oral Health Training Program for Pediatric Residents|Effective Educational Instruction in Preventive Oral Health: Hands On Training (HOT)Versus Web Based Training (WBT): A Randomized Control Trial|Completed||N/A|56|Actual|Children's Mercy Hospital Kansas City||2|||f||||t||||||||||2017-02-18 13:22:48.010882|2017-02-18 13:22:48.010882
NCT00846053|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2011-03-02|||February 2009||2009-02-01|March 2011|2011-03-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Observational|||FDG-PET Imaging in Young Cystic Fibrosis Patients|FDG-PET Imaging in Young Cystic Fibrosis Patients|Unknown status|Recruiting|N/A|28|Anticipated|Washington University School of Medicine|||1||f||||t||||||||||2017-02-18 13:22:48.426112|2017-02-18 13:22:48.426112
NCT00846040|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-14|2017-01-24|||February 12, 2009||2009-02-12|February 8, 2016|2016-02-08||||||||Observational|||Reduced Carbohydrate vs. Fat|Selective Reduction of Dietary Carbohydrate Versus Fat: Effects on Metabolism, Endocrine Physiology, Brain Activity and Reward Circuitry|Completed||N/A|71|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:22:48.520777|2017-02-18 13:22:48.520777
NCT00846027|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-07-09|2014-05-27||January 2009||2009-01-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|December 2011|Actual|2011-12-01||Interventional||Intent-to-treat population: All participants enrolled in the study.|A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer|An Open Label Study to Assess the Effect of First Line Treatment With Avastin in Combination With Paclitaxel and Gemcitabine in Progression-free Survival in Patients With HER-2 Negative Breast Cancer|Completed||Phase 2|90|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:22:48.627942|2017-02-18 13:22:48.627942
NCT00846014|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2012-09-18|||January 2009||2009-01-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Asthma Exacerbation and Helium-3 MRI|Asthma Exacerbation and Helium-3 MRI|Withdrawn||N/A|0|Actual|University of Massachusetts, Worcester||1||Subjects which fit the strict inclusion criteria were not found.|f||||f||||||||||2017-02-18 13:22:48.998113|2017-02-18 13:22:48.998113
NCT00846001|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2015-07-14|||September 2007||2007-09-01|July 2015|2015-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|RESCUE||Resynchronization Surgery Combined Unified Efficacy|Study of Resynchronization and CABG Unified Efficacy in Ischemic Heart Failure Patients|Completed||Phase 3|178|Actual|Meshalkin Research Institute of Pathology of Circulation||2|||f||||t||||||||||2017-02-18 13:22:49.108504|2017-02-18 13:22:49.108504
NCT00845988|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-14|2013-12-04|||December 2008||2008-12-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders|Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders Having Drug-induced Weight Gain|Completed||Phase 4|28|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 13:22:49.219081|2017-02-18 13:22:49.219081
NCT00845975|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2014-05-07|2013-04-11||August 2008||2008-08-01|May 2014|2014-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Low Level Laser Therapy and Tinnitus Relief|A Double-blind, Placebo-controlled Randomized Evaluation of the Application of Low Level Laser Light Therapy Using the Erchonia Hearing Lasers for the Relief of Tinnitus Clinical Study Protocol.|Terminated||N/A|18|Actual|Erchonia Corporation||2||New information suggested a more effective treatment protocol.|f||||t||||||||||2017-02-18 13:22:49.332641|2017-02-18 13:22:49.332641
NCT00845962|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2010-01-26|||February 2009||2009-02-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Comparison of Bupivacaine and 2-chloroprocaine for Spinal Anesthesia|Spinal Anesthesia With Bupivacaine or 2-chloroprocaine for Outpatient Elective Surgery: a Prospective, Randomized, Double-blind Comparison.|Completed||N/A|106|Actual|Université de Montréal||2|||f||||f||||||||||2017-02-18 13:22:49.737036|2017-02-18 13:22:49.737036
NCT00845949|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2012-05-18|||November 2006||2006-11-01|May 2012|2012-05-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Observational|||Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological Changes|Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological Changes|Withdrawn||N/A|0|Actual|Far Eastern Memorial Hospital|||1|NO available budget and difficulty in recruiting|f||||t||||||Samples With DNA|"~     Synovial tissue~   "|||2017-02-18 13:22:49.85492|2017-02-18 13:22:49.85492
NCT00845936|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2009-02-18|||May 2009||2009-05-01|February 2009|2009-02-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics|Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics- Double Blind Placebo Controlled Study|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|BeerYaakov Mental Health Center||2|||f||||||||||||||2017-02-18 13:22:49.93885|2017-02-18 13:22:49.93885
NCT00845923|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2017-02-09||2014-04-30|March 2009||2009-03-01|February 2017|2017-02-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia|Phase II Proof of Concept Trial of Civamide Patch in the Treatment of Post-herpetic Neuralgia and Post-incisional Neuralgia|Completed||Phase 2|22|Actual|Winston Laboratories||1|||f||||f||||||||||2017-02-18 13:22:50.149265|2017-02-18 13:22:50.149265
NCT00845910|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2016-11-01|||May 2009||2009-05-01|November 2016|2016-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer|A Phase II Trial of Evaluating Circulating Endothelial Cell as A Surrogate Marker for Monitoring Treatment Efficacy of Docetaxel Plus Capecitabine With Bevacizumab as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer|Terminated||Phase 2|22|Actual|Hoffmann-La Roche||1||To be confirmed|f||||||||||||||2017-02-18 13:22:50.261011|2017-02-18 13:22:50.261011
NCT00845897|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2012-02-01|2011-08-11||March 2005||2005-03-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Botulinum Toxin Effects on Plantar Ulcer Recurrence|Botulinum Toxin Effects on Plantar Ulcer Recurrence|Completed||N/A|17|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 13:22:50.365221|2017-02-18 13:22:50.365221
NCT00845364|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2010-05-19|||February 2007||2007-02-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|CASPER||Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery|Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery|Completed||Phase 2/Phase 3|290|Actual|University Hospital Birmingham||2|||f||||t||||||||||2017-02-18 13:22:59.54099|2017-02-18 13:22:59.54099
NCT00845884|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2009-02-16|||February 2009||2009-02-01|February 2009|2009-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer|A Phase I/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Patients With Advanced Gastric Cancer|Unknown status|Not yet recruiting|Phase 1/Phase 2|49|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-02-18 13:22:50.81258|2017-02-18 13:22:50.81258
NCT00845871|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2014-05-07|||March 2009||2009-03-01|May 2014|2014-05-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food|A Single-arm, Open-label Study of the Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food|Completed||Phase 4|65|Actual|Novartis||1|||f||||f||||||||||2017-02-18 13:22:50.916193|2017-02-18 13:22:50.916193
NCT00845858|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-06-17|2014-04-17||April 2009||2009-04-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Provides at least 80% power (alpha=0.05 two sided) to detect a mean difference between treatment groups of 0.5, for the GCSI-DD total score. Based on the literature, the standard deviation (SD) of the endpoint is approximately 1.1 resulting in a sample size of 77 per treatment group.|Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis|A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Dose-Ranging Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Subjects With Gastroparesis|Completed||Phase 2|287|Actual|Evoke Pharma||3|||f||||f||||||||||2017-02-18 13:22:51.046217|2017-02-18 13:22:51.046217
NCT00845845|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-06-18|2013-02-06||March 2006||2006-03-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)|Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)|Terminated||Phase 2|12|Actual|University of Illinois at Chicago|The study was terminated on October 12, 2010 due to low enrollment. Consequently, no analyses were completed.|2||Terminated due to low enrollment.|f||||f||||||||||2017-02-18 13:22:51.865678|2017-02-18 13:22:51.865678
NCT00845832|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-12-15|2014-06-23||March 2009||2009-03-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Safety population: All participants who were randomized and received any part of an infusion of study medication; participants who received the incorrect therapy from that intended were summarized in the group according to the therapy actually received for the majority of the time through Week 48.|A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate|A Randomized, Active Controlled, Double-blind, Study to Compare the Safety and Reduction in Disease Activity With the Combination of Rituximab (MabThera®)and Tocilizumab (RoActemra®) Versus Tocilizumab in Patients With Active Rheumatoid Arthritis With an Incomplete Response to Methotrexate|Terminated||Phase 2|24|Actual|Hoffmann-La Roche||2||"The study was terminated early because of a related decision to stop the development of~   ocrelizumab in rheumatoid arthritis."|f||||||||||||||2017-02-18 13:22:52.298256|2017-02-18 13:22:52.298256
NCT00845819|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2015-01-20|||February 2009||2009-02-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|EGFOM||Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies|Randomized Phase II Study of Recombinant Human Epidermal Growth Factor (rhEGF) on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies|Completed||Phase 2|138|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-02-18 13:22:53.182734|2017-02-18 13:22:53.182734
NCT00845806|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2011-11-03|||February 2009||2009-02-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Neuronal Processing of Diacritics: An fMRI Study|Neuronal Processing of Diacritics: An fMRI Study|Completed||N/A|12|Actual|University of Massachusetts, Worcester|||1||f||||f||||||||||2017-02-18 13:22:53.311912|2017-02-18 13:22:53.311912
NCT00845793|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2009-02-17|||April 2009||2009-04-01|February 2009|2009-02-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||The Meal Tray as a Tool and Platform to Change Eating Habits Among Hospitalized Diabetic Patients - An Intervention Study|The Meal Tray as a Tool and Platform to Change Eating Habits Among Hospitalized Diabetic Patients - An Intervention Study|Unknown status|Not yet recruiting|N/A|500|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 13:22:53.409586|2017-02-18 13:22:53.409586
NCT00845780|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-06-23|||August 2000||2000-08-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|WISDOM||Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation|Withdrawal of Amiodarone Treatment Versus Continuation in Successfully Treated Patients With Persistent Atrial Fibrillation. A Randomized Study.|Completed||Phase 4|37|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-02-18 13:22:53.49769|2017-02-18 13:22:53.49769
NCT00845767|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-10-08|||April 2009||2009-04-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Cardiovascular Effects of Air Pollution: the Role of Nitric Oxide|The Cardiovascular Effects of Air Pollution: the Role of Nitric Oxide|Completed||N/A|16|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-02-18 13:22:53.596919|2017-02-18 13:22:53.596919
NCT00845754|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-14|2009-02-17|||September 1999||1999-09-01|February 2009|2009-02-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Post-Operative Treatment With Ketorolac After Abdominal Myomectomy|Effects of Ketorolac on Post-Operative Febrile Morbidity and Pain Management in Abdominal Myomectomy Patients|Completed||N/A|112|Actual|Ascher-Walsh, Charles, M.D.||2|||f||||||||||||||2017-02-18 13:22:53.696645|2017-02-18 13:22:53.696645
NCT00845741|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2011-01-20|||February 2009||2009-02-01|October 2010|2010-10-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Observational|||Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers|NGAL Evaluation in ED All-Comers|Completed||N/A|700|Actual|Biosite|||1||f||||f||||||||||2017-02-18 13:22:53.79708|2017-02-18 13:22:53.79708
NCT00845728|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2013-09-16|2013-07-03||March 2009||2009-03-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|INVIGORATE||Exacerbation Study|A Phase IIIb Multicenter, 52 Week Treatment, Randomized, Blinded, Double Dummy, Parallel Group Efficacy Study Comparing the Effect of Inhaled Indacaterol 150 µg o.d. vs Inhaled Tiotropium 18 µg o.d. on Lung Function, Rate of Exacerbations and Related Outcomes in Patients With COPD|Completed||Phase 3|3439|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:22:54.003646|2017-02-18 13:22:54.003646
NCT00845715|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-11-29|||July 2008||2008-07-01|November 2012|2012-11-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Early Range of Motion Following Arthroscopic Rotator Cuff Repair|The Effect of Early Range of Motion on Clinical Outcomes, Patient Satisfaction, and Cuff Integrity Following Arthroscopic Rotator Cuff Repair. A Prospective Randomized Study.|Unknown status|Active, not recruiting|N/A|70|Anticipated|UConn Health||2|||f||||f||||||||||2017-02-18 13:22:55.697577|2017-02-18 13:22:55.697577
NCT00845702|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2016-04-19|2011-09-22||April 2009||2009-04-01|April 2016|2016-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||Baseline measures were recorded for all 33 patients.|Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)|Evaluation of Dotarem-enhanced Magnetic Resonance Angiography (MRA) Compared to Time-Of-Flight (TOF) MRA in the Diagnosis of Renal Arterial Disease|Terminated||Phase 3|33|Actual|Guerbet|The study was not completed due to poor enrollment. The statistical analysis was not performed.|2||lack of recruitment.|f||||f||||||||||2017-02-18 13:22:55.793139|2017-02-18 13:22:55.793139
NCT00845689|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17||||||February 2009|2009-02-01||||||||Interventional|LTR||Prevention of Liver Damage During Liver Surgery|Study on the Potential Role of Intraoperative Hepatoprotection During Liver Resections|Unknown status|Active, not recruiting|Phase 1/Phase 2|||Ludwig-Maximilians - University of Munich||3|||f||||f||||||||||2017-02-18 13:22:56.029804|2017-02-18 13:22:56.029804
NCT00845676|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-04-10|2013-08-13||March 2008||2008-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Acute Hepatitis C Virus in HIV Co-Infection|Treatment of Acute Hepatitis C Virus in HIV Co-Infection|Completed||Phase 4|21|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 13:22:56.116881|2017-02-18 13:22:56.116881
NCT00845663|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-08-30|2009-08-25||October 2007||2007-10-01|December 2009|2009-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)|Open Label, Randomized, Parallel Group, Single Dose, 2-way Comparison Bioequivalence Study of Certolizumab Pegol Solution Injected Either by a Pre-filled Syringe (Reference) or by an Auto-injection Device (Test) to Healthy Volunteers.|Completed||Phase 1|98|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 13:22:56.361973|2017-02-18 13:22:56.361973
NCT00845650|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-11-21||2012-11-20|February 2009||2009-02-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)|A Randomized, Double-Blind, Dose-Escalation Study Evaluating Pharmacokinetics and Safety of Anthrax Immune Globulin Intravenous (AIGIV)|Completed||Phase 1/Phase 2|129|Actual|Emergent BioSolutions||2|||f||||t||||||||||2017-02-18 13:22:57.85124|2017-02-18 13:22:57.85124
NCT00845637|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2009-02-20|||March 2004||2004-03-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period|Effect of the Oral Administration of Eggplant Extract Capsules on Lipid Profile During Fasting and Postprandial Period: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 1|59|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-02-18 13:22:57.967747|2017-02-18 13:22:57.967747
NCT00845624|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2012-06-13|||January 2007||2007-01-01|February 2009|2009-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|SAT01ROP||Time Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm Infants|DURATION OF TIME OUTSIDE, BELOW, AND ABOVE THE TARGETED Oxygen SATURATION RANGE In Preterm Infants|Completed||N/A|102|Actual|University of Virginia|||1||f||||t||||||||||2017-02-18 13:22:58.073702|2017-02-18 13:22:58.073702
NCT00845611|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-04-04|||September 2008||2008-09-01|April 2012|2012-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer|Tumor Vaccine Therapy Against Advanced Gastric Cancer Using HLA-A*2402 Restricted Epitope Peptides Drived From URLC10|Completed||Phase 1|9|Actual|Kinki University||1|||f||||t||||||||||2017-02-18 13:22:58.17417|2017-02-18 13:22:58.17417
NCT00845429|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-12-13|2012-11-17||October 2007||2007-10-01|December 2012|2012-12-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects|Immunogenicity of Two Dosages of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine Administered in Healthy Adult Subjects Aged 18 to 49 Years|Completed||Phase 2|729|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 13:22:58.287183|2017-02-18 13:22:58.287183
NCT00845416|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-07-13|||March 2009||2009-03-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population|Newborn Screening for SCID in a High-Risk Population|Completed||N/A|1800|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:22:59.12807|2017-02-18 13:22:59.12807
NCT00845403|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2014-01-10|||September 2008||2008-09-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Antigen-specific Immune Response to Hepatitis B Virus in Utero|Antigen-specific Immune Response to Hepatitis B Virus and Influenza A (H1N1 Strain) in Utero|Unknown status|Recruiting|N/A|60|Anticipated|National University Hospital, Singapore|||1||f||||t||||||Samples Without DNA|"~     Cord Blood of HBsAg+ mothers will be collected at delivery after seeking informed consent.~     Mononuclear cells (T cells and monocytes) will be isolated.Purified populations of T cells~     will be stimulated with different mixtures of HBV peptides covering HBV proteins and~     experiments of ELISPOT or intracellular cytokine staining will be carried out to detect the~     specificty of the responsive T cell population. In addition, T cells willbe stained with~     HLA-tetramers specific for different HBV epitopes to directly analyze the frequency and~     phenotype of HBV-specific CD8+Tcells present in cord blood.~   "|||2017-02-18 13:22:59.232191|2017-02-18 13:22:59.232191
NCT00845390|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2012-04-26|||December 2008||2008-12-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Patient Expectations After Implantable-cardioverter Defibrillator (ICD) Implantation|Patient Expectations After ICD Implantation|Completed||N/A|100|Actual|University of California, San Francisco|||1||f||||t||||||||||2017-02-18 13:22:59.342494|2017-02-18 13:22:59.342494
NCT00845377|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||April 2008||2008-04-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|April 2010|Anticipated|2010-04-01||Interventional|||Changing Minds - Supporting Depressed Elderly People With an Individually Tailored Service Model|Changing Minds - Studying the Effects of a Tailored Psychosocial Support Model on Depressive Mood and Quality of Life in Depressive Elderly People|Unknown status|Recruiting|Phase 2|200|Anticipated|Central Union for the Welfare of the Aged||1|||f||||t||||||||||2017-02-18 13:22:59.429615|2017-02-18 13:22:59.429615
NCT00845338|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2014-11-28|||February 2007||2007-02-01|November 2014|2014-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity|A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity|Terminated||Phase 2|7|Actual|Bayer||1||"The enrollment rate at most centers was unlikely to result in the recruitment of the planned~   sample size of 40 evaluable subjects."|f||||f||||||||||2017-02-18 13:22:59.758619|2017-02-18 13:22:59.758619
NCT00845325|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2016-04-27|||December 2008||2008-12-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Early Motion Following Carpal Tunnel Release|Early Motion Following Carpal Tunnel Release, a Randomized Control Trial|Completed||N/A|16|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-02-18 13:22:59.877339|2017-02-18 13:22:59.877339
NCT00845312|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2011-02-13|||March 2009||2009-03-01|February 2009|2009-02-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Observational|||Prognostic Features for Mortality in Young Adults With Pneumonia|Prognostic Features for Mortality in Adult Pneumonia Patients at the Age of Sixty and Beneath.|Completed||N/A|1200|Anticipated|Rambam Health Care Campus|||1||f||||f||||||||||2017-02-18 13:23:00.00401|2017-02-18 13:23:00.00401
NCT00845299|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2013-09-16||2011-03-01|January 2009||2009-01-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma|An Open-Label, Randomized, Phase 2 Study of the Effects of Artificial Tears Preserved With Benzalkonium Chloride (AT-BAK) on the Response to the Latanoprost Punctal Plug Delivery System (L PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)|Completed||Phase 2|40|Actual|Mati Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 13:23:00.099716|2017-02-18 13:23:00.099716
NCT00845286|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2016-03-16|||September 2008||2008-09-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|March 2014|Actual|2014-03-01||Interventional|MAGIC||Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-Trial|Investigation of Myocardial Function and Vascular Adaptation in Association With Genotype in Marathon Runners|Completed||N/A|162|Actual|Technische Universität München||1|||f||||t||||||||||2017-02-18 13:23:00.226098|2017-02-18 13:23:00.226098
NCT00845273|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2015-09-30|||November 2008||2008-11-01|September 2015|2015-09-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan).|Completed||N/A|3538|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:23:00.320719|2017-02-18 13:23:00.320719
NCT00845260|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||December 2004||2004-12-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|IP2||Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder|Internet- Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder in a Psychiatric Setting: A Randomized Equivalence Trial|Completed||Phase 3|113|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 13:23:00.4282|2017-02-18 13:23:00.4282
NCT00845247|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-08-30|||March 2009||2009-03-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||The Effect of Case Management in Complex Cancer Pathways|The Effect of Case Management in Complex Cancer Pathways|Completed||N/A|280|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 13:23:00.520171|2017-02-18 13:23:00.520171
NCT00845234|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-02-25|||July 2008||2008-07-01|February 2013|2013-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education|Establishing a Standard for Peri-operative ICD Patient Education: A Demonstration Project|Completed||N/A|62|Actual|East Carolina University||2|||f||||t||||||||||2017-02-18 13:23:00.619739|2017-02-18 13:23:00.619739
NCT00845221|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-16|2016-10-10|||July 2004||2004-07-01|October 2016|2016-10-01||||November 2011|Actual|2011-11-01||Interventional|||Glivec in Pediatric Chronic Myeloid Leukemia (CML)||Completed||Phase 4|44|Actual|Poitiers University Hospital||1|||f||||||||||||||2017-02-18 13:23:00.714594|2017-02-18 13:23:00.714594
NCT00845208|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2011-09-19|||March 2002||2002-03-01|September 2011|2011-09-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||Network Support for Treatment of Alcohol Dependence|Network and Contingency Management for Alcohol Treatment|Completed||Phase 2|210|Actual|UConn Health||3|||f||||f||||||||||2017-02-18 13:23:00.805282|2017-02-18 13:23:00.805282
NCT00845195|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2010-04-22|2010-03-25||March 2009||2009-03-01|April 2010|2010-04-01||||May 2009|Actual|2009-05-01||Interventional|||Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid||Completed||Phase 4|150|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:23:00.909034|2017-02-18 13:23:00.909034
NCT00845182|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2015-08-08|2013-04-04||June 2007||2007-06-01|August 2015|2015-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|PIO-EX||Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function|Effect of Pioglitazone With and Without Exenatide on Body Weight, Fat Topography, Beta Cell Function, and Glycemic Control in Type 2 Diabetic Patients|Completed||Phase 4|43|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-02-18 13:23:03.629521|2017-02-18 13:23:03.629521
NCT00845169|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2014-12-01|||April 2012||2012-04-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||The Role of Nitric Oxide Synthase Isoforms in the Cardiovascular Effects of Air Pollution|The Role of Nitric Oxide Synthase Isoforms in the Cardiovascular Effects of Air Pollution|Completed||N/A|16|Actual|University of Edinburgh||2|||f||||f||||||||||2017-02-18 13:23:04.127175|2017-02-18 13:23:04.127175
NCT00845156|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-06-18|||January 2008||2008-01-01|June 2013|2013-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Alpha Lipoic Acid and Insulin Resistance|Alpha Lipoic Acid and Insulin Resistance|Completed||N/A|68|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:23:04.237415|2017-02-18 13:23:04.237415
NCT00845143|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2009-02-17|||February 2009||2009-02-01|February 2009|2009-02-01|August 2011|Anticipated|2011-08-01|February 2011|Anticipated|2011-02-01||Observational|||Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer|Vibration Response Imaging (VRI) in the Preoperative Management in Patients With Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|N/A|100|Anticipated|Heidelberg University|||1||f||||f||||||||||2017-02-18 13:23:04.347487|2017-02-18 13:23:04.347487
NCT00845130|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-15|2016-11-02|2016-06-09||September 2009||2009-09-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes|Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes|Active, not recruiting||N/A|42|Actual|University of Kansas Medical Center||2|||f||||t||||||||No|No, there is not a plan to share individual data.|2017-02-18 13:23:04.428168|2017-02-18 13:23:04.428168
NCT00845117|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2013-06-19|||July 2008||2008-07-01|June 2013|2013-06-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|LECT||Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency|Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency|Unknown status|Active, not recruiting|Phase 1/Phase 2|21|Actual|University Hospital, Antwerp||1|||f||||||||||||||2017-02-18 13:23:04.822426|2017-02-18 13:23:04.822426
NCT00845104|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-17|2015-03-04|||January 2009||2009-01-01|March 2015|2015-03-01||||||||Interventional|||Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment|A Phase II Study of Fludarabine (F), Rituxan (R) and Avastin (A) Followed by RA Maintenance in Patients With Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (CLL)|Withdrawn||Phase 2|0|Actual|Fred Hutchinson Cancer Research Center||1||No patients enrolled.|f||||t||||||||||2017-02-18 13:23:05.110385|2017-02-18 13:23:05.110385
NCT00845091|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2014-01-07|||February 2009||2009-02-01|January 2014|2014-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|CARE-E||Cardiac Autonomic Regulation Enhancement Through Exercise Trial|Cardiac Autonomic Regulation Enhancement Through Exercise Trial|Completed||Phase 1|22|Actual|The Miriam Hospital||2|||f||||t||||||||||2017-02-18 13:23:05.238596|2017-02-18 13:23:05.238596
NCT00845078|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-13|||December 2008||2008-12-01|February 2009|2009-02-01||||||||Observational|||Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer|Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer|Unknown status|Recruiting|N/A|144|Anticipated|University of Pittsburgh|||2||f||||f||||||||||2017-02-18 13:23:05.347957|2017-02-18 13:23:05.347957
NCT00845065|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-09-24|2011-10-10||February 2009||2009-02-01|September 2015|2015-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLETED)|A Phase 3 Safety and Efficacy Study of Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin|Completed||Phase 3|202|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 13:23:05.463963|2017-02-18 13:23:05.463963
NCT00845052|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2017-02-02|||July 2008||2008-07-01|February 2017|2017-02-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Observational|||Survey of Housestaff Attitudes Toward Patient Care and Safety|Changing Housestaff Culture and Tracking Housestaff Attitudes Regarding Patient Care and Safety|Completed||N/A|674|Actual|Weill Medical College of Cornell University|||3||f||||f||||||||No||2017-02-18 13:23:05.972333|2017-02-18 13:23:05.972333
NCT00845039|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-02-02||2010-11-11|May 2009||2009-05-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|FC-4||A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of People With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab|A Randomized Phase II Clinical Trial Investigating Irinotecan Plus Cetuximab With or Without Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody (IMC-A12) for the Treatment of Patients With Metastatic K-Ras Wild Type Carcinoma of the Colon or Rectum That Has Progressed on Oxaliplatin and Bevacizumab Given as First-Line Therapy|Completed||Phase 2|4|Actual|ImClone LLC||2|||f||||f||||||||||2017-02-18 13:23:06.053378|2017-02-18 13:23:06.053378
NCT00845026|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-02-25||2011-02-25|March 2009||2009-03-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients|A Long-Term, Phase 2, Multicenter, Randomized, Open-Label Comparative Safety Study of LY2140023 Versus Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia|Completed||Phase 2|261|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 13:23:06.178114|2017-02-18 13:23:06.178114
NCT00845013|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-05-29|||November 2007||2007-11-01|May 2015|2015-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension|Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension|Active, not recruiting||N/A|125|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     serum, plasma, PBMCS, BAL~   "|||2017-02-18 13:23:06.315037|2017-02-18 13:23:06.315037
NCT00845000|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2016-06-09|2016-04-18||April 2009||2009-04-01|June 2016|2016-06-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)|Acute Effects of SCH 420814 on Dyskinesia and Parkinsonism in Levodopa Treated Patients|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 13:23:06.413387|2017-02-18 13:23:06.413387
NCT00844987|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2010-05-26|||January 2007||2007-01-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Vascular Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Hepatocyte Growth Factor (HGF) in Patients With Acute Coronary Syndrome (ACS)|The Importance of Vascular Endothelial Growth Factor (VEGF), Hepatocyte Growth Factor (HGF) and Platelet Derived Growth Factor (PDGF) as a New Indicators of Myocardial Ischemic Injury in Comparison With Commonly Used Biomarkers.|Completed||N/A|120|Anticipated|Institute of Cardiology, Warsaw, Poland|||1||f||||f||||||Samples Without DNA|"~     serum and plasma~   "|||2017-02-18 13:23:07.169792|2017-02-18 13:23:07.169792
NCT00844974|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-11-14|||December 2007||2007-12-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms|Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder Depressed Type: Prevalence and Symptoms With Treating of Depressive Symptoms|Completed||N/A|33|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:23:07.363135|2017-02-18 13:23:07.363135
NCT00844584|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-02-12|||October 2008||2008-10-01|January 2009|2009-01-01|June 2011|Anticipated|2011-06-01|December 2010|Anticipated|2010-12-01||Interventional|||Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope|Clinical Study of Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope|Unknown status|Recruiting|N/A|20|Anticipated|Xijing Hospital||1|||f||||t||||||||||2017-02-18 13:23:17.452192|2017-02-18 13:23:17.452192
NCT00844961|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-11-08|||November 2008||2008-11-01|February 2009|2009-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effectiveness of Internet Delivered Cognitive Behavior Therapy (CBT) for Irritable Bowel Syndrome (IBS)|Study of the Effectiveness of Internet Delivered Cognitive Behavior Therapy in a Sample of Consecutively Recruited Patients Diagnosed With Irritable Bowel Syndrome|Completed||N/A|61|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 13:23:07.458641|2017-02-18 13:23:07.458641
NCT00844948|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-05-04|||October 2008||2008-10-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|June 2011|Actual|2011-06-01||Observational|Speech2||Vocal Acoustic Biomarkers in Depression|Development of a Convenient, Automated, Objective Measure of Depression|Completed||N/A|125|Actual|Center for Psychological Research, Madison, WI|||3||f||||f||||||||||2017-02-18 13:23:07.569533|2017-02-18 13:23:07.569533
NCT00844935|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-03-26|||September 2011||2011-09-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Electrocardiographic Autonomic Function Measures in Mechanically Ventilated Patients|The Value of Electrocardiographic Autonomic Nervous System Function Measures for Predicting Cardiopulmonary Recovery of Mechanically Ventilated Patients in Intensive Care|Withdrawn||N/A|0|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:23:07.682666|2017-02-18 13:23:07.682666
NCT00844922|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2014-12-30|||September 2005||2005-09-01|December 2014|2014-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)|Double-blind, Placebo-controlled Trial Investigating the Safety of Re-exposure to 900 mg of Org 34517, Used as Adjunctive Therapy in Subjects With Psychotic Major Depression (Major Depressive Episode, Severe, With Psychotic Features), Who Participated in Trial 28130|Completed||Phase 2|16|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 13:23:07.774691|2017-02-18 13:23:07.774691
NCT00844909|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2010-04-26|||January 2009||2009-01-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|||||Interventional|||A Study of the Safety and How the Body Effects a Drug CNTO 136 in Healthy Male Japanese and Caucasian Volunteers|A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of CNTO136 Following a Single Subcutaneous Administration to Healthy Japanese and Caucasian Subjects.|Completed||Phase 1|62|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 13:23:07.874325|2017-02-18 13:23:07.874325
NCT00844896|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-10-08|2012-06-12||May 2008||2008-05-01|October 2014|2014-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Intervention to Reduce Stress in 0-5 Year Olds With Burns|RCT Intervention to Reduce Stress in 0-5 Year Olds With Burns|Completed||N/A|57|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:23:07.961562|2017-02-18 13:23:07.961562
NCT00844883|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2014-01-30|||February 2009||2009-02-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma|Phase II Trial of Sorafenib Combined With Doxorubicin Eluting Bead-Transarterial Chemoembolization (LC Bead-TACE) for Patients With Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 2|50|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:23:08.501082|2017-02-18 13:23:08.501082
NCT00844870|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-13|||April 2007||2007-04-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Exploring New Approaches in Reaching Behavior Post Stroke|Training With or Without Upper Body Restraint During Reaching in Individuals Post Stroke|Completed||N/A|24|Actual|University of the Sciences in Philadelphia||2|||f||||f||||||||||2017-02-18 13:23:08.611408|2017-02-18 13:23:08.611408
NCT00844857|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2013-01-16|2013-01-16||April 2009||2009-04-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression|Study to Assess the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar I Disorder|Completed||Phase 4|291|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:23:08.734198|2017-02-18 13:23:08.734198
NCT00844844|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-06-30|2014-10-21||May 2009||2009-05-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|September 2010|Actual|2010-09-01||Interventional|aHUS|The intent-to-treat (ITT) population was defined as all patients who received any amount of eculizumab, and were considered evaluable for safety and efficacy analyses. For both the efficacy and safety analyses, all 17 patients who were treated with study drug were included in the ITT population.|Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS|An Open-Label, Multi-Center Controlled Clinical Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant Atypical Hemolytic Uremic Syndrome (aHUS)|Completed||Phase 2|1|Actual|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-02-18 13:23:09.913519|2017-02-18 13:23:09.913519
NCT00844831|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2010-06-21|||May 2009||2009-05-01|April 2009|2009-04-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit|Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit|Unknown status|Active, not recruiting|Phase 4|20|Anticipated|University of Louisville||1|||f||||f||||||||||2017-02-18 13:23:10.737994|2017-02-18 13:23:10.737994
NCT00844818|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||February 2005||2005-02-01|February 2009|2009-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|NEWS||An Intervention to Address Parental Smoking During the Postpartum Hospitalization.|Using the Postpartum Hospital Stay to Address Mother's and Father's Smoking: the NEWS Study|Completed||N/A|101|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:23:10.837427|2017-02-18 13:23:10.837427
NCT00844805|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-02-24|2012-09-20||September 2009||2009-09-01|February 2015|2015-02-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|INFAST||Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)|Infliximab as First Line Therapy in Patients With Early Active Axial Spondyloarthritis Trial|Completed||Phase 3|158|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:23:10.935522|2017-02-18 13:23:10.935522
NCT00844792|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-12-21|||October 2008||2008-10-01|December 2015|2015-12-01||||December 2013|Actual|2013-12-01||Interventional|||Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer|A Randomized, Double-Blind Study of Combination Vitamin E, Selenium and Lycopene vs. Placebo in Men Undergoing Radical Prostatectomy for Prostate Cancer|Completed||Phase 2|48|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:23:11.694365|2017-02-18 13:23:11.694365
NCT00844779|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-04-24|||February 2009||2009-02-01|April 2009|2009-04-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Observational|||Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients|Evaluation of Non Alcoholic Metabolic Liver Diseases in Patients Harboring Central Adiposity and Insulin Resistance by Biochemical and Functional Genomic Approaches|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Strasbourg, France|||3||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:23:11.795789|2017-02-18 13:23:11.795789
NCT00844766|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-13|||December 2006||2006-12-01|February 2009|2009-02-01||||||||Observational|||Validation of a Home-Screening Test for Lactose Intolerance|A Study to Validate a Home-Screening Test for Lactose Intolerant People|Suspended||Early Phase 1|40|Anticipated|University Hospitals, Leicester|||1|This study was stopped as no patient asked to participate was prepared to do so|f||||||||||||||2017-02-18 13:23:11.891182|2017-02-18 13:23:11.891182
NCT00844753|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2016-01-05|2015-11-23||October 2008||2008-10-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|Strattera||Atomoxetine, Placebo and Parent Management Training in Autism|Atomoxetine, Placebo and Parent Management Training in Autism|Completed||Phase 4|128|Actual|University of Rochester||4|||f||||t||||||||||2017-02-18 13:23:11.961738|2017-02-18 13:23:11.961738
NCT00844740|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-13|||February 2009||2009-02-01|February 2009|2009-02-01||||June 2010|Anticipated|2010-06-01||Interventional|CHR||Calcimimetics in Hypophosphatemic Rickets|Effect of Cinacalcet on the Long-Term Treatment of Familial Hypophosphatemic Rickets|Unknown status|Enrolling by invitation|N/A|10|Anticipated|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-02-18 13:23:12.457336|2017-02-18 13:23:12.457336
NCT00844727|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-07-03|||September 2003||2003-09-01|February 2009|2009-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Coxib-inhibition of Duodenal Polyp Growth in FAP|Coxib-inhibition of Duodenal Polyp Growth in Familial Adenomatous Polyposis|Terminated||Phase 2/Phase 3|38|Actual|Oslo University Hospital||2||Drug withdrawal|f||||f||||||||||2017-02-18 13:23:12.56581|2017-02-18 13:23:12.56581
NCT00844714|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-05-29|2014-05-19||November 2009||2009-11-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Interventional||per protocol, patients with active rheumatoid arthritis (RA) who had high levels of systemic inflammation|Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy|Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy|Completed||N/A|20|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 13:23:12.643557|2017-02-18 13:23:12.643557
NCT00844701|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-10-31|||February 2008||2008-02-01|October 2009|2009-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Cue Induced Imaging in Nicotine Dependent Smokers|Validation of Cue Induced Imaging Paradigm in Nicotine Dependent Smokers|Completed||N/A|52|Actual|Medical University of South Carolina|||2||f||||f||||||||||2017-02-18 13:23:13.044383|2017-02-18 13:23:13.044383
NCT00844688|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-13|||September 2008||2008-09-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|HCC||Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)|A Phase II Feasibility Study of Sorafenib and Gemcitabine Combination Treatment in Patients With Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|30|Anticipated|Combined Military Hospital, Pakistan||1|||f||||t||||||||||2017-02-18 13:23:13.141331|2017-02-18 13:23:13.141331
NCT00844675|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2012-10-16|||October 2007||2007-10-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection|Effects of Preoperative Administration of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection(EMR): Prospective, Randomized, Placebo-controlled, Comparative Study|Completed||Phase 4|120|Actual|The Catholic University of Korea||2|||f||||f||||||||||2017-02-18 13:23:13.250995|2017-02-18 13:23:13.250995
NCT00844662|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2010-10-18|||July 2009||2009-07-01|October 2010|2010-10-01|October 2011|Anticipated|2011-10-01|September 2011|Anticipated|2011-09-01||Interventional|||Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride|An Open, Randomised, Controlled, Parallel Group, Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride in Haemodialysis Patients With Hyperphosphataemia|Terminated||Phase 3|1000|Anticipated|Ineos Healthcare Limited||2|||f||||t||||||||||2017-02-18 13:23:13.369434|2017-02-18 13:23:13.369434
NCT00844649|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2016-11-21|2013-10-21||March 2009||2009-03-01|November 2016|2016-11-01|April 2013|Actual|2013-04-01|September 2012|Actual|2012-09-01||Interventional||For the Karnofsky Performance Status (KPS) baseline characteristic, some of the participants did not have a baseline KPS recorded by the clinical site.|Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas|A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas|Completed||Phase 3|861|Actual|Celgene Corporation||2|||f||||t||||||||||2017-02-18 13:23:13.624512|2017-02-18 13:23:13.624512
NCT00844636|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-13|||January 2005||2005-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||A Trial of Blunt Needles for the Reduction of Needlestick Injuries During Cesarean Section|A Randomized Trial of Blunt Needles for the Reduction of Needlestick Injuries During Cesarean Section|Completed||N/A|197|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 13:23:15.697677|2017-02-18 13:23:15.697677
NCT00844623|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2013-01-15|||December 2002||2002-12-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|November 2003|Actual|2003-11-01||Interventional|||TK-based Suicide Gene Therapy for Hepatocellular Carcinoma|Phase I Clinical Trial Of Gene Therapy For Hepatocellular Carcinoma By Intratumoral Injection Of TK99UN (An Adenoviral Vector Containing The Thymidine Kinase Of Herpes Simplex Virus)|Completed||Phase 1|10|Actual|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||||2017-02-18 13:23:15.798293|2017-02-18 13:23:15.798293
NCT00844597|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2015-09-03|2015-06-08||January 2009||2009-01-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients|Clinical Study to Assess the Safety fo AVI-4658 in Subjects With Duchenne Muscular Dystrophy Due to a Frame-shift Mutation Amenable to Correction by Skipping Exon 51.|Completed||Phase 1/Phase 2|19|Actual|Sarepta Therapeutics|"Due to the small number of study participants, a single adverse event (AE) in 1 patient exceeds the reporting threshold of 5%. Refer to the Post-Hoc Outcome Measures #5 for a summary of frequent and related AEs."|6|||f||||t||||||||||2017-02-18 13:23:15.914802|2017-02-18 13:23:15.914802
NCT00844571|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-11-23|||August 2008||2008-08-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|April 2009|Anticipated|2009-04-01||Observational|||Effect E-learning Program About Child Maltreatment|The Effectiveness of an E-learning Program About Child Maltreatment for Nurses on an A&E Department: a Randomised Controlled Trial|Unknown status|Enrolling by invitation|N/A|38|Anticipated|UMC Utrecht|||2||f||||f||||||||||2017-02-18 13:23:17.550262|2017-02-18 13:23:17.550262
NCT00844558|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2016-05-02|2015-07-02||August 2008||2008-08-01|May 2016|2016-05-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|MOVE|The objective of this study was to determine whether individualized gait training is more effective than usual care for reducing mobility disability and pain in individuals with symptomatic knee osteoarthritis.|Mobility Optimization Through Velocity Exercise|Optimizing Mobility in Older Adults With Knee Osteoarthritis|Completed||N/A|58|Actual|University of Iowa||2|||f||||f||||||||||2017-02-18 13:23:17.655886|2017-02-18 13:23:17.655886
NCT00844545|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-06-30|2014-10-21||May 2009||2009-05-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|September 2010|Actual|2010-09-01||Interventional|aHUS|The intent-to-treat (ITT) population was defined as all patients who received any amount of eculizumab, and were considered evaluable for safety and efficacy analyses. For both the efficacy and safety analyses, all 17 patients who were treated with study drug were included in the ITT population.|Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS|An Open-Label, Multi-Center Controlled Clinical Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant Atypical Hemolytic Uremic Syndrome (aHUS)|Completed||Phase 2|16|Actual|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-02-18 13:23:18.079998|2017-02-18 13:23:18.079998
NCT00844532|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-05-14|2012-03-30||March 2009||2009-03-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|March 2011|Actual|2011-03-01||Interventional|MOBILITY AP||Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.|A Prospective, Non-randomized, 2 Arm (AP Arm & Omni-Link Elite [OE] Arm-separately Posted as: NCT01396525), Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System and the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery. CAUTION: The Omnilink Elite™ Peripheral Balloon-expandable Stent System is an Investigational Device. Limited by Federal (U.S.) Law to Investigational Use Only.|Completed||Phase 3|151|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 13:23:18.752697|2017-02-18 13:23:18.752697
NCT00844519|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2014-07-16|2014-05-19||January 2010||2010-01-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|December 2012|Actual|2012-12-01||Interventional||per protocol|Effect of Maraviroc on Endothelial Function in HIV-Infected Patients||Completed||Phase 3|52|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 13:23:20.156213|2017-02-18 13:23:20.156213
NCT00844506|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-02-24|||October 2008||2008-10-01|February 2011|2011-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|ISA-P53-CTX||p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer|p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer a Phase II Trial|Completed||Phase 2|19|Anticipated|University Medical Center Groningen||1|||f||||t||||||||||2017-02-18 13:23:20.471459|2017-02-18 13:23:20.471459
NCT00844493|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2014-09-11|||February 2009||2009-02-01|April 2013|2013-04-01|June 2013|Actual|2013-06-01|February 2012|Actual|2012-02-01||Interventional|||Low-dose Challenge Model With Enterotoxigenic E Coli|Validation of Low-dose ETEC Challenge Model in U.S. Adults and Re-challenge of Immune Subjects With a Homologous ETEC Strain (H10407)|Completed||Phase 1|30|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||||2017-02-18 13:23:20.56912|2017-02-18 13:23:20.56912
NCT00844480|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2016-05-06|||March 2010||2010-03-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|||Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss|Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss|Terminated||Phase 2|17|Actual|Northwestern University||2||difficulty in enrollment|f||||f||||||||Undecided||2017-02-18 13:23:20.837335|2017-02-18 13:23:20.837335
NCT00844467|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-13|||February 2009||2009-02-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Observational|IPD in saudi||A Retrospective Epidemiological Study on Pneumococcal Infection in Children in Ministry of Health Hospital at EHSA Region in the Eastern Province|Serotyping of Pneumococci|Unknown status|Active, not recruiting|N/A|300|Anticipated|King Saud University|||1||f||||||||||||||2017-02-18 13:23:20.943191|2017-02-18 13:23:20.943191
NCT00844454|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-08-10|||May 2008||2008-05-01|August 2009|2009-08-01|May 2011|Anticipated|2011-05-01|May 2010|Anticipated|2010-05-01||Interventional|QPEAvsRFA||Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma|Ethanol Ablation Using a Multi-pronged Needle and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma: a Randomized Clinical Trial|Unknown status|Recruiting|Phase 2|80|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:23:21.019406|2017-02-18 13:23:21.019406
NCT00844441|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-05-17|||December 2008||2008-12-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia|Pilot Study of Feasibility, Safety, and Economics of Early Discharge and Outpatient Management of Adult Patients Following Intensive Induction Chemotherapy for Myelodysplastic Syndrome and Non-APL Acute Myeloid Leukemia|Completed||N/A|96|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 13:23:21.130498|2017-02-18 13:23:21.130498
NCT00844428|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-06-30|2014-12-15||July 2009||2009-07-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional|aHUS|The intent-to-treat (ITT) population was defined as all patients who received any amount of eculizumab, and were considered evaluable for safety and efficacy analyses. For both the efficacy and safety analyses, all 20 patients who were treated with study drug were included in the ITT population.|Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS|An Open-Label, Multi-Center Controlled Clinical Trial Of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive Atypical Hemolytic Uremic Syndrome (AHUS)|Completed||Phase 2|5|Actual|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-02-18 13:23:21.242553|2017-02-18 13:23:21.242553
NCT00844415|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2014-06-03|2013-02-13||June 2009||2009-06-01|December 2013|2013-12-01||||February 2012|Actual|2012-02-01||Interventional|||Safety and Tolerability of Dabigatran Etexilate in Adolescents|Open-label Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given for 3 Days at the End of Standard Anticoagulant Therapy in Children Aged 12 Years to Less Than 18 Years|Completed||Phase 2|9|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-02-18 13:23:22.028643|2017-02-18 13:23:22.028643
NCT00844402|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-13|||January 2006||2006-01-01|February 2009|2009-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis|Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis|Completed||Phase 3|40|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 13:23:22.356186|2017-02-18 13:23:22.356186
NCT00844389|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-09-30|||April 2009||2009-04-01|September 2009|2009-09-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|||Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy|Near to Infrared Light Stimulation Effect on Ganglion Cell Function in Glaucomatous Optic Neuropathy|Unknown status|Active, not recruiting|Early Phase 1|40|Anticipated|Universidad de Valparaiso||2|||f||||f||||||||||2017-02-18 13:23:22.467713|2017-02-18 13:23:22.467713
NCT00844376|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-10-21|2009-03-05||February 2008||2008-02-01|July 2009|2009-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Bioavailability Study for New Atorvastatin Formulation|An Open Label, Single Dose, Randomized 2-Way Crossover Study To Estimate The Relative Bioavailability Of Atorvastatin Commercial Tablet, And An Extemporaneous Preparation (EP) Suspension Formulation, In Healthy Subjects|Completed||Phase 4|12|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:23:22.581542|2017-02-18 13:23:22.581542
NCT00844363|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-06-29|||November 2008||2008-11-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris|Mechanism of Action of Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris|Terminated||N/A|20|Anticipated|Rockefeller University||1||Unable to isolate sufficient cells from the skin biopsy to perform study related experiments|f||||f||||||||||2017-02-18 13:23:22.960095|2017-02-18 13:23:22.960095
NCT00844350|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-13|||October 2006||2006-10-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||The Effect of Oxytocin (OT) and Oxytocin Plus Human Chorionic Gonadotropin (hCG), in Cycles Induced by Letrozole or Clomiphene Citrate||Completed||Phase 2|177|Actual|Tabriz University||5|||f||||f||||||||||2017-02-18 13:23:23.061326|2017-02-18 13:23:23.061326
NCT00844337|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2014-09-12|||March 2009||2009-03-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh|Safety and Efficacy of Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh|Completed||N/A|2490|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-02-18 13:23:23.150771|2017-02-18 13:23:23.150771
NCT00844324|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2010-12-06|||March 2009||2009-03-01|December 2010|2010-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Bioequivalence Study in Healthy Subjects|A Single Dose, 2-Period, Cross-over, Bioequivalence Study in Healthy Subjects to Evaluate the Proposed Commercial Oral Suspension of Candesartan Cilexetil|Completed||Phase 1|36|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:23:23.277259|2017-02-18 13:23:23.277259
NCT00844311|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2010-08-03|||February 2009||2009-02-01|February 2009|2009-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Supplementation With Human Chorionic Gonadotropin (hCG) During Controlled Ovarian Stimulation With Recombinant Follicle-stimulating Hormone (FSH) for In Vitro Fertilisation|Supplementation With hCG During Controlled Ovarian Stimulation With Recombinant FSH for in Vitro Fertilisation. A Randomized Controlled Clinical Study. Clinical, Embryological, Endocrine and Genetic Aspects.|Completed||Phase 4|60|Anticipated|Rigshospitalet, Denmark||4|||f||||t||||||||||2017-02-18 13:23:23.370724|2017-02-18 13:23:23.370724
NCT00844298|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-08-07|2015-08-07||January 2009||2009-01-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|June 2012|Actual|2012-06-01||Interventional|||Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|Tasigna® (Nilotinib) Plus Multi-Agent Chemotherapy for Newly-Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia|Completed||Phase 2|91|Actual|Asan Medical Center|The limitation of the current study was that this study was not performed in a randomized comparative way, and the advantages of nilotinib over other TKIs were not definitely demonstrated.|1|||f||||f||||||||||2017-02-18 13:23:23.476911|2017-02-18 13:23:23.476911
NCT00844285|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2016-11-16|||January 2009||2009-01-01|November 2016|2016-11-01|January 2027|Anticipated|2027-01-01|January 2027|Anticipated|2027-01-01||Observational|SECURE||SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry|A Non-Interventional Long-term Post-Marketing Registry of Patients Treated With Certolizumab Pegol (Cimzia ®) for Crohn's Disease|Enrolling by invitation||N/A|4000|Anticipated|UCB Pharma|||2||f||||f||||||||||2017-02-18 13:23:23.715586|2017-02-18 13:23:23.715586
NCT00844272|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-05-27|||May 2005||2005-05-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|Permit||Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment|Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment|Completed||Phase 4|189|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||t||||||||||2017-02-18 13:23:24.281658|2017-02-18 13:23:24.281658
NCT00844259|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-13|||July 2006||2006-07-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Functional Communicative Profile of Children With Down Syndrome|Functional Communicative Profile of Children With Down Syndrome|Completed||N/A|15|Actual|University of Sao Paulo|||1||f||||t||||||||||2017-02-18 13:23:24.400475|2017-02-18 13:23:24.400475
NCT00844246|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2011-11-08|||November 2008||2008-11-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|TEDS||Translating Evidence Based Developmental Screening Into Pediatric Primary Care|Translating Evidence Based Developmental Screening Into Pediatric Primary Care ( Aims 2 and 3 )|Completed||Phase 2|2314|Actual|Children's Hospital of Philadelphia||3|||f||||f||||||||||2017-02-18 13:23:24.501346|2017-02-18 13:23:24.501346
NCT00843466|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2009-02-12|||May 2007||2007-05-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|||Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis|Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis|Completed||N/A|46|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 13:23:41.242886|2017-02-18 13:23:41.242886
NCT00844233|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2013-03-28|||February 2009||2009-02-01|September 2011|2011-09-01|October 2012|Actual|2012-10-01|September 2011|Actual|2011-09-01||Interventional|PARAGON-II||Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer|A Single Arm Phase II Study of Neoadjuvant Therapy Using Irinotecan Bead in Patients With Resectable Liver Metastases From Colorectal Cancer|Completed||Phase 1/Phase 2|40|Actual|Biocompatibles UK Ltd||1|||f||||f||||||||||2017-02-18 13:23:24.623428|2017-02-18 13:23:24.623428
NCT00844220|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2016-11-01|||February 2009||2009-02-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2015|Actual|2015-09-01||Interventional|CAD-Man||Coronary Artery Disease Management Using Multislice Computed Tomography and Magnetic Resonance Imaging|Coronary Artery Disease Management Using Multislice Computed Tomography and Magnetic Resonance Imaging|Active, not recruiting||N/A|340|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 13:23:24.748916|2017-02-18 13:23:24.748916
NCT00844207|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-04-20|||February 2009||2009-02-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|AZCQ||A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine|A Phase 1, Open Label, Randomized, Single Dose, Parallel Group Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine In Healthy Adult Subjects|Completed||Phase 1|40|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:23:24.863877|2017-02-18 13:23:24.863877
NCT00844194|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2014-05-02|2011-06-07||February 2009||2009-02-01|December 2013|2013-12-01||||June 2010|Actual|2010-06-01||Interventional||All patients receiving at least one dose of study medication (TS).|Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder|A 12 Weeks Open Label Two Parallel Groups Study to Assess the Efficacy of Orally Administered Duloxetine 60 mg and 120 mg Per Day on Treatment Outcomes in Patients With Diabetic Peripheral Neuropathic Pain With and Without Co-morbid Major Depressive Disorder. The Primary Objective of This Study is to Evaluate Whether the Efficacy of Duloxetine Given as 60 mg to 120 mg Once Daily (QD), Measured by the BPI Interference Score After 12 Weeks Shows a Clinically Relevant Improvement in the DPNP Patients With Co-morbid MDD|Completed||Phase 4|108|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 13:23:25.006197|2017-02-18 13:23:25.006197
NCT00844181|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2009-02-13|||October 2007||2007-10-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Racial Differences in Orthostatic Tolerance|Racial Differences in Orthostatic Tolerance|Completed||N/A|18|Actual|Yale University|||2||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:23:27.323761|2017-02-18 13:23:27.323761
NCT00844168|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2015-03-25|||January 2009||2009-01-01|March 2015|2015-03-01||||June 2010|Actual|2010-06-01||Interventional|||Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant|Phase I Adjuvant Trial of Sorafenib in Hepatocellular Carcinoma Patients After Liver Transplantation|Completed||Phase 1|4|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 13:23:27.400659|2017-02-18 13:23:27.400659
NCT00844155|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-13|2010-04-01|||March 2009||2009-03-01|February 2010|2010-02-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit|A Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir (Tamiflu®) in Patients in the Intensive Care Unit|Withdrawn||N/A|0|Actual|University of Manitoba||2||Study has been withdrawn as the H1N1 epidemic made this study redundant|f||||f||||||||||2017-02-18 13:23:27.505658|2017-02-18 13:23:27.505658
NCT00844142|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||November 2005||2005-11-01|February 2009|2009-02-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)|Randomized Controlled 12 Months Trial With Etanercept (Enbrel ®) vs. Sulfasalazine in Early Axial Spondyloarthritis With Focus on Improvement of Acute Inflammatory Lesions as Detected by MRI. Amendment 4: 1-Year Extension of Study|Unknown status|Recruiting|Phase 2|80|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 13:23:27.614294|2017-02-18 13:23:27.614294
NCT00844129|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-01-17|||December 2006||2006-12-01|January 2014|2014-01-01||||September 2012|Actual|2012-09-01||Observational|Spine||Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)|Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)|Completed||N/A|112|Actual|University of Utah|||1||f||||f||||||Samples With DNA|"~     Urine~   "|||2017-02-18 13:23:27.726423|2017-02-18 13:23:27.726423
NCT00844116|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-05-15|||January 2009||2009-01-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||"Efficacy of On Line Telematic Spirometry"|"Efficacy of On Line Telematic Spirometry"|Completed||N/A|226|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||f||||||||||2017-02-18 13:23:27.815996|2017-02-18 13:23:27.815996
NCT00844103|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-04-29|||January 2009||2009-01-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of AZD8566.|A Phase I, Randomised, Double Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of AZD8566 in Healthy Volunteers|Completed||Phase 1|36|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:23:27.912973|2017-02-18 13:23:27.912973
NCT00844090|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-03-18|2013-12-02||July 2009||2009-07-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional||The number of participants for analysis was 92 in total since only 92 participants completed the study.|The Role of Apathy in Glycemic Control|The Role of Apathy in Glycemic Control|Completed||N/A|106|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:23:28.008822|2017-02-18 13:23:28.008822
NCT00844077|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-12-05|||October 2007||2007-10-01|December 2011|2011-12-01||||April 2011|Actual|2011-04-01||Observational|||Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus|Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus Progression to Dysplasia and Adenocarcinoma|Completed||N/A|255|Actual|University of Michigan|||1||f||||t||||||Samples With DNA|"~     Plasma,serum, DNA, urine, Barrett's tissue (Fixed and Frozen), Normal Esophagus tissue~     (Fixed and Frozen)~   "|||2017-02-18 13:23:30.67762|2017-02-18 13:23:30.67762
NCT00843869|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-03-24|||August 2008||2008-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Reversal of Tobacco-Related Sinusitis|Reversal of Tobacco-Related Sinusitis (Flight Attendant Medical Research Institute (FAMRI) Young Clinical Scientist Award)|Completed||N/A|282|Actual|University of Alabama at Birmingham|||1||f||||f||||||Samples Without DNA|"~     Zinc levels and hair samples will be collected.~   "|||2017-02-18 13:23:33.753628|2017-02-18 13:23:33.753628
NCT00844064|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-11-18|||January 2005||2005-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2|An Open-Label, Multicenter Dose-Escalation Study to Evaluate the Safety and Tolerability of AP 12009 (Trabedersen), Administered Intravenously in Patients With Advanced Tumors Known to Overproduce TGF-β2.|Completed||Phase 1|62|Actual|Isarna Therapeutics GmbH||1|||f||||t||||||||||2017-02-18 13:23:30.783636|2017-02-18 13:23:30.783636
NCT00844051|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-08-01|2015-03-02||January 2009||2009-01-01|August 2016|2016-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study to Evaluate Impact of School-based Influenza Vaccination on School Populations|Prospective Study of School-based Influenza Vaccination's Impact on School Populations|Completed||N/A|4455|Actual|Children's Hospital Los Angeles||2|||f||||f||||||||||2017-02-18 13:23:30.906416|2017-02-18 13:23:30.906416
NCT00844038|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||August 2008||2008-08-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Observational|||Stevens-Johnson Syndrome Antimicrobial|Stevens-Johnson Syndrome Associated With Antimicrobial|Completed||N/A|1|Actual|University of Pernambuco|||1||f||||t||||||||||2017-02-18 13:23:31.289501|2017-02-18 13:23:31.289501
NCT00844025|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-03-30|||February 2009||2009-02-01|March 2009|2009-03-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication|Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication: a Randomized-Controlled Trial|Unknown status|Enrolling by invitation|N/A|120|Anticipated|Shin Kong Wu Ho-Su Memorial Hospital||2|||f||||t||||||||||2017-02-18 13:23:31.383156|2017-02-18 13:23:31.383156
NCT00844012|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-03-10|||May 2009||2009-05-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|May 2010|Anticipated|2010-05-01||Interventional|||Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain|Continuous Versus Cyclic Postoperative Use of Low-Dose Combined Oral Contraceptive Belara® for the Treatment of Endometriosis-Related Chronic Pelvic Pain: a Randomized Controlled Trial.|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|University Magna Graecia||2|||f||||f||||||||||2017-02-18 13:23:31.490579|2017-02-18 13:23:31.490579
NCT00843986|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2014-04-30|2010-09-09||April 2009||2009-04-01|April 2014|2014-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|CONVERT-H||Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)|A Phase-3b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Conivaptan in Symptomatic Acute Decompensated Heart Failure (ADHF) Subjects With Hyponatremia|Terminated||Phase 3|9|Actual|Cumberland Pharmaceuticals|"The study was terminated because of difficulties in enrolling eligible patients per the protocol inclusion and exclusion criteria.~Outcome Measures were not analyzed due to the abbreviated enrollment at early study termination."|2||"The clinical study has been terminated based on difficulties to enroll eligible subjects per~   protocol inclusion and exclusion criteria."|f||||f||||||||||2017-02-18 13:23:31.599024|2017-02-18 13:23:31.599024
NCT00843973|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-10-07|||June 2008||2008-06-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|October 2011|Actual|2011-10-01||Observational|||Osteogenic Cell Viability in Bone Graft|Osteogenic Cell Viability in Bone Graft Obtained Using the Reamer Irrigator Aspirator (RIA) System Versus Iliac Crest Bone Graft|Completed||N/A|83|Actual|University of Missouri-Columbia|||2||f||||f||||||||No||2017-02-18 13:23:32.278811|2017-02-18 13:23:32.278811
NCT00843960|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-10-06|||February 2009||2009-02-01|October 2009|2009-10-01|December 2013|Anticipated|2013-12-01|January 2010|Anticipated|2010-01-01||Interventional|||Medication Adherence Enhancement in Heart Transplant Recipients|Medication Adherence Enhancement in Heart Transplant Recipients: a Randomized Clinical Trial|Unknown status|Recruiting|N/A|150|Anticipated|Hannover Medical School||2|||f||||t||||||||||2017-02-18 13:23:32.390626|2017-02-18 13:23:32.390626
NCT00843947|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||June 2007||2007-06-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan|Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan|Unknown status|Recruiting|Phase 2|20|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-02-18 13:23:32.481568|2017-02-18 13:23:32.481568
NCT00843934|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-10-17|||March 2009||2009-03-01|October 2012|2012-10-01|February 2015|Anticipated|2015-02-01|December 2012|Anticipated|2012-12-01||Interventional|ACE500||Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma|Randomized Controlled Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2/Phase 3|450|Anticipated|Nihon University||1|||f||||t||||||||||2017-02-18 13:23:32.570601|2017-02-18 13:23:32.570601
NCT00843921|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-08-15|||August 2008||2008-08-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|||N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia|N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia|Recruiting||Phase 2/Phase 3|70|Anticipated|Children's Research Institute||1|||f||||t||||||||Yes|Individual participant data will be shared with that particular participant|2017-02-18 13:23:32.677394|2017-02-18 13:23:32.677394
NCT00843908|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-08-26|||February 2008||2008-02-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||Tension Free Vaginal Tape (TVT) Versus the Miniarc Sling|A Randomized Study of the Treatment of Urodynamic Stress Incontinence: the Tension Free Vaginal Tape (TVT) Versus the Miniarc Sling.|Completed||N/A|70|Anticipated|Medway NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:23:32.794579|2017-02-18 13:23:32.794579
NCT00843895|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-11|||March 2009||2009-03-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|Pneumococci||Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years|Serotyping of Pneumococci|Unknown status|Not yet recruiting|N/A|400|Anticipated|King Saud University||1|||f||||||||||||||2017-02-18 13:23:32.89867|2017-02-18 13:23:32.89867
NCT00843882|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2017-02-16|||January 2009||2009-01-01|December 2016|2016-12-01||||April 2017|Anticipated|2017-04-01||Interventional|||Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia|Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment With Lenalidomide (Revlimid®) Alone and in Combination With Epoetin Alfa (Procrit®) in Subjects With Low- or Intermediate-1 Risk MDS and Symptomatic Anemia|Active, not recruiting||Phase 3|252|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 13:23:33.003865|2017-02-18 13:23:33.003865
NCT00843856|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-02-23|||February 2009||2009-02-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|MTAC||Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis (IMG)|Mycophenolate Mofetil and Tacrolimus vs Tacrolimus Alone for the Treatment of Idiopathic Membranous Glomerulonephritis|Active, not recruiting||Phase 4|40|Actual|Imperial College Healthcare NHS Trust||2|||f||||f||||||||||2017-02-18 13:23:33.841977|2017-02-18 13:23:33.841977
NCT00843843|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-02-09|2015-11-02||March 2008||2008-03-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|HAM||Sleep Length and Circadian Regulation in Humans|Sleep Length and Circadian Regulation in Humans|Completed||N/A|16|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 13:23:33.948712|2017-02-18 13:23:33.948712
NCT00843830|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-11-06|2014-10-29||October 2006||2006-10-01|November 2015|2015-11-01|April 2010|Actual|2010-04-01|December 2008|Actual|2008-12-01||Interventional|||A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma||Terminated||Phase 1|4|Actual|University of Michigan Cancer Center|The study was closed early secondary to inability to obtain grant funding to conduct.|1||Study closed early secondary to inability to obtain grant funding to conduct.|f||||t||||||||||2017-02-18 13:23:34.47173|2017-02-18 13:23:34.47173
NCT00843817|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12||||||February 2009|2009-02-01||||December 2010|Anticipated|2010-12-01||Interventional|BioDNase||RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum|RhDNase Effect on Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-02-18 13:23:34.67683|2017-02-18 13:23:34.67683
NCT00843804|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2010-06-25|||March 2007||2007-03-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|||||Observational|Oncoped2006||Surveillance for Nosocomial Infections in Pediatric Cancer Patients|Prospective Surveillance for Nosocomial Infections and Catheter-related Thrombotic Events in Pediatric Patients|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Bonn|||1||f||||f||||||Samples With DNA|"~     Blood culture isolates~   "|||2017-02-18 13:23:34.956444|2017-02-18 13:23:34.956444
NCT00843791|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-06-04|||February 2009||2009-02-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin|Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin|Completed||N/A|6|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 13:23:35.054364|2017-02-18 13:23:35.054364
NCT00843778|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2014-01-17|2013-08-19||January 2009||2009-01-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CERTAIN 2|"One subject did not receive treatment during C87080, so it is excluded from the Full Analysis Set (FAS) and Safety Set (SS).~Full Analysis Set (FAS) consists of all subjects from the Enrolled Set who were dispensed medication.~Safety Set is identical to the FAS."|Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study|A Phase IIIB, Multi-center, Open Label Follow-up Study to Evaluate the Safety and Efficacy of Certolizumab Pegol Administered Concomitantly With DMARDs in Patients With Active Rheumatoid Arthritis Who Participated in C87076.|Completed||Phase 3|131|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 13:23:35.180776|2017-02-18 13:23:35.180776
NCT00843765|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-02-13|||December 2007||2007-12-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|February 2009|Actual|2009-02-01||Interventional|||Efficiency Study of Traditional Chinese Medicine (TCM) Versus Western Medicine (WM) on Ischemic Stroke|Program of TCM on Early Rehabilitation and Secondary Prevention of Ischemic Stroke|Completed||N/A|1151|Actual|China Academy of Chinese Medical Sciences||2|||f||||t||||||||||2017-02-18 13:23:35.866644|2017-02-18 13:23:35.866644
NCT00843752|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-12|||February 2009||2009-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:23:35.976545|2017-02-18 13:23:35.976545
NCT00843739|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-09-16|||January 2004||2004-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|EMST||Expiratory Muscle Training in Patients With Parkinson's Disease|Expiratory Muscle Training in Patients With Parkinson's Disease|Completed||Phase 1/Phase 2|90|Actual|University of Florida||3|||f||||t||||||||||2017-02-18 13:23:36.025533|2017-02-18 13:23:36.025533
NCT00843726|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-05-04|||September 2008||2008-09-01|May 2016|2016-05-01||||April 2020|Anticipated|2020-04-01||Interventional|||Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer|A Phase II Randomized Study of 2 Stereotactic Body Radiation Therapy (SBRT) Regimens for Medically Inoperable Patients With Node Negative, Peripheral Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|98|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-02-18 13:23:36.139257|2017-02-18 13:23:36.139257
NCT00843713|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-05-26|2015-01-30||January 2009||2009-01-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|November 2013|Actual|2013-11-01||Interventional|||Effect of Raltegravir on Endothelial Function in HIV-Infected Patients|A Randomized, Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection|Completed||Phase 4|56|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 13:23:36.245822|2017-02-18 13:23:36.245822
NCT00843700|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-01-08|||September 2007||2007-09-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Women's Depression Treatment Study|Effectiveness of IPT Adapted for Depressed Women With Trauma Histories in a Community Mental Health Center|Completed||Phase 2|162|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 13:23:36.609198|2017-02-18 13:23:36.609198
NCT00843687|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-06-02||2011-06-02|September 2005||2005-09-01|June 2011|2011-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.|Comparative Single-Dose Pharmacokinetics and Safety of Gluteal and Deltoid Intramuscular Injection of Long-Acting Injectable Risperidone in Subjects With Chronic Stable Schizophrenia|Completed||Phase 3|188|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:23:36.713857|2017-02-18 13:23:36.713857
NCT00843479|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2013-03-07|2011-10-04||June 2009||2009-06-01|March 2013|2013-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly|The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly.|Completed||N/A|24|Actual|University of Campinas, Brazil|||2||f||||f||||||Samples Without DNA|"~     Sera and plasma~   "|||2017-02-18 13:23:40.78336|2017-02-18 13:23:40.78336
NCT00843661|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-08-01|||March 2009||2009-03-01|July 2011|2011-07-01|July 2012|Anticipated|2012-07-01|December 2011|Anticipated|2011-12-01||Interventional|||Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients|Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients Receiving Protease Inhibitors: a Randomized, Prospective, Controlled Pilot Study.|Unknown status|Recruiting|Phase 4|60|Anticipated|Ospedale di Circolo - Fondazione Macchi||2|||f||||||||||||||2017-02-18 13:23:36.810882|2017-02-18 13:23:36.810882
NCT00843648|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||March 2009||2009-03-01|February 2009|2009-02-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Observational|||Study of the Development of Human Immune System of Newborns by Antigen Chips||Unknown status|Not yet recruiting|N/A|100|Anticipated|Sheba Medical Center|||4||f||||f||||||||||2017-02-18 13:23:36.906607|2017-02-18 13:23:36.906607
NCT00843635|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-09-25|2015-06-03||September 2008||2008-09-01|September 2015|2015-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Race/ethnicity reported for 34 of the 35 participants, specifically for 14 of the 15 participants in Arm B - Tadalafil 20mg.|Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx|Pilot Study of Phosphodiesterase-5 Inhibitor Tadalafil (Cialis) as an Immunomodulator in Patients With Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.|Completed||N/A|35|Actual|University of Miami|Race/Ethnicity baseline characteristics reported for 34 of 35 patients enrolled. Data analyzed for outcome measure for the 31 participants who completed the study.|3|||f||||t||||||||||2017-02-18 13:23:36.994244|2017-02-18 13:23:36.994244
NCT00843622|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-05-15|2014-05-15||February 2009||2009-02-01|May 2014|2014-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers|"A Controlled Study of the Ability of a Traditional Swedish Smokeless Tobacco Product (Snus) to Increase the Quit Rate Among Cigarette Smokers Who Wish to Stop Smoking"|Completed||Phase 4|250|Actual|Swedish Match AB||2|||f||||f||||||||||2017-02-18 13:23:38.542332|2017-02-18 13:23:38.542332
NCT00843609|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2010-02-04|||October 2008||2008-10-01|June 2009|2009-06-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||International Navigator Hypoglycaemia Study|International Navigator Hypoglycaemia Study: Evaluation of the Incidence and Duration of Hypoglycaemia Using the Freestyle Navigator® Continuous Glucose Monitoring System|Completed||N/A|122|Actual|University Medical Centre Ljubljana||2|||f||||t||||||||||2017-02-18 13:23:38.900599|2017-02-18 13:23:38.900599
NCT00843596|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-02-17|||October 2009||2009-10-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|HEMOCARD||Surgical Bleeding Control of Extra-corporeal Circulation (ECC) by Vacuum Devices||Completed||Phase 1/Phase 2|30|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-02-18 13:23:39.008229|2017-02-18 13:23:39.008229
NCT00843583|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-12-29|||February 2009||2009-02-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||A Cross-sectional Study of the Occurrence and Effect of Obstructive Sleep Apnea in Subjects With Resistant Hypertension|A Cross-sectional Study of the Occurrence and Effect of Obstructive Sleep Apnea in Subjects With Resistant Hypertension|Completed||N/A|96|Anticipated|The University of Hong Kong|||1||f||||f||||||Samples Without DNA|"~     Blood test for glucose, lipid, vascular and metabolic markers~   "|||2017-02-18 13:23:39.110319|2017-02-18 13:23:39.110319
NCT00843570|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2013-07-24|||November 2009||2009-11-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment|A Randomised Controlled Trial of Natural Versus Hormone Replacement Therapy Cycles in Frozen Embryo Replacement IVF: a Pilot Study|Completed||Phase 4|159|Actual|University of Oxford||2|||f||||t||||||||||2017-02-18 13:23:39.208147|2017-02-18 13:23:39.208147
NCT00843557|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-10-25|||September 2001||2001-09-01|October 2016|2016-10-01|April 2008|Actual|2008-04-01|May 2006|Actual|2006-05-01||Observational|||Impact of Gender on Hospitalized Patients||Completed||N/A|2400|Actual|University of Virginia|||1||f||||f||||||||||2017-02-18 13:23:39.319288|2017-02-18 13:23:39.319288
NCT00843544|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||March 2006||2006-03-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Integrative Medicine Approach to the Management of Asthma in Adults|Effect of an Integrative Medicine Approach to the Management of Asthma in Adults on Quality of Life and Clinical Outcomes|Completed||Phase 2/Phase 3|156|Actual|Beth Israel Medical Center||2|||f||||f||||||||||2017-02-18 13:23:39.596794|2017-02-18 13:23:39.596794
NCT00843531|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-05-15|||June 2009||2009-06-01|January 2015|2015-01-01|January 2016|Anticipated|2016-01-01|July 2013|Actual|2013-07-01||Interventional|||RAD001 and Erlotinib in Patients With Neuroendocrine Tumors|A Phase II Study to Evaluate the Safety and Efficacy of RAD001 Plus Erlotinib in Patients With Well- to Moderately-Differentiated Neuroendocrine Tumors|Unknown status|Active, not recruiting|Phase 2|17|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 13:23:39.70085|2017-02-18 13:23:39.70085
NCT00843518|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-09-20||2011-09-20|February 2009||2009-02-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Treatment for Aggression and Agitation in Patients With Alzheimer's Disease|Assessment of LY451395 for Neuropsychiatric Symptoms of Aggression and Agitation in Alzheimer's Disease|Completed||Phase 2|98|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:23:39.825277|2017-02-18 13:23:39.825277
NCT00843505|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-10-04|||June 2009||2009-06-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Evaluating a Telemedicine Smoking Cessation Program in Rural Primary Care Practices|Telemedicine for Smoking Cessation in Rural Primary Care|Completed||Phase 3|566|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 13:23:39.959784|2017-02-18 13:23:39.959784
NCT00843492|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-02-18|2012-05-24||December 2008||2008-12-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|FONDACAST||A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery|A Multicentre, Randomized, Open-label Study to Evaluate the Efficacy andSafety of Fondaparinux Versus Low Molecular Weight Heparin(Nadroparin) in Patients Requiring Rigid or Semi-rigid Immobilization for at Least 21 Days and up to 45 Days Because of Isolated Non-surgical Below-Knee Injury|Completed||Phase 3|1351|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:23:40.14|2017-02-18 13:23:40.14
NCT00843453|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-07-21|||November 2006||2006-11-01|July 2009|2009-07-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly|Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly|Completed||N/A|36|Actual|University of Delaware||2|||f||||t||||||||||2017-02-18 13:23:41.342692|2017-02-18 13:23:41.342692
NCT00843440|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2013-05-29|||March 2009||2009-03-01|October 2009|2009-10-01|March 2012|Actual|2012-03-01|March 2009|Actual|2009-03-01||Interventional|METAFORE||Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study|Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study.|Completed||Phase 2|25|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-02-18 13:23:41.453261|2017-02-18 13:23:41.453261
NCT00843427|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-10-30|||September 2008||2008-09-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||fMRI of Language Recovery Following Stroke in Adults|fMRI of Language Recovery Following Stroke in Adults|Completed||N/A|24|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 13:23:41.557577|2017-02-18 13:23:41.557577
NCT00843414|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-07-05|||March 1978||1978-03-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Immunological Characterization of Bronchoalveolar Cells in Normals|Immunological Characterization of Bronchoalveolar Cells in Normals|Completed||N/A|1232|Actual|Ohio State University|||1||f||||f||||||Samples With DNA|"~     blood lung fluid (BAL)~   "|||2017-02-18 13:23:41.668443|2017-02-18 13:23:41.668443
NCT00843401|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-02-01|||January 2009||2009-01-01|February 2011|2011-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Clinical Performance Evaluation of Pediatric and Neonatal Low Saturation Oximetry Sensors|Clinical Performance Evaluation of Pediatric and Neonatal Low Saturation Oximetry Sensors|Completed||N/A|100|Anticipated|Children's Research Institute|||1||f||||f||||||||||2017-02-18 13:23:41.752908|2017-02-18 13:23:41.752908
NCT00843388|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||March 2009||2009-03-01|January 2009|2009-01-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria|A Randomized Doubleblind Placebo Controlled Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|Steno Diabetes Center||2|||f||||t||||||||||2017-02-18 13:23:41.833079|2017-02-18 13:23:41.833079
NCT00843375|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-03-15|||December 2005||2005-12-01|March 2011|2011-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas|Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas|Completed||N/A|695|Actual|University of Michigan|||4||f||||t||||||Samples With DNA|"~     Tissue (normal colonic mucosa (fixed and frozen) plus adenoma or cancer), plasma, serum,~     FOBT cards, frozen stool samples, DNA and urine.~   "|||2017-02-18 13:23:41.912963|2017-02-18 13:23:41.912963
NCT00843362|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||December 2006||2006-12-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||24-Hour Vaginal Dinoprostone Pessary Versus Gel for Labour Induction|A Randomised Controlled Trial of 24-Hours Vaginal Dinoprostone Pessary vs. Gel for Induction of Labour in Term Pregnancies With a Bishop Score ≤4|Completed||Phase 4|133|Actual|Università degli Studi di Brescia||2|||f||||f||||||||||2017-02-18 13:23:41.999831|2017-02-18 13:23:41.999831
NCT00843349|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2013-05-01|2013-02-07||July 2009||2009-07-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)|Fibroblast Growth Factor-23 Reduction in Predialysis Chronic Kidney Disease|Completed||N/A|43|Actual|University of Miami||4|||f||||t||||||||||2017-02-18 13:23:42.112395|2017-02-18 13:23:42.112395
NCT00843336|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-09-22|||February 2009||2009-02-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Two Internet Supported Natural Family Planning Methods|Randomized Comparison of Two Internet Supported Natural Family Planning Methods|Completed||Phase 3|358|Actual|Marquette University||2|||f||||f||||||||||2017-02-18 13:23:42.694165|2017-02-18 13:23:42.694165
NCT00843323|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2010-06-10|||December 2008||2008-12-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|PDT||Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged Skin|Histological and Immunohistochemical Study of Photodamaged Skin Submitted to MAL-PDT|Completed||N/A|26|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-02-18 13:23:42.801071|2017-02-18 13:23:42.801071
NCT00843310|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2013-08-13|2013-08-13||November 2008||2008-11-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma|Phase II Study of Revlimid (Lenalidomide), Melphalan, and Dexamethasone (ReMeDex) for Newly Diagnosed Multiple Myeloma Patients Not Undergoing Autologous Transplantation|Terminated||Phase 2|8|Actual|New York University School of Medicine||1||Due to slow accrual|f||||t||||||||||2017-02-18 13:23:42.889748|2017-02-18 13:23:42.889748
NCT00843297|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2010-02-01|||April 2008||2008-04-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|COOL||COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest|Clinical and Neurological Outcome With Two Different Cooling Methods (Invasive and Non-invasive) After Sudden Cardiac Arrest|Completed||Phase 4|120|Anticipated|University of Leipzig||3|||f||||f||||||||||2017-02-18 13:23:43.269106|2017-02-18 13:23:43.269106
NCT00843284|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-10-21|2009-03-11||September 2006||2006-09-01|October 2009|2009-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|NI-PMS||Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA|Assessing the Treatment of Patients With Neuropathic Pain Using LYRICA; A Non Interventional Post-marketing Study (NI-PMS)|Completed||Phase 4|691|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:23:43.375138|2017-02-18 13:23:43.375138
NCT00843271|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-01-12|||October 2004||2004-10-01|January 2012|2012-01-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Observational|MESA-LUNG||Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA|Endothelial Dysfunction, Biomarkers, and Lung Function (MESA LUNG)|Unknown status|Active, not recruiting|N/A|4359|Actual|Columbia University|||1||f||||t||||||||||2017-02-18 13:23:43.952703|2017-02-18 13:23:43.952703
NCT00843258|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||February 1998||1998-02-01|February 2009|2009-02-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Treatment for Mild Hip Dysplasia in Newborns|Immediate Treatment Compared With Active Sonographic Surveillance in the Management of Mild Hip Dysplasia in Newborn Infants: A Randomized, Controlled Trial|Completed||N/A|140|Actual|University of Bergen||2|||f||||t||||||||||2017-02-18 13:23:44.057552|2017-02-18 13:23:44.057552
NCT00843245|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-06-21|||April 2009||2009-04-01|June 2011|2011-06-01||||||||Observational|BELIC||Study of Electrical Bioimpedance in Heart Failure.|Study of Electrical Bioimpedance in Heart Failure Patients Followed at the Heart Failure Unit of the Santa Creu i Sant Pau Hospital.|Unknown status|Recruiting|N/A|400|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||1||f||||f||||||Samples Without DNA|"~     Blood serum obtained from routine blood test~   "|||2017-02-18 13:23:44.160288|2017-02-18 13:23:44.160288
NCT00843232|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-02-03|||July 2009||2009-07-01|February 2011|2011-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old|Physiopathology of Type 2 Diabetes Initiated After Sixty Years Old: Characterization of a Diabetic-related Incretinpathy in Aging Subjects.|Completed||N/A|24|Actual|University of Campinas, Brazil|||2||f||||f||||||Samples Without DNA|"~     Sera and plasma~   "|||2017-02-18 13:23:44.275661|2017-02-18 13:23:44.275661
NCT00843219|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-02-15|||March 2009||2009-03-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating|Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating|Completed||N/A|12|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:23:44.377732|2017-02-18 13:23:44.377732
NCT00843193|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2013-09-19||2012-02-23|December 2008||2008-12-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma|A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose Study to Evaluate the Efficacy and Safety of Intravenous GSK679586 in Patients With Severe Asthma|Completed||Phase 2|160|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:23:44.493837|2017-02-18 13:23:44.493837
NCT00843180|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-05-02|2012-02-07||November 2008||2008-11-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Massage for Pediatric Oncology|Massage for Children Undergoing Bone Marrow Transplantation|Completed||N/A|23|Actual|University of California, San Francisco|"small sample size~limited number of time points for self-report assessments.~the dose of the massage intervention averaged 1.8 massages per week, while the target dose was 3 per week."|2|||f||||f||||||||||2017-02-18 13:23:44.644291|2017-02-18 13:23:44.644291
NCT00843167|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2015-10-20|2014-12-30||August 2009||2009-08-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy|Sulforaphane: A Dietary Histone Deacetylase (HDAC) Inhibitor in Ductal Carcinoma in Situ (DCIS)|Completed||Phase 2|54|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-02-18 13:23:45.06791|2017-02-18 13:23:45.06791
NCT00843154|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2010-06-09|||December 2005||2005-12-01|June 2010|2010-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|CANDHEART||Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure|Effects Of Candesartan Cilexetil vs Standard Therapy on Serum Levels of Brain Natriuretic Peptide in Patients Suffering From Chronic Heart Failure With Depressed and Preserved Systolic Function|Terminated||Phase 3|571|Actual|Takeda||2||Insufficient enrollment|f||||f||||||||||2017-02-18 13:23:45.651887|2017-02-18 13:23:45.651887
NCT00843141|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-08-15|||May 2009||2009-05-01|February 2009|2009-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||The Efficacy of Computerized Cognitive Training in Adults With ADHD: Change in ADHD Symptoms, Executive Functions and Quality of Life Following Three Months of Training.|ADHD Symptoms, Executive Functions and Quality of Life Following Three Months of Training.|Completed||N/A|60|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:23:45.751939|2017-02-18 13:23:45.751939
NCT00843128|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2011-04-07|||March 2009||2009-03-01|February 2009|2009-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||The Effectiveness of Locomotor Therapy Using Robot-Driven Gait Orthosis System in Multiple Sclerosis Patients|Phase II Study of the Effectiveness of Locomotor Therapy Using Robot-Driven Gait Orthosis System in Acute Stroke Patients: A Randomized Controlled Trial.|Completed||Phase 2|40|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:23:45.844154|2017-02-18 13:23:45.844154
NCT00843115|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-02-11|2009-04-08||February 2007||2007-02-01|February 2014|2014-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Observational Study Of Donepezil In Routine Clinical Practice|Ecological Perspective On The Efficacy And Tolerability Of Donepezil In A Routine Clinical Practice: A Patient Centered Observational Study|Terminated||Phase 4|370|Actual|Pfizer|||1|See Detailed Description.|f||||f||||||||||2017-02-18 13:23:46.020058|2017-02-18 13:23:46.020058
NCT00843102|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-06-12|||December 2007||2007-12-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|December 2009|Actual|2009-12-01||Observational|||Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis|Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis|Completed||N/A|120|Actual|University of Pecs|||1||f||||f||||||Samples Without DNA|"~     Serum samples~   "|||2017-02-18 13:23:49.144444|2017-02-18 13:23:49.144444
NCT00843089|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2014-06-27|||January 2009||2009-01-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Secondary Prevention After Coronary Bypass Surgery|Secondary Prevention After Coronary Bypass Surgery: A Pilot Study|Completed||N/A|115|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 13:23:49.237067|2017-02-18 13:23:49.237067
NCT00843076|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2013-11-08|||January 2009||2009-01-01|November 2013|2013-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|Viro-steatosis||Impact of Hepatitis C Virus Variability on Steatosis|Impact of the Hepatitis C Virus Variability on Liver Steatosis|Terminated||N/A|27|Actual|University Hospital, Tours|||1||f||||f||||||Samples With DNA|"~     Liver biopsy~      Blood sample~   "|||2017-02-18 13:23:49.339234|2017-02-18 13:23:49.339234
NCT00843063|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-02-12|||August 2004||2004-08-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion|Famotidine vs. Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion - a Randomized Controlled Study|Completed||Phase 4|161|Actual|Ruttonjee Hospital||2|||f||||t||||||||||2017-02-18 13:23:49.416998|2017-02-18 13:23:49.416998
NCT00843050|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2012-06-20|2012-02-29||November 2009||2009-11-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|February 2011|Actual|2011-02-01||Interventional|||A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma|Single-Arm, Open-Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of P276-00 in Patients With Relapsed and/or Refractory Mantle Cell Lymphoma|Terminated||Phase 2|13|Actual|Piramal Enterprises Limited|The Sponsor has terminated the study based on interim results. All subjects were off study at the time of termination. There are no major safety or tolerability concerns from this study. The study results published here are preliminary results.|1||"The study was terminated based on interim results and all subjects were off study at that~   time. No major safety or tolerability concerns"|f||||f||||||||||2017-02-18 13:23:49.526728|2017-02-18 13:23:49.526728
NCT00843037|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-06-21|||February 2009||2009-02-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SNIPP||Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma|A Investigator Initiated Phase II Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma|Recruiting||Phase 2|28|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 13:23:50.042176|2017-02-18 13:23:50.042176
NCT00843024|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2016-11-30|2011-01-22||December 2008||2008-12-01|November 2016|2016-11-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Migraine Study in Adolescent Patients|TXA107979: A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of a Combination Product Containing Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents|Completed||Phase 3|589|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:23:50.202385|2017-02-18 13:23:50.202385
NCT00843011|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-12|2009-05-29|||August 2008||2008-08-01|May 2009|2009-05-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|Food/rel BA||Food and Relative Bioavailability Study|A Open-Label, Randomized, Single-Dose, 3-Way Crossover Study to Investigate the Pharmacokinetics, Safety and Tolerability of 2 Different Formulations of Orvepitant and the Effect of Food in Healthy Volunteers.|Completed||Phase 1|14|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:23:52.018093|2017-02-18 13:23:52.018093
NCT00842998|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-06-25|||February 2009||2009-02-01|June 2009|2009-06-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|HERLAP||Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer|A Phase II, Randomized Trial With Single Agent Trastuzumab or Lapatinib in Patients With Metastatic HER2-Overexpressing Breast Cancer|Unknown status|Recruiting|Phase 2|120|Anticipated|Azienda Ospedaliera Ordine Mauriziano di Torino||2|||f||||f||||||||||2017-02-18 13:23:52.116315|2017-02-18 13:23:52.116315
NCT00842985|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-10-13|2011-08-05||September 2008||2008-09-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Dronabinol Interactions in Humans|Dronabinol Interactions in Humans|Completed||Early Phase 1|53|Actual|Yale University|"One dose of modafinil Brief treatment duration and use of a low dose of THC Cognitive testing assessed only two tasks. Outcome measures were limited by small sample size.~Limited generalizability because heavy cannibas users were excluded"|4|||f||||t||||||||||2017-02-18 13:23:52.242559|2017-02-18 13:23:52.242559
NCT00842972|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-09-14||||||September 2009|2009-09-01||||||||Observational|||Is Carotid Intima-media Thickness Affected by A1C Variability?||Completed||N/A|||Yonsei University|||2||f||||||||||||||2017-02-18 13:23:52.51681|2017-02-18 13:23:52.51681
NCT00842959|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2011-06-15|||February 2009||2009-02-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|ZO Okulix||Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX|Check of Optical Features and Accuracy of the Zeiss ZO Lens of the Company Carl Zeiss Meditec After Selection and Calculation With OKULIX|Completed||Phase 4|120|Anticipated|Carl Zeiss Meditec AG||1|||f||||f||||||||||2017-02-18 13:23:52.574887|2017-02-18 13:23:52.574887
NCT00842946|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2014-05-01|2014-05-01||February 2009||2009-02-01|May 2014|2014-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety|Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety|Completed||N/A|45|Actual|Drexel University||2|||f||||f||||||||||2017-02-18 13:23:52.675813|2017-02-18 13:23:52.675813
NCT00842933|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2011-06-28|||May 2007||2007-05-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||Adrenal Insufficiency in Septic Shock|An Open-label, Prospective, Randomized, Controlled Clinical Trial of the Use of Reduced Duration Versus Standard Duration Steroid Replacement Therapy for Acute Adrenal Insufficiency in Patients With Septic Shock|Terminated||Phase 4|32|Anticipated|The Methodist Hospital System||2||Unable to meet enrollment goal prior to PI transfer|f||||t||||||||||2017-02-18 13:23:53.021935|2017-02-18 13:23:53.021935
NCT00842920|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2015-09-15|||December 2008||2008-12-01|September 2015|2015-09-01|March 2019|Anticipated|2019-03-01|October 2018|Anticipated|2018-10-01||Interventional|SIMaMCI||Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients|Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients|Recruiting||Phase 4|520|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 13:23:53.134516|2017-02-18 13:23:53.134516
NCT00842907|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2010-06-07|||May 2009||2009-05-01|April 2009|2009-04-01|August 2010|Anticipated|2010-08-01|December 2009|Anticipated|2009-12-01||Interventional|||Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage|A Clinical, Laboratorial and Quality of Life Study to Evaluate the Efficacy and Safety of Oral Isotretinoin in the Treatment of Cutaneous Photodamage|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 13:23:53.287673|2017-02-18 13:23:53.287673
NCT00842894|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2014-08-13|||May 2009||2009-05-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia|A Prospective, Multicentre, Open Label, Non-controlled, Observational, 26-week Study in Patients Using NovoMix® 30 (Biphasic Insulin Aspart 30) or Levemir® (Insulin Detemir) for Treatment of Type 2 Diabetes Mellitus in Macedonia|Completed||N/A|3421|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 13:23:53.396299|2017-02-18 13:23:53.396299
NCT00842504|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2012-02-15|||July 2007||2007-07-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Alternate Day Micafungin: A PK Study in Pediatric Patients|Alternate Day Micafungin Anti-Fungal Prophylaxis in Immunocompromised Pediatric Patients: A Pharmacokinetic Study|Completed||Phase 1|15|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||f||||||||||2017-02-18 13:24:01.378196|2017-02-18 13:24:01.378196
NCT00842881|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-09-23|||August 2008||2008-08-01|September 2009|2009-09-01|September 2009|Anticipated|2009-09-01|March 2009|Anticipated|2009-03-01||Interventional|Healingstone||A Trial for Evaluation of Clinical Efficacy and Safety of Healing Stone Navel Belt in Patients With Primary Dysmenorrhea|Clinical Efficacy and Safety of Healing Stone Navel Belt in Patients With Primary Dysmenorrhea|Unknown status|Enrolling by invitation|Phase 3|102|Anticipated|Healingstone Co., Ltd.||2|||f||||t||||||||||2017-02-18 13:23:53.514796|2017-02-18 13:23:53.514796
NCT00842868|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-09-16|||September 2008||2008-09-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|CASABLANCA||The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases|The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases. An Observational Biomarker Study|Completed||N/A|1298|Actual|Massachusetts General Hospital|||1||f||||f||||||Samples Without DNA|"~     serum and plasma~   "|||2017-02-18 13:23:53.609929|2017-02-18 13:23:53.609929
NCT00842855|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2011-02-04|||February 2009||2009-02-01|February 2011|2011-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|REMAIN||Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France|Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient|Completed||N/A|275|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:23:53.704295|2017-02-18 13:23:53.704295
NCT00842842|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2015-08-17|||August 2009||2009-08-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|June 2010|Actual|2010-06-01||Interventional|MEFIXIT||Mesh Fixation With Intraperitoneal Tisseel|A Prospective, Controlled, Randomized, Patient and Evaluator Blinded Study to Evaluate Pain and Recovery in Patients Undergoing Laparoscopic Umbilical Hernia Repair by Fixing the Mesh With Tisseel Versus Tackers|Completed||N/A|40|Actual|Herlev Hospital||2|||f||||f||||||||||2017-02-18 13:23:53.927055|2017-02-18 13:23:53.927055
NCT00842829|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-09-19|2012-08-17||January 2009||2009-01-01|September 2012|2012-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients|A European Multicenter Open-Label Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients|Terminated||Phase 4|330|Actual|Teva Pharmaceutical Industries||2||Recruitment stopped at the end of the recruitment timeframe|f||||f||||||||||2017-02-18 13:23:54.060291|2017-02-18 13:23:54.060291
NCT00842816|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-06-05|||February 2009||2009-02-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease|A Double-Blind Placebo-Controlled Preliminary Study of the Efficacy, Safety and Tolerability of ST101 Tablets in the Treatment of Alzheimer's Disease in Subjects Concurrently Receiving Donepezil (Aricept®)|Completed||Phase 2|210|Actual|Sonexa Therapeutics, Inc.||4|||f||||f||||||||||2017-02-18 13:23:55.562488|2017-02-18 13:23:55.562488
NCT00842803|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-09-17|||January 2010||2010-01-01|September 2009|2009-09-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant|Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant Recipients Status 1-2. A Prospective Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|100|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-02-18 13:23:55.699792|2017-02-18 13:23:55.699792
NCT00842790|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2015-10-05|||September 2008||2008-09-01|February 2009|2009-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|REMISCAN||Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging|Medical and Economical Impact of Predicting the Response to Anti-angiogenic Treatment in Metastatic Renal Cell Carcinoma Using Functional CT and MRI|Completed||N/A|107|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 13:23:55.791544|2017-02-18 13:23:55.791544
NCT00842777|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-07-27|||October 2004||2004-10-01|July 2016|2016-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Childhood Obesity: a Study of Group Treatment Targeting Parents Behaviour|Childhood Obesity; a Randomized Controlled Study of Group Treatment Targeting Parents Behaviour|Completed||Phase 2|99|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 13:23:55.883837|2017-02-18 13:23:55.883837
NCT00842764|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2017-02-08|||January 2009||2009-01-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Minimally Invasive Holmium:YAG Laser Blepharoplasty|Minimally Invasive Holmium:YAG Laser Blepharoplasty|Completed||Phase 1/Phase 2|7|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 13:23:55.993547|2017-02-18 13:23:55.993547
NCT00842751|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2013-12-10|2011-03-21||July 2009||2009-07-01|December 2013|2013-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|Oral T7|Each subject was administered each of the three treatments over a 6-week period with 1 week of no treatment (wash-out) between each of the treatment period.|Oral T7 Oral Testosterone in Man|Pharmacokinetics of a Novel Oral Testosterone Undecanoate Formulation With Concomitant Inhibition of 5alpha-Reductase by Finasteride|Completed||Phase 2|11|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 13:23:56.099792|2017-02-18 13:23:56.099792
NCT00842738|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2010-01-13|||March 2009||2009-03-01|February 2009|2009-02-01|December 2011|Anticipated|2011-12-01|June 2010|Anticipated|2010-06-01||Interventional|||Can Alternative Treatment Have an Impact on Cervical Dysplasia?|Can Mindfulness Meditation Limit the Progression and/or Increase the Remission of Cervical Dysplasia?|Unknown status|Enrolling by invitation|Phase 4|200|Anticipated|University of Copenhagen||3|||f||||f||||||||||2017-02-18 13:23:56.563821|2017-02-18 13:23:56.563821
NCT00842712|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2017-01-12|2014-07-31||February 2009||2009-02-01|January 2017|2017-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|CERTO|Intent-to-treat (ITT) population included all participants who were randomized to trial treatment.|Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)|Open-label, Randomized, Controlled, Multicenter Phase II Trial Investigating 2 Cilengitide Regimens in Combination With Cetuximab and Platinum-based Chemotherapy (Cisplatin/Vinorelbine or Cisplatin/Gemcitabine) Compared to Cetuximab and Platinum-based Chemotherapy Alone as First Line Treatment for Subjects With Advanced NSCLC|Completed||Phase 2|232|Actual|Merck KGaA||7|||f||||||||||||||2017-02-18 13:23:56.696193|2017-02-18 13:23:56.696193
NCT00842491|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2015-05-17|||November 2008||2008-11-01|May 2015|2015-05-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer|A Phase II Study of Endostar (Recombinant Human Endostatin ®) With Cisplatin and Capecitabine (Xeloda) as 1st Line Treatment in the Advanced Gastric Cancer|Completed||Phase 2|45|Actual|Peking University||1|||f||||t||||||||||2017-02-18 13:24:01.490545|2017-02-18 13:24:01.490545
NCT00842699|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2011-06-27|||September 2008||2008-09-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Observational|||Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab|Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab|Completed||N/A|40|Anticipated|Brigham and Women's Hospital|||2||f||||f||||||||||2017-02-18 13:23:59.042031|2017-02-18 13:23:59.042031
NCT00842686|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2012-03-23|||January 2009||2009-01-01|March 2012|2012-03-01|August 2014|Anticipated|2014-08-01|August 2010|Actual|2010-08-01||Interventional|CRAB||Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study|Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Institute of Oncology Ljubljana||1|||f||||t||||||||||2017-02-18 13:23:59.128907|2017-02-18 13:23:59.128907
NCT00842673|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-06-05|||February 2009||2009-02-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease|A Double-Blind Placebo-Controlled Preliminary Study of the Efficacy, Safety and Tolerability of ST101 Tablets in the Treatment of Alzheimer's Disease|Completed||Phase 2|168|Actual|Sonexa Therapeutics, Inc.||4|||f||||f||||||||||2017-02-18 13:23:59.240444|2017-02-18 13:23:59.240444
NCT00842660|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-08|2010-01-03|||February 2009||2009-02-01|February 2009|2009-02-01|January 2013|Anticipated|2013-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical Cancer|Phase III Trial for Primary Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in PET/CT Defined Poor-Prognostic Cervical Cancer Patients|Unknown status|Enrolling by invitation|Phase 3|172|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-02-18 13:23:59.357682|2017-02-18 13:23:59.357682
NCT00842647|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-04-07|||July 2006||2006-07-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|July 2009|Anticipated|2009-07-01||Observational|HCC||Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma|Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|1200|Anticipated|Sun Yat-sen University|||1||f||||t||||||||||2017-02-18 13:23:59.46438|2017-02-18 13:23:59.46438
NCT00842634|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2016-11-11|||January 2009||2009-01-01|November 2016|2016-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|Zinc-Finger||Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV|A Phase I Study of Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 in HIV-Infected Patients|Completed||Phase 1|12|Actual|University of Pennsylvania||3|||f||||t||||||||No||2017-02-18 13:23:59.537082|2017-02-18 13:23:59.537082
NCT00842621|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-06-24|||March 2009||2009-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Long Term Effects of Erythrocyte Lysis|Long Term Effects of Erythrocyte Lysis|Completed||N/A|390|Actual|St. Jude Children's Research Hospital|||3||f||||f||||||Samples With DNA|"~     Blood Serum Plasma Urine~   "|||2017-02-18 13:23:59.644708|2017-02-18 13:23:59.644708
NCT00842608|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-04-11|||February 2009||2009-02-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|PMD||Pharmacological Management of Delirium|Pharmacological Management of Delirium|Completed||N/A|551|Actual|Indiana University||4|||f||||t||||||||||2017-02-18 13:23:59.837257|2017-02-18 13:23:59.837257
NCT00842595|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2013-07-23|||December 2003||2003-12-01|July 2010|2010-07-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas|Phase II Study of Treatment of Relapsed Agressive Lymphomas|Completed||Phase 2|50|Actual|French Innovative Leukemia Organisation||1|||f||||t||||||||||2017-02-18 13:23:59.955472|2017-02-18 13:23:59.955472
NCT00842582|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-11-01|||February 2009||2009-02-01|November 2016|2016-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer|Neoadjuvant Azacitidine With Carboplatin and Paclitaxel for Suboptimal Newly Diagnosed Ovarian Cancer|Withdrawn||Phase 1|0|Actual|Loyola University||1||No enrollment. Unable to recruit due to lack of eligible patients.|f||||f||||||||No||2017-02-18 13:24:00.088962|2017-02-18 13:24:00.088962
NCT00842569|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||January 2008||2008-01-01|February 2009|2009-02-01||||December 2008|Actual|2008-12-01||Observational|||Brain Electrophysiological Patterns in Obesity|ERP Study of Brain Electrophysiological Patterns in Obesity|Completed||N/A|69|Actual|Centre de Recherche en Nutrition Humaine Rhone-Alpe|||2||f||||f||||||||||2017-02-18 13:24:00.205172|2017-02-18 13:24:00.205172
NCT00842556|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-10-14|||March 2009||2009-03-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects|Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects|Completed||Phase 1|18|Actual|AstraZeneca||5|||f||||f||||||||||2017-02-18 13:24:00.312411|2017-02-18 13:24:00.312411
NCT00842543|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2013-07-16|2012-05-18||July 2008||2008-07-01|July 2013|2013-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|FVJC||Fruit and Vegetable Juice Concentrate Effects on RBP4 and Antioxidant Capacity in Lean and Overweight 6-10 Year Old Boys|Effects Of A Fruit And Vegetable Juice Concentrate (FVJC) In-Vivo On Retinol Binding Protein 4 And Antioxidant Capacity In Normal And Overweight Boys -A Pilot Randomized Placebo Controlled Study|Completed||N/A|39|Actual|Nemours Children's Clinic||2|||f||||t||||||||||2017-02-18 13:24:00.428815|2017-02-18 13:24:00.428815
NCT00842530|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2014-09-18|||February 2009||2009-02-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|||Efficacy and Safety of Dengue Vaccine in Healthy Children|Efficacy and Safety of Dengue Vaccine in Healthy Children Aged 4 to 11 Years in Thailand|Completed||Phase 2|4002|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:24:01.155664|2017-02-18 13:24:01.155664
NCT00842517|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-02-11|||September 2004||2004-09-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Long Term Maintenance of Drug Abstinence|A Behavioral Model for Maintenance of Drug Abstinence|Completed||Phase 1|166|Actual|Treatment Research Institute||2|||f||||t||||||||||2017-02-18 13:24:01.267288|2017-02-18 13:24:01.267288
NCT00841139|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2011-11-25|||February 2009||2009-02-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Metabolic Manipulation in Chronic Heart Failure|Metabolic Manipulation in Chronic Heart Failure|Completed||Phase 2|50|Actual|University Hospital Birmingham NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 13:24:27.289412|2017-02-18 13:24:27.289412
NCT00842478|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||May 2005||2005-05-01|February 2009|2009-02-01||||||||Interventional|RASPALL||Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia|Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia|Unknown status|Recruiting|Phase 2/Phase 3|400|Anticipated|Hospital Universitari Joan XXIII de Tarragona.||2|||f||||t||||||||||2017-02-18 13:24:01.60145|2017-02-18 13:24:01.60145
NCT00842465|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-11-21|||September 2008||2008-09-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|Prolacsein||Prolactin Receptor and Breast Diseases|Characterization and Implication of Prolactin Receptor Mutants in Human Breast Diseases|Completed||N/A|735|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||t||||||Samples Without DNA|"~     blood collection breast Biopsy or surgery~   "|||2017-02-18 13:24:01.687552|2017-02-18 13:24:01.687552
NCT00842452|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2013-04-03|||February 2009||2009-02-01|April 2013|2013-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery|A Phase I Study of Weekly Oral Topotecan in Gynecologic Malignancies|Completed||Phase 1|26|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:24:01.798624|2017-02-18 13:24:01.798624
NCT00842439|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-08-17|||February 2009||2009-02-01|August 2016|2016-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|HBB||Healthy Brains & Behavior: Understanding and Treating Youth Aggression|Biosocial Prediction and Intervention on Childhood Aggression|Completed||N/A|335|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-02-18 13:24:01.914126|2017-02-18 13:24:01.914126
NCT00842426|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2012-09-11|||June 2009||2009-06-01|September 2012|2012-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|E-LITE||Evaluation of Lifestyle Interventions to Treat Elevated Cardiometabolic Risk in Primary Care|A Pilot of Customized Continuous Care Management of Obesity in Pre-Diabetics|Completed||Phase 2|241|Actual|Palo Alto Medical Foundation||3|||f||||t||||||||||2017-02-18 13:24:02.013209|2017-02-18 13:24:02.013209
NCT00842413|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||May 2007||2007-05-01|November 2008|2008-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Investigating the Role of the Premotor Cortex in Higher Cognitive Functions|What Part Does the Premotor Cortex Play in Subjective Visual Perception and in the Perception of Others' Actions?|Terminated||N/A|9|Actual|Assistance Publique - Hôpitaux de Paris|||2|not enough enrollment|f||||f||||||||||2017-02-18 13:24:02.123434|2017-02-18 13:24:02.123434
NCT00842400|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-01-20|||February 2009||2009-02-01|January 2010|2010-01-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.|A Phase I, Single-Center, Open-Label, Non-randomized, One-Sequence Crossover, Pharmacokinetic Interaction Study of the Combination Product VI-0521 (Phentermine Plus Topiramate) With Metformin, Sitagliptin or Probenecid in Healthy Subjects|Completed||Phase 1|20|Actual|VIVUS, Inc.||1|||f||||f||||||||||2017-02-18 13:24:02.212426|2017-02-18 13:24:02.212426
NCT00842387|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-12-22|||January 2009||2009-01-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|||||Observational|||Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)|Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)|Completed||N/A|2370|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:24:02.323511|2017-02-18 13:24:02.323511
NCT00842374|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2013-04-24|||December 2008||2008-12-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|||Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin|Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin|Completed||N/A|32|Actual|Minneapolis Heart Institute Foundation|||1||f||||f||||||||||2017-02-18 13:24:02.702297|2017-02-18 13:24:02.702297
NCT00842361|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-12-15|2015-10-19||January 2009||2009-01-01|December 2016|2016-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus|A 6-week, Randomised, Multi-centre, Open-labelled, Parallel Group, Exploratory Trial to Investigate the Safety of SIAC Compared to Mix30 (NovoRapid®30Mix) on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|66|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 13:24:02.797886|2017-02-18 13:24:02.797886
NCT00842348|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-12-28|2016-12-28||February 2009||2009-02-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|NET729|Safety Population: All patients who received at least one dose of lanreotide Autogel in Study 729.|Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour|Open Label Extension Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero-pancreatic Endocrine Tumour|Completed||Phase 3|89|Actual|Ipsen||1|||f||||f||||||||||2017-02-18 13:24:03.281151|2017-02-18 13:24:03.281151
NCT00842335|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2013-06-21|2012-12-12||February 2009||2009-02-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|July 2010|Actual|2010-07-01||Interventional|||A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors|A Multicenter, Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors|Completed||Phase 1/Phase 2|18|Actual|Jubilant Innovation Ltd.||1|||f||||f||||||||||2017-02-18 13:24:04.112665|2017-02-18 13:24:04.112665
NCT00842322|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-12||||||February 2009|2009-02-01||||||||Interventional|||Fluid Intake in Kidney Failure|The Effect of Increased Fluid Intake on Chronic Renal Failure|Completed||N/A|76|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:24:04.515505|2017-02-18 13:24:04.515505
NCT00842309|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-05-27|||November 2008||2008-11-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|BDD/DCS||D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder|A Randomized, Double-blind, Placebo-controlled Trial of D-cycloserine Augmentation of Behavior Therapy for Body Dysmorphic Disorder|Recruiting||Early Phase 1|50|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:24:04.61635|2017-02-18 13:24:04.61635
NCT00842296|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-03-19|||April 2006||2006-04-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||ClosureFAST - Radiofrequency Great Saphenous Vein Treatment|ClosureFAST - Endovascular Radiofrequency Great Saphenous Vein Treatment Using a Catheter With an Integrated Heating Element|Unknown status|Active, not recruiting|Phase 4|396|Actual|VNUS Medical Technologies, A Covidien Company||1|||f||||f||||||||||2017-02-18 13:24:04.739167|2017-02-18 13:24:04.739167
NCT00842283|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2017-02-08|||November 2008||2008-11-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target|Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target|Recruiting||N/A|100|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:24:04.833491|2017-02-18 13:24:04.833491
NCT00842270|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||January 2006||2006-01-01|February 2009|2009-02-01||||July 2007|Actual|2007-07-01||Interventional|||Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma|A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma|Completed||Phase 2|44|Actual|AB Science||4|||f||||f||||||||||2017-02-18 13:24:04.943438|2017-02-18 13:24:04.943438
NCT00842257|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2010-05-03|||September 2010||2010-09-01|May 2010|2010-05-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|||Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer|A Single Arm Phase II Trial of Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer|Unknown status|Not yet recruiting|Phase 2|32|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 13:24:05.037016|2017-02-18 13:24:05.037016
NCT00842244|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2013-10-17|2012-02-25||April 2009||2009-04-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|December 2009|Actual|2009-12-01||Interventional|||Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer|A Phase 1 Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer|Completed||Phase 1|22|Actual|Pfizer|AUC (0-24) was evaluated and reported for axitinib instead of AUClast as AUC0-24 was a more appropriate measure of steady-state exposure for this drug.|1|||f||||f||||||||||2017-02-18 13:24:05.140115|2017-02-18 13:24:05.140115
NCT00842231|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2010-09-23|2010-08-11||January 2009||2009-01-01|September 2010|2010-09-01||||March 2009|Actual|2009-03-01||Observational|||Assessment of Visual Performance in Patients With Low Levels of Astigmatism||Completed||N/A|40|Actual|Alcon Research|||1||f||||f||||||||||2017-02-18 13:24:05.733544|2017-02-18 13:24:05.733544
NCT00842218|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-11|||January 2009||2009-01-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|April 2009|Anticipated|2009-04-01||Observational|scoliosis||The Idiopathic Scoliosis and Its Treatment (Orthopaedic and Surgery): Effect of the Severity, the Orthosis and the Arthrodesis on the Gait|Effect of the Severity and the Treatment (Orthosis Versus Surgery)of the Idiopathic Scoliosis on the Locomotor Mechanism of the Gait.|Unknown status|Recruiting|N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||t||||||||||2017-02-18 13:24:06.118931|2017-02-18 13:24:06.118931
NCT00842205|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||January 2007||2007-01-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection|Role of Heme Oxygenase in the Pathogenesis od Hepatocellular Injury in Chronic HCV Infection|Unknown status|Recruiting|N/A|150|Anticipated|Charles University, Czech Republic||2|||f||||f||||||||||2017-02-18 13:24:06.222293|2017-02-18 13:24:06.222293
NCT00842192|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-12-06|||April 2009||2009-04-01|December 2016|2016-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|BO2NE||An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries|A Prospective, Multicentre, Multinational, Open Label, Non-controlled, Observational, 24-week Study in Patients Using Oral Anti-Diabetic (OAD) Drugs + Levemir® (Insulin Detemir) for Treatment of Type 2 Diabetes Mellitus in Near East Region Countries|Completed||N/A|2155|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:24:06.335193|2017-02-18 13:24:06.335193
NCT00842179|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-11|||June 2008||2008-06-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Groin Complications Post Percutaneous Coronary Intervention Using Either Manual Compression or PERCLOSE Device|Femoral Access Site Groin Complication Rates After 2517 Groin Punctures Undergoing Vascular Closure by Either Manual Compression or the Perclose Vascular Closure Device|Completed||N/A|2517|Actual|Clinyx, LLC|||2||f||||f||||||||||2017-02-18 13:24:06.447607|2017-02-18 13:24:06.447607
NCT00842166|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2014-08-28|||February 2009||2009-02-01|August 2014|2014-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Surveillance of Summer Febrile Syndromes of Viral Origin in South of France||Completed||N/A|90|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 13:24:06.53859|2017-02-18 13:24:06.53859
NCT00842153|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2011-12-21|2011-12-21||November 2007||2007-11-01|September 2011|2011-09-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam|A Study to Evaluate the Efficacy and Tolerability of Clobetasol Propionate vs. Vehicle in the Treatment of Mild to Moderate Plaque-Type Psoriasis|Completed||Phase 4|58|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:24:06.632746|2017-02-18 13:24:06.632746
NCT00842140|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2010-07-21|||February 2006||2006-02-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women|Metabolic Effects of Multiple Therapies in Polycystic Ovary Syndrome (PCOS) Women|Completed||N/A|75|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-02-18 13:24:07.360879|2017-02-18 13:24:07.360879
NCT00842127|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||March 2006||2006-03-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD)|Genetic Polymorphism of Drug Transporters in OROS-Methylphenidate Treatment in Children and Adolescents With Attention Deficit Hyperactivity Disorder(ADHD)|Completed||Phase 4|150|Actual|Bundang CHA Hospital||1|||f||||t||||||||||2017-02-18 13:24:07.472221|2017-02-18 13:24:07.472221
NCT00842114|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-03-31|||February 2006||2006-02-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|LNH-Pro-05||Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)|Association of Rituximab to Immunochemotherapy With CVP + Interferon in Newly Diagnosed Follicular Lymphoma Patients With Intermediate-high FLIPI Score. Phase II Study.|Completed||Phase 2|50|Actual|Fundación Leucemia y Linfoma, Spain||1|||f||||f||||||||||2017-02-18 13:24:07.583676|2017-02-18 13:24:07.583676
NCT00842101|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-11|||December 2005||2005-12-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Observational|||Compartmental Overpressures Associated to Reamed Intramedullary Nails|Effect of Reamed Intramedullary Nails in Tibial Fractures as a Factor of Rising Intracompartmental Pressures: A Clinical Study|Completed||N/A|80|Actual|University of Andorra|||1||f||||t||||||None Retained|"~     Serum~   "|||2017-02-18 13:24:07.694199|2017-02-18 13:24:07.694199
NCT00842088|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2011-07-28||2011-07-01|March 2009||2009-03-01|July 2011|2011-07-01||||July 2010|Actual|2010-07-01||Interventional|||Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Patients With Sickle Cell Disease|A Randomized, Blinded, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 in Subjects With Sickle Cell Disease|Completed||Phase 1/Phase 2|24|Actual|HemaQuest Pharmaceuticals Inc.||2|||f||||t||||||||||2017-02-18 13:24:07.806319|2017-02-18 13:24:07.806319
NCT00842075|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-05-26|2012-09-17||December 2006||2006-12-01|September 2012|2012-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Pramlintide in Adolescents With Type 1 Diabetes|Effects of Pramlintide in Adolescents With Type 1 Diabetes|Completed||N/A|10|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 13:24:07.905973|2017-02-18 13:24:07.905973
NCT00842062|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2015-03-23|||February 2009||2009-02-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation|Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation|Completed||Phase 1/Phase 2|380|Actual|MyoScience, Inc||1|||f||||f||||||||||2017-02-18 13:24:08.293606|2017-02-18 13:24:08.293606
NCT00842049|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2011-02-22|||November 2006||2006-11-01|February 2009|2009-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|LUMAS||Lumbar Drainage in Subarachnoid Haemorrhage|Lumbar Drainage of Cerebrospinal Fluid in Aneurysmal Subarachnoid Haemorrhage: A Prospective Randomised Controlled Trial|Completed||Phase 2|210|Actual|The Leeds Teaching Hospitals NHS Trust||2|||f||||t||||||||||2017-02-18 13:24:08.387116|2017-02-18 13:24:08.387116
NCT00842036|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2010-06-24|||January 2006||2006-01-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||CRAFT Behavior Therapy: Treatment Entry Component|CRAFT Behavior Therapy Phase 2 Study: Treatment Entry Component|Completed||Phase 2|180|Anticipated|Treatment Research Institute||3|||f||||t||||||||||2017-02-18 13:24:08.498167|2017-02-18 13:24:08.498167
NCT00842023|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2013-08-29|2012-02-03||July 2006||2006-07-01|August 2013|2013-08-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|ABC-HFT||Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy|A Randomized Controlled Trial to Evaluate Renal Function, Inflammatory Mediators, and Neurohormonal Markers in Acutely Decompensated Heart Failure Patients Receiving Nesiritide Compared to Nitroglycerin.|Completed||Phase 4|89|Actual|Western University of Health Sciences||2|||f||||t||||||||||2017-02-18 13:24:08.610871|2017-02-18 13:24:08.610871
NCT00842010|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||March 2006||2006-03-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Observational|||Characteristics of Non Diabetic Hyperglycemic Inpatients|Hyperglycemic Non Diabetic (HND) Hospital Patients: Are They Different From Diabetic Hyperglycemic and Non-Hyperglycemic Non-Diabetic(NHND) Patients?|Completed||N/A|600|Actual|John H. Stroger Hospital|||3||f||||f||||||||||2017-02-18 13:24:09.030579|2017-02-18 13:24:09.030579
NCT00841984|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2009-02-11|||July 2006||2006-07-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Observational|SPECMET||In Vitro NMR Spectroscopy in Neurological Diseases|Evaluation of in Vitro NMR Spectroscopy to Identify Inborn Errors of Metabolism in Patients With Complex Neurological Diseases|Terminated||N/A|271|Actual|Assistance Publique - Hôpitaux de Paris|||3|not enough enrollment|f||||f||||||Samples Without DNA|"~     urines, cerebrospinal fluid~   "|||2017-02-18 13:24:09.227007|2017-02-18 13:24:09.227007
NCT00841971|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2014-12-15|2014-12-08||February 2010||2010-02-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|||Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients|Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial|Completed||Phase 4|200|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:24:09.332284|2017-02-18 13:24:09.332284
NCT00841958|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-04-23|||February 2007||2007-02-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ESCAPE||Endocardial Stem Cells Approach Efficacy|Efficacy of the Endocardial Stem Cells Implantation in Ischemic Heart Failure Patients|Completed||Phase 3|250|Actual|Meshalkin Research Institute of Pathology of Circulation||1|||f||||t||||||||||2017-02-18 13:24:09.777662|2017-02-18 13:24:09.777662
NCT00841945|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-03-15|||April 2005||2005-04-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Treatment of Aggressive Localized Lymphoma|Phase III Study of the Interest of Radiotherapy After 4 or 6 Cycles of CHOP 14 Rituximab Regimen of Chemotherapy , Patients With Agressive Localized Lymphoma|Terminated||Phase 3|334|Actual|French Innovative Leukemia Organisation||2||other drugs other studies|f||||t||||||||No||2017-02-18 13:24:09.865587|2017-02-18 13:24:09.865587
NCT00841932|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-11|||August 2008||2008-08-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Performing Fractional Flow Reserve Without Anticoagulation During Diagnostic Catheterization|Retrospective Assessment of the Safety of Performing Fractional Flow Reserve (FFR) of the Myocardium Without Anticoagulation During Diagnostic Cardiac Catheterization|Completed||N/A|100|Actual|Clinyx, LLC|||1||f||||f||||||||||2017-02-18 13:24:09.983438|2017-02-18 13:24:09.983438
NCT00841919|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-09-08|||December 2006||2006-12-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Insulin Therapy in the Hospital Comparing Two Protocols|Basal/Bolus Insulin Therapy in the Hospital Ward Comparison of Two Protocols: Feasibility Study|Completed||Phase 4|60|Anticipated|John H. Stroger Hospital||2|||f||||f||||||||||2017-02-18 13:24:10.073839|2017-02-18 13:24:10.073839
NCT00841906|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-11|2016-10-05|2016-07-13||September 2008||2008-09-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Alice PDx User/Validation Extended Trial|Alice PDx User/Validation Extended Trial|Completed||N/A|30|Actual|Philips Respironics||2|||f||||f||||||||||2017-02-18 13:24:10.183553|2017-02-18 13:24:10.183553
NCT00841893|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-10|||August 2008||2008-08-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of a Specific Spice on Energy Metabolism|Effects of a Specific Spice on Energy Expenditure, Substrate Oxidation, Appetite and Energy Intake|Completed||N/A|16|Actual|University of Copenhagen||2|||f||||f||||||||||2017-02-18 13:24:10.939254|2017-02-18 13:24:10.939254
NCT00841880|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2010-08-26|||January 2009||2009-01-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||China Medical University Hospital (CMUH) Triapin Listing|A Prospective, Open Label, Randomized, Comparative Study of Ramipril 5mg Plus Felodipine 5mg Combined Regimen and Ramipril 10mg in Uncontrolled Hypertensive Patients|Completed||Phase 4|49|Actual|Sanofi||2|||f||||||||||||||2017-02-18 13:24:11.042087|2017-02-18 13:24:11.042087
NCT00841867|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-11-16|||December 2008||2008-12-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|Pilot OGTT||The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism)|A Pilot Study Investigating the Effects of Partial Pancreatectomy on Glucose Tolerance|Completed||N/A|24|Actual|University of California, Los Angeles|||2||f||||t||||||||||2017-02-18 13:24:11.144036|2017-02-18 13:24:11.144036
NCT00841854|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-12-04|||June 2008||2008-06-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Interventional|||Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication|Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication.|Completed||Phase 4|199|Actual|Asan Medical Center||2|||f||||f||||||||||2017-02-18 13:24:11.240838|2017-02-18 13:24:11.240838
NCT00841841|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2013-02-08|||March 2006||2006-03-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Dipyrone Versus Acetaminophen in the Control of Postoperative Pain|Dipyrone Versus Acetaminophen in the Control of Postoperative Pain|Completed||Phase 2|30|Actual|University Center of Araraquara||2|||f||||t||||||||||2017-02-18 13:24:11.343047|2017-02-18 13:24:11.343047
NCT00841828|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2013-06-07|||February 2009||2009-02-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2011|Actual|2011-12-01||Interventional|||Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients|A Phase II Randomised, Multicentre Compare Epirubicine and Cyclophosphamide Treatment Plus Docetaxel and Trastuzumab Versus Epirubicine and Cyclophosphamide Treatment Plus Docetaxel and Lapatinib in Women With Primary Resectable Breast Cancer or Locally Advanced Breast Cancer Positive Her 2.|Unknown status|Active, not recruiting|Phase 2/Phase 3|102|Anticipated|Spanish Breast Cancer Research Group||2|||f||||f||||||||||2017-02-18 13:24:11.441881|2017-02-18 13:24:11.441881
NCT00841815|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-07-06|2009-05-06||April 2003||2003-04-01|July 2009|2009-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Amlodipine 10 mg Tablets Under Fed Conditions|A Two-Way Crossover, Open-Label, Single-Dose, Fed, Bioequivalence Study of Amlodipine 10 mg Tablets Versus Norvasc® 10 mg Tablets in Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|28|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:11.566118|2017-02-18 13:24:11.566118
NCT00841802|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2016-12-07|||July 2008||2008-07-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study|Glucocorticosteroid Action in Inflammatory Disease|Active, not recruiting||Phase 4|50|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 13:24:11.982516|2017-02-18 13:24:11.982516
NCT00841789|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-10-13|||March 2009||2009-03-01|October 2016|2016-10-01|October 2016|Anticipated|2016-10-01|July 2016|Actual|2016-07-01||Interventional|||Etanercept in Kawasaki Disease|A Randomized, Double Blind, Placebo Controlled Study of the Effects of Etanercept in Children Presenting With Kawasaki Disease|Active, not recruiting||Phase 2|196|Anticipated|Seattle Children's Hospital||2|||f||||t||||||||||2017-02-18 13:24:12.101041|2017-02-18 13:24:12.101041
NCT00841776|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2011-07-12|2010-04-07||August 2007||2007-08-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne|Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Moderate to Moderately Severe Facial Acne Vulgaris|Completed||Phase 4|54|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:24:12.222244|2017-02-18 13:24:12.222244
NCT00841763|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2013-01-18|2011-07-04||October 2008||2008-10-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|||Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects|A Phase III, Randomized, Controlled, Observer-blind, Multicenter Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Doses of a Monovalent A/H5N1 Influenza Vaccine Adjuvanted With MF59 (Fluad-H5N1) in Adult and Elderly Subjects|Completed||Phase 3|3647|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:24:12.885215|2017-02-18 13:24:12.885215
NCT00841750|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2011-07-19|||July 2008||2008-07-01|July 2011|2011-07-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|NOTUBE||Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection|The NoTube Study: Evaluation of the Necessity of a Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection.|Unknown status|Recruiting|Phase 3|100|Anticipated|Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle||2|||f||||t||||||||||2017-02-18 13:24:14.183201|2017-02-18 13:24:14.183201
NCT00841737|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-08-05|||January 2008||2008-01-01|August 2009|2009-08-01|April 2010|Anticipated|2010-04-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of a Psychoeducation Group Program for Mild/Moderate Depression|Evaluation of the Effectiveness and Efficiency of a Psychoeducational Group Sessions Intervention Program in the Depressive Episode Realized by Primary Health Care Center Nurses in Barcelona City.|Unknown status|Recruiting|N/A|192|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-02-18 13:24:14.403848|2017-02-18 13:24:14.403848
NCT00841724|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-05-15|||January 2009||2009-01-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|ITT 08-01||"Study of a Reduced-toxicity Submyeloablative Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies"|"Phase II Study of a Reduced-toxicity  Submyeloablative  Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies"|Completed||Phase 2|82|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-02-18 13:24:14.515466|2017-02-18 13:24:14.515466
NCT00841711|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-08-10|||September 2008||2008-09-01|August 2016|2016-08-01|August 2013|Actual|2013-08-01|August 2012|Actual|2012-08-01||Interventional|||Transitions: Linkages From Jail To Community|Transitions: Linkages From Jail to Community|Completed||N/A|127|Actual|Yale University||1|||f||||f||||||||||2017-02-18 13:24:14.623215|2017-02-18 13:24:14.623215
NCT00841698|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-09-09|2009-07-02||October 2002||2002-10-01|September 2009|2009-09-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Paroxetine Hydrochloride 40 mg Film-Coated Tablets and Paxil® 40 mg Film-Coated Tablets Administered as 1 x 40 mg Film-Coated Tablet in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|50|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:14.737819|2017-02-18 13:24:14.737819
NCT00841685|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2014-12-04|||December 2008||2008-12-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate|The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Ghent||5|||f||||f||||||||||2017-02-18 13:24:15.18209|2017-02-18 13:24:15.18209
NCT00841672|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2011-07-05|2011-01-05||January 2009||2009-01-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension|An 8-week, Double-blind, Randomized, Parallel Group, Multi-center Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren 300 mg and Amlodipine 10 mg Compared to Amlodipine 10 mg in Patients|Completed||Phase 3|485|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:24:15.294791|2017-02-18 13:24:15.294791
NCT00841659|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-09-09|2009-07-02||August 2002||2002-08-01|September 2009|2009-09-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Paroxetine Hydrochloride 40 mg Film-Coated Tablets and Paxil® 40 mg Film-Coated Tablets Administered as 1 x 40 mg Film-Coated Tablet in Healthy Subjects Under Fed Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:15.858805|2017-02-18 13:24:15.858805
NCT00841646|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-11-30|||December 2008||2008-12-01|December 2011|2011-12-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects|A Phase II, Open-label, Multi-center Study to Evaluate the Immunogenicity, Safety and Tolerability of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects|Completed||Phase 2|343|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:24:16.302432|2017-02-18 13:24:16.302432
NCT00841633|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2011-10-11|||February 2009||2009-02-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility Study|Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility Study|Terminated||Phase 3|15|Actual|UMC Utrecht||2||"Our RCT recently started. The RCT is similar to the feasibility trial, so it was terminated to~   avoid 2 trials running simultaniously."|f||||f||||||||||2017-02-18 13:24:16.426814|2017-02-18 13:24:16.426814
NCT00841620|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2015-04-30|||September 1999||1999-09-01|April 2015|2015-04-01|April 2007|Actual|2007-04-01|January 2001|Actual|2001-01-01||Interventional|||Symptom Control 1-year After Circular Stapler Anopexy or Diathermy Excision for Prolapsed Haemorhoids|Symptom Control 1-year After Circular Stapler Anopey or Diathermy Excision for Prolapsed Haemorrhoids: an International Randomsed Trial (the STOPP-trial|Completed||Phase 4|207|Actual|Odense University Hospital||2|||f||||t||||||||||2017-02-18 13:24:16.537509|2017-02-18 13:24:16.537509
NCT00841607|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-10-17|||August 2006||2006-08-01|October 2016|2016-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy|Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy|Completed||N/A|162|Actual|Tom Baker Cancer Centre||2|||f||||||||||||||2017-02-18 13:24:16.641137|2017-02-18 13:24:16.641137
NCT00841594|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2011-05-13|||February 2009||2009-02-01|May 2011|2011-05-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison|MXQ-503 Applied To The Hand Vs. Nitroglycerin Ointment 2%, USP, Applied To The Chest: A Pharmacokinetic Comparison In Normal Subjects|Completed||Phase 1|12|Anticipated|MediQuest Therapeutics||2|||f||||f||||||||||2017-02-18 13:24:16.752192|2017-02-18 13:24:16.752192
NCT00841581|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2011-12-07|||December 2008||2008-12-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Lucentis to Treat Pigment Epithelial Detachment|Intravitreal Lucentis (iL) (Ranibizumab) for the Treatment of AMD Related Pigment Epithelial Detachment (PED)|Completed||Phase 2|32|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 13:24:16.857607|2017-02-18 13:24:16.857607
NCT00841568|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2011-04-07|||April 2006||2006-04-01|April 2011|2011-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]|A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]|Completed||Phase 2|17|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 13:24:17.204346|2017-02-18 13:24:17.204346
NCT00841555|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-03-24|2016-03-24||February 2009||2009-02-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|February 2013|Actual|2013-02-01||Interventional||Glioblastoma multiforme (GBM) patients|Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma|A Phase I Trial of Hypofraction Radiotherapy + Temozolomide in the Treatment of Patients With Glioblastoma Multiforme and Anaplastic Astrocytoma of the Brain|Completed||Phase 1|9|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:24:17.316056|2017-02-18 13:24:17.316056
NCT00841542|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-07-06|2009-05-06||April 2003||2003-04-01|July 2009|2009-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Amlodipine 10 mg Tablets Under Fasting Conditions|A Two-Way Crossover, Open-Label, Single-Dose, Fasting, Bioequivalence Study of Amlodipine 10 mg Tablets Versus Norvasc® 10 mg Tablets in Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|28|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:17.591832|2017-02-18 13:24:17.591832
NCT00841529|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-10-18||2012-10-01|March 2009||2009-03-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage|Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage|Terminated||Phase 2|40|Actual|Medtronic Cardiovascular||1||Medtronic Business Decision|f||||t||||||||||2017-02-18 13:24:18.045978|2017-02-18 13:24:18.045978
NCT00841516|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2013-11-07|||December 2007||2007-12-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|April 2011|Actual|2011-04-01||Interventional|||Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative|A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for the Immunological and Histological Evaluation of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Recombinant Hypoallergenic Derivative of the Major Birch Pollen Allergen, rBet v1-FV|Completed||Phase 2|14|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 13:24:18.147483|2017-02-18 13:24:18.147483
NCT00841503|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-03-20|||September 2008||2008-09-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Exploring Buckwheat's Glucose Lowering Potential|A Double-Blind, Randomized, Controlled Study to Determine Buckwheat's Glucose Lowering Effects in Healthy Volunteers and Volunteers With Type 2 Diabetes|Completed||N/A|24|Actual|St. Boniface General Hospital Research Centre|||2||f||||f||||||||||2017-02-18 13:24:18.276773|2017-02-18 13:24:18.276773
NCT00841490|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2010-06-01|||September 2008||2008-09-01|May 2010|2010-05-01|June 2010|Anticipated|2010-06-01|March 2010|Anticipated|2010-03-01||Observational|||Oral H. Pylori Prevalence in Intellectually & Developmentally Disabled Adults|Oral H. Pylori Prevalence in Intellectually & Developmentally Disabled Adults|Unknown status|Active, not recruiting|N/A|220|Anticipated|University of Louisville|||2||f||||t||||||Samples With DNA|"~     Samples of dental plaque.~   "|||2017-02-18 13:24:18.602013|2017-02-18 13:24:18.602013
NCT00841477|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2017-01-10|||January 2004||2004-01-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|June 2007|Actual|2007-06-01||Interventional|||An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users|An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users|Completed||Phase 3|1260|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||t||||||||||2017-02-18 13:24:18.700725|2017-02-18 13:24:18.700725
NCT00841464|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-07-09|||March 2009||2009-03-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|||||Observational|||Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease|Prospective Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease|Completed||N/A|20|Actual|Parkinson's Disease Research, Education, and Clinical Center, Philadelphia|||1||f||||f||||||||||2017-02-18 13:24:18.81761|2017-02-18 13:24:18.81761
NCT00841451|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-03-22||||||March 2016|2016-03-01||||||||Expanded Access|PUFA||Pulmonary Vein Isolation Outcomes With Fish Oils|Pulmonary Vein Isolation Outcomes With Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid (DHA)|No longer available||N/A|||St. Luke's-Roosevelt Hospital Center|||||f||||||||||||||2017-02-18 13:24:18.905194|2017-02-18 13:24:18.905194
NCT00841438|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2010-05-03|||July 2007||2007-07-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ECLAT-STEMI||Efficacy of Early Administration of Clotinab in Acute Myocardial Infarction|Efficacy of Clotinab in Acute Myocardial Infarction Trial- ST Elevation Myocardial Infarction|Completed||Phase 4|786|Actual|Yonsei University||2|||f||||t||||||||||2017-02-18 13:24:18.9958|2017-02-18 13:24:18.9958
NCT00841425|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-23|||February 2009||2009-02-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|June 2009|Anticipated|2009-06-01||Observational|||Airway Responsiveness and Inflammation in Adolescent Elite Swimmers: a 3-Year Prospective Follow-up Study|Airway Responsiveness and Inflammation in Adolescent Elite Swimmers: a 3-Year Prospective Follow-up Study|Unknown status|Recruiting|N/A|33|Anticipated|Bispebjerg Hospital|||1||f||||||||||Samples Without DNA|"~     Blood (serum, whole blood) Exhaled breath condensate Induced sputum~   "|||2017-02-18 13:24:19.1266|2017-02-18 13:24:19.1266
NCT00841412|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2015-04-06|2014-10-28||February 2009||2009-02-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|October 2011|Actual|2011-10-01||Interventional||200 long-stay veterans completed baseline assessments.|Prevention of Weight Loss in Long Term Care Veterans|Prevention of Weight Loss in Long-Term Care Veterans|Completed||N/A|222|Actual|VA Office of Research and Development|This study was conducted in only two VA facilities in one geographic region with predominately White, male residents. All study results have been published in a series of papers.|2|||f||||t||||||||||2017-02-18 13:24:19.216424|2017-02-18 13:24:19.216424
NCT00841399|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2014-06-02|||July 2001||2001-07-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients|Phase Ib Trial of HER2/Neu Peptide (E75) Vaccine in Breast Cancer Patients at Risk for Recurrence After Surgical and Medical Therapies|Completed||Phase 1/Phase 2|100|Actual|Walter Reed Army Medical Center||2|||f||||f||||||||||2017-02-18 13:24:19.481138|2017-02-18 13:24:19.481138
NCT00841386|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-10|||September 2008||2008-09-01|January 2009|2009-01-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Treatment of Keratoconus Using Collagen Cross-Linking|Treatment of Keratoconus Using Collagen Cross-Linking By Means of Topical Riboflavin and UV Light.|Unknown status|Recruiting|Phase 2/Phase 3|150|Anticipated|University at Buffalo||2|||f||||f||||||||||2017-02-18 13:24:19.711803|2017-02-18 13:24:19.711803
NCT00841373|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2014-11-17|||July 2007||2007-07-01|November 2014|2014-11-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Interventional|||Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease|Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease|Completed||Phase 1/Phase 2|1|Actual|Southern New England Retina Associates||2|||f||||t||||||||||2017-02-18 13:24:19.840839|2017-02-18 13:24:19.840839
NCT00841360|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2016-02-29|||January 2009||2009-01-01|February 2016|2016-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||ID and Testing Via Friendship Networks|A Pilot Study to Identify Undiagnosed Asymptomatic HIV Infections in Adolescent and Young Adult Women|Completed||N/A|535|Actual|Westat|||4||f||||t||||||||||2017-02-18 13:24:19.952429|2017-02-18 13:24:19.952429
NCT00841347|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-03-23|||February 2009||2009-02-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Sleep and Obesity in Teenagers|Sleep and Obesity in Teenagers: Impact of Sleep Length and Quality on Obesity and Diabetes Risks in Teenagers.|Completed||N/A|15|Actual|Hospices Civils de Lyon||3|||f||||f||||||||||2017-02-18 13:24:20.065134|2017-02-18 13:24:20.065134
NCT00841334|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2013-01-22|||May 2008||2008-05-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|May 2010|Actual|2010-05-01||Interventional|ACTION||Adolescents Committed to Nutrition and Physical Activity|Adolescents Committed to Improvement of Nutrition and Physical Activity (ACTION)|Completed||Phase 1/Phase 2|145|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 13:24:20.171048|2017-02-18 13:24:20.171048
NCT00841321|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2014-05-23|2013-10-22||January 2009||2009-01-01|May 2014|2014-05-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional||Based on pilot data (compliance of 80%,dropout rate of 20%) the estimated sample size needed to power the study was 158 enrolled to yield 110 with complete observations. In this study, enrollment was stopped at 121 participants with more than 110 subjects completing the study (dropout rate less than 5%).|Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis|Ginkgo Biloba for Cognitive Impairment in Multiple Sclerosis|Completed||Phase 2|120|Actual|VA Office of Research and Development|Limitations include underrepresentation of minorities. Subjects overall had mild impairment.|2|||f||||t||||||||||2017-02-18 13:24:20.275636|2017-02-18 13:24:20.275636
NCT00841308|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-05-24|||February 2009||2009-02-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|HBP10||Home Blood Pressure in Hypertension Management|Antihypertensive Drug Treatment Decisions Based on Home Blood Pressure Monitoring|Unknown status|Recruiting|Phase 4|150|Anticipated|University of Athens||2|||f||||f||||||||||2017-02-18 13:24:20.901749|2017-02-18 13:24:20.901749
NCT00841295|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-05-25|||July 2008||2008-07-01|May 2016|2016-05-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|CarniPrema||Effects of Parenteral L-carnitine Supplementation in Premature Neonates|Effects of Parenteral L-carnitine Supplementation in Premature Neonates|Completed||N/A|53|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-02-18 13:24:20.992367|2017-02-18 13:24:20.992367
NCT00841282|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-10|||October 2008||2008-10-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||RCT of Air Insufflation Versus Water Infusion Colonoscopy by Supervised Trainees|Comparison of Study Versus Conventional Method for Performing Colonoscopy by Supervised Trainees for Colorectal Cancer Screening and Surveillance|Completed||N/A|62|Actual|East Bay Institute for Research and Education||2|||f||||t||||||||||2017-02-18 13:24:21.093666|2017-02-18 13:24:21.093666
NCT00841269|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2015-01-06|2014-12-10||May 2009||2009-05-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Oral Uridine for Treatment of Bipolar Depression in Adolescents|Oral Administration of Uridine for Treatment of Bipolar Depression in Adolescents: A Magnetic Resonance Spectroscopy Study|Completed||Phase 2|7|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 13:24:21.199296|2017-02-18 13:24:21.199296
NCT00841256|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-10-15|||February 2008||2008-02-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|June 2012|Actual|2012-06-01||Interventional|||Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children|... Study to Evaluate Efficacy and Safety of Perennial Sublingual SIT With a Solution of Grass Pollen Allergen ... in Children With Clinically Relevant Grass Pollen Sensitivity in Comparison to a ... Standard Treatment With Add on Placebo|Completed||Phase 3|207|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 13:24:21.517739|2017-02-18 13:24:21.517739
NCT00841243|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-10|||March 2009||2009-03-01|February 2009|2009-02-01|August 2010|Anticipated|2010-08-01|March 2010|Anticipated|2010-03-01||Interventional|||Nutritional Support During Antiviral Therapy for Hepatitis C|The Effects of Preventive Versus on Demand Nutritional Advice and Support on the Nutritional Status of Patients During Antiviral Therapy for Hepatitis C A Randomized, Multi Center Trial|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-02-18 13:24:21.641651|2017-02-18 13:24:21.641651
NCT00841230|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-10|||February 2009||2009-02-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Deanxit and Rivotril in Tinnitus Patients|Additional Value of Deanxit in Tinnitus Patients Treated With Rivotril|Completed||Phase 4|50|Anticipated|University Hospital, Antwerp||2|||f||||f||||||||||2017-02-18 13:24:21.754488|2017-02-18 13:24:21.754488
NCT00841217|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-10|||April 2003||2003-04-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|August 2005|Actual|2005-08-01||Interventional|||Regulation of Lipoprotein Transport in Metabolic Syndrome|Effect of PPAR-Delta Agonist on Lipoprotein Kinetics in Metabolic Syndrome|Completed||Phase 4|13|Actual|The University of Western Australia||2|||f||||f||||||||||2017-02-18 13:24:21.849618|2017-02-18 13:24:21.849618
NCT00841204|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2014-05-29|2012-02-14||February 2009||2009-02-01|March 2013|2013-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma|Phase II Trial of Sulindac in Individuals at Increased Risk for Melanoma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:24:24.155797|2017-02-18 13:24:24.155797
NCT00841191|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2014-05-13|||March 2009||2009-03-01|May 2014|2014-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors|A Phase 1/2, Multiple-Dose, Dose-Escalation Study to Assess the Safety, Efficacy, and Pharmacokinetics of Intravenous CNTO 328, an Anti-Interleukin 6 (IL-6) Monoclonal Antibody, in Subjects With Solid Tumors|Completed||Phase 1/Phase 2|84|Actual|Centocor, Inc.||7|||f||||t||||||||||2017-02-18 13:24:24.617599|2017-02-18 13:24:24.617599
NCT00841178|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2014-12-02|||October 2005||2005-10-01|December 2014|2014-12-01||||August 2011|Actual|2011-08-01||Interventional|||Endovenous Laser Therapy (EVLT) for Sapheno-Popliteal Incompetence and Short Saphenous Vein (SSV) Reflux: A RCT|A Randomised Controlled Trial of the Clinical and Cost Effectiveness of Endovenous Laser Therapy in the Treatment of Varicose Veins Secondary to Isolated Sapheno-Popliteal Incompetence and Short Saphenous Reflux|Unknown status|Active, not recruiting|N/A|106|Anticipated|University of Hull||2|||f||||f||||||||||2017-02-18 13:24:24.763815|2017-02-18 13:24:24.763815
NCT00841165|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2010-04-01|||January 2009||2009-01-01|April 2010|2010-04-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|COMET||Carbon Monoxide Monitoring and Emergency Treatment|Randomized Trial of Carbon Monoxide Elimination Kinetics With Oxygen Delivered by Continuous Positive Airway Pressure Compared to Face Mask|Unknown status|Recruiting|N/A|40|Anticipated|University of Vermont||2|||f||||t||||||||||2017-02-18 13:24:24.873406|2017-02-18 13:24:24.873406
NCT00841152|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2017-02-10|||March 2009|Actual|2009-03-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|February 2014|Actual|2014-02-01||Observational|BAGvsTCP||Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute|A National, Prospective, Randomized, Multicenter, Controlled Head-to-Head Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute in Filling of Contained Bone Defects|Active, not recruiting||N/A|120|Actual|Turku University Hospital|||2||f||||f||||||||||2017-02-18 13:24:24.985663|2017-02-18 13:24:24.985663
NCT00841126|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2010-10-18|||July 2009||2009-07-01|October 2010|2010-10-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate|An Open, Randomized, Controlled, Parallel Group, Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate Together With a Randomized Placebo Controlled Double Blind Fermagate Comparison in Hemodialysis Patients With Hyperphosphatemia|Terminated||Phase 3|657|Anticipated|Ineos Healthcare Limited||3|||f||||t||||||||||2017-02-18 13:24:27.401382|2017-02-18 13:24:27.401382
NCT00841113|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-10|||January 1999||1999-01-01|February 2009|2009-02-01|February 2003|Actual|2003-02-01|February 2001|Actual|2001-02-01||Interventional|||Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer|Phase III Study of the Comparison of Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer. A One Year Randomised, Open Label, Multi-Centre Phase III Trial.|Completed||Phase 3|177|Actual|Speciality European Pharma Limited||2|||f||||f||||||||||2017-02-18 13:24:27.80759|2017-02-18 13:24:27.80759
NCT00841100|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-03-10|||December 2008||2008-12-01|February 2009|2009-02-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response|Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response|Unknown status|Recruiting|N/A|20|Anticipated|University of Miami||1|||f||||t||||||||||2017-02-18 13:24:27.918601|2017-02-18 13:24:27.918601
NCT00841087|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2015-10-16|2015-10-16||January 2009||2009-01-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes|A 6-week, Randomised, Multi-centre, Open-labelled, Parallel Group, Exploratory Trial to Investigate the Safety of SIBA Once Daily + NovoRapid® Compared to Insulin Detemir Once Daily + NovoRapid®, All in a Basal-bolus Regimen in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 2|65|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 13:24:28.033531|2017-02-18 13:24:28.033531
NCT00841074|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2016-12-01|||January 2006||2006-01-01|December 2016|2016-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Chlorhexidine & Pneumonia in Nursing Home Residents|Effect of Topical Oral Chlorhexidine in Reducing Pneumonia in Nursing Home Residents|Completed||Phase 1|75|Actual|University of Louisville||2|||f||||t||||||||||2017-02-18 13:24:28.499819|2017-02-18 13:24:28.499819
NCT00841061|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-09|||July 2003||2003-07-01|January 2009|2009-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|Bfe03B||Cereals as a Source of Iron for Breastfed Infants|Breast Feeding and Iron: Comparison of Cereals Fortified With Different Forms of Iron|Completed||N/A|111|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 13:24:28.603728|2017-02-18 13:24:28.603728
NCT00841048|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-09-29|||February 2009||2009-02-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|||||Interventional|MAD||Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses|A Randomised, Single-blind, Placebo-controlled, Single Centre, Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses|Completed||Phase 1|107|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:24:28.701865|2017-02-18 13:24:28.701865
NCT00841035|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2014-09-29|2013-07-03||February 2009||2009-02-01|September 2014|2014-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients|University of Alabama at Birmingham(UAB 0808), A Phase II Study of Short-course Preoperative Erlotinib Followed by Post-operative Erlotinib-gemcitabine in Patients With Resectable Pancreatic Adenocarcinoma|Terminated||Phase 2|6|Actual|University of Alabama at Birmingham|Early termination by sponsor and No good clinical data was analyzed to the early termination of the study.|1||Sponsor stopped due to slow enrollment|f||||t||||||||||2017-02-18 13:24:28.808718|2017-02-18 13:24:28.808718
NCT00841022|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2013-10-22|||February 2009||2009-02-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Information and Anaesthesia in Paediatrics|Effects of Comics on Anaesthesia's Anxiety in Paediatrics: A Randomized Controlled Trial|Completed||N/A|115|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-02-18 13:24:29.042194|2017-02-18 13:24:29.042194
NCT00841009|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-05-03|||July 2005||2005-07-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|May 2012|Actual|2012-05-01||Observational|||Effect of Gastric Bypass-induced Weight Loss on Myocardial Structure, Function and Metabolism|Effect of Gastric Bypass-induced Weight Loss on Myocardial Structure, Function and Metabolism|Completed||N/A|18|Actual|Washington University School of Medicine|||1||f||||f||||||Samples With DNA|"~     2 tubes of blood (1 tablespoon total) will be collected (with permission), tested and stored~     for a length of time~   "|||2017-02-18 13:24:29.139626|2017-02-18 13:24:29.139626
NCT00840996|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-10-31|2016-06-27||May 2008||2008-05-01|October 2016|2016-10-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Perioperative Intravenous Lidocaine or Epidural Anesthesia on Outcomes in Complex Spine Surgery|Effect of Perioperative Intravenous Lidocaine Administration or Epidural Anesthesia on Postoperative Outcomes in Complex Spine Surgery|Completed||N/A|116|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 13:24:29.321817|2017-02-18 13:24:29.321817
NCT00840983|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2015-11-27|||August 2003||2003-08-01|November 2015|2015-11-01|December 2006|Actual|2006-12-01|November 2005|Actual|2005-11-01||Interventional|||Effects of Delayed Cord Clamping in Very Low Birth Weight Infants|Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants|Completed||Phase 1|72|Actual|University of Rhode Island||2|||f||||t||||||||||2017-02-18 13:24:29.730946|2017-02-18 13:24:29.730946
NCT00840970|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2015-03-25|||March 2008||2008-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:24:29.839139|2017-02-18 13:24:29.839139
NCT00840957|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2015-04-08|||November 2007||2007-11-01|April 2015|2015-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|FAKIR||Pharmaco Kinetic Variability of Infliximab in Rheumatoid Arthritis|Pharmaco Kinetic and Pharmacokinetic-Pharmacodynamic Variability of Infliximab|Completed||N/A|84|Actual|University Hospital, Tours|||1||f||||f||||||Samples With DNA|"~     whole blood and serum~   "|||2017-02-18 13:24:29.884459|2017-02-18 13:24:29.884459
NCT00840944|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2014-08-07|||January 2008||2008-01-01|August 2014|2014-08-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|ZomaTrip||A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height|Efficacy and Safety of a 4 Year Combination Therapy of Growth Hormone and Gonadotropin- Releasing Hormone Agonist in Children With a Short Predicted Height.|Recruiting||Phase 4|30|Anticipated|Belgian Study Group for Pediatric Endocrinology||2|||f||||f||||||||||2017-02-18 13:24:30.183425|2017-02-18 13:24:30.183425
NCT00840931|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2017-01-23|||February 2009||2009-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|February 2014|Actual|2014-02-01||Interventional|||Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)|"A Phase I Pilot Study of Immunotherapy Using Lenalidomide Plus Bystander Vaccine in Patients With High-Risk Myelodysplastic Syndrome (MDS)"|Active, not recruiting||Phase 1|22|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 13:24:30.320402|2017-02-18 13:24:30.320402
NCT00840918|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2016-07-18|||February 2009||2009-02-01|July 2016|2016-07-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery|The Effect of Perioperative Intravenous Lidocaine on Postoperative Outcomes After Cardiac Surgery|Recruiting||N/A|1294|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 13:24:30.44104|2017-02-18 13:24:30.44104
NCT00840905|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2012-11-06|||February 2009||2009-02-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Observational|||A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil|A Pilot Observational Study to Determine the Prevalence of HPV Serology in HIV Seropositive Women From Subsaharan Africa and Brasil|Completed||N/A|487|Actual|University of Witwatersrand, South Africa|||3||f||||f||||||None Retained|"~     Blood /plasma specimen 10cc~   "|||2017-02-18 13:24:30.568722|2017-02-18 13:24:30.568722
NCT00840892|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-10|2009-02-10|||January 2002||2002-01-01|February 2009|2009-02-01|March 2007|Actual|2007-03-01|||||Interventional|||(Cost-)Effectiveness Interdisciplinary Community-Based COPD Management Program (INTERCOM)|Randomized Controlled Trial to Establish the (Cost-)Effectiveness of an Interdisciplinary Community-Based COPD Management Program Relative to Usual Care.|Completed||N/A|199|Actual|Maastricht University Medical Center||2|||f||||||||||||||2017-02-18 13:24:30.663255|2017-02-18 13:24:30.663255
NCT00840879|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-09-01|2009-06-30||February 2004||2004-02-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Meloxicam 15 mg Tablets Under Non-Fasting Conditions|A Two-Way Crossover, Open-Label, Single-Dose, Fed, Bioequivalence Study of Meloxicam 15 mg Tablets Versus Mobic® 15 mg Tablets in Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|28|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:30.761975|2017-02-18 13:24:30.761975
NCT00840866|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-08-14|2009-06-18||September 2003||2003-09-01|August 2009|2009-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Cefprozil 500 mg Tablets Under Fed Conditions|A Relative Bioavailability Study of Cefprozil 500 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|39|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:31.216613|2017-02-18 13:24:31.216613
NCT00840853|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2016-07-20|||April 2009||2009-04-01|July 2016|2016-07-01|April 2031|Anticipated|2031-04-01|April 2016|Actual|2016-04-01||Interventional|MULTIPRAT||Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT|Phase I Study of the Administration of Multi-Virus-Specific Cytotoxic T Lymphocytes Expressing CD19 Chimeric Receptors for Prophylaxis or Therapy of Relapse of CD19 Positive Malignancies Post Hematopoietic Stem Cell Transplantation|Active, not recruiting||Phase 1|68|Anticipated|Baylor College of Medicine||4|||f||||t||||||||||2017-02-18 13:24:31.62358|2017-02-18 13:24:31.62358
NCT00840840|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-07-08|2009-05-18||August 2002||2002-08-01|July 2009|2009-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions|An Open-Label, Single-Dose, Two-Way Crossover Bioequivalence Study of Two Oral Suspension Formulations of Amoxicillin/Clavulanate Potassium, 600/42.9 mg/5 mL in Healthy Subjects, Under Fed Conditions|Completed||Phase 1|48|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:31.73591|2017-02-18 13:24:31.73591
NCT00840827|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2011-03-08|||December 2008||2008-12-01|March 2011|2011-03-01||||December 2010|Actual|2010-12-01||Interventional|||Study of the Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes|A Single-Arm, Open-Label Study of the Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Red Blood Cell Transfusion-Dependent Myelodysplastic Syndromes|Completed||Phase 2|40|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 13:24:32.207959|2017-02-18 13:24:32.207959
NCT00840814|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2012-02-20|||May 2008||2008-05-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer|Development of a Lymphedema Symptom Checklist in Head and Neck Cancer Patients|Completed||Phase 1/Phase 2|55|Actual|Vanderbilt University|||1||f||||||||||||||2017-02-18 13:24:32.317082|2017-02-18 13:24:32.317082
NCT00840801|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2015-05-20|||February 2009||2009-02-01|May 2015|2015-05-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Interventional|||Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children|Single-blind, Randomized, Phase 3B Study in Children Aged 1 - 11 Years to Investigate the Immunogenicity, Safety and Interchangeability of Two Tick-borne Encephalitis (Tbe) Vaccines Administered According to a Conventional Schedule|Completed||Phase 3|302|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 13:24:32.41098|2017-02-18 13:24:32.41098
NCT00840788|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-09|||May 2005||2005-05-01|February 2009|2009-02-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Adhesive Glue With Skin Suture for Repair of Episiotomy|Skin Adhesive Versus Subcuticular Suture for Perineal Skin Repair After Episiotomy - a Randomized Controlled Trial.|Completed||N/A|100|Actual|Hospital Sao Joao||2|||f||||f||||||||||2017-02-18 13:24:32.512857|2017-02-18 13:24:32.512857
NCT00840775|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2011-08-11|||April 2009||2009-04-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)|Clinical Protocol Presillion™ and Presillion™ Plus Stent Systems|Completed||Phase 4|278|Actual|Medinol Ltd.||1|||f||||f||||||||||2017-02-18 13:24:32.614392|2017-02-18 13:24:32.614392
NCT00840762|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2010-01-25|||March 2009||2009-03-01|January 2010|2010-01-01|July 2012|Anticipated|2012-07-01|February 2012|Anticipated|2012-02-01||Interventional|||A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication|A Randomized Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication|Unknown status|Recruiting|Phase 4|756|Anticipated|Ruth M. Rothstein CORE Center||2|||f||||f||||||||||2017-02-18 13:24:32.730863|2017-02-18 13:24:32.730863
NCT00840749|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2013-04-05|||December 2008||2008-12-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|STARS||Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer|International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer|Terminated||Phase 3|36|Actual|Accuray Incorporated||2||Lack of enrollment|f||||t||||||||||2017-02-18 13:24:32.845426|2017-02-18 13:24:32.845426
NCT00840736|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-09|||May 2007||2007-05-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||LAGB Versus VBG: 7-Year Results|Laparoscopic Adjustable Gastric Banding Versus Open Vertical Banded Gastroplasty: 7-Year Results of a Prospective Randomized Trial|Completed||N/A|100|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:24:33.16491|2017-02-18 13:24:33.16491
NCT00840723|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2013-09-03|||February 2009||2009-02-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|SCCOR Bronch||Bronchoscopy Assisted Sampling of Cells and Fluid From the Lower Respiratory Tract of Human Subjects|Bronchoscopy-Assisted Sampling of Cells and Fluid From the Lower Respiratory Tract of Human Subjects|Completed||N/A|30|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"~     Whole blood, Bronchial Lavage Fluid (BALF), cytology brushings~   "|||2017-02-18 13:24:33.277197|2017-02-18 13:24:33.277197
NCT00840710|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-08|2009-12-27|||February 2010||2010-02-01|February 2009|2009-02-01|August 2010|Anticipated|2010-08-01|||||Observational|BT||Clinical Feasibility of Birth- Track II System|Clinical Feasibility of Birth- Track II System|Unknown status|Not yet recruiting|N/A|15|Anticipated|Barnev Ltd|||1||f||||f||||||||||2017-02-18 13:24:33.372396|2017-02-18 13:24:33.372396
NCT00840697|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2011-06-24|||August 2009||2009-08-01|May 2011|2011-05-01|August 2013|Anticipated|2013-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Effect of Interventions in Return to Work for Patients With Neck and Low Back Pain|Facilitating and Inhibiting Factors and Effect of Interventions in Return to Work for Patients With Neck and Low Back Pain|Unknown status|Recruiting|N/A|400|Anticipated|Oslo University Hospital||3|||f||||t||||||||||2017-02-18 13:24:33.452597|2017-02-18 13:24:33.452597
NCT00840684|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2011-05-12|||January 2009||2009-01-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia|A PHASE I-II MULTICENTER STUDY OF THE CLORETAZINE-DAUNORUBICIN-ARACYTINE COMBINATION FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) WITH UNFAVORABLE CYTOGENETICS|Completed||Phase 1/Phase 2|135|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:24:33.570161|2017-02-18 13:24:33.570161
NCT00840671|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2010-12-27|||October 2005||2005-10-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|March 2008|Actual|2008-03-01||Interventional|CERE-LYSE-1||Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke|A Prospective, Randomised, Placebo Controlled, Double Blind Trial About Safety and Efficacy of Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke|Completed||Phase 3|119|Actual|Ever Neuro Pharma GmbH||2|||f||||f||||||||||2017-02-18 13:24:33.679753|2017-02-18 13:24:33.679753
NCT00840658|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2014-12-05|2012-07-02||October 2008||2008-10-01|December 2014|2014-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|FSW-IDU||Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico|Epidemiologic Study on Changing HIV Risks Among FSW-IDUs on the Mexico-US Border|Completed||Phase 2|584|Actual|University of California, San Diego|Observed important site differences at enrollment need to be considered in outcome analysis.|4|||f||||t||||||||||2017-02-18 13:24:33.823922|2017-02-18 13:24:33.823922
NCT00840645|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-08|2016-01-04|||December 2008||2008-12-01|January 2016|2016-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients|Long-term Study of YM178: Long Term Study of YM178 in Subjects With Overactive Bladder|Completed||Phase 3|204|Actual|Astellas Pharma Inc||1|||f||||f||||||||Undecided||2017-02-18 13:24:34.28547|2017-02-18 13:24:34.28547
NCT00840632|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-07-06|2009-07-06||October 2004||2004-10-01|July 2009|2009-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Trandolapril 4 mg Tablet Under Fasting Conditions|A Two-Way Crossover, Open-Label, Single-Dose, Fasting, Bioequivalence Study of Trandolapril 4 mg Tablets Versus Mavik® 4 mg Tablets in Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:34.400513|2017-02-18 13:24:34.400513
NCT00840619|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-09|||May 2008||2008-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:24:34.925801|2017-02-18 13:24:34.925801
NCT00840606|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-09|||December 2001||2001-12-01|February 2009|2009-02-01|April 2002|Actual|2002-04-01|December 2001|Actual|2001-12-01||Interventional|||Buspirone Hydrochloride 30mg Tablets, Fasting|A Relative Bioavailability Study of 30 mg Buspirone Hydrochloride Tablets Under Fasting Conditions|Completed||Phase 1|70|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:34.96939|2017-02-18 13:24:34.96939
NCT00840593|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2011-12-07|||February 2009||2009-02-01|December 2011|2011-12-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||A Prospective, Randomised Long-term Follow-up of Operative Versus Non-operative Treatment of Gr. 3 Acromioclavicular Dislocation|A Prospective, Randomised 18 -Year Follow-up Study of Operative and Non-operative Treatment of Acute, Total Acromioclavicular Dislocation.|Completed||N/A|39|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 13:24:35.066455|2017-02-18 13:24:35.066455
NCT00840580|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2012-07-19|||January 2009||2009-01-01|July 2012|2012-07-01||||September 2009|Actual|2009-09-01||Interventional|||Effect on Wound Healing of Vigamox Versus Cravit|Prospective, Randomized Study Comparing Effect on Wound Healing of Vigamox (Moxifloxacin 0.5% Ophthalmic Solution) and Cravit (Levofloxacin 0.5% Ophthalmic Solution) Administered Post-Surgically in Patients Undergoing Cataract Extraction|Completed||Phase 4|79|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:24:35.181458|2017-02-18 13:24:35.181458
NCT00840567|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2013-07-09|||February 2009||2009-02-01|July 2013|2013-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Skin and Blood Research Samples From Healthy Volunteers and Patients With Hematologic Diseases|Acquisition of Skin Biopsies and Blood Samples From Normal Volunteers and Patients With Benign, Inherited Hematologic Diseases for Research Purposes|Terminated||N/A|7|Actual|Washington University School of Medicine||2||"Key samples protocols will be provided by a collaborator and we were not able to produce IPS~   lines from human fibroblasts."|f||||f||||||||||2017-02-18 13:24:35.287494|2017-02-18 13:24:35.287494
NCT00840554|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-07-10|||February 2009||2009-02-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Effects of Adding a Home Exercise Program to a Clinical Physical Therapy Program on Cancer-Related Fatigue|The Effects of Adding a Home Exercise Program (HEP) to a Clinical Physical Therapy Program (CPTP) on the Cancer-Related Fatigue Reported by Patients Undergoing Concurrent Radiation and Chemotherapy for High-Grade Glioma (HGG)|Completed||N/A|20|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 13:24:35.401495|2017-02-18 13:24:35.401495
NCT00840541|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2014-04-04|||January 2009||2009-01-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2010|Actual|2010-01-01||Observational|||Phenotyping Diabetic Retinopathy|Observational Study of Type-2 Diabetic Subjects to Validate Diabetic Retinopathy Phenotypes|Completed||N/A|80|Actual|Association for Innovation and Biomedical Research on Light and Image|||1||f||||f||||||||||2017-02-18 13:24:35.504572|2017-02-18 13:24:35.504572
NCT00840528|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2016-09-08|||February 2002||2002-02-01|September 2016|2016-09-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|GARBOZ||Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans|Genetic Susceptibility TO Ozone-induced Bronchial Airway Inflammatory Responses In Humans|Active, not recruiting||N/A|200|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 13:24:35.596797|2017-02-18 13:24:35.596797
NCT00840515|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2009-05-05|||February 2009||2009-02-01|May 2009|2009-05-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Observational|||PraevoSkin Emulsion in the Prevention of Radiation Induced Dermatitis|A Phase 2,Double Blind Randomized Study of PraevoSkin,a Melatonin Containing Emulsion, in the Prevention of Radiation Induced Dermatitis.|Unknown status|Active, not recruiting|Phase 2|1|Anticipated|Pharm Olam Pharmaceuticals Ltd.|||1||f||||f||||||||||2017-02-18 13:24:35.706893|2017-02-18 13:24:35.706893
NCT00840502|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2016-02-12|||February 2009||2009-02-01|February 2016|2016-02-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Observational|UPS||Ultrasound Study in Pregnant Women With Malaria|Impact of Malaria Infection in Pregnancy on Fetal and Newborn Growth|Recruiting||N/A|400|Anticipated|University of Oxford|||1||f||||f||||||||||2017-02-18 13:24:35.781429|2017-02-18 13:24:35.781429
NCT00840489|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2013-01-30|||January 2009||2009-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|RIBACIR||Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis|Phase II Trial of Long-term Monotherapy With Ribavirin Against Colchicine on Progression of Chronic Hepatitis C With Advanced Fibrosis in Patients With Non-response to Standard Antiviral Therapy|Terminated||Phase 2|50|Actual|Hospital Universitario Ramon y Cajal||2||Preliminary analysis|f||||f||||||||||2017-02-18 13:24:35.874411|2017-02-18 13:24:35.874411
NCT00840476|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-09-01|2009-06-30||February 2004||2004-02-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Meloxicam 15 mg Tablets Under Fasting Conditions|A Two-way Crossover, Open-label, Single-dose, Fasting, Bioequivalence Study of Meloxicam 15 mg Tablets Versus Mobic® 15 mg Tablets in Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|28|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:35.98283|2017-02-18 13:24:35.98283
NCT00840463|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-06-10|||January 2009||2009-01-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan|Safety and Efficacy Trial Using Ambrisentan for Pulmonary Hypertension Associated With Congestive Heart Failure With Preserved Left Ventricular Ejection Fraction|Terminated||Phase 4|3|Actual|University of Texas Southwestern Medical Center||2||Poor enrolment|f||||t||||||||||2017-02-18 13:24:36.597245|2017-02-18 13:24:36.597245
NCT00840450|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2012-11-12|2011-08-18||April 2007||2007-04-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|April 2010|Actual|2010-04-01||Interventional|||Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin|Phase II Study of Paclitaxel With Imatinib Mesylate (Gleevec) in Taxane-pretreated Ovarian and Other Cancers of Mullerian Origin|Terminated||Phase 2|14|Actual|New York University School of Medicine|Premature closure led to small numbers of subjects analyzed (12 out of 50 targeted accrual number).|1||Due to slow accrual|f||||t||||||||||2017-02-18 13:24:36.718766|2017-02-18 13:24:36.718766
NCT00840437|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2013-12-03|||December 2008||2008-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|||Quality of Life in Patients With Refractory Angina|Health Status of Patients Enrolled in the OPTions In Myocardial Ischemic Syndrome Therapy (OPTIMIST) Program|Completed||N/A|90|Actual|Minneapolis Heart Institute Foundation|||1||f||||f||||||||||2017-02-18 13:24:37.022179|2017-02-18 13:24:37.022179
NCT00840411|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-09-01|2009-06-18||September 2002||2002-09-01|September 2009|2009-09-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions|A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Relative Bioavailability of a Test Extended Release Tablet Formulation of Clarithromycin (500 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Biaxin® XL Filmtab) in 66 Fasted, Healthy, Adult Subjects|Completed||Phase 1|66|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:37.118317|2017-02-18 13:24:37.118317
NCT00840398|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-09|||December 2001||2001-12-01|February 2009|2009-02-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Buspirone Hydrochloride 30mg Tablets, Non-Fasting|A Relative Bioavailability Study of 30 mg Buspirone Hydrochloride Tablets Under Non-Fasting Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:37.568547|2017-02-18 13:24:37.568547
NCT00840385|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2010-09-14|||November 2007||2007-11-01|September 2010|2010-09-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Interventional|FAD||Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL)|Phase II Study of Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed PTCL|Unknown status|Recruiting|Phase 2|30|Anticipated|Fudan University||1|||f||||f||||||||||2017-02-18 13:24:37.665759|2017-02-18 13:24:37.665759
NCT00840359|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-08|2011-08-15|||September 2009||2009-09-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis|Phase 2 Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis|Unknown status|Enrolling by invitation|Phase 2|44|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:24:37.883555|2017-02-18 13:24:37.883555
NCT00840346|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2016-05-16|||September 2009||2009-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|PANOBIDARA||Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML)|A Phase I/II Multicenter, National, Open-Label Study of Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML)|Completed||Phase 1/Phase 2|46|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 13:24:37.978904|2017-02-18 13:24:37.978904
NCT00840333|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2010-03-01|||April 2009||2009-04-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||"Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"|A Phase 1B, Multi-Center, Open Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MP-376 Inhalation Solution Given Daily for 14 Days to Stable Pediatric Cystic Fibrosis Patients.|Completed||Phase 1|27|Actual|Forest Laboratories|||2||f||||f||||||Samples Without DNA|"~     Serum and sputum samples for PK measurements~   "|||2017-02-18 13:24:38.100389|2017-02-18 13:24:38.100389
NCT00840320|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2013-02-28|||March 2009||2009-03-01|February 2013|2013-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Repeat Dose Safety Study for Compound to Treat Anemia|A Phase I, Randomized, Single-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Repeat Oral Doses of 1278863A in Healthy Subjects|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:24:38.205442|2017-02-18 13:24:38.205442
NCT00840307|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-05-26|||August 2008||2008-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Changes in Ectopic Fat Following Surgically Induced Weight Loss|Changes in Ectopic Fat Following Surgically Induced Weight Loss: Does it Explain the Resolution of Diabetes?|Completed||N/A|18|Actual|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-02-18 13:24:38.304119|2017-02-18 13:24:38.304119
NCT00840294|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2014-07-07|2014-07-07||January 2009||2009-01-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||Subjects with complete data are included|Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)|Randomized, Multi-Institution Trial of Ciprofloxacin Versus Observation for Men With an Elevated Prostate Specific Antigen (PSA)|Terminated||Phase 3|85|Actual|University of Chicago|Early termination due to poor accrual and interim futility analysis.|2||Combination of futility analysis and poor accrual|f||||f||||||||||2017-02-18 13:24:38.390309|2017-02-18 13:24:38.390309
NCT00840281|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-08-14|2009-06-18||September 2003||2003-09-01|August 2009|2009-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Cefprozil 500 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of Cefprozil 500 mg Tablets Under Fasting Conditions|Completed||Phase 1|38|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:38.819482|2017-02-18 13:24:38.819482
NCT00840268|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2014-07-15||2014-07-15|February 2009||2009-02-01|July 2014|2014-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients||Completed||Phase 2|427|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:24:39.248863|2017-02-18 13:24:39.248863
NCT00840255|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2012-06-15|||April 2009||2009-04-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|BBTIMVII||Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 2 (BBTIMVII)|Treatment of Insomnia in Military Veterans:Phase 2|Completed||N/A|40|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:24:39.346876|2017-02-18 13:24:39.346876
NCT00840242|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2012-04-24|||February 1999||1999-02-01|April 2012|2012-04-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Smoking Reduction or Cessation With Nicotine Replacement Therapy|Smoking Reduction or Cessation With Nicotine Replacement Therapy. A Placebo Controlled Double Blind Trial With Nicotine Gum or Inhaler.|Completed||Phase 3|314|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||f||||||||||2017-02-18 13:24:39.454105|2017-02-18 13:24:39.454105
NCT00840229|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-08|2013-11-24|||February 2009||2009-02-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Rotator Interval and Intra-articular Corticosteroid Injection for Frozen Shoulder|Rotator Interval and Intra-articular Corticosteroid Injection for Adhesive Capsulitis (Frozen Shoulder): a Randomised, Double Blind, Placebo Controlled Trial|Completed||N/A|122|Actual|Oslo University Hospital||3|||f||||f||||||||||2017-02-18 13:24:39.555866|2017-02-18 13:24:39.555866
NCT00840216|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-09-01|2009-06-18||August 2002||2002-08-01|September 2009|2009-09-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.|A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Relative Bioavailability of a Test Extended Release Tablet Formulation of Clarithromycin (500 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Biaxin® XL Filmtab) in 22 Fed, Healthy, Adult Subjects|Completed||Phase 1|22|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:39.666934|2017-02-18 13:24:39.666934
NCT00840203|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-09-01|2009-06-30||May 2003||2003-05-01|September 2009|2009-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Mesalamine 4 gm/60 mL Rectal Enema|A Study to Evaluate the Relative Bioavailability of Two Mesalamine 4 gm/60 mL Rectal Enema Formulations|Completed||Phase 1|72|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:40.081104|2017-02-18 13:24:40.081104
NCT00840190|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-11-20|||December 2008||2008-12-01|November 2012|2012-11-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Interventional|Serenity||A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies|An Open Label, Multicenter Phase I Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies|Completed||Phase 1|29|Actual|Piramal Enterprises Limited||1|||f||||f||||||||||2017-02-18 13:24:40.814169|2017-02-18 13:24:40.814169
NCT00840177|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2017-01-04|||August 2009||2009-08-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|December 2018|Anticipated|2018-12-01||Interventional|||S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia|S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)|Recruiting||Phase 2|110|Anticipated|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 13:24:40.932271|2017-02-18 13:24:40.932271
NCT00840164|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-08|2011-10-13|||February 2009||2009-02-01|August 2011|2011-08-01|December 2013|Anticipated|2013-12-01|December 2011|Anticipated|2011-12-01||Observational|||Pathology of Skin, Nerve and Vasculature in the Amputated Limb of Diabetes|Pathology of Skin, Nerve and Vasculature in the Amputated Limb of Diabetes|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     After amputation, sural nerve, posterior tibial nerve, and the accompanying vasculature will~     be harvested from the amputated leg. 3mm-puch skin will be taken from the amputated leg, 10~     cm above the lateral malleolus.~   "|||2017-02-18 13:24:41.219897|2017-02-18 13:24:41.219897
NCT00840151|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2014-11-06|||January 2009||2009-01-01|November 2014|2014-11-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A SMART Design for Attendance-based Prize CM|A SMART Design for Attendance-based Prize CM|Completed||Phase 2|360|Actual|UConn Health||4|||f||||f||||||||||2017-02-18 13:24:41.309616|2017-02-18 13:24:41.309616
NCT00840138|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-09|||January 1996||1996-01-01|February 2009|2009-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||A Comparison of Bile Duct Injuries Following Open Cholecystectomy Versus Laparoscopic Cholecystectomy|Comparison of Iatrogenic Common Bile Duct Injuries Following Open Cholecystectomy vs Laparoscopic Cholecystectomy|Unknown status|Active, not recruiting|N/A|70|Actual|Centre of Postgraduate Medical Education|||2||f||||f||||||||||2017-02-18 13:24:41.4052|2017-02-18 13:24:41.4052
NCT00840125|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2012-10-29|||February 2009||2009-02-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|December 2010|Actual|2010-12-01||Interventional|||Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment|A Phase II Open-Label Study Designed to Evaluate the Efficacy and Safety, of Erlotinib in Combination With Docetaxel in Selected Non Small Cell Lung Cancer Patients Eligible for First Line Treatment|Completed||Phase 2|4|Actual|Meir Medical Center||1|||f||||t||||||||||2017-02-18 13:24:41.483912|2017-02-18 13:24:41.483912
NCT00840112|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2015-10-20|||July 2010||2010-07-01|July 2010|2010-07-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|||Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy|Vitamin E Treatment for LCHAD Associated Neuropathy|Terminated||N/A|1|Actual|Oregon Health and Science University||1||New data does not support a role of vitamin E in LCHAD associated neuropathy.|f||||f||||||||||2017-02-18 13:24:41.703321|2017-02-18 13:24:41.703321
NCT00840099|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-07-08|2009-05-18||August 2002||2002-08-01|July 2009|2009-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions|An Open-Label, Single-Dose, Two-Way Crossover Bioequivalence Study of Two Oral Suspension Formulations of Amoxicillin/Clavulanate Potassium, 600/42.9 mg/5 mL in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|48|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:42.02341|2017-02-18 13:24:42.02341
NCT00840086|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-01-07|2013-11-14||April 2009||2009-04-01|January 2015|2015-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|guardian™1||Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects|A Multi-centre, Open-label, Non-controlled Trial on Safety and Efficacy of N8 in Prevention and Treatment of Bleeds in Previously Treated Subjects With Haemophilia A. Sub-trial: Safety and Efficacy of N8 in Prevention and Treatment of Bleeding During Surgical Procedures in Subjects With Haemophilia A|Completed||Phase 3|150|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 13:24:42.528838|2017-02-18 13:24:42.528838
NCT00840073|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-07-06|2009-07-06||October 2004||2004-10-01|July 2009|2009-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Trandolapril 4 mg Tablet Under Non-Fasting Conditions|A Single-Dose, Comparative Bioavailability Study of Two Formulations of Trandolapril 4 mg Tablets Under Fed Conditions.|Completed||Phase 1|50|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:42.925894|2017-02-18 13:24:42.925894
NCT00840060|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2012-05-14|2012-04-13||January 2009||2009-01-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|AMALS||Efficacy of AMALS in Treating Language Impairment in Children|AMALS: Addressing Multiple Aspects of Language Simultaneously: A Randomized Clinical Trial|Completed||Phase 2|40|Actual|Lamar University|Problems with stratification according to dialect prior to randomization lead to difficulty interpreting results related to dialect|2|||f||||t||||||||||2017-02-18 13:24:43.411944|2017-02-18 13:24:43.411944
NCT00840047|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2017-01-05|||May 2009||2009-05-01|January 2017|2017-01-01|May 2023|Anticipated|2023-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Methionine PET/CT Studies In Patients With Cancer|Methionine PET/CT Studies In Patients With Cancer|Recruiting||N/A|650|Anticipated|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 13:24:43.811746|2017-02-18 13:24:43.811746
NCT00840034|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2010-10-25||2010-10-25|February 2009||2009-02-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder|A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment|Completed||Phase 2|227|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:24:43.935441|2017-02-18 13:24:43.935441
NCT00840008|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2011-08-25|||September 2008||2008-09-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|REASON-II||The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding|The Dissemination of Consensus Recommendations on the Management of Canadian Patients With Non Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of a Multifaceted Tailored Implementation Strategy|Completed||Phase 4|3157|Actual|McGill University Health Center||2|||f||||f||||||||||2017-02-18 13:24:44.061363|2017-02-18 13:24:44.061363
NCT00839995|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-03-02|||February 2009||2009-02-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Observational|ROTEM||Use of ROTEM for Multi-level Spine Surgery|A Prospective Observational Study to Evaluate Perioperative Coagulation Profiles Using Rotational Thromboelastometry (ROTEM®) in Patients Undergoing Multi-level Spine Surgery|Completed||N/A|41|Actual|Weill Medical College of Cornell University|||1||f||||f||||||Samples With DNA|"~     a small sample of blood will be obtained from a pre-existing arterial line.~   "|||2017-02-18 13:24:44.222427|2017-02-18 13:24:44.222427
NCT00839982|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2013-08-06|||November 2008||2008-11-01|August 2013|2013-08-01||||December 2012|Actual|2012-12-01||Interventional|||Clofarabine and Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes That Have Relapsed or Not Responded to Treatment|Study of Oral Clofarabine Plus Low-dose Cytarabine in Previously Treated AML and High-Risk MDS Patients at Least 60 Years of Age|Completed||Phase 1/Phase 2|35|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 13:24:44.451315|2017-02-18 13:24:44.451315
NCT00839969|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-09|||January 2009||2009-01-01|February 2009|2009-02-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding|A Randomized Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding.|Unknown status|Recruiting|N/A|30|Anticipated|Medway NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:24:44.571791|2017-02-18 13:24:44.571791
NCT00839956|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-07|2016-08-29|||February 2009||2009-02-01|August 2016|2016-08-01||||August 2012|Actual|2012-08-01||Interventional|||Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant|Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant for Multiple Myeloma|Active, not recruiting||Phase 2|31|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 13:24:44.675321|2017-02-18 13:24:44.675321
NCT00839943|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-08-24|||May 2006||2006-05-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|OBOZ||Effect Of Obesity On Ozone-Induced Airway Inflammation|Effect Of Obesity On Ozone-Induced Airway Inflammation|Completed||N/A|40|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 13:24:44.786314|2017-02-18 13:24:44.786314
NCT00839930|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-09-01|2009-06-18||February 2004||2004-02-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Cilostazol 50 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 50 mg Cilostazol Tablets Under Fasting Conditions|Completed||Phase 1|30|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:24:44.892891|2017-02-18 13:24:44.892891
NCT00839917|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-10-01|2012-09-07||February 2008||2008-02-01|October 2015|2015-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study of ProQuad™ in Healthy Children in Korea (V221-023)|A Multicenter, Randomized, Open-Label Study to Compare the Immunogenicity, Safety, and Tolerability of Measles, Mumps, Rubella, and Varicella of Combination Vaccine ProQuad With Concomitant Administration of M-M-R II and VARIVAX in Healthy Korean Children|Terminated||Phase 3|30|Actual|Merck Sharp & Dohme Corp.|Formal testing of the study hypotheses was not possible because of low enrollment|2||"Study terminated early because of insufficient enrollment before expiration date of the~   investigational vaccine lot"|f||||t||||||||||2017-02-18 13:24:45.326705|2017-02-18 13:24:45.326705
NCT00839904|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-08|2013-07-29|||February 2010||2010-02-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Physical Activity and Health of Children With Cancer in Remission|The Effect of Physical Activity on the Mental and Physical Health of Children With Cancer in Remission|Completed||N/A|22|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:24:45.936261|2017-02-18 13:24:45.936261
NCT00839891|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-01-20|||February 2009||2009-02-01|January 2010|2010-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|TQT||A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers|A Phase 1 Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group/Crossover Thorough QT/QTc Study to Evaluate the Effect of a Therapeutic Dose and a Supra-therapeutic Dose of VI-0521 on Cardiac Repolarization in Healthy Male and Female Volunteers|Completed||Phase 1|112|Actual|VIVUS, Inc.||1|||f||||f||||||||||2017-02-18 13:24:46.014863|2017-02-18 13:24:46.014863
NCT00839878|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2016-10-13|||March 2009||2009-03-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|DiabCare Asia||A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Bangladesh|A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia and To Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in Asia DiabCare Asia 2008 (Bangladesh)|Completed||N/A|2092|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"~     Blood sample~   "|||2017-02-18 13:24:46.112631|2017-02-18 13:24:46.112631
NCT00839865|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-09|||November 2008||2008-11-01|February 2009|2009-02-01|March 2011|Anticipated|2011-03-01|November 2010|Anticipated|2010-11-01||Interventional|||Trial of Herb Yuyang Ointment to Diabetic Foot Ulcer|Phase 1 Study of Herb Yuyang Ointment That Expressed Good Effect in Diabetic Foot Ulcer|Unknown status|Recruiting|Phase 2|100|Anticipated|Guiyang No.1 People's Hospital||2|||t||||t||||||||||2017-02-18 13:24:46.211733|2017-02-18 13:24:46.211733
NCT00839852|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2011-09-13||2011-09-13|May 2009||2009-05-01|September 2011|2011-09-01||||August 2010|Actual|2010-08-01||Interventional|||The Purpose of the Study is to Determine Whether Cariprazine is a Safe and Tolerated Long-term Treatment in Patients With Chronic Stable Schizophrenia|A Long-Term, Open-label Extension Study of the Safety and Tolerability of RGH-188 (Cariprazine) in Patients With Schizophrenia|Completed||Phase 2|93|Actual|Forest Laboratories||1|||f||||||||||||||2017-02-18 13:24:46.325006|2017-02-18 13:24:46.325006
NCT00839839|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2015-12-01|||February 2009||2009-02-01|December 2015|2015-12-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||Egg Freezing Pilot Study|Oocyte Cryopreservation in Assisted Reproduction|Completed||N/A|10|Actual|University Reproductive Associates||1|||f||||f||||||||||2017-02-18 13:24:46.476159|2017-02-18 13:24:46.476159
NCT00839826|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2014-12-15|||December 2002||2002-12-01|December 2014|2014-12-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|ODiXaHip||ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial|Oral Direct Factor Xa Inhibitor BAY 59-7939 in the Prevention of VTE in Patients Undergoing Total Hip Replacement. ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial|Completed||Phase 2|641|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:24:46.577417|2017-02-18 13:24:46.577417
NCT00839813|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2011-04-04|||November 2008||2008-11-01|April 2011|2011-04-01|May 2011|Anticipated|2011-05-01|May 2011|Anticipated|2011-05-01||Interventional|||Efficacy of Yoga for Treatment-Resistant Posttraumatic Stress Disorder|Efficacy of Yoga for Treatment-Resistant PTSD|Unknown status|Recruiting|N/A|64|Anticipated|Justice Resource Institute||2|||f||||t||||||||||2017-02-18 13:24:46.71666|2017-02-18 13:24:46.71666
NCT00839800|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-11-26|2012-02-21||February 2009||2009-02-01|November 2012|2012-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|SAKURA||Study to Investigate the Efficacy of Symbicort® SMART.|A Comparison of Symbicort® SMART (160/4.5μg) and Symbicort® Turbuhaler 160/4.5 μg, Plus Terbutaline Turbuhaler 0.4 mg as Needed, for Treatment of Asthma - a 12-month, Randomized, Double-blind, Parallel Group, Active-controlled, Multinational Phase III Study in Asthmatic Patients From 16 Years|Completed||Phase 3|2091|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:24:46.902399|2017-02-18 13:24:46.902399
NCT00839787|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-09|||December 2008||2008-12-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||The Effect of Pain Medication in Children With Acute Abdominal Pain and Its Implication Over the Surgeon's Decision|The Effect of Opiate Administration in Children With Acute Abdominal Pain and Peritoneal Signs on the Decision for Surgical Intervention|Unknown status|Active, not recruiting|N/A|500|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 13:24:47.857537|2017-02-18 13:24:47.857537
NCT00839774|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-06-18|||February 2007||2007-02-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Pulse Fractions on Indices on Cardiovascular Disease and Diabetes Risk Factors|Effect of Pulse Fractions on Indices of Lipid, Carbohydrate and Energy Metabolism as Well as Oxidative Status in Overweight, Hyperlipidemic Individuals|Completed||Phase 2|23|Actual|University of Manitoba||3|||f||||f||||||||||2017-02-18 13:24:47.95859|2017-02-18 13:24:47.95859
NCT00839761|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-09|2009-02-09|||December 2006||2006-12-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Use of Ultra Rice Compared to Iron Drops Consumed by Anemic Children|Efficacy of Iron Fortified Ultra Rice Compared to Supplemental Iron Drops in Infants and Young Children|Completed||N/A|175|Actual|Federal University of Minas Gerais||2|||f||||t||||||||||2017-02-18 13:24:48.06023|2017-02-18 13:24:48.06023
NCT00839748|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2013-11-18|||February 2004||2004-02-01|November 2013|2013-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||The Ohio State University Asthma Registry|The Ohio State University Asthma Registry|Unknown status|Recruiting|N/A|500|Anticipated|Ohio State University|||1||f||||f||||||||||2017-02-18 13:24:48.150336|2017-02-18 13:24:48.150336
NCT00839735|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-06|||February 2009||2009-02-01|February 2009|2009-02-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Observational|||Trefoil Peptides in Lung Diseases|Trefoil Peptides in Lung Diseases|Unknown status|Recruiting|N/A|60|Anticipated|Bispebjerg Hospital|||3||f||||||||||||||2017-02-18 13:24:48.238221|2017-02-18 13:24:48.238221
NCT00839722|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-10-12|||February 2009||2009-02-01|June 2011|2011-06-01|July 2012|Actual|2012-07-01|July 2011|Actual|2011-07-01||Interventional|EFU||Fertility After Uterine Artery Embolisation for the Treatment of Leiomyomas|Fertility After Uterine Artery Embolisation for the Treatment of Leiomyomas|Completed||Phase 2|16|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 13:24:48.324157|2017-02-18 13:24:48.324157
NCT00839709|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2011-03-01|||March 2009||2009-03-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|September 2010|Actual|2010-09-01||Observational|||Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols|Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion vs. Non-depletion Protocols|Completed||N/A|30|Anticipated|University of Washington|||2||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 13:24:48.422244|2017-02-18 13:24:48.422244
NCT00839696|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2014-12-05|||July 2008||2008-07-01|December 2014|2014-12-01|April 2010|Actual|2010-04-01|June 2009|Actual|2009-06-01||Observational|||Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk|Total Xonoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Risk|Completed||Phase 4|270|Actual|University of Wisconsin, Madison|||1||f||||f||||||Samples Without DNA|"~     Serum Xenoestrogen~   "|||2017-02-18 13:24:48.51095|2017-02-18 13:24:48.51095
NCT00839683|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-10-14|||February 2009||2009-02-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects|Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects|Completed||Phase 1|24|Actual|AstraZeneca||5|||f||||f||||||||||2017-02-18 13:24:48.59015|2017-02-18 13:24:48.59015
NCT00839670|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-01-09|||February 2009||2009-02-01|February 2009|2009-02-01|June 2011|Actual|2011-06-01|November 2010|Actual|2010-11-01||Interventional|LICITE||Light Constraint Induced Therapy Experiment|Effects of a Modified Constraint Induced Therapy Intervention in Stroke Patients: A Multicenter, Randomized Controlled Trial.|Terminated||Phase 3|34|Actual|Assistance Publique - Hôpitaux de Paris||2||departure of the investigator coordinator into other country|f||||f||||||||||2017-02-18 13:24:48.702708|2017-02-18 13:24:48.702708
NCT00839657|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2016-04-19|||September 2009||2009-09-01|May 2013|2013-05-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|COAG||Clarification of Optimal Anticoagulation Through Genetics|A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients|Completed||Phase 3|1015|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 13:24:48.811235|2017-02-18 13:24:48.811235
NCT00839644|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2012-10-01|||December 1999||1999-12-01|October 2012|2012-10-01|June 2003|Actual|2003-06-01|December 2002|Actual|2002-12-01||Interventional|||Airway Secretion Clearance in Cystic Fibrosis|Airway Secretion Clearance in Cystic Fibrosis|Terminated||N/A|166|Actual|University of Colorado, Denver||3||High dropout, problems recruiting, and smaller than expected decline in FEV1.|f||||t||||||||||2017-02-18 13:24:48.933502|2017-02-18 13:24:48.933502
NCT00839631|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-04-30|||March 2009||2009-03-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors|A Phase 1, Open Label, Dose Escalation Study Evaluating the Safety and Pharmacokinetics of Enteric Coated D-3263 Hydrochloride in Subjects With Advanced Solid Tumors|Completed||Phase 1|23|Actual|Dendreon||1|||f||||f||||||||||2017-02-18 13:24:49.046072|2017-02-18 13:24:49.046072
NCT00839605|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-10-03|||March 2009||2009-03-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|Dex-One-Lung||Dexmedetomidine and Hypoxic Pulmonary Vasoconstriction in Thoracic Surgical Procedures and One-Lung Ventilation|Dexmedetomidine and Hypoxic Pulmonary Vasoconstriction in Thoracic Surgical Procedure and One-Lung Ventilation(OLV)|Completed||N/A|25|Actual|University of Missouri-Columbia|||2||f||||f||||||||No||2017-02-18 13:24:49.128051|2017-02-18 13:24:49.128051
NCT00839566|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2017-02-14|||November 2008||2008-11-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|PAF-HEFT||PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)|Permanent Atrial Fibrillation in Heart Failure Trial|Terminated||Phase 4|12|Actual|Medtronic Bakken Research Center||3||Number of eligible patients too small.|f||||f||||||||No|"Not applicable as NO is selected above for 'Plan to share IPD?"|2017-02-18 13:24:49.441982|2017-02-18 13:24:49.441982
NCT00839553|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-06|||April 2007||2007-04-01|February 2009|2009-02-01|April 2009|Anticipated|2009-04-01|||||Interventional|||Intrapleural Minocycline After Aspiration of Spontaneous Pneumothorax|Intrapleural Minocycline After Manual Aspiration for the Prevention of Primary Spontaneous Pneumothorax. A Phase III Multicenter Prospective Randomized Controlled Trial|Unknown status|Recruiting|N/A|100|Anticipated|Far Eastern Memorial Hospital|||||f||||t||||||||||2017-02-18 13:24:49.536842|2017-02-18 13:24:49.536842
NCT00839540|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-02-27|2012-01-23||December 2008||2008-12-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins|Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins in Patients With Presumptive Candidemia|Completed||Phase 4|21|Actual|Michigan State University||3|||f||||f||||||||||2017-02-18 13:24:49.621125|2017-02-18 13:24:49.621125
NCT00839527|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-11-18|2014-04-24||February 2009||2009-02-01|November 2016|2016-11-01|April 2013|Actual|2013-04-01|January 2012|Actual|2012-01-01||Interventional|||A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes|A Randomized, Double-blind, Placebo and Active-Controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and With Metformin Plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|685|Actual|GlaxoSmithKline||3|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:24:50.180092|2017-02-18 13:24:50.180092
NCT00839514|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-06-06|||February 2009||2009-02-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|TCE||Trichloroethylene (TCE) Exposure in an Industrial Population|Evaluation of Parkinson Disease Symptoms in Trichloroethylene Exposed Patients in an Industrial Population|Completed||N/A|27|Actual|University of Kentucky|||1||f||||f||||||||||2017-02-18 13:24:52.012142|2017-02-18 13:24:52.012142
NCT00839501|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2012-01-19|||December 2008||2008-12-01|January 2012|2012-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome|Therapeutic Trial of Potassium and Acetazolamide in Andersen-Tawil Syndrome|Terminated||Phase 1|3|Actual|University of Rochester||1||Unable to recruit sufficient number of participants|f||||t||||||||||2017-02-18 13:24:52.103723|2017-02-18 13:24:52.103723
NCT00839488|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2013-10-12|||April 2008||2008-04-01|October 2013|2013-10-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis|Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis in Patients After Major Abdominal Surgery|Terminated||Phase 4|6|Actual|Far Eastern Memorial Hospital||2||the chief of GS left the hopsital and the successor did't want to keep on this study|f||||t||||||||||2017-02-18 13:24:52.20682|2017-02-18 13:24:52.20682
NCT00839475|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2010-03-22|||June 2008||2008-06-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|November 2008|Actual|2008-11-01||Observational|||Investigation of the Uterine Cervix Using CervicalMD|Investigational Study: Imaging the Uterine Cervix Using C30 Investigational Device|Completed||N/A|26|Actual|STI-Medical Systems|||1||f||||f||||||Samples Without DNA|"~     LEEP specimens~   "|||2017-02-18 13:24:52.32316|2017-02-18 13:24:52.32316
NCT00839462|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2013-10-18|||September 2007||2007-09-01|October 2013|2013-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy of Dexpanthenol in Thermic Erythema|Evaluation of the Effect of Bepanthen Burn Relief Foam Spray New Formula on a Thermic Erythema. Equivalence Trial. Intra-individual Design.|Completed||Phase 2|55|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:24:52.385175|2017-02-18 13:24:52.385175
NCT00839449|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-09-01|||December 2004||2004-12-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|EVAS||Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study|Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study (EVAS): Effect of Eicosapentaenoic Acid on Cerebral Vasospasm Following Subarachnoid Hemorrhage|Completed||Phase 4|200|Actual|Yamaguchi University Hospital||2|||f||||t||||||||||2017-02-18 13:24:52.568438|2017-02-18 13:24:52.568438
NCT00839436|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-10-14|2015-10-14||February 2009||2009-02-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|May 2014|Actual|2014-05-01||Interventional|||Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)|Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)|Terminated||Phase 1/Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)||3||Bankruptcy of Drug manufacturer: Drug not available|f||||t||||||||||2017-02-18 13:24:52.704992|2017-02-18 13:24:52.704992
NCT00839423|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2014-04-22|2013-10-28||August 2006||2006-08-01|April 2014|2014-04-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults|Double-blind, Randomised, Placebo-controlled Study Comparing the Efficacy and Safety of Two Fixed Dosages of a Novel Antidepressant Compound to That of Placebo in Patients With Major Depressive Disorder|Completed||Phase 2|426|Actual|H. Lundbeck A/S||4|||f||||f||||||||||2017-02-18 13:24:53.609519|2017-02-18 13:24:53.609519
NCT00839410|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2016-02-10|||September 2003||2003-09-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|Melan-Cohort||Multicentric Cohort of Melanoma Patients in Ile de France Area|Multicentric Cohort of Melanoma Patients in Ile de France Area|Active, not recruiting||N/A|1255|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"~     DNA,RNA,SERUM,PLASMA,PROTEOMICS~   "|||2017-02-18 13:24:54.560309|2017-02-18 13:24:54.560309
NCT00839397|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2014-03-06|||May 2002||2002-05-01|March 2014|2014-03-01|June 2005|Actual|2005-06-01|November 2004|Actual|2004-11-01||Interventional|||BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder|BRL29060A in Posttraumatic Stress Disorder|Completed||Phase 3|52|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 13:24:54.647538|2017-02-18 13:24:54.647538
NCT00839384|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-23|||February 2009||2009-02-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Interventional|||AdvisaTM IPG Clinical Evaluation Study|Clinical Study to Evaluate System Safety and Clinical Performance of the AdvisaTM IPG|Unknown status|Recruiting|N/A|80|Anticipated|Medtronic Bakken Research Center||1|||f||||f||||||||||2017-02-18 13:24:54.739137|2017-02-18 13:24:54.739137
NCT00839371|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-06|||January 2005||2005-01-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Bronchoscopy and Bispectral Index (BIS) - Guided Sedation|Bronchoscopy Under Titrated Sedation With Propofol or Midazolam: a Randomized Trial.|Completed||Phase 4|84|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 13:24:54.836336|2017-02-18 13:24:54.836336
NCT00839358|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2016-08-17|||August 2008||2008-08-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|MACHT||Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation|Midodrine and Albumin for Cirrhotic Patients in the Waiting List for Liver Transplantation|Completed||Phase 4|199|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 13:24:54.942515|2017-02-18 13:24:54.942515
NCT00839345|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-09||||||February 2009|2009-02-01||||||||Expanded Access|||Clopidogrel Resistance and the Possibility of Its Affection|Resistance to Antiplatelet Agents, Its Etiology and the Possibility of Its Affection|Temporarily not available||N/A|||Charles University, Czech Republic|||||f||||||||||||||2017-02-18 13:24:55.06867|2017-02-18 13:24:55.06867
NCT00839332|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2014-04-14||2014-04-14|March 2009||2009-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|||A Study for Patients With Pancreatic Cancer|A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination With Gemcitabine in Patients With Pancreatic Cancer|Completed||Phase 1/Phase 2|125|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 13:24:55.168271|2017-02-18 13:24:55.168271
NCT00839319|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-12-09|2010-10-15||March 2009||2009-03-01|December 2015|2015-12-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|HOP-3||HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone|Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3)|Completed||Phase 1/Phase 2|59|Actual|University of Washington||5|||f||||f||||||||||2017-02-18 13:24:55.326292|2017-02-18 13:24:55.326292
NCT00839306|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-01-11|2015-06-08||August 2008||2008-08-01|January 2016|2016-01-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)|A Randomized Double-Blind Parallel Study of Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|240|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 13:24:56.376995|2017-02-18 13:24:56.376995
NCT00839293|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-10-14|||February 2009||2009-02-01|September 2010|2010-09-01||||March 2009|Actual|2009-03-01||Interventional|||Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules|Comparison of Fenofibric Acid Bioavailability From 45 mg and 135 mg Strength ABT-335 Capsules|Completed||Phase 1|32|Anticipated|Abbott||2|||f||||||||||||||2017-02-18 13:24:56.710078|2017-02-18 13:24:56.710078
NCT00839280|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2014-10-14|||August 2007||2007-08-01|October 2014|2014-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Moisturizing Effect of Two Dexpanthenol Formulations|Evaluation of the Moisturizing Effect of Bepanthen Burn Relief Foam Spray New Formula Versus Bepanthen Burn Relief Foam Spray (Current Formula). Equivalence Trial. Intra-individual Design.|Completed||Phase 2|19|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:24:56.814561|2017-02-18 13:24:56.814561
NCT00839267|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-09|||June 2006||2006-06-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|||||Observational|||Clopidogrel Efficacy and Acute Coronary Syndromes|The Comparison of Clopidogrel Efficacy in Patients With Acute Myocardial Infarction and Severe Hemodynamic Instability to Patients With Hemodynamically Uncomplicated Myocardial Infarction|Completed||N/A|40|Actual|Charles University, Czech Republic|||2||f||||f||||||Samples Without DNA|"~     Whole blood~   "|||2017-02-18 13:24:56.926427|2017-02-18 13:24:56.926427
NCT00839254|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2017-01-09||2013-02-14|February 2009||2009-02-01|January 2017|2017-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A|Impact on Nasopharyngeal Carriage, Acute Otitis Media, Immunogenicity and Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A|Completed||Phase 3|6181|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:24:57.022584|2017-02-18 13:24:57.022584
NCT00839241|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-09-27|2010-07-19||January 2009||2009-01-01|September 2012|2012-09-01||||July 2009|Actual|2009-07-01||Interventional|||"A Clinical Study to Investigate if Transfusion of Patients Own Shed Blood Improves the Immunological Status in Comparison to Transfusion of Donor Blood (Bank Blood)"|An Open , Prospective, Randomized, Parallel Group Study to Investigate Whether Postoperatively Collected and Transfused Autologous Whole Blood Improves the Immunological Status in Comparison to Allogenic Blood Transfusion in Patients Undergoing Total Knee Replacement|Completed||N/A|45|Actual|Wellspect HealthCare||2|||f||||f||||||||||2017-02-18 13:24:57.164473|2017-02-18 13:24:57.164473
NCT00839228|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-11-04|||March 2009||2009-03-01|November 2015|2015-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome|Randomised Double Blind Placebo Controlled Trial of Perhexiline in Heart Failure With Preserved Ejection Fraction Syndrome (HFpEF)|Completed||Phase 2|70|Anticipated|University of Aberdeen||2|||f||||t||||||||||2017-02-18 13:25:00.488721|2017-02-18 13:25:00.488721
NCT00839202|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2017-01-31|||September 2006||2006-09-01|January 2017|2017-01-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay|Pharmacokinetic (PK) Analysis of a Novel Immunoassay in Hemophilia A|Completed||N/A|7|Actual|Children's Hospital Los Angeles||1|||f||||f||||||||No||2017-02-18 13:25:00.601897|2017-02-18 13:25:00.601897
NCT00839189|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-12-08|||October 2002||2002-10-01|December 2009|2009-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults|Safety Study To Determine the Effect of a 10,000 EU Dose of Clinical Center Reference Endotoxin in Allergic and Mildly Asthmatic Adults|Completed||Phase 1|11|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 13:25:00.711224|2017-02-18 13:25:00.711224
NCT00839176|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2013-11-18|||January 2009||2009-01-01|November 2013|2013-11-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)|A Double-blinded, Randomized, Placebo-controlled, Dose-Exploring Study of RX-10100 When Given for Eight Consecutive Weeks to Subjects With Major Depression Disorder (MDD)|Completed||Phase 2|118|Actual|Rexahn Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 13:25:00.817444|2017-02-18 13:25:00.817444
NCT00839163|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2014-10-27|||March 2004||2004-03-01|October 2014|2014-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)|ODIXa-DVTA Prospective, Randomized, Multinational, Multicenter, Partially Blinded, Parallel-group, Open-label Active Comparator Controlled Phase II Dose Finding and Proof of Principle Trial.|Completed||Phase 2|613|Actual|Bayer||5|||f||||t||||||||||2017-02-18 13:25:01.127257|2017-02-18 13:25:01.127257
NCT00839150|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2011-09-16|||May 2005||2005-05-01|June 2009|2009-06-01|May 2007|Actual|2007-05-01|January 2007|Actual|2007-01-01||Observational|NEURODIAB||Retinal Function in Diabetic Patients Without Retinopathy|Assessment of Retinal Functional Abnormalities in Diabetic Patients Without Retinopathy|Completed||N/A|56|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||||||2017-02-18 13:25:01.345751|2017-02-18 13:25:01.345751
NCT00839137|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-05-26|||December 2003||2003-12-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|ETA||Exercise Therapy for Asthma (ETA Trial)|Exercise Therapy for Asthma (ETA Trial)|Terminated||N/A|13|Actual|Ohio State University|||2|Study proved difficult to recruit|f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 13:25:01.443928|2017-02-18 13:25:01.443928
NCT00839124|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-12-04|||January 2009||2009-01-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|Endomac||A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals|A Study of Inhalation of 20,000 EU Clinical Center Reference Endotoxin in Normal Volunteers Compared to Allergic Asthmatic Individuals|Completed||Phase 1|32|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 13:25:01.539121|2017-02-18 13:25:01.539121
NCT00839111|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-09-14|||November 2008||2008-11-01|September 2010|2010-09-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Interventional|||Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment|A Phase Ⅱ Open Label, Non Randomized Study, in Which Sorafenib is Used in Combination With Irinotecan, Leucovorin and Fluorouracil in Patients With Advanced Colorectal Cancer After Failure of Oxaliplatin Treatment|Unknown status|Recruiting|Phase 2|43|Anticipated|Fudan University||1|||f||||f||||||||||2017-02-18 13:25:01.661788|2017-02-18 13:25:01.661788
NCT00839098|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2016-01-05|2015-03-09||November 2011||2011-11-01|January 2016|2016-01-01|November 2014|Actual|2014-11-01|December 2013|Actual|2013-12-01||Interventional||"The average age of the participants was 53.2 years old (+/- 14.0 years old). Twelve out of 28 were female (42.9%). Two of the participants were veterans, and one of them was recruited from VA Wheelchair Seating clinic.~Arm 1 (control group) was removed from the study through IRB modification because of difficulties in recruiting participants."|Powered Seating Function Usage Among Veterans - Compliance and Coaching|Powered Seating Function Usage Among Veterans - Compliance and Coaching|Completed||N/A|28|Actual|VA Office of Research and Development|It was difficult to recruit power wheelchair users to participate in the study. Participants withdrew from the study because the study wheelchair could not meet their needs, or they could not use the Virtual Seating Coach independently.|3|||f||||f||||||||||2017-02-18 13:25:01.832357|2017-02-18 13:25:01.832357
NCT00839085|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-02-09|||November 2008||2008-11-01|February 2009|2009-02-01|March 2009|Anticipated|2009-03-01|January 2009|Anticipated|2009-01-01||Interventional|||Comparison of Ascorbic Acid and Grape Seed Extract in Oxidative Stress Induced by on Pump Heart Surgery|"Effect of Ascorbic Acid and Grape Seed Extract Vitis Vinifera L. in Oxidative Stress Induced by on Pump Coronary Artery by Pass Grafting Surgery"|Unknown status|Active, not recruiting|N/A|72|Actual|Tabriz University||3|||f||||f||||||||||2017-02-18 13:25:02.469761|2017-02-18 13:25:02.469761
NCT00839072|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-04-24|2010-06-22||February 2009||2009-02-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult Volunteers|Crossover Comparative Bioavailability Study of Trazodone Contramid(r) OAD 300 mg Extended-release Caplets and Desyrel(r) 100 mg Immediate-release Tablets in Healthy Adult Volunteers Under Fasting Conditions|Completed||Phase 1|24|Actual|Labopharm Inc.||2|||f||||f||||||||||2017-02-18 13:25:02.593504|2017-02-18 13:25:02.593504
NCT00839059|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2011-07-28|||January 2009||2009-01-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Lenalidomide In Patients With Acute Myeloid Leukemia|Open-Label, Multi-Center Phase I Dose-Escalation Study With Lenalidomide In Patients With Acute Myeloid Leukemia|Terminated||Phase 1|14|Actual|University of Ulm||1||"Results of an interim analysis and a hardly ongoing enrolment in the last 10 months in all six~   participating centres"|f||||t||||||||||2017-02-18 13:25:03.249654|2017-02-18 13:25:03.249654
NCT00839046|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2011-08-18|||August 2007||2007-08-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|CAAA||A Community-based Participatory Research (CBPR) Intervention for Childhood Asthma Using Air Filters and Air Conditioners|A Community Based Participatory Research Intervention for Childhood Asthma Using Air Filters and Air Conditioners|Completed||Phase 3|126|Actual|University of Michigan||3|||f||||t||||||||||2017-02-18 13:25:03.368555|2017-02-18 13:25:03.368555
NCT00839033|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-05-27|||June 2009||2009-06-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|February 2011|Actual|2011-02-01||Interventional|Nemucough||Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders|Evaluation of a Mechanical Insufflation-exsufflation Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders: a Prospective, Randomized, Controlled, Multicenter Study|Terminated||Phase 3|14|Actual|Assistance Publique - Hôpitaux de Paris||2||No inclusion|f||||f||||||||||2017-02-18 13:25:03.497638|2017-02-18 13:25:03.497638
NCT00839020|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2016-07-25|||November 2007||2007-11-01|July 2016|2016-07-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Interventional|||Minimally Invasive Versus Conventional Approaches in Navigated Total Knee Arthroplasty (TKA)|Comparison of a Minimally Invasive and a Conventional Approach in Computer Assisted Total Knee Arthroplasty.|Terminated||Phase 4|26|Actual|Aesculap AG||2||Number of patients willing to participate in the study too low|f||||f||||||||||2017-02-18 13:25:03.639451|2017-02-18 13:25:03.639451
NCT00839007|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-09-15|||June 2009||2009-06-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure|A Multi-Center, Single-Blind, Placebo-Controlled Phase 2 Study Assessing the Safety and Efficacy of Intravenous CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure|Completed||Phase 2|77|Actual|Nile Therapeutics||7|||f||||t||||||||||2017-02-18 13:25:03.75203|2017-02-18 13:25:03.75203
NCT00838994|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2010-01-12|||October 2007||2007-10-01|January 2010|2010-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Acupuncture for Residual Insomnia Associated With Major Depressive Disorder|A Randomized Controlled Trial of Acupuncture for Residual Insomnia Associated With Major Depressive Disorder|Completed||N/A|78|Actual|The University of Hong Kong||3|||f||||f||||||||||2017-02-18 13:25:03.872337|2017-02-18 13:25:03.872337
NCT00838981|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-07-07|||May 2008||2008-05-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Pharmacotherapy & CM for Opioid and Cocaine Dependence|Pharmacotherapy & CM for Opioid and Cocaine Dependence|Completed||N/A|90|Actual|Yale University||2|||f||||t||||||||||2017-02-18 13:25:03.982759|2017-02-18 13:25:03.982759
NCT00838968|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-08-21|||January 2008||2008-01-01|August 2012|2012-08-01|January 2013|Anticipated|2013-01-01|October 2012|Anticipated|2012-10-01||Interventional|||The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma|The Efficiency of Postoperative Interferon-alpha(IFNa) Treatment in p48 Positive Patients With Hepatocellular Carcinoma|Withdrawn||N/A|0|Actual|Fudan University||2||"we have found another marker (microRNA26) which is more sensitive to evaluate the effect of~   postoperative IFNa treatment in patients with HCC"|f||||t||||||||||2017-02-18 13:25:04.101826|2017-02-18 13:25:04.101826
NCT00838955|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-10-29|||January 2009||2009-01-01|October 2012|2012-10-01|January 2017|Anticipated|2017-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma|Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 2|30|Anticipated|Loyola University||1|||f||||t||||||||||2017-02-18 13:25:04.199344|2017-02-18 13:25:04.199344
NCT00838942|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2011-10-27|||December 2004||2004-12-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Observational|VIVA||Life From Vision in Alzheimer Disease|Cataract Surgery Benefice in Improvement of Behaviour, Autonomy and Mood for Alzheimer Patients.|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 13:25:04.311413|2017-02-18 13:25:04.311413
NCT00838929|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2016-10-19|2013-03-14||March 2009||2009-03-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|January 2012|Actual|2012-01-01||Interventional|||Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases|Phase I Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases|Completed||Phase 1|17|Actual|Thomas Jefferson University||3|||f||||t||||||||||2017-02-18 13:25:04.416918|2017-02-18 13:25:04.416918
NCT00838916|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-11-18|2014-04-17||February 2009||2009-02-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|January 2012|Actual|2012-01-01||Interventional|||A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes|A Randomized, Open-label, Parallel-group, Multicenter Study to Determine the Efficacy and Long-term Safety of Albiglutide Compared With Insulin in Subjects With Type 2 Diabetes Mellitus.|Completed||Phase 3|779|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:25:04.943961|2017-02-18 13:25:04.943961
NCT00838903|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-11-18|2014-04-17||February 2009||2009-02-01|November 2016|2016-11-01|April 2013|Actual|2013-04-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes|A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|1049|Actual|GlaxoSmithKline||4|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:25:06.721327|2017-02-18 13:25:06.721327
NCT00838890|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-09-23||2011-06-21|March 2009||2009-03-01|September 2015|2015-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study of BMS-863233 in Patients With Hematologic Cancer|A Phase 1/2, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-863233 in Subjects With Refractory Hematologic Malignancies|Terminated||Phase 1/Phase 2|11|Actual|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 13:25:09.388966|2017-02-18 13:25:09.388966
NCT00838877|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2009-10-21|||January 2009||2009-01-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|||||Interventional|PET||Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid|Open Label Positron Emission Tomography Study With [18F]AZD4694 and [11C]AZD2184, Candidate Radioligands for AB Amyloid, to Determine and Compare in Vivo Brain Uptake and Distribution in Healthy Volunteers and Patients With Alzheimer's Disease|Completed||Phase 1|26|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:25:09.499385|2017-02-18 13:25:09.499385
NCT00838864|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2015-08-28|||March 2009||2009-03-01|January 2009|2009-01-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding|Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis in Patients With Acute Variceal Bleeding|Completed||Phase 4|79|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-02-18 13:25:09.690284|2017-02-18 13:25:09.690284
NCT00838851|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-06|2012-10-05|||August 2003||2003-08-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Response of Airway Cells to 20,000 EU of Endotoxin in Normal Adults|Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Normal Adult|Terminated||Phase 1|26|Actual|University of North Carolina, Chapel Hill||1||no further funding|f||||f||||||||||2017-02-18 13:25:09.811338|2017-02-18 13:25:09.811338
NCT00838838|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2010-04-13|||September 2005||2005-09-01|April 2010|2010-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis|Nebido® Therapy in Hypogonadal Male Patients With Osteoporosis Associated With Paraplegia Compared With Conventional Osteoporosis - Prophylaxis / Therapy in Hypogonadal and Eugonadal Patients With Osteoporosis Associated With Paraplegia|Completed||N/A|26|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:25:09.916022|2017-02-18 13:25:09.916022
NCT00838825|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-05-06|||April 2005||2005-04-01|May 2016|2016-05-01|April 2011|Actual|2011-04-01|March 2008|Actual|2008-03-01||Interventional|||Continuous Quality Improvement for Diabetes|Continuous Quality Improvement for Diabetes: Unique Care Delivery Design's Effect on Quality of Care and Utilization of Resources|Completed||Phase 2|10|Actual|Santa Clara Valley Health & Hospital System||2|||f||||t||||||||No|Data will be shared in a peer review journal|2017-02-18 13:25:10.020211|2017-02-18 13:25:10.020211
NCT00838812|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2010-05-24|||March 2009||2009-03-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate|Monocentric Study, Prospective, Open and Non Controlled for to Evaluate the Effectiveness, and Tolerability the Safety of Association of Clindamycin Phosphate 1.2% and Tretinoin 0,025% in the Treatment of Acne Vulgaris Mild to Moderate, When Used Once Daily for 12 Weeks.|Completed||Phase 3|154|Actual|Igefarma Laboratorios S.A.||1|||f||||f||||||||||2017-02-18 13:25:10.122261|2017-02-18 13:25:10.122261
NCT00838799|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2011-07-06||2011-07-06|February 2009||2009-02-01|July 2011|2011-07-01||||April 2010|Actual|2010-04-01||Interventional|||Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain|A Randomized, Double-Blind, Placebo- and Active-Controlled Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain|Completed||Phase 2|458|Actual|Forest Laboratories||5|||f||||f||||||||||2017-02-18 13:25:10.220248|2017-02-18 13:25:10.220248
NCT00838773|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-04-21|||May 2007||2007-05-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|April 2012|Actual|2012-04-01||Interventional|||International Social Network Intervention|HIV Prevention Within High-Risk Social Networks|Completed||Phase 2|1292|Actual|Medical College of Wisconsin||4|||f||||t||||||||||2017-02-18 13:25:10.373313|2017-02-18 13:25:10.373313
NCT00838760|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2010-04-26|||February 2009||2009-02-01|April 2010|2010-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||PEPI-TiDP23-C103: First-in-Human Study to Examine the Safety, Tolerability, and Plasma Pharmacokinetics of Increasing Single and Repeated Oral Doses of TMC558445 and of a Combined Single Day Dosing of Oral TMC558445 and Oral TMC310911 and Also Oral Darunavir|Phase I, Double-blind, Randomized, Placebo-controlled Trial to Examine the Safety, Tolerability and Plasma Pharmacokinetics of Increasing Single Oral Doses of TMC558445 With and Without Food, and Increasing Repeated Oral Doses in Combination With a Single Dose of TMC310911|Completed||Phase 1|54|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:25:10.634761|2017-02-18 13:25:10.634761
NCT00838747|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-05-25|||September 2008||2008-09-01|May 2016|2016-05-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Observational|||Measurement of the Folate Receptor in Blood|Measurement of the Folate Receptor in Blood|Completed||N/A|7|Actual|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-02-18 13:25:10.723226|2017-02-18 13:25:10.723226
NCT00838734|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-05|||June 2008||2008-06-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|||||Observational|||Compare Anterior Chamber Biometry in Healthy and Post-LASIK Patients|Compare Anterior Chamber Biometry in Healthy and Post-LASIK Pati|Unknown status|Recruiting|N/A|100|Anticipated|Far Eastern Memorial Hospital|||2||f||||t||||||||||2017-02-18 13:25:10.814634|2017-02-18 13:25:10.814634
NCT00838721|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-10-12|||March 2008||2008-03-01|February 2009|2009-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|PLT||Evaluation of Pascal Laser Trabeculoplaty|Prospective Evaluation of the Efficacy of Pascal Trabeculoplasty: A Pilot Study|Completed||N/A|50|Actual|Santa Clara Valley Health & Hospital System||1|||f||||f||||||||||2017-02-18 13:25:10.900768|2017-02-18 13:25:10.900768
NCT00838708|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-10-29|||January 2009||2009-01-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus|A Phase II, Randomised, Double-blind, Vehicle-controlled, Cross-over Study to Determine the Anti-pruritic Efficacy, Safety and Local Dermal Toleration of SRD174 Cream in Subjects With Atopic Dermatitis.|Completed||Phase 2|62|Actual|Serentis Ltd.||2|||f||||f||||||||||2017-02-18 13:25:10.994591|2017-02-18 13:25:10.994591
NCT00838695|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2016-10-31|||January 2009||2009-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Variability in Adrenergic Response|Variability in Adrenergic Response|Active, not recruiting||N/A|200|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 13:25:11.10445|2017-02-18 13:25:11.10445
NCT00838682|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2010-08-31|2010-08-02||April 2006||2006-04-01|August 2010|2010-08-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers|Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers|Terminated||Phase 4|106|Actual|The Catholic University of Korea|This was the two-center study and was stopped before the complete enrollment leading to small numbers of subjects statistically underpowered.|2||Terminated before the complete enrollment due to slow enrollment|f||||f||||||||||2017-02-18 13:25:11.218375|2017-02-18 13:25:11.218375
NCT00838669|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2011-05-17|||August 2005||2005-08-01|March 2010|2010-03-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone|Evaluation of the Effect of Food and Posture on the Pharmacokinetics of Paliperidone After a Single Administration of 12 mg ER OROS Paliperidone to Healthy Men|Completed||Phase 1|74|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:25:11.692333|2017-02-18 13:25:11.692333
NCT00838656|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2013-09-16|||October 2007||2007-10-01|June 2011|2011-06-01||||June 2009|Anticipated|2009-06-01||Interventional|||Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Randomised Feasibility Study of Extended Chemotherapy With Neoadjuvant Carboplatin, Then Surgery Followed by Adjuvant Paclitaxel and Gemcitabine Verses Neoadjuvant Gemcitabine and Carboplatin, Then Surgery, Followed by Adjuvant Paclitaxel|Unknown status|Active, not recruiting|Phase 2|88|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:25:11.777305|2017-02-18 13:25:11.777305
NCT00838643|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-02-06|||May 2002||2002-05-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|June 2007|Actual|2007-06-01||Observational|||Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|Incidence of Invasive Aspergillosis in Allogeneic Stem Cell Transplantation Patients: an Italian Prospective Multicentre Study|Unknown status|Active, not recruiting|N/A|220|Actual|Ospedale Santa Croce-Carle Cuneo|||1||f||||f||||||||||2017-02-18 13:25:11.894235|2017-02-18 13:25:11.894235
NCT00838630|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-09-01|2009-06-18||November 2003||2003-11-01|September 2009|2009-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Cilostazol 100 mg Tablet Formulations Under Fasting Conditions|A Randomized, Two-Way, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Cilostazol, 100 mg, Compared to an Equivalent Dose of a Commercially Available Reference Drug Product in 36 Fasted, Healthy, Adult Subjects|Completed||Phase 1|36|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:11.976371|2017-02-18 13:25:11.976371
NCT00838617|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-12-10|||February 2009||2009-02-01|December 2009|2009-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)|Muscle Ultrasound: A New Tool for Measuring Progression in ALS|Completed||N/A|10|Actual|Vanderbilt University|||1||f||||t||||||||||2017-02-18 13:25:12.398498|2017-02-18 13:25:12.398498
NCT00838591|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2013-09-04||2013-04-22|March 2009||2009-03-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma|MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma|Completed||Phase 2|176|Actual|MediciNova||2|||f||||t||||||||||2017-02-18 13:25:12.492498|2017-02-18 13:25:12.492498
NCT00838578|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2015-11-05|2014-03-19||March 2009||2009-03-01|November 2015|2015-11-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer|Phase I/II Study of KRN330 Plus Irinotecan After First-Line or Adjuvant FOLFOX/CapOx Failure in Patients With Metastatic Colorectal Cancer|Terminated||Phase 1/Phase 2|65|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1||Per protocol, the study was terminated based on interim analysis results|f||||f||||||||||2017-02-18 13:25:12.640957|2017-02-18 13:25:12.640957
NCT00838565|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-03-28|||May 2009||2009-05-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis|Phase I, Randomized, Patient and Investigator-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Intravenously Administered Doses of PF-04236921 in Patients With Rheumatoid Arthritis Receiving Methotrexate|Completed||Phase 1|41|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:25:13.561951|2017-02-18 13:25:13.561951
NCT00838552|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2016-12-05|||October 2007||2007-10-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|October 2020|Anticipated|2020-10-01||Observational|||Markers of Airway Inflammation in BAL Fluid From Children With Asthma|Prospective Analysis of Markers of Airway Inflammation and Remodeling in Bronchoalveolar Lavage Fluid From Children With Asthma.|Enrolling by invitation||N/A|40|Anticipated|National Jewish Health|||2||f||||f||||||||||2017-02-18 13:25:13.673832|2017-02-18 13:25:13.673832
NCT00838539|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-11-22|||April 2009||2009-04-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|June 2011|Actual|2011-06-01||Interventional|||Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors|A Phase 1 Study Of Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors|Completed||Phase 1|63|Actual|Puma Biotechnology, Inc.||1|||f||||f||||||||||2017-02-18 13:25:13.762333|2017-02-18 13:25:13.762333
NCT00838526|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2015-10-15|2015-06-08||August 2008||2008-08-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)|Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|240|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 13:25:13.871116|2017-02-18 13:25:13.871116
NCT00838513|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-06-30|2014-12-15||July 2009||2009-07-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional|aHUS|The intent-to-treat (ITT) population was defined as all patients who received any amount of eculizumab, and were considered evaluable for safety and efficacy analyses. For both the efficacy and safety analyses, all 20 patients who were treated with study drug were included in the ITT population.|Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)|An Open-label, Multi-center Controlled Clinical Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (AHUS)|Completed||Phase 2|15|Actual|Alexion Pharmaceuticals||1|||f||||t||||||||||2017-02-18 13:25:14.387344|2017-02-18 13:25:14.387344
NCT00838500|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2012-09-28|||May 2008||2008-05-01|September 2012|2012-09-01|November 2011|Actual|2011-11-01|December 2010|Actual|2010-12-01||Interventional|||THERMES ET VEINES: Spa for Prevention of Leg Ulcers|Evaluation of the Efficacy of Spa Treatment for Prevention of Leg Ulcers in Advanced Chronic Venous Insufficiency.|Completed||Phase 3|425|Actual|Association Francaise pour la Recherche Thermale||2|||f||||t||||||||||2017-02-18 13:25:15.019216|2017-02-18 13:25:15.019216
NCT00838487|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-10-09|||March 2009||2009-03-01|October 2009|2009-10-01|March 2010|Anticipated|2010-03-01|July 2009|Anticipated|2009-07-01||Interventional|ZD20108||Evaluate Safety & Efficacy of Condroflex in Subjects With OA|Phase 3 Study, to Evaluate Safety & Efficacy of the Association Condroflex + Therapeutic Exercises Compared to Placebo + Therapeutic Exercises, in Subjects With Knee OA|Unknown status|Recruiting|Phase 3|240|Anticipated|Zodiac Produtos Farmaceuticos S.A.||2|||f||||t||||||||||2017-02-18 13:25:15.1521|2017-02-18 13:25:15.1521
NCT00838474|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-02-05|||October 2007||2007-10-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Music by Mozart on Energy Expenditure in Growing Preterm Infants|The Effect of Music by Mozart on Energy Expenditure in Growing Preterm Infants|Completed||N/A|20|Actual|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 13:25:15.26315|2017-02-18 13:25:15.26315
NCT00838461|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-07-31|||March 2009||2009-03-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study Evaluating the Safety, Pharmacokinetics (PK), and Pharmacodynamices (PD) of HSD-016|Multiple Ascending Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of HSD-016 Administered Orally to Healthy Subjects|Completed||Phase 1|32|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:25:15.352211|2017-02-18 13:25:15.352211
NCT00838448|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2013-06-11|||January 2009||2009-01-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|January 2011|Actual|2011-01-01||Interventional|||Interactions Between Physical Activity and Cannabis Use in Adults|Interactions Between Physical Activity and Cannabis Use in Adults|Completed||N/A|30|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 13:25:15.435653|2017-02-18 13:25:15.435653
NCT00838435|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2017-01-10|||February 2009||2009-02-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|August 2019|Anticipated|2019-08-01||Interventional|PKU-015||Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU|A Phase 3b Open-Label Study to Evaluate the Effect of Kuvan® on Neurocognitive Function, Maintenance of Blood Phenylalanine Concentrations, Safety, and Population Pharmacokinetics in Young Children With Phenylketonuria|Active, not recruiting||Phase 3|230|Anticipated|BioMarin Pharmaceutical||1|||f||||f||||||||||2017-02-18 13:25:15.536447|2017-02-18 13:25:15.536447
NCT00838422|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-05|||June 2008||2008-06-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Observational|||Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound|Repeatability and Reproducibility of Pachymetric Mapping With Fourier Domain Optical Coherence Tomography, Ocular Response Analyzer, Confoscan 4 and Ultrasound|Unknown status|Recruiting|N/A|100|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-02-18 13:25:15.662226|2017-02-18 13:25:15.662226
NCT00838409|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2011-09-13|||May 2008||2008-05-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||USDA Behavior, Motivation & Nutrition Study|Examination of Metabolic Determinants of Behavior and Motivation in Obesity: Implication to the Development of New Strategies for Achieving Body Weight Health|Completed||N/A|40|Actual|USDA, Western Human Nutrition Research Center|||1||f||||f||||||Samples With DNA|"~     Blood and saliva samples will be kept for future research purposes.~   "|||2017-02-18 13:25:15.762932|2017-02-18 13:25:15.762932
NCT00838396|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-09-12|||October 2005||2005-10-01|September 2016|2016-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Two Period Crossover, Single Dose-Finding Study to Assess the Efficacy and Safety of Controlled Release XP19986 in Patients With Gastroesophageal Reflux Disease|Completed||Phase 2|58|Actual|Indivior Inc.||2|||f||||f||||||||No||2017-02-18 13:25:15.852733|2017-02-18 13:25:15.852733
NCT00838383|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2012-02-02||2012-01-27|August 2006||2006-08-01|February 2012|2012-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|FCAD02||Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery|Selective Endothelin Type A Receptor Inhibition In Cardiac Surgery Subjects With Pre-Existing Cardiovascular Risk Factors: A Dose Confirmation Study|Completed||Phase 2|29|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:25:15.962167|2017-02-18 13:25:15.962167
NCT00838370|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2014-03-03|||May 2007||2007-05-01|March 2014|2014-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines|Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines|Completed||Phase 1|22|Actual|The Netherlands Cancer Institute||1|||f||||t||||||||||2017-02-18 13:25:16.075221|2017-02-18 13:25:16.075221
NCT00838357|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2015-03-19|||September 2008||2008-09-01|March 2015|2015-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|PREDICT||A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).|Plerixafor and G−CSF for the Mobilisation of Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Patients With Non−Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) − Safety Study in a General Autologous Transplant Population|Completed||Phase 3|118|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:25:16.188692|2017-02-18 13:25:16.188692
NCT00838344|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-09-28|||April 2008||2008-04-01|September 2009|2009-09-01|June 2010|Anticipated|2010-06-01|January 2010|Anticipated|2010-01-01||Interventional|MAP||The Medication Adherence Program|The Medication Adherence Program:Promoting Diabetes Self-Management Through Community Pharmacies|Unknown status|Active, not recruiting|N/A|240|Anticipated|University of Washington||2|||f||||f||||||||||2017-02-18 13:25:16.321978|2017-02-18 13:25:16.321978
NCT00838331|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2015-03-04|2015-02-13||April 2009||2009-04-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|May 2013|Actual|2013-05-01||Interventional|INOBA|Only the 8 volunteers who completed both arms of this study are analyzed here.|Adverse Effects of RBC Transfusions: A Unifying Hypothesis|Adverse Effects of RBC Transfusions: A Unifying Hypothesis|Completed||Phase 2|24|Actual|Emory University|Primary limitation is that we are studying transfusion effects of fresh vs stored RBCs in healthy individuals, and not sick, anemic individuals as are often encountered in the hospital.|1|||f||||t||||||||||2017-02-18 13:25:16.41432|2017-02-18 13:25:16.41432
NCT00838318|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2012-07-26|||February 2004||2004-02-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients|Colorectal Cancer (CRC) Screening in First-Degree Relatives (FDRs) of Hispanic CRC Patients|Completed||N/A|26|Actual|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-02-18 13:25:16.674273|2017-02-18 13:25:16.674273
NCT00838305|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2013-05-29|||February 2009||2009-02-01|May 2013|2013-05-01|August 2011|Actual|2011-08-01|December 2009|Actual|2009-12-01||Interventional|||Role of Serotonin in Acute and Subacute MDMA Effects||Completed||N/A|13|Actual|California Pacific Medical Center Research Institute||2|||f||||||||||||||2017-02-18 13:25:16.778153|2017-02-18 13:25:16.778153
NCT00838292|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-03-12|||August 2006||2006-08-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya|Randomized Controlled Evaluation of the Impact of Food Supplements on Malnourished HIV-Infected Adult ART Clients and Malnourished, HIV-Infected Pre-ART Adults in Kenya|Completed||N/A|1049|Actual|Academy for Educational Development||4|||f||||f||||||||||2017-02-18 13:25:17.185493|2017-02-18 13:25:17.185493
NCT00838279|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-09-01|2009-06-30||February 2002||2002-02-01|September 2009|2009-09-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Lamotrigine 25 mg Chewable Tablets, Fasting|Randomized, 2-Way Crossover, Bioequivalence Study of Lamotrigine 25 mg Chewable Dispersible Tablets and Lamictal® 25 mg Chewable Dispersible Tablets in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:17.301119|2017-02-18 13:25:17.301119
NCT00838266|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-09-22|||February 2009||2009-02-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|Bain de bouche||Study of Growing Biofilm by an Antiplaque Mouthrinse|A Double Blind Randomized, Placebo-controlled, Cross-over Trial to Evaluate the Efficiency of a Mouthrinse, Containing Red Grape Seed Extract and nicométhanol Fluorhydrate, in the Control of Dental Plaque Deposit in a 4-days Plaque Regrowth Model|Completed||Phase 3|50|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 13:25:17.74304|2017-02-18 13:25:17.74304
NCT00838253|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2014-10-21|||June 2009||2009-06-01|October 2014|2014-10-01||||||||Interventional|||Safety and Efficacy Study of Istaroxime in Acute Decompensated Heart Failure Patients|A Multicenter, Randomized, Double-blind, Placebo-controlled Staggered Dose-escalating Phase IIb Study of the Safety and Efficacy of Istaroxime Over 24 Hours at Three Doses in Acute Decompensated Heart Failure Patients (The IGNITE Trial)|Withdrawn||Phase 2|0|Actual|Debiopharm International SA||4||The study was not started due to a re-evaluation of the istaroxime development program|f||||t||||||||||2017-02-18 13:25:17.849255|2017-02-18 13:25:17.849255
NCT00838240|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2012-07-19|||November 2008||2008-11-01|July 2012|2012-07-01||||December 2012|Anticipated|2012-12-01||Interventional|AML-14A||Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia|Clofarabine in Combination With a Standard Remission Induction Regimen (AraC and Idarubicin) in Patients 18-60 Years Old With Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS) : a Phase I-II Study of the EORTC-LG and GIMEMA (AML-14A Trial)|Unknown status|Recruiting|Phase 1/Phase 2|114|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-02-18 13:25:17.955435|2017-02-18 13:25:17.955435
NCT00838227|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2014-09-16|||February 2008||2008-02-01|September 2014|2014-09-01|June 2012|Anticipated|2012-06-01|January 2012|Anticipated|2012-01-01||Interventional|||Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder|Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder: A Pilot Study|Withdrawn||Phase 2|0|Actual|Manhattan Psychiatric Center||1||This study was withdrawn because there was no source of funding to implement the study.|f||||t||||||||||2017-02-18 13:25:18.075733|2017-02-18 13:25:18.075733
NCT00838214|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-02-05|||March 2001||2001-03-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis|Efficacy and Safety of Budesonide Capsules (3x3mg/d)Versus Prednisone in Patients With a Diagnose of Active Autoimmune Hepatitis. A Double-Blind, Randomized, Active-Controlled, Multicentre Study|Completed||Phase 2/Phase 3|208|Actual|Dr. Falk Pharma GmbH||2|||f||||t||||||||||2017-02-18 13:25:18.176677|2017-02-18 13:25:18.176677
NCT00838201|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2013-11-01|2013-07-23||February 2009||2009-02-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer|An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer|Completed||Phase 3|384|Actual|Amgen||1|||f||||f||||||||||2017-02-18 13:25:18.435592|2017-02-18 13:25:18.435592
NCT00838188|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-02-05|||November 2007||2007-11-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|||||Observational|||Energy Expenditure in Breast and Bottle Feeding Preterm Infants Fed Their Mother's Breast Milk|Energy Expenditure in Breast and Bottle Feeding Preterm Infants Fed Their Mother's Breast Milk|Completed||N/A|23|Actual|Tel-Aviv Sourasky Medical Center|||5||f||||f||||||Samples Without DNA|"~     Maternal breast milk~   "|||2017-02-18 13:25:19.269174|2017-02-18 13:25:19.269174
NCT00838175|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-05|||June 2007||2007-06-01|February 2009|2009-02-01|May 2009|Anticipated|2009-05-01|February 2009|Anticipated|2009-02-01||Observational|||Characteristics Predictive of Success and Complications in the Use of Suture-Mediated Closure of Femoral Venous Access|Characteristics Predictive of Success and Complications in the Use of Suture-Mediated Closure of Femoral Venous Access|Unknown status|Active, not recruiting|N/A|250|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 13:25:19.3823|2017-02-18 13:25:19.3823
NCT00838162|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2013-06-03|2013-01-30||June 2009||2009-06-01|June 2013|2013-06-01|February 2011|Actual|2011-02-01|August 2009|Actual|2009-08-01||Interventional|||A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients|A Phase IIa, Open-label, Randomized Trial in Treatment-naive HIV-1-infected Subjects to Determine the Antiviral Activity of 14 Days of Monotherapy With 4 Different Dose Regimens of TMC310911 Coadministered With Ritonavir|Completed||Phase 2|33|Actual|Tibotec Pharmaceuticals, Ireland||4|||f||||f||||||||||2017-02-18 13:25:19.490461|2017-02-18 13:25:19.490461
NCT00838149|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-02-05|||November 2005||2005-11-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Glutamine on Intestinal Permeability in Crohn's Disease|Effect of Glutamine Supplementation on the Structure and Function of the Mucosa of Small Intestine in Crohn's Disease: A Randomized Controlled Trial|Completed||Phase 1|30|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 13:25:20.335562|2017-02-18 13:25:20.335562
NCT00838136|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-09-01|2009-06-30||February 2002||2002-02-01|September 2009|2009-09-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Lamotrigine 25 mg Chewable Tablets, Non-Fasting|Randomized, 2-Way Crossover, Bioequivalence Study of Lamotrigine 25 mg Chewable Dispersible Tablets and Lamictal® 25 mg Chewable Dispersible Tablets in Healthy Subjects Under Fed Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:20.52924|2017-02-18 13:25:20.52924
NCT00838123|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-05|||August 2008||2008-08-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|||||Observational|||Cognitive Functioning Related to Job Tenure Among Patients With Schizophrenia||Completed||N/A|60|Anticipated|Far Eastern Memorial Hospital|||2||f||||t||||||||||2017-02-18 13:25:20.974226|2017-02-18 13:25:20.974226
NCT00838110|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2013-01-07|2012-10-11||February 2009||2009-02-01|January 2013|2013-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease|A Phase 3, Multi-Center, Randomized, Double-Blind Placebo-Controlled Study To Evaluate The Safety And Tolerability Of Dimebon (PF-01913539) For Up To 26-Weeks In Patients With Mild To Moderate Alzheimer's Disease|Completed||Phase 3|742|Actual|Pfizer|This safety study did not specify primary or secondary outcome measures. Relevant summaries of all safety assessments are thus provided. Urine blood abnormalities seen are deemed due to interference with dipstick test by a metabolite of dimebon.|4|||f||||t||||||||||2017-02-18 13:25:21.055954|2017-02-18 13:25:21.055954
NCT00838097|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2014-07-29|2014-03-04||February 2008||2008-02-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01|2 Years|Observational [Patient Registry]||Full Analysis Set: all participants who received at least 1 dose of darbepoetin alfa during the study.|European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin Alfa|A Prospective Registry Study Observing the Safety and Patterns of Use of Darbepoetin Alfa in EU Paediatric Chronic Kidney Disease Patients Receiving or Not Receiving Dialysis|Completed||N/A|321|Actual|Amgen|||1||f||||||||||||||2017-02-18 13:25:24.361818|2017-02-18 13:25:24.361818
NCT00838084|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-07-14|||December 2008||2008-12-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Safety Study of LY2811376 Single Doses in Healthy Subjects|Single-Ascending Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of LY2811376 in Healthy Subjects|Completed||Phase 1|61|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-02-18 13:25:25.12934|2017-02-18 13:25:25.12934
NCT00838071|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-02-05|||October 2003||2003-10-01|February 2009|2009-02-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation|Evaluation of Anti-Hepatitis B Antibodies Levels in Serum After the Intravenous Administration of Specific Anti-Hepatitis B Immunoglobulin (IGIV-HB Grifols) in Patients Having Previously Undergone Liver Transplantation|Completed||Phase 3|20|Actual|Grifols Biologicals Inc.||1|||f||||f||||||||||2017-02-18 13:25:25.241005|2017-02-18 13:25:25.241005
NCT00838058|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-10-10|||January 2009||2009-01-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.|An Open-Label Two-Part Randomized, Crossover Study Of The Pharmacokinetics Of CE-224,535 Administered As Controlled And Immediate Release Formulations In Healthy Volunteers|Completed||Phase 1|11|Actual|Pfizer||8|||f||||f||||||||||2017-02-18 13:25:25.358649|2017-02-18 13:25:25.358649
NCT00838045|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2011-12-07|||September 2006||2006-09-01|December 2011|2011-12-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens|A Prospective, Multi-Center Clinical Investigation to Evaluate the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL (Model MI60) Intraocular Lens|Completed||Phase 4|125|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 13:25:25.482144|2017-02-18 13:25:25.482144
NCT00838032|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-03-31|||August 2008||2008-08-01|March 2009|2009-03-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia||Unknown status|Recruiting|Phase 4|70|Anticipated|Sichuan University||2|||f||||t||||||||||2017-02-18 13:25:25.572123|2017-02-18 13:25:25.572123
NCT00838019|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-02-05|||February 2009||2009-02-01|February 2009|2009-02-01|February 2011|Anticipated|2011-02-01|February 2011|Anticipated|2011-02-01||Interventional|||Intrabone Cord Blood Transplantation|Pilot Study About Viability and Efficacy of Intrabone Administration of Umbilical Cord Blood for Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|Phase 4|10|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-02-18 13:25:25.684068|2017-02-18 13:25:25.684068
NCT00838006|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2014-07-16|||September 2008||2008-09-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Psychophysiologic Predictors of Post-deployment Mental Health Outcomes|Identification of and At-Risk Interventions for Pre-deployment Psychophysiologic Predictors of Post-deployment Mental Health Outcomes|Completed||N/A|426|Actual|Biomedical Research Foundation||3|||f||||f||||||||||2017-02-18 13:25:25.771182|2017-02-18 13:25:25.771182
NCT00837993|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2012-12-20|||August 2007||2007-08-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System|An Ancillary Study of Patients With Advanced Stage Serous Carcinoma of the Ovary Treated on GOG Protocol 158: A Survival Analysis Based on Reclassification to a Two-tier Grading System|Completed||N/A|241|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:25:25.872331|2017-02-18 13:25:25.872331
NCT00837980|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2009-02-05|||February 2009||2009-02-01|February 2009|2009-02-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Observational|||Functional Imaging in HNC Undergoing Chemoradiation|Investigation of the Role of Functional Imaging in Characterising Radiotherapy Target Volumes and Assessing Disease Response in Patients Undergoing Chemoradiation for Head and Neck Cancer (HNC)|Unknown status|Recruiting|N/A|10|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-02-18 13:25:25.968644|2017-02-18 13:25:25.968644
NCT00837967|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2012-08-27|2010-07-05||January 2009||2009-01-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients|A Comparison of Tolerability of 10 Inhalations of Symbicort® Turbuhaler® 160/4.5 μg and 10 Inhalations of Terbutaline Turbuhaler® 0.4 mg on Top of Symbicort® Turbuhaler® 160/4.5 μg 1 Inhalation Bid, Randomized, Double-blind, Cross Over, Phase III Study in Japanese Adults Asthma Patients|Completed||Phase 3|25|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:25:26.06546|2017-02-18 13:25:26.06546
NCT00837954|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2015-05-27|||February 2009||2009-02-01|May 2015|2015-05-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|COBBANA||Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis|Randomized, Controlled, Prospective Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis|Completed||Phase 4|32|Actual|Aesculap AG||4|||f||||f||||||||||2017-02-18 13:25:26.41489|2017-02-18 13:25:26.41489
NCT00837941|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2015-07-24|||April 2009||2009-04-01|July 2015|2015-07-01|September 2009|Anticipated|2009-09-01|August 2009|Anticipated|2009-08-01||Interventional|||A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)|Qualification of Single Dose Administration of Analgesic Therapy in the Treatment of Chronic Neuropathic Pain in Patients With Painful Diabetic Neuropathy|Withdrawn||Phase 2|0|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 13:25:26.548707|2017-02-18 13:25:26.548707
NCT00837928|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2016-08-18|||February 2009||2009-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors|Phase I Study of Bendamustine and Fractionated Stereotactic Radiotherapy of Patients With 1- 4 Brain Metastases From Solid Malignancies|Active, not recruiting||Phase 1|18|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:25:26.646055|2017-02-18 13:25:26.646055
NCT00837915|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-02-05|||June 2002||2002-06-01|February 2009|2009-02-01|November 2002|Actual|2002-11-01|August 2002|Actual|2002-08-01||Interventional|||Bioequivalnce Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, Fully Replicated, 4-Way Crossover Bioavailability Study of Ranbaxy and Schering (Claritin_D® 24 Hour) Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended-Release Tablets, in Healthy Adult Volunteers Under Fasting Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:25:26.763352|2017-02-18 13:25:26.763352
NCT00837902|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2016-10-31|||January 2009||2009-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Genetic Determinants of Response to Beta Blockade|Genetic Determinants of Response to Beta Blockade|Active, not recruiting||N/A|500|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 13:25:27.053293|2017-02-18 13:25:27.053293
NCT00837889|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-11-04|||January 2009||2009-01-01|November 2010|2010-11-01|May 2011|Anticipated|2011-05-01|November 2010|Actual|2010-11-01||Observational|CogImpairHF||Cognitive Impairment in Patients With Heart Failure|Cognitive Impairment and Prognosis in Patients With Decompensated Heart Failure|Unknown status|Active, not recruiting|N/A|60|Actual|University Hospital, Saarland|||3||f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 13:25:27.163858|2017-02-18 13:25:27.163858
NCT00837876|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-05|2014-06-13|2012-04-02||October 2008||2008-10-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|April 2011|Actual|2011-04-01||Interventional|||Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery|A Phase II Trial of Sorafenib and Erlotinib in Unresectable Pancreatic Cancer|Completed||Phase 2|37|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 13:25:27.28234|2017-02-18 13:25:27.28234
NCT00837863|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-05-06|||March 2009||2009-03-01|May 2009|2009-05-01||||September 2010|Anticipated|2010-09-01||Interventional|||Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency|A Twelve Month, Phase II, Randomized, Open-Label, Multi-Center, Dose-Ranging Study of Weekly ALTU-238 (Somatropin) as Compared With Daily Nutropin AQ (Somatropin) in Prepubertal Children With Growth Hormone Deficiency|Unknown status|Recruiting|Phase 2|36|Anticipated|Altus Pharmaceuticals||4|||f||||f||||||||||2017-02-18 13:25:27.694167|2017-02-18 13:25:27.694167
NCT00837850|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2011-08-25|||October 2002||2002-10-01|August 2011|2011-08-01|October 2008|Actual|2008-10-01|October 2003|Actual|2003-10-01||Interventional|||SmartSet HV and Palacos R RSA Bone Cements in Primary Total Hip Arthroplasty|A Randomised Prospective Trial of SmartSet HV and Palacos R Bone Cements in Primary Total Hip Arthroplasty. A Radiostereometric Analysis of the Charnley Femoral Component.|Completed||N/A|35|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 13:25:27.799787|2017-02-18 13:25:27.799787
NCT00837837|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2013-02-21|||December 2008||2008-12-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents|A Single-Dose, Open-Label, Pharmacokinetic Study of Chlorpheniramine Maleate Liquid in Children and Adolescents|Completed||Phase 2|36|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:25:27.901758|2017-02-18 13:25:27.901758
NCT00837824|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-03-19|2008-12-05||December 2002||2002-12-01|March 2015|2015-03-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme|A Phase 2, Randomized, Open Label, Dose-Ranging, Multiple Dose Study of Fabrazyme® In Patients With Fabry Disease and With Severe Renal Disease|Terminated||Phase 2|20|Actual|Sanofi|The trial was terminated early due to inadequate study design, leading to small numbers of subjects analyzed.|2||The trial was terminated early due to inadequate study design.|f||||t||||||||||2017-02-18 13:25:28.014679|2017-02-18 13:25:28.014679
NCT00837811|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-01-31||2011-04-05|February 2009||2009-02-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||An Open Label Extension Study in Patients With Rheumatoid Arthritis|An Open Label Extension Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Rheumatoid Arthritis.|Completed||Phase 2|183|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 13:25:28.571994|2017-02-18 13:25:28.571994
NCT00837798|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-12-18|||October 2006||2006-10-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|RATE||RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population|Registry of AT/AF Episodes in the CRM Device Population: RATE Registry|Completed||N/A|5379|Actual|St. Jude Medical|||1||f||||f||||||||||2017-02-18 13:25:28.730376|2017-02-18 13:25:28.730376
NCT00837785|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2011-01-27|||February 2009||2009-02-01|January 2011|2011-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS|A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With Multiple Sclerosis|Completed||Phase 1|48|Actual|Biogen||2|||f||||f||||||||||2017-02-18 13:25:28.818881|2017-02-18 13:25:28.818881
NCT00837772|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-04-04|||January 2008||2008-01-01|April 2016|2016-04-01|July 2014|Actual|2014-07-01|July 2012|Actual|2012-07-01||Interventional|||Total Knee Replacement Study Using Standard Cutting Guide vs Otismed MRI Generated Cutting Guide|Total Knee Replacement Using Standard Knee Cutting Guides vs Otismed MRI Generated Cutting Guide|Completed||N/A|120|Actual|Phoenix VA Health Care System||2|||f||||f||||||||No||2017-02-18 13:25:28.914045|2017-02-18 13:25:28.914045
NCT00837759|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-12-31|2012-03-24||February 2009||2009-02-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes|Novel Therapy Combining Regenerative Stimuli Immunomodulation to Preserve Beta Cell Function in New Onset Type 1 Diabetes|Terminated||Phase 2|7|Actual|National Institutes of Health Clinical Center (CC)||1||Changes to study personnel.|f||||f||||||||||2017-02-18 13:25:29.031316|2017-02-18 13:25:29.031316
NCT00837746|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-06-03|||April 2003||2003-04-01|June 2013|2013-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate|Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Risedronate Daily or Weekly|Completed||Phase 4|29|Actual|Warner Chilcott|||1||f||||f||||||||||2017-02-18 13:25:29.574172|2017-02-18 13:25:29.574172
NCT00837733|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-04|||January 2008||2008-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Endometrial Local Injury and Implantation Failure|Endometrial Local Injury Improves the Pregnancy Rate Among Recurrent Implantation Failure Patients Undergoing IVF/ICSI|Completed||N/A|115|Actual|Yazd Research & Clinical Center for Infertility||1|||f||||t||||||||||2017-02-18 13:25:29.686818|2017-02-18 13:25:29.686818
NCT00837720|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-05|||March 2006||2006-03-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|||||Observational|||Evaluation of Atacand® (Candesartan) in Daily Medical Practice|A 12-Week Open-Label Non-Interventional Evaluation of Atacand® (Candesartan) Efficacy, Tolerability, Compliance and Treatment Satisfaction in Patients With Arterial Hypertension|Completed||N/A|750|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:25:29.792643|2017-02-18 13:25:29.792643
NCT00837707|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-04|||June 2008||2008-06-01|February 2009|2009-02-01|February 2010|Anticipated|2010-02-01|August 2009|Anticipated|2009-08-01||Interventional|||Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia|Aripiprazole for Pre-Existing Neuroleptic-Induced Tardive Dyskinesia: a Prospective 26-Week Observational Study|Unknown status|Recruiting|Phase 4|25|Anticipated|Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan||1|||f||||f||||||||||2017-02-18 13:25:29.877074|2017-02-18 13:25:29.877074
NCT00837694|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-04|||May 2007||2007-05-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Snack Food Reinforcement in Obese and Non-Obese Women|Differential Effects of Daily Snack Food Intake on Reinforcing Value of Food in Obese and Non-Obese Women.|Completed||N/A|||State University of New York at Buffalo|||6||f||||f||||||||||2017-02-18 13:25:29.989095|2017-02-18 13:25:29.989095
NCT00837681|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2015-10-13|||October 2005||2005-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Pulmonary Complications of Hematopoietic Stem Cell Transplantation|Pulmonary Complications of Hematopoietic Stem Cell Transplantation|Active, not recruiting||N/A|350|Anticipated|Ohio State University|||1||f||||t||||||Samples With DNA|"~     Blood draw will be 10cc of blood, analysis includes % of CD8+CD57+ and CD8+CD28-. On one~     occasion, after the 6 mo. post transplant timepoint the subject will be asked to donate a~     larger amount of blood (50cc) if they are not anemic.~      ***Respiratory Specimens of extra BAL or biopsy specimens will be collected at any point a~     study patient undergoes a clinically warranted bronchoscopy or lung biopsy procedure and the~     diagnostic physician feels there is adequate specimen to use extra sample for research~     purposes.~   "|||2017-02-18 13:25:30.091925|2017-02-18 13:25:30.091925
NCT00837668|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2010-07-21|||April 2005||2005-04-01|July 2010|2010-07-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Observational|||Stromal Gene Expression During Pulmonary Sarcoidosis|Stromal Gene Expression During Pulmonary Sarcoidosis|Suspended||N/A|110|Anticipated|Ohio State University|||1|Interim analysis|f||||f||||||Samples With DNA|"~     lung tissue~   "|||2017-02-18 13:25:30.201877|2017-02-18 13:25:30.201877
NCT00837655|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-09-25|||January 2009||2009-01-01|January 2009|2009-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|SIR||Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)|Study of the Effect of Treatment With Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure|Withdrawn||N/A|0|Actual|Karolinska Institutet||2||PI retired|f||||t||||||||||2017-02-18 13:25:30.316055|2017-02-18 13:25:30.316055
NCT00837642|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-04|||March 2008||2008-03-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|April 2009|Anticipated|2009-04-01||Interventional|||Vascular Dysfunction in Offspring of Assisted Reproduction Technologies|Vascular Dysfunction in Offspring of Assisted Reproduction Technologies|Unknown status|Recruiting|N/A|||University of Lausanne Hospitals|||||f||||f||||||||||2017-02-18 13:25:30.435631|2017-02-18 13:25:30.435631
NCT00837629|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2011-01-21|||February 2007||2007-02-01|January 2011|2011-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)|An Open-label Non-interventional Evaluation of Efficacy of Symbicort® Forte Turbuhaler 320/9 µg (Budesonide / Formoterol) and Symbicort® Turbuhaler® 160/4,5 µg (Budesonide / Formoterol)in Functional Status Improvement of Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|743|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:25:30.535769|2017-02-18 13:25:30.535769
NCT00837616|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2014-02-26|2013-05-28||January 2009||2009-01-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism|Estrogen Dosing in Turner Syndrome:Pharmacology & Metabolism|Completed||Phase 4|41|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-02-18 13:25:30.62084|2017-02-18 13:25:30.62084
NCT00837603|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-03-08|||February 2009||2009-02-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|TrainingTGA||Physical Training in Transposition of the Great Arteries|Influence of Physical Training on Cardiopulmonary Exercise Capacity and Right Ventricular Function in Patients With D-TGA and Atrial Switch Operation.|Completed||N/A|48|Anticipated|Hannover Medical School||2|||f||||t||||||||||2017-02-18 13:25:31.200453|2017-02-18 13:25:31.200453
NCT00837590|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-05-21|||March 2009||2009-03-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Vascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy Controls|Vascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy Controls|Completed||N/A|14|Actual|Indiana University||3|||f||||t||||||||||2017-02-18 13:25:31.312652|2017-02-18 13:25:31.312652
NCT00837577|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-07-16|2011-08-09||February 2009||2009-02-01|July 2015|2015-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)|A Phase III, Randomized, Placebo-controlled, Double-blind Clinical Trial and Subsequent Open-label, Extension Clinical Trial to Study the Efficacy and Safety of Addition of Sitagliptin in Japanese Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy and Voglibose Monotherapy|Completed||Phase 3|133|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:25:31.425885|2017-02-18 13:25:31.425885
NCT00837564|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2010-06-29|||February 2009||2009-02-01|July 2010|2010-07-01|April 2011|Anticipated|2011-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression|Differential Responses to Cognitive Behavioural Analysis System of Psychotherapy (CBASP)Versus Escitalopram in Chronic Major Depression With and Without Early Trauma|Unknown status|Recruiting|Phase 3|60|Anticipated|University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 13:25:31.885044|2017-02-18 13:25:31.885044
NCT00837551|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03|||March 2008||2008-03-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|WBI-1001-201||Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis|A Randomized, Double-Blinded, Vehicle-Controlled Phase IIa Study to Evaluate Topically Applied WBI-1001 Cream in Patients With Atopic Dermatitis.|Completed||Phase 1/Phase 2|36|Actual|Welichem Biotech Inc.||3|||f||||t||||||||||2017-02-18 13:25:31.995568|2017-02-18 13:25:31.995568
NCT00837538|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2011-03-18|||February 2009||2009-02-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Screening of Instability of the Spinal Column With Spinal Mouse® and X-ray|A Comparison of Spinal Mouse® and X-ray Film to Measure a Instability of Lumbar Spine|Completed||N/A|100|Actual|Jyväskylä Central Hospital|||1||f||||f||||||||||2017-02-18 13:25:32.105277|2017-02-18 13:25:32.105277
NCT00837525|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-04|||February 2009||2009-02-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|May 2010|Anticipated|2010-05-01||Interventional|||Validity Study of a Nasal Valve Implant|Validity of Biodegradable Injectable Implant for the Treatment of External Nasal Valve Collapse.|Unknown status|Enrolling by invitation|N/A|4|Anticipated|Nasoform, LLC||1|||f||||f||||||||||2017-02-18 13:25:32.184234|2017-02-18 13:25:32.184234
NCT00837512|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2013-11-20|2013-08-13||September 2008||2008-09-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Insulin Delivery Using Microneedles in Type 1 Diabetes|Insulin Delivery Using Microneedles in Type 1 Diabetes|Completed||Phase 2/Phase 3|16|Actual|Emory University||2|||f||||t||||||||||2017-02-18 13:25:32.267682|2017-02-18 13:25:32.267682
NCT00837499|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2016-09-26|||September 2008||2008-09-01|September 2016|2016-09-01||||September 2018|Anticipated|2018-09-01||Observational|||Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.|Comparative Study of Breast Cancers and Their Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.|Active, not recruiting||N/A|1825|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||Samples With DNA|"~     One-time blood draw (about 3 tablespoons). If blood cannot be drawn or not enough blood can~     be drawn, a saliva sample will be taken.~   "|||2017-02-18 13:25:32.551469|2017-02-18 13:25:32.551469
NCT00837486|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-05-06|2015-03-13||February 2009||2009-02-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|December 2010|Actual|2010-12-01||Interventional||All enrolled participants are included.|Reclaim Deep Brain Stimulation Clinical Study for Treatment-Resistant Depression|Reclaim Deep Brain Stimulation Clinical Study for Treatment-Resistant Depression|Completed||Phase 2|30|Actual|MedtronicNeuro|With this 30-subject cohort, and only 29 subjects completing the blinded-treatment phase per protocol, the comparisons of response rates and improvements were not adequately powered.|2|||f||||t||||||||||2017-02-18 13:25:32.666615|2017-02-18 13:25:32.666615
NCT00837473|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-09-14|||January 2009||2009-01-01|September 2012|2012-09-01|October 2011|Actual|2011-10-01|March 2011|Actual|2011-03-01||Interventional|||Study Performance of The Plexur P™ Bone Void Filler Device in Patients Undergoing Iliac Crest Harvesting Procedures|A Prospective Pilot Study on the Performance of The Plexur P™ Bone Void Filler|Completed||Phase 1|15|Actual|Osteotech, Inc||1|||f||||f||||||||||2017-02-18 13:25:33.394207|2017-02-18 13:25:33.394207
NCT00837460|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2010-03-29|||September 2006||2006-09-01|March 2010|2010-03-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Effect of Rehabilitation of Patients With a Central Nervous System Lesion||Completed||N/A|15|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-02-18 13:25:33.495895|2017-02-18 13:25:33.495895
NCT00837447|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2013-03-05|2011-06-23||October 2004||2004-10-01|March 2013|2013-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Range of Motion of Standard and High-Flexion Posterior Cruciate Retaining Total Knee Prostheses|Range of Motion of Standard and High-Flexion Posterior Cruciate Retaining Total Knee Prostheses A Prospective, Randomized Study|Completed||Phase 4|54|Actual|Ewha Womans University|First, the knee scoring system is prone to intraobserver variability. Second, we had no interobserver variability and this could have lead to bias in interpreting radiographic results.|2|||f||||f||||||||||2017-02-18 13:25:33.594538|2017-02-18 13:25:33.594538
NCT00837434|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-04-10|2015-03-18||March 2009||2009-03-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|November 2013|Actual|2013-11-01||Interventional||The Modified Intent-to-Treat population included all randomized subjects who received at least one dose of either etanercept or adalimumab.|Anti-TNF Agents for the Treatment of Rheumatoid Arthritis|A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis|Completed||Phase 4|63|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:25:33.823428|2017-02-18 13:25:33.823428
NCT00837421|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2017-01-30|||December 2006||2006-12-01|January 2017|2017-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||The Ohio State University Sepsis Registry|The Ohio State University Sepsis Registry|Terminated||N/A|230|Actual|Ohio State University|||1|Lack of resources has prevented the study from continuation.|f||||f||||||Samples With DNA|"~     Blood~   "|No|The study was terminated and after analysis data integrity issues prohibited accurate IPD sharing. The data records have been destroyed.|2017-02-18 13:25:34.789134|2017-02-18 13:25:34.789134
NCT00837408|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2017-01-24|||January 30, 2009||2009-01-30|September 14, 2016|2016-09-14||||||||Observational|||Genetics of Type 2 Diabetes Among Han Chinese|Genetics of Type 2 Diabetes Among Han Chinese|Completed||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:25:34.884922|2017-02-18 13:25:34.884922
NCT00837395|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2017-01-17|||February 2009||2009-02-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Observational|||Inflammatory Mediators and microRNA Analysis in Premenstrual Asthma|Inflammatory Mediators and microRNA Analysis in Premenstrual Asthma|Recruiting||N/A|25|Anticipated|Ohio State University|||1||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 13:25:34.966331|2017-02-18 13:25:34.966331
NCT00837382|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-09-28|||January 2010||2010-01-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Imagery Rescripting for Posttraumatic Nightmares in Rural Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans With Posttraumatic Stress Disorder (PTSD)|Imagery Rescripting for Posttraumatic Nightmares in Rural Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans With Posttraumatic Stress Disorder (PTSD)|Terminated||N/A|7|Anticipated|VA Office of Research and Development||2||Primary investigator is no longer a part of the VA.|f||||f||||||||||2017-02-18 13:25:35.061018|2017-02-18 13:25:35.061018
NCT00837369|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-07-19|||May 2009||2009-05-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Regadenoson R-T Perfusion Imaging Trial|Regadenoson Real Time Perfusion Imaging Trial|Completed||N/A|100|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 13:25:35.156905|2017-02-18 13:25:35.156905
NCT00837187|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2010-01-12|||March 2009||2009-03-01|January 2009|2009-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|INDEX||Bioavailability of Dexmedetomidine After Intranasal Administration|Bioavailability of Dexmedetomidine After Intranasal Administration in Healthy Subjects|Completed||Phase 1|7|Actual|University of Turku||2|||f||||f||||||||||2017-02-18 13:25:38.125392|2017-02-18 13:25:38.125392
NCT00837356|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2017-02-09|||March 2009||2009-03-01|February 2017|2017-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects|A Multi-centre, Multi-national Open-label Sequential Trial Comparing Pharmacokinetics and Safety of N8 and Advate® in Subjects With Haemophilia A|Completed||Phase 1|23|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 13:25:35.270235|2017-02-18 13:25:35.270235
NCT00837343|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-04|||December 2008||2008-12-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|October 2010|Anticipated|2010-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder|An Open Label, Multicenter, Single Arm, 4-Week Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder|Unknown status|Recruiting|Phase 4|120|Anticipated|Guangzhou Mental Hospital||1|||f||||t||||||||||2017-02-18 13:25:35.386959|2017-02-18 13:25:35.386959
NCT00837330|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2014-11-17|2011-11-03||May 2006||2006-05-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||10 subjects were enrolled into each of the two ranibizumab groups (0.3 mg/ 0.5 mg)|Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy|Treatment of Polypoidal Choroidal Vasculopathy With Ranibizumab(Lucentis): A Phase I/II Safety Study.|Completed||Phase 1/Phase 2|20|Actual|Southeast Retina Center, Georgia||2|||f||||f||||||||||2017-02-18 13:25:35.494346|2017-02-18 13:25:35.494346
NCT00837317|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-05-12|||January 2009||2009-01-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Different Oils For Frying and Endothelial Function|Comparative Effect Of Different Oils For Frying On The Endothelial Function, The Oxidative Stress And The Postprandial Inflammatory Response|Completed||N/A|26|Actual|Hospital Universitario Reina Sofia||1|||f||||f||||||||||2017-02-18 13:25:35.946|2017-02-18 13:25:35.946
NCT00837304|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-12-07|||January 2009||2009-01-01|February 2009|2009-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative Colitis|Colon Capsule Endoscopy Versus Standard Colonoscopy in Assessing Disease Activity in Patients With Ulcerative Colitis - A Prospective Trial|Terminated||N/A|14|Actual|University Hospital Muenster|||1||f||||t||||||||||2017-02-18 13:25:36.048959|2017-02-18 13:25:36.048959
NCT00837291|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-12-16|||November 2016||2016-11-01|December 2015|2015-12-01|January 2019|Anticipated|2019-01-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Daily CF101 Administered Orally for 12 Weeks to Patients With Osteoarthritis of the Knee|Not yet recruiting||Phase 2|188|Anticipated|Can-Fite BioPharma||2|||f||||t||||||||||2017-02-18 13:25:36.137556|2017-02-18 13:25:36.137556
NCT00837278|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-09-17|||June 2008||2008-06-01|September 2009|2009-09-01|June 2010|Anticipated|2010-06-01|March 2010|Anticipated|2010-03-01||Observational|||Maternal Serum Cytokine Levels and Angiogenic Factor Levels in IVF vs Spontaneously Conceived Pregnancies|Maternal Serum Cytokine Levels and Angiogenic Factor Levels in Singleton IVF Pregnancies vs Spontaneously Conceived Pregnancies|Unknown status|Recruiting|N/A|40|Anticipated|MemorialCare|||2||f||||f||||||Samples Without DNA|"~     Maternal blood draws are to be performed at four times. These are 10-15 weeks, 22-28 weeks,~     34-40 weeks, and 4-8 weeks postpartum. Additionally, placental biopsies and umbilical cord~     blood specimens are to be collected for possible future analysis.~   "|||2017-02-18 13:25:36.281774|2017-02-18 13:25:36.281774
NCT00837265|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2016-07-19||2013-08-27|August 2008||2008-08-01|July 2016|2016-07-01|July 2010|Actual|2010-07-01|September 2009|Actual|2009-09-01||Interventional|NEUGR-002||Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel|A Randomized Study of Subcutaneously Administered Neugranin (Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor) or Pegfilgrastim in Subjects With Breast Cancer Receiving Myelosuppressive Chemotherapy (Doxorubicin/Docetaxel)|Completed||Phase 2/Phase 3|334|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-02-18 13:25:36.375917|2017-02-18 13:25:36.375917
NCT00837252|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2016-09-22|2011-04-21||February 2009||2009-02-01|September 2016|2016-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy|Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy|Completed||Phase 1/Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 13:25:36.52553|2017-02-18 13:25:36.52553
NCT00837239|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-07-10|||June 2007||2007-06-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Huachansu & Gemcitabine in Pancreatic Cancer|A Randomized, Placebo-controlled, Blinded Phase II Study of Huachansu & Gemcitabine in Pancreatic Cancer|Completed||Phase 2|80|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 13:25:37.05831|2017-02-18 13:25:37.05831
NCT00837226|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2015-12-04|||September 2010||2010-09-01|December 2015|2015-12-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Observational|IOP||Effects of Weight Loss From Bariatric Surgery on Intraocular Pressure (IOP)|The Effects of Weight Loss From Bariatric Surgery on Intraocular Pressure|Withdrawn||N/A|0|Actual|The University of Texas Health Science Center, Houston|||2||f||||f||||||||||2017-02-18 13:25:37.183494|2017-02-18 13:25:37.183494
NCT00837213|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2011-07-12|2010-04-07||August 2007||2007-08-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne|Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne|Completed||Phase 4|33|Actual|GlaxoSmithKline|Small sample size did not provide adequate power. Even with the limited sample size, total lesion counts provides a more reliable view of the study data due to the greater number of lesions to work with.|2|||f||||f||||||||||2017-02-18 13:25:37.26525|2017-02-18 13:25:37.26525
NCT00837200|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2014-09-18|2014-05-02||March 2009||2009-03-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|January 2011|Actual|2011-01-01||Interventional|||Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies|Phase II Pilot Efficacy Trial of the Combination Regimen Oncaspar/Doxil/Decadron (ODD) in Patients With Refractory Lymphoid Malignancies|Completed||Phase 2|13|Actual|Milton S. Hershey Medical Center||1|||f||||t||||||||||2017-02-18 13:25:37.793833|2017-02-18 13:25:37.793833
NCT00837174|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-06-13|||June 2010||2010-06-01|June 2012|2012-06-01||||April 2014|Anticipated|2014-04-01||Interventional|COMBOSTAT||Relapsed and/or Refractory Non-Hodgkin Lymphoma Study|Phase II Study of Combination Vorinostat and Bortezomib in Patients With Relapsed and/or Refractory Non-Hodgkin Lymphoma|Withdrawn||Phase 2|0|Actual|The Methodist Hospital System||1|||f||||t||||||||||2017-02-18 13:25:38.237286|2017-02-18 13:25:38.237286
NCT00837161|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2012-11-30|2011-07-01||January 2009||2009-01-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids|Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids|Completed||Phase 1/Phase 2|11|Actual|Philips Healthcare||1|||f||||f||||||||||2017-02-18 13:25:38.351517|2017-02-18 13:25:38.351517
NCT00837148|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2015-10-19|2015-10-19||February 2009||2009-02-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Sorafenib and Dacarbazine in Soft Tissue Sarcoma|Phase II Trial of Sorafenib and Dacarbazine in Soft Tissue Sarcoma|Completed||Phase 2|37|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:25:38.662875|2017-02-18 13:25:38.662875
NCT00837135|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2016-08-16|||January 2008||2008-01-01|August 2016|2016-08-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||GI-4000 With Adoptive Transfer in Pancreatic Cancer|Pilot Study Of Safety And Feasibility Of GI-4000, An Inactivated Recombinant Saccharomyces Cerevisiae Expressing Mutant Ras Protein Combined With Adoptive Transfer And Chemoradiation in Locally Advanced Pancreatic Cancer|Withdrawn||Phase 1|0|Actual|University of Pennsylvania||4||Withdrawn due to transfer of Investigator|f||||f||||||||||2017-02-18 13:25:38.906171|2017-02-18 13:25:38.906171
NCT00837122|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2017-01-24|||January 30, 2009||2009-01-30|November 15, 2016|2016-11-15||||||||Observational|||Genetics of Type 2 Diabetes in West Africans|Genetics of Tye 2 Diabetes in Diverse Populations|Recruiting||N/A|9000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:25:39.01693|2017-02-18 13:25:39.01693
NCT00837109|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-09-28|||February 2009||2009-02-01|September 2010|2010-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Randomized Clinical Trial of Imagery Rescripting Treatment In Veterans With Trauma-Related Nightmares And Posttraumatic Stress Disorder (PTSD)|Randomized Clinical Trial of Imagery Rescripting Treatment In Veterans With Trauma-Related Nightmares And Posttraumatic Stress Disorder (PTSD)|Terminated||N/A|50|Anticipated|VA Office of Research and Development||2||Primary investigator is no longer a part of the VA|f||||f||||||||||2017-02-18 13:25:39.108042|2017-02-18 13:25:39.108042
NCT00837096|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-10-10|||June 2007||2007-06-01|October 2013|2013-10-01||||April 2008|Actual|2008-04-01||Interventional|VAC 2006-19||A Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds|A Prospective, Randomized, Multicenter, Parallel Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds|Terminated||N/A|17|Actual|KCI USA, Inc.||2||Business objectives changed.|f||||t||||||||||2017-02-18 13:25:39.200822|2017-02-18 13:25:39.200822
NCT00837083|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-05|||January 2007||2007-01-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|||||Observational|||Evaluation of Crestor® (Rosuvastatin) in Daily Practice|Open-Label Non-Interventional Evaluation of Efficacy of Crestor® (Rosuvastatin) in Reduction of LDL-Cholesterol and Cardiovascular Risk Parameters in Patients With Hypercholesterolaemia|Completed||N/A|602|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:25:39.409604|2017-02-18 13:25:39.409604
NCT00837070|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2010-03-02|||January 2009||2009-01-01|January 2009|2009-01-01|January 2012|Anticipated|2012-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Percutaneous Rupture of Zygapophyseal Joint Cysts|Percutaneous Rupture of Zygapophyseal Joint Cysts|Unknown status|Recruiting|Phase 2|30|Anticipated|Ullevaal University Hospital||1|||f||||t||||||||||2017-02-18 13:25:39.487879|2017-02-18 13:25:39.487879
NCT00837057|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-04|||February 2009||2009-02-01|January 2009|2009-01-01||||January 2011|Anticipated|2011-01-01||Interventional|||Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney Injury|A Randomized Controlled Multi-Center Trial of the Early Application of CRRT in Patients With Severe Sepsis or Septic Shock|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Asan Medical Center||1|||f||||f||||||||||2017-02-18 13:25:39.598718|2017-02-18 13:25:39.598718
NCT00837044|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2009-02-04|||February 2009||2009-02-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|July 2009|Anticipated|2009-07-01||Interventional|||Treximet in Acute Migraine Headache: Assessing Cognitive Function|An Evaluation of Treximet in the Treatment of Acute Migraine Headache: A Placebo-Controlled, Double-Blind, Crossover Study, Assessing Cognitive Function.|Unknown status|Recruiting|N/A|30|Anticipated|Neurological Research Center||2|||f||||f||||||||||2017-02-18 13:25:39.694616|2017-02-18 13:25:39.694616
NCT00837031|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-04|2013-02-08|2013-02-08||February 2009||2009-02-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|April 2010|Actual|2010-04-01||Interventional|||Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas|A Phase II Study of Lenalidomide in Combination With Gemcitabine in Subjects With Untreated Advanced Carcinoma of the Pancreas|Completed||Phase 2|72|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 13:25:39.819067|2017-02-18 13:25:39.819067
NCT00837018|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-03-04|||June 2005||2005-06-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2010|Actual|2010-05-01||Interventional|EXAOS||Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients|Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients: Cardiovascular and Metabolic Characterisation During Exercise. Treatments Effect.|Completed||N/A|30|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-02-18 13:25:40.110811|2017-02-18 13:25:40.110811
NCT00837005|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-03-28|||January 2005||2005-01-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|DS-Prognosis||Prognostic Value of High Dose Dobutamine Stress Magnetic Resonance Imaging|Prognostic Value of High Dose Dobutamine Stress Magnetic Resonance in Patients With Ischemic Heart Disease. Assessment of Myocardial Perfusion and Wall Motion.|Completed||N/A|2500|Actual|Heidelberg University|||2||f||||f||||||||||2017-02-18 13:25:40.21952|2017-02-18 13:25:40.21952
NCT00836992|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-04-19|||January 2009||2009-01-01|April 2016|2016-04-01||||September 2011|Actual|2011-09-01||Observational|||Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer|Assessing the Clinical Significance of Real-time Quality of Life Data in Cancer Patients Treated With Radiation Therapy|Active, not recruiting||N/A|132|Anticipated|Mayo Clinic|||2||f||||t||||||||||2017-02-18 13:25:40.476087|2017-02-18 13:25:40.476087
NCT00836979|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-04-03|||October 2008||2008-10-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|RRISK3||Urinary Incontinence: Reproductive/Hormonal Risk Factors|Urinary Incontinence: Reproductive/Hormonal Risk Factors III|Completed||N/A|2161|Actual|Kaiser Permanente|||1||f||||f||||||Samples With DNA|"~     Sera will be banked for this cohort.~   "|||2017-02-18 13:25:40.587403|2017-02-18 13:25:40.587403
NCT00836966|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-03|||June 2006||2006-06-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Sampling Biomarkers in Meniscus Injury to the Knee|Diagnostic Utility of Cytokine Biomarkers in the Evaluation of Acute Knee Pain|Completed||N/A|73|Actual|Scuderi, Gaetano J., M.D.|||1||f||||f||||||Samples Without DNA|"~     saline lavage from joint space~   "|||2017-02-18 13:25:40.694095|2017-02-18 13:25:40.694095
NCT00836953|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-04-12|2009-07-20||September 2003||2003-09-01|April 2016|2016-04-01|July 2004|Actual|2004-07-01|January 2004|Actual|2004-01-01||Interventional|||Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®|A Trial for the Collection of Sera in Healthy Children Receiving Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone® 2003/2004|Completed||Phase 4|33|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:25:40.785337|2017-02-18 13:25:40.785337
NCT00836940|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-09-23|||June 2008||2008-06-01|September 2009|2009-09-01|October 2009|Anticipated|2009-10-01|May 2009|Actual|2009-05-01||Interventional|||A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus|A 12-week Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of GRC 8200, a New Oral DPP -IV Inhibitor, in Patients With Type 2 Diabetes Mellitus.|Unknown status|Active, not recruiting|Phase 2|480|Anticipated|Glenmark Pharmaceuticals Europe Ltd. (R&D)||5|||f||||t||||||||||2017-02-18 13:25:41.160304|2017-02-18 13:25:41.160304
NCT00836927|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-11-24|||February 2009||2009-02-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Extension Trial of Deforolimus in Patients With Advanced Cancer (8669-038)|An Extension Trial of Deforolimus (AP23573; MK-8669), an mTOR Inhibitor, for Patients With Advanced Cancer|Active, not recruiting||Phase 2|7|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:25:41.259007|2017-02-18 13:25:41.259007
NCT00836914|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-01-04|||February 2009||2009-02-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover Study to Investigate the Safety of CAL-101 in Allergic Rhinitis Subjects and Effects on the Response to Environmental Chamber Allergen Challenge|Completed||Phase 1|41|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 13:25:41.348765|2017-02-18 13:25:41.348765
NCT00836901|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-07-06|2009-05-07||September 2003||2003-09-01|July 2009|2009-07-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Amoxicillin-Clavulanic Acid 400 mg-57 mg Chewable Tablets Under Non-Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Amoxicillin-Clavulanic Acid 400 mg-57 mg Chewable Tablets and AUGMENTIN® 400 mg-57 mg Chewable Tablets Administered as 1 x 400 mg-57 mg Chewable Tablet in Healthy Subjects Under Fed Conditions|Completed||Phase 1|52|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:41.463519|2017-02-18 13:25:41.463519
NCT00836888|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-11-24|||January 2009||2009-01-01|April 2015|2015-04-01||||September 2010|Actual|2010-09-01||Interventional|||ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan|ONO-4538 Phase I Study - A Single Center, Open Label, Dose Escalation Single Dose, Followed by Multiple Dose Study of ONO-4538, a Fully Human mAb to PD-1, in Patients With Advanced Malignant Solid Tumors|Completed||Phase 1|17|Actual|Ono Pharmaceutical Co. Ltd||1|||f||||||||||||||2017-02-18 13:25:41.963993|2017-02-18 13:25:41.963993
NCT00836875|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-08-16|2014-05-09||May 2009||2009-05-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Safety population: included all participants who received at least 1 dose of study medication.|A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children|A Prospective, Open-label, Non-randomized, Multi-center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients.|Terminated||Phase 3|31|Actual|Pfizer|The study was prematurely terminated due to slow enrollment. The study was not terminated due to any safety issues or concerns. Interpretation of the data are limited due to the small sample size and descriptive design.|1||"This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of~   any safety issues or concerns."|f||||t||||||||||2017-02-18 13:25:42.073436|2017-02-18 13:25:42.073436
NCT00836862|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-07-15|||February 2009||2009-02-01|July 2010|2010-07-01||||November 2011|Anticipated|2011-11-01||Observational|||Arteriovenous Fistula Tissue Bank|Arteriovenous Fistula Tissue Bank|Unknown status|Recruiting|N/A|50|Anticipated|University of Nebraska|||1||f||||f||||||Samples With DNA|"~     Serum, Whole Blood, Tissue~   "|||2017-02-18 13:25:42.746983|2017-02-18 13:25:42.746983
NCT00836849|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03|||March 2002||2002-03-01|February 2009|2009-02-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Sertraline Hydrochloride 100 mg Tablets, Fasting|Randomized, 2-Way Crossover, Bioequivalence Study of Sertraline Hydrochloride 100 mg Tablets and Zoloft® 100 mg Tablets Administered as 1 x 100 mg Tablet in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:42.833618|2017-02-18 13:25:42.833618
NCT00836836|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2011-06-20|||May 2009||2009-05-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|mAD||Modified Atkins Diet in Childhood Epilepsy|Evaluation Of The Efficacy Of The Modified Atkins Diet In Children With Refractory Epilepsy: A Randomized Controlled Trial.|Completed||Phase 2/Phase 3|96|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 13:25:42.929171|2017-02-18 13:25:42.929171
NCT00836823|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2010-10-18|||December 2005||2005-12-01|October 2010|2010-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Evaluation of Symptom-specific Goal Achievement|The Long Term Effects of Alfuzosin (Xatral XL) in LUTS/BPH Patients: Evaluation of Symptom-specific Goal Achievement According to Symptom Improvement, Bladder Outlet Obstruction Grade and Bladder Contractility|Completed||Phase 4|130|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 13:25:43.032405|2017-02-18 13:25:43.032405
NCT00835289|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-04-22|||March 2009||2009-03-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|COD-Fish||The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial|The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial|Completed||Phase 2|40|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 13:26:15.586526|2017-02-18 13:26:15.586526
NCT00836810|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-09-04|||October 2009||2009-10-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|November 2010|Actual|2010-11-01||Interventional|||Timed Release Tablet Prednisone in Polymyalgia Rheumatica|Circadian Variation in Cytokines and the Effect of Timed Release Tablet Prednisone in Polymyalgia Rheumatica|Completed||Phase 2/Phase 3|12|Actual|University Hospitals Bristol NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:25:43.142892|2017-02-18 13:25:43.142892
NCT00836797|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03|||May 2007||2007-05-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Observational|||Radiographic Assessment of Bone Regeneration in Alveolar Sockets With PLGA Scaffold|Phase I Radiographic Assessment of Bone Regeneration in Alveolar Sockets With PLGA Bioscaffold After Teeth Extraction|Completed||N/A|33|Actual|Bio-Scaffold International Pte Ltd|||2||f||||f||||||||||2017-02-18 13:25:43.25549|2017-02-18 13:25:43.25549
NCT00836784|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-05-04|||February 2009||2009-02-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Comparison of New and 3-Month-Old Toothbrush in the Removal of Plaque in Children|Comparing Efficacy of Old Versus New Toothbrushes in Plaque Removal in the Hands of 7-9 Year Old Children.|Completed||N/A|93|Actual|Shahid Beheshti University||2|||f||||f||||||||||2017-02-18 13:25:43.445667|2017-02-18 13:25:43.445667
NCT00836771|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-07-30|||July 2009||2009-07-01|May 2012|2012-05-01|December 2014|Anticipated|2014-12-01|January 2014|Anticipated|2014-01-01||Interventional|||Infant Formula Supplemented With Probiotic Microorganisms and/or Prebiotic.|Evaluation of the Effect of Milk Based Infant Formula Supplemented Either With Probiotic Microorganisms and/or With Prebiotic on the Intestinal Microflora During the First 4 Months of Life of Healthy, Full Term Infants and it's Long Term Effect on Morbidity up to the Age of 9 Months|Unknown status|Active, not recruiting|N/A|270|Anticipated|Materna Laboratories||5|||f||||t||||||||||2017-02-18 13:25:43.554847|2017-02-18 13:25:43.554847
NCT00836758|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-07-28||2010-07-19|February 2009||2009-02-01|July 2010|2010-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Comparison of Breathing Event Detection by a CPAP Device to Clinical Polysomnography|Validation of Breathing Event Detection of the REMstar Auto With Aflex Compared to Clinical Polysomnography|Completed||N/A|30|Actual|Philips Respironics||1|||f||||f||||||||||2017-02-18 13:25:43.666115|2017-02-18 13:25:43.666115
NCT00836745|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-11-26|2013-07-29||March 2009||2009-03-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent|Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent|Completed||N/A|36|Actual|Pfizer|Relatively small sample size might limit any useful interpretation and applicability of data for larger populations.||1||f||||f||||||||||2017-02-18 13:25:43.75605|2017-02-18 13:25:43.75605
NCT00836732|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-09-27|||November 2008||2008-11-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|MESSAGE||Mesenchymal Stem Cells: Alterations in Genome|MESenchymal Stem Cells: Alterations in GEnome|Completed||N/A|35|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-02-18 13:25:44.075449|2017-02-18 13:25:44.075449
NCT00836719|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-05-21|2013-04-04||February 2009||2009-02-01|May 2013|2013-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Safety of Polyphenon E in Multiple Sclerosis Pilot Study|Safety and Neuroprotective Effects of Polyphenon E in Multiple Sclerosis|Completed||Phase 1|10|Actual|Louisiana State University Health Sciences Center in New Orleans|The study was a pilot study with a small sample size and no control group. The primary endpoint was futility in change in NAA thus the p-values for the primary endpoint are nominal only.|1|||f||||t||||||||||2017-02-18 13:25:44.155278|2017-02-18 13:25:44.155278
NCT00836706|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-09-01|2009-06-18||July 2002||2002-07-01|September 2009|2009-09-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Clarithromycin 500 mg Tablets Under Non-Fasting Conditions|A Relative Bioavailability Study of 500 mg Clarithromycin Tablets Under Non-Fasting Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:44.677518|2017-02-18 13:25:44.677518
NCT00836693|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2010-12-15|2010-12-15||January 2009||2009-01-01|December 2010|2010-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of Tadalafil Once a Day in Men With Erectile Dysfunction|A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy and Safety of Tadalafil (LY450190) Once a Day in Subjects With Erectile Dysfunction Who Are Naïve to PDE5 Inhibitors|Completed||Phase 3|217|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:25:45.166645|2017-02-18 13:25:45.166645
NCT00836680|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-02-02|||January 2009||2009-01-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|May 2009|Anticipated|2009-05-01||Interventional|||Clinical Study for the Evaluation of the Efficiency of a Device for the Diagnosis of an Internal Rectal Prolapse, a Pelvic Floor Ptosis and for the Determination of an Internal Hernia Into the Douglas Pouch|Study for the Evaluation of the Efficiency of a Device for the Diagnosis of an Internal Rectal Prolapse, a Pelvic Floor Ptosis and for the Determination of an Internal Hernia Into the Douglas Pouch|Unknown status|Recruiting|N/A|15|Anticipated|Gerhard Pejcl Medizintechnik GmbH||1|||f||||t||||||||||2017-02-18 13:25:46.193935|2017-02-18 13:25:46.193935
NCT00836667|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03|||March 2002||2002-03-01|February 2009|2009-02-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Sertraline Hydrochloride 100 mg Tablets, Fed|Randomized, 2-Way Crossover, Bioequivalence Study of Sertraline Hydrochloride 100 mg Tablets and Zoloft® 100 mg Tablets Administered as 1 x 100 mg Tablet in Healthy Subjects Under Fed Conditions.|Completed||Phase 1|18|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:46.292558|2017-02-18 13:25:46.292558
NCT00836654|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-04|||September 2004||2004-09-01|February 2009|2009-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group|Two-Arm, Randomized (2:1), Open-Label Phase II/III Study in EpCAM Positive Cancer Patients With Symptomatic Malignant Ascites Using the Trifuncitonal Bispecific Antibody Removab (Anti-EpCAM x Anti-CD3) Versus an Untreated Control Group|Completed||Phase 2/Phase 3|258|Actual|Neovii Biotech||2|||f||||||||||||||2017-02-18 13:25:46.399156|2017-02-18 13:25:46.399156
NCT00836641|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-07-30|2013-04-04||October 2006||2006-10-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|PAPSI||Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool Asthmatics|Prospective Randomized Controlled Phase 4 Study on the Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool Asthmatics|Completed||Phase 4|70|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||t||||||||||2017-02-18 13:25:46.492549|2017-02-18 13:25:46.492549
NCT00836628|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-02-04|||July 2008||2008-07-01|February 2016|2016-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Study of Busulfan for Refractory Central Nervous System (CNS) Tumors|A Phase I Study Using Submyeloablative DOsing of Intravenous Busulfan (Busulfex) for Refractory Brain Tumors|Withdrawn||Phase 1|0|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||1||slow accrual|f||||t||||||||Undecided||2017-02-18 13:25:46.952124|2017-02-18 13:25:46.952124
NCT00836602|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2011-02-22|||February 2009||2009-02-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects|Placebo-Controlled, Ascending, Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects|Completed||Phase 1|25|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 13:25:47.058097|2017-02-18 13:25:47.058097
NCT00836589|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2017-02-10|||December 2008||2008-12-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|GALAXY||Long-term Evaluation of the Linox Family ICD Leads Registry (GALAXY)|GALAXY Registry: Long-term Evaluation of the Linox Family ICD Leads Registry|Completed||N/A|1997|Actual|Biotronik, Inc.|||1||f||||f||||||||||2017-02-18 13:25:47.16575|2017-02-18 13:25:47.16575
NCT00836576|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03|||February 2001||2001-02-01|February 2009|2009-02-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Benazepril HCl 40 mg Tablets, Fasting|A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Relative Bioavailability of a Test Tablet Formulation of Benazepril HCl (40 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Lotensin®, Novartis Pharmaceuticals Corporation) in 40 Fasted, Healthy, Adult Subjects|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:47.338589|2017-02-18 13:25:47.338589
NCT00836563|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-07-15|||January 2009||2009-01-01|July 2010|2010-07-01||||December 2011|Anticipated|2011-12-01||Observational|||Vascular Changes Following Forearm Loop Arteriovenous Graft Placement|The Natural History of Upper Arm Vessels Following Forearm Loop Arteriovenous|Unknown status|Recruiting|N/A|12|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-02-18 13:25:47.430214|2017-02-18 13:25:47.430214
NCT00836550|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-09-18|||August 2008||2008-08-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Video-based Counseling & Rapid HIV Testing for Teens|An RCT to Evaluate the Effectiveness of an Emergency Department Based Multimedia HIV Testing Model in Adolescents|Completed||N/A|200|Actual|North Bronx Healthcare Network||2|||f||||t||||||||||2017-02-18 13:25:47.518998|2017-02-18 13:25:47.518998
NCT00836537|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03|||March 2001||2001-03-01|February 2009|2009-02-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Benazepril HCl 40 mg Tablets, Fed|A Relative Bioavailability Study of 40 mg Benazepril Hydrochloride Tablets Under Non-Fasting Conditions|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:47.620252|2017-02-18 13:25:47.620252
NCT00836524|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2011-10-27|||January 2009||2009-01-01|October 2011|2011-10-01|September 2012|Anticipated|2012-09-01|November 2011|Anticipated|2011-11-01||Observational|||Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?|"Kan IUGR og præeclampsi Forudsiges ud Fra YKL-40 målt i Serum? Metoder Til at Vurdere om Den Gravide Har Risiko for at Udvikle Svangerskabsforgiftning og/Eller væksthæmning Hos Fosteret."|Unknown status|Active, not recruiting|N/A|2000|Anticipated|University Hospital Roskilde|||1||f||||f||||||Samples With DNA|"~     Bloodsamples will be collected as well as placenta tissue for histology.~   "|||2017-02-18 13:25:47.721982|2017-02-18 13:25:47.721982
NCT00836498|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-04-10|2011-01-12||January 2009||2009-01-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)|V260-027 Safety and Immunogenicity of RotaTeq™ in Elderly Subjects|Terminated||Phase 1|66|Actual|Merck Sharp & Dohme Corp.||5||Strategic business decision not to pursue indication due to lack of demonstrable medical need|f||||||||||||||2017-02-18 13:25:47.820775|2017-02-18 13:25:47.820775
NCT00836485|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-05-15|||February 2009||2009-02-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis|A Prospective, Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis|Completed||Phase 2|120|Anticipated|Senju USA, Inc.||4|||f||||f||||||||||2017-02-18 13:25:48.3767|2017-02-18 13:25:48.3767
NCT00836472|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-09-01|2009-06-30||April 2003||2003-04-01|September 2009|2009-09-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting|Randomized, 2-Way Crossover, Bioequivalence Study of Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets and Glucovance® 5 mg/500 mg Film-Coated Tablets in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|60|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:48.48303|2017-02-18 13:25:48.48303
NCT00836459|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2014-12-01|||November 2009||2009-11-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|Booster||Sheffield Physical Activity Booster Trial|"A Randomised Controlled Trial and Cost-effectiveness Evaluation of Booster Interventions to Sustain Increases in Physical Activity in Middle-aged Adults in Deprived Urban Neighbourhoods."|Completed||N/A|282|Actual|University of Sheffield||3|||f||||f||||||||||2017-02-18 13:25:51.344288|2017-02-18 13:25:51.344288
NCT00836446|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-03-10|||August 2008||2008-08-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Effects of Physical Activity on Cardiovascular Risk Markers in School-Aged Mexican Children|Effects of Physical Activity on Cardiovascular Risk Markers in School-Aged Mexican Children|Completed||N/A|214|Actual|Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes||2|||f||||f||||||||||2017-02-18 13:25:51.455582|2017-02-18 13:25:51.455582
NCT00836433|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-04-06|2014-10-09||February 2010||2010-02-01|October 2014|2014-10-01|August 2012|Actual|2012-08-01|October 2011|Actual|2011-10-01||Interventional|CONNECT||CONNECT for Better Falls Prevention in VA Community Living Centers|CONNECT for Better Falls Prevention in VA Community Living Centers|Completed||Phase 3|689|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:25:51.556605|2017-02-18 13:25:51.556605
NCT00836420|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-10-26|||January 2000||2000-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Cerebral Microdialysis in Patients With Fulminant Hepatic Failure|Cerebral Microdialysis in Patients With Fulminant Hepatic Failure|Completed||N/A|50|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples Without DNA|"~     microdialysate from the brain as part of rutine monitoring~   "|||2017-02-18 13:25:51.927699|2017-02-18 13:25:51.927699
NCT00836407|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-10-16|2013-10-16||February 2009||2009-02-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer|A Phase Ib Trial Evaluating the Safety and Feasibility of Ipilimumab (BMS-734016) Alone or in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene for the Treatment of Locally Advanced, Unresectable or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 1|30|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 13:25:52.032112|2017-02-18 13:25:52.032112
NCT00836394|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2011-06-27|||February 2009||2009-02-01|May 2009|2009-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|WBV-JIA||Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis|The Effect of Whole Body Vibration Therapy on Muscle Function and Joint Loading in Children With Juvenile Idiopathic Arthritis|Completed||N/A|70|Anticipated|Children's Hospital of Eastern Ontario||2|||f||||f||||||||||2017-02-18 13:25:52.66764|2017-02-18 13:25:52.66764
NCT00836381|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-05-29|||February 2009||2009-02-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder|Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder (Phase Ⅳ)|Completed||Phase 4|56|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 13:25:52.776348|2017-02-18 13:25:52.776348
NCT00836368|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2011-11-04|||December 2008||2008-12-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Gammaphil||In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics|In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics|Completed||Phase 1|25|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 13:25:52.888853|2017-02-18 13:25:52.888853
NCT00836355|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-03-29|2016-02-29||April 2009||2009-04-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Enoxaparin and/or Minocycline in Acute Stroke|Pilot Study of Treatment With Intravenous Enoxaparin and/or Oral Minocycline to Limit Infarct Size After Ischemic Stroke|Terminated||N/A|6|Actual|New York University School of Medicine|This trial was terminated early because of logistical challenges in data collection. No outcome measures data was able to be collected.|4||Too few acute stroke patients available to meet enrollment requirements.|f||||f||||||||||2017-02-18 13:25:53.000614|2017-02-18 13:25:53.000614
NCT00836342|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2012-06-24|2012-05-14||February 2009||2009-02-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer|Comparison of Skin Carotenoid Levels Between Subjects With History of Cutaneous Squamous Cell Carcinoma and Subjects With History of Basal Cell Carcinoma Versus a Control Group|Completed||N/A|81|Actual|Massachusetts General Hospital|Limitations include a small sample size||3||f||||f||||||||||2017-02-18 13:25:53.465981|2017-02-18 13:25:53.465981
NCT00836329|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-07-11|||December 2008||2008-12-01|July 2009|2009-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery|Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery|Completed||Phase 3|133|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 13:25:54.028824|2017-02-18 13:25:54.028824
NCT00836316|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03||||||February 2009|2009-02-01||||||||Interventional|||Levobupivacaine During Cholecystectomy|Effects of Intraperitoneal Levobupivacaine on Pain After Laparoscopic Cholecystectomy: A Prospective, Randomized, Double-Blinded Study|Completed||Phase 4|40|Actual|Ege University||1|||f||||||||||||||2017-02-18 13:25:54.129736|2017-02-18 13:25:54.129736
NCT00836303|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-02|||December 2005||2005-12-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Trial of a Multilevel Intervention to Increase Colorectal Cancer Screening|A Randomized Controlled Trial of a Multilevel Intervention to Increase Colorectal Cancer Screening Among Latino Immigrants in a Primary Care Facility|Completed||N/A|130|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-02-18 13:25:54.210165|2017-02-18 13:25:54.210165
NCT00836290|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-10-19|||January 2008||2008-01-01|October 2015|2015-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|Project PLUS||Positive Lifestyles Using Safety|Positive Lifestyles Using Safety|Completed||N/A|90|Actual|Yale University||3|||f||||f||||||||||2017-02-18 13:25:54.307009|2017-02-18 13:25:54.307009
NCT00836277|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-09-23|2016-07-27||May 2009||2009-05-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Phase II Study of Irinotecan and Panitumumab|Phase II Study of Irinotecan and Panitumumab as Second-Line Therapy for Patients With Advanced Esophageal Adenocarcinoma|Completed||Phase 2|24|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:25:54.422308|2017-02-18 13:25:54.422308
NCT00836264|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2017-01-19|||December 2015|Actual|2015-12-01|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|December 2018|Anticipated|2018-12-01||Observational|||Pharmacogenomics Analysis of Morphine Pharmacokinetics in Pediatric Tonsillectomy and Adenoidectomy|Pharmacogenomic Analysis of Morphine Pharmacokinetics and Response Variability Following Pediatric Tonsillectomy and Adenoidectomy: A Genome-Wide Association Approach|Suspended||N/A|1650|Anticipated|Children's Hospital of Philadelphia|||1|Enrollment is on hold dependent upon funding|f||||f||||||Samples Without DNA|"~     PK plasma samples will be obtained~   "|||2017-02-18 13:25:54.993223|2017-02-18 13:25:54.993223
NCT00836251|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2014-03-12|||April 2006||2006-04-01|March 2014|2014-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|DLW||Effects of Antipsychotic Medications on Energy Intake and Expenditure|Effects of Antipsychotic Medications on Energy Intake and Expenditure|Completed||N/A|15|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 13:25:55.087128|2017-02-18 13:25:55.087128
NCT00836238|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-07-31|||February 2009||2009-02-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Questionnaire and Fall Risk Assessment|A Cross-Sectional Study of the Predictability of a Questionnaire About Difficulty in Climbing Up or Down Stairs in Objective Measures of Functional Status in Elderly Patients With Prostate Cancer|Completed||N/A|34|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:25:55.198985|2017-02-18 13:25:55.198985
NCT00836225|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2012-02-02|||January 2009||2009-01-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers|A Phase I , Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 388626 Administered to Healthy Volunteers|Completed||Phase 1|103|Actual|Ionis Pharmaceuticals, Inc.||10|||f||||t||||||||||2017-02-18 13:25:55.331202|2017-02-18 13:25:55.331202
NCT00836212|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-07-21|||March 2008||2008-03-01|July 2009|2009-07-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|TDM||Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring|Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring|Unknown status|Recruiting|Phase 4|12|Anticipated|University Hospital, Geneva||2|||f||||||||||||||2017-02-18 13:25:55.447457|2017-02-18 13:25:55.447457
NCT00836199|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-05-08|||October 2009||2009-10-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||NicVAX/Placebo as an Aid for Smoking Cessation|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy, Immunogenicity and Safety of 3'-Aminomethylnicotine-P. Aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) as an Aid to Smoking Cessation|Completed||Phase 3|1000|Actual|Nabi Biopharmaceuticals||2|||f||||t||||||||||2017-02-18 13:25:55.556027|2017-02-18 13:25:55.556027
NCT00836186|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2014-03-28|||March 2009||2009-03-01|March 2014|2014-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Cytokine Expression During Radiation for Breast Cancer|Cytokine Expression During Radiation for Breast Cancer|Unknown status|Recruiting|N/A|100|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:25:55.687012|2017-02-18 13:25:55.687012
NCT00836173|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2016-03-14|||July 2008||2008-07-01|March 2016|2016-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma|A Phase II Study Evaluating Three Cyslces of Ifosfamide, Carboplatin, Etoposide, and Rituximab (RICE) Followed by Two Cycles of Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma MA|Withdrawn||Phase 2|0|Actual|Loyola University||1||Gallium is no longer available for the conduct of this study.|f||||t||||||||||2017-02-18 13:25:55.778603|2017-02-18 13:25:55.778603
NCT00836160|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-09-19|||August 2009||2009-08-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy|Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy|Completed||N/A|36|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:25:55.889084|2017-02-18 13:25:55.889084
NCT00836147|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-09-27|||February 2009||2009-02-01|September 2010|2010-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids|A Single-centre, Double Blind, Randomised, Exploratory Study to Explore the Efficacy and Safety of Juvista 250ng/100µL/Linear cm When Administered Following Excision of Ear Lobe Keloids.|Completed||Phase 1/Phase 2|20|Actual|Renovo||2|||f||||f||||||||||2017-02-18 13:25:55.978343|2017-02-18 13:25:55.978343
NCT00836134|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2014-06-10|||February 2009||2009-02-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Ultrasound-guided Rectus Sheath Block for Post-operative Pain Control Following Umbilical Hernia Repair|Ultrasound-guided Rectus Sheath Block for Post-operative Pain Control Following Umbilical Hernia Repair|Completed||N/A|40|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-02-18 13:25:56.065788|2017-02-18 13:25:56.065788
NCT00836121|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-03|||September 2008||2008-09-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Observational|||Anterior Mediastinum Teratoma: A Case Report|Case Report of a 39 Years Old Man That Has Been Cured by a Total Resection of a Anterior Mediastinum Teratoma.|Completed||N/A|1|Actual|Faculdade de Medicina de Catanduva|||1||f||||t||||||||||2017-02-18 13:25:56.168774|2017-02-18 13:25:56.168774
NCT00836108|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-07-10|||February 2009||2009-02-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Unsupported Arm Exercise and Breathing Strategy in Patients With Chronic Obstructive Pulmonary Disease|Unsupported Arm Exercise and Breathing Strategy in Patients With Chronic|Completed||N/A|36|Actual|West Park Healthcare Centre||3|||f||||f||||||||||2017-02-18 13:25:56.258443|2017-02-18 13:25:56.258443
NCT00836095|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-03-17|2014-05-05||January 2009||2009-01-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|||Comparison of ProSeal Laryngeal Mask Airway to Laryngeal Mask Airway Supreme|A Randomized Controlled Trial Comparing the ProSeal Laryngeal Mask Airway With the Laryngeal Mask Airway Supreme in Mechanically Ventilated Patients|Completed||Phase 4|52|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||||2017-02-18 13:25:56.357702|2017-02-18 13:25:56.357702
NCT00836082|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-08-05|||February 2009||2009-02-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers|A Phase 1, Double-Blind (Sponsor Open), Randomised, Placebo-Controlled, Parallel Group, Oral Multiple-Dose Trial To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04457845 In Healthy Volunteers|Completed||Phase 1|41|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:25:56.650517|2017-02-18 13:25:56.650517
NCT00836069|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-05-29|||October 2008||2008-10-01|May 2009|2009-05-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder|A Phase 3, Randomized, Double-Blind, Parallel Group, 10-Week Placebo Controlled Fixed Dose Study of PD 0332334 and Paroxetine Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder|Terminated||Phase 3|15|Anticipated|Cedars-Sinai Medical Center||4||Pfizer has terminated the execution of this protocol|f||||f||||||||||2017-02-18 13:25:56.763617|2017-02-18 13:25:56.763617
NCT00836056|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-09-01|2009-06-18||November 2003||2003-11-01|September 2009|2009-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Clindamycin 300 mg Capsules and Cleocin HCl Administered as 1 x 300 mg Capsule in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:56.877452|2017-02-18 13:25:56.877452
NCT00836043|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-12-02|||October 2008||2008-10-01|December 2013|2013-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia|Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia (CLL)|Terminated||N/A|6|Actual|Sanofi|||1|Study terminated due to low enrollment.|f||||f||||||||||2017-02-18 13:25:57.28137|2017-02-18 13:25:57.28137
NCT00836030|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2016-11-21|||January 2009||2009-01-01|November 2016|2016-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|DiabCare Asia||A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Singapore|DiabCare Asia 2008. A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia and To Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in Asia|Completed||N/A|854|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"~     Blood sample~   "|||2017-02-18 13:25:57.403583|2017-02-18 13:25:57.403583
NCT00836017|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2014-06-19|2014-06-19||January 2009||2009-01-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational||Baseline measures were based on all enrolled participants who received treatment.|CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy||Completed||N/A|1046|Actual|Allergan|||1||f||||f||||||||||2017-02-18 13:25:57.577431|2017-02-18 13:25:57.577431
NCT00836004|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-09-01|2009-06-18||November 2003||2003-11-01|September 2009|2009-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Clindamycin 300 mg Capsules and Cleocin Hcl Administered as 1 x 300 mg Capsule in Healthy Subjects Under Fed Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:58.011395|2017-02-18 13:25:58.011395
NCT00835991|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-09-01|2009-06-30||February 2003||2003-02-01|September 2009|2009-09-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed|Randomized, 2-Way Crossover, Bioequivalence Study of Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets and Glucovance® 5 mg/500 mg Film-Coated Tablets in Healthy Subjects Under Fed Conditions|Completed||Phase 1|60|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:25:58.404083|2017-02-18 13:25:58.404083
NCT00835978|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-05-11|2013-10-11||August 2009||2009-08-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|October 2012|Actual|2012-10-01||Interventional||The safety analysis (SA) population consists of all participants who received at least one dose of study medication.|Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer|Randomized, Double-blind Phase 2 Study Of Axitinib (Ag-013736) With Or Without Dose Titration In Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|213|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:25:59.008038|2017-02-18 13:25:59.008038
NCT00835965|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03|||February 2009||2009-02-01|February 2009|2009-02-01||||December 2009|Anticipated|2009-12-01||Interventional|||Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries|A Randomized, Double-Blind Comparison of Oral Aprepitant and Lower Dose Dexamethasone vs Aprepitant Alone for Preventing Postoperative Nausea and Vomiting After Elective Laparoscopic Surgeries|Unknown status|Not yet recruiting|N/A|50|Anticipated|Main Line Health||2|||f||||f||||||||||2017-02-18 13:26:00.98971|2017-02-18 13:26:00.98971
NCT00835952|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-01-25|||November 2008||2008-11-01|January 2010|2010-01-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|ATX-101-08-10||ATX-101 Abdominoplasty|Phase 1, Open-label Study of the Safety, Tolerability, and Histological Effect of Single Doses of ATX-101 (Sodium Deoxycholate for Injection) Administered in Abdominal Fat in Subjects Undergoing Abdominoplasty|Completed||Phase 1|14|Anticipated|Kythera Biopharmaceuticals||1|||f||||f||||||||||2017-02-18 13:26:01.107268|2017-02-18 13:26:01.107268
NCT00835939|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-02-03|||September 2007||2007-09-01|February 2009|2009-02-01||||January 2010|Anticipated|2010-01-01||Interventional|||Treatment for Achilles Tendinopathy|Treatment for Achilles Tendinopathy|Unknown status|Active, not recruiting|Phase 2/Phase 3|17|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 13:26:01.198176|2017-02-18 13:26:01.198176
NCT00835926|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-04-12|2009-09-23||July 2003||2003-07-01|April 2016|2016-04-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination|Safety and Immunogenicity of Influenza Virus Vaccine USP Trivalent Types A and B (Zonal Purified Subvirion) Fluzone® 2003/2004|Completed||Phase 4|121|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:26:01.308143|2017-02-18 13:26:01.308143
NCT00835913|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-01-16|||October 2008||2008-10-01|July 2010|2010-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|SNA&Sepsis||Autonomic Nervous System Alteration Induce by Sepsis: Assessment and Prognosis Impact|Autonomic Nervous System Alteration Induce by Sepsis:Assessment and Prognosis Impact|Completed||Phase 4|13|Actual|University Hospital, Grenoble|||1||f||||t||||||Samples Without DNA|"~     Peptid and protein sAmple~   "|||2017-02-18 13:26:01.868157|2017-02-18 13:26:01.868157
NCT00835900|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-08-11|||March 2009||2009-03-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|July 2010|Actual|2010-07-01||Interventional|||An Alternative Dosing Schedule of Varenicline for Smoking Cessation|Extended Varenicline for Smoking Cessation: A Pilot Study|Completed||Phase 2|60|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-02-18 13:26:01.96521|2017-02-18 13:26:01.96521
NCT00835887|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-09-22||||||September 2015|2015-09-01||||||||Interventional|ESRD||Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease|Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease, a Phase 2 Study|Withdrawn||Phase 2|0|Actual|RWTH Aachen University||2||no patients recruited, responsible physician left clinic|f||||f||||||||||2017-02-18 13:26:02.086744|2017-02-18 13:26:02.086744
NCT00835874|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2012-08-01|||June 2007||2007-06-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis|Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis|Terminated||N/A|57|Actual|Tel-Aviv Sourasky Medical Center||1||"Difficulty in recruitment. Mothers of infants preferred to take probiotics bought~   over-the-counter over the possibility of being in a placebo group"|f||||f||||||||||2017-02-18 13:26:02.185516|2017-02-18 13:26:02.185516
NCT00835861|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2014-04-24|2013-08-14||August 2008||2008-08-01|April 2014|2014-04-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|MIPOD|Three women who never received the allocated treatment were excluded from the analysis.|Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes|Pilot Study of Metformin vs. Insulin in Pregnant Overt Diabetics (MIPOD)|Completed||Phase 2|31|Actual|University of North Carolina, Chapel Hill|Unable to achieve enrollment goal before funding period expired because recruitment progressed more slowly than anticipated.|2|||f||||f||||||||||2017-02-18 13:26:02.287825|2017-02-18 13:26:02.287825
NCT00835848|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-05-04|||January 2009||2009-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|December 2009|Actual|2009-12-01||Interventional|POSTCON II||Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI|Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI in Patients With STEMI|Completed||Phase 4|100|Anticipated|Rigshospitalet, Denmark||2|||f||||||||||||||2017-02-18 13:26:02.848134|2017-02-18 13:26:02.848134
NCT00835835|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2015-11-09|||February 2008||2008-02-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|October 2011|Actual|2011-10-01||Interventional|||Lokomat Treadmill Training Effects on MS Gait|Lokomat Treadmill Training Effects on MS Gait|Completed||N/A|8|Actual|Mount Sinai Rehabilitation Hospital||2|||f||||f||||||||||2017-02-18 13:26:02.956639|2017-02-18 13:26:02.956639
NCT00835822|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-03|||May 2005||2005-05-01|February 2009|2009-02-01||||October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency|Multicenter, Prospective, Randomized, Double-Blind Study to Assess the Therapeutic Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency|Completed||Phase 4|216|Actual|Abbott||2|||f||||f||||||||||2017-02-18 13:26:03.062491|2017-02-18 13:26:03.062491
NCT00835809|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-09-06|||October 2008||2008-10-01|September 2010|2010-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|BIO-IRA||Multi Marker Approach Interest in Emergency in Acute Respiratory Insufficiency Diagnostic|Multi Marker Approach Interest in Emergency in Acute Respiratory Insufficiency Diagnostic|Completed||N/A|400|Actual|University Hospital, Grenoble|||1||f||||t||||||Samples With DNA|"~     Protein sample~   "|||2017-02-18 13:26:03.16458|2017-02-18 13:26:03.16458
NCT00835796|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-09-01|2009-06-22||June 2002||2002-06-01|September 2009|2009-09-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Finasteride 5 mg Tablets, Non-fasting|A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|20|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:03.256754|2017-02-18 13:26:03.256754
NCT00835783|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2014-10-26|||November 2008||2008-11-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|PIN-UP||Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation|PET/CT in Infection and Inflammation Imaging: Current Utility and Future Perspectives (The PIN-UP Study)|Terminated||N/A|30|Actual|Odense University Hospital|||3|Study logistics proved difficult and enrollment never moved beyond the pilot phase.|f||||f||||||||||2017-02-18 13:26:03.710205|2017-02-18 13:26:03.710205
NCT00835770|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2017-02-14|||February 2009||2009-02-01|February 2017|2017-02-01|February 2023|Anticipated|2023-02-01|February 2023|Anticipated|2023-02-01||Interventional|ENDORSE||BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)|A Dose-Blind, Multicenter, Extension Study to Determine the Long-Term Safety and Efficacy of Two Doses of BG00012 Monotherapy in Subjects With Relapsing-Remitting Multiple Sclerosis|Active, not recruiting||Phase 3|1738|Actual|Biogen||2|||f||||f||||||||||2017-02-18 13:26:03.810841|2017-02-18 13:26:03.810841
NCT00835757|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-12-13|||September 2008||2008-09-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|||Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy|"Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy"|Completed||N/A|50|Actual|University of Michigan|||2||f||||f||||||||||2017-02-18 13:26:04.396873|2017-02-18 13:26:04.396873
NCT00835744|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2012-03-27|||August 2008||2008-08-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|cc versus FSH||Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles|Among Non-IVF Patients Undergoing Ovulation Induction With Clomiphene Citrate (Clomid® 50 mg), Does Administration of an Increased Dose of Clomiphene Citrate (Clomid® 100 mg) Compared With Gonadotropins, Achieve Similar Rates of Folliculogenesis?|Completed||Phase 4|40|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-02-18 13:26:04.477825|2017-02-18 13:26:04.477825
NCT00835731|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2013-11-20|2013-06-13||January 2009||2009-01-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Misoprostol Versus Dilapan-S for Cervical Preparation|Cervical Preparation Before Same-day Second Trimester Abortion With Buccal Misoprostol Versus Dilapan-S: A Randomized Placebo Controlled Trial|Completed||N/A|125|Actual|Planned Parenthood League of Massachusetts||2|||f||||f||||||||||2017-02-18 13:26:04.585671|2017-02-18 13:26:04.585671
NCT00835718|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2010-03-26|||February 2009||2009-02-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study of MK0594 in Patients With Alcohol Dependence|A Phase II Multicenter, Randomized, Double-Blind, Two-Stage Clinical Trial to Evaluate the Efficacy and Safety of MK0594 in Patients With Alcohol Dependence|Terminated||Phase 2|162|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 13:26:05.002005|2017-02-18 13:26:05.002005
NCT00835705|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-07-06|2009-05-07||September 2003||2003-09-01|July 2009|2009-07-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Amoxicillin-Clavulanic Acid 400 mg-57 mg Chewable Tablets Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Amoxicillin-Clavulanic Acid 400 mg-57 mg Chewable Tablets and AUGMENTIN® 400 mg-57 mg Chewable Tablets Administered as 1 x 400 mg-57 mg Chewable Tablet in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|52|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:05.099655|2017-02-18 13:26:05.099655
NCT00835692|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-09-01|2009-06-18||September 2002||2002-09-01|September 2009|2009-09-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Clarithromycin 500 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 500 mg Clarithromycin Tablets Under Fasting COnditions|Completed||Phase 1|60|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:05.80311|2017-02-18 13:26:05.80311
NCT00835276|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-30||March 2002||2002-03-01|August 2009|2009-08-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 180 mg Fexofenadine Hydrochloride Tablets Under Fasting Conditions.|Completed||Phase 1|60|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:15.813001|2017-02-18 13:26:15.813001
NCT00835679|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2014-05-07|2012-03-12||December 2009||2009-12-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|February 2011|Actual|2011-02-01||Interventional|||Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery|A Preoperative Biological Trial of Cetuximab, Dasatinib or the Combination in Colorectal Cancer Patients With Resectable Liver Metastases|Terminated||Early Phase 1|9|Actual|National Cancer Institute (NCI)|"Due to study design and slow accrual, no drug was received, no biomarkers were determined and no data obtained. 0 data is entered in the outcomes measures database as suggested by CT.gov previously. Detailed explanations are given."|4|||f||||||||||||||2017-02-18 13:26:06.26415|2017-02-18 13:26:06.26415
NCT00835666|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-03|2009-09-01|2009-06-22||June 2002||2002-06-01|September 2009|2009-09-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Finasteride 5 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:06.759842|2017-02-18 13:26:06.759842
NCT00835653|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-09-22|||January 2009||2009-01-01|September 2016|2016-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Efficacy of Median Nerve Block Performed Using Echographic Guidance|Efficacy of Median Nerve Block Performed Using Echographic Guidance|Completed||N/A|70|Anticipated|Hopital Foch|||2||f||||f||||||||||2017-02-18 13:26:07.364335|2017-02-18 13:26:07.364335
NCT00835640|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-30||January 2002||2002-01-01|August 2009|2009-08-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions|A Relative Bioavailability Study of 180 mg Fexofenadine Hydrochloride Tablets Under Fed Conditions.|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:07.472158|2017-02-18 13:26:07.472158
NCT00835627|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2014-11-07|||September 2008||2008-09-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|NEST-T_1||Treatment Trial for Psychogenic Nonepileptic Seizures|Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures|Completed||Phase 4|38|Actual|Rhode Island Hospital||4|||f||||t||||||||||2017-02-18 13:26:07.878606|2017-02-18 13:26:07.878606
NCT00835614|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-18||April 2004||2004-04-01|August 2009|2009-08-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Cefprozil for Oral Suspension 250 mg/5 mL, Fasting|A Relative Bioavailability Study of Cefprozil for Oral Suspension 250 mg/5 mL Under Fasting Conditions|Completed||Phase 1|26|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:08.027337|2017-02-18 13:26:08.027337
NCT00835601|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2011-05-13|||January 2009||2009-01-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Observational|CCD||Resistive/Cardiovascular Training Study|An Integrated Musculoskeletal Countermeasure Battery for Long-Duration Lunar Missions|Completed||N/A|36|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:26:08.467392|2017-02-18 13:26:08.467392
NCT00835588|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-09-09|2009-07-02||December 2003||2003-12-01|September 2009|2009-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions|A Relative Bioavailability Study of Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions|Completed||Phase 1|100|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:08.538108|2017-02-18 13:26:08.538108
NCT00835575|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-07-02||July 2003||2003-07-01|September 2009|2009-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||15 mg Mirtazapine Orally Disintegrating Tablets, Fasting|A Relative Bioavailability Study of 15 mg Mirtazapine Orally Disintegrating Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:09.049326|2017-02-18 13:26:09.049326
NCT00835562|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2012-06-06|||April 2009||2009-04-01|June 2012|2012-06-01||||March 2013|Anticipated|2013-03-01||Interventional|||Effect of Osteosynthesis, Primary Hemi-arthroplasty, and Non-surgical Management for Fractures of the Proximal Humerus|Effect of Osteosynthesis, Primary Hemi-arthroplasty, and Non-surgical Management for Displaced Four-part Fractures of the Proximal Humerus in Elderly: a Multi-centre, Randomised Clinical Trial|Unknown status|Recruiting|Phase 3|162|Anticipated|Herlev Hospital||3|||f||||f||||||||||2017-02-18 13:26:09.466906|2017-02-18 13:26:09.466906
NCT00835549|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-18||March 2005||2005-03-01|August 2009|2009-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting|A Relative Bioavailability Study of Cefdinir for Oral Suspension 250 mg/5mL Under Non-Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:09.562331|2017-02-18 13:26:09.562331
NCT00835536|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-07-02||September 2003||2003-09-01|September 2009|2009-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Ribavirin 200 mg Tablets Under Non-Fasting Conditions|A Relative Bioavailability Study of Ribavirin 200 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|27|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:10.029664|2017-02-18 13:26:10.029664
NCT00835523|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2012-06-13|||May 2008||2008-05-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist|OHSS Prevention by GnRH-agonist Triggering of Final Oocyte Maturation and Cryoperservation of All Two-pronucleate Oocytes in Women Undergoing Stimulation for IVF With Gonadotrophins and GnRH-analogues: a Prospective, Observational, Multicentric, Clinical Cohort Study|Completed||N/A|51|Actual|University of Schleswig-Holstein|||1||f||||t||||||||||2017-02-18 13:26:10.591385|2017-02-18 13:26:10.591385
NCT00835510|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2014-01-02|2009-05-04||June 2008||2008-06-01|January 2014|2014-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis|A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis|Completed||Phase 1|548|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-02-18 13:26:10.694617|2017-02-18 13:26:10.694617
NCT00835497|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-09|2009-07-02||June 2004||2004-06-01|September 2009|2009-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting|A Relative Bioavailability Study of 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets Under Fasting Conditions.|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:11.264094|2017-02-18 13:26:11.264094
NCT00835484|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-18||July 2005||2005-07-01|August 2009|2009-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Cefdinir Capsules 300 mg, Fasting|A Relative Bioavailability Study of 300 mg Cefdinir Capsules Under Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:12.026916|2017-02-18 13:26:12.026916
NCT00835471|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2010-07-23|||March 2009||2009-03-01|July 2010|2010-07-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|NVALT10||2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)|A Randomized Phase II Study of Erlotinib Compared to Single Agent Chemotherapy-erlotinib Combination in Pretreated Patients With Advanced NSCLC (NVALT10 Study)|Unknown status|Recruiting|Phase 2|230|Anticipated|Dutch Society of Physicians for Pulmonology and Tuberculosis||2|||f||||f||||||||||2017-02-18 13:26:12.509634|2017-02-18 13:26:12.509634
NCT00835458|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-10|||February 2009||2009-02-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Endoscopic Treatment of Intestinal Fistulas and Perforations|Closure of Fistulas and Perforations Endoscopically to Avoid Laparoscopic or Open Surgery|Unknown status|Enrolling by invitation|N/A|5|Actual|Legacy Health System||1|||f||||f||||||||||2017-02-18 13:26:12.645771|2017-02-18 13:26:12.645771
NCT00835445|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2011-01-06|||July 2007||2007-07-01|December 2010|2010-12-01|September 2009|Actual|2009-09-01|October 2008|Actual|2008-10-01||Observational|||Biopsies and Polyps|Nasal Features of Subjects With Nasal Polyposis With or Without Asthma|Completed||N/A|25|Actual|Laval University|||2||f||||f||||||Samples Without DNA|"~     Nasal polyps (Biopsies) Normal nasal mucosa (Biopsies) Sputum~   "|||2017-02-18 13:26:12.750651|2017-02-18 13:26:12.750651
NCT00835432|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-02|||October 2005||2005-10-01|February 2009|2009-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|BCP+Collagen||Morphometric, Clinical and Histological Study on One Stage Bone Augmentation Using BoneCeramic (BCP) and Collagen Membranes|Prospective Clinical, Morphometric and Histological Study on Augmentation Using BoneCeramic as Bone Substitute in Combination With Either Cross-Linked or Non Cross-Linked Collagen Membrane in Dehiscent Type of Defects .|Completed||Phase 4|40|Actual|Charite University, Berlin, Germany|||||f||||f||||||||||2017-02-18 13:26:12.843296|2017-02-18 13:26:12.843296
NCT00835419|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2012-12-03|||May 2009||2009-05-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|April 2011|Actual|2011-04-01||Interventional|ENVER||Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression|An Open Label, Multicentre, Two Stage, Phase II Study To Evaluate Efficacy And Safety Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression|Completed||Phase 2|12|Actual|Piramal Enterprises Limited||1|||f||||f||||||||||2017-02-18 13:26:12.923275|2017-02-18 13:26:12.923275
NCT00835406|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-06-29|2009-04-24||June 2000||2000-06-01|June 2009|2009-06-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.|Randomized, 2-Way Crossover, Bioequivalence Study of Teva Pharmaceuticals USA and Merck Sharp & Dohme (USA) (Fosamax®) Alendronate Sodium Tablets Administered as a 1 x 70 mg in Healthy Adult Males Under Fasting Conditions|Completed||Phase 1|140|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:13.035996|2017-02-18 13:26:13.035996
NCT00835393|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-02|||December 2003||2003-12-01|January 2009|2009-01-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions|A Relative Bioavailability Replicated Crossover Study of Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions.|Completed||Phase 1|50|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:13.533975|2017-02-18 13:26:13.533975
NCT00835380|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2015-05-27|2009-10-19||March 2008||2008-03-01|May 2015|2015-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)|A Phase III Open-Label Study of Immunogenicity, Safety, and Tolerability of 2 Doses of VAQTA™ (Formalin, Inactivated, Alum-Adjuvanted Hepatitis A Vaccine) in Healthy Children 12 to 23 Months of Age|Completed||Phase 3|80|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:26:13.638445|2017-02-18 13:26:13.638445
NCT00835367|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-07-06|2009-05-06||March 2004||2004-03-01|July 2009|2009-07-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions|Randomized, 2-Way, Crossover, Bioequivalence Study of Amlodipine-Benazepril 10mg-20mg Capsules and Lotrel® Administered as 1 x 10 mg-20 mg Capsule in Healthy Subjects Under Fed Conditions.|Completed||Phase 1|68|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:13.886264|2017-02-18 13:26:13.886264
NCT00835354|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-18||May 2004||2004-05-01|August 2009|2009-08-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting|A Relative Bioavailability Study of Cefprozil for Oral Suspension 250 mg/5 mL Under Non-Fasting Conditions|Completed||Phase 1|26|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:14.422579|2017-02-18 13:26:14.422579
NCT00835341|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-05-07|2009-10-21||March 2005||2005-03-01|May 2015|2015-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Methylation of p16 CpG Island And Malignant Transformation of Oral Epithelial Dysplasia|A Cohort Study on Prediction of Malignant Transformation of Oral Epithelial Dysplasia by p16 Methylation|Completed||N/A|93|Actual|Peking University|||2||f||||t||||||Samples With DNA|"~     Tissue specimen are collected from outpatients and inpatients with oral leukoplakia by~     biopsy or surgical resection, fixed in neutral buffered formalin, and embedded in paraffin.~     Genomic DNA is extracted from tissue sections.~   "|||2017-02-18 13:26:14.891152|2017-02-18 13:26:14.891152
NCT00835328|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-09-08|||February 2009||2009-02-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia|Role of GLP-1 In Congenital Hyperinsulinism: Effect Of Exendin-(9-39)On Glucose Requirements To Maintain Euglycemia|Recruiting||Phase 1/Phase 2|20|Anticipated|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 13:26:15.263497|2017-02-18 13:26:15.263497
NCT00835315|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2010-08-11|||January 2008||2008-01-01|February 2009|2009-02-01||||||||Observational|||Prevalence of Psoriasis Alba in Psoriatic Patients||Unknown status|Enrolling by invitation|N/A|300|Actual|Hadassah Medical Organization|||1||f||||t||||||||||2017-02-18 13:26:15.39401|2017-02-18 13:26:15.39401
NCT00835302|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-01-29|||October 2006||2006-10-01|February 2009|2009-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Development of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation|Development of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation|Completed||Phase 2|80|Actual|University of Colorado, Denver||1|||f||||f||||||||||2017-02-18 13:26:15.475394|2017-02-18 13:26:15.475394
NCT00835263|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-06-30||January 2002||2002-01-01|September 2009|2009-09-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions|Randomized, 2-Way, Crossover, Bioequivalence Study of Lamotrigine 200 mg Tablets and Lamictal® 200 mg Tablets Administered as 1 x 200 mg Tablet in Healthy Subjects Under Fed Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:16.288387|2017-02-18 13:26:16.288387
NCT00835250|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-03-11|||February 2009||2009-02-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|May 2011|Actual|2011-05-01||Interventional|||Laparoscopic Cholecystectomy vs Hybrid Natural Orifice Translumenal Surgery|Prospective Randomized Clinical Trial Comparing Laparoscopic Cholecystectomy and Hybrid Natural Orifice Translumenal Endoscopic Surgery (NOTES)|Completed||Phase 3|60|Actual|Hospital Son Llatzer||3|||f||||f||||||||||2017-02-18 13:26:16.700152|2017-02-18 13:26:16.700152
NCT00835237|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-10-06|2010-07-08||February 2009||2009-02-01|October 2016|2016-10-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.|Evaluation of GSK Biologicals' Boostrix® Vaccine When Compared With Decavac™ in Adults Aged 65 Years or Older.|Completed||Phase 3|1332|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:26:16.818311|2017-02-18 13:26:16.818311
NCT00835224|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2014-03-21|2013-09-12||May 2010||2010-05-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional||30 subjects were anticipated but 34 were enrolled following an IRB approval to expand the n. Increased recruitment was due to a number of subjects withdrawing from participation for various reasons listed below.|Safety and Efficacy of L-NAME and Midodrine to Increase MAP|Safety and Efficacy of L-NAME and Midodrine to Increase MAP in Persons With Tetraplegia|Completed||Phase 2|34|Actual|VA Office of Research and Development|Study population was relatively small and were not blinded to the interventions.|3|||f||||f||||||||||2017-02-18 13:26:17.663946|2017-02-18 13:26:17.663946
NCT00835211|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-06-30||July 2003||2003-07-01|September 2009|2009-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Desmopressin Acetate 0.2 mg Tablets, Fasting|Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of TEVA and Aventis Pharmaceuticals (DDAVP®) 0.2 mg Desmopressin Acetate Tablets in Healthy Adult Subjects Following a 0.8 mg Dose Under Fasting Conditions|Completed||Phase 1|48|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:17.991916|2017-02-18 13:26:17.991916
NCT00835198|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2011-09-22|2011-09-22||December 2008||2008-12-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris||Completed||Phase 4|163|Actual|Allergan||2|||f||||||||||||||2017-02-18 13:26:18.443616|2017-02-18 13:26:18.443616
NCT00835185|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-12-21|2015-12-21||August 2007||2007-08-01|December 2015|2015-12-01|October 2010|Actual|2010-10-01|January 2010|Actual|2010-01-01||Interventional||All enrolled participants who received any quantity of study drug.|Study of IMC-11F8 in Participants With Colorectal Cancer|Open Label, Multicenter, Phase II Study Evaluating the Efficacy and Safety of IMC-11F8 in Combination With 5-FU/FA and Oxaliplatin (mFOLFOX-6) in Patients With Treatment-naïve, Locally-advanced or Metastatic Colorectal Cancer|Completed||Phase 2|44|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 13:26:18.799122|2017-02-18 13:26:18.799122
NCT00835172|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-06-22||March 2003||2003-03-01|September 2009|2009-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Glimepiride 4 mg Tablets Under Non-Fasting Conditions|A Relative Bioavailability Study of Glimepiride 4 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:19.451239|2017-02-18 13:26:19.451239
NCT00835159|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-01-26|2013-04-12||December 2008||2008-12-01|January 2015|2015-01-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|||Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial|Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial|Completed||Phase 4|30|Actual|New York University School of Medicine|The study was halted prematurely because of a warning letter issued by the rivastigmine manufacturer indicating the possibility of increased mortality associated with the oral administration of the drug in critically ill patients.|2|||f||||f||||||||||2017-02-18 13:26:19.926219|2017-02-18 13:26:19.926219
NCT00835146|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-07-02||September 2003||2003-09-01|September 2009|2009-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Ribavirin 200 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of Ribavirin 200 mg Tablets Under Fasting Conditions|Completed||Phase 1|28|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:20.315696|2017-02-18 13:26:20.315696
NCT00835133|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-31|2016-09-12|||August 2002||2002-08-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma|Biospecimen Resource for Familial Pancreas Research, a Data and Tissue Registry (Also Known as a Bio-repository, Bio-bank, Data and Tissue Database, Data and Tissue Bank, Etc.) to Help Advance Research in Familial Pancreas Disease|Recruiting||N/A|4000|Anticipated|Mayo Clinic|||1||f||||t||||||Samples With DNA|"~     Two 10mL plasma tubes and two 10mL serum tubes collected. DNA extracted from blood~     lymphocytes. Possible saliva sample for DNA extraction. Waste tissue from previous surgery~     may be requested.~   "|||2017-02-18 13:26:20.76205|2017-02-18 13:26:20.76205
NCT00835120|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-11-30|2014-10-10||March 2009||2009-03-01|November 2016|2016-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance|Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance|Completed||Phase 4|34|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-02-18 13:26:20.879299|2017-02-18 13:26:20.879299
NCT00835107|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-12-14|||February 2009||2009-02-01|December 2015|2015-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression|An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression|Completed||Phase 4|14|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 13:26:21.377561|2017-02-18 13:26:21.377561
NCT00834418|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-09|2009-07-02||June 2002||2002-06-01|September 2009|2009-09-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Leflunomide 20 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 20 mg Leflunomide Tablets Under Fasting Conditions|Completed||Phase 1|84|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:54.250761|2017-02-18 13:26:54.250761
NCT00835094|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-04-27|||October 2002||2002-10-01|April 2015|2015-04-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177)|A Randomized Trial Assessing the Chronobiology of Once Daily Administration of Mometasone Furoate DPI in Patients With Asthma|Completed||Phase 4|216|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:26:21.493515|2017-02-18 13:26:21.493515
NCT00835081|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-18||September 2004||2004-09-01|August 2009|2009-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.|A Two-Way , Crossover, Open-Label, Single-Dose, Fed, Bioequivalence Study of Cefadroxil 500 mg Capsules Versus DURICEF® 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.|Completed||Phase 1|26|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:21.592475|2017-02-18 13:26:21.592475
NCT00835068|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2014-09-11|2014-09-11||January 2009||2009-01-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational||Safety population included all participants who received at least one dose of BeneFIX.|Post Marketing Observational Study of Reformulated BeneFIX|Post Marketing Observational Study Of Reformulated BeneFIX|Completed||N/A|58|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:26:22.114489|2017-02-18 13:26:22.114489
NCT00835055|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-09-21|||April 2005||2005-04-01|September 2009|2009-09-01||||||||Observational|||Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer||Unknown status|Recruiting|N/A|100|Anticipated|St. Claraspital AG|||1||f||||||||||||||2017-02-18 13:26:25.017937|2017-02-18 13:26:25.017937
NCT00835042|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-07-02||October 2003||2003-10-01|September 2009|2009-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions|Completed||Phase 1|60|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:25.092782|2017-02-18 13:26:25.092782
NCT00835029|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2015-03-24|||March 2009||2009-03-01|March 2015|2015-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches|Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis|Completed||Phase 2|13|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:26:25.856633|2017-02-18 13:26:25.856633
NCT00835016|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2015-09-19|||February 2009||2009-02-01|September 2015|2015-09-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01||Interventional|LTP||Early Psychosocial Stimulation Program for Children of Depressed Mothers|Early Psychosocial Stimulation (LTP) Program for Children of Depressed Mothers: An RCT|Completed||Phase 2|260|Actual|Pakistan Institute of Learning and Living||2|||f||||f||||||||||2017-02-18 13:26:25.956947|2017-02-18 13:26:25.956947
NCT00835003|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2014-06-03|2014-06-03||March 2009||2009-03-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|November 2011|Actual|2011-11-01||Interventional|||Timing of Planned Caesarean Section and Morbidity of the Newborn|Timing of Elective Caesarean Section and Neonatal Morbidity - a Randomised Multicentre Study|Completed||N/A|1273|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-02-18 13:26:26.082941|2017-02-18 13:26:26.082941
NCT00834990|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-22||September 2003||2003-09-01|August 2009|2009-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions|A Relative Bioavailability Study of 500 mg Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:26.425955|2017-02-18 13:26:26.425955
NCT00834977|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-07-06|2009-05-06||April 2004||2004-04-01|July 2009|2009-07-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions|Randomized, 2-Way, Crossover, Bioequivalence Study of Amlodipine-Benazepril 10mg-20mg Capsules and Lotrel® Administered as 1 x 10 mg-20 mg Capsule in Healthy Subjects Under Fasting Conditions.|Completed||Phase 1|48|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:26.8306|2017-02-18 13:26:26.8306
NCT00834964|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-11|2009-07-06||December 2002||2002-12-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Venlafaxine 25 mg Tablets Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Venlafaxine 25 mg Tablets and Effexor® 25 mg Tablets Administered as 1 x 25 mg Tablet in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|30|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:27.369594|2017-02-18 13:26:27.369594
NCT00834951|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-02|||January 2003||2003-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma|A Prospective Multicenter Phase II Study of MabThera (Rituximab) Plus 2 Weekly CHOP Followed by Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma|Completed||Phase 2|40|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 13:26:27.83099|2017-02-18 13:26:27.83099
NCT00834938|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2011-08-09|||July 2007||2007-07-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2008|Actual|2008-07-01||Observational|||Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery|Long Term Effects of Bariatric Surgery on Diabetes: Comparison Between Patients With or Without Diabetes Recovery.|Completed||N/A|24|Actual|University of Campinas, Brazil|||2||f||||f||||||||||2017-02-18 13:26:27.913097|2017-02-18 13:26:27.913097
NCT00834925|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2011-07-25|||August 2009||2009-08-01|July 2011|2011-07-01|August 2011|Anticipated|2011-08-01|August 2009|Actual|2009-08-01||Interventional|||Low Dose of Diltiazem for Rate Control of Atrial Fibrillation||Unknown status|Recruiting|Phase 4|380|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-02-18 13:26:28.224383|2017-02-18 13:26:28.224383
NCT00834912|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-04-25|2009-04-09||February 2006||2006-02-01|April 2012|2012-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Two Tramadol Contramid® OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions||Completed||Phase 1|36|Actual|Labopharm Inc.||3|||f||||||||||||||2017-02-18 13:26:28.324046|2017-02-18 13:26:28.324046
NCT00833586|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-11|2009-07-06||January 2002||2002-01-01|September 2009|2009-09-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Terbinafine HCl 250 mg Tablet Under Fasting Conditions|The Relative Bioavailability of Two Terbinafine HCl 250 mg Tablet Formulations Under Fasting Conditions|Completed||Phase 1|28|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:40.289888|2017-02-18 13:26:40.289888
NCT00834899|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-31|2013-05-22|2013-02-24||January 2009||2009-01-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Safety Study of Eptifibatide in Patients With Sickle Cell Disease|A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Eptifibatide as Treatment for Acute Pain Episodes in Sickle Cell Disease|Terminated||Phase 1/Phase 2|13|Actual|University of North Carolina, Chapel Hill|The study was terminated early resulting in small numbers of subjects analyzed.|2||Slow accrual and no cost extension not approved by NHLBI|f||||t||||||||||2017-02-18 13:26:29.031244|2017-02-18 13:26:29.031244
NCT00834886|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2016-03-09|2014-08-01||October 2008||2008-10-01|March 2016|2016-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Randomized Controlled Trial on the Treatment Effects of Melatonin and Light Therapy on Delayed Sleep Phase Syndrome|Delayed Sleep Phase Syndrome in Adolescents and Young Adults. Sleep, Personality, Developmental History, Circadian Rhythm, Daytime Functioning and Treatment|Completed||Phase 4|40|Actual|University of Bergen||4|||f||||t||||||||No|Publications from the stury are reported here. IPD can be retrieved upon request to the study investigator.|2017-02-18 13:26:29.745193|2017-02-18 13:26:29.745193
NCT00834873|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-11|2009-05-08||December 2001||2001-12-01|September 2009|2009-09-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects|A Randomized, Two-Way Crossover, Single-Dose, Open Label Study to Evaluate the Relative Bioavailability of a Test Tablet Formulation of Carvedilol (25 mg), Compared to an Equivalent Dose of COREG® (SmithKline Beecham Pharmaceuticals) in 24 Fed, Healthy, Adult Subjects|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:30.277473|2017-02-18 13:26:30.277473
NCT00834860|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2010-02-11|||January 2007||2007-01-01|February 2009|2009-02-01|February 2010|Anticipated|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma|The Response and Outcomes of Pegylated Interferon Plus Ribavirin Combination Therapy for Chronic Hepatitis C Patients Concomitant With Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 4|179|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-02-18 13:26:30.708081|2017-02-18 13:26:30.708081
NCT00834847|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-01-30|||August 2000||2000-08-01|January 2009|2009-01-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Pravastatin Sodium 40 mg Tablets Food Challenge Study|A Relative Bioavailability Food Challenge Study of Pravastatin Sodium 40 mg Tablets|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||3|||f||||f||||||||||2017-02-18 13:26:30.831639|2017-02-18 13:26:30.831639
NCT00834834|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-09-25|||March 2009||2009-03-01|September 2013|2013-09-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder|Treating Suicidal Behavior and Self-Mutilation in Borderline Personality Disorder: Predictors of Change|Unknown status|Recruiting|Phase 4|120|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 13:26:30.928172|2017-02-18 13:26:30.928172
NCT00834821|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2014-01-17|||November 2008||2008-11-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Effectiveness of a Behavioral Treatment Program for Attention Deficit Hyperactivity Disorder, Inattentive Type|Integrated Multi-setting Psychosocial Treatment for ADHD-Inattentive Type|Unknown status|Active, not recruiting|N/A|210|Anticipated|University of California, San Francisco||3|||f||||f||||||||||2017-02-18 13:26:31.050552|2017-02-18 13:26:31.050552
NCT00834808|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-04-24|2009-04-08||November 2002||2002-11-01|April 2012|2012-04-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Dose Linearity Study of the Labopharm Formulation of Tramadol HCl/Contramid®, 100 mg, 200 mg and 300 mg After A Single Oral Administration In Fasting Condition, In Healthy Human Volunteers||Completed||Phase 1|27|Actual|Labopharm Inc.||3|||f||||||||||||||2017-02-18 13:26:31.158858|2017-02-18 13:26:31.158858
NCT00834795|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-11|2009-05-08||December 2001||2001-12-01|September 2009|2009-09-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects|A Randomized, Two-Way Crossover, Single-Dose, Open Label Study to Evaluate the Relative Bioavailability of a Test Tablet Formulation of Carvedilol (25 mg), Compared to an Equivalent Dose of COREG® (SmithKline Beecham Pharmaceuticals) in 36 Fasted, Healthy, Adult Subjects|Completed||Phase 1|36|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:31.655228|2017-02-18 13:26:31.655228
NCT00834782|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-09-13|||May 2009||2009-05-01|September 2009|2009-09-01|May 2010|Anticipated|2010-05-01|December 2009|Anticipated|2009-12-01||Observational|||Comparison of DCT, ORA and GAT in Eyes After Penetrating Keratoplasty|Comparison of Pascal Dynamic Contour Tonometer, Reichart Ocular Response Analyzer and Goldmann Applanation Tonometer in Eyes After Penetrating Keratoplasty|Unknown status|Recruiting|Phase 4|35|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 13:26:32.309823|2017-02-18 13:26:32.309823
NCT00833807|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2015-11-25|||February 2009||2009-02-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver|Phase I Study Of Hepatic Arterial Infusion Of Nab-Paclitaxel (Abraxane®) In Patients With Metastatic Melanoma In The Liver|Completed||Phase 1|30|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:26:32.428174|2017-02-18 13:26:32.428174
NCT00833794|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-04-25|2009-04-09||October 2004||2004-10-01|April 2012|2012-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol HCl Once-a-Day Versus Placebo for the Treatment of Pain Due to Osteoarthritis||Completed||Phase 3|1028|Actual|Labopharm Inc.||2|||f||||||||||||||2017-02-18 13:26:32.554438|2017-02-18 13:26:32.554438
NCT00833781|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-03-03|2015-10-15||August 2009||2009-08-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PARC002||A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects|A Pilot, Double-blind, Placebo-controlled, Randomized Clinical Trial of mRNA-transfected Autologous Dendritic Cells in Subjects With Well-controlled Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy|Completed||Phase 1/Phase 2|15|Actual|Massachusetts General Hospital|The trial size is small, precluding detection of small effect sizes.|2|||f||||t||||||||||2017-02-18 13:26:33.18917|2017-02-18 13:26:33.18917
NCT00833573|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-11-13|||January 2009||2009-01-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|||||Observational|RGO à trav||National Survey on GERD Patients (Adults and Children)|National Survey on GERD Patients (Adults and Children)|Completed||N/A|4400|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:26:40.779487|2017-02-18 13:26:40.779487
NCT00833768|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2015-03-19|||January 2009||2009-01-01|March 2015|2015-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|ASPIRE||A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis|A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease (CKD) Patients Not on Dialysis|Terminated||Phase 3|5|Actual|Sanofi||2||"After an extensive review,the ASPIRE in CKD study was terminated because it was not possible~   to complete the study in an appropriate time frame."|f||||f||||||||||2017-02-18 13:26:33.565995|2017-02-18 13:26:33.565995
NCT00833755|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-11-17|2016-09-20||September 2008||2008-09-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Ketamine on Opioid-Induced Hyperalgesia|Effect of Ketamine on Opioid-Induced Hyperalgesia|Completed||N/A|79|Actual|Massachusetts General Hospital||4|||f||||t||||||||No||2017-02-18 13:26:33.710235|2017-02-18 13:26:33.710235
NCT00833742|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2009-01-30|||January 2002||2002-01-01|January 2009|2009-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|ISTDPED||Intensive Short-Term Dynamic Psychotherapy (ISTDP) in the Emergency Department|Emotion-Focused Diagnosis and Treatment of Somatization in the ED|Completed||N/A|77|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-02-18 13:26:34.306464|2017-02-18 13:26:34.306464
NCT00833729|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2010-06-25|||February 2009||2009-02-01|June 2010|2010-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab|An Open Label, Prospective Cohort Pilot Study to Evaluate the Efficacy and Safety of Etanercept in the Treatment of Moderate to Severe Plaque Psoriasis in Patients Who Have Not Had an Adequate Response to Adalimumab|Completed||Phase 4|10|Anticipated|Dermatrials Research||1|||f||||||||||||||2017-02-18 13:26:34.419676|2017-02-18 13:26:34.419676
NCT00833716|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2017-02-06|||February 2009||2009-02-01|February 2017|2017-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effect of Renal Impairment on the Pharmacokinetics of NN9535|An Open-label Trial Investigating the Pharmacokinetics and the Tolerability of NN9535 in Subjects With Normal Renal Function and Various Degrees of Impaired Renal Function|Completed||Phase 1|62|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 13:26:34.539296|2017-02-18 13:26:34.539296
NCT00833703|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2011-08-18|2011-07-20||January 2009||2009-01-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|CLARINET LT||Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation|Long Term Safety Study in Patients Included in the CLARINET Study With Cyanotic Congenital Heart Disease Palliated With a Systemic-to-pulmonary Artery Shunt and for Whom the Shunt is Still in Place at One Year of Age|Completed||Phase 3|49|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:26:34.651627|2017-02-18 13:26:34.651627
NCT00833690|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2014-05-30|2013-12-26||June 2009||2009-06-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|SURE-PD||Safety of Urate Elevation in Parkinson's Disease|A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease|Completed||Phase 2|75|Actual|The Parkinson Study Group||3|||f||||t||||||||||2017-02-18 13:26:35.607279|2017-02-18 13:26:35.607279
NCT00833677|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2013-10-29|||February 2009||2009-02-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Community Based Participatory Research With Immigrant Chinese With Diabetes|Community Based Participatory Research With Immigrant Chinese With Type 2 Diabetes: Adapting and Testing Coping Skills Training.|Completed||N/A|148|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 13:26:37.803987|2017-02-18 13:26:37.803987
NCT00833664|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-11|2009-07-06||January 2002||2002-01-01|September 2009|2009-09-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions|The Relative Bioavailability of Two Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions|Completed||Phase 1|22|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:37.908843|2017-02-18 13:26:37.908843
NCT00833651|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2013-11-21|||November 2006||2006-11-01|November 2013|2013-11-01|October 2011|Actual|2011-10-01|February 2010|Actual|2010-02-01||Observational|PIP-02||Protective Immunity Project 02|A Prospective Comparison of the Magnitude and Character of the Immune Response to Influenza Vaccine in Immunosuppressed Renal Transplant Patients and Healthy Age-matched Volunteers|Completed||N/A|97|Actual|Emory University|||3||f||||t||||||Samples Without DNA|"~     serum, PBMCs~   "|||2017-02-18 13:26:38.325681|2017-02-18 13:26:38.325681
NCT00833638|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2010-08-18|2010-06-03||February 2009||2009-02-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study in Erectile Dysfunction|Tadalafil 2.5 mg and 5 mg Once a Day Compared to Placebo in Day of Onset of Efficacy|Completed||Phase 4|372|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 13:26:38.418301|2017-02-18 13:26:38.418301
NCT00833625|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-10-26|||February 2009||2009-02-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||FDG-PET-CT and Biomarkers in Esophageal Cancer|FDG-PET-CT and Biomarkers to Assess Pathologic Response in Surgical Specimens of Patients With Localized Esophageal Cancer After Chemoradiation|Completed||N/A|31|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:26:39.6964|2017-02-18 13:26:39.6964
NCT00833612|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-06-24|||December 2008||2008-12-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|CRISP-AMI||Counterpulsation Reduces Infarct Size Pre-PCI for AMI|A Multi-center, Randomized, Controlled Study of Mechanical Left Ventricular Unloading With Counterpulsation to Reduce Infarct Size Pre-PCI for Acute Myocardial Infarction - CRISP AMI|Completed||Phase 4|339|Actual|Datascope Corp.||1|||f||||t||||||||||2017-02-18 13:26:40.004919|2017-02-18 13:26:40.004919
NCT00833599|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2016-01-14|||January 2009||2009-01-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Observational|||Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders|Phase I/II Combinational Investigational New Drug Application: Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders|Enrolling by invitation||N/A|258|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||f||||||Samples With DNA|"~     DNA from blood or saliva~   "|||2017-02-18 13:26:40.170974|2017-02-18 13:26:40.170974
NCT00833560|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2014-11-11|2013-10-30||March 2006||2006-03-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy|Clinical Study on Induction of Remission Using Bortezomib (Vel), Cyclophosphamide (C), and Dexamethasone (D) in Patients Until 60 Years of Age With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy: (VelCD; Deutsche Studiengruppe Multiples Myelom [DSMM] XIa)|Completed||Phase 2|401|Actual|Janssen-Cilag G.m.b.H||1|||f||||f||||||||||2017-02-18 13:26:42.547637|2017-02-18 13:26:42.547637
NCT00833547|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2014-08-26|2014-07-17||September 2006||2006-09-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia|Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia|Completed||N/A|25|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:26:43.094311|2017-02-18 13:26:43.094311
NCT00833534|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2015-03-04|||February 2009||2009-02-01|March 2015|2015-03-01||||||||Interventional|||Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant|Consolidation Therapy With Lenalidomide (Revlimid®) With or Without Rituximab Followed by Maintenance Therapy With Revlimid® After Autologous/Syngeneic Transplant for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Withdrawn||Phase 2|0|Actual|Fred Hutchinson Cancer Research Center||2||"No patient enrolled on study. Did not get patients in timely fashion. All referrals for study~   when assessed were not eligible."|f||||||||||||||2017-02-18 13:26:43.436549|2017-02-18 13:26:43.436549
NCT00834769|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-09-22|||December 2008||2008-12-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Chronic Pain After Thoracotomy, an Incidence Study in a Single Surgical Center|Chronic Pain After Thoracotomy, an Incidence Study in a Single Surgical Center|Completed||N/A|65|Actual|Hopital Foch|||1||f||||f||||||||||2017-02-18 13:26:43.543953|2017-02-18 13:26:43.543953
NCT00834756|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-11|2009-05-07||September 2002||2002-09-01|September 2009|2009-09-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Azithromycin 600 Mg Tablets, Fasting|A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Relative Bioavailability of a Test Tablet Formulation of Azithromycin (600 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Zithromax®, Pfizer, Inc.) in 36 Fasted, Healthy, Adult Subjects|Completed||Phase 1|36|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:43.629455|2017-02-18 13:26:43.629455
NCT00834743|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-07-02||August 2003||2003-08-01|September 2009|2009-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Metformin ER 750 mg Tablets, Fasting|A Two-Way Crossover, Open-Label, Single-Dose, Fasting, Bioequivalence Study of Metformin ER 750 mg Tablets Versus Glucophage® XR 750 mg Tablets in Normal Healthy Non-smoking Male and Female Subjects|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:44.07414|2017-02-18 13:26:44.07414
NCT00834730|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2011-09-13|||January 2009||2009-01-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|PSA||Comparison of N2O Inhalation and Ketamine in Pediatric PSA|Comparison of N2O Inhalation and Ketamine IV Injection for Sedation in the Treatment of Laceration of Pediatric Patients.|Completed||Phase 4|32|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-02-18 13:26:44.729683|2017-02-18 13:26:44.729683
NCT00834717|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-06-30||September 2005||2005-09-01|September 2009|2009-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Granisetron 1 mg Tablets Under Fasting Conditions|A Single-Dose, Comparative Bioavailability Study of Two Formulations of Granisetron 1 mg Tablets Under Fasting Conditions|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:44.857594|2017-02-18 13:26:44.857594
NCT00834704|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2013-03-24|||February 2009||2009-02-01|September 2012|2012-09-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|PEG||Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors|Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacodynamic, and Pharmacokinetic Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Given Intravenously to Patients With Advanced Solid Tumors|Completed||Phase 1|14|Actual|Halozyme Therapeutics||1|||f||||f||||||||||2017-02-18 13:26:45.334386|2017-02-18 13:26:45.334386
NCT00834691|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2010-07-30|||January 2008||2008-01-01|July 2010|2010-07-01||||February 2010|Actual|2010-02-01||Observational|ANCHOR||An Evaluation of the Causes of Anemia in Patients With Heart Failure|Anemia in Chronic Heart Failure: Etiology, Comparisons With Renal Disease, and Relationships With Biomarkers and Left Ventricular Remodeling.|Completed||N/A|180|Anticipated|Montreal Heart Institute|||3||f||||f||||||Samples Without DNA|"~     Plasma and serum samples for analysis of biomarkers.~   "|||2017-02-18 13:26:45.437889|2017-02-18 13:26:45.437889
NCT00834678|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-31|2015-05-01|2014-09-26||April 2009||2009-04-01|May 2015|2015-05-01|September 2014|Actual|2014-09-01|August 2013|Actual|2013-08-01||Interventional|||Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer|Phase I/II Study of Bendamustine and Erlotinib for Metastatic or Locally Advanced Triple Negative Breast Cancer|Completed||Phase 1/Phase 2|11|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:26:45.527975|2017-02-18 13:26:45.527975
NCT00834665|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2016-08-17|||December 2006||2006-12-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma|Phase I/II Combination Immunotherapy After ASCT for Advanced Myeloma to Study HTERT Vaccination Followed by Adoptive Transfer of Vaccine-Primed Autologous T Cells|Active, not recruiting||Phase 1/Phase 2|56|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 13:26:46.215287|2017-02-18 13:26:46.215287
NCT00834652|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-08-06|||September 2007||2007-09-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight|Improving Depression Treatment Outcomes With an Insulin-Sensitizing Agent|Completed||Phase 4|255|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:26:46.323616|2017-02-18 13:26:46.323616
NCT00834639|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-22||September 2003||2003-09-01|August 2009|2009-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions|A Relative Bioavailability Study of 500 mg Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:46.44497|2017-02-18 13:26:46.44497
NCT00834626|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2012-08-30|2011-02-03||January 2008||2008-01-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|IISG||Ileal Interposition With Sleeve Gastrectomy for Control of Diabetes|Interventional Study of Effects of Ileal Interposition With Sleeve Gastrectomy for Control of Type 2 Diabetes|Completed||N/A|30|Actual|Kirloskar Hospital|Non-availability of hormonal tests like Glucagon-Like Peptide-1 estimation pre- & post-operative.|1|||f||||t||||||||||2017-02-18 13:26:46.875411|2017-02-18 13:26:46.875411
NCT00834613|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-07-02||August 2003||2003-08-01|September 2009|2009-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Metformin ER 750 mg Tablets, Fed|A Two-Way Crossover, Open-Label, Single-Dose, Fed, Bioequivalence Study of Metformin ER 750 mg Tablets Versus Glucophage® XR 750 mg Tablets in Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:47.131123|2017-02-18 13:26:47.131123
NCT00834600|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-04-18|||December 2005||2005-12-01|October 2010|2010-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Renin Profiling in Selection of Initial Antihypertensive Drug|A Clinical Trial of Renin Profiling in Selection of Initial Antihypertensive Drug|Completed||N/A|185|Actual|The Louis & Rachel Rudin Foundation||2|||f||||t||||||||||2017-02-18 13:26:47.557224|2017-02-18 13:26:47.557224
NCT00834587|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-09|2009-07-02||June 2004||2004-06-01|September 2009|2009-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting|A Relative Bioavailability Study of 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets Under Non-Fasting Conditions.|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:47.671427|2017-02-18 13:26:47.671427
NCT00834574|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-18||February 2005||2005-02-01|August 2009|2009-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Cefdinir for Oral Suspension 250 mg/5mL, Fasting|A Relative Bioavailability Study of Cefdinir for Oral Suspension 250 mg/5mL Under Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:48.283448|2017-02-18 13:26:48.283448
NCT00834561|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-06-30||January 2002||2002-01-01|September 2009|2009-09-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions|Randomized, Two-Way Crossover, Single-Dose, Fasting Bioequivalence Study of Lamotrigine 1 x 200 mg Tablet|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:48.750766|2017-02-18 13:26:48.750766
NCT00834548|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2009-02-01|||June 2008||2008-06-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|||||Observational|||Whole-Body MRA at 3T - A Comparison Between Two Different Scan Protocols|Whole-Body MRA at 3T - A Comparison Between Two Different Scan Protocols|Completed||N/A|26|Anticipated|Copenhagen University Hospital at Herlev|||2||f||||t||||||||||2017-02-18 13:26:49.143273|2017-02-18 13:26:49.143273
NCT00834535|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-18||July 2005||2005-07-01|August 2009|2009-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Cefdinir Capsules 300 mg, Non-fasting|A Relative Bioavailability Study of 300 mg Cefdinir Capsules Under Non-fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:49.246864|2017-02-18 13:26:49.246864
NCT00834522|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-06-30||July 2005||2005-07-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Granisetron 1 mg Tablets, Non-fasting|A Single-Dose, Comparative Bioavailability Study of Two Formulations of Granisetron 1 mg Tablets Under Fed Conditions|Completed||Phase 1|80|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:49.644834|2017-02-18 13:26:49.644834
NCT00834509|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-05-27|||April 2008||2008-04-01|May 2015|2015-05-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|BOSA||Biomarkers for Obstructive Sleep Apnea|Towards a Blood Test for Diagnosis of Obstructive Sleep Apnea|Active, not recruiting||N/A|40|Anticipated|University of Pennsylvania|||2||f||||t||||||||||2017-02-18 13:26:50.095191|2017-02-18 13:26:50.095191
NCT00834496|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2017-01-11|||January 2009||2009-01-01|January 2017|2017-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation|Sirolimus Switching From Calcinurin Inhibitors (CNI) 90 - 180 Days After Liver Transplantation|Withdrawn||N/A|0|Actual|Thomas Jefferson University|||1||f||||t||||||||||2017-02-18 13:26:50.195604|2017-02-18 13:26:50.195604
NCT00834483|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2014-09-09|2013-02-02||February 2009||2009-02-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|January 2011|Actual|2011-01-01||Interventional|||Use of Knotless Suture for Closure of Total Hip and Knee Arthroplasties|Use of Knotless Suture for Closure of Total Hip and Knee Arthroplasties: A Prospective-randomized Clinical Trial|Completed||N/A|65|Actual|Rush University Medical Center|Five patients were offered enrollment but refused to participate, however this does not alter our data as sixty others did enroll.|2|||f||||t||||||||||2017-02-18 13:26:50.292619|2017-02-18 13:26:50.292619
NCT00834470|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2012-08-03|||August 2008||2008-08-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Adjunctive Atropine During Ketamine Sedation|Is Atropine Needed With Ketamine Sedation?|Completed||Phase 4|140|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-02-18 13:26:53.062228|2017-02-18 13:26:53.062228
NCT00834457|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2014-10-29|||June 2007||2007-06-01|October 2014|2014-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe|A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe|Completed||Phase 2/Phase 3|49|Actual|Parirenyatwa Hospital||2|||f||||t||||||||||2017-02-18 13:26:53.190835|2017-02-18 13:26:53.190835
NCT00834444|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-30||August 2004||2004-08-01|August 2009|2009-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Famciclovir 500 mg Tablets Under Non-Fasting Conditions|A Single Dose, Comparative Bioavailability Study of Two Formulations of Famciclovir 500 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|36|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:53.305217|2017-02-18 13:26:53.305217
NCT00834431|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-30||August 2004||2004-08-01|August 2009|2009-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Famciclovir 500 mg Tablets Under Fasting Conditions|A Single Dose, Comparative Bioavailability Study of Two Formulations of Famciclovir 500 mg Tablets Under Fasting Conditions|Completed||Phase 1|36|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:53.792902|2017-02-18 13:26:53.792902
NCT00834405|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-09|2009-07-02||April 2002||2002-04-01|September 2009|2009-09-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Leflunomide 20 mg Tablets, Non-Fasting|A Relative Bioavailability, Parallel Study of Leflunomide 20 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|37|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:54.866522|2017-02-18 13:26:54.866522
NCT00834392|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2011-01-31|||October 2008||2008-10-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Exercise in Men With Prostate Cancer|A Pilot Study of Exercise in Men With Prostate Cancer Receiving Androgen Depletion Therapy|Completed||N/A|30|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-02-18 13:26:55.31237|2017-02-18 13:26:55.31237
NCT00834379|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-01-30|||September 2000||2000-09-01|January 2009|2009-01-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions|Completed||Phase 1|58|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:55.415007|2017-02-18 13:26:55.415007
NCT00834366|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-04-25|2009-04-06||February 2005||2005-02-01|April 2012|2012-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study to Compare the Relative Bioavailability of Two 200 Mg Tramadol Hydrochloride Tablet Products Under Fasting Conditions||Completed||Phase 1|26|Actual|Labopharm Inc.||2|||f||||||||||||||2017-02-18 13:26:55.52662|2017-02-18 13:26:55.52662
NCT00834353|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-02|||September 2005||2005-09-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Observational|||Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis|Prospective Study of N-acetyltransferase2 (NAT2) Gene and Rifampicin Induced Cytochrome P-450 as Susceptible Risk Factors for Antituberculosis Drug Induced Hepatitis|Completed||N/A|||Maulana Azad Medical College|||1||f||||t||||||||||2017-02-18 13:26:55.913034|2017-02-18 13:26:55.913034
NCT00834340|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-06-22||February 2003||2003-02-01|September 2009|2009-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Glimepiride 4 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of Glimepiride 4 mg Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:56.009395|2017-02-18 13:26:56.009395
NCT00834327|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-10-12|||February 2009||2009-02-01|October 2009|2009-10-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|||Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome|A Randomized, Double-Blind, Placebo-Controlled Four Week Study of the Efficacy and Safety of Four Doses (0.05 mg, 0.1 mg, 0.25 mg, 0.5 mg) of Aplindore MR Tablets vs. Placebo in Idiopathic Restless Legs Syndrome.|Terminated||Phase 2|230|Anticipated|Neurogen Corporation||5||"Neurogen acquired by Ligand Pharmaceuticals - no further support for the study. No safety~   concerns identified."|f||||f||||||||||2017-02-18 13:26:56.46976|2017-02-18 13:26:56.46976
NCT00834314|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-12-07|||February 2010||2010-02-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|ABDOVAC||Randomized Pilot Study Comparing Two Vacuum-wound-dressings for Open Abdomen Treatment|"Vacuum-Therapy in Open Abdomen Treatment - Randomized Pilot-trial Comparing Fascial Closure and Survival With Vacuum-Pack-Technique vs. Abdominal Dressing"|Terminated||N/A|3|Actual|Universitätsmedizin Mannheim||2||"extended obligations of amended medical device law in Germany 2010 did not allow to continue~   and complete the trial due to budget limitation"|f||||t||||||||||2017-02-18 13:26:56.592652|2017-02-18 13:26:56.592652
NCT00834301|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-02|||January 2009||2009-01-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients|An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients|Unknown status|Recruiting|Phase 2|25|Anticipated|Nephrian||1|||f||||f||||||||||2017-02-18 13:26:56.69194|2017-02-18 13:26:56.69194
NCT00834288|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-04-24|2009-04-08||June 2003||2003-06-01|April 2012|2012-04-01||||August 2003|Actual|2003-08-01||Interventional|||A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions|A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions|Completed||Phase 1|26|Actual|Labopharm Inc.||2|||f||||||||||||||2017-02-18 13:26:56.790453|2017-02-18 13:26:56.790453
NCT00834275|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-08-14|2009-06-18||September 2004||2004-09-01|August 2009|2009-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Cefadroxil 500 mg Capsules Under Fasting Conditions|A Two-Way Crossover, Open-Label, Single-Dose Fasting, Bioequivalence Study of Cefadroxil 500 mg Capsules Versus DURICEF® 500 mg Capsules in Normal Healthy Non-smoking Male and Female Subjects.|Completed||Phase 1|26|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:57.427353|2017-02-18 13:26:57.427353
NCT00834262|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-10-27|||April 2009||2009-04-01|October 2016|2016-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients|A Multi Centre, Open Label, Non-Randomized, Non Interventional, Observational Study on the Safety and Efficacy of Biphasic Insulin Aspart (NovoMix® 30, NovoMix® 50 and NovoMix® 70 or Combinations) in Type 2 Diabetes Mellitus Patients|Completed||N/A|339|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:26:57.997765|2017-02-18 13:26:57.997765
NCT00834249|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-11|2009-07-06||December 2002||2002-12-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Venlafaxine 25 mg Tablets Under Non-Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Venlafaxine 25 mg Tablets and Effexor® 25 mg Tablets Administered as 1 x 25 mg Tablet in Healthy Subjects Under Fed Conditions|Completed||Phase 1|18|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:58.111036|2017-02-18 13:26:58.111036
NCT00834236|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2015-11-03|2015-09-30||March 2008||2008-03-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Proteiomic Fingerprints of Gastric Juice|Diagnosis of Gastroduodenal Diseases by Proteiomic Fingerprints of Gastric Juice|Completed||N/A|76|Actual|Kaohsiung Veterans General Hospital.|The trial was performed in a single country|2|||f||||t||||||||||2017-02-18 13:26:58.583235|2017-02-18 13:26:58.583235
NCT00833404|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2011-09-09|||December 2008||2008-12-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|||Smoking Cessation and Sexual Health in Men|Effects of Smoking Cessation on Sexual Health in Men|Completed||Phase 1|80|Anticipated|University of Texas at Austin||2|||f||||f||||||||||2017-02-18 13:27:16.188109|2017-02-18 13:27:16.188109
NCT00834223|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2011-03-31|||January 2009||2009-01-01|March 2011|2011-03-01|May 2010|Actual|2010-05-01|September 2009|Actual|2009-09-01||Interventional|||A Prospective, Multicenter, Open-label, Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO's Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG)|A Prospective, Multicenter, Open-label, Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO's Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG)|Completed||N/A|15|Actual|OPKO Health, Inc.||1|||f||||f||||||||||2017-02-18 13:26:58.936195|2017-02-18 13:26:58.936195
NCT00834210|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2011-09-22|2011-09-22||December 2008||2008-12-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris||Completed||Phase 4|171|Actual|Allergan||2|||f||||||||||||||2017-02-18 13:26:59.030357|2017-02-18 13:26:59.030357
NCT00834197|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-07-02||July 2003||2003-07-01|September 2009|2009-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting|A Relative Bioavailability Study of 15 mg Mirtazapine Orally Disintegrating Tablets Under Non-Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:26:59.362884|2017-02-18 13:26:59.362884
NCT00834184|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-02-12|||October 2008||2008-10-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety and PK of Nikkomycin Z in Healthy Subjects|Phase I, Randomized, Double-blind, Placebo Controlled, Multiple-dose Evaluation of the Safety Tolerance and Pharmacokinetics of Nikkomycin Z in Healthy Subjects|Completed||Phase 1|33|Actual|University of Arizona||4|||f||||t||||||||||2017-02-18 13:26:59.797076|2017-02-18 13:26:59.797076
NCT00834171|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2011-08-17|2011-08-17||January 2009||2009-01-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin||Completed||N/A|50|Actual|Allergan|||2||f||||||||||||||2017-02-18 13:26:59.896296|2017-02-18 13:26:59.896296
NCT00834158|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-31|2016-03-30|||January 2009||2009-01-01|March 2016|2016-03-01|November 2010|Actual|2010-11-01|December 2009|Actual|2009-12-01||Interventional|TACEPVE||Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC|Efficacy of Sequential Arterial and Portal Vein Embolizations on Increasing the Resectability of Hepatitis B Related Primary Hepatocellular Carcinoma|Completed||N/A|20|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:27:00.229606|2017-02-18 13:27:00.229606
NCT00834145|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2009-02-02|||March 2009||2009-03-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Effect of Normatec Pump for Relief of Leg Edema in Patients With Right Heart Failure|Effect of Normatec Pump for Relief of Leg Edema in Patients With Right Heart Failure: Short- Intermediate- and Long-Term Outcomes|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center||2|||f||||||||||||||2017-02-18 13:27:00.3526|2017-02-18 13:27:00.3526
NCT00834132|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-11|2009-05-07||July 2002||2002-07-01|September 2009|2009-09-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Azithromycin 600 Mg Tablets, Fed|A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Relative Bioavailability of a Test Tablet Formulation of Azithromycin (600 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Zithromax®, Pfizer, Inc.) in 24 Fed, Healthy, Adult Subjects|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:27:00.46554|2017-02-18 13:27:00.46554
NCT00834119|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-04-27|||September 2003||2003-09-01|April 2015|2015-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)|Assessment of the Effectiveness of Regular Use of Intranasal Steroids in Alleviating Nasal Symptoms in Allergic Rhinitis When Used Alone or in Combination With Oral Antihistamine|Completed||Phase 4|72|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:27:01.111537|2017-02-18 13:27:01.111537
NCT00834106|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2016-12-09||2013-04-25|December 2008||2008-12-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|May 2012|Actual|2012-05-01||Interventional|||Prevention of HPV in 20 to 45 Year Old Chinese Women (V501-041)|A Randomized, Placebo-Controlled, Double-Blind Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine to Investigate the Safety, and Efficacy in Chinese 20 - to 45-Years-Old Women|Completed||Phase 3|3006|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:27:01.205097|2017-02-18 13:27:01.205097
NCT00834093|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-08-10|||January 2009||2009-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma|A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma|Active, not recruiting||Phase 2|20|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No|There are no plans to share IPD. Cumulative results will be posted and published.|2017-02-18 13:27:01.310372|2017-02-18 13:27:01.310372
NCT00834080|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2013-05-30|2013-05-30||March 2009||2009-03-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||The Safety Population, defined as all subjects who received at least 1 dose (injection) of study drug, was used for presentation and analysis of both safety and efficacy data.|ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals|Open-Label Study of the Safety and Tolerability of VIVITROL Administered to Health Care Professionals Participating in an Extended Outpatient Treatment Program for Opioid Dependence|Completed||Phase 3|38|Actual|Alkermes, Inc.|After screening 49 subjects, Alkermes made a business decision to stop enrollment, resulting in 38 total subjects enrolled.|1|||f||||f||||||||||2017-02-18 13:27:01.432604|2017-02-18 13:27:01.432604
NCT00834067|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-09-01|2009-07-02||October 2003||2003-10-01|September 2009|2009-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions|A Relative Bioavailability Study of Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|60|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:27:01.740321|2017-02-18 13:27:01.740321
NCT00834054|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-02|2016-09-22|||January 2009||2009-01-01|September 2016|2016-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|PICCO-LungT||Measurement of Lung Water by Transpulmonary Thermodilution in Lung Transplanted Patients|Interest of Repeated Extravascular Lung Water Measurements With the PICCO Device in Lung Transplanted Patients|Completed||N/A|15|Anticipated|Hopital Foch|||1||f||||f||||||||||2017-02-18 13:27:02.402848|2017-02-18 13:27:02.402848
NCT00834041|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2011-04-15|2011-01-18||April 2009||2009-04-01|April 2011|2011-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age|An 8-day Open-label, Multiple-dose, Multicenter Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age|Completed||Phase 1/Phase 2|39|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:27:02.51681|2017-02-18 13:27:02.51681
NCT00834028|ClinicalTrials.gov processed this data on February 17, 2017|2009-02-01|2009-02-01|||February 2007||2007-02-01|November 2006|2006-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization|Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization : The Roles of VEGF, Cathepsin L, Endostatin, and Angiopoietin-2.|Completed||N/A|60|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||Samples With DNA|"~     serum~   "|||2017-02-18 13:27:03.020428|2017-02-18 13:27:03.020428
NCT00834015|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2015-04-13|||May 2010||2010-05-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Spinal Fusion and Rehabilitation Study|Outcome of Lumbar Spinal Fusion Patients and Significance of Postoperative Exercise Therapy: Randomized Controlled Trial and Spine Register Study|Completed||N/A|100|Actual|Jyväskylä Central Hospital||1|||f||||f||||||||||2017-02-18 13:27:03.12739|2017-02-18 13:27:03.12739
NCT00834002|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2010-02-05|||March 2005||2005-03-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|November 2007|Actual|2007-11-01||Interventional|CCRG 05-001||Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission|Wilms Tumor Gene (WT1) mRNA-transfected Autologous Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia (AML): a Phase I Trial|Completed||Phase 1|10|Actual|University Hospital, Antwerp||1|||f||||f||||||||||2017-02-18 13:27:03.250647|2017-02-18 13:27:03.250647
NCT00833989|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-11-29||2012-03-15|July 2009||2009-07-01|November 2016|2016-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|MAG111539||Safety Escalating Repeat IV, in Stroke Patients|A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke|Completed||Phase 2|42|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:27:03.356421|2017-02-18 13:27:03.356421
NCT00833976|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-03-14|2015-04-14||July 2009||2009-07-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia|Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia|Completed||Phase 4|65|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:27:03.491651|2017-02-18 13:27:03.491651
NCT00833963|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2014-10-21|||December 2008||2008-12-01|October 2014|2014-10-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01|21 Months|Observational [Patient Registry]|MotHER||An Observational Study of Pregnancy And Pregnancy Outcomes in Women With Breast Cancer Treated With Herceptin, Perjeta In Combination With Herceptin, or Kadcyla During Pregnancy or Within 7 Months Prior To Conception (MotHER)|An Observational Study of Pregnancy And Pregnancy Outcomes in Women With Breast Cancer Treated With Herceptin, Perjeta In Combination With Herceptin, or Kadcyla During Pregnancy or Within 7 Months Prior To Conception|Recruiting||Phase 4|100|Anticipated|Genentech, Inc.|||1||f||||||||||||||2017-02-18 13:27:03.72681|2017-02-18 13:27:03.72681
NCT00833950|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-03-02|||March 2008||2008-03-01|December 2008|2008-12-01||||March 2009|Actual|2009-03-01||Interventional|||Phase Out in Tinnitus Patients|Phase Out Treatment for Tinnitus|Completed||Phase 4|40|Anticipated|University Hospital, Antwerp||1|||f||||f||||||||||2017-02-18 13:27:03.81644|2017-02-18 13:27:03.81644
NCT00833937|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-07-06|2009-07-06||March 2002||2002-03-01|July 2009|2009-07-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions|A Relative Bioavailability Study of Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:27:03.915977|2017-02-18 13:27:03.915977
NCT00833924|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2016-12-13|2015-12-18||May 2008||2008-05-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|October 2011|Actual|2011-10-01||Interventional|||Zenith(R) Low Profile AAA Endovascular Graft Clinical Study|Evaluation of the Safety and Effectiveness of the Zenith(R) Low Profile AAA Endovascular Graft|Completed||N/A|120|Actual|Cook||1|||t||||||||||||||2017-02-18 13:27:04.603412|2017-02-18 13:27:04.603412
NCT00833911|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-04-25|2009-04-08||April 2003||2003-04-01|April 2012|2012-04-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee|An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee|Completed||Phase 3|392|Actual|Labopharm Inc.||1|||f||||f||||||||||2017-02-18 13:27:05.017752|2017-02-18 13:27:05.017752
NCT00833898|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2015-11-06|2015-06-08||November 2008||2008-11-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)|Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome|Completed||Phase 3|298|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 13:27:05.382583|2017-02-18 13:27:05.382583
NCT00833885|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2011-04-21|||January 2009||2009-01-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza|Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza|Completed||N/A|300|Anticipated|Robert Koch Institut||3|||f||||f||||||||||2017-02-18 13:27:06.829101|2017-02-18 13:27:06.829101
NCT00833872|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2016-03-02|||January 2009||2009-01-01|March 2016|2016-03-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects|LEO 22811 - A Phase I, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects|Completed||Phase 1|58|Actual|LEO Pharma||2|||f||||f||||||||||2017-02-18 13:27:06.92794|2017-02-18 13:27:06.92794
NCT00833859|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2013-12-13|2011-03-30||March 2009||2009-03-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery|A Phase 2 Study of GTX-SRS: Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery for Borderline Resectable Pancreatic Cancer|Terminated||Phase 2|2|Actual|H. Lee Moffitt Cancer Center and Research Institute|Early termination of study due to termination of funding. The study was closed to accrual on 12/17/09 and final closed on 3/12/10. The sample size goal of 33 evaluable participants could not be met.|1||Abandoned - Lack of funding after only 2 patients enrolled|f||||t||||||||||2017-02-18 13:27:07.038902|2017-02-18 13:27:07.038902
NCT00833846|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2017-01-24|||January 27, 2009||2009-01-27|October 24, 2011|2011-10-24|October 24, 2011||2011-10-24|||||Observational|||Pilot Study of Mitochondrial Biology in Human Platelets|Pilot Study of Mitochondrial Biology in Human Platelets|Completed||N/A|18|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:27:07.302657|2017-02-18 13:27:07.302657
NCT00833833|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2016-03-25|2013-03-08||June 2008||2008-06-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|April 2011|Actual|2011-04-01||Interventional||Intent to treat population from both phases|MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma|A Phase I/II Multicenter, Randomized, Open Label, Dose-Escalation Study To Determine The Maximum Tolerated Dose, Safety, And Efficacy Of CC-4047 Alone Or In Combination With Low-Dose Dexamethasone In Patients Wth Relapsed And Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide And Bortezomib|Completed||Phase 1/Phase 2|259|Actual|Celgene Corporation||6|||f||||t||||||||||2017-02-18 13:27:07.408224|2017-02-18 13:27:07.408224
NCT00833820|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-01-30|||May 2007||2007-05-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|rTMS-ALS||Repetitive Transcranial Magnetic Stimulation (rTMS) in Amyotrophic Lateral Sclerosis|Repetitive Transcranial Magnetic Stimulation in Amyotrophic Lateral Sclerosis|Completed||Phase 2/Phase 3|20|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-02-18 13:27:12.162724|2017-02-18 13:27:12.162724
NCT00833521|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2009-07-06|2009-07-06||February 2002||2002-02-01|July 2009|2009-07-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions|A Relative BioAvailability Study of Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions|Completed||Phase 1|38|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:27:12.457642|2017-02-18 13:27:12.457642
NCT00833508|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2016-02-15|||January 2009||2009-01-01|February 2016|2016-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing|Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing|Completed||N/A|40|Actual|Imperial College London||1|||f||||f||||||||||2017-02-18 13:27:12.927363|2017-02-18 13:27:12.927363
NCT00833495|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-03-08||2010-09-28|January 2009||2009-01-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation|A Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Co-Administration of FOV1101-00 (Cyclosporine 0.01% or 0.02%) and Prednisolone Acetate 0.12% (PredMild®) Compared to Prednisolone Acetate 1% Alone or Vehicle Alone in Patients With Mild Ongoing Ocular Allergic Inflammation|Completed||Phase 2|155|Actual|Fovea Pharmaceuticals SA||4|||f||||f||||||||||2017-02-18 13:27:13.032703|2017-02-18 13:27:13.032703
NCT00833482|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-09-24|2012-07-23||September 2009||2009-09-01|September 2012|2012-09-01|February 2011|Actual|2011-02-01|July 2010|Actual|2010-07-01||Interventional|||Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants|Study to Assess the Pharmacokinetic Drug - Drug Interactions Between Atazanavir Plus Ritonavir Coadministered With Voriconazole in Healthy Subjects|Completed||Phase 1|185|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-02-18 13:27:13.136863|2017-02-18 13:27:13.136863
NCT00833469|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2014-08-05|2014-07-11||January 2009||2009-01-01|August 2014|2014-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|LexaproPPD|Of the 7 subjects consented, 5 were eligible to initiate study intervention. Out of these 5, 1 subject dropped prior to V1 and no baseline information is available for her.|Escitalopram (Lexapro) for the Treatment of Postpartum Depression|Escitalopram for the Treatment of Postpartum Depression|Completed||Phase 4|7|Actual|Massachusetts General Hospital|We recruited only 7 patients out of a projected 20. Patients were not referred because they were breastfeeding or preferred to receive treatment from their primary care doctor. We also suspect that many women with PPD do not seek treatment at all.|1|||f||||f||||||||||2017-02-18 13:27:14.362543|2017-02-18 13:27:14.362543
NCT00833456|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2011-10-13|||February 2009||2009-02-01|October 2011|2011-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia|Non-interventional Clinical Study to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia, Treated With Atypical Antipsychotics|Completed||N/A|106|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:27:14.679571|2017-02-18 13:27:14.679571
NCT00833443|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2014-01-10|2014-01-10||January 2009||2009-01-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|BUP PGx||Study of Medical Treatment for Methamphetamine Addiction|Pharmacogenomics and Medication Development for Methamphetamine Dependence|Completed||Phase 2|84|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 13:27:14.791393|2017-02-18 13:27:14.791393
NCT00833430|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-02-18|||June 2006||2006-06-01|February 2016|2016-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Avascular Necrosis (AVN) Long-Term Follow-up|Hedrocel Avascular Necrosis (AVN) Intervention Implant|Terminated||N/A|35|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 13:27:15.43584|2017-02-18 13:27:15.43584
NCT00833417|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2015-05-01|2012-02-23||February 2009||2009-02-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|November 2010|Actual|2010-11-01||Interventional|||A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma|A Pivotal Phase II, Multicenter, Single-arm, Two-cohort Trial Evaluating the Efficacy and Safety of GDC-0449 in Patients With Advanced Basal Cell Carcinoma|Completed||Phase 2|104|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 13:27:15.523079|2017-02-18 13:27:15.523079
NCT00833391|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2013-05-10|||January 2009||2009-01-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Relative Bioavailability Study for GSK1838262 (Gabapentin Enacarbil)|An Open-label, Randomized, Single Dose, Five-period Crossover Study to Evaluate the Relative Bioavailability of Different Formulations of GSK1838262 in Healthy Volunteers.|Completed||Phase 1|16|Actual|XenoPort, Inc.||1|||f||||||||||||||2017-02-18 13:27:16.301537|2017-02-18 13:27:16.301537
NCT00833378|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2011-04-07|||January 2009||2009-01-01|April 2011|2011-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects.|A Phase I, Open-label, Single Sequence, Crossover Study Evaluating the Safety and the Pharmacokinetics of Lopinavir/Ritonavir and Eltrombopag Given Alone and When Co-administered in Healthy Adult Subjects.|Completed||Phase 1|40|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 13:27:16.406605|2017-02-18 13:27:16.406605
NCT00833365|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-05-24|2015-05-01||January 2009||2009-01-01|December 2014|2014-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure|Early vs. Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure and Pain/Stress Reduction|Terminated||N/A|15|Actual|University of Utah||2||Study drug not available|f||||f||||||||||2017-02-18 13:27:16.520002|2017-02-18 13:27:16.520002
NCT00833352|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2014-01-29|||November 2008||2008-11-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SEPTAL-CRT||Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device|Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device|Completed||N/A|263|Actual|Guidant Corporation||2|||f||||f||||||||||2017-02-18 13:27:16.8921|2017-02-18 13:27:16.8921
NCT00833339|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2015-03-30|||May 2008||2008-05-01|March 2015|2015-03-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Trial of Mifepristone in Combat Veterans With Posttraumatic Stress Disorder|Novel Therapeutics in PTSD: A Randomized Clinical Trial of Mifepristone|Recruiting||Phase 2|80|Anticipated|James J. Peters Veterans Affairs Medical Center||2|||f||||t||||||||||2017-02-18 13:27:17.030892|2017-02-18 13:27:17.030892
NCT00833326|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-09-28|||January 2009||2009-01-01|September 2012|2012-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer||Completed||Phase 1|27|Actual|Array BioPharma||1|||f||||f||||||||||2017-02-18 13:27:17.143827|2017-02-18 13:27:17.143827
NCT00833313|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2016-07-20|||August 2008||2008-08-01|July 2016|2016-07-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Gene Expression Profiling in Subjects With Postoperative Atrial Fibrillation After Cardiac Surgery|Gene Expression Profiling in Subjects With Postoperative Atrial Fibrillation After Cardiac Surgery|Recruiting||N/A|240|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"~     Atrial tissue sample~   "|||2017-02-18 13:27:17.241367|2017-02-18 13:27:17.241367
NCT00833300|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-08-02|||June 2008||2008-06-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Haloperidol vs Olanzapine for the Management of ICU Delirium|Haloperidol vs Olanzapine for the Management of ICU Delirium: A Randomized Clinical Trial|Terminated||N/A|200|Anticipated|Nova Scotia Health Authority||2|||f||||||||||||||2017-02-18 13:27:17.335664|2017-02-18 13:27:17.335664
NCT00833287|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-04-05|||November 2008||2008-11-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|ObesityRole||Immunoregulatory Dysfunction in Trauma Patients: Role of Obesity|Immunoregulatory Dysfunction in Trauma Patients: Role of Obesity|Terminated||N/A|10|Actual|University of Mississippi Medical Center|||1|Enrollment process not efficient|f||||f||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 13:27:17.461283|2017-02-18 13:27:17.461283
NCT00833274|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2011-12-08|||February 2009||2009-02-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases|Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases|Completed||N/A|70|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:27:17.5329|2017-02-18 13:27:17.5329
NCT00833261|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2015-03-19|||December 2008||2008-12-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer|A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck|Unknown status|Active, not recruiting|Phase 2|50|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-02-18 13:27:17.63175|2017-02-18 13:27:17.63175
NCT00833248|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2012-09-27|2012-08-27||April 2009||2009-04-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer|A Randomised, Parallel Arm, Open-label Trial Comparing Degarelix With Goserelin Plus Anti-androgen Flare Protection (Bicalutamide), in Terms of Prostate Size Reduction in Prostate Cancer Patients of Intermediate-to-high Risk, Who Require Neoadjuvant Hormone Therapy Prior to Radiotherapy (Curative Intent)|Completed||Phase 3|246|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:27:17.752563|2017-02-18 13:27:17.752563
NCT00833235|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-30|2017-01-18|||February 2009||2009-02-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Natural History Study of Patients With Dry Eye||Active, not recruiting||N/A|284|Actual|Allergan|||2||f||||f||||||Samples With DNA|"~     Tear collection~   "|||2017-02-18 13:27:18.925346|2017-02-18 13:27:18.925346
NCT00833222|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-07-02|||January 2008||2008-01-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|PREMA||Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants|Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants|Completed||N/A|72|Actual|University of Utah|||2||f||||f||||||Samples With DNA|"~     Saliva; Urine~   "|||2017-02-18 13:27:19.030644|2017-02-18 13:27:19.030644
NCT00833209|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-07-31|||February 2009||2009-02-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|July 2011|Actual|2011-07-01||Interventional|MOH-PET||Orbitofrontal Cortex (OFC) Influence on Addictive Medication Overuse Headache (MOH) Deriving From Migraine|Orbitofrontal Cortex (OFC) Influence on Addictive Behaviour in Medication Overuse Headache (MOH) Deriving From Migraine|Completed||N/A|53|Actual|University Hospital, Bordeaux||3|||f||||f||||||||||2017-02-18 13:27:19.227164|2017-02-18 13:27:19.227164
NCT00833196|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2010-07-06|||February 2009||2009-02-01|July 2010|2010-07-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Observational|||Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia|Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia|Completed||N/A|400|Anticipated|Ipsen|||1||f||||f||||||||||2017-02-18 13:27:19.331442|2017-02-18 13:27:19.331442
NCT00833183|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-01-29|||July 2007||2007-07-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne|A Study of Safety and Efficacy of Topical Methylaminolevulinate 80mg/g With and Without Occlusion Followed by Red Light Exposure in Subjects With Facial Acne|Completed||Phase 2|44|Actual|Photocure||4|||f||||f||||||||||2017-02-18 13:27:19.442482|2017-02-18 13:27:19.442482
NCT00833170|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-02-03|||January 2002||2002-01-01|February 2015|2015-02-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Observational|||Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry|Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry|Unknown status|Active, not recruiting|N/A|1000|Anticipated|Connecticut Children's Medical Center|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 13:27:19.538549|2017-02-18 13:27:19.538549
NCT00833157|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-01-29|||February 2005||2005-02-01|January 2009|2009-01-01|March 2009|Anticipated|2009-03-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Glucosamine or Ibuprofen Combined With Physical Training in Patients With Knee-Osteoarthritis|Effect of Glucosamine or Ibuprofen Combined With Physical Training in Patients With Knee-Osteoarthritis|Unknown status|Active, not recruiting|Phase 1|36|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-02-18 13:27:19.662266|2017-02-18 13:27:19.662266
NCT00833144|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2013-12-12|||February 2009||2009-02-01|December 2013|2013-12-01|February 2011|Actual|2011-02-01|February 2010|Actual|2010-02-01||Observational|||Bedside Ultrasound Identifies Congestive Heart Failure|Emergency Physician-Performed Thoracic Ultrasound Rapidly Identifies Patients With Congestive Heart Failure|Completed||N/A|375|Actual|Emory University|||2||f||||t||||||||||2017-02-18 13:27:19.774171|2017-02-18 13:27:19.774171
NCT00833131|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2010-04-14|||November 2008||2008-11-01|April 2010|2010-04-01|November 2015|Anticipated|2015-11-01|November 2012|Anticipated|2012-11-01||Interventional|||The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer|Short-course Preoperative Radiotherapy With Consolidating Chemotherapy vs. Preoperative Chemoradiation in Patients With Unresectable Rectal Cancer: Phase III Study|Unknown status|Recruiting|Phase 3|540|Anticipated|Polish Colorectal Cancer Study Group||2|||f||||t||||||||||2017-02-18 13:27:20.01265|2017-02-18 13:27:20.01265
NCT00833118|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2010-02-11|||November 2008||2008-11-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Tongue Pull Versus Jaw Thrust|Tongue Pull Versus Jaw Thrust|Completed||N/A|100|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 13:27:20.148258|2017-02-18 13:27:20.148258
NCT00833105|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2014-04-28|||January 2009||2009-01-01|April 2014|2014-04-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Rehabilitation of the Upper Extremity With Enhanced Proprioceptive Feedback Following Incomplete Spinal Cord Injury|Rehabilitation of the Upper Extremity With Enhanced Proprioceptive Feedback Following Incomplete Spinal Cord Injury (SCI)|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|Oregon Health and Science University||1|||f||||t||||||||||2017-02-18 13:27:20.244375|2017-02-18 13:27:20.244375
NCT00833092|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2015-03-06|2011-07-27||January 2008||2008-01-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Magnesium Nutrition and Sleep Behavior in Older Adults|Magnesium Nutrition and Sleep Behavior in Older Adults|Completed||N/A|111|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-02-18 13:27:20.372611|2017-02-18 13:27:20.372611
NCT00833079|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2014-01-19|||October 2008||2008-10-01|January 2014|2014-01-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis|A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-Site Clinical Study to Evaluate the Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Moderate to Severe Atopic Dermatitis|Completed||Phase 1|500|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-02-18 13:27:20.751448|2017-02-18 13:27:20.751448
NCT00833066|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2011-11-16|||February 2009||2009-02-01|November 2011|2011-11-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis|Preliminary Assessment of the Clinical Tolerability, Safety and Immunogenicity of Three Different Doses of Grass Pollen-derived Peptides for Oral Use in Antigen-specific Immunotherapy of Seasonal Allergic Rhinoconjunctivitis|Completed||Phase 1/Phase 2|54|Actual|BioTech Tools S.A.||4|||f||||t||||||||||2017-02-18 13:27:20.856186|2017-02-18 13:27:20.856186
NCT00833053|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2015-08-13|2012-03-15||October 2009||2009-10-01|August 2015|2015-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|DOSE||Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)|A Study of Dose Optimization of Infliximab in the Treatment of Moderate to Severe Plaque Psoriasis|Terminated||Phase 3|39|Actual|Merck Sharp & Dohme Corp.||2||"In Amendment 1 of P05319 [NCT 00779675], the option to enroll into this study, was~   discontinued due to low numbers of participants with suboptimal response."|f||||f||||||||||2017-02-18 13:27:20.971736|2017-02-18 13:27:20.971736
NCT00833040|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2014-12-18|2014-01-06||April 2009||2009-04-01|December 2014|2014-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain|A Multicenter, Randomized, Placebo-Controlled, Crossover Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 Compared to Placebo in the Treatment of Cancer Breakthrough Pain|Completed||Phase 2|34|Actual|AcelRx Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:27:21.402161|2017-02-18 13:27:21.402161
NCT00833027|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-02-03|2010-08-26||March 2008||2008-03-01|February 2016|2016-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||ALPHA Sitagliptin Add on to Metformin (0431-103)|A 24 Week, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Adding Sitagliptin 100 mg Once Daily in Patients With T2DM Who Have Inadequate Glycemic Control on Metformin Therapy|Completed||Phase 4|608|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:27:21.676439|2017-02-18 13:27:21.676439
NCT00833014|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-29|||December 2008||2008-12-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|DYANA||Dynamic Annuloplasty System With Activation for the Treatment of Mitral Regurgitation|Dynamic Annuloplasty System With Activation for the Treatment of Mitral Regurgitation|Unknown status|Recruiting|Phase 2|130|Anticipated|MiCardia Corporation||1|||f||||f||||||||||2017-02-18 13:27:21.971238|2017-02-18 13:27:21.971238
NCT00833001|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2014-05-05|||April 2008||2008-04-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|November 2009|Actual|2009-11-01||Observational|||Clinical Performance of the GYNECARE PROLIFT + M* Pelvic Floor Repair System as a Device for Pelvic Organ Prolapse|A Prospective, Multi-center Study to Evaluate the Clinical Performance of the GYNECARE PROLIFT + M* Pelvic Floor Repair System as a Device for Pelvic Organ Prolapse|Completed||Phase 2/Phase 3|126|Actual|Ethicon, Inc.|||1||f||||f||||||||||2017-02-18 13:27:22.083597|2017-02-18 13:27:22.083597
NCT00832988|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2013-06-07|||October 2008||2008-10-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|CONFIRM||CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements|Comparison of in Office Interrogation vs. Remote Measurements|Completed||N/A|115|Actual|St. Jude Medical|||1||f||||t||||||||||2017-02-18 13:27:22.196873|2017-02-18 13:27:22.196873
NCT00832975|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-10-21|2015-02-17||December 2008||2008-12-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Observational|AVAI|All patients|AVAI: Atrial Ventricular Arrythmia Incidence|Study of Slow Ventricular Tachycardia and Atrial Fibrillation Incidence Documented by Intracardiac Electrogram in Patients Implanted With an Implantable Cardiac Device (ICD) .|Completed||N/A|157|Actual|St. Jude Medical|||1||f||||f||||||||||2017-02-18 13:27:22.289194|2017-02-18 13:27:22.289194
NCT00832962|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2015-03-25|||January 2009||2009-01-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|GENIFERH||Routine Fetal RhD Genotyping for RhD- Pregnant Women|Effectiveness of Routine Fetal RhD Genotyping for RhD- Pregnant Women|Completed||N/A|2532|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"~     Whole blood sample (0.5 ml)~   "|||2017-02-18 13:27:22.592119|2017-02-18 13:27:22.592119
NCT00832949|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-01-06|||January 2009||2009-01-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers: Patient Perspectives (One-on-one Interviews)|Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers: Patient Perspectives (One-on-one Interviews)|Completed||N/A|10|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 13:27:22.706263|2017-02-18 13:27:22.706263
NCT00832923|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2014-09-10|||January 2009||2009-01-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|PEPAC||Improving Asthma Care Through Parental Empowerment|Improving Asthma Care Through Parental Empowerment: Effect on Healthcare Utilization and Parent Self-Efficacy|Completed||N/A|150|Actual|Children's Research Institute||2|||f||||f||||||||||2017-02-18 13:27:22.811076|2017-02-18 13:27:22.811076
NCT00832910|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-01-29|||June 2007||2007-06-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|||||Observational|BIRA||Assessment of Body Image in Patients With Rheumatoid Arthritis|Body Image in Patients With Rheumatoid Arthritis|Completed||N/A|82|Actual|Federal University of São Paulo|||2||f||||f||||||None Retained|"~     None Retained~   "|||2017-02-18 13:27:22.905244|2017-02-18 13:27:22.905244
NCT00832897|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2011-01-06|||March 2008||2008-03-01|January 2011|2011-01-01|October 2010|Actual|2010-10-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Corneal Ring|"Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Intrastromal Corneal Ring for Treatment of Keratoconus and Others Irregulars Astigmatisms."|Completed||N/A|31|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 13:27:22.989139|2017-02-18 13:27:22.989139
NCT00832884|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2014-10-13|||March 2010||2010-03-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|||The Safety of Intravenous Lacosamide|IV Lacosamide: The Safety of Intravenous Lacosamide|Completed||Phase 4|40|Actual|Le Bonheur Children's Hospital||8|||f||||t||||||||||2017-02-18 13:27:23.1101|2017-02-18 13:27:23.1101
NCT00832871|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-06-22|2016-06-22||November 2008||2008-11-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers|INST 0817: Compassionate Use of Mifepristone|Terminated||N/A|4|Actual|New Mexico Cancer Care Alliance|This is a compassionate use protocol. No statistical analysis was specified in the protocol; it states that only descriptive data will be collected. Data from only 4 patients should not be considered reliable.|1||Low accrual; 4 patients enrolled between 2008-2015|f||||f||||||||||2017-02-18 13:27:23.256789|2017-02-18 13:27:23.256789
NCT00832845|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-08-16|||June 2008||2008-06-01|August 2016|2016-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|CBSST||Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study|Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study|Completed||N/A|80|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||No||2017-02-18 13:27:23.516941|2017-02-18 13:27:23.516941
NCT00832832|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-09-19|||January 2009||2009-01-01|September 2012|2012-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Eyelid Closure in Glaucoma Therapy|Eyelid Closure in Topical Glaucoma Therapy|Completed||N/A|60|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 13:27:23.646197|2017-02-18 13:27:23.646197
NCT00832819|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2015-04-09|2015-02-21||February 2009||2009-02-01|February 2015|2015-02-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)|E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1|28|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 13:27:23.772308|2017-02-18 13:27:23.772308
NCT00832806|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2011-11-28|||January 2008||2008-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Smoke-Free Living Study|Smoking Cessation With Varenicline (Champix) and Integrated Voice Response Technology (IVR)|Completed||Phase 1|100|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 13:27:24.435078|2017-02-18 13:27:24.435078
NCT00832793|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-01-06|||January 2009||2009-01-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers Patient Perspectives: Perspectives of Health Care Providers|Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers Patient Perspectives: Perspectives of Health Care Providers|Completed||N/A|10|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 13:27:26.829031|2017-02-18 13:27:26.829031
NCT00832780|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-06-07|||January 2008||2008-01-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung|INST 0810: Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung|Active, not recruiting||Phase 2|47|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||No||2017-02-18 13:27:26.937401|2017-02-18 13:27:26.937401
NCT00832767|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-07-31|||April 2009||2009-04-01|January 2012|2012-01-01|August 2012|Anticipated|2012-08-01|September 2011|Actual|2011-09-01||Interventional|||SILS™ Port Laparoscopic Cholecystectomy Post Market Study|Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy|Unknown status|Active, not recruiting|Phase 4|200|Actual|Medtronic - MITG||2|||f||||t||||||||||2017-02-18 13:27:27.04914|2017-02-18 13:27:27.04914
NCT00832754|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-12-20|||March 2009||2009-03-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|RDT-ACT||Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial|Effects of Restricting the Use of AS-AQ Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial|Completed||Phase 4|3063|Actual|Kintampo Health Research Centre, Ghana||2|||f||||t||||||||||2017-02-18 13:27:27.152414|2017-02-18 13:27:27.152414
NCT00832741|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-01-29|||May 2008||2008-05-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus|Secretion and Significance of the Incretin Hormones on the Postprandial Glycemic Response in Type-1 Diabetes Mellitus|Completed||N/A|30|Actual|Hvidovre University Hospital|||1||f||||f||||||Samples With DNA|"~     whole blood, plasma~   "|||2017-02-18 13:27:27.256209|2017-02-18 13:27:27.256209
NCT00832728|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-07-24|||March 2009||2009-03-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ELAD||Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)|Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)|Withdrawn||Phase 2|0|Actual|Vital Therapies, Inc.||2||To focus on another clinical indication.|f||||f||||||||||2017-02-18 13:27:27.351732|2017-02-18 13:27:27.351732
NCT00832715|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-07-18|||April 2009||2009-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)|Diagnostic Utility of Endobronchial Ultrasound Guided Mediastinal Lymph Node Sampling in Clinical Stage I and II Non Small Cell Lung Cancer|Completed||Phase 1/Phase 2|120|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:27:27.46703|2017-02-18 13:27:27.46703
NCT00832702|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-10-18|||September 2008||2008-09-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction|Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction|Active, not recruiting||Phase 3|433|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||Samples With DNA|"~     Blood sample will be collected for future genetic studies to better understand heart artery~     disease by identifing genetic factors that contribute to heart artery disorders, and for~     extraction and creation of cell lines.~   "|||2017-02-18 13:27:27.585133|2017-02-18 13:27:27.585133
NCT00832689|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2011-03-25|||June 2008||2008-06-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer||Completed||Phase 2|39|Actual|Yonsei University||1|||f||||||||||||||2017-02-18 13:27:27.681323|2017-02-18 13:27:27.681323
NCT00832676|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-01-06|||January 2009||2009-01-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers: Patient Perspectives (Focus Groups)|Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers: Patient Perspectives (Focus Groups)|Completed||N/A|24|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 13:27:27.844053|2017-02-18 13:27:27.844053
NCT00832663|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2010-03-15|||April 2009||2009-04-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Influence of Non-steroidal Anti-inflammatory Drugs (NSAID) on Muscle Regeneration|The Influence of Blocking Inflammatory Activity in Vivo on Skeletal Muscle Regeneration in Humans|Completed||N/A|32|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-02-18 13:27:28.085663|2017-02-18 13:27:28.085663
NCT00832650|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2010-12-02|2010-12-02||April 2009||2009-04-01|December 2010|2010-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit|A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Dose Study To Investigate The Effects Of 8 Mg Fesoterodine SR Tablets And 10 Mg Solifenacin Tablet On Gastrointestinal Transit In Healthy Female Subjects.|Terminated||Phase 1|60|Actual|Pfizer|Study was terminated due to futility based on interim analysis with 60 subjects. Although the results of statistical test for the primary endpoint was interpreted, the other endpoint results were interpreted based on statistical inference.|3||"Protocol A0221057 was terminated on December 25, 2009 for futility. There were no safety~   concerns related to this decision."|f||||f||||||||||2017-02-18 13:27:28.200893|2017-02-18 13:27:28.200893
NCT00832637|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-03-15|2015-06-15||August 2007||2007-08-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|June 2013|Actual|2013-06-01||Interventional|Gem-ox||Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers|Gemcitabine and Cisplatin With Erlotinib in Hepatocellular Carcinoma (HCC) and Biliary Tree Cancer (BTC) (Intra- and Extra-hepatic Cholangiocarcinoma, Bile Duct Cancer, Adenocarcinoma of the Ampulla of Vater and Gallbladder Carcinoma)|Terminated||Phase 2|33|Actual|New Mexico Cancer Care Alliance||1||Low accrual|f||||t||||||||No||2017-02-18 13:27:28.972564|2017-02-18 13:27:28.972564
NCT00832624|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-02-04|2010-07-06||November 2008||2008-11-01|February 2016|2016-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)|Open-label, Non Placebo-Controlled Study To Verify the Effect of Sitagliptin In Adult Patients With Type 2 Diabetes and Inadequate Glycemic Control|Terminated||Phase 4|10|Actual|Merck Sharp & Dohme Corp.|The planned 18-week study was terminated early due to reconsideration of the study design. None of the 10 patients progressed beyond the second study visit, no laboratory tests were performed, and adverse experience data were not collected.|1||Business Reasons|f||||f||||||||||2017-02-18 13:27:29.325929|2017-02-18 13:27:29.325929
NCT00832611|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-01-27|||November 2008||2008-11-01|January 2015|2015-01-01|November 2011|Actual|2011-11-01|March 2011|Actual|2011-03-01||Interventional|||Study of the Effect of the ROX AC1 on Exercise Capacity and Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients|A Study of the Effect of the ROX Percutaneous Arteriovenous Fistula System (ROX AC1) on Exercise Capacity and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|46|Actual|ROX Medical, Inc.||1|||f||||t||||||||||2017-02-18 13:27:29.544747|2017-02-18 13:27:29.544747
NCT00832598|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2017-02-15|||January 2009|Actual|2009-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors|18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors|Active, not recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:27:29.675434|2017-02-18 13:27:29.675434
NCT00832585|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2011-03-04|2010-07-09||January 2008||2008-01-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis|A Phase IV, Open Label Study to Evaluate the Safety and Efficacy of Intramuscular (IM) Alefacept (Amevive) 15mg/wk in Subjects 18 Years and Older With Moderate to Severe Atopic Dermatitis|Completed||Phase 4|5|Actual|Rush University Medical Center||1|||f||||f||||||||||2017-02-18 13:27:29.776223|2017-02-18 13:27:29.776223
NCT00832572|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2014-05-23|2013-05-28||January 2009||2009-01-01|May 2014|2014-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||All enrolled and treated participants|Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy|A Double-blind, Placebo-controlled, Cross-over Study of Ranolazine in Patients With Coronary Artery Disease for the Treatment of Painful Polyneuropathy|Terminated||Phase 4|5|Actual|Gilead Sciences|The study was stopped after 5 participants were enrolled. No outcome measure analyses were performed. Adverse events were collected and reported to the study center's Institutional Review Board.|2||Lack of enrollment|f||||f||||||||||2017-02-18 13:27:30.234568|2017-02-18 13:27:30.234568
NCT00832559|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-02-22|||January 2009||2009-01-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of the Intratumoural Administration of CAVATAK to Head and Neck Cancer Patients|A Phase I, Open-label, Dosage Escalation, Study of Multiple Doses of CAVATAKTM (CVA21; Coxsackievirus A21) Administered Intratumourally in the Treatment of Squamous Cell Carcinoma of the Head and Neck Bearing ICAM-1 Receptors|Terminated||Phase 1|4|Actual|Viralytics||1||Poor recruitment rate.|f||||||||||||||2017-02-18 13:27:30.68485|2017-02-18 13:27:30.68485
NCT00832546|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2009-01-29|||May 2008||2008-05-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers|A Double-Blind, Randomized, Placebo Controlled, Cross-Over, Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Volunteers|Completed||Phase 1|18|Actual|TorreyPines Therapeutics||3|||f||||t||||||||||2017-02-18 13:27:30.786044|2017-02-18 13:27:30.786044
NCT00832533|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2015-09-24|||November 2008||2008-11-01|September 2015|2015-09-01|January 2010|Actual|2010-01-01|February 2009|Actual|2009-02-01||Observational|||The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure|INST 0814: The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light Exposure|Completed||N/A|9|Actual|New Mexico Cancer Care Alliance|||1||f||||t||||||Samples With DNA|"~     Blood samples and Buccal Smear~   "|||2017-02-18 13:27:30.88224|2017-02-18 13:27:30.88224
NCT00832520|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2015-06-16|2012-07-20||November 2008||2008-11-01|June 2015|2015-06-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|||Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight|INST 0816: Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight|Terminated||Phase 2|13|Actual|New Mexico Cancer Care Alliance|Early termination leading to no subjects analyzed.There will be no publication, as this study was terminated after the original PI left employment with the institution.|1||Low accrual rate.|f||||t||||||||||2017-02-18 13:27:30.986431|2017-02-18 13:27:30.986431
NCT00832507|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2014-01-03||2014-01-03|January 2009||2009-01-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)|A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter, Dose-ranging Study of Cicletanine in Subjects With Pulmonary Arterial Hypertension|Terminated||Phase 2|162|Actual|Gilead Sciences||4|||f||||t||||||||||2017-02-18 13:27:31.236052|2017-02-18 13:27:31.236052
NCT00832494|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-01-29|||September 2004||2004-09-01|January 2009|2009-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer|An Open Label, Randomized, Phase I/II Study of DMXAA in Combination With Carboplatin and Paclitaxel in Patients With Locally Advanced and Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|105|Actual|Antisoma Research||2|||f||||t||||||||||2017-02-18 13:27:31.414595|2017-02-18 13:27:31.414595
NCT00832481|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-08-24|||January 2009||2009-01-01|August 2009|2009-08-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions|Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions in Newly Diagnosed Type 2 Diabetes Patients in China|Unknown status|Recruiting|N/A|60|Anticipated|Chinese PLA General Hospital||2|||f||||f||||||||||2017-02-18 13:27:31.511158|2017-02-18 13:27:31.511158
NCT00832468|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-12-07|||December 2008||2008-12-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||The Complementary Effect of Ear Acupressure on Older Patients With Chronic Insomnia|The Complementary Effect of Ear Acupressure on Older Patients With Chronic Insomnia and Anxiety|Completed||Phase 2|72|Actual|National Yang Ming University||2|||f||||t||||||||||2017-02-18 13:27:31.631168|2017-02-18 13:27:31.631168
NCT00832455|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-10-30|2009-08-25||June 2006||2006-06-01|October 2015|2015-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)|A 12 Week Multicenter, Open-label, Observational Study to Evaluate the Effectiveness of Montelukast Sodium (Singulair®), 4 or 5 mg/Day in Pediatric Subjects With Uncontrolled Asthma|Completed||Phase 4|445|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 13:27:31.749596|2017-02-18 13:27:31.749596
NCT00832442|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2012-05-08|||August 2008||2008-08-01|January 2009|2009-01-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|BB-META-HF||Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure|Collaborative Systematic Overview of Randomised Controlled Trials of Beta-Blockers in the Treatment of Heart Failure|Unknown status|Enrolling by invitation|N/A|18240|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||2||f||||t||||||||||2017-02-18 13:27:32.220743|2017-02-18 13:27:32.220743
NCT00832429|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-11-02|||February 2009||2009-02-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||Sentinel Lymph Node (SLN) Biopsy for Sebaceous Gland Carcinoma of Eyelid|Sentinel Lymph Node Localization and Biopsy for Sebaceous Gland Carcinoma of the Eyelid|Recruiting||Phase 2|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:27:32.341876|2017-02-18 13:27:32.341876
NCT00832416|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2012-04-25|2009-04-08||January 2003||2003-01-01|April 2012|2012-04-01||||August 2003|Actual|2003-08-01||Interventional|||A Four-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol Once a Day 100, 200 and 300 mg Versus Placebo for the Treatment of Pain Due to Osteoarthritis of the Knee||Completed||Phase 3|565|Actual|Labopharm Inc.||4|||f||||||||||||||2017-02-18 13:27:32.528984|2017-02-18 13:27:32.528984
NCT00832403|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-29|||November 2006||2006-11-01|January 2009|2009-01-01||||February 2008|Actual|2008-02-01||Observational|RA||Gore Tex Implants in the Treatment of Atrophic Rhinitis|Gore Tex Implants in the Treatment of Atrophic Rhinitis|Suspended||N/A|5|Actual|Hospital Felicio Rocho|||1|lack of new patients|f||||f||||||||||2017-02-18 13:27:33.567786|2017-02-18 13:27:33.567786
NCT00832390|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-02-03|2009-06-11||February 2007||2007-02-01|February 2016|2016-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)|Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise|Completed||Phase 4|29|Actual|Merck Sharp & Dohme Corp.|"Few participants were recruited into this single-site study as the investigator preferred the use of initial combination therapy.~Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data."|1|||f||||f||||||||||2017-02-18 13:27:33.670493|2017-02-18 13:27:33.670493
NCT00832377|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2015-02-06|2011-02-25||April 2009||2009-04-01|February 2015|2015-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||COSOPT (Timolol/Dorzolamide Combination) Normal Tension Glaucoma Study (MK0507A-161)(COMPLETED)|Prospective, Open-label, Single-arm Study to Evaluate Efficacy and Safety of Combination Therapy of Timolol and Dorzolamide (COSOPT) as Initial Treatment for Patients With Normal Tension Glaucoma|Completed||Phase 2|37|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:27:34.108407|2017-02-18 13:27:34.108407
NCT00832364|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2015-04-20|||October 2009||2009-10-01|June 2011|2011-06-01|April 2010|Anticipated|2010-04-01|March 2010|Anticipated|2010-03-01||Interventional|||Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis|Randomized, Controlled Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis|Withdrawn||Phase 4|0|Actual|GlaxoSmithKline||2||Business decision. No patients were enrolled|f||||f||||||||||2017-02-18 13:27:34.392776|2017-02-18 13:27:34.392776
NCT00832351|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2015-12-30|||March 2009||2009-03-01|December 2015|2015-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|AKEMIS||Akershus Early Mobilisation in Stroke Study|Effect of Immediate Mobilisation After Stroke on Mortality, Morbidity and Functional Outcome|Completed||N/A|65|Actual|University Hospital, Akershus||2|||f||||f||||||||||2017-02-18 13:27:34.519371|2017-02-18 13:27:34.519371
NCT00832338|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2015-11-05|||April 2009||2009-04-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores|Phase II Trial of Pre-Operative Docetaxel-Cytoxan (TC) in Patients With Hormone Receptor-Positive Cancers With Recurrence Scores ≥ 25|Terminated||Phase 2|23|Actual|Emory University||1||Funding withdrawn|f||||t||||||||||2017-02-18 13:27:34.628861|2017-02-18 13:27:34.628861
NCT00832325|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2017-02-02|||January 2009||2009-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Adolescent and Young Adult Cancer Survivors: Identity Development|Adolescent and Young Adult Cancer Survivors: Identity Development|Active, not recruiting||N/A|300|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 13:27:34.761433|2017-02-18 13:27:34.761433
NCT00832312|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-07-27|||August 2009||2009-08-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Intraarticular Ozone Therapy for Pain Control in Osteoarthritis of the Knee|Intraarticular Ozone Therapy for Pain Control in Osteoarthritis of the Knee|Terminated||Phase 2|20|Actual|Ben-Gurion University of the Negev||2||Because of technical problems (researcher moved to different city).|f||||f||||||||||2017-02-18 13:27:34.873896|2017-02-18 13:27:34.873896
NCT00832299|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-03-07|2013-02-25||January 2009||2009-01-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Neo-Adjuvant FOLFOX for Rectal Carcinoma|A Phase II Open- Labeled, Prospective Study to Determine the Efficacy of Pre- Operative Chemotherapy With Six Cycles of Modified FOLFOX 6 Followed by Total Mesorectal Excision (TME) Followed by an Additional Six Cycles of FOLFOX 6|Terminated||Phase 2|2|Actual|Beth Israel Medical Center||1||terminated for lack of enrollment|f||||f||||||||||2017-02-18 13:27:34.993687|2017-02-18 13:27:34.993687
NCT00832286|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-11-23|||July 2009||2009-07-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|||Longitudinal Study of the Human Intestinal Microbiome|Longitudinal Study of the Human Intestinal Microbiome Before and After Antibiotic Administration|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 13:27:35.233352|2017-02-18 13:27:35.233352
NCT00828633|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2015-07-21|||August 2008||2008-08-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|December 2010|Actual|2010-12-01||Observational|||Health-Related Quality of Life in Gay Men With Localized Prostate Cancer|Patient-Reported Outcomes For Gay Men With Localized Prostate Cancer|Completed||N/A|92|Actual|Baylor College of Medicine|||1||f||||f||||||||||2017-02-18 13:28:59.534314|2017-02-18 13:28:59.534314
NCT00832273|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2013-09-09||||||September 2013|2013-09-01||||||||Expanded Access|||Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery|Use of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Liver Failure: Uncontrolled Treatment Protocol to Provide Expanded Access With Cost Recovery|No longer available||N/A|||Vital Therapies, Inc.|||||||||||||||||||2017-02-18 13:27:35.354159|2017-02-18 13:27:35.354159
NCT00832260|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2014-09-25|2014-08-27||January 2009||2009-01-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|June 2011|Actual|2011-06-01||Observational|IES-ACap||IES-ACap: Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.|Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.|Completed||N/A|70|Actual|St. Jude Medical|||1||f||||f||||||||||2017-02-18 13:27:35.439105|2017-02-18 13:27:35.439105
NCT00832247|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-01-29|||January 2009||2009-01-01|January 2009|2009-01-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|CELTHEP-02||Autologous Bone Marrow Mononuclear Cells in Liver Cirrhosis|Phase 1 Study of Autologous Bone Marrow Mononuclear Cells Infusion in Peripheral Vein in Liver Cirrhosis Due to Hepatitis C Virus|Unknown status|Recruiting|Phase 1|15|Anticipated|Universidade Federal do Rio de Janeiro||1|||f||||t||||||||||2017-02-18 13:27:35.673753|2017-02-18 13:27:35.673753
NCT00832234|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2015-02-16|||September 2006||2006-09-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2010|Actual|2010-06-01||Interventional|BDR-WM||Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia|Phase II Study of Combination Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstroms Macroglobulinemia: A Multicenter Trial of the European Myeloma Network|Completed||Phase 2|59|Actual|European Myeloma Network||1|||f||||f||||||||||2017-02-18 13:27:35.772225|2017-02-18 13:27:35.772225
NCT00832221|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-09-11|||January 2009||2009-01-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|||||Interventional|PET||Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL|An Open Label, 1-sequence Cross-over, Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Receptor Occupancy of Quetiapine Fumarate Immediate Release (SEROQUEL®) With Quetiapine Fumarate Extended Release (SEROQUEL XR®) in Healthy Male Volunteers|Completed||Phase 1|10|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:27:36.095943|2017-02-18 13:27:36.095943
NCT00832208|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-01-20|||April 2009||2009-04-01|January 2016|2016-01-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL|Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With Visceral Leishmaniasis|Terminated||Phase 2|124|Actual|Drugs for Neglected Diseases||2|||f||||t||||||||||2017-02-18 13:27:36.215444|2017-02-18 13:27:36.215444
NCT00832195|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2014-02-17|||March 2009||2009-03-01|February 2014|2014-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Footwear and Injury Prevention Study|Footwear Prevention Study: Investigating the Effects of Running Shoe Pronation Control on the Risk of Injury|Completed||Phase 3|103|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:27:36.3321|2017-02-18 13:27:36.3321
NCT00832182|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2016-12-19|||December 1999||1999-12-01|December 2016|2016-12-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes|An Open-labelled, Non-randomized, Multi-centre, Multinational Extension Trial Assessing the Safety of Insulin Aspart in Patients With Type I Diabetes Treated With a Basal-bolus Regimen|Completed||Phase 3|75|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 13:27:36.443951|2017-02-18 13:27:36.443951
NCT00832169|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-29|2009-04-27|||January 2009||2009-01-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|||||Interventional|||Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386|An Open, Single Dose, Phase I Study of the Excretion of Radioactivity, Metabolism and Pharmacokinetics Following Oral Administration of [14C]AZD1386 to Healthy Male Volunteers|Completed||Phase 1|6|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:27:36.566914|2017-02-18 13:27:36.566914
NCT00832156|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2014-06-11|||June 2008||2008-06-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|KC||Application of Cultured Autologous Keratinocytes for Burn Wound Healing|Application of Cultured Autologous Keratinocytes in Combination With a Meshed Split Skin Autograft for Burn Wound Healing|Completed||Phase 3|40|Actual|Association of Dutch Burn Centres||2|||f||||t||||||||||2017-02-18 13:27:36.673243|2017-02-18 13:27:36.673243
NCT00832143|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2009-01-28|||March 2007||2007-03-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|Referral Card||Effect of Referral Card on Neonatal Medical Care Seeking for Institutional Births in Urban Lucknow|Effect of Referral Card on Neonatal Medical Care Seeking for Institutional Births in Urban Lucknow|Completed||N/A|1020|Actual|King George's Medical University||2|||f||||f||||||||||2017-02-18 13:27:36.786991|2017-02-18 13:27:36.786991
NCT00832130|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-12-05|2011-09-19||February 2009||2009-02-01|December 2011|2011-12-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye|Randomized Clinical Trial for Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye|Completed||N/A|139|Actual|TearScience, Inc.||2|||f||||f||||||||||2017-02-18 13:27:36.896952|2017-02-18 13:27:36.896952
NCT00832117|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-02-09|2012-02-21||May 2009||2009-05-01|February 2016|2016-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Phase I Combination Ixabepilone + Cisplatin|Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors|Completed||Phase 1|30|Actual|R-Pharm||1|||f||||f||||||||||2017-02-18 13:27:37.458421|2017-02-18 13:27:37.458421
NCT00832091|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2010-03-24|2010-01-19||July 2006||2006-07-01|March 2010|2010-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|SSVS||Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers|A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Venous Stasis Ulcers|Completed||Phase 2|72|Actual|RegeneRx Biopharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 13:27:38.158645|2017-02-18 13:27:38.158645
NCT00832078|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-08-02|2012-01-09||January 2009||2009-01-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|Test catheter||Test Catheter Pilot Study in Healthy Volunteers|Test Catheter Pilot Study in Healthy Volunteers|Completed||N/A|28|Actual|Coloplast A/S||2|||f||||f||||||||||2017-02-18 13:27:38.6813|2017-02-18 13:27:38.6813
NCT00832065|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-12-15|||January 2009||2009-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Observational|||Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome|Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome And Its Effects With CPAP Therapy|Active, not recruiting||N/A|200|Anticipated|Lahey Clinic|||1||f||||f||||||||||2017-02-18 13:27:38.924515|2017-02-18 13:27:38.924515
NCT00832052|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-06-09|||January 2009||2009-01-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.|An Investigator And Subject-Blind Phase 1 Study To Characterize The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Doses Of PF-04447943 Up To An Exposure Cap In Healthy Elderly Subjects|Completed||Phase 1|32|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 13:27:39.028871|2017-02-18 13:27:39.028871
NCT00832039|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-08-11|||November 2009||2009-11-01|August 2016|2016-08-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|SISPCT||Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis|Prospective, Randomized Multicenter Trial of Adjunctive Intravenous Therapy With Sodium-selenite(Selenase®, Double-blinded) and a Procalcitonin Guided Causal Therapy (Open) of Severe Sepsis or Septic Shock.|Completed||Phase 3|1089|Actual|Kompetenznetz Sepsis||4|||f||||t||||||||||2017-02-18 13:27:39.132976|2017-02-18 13:27:39.132976
NCT00832026|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-28|||July 2004||2004-07-01|January 2009|2009-01-01||||||||Observational|TNI||Trans Nasal Insuflation for the Treatment of Snoring|Trans Nasal Insuflation for the Treatment of Snoring and Obstructive Sleep Apnea|Unknown status|Active, not recruiting|N/A|100|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 13:27:39.510024|2017-02-18 13:27:39.510024
NCT00832013|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-08-17|||June 2008||2008-06-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||Safe Administration of Propofol for Sedation in Children|Safe Administration of Propofol for Sedation in Children|Completed||N/A|120|Anticipated|University of British Columbia||2|||f||||||||||||||2017-02-18 13:27:39.61138|2017-02-18 13:27:39.61138
NCT00832000|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-08-19|2012-10-02||December 2008||2008-12-01|August 2013|2013-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effectiveness of Mexiletine for Treating People With Non-Dystrophic Myotonia|Phase II Therapeutic Trial of Mexiletine in Non-Dystrophic Myotonia|Completed||Phase 2|59|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 13:27:39.726993|2017-02-18 13:27:39.726993
NCT00831987|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-04-12|2009-07-20||August 2004||2004-08-01|April 2016|2016-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine|Annual Study of Safety and Immunogenicity of Influenza Virus Vaccine Fluzone® 2004-2005|Completed||Phase 4|120|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:27:40.383527|2017-02-18 13:27:40.383527
NCT00831974|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2013-08-13|||October 2004||2004-10-01|January 2009|2009-01-01||||February 2007|Actual|2007-02-01||Interventional|||Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis|Phase IIa, Open-label, Randomized Study of Oral AB1010 in Patients With Systemic Indolent Mastocytosis With Handicap and Not Bearing Activating Point Mutations in the Phosphotransferase Domain of c-Kit Such as the Main Mutation Asp-816-Val (D816V)|Completed||Phase 2|23|Actual|AB Science||2|||f||||f||||||||||2017-02-18 13:27:40.915072|2017-02-18 13:27:40.915072
NCT00831961|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-12-07|||January 2009||2009-01-01|December 2015|2015-12-01||||November 2009|Actual|2009-11-01||Observational|ARCaNE||Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics|Prospective, Randomized, Observational Cohort Study of Antibiotic Resistance After Repeated Application of Topical Antibiotics|Completed||N/A|24|Actual|Vanderbilt University|||4||f||||f||||||||||2017-02-18 13:27:41.010152|2017-02-18 13:27:41.010152
NCT00831948|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2009-01-28|||December 2008||2008-12-01|January 2009|2009-01-01||||||||Observational|||Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.|Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.|Unknown status|Recruiting|N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||||2017-02-18 13:27:41.116299|2017-02-18 13:27:41.116299
NCT00831935|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2013-04-05|||January 2009||2009-01-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Use of Conversation and Acoustic Signals in Measuring Depression Severity|Use of Conversation and Acoustic Signals in Measuring Depression Severity|Completed||N/A|89|Actual|Boston Medical Center|||2||f||||f||||||||||2017-02-18 13:27:41.205003|2017-02-18 13:27:41.205003
NCT00831922|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2009-08-11|||September 2004||2004-09-01|August 2009|2009-08-01||||October 2006|Actual|2006-10-01||Interventional|||Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis|A Multicenter, Open Label, Randomized, Parallel-group Study to Evaluate the Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis With Inadequate Response to at Least One Disease Modifying Anti Rheumatic Drugs (DMARD)|Completed||Phase 2|43|Actual|AB Science||2|||f||||f||||||||||2017-02-18 13:27:41.291515|2017-02-18 13:27:41.291515
NCT00831909|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2010-08-09|||January 2009||2009-01-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|EPICLIN||Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN|Epidemiological Study to Describe Non-small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Europe. Lung|Completed||N/A|3513|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:27:41.390307|2017-02-18 13:27:41.390307
NCT00831896|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-12-01|||March 2009||2009-03-01|December 2011|2011-12-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|||Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies|A Multicenter, Open-Label, Dose Escalation Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematologic Malignancies|Completed||Phase 1|27|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:27:41.71489|2017-02-18 13:27:41.71489
NCT00831883|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2012-12-03|||February 2009||2009-02-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|GET UP||Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents|Partner-Specific HIV Risk Reduction Intervention for Drug-Using Incarcerated Adolescents|Completed||N/A|59|Actual|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||||2017-02-18 13:27:41.798299|2017-02-18 13:27:41.798299
NCT00828425|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2010-08-17|||December 2008||2008-12-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|||||Observational|||Management of Diabetes Mellitus Patients With Retinopathy|Management of Diabetes Mellitus Patients With Retinopathy|Completed||N/A|2500|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:29:02.344396|2017-02-18 13:29:02.344396
NCT00831870|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2012-08-29|||October 2008||2008-10-01|August 2012|2012-08-01|October 2012|Anticipated|2012-10-01|||||Observational|PRICELESS||EndoSure Sensor for Long-term Follow-up After Endovascular AAA Repair|PRessure and Imaging—Using the CardioMEMS EndoSure Sensor for Long-term Follow-up After EVAR With Standard Surveillance (Prospective Registry)|Unknown status|Enrolling by invitation|N/A|900|Anticipated|CardioMEMS|||1||f||||f||||||||||2017-02-18 13:27:41.896524|2017-02-18 13:27:41.896524
NCT00831857|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-10-01|||January 2009||2009-01-01|October 2015|2015-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|Renimage||VEGF Imaging in Renal Cell Carcinoma|89Zr-bevacizumab PET Imaging in Patients With Renal Cell Carcinoma Treated With Sunitinib or Bevacizumab Plus Interferon; a Pilot Study|Completed||N/A|26|Actual|University Medical Center Groningen|||2||f||||f||||||||||2017-02-18 13:27:41.961173|2017-02-18 13:27:41.961173
NCT00831844|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-03-18|2015-03-18||January 2009||2009-01-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional||Group 10, Recurrent or Refractory Retinoblastoma no patients were enrolled.|Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors|A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, NSC #742460) in Children With Relapsed/Refractory Solid Tumors|Completed||Phase 2|116|Actual|National Cancer Institute (NCI)||10|||f||||t||||||||||2017-02-18 13:27:42.215454|2017-02-18 13:27:42.215454
NCT00831831|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-07-11|||April 2008||2008-04-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|January 2010|Actual|2010-01-01||Interventional|||Can Safety Planning Improve Perinatal Outcomes Among Pregnant Women Exposed to Intimate Partner Violence?|Can Safety Planning Improve Perinatal Outcomes Among Pregnant Women Exposed to Intimate Partner Violence?|Withdrawn||Phase 3|0|Actual|University of British Columbia||1||The team wasn't able to work effectively with the social worker at the site|f||||f||||||||||2017-02-18 13:27:45.339803|2017-02-18 13:27:45.339803
NCT00831818|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2011-05-31|||July 2008||2008-07-01|May 2011|2011-05-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Observational|||Effects of Breastfeeding on Maternal Plasma Ghrelin and Peptide Tyrosine Tyrosine (PYY) Levels|Effects of Breastfeeding on Maternal Plasma Ghrelin and PYY Levels|Completed||N/A|20|Anticipated|Medical University of Vienna|||2||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:27:45.452277|2017-02-18 13:27:45.452277
NCT00831805|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-01-18|||December 2008||2008-12-01|December 2008|2008-12-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|EMG||Screening of Psycho-cognitive Troubles in Elderly Patients|Impact of a Geriatric Mobile Unit on the Screening of Psycho-cognitive Troubles in Internal Medicine Departments and Circumstances of Calling in This Unit.|Completed||N/A|200|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 13:27:45.618495|2017-02-18 13:27:45.618495
NCT00831792|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-04-08|||April 2010||2010-04-01|April 2016|2016-04-01||||April 2018|Anticipated|2018-04-01||Interventional|||TKI258 in Castrate Resistant Prostate Cancer|An Observational Study of Continuous TKI258, in Castration-Resistant Prostate Cancer Patients Evaluating Markers of FGF Signaling in Bone Marrow Plasma.|Active, not recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:27:45.704933|2017-02-18 13:27:45.704933
NCT00831779|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-03-20||2012-03-24|April 2009||2009-04-01|March 2015|2015-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Trial to Evaluate the Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes|Completed||Phase 2|44|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:27:45.815611|2017-02-18 13:27:45.815611
NCT00831766|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-12-13|2016-02-25||January 2009||2009-01-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|February 2015|Actual|2015-02-01||Interventional||All participants enrolled, according to study phase. Outcome measure groups may vary depending on the analysis required.|Phase 1/2 Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)|A Phase 1/2 Study of Sequential Idarubicin + Cytarabine, Followed by Lenalidomide, in Patients With Myelodysplastic Syndrome (RAEB-2) or With Previously Untreated Acute Myeloid Leukemia|Active, not recruiting||Phase 1/Phase 2|51|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-02-18 13:27:45.924459|2017-02-18 13:27:45.924459
NCT00831753|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-04-08|2014-02-14||May 2008||2008-05-01|April 2016|2016-04-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants|Immunogenicity Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Comparison to Infanrix®Hexa, at 2-4-6 Months of Age in Healthy Peruvian Infants|Completed||Phase 3|263|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:27:46.698507|2017-02-18 13:27:46.698507
NCT00831740|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2010-11-03|||October 2006||2006-10-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|ACT NoW||ACT NoW: Assessing the Effectiveness of Communication Therapy in the North West|ACT NoW: Assessing the Effectiveness of Communication Therapy in the North West: a Pragmatic, Multi-centre Randomised Controlled Trial|Completed||N/A|170|Actual|University of Manchester||2|||f||||t||||||||||2017-02-18 13:27:47.24046|2017-02-18 13:27:47.24046
NCT00831727|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-05-10|||February 2009||2009-02-01|May 2016|2016-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||The Role of Affect Regulation and Self-presentation in the Expressive Writing Intervention|Examining Potential Moderators and Mediators in the Expressive Writing Intervention: The Role of Affect Regulation and Self-presentation.|Completed||N/A|75|Actual|University of Toronto||2|||f||||f||||||||||2017-02-18 13:27:47.350979|2017-02-18 13:27:47.350979
NCT00831714|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2017-01-19|||February 2009||2009-02-01|January 2017|2017-01-01|April 2013|Actual|2013-04-01|June 2011|Actual|2011-06-01||Observational|XAMOS||Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty|Xarelto in the Prophylaxis of Post Surgical Venous Thromboembolism After Elective Major Orthopedic Surgery of Hip or Knee|Completed||N/A|19076|Actual|Bayer|||2||f||||f||||||||||2017-02-18 13:27:47.463142|2017-02-18 13:27:47.463142
NCT00831701|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2010-05-19|2010-01-11||September 2006||2006-09-01|May 2010|2010-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Medical Expulsive Therapy of Single Distal Ureteral Stones|Medical Expulsive Therapy of Single Distal Ureteral Stones. A Randomised, Double-blind and Placebo-controlled Study|Completed||N/A|100|Actual|University of Zurich|Not all patients were able to record the exact time of stone passage. Thus, the secondary end point of time to stone passage is based on Kaplan-Meier estimation.|2|||f||||f||||||||||2017-02-18 13:27:47.613007|2017-02-18 13:27:47.613007
NCT00831688|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2009-04-20|||August 2005||2005-08-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy of Local Overpressure Treatment for Meniere's Disease|Phase 3 Study of Efficacy of Local Overpressure Treatment for Meniere's Disease|Completed||Phase 4|80|Anticipated|Klinikum der Universitaet Muenchen, Grosshadern||2|||f||||f||||||||||2017-02-18 13:27:48.049034|2017-02-18 13:27:48.049034
NCT00831675|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-04-12|2009-07-20||September 2004||2004-09-01|April 2016|2016-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Safety and Immunogenicity of Fluzone® in Healthy Children|Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Influenza Virus Vaccine Fluzone® 2004-2005|Completed||Phase 4|30|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:27:48.157754|2017-02-18 13:27:48.157754
NCT00831662|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2014-12-21||2011-03-24|January 2009||2009-01-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)||Completed||Phase 3|490|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:27:48.86653|2017-02-18 13:27:48.86653
NCT00831649|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-06-14|||September 2004||2004-09-01|January 2009|2009-01-01||||February 2005|Actual|2005-02-01||Interventional|||A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201|A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201|Terminated||Phase 2|||Biogen||1||"The biological effect seen with natalizumab was not sufficient to warrant further development~   in RA."|||||||||||||||2017-02-18 13:27:48.964139|2017-02-18 13:27:48.964139
NCT00831636|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2013-09-12|||April 2008||2008-04-01|September 2013|2013-09-01|April 2010|Actual|2010-04-01|November 2009|Actual|2009-11-01||Interventional|||A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer|A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer|Completed||Phase 1/Phase 2|28|Actual|Clavis Pharma||1|||f||||f||||||||||2017-02-18 13:27:49.056392|2017-02-18 13:27:49.056392
NCT00831623|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2016-11-11|||March 2009||2009-03-01|November 2016|2016-11-01|June 2025|Anticipated|2025-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer|Phase I-II Trial of Hypofractionated Conformal Proton Beam Radiation Therapy for Favorable-risk Prostate Cancer|Recruiting||N/A|200|Anticipated|Loma Linda University||1|||f||||t||||||||||2017-02-18 13:27:49.174175|2017-02-18 13:27:49.174175
NCT00831610|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2012-05-25|||August 2006||2006-08-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|October 2008|Actual|2008-10-01||Interventional|||Post-bariatric Abdominoplasty: Skin Sensation Evaluation|Post-bariatric Abdominoplasty: Skin Sensation Evaluation.|Completed||N/A|100|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 13:27:49.289536|2017-02-18 13:27:49.289536
NCT00831597|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-04-18|||November 2008||2008-11-01|May 2012|2012-05-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|904||Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Completed||Phase 2|61|Actual|Pharmatech||1|||f||||t||||||||||2017-02-18 13:27:49.406069|2017-02-18 13:27:49.406069
NCT00831571|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-04-12|||February 2009||2009-02-01|April 2016|2016-04-01||||July 2016|Anticipated|2016-07-01||Observational|||Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin|Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin|Active, not recruiting||N/A|200|Anticipated|Dana-Farber Cancer Institute|||2||f||||t||||||||||2017-02-18 13:27:49.697887|2017-02-18 13:27:49.697887
NCT00831545|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-05-25|||December 2000||2000-12-01|May 2015|2015-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)|Multicenter Phase 2 Evaluation of Temozolomide for Treatment of Brain Metastases of Either Malignant Melanoma, Breast and Non-small Cell Lung Cancer.|Completed||Phase 2|162|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:27:49.808712|2017-02-18 13:27:49.808712
NCT00831532|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-09-14||2009-09-14|February 2009||2009-02-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function|A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function|Completed||Phase 1|23|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:27:49.904737|2017-02-18 13:27:49.904737
NCT00831519|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2014-06-19|||January 2009||2009-01-01|June 2014|2014-06-01|December 2015|Anticipated|2015-12-01|February 2015|Anticipated|2015-02-01||Observational|||The Effect of Diabetes on the Newborn|Biochemical, Hematologic, and Inflammatory Effects of Diabetes on the Newborn|Unknown status|Recruiting|N/A|40|Anticipated|Western Galilee Hospital-Nahariya|||2||f||||f||||||||||2017-02-18 13:27:50.010239|2017-02-18 13:27:50.010239
NCT00831506|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-06-09|||February 2009||2009-02-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF-01913539) On The Safety, Tolerability, And Steady-State Pharmacokinetics Of Digoxin In Healthy Subjects|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:27:50.08963|2017-02-18 13:27:50.08963
NCT00831493|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-02-27|2012-02-13||May 2009||2009-05-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Vorinostat Plus Radiation Therapy in Pancreatic Cancer|Phase I/II Trial of Vorinostat and Radiation Therapy in Patients With Locally Advanced Pancreatic Cancer|Terminated||Phase 1/Phase 2|3|Actual|M.D. Anderson Cancer Center||1||Slow Accrual.|f||||f||||||||||2017-02-18 13:27:50.201307|2017-02-18 13:27:50.201307
NCT00831480|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-02-19|2014-11-20||April 2011||2011-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2013|Actual|2013-11-01||Interventional||Patients with clinically measurable metastatic RCC|Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal|Neoadjuvant Everolimus (RAD001)for Advanced RCC Before Cytoreductive Nephrectomy, With Correlative Tumor Studies (Protocol #: 06-08-20-01)|Terminated||Phase 2|15|Actual|Baylor College of Medicine||1||Difficulty in accrual and by the order of the cancer center.|f||||t||||||||Undecided||2017-02-18 13:27:50.429758|2017-02-18 13:27:50.429758
NCT00831467|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-10-25|||January 2009||2009-01-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease|Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease|Completed||Phase 1/Phase 2|48|Actual|CureVac AG||1|||f||||t||||||||||2017-02-18 13:27:50.743721|2017-02-18 13:27:50.743721
NCT00831454|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2014-11-27|||September 2008||2008-09-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection|Relationship of Polymorphisms and Mutations of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitors Responsiveness in Non-small-cell Lung Cancer Patients|Completed||N/A|51|Actual|Istituto Clinico Humanitas|||1||f||||f||||||Samples With DNA|"~     blood samples tissue samples~   "|||2017-02-18 13:27:50.86811|2017-02-18 13:27:50.86811
NCT00831441|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2015-12-18|2015-12-18||March 2009||2009-03-01|December 2015|2015-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|APPRAISE-2|Randomized participants|Phase III Acute Coronary Syndrome|Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome|Terminated||Phase 3|7484|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:27:50.992813|2017-02-18 13:27:50.992813
NCT00831428|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2011-08-11|2011-08-11||February 2009||2009-02-01|May 2009|2009-05-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Observational|CLE004||Screening Scottish Swimmers for Asthma and Rhinitis|A Pilot Study to Identify the Prevalence of Exercise- Induced Asthma and Rhinitis in Scottish Swimmers, Using Mannitol Challenge as a Screening Tool.|Completed||N/A|97|Actual|University of Dundee|||1||f||||f||||||||||2017-02-18 13:27:55.560191|2017-02-18 13:27:55.560191
NCT00831415|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-12-22|2011-12-22||March 2009||2009-03-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)|A 10-Month Open-Label Evaluation Of The Long-Term Safety Of Desvenlafaxine Succinate Sustained Release In Japanese Adults With Major Depressive Disorder|Completed||Phase 3|304|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:27:55.793115|2017-02-18 13:27:55.793115
NCT00831402|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-28|2012-03-23|||June 2007||2007-06-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|July 2007|Actual|2007-07-01||Interventional|||Thyroid Function Throughout Pregnancy With and Without Iodine Supplementation|Assessment of Thyroid Function Throughout Pregnancy With and Without Iodine Supplementation|Completed||N/A|111|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:27:56.469259|2017-02-18 13:27:56.469259
NCT00831389|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-09-10|2012-06-08||January 2009||2009-01-01|September 2012|2012-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|ePID-03||Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia|Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia|Completed||N/A|13|Actual|Medtronic Diabetes||1|||f||||f||||||||||2017-02-18 13:27:56.575985|2017-02-18 13:27:56.575985
NCT00831376|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-06-11|||January 2009||2009-01-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|NAI009||Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol|A Proof of Concept Study to Evaluate the Trough Bronchoprotection Conferred by Chronic Dosing With Levosalbutamol and Racemic Salbutamol in Persistent Asthmatics|Completed||Phase 4|30|Actual|University of Dundee||3|||f||||f||||||||||2017-02-18 13:27:57.002163|2017-02-18 13:27:57.002163
NCT00831363|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-27||||||January 2009|2009-01-01||||||||Observational|||Minimal Invasive Versus Traditional Transgluteal Approach in Total Hip Arthroplasty: a Comparative Gait Analysis|Minimal Invasive Versus Traditional Transgluteal Approach in Total Hip Arthroplasty: a Comparative Gait Analysis|Completed||N/A|||Orthopedic Hospital Vienna Speising|||2||f||||||||||||||2017-02-18 13:27:57.110259|2017-02-18 13:27:57.110259
NCT00831350|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-27||||||January 2009|2009-01-01||||||||Interventional|PADDLE||Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations|Posterior Vitreous Detachment (PVD) Assessment During Dual RVO Lucentis Evaluations (PADDLE Study)|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Barnes Retina Institute||1|||f||||f||||||||||2017-02-18 13:27:57.197992|2017-02-18 13:27:57.197992
NCT00831337|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-11-21|||April 2007||2007-04-01|November 2016|2016-11-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||Evaluation of Probiotics in the Treatment of Portal Hypertension|The Study of Probiotics in Liver Cirrhosis Patients With Portal Hypertension.|Completed||N/A|33|Actual|Pomeranian Medical University Szczecin||3|||f||||t||||||||||2017-02-18 13:27:57.309355|2017-02-18 13:27:57.309355
NCT00831324|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2015-05-27|||January 2009||2009-01-01|May 2015|2015-05-01|January 2017|Anticipated|2017-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Everolimus in Treating Patients With Recurrent or Progressive Low-Grade Glioma|Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma|Recruiting||Phase 2|60|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 13:27:57.421842|2017-02-18 13:27:57.421842
NCT00831311|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-11-21|2013-09-19||October 2004||2004-10-01|November 2013|2013-11-01|March 2007|Actual|2007-03-01|November 2005|Actual|2005-11-01||Interventional|||Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants|Phase-II Immunogenicity Study of a DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO at 2, 4, and 6 Months of Age in Healthy Argentinean Infants|Completed||Phase 2|624|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:27:57.546686|2017-02-18 13:27:57.546686
NCT00831298|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-12-08|||July 2010||2010-07-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Assessment of Sleep Disturbance in Alzheimer Disease|Assessment of Sleep Disturbance in Alzheimer Disease|Completed||N/A|70|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:27:58.264651|2017-02-18 13:27:58.264651
NCT00831285|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2010-02-18|||December 2008||2008-12-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Barley Tortillas Study in Healthy Volunteers|A Double-Blind, Randomized, Controlled Study to Examine the Glycemic Response of Barley Tortillas in Healthy Volunteers|Completed||N/A|12|Actual|University of Manitoba||6|||f||||f||||||||||2017-02-18 13:27:58.35583|2017-02-18 13:27:58.35583
NCT00831272|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2014-06-30|||January 2009||2009-01-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Pharmacogenetic Response to Naltrexone For Alcohol Dependence|Pharmacogenetic Response to Naltrexone for Alcohol Dependence|Completed||Phase 4|221|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 13:27:58.462561|2017-02-18 13:27:58.462561
NCT00831259|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-05-19|||October 2007||2007-10-01|May 2011|2011-05-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Observational|ICEP||Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)|Silent Cerebral Infarcts in Patients With Pulmonary Embolism and a Patent Foramen Ovale: a Prospective Diffusion-weighted Magnetic Resonance Imaging Study.|Completed||N/A|70|Anticipated|University Hospital, Caen|||2||f||||t||||||||||2017-02-18 13:27:58.56869|2017-02-18 13:27:58.56869
NCT00831246|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2010-06-07|||April 2008||2008-04-01|June 2010|2010-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Prevention of Ileus After Gynecologic Surgery Using Chewing Gum|Prevention of Post-Op Ileus After Gynecologic Surgery Using Chewing Gum|Completed||N/A|400|Anticipated|Aultman Health Foundation||2|||f||||f||||||||||2017-02-18 13:27:58.648054|2017-02-18 13:27:58.648054
NCT00831233|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-10-18|2011-06-14||April 2009||2009-04-01|October 2013|2013-10-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer|A Randomised, Parallel-arm, Open-label Trial Comparing Degarelix With Goserelin Plus Anti-androgen Flare Protection (Bicalutamide), in Terms of Reduction in International Prostate Symptom Score (IPSS), in Patients With Lower Urinary Tract Symptoms (LUTS) Secondary to Locally Advanced Prostate Cancer|Terminated||Phase 3|42|Actual|Ferring Pharmaceuticals|Early termination leading to small numbers of subjects analyzed.|2||Poor recruitment due to rare targeted population|f||||f||||||||||2017-02-18 13:27:58.856122|2017-02-18 13:27:58.856122
NCT00831220|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-27|||March 2005||2005-03-01|January 2009|2009-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease|Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease|Completed||N/A|99|Actual|Hospital Universitari Son Dureta|||4||f||||f||||||Samples Without DNA|"~     Plasma and serum.~   "|||2017-02-18 13:27:59.946284|2017-02-18 13:27:59.946284
NCT00831207|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2009-01-27|||August 2004||2004-08-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|November 2005|Actual|2005-11-01||Observational|||Beta-2 Microglobulin and Serum Cytokines x HAART|Beta-2 Microglobulin and Serum Cytokines as Indicators of Antiretroviral Therapy Failure|Completed||N/A|109|Actual|UPECLIN HC FM Botucatu Unesp|||4||f||||t||||||||||2017-02-18 13:28:00.04534|2017-02-18 13:28:00.04534
NCT00831194|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-07-31|||March 2009||2009-03-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2010|Actual|2010-07-01||Interventional|||Stress, Dietary Lapse and Weight Loss Among Adults With Type 2 Diabetes|Stress, Dietary Lapse and Weight Loss Among Adults With Type 2 Diabetes|Completed||N/A|70|Anticipated|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||||2017-02-18 13:28:00.1335|2017-02-18 13:28:00.1335
NCT00831181|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-06-16|||January 2009||2009-01-01|June 2009|2009-06-01||||January 2012|Anticipated|2012-01-01||Interventional|||Combination Chemotherapy in Treating Patients Undergoing Surgery for Rectal Cancer|A Phase II Open- Labeled, Prospective Study to Determine the Efficacy of Pre- Operative Chemotherapy With Six Cycles of Modified FOLFOX 6 Followed by Total Mesorectal Excision (TME) Followed by an Additional Six Cycles of FOLFOX 6|Unknown status|Recruiting|Phase 2|22|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:28:00.272878|2017-02-18 13:28:00.272878
NCT00831168|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-27|||October 2005||2005-10-01|January 2009|2009-01-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|BEADI||BEADI - The Bliss Cluster Randomised Control Trial on the Effects of Active Dissemination of Information (BEADI)|The Bliss Cluster Randomised Control Trial on the Effects of Active Dissemination of Information on Outcomes of Premature Babies.|Unknown status|Active, not recruiting|Phase 1/Phase 2|200|Anticipated|Confidential Enquiry into Maternal and Child Health||1|||f||||f||||||||||2017-02-18 13:28:00.404281|2017-02-18 13:28:00.404281
NCT00831155|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2015-04-17|||January 2009||2009-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Extinction01||Extinction Based Treatment for Nicotine Dependence|Brain Substrates of Extinction Based Treatment for Nicotine Dependence|Completed||Phase 1|257|Actual|Duke University||2|||f||||f||||||||||2017-02-18 13:28:00.484503|2017-02-18 13:28:00.484503
NCT00831142|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2015-11-30|||June 2006||2006-06-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|January 2012|Actual|2012-01-01||Observational|||Characterization of Prostate Cancer With 3T MR|Characterization of Prostate Cancer With 3T MR|Active, not recruiting||N/A|236|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-02-18 13:28:00.595304|2017-02-18 13:28:00.595304
NCT00831129|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-12-19|2013-06-27||September 2006||2006-09-01|December 2016|2016-12-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|SIROCO||A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs|Effects of Simvastatin and Rosiglitazone Combination in Patients With the Metabolic Syndrome.|Completed||Phase 2/Phase 3|53|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 13:28:00.69408|2017-02-18 13:28:00.69408
NCT00831116|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-08-29|||February 2009||2009-02-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|February 2016|Actual|2016-02-01||Observational|COLOR||An Observational Study of Cholesterol in Coronary Arteries|Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry|Active, not recruiting||N/A|2067|Actual|InfraReDx|||1||f||||t||||||||||2017-02-18 13:28:01.312221|2017-02-18 13:28:01.312221
NCT00831103|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2013-12-03|||November 2007||2007-11-01|December 2013|2013-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster|A Randomized, Double-blind, Active-controlled, Multi-center, Parallel-group Dose-ranging Study Assessing the Safety and Efficacy of EPB-348 Versus Valacyclovir Among Immunocompetent Patients With an Acute Episode of Herpes Zoster|Completed||Phase 2|373|Actual|Epiphany Biosciences||4|||f||||f||||||||||2017-02-18 13:28:01.440783|2017-02-18 13:28:01.440783
NCT00831090|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-04-01|||January 2009||2009-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|EFVGR||Endothelial Function and Vein Graft Remodeling|Endothelial Function and Vein Graft Remodeling|Recruiting||N/A|60|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples Without DNA|"~     A segment of vein that would usually be discarded will be taken to a lab for testing of~     endothelial reactivity and quantification of endothelial coverage through CD31 staining.~   "|||2017-02-18 13:28:01.557921|2017-02-18 13:28:01.557921
NCT00831077|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-10-07|||January 2009||2009-01-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Early Phase I Microdosing Study of ORM-14540 and ORM-12741|Pharmacokinetic Properties of ORM-14540 and ORM-12741 After Administration of a Microdose of 14C-labelled Drug; An Open, Non-randomised, Single Dose, Single Centre Study in Healthy Male Subjects|Completed||Early Phase 1|6|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-02-18 13:28:01.656058|2017-02-18 13:28:01.656058
NCT00831064|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-06-09|||September 2007||2007-09-01|June 2016|2016-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Trial of Four Different Bowel Cleansing Regimens Prior to Colonoscopy|A Randomized Controlled Trial of Four Different Bowel Cleansing Regimens Prior to Colonoscopy: Efficacy, Patient Tolerability and Safety|Completed||N/A|200|Actual|University of Alberta||4|||f||||f||||||||||2017-02-18 13:28:01.756651|2017-02-18 13:28:01.756651
NCT00831051|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-05-15||2010-08-25|December 2008||2008-12-01|May 2012|2012-05-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients|A Double-Blind, Randomized, Multi-Center, Repeat-Dose, Comparison of the Analgesic Efficacy and Safety of the Opioid Combination Q8003 to Each of the Individual Milligram Components (Oxycodone and Morphine) in the Management of Acute Moderate to Severe Pain Following Bunionectomy Surgery|Completed||Phase 2|197|Actual|QRxPharma Inc.||6|||f||||f||||||||||2017-02-18 13:28:01.87864|2017-02-18 13:28:01.87864
NCT00831038|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-11-28|||August 2008||2008-08-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Pilot Study of Pulmonary Function in Dysphagic Infants|A Pilot Study of Pulmonary Function in Dysphagic Infants|Completed||N/A|26|Actual|University of Tennessee||1|||f||||f||||||||||2017-02-18 13:28:01.991998|2017-02-18 13:28:01.991998
NCT00831025|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-11-08|||January 2008||2008-01-01|August 2011|2011-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|OLEA||Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen|Multicenter, Randomised, Double-blind Placebo-controlled, Subcutaneous Immunotherapy Clinical Trial With Depigmented and Polymerized Allergen Extract of Olea Europaea Pollen in Patients With Hypersensitivity to Olea Pollen|Completed||Phase 3|158|Actual|Laboratorios Leti, S.L.||2|||f||||f||||||||||2017-02-18 13:28:02.09852|2017-02-18 13:28:02.09852
NCT00831012|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-11-13|||September 2009||2009-09-01|November 2013|2013-11-01||||June 2011|Actual|2011-06-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults|A Phase I Dose Comparison Study of the Safety and Immunogenicity of rDEN3delta30/31‐7164, a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 3|Completed||Phase 1|56|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:28:02.233788|2017-02-18 13:28:02.233788
NCT00830999|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2013-01-18|||April 2006||2006-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|DEV||Fat Metabolism in Response to Acute Diet- and Exercise-induced Changes in Energy Balance|VLDL-triglyceride Metabolism in Response to Acute Diet- and Exercise-induced Changes in Energy Balance|Completed||N/A|12|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-02-18 13:28:02.342169|2017-02-18 13:28:02.342169
NCT00830986|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-04-14|||July 2005||2005-07-01|January 2009|2009-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|Minimental||Cognition Following Computer Assisted Total Knee Arthroplasty|Cognition Following Computer Assisted Total Knee Arthroplasty: A Prospective Cohort Study|Completed||N/A|100|Actual|Rothman Institute Orthopaedics|||2||f||||f||||||||||2017-02-18 13:28:02.454858|2017-02-18 13:28:02.454858
NCT00830973|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-10-12|||October 2007||2007-10-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|MHSLabCorp1||The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer|Tamoxifen Pharmacogenomics and the Prevention of Recurrent Breast Cancer|Completed||N/A|184|Actual|Medco Health Solutions, Inc.|||1||f||||t||||||Samples With DNA|"~     Buccal swab~   "|||2017-02-18 13:28:02.557425|2017-02-18 13:28:02.557425
NCT00830960|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-09-22|2011-06-17||February 2009||2009-02-01|September 2011|2011-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome|A Comparison of Platelet Inhibition Following Prasugrel or Clopidogrel Administration in Asian Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention|Completed||Phase 3|720|Actual|Eli Lilly and Company||6|||f||||t||||||||||2017-02-18 13:28:02.802284|2017-02-18 13:28:02.802284
NCT00830947|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2013-11-05|2013-06-20||February 2009||2009-02-01|November 2013|2013-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Effect of Cyclic Loading (Vibration) on Orthodontic Tooth Movement|The OrthoAccel (OATI) Celerect Device Pivotal Study - Effect of Cyclic Loading (Vibration) on Orthodontic Tooth Movement|Completed||Phase 3|45|Actual|OrthoAccel Technologies Inc.||2|||f||||f||||||||||2017-02-18 13:28:07.8063|2017-02-18 13:28:07.8063
NCT00830934|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-27|||April 2009||2009-04-01|January 2009|2009-01-01|September 2010|Anticipated|2010-09-01|March 2010|Anticipated|2010-03-01||Interventional|GRIP||Trial for the Treatment of Pelvic and Back Pain in Pregnancy|Randomised Controlled Trial for the Treatment of Pelvic Girdle Pain in Pregnancy|Unknown status|Not yet recruiting|N/A|226|Anticipated|University College Cork||2|||f||||t||||||||||2017-02-18 13:28:08.118135|2017-02-18 13:28:08.118135
NCT00830921|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-06-15|||February 2008||2008-02-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|||||Observational|TMS||Does Transcranial Magnetic Stimulation of the Cingulate Cortex Modulate the Perception of Dyspnoea?|"A Randomised Crossover Study to Investigate the Effect of Transcranial Magnetic Stimulation of the Anterior Cingulate Cortex on Air Hunger"|Terminated||N/A|12|Anticipated|University of Oxford|||1|Lack of patients|f||||f||||||||||2017-02-18 13:28:08.228732|2017-02-18 13:28:08.228732
NCT00830908|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-06-25|||January 2009||2009-01-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis|An Open-Label Study of the HairMax LaserComb(r) in the Treatment of Seborrheic Dermatitis of the Scalp.|Completed||N/A|10|Anticipated|Lexington International, LLC||1|||f||||t||||||||||2017-02-18 13:28:08.324427|2017-02-18 13:28:08.324427
NCT00830895|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-04-11|||January 2009||2009-01-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|October 2010|Actual|2010-10-01||Interventional|||RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)|A Phase II Study to Evaluate the Efficacy of RAD001 in Metastatic Non-clear Cell Renal Cell Carcinoma|Completed||Phase 2|49|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-02-18 13:28:08.422817|2017-02-18 13:28:08.422817
NCT00830882|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-06-11|||January 2009||2009-01-01|June 2012|2012-06-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|NAI007||Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol|A Proof of Concept Study to Evaluate the Peak Bronchoprotection Conferred by Single and Chronic Dosing With Levosalbutamol and Racemic Salbutamol in Persistent Asthmatics.|Withdrawn||Phase 4|0|Actual|University of Dundee||3||Lack of funding|f||||f||||||||||2017-02-18 13:28:08.727089|2017-02-18 13:28:08.727089
NCT00830869|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2014-06-23|||March 2009||2009-03-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies|An Open-Label, Dose Escalation, Phase 1 Study of IXAZOMIB (MLN9708), a Second-Generation Proteasome Inhibitor, in Adult Patients With Advanced Nonhematologic Malignancies|Completed||Phase 1|116|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:28:08.834808|2017-02-18 13:28:08.834808
NCT00830856|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-07-14|||October 2006||2006-10-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa|Randomized Control Trial of Early vs Delayed ART in the Treatment of Cryptococcal Meningitis.|Completed||N/A|54|Actual|University of Zimbabwe||2|||f||||t||||||||||2017-02-18 13:28:08.936339|2017-02-18 13:28:08.936339
NCT00830843|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-08-19|||January 2009||2009-01-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|GAS-SAH||Inhalatorial Sedation in Patient With Subarachnoid Hemorrhage (SAH) Versus Conventional Intravenous Sedation|Inhalatorial Sedation in Patient With SAH Versus Conventional Intravenous Sedation (GAS-SAH)|Completed||Phase 4|13|Actual|Azienda Ospedaliera San Gerardo di Monza||2|||f||||f||||||||||2017-02-18 13:28:09.039523|2017-02-18 13:28:09.039523
NCT00830830|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-03-18|||December 2005||2005-12-01|March 2009|2009-03-01|October 2006|Actual|2006-10-01|||||Interventional|||TREAD-20 Extension - Treatment of Knee Pain Due to Osteoarthritis|A Double-Blind, Randomized Trial of Intra-Articular Injections of 20mg of Hyalgan for the Treatment of Knee Pain Due to Osteoarthritis (Three Injection Regimen for Efficacy and Duration - 20mg/2ml Dose) - Extension Study|Completed||Phase 4|40|Actual|Sanofi|||||f||||||||||||||2017-02-18 13:28:09.145886|2017-02-18 13:28:09.145886
NCT00830817|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-01-27|||July 2007||2007-07-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Observational|WBI-1001-101||Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis|A Randomized, Double-Blind Phase I Study to Evaluate Topically Applied WBI-1001 Cream in Patients With Psoriasis.|Completed||N/A|36|Actual|Welichem Biotech Inc.|||1||f||||t||||||Samples Without DNA|"~     Blood plasma samples retained following PK analyses.~   "|||2017-02-18 13:28:09.233303|2017-02-18 13:28:09.233303
NCT00830804|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-01-04|2011-09-07||April 2009||2009-04-01|January 2016|2016-01-01|September 2010|Actual|2010-09-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults|A Pilot Efficacy and Safety Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects|Completed||Phase 2|113|Actual|AIDS Clinical Trials Group|This is a single-arm study.|1|||f||||t||||||||||2017-02-18 13:28:09.324703|2017-02-18 13:28:09.324703
NCT00830791|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2015-02-09|2012-05-01||January 2009||2009-01-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02)|A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Subjects With Renal Insufficiency|Terminated||Phase 1|32|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 13:28:09.974169|2017-02-18 13:28:09.974169
NCT00830778|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-09-11|||June 2009||2009-06-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy|Reduced Postoperative Pancreatic Fistula Rate Following Pancreaticoduodenectomy; Multicentric Randomized Controlled Trial on Pancreaticogastrostomy vs. Pancreaticojejunostomy|Completed||Phase 3|336|Anticipated|University Hospital, Gasthuisberg||2|||f||||t||||||||||2017-02-18 13:28:11.081373|2017-02-18 13:28:11.081373
NCT00830765|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-01-17|2012-05-22||June 2004||2004-06-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||The Use of Progesterone to Reduce Preterm Birth|The Use of Progesterone to Reduce Preterm Birth|Completed||N/A|144|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-02-18 13:28:11.208055|2017-02-18 13:28:11.208055
NCT00830752|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-27|||February 2009||2009-02-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Observational|ALEX||Neurobiological, Neuropsychological,Linguistic and Gestural Processes and Phenomena in Individuals With Alexithymia|Understanding Alexithymia|Unknown status|Not yet recruiting|N/A|70|Anticipated|Charite University, Berlin, Germany|||1||f||||f||||||Samples With DNA|"~     whole blood, serum~   "|||2017-02-18 13:28:11.608217|2017-02-18 13:28:11.608217
NCT00830739|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2017-01-24|||November 25, 2008||2008-11-25|February 26, 2013|2013-02-26|February 26, 2013||2013-02-26|||||Observational|||A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control|A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control|Completed||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:28:11.677065|2017-02-18 13:28:11.677065
NCT00830726|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-06-22|||February 2009||2009-02-01|June 2011|2011-06-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Observational|||Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease|Water-and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease, Evaluated by the Excretion of Aquaporin-2 and Epithelial Sodium Channels in the Urine|Unknown status|Recruiting|N/A|150|Anticipated|Kolding Sygehus|||6||f||||f||||||Samples Without DNA|"~     Plasma and Urine samples~   "|||2017-02-18 13:28:11.769709|2017-02-18 13:28:11.769709
NCT00830713|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-09-04|||January 2009||2009-01-01|May 2010|2010-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|MKTP||Vitiligo Skin Transplantation|Safety and Efficacy of Melanocyte-keratinocyte Transplantation in the Treatment of Vitiligo|Completed||Phase 3|40|Actual|Henry Ford Health System||1|||f||||f||||||||||2017-02-18 13:28:11.896971|2017-02-18 13:28:11.896971
NCT00830700|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2014-02-07|||September 2009||2009-09-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|CATTS||Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study|Telemental Health to Improve Mental Health Care and Outcomes for Children in Underserved Areas|Completed||N/A|223|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-02-18 13:28:11.996925|2017-02-18 13:28:11.996925
NCT00830128|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-04-02|2012-01-23||July 2009||2009-07-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia|An Open-Label Extension Safety And Efficacy Study Of Pregabalin (CI-1008) For The Treatment Of Fibromyalgia|Completed||Phase 3|106|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:28:21.158846|2017-02-18 13:28:21.158846
NCT00830687|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-25|2010-09-05|||January 2009||2009-01-01|September 2010|2010-09-01|January 2012|Anticipated|2012-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Intracapsular Femoral Neck Fractures Fixation With a Dynamic Locking Plate and Screw System, Targon FN|Intracapsular Femoral Neck Fractures Fixation With a Dynamic Locking Plate and Screw System, Targon FN. Prospective and Retrospective Cohort Study.|Unknown status|Recruiting|N/A|100|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 13:28:12.097987|2017-02-18 13:28:12.097987
NCT00830674|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-10-18|||December 2008||2008-12-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|December 2011|Actual|2011-12-01||Interventional|||A Study of KRN23 in X-linked Hypophosphatemia|A Phase I, Double-blind, Randomized, Placebo-controlled, Single-dose, Dose-escalation Study of KRN23 in X-linked Hypophosphatemia|Completed||Phase 1|42|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||2|||f||||t||||||||||2017-02-18 13:28:12.205308|2017-02-18 13:28:12.205308
NCT00830661|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-05-28|||March 2009||2009-03-01|May 2009|2009-05-01||||March 2012|Anticipated|2012-03-01||Interventional|LIFT vs PLUG||Ligation of Intersphincteric Fistula Tract (LIFT) Procedure Versus Use of an Anal Fistula Plug for Anal Fistula Repair|A Randomized, Prospective, Multi-Centered Study Comparing Clinical Outcomes of the Ligation of Intersphincteric Fistula Tract (LIFT)Procedure Versus Use of Anal Fistula Plug (AFP)in the Surgical Repair of Trans-Sphincteric Anal Fistulae of Cryptoglandular Origin|Unknown status|Recruiting|N/A|124|Anticipated|Colon and Rectal Surgery Associates, Ltd.||2|||f||||t||||||||||2017-02-18 13:28:12.303996|2017-02-18 13:28:12.303996
NCT00830648|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-06-06|||January 2009||2009-01-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Safety of a Second Dose of Biken's Varicella Vaccine|Safety of a Second Dose of Biken's Varicella Vaccine Administered at 4 to 6 Years of Age in Healthy Children in Argentina|Completed||Phase 4|122|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:28:12.40969|2017-02-18 13:28:12.40969
NCT00830635|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2015-06-12|||September 2008||2008-09-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional|||Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer|Cancer Information Service Research Consortium: Years 2006-2011 Program Narrative and Overview|Completed||N/A|1800|Actual|University of Colorado, Denver||1|||f||||f||||||||||2017-02-18 13:28:12.517507|2017-02-18 13:28:12.517507
NCT00830622|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2010-06-18|||May 2007||2007-05-01|January 2009|2009-01-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya|A Targeted Cell Phone Intervention to Improve Patient Access to Care and Drug Adherence in Patients Taking Antiretroviral (ARV) Medications in Kenya|Completed||N/A|536|Actual|University of Manitoba||2|||f||||f||||||||||2017-02-18 13:28:12.615512|2017-02-18 13:28:12.615512
NCT00830609|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-03-12|||November 2008||2008-11-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|DARGEN-3||High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3|Effect of High Dose vs. Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3, High Viral Load Without Rapid Virological Response|Completed||Phase 4|101|Actual|Hospital Universitario Fundación Alcorcón||3|||f||||t||||||||||2017-02-18 13:28:12.728894|2017-02-18 13:28:12.728894
NCT00830596|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2015-09-04|||July 2007||2007-07-01|September 2015|2015-09-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|D2P3||Effect of Spinal Manipulation on Sensorimotor Functions in Back Pain Patients|Effect of Spinal Manipulation on Sensorimotor Functions in Back Pain Patients|Completed||Phase 2|221|Actual|Palmer College of Chiropractic||3|||f||||t||||||||||2017-02-18 13:28:12.868133|2017-02-18 13:28:12.868133
NCT00830583|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-12-07|||January 2009||2009-01-01|January 2009|2009-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|POPS||Pompe Prevalence Study in Patients With Muscle Weakness Without Diagnosis|Pompe Prevalence Study in Patients With Muscle Weakness Without Diagnosis|Completed||N/A|400|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:28:13.053648|2017-02-18 13:28:13.053648
NCT00830570|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2010-11-15|||July 2007||2007-07-01|November 2010|2010-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|MHSMayoWarf1||The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings|in Typical Community Practice Settings|Completed||N/A|1635|Actual|Medco Health Solutions, Inc.|||3||f||||t||||||Samples With DNA|"~     Blood draw and buccal swab~   "|||2017-02-18 13:28:13.14602|2017-02-18 13:28:13.14602
NCT00830557|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-09-12|||October 2000||2000-10-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders|Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease|Recruiting||N/A|7500|Anticipated|Mayo Clinic|||1||f||||t||||||Samples With DNA|"~     Two 10mL plasma tubes, two 10mL serum tubes and one 10mL heparin tube collected. DNA~     extracted from lymphocytes. Possible saliva collection for DNA extraction. Waste tissue from~     prior surgery may be collected. Stool samples may be collected.~   "|||2017-02-18 13:28:13.255365|2017-02-18 13:28:13.255365
NCT00830544|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2012-07-12|||July 2008||2008-07-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2011|Actual|2011-12-01||Interventional|Neoadjuvant||Study of Neoadjuvant Chemotherapy of Breast Cancer|Phase II Study of Neoadjuvant Chemotherapy of Breast Cancer|Unknown status|Active, not recruiting|Phase 2|54|Anticipated|Auxilio Mutuo Cancer Center||1|||f||||f||||||||||2017-02-18 13:28:13.36614|2017-02-18 13:28:13.36614
NCT00830531|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2016-10-14|||January 2010||2010-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Pilot Study of Bumetanide for Newborn Seizures|Pilot Study of Bumetanide for Newborn Seizures: A Phase I Study of Pharmacokinetics and Safety of Bumetanide for Neonatal Seizures|Recruiting||Phase 1|47|Anticipated|Soul, Janet , M.D.||2|||f||||t||||||||||2017-02-18 13:28:13.478369|2017-02-18 13:28:13.478369
NCT00830518|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2013-12-10||2012-01-26|February 2009||2009-02-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|March 2010|Actual|2010-03-01||Interventional|||A Phase 2 Trial of MLN8237 in Adult Patients With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome|A Phase 2 Trial of MLN8237, an Oral Aurora A Kinase Inhibitor, in Adult Patients With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome|Completed||Phase 2|57|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:28:13.759146|2017-02-18 13:28:13.759146
NCT00830505|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-27|||February 2009||2009-02-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|CLE001||Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma|A Randomized, Double-Blind, Cross-Over Study to Demonstrate Superiority of Fluticasone/Salmeterol Over Double the Dose of Fluticasone on Methacholine Hyper-Reactivity in Patients With Persistent, Mild to Moderate Asthma|Unknown status|Not yet recruiting|Phase 4|32|Anticipated|University of Dundee||2|||f||||f||||||||||2017-02-18 13:28:13.857585|2017-02-18 13:28:13.857585
NCT00830492|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2009-01-27|||January 2008||2008-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist|Comparisin CC/Gonadotropin/GnRH Antagonist and Gonadotropin/GnRH Agonist in IVF Outcome.|Completed||Phase 4|200|Anticipated|Yazd Research & Clinical Center for Infertility||2|||f||||t||||||||||2017-02-18 13:28:13.968869|2017-02-18 13:28:13.968869
NCT00830479|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-08-11|||January 2009||2009-01-01|August 2011|2011-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|STRETCH||Study of Endoscopic Versus Open Surgery for Urinary Reflux|A Randomized Trial of Endoscopic vs. Open Anti-Reflux Surgery For Treatment of Low-Grade Vesicoureteral Reflux: Surgical Treatment of Reflux: Endoscopic vs. Traditional CHoices (STRETCH) Study|Withdrawn||N/A|0|Actual|Boston Children’s Hospital||2||unable to enroll patients for randomization|f||||t||||||||||2017-02-18 13:28:14.07175|2017-02-18 13:28:14.07175
NCT00830466|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2017-02-08|||December 2008||2008-12-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.|A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.|Completed||Phase 1|22|Actual|University of California, Irvine||1|||f||||f||||||||Undecided||2017-02-18 13:28:14.168723|2017-02-18 13:28:14.168723
NCT00830453|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-27|2011-09-02|||November 2003||2003-11-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|HYBOBI||Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury|Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury|Completed||Phase 2|60|Anticipated|Intermountain Health Care, Inc.||1|||f||||f||||||||||2017-02-18 13:28:14.294284|2017-02-18 13:28:14.294284
NCT00830440|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2010-04-19||2010-04-06|January 2007||2007-01-01|April 2010|2010-04-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||A Multicenter Study for Pre-Surgical Weight Loss|A Multi-Center, Pilot Efficacy Study of the GI Sleeve™ for Pre-Surgical Weight Loss|Completed||N/A|40|Actual|GI Dynamics||2|||f||||f||||||||||2017-02-18 13:28:14.403956|2017-02-18 13:28:14.403956
NCT00830427|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-03-11|||July 2009||2009-07-01|March 2011|2011-03-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|A7881006||A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects|A Phase IIb Randomised, Double Blind, Placebo Controlled Parallel Group Study To Investigate The Efficacy And Safety Of PF-00610355 Over 4 Weeks In Moderately Asthmatic Subjects.|Withdrawn||Phase 2|350|Anticipated|Pfizer||3|||f||||f||||||||||2017-02-18 13:28:14.515369|2017-02-18 13:28:14.515369
NCT00830414|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-01-26|||April 2002||2002-04-01|January 2009|2009-01-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women|A Pivotal Study to Evaluate the Bioequivalence of 150 mg/1 mL Medroxyprogesterone Acetate Injection in Postmenopausal Women|Completed||Phase 1|124|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:14.625849|2017-02-18 13:28:14.625849
NCT00830401|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2015-06-03|||June 2007||2007-06-01|June 2015|2015-06-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases|Comparative Controlled Trial of Treatment of Minor Unexpected Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy Screening in Women Indicated for IVF|Terminated||Phase 2|700|Actual|UMC Utrecht||2||Abnormality prevalence revealed to be much lower than expected.|f||||f||||||||||2017-02-18 13:28:14.738208|2017-02-18 13:28:14.738208
NCT00830388|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-08-21|2012-05-01||November 2008||2008-11-01|July 2012|2012-07-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Ketoconazole Foam 2% for the Treatment of Versicolor|Ketoconazole Foam 2% for the Treatment of Versicolor|Completed||Phase 4|11|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-02-18 13:28:14.849967|2017-02-18 13:28:14.849967
NCT00830375|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-04-09|2012-03-01||December 2008||2008-12-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Memantine Treatment of Compulsive Buying|Memantine Treatment of Compulsive Buying: An Open-Label Study|Completed||Phase 2|10|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 13:28:15.091494|2017-02-18 13:28:15.091494
NCT00830362|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-10-31|2012-08-24||February 2009||2009-02-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Beta-blockade Effects on Memory for Cocaine Craving|Treatment Implications of Beta-blockade Effects on Memory for Cocaine Craving|Completed||Phase 2|50|Actual|Medical University of South Carolina|Lack of a “no retrieval” control group. Lack of determination of plasma propranolol levels following the medicated retrieval session. The sample size was insufficient to assess the more distal effects at 1-week follow-up.|2|||f||||t||||||||||2017-02-18 13:28:15.329076|2017-02-18 13:28:15.329076
NCT00830349|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-01-26|||June 2001||2001-06-01|January 2009|2009-01-01|July 2004|Actual|2004-07-01|July 2001|Actual|2001-07-01||Interventional|||Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Risperidone 1 mg Tablets and Risperdal 1 mg Tablets Administered as a 1 x 1 mg Tablet in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|30|Actual|Teva Pharmaceuticals USA||2|||f||||||||||||||2017-02-18 13:28:15.626357|2017-02-18 13:28:15.626357
NCT00830336|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-09-01|2009-06-18||October 2005||2005-10-01|September 2009|2009-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions|A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions|Completed||Phase 1|80|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:15.737648|2017-02-18 13:28:15.737648
NCT00830115|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-05-04|2010-07-20||January 2009||2009-01-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Observational|PANDA||Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders|Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders|Completed||N/A|1045|Actual|Nycomed|||1||f||||f||||||||||2017-02-18 13:28:21.727526|2017-02-18 13:28:21.727526
NCT00830323|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2010-09-29|||January 2009||2009-01-01|October 2009|2009-10-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|Combina||Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection|Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection|Terminated||Phase 2|60|Anticipated|Hospices Civils de Lyon||3|||f||||t||||||||||2017-02-18 13:28:16.224859|2017-02-18 13:28:16.224859
NCT00830310|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2014-12-08|2011-10-24||January 2009||2009-01-01|December 2014|2014-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|UH CAE||Customized Medication Adherence Enhancement for Adults With Bipolar Disorder|Customized Adherence Enhancement (CAE) Among Individuals With Bipolar Disorder|Completed||N/A|43|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-02-18 13:28:16.333299|2017-02-18 13:28:16.333299
NCT00830297|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-08-30|||January 2009||2009-01-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|TIP||Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia|Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia (TIP): Efficacy and Safety of a Novel Protocol in Renal Transplant Recipients Receiving a Tacrolimus-based Immunosuppression|Completed||Phase 2|50|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:28:17.018309|2017-02-18 13:28:17.018309
NCT00830284|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2016-12-23|2016-12-23||November 2008||2008-11-01|December 2016|2016-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|Recruitment||Efficacy and Safety of a Lung Recruitment Protocol in Children With Acute Lung Injury|Efficacy and Safety of a Lung Recruitment Protocol in Children With Acute Lung Injury|Completed||N/A|12|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 13:28:17.131928|2017-02-18 13:28:17.131928
NCT00830271|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-02-02|||December 2008||2008-12-01|January 2009|2009-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Vicryl Plus and Monocryl Plus in Breast Surgery|Pilot Study of Vicryl Plus and Monocryl Plus in Breast Surgery|Completed||Phase 4|150|Anticipated|Cardiff and Vale University Health Board||2|||f||||t||||||||||2017-02-18 13:28:17.358651|2017-02-18 13:28:17.358651
NCT00830258|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-09-09|2009-07-02||April 2005||2005-04-01|September 2009|2009-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Pravastatin Sodium 80 mg Tablets Under Fasting Conditions|A Single-Dose, Comparative, Bioavailability Study of Two Formulations of Pravastatin Sodium 80 mg Tablets Under Fasting Conditions|Completed||Phase 1|60|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:17.449679|2017-02-18 13:28:17.449679
NCT00830245|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-24|2011-07-25|||January 2009||2009-01-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer||Terminated||Phase 2|20|Anticipated|Clinical Research Center for Solid Tumor, Korea||1||low accrual rate|f||||f||||||||||2017-02-18 13:28:18.072123|2017-02-18 13:28:18.072123
NCT00830232|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-08-01|2013-03-08||December 2008||2008-12-01|August 2016|2016-08-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Carotid Stent Design on Cerebral Embolization|Effects of Carotid Stent Design on Cerebral Embolization|Completed||N/A|40|Actual|Dallas VA Medical Center|1. Small sample size 2.randomization did not eliminate all pretreatment differences between groups because of the small sample size.3.All patients underwent Stenting under ﬁlter embolic protection.|2|||f||||f||||||||||2017-02-18 13:28:18.189709|2017-02-18 13:28:18.189709
NCT00830219|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-09-01|2009-07-06||November 2004||2004-11-01|September 2009|2009-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions|The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions|Completed||Phase 1|46|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:18.580899|2017-02-18 13:28:18.580899
NCT00830206|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-09-01|2009-06-18||January 2006||2006-01-01|September 2009|2009-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions|A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions|Completed||Phase 1|80|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:19.038258|2017-02-18 13:28:19.038258
NCT00830193|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-26|||August 2002||2002-08-01|January 2009|2009-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography|N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography: A Randomized Trial|Completed||Phase 2/Phase 3|45|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 13:28:19.511632|2017-02-18 13:28:19.511632
NCT00830180|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2014-03-03||2014-03-03|October 2009||2009-10-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Open Label Extension In Cancer Patients|Phase II Open-Label Safety Extension Study Of Tanezumab In Cancer Patients With Pain Due To Bone Metastases|Completed||Phase 2|41|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 13:28:19.632064|2017-02-18 13:28:19.632064
NCT00830167|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-04-30|2012-04-30||March 2009||2009-03-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia|Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin（CI-1008）In The Treatment Of Fibromyalgia|Completed||Phase 3|498|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 13:28:19.76595|2017-02-18 13:28:19.76595
NCT00830154|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-25|2012-08-20||2012-08-20|February 2009||2009-02-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering|A 3 Arm, Double-blind, Placebo-controlled Parallel Group Study to Assess the Efficacy,Safety and Tolerability of Pagoclone for Adults With Stuttering|Completed||Phase 2/Phase 3|321|Actual|Endo Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:28:20.955837|2017-02-18 13:28:20.955837
NCT00830141|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-25|2015-07-02|||January 2009||2009-01-01|July 2015|2015-07-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|Ghrelin||Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in Children|Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in Children|Completed||N/A|259|Actual|HaEmek Medical Center, Israel|||5||f||||f||||||Samples With DNA|"~     Genomic DNA will be isolated from peripheral blood by standard methods. The corresponding~     intron-exon boundaries of ghrelin and GHSR genes will be analyzed by direct sequencing using~     the ABI Prism 3100 DNA Analyzer~   "|||2017-02-18 13:28:21.071845|2017-02-18 13:28:21.071845
NCT00830102|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-06-08||2011-06-08|October 2004||2004-10-01|June 2011|2011-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients|A Randomized, Placebo-controlled, Double-blind, Six-way Crossover, Single-dose Exposure Study to Compare the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™100/10μg and 250/10μg) in a Single Inhaler (SkyePharma HFA MDI) With the Administration of Fluticasone (250μg) and Formoterol (12μg) Concurrently or Alone in Patients With Asthma|Completed||Phase 2|64|Actual|SkyePharma AG||6|||f||||f||||||||||2017-02-18 13:28:22.560398|2017-02-18 13:28:22.560398
NCT00830089|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-24|2012-01-18|||September 2009||2009-09-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery|A Prospective Randomised Controlled Trial of the Efficacy of a Transversus Abdominis Plane Block in Laparoscopic Colorectal Surgery.|Completed||N/A|66|Actual|University of Nottingham||2|||f||||f||||||||||2017-02-18 13:28:22.675764|2017-02-18 13:28:22.675764
NCT00830076|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2015-08-03|2011-09-29||December 2008||2008-12-01|August 2015|2015-08-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)|A Study to Assess the Effects of Co-Administration of Sitagliptin and Metformin on Incretin Hormone Concentrations|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:28:22.785544|2017-02-18 13:28:22.785544
NCT00830063|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2011-06-07||2011-06-02|May 2009||2009-05-01|June 2011|2011-06-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|||Tanezumab In Osteoarthritis Of The Knee (2)|A Phase 3 Randomized, Double Blind Placebo And Naproxen Controlled Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Osteoarthritis Of The Knee|Completed||Phase 3|848|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 13:28:23.270087|2017-02-18 13:28:23.270087
NCT00830050|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-03-10|||July 2010||2010-07-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Brain Imaging To Examine The Effect Of Naproxen In Hand Osteoarthritis Patients|A Study To Determine The Ability Of FMRI To Detect And Quantify The Effect Of Naproxen On Osteoarthritis Of The Hand|Completed||Early Phase 1|24|Actual|Pfizer||2|||f||||||||||||||2017-02-18 13:28:23.472781|2017-02-18 13:28:23.472781
NCT00830037|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-06-09|2016-04-28||August 2008||2008-08-01|June 2016|2016-06-01||||November 2014|Actual|2014-11-01||Interventional|||A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease|Pathobiology of Kidney Disease: Role of Iron|Terminated||Phase 4|136|Actual|Indiana University||2||"Terminated by the DSMB based on low chance of finding differences in mGFR slopes, but higher~   risk of serious adverse events in the IV iron group (aIRR = 1.60)"|f||||t||||||||||2017-02-18 13:28:23.588923|2017-02-18 13:28:23.588923
NCT00830024|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-09-01|2009-06-18||June 2005||2005-06-01|September 2009|2009-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions|A Relative Bioavailability Study of 3 mg Alprazolam Extended Release Tablets Under Non-fasting Conditions|Completed||Phase 1|36|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:24.179471|2017-02-18 13:28:24.179471
NCT00830011|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-24|2011-07-27|||September 2004||2004-09-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Cognitive Behavioral Therapy for Painful Diabetic Neuropathy|Cognitive Behavioral Therapy for Painful Diabetic Neuropathy|Completed||N/A|80|Anticipated|VA Connecticut Healthcare System||2|||f||||f||||||||||2017-02-18 13:28:24.620783|2017-02-18 13:28:24.620783
NCT00829998|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-07-06|2009-07-06||February 2004||2004-02-01|July 2009|2009-07-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Zaleplon 10mg Capsules Under Fasting Conditions|A Relative Bioavailability Study of Zaleplon 10mg Capsules Under Fasting Conditions|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:24.722083|2017-02-18 13:28:24.722083
NCT00829985|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2015-06-02|2013-01-31||January 2009||2009-01-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)|A Biomarker-based Pilot Study of Cockroach Sublingual Immunotherapy in Cockroach Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis (ICAC-12)|Completed||Phase 1/Phase 2|54|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:28:25.249692|2017-02-18 13:28:25.249692
NCT00829972|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-01-26|||January 2009||2009-01-01|January 2009|2009-01-01|November 2009|Anticipated|2009-11-01|September 2009|Anticipated|2009-09-01||Observational|||Vitamin D Levels in Children Undergoing Adenotonsillectomies and Controls|Vitamin D Levels in Children Undergoing Adenotonsillectomies and Controls|Unknown status|Recruiting|N/A|60|Anticipated|University of Chicago|||2||f||||f||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 13:28:25.742709|2017-02-18 13:28:25.742709
NCT00829959|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-08-03|||February 2009||2009-02-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)|Attitudes About Childbearing And Fertility In Women Seeking Genetic Testing For Inherited Breast And Ovarian Cancer Syndromes (HBOC)|Completed||N/A|156|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:28:25.818416|2017-02-18 13:28:25.818416
NCT00829946|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-01-26|||January 2008||2008-01-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Resistance Strength Training on Functional Capacity and Well Being of Anorexic Patients|Effects of Resistance Strength Training on Functional Capacity and Well Being of Anorexic Patients; A Randomized Controlled Trial|Completed||N/A|35|Actual|Universidad Europea de Madrid||1|||f||||t||||||||||2017-02-18 13:28:25.920871|2017-02-18 13:28:25.920871
NCT00829933|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2015-02-03|2015-01-15||March 2007||2007-03-01|February 2015|2015-02-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional||Baseline Analysis Population is based on Full Analysis Set. FAS defined as all subjects enrolled in study, but excluded those who had GCP violations, who did not receive any dose of study drug, or who did not have atrial fibrillation confirmed by ECG performed at least twice within a 1-week or longer interval within 1 year before registration|Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation|A Randomized Dose-ranging Controlled Trial of DU-176b Versus Warfarin Potassium in Patients With Non-valvular Atrial Fibrillation|Completed||Phase 2|536|Actual|Daiichi Sankyo Inc.||4|||f||||t||||||||||2017-02-18 13:28:26.009616|2017-02-18 13:28:26.009616
NCT00829920|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-25|2013-06-21|||November 2008||2008-11-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Observational|||The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease|The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease|Completed||N/A|44|Actual|University of Colorado, Denver|||1||f||||t||||||Samples With DNA|"~     Serum from patients undergoing treatment for muscle-invasive or metastatic bladder cancer~     who are planning for surgical bladder removal or chemotherapy will be acquired.~   "|||2017-02-18 13:28:26.950856|2017-02-18 13:28:26.950856
NCT00829907|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2009-11-23|||January 2009||2009-01-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A PET Study With ORM-12741|Effect of ORM-12741 on Receptor Occupancy Studied by Positron Emission Tomography; an Open, Single Dose, Dose Ranging Study in Healthy Males|Completed||Phase 1|26|Actual|Orion Corporation, Orion Pharma||1|||f||||t||||||||||2017-02-18 13:28:27.041943|2017-02-18 13:28:27.041943
NCT00829894|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-01-26|||June 2001||2001-06-01|January 2009|2009-01-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Risperidone 1 mg Tablets and Risperdal® 1 mg Tablets Administered as a 1 x 1 mg Tablets in Subjects Under Fed Conditions|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||||||||||||2017-02-18 13:28:27.139161|2017-02-18 13:28:27.139161
NCT00829881|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2013-09-25|||January 2009||2009-01-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder|Betahistine: Novel Therapeutic in Attention Deficit Hyperactivity Disorder|Completed||Phase 1|16|Actual|P2D, Inc.||2|||f||||f||||||||||2017-02-18 13:28:27.243042|2017-02-18 13:28:27.243042
NCT00829868|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-07-06|2009-07-06||February 2004||2004-02-01|July 2009|2009-07-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Zaleplon 10 mg Capsules Under Non-Fasting Conditions|A Relative Bioavailability Study of Zaleplon 10 mg Capsules Under Non-Fasting Conditions|Completed||Phase 1|42|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:27.355133|2017-02-18 13:28:27.355133
NCT00829855|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2013-03-04|||May 2008||2008-05-01|March 2013|2013-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Echocardiographic Evaluation of Hypertensive Acute Pulmonary Edema|Echocardiographic Evaluation of Hypertensive Acute Pulmonary Edema|Completed||N/A|51|Actual|Carol Davila University of Medicine and Pharmacy|||2||f||||t||||||||||2017-02-18 13:28:27.820093|2017-02-18 13:28:27.820093
NCT00829842|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-01-26|||February 2006||2006-02-01|January 2009|2009-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery|Evaluation of Oral Hygiene With 0.12% Chlorhexidine Antiseptic Solution on the Incidence of Nosocomial Pneumonia and Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery|Completed||Phase 3|160|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:28:27.905294|2017-02-18 13:28:27.905294
NCT00829829|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-04-26||2011-01-05|February 2009||2009-02-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|PRE-SURGE1||PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1|A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Rilonacept for the Prophylaxis of Gout Flares During the Initiation of Allopurinol Therapy|Completed||Phase 3|241|Actual|Regeneron Pharmaceuticals||3|||f||||||||||||||2017-02-18 13:28:27.988699|2017-02-18 13:28:27.988699
NCT00829816|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2015-11-06|||December 2008||2008-12-01|November 2015|2015-11-01|August 2010|Actual|2010-08-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil|A Multi-Center Phase 1 Study of the Safety and Tolerability of Dimebon in Alzheimer's Disease Patients on Memantine (Cohort 1) and Memantine Plus Donepezil (Cohort 2)|Completed||Phase 1|46|Actual|Medivation, Inc.||2|||f||||f||||||||||2017-02-18 13:28:28.180211|2017-02-18 13:28:28.180211
NCT00829803|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2010-06-22|||February 2009||2009-02-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|Precision GA||A Study to Assess Indeics of SNAP vs VISTA on Surgical Patients Undergoing General Anesthesia|A Prospective Randomized Double Blinded Study Assessing Indeics of SNAP vs VISTA on Surgical Patients Undergoing General Anesthesia|Unknown status|Recruiting|Phase 4|40|Anticipated|Stryker Instruments||2|||f||||f||||||||||2017-02-18 13:28:28.279747|2017-02-18 13:28:28.279747
NCT00829790|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-08-14|2009-06-30||October 2006||2006-10-01|August 2009|2009-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Study of Doxycycline Monohydrate 25 mg as a 5mL Oral Suspension Under Fed Conditions|Completed||Phase 1|30|Actual|Teva Pharmaceuticals USA||2|||f||||||||||||||2017-02-18 13:28:28.373703|2017-02-18 13:28:28.373703
NCT00829777|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-09-14|||March 2009||2009-03-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|AIKO-150||Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects|A Phase-I, Two-Stage, Double-Blind, Placebo-Controlled, Pharmacokinetic and Pharmacodynamic Trial of Low Doses of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects.|Completed||Phase 1|8|Anticipated|California Pacific Medical Center Research Institute||1|||f||||f||||||||||2017-02-18 13:28:28.83369|2017-02-18 13:28:28.83369
NCT00829764|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-08-14|2009-06-30||October 2006||2006-10-01|August 2009|2009-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Study of Doxycycline Monohydrate 25 mg as a 5 mL Oral Suspension Under Fasting Conditions|Completed||Phase 1|30|Actual|Teva Pharmaceuticals USA||2|||f||||||||||||||2017-02-18 13:28:28.933514|2017-02-18 13:28:28.933514
NCT00829751|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2013-05-31|||November 2008||2008-11-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility|The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility|Completed||N/A|26|Actual|Southern California College of Optometry||2|||f||||f||||||||||2017-02-18 13:28:29.499996|2017-02-18 13:28:29.499996
NCT00829738|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-05-04|2010-09-01||January 2009||2009-01-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Observational|PARADE||Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease|Pantoprazole 20/40 mg in Reflux-Associated Complaints With Focus on Gastrointestinal Symptoms|Completed||N/A|4188|Actual|Nycomed|||1||f||||f||||||||||2017-02-18 13:28:29.630935|2017-02-18 13:28:29.630935
NCT00829725|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-25|2010-09-05|||January 2009||2009-01-01|September 2010|2010-09-01|January 2012|Anticipated|2012-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Comparison Study of 3-4-screws-internal Fixation With Multi-screw-system Targon FN for Femoral Neck Fracture|Randomized, Prospective, Multi-center, Comparison Study of 3-4-screws-internal Fixation With Multi-screw-system Targon FN for Femoral Neck Fracture|Unknown status|Recruiting|Phase 4|300|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 13:28:31.257765|2017-02-18 13:28:31.257765
NCT00829712|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-08-14|2009-06-22||June 2004||2004-06-01|August 2009|2009-08-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions|A Randomized, Two-Way, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Dexmethylphenidate Hydrochloride, (10 mg), Compared to and Equivalent Dose of a Commercially Available Reference Drug Product (Focalin®, Novartis Pharmaceuticals Corporation) in 24 Fasted, Healthy, Adult Subjects|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:31.363981|2017-02-18 13:28:31.363981
NCT00829699|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2017-02-09|||July 2009||2009-07-01|February 2017|2017-02-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Interventional|||Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus|Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus, Question 3|Completed||Early Phase 1|31|Actual|University of Maryland||4|||f||||t||||||||||2017-02-18 13:28:31.884571|2017-02-18 13:28:31.884571
NCT00829686|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-07-27|2009-06-05||June 2008||2008-06-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Trial of Antibiotic Treatment for Skin Abscess in Patients at Risk for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection|Prospective Randomized Controlled Trial of Antibiotic Treatment for Uncomplicated Skin Abscess in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection|Completed||N/A|31|Actual|Wilford Hall Medical Center||2|||f||||f||||||||||2017-02-18 13:28:31.997971|2017-02-18 13:28:31.997971
NCT00829673|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-08-14|2009-06-22||June 2004||2004-06-01|August 2009|2009-08-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions|A Randomized, Two-Way, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Dexmethylphenidate Hydrochloride, (10 mg), Compared to an Equivalent Dose of a Commercially Available Reference Product (Focalin®, Novartis Pharmaceuticals Corporation) in 24 Fed, Healthy, Adult Subjects|Completed||Phase 1|24|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:32.405365|2017-02-18 13:28:32.405365
NCT00829660|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2017-01-12|||February 2009||2009-02-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|July 2017|Anticipated|2017-07-01||Interventional|ACE||Acarbose Cardiovascular Evaluation Trial|A Long-term, Multicentre, Double-blind, Randomised Parallel-group Trial to Determine Whether Reducing Post-prandial Glycaemia Can Reduce Cardiovascular-related Morbidity and Mortality in Patients With Established Coronary Heart Disease or Acute Coronary Syndrome Who Have Impaired Glucose Tolerance|Active, not recruiting||Phase 4|6526|Actual|University of Oxford||2|||f||||t||||||||Undecided||2017-02-18 13:28:32.816821|2017-02-18 13:28:32.816821
NCT00829647|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-10-13|||January 2009||2009-01-01|October 2009|2009-10-01|June 2010|Anticipated|2010-06-01|January 2010|Anticipated|2010-01-01||Interventional|||A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia|A Phase I/II Study of Combination Dasatinib and Lenalidomide in Purine Analogue-Failed Chronic Lymphocytic Leukemia|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Scripps Health||1|||f||||f||||||||||2017-02-18 13:28:33.278551|2017-02-18 13:28:33.278551
NCT00829634|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2013-05-29|||October 2008||2008-10-01|May 2013|2013-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation||Completed||N/A|12|Actual|California Pacific Medical Center Research Institute||1|||f||||||||||||||2017-02-18 13:28:33.397833|2017-02-18 13:28:33.397833
NCT00829621|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-10-02|2014-01-01||December 2008||2008-12-01|October 2016|2016-10-01|December 2013|Actual|2013-12-01|May 2012|Actual|2012-05-01||Interventional|||Incisional Vacuum Assisted Closure (IVAC) Device and Its Effect on Implanted Bone Morphogenic Protein (BMP-2)|Incisional Vacuum Assisted Closure (IVAC) Device and Its Effect on Implanted Bone Morphogenic Protein (BMP-2)|Completed||N/A|20|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-02-18 13:28:33.50813|2017-02-18 13:28:33.50813
NCT00829608|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2016-10-03|||January 2009||2009-01-01|October 2016|2016-10-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis|Investigator Initiated Study of Effects of Progression of Recurrent Respiratory Papillomatosis in Patients After They Are Given Human Papillomavirus Quadrivalent Vaccine|Withdrawn||Early Phase 1|0|Actual|University of Missouri-Columbia||1||investigator has left the institution|f||||f||||||||No||2017-02-18 13:28:33.814914|2017-02-18 13:28:33.814914
NCT00829595|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-01-26|||May 2005||2005-05-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease|Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease|Completed||N/A|69|Actual|Cedars-Sinai Medical Center||3|||f||||f||||||||||2017-02-18 13:28:33.926653|2017-02-18 13:28:33.926653
NCT00829582|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2010-01-18|||February 2009||2009-02-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Dose-Escalation Study With ETI-204|Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Phase I Study of the Safety, Tolerability and Pharmacokinetics of a Single Intravenous Dose of ETI-204 (AnthimTM) [Elusys Protocol Number AH-102]|Completed||Phase 1|45|Anticipated|Elusys Therapeutics||2|||f||||t||||||||||2017-02-18 13:28:34.038855|2017-02-18 13:28:34.038855
NCT00829569|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2011-11-03|||January 2004||2004-01-01|November 2011|2011-11-01|October 2008|Actual|2008-10-01|May 2004|Actual|2004-05-01||Interventional|||n-3 Fatty Acid Infusion and Type 2 Diabetes|Effects of Marine n-3 Fatty Acid Infusion on Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes|Completed||N/A|11|Actual|St. Olavs Hospital||1|||f||||f||||||||||2017-02-18 13:28:34.128208|2017-02-18 13:28:34.128208
NCT00829556|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-12-18|||April 2008||2008-04-01|December 2009|2009-12-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement|Single-Center, Randomized Trial to Study the Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing|Completed||N/A|160|Anticipated|Rothman Institute Orthopaedics||2|||f||||f||||||||||2017-02-18 13:28:34.264472|2017-02-18 13:28:34.264472
NCT00829543|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-02-02|||September 2004||2004-09-01|February 2009|2009-02-01|February 2009|Anticipated|2009-02-01|January 2007|Actual|2007-01-01||Interventional|||Unguided Sacroiliac Injection: Effect on Refractory Buttock Pain in Patients With Spondyloarthropathies|Guide-Free Sacroiliac Injection in Spondyloarthropathies|Unknown status|Enrolling by invitation|Early Phase 1|35|Anticipated|Tabriz University||1|||f||||t||||||||||2017-02-18 13:28:34.3595|2017-02-18 13:28:34.3595
NCT00829530|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-09-01|2009-07-02||August 2004||2004-08-01|September 2009|2009-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Ramipril 10 mg Capsule and Altace® Administered as 1 x 10 mg Capsule in Healthy Subjects Under Fed Conditions|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||||||||||||2017-02-18 13:28:34.488849|2017-02-18 13:28:34.488849
NCT00829517|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-02-15|||January 2011||2011-01-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Computer-Assisted Provision of Reproductive Health Care|Computer-Assisted Provision of Reproductive Health Care|Completed||N/A|814|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:28:34.965832|2017-02-18 13:28:34.965832
NCT00829504|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-09-01|2009-07-06||October 2004||2004-10-01|September 2009|2009-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Ropinirole 0.25 mg Tablets Under Fasting Conditions|The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fasting Conditions.|Completed||Phase 1|44|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:35.08001|2017-02-18 13:28:35.08001
NCT00829491|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-07-13|||March 2007||2007-03-01|July 2012|2012-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Denver Health Cardiovascular Disease (CVD) Prevention Program|Denver Health Cardiovascular Prevention Program|Completed||N/A|340|Actual|Denver Health and Hospital Authority||1|||f||||f||||||||||2017-02-18 13:28:35.525403|2017-02-18 13:28:35.525403
NCT00829478|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-24|2012-03-16|||October 2008||2008-10-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|AFIB||Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making|Improving Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making|Completed||Phase 1|135|Actual|VA Connecticut Healthcare System||2|||f||||t||||||||||2017-02-18 13:28:35.614863|2017-02-18 13:28:35.614863
NCT00829465|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2016-03-30|||December 2008||2008-12-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma|Clinical Research of in the Treatment of Unresectable Hepatocellular Carcinoma|Completed||Phase 4|400|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:28:35.717541|2017-02-18 13:28:35.717541
NCT00829452|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-09-01|2009-07-02||August 2004||2004-08-01|September 2009|2009-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions|Randomized, 2-Way Crossover Bioequivalence Study of Ramipril 10 mg Capsule and Altace® Administered as the Content of 1 x 10 mg Capsule Mixed With Applesauce in Healthy Subjects Under Fasting Conditions.|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||||||||||||2017-02-18 13:28:35.828387|2017-02-18 13:28:35.828387
NCT00829439|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-09-29|2016-08-05||January 2009||2009-01-01|September 2016|2016-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome|A Dose-escalation Tolerability Study of Levodopa/Carbidopa in Angelman Syndrome|Completed||Phase 1|16|Actual|Boston Children’s Hospital||1|||f||||t||||||||Undecided||2017-02-18 13:28:36.46275|2017-02-18 13:28:36.46275
NCT00829426|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-06-18|2009-06-18||June 2005||2005-06-01|June 2009|2009-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions|A Relative Bioavailability Study of 3 mg Alprazolam Extended Release Tablets Under Fasting Conditions|Completed||Phase 1|32|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:36.701816|2017-02-18 13:28:36.701816
NCT00829413|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2014-08-19||2014-08-18|June 2010||2010-06-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization|Characterization Of Focal Liver Lesions With Sonovue®-Enhanced Ultrasound Imaging: A Phase III, Intrapatient Comparative Study Versus Unenhanced Ultrasound Imaging Using Histology Or Combined Imaging/Clinical Data As Truth Standard|Completed||Phase 3|353|Actual|Bracco Diagnostics, Inc||2|||f||||f||||||||||2017-02-18 13:28:37.164525|2017-02-18 13:28:37.164525
NCT00829400|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-24|2016-12-19|||May 2008||2008-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Cognitive Training to Enhance VA Work Program Outcomes|Cognitive Training to Enhance VA Work Program Outcomes|Completed||Phase 3|77|Actual|VA Connecticut Healthcare System||2|||f||||f||||||||||2017-02-18 13:28:37.258416|2017-02-18 13:28:37.258416
NCT00829387|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-24|2015-06-01|2015-01-02||March 2010||2010-03-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Cognitive Behavioral Therapy for Diabetic Neuropathic Pain|Cognitive Behavioral Therapy for Diabetic Peripheral Neuropathic Pain|Completed||N/A|47|Actual|VA Connecticut Healthcare System||2|||f||||f||||||||||2017-02-18 13:28:37.521263|2017-02-18 13:28:37.521263
NCT00829374|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2016-09-24||2016-09-24|March 2009||2009-03-01|September 2016|2016-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|CONCERT||Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil|CONCERT: A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Twelve-Month Safety and Efficacy Study Evaluating Dimebon in Patients With Mild-to-Moderate Alzheimer's Disease on Donepezil|Completed||Phase 3|1003|Actual|Medivation, Inc.||3|||f||||t||||||||||2017-02-18 13:28:38.157602|2017-02-18 13:28:38.157602
NCT00829361|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2015-11-23|||October 2008||2008-10-01|November 2015|2015-11-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|STARR||Stroke Telemedicine for Arizona Rural Residents Trial|Stroke Telemedicine for Arizona Rural Residents Trial|Completed||N/A|447|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 13:28:38.379291|2017-02-18 13:28:38.379291
NCT00829348|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-12-29|||August 2006||2006-08-01|December 2009|2009-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins|Short Massages Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins.|Completed||N/A|120|Actual|Hillel Yaffe Medical Center||2|||f||||f||||||||||2017-02-18 13:28:38.504641|2017-02-18 13:28:38.504641
NCT00829335|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-01-26|||January 2007||2007-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach|Anatomical Segmental and Subsegmental Resection of the Liver for Hepatocellular Carcinoma: a New Approach by Means of Ultrasound-Guided Vessel Compression|Completed||N/A|30|Actual|University of Milan|||1||f||||t||||||||||2017-02-18 13:28:38.622409|2017-02-18 13:28:38.622409
NCT00829322|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2013-08-16|||February 2009||2009-02-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Modafinil for the Treatment of Fatigue in Lung Cancer V9.0|Modafinil for the Treatment of Fatigue in Lung Cancer: a Multicentre, Randomised, Double-blinded, Placebo-controlled Trial|Completed||Phase 4|208|Actual|University of Oxford||2|||f||||t||||||||||2017-02-18 13:28:38.739638|2017-02-18 13:28:38.739638
NCT00829309|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2009-09-09|2009-07-02||March 2005||2005-03-01|September 2009|2009-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions|A Relative Bioavailability Study of 80 mg Pravastatin Sodium Tablets Under Non-Fasting Conditions|Completed||Phase 1|16|Actual|Teva Pharmaceuticals USA||2|||f||||f||||||||||2017-02-18 13:28:38.859791|2017-02-18 13:28:38.859791
NCT00829296|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2016-01-08|2014-08-04||January 2009||2009-01-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Interventional|EFFORT||Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries|The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetics|Completed||Phase 2/Phase 3|70|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 13:28:39.2909|2017-02-18 13:28:39.2909
NCT00829283|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2015-12-28|2015-10-27||November 2008||2008-11-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care|Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care|Completed||N/A|191|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:28:39.647712|2017-02-18 13:28:39.647712
NCT00829270|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-12-17|||March 2009||2009-03-01|January 2009|2009-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Economic and Medical Evaluation of the Whole Mitochondrial DNA Screening by Surveyor and Mitochips Techniques|Economic and Medical Evaluation of the Whole Mitochondrial DNA Screening by Surveyor and Mitochips Techniques.|Completed||N/A|550|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||Samples With DNA|"~     patients presenting clinical features of mitochondrial diseases~   "|||2017-02-18 13:28:40.145594|2017-02-18 13:28:40.145594
NCT00829257|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-26|2012-06-11|||January 2009||2009-01-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|PAW01||Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma|A Proof of Concept Study to Evaluate the Additive Effects of HFA-BDP (Qvar) to Fluticasone/Salmeterol (Seretide) on Surrogate Markers of Small and Large Airway Inflammation in Refractory Asthma|Completed||Phase 4|15|Actual|University of Dundee||2|||f||||t||||||||||2017-02-18 13:28:40.231435|2017-02-18 13:28:40.231435
NCT00829244|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2014-01-20|2012-06-01||August 2008||2008-08-01|January 2014|2014-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||CONSORT Randomized Controlled Trial in Assisted Reproductive Technology|A Phase IV Prospective, Multicenter, Randomized, Open-label Trial to Assess the Efficacy and Safety of GONAL f® at a Dose Based on Subject Baseline Characteristics Determined According to the CONSORT Calculator Compared With a Standard Dose of GONAL f® 150 IU Per Day for Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology (ART)|Completed||Phase 4|200|Actual|Merck KGaA||2|||f||||||||||||||2017-02-18 13:28:40.338239|2017-02-18 13:28:40.338239
NCT00829231|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2014-10-31|||January 2009||2009-01-01|October 2014|2014-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Hepatic Impairment Study|Open Label, Phase 1 to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetic of Sorafenib ( BAY43-9006)|Completed||Phase 1|45|Actual|Bayer||3|||f||||f||||||||||2017-02-18 13:28:41.187234|2017-02-18 13:28:41.187234
NCT00829218|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2013-12-21|||January 2009||2009-01-01|December 2013|2013-12-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional|||Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM)|A Clinical Trial Examining the Effects of the Food Additive Glutamate on Irritable Bowel Syndrome and Fibromyalgia|Completed||N/A|60|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 13:28:41.301751|2017-02-18 13:28:41.301751
NCT00829205|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2013-08-23|||January 2009||2009-01-01|July 2009|2009-07-01||||||||Interventional|||Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment|A Phase I/II Study of Methylselenocysteine (MSC) in Combination With Immunochemotherapy (R-ICE) in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)|Withdrawn||Phase 1/Phase 2|0|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:28:41.406738|2017-02-18 13:28:41.406738
NCT00829192|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2010-12-03|||November 2007||2007-11-01|December 2010|2010-12-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||Phase II AK Study in Organ Transplant Patients|A Multicentre, Randomised, Double-Blind, Placebo Controlled, Phase II Study to Evaluate the Safety and Efficacy of Subcutaneous Bioresorbable Implants of Afamelanotide (CUV1647) for the Prophylactic Treatment of Pre-Cancerous Skin Lesions of the Head, Forearms and Hands in Immune Compromised, Organ Transplant Patients.|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|Clinuvel Pharmaceuticals Limited||2|||f||||t||||||||||2017-02-18 13:28:41.513494|2017-02-18 13:28:41.513494
NCT00829179|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-01-12|2009-02-22||October 2002||2002-10-01|January 2016|2016-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma|Role of RhuMab-E25 in Reducing Exhaled NO in Allergic Asthma|Completed||Phase 3|20|Actual|Duke University|Pilot study with small sample size.|1|||f||||f||||||||||2017-02-18 13:28:41.631319|2017-02-18 13:28:41.631319
NCT00829166|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-09-10|2013-02-22||February 2009||2009-02-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|July 2012|Actual|2012-07-01||Interventional|EMILIA|Intent-to-treat (ITT) population included all randomized participants on the basis of the treatment assigned at randomization.|A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer|A Randomized, Multicenter, Phase III Open-label Study of the Efficacy and Safety of Trastuzumab MCC-DM1 vs. Capecitabine + Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trastuzumab-Based Therapy|Completed||Phase 3|991|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-02-18 13:28:41.873328|2017-02-18 13:28:41.873328
NCT00829153|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2010-03-15|||January 2007||2007-01-01|March 2010|2010-03-01||||August 2010|Anticipated|2010-08-01||Interventional|||U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis|A Pilot, Randomised, Blinded Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis for Creating of Autologous Arteriovenous Fistulae|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Royal Hobart Hospital||2|||f||||f||||||||||2017-02-18 13:28:46.229762|2017-02-18 13:28:46.229762
NCT00829140|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2010-11-01|||November 2008||2008-11-01|November 2010|2010-11-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional|TULIP||To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake|A 56-Day , Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake in Overweight and Obese Patients (TULIP)|Completed||Phase 1|56|Anticipated|Arena Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:28:46.332172|2017-02-18 13:28:46.332172
NCT00829127|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2011-08-24|||January 2009||2009-01-01|August 2011|2011-08-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers|A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers|Withdrawn||Phase 1|27|Anticipated|AstraZeneca||2||Due to termination of study D3801C00001, due to reports of turbid urine.|f||||f||||||||||2017-02-18 13:28:46.4348|2017-02-18 13:28:46.4348
NCT00829114|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2011-10-28|||March 2009||2009-03-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)|Interactions Between Antiretrovirals and Combined Oral Contraceptive Pills|Completed||Phase 4|370|Anticipated|FHI 360||2|||f||||f||||||||||2017-02-18 13:28:46.523965|2017-02-18 13:28:46.523965
NCT00829101|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2014-07-01|||January 2009||2009-01-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|APCLP||Articulation and Phonology in Children With Unilateral Cleft Lip and Palate|Articulatory and Phonological Competence at 3 and 5 Years of Age in Children With Unilateral Cleft Lip and Palate Who Have Undergone Different Methods of Primary Palatal Surgery|Completed||N/A|30|Actual|Region Skane|||3||f||||f||||||||||2017-02-18 13:28:46.634923|2017-02-18 13:28:46.634923
NCT00829088|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-02-24|||January 2009||2009-01-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|||||Interventional|||Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066|An Open Label, Single Dose, Phase I Study of the Excretion of Radioactivity, Metabolism and Pharmacokinetics Following Oral Administration of [14C]AZD2066 to Healthy Male Subjects|Completed||Phase 1|6|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:28:46.733449|2017-02-18 13:28:46.733449
NCT00829075|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-01-23|||January 2005||2005-01-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|||||Interventional|||Impact of Three Different Gonadotrophin Regimes on Egg Donation Program|A Prospective, Randomized, Controlled Trial Comparing Three Different Gonadotrophin Regimens in Oocyte Donors: Ovarian Response and IVF Outcome|Completed||Phase 4|||Instituto Valenciano de Infertilidad, IVI VALENCIA||3|||f||||f||||||||||2017-02-18 13:28:46.816801|2017-02-18 13:28:46.816801
NCT00829062|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2010-07-29|||January 2009||2009-01-01|July 2010|2010-07-01|July 2010|Anticipated|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Expanding Coverage of Continuous Subcutaneous Insulin Infusion in Pediatric Patients With Diabetes|Presenting Evidence Based Practice to an Insurance Provider to Expand Coverage of Continuous Subcutaneous Insulin Infusion (CSII) in Pediatric Patients With Diabetes|Withdrawn||N/A|0|Actual|Children's Mercy Hospital Kansas City||1||No participants met inclusion criteria.|f||||t||||||||||2017-02-18 13:28:46.899942|2017-02-18 13:28:46.899942
NCT00829049|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-08-20|2011-09-22||October 2007||2007-10-01|August 2012|2012-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris||Terminated||Phase 4|165|Actual|Allergan|Study enrollment was terminated due to company decision before the target enrollment of 220 patients was reached.|2||"Study enrollment was terminated due to company decision before the target enrollment of 220~   patients was reached."|f||||f||||||||||2017-02-18 13:28:47.014004|2017-02-18 13:28:47.014004
NCT00829036|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2014-02-18|2014-02-18||October 2012||2012-10-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Using Repeated Measures ANOVA for the 24 participants, and assuming a minimum correlation between repeated measures of .7, our analyses will be sensitive to a between factor effect size of f=.33, with power set to .80 and alpha level set to .05. This should be sufficient to reveal significant differences between baseline and device use.|Wayfinding Information Access System for People With Vision Loss|Wayfinding Information Access System for People With Vision Loss|Completed||N/A|24|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 13:28:47.33902|2017-02-18 13:28:47.33902
NCT00829023|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-23|||June 2007||2007-06-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of Surgical Preparation Solutions in Shoulder Surgery|Efficacy of Surgical Preparation Solutions in Shoulder Surgery|Completed||N/A|150|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 13:28:47.591953|2017-02-18 13:28:47.591953
NCT00829010|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2015-10-22|2012-05-08||February 2009||2009-02-01|September 2015|2015-09-01|August 2012|Actual|2012-08-01|May 2011|Actual|2011-05-01||Interventional|||Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.|Primary and Booster Vaccination Course in Human Immunodeficiency Virus (HIV) Infected Infants, HIV Exposed Uninfected Infants and Unexposed Uninfected Infants Receiving the Pneumococcal Vaccine GSK 1024850A.|Completed||Phase 3|489|Actual|GlaxoSmithKline|The study aimed to enrol 100 HIV+/+ subjects but succeeded to enrol 83 mainly due to decrease of vertical HIV transmission in South Africa. Some subjects, HIV+ at screening, tested negative at subsequent HIV testing, were reallocated in HIV+/-Group.|5|||f||||||||||||||2017-02-18 13:28:47.7171|2017-02-18 13:28:47.7171
NCT00828997|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2013-11-06|||August 2008||2008-08-01|October 2013|2013-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|PVA||Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar®|Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar®|Unknown status|Enrolling by invitation|Phase 4|500|Anticipated|Region Skane||1|||f||||t||||||||||2017-02-18 13:28:50.858499|2017-02-18 13:28:50.858499
NCT00828984|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2016-11-18|2016-11-18||October 2009||2009-10-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer|Polyethylene Glycol for ACF Reduction and Biomarker Modulation in Individuals With CRC Risk|Completed||Phase 2|140|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 13:28:51.16094|2017-02-18 13:28:51.16094
NCT00828971|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2014-12-05|||November 2008||2008-11-01|December 2014|2014-12-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|MERAK||A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs|A Prospective, Randomized, Open Label, Active Comparator, Multicenter, National Trial to Compare the Efficacy and Safety of Sequential IV/PO Moxifloxacin 400 mg Once Daily Versus IV Amoxicillin/Clavulanate 2,0/0,2 g Every 8 Hours Followed by Oral Amoxicillin/Clavulanate 875/125 mg Every 8 Hours in the Treatment of Adult Subjects With Complicated Skin and Skin Structure Infections|Completed||Phase 3|16|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:28:52.057576|2017-02-18 13:28:52.057576
NCT00828958|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2011-05-17|||February 2006||2006-02-01|March 2010|2010-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.|Local Site Tolerability of Multiple Dose Treatment With Deltoid Intramuscular Injection of RISPERDAL CONSTA in Subjects With Chronic Schizophrenia.|Completed||Phase 3|53|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:28:52.190683|2017-02-18 13:28:52.190683
NCT00828945|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-02-16|2012-02-16||February 2009||2009-02-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|COLL||Compliance With Treatment For Patients With Hyperlipidemia|A Non-Randomized, Non-Controlled, Open Study In Order To Document The Compliance With Treatment, According To Clinical Praxis And National Guidelines For Patients With Hyperlipidemia. COLL: Control Of Lipid Lowering|Completed||N/A|259|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:28:52.275798|2017-02-18 13:28:52.275798
NCT00828932|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-07-27|||August 2008||2008-08-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment|An Open Label, Single Dose Study of the Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment|Completed||Phase 1|24|Anticipated|Arena Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:28:52.612598|2017-02-18 13:28:52.612598
NCT00828919|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2016-11-11|||March 2003||2003-03-01|November 2016|2016-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Continuing Access To AG- 013736 (A406) For Patients Previously Receiving AG 013736 In Clinical Trials|Continuing Access To The Tyrosine Kinase Inhibitor Of Vegfr 2, Ag 013736 (a406) For Patients Previously Receiving Ag 013736 In Clinical Trials|Active, not recruiting||N/A|53|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 13:28:52.715992|2017-02-18 13:28:52.715992
NCT00828906|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-09-18|||February 2009||2009-02-01|July 2012|2012-07-01||||November 2009|Actual|2009-11-01||Interventional|||DuoTrav® Eye Drops As Replacement Therapy Program||Completed||Phase 4|128|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:28:52.855392|2017-02-18 13:28:52.855392
NCT00828893|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-02-17|||October 2009||2009-10-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|CT-Nav||Navigation Guidance Gestures Carried Out Under CT|Interest of the Use of a Navigation Guidance Gestures Carried Out Under CT|Completed||Phase 2/Phase 3|120|Actual|University Hospital, Grenoble||1|||f||||t||||||||||2017-02-18 13:28:52.947958|2017-02-18 13:28:52.947958
NCT00828880|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-01-23||||||January 2009|2009-01-01||||||||Observational|||Restoration of Disc Height Reduces Chronic Low Back Pain|Restoration of Disk Height Through Non-Invasive Spinal Decompression is Associated With Decreased Discogenic Low-Back Pain: A Retrospective Cohort Study|Completed||N/A|||NEMA Research, Inc.|||1||f||||f||||||||||2017-02-18 13:28:53.033153|2017-02-18 13:28:53.033153
NCT00828867|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-10-11|||November 2008||2008-11-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Single Dose Escalation First Time in Human PK Study|A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Investigational Study Drug in Healthy Subjects|Completed||Phase 1|41|Actual|GlaxoSmithKline||9|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:28:53.248068|2017-02-18 13:28:53.248068
NCT00828854|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2010-02-02|||April 2008||2008-04-01|February 2010|2010-02-01||||February 2010|Actual|2010-02-01||Interventional|||A Phase 2, Multicenter Study of the Effect of the Addition of SNDX-275 to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing|A Phase 2, Multicenter Study of the Effect of the Addition of SNDX-275 to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing|Completed||Phase 2|25|Anticipated|Syndax Pharmaceuticals||1|||f||||t||||||||||2017-02-18 13:28:53.382903|2017-02-18 13:28:53.382903
NCT00828841|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2013-10-11|2013-08-07||December 2008||2008-12-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC|A Multi-Center Randomized Phase 2b Study of Cetuximab (Erbitux) in Combination With Platinum-Based Chemotherapy as First Line Treatment of Patients With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|601|Actual|Accelerated Community Oncology Research Network||3|||f||||t||||||||||2017-02-18 13:28:53.524045|2017-02-18 13:28:53.524045
NCT00828828|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-05-20|||December 2008||2008-12-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Observational|IVS||Antibody Response to Influenza Vaccine in Patients With Sarcoidosis|Controlled Trial of Serologic Efficacy of Influenza Vaccine in Patients With Sarcoidosis|Completed||Phase 3|49|Actual|Shahid Beheshti University of Medical Sciences|||2||f||||t||||||||||2017-02-18 13:28:56.128989|2017-02-18 13:28:56.128989
NCT00828815|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2011-06-08|||March 2009||2009-03-01|October 2010|2010-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.|A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Subjects on Stable Buprenorphine/Naloxone Maintenance Therapy.|Completed||Phase 1|22|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:28:56.244798|2017-02-18 13:28:56.244798
NCT00828802|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2013-09-06|||March 2009||2009-03-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes|A Phase I Study of Lenalidomide in Combination With Decitabine for Patients With High Grade Myelodysplastic Syndromes|Completed||Phase 1|15|Actual|Duke University||5|||f||||f||||||||||2017-02-18 13:28:56.336183|2017-02-18 13:28:56.336183
NCT00828789|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2010-12-16|||February 2009||2009-02-01|December 2010|2010-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer|A Phase I, Open-label, Randomized, Crossover Trial in 20 Healthy Subjects to Investigate the Pharmacokinetic Interactions Between the Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir.|Completed||Phase 1|20|Actual|Tibotec BVBA|||||f||||||||||||||2017-02-18 13:28:56.447189|2017-02-18 13:28:56.447189
NCT00828776|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-01-23|||September 2007||2007-09-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|heparin||Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure|Clinical Trial of Pharmacodynamic Effects and Non-Clinical Inferiority of the Drug Heparin Sodium Produced by the Laboratory Cristália When Compared With the Product Liquemine of Roche Laboratory in Patients With Chronic Renal Failure|Completed||Phase 2/Phase 3|62|Actual|Azidus Brasil||2|||f||||f||||||||||2017-02-18 13:28:56.537352|2017-02-18 13:28:56.537352
NCT00828763|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-06-04|||February 2009||2009-02-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||GSK1349572 Mass Balance Study|An Open Label, Non-Randomized, Single Dose, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1349572 20 mg, Administered as a Single Oral Suspension Dose to Healthy Adult Subjects (ING111853)|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:28:56.785991|2017-02-18 13:28:56.785991
NCT00828750|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2011-10-31|2011-09-15||May 2008||2008-05-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)|Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)-An Extension Study of Eltrombopag in Subjects, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study TRA108109 (NCT00540423)-<Phase III Study>|Completed||Phase 3|19|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:28:56.893482|2017-02-18 13:28:56.893482
NCT00828737|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-02-16|||December 2008||2008-12-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|GRIP||Safety of Gadovist in Renally Impaired Patients|Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Gadovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information|Completed||Phase 4|927|Actual|Bayer||1|||f||||f||||||||||2017-02-18 13:28:57.534111|2017-02-18 13:28:57.534111
NCT00828724|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-01-23|||November 2008||2008-11-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State|An Open Label, Single Dose, Cross-Over Study to Assess the Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State|Completed||Phase 1|24|Actual|Arena Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:28:57.877782|2017-02-18 13:28:57.877782
NCT00828711|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2014-03-10|2014-01-24||April 2009||2009-04-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor|A Multicenter, Randomized, Double-Blind, Dose-Ranging, Phase II Study to Assess the Efficacy and Safety of the 100, 150 and 200 mcg Misoprostol Vaginal Insert for Women Requiring Cervical Ripening and Induction of Labor|Completed||Phase 2|374|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-02-18 13:28:57.966792|2017-02-18 13:28:57.966792
NCT00828698|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-01-23|||January 1996||1996-01-01|January 2009|2009-01-01||||January 2000|Actual|2000-01-01||Observational|FINGER||FINGER; Finland-Germany Myocardial Infarction Study|Finnish-German Prospective, Observational Follow-up Study on Risk Assessment of Mortality After Myocardial Infarction|Completed||N/A|||University of Oulu|||1||f||||||||||Samples With DNA|"~     DNA samples from Finnish subjects in the study have been retained.~   "|||2017-02-18 13:28:58.974103|2017-02-18 13:28:58.974103
NCT00828685|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2017-02-03||||||February 2017|2017-02-01||||||||Interventional|||Early Functional Outcomes After Closed Reduction With Pinning Versus Open Reduction Internal Fixation of Wrist Fractures|Early Functional Outcomes After Closed Reduction Percutaneous Pinning vs. Open Reduction Internal Fixation of Distal Radius Fractures: A Prospective Randomized Trial|Completed||N/A|||Beth Israel Deaconess Medical Center||2|||f||||||||||||||2017-02-18 13:28:59.083768|2017-02-18 13:28:59.083768
NCT00828672|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2015-11-05|||June 2009||2009-06-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|March 2014|Actual|2014-03-01||Interventional|AXE BEAM||Phase II Study of Neo Adjuvant Treatment With Avastin, Xeloda and/or Eloxatin in Colorectal Cancer|A Randomized Phase II Study of Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin in the Preoperative Treatment of Locally Advanced Rectal Cancer|Active, not recruiting||Phase 2|80|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-02-18 13:28:59.196665|2017-02-18 13:28:59.196665
NCT00828659|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-07-27|||December 2008||2008-12-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users|A Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users|Completed||Phase 1|35|Anticipated|Arena Pharmaceuticals||7|||f||||f||||||||||2017-02-18 13:28:59.32574|2017-02-18 13:28:59.32574
NCT00828646|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2011-01-06|||October 2008||2008-10-01|March 2009|2009-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|JMAD||Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese|Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-708163 in Healthy Male Japanese Subjects and a Comparison to Healthy Elderly Japanese Subjects|Completed||Phase 1|32|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 13:28:59.432298|2017-02-18 13:28:59.432298
NCT00828620|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-08-09|||January 2009||2009-01-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|October 2011|Actual|2011-10-01||Observational|||Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project|Imaging for Early Response Prediction to EGF-receptor Blocking Monoclonal Antibodies in Combination Therapy for Colorectal Cancer|Terminated||N/A|21|Actual|Universitaire Ziekenhuizen Leuven|||1|Lack of recruitment|f||||t||||||||||2017-02-18 13:28:59.628447|2017-02-18 13:28:59.628447
NCT00828607|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2015-07-27|||January 2009||2009-01-01|July 2015|2015-07-01|August 2016|Anticipated|2016-08-01|December 2015|Anticipated|2015-12-01||Observational|||Contrast Enhanced (CE) Ultrasound and CE Computed Tomography or CE Magnetic Resonance Imaging in Liver Masses|Characterization of Liver Masses With Contrast Enhanced Ultrasound (CEUS): A Comparison With Standard Institutional Contrast Enhanced CT (CECT) or MR Scan (CEMRI)|Recruiting||N/A|250|Anticipated|Foothills Medical Centre|||1||f||||f||||||||||2017-02-18 13:28:59.739414|2017-02-18 13:28:59.739414
NCT00828594|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2013-04-09|||December 2008||2008-12-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma|A Phase 1 Open Label/ Phase 2 Randomized, Double-blind, Multicenter Study Investigating the Combination of RAD001 and Sorafenib (Nexavar®) in Patients With Advanced Hepatocellular Carcinoma|Terminated||Phase 1|130|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:28:59.850018|2017-02-18 13:28:59.850018
NCT00828581|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-01-23|||October 2008||2008-10-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects|An Open-Label, Single-Dose Study of the Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects|Completed||Phase 1|24|Actual|Arena Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:28:59.96244|2017-02-18 13:28:59.96244
NCT00828568|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2013-12-21|2009-09-17||June 2008||2008-06-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Bioequivalence Study of Two Imiquimod Cream 5%|A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Two Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis|Completed||Phase 1|425|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-02-18 13:29:00.071256|2017-02-18 13:29:00.071256
NCT00828555|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-10-15|||November 2008||2008-11-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|April 2009|Actual|2009-04-01||Observational|||Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting|Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting|Completed||N/A|3988|Actual|Duke University|||1||f||||f||||||||||2017-02-18 13:29:00.706092|2017-02-18 13:29:00.706092
NCT00828542|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2009-01-23|||July 2007||2007-07-01|January 2009|2009-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety of the Etonogestrel-Releasing Implant During the Puerperium of Healthy Women|Safety of the Etonogestrel-Releasing Implant During the Puerperium of Healthy Women|Completed||N/A|40|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 13:29:00.796833|2017-02-18 13:29:00.796833
NCT00828529|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-08-14|||February 2009||2009-02-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer|A Phase I, Open-label, Randomized Crossover Trial to Investigate the Pharmacokinetic Interaction Between Steady-state Lopinavir/Ritonavir and Single-dose TMC207 in Healthy Subjects.|Completed||Phase 1|16|Actual|Tibotec BVBA|||||||||f||||||||||2017-02-18 13:29:00.904917|2017-02-18 13:29:00.904917
NCT00828516|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-12-07|2012-11-09||April 2008||2008-04-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|AMWELL-SL||Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema|Using Acupuncture and Moxibustion to Promote Wellbeing and Improve Quality of Life for Patients With Upper Body Lymphoedema Secondary to Cancer Treatment|Completed||N/A|56|Actual|East and North Hertfordshire NHS Trust||1|||f||||f||||||||||2017-02-18 13:29:00.996059|2017-02-18 13:29:00.996059
NCT00828503|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2012-08-30|||December 2008||2008-12-01|August 2012|2012-08-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|Certi-CMV||Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients|Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients|Unknown status|Recruiting|Phase 2|40|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:29:01.276716|2017-02-18 13:29:01.276716
NCT00828490|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-23|2010-03-21|||July 2007||2007-07-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|ePRM||Electronic Pharmacotherapy Risk Management|Developing a Utah Pharmacotherapy Risk Management System With an Electronic Surveillance Tool (Utah ePRM)|Completed||N/A|174000|Actual|University of Utah|||6||f||||f||||||||||2017-02-18 13:29:01.519954|2017-02-18 13:29:01.519954
NCT00828477|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-06-08|||January 2009||2009-01-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)|Evaluation of Comfort With the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Xibrom (Bromfenac Ophthalmic Solution) 0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)|Completed||Phase 4|25|Anticipated|Bp Consulting, Inc||2|||f||||f||||||||||2017-02-18 13:29:01.628502|2017-02-18 13:29:01.628502
NCT00828464|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-09-21|2010-04-07||October 2008||2008-10-01|September 2012|2012-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis|An Open Label Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for the Condition of Chronic Hand Dermatitis|Completed||Phase 4|30|Actual|GlaxoSmithKline|Open label study|1|||f||||f||||||||||2017-02-18 13:29:01.745717|2017-02-18 13:29:01.745717
NCT00828451|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-12-17|||May 2008||2008-05-01|December 2009|2009-12-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Collaborative Research Group for Necrotizing Enterocolitis|Collaborative Research Group for Necrotizing Enterocolitis|Unknown status|Active, not recruiting|N/A|48|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 13:29:02.148474|2017-02-18 13:29:02.148474
NCT00828438|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-07-27|||October 2008||2008-10-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment|A Phase 1, Open-Label, Single-Dose Study of the Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment|Completed||Phase 1|40|Anticipated|Arena Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:29:02.251871|2017-02-18 13:29:02.251871
NCT00828412|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-12-01|2013-09-17||March 2009||2009-03-01|December 2016|2016-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis|A Randomized, Investigator-Blind, Six-Week, Parallel Group, Multicenter Pilot Study to Compare the Safety and Efficacy of EpiCeram Skin Barrier Emulsion and Desonide Cream 0.05% in the Twice Daily Treatment of Pediatric Subjects With Moderate Atopic Dermatitis|Completed||Phase 4|100|Actual|Promius Pharma, LLC||2|||f||||f||||||||||2017-02-18 13:29:02.636417|2017-02-18 13:29:02.636417
NCT00828399|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2011-05-24|||January 2009||2009-01-01|January 2009|2009-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Prevention of Acute Radiation Enteritis With Glutamine|Efficacy of Glutamine in the Prevention of Acute Radiation Enteritis Among Patients Treated With Radiation of Abdomen and Pelvis.|Completed||Phase 4|70|Actual|Castilla-León Health Service||2|||f||||f||||||||||2017-02-18 13:29:03.006569|2017-02-18 13:29:03.006569
NCT00828386|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2015-03-23|||January 2009||2009-01-01|March 2015|2015-03-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|GORTEC-NPC2006||Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers|A Randomized, Multicenter, Phase III Trial Comparing Induction Chemotherapy With Docetaxel, Cisplatin and 5-Fluorouracil (TPF) Followed by Concurrent Chemoradiotherapy to Concurrent Chemoradiotherapy Alone, in Nasopharyngeal Cancers Staged as T2b, T3, T4 and/or With Lymph Node Involvement (>N1)|Terminated||Phase 3|83|Actual|Groupe Oncologie Radiotherapie Tete et Cou||2||Low accrual|f||||||||||||||2017-02-18 13:29:03.110509|2017-02-18 13:29:03.110509
NCT00828373|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2011-07-14|||August 2009||2009-08-01|August 2009|2009-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|LidoRoc||The Influence of Intravenous Lidocaine on the Action of the Neuromuscular Blocker Rocuronium|The Effect of Intravenous Lidocaine on the Time Course of Rocuronium Induced Neuromuscular Block. A Randomised, Placebo-controlled, Electrophysiological Study|Completed||Phase 4|52|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 13:29:03.225181|2017-02-18 13:29:03.225181
NCT00828360|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-01-22|||July 2006||2006-07-01|January 2009|2009-01-01|September 2009|Anticipated|2009-09-01|April 2009|Anticipated|2009-04-01||Observational|LODO-CRT||Dobutamine Stress Echocardiography in Cardiac Resynchronization Therapy (CRT) Patients Selection|Efficacy Of Low-Dose Dobutamine Stress-Echocardiography To Predict Cardiac Resynchronization Therapy Response|Unknown status|Active, not recruiting|N/A|270|Anticipated|Ospedale Santa Maria di Loreto Mare|||1||f||||f||||||||||2017-02-18 13:29:03.31961|2017-02-18 13:29:03.31961
NCT00828347|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2015-12-16|2011-07-05||January 2008||2008-01-01|December 2015|2015-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)|A Study of Maintenance Therapy After Intravenous Maxacalcitol for Secondary Hyperparathyroidism|Completed||N/A|35|Actual|Kumamoto University|Sample size was small, so it will be necessary to conduct further studies in a larger number of patients.|2|||f||||t||||||||||2017-02-18 13:29:03.430333|2017-02-18 13:29:03.430333
NCT00828334|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-01-22|||November 2002||2002-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:29:03.809308|2017-02-18 13:29:03.809308
NCT00828321|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-09-01|2009-07-02||August 2004||2004-08-01|September 2009|2009-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions|Randomized , 2- Way Crossover, Bioequivalence Study of Ramipril 10 mg Capsule and Altace® Administered as 1 x 10 mg Capsule in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|40|Actual|Teva Pharmaceuticals USA||2|||f||||||||||||||2017-02-18 13:29:03.86468|2017-02-18 13:29:03.86468
NCT00828308|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-07-18|2013-08-20||February 2009||2009-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|March 2011|Actual|2011-03-01||Interventional|BrUOG-Pros-221||Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer|BrUOG-PROS-221 Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: A Phase II Study|Active, not recruiting||Phase 2|16|Actual|Brown University||1|||f||||t||||||||||2017-02-18 13:29:04.338683|2017-02-18 13:29:04.338683
NCT00828295|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2015-03-17|2014-06-27||August 2008||2008-08-01|July 2014|2014-07-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients|A Multicenter, Double-blind, Randomized, Parallel Group, Stratified Study to Assess the Safety and Efficacy of Single IV Doses of Palonosetron to Prevent Postoperative Nausea and Vomiting in Pediatric Patients|Completed||Phase 3|150|Actual|Helsinn Healthcare SA||2|||f||||f||||||||||2017-02-18 13:29:04.634599|2017-02-18 13:29:04.634599
NCT00828282|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2014-05-23|||March 2009||2009-03-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|January 2011|Actual|2011-01-01||Interventional|||High-dose HMG-CoA Inhibitor Simvastatin Relapsed CLL|High-dose HMG-CoA Inhibitor Simvastatin for Patients With Relapsed CLL: Pilot Trial and Pharmacokinetic-pharmacodynamic Studies|Completed||Phase 1|3|Actual|University of Kentucky||1|||f||||t||||||||||2017-02-18 13:29:05.209549|2017-02-18 13:29:05.209549
NCT00828269|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-04-21|||April 2009||2009-04-01|April 2015|2015-04-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)|Evaluation of RNA Quality and the Reproducibility of Gene Expression Profiling From Liver Tissue Obtained by Fine Needle Aspiration in Patients With Chronic Hepatitis C.|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 13:29:05.320326|2017-02-18 13:29:05.320326
NCT00828256|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-01-22|||February 2009||2009-02-01|January 2009|2009-01-01|June 2009|Anticipated|2009-06-01|May 2009|Anticipated|2009-05-01||Observational|||Outcome of Arthroscopic Repair of Chronic Rotator Cuff Tears Between 2005-2008|Outcome Study of Arthroscopic Repair of Chronic Rotator Cuff Tears Between 2005-2008, at the Soroka University Medical Center, Beer Sheva, Israel|Unknown status|Enrolling by invitation|N/A|80|Anticipated|Soroka University Medical Center|||1||f||||||||||||||2017-02-18 13:29:05.406777|2017-02-18 13:29:05.406777
NCT00828243|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2014-10-19|||November 2007||2007-11-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Genetic Regulation of Surfactant Deficiency|Genetic Regulation of Surfactant Deficiency in Human Newborn Infants|Completed||N/A|773|Actual|Washington University School of Medicine|||2||f||||t||||||Samples With DNA|"~     DNA samples and tracheal aspirate samples will be retained on each study participant.~   "|||2017-02-18 13:29:05.475617|2017-02-18 13:29:05.475617
NCT00828230|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-01-26|||September 2008||2008-09-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis|Randomised, Double-blind, Placebo-controlled, Multicentre, Comparative Phase II Pilot Study on the Efficacy and Tolerability of an 8-week Rectal Treatment With 2 mg Budesonide or Placebo for the Prevention of Acute Radiation Proctitis|Terminated||Phase 2|17|Actual|Dr. Falk Pharma GmbH||2||"Study was prematurely stopped due to slow recruitment after 17 of 32 anticipated patients were~   recruited."|f||||f||||||||||2017-02-18 13:29:05.590448|2017-02-18 13:29:05.590448
NCT00828217|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2010-09-23|||November 2008||2008-11-01|September 2010|2010-09-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Interventional|ACTIVHOP||Adapted Physical Activity, Health-related Quality of Life and Satisfaction With Care in Hospitalized Children|ACTIVHOP: Adapted Physical Activity, Health-related Quality of Life and Satisfaction With Care in Hospitalized Children; a Randomized Controlled Study|Unknown status|Recruiting|N/A|312|Anticipated|Central Hospital, Nancy, France||2|||f||||f||||||||||2017-02-18 13:29:05.69659|2017-02-18 13:29:05.69659
NCT00828204|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2014-05-08|2011-07-13||January 2009||2009-01-01|May 2014|2014-05-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional||This table presents the baseline characteristics for both the Initial Subset and Main Subset populations. As represented in the Participant Flow module, these 2 groups participated prior to and after study suspension, respectively; therefore the total column should not be interpreted as cumulative.|Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects|An Open-Label, Multicenter Study to Evaluate the Safe and Effective Use of the Single-Use Autoinjector With an Avonex® Prefilled Syringe in Multiple Sclerosis Subjects|Completed||Phase 3|95|Actual|Biogen|The Initial Subset is too small a population from which to draw conclusions.|1|||f||||f||||||||||2017-02-18 13:29:05.799258|2017-02-18 13:29:05.799258
NCT00828191|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2013-01-28|2012-11-26||December 2008||2008-12-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Interventional|||Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)|Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) Versus Vaginal Progesterone for Luteal Phase Support in Patients Undergoing In Vitro Fertilization (IVF)|Completed||Phase 3|800|Actual|IBSA Institut Biochimique SA|No limitations of the trial reported.|2|||f||||||||||||||2017-02-18 13:29:06.475893|2017-02-18 13:29:06.475893
NCT00828178|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-09-28|2013-09-17||February 2009||2009-02-01|September 2016|2016-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy of Fish Oil in Lupus Patients|A Randomized, Double-blind, Placebo-controlled, Clinical Trial of Omega-3-polyunsaturated Fatty Acids in Subjects With SLE.|Completed||Phase 4|106|Actual|Johns Hopkins University||2|||f||||t||||||||No||2017-02-18 13:29:06.902155|2017-02-18 13:29:06.902155
NCT00828165|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-08-29|||January 2009||2009-01-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Safety Study of ARRY-300 in Healthy Subjects||Completed||Phase 1|12|Actual|Array BioPharma||2|||f||||f||||||||||2017-02-18 13:29:07.328554|2017-02-18 13:29:07.328554
NCT00828152|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2015-05-05|||January 2009||2009-01-01|June 2010|2010-06-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|Ha1b||Internet-delivered Cognitive Behavioral Therapy (CBT) for Health Anxiety|Internet-delivered Cognitive Behavioural Therapy for Health Anxiety - a Randomized Controlled Trial|Completed||Phase 2|80|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 13:29:07.560732|2017-02-18 13:29:07.560732
NCT00828139|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-12-28|2015-11-05||May 2009||2009-05-01|December 2016|2016-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Randomized Phase II Trial of Weekly Topotecan With and Without AVE0005 (Aflibercept; NSC-724770) in Patients With Platinum Treated Extensive Stage Small Cell Lung Cancer (E-SCLC)|Completed||Phase 2|189|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:29:07.677739|2017-02-18 13:29:07.677739
NCT00828126|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-03-26|||January 2009||2009-01-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma|PET-CT in the Management of Patients With Stage III Or IV Metastatic Melanoma Considered Candidates for Surgery: Evaluation of Additive Value Following Conventional Imaging|Completed||N/A|38|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:29:09.269891|2017-02-18 13:29:09.269891
NCT00828113|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-10-22|2012-06-13||January 2009||2009-01-01|October 2015|2015-10-01|February 2011|Actual|2011-02-01|September 2010|Actual|2010-09-01||Interventional|||Long-term Varenicline Treatment for Smoking Cessation|Long-term Varenicline Treatment for Smoking Cessation|Completed||Phase 4|101|Actual|University of Wisconsin, Madison|Feasibility study with limited statistical power at baseline compounded by a significant rate of attrition during the study.|2|||f||||t||||||||||2017-02-18 13:29:09.376027|2017-02-18 13:29:09.376027
NCT00828100|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-03-05|||February 2009||2009-02-01|March 2009|2009-03-01||||May 2009|Anticipated|2009-05-01||Interventional|||Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B|Comparison of fluID Rapid Influenza and BinaxNOW® Influenza A & B|Suspended||Phase 3|650|Anticipated|Nanogen, Inc.||||Study currently suspended due to a lack of available funding.|f||||f||||||||||2017-02-18 13:29:09.863487|2017-02-18 13:29:09.863487
NCT00828087|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2015-05-18|||December 2008||2008-12-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study|A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction.EXAMINATION Study|Completed||N/A|1504|Actual|Spanish Society of Cardiology||2|||f||||f||||||||||2017-02-18 13:29:09.953485|2017-02-18 13:29:09.953485
NCT00828074|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2014-05-05|||November 2008||2008-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer|Phase I/II Vinorelbine and Sorafenib as Salvage Therapy in Metastatic Breast Cancer|Completed||Phase 1/Phase 2|46|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:29:10.090145|2017-02-18 13:29:10.090145
NCT00828061|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-08-04|2010-04-12||February 2009||2009-02-01|August 2015|2015-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study of the Effects of Single Dose Corticosteroids on Response to Allergens|A Randomized Clinical Trial to Study the Effects of Single Dose of Corticosteroid on Response to Nasal Allergen Challenge in Patients|Completed||Phase 1|19|Actual|Merck Sharp & Dohme Corp.|Poor cell yields from nasal lavage significantly reduced the utility of eosinophil count data.|3|||f||||f||||||||||2017-02-18 13:29:10.200523|2017-02-18 13:29:10.200523
NCT00828048|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-01-12|||March 2008||2008-03-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||International Registry for Intraductal Papillary Mucinous Neoplasma|International Registry for Intraductal Papillary Mucinous Neoplasma|Active, not recruiting||N/A|560|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-02-18 13:29:10.557745|2017-02-18 13:29:10.557745
NCT00828035|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-09-17|||April 2008||2008-04-01|September 2012|2012-09-01|April 2011|Actual|2011-04-01|April 2008|Actual|2008-04-01||Interventional|||Light Endoscopic Robot Use in Laparoscopic Surgery|Light Endoscopic Robot Use in Abdominal and Urological Laparoscopic Surgery|Completed||Phase 2/Phase 3|78|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-02-18 13:29:10.645063|2017-02-18 13:29:10.645063
NCT00828022|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-01-22|||March 2009||2009-03-01|January 2009|2009-01-01||||||||Interventional|SMC4692||Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer|A Single-Institution, Open-Label, Single-Arm phase1/2 Study of Measles Vaccine as Consolidation in Patients With Measles Virus-Positive, Stage 3B/4 Non-Small Cell Lung Cancer|Unknown status|Not yet recruiting|Phase 1/Phase 2|15|Anticipated|Soroka University Medical Center||1|||f||||t||||||||||2017-02-18 13:29:10.749759|2017-02-18 13:29:10.749759
NCT00828009|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2014-09-16|||December 2010||2010-12-01|September 2014|2014-09-01||||January 2016|Anticipated|2016-01-01||Interventional|||BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|A Phase II Study of L-BLP25 and Bevacizumab in Unresectable Stage IIIA and IIIB Non-Squamous Non-Small Cell Lung Cancer After Definitive Chemoradiation|Unknown status|Recruiting|Phase 2|55|Anticipated|Eastern Cooperative Oncology Group||1|||f||||||||||||||2017-02-18 13:29:10.843745|2017-02-18 13:29:10.843745
NCT00827996|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-22|||February 2007||2007-02-01|January 2009|2009-01-01|August 2008||2008-08-01|November 2007|Actual|2007-11-01||Interventional|HIDRI2007||To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa|Open Label,Phase Two Study to Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa|Completed||Phase 2|10|Actual|Florida Academic Dermatology Centers||1|||f||||t||||||||||2017-02-18 13:29:11.020608|2017-02-18 13:29:11.020608
NCT00827983|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2013-01-28|2012-11-26||January 2009||2009-01-01|January 2013|2013-01-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|||Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)|Efficacy and Tolerability of Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)|Completed||Phase 3|683|Actual|IBSA Institut Biochimique SA|no special limitations of the trial were detected.|2|||f||||||||||||||2017-02-18 13:29:13.285826|2017-02-18 13:29:13.285826
NCT00827970|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-01-22|||October 1997||1997-10-01|January 2009|2009-01-01|August 2007|Actual|2007-08-01|February 1998|Actual|1998-02-01||Interventional|||Randomized Population-Based Study on Chlamydia Trachomatis Screening|Populationbased Screening for Urogenital Chlamydia Trachomatis Infections by Use of Home-Obtained and Mailed Samples: A Randomized Study|Completed||N/A|30000|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 13:29:14.062505|2017-02-18 13:29:14.062505
NCT00827957|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2017-02-09|||October 2008||2008-10-01|February 2017|2017-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|Hypothermia||Comparing Therapeutic Hypothermia Using External and Internal Cooling for Post-Cardiac Arrest Patients|A Phased Prospective Clinical Study Comparing Controlled Therapeutic Hypothermia Post Resuscitation After Cardiac Arrest Using External and Internal Cooling to Standard Intensive Care Unit Therapy|Completed||Phase 4|51|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-02-18 13:29:14.162978|2017-02-18 13:29:14.162978
NCT00827944|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-11-16|2013-08-23||October 2008||2008-10-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Parietex Progrip Study|ProGrip Mesh Repair Versus Lichtenstein Mesh Repair: a Comparative Randomized Study in Primary Inguinal Hernia|Completed||Phase 4|603|Actual|Medtronic - MITG||2|||f||||f||||||||||2017-02-18 13:29:14.279286|2017-02-18 13:29:14.279286
NCT00827931|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-04-02|2012-04-02||September 2009||2009-09-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery|Prospective Randomized Phase IV Open Label Comparative Study Of Tranexamic Acid Plus Standard Of Care Vs Standard Of Care For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery|Completed||Phase 4|94|Actual|Pfizer|The intended FAS population was planned to include participants from 2 sites, however due to non-reliability of data from one of the sites, the actual FAS population included participants from a single site only.|2|||f||||t||||||||||2017-02-18 13:29:17.069715|2017-02-18 13:29:17.069715
NCT00827918|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2015-10-20|2013-09-24||March 2009||2009-03-01|October 2015|2015-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)|A Phase IIa, Randomized, Multicenter, Double-Blind, Active Comparator- and Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of MK8998 in Acutely Psychotic Patients With Schizophrenia|Completed||Phase 2|216|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 13:29:17.613736|2017-02-18 13:29:17.613736
NCT00827905|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2010-08-04|||January 2009||2009-01-01|August 2010|2010-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Substantial Equivalence Study for Kai Sensors RSpot Non-Contact Respiratory Rate Spot Check|Remote Doppler System to Measure Heart Rate and Breathing Pattern|Completed||N/A|20|Anticipated|Kai Medical, Inc.|||1||f||||f||||||||||2017-02-18 13:29:18.363272|2017-02-18 13:29:18.363272
NCT00827892|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-10-01|||March 2009||2009-03-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|SHRINC||Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage|Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage|Completed||Phase 2|84|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-02-18 13:29:18.463096|2017-02-18 13:29:18.463096
NCT00827879|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-01-12|||February 2009||2009-02-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Strength at Home Couples Program (PTSD-Focused Relationship Enhancement Therapy for Returning Veterans)|Strength at Home Couples Program (Formerly: PTSD-Focused Relationship Enhancement Therapy for Returning Veterans and Their Partners)|Completed||N/A|156|Actual|Boston VA Research Institute, Inc.||2|||f||||t||||||||||2017-02-18 13:29:18.588445|2017-02-18 13:29:18.588445
NCT00827853|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2013-11-01|||November 2008||2008-11-01|November 2013|2013-11-01|February 2012|Actual|2012-02-01|August 2011|Actual|2011-08-01||Interventional|COBRA||Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease|PolarCath® Cryoplasty Versus Conventional Balloon Post-dilation of Nitinol Stents for Peripheral Vascular Interventions (COBRA)|Completed||N/A|90|Actual|North Texas Veterans Healthcare System||2|||f||||t||||||||||2017-02-18 13:29:18.809709|2017-02-18 13:29:18.809709
NCT00827840|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2011-12-22|||November 2008||2008-11-01|December 2011|2011-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia|Paliperidone ER Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia: a Randomized, Open-label, Controlled Trial|Completed||Phase 4|58|Actual|Chonnam National University Hospital||2|||f||||t||||||||||2017-02-18 13:29:18.920071|2017-02-18 13:29:18.920071
NCT00827827|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-09-22|2014-12-29||April 2009||2009-04-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|August 2013|Actual|2013-08-01||Interventional||Disabled stroke survivors|Strength Training for Skeletal Muscle Adaptation After Stroke|Strength Training for Skeletal Muscle Adaptation After Stroke|Active, not recruiting||N/A|38|Actual|VA Office of Research and Development|"Scanning results and muscle biopsy outcomes are still pending and won't be available for some time.~Numbers of participants qualifying for and agreeing to metabolic testing will be too low to yield reportable results."|2|||f||||t||||||||Yes|if requested, we can make some of it available.|2017-02-18 13:29:19.034878|2017-02-18 13:29:19.034878
NCT00827814|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-06-08|||June 2006||2006-06-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction|Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction: A 24-Week Open-Label, Single-Arm Pilot Study|Completed||Phase 4|36|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-02-18 13:29:19.743407|2017-02-18 13:29:19.743407
NCT00827801|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-07-19|||January 2009||2009-01-01|July 2012|2012-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program|MDASI-HF: Bridging the Symptom Management Gap in Patients With Cancer and Concurrent Heart Failure to Improve Outcomes|Completed||N/A|26|Actual|M.D. Anderson Cancer Center|||2||f||||t||||||||||2017-02-18 13:29:19.847852|2017-02-18 13:29:19.847852
NCT00827788|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2010-11-15|||December 2008||2008-12-01|September 2009|2009-09-01||||April 2010|Actual|2010-04-01||Interventional|CONTRAST-AMI||Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)|The Contrast Media and Nephrotoxicity Following Coronary Revascularization by Primary Angioplasty for Acute Myocardial Infarction. The CONTRAST-AMI Study.|Completed||Phase 4|432|Anticipated|Ospedale San Donato||2|||f||||f||||||||||2017-02-18 13:29:20.161411|2017-02-18 13:29:20.161411
NCT00827775|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2014-01-27|||June 2009||2009-06-01|January 2014|2014-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|MATCH||Mechanisms and Treatment of Intradialytic Hypertension|Blood Pressure, Endothelial Cell Dysfunction, and Outcomes in Dialysis Patients|Completed||Phase 4|59|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 13:29:20.289436|2017-02-18 13:29:20.289436
NCT00827762|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2013-12-03|||January 2009||2009-01-01|December 2013|2013-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Behavioral Effects of Kuvan in Children With Mild Phenylketonuria|Behavioral Effects of Kuvan in Children With Mild Phenylketonuria|Terminated||N/A|2|Actual|Washington University School of Medicine|||1|Too few participants recruited within timeframe|f||||f||||||||||2017-02-18 13:29:20.408475|2017-02-18 13:29:20.408475
NCT00827749|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2010-07-21|||November 2008||2008-11-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PRIOD||Swallowing Disorders in Geriatrics Studied With Respiratory Plethysmography by Inductance|Contribution of Respiratory Plethysmography by Inductance and of Informatic Tool for the Study of Swallowing Disorders in Geriatrics (PRIOD)|Completed||Early Phase 1|30|Anticipated|University Hospital, Grenoble||1|||f||||t||||||||||2017-02-18 13:29:20.530253|2017-02-18 13:29:20.530253
NCT00827736|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-01-22|||June 2002||2002-06-01|January 2009|2009-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure|Botulin Toxin Versus Isosorbidedinitrate Ointment in Treatment Anal Fissure; A Prospective, Blinded, Randomized Trial|Completed||Phase 4|73|Actual|Onze Lieve Vrouwe Gasthuis||2|||f||||f||||||||||2017-02-18 13:29:20.625103|2017-02-18 13:29:20.625103
NCT00827723|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2016-01-27|||February 2009||2009-02-01|January 2016|2016-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma|Makuuchi Versus Barcelona Clinic of Liver Cancer Criteria in Cirrhotic Patients With Hepatocellular Carcinoma. Does Etiology of Cirrhosis Influence the Relationship Between the Portal Pressure and Quantitative Tests of Liver Function?|Recruiting||N/A|60|Anticipated|University of Lausanne Hospitals|||2||f||||t||||||||||2017-02-18 13:29:20.734451|2017-02-18 13:29:20.734451
NCT00827710|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2012-04-29|||December 2007||2007-12-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|||Automated Diabetes Registry Tools to Enhance Patient Self-Management and Provider Performance Feedback||Completed||N/A|5457|Actual|Denver Health and Hospital Authority||4|||f||||t||||||||||2017-02-18 13:29:20.847569|2017-02-18 13:29:20.847569
NCT00827697|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-08-15|||May 2009||2009-05-01|August 2016|2016-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples|A Validation Study of the Gen-Probe APTIMA Combo2 (AC2) for Detecting Chlamydia Trachomatis and Neisseria Gonorrhoeae in Rectal Samples.|Completed||N/A|399|Actual|University of Pittsburgh|||1||f||||f||||||||No||2017-02-18 13:29:20.957447|2017-02-18 13:29:20.957447
NCT00827684|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2011-06-07|||March 2009||2009-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|TIRASMUS||Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations|Phase II Study of Temsirolimus and Irinotecan in Chemotherapy Refractory Patients With KRAS Mutated Metastatic Colorectal Cancer|Completed||Phase 2|50|Anticipated|Vejle Hospital||2|||f||||t||||||||||2017-02-18 13:29:21.04918|2017-02-18 13:29:21.04918
NCT00827671|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2010-10-25|||March 2009||2009-03-01|October 2010|2010-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|TRACC||Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma|Multi-Modality Treatment of Resectable Oesophageal Adenocarcinoma Using Peri-operative Chemotherapy With Additional Pre-operative Combined Radiotherapy and Cetuximab|Terminated||Phase 2|12|Actual|UMC Utrecht||1||Experimental treatment not feasible due to high rate of drop out|f||||t||||||||||2017-02-18 13:29:21.15395|2017-02-18 13:29:21.15395
NCT00827658|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-22|||February 2008||2008-02-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Ulnar Nerve Block for Procedural Anesthesia - Wrist Versus Palm|Ulnar Nerve Block for Procedural Anesthesia - Wrist Versus Palm|Unknown status|Recruiting|N/A|246|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 13:29:21.253519|2017-02-18 13:29:21.253519
NCT00827645|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2010-02-17|||January 2009||2009-01-01|January 2010|2010-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Uterine Artery Embolization and Pelvic Floor Symptoms|Effect of Uterine Artery Embolization on Symptoms of Pelvic Floor Dysfunction|Unknown status|Recruiting|N/A|56|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-02-18 13:29:21.34878|2017-02-18 13:29:21.34878
NCT00827632|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-12-11|2010-10-11||July 2006||2006-07-01|December 2012|2012-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|20/30||Obesity, Oral Contraception, and Ovarian Suppression|Oral Contraception and Ovarian Suppression in Women With Different Weights|Completed||Phase 4|226|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 13:29:21.429031|2017-02-18 13:29:21.429031
NCT00827619|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2015-12-03|||February 2009||2009-02-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2011|Actual|2011-11-01||Interventional|||Zilver® Flex™ Vascular Stent Study|Evaluation of the Zilver® Flex™ Vascular Stent in the Above-the-Knee Femoropopliteal Artery|Completed||N/A|110|Actual|Cook||1|||f||||||||||||||2017-02-18 13:29:21.939154|2017-02-18 13:29:21.939154
NCT00827606|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-08-16|2014-09-11||March 2009||2009-03-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Full Analysis Set (FAS): all participants who took at least one dose of study drug.|Atorvastatin Three Year Pediatric Study|A Three Year, Prospective, Open-label, Study To Evaluate Clinical Efficacy, Safety And Tolerability Of Atorvastatin In Children And Adolescents With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|272|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 13:29:22.070863|2017-02-18 13:29:22.070863
NCT00827593|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2012-04-12|||November 2008||2008-11-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|April 2011|Actual|2011-04-01||Interventional|||Managing Obesity by Combining Behavioral Weight Loss and Commercial Approaches|Managing Obesity by Combining Behavioral Weight Loss and Commercial Approaches|Completed||N/A|144|Actual|Baruch College City University of New York||3|||f||||t||||||||||2017-02-18 13:29:24.046456|2017-02-18 13:29:24.046456
NCT00827580|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-22|2009-08-27|||January 2009||2009-01-01|August 2009|2009-08-01||||||||Interventional|||Eniluracil Hand Foot Syndrome|A Pilot Study of Eniluracil Containing Ointment for Prevention of Hand Foot Syndrome (HRS) Following Capecitabine (Xeloda)|Completed||Phase 1|35|Anticipated|West Virginia University||2|||f||||t||||||||||2017-02-18 13:29:24.135691|2017-02-18 13:29:24.135691
NCT00827567|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2013-12-11|2011-08-16||April 2009||2009-04-01|December 2013|2013-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Trial of RAD001 in Triple Negative Metastatic Breast Cancer|A Phase II Trial of RAD001 in Triple Negative Metastatic Breast Cancer|Terminated||Phase 2|6|Actual|Milton S. Hershey Medical Center||1||Slow accrual|f||||t||||||||||2017-02-18 13:29:24.237562|2017-02-18 13:29:24.237562
NCT00827554|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-03-30|||December 2008||2008-12-01|March 2016|2016-03-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma|A Clinical Randomized Control Trial of Combination TACE With and Without Low-molecular-weight Heparin in Hepatocellular Carcinoma|Completed||Phase 2/Phase 3|100|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:29:24.477906|2017-02-18 13:29:24.477906
NCT00827541|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2011-12-23|2011-12-23||August 2008||2008-08-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|HORUS||Post-Authorization Study Evaluating Safety Of Tigecycline|A Phase IV Pharmacovigilance, Post-Authorization Clinical Trial To Evaluate And Assess The Safety Of Tigecycline In The Approved Indications In The Usual Health Care Setting|Completed||N/A|115|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:29:24.587801|2017-02-18 13:29:24.587801
NCT00827528|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-03-22|||August 2006||2006-08-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||SIS Graft and Traditional Repair in Vaginal Wall Prolapse|Surgical Treatment of Anterior Vaginal Wall Prolapse: Comparison of SIS Graft and Traditional Repair.|Completed||Phase 4|56|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 13:29:25.283153|2017-02-18 13:29:25.283153
NCT00827515|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-03-04|||February 2009||2009-02-01|March 2015|2015-03-01|May 2009|Anticipated|2009-05-01|April 2009|Anticipated|2009-04-01||Interventional|||Relative Bioavailability and Food Effect Study|A Phase 1, Randomized, Open-Label, Single Dose, 4-Way Crossover Study In Healthy Volunteers To Assess The Relative Bioavailability Of The Oral Powder In Capsule (PIC) And An Immediate Release (IR) Film-Coated Tablet Of PH-797804 In The Fed And Fasted State|Withdrawn||Phase 1|0|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:29:25.39387|2017-02-18 13:29:25.39387
NCT00827502|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2011-04-25|2010-03-30||February 2009||2009-02-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections|Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections|Completed||N/A|421|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:29:25.484739|2017-02-18 13:29:25.484739
NCT00827489|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-09-01|||January 2009||2009-01-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Evaluating HTC-867 in Healthy Young and Elderly Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTC-867 Administered Orally to Healthy Subjects|Terminated||Phase 1|72|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:29:25.776314|2017-02-18 13:29:25.776314
NCT00827476|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-21|||January 2009||2009-01-01|January 2009|2009-01-01|January 2015|Anticipated|2015-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Improving Human Ovarian Transplantation|Phase 1 Study to Improve Results of Human Ovarian Transplantation|Unknown status|Active, not recruiting|Early Phase 1|100|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-02-18 13:29:25.872252|2017-02-18 13:29:25.872252
NCT00827463|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2016-08-19|||January 2009||2009-01-01|September 2009|2009-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|anémie||Early Detection of Anaemia During the Maternity|The Early Detection of Anaemia During the Maternity Decreases the Anaemia at the End of the Maternity.|Completed||Phase 3|80|Actual|University Hospital, Limoges||2|||f||||t||||||||||2017-02-18 13:29:25.953734|2017-02-18 13:29:25.953734
NCT00827450|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-02-23|||February 2009||2009-02-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|COLIBRI||Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet|Effects of Coffees With Various Compositions of Antioxidants on Hepatic Steatosis Induced by a High Fructose, Hypercaloric Diet|Completed||N/A|13|Actual|University of Lausanne||5|||f||||t||||||||||2017-02-18 13:29:26.060135|2017-02-18 13:29:26.060135
NCT00827437|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2012-04-20|||January 2004||2004-01-01|June 2011|2011-06-01||||November 2007|Actual|2007-11-01||Interventional|||Family-Staff Communication Intervention at the Time of Difficult Treatment Decision Making|Family-Staff Communication Intervention at the Time of Difficult Treatment Decision Making|Completed||N/A|401|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 13:29:26.175975|2017-02-18 13:29:26.175975
NCT00827424|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2010-08-23|||December 2008||2008-12-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|AWESOME||The Impact of the PACE Program Implementation on Health Services Utilization by Obese Arab Women|The Impact of the PACE Program Implementation on Health Services Utilization by Obese Arab Women (The AWESOME Study: Arab WomEn Study on Obesity Metabolism and Exercise)|Completed||N/A|100|Anticipated|Clalit Health Services||2|||f||||f||||||||||2017-02-18 13:29:26.270758|2017-02-18 13:29:26.270758
NCT00827411|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-04-11|||January 2009||2009-01-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|March 2012|Actual|2012-03-01||Interventional|ARCTIC||Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy|Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and a Interruption Versus Continuation of Double Antiplatelet Therapy, One Year After Stenting|Completed||Phase 4|2500|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||t||||||||||2017-02-18 13:29:26.37268|2017-02-18 13:29:26.37268
NCT00827398|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2014-11-05|||January 2009||2009-01-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|MSCforGVHD||Treatment of Steroid Resistant GVHD by Infusion MSC|Treatment of Steroid Resistant Grade II to IV GVHD by Infusion MSCof Mesenchymal Stem Cells Expanded With Human Plasma and Platelet Lysate a Phase I/II Study|Completed||Phase 1/Phase 2|50|Actual|UMC Utrecht||1|||f||||f||||||||||2017-02-18 13:29:26.493541|2017-02-18 13:29:26.493541
NCT00827385|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-02-02|||January 2009||2009-01-01|February 2015|2015-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Intraoperative Blood Pressure and Cognitive Performance|Impact of Intraoperative Blood Pressure on Cognitive Performance in Patients With and Without Hypertension: a Prospective Observational Study|Completed||N/A|100|Actual|Weill Medical College of Cornell University|||2||f||||f||||||||||2017-02-18 13:29:26.594464|2017-02-18 13:29:26.594464
NCT00827372|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2014-10-15|2014-09-02||January 2009||2009-01-01|October 2014|2014-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer|A Phase II Study of VEGF Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer|Completed||Phase 2|10|Actual|Indiana University|This study was to enroll 14-15 patients. Due to toxicity and enough patients met the definition of response, enrollment to this study was halted early, leading to a smaller number of subjects analyzed.|1|||f||||t||||||||||2017-02-18 13:29:26.674763|2017-02-18 13:29:26.674763
NCT00827359|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-08-29|||March 2009||2009-03-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma|A Phase II Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 2|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:29:27.102582|2017-02-18 13:29:27.102582
NCT00827346|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2011-04-28|||January 2009||2009-01-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty|Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty|Completed||Phase 2/Phase 3|100|Anticipated|Ottawa Heart Institute Research Corporation||4|||f||||f||||||||||2017-02-18 13:29:27.213697|2017-02-18 13:29:27.213697
NCT00827333|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-07-29|||September 2009||2009-09-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer|Palliative Care for Quality of Life and Symptom Concerns in Family Caregivers of Lung Cancer Patients|Completed||N/A|372|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 13:29:27.325593|2017-02-18 13:29:27.325593
NCT00827320|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-01-21|||June 2007||2007-06-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions|Completed||N/A|26|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 13:29:27.437325|2017-02-18 13:29:27.437325
NCT00827307|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2011-08-05|||June 2008||2008-06-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Zoladex Plus Tamoxifen in Breast Cancer|The Effects of Adjuvant Zoladex Plus Tamoxifen on Breast Density in Pre- or Peri-menopausal Women With Early-stage Breast Cancer|Completed||N/A|100|Anticipated|Zhejiang Cancer Hospital||2|||f||||f||||||||||2017-02-18 13:29:27.528819|2017-02-18 13:29:27.528819
NCT00827294|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-09-11|||January 2009||2009-01-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Home-based Self-delivered Mirror Therapy for Phantom Limb Pain|A Pilot Study of Self-delivered Home-based Mirror Therapy for Phantom Limb Pain|Unknown status|Recruiting|Early Phase 1|16|Anticipated|Oregon Health and Science University||1|||f||||t||||||||||2017-02-18 13:29:27.632003|2017-02-18 13:29:27.632003
NCT00827281|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-07-20|||August 2008||2008-08-01|July 2015|2015-07-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)|D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation|Withdrawn||Phase 2|0|Actual|Boston University||2||Study was not funded and pilot work proved impractical.|f||||f||||||||||2017-02-18 13:29:27.722081|2017-02-18 13:29:27.722081
NCT00827268|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-10-15|||June 2009||2009-06-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|December 2011|Actual|2011-12-01||Interventional|||Multimodal Treatment of Phonological Alexia: Behavioral & fMRI Outcomes|Multimodal Treatment of Phonological Alexia: Behavioral & fMRI Outcomes|Completed||Phase 1/Phase 2|18|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 13:29:27.918073|2017-02-18 13:29:27.918073
NCT00827255|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-07-16|2011-10-17||January 2009||2009-01-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Observational|||Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%||Completed||N/A|35|Actual|Allergan|||1||f||||f||||||||||2017-02-18 13:29:28.026301|2017-02-18 13:29:28.026301
NCT00827242|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2010-10-19|2010-10-19||January 2009||2009-01-01|October 2010|2010-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multinational Study to Evaluate the Efficacy and Safety of Daily Tadalafil for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|325|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:29:28.260357|2017-02-18 13:29:28.260357
NCT00827229|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-21|||January 2007||2007-01-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of Laborpro - a New Device for the Assessment of Progress of Labor||Completed||N/A|110|Actual|Trig Medical Inc||1|||f||||f||||||||||2017-02-18 13:29:29.959159|2017-02-18 13:29:29.959159
NCT00827216|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-06-22|||January 2009||2009-01-01|June 2015|2015-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Intravenous Erythromycin on Gastric Emptying in Non-fasted Patients Before Emergency Total Anesthesia|The Effect of Intravenous Erythromycin on Gastric Emptying in Patients Undergoing Rapid Sequence Intubation for Full Stomach - A Randomised, Placebo-controlled, Double-blind Study|Completed||Phase 2|132|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 13:29:30.045987|2017-02-18 13:29:30.045987
NCT00827203|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-03-06|||January 2009||2009-01-01|March 2009|2009-03-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|||A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors|A Phase 1 Multi-Dose Dose-Escalation Study of Elesclomol Sodium, Administered Once Weekly to Subjects With Solid Tumors|Suspended||Phase 1|30|Anticipated|Synta Pharmaceuticals Corp.||1|||f||||f||||||||||2017-02-18 13:29:30.170441|2017-02-18 13:29:30.170441
NCT00827190|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2010-02-02|||February 2009||2009-02-01|February 2010|2010-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study Evaluating Single Ascending Doses Of ILS-920|Ascending Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of ILS-920 Administered Intravenously To Healthy Adult Subjects|Completed||Phase 1|16|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:29:30.270396|2017-02-18 13:29:30.270396
NCT00827177|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2014-01-23|||September 2009||2009-09-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|September 2012|Actual|2012-09-01||Interventional|||Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors|A Phase 1 Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|87|Actual|ArQule||1|||f||||f||||||||||2017-02-18 13:29:30.36374|2017-02-18 13:29:30.36374
NCT00827164|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-05-09|||January 2011||2011-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer|Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer|Completed||Phase 2|29|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 13:29:30.474309|2017-02-18 13:29:30.474309
NCT00827151|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2015-09-21|||December 2008||2008-12-01|September 2015|2015-09-01|January 2015|Anticipated|2015-01-01|May 2011|Actual|2011-05-01||Interventional|838||Bone Mass Accrual in Adolescent Athletes|"2008P-00346: Bone Mass Accrual in Adolescent Athletes"|Withdrawn||Phase 3|0|Actual|Massachusetts General Hospital||2||The study was not funded|f||||t||||||||||2017-02-18 13:29:30.595765|2017-02-18 13:29:30.595765
NCT00827138|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2014-07-16|||March 2009||2009-03-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)|A Multicenter Phase 1 Clinical and Pharmacokinetic Study of DCC-2036 in Subjects With Leukemias (Ph+CML With T315I Mutation Only)|Completed||Phase 1|57|Actual|Deciphera Pharmaceuticals LLC||1|||f||||f||||||||||2017-02-18 13:29:30.702441|2017-02-18 13:29:30.702441
NCT00827125|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2010-01-04|||March 2009||2009-03-01|January 2009|2009-01-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Determination of Labor Progression Patterns Using Non-invasive, Ultrasound Based, Multiple Parameters|Determination of Labor Progression Patterns Using Non-invasive, Ultrasound Based, Multiple Parameters|Unknown status|Recruiting|Phase 2|650|Anticipated|Trig Medical Inc||1|||f||||f||||||||||2017-02-18 13:29:30.828412|2017-02-18 13:29:30.828412
NCT00827112|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-06-08|2011-07-11||March 2009||2009-03-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Interventional|||A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients|Pilot Study Of Novel Combination Of Maraviroc + Atazanavir/Ritonavir vs. Atazanavir/Ritonavir + Emtricitabine/Tenofovir For The Treatment Of Naïve HIV-Infected Patients With R5 HIV-1|Completed||Phase 2|129|Actual|ViiV Healthcare||2|||f||||t||||||||||2017-02-18 13:29:30.930104|2017-02-18 13:29:30.930104
NCT00827099|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-03-19|2011-07-28||June 2006||2006-06-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer|Transplantation of Two Partially Matched Umbilical Cord Blood Units Following Reduced Intensity Conditioning to Enhance Engraftment and Limit Transplant-Related Mortality in Adults With Hematologic Malignancies|Terminated||Phase 2|5|Actual|Northside Hospital, Inc.|This study was terminated early, therefore no additional data measures or outcomes are available.|1||Unacceptable morbidity & mortality|f||||f||||||||||2017-02-18 13:29:31.827141|2017-02-18 13:29:31.827141
NCT00827086|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2011-07-20|||March 2008||2008-03-01|July 2010|2010-07-01|July 2011|Actual|2011-07-01|||||Observational|||Influencing Factors in Uveitis|Evaluation of Influencing Factors in Uveitis|Completed||N/A|500|Anticipated|St. Franziskus Hospital|||2||f||||f||||||||||2017-02-18 13:29:32.179795|2017-02-18 13:29:32.179795
NCT00827073|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2014-07-11|2014-03-11||November 2008||2008-11-01|July 2014|2014-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Comparison of Tetracaine 0.5% and Lidocaine 2% Jelly for Topical Phacoemulsification Cataract Surgery|The Effects on Betadine 5% Penetration When Using Lidocaine 2% Jelly Versus Topical Tetracaine 0.5% for Topical Phacoemulsification Cataract Surgery.|Completed||N/A|40|Actual|Hermann Eye Center||2|||f||||f||||||||||2017-02-18 13:29:32.264867|2017-02-18 13:29:32.264867
NCT00827060|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-27|||December 2006||2006-12-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Observational|||Observation of Initial Procalcitonin and the Clinical Course of Patients With Acute Respiratory Tract Infections|Observation of the Initial Procalcitonin Values and the Clinical Course of Patients With Acute Respiratory Tract Infections at General Medical Practices in Greater Hannover|Completed||N/A|702|Actual|Hannover Medical School|||1||f||||f||||||||||2017-02-18 13:29:32.638873|2017-02-18 13:29:32.638873
NCT00827047|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-03-30|||January 2009||2009-01-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|||Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment|A Prospective Randomized Controlled Trial of Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment|Completed||N/A|150|Actual|Eastern Hepatobiliary Surgery Hospital||3|||f||||t||||||||||2017-02-18 13:29:32.720657|2017-02-18 13:29:32.720657
NCT00827034|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-04-20|||February 2009||2009-02-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects|A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects|Completed||Phase 1|14|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:29:32.833422|2017-02-18 13:29:32.833422
NCT00827021|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-07-15|||July 2009||2009-07-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|CEDOSE||The Clinical Evaluation of the Dose of Erythropoietins Trial|Effects of the Dose of Erythropoiesis Stimulating Agents on Cardiac-cerebrovascular Outcomes Quality of Life and Costs in Hemodialysis Patients. The Clinical Evaluation of the DOSe of Erythropoietins (C.E. DOSE) Trial|Completed||Phase 3|656|Actual|Consorzio Mario Negri Sud||2|||f||||t||||||||||2017-02-18 13:29:32.938778|2017-02-18 13:29:32.938778
NCT00827008|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-11-27||2012-11-27|January 2009||2009-01-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|OLLTT||Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus|An Open-Label, Long-Term Treatment Study to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane With Subjective Tinnitus|Terminated||Phase 3|821|Actual|Merz Pharmaceuticals GmbH||1|||f||||f||||||||||2017-02-18 13:29:35.415214|2017-02-18 13:29:35.415214
NCT00826995|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-04-20|||January 2009||2009-01-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of Video-Based Versus Written Patient Education on Melanoma|Comparison of Video-based Versus Written Patient Education on Melanoma|Completed||N/A|78|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 13:29:35.83013|2017-02-18 13:29:35.83013
NCT00826982|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-05-15|||January 2008||2008-01-01|May 2012|2012-05-01||||August 2011|Actual|2011-08-01||Observational|Sonoma||Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer|Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer|Completed||N/A|90|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 13:29:35.943494|2017-02-18 13:29:35.943494
NCT00826969|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-12-01|||September 2008||2008-09-01|October 2016|2016-10-01|October 2011|Actual|2011-10-01|July 2010|Actual|2010-07-01||Interventional|||Ciclesonide for the Treatment of Airway Hyperresponsiveness|Ciclesonide for the Treatment of Airway Hyperresponsiveness. The Mannitol-Asthma-Ciclesonide Study (MACS). A Double-blind, Randomized, Parallel Group Study.|Completed||Phase 4|64|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:29:36.022605|2017-02-18 13:29:36.022605
NCT00826956|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-21||||||January 2009|2009-01-01||||||||Expanded Access|||The Change of Pulmonary Blood Flow During One Lung Ventilation|The Changes of Pulmonary Blood Flow in Nondependent Lung During One Lung Ventilation|Temporarily not available||N/A|||Sichuan University|||||f||||||||||||||2017-02-18 13:29:36.124177|2017-02-18 13:29:36.124177
NCT00826943|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2014-02-19|2009-06-25||January 2009||2009-01-01|February 2014|2014-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Is Levocetirizine Less Sedating Than Cetirizine?|Is Levocetirizine Less Sedating Than Cetirizine? A Randomized, Double-blind, Placebo Controlled Trial.|Completed||Phase 4|30|Actual|Vanderbilt University||3|||f||||f||||||||||2017-02-18 13:29:36.186056|2017-02-18 13:29:36.186056
NCT00826930|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2010-08-11|||March 2009||2009-03-01|August 2010|2010-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma|Open-label Study to Determine the Effect of Trans Sodium Crocetinate (TSC) on Intra-tumoral Oxygen Concentration, Tolerability, and Pharmacokinetics of TSC in Post-operative Patients With High Grade Glioma (HGG)|Terminated||Phase 1|1|Actual|Diffusion Pharmaceuticals LLC||8||Sponsor business decision, not based on safety or efficacy data.|f||||t||||||||||2017-02-18 13:29:36.601952|2017-02-18 13:29:36.601952
NCT00826917|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-05-31|||March 2008||2008-03-01|May 2015|2015-05-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Observational|||Use of 3D/4D Ultrasound in the Evaluation of Fetal Anomalies|Use of 3D/4D Ultrasound in the Evaluation of Fetal Anomalies - The Use of Volumetry by Three Dimensional Ultrasound in the First Trimester|Completed||N/A|195|Actual|The University of Hong Kong|||4||f||||t||||||||||2017-02-18 13:29:36.713734|2017-02-18 13:29:36.713734
NCT00826904|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-06-16|||October 2007||2007-10-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Regulation Of Maternal Fuel Supply And Neonatal Adiposity|Regulation Of Maternal Fuel Supply And Neonatal Adiposity|Recruiting||N/A|40|Anticipated|University of Colorado, Denver|||2||f||||t||||||||||2017-02-18 13:29:36.828198|2017-02-18 13:29:36.828198
NCT00826891|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-01-20|||February 2009||2009-02-01|January 2009|2009-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Study of Cisplatin in Cervical Cancer Stage IVB|Phase II Study of Cisplatin Combined With Topotecan in Advanced (Stage IVB) Recurrent or Persistent Cervical Cancer|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|Chinese Anti-Cancer Association||1|||f||||f||||||||||2017-02-18 13:29:36.933389|2017-02-18 13:29:36.933389
NCT00826878|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-06-27|||January 2009||2009-01-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC)|A Phase 1b/2a Open-Label Study to Evaluate the Safety and Activity of Once Daily Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer|Completed||Phase 1|17|Actual|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:29:37.009448|2017-02-18 13:29:37.009448
NCT00826865|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-01-21|||August 2005||2005-08-01|January 2009|2009-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions|Completed||N/A|27|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 13:29:37.112598|2017-02-18 13:29:37.112598
NCT00826852|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2010-07-26|||October 2003||2003-10-01|July 2010|2010-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax|Phase II Trial of Weekly Docetaxel and Four Weekly Carboplatin Combination in the First-line Treatment of Advanced Non-small Cell Lung Cancer|Completed||Phase 2|49|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:29:37.201379|2017-02-18 13:29:37.201379
NCT00826839|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2013-06-21|||January 2009||2009-01-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|September 2010|Actual|2010-09-01||Interventional|OMLET||Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients|A Randomized Controlled Trial of Treatment Protocols to Optimize Outcomes in Poor Responder In Vitro Fertilization (IVF) Patients: E2 Patch/Antagonist Protocol Versus OCP/Microdose Lupron Protocol|Withdrawn||Phase 4|0|Actual|Weill Medical College of Cornell University||2||poor enrollment|f||||f||||||||||2017-02-18 13:29:37.287606|2017-02-18 13:29:37.287606
NCT00826826|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2014-03-04|||January 2009||2009-01-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|AMIO-CAT||The Effect of Short Term Amiodarone Treatment After Catheter Ablation for Atrial Fibrillation|The Effect of Short Term Amiodarone Treatment on Success Rate and Quality of Life After Catheter Ablation for Atrial Fibrillation|Completed||N/A|212|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:29:37.408849|2017-02-18 13:29:37.408849
NCT00826813|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-21|||January 2009||2009-01-01|January 2009|2009-01-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Trial Using 125I Embedded Stent in Patients With Advanced Esophageal Cancer|Phase IV Study of Self-Expandable Esophageal Stent Loaded With 125I Seeds: a Randomized Controlled Multiple Center Trial in Patients With Advanced Esophageal Cancer|Unknown status|Active, not recruiting|N/A|250|Actual|Southeast University, China||1|||f||||t||||||||||2017-02-18 13:29:37.517022|2017-02-18 13:29:37.517022
NCT00826800|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-04-03|2015-04-03||February 2009||2009-02-01|April 2015|2015-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer|A Pilot Study of Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer|Terminated||N/A|2|Actual|Memorial Sloan Kettering Cancer Center|Early termination lead to small numbers of subjects analyzed.|1||Lack of accrual|f||||||||||||||2017-02-18 13:29:37.624993|2017-02-18 13:29:37.624993
NCT00826787|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-01-21|||August 2005||2005-08-01|January 2009|2009-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions|Completed||N/A|29|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 13:29:38.057853|2017-02-18 13:29:38.057853
NCT00826774|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-05-14|||January 2008||2008-01-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|Power-UP||Improving the Management of Obesity in Primary Care Practice (The Power-UP Trial)|Practice-based Opportunities for Weight Reduction Trial at University of Pennsylvania|Completed||Phase 3|390|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 13:29:38.165522|2017-02-18 13:29:38.165522
NCT00826761|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-06-14|||January 2009||2009-01-01|June 2012|2012-06-01||||June 2009|Actual|2009-06-01||Interventional|ProSat||ProSat - Effect of Probiotics on Satiety|Probiotics and Satiety - Acute Effects and Persistence of Acute Effects|Completed||N/A|22|Actual|University of Copenhagen||3|||f||||||||||||||2017-02-18 13:29:38.276233|2017-02-18 13:29:38.276233
NCT00826748|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-04-28|||November 2010||2010-11-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effect of Inhaled Steroids on Gene Expression in the Lungs - 2|Effect of Inhaled Steroids on Gene Expression in the Lungs of Healthy Smokers|Completed||Phase 4|60|Actual|Weill Medical College of Cornell University||3|||f||||t||||||||Undecided||2017-02-18 13:29:38.382252|2017-02-18 13:29:38.382252
NCT00826735|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-01-21|||January 2007||2007-01-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effect of Guided Imagery on the Third Stage of Labor|The Effect of Guided Imagery on the Third Stage of Labor|Completed||N/A|||Vanderbilt University||1|||f||||f||||||||||2017-02-18 13:29:38.507683|2017-02-18 13:29:38.507683
NCT00826722|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-01-21|||June 2007||2007-06-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Levetiracetam 1g Tablets Under Fasting Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 13:29:38.610567|2017-02-18 13:29:38.610567
NCT00826709|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-04-14|||February 2009||2009-02-01|April 2009|2009-04-01||||October 2009|Anticipated|2009-10-01||Interventional|||Prospective Evaluation of the Fluid Rapid Influenza Test|CLINICAL STUDY PROTOCOL for the Prospective Evaluation of the fluID Rapid Influenza Test|Suspended||Phase 3|1300|Anticipated|Nanogen, Inc.||3||The 2008-09 North American peak influenza season ended prior to study completion.|f||||f||||||||||2017-02-18 13:29:38.7028|2017-02-18 13:29:38.7028
NCT00826696|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2010-01-26|||January 2009||2009-01-01|January 2010|2010-01-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Observational|||A Retrospective Review of the Seasonality of Pre-Eclampsia|A Retrospective Review of the Seasonality of Pre-Eclampsia|Completed||N/A|500|Anticipated|Oklahoma State University Center for Health Sciences|||1||f||||t||||||||||2017-02-18 13:29:38.806921|2017-02-18 13:29:38.806921
NCT00826306|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-04-15|||January 2009||2009-01-01|April 2015|2015-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Comparison Of Video-based Versus Written Patient Education on Sunscreen|Comparison of Video-based Versus Written Patient Education on Sunscreen Behavior|Completed||N/A|94|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 13:29:43.656468|2017-02-18 13:29:43.656468
NCT00826683|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2016-08-19|||March 2009||2009-03-01|October 2009|2009-10-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|CBNPC:PCE||Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)|Detection of Circulating Endothelial Progenitor Cells (EPCs) in Peripheral Blood From Non-small Cell Lung Cancer Patients|Completed||Phase 3|140|Actual|University Hospital, Limoges||3|||f||||f||||||||||2017-02-18 13:29:38.89772|2017-02-18 13:29:38.89772
NCT00826670|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-08-06|||June 2009||2009-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study||Completed||Phase 4|58|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 13:29:39.006955|2017-02-18 13:29:39.006955
NCT00826657|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2015-05-19|||October 2004||2004-10-01|May 2015|2015-05-01|November 2006|Actual|2006-11-01|August 2005|Actual|2005-08-01||Interventional|||Vitamin B12 Supplementation Study|Assessment of Functional Vitamin B12 Deficiency in Mexican Women|Completed||N/A|180|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-02-18 13:29:39.094195|2017-02-18 13:29:39.094195
NCT00826644|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-01-09|||January 2009||2009-01-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|COMBAT||Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient|A Randomized Prospective Multicenter Trial of Belotecan/Cisplatin Versus Etoposide/Cisplatin in Patients With Previously Untreated, Extensive-stage Small-cell Lung Cancer|Unknown status|Recruiting|Phase 3|150|Anticipated|Chonnam National University Hospital||2|||f||||f||||||||||2017-02-18 13:29:39.19057|2017-02-18 13:29:39.19057
NCT00826631|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-21|||April 2006||2006-04-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||How Does 4 Weeks of Increased Fast Food Intake Affect Metabolism?|How Does 4 Weeks of Increased Fast Food Intake Affect Metabolism?|Completed||N/A|36|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-02-18 13:29:39.367153|2017-02-18 13:29:39.367153
NCT00826618|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2014-08-24|2014-08-06||June 2008||2008-06-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema|Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema|Completed||Phase 1|6|Actual|University of Miami|The main limitation of this study is the small number of patients.There is no comparative arm to better define the relative efficacy of ranibizumab as compared with intraocular steroids or other treatments.|1|||f||||t||||||||||2017-02-18 13:29:39.474125|2017-02-18 13:29:39.474125
NCT00826605|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2010-01-26|||January 2009||2009-01-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Observational|||Urobilinogen, Maternal Weight Loss and Impending Parturition at Term|Retrospective Investigation of Presence of Urobilinogen and Maternal Weight Loss as Indications of Impending Parturition in the Term Gravida|Completed||N/A|200|Anticipated|Oklahoma State University Center for Health Sciences|||2||f||||t||||||||||2017-02-18 13:29:39.733341|2017-02-18 13:29:39.733341
NCT00826592|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-04-15|||January 2009||2009-01-01|April 2015|2015-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis|Comparison of Video-based Versus Written Patient Education on Atopic Dermatitis|Completed||N/A|80|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 13:29:39.823147|2017-02-18 13:29:39.823147
NCT00826579|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2015-03-11|||May 2000||2000-05-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer|Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer|Completed||Phase 1/Phase 2|192|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-02-18 13:29:39.934968|2017-02-18 13:29:39.934968
NCT00826566|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-09-22|||January 2009||2009-01-01|September 2009|2009-09-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|||Anti-inflammatory Effects of Caffeine in Chronic Obstructive Pulmonary Disease (COPD) Subjects|Pilot Study to Investigate the Anti-inflammatory Effects of Caffeine in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Withdrawn||N/A|0|Actual|Maastricht University Medical Center||2||Suitable subjects could not be recruited within the estimated time frame.|f||||f||||||||||2017-02-18 13:29:40.047931|2017-02-18 13:29:40.047931
NCT00826553|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-11-04|||January 2009||2009-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|HYPNOS||How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units|Comparison of Polysomnographic Findings in Mechanically Ventilated Patients Sedated With α2 Agonists Versus GABA Agonists|Active, not recruiting||N/A|30|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:29:40.158806|2017-02-18 13:29:40.158806
NCT00826540|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-07-01|2013-11-27||September 2009||2009-09-01|July 2016|2016-07-01||||January 2010|Actual|2010-01-01||Interventional|||Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer|Phase II Study of Sorafenib/Avastin® as Salvage Therapy in Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|83|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 13:29:40.286869|2017-02-18 13:29:40.286869
NCT00826527|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-01-21|||January 2007||2007-01-01|January 2009|2009-01-01||||December 2009|Anticipated|2009-12-01||Interventional|||Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)|Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)for the Treatment of Clinically Significant Benign Prostate Hyperplasia (BPH)|Unknown status|Recruiting|Phase 4|23|Anticipated|Seattle Urology Research Center||1|||f||||t||||||||||2017-02-18 13:29:41.047646|2017-02-18 13:29:41.047646
NCT00826514|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2011-03-14||2011-03-14|March 2009||2009-03-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis|A Phase 2, 16 Week, Multicenter, Randomized, Double-Blind Placebo-Controlled, Parallel Group Proof-Of-Concept Study Evaluating The Efficacy And Safety Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis|Completed||Phase 2|62|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:29:41.14327|2017-02-18 13:29:41.14327
NCT00826501|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-03-15|||January 2009||2009-01-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|December 2009|Actual|2009-12-01||Interventional|||Randomized Trial Comparing Endoscopy and Surgery for Pancreatic Cyst-gastrostomy|Randomized Trial Comparing Endoscopy and Surgery for Pancreatic Cyst-gastrostomy|Completed||N/A|40|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 13:29:41.295067|2017-02-18 13:29:41.295067
NCT00826488|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-06-01|||March 2009||2009-03-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses|A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses: A Pilot Study|Completed||Early Phase 1|136|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 13:29:41.404433|2017-02-18 13:29:41.404433
NCT00826475|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2011-08-12|||January 2009||2009-01-01|January 2009|2009-01-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|||Randomized Trial to Evaluate the Effectiveness of a Mindfulness Based Intervention (MBSR) for Patients Suffering From Migraine|Randomized Trial to Evaluate the Effectiveness of a Mindfulness Based Intervention (MBSR) for Patients Suffering From Migraine|Completed||N/A|62|Actual|University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 13:29:41.515553|2017-02-18 13:29:41.515553
NCT00826462|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-05-28|||March 2009||2009-03-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Treatment Study of Steroid Injection and Physical Therapy for Acute Lateral Epicondylitis|Physiotherapy Alone, in Combination With Corticosteroid Injection or Wait-and-see for Acute Lateral Epicondylitis in General Practice: a Randomised, Placebo-controlled Study With 12 Months Follow-up|Completed||Phase 4|177|Actual|University of Oslo||3|||f||||f||||||||||2017-02-18 13:29:41.628784|2017-02-18 13:29:41.628784
NCT00826449|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2016-05-26|2015-09-18||February 2009||2009-02-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)|Phase I-II Study of Dasatinib and Erlotinib in Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|53|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:29:41.773133|2017-02-18 13:29:41.773133
NCT00826436|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-03-05|||November 2008||2008-11-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese Postmenopausal Women|A Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of PRA-027 Administered Orally to Japanese Postmenopausal Women|Completed||N/A|16|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||2||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:29:42.409928|2017-02-18 13:29:42.409928
NCT00826423|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-07-27|||June 2008||2008-06-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Observational|MAC||Mycobacterium Avium Intracellulare Complex (MAC) Study|Pilot Study to Assess Safety and Efficacy of Short Course Multiple Drug Therapy for Adult Patients With Mycobacterium Avium Intracellulare Complex (MAC) Infection Associated With Mulit Focal Bronchiectasis and Multiple Small Nodules|Completed||N/A|15|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"~     sputum and blood collection for analysis~   "|||2017-02-18 13:29:42.495495|2017-02-18 13:29:42.495495
NCT00826410|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-01-20|||May 2003||2003-05-01|January 2009|2009-01-01|January 2005|Actual|2005-01-01|December 2004|Actual|2004-12-01||Interventional|||Prospective Study on the Value of Subcutaneous Drains in Gastrointestinal Surgery|Prospective Study on the Value of Subcutaneous Drains in Gastrointestinal Surgery|Completed||Phase 3|200|Actual|University Hospital Freiburg||1|||f||||f||||||||||2017-02-18 13:29:42.580269|2017-02-18 13:29:42.580269
NCT00826397|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2013-02-19|||June 2005||2005-06-01|February 2013|2013-02-01|September 2009|Actual|2009-09-01|October 2008|Actual|2008-10-01||Interventional|||Randomized Trial of Acupuncture for Aromatase Inhibitor Induced Joint Pain|Pilot Study on the Effect of Acupuncture on Joint Pain Induced by Aromatase Inhibitors in Breast Cancer Patients|Completed||Phase 2/Phase 3|40|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 13:29:42.681858|2017-02-18 13:29:42.681858
NCT00826384|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-03-30|||October 2008||2008-10-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion|Phase 1,Single-blind, Randomized, Controlled Study to Evaluate the Safety and Effectivity of TACE Therapy of HCC(Hepatocellular Carcinoma) With Blocking Tumor Blood Temporarily and Enhancing Perfu|Completed||Phase 1/Phase 2|352|Actual|Eastern Hepatobiliary Surgery Hospital||1|||f||||t||||||||||2017-02-18 13:29:42.788668|2017-02-18 13:29:42.788668
NCT00826371|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2016-11-16|||January 2009||2009-01-01|November 2016|2016-11-01||||July 2010|Actual|2010-07-01||Interventional|EXTEND II||Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients|An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Ranibizumab (0.5 mg) in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration Over 12 Months|Completed||Phase 3|114|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:29:43.082703|2017-02-18 13:29:43.082703
NCT00826358|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-09-27|||November 2008||2008-11-01|September 2012|2012-09-01||||November 2008|Actual|2008-11-01||Interventional|||Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg||Completed||Phase 1|90|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:29:43.203818|2017-02-18 13:29:43.203818
NCT00826345|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2012-06-20|||January 2009||2009-01-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TCMAcuPilot||Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIV|Patient-Oriented TCM Intervention for DSP in HIV: A Pilot Study|Completed||N/A|20|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-02-18 13:29:43.304552|2017-02-18 13:29:43.304552
NCT00826332|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-21|||January 2009||2009-01-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|TVUSET||Transvaginal vs Transabdominal Ultrasound Guided Embryo Transfer|Transvaginal or Transabdominal Ultrasound Guided Embryo Transfer- Which is Better?|Unknown status|Recruiting|Phase 1|200|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 13:29:43.416195|2017-02-18 13:29:43.416195
NCT00826319|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-11-27|||June 2008||2008-06-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|CanPREDDICT||Canadian Study of Prediction of Risk and Evolution to Dialysis, Death and Interim Cardiovascular Events Over Time|CanPREDDICT: Canadian Study of Prediction of Risk and Evolution to Dialysis, Death and Interim Cardiovascular Events Over Time|Unknown status|Active, not recruiting|N/A|2602|Actual|University of British Columbia|||3||f||||f||||||Samples With DNA|"~     Serum,Plasma,Urine, DNA and RNA~   "|||2017-02-18 13:29:43.532635|2017-02-18 13:29:43.532635
NCT00826293|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-07-09|||January 2009||2009-01-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||The Clinical Efficacy of Belting Stabilization for Shoulder Pain|The Clinical Efficacy of Belting Stabilization for Shoulder Pain: A Double Blinded Randomized Clinical Trial|Completed||Phase 1|64|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 13:29:43.770695|2017-02-18 13:29:43.770695
NCT00826280|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2015-06-05|2011-07-08||March 2009||2009-03-01|June 2015|2015-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)|A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson|Completed||Phase 3|347|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|3|||f||||f||||||||||2017-02-18 13:29:43.880794|2017-02-18 13:29:43.880794
NCT00826267|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-12-05|2013-08-08||January 2009||2009-01-01|August 2013|2013-08-01||||August 2011|Actual|2011-08-01||Interventional|||6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab|Randomised Phase II Study of Neoadjuvant BIBW 2992 Versus Herceptin Versus Lapatinib in Her2 Positive Breast Cancer Patients|Completed||Phase 2|29|Actual|Boehringer Ingelheim|Because of slow enrollment and a high screen-failure rate, recruitment became a challenge and the sponsor chose to terminate the trial prior to reaching the target enrollment of 120 pat. Small number of subjects lead to some shortcomings in analyses.|3|||f||||||||||||||2017-02-18 13:29:44.726451|2017-02-18 13:29:44.726451
NCT00826254|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2011-07-03|||August 2003||2003-08-01|January 2009|2009-01-01|December 2011|Anticipated|2011-12-01|April 2007|Actual|2007-04-01||Interventional|||Nutritional Problems After Lung and Heart Transplantation|Nutritional Problems After Lung and Heart Transplantation|Unknown status|Active, not recruiting|N/A|94|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-02-18 13:29:45.538032|2017-02-18 13:29:45.538032
NCT00826241|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-10-21|||January 2009||2009-01-01|March 2015|2015-03-01||||January 2017|Anticipated|2017-01-01||Interventional|||Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma|A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma|Active, not recruiting||Phase 2|50|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 13:29:45.650374|2017-02-18 13:29:45.650374
NCT00826228|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-06-03|2013-04-17||June 2009||2009-06-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)|Effect of PTH Combined With Weight-Bearing on Bone Density and Bone Architecture in People With Spinal Cord Injury|Completed||Phase 4|12|Actual|Northwestern University|Small numbers of subjects analyzed with considerable between-subject variability.|1|||f||||f||||||||||2017-02-18 13:29:45.783974|2017-02-18 13:29:45.783974
NCT00826215|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2009-01-21|||March 2007||2007-03-01|January 2009|2009-01-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Electroacupuncture for Chronic Neck Pain|A Randomized Controlled Trial of the Long-Term Efficacy of Electroacupuncture for Chronic Neck Pain|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|Hong Kong Baptist University||2|||f||||f||||||||||2017-02-18 13:29:46.041087|2017-02-18 13:29:46.041087
NCT00826202|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2016-12-15|2015-04-15||March 2009||2009-03-01|December 2016|2016-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||Includes 35 subjects who received at least one post-baseline efficacy evaluation|D-serine for the Schizophrenia Prodrome|D-Serine vs Placebo for the Schizophrenia Prodrome|Completed||Phase 2|44|Actual|Nathan Kline Institute for Psychiatric Research||2|||f||||t||||||||||2017-02-18 13:29:46.132846|2017-02-18 13:29:46.132846
NCT00826189|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-21|2014-01-08|||May 2009||2009-05-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Influence of Probiotics on Atopy With Focus on Respiratory Allergic Diseases- Follow-up to 7 Years|A Follow-up Study to 7 Years of a Randomized, Double-blinded, Placebo-controlled Study on the Influence of Probiotics on Atopy With Focus on Respiratory Allergic Diseases|Completed||N/A|253|Actual|National University Hospital, Singapore|||1||f||||t||||||||||2017-02-18 13:29:46.565798|2017-02-18 13:29:46.565798
NCT00826176|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-10-06|2011-08-09||January 2010||2010-01-01|October 2015|2015-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Efficacy and Safety of 4.0 mg/kg Sugammadex at 1-2 PTC in Chinese and European Subjects (Study 19.4.335)(P05775AM1)(COMPLETED)|A Multi-center, Open Label Trial, to Show Efficacy and Safety of 4.0 mg.Kg-1 Sugammadex Administered at a Depth of Neuromuscular Blockade of 1-2 PTC Induced by Rocuronium in Chinese and European ASA I-III Subjects Undergoing Elective Surgery Under Propofol Anesthesia|Completed||Phase 3|164|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:29:46.655134|2017-02-18 13:29:46.655134
NCT00826163|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-09-10|||January 2009||2009-01-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients|Innate Immune Responses in Chronic Obstructive Pulmonary Disease Patients|Completed||Phase 3|20|Actual|Mahidol University||2|||f||||f||||||||||2017-02-18 13:29:47.010912|2017-02-18 13:29:47.010912
NCT00826150|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-18|2012-11-12|||June 2009||2009-06-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer|Phase 1/2a, Dose-Escalation, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Intraperitoneal Administration of DTA-H19 in Subjects With Advanced Stage Ovarian Cancer|Completed||Phase 1/Phase 2|14|Actual|BioCancell Ltd.||1|||f||||t||||||||||2017-02-18 13:29:47.10667|2017-02-18 13:29:47.10667
NCT00826137|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2012-06-13|||December 2008||2008-12-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|WGAAD||Preventing Childhood Antibiotic-associated Diarrhea by Prebiotics|Prebiotics in the Prevention of Antibiotic-associated Diarrhea in Children|Completed||Phase 3|200|Actual|Soroka University Medical Center||2|||f||||f||||||||||2017-02-18 13:29:47.412211|2017-02-18 13:29:47.412211
NCT00826124|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2011-06-22|||January 2009||2009-01-01|January 2009|2009-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Does Magnetic Resonance Imaging (MRI) Improve Interventional Outcomes for Lumbosacral Radiculopathy?|Does MRI Improve Interventional Outcomes for Lumbosacral Radiculopathy? A Randomized Study Comparing Epidural Steroid Injections Based on Clinical Findings Alone, or Clinical Findings and MRI|Completed||N/A|131|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 13:29:47.523751|2017-02-18 13:29:47.523751
NCT00826111|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2012-06-28|2011-10-27||August 2007||2007-08-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Interventional|||The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia|The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Co-morbid Anxiety and Insomnia: A Proton MRS Study|Completed||Phase 4|19|Actual|Steward St. Elizabeth's Medical Center of Boston, Inc.|Withdrawal of support by the funding sponsor due to other priorities resulted in a very small sample size with a small placebo group. Participant withdrawal and unusable data explains discrepancies in subject numbers in some analyses.|2|||f||||f||||||||||2017-02-18 13:29:47.641401|2017-02-18 13:29:47.641401
NCT00826098|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2015-02-09|||December 2008||2008-12-01|February 2015|2015-02-01|February 2013|Actual|2013-02-01|June 2011|Actual|2011-06-01||Interventional|||Platelet Rich Plasma (PRP) in Total Knee Replacement|Platelet Rich Plasma (PRP) in Total Knee Replacement: A Prospective, Randomized, Single-blind, Single-center Clinical Study to Evaluate the Effect of Platelet Rich Plasma (PRP) on Short-term Patient Outcomes Following Total Knee Replacement|Completed||Phase 4|70|Actual|Exactech||2|||f||||f||||||||||2017-02-18 13:29:48.17439|2017-02-18 13:29:48.17439
NCT00826085|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2017-01-27|||February 2013|Actual|2013-02-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|DIGNITY||Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall|A Phase I/II Study Evaluating the Maximum Tolerated Dose, Bioequivalence/Pharmacokinetics, Safety, and Efficacy of Hyperthermia and ThermoDox (Lyso-Thermosensitive Liposomal Doxorubucin) in Patients With Local-Regional Recurrent Breast Cancer.|Completed||Phase 1/Phase 2|17|Actual|Celsion||1|||f||||f||||||||||2017-02-18 13:29:48.27811|2017-02-18 13:29:48.27811
NCT00826072|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-05-02|||May 2008||2008-05-01|May 2013|2013-05-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Observational|||Inflammatory Genetic Polymorphism and Acute Lung Injury After Cardiac Surgery|Association Study of Inflammatory Genetic Polymorphism and Acute Lung Injury After Cardiac Surgery With Cardiopulmonary Bypass|Completed||N/A|107|Actual|Changhai Hospital|||2||f||||t||||||Samples With DNA|"~     3ml blood before surgery, after surgery and 24h after surgery respectively~   "|||2017-02-18 13:29:48.386058|2017-02-18 13:29:48.386058
NCT00826059|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2015-09-02|||January 2009||2009-01-01|September 2015|2015-09-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|ImpACT-24||Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window|A Multicenter, Randomized, Double Blind, Sham Control, Parallel Arm Trial to Assess Effectiveness and Safety of the Ischemic Stroke System ISS, as an Adjunct to Standard of Care in Subjects With Acute Ischemic Stroke|Recruiting||Phase 3|800|Anticipated|BrainsGate||2|||f||||t||||||||||2017-02-18 13:29:48.469135|2017-02-18 13:29:48.469135
NCT00826046|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2015-10-20||||||October 2015|2015-10-01||||||||Expanded Access|||Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute GVHD|Expanded Access of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD|No longer available||N/A|||Mesoblast, Ltd.|||||||||||||||||||2017-02-18 13:29:48.590083|2017-02-18 13:29:48.590083
NCT00826033|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-01-20||||||January 2009|2009-01-01||||||||Observational|||Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer|Fluorine-18-α-Methyltyrosine Positron Emission Tomography to Measure Therapy|Completed||N/A|||Gunma University|||1||f||||f||||||||||2017-02-18 13:29:48.67751|2017-02-18 13:29:48.67751
NCT00826020|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-05-04|||April 2009||2009-04-01|May 2009|2009-05-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Evaluation of Omegaven™ Parenteral Nutrition in Patients With TPN-Induced Cholestasis|Prospective Evaluation of a Parenteral Omega-3 Fatty Acid Preparation (Omegaven™) in Therapy of Patients With TPN-Induced Cholestasis|Unknown status|Enrolling by invitation|Phase 2|100|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 13:29:48.758239|2017-02-18 13:29:48.758239
NCT00826007|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2013-03-26|2013-03-26||January 2009||2009-01-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes|Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes|Completed||N/A|587|Actual|William Beaumont Hospitals|Point-of-care blood glucose testing was most often the means of measurement. Frequency of glucose monitoring was not standardized. Retrospective review.||1||f||||f||||||None Retained|"~     non applicable~   "|||2017-02-18 13:29:48.862305|2017-02-18 13:29:48.862305
NCT00825994|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2014-08-05|2011-05-10||November 2008||2008-11-01|August 2014|2014-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|O3Meno|24 subjects were eligible after V1.|Omega-3 for Peri- and Postmenopausal Depression|Omega-3 for Peri- and Postmenopausal Depression|Completed||N/A|31|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:29:49.336381|2017-02-18 13:29:49.336381
NCT00825981|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2010-07-22|||January 2009||2009-01-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Observational|HEMOCOR||Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery||Completed||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-02-18 13:29:49.79496|2017-02-18 13:29:49.79496
NCT00825968|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2011-09-16|||July 2008||2008-07-01|September 2011|2011-09-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Observational|||Data Collection and Analysis of Patients Who Have Had an Electrophysiological Procedure|Data Collection and Analysis of Patients Who Have Had an Electrophysiological Procedure Performed at the Ross Heart Hospital|Terminated||N/A|58|Actual|Ohio State University|||1|PI stopped study to make a more substantial database.|f||||f||||||||||2017-02-18 13:29:49.879639|2017-02-18 13:29:49.879639
NCT00825955|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2017-01-27||2015-09-23|February 2009||2009-02-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|November 2011|Actual|2011-11-01||Interventional|BRISK PS||Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment|A Randomized, Double-blind, Multi-center Phase III Study of Brivanib Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Subjects With Advanced Hepatocellular Carcinoma (HCC) Who Have Failed or Are Intolerant to Sorafenib: The BRISK PS Study (Brivanib Study in HCC Patients at Risk Post Sorafenib)|Active, not recruiting||Phase 3|414|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:29:49.968759|2017-02-18 13:29:49.968759
NCT00825591|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2011-02-07|||October 2008||2008-10-01|February 2011|2011-02-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Biological Clock Dysfunction in Optic Nerve Hypoplasia|Identification and Treatment of Biological Clock Dysfunction in Optic Nerve Hypoplasia|Unknown status|Recruiting|Early Phase 1|100|Anticipated|Yale University||2|||f||||f||||||||||2017-02-18 13:29:55.809859|2017-02-18 13:29:55.809859
NCT00825942|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2009-04-16|||July 2008||2008-07-01|April 2009|2009-04-01|November 2009|Anticipated|2009-11-01|October 2009|Anticipated|2009-10-01||Interventional|||An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis|An Open-Label Study of the Effect of C-KAD Ophthalmic Solution on Asteroid Hyalosis|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Chakshu Research, Inc.||1|||f||||f||||||||||2017-02-18 13:29:50.189384|2017-02-18 13:29:50.189384
NCT00825929|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2016-09-15|||February 2009||2009-02-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|PANNA||Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.|Study on Pharmacokinetics of Newly Developed ANtiretroviral Agents in HIV-infected pregNAnt Women (PANNA)|Recruiting||N/A|176|Anticipated|Radboud University|||1||f||||f||||||Samples Without DNA|"~     Plasma samples will be collected in Week 33 of the pregnancy and at 4-6 weeks after~     delivery. At the following time points samples will be collected: T=0 (prior to dosing), and~     T=1, 2, 3, 4, 6, 8, 12 and 24h (24h sample only in case of QD regimen) post-dosing (8 or 9~     samples).~      In case the infant needs post-exposure prophylaxis with at least one of the agents sparse PK~     sampling is optional.~   "|||2017-02-18 13:29:50.287949|2017-02-18 13:29:50.287949
NCT00825916|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-09-10|2012-05-17||March 2009||2009-03-01|September 2012|2012-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars|A Pilot Phase 2a Blinded, Placebo Controlled, Multicenter Parallel Group, Dose Ranging Study to Evaluate the Safety and Preliminary Efficacy of AZX100 Drug Product Following Excision of Keloids|Completed||Phase 2|59|Actual|Capstone Therapeutics||3|||f||||f||||||||||2017-02-18 13:29:50.454835|2017-02-18 13:29:50.454835
NCT00825903|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2011-12-31|||September 2008||2008-09-01|December 2011|2011-12-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|||The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population|The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population|Completed||N/A|16|Actual|Washington State University||1|||f||||t||||||||||2017-02-18 13:29:51.251158|2017-02-18 13:29:51.251158
NCT00825890|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2015-09-02|||January 2009||2009-01-01|September 2015|2015-09-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Observational|||The High Cup/Disc Ratio in Children||Completed||N/A|50|Actual|Kim's Eye Hospital|||1||f||||||||||||||2017-02-18 13:29:51.356163|2017-02-18 13:29:51.356163
NCT00825877|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-17|2017-01-24|||January 15, 2009||2009-01-15|June 29, 2012|2012-06-29|June 29, 2012||2012-06-29|||||Observational|||Long-term Follow-up of HALT-C Sustained Virological Responders|Long-Term Follow-Up of HALT-C Sustained Virologic Responders|Completed||N/A|4|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:29:51.633917|2017-02-18 13:29:51.633917
NCT00825864|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-18|2009-01-18|||January 2004||2004-01-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Diclofenac vs Dexamethasone in Combined Surgery|Evaluation the Effect of Diclofenac Drops vs Dexamethasone Drops in Trabeculectomy and Cataract Surgery|Completed||N/A|50|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 13:29:51.724574|2017-02-18 13:29:51.724574
NCT00825851|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-01-20|||August 2000||2000-08-01|January 2009|2009-01-01|January 2001|Actual|2001-01-01|December 2000|Actual|2000-12-01||Interventional|||Effect of Smoking, Abstention and Nicotine Replacement Therapy on Wound Healing|Effect of Smoking, Abstention and Nicotine Replacement Therapy on Wound Healing|Completed||N/A|78|Actual|Bispebjerg Hospital||4|||f||||f||||||||||2017-02-18 13:29:51.821142|2017-02-18 13:29:51.821142
NCT00825838|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-18|2009-01-20|||April 2006||2006-04-01|January 2009|2009-01-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Interventional|||Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase|A Randomized Double-Blind Placebo-Controlled Clinical Trial of a Purified Chili Pepper Extract (CH-19 Sweet Extract) to Evaluate Its Safety and Efficacy for Weight and Fat Loss and Metabolism Change in Overweight or Obese Healthy Male and Female Adults|Completed||Phase 2|80|Actual|Ajinomoto USA, INC.||2|||f||||||||||||||2017-02-18 13:29:51.944409|2017-02-18 13:29:51.944409
NCT00825825|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2015-06-16|2012-06-11||May 2007||2007-05-01|June 2015|2015-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Brain Effects of Escitalopram and Citalopram Using fMRI|A Comparison of the CNS Effects of Equivalent Doses of Escitalopram and Racemic Citalopram Using BOLD fMRI|Completed||Phase 4|27|Actual|Steward St. Elizabeth's Medical Center of Boston, Inc.|Data from several subjects had to be excluded due to one or more fMRI scans with poor data quality (usually high motion) or scheduling problems that prevented a scan from occuring during the specified time window.|3|||f||||f||||||||||2017-02-18 13:29:52.035839|2017-02-18 13:29:52.035839
NCT00825812|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-10-30|2011-07-22||January 2010||2010-01-01|October 2015|2015-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Comparison of 2.0 mg/kg Sugammadex and Neostigmine at Reappearance of T2 in Chinese and European Subjects (Study 19.4.324)(P05768AM1)(COMPLETED)|A Multi-center, Randomized, Parallel-group, Active-controlled, Safety-assessor Blinded Trial, Comparing the Efficacy and Safety of 2.0 mg.Kg-1 Sugammadex With 50 μg.Kg-1 Neostigmine Administered at Reappearance of T2 After Rocuronium in Chinese and European ASA I-III Subjects Undergoing Elective Surgery Under Propofol Anesthesia|Completed||Phase 3|308|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:29:52.505803|2017-02-18 13:29:52.505803
NCT00825799|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2014-01-02|||November 2007||2007-11-01|June 2013|2013-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Serum Markers as a Bioassay for Unipolar Depression|Validation of Serum Markers as a Bioassay for Unipolar Depression|Completed||N/A|160|Actual|Steward St. Elizabeth's Medical Center of Boston, Inc.|||2||f||||f||||||Samples Without DNA|"~     serum, plasma~   "|||2017-02-18 13:29:53.060183|2017-02-18 13:29:53.060183
NCT00825786|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2016-10-26|||September 2008||2008-09-01|October 2016|2016-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Ultrasound Guided Supraclavicular Nerve Block|Ultrasound Guided Supraclavicular Nerve Block: Comparison Between a Mixture of Mepivacaine and Ropivacaine, and Sequential Injection of Mepivacaine Followed by Ropivacaine|Completed||Phase 3|120|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 13:29:53.148092|2017-02-18 13:29:53.148092
NCT00825578|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2012-02-03|||January 2009||2009-01-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Use of Endobronchial Valves in Non-Upper Lobe Heterogeneous Emphysema|Comparative Study of Bronchoscopic Lung Volume Reduction to Evaluate Relative Efficacy in Patients With Non-Upper Lobe Emphysema|Completed||Phase 3|32|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:29:58.193237|2017-02-18 13:29:58.193237
NCT00825773|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2009-01-22|||October 2008||2008-10-01|January 2009|2009-01-01|April 2014|Anticipated|2014-04-01|April 2010|Anticipated|2010-04-01||Interventional|EVOLUTION||A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions|A Randomized Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus SirOlimus ELUting Stent With Non-Biodegradable Polymer in the Treatment of PatIents With de nOvo Coronary Artery LesioNs|Unknown status|Recruiting|Phase 4|1944|Anticipated|JW Medical Systems Ltd||2|||f||||t||||||||||2017-02-18 13:29:53.262681|2017-02-18 13:29:53.262681
NCT00825760|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2013-01-23|||January 2009||2009-01-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Clinical Trial to Investigate Treatment With Photodynamic Therapy to Reduce Levels of Bacteria in Leg Ulcers|Phase II Randomised, Placebo Controlled Trial to Investigate Repeat Dose Antimicrobial Photodynamic Therapy in Patients With Chronic Leg Ulcers.|Completed||Phase 2|57|Actual|Photopharmica||2|||f||||t||||||||||2017-02-18 13:29:53.376276|2017-02-18 13:29:53.376276
NCT00825747|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-18|2009-01-20|||January 2009||2009-01-01|January 2009|2009-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Evaluation of Seelens AF, an Aspheric Intra-Ocular Lens|Clinical Evaluation of the Aspheric SeeLens AF Intra-Ocular Lens.|Unknown status|Not yet recruiting|Phase 3|60|Anticipated|Hanita Lenses||1|||f||||t||||||||||2017-02-18 13:29:53.480543|2017-02-18 13:29:53.480543
NCT00825734|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2014-12-16|2014-11-21||March 2009||2009-03-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|June 2013|Actual|2013-06-01||Interventional|||Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer|Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer (MBC)|Completed||Phase 1/Phase 2|83|Actual|SCRI Development Innovations, LLC||3|||f||||f||||||||||2017-02-18 13:29:53.580678|2017-02-18 13:29:53.580678
NCT00825721|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2009-01-20|||November 2007||2007-11-01|January 2009|2009-01-01|September 2009|Anticipated|2009-09-01|August 2009|Anticipated|2009-08-01||Interventional|||Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract|A Randomized, Placebo-Controlled, Single-Masked, Dose-Ranging Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataracts|Unknown status|Active, not recruiting|Phase 2|81|Actual|Chakshu Research, Inc.||4|||f||||f||||||||||2017-02-18 13:29:53.92224|2017-02-18 13:29:53.92224
NCT00825708|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2009-01-20|||March 2007||2007-03-01|January 2009|2009-01-01||||March 2008|Anticipated|2008-03-01||Interventional|||Evaluation of the Effect of rTMS on Attention in Adults Diagnosed With Attention-Deficit Hyperactivity Disorder (ADHD)|Evaluation of the Effect of rTMS on Attention in Adults Diagnosed With ADHD|Unknown status|Recruiting|N/A|20|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-02-18 13:29:54.020339|2017-02-18 13:29:54.020339
NCT00825695|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2014-04-28|||January 2009||2009-01-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|March 2012|Actual|2012-03-01||Interventional|||Flavanol-Rich Cocoa and Cerebral Blood Flow|Flavanol-Rich Cocoa, Vascular Responses and Mechanisms|Completed||N/A|60|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:29:54.114633|2017-02-18 13:29:54.114633
NCT00825682|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2016-10-16|2012-07-03||May 2008||2008-05-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||The Effect of Reflexology on Radiation-related Fatigue in Breast Cancer Patients|The Effect of Reflexology on Radiation-related Fatigue and QOL in Breast Cancer Patients: a Pilot Study.|Completed||Phase 1/Phase 2|72|Actual|Sheba Medical Center|This was a pilot non-randomized controlled study, with a relatively small sample and a single therapist.The control group received no additional intervention.|2|||f||||f||||||||No||2017-02-18 13:29:54.206294|2017-02-18 13:29:54.206294
NCT00825669|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2016-03-30|||December 2008||2008-12-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection|A Randomized Controlled Trial of Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection|Completed||N/A|100|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:29:54.69282|2017-02-18 13:29:54.69282
NCT00825656|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2009-01-21|||September 2008||2008-09-01|January 2009|2009-01-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|SMAN||Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis|SINOL + MucoAd™ (SMAN) Evaluation Trial: A Double-Blind, Cross-Over Comparison of SINOL and SMAN in Subjects With Congestion Due to Allergic Rhinitis|Unknown status|Active, not recruiting|Phase 4|20|Anticipated|Strategic Biosciences||2|||f||||f||||||||||2017-02-18 13:29:54.803854|2017-02-18 13:29:54.803854
NCT00825643|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2017-02-10|||April 2008||2008-04-01|February 2017|2017-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|SOLVE™||Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes|A Multicentre, Open Label, Observational 24-week Study to Evaluate Safety of Initiating Insulin Therapy With Levemir® (Insulin Detemir) Once-daily in Oral Antidiabetic Drug-treated Patients With Type 2 Diabetes|Completed||N/A|18481|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:29:54.914986|2017-02-18 13:29:54.914986
NCT00825630|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2012-02-15|2011-06-19||November 2008||2008-11-01|February 2012|2012-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)|The Effect of High Dose Citric on PPI (Proton Pump Inhibitors)Induced False Negative H. Pylori UBT Rates|Completed||Phase 4|123|Actual|Exalenz Bioscience LTD.|It was hard to get people to agree to return for multiple tests within a few days, so the enrollment was difficult|4|||f||||t||||||||||2017-02-18 13:29:55.03071|2017-02-18 13:29:55.03071
NCT00825617|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-01-20|||October 1996||1996-10-01|January 2009|2009-01-01|June 2000|Actual|2000-06-01|October 1999|Actual|1999-10-01||Interventional|||Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy|Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy|Completed||N/A|16|Actual|University of Aarhus||1|||f||||t||||||||||2017-02-18 13:29:55.590617|2017-02-18 13:29:55.590617
NCT00825604|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-03-16|||January 2009||2009-01-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|LOBSTR||Quality of Life and Target Achievement After Treatment of Patients With Stable Angina Pectoris|Quality of Life and Achievement of Target of Treatment After Optimized Medical Treatment, Physical Training and Smoking Cessation With or Without Percutaneous Coronary Intervention in Patients With Stable Angina Pectoris.|Withdrawn||Phase 2|0|Actual|Göteborg University||2||Because of poor inclusion difficulties to find patient|f||||f||||||||||2017-02-18 13:29:55.703618|2017-02-18 13:29:55.703618
NCT00825565|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2015-05-15|2012-02-22||February 2009||2009-02-01|May 2015|2015-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of Alwextin® Cream in Treating Epidermolysis Bullosa|Open-label, Pilot Study to Investigate the Safety and Tolerability of Alwextin 3.0% Cream in the Treatment of Epidermolysis Bullosa|Completed||Phase 2|8|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 13:29:58.314649|2017-02-18 13:29:58.314649
NCT00825552|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-01-20|||January 2009||2009-01-01|January 2009|2009-01-01|November 2010|Anticipated|2010-11-01|January 2010|Anticipated|2010-01-01||Interventional|||Pharmacological Treatment of Children and Adolescents With Severe Mood Dysregulation|Pharmacological Treatment of Children and Adolescents With Severe Mood Dysregulation. An Open Trial With Risperidone.|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Federal University of Rio Grande do Sul||1|||f||||t||||||||||2017-02-18 13:29:58.561886|2017-02-18 13:29:58.561886
NCT00825539|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2013-02-21||2013-02-18|January 2009||2009-01-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia|A Single-dose, Placebo-controlled, Stratified, Randomized, Double-blind, Crossover to Study Pharmacodynamic Effects of AQW051 Followed by a 4-week Multiple-dose Safety and Tolerability in People With Chronic Stable Schizophrenia.|Completed||Phase 1/Phase 2|68|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:29:58.652409|2017-02-18 13:29:58.652409
NCT00825526|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2012-05-31|||July 2008||2008-07-01|May 2012|2012-05-01||||March 2012|Actual|2012-03-01||Interventional|HARMONY||HARMONY Study (Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga)|HARMONY Study (Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga)|Completed||N/A|101|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 13:29:58.74808|2017-02-18 13:29:58.74808
NCT00825513|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2013-03-19||2013-03-19|February 2009||2009-02-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Effectiveness of the Akreos Toric Intraocular Lens.|Monocular Study to Evaluate the Safety and Effectiveness of the Akreos™ Toric IOL When Used to Correct Primary Aphakia With the Reduction of Astigmatism|Completed||Phase 4|198|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 13:29:58.853025|2017-02-18 13:29:58.853025
NCT00825500|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2017-01-30|||January 2009||2009-01-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Staccato Loxapine in Migraine (Out Patient)|A Multi-center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Efficacy and Safety Study of Staccato® Loxapine for Inhalation in Outpatients With Migraine Headache|Completed||Phase 2|366|Actual|Alexza Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 13:29:58.938756|2017-02-18 13:29:58.938756
NCT00825487|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2011-10-17|||August 2009||2009-08-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|May 2011|Actual|2011-05-01||Interventional|||Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies|A Phase 1 Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies|Completed||Phase 1|50|Actual|ArQule||1|||f||||f||||||||||2017-02-18 13:29:59.04746|2017-02-18 13:29:59.04746
NCT00825474|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-03-30|||August 2008||2008-08-01|March 2016|2016-03-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|||A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma|A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma|Completed||N/A|160|Actual|Eastern Hepatobiliary Surgery Hospital||1|||f||||t||||||||||2017-02-18 13:29:59.342829|2017-02-18 13:29:59.342829
NCT00825461|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2009-09-23|||March 2009||2009-03-01|September 2009|2009-09-01|May 2009|Anticipated|2009-05-01|April 2009|Anticipated|2009-04-01||Observational|||Ghrelin With Anorexia Nervosa|Level of Ghrelin With Anorexia Nervosa (AN) Patients. Subgroup AN: With and Without Tubefeeding.|Suspended||N/A|20|Anticipated|Maastricht University Medical Center|||3|no METC approval obtained|f||||t||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:29:59.448722|2017-02-18 13:29:59.448722
NCT00825448|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2012-03-23|||January 2009||2009-01-01|December 2011|2011-12-01|January 2013|Anticipated|2013-01-01|September 2012|Anticipated|2012-09-01||Interventional|||Alcohol Addiction and Otorhinolaryngology Cancer|Impact for Care for Patients With Alcohol Addiction and Treated for ORL Cancer|Unknown status|Recruiting|N/A|115|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:29:59.543181|2017-02-18 13:29:59.543181
NCT00825435|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2009-01-20|||October 2008||2008-10-01|January 2009|2009-01-01||||June 2009|Anticipated|2009-06-01||Interventional|||Coronary CT Angiography in Acute Chest Pain is a Cost Effective Risk Stratification Strategy|Inclusion of Multi-Detector CT Angiography (MDCT) in Low to Intermediate Risk Chest Pain Patients Presenting to the Emergency Department; a Randomized Cost Analysis|Unknown status|Recruiting|Phase 3|60|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 13:29:59.648011|2017-02-18 13:29:59.648011
NCT00825422|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2012-06-19|||January 2009||2009-01-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|April 2010|Actual|2010-04-01||Interventional|ICALP||Local Anesthetic Infiltration to Prevent Postoperative Pain After Lumbar Surgery|Assessment of Efficacy and Safety of Continuous Wound Infiltration With Local Anesthesics Through a Parietal Paravertebral Catheter for Postoperative Analgesia After Posterior Lumbar Arthrodesis|Completed||Phase 3|50|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 13:29:59.744039|2017-02-18 13:29:59.744039
NCT00825396|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-06-09|||April 2007||2007-04-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension|A Pilot, Open-Label, Controlled Clinical Trial of C-KAD Ophthalmic Solution in Reducing Intraocular Pressure in Patients With Ocular Hypertension|Completed||N/A|12|Anticipated|Chakshu Research, Inc.||1|||f||||f||||||||||2017-02-18 13:29:59.85093|2017-02-18 13:29:59.85093
NCT00825383|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2013-06-19|||January 1993||1993-01-01|June 2013|2013-06-01|December 1995|Actual|1995-12-01|December 1995|Actual|1995-12-01||Interventional|||Effect of Dietary Fiber on Glucose & Lipids in Non Insulin Dependent Diabetes Mellitus (NIDDM)|Effect of Dietary Fiber on Glucose, Lipid, and Mineral Metabolism in Patients With Non Insulin Dependent Diabetes Mellitus|Completed||N/A|13|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 13:29:59.944193|2017-02-18 13:29:59.944193
NCT00825370|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2011-07-19|||October 2008||2008-10-01|July 2011|2011-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Protocolized vs Discretionary Use of Opioids in Acute Pain|Protocolized vs Discretionary Use of Opioids in Acute Pain|Completed||Phase 3|350|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-02-18 13:30:00.064666|2017-02-18 13:30:00.064666
NCT00825344|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2013-10-24|2013-04-12||January 2009||2009-01-01|January 2009|2009-01-01|August 2012|Actual|2012-08-01|November 2011|Actual|2011-11-01||Interventional|||Preoperative Etanercept Before Inguinal Hernia Surgery|A Randomized Controlled Study Evaluating Pre-operative Etanercept on the Severity of Postoperative Pain After Inguinal Hernia Surgery.|Completed||N/A|77|Actual|Johns Hopkins University|Only one type of surgery studied; more males than females enrolled (function of military treatment facility and type of population)|2|||f||||t||||||||||2017-02-18 13:30:00.281106|2017-02-18 13:30:00.281106
NCT00825331|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2015-09-22|||January 2009||2009-01-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Improvement of Periprocedural Guidewire Management for Cardiac Catheterization (PTCA)|Improvement of Periprocedural Guidewire Management for Cardiac Catheterization (PTCA)Using Preprocedural Marking of the Arterial Access Site and a Graduated Scheme for Removal of the Guidewire|Withdrawn||N/A|0|Actual|RWTH Aachen University|||4|Change of location for Investigators|f||||f||||||||||2017-02-18 13:30:00.684295|2017-02-18 13:30:00.684295
NCT00825318|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2014-04-28|2014-02-18||July 2009||2009-07-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparison Study of Daily Ultrafiltration and Twice-weekly Hemodialysis|Pilot Trial To Study Blood Pressure, Weight and Hydration State in Patients Undergoing A Treatment Regimen of Daily Ultrafiltration and Twice-weekly Hemodialysis As Compared to Conventional Three Times Per Week Hemodialysis|Completed||N/A|13|Actual|Renal Research Institute||1|||f||||f||||||||||2017-02-18 13:30:00.772156|2017-02-18 13:30:00.772156
NCT00825305|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-19|2011-12-07|2010-01-25||November 2008||2008-11-01|December 2011|2011-12-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule)|A Phase III, Single Center, Randomized, Open-label Study, Comparing PCECV Administered in the Abbreviated Zagreb Regimen (2-1-1) to the Conventional Essen Regimen (1-1-1-1-1) in Healthy Volunteers in China|Completed||Phase 3|825|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:30:01.031232|2017-02-18 13:30:01.031232
NCT00825292|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2009-01-20|||July 2006||2006-07-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Detection and Classification of Colon Polyps|Detection and Classification of Colon Polyps: A Comparison of High Definition White Light and Narrow Band Imaging (Endoscopic Trimodal Imaging; ETMI)|Completed||Phase 2|110|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 13:30:01.642598|2017-02-18 13:30:01.642598
NCT00825279|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-20|2010-05-27|||August 2007||2007-08-01|May 2010|2010-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|EUCATAX||A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent|Comparison Among a Paclitaxel Eluting Stent With Biodegradable Polymer Versus an Uncoated Bare Metal Stent. A Prospective, Multicentric and Randomized Study.(EUCATAX Trial)|Completed||Phase 4|300|Actual|Centro de estudios en Cardiologia Intervencionista||2|||f||||t||||||||||2017-02-18 13:30:01.806534|2017-02-18 13:30:01.806534
NCT00825266|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2011-07-22|||September 2008||2008-09-01|July 2011|2011-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Insulin Resistance in Pulmonary Arterial Hypertension|The Effect of Bosentan and Pioglitazone on Insulin Resistance in Pulmonary Arterial Hypertension|Terminated||Phase 4|2|Actual|Stanford University||2||difficulty in finding eligible subjects|f||||||||||||||2017-02-18 13:30:01.948705|2017-02-18 13:30:01.948705
NCT00825253|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2017-01-05|||March 2007||2007-03-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes|A Randomised, Open-labelled, 4-period Crossover Trial Characterising Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 Administered Once, Twice or Thrice Daily and Biphasic Human Insulin 30 Administered Once Daily in Subjects With Type 2 Diabetes|Completed||Phase 1|24|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 13:30:02.072462|2017-02-18 13:30:02.072462
NCT00825240|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-03-06|||December 2008||2008-12-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Formative Study of Tailored Survivor Health Promotion|Formative Study of Tailored Survivor Health Promotion|Completed||N/A|15|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:30:02.183064|2017-02-18 13:30:02.183064
NCT00825227|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2012-06-21|2011-07-28||December 2008||2008-12-01|June 2012|2012-06-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Armodafinil Treatment (150 mg/Day) for Patients With Fatigue Associated With Taxane Chemotherapy Alone or in Combination With Other Agents|Terminated||Phase 2|10|Actual|Teva Pharmaceutical Industries|This trial was discontinued early after only 10 of 160 planned subjects had been recruited. No efficacy data was analyzed.|2|||f||||f||||||||||2017-02-18 13:30:02.306229|2017-02-18 13:30:02.306229
NCT00825214|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-01-16|||March 2008||2008-03-01|January 2009|2009-01-01|February 2009|Anticipated|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of Zapperclick Device for Relief From Mosquito Bites|Evaluation of a Piezoelectric Device (Zapperclick) for Relief From Mosquito Bites|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-02-18 13:30:02.774409|2017-02-18 13:30:02.774409
NCT00825201|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2016-12-16|||January 2009||2009-01-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity|Phase I Trial of Intraperitoneal Nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity|Active, not recruiting||Phase 1|27|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:30:02.86483|2017-02-18 13:30:02.86483
NCT00825188|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2014-03-10|||January 2009||2009-01-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives|Investigation of Reduction of Blood Pressure and Metabolic Rate in Obese Hypertensive Patients Using Eplerenone: Implications for Treatment of Hypertension and Heart Failure|Completed||N/A|20|Anticipated|University of Mississippi Medical Center||2|||f||||t||||||||||2017-02-18 13:30:02.98324|2017-02-18 13:30:02.98324
NCT00825175|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-01-24|2011-08-05||March 2006||2006-03-01|January 2014|2014-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Treadmill Training and Orthotic Use in Infants With Down Syndrome|The Effect of Treadmill Training and Orthotic Use on the Development of Walking and Upright Play in Infants With Down Syndrome|Completed||N/A|22|Actual|University of Michigan|small sample size|2|||f||||t||||||||||2017-02-18 13:30:03.095983|2017-02-18 13:30:03.095983
NCT00825162|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-07-17|2011-07-03||March 2009||2009-03-01|July 2013|2013-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years|A Phase IV, Open Label, Multi-Centre Study to Evaluate the Safety and Tolerability of CSL Limited's Influenza Virus Vaccine in a Paediatric Population Aged >= 6 Months to < 18 Years|Completed||Phase 4|1992|Actual|Seqirus||3|||f||||t||||||||||2017-02-18 13:30:03.48238|2017-02-18 13:30:03.48238
NCT00825149|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2016-11-03|||February 2009||2009-02-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|GAUDI||A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma|An Open-Label, Multi-Centre, Randomised, Phase Ib Study to Investigate the Safety and Efficacy of RO5072759 Given in Combination With CHOP, FC or Bendamustine Chemotherapy in Patients With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma|Completed||Phase 1|137|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-02-18 13:30:04.501872|2017-02-18 13:30:04.501872
NCT00825136|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2012-08-19|||July 2008||2008-07-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring|A Study on Mental Health Care by Using Specific Vital Signs|Terminated||N/A|10|Actual|Chimei Medical Center||2||The main limitations were the small sample size and low completion rate.|f||||t||||||||||2017-02-18 13:30:04.666027|2017-02-18 13:30:04.666027
NCT00825123|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2011-11-07|||October 2008||2008-10-01|November 2009|2009-11-01|December 2012|Anticipated|2012-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals|The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals|Withdrawn||Phase 4|40|Anticipated|Bayside Health||3|||f||||f||||||||||2017-02-18 13:30:04.77215|2017-02-18 13:30:04.77215
NCT00825110|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-01-16|||November 2008||2008-11-01|January 2009|2009-01-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||SS-GCC1- Screening Study of Genetic Changes in Colorectal Cancer|SS-GCC1- Screening Study of Genetic Changes in Colorectal Cancer|Unknown status|Recruiting|N/A|3750|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||t||||||Samples With DNA|"~     biospecimen includes formalin-fixed, paraffin embedded tissue, fresh frozen tissue and blood~     smaples~   "|||2017-02-18 13:30:04.877713|2017-02-18 13:30:04.877713
NCT00825097|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2011-12-22|||October 2008||2008-10-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|Neurotomy||Efficacy Study of Selective Tibial Neurotomy in the Treatment of the Spastic Equinovarus Foot Among Adult Hemiplegic Patients|Study of the Efficacy of the Selective Neurotomy in the Treatment of the Spastic Equinovarus Foot Among Adult Hemiplegic Patient Following the ICF Model. A Prospective, Randomized, Controlled Single Blind Study|Completed||Phase 3|16|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-02-18 13:30:04.973897|2017-02-18 13:30:04.973897
NCT00825084|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2011-04-22|||February 2009||2009-02-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects|A Phase 1, Randomized, Subject- And Investigator-Blind, Sponsor-Open, Placebo-Controlled, Parallel-Cohort, Single-Dose Escalation, And Multiple-Dose Titration Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects|Completed||Phase 1|45|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:30:05.08685|2017-02-18 13:30:05.08685
NCT00825071|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-05-12|||November 2007||2007-11-01|May 2016|2016-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Dexamethasone for Postoperative Nausea and Vomiting|Optimizing Anesthesia Antiemetic Measures Versus Combination With Dexamethasone or Ondansetron in the Prevention of Postoperative Nausea and Vomiting.|Completed||Phase 4|180|Actual|University of Jordan||3|||f||||t||||||||||2017-02-18 13:30:05.190038|2017-02-18 13:30:05.190038
NCT00825058|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-03-24|||November 2003||2003-11-01|March 2009|2009-03-01|October 2004|Actual|2004-10-01|May 2004|Actual|2004-05-01||Interventional|||Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine|A Double-Blind, Multicenter Study Evaluating the Efficacy and Safety of One Fixed Dose of SR58611A (700 mg/Day) Versus Placebo and Paroxetine (20 mg/Day) in Patients With a Recurrent Major Depressive Episode.|Completed||Phase 3|317|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 13:30:05.304849|2017-02-18 13:30:05.304849
NCT00825045|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2016-09-12|||December 2008||2008-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia|Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia|Recruiting||N/A|14|Anticipated|Centre for Addiction and Mental Health||1|||f||||f||||||||Undecided||2017-02-18 13:30:05.41501|2017-02-18 13:30:05.41501
NCT00825032|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2011-08-02|||March 2007||2007-03-01|May 2009|2009-05-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01||Interventional|UEET-COPD||Efficacy of Arm Training in COPD Patients|Effects of Unsupported Upper Extremity Exercise Training in Patients With Chronic Obstructive Pulmonary Disease: a Randomized Clinical Trial|Completed||N/A|50|Actual|Villa Pineta Hospital||2|||f||||f||||||||||2017-02-18 13:30:05.532642|2017-02-18 13:30:05.532642
NCT00825019|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-03-24|||September 2003||2003-09-01|March 2009|2009-03-01|December 2004|Actual|2004-12-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine|A Double-Blind, Multicenter Study Evaluating the Efficacy and Safety of One Fixed Dose of SR58611A (700 mg/Day) Versus Placebo and Paroxetine (20 mg/Day) in Patients With a Recurrent Major Depressive Episode.|Completed||Phase 3|306|Actual|Sanofi||3|||f||||||||||||||2017-02-18 13:30:05.648305|2017-02-18 13:30:05.648305
NCT00825006|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2009-01-16|||January 2009||2009-01-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|July 2009|Anticipated|2009-07-01||Interventional|||The Effects of Anodal Stimulation on Echocardiographic Outcome in Patients With Cardiac Resynchronization Therapy|The Effects of Anodal Stimulation on Left Ventricular Desynchrony and Hemodynamics in Patients With a Biventricular Pacemaker|Unknown status|Recruiting|N/A|30|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 13:30:05.755272|2017-02-18 13:30:05.755272
NCT00824993|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-04-25|||December 2008||2008-12-01|April 2016|2016-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients|A Randomized, Controlled Study of Ibandronate for the Prevention of Bone Loss in Patients Who Have Received Allogeneic Bone Marrow Transplantation for Hematological Malignancies|Active, not recruiting||Phase 3|200|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 13:30:05.862859|2017-02-18 13:30:05.862859
NCT00824980|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-01-16|||January 2009||2009-01-01|January 2009|2009-01-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis|Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis - Phase II Single Center Study|Unknown status|Recruiting|Phase 2|24|Anticipated|Immune Technologies & Medicine GmbH||2|||f||||f||||||||||2017-02-18 13:30:05.981656|2017-02-18 13:30:05.981656
NCT00824967|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2012-03-23|||October 2007||2007-10-01|January 2009|2009-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Non Pharmacological Management of Behavioural Symptoms in Nursing Home|Not Pharmacologic Treatment Has Illness of Alzheimer and Pathologies Related. Application in Disturbances of Behaviour in EHPAD|Terminated||N/A|306|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:30:06.067602|2017-02-18 13:30:06.067602
NCT00824954|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2011-01-18|||June 2009||2009-06-01|January 2011|2011-01-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease|Evaluation of Extracorporeal Photochemotherapy in Children and Young Adults With Refractory Acute Graft Versus Host Disease After Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|30|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:30:06.166973|2017-02-18 13:30:06.166973
NCT00824941|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2017-01-24|||January 14, 2009||2009-01-14|January 5, 2017|2017-01-05||||||||Observational|||Brain-Gut Interactions in Overweight and Normal Weight Patients With Chronic Abdominal Pain|Brain-Gut Interactions in Overweight and Normal Weight Patients With Chronic Abdominal Pain|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:30:06.268475|2017-02-18 13:30:06.268475
NCT00824928|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-05-26|||January 2007||2007-01-01|June 2010|2010-06-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|SCORE||Salvage Cryotherapy in Recurrent Prostate Cancer|A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study|Terminated||N/A|60|Actual|University of Colorado, Denver|||1|Study was ended due to low enrollment|f||||f||||||||||2017-02-18 13:30:06.375129|2017-02-18 13:30:06.375129
NCT00824915|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2013-06-24|||August 2008||2008-08-01|June 2013|2013-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|RVLIA||Enhanced Surveillance of RV Lead Integrity Alert (RVLIA)|Enhanced Surveillance of RV Lead Integrity Alert (RVLIA)|Completed||N/A|1779|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-02-18 13:30:06.533511|2017-02-18 13:30:06.533511
NCT00824902|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-01-07|||December 2008||2008-12-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer Patients Undergoing Radical Prostatectomy|A Pilot Trial Evaluation of Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer in Patients Undergoing Radical Prostatectomy|Terminated||N/A|13|Actual|M.D. Anderson Cancer Center||1||Technical Issues|f||||f||||||||||2017-02-18 13:30:06.603577|2017-02-18 13:30:06.603577
NCT00824889|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-08-28|||February 2009||2009-02-01|August 2014|2014-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Exploratory Study of Natural Killer Cells in Human Skin|Exploratory Study of Natural Killer Cells in Human Skin|Completed||N/A|28|Actual|Assistance Publique Hopitaux De Marseille||7|||f||||f||||||||||2017-02-18 13:30:06.737696|2017-02-18 13:30:06.737696
NCT00824876|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-07-07|||January 2009||2009-01-01|July 2009|2009-07-01||||||||Observational|||Orthostatic Tolerance in Mamma Cancer Patients After Anaesthesia||Completed||N/A|||Rigshospitalet, Denmark|||1||f||||f||||||||||2017-02-18 13:30:06.848289|2017-02-18 13:30:06.848289
NCT00824863|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-08-19|||December 2008||2008-12-01|August 2014|2014-08-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of Ketoconazole 2% Foam in the Treatment of Pityrosporum Folliculitis|An Open-Label, Proof of Concept Study to Determine the Safety and Efficacy of Ketoconazole 2% Foam in the Treatment of Pityrosporum Folliculitis|Completed||Phase 4|10|Actual|Fujita, Wayne, M.D.||1|||f||||t||||||||||2017-02-18 13:30:06.929246|2017-02-18 13:30:06.929246
NCT00824850|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2011-10-05|2011-08-04||January 2010||2010-01-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|PILOT||Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort|Characterization of the Prevnar Infant Long-term Immune Response vs a Prevnar Naive Cohort|Completed||Phase 2|75|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:30:07.143765|2017-02-18 13:30:07.143765
NCT00824837|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-07-06|||October 2008||2008-10-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|HiCOF||Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane|Randomised, Cross Over Pilot Study Comparing Removal of beta2-Microglobulin by Standard Haemodialysis to Haemodialysis With a Novel Dialysis Membrane (P2SH) in Chronic Dialysis Patients|Completed||Phase 1/Phase 2|8|Actual|Austin Health||2|||f||||t||||||||||2017-02-18 13:30:09.399562|2017-02-18 13:30:09.399562
NCT00824824|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2016-10-27|2012-08-30||January 2009||2009-01-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||There are 14 subjects in this study whop have PAOG without RVD. There are 7 subjects with POAG with RVD. The 14 subjects without RVD did not continue in the two treament arms of this study.|Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG)|Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG)|Completed||N/A|21|Actual|Massachusetts Eye and Ear Infirmary|A potential limitation of this study is that no washout period occurred because the 6-week treatment periods extended beyond the typical 2-week washout period for dorzolamide and the 3-week washout period for brimonidine.|2|||f||||f||||||||No||2017-02-18 13:30:09.510608|2017-02-18 13:30:09.510608
NCT00824629|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2010-10-25|||October 2008||2008-10-01|August 2009|2009-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Embryo Transfer: Direct Versus Afterloading Trial|"Direct Transfer vs Previous Cervical Canalization Transfer (Afterloading): Randomized Clinical Trial."|Completed||N/A|400|Anticipated|Institut Universitari Dexeus||2|||f||||f||||||||||2017-02-18 13:30:12.918312|2017-02-18 13:30:12.918312
NCT00824811|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2012-08-01|||June 2009||2009-06-01|August 2012|2012-08-01||||||||Interventional|||Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel|A Double-Blind Study Evaluating the Safety and Efficacy of Cyclosporine Ophthalmic Emulsion 0.05% [Restasis] in Subjects With Epiphora Secondary to Docetaxel [Taxotere] Treatment for Various Cancers|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||2||Slow accrual.|f||||t||||||||||2017-02-18 13:30:09.963813|2017-02-18 13:30:09.963813
NCT00824798|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2014-07-10|||January 2009||2009-01-01|July 2014|2014-07-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|||Gait Evaluation in Haemophiliac Patients|Gait Evaluation in Haemophiliac Patients|Completed||N/A|200|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||t||||||||||2017-02-18 13:30:10.075968|2017-02-18 13:30:10.075968
NCT00824785|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2012-12-10|||May 2008||2008-05-01|December 2012|2012-12-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|REAL3||REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer|REAL 3 : A Randomised Open-labelled Multicentre Trial of the Efficacy of Epirubicin, Oxaliplatin and Capecitabine (EOX) With or Without Panitumumab in Previously Untreated Advanced Oesophago-gastric Cancer|Terminated||Phase 3|574|Actual|Royal Marsden NHS Foundation Trust||2||Lack of efficacy|f||||t||||||||||2017-02-18 13:30:10.153812|2017-02-18 13:30:10.153812
NCT00824772|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2013-05-26|2013-03-25||September 2008||2008-09-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Observational|||Evaluation of Pharmacogenetic Factors Affecting Fentanyl Requirements for Postoperative Pain Control|Evaluation of Pharmacogenetic Factors Contributing to Dose Requirement of Fentanyl for Postoperative Pain Control: Genetic Polymorphisms of OPRM1, ABCB1, CYP3A4 and CYP3A5|Completed||N/A|204|Actual|Inje University|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:30:10.266658|2017-02-18 13:30:10.266658
NCT00824759|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2014-11-18||||||November 2014|2014-11-01||||||||Interventional|||Cardioprotective Effects of Increased Endogenous Erythropoietin After Normobaric Oxygen Breathing||Withdrawn||N/A|0|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2||Because it seemed not of interest based on the current literature|f||||f||||||||||2017-02-18 13:30:10.491048|2017-02-18 13:30:10.491048
NCT00824746|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2013-01-22|2012-02-09||January 2009||2009-01-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|ReGaiN||Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)|Retreatment of Gefitinib in the Patients With Non-small Cell Lung Cancer (NSCLC) Previously Responded to Gefitinib A Single Arm, Open Label, Phase II Study|Completed||Phase 2|23|Actual|Chonnam National University Hospital|Our study has several limitations such as lack of generalizability outside a clinically and molecularly enriched population and the small number of repeat biopsies.|1|||f||||f||||||||||2017-02-18 13:30:10.595281|2017-02-18 13:30:10.595281
NCT00824733|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2015-12-09|2015-08-19||February 2009||2009-02-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|February 2013|Actual|2013-02-01||Interventional|||Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Phase II Open-label Study of Subcutaneous CPG ODN (PF03512676) in Combination With Trastuzumab in Patients With Metastatic Breast Cancer|Terminated||Phase 2|6|Actual|Ohio State University Comprehensive Cancer Center||1||Inaccurate patient accrual for trial|f||||t||||||||||2017-02-18 13:30:10.864741|2017-02-18 13:30:10.864741
NCT00824720|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-02-18|2010-04-15||December 2008||2008-12-01|February 2015|2015-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy of a Glaucoma Drug Delivery System||Completed||Phase 2|55|Actual|Vistakon Pharmaceuticals||3|||f||||||||||||||2017-02-18 13:30:11.199732|2017-02-18 13:30:11.199732
NCT00824707|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2016-03-30|||December 2008||2008-12-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer|A Randomized, Controlled Study to Evaluate the Efficacy and Significant of the Anti-virus Therapy for the Unresectable Hepatitis B Virus-related Primary Liver Cancer|Completed||N/A|200|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:30:11.663204|2017-02-18 13:30:11.663204
NCT00824694|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2011-06-21|||March 2009||2009-03-01|June 2011|2011-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Impact of Accu-Chek 360 in Veterans With Type 2 Diabetes|Impact of Accu-Chek 360 View on Practice Patterns and HBA1C in Veterans With Type 2 Diabetes.|Completed||N/A|348|Anticipated|Biomedical Research Institute of New Mexico||2|||f||||t||||||||||2017-02-18 13:30:11.789646|2017-02-18 13:30:11.789646
NCT00824681|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2010-07-22|||September 2007||2007-09-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|MTS3||Effect of Music Therapy on Families of Burn Patients|Sound Of Family Together (S.O.F.T.) Music Program: A Randomized-Controlled Study to Investigate the Effect of Music Therapy on the Coping and Adjustment of Children of Adults With Major Burns|Terminated||Phase 1|30|Anticipated|MetroHealth Medical Center||2||Music therapist left position.|f||||f||||||||||2017-02-18 13:30:11.915764|2017-02-18 13:30:11.915764
NCT00824668|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2017-01-05|||August 2007||2007-08-01|January 2017|2017-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes|A Randomised, Open-labelled, 2-period Crossover Trial Investigating Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 Thrice Daily and Basal-bolus Therapy With Insulin Glargine & Insulin Glulisine in Subjects With Type 2 Diabetes|Completed||Phase 1|24|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 13:30:12.022162|2017-02-18 13:30:12.022162
NCT00824655|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2011-08-04|2011-06-17||March 2009||2009-03-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children|A Phase 3, Open-Label Trial, Evaluating the Safety, Tolerability, and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine in Healthy Children Previously Partially Immunized With Prevenar|Completed||Phase 3|234|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:30:12.132944|2017-02-18 13:30:12.132944
NCT00824642|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2009-01-16|||May 2005||2005-05-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Acu-Transcutaneous Electrical Nerve Stimulation (TENS) on Post-Exercise Expiratory Flow Rate in Subjects With Asthma|Effect of Acu-TENS on Post-Exercise Expiratory Flow Rate in Subjects With Asthma- A Randomized Controlled Trial|Completed||N/A|30|Actual|The Hong Kong Polytechnic University||3|||f||||||||||||||2017-02-18 13:30:12.822431|2017-02-18 13:30:12.822431
NCT00824616|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2015-07-21|2012-07-17||January 2009||2009-01-01|July 2015|2015-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)|A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin|Completed||Phase 2|68|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:30:13.028635|2017-02-18 13:30:13.028635
NCT00824603|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-11-30|||June 2006||2006-06-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Impact of Continuing Medical Education (CME) Insulin Program|Impact of CME Program on Self-Reported Confidence and Use of Insulin in Persons With Type 2 Diabetes|Completed||N/A|294|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-02-18 13:30:13.354727|2017-02-18 13:30:13.354727
NCT00824590|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-12-29|||February 2009||2009-02-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function|A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function|Completed||Phase 1|20|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:30:13.445951|2017-02-18 13:30:13.445951
NCT00824577|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-16|2010-06-28|||December 2009||2009-12-01|June 2010|2010-06-01|September 2010|Anticipated|2010-09-01|June 2010|Anticipated|2010-06-01||Observational|||Heart Rate Variability in Chronic Kidney Disease Patients|Heart Rate Variability in Chronic Kidney Disease Patients|Unknown status|Active, not recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples Without DNA|"~     PD effluent and blood sample~   "|||2017-02-18 13:30:13.550945|2017-02-18 13:30:13.550945
NCT00824564|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-06-06|2011-06-06||April 2009||2009-04-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture|Prospective Randomized Phase IV Open Label Comparative Study Of Tranexamic Acid Plus Standard Of Care Versus Standard Of Care For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture|Completed||Phase 4|82|Actual|Pfizer|The data for hemoglobin levels was planned but not evaluated on the morning of Day 7 post-surgery.|2|||f||||t||||||||||2017-02-18 13:30:13.706382|2017-02-18 13:30:13.706382
NCT00824551|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-01-15|||January 2009||2009-01-01|December 2008|2008-12-01||||December 2010|Anticipated|2010-12-01||Interventional|||The Effects of Hyperbaric Oxygen Therapy (HBOT) on Acute Thermal Burns|The Effects of Hyperbaric Oxygen Therapy on Acute Thermal Burns|Unknown status|Recruiting|Phase 1|80|Anticipated|Singapore General Hospital||2|||f||||t||||||||||2017-02-18 13:30:14.406653|2017-02-18 13:30:14.406653
NCT00824538|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-04-10|2013-03-01||February 2009||2009-02-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Interventional|||Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow|Pilot Study to Evaluate the Effect of Sunitinib on Occult Tumor Cells in the Bone Marrow of Patients With High Risk Early Stage Breast Cancer|Completed||Phase 2|13|Actual|University of California, San Francisco|The study was closed early due to results released from a phase III metastatic breast cancer (MBC) study that demonstrated significant sunitinib toxicity without commensurate clinical benefit, the number of patients in this study was small.|1|||f||||t||||||||||2017-02-18 13:30:14.502185|2017-02-18 13:30:14.502185
NCT00824512|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2013-04-10|2012-10-30||June 2008||2008-06-01|April 2013|2013-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia|A Phase II, Randomised, Double Blind Study Assessing the Efficacy of EGb761 120mg Bid Versus Placebo in Patients Suffering From Friedreich Ataxia|Completed||Phase 2|22|Actual|Ipsen||2|||f||||f||||||||||2017-02-18 13:30:14.76912|2017-02-18 13:30:14.76912
NCT00824499|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-01-15|||February 2004||2004-02-01|January 2009|2009-01-01|June 2009|Anticipated|2009-06-01|December 2007|Actual|2007-12-01||Interventional|DPA||Development, Implementation and Evaluation of a Complex Regional Intervention for Type 2 Diabetes: Diabetes Project Aalst|Development, Implementation and Evaluation of a Complex Regional Intervention for Type 2 Diabetes.|Unknown status|Active, not recruiting|N/A|375|Actual|Universiteit Antwerpen||2|||f||||t||||||||||2017-02-18 13:30:15.644364|2017-02-18 13:30:15.644364
NCT00824486|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-01-15|||June 2003||2003-06-01|January 2009|2009-01-01|March 2007|Actual|2007-03-01|||||Interventional|||Home Safety Intervention Using a Safe Home Model|A Randomized Trial of a Home Safety Intervention Using a Safe Home Model|Completed||N/A|||Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-02-18 13:30:15.740897|2017-02-18 13:30:15.740897
NCT00824473|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-02-19|2009-09-30||December 2008||2008-12-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies|Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 in Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|506|Actual|Meda Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:30:15.829366|2017-02-18 13:30:15.829366
NCT00824460|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2014-03-03|2013-12-20||December 2008||2008-12-01|March 2014|2014-03-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Interventional|PA21|For baseline characteristics data, from All Randomised patients was used.|Study of Phosphate Levels in Patients With Chronic Kidney Disease|An Open-label, Randomised, Active Controlled Multi-center Phase II Dose Finding Study to Evaluate the Ability of PA21 to Lower Serum Phosphate Levels and the Tolerability in Patients With Chronic Kidney Disease on Maintenance Hemodialysis|Completed||Phase 2|154|Actual|Vifor Inc.||6|||f||||f||||||||||2017-02-18 13:30:16.425128|2017-02-18 13:30:16.425128
NCT00824447|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2010-05-04|||August 2007||2007-08-01|May 2010|2010-05-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||Long-term Efficacy and Safety Study With Oralgen Grass Pollen|A Randomised, DB, Plcb Controlled, Multicentre, Multinat. Phase II/III FU Study to Assess Longterm Efficacy and Safety of 3 Different Dose Regimens of Oralgen® GrassPollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis|Completed||Phase 2/Phase 3|356|Actual|Artu Biologicals||4|||f||||f||||||||||2017-02-18 13:30:17.795243|2017-02-18 13:30:17.795243
NCT00824434|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2012-08-17|2011-12-20||March 2009||2009-03-01|August 2012|2012-08-01|August 2010|Actual|2010-08-01|September 2009|Actual|2009-09-01||Interventional|PLATINUM QCA||A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)|A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)|Completed||Phase 3|100|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-02-18 13:30:17.936469|2017-02-18 13:30:17.936469
NCT00824421|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2013-12-09|2013-12-09||February 2009||2009-02-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||Intent-to-treat (ITT) population included all randomized participants who had received at least 1 dose of study medication.|A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1|A Phase 2B Multicenter, Randomized, Double-Blind, Comparative Trial Of UK-453,061, In Combination With Tenofovir Df And Emtricitabine Versus Efavirenz In Combination With Tenofovir DF And Emtricitabine For The Treatment Of Antiretroviral-Naive HIV-1 Infected Subjects|Completed||Phase 2|195|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 13:30:21.25716|2017-02-18 13:30:21.25716
NCT00824408|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-07-28|2016-07-28||March 2009||2009-03-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|September 2012|Actual|2012-09-01||Interventional||Randomized set, which included all patients randomised in the randomisation phase, whether treated or not|Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC|A Randomised Open-label Phase II Trial of BI 6727 Monotherapy and BI 6727 in Combination With Standard Dose Pemetrexed Compared to Pemetrexed Monotherapy in Second Line Non-small Cell Lung Cancer|Completed||Phase 2|143|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:30:23.015944|2017-02-18 13:30:23.015944
NCT00824395|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2011-02-02|||January 2006||2006-01-01|February 2011|2011-02-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Observational|||The Genetics of Diabetes in Southern California Chinese Americans|Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort|Unknown status|Recruiting|N/A|500|Anticipated|University of California, Irvine|||2||f||||f||||||Samples With DNA|"~     whole blood and serum~   "|||2017-02-18 13:30:24.604434|2017-02-18 13:30:24.604434
NCT00824382|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-06-17|2014-03-28||January 2009||2009-01-01|May 2014|2014-05-01||||March 2010|Actual|2010-03-01||Interventional||The treated set consisting of all randomised patients for whitch at least one investigational treatment was used.|Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD|Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 4 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL Delivered by the Respimat Inhaler in Japanese Patients With COPD|Completed||Phase 2|328|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 13:30:24.694193|2017-02-18 13:30:24.694193
NCT00824369|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-07-31|2014-01-16||July 2009||2009-07-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1|A Phase 2b Open-Label Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1 Infected Subjects|Terminated||Phase 2|52|Actual|Pfizer||1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:30:26.146249|2017-02-18 13:30:26.146249
NCT00824356|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-06-18|||June 2008||2008-06-01|June 2009|2009-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo|A Randomised, Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Assess the Efficacy and Safety of Single Dose Intranasal GSK1004723 Compared With Placebo in an Allergen Challenge Chamber in Male Subjects With Seasonal Allergic Rhinitis|Completed||Phase 2|54|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 13:30:27.228011|2017-02-18 13:30:27.228011
NCT00824343|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2013-07-08|||September 2008||2008-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|April 2011|Actual|2011-04-01||Interventional|MONARCH||A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer|An Open Label, Multicenter Phase II Study to Evaluate Efficacy and Safety of P276-00 in Indian Subjects With Recurrent, Metastatic or Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck|Completed||Phase 2|86|Actual|Piramal Enterprises Limited||1|||f||||f||||||||||2017-02-18 13:30:27.331197|2017-02-18 13:30:27.331197
NCT00824330|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2016-04-11|||January 2009||2009-01-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|July 2013|Actual|2013-07-01||Interventional|||Home-Based Walking Study in Older Adults With Type 2 Diabetes|The Use of a Home-based Walking Program to Treat Orthostatic Hypotension in Older Adults With Type 2 Diabetes|Completed||N/A|13|Actual|University of British Columbia||1|||f||||f||||||||No||2017-02-18 13:30:27.437939|2017-02-18 13:30:27.437939
NCT00824317|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-01-15|||October 2001||2001-10-01|January 2009|2009-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type|Stimulant Drug Treatment of AD/HD, Inattentive Type|Completed||N/A|25|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 13:30:27.547932|2017-02-18 13:30:27.547932
NCT00824304|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2013-02-14|||July 2007||2007-07-01|January 2009|2009-01-01|July 2009|Actual|2009-07-01|January 2008|Actual|2008-01-01||Observational|FeZn_FU||Long-term Effects of Iron and Zinc Supplementation During Infancy on Cognitive Performance and Growth|Long-Term Effects of Iron and Zinc Supplementation During Infancy on Cognitive Performance and Growth 8 Years Later: A Follow-Up Study|Completed||N/A|562|Actual|Mahidol University|||1||f||||f||||||Samples Without DNA|"~     Plasma and urine~   "|||2017-02-18 13:30:27.659596|2017-02-18 13:30:27.659596
NCT00824291|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-03-04|2010-10-26||February 2009||2009-02-01|March 2011|2011-03-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate Functional Outcome In Outpatients With Major Depressive Disorder Treated With Desvenlafaxine Succinare Sustained Release|Completed||Phase 3|437|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:30:27.763705|2017-02-18 13:30:27.763705
NCT00824278|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2017-01-24|||January 9, 2009||2009-01-09|July 12, 2016|2016-07-12||||||||Observational|||The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study|The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory, Pilot Study|Completed||N/A|257|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:30:28.494979|2017-02-18 13:30:28.494979
NCT00824265|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-06-15|2015-08-10||March 2009||2009-03-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|December 2014|Actual|2014-12-01||Interventional|||Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia|A Phase III, Open Label, Randomized Trial of Ofatumumab Added to Fludarabine-Cyclophosphamide vs. Fludarabine-Cyclophosphamide Combination in Subjects With Relapsed Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 3|365|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:30:28.616904|2017-02-18 13:30:28.616904
NCT00824239|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2012-06-08|||September 2008||2008-09-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Intermittent Sedation Versus Daily Interruption of Sedation in Mechanically Ventilated Patients|Randomized Trial Comparing Intermittent Sedation and Daily Interruption of Sedation in Mechanically Ventilated Patients|Completed||Phase 3|60|Actual|University of Sao Paulo General Hospital||2|||f||||t||||||||||2017-02-18 13:30:31.789305|2017-02-18 13:30:31.789305
NCT00824226|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2011-08-26|||January 2009||2009-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Magnesium Treatment in Hypoparathyroidism|Effect of Magnesium Treatment on Plasma Calcium in Hypoparathyroid Patients|Completed||N/A|10|Actual|University of Tartu||1|||f||||f||||||||||2017-02-18 13:30:31.901386|2017-02-18 13:30:31.901386
NCT00824213|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-06-02|||January 2009||2009-01-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|August 2011|Anticipated|2011-08-01||Observational|||Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer|Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer|Suspended||N/A|50|Anticipated|University of British Columbia|||1|"The first phase of this project is finished, now we are waiting until LGH gets the new~   SPECT/CT camera for the next stage. This will take at least 6 months."|f||||f||||||||||2017-02-18 13:30:31.983703|2017-02-18 13:30:31.983703
NCT00824200|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-01-06|||July 2008||2008-07-01|January 2014|2014-01-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|BEDTiMe||Behavior and Exercise Versus Drug Treatment in Men With Nocturia (BEDTiMe)|Behavior and Exercise Versus Drug Treatment in Men With Nocturia|Unknown status|Active, not recruiting|Phase 4|200|Anticipated|Atlanta VA Medical Center||3|||f||||f||||||||||2017-02-18 13:30:32.075031|2017-02-18 13:30:32.075031
NCT00824187|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-04-01|||January 2009||2009-01-01|April 2014|2014-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||YAZ Premenstrual Dysphoric Disorder (PMDD) in China|A Multicenter, Double-blind, Randomized, Placebo Controlled Study of the Monophasic Oral Contraceptive YAZ (20 µg Ethinylestradiol, 3 mg Drospirenone) in the Treatment of Chinese Patients With Premenstrual Dysphoric Disorder (PMDD)|Completed||Phase 3|187|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:30:32.201729|2017-02-18 13:30:32.201729
NCT00824174|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2012-10-01|||December 2008||2008-12-01|October 2012|2012-10-01||||September 2012|Actual|2012-09-01||Observational|||Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer|Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer|Completed||N/A|289|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:30:32.312829|2017-02-18 13:30:32.312829
NCT00824161|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2012-04-20|2011-06-21||January 2009||2009-01-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|||Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer|A Phase II Study of TAS-109 Given by Continuous Intravenous 14-day Infusion in Patients With Chemotherapy-refractory Advanced Colorectal Cancer|Terminated||Phase 2|28|Actual|Taiho Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-02-18 13:30:32.422544|2017-02-18 13:30:32.422544
NCT00824148|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2012-07-25|||January 2009||2009-01-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes Mellitus|Use of Real-time Continuous Glucose Monitoring System to Control Blood Glucose in Patients With Type 1 Diabetes Mellitus|Completed||N/A|30|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-02-18 13:30:32.814003|2017-02-18 13:30:32.814003
NCT00824135|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-12-30|||January 2009||2009-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2012|Actual|2012-10-01||Interventional|||Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies|Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies|Completed||Phase 1|34|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 13:30:32.921193|2017-02-18 13:30:32.921193
NCT00824122|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-10-11|||January 2008||2008-01-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|December 2008|Actual|2008-12-01||Observational|||Vancomycin Associated Red Man Syndrome (RMS)|Genetic Polymorphisms Associated With Histamine Disposition in Children With Vancomycin Associated Red Man Syndrome (RMS)|Completed||Phase 4|544|Actual|Children's Mercy Hospital Kansas City|||2||f||||f||||||Samples With DNA|"~     Frozen blood has been maintained for future genetic studies~   "|||2017-02-18 13:30:33.043074|2017-02-18 13:30:33.043074
NCT00824109|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-12-02|||July 2008||2008-07-01|December 2010|2010-12-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Prospective, Multicenter Study of the Second Generation Antimicrobial Graft in the Abdominal Position|Multicenter Clinical Study Assessing the Performance and the Safety of the Second Generation Antimicrobial Graft in the Abdominal Position|Unknown status|Recruiting|Phase 4|60|Anticipated|Datascope Corp.||1|||f||||f||||||||||2017-02-18 13:30:33.135054|2017-02-18 13:30:33.135054
NCT00824096|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-01-15|||December 2006||2006-12-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Use Bronchoscopy to Predict Post-Extubation Stridor in Critical Ill Patients||Unknown status|Recruiting|N/A|100|Anticipated|Chimei Medical Center||1|||f||||f||||||||||2017-02-18 13:30:33.246657|2017-02-18 13:30:33.246657
NCT00824083|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-04-27|||July 2009||2009-07-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment|Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment|Completed||N/A|950|Actual|University Hospital Muenster|||2||f||||f||||||||No||2017-02-18 13:30:33.331462|2017-02-18 13:30:33.331462
NCT00824070|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2011-12-07|2010-09-30||February 2009||2009-02-01|December 2011|2011-12-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects|An Open-Label, Randomized Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects After a Single Topical Dose|Completed||Phase 1|105|Actual|Bausch & Lomb Incorporated|All drug concentrations were significantly below MIC90 values for relevant staphylococcal species.|3|||f||||f||||||||||2017-02-18 13:30:33.436291|2017-02-18 13:30:33.436291
NCT00824057|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-07-30|||January 2009||2009-01-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|||||Interventional|CYP||Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)|A Phase I Open-labeled, Fixed Sequence Study to Determine the Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)|Completed||Phase 1|24|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:30:34.040731|2017-02-18 13:30:34.040731
NCT00824044|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2012-12-05|2012-12-05||July 2008||2008-07-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression|QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression|Completed||Phase 4|33|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:30:34.143347|2017-02-18 13:30:34.143347
NCT00824031|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-09-10|||January 2009||2009-01-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|||||Observational|||Study of Mental Care in Spain|Study of Mental Care in Spain|Completed||N/A|76|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:30:34.55999|2017-02-18 13:30:34.55999
NCT00823264|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2014-09-04|2013-08-14||August 2008||2008-08-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|July 2010|Actual|2010-07-01||Interventional|||Phenytoin and Multidose Activated Charcoal|Prospective Randomized Study of Multidose Activated Charcoal in Supratherapeutic Phenytoin Serum Levels|Completed||N/A|17|Actual|Emory University||2|||f||||f||||||||||2017-02-18 13:30:34.654144|2017-02-18 13:30:34.654144
NCT00822198|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||March 2006||2006-03-01|January 2009|2009-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||The Effect of Plantar Vibration on the Progression of Peripheral Neuropathy|The Effect of Plantar Vibration on the Progression of Peripheral Neuropathy|Completed||N/A|24|Actual|Binghamton University||1|||f||||f||||||||||2017-02-18 13:30:35.035704|2017-02-18 13:30:35.035704
NCT00822185|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-12-12|2013-09-27||January 2009||2009-01-01|December 2014|2014-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers|A Single-centre, Randomised, Placebo-controlled, Double-blind, Single-dose, Dose-escalation Trial to Assess the Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Doses of an Activated Recombinant FVII Analogue (NN1731) in Healthy Japanese Male Subjects|Completed||Phase 1|32|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-02-18 13:30:35.152918|2017-02-18 13:30:35.152918
NCT00822172|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-04-11|2013-03-01||September 2008||2008-09-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|ECLECTIC||Evaluation of Cilostazol in Combination With L-Carnitine|Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication|Completed||Phase 4|164|Actual|Colorado Prevention Center||2|||f||||f||||||||||2017-02-18 13:30:36.047381|2017-02-18 13:30:36.047381
NCT00822159|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2011-10-07|||November 2008||2008-11-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|Densiprobe||Influence of Bone Strength Measured by DensiProbe on Bone Related Fixation Failure|Prospective Multicenter Cohort Study to Evaluate the Influence of Bone Strength Measured by DensiProbe Hip on Bone Related Fixation Failure in Patients With Hip Fractures Undergoing DHS Surgical Treatment.|Terminated||N/A|198|Anticipated|AO Clinical Investigation and Documentation||1||Interim analysis showed statistically significant results|f||||f||||||||||2017-02-18 13:30:36.517799|2017-02-18 13:30:36.517799
NCT00822146|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-03-20|||December 2008||2008-12-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|December 2011|Actual|2011-12-01||Interventional|||Cardiac Resynchronization Therapy (CRT) Efficacy Study||Completed||Phase 4|9|Actual|Medtronic Bakken Research Center||1|||f||||f||||||||||2017-02-18 13:30:36.626428|2017-02-18 13:30:36.626428
NCT00822133|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||February 2009||2009-02-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Percutaneous Ketamine Versus Lidocaine or Placebo, for Post-Surgery Analgesia, in Patients Undergoing Laparoscopic Partial Lung Resection||Unknown status|Not yet recruiting|Phase 4|75|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||||2017-02-18 13:30:36.714819|2017-02-18 13:30:36.714819
NCT00822120|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-04-21|||July 2009||2009-07-01|April 2016|2016-04-01|April 2020|Anticipated|2020-04-01|April 2016|Actual|2016-04-01||Interventional|||S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma|A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma Using Early Interim FDG-PET Imaging|Active, not recruiting||Phase 2|230|Anticipated|Southwest Oncology Group||4|||f||||f||||||||||2017-02-18 13:30:36.839485|2017-02-18 13:30:36.839485
NCT00822107|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-03-28|||January 2009||2009-01-01|March 2016|2016-03-01|September 2013|Actual|2013-09-01|January 2013|Actual|2013-01-01||Interventional|||A Translational Approach to Gitelman Syndrome|A Translational Approach to Gitelman Syndrome|Completed||N/A|8|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 13:30:37.666787|2017-02-18 13:30:37.666787
NCT00822094|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2013-02-20||2013-02-20|February 2009||2009-02-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)|Phase IIB, Multicenter, Randomized, Open-Label Trial Of CPX-351 (Cytarabine : Daunorubicin) Liposome Injection Versus Intensive Salvage Therapy In Adult Patients ≤ 65 Years Old With AML In First Relapse Following An Initial CR > 1 Month Duration|Completed||Phase 2|125|Actual|Celator Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:30:37.773571|2017-02-18 13:30:37.773571
NCT00822081|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-13|||January 2005||2005-01-01|January 2009|2009-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 4|140|Actual|Bp Consulting, Inc||4|||f||||f||||||||||2017-02-18 13:30:37.945562|2017-02-18 13:30:37.945562
NCT00822068|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||January 2009||2009-01-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Improvement of Language Disturbances After Stroke by Intensive Training and Electrical Brain Stimulation|Improvement of Aphasia After Stroke by Intensive Training and Transcranial Direct Current Stimulation|Unknown status|Recruiting|Phase 2/Phase 3|20|Anticipated|University Hospital Muenster||3|||f||||f||||||||||2017-02-18 13:30:38.059451|2017-02-18 13:30:38.059451
NCT00822055|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||May 2005||2005-05-01|January 2009|2009-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 4|140|Actual|Allergan||4|||f||||f||||||||||2017-02-18 13:30:38.16983|2017-02-18 13:30:38.16983
NCT00822042|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-02-26|||August 2006||2006-08-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Observational|ADIPOKINES||Corticosteroid-induced Lipodystrophy and Adipokines|Study of Histological and Adipokines Expression Variations in Lipodystrophic Adipose Tissue During Corticosteroids-induced Lipodystrophy|Completed||N/A|32|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"~     Cytopunction (adipocytes), whole blood~   "|||2017-02-18 13:30:38.294378|2017-02-18 13:30:38.294378
NCT00822029|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-03-23|||February 2009||2009-02-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy|Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy|Terminated||Phase 3|2|Actual|Centre Hospitalier Universitaire de Nice||2||only 2 patients inclued and Study Principal Investigator has left the hospital|f||||f||||||||||2017-02-18 13:30:38.406348|2017-02-18 13:30:38.406348
NCT00822016|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-06-27|||July 2007||2007-07-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Observational|||Observational Study of Best Supportive Care With or Without Surgery, Chemo or Radiotherapy in Pts With Carcinoma of Lung|INST 0701C: An Observational Outcomes Protocol of Standard Practice of Best Supportive Care With or Without Surgery, Chemotherapy or Radiotherapy in Patients With Carcinoma of the Lung|Terminated||N/A|25|Actual|New Mexico Cancer Care Alliance|||1|PI left institution. Insufficient enrollment for analysis.|f||||t||||||||||2017-02-18 13:30:38.508743|2017-02-18 13:30:38.508743
NCT00822003|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||February 2008||2008-02-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male Subjects|Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile Following an Oral Glucose Tolerance Test in Healthy Male Subjects|Completed||Phase 1/Phase 2|16|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 13:30:38.60233|2017-02-18 13:30:38.60233
NCT00824018|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-01-15|||November 2008||2008-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:30:38.706218|2017-02-18 13:30:38.706218
NCT00824005|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-06-02|2012-08-30||March 2009||2009-03-01|June 2015|2015-06-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Interventional|||Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)|Randomized, Controlled, Phase II, Double-Blind Trial of Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance for Patients With Chronic Ischemic Heart Disease and Left Ventricular Dysfunction|Completed||Phase 2|92|Actual|The University of Texas Health Science Center, Houston|Sample size was small and required large improvements in order to show significant treatment effects. SPECT often underestimates reversibility and viability in those with multivessel disease. Presence of cardiac devices limited MRI evaluation.|2|||f||||t||||||||||2017-02-18 13:30:38.763625|2017-02-18 13:30:38.763625
NCT00823992|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-07-26||2016-07-26|January 2009||2009-01-01|July 2016|2016-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy|A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.|Completed||Phase 3|305|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:30:39.467023|2017-02-18 13:30:39.467023
NCT00823979|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-03-24|2014-01-28||March 2009||2009-03-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Intent-to-Treat (ITT) population included all randomized participants who received at least 1 dose of study drug.|A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1|A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1|Terminated||Phase 2|105|Actual|Pfizer|The trial was terminated on 12 April, 2012 due to lack of efficacy at the Week 24 analysis. The decision to terminate the trial was not based on any safety concerns.|3||See termination reason in detailed description.|f||||t||||||||||2017-02-18 13:30:39.651289|2017-02-18 13:30:39.651289
NCT00823966|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-06-02|2010-03-04||December 2003||2003-12-01|June 2010|2010-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients|Drug Use Investigation For Rescriptor (Regulatory Post Marketing Commitment Plan)|Completed||Phase 4|3|Actual|Pfizer|There is not enough data to analyze on the efficacy and safety of delavirdine mesylate in the 3 subjects with HIV infection assessed during this study.||1||f||||f||||||||||2017-02-18 13:30:43.005699|2017-02-18 13:30:43.005699
NCT00823953|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2012-06-09|||November 2008||2008-11-01|June 2012|2012-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Glycemic Response to Momordica Charantia in Type 2 Diabetes|The Effect of Momordica Charantia on Glycemic Control and Insulin Resistance in Type 2 Diabetes|Withdrawn||Phase 2|0|Actual|Services Hospital, Lahore||2||IP could not be made available in sufficient quantity for the expected enrollment|f||||t||||||||||2017-02-18 13:30:43.230825|2017-02-18 13:30:43.230825
NCT00823940|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-10-27|||January 2009||2009-01-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects|A Single-blind, Randomized, Placebo Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Healthy Normal Subjects.|Completed||Phase 1|42|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:30:43.355988|2017-02-18 13:30:43.355988
NCT00823927|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-04-20|||March 2006||2006-03-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|HIVE||Alveolar Macrophage Proteomics in HIV-associated Emphysema|Alveolar Macrophage Proteomics in HIV-associated Emphysema|Active, not recruiting||N/A|365|Actual|Ohio State University|||2||f||||t||||||Samples With DNA|"~     blood lung fluid (optional)~   "|||2017-02-18 13:30:43.470947|2017-02-18 13:30:43.470947
NCT00823914|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2013-06-25|||December 2008||2008-12-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life|Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life|Unknown status|Active, not recruiting|N/A|150|Anticipated|Massachusetts General Hospital|||1||f||||t||||||||||2017-02-18 13:30:43.564271|2017-02-18 13:30:43.564271
NCT00823901|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2012-06-19|2011-04-04||February 2009||2009-02-01|June 2012|2012-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea|A Double-Blind, Placebo-Controlled, Pilot Study to Determine the Safety and Efficacy of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel For The Treatment of Rosacea Over 12 Weeks|Completed||Phase 2/Phase 3|83|Actual|Massachusetts General Hospital|This study is limited by relatively small number of subjects. In addition, overall assessment of acne rosacea severity as determined by subjects’ self-assessment was not performed.|2|||f||||t||||||||||2017-02-18 13:30:43.666979|2017-02-18 13:30:43.666979
NCT00823888|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2011-07-19|||September 2008||2008-09-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Mechanics of Knee Bracing|Mechanics of Knee Bracing|Completed||N/A|20|Actual|The New England Baptist Hospital||1|||f||||f||||||||||2017-02-18 13:30:46.321598|2017-02-18 13:30:46.321598
NCT00823875|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2010-11-30|||March 2009||2009-03-01|January 2010|2010-01-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|||Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject|A Randomized, Control, Open Label, Multicentre Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject|Completed||Phase 4|200|Anticipated|Otsuka Beijing Research Institute||4|||f||||f||||||||||2017-02-18 13:30:46.416198|2017-02-18 13:30:46.416198
NCT00823862|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2016-08-23|||October 2008||2008-10-01|August 2016|2016-08-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection|A Phase I, Randomized, Single-Blind, Placebo-Controlled Dose-Escalation Study of SD-101 to Assess the Safety, Pharmacodynamics, and Preliminary Evidence of Anti-Viral Effect in Subjects Diagnosed With Chronic Hepatitis C, Genotype 1|Completed||Phase 1|34|Actual|Dynavax Technologies Corporation||1|||f||||f||||||||Undecided|a/o August 2016, decision still pending|2017-02-18 13:30:46.52281|2017-02-18 13:30:46.52281
NCT00823849|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-04-21|||October 2008||2008-10-01|April 2010|2010-04-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker|A Randomized, Control,Open Label, Multicentre Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker|Completed||Phase 4|200|Actual|Otsuka Beijing Research Institute||4|||f||||f||||||||||2017-02-18 13:30:46.636314|2017-02-18 13:30:46.636314
NCT00823836|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-11-30|2011-09-01||March 2009||2009-03-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease|Clinical Evaluation of Ropinirole PR/XR Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease|Completed||Phase 3|302|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:30:46.777819|2017-02-18 13:30:46.777819
NCT00823823|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-09-02|2014-09-02||January 2009||2009-01-01|September 2014|2014-09-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Randomized Trial of Casting Techniques for Displaced Forearm Fractures|Randomized Trial of Bivalved and Circumferential Casting for Displaced Forearm Fractures in Children|Completed||N/A|202|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 13:30:48.840674|2017-02-18 13:30:48.840674
NCT00823810|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2014-10-08|||December 2008||2008-12-01|October 2014|2014-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|RESCORE||Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT|Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT|Terminated||N/A|20|Actual|Turku University Hospital||1||Recruitment promlems|f||||f||||||||||2017-02-18 13:30:49.231538|2017-02-18 13:30:49.231538
NCT00823797|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-07-28|||October 2008||2008-10-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2015|Actual|2015-12-01||Interventional|||Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma|A Phase II Study of Bendamustine in the Treatment of Recurrent High-Grade Gliomas (Anaplastic Gliomas and Glioblastoma)|Active, not recruiting||Phase 2|47|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 13:30:49.340599|2017-02-18 13:30:49.340599
NCT00823784|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2009-01-15|||January 2008||2008-01-01|January 2009|2009-01-01|July 2009|Anticipated|2009-07-01|January 2009|Anticipated|2009-01-01||Interventional|THD/stapler||Prospective Randomized Trial Comparing THD Versus Stapler Operation for 3rd Degree Hemorrhoids|Prospective Randomized Trial Comparing Transanal Doppler de-Arterialization (THD) Versus Stapler Operation for 3rd Degree Hemorrhoids|Unknown status|Recruiting|Phase 3|270|Anticipated|Societa Italiana di Chirurgia ColoRettale||2|||f||||f||||||||||2017-02-18 13:30:49.460174|2017-02-18 13:30:49.460174
NCT00823771|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2017-01-31|||October 2007||2007-10-01|February 2013|2013-02-01|April 1, 2014|Actual|2014-04-01|October 2012|Actual|2012-10-01||Observational|PROFUGO||A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment|A Pilot Study in the Transfer of Follow-up Reviews to the General Practitioner for Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment|Terminated||N/A|107|Actual|Barwon Health|||2|Data review showed that the study was underpowered to draw clear conlcusions|f||||f||||||||||2017-02-18 13:30:49.57497|2017-02-18 13:30:49.57497
NCT00823758|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2017-01-24|||December 19, 2008|Actual|2008-12-19|January 2017|2017-01-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Observational|||Understanding Patient's Knowledge and Use of Acetaminophen|Understanding Patient's Knowledge and Use of Acetaminophen|Active, not recruiting||N/A|124|Anticipated|M.D. Anderson Cancer Center|||5||f||||f||||||||||2017-02-18 13:30:49.657281|2017-02-18 13:30:49.657281
NCT00823745|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2009-03-06|||January 2009||2009-01-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects|A Phase 1 Study To Evaluate The Metabolism And Excretion Of [14C] PF-00868554 In Healthy Adult Male Subjects|Completed||Phase 1|7|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:30:49.773924|2017-02-18 13:30:49.773924
NCT00823732|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2015-11-04|||October 2008||2008-10-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|Palliative Care for Quality of Life and Symptom Concerns in Late Stage Lung Cancer|Completed||N/A|280|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 13:30:49.875307|2017-02-18 13:30:49.875307
NCT00823719|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-03-07|2012-06-21||May 2009||2009-05-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)|A Single Arm, Safety and Efficacy Study of Ofatumumab in Combination With ICE or DHAP Chemotherapy in Relapsed or Refractory Aggressive Lymphoma Prior to Autologous Stem Cell Transplantation|Completed||Phase 2|61|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 13:30:50.003454|2017-02-18 13:30:50.003454
NCT00823706|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2011-04-04|||January 2009||2009-01-01|January 2009|2009-01-01||||||||Observational|||Prevalence of Angle Closure in Caucasian Hyperopes|Prevalence of Chronic Angle Closure in Caucasian Hyperopic Subjects|Unknown status|Recruiting|N/A|100|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-02-18 13:30:51.628919|2017-02-18 13:30:51.628919
NCT00823693|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-08-20||||||August 2009|2009-08-01||||||||Interventional|||Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis|Multi-center, Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Bimosiamose 5% Cream for the Treatment of Patients With Chronic Plaque Type Psoriasis|Completed||Phase 2|107|Actual|Revotar Biopharmaceuticals AG||2|||f||||||||||||||2017-02-18 13:30:51.709179|2017-02-18 13:30:51.709179
NCT00823680|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-15|2016-07-26||2016-07-26|April 2009||2009-04-01|July 2016|2016-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin|Multi-center, Randomized, Double-blind, 5-arm Parallel Group, Placebo Controlled 4 Week Study to Investigate the Safety, Tolerability and Efficacy of Two Doses Each (Near to Maximum Tolerated Dose and Lower Dose) of RO5093151 Administered Twice Daily (BID Regimen) and RO5027838 Administered Once da|Completed||Phase 2|110|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-02-18 13:30:51.798298|2017-02-18 13:30:51.798298
NCT00823667|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2014-09-18|||September 2009||2009-09-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer That Can Be Removed by Surgery|Palliative Care for Quality of Life and Symptom Concerns in Early Stage Lung Cancer|Completed||N/A|198|Actual|City of Hope Medical Center||2|||f||||f||||||||||2017-02-18 13:30:51.910988|2017-02-18 13:30:51.910988
NCT00823654|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2016-11-04|||January 2009||2009-01-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations|Multi-Center Study of Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer BRCA Mutations|Recruiting||N/A|320|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples Without DNA|"~     blood~   "|||2017-02-18 13:30:52.02272|2017-02-18 13:30:52.02272
NCT00823641|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2013-04-12|||October 2008||2008-10-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|HAM06||The HAM Infliximab Study|An Open, Non-randomised Pilot Study of Anti-TNF-alpha Therapy in Early or Progressing HAM/TSP|Terminated||Phase 2|3|Actual|Imperial College London||1||Higher toxicity rate than observed in studies in Rheumatoid arthritis|f||||t||||||||||2017-02-18 13:30:52.144204|2017-02-18 13:30:52.144204
NCT00823628|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-07-06|||February 2009||2009-02-01|April 2009|2009-04-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide|Comparison of Contrast-medium Induced Nephrotoxicity Between Iodixanol and Iopromide in Patients With Renal Insufficiency Undergoing Coronary Angiography|Completed||Phase 4|420|Anticipated|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-02-18 13:30:52.246238|2017-02-18 13:30:52.246238
NCT00823615|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-06-26|2010-09-07||December 2008||2008-12-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Comparison of Two New Silicone Hydrogel Multifocal Products|Comparison of Two New Silicone Hydrogel Multifocal Products|Completed||N/A|40|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 13:30:52.345029|2017-02-18 13:30:52.345029
NCT00823602|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-14|||March 2008||2008-03-01|January 2009|2009-01-01|January 2009|Anticipated|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH|Comparison Between GnRH Agonist Long Protocol And GnRH Antagonist Protocol In Outcome Of The First Cycle ART|Unknown status|Recruiting|Phase 3|2|Anticipated|Yazd Research & Clinical Center for Infertility||2|||f||||||||||||||2017-02-18 13:30:52.596026|2017-02-18 13:30:52.596026
NCT00823589|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2014-02-24|||January 2009||2009-01-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Immune Status of Elderly Population Admitted in an Acute Geriatric Unit|Immune Status of Elderly Population Admitted in an Acute Geriatric Unit|Completed||N/A|78|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 13:30:52.697109|2017-02-18 13:30:52.697109
NCT00823576|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-05-31|||December 2008||2008-12-01|January 2009|2009-01-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Efficacy of Ropivacaine Continuous Wound Instillation Versus Single Shot After Spine Fusion Surgery|Efficacy of Ropivacaine Continuous Wound Instillation Versus Single Shot After Spine Fusion Surgery|Terminated||Phase 4|64|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:30:52.783246|2017-02-18 13:30:52.783246
NCT00823563|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2014-07-07|||June 2007||2007-06-01|July 2014|2014-07-01||||June 2015|Anticipated|2015-06-01||Observational|||Sex Differences in Coronary Pathophysiology|Sex Differences in Symptomatic Non-Obstructive Coronary Disease: Do Women Have a Unique Coronary Pathophysiology?|Unknown status|Recruiting|N/A|126|Anticipated|Stanford University|||1||f||||t||||||||||2017-02-18 13:30:52.881045|2017-02-18 13:30:52.881045
NCT00823004|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2013-12-20|||June 2008||2008-06-01|December 2013|2013-12-01|October 2009|Actual|2009-10-01|February 2009|Actual|2009-02-01||Interventional|||Antagonist/Letrozole in Poor Responders|GnRH Antagonist /Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing in Vitro Fertilization|Completed||Phase 1/Phase 2|120|Actual|Yazd Research & Clinical Center for Infertility||2|||f||||t||||||||||2017-02-18 13:31:02.696311|2017-02-18 13:31:02.696311
NCT00823550|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-12-15|||January 2009||2009-01-01|January 2009|2009-01-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients|A Randomized, Open Label, Phase IV, Multicenter Study for Efficacy and Safety of Lamivudine Versus Entecarvir Therapy in HBV-related Advanced Liver Disease Patients With High Viral Load and Normal or Slightly Elevated Transaminase|Unknown status|Active, not recruiting|Phase 4|462|Anticipated|Yonsei University||2|||f||||t||||||||||2017-02-18 13:30:52.990749|2017-02-18 13:30:52.990749
NCT00823537|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-01-14|||January 2009||2009-01-01|January 2009|2009-01-01|February 2011|Anticipated|2011-02-01|December 2010|Anticipated|2010-12-01||Interventional|TES||Power-Assisted Therapeutic Electrical Stimulation to Upper Extremities|Power-Assisted Therapeutic Electrical Stimulation to Upper Extremities in Acute Stroke Patients. A Randomized Controlled Trial.|Unknown status|Not yet recruiting|N/A|||Fujita Health University|||||f||||f||||||||||2017-02-18 13:30:53.10781|2017-02-18 13:30:53.10781
NCT00823524|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2013-02-18|||January 2009||2009-01-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer|Donor NK Cell Infusion for Progression/Recurrence of Underlying Malignant Disorders After HLA-haploidentical HCT - a Phase 1-2 Study|Completed||Phase 1/Phase 2|47|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 13:30:53.181523|2017-02-18 13:30:53.181523
NCT00823511|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2015-01-27|||October 2006||2006-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|January 2012|Actual|2012-01-01||Observational|||The Human Papillomavirus (HPV) Transmission Pilot Study|The Human Papillomavirus (HPV) Transmission Pilot Study|Completed||N/A|137|Actual|H. Lee Moffitt Cancer Center and Research Institute|||1||f||||f||||||||||2017-02-18 13:30:53.304748|2017-02-18 13:30:53.304748
NCT00823498|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2017-02-02|||January 2009||2009-01-01|February 2017|2017-02-01||||December 2018|Anticipated|2018-12-01||Observational|||Physical Activity in Public Housing - II|Perceptions of School, Recreation, and Transportation Environments Among African American Families in Public Housing--II|Active, not recruiting||N/A|84|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 13:30:53.404297|2017-02-18 13:30:53.404297
NCT00823485|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-12-08|||October 2005||2005-10-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm Rupture|Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm Rupture|Completed||Phase 2/Phase 3|19|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:30:53.518713|2017-02-18 13:30:53.518713
NCT00823472|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2010-11-02|2010-11-02||January 2009||2009-01-01|January 2009|2009-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|LITE||Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)|Among IVF Patients Undergoing Fixed Antagonist Protocols With Recombinant FSH, Does Administration of Recombinant FSH From Cycle Day 5 Onwards Compared With Cycle Day 2 Onwards, Yield a Higher Number of Good Quality Embryos?|Terminated||Phase 4|147|Actual|UMC Utrecht|Early termination of the trial lead to small number of subjects to be analyzed. Only half of the expected patients were included.|2||"Inclusion of the study didn't go as fast as expected. Expect: 234 patients in 1 year in 2~   centers. After 1,5 year only 147 patients were recruited."|f||||t||||||||||2017-02-18 13:30:53.611895|2017-02-18 13:30:53.611895
NCT00823459|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-02-16|||January 2009||2009-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|RAD001||Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma|Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma|Completed||Phase 2|58|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 13:30:54.036263|2017-02-18 13:30:54.036263
NCT00823446|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-06-22|||March 2008||2008-03-01|June 2012|2012-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers|A Feasibility, Double Blind, Randomized, Controlled Clinical Study to Evaluate the Safety of Topically Applied Revera vs. Control in Subjects With Venous Leg Ulcers.|Completed||Phase 1|13|Actual|Revalesio Corporation||2|||f||||f||||||||||2017-02-18 13:30:54.146948|2017-02-18 13:30:54.146948
NCT00823433|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-11-02|||January 2009||2009-01-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood|Does Oral Penicillin Reach and Simulate Intravenous Penicillin Levels in Venous Umbilical Cord Blood of Laboring Pregnant Patients?|Terminated||Early Phase 1|25|Actual|William Beaumont Hospitals||1||Insufficient enrollment.|f||||t||||||||||2017-02-18 13:30:54.246228|2017-02-18 13:30:54.246228
NCT00823420|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-12-04|||May 2009||2009-05-01|January 2009|2009-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential|Influence of a Prematuration Culture With a PDE3-I on Embryonic Aneuploidy Rate and Developmental Potential|Terminated||Phase 1|213|Actual|Universitair Ziekenhuis Brussel||1||"The Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) has been replaced by a~   different formulation"|f||||t||||||||||2017-02-18 13:30:54.370109|2017-02-18 13:30:54.370109
NCT00823407|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2013-05-29|||January 2009||2009-01-01|May 2013|2013-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|MDA||Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]|Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]|Completed||N/A|12|Actual|California Pacific Medical Center Research Institute||1|||f||||f||||||||||2017-02-18 13:30:54.463063|2017-02-18 13:30:54.463063
NCT00823394|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2016-09-12|||December 2008||2008-12-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Observational|||African American Church-based Cohort|African American Cancer Prevention Project: Establishing a Cohort to Investigate Health Disparities|Active, not recruiting||N/A|1501|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:30:54.57545|2017-02-18 13:30:54.57545
NCT00823381|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-12-09|||January 2009||2009-01-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Resvida||Effect of Resvida, a Comparison With Calorie Restriction Regimen|Effect of Resvida(tm) Dietary Supplementation on Muscle Gene Expression: A Comparison With Calorie Restriction Regimen|Completed||N/A|58|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 13:30:54.681758|2017-02-18 13:30:54.681758
NCT00823368|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-07-30|||January 2009||2009-01-01|July 2013|2013-07-01||||March 2010|Actual|2010-03-01||Observational|||Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001|Biomarker Testing and DNA Collection in Subjects Participating in a Double-Blind, Placebo-Controlled, Crossover, Flexible-Dose Evaluation of the Efficacy, Safety, and Tolerability of STX209 in the Treatment of Irritability in Subjects With Fragile X Syndrome|Completed||N/A|||Seaside Therapeutics, Inc.|||2||f||||t||||||Samples With DNA|"~     DNA from blood,plasma~   "|||2017-02-18 13:30:54.784463|2017-02-18 13:30:54.784463
NCT00823355|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-09-20|||January 2009||2009-01-01|September 2013|2013-09-01||||August 2013|Actual|2013-08-01||Interventional|||Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies|A Phase I, Open Label, Dose Ascending Study of BCX1777 (Oral) in Patients With Recurrent or Refractory T/NK-cell Malignancies|Completed||Phase 1|24|Anticipated|Mundipharma K.K.||1|||f||||f||||||||||2017-02-18 13:30:54.88731|2017-02-18 13:30:54.88731
NCT00823342|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-05-07|||December 2008||2008-12-01|May 2009|2009-05-01|September 2011|Anticipated|2011-09-01|March 2011|Anticipated|2011-03-01||Interventional|||ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy|ANRS HB 05 : A Randomized, Double Blind, Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy|Terminated||Phase 3|150|Anticipated|French National Agency for Research on AIDS and Viral Hepatitis||3|||f||||t||||||||||2017-02-18 13:30:54.989093|2017-02-18 13:30:54.989093
NCT00823329|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-10-10|||October 2012||2012-10-01|October 2012|2012-10-01|October 2012||2012-10-01|October 2012||2012-10-01||Interventional|PCMMS||Calorie Balance Monitoring and Analysis of Body Composition and Hydration Status|Calorie Balance Monitoring and Analysis of Body Composition and Hydration|Suspended||Early Phase 1|10|Anticipated|Ori Diagnostic Instruments LLC||1||lack of funding|f||||f||||||||||2017-02-18 13:30:55.307476|2017-02-18 13:30:55.307476
NCT00823316|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-04-20|||August 2008||2008-08-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation|Phase 1/2 Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells Infusion for Promotion of Engraftment and Prevention of an Graft Rejection and Graft-versus-Host Disease After Unrelated Hematopoietic Stem Cell Transplantation.|Completed||Phase 1/Phase 2|10|Actual|Medipost Co Ltd.||2|||f||||t||||||||||2017-02-18 13:30:55.394473|2017-02-18 13:30:55.394473
NCT00823303|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2014-08-04|2014-06-05||February 2009||2009-02-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|PACE|Stage 3 and 4 CKD with SHPT, age >18, a stable dose of phosphate binder (if receiving a binder), estimated glomerular filtration rate (eGFR) of 15-59 mL/min using the abbreviated MDRD equation, PTH >120 pg/mL, albumin-corrected calcium >8.5 mg/dL and <10.0 mg/dL, phosphorus <4.6 mg/dL.|Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)|A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism|Completed||Phase 4|110|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 13:30:55.500045|2017-02-18 13:30:55.500045
NCT00823290|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-01-11|||January 2009||2009-01-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)|A Phase I Trial of Sorafenib and LBH589 in the Treatment of Advanced HCC|Unknown status|Recruiting|Phase 1|18|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-02-18 13:30:55.937202|2017-02-18 13:30:55.937202
NCT00823277|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2014-04-30|||January 2009||2009-01-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight|Indicators for the Metabolic Syndrome as Well as the Influence of Different Gen-polymorphs on Weightloss and the Maintenance of Lower Weight Among Children in Treatment for Overweight|Completed||N/A|517|Actual|Zealand University Hospital|||1||f||||f||||||Samples With DNA|"~     Blood samples of Whoole Blood.~   "|||2017-02-18 13:30:56.029978|2017-02-18 13:30:56.029978
NCT00823251|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2015-01-07|||December 2008||2008-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:30:56.135224|2017-02-18 13:30:56.135224
NCT00823238|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2011-04-15|||July 2004||2004-07-01|April 2011|2011-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|CAPEC||Comparison of Antibiotics for Pseudomonas in Early CF|Comparison of Antibiotics for Pseudomonas in Early CF|Completed||Phase 1|21|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 13:30:56.184704|2017-02-18 13:30:56.184704
NCT00823225|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2015-03-12|||June 2008||2008-06-01|March 2015|2015-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Urokinase Therapy in Patients With Diabetic Foot Syndrome|Low Dose Urokinase Therapy in Patients With Diabetic Foot Syndrome and Critical Limb Ischemia Versus Conventional Standard Therapy|Terminated||Phase 3|5|Actual|medac GmbH||2||Insufficient recruitment of study patients|f||||f||||||||||2017-02-18 13:30:56.28774|2017-02-18 13:30:56.28774
NCT00823212|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-01-29|2011-12-21||January 2009||2009-01-01|January 2014|2014-01-01|November 2014|Anticipated|2014-11-01|September 2010|Actual|2010-09-01||Interventional|PLATINUM||The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions|PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) for the Treatment of up to Two De Novo Coronary Artery Lesions|Unknown status|Active, not recruiting|Phase 3|1530|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 13:30:56.422033|2017-02-18 13:30:56.422033
NCT00823199|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2015-07-20|2012-04-25||November 2005||2005-11-01|July 2015|2015-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia|An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia|Completed||N/A|10|Actual|Bronx Psychiatric Center||1|||f||||f||||||||||2017-02-18 13:30:59.596886|2017-02-18 13:30:59.596886
NCT00823186|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2010-01-03|||February 2009||2009-02-01|January 2009|2009-01-01|January 2013|Anticipated|2013-01-01|January 2012|Anticipated|2012-01-01||Interventional|Chemothreapy||Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical Cancer|Phase I Dose Escalation Study Of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in FIGO IB2 and Bulky IIA Cervical Cancer|Unknown status|Enrolling by invitation|Phase 1|21|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-02-18 13:30:59.844133|2017-02-18 13:30:59.844133
NCT00823173|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-05-25|||January 2009||2009-01-01|September 2010|2010-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis|An Open Label Exploratory Study to Assess the Safety, Tolerability and Clinical Activity of Topically Applied ESBA105 in Patients With Acute Anterior Uveitis|Completed||Phase 2|9|Actual|ESBATech AG||1|||f||||f||||||||||2017-02-18 13:30:59.954778|2017-02-18 13:30:59.954778
NCT00823160|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-02-18|||October 2001||2001-10-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Surgical Management of Blood in the Pericardial Sac After Penetrating Trauma|A Randomized Prospective Study of the Definitive Management of the Stable Haemopericardium Following Penetrating Cardiac Injury Utilising Subxyphoid Window and Drainage.|Completed||N/A|111|Actual|University of Cape Town||2|||f||||t||||||||||2017-02-18 13:31:00.091356|2017-02-18 13:31:00.091356
NCT00823147|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-09-11|||January 2009||2009-01-01|September 2009|2009-09-01|June 2020|Anticipated|2020-06-01|June 2010|Anticipated|2010-06-01||Observational|||Pain Catastrophizing as a Cause for Systemic Inflammation|Pain Catastrophizing as a Cause for Systemic Inflammation|Recruiting||N/A|60|Anticipated|Oregon Health and Science University|||2||f||||f||||||Samples With DNA|"~     Whole Blood, saliva~   "|||2017-02-18 13:31:00.244865|2017-02-18 13:31:00.244865
NCT00823134|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2011-10-31|||December 2008||2008-12-01|January 2009|2009-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Evaluation of ApneaLink Plus Scoring Capabilities|Evaluation of ApneaLink Plus Scoring Capabilities|Completed||N/A|30|Anticipated|ResMed|||1||f||||f||||||||||2017-02-18 13:31:00.372542|2017-02-18 13:31:00.372542
NCT00823121|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-01-19|||August 2008||2008-08-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|February 2009|Anticipated|2009-02-01||Interventional|||Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification|Can Fresh Embryo Transfers be Replaced by Cryopreserved-thawed Embryo Transfers in Assisted Reproductive Cycles?|Unknown status|Recruiting|Phase 1/Phase 2|500|Anticipated|Yazd Research & Clinical Center for Infertility||2|||f||||t||||||||||2017-02-18 13:31:00.466715|2017-02-18 13:31:00.466715
NCT00823108|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2011-05-31|||March 2009||2009-03-01|May 2011|2011-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Rapid Administration of Insulin in Sepsis|Rapid Administration of Insulin in Sepsis: A Pilot Study|Completed||Phase 1|20|Anticipated|Carolinas Healthcare System||2|||f||||t||||||||||2017-02-18 13:31:00.584314|2017-02-18 13:31:00.584314
NCT00823095|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-01-28|2013-08-02||December 2005||2005-12-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Topical Nitric Oxide Trial in Chronic Non-Healing Wounds|The Observational Effects of the Topical Application of ViaNOx-H (Gaseous Nitric Oxide) on the Bio-Burden in Chronic Non-Healing Colonized Ulcers of the Lower Extremities|Terminated||Phase 2|7|Actual|Loma Linda University|No data available for this study due to dissolution of company contracted to perform study analysis.|1||Subject recuitment halted and won't resume; subjects are no longer being treated.|f||||t||||||||||2017-02-18 13:31:00.683002|2017-02-18 13:31:00.683002
NCT00823082|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2016-08-10|2016-04-05||June 2009||2009-06-01|August 2016|2016-08-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional||206 subjects were randomized; six were screen failures. 100 subjects in the Anbinex treatment group and 94 subjects in the control group were included in the Intent-to-treat and Per-protocol populations (6 subjects in the control group were excluded). 199 subject were included in the Safety population (100 Anbinex and 99 control).|Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass|A Prospective Randomized Pilot Study to Evaluate the Effect of Preoperative Antithrombin Supplementation on Postoperative Levels of Antithrombin in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Completed||Phase 2|200|Actual|Grifols Biologicals Inc.||2|||f||||f||||||||||2017-02-18 13:31:00.948703|2017-02-18 13:31:00.948703
NCT00823069|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-11-01|2010-08-25||January 2009||2009-01-01|November 2010|2010-11-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose|A Randomized, Double-Blind Study Comparing Safety and Tolerability of Perlane® With and Without Addition of 0.3% Lidocaine HCL During Correction of Nasolabial Folds|Completed||N/A|60|Actual|Medicis Global Service Corporation||1|||f||||f||||||||||2017-02-18 13:31:01.787768|2017-02-18 13:31:01.787768
NCT00823056|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2012-04-22|||January 2009||2009-01-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Effect of Probiotics on Infections in Toddlers|The Effect of Probiotics on Infections in Toddlers|Completed||Phase 3|454|Actual|Zealand University Hospital||2|||f||||f||||||||||2017-02-18 13:31:02.036359|2017-02-18 13:31:02.036359
NCT00823043|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2015-02-18|2010-08-02||January 2009||2009-01-01|February 2015|2015-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs|A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With Timolol Hemihydrate 0.5% Solution Once or Twice Daily Versus Timolol Maleate in Sorbate|Completed||N/A|103|Actual|Vistakon Pharmaceuticals|||2||f||||f||||||||||2017-02-18 13:31:02.152583|2017-02-18 13:31:02.152583
NCT00823030|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2015-10-12|||January 2009||2009-01-01|October 2015|2015-10-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis|Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis|Withdrawn||N/A|0|Actual|Northwell Health||2|||f||||f||||||||||2017-02-18 13:31:02.470777|2017-02-18 13:31:02.470777
NCT00823017|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-07-22|||July 2006||2006-07-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|MTS2||Effect of Music on Patients in Intensive Care Units|The Effect of Patient-Preferred Music, Relaxation Music, and Standard Care Environment on Patients in Intensive Care Units|Completed||Phase 1|40|Anticipated|MetroHealth Medical Center||3|||f||||f||||||||||2017-02-18 13:31:02.589023|2017-02-18 13:31:02.589023
NCT00822991|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2010-12-29|||January 2009||2009-01-01|January 2009|2009-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Sonazoid Enhanced Liver Cancer Trial for Early Detection|Sonazoid Enhanced Liver Cancer Trial for Early Detection|Recruiting||N/A|760|Anticipated|Japan Liver Oncology Group||2|||f||||t||||||||||2017-02-18 13:31:02.812429|2017-02-18 13:31:02.812429
NCT00822978|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-02-24|||January 2009||2009-01-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase 1 Study for Safety of ACHN-490|A Double-Blind, Randomized, Placebo-controlled, Parallel-Group, Single and Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-490 Injection Administered Intravenously in Healthy Volunteers|Completed||Phase 1|39|Actual|Achaogen, Inc.||2|||f||||f||||||||||2017-02-18 13:31:02.92668|2017-02-18 13:31:02.92668
NCT00822965|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-01-05|||January 2009||2009-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Enhancing Knowledge Implantable Cardioverter-Defibrillators (ICDs)|Patient Knowledge of Pacemaker/Implantable Cardioverter-Defibrillator-Phase II|Completed||N/A|104|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:31:03.011919|2017-02-18 13:31:03.011919
NCT00822952|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2014-03-28|||October 2008||2008-10-01|March 2014|2014-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|PMI||Prostate Mechanical Imager (PMI) Clinical Bridging Study|Prostate Mechanical Imager (PMI) Clinical Bridging Study|Completed||N/A|71|Actual|Artann Laboratories|||1||f||||f||||||||||2017-02-18 13:31:03.116324|2017-02-18 13:31:03.116324
NCT00822926|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2013-05-14|||January 2009||2009-01-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial|Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial|Suspended||N/A|20|Anticipated|Stanford University||2||Further enrollment is pending analysis of another trial|f||||||||||||||2017-02-18 13:31:03.218675|2017-02-18 13:31:03.218675
NCT00822913|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2009-01-14|||June 2008||2008-06-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|Botox-PD||Botulinum A Toxin in Patients With Parkinson's Disease|The Use of Toxin Botulinum A Toxin in Patients With Parkinson's Disease and Multiple System Disease, Affected by Refractory Detrusor Overactivity.|Unknown status|Enrolling by invitation|Phase 4|20|Anticipated|University Of Perugia||1|||f||||t||||||||||2017-02-18 13:31:03.335025|2017-02-18 13:31:03.335025
NCT00822900|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2015-12-16|2015-04-01||March 2010||2010-03-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|ProTECT||Progesterone for the Treatment of Traumatic Brain Injury III|Phase 3 Clinical Trial to Determine if Progesterone Along With Standard Medical Care for Brain Injury is More Effective at Limiting the Amount of Damage Cause by a Traumatic Brain Injury Than Standard Medical Care Alone.|Terminated||Phase 3|882|Actual|Emory University|The trial was stopped early for futility with respect to the primary outcome.|2||futility: low conditional power to demonstrate benefit of progesterone|f||||t||||||||||2017-02-18 13:31:03.451765|2017-02-18 13:31:03.451765
NCT00822887|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-06-24|||March 2007||2007-03-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|May 2010|Actual|2010-05-01||Interventional|IRUSZACT0073||Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas|A Phase I Dose Escalation Study of Vandetanib (ZACTIMA, ZD6474) With Hypofractionated Stereotactic Radiotherapy in Patients With Recurrent Malignant Gliomas|Completed||Phase 1|13|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-02-18 13:31:07.564684|2017-02-18 13:31:07.564684
NCT00822874|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-12-02|||January 2009||2009-01-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential|Influence of a Prematuration Culture With a PDE3-I on Embryonic Aneuploidy Rate and Developmental Potential - a Pilot Study|Terminated||Phase 1|115|Actual|Universitair Ziekenhuis Brussel||1||"Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) has been replaced by other~   system"|f||||t||||||||||2017-02-18 13:31:07.671747|2017-02-18 13:31:07.671747
NCT00822861|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-11-14|||April 2009||2009-04-01|November 2013|2013-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma|A Single Center, Open Label, Stepwise, Dose Profiling Study to Evaluate the Efficacy and Safety of Four Dose Regimens of Inhaled TPI ASM8 in Patients With Allergic Asthma|Completed||Phase 2|14|Actual|Pharmaxis||4|||f||||t||||||||||2017-02-18 13:31:07.767445|2017-02-18 13:31:07.767445
NCT00822848|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-14|2016-08-09|||February 2009||2009-02-01|August 2016|2016-08-01||||September 2012|Actual|2012-09-01||Interventional|||Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma|Antiangiogenic Potentiation of Preoperative Chemoradiotherapy for High Risk Extremity Soft Tissue Sarcomas: A Phase I Study of Sorafenib With Epirubicin, Ifosfamide, Hypofractionated Radiation, and Surgery|Active, not recruiting||Phase 1|18|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 13:31:07.879054|2017-02-18 13:31:07.879054
NCT00822835|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-09-17|||January 2009||2009-01-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study Evaluating Single Doses of ILV-095 in Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ILV-095 Administered Subcutaneously to Healthy Subjects|Completed||Phase 1|48|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:31:08.019914|2017-02-18 13:31:08.019914
NCT00822822|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-11-21|||March 2006||2006-03-01|October 2010|2010-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess|Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assessment|Completed||N/A|17|Actual|H. Lee Moffitt Cancer Center and Research Institute|||1||f||||f||||||||||2017-02-18 13:31:08.11042|2017-02-18 13:31:08.11042
NCT00822809|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2012-10-02|||December 2008||2008-12-01|August 2012|2012-08-01|April 2011|Actual|2011-04-01|November 2010|Actual|2010-11-01||Interventional|CASIMAS||CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers|Two-arm, Randomized, Open-label, Phase IIIb Study Investigating the Safety of a 3 Hour i.p. Infusion of Catumaxomab With and Without Prednisolone Premedication in Patients With Malignant Ascites Due to Epithelial Cancer|Completed||Phase 3|230|Actual|Neovii Biotech||2|||f||||t||||||||||2017-02-18 13:31:08.223973|2017-02-18 13:31:08.223973
NCT00822796|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-07-22|||September 2008||2008-09-01|July 2013|2013-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Thermogard™ Efficacy Trial|Thermogard™ Efficacy Trial|Terminated||N/A|9|Actual|Brooke Army Medical Center||2||Difficulty in obtaining surrogate consent on critically ill subjects.|f||||t||||||||||2017-02-18 13:31:08.340777|2017-02-18 13:31:08.340777
NCT00822783|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||October 2001||2001-10-01|January 2009|2009-01-01|April 2003||2003-04-01|||||Interventional|||Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients|An Exploratory 16 Week, Double Blind, Placebo-Controlled Single Center Mechanistic Study to Determine the Effect of Rhumab-E25 on Phenotype and Function of IgE Mediated Antigen Presentation by Dendritic Cells in Subjects With Atopic Dermatitis.|Completed||Phase 4|||Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:31:08.454696|2017-02-18 13:31:08.454696
NCT00822770|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-06-13|2014-06-13||January 2009||2009-01-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin|G-CSF and Plerixafor With Busulfan and Fludarabine for Allogeneic Stem Cell Transplantation for Myeloid Leukemias|Completed||Phase 1/Phase 2|47|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 13:31:08.560408|2017-02-18 13:31:08.560408
NCT00822757|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2015-10-01|2011-06-22||August 2007||2007-08-01|October 2015|2015-10-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Immunogenicity Study of V710 Lyophilized Formulation (V710-004)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Single Dose of the Lyophilized Formulation of Merck Staphylococcus Aureus Vaccine (V710) in Healthy Adults|Completed||Phase 1|51|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:31:09.009881|2017-02-18 13:31:09.009881
NCT00822744|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-03-14|||December 2008||2008-12-01|March 2013|2013-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|FIDELIO||An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients|An Eight-week, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-finding Study, With Escitalopram (10 mg Daily) as Active Control, to Evaluate the Efficacy, Safety and Tolerability of Three Fixed Doses of SSR411298 (10, 50, or 200 mg Daily) in Elderly Patients With Major Depressive Disorder|Completed||Phase 2|527|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 13:31:09.486522|2017-02-18 13:31:09.486522
NCT00822731|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2012-05-22|||September 2008||2008-09-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SMC-LCS||Samsung Medical Center-Lymphoma Cohort Study|Development of a Predictive Model for Treatment Outcome and Treatment-related Morbidity in a Prospective Cohort Study of Patients With Lymphoma|Completed||N/A|953|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 13:31:09.604792|2017-02-18 13:31:09.604792
NCT00822718|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-13|||January 2005||2005-01-01|January 2009|2009-01-01|July 2007|Actual|2007-07-01|||||Observational|||Obestatin Change in Distal Gastrectomy||Completed||N/A|100|Actual|Samsung Medical Center|||||f||||t||||||||||2017-02-18 13:31:09.713819|2017-02-18 13:31:09.713819
NCT00822705|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||August 2008||2008-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36|Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36: a Phase 1 Study|Completed||Phase 1/Phase 2|16|Actual|University Hospital, Basel, Switzerland||4|||f||||f||||||||||2017-02-18 13:31:09.804154|2017-02-18 13:31:09.804154
NCT00822692|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2015-12-17|2009-07-29||July 2008||2008-07-01|December 2015|2015-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection|Prospective Randomized Double Blind, Placebo-Controlled Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection on 30 Day Recurrence Rates.|Completed||N/A|139|Actual|Wilford Hall Medical Center||2|||f||||f||||||||||2017-02-18 13:31:09.904874|2017-02-18 13:31:09.904874
NCT00822679|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2016-10-26|2016-10-26||October 2007||2007-10-01|October 2016|2016-10-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome|Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome|Completed||Phase 4|5|Actual|University of Arizona|Zero subjects were randomized. Many potential participants screen-failed. Study was closed due to difficulty with recruitment.|2|||f||||f||||||||||2017-02-18 13:31:10.283497|2017-02-18 13:31:10.283497
NCT00822666|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-12-10|||October 2008||2008-10-01|January 2009|2009-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|CLOVIS2||Clopidogrel and Response Variability Investigation Study 2|Effect of the Genetic Variant 2C19*2 on Clopidogrel Biological Response in Patients With Premature Coronary Artery Disease|Completed||Phase 3|109|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:31:10.525203|2017-02-18 13:31:10.525203
NCT00822653|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-09-22|||June 2008||2008-06-01|September 2016|2016-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effects of Plantar Stimulation on Hypotension, Treatment Efficacy and Quality of Life With Adults on Hemodialysis|the Effects of Plantar Stimulation on Hypotension, Treatment Efficacy and Quality of Life|Withdrawn||N/A|0|Actual|Binghamton University||1||Original principal investigator left the university before enrollment started|f||||f||||||||Yes|Team is willing to share anonymous data with interested investigators|2017-02-18 13:31:10.636562|2017-02-18 13:31:10.636562
NCT00822640|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-05-13|||March 2004||2004-03-01|May 2013|2013-05-01|July 2008|Actual|2008-07-01|June 2007|Actual|2007-06-01||Interventional|||Comparison of Rotating vs. Fixed Platform of the COLUMBUS Knee Prosthesis|Clinical Outcome With Attention to Functional Results One Year After Fixed or Mobile Bearing Total Knee Replacement in a Randomized Controlled Trial|Completed||Phase 4|100|Actual|Aesculap AG||2|||f||||f||||||||||2017-02-18 13:31:10.732449|2017-02-18 13:31:10.732449
NCT00822627|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-13|||November 2007||2007-11-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Influenza Vaccination in the Emergency Department|Influenza Vaccination in the Emergency Department|Completed||N/A|140|Actual|University of Arizona||2|||f||||f||||||||||2017-02-18 13:31:10.844735|2017-02-18 13:31:10.844735
NCT00822614|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-13|||December 2008||2008-12-01|January 2009|2009-01-01|January 2010|Anticipated|2010-01-01|December 2009|Anticipated|2009-12-01||Interventional|FINDS||Safety of Fentanyl TAIFUN Treatment|The Safety of Fentanyl TAIFUN Treatment After Titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients|Unknown status|Recruiting|Phase 3|500|Anticipated|Akela Pharma, Inc.||2|||f||||f||||||||||2017-02-18 13:31:10.948437|2017-02-18 13:31:10.948437
NCT00822601|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-07-30|||November 2008||2008-11-01|January 2009|2009-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|TMS-TOC||Study of Repetitive Transcranial Magnetic Stimulation Efficacy on Obsessive Compulsive Disorder (OCD)|A Controlled Study of rTMS Over Supplementary Motor Area (SMA) in Obsessive Compulsive Disorder|Completed||Phase 2|40|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:31:11.049278|2017-02-18 13:31:11.049278
NCT00822588|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-09-27|2011-02-18||May 2009||2009-05-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not|A Prospective, Randomized, Controlled Trial of Retransfusion of Intra-operatively Collected Filtered Whole Blood in Total Hip Surgery|Completed||N/A|227|Actual|Wellspect HealthCare||2|||f||||f||||||||||2017-02-18 13:31:11.156558|2017-02-18 13:31:11.156558
NCT00822575|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||April 2008||2008-04-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of a Device to Relieve Mosquito Bite Itching.|Relief From Itching of Mosquito Bites Clinical Study Protocol.|Completed||N/A|60|Actual|Ecobrands, Ltd.||2|||f||||f||||||||||2017-02-18 13:31:11.614155|2017-02-18 13:31:11.614155
NCT00822562|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2016-03-30|||January 2009||2009-01-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|January 2009|Actual|2009-01-01||Interventional|||Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer|Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer|Completed||N/A|100|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:31:11.717599|2017-02-18 13:31:11.717599
NCT00822549|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-12-10|||September 2006||2006-09-01|January 2009|2009-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Pharmacokinetic, Pharmacodynamic and Pharmacogenetic of Morphine After Surgery|Assessment of the Pharmacokinetic, Pharmacodynamic, Pharmacogenetic Relationships of Morphine and Metabolites After Severe Postoperative Pain in Adults|Completed||N/A|438|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 13:31:11.818253|2017-02-18 13:31:11.818253
NCT00822536|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-10-16|||January 2009||2009-01-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|OPTIDUAL||Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation|Optimal Duration of Dual Antiplatelet Therapy After Drug Eluting Stent (DES) Implantation|Completed||Phase 4|1798|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:31:11.920982|2017-02-18 13:31:11.920982
NCT00822523|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2016-08-05|2015-10-16||January 2009||2009-01-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|March 2009|Actual|2009-03-01||Interventional|||Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies|Strain Gauge Feasibility Assessment & Correlation With Compound Muscle Action Potential & Surface Electromyogram Parameters Before & After a Single Intramuscular Injection of Botulinum Toxin Type A Into Extensor Digitorum Brevis Muscle|Completed||N/A|13|Actual|Loma Linda University||3|||f||||f||||||||No||2017-02-18 13:31:12.041337|2017-02-18 13:31:12.041337
NCT00822510|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2016-06-22|2015-11-30||September 2006||2006-09-01|June 2016|2016-06-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Telephone Counseling: Men With Prostate Cancer & Partners|Telephone Counseling With Men With Prostate Cancer and Partners|Completed||Phase 1|79|Actual|University of Arizona||2|||f||||t||||||||No||2017-02-18 13:31:13.217679|2017-02-18 13:31:13.217679
NCT00822497|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2010-07-22|||October 2004||2004-10-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|MTS1||Efficacy of Music Therapy Protocols for Burn Debridement|The Efficacy of Music Therapy Protocols for Decreasing Pain, Anxiety, and Muscle Tension Levels During Burn Debridement: A Prospective Randomized Crossover Trial|Completed||Phase 1|50|Anticipated|MetroHealth Medical Center||3|||f||||f||||||||||2017-02-18 13:31:13.831522|2017-02-18 13:31:13.831522
NCT00822484|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2011-05-04|||February 2009||2009-02-01|May 2011|2011-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study Evaluating Single Doses of ILV-095 in Healthy Japanese Male Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ILV-095 Administered Subcutaneously to Healthy Japanese Male Subjects|Completed||Phase 1|48|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:31:13.935323|2017-02-18 13:31:13.935323
NCT00822471|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-13|||January 2003||2003-01-01|January 2009|2009-01-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||"Feasibility and Impact of ABCs of Diabetes Self-Management Education Program at an Urban Public Library"|"Feasibility and Impact of of ABC's of Diabetes Self Management Education (DSME) Program for African Americans at an Urban Public Library on A1C, Lipid Lowering Agent Prescriptions and Emergency Department Visits"|Completed||N/A|360|Actual|Medstar Health Research Institute||1|||f||||f||||||||||2017-02-18 13:31:14.032173|2017-02-18 13:31:14.032173
NCT00822458|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-04-01|||January 2009||2009-01-01|June 2013|2013-06-01||||September 2013|Actual|2013-09-01||Interventional|||GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment|A Phase I Pharmacokinetic and Safety Study in Children With Recurrent or Refractory Medulloblastoma to Identify a Pharmacokinetic Based Dose for GDC-0449|Completed||Phase 1|34|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:31:14.143017|2017-02-18 13:31:14.143017
NCT00822445|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-10-30|||June 2008||2008-06-01|February 2008|2008-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|S100||S100 Protein in Minor/Mild Traumatic Brain Injury|Diagnostic Value and Prognostic Value of the Blood Level Determination of S100 Protein in Minor or Mild Traumatic Brain Injury (GCS Glasgow Score 9 to 15).|Completed||N/A|500|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 13:31:14.255384|2017-02-18 13:31:14.255384
NCT00822432|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-07-30|||October 2007||2007-10-01|January 2009|2009-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|COMETH||Coproporphyrine Isomers and Methotrexate Elimination|Urinary Ratio of the Coproporphyrins Isomers I and III and Its Relationships With Methotrexate Elimination in Patients With a Lymphoid Malignancy|Completed||N/A|85|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"~     blood~   "|||2017-02-18 13:31:14.348205|2017-02-18 13:31:14.348205
NCT00822419|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||February 2009||2009-02-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Percutaneous Ketamine Versus Lidocaine for Mid-Sternotomy||Unknown status|Not yet recruiting|Phase 4|75|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||f||||||||||2017-02-18 13:31:14.456953|2017-02-18 13:31:14.456953
NCT00822406|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-26|||July 2002||2002-07-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|||||Interventional|||Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis|Quantitative-Qualitative Clinical Trial to Evaluate the Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis|Completed||Phase 4|41|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:31:14.559349|2017-02-18 13:31:14.559349
NCT00822393|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2017-01-20|||November 2008||2008-11-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|January 2019|Anticipated|2019-01-01||Interventional|||Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)|Clinical Phase III Trial to Compare Treosulfan-based Conditioning Therapy With Busulfan-based Reduced-intensity Conditioning (RIC) Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With AML or MDS Considered Ineligible to Standard Conditioning Regimens|Active, not recruiting||Phase 3|570|Actual|medac GmbH||2|||f||||t||||||||Undecided||2017-02-18 13:31:14.646056|2017-02-18 13:31:14.646056
NCT00822380|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||March 2003||2003-03-01|January 2009|2009-01-01|November 2004|Actual|2004-11-01|November 2003|Actual|2003-11-01||Interventional|||Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children|Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children: A Randomized Clinical Trial|Completed||N/A|680|Actual|Universidad Autonoma de Queretaro||1|||f||||f||||||||||2017-02-18 13:31:14.788505|2017-02-18 13:31:14.788505
NCT00822367|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||May 2006||2006-05-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||Blood Sugar Response to Commercial Nutritional Supplements in Patients With Type 2 Diabetes|Assessment of Glycemic Response to Commercial Nutritional Supplements in Patients With Type 2 Diabetes Mellitus|Completed||N/A|19|Actual|Walter Reed Army Medical Center||1|||f||||f||||||||||2017-02-18 13:31:14.872137|2017-02-18 13:31:14.872137
NCT00822354|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-31|2014-12-02|2014-09-11||September 2008||2008-09-01|December 2014|2014-12-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|||Tadalafil for the Treatment of Raynaud's|Tadalafil for the Treatment of Secondary Raynaud's Phenomenon|Completed||N/A|10|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 13:31:14.974146|2017-02-18 13:31:14.974146
NCT00822341|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-03-25|||April 2008||2008-04-01|March 2014|2014-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Sequential Ascending Single Intravenous Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TG-0054 in Healthy Subjects|Completed||Phase 1|64|Actual|TaiGen Biotechnology Co., Ltd.||1|||f||||||||||||||2017-02-18 13:31:15.49065|2017-02-18 13:31:15.49065
NCT00822328|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-08-27|2009-03-23||January 2009||2009-01-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Fermented Milk Drink on Human Intestinal Microflora|Effects of a Fermented Milk Drink Containing Lactobacillus Casei Strain Shirota on the Human Intestinal Microflora|Completed||Phase 2|24|Actual|Cheng Hsin Rehabilitation Medical Center||2|||f||||f||||||||||2017-02-18 13:31:15.572201|2017-02-18 13:31:15.572201
NCT00822315|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-07-16|||July 2009||2009-07-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis|Phase II Open-label Randomized Multicenter Trial to Compare the Efficacy and Safety of Two Different Doses of Raltegravir and Efavirenz, All in Combination With Tenofovir and Lamivudine, in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis|Completed||Phase 2|155|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||3|||f||||t||||||||||2017-02-18 13:31:15.956458|2017-02-18 13:31:15.956458
NCT00822302|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2015-06-05|||February 2006||2006-02-01|January 2009|2009-01-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|REVEAL||Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia|Does recHDL Given i.v. Before CEA Prevent Cerebral Ischaemia? - the Reveal Study.|Completed||N/A|40|Actual|St George's, University of London||2|||f||||t||||||||||2017-02-18 13:31:16.27365|2017-02-18 13:31:16.27365
NCT00822289|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2009-01-13|||February 2009||2009-02-01|January 2009|2009-01-01||||||||Observational|||The Effect of Radioactive Iodine Administration for Thyroid Diseases on H.Pylori Eradication|Effect of Radioactive Iodine on Eradication of Helicobacter Pylori in Patients Treated for Thyroid Diseases|Unknown status|Enrolling by invitation|N/A|120|Anticipated|Rabin Medical Center|||1||f||||f||||||||||2017-02-18 13:31:16.380012|2017-02-18 13:31:16.380012
NCT00822276|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2014-04-03|||February 2009||2009-02-01|April 2014|2014-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|MRSA||The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)|Pilot Study To Determine The Underlying Mechanisms For Infection And Colonization By Staphylococcus Aureus Of The Skin Of Atopic Dermatitis Subjects With And Without A History Of Eczema Herpeticum (ADVN MRSA 10)|Completed||N/A|65|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||7||f||||t||||||Samples With DNA|"~     Nasal swabs, skin swabs, tape strippings, and blood draws.~   "|||2017-02-18 13:31:16.461228|2017-02-18 13:31:16.461228
NCT00822263|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2010-08-09|||November 2008||2008-11-01|January 2009|2009-01-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure|The Use of Anti-oxidants to Reduce Sequela of Mild TBI (mTBI) After Blast Exposure|Completed||N/A|150|Anticipated|Brooke Army Medical Center||2|||f||||t||||||||||2017-02-18 13:31:16.570833|2017-02-18 13:31:16.570833
NCT00822250|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2010-10-20|||April 2008||2008-04-01|October 2010|2010-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Clinical and Biological Study of Sub-pigmentation During Infantile Cystinosis|Clinical and Biological Study of Sub-pigmentation During Infantile Cystinosis|Completed||N/A|30|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:31:16.679953|2017-02-18 13:31:16.679953
NCT00822237|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-10-29|2010-10-28||January 2009||2009-01-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)|Safety, Tolerability, and Immunogenicity of VARIVAX (2007 Commercial VZV Bulk Process) Administered Concomitantly With M-M-R II in Healthy Children 12-to-23 Months of Age|Completed||Phase 3|598|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:31:16.772225|2017-02-18 13:31:16.772225
NCT00822224|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2011-12-08|||January 2009||2009-01-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen) for Elderly With Dementia|Use of MEOPA for Elderly With Dementia.|Completed||N/A|50|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:31:17.081627|2017-02-18 13:31:17.081627
NCT00822211|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-11-16|||December 2008||2008-12-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy|A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 24 Weeks Treatment With Vildagliptin 50 mg Bid to Placebo as Add-On Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy|Completed||Phase 3|404|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:31:17.176145|2017-02-18 13:31:17.176145
NCT00821990|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2012-01-18|||September 2008||2008-09-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Interventional|||Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer|A Patient Preference Randomized Phase III Clinical Trial of Second-line Chemotherapy (SLC) in Advanced Gastric Cancer (AGC) Patients Pretreated With Both Fluoropyrimidines and Platinum|Completed||Phase 3|200|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 13:31:17.302625|2017-02-18 13:31:17.302625
NCT00821977|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-01-02||2013-01-02|November 2008||2008-11-01|May 2012|2012-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes||Completed||Phase 2/Phase 3|338|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:31:17.418351|2017-02-18 13:31:17.418351
NCT00821964|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-08-08|||December 2008||2008-12-01|August 2016|2016-08-01||||January 2013|Actual|2013-01-01||Interventional|||Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer|Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases|Active, not recruiting||Phase 2|15|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 13:31:17.684297|2017-02-18 13:31:17.684297
NCT00821951|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-12-07|2012-12-07||May 2009||2009-05-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer|A Dose Escalation Study of Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer|Completed||Phase 1|17|Actual|Yale University||1|||f||||f||||||||||2017-02-18 13:31:17.812522|2017-02-18 13:31:17.812522
NCT00821938|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2016-11-23|||November 2008||2008-11-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2012|Actual|2012-07-01||Interventional|CRT-Narrow||Cardiac Resynchronization Therapy (CRT)-Narrow-dp/Dt-Study|CRT in Patients With Narrow QRS, Echodesynchronisation and LV dp/Dt-Response With Pressure Wire|Completed||Phase 4|30|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-02-18 13:31:18.036311|2017-02-18 13:31:18.036311
NCT00821925|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2011-12-07|||December 2006||2006-12-01|January 2009|2009-01-01||||||||Interventional|||Estimation of Osteoporosis' Prevalence in France: Pilot Study in the Department of the Alpes-Maritimes|Estimation of Osteoporosis' Prevalence in France: Pilot Study in the Department of the Alpes-Maritimes|Completed||N/A|800|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:31:18.1294|2017-02-18 13:31:18.1294
NCT00821912|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-02-27|||March 2006||2006-03-01|February 2012|2012-02-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Interventional|TaxXel||TaxXel: Taxotere and Xeloda in Esophageal Cancer|A Phase I/II Study on the Treatment With Taxotere in Combination With Xeloda in Patients With Metastatic Oesophageal Cancer or Cancer in the Cardia Region|Unknown status|Active, not recruiting|Phase 1/Phase 2|93|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-02-18 13:31:18.208775|2017-02-18 13:31:18.208775
NCT00821899|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-03-19|||January 2009||2009-01-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Bone Marrow Autotransplantation in Type 1 Diabetes|Regeneration of Insulin Production in Patients With Type 1 Diabetes by Autologous Bone Marrow Blood Infusion|Completed||N/A|3|Actual|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-02-18 13:31:18.322007|2017-02-18 13:31:18.322007
NCT00821886|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2014-12-12|2014-12-12||February 2009||2009-02-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|July 2011|Actual|2011-07-01||Interventional|||Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer|Phase II Study of Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 13:31:18.415969|2017-02-18 13:31:18.415969
NCT00821873|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2013-11-06|2013-08-01||December 2008||2008-12-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|CRB||Evaluation of the CR Plug for Repair of Defects Created at the Harvest Site From an Autograft in the Knee.|Evaluation of the Composite of Cancellous and Demineralized Bone Plug (CR Plug) for Repair of Defects Created at the Harvest Site During the Osteochondral Autograft Transfer System(OATS)Procedure|Completed||Phase 3|9|Actual|RTI Surgical|"Enrollment was closed early due for 2 factors:~1) Slow enrollment and 2) A potential change in the regulatory pathway for allografts used in cartilage repair.~Of the 9 patients enrolled, 4 were lost to follow-up."|1|||f||||f||||||||||2017-02-18 13:31:18.759277|2017-02-18 13:31:18.759277
NCT00821860|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2013-06-27|||September 2003||2003-09-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|MesoVATS||Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma|Prospective Randomised Controlled Trial of Video-Assisted Thoracoscopic (VAT) Cytoreductive Pleurectomy Compared to Talc Pleurodesis in Patients With Suspected or Proven Malignant Mesothelioma|Completed||Phase 3|196|Actual|Papworth Hospital NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 13:31:18.99898|2017-02-18 13:31:18.99898
NCT00821847|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2012-07-30|||June 2009||2009-06-01|June 2008|2008-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|HIVERS||Renal Function Assessment in HIV Patient|Markers of Glomerular Filtration Rate in the HIV Infected Patient - Role of Body Composition|Completed||N/A|45|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-02-18 13:31:19.174499|2017-02-18 13:31:19.174499
NCT00821652|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2015-01-06|||February 2009||2009-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|January 2010|Actual|2010-01-01||Interventional|||Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination|Phase I Randomized, Double-blind, Placebo-controlled Study of Topical Resiquimod as an Adjuvant for NY-ESO1 Protein+Montanide Vaccination in Patients With Tumors That Often Express NY-ESO-1|Completed||Phase 1|26|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 13:31:21.784217|2017-02-18 13:31:21.784217
NCT00821834|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2011-07-25|||December 2008||2008-12-01|July 2011|2011-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|CLEAN||Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned|A Randomized, Double Blind, Parallel Group Study to Investigate the Safety of 12 Weeks of Clopidogrel 75 mg Once Daily With a 300 mg Loading Dose Versus Ticlopidine 100 mg Twice Daily in Patients With Stable Angina or Old (Healed) Myocardial Infarction to Which Percutaneous Coronary Intervention is Being Planned - With Extended Treatment of Clopidogrel 75 mg Once Daily for 40 Weeks in a Patients' Subset|Completed||Phase 3|1003|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:31:19.282704|2017-02-18 13:31:19.282704
NCT00821821|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2014-04-07|2014-01-05||February 2009||2009-02-01|April 2014|2014-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke|A Phase IIa, Multi-centre, Randomised, Double-blind, Placebo Controlled, Clinical Study Investigating the Safety, Tolerability and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke|Completed||Phase 2|36|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||t||||||||||2017-02-18 13:31:19.40242|2017-02-18 13:31:19.40242
NCT00821808|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-13|2015-10-12|||May 2008||2008-05-01|October 2015|2015-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Pressure Relted Study Comparing a Compression Device and Profore® on Healthy Volunteers|A Phase I, Randomized, Open-label, One-arm, Active Controlled Study to Evaluate the Pressure Interface Between Device and Skin of a Compression Device and Profore® on Healthy Volunteers|Completed||Phase 1|12|Actual|ConvaTec Inc.||1|||f||||f||||||||||2017-02-18 13:31:20.15967|2017-02-18 13:31:20.15967
NCT00821795|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2013-10-23|||February 2009||2009-02-01|October 2013|2013-10-01||||June 2013|Actual|2013-06-01||Interventional|VIISTA||Veterans Inpatient Insulin Study and Transition to Outpatient Therapy|Veterans Inpatient Insulin Study and Transition Algorithm: Efficacy of Insulin Analogs for Inpatient Glycemic Control and Transition to Outpatient Therapy|Completed||Phase 4|120|Actual|Lexington VA Medical Center||2|||f||||f||||||||||2017-02-18 13:31:20.244206|2017-02-18 13:31:20.244206
NCT00821782|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-05-18|||June 2006||2006-06-01|April 2010|2010-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Evaluation of Bacteria in the Mouth and Throat of Healthy Adults Before and After the Administration of Either Levofloxacin or Azithromycin, Both Antibiotic Medications|A Randomized, Open-Label Study Comparing Levofloxacin Once-Daily 750 mg PO for 5 Days and Azithromycin Once-Daily 500 mg on Day One and Then 250 mg Days 2 Through 5 In a Microbiologic Evaluation for Emergence of Resistance in the Oropharyngeal Flora of Healthy Subjects|Completed||Phase 1|143|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC|||||f||||||||||||||2017-02-18 13:31:20.374454|2017-02-18 13:31:20.374454
NCT00821769|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2010-07-16|||September 2007||2007-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:31:20.474632|2017-02-18 13:31:20.474632
NCT00821756|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-12|||January 2005||2005-01-01|January 2009|2009-01-01|August 2010|Anticipated|2010-08-01|August 2008|Actual|2008-08-01||Interventional|Amager||The Amager Project: Intervention After Suicide Attempt|The Amager Project. Intervention After Suicide Attempt: A Randomized Study.|Unknown status|Active, not recruiting|N/A|133|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:31:20.537205|2017-02-18 13:31:20.537205
NCT00821743|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2013-04-23|||March 2010||2010-03-01|March 2010|2010-03-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Pedunculo-Pontin Nucleus (PPN) - Deep Brain Stimulation (DBS) in Gait and Balance Disturbance in Parkinson's Disease (PPN-GAB-PARK Study)|Study of Deep Brain Stimulation of the Pedunculo-pontin Nucleus (PPN) for the Treatment of Gait and Balance Disturbances in Patients With Parkinson's Disease (PPN-GAB-PARK Study)|Unknown status|Recruiting|Phase 1/Phase 2|5|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:31:20.651336|2017-02-18 13:31:20.651336
NCT00821730|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2011-01-06|||January 2009||2009-01-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers: Perspectives of Family Members and Friends|Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers: Perspectives of Family Members and Friends|Completed||N/A|15|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||None Retained|"~     This is a qualitative research study~   "|||2017-02-18 13:31:20.760943|2017-02-18 13:31:20.760943
NCT00821717|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-06-01|||December 2008||2008-12-01|June 2015|2015-06-01|January 2011|Actual|2011-01-01|October 2009|Actual|2009-10-01||Interventional|EFFICACY-HF||EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure|A Randomised, Controlled, Observer-blinded Phase III Clinical Trial to Compare the Effect of Intravenous Ferric Carboxymaltose to Placebo on Exercise Capacity and Cardiac Function in Patients With Chronic Heart Failure and Iron Deficiency|Terminated||Phase 3|35|Actual|Vifor Inc.||2||"Positive FAIR-HF study data are available, this study is identical as EFFICACY-HF. Due to low~   recruitment in EFFICACY-HF the decision was made to terminate it."|f||||t||||||||||2017-02-18 13:31:20.860777|2017-02-18 13:31:20.860777
NCT00821691|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2014-04-18|||March 2009||2009-03-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|CELIC-1||Action of Amantadine on Post-Stroke Aphasic Patients|Action of the Amantadine on Post Stroke Aphasic Patients' Language and Communication|Completed||Phase 2/Phase 3|50|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:31:21.034871|2017-02-18 13:31:21.034871
NCT00821678|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-04-06|2015-02-19||November 2009||2009-11-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|TOP||Telemedicine Outreach for Post Traumatic Stress in CBOCs|Telemedicine Outreach for Post Traumatic Stress in CBOCs|Completed||Phase 4|265|Actual|VA Office of Research and Development|High enrollment refusal rates may limit external validity.|2|||f||||t||||||||||2017-02-18 13:31:21.165714|2017-02-18 13:31:21.165714
NCT00821665|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-12|||March 2007||2007-03-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Blood Glucose Homeostasis in Type 2 Diabetes: the Effects of Saccharose|Blood Glucose Homeostasis in Type 2 Diabetes: the Effects of Saccharose|Completed||N/A|39|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:31:21.677246|2017-02-18 13:31:21.677246
NCT00821626|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2015-05-26|||January 2009||2009-01-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Rapid Flu Tests in Travelers With Fever|Utility of Rapid Flu Tests in the Medical Management of Returning Travelers With Fever|Completed||Phase 4|200|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-02-18 13:31:21.975864|2017-02-18 13:31:21.975864
NCT00821613|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2012-02-07|||September 2009||2009-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Data Collection Study of Raw Thermal Images for the Purpose of Developing a Device for Early Detection of Breast Cancer|Collection of Raw Data of Thermal Imaging for the Purpose of Developing a Device for Early Detection of Breast Cancer|Completed||N/A|1827|Actual|Real Imaging Ltd.|||1||f||||f||||||||||2017-02-18 13:31:22.086409|2017-02-18 13:31:22.086409
NCT00821600|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2014-05-20|||December 2008||2008-12-01|May 2014|2014-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia|Single-Dose, Open-Label Pilot Study to Explore the Pharmacokinetics, Safety and Tolerability of a Gluteal Intramuscular Injection of a 4-Week Long-Acting Injectable Formulation of Risperidone in Patients With Chronic Stable Schizophrenia|Completed||Phase 1|24|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 13:31:22.157045|2017-02-18 13:31:22.157045
NCT00821587|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-11-02|2011-08-04||June 2004||2004-06-01|November 2011|2011-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation|Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation|Completed||Phase 4|39|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 13:31:22.269948|2017-02-18 13:31:22.269948
NCT00821574|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2010-06-15|||July 2005||2005-07-01|January 2009|2009-01-01||||March 2007|Actual|2007-03-01||Interventional|LesScore||Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome|Project to Promote the Evaluation of the Cardiovascular Risk in the Clinical Practice and to Evaluate Its Evolution Following the Implementation of a Preventive Multifactorial Strategy Aimed to Reduce the Total Risk Level (SCORE Algorithm), in Subjects Suffering From Metabolic Syndrome and With a Risk Level ≥5%|Completed||Phase 4|144|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:31:22.648561|2017-02-18 13:31:22.648561
NCT00821561|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-10|2010-02-24|||March 2009||2009-03-01|February 2010|2010-02-01|March 2010|Anticipated|2010-03-01|November 2009|Anticipated|2009-11-01||Interventional|||A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects|A Phase 2, Randomized, Prospective, Double-masked, Vehicle-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Nexagon® in Subjects With Persistent Corneal Epithelial Defects (PED) From Chemical Burn Injuries.|Withdrawn||Phase 2|90|Anticipated|CoDa Therapeutics Inc.||||Withdrawn prior to recruitment for business reasons.|f||||f||||||||||2017-02-18 13:31:22.814922|2017-02-18 13:31:22.814922
NCT00821548|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-12|||January 2008||2008-01-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Electrostimulation of Shoulder Girdle and Quadriceps Muscles in Facioscapulohumeral Muscular Dystrophy Patients||Completed||N/A|9|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:31:22.880041|2017-02-18 13:31:22.880041
NCT00821535|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2010-11-15|||February 2009||2009-02-01|November 2010|2010-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers|An Open Label Single Dose Study To Investigate Safety And Pharmacokinetics Of Maraviroc Following A Single Oral Dose Of 300 Mg Maraviroc (Two 150 Mg Maraviroc Commercial Tablets) Under Fasting Conditions In Healthy Male Japanese Volunteers|Completed||Phase 1|12|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-02-18 13:31:22.978361|2017-02-18 13:31:22.978361
NCT00821522|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2010-07-21|||November 2008||2008-11-01|April 2010|2010-04-01|May 2010|Anticipated|2010-05-01|March 2010|Anticipated|2010-03-01||Interventional|||The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery|The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery|Unknown status|Enrolling by invitation|Phase 1|120|Anticipated|Maine Medical Center Research Institute||2|||f||||f||||||||||2017-02-18 13:31:23.090124|2017-02-18 13:31:23.090124
NCT00821509|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2012-02-06|2011-10-05||January 2009||2009-01-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|July 2010|Actual|2010-07-01||Interventional|||STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?|STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?|Completed||N/A|683|Actual|National Institute for Health and Welfare, Finland|"In a pre-study interview, 90% stated when I have cold I usually come to work if I only can. Participants in the intervention arms, but not those of the control arm, were advised to stay home when sick: possible contribution to outcome measure 1."|3|||f||||f||||||||||2017-02-18 13:31:23.193088|2017-02-18 13:31:23.193088
NCT00821496|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-11-30|||January 2009||2009-01-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects|A Phase I, Open Label, Fixed Sequence, Single-Center Study to Evaluate the Effect of Multiple Dose Administration of VI-0521 on the Pharmacokinetics of a Single Dose of Oral Contraceptive in Healthy Female Subjects|Completed||Phase 1|20|Actual|VIVUS, Inc.||1|||f||||f||||||||||2017-02-18 13:31:23.644973|2017-02-18 13:31:23.644973
NCT00821483|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2013-04-16|||November 2006||2006-11-01|April 2013|2013-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine|Phase 3 Study to Assess the Efficacy and Safety of Frovatriptan|Completed||Phase 3|298|Actual|SK Chemicals Co.,Ltd.||2|||f||||t||||||||||2017-02-18 13:31:23.75138|2017-02-18 13:31:23.75138
NCT00821470|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-13|||January 1999||1999-01-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Osteonecrosis of the Femoral Head by Bone Marrow Transplantation|Treatment of Osteonecrosis of the Femoral Head With Implantation of Autologous Bone Marrow Cells, a Pilot Study|Completed||Phase 1|21|Actual|Erasme University Hospital||2|||f||||t||||||||||2017-02-18 13:31:23.834722|2017-02-18 13:31:23.834722
NCT00821457|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2010-03-08|||January 2009||2009-01-01|March 2010|2010-03-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Juvista in the Non-surgical Improvement of Existing Scars|A Within Patient, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy of Juvista in Improving the Appearance of Existing Scars That Are 2-6 Months Old|Withdrawn||N/A|40|Anticipated|Renovo||2|||f||||f||||||||||2017-02-18 13:31:23.934813|2017-02-18 13:31:23.934813
NCT00821444|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-04-11|||January 2009||2009-01-01|April 2011|2011-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules|Phase 1 Study Of Ziprasidone Pharmacokinetics Of Reduced Food Effect Formulation B16 Under Fed And Fasting Conditions Compared To Commercial Geodon Capsules Under Fed Conditions In Healthy Subjects|Completed||Phase 1|11|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:31:24.039881|2017-02-18 13:31:24.039881
NCT00821431|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-01-08|2014-09-03||May 2006||2006-05-01|January 2015|2015-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Compression Device Versus 4-layer Compression System|A Phase II Study to Compare the Effect of a Compression Device to That of a 4-layer Compression System on Subjects With Venous Leg Ulcers.|Completed||Phase 2|90|Actual|ConvaTec Inc.||2|||f||||f||||||||||2017-02-18 13:31:24.146158|2017-02-18 13:31:24.146158
NCT00821418|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2010-05-08|||August 2009||2009-08-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Assessment of Treatment With PulseHaler on Patients With Chronic Obstructive Pulmonary Disease (COPD)|Assessment of the Safety and the Effect on Patients With COPD of Treatment With PulseHaler™ - a Novel Device for Pulsating Positive Expiratory Pressure Ventilation|Completed||N/A|30|Anticipated|Respinova LTD||2|||f||||||||||||||2017-02-18 13:31:26.883554|2017-02-18 13:31:26.883554
NCT00821405|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-12|||March 2009||2009-03-01|January 2009|2009-01-01|March 2010|Anticipated|2010-03-01|September 2009|Anticipated|2009-09-01||Observational|||Study of Peritoneal/Bowel Morphology and Splanchnic Hemodynamics by Sonography, Doppler Ultrasound and Computed Tomography in CAPD Patients||Unknown status|Not yet recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:31:26.973487|2017-02-18 13:31:26.973487
NCT00821392|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-12|||August 2006||2006-08-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Phase III Trial of Febuxostat in Korea Gout Patients|A Randomized, Multi-Center, Double Blinded, Allopurinol-Controlled, Placebo-Controlled Parallel Group, 5-Arm, Dose-Response,Bridging Study to Assess the Efficacy and Safety of Febuxostat in Subject With Gout|Completed||Phase 3|181|Actual|SK Chemicals Co.,Ltd.||5|||f||||||||||||||2017-02-18 13:31:27.054517|2017-02-18 13:31:27.054517
NCT00821379|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2012-12-19|||April 2008||2008-04-01|January 2009|2009-01-01|September 2012|Actual|2012-09-01|January 2011|Actual|2011-01-01||Observational|CoPPer||CoPPer Study - Complications of Polycystic Ovary Syndrome (PCOS) Pregnancy: Evaluating Risk|Complications of PCOS Pregnancy: Evaluating Risk|Completed||N/A|300|Actual|UMC Utrecht|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum and lithium heparine, urine and placenta tissue~   "|||2017-02-18 13:31:27.135415|2017-02-18 13:31:27.135415
NCT00821366|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-02-25|||October 2007||2007-10-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|FEATS||Effective Aids Treatment and Support in the Free State (FEATS)|Effective Aids Treatment and Support in the Free State (FEATS): Adherence and Nutritional Support for Effective and Sustainable Antiretroviral Treatment in Resource Constrained Settings|Unknown status|Active, not recruiting|Phase 3|648|Actual|Centre for Health Systems Research & Development, University of the Free State||4|||f||||f||||||||||2017-02-18 13:31:27.216203|2017-02-18 13:31:27.216203
NCT00821353|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-11|2013-02-04|||January 2009||2009-01-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy|Sinus Rhythm Maintenance in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation - Randomized Comparison of Antiarrhythmic Therapy vs. Radiofrequency Catheter Ablation (SHAARC)|Completed||Phase 3|90|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||f||||||||||2017-02-18 13:31:27.333877|2017-02-18 13:31:27.333877
NCT00821340|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2010-03-01|||January 2010||2010-01-01|February 2010|2010-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations|Phase I Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-hRPE65) Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations|Unknown status|Recruiting|Phase 1|10|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-02-18 13:31:27.435391|2017-02-18 13:31:27.435391
NCT00821327|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2016-09-15|2016-01-12||August 2008||2008-08-01|September 2016|2016-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Gemzar, Cisp, Sunitinib Urothelial Ca|Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma|Completed||Phase 2|36|Actual|US Oncology Research||1|||f||||f||||||||||2017-02-18 13:31:27.528655|2017-02-18 13:31:27.528655
NCT00821314|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2010-06-15|||April 2009||2009-04-01|June 2010|2010-06-01||||December 2010|Anticipated|2010-12-01||Observational|||The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome|The Effect of Position (Sit/Stand up vs Supine Position) on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome|Unknown status|Recruiting|N/A|100|Anticipated|Maastricht University Medical Center|||1||f||||t||||||||||2017-02-18 13:31:28.059701|2017-02-18 13:31:28.059701
NCT00821301|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-01-12|||December 2008||2008-12-01|January 2009|2009-01-01|October 2010|Anticipated|2010-10-01|August 2010|Anticipated|2010-08-01||Interventional|||Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma|Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma|Unknown status|Recruiting|Phase 1|30|Anticipated|Immune Control||1|||f||||t||||||||||2017-02-18 13:31:28.139478|2017-02-18 13:31:28.139478
NCT00821288|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2015-07-14|||July 2007||2007-07-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|October 2011|Actual|2011-10-01||Interventional|||Post-treatment Care of Breast Cancer Survivors|Post-treatment Care of Breast Cancer Survivors|Completed||Phase 3|140|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 13:31:28.237323|2017-02-18 13:31:28.237323
NCT00821275|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-01-09|||January 2008||2008-01-01|January 2009|2009-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma|Multi-Center Clinical Trial of Uterine Artery Embolization Treatment of Uterine Leiomyoma|Enrolling by invitation||Phase 2/Phase 3|900|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:31:28.343843|2017-02-18 13:31:28.343843
NCT00821262|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2015-10-13|||September 2008||2008-09-01|October 2015|2015-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|SEVO AIFA||Sevoflurane in Cardiac Surgery|Sevoflurane and Cardiac Protection in High Risk Patients Undergoing Cardiac Surgery. A Randomized Controlled Study.|Completed||Phase 4|200|Actual|Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-02-18 13:31:28.452381|2017-02-18 13:31:28.452381
NCT00821236|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2013-01-25|2011-03-24||January 2009||2009-01-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|WLCVLV-001||Contralateral Comparison of Three Excimer Laser Systems in Performing LASIK|A Prospective, Multi Center Clinical Comparison of Fellow Eyes Undergoing Lasik Using the Wavelight Allegretto Wave™ Excimer Laser in One Eye and the Amo/Visx Customvue™ or the Ladarvision 4000 Excimer Laser System in the Contralateral Eye|Completed||Phase 4|40|Actual|Durrie Vision||3|||f||||f||||||||||2017-02-18 13:31:28.691469|2017-02-18 13:31:28.691469
NCT00821223|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2010-05-18|||February 2009||2009-02-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Outcome Following Phacoemulsification Versus Small Incision Cataract Surgery (SICS)|Comparison of Phacoemulsification Versus Manual Small Incision Cataract Surgery (SICS) : A Randomized Control Trial|Completed||N/A|420|Actual|Iladevi Cataract and IOL Research Center||2|||f||||t||||||||||2017-02-18 13:31:29.134442|2017-02-18 13:31:29.134442
NCT00821210|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2010-11-30|||January 2008||2008-01-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|January 2010|Actual|2010-01-01||Interventional|||Obstructive Sleep Apnea and Acute Myocardial Infarction and the Role of Continuous Positive Airway Pressure (CPAP)Treatment|Obstructive Sleep Apnea and Acute Myocardial Infarction and the Role of CPAP Treatment: a Double -Blind, Randomized Control Trial|Completed||N/A|120|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:31:29.254209|2017-02-18 13:31:29.254209
NCT00821197|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2016-10-31|||February 2011||2011-02-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Long-limb or Distal Gastric Bypass for Superobesity - Randomized Study|Long -Limb Gastric or Distal Gastric Bypass in the Treatment of Super Obese Patients - a Prospective Randomized Study|Active, not recruiting||N/A|115|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 13:31:29.359984|2017-02-18 13:31:29.359984
NCT00821184|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2010-07-29|2009-12-04||September 2006||2006-09-01|July 2010|2010-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder|A Prospective Randomized Trial of Behavioral Modification and Solifenacin (Vesicare)vs Solifenacin (Vesicare) Alone for the Treatment of Urge Incontinence in Patients With an Overactive Bladder|Terminated||Phase 3|12|Actual|Lahey Clinic||2||Insufficient subject availability/findings for data analysis|f||||f||||||||||2017-02-18 13:31:29.470716|2017-02-18 13:31:29.470716
NCT00821158|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2009-01-12|||February 2009||2009-02-01|January 2009|2009-01-01||||February 2011|Anticipated|2011-02-01||Interventional|||The DIEP Flap as a Model of Ischemia-Reperfusion: an Intervention Study|The DIEP Flap as a Model of Ischemia-Reperfusion: an Intervention Study|Unknown status|Not yet recruiting|Phase 3|30|Anticipated|Maastricht University Medical Center||3|||f||||t||||||||||2017-02-18 13:31:30.043069|2017-02-18 13:31:30.043069
NCT00821145|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-07-11|||January 2009||2009-01-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|LapAorta||Laparoscopic Versus Open Abdominal Aortic Aneurysm (AAA) Exclusion|Laparoscopic Aortic Resection Versus Open Surgery in Patients With AAA|Withdrawn||Phase 3|0|Actual|Augusta Hospital Duesseldorf||3||inability to recruit sufficient number of patients|f||||f||||||||||2017-02-18 13:31:30.149405|2017-02-18 13:31:30.149405
NCT00821132|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2017-01-04|||January 1991||1991-01-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Observational|ALS||Genetics of Familial and Sporadic ALS|Identification of Genes Causing Familial ALS or Increasing Risk for Sporadic ALS and ALS With Frontotemporal Dementia and Understanding Disease Mechanism.|Recruiting||N/A|15000|Anticipated|Northwestern University|||1||f||||t||||||Samples With DNA|"~     Whole blood and/or skin and CSF samples~      The investigators also collect brain and spinal cord tissue specimans.~   "|No||2017-02-18 13:31:30.257776|2017-02-18 13:31:30.257776
NCT00821119|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-12|2013-03-03|2012-09-24||August 2007||2007-08-01|March 2013|2013-03-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Trial of Non Invasive Ventilation for Respiratoy Distress Syndrome|A Randomized Controlled Trial of Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Pressure as a Primary Mode for Respiratory Distress Syndrome in Preterm Infants|Completed||N/A|200|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||f||||||||||2017-02-18 13:31:30.412316|2017-02-18 13:31:30.412316
NCT00821106|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2010-03-18|||January 2009||2009-01-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|TALENT||Left Versus Right Transradial Approach for Percutaneous Coronary Procedures|Transradial Approach [LEft vs Right] aNd Procedural Times During Percutaneous Coronary Procedures: TALENT Study|Completed||N/A|1540|Actual|Policlinico Casilino ASL RMB||2|||f||||f||||||||||2017-02-18 13:31:30.854461|2017-02-18 13:31:30.854461
NCT00821093|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-07-22|2011-07-22||January 2009||2009-01-01|July 2011|2011-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|INSIST||Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)|A 12 Week Treatment, Multi-center, Randomized, Parallel Group, Double Blind, Double Dummy Study to Assess the Superiority of Indacaterol (150 µg o.d.) Via a SDDPI in Patients With Moderate to Severe COPD, Using Salmeterol (50 µg b.i.d.) as an Active Comparator Delivered Via a DISKUS Inhaler|Completed||Phase 3|1123|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:31:30.961684|2017-02-18 13:31:30.961684
NCT00821080|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-04-30|||October 2008||2008-10-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma|A Phase I Study of Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma|Completed||Phase 1|33|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 13:31:31.520247|2017-02-18 13:31:31.520247
NCT00821067|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-12-04|||January 2009||2009-01-01|December 2009|2009-12-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||"The Effect of Oral D-Ribose in Baby Boomers With Fatigue. A Randomized, Double-Blind Study"|"The Effect of Oral D-Ribose in Baby Boomers With Fatigue. A Randomized, Double-Blind Study"|Completed||N/A|40|Anticipated|Bioenergy Life Science, Inc.||2|||f||||f||||||||||2017-02-18 13:31:31.627372|2017-02-18 13:31:31.627372
NCT00821054|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-11-08|||March 2009||2009-03-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients|An Open Label Study to Examine the Effects of Low-Fat and High-Fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients|Completed||Phase 1|25|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 13:31:31.717578|2017-02-18 13:31:31.717578
NCT00821028|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-12-19|||January 2009||2009-01-01|December 2013|2013-12-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|IRRITAX||Local Paclitaxel Delivery for SFA Disease|Treatment of Superficial Femoral Artery Atherosclerotic Disease With Local Delivery of Paclitaxel Using an Irrigating Catheter: a Randomized, Single-center Pilot Study|Completed||N/A|27|Actual|University of Oklahoma||1|||f||||t||||||||||2017-02-18 13:31:32.348826|2017-02-18 13:31:32.348826
NCT00821015|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2016-06-28|||June 2010||2010-06-01|June 2016|2016-06-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|CRYO-LA||Effect of Balloon Cryoablation on Left Atrial Function|Effect of Balloon Cryoablation on Left Atrial Function (CRYO-LA)|Completed||Phase 3|27|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||No||2017-02-18 13:31:32.473907|2017-02-18 13:31:32.473907
NCT00821002|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-09-16||2011-03-01|January 2009||2009-01-01|September 2013|2013-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)|An Open-Label, Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)|Completed||Phase 2|32|Actual|Mati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 13:31:32.583205|2017-02-18 13:31:32.583205
NCT00820989|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2014-05-20|||February 2000||2000-02-01|May 2014|2014-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|Mono||Inflammation and the Host Response to Injury (In Healthy Volunteers)|Inflammation and the Host Response to Injury (In Healthy Volunteers)|Completed||Phase 1|116|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 13:31:32.683225|2017-02-18 13:31:32.683225
NCT00820976|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-01-09|||March 1996||1996-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|March 2000|Actual|2000-03-01||Interventional|TLG-AML-95-002||Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML|A Phase III, Randomized Multicenter Study of Induction With or Without Granulocyte Colony-Stimulating Factor in AML|Completed||Phase 3|260|Actual|Turkish Leukemia Study Group||2|||f||||t||||||||||2017-02-18 13:31:32.787402|2017-02-18 13:31:32.787402
NCT00820963|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-05-11|||July 2006||2006-07-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme|Randomized Study of Normal-fractionated Radiotherapy Versus Hypofractionated Radiotherapy Versus Chemotherapy in Patients Over 60 Years With Malignant Glioma|Completed||Phase 3|70|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 13:31:32.87658|2017-02-18 13:31:32.87658
NCT00820950|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-03-13||2010-06-17|May 2007||2007-05-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||A Study of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis|A Double-Blind, Vehicle-Controlled, Rising Dose, Safety, Tolerability, Pharmacokinetic and Preliminary Efficacy Study of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis|Completed||Phase 2|29|Actual|Incyte Corporation||6|||f||||f||||||||||2017-02-18 13:31:32.976697|2017-02-18 13:31:32.976697
NCT00820937|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-27|2009-08-26|||March 2006||2006-03-01|August 2009|2009-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|DatScan||Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)|Interest of the Combination of the DaTSCAN Scintigraphy and MRI Scan in the Differential Diagnosis of Lewy Body Dementia From Alzheimer Disease in Patients With Hallucinations|Completed||N/A|20|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-02-18 13:31:33.085988|2017-02-18 13:31:33.085988
NCT00820924|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-03-22||2012-03-22|June 2008||2008-06-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells|A Phase II Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Daily Dose of Lapatinib in Advanced Breast Cancer Patients With HER-2 Non-amplified Primary Tumours and HER-2 Positive Circulating Tumour Cells or EGFR Positive Circulating Tumor Cells|Terminated||Phase 2|23|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 13:31:33.173408|2017-02-18 13:31:33.173408
NCT00820911|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-03-13|||September 2008||2008-09-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients|An Extension to a 12-month, Open-label, Randomised, Multicenter, Sequential Cohort, Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of Oral AEB071 Versus Cyclosporine in Combination With Everolimus, Basiliximab and Corticosteroids in de Novo Adult Renal Transplant Recipients|Completed||Phase 2|175|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:31:33.295526|2017-02-18 13:31:33.295526
NCT00820898|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-05-27|||February 2009||2009-02-01|May 2015|2015-05-01||||January 2011|Actual|2011-01-01||Interventional|||Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Gemcitabine (Gemzar®, LY188011) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|24|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 13:31:33.423237|2017-02-18 13:31:33.423237
NCT00820885|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2015-11-11|||July 2006||2006-07-01|January 2009|2009-01-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide|A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide|Completed||Phase 1|95|Actual|Shire||8|||f||||t||||||||||2017-02-18 13:31:33.555076|2017-02-18 13:31:33.555076
NCT00820872|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2016-08-11|||February 2009||2009-02-01|August 2016|2016-08-01||||December 2010|Actual|2010-12-01||Interventional|||Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer|Phase II Safety Study of Docetaxel and Carboplatin in Combination With Trastuzumab and Lapatinib in Early Breast Cancer|Active, not recruiting||Phase 2|33|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 13:31:33.671792|2017-02-18 13:31:33.671792
NCT00820859|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-07-01|||June 2006||2006-06-01|July 2009|2009-07-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|TREA||Treatment Routes for Exploring Agitation|Treatment of Agitation in the Nursing Home|Unknown status|Recruiting|N/A|200|Anticipated|National Institute on Aging (NIA)||2|||f||||f||||||||||2017-02-18 13:31:33.911847|2017-02-18 13:31:33.911847
NCT00820001|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2013-02-15|||December 2003||2003-12-01|February 2013|2013-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|REACH||Resources to Enhance the Adjustment of Children (REACH)|Enhancing Long-Term Outcome in Child Behavior Disorders|Completed||N/A|254|Actual|University of Pittsburgh||4|||f||||f||||||||||2017-02-18 13:31:49.722368|2017-02-18 13:31:49.722368
NCT00820846|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2016-02-01||2015-05-28|January 2009||2009-01-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|August 2012|Actual|2012-08-01||Interventional|||Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults|A Phase 2a Clinical Trial to Evaluate the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of pGA2/JS7 DNA and MVA/HIV62, in Healthy, HIV Uninfected Vaccinia-naive Adult Participants|Completed||Phase 2|299|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-02-18 13:31:34.018669|2017-02-18 13:31:34.018669
NCT00820833|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2015-03-25|||October 2007||2007-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Formula on Growth of Infants From Overweight or Obese Mothers|Effect of Protein Levels and Caloric Density on the Growth of Formula Fed Infants From Overweight or Obese Mothers|Completed||N/A|230|Actual|Nestlé||3|||f||||f||||||||||2017-02-18 13:31:34.149238|2017-02-18 13:31:34.149238
NCT00820820|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2012-10-08|||January 2009||2009-01-01|October 2012|2012-10-01||||July 2012|Actual|2012-07-01||Interventional|IDA-Adult||IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis|Immunotherapy of Atopic Dermatitis in Adult Patients by Anti-measles Vaccination IDA (Immunothérapie de la Dermatite Atopique)Protocol|Completed||N/A|20|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||f||||||||||2017-02-18 13:31:34.245213|2017-02-18 13:31:34.245213
NCT00820807|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2011-06-16|||January 2009||2009-01-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Novel Fiber on Glucose Homeostasis in Individuals at Risk for Diabetes|Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes: a Randomized, Placebo-controlled, Double-blind, Parallel Group Clinical Trial|Terminated||N/A|60|Anticipated|Cargill||3||Stopped due to a non-safety-related issue with the beverage (test vehicle).|f||||f||||||||||2017-02-18 13:31:34.352743|2017-02-18 13:31:34.352743
NCT00820794|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-03-04|||May 2009||2009-05-01|March 2015|2015-03-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects|A Phase 1, Open-Label, Randomized, Cross-Over Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects|Withdrawn||Phase 1|0|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:31:34.46322|2017-02-18 13:31:34.46322
NCT00820781|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-09|||August 1977||1977-08-01|December 2008|2008-12-01|April 2003|Actual|2003-04-01|December 1977|Actual|1977-12-01||Interventional|||Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices|Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding|Completed||N/A|518|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 13:31:34.571524|2017-02-18 13:31:34.571524
NCT00820768|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-07-14|||April 2012||2012-04-01|July 2011|2011-07-01|April 2014|Anticipated|2014-04-01|April 2013|Anticipated|2013-04-01||Interventional|||A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies|A Phase I of ABI-010 (Nab-17-AAG) and ABI-007 (Abraxane) Administered Weekly in Patients With Advanced Non-Hematologic Malignancies|Withdrawn||Phase 1|42|Anticipated|Celgene Corporation||1|||f||||f||||||||||2017-02-18 13:31:34.674118|2017-02-18 13:31:34.674118
NCT00820755|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2014-04-04|2013-07-01||January 2009||2009-01-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|December 2011|Actual|2011-12-01||Interventional|NEXT||Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)|Open, Randomized, Multinational Phase IIIb Trial Evaluating the Activity and Safety of Cetuximab as 250 mg/m^2 Weekly and 500 mg/m^2 Every Two Weeks Maintenance Therapy After Platinum-based Chemotherapy in Combination With Cetuximab as First-line Treatment for Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 3|583|Actual|Merck KGaA|Enrollment was stopped prematurely when cetuximab did not gain regulatory approval in this indication.|3|||f||||||||||||||2017-02-18 13:31:34.976706|2017-02-18 13:31:34.976706
NCT00820742|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2015-03-04|||February 2008||2008-02-01|March 2015|2015-03-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Observational|||Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.|The Efficacy, Safety, and Tolerability of Pegaptanib Sodium in Filipino Patients With Neovascular Age-related Macular Degeneration: A Post Marketing Surveillance Study.|Withdrawn||Phase 4|0|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:31:36.103096|2017-02-18 13:31:36.103096
NCT00820729|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2012-09-17|||March 2009||2009-03-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease|The Prevalence of Pulmonary Hypertension and the Significance of Different Biomarkers in Chronic Interstitial Lung Disease|Completed||N/A|212|Actual|University of Aarhus|||1||f||||f||||||Samples With DNA|"~     blood samples~   "|||2017-02-18 13:31:36.198115|2017-02-18 13:31:36.198115
NCT00820716|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-08-29||||||August 2011|2011-08-01||||||||Interventional|||Exercise Training in Asthma|Comparison of Two Types of Exercise Training for Asthmatic Subjects : Interests and Limits|Unknown status|Recruiting|N/A|45|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 13:31:36.285803|2017-02-18 13:31:36.285803
NCT00820703|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2010-08-29|||April 2009||2009-04-01|August 2010|2010-08-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers|A Randomized, Prospective, Double-blind, Vehicle-controlled, Dose-escalation, Single-center Study of the Safety and Clinical Effect of Nexagon® in the Treatment of Participants With Diabetic Foot Ulcers|Terminated||Phase 1/Phase 2|24|Anticipated|CoDa Therapeutics Inc.||||For business reasons|f||||f||||||||||2017-02-18 13:31:36.386081|2017-02-18 13:31:36.386081
NCT00820690|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-08-03|||July 2008||2008-07-01|August 2015|2015-08-01|September 2017|Anticipated|2017-09-01|April 2012|Actual|2012-04-01||Observational|LABC||Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer|Gene Expression Signature and Immunohistochemical Markers Associated With Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer|Active, not recruiting||N/A|80|Actual|Barretos Cancer Hospital|||1||f||||f||||||Samples With DNA|"~     frozen tissue; parafin tissue~   "|||2017-02-18 13:31:36.473626|2017-02-18 13:31:36.473626
NCT00820677|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-12-11|||November 2008||2008-11-01|January 2009|2009-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Newborn Health Information Study|Innovative Delivery of Newborn Anticipatory Guidance: The Incorporation of Media-Based Learning Into the Primary Care Office.|Completed||N/A|137|Actual|University of Rochester||1|||f||||f||||||||||2017-02-18 13:31:36.604162|2017-02-18 13:31:36.604162
NCT00820664|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2016-01-21|2010-04-13||December 2008||2008-12-01|January 2016|2016-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women|A Randomized Clinical Trial to Evaluate the Effects of Estrogen on Uterine Endometrium in Healthy Postmenopausal Women|Completed||Phase 1|29|Actual|Merck Sharp & Dohme Corp.|"The registered secondary outcome: Mean gene expression intensity after 4 weeks of either 0.5 or 2 mg Estrace compared to placebo results are not available because of inadequate quantity and quality of tissue samples that were obtained."|3|||f||||f||||||||||2017-02-18 13:31:36.693248|2017-02-18 13:31:36.693248
NCT00820651|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2012-04-25|||November 2009||2009-11-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis|Efficacy and Safety of Diamel, a Nutritional Supplement, in Patients With Nonalcoholic Steatohepatitis. A Randomized and Double Blind Controlled Study|Completed||Phase 3|158|Actual|Catalysis SL||2|||f||||t||||||||||2017-02-18 13:31:37.162829|2017-02-18 13:31:37.162829
NCT00820638|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-09|||November 2008||2008-11-01|January 2009|2009-01-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Myomo e100 NeuroRobotic System Home Safety Study|Myomo NeuroRobotic System Home Safety Study For Use by Stroke Survivors for Upper Extremity Rehabilitation in Their Homes|Unknown status|Recruiting|Phase 1|25|Anticipated|Myomo||1|||f||||f||||||||||2017-02-18 13:31:37.274537|2017-02-18 13:31:37.274537
NCT00820625|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2017-02-06|||May 2008||2008-05-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|Alster-Lost||Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation|Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation - Pulmonary Vein Isolation With or Without Ablation of Complex Fragmented Atrial Potentials|Completed||N/A|124|Actual|Asklepios proresearch||2|||f||||f||||||||Undecided||2017-02-18 13:31:37.385142|2017-02-18 13:31:37.385142
NCT00820612|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2013-02-21|2013-01-10||January 2009||2009-01-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Rectal Indomethacin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High Risk Patients|A Prospective, Randomized, Controlled Trial of Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis in High Risk Patients.|Terminated||Phase 4|602|Actual|University of Michigan||2||"Stopped by DSMB for overwhelming benefit of indomethacin (unethical to withhold indomethacin~   from patients)"|f||||t||||||||||2017-02-18 13:31:37.476753|2017-02-18 13:31:37.476753
NCT00820599|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2017-02-07|||December 2008|Actual|2008-12-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|December 2010|Actual|2010-12-01||Interventional|PREVAIL-TF||Transfemoral Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe)|Transfemoral Placement of AoRtic Balloon Expandable Transcatheter VAlves TrIaL (EUROPE)|Completed||N/A|213|Actual|Edwards Lifesciences||1|||f||||t|f|t|f|f||||Undecided||2017-02-18 13:31:38.057382|2017-02-18 13:31:38.057382
NCT00820586|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-02-01|||May 2007||2007-05-01|February 2012|2012-02-01|December 2018|Anticipated|2018-12-01|January 2011|Actual|2011-01-01||Interventional|||Intramyocardial Delivery of Autologous Bone Marrow|Intramyocardial Delivery of Autologous Bone Marrow|Suspended||Phase 2|13|Actual|IRCCS San Raffaele||2||No more funding support for additional procedures|f||||f||||||||||2017-02-18 13:31:38.169306|2017-02-18 13:31:38.169306
NCT00820573|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-12-11|2012-11-05||October 2009||2009-10-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM|Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|16|Actual|The University of Texas Health Science Center at San Antonio||4|||f||||f||||||||||2017-02-18 13:31:38.284383|2017-02-18 13:31:38.284383
NCT00820560|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-01-20|||January 2005||2005-01-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB007839 Following Multiple Oral Doses in Patients With Solid Tumors|Completed||Phase 1|41|Actual|Incyte Corporation||2|||f||||f||||||||||2017-02-18 13:31:38.888182|2017-02-18 13:31:38.888182
NCT00820547|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2016-06-22|||January 2009||2009-01-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|April 2015|Actual|2015-04-01||Interventional|Beverly1||Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients|Phase II Study Evaluating the Efficacy and Tolerance of Bevacizumab (Avastin) in HER2- Inflammatory Breast Cancer|Active, not recruiting||Phase 2|100|Actual|UNICANCER||1|||f||||t||||||||||2017-02-18 13:31:38.974834|2017-02-18 13:31:38.974834
NCT00820534|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2012-04-18|2010-11-12||December 2008||2008-12-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers|A Randomised, Double-blind, Vehicle Controlled, Single Center, Parallel Group, Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers|Completed||Phase 4|126|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:31:39.12105|2017-02-18 13:31:39.12105
NCT00820521|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-01-30|||February 2009||2009-02-01|January 2009|2009-01-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Study Evaluating Single Doses of GAP-134|Ascending Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Orally to Healthy Subjects|Withdrawn||Phase 1|24|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:31:39.508024|2017-02-18 13:31:39.508024
NCT00820508|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-11-25|||December 2008||2008-12-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|CHR-2845-001||Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies|A Phase I Study to Evaluate the Safety and Tolerability of the Histone Deacetylase Inhibitor, CHR-2845, in Patients With Advanced or Treatment Refractory Haematological Diseases or Lymphoid Malignancies|Completed||Phase 1|18|Actual|Chroma Therapeutics||1|||f||||f||||||||||2017-02-18 13:31:39.586913|2017-02-18 13:31:39.586913
NCT00820495|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-08-02|||May 2009||2009-05-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users|Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users|Completed||Phase 2|1683|Actual|Oregon Research Institute||4|||f||||f||||||||||2017-02-18 13:31:39.692599|2017-02-18 13:31:39.692599
NCT00820482|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-09-17|||January 2009||2009-01-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparing Highly Purified hMG With Recombinant FSH + Recombinant LH in Women Undergoing Intrauterine Insemination.|A Prospective, Randomized, Controlled Trial Comparing Highly Purified hMG With Recombinant FSH + Recombinant LH in Women Undergoing Intrauterine Insemination: Ovarian Response and Clinical Outcomes.|Completed||Phase 4|80|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 13:31:39.803799|2017-02-18 13:31:39.803799
NCT00820469|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-09-29|||September 2008||2008-09-01|September 2015|2015-09-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|PK-rituximab||Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab|Influence of Plasma Exchange Therapy on the Pharmacokinetics of Rituximab in Patients Treated for Autoimmune Disorders.|Completed||Phase 4|20|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 13:31:39.90403|2017-02-18 13:31:39.90403
NCT00820456|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-12-20|||April 2008||2008-04-01|March 2010|2010-03-01||||||||Observational|||Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI|Angle Interleaved Projection Reconstruction With K-Space Weighted Image Reconstruction for Dynamic Contrast MRI of Cancer Therapy Response|Unknown status|Active, not recruiting|N/A|60|Anticipated|American College of Radiology Imaging Network|||2||f||||t||||||||||2017-02-18 13:31:40.010498|2017-02-18 13:31:40.010498
NCT00820443|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2015-08-28|2015-05-07||June 2007||2007-06-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|COM||Ceramic on Metal Total Hip Replacement System Multi-Center,Investigational Device Exemption Clinical Trial|Ceramic on Metal Total Hip Replacement System IDE: A Non-Randomized, Multi-center, Historically Controlled Safety and Efficacy Study (Protocol Number:06-LJH-002)|Terminated||Phase 4|253|Actual|MicroPort Orthopedics Inc.||1||"not move forward with the commercialization of this product based on marketing needs and there~   is not a known safety issue or concern"|f||||f||||||||||2017-02-18 13:31:40.132574|2017-02-18 13:31:40.132574
NCT00820430|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-01-09|||November 2006||2006-11-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||MRI Markers of Cartilage Damage in Knee With Osteoarthritis|A Multi-Center Trial on MR Image Markers of Knee Articular Cartilage Damage in Osteoarthritis|Completed||N/A|53|Actual|American College of Radiology Imaging Network|||3||f||||t||||||||||2017-02-18 13:31:40.596054|2017-02-18 13:31:40.596054
NCT00820417|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-01-09|||June 2004||2004-06-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|September 2007|Actual|2007-09-01||Interventional|||Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib|Phase 1 Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of the Combination of Cetuximab (C-225), a Chimeric Monoclonal Antibody Against the Epidermal Growth Factor Receptor (EGFR), and Gefitinib (ZD1839), a Selective EGFR Tyrosine Kinase Inhibitor, in Patients With Advanced Cancer|Completed||Phase 1|63|Actual|Harrison Clinical Research||2|||f||||f||||||||||2017-02-18 13:31:40.708011|2017-02-18 13:31:40.708011
NCT00820404|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-07-16|||January 2009||2009-01-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Evaluating Single Doses of BLI-489 in Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of BLI-489 Administered Intravenously to Healthy Subjects|Completed||Phase 1|54|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:31:40.817837|2017-02-18 13:31:40.817837
NCT00820391|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-09|||January 2005||2005-01-01|January 2009|2009-01-01|October 2005|Actual|2005-10-01|January 2005|Actual|2005-01-01||Interventional|||KIDNET Versus Meditation/Relaxation - a Dissemination RCTT for Children in Sri Lanka Traumatized by the War and the Tsunami|KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Treatment Trial for Children in Sri Lanka Traumatized by the War and the Tsunami|Completed||Phase 3|31|Actual|University of Konstanz||2|||f||||f||||||||||2017-02-18 13:31:40.908196|2017-02-18 13:31:40.908196
NCT00820378|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-12|||January 2009||2009-01-01|January 2009|2009-01-01|December 2015|Anticipated|2015-12-01|December 2010|Anticipated|2010-12-01||Observational|||The Epidemiology of Aortic Diameter in China|Epidemiology of Aortic Dimensions in Patients With Clinically Evident Arterial Disease or Cardiovascular Risk Factors|Unknown status|Recruiting|N/A|2000|Anticipated|Zhejiang University|||1||f||||t||||||||||2017-02-18 13:31:40.993589|2017-02-18 13:31:40.993589
NCT00820365|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2011-05-17|||March 2009||2009-03-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|ENTRANCE||SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease|Exploratory, Open-label Study to Demonstrate Efficacy, Safety and Tolerability of SC12267 (35 mg) in Patients With Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)|Completed||Phase 2|34|Actual|4SC AG||1|||f||||t||||||||||2017-02-18 13:31:41.101121|2017-02-18 13:31:41.101121
NCT00820352|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2014-06-27|||January 2009||2009-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|BADDHY||Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension|Endothelin Receptor Blockade in Heart Failure With Diastolic Dysfunction and Pulmonary Hypertension|Completed||Phase 3|20|Actual|University Teaching Hospital Hall in Tirol||2|||f||||f||||||||||2017-02-18 13:31:41.356152|2017-02-18 13:31:41.356152
NCT00820339|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2016-03-30|||January 2009||2009-01-01|March 2016|2016-03-01|November 2012|Actual|2012-11-01|December 2010|Actual|2010-12-01||Interventional|SHVE||Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy|Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy About Recurrence and Survival :A Prospective Randomized Trial|Completed||Phase 2/Phase 3|132|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:31:41.486166|2017-02-18 13:31:41.486166
NCT00820326|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-27|2009-01-09|||March 2004||2004-03-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|||||Interventional|Dolastron||Efficacy of Dolasetron in Patients With Fibromyalgia|A Randomized, Double-Blind, Placebo-Controlled, Study of Efficacy of DOLASETRON in Patients With Fibromyalgia|Completed||Phase 3|60|Actual|University Hospital, Limoges||2|||f||||f||||||||||2017-02-18 13:31:41.598079|2017-02-18 13:31:41.598079
NCT00820313|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-09|||October 2006||2006-10-01|January 2009|2009-01-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||A Prospective Evaluation of Health Services Outcomes and Emerging Cardiovascular Disease Biomarkers|Coronary Events, Risk Factors, and Quality of Life in Men and Women Enrolled in Intensive Lifestyle Interventions - A Prospective Evaluation of Health Services Outcomes and Emerging Cardiovascular Disease Biomarkers|Unknown status|Active, not recruiting|N/A|131|Actual|Preventive Medicine Research Institute||1|||f||||f||||||||||2017-02-18 13:31:41.704772|2017-02-18 13:31:41.704772
NCT00820300|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-09-16||2011-03-01|January 2009||2009-01-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma|An Open-Label, Phase 2 Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open Angle Glaucoma (OAG)|Completed||Phase 2|113|Actual|Mati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 13:31:41.816391|2017-02-18 13:31:41.816391
NCT00820287|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2012-03-23|||September 2005||2005-09-01|January 2009|2009-01-01|June 2011|Actual|2011-06-01|January 2009|Actual|2009-01-01||Interventional|||Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk|Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk|Terminated||N/A|44|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 13:31:41.910516|2017-02-18 13:31:41.910516
NCT00820274|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2015-08-31|||January 2009||2009-01-01|December 2013|2013-12-01|June 2016|Anticipated|2016-06-01|December 2013|Actual|2013-12-01||Interventional|MAUV||Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers|Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers|Terminated||Phase 2|10|Actual|University Hospital, Limoges||1||clinical trial have encountered difficulties enrolling a sufficient number of patients|f||||t||||||||||2017-02-18 13:31:41.99378|2017-02-18 13:31:41.99378
NCT00820261|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2012-09-06|||August 2009||2009-08-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|Rotavirus||Molecular Epidemiology of Rotavirus Diarrhea Among Infants and Young Children Attending Maua Methodist Hospital, Kenya|Molecular Epidemiology of Rotavirus Diarrhea Among Infants and Young Children Attending Maua Methodist Hospital, Kenya|Completed||N/A|630|Actual|Institute of Primate Research|||1||f||||t||||||Samples With DNA|"~     The positive samples will be evaluated by sodium dodecyl polyacrylamide gel electrophoresis~     (SDS-PAGE) to determine the electropherotypes and genotyped using reverse transcriptase~     polymerase chain reaction (RT-PCR) on VP7 and VP4 gene and sequencing. Also, these positive~     samples will be retained for quality assurance and quality control.~   "|||2017-02-18 13:31:42.090313|2017-02-18 13:31:42.090313
NCT00820248|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2017-01-17|||December 2008||2008-12-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|October 2014|Actual|2014-10-01||Interventional|||Radiation Therapy and Cisplatin or Panitumumab in Treating Patients With Locally Advanced Stage III or Stage IV Head and Neck Cancer|A Phase III Study of Standard Fractionation Radiotherapy With Concurrent High-Dose Cisplatin Versus Accelerated Fractionation Radiotherapy With Panitumumab in Patients With Locally Advanced Stage III and IV Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 3|320|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 13:31:42.192153|2017-02-18 13:31:42.192153
NCT00820235|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2017-02-03|||February 2009||2009-02-01|February 2017|2017-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||Study Comparing Appearance and Function of Three Different Dental Implant Designs When Placed in Front Region of Upper Jaw|Prospective, Comparative Assessment of Single-tooth Replacement in Different Implant-abutment Settings|Active, not recruiting||N/A|144|Anticipated|Dentsply Sirona Implants||3|||f||||f||||||||||2017-02-18 13:31:42.330041|2017-02-18 13:31:42.330041
NCT00820222|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2016-08-07|2013-01-17||April 2009||2009-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2012|Actual|2012-06-01||Interventional|||Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer|A Randomized, Multicentre, Open-Label, Phase III Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Anthracycline- or Taxane-Exposed ErbB2-Positive Metastatic Breast Cancer|Active, not recruiting||Phase 3|546|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:31:42.449108|2017-02-18 13:31:42.449108
NCT00820196|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-09-16|||March 2009||2009-03-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)|A Randomized, Double-Blind, Vehicle-controlled, Parallel Group, Dose-Ranging, Multi-center Study of the Efficacy and Safety of Nexagon® in the Treatment of Participants With Venous Leg Ulcers|Completed||Phase 2|98|Actual|CoDa Therapeutics Inc.|||||f||||t||||||||||2017-02-18 13:31:43.59389|2017-02-18 13:31:43.59389
NCT00820183|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2009-05-06|||February 2006||2006-02-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|April 2007|Actual|2007-04-01||Interventional|INCOTECA||A Quality Improvement Plan for Hypertension Control|A Quality Improvement Plan for Hypertension Control: the INCOTECA Project|Completed||N/A|34327|Actual|Jordi Gol i Gurina Foundation||2|||f||||f||||||||||2017-02-18 13:31:43.697319|2017-02-18 13:31:43.697319
NCT00820170|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2017-02-02|||January 2009||2009-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194|A Phase I-II Study of Dasatinib in Combination With Weekly Paclitaxel for Patients With Metastatic Breast Carcinoma|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:31:43.808254|2017-02-18 13:31:43.808254
NCT00820157|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-08-10|||November 2008||2008-11-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|November 2010|Actual|2010-11-01||Interventional|TACE||Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma|A Prospective Randomized Trial Comparing Cytoreductive Surgery Followed by Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Multinodular Hepatocellular Carcinoma (MNHCC)|Completed||N/A|120|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:31:43.919611|2017-02-18 13:31:43.919611
NCT00820144|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-01-09|||April 2006||2006-04-01|January 2009|2009-01-01|February 2007|Actual|2007-02-01|April 2006|Actual|2006-04-01||Interventional|||Cholera Toxin B Subunit (CTB) Administered by Mucosal Way in Healthy Adult Volunteer|Functional Exploration of the Immune Response Using the B-Subunit of Cholera Toxin Administered by Mucosal Way in Healthy Adult Volunteer: Potential Role in Development of Vaccine Processes|Completed||Phase 1|40|Actual|Centre Hospitalier Universitaire de Nice||5|||f||||f||||||||||2017-02-18 13:31:44.030523|2017-02-18 13:31:44.030523
NCT00820131|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2014-12-08|||January 2008||2008-01-01|January 2009|2009-01-01|December 2014|Actual|2014-12-01|January 2013|Actual|2013-01-01||Interventional|GRIP-ME||Chronic Pain After Inguinal Hernia Repair|A Multicenter Prospective Randomized Trial on Chronic Pain After Inguinal Hernia Repair Using a Selfgrip-mesh|Completed||Phase 4|250|Anticipated|Medical University of Vienna||2|||f||||||||||||||2017-02-18 13:31:44.140951|2017-02-18 13:31:44.140951
NCT00820118|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-05-22|||May 2009||2009-05-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|TIPI||Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults|ARNS 141 TIPI : A Pilot Trial to Assess the Ability of an Intermittent Antiretroviral Therapy in Maintaining an Immunological Stability in Antiretroviral naïve HIV Infected Adults, With CD4 Count Above 500/mm3|Completed||Phase 2|45|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-02-18 13:31:44.231699|2017-02-18 13:31:44.231699
NCT00820105|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-12-23|||December 2008||2008-12-01|December 2009|2009-12-01||||January 2010|Anticipated|2010-01-01||Interventional|||ADX10059 Migraine Prevention Study|A Phase 2B, Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-ranging, Multicentre Study to Investigate the Efficacy, Safety and Tolerability of the mGluR5 Negative Allosteric Modulator ADX10059 for the Prevention of Migraine|Terminated||Phase 2|350|Anticipated|Addex Pharma S.A.||4||Incidence of abnormalities of liver function tests is higher than expected in this population.|f||||f||||||||||2017-02-18 13:31:44.479476|2017-02-18 13:31:44.479476
NCT00820092|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-14|2013-07-29|||December 2008||2008-12-01|July 2013|2013-07-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers|A Phase 1,Dose Escalation Study to Compare the Safety, Tolerability,Pharmacokinetic and Pharmacodynamic Profiles of the 24-hour Intravenous Administration of Xerecept in Healthy Japanese and Caucasian Adult Volunteers|Completed||Phase 1|38|Actual|Celtic Pharma Development Services||3|||f||||t||||||||||2017-02-18 13:31:44.633637|2017-02-18 13:31:44.633637
NCT00820079|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-12-23|||December 2008||2008-12-01|December 2009|2009-12-01||||October 2009|Actual|2009-10-01||Interventional|||ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)|A Phase 2B, Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Study to Investigate the Efficacy, Mechanism of Action, Pharmacokinetics, Safety and Tolerability of the mGluR5 Negative Allosteric Modulator ADX10059 as Monotherapy in Patients With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 2|120|Anticipated|Addex Pharma S.A.||2|||f||||f||||||||||2017-02-18 13:31:44.74283|2017-02-18 13:31:44.74283
NCT00820053|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2016-03-30|||January 2009||2009-01-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection|Eastern Hepatobilliary Surgical Hospital|Completed||Phase 2|450|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:31:44.86775|2017-02-18 13:31:44.86775
NCT00819208|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2017-01-09|||December 2008||2008-12-01|November 2016|2016-11-01|December 2030|Anticipated|2030-12-01|December 2029|Anticipated|2029-12-01||Interventional|||Health Education Materials With or Without a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer|A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE)|Recruiting||Phase 3|962|Anticipated|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 13:31:44.993278|2017-02-18 13:31:44.993278
NCT00819195|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-10-04|||December 2008||2008-12-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis|Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis|Completed||N/A|17|Actual|University of California, San Francisco|||2||f||||f||||||Samples Without DNA|"~     Peripheral blood mononuclear cells (PBMC) Serum RNA~   "|||2017-02-18 13:31:45.25349|2017-02-18 13:31:45.25349
NCT00819182|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2016-02-24|2013-05-01||April 2008||2008-04-01|February 2016|2016-02-01|February 2013|Actual|2013-02-01|June 2011|Actual|2011-06-01||Interventional|||Breathe for Hot Flashes Randomized Controlled Trial|Breathe-intervention for Hot Flashes, Associated Outcomes, and Interference|Completed||N/A|218|Actual|Indiana University||3|||f||||t||||||||No|De-identified data available upon request.|2017-02-18 13:31:45.367385|2017-02-18 13:31:45.367385
NCT00819169|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2016-11-02||2015-07-13|January 2009||2009-01-01|November 2016|2016-11-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors|A Phase 1b/2 Open Label, Dose Escalation Study of AMG 655 in Combination With AMG 479 in Subjects With Advanced, Refractory Solid Tumors|Terminated||Phase 1/Phase 2|89|Actual|NantCell, Inc.||4||Sponsor decision - subjects rolled over to protocol 20101116|f||||||||||||||2017-02-18 13:31:46.392686|2017-02-18 13:31:46.392686
NCT00819156|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2011-12-20|2009-01-22||February 2004||2004-02-01|December 2011|2011-12-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|||Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer|An Open-label, Randomised, Multi-centre, Parallel Group Comparison of the Efficacy and Safety of Degarelix at Six Different Dosing Regimens in Patients With Prostate Cancer Treated for 12 Months|Completed||Phase 2|189|Actual|Ferring Pharmaceuticals||6|||f||||t||||||||||2017-02-18 13:31:46.524724|2017-02-18 13:31:46.524724
NCT00819143|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2017-01-24|||December 29, 2008||2008-12-29|July 13, 2011|2011-07-13|July 13, 2011||2011-07-13|||||Observational|||Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease|Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease|Completed||N/A|3|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:31:49.392065|2017-02-18 13:31:49.392065
NCT00820040|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-07-15|||July 2009||2009-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:31:49.473485|2017-02-18 13:31:49.473485
NCT00820027|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-05-26|||December 2008||2008-12-01|May 2015|2015-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)|A Phase III Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Multiple-Dose, Clinical Trial to Study the Safety and Efficacy of MK0663/Etoricoxib and Ibuprofen in the Treatment of Postorthopedic Knee Replacement Surgery Pain|Completed||Phase 3|776|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:31:49.51795|2017-02-18 13:31:49.51795
NCT00820014|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2010-09-23|||January 2009||2009-01-01|January 2009|2009-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Ocular Biodistribution Study for Topically Applied ESBA105|Evaluation of Tolerability, Safety and Ocular Pharmacokinetics of Topically Applied ESBA105 in Patients Undergoing Cataract Surgery or Combined Cataract Surgery and Vitrectomy|Completed||Phase 1/Phase 2|79|Actual|ESBATech AG||2|||f||||f||||||||||2017-02-18 13:31:49.61797|2017-02-18 13:31:49.61797
NCT00819988|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-01-09|||May 2009||2009-05-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Pregabalin in the Prevention of Postoperative Delirium and Pain|A Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety and Efficacy of the Perioperative Administration of Pregabalin in Reducing the Incidence of Postoperative Delirium and Improving Acute Postoperative Pain Management|Completed||Phase 3|240|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 13:31:52.189602|2017-02-18 13:31:52.189602
NCT00819975|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-08||||||January 2009|2009-01-01|May 2008|Actual|2008-05-01|||||Interventional|||Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes|Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes|Completed||N/A|12|Actual|Aarhus University Hospital||4|||f||||f||||||||||2017-02-18 13:31:52.311769|2017-02-18 13:31:52.311769
NCT00819962|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-09-13|||September 2014||2014-09-01|November 2014|2014-11-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Perioperative Analgesia Using Ultrasound (US) Guided Transversus Abdominis Plane (TAP) Block||Unknown status|Recruiting|Early Phase 1|42|Anticipated|King Saud University||1|||f||||t||||||||||2017-02-18 13:31:52.419751|2017-02-18 13:31:52.419751
NCT00819949|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2013-09-18|||October 2008||2008-10-01|September 2013|2013-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease|Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease|Completed||Phase 1/Phase 2|20|Anticipated|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 13:31:52.514329|2017-02-18 13:31:52.514329
NCT00819936|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-08|||January 2005||2005-01-01|January 2009|2009-01-01|December 2006||2006-12-01|December 2005|Actual|2005-12-01||Interventional|||A Controlled Trial of Effectiveness of a Backward Walking Program in Patients Recovering From Abdominal Aorta Surgery|A Controlled Trial of Effectiveness of a Backward Walking Program in Patients Recovering From an Abdominal Aorta Surgery|Completed||Phase 4|47|Actual|Medical University of Silesia||2|||f||||f||||||||||2017-02-18 13:31:52.608985|2017-02-18 13:31:52.608985
NCT00819923|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2011-05-04|||November 2008||2008-11-01|May 2011|2011-05-01|December 2014|Anticipated|2014-12-01|May 2013|Anticipated|2013-05-01||Interventional|BASE-ACS||Comparison of Bio-Active-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome|Comparison of Bio-Active-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome (A Prospective, Randomized and a Multicenter Clinical Study)|Unknown status|Active, not recruiting|Phase 3|825|Actual|The Hospital District of Satakunta||2|||f||||t||||||||||2017-02-18 13:31:52.680962|2017-02-18 13:31:52.680962
NCT00819910|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2014-04-08|2013-02-06||September 2008||2008-09-01|April 2014|2014-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|RAFAEL||Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)|Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)|Terminated||Phase 4|41|Actual|Brooke Army Medical Center|First, the study was terminated early per FDA recommendations restricting rosiglitazone use. Second, recruitment of patients was slow due to deployment restraints.|4||Slow recruitment and increase in deployment overseas limiting follow up|f||||t||||||||||2017-02-18 13:31:52.807924|2017-02-18 13:31:52.807924
NCT00819897|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2016-05-11|||June 2008||2008-06-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|QUALICIS||Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta|Longitudinal Study in Clinical Isolated Syndrome Patients Treated With Interferon Beta. Correlation With Cognitive Disorders and Quality of Life.|Terminated||N/A|37|Actual|Centre Hospitalier Universitaire de Nice|||1||f||||f||||||||||2017-02-18 13:31:53.788596|2017-02-18 13:31:53.788596
NCT00819884|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-05-06|||January 2009||2009-01-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||To Evaluate 24-hr Glucose After OD vs BD AZD1656|A Randomised, Two Way Cross-Over, Single-Blind, Phase I Study to Evaluate 24-hr Glucose Profiles in Patients With T2DM When Dosed OD and BD on Top of Metformin for Four Days With AZD1656|Completed||Phase 1|36|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 13:31:53.897801|2017-02-18 13:31:53.897801
NCT00819871|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-05-02|||May 2008||2008-05-01|May 2013|2013-05-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Observational|||Nuclear Factor Kappa-B (NFKB1) Polymorphism and Organ Injury After Cardiac Surgery|Association of NFKB1 -94 Polymorphism With Lung and/or Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass|Completed||N/A|105|Actual|Changhai Hospital|||4||f||||t||||||Samples With DNA|"~     3ml blood before surgery, after surgery and 24h after surgery respectively~   "|||2017-02-18 13:31:53.994405|2017-02-18 13:31:53.994405
NCT00819858|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-10-15|||January 2009||2009-01-01|October 2013|2013-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Ready to Use Therapeutic Food (RUTF) Supplement After an Episode of Malaria Falciparum on Weight|The Effectiveness of Ready to Use Therapeutic Food (RUTF) in Catch up Growth in Children After an Episode of P. Falciparum Malaria|Completed||N/A|180|Actual|Medecins Sans Frontieres, Netherlands||2|||f||||t||||||||||2017-02-18 13:31:54.07705|2017-02-18 13:31:54.07705
NCT00819845|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2016-01-27|||December 2008||2008-12-01|January 2009|2009-01-01|December 2016|Anticipated|2016-12-01|June 2009|Actual|2009-06-01||Interventional|||Ramipril Versus Carvedilol in Duchenne and Becker Patients|Effects of Cardioprotective Therapy, Carvedilol vs Ramipril, in Patients Affected by Duchenne and Becker Muscular Dystrophy. Clinical Significance and Prognostic Value of Cardiac Magnetic Resonance Study.|Unknown status|Recruiting|Phase 4|194|Anticipated|Catholic University, Italy||2|||f||||f||||||||||2017-02-18 13:31:54.190317|2017-02-18 13:31:54.190317
NCT00819832|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2013-11-27|2010-08-16||December 2008||2008-12-01|November 2013|2013-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Anderson Circulating Tumor Cell Burden (CTCB) Study|Assessment of Circulating Tumor Cell Burden After Radiofrequency-Based Plasma Ablation (COBLATION®) in Conjunction With Vertebroplasty or Kyphoplasty for Augmenting Painful Vertebral Compression Fractures Secondary to Malignancy|Terminated||Phase 4|3|Actual|M.D. Anderson Cancer Center||6||Terminated by sponsor.|f||||t||||||||||2017-02-18 13:31:54.318179|2017-02-18 13:31:54.318179
NCT00819819|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-09-23|||April 2008||2008-04-01|September 2015|2015-09-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Infant Nutrition and Risk of Celiac Disease|Infant Nutrition and Risk of Celiac Disease: Proposal for an Intervention, Prospective Multicenter Study|Active, not recruiting||N/A|1042|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 13:31:54.785441|2017-02-18 13:31:54.785441
NCT00819806|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2016-01-13|||January 2009||2009-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|May 2012|Actual|2012-05-01||Interventional|||CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors|Phase I Study of Vaccination With CpG 7909 and Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein in Patients With NY-ESO-1-expressing Tumors|Completed||Phase 1|21|Actual|University of Pittsburgh||6|||f||||t||||||||||2017-02-18 13:31:54.899019|2017-02-18 13:31:54.899019
NCT00819793|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2016-04-08||2014-05-30|October 2008||2008-10-01|April 2016|2016-04-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|||CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass|Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial|Completed||N/A|32|Actual|St. Jude Medical||1|||f||||t||||||||||2017-02-18 13:31:55.009377|2017-02-18 13:31:55.009377
NCT00819780|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2016-07-21|2014-07-10||April 2009||2009-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|May 2012|Actual|2012-05-01||Interventional|||PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors|A Randomized, Multicenter, Phase 2 Study to Compare the Efficacy of Panitumumab in Combination With mFOLFOX6 to the Efficacy of Bevacizumab in Combination With mFOLFOX6 in Patients With Previously Untreated, KRAS Wild-Type, Unresectable, Metastatic Colorectal Cancer|Completed||Phase 2|285|Actual|Amgen||2|||f||||||||||||||2017-02-18 13:31:55.145771|2017-02-18 13:31:55.145771
NCT00819767|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2011-06-02|2010-12-07||February 2009||2009-02-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise|An Eight-week, Randomized, Double-blind, Parallel-group, Pilot Study to Evaluate the Efficacy and Safety of Aliskiren 300 mg in Comparison With Valsartan 320 mg in Patients With Mild to Moderate Hypertension During Exercise After a Missed Dose|Completed||Phase 2|68|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:31:56.682801|2017-02-18 13:31:56.682801
NCT00819754|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2014-01-10|||November 2003||2003-11-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|IXO+A||A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer|A Phase I/II Clinical Trial of Combination of Irinotecan, Xeloda and Oxaliplatin (IXO) Regimen With Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer|Terminated||Phase 1/Phase 2|23|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-02-18 13:31:57.024654|2017-02-18 13:31:57.024654
NCT00819741|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2016-12-19|2010-11-05||February 2009||2009-02-01|December 2016|2016-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs|A 16-week, Open-label, Multicentre, Randomised, Parallel Study to Evaluate Efficacy and Safety of Repaglinide and Metformin Combination Therapy Compared to Repaglinide Monotherapy in Chinese OAD Naive Type 2 Diabetic Patients|Completed||Phase 4|433|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 13:31:57.13163|2017-02-18 13:31:57.13163
NCT00819728|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2011-01-10|||June 2000||2000-06-01|January 2011|2011-01-01|January 2003|Actual|2003-01-01|||||Interventional|||Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer|Multicenter Phase II Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer|Completed||Phase 2|35|Actual|Sanofi||1|||||||||||||||||2017-02-18 13:31:57.893043|2017-02-18 13:31:57.893043
NCT00819715|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2010-10-10|||June 2008||2008-06-01|June 2009|2009-06-01||||January 2010|Actual|2010-01-01||Observational|||Electrogastrography in Small for Gestational Age Preterm Infants|Electrogastrography in Small for Gestational Age Preterm Infants Compared to Appropriate for Gestational Age Infants|Completed||N/A|30|Anticipated|Meir Medical Center|||2||f||||t||||||||||2017-02-18 13:31:58.185716|2017-02-18 13:31:58.185716
NCT00819702|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2010-08-02|||May 2006||2006-05-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|March 2009|Actual|2009-03-01||Interventional|SEEK II||A Safe Environment for Every Kid (SEEK II)|Preventing Child Maltreatment: A Role for Community Pediatricians|Completed||N/A|905|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 13:31:58.273896|2017-02-18 13:31:58.273896
NCT00819676|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-07-31|||January 2009||2009-01-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Analysis of Exhaled Breath by Biosensors in Adults With Asthma|"Analysis of Exhaled Breath by Biosensors in Adults With Asthma: Observational Part of the Study Effects of add-on Therapy With Oral Montelukast on the Analysis of Exhale Breath by Biosensors in Adults With Asthma"|Completed||N/A|47|Actual|Catholic University of the Sacred Heart|||2||f||||t||||||||||2017-02-18 13:31:58.370735|2017-02-18 13:31:58.370735
NCT00819663|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2011-08-17|||February 2009||2009-02-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Intestinal Wall Remodeling (Infliximab Therapy) in Crohn's Disease Patients Undergoing Serial Computed Tomography (CT) Enterography|Intestinal Wall Remodeling After Initiation of Infliximab Therapy in Crohn's Disease Patients Undergoing Serial CT Enterography|Completed||N/A|67|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 13:31:58.462943|2017-02-18 13:31:58.462943
NCT00819650|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-01|2016-03-30|||December 2008||2008-12-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection|Eastern Hepatobiliary Surgical Hospital|Completed||Phase 2|200|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:31:58.557169|2017-02-18 13:31:58.557169
NCT00819637|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2015-03-17|2010-02-17||January 2009||2009-01-01|March 2015|2015-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients|A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients Presenting to the Emergency Department and to Evaluate Its Side Effect and Safety Profile When Used in This Clinical Situation.|Terminated||Phase 4|2|Actual|Henry Ford Health System||3||Unable to enroll r/t study design & staffing issues. The trial terminated.|f||||f||||||||||2017-02-18 13:31:58.669319|2017-02-18 13:31:58.669319
NCT00819624|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2010-02-12|||January 2009||2009-01-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Compare Two Ways of Completing Pain and Sleep Questions and to Evaluate a New Daily Questionaire for Assessing Fatigue in Fibromyalgia Patients|A Non-Drug Methodology Study To Explore The Psychometric Properties Of A Daily Diary Of Fatigue Symptoms And To Compare Two Modes Of Administration Of Pain And Sleep Interference Questions For Use With Fibromyalgia Patients|Completed||N/A|185|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:31:59.026279|2017-02-18 13:31:59.026279
NCT00819611|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2014-01-09|||June 2009||2009-06-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Interventional|||Working Memory Training in Young ADHD Children|Working Memory Training: A Randomised Controlled Treatment Study in Young ADHD Children|Completed||Phase 4|51|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 13:31:59.1432|2017-02-18 13:31:59.1432
NCT00819598|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2009-11-10|||January 2009||2009-01-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Pilot Study to Determine the Optimal Technique for Measurement of Ankle Blood Pressures|Pilot Study to Determine the Optimal Oscillometric-Based Technique for Measurement of Ankle Blood Pressures for the Ankle-brachial Index|Completed||N/A|70|Anticipated|Summit Doppler Systems, Inc.|||1||f||||f||||||||||2017-02-18 13:31:59.249463|2017-02-18 13:31:59.249463
NCT00819585|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2011-04-12|2011-02-28||December 2008||2008-12-01|April 2011|2011-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy|A 24-week, Dose-ranging, Multi-center, Double-blind, Double-dummy, Active-controlled Study to Evaluate Canakinumab (ACZ885) for Prophylaxis of Signs and Symptoms of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy|Completed||Phase 2|432|Actual|Novartis||7|||f||||||||||||||2017-02-18 13:31:59.349165|2017-02-18 13:31:59.349165
NCT00819572|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2010-09-23|||December 2008||2008-12-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee|A Double-blind, Randomised, Placebo-controlled Phase I/IIa Study to Investigate the Safety, Tolerability and Efficacy on Pain of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee|Completed||Phase 1/Phase 2|27|Actual|ESBATech AG||3|||f||||t||||||||||2017-02-18 13:32:00.997005|2017-02-18 13:32:00.997005
NCT00819559|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2009-01-08|||March 2009||2009-03-01|January 2009|2009-01-01|December 2016|Anticipated|2016-12-01|February 2011|Anticipated|2011-02-01||Interventional|||Preoperative Chemoradiotheray for Rectal Cancer|Role of Preoperative Chemoradiotherapy in Clinically T3No Mid and Low Rectal Cancer : Multi-Institute Clinical Study|Unknown status|Not yet recruiting|N/A|1160|Anticipated|Korean Rectal Cancer Study Group||4|||f||||t||||||||||2017-02-18 13:32:01.109588|2017-02-18 13:32:01.109588
NCT00819546|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2016-02-19|||January 2009||2009-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS|A Phase I Trial of Escalating Dose of RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS|Active, not recruiting||Phase 1|36|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:32:01.216309|2017-02-18 13:32:01.216309
NCT00819533|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-12-27|||January 2008||2008-01-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety & Accuracy Study of the ActiSight Needle Guidance System in Patients Undergoing CT-Guided Percutaneous Chest Aspiration and Biopsy|A Prospective, Open-Label, Single-Arm, Single-Center Study Evaluating the Preliminary Safety and Accuracy of the ActiSight Needle Guidance System in Patients Undergoing CT-Guided Percutaneous Chest Aspiration and Biopsy|Completed||N/A|40|Actual|ActiViews Ltd.||1|||f||||f||||||||||2017-02-18 13:32:01.328471|2017-02-18 13:32:01.328471
NCT00819520|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2011-08-19|||February 2004||2004-02-01|August 2011|2011-08-01|October 2004|Actual|2004-10-01|September 2004|Actual|2004-09-01||Interventional|||Ivermectin in the Treatment of Head Lice|A Randomised, Double-Blind, Multicentre Study to Compare the Efficacy and Tolerability of Oral Ivermectin to Malathion 0.5% Lotion in the Treatment of Head Lice Infestation|Completed||Phase 3|812|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-02-18 13:32:01.434724|2017-02-18 13:32:01.434724
NCT00819507|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-08-11|||January 2009||2009-01-01|August 2009|2009-08-01||||January 2010|Anticipated|2010-01-01||Interventional|||VANOS Cream and Skin Barrier Function|Effects of a Novel Formulation of Fluocinonide 0.1% Cream on Skin Barrier Function in Atopic Dermatitis|Unknown status|Recruiting|Phase 4|25|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 13:32:01.561851|2017-02-18 13:32:01.561851
NCT00819494|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2010-11-17|||November 2008||2008-11-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Role of Skin Tests for the Diagnosis of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media|Role of Skin Tests for the Diagnosis of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media|Completed||N/A|63|Actual|Chulalongkorn University||2|||f||||f||||||||||2017-02-18 13:32:01.871318|2017-02-18 13:32:01.871318
NCT00819481|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2017-02-06|||February 2009||2009-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|January 2014|Actual|2014-01-01||Observational|||Post-Market Study of the 3DKnee™ System|Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700|Active, not recruiting||N/A|300|Anticipated|Encore Medical, L.P.|||1||f||||f||||||||||2017-02-18 13:32:01.981311|2017-02-18 13:32:01.981311
NCT00819468|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-08|||July 2007||2007-07-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Pharmacokinetics of 20 mg Teduglutide in Subjects With Moderately Impaired Hepatic Function Compared to Healthy Subjects With Normal Hepatic Function|Pharmacokinetics of 20 mg Teduglutide in Subjects With Moderately Impaired Hepatic Function Compared to Healthy Subjects With Normal Hepatic Function|Completed||Phase 1|24|Actual|NPS Pharma||2|||f||||f||||||||||2017-02-18 13:32:02.110117|2017-02-18 13:32:02.110117
NCT00819455|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-02-13|||March 2009||2009-03-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Use of Information Technology in the Prevention of Diabetes|The Role of Information Technology in the Primary Prevention of Type 2 Diabetes|Completed||N/A|537|Actual|India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals||2|||f||||t||||||||||2017-02-18 13:32:02.217377|2017-02-18 13:32:02.217377
NCT00819442|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-01-08|||January 2009||2009-01-01|January 2009|2009-01-01|June 2011|Anticipated|2011-06-01|January 2011|Anticipated|2011-01-01||Interventional|DESMIN||Relationship Between Abnormalities of Desmin Cytoskeleton, Mitochondrial Activity and Expression of Ubiquitin in Aspect of Pathogenesis of Heart Failure and Prognosis|Relationship Between Abnormalities of Desmin Cytoskeleton, Mitochondrial Activity and Expression of Ubiquitin in Aspect of Pathogenesis of Heart Failure and Prognosis.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Ministry of Scientific Research and Information Technology, Poland||3|||f||||t||||||||||2017-02-18 13:32:02.332626|2017-02-18 13:32:02.332626
NCT00819429|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2015-05-13|||September 2009||2009-09-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|SASSI||Supplements and Social Skills Intervention Study|A Nutritional and Social Skills Intervention on Conduct Disorder and Hyperactivity|Completed||N/A|282|Actual|National Healthcare Group, Singapore||4|||f||||t||||||||||2017-02-18 13:32:02.435228|2017-02-18 13:32:02.435228
NCT00819416|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2010-04-13|||February 2009||2009-02-01|April 2010|2010-04-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|PRECISE||Fluid Resuscitation in Early Septic Shock|Five Percent Albumin Versus Normal Saline as Fluid Resuscitation Strategies for the Management of Early Suspected Septic Shock|Completed||Phase 2|47|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 13:32:02.555543|2017-02-18 13:32:02.555543
NCT00819403|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2014-12-10|2013-02-27||January 2009||2009-01-01|December 2014|2014-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment|The Effects of Ezetimibe/Simvastatin Versus Simvastatin Alone on Platelet and Inflammatory Biomarkers in Patients With the Metabolic Syndrome|Completed||Phase 4|15|Actual|University of Maryland||2|||f||||f||||||||||2017-02-18 13:32:02.677483|2017-02-18 13:32:02.677483
NCT00819390|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2014-10-03|2014-08-26||March 2009||2009-03-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional||Results are for all participants, off-ART and on-ART, who enrolled in the study.|Chloroquine for Reducing Immune Activation in HIV- Infected Individuals|A Phase II, Double Blind, Randomized, Exploratory Study of Chloroquine for Reducing HIV-Associated Immune Activation|Completed||Phase 2|70|Actual|AIDS Clinical Trials Group||4|||f||||t||||||||||2017-02-18 13:32:03.128948|2017-02-18 13:32:03.128948
NCT00819377|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2013-10-23|||February 2009||2009-02-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|||Milrinone Inhaled in Cardiac Surgery|2- Inhaled Milrinone Prevents the Increase in Pulmonary Artery Pressure After CPB|Completed||Phase 2|124|Anticipated|Montreal Heart Institute||2|||f||||f||||||||||2017-02-18 13:32:05.099093|2017-02-18 13:32:05.099093
NCT00819364|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2009-08-10|||August 2009||2009-08-01|August 2009|2009-08-01|August 2016|Anticipated|2016-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Early Intervention Program for Children With Autism (BCRI Model)|Early Intervention Program for Children With Autism (BCRI Model)|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:32:05.22384|2017-02-18 13:32:05.22384
NCT00819351|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-05-22|||February 2009||2009-02-01|May 2012|2012-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase|NOPHO Treatment Protocol for Children (1.0 - 17.9 Years of Age) and Young Adults(18.0-45.0 Years) With Acute Lymphoblastic Leukemia. Intermittent Versus Continuous PEG-asparaginase for Asparagine Depletion|Recruiting||Phase 3|1000|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:32:05.320331|2017-02-18 13:32:05.320331
NCT00819338|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-08|2012-07-03|||January 2009||2009-01-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease|The Effect of n-3 Polyunsaturated Fatty Acid Supplementation in Patients With Non-alcoholic Fatty Liver Disease|Completed||Phase 2|58|Actual|University of Nottingham||2|||f||||f||||||||||2017-02-18 13:32:05.463632|2017-02-18 13:32:05.463632
NCT00819325|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-01-06|||August 2002||2002-08-01|January 2009|2009-01-01|March 2007|Actual|2007-03-01|November 2006|Actual|2006-11-01||Interventional|PPAR-G||Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients|Prevention of Neointimal Proliferation With Aggressive Reduction of Glucose Concentrations (Pioglitazone) Study -- PPAR-G -- An IVUS Pilot Feasibility Study in Type 2 Diabetic Patients.|Completed||Phase 4|50|Actual|Queen Elizabeth II Health Sciences Centre||2|||f||||f||||||||||2017-02-18 13:32:05.577081|2017-02-18 13:32:05.577081
NCT00819312|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-01-27|||December 2008||2008-12-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||YAZ, Oral Contraceptive Registration in China|A Multicenter, Open-label, Single-arm Study to Investigate the Efficacy and Safety of the Oral Contraceptive YAZ (20 μg Ethinylestradiol, 3 mg Drospirenone) for 13 Cycles in 670 Healthy Chinese Female Volunteers.|Completed||Phase 3|675|Actual|Bayer||1|||f||||f||||||||||2017-02-18 13:32:05.691256|2017-02-18 13:32:05.691256
NCT00819299|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2016-06-01|||December 2008||2008-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:32:05.806141|2017-02-18 13:32:05.806141
NCT00819286|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2013-05-01|2011-12-27||November 2008||2008-11-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Interventional|RESTORE||Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain|A Prospective, Randomized-Controlled, Multicenter Study Evaluating Primary Plating in High-Risk Median Sternotomy Patients for Osteosynthesis and Pain|Completed||Phase 4|140|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:32:05.857752|2017-02-18 13:32:05.857752
NCT00819273|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2010-12-02|||March 2009||2009-03-01|December 2010|2010-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|CALLISTO||Investigation Into the Correlation of Plasma Hs-CRP Concentrations and Cardiovascular Risk in Korean Population|Investigation Into the CorrelAtion of pLasma Hs-CRP Concentrations and cardiovascuLar rISk in Korean populaTiOn|Completed||N/A|1700|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:32:06.24689|2017-02-18 13:32:06.24689
NCT00819260|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2013-05-17|2011-11-29||March 2009||2009-03-01|May 2013|2013-05-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery|A Randomized Clinical Trial Comparing the Harmonic Scalpel to Electrocautery in Breast Reduction Surgery|Terminated||N/A|31|Actual|Dartmouth-Hitchcock Medical Center|We made a first analysis after 26 (intended enrollment 50) patients were enrolled and a result was strongly suggested. While the analysis was refined, 5 more patients enrolled. The study was then stopped after 31 patients enrolled.|2||Significant result achieved after enrollment of 31 of planned 50 subjects.|f||||f||||||||||2017-02-18 13:32:06.344651|2017-02-18 13:32:06.344651
NCT00819247|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2011-05-18|2009-01-22||March 2001||2001-03-01|May 2011|2011-05-01|August 2002|Actual|2002-08-01|May 2002|Actual|2002-05-01||Interventional|||The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer|A Six Month, Multi-centre, Open-labelled, 1:1:1 Randomised, Parallel Group Study Investigating the Efficacy and Safety of Three Dose Regimens of FE 200486 in Prostate Cancer Patients|Completed||Phase 2|129|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:32:06.854035|2017-02-18 13:32:06.854035
NCT00819234|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2015-03-26|2013-08-12||November 2008||2008-11-01|March 2015|2015-03-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional||All participants who completed original study and chose to be enrolled into this extension study and were treated with study drug.|Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin|Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin in Obese and Overweight Subjects|Completed||Phase 2|274|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 13:32:08.193529|2017-02-18 13:32:08.193529
NCT00819221|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2016-11-21|||January 2009||2009-01-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2011|Actual|2011-11-01||Interventional|||AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours|A Phase I, Open Label, Multicenter Study to Assess the Safety, Tolerability and Pharmacology of AZD2281 in Combination With Liposomal Doxorubicin (Caelyx®) in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|44|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:32:10.77382|2017-02-18 13:32:10.77382
NCT00819130|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-06-15|||December 2008||2008-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:32:10.880797|2017-02-18 13:32:10.880797
NCT00819117|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2010-01-06|||November 2007||2007-11-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|INTREPID||Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Technique|INvestigation of TRansvenous Versus EPIcarDial Left Ventricular Stimulation Technique|Completed||N/A|20|Anticipated|St. Jude Medical||2|||f||||f||||||||||2017-02-18 13:32:10.936177|2017-02-18 13:32:10.936177
NCT00819104|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2009-09-07|||November 2008||2008-11-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|||||Interventional|MARS||A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components|A Five-arm, Randomised, Open Label, Multi-centre, Prospective Study to Compare the Efficacy, Safety and Tolerability of Metoprolol XL Plus Amlodipine Combination (Selomax TM) With Metoprolol XL and Amlodipine as Individual Components in Management of Hypertension in Indian Patients.|Completed||Phase 4|402|Actual|AstraZeneca||5|||f||||f||||||||||2017-02-18 13:32:11.048654|2017-02-18 13:32:11.048654
NCT00819091|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2014-06-17|2011-05-13||December 2008||2008-12-01|December 2013|2013-12-01||||January 2010|Actual|2010-01-01||Interventional|||Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug|A Randomized, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg Administered Orally Once Daily) Over 18 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control (HbA1c 7.0-10%) Despite Background Therapy With a Sulfonylurea Drug.|Completed||Phase 3|245|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:32:13.455527|2017-02-18 13:32:13.455527
NCT00819078|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2009-01-07|||January 2009||2009-01-01|January 2009|2009-01-01|January 2014|Anticipated|2014-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Comparative Study of SR Bupropion for Adolescent Smoking Cessation|Randomized, Double-Blind, Placebo-Controlled Trial of SR Bupropion for Adolescent Smoking Cessation|Unknown status|Not yet recruiting|N/A|80|Anticipated|Geha Mental Health Center||2|||f||||f||||||||||2017-02-18 13:32:14.220842|2017-02-18 13:32:14.220842
NCT00819065|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2011-07-06|||March 2009||2009-03-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity|Randomized Double-blind Clinical Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity|Completed||Phase 3|56|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 13:32:14.532271|2017-02-18 13:32:14.532271
NCT00819052|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2014-11-07|2011-12-13||December 2008||2008-12-01|November 2014|2014-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||Full Analysis Set (FAS) includes all participants randomized to treatment and confirmed to have taken at least one dose of treatment|Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients|An Open Label, Phase IIIb, Randomised Parallel Group Study to Assess the Efficacy and Safety of Switching HIV-1 Infected Patients Successfully Treated With a Nevirapine IR Based Regiment to Nevirapine XR 400 mg QD or Remaining on Nevirapine IR 200 mg BID Based Program|Completed||Phase 3|445|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:32:14.701766|2017-02-18 13:32:14.701766
NCT00819039|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-06-08|2013-12-23||January 2009||2009-01-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)|A Multi-center, 2-Part Study to Evaluate the Pharmacokinetics Safety and Tolerability of Aprepitant in Pediatric Patients Undergoing Surgery|Completed||Phase 1|98|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:32:17.033685|2017-02-18 13:32:17.033685
NCT00819026|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2014-12-09|||October 2008||2008-10-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors||Completed||N/A|15|Actual|University of Wisconsin, Madison|||1||f||||f||||||Samples Without DNA|"~     viral RNA~   "|||2017-02-18 13:32:17.700086|2017-02-18 13:32:17.700086
NCT00819013|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-01-16|2011-11-01||July 2007||2007-07-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|FLU-A||Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults|A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Safety, Reactogenicity, and Immunogenicity of Recombinant M2e Influenza-A Vaccine Candidate ACAM FLU-A) in Healthy Adults|Completed||Phase 1|87|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 13:32:17.794713|2017-02-18 13:32:17.794713
NCT00819000|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2013-01-28|||December 2008||2008-12-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|TOP MS||Therapy Optimization in Multiple Sclerosis (MS)|TOP MS is a Study of Multiple Sclerosis Disease Management in Collaboration With Specialty Pharmacies|Completed||N/A|2878|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-02-18 13:32:19.35028|2017-02-18 13:32:19.35028
NCT00818792|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2013-01-14|||January 2009||2009-01-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|February 2012|Actual|2012-02-01||Interventional|RENAL-DES||Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease|A Multicenter, Randomized Trial to Compare Xience and Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease|Completed||Phase 2|215|Actual|European Hospital||2|||f||||t||||||||||2017-02-18 13:32:22.744595|2017-02-18 13:32:22.744595
NCT00818987|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2011-02-17|||November 2010||2010-11-01|February 2011|2011-02-01|October 2011|Anticipated|2011-10-01|May 2011|Anticipated|2011-05-01||Interventional|||Operative Versus Non Operative Treatment of Proximal Humerus (Shoulder Joint) Fractures|A Multicentre Prospective Randomized Control Trial on the Treatment of Three and Four Part Proximal Humerus Fractures in Patients 70 Years and Older: Comparing Open Reduction and Internal Fixation With Non Operative Treatment|Unknown status|Recruiting|Phase 1|120|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:32:19.460115|2017-02-18 13:32:19.460115
NCT00818961|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2013-10-28|2013-03-22||May 2005||2005-05-01|October 2013|2013-10-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer|Reduced Intensity Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies|Terminated||Phase 2|36|Actual|Northside Hospital, Inc.||1||terminated early due to meeting end point with fewer patients than anticipated|f||||f||||||||||2017-02-18 13:32:19.566525|2017-02-18 13:32:19.566525
NCT00818948|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-09-11|||March 2009||2009-03-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|June 2014|Actual|2014-06-01||Interventional|||Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis|A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis|Completed||Phase 1|56|Actual|Amgen||2|||f||||f||||||||||2017-02-18 13:32:20.104544|2017-02-18 13:32:20.104544
NCT00818935|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-01-06|||June 2004||2004-06-01|January 2009|2009-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Low-Intermediate-Glycemic Index Caribbean Foods Versus High Glycemic Index Foods in Type 2 Diabetes|Glycemic Indices of Caribbean Foods and Application in Dietary Lifestyle Intervention for Management of Type 2 Diabetes Mellitus|Completed||N/A|65|Actual|University Hospital of the West Indies||2|||f||||t||||||||||2017-02-18 13:32:20.222225|2017-02-18 13:32:20.222225
NCT00818922|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-12-08|||February 2009||2009-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:32:20.325676|2017-02-18 13:32:20.325676
NCT00818909|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2012-01-31|||January 2009||2009-01-01|January 2012|2012-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Systane Clinical Experience Study|Study to Evaluate the Physical Effect of SYSTANE QID in People That Have Moderate to Severe Dry Feeling Eyes|Completed||Phase 4|941|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:32:20.371596|2017-02-18 13:32:20.371596
NCT00818896|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-09-18|||April 2008||2008-04-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Observational|||Maternal Hypothyroidism in Pregnancy|A Model Statewide Trial to Detect and Treat Maternal Hypothyroidism in Pregnancy|Completed||N/A|72|Actual|Women and Infants Hospital of Rhode Island|||1||f||||t||||||Samples Without DNA|"~     Serum and urine samples from women who consent are to be stored in the freezer. Iodine~     measurements will be performed in urine samples and, possibly, serum samples. Consent is~     also asked for use of stored samples for other research purposes in the future.~   "|||2017-02-18 13:32:20.465104|2017-02-18 13:32:20.465104
NCT00818883|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2012-01-04|2012-01-04||February 2009||2009-02-01|January 2012|2012-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension|A Phase 3, Double-Blind, Randomized, Efficacy and Safety Study of the TAK 491 Plus Chlorthalidone Fixed-Dose Combination Compared With TAK-491 and Hydrochlorothiazide Coadministration Therapy in Subjects With Moderate to Severe Essential Hypertension|Completed||Phase 3|609|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:32:20.573022|2017-02-18 13:32:20.573022
NCT00818870|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2010-01-26|||December 2008||2008-12-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH|A Randomized, Open-Label, Cross-Over, Dose-Ranging Study to Assess the Effect of Vecam 40/300 and Vecam 20/300 Administered at Bedtime Compared to Omeprazole 20 mg Administered Before Breakfast on Gastric pH|Completed||Phase 1|60|Anticipated|Vecta Ltd.||3|||f||||f||||||||||2017-02-18 13:32:21.760977|2017-02-18 13:32:21.760977
NCT00818857|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2016-06-16|||January 2009||2009-01-01|June 2016|2016-06-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional|Get Screened||Primary Care Based Randomized Trial to Reduce Cancer Screening Disparities|Primary Care Based Randomized Trial to Reduce Cancer Screening Disparities|Completed||N/A|1072|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 13:32:21.868047|2017-02-18 13:32:21.868047
NCT00818844|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-07-27||2015-07-27|January 2009||2009-01-01|February 2012|2012-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery||Completed||Phase 4|40|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:32:21.965053|2017-02-18 13:32:21.965053
NCT00818831|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-01-27|||January 2009||2009-01-01|January 2015|2015-01-01||||October 2015|Anticipated|2015-10-01||Interventional|||A Study of QBI-139 in Subjects With Advanced Solid Tumors|Phase I Safety and Pharmacokinetic Study of QBI-139 Injection Administered by Weekly Intravenous Infusion in Patients With Refractory Malignancies|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|Quintessence Biosciences, Inc.||1|||f||||||||||||||2017-02-18 13:32:22.061209|2017-02-18 13:32:22.061209
NCT00818818|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2010-10-07|||August 2008||2008-08-01|October 2010|2010-10-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|Sbold||Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients|Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients Infected With Leishmania (Viannia) Braziliensis in Bahia State, Brazil. An Open Uncontrolled Trial.|Completed||Phase 4|13|Actual|University of Brasilia||1|||f||||f||||||||||2017-02-18 13:32:22.201853|2017-02-18 13:32:22.201853
NCT00818805|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2012-05-29|2009-12-03||July 2008||2008-07-01|March 2010|2010-03-01||||July 2008|Actual|2008-07-01||Interventional|||Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)||Completed||Phase 4|50|Actual|Alcon Research|Technical problems with measurement leading to unreliable or uninterpretable data.|4|||f||||f||||||||||2017-02-18 13:32:22.456908|2017-02-18 13:32:22.456908
NCT00816920|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-09-17|||September 2005||2005-09-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|CALTHRO||Natural History of Isolated Deep Vein Thrombosis of the Calf|"Diagnosis and Evolution of Isolated Deep Vein Thrombosis of the Calf in Symptomatic Outpatients. The Blind, Prospective CALTHRO Study."|Completed||N/A|500|Anticipated|St. Orsola Hospital|||1||f||||t||||||||||2017-02-18 13:32:59.441521|2017-02-18 13:32:59.441521
NCT00818779|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-10-18|2012-06-18||January 2008||2008-01-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Direct Renin Inhibition Effects on Atherosclerotic Biomarkers|Effects of Direct Renin Inhibition on Atherosclerotic Biomarkers in Patients With Stable Coronary Heart Disease and Type 2 Diabetes Mellitus|Completed||Phase 4|38|Actual|Texas Tech University Health Sciences Center|Small sample size led to large standard deviation in biomarkers assessed and limited power to detect a diffference|2|||f||||t||||||||||2017-02-18 13:32:22.855143|2017-02-18 13:32:22.855143
NCT00818766|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2012-05-16|||March 2008||2008-03-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Efficacy of Post-operative Antibiotic Prophylaxis for Thoracic Surgery Requiring Tube Thoracostomy.|Extended Antibiotic Prophylaxis for the Prevention of Infectious Complications Associated With Tube Thoracostomy in Patients Undergoing Elective Thoracic Surgery: A Prospective, Randomized, Placebo-Controlled Trial|Completed||N/A|251|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:32:23.238943|2017-02-18 13:32:23.238943
NCT00818753|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2014-06-03|2011-08-05||January 2009||2009-01-01|December 2013|2013-12-01||||August 2010|Actual|2010-08-01||Interventional|||Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention|The Safety and Pharmacodynamics of Two Doses of Dabigatran Etexilate in Patients Undergoing Cardiac Catheterization|Completed||Phase 2|53|Actual|Boehringer Ingelheim|Although a total of 50 patients are included in the FAS, 4 of these patients did not have data for the primary endpoint and are therefore not included in the odd ratio calculation|3|||f||||||||||||||2017-02-18 13:32:23.353849|2017-02-18 13:32:23.353849
NCT00818740|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2009-10-07|||January 2009||2009-01-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Pharmacokinetic Study of ORM-12741 in Healthy Volunteers|Pharmacokinetics of ORM-12741 After Intravenous and Oral Administration and Effects of Food on ORM-12741 Pharmacokinetics; An Open, Randomised, Single Dose, Single Centre, Crossover Study in Healthy Male Subjects|Completed||Phase 1|12|Actual|Orion Corporation, Orion Pharma||4|||f||||f||||||||||2017-02-18 13:32:23.899662|2017-02-18 13:32:23.899662
NCT00817752|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2010-03-17|||May 2007||2007-05-01|January 2009|2009-01-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation|Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation|Completed||Phase 1|25|Actual|National College of Natural Medicine||1|||f||||t||||||||||2017-02-18 13:32:23.990576|2017-02-18 13:32:23.990576
NCT00817739|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-07-27|||December 1996||1996-12-01|July 2015|2015-07-01|December 2008|Actual|2008-12-01|September 2005|Actual|2005-09-01||Interventional|||Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c|Intermittent Hormonal Therapy With Leuprorelin (3.75 mg SR) and Flutamide in the Treatment of Stage D2 or Tx Nx M1 ≠ M1a Metastatic Cancer of the Prostate|Completed||Phase 2|341|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:32:24.097232|2017-02-18 13:32:24.097232
NCT00817726|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2016-09-06|||January 2009||2009-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|RBD6YR||RBD Longitudinal as Prognostic for PD|A Natural History Analysis of Rapid Eye Movement Sleep Behavior Disorder as Prognostic for Parkinson's Disease|Recruiting||N/A|240|Anticipated|The University of Texas Health Science Center, Houston|||2||f||||f||||||Samples With DNA|"~     blood (serum)~   "|||2017-02-18 13:32:24.195893|2017-02-18 13:32:24.195893
NCT00817713|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2011-02-15|||January 2009||2009-01-01|April 2009|2009-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?|Can Anthelminthic Treatment Delay the Progression of HIV? Randomised Open-label Trial Testing Presumptive Anthelminthic Treatment on Progression of HIV in ART-naïve HIV-positive Patients in a Rural African Setting With Presumed High Prevalence of Helminth Infections.|Terminated||N/A|295|Actual|Swiss Tropical & Public Health Institute||2||"Terminated prematurely due to recruitment difficulties. Expansion to more study sites not~   planned."|f||||f||||||||||2017-02-18 13:32:24.304922|2017-02-18 13:32:24.304922
NCT00817700|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2017-01-09|||April 2005||2005-04-01|January 2017|2017-01-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional|PPG||Impact of a Sleep Debt in Middle-Aged and Older Adults|Alteration of Sleep and Circadian Timing in Aging- Impact of a Sleep Debt in Middle-Aged and Older Adults|Completed||N/A|72|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 13:32:24.426643|2017-02-18 13:32:24.426643
NCT00817687|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2012-07-05|||January 2009||2009-01-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation|A Randomised, Multicenter, Open-label Study Evaluating the Impact on the Fibrosis at Week 52 of an Early Biopsy at (D10) Versus Standard Management in Patients Who Have Undergone de Novo Renal Transplantation and Received a Marginal Organ Transplant|Completed||Phase 4|66|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:32:24.528558|2017-02-18 13:32:24.528558
NCT00817674|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-09-04|||November 2007||2007-11-01|September 2013|2013-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|CRIC||Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy|Sleep Disturbances as a Non-traditional Risk Factor in CKD-Wrist Actigraphy|Completed||N/A|353|Actual|University of Chicago|||2||f||||f||||||||||2017-02-18 13:32:24.645001|2017-02-18 13:32:24.645001
NCT00817661|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-04|2013-01-01|||February 2009||2009-02-01|January 2009|2009-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Vitamin A and Maternal-infant Flu Vaccine Response|Effect of Maternal Vitamin A Supplementation on Maternal Immune Response to Inactivated Influenza Vaccination, and on Passive Protection of Infants|Completed||N/A|66|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-02-18 13:32:24.742697|2017-02-18 13:32:24.742697
NCT00817648|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2010-06-11|||December 2008||2008-12-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia|A 6-Week, Multicenter, Rater-blind, Randomized, Risperidone-controlled Study to Evaluate the Efficacy and Safety of Seroquel (Quetiapine Fumarate) in the Treatment of Chinese Han Patients With Schizophrenia|Completed||Phase 4|120|Actual|Shanghai Mental Health Center||2|||f||||f||||||||||2017-02-18 13:32:24.854023|2017-02-18 13:32:24.854023
NCT00816725|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2014-04-10|||January 2009||2009-01-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effectiveness of a Web-based Prevention Program for Postpartum Depression|Using the Internet for English/Spanish Randomized Trials for Postpartum Depression|Completed||N/A|1000|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 13:33:02.424148|2017-02-18 13:33:02.424148
NCT00817635|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2012-11-30||2012-11-30|December 2008||2008-12-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Evaluate the Effects of LCI699 on Safety and Efficacy in Subjects With Resistant Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic|A Phase II, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Multi-center, Dose Ranging Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo After 8 Weeks Treatment in Patients With Resistant Hypertension|Completed||Phase 2|155|Actual|Novartis||5|||f||||f||||||||||2017-02-18 13:32:24.978052|2017-02-18 13:32:24.978052
NCT00818727|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2009-01-07|||February 2009||2009-02-01|January 2009|2009-01-01||||January 2011|Anticipated|2011-01-01||Observational|||Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)||Unknown status|Not yet recruiting|N/A|40|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 13:32:25.123677|2017-02-18 13:32:25.123677
NCT00818714|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-11-30|||January 2009||2009-01-01|November 2015|2015-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516|0516 GCC: Stereotactic Body Radiation Therapy As A Boost After Definitive Treatment With Concurrent Chemoradiation In Patients With Non-Small Cell Lung Cancer|Withdrawn||Phase 1|0|Actual|University of Maryland||1||There was no patient accrual nor study activity due to inability to fund PFTs.|f||||t||||||||||2017-02-18 13:32:25.188825|2017-02-18 13:32:25.188825
NCT00818701|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2010-09-23|||February 2009||2009-02-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|BNP+PDEVI||Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction|A Randomized, Double Blinded Placebo Controlled Cross-over Study of Low Dose B-type Natriuretic Peptide (Nesiritide) With or Without Concomitant Phosphodiesterase V (PDE V) Inhibition(Sildenafil) in Congestive Heart Failure Patients With Renal Dysfunction|Terminated||Phase 1|1|Actual|Mayo Clinic||2||started a NIH study that is competing for same subjects|f||||t||||||||||2017-02-18 13:32:25.281265|2017-02-18 13:32:25.281265
NCT00818688|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2009-01-12|||March 2005||2005-03-01|January 2009|2009-01-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Observational|POST||POST (Prospective Observational Superfial Thrombophlebitis)|Superficial Thrombophlebitis and Venous Thromboembolism: A Large Prospective Epidemiological Study|Completed||N/A|844|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||||||2017-02-18 13:32:25.396358|2017-02-18 13:32:25.396358
NCT00818675|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-01-19|||March 2009||2009-03-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)|A Randomized Discontinuation Phase II Trial of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With KRAS Mutations|Terminated||Phase 2|80|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:32:25.497973|2017-02-18 13:32:25.497973
NCT00818662|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2015-06-26|2014-06-27||December 2008||2008-12-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease|A Randomized, Double-Blind, Placebo-Controlled, Two Dose Arm, Parallel Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease|Completed||Phase 3|390|Actual|Baxalta US Inc.||4|||f||||t||||||||||2017-02-18 13:32:25.622348|2017-02-18 13:32:25.622348
NCT00818649|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2013-01-17|2013-01-17||January 2009||2009-01-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia|Phase II Trial of Velcade Plus Vorinostat in the Treatment of High Risk MDS and Relapsed/Refractory AML|Terminated||Phase 2|16|Actual|Masonic Cancer Center, University of Minnesota|Natural Killer cell studies were discontinued after the first 3 patients because the results were not helpful. So, secondary outcome measures were not completed.|1||Met protocol stop rule [i.e., extreme toxicity]|f||||t||||||||||2017-02-18 13:32:27.764561|2017-02-18 13:32:27.764561
NCT00818636|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-01-26|||August 2008||2008-08-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|March 2010|Actual|2010-03-01||Interventional|||Expressive Writing for Co-Occurring Depression and Alcohol Misuse|Expressive Writing for Co-Occurring Depression and Alcohol Misuse|Completed||N/A|89|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 13:32:28.08641|2017-02-18 13:32:28.08641
NCT00818623|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-07|2011-05-18|2009-01-22||November 2002||2002-11-01|May 2011|2011-05-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients|An Open-Label, Multi-Center, Parallel and Sequential, Ascending Single Dose Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 in Prostate Cancer Patients|Completed||Phase 2|172|Actual|Ferring Pharmaceuticals||8|||f||||f||||||||||2017-02-18 13:32:28.21461|2017-02-18 13:32:28.21461
NCT00818610|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2013-04-24|||January 2009||2009-01-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Interventional|BICAP||Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia|Beta-lactam Monotherapy Versus Beta-lactam - Macrolide Association as Empiric Antibiotherapy Strategies in Non-severe Hospitalized Community-acquired Pneumonia: a Randomized, Non-inferiority, Open Trial.|Completed||Phase 4|601|Actual|Swiss National Fund for Scientific Research||2|||f||||t||||||||||2017-02-18 13:32:33.441697|2017-02-18 13:32:33.441697
NCT00818597|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2009-01-06|||December 2003||2003-12-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|April 2004|Actual|2004-04-01||Interventional|EISS-1||Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients|PhaseI/II Study of the Safety and Efficacy of the Use of Granulocyte-Concentrates Applied in Extracorporeal Circulation Devices-the EISS-1 Study|Completed||Phase 1/Phase 2|10|Actual|University of Rostock||1|||f||||f||||||||||2017-02-18 13:32:33.549768|2017-02-18 13:32:33.549768
NCT00818584|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2013-03-04|||August 2007||2007-08-01|March 2013|2013-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates|A Phase 1 Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates|Completed||Phase 1|13|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 13:32:33.647539|2017-02-18 13:32:33.647539
NCT00818571|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2016-01-12||2015-05-20|December 2008||2008-12-01|January 2016|2016-01-01||||May 2009|Actual|2009-05-01||Interventional|||Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients|An Open-label, Parallel Group Study to Determine the PK of 25 and 50 mg OD Single and Multiple Dose Over 14 Days, of Vildagliptin and Its Metabolites in Renal Impaired Patients Compared to Matching Healthy Volunteers|Completed||Phase 1/Phase 2|96|Actual|Novartis||4|||f||||||||||||||2017-02-18 13:32:33.764608|2017-02-18 13:32:33.764608
NCT00818558|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2011-12-07|||October 2008||2008-10-01|December 2011|2011-12-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||The Method ISET (Insulation by Size of Epithelial Tumor Cells)|Evaluation of the Value Forecasts of the Identification of the Circulating Tumoral Cells (CTC) in the Broncho-lung Carcinomas Not in Small Cells of Stages I and II by the Method ISET (Insulation by Size of Epithelial Tumor Cells)|Unknown status|Recruiting|N/A|520|Anticipated|Centre Hospitalier Universitaire de Nice||6|||f||||||||||||||2017-02-18 13:32:33.873296|2017-02-18 13:32:33.873296
NCT00818545|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-01-06|||November 2007||2007-11-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Transcriptomic Study of ER 4017 Topical Application in Elderly Subject|Transcriptomic Study of ER 4017 Topical Application in Elderly Subject|Completed||N/A|10|Actual|L'Oreal||2|||f||||t||||||||||2017-02-18 13:32:33.979772|2017-02-18 13:32:33.979772
NCT00818532|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-04-06|||December 2008||2008-12-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Corneal Astigmatism Measurement Study||Completed||N/A|50|Actual|Alcon Research|||1||f||||f||||||||||2017-02-18 13:32:34.08817|2017-02-18 13:32:34.08817
NCT00818519|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-08-12|2011-04-06||December 2008||2008-12-01|August 2015|2015-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||GA YAZ ACNE in China Phase III|A Multicenter, Double-blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of an Oral Contraceptive Preparation YAZ (Drospirenone 3 mg / Ethinylestradiol 20 µg) for 6 Treatment Cycles in Women With Moderate Acne|Completed||Phase 3|179|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:32:34.39414|2017-02-18 13:32:34.39414
NCT00818506|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-11-20|||March 2009||2009-03-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|||||Observational|||Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression|Associations Between Depression and Cardiovascular Disease in Patients With Late Onset, Single Episode Major Depressive Disorder|Completed||N/A|55|Actual|University of Aarhus|||2||f||||f||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 13:32:34.979027|2017-02-18 13:32:34.979027
NCT00818493|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-05-15||2010-08-25|February 2009||2009-02-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty|An Open-Label Pilot Study of the Analgesic Efficacy and Safety Of Q8003 and of the Conversion From IV Morphine PCA Analgesia to Q8003 or to Percocet® in Patients Who Have Undergone Primary Unilateral Total Knee Arthroplasty or Total Hip Arthroplasty|Completed||Phase 2|44|Actual|QRxPharma Inc.||3|||f||||f||||||||||2017-02-18 13:32:35.081204|2017-02-18 13:32:35.081204
NCT00818480|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-08-20||2015-08-20|February 2006||2006-02-01|August 2015|2015-08-01|August 2012|Actual|2012-08-01|March 2011|Actual|2011-03-01||Interventional|||An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155|Phase II: An Open-Label Extension Study of 168-Hour Continuous Infusion of YM155 in Subjects Previously Enrolled in a Phase I or Phase II Protocol Administering YM155|Completed||Phase 2|10|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 13:32:35.195463|2017-02-18 13:32:35.195463
NCT00818467|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-11-27|||May 2008||2008-05-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|Sunscreen||UVB Light and Sunscreen|3% Dihydroxyacetone (DHA or Sunless Tanning Agent) Inhibits Vitamin D Production in the Skin in Response to Ultraviolet Light|Completed||Phase 4|50|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 13:32:35.303006|2017-02-18 13:32:35.303006
NCT00818454|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2014-01-21|2010-09-21||December 2008||2008-12-01|January 2014|2014-01-01||||September 2009|Actual|2009-09-01||Interventional|||4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma|A Multicenter Randomized Study Starting With a 4 Week 2 Way Crossover Double Blind Treatment Phase Comparing the Efficacy and Safety of Combivent CFC MDI to Albuterol HFA MDI Followed by a 4 Week Open Label Combivent Respimat Treatment Phase When All Study Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma (GINA 2007 Treatment Steps 3-5)|Completed||Phase 2|226|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 13:32:35.6281|2017-02-18 13:32:35.6281
NCT00818441|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2016-04-25|2016-04-25||March 2009||2009-03-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2012|Actual|2012-04-01||Interventional|||Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung|A Phase 2, Open-Label Trial Of Dacomitinib (PF-00299804) In Selected Patients With Advanced Adenocarcinoma Of The Lung|Completed||Phase 2|119|Actual|Pfizer|Results have been included for Cohort B and updated for Cohort A since the Primary completion date.|2|||f||||f||||||||||2017-02-18 13:32:36.370914|2017-02-18 13:32:36.370914
NCT00818428|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2009-09-22|||November 2008||2008-11-01|September 2009|2009-09-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|ECRIP||Randomized Clinical Trial of Phonological Interventions|The Contribution of a Speech Perception Intervention to the Prevention of Phonological Awareness Deficits in Children With Speech Sound Disorders|Unknown status|Recruiting|Phase 2/Phase 3|96|Anticipated|McGill University||4|||f||||f||||||||||2017-02-18 13:32:37.833016|2017-02-18 13:32:37.833016
NCT00818415|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2014-05-16|||November 2008||2008-11-01|May 2014|2014-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Naproxen Sodium ER Pharmacokinetic Study|An Open Label, Randomised Two Way Crossover Trial to Determine the Pharmacokinetic Profile of an Extended Release Naproxen Sodium Tablet Relative to Aleve Tablets Following Single and Multiple Dose Administration Under Fed Conditions.|Completed||Phase 1|32|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:32:37.979615|2017-02-18 13:32:37.979615
NCT00818402|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-05-28|||August 2008||2008-08-01|May 2015|2015-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|SILKE||Non-small Cell Lung Cancer and Quality of Life|Treatment of Non-small Cell Lung Cancer -Effects on Quality of Life and Symptom Control|Completed||N/A|130|Actual|University of Turku|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:32:38.079235|2017-02-18 13:32:38.079235
NCT00818389|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2011-03-18|2010-05-10||January 2009||2009-01-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)|A Multicenter, Double-Blind, Placebo-Controlled, Study to Investigate the Safety and Efficacy of Lithium in Combination With Riluzole in Volunteers With Amyotrophic Lateral Sclerosis (ALS)|Terminated||Phase 2/Phase 3|84|Actual|Massachusetts General Hospital||2||"NINDS DSMB recommended trial be terminated for futility after reviewing an interim analysis of~   84 subjects."|f||||t||||||||||2017-02-18 13:32:38.153631|2017-02-18 13:32:38.153631
NCT00818376|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-01-29|||June 2006||2006-06-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|November 2006|Actual|2006-11-01||Interventional|||Staining and Calculus Formation After 0.12% Chlorhexidine Rinses|Staining And Calculus Formation After 0.12% Chlorhexidine Rinses In Plaque-Free And Plaque-Covered Surfaces. A Randomized Trial.|Completed||Phase 2|20|Actual|Lutheran University of Brazil|||||f||||t||||||||||2017-02-18 13:32:39.051874|2017-02-18 13:32:39.051874
NCT00818363|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2014-08-20||2010-02-04|December 2008||2008-12-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Safety and Effectiveness Study of SABER™-Bupivacaine for Pain Following Shoulder Surgery|A Double-Blind, Multi-Center, Placebo-Controlled Trial of SABER™-Bupivacaine for Post-Operative Pain Control and Opioid Sparing/Opioid-Related Adverse Event Reduction Following Arthroscopic Shoulder Surgery|Completed||Phase 2|60|Actual|Durect||2|||f||||f||||||||||2017-02-18 13:32:39.14113|2017-02-18 13:32:39.14113
NCT00818350|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2009-01-06|||January 2009||2009-01-01|January 2009|2009-01-01|January 2011|Anticipated|2011-01-01|August 2009|Anticipated|2009-08-01||Interventional|||Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer|Phase II Study of Sunitinib in Metastatic and Pretreated Urothelial Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|25|Actual|Campania Younger Oncologists Association||1|||f||||f||||||||||2017-02-18 13:32:39.251442|2017-02-18 13:32:39.251442
NCT00818337|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-11-06|2011-08-08||November 2008||2008-11-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Aspirin Responsiveness in Women at Risk for Cardiac Events|Aspirin Responsiveness in Women at Risk for Cardiac Events: A Pilot Study.|Completed||Phase 4|36|Actual|Creighton University||1|||f||||t||||||||||2017-02-18 13:32:39.353426|2017-02-18 13:32:39.353426
NCT00818324|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-04|2014-01-07|2014-01-07||January 2009||2009-01-01|January 2014|2014-01-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|||Long Term Administration Study of OPC-12759 Ophthalmic Suspension|Long Term Administration Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients|Completed||Phase 3|154|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 13:32:39.588857|2017-02-18 13:32:39.588857
NCT00818311|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-01-06|||June 2008||2008-06-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects|Evaluation of the Effect of Photomodulation on Skin Safety Profile Following Different Schedules of Exposure to the Light Emitting Diode LED (Gentlewaves®) in Randomized Healthy Subjects|Completed||N/A|100|Actual|L'Oreal||1|||f||||t||||||||||2017-02-18 13:32:39.896317|2017-02-18 13:32:39.896317
NCT00818298|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-07-06|||January 2009||2009-01-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study|24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study|Completed||N/A|12|Actual|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-02-18 13:32:40.013717|2017-02-18 13:32:40.013717
NCT00818285|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-04-25|||September 2008||2008-09-01|April 2013|2013-04-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Reducing Injuries From Medication-Related Falls Using Computerized Alerts for High Risk Patients|Reducing Injuries From Medication-Related Falls by Generating Targeted Computerized Alerts for High Risk Patients Within an Electronic Prescribing System|Unknown status|Recruiting|N/A|4800|Anticipated|McGill University||2|||f||||f||||||||||2017-02-18 13:32:40.136085|2017-02-18 13:32:40.136085
NCT00818272|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-09-02|2011-12-22||December 2002||2002-12-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)|Remicade Safety Line (Crohn's Disease)|Completed||N/A|148|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:32:40.24026|2017-02-18 13:32:40.24026
NCT00818259|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-04-17|2014-10-02||February 2009||2009-02-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||For analysis purposes, baseline (BL) data are presented by study part groups. The BL analysis population includes all unique enrolled participants in Parts I, II, III, IV and V. Part III participants who entered Parts IV and V are only counted in Part III; Part IV participants who entered Part V are only counted in Part IV.|A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)|A Multicenter, Open-Label, 5-Part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Aprepitant and Fosaprepitant Dimeglumine in Pediatric Patients Receiving Emetogenic Chemotherapy|Terminated||Phase 1|92|Actual|Merck Sharp & Dohme Corp.||7||"Study terminated early prior to completing targeted enrollment of participants <6 months of~   age due to recruitment challenges."|f||||f||||||||||2017-02-18 13:32:40.506926|2017-02-18 13:32:40.506926
NCT00818246|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2009-10-07|2009-01-07|||||October 2009|2009-10-01||||||||Interventional|||Light Emitting Diode (LED) for the Treatment of Wrinkles|Non-ablative Light Source for the Treatment of Rhytides (Wrinkles)|Completed||Phase 2/Phase 3|40|Actual|RoseLab Skin Optics Laboratory||2|||f||||f||||||||||2017-02-18 13:32:42.633812|2017-02-18 13:32:42.633812
NCT00818233|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-05-11|||January 2009||2009-01-01|May 2016|2016-05-01||||||||Observational|||Intra-observer and Inter-observer Variability With Dynamic Contour Tonometry.|Intra-observer and Inter-observer Variability With Dynamic Contour Tonometry.|Withdrawn||N/A|0|Actual|Yale University|||1|Difficulty recruiting patients. PI left research facility.|f||||t||||||||||2017-02-18 13:32:43.087626|2017-02-18 13:32:43.087626
NCT00818220|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-05-26|||February 2008||2008-02-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Protective Effects of Delayed Cord Clamping in Very Low Birth Weight (VLBW) Infants|Protective Effects of Delayed Cord Clamping in VLBW Infants|Completed||Phase 2|211|Actual|University of Rhode Island||2|||f||||t||||||||||2017-02-18 13:32:43.179536|2017-02-18 13:32:43.179536
NCT00816348|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2016-01-11|2015-08-07||December 2008||2008-12-01|January 2016|2016-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Compassionate Use of Omegaven IV Fat Emulsion|Compassionate Use of Omegaven IV Fat Emulsion|Terminated||Phase 2|15|Actual|Northwell Health||1|||f||||f||||||||||2017-02-18 13:33:06.722833|2017-02-18 13:33:06.722833
NCT00818207|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-02-29|2012-02-29||March 2009||2009-03-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|ACCESSATION||Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit|A Pragmatic, Randomized, Controlled Study Evaluating The Impact Of Access To Smoking Cessation Treatment Reimbursement On The Proportion Of Successful Quitters In A Canadian Population Of Smokers Motivated To Quit|Completed||Phase 4|1380|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:32:43.29299|2017-02-18 13:32:43.29299
NCT00818194|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2014-07-07|||April 2008||2008-04-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers|A Comparison of Effects of Short-term Low Dose Exposure of Advagraf® and Neoral® Microemulsion Cyclosporine A on Renal Perfusion and Function in Healthy Volunteers|Completed||Phase 1|18|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 13:32:43.927077|2017-02-18 13:32:43.927077
NCT00818181|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2013-03-08|||June 2008||2008-06-01|March 2013|2013-03-01|August 2010|Actual|2010-08-01|February 2009|Actual|2009-02-01||Interventional|||Open Label Safety Study of a Birch Pollen Allergen Extract|A Multicentre Open Label Safety Study of a Sublingual Specific Immunotherapy With a Solution of Birch Pollen Allergen Extract in Patients With Clinically Relevant Birch Pollen Allergy|Completed||Phase 2|73|Actual|Allergopharma GmbH & Co. KG||1|||f||||||||||||||2017-02-18 13:32:44.039798|2017-02-18 13:32:44.039798
NCT00818168|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-09-02|2011-12-22||July 2003||2003-07-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)|Remicade Safety Line (Ankylosing Spondylitis)|Completed||N/A|320|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:32:44.141361|2017-02-18 13:32:44.141361
NCT00818155|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2013-01-28|||January 2009||2009-01-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Desvenlafaxine Succinate Sustained Release Administered Orally to Healthy Chinese Subjects.|Completed||Phase 1|36|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:32:44.408094|2017-02-18 13:32:44.408094
NCT00818142|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-11-30|||January 2008||2008-01-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Support Group Surveys for Individuals Who Have Type 1 Diabetes and an Eating Disorder|Support Group Surveys for Individuals Who Have Type 1 Diabetes and an Eating Disorder|Completed||N/A|16|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-02-18 13:32:44.502754|2017-02-18 13:32:44.502754
NCT00818129|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2009-07-22|||December 2008||2008-12-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|||||Interventional|||Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese|A Phase I, Randomized, Double-Blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7295 Following Single and Multiple Ascending Oral Dose Administration in Healthy Male Japanese Subjects|Completed||Phase 1|62|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:32:44.606111|2017-02-18 13:32:44.606111
NCT00818116|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2010-06-30|2010-06-30||December 2008||2008-12-01|June 2010|2010-06-01||||July 2009|Actual|2009-07-01||Interventional|||Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL|Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric Intraocular Lens (IOL): Postmarket Evaluation|Completed||Phase 4|34|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:32:44.701137|2017-02-18 13:32:44.701137
NCT00818103|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2009-09-27|||January 2006||2006-01-01|September 2009|2009-09-01|January 2016|Anticipated|2016-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Characteristic Study on Chinese Patients With Multiple Sclerosis|Characteristic Study on Chinese Patients With Multiple Sclerosis|Unknown status|Recruiting|N/A|600|Anticipated|Sun Yat-sen University||1|||t||||||||||||||2017-02-18 13:32:44.901509|2017-02-18 13:32:44.901509
NCT00818090|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-04-11|||September 2008||2008-09-01|September 2012|2012-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Paclitaxel and Cisplatin for Thymic Neoplasm|A Phase II Study of Paclitaxel and Cisplatin in Previously Untreated, Unresectable Invasive Thymoma or Thymic Carcinoma|Terminated||Phase 2|39|Actual|Korean Cancer Study Group||1||marginal statistical significance|f||||f||||||||||2017-02-18 13:32:45.015487|2017-02-18 13:32:45.015487
NCT00818077|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-11-30|||January 2008||2008-01-01|August 2013|2013-08-01|September 2010|Actual|2010-09-01|July 2008|Actual|2008-07-01||Observational|||Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food|Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food|Completed||N/A|15|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-02-18 13:32:45.132339|2017-02-18 13:32:45.132339
NCT00818064|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2017-02-08|||December 2008||2008-12-01|February 2017|2017-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis|A Randomised, Double-blind, Placebo-controlled, Single- Dose, Dose-escalation Trial of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis|Completed||Phase 1|32|Anticipated|Novo Nordisk A/S||8|||f||||f||||||||||2017-02-18 13:32:45.236767|2017-02-18 13:32:45.236767
NCT00818051|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2011-01-06|||August 2008||2008-08-01|January 2009|2009-01-01||||||||Interventional|||Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer|Randomized Trial Testing Dose Escalated Intensity Modulated Radiotherapy for Women Treated by Breast Conservation Surgery and Appropriate Systemic Therapy for Early Breast Cancer|Unknown status|Recruiting|Phase 3|840|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 13:32:45.357721|2017-02-18 13:32:45.357721
NCT00818038|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2014-06-25|||March 2009||2009-03-01|June 2014|2014-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|TRUST||A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function|Phase IV, Proof of Concept Study to Evaluate Tysabri Effectiveness in RRMS Patient Bladder Function|Completed||N/A|30|Actual|Biogen|||1||f||||f||||||||||2017-02-18 13:32:45.466083|2017-02-18 13:32:45.466083
NCT00818025|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2016-09-29|||January 2009||2009-01-01|September 2016|2016-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Comparing Methods for Tracking Health Information at Home After Lung Transplant|Phase III Trial of Pocket PATH: A Computerized Intervention to Promote Self-Care|Completed||N/A|211|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:32:45.571912|2017-02-18 13:32:45.571912
NCT00818012|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2014-08-11|||August 2008||2008-08-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|APPRAISE||Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation|Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation In Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm|Completed||N/A|129|Actual|Creighton University|||1||f||||f||||||||||2017-02-18 13:32:45.682373|2017-02-18 13:32:45.682373
NCT00817999|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-08-28|2011-08-08||November 2008||2008-11-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Impact of Grapefruit Juice on the Response to Clopidogrel|The Impact of Grapefruit Juice on the Response to a Loading Dose and Maintenance Dose of Clopidogrel in Healthy Volunteers|Completed||Phase 4|32|Actual|Creighton University||2|||f||||t||||||||||2017-02-18 13:32:45.774246|2017-02-18 13:32:45.774246
NCT00817986|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2016-09-09||2010-09-08|December 2008||2008-12-01|September 2016|2016-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Arbaclofen Placarbil (XP19986) in Subjects With Acute Back Spasms|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of XP19986 in Subjects With Acute Back Spasms|Completed||Phase 2|161|Actual|Indivior Inc.||4|||f||||f||||||||No||2017-02-18 13:32:46.154079|2017-02-18 13:32:46.154079
NCT00817973|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-01-08||||||January 2009|2009-01-01||||||||Interventional|||Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein|Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein|Completed||N/A|12|Actual|Aarhus University Hospital||4|||f||||f||||||||||2017-02-18 13:32:46.280278|2017-02-18 13:32:46.280278
NCT00817960|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2012-06-19|||July 2011||2011-07-01|December 2008|2008-12-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Ritalin on Postural Stability of Old Adults|Effects of Methylphenidate on Postural Stability of Old Adults Under Single and Dual Task Conditions.|Completed||N/A|30|Actual|Soroka University Medical Center||1|||f||||t||||||||||2017-02-18 13:32:46.387489|2017-02-18 13:32:46.387489
NCT00817947|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2009-01-06|||January 2007||2007-01-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Airway Clearance Using High Frequency Chest Wall Oscillation|An Assessment of the Short-Term Effects of the Airway Clearance Technique of High Frequency Chest Wall Oscillation in People With Cystic Fibrosis|Completed||Phase 3|30|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:32:46.58915|2017-02-18 13:32:46.58915
NCT00817934|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2009-01-06|||January 2009||2009-01-01|January 2009|2009-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|ABP||Safe, Effective, and More Tolerable 16 Tablets Colon Prep|Phase III of the AB Prep Safety and Efficacy in Colon Cleansing|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|Long Neck Medical Enterprises|||1||f||||t||||||||||2017-02-18 13:32:46.684826|2017-02-18 13:32:46.684826
NCT00817921|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2014-02-04|||November 2008||2008-11-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|SUIVIREIN||Effect of Prematurity on Renal Function in 5 Years Old Children|Effect of Prematurity on Renal Function in 5 Years Old Children Comparison of Former Premature Children Treated by Ibuprofen in the Neonatal Period to Controls|Completed||N/A|168|Actual|Maternite Regionale Universitaire|||3||f||||f||||||Samples Without DNA|"~     Blood and urine samples~   "|||2017-02-18 13:32:46.781007|2017-02-18 13:32:46.781007
NCT00817908|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-04-20|||May 2008||2008-05-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Observational|||Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients|Quantiferon - CMV and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients|Completed||N/A|131|Actual|University of Alberta|||1||f||||f||||||||||2017-02-18 13:32:46.874334|2017-02-18 13:32:46.874334
NCT00817895|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-04|2016-03-29|||December 2008||2008-12-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence|Clinical Randomized Control Trial of Intraoperative Implanting Chemotherapeutic Drugs Sustained Release Following Resection of Hepatocellular Carcinoma Against Postoperative Short-term Recurrence|Completed||N/A|150|Actual|Eastern Hepatobiliary Surgery Hospital||3|||f||||t||||||||||2017-02-18 13:32:46.968952|2017-02-18 13:32:46.968952
NCT00817882|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2010-11-22|||May 2009||2009-05-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Working Well With Back Pain (Feasibility RCT of Vocational Rehabilitation)|Changing Perceptions of Work Ability in People With Low Back Pain: Feasibility Randomised Controlled Trial and Economic Evaluation.|Completed||Phase 1/Phase 2|52|Actual|University of Nottingham||2|||f||||f||||||||||2017-02-18 13:32:47.083759|2017-02-18 13:32:47.083759
NCT00817869|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2014-11-28|||April 2010||2010-04-01|November 2014|2014-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||The HIP-HOP Flooring Study: Helping Injury Prevention in Hospitalised Older People|Pilot Cluster Randomised Controlled Trial of Flooring to Reduce Injuries From Falls in Elderly Care Units|Completed||N/A|571|Actual|University of Portsmouth||2|||f||||f||||||||||2017-02-18 13:32:47.179685|2017-02-18 13:32:47.179685
NCT00817843|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2013-01-04|2012-06-18||April 2009||2009-04-01|January 2013|2013-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|PANACEA||The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study|Multicenter,Double Blind,Randomized, 2-period, Crossover Study to Compare Ezetimibe/Simvastatin (10mg/10 mg) Combination Tablet Versus Simvastatin 80mg Tablet on Postprandial Arterial Endothelial Function in Patients With Metabolic Syndrome|Completed||Phase 4|100|Actual|UMC Utrecht|One limitation is that the study was conducted in obese patients with the metabolic syndrome.|2|||f||||f||||||||||2017-02-18 13:32:47.295821|2017-02-18 13:32:47.295821
NCT00817830|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-07-15|||November 2008||2008-11-01|June 2011|2011-06-01|October 2009||2009-10-01|May 2009||2009-05-01||Interventional|||Cardiovascular Safety Study of Lodenafil Carbonate in Patients With Coronaropathy During Physical Effort|Cardiovascular Safety Evaluation in Patients With Coronary Artery Disease During Physical Effort After Use Lodenafil Carbonate|Withdrawn||Phase 4|0|Actual|Cristália Produtos Químicos Farmacêuticos Ltda.||1||Difficulty in patient recruitment|f||||t||||||||||2017-02-18 13:32:47.739376|2017-02-18 13:32:47.739376
NCT00817817|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-06|2015-05-04|||October 2002||2002-10-01|May 2015|2015-05-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524)|An Open-Label, Comparative, Randomized, Parallel, Multicenter Study to Determine the Efficacy and Safety of Two Dry Powder Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma|Completed||Phase 3|93|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:32:47.850499|2017-02-18 13:32:47.850499
NCT00817804|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-03|2009-08-12|2009-05-05||January 2009||2009-01-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators|Cross-over Comparison of the V60 System to Other Bi-Level Noninvasive Ventilators for Pediatric Patients With Respiratory Failure or Respiratory Insufficiency|Completed||N/A|3|Actual|Respironics, California, Inc.|Terminated before 20 patients enrolled|2|||f||||f||||||||||2017-02-18 13:32:47.953871|2017-02-18 13:32:47.953871
NCT00817791|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-06-12|||November 2007||2007-11-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Interventional|||Preconditioning With Hyperbaric Oxygen in Cardiovascular Surgery|Phase 1 Study of Protective Effect of Hyperbaric Oxygen Preconditioning on Brain and Myocardium Injury During CABG Surgery|Completed||N/A|49|Actual|Xijing Hospital||1|||f||||t||||||||||2017-02-18 13:32:48.34905|2017-02-18 13:32:48.34905
NCT00817778|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2012-10-16|2012-07-24||January 2009||2009-01-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin|A Randomised, Single-Blind, Placebo-Controlled, Phase IIA Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin|Completed||Phase 2|27|Actual|AstraZeneca|"The primary objective of the study was to assess safety and tolerability and hence the study was not sized based on statistical considerations. The most import outcome, no safety or tolerability concerns were identified, is not a numerical variable"|2|||f||||f||||||||||2017-02-18 13:32:48.453294|2017-02-18 13:32:48.453294
NCT00817765|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2009-11-27|||January 2009||2009-01-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|EPOS||Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir|Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir|Completed||Phase 1|24|Anticipated|Radboud University||3|||f||||f||||||||||2017-02-18 13:32:48.971041|2017-02-18 13:32:48.971041
NCT00817622|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-03|2009-11-17|||January 2007||2007-01-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|EPA||Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DM|Effects of EPA Alone and Combined With Vitamin E on Blood Leptin, Adiponectin and Enzymatic Antioxidants Levels in Type II Diabetic Patients; A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 4|129|Actual|Tehran University of Medical Sciences||4|||f||||t||||||||||2017-02-18 13:32:49.097891|2017-02-18 13:32:49.097891
NCT00817609|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2010-05-26||||||September 2009|2009-09-01||||||||Interventional|||Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke||Unknown status|Not yet recruiting|Phase 2/Phase 3|60|Anticipated|Fudan University||2|||f||||||||||||||2017-02-18 13:32:49.213456|2017-02-18 13:32:49.213456
NCT00817596|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2012-08-13|2012-03-02||January 2007||2007-01-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|March 2008|Actual|2008-03-01||Interventional|PUMP||Prometra's Utilization in Mitigating Pain (PUMP)|Prometra's Utilization in Mitigating Pain (PUMP)|Completed||N/A|110|Actual|Flowonix Medical||1|||f||||f||||||||||2017-02-18 13:32:49.320719|2017-02-18 13:32:49.320719
NCT00817583|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2009-01-26|||January 2009||2009-01-01|January 2009|2009-01-01|July 2011|Anticipated|2011-07-01|July 2010|Anticipated|2010-07-01||Interventional|TPF for NPC||Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)|Phse II Study of Induction Chemotherapy With TPF Regimen Followed by Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma|Unknown status|Not yet recruiting|Phase 2|100|Anticipated|Fudan University||1|||f||||t||||||||||2017-02-18 13:32:49.541|2017-02-18 13:32:49.541
NCT00817570|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-04|2009-10-21|||April 2009||2009-04-01|October 2009|2009-10-01||||||||Observational|||Evaluation of Balance Reactions of Transfemoral Amputees Using the Virtual Analysis System|Evaluation of Balance Reactions of Transfemoral Amputees Using the Virtual|Suspended||N/A|60|Anticipated|Sheba Medical Center|||3||f||||f||||||||||2017-02-18 13:32:49.653198|2017-02-18 13:32:49.653198
NCT00817557|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-01-05|||January 2009||2009-01-01|January 2009|2009-01-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|||Use of Loteprednol for Contact Lens Intolerance and Dryness|Use of Loteprednol for Contact Lens Intolerance and Dryness|Unknown status|Enrolling by invitation|Phase 4|25|Anticipated|Hom, Milton M., OD, FAAO||2|||f||||t||||||||||2017-02-18 13:32:49.727548|2017-02-18 13:32:49.727548
NCT00817544|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2009-03-13|||January 2009||2009-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|ALMAS||Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741|Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741; an Open, Non-Randomised, Single Centre Study in Healthy Male Subjects|Completed||Phase 1|6|Anticipated|Orion Corporation, Orion Pharma||1|||f||||f||||||||||2017-02-18 13:32:49.82499|2017-02-18 13:32:49.82499
NCT00817531|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2012-08-27|2012-05-07||December 2008||2008-12-01|August 2012|2012-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients|A Biologic Efficacy Study of Dasatinib, a Multi-Targeted Tyrosine Kinase, in Locally Advanced Triple-Negative Breast Cancer Patients Developing Effective Therapies for Er-Negative Breast Cancer Using Genomics and Proteomics: Project 3|Terminated||Phase 2|22|Actual|Baylor Breast Care Center|The study was terminated after internal analysis due to treatment futility. It does not meet the required number of responses to continue the study.|1||terminated due to futility after interim analysis|f||||t||||||||||2017-02-18 13:32:49.932905|2017-02-18 13:32:49.932905
NCT00817518|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-09-01|||January 2009||2009-01-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors|An Open-label, Dose-escalation Study With Extension to Evaluate Safety, Pharmacokinetics and Anti-tumor Activity of RO4987655, a MEK Inhibitor, Administered Orally as Monotherapy in Patients With Advanced Tumors|Completed||Phase 1|145|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:32:50.194454|2017-02-18 13:32:50.194454
NCT00817505|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2009-11-02|||December 2008||2008-12-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||To Evaluate the Bioavailability of a Tablet of AZD1656|A Randomized, Open, Single-Dose, Single-Centre, Cross-over, Phase I Study in Type 1 Diabetes Mellitus Patients to Estimate the Extent and Rate of Absorption of AZD1656 After Administration of a Tablet Formulation in the Fasting State and Just Before Food in Comparison With an Oral Suspension of AZD1|Completed||Phase 1|11|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 13:32:50.304865|2017-02-18 13:32:50.304865
NCT00817492|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-09-04|||July 2006||2006-07-01|September 2013|2013-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|CRIC||Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois|Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease|Completed||N/A|89|Actual|University of Chicago|||2||f||||f||||||||||2017-02-18 13:32:50.39817|2017-02-18 13:32:50.39817
NCT00817479|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2016-06-02|2016-06-02||January 2003||2003-01-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Tumor Gene Expression in Women With Ovarian Cancer|Tumor Gene Expression Before and After Intraoperative Dexamethasone in Women With Ovarian Cancer|Completed||Phase 4|20|Actual|University of Chicago||2|||f||||t||||||||No||2017-02-18 13:32:50.595857|2017-02-18 13:32:50.595857
NCT00817466|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2012-11-01|||January 2010||2010-01-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|June 2011|Actual|2011-06-01||Interventional|||Bronchiolitis All-study, SE-Norway|Bronchiolitis All-study, SE-Norway What is the Optimal Inhalation Treatment for Children 0-12 Months With Acute Bronchiolitis?|Unknown status|Active, not recruiting|Phase 4|500|Anticipated|Oslo University Hospital||4|||f||||t||||||||||2017-02-18 13:32:50.929504|2017-02-18 13:32:50.929504
NCT00817453|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2011-04-12|||January 2009||2009-01-01|April 2011|2011-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|EPDX||Early Parkinson's Disease (PD) Cross-Sectional|Cross-Sectional Cohort Study of Laboratory and Clinical Patterns in Early PD|Terminated||N/A|150|Anticipated|The University of Texas Health Science Center, Houston|||3|All subjects transferred to long term study NCT00817726 RBD Longitudinal|f||||f||||||Samples With DNA|"~     CSF and serum~   "|||2017-02-18 13:32:51.055672|2017-02-18 13:32:51.055672
NCT00817440|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2011-01-10|||December 2008||2008-12-01|January 2011|2011-01-01||||May 2009|Actual|2009-05-01||Interventional|FEIGH||Effects of Fasting and Exercise on Insulin and GH Signaltransduction in Muscle and Fat|Effects of Fasting and Exercise on Insulin and GH Signaltransduction in Muscle and Fat|Completed||N/A|8|Actual|University of Aarhus||3|||f||||||||||||||2017-02-18 13:32:51.151441|2017-02-18 13:32:51.151441
NCT00817427|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-09-04|||October 2008||2008-10-01|September 2013|2013-09-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|CRIC||Sleep Disturbances as a Risk Factor in Chronic Kidney Disease|Sleep Disturbance as a Non-Traditional Risk Factor in CKD|Completed||N/A|40|Actual|University of Chicago||3|||f||||f||||||||||2017-02-18 13:32:51.245861|2017-02-18 13:32:51.245861
NCT00817414|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2012-11-30||2012-11-30|December 2008||2008-12-01|November 2012|2012-11-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||An Evaluation of the Effects of LCI699 on Cortisol in Patients With Hypertension|A Phase II, Randomized, Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Effects of LCI699 on Cortisol in Patients With Hypertension|Completed||Phase 2|63|Actual|Novartis||6|||f||||f||||||||||2017-02-18 13:32:51.348261|2017-02-18 13:32:51.348261
NCT00817401|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-01-05|||July 2002||2002-07-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy|Effect of Systemic Hypothermia on Neonatal Hypoxic-Ischemic Encephalopathy|Completed||Phase 1/Phase 2|100|Actual|Zhengzhou University||1|||f||||t||||||||||2017-02-18 13:32:51.466898|2017-02-18 13:32:51.466898
NCT00817388|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2010-06-04|||January 2009||2009-01-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Correlating Ic/Pbs Symptoms With Urine Biomarkers|Correlating Ic/Pbs Symptoms With Urine Biomarkers|Completed||N/A|26|Actual|William Beaumont Hospitals|||1||f||||f||||||Samples Without DNA|"~     Urine specimen.~   "|||2017-02-18 13:32:51.562064|2017-02-18 13:32:51.562064
NCT00817375|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-12-30|||February 2003||2003-02-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients|Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients|Recruiting||N/A|1000|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-02-18 13:32:51.662688|2017-02-18 13:32:51.662688
NCT00817362|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2012-12-07||2012-12-06|March 2009||2009-03-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|August 2010|Actual|2010-08-01||Interventional|||Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer|A Phase 2 Multicenter Study Evaluating the Efficacy and Safety of IPI-504 in Combination With Trastuzumab in Patients With Pretreated, Locally Advanced or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer|Terminated||Phase 2|29|Actual|Infinity Pharmaceuticals, Inc.||1||Limited efficacy response observed during interim analysis.|f||||f||||||||||2017-02-18 13:32:51.782927|2017-02-18 13:32:51.782927
NCT00817349|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2010-04-23|||July 2008||2008-07-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Angio-Seal Evolution Device Registry|Clinical Registry of the St. Jude Medical Angio-Seal(TM) Evolution(TM) Vascular Closure Device Following Diagnostic and/or Interventional Endovascular Procedures|Completed||N/A|1004|Actual|St. Jude Medical|||1||f||||f||||||||||2017-02-18 13:32:51.912358|2017-02-18 13:32:51.912358
NCT00817336|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-04-15|||June 2009||2009-06-01|June 2011|2011-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Biomarkers in Schizophrenia|Effect of an NMDA-based Intervention on Biomarker Measures of Cognitive Dysfunction in Schizophrenia|Completed||Phase 2|16|Actual|Nathan Kline Institute for Psychiatric Research||2|||f||||t||||||||||2017-02-18 13:32:52.008124|2017-02-18 13:32:52.008124
NCT00817323|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2014-07-04|||January 2009||2009-01-01|July 2014|2014-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?|What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression? Evidence From Selective Neurotransmitter Depletion Studies|Withdrawn||Phase 3|0|Actual|University of British Columbia||1||"Recruitment did not take place for this research due to several delays and then one of the PIs~   moved out of the country and the project was closed"|f||||f||||||||||2017-02-18 13:32:52.111614|2017-02-18 13:32:52.111614
NCT00817310|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-12-16|||January 2009||2009-01-01|December 2013|2013-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)|Influence of Altered Cerebral Spinal Fluid and Arterial Flows on Cerebral Processing Functions in Premature Infants With Severe Intraventricular Hemorrhage|Completed||N/A|60|Actual|Vanderbilt University|||2||f||||t||||||||||2017-02-18 13:32:52.216989|2017-02-18 13:32:52.216989
NCT00817297|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-03|2015-06-27|||January 2009||2009-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:32:52.294238|2017-02-18 13:32:52.294238
NCT00817284|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-11-29|||November 2008||2008-11-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)|A Randomized Phase II Trial With Bevacizumab, Irinotecan and Cerebral Radiotherapy Versus Bevacizumab, Temozolomide and Cerebral Radiotherapy as First Line Treatment for Patients With Glioblastoma Multiforme|Completed||Phase 2|60|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 13:32:52.338845|2017-02-18 13:32:52.338845
NCT00817271|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2009-05-06|||February 2009||2009-02-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||To Evaluate the Response to Glucagon During Hypoglycemia|A Randomised, Open, Two-Way Cross-Over, Phase I Study to Evaluate the Response to Glucagon Versus the Spontaneous Counter-Regulatory Response in T2DM Patients Treated With AZD1656 and Metformin During Hypoglycemia|Completed||Phase 1|8|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:32:54.745043|2017-02-18 13:32:54.745043
NCT00817258|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-01-05|||January 2007||2007-01-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma|Phase Ⅱ Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2|37|Anticipated|Fudan University||1|||f||||t||||||||||2017-02-18 13:32:55.071761|2017-02-18 13:32:55.071761
NCT00817245|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-01|2009-01-05|||March 2008||2008-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|ICSCR||Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)|Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)|Completed||Phase 1/Phase 2|50|Actual|Tabriz University||2|||f||||t||||||||||2017-02-18 13:32:55.21379|2017-02-18 13:32:55.21379
NCT00817232|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2010-06-18|||December 2008||2008-12-01|August 2009|2009-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effectiveness of Microcurrent for Treatment of Tennis Elbow|Effectiveness of Microcurrent in the Treatment of Chronic Tennis Elbow - a Preliminary Trial|Completed||Phase 2/Phase 3|24|Anticipated|University of Hertfordshire||2|||f||||f||||||||||2017-02-18 13:32:55.324708|2017-02-18 13:32:55.324708
NCT00817219|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-03-25|2012-12-04||July 2009||2009-07-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris|Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris|Completed||Phase 2|33|Actual|LEO Pharma||1|||f||||f||||||||||2017-02-18 13:32:55.436421|2017-02-18 13:32:55.436421
NCT00817206|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-08-11|2015-08-11||December 2008||2008-12-01|August 2015|2015-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional||Demographic information is given for all randomized subjects.|Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily|Ph3, Open Label, Multi-Ctr, Pros, Rand Study -Efficacy and Safety, Conversion Prograf® Capsules BID to LCPTacro Tablets QD, for Prevent of Acute Allograft Rejection in Stable Kidney Transplant pt.|Completed||Phase 3|326|Actual|Veloxis Pharmaceuticals||2|||f||||t||||||||||2017-02-18 13:32:55.737892|2017-02-18 13:32:55.737892
NCT00817193|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2010-05-27|||January 2009||2009-01-01|May 2010|2010-05-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|STEP||Staying Healthy Through Education and Prevention Study|Early Screening and Exercise for Prevention of Disability in Persons Residing in Continuing Care Retirement Communities|Unknown status|Active, not recruiting|N/A|320|Anticipated|American Association of Homes and Services for the Aging||2|||f||||f||||||||||2017-02-18 13:32:57.002765|2017-02-18 13:32:57.002765
NCT00817180|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2014-03-14|||October 2008||2008-10-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Interventional|||Long-term Study, Comparing Vest Therapy to Positive Expiratory Pressure (PEP) Therapy in the Treatment of Cystic Fibrosis|Multi-centre, Long-term Comparative Trial of High Frequency Chest Wall Oscillation Versus Positive Expiratory Pressure Mask in the Treatment of Cystic Fibrosis|Completed||Phase 2|107|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 13:32:57.131264|2017-02-18 13:32:57.131264
NCT00817167|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-01|2014-11-17|||January 2009||2009-01-01|November 2014|2014-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Added Value of inReach Software on Performance Characteristics of Standard Bronchoscopy|Open Label, Randomized, Comparative, Single Center, Pilot Study to Assess the Added Value of inReach Technology Software on Performance Characteristics of Standard Bronchoscopy.|Completed||N/A|30|Actual|superDimension Ltd.||2|||f||||f||||||||||2017-02-18 13:32:57.269343|2017-02-18 13:32:57.269343
NCT00817154|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2014-05-05|||November 2009||2009-11-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI)|Individually Based Psychosocial Rehabilitation for Older People With SMI|Completed||Phase 1|38|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 13:32:57.372494|2017-02-18 13:32:57.372494
NCT00817141|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2010-01-12|||March 2008||2008-03-01|March 2008|2008-03-01||||||||Observational|||Urinary Catheter and Fast-track Surgery|Is Urinary Catheter Necessary After Fast-Track Colonic Surgery?|Completed||N/A|50|Anticipated|Université Catholique de Louvain|||1||f||||f||||||||||2017-02-18 13:32:57.465534|2017-02-18 13:32:57.465534
NCT00817128|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-07-23|||January 2009||2009-01-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|PEPTOC||Pain Exposure Physical Therapy (PEPT) Versus CBO in Patients With Complex Regional Pain Syndrome Type I (CRPS-1)|Pain Exposure Physical Therapy Or Conservative Therapy for Patients With Complex Regional Pain Syndrome Type I|Completed||Phase 2/Phase 3|62|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 13:32:57.546125|2017-02-18 13:32:57.546125
NCT00817115|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2009-08-06|||February 2009||2009-02-01|January 2009|2009-01-01||||December 2009|Anticipated|2009-12-01||Interventional|||Evaluation of Exposure Reduction Using Region-of-Interest Fluoroscopy (X-ray Fovea Imaging) in Cardiac Interventions|Trial to Determine Non-inferiority of Exposure Dose Reduction and Diagnostic Performance of Region-of-Interest Fluoroscopy (X-ray Fovea Imaging) Compared to Standard Fluoroscopy in Patients Undergoing Cardiac Interventional Procedures|Unknown status|Active, not recruiting|Phase 1|75|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||||||||||||2017-02-18 13:32:57.656048|2017-02-18 13:32:57.656048
NCT00817102|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2014-04-14|||November 2008||2008-11-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|November 2011|Actual|2011-11-01||Interventional|||Validation of Stenosis Assessment by Coronary Artery Computed Tomography Against Invasive Measurements of Fractional Flow Reserve in Patients With Significant Coronary Artery Stenoses||Completed||N/A|25|Actual|Piedmont Healthcare||1|||f||||f||||||||||2017-02-18 13:32:57.753881|2017-02-18 13:32:57.753881
NCT00817089|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2011-08-03|||December 2007||2007-12-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|DEFINE II||Understanding Treatment Response With Naltrexone Among White Alcoholics|Defining an Endopheneotype for Alcohol Treatment With Naltrexone|Completed||Phase 4|40|Anticipated|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 13:32:57.853271|2017-02-18 13:32:57.853271
NCT00817076|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-04-20|||March 2003||2003-03-01|April 2015|2015-04-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)|Evaluation of the Efficacy and Safety of Desloratadine Syrup in Childhood Atopic Dermatitis|Completed||Phase 3|40|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:32:58.16063|2017-02-18 13:32:58.16063
NCT00817063|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2013-04-18||2013-02-14|January 2009||2009-01-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|HANDEL||Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema|Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy|Completed||Phase 3|600|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:32:58.246907|2017-02-18 13:32:58.246907
NCT00817050|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-06-29|||December 2004||2004-12-01|June 2015|2015-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)|A Preference Evaluation of Nasonex® Nasal Spray (Unscented) vs. Flonase® Nasal Spray (Scented) in Subjects With Symptomatic Allergic Rhinitis (AR) - Single-Dose Cross-over|Completed||Phase 4|100|Actual|Merck Sharp & Dohme Corp.||2|||t||||f||||||||||2017-02-18 13:32:58.417982|2017-02-18 13:32:58.417982
NCT00817037|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2009-01-05|||May 2007||2007-05-01|January 2009|2009-01-01||||March 2009|Anticipated|2009-03-01||Interventional|||Sitaxsentan in Proteinuric Chronic Kidney Disease|The Effect of Sitaxsentan Once Daily Dosing on Proteinuria, 24-Hour Systemic Blood Pressure, and Arterial Stiffness in Subjects With Chronic Kidney Disease|Unknown status|Active, not recruiting|Phase 2|27|Actual|University of Edinburgh||3|||f||||t||||||||||2017-02-18 13:32:58.506156|2017-02-18 13:32:58.506156
NCT00817024|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-04|2012-05-31|||March 2008||2008-03-01|January 2009|2009-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)|Clinical Study of Herbal Formula in Post PCI Patients.|Completed||N/A|90|Anticipated|Guang'anmen Hospital of China Academy of Chinese Medical Sciences||3|||f||||t||||||||||2017-02-18 13:32:58.611379|2017-02-18 13:32:58.611379
NCT00817011|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-12-30|||April 2006||2006-04-01|December 2015|2015-12-01|March 2018|Anticipated|2018-03-01|December 2016|Anticipated|2016-12-01||Interventional|PG||Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness|Phase 4 Study of Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness|Recruiting||N/A|1000|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-02-18 13:32:58.710866|2017-02-18 13:32:58.710866
NCT00816998|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2011-04-06|||October 2006||2006-10-01|April 2011|2011-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Range of Motion and Patients With Distal Radius Fractures|The Effect of Early vs. Delayed Range of Motion in the Outcome of Patients With Distal Radius Fractures|Completed||N/A|39|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:32:58.838149|2017-02-18 13:32:58.838149
NCT00816985|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2016-09-09|||June 2008||2008-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Liposuction for Arm Lymphedema Following Breast Cancer Surgery|Liposuction for Arm Lymphedema Following Breast Cancer Surgery|Active, not recruiting||Phase 2|7|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 13:32:58.940202|2017-02-18 13:32:58.940202
NCT00816972|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2015-07-21|||April 2005||2005-04-01|July 2015|2015-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)|Pilot Efficacy and Safety Field Trial of Desloratadine Administered Concomitantly With Oxybutynin, in Subjects With Seasonal Allergic Rhinitis and Post-Nasal Drip|Completed||Phase 2|540|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 13:32:59.037199|2017-02-18 13:32:59.037199
NCT00816959|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-05|2011-07-19|||July 2011||2011-07-01|July 2011|2011-07-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma|Phase III Randomized, Multi-center Study to Evaluate the Effect of R-mabHDI in Patients With Lymphocytic Predominant Hodgkin's Lymphoma|Unknown status|Not yet recruiting|Phase 3|1200|Anticipated|American Scitech International||2|||f||||f||||||||||2017-02-18 13:32:59.133935|2017-02-18 13:32:59.133935
NCT00816946|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2011-08-09|||July 2008||2008-07-01|January 2009|2009-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|NF Nutrition||District-based Mainstreaming Nutrition Project in Rural Pakistan|Scaling up Evidence-based Nutrition Interventions to Address Maternal and Child Health Outcomes in Pakistan: a District-based Demonstration Project in Rural Sindh|Completed||N/A|3000|Actual|Aga Khan University||2|||f||||f||||||||||2017-02-18 13:32:59.240677|2017-02-18 13:32:59.240677
NCT00816933|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-01-05|||January 2009||2009-01-01|January 2009|2009-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Trial on Postoperative Outcomes According to the Number of Trocar During Laparoscopic Appendectomy|Prospective Randomized Trial on the Assessment of Postoperative Outcomes According to the Number of Trocar During Laparoscopic Appendectomy|Unknown status|Recruiting|Phase 1|140|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-02-18 13:32:59.349198|2017-02-18 13:32:59.349198
NCT00816907|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2013-02-13|2013-01-03||January 2009||2009-01-01|November 2010|2010-11-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|METS||The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)|Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (METS) - Pilot Study|Completed||Phase 4|146|Actual|National Institute of Mental Health (NIMH)|Changes over periods of more than 16 weeks are unknown.|2|||f||||t||||||||||2017-02-18 13:32:59.557636|2017-02-18 13:32:59.557636
NCT00816894|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-01|2013-12-09|||January 2009||2009-01-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||D-serine Monotherapy for Schizophrenia|D-serine Antipsychotic Monotherapy for Treatment Refractory Schizophrenia|Completed||Phase 2|18|Actual|Herzog Hospital||2|||f||||t||||||||||2017-02-18 13:33:00.035856|2017-02-18 13:33:00.035856
NCT00816881|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2012-06-21|||January 2009||2009-01-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Application and Generalization of Flutter Mucus Clearance Device|Application and Generalization of Flutter Mucus Clearance Device|Completed||N/A|356|Actual|Tongji University||2|||f||||t||||||||||2017-02-18 13:33:00.153505|2017-02-18 13:33:00.153505
NCT00816868|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2012-02-28|||January 2009||2009-01-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|May 2010|Actual|2010-05-01||Interventional|||A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung|A Phase II Study of Erlotinib in Combination With Capecitabine as First-line Treatment in Elderly Patients With Stage IIIB/IV Adenocarcinoma Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|62|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-02-18 13:33:00.276988|2017-02-18 13:33:00.276988
NCT00816855|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-01-02|||February 2007||2007-02-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma|Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2|52|Anticipated|Fudan University||1|||f||||t||||||||||2017-02-18 13:33:00.597712|2017-02-18 13:33:00.597712
NCT00816842|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-01-02|||October 1998||1998-10-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Observational|||Plasma Citrulline Concentration in Tropical Enteropathy|Plasma Citrulline as Quantitative Biomarker of HIV Associate Villous Atrophy in a Tropical Enteropathy Population|Completed||N/A|||Azienda Ospedaliero-Universitaria di Parma|||||f||||||||||||||2017-02-18 13:33:00.712485|2017-02-18 13:33:00.712485
NCT00816829|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-07-17|2009-01-08||September 2005||2005-09-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Fenofibrate on Sleep Apnea Syndrome|A 1-month, Randomized, Double-blind, Placebo-controlled Study of Fenofibrate 145 mg Tablet in Patients With Sleep Apnea Syndrome|Terminated||Phase 2|34|Actual|Solvay Pharmaceuticals|Only treatment emergent events have been presented. They are defined as events started at or after the 1st administration of study medication and includes events started prior to the 1st administration but which worsened after the 1st intake.|2||The study was prematurely terminated because of slow recruitment|f||||f||||||||||2017-02-18 13:33:00.821958|2017-02-18 13:33:00.821958
NCT00816816|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2009-01-02|||February 2007||2007-02-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma|Phase ⅡStudy of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2|64|Anticipated|Fudan University||1|||f||||t||||||||||2017-02-18 13:33:01.356989|2017-02-18 13:33:01.356989
NCT00816803|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2009-01-02|||May 2005||2005-05-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Cell Transplant in Spinal Cord Injury Patients|Autologous Bone Marrow Derived Cell Transplant in Spinal Cord Injury Patients|Completed||Phase 1/Phase 2|80|Actual|Cairo University||2|||f||||t||||||||||2017-02-18 13:33:01.464542|2017-02-18 13:33:01.464542
NCT00816790|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2015-09-10|||January 2009||2009-01-01|September 2015|2015-09-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock|A Comparison of Standard Vs Renal Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock|Terminated||Phase 4|20|Anticipated|Fraser Health||2||Study stopped because of study personel movement to another institution.|f||||f||||||||||2017-02-18 13:33:01.562626|2017-02-18 13:33:01.562626
NCT00816777|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2015-08-17|2014-08-12||December 2008||2008-12-01|August 2015|2015-08-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|PARAGON||Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer|Feasibility and Prospective Randomized Study of Transarterial Chemoembolization Using Irinotecan Bead in Combination With Second Line Chemotherapy in the Treatment of Patients With Unresectable Metastatic Colorectal Cancer|Terminated||Phase 1/Phase 2|4|Actual|Generic Devices Consulting, Inc.||2||Lack of enrollment|f||||f||||||||||2017-02-18 13:33:01.695565|2017-02-18 13:33:01.695565
NCT00816764|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-01|2013-02-26|||October 2008||2008-10-01|November 2010|2010-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer|A Phase 1, Open-label, Multi-center, Dose Escalation Study of the Safety and Pharmacokinetics of AGS-8M4 Given as Monotherapy in Subjects With Advanced Ovarian Cancer|Completed||Phase 1|18|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-02-18 13:33:02.114717|2017-02-18 13:33:02.114717
NCT00816751|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2009-01-02|||December 2007||2007-12-01|January 2009|2009-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Paracervical Versus Intracervical Lidocaine|Paracervical Versus Intracervical Lidocaine for Suction Curettage: A Randomized Controlled Trial|Completed||N/A|132|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 13:33:02.228814|2017-02-18 13:33:02.228814
NCT00816738|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2009-01-02|||January 2008||2008-01-01|December 2008|2008-12-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Observational|||Evaluation of the Treatment of Recurrent Corneal Erosions by Anterior Stromal Puncture With Nd: YAG Laser|Evaluation of the Treatment of Recurrent Corneal Erosions by Anterior Stromal Puncture With Nd: YAG Laser|Completed||N/A|33|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:33:02.332725|2017-02-18 13:33:02.332725
NCT00815997|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2013-09-02|||January 2009||2009-01-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|NAUSICA||Novel Angioplasty Using Coronary Accessor|Novel Angioplasty USIng Coronary Accessor|Completed||N/A|177|Actual|NAUSICA Investigators||2|||f||||t||||||||||2017-02-18 13:33:12.723088|2017-02-18 13:33:12.723088
NCT00816712|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2015-02-12|||January 2008||2008-01-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (MK-0000-064)|A Randomized, Single-Blind, Placebo-Controlled, Single-dose, Parallel Design Study to Evaluate the Effect of Testosterone on Muscle Fractional Synthetic Rate (FSR)|Completed||Phase 1|28|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 13:33:02.534078|2017-02-18 13:33:02.534078
NCT00816699|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-01|2011-03-10|||December 2008||2008-12-01|March 2011|2011-03-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Effects of Providing Preprint Preoperative Anesthetic Risk Information|Effects of Providing Preprint Preoperative Anesthetic Risk Information|Completed||Phase 1/Phase 2|103|Actual|Mahidol University||2|||f||||f||||||||||2017-02-18 13:33:02.625877|2017-02-18 13:33:02.625877
NCT00816686|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-01|2013-02-26|||October 2008||2008-10-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer|A Phase 1, Open-Label, Multi-center, Dose Escalation Study of the Safety and Pharmacokinetics of AGS-16M18 Given as Monotherapy in Subjects With Advanced Renal Cell Carcinoma|Terminated||Phase 1|7|Actual|Astellas Pharma Inc||5||Trial was terminated due to the need to re-formulate the study drug.|f||||f||||||||||2017-02-18 13:33:02.722393|2017-02-18 13:33:02.722393
NCT00816673|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2009-01-04|||September 1996||1996-09-01|January 2009|2009-01-01|September 1997|Actual|1997-09-01|May 1997|Actual|1997-05-01||Interventional|Neu I||Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs|Phase II Study of Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs.|Completed||Phase 2|40|Actual|Neurim Pharmaceuticals Ltd.||2|||f||||||||||||||2017-02-18 13:33:02.832904|2017-02-18 13:33:02.832904
NCT00816660|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-02|2015-06-26|||December 2008||2008-12-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease|Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability in Type 3 Von Willebrand Disease (VWD)|Completed||Phase 1|32|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-02-18 13:33:02.934181|2017-02-18 13:33:02.934181
NCT00816647|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2011-06-13|||December 2008||2008-12-01|July 2009|2009-07-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|||A Prospective Randomized Study of Medial Patellofemoral Ligament (MPFL) Reconstruction|A Prospective Randomized Study of Medial Patellofemoral Ligament Reconstruction Compared With Medial Reefing|Terminated||N/A|50|Anticipated|Finnish Defense Forces||2||"Stopped for benefit of the MPFL reconstruction arm and due to safety concerns of the medial~   reefing arm."|f||||f||||||||||2017-02-18 13:33:03.049673|2017-02-18 13:33:03.049673
NCT00816634|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2011-09-06|||October 2008||2008-10-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|XP versus XT||Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma|A Randomized Phase II Trial of Capecitabine Plus Cisplatin (XP) Versus Capecitabine Plus Paclitaxel (XT) as a First-line Treatment for Advanced or Recurrent Esophageal Squamous Cell Carcinoma|Unknown status|Recruiting|Phase 2|94|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 13:33:03.15056|2017-02-18 13:33:03.15056
NCT00816621|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2016-12-19|||January 2009||2009-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of a Parent Training Program for Parents of Children Adopted Internationally|Early Intervention for Children Adopted Internationally|Active, not recruiting||N/A|220|Actual|University of Delaware||2|||f||||t||||||||||2017-02-18 13:33:03.245218|2017-02-18 13:33:03.245218
NCT00816608|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2013-10-24|||August 2006||2006-08-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Observational|MAXWEL||The Effect of Maximum Body Weight in Lifetime on the Development of Type 2 Diabetes|Study of MAXimum Weight in Lifetime on Glucose Homeostasis (MAXWEL)|Completed||N/A|3000|Actual|Seoul National University Bundang Hospital|||1||f||||t||||||||||2017-02-18 13:33:03.351826|2017-02-18 13:33:03.351826
NCT00816595|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2016-04-13|2014-04-09||February 2009||2009-02-01|April 2016|2016-04-01|May 2016|Anticipated|2016-05-01|July 2013|Actual|2013-07-01||Interventional|||Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Randomized Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab With or Without Concurrent Avastin® for Previously Untreated B-Chronic Lymphocytic Leukemia (CLL)|Active, not recruiting||Phase 2|68|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 13:33:03.442503|2017-02-18 13:33:03.442503
NCT00816582|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2016-03-04|||November 2010||2010-11-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|||PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer|A Phase II Clinical Trial to Evaluate 18F-Fluoroestradiol Positron Emission Tomography / Computerized Tomography (PET/CT) Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer|Recruiting||Phase 2|100|Anticipated|British Columbia Cancer Agency||1|||f||||t||||||||||2017-02-18 13:33:04.195211|2017-02-18 13:33:04.195211
NCT00816569|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2008-12-31|||February 2009||2009-02-01|December 2008|2008-12-01|August 2009|Anticipated|2009-08-01|July 2009|Anticipated|2009-07-01||Interventional|||Orthokeratology for Keratoconus|Orthokeratology Contact Lenses for Keratoconus|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 13:33:04.336231|2017-02-18 13:33:04.336231
NCT00816556|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2014-02-12|2014-02-12||October 2008||2008-10-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis|A Randomized Controlled Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis|Terminated||Phase 3|63|Actual|Mayo Clinic||3||Funding|f||||f||||||||||2017-02-18 13:33:04.43715|2017-02-18 13:33:04.43715
NCT00816543|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2012-12-17|||December 2008||2008-12-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma|A Single Arm Phase II Feasibility Study of Neoadjuvant Docetaxel, Oxaliplatin and S-1 Chemotherapy in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma.|Completed||Phase 2|41|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:33:05.014013|2017-02-18 13:33:05.014013
NCT00816530|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2014-12-01|||March 2009||2009-03-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Observational|somo•InSIGHT||A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts.|A Prospective Multicenter Matched-pair Clinical Study to Evaluate the Sensitivity and Specificity of ABUS and Digital X-Ray Mammography (XRM) Together as a Breast Cancer Screening Method Compared to XRM Alone in Women With >50% Parenchymal Density.|Completed||N/A|15679|Actual|U-Systems, Inc.|||1||f||||f||||||||||2017-02-18 13:33:05.12175|2017-02-18 13:33:05.12175
NCT00816517|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2016-03-31|||January 2009||2009-01-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Use of Botulinum Toxin to Treat Psoriasis|Pilot Study on the Safety and Efficacy of Botulinum Toxin Injections in the Treatment of Psoriasis Vulgaris.|Completed||Phase 1|8|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 13:33:05.275853|2017-02-18 13:33:05.275853
NCT00816504|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2015-09-03|||December 2008||2008-12-01|September 2015|2015-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5|Effect of Galactose on Permeability Factor in Patients With Focal Segmental Glomerulosclerosis (FSGS)and Chronic Kidney Disease Stage 5|Withdrawn||Phase 1|0|Actual|Northwell Health||1||Under additional IRB Review|f||||f||||||||||2017-02-18 13:33:05.390451|2017-02-18 13:33:05.390451
NCT00816491|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2009-01-15|||October 2008||2008-10-01|January 2009|2009-01-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|||Comparison Between Chromoendoscopy and Conventional Colonoscopy to Improve the Detection of Neoplasia in Patients With Ulcerative Colitis (UC)|Comparaison de la Chromo Endoscopie Virtuelle FICE (Fujinon Intelligent Chromoendoscopy) Avec la Coloscopie Conventionnelle Dans la détection de la Dysplasie Chez Patients Porteurs de Recto Colite ulcéro hémorragique (RCH).|Unknown status|Recruiting|N/A|80|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:33:05.515992|2017-02-18 13:33:05.515992
NCT00816478|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2015-09-08|||December 2008||2008-12-01|September 2015|2015-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor|Effect of Galactose on Permeability Factor in Patients With Focal Segmental Glomerulosclerosis (FSGS)|Terminated||Phase 1|15|Actual|Northwell Health||1||Study closed by Institutional Review Board|f||||t||||||||||2017-02-18 13:33:05.628888|2017-02-18 13:33:05.628888
NCT00816465|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2010-09-16|||May 2009||2009-05-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)||Completed||Phase 1|20|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 13:33:05.739316|2017-02-18 13:33:05.739316
NCT00816452|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2010-11-02|||January 2009||2009-01-01|November 2010|2010-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|InoPro||Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer|Title: Increase Awareness to Osteopenia/Osteoporosis Treatment of Patients With Prostate Cancer, by Bisphosphonate Therapy - Registry.|Completed||N/A|180|Actual|Sanofi|||1||f||||||||||||||2017-02-18 13:33:05.839781|2017-02-18 13:33:05.839781
NCT00816439|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2017-01-24|||December 29, 2008||2008-12-29|August 28, 2014|2014-08-28|August 28, 2014||2014-08-28|||||Observational|||Imaging Cannabinoid CB1 Receptors in Alcohol Dependence|Imaging Cannabinoid CB1 Receptors in Alcohol Dependence|Completed||N/A|101|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:33:05.934221|2017-02-18 13:33:05.934221
NCT00816426|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2017-01-26|||December 29, 2008||2008-12-29|January 9, 2017|2017-01-09|August 26, 2014|Actual|2014-08-26|August 26, 2014|Actual|2014-08-26||Interventional|||Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis|Pharmacokinetics of Standard First and Second Line Anti-TB Drugs in the Lung and Lesions of Subjects Elected for Resection Surgery|Completed||Phase 1|25|Anticipated|National Institutes of Health Clinical Center (CC)||5|||f||||||||||||||2017-02-18 13:33:06.02493|2017-02-18 13:33:06.02493
NCT00816413|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2013-06-17|||September 2008||2008-09-01|June 2013|2013-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer|T Cell-Reduced Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation With Pentostatin and Low-Dose Total Body Irradiation|Withdrawn||Phase 1/Phase 2|0|Actual|University of Nebraska||1||Screenings yielded inadequate eligible subjects to enroll.|f||||t||||||||||2017-02-18 13:33:06.163169|2017-02-18 13:33:06.163169
NCT00816400|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2012-09-10|||January 2009||2009-01-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Interventional|MEDI-575||A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.|A Phase 1, Multicenter, Open-label, Single-arm, Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, a Fully Human Monoclonal Antibody Directed Against Platelet-derived Growth Factor Receptor Alpha (PDGFRα), in Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy Exists|Completed||Phase 1|35|Actual|MedImmune LLC||1|||f||||f||||||||||2017-02-18 13:33:06.295664|2017-02-18 13:33:06.295664
NCT00816387|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2010-12-02|||October 2007||2007-10-01|March 2009|2009-03-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Fallopian Tube Sperm Perfusion (FSP) Versus Intra-uterine Insemination (IUI) in Natural Cycle|Fallopian Tube Sperm Perfusion (FSP) Versus Intra-uterine Insemination (IUI) in Natural Cycle: a Prospective Randomized Study|Completed||N/A|400|Anticipated|IRCCS Burlo Garofolo||2|||f||||t||||||||||2017-02-18 13:33:06.397182|2017-02-18 13:33:06.397182
NCT00816374|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2014-05-15|||August 2005||2005-08-01|May 2014|2014-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Tailored Intervention for Melanoma Patient's Families|Tailored Intervention for Melanoma Patient's Families|Completed||N/A|553|Actual|Fox Chase Cancer Center||2|||f||||f||||||||||2017-02-18 13:33:06.49654|2017-02-18 13:33:06.49654
NCT00816361|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2014-01-06|||March 2009||2009-03-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors|A Phase 1, Multicenter, Open-label, Single-arm, Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573, a Fully Human Monoclonal Antibody Directed Against Insulin-like Growth Factors I and II, in Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy Exists|Completed||Phase 1|43|Actual|MedImmune LLC||1|||f||||f||||||||||2017-02-18 13:33:06.625583|2017-02-18 13:33:06.625583
NCT00816335|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2016-03-31|||October 2008||2008-10-01|March 2016|2016-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors|Pilot Study Evaluating a Combined and Integrated Technological Approach of F-18-FDG-Directed Perioperative PET/CT Imaging and Intraoperative Handheld Gamma Prove Detection of Known and Occult Disease in Patients Undergoing Surgery for Solid Malignancies|Completed||Early Phase 1|65|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:33:06.952807|2017-02-18 13:33:06.952807
NCT00816322|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2015-04-13|||January 2005||2005-01-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Interventional|||The Effect of Fish Oil in Major Depressive Disorder|The Effect of Fish Oil in Major Depressive Disorder: a Double-blind Placebo-controlled Monotherapy Trail and a RCT for Recurrence Prevention|Completed||N/A|120|Actual|National Science Council, Taiwan||2|||f||||t||||||||||2017-02-18 13:33:07.080435|2017-02-18 13:33:07.080435
NCT00816309|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2011-03-31|||October 2007||2007-10-01|July 2010|2010-07-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?|Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?|Completed||Phase 4|20|Actual|NHS Lothian||2|||f||||f||||||||||2017-02-18 13:33:07.170349|2017-02-18 13:33:07.170349
NCT00816296|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2015-08-21|||October 2008||2008-10-01|August 2015|2015-08-01|October 2012|Anticipated|2012-10-01|October 2011|Anticipated|2011-10-01||Observational|||Evaluation of Intestinal Microbiome in Obese Kids|Evaluation of the Intestinal Microbiome in Obese Children With and Without Non-Alcoholic Fatty Liver Disease|Withdrawn||N/A|0|Actual|Medical College of Wisconsin|||2|PI has left institution|f||||f||||||Samples With DNA|"~     Participants will need to give a blood and stool samples on 3 separate occasions.~   "|||2017-02-18 13:33:07.282627|2017-02-18 13:33:07.282627
NCT00816283|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2012-07-16|||September 2008||2008-09-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia|BMS CA180157: A Phase I Combination Study of Dasatinib Plus Vorinostat in Accelerated Phase, Chronic Phase Refractory to Second Line Therapy or Blast Crisis Chronic Myelogenous Leukemia (CML), and in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1|5|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:33:07.398816|2017-02-18 13:33:07.398816
NCT00816270|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2008-12-31|||April 2008||2008-04-01|December 2008|2008-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Liquid Bandage (2-Octyl-Cyanoacrylate) in Upper Lid Blepharoplasty|Comparison Between Liquid Bandage(2-Octyl-Cyanoacrylate)and Traditional Suture Closure in Upper Lid Blepharoplasty|Terminated||N/A|11|Actual|Federal University of São Paulo||1||Experimental results were unsatisfatory compared with control.|f||||t||||||||||2017-02-18 13:33:07.499154|2017-02-18 13:33:07.499154
NCT00816257|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2013-11-18|||November 2005||2005-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Lung Transplant Specimen Repository and Data Registry Protocol|Lung Transplant Specimen Repository and Data Registry Protocol|Completed||N/A|64|Actual|Ohio State University|||1||f||||f||||||Samples With DNA|"~     BAL specimen blood lung biopsy specimens~   "|||2017-02-18 13:33:07.607953|2017-02-18 13:33:07.607953
NCT00816244|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2012-04-12|||January 2009||2009-01-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer|A Phase II Study of Neo-Adjuvant Statin Therapy in Postmenopausal Primary Breast Cancer: A Window-of-Opportunity Study|Completed||Phase 2|50|Actual|Lund University Hospital||1|||f||||f||||||||||2017-02-18 13:33:07.88519|2017-02-18 13:33:07.88519
NCT00816231|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2016-10-05|||May 2006||2006-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|March 2014|Actual|2014-03-01||Interventional|||Drug /Cue Interactions In Alcohol-Tobacco Comorbidity|Drug /Cue Interactions In Alcohol-Tobacco Comorbidity|Active, not recruiting||N/A|244|Actual|H. Lee Moffitt Cancer Center and Research Institute||4|||f||||f||||||||||2017-02-18 13:33:07.997847|2017-02-18 13:33:07.997847
NCT00816218|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2012-05-30|||March 2003||2003-03-01|May 2012|2012-05-01|November 2008|Actual|2008-11-01|July 2006|Actual|2006-07-01||Interventional|||Molecular Mechanisms of Type 2 Diabetes Mellitus|Molecular Mechanisms of Endothelial Dysfunction in Type 2 Diabetes Mellitus|Completed||Phase 4|39|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||||2017-02-18 13:33:08.115795|2017-02-18 13:33:08.115795
NCT00816205|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-31|2009-04-06||||||April 2009|2009-04-01|April 2009|Actual|2009-04-01|||||Interventional|||An Open Label Study to Examine the Effect of Coated Nifedipine Suppositories on Anal Pressure in Healthy Subjects|An Open Label Study to Examine the Effect of Coated Nifedipine Suppositories on Anal Pressure in Healthy Subjects|Completed||Phase 1/Phase 2|||RDD Pharma Ltd||1|||f||||f||||||||||2017-02-18 13:33:08.229869|2017-02-18 13:33:08.229869
NCT00816192|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2012-07-26|||December 2008||2008-12-01|July 2012|2012-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|CATAFABL||Comparison of Externally Versus Internally Cooled Tip Catheter Ablation in Paroxysmal Atrial Fibrillation|Comparison of Externally Versus Internally Cooled Tip Catheter in Achieving Long-term Electrical Isolation of Pulmonary Veins in Paroxysmal Atrial Fibrillation|Terminated||N/A|86|Actual|University Hospital, Bordeaux||2||The production of the device used in this study has been suspended.|f||||f||||||||||2017-02-18 13:33:08.333514|2017-02-18 13:33:08.333514
NCT00816179|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2014-10-30|||July 2008||2008-07-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Diagnostic Endoscopic Exploration for Pancreatic Head Mass|Human Clinical Trial of Diagnostic Transgastric Endoscopic Peritoneoscopy for Staging of Pancreatic Head Mass|Terminated||N/A|11|Actual|Ohio State University||1||"Helical CT scans at our institution preclude the necessity for diagnostic laparoscopy in most~   cases at our institution."|f||||f||||||||||2017-02-18 13:33:08.446243|2017-02-18 13:33:08.446243
NCT00815984|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2010-02-09|||January 2009||2009-01-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases|FeNO Result Prediction Factors in Children With Allergic Diseases|Completed||N/A|800|Actual|Medical Universtity of Lodz|||1||f||||f||||||||||2017-02-18 13:33:13.045678|2017-02-18 13:33:13.045678
NCT00815269|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2009-12-22|||December 2008||2008-12-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|VEFIHA||Vasodilation Effect of Inhalational Anesthetics|Vasodilation Effect of Inhalational Anesthetics Including Halothane, Isoflurane, Sevoflurane, Desflurane and Enflurane|Completed||N/A|300|Actual|Nanjing Medical University||5|||f||||t||||||||||2017-02-18 13:33:31.726898|2017-02-18 13:33:31.726898
NCT00816166|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2015-02-02|2014-04-18||October 2008||2008-10-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|April 2013|Actual|2013-04-01||Interventional|VISSIT|Analyses were based on an Intent-to-Treat (ITT) population, defined ad enrolled subjects who met the inclusion/exclusion criteria and who were randomized post angiogram. Stent and medical Therapy Group subjects were analyzed to their ITT randomized group regardless of treatment received.|VISSIT Intracranial Stent Study for Ischemic Therapy|Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease|Terminated||Phase 2/Phase 3|125|Actual|Codman & Shurtleff|Early termination of enrollment led to small numbers of subjects analyzed (less than 50% of the prospectively planned sample size). Various endpoints, subgroup and sensitivity analyses were not conducted because the study was not fully enrolled.|2|||f||||t||||||||||2017-02-18 13:33:08.577721|2017-02-18 13:33:08.577721
NCT00816153|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2008-12-30|||March 2008||2008-03-01|December 2008|2008-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Pleth Variability Index and Fluid Management During Surgery|Is Pleth Variability Index Able to Guide Fluid Management During Surgery?|Completed||N/A|97|Actual|Université Catholique de Louvain||2|||f||||f||||||||||2017-02-18 13:33:09.522252|2017-02-18 13:33:09.522252
NCT00816140|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2011-04-21|||June 2007||2007-06-01|March 2011|2011-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication|Comparative Study of the Levofloxacin-Based and Clarithromycin-Based Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication and Change of Gut Flora and Drug Susceptibility Before and After Treatment|Completed||Phase 4|432|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 13:33:09.618909|2017-02-18 13:33:09.618909
NCT00816127|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2008-12-31|||October 2003||2003-10-01|December 2008|2008-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction|Intranasal DDAVP in Preventing Bleeding During Dental Extraction in Cirrhotic Patients|Completed||N/A|36|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 13:33:09.728069|2017-02-18 13:33:09.728069
NCT00816114|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2016-10-03|||June 2005||2005-06-01|October 2016|2016-10-01||||June 2018|Anticipated|2018-06-01||Observational|||Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial|Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial|Recruiting||N/A|850|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:33:09.84036|2017-02-18 13:33:09.84036
NCT00816101|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2011-03-04|2010-12-13||March 2008||2008-03-01|March 2011|2011-03-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation|Efficacy of the PROCELLERA™ Wound Dressing in the Healing of Wounds After a Curettage and Electrodesiccation of Skin Lesions|Completed||Phase 2|26|Actual|Vomaris Innovations||3|||f||||f||||||||||2017-02-18 13:33:09.966258|2017-02-18 13:33:09.966258
NCT00816088|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2014-12-22|||December 2008||2008-12-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Diagnostic and Management Strategies for Invasive Aspergillosis|Diagnostic and Management Strategies for Invasive Aspergillosis in Neutropenic Adult Haemato-Oncology Patients With a Proposal for Investigation of a Novel Potential Marker for Early Diagnosis: a Prospective Cohort Study|Completed||N/A|203|Actual|King's College Hospital NHS Trust|||1||f||||f||||||Samples With DNA|"~     Seum, Whole blood, urine, broncho-alveolar lavage, tissue~   "|||2017-02-18 13:33:10.496186|2017-02-18 13:33:10.496186
NCT00816075|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2009-02-16|||February 2009||2009-02-01|February 2009|2009-02-01|April 2011|Anticipated|2011-04-01|January 2011|Anticipated|2011-01-01||Interventional|||Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection|The Efficacy of Distilled Water vs Mitomycin C as a Single Dose Immediate Instillation After Transurethral Resection of Intermediate Risk, Recurrent Superficial Bladder Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|40|Anticipated|Bozyaka Training and Research Hospital||1|||f||||f||||||||||2017-02-18 13:33:10.594707|2017-02-18 13:33:10.594707
NCT00816062|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2016-01-27|||December 2008||2008-12-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|VITALITY||Post-Approval Trial of the Talent™ Abdominal Stent Graft to Treat Aortic Aneurysms|Endovascular Repair Using the Talent™ Abdominal Stent Graft System in Abdominal Aortic Aneurysms (VITALITY)|Completed||Phase 4|94|Actual|Medtronic Endovascular||1|||f||||f||||||||||2017-02-18 13:33:10.704157|2017-02-18 13:33:10.704157
NCT00816049|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2012-05-22|||June 2009||2009-06-01|May 2012|2012-05-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|ALL2008con||ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy|Nordic Society of Paediatric Haematology and Oncology Treatment Protocol for Children (1.0 - 17.9 Years of Age) and Young Adults (18-45 Years of Age) With ALL. Efficacy of Individualised 6MP Dosing During Consolidation Therapy|Recruiting||Phase 3|1000|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:33:10.832557|2017-02-18 13:33:10.832557
NCT00816036|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2015-04-06|2014-07-08||May 2009||2009-05-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional|||Improving the Delivery of Smoking Cessation Guidelines in Hospitalized Veterans|Improving the Delivery of Smoking Cessation Guidelines in Hospitalized Veterans|Completed||N/A|898|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:33:11.18883|2017-02-18 13:33:11.18883
NCT00816023|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2015-07-21|2010-12-14||March 2009||2009-03-01|July 2015|2015-07-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|CONSERV-1||A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume|CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery|Completed||Phase 2|276|Actual|Cubist Pharmaceuticals LLC|Secondary efficacy variables were considered exploratory and, based on failure of the primary endpoint to meet statistical significance and early termination of the trial, are not presented.|4|||f||||t||||||||||2017-02-18 13:33:11.550658|2017-02-18 13:33:11.550658
NCT00816010|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2012-02-20|||July 2008||2008-07-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes|A Multicentre, Randomised Study to Examine the Effects of Telephone Intervention in Patients With Coronary Heart Disease and Diabetes|Terminated||N/A|137|Actual|Chinese University of Hong Kong||2||Due to lack of manpower at the various study sites|f||||f||||||||||2017-02-18 13:33:12.624258|2017-02-18 13:33:12.624258
NCT00815971|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2008-12-30|||May 2008||2008-05-01|December 2008|2008-12-01|May 2011|Anticipated|2011-05-01|May 2011|Anticipated|2011-05-01||Observational|||Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib|Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib|Unknown status|Recruiting|N/A|300|Anticipated|Aarhus University Hospital|||1||f||||t||||||Samples With DNA|"~     a fine neddle biopsi taken when the diagnosis non-small cell lung carcinoma was made +~     severals blood samples taken before and during treatment with erlotinib.~   "|||2017-02-18 13:33:13.156673|2017-02-18 13:33:13.156673
NCT00815958|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2017-01-20|||December 2007||2007-12-01|January 2017|2017-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Embolic Events Detected During Total Knee Arthroplasty With the Use of RIA (Reamer-Irrigator-Aspirator)|Embolic Events Detected During Total Knee Arthroplasty With and Without the Use of RIA (Reamer-Irrigator-Aspirator): A Blinded, Randomized, Controlled Clinical Study|Terminated||N/A|6|Actual|Ohio State University||2||administrative reasons|f||||f||||||||||2017-02-18 13:33:13.25781|2017-02-18 13:33:13.25781
NCT00815945|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2017-02-13|||June 2008||2008-06-01|March 2014|2014-03-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors|Phase II Study Evaluating PegLiposomal Doxorubicin (PLD) and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors|Completed||Phase 2|41|Actual|AGO Study Group||1|||f||||f||||||||No||2017-02-18 13:33:13.364892|2017-02-18 13:33:13.364892
NCT00815932|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2016-05-02|||September 2016||2016-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic Neuropathy|The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To Complex Regional Pain Syndrome (CRPS) or Diabetic Neuropathy-A PILOT, DOUBLE-BLIND, SHAM-CONTROLLED, CROSS-OVER STUDY|Not yet recruiting||N/A|60|Anticipated|Soroka University Medical Center||4|||f||||||||||||||2017-02-18 13:33:13.495773|2017-02-18 13:33:13.495773
NCT00815919|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2015-06-29|2014-01-17||December 2008||2008-12-01|June 2015|2015-06-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Interventional|||Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease|A Phase II Trial of Bortezomib (Velcade) Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease|Completed||Phase 2|22|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:33:13.609837|2017-02-18 13:33:13.609837
NCT00815906|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-06-15|||December 2008||2008-12-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis|An Ascending Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of SBI-087 Administered To Japanese Subjects With Rheumatoid Arthritis|Completed||Phase 1|20|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:33:13.906469|2017-02-18 13:33:13.906469
NCT00815893|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2009-07-27|||August 2008||2008-08-01|December 2008|2008-12-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||The Feasibility of Dexmedetomidine for Awake Fiberoptic Nasal Intubation|Interventional Study of Dexmedetomidine for Sedating Anticipated Difficult Airway Patients Undergoing Awake Fiberoptic Nasal Intubation|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||t||||||||||2017-02-18 13:33:14.017606|2017-02-18 13:33:14.017606
NCT00815880|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2015-03-31|||December 2008||2008-12-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||C-Pulse IDE Feasibility Study- A Heart Assist System|C-Pulse Implantable Counterpulsation Pump (ICP) Feasibility Study - A Heart Assist System|Completed||Phase 1|20|Actual|Sunshine Heart Inc.||1|||f||||t||||||||||2017-02-18 13:33:14.128761|2017-02-18 13:33:14.128761
NCT00815867|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2016-04-27|||October 2007||2007-10-01|April 2016|2016-04-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|Neo-PDGF||Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant|Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant|Completed||Phase 3|108|Actual|Centre Hospitalier Universitaire, Amiens||2|||f||||t||||||||||2017-02-18 13:33:14.240202|2017-02-18 13:33:14.240202
NCT00815854|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2016-05-23|||October 2008||2008-10-01|May 2016|2016-05-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects|Folate Pharmacogenomics and Risk of Atypical Antipsychotic Metabolic Side Effects|Recruiting||N/A|150|Anticipated|University of Michigan||1|||f||||t||||||||||2017-02-18 13:33:14.376555|2017-02-18 13:33:14.376555
NCT00815841|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2008-12-30|||January 2009||2009-01-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Methylphenidate in Healthy Young Adults||Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-02-18 13:33:14.507643|2017-02-18 13:33:14.507643
NCT00815828|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-30|2008-12-30|||October 2006||2006-10-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||The Effects of Resistance Exercises in Glycemic Control of Women With Gestational Diabetes|The Effects of Resistance Exercises in Glycemic Control of Women With Gestational Diabetes - A Randomized Clinical Trial|Completed||N/A|64|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-02-18 13:33:14.588929|2017-02-18 13:33:14.588929
NCT00815815|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2013-08-08|||February 2004||2004-02-01|August 2013|2013-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effectiveness of High Intensity Inpatient Versus Stepped Intensity Treatment for Anorexia Nervosa|Anorexia Nervosa: The Importance of Treatment Intensity|Completed||N/A|41|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 13:33:14.698822|2017-02-18 13:33:14.698822
NCT00815802|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2008-12-29|||July 2007||2007-07-01|December 2008|2008-12-01||||||||Observational|FcrèchMV||Detection of Human Cytomegalovirus in the Saliva|Detection of Human Cytomegalovirus in the Saliva of 3 Month to 6 Year-Old Children in Day Care Centers : a Pilot Study.|Completed||N/A|655|Actual|University Hospital, Limoges|||1||f||||f||||||||||2017-02-18 13:33:14.813499|2017-02-18 13:33:14.813499
NCT00815789|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2014-07-18|||December 2008||2008-12-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|CHANGE||Cholesterol, Hypertension and Glucose Education Study|Prevention of Cardiovascular Outcomes in African Americans With Diabetes|Completed||N/A|362|Actual|Duke University||2|||f||||f||||||||||2017-02-18 13:33:14.892633|2017-02-18 13:33:14.892633
NCT00815776|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2010-08-16|2010-03-23||April 2008||2008-04-01|August 2010|2010-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial|Treatment Outcome of Temporomandibular Disorders Via the Clayton Intra-aural Device (CID): A Randomized Clinical Trial|Completed||Phase 1/Phase 2|152|Actual|Ascentia Health, Inc.||3|||f||||f||||||||||2017-02-18 13:33:14.99548|2017-02-18 13:33:14.99548
NCT00815763|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2008-12-29|||September 2006||2006-09-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke|Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled, Phase 3, Multicenter Trial|Completed||Phase 3|390|Actual|Xijing Hospital||2|||f||||t||||||||||2017-02-18 13:33:15.654529|2017-02-18 13:33:15.654529
NCT00815750|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2014-07-30|||August 2008||2008-08-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients|Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients|Completed||N/A|147|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-02-18 13:33:15.764903|2017-02-18 13:33:15.764903
NCT00815737|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2010-05-26|||January 2009||2009-01-01|September 2009|2009-09-01||||||||Interventional|||Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage||Unknown status|Active, not recruiting|Phase 2/Phase 3|100|Anticipated|Fudan University||2|||f||||||||||||||2017-02-18 13:33:15.875594|2017-02-18 13:33:15.875594
NCT00815724|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2013-03-07|||February 2007||2007-02-01|March 2013|2013-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|DALI||Evaluating a Distance Learning Asthma Education Program for Pediatricians (The DALI Study)|Distributed Asthma Learning Initiative|Completed||N/A|24|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 13:33:15.986233|2017-02-18 13:33:15.986233
NCT00815711|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2014-08-21|||December 2008||2008-12-01|August 2014|2014-08-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Idiopathic Pulmonary Fibrosis Registry for Future Studies|Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis|Unknown status|Recruiting|N/A|84|Anticipated|Ohio State University|||1||f||||f||||||Samples With DNA|"~     blood serum BAL fluid lung biopsy~   "|||2017-02-18 13:33:16.183641|2017-02-18 13:33:16.183641
NCT00815698|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2016-02-22|2015-03-18||December 2008||2008-12-01|February 2016|2016-02-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|Dangrip||Effect of Suture for Mesh Fixation in Lichtenstein Hernia Repair|Effect of Suture for Mesh Fixation in Lichtenstein Hernia Repair, a Prospective Controlled Randomized Trial|Completed||N/A|334|Actual|Herlev Hospital||2|||f||||f||||||||No||2017-02-18 13:33:16.281304|2017-02-18 13:33:16.281304
NCT00815685|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2013-12-13|2011-04-27||July 2007||2007-07-01|December 2013|2013-12-01|August 2010|Actual|2010-08-01|March 2010|Actual|2010-03-01||Interventional|||A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia|A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia|Completed||N/A|36|Actual|H. Lee Moffitt Cancer Center and Research Institute|This was a Pilot Supportive Care Intervention.|1|||f||||f||||||||||2017-02-18 13:33:16.631916|2017-02-18 13:33:16.631916
NCT00815672|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2016-05-10|||December 2007||2007-12-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|EXCAP||Exercise for Prostate Cancer Patients|The Influence of Home-based Aerobic and Resistance Exercise on Cancer-Related Fatigue, Strength, and Muscle Mass in Prostate Patients.|Active, not recruiting||N/A|122|Anticipated|University of Rochester||2|||f||||t||||||||||2017-02-18 13:33:16.933144|2017-02-18 13:33:16.933144
NCT00815659|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2011-08-29|2011-03-24||December 2008||2008-12-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|EFFORT||Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome|Open-labelled, Single Arm, Phase IV Clinical Study to Evaluate the Impact of Rosuvastatin on Lipid Levels in Patients With Metabolic Syndrome (EFFORT)|Completed||Phase 4|97|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:33:17.052804|2017-02-18 13:33:17.052804
NCT00815646|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2016-01-25|||January 2008||2008-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Prevention and Treatment of Immersion Pulmonary Edema|Effects of the Dive Reflex on Pulmonary Arterial and Pulmonary Artery Wedge Pressures in Subjects Who Have Experienced Immersion Pulmonary Edema|Completed||Early Phase 1|10|Actual|Duke University||1|||f||||f||||||||||2017-02-18 13:33:17.744037|2017-02-18 13:33:17.744037
NCT00815633|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2009-11-09|||December 2008||2008-12-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris|A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris.|Terminated||Phase 4|10|Anticipated|Icahn School of Medicine at Mount Sinai||1||Failed to enroll patients|f||||t||||||||||2017-02-18 13:33:17.86617|2017-02-18 13:33:17.86617
NCT00815620|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2016-01-04|||November 2008||2008-11-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|BESTTHERAPYNET||Best Therapy for Patients With Neuroendocrine Tumors|Best Therapy for Patients With Neuroendocrine Tumors|Recruiting||N/A|5|Anticipated|Zentralklinik Bad Berka|||3||f||||f||||||||||2017-02-18 13:33:17.970687|2017-02-18 13:33:17.970687
NCT00815607|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2013-07-17|||April 2009||2009-04-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma|Phase 1b' Open Label, Single Arm, Multicenter Trial to Evaluate the Safety, Tolerance, Response Rate and Immunological Effects of Repeated Intratumoral Injections of Adenoviral Transduced Autologous Dendritic Cells Engineered to Express hIL-12(INXN-3001) in Response to an Oral Activator Ligand in Patients With Unresectable Stage III C or IV Malignant Melanoma|Completed||Phase 1|12|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 13:33:20.398626|2017-02-18 13:33:20.398626
NCT00815594|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2008-12-29|||December 2008||2008-12-01|December 2008|2008-12-01|May 2009|Anticipated|2009-05-01|March 2009|Anticipated|2009-03-01||Interventional|||Bleb Vascularity Change After Subconjunctival Injection Bevacizumab|Bleb Vascularity Change After Subconjunctival Injection of Bevacizumab|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Capital Medical University||1|||f||||t||||||||||2017-02-18 13:33:20.514459|2017-02-18 13:33:20.514459
NCT00814905|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2009-08-27|||June 2009||2009-06-01|August 2009|2009-08-01|April 2011|Anticipated|2011-04-01|January 2011|Anticipated|2011-01-01||Interventional|||Treatment of Chorioamnionitis After Delivery|Treatment of Chorioamnionitis After Delivery|Unknown status|Recruiting|N/A|300|Anticipated|United States Naval Medical Center, Portsmouth||4|||f||||f||||||||||2017-02-18 13:33:20.604859|2017-02-18 13:33:20.604859
NCT00814892|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2013-10-08|2013-05-16||January 2009||2009-01-01|October 2013|2013-10-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional||Since only two participants were accrued, patient confidentiality prevents the reporting of these two participants.|Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer|A Phase II Trial to Determine the Safety, Tolerability and Efficacy of an Allogeneic Whole Cell Vaccine Administered With Autologous Myeloid Dendritic Cells to Patients With Non-Metastatic Androgen Independent Prostate Carcinoma|Terminated||Phase 2|2|Actual|Mayo Clinic||1||Study was terminated due to funding issues.|f||||t||||||||||2017-02-18 13:33:20.71525|2017-02-18 13:33:20.71525
NCT00814879|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-01-04|2015-11-23||May 2009||2009-05-01|January 2016|2016-01-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional|||Pilot Study of a Raltegravir Based NRTI Sparing Regimen|A Pilot Randomized, Open-Label Study Comparing the Safety and Efficacy of a Raltegravir Based NRTI Sparing Regimen|Completed||N/A|60|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:33:20.960365|2017-02-18 13:33:20.960365
NCT00814866|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-10-26|||September 2008||2008-09-01|December 2013|2013-12-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|BROCA||Bone Resorption, Osteoclastogenesis and Adalimumab|Bone Resorption, Osteoclastogenesis and Adalimumab|Completed||N/A|28|Actual|Université de Sherbrooke||1|||f||||t||||||||Undecided||2017-02-18 13:33:21.7861|2017-02-18 13:33:21.7861
NCT00814853|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2009-08-03|||October 2008||2008-10-01|August 2009|2009-08-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Observational|NAVA||Electrical Activity of the Diaphragm During Extubation Readiness Testing|Electrical Activity of the Diaphragm During Extubation Readiness Testing|Unknown status|Recruiting|N/A|25|Anticipated|Boston Children’s Hospital|||1||f||||t||||||||||2017-02-18 13:33:21.912916|2017-02-18 13:33:21.912916
NCT00814840|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2016-04-12|||February 2008||2008-02-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|July 2010|Actual|2010-07-01||Interventional|TRUST CRT||Efficiency Study of Triple-Site Cardiac Resynchronization in Patients With Heart Failure|Triple-Site Versus Standard Cardiac Resynchronization Therapy (TRUST CRT) Randomized Trial|Completed||Phase 2/Phase 3|100|Actual|Silesian Centre for Heart Diseases||2|||f||||t||||||||||2017-02-18 13:33:22.019904|2017-02-18 13:33:22.019904
NCT00814827|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2017-01-24|||December 20, 2008||2008-12-20|May 26, 2016|2016-05-26||||||||Observational|||Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma|Mycobacterial and Opportunistic Infections in HIV-Negative Patients Associated With Autoantibodies to Interferon-gamma|Active, not recruiting||N/A|265|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:33:22.127481|2017-02-18 13:33:22.127481
NCT00814814|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2016-04-19|||August 2008||2008-08-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|March 2017|Anticipated|2017-03-01||Observational|||Protein S100 Beta as a Predictor of Resuscitation Outcome|Protein S100 Beta as a Predictor of the Outcome of Cardiopulmonary Resuscitation|Active, not recruiting||N/A|313|Actual|Shaare Zedek Medical Center|||1||f||||f||||||Samples With DNA|"~     Blood~   "|Yes||2017-02-18 13:33:22.219875|2017-02-18 13:33:22.219875
NCT00814801|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2014-03-31|2012-03-13||February 2007||2007-02-01|March 2014|2014-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease|Placebo-controlled Confirmatory Study of Galantamine (R113675) for Alzheimer's Type Dementia|Completed||Phase 3|580|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-02-18 13:33:22.31743|2017-02-18 13:33:22.31743
NCT00814788|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2016-01-07|||December 2008||2008-12-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|UCDCC#215||Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer|Phase II Trial of Bicalutamide + RAD001 in Patients With Hormone-Independent Prostatic Adenocarcinoma (HIPC) After the First-Line Androgen Deprivation Therapy|Completed||Phase 2|29|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 13:33:22.956354|2017-02-18 13:33:22.956354
NCT00814775|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-08-22|2016-06-20||August 2008||2008-08-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Comparison Between the Fastrach and CTrach Laryngeal Mask Airway|Comparison Between the Fastrach and CTrach Laryngeal Mask Airway for Intubation of Patients With a Mallampati Score 3 or 4|Terminated||N/A|43|Actual|The Cleveland Clinic||2||recruitment challenges, device no longer available|f||||f||||||||||2017-02-18 13:33:23.081397|2017-02-18 13:33:23.081397
NCT00814762|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2011-10-27|||February 2009||2009-02-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Safety of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old|Study to Evaluate the Safety and Reactogenicity of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old|Completed||Phase 1|41|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 13:33:23.38356|2017-02-18 13:33:23.38356
NCT00814749|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2008-12-24|||November 2008||2008-11-01|December 2008|2008-12-01|January 2011|Anticipated|2011-01-01|January 2010|Anticipated|2010-01-01||Interventional|VUSIS 2||Value of Urodynamics Prior to Stress Incontinence Surgery 2|a Multicentered Randomised Controlled Trial to Test the Cost Effectiveness of Urodynamics in Women With Symptoms of Stress Urinary Incontinence in Whom Surgical Treatment is Considered|Unknown status|Recruiting|N/A|600|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 13:33:23.691751|2017-02-18 13:33:23.691751
NCT00814736|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2008-12-22|||August 2008||2008-08-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031|A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate The Safety And Toleration Of Single Dose Sildenafil In Subjects Receiving Chronic UK-369,003.|Completed||Phase 1|22|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:33:23.790789|2017-02-18 13:33:23.790789
NCT00814723|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2008-12-24|||September 2005||2005-09-01|December 2008|2008-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk|Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk|Completed||Phase 4|90|Actual|Medical University of Graz||2|||f||||t||||||||||2017-02-18 13:33:23.897162|2017-02-18 13:33:23.897162
NCT00815282|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2014-07-29|||February 2009||2009-02-01|July 2014|2014-07-01|December 2016|Anticipated|2016-12-01|September 2016|Anticipated|2016-09-01||Interventional|HPV-kind||Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease|Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease|Unknown status|Recruiting|Phase 4|330|Anticipated|UMC Utrecht||1|||f||||f||||||||||2017-02-18 13:33:31.621952|2017-02-18 13:33:31.621952
NCT00814710|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-10-06|2010-10-21||March 2009||2009-03-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age|Primary Vaccination Course in Healthy Children Receiving the Pneumococcal Vaccine GSK 1024850A Co-administered With Tritanrix™-HepB/Hib at 6, 10 and 14 Weeks of Age|Completed||Phase 3|360|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:33:24.006796|2017-02-18 13:33:24.006796
NCT00814697|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2014-01-08|2013-05-02||December 2008||2008-12-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease|Open-label, Exploratory Study of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Naming and Verbal Fluency in Patients With Alzheimer's Disease With Functional Imaging Correlates|Completed||Phase 2|12|Actual|The New York Memory Services||1|||f||||f||||||||||2017-02-18 13:33:24.764174|2017-02-18 13:33:24.764174
NCT00814671|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2016-08-03|2016-08-03||April 2010||2010-04-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|June 2013|Actual|2013-06-01||Interventional|||Study of Daily Rifapentine for Pulmonary Tuberculosis|A Phase 2 Randomized, Open-label Trial of Daily Rifapentine 450mg or 600mg in Place of Rifampicin 600mg for Intensive Phase Treatment of Smear-positive Pulmonary Tuberculosis|Completed||Phase 2|153|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 13:33:24.996855|2017-02-18 13:33:24.996855
NCT00814658|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2013-08-22|2012-11-27||June 2008||2008-06-01|August 2013|2013-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life|The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life|Completed||Phase 4|22|Actual|Janssen-Cilag Farmaceutica Ltda.|The major limitation of this study was the small sample size. This was probably due to the short enrollment period and to the rigorous inclusion criteria that were adopted.|2|||f||||||||||||||2017-02-18 13:33:25.591622|2017-02-18 13:33:25.591622
NCT00814645|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2012-02-15|||December 2008||2008-12-01|February 2012|2012-02-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|AIR001-CS02||Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers|A Placebo-Controlled, Phase 1b, Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution (AIR001 INHALATION SOLUTION) in Normal, Healthy Volunteers|Completed||Phase 1|25|Actual|Aires Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-02-18 13:33:26.451545|2017-02-18 13:33:26.451545
NCT00815581|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2010-04-07|||May 2008||2008-05-01|December 2008|2008-12-01||||||||Interventional|||Comparison of Photorefraction With Cycloautorefraction and Cycloretinoscopy at Emam Hosein Medical Centre in 2008-2009|Comparison of Photorefraction With Cycloautorefraction and Cycloretinoscopy at Emam Hosein Medical Centre in 2008-2009|Completed||Phase 1/Phase 2|||Shahid Beheshti University of Medical Sciences||1|||f||||t||||||||||2017-02-18 13:33:26.55074|2017-02-18 13:33:26.55074
NCT00815568|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2008-12-29|||August 2008||2008-08-01|December 2008|2008-12-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)|Prospective Phase II Clinical Trial of Myeloablative Conditioning Regimen With Fludarabine and Busulfan Plus 400 cGy Total Body Irradiation for Hematologic Malignancies|Unknown status|Recruiting|Phase 2|114|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 13:33:26.636169|2017-02-18 13:33:26.636169
NCT00815555|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-28|2008-12-29|||December 2008||2008-12-01|December 2008|2008-12-01||||December 2011|Anticipated|2011-12-01||Observational|||CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients|CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients|Unknown status|Recruiting|N/A|500|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 13:33:26.73544|2017-02-18 13:33:26.73544
NCT00815542|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-25|2012-03-22|||June 2012||2012-06-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Induction of Labor in Oligohydramnios|Induction of Labor in Oligohydramnios - A Comparison Between Two Modes of Cervical Ripening for Patients With Oligohydramnios at Term|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|Meir Medical Center||2|||f||||f||||||||||2017-02-18 13:33:26.827166|2017-02-18 13:33:26.827166
NCT00815529|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2008-12-29||||||December 2008|2008-12-01||||||||Expanded Access|||Clinical Research on the Efficacy of Acupuncture Treatment in Chronic Low Back Pain|Clinical Research on the Efficacy of Acupuncture Treatment in Chronic Low Back Pain|Available||N/A|||Kyunghee University Medical Center|||||f||||||||||||||2017-02-18 13:33:27.126109|2017-02-18 13:33:27.126109
NCT00815516|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-27|2015-10-12|2015-08-14||February 2013||2013-02-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|MAGIC-2||Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis|A Phase 3, Randomized, Double-Blind, Multi-Center Study to Compare the Efficacy and Safety of Micafungin Versus Amphotericin B Deoxycholate for the Treatment of Neonatal Candidiasis|Terminated||Phase 3|30|Actual|Astellas Pharma Inc||2||It was decided to discontinue the study due to insufficient recruitment.|f||||t||||||||||2017-02-18 13:33:27.232003|2017-02-18 13:33:27.232003
NCT00815503|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2011-03-15|||January 2009||2009-01-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Postoperative Analgesia With Local Infiltration After Periacetabular Osteotomy|Postoperative Analgesia With Local Infiltration After Periacetabular Osteotomy For The Treatment Of Dysplasia|Completed||Phase 4|70|Actual|Odense University Hospital||2|||f||||t||||||||||2017-02-18 13:33:28.312055|2017-02-18 13:33:28.312055
NCT00815490|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2013-03-06|2012-11-19||June 2008||2008-06-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|November 2008|Actual|2008-11-01||Interventional|||Validation of Brain Oxygenation Monitor|Calibration and Validation of the Nonin Non-invasive Cerebral Oxygen Saturation Oximeter and Cerebral Sensor in Human Volunteers|Completed||N/A|18|Actual|Duke University||1|||f||||f||||||||||2017-02-18 13:33:28.407208|2017-02-18 13:33:28.407208
NCT00815477|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2012-02-17|||September 2007||2007-09-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|I-START||Internet-Based Strategic Transdisciplinary Approach To Risk Reduction And Treatment|I-START: Internet-based Strategic Transdisciplinay Approach to Risk Reduction And Treatment|Completed||Phase 2/Phase 3|387|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:33:28.755017|2017-02-18 13:33:28.755017
NCT00815464|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2008-12-29|||March 2009||2009-03-01|December 2008|2008-12-01|March 2010|Anticipated|2010-03-01|September 2009|Anticipated|2009-09-01||Interventional|CHB||A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B|Efficacy Study of Liquid Acupuncture(Herb Acupoint Injection) Therapeutics in Chronic Hepatitis B(CHB) Based on Patients' Individual Condition|Unknown status|Not yet recruiting|N/A|30|Anticipated|Yu Medical Garden||1|||f||||t||||||||||2017-02-18 13:33:28.852877|2017-02-18 13:33:28.852877
NCT00815451|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2009-09-17|||November 2008||2008-11-01|September 2009|2009-09-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Effect of Polyphenol-rich Dark Chocolate on Obesity|Effect of Polyphenols on Glucoregulatory Biomarkers, Blood Pressure and Lipid Profile in Overweight and Obese Subjects|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Queen Margaret University||2|||f||||t||||||||||2017-02-18 13:33:28.955788|2017-02-18 13:33:28.955788
NCT00815438|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2016-09-29|||January 2009||2009-01-01|September 2016|2016-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Transvaginal Cholecystectomy Using Endoscopic Assistance|Laparoscopic Cholecystectomy Using Transvaginal Endoscopic Assistance|Withdrawn||Phase 1|0|Actual|University of Missouri-Columbia||1||Study personnel left institution|f||||f||||||||No||2017-02-18 13:33:29.061464|2017-02-18 13:33:29.061464
NCT00815425|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2014-12-01|||September 2000||2000-09-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Observational|CLEAR||Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)|Consortium for the Longitudinal Evaluation of African-Americans With Early Rheumatoid Arthritis (CLEAR) Registry|Completed||N/A|1613|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||2||f||||t||||||Samples With DNA|"~     Blood, including DNA and serum, and urine~   "|||2017-02-18 13:33:29.165943|2017-02-18 13:33:29.165943
NCT00815412|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2015-11-25|||September 2004||2004-09-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|ACTIVATE||ACTIVATE: Standard Worksite Health Program vs. Activated Consumer|ACTIVATE: Standard Worksite Health Program vs. Activated Consumer|Completed||N/A|631|Actual|HealthPartners Institute||3|||f||||t||||||||||2017-02-18 13:33:29.256076|2017-02-18 13:33:29.256076
NCT00815399|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2015-11-17|||October 2007||2007-10-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|||Pioglitazone Versus Metformin in Type 2 Diabetes|Effect of Pioglitazone Compared With Metformin on Endothelial Microparticles in Type 2 Diabetes. A Randomized Trial|Completed||Phase 4|150|Actual|Second University of Naples||2|||f||||f||||||||||2017-02-18 13:33:29.343931|2017-02-18 13:33:29.343931
NCT00815386|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2011-02-10|||February 2009||2009-02-01|February 2011|2011-02-01|December 2015|Anticipated|2015-12-01|December 2010|Actual|2010-12-01||Interventional|PTOLEMY2Canada||Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure|Safety and Efficacy of Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients With Heart Failure|Suspended||Phase 2/Phase 3|20|Anticipated|Viacor||1||Company ended operations in January 2011|f||||t||||||||||2017-02-18 13:33:29.43882|2017-02-18 13:33:29.43882
NCT00815373|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-03-15|||December 2008||2008-12-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Interventional|Xal-Cos||The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)|A Comparative Analysis of the Effects of Cosopt® Versus Xalacom® on Ocular Hemodynamics and Intraocular Pressure in Patients With Primary Open-angle Glaucoma|Withdrawn||N/A|0|Actual|Meir Medical Center||2||no participants recruded.|f||||t||||||||||2017-02-18 13:33:29.567461|2017-02-18 13:33:29.567461
NCT00815360|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2015-02-04|2013-05-23||February 2008||2008-02-01|October 2014|2014-10-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|RaScaL||Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion|Ranibizumab (rhuFab V2) and Scatter Laser Photocoagulation in Treatment of Patients With Clinically-significant Diabetic Macular Edema With Peripheral Retinal Nonperfusion (RaScaL)|Completed||Phase 2|22|Actual|Retina Associates of Florida, P.A.|small study size|2|||f||||f||||||||||2017-02-18 13:33:29.680297|2017-02-18 13:33:29.680297
NCT00815347|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2012-09-28|2012-06-16||December 2008||2008-12-01|September 2012|2012-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Bosentan for Poorly Controlled Asthma|The Effect of the ET-1 Receptor Antagonist, Bosentan on Patients With Poorly Controlled Asthma-A 17 Week, Double-blind, Placebo Controlled Crossover Trial|Terminated||Phase 2|11|Actual|UConn Health|Early termination leading to small numbers of subjects analyzed.|1||Difficulty in recruitment.|f||||t||||||||||2017-02-18 13:33:30.056236|2017-02-18 13:33:30.056236
NCT00815334|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-28|2009-06-16|||October 2008||2008-10-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance|Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder Compliance|Completed||N/A|47|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 13:33:30.383229|2017-02-18 13:33:30.383229
NCT00815321|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-28|2017-02-09|||December 2008||2008-12-01|February 2017|2017-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy|Autologous Cytokine Induced Killer Cells as Adjuvant Adoptive Immunotherapy in Patients With Chronic Myeloid Leukemia on Standard Drug Therapy|Completed||Phase 2|11|Actual|Singapore General Hospital||1|||f||||t||||||||||2017-02-18 13:33:30.475868|2017-02-18 13:33:30.475868
NCT00815308|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-29|2011-02-04|2010-10-15||January 2009||2009-01-01|July 2009|2009-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|EXCEL||Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma|An Open-labeled Study to Evaluate Efficacy of Combining Erbitux Plus Concurrent Chemo-radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)|Completed||Phase 2|55|Actual|Shandong Cancer Hospital and Institute||1|||f||||t||||||||||2017-02-18 13:33:30.570922|2017-02-18 13:33:30.570922
NCT00815295|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2014-12-05|2014-12-01||January 2008||2008-01-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Study of Sorafenib/Cetuximab in Head and Neck Cancer|Sorafenib and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN):a Phase I B/II Trial|Completed||Phase 1/Phase 2|31|Actual|Duke University||1|||f||||t||||||||||2017-02-18 13:33:30.847484|2017-02-18 13:33:30.847484
NCT00815074|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2008-12-24||||||December 2008|2008-12-01||||||||Observational|||Military Women's Health and Illness Behaviors in Deployed Settings||Unknown status|Not yet recruiting|N/A|||Wilford Hall Medical Center|||1||f||||f||||||||||2017-02-18 13:33:33.824083|2017-02-18 13:33:33.824083
NCT00815256|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2008-12-26|||August 2008||2008-08-01|November 2008|2008-11-01||||August 2009|Anticipated|2009-08-01||Interventional|||Safety and Effectiveness of Collagen Cross Linking in Progressive Mild and Moderate Keratoconus|The Safety and Effectiveness of Collagen Cross Linking With Riboflavin and Ultraviolet-A Light in Progressive Mild and Moderate Grades of Keratoconus.|Unknown status|Recruiting|Phase 3|15|Anticipated|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 13:33:31.837716|2017-02-18 13:33:31.837716
NCT00815243|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2008-12-26|||September 2007||2007-09-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|TeleTO||Telemedicine Consultation in Trauma and Orthopedic|Study of Clinical Workflow Changes, Anatomical and Functional Outcomes Due to Telemedicine Consultations in Trauma and Orthopedic|Completed||N/A|300|Actual|Donetsk National Medical University||3|||f||||f||||||||||2017-02-18 13:33:31.944658|2017-02-18 13:33:31.944658
NCT00815230|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-25|2009-05-17|||January 2009||2009-01-01|December 2008|2008-12-01|March 2009|Anticipated|2009-03-01|||||Observational|||Effect of Cardiac Computed Tomography Angiography on the Blood Reactive Oxygen Species Level|Effect of Cardiac Computed Tomography Angiography on the Blood Reactive Oxygen Species Level|Withdrawn||N/A|20|Anticipated|National Taiwan University Hospital|||1|because of unexpected administrative barrier, it was very difficult to enroll case.|f||||f||||||None Retained|"~     only peripheral blood will be collected for measurement of reactive oxygen species.~   "|||2017-02-18 13:33:32.078032|2017-02-18 13:33:32.078032
NCT00815217|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2008-12-24|||February 2009||2009-02-01|December 2008|2008-12-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers|The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers|Unknown status|Not yet recruiting|N/A|250|Anticipated|Washington D.C. Veterans Affairs Medical Center||2|||f||||f||||||||||2017-02-18 13:33:32.151753|2017-02-18 13:33:32.151753
NCT00815204|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2015-02-02|||May 2008||2008-05-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Measurement of Pituitary Volume and Hormonal Changes in Patients With Post-traumatic Stress Disorder|Measurement of Pituitary Volume and Hormonal Changes in Patients With Post-traumatic Stress Disorder|Completed||N/A|39|Actual|Cedars-Sinai Medical Center|||3||f||||f||||||Samples Without DNA|"~     Will be collecting blood to check for hormone levels~   "|||2017-02-18 13:33:32.251355|2017-02-18 13:33:32.251355
NCT00815191|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2016-06-07|2016-02-27||January 2008||2008-01-01|June 2016|2016-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||5 patients with missing data, including 3 in the warm-water sleeve group and 2 in the forced air group.|Comparison of Vital HEAT (vH2) Temperature Management System to Upper-body Forced-air Warming|A Comparison Study of the Vital HEAT (vH2) Temperature Management System to Upper-body Forced-air Warming in Patients Undergoing Open Abdominal Surgery Under General Anesthesia|Completed||N/A|73|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-02-18 13:33:32.364789|2017-02-18 13:33:32.364789
NCT00815178|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2008-12-26|||September 2006||2006-09-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Inspiratory Muscle Training on Type 2 Diabetes Mellitus Patients With Inspiratory Muscle Weakness|Effects of Inspiratory Muscle Training on Type 2 Diabetes Mellitus Patients With Inspiratory Muscle Weakness: A Randomized, Controlled Clinical Trial|Completed||N/A|25|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 13:33:32.750974|2017-02-18 13:33:32.750974
NCT00815165|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2013-09-05|||June 2006||2006-06-01|September 2013|2013-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Cytomegalovirus Cell-Mediated Immunity|Cell-Mediated Immune Responses to Cytomegalovirus gB/MF59 Vaccine|Completed||N/A|165|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     Blood.~   "|||2017-02-18 13:33:32.850758|2017-02-18 13:33:32.850758
NCT00815152|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2013-05-03|||December 2008||2008-12-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Coping With High Grade Glioma|Coping With High Grade Glioma|Terminated||N/A|14|Actual|Duke University||2||PI transferred to new institution.|f||||t||||||||||2017-02-18 13:33:32.944947|2017-02-18 13:33:32.944947
NCT00815139|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2008-12-26|||February 2008||2008-02-01|December 2008|2008-12-01||||November 2008|Actual|2008-11-01||Observational|ENDEAVOR OCT||Evaluation of Zotarolimus Eluting Stent at 3 Months Using Optical Coherence Tomography|Evaluation in 3 moNths Duration of nEointimAl coVerAge After zOtaRolimus-Eluting Stent Implantation by Optical Coherence Tomography (ENDEAVOR OCT)|Completed||N/A|30|Actual|Yonsei University|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 13:33:33.05879|2017-02-18 13:33:33.05879
NCT00815126|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2010-11-17|||November 2008||2008-11-01|November 2010|2010-11-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Nasal Provocation Test With Lysine-Acetylsalicylate (ASA) in Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity|Association Between Nasal Provocation Test With Lysine-Acetylsalicylate(ASA) and Clinical Diagnosis in Patients With Aspirin/Nonsteroidal Anti-Inflammatory Drugs(NSAIDs) and/or Acetaminophen Immediate Sensitivity Reactions|Completed||N/A|34|Actual|Chulalongkorn University||3|||f||||f||||||||||2017-02-18 13:33:33.157379|2017-02-18 13:33:33.157379
NCT00815113|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-25|2012-12-02|||October 2009||2009-10-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|October 2013|Anticipated|2013-10-01||Observational|Stomach||Screening for Gastric Cancer in High-risk Population|Screening for Gastric Cancer in High-risk Population|Unknown status|Recruiting|N/A|450|Anticipated|Rabin Medical Center|||2||f||||t||||||Samples With DNA|"~     Gastric biopsies~   "|||2017-02-18 13:33:33.258544|2017-02-18 13:33:33.258544
NCT00815100|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-25|2011-04-05|||April 2009||2009-04-01|April 2011|2011-04-01|April 2012|Anticipated|2012-04-01|April 2011|Anticipated|2011-04-01||Interventional|||Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome|Randomised, Double-blind, Placebo-controlled Trial of IVabradine in Patients With Acute Coronary Syndrome: Effects of the If Current Inhibitor Ivabradine or rEduction of Inflammation maRkers in Patients With Acute Coronary Syndrome|Unknown status|Recruiting|Phase 4|1270|Anticipated|Hospital Universitario de Canarias||2|||f||||t||||||||||2017-02-18 13:33:33.363678|2017-02-18 13:33:33.363678
NCT00815087|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-25|2014-03-02|2013-11-13||July 2008||2008-07-01|March 2014|2014-03-01|October 2013|Actual|2013-10-01|February 2009|Actual|2009-02-01||Interventional||We decided to make the cut point when the numbers of 2 groups are equal.|Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)|Efficacy of Functional Electrical Stimulation in Dysphagia of Nasopharyngeal Cancer Post Radiotherapy|Completed||Phase 2|20|Actual|National Taiwan University Hospital|Lack of information about muscle fibrosis, no control group. and the results from the small amount of subjects.|2|||f||||t||||||||||2017-02-18 13:33:33.477319|2017-02-18 13:33:33.477319
NCT00815061|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2012-12-02|||July 2008||2008-07-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|July 2013|Anticipated|2013-07-01||Observational|||Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population|Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population|Unknown status|Recruiting|N/A|200|Anticipated|Rabin Medical Center|||1||f||||f||||||||||2017-02-18 13:33:33.906798|2017-02-18 13:33:33.906798
NCT00815048|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2008-12-26|||January 2006||2006-01-01|December 2008|2008-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|RAIN||Remifentanil and Atropine for Intubation in Neonates|Remifentanil and Atropine for Intubation in Neonates; a Randomized Controlled Trial|Completed||Phase 4|30|Actual|King Saud University||2|||f||||t||||||||||2017-02-18 13:33:33.997038|2017-02-18 13:33:33.997038
NCT00815035|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2016-10-20|||April 2009||2009-04-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|PnOIT3||Oral Immunotherapy (OIT) for Peanut Allergy|Oral Immunotherapy for Peanut Allergy- Peanut Oral Immunotherapy (PnOIT3)|Active, not recruiting||Phase 2|60|Anticipated|University of North Carolina, Chapel Hill||3|||f||||t||||||||No||2017-02-18 13:33:34.107733|2017-02-18 13:33:34.107733
NCT00815022|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2014-01-11|||December 2008||2008-12-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|ATOCEB||Influence of Anesthetic Temperature on Cephalad Sensory Blockade With Spinal Anesthesia|Influence of Anesthetic Temperature on Cephalad Sensory Blockade With Spinal Anesthesia for Cesarean Delivery|Completed||N/A|400|Actual|Nanjing Medical University||6|||f||||t||||||||||2017-02-18 13:33:34.222345|2017-02-18 13:33:34.222345
NCT00815009|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2012-07-13|||October 2008||2008-10-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|NAFLD||Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease|Prospective Histopathologic Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease|Completed||N/A|56|Actual|San Antonio Military Medical Center||4|||f||||f||||||||||2017-02-18 13:33:34.3293|2017-02-18 13:33:34.3293
NCT00814996|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-25|2008-12-26|||August 2008||2008-08-01|December 2008|2008-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Social Functioning in Schizophrenia||Completed||N/A|60|Anticipated|Far Eastern Memorial Hospital|||2||f||||||||||||||2017-02-18 13:33:34.440277|2017-02-18 13:33:34.440277
NCT00814983|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-26|2013-09-25|2013-09-25||July 2007||2007-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft|Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft|Terminated||Phase 1/Phase 2|15|Actual|Duke University||2||IND approval for naive T-cell depletion not obtained|f||||t||||||||||2017-02-18 13:33:34.50344|2017-02-18 13:33:34.50344
NCT00814970|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-03-14|2014-04-22||November 2008||2008-11-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|September 2011|Actual|2011-09-01||Interventional|||The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions|The Complete® SE SFA Study: The Medtronic Complete Self-Expanding SFA Stent System for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Proximal Popliteal Arteries|Completed||N/A|196|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-02-18 13:33:34.826348|2017-02-18 13:33:34.826348
NCT00814957|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-10-11|||December 2008||2008-12-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand|An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain Dopamine D3 Receptor Occupancy, Pharmacokinetics and Safety of Single Oral Doses of GSK618334, Using 11C-PHNO as PET Ligand.|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:33:35.376132|2017-02-18 13:33:35.376132
NCT00814944|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2013-01-08|||April 2009||2009-04-01|July 2010|2010-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model|A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model|Completed||Phase 2|143|Actual|Santen Inc.||4|||f||||f||||||||||2017-02-18 13:33:35.487336|2017-02-18 13:33:35.487336
NCT00814931|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2009-01-09|||December 2008||2008-12-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CXB722-100||Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males|A Phase 1, Multiple Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Examining the Effects of CXB722 in Mitigating Neuroendocrine Stress Response in Healthy Males|Completed||Phase 1|23|Actual|National Institute on Aging (NIA)||2|||f||||f||||||||||2017-02-18 13:33:35.804013|2017-02-18 13:33:35.804013
NCT00814918|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2014-12-02|||February 2009||2009-02-01|December 2014|2014-12-01|February 2014|Anticipated|2014-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris|Topical 5-ALA-PDT With Blu-U Therapy Vs. Topical 5-ALA With Pulse Dye Laser In Treatine Recalcitrant Acne Vulgaris|Withdrawn||N/A|0|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 13:33:35.915691|2017-02-18 13:33:35.915691
NCT00814632|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2015-08-11|2013-12-24||December 2008||2008-12-01|August 2015|2015-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||CC-10004 For The Treatment Of Vulvodynia|A Clinical Trial Of CC-10004 For The Treatment Of Vulvodynia|Completed||Phase 2|10|Actual|William Beaumont Hospitals|Small pilot study without placebo arm. Only 7 subjects completed treatment.|1|||f||||t||||||||||2017-02-18 13:33:36.025376|2017-02-18 13:33:36.025376
NCT00814619|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2014-04-29|||November 2008||2008-11-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|May 2010|Actual|2010-05-01||Interventional|||Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer|Neoadjuvant Radiotherapy and Capecitabine With or Without Panitumumab in Patients With Advanced, K-ras Unmutated Rectal Cancer. A Randomized Multicenter Phase II Trial|Completed||Phase 2|68|Actual|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||||2017-02-18 13:33:36.275631|2017-02-18 13:33:36.275631
NCT00813917|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2012-07-10|2011-08-05||February 2009||2009-02-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|October 2010|Actual|2010-10-01||Interventional|CHANCHEW||Varenicline for the Treatment of Smokeless Tobacco|Varenicline for the Treatment of Smokeless Tobacco Use|Completed||N/A|76|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:34:04.259177|2017-02-18 13:34:04.259177
NCT00814606|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2013-06-28|||February 2010||2010-02-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C|A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C|Withdrawn||Phase 2|0|Actual|University of Chicago||1||no one ever enrolled|f||||f||||||||||2017-02-18 13:33:36.442067|2017-02-18 13:33:36.442067
NCT00814593|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2014-06-30|||November 2008||2008-11-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|||Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery|Randomized Phase II Trial of Intralesional Lymphokine Activated Killer Cells or Polifeprosan 20 With Carmustine Implant (Gliadel® Wafer) as Consolidation Therapy After Primary Treatment of Newly Diagnosed Resectable Glioblastoma|Terminated||Phase 2|80|Actual|Caladrius Biosciences, Inc.||2||Hoag Hospital ceased support.|f||||f||||||||||2017-02-18 13:33:36.554005|2017-02-18 13:33:36.554005
NCT00814580|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2012-11-13|2011-03-10||December 2008||2008-12-01|November 2012|2012-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery|A Randomized, Double-Blind, Multi-Center, Parallel-Group Study of Tapentadol Immediate Release (IR) Versus Oxycodone IR for the Treatment of Subjects With Acute Post-Operative Pain Following Elective Arthroscopic Shoulder Surgery|Completed||Phase 3|382|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC|No notable study limitations were identified by the Sponsor|2|||f||||f||||||||||2017-02-18 13:33:36.68364|2017-02-18 13:33:36.68364
NCT00814567|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2011-01-06|||October 2006||2006-10-01|December 2008|2008-12-01||||June 2010|Anticipated|2010-06-01||Interventional|||Radiation Therapy in Treating Women With Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery|Randomised Trial Testing Intensity Modulated and Partial Organ Radiotherapy After Breast Conservation Surgery for Early Breast Cancer|Unknown status|Recruiting|Phase 3|1935|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 13:33:38.559322|2017-02-18 13:33:38.559322
NCT00814554|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2010-06-29|||September 2006||2006-09-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|PRALIMAP||Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers|PRALIMAP: Effectiveness Evaluation of Three Strategies of Prevention of Overweight and Obesity in Adolescents; a Cluster Randomised Controlled Trial|Completed||N/A|5458|Actual|University of Nancy||8|||f||||t||||||||||2017-02-18 13:33:38.673443|2017-02-18 13:33:38.673443
NCT00814541|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2014-12-30|||December 2005||2005-12-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|June 2009|Actual|2009-06-01||Interventional|||PAD. ICORG 05-01, V11|Phase II Study to Assess the Safety, Efficacy, and Tolerability of Combination Therapy With Velcade (Bortezomib), Doxorubicin, and Dexamethasone (PAD) as Therapy for Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|53|Actual|Cancer Trials Ireland||3|||f||||||||||||||2017-02-18 13:33:38.84496|2017-02-18 13:33:38.84496
NCT00814528|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2014-03-24|||November 2007||2007-11-01|March 2014|2014-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses|Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses|Terminated||N/A|3|Actual|University of Chicago||2||Not enough subjects for study to be completed.|f||||f||||||||||2017-02-18 13:33:38.963602|2017-02-18 13:33:38.963602
NCT00814515|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-24|2010-07-15|||September 2007||2007-09-01|July 2010|2010-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome|A Phase III, Multicenter, Randomized, Controlled, Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome|Completed||Phase 3|482|Anticipated|Santen SAS||2|||f||||t||||||||||2017-02-18 13:33:39.069202|2017-02-18 13:33:39.069202
NCT00814502|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-12-19|||December 2008||2008-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Zolpidem CR and Hospitalized Patients With Dementia|Does Zolpidem CR Treatment Change Clinical Outcomes in Elderly Hospitalized Patients With Dementia- A Pilot Study|Completed||N/A|17|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 13:33:39.163359|2017-02-18 13:33:39.163359
NCT00814489|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2013-07-18|2012-12-19||January 2009||2009-01-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults|A Study to Evaluate GlaxoSmithKline (GSK) Biologicals' Investigational Vaccination Regimen in Healthy Young Adults|Completed||Phase 1|40|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 13:33:39.276028|2017-02-18 13:33:39.276028
NCT00814476|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2013-07-09|||January 2009||2009-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CareLink||The Effects of Regular Home Use Vs Diabetic Team- Supported Use of the Medtronic CareLink Therapy Management System.|The Efficacy, Short and Long Term Effects of Regular Home Use Vs Diabetic Team - Supported Use of the Medtronic CareLink Therapy Management System in Patients With Diabetes|Completed||Phase 4|70|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 13:33:42.722143|2017-02-18 13:33:42.722143
NCT00814463|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2014-08-04|2013-01-23||August 2008||2008-08-01|May 2013|2013-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases|Phase II Single-arm Study of Post-operative Stereotactic Radiosurgery for Brain Metastases.|Terminated||Phase 2|1|Actual|Duke University||1||Early analysis indicated SRS not as beneficial post-op as pre-op|f||||f||||||||||2017-02-18 13:33:43.027494|2017-02-18 13:33:43.027494
NCT00814450|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2009-12-29|||December 2008||2008-12-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|ANGS-PCAB||Safety & Accuracy of the ActiSight Needle Guidance System in Percutaneous Chest Aspiration and Biopsy|A Prospective, Open-Label, Single-Arm, Single-Center Study Evaluating The Preliminary Safety And Accuracy Of The Actisight™ Needle Guidance System In Patients Undergoing CT-Guided Percutaneous Chest Aspiration And Biopsy|Completed||N/A|20|Actual|ActiViews Ltd.||1|||f||||f||||||||||2017-02-18 13:33:43.291144|2017-02-18 13:33:43.291144
NCT00814437|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-01-15|||April 2009||2009-04-01|January 2016|2016-01-01||||December 2012|Anticipated|2012-12-01||Observational|001-KIS||Physiological Role of KiSS-1/GPR54 System in the Human Ovary|Physiological Role of KiSS-1/GPR54 System in the Human Ovary|Withdrawn||N/A|0|Actual|IVI Sevilla|||1|Lack of funding|f||||f||||||Samples With DNA|"~     Human granulosa cells~   "|||2017-02-18 13:33:43.376317|2017-02-18 13:33:43.376317
NCT00814424|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2008-12-23|||January 2009||2009-01-01|December 2008|2008-12-01|July 2009|Anticipated|2009-07-01|May 2009|Anticipated|2009-05-01||Interventional|||Quantitive And Qualitive Assessment Of The Oxygen Delivery And EtCO2 Sampling With The Smart Bite Block Mark III During An Upper Endoscopic Procedure Under Sedation|Quantitive And Qualitive Assessment Of The Oxygen Delivery And EtCO2 Sampling With The Smart Bite Block Mark III During An Upper Endoscopic Procedure Under Sedation|Unknown status|Not yet recruiting|N/A|70|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:33:43.448995|2017-02-18 13:33:43.448995
NCT00814411|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2008-12-23|||June 2008||2008-06-01|December 2008|2008-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|GCFP||A Trial of Group Versus Individual Family Planning Counseling in Ghana|A Randomized Trial of Group vs. Individual Family Planning Counseling in Ghana|Completed||Phase 3|648|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-02-18 13:33:43.542663|2017-02-18 13:33:43.542663
NCT00814398|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-01-15|||December 2008||2008-12-01|March 2011|2011-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Single Embryo Transfer Versus Double Embryo Transfer|Single Embryo Transfer Versus Double Embryo Transfer in Day 3 or Blastocyst Stage|Terminated||N/A|199|Actual|IVI Sevilla||4||Change in cryopreservation protocol|f||||f||||||||||2017-02-18 13:33:43.63602|2017-02-18 13:33:43.63602
NCT00814385|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2014-06-02|||November 2008||2008-11-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Immunogenicity of Adjuvanted or Non-adjuvanted H5N1 Booster Vaccine in Adults Primed to A/VN/1194/04|A Randomized, Partially Observer-blind, Single-centre Study to Evaluate Safety and Immunogenicity of MF59-adjuvanted or Non-adjuvanted H5N1 Influenza Vaccines in Adults Primed With Adjuvanted Influenza A/Vietnam/1194/04 (H5N1) Vaccine|Completed||Phase 1/Phase 2|606|Actual|University Hospitals, Leicester||9|||f||||t||||||||||2017-02-18 13:33:43.735224|2017-02-18 13:33:43.735224
NCT00814372|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2015-03-30||2015-02-16|December 2008||2008-12-01|March 2015|2015-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin|A Phase 2 Multicenter, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of MBX-102/JNJ-39659100 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy|Terminated||Phase 2|242|Actual|CymaBay Therapeutics, Inc.||4||MBX-102 did not meet the target efficacy profile of HbA1c change.|f||||f||||||||||2017-02-18 13:33:43.872631|2017-02-18 13:33:43.872631
NCT00814359|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2011-01-19|||May 2009||2009-05-01|May 2009|2009-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis|A Phase III Study of Magic Mouthwash Plus Sucralfate Versus Benzydamine HCl for Treatment of Radiation-induced Oral Mucositis in Head and Neck Cancer Patients.|Completed||Phase 3|67|Actual|Juravinski Cancer Centre Foundation||2|||f||||f||||||||||2017-02-18 13:33:44.013056|2017-02-18 13:33:44.013056
NCT00814346|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-02-26|2015-09-11||October 2008||2008-10-01|February 2016|2016-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions|Effect of Oral EGb761® on Brain Glucose Metabolism in Three Groups of Elderly With Memory Complaint, Mild Alzheimer's Disease, and Cognitively Normal Elderly. Phase II, Randomised, Double-blind, Parallel Groups, Placebo-controlled Study|Completed||Phase 2|49|Actual|Ipsen||2|||f||||f||||||||||2017-02-18 13:33:44.145454|2017-02-18 13:33:44.145454
NCT00814333|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2015-12-10|2015-12-10||December 2008||2008-12-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis|A Randomized Controlled Trial Comparing Outcomes in Patients Treated With Merocel Packing or Thrombin-JMI for Anterior Epistaxis|Terminated||N/A|1|Actual|University of Kansas Medical Center||2||Product supplier change - bought out. Unable to enroll patients.|f||||f||||||||||2017-02-18 13:33:45.619323|2017-02-18 13:33:45.619323
NCT00814320|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2015-10-30|2015-01-21||December 2008||2008-12-01|October 2015|2015-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Gammagard Liquid and rHuPH20 in PID|Efficacy, Tolerability and Pharmacokinetic Comparison of Immune Globulin Intravenous (Human), 10% (GAMMAGARD LIQUID/KIOVIG) Administered Intravenously or Subcutaneously Following Administration of Recombinant Human Hyaluronidase (rHuPH20) in Subjects With Primary Immunodeficiency Diseases|Completed||Phase 3|89|Actual|Baxalta US Inc.||2|||f||||f||||||||||2017-02-18 13:33:46.008828|2017-02-18 13:33:46.008828
NCT00814307|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2013-01-10|2012-12-05||February 2009||2009-02-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis|Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of 2 Doses Of CP-690,550 Monotherapy In Patients With Active Rheumatoid Arthritis|Completed||Phase 3|611|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 13:33:51.77649|2017-02-18 13:33:51.77649
NCT00814294|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2009-06-29|||December 2008||2008-12-01|June 2009|2009-06-01|October 2009|Anticipated|2009-10-01|September 2009|Anticipated|2009-09-01||Interventional|||Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus|An 18-Week Randomized, Double-Blind, Multicenter, Comparator Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 2/Phase 3|230|Anticipated|Diasome Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:33:57.423197|2017-02-18 13:33:57.423197
NCT00814281|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2009-05-20|||May 2007||2007-05-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?|Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?|Completed||N/A|24|Anticipated|Marywood University||4|||f||||f||||||||||2017-02-18 13:33:57.575955|2017-02-18 13:33:57.575955
NCT00811733|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-03-26|2012-02-09||March 2009||2009-03-01|February 2015|2015-02-01|August 2014|Actual|2014-08-01|June 2011|Actual|2011-06-01||Interventional|||A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia|A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia|Completed||Phase 2|37|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 13:34:51.904021|2017-02-18 13:34:51.904021
NCT00814268|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2014-02-27|||December 2008||2008-12-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|COMPRESS||COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke|COMbination of Clopidogrel and Aspirin for Prevention of REcurrence in Acute Atherothrombotic Stroke Study: Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Trial|Completed||Phase 4|358|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:33:57.684186|2017-02-18 13:33:57.684186
NCT00814255|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2016-07-01|2015-09-09||December 2008||2008-12-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|June 2013|Actual|2013-06-01||Interventional|FONTII||Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial|Novel Therapies for Resistant Focal Segmental Glomerulosclerosis|Completed||Phase 2|32|Actual|New York University School of Medicine|"Limited sample size~Extended enrollment period~Replacement of rosiglitazone with galactose after start of trial"|3|||f||||t||||||||Yes|will comply with NIDDK guidelines|2017-02-18 13:33:57.798344|2017-02-18 13:33:57.798344
NCT00814242|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-03-30|||December 2008||2008-12-01|March 2016|2016-03-01|November 2011|Actual|2011-11-01|December 2009|Actual|2009-12-01||Interventional|||Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels|A Randomized Control Trial of Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels|Completed||Phase 2/Phase 3|120|Actual|Eastern Hepatobiliary Surgery Hospital||2|||f||||t||||||||||2017-02-18 13:33:58.556363|2017-02-18 13:33:58.556363
NCT00814229|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2009-07-20|||August 2007||2007-08-01|July 2009|2009-07-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Immunogenicity of Influenza H9 Vaccine in Humans|Randomised Dose Ranging Observer Blind Single Centre Study to Evaluate Safety and Immunogenicity of Adjuvanted and Non-adjuvanted Influenza H9 Influenza Vaccine in Humans|Completed||Phase 1|353|Actual|University Hospitals, Leicester||14|||f||||t||||||||||2017-02-18 13:33:58.671783|2017-02-18 13:33:58.671783
NCT00814216|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2010-09-22|||December 2008||2008-12-01|September 2010|2010-09-01||||October 2009|Actual|2009-10-01||Interventional|||Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients|Randomized, Double-blind, Two Way Cross-over, Proof of Concept Study to Compare Efficacy, Safety, Pharmacokinetics & Pharmacodynamics of QAV680 Versus Placebo, With an Extended Open-label Corticosteroid Period, in Steroid-free, Mild to Moderate Persistent Asthma Patients.|Completed||Phase 2|37|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:33:58.805743|2017-02-18 13:33:58.805743
NCT00814203|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2015-04-20|||December 2008||2008-12-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||A Registry of COPD Patients to be Used for Future Studies|The Ohio State University COPD Registry|Recruiting||N/A|600|Anticipated|Ohio State University|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:33:58.922379|2017-02-18 13:33:58.922379
NCT00814190|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2010-01-05|||January 2009||2009-01-01|August 2009|2009-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM)|Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus|Completed||N/A|50|Actual|Endocrine Research Society||2|||f||||f||||||||||2017-02-18 13:33:59.026634|2017-02-18 13:33:59.026634
NCT00814177|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2012-07-24|2009-10-07||July 2006||2006-07-01|July 2012|2012-07-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|FORESPEAK-0||Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients|Management of Prothrombin Times Outside the Therapeutic Range in Patients on Warfarin and With Otherwise Stable Levels|Completed||Phase 2|160|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 13:33:59.144089|2017-02-18 13:33:59.144089
NCT00814164|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-07-07|2016-05-18||December 2008||2008-12-01|July 2016|2016-07-01|August 2013|Actual|2013-08-01|June 2013|Actual|2013-06-01||Interventional||All treated and eligible patients|Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase II Study Evaluating Mechanisms of Resistance Following Treatment With Clofarabine and Daunorubicin in Newly Diagnosed Adult Acute Myeloid Leukemia Patients > or = to 60 Years Old|Terminated||Phase 2|21|Actual|Roswell Park Cancer Institute||1||Sponsor withdrew support|f||||t||||||||||2017-02-18 13:33:59.527525|2017-02-18 13:33:59.527525
NCT00814151|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2008-12-23|||July 2008||2008-07-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial|Primary Investigation Into the Performance of the MicroPhage S. Aureus / MSSA / MRSA Test Direct From Blood Culture.|Completed||N/A|712|Actual|MicroPhage, Inc.|||2||f||||f||||||Samples Without DNA|"~     Retention of discrepant blood culture specimens only.~   "|||2017-02-18 13:33:59.995545|2017-02-18 13:33:59.995545
NCT00814138|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-23|2016-04-26|2015-07-23||April 2009||2009-04-01|April 2016|2016-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Eligible participatns were aged at least 18 years; had a diagnosis of generalized Myasthenia Gravis Foundation of America class II, III or IV; positive acetylcholine receptor antibodies; stable dose of greater than or equal to 10 mg/day of prednisone.|Efficacy of Methotrexate in Myasthenia Gravis|Phase II Trial of Methotrexate in Myasthenia Gravis|Completed||Phase 2|50|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 13:34:00.103683|2017-02-18 13:34:00.103683
NCT00814125|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2009-04-30|||June 1997||1997-06-01|April 2009|2009-04-01|December 2005|Actual|2005-12-01|||||Interventional|||ATAC - Endometrial Sub-Protocol|A Randomised, Double Blind Trial to Assess the Incidence of Endometrial Changes With Arimidex Alone, Nolvadex Alone, or Arimidex and Nolvadex in Combination, When Used as Adjuvant Treatment for Breast Cancer in Postmenopausal Women|Completed||Phase 3|285|Actual|AstraZeneca||3|||f||||t||||||||||2017-02-18 13:34:00.849339|2017-02-18 13:34:00.849339
NCT00814112|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2009-10-07|||November 2008||2008-11-01|October 2009|2009-10-01||||November 2010|Anticipated|2010-11-01||Observational|GAGS||Glycosaminoglycans During Septic Shock - a Temporal Study|GAGS - Glykosaminoglykaner Vid Sepsis|Unknown status|Recruiting|N/A|20|Anticipated|Region Skane|||2||f||||f||||||Samples Without DNA|"~     Plasma and Urine.~   "|||2017-02-18 13:34:00.944942|2017-02-18 13:34:00.944942
NCT00814099|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-07-14|||January 2009||2009-01-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|RESTORE||Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)|Sedation Management in Pediatric Patients With Acute Respiratory Failure|Completed||Phase 3|2449|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 13:34:01.02907|2017-02-18 13:34:01.02907
NCT00811525|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2014-11-25|||August 2004||2004-08-01|November 2014|2014-11-01||||||||Expanded Access|CPG-CA||Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant|Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant|Approved for marketing||N/A|||Mentor Worldwide, LLC|||||||||f||||||||||2017-02-18 13:34:57.398274|2017-02-18 13:34:57.398274
NCT00814086|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-20|2014-12-29|||February 2009||2009-02-01|December 2014|2014-12-01||||July 2011|Actual|2011-07-01||Interventional|||Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer|A Phase I Feasibility Trial IP Cisplatin and IV Paclitaxel on Day 1 Followed by IP Paclitaxel on Day 8 Every 21 Days as Front-Line Treatment of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma|Completed||Phase 1|23|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 13:34:01.19761|2017-02-18 13:34:01.19761
NCT00814073|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2012-09-25|||December 2008||2008-12-01|September 2012|2012-09-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap|A 24-week With Possible Extension, Prospective, Multicentre, Randomized, Double Blind, Placebo-controlled, 2-parallel Group With a Randomization 1:1, Phase III Study to Compare Efficacy and Safety of Masitinib at 6 mg/kg/Day to Placebo in Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap|Unknown status|Recruiting|Phase 3|200|Anticipated|AB Science||2|||f||||t||||||||||2017-02-18 13:34:01.315292|2017-02-18 13:34:01.315292
NCT00814060|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-05-10|||January 2009||2009-01-01|May 2012|2012-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)|A Single Dose Bioavailability Study of 2 New Tablet Formulations of Neratinib Compared With a Reference Capsule in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Puma Biotechnology, Inc.||3|||f||||f||||||||||2017-02-18 13:34:01.443988|2017-02-18 13:34:01.443988
NCT00814047|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2008-12-22||||||December 2008|2008-12-01||||||||Interventional|||The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery|The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery|Completed||Phase 4|18||Medical University of Vienna|||||f||||t||||||||||2017-02-18 13:34:01.534701|2017-02-18 13:34:01.534701
NCT00814034|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2015-09-04|||February 2008||2008-02-01|September 2015|2015-09-01|December 2011|Actual|2011-12-01|December 2009|Actual|2009-12-01||Observational|COPA||Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy|An Observational, Prospective Cohort Study, on Blood Coagulation Parameters in Postmenopausal Patients With Operable Breast Cancer Who Are Treated as Per Standard Practice With Adjuvant Hormonal Therapy for a Total of 5 Years|Completed||N/A|306|Actual|Hellenic Breast Surgeons Society|||3||f||||t||||||||||2017-02-18 13:34:01.627695|2017-02-18 13:34:01.627695
NCT00814021|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-20|2014-11-04|||April 2009||2009-04-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain|Phase II Study, Multicenter, Open-label, Evaluating Efficacy of Treatment With Sutent® (Sunitinib) in Patients With Previously Untreated or Recurrent Brain Metastases Originating From Renal Cancer|Completed||Phase 2|21|Actual|Institut Claudius Regaud||1|||f||||||||||||||2017-02-18 13:34:01.741593|2017-02-18 13:34:01.741593
NCT00814008|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2008-12-22|||March 1999||1999-03-01|December 2008|2008-12-01|December 2003|Actual|2003-12-01|April 2000|Actual|2000-04-01||Interventional|||The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp|The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp|Completed||Phase 2|64|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-02-18 13:34:01.854572|2017-02-18 13:34:01.854572
NCT00813995|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-07-21|2011-08-09||December 2008||2008-12-01|July 2015|2015-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)|A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin 100 mg Once Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Monotherapy|Completed||Phase 3|395|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:34:01.96074|2017-02-18 13:34:01.96074
NCT00813982|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2012-06-26|2010-09-03||November 2008||2008-11-01|January 2011|2011-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Daily Wear Comparison of Enhanced and Non-Enhanced Silicone Hydrogel Lenses|Daily Wear Comparison of Enhanced and Non-Enhanced Silicone Hydrogel Lenses|Completed||N/A|60|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 13:34:02.47365|2017-02-18 13:34:02.47365
NCT00813969|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2016-03-28|||March 2011||2011-03-01|March 2016|2016-03-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS|A Phase I Study to Assess the Feasibility, Safety, and Tolerability of Autologous Mesenchymal Stem Cell Transplantation in Patients With Relapsing Forms of Multiple Sclerosis|Completed||Phase 1|24|Actual|The Cleveland Clinic||1|||f||||t||||||||||2017-02-18 13:34:02.667495|2017-02-18 13:34:02.667495
NCT00813956|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2016-02-17||2016-02-17|December 2008||2008-12-01|February 2016|2016-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer||Completed||Phase 2|80|Actual|Sanofi||1|||t||||f||||||||||2017-02-18 13:34:02.76455|2017-02-18 13:34:02.76455
NCT00813943|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2017-01-12|2014-08-29||March 2009||2009-03-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|February 2013|Actual|2013-02-01||Interventional|CORE|Intent-to-treat (ITT) population included all the participants who were randomized to study treatment.|Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status|Cilengitide in Subjects With Newly Diagnosed Glioblastoma and Unmethylated MGMT Gene Promoter - a Multicenter, Open-label Phase II Study, Investigating Two Cilengitide Regimens in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy). [The CORE Study]|Completed||Phase 2|265|Actual|EMD Serono||3|||f||||||||||||||2017-02-18 13:34:02.880854|2017-02-18 13:34:02.880854
NCT00813930|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2010-03-22|||November 2008||2008-11-01|March 2010|2010-03-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|LIFE-DM||Lifestyle Intervention For Effective Diabetes Management|Lifestyle Intervention For Effective Diabetes Management (LIFE-DM) Trial|Unknown status|Active, not recruiting|N/A|50|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 13:34:04.141941|2017-02-18 13:34:04.141941
NCT00813904|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2011-11-03|2011-11-03||January 2009||2009-01-01|November 2011|2011-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Immunogenicity and Safety Study of rThrombin in Surgical Hemostasis|A Phase 4, Open-Label, Single-Group Immunogenicity and Safety Study of Re-exposure to RECOTHROM� (rThrombin) in Surgical Hemostasis|Completed||Phase 4|31|Actual|ZymoGenetics||1|||f||||t||||||||||2017-02-18 13:34:04.672906|2017-02-18 13:34:04.672906
NCT00813891|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2008-12-22|||January 2009||2009-01-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration|Efficacy of Ranibizumab (Lucentis) in Combination With Photodynamic Therapy for Neovascular Age-Related Macular Degeneration|Unknown status|Not yet recruiting|Phase 4|180|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-02-18 13:34:04.975733|2017-02-18 13:34:04.975733
NCT00813878|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-20|2015-10-01|||July 2001||2001-07-01|October 2015|2015-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease|Optical Biosensor for the Early Detection of Breast Cancer|Terminated||N/A|126|Actual|City of Hope Medical Center||2||Closed due to low accrual|f||||t||||||||||2017-02-18 13:34:05.105905|2017-02-18 13:34:05.105905
NCT00813865|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2012-09-07||2012-09-07|January 2009||2009-01-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Long-Term Extension Study of AT2101 in Type 1 Gaucher Patients|An Open-label, Multicenter, Long-term Extension Study to Assess the Safety, Efficacy, and Pharmacodynamics of AT2101 in Adult Patients With Type 1 Gaucher Disease|Completed||Phase 2|8|Actual|Amicus Therapeutics||2|||f||||f||||||||||2017-02-18 13:34:05.222067|2017-02-18 13:34:05.222067
NCT00813852|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-21|2012-06-14|||August 2007||2007-08-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2008|Actual|2008-07-01||Interventional|||The Study of Skeletal Muscle Function in Obstructive Sleep Apnea|The Study of Skeletal Muscle Function in Obstructive Sleep Apnea|Completed||N/A|129|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 13:34:05.327664|2017-02-18 13:34:05.327664
NCT00813839|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-05-06|||November 2008||2008-11-01|May 2015|2015-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Automated Ventilator Controlled Weaning vs Daily Spontaneous Breathing Trial in Difficult to Wean ICU Patients|Comparison of Automated Ventilator Controlled Weaning to Daily Spontaneous Breathing Trial Weaning Protocol in ICU Patients Following Prolonged Mechanical Ventilation.|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||2||for inability to enroll subjects.|f||||f||||||||||2017-02-18 13:34:05.438515|2017-02-18 13:34:05.438515
NCT00813826|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-07-29|||January 2009||2009-01-01|July 2009|2009-07-01|November 2009|Anticipated|2009-11-01|October 2009|Anticipated|2009-10-01||Interventional|||Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study Evaluating the Efficacy and Tolerability of Oral SLC022 300 mg TID, a Glial Cell Modulating Agent, Versus Placebo in the Treatment of Post Herpetic Neuralgia|Unknown status|Active, not recruiting|Phase 2|204|Anticipated|Solace Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:34:05.532841|2017-02-18 13:34:05.532841
NCT00813813|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2016-01-26|2015-12-18||June 2008||2008-06-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Intradiscal rhGDF-5 Phase I/II Clinical Trial|Phase I/II, Multicenter, Open-label, Single Administration, Dose Finding, Clinical Trial to Evaluate the Safety and Tolerability of Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration|Completed||Phase 1/Phase 2|32|Actual|DePuy Spine||1|||f||||t||||||||||2017-02-18 13:34:05.665743|2017-02-18 13:34:05.665743
NCT00813800|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2011-12-23|2011-11-11||January 2009||2009-01-01|December 2011|2011-12-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|Varenicline||Varenicline in Bipolar Depressed Patients|Varenicline for Smoking Cessation in Bipolar Depressed Patients: An Open-Label 12-week Feasibility Trial|Completed||N/A|11|Actual|Mayo Clinic|Small sample size; limitations finding participants with stable state within their bipolar disorder.|1|||f||||f||||||||||2017-02-18 13:34:06.133245|2017-02-18 13:34:06.133245
NCT00813787|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2014-10-01|||February 2009||2009-02-01|October 2014|2014-10-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Observational|||Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components|Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using a Specialized MRI Technique Called Multiexponential T2 Component Analysis|Unknown status|Recruiting|N/A|20|Anticipated|AHS Cancer Control Alberta|||2||f||||t||||||||||2017-02-18 13:34:06.412706|2017-02-18 13:34:06.412706
NCT00813774|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2013-09-06|||February 2008||2008-02-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy Volunteers|Open, Randomized, Parallel Group, Single Dose, Bioavailability Comparison of 3 Certolizumab Pegol Solution Formulations (Lyophilized, Liquid, Pre-filled Syringe Formulation) to Healthy Volunteers|Completed||Phase 1|149|Actual|UCB Pharma||3|||f||||f||||||||||2017-02-18 13:34:06.51088|2017-02-18 13:34:06.51088
NCT00813761|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2015-05-06|2011-10-24||September 2008||2008-09-01|May 2015|2015-05-01||||August 2009|Actual|2009-08-01||Interventional|||Clinical Evaluation of the Long‑Term Effects of Contact Lens Care Systems||Completed||N/A|473|Actual|Johnson & Johnson Vision Care, Inc.||8|||f||||f||||||||||2017-02-18 13:34:06.62624|2017-02-18 13:34:06.62624
NCT00813748|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2015-08-14|2015-08-14||March 2009||2009-03-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|X-PAND|All enrolled participants.|Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing|Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair(R) Dosing|Completed||Phase 4|118|Actual|Genentech, Inc.|Endpoint prioritization was not specified in study protocol; hence, all endpoints are reported as primary.||1||f||||||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:34:07.518547|2017-02-18 13:34:07.518547
NCT00813735|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2012-10-02|||September 2006||2006-09-01|October 2012|2012-10-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder|Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder|Completed||Phase 4|60|Actual|Lehigh Center for Clinical Research||2|||f||||t||||||||||2017-02-18 13:34:08.481071|2017-02-18 13:34:08.481071
NCT00813722|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2008-12-19|||March 1999||1999-03-01|December 2008|2008-12-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment|Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment: An Open and Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 4|400|Actual|University of Sao Paulo||4|||f||||f||||||||||2017-02-18 13:34:08.616897|2017-02-18 13:34:08.616897
NCT00813709|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2015-07-23|2012-11-27||December 2008||2008-12-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|August 2011|Actual|2011-08-01||Interventional|REFLEXION|Baseline data was presented for ITT population (402 participants) which included participants who had completed the REFLEX Study 27025 (NCT00404352) and were enrolled in this extension Study 28981 (REFLEXION).|Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)|Double-blind Extension of the Study 27025 (REFLEX) to Obtain Long-term Follow-up Data in Patients With Clinically Definite MS and Patients With a First Demyelinating Event at High Risk of Converting to MS, Treated With Rebif® New Formulation (REFLEXION)|Completed||Phase 3|402|Actual|Merck KGaA||3|||f||||||||||||||2017-02-18 13:34:08.752038|2017-02-18 13:34:08.752038
NCT00813696|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2008-12-22|||April 2002||2002-04-01|December 2008|2008-12-01|September 2009|Anticipated|2009-09-01|March 2009|Anticipated|2009-03-01||Interventional|GIP-1||Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer|Gemcitabine vs Gemcitabine + Cisplatin in the Treatment of Advanced Pancreatic Cancer (Stage II III IV)|Unknown status|Active, not recruiting|Phase 3|400|Actual|Istituti Tumori Giovanni Paolo II||2|||f||||f||||||||||2017-02-18 13:34:10.462891|2017-02-18 13:34:10.462891
NCT00813683|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2015-10-19|||February 2008||2008-02-01|December 2008|2008-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Cephalic Version by Acupuncture for Breech Presentation|Study of Cephalic Version by Acupuncture for Breech Presentation.|Completed||N/A|259|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 13:34:10.614906|2017-02-18 13:34:10.614906
NCT00813670|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-09-10|||November 2008||2008-11-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers|Phase 1, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XPF-001 and to Investigate the Effect of Food on the Pharmacokinetics of a Single Dose of XPF-001 in Healthy Subjects|Completed||Phase 1|64|Anticipated|Xenon Pharmaceuticals Inc.||8|||f||||||||||||||2017-02-18 13:34:10.706453|2017-02-18 13:34:10.706453
NCT00813657|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2008-12-22|||January 2000||2000-01-01|December 2008|2008-12-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Resistance Exercise Training During Pregnancy: a Randomized Controlled Trial|Effects of Resistance Exercise Training Program Performed During the 2nd and 3rd Trimesters of Pregnancy on Maternal and Newborn Health|Completed||Phase 4|80|Actual|Universidad Politecnica de Madrid||1|||f||||t||||||||||2017-02-18 13:34:10.797928|2017-02-18 13:34:10.797928
NCT00813644|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-21|2008-12-22|||December 2008||2008-12-01|December 2008|2008-12-01||||||||Observational|UROSIMULATOR08||A Study of Flexible Ureteroscopy Proficiency After Training on the Uromentor Simulator||Unknown status|Active, not recruiting|N/A|20|Anticipated|Rabin Medical Center|||2||f||||||||||||||2017-02-18 13:34:10.881914|2017-02-18 13:34:10.881914
NCT00813631|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-21|2009-05-17|||January 2009||2009-01-01|March 2009|2009-03-01|November 2009|Anticipated|2009-11-01|May 2009|Anticipated|2009-05-01||Interventional|MFW||The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound|The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound|Unknown status|Recruiting|Phase 4|70|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 13:34:10.954912|2017-02-18 13:34:10.954912
NCT00813618|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2008-12-19|||September 1999||1999-09-01|December 2008|2008-12-01|August 2004|Actual|2004-08-01|June 2004|Actual|2004-06-01||Interventional|Pediatric GvHD||Study of MEDI 507 in the Treatment of Pediatric Patients|Phase I Study of MEDI 507 in the Treatment of Pediatric Patients With at Least Grade II Acute Graft-Versus-Host Disease (GvHD)|Completed||Phase 1|10|Actual|MedImmune LLC||3|||f||||f||||||||||2017-02-18 13:34:11.064105|2017-02-18 13:34:11.064105
NCT00813605|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2016-10-26||2016-03-07|March 2009||2009-03-01|October 2016|2016-10-01|June 2012|Actual|2012-06-01|January 2011|Actual|2011-01-01||Interventional|||QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma|A Phase 2, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of FOLFIRI in Combination With AMG 479 or AMG 655 Versus FOLFIRI for the Second-line Treatment of KRAS-mutant Metastatic Colorectal Carcinoma|Completed||Phase 2|155|Actual|NantCell, Inc.||3|||f||||f||||||||||2017-02-18 13:34:11.169145|2017-02-18 13:34:11.169145
NCT00813592|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2014-06-04|2014-04-02||November 2008||2008-11-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma|A Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma Who Have Previously Undergone or Are Not Candidates for Additional Surgery or Radiation|Terminated||Phase 2|2|Actual|University of Utah||1||Original PI left and company withdrew support.|f||||t||||||||||2017-02-18 13:34:13.682282|2017-02-18 13:34:13.682282
NCT00813579|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2008-12-22|||January 2008||2008-01-01|December 2008|2008-12-01|January 2011|Anticipated|2011-01-01|January 2010|Anticipated|2010-01-01||Observational|||Study of Prospective Assessment of Living Kidney Donors: Pre and Post Donation|Study of Prospective Assessment of Living Kidney Donors:Pre and Post Donation|Unknown status|Enrolling by invitation|N/A|80|Anticipated|Mansoura University|||1||f||||t||||||||||2017-02-18 13:34:14.005795|2017-02-18 13:34:14.005795
NCT00813566|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-12-28|||December 2008||2008-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Multi-Tracer PET Assessment of Primary Brain Tumors|Multi-Tracer PET Assessment of Primary Brain Tumors|Recruiting||N/A|20|Anticipated|University of Utah|||1||f||||t||||||||||2017-02-18 13:34:14.065024|2017-02-18 13:34:14.065024
NCT00813553|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2012-04-24|||December 2008||2008-12-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|LitmusMagnet||Effect of β-alanine Supplementation on Muscle Carnosine|Effect of Two 8-week β-alanine Supplementation Protocols on Muscle Carnosine|Completed||N/A|30|Anticipated|Nestlé||3|||f||||f||||||||||2017-02-18 13:34:14.170796|2017-02-18 13:34:14.170796
NCT00813540|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2016-03-10|||March 2009||2009-03-01|April 2012|2012-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors|The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|52|Actual|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-02-18 13:34:14.271395|2017-02-18 13:34:14.271395
NCT00813527|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2012-05-23|||February 2006||2006-02-01|May 2012|2012-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels|A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 or Placebo When Coadministered With Fenofibrate in Subjects With Combined Hyperlipidemia|Completed||Phase 2|213|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:34:14.371344|2017-02-18 13:34:14.371344
NCT00813514|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2014-11-20|||January 2009||2009-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?|Does VEGF or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With CNV?|Withdrawn||N/A|0|Actual|Medical University of Vienna||1|||f||||||||||||||2017-02-18 13:34:14.728833|2017-02-18 13:34:14.728833
NCT00813501|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-20|2011-03-03|||June 2008||2008-06-01|March 2011|2011-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases|Evaluation of Clinical Utility of the Cylex ImmunKnow Assay in Hematopoietic Cell Transplantation|Terminated||N/A|60|Actual|City of Hope Medical Center|||1|Terminated at the request of the study sponsor|f||||t||||||||||2017-02-18 13:34:14.833957|2017-02-18 13:34:14.833957
NCT00813488|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2012-05-22|2010-08-31||December 2008||2008-12-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain|A Double Blind, Active Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for the Management of Breakthrough Pain in Opioid Tolerant Patients With Chronic Pain|Completed||Phase 3|213|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 13:34:14.978331|2017-02-18 13:34:14.978331
NCT00813475|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-21|2008-12-22|||January 2009||2009-01-01|December 2008|2008-12-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Interventional|||Effect of Diabetes Control on Outcome in Hospitalized Patients: A National Israeli Study|Clinical Outcome of Tight Glucose Control of Diabetic Patients Hospitalized In General Internal Medicine Wards A National Israeli Study|Unknown status|Not yet recruiting|N/A|200|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 13:34:16.626063|2017-02-18 13:34:16.626063
NCT00813449|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-12-06|||August 2008||2008-08-01|November 2009|2009-11-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|melanoma||Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma|Multicenter, Double-blinding, Randomized Controlled, Phase II Clinical Trial on Combined Chemotherapy of Endostar (Recombinant Human Endostatin) for Untreated Patients With Advanced Melanoma|Unknown status|Recruiting|Phase 2|140|Anticipated|Simcere Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-02-18 13:34:16.728102|2017-02-18 13:34:16.728102
NCT00813436|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2009-02-04|||May 2008||2008-05-01|December 2008|2008-12-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|20070766||The Effect of Intranasal Administration of Oxytocin on Empathic Abilities.|The Effect of Intranasal Administration of Oxytocin on Empathic Abilities of Healthy People and People Who Suffer From Schizophrenia.|Unknown status|Recruiting|Phase 2|100|Anticipated|Shalvata Mental Health Center||2|||f||||||||||||||2017-02-18 13:34:16.847362|2017-02-18 13:34:16.847362
NCT00813423|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-20|2017-01-31|||January 2010||2010-01-01|November 2016|2016-11-01||||July 2013|Actual|2013-07-01||Interventional|||Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy|Autophagic Modulation With Anti-angiogenic Therapy in Patients With Advanced Malignancies: A Phase I Trial of Sunitinib and Hydroxychloroquine|Active, not recruiting||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:34:16.962432|2017-02-18 13:34:16.962432
NCT00813410|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-20|2008-12-20|||February 2007||2007-02-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of a Novel Method for Integrating Insulin Delivery and Glucose Sensing in Adipose Tissue of Diabetic Patients|A Single Center, Open-Labeled Exploratory Study to Evaluate a Novel Method for Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue of Type-1 Diabetic Patients|Completed||N/A|14|Actual|Medical University of Graz||1|||f||||t||||||||||2017-02-18 13:34:17.081827|2017-02-18 13:34:17.081827
NCT00813397|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-05-21|||September 2008||2008-09-01|May 2015|2015-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|C-MUST||Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.|Manageability and Safety Assessment of the SepraSpray Anti-adhesion Barrier in Abdominal Coelioscopic Surgery|Completed||N/A|210|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:34:17.167179|2017-02-18 13:34:17.167179
NCT00813384|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2014-12-12|||December 2008||2008-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|February 2013|Actual|2013-02-01||Interventional|||A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors|A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 208 in Adult Subjects With Advanced Solid Tumors|Completed||Phase 1|54|Actual|Amgen||2|||f||||f||||||||||2017-02-18 13:34:17.268689|2017-02-18 13:34:17.268689
NCT00813371|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2009-08-24|||December 2008||2008-12-01|August 2009|2009-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Airway Pressure Release Ventilation as a Preventative Strategy|Airway Pressure Release Ventilation as a Preventative Strategy in Patients at Risk for Acute Respiratory Distress Syndrome|Withdrawn||N/A|0|Actual|Texas Tech University Health Sciences Center||2||Principal Investigator left the institution before subjects were enrolled|f||||f||||||||||2017-02-18 13:34:17.38111|2017-02-18 13:34:17.38111
NCT00813358|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2016-04-21|||July 2009||2009-07-01|April 2016|2016-04-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|TX2 2PAS||Zenith TX2® Post-market Approval Study|Zenith TX2® TAA Endovascular Graft Post-approval Study|Active, not recruiting||N/A|115|Actual|Cook||1|||f||||||||||||||2017-02-18 13:34:17.474336|2017-02-18 13:34:17.474336
NCT00813345|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2009-04-24|||January 2009||2009-01-01|April 2009|2009-04-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|LI-AMB||Ambulatory Anesthesia and Light Therapy|A Role for Light Therapy at Immediate Recovery From Short Duration Ambulatory Anesthesia to Prevent Dysregulation of Circadian Rest-Activity Rhythm in Patients Submitted to Colonoscopy.|Unknown status|Recruiting|N/A|360|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 13:34:17.589809|2017-02-18 13:34:17.589809
NCT00813332|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2010-01-22|||October 2008||2008-10-01|December 2009|2009-12-01|October 2010|Anticipated|2010-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)|A Double Blind , Randomized, Multicenter Study of Second Line Treatment of Endostar（rh Recombined Endostatin）With Single Docetaxel In NSCLC Patients|Unknown status|Recruiting|Phase 4|300|Anticipated|Simcere Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-02-18 13:34:17.693009|2017-02-18 13:34:17.693009
NCT00813319|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2014-08-11|2014-06-10||October 2009||2009-10-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|November 2012|Actual|2012-11-01||Interventional|Girls OnGuard||Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent Females|Overcoming Barriers to Vaccination With GARDASIL in Underserved Girls and Adolescents|Completed||Phase 3|216|Actual|Emory University|Limited sample size; Brevity of the computer-administered intervention; Substantial variability between and within clinics with respect to patient-provider interactions; Lack of a follow-up assessment.|2|||f||||t||||||||||2017-02-18 13:34:17.802333|2017-02-18 13:34:17.802333
NCT00813306|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2010-12-06|||December 2008||2008-12-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|||||Interventional|||14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations|A Double-blind, Randomized, Placebo-controlled, Single-centre Phase I Pharmacodynamic Cross-over Study to Assess the Effect of a Single Dose of AZD2066 Oral Solution in Comparison to Placebo on Transient Lower Esophageal Sphincter Relaxations (TLESRs) in Healthy Subjects|Completed||Phase 1/Phase 2|40|Anticipated|AstraZeneca||5|||f||||f||||||||||2017-02-18 13:34:18.415196|2017-02-18 13:34:18.415196
NCT00813293|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2016-03-24|||January 2009||2009-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer|Randomized, Double-Blind, Placebo-Controlled, Phase II Trial Of Short Course Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized (3.5 to 7cm) Hepatocellular Cancer|Active, not recruiting||Phase 2|20|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 13:34:18.520869|2017-02-18 13:34:18.520869
NCT00813280|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-11-25|||June 2008||2008-06-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Observational|||Barriers to the Implementation of Complete Insulin Order Sets|Barriers to the Implementation of Complete Insulin Order Sets in the Management of Individuals With Hyperglycemia or Diabetes at Park Nicollet Methodist Hospital|Completed||N/A|200|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-02-18 13:34:18.643412|2017-02-18 13:34:18.643412
NCT00813267|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-21|2012-10-06|||December 2009||2009-12-01|October 2012|2012-10-01|August 2015|Anticipated|2015-08-01|August 2011|Actual|2011-08-01||Interventional|||Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head|Mesenchymal Stem Cell Transplantation in the Treatment of Osteonecrosis of the Femoral Head|Unknown status|Active, not recruiting|Early Phase 1|15|Actual|Fuzhou General Hospital||1|||f||||t||||||||||2017-02-18 13:34:18.727529|2017-02-18 13:34:18.727529
NCT00813254|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2012-04-18|||December 2008||2008-12-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Cost Utility Analysis in Recurrent Ovarian Cancer|Quality of Life and Cost Utility Analysis in the Treatment of Recurrent, Platinum-Resistant Ovarian Cancer|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:34:18.839555|2017-02-18 13:34:18.839555
NCT00813241|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-22|2010-03-01|||January 2009||2009-01-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers|A Pilot, Open-Label, Randomized, Crossover, Pharmacokinetic Study Of Enhanced Bioavailability Formulations Of Celecoxib In Healthy Volunteers|Completed||Phase 1|16|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:34:18.950443|2017-02-18 13:34:18.950443
NCT00813228|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2017-02-14|||December 17, 2008||2008-12-17|January 25, 2017|2017-01-25|June 17, 2011|Actual|2011-06-17|||||Interventional|||Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals|Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals|Completed||Phase 1|76|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:34:19.06585|2017-02-18 13:34:19.06585
NCT00813215|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2011-03-07|||January 2009||2009-01-01|December 2008|2008-12-01|August 2011|Anticipated|2011-08-01|December 2010|Actual|2010-12-01||Interventional|PPDysMet||Postprandial Dysmetabolism|Postprandial Dysmetabolism - The Effects of Monounsaturated vs. Saturated Lipids on Lipid and Carbohydrate Metabolism and Inflammation in Healthy 1st Degree Relatives of Patients With Type 2 Diabetes.|Unknown status|Active, not recruiting|N/A|34|Actual|Aarhus University Hospital||2|||f||||t||||||||||2017-02-18 13:34:19.174199|2017-02-18 13:34:19.174199
NCT00813202|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-02-26|||October 2006||2006-10-01|February 2014|2014-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure|An Open-label, Single Arm, Multi-centered Clinical Trial on the Hemodynamics and Safety of Nesiritide in the Treatment of Patients With Acute Decompensate Heart Failure|Completed||Phase 3|41|Actual|Xian-Janssen Pharmaceutical Ltd.||1|||f||||f||||||||||2017-02-18 13:34:19.28577|2017-02-18 13:34:19.28577
NCT00813189|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-05-04|||April 2005||2005-04-01|May 2015|2015-05-01|May 2012|Actual|2012-05-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid|Effects of Growth Hormone on Corticoid Myopathy in Children With Chronic Disease: Effects on Muscle Mass and Strength|Completed||Phase 3|30|Actual|Association REMEDE||2|||f||||f||||||||||2017-02-18 13:34:19.396449|2017-02-18 13:34:19.396449
NCT00813176|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-19|||March 2007||2007-03-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||One-Lung Ventilation in the Morbidly Obese Patient: A Comparison of a Left-Sided Broncho-Cath® Double Lumen Tube With the Arndt® Wire-Guided Blocker||Completed||N/A|50|Actual|University of Iowa||2|||f||||t||||||||||2017-02-18 13:34:19.508625|2017-02-18 13:34:19.508625
NCT00813163|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-01-12||2014-06-28|January 2009||2009-01-01|January 2015|2015-01-01|July 2012|Actual|2012-07-01|December 2010|Actual|2010-12-01||Interventional|||Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer|A Phase II Study of PEP02 as a Second Line Therapy for Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|41|Actual|PharmaEngine||1|||f||||f||||||||||2017-02-18 13:34:19.60041|2017-02-18 13:34:19.60041
NCT00813150|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-07-31|2014-03-28||January 2009||2009-01-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Number of Intent-to-treat (ITT) participants were included in Baseline analysis. Out of 93 randomized participants (Vd=46; Vcd=47), follow-up data on treatment response was not available for 3 participants, so, they were excluded from the Intent-to-treat (ITT) analysis data set and so, ITT included 90 participants (Vd=43; Vcd=47).|Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma|Randomized Phase III Study on Bortezomib and Low-Dose Dexamethasone With or Without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma|Completed||Phase 3|96|Actual|Janssen-Cilag G.m.b.H||2|||f||||f||||||||||2017-02-18 13:34:19.722625|2017-02-18 13:34:19.722625
NCT00813137|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-12-06|||October 2008||2008-10-01|December 2009|2009-12-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|||FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer|A Multi-center Study of Folfox4 Combined With Recombinant Human Endostatin(Endostar)in Advanced Colorectal Cancer|Unknown status|Recruiting|Phase 2|120|Anticipated|Simcere Pharmaceutical Co., Ltd||1|||f||||t||||||||||2017-02-18 13:34:20.579954|2017-02-18 13:34:20.579954
NCT00813124|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-09-30|||December 2008||2008-12-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)|Azacitidine Maintenance Therapy After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia (CML)|Completed||Phase 2|24|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:34:20.719922|2017-02-18 13:34:20.719922
NCT00813111|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2013-11-30|2011-11-22||November 2008||2008-11-01|November 2013|2013-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation|A Phase 3, Multicenter, Randomized, Double-blind Parallel-group, Active-control Study to Evaluate the Safety and Efficacy of Local Administration of SKY0402 for Prolonged Postoperative Analgesia in Subjects Undergoing Bilateral, Cosmetic Sub-muscular Breast Augmentation|Terminated||Phase 3|136|Actual|Pacira Pharmaceuticals, Inc||2||Sponsor decision, unrelated to safety|f||||f||||||||||2017-02-18 13:34:20.853151|2017-02-18 13:34:20.853151
NCT00813098|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2010-11-04|2010-10-05||December 2008||2008-12-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|July 2009|Actual|2009-07-01||Interventional|||Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Determine the Safety and Efficacy of Orally Administered LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome|Completed||Phase 2|155|Actual|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:34:21.466503|2017-02-18 13:34:21.466503
NCT00813085|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-19|||April 2002||2002-04-01|December 2008|2008-12-01|December 2003|Actual|2003-12-01|September 2003|Actual|2003-09-01||Interventional|COMPETEII||A Randomized Trial of Electronic Integration of Care for Better Diabetes Outcomes; The COMPETE II Study|A Randomized Trial of Electronic Integration of Care for Better Diabetes Outcomes; The COMPETE II Study|Completed||N/A|511|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 13:34:22.174348|2017-02-18 13:34:22.174348
NCT00813072|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-03-01|||November 2007||2007-11-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma|A Randomized Phase II Study of PEP02, Irinotecan or Docetaxel as a Second Line Therapy in Patients With Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|Completed||Phase 2|135|Actual|PharmaEngine||3|||f||||t||||||||||2017-02-18 13:34:22.27332|2017-02-18 13:34:22.27332
NCT00813059|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2012-02-06|||February 2009||2009-02-01|February 2012|2012-02-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy|Intravitreal Bevacizumab for Treatment of the Second Eye With Non-Arteritic Ischemic Optic Neuropathy|Unknown status|Recruiting|Phase 2|10|Anticipated|Mount Sinai Hospital, Canada||1|||f||||t||||||||||2017-02-18 13:34:22.416185|2017-02-18 13:34:22.416185
NCT00813046|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2014-05-23|||December 2008||2008-12-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis|Preliminary Assessment of the Short Term Clinical Tolerability and Safety of Grass Pollen-derived Peptides for Oral Use in Antigen-specific Immunotherapy of Seasonal Allergic Rhinoconjunctivitis|Completed||Phase 1|8|Actual|BioTech Tools S.A.||1|||f||||t||||||||||2017-02-18 13:34:22.527734|2017-02-18 13:34:22.527734
NCT00813033|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2011-06-22|||December 2008||2008-12-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Use of a Patient Decision Aid for Gastrologic Endoscopy in a Pediatric Setting|Creation and Pilot Evaluation of a Patient Decision Aid as an Adjunct to the Consenting Process for Gastrointestinal Endoscopy in a Pediatric Setting|Completed||N/A|80|Anticipated|Children's Mercy Hospital Kansas City||1|||f||||f||||||||||2017-02-18 13:34:22.617701|2017-02-18 13:34:22.617701
NCT00813020|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-02-20|||January 2009||2009-01-01|February 2015|2015-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects|A Randomised, Single Centre, Double-blind, Incomplete Block Trial to Test for Equivalence Between Subcutaneous Injections of the GLP-1 Analogue NN9535 in 1 mg/ml, 3 mg/ml and 10 mg/ml Concentrations in Healthy Male Subject|Completed||Phase 1|44|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-02-18 13:34:22.717181|2017-02-18 13:34:22.717181
NCT00813007|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-11-09|||December 2008||2008-12-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Observational|||Radical Trachelectomy for Women With Early Stage Cervical Cancer|Radical Trachelectomy for Women With Early Stage Cervical Cancer|Recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:34:22.828594|2017-02-18 13:34:22.828594
NCT00812994|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2008-12-19|||January 2003||2003-01-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|December 2006|Actual|2006-12-01||Interventional|Lex/BDNF||Neurotrophic Factors and Depression|Blood Levels of Neurosteroids and Neurotrophic Factors in Normal Controls and in Patients With Major Depression|Completed||Phase 4|30|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:34:22.946218|2017-02-18 13:34:22.946218
NCT00811512|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-18|||May 2007||2007-05-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Observational|||Fundus Changes in the Microphthalmy Eyes|Fundus Changes in the Microphthalmy Eyes|Completed||N/A|3|Actual|Hospital de Olhos Sadalla Amin Ghanem|||1||f||||t||||||||||2017-02-18 13:34:57.487993|2017-02-18 13:34:57.487993
NCT00812981|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-10-11||2009-09-09|November 2008||2008-11-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine.|Non-inferiority Study of GSK Biologicals' Pandemic Influenza Vaccine 1562902A.|Completed||Phase 3|320|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:34:23.061153|2017-02-18 13:34:23.061153
NCT00812968|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-10-28|2013-09-30||September 2007||2007-09-01|October 2016|2016-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.|A Multicenter, Single-arm Study to Assess the Safety, Pharmacokinetics and Efficacy of Lenalidomide in Japanese Subjects With Low- or Intern=Mediate-1-risk Myelodysplastic Syndromes (MDS) Associated With a Deletion 5 (q31-33) Abnormality and Symptomatic Anemia|Completed||Phase 2|11|Actual|Celgene Corporation||1|||f||||t||||||||||2017-02-18 13:34:23.181983|2017-02-18 13:34:23.181983
NCT00812955|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-09-27|2012-04-25||November 2008||2008-11-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||"Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol (Bad Cholesterol) and Triglycerides"|An 8-Week, Multicenter, Randomized, Double-blind, Four-arm, Parallel-group Study Comparing the Safety and Efficacy of ABT-143 to Simvastatin in Subjects With Hypercholesterolemia|Completed||Phase 3|474|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 13:34:23.986942|2017-02-18 13:34:23.986942
NCT00812942|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-19|||November 2003||2003-11-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2005|Actual|2005-11-01||Interventional|||Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy|Participation to Colorectal Cancer Screening With Faecal Occult Blood Test and Colonoscopy: an Italian, Multicenter, Randomized Population Study|Completed||N/A|9889|Actual|Istituto Superiore di Sanità||2|||f||||f||||||||||2017-02-18 13:34:24.985511|2017-02-18 13:34:24.985511
NCT00812929|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-10-11||2010-02-05|December 2008||2008-12-01|October 2016|2016-10-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise|A Multi-centre, Randomized, Double-blind, Five-way Crossover Study Evaluating the Dose Response and Duration of Action of GSK2190915 Compared to Placebo in Subjects With Mild Asthma Who Experience Exercise Induced Bronchoconstriction.|Completed||Phase 2|47|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:34:25.080006|2017-02-18 13:34:25.080006
NCT00812916|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2016-01-13|2015-11-12||September 2008||2008-09-01|January 2016|2016-01-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Observational|EXPRESSO|Enrolled patients|European Carto® XP REgistry for Validating Specialized CFAE SOftware|EXPRESSO - European Carto® XP REgistry for Validating Specialized CFAE SOftware|Completed||N/A|206|Actual|Biosense Webster, Inc.|||1||f||||f||||||||||2017-02-18 13:34:25.211444|2017-02-18 13:34:25.211444
NCT00812903|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-12-01|||March 2009||2009-03-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|July 2010|Actual|2010-07-01||Interventional|||Neck Pain in Danish Military Pilots and Flight Crew|Neck Pain in Danish Military Pilots and Flight Crew - Environmental Factors With Influence on Performance (PH.D.-Project)|Completed||N/A|60|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-02-18 13:34:25.496759|2017-02-18 13:34:25.496759
NCT00812890|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2011-07-20|||November 2008||2008-11-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision|Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision|Completed||Phase 1|400|Actual|Stanford University||1|||f||||||||||||||2017-02-18 13:34:25.60758|2017-02-18 13:34:25.60758
NCT00812877|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-05-03|2013-08-15||May 2009||2009-05-01|May 2015|2015-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|MTA||Pulp Capping With Two Different Agents|Mineral Trioxide Aggregate (MTA) vs. Calcium Hydroxide (CaOH) in Direct Pulp Capping in NW PRECEDENT (Northwest Practice-based REsearch Collaborative in Evidence-based DENTistry Practices.|Completed||N/A|376|Actual|Oregon Health and Science University|"Randomization was by practice therefore, some dentists may have used a material with which they had little familiarity.~Lack of on-going monitoring of study procedures may have caused an inordinate number of failures in one practice."|2|||f||||t||||||||||2017-02-18 13:34:25.70736|2017-02-18 13:34:25.70736
NCT00812864|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2012-12-04|||January 2009||2009-01-01|September 2009|2009-09-01|November 2012|Actual|2012-11-01|October 2011|Actual|2011-10-01||Interventional|capagec||Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)|Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥75 Years)|Completed||Phase 4|20|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-02-18 13:34:26.158591|2017-02-18 13:34:26.158591
NCT00812851|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2009-02-17|||April 2005||2005-04-01|November 2008|2008-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS)|Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS)|Completed||N/A|24|Actual|Cantonal Hospital of St. Gallen|||||f||||f||||||||||2017-02-18 13:34:26.256261|2017-02-18 13:34:26.256261
NCT00812838|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-11-07|||February 2009||2009-02-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|July 2017|Anticipated|2017-07-01||Interventional|||H-22411: BOTOX® for Peyronie's Disease|The Efficacy of Botulinum Toxin Type a in Treating Peyronie's Disease|Recruiting||Phase 2|20|Anticipated|Baylor College of Medicine||2|||f||||f||||||||No|Data will be published in aggregate.|2017-02-18 13:34:26.363638|2017-02-18 13:34:26.363638
NCT00812825|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-08-11|||January 2009||2009-01-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers|A Phase 1, Active and Placebo-Controlled, Multiple-Dose Escalation Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04171327 (Part 1), and a Single Dose Pharmacokinetic Assessment of a Tablet Formulation (Part 2) in Healthy Volunteers|Completed||Phase 1|78|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 13:34:26.496279|2017-02-18 13:34:26.496279
NCT00812812|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-11-29|2011-09-08||March 2009||2009-03-01|November 2016|2016-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)|A Randomised, Double-blind, Placebo Controlled, Parallel Group , Flexible Dose Study to Evaluate the Efficacy and Safety of Paxil® Tablets in Children and Adolescents With Major Depressive Disorder<Post-marketing Clinical Study>|Terminated||Phase 4|56|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:34:26.61163|2017-02-18 13:34:26.61163
NCT00812799|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2010-04-29|||December 2008||2008-12-01|April 2010|2010-04-01|December 2011|Anticipated|2011-12-01|August 2011|Anticipated|2011-08-01||Interventional|||A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis|A Randomised Double Blind Placebo-controlled, Long-term Phase III Study to Assess the Efficacy and Safety of Oralgen Grass Pollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis|Unknown status|Active, not recruiting|Phase 3|374|Actual|Artu Biologicals||2|||f||||f||||||||||2017-02-18 13:34:27.111449|2017-02-18 13:34:27.111449
NCT00812786|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2013-08-23|||July 2007||2007-07-01|December 2008|2008-12-01|May 2012|Actual|2012-05-01|May 2011|Actual|2011-05-01||Interventional|PIGREC||Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients|Multicentre, Open Study for the Setting up of Population Pharmacokinetic Models and Bayesian Estimators for Individual Dose Adjustment of Immunosuppressive Drugs (Cyclosporine, Tacrolimus, Mycophenolate Mofetil, Everolimus) During the First Year Post-grafting in Adult Heart Transplant Recipients.|Completed||Phase 4|42|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-02-18 13:34:27.266123|2017-02-18 13:34:27.266123
NCT00812773|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-10-11|||December 2008||2008-12-01|October 2016|2016-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study to Evaluate GSK2190915 in Subjects With Mild Asthma|A Randomised, Double-blind, Placebo-controlled, 3-period Cross-over Study to Evaluate the Effect of Two Doses of GSK2190915 on the Allergen-induced Early Asthmatic Response in Subjects With Mild Asthma|Completed||Phase 2|17|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:34:27.366472|2017-02-18 13:34:27.366472
NCT00812760|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-19|||October 2001||2001-10-01|December 2008|2008-12-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Effect of Levodopa on Human Multifocal Electroretinogram|Effect of Levodopa on Human Multifocal Electroretinogram|Completed||Phase 4|20|Actual|Medical University of Vienna||1|||f||||||||||||||2017-02-18 13:34:27.470954|2017-02-18 13:34:27.470954
NCT00812747|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2008-12-19|||June 2007||2007-06-01|December 2008|2008-12-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Observational|||Surgical Wound Infections After Vascular Surgery: Prospective Multicenter Trial|Surgical Wound Infections After Vascular Surgery: Prospective Multicenter Trial|Completed||N/A|||North Karelia Central Hospital|||1||f||||f||||||||||2017-02-18 13:34:27.582035|2017-02-18 13:34:27.582035
NCT00812734|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2013-04-02|||April 2006||2006-04-01|April 2013|2013-04-01|September 2011|Actual|2011-09-01|March 2010|Actual|2010-03-01||Observational|EDONIS||Epidemiologic Multicentre Study of Neuropathic Post-surgical Pain|Etude épidémiologique Multicentrique Des Douleurs Neuropathiques Post-opératoires|Completed||N/A|3322|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-02-18 13:34:27.732759|2017-02-18 13:34:27.732759
NCT00812721|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2009-09-24|||January 2009||2009-01-01|December 2008|2008-12-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Interventional|||Tears Substitutions and Their Effects on Higher Order Aberrometery|Tears Substitutions and Their Effects on Higher Order Aberrometery|Unknown status|Not yet recruiting|N/A|50|Anticipated|University of Iowa||5|||f||||t||||||||||2017-02-18 13:34:27.833054|2017-02-18 13:34:27.833054
NCT00812708|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-05-26|||September 2002||2002-09-01|May 2015|2015-05-01|December 2030|Anticipated|2030-12-01|June 2014|Actual|2014-06-01||Interventional|||Morcher Artificial Iris Devices to Treat Light and Glare Sensitivity in Partial or Complete Aniridia|Compassionate Use Study of Morcher Artificial Iris Devices to Treat Light and Glare Sensitivity in Partial or Complete Aniridia|Active, not recruiting||Phase 1|72|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-02-18 13:34:27.936199|2017-02-18 13:34:27.936199
NCT00812695|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2011-11-21|||October 2008||2008-10-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effects of Continuous Positive Airway Pressure (CPAP) in Patients With Resistant Hypertension and Obstructive Sleep Apnea (OSA)|Effects of Continuous Positive Airway Pressure in Patients With Resistant Hypertension and Obstructive Sleep Apnea|Completed||Phase 3|40|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:34:28.052211|2017-02-18 13:34:28.052211
NCT00812682|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2011-01-21|||September 2006||2006-09-01|January 2011|2011-01-01|August 2007|Actual|2007-08-01|||||Observational|REALITY||Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler|Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler|Completed||N/A|217|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:34:28.150596|2017-02-18 13:34:28.150596
NCT00812669|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2016-02-12|||August 2008||2008-08-01|February 2016|2016-02-01||||June 2021|Anticipated|2021-06-01||Interventional|||CLL-Irl Study. ICORG 07-01, V7|An Open-label Phase II Study of the Efficacy and Safety of the Combination of Fludarabine, Cyclophosphamide and Rituximab in Patients With Chronic Lymphocytic Leukaemia Who Are Newly Diagnosed, Have Relapsed or Are Resistant to First-Line Treatment|Active, not recruiting||Phase 2|145|Anticipated|Cancer Trials Ireland||1|||f||||||||||||||2017-02-18 13:34:28.228418|2017-02-18 13:34:28.228418
NCT00812656|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-12-02|||December 2008||2008-12-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|Stroke08||Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Serial Measurement of a Plasma Stroke Biomarker Panel in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass|Completed||N/A|50|Actual|Klinikum Ludwigshafen|||1||f||||f||||||||||2017-02-18 13:34:28.358426|2017-02-18 13:34:28.358426
NCT00812643|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-03-10|||January 2009||2009-01-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|||||Interventional|||Excretion of Radiolabelled AZD0837|An Open, Single Centre Pharmacokinetic (Phase 1) Study of the Biliary Excretion of AZD0837 and Metabolites Following a Single Dose of [3H] AZD0837 Given in the Duodenum Via a Loc-I-Gut Catheter to Young Healthy Male Subjects|Completed||Phase 1|8|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:34:28.435509|2017-02-18 13:34:28.435509
NCT00812630|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-04-16|||December 2008||2008-12-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Two-part Trial Assessing the Effects of 7α-methyl-19-nortestosterone (MENT) on Blood Pressure in Normal Men: an Open-label Pilot Study Followed by a Randomized, Double-blind, Placebo-controlled Study|A Two-part Trial Assessing the Effects of 7α-methyl-19-nortestosterone (MENT) on Blood Pressure in Normal Men: an Open-label Pilot Study Followed by a Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 1|68|Anticipated|Population Council||1|||f||||f||||||||||2017-02-18 13:34:28.516798|2017-02-18 13:34:28.516798
NCT00812617|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-10-05|||December 2008||2008-12-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|||||Interventional|||Effects of Mineral Water Consumption on Serum Lipid Parameters|Effects of Mineral Water Consumption on Serum Lipid Parameters: a Double-Blind, Randomized Controlled Trial|Completed||N/A|90|Anticipated|Hiroshima University||2|||f||||||||||||||2017-02-18 13:34:28.614961|2017-02-18 13:34:28.614961
NCT00812604|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2014-05-21|2012-06-26||April 2007||2007-04-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Analgesic Ointment on Temporomandibular Joint and Masticatory Muscle Pain|Effect of an Analgesic Ointment on the Relief of Temporomandibular Joint and Masticatory Muscle Pain: a Randomized, Double Blinded, Placebo-controlled Study.|Completed||N/A|55|Actual|The University of Hong Kong|In this study, the subjects were screened by clinical examinations and self-reported questionnaires. Ideally, the diagnosis should be made with a combination of radiographs, Magnetic Resonance Imaging or Computer Tomography.|2|||f||||f||||||||||2017-02-18 13:34:31.025277|2017-02-18 13:34:31.025277
NCT00812591|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2011-10-18|||May 2006||2006-05-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients|Evaluation of a Novel Method for Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients|Completed||N/A|20|Actual|Medical University of Graz||1|||f||||t||||||||||2017-02-18 13:34:31.423782|2017-02-18 13:34:31.423782
NCT00812578|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2010-07-09|||December 2008||2008-12-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|ProjectD||Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes|Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes - a Randomized Controlled Trial|Completed||Phase 2|16|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 13:34:31.509333|2017-02-18 13:34:31.509333
NCT00812565|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2014-04-02|2013-12-02||February 2009||2009-02-01|April 2014|2014-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||Full analysis set: All randomized patients who received at least 1 infusion of the study medication and had at least 1 post-baseline efficacy assessment.|Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease|Prospective 24-week, Double-blind, Randomised, Placebo-controlled, Multicenter Study Evaluating Safety and Change in Efficacy-related Surrogate Parameters in Patients With Dementia of the Alzheimer's Type Under Treatment With Increasing Dosages of Intravenous Immunoglobulin (Octagam 10%)|Completed||Phase 2|58|Actual|Octapharma|Small numbers of patients per treatment group (between 5 and 8) and variable total Aβ levels over time.|8|||f||||t||||||||||2017-02-18 13:34:31.628651|2017-02-18 13:34:31.628651
NCT00812552|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-04-22|||September 2009||2009-09-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|DESERT||Drug Eluting Stent Registry of Thrombosis|Drug Eluting Stent Registry of Thrombosis|Completed||N/A|984|Actual|Medstar Health Research Institute|||2||f||||||||||||||2017-02-18 13:34:33.855222|2017-02-18 13:34:33.855222
NCT00812539|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-08-01|||February 2009||2009-02-01|August 2013|2013-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Diabetes Connect: Patients and Providers Use of a Secure Website for Blood Glucose Monitoring in Type-2 Diabetes|A Randomized Clinical Trial of a Secure Website Shared Between Patients and Providers for Blood Glucose Monitoring in Type-2 Diabetes|Completed||N/A|20|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:34:33.948383|2017-02-18 13:34:33.948383
NCT00812526|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-19|||September 2002||2002-09-01|December 2008|2008-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Regulation of Choroidal Blood Flow During Combined Changes in Intraocular Pressure and Arterial Blood Pressure|Regulation of Choroidal Blood Flow During Combined Changes in Intraocular Pressure and Arterial Blood Pressure|Completed||N/A|18|Actual|Medical University of Vienna||1|||f||||||||||||||2017-02-18 13:34:34.052154|2017-02-18 13:34:34.052154
NCT00812513|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2011-07-19|||July 2011||2011-07-01|July 2011|2011-07-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Efficacy of R-Pdf/Gbb in Healing Wounds Caused by Third Degree Thermal and Electrical Burns|Phase II Study of Efficacy of Recombinant Human Platelet-derived Growth Factor (R-Pdf/Gbb) in Healing Wounds Caused by Third Degree Thermal and Electrical Burns.|Unknown status|Not yet recruiting|Phase 2|120|Anticipated|American Scitech International||1|||f||||f||||||||||2017-02-18 13:34:34.134924|2017-02-18 13:34:34.134924
NCT00812500|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-09-23|||May 2002||2002-05-01|December 2008|2008-12-01|January 2006|Actual|2006-01-01|May 2003|Actual|2003-05-01||Interventional|||Dietary Protein Requirement of Elderly Men and Women|Dietary Protein Requirement of Elderly Men and Women|Completed||N/A|48|Actual|Purdue University||4|||f||||||||||||||2017-02-18 13:34:34.241986|2017-02-18 13:34:34.241986
NCT00812487|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2013-11-09|2013-09-06||January 2009||2009-01-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|August 2012|Actual|2012-08-01||Interventional||"Patients were excluded from the analyses as described in Participant Flow"|Glycemic Control and Variability for Congestive Heart Failure Exacerbation|Glycemic Control and Variability for Congestive Heart Failure Exacerbation|Completed||Phase 1/Phase 2|75|Actual|Ohio State University|The study was limited by study drop-out. Sensor glucose values were reduced due to sensor failures, and cardiac assessments were limited due to a high number of patients with ectopy, arrhythmia or paced rhythms at baseline precluding analysis.|2|||f||||t||||||||||2017-02-18 13:34:34.339307|2017-02-18 13:34:34.339307
NCT00812474|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-11-16|||December 2008||2008-12-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|June 2009|Actual|2009-06-01||Observational|||Regional Cortical Cerebral Quantitative MRI Perfusion Correlation Neurocognition in Multiple Sclerosis|Regional Cortical Cerebral Quantitative MRI Perfusion Correlation Neurocognition in Multiple Sclerosis|Completed||N/A|60|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 13:34:35.08064|2017-02-18 13:34:35.08064
NCT00811499|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-03-01||2009-12-08|December 2008||2008-12-01|March 2012|2012-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis||Terminated||Phase 2|25|Actual|Array BioPharma||3|||f||||f||||||||||2017-02-18 13:34:57.76948|2017-02-18 13:34:57.76948
NCT00812461|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2013-07-17|2013-03-12||March 2009||2009-03-01|July 2013|2013-07-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|ESENSE2||Efficacy of Nalmefene in Patients With Alcohol Dependence|Nalmefene Efficacy Study II: Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy Study of 20 mg Nalmefene, as Needed Use, in Patients With Alcohol Dependence|Completed||Phase 3|678|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:34:35.165952|2017-02-18 13:34:35.165952
NCT00812448|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2009-11-24|||December 2008||2008-12-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Catechin Containing Mask for the Prevention of Influenza Infection|The Effects of Tea Catechin Extracts Containing Mask on the Prevention of Influenza Infection|Completed||N/A|180|Actual|University of Shizuoka||1|||f||||f||||||||||2017-02-18 13:34:36.031007|2017-02-18 13:34:36.031007
NCT00812435|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-17|2014-08-08|||August 2007||2007-08-01|August 2014|2014-08-01|March 2011|Actual|2011-03-01|July 2010|Actual|2010-07-01||Interventional|ESTEEM||Eptifibatide and ST Segment Resolution Following Primary PCI|Eptifibatide and ST Segment Resolution Following Primary PCI|Terminated||Phase 3|22|Actual|Medstar Health Research Institute||1|||f||||t||||||||||2017-02-18 13:34:36.133215|2017-02-18 13:34:36.133215
NCT00812422|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2010-01-15|||February 2008||2008-02-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Efficacy and Safety of Dexibuprofen Syrup|Multi-center, Randomized, Double Blinded (Double-dummy), Active-Controlled Parallel-group Comparative, Phase 3 Clinical Trial to Assess the Efficacy and Safety of Dexibuprofen Syrup Compared to Ibuprofen Syrup in Patients With Fever of Common Cold (Acute Upper Respiratory Infection)|Completed||Phase 3|260|Actual|Inje University||3|||f||||t||||||||||2017-02-18 13:34:36.242665|2017-02-18 13:34:36.242665
NCT00812409|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-01-16|||April 2007||2007-04-01|January 2013|2013-01-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|S-017||Resistance and Aerobic Exercise With Nutritional Supplementation in Men and Women|Resistance and Aerobic Exercise With Nutritional Supplementation in Men and Women|Completed||N/A|580|Actual|Purdue University||4|||f||||||||||||||2017-02-18 13:34:36.43887|2017-02-18 13:34:36.43887
NCT00812396|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2015-01-29|||November 2007||2007-11-01|January 2015|2015-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Biomarkers of Muscle Anabolism (MK-0000-082)|A Randomized, Single-Blind, Placebo-Controlled, Fixed-Sequence, Single-Dose, Parallel Design Study to Utilize Comparative Proteomics to Identify Early Biomarkers of Muscle Anabolism|Completed||Phase 1|30|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:34:36.531853|2017-02-18 13:34:36.531853
NCT00812383|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-10-31|||August 2003||2003-08-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|COBRA||Carotid With Bivalirudin Angioplasty|Carotid With Bivalirudin Angioplasty|Completed||Phase 2/Phase 3|299|Actual|Medstar Health Research Institute||2|||f||||||||||||||2017-02-18 13:34:36.624256|2017-02-18 13:34:36.624256
NCT00812370|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-07-13|||September 2008||2008-09-01|July 2016|2016-07-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|UNBLOCK||The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids|An Open-label, Dose-finding, Pharmacokinetic, Safety and Efficacy Study of Bivalirudin in Children Between 6 Months and 18 Years of Age|Completed||Phase 1|18|Actual|Children's Hospital Los Angeles||1|||f||||t||||||||||2017-02-18 13:34:36.722635|2017-02-18 13:34:36.722635
NCT00812357|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2011-12-27|||April 2009||2009-04-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Observational|SYMBIOSE||Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France|Descriptive Pharmacoepidemiological Study on the Use of Symbicort Turbuhaler in the Treatment of Asthma in France and Impact of a New Therapeutic Strategy on the Compliance and Control of Asthma|Completed||N/A|579|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:34:36.843864|2017-02-18 13:34:36.843864
NCT00812344|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2010-12-02|||December 2008||2008-12-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Ketoconazole on Biliary Excretion of AZD0837|An Open, Randomised, Cross-over, Single Centre Pharmacokinetic (Phase I) Study of the Biliary Excretion Following Single Doses of AZD0837, Given in the Duodenum Via a Loc-I-Gut Catheter, Alone or in Combination With Ketoconazole (Once Daily for 4 Days), to Young Healthy Male Subjects|Completed||Phase 1|20|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:34:37.253485|2017-02-18 13:34:37.253485
NCT00812331|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-07-01|2013-12-24||March 2009||2009-03-01|July 2014|2014-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV)|An Open-label Trial in Genotype 2, 3, 4, 5 and 6 Hepatitis C-infected Subjects to Evaluate the Antiviral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 Following 7 Days Once Daily Dosing as Monotherapy.|Completed||Phase 2|37|Actual|Tibotec Pharmaceuticals, Ireland||5|||f||||f||||||||||2017-02-18 13:34:37.36309|2017-02-18 13:34:37.36309
NCT00812318|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-03-29|||June 2008||2008-06-01|March 2012|2012-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.|A Single Dose, Randomized Study to Assess the Relative Bioavailability of Two Formulations and Food Effect on GSK1265744 in Healthy Male and Female Subjects|Completed||Phase 1|45|Actual|ViiV Healthcare||3|||f||||f||||||||||2017-02-18 13:34:38.50919|2017-02-18 13:34:38.50919
NCT00812305|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2010-09-03||2010-08-25|January 2009||2009-01-01|September 2010|2010-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired Subjects|A Randomized, Double-Blind, Phase 1 Study to Assess the Pharmacokinetics and Safety of SKY0402 in Subjects With Impaired Hepatic Function|Completed||Phase 1|16|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 13:34:38.618244|2017-02-18 13:34:38.618244
NCT00812292|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2011-06-08|||January 2009||2009-01-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation|A Phase I, Open-label, Randomized, Crossover Trial in Healthy Adults to Compare the Oral Bioavailability of TMC278 From Three Concept Pediatric Formulations (Solution, Suspension, Granules) With That From the Adult Phase III Tablet Formulation.|Completed||Phase 1|36|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:34:38.716776|2017-02-18 13:34:38.716776
NCT00812279|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2009-03-05|||November 2008||2008-11-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Investigate the Exposure to Selected Smoke Constituents in Smokers Switching to Distillation Based Smoking Article|A Controlled, Randomised, Open-Label, 3-Arm Parallel Single-Centre Confinement Study to Investigate Exposure to Selected Smoke Constituents in Smokers Switching From Conventional Cigarettes to SMAR Cigarettes for 5 Days|Completed||N/A|112|Actual|Philip Morris Products S.A.||3|||f||||f||||||||||2017-02-18 13:34:38.799281|2017-02-18 13:34:38.799281
NCT00812266|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2016-01-23|||January 2006||2006-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|December 2013|Actual|2013-12-01||Interventional|||Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)|Randomized Phase III Trial of Topotecan and Cisplatin Versus Etoposide and Carboplatin in the Treatment of Patients With Previously Untreated Small Cell Lung Cancer and Extensive Disease|Terminated||Phase 3|281|Actual|Danish Oncological Lung Cancer Group||2||Slow accrual|f||||f||||||||||2017-02-18 13:34:38.906665|2017-02-18 13:34:38.906665
NCT00812253|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2014-07-14|2014-06-12||January 2009||2009-01-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Interventional||Baseline population consists of patients with available study data.|Intensive Glycemic Control for Congestive Heart Failure Exacerbation|Intensive Glycemic Control for Congestive Heart Failure Exacerbation|Completed||Phase 2|74|Actual|Ohio State University||2|||f||||t||||||||||2017-02-18 13:34:39.008256|2017-02-18 13:34:39.008256
NCT00812240|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2012-09-25|||January 2009||2009-01-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment|A Prospective, Multicenter, Randomized, Open-label, Active-controlled, 2-parallel Group, Phase III Study to Compare Efficacy and Safety of Masitinib at 7.5 mg/kg/Day to Imatinib at 400 or 600 mg in Treatment of Patients With Gastro-intestinal Stromal Tumour in First Line Medical Treatment|Unknown status|Recruiting|Phase 3|222|Anticipated|AB Science||2|||f||||t||||||||||2017-02-18 13:34:39.408281|2017-02-18 13:34:39.408281
NCT00812227|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-05-09|||August 2008||2008-08-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Neural Correlates of Psychodynamic Psychotherapy for Depression|Neural Correlates of Psychodynamic Psychotherapy for Depression|Completed||N/A|35|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:34:39.642408|2017-02-18 13:34:39.642408
NCT00812214|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-19|||April 2007||2007-04-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Insomnia in Migraineurs|Treatment of Insomnia in Migraineurs With Eszopiclone (Lunesta™) and Its Effect on Sleep Time, Headache Frequency, and Daytime Functioning: a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study|Completed||Phase 4|113|Actual|MedVadis Research Corporation||2|||f||||f||||||||||2017-02-18 13:34:39.743927|2017-02-18 13:34:39.743927
NCT00812201|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-10-02|||December 2008||2008-12-01|October 2012|2012-10-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Observational|ELEVATE||Evaluation of Left Ventricular AutoThreshold|Evaluation of Left Ventricular AutoThreshold|Completed||N/A|80|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-02-18 13:34:39.848948|2017-02-18 13:34:39.848948
NCT00812188|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-12-08|||November 2004||2004-11-01|December 2014|2014-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.|A Prospective, Open Label Trial of High Dose UVA-1, 3x/Week or Medium Dose UVA-1, 3x/Week vs. Fluocinonide 0.05% Cream Treatment of Morphea|Completed||N/A|24|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 13:34:39.946215|2017-02-18 13:34:39.946215
NCT00812175|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2016-10-14|||January 2009||2009-01-01|October 2016|2016-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|GIDEON||Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib|Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib|Completed||N/A|3371|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:34:40.050353|2017-02-18 13:34:40.050353
NCT00812162|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-01-16|||January 2007||2007-01-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|February 2009|Actual|2009-02-01||Interventional|||Effects of Dietary Pork and Egg on Appetite, Meal-patterning, and Weight Loss in Men|Effects of Dietary Pork and Egg on Appetite, Meal-patterning, and Weight Loss in Men|Completed||N/A|48|Actual|Purdue University||2|||f||||t||||||||||2017-02-18 13:34:40.383206|2017-02-18 13:34:40.383206
NCT00812149|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-19|2017-01-24|||December 17, 2008||2008-12-17|May 16, 2014|2014-05-16|May 16, 2014||2014-05-16|||||Observational|||Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3|Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers:The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3|Completed||N/A|86|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:34:40.473843|2017-02-18 13:34:40.473843
NCT00812136|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-19||||||October 2008|2008-10-01||||||||Interventional|PMA||Parent Mentor Asthma Study|Using Parent Mentors to Improve Asthma Care for Urban Minority Children|Completed||N/A|||University of Texas Southwestern Medical Center|||||f||||t||||||||||2017-02-18 13:34:40.561536|2017-02-18 13:34:40.561536
NCT00812123|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-18|||January 2001||2001-01-01|December 2008|2008-12-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Calcineurin Free Immunosuppression in Renal Transplant Recipients|Open, Single Center, Randomised, Parallel Group Pilot Study to Investigate a Calcineurin Free Immunosuppressive Treatment for de Novo Renal Transplant Recipients: A Comparison of a Rapamycin/MMF/Steroids Regime to a Cyclosporine A Neoral/MMF/Steroids Regimen in the Prevention of Acute Rejection Following Renal Transplantation|Completed||Phase 4|127|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 13:34:40.634076|2017-02-18 13:34:40.634076
NCT00812110|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-12-13|2011-10-31||December 2008||2008-12-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home|Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home|Completed||Phase 4|336|Actual|Akron Children's Hospital|Exclusively urban,lower socioeconomic status population limits external generalizability. Study was uncontrolled; historical controls were referenced instead. Baseline vaccination rates were self-reported. Possible bias in at-risk determination.|1|||f||||f||||||||||2017-02-18 13:34:40.762073|2017-02-18 13:34:40.762073
NCT00812097|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-03-07|2015-08-24||February 2002||2002-02-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CPG|All enrolled subjects are included.|Mentor Siltex® Contour Profile Gel Mammary Prosthesis Clinical Trial|Study of the Safety and Effectiveness of Mentor Siltex® Contour Profile Gel Mammary Prostheses in Patients Who Are Undergoing Primary Breast Augmentation,Primary Breast Reconstruction or Revision|Completed||Phase 3|955|Actual|Mentor Worldwide, LLC||4|||f||||f||||||||||2017-02-18 13:34:41.024357|2017-02-18 13:34:41.024357
NCT00812084|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-06-11|||November 2008||2008-11-01|June 2015|2015-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|CHO-CAP||Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia)|Collecting Health Outcomes and Economic Data on Hospitalized Community-Acquired Pneumonia - a Prospective Cohort Study|Completed||N/A|48634|Actual|UMC Utrecht|||2||f||||f||||||||||2017-02-18 13:34:41.832655|2017-02-18 13:34:41.832655
NCT00812071|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-08-19|||March 2008||2008-03-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|FDA-OPD||Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin|Phase 1 Study of the Safety and Immunogenicity of RiVax With Alum in Healthy Adults|Completed||Phase 1|30|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-02-18 13:34:41.925702|2017-02-18 13:34:41.925702
NCT00812058|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2011-01-13|||November 2008||2008-11-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression|A Phase II Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Safety, Tolerability and Efficacy of RG2417 (Uridine) in the Treatment of Bipolar I Depression|Completed||Phase 2|180|Anticipated|Repligen Corporation||2|||f||||t||||||||||2017-02-18 13:34:42.021752|2017-02-18 13:34:42.021752
NCT00812045|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2009-05-05|||December 2009||2009-12-01|May 2009|2009-05-01|August 2010|Anticipated|2010-08-01|||||Interventional|CYBER||Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis|A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase II Study to Assess the Efficacy of 28 Day Oral Administration of AZD1236 in Adult Patients With Cystic Fibrosis|Withdrawn||Phase 2|44|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:34:42.153746|2017-02-18 13:34:42.153746
NCT00812032|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2010-07-30|||January 2008||2008-01-01|December 2009|2009-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|DM-ASA 001||Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients|Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients|Completed||Phase 4|25|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-02-18 13:34:42.26024|2017-02-18 13:34:42.26024
NCT00812019|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2011-10-10|||November 2008||2008-11-01|October 2011|2011-10-01|November 2010|Actual|2010-11-01|March 2009|Actual|2009-03-01||Interventional|||Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)|A Phase I/II, Randomized, Observer-blind, Multicenter, Dose Ranging Study to Evaluate the Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted or Non-Adjuvanted Cell Culture-Derived H5N1 Subunit Influenza Virus Vaccine in Healthy Subjects 18 - 40 Years of Age.|Completed||Phase 1/Phase 2|753|Actual|Novartis||12|||f||||t||||||||||2017-02-18 13:34:42.357685|2017-02-18 13:34:42.357685
NCT00812006|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2015-02-13|2010-09-23||March 2009||2009-03-01|February 2015|2015-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg ODT for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis|Completed||Phase 3|108|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:34:42.475388|2017-02-18 13:34:42.475388
NCT00811993|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-11-01|||February 2009||2009-02-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors|Phase Ib Study To Evaluate The Safety Of Combining IGF-1R Antagonist R1507 With Multiple Standard Chemotherapy Drug Treatments In Patients With Advanced Malignancies|Terminated||Phase 1|104|Actual|Hoffmann-La Roche||13|||f||||||||||||||2017-02-18 13:34:43.058697|2017-02-18 13:34:43.058697
NCT00811980|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2011-11-23|||January 2009||2009-01-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents|The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents|Completed||N/A|60|Actual|University of Utah|||1||f||||f||||||Samples Without DNA|"~     Whole blood~   "|||2017-02-18 13:34:43.185434|2017-02-18 13:34:43.185434
NCT00811967|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-04-09|||February 2003||2003-02-01|April 2015|2015-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)|Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis|Terminated||Phase 3|50|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:34:43.277277|2017-02-18 13:34:43.277277
NCT00811954|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-09-04|2014-06-23||May 2009||2009-05-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Intention to treat: All eligible participants were included in the baseline characteristics.|Comparative Study of Three NNRTI-Sparing HAART Regimens|The ARDENT Study: Atazanavir, Raltegravir, or Darunavir With Emtricitabine/Tenofovir for Naive Treatment|Completed||Phase 3|1814|Actual|AIDS Clinical Trials Group||3|||f||||t||||||||||2017-02-18 13:34:43.380773|2017-02-18 13:34:43.380773
NCT00811941|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-07-05|2013-03-12||March 2009||2009-03-01|July 2013|2013-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|SENSE||Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence|A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Safety, Tolerability and Efficacy Study of Nalmefene, as Needed Use, in Patients With Alcohol Dependence|Completed||Phase 3|665|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:34:45.932916|2017-02-18 13:34:45.932916
NCT00811928|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-10-05|2011-05-26||November 2008||2008-11-01|October 2015|2015-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)|A Randomized, Open Label Parallel Controlled, Multicenter Study to Evaluate Safety and Efficacy of Posaconazole Oral Suspension Vs. Fluconazole (Capsule) in High-risk Leukopenic Patients for Prevention of Invasive Fungal Infection|Completed||Phase 3|252|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:34:47.057107|2017-02-18 13:34:47.057107
NCT00811915|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-06-18|||January 2009||2009-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|EPARGNE||Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation|A Prospective, Comparative, Multicenter, Randomized Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation|Completed||Phase 3|65|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-02-18 13:34:47.494642|2017-02-18 13:34:47.494642
NCT00811902|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-01-28||2016-01-28|December 2008||2008-12-01|January 2016|2016-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis|A 14-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Nerispirdine 50 mg, 100 mg, and 200 mg in Patients With Multiple Sclerosis.|Completed||Phase 2|405|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 13:34:47.598859|2017-02-18 13:34:47.598859
NCT00811889|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-06-12||2012-05-31|April 2009||2009-04-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease|A 52-Week, Multi-center, Double-blind, Randomized, Placebo-controlled Phase IIb Trial to Determine the Effects of Bardoxolone Methyl (RTA 402) on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease With an eGFR of 20 - 45 mL/Min/1.73m2|Completed||Phase 2|227|Actual|Reata Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-02-18 13:34:50.023724|2017-02-18 13:34:50.023724
NCT00811876|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2010-01-21|||September 2008||2008-09-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|OCT||Retrospective, Non-interventional Study of Depo-Eligard®.|Monitoring Tolerance, Safety and Acceptance of Depo-Eligard® in an Open Label, Retrospective, Non-interventional Clinical Trial|Completed||N/A|140|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-02-18 13:34:50.165186|2017-02-18 13:34:50.165186
NCT00811863|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2010-03-15|||February 2009||2009-02-01|March 2010|2010-03-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Observational|SHERLOC||Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection|A Prospective Study for the Detection of Nephrogenic Systemic Fibrosis in Patients With Renal Impairment Undergoing Gadoversetamide-enhanced Magnetic Resonance Imaging|Suspended||N/A|1000|Anticipated|Mallinckrodt|||2|Study drug currently unavailable|f||||f||||||Samples Without DNA|"~     Serum; Plasma; Fixed tissue samples~   "|||2017-02-18 13:34:50.281247|2017-02-18 13:34:50.281247
NCT00811850|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-07-25|2011-10-24||December 2008||2008-12-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow||Completed||Phase 4|15|Actual|Allergan||2|||f||||f||||||||||2017-02-18 13:34:50.373953|2017-02-18 13:34:50.373953
NCT00811837|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2009-11-17|||January 2009||2009-01-01|November 2009|2009-11-01|September 2009|Anticipated|2009-09-01|July 2009|Anticipated|2009-07-01||Interventional|RemiSun 1||The Effect of Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers|The Effect of Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers|Unknown status|Recruiting|Phase 4|24|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:34:50.912908|2017-02-18 13:34:50.912908
NCT00811824|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-02-21|||July 2007||2007-07-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|September 2009|Actual|2009-09-01||Interventional|||Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors|Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors|Completed||Phase 2|42|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 13:34:51.034228|2017-02-18 13:34:51.034228
NCT00811811|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-18|||May 2005||2005-05-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|August 2006|Actual|2006-08-01||Interventional|||Behavioral Neurocardiac Training and Hypertension|Behavioral Neurocardiac Training With Biofeedback Augments Vagal-Heart Rate Modulation and Baroreflex Sensitivity Among Patients With Hypertension|Completed||N/A|65|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:34:51.14115|2017-02-18 13:34:51.14115
NCT00811798|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-09-23|2011-09-08||May 2009||2009-05-01|September 2016|2016-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects.|Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK-580299) in Healthy Female Subjects.|Completed||Phase 3|92|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:34:51.249165|2017-02-18 13:34:51.249165
NCT00811785|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2017-01-24|||December 17, 2008||2008-12-17|January 11, 2017|2017-01-11|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency|Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency|Recruiting||Phase 3|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:34:51.453408|2017-02-18 13:34:51.453408
NCT00811772|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-05-23|||September 2008||2008-09-01|May 2016|2016-05-01|September 2020|Anticipated|2020-09-01|December 2014|Actual|2014-12-01||Interventional|NORSTENT||Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis|Comparison of the Long-term Effects on Mortality and Cardiovascular Morbidity of Percutaneous Coronary Intervention With Drug-eluting Stent Versus Bare-metal Stent. Randomized, Five-year Prospective, Multicenter Clinical Trial|Active, not recruiting||Phase 4|9000|Anticipated|University of Tromso||2|||f||||t||||||||Undecided||2017-02-18 13:34:51.565207|2017-02-18 13:34:51.565207
NCT00811759|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2010-10-06|||June 2007||2007-06-01|July 2009|2009-07-01||||May 2009|Anticipated|2009-05-01||Interventional|||Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma|Open-label, Single Center, Uncontrolled Phase I/II Study Evaluating the Safety and Maximum Tolerated Dose of Daily Sorafenib Administered in Combination With Prolonged Temozolomide in Patients With Metastatic Melanoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|58|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:34:51.675553|2017-02-18 13:34:51.675553
NCT00811746|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2013-05-28|||December 2008||2008-12-01|May 2013|2013-05-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?|Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?|Completed||N/A|90|Anticipated|Southern California Institute for Research and Education||3|||f||||f||||||||||2017-02-18 13:34:51.768219|2017-02-18 13:34:51.768219
NCT00811720|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-07-05|2013-03-12||December 2008||2008-12-01|July 2013|2013-07-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|ESENSE1||Efficacy of Nalmefene in Patients With Alcohol Dependence|Nalmefene Efficacy Study I: Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy Study of 20 mg Nalmefene, As-needed Use, in Patients With Alcohol Dependence|Completed||Phase 3|598|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:34:53.39092|2017-02-18 13:34:53.39092
NCT00811707|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2008-12-18|||June 2008||2008-06-01|August 2008|2008-08-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Observational|||Epidural Sonoanatomy Between Parturient and Non-Pregnant|To Compare Epidural Sonoanatomy Between Parturient and Non-Pregnant Young Female in Chinese Population|Unknown status|Recruiting|N/A|40|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||2||f||||f||||||||||2017-02-18 13:34:54.444588|2017-02-18 13:34:54.444588
NCT00811694|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2014-11-20|||October 2006||2006-10-01|November 2014|2014-11-01|May 2012|Actual|2012-05-01|April 2007|Actual|2007-04-01||Observational|||Neurovascular Coupling in Patients With Open Angle Glaucoma|Neurovascular Coupling in Patients With Open Angle Glaucoma|Terminated||N/A|15|Anticipated|Medical University of Vienna|||2||f||||t||||||||||2017-02-18 13:34:54.525797|2017-02-18 13:34:54.525797
NCT00811681|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-09-02|||December 2008||2008-12-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|ACTFRIE||Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept|Effect of Pioglitazone Administered to Patients With Friedreich's ATAXIA:Proof of Concept|Completed||Phase 3|40|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:34:54.626298|2017-02-18 13:34:54.626298
NCT00811668|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2011-08-01|||May 2008||2008-05-01|August 2011|2011-08-01|October 2009|Actual|2009-10-01|February 2009|Actual|2009-02-01||Interventional|VCR||Comparison of CPAP With SOMNOventCR in Patients With Underlying Heart Disease, Combined OSA and CSR|Crossover Comparison of Treatment With Continuous Positive Airway Pressure and Treatment With Adaptive Servo Ventilation (SOMNOventCR) in Patients With Underlying Heart Disease, Combined Obstructive Sleep Apnea and Cheyne-Stokes Respiration.|Completed||N/A|40|Actual|Wissenschaftliches Institut Bethanien e.V||2|||f||||f||||||||||2017-02-18 13:34:54.745208|2017-02-18 13:34:54.745208
NCT00811655|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-10-30|2013-08-15||October 2008||2008-10-01|October 2013|2013-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Stereotactic Radiosurgery in Treating Patients With Brain Metastases|Phase II Single-arm Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases.|Terminated||Phase 2|6|Actual|Duke University|Early termination leading to small numbers of subjects analyzed.|1||Slow recruitment|f||||f||||||||||2017-02-18 13:34:54.856394|2017-02-18 13:34:54.856394
NCT00811642|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-06-04|2011-03-31||November 2008||2008-11-01|June 2015|2015-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)|A Multicenter, Open Label Study to Evaluate Safety and Efficacy of Posaconazole Oral Suspension in Treatment of Invasive Fungal Infection|Completed||Phase 3|63|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:34:55.179927|2017-02-18 13:34:55.179927
NCT00811629|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-09-30|||January 2009||2009-01-01|September 2013|2013-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU Patients|Soluble Form of the Receptor for Advanced Glycation End Products (sRAGE) Levels in the Pulmonary Edema Fluid and Plasma From ICU Patients With ALI/ARDS and Severe Sepsis : an Observational Prospective Study.|Completed||N/A|60|Actual|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-02-18 13:34:55.498095|2017-02-18 13:34:55.498095
NCT00811616|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2010-05-10|||July 2006||2006-07-01|May 2010|2010-05-01|March 2008|Actual|2008-03-01|||||Interventional|Maximus||A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute|Safety And Efficacy Evaluation of Sirolimus Eluting Supralimus-Core™ Stent at MAX DDHV Institute in the Treatment of de Novo Native Coronary Artery Lesions|Completed||N/A|105|Actual|Sahajanand Medical Technologies Pvt. Ltd.||1|||f||||t||||||||||2017-02-18 13:34:55.610125|2017-02-18 13:34:55.610125
NCT00811603|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2009-09-17|||August 2008||2008-08-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Trial Comparing the Optimal Timing of Antibiotic Prophylaxis at the Time of Cesarean Delivery|Optimal Timing for Antibiotic Prophylaxis for Elective Cesarean Delivery in Term Gestations: A Randomized, Controlled Trial Comparing Cefazolin Administration Prior to Skin Incision Versus Following Cord Clamping|Completed||Phase 3|50|Actual|MemorialCare||2|||f||||t||||||||||2017-02-18 13:34:55.704215|2017-02-18 13:34:55.704215
NCT00811590|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-07-19|2012-03-06||November 2008||2008-11-01|July 2013|2013-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome|Pilot Study of mTOR Inhibitor Therapy for Treatment of Intestinal Polyps in Peutz-Jeghers Syndrome|Terminated||Phase 2|3|Actual|University of Utah|Early termination leading to small numbers of subjects analyzed|1||The study was ended early due to low enrollment.|f||||t||||||||||2017-02-18 13:34:55.806825|2017-02-18 13:34:55.806825
NCT00811577|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-09-10|2012-05-16||January 2009||2009-01-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients|A Phase 2a Double Blind, Placebo Within-Patient Controlled, Multi-Center Dose Ranging Study to Evaluate the Safety and Preliminary Efficacy of AZX100 Drug Product in Trocar Sites of Arthroscopic Shoulder Surgery Patients|Completed||Phase 2|150|Actual|Capstone Therapeutics||2|||f||||f||||||||||2017-02-18 13:34:56.032328|2017-02-18 13:34:56.032328
NCT00811564|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2011-08-17|2011-08-17||December 2008||2008-12-01|August 2011|2011-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects||Completed||Phase 4|148|Actual|Allergan||2|||f||||||||||||||2017-02-18 13:34:56.913539|2017-02-18 13:34:56.913539
NCT00811551|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-07-23|||December 2008||2008-12-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|zWedge||Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices|zWedge Clinical Feasibility IDE Study|Completed||N/A|22|Actual|St. Jude Medical|||1||f||||f||||||||||2017-02-18 13:34:57.200507|2017-02-18 13:34:57.200507
NCT00811538|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-04-11|||December 2007||2007-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Observational|SWISS||Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry|Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry (SWISS)|Completed||N/A|1476|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-02-18 13:34:57.290432|2017-02-18 13:34:57.290432
NCT00811486|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2013-01-25|||January 2009||2009-01-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure|Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure|Withdrawn||N/A|0|Actual|University of Colorado, Denver||2||Only 1 patient recruited, and he withdrew|f||||t||||||||||2017-02-18 13:34:57.87229|2017-02-18 13:34:57.87229
NCT00811473|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-07-02|2011-10-27||January 2009||2009-01-01|July 2014|2014-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Pediatric Bipolar Depression|An 8-week, Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended-Release in Children and Adolescent Subjects With Bipolar Depression|Completed||Phase 3|193|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 13:34:57.974|2017-02-18 13:34:57.974
NCT00811460|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-11-01|||November 2008||2008-11-01|November 2016|2016-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study of Taspoglutide in Type 2 Diabetic Patients|A Double-blind, Crossover, Randomized, Placebo-controlled Study to Investigate the Effect of Two Different Doses of Taspoglutide IRF Administered as Continuous Subcutaneous Infusion on First- and Second-phase Insulin Secretion in Type 2 Diabetic Patients|Completed||Phase 1|18|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:34:58.464451|2017-02-18 13:34:58.464451
NCT00811447|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-08-30|||November 2008||2008-11-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Taxotere New Indication - Gastric Cancer Treatment Registration Trial|Open Label, Randomized Multicenter Study Docetaxel + 5-fluorouracil + Cisplatin Compared to Cisplatin + 5-fluorouracil in Patients With Metastatic or Locally Recurrent Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease|Completed||Phase 3|243|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:34:58.559395|2017-02-18 13:34:58.559395
NCT00811434|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-02-07|2012-10-09||January 2009||2009-01-01|February 2014|2014-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|MHE||Study of Lactulose in Children With Chronic Liver Disease|Improvement of Cognitive Function and Healthcare -Related Quality of Life After Lactulose Treatment in Children With Chronic Liver Disease|Terminated||Phase 2|16|Actual|Indiana University||2||funding period ended|f||||t||||||||||2017-02-18 13:34:58.663839|2017-02-18 13:34:58.663839
NCT00811421|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-03-19|||September 2009||2009-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|MiPPAD||Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy|Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy|Completed||N/A|5820|Actual|Hospital Clinic of Barcelona||5|||f||||t||||||||||2017-02-18 13:34:58.92808|2017-02-18 13:34:58.92808
NCT00811408|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2010-01-27|||April 2008||2008-04-01|July 2009|2009-07-01||||October 2009|Anticipated|2009-10-01||Interventional|||Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy|Modulating the Expression of Oncoproteins of Papillomavirus (HPV) to Increase Radiosensitivity: a Phase I Study of Antiviral Agent Cidofovir and Chemoradiotherapy Therapy in Cervical Cancers|Unknown status|Recruiting|Phase 1|24|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:34:59.049248|2017-02-18 13:34:59.049248
NCT00811395|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2012-12-18|2012-10-03||October 2007||2007-10-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis|Long-term Extension of the Multinational, Double-blind, Placebo Controlled Studies PDY6045 and PDY6046 to Document the Safety of Teriflunomide When Added to Treatment With Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis With Relapses|Completed||Phase 2|182|Actual|Sanofi||6|||f||||t||||||||||2017-02-18 13:34:59.15411|2017-02-18 13:34:59.15411
NCT00811382|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2015-10-23|||May 2008||2008-05-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|January 2014|Actual|2014-01-01||Interventional|effecT||Clinical effecT of Heart Failure Management Via Home Monitoring With a Focus on Atrial Fibrillation (effecT)|Clinical effecT of Heart Failure Management Via Home Monitoring With a Focus on Atrial Fibrillation (effecT)|Completed||N/A|166|Actual|Biotronik SE & Co. KG||2|||f||||t||||||||||2017-02-18 13:35:00.703416|2017-02-18 13:35:00.703416
NCT00811369|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-11-15|||August 2009||2009-08-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|October 2012|Actual|2012-10-01||Interventional|ZAMBONEY||Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer|A Phase II, Multi-Centre, Randomized, Double-blind Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA or Fulvestrant Plus Placebo in Postmenopausal Women With Bone Only or Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer|Completed||Phase 2|126|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-02-18 13:35:00.826987|2017-02-18 13:35:00.826987
NCT00811356|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2016-10-26|||December 2008||2008-12-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria|A Single-Blind, Placebo-Controlled, Randomized First Time in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Dose Escalation of GSK932121 in Healthy Adult Subjects|Terminated||Phase 1|12|Actual|GlaxoSmithKline||1||safety issues (toxicity)|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:35:00.970087|2017-02-18 13:35:00.970087
NCT00811343|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-18|2014-01-06|||December 2008||2008-12-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Interventional|ETAT||Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy|Impact of New Immunological Diagnosis Tests of Latent Tuberculosis in Adults Patients Who Need Anti TNF Therapy.|Completed||N/A|430|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 13:35:01.087482|2017-02-18 13:35:01.087482
NCT00811330|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2015-06-18|||December 2008||2008-12-01|June 2015|2015-06-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis|Interest of Statin in Surgical Aortic Stenosis: From Myocardial Preconditioning to Ventricular Reverse Remodeling.|Recruiting||Phase 3|60|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 13:35:01.400413|2017-02-18 13:35:01.400413
NCT00811317|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2010-04-15|||May 2008||2008-05-01|April 2010|2010-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Closed-loop Glucose Control for Automated Management of Type 1 Diabetes|Closed-loop Glucose Control for Automated Management of Type 1 Diabetes|Completed||N/A|38|Actual|Boston University||2|||f||||t||||||||||2017-02-18 13:35:01.510221|2017-02-18 13:35:01.510221
NCT00811304|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-02-01|||January 2009||2009-01-01|February 2013|2013-02-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Observational|||Real-time Ultrasound Guided Labor Epidural Placement|Real-time Ultrasound Guided Labor Epidural Placement|Withdrawn||N/A|0|Actual|University of Pittsburgh|||1|"We are unable to find a clip used to stabilize the epidural needle on the ultrasound probe to~   allow adequate epidural catheter placement."|f||||t||||||||||2017-02-18 13:35:01.637418|2017-02-18 13:35:01.637418
NCT00811291|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-07-03|||September 2008||2008-09-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|August 2009|Actual|2009-08-01||Interventional|SIMBA||Influence of Vitamin-B-complex on Cognitive Ability of Kindergarten Kids|SIMBA-Study Investigating Mental Acuity Effects of B-vitamins in Children|Completed||N/A|250|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-02-18 13:35:01.727558|2017-02-18 13:35:01.727558
NCT00811278|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2011-10-07|||December 2008||2008-12-01|October 2011|2011-10-01||||June 2011|Actual|2011-06-01||Observational|||Approach to Predict Steroid Sensitivity in Patients With Asthma|A Non-Invasive Approach to Predict Steroid Sensitivity in Patients With Asthma|Completed||N/A|30|Anticipated|Children's Mercy Hospital Kansas City|||3||f||||f||||||Samples With DNA|"~     Whole blood, DNA, RNA~   "|||2017-02-18 13:35:01.831293|2017-02-18 13:35:01.831293
NCT00811265|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-03-07|||January 2009||2009-01-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety Evaluation of ExAblate MRgFUS for Prostate Cancer|Safety, Compatibility and Imaging Quality of ExAblate Prostate Applicator for Prostate Cancer|Completed||Phase 1|10|Anticipated|InSightec||1|||f||||f||||||||||2017-02-18 13:35:01.927933|2017-02-18 13:35:01.927933
NCT00811252|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2013-12-23|2013-10-28||January 2009||2009-01-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional||Full-analysis set (FAS) – all patients in the all-patients-treated set (APTS) who had at least one valid post-baseline assessment of the primary efficacy variable|Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients|Randomised, Double-blind, Parallel-group, Placebo-controlled, Duloxetine-referenced, Fixed Dose Study Comparing the Efficacy and Safety of [Vortioxetine] Lu AA21004 in Acute Treatment of Major Depressive Disorder in Elderly Patients|Completed||Phase 3|453|Actual|H. Lundbeck A/S||3|||f||||f||||||||||2017-02-18 13:35:02.053846|2017-02-18 13:35:02.053846
NCT00811239|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2008-12-17|||March 2004||2004-03-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus|A Controlled Clinical Trial on The Use of a Specific Antivenom Against Envenoming by Bungarus Multicinctus|Completed||Phase 1/Phase 2|81|Actual|Hanoi Medical University||2|||f||||t||||||||||2017-02-18 13:35:03.012942|2017-02-18 13:35:03.012942
NCT00811226|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-12-16|||April 2007||2007-04-01|December 2008|2008-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Assessment of the Effectiveness of OLMETEC® and OLMETEC PLUS® for Treatment of Hypertension in Stage I and II Patients (Study P05254)(COMPLETED)|Prospective, Multicentric, Open Clinic Essay to Evaluate the Use of OLMETEC® (Olmesartan Medoxomile) and OLMETEC PLUS® (Olmesartan Medoxomile Hydrochlorothiazide) in Stade I and II, According to JNC VII|Completed||N/A|450|Anticipated|Schering-Plough|||1||f||||f||||||||||2017-02-18 13:35:03.128649|2017-02-18 13:35:03.128649
NCT00811213|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-07-10|||October 2008||2008-10-01|July 2011|2011-07-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|SASQT||SensAwake™ Sleep Quality Trial|SASQT: SensAwake™ Sleep Quality Trial A Study to Test the Efficacy of the SensAwake™ Modification to Automatically Titrating Continuous Positive Airway Pressure to Reduce Wake After Sleep Onset in Patients With Moderate to Severe Obstructive Sleep Apnea.|Completed||Phase 4|45|Anticipated|Fisher and Paykel Healthcare||2|||f||||f||||||||||2017-02-18 13:35:03.235823|2017-02-18 13:35:03.235823
NCT00811200|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2009-06-30|||September 2009||2009-09-01|June 2009|2009-06-01||||January 2012|Anticipated|2012-01-01||Interventional|TORR||Treatment Of Radiation Retinopathy Trial|Treatment Of Radiation Retinopathy Trial Subtitle: Treatment of Radiation Retinopathy; Influence of Lucentis® and Kenalog® on Radiation Retinopathy After Irradiation of Choroidal Melanoma.|Unknown status|Not yet recruiting|Phase 2/Phase 3|220|Anticipated|Leiden University Medical Center||3|||f||||t||||||||||2017-02-18 13:35:03.347263|2017-02-18 13:35:03.347263
NCT00811187|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2008-12-17|||March 2007||2007-03-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||Paracervical Block During Office Hysteroscopy|Paracervical Block During Office Hysteroscopy: A Randomized Double Blind Placebo-Controlled Trial|Completed||N/A|80|Actual|Montefiore Medical Center||2|||f||||f||||||||||2017-02-18 13:35:03.457605|2017-02-18 13:35:03.457605
NCT00811174|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2013-05-06|||January 2009||2009-01-01|May 2013|2013-05-01||||September 2010|Actual|2010-09-01||Interventional|||Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases|Clinical Study to Evaluate the Efficacy, Safety and Kinetics of Octagam 10% for Replacement Therapy in Primary Immunodeficiency Diseases|Terminated||Phase 3|5|Actual|Octapharma||1|||f||||f||||||||||2017-02-18 13:35:03.552494|2017-02-18 13:35:03.552494
NCT00811161|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2009-06-03|||May 2009||2009-05-01|June 2009|2009-06-01|April 2010|Anticipated|2010-04-01|February 2010|Anticipated|2010-02-01||Interventional|||An Open Label Study to Evaluate the Efficacy of Airgent in Treating Damaged and Wrinkled Skin|An Open Label Study to Evaluate the Efficacy of Airgent in Treating Damaged and Wrinkled Skin|Unknown status|Recruiting|N/A|30|Anticipated|PerfAction Ltd.||1|||f||||f||||||||||2017-02-18 13:35:03.655281|2017-02-18 13:35:03.655281
NCT00811148|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-09-20|||March 2006||2006-03-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|FCBTR||Florida Center for Brain Tumor Research|Establishment of a UF Brain Tumor Tissue Bank: Florida Center for Brain Tumor Research|Recruiting||N/A|4000|Anticipated|University of Florida|||1||f||||f||||||Samples With DNA|"~     Tissue, medical information, cerebrospinal fluid, blood and answers to Quality of Life~     questionnaires will be stored and made available to researchers.~   "|No||2017-02-18 13:35:03.759642|2017-02-18 13:35:03.759642
NCT00811135|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-08-23|2015-11-03||December 2008||2008-12-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional||The Intention-To-Treat (ITT) population included all participants enrolled in the study who received at least one dose of any study medication.|A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer|A Single Arm Open-label, Phase II Study of Bevacizumab in Combination With Trastuzumab and Capecitabine as First-line Treatment of Patients With HER2-positive Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 2|88|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:35:03.883883|2017-02-18 13:35:03.883883
NCT00811122|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-08-09|||November 2009||2009-11-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|February 2017|Anticipated|2017-02-01||Interventional|11C-PIB PET||Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly|Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly|Active, not recruiting||Early Phase 1|30|Anticipated|University of Utah||1|||f||||t||||||||||2017-02-18 13:35:04.2452|2017-02-18 13:35:04.2452
NCT00811109|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2010-03-02|||December 2008||2008-12-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|HEMOTOL||HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit|HEMOTOL: Effects of New Dialysis On-line Monitoring Devices on Hemodynamic Stability During Intermittent Hemodialysis in Critically Ill Patients With Acute Kidney Injury : a Prospective Randomized Study.|Completed||Phase 2/Phase 3|600|Anticipated|University Hospital, Caen||3|||f||||t||||||||||2017-02-18 13:35:04.348694|2017-02-18 13:35:04.348694
NCT00811096|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-11-30|||November 2008||2008-11-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax|Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax|Completed||Phase 2|20|Actual|Walter Reed Army Institute of Research (WRAIR)||2|||f||||t||||||||||2017-02-18 13:35:04.458658|2017-02-18 13:35:04.458658
NCT00811083|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2008-12-17|||May 2005||2005-05-01|December 2008|2008-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Dimercaptosuccinic Acid (DMSA) Treatment of Children With Autism and Heavy Metal Toxicity|DMSA Treatment of Children With Autism and Heavy Metal Toxicity|Completed||Phase 1/Phase 2|80|Actual|Southwest College of Naturopathic Medicine||2|||f||||f||||||||||2017-02-18 13:35:04.860754|2017-02-18 13:35:04.860754
NCT00811070|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-05-19|2014-03-03||December 2007||2007-12-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|March 2013|Actual|2013-03-01||Interventional|||Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias|A Phase 1/2 Study Of SKI-606 Administered As A Single Agent In Japanese Subjects With Philadelphia Chromosome Positive Leukemias|Completed||Phase 2|63|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 13:35:04.994459|2017-02-18 13:35:04.994459
NCT00811057|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-02-25|2013-02-25||June 2004||2004-06-01|February 2013|2013-02-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Tocolysis for Preterm Labor|Tocolysis for Preterm Labor|Completed||N/A|301|Actual|University of Mississippi Medical Center||3|||f||||f||||||||||2017-02-18 13:35:06.600228|2017-02-18 13:35:06.600228
NCT00811044|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2010-10-01|||October 2000||2000-10-01|October 2010|2010-10-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|RHIE||Regulation of Hepatic Insulin Extraction|Regulation of Hepatic Insulin Extraction:Alterations of Insulin Secretion in Subjects With Genetic Variants That Determine Risk for Non-Insulin Dependant Diabetes Mellitus|Withdrawn||N/A|1250|Anticipated|Washington University School of Medicine|||3|PI, Dr. K. Polonsky has moved to the University of Chicago.|f||||f||||||Samples With DNA|"~     Samples are collected for Glucose & various human peptide measurements and DNA. As peptide~     assay evolves, specimens may be re-tested.~   "|||2017-02-18 13:35:07.07992|2017-02-18 13:35:07.07992
NCT00811031|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2012-07-27||||||July 2012|2012-07-01||||||||Interventional|||Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)|A Phase II Study of Pre-operative Docetaxel for Progressive Localized Castration Resistant Prostate Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:35:07.182476|2017-02-18 13:35:07.182476
NCT00811018|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-03-29|2012-03-29||March 2003||2003-03-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|STRIDE-3||A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension|A Long-Term, Open-Label Study To Evaluate The Safety Of Sitaxsentan Sodium Treatment In Patients With Pulmonary Arterial Hypertension|Terminated||Phase 3|1192|Actual|Pfizer|Mean and dispersion for clinical abnormalities were intended to be reported but due to early termination of study (09-Dec-2010) only number and percent of participants are available.|1||"This trial was prematurely terminated on Dec 9 2010 due to safety concerns, specifically~   emerging evidence of hepatic injury."|f||||f||||||||||2017-02-18 13:35:07.308415|2017-02-18 13:35:07.308415
NCT00811005|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2009-09-17|||October 2008||2008-10-01|September 2009|2009-09-01|October 2010|Anticipated|2010-10-01|October 2009|Anticipated|2009-10-01||Interventional|FVSA-PUVA||Fumaric Acid Ester-PUVA Therapy Versus Acitretin -PUVA Therapy in Pustular Palmoplantar Psoriasis|Comparison of Fumaric Acid Ester-PUVA (FAE-PUVA) Versus Acitretin-PUVA (Re-PUVA) in Pustular Palmoplantar Psoriasis,a Prospective, Randomized, Controlled, Single-blinded Study|Unknown status|Active, not recruiting|Phase 3|20|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:35:08.393689|2017-02-18 13:35:08.393689
NCT00810992|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2013-01-11|||January 2009||2009-01-01|January 2013|2013-01-01|April 2011|Actual|2011-04-01|November 2010|Actual|2010-11-01||Interventional|TTM in CAD||Traditional Tibetan Medicine for Patients With Coronary Artery Disease|Behavioral and Nutritional Therapy in Patients With Coronary Artery Disease According to Traditional Tibetan Medicine Protocol|Completed||N/A|524|Actual|University Hospital Tuebingen||2|||f||||||||||||||2017-02-18 13:35:10.834866|2017-02-18 13:35:10.834866
NCT00810979|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2015-01-16||2014-12-09|January 2009||2009-01-01|January 2015|2015-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Different Doses of SLx-4090 in Combination With a Statin vs. Statin Mono-therapy in Patients With Hyperlipidemia|Completed||Phase 2|133|Actual|Kadmon Corporation, LLC||3|||f||||f||||||||||2017-02-18 13:35:10.937895|2017-02-18 13:35:10.937895
NCT00810953|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-06-27|||January 2009||2009-01-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy|A Phase I/II Clinical Study Using Pentamidine in Patients With Locally Advanced or Metastatic Pancreatic Cancer Undergoing Standard Therapy|Completed||Phase 1/Phase 2|10|Actual|Oncozyme Pharma Inc.||1|||f||||t||||||||||2017-02-18 13:35:11.050116|2017-02-18 13:35:11.050116
NCT00810940|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2010-12-06|||October 2010||2010-10-01|December 2010|2010-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|ABELADRUG200||Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury|Phase 1/2 Multicenter, Randomized, Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Abela Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 13:35:11.14355|2017-02-18 13:35:11.14355
NCT00810927|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2008-12-17|||September 2003||2003-09-01|December 2008|2008-12-01|August 2005|Actual|2005-08-01|February 2004|Actual|2004-02-01||Interventional|||Role of Nitrogen Oxide (NO) in the Control of Choroidal Blood Flow During a Decrease in Ocular Perfusion Pressure|Role of NO in the Control of Choroidal Blood Flow During a Decrease in Ocular Perfusion Pressure|Completed||Phase 2|22|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-02-18 13:35:11.242167|2017-02-18 13:35:11.242167
NCT00810914|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2009-09-17|||March 2006||2006-03-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|Epidural||Patient Controlled Epidural Analgesia Versus Continuous Epidural Infusion: Obstetrical and Neonatal Outcomes|Patient Controlled Epidural Infusion Vs. Continuous Epidural Infusion: Obstetrical and Neonatal Outcomes|Unknown status|Recruiting|N/A|270|Anticipated|MemorialCare||3|||f||||f||||||||||2017-02-18 13:35:11.340923|2017-02-18 13:35:11.340923
NCT00810901|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2015-06-23|2015-01-09||April 2008||2008-04-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Idecide||Intervention to Motivate Teens to be a Designated Organ Donor on Driver's License|Multimedia Intervention to Motivate Ethnic Teens to be Designated Donors|Completed||N/A|429|Actual|University of Hawaii||2|||f||||t||||||||||2017-02-18 13:35:11.455993|2017-02-18 13:35:11.455993
NCT00810888|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-11-17|||November 2010||2010-11-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|STOP-IT||The Spot Sign for Predicting and Treating ICH Growth Study|The Spot Sign for Predicting and Treating Intracerebral Hemorrhage Growth Study|Completed||Phase 2|92|Actual|University of Cincinnati||3|||f||||t||||||||||2017-02-18 13:35:12.223488|2017-02-18 13:35:12.223488
NCT00810875|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2014-08-21|||April 2009||2009-04-01|August 2014|2014-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy|Analysis of the Maternal-fetal Interface During Maternal Hepatitis C Virus Infection and Influenza Virus Vaccination|Terminated||N/A|6|Actual|University of California, San Francisco|||2|Terminated due to lack of enrollment|f||||f||||||Samples With DNA|"~     Plasma, peripheral and cord blood mononuclear cells, placental tissue~   "|||2017-02-18 13:35:12.354672|2017-02-18 13:35:12.354672
NCT00810862|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2008-12-17|||November 2006||2006-11-01|December 2008|2008-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children|A 3-Week, Single-Blind, Placebo-Controlled, Within-Patient, Randomized Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children|Terminated||Phase 4|18|Actual|Children's Hospital of Michigan||2||Lack of subject enrollment over the past two years.|f||||f||||||||||2017-02-18 13:35:12.459178|2017-02-18 13:35:12.459178
NCT00810849|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2014-09-02|||December 2008||2008-12-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|IMPI||A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis|A Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis|Completed||Phase 3|1400|Actual|University of Cape Town||2|||f||||t||||||||||2017-02-18 13:35:12.569903|2017-02-18 13:35:12.569903
NCT00810836|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2013-09-12|||December 2008||2008-12-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis|A Phase 2a, Randomised, Double-Blind, Placebo-Controlled, Multicentre Study to Evaluate the Efficacy, Safety and Tolerability of BG00012 When Given With Methotrexate to Subjects With Active RA Who Have Had an Inadequate Response to Conventional Disease-Modifying Anti-rheumatic Drug Therapy|Completed||Phase 2|153|Actual|Biogen||3|||f||||f||||||||||2017-02-18 13:35:12.694906|2017-02-18 13:35:12.694906
NCT00810823|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2011-07-05|||January 2009||2009-01-01|December 2008|2008-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||The Effect of Gastric Bypass Surgery on the Glucose Metabolism Seen in Patients With Type 2 Diabetes|The Effect of Gastric Bypass Surgery on the Glucose Metabolism Seen in Patients With Type 2 Diabetes|Completed||N/A|25|Actual|Hvidovre University Hospital|||2||f||||f||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 13:35:12.821478|2017-02-18 13:35:12.821478
NCT00810810|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-06-22|||July 2006||2006-07-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Immunomodulation Following Transfusion|Immunomodulation Following Transfusion|Completed||Phase 4|287|Actual|University of Washington||3|||f||||f||||||||||2017-02-18 13:35:12.911525|2017-02-18 13:35:12.911525
NCT00810797|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2017-01-27|||December 2008||2008-12-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer|Intermittent Exemestane Therapy for Metastatic Breast Cancer|Active, not recruiting||Phase 2|36|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:35:13.025079|2017-02-18 13:35:13.025079
NCT00810784|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2008-12-17|||March 2005||2005-03-01|December 2008|2008-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients|Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients|Completed||N/A|121|Actual|University of Utah|||2||f||||t||||||||||2017-02-18 13:35:13.139108|2017-02-18 13:35:13.139108
NCT00810394|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-06-20|||December 2008||2008-12-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||Sorafenib in Treating Patients With Advanced Malignant Solid Tumors|Single Agent Sorafenib in Advanced Solid Tumors: Phase II Evaluation of Dose Re-Escalation Following a Dose Reduction (IST000375)|Completed||Phase 2|51|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 13:35:20.210603|2017-02-18 13:35:20.210603
NCT00810771|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-06-01|2015-03-26||February 2009||2009-02-01|June 2015|2015-06-01|August 2012|Actual|2012-08-01|May 2012|Actual|2012-05-01||Interventional|EPIIC|"Baseline participants in Arm 1 and 2 reflect the number completing the survey. Not all participants enrolled to these arms completed the survey. Arm 3, usual care arm, was not a true 3rd arm and participants in this group did not complete the survey."|Evaluating a Preference-based Intervention for Increasing Colorectal Cancer Screening|Evaluating a Preference-based Intervention for Increasing CRC Screening|Completed||N/A|466|Actual|VA Office of Research and Development|Usual care arm was not true 3rd arm. We identified pts meeting eligibility criteria & randomized ~ 10th pt to be followed, measuring CRC screening 6 mos later. No intervention or survey. Only 79.6% of those enrolled completed survey.|3|||f||||t||||||||||2017-02-18 13:35:13.245208|2017-02-18 13:35:13.245208
NCT00810758|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2009-11-30|||January 2009||2009-01-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691|A Phase 1, Randomized, Placebo Controlled, Blinded (3rd Party Open), Sequential, Multiple-Dose Escalation Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691 In Healthy Volunteers|Completed||Phase 1|24|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:35:13.851809|2017-02-18 13:35:13.851809
NCT00810745|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2009-02-25|||January 2006||2006-01-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||What Benefit With a New Stapler Device in the Surgical Treatment of Obstructed Defecation?|What Benefit With a New Stapler Device in the Surgical Treatment of Obstructed Defecation? Two-Year Outcomes From a Randomized Controlled Trial|Completed||Phase 4|80|Actual|University of Milan||1|||f||||f||||||||||2017-02-18 13:35:13.950061|2017-02-18 13:35:13.950061
NCT00810732|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-08-08||2012-01-27|May 2007||2007-05-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|FCRD01||Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects|The Effects Of Sitaxsentan Once Daily Dosing On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Subjects With Chronic Kidney Disease.|Completed||Phase 2|27|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:35:14.108631|2017-02-18 13:35:14.108631
NCT00810719|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2014-08-18|||April 2009||2009-04-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|January 2013|Actual|2013-01-01||Interventional|UCDCC#211||Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer|Phase II Study of Gemcitabine and Intermittent Erlotinib in Advanced Pancreatic Cancer (OSI 4132s)|Completed||Phase 2|30|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 13:35:14.371006|2017-02-18 13:35:14.371006
NCT00810706|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2008-12-16|||April 2001||2001-04-01|December 2008|2008-12-01|November 2005|Actual|2005-11-01|||||Interventional|ATENA||Adjuvant Post-Tamoxifen Exemestane Trial|A Phase III Randomized Parallel-Group Multicenter Trial, Designed to Compare 5 Years of Adjuvant Exemestane Versus 5 Years of Observation in Postmenopausal Women With Operable Breast Cancer Who Have Received 5-7 Years of Adjuvant Tamoxifen.|Terminated||Phase 3|448|Actual|Hellenic Breast Surgeons Society||2||Publication of MA17 results (similar trial in the extented adjuvant setting with letrozole)|f||||f||||||||||2017-02-18 13:35:14.488777|2017-02-18 13:35:14.488777
NCT00810693|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-10-14|2013-11-05||December 2008||2008-12-01|October 2016|2016-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PATENT-1||A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)|Randomized, Double-blind, Placebo-controlled, Multi-centre, Multi-national Study to Evaluate the Efficacy and Safety of Oral BAY63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)|Completed||Phase 3|445|Actual|Bayer||3|||f||||t||||||||||2017-02-18 13:35:14.614462|2017-02-18 13:35:14.614462
NCT00810680|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2008-12-17|||September 2008||2008-09-01|December 2008|2008-12-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)|Use of Valproic Acid in Relapsed or Refractory Chronic Lymphocytic Leukemia|Unknown status|Recruiting|N/A|10|Anticipated|All India Institute of Medical Sciences, New Delhi||1|||f||||f||||||||||2017-02-18 13:35:16.835182|2017-02-18 13:35:16.835182
NCT00810667|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-11-07|||November 2008||2008-11-01|November 2016|2016-11-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia|A Randomised, Double-blind, Parallel-Group, Fixed Dose Study Exploring the Efficacy and Safety of Lu AE58054 as Augmentation Therapy to Risperidone in Patients With Schizophrenia|Completed||Phase 2|124|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:35:16.954125|2017-02-18 13:35:16.954125
NCT00810654|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2011-01-18|||May 2008||2008-05-01|May 2009|2009-05-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease|Study on The Effectiveness of Oral Administration of Prolyl Endoprotease for Gluten Detoxification as a Means to Treat Coeliac Disease|Completed||Phase 1/Phase 2|14|Anticipated|VU University Medical Center||2|||f||||f||||||||||2017-02-18 13:35:17.103394|2017-02-18 13:35:17.103394
NCT00810641|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2011-05-31|2011-05-25||January 2009||2009-01-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|BPPV-HC||Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo|Randomized Multicenter Study of Treatment of Horizontal Canal Benign Paroxysmal Positional Vertigo|Completed||Phase 3|157|Actual|Chonbuk National University|In this study, resolution of BPPV was determined using a telephone interview during the follow-ups after one week.|3|||f||||t||||||||||2017-02-18 13:35:17.226079|2017-02-18 13:35:17.226079
NCT00810628|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2014-10-23|||January 2009||2009-01-01|December 2008|2008-12-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Cognitive Behavioral Therapy for Depression in Parkinson's Disease|Depression in Parkinson's Disease: A Pilot Project Using Cognitive Behavioral Therapy (CBT) to Improve Depression and Coping|Terminated||N/A|12|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 13:35:17.688965|2017-02-18 13:35:17.688965
NCT00810615|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2013-02-28|||February 2009||2009-02-01|February 2013|2013-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Treatment of Traumatic Brain Injury With Hyperbaric Oxygen Therapy|Treatment of Moderate to Mild Cognitive Dysfunction Caused by Traumatic Brain Injury (TBI) With Hyperbaric Oxygen Therapy (HBOT)|Completed||Phase 1/Phase 2|50|Actual|San Antonio Military Medical Center||2|||f||||t||||||||||2017-02-18 13:35:17.791347|2017-02-18 13:35:17.791347
NCT00810602|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2014-03-05|2013-11-27||January 2009||2009-01-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional||Only participants that completed 21 days of vorinostat were considered evaluable for both toxicity and the primary outcome, therfore only 50 of the 61 patients initially enrolled are represented in baseline characteristics.|Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant|Phase II Trial of Vorinostat Plus Tacrolimus & Mycophenolate to Prevent Graft Versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant|Completed||Phase 1/Phase 2|61|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 13:35:17.89439|2017-02-18 13:35:17.89439
NCT00810589|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2008-12-17|||November 2008||2008-11-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ENM-HS-001||A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial|A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial to Compare the Pharmacodynamic Effects of Single Doses of Insulin Detemir and Neutral Protamin Lispro (NPL) Insulin in Subjects With Type 1 Diabetes|Completed||Phase 1|30|Actual|Medical University of Graz||2|||f||||t||||||||||2017-02-18 13:35:18.344303|2017-02-18 13:35:18.344303
NCT00810576|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2012-08-01|2010-06-11||January 2009||2009-01-01|August 2012|2012-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma|A Phase II Study To Determine The Safety and Efficacy Of The Combination of Vorinostat and Bortezomib In Patients With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||1||Terminated due to slow accrual.|f||||f||||||||||2017-02-18 13:35:18.448488|2017-02-18 13:35:18.448488
NCT00810563|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2009-08-27|||August 2008||2008-08-01|August 2009|2009-08-01|August 2009|Anticipated|2009-08-01|March 2009|Anticipated|2009-03-01||Interventional|DOPOL||Does Bupivacaine in Laparoscopic Portals Reduce Post Surgery Pain in Tubal Ligation by Electrocoagulation?|Assessment of Postoperatory Pain After Laparoscopic Tubal Ligation by Electrocoagulation With Bupivacaine or Placebo|Unknown status|Recruiting|N/A|46|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-02-18 13:35:18.68107|2017-02-18 13:35:18.68107
NCT00810550|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-04-05|||October 2005||2005-10-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CUE-HF||Carotid Ultrasound in the Evaluation of Heart Failure|Carotid Ultrasound in the Evaluation of Heart Failure|Completed||N/A|150|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-02-18 13:35:18.792159|2017-02-18 13:35:18.792159
NCT00810524|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2008-12-17|||January 2007||2007-01-01|October 2008|2008-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection|Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection.|Unknown status|Recruiting|Phase 4|600|Anticipated|Sun Yat-sen University||4|||f||||t||||||||||2017-02-18 13:35:18.877843|2017-02-18 13:35:18.877843
NCT00810511|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-06-26|2010-07-23||November 2008||2008-11-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Two Silicone Hydrogel Lenses Over a One Month Period|Evaluation of Two Silicone Hydrogel Lenses Over a One Month Period|Completed||N/A|213|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 13:35:18.988143|2017-02-18 13:35:18.988143
NCT00810498|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2010-06-29|||March 2008||2008-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:35:19.313439|2017-02-18 13:35:19.313439
NCT00810485|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-07-13|||December 2008||2008-12-01|July 2012|2012-07-01||||December 2009|Actual|2009-12-01||Interventional|||ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)|A Phase 2B, Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-ranging, Multi-centre Study to Investigate the Efficacy, Safety and Tolerability of the mGluR5 Negative Allosteric Modulator ADX10059 in Patients With Gastroesophageal Reflux Disease (GERD) Who Are Partial Responders to Proton Pump Inhibitor (PPI) Treatment|Completed||Phase 2|298|Actual|Addex Pharma S.A.||4|||f||||f||||||||||2017-02-18 13:35:19.357739|2017-02-18 13:35:19.357739
NCT00810472|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-10-24|||September 2009||2009-09-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|FANCY||Functional Antigen Matching in Corneal Transplantation|Clinical Trial to Investigate Superiority of HLA Matching in Comparison to Random Graft Assignment With Respect to the Endpoint 'Time to First Endothelial Graft Rejection' in Penetrating Keratoplasty.|Completed||N/A|650|Anticipated|University Hospital Freiburg||2|||f||||t||||||||||2017-02-18 13:35:19.488392|2017-02-18 13:35:19.488392
NCT00810459|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2010-06-29|||March 2008||2008-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:35:19.576828|2017-02-18 13:35:19.576828
NCT00810446|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2017-02-15|||June 2009||2009-06-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Safety And Efficacy Of Rifabutin In HIV Patients|Drug Use Investigation For Hiv Infection Patients Of Mycobutin (Regulatory Post Marketing Commitment Plan).|Active, not recruiting||N/A|500|Anticipated|Pfizer|||1||f||||f||||||||||2017-02-18 13:35:19.6263|2017-02-18 13:35:19.6263
NCT00810433|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2014-02-06|||February 2009||2009-02-01|February 2014|2014-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Clinical Study of the GO-LIF® Approach for Lumbar Spinal Fixation|A Clinical Safety and Feasibility Study of the GO-LIF® Approach|Completed||N/A|10|Actual|Mazor Robotics||1|||f||||f||||||||||2017-02-18 13:35:19.779271|2017-02-18 13:35:19.779271
NCT00810420|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2008-12-17|||February 2007||2007-02-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01||Observational|||EEG-Changes During Insulininduced Hypoglycemia in Type 1 Diabetes|EEG-Changes During Insulininduced Hypoglycemia in Type 1 Diabetes|Completed||N/A|||Hypo-Safe A/S|||||f||||f||||||||||2017-02-18 13:35:20.025245|2017-02-18 13:35:20.025245
NCT00810407|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2016-09-20|||November 2008||2008-11-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients|Special Investigation For Non-hiv Patients Of Mycobutin (Regulatory Post Marketing Commitment Plan).|Completed||N/A|500|Anticipated|Pfizer|||1||f||||f||||||||||2017-02-18 13:35:20.11108|2017-02-18 13:35:20.11108
NCT00810381|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2008-12-17|||January 1999||1999-01-01|December 2008|2008-12-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects|Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects|Completed||N/A|14|Actual|Medical University of Vienna||4|||f||||t||||||||||2017-02-18 13:35:20.320205|2017-02-18 13:35:20.320205
NCT00810368|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2016-07-08|2014-03-24||August 2008||2008-08-01|July 2016|2016-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Prior 2-back working memory scores in Gulf War Illness were an average of 17 out of 35 correct (5=95%CI). Sample size for a 50% increase in 2-back working memory scores was 13 per group. 10% per month drop out rate was predicted so our aim was to have 36 subjects enter the study.|Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)|Carnosine Versus Placebo Treatment Study in Gulf War Illness (GWI)|Completed||Phase 2|33|Actual|Georgetown University|"Small sample sizes. No measure of changes in brain carnosine/homocarnosine/GABA.~Subjective outcomes were insensitive to change. Stool consistency needed better scoring system."|2|||f||||f||||||||No||2017-02-18 13:35:20.42307|2017-02-18 13:35:20.42307
NCT00810355|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-10-31|2016-07-22||October 2009||2009-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|August 2015|Actual|2015-08-01||Interventional|||Cognitive Behavior Therapy and Work Outcome|Effects of CBT and Cognitive Remediation on Work in Schizophrenia|Active, not recruiting||N/A|87|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 13:35:20.898653|2017-02-18 13:35:20.898653
NCT00810342|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2015-06-01|2015-01-09||April 2008||2008-04-01|January 2015|2015-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|"NaMikimiki"|Chi square test for differences in proportions; t test for differences in means|Physical Activity in Women With Infants|Physical Activity in Women With Infants|Completed||Phase 3|311|Actual|University of Hawaii||2|||f||||t||||||||||2017-02-18 13:35:21.559317|2017-02-18 13:35:21.559317
NCT00810329|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2014-02-24|||July 2007||2007-07-01|February 2014|2014-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome|Identify Unique Set of Proteins in Cerebrospinal Fluid, Which Are Believed to be Found in Chronic Fatigue Syndrome Participants, But Not in Healthy Controls.|Completed||N/A|160|Actual|Georgetown University|||2||f||||t||||||Samples With DNA|"~     Cheek swabs, on the right and left inner cheek. Others:Cerebrospinal fluid samples,Blood~     samples Urine samples.~   "|||2017-02-18 13:35:22.110614|2017-02-18 13:35:22.110614
NCT00810316|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2009-09-30|||October 2008||2008-10-01|September 2009|2009-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population|Evaluate The Pharmacokinetics Of Two Alprazolam Formulations (Immediate Release And Extended Release Tablets) And A Clonazepam Tablet In A Healthy Mexican Population|Completed||Phase 1|24|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:35:22.221947|2017-02-18 13:35:22.221947
NCT00810303|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2010-09-23|2010-06-21||March 2009||2009-03-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2||Completed||Phase 1|12|Actual|University Medicine Greifswald||1|||f||||f||||||||||2017-02-18 13:35:22.345234|2017-02-18 13:35:22.345234
NCT00810290|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2010-02-04|||July 2004||2004-07-01|February 2010|2010-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|LLDPP||Lawrence Latino Diabetes Prevention Project|Lawrence Latino Diabetes Prevention Project|Completed||N/A|312|Actual|University of Massachusetts, Worcester||1|||f||||f||||||||||2017-02-18 13:35:22.904233|2017-02-18 13:35:22.904233
NCT00810277|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-03-01|2016-03-01||November 2008||2008-11-01|March 2016|2016-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||Analysis population included all participants who entered the study.|A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs|An Open Label Study to Evaluate the Safety and Effect on Disease Activity of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have an Inadequate Response to Current Non-biologic DMARDs.|Completed||Phase 3|14|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:35:23.005935|2017-02-18 13:35:23.005935
NCT00810264|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2017-02-02|||December 2008||2008-12-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|CELESTIAL||Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar|CELESTIAL Post Approval Registry: Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar Post Approval Registry|Active, not recruiting||N/A|2500|Anticipated|Biotronik, Inc.|||1||f||||f||||||||||2017-02-18 13:35:23.382964|2017-02-18 13:35:23.382964
NCT00810251|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-07-05|||December 2008||2008-12-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Observational|MatrixRIB||MatrixRIB Implants for Surgical Stabilization of Flail Chest Injuries: A Registry|A Multi-Site Prospective, Non-Randomized Observational Study Utilizing MatrixRIB Implants for Surgical Stabilization of Flail Chest Injuries|Completed||Phase 4|20|Actual|Legacy Biomechanics Laboratory|||1||f||||f||||||||||2017-02-18 13:35:23.75568|2017-02-18 13:35:23.75568
NCT00810238|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2012-09-03|||December 2008||2008-12-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|July 2010|Actual|2010-07-01||Interventional|||C-Cure Clinical Trial|C-Cure - Safety, Feasibility and Efficacy of Guided Bone Marrow-derived Mesenchymal Cardiopoietic Cells for the Treatment of Heart Failure Secondary to Ischemic Cardiomyopathy|Completed||Phase 2/Phase 3|240|Anticipated|Celyad (formerly named Cardio3 BioSciences)||2|||f||||t||||||||||2017-02-18 13:35:23.863274|2017-02-18 13:35:23.863274
NCT00810225|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2014-02-24|||August 2008||2008-08-01|February 2014|2014-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans|CNDP1 Polymorphisms in Gulf War Illness (GWI)|Completed||N/A|516|Anticipated|Georgetown University|||2||f||||f||||||Samples With DNA|"~     Plasma, serum, urine, and buccal swab samples retained for testing as described in protocol.~   "|||2017-02-18 13:35:23.969199|2017-02-18 13:35:23.969199
NCT00810212|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-17|2014-11-06|||November 2008||2008-11-01|October 2008|2008-10-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|||Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion|A Prospective, Multicenter, Randomized, Open-Label, Controlled Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With Mastergraft Granules in Subjects Undergoing Posterolateral Lumbar Fusion With Instrumentation|Withdrawn||Phase 1/Phase 2|0|Actual|Mesoblast, Ltd.||4||Sponsor preferred a better study design|f||||t||||||||||2017-02-18 13:35:24.071261|2017-02-18 13:35:24.071261
NCT00810199|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2014-07-16|2014-05-01||March 2009||2009-03-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|August 2010|Actual|2010-08-01||Interventional||Baseline measures are based on the Safety Population and include all randomized participants who received at least one dose of study drug.|A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment|Randomized Placebo-controlled Study of Two Treatment Strategies Based on Tocilizumab (TCZ) With or Without Methotrexate (MTX) and Possible Addition of Other Disease-modifying Anti-rheumatic Drugs (DMARDs) in Patients...|Completed||Phase 3|556|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:35:24.397506|2017-02-18 13:35:24.397506
NCT00810186|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-03-21|||April 2009||2009-04-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Continuous Monitoring of Lung Ventilation|Continuous Monitoring of Lungs Ventilation Dynamics by Small Surface Patches That Include Safe Mechanical Sensors. A Multicenter Study.|Completed||N/A|77|Actual|Pneumedicare Ltd.|||1||f||||t||||||||||2017-02-18 13:35:26.34996|2017-02-18 13:35:26.34996
NCT00810173|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2008-12-16|||January 2008||2008-01-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phone Call in Type 2 Diabetes Patient|Phone Call as an Intervention for Improving Walking Practice in Type 2 Diabetes: Influence of Personality Profile in This Response|Completed||N/A|48|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 13:35:26.45374|2017-02-18 13:35:26.45374
NCT00810160|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2014-12-15|||June 2009||2009-06-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants|Phase 1A Study of Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants|Unknown status|Recruiting|Phase 1|36|Anticipated|University of California, Davis||4|||f||||t||||||||||2017-02-18 13:35:26.546701|2017-02-18 13:35:26.546701
NCT00810147|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-09-23||2012-03-24|February 2009||2009-02-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease|Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|209|Actual|Bristol-Myers Squibb||5|||f||||t||||||||||2017-02-18 13:35:26.668872|2017-02-18 13:35:26.668872
NCT00810134|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-16|||January 2003||2003-01-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Bypass or Thurpass for Superficial Femoral Artery Occlusion? Scandinavian Thurpass Study|A Randomised Controlled Trial for the Treatment of 5 - 25 cm Superficial Femoral Artery oc-Clusions Comparing Femoropopliteal Bypass With 6 mm PTFE-Prosthesis and 6 - 7 mm Viabahn Endoprosthesis|Terminated||N/A|44|Actual|Helsinki University||2||Due to the results of interim analysis at the time 44 patients were recruited.|f||||f||||||||||2017-02-18 13:35:26.857108|2017-02-18 13:35:26.857108
NCT00810121|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2009-09-24|||November 2008||2008-11-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)|Non-inferiority Study of Bi-Profenid® 200 mg Versus Bi-Profenid® 300 mg in Patients Presenting With Pain Related to Closed, Benign, Acute Post-traumatic Conditions of the Motor System or Acute, Non-infectious Rheumatologic Conditions|Completed||Phase 3|409|Actual|Sanofi||2|||f||||||||||||||2017-02-18 13:35:26.963212|2017-02-18 13:35:26.963212
NCT00810108|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2012-06-02|2012-04-25||June 2006||2006-06-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Lopinavir/Ritonavir (Kaletra) PK in Children|Pharmacokinetics of Lopinavir Crushed Versus Whole Tablets in Pediatric Patients|Completed||Phase 4|12|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|The AUC of the crushed tablet administration were measured after a single dose only, rather than at steady-state; variable adherence may have impacted results.|2|||f||||f||||||||||2017-02-18 13:35:27.07071|2017-02-18 13:35:27.07071
NCT00810095|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2012-06-19|2012-03-21||March 2009||2009-03-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|PRIISM||Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical Study|A Feasibility Trial to Evaluate the MindFrame System in the Recanalization of Occluded Vessels in Patients Experiencing an Ischemic Stroke|Completed||Phase 2|40|Actual|MindFrame, Inc.||1|||f||||t||||||||||2017-02-18 13:35:27.47931|2017-02-18 13:35:27.47931
NCT00810082|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2012-02-21|2011-10-24||December 2008||2008-12-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|RACE||Randomized ActiveStep Clinical Evaluation|Randomized ActiveStep Clinical Evaluation|Completed||Phase 4|65|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-02-18 13:35:27.797208|2017-02-18 13:35:27.797208
NCT00810069|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-05-20|2011-02-04||November 2008||2008-11-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder|Comparison of Two Different Treatment Strategies in Patients With Major Depressive Disorder Not Exhibiting Improvement on Escitalopram Treatment: Early vs. Delayed Intervention Strategy|Completed||Phase 4|840|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:35:28.090765|2017-02-18 13:35:28.090765
NCT00810056|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-12-05|||June 2007||2007-06-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Fostering Healthy Futures Efficacy Trial for Preadolescent Youth in Foster Care|Fostering Healthy Futures Efficacy Trial for Preadolescent Youth in Foster Care|Active, not recruiting||N/A|256|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 13:35:30.096101|2017-02-18 13:35:30.096101
NCT00810043|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2014-04-03|2011-10-26||February 2009||2009-02-01|April 2014|2014-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|MDTSCORE||Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty|Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty|Completed||Phase 4|120|Actual|Medtronic Spine LLC||2|||f||||f||||||||||2017-02-18 13:35:30.230122|2017-02-18 13:35:30.230122
NCT00809627|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-10-28|||January 2007||2007-01-01|October 2013|2013-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Caffeine Versus Placebo for Spinal Headaches|A Prospective Trial of IV Caffeine vs Placebo for Post-Dural-Puncture Headache in the Emergency Department|Completed||N/A|21|Actual|United States Naval Medical Center, Portsmouth||2|||f||||t||||||||||2017-02-18 13:35:47.060345|2017-02-18 13:35:47.060345
NCT00810030|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2012-12-19|||October 2008||2008-10-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|FER-IBD-COR||FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR|Select A Multi-centre Randomised Prospective Open-label Study to Investigate the Efficacy & Safety of a Standardised Correction Dosage Regimen of i.v. Ferric Carboxymaltose Versus Iron Sucrose for Treatment of Iron Deficiency Anaemia in Patients With Inflammatory Bowel Disease|Completed||Phase 3|484|Actual|Vifor Inc.||2|||f||||f||||||||||2017-02-18 13:35:31.034719|2017-02-18 13:35:31.034719
NCT00810017|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-11-04|||February 2009||2009-02-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer|Phase II Clinical Study Combining Trastuzumab With Etoposide in Treatment of HER2-Positive Metastatic Breast Cancer.|Terminated||Phase 2|2|Actual|Washington Hospital Center||1||Terminated due to difficulty in accruing patients|f||||t||||||||||2017-02-18 13:35:31.160176|2017-02-18 13:35:31.160176
NCT00810004|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2012-12-19|||February 2009||2009-02-01|December 2012|2012-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|FER-IBD-MAIN||Maintenance Treatment of Iron Deficiency in IBD Patients|A Multi-centre, Randomised, Prospective, Single-blinded, Controlled Study to Investigate the Efficacy and Safety of a Standardised Maintenance Dosage Regimen of Intravenous Ferric Carboxymaltose (FERINJECT®) Versus Placebo in Patients With Iron Deficiency Caused by Inflammatory Bowel Disease|Completed||Phase 3|245|Actual|Vifor Inc.||2|||f||||f||||||||||2017-02-18 13:35:31.266263|2017-02-18 13:35:31.266263
NCT00809991|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-04-12|||November 2008||2008-11-01|April 2016|2016-04-01||||November 2016|Anticipated|2016-11-01||Interventional|||Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate|Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate|Recruiting||Phase 2|188|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:35:31.364299|2017-02-18 13:35:31.364299
NCT00809965|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2014-08-26|2014-05-05||November 2008||2008-11-01|August 2014|2014-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome|A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects With a Recent Acute Coronary Syndrome|Completed||Phase 3|15526|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||t||||||||||2017-02-18 13:35:31.515844|2017-02-18 13:35:31.515844
NCT00809952|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15||||||December 2008|2008-12-01||||||||Observational|UGAI||Ultrasound Guided Artificial Insemination||Completed||Phase 4|||Hospital de Cruces|||1||f||||||||||||||2017-02-18 13:35:38.890692|2017-02-18 13:35:38.890692
NCT00809939|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-08-27|||December 2010||2010-12-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor||Unknown status|Active, not recruiting|Phase 3|800|Anticipated|Meir Medical Center||4|||f||||f||||||||||2017-02-18 13:35:38.971877|2017-02-18 13:35:38.971877
NCT00809926|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-03-31|2010-12-10||January 2009||2009-01-01|March 2011|2011-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|VANTAGE||8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension|An 8-week Randomized, Double-Blind, Parallel Group, Multi-Center, Active Controlled Study to Evaluate the Efficacy and Safety of Valsartan Administered in Combination With Aliskiren (160/150 mg, 320/300 mg) Versus Valsartan Alone (160 mg, 320 mg) in Patients With Stage 2 Hypertension|Completed||Phase 4|451|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:35:39.074129|2017-02-18 13:35:39.074129
NCT00809913|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-09-15|||December 2008||2008-12-01|September 2016|2016-09-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|FUTIRST||Febrile Urinary Tract Infection Randomized Short Treatment Trial|Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population With Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort Trial Comparing Short (7 Days) Antibiotic Treatment With Conventional Treatment (14 Days)|Completed||Phase 4|200|Actual|Leiden University Medical Center||2|||f||||t||||||||||2017-02-18 13:35:41.842422|2017-02-18 13:35:41.842422
NCT00809900|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2009-12-01|||June 2007||2007-06-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Bioavailability and Metabolism of Anthocyanins Following Acute Cranberry Consumption|Bioavailability and Metabolism of Anthocyanins Following Acute Cranberry (Vaccinium Macrocarpon)Consumption|Completed||N/A|15|Actual|Tufts University|||1||f||||f||||||||||2017-02-18 13:35:41.977863|2017-02-18 13:35:41.977863
NCT00809887|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||June 2006||2006-06-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|June 2008|Anticipated|2008-06-01||Interventional|||Micafungin Lock Therapy|Micafungin Lock Therapy to Clear Fungemia While Attempting to Preserve Central Venous Catheters|Terminated||Phase 1|20|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2||Inability to enroll subjects|f||||f||||||||||2017-02-18 13:35:42.084775|2017-02-18 13:35:42.084775
NCT00809874|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2009-11-09|||February 2008||2008-02-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects|Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects|Completed||N/A|11|Actual|Aarhus University Hospital||4|||f||||f||||||||||2017-02-18 13:35:42.18824|2017-02-18 13:35:42.18824
NCT00809861|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2014-05-28|||August 2008||2008-08-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Volar Locking Plate Versus External Fixator/Cast Fixation for the Treatment of Distal Radius Fractures|Volar Locking Plate Versus External Fixator/Cast Fixation for the Treatment of Distal Radius Fractures. A Randomised Controlled Prospective Study|Completed||N/A|52|Actual|Mackay Base Hospital||2|||f||||t||||||||||2017-02-18 13:35:42.294158|2017-02-18 13:35:42.294158
NCT00809848|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-08-13|2013-08-13||February 2009||2009-02-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma||Completed||Phase 1/Phase 2|172|Actual|Allergan||5|||f||||f||||||||||2017-02-18 13:35:42.390219|2017-02-18 13:35:42.390219
NCT00809835|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-04-08|||December 2007||2007-12-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse|Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse With Methadone Maintained Individuals|Completed||Phase 2|100|Actual|Yale University||4|||f||||t||||||||||2017-02-18 13:35:42.975899|2017-02-18 13:35:42.975899
NCT00809822|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2010-10-21|||November 2008||2008-11-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|NPB-01||Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.|NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Bullous Pemphigoid Unresponsive to Corticosteroids: Randomized, Double-Blind, Placebo Control,Parallel Assignment Study(PhaseⅡ).|Completed||Phase 2|20|Anticipated|Nihon Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-02-18 13:35:43.087194|2017-02-18 13:35:43.087194
NCT00809809|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-11-19|2012-03-21||December 2008||2008-12-01|November 2013|2013-11-01|December 2010|Actual|2010-12-01|September 2009|Actual|2009-09-01||Interventional|||Zinc for the Treatment of Herpes Simplex Labialis (HSL)|A Randomized, Double-blind, Placebo-controlled, Multi-Center Trial of Zinc for the Treatment of Herpes Simplex Labialis (HSL)|Completed||Phase 3|157|Actual|Integrative Medicine Institute|There may have been differences between the populations in the different study sites that influenced the outcome of this clinical trial.|2|||f||||t||||||||||2017-02-18 13:35:43.265748|2017-02-18 13:35:43.265748
NCT00809796|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2011-06-27|||March 2008||2008-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment|A Phase I/II Clinical Study Using Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Folinic Acid, 5-Fluorouracil, or Capecitabine and Oxaliplatin Chemotherapy as Second-line and/or Third-line Treatment|Completed||Phase 1/Phase 2|15|Anticipated|Oncozyme Pharma Inc.||1|||f||||t||||||||||2017-02-18 13:35:43.807839|2017-02-18 13:35:43.807839
NCT00809783|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-11-02||2011-11-02|February 2009||2009-02-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|October 2010|Actual|2010-10-01||Interventional|||Extension Study Of Tanezumab In Osteoarthritis|A Phase 3, Multicenter, Randomized, Long Term Study Of The Safety Of Tanezumab In Patients With Osteoarthritis Of The Knee Or Hip|Terminated||Phase 3|2147|Actual|Pfizer||3||See termination reason in detailed description.|f||||t||||||||||2017-02-18 13:35:43.90919|2017-02-18 13:35:43.90919
NCT00809770|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-11-07|||April 2008||2008-04-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|July 2012|Actual|2012-07-01||Interventional|||Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill|Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill|Completed||N/A|176|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 13:35:44.021968|2017-02-18 13:35:44.021968
NCT00809757|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2014-07-01|2014-05-27||December 2008||2008-12-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||One subject was randomized but not dosed in the Levalbuterol UDV arm.|A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma|A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months With Asthma|Completed||Phase 3|197|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 13:35:44.150187|2017-02-18 13:35:44.150187
NCT00809744|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-11-02|||November 2008||2008-11-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|D-clamp||Vitamin D AND Glucose Handling Evaluated by Glucose Clamp|Vitamin D AND Cardiovascular Disease|Completed||Phase 2|160|Actual|University Hospital of North Norway||1|||f||||f||||||||||2017-02-18 13:35:46.074399|2017-02-18 13:35:46.074399
NCT00809731|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2010-12-08|||December 2008||2008-12-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|QTP NIS||Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment|A Naturalistic Observational Study to Evaluate Efficacy of 2nd-generation Antipsychotics and Remission Status for Patients With Schizophrenia / Schizoaffective Disorder|Completed||N/A|490|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:35:46.174778|2017-02-18 13:35:46.174778
NCT00809718|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2015-10-21|||February 2009||2009-02-01|October 2015|2015-10-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||The Effect of Rifapentine on Raltegravir|The Effect of Rifapentine on Plasma Concentrations of Raltegravir|Completed||Phase 1|27|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 13:35:46.285177|2017-02-18 13:35:46.285177
NCT00809705|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-11-01|||December 2008||2008-12-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes|A Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Investigate the Effect of Taspoglutide on Gastric Emptying Measured by a Paracetamol Test After Single Dose and After Multiple Doses in Patients With Type 2 Diabetes|Completed||Phase 3|60|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 13:35:46.39832|2017-02-18 13:35:46.39832
NCT00809692|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-04-30|||September 2007||2007-09-01|April 2013|2013-04-01||||May 2015|Anticipated|2015-05-01||Interventional|||In Vivo Assessment of Histamine Pharmacodynamics|In Vivo Functional Assessment of Histamine Pharmacodynamics in Children|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-02-18 13:35:46.507102|2017-02-18 13:35:46.507102
NCT00809679|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2012-06-06||2010-06-25|December 2008||2008-12-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia|A Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled, Pilot Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia|Terminated||Phase 2|19|Actual|Pfizer||3||Some patients experienced asymptomatic, transient elevations in liver transaminases|f||||t||||||||||2017-02-18 13:35:46.617069|2017-02-18 13:35:46.617069
NCT00809666|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||May 2000||2000-05-01|December 2008|2008-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|PRAM||Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device|A Prospective Randomised Study of Automated Versus Mercury Blood Pressure Recordings in Pregnancy|Completed||N/A|220|Actual|St George Hospital, Australia||1|||f||||f||||||||||2017-02-18 13:35:46.739465|2017-02-18 13:35:46.739465
NCT00809653|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2010-03-30|||January 2009||2009-01-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Reducing the Pro-ischaemic Effects of Air Pollution Exposure Using a Simple Face Mask|Reducing the Pro-ischaemic Effects of Ambient Particulate Air Pollution in Patients With Coronary Heart Disease Using a Simple Face Mask Intervention|Completed||N/A|100|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-02-18 13:35:46.837429|2017-02-18 13:35:46.837429
NCT00809640|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2009-12-04|||February 2009||2009-02-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Active Management for Low Back Pain for 6 to 8 Year Old Schoolchildren|Active Management for Low Back Pain Taught to 6 to 8 Year Old Schoolchildren|Completed||N/A|700|Anticipated|Kovacs Foundation||2|||f||||t||||||||||2017-02-18 13:35:46.954381|2017-02-18 13:35:46.954381
NCT00809614|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-10-14|2015-02-01||March 2009||2009-03-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||All patients who received at least one dose of study drug were included in the safety and tolerability evaluation.|Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis|Randomized, Double-blind Placebo-controlled Multi-center Proof-of-concept Study to Assess the Efficacy of AIN457 in Patients With Psoriatic Arthritis|Completed||Phase 2|42|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:35:47.188148|2017-02-18 13:35:47.188148
NCT00809601|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2013-03-21|||May 2008||2008-05-01|March 2013|2013-03-01|September 2015|Anticipated|2015-09-01|September 2014|Anticipated|2014-09-01||Interventional|||Study of Different Kinds of Ear Tubes|Randomized Controlled Study of Transmyringeal Tubes|Unknown status|Active, not recruiting|N/A|400|Anticipated|Danderyd Hospital||1|||f||||f||||||||||2017-02-18 13:35:47.924678|2017-02-18 13:35:47.924678
NCT00809588|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2017-01-04|||October 2003||2003-10-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)|A Phase IB Study of Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Stimulating Factor|Active, not recruiting||Phase 1|70|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:35:48.018045|2017-02-18 13:35:48.018045
NCT00809575|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2017-01-24|||November 2008||2008-11-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|PROMYS||Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes|Prognostic Significance and Longitudinal Assessment of Patient-reported Quality of Life and Symptoms in Myelodysplastic Syndromes. A Large-scale International, Observational Study: PROMYS Study|Recruiting||N/A|1070|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||1||f||||f||||||||||2017-02-18 13:35:48.122006|2017-02-18 13:35:48.122006
NCT00809562|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-11-01||2016-11-01|March 2009||2009-03-01|November 2016|2016-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study of RO4917523 in Patients With Treatment Resistant Depression|An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression|Completed||Phase 2|46|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:35:48.371441|2017-02-18 13:35:48.371441
NCT00809549|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2012-07-11|||July 2006||2006-07-01|July 2012|2012-07-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|GIST||Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery|Granulocyte-Colony Stimulating Factor In Ischemic Stroke (GIST): A Pilot Study|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 13:35:48.631034|2017-02-18 13:35:48.631034
NCT00809536|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2010-02-16|||January 2009||2009-01-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time|A Phase 1, Open-Label, Randomized, Cross-Over Study To Estimate The Pharmacokinetics Of PD 0332334 And Metformin When Administered Concurrently In Healthy Subjects|Terminated||Phase 1|24|Actual|Pfizer||2||Please Detailed Description for termination reason.|f||||f||||||||||2017-02-18 13:35:48.743649|2017-02-18 13:35:48.743649
NCT00809523|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-01-29|2012-09-07||December 2008||2008-12-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)|A Multicenter, Randomized Controlled Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy for Seasonal Affective Disorder (SAD)|Completed||Phase 2/Phase 3|106|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:35:48.865775|2017-02-18 13:35:48.865775
NCT00809510|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2011-09-01||2011-09-01|January 2009||2009-01-01|September 2011|2011-09-01||||June 2009|Actual|2009-06-01||Interventional|||A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study||Terminated||Phase 2|63|Actual|Abbott||1|||f||||||||||||||2017-02-18 13:35:49.326494|2017-02-18 13:35:49.326494
NCT00809497|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2012-03-28|||May 2008||2008-05-01|March 2008|2008-03-01|January 2011|Actual|2011-01-01|September 2009|Actual|2009-09-01||Interventional|PLC||A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases|A Randomized, Multi-centre, Double-blind and Placebo Controlled Clinical Study of the Propionyl-L-carnitine Hydrochloride Tablets|Completed||Phase 3|239|Actual|Lee's Pharmaceutical Limited||1|||f||||t||||||||||2017-02-18 13:35:49.441967|2017-02-18 13:35:49.441967
NCT00809484|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2009-01-03|||May 2004||2004-05-01|December 2008|2008-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|ARBI||Arimidex Bone Mass Index and Oral Bisphosphonates|A Phase III-IV, Multicenter Open Label Trial of Arimidex Alone Versus Arimidex Plus Bisphosphonates in Postmenopausal Patients With Early, Endocrine Positive Breast Cancer.|Completed||N/A|220|Actual|Hellenic Breast Surgeons Society|||3||f||||f||||||||||2017-02-18 13:35:49.547596|2017-02-18 13:35:49.547596
NCT00809471|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2012-08-10|2012-05-25||December 2008||2008-12-01|August 2012|2012-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|REVIVE-D||Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)|A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil (TA-1790) in the Treatment of Erectile Dysfunction in Diabetic Men|Completed||Phase 3|390|Actual|VIVUS, Inc.||3|||f||||f||||||||||2017-02-18 13:35:49.649515|2017-02-18 13:35:49.649515
NCT00809458|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2015-06-22|2015-06-06||September 2008||2008-09-01|June 2015|2015-06-01|February 2013|Actual|2013-02-01|May 2010|Actual|2010-05-01||Interventional|||Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer|A Phase III Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer Prior to Prostatectomy or Brachytherapy|Terminated||Phase 3|15|Actual|New Mexico Cancer Care Alliance||2||Low rate of accrual.|f||||t||||||||||2017-02-18 13:35:50.183598|2017-02-18 13:35:50.183598
NCT00809445|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-10-13|2014-08-28||January 2009||2009-01-01|September 2014|2014-09-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional||Participants were recruited from 12 community-based drug treatment programs. The Baseline Analysis Population represents the 1281 participants who completed baseline and were subsequently randomized.|Rapid HIV Testing and Counseling in Drug Abuse Treatment|HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.|Completed||Phase 3|1281|Actual|University of Miami||3|||f||||t||||||||||2017-02-18 13:35:50.611525|2017-02-18 13:35:50.611525
NCT00809432|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||August 2008||2008-08-01|December 2008|2008-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||The Cardiovascular Benefits of Reducing Personal Exposure to Air Pollution|Beneficial Cardiovascular Effects of Reducing Exposure to Particulate Air Pollution With a Simple Facemask|Completed||N/A|15|Actual|University of Edinburgh||2|||f||||f||||||||||2017-02-18 13:35:51.350138|2017-02-18 13:35:51.350138
NCT00809419|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2011-07-26|||November 2008||2008-11-01|July 2011|2011-07-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|MERITAGE||A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy|A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal Choroidal Neovascularization Associated With Wet Age-Related Macular Degeneration in Patients That Require Persistent Anti-VEGF Therapy|Unknown status|Active, not recruiting|Phase 1/Phase 2|32|Anticipated|NeoVista||1|||f||||f||||||||||2017-02-18 13:35:51.446783|2017-02-18 13:35:51.446783
NCT00809406|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2008-12-15|||October 2007||2007-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:35:51.553461|2017-02-18 13:35:51.553461
NCT00809393|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-09-22|||February 2009||2009-02-01|September 2016|2016-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|Exacylcardio||Dose-ranging Study of Two Doses of Tranexamic Acid During Cardiac Surgery|Comparison of Two Tranexamic Acid Dose Regimens on Transfusion Needs During Cardiac Surgery With Cardiopulmonary Bypass|Completed||Phase 4|600|Actual|Hopital Foch||2|||f||||f||||||||||2017-02-18 13:35:51.60896|2017-02-18 13:35:51.60896
NCT00809380|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-03-18|||June 2009||2009-06-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|PP||Parental Presence During Fracture Reduction in Children at the Emergency Department; A Randomized Controlled Trial|Parental Presence During Fracture Reduction in Children at the Emergency Department; A Randomized Controlled Trial|Terminated||N/A|12|Actual|St. Justine's Hospital||2||Study ws terminated because of a too low recruitment rate.|f||||f||||||||||2017-02-18 13:35:51.721336|2017-02-18 13:35:51.721336
NCT00809367|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-02-06|||October 2008||2008-10-01|January 2013|2013-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Collection and Banking of Leukemia Cells MDS/AML|Collection and Banking of Leukemia Cells for Vaccine Generation and Research in Patients With Advanced MDS or AML|Completed||N/A|90|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:35:51.826263|2017-02-18 13:35:51.826263
NCT00809354|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-03-04||2011-11-02|February 2009||2009-02-01|March 2015|2015-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip|A Phase 3, Multi-Center, Randomized, Double-Blind, Controlled Study Of The Long-Term Analgesic Efficacy And Safety of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip|Terminated||Phase 3|2720|Actual|Pfizer||5||See termination reason in detailed description.|f||||t||||||||||2017-02-18 13:35:51.945249|2017-02-18 13:35:51.945249
NCT00809341|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-10-30|||January 2009||2009-01-01|October 2015|2015-10-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Treatment Intensification With R-ICE and High-Dose Cyclophosphamide for Diffuse Large B-Cell Non-Hodgkin's Lymphoma Based on Early [18F] FDG-PET Scanning|Terminated||Phase 2|26|Actual|Sidney Kimmel Comprehensive Cancer Center||2||Low accrual|f||||t||||||||||2017-02-18 13:35:52.54149|2017-02-18 13:35:52.54149
NCT00809328|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-05-16|2011-03-22||February 2009||2009-02-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)|A Multicenter, Non-Randomized, Open Label Study Of Azithromycin Intravenous Followed By Oral Administration In Japanese Adult Subjects With Community Acquired Pneumonia (CAP) Requiring Initial Intravenous Therapy|Completed||Phase 3|102|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:35:52.661808|2017-02-18 13:35:52.661808
NCT00809315|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-12-05|||August 2002||2002-08-01|December 2016|2016-12-01||||December 2020|Anticipated|2020-12-01||Interventional|||Intervention Development and Pilot for Foster Care Youth|Intervention Development and Pilot for Foster Care Youth|Active, not recruiting||N/A|152|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 13:35:52.968163|2017-02-18 13:35:52.968163
NCT00809302|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2009-08-27|||December 2008||2008-12-01|August 2009|2009-08-01|October 2009|Anticipated|2009-10-01|August 2009|Anticipated|2009-08-01||Interventional|||Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Doses of Aplindore MR (1, 3, and 6 mg Twice Daily) in Patients With Early Parkinson Disease (APLIED)|Terminated||Phase 2|9|Actual|Neurogen Corporation||4||"Neurogen acquired by Ligand Pharmaceuticals - no further support for study. No safety concerns~   identified."|f||||t||||||||||2017-02-18 13:35:53.080239|2017-02-18 13:35:53.080239
NCT00809289|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2011-04-06|||December 2008||2008-12-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|TQT||Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers|A Randomized, Multiple Dose, Placebo and Active Controlled 3-way Crossover Study to Investigate the Effects of Esreboxetine on QTc Interval in Healthy Volunteers|Completed||Phase 1|40|Anticipated|Pfizer||3|||f||||f||||||||||2017-02-18 13:35:53.200407|2017-02-18 13:35:53.200407
NCT00809276|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-01-29|2014-12-19||May 2009||2009-05-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY|Trial of Allogeneic BMT for Hematologic Malignancies Using HLA-matched Related or Unrelated Donors With Fludarabine and IV Busulfan as Pre-transplant Conditioning Followed by Post-transplant Immunosuppression With High-dose Cyclophosphamide|Completed||Phase 1/Phase 2|92|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:35:53.311584|2017-02-18 13:35:53.311584
NCT00809263|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2014-02-12|||October 2009||2009-10-01|February 2014|2014-02-01|December 2012|Anticipated|2012-12-01|January 2012|Anticipated|2012-01-01||Interventional|||Homeopathic Drug Provings|A Randomized, Double-blind, Placebo-controlled, Homeopathic Drug Proving Using a Crossover Design|Withdrawn||N/A|0|Actual|Integrative Medicine Institute||1|||f||||t||||||||||2017-02-18 13:35:53.559156|2017-02-18 13:35:53.559156
NCT00809250|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-08-08|||November 2008||2008-11-01|August 2016|2016-08-01|December 2026|Anticipated|2026-12-01|May 2011|Actual|2011-05-01||Interventional|||Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation|Vaccination With Lethally Irradiated Autologous Myeloblasts With Granulocyte Macrophage-colony Stimulating Factor Secreting K562 Cells (GM-K562) in Patients With Advanced MDS or AML After Allogeneic Hematopoietic Stem Cell Transplantation|Terminated||Phase 1|33|Actual|Dana-Farber Cancer Institute||1||Permanently closed to accrual per investigator|f||||t||||||||||2017-02-18 13:35:53.684846|2017-02-18 13:35:53.684846
NCT00809237|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-12-08|||November 2008||2008-11-01|December 2013|2013-12-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Hydroxychloroquine and Gefitinib to Treat Lung Cancer|A Phase II With a Lead in Phase I Study to Examine the Tolerability, Safety Profile and Efficacy of Hydroxychloroquine and Gefitinib in Advanced Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 1/Phase 2|71|Anticipated|National University Hospital, Singapore||1|||f||||t||||||||||2017-02-18 13:35:53.897596|2017-02-18 13:35:53.897596
NCT00809224|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-05-12|||May 2008||2008-05-01|May 2016|2016-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)|Tracking Brain Changes During Real and Imagined Movements in People With ALS (Lou Gehrig's Disease) and Healthy Volunteers.|Completed||N/A|92|Actual|University of Michigan|||2||f||||f||||||||||2017-02-18 13:35:54.007234|2017-02-18 13:35:54.007234
NCT00809211|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-06-30|||October 2008||2008-10-01|June 2016|2016-06-01||||December 2016|Anticipated|2016-12-01||Interventional|||Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia|A Phase II Multi-center, Open-label, Study of Nilotinib at a Dose of 300mg Twice Daily in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|Active, not recruiting||Phase 2|40|Anticipated|Cancer Trials Ireland||1|||f||||||||||||||2017-02-18 13:35:54.113403|2017-02-18 13:35:54.113403
NCT00809198|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2012-02-01|||December 2008||2008-12-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Kynex Versus Refresh Plus Study in Subject With Dry Eye|The Effect of Kynex Versus Refresh Plus in Subjects With Mild to Moderate Dry Eye - A Parallel Group, Randomized, Masked Study|Completed||Phase 4|67|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:35:54.221344|2017-02-18 13:35:54.221344
NCT00809185|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-09-29|2012-01-20||November 2005||2005-11-01|September 2015|2015-09-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes|A Phase 2 Trial of RAD001(Everolimus) in Low and Intermediate-1 Risk Myelodysplastic Syndrome|Terminated||Phase 2|7|Actual|Case Comprehensive Cancer Center|The trial was stopped early due to slow accrual. 18-33 patients were needed to address objectives, however only 7 patients were enrolled. Insufficient patients responded to the treatment to allow laboratory correlates with response to be analyzed.|1||slow accrual|f||||t||||||||||2017-02-18 13:35:54.317813|2017-02-18 13:35:54.317813
NCT00809172|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2013-05-13|||December 2008||2008-12-01|October 2009|2009-10-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|METHODA||Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients|Multicenter Randomised Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients|Completed||Phase 3|100|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-02-18 13:35:54.542278|2017-02-18 13:35:54.542278
NCT00809159|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2015-12-07|2015-01-29||March 2009||2009-03-01|August 2015|2015-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis|Randomized, Placebo Controlled Double Blind, Multi-center Phase II Proof-of-concept Study to Assess the Efficacy of AIN457 in Patients With Moderate to Severe Ankylosing Spondylitis|Completed||Phase 2|60|Actual|Novartis||5|||f||||||||||||||2017-02-18 13:35:54.655795|2017-02-18 13:35:54.655795
NCT00809146|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-05-10|2012-03-18||June 2009||2009-06-01|May 2016|2016-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|RAMPART||Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications|A Double-blind Randomized Clinical Trial of the Efficacy of IM Midazolam Versus IV Lorazepam in the Pre-hospital Treatment of Status Epilepticus by Paramedics|Completed||Phase 3|1023|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 13:35:56.41491|2017-02-18 13:35:56.41491
NCT00809133|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2016-02-16|2016-02-16||May 2007||2007-05-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Treated Set: Patients who received at least 1 dose of study treatment were included in the treated set.|Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours|A Phase I Open Label Trial of Continuous Dosing With BIBW 2992 Combined With Paclitaxel and BIBW 2992 Combined With Paclitaxel and Bevacizumab, BIBW 2992 Combined With Carboplatin and BIBW 2992 Combined With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumours|Completed||Phase 1|83|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 13:35:57.605538|2017-02-18 13:35:57.605538
NCT00809120|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2010-06-09|||December 2008||2008-12-01|September 2008|2008-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|TOES||Tolerance to Electrostimulation in COPD Patients|Investigation of Clinical Tolerance, Cardio-respiratory Response and Muscle Fatigue During Electrostimulation|Completed||N/A|20|Actual|Laval University||1|||f||||f||||||||||2017-02-18 13:36:06.366774|2017-02-18 13:36:06.366774
NCT00809107|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-16|2009-02-18|||October 2006||2006-10-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|FRET||Frozen Embryo Transfer (FET) in Natural Cycles or in Natural Cycles Controlled by Human Chorionic Gonadotropin (hCG) Administration|Cryopreserved-Thawed Embryo Transfer in Natural Cycle or in Natural Cycles Controlled by External Administration of hCG: a Prospective Randomized Study|Completed||N/A|150|Anticipated|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-02-18 13:36:06.46134|2017-02-18 13:36:06.46134
NCT00809094|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-04-15|2013-02-14||November 2008||2008-11-01|April 2013|2013-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients|A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients|Completed||Phase 2|70|Actual|Stanford University||2|||f||||||||||||||2017-02-18 13:36:06.565602|2017-02-18 13:36:06.565602
NCT00809081|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||July 2007||2007-07-01|December 2008|2008-12-01|January 2010|Anticipated|2010-01-01|June 2009|Anticipated|2009-06-01||Interventional|||Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy|A Prospective, Randomized Trial of Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy|Unknown status|Recruiting|Phase 3|38|Anticipated|Yonsei University||2|||f||||t||||||||||2017-02-18 13:36:07.04773|2017-02-18 13:36:07.04773
NCT00809068|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2010-01-31|||August 2005||2005-08-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|TibFen||High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone|Effects of Tibolone and PPARα-agonist on HDL Metabolism in Postmenopausal Women|Completed||Phase 4|20|Anticipated|Keogh Institute for Medical Research||2|||f||||t||||||||||2017-02-18 13:36:07.360996|2017-02-18 13:36:07.360996
NCT00809055|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-01-26|2015-12-17||November 2008||2008-11-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2010|Actual|2010-12-01||Interventional|||MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine|Magnetic Resonance Imaging and Neurodevelopmental Outcomes in Preterm Infants Following Administration of High-Dose Caffeine - A Pilot Study|Completed||Phase 4|74|Actual|Washington University School of Medicine||2|||f||||t||||||||No||2017-02-18 13:36:07.491291|2017-02-18 13:36:07.491291
NCT00809042|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||June 2007||2007-06-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia|The Effect of Combination Therapy of Hydroxyurea With L- Carnitine and Magnesium Chloride on he-Matologic Parameters and Cardiac Function of β-Thalassemia Intermedia Patients.|Completed||Phase 2|120|Anticipated|Shiraz University of Medical Sciences||4|||f||||t||||||||||2017-02-18 13:36:08.136967|2017-02-18 13:36:08.136967
NCT00809029|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2011-12-20|||April 2011||2011-04-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study|The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Hormone Sensitive Lipase, Lipoprotein Lipase And Adipokine Expression In Human Subcutaneous Adipose Tissue: An In Vivo Study|Unknown status|Recruiting|N/A|12|Anticipated|Aintree University Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 13:36:08.250108|2017-02-18 13:36:08.250108
NCT00809016|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-13|2011-05-12|||May 2007||2007-05-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy|Contribution of Positron Emission Tomography in Biological Targeting by Conformational Radiotherapy and Intensity-modulated Radiotherapy of Ear, Nose and Throat Tumors|Completed||N/A|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:36:08.343889|2017-02-18 13:36:08.343889
NCT00809003|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2008-12-15|||September 2007||2007-09-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Observational|JADE||Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease|Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease|Completed||N/A|60|Actual|University of Waterloo|||3||f||||f||||||||||2017-02-18 13:36:08.449686|2017-02-18 13:36:08.449686
NCT00808990|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-04-07|||February 2013||2013-02-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||The Effect of Probiotics on Non Alcoholic Fatty Liver Disease|Probiotics and Non Alcoholic Steatohepatitis (NASH)|Terminated||Phase 1|38|Actual|Rabin Medical Center||2||"Time table was unfulfilled due to incompetent research coordinator. Inaccurate results and No~   conclusions can be withdrawn"|f||||f||||||||||2017-02-18 13:36:08.544805|2017-02-18 13:36:08.544805
NCT00808977|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2010-11-16|||December 2008||2008-12-01|November 2010|2010-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis|A Double-blind, Randomised, Placebo and Mesalazine Controlled Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Active Colitis|Completed||Phase 2|80|Anticipated|Palau Pharma S.A.||3|||f||||f||||||||||2017-02-18 13:36:08.676904|2017-02-18 13:36:08.676904
NCT00808964|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2011-06-08|||January 2013||2013-01-01|June 2011|2011-06-01|September 2013|Anticipated|2013-09-01|June 2013|Anticipated|2013-06-01||Interventional|SNAP-CABG-OFF||Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery|Phase 2 Study of NU172 Anticoagulation in Patients Undergoing Coronary Artery Bypass Graft Surgery OFF-Pump|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|ARCA Biopharma, Inc.||1|||f||||t||||||||||2017-02-18 13:36:08.807892|2017-02-18 13:36:08.807892
NCT00808951|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-07-30|||December 2008||2008-12-01|July 2015|2015-07-01|February 2011|Actual|2011-02-01|October 2010|Actual|2010-10-01||Interventional|||In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso|In Vivo and in Vitro Efficacy of the Recommended First Line Antimalarial Treatments (Artemether-Lumefantrine and Amodiaquine-Artesunate) in Children With Uncomplicated Malaria in Burkina Faso|Completed||Phase 4|440|Actual|Centre Muraz||2|||f||||f||||||||||2017-02-18 13:36:08.885155|2017-02-18 13:36:08.885155
NCT00808938|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-02-11|||January 2009||2009-01-01|December 2008|2008-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|MST||A Pilot Study of the Use of Magnetic Seizure Therapy for Depression|A Pilot Study of the Use of Magnetic Seizure Therapy for Treatment Resistant Depression|Completed||Phase 2|15|Actual|Bayside Health||1|||f||||f||||||||||2017-02-18 13:36:09.003322|2017-02-18 13:36:09.003322
NCT00808925|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-12-18|||January 2009||2009-01-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||The Impact of Heat Acclimation on Pro- and Anti- Inflammatory Cytokine Response|The Impact of Heat Acclimation on Pro- and Anti- Inflammatory Cytokine Response|Terminated||N/A|10|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 13:36:09.277977|2017-02-18 13:36:09.277977
NCT00808912|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2010-06-22|||December 2008||2008-12-01|June 2010|2010-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Does Sildenafil Increase Exercise Performance in Air Pollution?|Decreased Pulmonary Artery Pressure by Oral Sildenafil Injection During Exercise in Air Pollution Increases Exercise Performance.|Completed||N/A|24|Anticipated|Marywood University||4|||f||||f||||||||||2017-02-18 13:36:09.382656|2017-02-18 13:36:09.382656
NCT00808691|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2015-01-05|||September 2007||2007-09-01|January 2015|2015-01-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Observational|||Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit|Microcirculation and Oxidative Stress in Critically Ill Patients in Surgical Intensive Care Unit|Completed||N/A|124|Actual|National Taiwan University Hospital|||6||f||||f||||||||||2017-02-18 13:36:12.042707|2017-02-18 13:36:12.042707
NCT00808899|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2010-05-25|2010-04-19||December 2008||2008-12-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma|Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma|Terminated||Phase 2|4|Actual|St. Jude Children's Research Hospital|NB2008 was closed because of the publication of a new standard of care for treating high-risk neuroblastoma.At the time of closure, NB2008 had enrolled only 4 patients, which was an insufficient number of patients to answer the primary objective.|1||Voluntarily closed and terminated by the PI due to lack of feasibility|f||||f||||||||||2017-02-18 13:36:09.500583|2017-02-18 13:36:09.500583
NCT00808886|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||December 2008||2008-12-01|November 2008|2008-11-01|May 2009|Anticipated|2009-05-01|April 2009|Anticipated|2009-04-01||Observational|||Study of Comparison Between Pentacam and locs3|Comparison Between Pentacam Scheimpflug System and locs3 in Grading of Cataract|Unknown status|Not yet recruiting|N/A|||Soroka University Medical Center|||1||f||||f||||||||||2017-02-18 13:36:09.760923|2017-02-18 13:36:09.760923
NCT00808873|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||November 2008||2008-11-01|November 2008|2008-11-01|March 2011|Anticipated|2011-03-01|February 2011|Anticipated|2011-02-01||Interventional|||Socio-Educational Intervention for Rural Suicide Attempters|A Randomized Control Trial of a Socio-Educational Intervention for Rural Suicide Attempters in Tianjin Municipality and Shandong Province of China|Unknown status|Recruiting|N/A|450|Anticipated|Beijing HuiLongGuan Hospital||2|||f||||f||||||||||2017-02-18 13:36:09.826485|2017-02-18 13:36:09.826485
NCT00808860|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2010-12-03|||February 2008||2008-02-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients|Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients|Completed||Phase 1/Phase 2|25|Actual|Hanoi Medical University||2|||f||||t||||||||||2017-02-18 13:36:09.929655|2017-02-18 13:36:09.929655
NCT00808834|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2012-06-26|2010-06-18||November 2008||2008-11-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Non-dispense Comfort Comparison of Two Silicone Hydrogel Lenses|Non-dispense Comfort Comparison of Two Silicone Hydrogel Lenses|Completed||N/A|196|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:36:10.041141|2017-02-18 13:36:10.041141
NCT00808821|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15||||||October 2008|2008-10-01||||||||Observational|||Pharyngeal Carriage Rates and Genetic Typing of Group A Streptococcus and Streptococcus Pneumonia Among Israeli Military Basic Trainees|Pharyngeal Carriage Rates and Genetic Typing of Group A Streptococcus and Streptococcus Pneumonia Among Israeli Military Basic Trainees|Completed||N/A|||Medical Corps, Israel Defense Force|||||f||||||||||||||2017-02-18 13:36:10.25599|2017-02-18 13:36:10.25599
NCT00808808|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2013-10-28|2012-07-30||September 2008||2008-09-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Observational|MA181||Assessing Choice in the Employer Setting (ACES) Study|Assessing Choice in the Employer Setting (ACES Study): An Observational Study to Assess the Impact of Offering Intranasal Vaccine on Influenza Vaccination Rates in the Employer Setting|Completed||N/A|4411|Actual|MedImmune LLC|The study was conducted during a single season, data to evaluate effects of the intervention by race were unavailable, baseline vaccination data were available at the company level only, and vaccines received outside the workplace were not assessed.||3||f||||f||||||||||2017-02-18 13:36:10.465723|2017-02-18 13:36:10.465723
NCT00808795|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-13|2008-12-15|||April 2006||2006-04-01|December 2008|2008-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease|Efficacy of N-Acetylcysteine in Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization in Patients With Diabetes Mellitus and Chronic Kidney Disease: A Randomized Clinical Trial|Completed||Phase 3|90|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 13:36:11.046622|2017-02-18 13:36:11.046622
NCT00808782|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-14|2013-02-06|||December 2008||2008-12-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder|The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder|Completed||N/A|30|Actual|Bayside Health||2|||f||||f||||||||||2017-02-18 13:36:11.157788|2017-02-18 13:36:11.157788
NCT00808769|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2015-05-07|2010-05-19||November 2008||2008-11-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression|Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression|Completed||Phase 4|30|Actual|Procter and Gamble|Results of this study were uninterpretable as noted in the Analysis Population Description.|2|||f||||f||||||||||2017-02-18 13:36:11.265991|2017-02-18 13:36:11.265991
NCT00808756|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2012-08-07|||September 2008||2008-09-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|September 2010|Actual|2010-09-01||Interventional|BAMBINOL||Study on Fermentable Carbohydrates in Healthy Infants|Study on Fermentable Carbohydrates in Healthy Infants|Completed||N/A|388|Actual|University Rovira i Virgili||3|||f||||t||||||||||2017-02-18 13:36:11.506837|2017-02-18 13:36:11.506837
NCT00808743|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-05-15|||May 2009||2009-05-01|August 2010|2010-08-01|January 2013|Actual|2013-01-01|July 2011|Actual|2011-07-01||Interventional|PreDuoFAP||Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis|Prevention of Progression of Duodenal Adenomas to Cancer in Patients With Familial Adenomatous Polyposis (FAP)|Completed||Phase 2/Phase 3|37|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 13:36:11.617797|2017-02-18 13:36:11.617797
NCT00808730|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2010-02-15|||February 2009||2009-02-01|February 2010|2010-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|MITASTHME||Role of Mitochondria in Non Severe Asthma|Role of Mitochondria in Human Bronchial Smooth Muscle Remodeling in Non Severe Asthma|Completed||N/A|32|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-02-18 13:36:11.732228|2017-02-18 13:36:11.732228
NCT00808717|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2009-07-14|||July 2007||2007-07-01|July 2009|2009-07-01||||December 2008|Actual|2008-12-01||Interventional|STATIN STEMI||Efficacy of High Dose atorvaSTATIN Loading Before Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction (STATIN STEMI)|Efficacy of High Dose Atorvastatin Loading in ST Elevation Myocardial Infarction|Completed||Phase 4|170|Anticipated|Yonsei University||2|||f||||t||||||||||2017-02-18 13:36:11.833946|2017-02-18 13:36:11.833946
NCT00808704|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||August 2003||2003-08-01|December 2008|2008-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy|Effect of Erythropoietin on Neonatal Hypoxic Ischemic Encephalopathy|Completed||Phase 1/Phase 2|167|Actual|Zhengzhou University||1|||f||||t||||||||||2017-02-18 13:36:11.931372|2017-02-18 13:36:11.931372
NCT00808678|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-09-27|||December 2008||2008-12-01|September 2012|2012-09-01||||January 2009|Actual|2009-01-01||Interventional|||Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium||Completed||Phase 1|90|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:36:12.135568|2017-02-18 13:36:12.135568
NCT00808665|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2014-01-29|||June 2009||2009-06-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|DEXREDLOS||Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion|Does Continuous Perioperative Dexmedetomidine Infusion Reduce Time to Discharge in Patients Undergoing Major Lumbar Fusion? A Double-Blind, Placebo-Controlled Study|Completed||Phase 4|54|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 13:36:12.230744|2017-02-18 13:36:12.230744
NCT00808652|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2016-05-05|||March 2009||2009-03-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Prevalence and Outcome of Brachial Artery Endothelial Function in Morbidly Obese Patients Undergoing Bariatric Surgery|Prevalence and Outcome of Brachial Artery Endothelial Function in Morbidly Obese Patients Undergoing Bariatric Surgery|Terminated||N/A|13|Actual|Sheba Medical Center|||1|not enough recruits|f||||f||||||||No||2017-02-18 13:36:12.34481|2017-02-18 13:36:12.34481
NCT00808639|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2016-09-09|2014-01-14||December 2008||2008-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|December 2013|Actual|2013-12-01||Interventional|||Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma|A Phase II Trial of Neoadjuvant Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma|Completed||Phase 2|39|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 13:36:12.425985|2017-02-18 13:36:12.425985
NCT00808626|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2015-05-01|||December 2008||2008-12-01|May 2015|2015-05-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis|Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis|Withdrawn||Phase 1/Phase 2|0|Actual|Temple University||1||Lack of funding to complete trial. A lead member of research team retired.|f||||||||||||||2017-02-18 13:36:12.845989|2017-02-18 13:36:12.845989
NCT00808613|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2013-02-25|||December 2008||2008-12-01|February 2013|2013-02-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Optetrak Posterior Stabilized Versus Optetrak Hi-Flex|A Prospective, Single-center, Non-randomized, Consecutive Series Clinical Study Comparing the Functional Differences Between a Standard Posterior Stabilized Total Knee Replacement and a High-flexion Posterior Stabilized Total Knee Replacement|Withdrawn||Phase 4|0|Actual|Exactech||2||Study withdrawn prior to initiation|f||||f||||||||||2017-02-18 13:36:12.944043|2017-02-18 13:36:12.944043
NCT00808600|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2009-08-18|||October 2009||2009-10-01|August 2009|2009-08-01|January 2014|Anticipated|2014-01-01|July 2013|Anticipated|2013-07-01||Interventional|||Empowerment of Lung and Heart-lung Transplant Patients|Empowerment of Lung and Heart-lung Transplant Patients by a Multimodal Resource-activating Behavioural Training Programme and Cardiopulmonary Exercise - a Randomised Controlled Study|Unknown status|Not yet recruiting|N/A|132|Anticipated|Hannover Medical School||4|||f||||f||||||||||2017-02-18 13:36:13.044714|2017-02-18 13:36:13.044714
NCT00808587|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2016-04-12|||October 2008||2008-10-01|April 2016|2016-04-01|March 2029|Anticipated|2029-03-01|September 2009|Actual|2009-09-01||Observational|||Scripps Genomics Health Initiative|Scripps Genomics Health Initiative|Active, not recruiting||N/A|10000|Anticipated|Scripps Translational Science Institute|||1||f||||f||||||||||2017-02-18 13:36:13.161372|2017-02-18 13:36:13.161372
NCT00808574|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2008-12-12|||July 2008||2008-07-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Screening for Obstructive Sleep Apnea Among Members of an Internet Weight Loss Community|Effect of a Web-Based Presentation on Communication With Healthcare Providers|Completed||Early Phase 1|168|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 13:36:13.238422|2017-02-18 13:36:13.238422
NCT00808561|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2016-03-10|||December 2008||2008-12-01|March 2016|2016-03-01|January 2013|Actual|2013-01-01|January 2011|Actual|2011-01-01||Interventional|||Randomized Fistula Study|Prospective Randomized Trial of Fistula vs. Forearm AV Graft in Patients With Poor Venous Access; Protocol #3, Version 1|Terminated||N/A|6|Actual|University of Pittsburgh||2||Slow enrollment due to multiple screen failures|f||||t||||||||||2017-02-18 13:36:13.329267|2017-02-18 13:36:13.329267
NCT00808548|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2008-12-15|||December 2008||2008-12-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|February 2009|Anticipated|2009-02-01||Observational|||Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome||Unknown status|Not yet recruiting|N/A|8|Anticipated|Taichung Veterans General Hospital|||1||f||||t||||||||||2017-02-18 13:36:13.4308|2017-02-18 13:36:13.4308
NCT00808535|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-15|2009-02-06|||February 2009||2009-02-01|February 2009|2009-02-01|March 2010|Anticipated|2010-03-01|February 2010|Anticipated|2010-02-01||Observational|||Cardiac Magnetic Resonance Imaging for Detecting Endothelial Dysfunction|A Pilot Study of Cardiac Magnetic Resonance Imaging For Detection of Myocardial Perfusion Abnormalities in Endothelial Dysfunction|Unknown status|Not yet recruiting|N/A|60|Anticipated|University of California, Los Angeles|||2||f||||f||||||||||2017-02-18 13:36:13.520542|2017-02-18 13:36:13.520542
NCT00808522|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-13|2008-12-15|||December 2008||2008-12-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women|Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women.|Unknown status|Recruiting|Phase 3|84|Anticipated|New York Presbyterian Hospital||2|||f||||f||||||||||2017-02-18 13:36:13.607641|2017-02-18 13:36:13.607641
NCT00808509|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2013-11-21|2013-09-19||January 2009||2009-01-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|ADMIRE||A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission|A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission (ADMIRE)|Completed||Phase 4|33|Actual|AbbVie||2|||f||||f||||||||||2017-02-18 13:36:13.895359|2017-02-18 13:36:13.895359
NCT00808496|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2011-10-06|||June 2009||2009-06-01|October 2011|2011-10-01|April 2013|Anticipated|2013-04-01|October 2012|Anticipated|2012-10-01||Interventional|MRx||The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis|A Double Blind Randomized Controlled Trial to Compare Biannual Peripheral Magnetic Resonance Imaging, Radiography, and Standard of Care on Pharmacotherapeutic Escalation in Inflammatory Arthritis|Unknown status|Active, not recruiting|Phase 4|186|Anticipated|McMaster University||3|||f||||t||||||||||2017-02-18 13:36:16.491722|2017-02-18 13:36:16.491722
NCT00808483|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2015-01-08|2014-12-09||October 2008||2008-10-01|January 2015|2015-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Walking Skill Training Program Effects in Patients With Total Hip Arthroplasty|Effect of a Walking Skill Training Program in Patients Who Have Undergone Total Hip Arthroplasty: Followup One Year After Surgery|Completed||N/A|68|Actual|University of Oslo||2|||f||||t||||||||||2017-02-18 13:36:16.769226|2017-02-18 13:36:16.769226
NCT00808470|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2014-01-23|||October 2008||2008-10-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Micronutrients to Prevent Noise-induced Hearing Loss|Micronutrient Intervention to Reduce Noise-Induced Hearing Loss: Prevention of Temporary Threshold Changes Induced by Use of a Digital Music Player|Completed||Phase 2|101|Actual|University of Michigan||4|||f||||t||||||||||2017-02-18 13:36:17.241114|2017-02-18 13:36:17.241114
NCT00808457|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2011-08-12|||September 2007||2007-09-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Role of Chest Ultrasound in Diagnosing and Follow-up of Pneumonia|"Role of Chest Ultrasound in Diagnosing and Follow-up of Pneumonia. Prospective Comparison Between X-ray Chest Film in Two Planes and Low-dose Spiral Computed Tomography"|Completed||N/A|397|Actual|University of Jena|||1||f||||f||||||||||2017-02-18 13:36:17.367054|2017-02-18 13:36:17.367054
NCT00808444|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-10-06|2010-10-25||January 2009||2009-01-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age|Non-inferiority of a Commercial Lot of the Pneumococcal Vaccine GSK1024850A Compared to a Clinical Lot.|Completed||Phase 3|466|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:36:17.475214|2017-02-18 13:36:17.475214
NCT00808431|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2013-12-17|||July 2008||2008-07-01|December 2013|2013-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity|ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity|Completed||Phase 2/Phase 3|100|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 13:36:18.257574|2017-02-18 13:36:18.257574
NCT00808418|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2014-01-31|||November 2008||2008-11-01|January 2014|2014-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer|A Phase 1 Study of Weekly Elesclomol Sodium Plus Docetaxel and Concomitant Prednisone in Subjects With Metastatic Castration Refractory Prostate Cancer (m-CRPC)|Completed||Phase 1|34|Actual|Synta Pharmaceuticals Corp.||1|||f||||f||||||||||2017-02-18 13:36:18.355635|2017-02-18 13:36:18.355635
NCT00808405|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2013-11-15|2012-04-20||January 2009||2009-01-01|November 2013|2013-11-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|PK/GUD||GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women|Prospective Study of Pharmacokinetics, Clinical and Virologic Response to Acyclovir Episodic Therapy for Genital Herpes Ulcers in HIV Negative African Women|Completed||N/A|88|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 13:36:18.459451|2017-02-18 13:36:18.459451
NCT00808392|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2011-12-26|||November 2008||2008-11-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b|A Phase III, Observer-blind, Randomized, Controlled, Multicenter Study to Investigate Immunogenicity and Safety of Haemophilus Influenzae Type b Vaccine in 2 - 4 Months Old Healthy Infants in China, According to the Recommended Regimen of 3 Intramuscular Doses Given One Month Apart|Completed||Phase 3|916|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:36:18.870356|2017-02-18 13:36:18.870356
NCT00808379|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2008-12-12|||May 2006||2006-05-01|December 2008|2008-12-01|July 2009|Anticipated|2009-07-01|February 2009|Anticipated|2009-02-01||Interventional|||Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers|Concurrent Chemo-Radiotherapy vs Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers. A Randomized Phase II Study|Unknown status|Active, not recruiting|Phase 2|90|Actual|Tata Memorial Hospital||2|||f||||t||||||||||2017-02-18 13:36:18.965834|2017-02-18 13:36:18.965834
NCT00808366|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2008-12-12|||October 2008||2008-10-01|December 2008|2008-12-01|October 2009|Anticipated|2009-10-01|June 2009|Anticipated|2009-06-01||Interventional|||Efficacy and Safety of RV4104A Ointment in Onychomycosis|A Randomized, Parallel-Group, Multicentre, Open-Labelled, Active-Controlled Study to Assess the Efficacy, Safety and Tolerability of RV4104A Ointment Versus Bifonazole-Urea Ointment for the Complete Removal of the Clinically Infected Nail Plate Area in Patients With Toenail Onychomycosis|Unknown status|Recruiting|N/A|228|Anticipated|Pierre Fabre Dermo Cosmetique||2|||f||||f||||||||||2017-02-18 13:36:19.075653|2017-02-18 13:36:19.075653
NCT00808353|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2008-12-12|||July 1985||1985-07-01|December 2008|2008-12-01||||||||Observational|||Genomic Approaches to Common Chronic Disease - Ancillary to ARIC|Genomic Approaches to Common Chronic Disease|Completed||N/A|15792|Actual|University of Michigan|||1||f||||t||||||Samples With DNA|"~     Blood and urine~   "|||2017-02-18 13:36:19.170431|2017-02-18 13:36:19.170431
NCT00808340|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2015-05-05|2010-07-30||November 2008||2008-11-01|May 2015|2015-05-01||||December 2008|Actual|2008-12-01||Interventional|||Comparison of Three Soft Bifocal Contact Lenses||Completed||N/A|37|Actual|Johnson & Johnson Vision Care, Inc.||6|||f||||||||||||||2017-02-18 13:36:19.252926|2017-02-18 13:36:19.252926
NCT00808327|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2009-11-19|||January 2009||2009-01-01|November 2009|2009-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Spinal Anesthesia for Cesarean Delivery: Bupivacaine With or Without Fentanyl|Spinal Anesthesia for Cesarean Delivery: Bupivacaine With or Without Fentanyl|Completed||N/A|140|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-02-18 13:36:19.725912|2017-02-18 13:36:19.725912
NCT00808314|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2012-08-01|||December 2008||2008-12-01|August 2012|2012-08-01|September 2012|Anticipated|2012-09-01|December 2010|Actual|2010-12-01||Interventional|||Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress|Lexiscan(TM) Rb-82 Myocardial Perfusion Positron Emission Computed Tomography: A Comparison With Dipyridamole|Unknown status|Active, not recruiting|Phase 4|32|Anticipated|Cardiovascular Imaging Technologies||2|||f||||f||||||||||2017-02-18 13:36:19.837099|2017-02-18 13:36:19.837099
NCT00808301|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2015-03-17|||January 2009||2009-01-01|March 2015|2015-03-01|October 2015|Anticipated|2015-10-01|July 2014|Actual|2014-07-01||Interventional|||Oat Products in the Treatment of Coeliac Disease in Children|Multicentre Clinical Trial on Oat Products in the Treatment of Coeliac Disease in Children|Active, not recruiting||N/A|300|Anticipated|Heinz Italia SpA||1|||f||||f||||||||||2017-02-18 13:36:19.93304|2017-02-18 13:36:19.93304
NCT00808288|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2011-10-06|||March 2010||2010-03-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|A7881013||A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.|A Phase 2b, Parallel Group, Placebo And Active Comparator Controlled Study To Investigate The Safety, Toleration And Efficacy Of 6-Week Once Daily Administration Of Inhaled PF-00610355 Dry Powder In Patients With Moderate Chronic Obstructive Pulmonary Disease.|Completed||Phase 2|405|Actual|Pfizer||5|||f||||t||||||||||2017-02-18 13:36:20.061783|2017-02-18 13:36:20.061783
NCT00808275|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2011-12-02|||September 2004||2004-09-01|December 2011|2011-12-01|October 2007|Actual|2007-10-01|September 2006|Actual|2006-09-01||Interventional|||Caloric Restriction and Body Weight in Adults|Effect of Dietary Calcium on Body Weight Regulation in Adults|Completed||N/A|79|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 13:36:20.244836|2017-02-18 13:36:20.244836
NCT00808262|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2011-06-07|||October 2008||2008-10-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease|"A Phase I/II, Open-label, Escalating Dose, Optimal Two-stage, Study of TNFα-Kinoid (TNF- K) Immunization in Crohn's Disease Patients"|Completed||Phase 1/Phase 2|21|Actual|Neovacs||3|||f||||t||||||||||2017-02-18 13:36:20.334524|2017-02-18 13:36:20.334524
NCT00808249|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2011-06-15|2011-01-28||December 2008||2008-12-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)|A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Efficacy and Safety Study of AZD7325 in the Treatment of Generalized Anxiety Disorder (GAD)|Completed||Phase 2|725|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 13:36:20.441363|2017-02-18 13:36:20.441363
NCT00808236|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2011-06-08|2010-05-21||November 2008||2008-11-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|PRINCE||Pre-ROSC Intra-Nasal Cooling Effectiveness|Trans-Nasal Cooling With the RhinoChill Device Following Cardiac Arrest: A Pilot Study|Completed||N/A|200|Actual|BeneChill, Inc||2|||f||||f||||||||||2017-02-18 13:36:23.508385|2017-02-18 13:36:23.508385
NCT00808223|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2013-12-10|||April 2009||2009-04-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis|A Phase 2, Single-Arm Study to Evaluate the Safety and Pharmacokinetics of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis [ISN 0485-CL-0004]|Completed||Phase 2|30|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-02-18 13:36:24.767894|2017-02-18 13:36:24.767894
NCT00808210|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-11-01||2014-01-27|March 2009||2009-03-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab|A PHASE II RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OCRELIZUMAB IN COMBINATION WITH METHOTREXATE, COMPARED TO INFLIXIMAB PLUS METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS CURRENTLY RESPONDING INADEQUATELY TO ETANERCEPT OR ADALIMUMAB|Terminated||Phase 2|28|Actual|Genentech, Inc.||2||"Based on analysis of results and consideration of available treatments, the overall benefit to~   risk profile of ocrelizumab was not favorable in RA."|f||||||||||||||2017-02-18 13:36:24.89374|2017-02-18 13:36:24.89374
NCT00808197|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2008-12-12||||||December 2008|2008-12-01||||||||Interventional|||Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal Neovascularisation|Choroidal Blood Flow and Progression of Age-Related Macular Degeneration in the Fellow Eye in Patients With Unilateral Choroidal Neovascularisation|Completed||N/A|41|Anticipated|Medical University of Vienna||1|||f||||||||||||||2017-02-18 13:36:25.124091|2017-02-18 13:36:25.124091
NCT00808184|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2012-10-31|||April 2010||2010-04-01|April 2010|2010-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype|Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype|Completed||Phase 4|25|Actual|National University Hospital, Singapore||1|||f||||f||||||||||2017-02-18 13:36:25.2138|2017-02-18 13:36:25.2138
NCT00808171|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2014-07-25|||February 2009||2009-02-01|July 2014|2014-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture|Evaluation of the Analgesy Using a Local Anesthetic (Lidocaine and Prolocaine) Eutectic Mixture and/or Nitric Oxide at 50% in Oxygen (Livopan®) in Pediatric Patients That During Lumbar Puncture|Completed||Phase 4|52|Actual|Federal University of Minas Gerais||3|||f||||t||||||||||2017-02-18 13:36:25.326107|2017-02-18 13:36:25.326107
NCT00808158|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2012-11-29|||October 2008||2008-10-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|STRONG Kids||Examining the Relationship Between Tobacco Exposure, Abdominal Obesity, and Metabolic Syndrome in Adolescents (The STRONG Kids Study)|Metabolic Syndrome in Adolescents: Contribution of Tobacco and Central Fat|Completed||N/A|117|Actual|University of Rochester|||1||f||||t||||||Samples With DNA|"~     Serum, whole blood, white blood cells, saliva, urine~   "|||2017-02-18 13:36:25.450169|2017-02-18 13:36:25.450169
NCT00808145|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2014-10-21|||February 2009||2009-02-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)|A Phase II Study of Sorafenib With Gemcitabine/Cisplatin in Advanced Hepatocellular Carcinoma|Withdrawn||Phase 2|0|Actual|Lahey Clinic||1||Lack of enrollment, many screen failures and non eligible study participants|f||||f||||||||||2017-02-18 13:36:25.548521|2017-02-18 13:36:25.548521
NCT00808132|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2014-03-10|2013-10-30||January 2009||2009-01-01|March 2014|2014-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional||Safety population included all randomized participants who received at least one dose of study drug.|Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis|A Double-Blind, Randomized, Placebo And Active- Controlled Efficacy And Safety Study Of The Effects Of Bazedoxifene/Conjugated Estrogens Combinations On Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women|Completed||Phase 3|1886|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 13:36:25.694549|2017-02-18 13:36:25.694549
NCT00803816|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-05-22|||November 2007||2007-11-01|May 2015|2015-05-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A|Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A|Completed||Phase 2|12|Actual|St. Franziskus Hospital||1|||f||||t||||||||||2017-02-18 13:38:10.892701|2017-02-18 13:38:10.892701
NCT00808119|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2009-07-17|||October 2008||2008-10-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects|A Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects|Completed||Phase 1|30|Anticipated|RTI International||1|||f||||t||||||||||2017-02-18 13:36:28.723623|2017-02-18 13:36:28.723623
NCT00808106|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2017-01-24|||December 10, 2008||2008-12-10|September 26, 2016|2016-09-26||||||||Observational|||Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism|Clinical, Cellular, and Molecular Investigations Into Oculocutaneous Albinism|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:36:28.815557|2017-02-18 13:36:28.815557
NCT00808093|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2011-04-07|||May 2008||2008-05-01|April 2011|2011-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects|Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects|Completed||Phase 1|30|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:36:28.922099|2017-02-18 13:36:28.922099
NCT00808080|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2016-01-25|2015-11-30||January 2010||2010-01-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|AMLCTL||A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)|A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia|Terminated||Phase 1/Phase 2|6|Actual|University of California, San Diego|Accrual trial was insufficient. No patient became eligible for CTL infusion. Cell culture information gleaned from a comparison of different culture methods will greatly facilitate future studies of autologous CTL-directed immunotherapy for AML.|1||lack of accrual|f||||t||||||||||2017-02-18 13:36:29.026541|2017-02-18 13:36:29.026541
NCT00808067|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2014-06-03|2013-12-20||November 2008||2008-11-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||SAF - Safety set; included all treated subjects, but excluded subjects from sites 1059 and 0246.|RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial|RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes|Completed||Phase 3|5897|Actual|Boehringer Ingelheim|Non-serious adverse events were not collected on subjects in this study.|2|||f||||||||||||||2017-02-18 13:36:29.530933|2017-02-18 13:36:29.530933
NCT00808054|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2014-07-24|||November 2008||2008-11-01|July 2014|2014-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation of Analgesia With EMLA and Glucose Oral Solution|Evaluation of Analgesia With the Use of Eutectic Mixture of Local Anesthetics (Lidocaine and Prilocaine) and Oral Solution of Glucose to 25% in Preterm Neonates During Arterial Puncture and / or the Installation of Percutaneous Catheter|Completed||Phase 4|60|Actual|Federal University of Minas Gerais||3|||f||||t||||||||||2017-02-18 13:36:32.868317|2017-02-18 13:36:32.868317
NCT00808041|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2015-07-21|||July 2009||2009-07-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|September 2012|Actual|2012-09-01||Observational|||Chemotherapy Monitoring With Breast Computed Tomography (CT)|Breast Cancer Chemotherapy Monitoring With Dedicated Breast Computed Tomography|Completed||N/A|3|Actual|Emory University|||1||f||||f||||||||||2017-02-18 13:36:32.986673|2017-02-18 13:36:32.986673
NCT00808028|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2015-03-27|2015-03-27||February 2009||2009-02-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||The stage 1 intent-to-treat (ITT) population included all randomized participants who received at least 1 vaccination and have at least 1 valid and determinate assay result from blood samples drawn during stage 1.|A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents|A Randomized, Single-blind, Placebo-controlled, Phase 2 Trial Of The Safety, Immunogenicity, And Tolerability Of Meningococcal Serogroup B (Mnb) Rlp2086 Vaccine At Doses Of 60 Mug, 120 Mug, And 200 Mug In Healthy Adolescents Aged 11 To 18 Years|Completed||Phase 2|538|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:36:33.104691|2017-02-18 13:36:33.104691
NCT00808015|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2015-04-21|2011-06-30||February 2009||2009-02-01|April 2015|2015-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|ASIA CHOICES||ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking|ASIA CHOICES CHampix Observational Investigation in the CEssation of Smoking|Completed||N/A|1373|Actual|Pfizer|Outcome measures were not designated as primary or secondary measures as this study was a post-marketing, prospective, non-comparative and non-interventional study.||1||f||||f||||||||||2017-02-18 13:36:35.706811|2017-02-18 13:36:35.706811
NCT00808002|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2014-09-05|||February 2009||2009-02-01|September 2014|2014-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine|Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine.|Completed||Phase 3|30|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 13:36:41.743604|2017-02-18 13:36:41.743604
NCT00807989|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2015-06-29|2014-01-20||March 2008||2008-03-01|June 2015|2015-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||The Efficacy and Safety of Low Dose Combination of LTG and VPA Compared to CBZ Monotherapy|An Open Label, Randomized, Multicenter Clinical Trial to Compare the Efficacy and Safety of Lamotrigine / Valproate Coadministration and Carbamazepine as Initial Pharmacotherapy in Epilepsies (Phase Ⅳ)|Completed||Phase 4|207|Actual|Yonsei University||2|||f||||f||||||||||2017-02-18 13:36:41.858516|2017-02-18 13:36:41.858516
NCT00807976|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2010-10-07|||January 2009||2009-01-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|ODET||Orthostatic Hypotension and Diabetes Mellitus|The Orthostatic Hypotension in the Diabetic Elderly Patients Trial (ODET)|Completed||N/A|500|Anticipated|Medical Research Foundation, The Netherlands|||2||f||||f||||||||||2017-02-18 13:36:42.227124|2017-02-18 13:36:42.227124
NCT00807963|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2009-06-03|||December 2008||2008-12-01|June 2009|2009-06-01|September 2009|Anticipated|2009-09-01|July 2009|Anticipated|2009-07-01||Interventional|||Pharmacokinetic, Safety and Tolerability Study of SC Administered Bisphosphonate With rHuPH20 vs Bisphosphonate Alone|Phase I, Open-Label, Pharmacokinetic, Safety and Tolerability Study of Subcutaneously Administered Bisphosphonate With Recombinant Human Hyaluronidase (rHuPH20) vs Bisphosphonate|Unknown status|Active, not recruiting|Phase 1|72|Anticipated|Halozyme Therapeutics||1|||f||||f||||||||||2017-02-18 13:36:42.319006|2017-02-18 13:36:42.319006
NCT00807950|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2014-01-21|||March 2008||2008-03-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast Cancer|Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast Cancer|Unknown status|Active, not recruiting|Phase 2|100||National University Hospital, Singapore|||||f||||f||||||||||2017-02-18 13:36:42.565746|2017-02-18 13:36:42.565746
NCT00807937|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-12|2010-09-16|2010-07-29||December 2008||2008-12-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325|A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase II Study of 2 Oral Dose Groups of AZD7325, With a Lorazepam Arm, in Subjects With Generalized Anxiety Disorder (GAD)|Completed||Phase 2|369|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 13:36:42.676609|2017-02-18 13:36:42.676609
NCT00807924|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-09-16|||December 2008||2008-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|ABLATE||American Breast Laser Ablation Therapy Evaluation|American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application|Recruiting||N/A|200|Anticipated|Novian Health Inc.|||1||f||||f||||||||||2017-02-18 13:36:43.325474|2017-02-18 13:36:43.325474
NCT00807911|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-01-11|||November 2008||2008-11-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|July 2014|Actual|2014-07-01||Interventional|||Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer|Randomized Phase II Study of Adjuvant Chemotherapy With 5-FU/Leucovorin vs. Oxaliplatin/5-FU/Leucovorin After Preoperative Chemoradiotherapy With Fluoropyrimidines Followed by Surgery in Patients With Locally Advanced Rectal Cancer|Active, not recruiting||Phase 2|320|Anticipated|Asan Medical Center||2|||f||||t||||||||||2017-02-18 13:36:43.441365|2017-02-18 13:36:43.441365
NCT00807898|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2011-01-28|||January 2009||2009-01-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Observational|||Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making|Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making|Completed||N/A|150|Anticipated|University of Louisville|||1||f||||||||||||||2017-02-18 13:36:43.712935|2017-02-18 13:36:43.712935
NCT00807885|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-10-21|2011-09-12||December 2008||2008-12-01|October 2011|2011-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|INFUSE-AT||Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase|INcreased Flow Utilizing Subcutaneously-Enabled Fluids Administration Technique Study (INFUSE-AT): A Randomized, Open-Label, Parallel Group, Phase IV, Study Evaluating the Techniques of Administration of Subcutaneous Fluids Enabled by Human Recombinant Hyaluronidase (Hylenex) in Healthy Adult Volunteers|Completed||Phase 4|100|Actual|Baxter Healthcare Corporation||9|||f||||f||||||||||2017-02-18 13:36:43.801474|2017-02-18 13:36:43.801474
NCT00807872|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2013-09-17|||December 2008||2008-12-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|March 2012|Actual|2012-03-01||Interventional|||Radioimmunoimaging of AL Amyloidosis|Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody Mu 11-1F4|Completed||Phase 1|40|Actual|University of Tennessee||1|||f||||f||||||||||2017-02-18 13:36:45.0611|2017-02-18 13:36:45.0611
NCT00807859|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2015-10-30|||March 2009||2009-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|February 2014|Actual|2014-02-01||Interventional|||Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer|An Open-Label Study of AMG 386 in Combination With Either Paclitaxel and Trastuzumab or Capecitabine and Lapatinib in Subjects With HER2-positive Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 1|65|Actual|Amgen||4|||f||||||||||||||2017-02-18 13:36:45.206271|2017-02-18 13:36:45.206271
NCT00807846|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-10-07|2013-12-12||September 2009||2009-09-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects|A Phase 4, 6-week, Randomized Double Blind, Multicenter, Active-controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis.|Completed||Phase 4|201|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 13:36:45.35387|2017-02-18 13:36:45.35387
NCT00807833|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2015-08-17|||February 2009||2009-02-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Observational|||Cerebral Blood Flow (CBF) Disturbances Following Traumatic Brain Injury (TBI) and Subarachnoid Hemorrhage (SAH)|Cerebral Blood Flow (CBF) Disturbances Following Traumatic Brain Injury (TBI) and Subarachnoid Hemorrhage (SAH)|Completed||N/A|20|Actual|Azienda Ospedaliera San Gerardo di Monza|||1||f||||f||||||||||2017-02-18 13:36:45.99327|2017-02-18 13:36:45.99327
NCT00807820|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2014-01-23|||March 2008||2008-03-01|January 2014|2014-01-01|January 2012|Actual|2012-01-01|June 2011|Actual|2011-06-01||Observational|||Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy|Phase I Study of Targeting Dominant Intraprostatic Lesion Using Functional MR Spectroscopy and High Dose Rate Brachytherapy|Completed||Phase 1|10|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:36:46.095138|2017-02-18 13:36:46.095138
NCT00807807|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-07-28|||June 1996||1996-06-01|December 2008|2008-12-01|September 1996|Actual|1996-09-01|September 1996|Actual|1996-09-01||Interventional|FAST||Evaluating the Effects of Folic Acid Supplementation in Older Adults: The Folic Acid Supplementation Trial (The FAST Study)|Phase III Study of the Effects of Folic Acid Supplementation on Serum Folate and Plasma Homocysteine in Older Adults: A Dose-Response Trial|Completed||Phase 3|133|Actual|National Heart, Lung, and Blood Institute (NHLBI)||5|||f||||f||||||||||2017-02-18 13:36:46.181109|2017-02-18 13:36:46.181109
NCT00807794|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2008-12-10|||February 1997||1997-02-01|December 2008|2008-12-01|January 1998|Actual|1998-01-01|November 1997|Actual|1997-11-01||Interventional|||A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection|Phase I Evaluation of the Pharmacokinetics, Pharmacodynamics and Safety of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection|Completed||Phase 1|13|Actual|MedImmune LLC||5|||f||||||||||||||2017-02-18 13:36:46.415477|2017-02-18 13:36:46.415477
NCT00807781|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2015-01-02|||October 2009||2009-10-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|||Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Mammaglobin-A DNA Vaccine in Breast Cancer Patients With Metastatic Disease|Completed||Phase 1|15|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 13:36:46.520577|2017-02-18 13:36:46.520577
NCT00807768|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-03-17|||March 2009||2009-03-01|March 2016|2016-03-01||||December 2014|Actual|2014-12-01||Interventional|||Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer|A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients With High Risk, Early Stage Endometrial Carcinoma|Active, not recruiting||Phase 3|555|Actual|Gynecologic Oncology Group||2|||f||||f||||||||||2017-02-18 13:36:46.844662|2017-02-18 13:36:46.844662
NCT00807755|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-01-27|||January 2009||2009-01-01|January 2016|2016-01-01||||August 2010|Actual|2010-08-01||Interventional|||Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors|Phase I Trial of Carboplatin and Etoposide in Combination With Everolimus (RAD001) in Advanced Solid Tumors, With Emphasis on Small Cell Lung Cancer (SCLC)|Terminated||Phase 1|5|Actual|University of California, Davis||1||"The study was closed because of the number of known toxicities observed despite a~   treatment-naïve population."|f||||t||||||||||2017-02-18 13:36:48.009368|2017-02-18 13:36:48.009368
NCT00807742|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2011-06-23|||October 2008||2008-10-01|February 2009|2009-02-01|March 2013|Anticipated|2013-03-01|March 2012|Anticipated|2012-03-01||Interventional|SCMSUD||Contingency Management for Smoking in Substance Abusers|Contingent Vouchers for Smoking in Substance Abusers as Adjunct to Nicotine Patch|Unknown status|Recruiting|N/A|274|Anticipated|Brown University||2|||f||||f||||||||||2017-02-18 13:36:48.11856|2017-02-18 13:36:48.11856
NCT00807729|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2009-09-02|||January 1997||1997-01-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|July 2003|Actual|2003-07-01||Interventional|ERCP/CBDE||Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely Choledocholithiasis|Prospective Randomized Trial of Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration (LC + LCBDE) Versus Endoscopic Retrograde Cholangiopancreatography Sphincterotomy Plus Laparoscopic Cholecystectomy (ERCP/S + LC) for Common Bile Duct Stone Disease|Completed||N/A|122|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:36:48.231709|2017-02-18 13:36:48.231709
NCT00807716|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2014-12-04|||October 2008||2008-10-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Effect of Physiotherapy After Total Knee Replacement|The Immediate and Long Term Effects of a Walking-skill Program Compared to Usual Physiotherapy Care in Patients Who Have Undergone Total Knee Arthroplasty (TKA): A Randomized Controlled Trial|Completed||N/A|57|Actual|University of Oslo||2|||f||||t||||||||||2017-02-18 13:36:48.336154|2017-02-18 13:36:48.336154
NCT00807703|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2009-12-16|||September 2008||2008-09-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|Select Stim||"Select Stim: Selective Stimulation of the Subthalamic Nucleus in Parkinson's Disease. A Feasibility Study"|"Select Stim: Selective Stimulation of the Subthalamic Nucleus in Parkinson's Disease. A Feasibility Study"|Completed||N/A|5|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 13:36:48.434102|2017-02-18 13:36:48.434102
NCT00807690|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2008-12-11|||November 2005||2005-11-01|December 2008|2008-12-01|January 2008|Actual|2008-01-01|||||Interventional|||Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo|Treatment of Vitiligo With Narrowband UVB (TL01) Combined With Tacrolimus (0.1%) Versus Placebo Ointment, a Randomized Right/Left Double Blind Comparative Study|Completed||Phase 3|||Oslo University Hospital|||||f||||||||||||||2017-02-18 13:36:48.531812|2017-02-18 13:36:48.531812
NCT00807677|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2013-07-01|||March 2009||2009-03-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies|A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies|Completed||Phase 1|31|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:36:48.602859|2017-02-18 13:36:48.602859
NCT00807664|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2010-06-02|||December 2008||2008-12-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Biatain Ag vs Biatain in the Treament of Leg Ulcers|Clinical Assessment of Biatain Ag Dressings Compared to Biatain Dressings in the Treatment of Leg Ulcers|Completed||Phase 4|183|Actual|Coloplast A/S||2|||f||||f||||||||||2017-02-18 13:36:48.701866|2017-02-18 13:36:48.701866
NCT00807651|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-06-04|||February 2008||2008-02-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes|Safety and Efficacy Study of Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes-a Phase II Study|Active, not recruiting||Phase 2|40|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-02-18 13:36:48.782736|2017-02-18 13:36:48.782736
NCT00807625|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2012-07-12|||November 2008||2008-11-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|MSRC||Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia|Mucosal and Systemic Responses to Contraceptives in HIV-Infected Women in Zambia|Completed||Phase 2|66|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 13:36:48.898941|2017-02-18 13:36:48.898941
NCT00807612|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2014-09-19||2014-09-19|January 2009||2009-01-01|September 2014|2014-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer|A Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|49|Actual|Amgen||3||Study was closed due to administrative decision|f||||||||||||||2017-02-18 13:36:49.102642|2017-02-18 13:36:49.102642
NCT00807599|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-06-08|||December 2008||2008-12-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L|A Phase II Clinical Trial for Untreated Patients With Multiple Myeloma Eligible for Stem Cell Transplant: Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L|Active, not recruiting||Phase 2|67|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||t||||||||||2017-02-18 13:36:49.23311|2017-02-18 13:36:49.23311
NCT00807586|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2013-04-23|||December 2008||2008-12-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2009|Actual|2009-12-01||Interventional|SAAB||Corticosteroid Pulse After Ablation|SAAB: Randomized, Double Blind STudy of Corticosteroid Pulse After Ablation|Unknown status|Active, not recruiting|Phase 4|120|Actual|Minneapolis Heart Institute Foundation||2|||f||||f||||||||||2017-02-18 13:36:49.355055|2017-02-18 13:36:49.355055
NCT00807573|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2015-11-24|2015-10-19||December 2008||2008-12-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment|A Phase II Trial of Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment|Completed||Phase 2|44|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:36:49.468273|2017-02-18 13:36:49.468273
NCT00807560|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2015-12-02|2014-03-04||September 2008||2008-09-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PO||Parent-Based Treatment for Pediatric Overweight|Parent-Based Treatment for Pediatric Overweight|Completed||Phase 1/Phase 2|77|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 13:36:49.741847|2017-02-18 13:36:49.741847
NCT00807547|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-12-28|||April 2008||2008-04-01|December 2015|2015-12-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||Intraseasonal Short-time Up-dosing With Alutard SQ Grasses|A Randomised, Parallel-group, Double-blind, Placebo-controlled, Multicentre Phase III Trial Assessing the Pharmacodynamic Efficacy and Safety of an Intra-seasonal Short-time Updosing Schedule for Alutard SQ|Completed||Phase 3|149|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-02-18 13:36:50.479782|2017-02-18 13:36:50.479782
NCT00807534|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-02-07|||October 2008||2008-10-01|May 2010|2010-05-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)|Measurement of Exertional Dyspnea in the Primary Care Setting in Patients With COPD, Phase 2: Sensitivity of the Step Test and Shuttle Walk to Detect Improvement in Dyspnea Following Bronchodilation in Patients With COPD|Completed||N/A|44|Anticipated|Laval University||2|||f||||f||||||||||2017-02-18 13:36:50.573736|2017-02-18 13:36:50.573736
NCT00807521|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2014-12-16|||December 2008||2008-12-01|December 2014|2014-12-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|STRESS||Steroid-induced Reduction of Surgical Stress Study|Reduction of the Cardiac Proapoptotic Stress Response by Dexamethasone in Patients Undergoing Coronary Artery Bypass Grafting Surgery|Withdrawn||N/A|0|Actual|VU University Medical Center||2||Research question was integrated in other study protocol|f||||f||||||||||2017-02-18 13:36:50.701033|2017-02-18 13:36:50.701033
NCT00807508|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2008-12-11|||January 2007||2007-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Leucine Supplementation in Elderly Men|The Influence of Leucine Supplementation on Body Composition and Muscle Characteristics in Healthy Elderly|Completed||Phase 1/Phase 2|29|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:36:50.812643|2017-02-18 13:36:50.812643
NCT00807495|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2013-11-15||2012-06-19|February 2009||2009-02-01|November 2013|2013-11-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma|A Phase 2 Trial of MLN8237, an Oral Aurora A Kinase Inhibitor, in Adult Patients With Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|48|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:36:50.906908|2017-02-18 13:36:50.906908
NCT00807482|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-09-06|||January 2004||2004-01-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease|Diagnostic and Clinical Characterization of Patients With Unusual Genetic Disorders of the Airways|Recruiting||N/A|1800|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"~     Blood samples, buckle scrape, semen, and scrape biopsy of nasal cells~   "|||2017-02-18 13:36:51.017999|2017-02-18 13:36:51.017999
NCT00807469|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2008-12-11|||January 2009||2009-01-01|December 2008|2008-12-01|January 2015|Anticipated|2015-01-01|January 2013|Anticipated|2013-01-01||Observational|||Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPD|Acute and Chronic Inflammatory Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPD: From Specific Disease Phenotyping Towards Novel Made Therapy (Study 1)|Unknown status|Not yet recruiting|N/A|120|Anticipated|Top Institute Pharma|||5||f||||t||||||Samples With DNA|"~     Blood will be retained to investigate diffences in candidate genes (SNPs) for COPD between~     the 5 different groups.~   "|||2017-02-18 13:36:51.129657|2017-02-18 13:36:51.129657
NCT00807456|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2016-04-26|2016-03-16||November 2008||2008-11-01|April 2016|2016-04-01||||June 2013|Actual|2013-06-01||Interventional|||Study to Evaluate an Implant With a Sloped Top in Patients With a Sloped Jaw Bone|A Prospective, Open, Single Arm, Multi-center Study to Evaluate Maintenance of Lingual Bone in Healed Ridges With the ASTRA TECH Implant System, OsseoSpeed™ Profile Implant. A 3-year Follow-up Study|Completed||N/A|65|Actual|Dentsply Sirona Implants||1|||f||||f||||||||||2017-02-18 13:36:51.226469|2017-02-18 13:36:51.226469
NCT00807443|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-11|2013-01-31|||September 2009||2009-09-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1|Pilot Study Of The Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1 In Patients Taking Highly Active Antiretroviral Therapy|Completed||Phase 2|10|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||1|||f||||f||||||||||2017-02-18 13:36:51.618196|2017-02-18 13:36:51.618196
NCT00807430|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2009-10-20|||February 2009||2009-02-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Treatment Period and Long-term Effect of Functional Electric Stimulation (FES) for Bruxism|A Single Centre, Randomised, Clinical Placebo Controlled Study of the Optimal Treatment and Long-term Effect of FES on Bruxism|Terminated||N/A|48|Anticipated|Medotech A/S||2|||f||||f||||||||||2017-02-18 13:36:51.719494|2017-02-18 13:36:51.719494
NCT00807404|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2010-05-26|||November 2006||2006-11-01|May 2010|2010-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Optical Coherence Tomography in Tissue Samples From Women Undergoing Mastectomy for the Treatment or Prevention of Breast Ductal Intraepithelial Neoplasia|Forward Image Guided Ductoscopy for Early Cancer Screening|Completed||N/A|50|Anticipated|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 13:36:51.813024|2017-02-18 13:36:51.813024
NCT00807391|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2011-06-22|||July 2009||2009-07-01|August 2009|2009-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Transbronchial Catheter Aspiration and Transbronchial Needle Aspiration in the Diagnosis of Lung Cancer|Transbronchial Catheter Aspiration Compared to Transbronchial Needle Aspiration in the Diagnosis of Peripheral Nodules and Masses of the Lung|Completed||N/A|48|Actual|Helios Klinik Ambrock||1|||f||||f||||||||||2017-02-18 13:36:51.911769|2017-02-18 13:36:51.911769
NCT00807378|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2010-05-19|||July 2008||2008-07-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Observational|VIMPAC||Rijavithi Viral and Mycobacterium PCR Arrays in CNS Infection Study|Cerebrospinal Fluid Polymerase Chain Reaction Arrays for Central Nervous System Neurotropic Viral Infection and Mycobacterium Infection Study|Completed||N/A|200|Anticipated|Rajavithi Hospital|||2||f||||t||||||Samples With DNA|"~     CSF DNA/RNA virus~   "|||2017-02-18 13:36:52.02331|2017-02-18 13:36:52.02331
NCT00807365|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2010-03-25|||December 2007||2007-12-01|March 2010|2010-03-01|August 2011|Anticipated|2011-08-01|August 2010|Anticipated|2010-08-01||Interventional|PP2||Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly|Six Month Treatment of GHRH in the Elderly|Unknown status|Active, not recruiting|Phase 2|48|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 13:36:52.095869|2017-02-18 13:36:52.095869
NCT00807352|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-08-04|||April 2009||2009-04-01|July 2011|2011-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|PERC CTAS||The Canadian Triage and Acuity Scale for Children; A Prospective Multi-Center Evaluation.|The Canadian Triage and Acuity Scale for Children; A Prospective Multi-Center Evaluation.|Completed||N/A|1464|Actual|St. Justine's Hospital|||4||f||||f||||||||||2017-02-18 13:36:52.198033|2017-02-18 13:36:52.198033
NCT00807339|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-04-07|||March 2006||2006-03-01|April 2011|2011-04-01||||October 2011|Anticipated|2011-10-01||Interventional|||CyberKnife for Unresectable Renal Tumors|CyberKnife Stereotactic Radiation for Unresectable Renal Tumors/PhaseI Study|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||t||||||||||2017-02-18 13:36:52.29389|2017-02-18 13:36:52.29389
NCT00807326|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-07-06|||November 2008||2008-11-01|July 2012|2012-07-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||A Comparison of Three Medications to Treat Diarrhea in Adults.|A Randomized, Parallel Group Comparison of Loperamide/Simeticone Caplet, Loperamide/Simeticone Chewable Tablet (IMODIUM® PLUS) and a Probiotic (Saccharomyces Boulardii) in the Treatment of Acute Diarrhea in Adults|Completed||Phase 4|415|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-02-18 13:36:52.383117|2017-02-18 13:36:52.383117
NCT00807313|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2013-04-29|||December 2008||2008-12-01|April 2013|2013-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|tomoligo||Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer|Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer|Completed||N/A|53|Actual|Universitair Ziekenhuis Brussel|||2||f||||f||||||||||2017-02-18 13:36:52.504053|2017-02-18 13:36:52.504053
NCT00807300|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2015-12-02|||October 2006||2006-10-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CEAL||Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma|Phase-III-Study to Evaluate the Efficacy of CT-guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma.|Completed||Phase 2|77|Actual|University of Magdeburg||2|||f||||f||||||||||2017-02-18 13:36:52.702289|2017-02-18 13:36:52.702289
NCT00807287|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2008-12-10|||February 2005||2005-02-01|December 2008|2008-12-01|April 2006|Actual|2006-04-01|February 2006|Actual|2006-02-01||Interventional|||Evaluation of Two Methods of Jejunal Placement of Enteral Feeding Tubes in Critically Ill Patients|Evaluation of Two Methods of Jejunal Placement of Enteral Feeding Tubes in Critically Ill Patients: Endoscopic Versus Unguided, Frictional Method|Completed||N/A|42|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:36:52.804911|2017-02-18 13:36:52.804911
NCT00807274|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2009-09-24|||September 2008||2008-09-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|||||Observational|||Renal Function in Adults With Congenital Heart Disease.|Prospective Evaluation of Renal Function in Adults With Congenital Heart Disease.|Withdrawn||N/A|1200|Anticipated|Royal Brompton & Harefield NHS Foundation Trust|||1|Alternative trial planned|f||||f||||||Samples Without DNA|"~     Plasma, serum and urine samples~   "|||2017-02-18 13:36:52.916608|2017-02-18 13:36:52.916608
NCT00807261|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2008-12-11|||September 2008||2008-09-01|December 2008|2008-12-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy|PhaseⅡ Study of Weekly Docetaxel and Fixed-Dose Rate Gemcitabine in Patient With Previously Treated Advanced Soft Tissue and Bone Sarcoma Prospective, Open Label, Multi-Institutional|Unknown status|Enrolling by invitation|Phase 2|30|Anticipated|Asan Medical Center||1|||f||||t||||||||||2017-02-18 13:36:52.999012|2017-02-18 13:36:52.999012
NCT00807248|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2012-12-13|2011-06-15||November 2008||2008-11-01|December 2012|2012-12-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder|Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study of Escitalopram in Combination With Two Fixed Doses of Gaboxadol Compared to Escitalopram in Major Depressive Disorder|Completed||Phase 2|490|Actual|H. Lundbeck A/S||4|||f||||f||||||||||2017-02-18 13:36:53.086721|2017-02-18 13:36:53.086721
NCT00807235|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2012-05-11|2012-04-02||January 2005||2005-01-01|May 2012|2012-05-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants|An Open Label, Multicenter, Phase 2, Pilot Evaluation of SURFAXIN®(Lucinactant) Delivered as an Aerosol Via Nasal Continuous Positive Airway Pressure (nCPAP) in the Prevention of Respiratory Distress Syndrome in Premature Infants|Terminated||Phase 2|17|Actual|Windtree Therapeutics||2||Slow enrollment|f||||f||||||||||2017-02-18 13:36:54.338961|2017-02-18 13:36:54.338961
NCT00807222|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2008-12-10|||April 2008||2008-04-01|December 2008|2008-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)|Study of the Effect of Vyvanse (Lisdexamfetamine Dimesylate) on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|24|Actual|Clinical Study Centers, LLC||2|||f||||f||||||||||2017-02-18 13:36:54.98122|2017-02-18 13:36:54.98122
NCT00807209|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-04-15|2011-11-29||December 2008||2008-12-01|November 2011|2011-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Dose Finding Posterolateral Thoracotomy Study|A Phase 2 Open-Label, Parallel Group, Randomized, Dose-Finding Study to Assess the Efficacy and Safety of Intercostal SKY0402 in Subjects Undergoing Posterolateral Thoracotomy|Terminated||Phase 2|3|Actual|Pacira Pharmaceuticals, Inc|The study was terminated early due to Sponsor's decision, unrelated to safety. As there was only one patient in each group, no efficacy analyses were performed.|3||Sponsor decision unrelated to safety|f||||f||||||||||2017-02-18 13:36:55.102932|2017-02-18 13:36:55.102932
NCT00807196|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2008-12-10|||September 2008||2008-09-01|December 2008|2008-12-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma|Phase I-II Non-Randomized Study of Yttrium 90 Ibritumomab Tiuxetan (Zevalin) With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Relapsed, Refractory, or Transformed Indolent Non Hodgkin Lymphoma|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Maisonneuve-Rosemont Hospital||1|||f||||t||||||||||2017-02-18 13:36:55.578566|2017-02-18 13:36:55.578566
NCT00807183|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-04-14|||December 2008||2008-12-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|ARTIS||Indoor Woodsmoke PM and Asthma|Indoor Woodsmoke PM and Asthma: a Randomized Trial|Completed||Phase 3|122|Actual|National Institute of Environmental Health Sciences (NIEHS)||3|||f||||f||||||||||2017-02-18 13:36:55.687927|2017-02-18 13:36:55.687927
NCT00807170|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2016-08-26|||May 2009||2009-05-01|August 2016|2016-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases|A Phase I Study of ZD6474 (Vandetanib) Concurrent With Whole Brain Radiotherapy for the Treatment of Brain Metastases in Patients With Non-small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|5|Actual|Sanofi||1||Very slow recruitment|f||||t||||||||||2017-02-18 13:36:55.785267|2017-02-18 13:36:55.785267
NCT00807157|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2009-04-23|||December 2008||2008-12-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|BIOSTRESS||Evaluation of a Probiotic On Anxiety and Stress in Healthy Adults Sensible to Daily Stress|Evaluation Des Effets Anti-Stress D'un Probiotique Nomme PROBIOSTICK® Sur Des Sujets Humains Volontaires Sains Sensibles Au Stress De La Vie Quotidienne|Completed||N/A|66|Anticipated|Institut Rosell Lallemand||2|||f||||t||||||||||2017-02-18 13:36:55.888324|2017-02-18 13:36:55.888324
NCT00807144|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-06-27|||December 2008||2008-12-01|June 2011|2011-06-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|TAESR||Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation|A Phase-IV Study Comparing Standard Release Tacrolimus (Prograf) vs Prolonged-release Tacrolimus (Advagraf) Monotherapy as Maintenance Immunosuppression After Induction With Alemtuzumab in Kidney Transplantation|Unknown status|Recruiting|Phase 4|100|Anticipated|Hammersmith Hospitals NHS Trust||2|||f||||t||||||||||2017-02-18 13:36:55.972755|2017-02-18 13:36:55.972755
NCT00807131|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2008-12-10|||September 2006||2006-09-01|December 2008|2008-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|EPHACA||Effectiveness of Pharmaceutical Care on Primary Care Patients With Uncontrolled Hypertension|Effectiveness of a Pharmaceutical Care Program on Primary Care Patients With Uncontrolled Hypertension- A Brazilian Multicenter RCT|Completed||N/A|301|Actual|Hospital de Clinicas de Porto Alegre||4|||f||||f||||||||||2017-02-18 13:36:56.079345|2017-02-18 13:36:56.079345
NCT00807118|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2010-03-23|||October 2008||2008-10-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect|A Phase 1, Open-Label, Randomized, Single-Dose, 2-Cohort, 3-Way Crossover Study To Determine Bioequivalence Of 4 Mg And 8 Mg Fesoterodine SR Tablet Of Commercial Formulation And 8 Mg Fesoterodine SR Tablet Between Formulation E(1) And Formulation F And Investigate Food Effect On Commercial Formulation In Healthy Subjects.|Completed||Phase 1|108|Anticipated|Pfizer||6|||f||||f||||||||||2017-02-18 13:36:56.188236|2017-02-18 13:36:56.188236
NCT00807105|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-01-04|||June 2008||2008-06-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode||Completed||Phase 2|29|Actual|Shalvata Mental Health Center||1|||f||||t||||||||||2017-02-18 13:36:56.299695|2017-02-18 13:36:56.299695
NCT00807092|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-02-13|2010-11-12||December 2008||2008-12-01|February 2015|2015-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes|Comparison of the Efficacy on Glycaemic Control and Safety Profile of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 Both in Combination With Metformin in Insulin-naïve Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Drugs (OADs) Therapy|Completed||Phase 4|145|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 13:36:56.388934|2017-02-18 13:36:56.388934
NCT00807079|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2014-10-28|||September 2008||2008-09-01|October 2014|2014-10-01||||May 2011|Actual|2011-05-01||Interventional|||Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer|Phase I/II Study of Carboplatin in Association With Weekly Oral Topotecan in Patients With Metastatic or Recurrent Cervical Cancer|Completed||Phase 1/Phase 2|12|Actual|ARCAGY/ GINECO GROUP||1|||f||||t||||||||||2017-02-18 13:36:57.354412|2017-02-18 13:36:57.354412
NCT00807066|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2012-04-20|||November 2008||2008-11-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|November 2009|Actual|2009-11-01||Interventional|RANGE||Randomized Gefitinib Trial|Multicentric Randomized Phase III Study Comparing Gefitinib Versus Platinum-Based Chemotherapy In EGFR Fish Positive NSCLC Patients (Range)|Completed||Phase 3|1|Actual|Fondazione Humanitas per la Ricerca||2|||f||||f||||||||||2017-02-18 13:36:57.46231|2017-02-18 13:36:57.46231
NCT00807053|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-12-02|||April 2007||2007-04-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)|A Double-blind, Randomized, Placebo-controlled, Parallel Group, Multicenter, Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 2|480|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 13:36:57.558297|2017-02-18 13:36:57.558297
NCT00807040|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-04-10|||December 2008||2008-12-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|April 2013|Actual|2013-04-01||Interventional|||Comparing the Effectiveness of Repairing Versus Replacing the Heart's Mitral Valve in People With Severe Chronic Ischemic Mitral Regurgitation|Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation|Completed||Phase 2|251|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 13:36:57.702695|2017-02-18 13:36:57.702695
NCT00807027|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2012-10-24|||December 2008||2008-12-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea|Multi-center, Randomized, Open-label Phase 3 Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea|Completed||Phase 3|180|Actual|Green Cross Cell Corporation||2|||f||||f||||||||||2017-02-18 13:36:57.985837|2017-02-18 13:36:57.985837
NCT00807014|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2012-03-15|2011-11-23||November 2006||2006-11-01|February 2012|2012-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne|Single-blind, Multicenter, Parallel, Comparative, Randomized, Phase 4 Clinical Trial for the Evaluation of the Quality of Life, Efficacy and Tolerance of Duac® Gel Against Differin® Gel in the Topical Treatment of Mild to Moderate Acne Vulgaris.|Completed||Phase 4|169|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:36:58.106443|2017-02-18 13:36:58.106443
NCT00807001|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-08-18|2010-10-08||December 2008||2008-12-01|August 2016|2016-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects|A Phase I/II, Double-Blind, Dose-Escalation Study to Evaluate the Safety and Antiviral Activity of IDX184 in Treatment-Naïve Subjects Infected With Genotype 1 Chronic Hepatitis C|Completed||Phase 1/Phase 2|41|Actual|Merck Sharp & Dohme Corp.|Adverse events summarized the 3 days of IDX184 dosing and 14 days of treatment free follow up.|4|||f||||f||||||||||2017-02-18 13:36:58.966714|2017-02-18 13:36:58.966714
NCT00806988|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-10-02|||December 2008||2008-12-01|October 2015|2015-10-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Comparing the Effectiveness of a Mitral Valve Repair Procedure in Combination With Coronary Artery Bypass Grafting (CABG) Versus CABG Alone in People With Moderate Ischemic Mitral Regurgitation|Surgical Interventions for Moderate Ischemic Mitral Regurgitation|Completed||Phase 2|301|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 13:36:59.786376|2017-02-18 13:36:59.786376
NCT00806975|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2008-12-10|||January 2009||2009-01-01|December 2008|2008-12-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic Patients|Randomized，Open-Label，2-Period，Crossover Comparison of Randomized，Open-Label，2-Period，Crossover Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Adult Patients With Type 2 Diabetes Mellitus|Unknown status|Not yet recruiting|N/A|200|Anticipated|Nagaoka Red Cross Hospital||1|||f||||f||||||||||2017-02-18 13:36:59.928874|2017-02-18 13:36:59.928874
NCT00806962|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-05-05|||November 2008||2008-11-01|May 2015|2015-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase 1 Norwalk Vaccine Study|Randomized Double-Blind Placebo-Controlled Phase 1, Safety and Immunogenicity Study of Two Dosages of Intranasal Norwalk Virus-like Particle Vaccine ( Norwalk VLP Antigen, MPL®, Chitosan, Mannitol, and Sucrose) Compared to Adjuvant/Excipients (MPL®, Chitosan, Mannitol, and Sucrose) and to Placebo (Empty Device|Completed||Phase 1|61|Actual|Takeda||4|||f||||t||||||||||2017-02-18 13:37:00.04048|2017-02-18 13:37:00.04048
NCT00806936|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-10-26|||December 2008||2008-12-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects|A 16-week Multicentre, Open Label, Non-interventional, Observational Study to Investigate the Status of Human Insulin or Insulin Analogue Treatments With Focusing on Efficacy and Safety in Type 2 Diabetes Subjects Inadequately Controlled With Two or More Oral Antidiabetic Drugs in China|Completed||N/A|4847|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 13:37:00.13713|2017-02-18 13:37:00.13713
NCT00806923|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-11-01|||February 2005||2005-02-01|November 2016|2016-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)|A Randomized, Double-blind Study of the Effect of Avastin Plus Cisplatin and Gemcitabine or Placebo Plus Cisplatin and Gemcitabine on Progression-free Survival in Treatment-naïve Patients With Advanced or Recurrent Non-squamous NSCLC|Completed||Phase 3|1044|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 13:37:00.245814|2017-02-18 13:37:00.245814
NCT00806910|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-06-22|||October 2008||2008-10-01|June 2011|2011-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion|Evaluation of the Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion|Withdrawn||Phase 4|0|Actual|Albert Einstein Healthcare Network||2||Sponsor support withdrawn|f||||f||||||||||2017-02-18 13:37:00.596258|2017-02-18 13:37:00.596258
NCT00806897|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-11-22|||January 2009||2009-01-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|LITHULEV1||Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®|Prospective, Multicentre, Open Label, Non-controlled, 24-week Observation in Type 2 Diabetics Using Once Daily Levemir® (Insulin Detemir) as Part of Their ITT Regimen|Completed||N/A|74|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:37:00.712687|2017-02-18 13:37:00.712687
NCT00806884|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-06-04|||June 2008||2008-06-01|December 2008|2008-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Do Physiotherapy Techniques Improve Posture During Admission for a Chest Infection in Adults With Cystic Fibrosis?|Do Physiotherapy Joint and Muscle Movement (Musculoskeletal) Techniques Improve Posture, Pain, Sputum Clearance, Lung Function or Quality of Life During Admission for a Respiratory Exacerbation in Adults With Cystic Fibrosis?|Completed||N/A|50|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 13:37:00.819174|2017-02-18 13:37:00.819174
NCT00806871|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2012-04-03|||November 2008||2008-11-01|March 2011|2011-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Steroid Injection Treatment of Carpal Tunnel Syndrome|Local Steroid Injection in the Treatment of Idiopathic Carpal Tunnel Syndrome: A Randomized Double-blind Placebo-controlled Trial Among Patients Planned for Surgical Treatment|Completed||Phase 2/Phase 3|112|Actual|Region Skane||3|||f||||t||||||||||2017-02-18 13:37:00.93547|2017-02-18 13:37:00.93547
NCT00805805|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2013-01-25|||April 2006||2006-04-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis|Phase III Trial of Tetrathiomolybdate (TM) in Primary Biliary Cirrhosis|Completed||Phase 3|29|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 13:37:28.22982|2017-02-18 13:37:28.22982
NCT00806858|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-11-22|||November 2008||2008-11-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus|NovoPen®4 Clinical Experience Programme: A Multicentre, Observational Study of NovoPen®4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus|Completed||N/A|526|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:37:01.064476|2017-02-18 13:37:01.064476
NCT00806845|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-05-12|||July 2008||2008-07-01|May 2015|2015-05-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Observational|||Examination of B Cell Responses in Human Blood|Gewinnung Humaner antikörperproduzierender Zellen Aus Dem Blut|Completed||N/A|50|Actual|Regenerative Medicine Network|||5||f||||t||||||Samples Without DNA|"~     peripheral blood~   "|||2017-02-18 13:37:01.162398|2017-02-18 13:37:01.162398
NCT00806832|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2015-07-06|||December 2008||2008-12-01|July 2015|2015-07-01|March 2010|Actual|2010-03-01|April 2009|Actual|2009-04-01||Observational|||The Effects of Medical Clowning on Blood Pressure and Pulse Rate of Patients Undergoing Cataract Surgery Under Local Anesthesia|The Effects of Medical Clowning on Blood Pressure and Pulse Rate of Patients Undergoing Cataract Surgery Under Local Anesthesia|Completed||N/A|100|Anticipated|HaEmek Medical Center, Israel|||2||f||||f||||||||||2017-02-18 13:37:01.260305|2017-02-18 13:37:01.260305
NCT00806819|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-12-08|2014-11-14||December 2008||2008-12-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|June 2011|Actual|2011-06-01||Interventional||Randomised set uncut (RS): all patients who were randomised whether patients had received study treatment or not. Patients were allocated to the treatment groups as randomised, regardless of the actual medication taken.|Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC|Multicenter, Randomized, Double-blind, Phase III Trial to Investigate the Efficacy and Safety of Oral BIBF 1120 Plus Standard Pemetrexed Therapy Compared to Placebo Plus Standard Pemetrexed Therapy in Patients With Stage IIIB/IV or Recurrent Non Small Cell Lung Cancer After Failure of First Line Chemotherapy|Completed||Phase 3|718|Actual|Boehringer Ingelheim|Recruitment for the study was stopped early based on the results of a pre defined futility analysis.|5|||f||||||||||||||2017-02-18 13:37:01.365897|2017-02-18 13:37:01.365897
NCT00806806|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2010-08-31||2010-08-25|October 2008||2008-10-01|August 2010|2010-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|TTO||Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers|A Phase 1 Randomized, Single-blind, Sequential Cohort, Crossover Study to Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers|Completed||Phase 1|128|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 13:37:05.45162|2017-02-18 13:37:05.45162
NCT00806780|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2008-12-10|||June 2003||2003-06-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Role of Routine on-Table Cholangiography in Laparoscopic Cholecystectomy|Is There a Role for Routine Intraoperative Cholangiography During Laparoscopic Cholecystectomy|Completed||N/A|200|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:37:05.558273|2017-02-18 13:37:05.558273
NCT00806767|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-05-14|||March 2007||2007-03-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer|Phase II Study of Allogeneic Transplant of Hematopoietic Stem Cells From a Compatible Family Donor in the Treatment of Patients Over 55 Years With Hematological Malignancies|Completed||Phase 2|82|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:37:05.647902|2017-02-18 13:37:05.647902
NCT00806754|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-11-22|||November 2006||2006-11-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)|Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy|Completed||Phase 4|340|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:37:05.762204|2017-02-18 13:37:05.762204
NCT00806741|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2012-11-29|||September 2009||2009-09-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|March 2010|Actual|2010-03-01||Interventional|||Role of Nitric Oxide in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy Humans|Role of Nitric Oxide in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy Humans|Completed||N/A|18|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-02-18 13:37:05.901249|2017-02-18 13:37:05.901249
NCT00806728|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2008-12-10|||May 1998||1998-05-01|December 2008|2008-12-01|December 1998|Actual|1998-12-01|November 1998|Actual|1998-11-01||Interventional|||Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease|Phase I Study of MEDI-507 in the Treatment of Adult Patients With at Least Grade II Steroid-Resistant Acute Graft-Versus-Host Disease|Completed||Phase 1|17|Actual|MedImmune LLC||2|||f||||||||||||||2017-02-18 13:37:06.00672|2017-02-18 13:37:06.00672
NCT00806715|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-06-22|||February 2007||2007-02-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Iron Overload in Stem Cell Transplant Recipients|Impact of Iron Overload in Pediatric Patients Undergoing Stem Cell Transplantation|Completed||N/A|38|Actual|Boston Children’s Hospital|||1||f||||f||||||Samples With DNA|"~     Peripheral blood specimens.~   "|||2017-02-18 13:37:06.111821|2017-02-18 13:37:06.111821
NCT00806689|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2010-07-01|||July 2007||2007-07-01|December 2008|2008-12-01|July 2011|Anticipated|2011-07-01|December 2008|Anticipated|2008-12-01||Observational|||Full Disclosure Observational Cardiac Rhythm Documentation Follow-up After Surgical Atrial Fibrillation Therapy||Unknown status|Recruiting|N/A|100|Anticipated|University of Luebeck|||1||f||||f||||||||||2017-02-18 13:37:06.204159|2017-02-18 13:37:06.204159
NCT00806676|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2015-08-31|||December 2008||2008-12-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease|Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease|Completed||N/A|67|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-02-18 13:37:06.315673|2017-02-18 13:37:06.315673
NCT00806663|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2012-09-07|||August 2008||2008-08-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|July 2010|Actual|2010-07-01||Interventional|||FOLFIRI and Sunitinib in Metastatic Colorectal Cancer|A Prospective Angiogenic Imaging Study With DCE-MRI and DCE-USI in Patients With Colorectal Cancer and Liver Metastases Receiving Sunitinib in Addition to 5-FU, Folinic Acid and Irinotecan (FOLFIRI) as 1st Line Therapy|Completed||Phase 2|22|Anticipated|Central European Society for Anticancer Drug Research||1|||f||||f||||||||||2017-02-18 13:37:06.426243|2017-02-18 13:37:06.426243
NCT00806650|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-10-13|||July 2008||2008-07-01|October 2016|2016-10-01||||October 2017|Anticipated|2017-10-01||Interventional|||Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer|Development of a Blood Test of Anti-IMP3 Autoantibody and Serum MicroRNA Signature for the Detection of Renal Cell Carcinoma With Metastasis and Metastatic Potential|Active, not recruiting||N/A|230|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:37:06.539115|2017-02-18 13:37:06.539115
NCT00806637|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2008-12-10|||October 2008||2008-10-01|October 2008|2008-10-01|September 2009|Anticipated|2009-09-01|May 2009|Anticipated|2009-05-01||Interventional|||Vessel Sealing System Uvulopalatoplasty Versus Uvulopalatal Flap|Vessel Sealing System Uvulopalatoplasty vs Uvulopalatal Flap: a Randomized, Control Study of Efficacy and Adverse Effects|Unknown status|Enrolling by invitation|N/A|30|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-02-18 13:37:06.650603|2017-02-18 13:37:06.650603
NCT00806624|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-01-15|2015-01-15||October 2007||2007-10-01|January 2015|2015-01-01|November 2009|Actual|2009-11-01|October 2008|Actual|2008-10-01||Interventional|||DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation|A Phase 2, Randomized, Parallel Group, Multi-Center, Multi-National Study for the Evaluation of Safety and Efficacy of Two Fixed Dosages of DU-176b in Subjects With Non-Valvular Atrial Fibrillation|Completed||Phase 2|234|Actual|Daiichi Sankyo Inc.||3|||f||||t||||||||||2017-02-18 13:37:06.779072|2017-02-18 13:37:06.779072
NCT00806611|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-10-19|||September 2008||2008-09-01|October 2016|2016-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer|A Randomized, Controlled Trial of Intraoperative Celiac Plexus Neurolysis for Patients With Operable (Resectable and Unresectable) Pancreatic and Periampullary Cancer|Completed||Phase 3|438|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 13:37:07.611638|2017-02-18 13:37:07.611638
NCT00806598|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2013-03-08|2013-01-30||May 2005||2005-05-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome|Phase II Study of Combination of Thymoglobulin, Cyclosporine, Methylprednisone, and Granulocyte Colony-stimulating Factor (GCSF) in Patients With Newly Diagnosed Aplastic Anemia or With Hypoplastic or Low/Intermediate-1 Risk Myelodysplastic Syndrome|Completed||Phase 2|53|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:37:07.917374|2017-02-18 13:37:07.917374
NCT00806585|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2015-09-18|2013-10-18||December 2008||2008-12-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)|A Worldwide, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy & Tolerability of MK0736 When Added to Ongoing Therapy With Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) in Patients With T2DM and Hypertension|Terminated||Phase 2|620|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 13:37:08.185084|2017-02-18 13:37:08.185084
NCT00806572|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2017-02-06|||May 2002||2002-05-01|February 2017|2017-02-01|August 2007|Actual|2007-08-01|July 2004|Actual|2004-07-01||Interventional|||Treatment With hOKT3gamma1(Ala-Ala) in T1DM|Phase II Multiple Dose Treatment of Type 1 Diabetes Mellitus With hOKT3gamma1(Ala-Ala)|Terminated||Phase 2|10|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2||Adverse events related to drug lot|f||||t||||||||Yes|Data access is provided to the public in Participant level data and additional relevant materials are available to the public in : 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools available to researchers; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal that makes data from the consortium's clinical trials publicly available.|2017-02-18 13:37:09.092512|2017-02-18 13:37:09.092512
NCT00806559|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2011-12-13|||July 2007||2007-07-01|December 2011|2011-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|SIT||Space and Interaction Trial: Room Design and Patient-physician Interaction|SIT Trial: The Effect of Clinical Room Design on the Quality of the Clinical Encounter|Completed||N/A|60|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-02-18 13:37:09.204991|2017-02-18 13:37:09.204991
NCT00806546|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2016-02-02|2013-02-15||February 2009||2009-02-01|February 2016|2016-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|NP101-009|Patients were asked to use study patches to treat migraine episodes with mild to severe headache pain for up to 12 months. The safety population included all subjects who applied at least one NP101 patch. Of the 514 subjects enrolled, 35 subjects did not treat for a total of 479 subjects in the safety population.|An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months|An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months|Completed||Phase 3|514|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 13:37:09.300883|2017-02-18 13:37:09.300883
NCT00806533|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-10|2009-05-15|||May 2006||2006-05-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Non-Interventional (Observational) Post-Authorization Safety Study of HES 130/0.42 in Paediatric Patients|Infusion of Venofundin 6% or Tetraspan 6% in Paediatric Patients Aged up to 12 Years|Completed||N/A|1130|Actual|B. Braun Melsungen AG|||1||f||||f||||||||||2017-02-18 13:37:09.566777|2017-02-18 13:37:09.566777
NCT00806520|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2015-11-30|||April 2008||2008-04-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control|Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control Addendum to: A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Long-Acting Release to Those of Sitagliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus Treated With Metformin (Study BCB106)|Completed||N/A|16|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-02-18 13:37:09.67322|2017-02-18 13:37:09.67322
NCT00806507|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-07-19|||November 2008||2008-11-01|July 2012|2012-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients|Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients|Completed||N/A|45|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:37:09.762974|2017-02-18 13:37:09.762974
NCT00806494|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2011-01-04|2011-01-04||February 2009||2009-02-01|January 2011|2011-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|SAFINA||UK Study Assessing Flexible Dose Fesoterodine in Adults|A 12 Week, Multi-centre, Open Label Study To Evaluate The Efficacy, Tolerability And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Overactive Bladder.|Completed||Phase 4|331|Actual|Pfizer|This was a single arm, non-comparative study. Hence no formal hypothesis testing was performed, and assessment of efficacy was based on changes from baseline in efficacy endpoints.|1|||f||||f||||||||||2017-02-18 13:37:09.879907|2017-02-18 13:37:09.879907
NCT00806481|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2011-11-22|||February 2009||2009-02-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease|Does Phosphate Binding With Sevelamer Carbonate Improve Cardiovascular Structure and Function in Patients With Early Chronic Kidney Disease?|Completed||Phase 2|120|Actual|University Hospital Birmingham NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:37:10.605387|2017-02-18 13:37:10.605387
NCT00806468|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2010-12-17|||February 2009||2009-02-01|June 2010|2010-06-01|February 2011|Anticipated|2011-02-01|December 2010|Anticipated|2010-12-01||Interventional|DEPOPA||Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease|A Double Blind, Placebo Controlled, Randomized, Monocentre Cross-over Study to Investigate the Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease|Terminated||Phase 4|1|Actual|Johannes Gutenberg University Mainz||1||lack of recruitment|f||||f||||||||||2017-02-18 13:37:10.714933|2017-02-18 13:37:10.714933
NCT00806455|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2013-11-18|||July 2008||2008-07-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Exercise-Induced Bronchospasm in Cystic Fibrosis|Exercise-Induced Bronchospasm in Cystic Fibrosis|Completed||N/A|14|Actual|Ohio State University|||1||f||||f||||||Samples Without DNA|"~     blood, sputum~   "|||2017-02-18 13:37:10.817792|2017-02-18 13:37:10.817792
NCT00806442|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2010-05-03|||December 2008||2008-12-01|May 2010|2010-05-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Treatment of Bronchial Asthma With Borage and Echium Seed Oils|Treatment of Bronchial Asthma With Borage and Echium Seed Oils|Unknown status|Recruiting|Phase 1/Phase 2|28|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:37:10.910021|2017-02-18 13:37:10.910021
NCT00806429|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-08|||August 2008||2008-08-01|December 2008|2008-12-01||||December 2009|Anticipated|2009-12-01||Interventional|||Transvaginal Appendectomy|Transvaginal Appendectomy|Unknown status|Recruiting|N/A|20|Anticipated|Yale University||2|||f||||f||||||||||2017-02-18 13:37:11.032278|2017-02-18 13:37:11.032278
NCT00806416|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2015-10-01|2010-01-08||May 2003||2003-05-01|October 2015|2015-10-01|January 2004|Actual|2004-01-01|August 2003|Actual|2003-08-01||Interventional|||A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D|A 2-Part, Open-Label, Randomized, Crossover Study to Evaluate the Bioequivalence of the 70 mg Alendronate/2800 IU Vitamin D3 Final Market Combination Tablet to a 70 mg Alendronate Marketed Tablet, and the Relative Bioavailability of Vitamin D3|Completed||Phase 1|244|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:37:11.135529|2017-02-18 13:37:11.135529
NCT00806403|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2008-12-02|2008-11-07||November 2001||2001-11-01|November 2008|2008-11-01|June 2004|Actual|2004-06-01|June 2003|Actual|2003-06-01||Interventional|SWEDES||Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction|Very Early Initiation of Treatment With Thrombolysis and Low Molecular Weight Heparin, Versus Abciximab and Low Molecular Weight Heparin Followed by Percutaneous Coronary Intervention, for Acute ST-Elevation Myocardial Infarction|Completed||Phase 4|205|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||t||||||||||2017-02-18 13:37:11.633614|2017-02-18 13:37:11.633614
NCT00806390|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2014-06-20|2014-05-19||July 2008||2008-07-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol|GCC0766: Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol|Terminated||Phase 4|15|Actual|University of Maryland||2||Poor enrollment|f||||t||||||||||2017-02-18 13:37:12.124014|2017-02-18 13:37:12.124014
NCT00806377|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2013-05-09|||December 2008||2008-12-01|May 2013|2013-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|Dinosur||Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures|Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures|Completed||N/A|100|Actual|Minneapolis Heart Institute Foundation|||1||f||||f||||||||||2017-02-18 13:37:12.480124|2017-02-18 13:37:12.480124
NCT00806364|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2017-01-24|||December 8, 2008||2008-12-08|December 7, 2016|2016-12-07||||||||Observational|||Normal Blood, Bone Marrow and Buccal Mucosa Protocol|Normal Blood, Bone Marrow and Buccal Mucosa Protocol|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:37:12.578499|2017-02-18 13:37:12.578499
NCT00806351|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2012-11-20|2012-11-20||August 2009||2009-08-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System|Efficacy And Safety Of Eraxis/Ecalta (Anidulafungin) Compared To Cancidas (Caspofungin) In Neutropenic Patients With Invasive Candida Infection|Terminated||Phase 3|21|Actual|Pfizer|Study prematurely terminated due to slow enrollment, not due to safety issues. Meaningful interpretation and comparison of treatment outcomes with caspofungin was difficult due to low number of participants (n=3) with confirmed Candida infection.|2||"The study was prematurely terminated on May 18, 2012 due to slow enrollment. The study was not~   terminate due to any safety issues or concerns."|f||||t||||||||||2017-02-18 13:37:12.696337|2017-02-18 13:37:12.696337
NCT00806338|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2009-04-14|||November 2008||2008-11-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers|A Phase I, Double-Blind, Randomized, Placebo-Controlled Ascending IV Multiple Dose Tolerance and Pharmacokinetic Study of Trodusquemine (MSI-1436) in Obese or Overweight Type 2 Diabetic Volunteers|Completed||Phase 1|22|Actual|Genaera Corporation||4|||f||||f||||||||||2017-02-18 13:37:13.483357|2017-02-18 13:37:13.483357
NCT00806325|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2017-01-30|||November 2007||2007-11-01|January 2017|2017-01-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Observational|AML||Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia|Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia|Completed||N/A|120|Actual|Ohio State University|||1||f||||f||||||Samples With DNA|"~     baseline blood sample drawn (2 tablespoons or 30 ml) at the beginning of the study. If~     subjects experience a fever another blood sample (10 ml up to 2 times) will be drawn at that~     time.~   "|No||2017-02-18 13:37:13.587799|2017-02-18 13:37:13.587799
NCT00806312|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2014-03-27|||July 2008||2008-07-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||The Expression and Significance of MiRNA|The Expression and Significance of miRNA Profile and Markers of Inflammation in Patients With Pulmonary Arterial Hypertension|Unknown status|Recruiting|N/A|200|Anticipated|Ohio State University|||2||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 13:37:13.684136|2017-02-18 13:37:13.684136
NCT00806299|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2011-10-04|||November 2008||2008-11-01|October 2011|2011-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Loperamide Grapefruit Juice Interaction PK Trial|An Open Label, Randomized, Single-dose, Fixed-Sequence Crossover Drug Interaction Study of Loperamide HCL With Grapefruit Juice|Completed||Phase 1|33|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-02-18 13:37:13.771192|2017-02-18 13:37:13.771192
NCT00806286|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2013-03-15||2013-03-11|December 2008||2008-12-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer|Phase 2 Randomized Study of Carboplatin/Paclitaxel With or Without CS-7017 in Chemotherapy-Naïve Subjects With Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|111|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:37:13.869308|2017-02-18 13:37:13.869308
NCT00806273|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2009-10-07|||January 2009||2009-01-01|October 2009|2009-10-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||An in Vivo Comparison of the Debridement Efficiency of Needle Irrigation Versus Ultrasonic Irrigation|An in Vivo Comparison of the Debridement Efficacy of Needle Irrigation and Ultrasonic Root Canal Irrigation Techniques|Withdrawn||N/A|30|Anticipated|Oregon Health and Science University||2||Manufacturer changed device so no study will be done; ie it was never started|f||||f||||||||||2017-02-18 13:37:14.188315|2017-02-18 13:37:14.188315
NCT00806260|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2013-08-01|2012-07-31||December 2008||2008-12-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.|A Phase 2, Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Psychomotor Effect of VI-0521 in Healthy Overweight and Obese Subjects.|Completed||Phase 2|80|Actual|VIVUS, Inc.|Due to technical issues, an additional cohort of subjects were added to Period 1 only, which produced two additional treatment arms, alcohol only and alcohol placebo only. No change was made in the data analysis.|4|||f||||f||||||||||2017-02-18 13:37:14.276478|2017-02-18 13:37:14.276478
NCT00806247|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-05-17|||January 2005||2005-01-01|April 2010|2010-04-01|August 2005|Actual|2005-08-01|||||Interventional|||A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of Tapentadol IR for Postoperative Pain Following Bunionectomy Surgery|A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of CG5503 (Tapentadol) IR for Postoperative Pain Following Bunionectomy Surgery|Completed||Phase 2|480|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:37:14.932402|2017-02-18 13:37:14.932402
NCT00806234|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2014-05-15|||January 2009||2009-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|IMPACT||Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics|Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)|Completed||Phase 4|127|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 13:37:15.027517|2017-02-18 13:37:15.027517
NCT00806221|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2008-12-09|||November 2006||2006-11-01|December 2008|2008-12-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Interventional|||Eczema Prevention Study|An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis|Unknown status|Recruiting|Phase 2|25|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 13:37:15.159581|2017-02-18 13:37:15.159581
NCT00806208|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2008-12-10|||January 1999||1999-01-01|December 2008|2008-12-01|March 2000|Actual|2000-03-01|January 2000|Actual|2000-01-01||Interventional|||Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD)|Phase I Evaluation of Safety, Pharmacokinetics and Activity of Escalating Dose Levels of MEDI 507 in Patients Receiving Methylprednisolone for Initial Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD)|Completed||Phase 1|34|Actual|MedImmune LLC||5|||f||||||||||||||2017-02-18 13:37:15.267155|2017-02-18 13:37:15.267155
NCT00806195|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2013-05-13|2013-05-13||December 2008||2008-12-01|May 2013|2013-05-01|November 2011|Actual|2011-11-01|March 2011|Actual|2011-03-01||Interventional|||Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants|A Phase 3b, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants|Completed||Phase 3|7744|Actual|Novartis||6|||f||||||||||||||2017-02-18 13:37:15.393315|2017-02-18 13:37:15.393315
NCT00806182|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2014-01-24|||January 2008||2008-01-01|January 2014|2014-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|OMS||Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome|Cytokines as Biomarkers and Therapeutic Targets in Paraneoplastic Opsoclonus-Myoclonus Syndrome (OMS)|Unknown status|Recruiting|N/A|400|Anticipated|National Pediatric Myoclonus Center|||2||f||||f||||||Samples Without DNA|"~     serum, plasma, cerebrospinal fluid~   "|||2017-02-18 13:37:16.632127|2017-02-18 13:37:16.632127
NCT00806169|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-09-26|||April 2006||2006-04-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Combined Triple Therapy in Diabetic Retinopathy (DRP)|Intravitreal Combination Therapy Using Triamcinolone and Bevacizumab Improves Vision in Patients With Diabetic Retinopathy|Completed||Phase 3|40|Actual|Johann Wolfgang Goethe University Hospital||3|||f||||f||||||||||2017-02-18 13:37:16.734471|2017-02-18 13:37:16.734471
NCT00806156|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-08-12||2014-08-12|October 2008||2008-10-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer|A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Platinum-Resistant Ovarian Cancer|Completed||Phase 2|178|Actual|Nektar Therapeutics||2|||f||||f||||||||||2017-02-18 13:37:16.835807|2017-02-18 13:37:16.835807
NCT00806143|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-02-23|||September 2008||2008-09-01|February 2011|2011-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression|Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression|Completed||Phase 4|16|Actual|Institute of Neuroscience, Florence, Italy||2|||f||||t||||||||||2017-02-18 13:37:16.953341|2017-02-18 13:37:16.953341
NCT00804440|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-03-15|||January 2004||2004-01-01|March 2012|2012-03-01||||January 2004|Actual|2004-01-01||Interventional|||Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions|A Randomized, Single-Dose, Two-Way Crossover Relative Bioavailability Study of Ibuprofen Tablet Formulations in Fasted Normal, Healthy Subjects|Completed||Phase 1|30|Actual|Perrigo Company||2|||f||||||||||||||2017-02-18 13:37:17.058396|2017-02-18 13:37:17.058396
NCT00804427|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-05-21|||December 2008||2008-12-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|||Effect of Fish Oil on Plasma Triglycerides in Adults|Effect of Fish Oil as an Ethyl Ester or Triglyceride Preparation on Plasma Triglycerides in Hypertriglyceridemic Adults|Completed||Phase 2|60|Actual|Stanford University||4|||f||||||||||||||2017-02-18 13:37:17.143145|2017-02-18 13:37:17.143145
NCT00804414|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2010-01-25|||October 2008||2008-10-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers|A Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Soluble Beta-1,3/1,6-glucan (SBG) in Chronic Foot Ulcers in Patients With Diabetes|Completed||Phase 3|133|Actual|Biotec Pharmacon ASA||2|||f||||f||||||||||2017-02-18 13:37:17.231593|2017-02-18 13:37:17.231593
NCT00804401|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-03-15|||June 2004||2004-06-01|March 2012|2012-03-01||||July 2004|Actual|2004-07-01||Interventional|||Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Two Oral Formulations of Naproxen 500 mg Tablets Administered as 1 x 500 mg Tablet in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|34|Actual|Perrigo Company||2|||f||||||||||||||2017-02-18 13:37:17.539135|2017-02-18 13:37:17.539135
NCT00804388|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2011-01-06|||December 2008||2008-12-01|January 2011|2011-01-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Wear Measurements of E-Poly in an Uncemented THA With Either 32 or 36 mm Caput of Ceramics.|Comparing Polyethylene Wear Using 3. Generation Highly Crosslinked Polyethylene in an Uncemented Total Hip Prostheses With Either 32 mm or 36 mm Caput of Ceramics|Unknown status|Active, not recruiting|N/A|50|Anticipated|Lovisenberg Diakonale Hospital||2|||f||||f||||||||||2017-02-18 13:37:17.630923|2017-02-18 13:37:17.630923
NCT00804375|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2010-03-22|||December 2008||2008-12-01|March 2010|2010-03-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain|Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain.|Unknown status|Recruiting|Phase 2|150|Anticipated|Smerud Medical Research International AS||2|||f||||f||||||||||2017-02-18 13:37:17.745443|2017-02-18 13:37:17.745443
NCT00804362|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-07-29|||December 2008||2008-12-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Validation of the Sickle Cell Disease Pain Burden Interview||Completed||N/A|131|Actual|Connecticut Children's Medical Center|||1||f||||||||||||||2017-02-18 13:37:17.85964|2017-02-18 13:37:17.85964
NCT00804349|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-02-13|||October 2008||2008-10-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|ARIA-II||Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure Patients|Apnea Rampant In Acute Decompensated Heart Failure II|Completed||Phase 4|6|Actual|Albert Einstein Healthcare Network||2|||f||||f||||||||||2017-02-18 13:37:17.936112|2017-02-18 13:37:17.936112
NCT00804336|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-10-18|||October 2008||2008-10-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|September 2014|Actual|2014-09-01||Interventional|||Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors|Phase I Study of Pasireotide (SOM230) in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors|Completed||Phase 1|22|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:37:18.040902|2017-02-18 13:37:18.040902
NCT00804323|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-06|||December 2007||2007-12-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||PASCAL Trabeculoplasty|Semi-Automated Patterned Laser Trabeculoplasty|Unknown status|Recruiting|Phase 4|24|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||t||||||||||2017-02-18 13:37:18.168748|2017-02-18 13:37:18.168748
NCT00804310|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-03-27|||August 2009||2009-08-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|UCDCC#207||Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors|Phase I Study of Lapatinib (GW572016) in Combination With Weekly Ixabepilone (BMS 247550) in Advanced Solid Tumors|Terminated||Phase 1|5|Actual|University of California, Davis||1||Lack of funding|f||||t||||||||||2017-02-18 13:37:18.266076|2017-02-18 13:37:18.266076
NCT00804297|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-05|||June 2005||2005-06-01|December 2008|2008-12-01|January 2007||2007-01-01|||||Interventional|||Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia|Comparison of Octreotide and Standard Therapy vs. Standard Therapy Alone for the Treatment of Hypoglycemia in Patients Taking Sulfonylureas or a Combination of Insulin and Sulfonylureas Presenting to the Emergency Department|Completed||Phase 3|40||Albert Einstein Healthcare Network|||||f||||||||||||||2017-02-18 13:37:18.389109|2017-02-18 13:37:18.389109
NCT00804284|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-08-17|||September 2008||2008-09-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Observational|||Database Surveillance Safety Study of PENTACEL® Vaccine|Post-Licensure Safety Surveillance Study of Routine Use of PENTACEL® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine|Completed||N/A|62538|Actual|Sanofi|||2||f||||f||||||||||2017-02-18 13:37:18.490873|2017-02-18 13:37:18.490873
NCT00804271|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-02-21|||December 2008||2008-12-01|February 2013|2013-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Memantine and Validation of a New Alzheimer's Disease Scale|Open Label, Single-Arm, Multi-Centre, Study to Validate a New Alzheimer's Disease Scale in Patients With DAT, Treated With Memantine|Completed||Phase 3|487|Actual|Merz Pharmaceuticals GmbH||1|||f||||f||||||||||2017-02-18 13:37:18.618659|2017-02-18 13:37:18.618659
NCT00804258|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-11-04|||August 2007||2007-08-01|November 2015|2015-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer|Integration of Palliative Care in Use of Intra-Peritoneal Chemotherapy for Ovarian Cancer|Completed||N/A|17|Actual|City of Hope Medical Center|||1||f||||t||||||||||2017-02-18 13:37:18.733511|2017-02-18 13:37:18.733511
NCT00804245|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-09-29|||August 2008||2008-08-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|June 2012|Actual|2012-06-01||Interventional|||C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer|A Pilot Study of Use of 11C-Choline PET-CT in the Metastatic Evaluation of Patients With Newly Diagnosed High Risk Adenocarcinoma of the Prostate|Completed||Phase 1|18|Actual|Wake Forest University Health Sciences||1|||f||||t||||||||||2017-02-18 13:37:18.837434|2017-02-18 13:37:18.837434
NCT00804232|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-05|||January 2008||2008-01-01|December 2008|2008-12-01|December 2015|Anticipated|2015-12-01|September 2010|Anticipated|2010-09-01||Interventional|||Childhood Diabetes|Childhood Diabetes - Family Based Health Interventions for Child Health|Unknown status|Recruiting|N/A|210|Anticipated|Vardalinstitutet The Swedish Institute for Health Sciences||2|||f||||f||||||||||2017-02-18 13:37:18.952592|2017-02-18 13:37:18.952592
NCT00804219|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2011-07-20|||December 2008||2008-12-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination|Characterization of Humoral and Cellular Immunity of Low and High-responders After TBE Vaccination|Completed||Phase 4|67|Actual|Medical University of Vienna||3|||f||||||||||||||2017-02-18 13:37:19.065371|2017-02-18 13:37:19.065371
NCT00804206|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-05|||July 2008||2008-07-01|December 2008|2008-12-01||||July 2008|Anticipated|2008-07-01||Interventional|||Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation|Phase 4 Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation|Unknown status|Recruiting|Phase 4|15|Anticipated|Asociación para Evitar la Ceguera en México||2|||f||||||||||||||2017-02-18 13:37:19.170262|2017-02-18 13:37:19.170262
NCT00806130|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2008-12-09|||September 2008||2008-09-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients|Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients, a Cross-Sectional Study|Completed||N/A|40|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 13:37:19.266845|2017-02-18 13:37:19.266845
NCT00806117|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-03-13|||February 2008||2008-02-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Comparison of Post-surgery Adjuvant Therapy for Cervical Carcinoma|Comparison of Different Adjuvant Treatments Following Radical Surgery in Early Stage Cervical Carcinoma|Recruiting||Phase 3|990|Anticipated|Sun Yat-sen University||3|||f||||t||||||||||2017-02-18 13:37:19.348352|2017-02-18 13:37:19.348352
NCT00806104|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2011-01-14|||March 2009||2009-03-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Fructo-oligosaccharides and Irritable Bowel Syndrome|Effect of Dietary Supplementation With Fructo-oligosaccharides on Visceral Sensitivity and on Taxonomic and Functional Composition of Intestinal Microbiota of IBS Patients|Completed||N/A|60|Anticipated|Beghin-Meiji||2|||f||||||||||||||2017-02-18 13:37:19.474233|2017-02-18 13:37:19.474233
NCT00806091|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2008-12-09|||July 2004||2004-07-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Observational|||Functional Proteomics of Alveolar Macrophages|Functional Proteomics of Alveolar Macrophages|Completed||N/A|72|Actual|Ohio State University|||1||f||||f||||||Samples With DNA|"~     blood BAL fluid breathe condensation saliva~   "|||2017-02-18 13:37:19.568309|2017-02-18 13:37:19.568309
NCT00806078|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-08-22|2008-12-18||July 2007||2007-07-01|August 2012|2012-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Comparison Bioavailability Study of Quinine Sulfate in Chocolate Pudding|A Comparison of the Bioavailability of Quinine Sulfate Capsules Following a 648 mg Dose When Mixed in Chocolate Pudding Relative to That With Intact Capsules in Healthy Adults Under Fasting Conditions|Completed||Phase 1|18|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 13:37:19.670645|2017-02-18 13:37:19.670645
NCT00806065|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-01-19|||December 2008||2008-12-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Study of ENMD-2076 in Patients With Multiple Myeloma|A Phase 1 Study of ENMD-2076 in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|13|Actual|CASI Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:37:20.076112|2017-02-18 13:37:20.076112
NCT00806052|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-05-26|||February 2006||2006-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:37:20.162321|2017-02-18 13:37:20.162321
NCT00806039|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2009-07-14|||December 2008||2008-12-01|July 2009|2009-07-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|EARLI||Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure|Impact of EArly Renal Involvement on the Developement of Severe In-hospital Renal Failure|Unknown status|Active, not recruiting|N/A|300|Anticipated|Saint Louis VA Medical Center||2|||f||||f||||||||||2017-02-18 13:37:20.221906|2017-02-18 13:37:20.221906
NCT00806026|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-08-27|2012-05-07||December 2008||2008-12-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|RLS||Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients|Randomized, Double Blind, 12-Month Study Of Pregabalin In Subjects With Restless Legs Syndrome|Completed||Phase 3|731|Actual|Pfizer|Names of Daytime Function-Participant Reported Outcome (DF-PRO) and Limb Pain-Numerical Rating Scale (Limb Pain-NRS) were updated to RLS-NDI and Limb Pain-VAS respectively to reflect measurement appropriately.|6|||f||||t||||||||||2017-02-18 13:37:20.341375|2017-02-18 13:37:20.341375
NCT00805792|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-10-04|2012-07-17||November 2008||2008-11-01|October 2012|2012-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|MASTER||Mayo Acute Stroke Trial for Enhancing Recovery|Mayo Acute Stroke Trial for Enhancing Recovery|Completed||Phase 2|33|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 13:37:28.331136|2017-02-18 13:37:28.331136
NCT00806013|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2010-01-26|||August 2008||2008-08-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|||||Observational|||Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide|Study the Effects of CYP2C9 and CYP2C19 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide in Healthy Chinese Subject|Completed||N/A|36|Actual|Chinese Academy of Sciences|||3||f||||f||||||Samples With DNA|"~     The whole blood samples of each person are stored at -80℃.~   "|||2017-02-18 13:37:24.65912|2017-02-18 13:37:24.65912
NCT00806000|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-10-09|||December 2008||2008-12-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Prevalence of Exercise-Induced Asthma in Select Cohorts of College Athletes|Prevalence of Exercise-Induced Asthma in Select Cohorts of College Athletes|Completed||N/A|150|Actual|Ohio State University|||1||f||||t||||||||||2017-02-18 13:37:24.746754|2017-02-18 13:37:24.746754
NCT00805974|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2009-01-13|||October 2005||2005-10-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|DIAPASOM||Study of the Relationship Between Sleep Quality and Daytime-Nighttime Variations of Blood Pressure and Plasma Glucose Type I|Study of the Relationship Between Sleep Quality and Daytime-Nighttime Variations of Blood Pressure and Plasma Glucose Type I|Terminated||N/A|23|Actual|University Hospital, Grenoble||||difficulties for including diabetic patients|f||||f||||||||||2017-02-18 13:37:24.845288|2017-02-18 13:37:24.845288
NCT00805961|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2013-07-01|2012-08-22||January 2009||2009-01-01|August 2012|2012-08-01|May 2013|Actual|2013-05-01|October 2009|Actual|2009-10-01||Interventional|||RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM|A Phase II Study of Concurrent Radiation Therapy, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in the First-line of Treatment of Patients With Glioblastoma Multiforme|Completed||Phase 2|68|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 13:37:24.948666|2017-02-18 13:37:24.948666
NCT00805948|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2017-02-06|||January 2009||2009-01-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|January 2019|Anticipated|2019-01-01||Interventional|THRIVE||Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)|Descending Thoracic Aortic Aneurysm Endovascular Repair Post-approval Study (THRIVE)|Active, not recruiting||N/A|256|Anticipated|Medtronic Endovascular||1|||f||||f||||||||||2017-02-18 13:37:25.492014|2017-02-18 13:37:25.492014
NCT00805935|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-01-26|2011-11-28||January 2009||2009-01-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)|A Multi-Center, Randomized, Open-Label Evaluation of MENOPUR® Versus FOLLISTIM® in Polycystic Ovarian Syndrome (PCOS) Patients|Completed||Phase 4|110|Actual|Ferring Pharmaceuticals||4|||f||||f||||||||||2017-02-18 13:37:25.636985|2017-02-18 13:37:25.636985
NCT00805922|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2016-11-21|||December 2008||2008-12-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|DiabCare Asia||A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand|DiabCare Asia 2008. A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia and To Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in Asia|Completed||N/A|2342|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"~     Capillary or venous blood will be drawn for analysing HbA1c.~   "|||2017-02-18 13:37:26.837815|2017-02-18 13:37:26.837815
NCT00805909|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2009-06-08|||August 2007||2007-08-01|June 2009|2009-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||NI-0401 in Patients With Acute Renal Allograft Rejection|A Phase IIa, Open-Label, Dose-Titration, Multicenter Study to Assess the Safety and Preliminary Efficacy of NI-0401 in Patients With Acute Cellular Renal Allograft Rejection|Completed||Phase 1/Phase 2|12|Anticipated|NovImmune SA||1|||f||||t||||||||||2017-02-18 13:37:26.933006|2017-02-18 13:37:26.933006
NCT00805896|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2008-12-30|||December 2008||2008-12-01|December 2008|2008-12-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma|Effectiveness and Safety Study of TACE Plus Oral Songyou Granule for Unresectable HCC|Unknown status|Active, not recruiting|Phase 2|260|Anticipated|Fudan University||2|||f||||t||||||||||2017-02-18 13:37:27.006591|2017-02-18 13:37:27.006591
NCT00805883|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-05-26|||February 2009||2009-02-01|December 2008|2008-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy|MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy|Completed||Phase 1|10|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 13:37:27.102058|2017-02-18 13:37:27.102058
NCT00805870|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-08-01|2011-08-11||March 2009||2009-03-01|August 2012|2012-08-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers|The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers|Completed||Phase 2|20|Actual|Western Michigan University||2|||f||||f||||||||||2017-02-18 13:37:27.200042|2017-02-18 13:37:27.200042
NCT00805857|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-12-09|||June 2008||2008-06-01|December 2008|2008-12-01||||December 2009|Anticipated|2009-12-01||Observational|||Surveillance Cohort Long-Term Toxicity Antiretrovirals in HIV-Infected Patients Enrolled in TPV Cohort|SCOLTA: SURVEILLANCE COHORT LONG-TERM TOXICITY ANTIRETROVIRALS|Withdrawn||N/A|150|Anticipated|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 13:37:27.696985|2017-02-18 13:37:27.696985
NCT00805844|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2011-07-13|||September 2008||2008-09-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Observational|||Motor Evoked Potentials and SedLine|Monitoring Depth of Anesthesia With the SedLine Facilitates Motor Evoked Potential (MEP) Monitoring During Corrective Spinal Surgery|Terminated||N/A|70|Anticipated|University of California, San Francisco|||2|Sponsor terminated the study|f||||f||||||||||2017-02-18 13:37:27.919977|2017-02-18 13:37:27.919977
NCT00805831|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2010-07-04|||October 2008||2008-10-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Safety and Efficacy of Using HDH Device and Method - a Novel Sutureless Vascular Anastomosis|Safety and Efficacy of Using HDH Device and Method - a Novel Sutureless Vascular Anastomosis|Completed||N/A|10|Anticipated|HDH Medical Ltd||1|||f||||f||||||||||2017-02-18 13:37:28.004693|2017-02-18 13:37:28.004693
NCT00805818|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-05-25|||April 2010||2010-04-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|INTREPID2566||Study of NNZ-2566 in Patients With Traumatic Brain Injury|A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of NNZ-2566 in Patients With Traumatic Brain Injury|Completed||Phase 2|261|Actual|Neuren Pharmaceuticals Limited||2|||f||||t||||||||No||2017-02-18 13:37:28.099761|2017-02-18 13:37:28.099761
NCT00805779|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-06-06|||December 2008||2008-12-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Pulsed Electromagnetic Stimulation for Treatment of Overactive Bladder|Pulsed Electromagnetic Stimulation for Treatment of Overactive Bladder|Terminated||N/A|4|Actual|EMKinetics, Inc||1||Major protocol changes needeed|f||||f||||||||||2017-02-18 13:37:28.658479|2017-02-18 13:37:28.658479
NCT00805766|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-12-05|2012-09-02||December 2008||2008-12-01|December 2012|2012-12-01|July 2010|Actual|2010-07-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)|Clinical Study to Assess the Efficacy and Safety of Increased Dose of TA-650 in Patients With Crohn's Disease (CD)|Completed||Phase 3|39|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-02-18 13:37:28.756017|2017-02-18 13:37:28.756017
NCT00805753|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2014-10-10|||January 2009||2009-01-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|MN||Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy|A Dose-Finding Pilot Study of ACTH on the Serum Lipoprotein Profile and Proteinuria in Patients With Idiopathic Membranous Nephropathy (MN)|Completed||Phase 1|20|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 13:37:29.106666|2017-02-18 13:37:29.106666
NCT00805740|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-05-30|2013-05-30||April 2009||2009-04-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida|Efficacy And Safety Of Eraxis/Ecalta (Anidulafungin) Compared To Cancidas (Caspofungin) In Patients With Candida Deep Tissue Infection|Terminated||Phase 3|41|Actual|Pfizer|The study was prematurely terminated due to slow enrollment. The study was not terminated due to any safety issues or concerns.|2||"The study was terminated prematurely on May 18, 2012 due to slow enrollment. The study was not~   terminated due to any safety issues or concerns."|f||||t||||||||||2017-02-18 13:37:29.221258|2017-02-18 13:37:29.221258
NCT00805714|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-03-28|||April 2007||2007-04-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|August 2010|Actual|2010-08-01||Observational|LAMIS||Livalo Acute Myocardial Infarction Study|A Prospective Clinical Observation Study to Evaluate the Influence of Long Term Treatment of Pitavastatin on the Therapeutic Prognosis and Safety in Acute Myocardial Infarction|Completed||N/A|1128|Actual|JW Pharmaceutical|||1||f||||f||||||||||2017-02-18 13:37:29.983058|2017-02-18 13:37:29.983058
NCT00805701|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2014-05-12|||January 2009||2009-01-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation|Randomized, Double-Blind, Placebo-Controlled Trial Assessing The Efficacy And Safety Of Dutasteride At Improving Lower Urinary Tract Symptoms In Men With Clinically Localized Prostate Cancer Being Treated With Single-Dose Goserelin, Trans-Urethral Incision Of Prostate, And Interval Brachytherapy|Completed||Phase 4|40|Actual|Bay State Clinical Trials, Inc.||2|||f||||f||||||||||2017-02-18 13:37:30.078978|2017-02-18 13:37:30.078978
NCT00805688|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2017-02-02|||November 2008||2008-11-01|February 2017|2017-02-01||||November 2018|Anticipated|2018-11-01||Observational|||Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer|A Feasibility Study for Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer|Active, not recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood drawn (around 3½ tablespoons) before treatment starts to measure cytokines~     (biomarkers) and DNA.~   "|||2017-02-18 13:37:30.190203|2017-02-18 13:37:30.190203
NCT00805675|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-09|2012-01-26|2011-12-12||November 2008||2008-11-01|January 2012|2012-01-01||||December 2010|Actual|2010-12-01||Interventional|||Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB|A Randomized, Open-label, Controlled, Exploratory Trial to Characterize the Results of Daily Oral Administration of Telbivudine 600 mg and Tenofovir Disproxil Fumarate 300 mg in Combination or Telbivudine 600 mg or Tenofovir Disproxil Fumarate 300 mg Monotherapy Given Over 12 Weeks on the Kinetics of Hepatitis B Virus DNA in Adults With HBeAg Positive Compensated CHB|Completed||Phase 3|83|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:37:30.382109|2017-02-18 13:37:30.382109
NCT00805662|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-08|||May 2003||2003-05-01|December 2008|2008-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|Oxy||Nasal Oxcytocin During IUI|Nasal Oxcytocin Fails to Increase Pregnancy Rate of IUI|Completed||N/A|86|Actual|Ludwig-Maximilians - University of Munich||1|||f||||t||||||||||2017-02-18 13:37:31.172118|2017-02-18 13:37:31.172118
NCT00805649|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-09-26|||January 2006||2006-01-01|September 2012|2012-09-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Combined Therapy in Age-Related Macular Degeneration (ARMD)|Combined Therapy in ARMD - Retrospective Case Series|Completed||Phase 4|150|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-02-18 13:37:31.281075|2017-02-18 13:37:31.281075
NCT00805636|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-07|2010-05-11|||November 2008||2008-11-01|April 2010|2010-04-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|||Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.|Evaluation of Efficacy and Safety of 18FML10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Non-Hematological Solid Tumors to Radiation Therapy|Unknown status|Recruiting|Phase 2|30|Anticipated|Aposense Ltd.||1|||f||||||||||||||2017-02-18 13:37:31.409619|2017-02-18 13:37:31.409619
NCT00805623|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-07|2008-12-08|||March 2009||2009-03-01|December 2008|2008-12-01|October 2009|Anticipated|2009-10-01|August 2009|Anticipated|2009-08-01||Interventional|||Sucking and Sucrose as Pain Relief for Infants|Partial Blinded Controlled Study to Compare SucroseVs Water, With and Without Pacifier as Pain Reliever During Venous Puncture in Infants 3-12 Months Old|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Rabin Medical Center||4|||f||||f||||||||||2017-02-18 13:37:31.518217|2017-02-18 13:37:31.518217
NCT00805610|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2014-08-01|||June 2014||2014-06-01|August 2014|2014-08-01|June 2018|Anticipated|2018-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Hepatocyte Transplantation in Liver Failure|The Use of Human Hepatocyte Transplantation as a Life Support Bridge in Terminal Liver Failure.|Withdrawn||Phase 1/Phase 2|0|Actual|Virginia Commonwealth University||1||Investigator taking position at another university-0 enrolled under this protocol.|f||||t||||||||||2017-02-18 13:37:31.627826|2017-02-18 13:37:31.627826
NCT00803803|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-11-20|||August 1978||1978-08-01|November 2016|2016-11-01|December 1979|Actual|1979-12-01|August 1979|Actual|1979-08-01||Interventional|||Dose, Effects and Characteristics of Pilocarpine|Dose, Effects and Characteristics of Pilocarpine|Completed||Phase 4|37|Actual|Wills Eye||2|||f||||f||||||||No||2017-02-18 13:38:11.002684|2017-02-18 13:38:11.002684
NCT00805597|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-08-04|||June 2008||2008-06-01|August 2016|2016-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes|A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes|Terminated||Phase 3|40|Actual|Chinese Academy of Medical Sciences||2||The recuiting was to slow to complete the study|f||||t||||||||||2017-02-18 13:37:31.725825|2017-02-18 13:37:31.725825
NCT00805584|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-04-20|||May 2003||2003-05-01|April 2015|2015-04-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)|A Multi-center, Open-label, Non-comparative Study of the Relief of Nasal Symptoms and Tolerability in Subjects With Seasonal Allergic Rhinitis (SAR) Treated With Aerius.|Completed||Phase 4|311|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:37:31.838732|2017-02-18 13:37:31.838732
NCT00805571|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2010-03-11|||October 2008||2008-10-01|March 2010|2010-03-01||||February 2010|Actual|2010-02-01||Observational|||Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients|Urinary Kidney Injury Molecule-1 As Diagnostic Biomarker of Proximal Tubular Injury in Adult and Pediatric Transplant Recipients|Completed||N/A|120|Anticipated|Northwell Health|||2||f||||t||||||Samples With DNA|"~     Urine~   "|||2017-02-18 13:37:31.92623|2017-02-18 13:37:31.92623
NCT00805558|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2010-05-10|||February 2009||2009-02-01|October 2009|2009-10-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis|Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole as Adjunctive Therapy to Mechanical Treatment of Patients With Chronic Periodontitis|Completed||Phase 4|76|Actual|Facultad Nacional de Salud Publica||2|||f||||t||||||||||2017-02-18 13:37:32.00673|2017-02-18 13:37:32.00673
NCT00805545|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-03-19|2012-02-03||November 2008||2008-11-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Timing of Antibiotic Prophylaxis for Cesarean Deliveries|The Timing of Antibiotic Prophylaxis for Cesarean Delivery|Completed||N/A|400|Actual|University of Florida|There were no limitations to the study. No technical problems occurred during the study.|2|||f||||f||||||||||2017-02-18 13:37:32.137898|2017-02-18 13:37:32.137898
NCT00805532|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-09-06|||May 2009||2009-05-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Behavioral Activation for Posttraumatic Stress Disorder (PTSD)/ Depression Treatment in Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans|Behavioral Activation for PTSD, Depression Treatment in OIF/OEF Veterans|Completed||N/A|60|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:37:32.515411|2017-02-18 13:37:32.515411
NCT00805519|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2010-04-29|||February 2009||2009-02-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety of Prednisolone and Chloroquine Add on Therapy in Osteoarthritis of the Knee|Efficacy and Safety of Prednisolone and Chloroquine Add on Therapy in Osteoarthritis of the Knee Treated With Fixed Dose Combination of Glucosamine and Chondroitin Sulfate.|Completed||Phase 4|230|Actual|Ardabil University of Medical Sciences||4|||f||||t||||||||||2017-02-18 13:37:32.63296|2017-02-18 13:37:32.63296
NCT00805506|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-11-25|||February 2006||2006-02-01|December 2008|2008-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Evaluation of Glucose Monitoring Methods: Characterizing Glycemic Control in Subjects With Diabetes|Evaluation of Glucose Monitoring Methods: Characterizing Glycemic Control in Subjects With Diabetes|Completed||N/A|16|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-02-18 13:37:32.75082|2017-02-18 13:37:32.75082
NCT00805493|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-06|2015-10-06|2013-06-17||November 2008||2008-11-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder|Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|Limitations in enrollment led to early termination of the study.|3||Insufficient recruitment of participants|f||||f||||||||||2017-02-18 13:37:32.850508|2017-02-18 13:37:32.850508
NCT00805480|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-01-28|2015-01-28||December 2008||2008-12-01|January 2015|2015-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis|Phase II Randomized, Double-blind, Multi-center, Parallel-group, Placebo-controlled Multiple-loading Dose Regimen Study to Assess the Safety, Efficacy and Duration of Response of AIN457 in Patients With Chronic Plaque-type Psoriasis.|Completed||Phase 2|130|Actual|Novartis||4|||f||||f||||||||||2017-02-18 13:37:33.548896|2017-02-18 13:37:33.548896
NCT00805467|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2014-05-23|2014-01-22||August 2008||2008-08-01|May 2014|2014-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies|An Open-Label, Multicenter Extension Study to Evaluate the Safety of R935788 in Patients With Rheumatoid Arthritis Who Have Completed the Treatment Phase of a Rigel-Sponsored R935788 Study|Terminated||Phase 2|624|Actual|AstraZeneca||4||"AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to~   Rigel Pharmaceuticals."|f||||t||||||||||2017-02-18 13:37:34.980779|2017-02-18 13:37:34.980779
NCT00805454|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-05-06|||December 2008||2008-12-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712|A Phase I, Open-Label,Positron Emission Tomography (PET) Study Healthy Subjects Following a Single Oral Dose of OPC-34712|Completed||Phase 1|15|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|||||f||||t||||||||||2017-02-18 13:37:36.455658|2017-02-18 13:37:36.455658
NCT00805441|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2010-05-27||2010-05-27|December 2008||2008-12-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study in the Treatment of Alcohol Dependence.|A Phase 2 Study of LY686017 Compared With Placebo for the Treatment of Alcohol Dependence|Completed||Phase 2|190|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:37:36.553553|2017-02-18 13:37:36.553553
NCT00804193|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2014-01-09|2012-09-10||June 2004||2004-06-01|January 2014|2014-01-01|April 2005|Actual|2005-04-01|December 2004|Actual|2004-12-01||Interventional|||Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis|A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multi-center Study to Evaluate the Safety and Clinical Equivalence of a Generic Ciclopirox Olamine Topical Suspension to Reference Ciclopirox Topical Suspension 0.77% in the Treatment of Tinea Pedis|Completed||N/A|553|Actual|Perrigo Company||3|||f||||f||||||||||2017-02-18 13:37:36.682444|2017-02-18 13:37:36.682444
NCT00804180|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-06-19|||October 2008||2008-10-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Group Therapy Intervention for Children and Adolescents With Injection-Related Anxiety and Their Caregivers|Evaluation of a Group Therapy Intervention for Children and Adolescents With Injection-Related Anxiety and Their Caregivers|Withdrawn||N/A|0|Actual|Medical College of Wisconsin||1||Lack of recruitment/participants|f||||f||||||||||2017-02-18 13:37:37.4959|2017-02-18 13:37:37.4959
NCT00804167|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2009-07-19|||December 2008||2008-12-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|||||Observational|SERENITE||National Survey on Hypertension|Profile of Hypertensive Patients Aged of 75 Years and Older Seen in General Practitioner According to Their Renal Damage.|Completed||N/A|4500|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:37:37.651196|2017-02-18 13:37:37.651196
NCT00804154|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2017-01-24|||December 3, 2008||2008-12-03|October 11, 2016|2016-10-11|December 30, 2020|Anticipated|2020-12-30|June 30, 2020|Anticipated|2020-06-30||Interventional|||Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer|A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated With Advanced Cancer|Suspended||Phase 1|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:37:39.909585|2017-02-18 13:37:39.909585
NCT00804141|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2014-08-29|||December 2008||2008-12-01|June 2011|2011-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study Evaluating Long-Term Safety Of MOA-728 In Subjects With Opioid-Induced Constipation|An Open-Label Study To Evaluate The Long-Term Safety Of Subcutaneous MOA-728 For Treatment Of Opioid-Induced Constipation In Subjects With Nonmalignant Pain|Completed||Phase 3|1040|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-02-18 13:37:40.027025|2017-02-18 13:37:40.027025
NCT00805428|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2008-12-08|||September 2008||2008-09-01|December 2008|2008-12-01||||||||Observational|||Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group||Unknown status|Recruiting|N/A|32|Anticipated|Clinical Hospital Center, Split|||2||f||||f||||||||||2017-02-18 13:37:40.343904|2017-02-18 13:37:40.343904
NCT00805415|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-07-14|||March 2003||2003-03-01|July 2011|2011-07-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens|Multicenter, Open-label, Randomized, Comparative Study to Evaluate Ovulation Inhibition With Two 4-phasic Oral Contraceptive Regimens Containing Estradiol Valerate and Dienogest Applied Daily for Three Cycles to 200 Healthy Female Volunteer|Completed||Phase 2|209|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:37:40.420352|2017-02-18 13:37:40.420352
NCT00805402|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2010-09-03|||July 2008||2008-07-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|Cytoven||Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom Allergy|Interest of Flow Cytometry for the Diagnosis, the Follow up and SIT Arrest of Hymenoptera Venom Allergy|Completed||N/A|75|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-02-18 13:37:40.524798|2017-02-18 13:37:40.524798
NCT00805389|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-02-29|2012-12-19||December 2008||2008-12-01|February 2015|2015-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine|Comparison of the Immunogenicity and Safety of Various Investigational and Licensed Formulations of Hepatitis B Surface Antigen (HBsAg) Vaccines.|Completed||Phase 2|713|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-02-18 13:37:40.665937|2017-02-18 13:37:40.665937
NCT00805376|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2015-02-20|||February 2009||2009-02-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas|Phase I Trial of Conditionally Replication-Competent Adenovirus (DNX-2401, Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas|Completed||Phase 1|37|Actual|DNAtrix, Inc.||2|||f||||f||||||||||2017-02-18 13:37:46.462389|2017-02-18 13:37:46.462389
NCT00805350|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-02-05||2016-02-05|December 2008||2008-12-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|ECLIPSE||Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties|Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties: a 6-week, Randomized, Double-blind, Placebo-controlled, Polysomnography Study.|Completed||Phase 3|637|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:37:46.58216|2017-02-18 13:37:46.58216
NCT00805337|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-06||||||December 2008|2008-12-01||||||||Expanded Access|ADLG3||Low Levels of Electromagnetic Fields to Treat Advanced Cancer|Compassionate Treatment of Advanced Cancer With Amplitude-Modulated Electromagnetic Fields|No longer available||N/A|||Pasche, Boris, M.D.|||||f||||||||||||||2017-02-18 13:37:46.701434|2017-02-18 13:37:46.701434
NCT00805324|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-04-20|||May 2003||2003-05-01|April 2015|2015-04-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)|Evaluation of the Efficacy and Safety of Desloratadine Syrup in Children Suffering From Seasonal Allergic Rhinitis With or Without Intermittent Asthma|Completed||Phase 3|54|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:37:46.782873|2017-02-18 13:37:46.782873
NCT00805311|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2015-10-07|||April 2009||2009-04-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|AMTEC||Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis|Carotid Endarterectomy Versus Optimal Medical Treatment of Asymptomatic High Grade Carotid Artery Stenosis|Terminated||Phase 4|400|Actual|Russian Cardiology Research and Production Center||2||Due to the clear advantage of carotid endarterectomy|f||||t||||||||||2017-02-18 13:37:46.888828|2017-02-18 13:37:46.888828
NCT00805298|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-10-23|||August 2008||2008-08-01|October 2012|2012-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Assessment of the Operative Course in Connection With Removal of Lower Third Molars|Assessment of the Operative Course in Connection With Removal of Lower Third Molars With Particular Consideration to the Occurence of Pain and Swelling|Completed||N/A|154|Actual|University of Aarhus||4|||f||||t||||||||||2017-02-18 13:37:46.99917|2017-02-18 13:37:46.99917
NCT00804908|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-02-07|||February 2009||2009-02-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Evaluating the Efficacy of ABT-888 in Combination With Temozolomide Versus Temozolomide Alone in Subjects With Metastatic Melanoma|Completed||Phase 2|346|Actual|AbbVie||3|||f||||t||||||||||2017-02-18 13:38:01.015617|2017-02-18 13:38:01.015617
NCT00805285|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2013-03-30|2013-01-24||October 2008||2008-10-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Interventional||The only enrolled patient was withdrawn secondary to disease worsening.|The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis|Oral Budesonide and Rectal Hydrocortisone for the Treatment of Extensive Ulcerative Colitis: A Pilot Study|Terminated||Phase 2|2|Actual|University of Maryland|The study was terminated early by the University of Maryland HRPO secondary to limited recruitment of participants. This resulted in an inability to analyze the results.|1||Study terminated due to insufficient enrollment|f||||t||||||||||2017-02-18 13:37:47.283979|2017-02-18 13:37:47.283979
NCT00805272|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-03-16|||February 2009||2009-02-01|November 2008|2008-11-01|February 2012|Actual|2012-02-01|September 2011|Actual|2011-09-01||Interventional|IGRAVIH||Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients|Medical and Economical Evaluation of New Diagnosis Tests of Mycobacterium Tuberculosis, Specific Immune Responses in HIV-infected Adults|Completed||N/A|536|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 13:37:47.561595|2017-02-18 13:37:47.561595
NCT00805259|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-12-18|||August 2010||2010-08-01|December 2013|2013-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Promoting Mental Acuity in Elderly Populations Through Incentive for Technology Use|Promoting Mental Acuity in Elderly Populations Through Incentive for Technology Use|Completed||N/A|312|Actual|Carnegie Mellon University||4|||f||||f||||||||||2017-02-18 13:37:47.66757|2017-02-18 13:37:47.66757
NCT00805246|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-10-25|||December 2008||2008-12-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|July 2013|Actual|2013-07-01||Observational|||Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )|Identifying CT Imaging Biomarkers Associated With Prognosis of Pulmonary Embolism|Active, not recruiting||N/A|910|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 13:37:47.769791|2017-02-18 13:37:47.769791
NCT00805233|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-07-20|||December 2008||2008-12-01|October 2009|2009-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration|Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration|Completed||Phase 2|30|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 13:37:47.860805|2017-02-18 13:37:47.860805
NCT00805220|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2009-09-01|||December 2008||2008-12-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Nordic Walking as Gait Training for Frail Elderly|Nordic Walking for Frail Elderly: a Randomized Pilot Trial|Completed||Phase 2|30|Anticipated|McGill University||2|||f||||t||||||||||2017-02-18 13:37:47.970268|2017-02-18 13:37:47.970268
NCT00805207|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-04-11|||September 2007||2007-09-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|SCOR||Sex Steroids, Sleep, and Metabolic Dysfunction in Women|Sex Steroids, Sleep, and Metabolic Dysfunction in Women|Completed||N/A|61|Actual|Washington University School of Medicine||6|||f||||f||||||||||2017-02-18 13:37:48.085064|2017-02-18 13:37:48.085064
NCT00805194|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-09-06|2014-11-14||December 2008||2008-12-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|November 2010|Actual|2010-11-01||Interventional||Randomised Set (RS)- Includes all randomised patients, whether patients had received study treatment or not|LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer|Multicentre, Randomised, Double-blind, Phase III Trial to Investigate the Efficacy and Safety of Oral BIBF 1120 Plus Standard Docetaxel Therapy Compared to Placebo Plus Standard Docetaxel Therapy in Patients With Stage IIIB/IV or Recurrent Non Small Cell Lung Cancer After Failure of First Line Chemotherapy|Active, not recruiting||Phase 3|1314|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:37:48.22465|2017-02-18 13:37:48.22465
NCT00805181|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2010-10-06|||December 2008||2008-12-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Kinetics of Biomarkers in Acute Pyelonephritis|Kinetics of Procalcitonin, C-reactive Protein and Pyuria in Uncomplicated Pyelonephritis in Women: A Pilot Study|Completed||N/A|30|Anticipated|University Hospital, Geneva|||1||f||||f||||||||||2017-02-18 13:37:49.844637|2017-02-18 13:37:49.844637
NCT00805168|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2017-02-10|||May 2013||2013-05-01|February 2017|2017-02-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|INHALE 2||Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Patients With Gram-Negative Pneumonia|Recruiting||Phase 3|724|Anticipated|Bayer||2|||f||||t||||||||||2017-02-18 13:37:49.944462|2017-02-18 13:37:49.944462
NCT00805155|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-03-15|||February 2004||2004-02-01|March 2012|2012-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Observational|||Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions|Bioequivalence of Three Mometasone Furoate 0.1% Topical Lotions|Completed||N/A|80|Actual|Perrigo Company|||3||f||||f||||||||||2017-02-18 13:37:52.499391|2017-02-18 13:37:52.499391
NCT00805142|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2013-06-20|2013-03-22||November 2008||2008-11-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants|Phase II Study of JNS024PR in Cancer Pain Patients|Completed||Phase 2|78|Actual|Janssen Pharmaceutical K.K.||2|||f||||f||||||||||2017-02-18 13:37:52.600781|2017-02-18 13:37:52.600781
NCT00805129|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2017-01-04|||December 2008||2008-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium|Phase II Study of Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium|Active, not recruiting||Phase 2|46|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 13:37:55.340602|2017-02-18 13:37:55.340602
NCT00805116|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-05-06|||December 2008||2008-12-01|May 2016|2016-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Marine Oils and Arthritis|Whale Oil Versus Cod Liver Oil in Rheumatoid Arthritis|Terminated||N/A|7|Actual|National Institute of Nutrition and Seafood Research, Norway||2||Recruitment to slow, most patients to well for treatment|f||||f||||||||||2017-02-18 13:37:55.440063|2017-02-18 13:37:55.440063
NCT00805103|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-12-28|||December 2008||2008-12-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|HF-SRT||Perfexion Brain Metastasis|Hypofractionated Stereotactic Radiotherapy (HF-SRT) for Large-Volume Brain Metastases|Terminated||Phase 1|9|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 13:37:55.538448|2017-02-18 13:37:55.538448
NCT00805090|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2009-04-29|||December 2008||2008-12-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects|An Open-Label, Single-Dose Study to Evaluate the Safety and Pharmacokinetics of DIC075V in Subjects With Mild or Moderate Chronic Renal Insufficiency and in Subjects With Mild Chronic Hepatic Impairment Compared to Healthy Adult Volunteers and a Randomized, Open-Label, Single-Dose, Two-Way, Crossover Study to Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Adult Volunteers.|Completed||Phase 1|37|Actual|Javelin Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:37:55.636057|2017-02-18 13:37:55.636057
NCT00805077|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2013-07-26|||December 2008||2008-12-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|November 2011|Actual|2011-11-01||Interventional|VPP||Pulmonary Surgery and Protective Mechanical Ventilation|Pulmonary Surgery and Protective Mechanical Ventilation|Completed||N/A|347|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:37:55.739798|2017-02-18 13:37:55.739798
NCT00805064|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-09-26|||January 2006||2006-01-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|December 2007|Actual|2007-12-01||Interventional|||Combined Triple Procedure in Retinal Vein Occlusion (RVO)|Intravitreal Combination Therapy Using Triamcinolone and Bevacizumab Improves Vision in Patients With Retinal Vein Occlusion|Completed||Phase 3|40|Actual|Johann Wolfgang Goethe University Hospital||3|||f||||f||||||||||2017-02-18 13:37:56.04375|2017-02-18 13:37:56.04375
NCT00805051|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-09-29|||October 2008||2008-10-01|September 2011|2011-09-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Observational|||Acquired Von Willebrand Syndrome in Severe Aortic Stenosis|Does an Acquired Von Willebrand Syndrome Influence Perioperative Blood Loss in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement?|Completed||N/A|60|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 13:37:56.147873|2017-02-18 13:37:56.147873
NCT00805038|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-06-20|2011-05-24||January 2009||2009-01-01|December 2008|2008-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Transplant Navigator Intervention to Overcome Barriers to Kidney Transplantation|Transplant Navigator Intervention to Overcome Barriers to Kidney Transplantation|Completed||Phase 1/Phase 2|167|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-02-18 13:37:56.24343|2017-02-18 13:37:56.24343
NCT00805025|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2014-02-03|2013-09-09||December 2008||2008-12-01|February 2014|2014-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||Enrolled and treated participants|Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis|An Open-Label, Multicenter Trial to Validate the Quality of Life Questionnaire-Bronchiectasis and to Evaluate Perception of Symptom Improvement Following One Course of Aztreonam for Inhalation Solution (AZLI) in Subjects With Bronchiectasis and Gram-negative Bacteria in the Airways|Completed||Phase 2|89|Actual|Gilead Sciences||1|||f||||f||||||||||2017-02-18 13:37:56.614931|2017-02-18 13:37:56.614931
NCT00805012|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-06|2011-07-23|||December 2008||2008-12-01|July 2011|2011-07-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)|A Randomized, Multicenter, Phase II Study of Docetaxel and TS-1 Combination as a First-line Treatment in Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)|Terminated||Phase 2|96|Anticipated|Seoul National University Hospital||2||slow accrual rate|f||||f||||||||||2017-02-18 13:37:56.900148|2017-02-18 13:37:56.900148
NCT00804999|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-08|||November 2008||2008-11-01|December 2008|2008-12-01||||March 2009|Anticipated|2009-03-01||Interventional|||Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure|Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure|Unknown status|Recruiting|N/A|75|Anticipated|University of Iowa||4|||f||||f||||||||||2017-02-18 13:37:57.007638|2017-02-18 13:37:57.007638
NCT00804986|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-07-12|2011-05-13||December 2008||2008-12-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study for Patients With Type 2 Diabetes Mellitus|A 12-Week,Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|247|Actual|Eli Lilly and Company||6|||f||||||||||||||2017-02-18 13:37:57.148936|2017-02-18 13:37:57.148936
NCT00804973|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2010-04-16||2010-04-16|November 2008||2008-11-01|April 2010|2010-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study in Subjects With Acute Migraines Headaches.|A Safety, Tolerability, and Efficacy Study of LY2590443 in the Treatment of Acute Migraine Headache|Terminated||Phase 2|120|Actual|Eli Lilly and Company||3||Due to efficacy results of interim analysis|f||||f||||||||||2017-02-18 13:38:00.270911|2017-02-18 13:38:00.270911
NCT00804960|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-06-24|||September 2008||2008-09-01|June 2015|2015-06-01|April 2010|Anticipated|2010-04-01|December 2009|Anticipated|2009-12-01||Interventional|Cost-Less||Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?|Controlled Ovarian Stimulation With Letrozole Supplementation|Withdrawn||Phase 4|0|Actual|Center for Human Reproduction||2||lack of recruitment at this site|f||||f||||||||||2017-02-18 13:38:00.395162|2017-02-18 13:38:00.395162
NCT00804947|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-08|||September 2005||2005-09-01|December 2008|2008-12-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen|Ensayo Fase II de Trasplante autólogo de Sangre periférica en Pacientes Con Mieloma múltiple Tras Acondicionamiento Con Busulfan Intravenoso y Melfalan|Unknown status|Recruiting|Phase 2|50|Anticipated|Fundacion Para La Investigacion Hospital La Fe||1|||f||||f||||||||||2017-02-18 13:38:00.509304|2017-02-18 13:38:00.509304
NCT00804934|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-05-24|||February 2008||2008-02-01|May 2012|2012-05-01|January 2009|Actual|2009-01-01|February 2008|Actual|2008-02-01||Observational|||Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis|Phase II Study Intravitreally Admininstered Ranibizumab in 50 Subjects With AMD Having Received at Least 3 Doses of Intermittent Anti-VEGF Therapy in the Preceding 18 Months|Completed||Phase 2|100|Actual|Retina Institute of Hawaii|||1||f||||t||||||||||2017-02-18 13:38:00.614646|2017-02-18 13:38:00.614646
NCT00804921|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2008-12-08||||||December 2008|2008-12-01||||||||Interventional|||Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab|Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab Injection: Preliminary Results|Completed||Phase 2|||University of Sao Paulo|||||f||||t||||||||||2017-02-18 13:38:00.707188|2017-02-18 13:38:00.707188
NCT00804895|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-11-23|||December 2008||2008-12-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|CHCI||Cluster Headache Cortivazol Injection (CHCI)|A Double Blind Randomized Controlled Trial of Greater Occipital Nerve Infiltration in Cluster Headache|Completed||Phase 2/Phase 3|43|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:38:01.178818|2017-02-18 13:38:01.178818
NCT00804882|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2015-04-09|||October 2008||2008-10-01|April 2015|2015-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|CHAMP-HF||Hispanics With Metabolic Syndrome and Non-ischemic Heart Failure|Correlation in Hispanics of Accelerated Metabolic Risk Profile and Non-ischemic Heart Failure (CHAMP-HF)|Withdrawn||N/A|0|Actual|Texas Tech University Health Sciences Center|||4|Principal investigator is leaving the institution to obtain further training.|f||||f||||||Samples Without DNA|"~     Blood will be collected~   "|||2017-02-18 13:38:01.301621|2017-02-18 13:38:01.301621
NCT00804869|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-06|||October 2008||2008-10-01|December 2008|2008-12-01||||December 2008|Actual|2008-12-01||Observational|||A-Mode vs PalmScan Ultrasonography: Biometric Measurements.|Standard A-Mode Ultrasonography vs PalmScan Ultrasonography: Biometric Measurements.|Completed||N/A|||Asociación para Evitar la Ceguera en México|||2||f||||t||||||||||2017-02-18 13:38:01.403537|2017-02-18 13:38:01.403537
NCT00804856|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-08-22|||November 2008||2008-11-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|March 2012|Actual|2012-03-01||Interventional|||Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia|An Open Phase I/IIa Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics, and Efficacy of Intravenous BI 6727 as Monotherapy or in Combination With Subcutaneous Cytarabine in Patients With Acute Myeloid Leukaemia|Active, not recruiting||Phase 2|180|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 13:38:01.493979|2017-02-18 13:38:01.493979
NCT00804843|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2015-09-28|2011-12-21||April 2009||2009-04-01|September 2015|2015-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|MCAT||Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)|A Randomized Clinical Trial to Evaluate the Effects of High Dose Statin and Niacin Therapy on Excised Plaque Biomarkers in Patients Undergoing Carotid Endarterectomy (CEA)|Completed||Phase 2|100|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:38:01.631224|2017-02-18 13:38:01.631224
NCT00804830|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-08-20|||April 2008||2008-04-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer|Phase 2 Study With Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Region Skane||1|||f||||t||||||||||2017-02-18 13:38:02.017792|2017-02-18 13:38:02.017792
NCT00804817|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2010-08-26|||December 2007||2007-12-01|December 2008|2008-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Somatic-psychosocial Care Concept for Oncologic Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)|Somatic-psychosocial Multidisciplinary Care Concept for Oncologic Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): a Prospective Non-randomized Clinical Trial|Completed||N/A|84|Anticipated|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-02-18 13:38:02.14332|2017-02-18 13:38:02.14332
NCT00804804|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2011-03-04|||December 2008||2008-12-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|SOMVIE||Aging, Sleep, Cognitive Process|Aging,Sleep and Cognitive Process|Completed||N/A|28|Anticipated|University Hospital, Bordeaux||4|||f||||f||||||||||2017-02-18 13:38:02.249163|2017-02-18 13:38:02.249163
NCT00804791|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-01-31|||November 2008||2008-11-01|January 2012|2012-01-01||||February 2009|Actual|2009-02-01||Interventional|||Residence Time Evaluation of Marketed OTC Ophthalmic Products||Completed||N/A|25|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:38:02.358766|2017-02-18 13:38:02.358766
NCT00804778|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-08|||March 2006||2006-03-01|December 2008|2008-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Comparison of USCOM Cardiac Output and Continuous Thermodilution Cardiac Output|Comparison of USCOM Cardiac Output and Continuous Thermodilution Cardiac Output in Patients With Coronary Artery Bypass Grafting|Completed||N/A|18|Actual|Beijing Chao Yang Hospital|||2||f||||f||||||||||2017-02-18 13:38:02.440166|2017-02-18 13:38:02.440166
NCT00804765|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2014-08-25|||September 2008||2008-09-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|ETOIG||Impact of Education During Pregnancy in Overweight Pregnant Women|Impact of Pregnant Women Education in Case of Overweight or Obesity on Risk of Child Overweight and Pregnancy Outcome|Completed||N/A|275|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:38:02.539173|2017-02-18 13:38:02.539173
NCT00804752|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-07|2008-12-08||||||December 2008|2008-12-01||||||||Interventional|||Vitamin D Treatment in Patients With Chronic Hepatitis C||Unknown status|Recruiting|N/A|||Hillel Yaffe Medical Center||1|||f||||||||||||||2017-02-18 13:38:02.641219|2017-02-18 13:38:02.641219
NCT00804739|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-02-23|||January 2009||2009-01-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|MITT||Perinatal Depression Treatment in a Pediatric Setting- Pilot Phase|Adapting Collaborative Care Perinatal Depression Treatment to a Pediatric Setting - Pilot Phase|Completed||N/A|30|Actual|University of Rochester||1|||f||||t||||||||||2017-02-18 13:38:02.73911|2017-02-18 13:38:02.73911
NCT00804726|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2014-01-15|||November 2008||2008-11-01|January 2014|2014-01-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.|A Prospective, Open-label, Monocular Feasibility Clinical Evaluation of the Bausch & Lomb Akreos MI Five-O Accommodating Intraocular Lens.|Terminated||N/A|10|Actual|Bausch & Lomb Incorporated||1||Test lens did not meet near visual efficacy endpoints|f||||f||||||||||2017-02-18 13:38:02.844773|2017-02-18 13:38:02.844773
NCT00804713|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-05-13|2014-05-19||March 2009||2009-03-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|June 2009|Actual|2009-06-01||Interventional|LTBI|recruits at Fort Jackson, SC in 2009 between April 1 and June 11|Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits|Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits|Active, not recruiting||N/A|2017|Actual|Uniformed Services University of the Health Sciences|A limitation of this study is the lack of a gold standard for determining the presence of M. tuberculosis infection, making it difficult to assess the true significance of discordance between TST and the interferon-gamma release assays (IGRAs).|1|||f||||f||||||||||2017-02-18 13:38:02.936929|2017-02-18 13:38:02.936929
NCT00804700|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2010-04-21|||December 2008||2008-12-01|December 2008|2008-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Impact of Two Methods of Listening to Music During Exercise on Perceived Exertion and Overall Physical Activity|Impact of Two Methods of Listening to Music During Exercise on Perceived Exertion and Overall Physical Activity|Completed||N/A|46|Anticipated|Georgetown University||2|||f||||t||||||||||2017-02-18 13:38:03.202133|2017-02-18 13:38:03.202133
NCT00804687|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2013-09-27|2013-03-05||November 2008||2008-11-01|September 2013|2013-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis|A Randomized, Single-Dose, Single-Blind, Double-Dummy, Placebo-Controlled, Three-Way Cross-Over Study to Compare the Relative Efficacy of JNJ-39220675, Pseudoephedrine and Placebo for the Treatment of Allergic Rhinitis in an Environmental Exposure Chamber (EEC) Model|Completed||Phase 2|53|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||6|||f||||f||||||||||2017-02-18 13:38:03.383235|2017-02-18 13:38:03.383235
NCT00804674|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2011-06-30|||August 2005||2005-08-01|June 2011|2011-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pain Study Using Intermittent Bupivacain Injections After Breast Reconstruction With DIEP Flap|Improved Pain Relief Using Intermittent Bupivacain Injections at the Donor Site After Breast Reconstruction With Deep Inferior Epigastric Artery Perforator (DIEP) Flap|Completed||Phase 2|47|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 13:38:03.891006|2017-02-18 13:38:03.891006
NCT00804661|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2010-06-02|||July 2007||2007-07-01|May 2010|2010-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|Sommeil||Sleep in Patients With Cystic Fibrosis|Predictors of Nocturnal Hypoventilation in Patients With Cystic Fibrosis|Completed||N/A|76|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 13:38:03.971273|2017-02-18 13:38:03.971273
NCT00804648|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-02-18|2010-09-01||November 2008||2008-11-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension|Patient Satisfaction With Timolol Maleate in Sorbate, Generic Timolol Gel Forming Solution or Timolol Hemihydrate in Subjects With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 4|30|Actual|Vistakon Pharmaceuticals||6|||f||||f||||||||||2017-02-18 13:38:04.0919|2017-02-18 13:38:04.0919
NCT00804622|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2012-07-10|||December 2008||2008-12-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)|A Randomized, Open-label, Controlled, Exploratory Trial to Characterize the Results of Daily Oral Administration of Telbivudine 600 mg and Tenofovir Disproxil Fumarate 300 mg in Combination or Telbivudine 600 mg or Tenofovir Disproxil Fumarate 300 mg Monotherapy Given Over 12 Weeks on the Kinetics of Hepatitis B Virus DNA in Adults With HBeAg Positive Compensated CHB|Completed||Phase 2|15|Actual|The University of Hong Kong||3|||f||||f||||||||||2017-02-18 13:38:04.803127|2017-02-18 13:38:04.803127
NCT00804609|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-02-07|2015-02-03||September 2008||2008-09-01|February 2016|2016-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Epidural Lidocaine on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® After Cesarean Delivery|A Study to Evaluate the Effects of Epidural Lidocaine Administration on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® (Morphine Sulfate Extended-release Injection) in Patients Undergoing Cesarean Delivery|Completed||N/A|30|Actual|Stanford University||2|||f||||f||||||||No||2017-02-18 13:38:04.914526|2017-02-18 13:38:04.914526
NCT00804596|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-01-29|2009-12-16||December 2008||2008-12-01|January 2016|2016-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Labeling Comprehension and Performance of a New Blood Glucose Meter System|Labeling Comprehension and Performance Evaluation of the Apollo Blood Glucose Monitoring System With Capillary Blood [Commercial Name is CONTOUR® USB]|Completed||N/A|74|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-02-18 13:38:05.276318|2017-02-18 13:38:05.276318
NCT00804583|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-08-04|||March 2004||2004-03-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease|Genetic Modifiers of CF Liver Disease|Active, not recruiting||N/A|154|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"~     A one time blood draw of 35 mls~   "|||2017-02-18 13:38:05.52892|2017-02-18 13:38:05.52892
NCT00804570|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-12-09|2016-08-08||November 2008||2008-11-01|December 2016|2016-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study for the Treatment of Alcohol Dependence|A Phase 2 Study of LY2196044 Compared With Placebo in the Treatment of Alcohol Dependence|Completed||Phase 2|375|Actual|Eli Lilly and Company|Based on exposure data from an Alcohol Interaction study, H9T-MC-NABL (unregistered Phase 1 trial), the maximum dose in this study was reduced from 250 mg to 125 mg of LY2196044 after about 2/3 into the conduct of the trial.|2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 13:38:05.636766|2017-02-18 13:38:05.636766
NCT00804557|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2011-05-05|||October 2008||2008-10-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Efficacy And Safety Of The Uro-Ease® Urinary Catheter During Clean Intermittent Catheterization|Efficacy And Safety Of The Uro-Ease® Urinary Catheter During Clean Intermittent Catheterization|Terminated||N/A|25|Anticipated|Lahey Clinic|||2|pending design changes to the device|f||||f||||||||||2017-02-18 13:38:06.760095|2017-02-18 13:38:06.760095
NCT00804544|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-03-02|||September 2008||2008-09-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||99mTc-MIBI SPECT/CT in Breast Malignancy|Tc-99m Sestamibi SPECT/CT for Prediction of the Response of Locally Advanced Breast Malignancy to Neoadjuvant Chemotherapy|Terminated||N/A|4|Actual|Lawson Health Research Institute||1||"4 patients have been enrolled into the pilot study. No complications reported. Another~   clinical trial has been designed."|f||||f||||||||||2017-02-18 13:38:06.853312|2017-02-18 13:38:06.853312
NCT00804531|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-06-23|||April 2009||2009-04-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|May 2015|Actual|2015-05-01||Interventional|PREDID||Intra-discal Steroid Injection for MODIC I Discopathy|Intra-discal Steroid Injection for MODIC I Discopathy: A Randomized Control Trial|Completed||Phase 4|137|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:38:06.970017|2017-02-18 13:38:06.970017
NCT00804518|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2016-07-15|||November 2008||2008-11-01|July 2016|2016-07-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Exercise on Heart Function in Healthy Elderly People|Aerobic Interval Training Reduces and Compensates Age Related Decline in Cardiac Function|Completed||N/A|45|Actual|Norwegian University of Science and Technology||1|||f||||t||||||||||2017-02-18 13:38:07.071977|2017-02-18 13:38:07.071977
NCT00804505|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-08|2009-12-22|||June 2008||2008-06-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study|A 90 Day Multi-Center, Randomized, Parallel Group Daily Wear Investigation of a New Hybrid Lens SynergEyes SA Manufactured With a Rigid Gas Permeable Center (Petrafocon A) and a Silicone Hydrogel Skirt (Larafilcon A) Compared to SynergEyes A (Paflufocon D Hem-iberfilcon A)|Completed||N/A|98|Actual|SynergEyes, Inc.||2|||f||||f||||||||||2017-02-18 13:38:07.168022|2017-02-18 13:38:07.168022
NCT00804492|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-06-28|||June 2008||2008-06-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Establishment of an Integrated Model for Prevention of Elderly Falls|Bureau of Health Promotion,Department of Health, R.O.C. (Taiwan)|Completed||N/A|900|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 13:38:07.275809|2017-02-18 13:38:07.275809
NCT00804479|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-01-20|||January 2002||2002-01-01|January 2016|2016-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Observational|CALM-PD Cohort||The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)|Unblinded, Multicenter, Prospective Follow-up of Long-term Consequences of Initiating Patients With Parkinson's Disease on Either Pramipexole or Levodopa.|Terminated||N/A|222|Actual|University of Rochester|||1|Funding for the CALM-PD Cohort Study was terminated by sponsor.|f||||f||||||||||2017-02-18 13:38:07.36761|2017-02-18 13:38:07.36761
NCT00804466|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2017-01-24|||December 3, 2008||2008-12-03|October 27, 2016|2016-10-27|October 27, 2016|Actual|2016-10-27|October 27, 2016|Actual|2016-10-27||Interventional|||Human Papillomavirus Epidemiology in Nigeria|Epidemiologic and Molecular Features of Cervical Cancer in Nigeria - Project Itoju (Care)|Completed||Early Phase 1|3500|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:38:07.452934|2017-02-18 13:38:07.452934
NCT00804453|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2011-03-07|||November 2008||2008-11-01|March 2011|2011-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line|Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line: A Pilot Monocentric Open Randomized and Cross-over Study.|Completed||Phase 4|16|Actual|Gambro Lundia AB||2|||f||||f||||||||||2017-02-18 13:38:07.647221|2017-02-18 13:38:07.647221
NCT00804128|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2014-12-15|||October 2008||2008-10-01|December 2014|2014-12-01||||December 2014|Anticipated|2014-12-01||Observational|||Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers|Contrast-enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)|Unknown status|Recruiting|N/A|90|Anticipated|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:38:07.749542|2017-02-18 13:38:07.749542
NCT00804115|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-05|||August 2000||2000-08-01|December 2008|2008-12-01|December 2008|Anticipated|2008-12-01|September 2007|Actual|2007-09-01||Interventional|||The International Collaborative Exfoliation Syndrome Treatment Study|The International Collaborative Exfoliation Syndrome Treatment Study|Unknown status|Active, not recruiting|N/A|277|Actual|The New York Eye & Ear Infirmary||2|||f||||t||||||||||2017-02-18 13:38:07.842397|2017-02-18 13:38:07.842397
NCT00804102|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-05-03|||January 2008||2008-01-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Transcorneal Electrical Stimulation Therapy for Retinal Disease|Transcorneal Electrical Stimulation Therapy for Retinal Disease - A Randomized, Single-blind Pilot Study|Completed||N/A|80|Actual|Okuvision GmbH||12|||f||||t||||||||||2017-02-18 13:38:07.952692|2017-02-18 13:38:07.952692
NCT00804089|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-05|||December 2008||2008-12-01|December 2008|2008-12-01||||March 2009|Anticipated|2009-03-01||Interventional|||Traditional Acupuncture and Myofascial Trigger Point Dry Needling and Acupressure for Chronic Low Back Pain|Randomised Comparative Pragmatic Clinical Trial of Traditional Acupuncture and Superficial Dry Needling and Acupressure of Myofascial Trigger Points for the Treatment of Patients With Chronic Mechanical Low Back Pain|Unknown status|Recruiting|N/A|90|Anticipated|Hermano Miguel Foundation||3|||f||||t||||||||||2017-02-18 13:38:08.052793|2017-02-18 13:38:08.052793
NCT00804076|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-02-18|||February 2008||2008-02-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|November 2010|Actual|2010-11-01||Interventional|||Gene Transfer for Cancer Pain|Gene Transfer for Intractable Pain: A Phase I Clinical Trial to Determine the Maximum Tolerable Dose of a Replication-Defective Herpes Simplex Virus Type I (HSV-1) Vector Expressing Human Preproenkephalin (NP2) in Patients With Malignancies|Completed||Phase 1|10|Actual|Diamyd Inc||1|||f||||t||||||||||2017-02-18 13:38:08.149723|2017-02-18 13:38:08.149723
NCT00804063|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-01-07|||December 2008||2008-12-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Observational|||Serum Citrate in Diagnosis and Follow-up for Glaucoma|Serum Citrate in Diagnosis and Follow-up for Glaucoma|Completed||N/A|20|Actual|University Hospital, Basel, Switzerland|||2||f||||f||||||Samples With DNA|"~     blood, urine, serum, aqueous~   "|||2017-02-18 13:38:08.259803|2017-02-18 13:38:08.259803
NCT00804050|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2011-06-27|||March 2007||2007-03-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Interventional|||Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts|Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts|Terminated||Phase 3|184|Anticipated|Fondazione Italiana Sindromi Mielodisplastiche Onlus||2||Difficulties of enrollment|f||||t||||||||||2017-02-18 13:38:08.358888|2017-02-18 13:38:08.358888
NCT00804037|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-05|||January 2007||2007-01-01|November 2008|2008-11-01||||December 2008|Actual|2008-12-01||Interventional|||Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate|Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate. A Randomized, Placebo-Controlled Study in Human Patients|Unknown status|Active, not recruiting|N/A|20|Actual|University of Sao Paulo||2|||f||||||||||||||2017-02-18 13:38:08.622534|2017-02-18 13:38:08.622534
NCT00804024|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-04-18|||August 2008||2008-08-01|April 2013|2013-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01|1 Day|Observational [Patient Registry]|||ClearWay™ RX Registry Trial|Multi-center, Registry Trial of ClearWay™ RX Local Therapeutic Infusion Catheter for All Indications|Completed||N/A|102|Actual|Atrium Medical Corporation|||1||f||||||||||||||2017-02-18 13:38:08.726272|2017-02-18 13:38:08.726272
NCT00804011|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2008-12-05|||July 2004||2004-07-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|ATC||Automatic Tube Compensation (ATC) for Weaning Patients With Severe Neurotoxic Snake Envenoming|Automatic Tube Compensation Versus Pressure Support in Weaning Patients With Severe Neurotoxic Snake Envenoming|Completed||N/A|41|Actual|Postgraduate Institute of Medical Education and Research||2|||f||||f||||||||||2017-02-18 13:38:08.842784|2017-02-18 13:38:08.842784
NCT00803998|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-10-31|||February 1994||1994-02-01|December 2008|2008-12-01|December 2006||2006-12-01|||||Observational|||Ocular Hypertension Treatment Study (OHTS)|Ocular Hypertension Treatment Study|Completed||N/A|||The New York Eye & Ear Infirmary|||||f||||||||||||||2017-02-18 13:38:08.953612|2017-02-18 13:38:08.953612
NCT00803985|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-07-07|||April 2008||2008-04-01|July 2016|2016-07-01|January 2018|Anticipated|2018-01-01|January 2016|Actual|2016-01-01||Interventional|TEP-LICH||"Study Comparing Total Extraperitoneal Patch TEP Versus Lichtenstein According Chronic Pain"|Prospective Randomised Study Comparing TEP vs Lichtenstein in Primary Unilateral Inguinal Hernias According Chronic Pain|Enrolling by invitation||N/A|414|Actual|Skane University Hospital||2|||f||||f||||||||Undecided||2017-02-18 13:38:09.018578|2017-02-18 13:38:09.018578
NCT00803972|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-05-30|||November 2008||2008-11-01|May 2012|2012-05-01|January 2013|Anticipated|2013-01-01|December 2012|Anticipated|2012-12-01||Interventional|||Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20|A Phase I, Randomized, Dose-Ranging, Pharmacokinetic, Glucodynamic, Safety, and Tolerability Study of SC Administered Humulin R and Humalog With or Without Recombinant Human Hyaluronidase (rHuPH20) in Healthy Volunteers|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|Halozyme Therapeutics||1|||f||||f||||||||||2017-02-18 13:38:09.124367|2017-02-18 13:38:09.124367
NCT00803959|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-07-03|2013-05-07||November 2008||2008-11-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|ValUE||Value of Urodynamic Evaluation|A Randomized Trial of Urodynamic Testing Before Stress-Incontinence Surgery|Completed||Phase 4|630|Actual|New England Research Institutes||2|||f||||f||||||||||2017-02-18 13:38:09.23342|2017-02-18 13:38:09.23342
NCT00803946|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-03-15|||November 2003||2003-11-01|March 2012|2012-03-01||||November 2003|Actual|2003-11-01||Interventional|||Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions|A Randomized, Single-Dose, Two-Way Crossover Relative Bioavailability Study of Ibuprofen Tablet Formulations in Normal, Healthy Men and Women Following Standard Meal|Completed||Phase 1|30|Actual|Perrigo Company||2|||f||||||||||||||2017-02-18 13:38:09.898443|2017-02-18 13:38:09.898443
NCT00803933|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2008-12-05|||February 2003||2003-02-01|December 2008|2008-12-01|June 2005|Actual|2005-06-01|February 2004|Actual|2004-02-01||Interventional|||Trial of DB289 for the Treatment of Stage I African Trypanosomiasis|Phase II b Trial of DB289 for the Treatment of Stage I African Trypanosomiasis|Completed||Phase 2|111|Actual|Immtech Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 13:38:09.984324|2017-02-18 13:38:09.984324
NCT00803920|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2015-12-02|||December 2006||2006-12-01|August 2013|2013-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide|CGM Substudy, Addendum 2, of the Following Exenatide LAR Protocol 2993LAR-105: A Randomized, Open-Label, Multicenter, Comparator Controlled Study to Examine the Effects of Exenatide Long-Acting Release on Glucose Control (HbA1c) and Safety in Subjects With Type 2 Diabetes Mellitus Managed With Diet Modification and Exercise and/or Oral Antidiabetic Medications)|Completed||N/A|8|Actual|HealthPartners Institute|||2||f||||f||||||||||2017-02-18 13:38:10.100371|2017-02-18 13:38:10.100371
NCT00803907|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2012-06-12|||December 2008||2008-12-01|June 2012|2012-06-01|February 2013|Anticipated|2013-02-01|September 2012|Anticipated|2012-09-01||Interventional|Imiquimod||Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma|Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma|Unknown status|Recruiting|Phase 4|20|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-02-18 13:38:10.191094|2017-02-18 13:38:10.191094
NCT00803894|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-06-16|||December 2008||2008-12-01|June 2016|2016-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Clinical Study to Determine Biomarkers of Response to a Gamma Secretase Inhibitor|A Randomized Clinical Trial to Study the Effects of MK0752 Versus Placebo on Biomarkers in Healthy Young Adult Male Subjects|Completed||Phase 1|30|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:38:10.300096|2017-02-18 13:38:10.300096
NCT00803881|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-10-24|||December 2008||2008-12-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Observational|||Longitudinal Pathogen-colonization in Cystic Fibrosis Airways and Ability to Smell|Prevalence of Chronic Rhinosinusitis, Pathogen-colonization in the Upper and Lower Airways and Ability to Smell in Cystic Fibrosis|Recruiting||N/A|180|Anticipated|University of Jena|||1||f||||f||||||||||2017-02-18 13:38:10.400395|2017-02-18 13:38:10.400395
NCT00803868|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-07-23|||May 2009||2009-05-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia|Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia|Terminated||Phase 2/Phase 3|28|Actual|University of South Florida||2||"The DSMB recommended that the study be stopped as a result of concerns regarding safety and~   intolerability and insufficient evidence of efficacy."|f||||t||||||||||2017-02-18 13:38:10.513399|2017-02-18 13:38:10.513399
NCT00803855|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2009-05-14|||December 2008||2008-12-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|SAD||Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy Volunteers|A Phase I, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Single Ascending Dose Study to Asses the Safety, Tolerability, Pharmacokinetics of AZD1446 Including an Open Food Effect Panel in Healthy Male and Non-Fertile Female Volunteers|Completed||Phase 1|110|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:38:10.610529|2017-02-18 13:38:10.610529
NCT00803842|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2015-02-24|||October 2008||2008-10-01|February 2015|2015-02-01||||December 2009|Anticipated|2009-12-01||Interventional|||Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash|Evaluation of Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash|Withdrawn||N/A|0|Actual|Northwestern University||1||Investigator left the institution and decided not to continue with the study.|f||||t||||||||||2017-02-18 13:38:10.702118|2017-02-18 13:38:10.702118
NCT00803829|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2011-07-05|||January 2009||2009-01-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Synbiotic Treatment of Ulcerative Colitis Patients|Synbiotic Treatment of Ulcerative Colitis Patients|Completed||N/A|24|Actual|University of Dundee||1|||f||||f||||||||||2017-02-18 13:38:10.78552|2017-02-18 13:38:10.78552
NCT00803790|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-09-28|2011-01-27||May 2006||2006-05-01|September 2016|2016-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)|A 2-Part, Open-Label, Randomized, Crossover Study to Evaluate the Bioequivalence of the 70-mg Alendronate/5600 IU Vitamin D3 Final Market Combination Tablet to a 70-mg Alendronate Marketed Tablet, and the Relative Bioavailability of Vitamin D3|Completed||Phase 1|318|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 13:38:11.111882|2017-02-18 13:38:11.111882
NCT00803777|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2016-01-29|2010-03-08||December 2008||2008-12-01|January 2016|2016-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System|In-Clinic and Home-Use Study of the AVATAR Blood Glucose Monitoring System in Children and Young Adults|Completed||N/A|147|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-02-18 13:38:11.575734|2017-02-18 13:38:11.575734
NCT00803764|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2012-03-15|||June 2004||2004-06-01|March 2012|2012-03-01||||July 2004|Actual|2004-07-01||Interventional|||Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Two Oral Formulations of Naproxen 500 mg Tablets Administered as 1 x 500 mg Tablet in Healthy Subjects Under Fed Conditions|Completed||Phase 1|34|Actual|Perrigo Company||2|||f||||||||||||||2017-02-18 13:38:11.832861|2017-02-18 13:38:11.832861
NCT00803751|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2010-02-01|||May 2008||2008-05-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|Truview||A Comparison of the Infant Truview EVO2 Video Laryngoscope and the Macintosh Laryngoscope in Pediatric Patients|A Comparison of the Infant Truview EVO2 Video Laryngoscope and the Macintosh Laryngoscope in Pediatric Patients|Completed||N/A|50|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 13:38:11.912988|2017-02-18 13:38:11.912988
NCT00803738|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-05|2013-01-17|2012-05-11||December 2002||2002-12-01|January 2013|2013-01-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis|A Multi-center, Randomized, Investigator-blinded, Parallel-group Study, Designed to Evaluate the Safety and Clinical Equivalence of Terconazole Vaginal Suppositories, 80 mg (Test Product) and Terconazole Vaginal Suppositories, 80 mg (Reference Product) in the Treatment of Vulvovaginal Candidiasis Caused by Candida Species|Completed||N/A|572|Actual|Perrigo Company||2|||f||||f||||||||||2017-02-18 13:38:12.021108|2017-02-18 13:38:12.021108
NCT00803725|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-01-22|||August 2008||2008-08-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Spinal Mepivicaine With Fentanyl for Outpatient Knee Arthroscopy|Spinal Mepivicaine With Fentanyl for Outpatient Knee Arthroscopy Surgery|Completed||N/A|34|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:38:12.423089|2017-02-18 13:38:12.423089
NCT00803712|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-06-27|2013-12-03||February 2009||2009-02-01|June 2016|2016-06-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||20070360 Incident Dialysis|Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination With Low Dose Vitamin D for the Treatment of Subjects With Secondary Hyperparathyroidism (SHPT) Recently Initiating Hemodialysis|Completed||Phase 4|313|Actual|Amgen|This was an open-label study and neither investigators nor subjects were blinded to treatment modality. Cinacalcet was dosed by forced titration. Active vitamin D administration was at the discretion of the investigator in each treatment arm.|2|||f||||f||||||||||2017-02-18 13:38:12.527683|2017-02-18 13:38:12.527683
NCT00803699|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-04|||November 2005||2005-11-01|December 2008|2008-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|LoDoSe||Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels|Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels|Completed||N/A|262|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-02-18 13:38:16.749282|2017-02-18 13:38:16.749282
NCT00803686|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-06-05|2010-01-14||December 2008||2008-12-01|June 2014|2014-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||Only 12 women entered Part 1, the two-period crossover portion of the study; hence the same 12 received both oral treatments and should not be counted twice. Only 9 of those 12 went on to Part 2, the open label, non-crossover portion of the study.|A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women|A Randomized, Open-Label, Placebo-Controlled, Two-Period Crossover Study of the Effect on CTx-1 Concentrations of a Single 200 μg Recombinant Salmon Calcitonin (rsCT) Dose Given at Night to Normal, Healthy, Postmenopausal Women|Completed||Phase 2|12|Actual|Tarsa Therapeutics, Inc.||4|||f||||f||||||||||2017-02-18 13:38:16.864786|2017-02-18 13:38:16.864786
NCT00803673|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-11-04|||May 2008||2008-05-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Healthy Volunteer Study With Inhaled GSK573719 and Placebo|A Single Centre, Randomized, Double-blind, Dose Ascending, Placebo-controlled Study, in Two Parts, to Evaluate the Safety, Tolerability and Pharmacokinetics of Escalating Single and Repeat Inhaled Doses of GSK573719 and Placebo Formulated With the Excipient Magnesium Stearate, in Healthy Subjects and in a Healthy Population of Cytochrome P450 Isoenzyme 2D6 Poor Metabolisers.|Completed||Phase 1|36|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:38:17.402626|2017-02-18 13:38:17.402626
NCT00803660|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2009-07-08|||November 2008||2008-11-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|||||Observational|||Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes|In Practice Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes.|Completed||N/A|1060|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:38:17.51266|2017-02-18 13:38:17.51266
NCT00803647|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-07-26|2015-10-19||January 2010||2010-01-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|July 2013|Actual|2013-07-01||Interventional|||A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver|A Phase II Study to Determine the Surgical Conversion Rate in Patients Receiving Neoadjuvant mFOLFOX7 + Cetuximab for Unresectable Wild-Type K-RAS Colorectal Cancer With Metastases Confined to the Liver|Completed||Phase 2|20|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-02-18 13:38:17.615529|2017-02-18 13:38:17.615529
NCT00803452|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2010-11-23|||July 2008||2008-07-01|June 2010|2010-06-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Lipids of the Human Tear Film and Their Effect on Tear Stability|Lipids of the Human Tear Film and Their Effect on Tear Stability|Unknown status|Recruiting|Phase 4|400|Anticipated|University of Louisville||3|||f||||f||||||||||2017-02-18 13:38:21.29469|2017-02-18 13:38:21.29469
NCT00803634|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-08-21|2014-06-03||December 2008||2008-12-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|PRONTO|Safety Population: Includes all patients dosed with clevidipine (for patients randomized to the clevidipine arm) of standard of care (SOC) (for patients randomized to the SOC arm) continuous IV antihypertensive therapy.|Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)|A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)|Completed||Phase 3|117|Actual|The Medicines Company||2|||f||||t||||||||||2017-02-18 13:38:17.963339|2017-02-18 13:38:17.963339
NCT00803621|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-03-22|||June 2009||2009-06-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|TOXODFA||Cerebral Toxoplasmosis and AIDS|Cerebral Toxoplasmosis and AIDS in the French Departments of America (DFA). Diagnostic Contribution of a PCR Assay and Genetic Diversity of Toxoplasma Gondii.|Completed||N/A|46|Actual|University Hospital, Limoges|||1||f||||f||||||||||2017-02-18 13:38:18.982101|2017-02-18 13:38:18.982101
NCT00803608|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-08-12|||February 2009||2009-02-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CareFULPrevent||The CareFUL Prevention Trial|Prospective, Randomized, Multiple Site Clinical Trial Comparing the Effectiveness of Novel Pressure Based Insoles to Current Care For Ulcer Prevention|Completed||Phase 2|130|Actual|DIApedia, LLC||2|||f||||t||||||||||2017-02-18 13:38:19.079902|2017-02-18 13:38:19.079902
NCT00803595|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2011-11-29|2011-10-12||November 2008||2008-11-01|November 2011|2011-11-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|MARVEL||A Multinational Phase III Study of CS-8958 (MARVEL)|A Randomized Double-blind Controlled Study of CS-8958 Versus Oseltamivir Phosphate in Patients With Influenza Virus Infection|Completed||Phase 3|1002|Actual|Daiichi Sankyo Inc.||3|||f||||f||||||||||2017-02-18 13:38:19.205751|2017-02-18 13:38:19.205751
NCT00803582|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-01-20|||February 2007||2007-02-01|January 2010|2010-01-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Effectiveness of Acupuncture for Phonotraumatic Injuries|Effectiveness of Acupuncture for Phonotraumatic Injuries|Unknown status|Recruiting|Phase 2|135|Anticipated|The University of Hong Kong||3|||f||||t||||||||||2017-02-18 13:38:20.028734|2017-02-18 13:38:20.028734
NCT00803569|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2011-06-21|||November 2008||2008-11-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer|Phase I Study of ALVAC(2)-NY-ESO-1(M)/TRICOM in Patients With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen|Completed||Phase 1|6|Actual|Ludwig Institute for Cancer Research||1|||f||||t||||||||||2017-02-18 13:38:20.134123|2017-02-18 13:38:20.134123
NCT00803556|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2011-06-23|||January 2006||2006-01-01|June 2011|2011-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy|Phase 1 Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel|Completed||Phase 1|29|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 13:38:20.2372|2017-02-18 13:38:20.2372
NCT00803543|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-12-02|||January 2009||2009-01-01|November 2013|2013-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding|Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daiy Valacyclovir in the Reduction of HSV-2 Recurrences and Viral Shedding|Completed||N/A|103|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-02-18 13:38:20.351851|2017-02-18 13:38:20.351851
NCT00803530|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2011-06-27|||September 2005||2005-09-01|June 2011|2011-06-01|August 2010|Actual|2010-08-01|January 2007|Actual|2007-01-01||Interventional|||Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes|Phase II Multicenter Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes|Terminated||Phase 2|55|Anticipated|Fondazione Italiana Sindromi Mielodisplastiche Onlus||1||difficulties of enrollement|f||||f||||||||||2017-02-18 13:38:20.463859|2017-02-18 13:38:20.463859
NCT00803517|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2009-03-11|2008-11-12||March 2008||2008-03-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy|Comparison of Multifocal Electroretinogram Assessment Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy|Completed||N/A|24|Actual|Samsung Medical Center|||2||f||||t||||||||||2017-02-18 13:38:20.579596|2017-02-18 13:38:20.579596
NCT00803504|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-04|||November 2006||2006-11-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|||||Observational|||Correlation of Optic Disk Morphology and Ocular Perfusion Parameters in Patients With Primary Open Angle Glaucoma|Correlation of Optic Disk Morphology and Ocular Perfusion Parameters in Patients With Primary Open Angle Glaucoma|Completed||N/A|103|Actual|Medical University of Vienna|||||f||||t||||||||||2017-02-18 13:38:20.929474|2017-02-18 13:38:20.929474
NCT00803491|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-08-17|||December 2008||2008-12-01|August 2010|2010-08-01|February 2013|Anticipated|2013-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Health Related Quality of Life After a Self-promoting Learning Program for People With Rheumatic Diseases|Health Related Quality of Life After a Self-promoting Problem-based Learning Program for People With Rheumatic Diseases: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|200|Anticipated|Spenshult Hospital||2|||f||||f||||||||||2017-02-18 13:38:21.017555|2017-02-18 13:38:21.017555
NCT00803478|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-02-01|||June 2004||2004-06-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|September 2008|Actual|2008-09-01||Interventional|IDES||The Effect of Hinge Position and Hinge Width on Corneal Sensation and Dry Eye After IntraLase LASIK Procedure|The Effect of Hinge Position and Hinge Width on Corneal Sensation and Dry Eye After IntraLase LASIK Procedure|Withdrawn||N/A|0|Actual|University of Michigan||3|||f||||f||||||||||2017-02-18 13:38:21.115474|2017-02-18 13:38:21.115474
NCT00803465|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-03-15|||April 2003||2003-04-01|March 2012|2012-03-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Observational|||Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams|Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams|Completed||N/A|115|Actual|Perrigo Company|||5||f||||f||||||||||2017-02-18 13:38:21.209561|2017-02-18 13:38:21.209561
NCT00803439|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-03-15|||April 2005||2005-04-01|March 2012|2012-03-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Observational|||Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams|Bioequivalence of Two Clobetasol Propionate 0.05% Topical Foams|Completed||N/A|80|Actual|Perrigo Company|||4||f||||f||||||||||2017-02-18 13:38:21.405195|2017-02-18 13:38:21.405195
NCT00803426|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2009-08-07|||July 2008||2008-07-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Ultrasound Guided Popliteal Fossa Block. Does Blockade Distal to Sciatic Nerve Bifurcation Speed Onset Time? A Prospective, Randomized Trial|Ultrasound Guided Popliteal Fossa Block. Does Blockade Distal to Sciatic Nerve Bifurcation Speed Onset Time? A Prospective, Randomized Trial|Completed||N/A|55|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:38:21.490701|2017-02-18 13:38:21.490701
NCT00803413|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2008-12-04|2008-11-07||August 2002||2002-08-01|December 2008|2008-12-01|March 2004|Actual|2004-03-01|June 2003|Actual|2003-06-01||Interventional|||Effect of Back School and Supervised Walking in Sedentary Women With Chronic Low Back Pain|Effect of Back School and Supervised Walking in Sedentary Women With Chronic Low Back Pain: a Randomized Controlled Trial.|Completed||N/A|119|Actual|University of Sao Paulo||4|||f||||f||||||||||2017-02-18 13:38:21.596771|2017-02-18 13:38:21.596771
NCT00803400|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2009-04-21|2008-11-07||July 2005||2005-07-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|AEIPDT||Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment|Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment: a Clinical Randomized Trial|Completed||Phase 4|150|Actual|University of Buenos Aires|"Panic patients may sometimes be reluctant to use medication. This could lead to early drop outs.~Possible difficulties in following the exercise protocol."|2|||f||||f||||||||||2017-02-18 13:38:22.322296|2017-02-18 13:38:22.322296
NCT00803387|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2008-12-04|||April 2008||2008-04-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative|Dry Eye and Irritation Comparison of Latanoprost 0.005% With the Preservative Benzalkonium Chloride (BAC) Vs Travoprost 0.004% Without BAC|Completed||N/A|33|Actual|United States Air Force|||1||f||||||||||||||2017-02-18 13:38:22.767767|2017-02-18 13:38:22.767767
NCT00803374|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2011-11-18|||November 2010||2010-11-01|November 2011|2011-11-01|January 2013|Anticipated|2013-01-01|July 2012|Anticipated|2012-07-01||Interventional|||Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma|A Phase I, Multiple Ascending Dose Study of BMS-663513 (Anti CD137) in Combination With Ipilimumab (BMS-734016/Anti-CTLA-4) in Subjects With Unresectable Stage III or Stage IV Melanoma|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-02-18 13:38:22.88007|2017-02-18 13:38:22.88007
NCT00803361|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2010-11-19|2010-11-19||December 2008||2008-12-01|November 2010|2010-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Duloxetine for the Treatment of Generalized Anxiety Disorder|Duloxetine Versus Placebo in the Treatment of Patients With Generalized Anxiety Disorder in China|Completed||Phase 3|210|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:38:23.015428|2017-02-18 13:38:23.015428
NCT00803348|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-04-25|||May 2009||2009-05-01|January 2010|2010-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee Arthroplasty|The Secret Recipe for Femoral Nerve Blockade After Total Knee Arthroplasty: A Randomized, Placebo-controlled, Double-blind Trial|Completed||N/A|99|Actual|University Health Network, Toronto||3|||f||||f||||||||||2017-02-18 13:38:23.818292|2017-02-18 13:38:23.818292
NCT00803335|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2015-05-25|||December 2008||2008-12-01|February 2014|2014-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse|The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse: A Randomized Control Trial|Completed||Phase 3|54|Actual|TriHealth Inc.||3|||f||||f||||||||||2017-02-18 13:38:23.919056|2017-02-18 13:38:23.919056
NCT00803322|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-04|||September 2006||2006-09-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|September 2007|Actual|2007-09-01||Observational|community||Improving Community Based Tuberculosis Care in Ethiopia|Community Health Workers Improve Tuberculosis Case Notification and Treatment Success in Southern Ethiopia|Completed||Phase 4|318|Actual|University of Bergen|||2||f||||f||||||||||2017-02-18 13:38:24.039137|2017-02-18 13:38:24.039137
NCT00803309|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2015-03-18|||November 2008||2008-11-01|March 2015|2015-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|OPTEX2/3||Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients|Optimization of Treatment for Patients With Chronic Hepatitis C Infected With HCV-genotype 2 or 3: 12 vs. 24 Weeks of Treatment Extension for Patients Without Rapid Virological Response|Terminated||Phase 4|99|Actual|HepNet Study House, German Liverfoundation||2||"At the end of the planned recruitment period the expected number of subjects could not be~   included in the trial."|f||||t||||||||||2017-02-18 13:38:24.139775|2017-02-18 13:38:24.139775
NCT00803296|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-01-12|||January 2006||2006-01-01|December 2008|2008-12-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Observational|BMI-INK||Incretin Effect in Lean and Obese Subjects|The Impact of Obesity and Insulin Resistance on the Incretin Effect in Patients With Type 2 Diabetes and Healthy Subjects|Completed||N/A|32|Actual|University Hospital, Gentofte, Copenhagen|||4||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 13:38:24.311776|2017-02-18 13:38:24.311776
NCT00803283|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2013-08-08|2013-05-07||November 2008||2008-11-01|August 2013|2013-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain|A Randomized, Open-Labeled, Multi-Center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCl Comparing With Morphine SR in Cancer Pain Patients|Terminated||Phase 3|2|Actual|Johnson & Johnson Taiwan Ltd|This study had inadequate number of participants. 'The study was terminated early and the data for efficacy assessments were missing.|2|||f||||||||||||||2017-02-18 13:38:24.422006|2017-02-18 13:38:24.422006
NCT00803270|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2013-05-08|2012-03-26||October 2008||2008-10-01|May 2013|2013-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|MIMOSA||Mixed Incontinence: Medical Or Surgical Approach?|Mixed Incontinence: Medical Or Surgical Approach?|Terminated||Phase 4|27|Actual|New England Research Institutes|Early termination leading to small numbers of participants for data analysis.|2||Feasibility Period ended.|f||||t||||||||||2017-02-18 13:38:24.863877|2017-02-18 13:38:24.863877
NCT00803244|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-27|2016-04-18|2016-01-25||January 2009||2009-01-01|April 2016|2016-04-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional||"Safety Set: The Safety Set included all patients who received at least one dose of the investigational product.~The Full Analysis Set included all patients who received at least one dose of the investigational product and had at least one Adjusted Symptom Score during the pollen period while on treatment."|Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis|A Randomised, Double-blind, Placebo-controlled, Multi National, Phase III Study of the Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablet, Starting 2 Months Before the Grass Pollen Season Once Daily to Patients Suffering From Grass Pollen Rhinoconjunctivitis|Completed||Phase 3|381|Actual|Stallergenes||2|||f||||f||||||||||2017-02-18 13:38:25.363045|2017-02-18 13:38:25.363045
NCT00803231|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-02-01|||November 2008||2008-11-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Follow-up Data of Patients Treated With XIGRIS® in France|Follow-up Data of Patients Treated With XIGRIS® DROTRECOGIN ALFA (ACTIVATED) in France|Completed||N/A|1004|Actual|Eli Lilly and Company|||2||f||||f||||||||||2017-02-18 13:38:25.695346|2017-02-18 13:38:25.695346
NCT00803218|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-03-15|||November 2002||2002-11-01|March 2012|2012-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Observational|||Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments|Bioequivalence of Two Fluticasone Propionate 0.005% Topical Ointments|Completed||N/A|56|Actual|Perrigo Company|||2||f||||f||||||||||2017-02-18 13:38:25.987016|2017-02-18 13:38:25.987016
NCT00803205|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2013-08-14||2013-06-27|July 2009||2009-07-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|November 2011|Actual|2011-11-01||Interventional|||Study of Ataluren (PTC124™) in Cystic Fibrosis|A Phase 3 Efficacy and Safety Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis|Completed||Phase 3|238|Actual|PTC Therapeutics||2|||f||||t||||||||||2017-02-18 13:38:26.07278|2017-02-18 13:38:26.07278
NCT00803192|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2012-03-15|||June 2004||2004-06-01|March 2012|2012-03-01||||June 2004|Actual|2004-06-01||Interventional|||Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Famotidine 40 mg Tablets Administered as 1 x 40 mg Tablet in Healthy Subjects Under Fed Conditions|Completed||Phase 1|44|Actual|Perrigo Company||2|||f||||||||||||||2017-02-18 13:38:26.233518|2017-02-18 13:38:26.233518
NCT00803179|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-12-10|2012-11-13||November 2008||2008-11-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Growth Hormone Therapy for Wasting in Cystic Fibrosis|Growth Hormone Therapy for Wasting in Cystic Fibrosis|Terminated||Phase 1|5|Actual|University of Massachusetts, Worcester||1||Poor enrollment, patients were lost to follow up|f||||f||||||||||2017-02-18 13:38:26.316643|2017-02-18 13:38:26.316643
NCT00803166|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-03-15|||January 2004||2004-01-01|March 2012|2012-03-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Observational|||Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams|Bioequivalence of Three Halobetasol Propionate 0.05% Topical Creams|Completed||N/A|60|Actual|Perrigo Company|||2||f||||f||||||||||2017-02-18 13:38:26.545346|2017-02-18 13:38:26.545346
NCT00803153|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-04||||||December 2008|2008-12-01||||||||Observational|||PASCAL: Safety and Complications, Experience After 1301 Consecutive Cases|Pattern Scan Laser Photocoagulation: Safety and Complications, Experience After 1301 Consecutive Cases.|Completed||N/A|||Asociación para Evitar la Ceguera en México|||1||f||||t||||||||||2017-02-18 13:38:26.638837|2017-02-18 13:38:26.638837
NCT00803140|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2015-05-27|||November 2008||2008-11-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Cutaneous Scarring of Scalpel Versus Cautery|A Pilot Study Comparing Cutaneous Scarring When Scalpel Versus Cautery is Used to Make Skin Incisions|Terminated||N/A|4|Actual|Scott and White Hospital & Clinic||2||Slow accrual of subject enrollment.|f||||f||||||||||2017-02-18 13:38:26.719609|2017-02-18 13:38:26.719609
NCT00803127|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2009-08-10|||January 2009||2009-01-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Observational|||VS-Sense Result Reading Clarity|VS-Sense Result Reading Clarity|Completed||N/A|120|Anticipated|Carmel Medical Center|||1||f||||||||||Samples With DNA|"~     VAGINAL DISCHARGE~   "|||2017-02-18 13:38:26.824635|2017-02-18 13:38:26.824635
NCT00803114|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2009-01-13|2008-11-07||March 2002||2002-03-01|December 2008|2008-12-01|February 2005|Actual|2005-02-01|November 2004|Actual|2004-11-01||Interventional|||Epidural Morphine Following Vaginal Delivery|Epidural Morphine Following Vaginal Delivery: A Randomised, Double-Blind, Placebo-Controlled Trial|Completed||Phase 4|228|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-02-18 13:38:26.921446|2017-02-18 13:38:26.921446
NCT00803101|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2015-03-18|2014-01-12||February 2009||2009-02-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|BE1116_3003|The Intention-to-Treat Efficacy (ITT-E) population included all randomized participants who had received any study product, underwent the intended surgical procedure, and had an INR > 1.3 prior to the infusion. Participants in the ITT-E population were analyzed 'as randomized'.|An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure|An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure|Completed||Phase 3|176|Actual|CSL Behring||2|||f||||||||||||||2017-02-18 13:38:27.500838|2017-02-18 13:38:27.500838
NCT00803088|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2015-06-17|||July 2010||2010-07-01|June 2015|2015-06-01||||December 2011|Anticipated|2011-12-01||Interventional|3to2||Safety of Bronchial Thermoplasty Performed With the Alair® System During Two Treatment Sessions to Treat Severe Asthma|A Multicenter Clinical Trial Evaluating the Safety of Bronchial Thermoplasty Performed With the Alair® System During Two Treatment Sessions to Treat Severe Asthma.|Withdrawn||N/A|0|Actual|Asthmatx, Inc.||1||Current treatment regimen of 3 procedures considered acceptable.|f||||t||||||||||2017-02-18 13:38:28.257123|2017-02-18 13:38:28.257123
NCT00803075|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2008-12-18|||February 2002||2002-02-01|December 2008|2008-12-01||||||||Interventional|||Endovascular Repair of Abdominal Aortic Aneurysms|TALENT Endoluminal Stent Graft System for the Treatment of Abdominal Aortic Aneurysms|Completed||Phase 4|200||Stanford University|||||||||||||||||||2017-02-18 13:38:28.359189|2017-02-18 13:38:28.359189
NCT00803062|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-04-15|2015-12-15||April 2009||2009-04-01|February 2015|2015-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||All enrolled patients.|Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer|A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865) Versus the Non-platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix|Completed||Phase 3|452|Actual|National Cancer Institute (NCI)||4|||f||||t||||||||||2017-02-18 13:38:28.493265|2017-02-18 13:38:28.493265
NCT00803049|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-12-05|2016-12-05||October 2006||2006-10-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis|Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses|Completed||Phase 3|742|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 13:38:31.44696|2017-02-18 13:38:31.44696
NCT00803036|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-11-08|||January 2009||2009-01-01|November 2010|2010-11-01|September 2013|Anticipated|2013-09-01|March 2013|Anticipated|2013-03-01||Observational|COSBID-TBI||Observational Study of Cortical Spreading Depression in Human Brain Trauma|Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain|Unknown status|Recruiting|N/A|180|Anticipated|University of Cincinnati|||1||f||||t||||||||||2017-02-18 13:38:35.657|2017-02-18 13:38:35.657
NCT00803023|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2011-08-17|2011-07-21||March 2010||2010-03-01|August 2011|2011-08-01||||July 2010|Actual|2010-07-01||Interventional|||Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia|Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia|Completed||Phase 3|129|Actual|Jazz Pharmaceuticals||4|||f||||f||||||||||2017-02-18 13:38:35.756711|2017-02-18 13:38:35.756711
NCT00803010|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2015-07-10|2013-12-10||September 2008||2008-09-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Based on our preliminary data collected from patients receiving TAC/MTX, the acute GVHD (aGVHD) rate is estimated to be 80% at 100 days. A two-sided log-rank test will achieve 90% power at a 0.1 significance level. The result of this calculation serves as an approximation of power/sample size for the test we propose to use for the primary endpoint.|Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation|Phase II Trial of Tacrolimus and Rapamycin vs. Tacrolimus and Methotrexate as GVHD Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation|Completed||Phase 2|74|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-02-18 13:38:37.065762|2017-02-18 13:38:37.065762
NCT00802997|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2013-11-08|2013-08-02||June 2008||2008-06-01|November 2013|2013-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Trial Assessing Cooled Radiofrequency Denervation as a Treatment for Sacroiliac Joint Pain Using the Sinergy System|A Double Blind, Randomized, Controlled Trial Assessing Cooled Radiofrequency Denervation as a Treatment fr Sacroiliac Joint Pain Using the Sinergy System|Completed||N/A|51|Actual|Baylis Medical Company||2|||f||||f||||||||||2017-02-18 13:38:37.510697|2017-02-18 13:38:37.510697
NCT00802984|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2008-12-12|||January 2002||2002-01-01|December 2008|2008-12-01||||||||Interventional|||Endovascular Repair of Descending Thoracic Aortic Aneurysms|Endovascular Treatment of Thoracic Aortic Aneurysms Using the TALENT Stent Graft System|Completed||Phase 4|100||Stanford University|||||||||||||||||||2017-02-18 13:38:37.870322|2017-02-18 13:38:37.870322
NCT00802971|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2009-11-16|||December 2008||2008-12-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Idiopathic Reactive Hypoglycaemia and Treatment With Fructo-Oligosaccharide|Prevalence of Idiopathic Reactive Hypoglycaemia and Impact of Fructo-Oligosaccharide Supplementation on Blood Glucose Variability|Completed||N/A|12|Actual|Asker & Baerum Hospital||2|||f||||f||||||||||2017-02-18 13:38:37.962478|2017-02-18 13:38:37.962478
NCT00802958|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-03-15|||July 2003||2003-07-01|March 2012|2012-03-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Observational|||Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments|Bioequivalence of Two Halobetasol Propionate 0.05% Topical Ointments|Completed||N/A|76|Actual|Perrigo Company|||3||f||||f||||||||||2017-02-18 13:38:38.066532|2017-02-18 13:38:38.066532
NCT00802945|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-08-12||2014-08-12|October 2008||2008-10-01|August 2014|2014-08-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional|||Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer|A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 When Given on a Q14 Day or a Q21 Day Schedule in Patients With Metastatic or Locally Advanced Breast Cancer Whose Disease Has Failed Prior Taxane-Based Treatment|Completed||Phase 2|70|Actual|Nektar Therapeutics||2|||f||||f||||||||||2017-02-18 13:38:38.148863|2017-02-18 13:38:38.148863
NCT00802932|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2013-01-29|||March 2008||2008-03-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx|Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Treatment|Completed||N/A|61|Actual|H. Lee Moffitt Cancer Center and Research Institute|||2||f||||f||||||||||2017-02-18 13:38:38.259619|2017-02-18 13:38:38.259619
NCT00802919|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-05-16|||September 2008||2008-09-01|May 2012|2012-05-01||||December 2012|Anticipated|2012-12-01||Interventional|||Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors|Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors, Independent Investigator Study|Unknown status|Recruiting|Phase 4|60|Anticipated|Nathan Kline Institute for Psychiatric Research||2|||f||||f||||||||||2017-02-18 13:38:38.370533|2017-02-18 13:38:38.370533
NCT00802906|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-09-26|||May 2007||2007-05-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)|Prospective Study on the Efficacy of 1.5mg Bevacizumab Versus Selective Subthreshold Micropulslaser in Central Serous Chorioretinopathy|Completed||N/A|12|Actual|Johann Wolfgang Goethe University Hospital||3|||f||||f||||||||||2017-02-18 13:38:38.477051|2017-02-18 13:38:38.477051
NCT00802893|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2008-12-04|||December 2008||2008-12-01|December 2008|2008-12-01||||||||Interventional|||Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction|Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel Study of Oral 6R-BH4 in Subjects Wity Isolated Systolic Hypertension and Endothelial Dysfunction|Unknown status|Recruiting|Phase 2|100|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 13:38:38.576999|2017-02-18 13:38:38.576999
NCT00802880|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-12-20|2016-06-16||March 2009||2009-03-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma|Determination of Tumor Response Rate by RECIST and FDG-PET Criteria to Dacarbazine in Metastatic Soft Tissue and Bone Sarcoma|Completed||Phase 2|80|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 13:38:38.676439|2017-02-18 13:38:38.676439
NCT00802867|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-04-12|2009-09-24||February 2004||2004-02-01|April 2016|2016-04-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|||Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™|Safety and Immunogenicity of DAPTACEL® (CP10/5/5/3DT Aventis Pasteur 5-component Pertussis Vaccine in Combination With Tetanus and Diphtheria Toxoids Adsorbed) Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ (HCP20/20/5/3DT-mIPV//PRP-T)|Completed||Phase 4|989|Actual|Sanofi||1|||f||||t||||||||||2017-02-18 13:38:39.300293|2017-02-18 13:38:39.300293
NCT00802854|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2016-07-11|||March 2012||2012-03-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV|Post Marketing Surveillance Study To Observe Safety And Effectiveness Of Eraxis (Registered) Iv.|Completed||N/A|244|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:38:39.798344|2017-02-18 13:38:39.798344
NCT00802841|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2015-10-15|2015-07-15||May 2009||2009-05-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|LASOR||Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib|A Randomized Phase Lll Study of Imatinib Dose Optimization Compared With Nilotinib in Patients With Chronic Myelogenous Leukemia and Suboptimal Response to Standard-dose Imatinib|Completed||Phase 3|191|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:38:39.913953|2017-02-18 13:38:39.913953
NCT00802828|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2012-03-15|||June 2004||2004-06-01|March 2012|2012-03-01||||June 2004|Actual|2004-06-01||Interventional|||Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Famotidine 40 mg Tablets Administered as 1 x 40 mg Tablet in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|44|Actual|Perrigo Company||2|||f||||||||||||||2017-02-18 13:38:40.73824|2017-02-18 13:38:40.73824
NCT00802815|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-05-28|||April 2005||2005-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis|Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis|Completed||Early Phase 1|20|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 13:38:40.825461|2017-02-18 13:38:40.825461
NCT00802802|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-05-09|||October 2009||2009-10-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children|Dose-Finding and Pharmacogenetic Study of Efavirenz in HIV-infected and HIV/TB Co-infected Infants and Children 3 Months to Less Than 36 Months of Age|Completed||Phase 1|155|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 13:38:40.938919|2017-02-18 13:38:40.938919
NCT00802789|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-04-07|||April 2007||2007-04-01|April 2016|2016-04-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Observational|||Montelukast in Chronic Asthma|Montelukast in Chronic Asthma: Non-interventional Study With Montelukast 10 mg|Completed||N/A|2000|Actual|Merck Sharp & Dohme Corp.|||1||f||||||||||||||2017-02-18 13:38:41.074249|2017-02-18 13:38:41.074249
NCT00802776|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2015-06-04|||October 2007||2007-10-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|December 2010|Actual|2010-12-01||Interventional|FLAK||Femtosecond Laser Assisted Keratoplasty||Active, not recruiting||N/A|24|Actual|University of Michigan||2|||f||||||||||||||2017-02-18 13:38:41.15175|2017-02-18 13:38:41.15175
NCT00802763|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2008-12-04|||February 2009||2009-02-01|December 2008|2008-12-01|August 2009|Anticipated|2009-08-01|July 2009|Anticipated|2009-07-01||Observational|||Performance Proof of the New NORMA-SENSE|Performance Proof of the New NORMA-SENSE Panty Liner - in-Vivo STUD|Unknown status|Not yet recruiting|N/A|224|Anticipated|Carmel Medical Center|||1||f||||t||||||None Retained|"~     VAGINAL SECRETIONS~   "|||2017-02-18 13:38:41.248375|2017-02-18 13:38:41.248375
NCT00802750|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-09-27|||November 2008||2008-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:38:41.337499|2017-02-18 13:38:41.337499
NCT00802737|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-04-24|2012-05-17||January 2009||2009-01-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|September 2011|Actual|2011-09-01||Interventional|||Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)|A Single-arm, International, Multi-center Trial Investigating the Efficacy and Safety of Ofatumumab Retreatment and Maintenance in CLL Patients Who Progressed Following Response or Stable Disease After Ofatumumab Treatment in Hx-CD20-406|Completed||Phase 4|29|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 13:38:41.397532|2017-02-18 13:38:41.397532
NCT00802724|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-10-18|||February 2007||2007-02-01|October 2012|2012-10-01|November 2010|Actual|2010-11-01|August 2009|Actual|2009-08-01||Interventional|||Classification-Directed Treatment of Low Back Pain|Classification-Directed Treatment of Low Back Pain|Completed||Phase 1|101|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 13:38:42.625039|2017-02-18 13:38:42.625039
NCT00802711|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-12-30|||September 2008||2008-09-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer|Phase II Randomised Clinical Trial of Accelerated Partial Breast Irradiation (APBI) Comparing 3-Dimensional Conformal Radiation Therapy and Multi-Catheter Interstitial Brachytherapy.|Terminated||Phase 2|6|Actual|Cancer Trials Ireland||2||Slow accrual|f||||||||||||||2017-02-18 13:38:42.893941|2017-02-18 13:38:42.893941
NCT00802698|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-04|||April 2008||2008-04-01|December 2008|2008-12-01||||April 2008|Anticipated|2008-04-01||Interventional|||The Effect of Transcorneal Stimulation in Cases of Central Retinal Artery Occlusion Using a New Waveform||Unknown status|Recruiting|Phase 1/Phase 2|5|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||||||||||||2017-02-18 13:38:43.002285|2017-02-18 13:38:43.002285
NCT00802685|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-01-03|2013-06-17||November 2007||2007-11-01|December 2013|2013-12-01|February 2011|Actual|2011-02-01|August 2010|Actual|2010-08-01||Interventional|||Timing of PDA Closure and Respiratory Outcome in Premature Infants|Timing of PDA Closure and Respiratory Outcome in Premature Infants|Terminated||N/A|105|Actual|University of Miami||2||Lack of availability of IV ibuprofen as of 8/10 due to a manufacturer's recall|f||||t||||||||||2017-02-18 13:38:43.116506|2017-02-18 13:38:43.116506
NCT00802672|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2013-01-17|2012-05-17||December 2003||2003-12-01|January 2013|2013-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis|A Double-blind, Randomized, Parallel-group, Vehicle-controlled, Multi-center Study to Evaluate the Safety and Clinical Equivalence of a Generic Ciclopirox Olamine Cream to Ciclopirox Cream 0.77% in the Treatment of Tinea Pedis|Completed||Phase 3|561|Actual|Perrigo Company||3|||f||||f||||||||||2017-02-18 13:38:43.532905|2017-02-18 13:38:43.532905
NCT00802659|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2014-11-18|2014-11-10||March 2008||2008-03-01|November 2014|2014-11-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain|A Phase I/II Dose Escalation Study to Evaluate Pain Response Using Extracranial Stereotactic Radiosurgery to Treat Paraspinal Metastasis in Patients Who Have Received Prior Spinal Irradiation|Terminated||N/A|2|Actual|Washington University School of Medicine|The study was closed early due to slow accrual.|4||Terminated due to low accrual|f||||t||||||||||2017-02-18 13:38:44.07769|2017-02-18 13:38:44.07769
NCT00802646|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2009-07-02|||June 2009||2009-06-01|July 2009|2009-07-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|CSE||The Effects of Combined Spinal Epidurals on Fever During Labor of First-Time Mothers|Randomized, Double-Blind, Placebo-Controlled Study of Effects of Combined Spinal Epidural Analgesia on Intrapartum Fever.|Withdrawn||N/A|168|Anticipated|Ochsner Health System||2||study moved to alternate site|f||||t||||||||||2017-02-18 13:38:44.621612|2017-02-18 13:38:44.621612
NCT00802633|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2013-12-21|2013-12-21||November 2008||2008-11-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?|Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?|Terminated||N/A|80|Actual|Vanderbilt University|Study terminated after 80 subjects|2||Enrollment was stopped after eighty patients were enrolled.|f||||f||||||||||2017-02-18 13:38:44.741962|2017-02-18 13:38:44.741962
NCT00802620|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2008-12-04|||June 2005||2005-06-01|December 2008|2008-12-01||||June 2005|Actual|2005-06-01||Interventional|||Amniotic Membrane Associated With Conjunctival Autograft Versus Conjunctival Autograft for Recurrent Pterygia||Unknown status|Enrolling by invitation|Phase 1|40|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 13:38:45.072943|2017-02-18 13:38:45.072943
NCT00802607|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2017-01-24|||December 2, 2008||2008-12-02|October 4, 2010|2010-10-04|October 4, 2010||2010-10-04|||||Observational|||Collection of Tissue Specimens for Analysis and Establishment of Cell Cultures|Procurement of Normal and Abnormal Bone, Dermis and Adipose Tissue for Establishment of Cell Cultures and Tissue Analysis|Completed||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:38:45.15441|2017-02-18 13:38:45.15441
NCT00802594|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-04|||August 2001||2001-08-01|December 2008|2008-12-01|November 2004|Actual|2004-11-01|August 2002|Actual|2002-08-01||Interventional|||A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis|Phase II A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis|Completed||Phase 2|30|Actual|Immtech Pharmaceuticals, Inc||1|||f||||f||||||||||2017-02-18 13:38:45.234138|2017-02-18 13:38:45.234138
NCT00802581|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2011-12-08|||May 2009||2009-05-01|May 2010|2010-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Circumferential Spread of Anesthetic and Success in Sciatic Nerve Blockade|Does Ensuring Circumferential Local Anesthetic Spread Improve the Success of Ultrasound Guided Sciatic Nerve Block at the Popliteal Fossa?|Completed||N/A|64|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:38:45.344966|2017-02-18 13:38:45.344966
NCT00802568|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2011-05-13|||April 2007||2007-04-01|December 2008|2008-12-01||||May 2011|Actual|2011-05-01||Interventional|||Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment|Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation Following Reduced Intensity Conditioning in Treating Patients With Multiple Myeloma|Completed||Phase 2|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:38:45.439779|2017-02-18 13:38:45.439779
NCT00802555|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-07-11|||January 2009||2009-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)|A Phase 1b Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)|Completed||Phase 1|21|Actual|ArQule||1|||f||||f||||||||||2017-02-18 13:38:45.542087|2017-02-18 13:38:45.542087
NCT00802542|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-12-02|||November 2008||2008-11-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||In-practice Evaluation of Atacand 16mg Antihypertensive Effect|In-practice Evaluation of Atacand 16mg Antihypertensive Effect|Completed||N/A|400|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:38:45.653377|2017-02-18 13:38:45.653377
NCT00802529|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-08-31|2016-05-09||April 2009||2009-04-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease|Effectiveness of Transtympanic Steroids in Unilateral Ménière's Disease: a Randomised Controlled Double-Blind Trial|Completed||Phase 2/Phase 3|60|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 13:38:45.756932|2017-02-18 13:38:45.756932
NCT00802516|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2008-12-04|||June 2003||2003-06-01|December 2008|2008-12-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|LTS||Long Term Effects of Plant Sterol and Stanol Esters|Effects of Long-Term Daily Consumption of Plant Sterol or Stanol Esters in Statin-Treated Patients|Completed||N/A|60|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-02-18 13:38:46.197122|2017-02-18 13:38:46.197122
NCT00802503|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2013-04-18|2013-01-07||May 2008||2008-05-01|April 2013|2013-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Impact of SPN on Infection Rate, Duration of Mechanical Ventilation & Rehabilitation in ICU Patients|Impact of Supplemental Parenteral Nutrition (SPN) on Infection Rate, Duration of Mechanical Ventilation and Rehabilitation in Intensive Care Unit Patients: A Quality Control Program for the Implementing of New Nutrition Guidelines|Completed||Phase 3|305|Actual|University Hospital, Geneva|The trial was limited by the fact that it was not double blinded by design. However, the risk of bias was reduced because the investigators worked independently from the physicians in charge of the patients.|2|||f||||f||||||||||2017-02-18 13:38:46.295475|2017-02-18 13:38:46.295475
NCT00802490|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2013-02-20|||May 2008||2008-05-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|EEG||Effectiveness of a Electroencephalogram (EEG) Biofeedback for the Treatment of ADHD|Pilot Trial of a Brain-computer Interface System Based Programme for the Treatment of ADHD|Completed||N/A|20|Anticipated|National Healthcare Group, Singapore||2|||f||||t||||||||||2017-02-18 13:38:46.794771|2017-02-18 13:38:46.794771
NCT00802477|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2011-07-29|||December 2008||2008-12-01|July 2011|2011-07-01|March 2012|Anticipated|2012-03-01|January 2012|Anticipated|2012-01-01||Interventional|||Application Of Autologous Blood Products During Modified Radical Mastectomy|Prospective Randomized Study Comparing Mastectomy Outcomes With Versus Without the Application of Autologous Blood Products to the Surgical Site|Unknown status|Recruiting|Phase 3|100|Anticipated|Marshall University||2|||f||||t||||||||||2017-02-18 13:38:46.90195|2017-02-18 13:38:46.90195
NCT00802464|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2010-10-21||2009-11-10|January 2009||2009-01-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years|Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older|Completed||Phase 2|410|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 13:38:47.093724|2017-02-18 13:38:47.093724
NCT00802451|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2012-03-15|||February 2003||2003-02-01|March 2012|2012-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations|A Study to Evaluate the Relative Bioavailability of Two Mesalamine 4 gm/60 ml Rectal Enema Formulations|Completed||N/A|48|Actual|Perrigo Company||2|||f||||f||||||||||2017-02-18 13:38:47.218499|2017-02-18 13:38:47.218499
NCT00802438|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-04|2016-05-04|||June 2008||2008-06-01|May 2016|2016-05-01|March 2018|Anticipated|2018-03-01|March 2013|Actual|2013-03-01||Interventional|||Eosinophilic Airway Inflammation and Mepolizumab|Eosinophilic Airway Inflammation: Relationship to Remodeling and Modulation by Mepolizumab|Active, not recruiting||N/A|20|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||Yes||2017-02-18 13:38:47.309292|2017-02-18 13:38:47.309292
NCT00802425|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-06-24||2013-01-29|December 2008||2008-12-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss|Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss: A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Dose-Escalation Phase II Study|Completed||Phase 2|210|Actual|Auris Medical, Inc.||3|||f||||t||||||||||2017-02-18 13:38:47.406743|2017-02-18 13:38:47.406743
NCT00802412|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2016-12-06|2016-09-27||January 2009||2009-01-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|November 2014|Actual|2014-11-01||Interventional|||Topiramate to Aid Smoking Cessation in Alcohol Dependent Men|Topiramate to Aid Smoking Cessation in Recovering Alcohol Dependent Men|Completed||Phase 2|132|Actual|VA Office of Research and Development|Dually-dependent male smokers with high rates of SUDs and psychiatric disorders, thus not generalizable to other populations; topiramate dose lower than the dose found to reduce smoking in active alcoholics; attrition may have impacted results.|2|||f||||t||||||||||2017-02-18 13:38:47.505827|2017-02-18 13:38:47.505827
NCT00802399|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2009-01-21|||September 2008||2008-09-01|August 2008|2008-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|PLPO||Partial Lacrimal Punctual Occlusion|Partial Lacrimal Punctual Occlusion in the Management of Dry Eye|Completed||N/A|37|Actual|University of Sao Paulo General Hospital||1|||f||||t||||||||||2017-02-18 13:38:47.933341|2017-02-18 13:38:47.933341
NCT00802386|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2015-07-30|||January 2008||2008-01-01|July 2015|2015-07-01|May 2011|Actual|2011-05-01|March 2009|Actual|2009-03-01||Observational|||Bacterial Vaginosis Screening at IUD Insertion|Screening for Bacterial Vaginosis Screening at IUD Insertion: Is There a Role?|Completed||N/A|70|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||Samples With DNA|"~     WHOLE BLOOD; VAGINAL SWAB~   "|||2017-02-18 13:38:48.017974|2017-02-18 13:38:48.017974
NCT00802373|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-09-17|||July 2003||2003-07-01|September 2014|2014-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|STAR||Solifenacin Succinate Versus Tolterodine 4mg Once Daily|Solifenacin in a Flexible Dose Regimen With Tolterodine as an Active Comparator in a Double-blind, Double-dummy, Randomised Overactive Bladder Symptom Trial|Completed||Phase 3|1355|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 13:38:48.258506|2017-02-18 13:38:48.258506
NCT00802360|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2011-10-31|2011-05-03||December 2008||2008-12-01|October 2011|2011-10-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||MENOPUR® Versus FOLLISTIM®|A Multi-Center, Randomized, Open-Label Evaluation of MENOPUR® Versus FOLLISTIM® in GnRH Antagonist Cycles|Completed||Phase 4|173|Actual|Ferring Pharmaceuticals|This was an exploratory study that could be used as the basis for larger, adequately-powered studies. This limitation is the reason no statistical analyses are offered for study outcomes.|4|||f||||f||||||||||2017-02-18 13:38:48.506152|2017-02-18 13:38:48.506152
NCT00802347|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-09-08||2014-09-08|December 2008||2008-12-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|November 2013|Actual|2013-11-01||Interventional|||I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation|Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation|Completed||Phase 1/Phase 2|374|Actual|Quark Pharmaceuticals||2|||f||||t||||||||||2017-02-18 13:38:49.642705|2017-02-18 13:38:49.642705
NCT00802334|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-03-24|||January 2008||2008-01-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||TDM of Generic Lopinavir/Ritonavir 200/50 mg|Therapeutic Drug Monitoring of the Generic Lopinavir/Ritonavir Tablets 200/50 mg in the Thai HIV-infected Patient|Completed||Phase 2|70|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||f||||||||||2017-02-18 13:38:49.791048|2017-02-18 13:38:49.791048
NCT00802321|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2010-09-22|||April 2006||2006-04-01|September 2010|2010-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects|Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects|Completed||N/A|40|Actual|UConn Health||1|||f||||f||||||||||2017-02-18 13:38:49.896158|2017-02-18 13:38:49.896158
NCT00802308|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-09-12|||December 2008||2008-12-01|September 2016|2016-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers|A Randomized, Partially Blind, Four-way Crossover Study to Determine the Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Male and Female Moderate Drinkers|Completed||Phase 1|24|Actual|Egalet Ltd||4|||f||||f||||||||||2017-02-18 13:38:50.008455|2017-02-18 13:38:50.008455
NCT00802295|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2009-09-17|||December 2008||2008-12-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Aneuploidies and Different Stimulation Protocols|Influence of Ovarian Stimulation and Embryo Aneuploidy|Completed||N/A|30|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 13:38:50.105782|2017-02-18 13:38:50.105782
NCT00802282|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2016-02-23|||August 2009||2009-08-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|February 2014|Actual|2014-02-01||Interventional|||Psilocybin and Spiritual Practice|Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior|Completed||Phase 1|75|Actual|Johns Hopkins University||5|||f||||t||||||||||2017-02-18 13:38:50.201737|2017-02-18 13:38:50.201737
NCT00802269|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-03|||March 2008||2008-03-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.|Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.|Completed||Phase 4|25|Actual|Asociación para Evitar la Ceguera en México||2|||f||||f||||||||||2017-02-18 13:38:50.312455|2017-02-18 13:38:50.312455
NCT00802256|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2009-04-09|||October 2008||2008-10-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Comparative Evaluation of Pulpotomized Primary Molars With Mineral Trioxide Aggregate and New Endodonthic Cement|Comparative Evaluation of Pulpotomized Primary Molars With Mineralized Trioxide Aggregate & New Endodonthic Cement|Unknown status|Recruiting|Phase 3|80|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 13:38:50.504017|2017-02-18 13:38:50.504017
NCT00802243|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-03|||September 2007||2007-09-01|December 2008|2008-12-01||||||||Interventional|ARABUL||Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid|Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid. An Open Prospective Study|Unknown status|Recruiting|Phase 2|54|Anticipated|University Hospital, Limoges||1|||f||||t||||||||||2017-02-18 13:38:50.602268|2017-02-18 13:38:50.602268
NCT00802230|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-03|||September 2002||2002-09-01|December 2008|2008-12-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|SELECT||Pharmacodynamic Study of Carvedilol Versus Metoprolol in Heart Failure|Beta-Receptor SELECTivity of Carvedilol and Metoprolol Succinnate in Patients With Heart Failure: A Randomized Dose Ranging Trial (SELECT Trial)|Completed||Phase 4|25|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 13:38:50.699442|2017-02-18 13:38:50.699442
NCT00802217|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2011-06-08|||November 2008||2008-11-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Oral Civamide Safety, Tolerability First in Human Study|A Phase 1 Open-Label, Single-Dose, Dose Escalation Study in Healthy Subjects to Evaluate the Safety and Pharmacokinetics of Orally Administered Civamide (Zucapsaicin)|Terminated||Phase 1|12|Anticipated|Winston Laboratories||2||PK results demonstrated no systemic absorption|f||||t||||||||||2017-02-18 13:38:50.790298|2017-02-18 13:38:50.790298
NCT00802204|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2015-12-12|||December 2008||2008-12-01|February 2011|2011-02-01|December 2012|Actual|2012-12-01|April 2011|Actual|2011-04-01||Interventional|||Dopamine and Insulin Resistance|Dopamine and Insulin Resistance|Completed||N/A|40|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 13:38:50.902016|2017-02-18 13:38:50.902016
NCT00802191|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-08-29|||August 2007||2007-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|May 2013|Actual|2013-05-01||Observational|||WiiMote Game Controller as a Device to Study Movement Disorders|WiiMote Game Controller as a Device to Study Movement Disorders|Terminated||N/A|250|Actual|Vanderbilt University|||2|Lack of study participants, no data published.|f||||f||||||||||2017-02-18 13:38:51.001357|2017-02-18 13:38:51.001357
NCT00802178|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-03-14|2009-09-30||February 2006||2006-02-01|March 2014|2014-03-01||||September 2007|Actual|2007-09-01||Observational||Treated set (TS)|First Presentation of Parkinson Disease Patients to Neurologist|CEE PMSS (Central Eastern European Post-Marketing Surveillance Study) First Presentation of Mirapexin in Parkinson Patients|Completed||N/A|2448|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 13:38:51.101713|2017-02-18 13:38:51.101713
NCT00802165|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-03|||December 2008||2008-12-01|December 2008|2008-12-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Effect of Electroacupuncture on Pain Threshold|Effect of Electroacupuncture on Pain Threshold|Unknown status|Recruiting|Phase 1|40|Anticipated|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 13:38:54.238119|2017-02-18 13:38:54.238119
NCT00802152|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-10-03|||May 2009||2009-05-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Using Health Information Technology (HIT) to Improve Ambulatory Chronic Disease Care: Smart Device Substudy|Using Health Information Technology (HIT) to Improve Ambulatory Chronic Disease Care: Smart Device Substudy|Completed||Early Phase 1|108|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-02-18 13:38:54.343439|2017-02-18 13:38:54.343439
NCT00802139|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2012-03-28|||February 2008||2008-02-01|March 2012|2012-03-01|October 2010|Actual|2010-10-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin|A Prospective, Randomized, Multi-centered Trial to Compare the Efficacy and Safety of Intravenous Iron Sucrose (Venoferrum®) With Oral Iron Acetyl-transferrin Hydroglycerin (Bolgre®) in Pregnant Women With Iron Deficiency Anemia|Completed||Phase 4|58|Actual|JW Pharmaceutical||2|||f||||t||||||||||2017-02-18 13:38:54.467745|2017-02-18 13:38:54.467745
NCT00802126|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-02-05|||November 2007||2007-11-01|February 2016|2016-02-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy|Efficacy of Combining Intravitreal Bevacizumab With Photodynamic Therapy Using Reduced Light Fluence Rate in Choroidal Neovascularization Secondary to Pathologic Myopia.|Completed||Phase 1|16|Actual|Second University of Naples||1|||f||||t||||||||||2017-02-18 13:38:54.581258|2017-02-18 13:38:54.581258
NCT00802113|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2015-04-22|||June 2003||2003-06-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Autologous and Allogeneic Transplant for Relapsed Lymphoma|Sequential Myeloablative Stem Cell Transplantation and Reduced Intensity Allogeneic Stem Cell Transplantation in Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma and Hodgkin's Disease|Completed||Phase 1/Phase 2|31|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 13:38:54.690598|2017-02-18 13:38:54.690598
NCT00802100|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2013-01-03|2012-11-19||December 2008||2008-12-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|COATS||Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia|Comparison of Optimal Antipsychotic Treatments for Schizophrenia Pilot Study|Completed||Phase 4|21|Actual|National Institute of Mental Health (NIMH)|It was determined in this pilot study that the existing procedures and eligibility criteria could not be adequately implemented and that a larger-scale study was not feasible.|3|||f||||t||||||||||2017-02-18 13:38:54.824311|2017-02-18 13:38:54.824311
NCT00802087|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-08-26|||November 2008||2008-11-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Single Dose Pharmacokinetics of Egalet® Hydrocodone|A Single-Centre, Single Dose, Randomized,Open Label, Exploratory, 5-way Crossover Study Evaluating the Pharmakokinetic Profiles of Various Egalet® Hydrocodone Formulations In Healthy Volunteers Under Fasting Conditions.|Completed||Phase 1|28|Actual|Egalet Ltd||5|||f||||f||||||||||2017-02-18 13:38:55.271596|2017-02-18 13:38:55.271596
NCT00802074|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2016-01-27|2015-03-23||December 2008||2008-12-01|January 2016|2016-01-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects|A Randomized, Open-Label, Six-Period, Drug Interaction Study to Assess Steady-State Plasma Amprenavir (APV) and Raltegravir (RTG) Pharmacokinetics Following Administration of RTG 400 mg BID for 14 Days Alone and in Combination With 14 Days of Either Fosamprenavir (FPV) 1400 mg BID, FPV 700 mg BID + RTV 100 mg BID or FPV 1400 mg + RTV 100 mg QD in Healthy Adult Subjects When Under Fasting Conditions|Completed||N/A|45|Actual|Garden State Infectious Disease Associates, PA|Data for Primary outcome measure assessments are not available per intervention. Values reported as means are of uncertain measure type (data are no longer available).|6|||f||||f||||||||||2017-02-18 13:38:55.385459|2017-02-18 13:38:55.385459
NCT00802061|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-03||||||December 2008|2008-12-01||||||||Interventional|||Sleep at 30 Degrees in Glaucoma||Completed||N/A|||University Health Network, Toronto|||||f||||t||||||||||2017-02-18 13:38:56.52369|2017-02-18 13:38:56.52369
NCT00802048|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2011-12-12|||February 2009||2009-02-01|December 2011|2011-12-01|August 2010|Actual|2010-08-01|January 2010|Actual|2010-01-01||Interventional|CARDIODOLAL||Local Anesthetic Infusion and Sternotomy|Study of Effectiveness of a Ropivacaïne Continuous Sternal Infusion to Reduce Postoperative Hyperalgesia Induced by Sternotomy After Cardiac Surgery|Terminated||Phase 3|21|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 13:38:56.806617|2017-02-18 13:38:56.806617
NCT00802035|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2011-08-22|||November 2008||2008-11-01|August 2011|2011-08-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||ALK29-002: A Study of Baclofen Formulations in Healthy Adults|A Phase 1, Single-Center, Open-Label Study of the Pharmacokinetics of Baclofen Formulations Administered to Healthy Adults|Completed||Phase 1|16|Actual|Alkermes, Inc.||4|||f||||f||||||||||2017-02-18 13:38:56.919984|2017-02-18 13:38:56.919984
NCT00802022|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2010-07-07|||January 2009||2009-01-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SCS||Effect of Spinal Cord Stimulation in Painful Diabetic Polyneuropathy|Effect of Spinal Cord Stimulation in Painful Diabetic Polyneuropathy (PDP Study) A Pilot Study|Completed||N/A|15|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-02-18 13:38:57.021094|2017-02-18 13:38:57.021094
NCT00802009|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2010-01-22|||May 2009||2009-05-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Dexamethasone and Analgesic Duration After Supraclavicular Brachial Plexus Blockade|Dexamethasone and Analgesic Duration After Supraclavicular Brachial Plexus Blockade|Completed||N/A|44|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:38:57.125638|2017-02-18 13:38:57.125638
NCT00801996|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2016-05-11|||September 2008||2008-09-01|May 2016|2016-05-01|September 2009|Anticipated|2009-09-01|September 2008|Anticipated|2008-09-01||Observational|ProstateCA||Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries|Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University|||2|Closed by Investigator|f||||f||||||Samples With DNA|"~     Blood and tissue will be collected from individuals with prostate cancer. Only blood will be~     collected from normal controls.~   "|Undecided||2017-02-18 13:38:57.227346|2017-02-18 13:38:57.227346
NCT00801983|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-08-06|2014-05-19||January 2009||2009-01-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|April 2011|Actual|2011-04-01||Interventional||GEE analyses allows a subjects inclusion even if they did not complete the full trial. Although we had a total of 15 subjects not complete the full trial we had sufficient data on 77 subjects to complete the GEE statistical analyses. With the crossover design we compared 77 subjects using the standard keyboard to 77 subjects using the alternative|The Effect of Alternative Keyboards on Discomfort and Typing Kinematics|The Effect of Alternative Keyboards on Discomfort and Typing Kinematics|Completed||N/A|85|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:38:57.328657|2017-02-18 13:38:57.328657
NCT00801970|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-03|||January 2008||2008-01-01|December 2008|2008-12-01|January 2011|Anticipated|2011-01-01|June 2010|Anticipated|2010-06-01||Interventional|||Fear of Childbirth (Tokophobia) - Etiology, Essence and Clinical Implications|Fear of Childbirth (Tokophobia) - Etiology, Essence and Clinical Implications|Unknown status|Recruiting|N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center||4|||f||||t||||||||||2017-02-18 13:38:58.043252|2017-02-18 13:38:58.043252
NCT00801957|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-09-17|||March 2003||2003-03-01|September 2014|2014-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis|A Double Blind, Multicentre, Randomised, Parallel Group Study to Demonstrate the Equivalence of the Response to Vaccination of a Tacrolimus Ointment Regimen to a Steroid Ointment Regimen in Children With Moderate to Severe Atopic Dermatitis|Completed||Phase 2|260|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 13:38:58.173561|2017-02-18 13:38:58.173561
NCT00801554|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2013-10-21|||October 2008||2008-10-01|October 2013|2013-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Autism Spectrum Disorders (ASD) Characterization Study|A Characterization Study of Individuals With Autism Spectrum Disorders|Completed||N/A|26|Actual|Massachusetts General Hospital|||2||f||||f||||||||||2017-02-18 13:39:03.14402|2017-02-18 13:39:03.14402
NCT00801944|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-09-17|||April 2004||2004-04-01|September 2014|2014-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|SUNRISE||Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms|Solifenacin in the Treatment of Urgency Symptoms of Overactive Bladder in a Rising Dose, Randomized, Placebo-controlled, Double-blind Trial|Completed||Phase 3|973|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 13:38:58.348889|2017-02-18 13:38:58.348889
NCT00801931|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-07-17|||September 2007||2007-09-01|July 2013|2013-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Double Cord Blood Transplantation|Double Umbilical Cord Blood Transplantation for Patients With Malignant and Non-Malignant Disorders|Terminated||Phase 1/Phase 2|1|Actual|Columbia University||6||Poor accrual|f||||t||||||||||2017-02-18 13:38:58.559384|2017-02-18 13:38:58.559384
NCT00801918|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2013-05-14|||December 2008||2008-12-01|October 2009|2009-10-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Interventional|||Denileukine Diftitox for Relapsed ALCL|A Phase II Pilot Multicenter Study of Denileukin Diftitox Alone and in Combination With ICE (ICED) Chemotherapy in Children, Adolescents and Young Adults (CAYA) With Relapsed or Refractory Anaplastic Large Cell Lymphoma|Withdrawn||Phase 2|0|Actual|Columbia University||2||Lack of funding|f||||t||||||||||2017-02-18 13:38:58.685819|2017-02-18 13:38:58.685819
NCT00801905|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-03|||August 2008||2008-08-01|December 2008|2008-12-01|March 2009|Anticipated|2009-03-01|December 2008|Anticipated|2008-12-01||Interventional|NEPAF||Effect of Topical Nepafenac in Macular Thickening Related to Pan-Retinal Photocoagulation|Effect of Topical Nepafenac in Macular Thickening Related to Pan-Retinal Photocoagulation|Unknown status|Recruiting|Phase 2|50|Anticipated|Asociación para Evitar la Ceguera en México||2|||f||||f||||||||||2017-02-18 13:38:58.806064|2017-02-18 13:38:58.806064
NCT00801892|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-02-11|2014-02-11||April 2009||2009-04-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|OSA_DM|Sample primarily middle aged adults with type 2 diabetes|Obstructive Sleep Apnea (OSA), Sleepiness, and Activity in Diabetes Management|OSA, Sleepiness, and Activity in Diabetes Management|Completed||Phase 4|23|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:38:58.924673|2017-02-18 13:38:58.924673
NCT00801879|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2014-10-28|||September 2003||2003-09-01|October 2014|2014-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection|Intranasal Mupirocin to Eliminate Carriage of Staphylococcus Aureus in HIV Infection|Completed||Phase 4|100|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 13:38:59.236478|2017-02-18 13:38:59.236478
NCT00801866|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-03||||||December 2008|2008-12-01||||||||Interventional|||Avastin for Post-Photocoagulation Macular Edema|Prevention of Post-Photocoagulation Macular Edema by Intravitreal Bevacizumab.|Completed||Phase 4|||Asociación para Evitar la Ceguera en México||2|||f||||t||||||||||2017-02-18 13:38:59.554134|2017-02-18 13:38:59.554134
NCT00801853|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2011-01-25|||March 2009||2009-03-01|November 2009|2009-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL|A Phase IIb Study to Investigate the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients Not Fully Controlled on Current Therapy|Completed||Phase 2|424|Anticipated|Aerovance, Inc.||4|||f||||f||||||||||2017-02-18 13:38:59.662731|2017-02-18 13:38:59.662731
NCT00801827|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2015-12-12|||January 2007||2007-01-01|March 2011|2011-03-01|June 2012|Actual|2012-06-01|March 2011|Actual|2011-03-01||Observational|||PET Imaging and Bariatric Surgery|PET Imaging and Bariatric Surgery|Completed||N/A|10|Anticipated|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     plasma and serum~   "|||2017-02-18 13:38:59.851618|2017-02-18 13:38:59.851618
NCT00801814|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2008-12-03|||April 2006||2006-04-01|December 2008|2008-12-01|August 2006|Actual|2006-08-01|May 2006|Actual|2006-05-01||Interventional|||Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia|Effect of Adding Escalating Doses of a Novel Highly Viscous Polysaccharide to Either a Liquid or a Solid Test Meal on Post Prandial Glycemia in Healthy Subjects: Determination of the Glycemic Reduction Index Potential (GRIP)|Completed||Phase 2/Phase 3|20|Actual|Glycemic Index Laboratories, Inc||6|||f||||f||||||||||2017-02-18 13:38:59.94038|2017-02-18 13:38:59.94038
NCT00801801|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-02-01|2012-06-08||January 2008||2008-01-01|February 2016|2016-02-01|March 2011|Actual|2011-03-01|October 2009|Actual|2009-10-01||Interventional|||Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC|Pilot Phase IIa Study of Metronomic Chemotherapy With Taxotere (Docetaxel) Plus Nexavar (Sorafenib) as First-Line Therapy in Performance Status-2 Patients With Advanced Non-Squamous Cell Non-Small Cell Lung Cancer|Terminated||Phase 2|5|Actual|University of Alabama at Birmingham|The study initially sought to accrue a maximum sample size of 43 subjects. However, due to subjects' measured response and levels of clinical benefit in addition to a cut in funding, the study was stopped early and terminated.|1||Sponsors withdrew funding; preliminary efficacy data was not encouraging.|f||||t||||||||||2017-02-18 13:39:00.054644|2017-02-18 13:39:00.054644
NCT00801788|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-08-26|||September 2008||2008-09-01|August 2016|2016-08-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||Single Dose Pharmacokinetics of Egalet® Oxycodone||Completed||Phase 1|16|Actual|Egalet Ltd||4|||f||||f||||||||||2017-02-18 13:39:00.308266|2017-02-18 13:39:00.308266
NCT00801775|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-03|2011-06-10|||August 2008||2008-08-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Improved Diagnosis of Peritoneal Dialysis Peritonitis by Calorimetry|Improved Diagnosis of Peritoneal Dialysis Peritonitis by Calorimetry|Terminated||N/A|8|Actual|University Hospital, Basel, Switzerland|||1|The study was stopped march 2009 due to recruitment problems.|f||||f||||||||||2017-02-18 13:39:00.407558|2017-02-18 13:39:00.407558
NCT00801762|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-02|||September 2008||2008-09-01|December 2008|2008-12-01|June 2009||2009-06-01|||||Observational|||Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology|Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology|Unknown status|Recruiting|N/A|30||Stanford University|||||f||||||||||||||2017-02-18 13:39:00.501315|2017-02-18 13:39:00.501315
NCT00801749|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-05|||March 2005||2005-03-01|December 2008|2008-12-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Sleep and Daytime Activity in Healthy Subjects||Completed||N/A|||Nagoya University|||||f||||||||||||||2017-02-18 13:39:00.582597|2017-02-18 13:39:00.582597
NCT00801541|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2015-03-18|||December 2005||2005-12-01|April 2014|2014-04-01|June 2014|Actual|2014-06-01|December 2008|Actual|2008-12-01||Observational|CNV-Markers||Characterization of Early Markers of Choroidal Neovascularization|Characterization of Early Markers of Choroidal Neovascularization in Fellow Eyes of Patients With AMD and CNV in One Eye. (CNV-Markers)|Completed||N/A|60|Actual|Association for Innovation and Biomedical Research on Light and Image|||1||f||||t||||||||||2017-02-18 13:39:03.226708|2017-02-18 13:39:03.226708
NCT00801736|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2013-12-09|||October 2009||2009-10-01|December 2012|2012-12-01||||July 2013|Actual|2013-07-01||Interventional|ET||ERCC1 Targeted Trial|A Multicentre, Randomised, Phase III Trial of Platinum-based Chemotherapy Versus Non-platinum Chemotherapy, After ERCC1 Stratification, in Patients With Advanced/Metastatic Non-small Cell Lung Cancer|Terminated||Phase 3|648|Actual|University College, London||2||The antibody used did not appear prognostic/predictive based on interim results.|f||||t||||||||||2017-02-18 13:39:00.64138|2017-02-18 13:39:00.64138
NCT00801723|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-04-08||2011-12-01|December 2008||2008-12-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.|Randomised, Double-Blind, Multi-Centre, 12 Month Extension Study to Evaluate the Safety And Efficacy of Daily Budesonide MMX 6 mg Versus Placebo in the Maintenance of Remission in Subjects With Ulcerative Colitis.|Completed||Phase 3|123|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 13:39:00.756312|2017-02-18 13:39:00.756312
NCT00801710|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2009-12-02|||September 2008||2008-09-01|December 2009|2009-12-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study|CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study|Completed||N/A|42|Actual|BridgePoint Medical||1|||f||||f||||||||||2017-02-18 13:39:00.920073|2017-02-18 13:39:00.920073
NCT00801697|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-06-20|||February 2009||2009-02-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector|A Phase 1B Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Adenoviral Subtype 35 (rAd35) and Subtype 5 (rAd5) HIV-1 Vaccines When Given as a Heterologous Prime-boost Regimen or as Boosts to a Recombinant DNA Vaccine in Healthy, Ad5-Naïve and Ad5-Exposed, Low Risk, HIV-1 Uninfected Adult Participants|Completed||Phase 1|192|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||||||||||||2017-02-18 13:39:01.022136|2017-02-18 13:39:01.022136
NCT00801684|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2011-08-17|2011-03-18||February 2009||2009-02-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD|Efficacy, Safety, Tolerability, and Pharmacokinetics of Trospium Inhalation Powder (TrIP) Administered to Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|24|Actual|Alkermes, Inc.||5|||f||||f||||||||||2017-02-18 13:39:01.179063|2017-02-18 13:39:01.179063
NCT00801671|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2011-06-15|||September 2008||2008-09-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Russian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in Hypertension|Study of Independent Role of Continuous Positive Airway Pressure Therapy on Systemic Arterial Pressure in Patients With Sleep Apnea Syndrome and Arterial Hypertension|Completed||Phase 3|50|Actual|Russian Cardiology Research and Production Center||2|||f||||f||||||||||2017-02-18 13:39:01.639647|2017-02-18 13:39:01.639647
NCT00801658|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-03|||January 2008||2008-01-01|December 2008|2008-12-01|July 2009||2009-07-01|||||Interventional|||Efficacy of SLT in Patients With Insufficient IOP Control Under Maximum Tolerated Drug Therapy (Eye Drops)||Completed||Phase 4|30|Actual|University of Zurich||1|||f||||f||||||||||2017-02-18 13:39:01.748635|2017-02-18 13:39:01.748635
NCT00801645|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-01-04|||August 2004||2004-08-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|October 2008|Actual|2008-10-01||Interventional|||Effects of Exercise on Arterial Function and Insulin Resistance Syndrome in Pre-pubertal Obese Children|Effects of Aerobic Exercise Training on Arterial Function and Insulin Resistance Syndrome in Obese Children: A Randomized Controlled Trial|Completed||N/A|67|Actual|University Hospital, Geneva||4|||f||||f||||||||||2017-02-18 13:39:01.860886|2017-02-18 13:39:01.860886
NCT00801632|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2015-11-06|2015-04-21||December 2008||2008-12-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional||Intent-to-treat|Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection|Renal Allograft Tolerance Through Mixed Chimerism|Completed||Phase 2|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 13:39:01.980031|2017-02-18 13:39:01.980031
NCT00801619|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-03-14|||November 2008||2008-11-01|March 2016|2016-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia|Bilicurves: Using Information Technology to Integrate Clinical Practice Guidelines Into the Management of Neonatal Hyperbilirubinemia|Completed||N/A|273|Actual|Massachusetts General Hospital|||2||f||||t||||||||||2017-02-18 13:39:02.441898|2017-02-18 13:39:02.441898
NCT00801606|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-02-08|||December 2008||2008-12-01|February 2016|2016-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|ICTBSG||Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis|Micronutrient Supplementation in Conjunction With Standard Anti-Tuberculosis Therapy in Paediatric (6 Months-15 Years) New Pulmonary Tuberculosis Patients|Completed||Phase 3|403|Actual|All India Institute of Medical Sciences, New Delhi||4|||f||||t||||||||No||2017-02-18 13:39:02.738225|2017-02-18 13:39:02.738225
NCT00801593|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-02|||May 2008||2008-05-01|December 2008|2008-12-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Observational|||Magnetic Resonance Imaging Follow-up on Temporomandibular Arthritis in Children With Juvenile Idiopathic Arthritis|Arthritis of the Temporomandibular Joints in Children With Juvenile Idiopathic Arthritis- Pilot Study on Diagnostic Value of Ultrasonography and Magnetic Resonance Imaging and Influence of Drug Treatment|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital Tuebingen|||1||f||||f||||||||||2017-02-18 13:39:02.848814|2017-02-18 13:39:02.848814
NCT00801580|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2009-09-14|||March 2008||2008-03-01|September 2009|2009-09-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia|Open Label, Non-randomized, Phase II Study on Fractioned Cyclophosphamide, Vincristine, Liposomal Doxorubicin or Doxorubicin, and Dexamethasone (MY HYPER-CVAD) in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia|Unknown status|Recruiting|Phase 2|3|Anticipated|University of Bologna||1|||f||||||||||||||2017-02-18 13:39:02.947838|2017-02-18 13:39:02.947838
NCT00801567|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-03-09|||June 2010||2010-06-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation|A Magnetic Resonance Spectroscopy Study of Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation|Withdrawn||N/A|0|Actual|Mclean Hospital||1||Departure of essential Co-Investigator from McLean Hospital|f||||f||||||||||2017-02-18 13:39:03.045559|2017-02-18 13:39:03.045559
NCT00801528|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2010-05-02|||April 2008||2008-04-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Diclofenac vs. Ropivacaine for Cesarean Section|The Analgesic Efficacy of Continuous Wound Instillation With Diclofenac or Ropivacaine Following Cesarean Section: a Randomized, Double-blind, Placebo Controlled Study|Completed||Phase 4|75|Anticipated|Meir Medical Center||3|||f||||t||||||||||2017-02-18 13:39:03.332625|2017-02-18 13:39:03.332625
NCT00801515|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2011-07-21|||August 2009||2009-08-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Expanded Access|||A Compassionate Access Protocol For Those Patients Who Have Completed A4001029|A Compassionate Access Protocol For Those Patients Who Have Completed A4001029|No longer available||Phase 3|||ViiV Healthcare|||||f||||f||||||||||2017-02-18 13:39:03.436753|2017-02-18 13:39:03.436753
NCT00801502|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-11-27|||May 2007||2007-05-01|December 2008|2008-12-01|March 2012|Actual|2012-03-01|August 2009|Actual|2009-08-01||Interventional|SiPS||Salmon in Pregnancy Study|The Effects of Oily Fish in Pregnancy on Markers and Manifestations of Allergic Diseases in Infants at Risk of Atopy|Completed||N/A|124|Actual|University Hospital Southampton NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 13:39:03.525395|2017-02-18 13:39:03.525395
NCT00801489|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-07-19|||April 2007||2007-04-01|July 2016|2016-07-01||||April 2018|Anticipated|2018-04-01||Interventional|||Fludarabine, Cytarabine, Filgrastim and Idarubicin in Core Binding Factor (CBF) Leukemias|A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia|Recruiting||Phase 2|180|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 13:39:03.637345|2017-02-18 13:39:03.637345
NCT00801476|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2009-11-17|||April 2008||2008-04-01|November 2009|2009-11-01|May 2010|Anticipated|2010-05-01|December 2009|Anticipated|2009-12-01||Interventional|||Pre-operative Magnetic Resonance Imaging (MRI) in Young Breast Cancer Patients|A Prospective Cohort Study to Evaluate the Impact of Preoperative Breast Magnetic Resonance Imaging (MRI) on Surgical Decision-Making in Young Patients With Breast Cancer|Unknown status|Recruiting|N/A|44|Anticipated|McMaster University||1|||f||||f||||||||||2017-02-18 13:39:03.777157|2017-02-18 13:39:03.777157
NCT00801463|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2011-05-17|||January 2009||2009-01-01|April 2009|2009-04-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis|Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis|Completed||N/A|67|Actual|Nanjing University School of Medicine||2|||f||||t||||||||||2017-02-18 13:39:03.885415|2017-02-18 13:39:03.885415
NCT00801450|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2009-10-08|||September 2007||2007-09-01|October 2009|2009-10-01|February 2009|Anticipated|2009-02-01|December 2008|Anticipated|2008-12-01||Interventional|||Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery||Unknown status|Active, not recruiting|Phase 1/Phase 2|24|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:39:03.997484|2017-02-18 13:39:03.997484
NCT00801437|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2011-06-28|||October 2008||2008-10-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.|Non Interventional Study in Slovak Patients With Primary Open Angle Glaucoma and/or Ocular Hypertension Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy Due to Ineffectivity or Intolerance.|Completed||Phase 4|457|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:39:04.106794|2017-02-18 13:39:04.106794
NCT00801424|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2010-10-01|||November 2008||2008-11-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|S2||Warmed Humidified Carbon Dioxide (CO2) for Open Surgery|Randomized Clinical Study for Core and Topical Warming of the Open Wound Cavity With Warmed Humidified CO2 Versus Control in Colon Surgery|Completed||N/A|80|Actual|Karolinska University Hospital||1|||f||||f||||||||||2017-02-18 13:39:04.253112|2017-02-18 13:39:04.253112
NCT00801411|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2009-06-16|||October 2008||2008-10-01|June 2009|2009-06-01||||||||Interventional|||Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery|A Randomised Phase 2 Study of Neoadjuvant Docetaxel and Cyclophosphamide Compared to Doxorubicin and Cyclophosphamide in Operable Node Negative Breast Cancer With Normal Topoisomerase IIα Expression|Unknown status|Recruiting|Phase 2|318|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:39:04.367593|2017-02-18 13:39:04.367593
NCT00801398|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2015-06-10|||December 2008||2008-12-01|June 2015|2015-06-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.|An Open-Label, Ascending, Two-Part, Single- and Multiple-Dose Evaluation of the Safety, Pharmacokinetics, and Effectiveness of Oxymorphone for Acute Postoperatiave Pain in Pediatric Subjects|Completed||Phase 3|60|Actual|Endo Pharmaceuticals||1|||f||||t||||||||||2017-02-18 13:39:04.477422|2017-02-18 13:39:04.477422
NCT00801385|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2009-08-21|||September 2008||2008-09-01|August 2009|2009-08-01||||June 2009|Anticipated|2009-06-01||Interventional|||Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy|A Multicenter, Open-label, Phase II Study of Sorafenib in Combination With Erlotinib in Non-small Cell Lung Cancer (NSCLC) Refractory to One or Two Prior Chemotherapy Regimens|Unknown status|Recruiting|Phase 2|47|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:39:04.605055|2017-02-18 13:39:04.605055
NCT00801372|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-09-01|||November 2008||2008-11-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells|Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells|Recruiting||N/A|1|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 13:39:04.713043|2017-02-18 13:39:04.713043
NCT00801359|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-15|||January 2008||2008-01-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||BSSPlus Versus Lactated Ringer's for Phacoemulsification|Comparison of Corneal Changes After Phacoemulsification Using BSSPlus Versus Lactated Ringer's Irrigating Solution|Completed||Phase 2|110|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:39:04.808196|2017-02-18 13:39:04.808196
NCT00801346|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2009-08-11|||November 2008||2008-11-01|November 2008|2008-11-01||||January 2015|Anticipated|2015-01-01||Observational|||Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission|The Metabolic Syndrome in Pediatric Acute Lymphoblastic Leukemia (ALL).|Unknown status|Recruiting|Phase 1|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:39:04.908727|2017-02-18 13:39:04.908727
NCT00801333|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-09-06|||November 2008||2008-11-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells|Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells|Recruiting||N/A|25|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 13:39:05.017236|2017-02-18 13:39:05.017236
NCT00801320|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-01-21|||September 2008||2008-09-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|August 2012|Actual|2012-08-01||Interventional|||Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Study of Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer (Ovarian Spore)|Active, not recruiting||N/A|100|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 13:39:05.109508|2017-02-18 13:39:05.109508
NCT00801307|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-08-08|||June 2008||2008-06-01|August 2014|2014-08-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Interventional|||Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function Disease|A Single Site,Exploratory,Phase I/II,Randomised Trial Comparing the Effect of He/O2 Mixtures(He/O2 78:22 and He/O2 65:35) to Medical Air on Pulmonary Function in Moderate/Severe Asthma and COPD Patients and Healthy Volunteers|Completed||Phase 1/Phase 2|30|Actual|Air Liquide SA||3|||f||||t||||||||||2017-02-18 13:39:05.218962|2017-02-18 13:39:05.218962
NCT00801294|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2013-10-30|||July 2006||2006-07-01|October 2013|2013-10-01||||November 2007|Actual|2007-11-01||Interventional|||A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer|A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer|Completed||Phase 2|46|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 13:39:05.329591|2017-02-18 13:39:05.329591
NCT00801281|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-02-17|||February 2007||2007-02-01|February 2016|2016-02-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|PLRG4||First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.|First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.A Multicentre, Phase III Randomized Study by the PLRG.|Active, not recruiting||Phase 3|250|Actual|Polish Lymphoma Research Group||2|||f||||t||||||||No||2017-02-18 13:39:05.451266|2017-02-18 13:39:05.451266
NCT00801268|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2015-03-27|||November 2008||2008-11-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease|Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Terminated||N/A|300|Actual|Nanjing University School of Medicine||2||high rate of drop-out|f||||t||||||||||2017-02-18 13:39:05.591997|2017-02-18 13:39:05.591997
NCT00801255|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2016-11-01|||November 2008||2008-11-01|November 2016|2016-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients|A Randomized, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Tolerability and Antiviral Activity of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591) in Genotype 1 Chronic Hepatitis C Patients. INFORM 1|Completed||Phase 1|88|Actual|Hoffmann-La Roche||7|||f||||||||||||||2017-02-18 13:39:05.709981|2017-02-18 13:39:05.709981
NCT00801242|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-09-02|2014-08-08||December 2008||2008-12-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|June 2012|Actual|2012-06-01||Interventional||FAS, Cycle 1.|Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer|An Open-Label, Multi-Centre, Uncontrolled, Trial Investigating Degarelix One-Month Dosing Regimen Administered as Intermittent Androgen Deprivation (IAD) for One or More Cycles in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy|Completed||Phase 3|220|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:39:05.831527|2017-02-18 13:39:05.831527
NCT00801229|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2014-02-05|2011-06-20||December 2008||2008-12-01|February 2014|2014-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effect of Vyvanse on Driving in Young Adults With ADHD|The Effects of Vyvanse on the Driving Performance of Young Adults With ADHD: A Randomized, Double-Blind, Placebo-Controlled Study|Completed||Phase 4|75|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:39:06.701294|2017-02-18 13:39:06.701294
NCT00801216|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2008-12-02|||January 2007||2007-01-01|October 2008|2008-10-01|January 2012|Anticipated|2012-01-01|January 2010|Anticipated|2010-01-01||Interventional|SCNSL1||High-Dose Sequential Chemoimmunotherapy for B-Cell Lymphomas With Central Nervous System Involvement|High-Dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-Cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse|Unknown status|Recruiting|Phase 2|38|Anticipated|IRCCS San Raffaele||1|||t||||t||||||||||2017-02-18 13:39:07.120048|2017-02-18 13:39:07.120048
NCT00801203|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2012-05-08|||December 2008||2008-12-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study to Evaluate the Effectiveness of the Induced Reflex Cough Test Plus Urodynamics to Identify Stress Urinary Incontinence in Female Subjects With a History of Stress Urinary Incontinence|A Phase II/III Controlled Study to Evaluate the Effectiveness of the Induced Reflex Cough Test Plus Urodynamics to Identify Stress Urinary Incontinence in Female Subjects With a History of Stress Urinary Incontinence|Completed||Phase 2/Phase 3|180|Actual|Pneumoflex Systems, LLC||2|||f||||f||||||||||2017-02-18 13:39:07.235798|2017-02-18 13:39:07.235798
NCT00801190|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-02|||December 2008||2008-12-01|December 2008|2008-12-01|April 2011|Anticipated|2011-04-01|April 2010|Anticipated|2010-04-01||Interventional|||This Study Will Compare the Effect of Starch Containing to Non-Starch Containing Intravenous Fluid on Blood Loss During Coronary Artery Bypass Graft Surgery|"A Prospective Randomized Double-Blind Placebo-Controlled Trial of the Effects of Colloid (HES 130/0.4) Versus Crystalloid (Ringer's Lactate) on Bleeding in Patients Undergoing Cardiopulmonary Bypass for Primary CABG, Single Valve Repair/Replacement, or Combined Single Valve/CABG Surgery"|Unknown status|Not yet recruiting|N/A|500|Anticipated|St. Boniface General Hospital Research Centre||2|||f||||t||||||||||2017-02-18 13:39:07.343198|2017-02-18 13:39:07.343198
NCT00801177|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2010-10-11|||November 2004||2004-11-01|October 2010|2010-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy|Phase I Study of the Fully Human Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody IMC-11F8 in Patients With Solid Tumors Who Have Failed Standard Therapy|Completed||Phase 1|60|Actual|ImClone LLC||2|||f||||f||||||||||2017-02-18 13:39:07.444121|2017-02-18 13:39:07.444121
NCT00801164|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-02-01|||December 2008||2008-12-01|February 2012|2012-02-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|Diabetes||Exploratory Study of Iocide Oral Rinse in a Diabetic Population|Exploratory Study of Iocide Oral Rinse in a Diabetic Population|Completed||Phase 1|30|Actual|Biomedical Development Corporation||2|||f||||f||||||||||2017-02-18 13:39:07.595654|2017-02-18 13:39:07.595654
NCT00801151|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2010-05-19|||January 2009||2009-01-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer|A Phase I Clinical Trial of Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer.|Terminated||Phase 1|30|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||||2017-02-18 13:39:07.707666|2017-02-18 13:39:07.707666
NCT00801138|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2011-02-17|||November 2008||2008-11-01|February 2011|2011-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||The Effect of Dexamethasone on the Duration of Interscalene Nerve Blocks With Ropivacaine or Bupivacaine|The Effect of Dexamethasone on the Duration of Interscalene Nerve Blocks With Ropivacaine or Bupivacaine|Terminated||Phase 2/Phase 3|218|Actual|Outcomes Research Consortium||4||"Based on a strong primary outcome (prolonged analgesia with dexamethasone) and futility for~   type of local anesthetic, study was terminated."|f||||f||||||||||2017-02-18 13:39:07.816088|2017-02-18 13:39:07.816088
NCT00801125|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-06-14|||December 2008||2008-12-01|January 2009|2009-01-01||||May 2010|Anticipated|2010-05-01||Interventional|||Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy|A Phase IV, Open-Label Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy|Withdrawn||Phase 4|0|Actual|Biogen||1||Study sponsor decided to withdraw the current study prior to enrollment of first participant.|f||||||||||||||2017-02-18 13:39:07.932409|2017-02-18 13:39:07.932409
NCT00801112|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-02|||January 2009||2009-01-01|December 2008|2008-12-01|January 2011|Anticipated|2011-01-01|||||Observational|||Bioimpedance as a Tool for Fluid Management in Peritoneal Dialysis (PD) Patients|Developing Bioimpedance (BIA) as a Tool for Fluid Management in Peritoneal Dialysis Patients: A Validation Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|University Hospital of North Staffordshire|||4||f||||f||||||Samples Without DNA|"~     Whole blood, urine and peritoneal fluid.~   "|||2017-02-18 13:39:08.017851|2017-02-18 13:39:08.017851
NCT00801099|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-07-16|2008-11-06||December 2004||2004-12-01|July 2015|2015-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|SSI2||Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections|Benefit of a Single Preoperative Dose of Antibiotics in a Sub-Saharan District Hospital: Minimal Input, Massive Impact|Completed||N/A|276|Actual|Swiss Tropical & Public Health Institute||1|||f||||f||||||||||2017-02-18 13:39:08.116395|2017-02-18 13:39:08.116395
NCT00801086|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2008-12-02|||November 2008||2008-11-01|December 2008|2008-12-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain|Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy|Unknown status|Recruiting|Phase 2|16|Anticipated|Mitos Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:39:08.338023|2017-02-18 13:39:08.338023
NCT00801073|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-02|||February 2005||2005-02-01|December 2008|2008-12-01||||February 2005|Actual|2005-02-01||Interventional|||Comparison Amongst Scleral, Corneal and Amniotic Membrane Grafts to Restore Scleral Thinning||Unknown status|Enrolling by invitation|Phase 2/Phase 3|49|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-02-18 13:39:08.448195|2017-02-18 13:39:08.448195
NCT00801060|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2015-09-17||2015-09-17|February 2008||2008-02-01|April 2011|2011-04-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)|A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Combination With Lumiliximab Versus FCR Alone in Subjects With Previously Untreated Chronic Lymphocytic Leukemia|Terminated||Phase 2|40|Actual|Biogen||2|||f||||f||||||||||2017-02-18 13:39:08.533072|2017-02-18 13:39:08.533072
NCT00801047|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2015-04-19|||February 2010||2010-02-01|February 2010|2010-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Intravenous Remifentanil Patient-controlled Analgesia (PCA) and Epidural Patient Controlled Epidural Analgesia (PCEA) for Labor Analgesia|Comparison of the Efficacy Intravenous Remifentanil PCA and Epidural PCEA for Labor Analgesia|Completed||Phase 4|50|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:39:08.671266|2017-02-18 13:39:08.671266
NCT00801034|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2015-08-19|||November 2008||2008-11-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||The Effects of Potassium on Physiological and Cardiovascular Variables in Healthy Persons|The Effects of Potassium on Physiological Variables in the Kidney and Cardiovascular Variables in Healthy Persons in a Double-blinded, Randomised, Placebo-controlled, Cross-over Study|Completed||Phase 1|25|Actual|Regional Hospital Holstebro||2|||f||||t||||||||||2017-02-18 13:39:08.776433|2017-02-18 13:39:08.776433
NCT00801021|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2010-03-04|||December 2008||2008-12-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|UTI||Treatment and/or Prevention of Urinary Tract Infections|Treatment and/or Prevention of Urinary Tract Infections|Completed||Phase 1|3|Actual|Biomedical Development Corporation||1|||f||||f||||||||||2017-02-18 13:39:08.865058|2017-02-18 13:39:08.865058
NCT00801008|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2012-04-19|||July 2009||2009-07-01|April 2012|2012-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Exercise and Relaxation Intervention for Young Adult Cancer Survivors||Unknown status|Recruiting|N/A|60|Anticipated|The Miriam Hospital||2|||f||||f||||||||||2017-02-18 13:39:08.97422|2017-02-18 13:39:08.97422
NCT00800995|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2008-12-02|||September 2005||2005-09-01|December 2008|2008-12-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Superoxide Dismutase (SOD) as Antioxidant Treatment OF Age Related Macular Degeneration (ARMD)|SOD as Antioxidant Treatment OF ARMD|Completed||Phase 3|46|Actual|Centre de Recherche en Nutrition Humaine Rhone-Alpe||2|||f||||f||||||||||2017-02-18 13:39:09.07475|2017-02-18 13:39:09.07475
NCT00799084|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2011-12-06|||April 2003||2003-04-01|December 2011|2011-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|ATSM||Automated Telephone Monitoring for Symptom Management|Automated Telephone Monitoring for Symptom Management|Completed||Phase 2|526|Actual|Michigan State University||2|||f||||f||||||||||2017-02-18 13:39:13.369946|2017-02-18 13:39:13.369946
NCT00800982|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2013-03-26|2013-02-19||October 2008||2008-10-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis|A Single-Center, Open-Label, Pilot Study to Evaluate the Efficacy and Tolerability of Narrow Band UVB Phototherapy in Enhancing Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque-Type Psoriasis|Completed||N/A|30|Actual|University of California, San Francisco|Of the 30 subjects enrolled, 3 were lost to follow-up, one moved out of state, and one voluntarily withdrew due to worsening of psoriasis.|2|||f||||t||||||||||2017-02-18 13:39:09.228317|2017-02-18 13:39:09.228317
NCT00800969|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2016-06-22|||October 2008||2008-10-01|June 2016|2016-06-01||||January 2015|Anticipated|2015-01-01||Interventional|||Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach||Withdrawn||Phase 2|0|Actual|University of Zurich||1|||f||||||||||||||2017-02-18 13:39:09.605202|2017-02-18 13:39:09.605202
NCT00800956|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2011-04-06|||January 2009||2009-01-01|April 2011|2011-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|ADME||Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion of Esreboxetine|An Open Label, Single Oral Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-Esreboxetine.|Completed||Phase 1|4|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 13:39:09.70018|2017-02-18 13:39:09.70018
NCT00800943|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2008-12-02|||December 2003||2003-12-01|December 2008|2008-12-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|CRC005||Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy|A Clinical Research Consortium (CRC) Phase II Study of Subcutaneous Campath-1H in Patients With B-Cell Chronic Lymphocytic Leukemia and Residual Disease After Chemotherapy|Unknown status|Active, not recruiting|Phase 2|31|Actual|Chronic Lymphocytic Leukemia Research Consortium||1|||f||||t||||||||||2017-02-18 13:39:09.800288|2017-02-18 13:39:09.800288
NCT00800930|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-02|2011-12-06|||January 2005||2005-01-01|December 2008|2008-12-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Therapeutic Induction of Endogenous Antibiotics|Therapeutic Induction of Endogenous Antibiotics for Improved Recovery in Shigellosis|Completed||Phase 2|80|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-02-18 13:39:09.90836|2017-02-18 13:39:09.90836
NCT00800917|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2010-06-01|||November 2008||2008-11-01|April 2010|2010-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme|A Phase II Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme|Completed||Phase 2|12|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-02-18 13:39:10.026785|2017-02-18 13:39:10.026785
NCT00800904|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2010-12-02|||May 2009||2009-05-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|||||Observational|||Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand|Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand|Completed||N/A|1210|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:39:10.114208|2017-02-18 13:39:10.114208
NCT00799188|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-12-11|||October 2008||2008-10-01|December 2013|2013-12-01||||September 2014|Anticipated|2014-09-01||Interventional|CERTICOEUR||CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial|CERTICOEUR a Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. An Open Labelled Randomized Everolimus vs Calcineurin Inhibitors Multicenter Trial|Unknown status|Active, not recruiting|Phase 3|175|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 13:39:10.224124|2017-02-18 13:39:10.224124
NCT00799175|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2008-11-26|||April 2007||2007-04-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|RAK-total||Local Infiltration Analgesia Following Total Knee Arthroplasty|Local Infiltration Analgesia With Ropivacaine, Ketorolac and Epinephrine Intra- and Postoperatively in Total Knee Arthroplasty|Completed||N/A|48|Actual|Region Örebro County||2|||f||||t||||||||||2017-02-18 13:39:12.640299|2017-02-18 13:39:12.640299
NCT00799162|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2011-09-23|||November 2008||2008-11-01|September 2011|2011-09-01|November 2013|Anticipated|2013-11-01|November 2012|Anticipated|2012-11-01||Observational|PPCSP||Prediction of Post-Cesarean Section Pain|Prediction of Post-Cesarean Section Pain|Unknown status|Recruiting|N/A|800|Anticipated|University of Washington|||1||f||||t||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:39:12.753456|2017-02-18 13:39:12.753456
NCT00799149|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2008-11-26|||June 2006||2006-06-01|November 2008|2008-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Etoricoxib Versus Gabapentin for Knee Arthroscopy|Phase 4 Study Comparing the Efficacy of Etoricoxib Versus Gabapentin as Part of a Multimodal Analgesic Regimen for Ambulatory Knee Arthroscopy|Completed||Phase 4|75|Actual|Meir Medical Center||3|||f||||f||||||||||2017-02-18 13:39:12.838745|2017-02-18 13:39:12.838745
NCT00799136|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-09-11|||February 2008||2008-02-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional|CATCH||A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL|Feasibility Study of CO-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of Acquired Immunodeficiency Syndrome (AIDS)-Related Lymphoma|Completed||Phase 2|6|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-02-18 13:39:12.934377|2017-02-18 13:39:12.934377
NCT00799123|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2010-04-09|||August 2008||2008-08-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Urine NT-proBNP Levels and Echocardiographic Findings in Very Low Birth Weight (VLBW) Infants||Completed||N/A|100|Anticipated|Charite University, Berlin, Germany|||1||f||||f|||||||"~     urine~   "|||2017-02-18 13:39:13.036139|2017-02-18 13:39:13.036139
NCT00799110|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-01-21|||August 2008||2008-08-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod|Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With GM-CSF and Imiquimod|Active, not recruiting||Phase 2|23|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 13:39:13.122256|2017-02-18 13:39:13.122256
NCT00799097|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2010-05-19|||July 2004||2004-07-01|November 2008|2008-11-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|||Determinants of Surgical Outcomes in Chronic Sinusitis|Determinants of Surgical Outcomes in Chronic Sinusitis|Completed||N/A|516|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-02-18 13:39:13.258733|2017-02-18 13:39:13.258733
NCT00799071|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2012-05-30|||February 2009||2009-02-01|May 2012|2012-05-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|iPOD||Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)|Investigation of POsaconazole Prophylaxis in Children With Chronic Granulomatous Disease (CGD): Pharmacokinetics and Tolerability (iPOD)|Completed||Phase 2|12|Actual|Radboud University||1|||f||||f||||||||||2017-02-18 13:39:13.480673|2017-02-18 13:39:13.480673
NCT00799058|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2017-01-26||2017-01-19|June 2009||2009-06-01|December 2016|2016-12-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Interventional|||A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States|A Multi-Center, Randomized, Double-Blind, PlaceboControlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring With Dapivirine for the Prevention of HIV-1 Infection in Women|Completed||Phase 1/Phase 2|180|Actual|International Partnership for Microbicides, Inc.||3|||f||||t||||||||No||2017-02-18 13:39:13.595987|2017-02-18 13:39:13.595987
NCT00799045|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2015-05-11|||October 2008||2008-10-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|April 2015|Actual|2015-04-01||Interventional|CANOA||Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects|Clopidogrel On Top of Aspirin For the Prevention of New Onset Migraine Headache Occurrence Following Transcatheter Closure of Atrial Septal Defects: A Prospective Randomized Trial (the CANOA Study)|Active, not recruiting||Phase 4|150|Anticipated|Laval University||2|||f||||f||||||||||2017-02-18 13:39:13.929039|2017-02-18 13:39:13.929039
NCT00800891|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-30|2009-04-01|||March 2008||2008-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:39:14.047236|2017-02-18 13:39:14.047236
NCT00800878|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2008-12-08|||February 2008||2008-02-01|November 2008|2008-11-01|April 2010|Anticipated|2010-04-01|December 2009|Anticipated|2009-12-01||Observational|CKD||Chronic Kidney Disease in Pakistani Population|Chronic Kidney Disease in the Pakistani Population|Unknown status|Recruiting|N/A|650|Anticipated|Aga Khan University|||1||f||||||||||||||2017-02-18 13:39:14.093788|2017-02-18 13:39:14.093788
NCT00800865|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2015-10-09|2011-01-12||January 2009||2009-01-01|October 2015|2015-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Evaluate Biomarkers in Patients With Solid Tumors (0000-097)(COMPLETED)|A 2-Stage, Open Label, Phase Ib Clinical Trial to Evaluate Biomarkers in Patients With Solid Tumor and Receiving a Single Dose of Cytotoxics|Completed||Phase 1|36|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:39:14.186637|2017-02-18 13:39:14.186637
NCT00800852|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-30|2008-12-01||||||November 2008|2008-11-01||||||||Observational|||Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome|Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome|Completed||N/A|||Samsung Medical Center|||||f||||t||||||||||2017-02-18 13:39:14.555472|2017-02-18 13:39:14.555472
NCT00800839|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-07-28|2016-07-28||September 2008||2008-09-01|July 2016|2016-07-01||||July 2015|Actual|2015-07-01||Interventional|||Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide|Busulfan (IV) and Fludarabine Followed by Post-allogeneic Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies.|Completed||Phase 2|56|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:39:14.635309|2017-02-18 13:39:14.635309
NCT00800826|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2008-12-01|||November 2006||2006-11-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|||||Interventional|||The Combination Effect of Dexmedetomidine and Morphine in Postoperative Patient-Controlled Analgesia||Completed||Phase 4|150|Actual|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 13:39:15.031069|2017-02-18 13:39:15.031069
NCT00800813|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2014-07-10|||November 2008||2008-11-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy|Assessing the Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy|Completed||N/A|121|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 13:39:15.106072|2017-02-18 13:39:15.106072
NCT00800800|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2010-12-02|||November 2002||2002-11-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|ASTRONOMER||Effects of Rosuvastatin on Aortic Stenosis Progression|Effect of Cholesterol Lowering on the Progression of Aortic Stenosis in Patients With Mild to Moderate Aortic Stenosis (ASTRONOMER)Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin and The Sub-Study Protocol.|Completed||Phase 3|378|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:39:15.204377|2017-02-18 13:39:15.204377
NCT00800787|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-01-15|||April 2010||2010-04-01|June 2010|2010-06-01|September 2010|Anticipated|2010-09-01|August 2010|Anticipated|2010-08-01||Interventional|Nabi-HB-SC||Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation|A Phase 3, Multicenter, Open Label Study to Assess the Safety and Efficacy of Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Associated Liver Disease Who Underwent Liver Transplantation|Withdrawn||Phase 3|0|Actual|Biotest Pharmaceuticals Corporation||1||New sponsor's existing product under evaluation for this indication|f||||t||||||||||2017-02-18 13:39:15.328897|2017-02-18 13:39:15.328897
NCT00800774|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2009-11-21|||January 1998||1998-01-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old|Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old|Completed||Phase 4|9|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-02-18 13:39:15.439373|2017-02-18 13:39:15.439373
NCT00800761|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2008-12-01|||December 2001||2001-12-01|December 2001|2001-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|DFODFPTM||Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major|Increased Survival and Reversion of Iron-Induced Cardiac Disease in Patients With Thalassemia Major Receiving Intensive Combined Chelation Therapy|Completed||Phase 4|||Ospedale Microcitemico||2|||f||||f||||||||||2017-02-18 13:39:15.550555|2017-02-18 13:39:15.550555
NCT00800748|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2017-01-26||||||January 2017|2017-01-01||||||||Expanded Access|||A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C|An Open, Phase IV, Multicentric Study, Evaluating Safety and Efficacy of Ribavirin (Copegus®) and Peginterferon Alfa-2a (Pegasys®) Combination in Specific Groups|No longer available||N/A|||Hoffmann-La Roche|||||f||||||||||||||2017-02-18 13:39:15.864207|2017-02-18 13:39:15.864207
NCT00800735|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2013-09-30|2013-07-05||April 2009||2009-04-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols|An Open-label, Multicenter Protocol Providing Pegylated-interferon Alfa-2a (PEGASYS®) as Monotherapy or in Combination With Ribavirin (COPEGUS®) for Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols|Completed||Phase 3|30|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:39:16.000129|2017-02-18 13:39:16.000129
NCT00800722|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2017-02-08|||November 2008||2008-11-01|February 2017|2017-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.|Phase I Combined Use of Pulsed Dye Laser and Rapamycin|Completed||Phase 1|21|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 13:39:16.296786|2017-02-18 13:39:16.296786
NCT00800709|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2010-12-02|||July 2008||2008-07-01|December 2010|2010-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease|Changes of Biological Markers and Brain PET Imaging and Clinical Effects of Memantine for Patients With Moderate to Severe Alzheimer's Disease: a 24 Week Double-blind, Randomized, Placebo-Controlled Study|Completed||Phase 4|26|Anticipated|Shanghai Mental Health Center||1|||f||||t||||||||||2017-02-18 13:39:16.408248|2017-02-18 13:39:16.408248
NCT00800696|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-30|2011-04-20|||September 2010||2010-09-01|April 2011|2011-04-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||Preventive Oral Care||Unknown status|Active, not recruiting|N/A|66|Anticipated|Shaare Zedek Medical Center||2|||f||||||||||||||2017-02-18 13:39:16.537985|2017-02-18 13:39:16.537985
NCT00800683|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2014-05-15|2011-12-30||December 2008||2008-12-01|May 2014|2014-05-01||||January 2011|Actual|2011-01-01||Interventional|||Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive|Safety in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 vs. Placebo, DB, Parallel Group, Randomized, Insulin Background Inclusive|Completed||Phase 3|133|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:39:16.64795|2017-02-18 13:39:16.64795
NCT00800670|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2013-08-06|||June 2009||2009-06-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine|Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine|Terminated||Phase 1|48|Anticipated|McMaster University||2||Study was terminated after the low dose cohort had been enrolled|f||||t||||||||||2017-02-18 13:39:17.700392|2017-02-18 13:39:17.700392
NCT00800657|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2011-06-22|||November 2008||2008-11-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|RCT and SCT||Stem Cells and Resynchronization Cardiac|Stem-Cells and Heart Failure in Several Ethiologies. Alternative Indication With Cardiac Resynchronization|Unknown status|Recruiting|Phase 1|30|Anticipated|Instituto de Molestias Cardiovasculares||1|||f||||t||||||||||2017-02-18 13:39:18.004525|2017-02-18 13:39:18.004525
NCT00800644|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-11-09|||November 2008||2008-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Observational|||Pelvic Fractures and Radiation Therapy for Cervical Cancer|Evaluation of Bone Density and Pelvic Fractures in Women Undergoing Definitive Pelvic Radiation Therapy for Cervical, Endometrial or Vaginal Cancer|Active, not recruiting||N/A|300|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:39:18.114479|2017-02-18 13:39:18.114479
NCT00800631|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2008-12-01|||January 2008||2008-01-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|January 2009|Anticipated|2009-01-01||Observational|||The Biomarker and Cardiac Function in Sepsis|The Biomarker and Associated Cardiac Function in the Patients With Sepsis|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:39:18.229301|2017-02-18 13:39:18.229301
NCT00800618|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2010-02-09|||November 2008||2008-11-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women|A Double Blind (3rd Party Open), Randomised, Placebo Controlled, Dose Escalating, Parallel Group Study To Investigate The Safety, Toleration, Pharmacology And Pharmacokinetics, Of Multiple Doses Of PF-02413873 In Healthy Female Subjects.|Completed||Phase 1|42|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:39:18.305594|2017-02-18 13:39:18.305594
NCT00800605|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2015-10-07||2009-10-28|December 2008||2008-12-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection|Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine to Prevent Culture Confirmed Influenza Infection|Completed||Phase 3|7252|Actual|Nanotherapeutics, Inc.||2|||f||||t||||||||||2017-02-18 13:39:18.419064|2017-02-18 13:39:18.419064
NCT00800592|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2011-05-30|||October 2008||2008-10-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Sildenafil IV Bolus Study|An Open Single Dose Study To Assess The Safety, Tolerability And Pharmacokinetics Of An Intravenous Bolus Dose (10 Mg) Of Sildenafil In Patients With Pulmonary Arterial Hypertension (PAH).|Completed||Phase 1|12|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 13:39:18.559329|2017-02-18 13:39:18.559329
NCT00800579|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2009-10-20|||November 2008||2008-11-01|October 2009|2009-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers|A Randomised, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers|Completed||Phase 1|12|Anticipated|Gilead Sciences||4|||f||||f||||||||||2017-02-18 13:39:18.671844|2017-02-18 13:39:18.671844
NCT00800566|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2012-07-31|||November 2008||2008-11-01|July 2012|2012-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)|Phase I Study of Oral Clofarabine for the Treatment of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1||Sponsor terminated.|f||||t||||||||||2017-02-18 13:39:18.783124|2017-02-18 13:39:18.783124
NCT00800553|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-08-02|||November 2006||2006-11-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults|The Neural and Behavioral Correlates of How Donepezil Modulates Memory and Inhibitory Efficiency in the Context of 24 Hours of Sleep Deprivation|Completed||Phase 4|43|Actual|Duke-NUS Graduate Medical School||2|||f||||t||||||||||2017-02-18 13:39:18.898758|2017-02-18 13:39:18.898758
NCT00800540|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2013-03-20|2013-01-31||February 2009||2009-02-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||This reporting group includes all enrolled participants.|Circadian Ocular Perfusion Pressure and Ocular Blood Flow|Effects of Topical Hypotensive Drugs on Circadian Ocular Perfusion Pressure and Ocular Blood Flow in Patients With Open-Angle Glaucoma|Completed||Phase 4|35|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:39:19.027634|2017-02-18 13:39:19.027634
NCT00800527|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2008-12-01|||November 2007||2007-11-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of Gabapentin in the Treatment of Chest Pain and Paresthesia in Patients With Sternotomy|Phase 4 Study of Efficacy of Gabapentin in the Treatment of Chest Pain and Paresthesia in Patients With Sternotomy|Completed||Phase 4|110|Actual|Usak State Hospital||2|||f||||f||||||||||2017-02-18 13:39:19.617704|2017-02-18 13:39:19.617704
NCT00800514|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2011-07-18|||January 2009||2009-01-01|July 2011|2011-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)|Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury|Terminated||N/A|16|Anticipated|Carolinas Healthcare System||1||Principal investigator took a position at another institution. No subjects enrolled.|f||||t||||||||||2017-02-18 13:39:19.753384|2017-02-18 13:39:19.753384
NCT00800501|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-29|2011-12-05|||December 2008||2008-12-01|December 2011|2011-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis|A Double-blind, Randomised, Parallel Group Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis, Using an Implanted Catheter and SynchroMed® II Pump|Completed||Phase 1/Phase 2|18|Actual|Newron Sweden AB||2|||f||||t||||||||||2017-02-18 13:39:19.856061|2017-02-18 13:39:19.856061
NCT00800488|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2014-07-25|||October 2008||2008-10-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Observational|PRONOUR||Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months|Usefulness of Serum Procalcitonin for Predicting Serious Bacterial Infection in Febrile Infants Less Than 3 Months|Completed||N/A|2209|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 13:39:19.966159|2017-02-18 13:39:19.966159
NCT00800475|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-08-09|||July 2005||2005-07-01|August 2013|2013-08-01|September 2005|Actual|2005-09-01|July 2005|Actual|2005-07-01||Interventional|||Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets|A Relative Bioequivalence Study of 600 mg Gemfibrozil Tablets Under Fasting Conditions|Completed||Phase 1|40|Actual|Blu Caribe||2|||f||||f||||||||||2017-02-18 13:39:20.053549|2017-02-18 13:39:20.053549
NCT00800462|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2013-04-04|||March 2008||2008-03-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity|Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity|Completed||Phase 4|23|Actual|Toronto Rehabilitation Institute||3|||f||||f||||||||||2017-02-18 13:39:20.13964|2017-02-18 13:39:20.13964
NCT00800449|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-30|2012-02-13|||August 2007||2007-08-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Observational|||Distribution of Haptoglobin Phenotype in Septic and Non Septic Pre-term Neonates (PTSH)|Prospective Assessment of the Distribution of Haptoglobin Phenotype in Septic and Non Septic Pre-term Neonates (PTSH)|Completed||N/A|133|Actual|Carmel Medical Center|||1||f||||t||||||Samples Without DNA|"~     Hp phenotype in blood test.~   "|||2017-02-18 13:39:20.249014|2017-02-18 13:39:20.249014
NCT00800436|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-10-24|2016-10-24||November 2008||2008-11-01|October 2016|2016-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||"Safety Population: All participants who received at least one dose of study medication, whether prematurely withdrawn from the study or not. The Total column (n=70) includes 4 female participants who were counted twice as they were treated in both Cohort 2 and Cohort A."|A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females|An Open-Label, Two-Part, Multi-Centre, Trastuzumab Dose-Finding Study in Healthy Male Volunteers and HER2 Positive Female Patients|Completed||Phase 1|66|Actual|Hoffmann-La Roche||7|||f||||||||||||||2017-02-18 13:39:20.35218|2017-02-18 13:39:20.35218
NCT00800423|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-30|2008-12-01|||January 2009||2009-01-01|November 2008|2008-11-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema|Phase 3 Study of Brimonidine Tartrate Drops Efficacy in Reducing Post Operative Corneal Edema After Cataract Surgery|Unknown status|Not yet recruiting|Phase 3|150|Anticipated|Rabin Medical Center||3|||f||||f||||||||||2017-02-18 13:39:21.840921|2017-02-18 13:39:21.840921
NCT00800410|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-05-25|||September 2004||2004-09-01|May 2016|2016-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||REACH Detroit Partnership Family Intervention|A Pilot Randomized Diabetes Intervention Among Inner-city African American and Latino Adults|Completed||Phase 2|183|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 13:39:21.954055|2017-02-18 13:39:21.954055
NCT00800397|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2009-08-11|||December 2007||2007-12-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Evaluation of the Noga System: Detecting of Respiratory Related Sleep Disorders in Cardiac Patients|Evaluation of the Noga System: Detecting of Respiratory Related Sleep Disorders in Cardiac Patients|Completed||N/A|80|Anticipated|WideMed LTD.|||1||f||||t||||||||||2017-02-18 13:39:22.046831|2017-02-18 13:39:22.046831
NCT00800384|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-27|2016-01-05|2015-10-13||January 2009||2009-01-01|March 2014|2014-03-01|May 2014|Actual|2014-05-01|October 2013|Actual|2013-10-01||Interventional|SIMPLE||Shockless Implant Evaluation|Shockless Implant Evaluation|Completed||N/A|2500|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 13:39:22.140405|2017-02-18 13:39:22.140405
NCT00800371|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2008-12-01|||May 2008||2008-05-01|November 2008|2008-11-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Observational|||Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)|Diagnostic Value of MRI and Ultrasound in Patients With JIA|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital Tuebingen|||1||f||||f||||||||||2017-02-18 13:39:23.184195|2017-02-18 13:39:23.184195
NCT00800358|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-30|2012-12-04|||November 2008||2008-11-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism|A Multi Centre, Open Label, Parallel Group, Randomized Controlled Trial to Compare the Safety and Efficacy of Oral Paricalcitol Versus Oral Calcitriol in the Treatment of Secondary Hyperparathyroidism in Dialysis Patients|Completed||N/A|69|Actual|Penang Hospital, Malaysia||2|||f||||t||||||||||2017-02-18 13:39:23.274096|2017-02-18 13:39:23.274096
NCT00800345|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-04-12|||April 2009||2009-04-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors|A Phase I Trial of Oral Metronomic Topotecan in Combination With Oral Pazopanib Utilizing a Daily Dosing Schedule to Treat Recurrent or Persistent Gynecologic Tumors|Completed||Phase 1|33|Actual|Vector Oncology||1|||f||||f||||||||Undecided||2017-02-18 13:39:23.398192|2017-02-18 13:39:23.398192
NCT00800332|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2010-11-11|||November 2008||2008-11-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|April 2010|Actual|2010-04-01||Interventional|||Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy|Double-blind, Placebo-controlled Dose-finding Study With CYT003-QbG10 in Adult Patients With Rhinoconjunctivitis Due to House Dust Mite Allergy|Completed||Phase 2|300|Anticipated|Cytos Biotechnology AG||3|||f||||f||||||||||2017-02-18 13:39:23.513937|2017-02-18 13:39:23.513937
NCT00800319|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2011-08-19|||December 2008||2008-12-01|August 2011|2011-08-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||ALK33-001: A Study of RDC-0313 Administered to Healthy Adults|ALK33-001: A Phase 1 Study of the Pharmacokinetics of RDC-0313 Administered to Healthy Adults|Completed||Phase 1|16|Actual|Alkermes, Inc.||6|||f||||t||||||||||2017-02-18 13:39:23.617369|2017-02-18 13:39:23.617369
NCT00800306|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2009-10-14|||November 2007||2007-11-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|February 2008|Actual|2008-02-01||Interventional|||Effects of Levosimendan on Microcirculation in Septic Shock|Levosimendan and Inhaled Nitric Oxide for Resuscitating the Microcirculation in Septic Shock. A Randomized Controlled Trial|Completed||Phase 2|40|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-02-18 13:39:23.729402|2017-02-18 13:39:23.729402
NCT00800293|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2012-03-15|||December 2002||2002-12-01|March 2012|2012-03-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|||Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams|Bioequivalence of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams|Completed||Phase 1|116|Actual|Perrigo Company|||4||f||||f||||||||||2017-02-18 13:39:23.847075|2017-02-18 13:39:23.847075
NCT00800280|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2010-02-16|||January 2009||2009-01-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body|A Phase 1, Open-Label, Randomized, Cross-Over Study To Estimate The Effects Of Steady-State Cimetidine On The Pharmacokinetics Of A Single Dose Of PD 0332334 In Healthy Subjects|Terminated||Phase 1|12|Actual|Pfizer||2||Please see Detailed Description for termination reason.|f||||f||||||||||2017-02-18 13:39:23.93701|2017-02-18 13:39:23.93701
NCT00800267|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2009-03-05|||July 1997||1997-07-01|March 2009|2009-03-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||A Study of Glaucoma or Ocular Hypertension in Patients Within the United States|A 6-Month, Randomized, Double-Masked Comparison of Fixed Combination of Latanoprost and Timolol With the Individual Components, Continuing Into a 6-Month Open Label Safety Study of Fixed Combination in Patients With Glaucoma or Ocular Hypertension. A Multicenter Study in the United States|Completed||Phase 3|418|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:39:24.058775|2017-02-18 13:39:24.058775
NCT00800254|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-30|2015-07-14|2015-05-28||October 2008||2008-10-01|July 2015|2015-07-01|November 2011|Actual|2011-11-01|December 2010|Actual|2010-12-01||Interventional|||Early Neuromuscular Electrical Stimulation For Quadriceps Muscle Activation Deficits Following Total Knee Replacement|Early Neuromuscular Electrical Stimulation For Quadriceps Muscle Activation Deficits Following Total Knee Replacement|Completed||Phase 2|66|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 13:39:24.221913|2017-02-18 13:39:24.221913
NCT00800241|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2010-12-02|||May 2009||2009-05-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|||||Observational|||Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand|Budesonide/Formoterol for Maintenance and Reliever Therapy: A Medication Use Evaluation Among Persistent Asthma Patients in General Practice in Thailand|Completed||N/A|1020|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:39:25.014213|2017-02-18 13:39:25.014213
NCT00800228|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-30|2008-11-30|||March 2003||2003-03-01|November 2008|2008-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Salt Study: Inhibited Breathing Pattern and Sodium Inhibitors in Sodium Sensitivity of Blood Pressure|Inhibited Breathing Pattern and Sodium Inhibitors in Sodium Sensitivity of Blood Pressure|Completed||N/A|96|Actual|National Institute on Aging (NIA)|||2||f||||f||||||||||2017-02-18 13:39:25.127242|2017-02-18 13:39:25.127242
NCT00800215|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2015-05-26|||March 2004||2004-03-01|May 2015|2015-05-01|November 2004|Actual|2004-11-01|August 2004|Actual|2004-08-01||Interventional|||A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927|A Multicenter, Double-blind, Double-dummy, Randomized Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures With or Without Secondary Generalization|Completed||Phase 2|60|Actual|UCB Pharma||4|||f||||t||||||||||2017-02-18 13:39:25.262468|2017-02-18 13:39:25.262468
NCT00800202|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2014-11-10|2014-06-23||April 2009||2009-04-01|November 2014|2014-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||The Intent-to-Treat (ITT) population: All participants enrolled in each arm who had at least one post-enrollment evaluation. Participants who were lost to follow-up immediately after enrollment were not included in the ITT population.|A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis|An Open Label Study to Assess the Effect of Avastin (Bevacizumab) Combined With First Line Paclitaxel-carboplatin or Second Line Tarceva (Erlotinib) on Progression-free Survival in Non-squamous Non-small Cell Lung Cancer Patients With Asymptomatic Untreated Brain Metastasis|Completed||Phase 2|91|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:39:25.38617|2017-02-18 13:39:25.38617
NCT00799994|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2016-11-20|||October 2004||2004-10-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Does Lowering Eye Pressure Affect the Results Obtained From Objective Visual Field Testing?|Effect of Acutely Lowering Intraocular Pressure on Multifocal Visual Evoked Potential Testing|Completed||N/A|23|Actual|Wills Eye|||2||f||||f||||||||No||2017-02-18 13:39:30.190009|2017-02-18 13:39:30.190009
NCT00800189|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2012-03-07|||August 2008||2008-08-01|March 2012|2012-03-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|Anterior EPI||Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI)|A Prospective Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy Tangentially With or Without Supraclavicular Treatment|Completed||N/A|200|Anticipated|British Columbia Cancer Agency||1|||f||||t||||||||||2017-02-18 13:39:25.938593|2017-02-18 13:39:25.938593
NCT00800176|ClinicalTrials.gov processed this data on February 17, 2017|2008-12-01|2016-07-26||2016-07-26|January 2009||2009-01-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus|A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/ Tolerability and Pharmacokinetics of Five Dose Levels of RO4998452 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|405|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-02-18 13:39:26.030353|2017-02-18 13:39:26.030353
NCT00800163|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2010-07-22|||September 2005||2005-09-01|November 2008|2008-11-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|EHART||Improving Door-to-Balloon Time in STEMI|Emergency Department Physician Activation of the Catheterization Laboratory and Immediate Transfer to an Immediately Available Catheterization Lab Reduce Door-to-Balloon Time in ST-Elevation Myocardial Infarction|Unknown status|Recruiting|N/A|1000|Anticipated|St. Francis Hospitals & Health Centers||1|||f||||f||||||||||2017-02-18 13:39:26.20479|2017-02-18 13:39:26.20479
NCT00800150|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-27|2015-06-03|||November 2008||2008-11-01|June 2015|2015-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment|Phase I Study of Escalating Doses of Radiation Therapy Using Helical Tomotherapy in Combination With Fludarabine (FLU) and Melphalan (MEL) as a Preparative Regimen for Allogeneic Hematopoietic Stem Cell (HSC) Transplantation in Patients With Advanced and Hematological Malignancies Who Are Not Eligible for Fully Myeloablative Regimen|Terminated||Phase 1|6|Actual|City of Hope Medical Center||1||"Protocol objective could not be met. A new study with amended eligibility criteria will be~   developed."|f||||t||||||||||2017-02-18 13:39:26.313217|2017-02-18 13:39:26.313217
NCT00800137|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-04-08|||December 2008||2008-12-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|BRUISECONTROL||Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial|Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISE CONTROL)|Terminated||Phase 4|984|Actual|Ottawa Heart Institute Research Corporation||2||At time of pre-specified 2nd interim analysis|f||||t||||||||||2017-02-18 13:39:26.432771|2017-02-18 13:39:26.432771
NCT00800124|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-27|2014-11-21|||June 2005||2005-06-01|November 2008|2008-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|CNC||Study on Cemented Versus Non-cemented Hemiarthroplasty in Elderly With Hip Fractures|A Prospective Randomized Multicenter Study on Cemented and Non-cemented Hemiprosthesis in Older Patients With Dislocated Hip Fracture.|Completed||N/A|334|Actual|Sykehuset Innlandet HF||2|||f||||f||||||||||2017-02-18 13:39:26.57367|2017-02-18 13:39:26.57367
NCT00800111|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2017-01-30|||February 2008||2008-02-01|January 2017|2017-01-01||||February 2024|Anticipated|2024-02-01||Interventional|||Study of Endothelial Keratoplasty Outcomes|Open-enrollment, Prospective Study of Endothelial Keratoplasty Outcomes|Recruiting||N/A|5000|Anticipated|Cornea Research Foundation of America||1|||f||||t||||||||||2017-02-18 13:39:26.684953|2017-02-18 13:39:26.684953
NCT00800098|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-06-21|||December 2008||2008-12-01|June 2013|2013-06-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional|||Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee|Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee|Completed||Early Phase 1|22|Actual|Stanford University||2|||f||||||||||||||2017-02-18 13:39:26.813336|2017-02-18 13:39:26.813336
NCT00800085|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2013-12-27|||October 2006||2006-10-01|December 2013|2013-12-01|October 2015|Anticipated|2015-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Beta Cell Function in (Pre) Type 1 Diabetes|Beta Cell Function in (Pre) Type 1 Diabetes|Unknown status|Enrolling by invitation|Phase 1/Phase 2|200|Anticipated|AZ-VUB||1|||f||||f||||||||||2017-02-18 13:39:26.909233|2017-02-18 13:39:26.909233
NCT00800072|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2014-02-26|||November 2008||2008-11-01|February 2014|2014-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||NOWOX Oxygen Therapy Monitoring Device|Evaluation of NOWOX: a Medical Device Developed to Record Duration of Oxygen Use and Respiration Rate in Patients Requiring Oxygen Therapy|Completed||N/A|10|Actual|Air Liquide SA||1|||f||||f||||||||||2017-02-18 13:39:27.019506|2017-02-18 13:39:27.019506
NCT00800059|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-27|2015-07-23|||November 2008||2008-11-01|July 2015|2015-07-01|November 2025|Anticipated|2025-11-01|November 2020|Anticipated|2020-11-01||Interventional|TMI-ASCT||Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma|A Dose Escalation Study of Total Marrow Irradiation (TMI) and Autologous Stem Cell Transplantation (ASCT) for the Treatment of Relapsed or Refractory Multiple Myeloma (MM)|Recruiting||Phase 1/Phase 2|27|Anticipated|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-02-18 13:39:27.126701|2017-02-18 13:39:27.126701
NCT00799032|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2008-11-27|||May 2007||2007-05-01|November 2008|2008-11-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|ATLANTA||The ATLANTA First in Man Study of the Catania Stent|Assessment of The Latest Non-Thrombogenic Angioplasty Stent (ATLANTA): Prospective, First in Man, Non-Randomized, Single Center for Patients With Documented Myocardial Ischemia Undergoing PCI|Completed||Phase 1|55|Actual|CeloNova BioSciences, Inc.||1|||f||||t||||||||||2017-02-18 13:39:27.368517|2017-02-18 13:39:27.368517
NCT00799019|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2014-01-27|||July 2008||2008-07-01|January 2014|2014-01-01|June 2014|Anticipated|2014-06-01|December 2013|Actual|2013-12-01||Observational|||A Prospective, Immunogenicity Surveillance Registry of Erythropoiesis Stimulating Agent (ESA) With Subcutaneous Exposure in Thailand|A Prospective, Immunogenicity Surveillance Registry of Erythropoiesis Stimulating Agent (ESA) With Subcutaneous Exposure in Thailand|Unknown status|Active, not recruiting|N/A|6500|Anticipated|Chulalongkorn University|||1||f||||t||||||||||2017-02-18 13:39:27.473119|2017-02-18 13:39:27.473119
NCT00799006|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2009-07-17|||November 2008||2008-11-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers|A Phase 1 Placebo-Controlled Trial To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Escalating Oral Doses Of PF-04620110 In Otherwise Healthy Overweight And Obese Subjects|Completed||Phase 1|27|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:39:27.547089|2017-02-18 13:39:27.547089
NCT00798993|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-06-06|||January 2009||2009-01-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients|The Effect of 25-hydroxyvitamin D Supplementation and a Structured Exercise Program on Exercise Capacity and Quality of Life in Dialysis Patients|Completed||Phase 4|19|Actual|Sir Charles Gairdner Hospital||3|||f||||f||||||||||2017-02-18 13:39:27.643632|2017-02-18 13:39:27.643632
NCT00798980|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2015-04-21|||February 2007||2007-02-01|April 2015|2015-04-01|November 2009|Actual|2009-11-01|June 2008|Actual|2008-06-01||Observational|||Scandinavian Mirena Insertion Nulliparous Trial.|Scandinavian Mirena Insertion Nulliparous Trial of an Observational Study.|Completed||N/A|224|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:39:27.750034|2017-02-18 13:39:27.750034
NCT00798967|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2015-11-10|2011-12-23||November 2008||2008-11-01|January 2015|2015-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|STEPS||Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects|A 24-Week Study of the Efficacy and Safety of Teduglutide in Subjects With Parenteral Nutrition-Dependent Short Bowel Syndrome|Completed||Phase 3|86|Actual|Shire||2|||f||||t||||||||||2017-02-18 13:39:27.857757|2017-02-18 13:39:27.857757
NCT00798954|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2010-06-09|||June 2007||2007-06-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|December 2008|Actual|2008-12-01||Interventional|SINGLEKISS||Treatment of Bifurcation Lesions by SINGLE STENT and KISSing Balloon Trial|A Multi-center Trial to Evaluate Paclitaxel- and Sirolimus-eluting Stents in Provisional T-stenting With Kissing Balloon Technique in the Treatment of Bifurcation Lesions|Completed||Phase 4|800|Anticipated|Vulnerable Plaque Society||2|||f||||t||||||||||2017-02-18 13:39:28.469053|2017-02-18 13:39:28.469053
NCT00798941|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2010-07-06|||February 2009||2009-02-01|June 2010|2010-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||ICU Patient and Family Comfort Study||Completed||N/A|120|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-02-18 13:39:28.586377|2017-02-18 13:39:28.586377
NCT00798915|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2014-07-21|||December 2008||2008-12-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus|Restoration of the GIP-mediated Incretin Effect in Persons With Type 2 Diabetes Mellitus|Completed||Phase 1|40|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 13:39:28.687312|2017-02-18 13:39:28.687312
NCT00798902|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-03-07|||November 2008||2008-11-01|March 2012|2012-03-01|October 2012|Anticipated|2012-10-01|July 2012|Anticipated|2012-07-01||Interventional|||Pilot Study to Assess Safety/Preliminary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery|A Multi-Center, Prospective, Parallel Group, Randomized, Pilot Study Evaluating Safety and Preliminary Effectiveness Of Prefix Compared To Iliac Crest Bone In Subjects With DDD Undergoing Transforaminal Lumbar Interbody Fusion|Unknown status|Active, not recruiting|Phase 1/Phase 2|22|Anticipated|BioSurface Engineering Technologies, Inc||2|||f||||t||||||||||2017-02-18 13:39:28.806194|2017-02-18 13:39:28.806194
NCT00798889|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-12-13|2012-12-13||March 2004||2004-03-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Rollover Protocol for Prior SU011248 Protocols|A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol|Completed||N/A|314|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:39:28.922381|2017-02-18 13:39:28.922381
NCT00798876|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-09-12|||December 2001||2001-12-01|September 2016|2016-09-01||||September 2010|Actual|2010-09-01||Interventional|||Low-Fat Fish Oil Diet for Prostate Cancer Prevention|Comparison Study of a Low-Fat Diet Supplemented With Fish Oil and a Standard Western Diet in Individuals With Prostate Cancer|Active, not recruiting||N/A|70|Anticipated|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 13:39:29.438494|2017-02-18 13:39:29.438494
NCT00798863|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2009-07-14|||January 2007||2007-01-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|VANSsubmand||Study Of The Safety And Efficacy Video Assisted Submandibular Gland Resection Using A New Two Step Technique|Video Assisted Submandibular Resection, Two Step Technique|Completed||N/A|12|Actual|Faculty of Medicine, University of Alexandria||1|||f||||t||||||||||2017-02-18 13:39:29.587966|2017-02-18 13:39:29.587966
NCT00798850|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2015-04-07|||August 2002||2002-08-01|April 2015|2015-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Trial of Nonsurgical Treatment of Intermittent Claudication Due to Femoro-popliteal Disease|Randomised Controlled Trial of Percutaneous Transluminal Angioplasty (PTA) Versus a Supervised Exercise Programme (SEP) in the Management of Intermittent Claudication (IC) Due to Femoro-popliteal Disease|Completed||N/A|178|Actual|University of Hull||3|||f||||f||||||||||2017-02-18 13:39:29.700558|2017-02-18 13:39:29.700558
NCT00798837|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-09-28|||December 2008||2008-12-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Intraprostatic MAXimal Simultaneous Boost|A Dose-escalation Study Using a Maximal Simultaneous Intraprostatic Boost With RapidArc Intensity Modulated Radiotherapy in Intermediate Risk Prostate Cancer|Terminated||Phase 1|10|Actual|British Columbia Cancer Agency||1||Excess risk in rectal bleeding of first 10 patients|f||||t||||||||||2017-02-18 13:39:29.839702|2017-02-18 13:39:29.839702
NCT00800046|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-10-21|||November 2008||2008-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:39:29.93682|2017-02-18 13:39:29.93682
NCT00800033|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2015-05-26|||November 2008||2008-11-01|May 2015|2015-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effectiveness of Pulse-Based Foods Combined With Exercise for Improving Components of the Metabolic Syndrome|Effectiveness of Pulse-Based Foods Combined With Exercise for Improving Components of the Metabolic Syndrome|Completed||Phase 3|87|Actual|University of Saskatchewan||4|||f||||f||||||||||2017-02-18 13:39:29.98286|2017-02-18 13:39:29.98286
NCT00800007|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2009-02-19|||November 2008||2008-11-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus|A Phase 1/2 Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Intravenous Doses of ANZ-521 in Hepatitis C Patients|Terminated||Phase 1/Phase 2|5|Actual|Anza Therapeutics, Inc.||2|||f||||t||||||||||2017-02-18 13:39:30.09008|2017-02-18 13:39:30.09008
NCT00799981|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2012-09-27|||November 2008||2008-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:39:30.284852|2017-02-18 13:39:30.284852
NCT00799968|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2008-11-28|||June 2002||2002-06-01|November 2008|2008-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|UKPTEC||12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China|Efficacy and Safety Evaluation of 12-h and 2-h Urokinase Regimes in the Treatment of Pulmonary Thromboembolism: A Multi-Center, Randomized Controlled Trial in China|Completed||Phase 4|129|Actual|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-02-18 13:39:30.339744|2017-02-18 13:39:30.339744
NCT00799955|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-01-22|||October 2008||2008-10-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Comparing 2 Types of Pain Relief After Cesarean Delivery: Spinal Morphine and TAP Block|Comparison of Efficacy and Side Effects of Intrathecal Morphine and TAP Block for Post-cesarean Analgesia|Completed||N/A|70|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 13:39:30.483186|2017-02-18 13:39:30.483186
NCT00799942|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-27|2010-06-30|||May 2009||2009-05-01|June 2010|2010-06-01||||||||Interventional|||Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus|Long-term Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of Neramexane Mesylate in Congenital Idiopathic Nystagmus and Acquired Nystagmus|Terminated||Phase 2|48|Anticipated|Merz Pharmaceuticals GmbH||1|||f||||f||||||||||2017-02-18 13:39:30.593134|2017-02-18 13:39:30.593134
NCT00799929|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2015-12-22|||December 2008||2008-12-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|||IVF Clinical Trial of Two Different Treatment Protocols.|Efficiency and Patient Satisfaction of Two Different IVF Protocols.|Completed||N/A|564|Actual|New Hope Fertility Center||2|||f||||t||||||||||2017-02-18 13:39:30.667982|2017-02-18 13:39:30.667982
NCT00799916|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2009-09-14|||January 2006||2006-01-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe Sepsis|Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe Sepsis|Completed||Phase 3|30|Anticipated|Universidad Nacional de La Plata||2|||f||||f||||||||||2017-02-18 13:39:30.774116|2017-02-18 13:39:30.774116
NCT00799903|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-11-18||2014-03-27|December 2008||2008-12-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|STABILITY||The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial|LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)|Completed||Phase 3|15828|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:39:30.897846|2017-02-18 13:39:30.897846
NCT00799890|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2016-03-21|||May 2009||2009-05-01|January 2016|2016-01-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SUPREMES||Sunphenon in Progressive Forms of Multiple Sclerosis|Monocentric, Prospective, Doubleblind, Randomised/Stratified, Placebocontrolled Two-arm Study to Evaluate the Effect of Sunphenon EGCg (Main Component Epigallocatechin-Gallat) on the Increase of Brain Atrophy in the Cerebral Magnetic Resonance Tomography in a 36-months Treatment Time in Patients With Primary or Secondary Chronic-progressive Multiple Sclerosis|Completed||Phase 2/Phase 3|60|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:39:31.981332|2017-02-18 13:39:31.981332
NCT00799877|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2017-02-02|||September 2008||2008-09-01|February 2017|2017-02-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|||Chronic Plaque Psoriasis (Ps) Registry|A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)|Active, not recruiting||N/A|6000|Anticipated|AbbVie|||1||f||||f||||||||||2017-02-18 13:39:32.120333|2017-02-18 13:39:32.120333
NCT00799864|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-12-23|||January 2011||2011-01-01|December 2016|2016-12-01|May 2024|Anticipated|2024-05-01|January 2020|Anticipated|2020-01-01||Interventional|||A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years|A Phase II, Open Label, Single Arm Trial to Evaluate the Pharmacokinetics,Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Antiretroviral Naive HIV-1 Infected Adolescents and Children Aged > = 6 to <18 Years|Recruiting||Phase 2|61|Anticipated|Janssen Sciences Ireland UC||1|||f||||t||||||||||2017-02-18 13:39:32.621558|2017-02-18 13:39:32.621558
NCT00799851|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2008-11-28|||November 2004||2004-11-01|November 2008|2008-11-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices|Endoscopic Treatment of Esophageal Varices in Advanced Liver Disease Patients: a Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection|Completed||Phase 4|38|Actual|Federal University of São Paulo||2|||||||t||||||||||2017-02-18 13:39:34.983384|2017-02-18 13:39:34.983384
NCT00799838|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2014-10-23|||November 2008||2008-11-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|DROPS||Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients|Local, Phase IV, Multicenter, Double-blind, Randomized, Parallel, With Two Treatment Arms, Placebo-controlled Study to Evaluate the Reduction of Inflammatory Symptoms in the Treatment of Bacterial Pharyngitis With Ketoprofen and Amoxicillin in Pediatric Patients.|Terminated||Phase 4|106|Actual|Sanofi||2||Recruitment challenges despite several attenpts to increase enrollment|f||||f||||||||||2017-02-18 13:39:35.101798|2017-02-18 13:39:35.101798
NCT00799825|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-12-23|2013-07-18||January 2009||2009-01-01|December 2016|2016-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US|Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK580299) in Female American and Canadian Subjects Who Had Received Control Vaccine in Study 580299/008|Completed||Phase 3|346|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:39:35.212002|2017-02-18 13:39:35.212002
NCT00799812|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2015-08-10|||November 2007||2007-11-01|August 2015|2015-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Test for Preoperative Skin Preparations|ChloraPrep Triple Swabsticks, Hibiclens and Sterile Triple Swabsticks (Using Sterile Deionized Water)|Completed||Phase 1/Phase 2|111|Actual|CareFusion||5|||f||||f||||||||||2017-02-18 13:39:35.506868|2017-02-18 13:39:35.506868
NCT00797732|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-01-27|||December 2008||2008-12-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||A Pilot Study of Acupuncture Treatment for Dysphagia|Acupuncture for Dysphagia After Chemoradiation Therapy in Head and Neck Cancer Patients: A Pilot Randomized Control Trial|Completed||N/A|42|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 13:40:17.388618|2017-02-18 13:40:17.388618
NCT00799799|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2009-09-23|||October 2005||2005-10-01|September 2009|2009-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells|Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells|Unknown status|Recruiting|Phase 1|15|Anticipated|University of Bologna||1|||f||||t||||||||||2017-02-18 13:39:35.618217|2017-02-18 13:39:35.618217
NCT00799786|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2010-08-12|||November 2008||2008-11-01|August 2010|2010-08-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Building Better Caregivers Online: An Online Workshop for Caregivers of Those With Traumatic Brain Injury, Post Traumatic Stress Disorder, or Alzheimer's or Other Dementia|Building Better Caregivers Online|Completed||Phase 1|120|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 13:39:37.957829|2017-02-18 13:39:37.957829
NCT00799773|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-07-18|2013-05-07||April 2009||2009-04-01|July 2013|2013-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|STAR||Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)|STAR - Study of TTP and Rituximab, A Randomized Clinical Trial|Terminated||Phase 3|3|Actual|New England Research Institutes|One treatment arm had only one subject, so to protect patient confidentiality, results are not being entered.|2||Low enrollment rate|f||||t||||||||||2017-02-18 13:39:38.065709|2017-02-18 13:39:38.065709
NCT00799760|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2012-03-16|||December 2008||2008-12-01|November 2008|2008-11-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Interventional|BIVIR||Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir|Evaluation of Combination Therapy With Oseltamivir and Zanamivir Versus Monotherapy in the Treatment of Virologically Confirmed Influenza in Primary Care a Randomises Double Blind Controlled Trial Study|Terminated||Phase 3|541|Actual|Assistance Publique - Hôpitaux de Paris||3||Just Terminated for the end of the pandemia|f||||t||||||||||2017-02-18 13:39:38.618447|2017-02-18 13:39:38.618447
NCT00799747|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2009-06-30|||December 2008||2008-12-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|||||Interventional|||Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.|A Randomised, Single-Blind, Placebo-Controlled, Single-Centre Phase I Study in Healthy Japanese Male Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of AZD4017 After Single Ascending Oral Doses|Completed||Phase 1|56|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:39:38.749805|2017-02-18 13:39:38.749805
NCT00799734|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2011-07-25|||April 2009||2009-04-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Chinese Medicine Therapy on Menopausal Symptoms|A Double-blind Randomized Placebo-controlled Clinical Trial on the Effects of Chinese Medicine Formula (Erxian Decoction) on Menopausal Symptoms|Completed||N/A|108|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-02-18 13:39:38.839792|2017-02-18 13:39:38.839792
NCT00799721|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2008-11-28|||August 2008||2008-08-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|February 2010|Anticipated|2010-02-01||Observational|||Urine VEGF Levels in Very Low Birth Weight (VLBW) Infants||Unknown status|Recruiting|N/A|160|Anticipated|Charite University, Berlin, Germany|||2||f||||||||||Samples Without DNA|"~     Urine samples that are centrifugated to get rid of any cells where stored at -80°C until~     ELISA is done.~   "|||2017-02-18 13:39:39.142609|2017-02-18 13:39:39.142609
NCT00799708|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-02-18|2010-06-25||May 2008||2008-05-01|February 2016|2016-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled Parallel Study to Evaluate the Effects of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women|Completed||Phase 1|27|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 13:39:39.236586|2017-02-18 13:39:39.236586
NCT00799695|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2008-11-28|||January 2008||2008-01-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population|Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population|Completed||N/A|561|Actual|Henry Ford Health System||1|||f||||f||||||||||2017-02-18 13:39:39.690808|2017-02-18 13:39:39.690808
NCT00799682|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2011-07-20|||October 2008||2008-10-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®|An 8 Week, Single Masked, Parallel-Group, Exploratory Study Comparing Ocular Surface Signs and Symptoms in Monotherapy Ocular Hypertension or Glaucoma Patients Randomized to Either Xalatan® or Travatan Z®|Completed||Phase 4|56|Actual|Ophthalmic Consultants of Long Island||2|||f||||||||||||||2017-02-18 13:39:39.795014|2017-02-18 13:39:39.795014
NCT00799669|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-27|2016-02-23|||February 2009||2009-02-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Observational|||Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use|Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use|Active, not recruiting||N/A|370|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 13:39:39.909966|2017-02-18 13:39:39.909966
NCT00799656|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-27|2011-03-31|||November 2008||2008-11-01|March 2011|2011-03-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|SERENEATI||Efficacy and Safety Study of Ataciguat Versus Placebo in Patients With Neuropathic Pain|Efficacy and Safety of Oral Ataciguat (HMR1766) 200 mg Administered Once Daily for 28 Days on Pain Reduction in Patients With Neuropathic Pain. A Randomized, Double-blind, Placebo-controlled, Cross-over Study|Completed||Phase 2|62|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:39:40.040512|2017-02-18 13:39:40.040512
NCT00799643|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2014-03-25|2013-09-13||November 2008||2008-11-01|March 2014|2014-03-01||||September 2012|Actual|2012-09-01||Interventional|TINSAL-T2D-II||Targeting Inflammation Using Salsalate for Type 2 Diabetes-stage II|Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate|Completed||Phase 2/Phase 3|638|Actual|Joslin Diabetes Center||2|||f||||t||||||||||2017-02-18 13:39:40.155081|2017-02-18 13:39:40.155081
NCT00799630|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2008-11-28|||November 2008||2008-11-01|November 2008|2008-11-01||||||||Interventional|||Effects of Nutraperf Consumption in Runners|Identification of the Effects of NUTRAPERF Consumption on Performance in Endurance-Type Exercise.|Completed||N/A|14|Actual|Lescuyer Laboratory||1|||f||||f||||||||||2017-02-18 13:39:40.596155|2017-02-18 13:39:40.596155
NCT00799617|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2015-11-03||2015-06-09|November 2009||2009-11-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|July 2014|Actual|2014-07-01||Interventional|||The Testosterone Trial in Older Men|Randomized, Placebo-controlled, Double-blind Study of Five Coordinated Testosterone Treatment Trials in Older Men|Active, not recruiting||Phase 3|800|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 13:39:40.677031|2017-02-18 13:39:40.677031
NCT00799604|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2014-08-21|2012-07-30||November 2008||2008-11-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|SPRINT|These analyses include the Safety population defined as all participants, irrespective of eligibility, who were enrolled in Treatment Period 1 (Bolus 1 - pre-anesthesia) and were dosed with clevidipine. The number of participants in the Safety population and Modified Intent-To-Treat (mITT) population are identical.|Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)|An Open-label Study in Patients Undergoing Cardiac Surgery to Evaluate the Effect of Bolus Clevidipine Administration (SPRINT)|Completed||Phase 2|30|Actual|The Medicines Company||1|||f||||f||||||||||2017-02-18 13:39:40.804047|2017-02-18 13:39:40.804047
NCT00799591|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2011-11-15|2011-09-08||September 2008||2008-09-01|September 2011|2011-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||French Study In ICU Patients Treated With Tigecycline|French Prospective Observational Study In Intensive Care Unit (ICU) Patients Treated With Tigecycline|Completed||N/A|156|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 13:39:41.971561|2017-02-18 13:39:41.971561
NCT00799578|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2013-12-13|2013-12-13||October 2008||2008-10-01|December 2013|2013-12-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)||Completed||Phase 1/Phase 2|13|Actual|University of California, San Diego||1|||f||||f||||||||||2017-02-18 13:39:42.599623|2017-02-18 13:39:42.599623
NCT00799565|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2011-07-13|||December 2008||2008-12-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|MVP-France||Mitral Valve Prolapse (MVP) - France Study|Genetic Polymorphisms in Idiopathic Mitral Valve Prolapse :A French Prospective Study Using a Genome Wide Analysis|Completed||N/A|1179|Actual|French Cardiology Society||2|||f||||t||||||||||2017-02-18 13:39:42.836691|2017-02-18 13:39:42.836691
NCT00799552|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2010-09-20||2010-09-07|November 2008||2008-11-01|September 2010|2010-09-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye|A Phase II, Multi-Center, Double-Masked, Randomized, Placebo Controlled, Study on the Safety and Efficacy of RX-10045 on the Signs and Symptoms of Dry Eye in Every Day Environmental Conditions and During Provocation Using the Controlled Adverse Environment (CAE) Model|Completed||Phase 2|232|Actual|Resolvyx Pharmaceuticals, Inc||2|||f||||t||||||||||2017-02-18 13:39:42.995889|2017-02-18 13:39:42.995889
NCT00799539|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2015-11-30||||||November 2015|2015-11-01||||||||Expanded Access|||A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients|An International Single-Arm Study to Provide Further Safety and Efficacy Data on the Bortezomib(Velcade)/Melphalan/Prednisone Regimen in Previously Untreated Transplant Ineligible Multiple Myeloma Patients|No longer available||Phase 3|||Janssen-Ortho Inc., Canada||||Company decision to cancel due to public funding|f||||f||||||||||2017-02-18 13:39:43.089723|2017-02-18 13:39:43.089723
NCT00799526|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2008-11-28|||November 2008||2008-11-01|November 2008|2008-11-01|November 2010|Anticipated|2010-11-01|November 2008|Actual|2008-11-01||Interventional|||Transplant of Epithelium Conjunctival Human Autologous Cultivated ex Vivo in Amniotic Membrane for the Treatment of Symblepharon||Unknown status|Active, not recruiting|Phase 1|10|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 13:39:43.188779|2017-02-18 13:39:43.188779
NCT00799513|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-03-21|||October 2009||2009-10-01|March 2012|2012-03-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell Lymphoma|A Phase II Trial to Evaluate the Safety and Activity of Single-agent Lenalidomide Given as Maintenance Therapy After Response to Second-line Therapy in Patients With Relapsed DLBCL, Not Eligible for High-dose Chemotherapy and ASCT|Unknown status|Recruiting|Phase 2|47|Anticipated|IRCCS San Raffaele||1|||f||||t||||||||||2017-02-18 13:39:43.270369|2017-02-18 13:39:43.270369
NCT00799500|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-28|2013-04-04|||January 2007||2007-01-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Bacterial Vaginosis in Pregnancy: Detection by Weekly Vaginal pH Testing|Impact on Prematurity of a First-trimester Screening for Bacterial Vaginosis in Pregnancy Through Weekly Vaginal pH Determination. An Interventional, Community Study.|Completed||N/A|1049|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 13:39:43.378496|2017-02-18 13:39:43.378496
NCT00799487|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2011-05-18|2010-06-25||January 2009||2009-01-01|March 2011|2011-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||CONCERTA Lab School Study|Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of CONCERTA on Older Children With ADHD (The ABC Study)|Completed||Phase 4|89|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC||2|||f||||||||||||||2017-02-18 13:39:43.476889|2017-02-18 13:39:43.476889
NCT00799474|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-02-25|2009-12-07||December 2008||2008-12-01|January 2010|2010-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination|Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination|Completed||N/A|609|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 13:39:44.788768|2017-02-18 13:39:44.788768
NCT00799461|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2012-03-05|||August 2008||2008-08-01|March 2012|2012-03-01||||November 2011|Actual|2011-11-01||Interventional|||Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications|INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation|Completed||Phase 3|1337|Actual|Fred Hutchinson Cancer Research Center||3|||f||||f||||||||||2017-02-18 13:39:45.016429|2017-02-18 13:39:45.016429
NCT00799448|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2013-03-06|||September 2003||2003-09-01|March 2013|2013-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes|Multi-centre, Open, Randomised, Parallel, Controlled Trial in Type 2 Diabetic Subjects Inadequately Controlled With SU +/ Biguanide Therapy, to Compare the Efficacy and Safety of Repaglinide Combined With Bedtime Insulin vs. Insulin Alone|Terminated||Phase 4|40|Actual|Novo Nordisk A/S||||Low recruitment status|f||||f||||||||||2017-02-18 13:39:45.164899|2017-02-18 13:39:45.164899
NCT00798655|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-06-28|2016-06-28||November 2007||2007-11-01|June 2016|2016-06-01|June 2020|Anticipated|2020-06-01|June 2015|Actual|2015-06-01||Interventional|||Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer|A Phase II Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer|Active, not recruiting||Phase 2|46|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:39:53.074518|2017-02-18 13:39:53.074518
NCT00799435|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2014-07-15|||July 2009||2009-07-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure|Treatment With Glucagon-Like Peptide-1 Receptor, Exenatide, in Patients With Diabetes and Heart Failure With Normal Left Ventricular Ejection Fraction|Terminated||Phase 4|2|Actual|Baylor College of Medicine||2||Inability to recruit adequate Sample Size who met the entry criteria|f||||||||||||||2017-02-18 13:39:45.260178|2017-02-18 13:39:45.260178
NCT00799422|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-11-14|2012-10-16||November 2008||2008-11-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Evaluation of Contact Lenses and Conjunctival Staining in Normal Patients|Evaluation of Lens Fit, Lens Parameters, and Circumlimbal Conjunctival Staining (CSS) in Normal Patients|Completed||N/A|26|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 13:39:45.38558|2017-02-18 13:39:45.38558
NCT00799409|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2014-04-24|2010-06-14||December 2008||2008-12-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Lab School Day Study for CONCERTA of Older Children With ADHD|The ABC Study: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral, and Cognitive Effects of CONCERTA on Older Children With ADHD|Completed||Phase 4|78|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC||2|||f||||f||||||||||2017-02-18 13:39:45.752001|2017-02-18 13:39:45.752001
NCT00799396|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2016-03-23|2016-02-18||July 2006||2006-07-01|March 2016|2016-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Participants were recruited from the Old Order Amish of Lancaster, Pennsylvania. They are well suited for genetic studies because they are a homogenous, closed, founder population.|Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)|Pharmacogenomics of Anti-Platelet Interventions (The PAPI Study)|Completed||Phase 4|682|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 13:39:46.831383|2017-02-18 13:39:46.831383
NCT00799383|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-04-02|||November 2008||2008-11-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia|Counteracting Risperidone-Induced Hyperprolactinemia in Youths|Completed||N/A|51|Actual|University of Iowa||2|||f||||f||||||||||2017-02-18 13:39:47.059493|2017-02-18 13:39:47.059493
NCT00799370|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-06-25|||November 2008||2008-11-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Randomized Control Trial on Postoperative Weight Bearing After High Tibial Osteotomy (HTO)|Prospective Study on Postoperative Weight Bearing After Opening Wedge High Tibial Osteotomy (HTO): Early Weight Bearing Versus Delayed. Open Labelled Randomized Clinical Study|Completed||N/A|50|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-02-18 13:39:47.165728|2017-02-18 13:39:47.165728
NCT00799357|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2010-01-11|||December 2008||2008-12-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Utility of Bedside Ultrasound in the Prediction of Difficult Airway|Utility of Bedside Ultrasound in the Prediction of Difficult Airway|Completed||N/A|162|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-02-18 13:39:47.263791|2017-02-18 13:39:47.263791
NCT00799344|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-01-15|||June 2008||2008-06-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Observational|REVEAL||REVEAL Study: Vessel Healing After Angioplasty|Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) Trial: Rationale, Objectives and Design|Completed||Phase 1|34|Actual|CeloNova BioSciences, Inc.|||1||f||||f||||||||||2017-02-18 13:39:47.340768|2017-02-18 13:39:47.340768
NCT00799331|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2009-06-08|||November 2008||2008-11-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Exploratory Study to Assess the Pharmacokinetics of AZD5985|An Exploratory Phase I, Single Centre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Pharmacokinetics of Increasing Oral Doses of AZD5985 in Healthy Male Volunteers|Completed||Phase 1|32|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:39:47.435899|2017-02-18 13:39:47.435899
NCT00799305|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2008-11-26|||January 2009||2009-01-01|November 2008|2008-11-01||||||||Observational|||Correlation of Airflow Limitation and Other Respiratory Characteristics With Radiologic Changes of Lung Structure||Unknown status|Not yet recruiting|N/A|30|Anticipated|Hillel Yaffe Medical Center|||1||f||||||||||||||2017-02-18 13:39:47.530117|2017-02-18 13:39:47.530117
NCT00799292|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2008-11-26|2008-10-21||January 2004||2004-01-01|November 2008|2008-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Comparison of the Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy: A Randomized, Placebo Controlled Trial|Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy|Completed||Phase 4|58|Actual|Ascher-Walsh, Charles, M.D.||2|||f||||f||||||||||2017-02-18 13:39:47.806908|2017-02-18 13:39:47.806908
NCT00799279|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2010-10-05|||January 2009||2009-01-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Interventional|||Integrating Smoking Cessation Into Routine Primary Care Practice|Comparative Evaluation of the Efficacy and Cost-effectiveness of Two Interventions for Integrating Smoking Cessation Into Routine Primary Care Practice: A Cluster-randomized Trial|Completed||N/A|835|Actual|University of Waterloo||2|||f||||f||||||||||2017-02-18 13:39:48.127899|2017-02-18 13:39:48.127899
NCT00799266|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2017-01-17|||December 2008||2008-12-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Research Study of Zoledronic Acid in Children and Adolescents With Osteoporosis|A Multicenter, Randomized, Double-blind, Placebo Controlled Efficacy and Safety Trial of Intravenous (i.v.) Zoledronic Acid Twice Yearly Compared to Placebo in Osteoporotic Children Treated With Glucocorticoids|Recruiting||Phase 3|92|Anticipated|Novartis||2|||f||||t||||||||||2017-02-18 13:39:48.22213|2017-02-18 13:39:48.22213
NCT00799240|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-11-05|||June 2009||2009-06-01|December 2013|2013-12-01|July 2014|Actual|2014-07-01|February 2011|Actual|2011-02-01||Interventional|IMPACT||MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer|MK-0646 IMPACT Study: MK-0646, Insulin Growth Factor 1 Receptor Antibody in Stage IIIB or IV Metastatic Non-Squamous Lung Cancer, Combined With Pemetrexed (Alimta) and Cisplatin, a Randomized Phase II Trial.|Completed||Phase 2|27|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 13:39:48.366007|2017-02-18 13:39:48.366007
NCT00799227|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-26|2014-07-10|2014-07-10||January 2009||2009-01-01|July 2014|2014-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema||Completed||Phase 2|56|Actual|Allergan||1|||f||||f||||||||||2017-02-18 13:39:48.48125|2017-02-18 13:39:48.48125
NCT00799214|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-10-25|||April 2014||2014-04-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||BASIC (Boric Acid, Alternate Solution for Intravaginal Colonization) Study|Back to BASICS: Boric Acid, Alternate Solution for Intravaginal Colonization, Comparing Intravaginal Metronidazole to Boric Acid in Women Symptomatic for Bacterial Vaginosis|Completed||Phase 2/Phase 3|13|Actual|University of British Columbia||3|||f||||f||||||||||2017-02-18 13:39:48.748915|2017-02-18 13:39:48.748915
NCT00799201|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-07-27|||August 2007||2007-08-01|July 2015|2015-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients|A Prospective, Randomized Trial of Enteral Naloxone Versus a Traditional Bowel Regimen in Prevention of Constipation and Decreased Gastric Motility in Critically Ill Trauma Patients|Terminated||Phase 4|3|Actual|CAMC Health System||1||"Naloxone became unavailable due to manufacturing shortatges requiring the study to be~   terminated."|f||||t||||||||||2017-02-18 13:39:48.858953|2017-02-18 13:39:48.858953
NCT00798824|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2010-10-12|||August 2008||2008-08-01|October 2010|2010-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Impact of Nasogastric Indwelling Versus Oral Intermittent Tube Feeding Methods on Premature Infants|The Impact of Nasogastric Indwelling Versus Oral Intermittent Tube Feeding Methods on Premature Infants|Completed||N/A|24|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-02-18 13:39:48.981479|2017-02-18 13:39:48.981479
NCT00798811|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-10-17|||September 2008||2008-09-01|October 2009|2009-10-01|October 2015|Actual|2015-10-01|October 2013|Actual|2013-10-01||Interventional|||High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors|Multicenter Clinical Trial to Evaluate Efficacy of High-dose Chemotherapy With Autologous Stem Cell Rescue for Children With High-risk Brain Tumors|Completed||Phase 2|100|Anticipated|Samsung Medical Center||3|||f||||t||||||||||2017-02-18 13:39:49.092191|2017-02-18 13:39:49.092191
NCT00798798|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2014-05-22|||April 2008||2008-04-01|May 2014|2014-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Effect of Externally Implantable Tissue Expansion Device on Scar Length|Effect of Externally Implantable Tissue Expansion Device on Scar Length|Withdrawn||N/A|0|Actual|Northwestern University||1||Inability to recruit eligible subjects|f||||f||||||||||2017-02-18 13:39:49.194824|2017-02-18 13:39:49.194824
NCT00798785|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2013-12-27|||October 2006||2006-10-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients|Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|AZ-VUB||4|||f||||f||||||||||2017-02-18 13:39:49.277412|2017-02-18 13:39:49.277412
NCT00798772|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-04-28|||January 2009||2009-01-01|April 2016|2016-04-01|June 2016|Anticipated|2016-06-01|May 2014|Actual|2014-05-01||Interventional|MAINTAIN||Micronutrients and Antioxidants in HIV Infection|A Randomized Control Clinical Trial Of Micronutrient & Antioxidant Supplementation in Persons With Untreated HIV Infection|Active, not recruiting||Phase 2/Phase 3|218|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 13:39:49.39266|2017-02-18 13:39:49.39266
NCT00798759|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-05-25|2012-03-30||December 2008||2008-12-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN|Examination of Ocular Surface Effects With Administration of TRAVATAN Z® and XALATAN®|Completed||Phase 4|236|Actual|Alcon Research|The subjective nature of the OSDI may not be sensitive enough to detect the effects of preservatives on the corneal surface. The measurement and quantification of OSD remains a considerable clinical challenge. (Pflugfelder and Baudoin, 2011)|2|||f||||f||||||||||2017-02-18 13:39:49.520045|2017-02-18 13:39:49.520045
NCT00798746|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-07-27|||November 2008||2008-11-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Quality of Life After Esophagectomy for Cancer|Role of Pyloric Drainage in Reflux Symptoms After Esophagectomy for Cancer|Completed||N/A|88|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 13:39:49.829766|2017-02-18 13:39:49.829766
NCT00798733|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-12-15|||October 2008||2008-10-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Study of Sacral Fractures Using Patient Based and Objective Outcomes|A Multicenter Prospective Cohort Study of Sacral Fractures Using Patient Based and Objective Outcomes|Recruiting||N/A|1000|Anticipated|Boston Medical Center|||2||f||||t||||||||||2017-02-18 13:39:49.941683|2017-02-18 13:39:49.941683
NCT00798720|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-09-29|2016-04-28||December 2008||2008-12-01|September 2016|2016-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer|Phase II Study of Vorinostat (SAHA, Zolinza) and Bortezomib (PS341, Velcade) as Third-Line Treatment in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|18|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 13:39:50.071165|2017-02-18 13:39:50.071165
NCT00798707|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2011-06-08|2011-03-07||December 2008||2008-12-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (25 and 50 mg/Day) of DVS SR Tablets in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|709|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:39:50.591442|2017-02-18 13:39:50.591442
NCT00798694|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-12-20|||November 2008||2008-11-01|December 2012|2012-12-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?|Ocular Surface Changes With Topical Prostaglandin Analog Therapy|Completed||Phase 4|58|Actual|Wills Eye||2|||f||||f||||||||||2017-02-18 13:39:52.758264|2017-02-18 13:39:52.758264
NCT00798681|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2010-08-09|||July 2008||2008-07-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|EPICOS||Evaluating the Influence of Ready-to-use (RTU) Parenteral Nutrition in the Clinical Outcome of Patients Study|EPICOS- Evaluating the Influence of RTU Parenteral Nutrition in the Clinical Outcome Patients Study|Completed||Phase 4|406|Actual|Fernandes Tavora Hospital||3|||f||||t||||||||||2017-02-18 13:39:52.872996|2017-02-18 13:39:52.872996
NCT00798668|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2013-09-23|||September 2006||2006-09-01|March 2010|2010-03-01|May 2008|Actual|2008-05-01|August 2007|Actual|2007-08-01||Interventional|||The Body's Response to Food Intake in Trained, Older Adults||Completed||N/A|50|Actual|Purdue University||4|||f||||||||||||||2017-02-18 13:39:52.988634|2017-02-18 13:39:52.988634
NCT00798642|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-04-01|||July 2007||2007-07-01|April 2014|2014-04-01|June 2012|Actual|2012-06-01|November 2011|Actual|2011-11-01||Interventional|UCRPT||Ulcerative Colitis Relapse Prevention Trial, Hypnosis|National Center for Complementary & Alternative Medicine, The Role of Gut-Directed Hypnotherapy in Relapse Prevention for Ulcerative Colitis|Completed||N/A|55|Actual|Northwestern University||3|||f||||t||||||||||2017-02-18 13:39:53.364469|2017-02-18 13:39:53.364469
NCT00798629|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-09-21|||November 2008||2008-11-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured|A Dose Ranging Trial of Adenovirus CCL-21 Transduced MART-1/gp100 Peptide-Pulsed Dendritic Cells Matured Using Cytokines for Patients With Chemotherapy-Resistant Metastatic Melanoma|Completed||Phase 1|13|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 13:39:53.523588|2017-02-18 13:39:53.523588
NCT00798616|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-12-05||||||October 2010|2010-10-01||||||||Interventional|SHARE||Steroids Helping Albuterol Responders Exclusively|"Are Steroids Efficacious in Hospitalized Patients With Bronchiolitis Who Show an Objective Clinical Improvement After Albuterol (Albuterol Responders)?"|Withdrawn||N/A|0|Actual|University Hospitals Cleveland Medical Center||4||We were unable to enroll a sufficient number of patients due to manpower.|f||||f||||||||||2017-02-18 13:39:53.628052|2017-02-18 13:39:53.628052
NCT00798603|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-12-01|2016-12-01||December 2008||2008-12-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|March 2011|Actual|2011-03-01||Interventional||All participants who received treatment.|Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II First-Line Study of a Combination of Pemetrexed, Carboplatin and Bevacizumab in Advanced Nonsquamous NSCLC Evaluating Efficacy and Tolerability in Elderly Patients (Age ≥ 70 Yrs) With Good Performance Status (PS < 2)|Completed||Phase 2|65|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 13:39:53.763546|2017-02-18 13:39:53.763546
NCT00798590|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2010-03-25|||December 2008||2008-12-01|March 2010|2010-03-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Interventional|||The Efficacy of GLP - 1(7-36) Amide for Glycemic Control in Critically Ill Patients|The Efficacy of GLP - 1 (7-36) Amide for Glycemic Control in Critically Ill Surgical Patients|Unknown status|Enrolling by invitation|Phase 2|180|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 13:39:57.04402|2017-02-18 13:39:57.04402
NCT00798577|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2010-03-30|2010-03-02||October 2008||2008-10-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment||Completed||Phase 4|24|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:39:57.156795|2017-02-18 13:39:57.156795
NCT00798564|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2011-08-02|||March 2008||2008-03-01|September 2008|2008-09-01|December 2009|Actual|2009-12-01|||||Observational|||Exercise Induced Asthma and Airway Reactivity in Athletes|"Explorative Study Exercise Induced Asthma and Airway Reactivity in Athletes"|Completed||N/A|300|Actual|Skåne University Hospital|||1||f||||f||||||||||2017-02-18 13:39:57.563413|2017-02-18 13:39:57.563413
NCT00798551|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2010-01-11|||November 2008||2008-11-01|January 2010|2010-01-01|June 2010|Anticipated|2010-06-01|April 2009|Anticipated|2009-04-01||Interventional|||Emergency Department Interventions to Improve Blood Pressure Follow-up|Emergency Department Interventions to Improve Blood Pressure Follow-up|Unknown status|Active, not recruiting|N/A|120|Anticipated|University of Nebraska||1|||f||||f||||||||||2017-02-18 13:39:57.642675|2017-02-18 13:39:57.642675
NCT00798538|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2015-07-23|||August 2005||2005-08-01|July 2015|2015-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|BELIEVE||Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)|Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)|Completed||Phase 4|60|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:39:57.733528|2017-02-18 13:39:57.733528
NCT00798525|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-06-20|||January 2009||2009-01-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|ALiCia||Argatroban Versus Lepirudin in Critically Ill Patients|Argatroban Versus Lepirudin in Critically Ill Patients - A Randomized Double-blind Trial|Terminated||Phase 4|70|Actual|Heinrich-Heine University, Duesseldorf||2||Supply of Lepirudin ended on 01. April 2012, thus trial terminated on 31. March 2012|f||||t||||||||||2017-02-18 13:39:57.838507|2017-02-18 13:39:57.838507
NCT00798512|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-03-14|||February 2008||2008-02-01|March 2016|2016-03-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|DESERVE||Diffusion Weighted-MRI Based Evaluation of the Effectiveness of Endovascular Clamping During Carotid Artery Stenting With the Mo.Ma Device.|DESERVE: Diffusion Weighted-MRI Based Evaluation of the Effectiveness of Endovascular Clamping During Carotid Artery Stenting With the Mo.Ma Device. A Prospective, Multicenter Study.|Completed||N/A|127|Actual|Invatec S.p.A.||1|||f||||t||||||||||2017-02-18 13:39:57.950176|2017-02-18 13:39:57.950176
NCT00798499|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2009-07-01|||December 2008||2008-12-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|||||Observational|||A Feasibility Study to Collect Data in Patients With Haemophilia|A Multi Centre Study With no Treatment, Designed to Gain Information About the Haemophilia Patient Population|Completed||Early Phase 1|50|Anticipated|AstraZeneca|||1||f||||||||||Samples Without DNA|"~     plasma~   "|||2017-02-18 13:39:58.046466|2017-02-18 13:39:58.046466
NCT00798486|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-01-29|2009-12-03||November 2008||2008-11-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of the A1CNow+ Test Kit|In-Clinic Evaluation of the Redwood A1c Test Kit With Lay-Users and Professionals|Completed||N/A|110|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-02-18 13:39:58.135422|2017-02-18 13:39:58.135422
NCT00798473|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2008-11-25|||September 2004||2004-09-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|September 2007|Actual|2007-09-01||Interventional|||Zoledronate for Osteopenia in Pediatric Crohn's|A Randomized Controlled Trial of Zoledronate in the Treatment of Osteopenia in Children and Adolescents With Crohn's Disease|Completed||Phase 3|13|Actual|McGill University Health Center||2|||f||||t||||||||||2017-02-18 13:39:58.575071|2017-02-18 13:39:58.575071
NCT00798460|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2011-06-22|||December 2008||2008-12-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients|A Multicenter, Randomized, Controlled Tial of Combination Therapy for Lamivudine-resistant Chronic Hepatitis B Patient: Comparing Clevudine Plus Adefovir With Lamivudine Plus Adefovir|Terminated||Phase 4|30|Actual|Inje University||2||could not enroll patients|f||||t||||||||||2017-02-18 13:39:58.701408|2017-02-18 13:39:58.701408
NCT00798447|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2011-06-08|||November 2008||2008-11-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery|A Prospective, Randomized, Double Blind Study to Compare the Efficacy and Safety of a n-3 Fatty Acid-containing Lipid Emulsion During Parenteral Nutrition in Patients Considered for Major Surgery for Gastric and Colorectal Cancer.|Completed||Phase 3|100|Anticipated|B. Braun Melsungen AG||2|||f||||f||||||||||2017-02-18 13:39:58.826874|2017-02-18 13:39:58.826874
NCT00798434|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2011-11-08|2011-07-11||June 2008||2008-06-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|SOFIA||A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.|A 24-Week, Multi-Centre Trial, Comprising A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase Followed By A 12-Week Open-Label Phase, To Evaluate The Efficacy And Safety Of A Fesoterodine Flexible Dose Regimen In Elderly Patients With Overactive Bladder.|Completed||Phase 4|794|Actual|Pfizer|The descriptive statistics and analyses of outcome measure 12 as defined in the protocol are not presented. Results are presented as defined in the statistical analysis plan.|2|||f||||f||||||||||2017-02-18 13:39:58.946727|2017-02-18 13:39:58.946727
NCT00798421|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2008-11-25|||December 2008||2008-12-01|November 2008|2008-11-01|May 2009|Anticipated|2009-05-01|April 2009|Anticipated|2009-04-01||Observational|||Study to Evaluate Nosocomial Transmission of Influenza|Pilot Study to Develop a Model to Evaluate Nosocomial Transmission of Influenza|Unknown status|Not yet recruiting|N/A|50|Anticipated|University Hospitals, Leicester|||1||f||||f||||||Samples Without DNA|"~     Throat and nose swabs~   "|||2017-02-18 13:40:00.935971|2017-02-18 13:40:00.935971
NCT00798408|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2013-09-23|||February 2006||2006-02-01|December 2009|2009-12-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||The Body's Response to Food Intake in Older Adults||Completed||N/A|35|Actual|Purdue University||2|||f||||||||||||||2017-02-18 13:40:01.033436|2017-02-18 13:40:01.033436
NCT00798395|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2015-10-12|||October 2007||2007-10-01|October 2015|2015-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)|A Randomized Double-blind, Placebo-controlled, 4-period Cross-over Study to Assess the Effect of Single and Multiple Doses of 1.5 mg and 4.5 mg Org 50081 and a Single Dose of 7.5 mg Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers.|Completed||Phase 1|32|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:40:01.129635|2017-02-18 13:40:01.129635
NCT00798382|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-06-12|||December 2008||2008-12-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants|Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Term Infants|Completed||Phase 2/Phase 3|154|Actual|Abbott Nutrition||3|||f||||t||||||||||2017-02-18 13:40:01.219057|2017-02-18 13:40:01.219057
NCT00798369|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-04-09|2011-01-20||November 2008||2008-11-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients|An Adaptive Dose-ranging, Multi-center, Single-blind, Double-dummy, Active-controlled Trial to Determine the Target Dose of Canakinumab (ACZ885) in the Treatment of Acute Flares in Gout Patients Who Are Refractory or Contraindicated to NSAIDs and/or Colchicine|Completed||Phase 2|200|Actual|Novartis||6|||f||||||||||||||2017-02-18 13:40:01.346726|2017-02-18 13:40:01.346726
NCT00798356|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2012-06-13|||November 2008||2008-11-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Yoga on Arrhythmia Burden and Quality of Life in Paroxysmal Atrial Fibrillation|The Effect of Yoga on Arrhythmia Burden and Quality of Life in Patients With Paroxysmal Atrial Fibrillation|Completed||N/A|84|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 13:40:02.568415|2017-02-18 13:40:02.568415
NCT00798343|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-06-02|||January 2009||2009-01-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|March 2010|Actual|2010-03-01||Interventional|||Heterosubtypic Immune Responses to Influenza in Older People|Evaluation of Heterosubtypic Immune Responses in Older People Before and After Seasonal and Pandemic Influenza Vaccination|Completed||Phase 1|292|Actual|University Hospitals, Leicester||2|||f||||t||||||||||2017-02-18 13:40:02.672997|2017-02-18 13:40:02.672997
NCT00798330|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2013-11-19|||September 2012||2012-09-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Dental Study in Cancer Patients With Central Venous Catheters|Pilot Study on Transient Bacteremia and Blood Stream Infections After Invasive Dental Procedures in Cancer Patients With Central Venous Catheters|Completed||N/A|27|Actual|UConn Health|||1||f||||t||||||||||2017-02-18 13:40:02.783817|2017-02-18 13:40:02.783817
NCT00798317|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-12-02|2012-12-20||December 2008||2008-12-01|April 2014|2014-04-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.|A Randomized, Placebo Controlled, Double-masked, Multicenter Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion.|Completed||Phase 3|326|Actual|ThromboGenics||2|||f||||t||||||||||2017-02-18 13:40:02.865411|2017-02-18 13:40:02.865411
NCT00798304|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2014-11-21|2014-11-21||January 2009||2009-01-01|November 2014|2014-11-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants|An Open Label, Randomized, Phase 1/2 Trial Of The Safety, Tolerability, And Immunogenicity Of Meningococcal Group B Rlp2086 Vaccine In Healthy Infants|Terminated||Phase 2|46|Actual|Pfizer|Immunogenicity results were not reported because the study was terminated due to the reactogenicity profile of the vaccine in infants prior to the first scheduled post-vaccination blood draw and no immunogenicity data were collected.|3||"Following program review within Pfizer, decision was made not to go ahead with this study.~   This study is cancelled"|f||||t||||||||||2017-02-18 13:40:03.299686|2017-02-18 13:40:03.299686
NCT00798291|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2010-03-19|||October 2008||2008-10-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation of AN777 in Elderly Subjects|Evaluation of AN777 in Elderly Subjects|Completed||Phase 2/Phase 3|108|Anticipated|Abbott Nutrition||4|||f||||t||||||||||2017-02-18 13:40:04.010586|2017-02-18 13:40:04.010586
NCT00798278|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2010-10-27|||July 2008||2008-07-01|November 2008|2008-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in Childhood|Exploratory Multicentre Clinical Trial to Compare the Efficacy of Urokinase Versus Video-assisted Thoracoscopic for Treatment of Complicated Parapneumonic Empyema in Childhood|Completed||Phase 3|200|Anticipated|Spanish Society of Pediatric Surgery||2|||f||||f||||||||||2017-02-18 13:40:04.105755|2017-02-18 13:40:04.105755
NCT00798265|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2017-01-24|||October 28, 2008||2008-10-28|October 27, 2016|2016-10-27|February 4, 2013|Actual|2013-02-04|September 22, 2012|Actual|2012-09-22||Interventional|||A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults|A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents and Young Adults|Completed||Phase 1|26|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 13:40:04.209052|2017-02-18 13:40:04.209052
NCT00798252|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2015-07-03|||March 2009||2009-03-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers|A Phase I, Multi-arm, Dose Escalation Study of Brivanib Alaninate Combined With Several Chemotherapy Regimens in Subjects With Solid Tumors|Completed||Phase 1|111|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-02-18 13:40:04.327426|2017-02-18 13:40:04.327426
NCT00798239|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-03-07|||November 2008||2008-11-01|March 2012|2012-03-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|||Pilot Study to Assess Safety/Prelimary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery|A Multi-Center, Prospective, Parallel Group, Randomized, Pilot Study Evaluating Safety and Preliminary Effectiveness Of Prefix Compared To Iliac Crest Bone In Subjects With DDD Undergoing Transforaminal Lumbar Interbody Fusion|Unknown status|Active, not recruiting|Phase 1/Phase 2|24|Anticipated|BioSurface Engineering Technologies, Inc||3|||f||||t||||||||||2017-02-18 13:40:04.459275|2017-02-18 13:40:04.459275
NCT00798226|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2015-07-27|||November 2008||2008-11-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|April 2016|Anticipated|2016-04-01||Interventional|||Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood|Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood: Interventional Trial in the COPSAC2010 (Copenhagen Studies on Asthma in Childhood) Birth Cohort|Active, not recruiting||Phase 3|800|Anticipated|Copenhagen Studies on Asthma in Childhood||2|||f||||f||||||||||2017-02-18 13:40:04.58093|2017-02-18 13:40:04.58093
NCT00798213|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2015-02-03|||January 2009||2009-01-01|February 2015|2015-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED)|A Phase 2 Study of SCH 727965 in Subjects With Relapsed and Refractory Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia|Terminated||Phase 2|29|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:40:04.694066|2017-02-18 13:40:04.694066
NCT00798200|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-25|2016-03-02|||March 2009||2009-03-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|CanWell||Community Based Exercise Program for Well Cancer Survivors|CanWell: YMCA Based Exercise Program for Well Cancer Survivors|Completed||Phase 1|200|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 13:40:04.793319|2017-02-18 13:40:04.793319
NCT00798187|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-02-29|||May 2009||2009-05-01|February 2016|2016-02-01||||November 2017|Anticipated|2017-11-01||Observational|||Cancer Support Programs|Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis|Active, not recruiting||N/A|240|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-02-18 13:40:04.890284|2017-02-18 13:40:04.890284
NCT00798174|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2009-12-04|||November 2008||2008-11-01|December 2009|2009-12-01||||January 2010|Anticipated|2010-01-01||Interventional|||The Effect of an Azygos Vein Coil on Defibrillation Threshold|The Effect of an Azygos Vein Coil on Defibrillation Threshold|Suspended||N/A|32|Anticipated|Washington University School of Medicine||2||"Failure of an inroducer sheath used in the technique specified by the study. posing a risk. No~   adverse outcome has occurred in a study patient."|f||||f||||||||||2017-02-18 13:40:04.999538|2017-02-18 13:40:04.999538
NCT00798161|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2013-12-11|2011-05-20||December 2008||2008-12-01|December 2013|2013-12-01||||May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design|A Phase III Randomised, Double-blind, Placebo-controlled Parallel Group Study to Compare the Efficacy and Safety of Twice Daily Administration of the Free Combination of BI 1356 2.5 mg + Metformin 500 mg, or of BI 1356 2.5 mg + Metformin 1000 mg, With the Individual Components of Metformin (500 mg or 1000 mg Twice Daily), and BI 1356 (5.0 mg Once Daily) Over 24 Weeks in Drug Naive or Previously Treated (4 Weeks Wash-out and 2 Weeks Placebo run-in) Type 2 Diabetic Patients With Insufficient Glycaemic Control|Completed||Phase 3|857|Actual|Boehringer Ingelheim||6|||f||||||||||||||2017-02-18 13:40:05.128765|2017-02-18 13:40:05.128765
NCT00798148|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-23|2012-05-31|||September 2008||2008-09-01|May 2012|2012-05-01||||July 2012|Anticipated|2012-07-01||Interventional|||131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma|Evaluation of Benefit and Side Effects of 131I-MIBG in Combination With Myeloablative Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Tehran University of Medical Sciences||1|||f||||||||||||||2017-02-18 13:40:07.288216|2017-02-18 13:40:07.288216
NCT00798135|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-08-28|2014-08-25||November 2008||2008-11-01|August 2015|2015-08-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer|A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer|Completed||N/A|13|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 13:40:07.390051|2017-02-18 13:40:07.390051
NCT00798122|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-10-06|||March 2006||2006-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|SWAN||Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease|Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease|Active, not recruiting||N/A|50|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 13:40:07.811531|2017-02-18 13:40:07.811531
NCT00798109|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2014-06-13|||November 2008||2008-11-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|October 2012|Actual|2012-10-01||Interventional|SCHIZOCAN||Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse|An Open Multicentric Randomized Clinical Trial Assessing the Impact of Motivational Interviewing on Cannabis Consumption in Patients With Psychiatric Disease|Completed||N/A|97|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:40:07.922787|2017-02-18 13:40:07.922787
NCT00798096|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-08-09|2014-05-14||March 2009||2009-03-01|August 2016|2016-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma|Phase II, Multicenter, Simon Two-Stage Study of Fostamatinib Disodium in Patients With Relapsed or Refractory T-Cell Lymphoma|Completed||Phase 2|18|Actual|Rigel Pharmaceuticals|This is a small, non-randomized study.|1|||f||||t||||||||No||2017-02-18 13:40:08.043788|2017-02-18 13:40:08.043788
NCT00798083|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2011-06-21|||April 2008||2008-04-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|NP||Neuropathic Pain Caused by Radiation Therapy|Topical Amitriptyline, Ketamine and Lidocaine in Neuropathic Pain Caused by Radiation Skin Reaction: a Pilot Study|Completed||Phase 3|22|Anticipated|British Columbia Cancer Agency||1|||f||||t||||||||||2017-02-18 13:40:08.481264|2017-02-18 13:40:08.481264
NCT00798070|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-11-16|||February 2007||2007-02-01|November 2016|2016-11-01|January 2022|Anticipated|2022-01-01|April 2016|Actual|2016-04-01||Interventional|PANTHER||Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients|PANTHER. A Randomized Phase 3 Study Comparing Biweekly and Tailored Epirubicin + Cyclophosphamide Followed by Biweekly Tailored Docetaxel (dtEC→dtT) Versus Three Weekly Epirubicin + Cyclophosphamide + 5-fluorouracil Followed by Docetaxel (FEC→T) in Lymph Node Positive or High Risk Lymph Node Negative Breast Cancer Patients|Active, not recruiting||Phase 3|2017|Actual|Karolinska University Hospital||2|||f||||t||||||||Yes|Oral presentation at ASCO 4 June 2016 (completed). Study published in JAMA 8 Nov 2016.|2017-02-18 13:40:08.581136|2017-02-18 13:40:08.581136
NCT00798057|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-10-02|||October 2007||2007-10-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|PI01||Proton Radiation Therapy for Pituitary Adenoma|Clinical Outcomes Study of Proton Radiation Therapy for Pituitary Adenoma|Terminated||N/A|16|Actual|University of Florida|||1|Due to slow enrollment and feasibility issues.|f||||f||||||||||2017-02-18 13:40:08.791014|2017-02-18 13:40:08.791014
NCT00798044|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-01-18|||November 2006||2006-11-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||Patient Feedback Effectiveness Study|Patient Feedback Effectiveness Study|Completed||N/A|118|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 13:40:08.894083|2017-02-18 13:40:08.894083
NCT00798031|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2010-06-24|||October 2008||2008-10-01|June 2010|2010-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|Short implant||Case Series Evaluation of a Short Dental Implant|Case Series Evaluation of a Short Dental Implant Placed in the Posterior Maxilla in an Early Loading Protocol|Suspended||Phase 3|20|Anticipated|University of Iowa||1||"Recruitement currently suspended to allow project personnel to focus on other research.~   Recruitment should open in 2010."|f||||t||||||||||2017-02-18 13:40:09.000261|2017-02-18 13:40:09.000261
NCT00798018|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2009-12-17|2009-06-01||October 2008||2008-10-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena|Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena|Completed||N/A|100|Actual|Sichuan University||4|||f||||f||||||||||2017-02-18 13:40:09.109123|2017-02-18 13:40:09.109123
NCT00798005|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2010-09-02|||June 2002||2002-06-01|September 2010|2010-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|TALISMAN202||Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety Study of Different Doses and Schedules of Administration of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.|Completed||Phase 2|71|Actual|Sanofi|||||f||||||||||||||2017-02-18 13:40:09.661339|2017-02-18 13:40:09.661339
NCT00797992|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2008-11-24|||January 2007||2007-01-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Bevacizumab Intravitreal for Myopic Choroidal Neovascularization|Bevacizumab Intravitreal for Myopic Choroidal Neovascularization|Completed||Phase 4|5|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-02-18 13:40:09.74753|2017-02-18 13:40:09.74753
NCT00797979|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-11-23|||October 2009||2009-10-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|CRANIOSG||Implant System for Fixation of Cranial Bone Flaps After Craniotomy for Brain Surgery|Implant System for Fixation of Cranial Bone Flaps After Craniotomy for Brain Surgery|Completed||Phase 1|16|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:40:09.90321|2017-02-18 13:40:09.90321
NCT00797966|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-02-02|2015-08-07||May 2009||2009-05-01|February 2016|2016-02-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 2|850|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-02-18 13:40:10.024884|2017-02-18 13:40:10.024884
NCT00797953|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-12-10|||February 2007||2007-02-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|T89 phase 2||Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina|A Phase II, Double Blind, Placebo-controlled, Randominzed, Multi-Center, Parallel Group Study to Evaluate the Efficacy and Safety of T89 in Patient With Chronic Stable Angina Pectoris|Completed||Phase 2|124|Actual|Tasly Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-02-18 13:40:14.073115|2017-02-18 13:40:14.073115
NCT00797940|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-11-30|||January 2009||2009-01-01|November 2012|2012-11-01||||December 2010|Anticipated|2010-12-01||Interventional|CLARITY-1||Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)|Phase II, Multi-center, Open-Label, Single-Arm Study of Intratumoral Infusion of PRX321 in Subjects With Glioblastoma Multiforme at First Recurrence or Progression|Withdrawn||Phase 2|0|Actual|Sophiris Bio Corp||1||No funding for study|f||||f||||||||||2017-02-18 13:40:14.200939|2017-02-18 13:40:14.200939
NCT00797927|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2009-04-27|||January 2007||2007-01-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia|Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Patients With Schizophrenia|Completed||Phase 4|30|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 13:40:14.296439|2017-02-18 13:40:14.296439
NCT00797914|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-23|2016-07-11|||July 2008||2008-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Evaluation of Handheld Colonoscopy Force Monitor by Expert Endoscopists in the Performance of Colonoscopy|Phase I Study for Evaluation of Handheld Colonoscopy Force Monitor by Expert Endoscopists in the Performance of Colonoscopy|Completed||N/A|150|Actual|Artann Laboratories|||1||f||||f||||||||||2017-02-18 13:40:14.407624|2017-02-18 13:40:14.407624
NCT00797901|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2014-08-26|||August 2004||2004-08-01|August 2014|2014-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Depression Treatment in General Medical Settings|Depression Treatment in General Medical Settings|Completed||N/A|179|Actual|University of Puerto Rico||1|||f||||t||||||||||2017-02-18 13:40:14.504658|2017-02-18 13:40:14.504658
NCT00797888|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-09-05|||September 2008||2008-09-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|November 2011|Actual|2011-11-01||Interventional|Bronx A1c||Bronx A1c: Bring it Down for Health|Bronx A1c: Bring it Down for Health|Completed||N/A|941|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-02-18 13:40:14.59988|2017-02-18 13:40:14.59988
NCT00797875|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2008-11-24|||December 2008||2008-12-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||PNF Stretching for TKA on ROM|The Effects of PNF Stretching on Knee Motion Following TKA|Unknown status|Not yet recruiting|N/A|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 13:40:14.695438|2017-02-18 13:40:14.695438
NCT00797862|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2011-10-07|2011-04-21||November 2008||2008-11-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|ACCELERATE||Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension|A Randomized, 32 Week Double-blind, Parallel-group, Multicenter Study to Compare the Efficacy and Safety of Initiating Treatment With Combination (Aliskiren/Amlodipine) Therapy in Comparison With the Sequential add-on Treatment Strategies in Patients With Essential Hypertension|Completed||Phase 3|1254|Actual|Novartis||3|||f||||f||||||||||2017-02-18 13:40:14.79902|2017-02-18 13:40:14.79902
NCT00797849|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-03-12|||November 2008||2008-11-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees|A Randomized, Controlled Study to Evaluate the Effectiveness of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees|Completed||N/A|57|Actual|Southern California Institute for Research and Education||2|||f||||f||||||||||2017-02-18 13:40:15.665981|2017-02-18 13:40:15.665981
NCT00797836|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-01-09|||November 2008||2008-11-01|November 2008|2008-11-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|QUANTIPS||Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers|Cost-effectiveness of Quantiferon Gold in VITRO Test of T-lymphocytic Response for Detection of Latent Tuberculosis in At-risk Healthcare Workers|Completed||Phase 4|1024|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 13:40:15.785047|2017-02-18 13:40:15.785047
NCT00797823|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2011-10-04|2011-06-24||November 2008||2008-11-01|August 2009|2009-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone|A Comparison of Two Sensor-Augmented Glycemic Control Systems in Persons With Type 1 Diabetes Mellitus: Subcutaneous (SC) Insulin and Glucagon Delivery vs. SC Insulin Only|Completed||Phase 2|14|Actual|Legacy Health System||3|||f||||f||||||||||2017-02-18 13:40:15.893818|2017-02-18 13:40:15.893818
NCT00797810|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2009-09-14|||December 2006||2006-12-01|September 2009|2009-09-01||||||||Interventional|||Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults|Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults|Unknown status|Recruiting|Phase 4|25|Anticipated|University of Bologna||1|||f||||t||||||||||2017-02-18 13:40:16.393141|2017-02-18 13:40:16.393141
NCT00797797|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2011-01-20|2010-11-18||November 2008||2008-11-01|January 2011|2011-01-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia|A Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran When Added to Pregabalin in the Treatment of Fibromyalgia|Completed||Phase 3|364|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 13:40:16.509664|2017-02-18 13:40:16.509664
NCT00797784|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2010-05-25|||October 2008||2008-10-01|November 2008|2008-11-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|DISCLUP2008||The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus|A Phase 2 Open Label Study to Assess the Efficacy and Safety of Etanercept (Enbrel®)for the Treatment of Discoid Lupus Erythematosus|Unknown status|Recruiting|Phase 2|20|Anticipated|Florida Academic Dermatology Centers||1|||f||||t||||||||||2017-02-18 13:40:16.993224|2017-02-18 13:40:16.993224
NCT00797771|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-23|2011-06-08|||December 2008||2008-12-01|June 2009|2009-06-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||User Satisfaction Using the ADI Insulin Pump|Evaluation of User Satisfaction Using the ADI Insulin Pump|Completed||N/A|20|Anticipated|NiliMedix||1|||f||||f||||||||||2017-02-18 13:40:17.0853|2017-02-18 13:40:17.0853
NCT00797758|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2013-03-07|||October 2007||2007-10-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|MINICORD||Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia|Assessment of Reduction of Cord Blood Transplantation Toxicity by Using Reduced Intensity Conditioning in Patients With Acute Myeloid Leukemia.|Completed||Phase 2|76|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:40:17.177374|2017-02-18 13:40:17.177374
NCT00797745|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-01-21|||November 2008||2008-11-01|January 2015|2015-01-01|September 2010|Actual|2010-09-01|July 2009|Actual|2009-07-01||Interventional|NEXT-1||A Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED)|A Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104)|Completed||Phase 2|111|Actual|Merck Sharp & Dohme Corp.||7|||f||||t||||||||||2017-02-18 13:40:17.278331|2017-02-18 13:40:17.278331
NCT00797719|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-08-30|||October 2008||2008-10-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Short Neoadjuvant Hemithoracic IMRT for MPM|A Feasibility Study Evaluating Neoadjuvant Hemithoracic Intensity Modulated Radiation Therapy for Surgically Resectable Malignant Pleural Mesothelioma|Recruiting||Phase 1/Phase 2|100|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 13:40:17.486089|2017-02-18 13:40:17.486089
NCT00797706|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2010-02-04|||November 2008||2008-11-01|February 2010|2010-02-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers|A Phase I/II Double-Blind, Dose Ranging, Vehicle Controlled, Randomized, Parallel Groups, Safety, Tolerability and Efficacy Study of CHRONSEAL® (5-amino-acid Deleted Recombinant Human Hepatocyte Growth Factor (KP-dHGF)), in Subjects With Venous Leg Ulcers|Unknown status|Active, not recruiting|Phase 1/Phase 2|75|Anticipated|Kringle Pharma Europe AB||3|||f||||f||||||||||2017-02-18 13:40:17.592783|2017-02-18 13:40:17.592783
NCT00797693|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2008-11-24|||January 2008||2008-01-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Misoprostol in Termination of First Trimester Missed Abortion|Oral Versus Vaginal Misoprostol as Cervical Ripening Agent Prior to Surgical Termination of First Trimester Missed Abortions in Hawler Maternity Teaching Hospital in Erbil/Iraq|Completed||N/A|100|Actual|Hawler Medical University||2|||f||||t||||||||||2017-02-18 13:40:17.706465|2017-02-18 13:40:17.706465
NCT00797680|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-01-15|||October 2008||2008-10-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|April 2014|Actual|2014-04-01||Interventional|||Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest|Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest|Completed||Phase 2|34|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:40:17.80744|2017-02-18 13:40:17.80744
NCT00797667|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-11-02|2014-08-13||November 2008||2008-11-01|November 2015|2015-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional||All enrolled participants who recieved at least one dose of study drug.|MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)|A Phase IIa, Multicenter, Randomized, Placebo-controlled Clinical Trial to Study the Safety and Efficacy of MK0974 for Migraine Prophylaxis in Patients With Episodic Migraine|Terminated||Phase 2|660|Actual|Merck Sharp & Dohme Corp.|Based on a recommendation from the external Data Safety Monitoring Board (DSMB), a decision to terminate the trial was made on 26-Mar-2009.|3||"The study was terminated based on a recommendation of the DSMB following the identification of~   two patients with significant elevations in serum transaminases"|f||||t||||||||||2017-02-18 13:40:18.122323|2017-02-18 13:40:18.122323
NCT00797654|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-08-08|||August 2008||2008-08-01|August 2016|2016-08-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|||HIV Prevention and Trauma Treatment in Men Who Have Sex With Men and Who Have a History of Sexual Abuse|Integrated HIV Prevention and Trauma Treatment in MSM With Sexual Abuse History (Project THRIVE)|Completed||N/A|46|Actual|Fenway Community Health||2|||f||||f||||||||||2017-02-18 13:40:18.835296|2017-02-18 13:40:18.835296
NCT00797641|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2009-12-03|||January 2009||2009-01-01|December 2009|2009-12-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Observational|ENERGIB||European Survey of Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB)|European Survey of Non-Variceal Upper Gastro Intestinal Bleeding|Completed||N/A|2500|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:40:18.952423|2017-02-18 13:40:18.952423
NCT00797628|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2013-08-27|||March 2010||2010-03-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|QUIT-PRIMO||Web-delivered Provider Intervention for Tobacco Control|QUIT-PRIMO: Web-Delivered Clinical Microsystem Intervention for Tobacco Control|Completed||N/A|174|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 13:40:19.137195|2017-02-18 13:40:19.137195
NCT00797615|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2010-10-06|||November 2008||2008-11-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|GEMAS||Project Diabetes: Weight Gain Prevention in Hispanic Girls (GEMAS Study)|Project Diabetes: Weight Gain Prevention in Hispanic Girls (GEMAS Study)|Completed||N/A|132|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:40:19.229448|2017-02-18 13:40:19.229448
NCT00797602|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2017-02-14|||January 2007||2007-01-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|CH01||Proton Therapy for Chordomas and/or Chondrosarcomas|A Clinical Outcomes Protocol of Proton Beam Radiation Therapy for Chordomas and/or Chondrosarcomas of the Base of Skull and/or Spine|Completed||N/A|189|Actual|University of Florida|||1||f||||f|f|f||||||Undecided||2017-02-18 13:40:19.335052|2017-02-18 13:40:19.335052
NCT00797589|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-08-24|||January 2009||2009-01-01|August 2015|2015-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effect of Prime Solution on Fluid Balance After Open Heart Surgery|Effect of Prime Solution on Fluid Balance After Open Heart Surgery|Completed||Phase 4|35|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 13:40:19.45143|2017-02-18 13:40:19.45143
NCT00797576|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2010-06-21|||June 2008||2008-06-01|August 2009|2009-08-01|July 2010|Anticipated|2010-07-01|June 2010|Anticipated|2010-06-01||Observational|||Detection of Left Atrial Appendage (LAA) Thrombus: Comparison of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram|Detection of Left Atrial Appendage Thrombus in Patients Referred For Cardioversion: Comparative Analysis of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram|Unknown status|Recruiting|N/A|25|Anticipated|Gundersen Lutheran Medical Foundation|||2||f||||f||||||||||2017-02-18 13:40:19.558038|2017-02-18 13:40:19.558038
NCT00797563|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-01-29|2009-11-17||November 2008||2008-11-01|January 2016|2016-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of a New Blood Glucose Meter System With Capillary and Venous Blood|Clinical Evaluation of the Apollo Blood Glucose Monitoring System With Capillary and Venous Blood [Commercial Name is CONTOUR® USB]|Completed||N/A|102|Actual|Ascensia Diabetes Care||1|||f||||f||||||||||2017-02-18 13:40:19.672309|2017-02-18 13:40:19.672309
NCT00797550|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2008-11-24|||April 2006||2006-04-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|August 2006|Actual|2006-08-01||Interventional|||Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion|Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion|Completed||Phase 1/Phase 2|2|Actual|Vericel Corporation||2|||f||||f||||||||||2017-02-18 13:40:19.952782|2017-02-18 13:40:19.952782
NCT00797537|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-09-03|||May 2008||2008-05-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|chondro||Ultrasound and X-ray in Detecting Articular Cartilage Calcification|Concordance Entre l'échographie du Genou et la Radiographie Standard Dans la détection Des Calcifications Dans le Cadre de la Chondrocalcinose Articulaire|Completed||N/A|166|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-02-18 13:40:20.062678|2017-02-18 13:40:20.062678
NCT00797524|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-02-02|||November 2008||2008-11-01|February 2015|2015-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography|Function and Structure Imaging in Different Retinal Diseases. Retinal Leakage Analyzer vs. Optical Coherence Tomography.|Completed||N/A|35|Actual|Association for Innovation and Biomedical Research on Light and Image|||3||f||||f||||||||||2017-02-18 13:40:20.151229|2017-02-18 13:40:20.151229
NCT00797511|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2012-10-24|2012-10-24||November 2008||2008-11-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Immunogenicity and Safety of Adacel Polio Vaccine|Immunogenicity and Safety of ADACEL POLIO (TdcP-IPV Vaccine) Administered at 6 to 8 Years of Age as a Fifth Dose in Healthy Children in Taiwan|Completed||Phase 3|132|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:40:20.250194|2017-02-18 13:40:20.250194
NCT00797498|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2017-02-03|||August 2006||2006-08-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|SI01||Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses|A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses|Completed||N/A|174|Actual|University of Florida|||1||f||||f||||||||Undecided||2017-02-18 13:40:20.582175|2017-02-18 13:40:20.582175
NCT00797485|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-22|2013-08-23|||July 2008||2008-07-01|June 2009|2009-06-01||||July 2011|Anticipated|2011-07-01||Interventional|||Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Maintenance and Reinduction Chemotherapy With Avastin in Metastatic Colon Cancer: The MARTHA (SICOG 0803) Trial|Unknown status|Recruiting|Phase 3|672|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:40:20.699021|2017-02-18 13:40:20.699021
NCT00797472|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2011-07-19|||July 2011||2011-07-01|July 2011|2011-07-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease|A Phase II Open Label, Multicenter, Randomized, Parallel Study Comparing the Efficacy of R-mabHD Alone and a Combination of Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD)in Treating Patients With Hodgkin's Disease.|Unknown status|Not yet recruiting|Phase 2|120|Anticipated|American Scitech International||2|||f||||f||||||||||2017-02-18 13:40:20.811305|2017-02-18 13:40:20.811305
NCT00797459|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2013-08-20|2010-08-11||November 2008||2008-11-01|August 2013|2013-08-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds|A Randomized, Double-Blind Study Comparing Safety and Tolerability of Restylane® With and Without Addition of 0.3% Lidocaine HCL During Correction of Nasolabial Folds|Completed||N/A|60|Actual|Medicis Global Service Corporation||1|||f||||f||||||||||2017-02-18 13:40:20.928037|2017-02-18 13:40:20.928037
NCT00797446|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2017-02-03|||September 2007||2007-09-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|OP01||Photon/Proton Radiation Therapy for Oropharyngeal Cancers|A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Oropharyngeal Cancers|Terminated||N/A|10|Actual|University of Florida|||1|Slow enrollment, feasibility issues|f||||f||||||||Undecided||2017-02-18 13:40:21.420995|2017-02-18 13:40:21.420995
NCT00797433|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2010-09-20|||December 2008||2008-12-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Outcomes of Mechanically Ventilated Patients With Low Serum Testosterone|Outcomes of Mechanically Ventilated Patients With Low Serum Testosterone|Completed||N/A|28|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-02-18 13:40:21.537628|2017-02-18 13:40:21.537628
NCT00797420|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-23|2013-03-18|||November 2008||2008-11-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|January 2010|Actual|2010-01-01||Interventional|||Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers|Pharmacokinetics of a Fluconazole Loading Dose in Infants and Toddlers|Completed||Phase 1|13|Actual|Duke University||2|||f||||f||||||||||2017-02-18 13:40:21.630264|2017-02-18 13:40:21.630264
NCT00797407|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2008-11-24|||August 2006||2006-08-01|November 2008|2008-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs|Creatine Supplementation for the Prevention of Statin Myalgia|Completed||N/A|12|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-02-18 13:40:21.756729|2017-02-18 13:40:21.756729
NCT00797394|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2011-04-11|||November 2008||2008-11-01|April 2011|2011-04-01||||July 2010|Actual|2010-07-01||Interventional|||Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto||Completed||Phase 2|110|Anticipated|innoVactiv Inc.||2|||f||||||||||||||2017-02-18 13:40:21.860499|2017-02-18 13:40:21.860499
NCT00797381|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2008-11-24|||May 2009||2009-05-01|November 2008|2008-11-01|May 2011|Anticipated|2011-05-01|October 2010|Anticipated|2010-10-01||Observational|||Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety, Tolerability of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia|Unknown status|Not yet recruiting|N/A|100|Anticipated|Shanghai Public Health Clinical Center|||2||f||||f||||||Samples Without DNA|"~     3 ml plasm of each subject on week 4,8,12 and 24~   "|||2017-02-18 13:40:21.960133|2017-02-18 13:40:21.960133
NCT00797368|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2013-07-08|||November 2008||2008-11-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Manual Therapy and Exercise Versus Home Exercises in the Management of Patients Status Post Ankle Sprain|Manual Therapy and Exercise Versus Home Exercises in the Management of Patients Status Post Ankle Sprain: A Multi-Center Randomized Clinical Trial|Completed||N/A|74|Actual|Franklin Pierce University||2|||f||||f||||||||||2017-02-18 13:40:22.06854|2017-02-18 13:40:22.06854
NCT00797342|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2009-05-01|||December 2008||2008-12-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers|A Phase 1, Randomized, Double Blind (Sponsor Open), Placebo Controlled, Single-Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effect of PF-04629991 in Healthy Volunteers|Completed||Phase 1|27|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:40:22.17995|2017-02-18 13:40:22.17995
NCT00797329|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-23|2008-11-24|||July 2008||2008-07-01|November 2008|2008-11-01||||||||Observational|||Biological and Cognitive Markers of Violent Behavior in Forensic Patients With Polysubstance Use: Retrospective Evaluation||Unknown status|Active, not recruiting|N/A|200|Anticipated|BeerYaakov Mental Health Center|||1||f||||||||||||||2017-02-18 13:40:22.278146|2017-02-18 13:40:22.278146
NCT00797316|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2011-03-08|2010-12-14||November 2008||2008-11-01|March 2011|2011-03-01|December 2009||2009-12-01|December 2009|Actual|2009-12-01||Interventional|AIMS||Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension|An 8-week Randomized, Double-blind, Parallel-group, Multi-center, Forced-titration Study to Evaluate the Efficacy and Safety of Aliskiren Plus HCTZ Compared to Aliskiren Monotherapy in Metabolic Syndrome Patients With Stage 2 Hypertension|Completed||Phase 4|532|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:40:22.379127|2017-02-18 13:40:22.379127
NCT00797303|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-22|2011-12-01|||January 2006||2006-01-01|November 2011|2011-11-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|BQ-1-08-ARVO||The Effect of Bevacizumab on Corneal Neovascularization|The Effect of Bevacizumab on Corneal Neovascularization|Completed||Phase 4|8|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-02-18 13:40:22.851004|2017-02-18 13:40:22.851004
NCT00797290|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2017-02-09|||June 2008||2008-06-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|NP01||Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx|A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Carcinoma of the Nasopharynx|Terminated||N/A|9|Actual|University of Florida|||1|Slow enrollment, Feasibility issues|f||||f|f|f||||||No||2017-02-18 13:40:22.959143|2017-02-18 13:40:22.959143
NCT00797277|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2014-09-11|2013-08-12||July 2006||2006-07-01|September 2014|2014-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia|An Open-label, Randomized Trial of Intramuscular (IM) Olanzapine Versus Intramuscular Combination of Haloperidol and Lorazepam in the Treatment of Acute Agitation in Schizophrenia|Completed||Phase 3|67|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 13:40:23.071819|2017-02-18 13:40:23.071819
NCT00797264|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2013-04-10|||November 2008||2008-11-01|April 2013|2013-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|KETAMINE||Ketamine Associated With Morphine PCA After Total Hip Arthroplasty|Impact of the Route of Administration of Ketamine Associated With Morphine PCA on Analgesia After Total Hip Arthroplasty|Completed||N/A|18|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-02-18 13:40:23.415312|2017-02-18 13:40:23.415312
NCT00797251|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2008-11-24|||September 2007||2007-09-01|November 2008|2008-11-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Observational|||Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression|A Novel Simple Technique for Performing Anatomical Right Posterior Sectionectomy of the Liver: the Ultrasound-Guided Finger Compression|Unknown status|Active, not recruiting|N/A|10|Anticipated|University of Milan|||1||f||||t||||||||||2017-02-18 13:40:23.527964|2017-02-18 13:40:23.527964
NCT00797238|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2010-07-14|||September 2007||2007-09-01|July 2010|2010-07-01|August 2010|Anticipated|2010-08-01|||||Observational|||DNA Repair Genes and Outcomes in Patients With Stage III NSCLC||Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"~     lung cancer tissue before and after treatment~   "|||2017-02-18 13:40:23.645908|2017-02-18 13:40:23.645908
NCT00797225|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2013-01-02||2012-02-06|November 2008||2008-11-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety Study in Endometriosis With NBI-56418; Placebo and Active Controlled|A Phase II, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Efficacy and Safety of NBI-56418 in Subjects With Endometriosis|Completed||Phase 2|174|Actual|AbbVie||4|||f||||f||||||||||2017-02-18 13:40:23.741968|2017-02-18 13:40:23.741968
NCT00797212|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-09-29|2009-11-12||November 2008||2008-11-01|September 2016|2016-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A New Glucose Meter With Alternative Site Testing|Clinical Evaluation of the Apollo Blood Glucose Monitoring System With Alternative Site Testing [Commercial Name is CONTOUR® USB]|Completed||N/A|50|Actual|Ascensia Diabetes Care||1|||f||||f||||||||Yes||2017-02-18 13:40:23.877652|2017-02-18 13:40:23.877652
NCT00797199|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2016-03-22|||September 2011||2011-09-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Observational|TiBS-HRT||Monitoring of Breast Tissue Change Due to Hormone Replacement Therapy in Post-menopausal Women Using OBS|Short-term Evaluations of Breast Tissue Change in Post-menopausal Women Using Optical Breast Spectroscopy (OBS)|Completed||N/A|14|Actual|University Health Network, Toronto|||4||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:40:24.13507|2017-02-18 13:40:24.13507
NCT00797186|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2011-05-26|||November 2008||2008-11-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus|Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus Using Regadenoson Stress Cardiac Magnetic Resonance Imaging|Unknown status|Recruiting|N/A|150|Anticipated|University of Virginia||1|||f||||t||||||||||2017-02-18 13:40:24.237385|2017-02-18 13:40:24.237385
NCT00797160|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2008-11-24|||August 2008||2008-08-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Propofol Versus Midazolam as Premedication for Preterm Neonates With Respiratory Distress Syndrome (RDS)|Propofol and Remifentanil Versus Midazolam and Remifentanil as Premedication Allowing Very Early Extubation After Surfactant Treatment in Preterm Neonates With Respiratory Distress Syndrome|Unknown status|Recruiting|Phase 4|20|Anticipated|Federal University of Minas Gerais|||||f||||t||||||||||2017-02-18 13:40:24.341588|2017-02-18 13:40:24.341588
NCT00797134|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2015-02-02|||November 2008||2008-11-01|February 2015|2015-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Retinal Thickness Analysis Using Optical Coherence Tomography|Retinal Thickness Analysis Using Optical Coherence Tomography|Completed||N/A|45|Actual|Association for Innovation and Biomedical Research on Light and Image|||1||f||||f||||||||||2017-02-18 13:40:24.452427|2017-02-18 13:40:24.452427
NCT00797121|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2008-11-24|||May 2008||2008-05-01|November 2008|2008-11-01|May 2013|Anticipated|2013-05-01|May 2011|Anticipated|2011-05-01||Interventional|||Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma|Effect of Preoperative Biliary Drainage on Postoperative Complications in Resectable Patients With Hilar Cholangiocarcinoma(Klatskin Tumor)|Unknown status|Recruiting|Phase 4|82|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:40:24.544787|2017-02-18 13:40:24.544787
NCT00796588|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2008-11-21|||April 2005||2005-04-01|November 2008|2008-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||The Effect of Remote Ischemic Preconditioning in Patients Undergoing Major Liver Surgery|The Effect of Remote Ischemic Preconditioning in Patients Undergoing Major Liver Surgery|Unknown status|Enrolling by invitation|N/A|48|Anticipated|Royal Free Hampstead NHS Trust||2|||f||||f||||||||||2017-02-18 13:40:43.672472|2017-02-18 13:40:43.672472
NCT00797108|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2016-02-11|2015-07-08||January 2009||2009-01-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||Intent to treat (ITT) population included all randomized participants who received at least 1 dose of double blind study drug.|A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization|A Phase 2 Randomized, Double-blind, Double-dummy Efficacy, Safety And Tolerability Study Of Iv Sulopenem With Switch To Oral Pf-03709270 Compared To Ceftriaxone With Step Down To Amoxicillin/Clavulanate Potassium (Augmentin) In Subjects With Community Acquired Pneumonia (Cap) Requiring Hospitalization|Completed||Phase 2|35|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:40:24.683269|2017-02-18 13:40:24.683269
NCT00797095|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-22|2017-01-24|||November 19, 2008||2008-11-19|October 20, 2014|2014-10-20|October 20, 2014||2014-10-20|||||Observational|||Health Behaviors in School-age Children: 2009-2010|Health Behaviors in School-Age Children: 2009/2010|Completed||N/A|14672|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:40:25.500103|2017-02-18 13:40:25.500103
NCT00797082|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-07-29|||November 2008||2008-11-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|March 2011|Actual|2011-03-01||Interventional|MRDiabetics||Magnetic Resonance Diabetic Cardiac Stress Imaging|Magnetic Resonance Diabetic Cardiac Stress Imaging : MRDIABETICS|Terminated||Phase 4|62|Actual|Assistance Publique - Hôpitaux de Paris||1||default of inclusion|f||||f||||||||||2017-02-18 13:40:25.581857|2017-02-18 13:40:25.581857
NCT00797069|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-23|2010-07-29|||November 2008||2008-11-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Comparison of Nutritional Products for People With Type 2 Diabetes|Comparison of Nutritional Products for People With Type 2 Diabetes|Completed||Phase 3|58|Actual|Abbott Nutrition||3|||f||||f||||||||||2017-02-18 13:40:25.679919|2017-02-18 13:40:25.679919
NCT00797056|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-03-30|||April 2008||2008-04-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|STEMPAD||Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease|Pilot Study of Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease (STEMPAD Trial)|Completed||Early Phase 1|32|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 13:40:25.775527|2017-02-18 13:40:25.775527
NCT00797043|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-24|2017-02-03|||September 2008||2008-09-01|February 2017|2017-02-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|SK01||Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and Neck|A Clinical Outcomes Protocol of Photon/Proton Beam Radiation Therapy for Carcinoma of the Skin of the Head and Neck With Perineural Invasion|Terminated||N/A|11|Actual|University of Florida|||1|Slow enrollment, feasibility issues|f||||f||||||||Undecided||2017-02-18 13:40:26.096626|2017-02-18 13:40:26.096626
NCT00797030|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2008-11-21|||October 2006||2006-10-01|November 2008|2008-11-01|November 2008|Anticipated|2008-11-01|July 2008|Anticipated|2008-07-01||Interventional|||Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus|Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus|Unknown status|Active, not recruiting|Phase 4|20|Actual|Universidade Federal do Rio de Janeiro||2|||f||||t||||||||||2017-02-18 13:40:26.204078|2017-02-18 13:40:26.204078
NCT00797017|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2014-04-24|||May 2008||2008-05-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Study on Impact of Fentanyl Matrix on Improvement of Pain and Functioning in Spinal Disorder-related Pain|Impact of Fentanyl Matrix on Improvement of Pain and Functioning in Spinal Disorder-related Pain: Multicenter, Open Label, Prospective, Observational Study|Completed||Phase 4|1576|Actual|Janssen Korea, Ltd., Korea|||7||f||||f||||||||||2017-02-18 13:40:26.315982|2017-02-18 13:40:26.315982
NCT00797004|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2012-06-27|||November 2008||2008-11-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|ODOR||Olfactory Dysfunction of Rhinosinusitis|Olfactory Dysfunction of Rhinosinusitis|Completed||N/A|23|Actual|University of Washington|||1||f||||f||||||||||2017-02-18 13:40:26.434425|2017-02-18 13:40:26.434425
NCT00796991|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2013-12-31|2013-11-05||February 2009||2009-02-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|November 2009|Actual|2009-11-01||Interventional||All randomized and treated participants|Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine|A Randomized, Parallel, 3-arm Study to Characterize the Effect of Ipilimumab + Chemotherapy in Patients With Untreated Advanced Melanoma|Completed||Phase 1|72|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 13:40:26.552811|2017-02-18 13:40:26.552811
NCT00796978|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-07-15|||November 2008||2008-11-01|July 2015|2015-07-01||||November 2015|Anticipated|2015-11-01||Interventional|||Trastuzumab in Treating Older Women With Early-Stage Breast Cancer|Safety and Efficacy of Single Agent Adjuvant Trastuzumab in Older Women With Early Stage Breast Cancer: A Phase II Trial|Active, not recruiting||Phase 2|56|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:40:29.100724|2017-02-18 13:40:29.100724
NCT00796965|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2009-08-18|||December 2008||2008-12-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|||||Interventional|||Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects|A Phase I, Single-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects|Completed||Phase 1|48|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:40:29.221505|2017-02-18 13:40:29.221505
NCT00796952|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2011-09-16|||November 2001||2001-11-01|September 2011|2011-09-01|April 2005|Actual|2005-04-01|July 2004|Actual|2004-07-01||Interventional|Pharyngocise||Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients|"Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients Undergoing Radiotherapy: a Randomized Controlled Trial of Swallowing Therapy"|Completed||Phase 2|58|Actual|University of Florida||3|||f||||f||||||||||2017-02-18 13:40:29.319287|2017-02-18 13:40:29.319287
NCT00796939|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-04-09|||March 2006||2006-03-01|April 2015|2015-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Effects of Light Treatment During Sleep on Young Men|Randomized, Placebo-Controlled Trial of Short Wavelength Light Administered Just Prior to Waking in Young Men|Completed||N/A|30|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 13:40:29.431637|2017-02-18 13:40:29.431637
NCT00796926|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2011-10-04|2011-06-20||July 2009||2009-07-01|October 2011|2011-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes|Randomised Controlled Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes|Completed||Phase 3|30|Actual|Singapore National Eye Centre||2|||f||||f||||||||||2017-02-18 13:40:29.532309|2017-02-18 13:40:29.532309
NCT00796913|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-12-30|||January 2008||2008-01-01|January 2015|2015-01-01|January 2018|Anticipated|2018-01-01|October 2017|Anticipated|2017-10-01||Interventional|||Remission Induction and Sustenance in Graves' Disease 2|Prospective Randomized Study of Therapy Withdrawal vs Continued Low Dose Medical Therapy in Patients With Graves' Disease Entering Remission During ATD Therapy|Active, not recruiting||N/A|250|Anticipated|Aalborg Universitetshospital||3|||f||||f||||||||No||2017-02-18 13:40:32.298797|2017-02-18 13:40:32.298797
NCT00796900|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-05-11|||May 2008||2008-05-01|September 2009|2009-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|DTH1||Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)|Dantrolene as a Treatment for Hyperthermia in Patients After Subarachnoidal Hemorrhage|Terminated||Phase 2/Phase 3|34|Anticipated|Medical University of Vienna||2||organizationally not possible|f||||f||||||||||2017-02-18 13:40:32.406414|2017-02-18 13:40:32.406414
NCT00796887|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2012-09-12|||April 2009||2009-04-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery|Phase II, Randomized, Double-Blinded, Placebo-Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery|Completed||Phase 2|28|Actual|Henry Ford Health System||3|||f||||t||||||||||2017-02-18 13:40:32.517857|2017-02-18 13:40:32.517857
NCT00796874|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2013-07-24|||October 2008||2008-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance|MR Imaging to Stratify Prostate Cancer Progression Risk in Patients on Active Surveillance|Withdrawn||N/A|0|Actual|Roswell Park Cancer Institute||1||PI decided to terminate study.|f||||t||||||||||2017-02-18 13:40:32.630941|2017-02-18 13:40:32.630941
NCT00796861|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2017-01-26|||May 2007||2007-05-01|January 2017|2017-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Trial of Sunitinib for Refractory Malignant Ascites|Phase II Pilot Efficacy Trial of Sunitinib for Refractory Malignant Ascites|Terminated||Phase 2|4|Actual|Milton S. Hershey Medical Center||1||Phycisican decided to terminate study due to slow patient accrual.|f||||t||||||||No|Not enough valuable data|2017-02-18 13:40:32.720386|2017-02-18 13:40:32.720386
NCT00796848|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-03-05|||March 2009||2009-03-01|March 2015|2015-03-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Reversal of Hypoglycemia Unawareness Using Continuous Glucose Monitoring|Reversal of Hypoglycemia Unawareness Using Continuous Glucose Monitoring|Withdrawn||N/A|0|Actual|Stanford University||1|||f||||||||||||||2017-02-18 13:40:32.825698|2017-02-18 13:40:32.825698
NCT00796835|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-05-20|||July 2004||2004-07-01|March 2010|2010-03-01|October 2004|Actual|2004-10-01|||||Interventional|||A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone|Dose-proportionality Study of the Five ER OROS Paliperidone To-be-marketed Tablet Strengths (3, 6, 9, 12, and 15 mg) in Healthy Male Subjects|Completed||Phase 1|50|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:40:32.924596|2017-02-18 13:40:32.924596
NCT00796822|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2013-05-20|2013-03-13||January 2009||2009-01-01|May 2013|2013-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications|A Randomized, Placebo-Controlled Trial of Pentoxifylline to Improve Endothelial Function in HIV-Infected Patients Not Requiring Antiretroviral Therapy|Completed||Phase 2|26|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 13:40:33.012619|2017-02-18 13:40:33.012619
NCT00796809|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-12-11|||October 2007||2007-10-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Observational|||Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis|Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis|Completed||N/A|598|Actual|University of Arizona|||2||f||||t||||||||||2017-02-18 13:40:33.405942|2017-02-18 13:40:33.405942
NCT00796796|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2013-07-09|||March 2009||2009-03-01|July 2013|2013-07-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Temsirolimus and Radiation for Non-Small Cell Lung Cancer|A Phase I Study of Temsirolimus and Thoracic Radiation in Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|10|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:40:33.565489|2017-02-18 13:40:33.565489
NCT00796783|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2014-06-19|||February 2009||2009-02-01|June 2014|2014-06-01||||June 2010|Actual|2010-06-01||Observational|||A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia|A Study to Confirm the Presence of Recurrent or Persistent Cushing's Syndrome in Patients With Clinical Signs or Symptoms of Hypercortisolemia Who Have Been Treated for Cushing's Disease|Terminated||N/A|2|Actual|Corcept Therapeutics|||1||f||||f||||||||||2017-02-18 13:40:33.837027|2017-02-18 13:40:33.837027
NCT00796770|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2013-05-23|||November 2008||2008-11-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)|Vaccination of HIV-1 Infected Patients With Ex-vivo Generated Interferon-α Dendritic Cells Loaded With HIV-1 Lipopeptides and Activated With Lipopolysaccharide in Addition to Antiretroviral Treatment: Exploratory Phase I Study-(DALIA Trial)|Completed||Phase 1|19|Actual|Baylor Research Institute||1|||f||||t||||||||||2017-02-18 13:40:33.941973|2017-02-18 13:40:33.941973
NCT00796757|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-05-22|2014-08-04||December 2008||2008-12-01|May 2015|2015-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Intent-to-treat (ITT) population: All participants who received at least 1 dose of either or both study drugs and had a valid baseline assessment and at least 1 postbaseline assessment.|A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).|An Open Label Study of the Effect of First Line Treatment With Avastin (Bevacizumab) in Combination With Low-dose Interferon on Progression-free Survival in Patients With Metastatic Clear Cell Renal Cell Carcinoma.|Completed||Phase 2|146|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:40:34.053738|2017-02-18 13:40:34.053738
NCT00796744|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-08-27|2012-06-14||October 2008||2008-10-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers|Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Evaluate the Safety and Effectiveness of DSC127 in Treating Subjects With Diabetic Ulcers|Completed||Phase 2|78|Actual|US Biotest, Inc.||3|||f||||f||||||||||2017-02-18 13:40:34.548429|2017-02-18 13:40:34.548429
NCT00796731|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2012-07-16|||October 2008||2008-10-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma|A Dose-escalation, Safety and Pharmacokinetic Study of SAR3419 Administered as a Single Agent by Intravenous Infusion Once Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 1|77|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:40:35.150259|2017-02-18 13:40:35.150259
NCT00796718|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-07-14|2016-07-14||October 2008||2008-10-01|July 2016|2016-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional||All enrolled participants.|A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal Cancer|An Open Label Study of the Effect of Xeloda and Radiotherapy on Pathological Response Rate in Patients With Locally Advanced Rectal Cancer|Completed||Phase 2|62|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:40:35.458171|2017-02-18 13:40:35.458171
NCT00796705|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-09-28|2012-07-05||November 2008||2008-11-01|August 2012|2012-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)|Switching Anti-TNF-alpha Agents in Patients With RA With An Inadequate Response to TNF-alpha Inhibition|Terminated||Phase 4|13|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The study terminated early due to recruitment feasibility issues. Thirteen subjects were enrolled and received treatment. No mechanistic analyses were performed.|2||Lack of Enrollment|f||||t||||||||||2017-02-18 13:40:35.715288|2017-02-18 13:40:35.715288
NCT00796692|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2008-11-21|||June 2002||2002-06-01|November 2008|2008-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|NATSPUTE||Nadroparin for the Initial Treatment of Pulmonary Thromboembolism|Efficacy and Safety of Body Weight Adjusted Nadroparin vs Standard Unfractionated Heparin for the Initial Treatment of Pulmonary Thromboembolism：a Multi-Centre, Randomised Controlled Trial in China|Completed||Phase 4|274|Actual|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-02-18 13:40:36.64481|2017-02-18 13:40:36.64481
NCT00796679|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2017-01-07|||October 2008||2008-10-01|January 2017|2017-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease|A Prospective, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Oral Paricalcitol in Retarding Cardiac Hypertrophy, Reducing Inflammation and Atherosclerosis in Stage 3 - 5 Chronic Kidney Disease|Completed||N/A|60|Actual|The University of Hong Kong||2|||f||||t||||||||No||2017-02-18 13:40:36.801264|2017-02-18 13:40:36.801264
NCT00796666|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-03-04|2012-01-26||May 2009||2009-05-01|March 2015|2015-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil|A Phase 3, Multi-Center, Randomized, Double-Blind, Efficacy And Safety Study Of Monotherapy Sitaxsentan Sodium Versus Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension Who Have Completed Study B1321001 (NCT00795639)|Terminated||Phase 3|131|Actual|Pfizer|Study terminated early by sponsor, no Week 48 information collected.|2||"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,~   specifically new emerging evidence of hepatic injury."|f||||t||||||||||2017-02-18 13:40:36.929744|2017-02-18 13:40:36.929744
NCT00796653|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2014-06-17|2014-03-28||January 2009||2009-01-01|June 2014|2014-06-01||||December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 48 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (5 µg [2 Actuations of 2.5 ug] and 10 ug [2 Actuations of 5 ug]) Delivered by the Respimat® Inhaler, and 48 Weeks of Twice Daily Foradil® (12 µg) Delivered by the Aerolizer® Inhaler, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|937|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 13:40:38.179557|2017-02-18 13:40:38.179557
NCT00796640|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-06|||September 2003||2003-09-01|March 2010|2010-03-01|November 2003|Actual|2003-11-01|||||Interventional|||A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations|A Comparative Evaluation of the Pharmacokinetics and Pharmacodynamics Under Fasting and Fed Conditions of 2 Paliperidone Extended-release Pellet Formulations With Paliperidone Oral Solution in Healthy Adults|Completed||Phase 1|35|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:40:42.236058|2017-02-18 13:40:42.236058
NCT00796627|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-08-05|||December 2006||2006-12-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||HIF-1 Regulated Endothelial Progenitor Cell (EPC) Recruitment in Burn Wound Healing|HIF-1 Regulated Endothelial Progenitor Cell Recruitment in Burn Wound Healing|Terminated||N/A|41|Actual|Johns Hopkins University||2||unable to recruit enough patients|f||||f||||||||||2017-02-18 13:40:42.317512|2017-02-18 13:40:42.317512
NCT00796614|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-09-29|2012-08-06||January 2008||2008-01-01|September 2015|2015-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional||Treated Set (TS): Includes all patients who were documented to have taken at least one dose of randomised treatment.|Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder|A Phase IIb/III, Multi-centre, Double-blind, Randomised, Placebo-controlled, Dose Ranging Study of Tamsulosin Hydrochloride (Low, Medium and High Dose) as Treatment in Children With Neuropathic Bladder for Three Months|Completed||Phase 2/Phase 3|231|Actual|Boehringer Ingelheim|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|4|||f||||f||||||||||2017-02-18 13:40:42.420591|2017-02-18 13:40:42.420591
NCT00796601|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2009-03-17|||May 2009||2009-05-01|March 2009|2009-03-01|November 2010|Anticipated|2010-11-01|May 2010|Anticipated|2010-05-01||Interventional|||Maintenance of Efficacy.|A 6-Month, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Maintenance Of Effect Study Of Esreboxetine (PNU-165442g) Administered Once Daily (QD) In Patients With Fibromyalgia.|Withdrawn||Phase 3|650|Anticipated|Pfizer||2||"This study has been cancelled as the esreboxetine development program is being discontinued.~   Safety and efficacy were not factors."|f||||t||||||||||2017-02-18 13:40:43.572519|2017-02-18 13:40:43.572519
NCT00795847|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-22|||November 2008||2008-11-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Morning Hypertension and Preminent Therapy Study|The Efficacy and Safety of Losartan/Hydrochlorothiazide Combination Drug (Preminent) in Patients With Morning Hypertension|Completed||Phase 4|216|Actual|Kurume University||2|||f||||t||||||||||2017-02-18 13:40:57.325774|2017-02-18 13:40:57.325774
NCT00796575|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-04-02|||November 2008||2008-11-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Multiple Doses of CS-8080 in Healthy Volunteers|A Randomized, Placebo-Controlled, Multiple Ascending Dose Study To Assess The Safety, Pharmacokinetics and Pharmacodynamics Of CS-8080 In Healthy Volunteers|Terminated||Phase 1|16|Actual|Daiichi Sankyo Inc.||2||Safety concerns|f||||f||||||||||2017-02-18 13:40:43.782144|2017-02-18 13:40:43.782144
NCT00796562|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2016-12-13|||November 2008||2008-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|mylehaplo||Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy|A Phase II Trial of Myeloablative Conditioning and Transplantation of Partially HLA-mismatched Bone Marrow for Patients With Hematologic Malignancies|Completed||Phase 2|96|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||No||2017-02-18 13:40:43.881222|2017-02-18 13:40:43.881222
NCT00796549|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2014-07-21|2013-08-08||December 2008||2008-12-01|July 2014|2014-07-01||||May 2012|Actual|2012-05-01||Interventional|||BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients|A Phase II Single-arm Trial of BIBW 2992 in EGFR FISH Positive Non-small Cell Lung Cancer Patients|Completed||Phase 2|70|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-02-18 13:40:44.001471|2017-02-18 13:40:44.001471
NCT00796536|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2013-02-15|||June 2009||2009-06-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|June 2010|Actual|2010-06-01||Interventional|||Using Functional MRI to Evaluate Cognitive Behavioral Therapy Treatment Response in Adults With Chronic Pain|Using fMRI to Evaluate CBT Treatment Response for Patients With Chronic Pain|Completed||Phase 1/Phase 2|40|Actual|University of Vermont||2|||f||||f||||||||||2017-02-18 13:40:44.430476|2017-02-18 13:40:44.430476
NCT00796523|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-11-21|2008-10-16||August 2005||2005-08-01|November 2008|2008-11-01|May 2006|Actual|2006-05-01|February 2006|Actual|2006-02-01||Interventional|||An Intervention to Decrease Infant Crying|A Randomized, Controlled Trial to Decrease Infant Crying|Completed||N/A|51|Actual|Riverside Methodist Hospital||2|||f||||t||||||||||2017-02-18 13:40:44.54397|2017-02-18 13:40:44.54397
NCT00796510|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-01-20|2011-12-09||July 2010||2010-07-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety|A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term Safety Of Monotherapy Sitaxsentan Sodium And Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension|Terminated||Phase 3|3|Actual|Pfizer|Due to the premature termination only 3 participants were recruited into this study. No summarization or analysis was done.|2||"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,~   specifically new emerging evidence of hepatic injury"|f||||f||||||||||2017-02-18 13:40:44.981279|2017-02-18 13:40:44.981279
NCT00796497|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-02-23|||March 2008||2008-03-01|February 2011|2011-02-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)|Ondansetron Augmentation in Treatment Resistant Obsessive Compulsive Disorder: A Preliminary Single-Blind Prospective Study|Completed||Phase 4|14|Actual|Institute of Neuroscience, Florence, Italy||1|||f||||t||||||||||2017-02-18 13:40:45.431411|2017-02-18 13:40:45.431411
NCT00796484|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-08-19|||November 2008||2008-11-01|August 2015|2015-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL888 in Subjects With Solid Tumors|Terminated||Phase 1|33|Actual|Exelixis||1||Sponsor decision|f||||||||||||||2017-02-18 13:40:45.545216|2017-02-18 13:40:45.545216
NCT00796471|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-06|||June 2003||2003-06-01|March 2010|2010-03-01|August 2003|Actual|2003-08-01|||||Interventional|||A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations|A Comparative Evaluation of the Pharmacokinetics and Pharmacodynamics Under Fasting and Fed Conditions of 2 Paliperidone Extended-release Formulations With Paliperidone Oral Solution in Healthy Adults|Completed||Phase 1|35|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:40:45.636717|2017-02-18 13:40:45.636717
NCT00796458|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2013-08-09|||April 2005||2005-04-01|November 2008|2008-11-01||||October 2013|Anticipated|2013-10-01||Interventional|||Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer|Phase III Study of Chemo-hormonal Therapy Versus Hormonal Therapy Alone in Advanced Hormone-naives Prostate Cancer Patients.|Unknown status|Recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:40:45.724078|2017-02-18 13:40:45.724078
NCT00796445|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-09-29||2012-11-16|December 2008||2008-12-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor|GSK 2132231A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Resected Melanoma|Terminated||Phase 3|1351|Actual|GlaxoSmithKline||2||"The study was terminated early following assessment of the two co-primary endpoints showing~   the lack of efficacy of the study product."|f||||||||||||||2017-02-18 13:40:45.845541|2017-02-18 13:40:45.845541
NCT00796432|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-08|||March 2003||2003-03-01|March 2010|2010-03-01|June 2003|Actual|2003-06-01|||||Interventional|||A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone|Open-label Positron Emission Tomography (PET) Study of Central D2-receptor Occupancy in Healthy Subjects Following a Single Oral Dose of OROS Paliperidone|Completed||Phase 1|4|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:40:46.393826|2017-02-18 13:40:46.393826
NCT00796419|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-08-23|||January 2009||2009-01-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|November 2015|Actual|2015-11-01||Interventional|CEASE||Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)|Phase III Study Comparing Albumin and Hetastarch Therapy in Acute Lung Injury|Terminated||Phase 3|31|Actual|Emory University||2|||f||||t||||||||||2017-02-18 13:40:46.488865|2017-02-18 13:40:46.488865
NCT00796393|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2011-06-22|||November 2008||2008-11-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.|Effects of Daily Consumption of a Probiotic on the Evolution of Infectious Episodes (ENT, Gastro-intestinal and Pulmonary), in Subject Aged 60 Years or Over, During Winter.|Completed||N/A|200|Actual|Institut Rosell Lallemand||4|||f||||f||||||||||2017-02-18 13:40:46.601886|2017-02-18 13:40:46.601886
NCT00796380|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2008-11-21|||December 2008||2008-12-01|November 2008|2008-11-01|July 2010|Anticipated|2010-07-01|November 2009|Anticipated|2009-11-01||Interventional|||Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases|Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases|Unknown status|Not yet recruiting|Phase 4|1|Anticipated|Shenzhen Children's Hospital||1|||f||||t||||||||||2017-02-18 13:40:46.703936|2017-02-18 13:40:46.703936
NCT00796367|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-09-05|2012-07-31||December 2008||2008-12-01|September 2012|2012-09-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)|A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Extension Study (From Study OB-303 [NCT00553787]) to Determine the Safety and Efficacy Of VI-0521 for the Long-Term Treatment Of Obesity in Adults With Obesity-Related Co-Morbid Conditions.|Completed||Phase 3|676|Actual|VIVUS, Inc.||3|||f||||t||||||||||2017-02-18 13:40:46.774378|2017-02-18 13:40:46.774378
NCT00796354|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2010-02-15|||November 2008||2008-11-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Constipation Associated With Irritable Bowel Syndrome (IBS-C)|A Phase IIIb/IV, Multi-centre, Double-blind, Randomised, Placebo-controlled Parallel Group Study to Compare the Efficacy and Safety of Movicol® With Placebo in Patients With Constipation Associated With Irritable Bowel Syndrome (IBS)|Completed||Phase 3|210|Actual|Norgine||2|||f||||f||||||||||2017-02-18 13:40:47.419317|2017-02-18 13:40:47.419317
NCT00796341|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2008-12-01|||November 2007||2007-11-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Endometrial Injury and IVF-ET Outcome|Does Endometrial Injury in the Non-Transfer Cycle Improve the IVF-ET Outcome in the Subsequent Cycle in Patients With Previous Failed IVF Cycles: A Randomized Control Trial|Completed||N/A|99|Actual|Bangalore Assisted Conception Centre||2|||f||||f||||||||||2017-02-18 13:40:47.557527|2017-02-18 13:40:47.557527
NCT00796328|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-09-03|2014-03-14||November 2008||2008-11-01|September 2014|2014-09-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Up-Down Determination of the ED90 of Phenylephrine for Hypotension Prophylaxis in Cesarean Delivery|Up-down Determination of the ED90 of the Initial Rate of Infusion of Phenylephrine for the Prophylaxis of Spinal Induced Hypotension in Parturients Undergoing Cesarean Delivery|Terminated||Phase 4|45|Actual|IWK Health Centre||1||Results Invalid, study closed, analysis cannot proceed.|f||||t||||||||||2017-02-18 13:40:47.668889|2017-02-18 13:40:47.668889
NCT00796315|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2013-01-29|2012-12-19||December 2008||2008-12-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children|A Single-dose, Open-label, Multi-center Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children Ages 2 to < 18 Years|Completed||Phase 1|41|Actual|Procter and Gamble|Incidences of mild sedation are consistent with doxylamine's indication as an OTC sleep aid. Conclusive evaluation of sedation couldn't be undertaken in the absence of a control group. Also, children may nap in daytime confounding sedation assessment|1|||f||||f||||||||||2017-02-18 13:40:47.869025|2017-02-18 13:40:47.869025
NCT00796302|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-05-18|2016-02-18||August 2008||2008-08-01|May 2016|2016-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||ADHD & severe physical aggression|Treatment of Severe Childhood Aggression (The TOSCA Study)|Stimulant and Risperidone in Children With Severe Physical Aggression|Completed||Phase 2|168|Actual|Ohio State University|These results were obtained with children selected for severity of aggression and disruptive behavior, and the risk-benefit ratio may well be decreased for children with milder disruptive behavior or no physical aggression.|2|||f||||t||||||||||2017-02-18 13:40:48.221727|2017-02-18 13:40:48.221727
NCT00796289|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-08-26||2010-12-16|February 2009||2009-02-01|August 2015|2015-08-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females|A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch (Lutrepatch) Compared to Oral Treatment With Clomiphene Citrate or Placebo in Anovulatory or Oligoovulatory Infertile Females|Completed||Phase 2|350|Actual|Ferring Pharmaceuticals||5|||f||||f||||||||||2017-02-18 13:40:48.772858|2017-02-18 13:40:48.772858
NCT00796276|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-06|||May 2004||2004-05-01|March 2010|2010-03-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone|Disposition of Paliperidone Enantiomers After Treatment With Different Formulations of the Racemate and the Separate Enantiomers and the Determination of the Absolute Bioavailability of IR and ER OROS Paliperidone|Completed||Phase 1|20|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:40:48.914191|2017-02-18 13:40:48.914191
NCT00796263|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2017-01-25|||April 2009||2009-04-01|January 2017|2017-01-01|July 2021|Anticipated|2021-07-01|April 2021|Anticipated|2021-04-01||Interventional|AAHIV||Antiretroviral Therapy for Acute HIV Infection|Antiretroviral Therapy for Acute HIV Infection|Recruiting||Phase 3|500|Anticipated|South East Asia Research Collaboration with Hawaii||2|||f||||f||||||||Undecided||2017-02-18 13:40:48.994785|2017-02-18 13:40:48.994785
NCT00796250|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-04-21|||November 2003||2003-11-01|April 2015|2015-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)|"Efficacy of Infliximab as Bridging Therapy in the Treatment of Patients Affected by Corticodependent Crohn's Disease Under Standard Treatment With Azathioprine"|Terminated||Phase 3|9|Actual|Merck Sharp & Dohme Corp.||2||Due to poor patient recruitment, a decision was made to terminate this trial.|f||||f||||||||||2017-02-18 13:40:49.113425|2017-02-18 13:40:49.113425
NCT00796237|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2011-08-08|||May 2008||2008-05-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Effects of Whole Body Vibration in Subacute Stroke Patients|Effects of Whole Body Vibration Training on Bone Health, Physical Fitness, and Neuromotor Performance in Individuals With Subacute Stroke: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|60|Anticipated|The Hong Kong Polytechnic University||2|||f||||t||||||||||2017-02-18 13:40:49.206158|2017-02-18 13:40:49.206158
NCT00795275|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-12-27|||January 2008||2008-01-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|1651||Incretin Effect in People With Impaired Fasting Glucose|Exploring the Incretin Effect in People With IFG|Completed||N/A|23|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 13:41:07.57388|2017-02-18 13:41:07.57388
NCT00796224|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2010-02-01|2009-12-15||December 2008||2008-12-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media|A Open Label, Randomized, Single Dose, Parallel Arm Study To Determine Pharmacokinetics Of Azithromycin Following Oral Administration Of Immediate-Release Or Extended-Release Formulation In Pediatric Subjects With Acute Otitis Media|Completed||Phase 2|38|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:40:49.466239|2017-02-18 13:40:49.466239
NCT00796211|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2009-01-14|||November 2008||2008-11-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|197-002||A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis|A Single-Center, Randomized, Blinded, Vehicle- Controlled Exploratory Study to Assess the Activity of CRx-197 in Subjects With Plaque Psoriasis|Completed||Phase 2|20|Anticipated|Zalicus||5|||f||||f||||||||||2017-02-18 13:40:49.9904|2017-02-18 13:40:49.9904
NCT00796198|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2008-11-24|||December 2008||2008-12-01|November 2008|2008-11-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Interventional|||Effects of Cosopt on IOP and on Ocular Diastolic Perfusion Pressure|A Pilot Study on the Effects of Cosopt on IOP Lowering and Ocular Diastolic Perfusion Pressure in Patients Not Controlled With Xalatan Monotherapy|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|University of Turin, Italy||2|||f||||f||||||||||2017-02-18 13:40:50.112938|2017-02-18 13:40:50.112938
NCT00796185|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-06|||August 2003||2003-08-01|March 2010|2010-03-01|January 2004|Actual|2004-01-01|||||Interventional|||As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations|Comparison of Steady-state Pharmacokinetics of Paliperidone After Extended-release OROS� Paliperidone 15 mg and Immediate-release Oral Risperidone 8 mg b.i.d. in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|62|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:40:50.226951|2017-02-18 13:40:50.226951
NCT00796172|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-04-27|||December 2008||2008-12-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Evaluating the Effectiveness of a Computerized Medication Adherence System at Reducing Cardiovascular Disease Risk Factors|Clinic-based Intervention to Improve Medication Adherence to Reduce Cardiovascular Disease Risks|Completed||Phase 2|308|Actual|PHCC LP||2|||f||||||||||||||2017-02-18 13:40:50.326637|2017-02-18 13:40:50.326637
NCT00796159|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2009-12-21|||July 2007||2007-07-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide|A Post Marketing Surveillance, Multicenter, Open-Label, Dose-Titrating, 4-Week Study Evaluating The Efficacy, Tolerability And Safety Of Olmesartan Medoxomil 20mg In Combination With 12.5mg Hydrochlorothiazide In Subjects With Stage 1 To Stage 2 Hypertension|Completed||Phase 4|1723|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:40:50.437585|2017-02-18 13:40:50.437585
NCT00796146|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-12-07|||April 2009||2009-04-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|April 2019|Anticipated|2019-04-01||Observational|||Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population||Recruiting||N/A|271|Anticipated|South East Asia Research Collaboration with Hawaii|||1||f||||f||||||Samples With DNA|"~     serum, PBMC~   "|||2017-02-18 13:40:50.549891|2017-02-18 13:40:50.549891
NCT00796133|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2015-04-16|||November 2008||2008-11-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women|A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women|Completed||Phase 2|18|Anticipated|Population Council||3|||f||||f||||||||||2017-02-18 13:40:50.658501|2017-02-18 13:40:50.658501
NCT00796120|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-12-09|2014-03-25||November 2008||2008-11-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|August 2012|Actual|2012-08-01||Interventional|||An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)|A Randomized, Multicenter, Phase III Trial of Trabectedin (Yondelis) Versus Doxorubicin-based Chemotherapy as First-Line Therapy in Patients With Translocation-Related Sarcomas (TRS)|Completed||Phase 3|121|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-02-18 13:40:50.780585|2017-02-18 13:40:50.780585
NCT00796107|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-07-26||2016-07-07|January 2009||2009-01-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer|An Open Label Study to Evaluate the Safety, Tolerability and Effect on Tumor Response of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer.|Completed||Phase 2|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:40:51.443646|2017-02-18 13:40:51.443646
NCT00796094|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-11-08|||December 2008||2008-12-01|November 2016|2016-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Imaging of Soft Tissues|Elasticity Imaging of Soft Tissues|Completed||N/A|30|Actual|University of Michigan|||1||f||||f||||||||Undecided||2017-02-18 13:40:51.552166|2017-02-18 13:40:51.552166
NCT00796081|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-06|||January 2006||2006-01-01|March 2010|2010-03-01|August 2006|Actual|2006-08-01|||||Interventional|||A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder|Open-label Study to Evaluate the Safety and Pharmacokinetics of Single- and Multiple-dose Extended-release OROS Paliperidone in Pediatric Subjects (=10 to =17 Years of Age) With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder|Completed||Phase 1|25|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:40:51.641581|2017-02-18 13:40:51.641581
NCT00796068|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2016-12-16|||October 2008||2008-10-01|December 2016|2016-12-01||||June 2017|Anticipated|2017-06-01||Interventional|||Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant|Transplantation of Umbilical Cord Blood in Patients With Hematological Malignancies Using a Treosulfan Based Preparative Regimen|Recruiting||Phase 2|130|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-02-18 13:40:51.729526|2017-02-18 13:40:51.729526
NCT00795860|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-01-12|||June 2003||2003-06-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise|Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise|Completed||N/A|36|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 13:40:57.014155|2017-02-18 13:40:57.014155
NCT00796055|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-11-16|||August 2009||2009-08-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|MEDI-547||Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects With Relapsed or Refractory Solid Tumors|A Phase 1, Open-Label Study of MEDI-547 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biologic Activity of Intravenous Administration in Subjects With Relapsed or Refractory Solid Tumors Associated With EphA2 Expression|Terminated||Phase 1|6|Actual|MedImmune LLC||1||MI-CP177 study closed per sponsor decision.|f||||f||||||||||2017-02-18 13:40:51.867854|2017-02-18 13:40:51.867854
NCT00796042|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-21|2012-06-04|||January 2008||2008-01-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|WOUND||Interdisciplinary Pressure Management & Mobility Program as an Alternative to Usual Care: A Pilot Study|Interdisciplinary Pressure Management & Mobility Program as an Alternative to Bed Rest: A Pilot Study|Completed||Phase 3|14|Actual|University of Western Ontario, Canada||2|||f||||f||||||||||2017-02-18 13:40:51.958857|2017-02-18 13:40:51.958857
NCT00796029|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-06|||July 2003||2003-07-01|March 2010|2010-03-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose|Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose in Healthy Male Subjects|Completed||Phase 1|5|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:40:52.151296|2017-02-18 13:40:52.151296
NCT00796003|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2013-10-10|2013-05-31||July 2008||2008-07-01|October 2013|2013-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||For Baseline characteristics analysis, number of participants treated were analyzed (37) instead of number of participants enrolled (39). 2 enrolled participants were not treated.|A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome|A Phase I/II Clinical Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome|Completed||Phase 1|39|Actual|Janssen Pharmaceutical K.K.||3|||f||||t||||||||||2017-02-18 13:40:52.261707|2017-02-18 13:40:52.261707
NCT00795990|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2014-12-04|||November 2008||2008-11-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants|Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants|Completed||N/A|350|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 13:40:53.000177|2017-02-18 13:40:53.000177
NCT00795977|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2011-09-07|||November 2003||2003-11-01|September 2011|2011-09-01|November 2012|Anticipated|2012-11-01|November 2011|Anticipated|2011-11-01||Interventional|||Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer|Phase I/II Study on Intratumor Dendritic Cell Injection Immunotherapy Using Immature Dendritic Cells With S Pyogenes Preparation (OK-432) for Patients With Resectable Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|Fukushima Medical University||1|||f||||f||||||||||2017-02-18 13:40:53.090558|2017-02-18 13:40:53.090558
NCT00795964|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-09-23|||September 2008||2008-09-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|tidalvolume||Influence of Tidal Volume on Postoperative Pulmonary Function|Influence of Tidal Volume on Postoperative Pulmonary Function|Completed||N/A|101|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-02-18 13:40:53.195625|2017-02-18 13:40:53.195625
NCT00795951|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2013-12-19|2013-02-19||November 2008||2008-11-01|December 2013|2013-12-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents|Clinical Evaluation of T.R.U.E. TEST® Panel 1.1, 2.1 and 3.1: in Children and Adolescents|Completed||Phase 4|102|Actual|Allerderm||1|||f||||f||||||||||2017-02-18 13:40:53.29772|2017-02-18 13:40:53.29772
NCT00795938|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2010-05-06|||October 2008||2008-10-01|May 2010|2010-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects.|An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of An Experimental Tablet Of Sildenafil With Or Without Water Relative To Viagra® Conventional Oral Tablet With Water.|Completed||Phase 1|18|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:40:56.193748|2017-02-18 13:40:56.193748
NCT00795925|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-20|||October 2004||2004-10-01|November 2008|2008-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder|Dose-Escalating Study of Propiverine Hydrochloride (Mictonetten®) in Children Suffering From Frequency-Urgency-Syndrome and Urinary Incontinence Indicative of Detrusor Overactivity (Overactive Bladder)|Completed||Phase 2|30|Actual|APOGEPHA Arzneimittel GmbH||1|||f||||||||||||||2017-02-18 13:40:56.329501|2017-02-18 13:40:56.329501
NCT00795912|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2008-11-20|||May 2003||2003-05-01|November 2008|2008-11-01|January 2008|Actual|2008-01-01|November 2005|Actual|2005-11-01||Interventional|||A Study Of The Usage Of Statins In A Community Heart Failure Population|A Study Of The Usage Of Statins In A Community Heart Failure Population: The Impact of HMG Co-Enzyme A Reductase Inhibitors on Heart Structural Parameters, Brain Naturetic Peptide, Markers of Inflammation and Fibrosis|Completed||Phase 4|56|Actual|St Vincent's University Hospital, Ireland||2|||f||||t||||||||||2017-02-18 13:40:56.419522|2017-02-18 13:40:56.419522
NCT00795899|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-08-15|||January 2002||2002-01-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|December 2005|Actual|2005-12-01||Interventional|||Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)|Preoperative Therapy With Epirubicin/Cyclophosphamide Followed by Paclitaxel/Trastuzumab and Postoperative Therapy With Trastuzumab in Patients With HER-2 Over Expressed Breast Cancer|Completed||Phase 2|230|Actual|German Breast Group||1|||f||||t||||||||||2017-02-18 13:40:56.540931|2017-02-18 13:40:56.540931
NCT00795886|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2013-07-23|2011-03-01||August 2005||2005-08-01|July 2013|2013-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)|CHP-753, Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2|63|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 13:40:56.639379|2017-02-18 13:40:56.639379
NCT00795873|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2013-09-16|||December 2008||2008-12-01|March 2012|2012-03-01||||||||Observational|||OVATIO CRT and SITUS OTW LV Lead Post Approval Study|OVATIO CRT and SITUS OTW LV Lead Post Approval Study|Completed||N/A|2260|Anticipated|ELA Medical, Inc.|||1||f||||f||||||||||2017-02-18 13:40:56.905275|2017-02-18 13:40:56.905275
NCT00795834|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2008-11-19|||June 2008||2008-06-01|November 2008|2008-11-01|March 2009|Anticipated|2009-03-01|January 2009|Anticipated|2009-01-01||Interventional|||Effects of a Beverage Rich in Fruit Extracts on Risk Factors Associated With Cardiovascular Disease|Pilot Study to Assess Effects of Novel Beverages on Established and Novel Risk Markers for Vascular Disease|Unknown status|Recruiting|N/A|40|Anticipated|University of Glasgow||2|||f||||f||||||||||2017-02-18 13:40:57.426578|2017-02-18 13:40:57.426578
NCT00795821|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2011-04-07||2011-01-28|December 2008||2008-12-01|April 2011|2011-04-01|March 2011|Actual|2011-03-01|February 2010|Actual|2010-02-01||Interventional|||A Study in Adult Patients With Major Depressive Disorder|A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder|Completed||Phase 2/Phase 3|495|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 13:40:57.537208|2017-02-18 13:40:57.537208
NCT00795808|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2008-11-20|||August 2003||2003-08-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|PCOSMIC||PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene|Multi-Centre Randomised Controlled Trial of the Effectiveness of Metformin and Clomiphene Citrate for Treating Anovulatory Infertility in Women With Polycystic Ovary Syndrome|Completed||Phase 4|171|Actual|University of Auckland, New Zealand||2|||f||||t||||||||||2017-02-18 13:40:57.683772|2017-02-18 13:40:57.683772
NCT00795795|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-03-30|||December 2008||2008-12-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Preimplantation Genetic Screening in Women of Advanced Maternal Age|Randomized Controlled Trial (RCT) of Preimplantation Genetic Screening (PGS) in Women of Advanced Maternal Age (AMA)|Completed||N/A|640|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 13:40:57.795886|2017-02-18 13:40:57.795886
NCT00795782|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2016-04-13|||January 2009||2009-01-01|July 2011|2011-07-01|June 2014|Actual|2014-06-01|June 2012|Actual|2012-06-01||Interventional|||Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma|Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma: A Prospective Randomized Controlled Trial|Completed||Phase 3|258|Actual|Samsung Medical Center||3|||f||||t||||||||Undecided||2017-02-18 13:40:57.887426|2017-02-18 13:40:57.887426
NCT00795769|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-08-26|||August 2008||2008-08-01|August 2010|2010-08-01||||September 2009|Actual|2009-09-01||Interventional|||Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant|Prevention of DMSO-Related Nausea and Vomiting by Prophylactic Administration of Ondansetron for Patients Receiving Autologous Cryopreserved Peripheral Blood Stem Cells|Completed||Phase 2|50|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 13:40:57.990239|2017-02-18 13:40:57.990239
NCT00795756|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-10-21|||January 2008||2008-01-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia|A Randomized Study on CNS Prophylaxis With Liposome-Encapsulated Cytarabine in Association With a Lineage-Targeted and MRD-Oriented Postremission Strategy in Adult ALL|Completed||Phase 2/Phase 3|145|Actual|Northern Italy Leukemia Group||2|||f||||t||||||||||2017-02-18 13:40:58.13685|2017-02-18 13:40:58.13685
NCT00795743|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-05-05|||February 2008||2008-02-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Coagulation Changes in Trauma Patients|The Effect of Central Venous Catheters on Systemic Coagulation|Completed||N/A|40|Actual|University of Miami|||1||f||||f||||||||||2017-02-18 13:40:58.263974|2017-02-18 13:40:58.263974
NCT00795730|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2009-07-20|||January 2009||2009-01-01|July 2009|2009-07-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789|An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of NSA-789 Administered Orally to Healthy Subjects and Subjects With Alzheimer's Disease|Terminated||Phase 1|56|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:40:58.356482|2017-02-18 13:40:58.356482
NCT00795717|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-12-02|2013-05-07||July 2008||2008-07-01|December 2014|2014-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|HALO||Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial|Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial|Completed||Phase 4|41|Actual|Tufts University|We had low numbers that may not represent the overall population. There was not an HIV negative control arm. The 4 week wash out was too short and therefore difficult to compare the post-treatment vs true post placebo effects.|2|||f||||t||||||||||2017-02-18 13:40:58.469078|2017-02-18 13:40:58.469078
NCT00795704|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2012-06-29|2012-04-16||April 2008||2008-04-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|Mul-DM||Impact of Mulberry Leaf on Type 2 Diabetes|Effect of Mulberry Leaf Extract on Glycemic Durability in Non-insulin Dependent Diabetes Mellitus: a Double-blind, Randomized, Placebo-controlled Pilot Study (Mul-DM)|Completed||Phase 2/Phase 3|24|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-02-18 13:40:58.867177|2017-02-18 13:40:58.867177
NCT00795691|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2008-11-20|||May 2004||2004-05-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Diabetes Dietary Study- Low Carbohydrate and Low-Fat Diets in Type 2 Diabetes|High and Low Carbohydrate Weight Loss Approaches to Type 2 Diabetes Mellitus AKA The Diabetes Dietary Study (DDS)|Unknown status|Active, not recruiting|N/A|105|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-02-18 13:40:59.495674|2017-02-18 13:40:59.495674
NCT00795678|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2013-07-31|||September 2008||2008-09-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Chemotherapeutic Agents in Brain/Breast|Clinical Study to Assess Entry of Chemotherapeutic Agents Into Brain Metastases in Women With Breast Cancer|Completed||N/A|10|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"~     Collection of blood before and after chemotherapy is administered and before and after~     resection of tumor in the operating room. Analysis of small portions of the brain tumor~     obtained at the time of craniotomy for drug collection.~   "|||2017-02-18 13:40:59.614349|2017-02-18 13:40:59.614349
NCT00795665|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2016-01-04|||June 2008||2008-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|UCDCC#208||Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma|Phase II Study of Bevacizumab (Avastin) and BCNU for Treatment of Relapsed, High Grade Gliomas|Completed||Phase 2|7|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 13:40:59.729515|2017-02-18 13:40:59.729515
NCT00795652|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2016-09-01|||May 2006||2006-05-01|September 2016|2016-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|MOM||Mom: Managing Our Mood, Part of The Family Help Program|Evidence-based, Distance Treatment for Postpartum Depression, Mom: Managing Our Mood, Part of The Family Help Program|Completed||Phase 2|62|Actual|IWK Health Centre||2|||f||||f||||||||No|Aggregate summary data would be made available but not individual data.|2017-02-18 13:40:59.846436|2017-02-18 13:40:59.846436
NCT00795639|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-03-04|2012-01-30||December 2008||2008-12-01|March 2015|2015-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Subjects With Pulmonary Arterial Hypertension|Terminated||Phase 3|183|Actual|Pfizer|Study terminated early.|2||"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,~   specifically new emerging evidence of hepatic injury."|f||||t||||||||||2017-02-18 13:40:59.971816|2017-02-18 13:40:59.971816
NCT00795626|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2013-02-04|||January 2007||2007-01-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|NERE-CR||Impact of Systematic Nursing Orientations in the Reduction of Predicted Cardiovascular Risk in Patients With Coronary Artery Disease.|Impact of Systematic Nursing Orientations in the Reduction of Predicted Cardiovascular Risk in Patients With Coronary Artery Disease.|Completed||N/A|74|Actual|Hospital de Clinicas de Porto Alegre||1|||f||||t||||||||||2017-02-18 13:41:00.725365|2017-02-18 13:41:00.725365
NCT00795613|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-10-16|||June 2008||2008-06-01|October 2015|2015-10-01|October 2015|Anticipated|2015-10-01|November 2014|Actual|2014-11-01||Interventional|HD0607||Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)|Multicenter Clinical Study With Early Treatment Intensification In Patients With High- Risk Hodgkin Lymphoma, Identified As FDG-PET Scan Positive After 2 Conventional ABVD Courses|Active, not recruiting||Phase 2|450|Anticipated|Ospedale Santa Croce-Carle Cuneo||2|||f||||t||||||||||2017-02-18 13:41:00.838229|2017-02-18 13:41:00.838229
NCT00795600|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2016-02-18|2011-08-09||April 2009||2009-04-01|February 2016|2016-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment|A Multi-centre, Open-labelled, Randomised, Two-group Parallel Trial Comparing the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After 26 Weeks of Treatment With Insulin Detemir Once Daily Versus Insulin NPH Once Daily, Both With Insulin Aspart at Mealtimes|Completed||Phase 4|60|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 13:41:01.007474|2017-02-18 13:41:01.007474
NCT00795587|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-11-07|||October 2008||2008-10-01|November 2012|2012-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring|Compared Effects of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension|Terminated||Phase 4|3|Actual|University Hospital, Grenoble||2||evolution of patient's care allows no more recruitment|f||||t||||||||||2017-02-18 13:41:03.123693|2017-02-18 13:41:03.123693
NCT00795574|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2008-11-21|||June 2005||2005-06-01|November 2008|2008-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|HS2006||Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa|Phase 2 Study to Assess the Safety and Efficacy of Infliximab for the Treatment of Hidradenitis Suppurativa|Completed||Phase 2|38|Actual|Florida Academic Dermatology Centers||2|||f||||t||||||||||2017-02-18 13:41:03.22915|2017-02-18 13:41:03.22915
NCT00795561|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2014-01-13|||April 2009||2009-04-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|DIM||Management of Nausea and Vomiting of Pregnancy|Randomized Controlled Trial of Day Care Versus Inpatient Management of Nausea and Vomiting of Pregnancy|Completed||N/A|98|Actual|University College Cork||2|||f||||t||||||||||2017-02-18 13:41:03.322297|2017-02-18 13:41:03.322297
NCT00795548|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-01-20|||November 2008||2008-11-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|October 2010|Actual|2010-10-01||Interventional|||Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation|Phase-II Trial to Assess the Efficacy and Toxicity of 5-Azacitidine in Addition to Standard DLI for the Treatment of Patients With AML or MDS Relapsing After Allogeneic Stem Cell Transplantation|Completed||Phase 2|30|Actual|Heinrich-Heine University, Duesseldorf||1|||f||||f||||||||||2017-02-18 13:41:03.450238|2017-02-18 13:41:03.450238
NCT00795535|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-02-04|2014-12-12||May 2007||2007-05-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|HRV|75 patients with complete HRV and trauma registry data|Heart Rate Variability in Trauma Patients|Heart Rate Variability in Trauma Patients|Completed||N/A|95|Actual|University of Miami|||1||f||||f||||||||||2017-02-18 13:41:03.584113|2017-02-18 13:41:03.584113
NCT00795522|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-04-20|||July 2003||2003-07-01|April 2015|2015-04-01|March 2005|Actual|2005-03-01|February 2005|Actual|2005-02-01||Interventional|||An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)|An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria|Completed||Phase 4|51|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:41:03.829867|2017-02-18 13:41:03.829867
NCT00795509|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2012-06-05|2012-03-07||August 2007||2007-08-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).|Special Investigation For Long Term Use Of Detrusitol (Regulatory Post Marketing Commitment Plan).|Completed||N/A|374|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:41:03.918359|2017-02-18 13:41:03.918359
NCT00795496|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-04-19|||November 2008||2008-11-01|November 2008|2008-11-01|August 2010|Actual|2010-08-01|April 2010|Actual|2010-04-01||Observational|||Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up|Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up|Completed||N/A|50|Actual|Helsinki University|||1||f||||f||||||Samples Without DNA|"~     Serum is collected for measurement of IgE~   "|||2017-02-18 13:41:04.228411|2017-02-18 13:41:04.228411
NCT00795483|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2012-08-08|||November 2009||2009-11-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort|Efficacy and Security of Annual and Biennial Zoledronic Acid for Osteoporosis Treatment in an HIV-infected Patients' Cohort|Completed||Phase 4|33|Actual|Germans Trias i Pujol Hospital||3|||f||||f||||||||||2017-02-18 13:41:04.348404|2017-02-18 13:41:04.348404
NCT00795470|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-12-01|||January 2012||2012-01-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CAUTION||Factorial Trial of Antimicrobial Therapy and/or Catheter Change for Catheter Urinary Tract Infections.|A Pilot Concealed Randomized Double-blinded Placebo-controlled Factorial Trial of Antimicrobial Therapy and/or Catheter Change for Catheter-associated Urinary Tract Infections in the Critically Ill|Withdrawn||Phase 3|0|Actual|St. Michael's Hospital, Toronto||4||Not pursuing the study due to funding issues|f||||t||||||||||2017-02-18 13:41:04.470115|2017-02-18 13:41:04.470115
NCT00795457|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-12-13|||January 2009||2009-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|February 2013|Actual|2013-02-01||Interventional|||Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas|A Bi-Institutional Pilot Study to Evaluate the Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With WHO Grade II Low-Grade Gliomas|Completed||Early Phase 1|13|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:41:04.585111|2017-02-18 13:41:04.585111
NCT00795444|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-01-23|||March 2008||2008-03-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1|Pilot Study Of The Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1 In Patients Taking Highly Active Antiretroviral Therapy|Completed||Phase 2|10|Actual|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal||1|||f||||f||||||||||2017-02-18 13:41:04.693788|2017-02-18 13:41:04.693788
NCT00795418|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2012-05-02||2012-05-02|October 2008||2008-10-01|May 2012|2012-05-01||||November 2010|Actual|2010-11-01||Interventional|||Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients|A 52-week,Multi-center,Randomized,Double-blind,Placebo-controlled,Parallel Group Study in Patients With Mild Alzheimer's Disease to Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106|Completed||Phase 2|31|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:41:04.789857|2017-02-18 13:41:04.789857
NCT00795405|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2009-08-04|||August 2008||2008-08-01|August 2009|2009-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Cardiovascular Effects of Sporting Events|Cardiovascular Effects of Major Sporting Events in Subjects With Coronary Heart Disease|Completed||Early Phase 1|38|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-02-18 13:41:04.889838|2017-02-18 13:41:04.889838
NCT00795392|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2009-09-17|||November 2008||2008-11-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|PEPO||Preoperative Psychological Evaluation as Predictor of Outcomes|Preoperative Psychological Evaluation as Predictor of Post-surgical Outcomes|Completed||N/A|200|Actual|Nanjing Medical University|||2||f||||t||||||||||2017-02-18 13:41:04.984904|2017-02-18 13:41:04.984904
NCT00795379|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2008-11-20|||November 2008||2008-11-01|November 2008|2008-11-01||||November 2009|Anticipated|2009-11-01||Interventional|||Testing the Use of Interoceptive Exposure to Reduce Barriers to Psychotherapy|Testing the Use of Interoceptive Exposure to Reduce Barriers to Psychotherapy|Unknown status|Recruiting|N/A|40|Anticipated|G.V. (Sonny) Montgomery VA Medical Center||2|||f||||f||||||||||2017-02-18 13:41:05.070275|2017-02-18 13:41:05.070275
NCT00795366|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2014-12-11|2014-12-01||September 2008||2008-09-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|AVP||Vasopressin Versus Catecholamines for Cerebral Perfusion Pressure Control in Brain Injured Trauma Patients|Vasopressin Versus Catecholamines for Cerebral Perfusion Pressure Control in Brain Injured Trauma Patients|Completed||N/A|96|Actual|University of Miami||2|||f||||f||||||||||2017-02-18 13:41:05.15413|2017-02-18 13:41:05.15413
NCT00795353|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2013-02-27|||July 2008||2008-07-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|AWARE-2||Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Amevive Wisdom Acquired Through Real-world Evidence - 2 (A.W.A.R.E.-2) Program: Long-Term Study|Terminated||N/A|64|Actual|Astellas Pharma Inc|||1|"The study was terminated early due to insufficient subject enrolment in order to meet the~   primary and secondary endpoints"|f||||f||||||Samples With DNA|"~     10mL blood sample - Biomarker Substudy only~   "|||2017-02-18 13:41:05.690582|2017-02-18 13:41:05.690582
NCT00795340|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-11-18|2015-04-28||November 2008||2008-11-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|June 2011|Actual|2011-06-01||Interventional||Intention to treat population|Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Double Blind Randomized Trial of Cediranib Versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|306|Actual|Canadian Cancer Trials Group|Early termination at phase II part of the trial, leading to small numbers of subjects analyzed, and limited follow up time.|2|||f||||t||||||||||2017-02-18 13:41:05.830239|2017-02-18 13:41:05.830239
NCT00795327|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-10-01|||October 2008||2008-10-01|October 2010|2010-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring|The Canadian Study of the Use of Injectable Poly-L-Lactic Acid Dermal Implant for the Treatment of Hill and Valley Acne Scarring|Completed||Phase 4|22|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:41:06.667083|2017-02-18 13:41:06.667083
NCT00795314|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2009-07-14|||November 2008||2008-11-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|PABADUC||Propofol-butorphanol Anesthesia During Uterine Curettage|Propofol-butorphanol Combined Anesthesia During Uterine Curettage on Abortion|Completed||Phase 4|150|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 13:41:06.797105|2017-02-18 13:41:06.797105
NCT00795301|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2014-01-13|||July 2008||2008-07-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Interventional|||A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab|A Randomized, Phase II Study of Concurrent Radiotherapy and Oxaliplatin, Capecitabine With or Without Cetuximab in Rectal Cancer Tumor Stratified by KRAS Mutation Status.|Unknown status|Active, not recruiting|Phase 2|74||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 13:41:06.907501|2017-02-18 13:41:06.907501
NCT00795288|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2016-02-23|2014-12-08||August 2008||2008-08-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|||Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)|Effect of Statins on Cerebral Blood Flow After Subarachnoid Hemorrhage|Completed||Phase 1/Phase 2|42|Actual|Washington University School of Medicine||2|||f||||f||||||||No||2017-02-18 13:41:07.021906|2017-02-18 13:41:07.021906
NCT00795262|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-05-04|||July 2008||2008-07-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|QUALITY||Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension|A 22-week Randomized, Cross-over Study Comparing the Effects of Quinapril and Quinapril Plus Alpha-lipoic Acid (ALA) on Patients With Diabetes Mellitus and Hypertension|Completed||N/A|23|Actual|InVasc Therapeutics, Inc.||2|||f||||t||||||||||2017-02-18 13:41:07.673135|2017-02-18 13:41:07.673135
NCT00795249|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-06-22|||November 2008||2008-11-01|May 2010|2010-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle|Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle|Completed||Early Phase 1|100|Actual|Kurume University||2|||f||||t||||||||||2017-02-18 13:41:07.795408|2017-02-18 13:41:07.795408
NCT00795236|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2011-07-15|||November 2009||2009-11-01|July 2011|2011-07-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Melatonin Studies of Totally Blind Children|Melatonin Studies in Young Blind Children and Adolescents|Unknown status|Recruiting|N/A|90|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 13:41:07.887003|2017-02-18 13:41:07.887003
NCT00795223|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2009-09-28|||October 2008||2008-10-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA|Comparative Effect of 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for Femoral Nerve Block After Total Knee Replacement|Completed||Phase 4|160|Actual|Mahidol University||4|||f||||f||||||||||2017-02-18 13:41:07.993488|2017-02-18 13:41:07.993488
NCT00795210|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2013-12-06|2013-10-09||February 2009||2009-02-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effects of Short-term Growth Hormone in HIV-infected Patients|Effects of Short-term Growth Hormone in HIV-infected Patients|Completed||N/A|25|Actual|Massachusetts General Hospital|The study was completed early due to the lack of availability of study drug for one of the arms.|3|||f||||f||||||||||2017-02-18 13:41:08.101217|2017-02-18 13:41:08.101217
NCT00795197|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-05-07|||December 2008||2008-12-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||A Screening Study Evaluating Disease Status of Gaucher Type I Patients|A Screening Protocol to Characterize the Disease Status of Gaucher Type 1 Patients for Potential Inclusion in a Subsequent Phase 3 Clinical Study|Withdrawn||N/A|0|Actual|Sanofi|||1|No recruitment of patients|f||||f||||||Samples Without DNA|"~     Blood sample/Urine sample~   "|||2017-02-18 13:41:08.613324|2017-02-18 13:41:08.613324
NCT00795184|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2016-05-02|2012-06-04||November 2008||2008-11-01|May 2016|2016-05-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional|DONTBIOPCE||Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy|Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy|Completed||N/A|122|Actual|Mauna Kea Technologies||2|||f||||f||||||||No||2017-02-18 13:41:08.709676|2017-02-18 13:41:08.709676
NCT00795171|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-08-17|||November 2008||2008-11-01|August 2010|2010-08-01|July 2011|Anticipated|2011-07-01|April 2011|Anticipated|2011-04-01||Interventional|||Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer|Randomized, Controlled Biomarker Study Evaluating the Anti-angiogenic Activity of Sunitinib in Hormone Refractory Prostate Cancer Patients Treated by Docetaxel|Unknown status|Recruiting|Phase 2|60|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:41:09.015498|2017-02-18 13:41:09.015498
NCT00795158|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-05-04|||November 2002||2002-11-01|May 2015|2015-05-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988)|An Open-Label Study of the Effects of Desloratadine Treatment on the Quality of Life of Patients With Chronic Urticaria|Completed||Phase 3|282|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:41:09.12777|2017-02-18 13:41:09.12777
NCT00795145|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-05-17|2010-03-02||December 2008||2008-12-01|May 2010|2010-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study To Assess The Effect Of Linezolid On QTc Interval|Single Dose Safety, Tolerability And Pharmacokinetics Of Escalating Intravenous Doses Of Linezolid Followed By Evaluation Of The Effect Of Single Intravenous Doses Of Linezolid On QTc Interval In Healthy Subjects|Completed||Phase 1|49|Actual|Pfizer||7|||f||||f||||||||||2017-02-18 13:41:09.231404|2017-02-18 13:41:09.231404
NCT00795132|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2013-07-23|2012-01-30||April 2004||2004-04-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies|Reduced Intensity Conditioning Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies at High Risk for Transplant Related Mortality With Standard Transplantation|Completed||Phase 2|47|Actual|University of Utah|Participants who experienced early relapse or death before engraftment were excluded from analysis.|3|||f||||t||||||||||2017-02-18 13:41:10.38481|2017-02-18 13:41:10.38481
NCT00795119|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2009-04-02|||September 2007||2007-09-01|November 2008|2008-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|NIRS||A Trial to Determine the Efficacy of Near Infrared Spectroscopy to Detect Intracranial Hemorrhage in Children|A Clinical Assessment of the Reliability of Near Infrared Spectroscopy for the Detection of Intracranial Hemorrhage in Young Children|Completed||N/A|73|Actual|IWK Health Centre||1|||f||||f||||||||||2017-02-18 13:41:10.705368|2017-02-18 13:41:10.705368
NCT00795106|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2016-12-05|||November 2009||2009-11-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain|Double-blinded, Cross-over Randomized Controlled Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain|Withdrawn||Phase 2|0|Actual|Stamford Hospital||2||Difficulty finding a monitor|f||||t||||||||||2017-02-18 13:41:10.798071|2017-02-18 13:41:10.798071
NCT00795093|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-05-10|||November 2008||2008-11-01|May 2010|2010-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|REMAIN||Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US|Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient|Completed||N/A|552|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:41:10.906295|2017-02-18 13:41:10.906295
NCT00795080|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2017-02-08|||July 2012||2012-07-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Dynamic MRI and Quantitative MR CSF Flow Studies in Craniovertebral Junction Anomalies|Dynamic Magnetic Resonance Imaging (MRI) and Quantitative MR Cerebral Spinal Fluid (CSF) Flow Studies in Craniovertebral Junction Anomalies|Active, not recruiting||N/A|43|Actual|University of Michigan|||3||f||||f||||||||No||2017-02-18 13:41:11.042375|2017-02-18 13:41:11.042375
NCT00795067|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-03-30|||November 2008||2008-11-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2010|Actual|2010-11-01||Observational|||Relation of Circulating Endothelium-derived Microparticle to Carotid Atherosclerosis|Relation of Circulating Endothelium-derived Microparticle to Carotid Atherosclerosis|Completed||N/A|154|Actual|Kurume University|||1||f||||t||||||Samples Without DNA|"~     platelet-poor plasma whole blood urine~   "|||2017-02-18 13:41:11.139312|2017-02-18 13:41:11.139312
NCT00795054|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-10-05|||March 2009||2009-03-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|September 2012|Actual|2012-09-01||Observational|||The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family|The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family: A Pilot Study|Completed||N/A|30|Actual|Center for International Blood and Marrow Transplant Research|||1||f||||f||||||||||2017-02-18 13:41:11.235254|2017-02-18 13:41:11.235254
NCT00795041|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2010-10-15|||November 2008||2008-11-01|November 2008|2008-11-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Observational|||Temporally Splitting Ovarian Stimulation and Embryo Transfer|Temporally Splitting Ovarian Stimulation and Embryo Transfer|Completed||N/A|10|Actual|University of Luebeck|||1||f||||f||||||||||2017-02-18 13:41:11.345438|2017-02-18 13:41:11.345438
NCT00795028|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2013-03-26||||||March 2013|2013-03-01||||March 2013|Actual|2013-03-01||Interventional|||Preventing Falls and Disability in Older Adults After Hip Fracture|Preventing Falls and Disability in Older Adults After Hip Fracture|Withdrawn||N/A|0|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:41:11.429507|2017-02-18 13:41:11.429507
NCT00795015|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2011-03-15|||April 2006||2006-04-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin|Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With an Intravenous Insulin Infusion|Completed||Phase 4|93|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 13:41:11.532205|2017-02-18 13:41:11.532205
NCT00795002|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-06-03|2013-01-08||November 2008||2008-11-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|November 2010|Actual|2010-11-01||Interventional|||Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|Randomized Phase II Study Comparing Two Administration Schedules of Flavopiridol (Alvocidib, NSC 649890, IND 46, 211) Given in Timed Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone Hydrochloride for Adults With Newly Diagnosed, Previously Untreated, Poor Risk Acute Myelogenous Leukemias (AML)|Completed||Phase 2|78|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:41:11.645312|2017-02-18 13:41:11.645312
NCT00794989|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2016-06-01|||April 2008||2008-04-01|June 2016|2016-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer|A Study Evaluating the Effect of Flaxseed on Biomarkers of Breast Cancer Risk|Terminated||N/A|20|Actual|Roswell Park Cancer Institute||2||low accrual|f||||t||||||||||2017-02-18 13:41:12.045795|2017-02-18 13:41:12.045795
NCT00794976|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2015-05-11|||October 2008||2008-10-01|May 2015|2015-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of a Dexamethasone Iontophoretic Transdermal Patch for the Treatment of Pain Associated With Lateral Epicondylitis|Completed||Phase 2|216|Actual|Travanti Pharma Inc.||4|||f||||f||||||||||2017-02-18 13:41:12.152565|2017-02-18 13:41:12.152565
NCT00794963|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-04-14|2011-07-19||November 2008||2008-11-01|November 2011|2011-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|ATOMICS||Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia|Aggressive Treatment of Metabolic Syndrome in Patients Treated With Clozapine for Schizophrenia|Terminated||N/A|8|Actual|Northwell Health||2||Difficulty recruiting|f||||f||||||||||2017-02-18 13:41:12.270353|2017-02-18 13:41:12.270353
NCT00794950|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-20|2016-10-07|||January 2009||2009-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|Sutent||Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma|A Phase II Study of Intravesical Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma|Active, not recruiting||Phase 2|36|Anticipated|University of Michigan||1|||f||||t||||||||||2017-02-18 13:41:12.626492|2017-02-18 13:41:12.626492
NCT00794924|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-11-19|2008-10-28||February 2004||2004-02-01|November 2008|2008-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|PROAGE||Probiotics and Hospital Outcome in the Elderly|Effects of Commercially Available Probiotics on Hospital Outcome|Completed||N/A|345|Actual|Kaplan-Harzfeld Medical Center||2|||f||||t||||||||||2017-02-18 13:41:12.738112|2017-02-18 13:41:12.738112
NCT00794911|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2011-03-09|||September 2007||2007-09-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation|Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation|Completed||N/A|75|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||t||||||||||2017-02-18 13:41:13.05904|2017-02-18 13:41:13.05904
NCT00794898|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-05-26|||July 2003||2003-07-01|May 2015|2015-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)|Onset of Efficacy of Anti-TNF Chimeric Monoclonal Antibody (Remicade) in the Treatment of Patients With Active Rheumatoid Arthritis Despite Methotrexate Treatment|Completed||Phase 4|19|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:41:13.165464|2017-02-18 13:41:13.165464
NCT00794885|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-08-11|||May 2008||2008-05-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|August 2013|Actual|2013-08-01||Interventional|CSPPT||China Stroke Primary Prevention Trial|Enalapril Maleate and Folic Acid Tablets for Primary Prevention of Stroke in Patients With Hypertension: a Post-marketing, Double-blind, Randomized Controlled Trial.|Completed||Phase 4|20702|Actual|Shenzhen Ausa Pharmed Co.,Ltd||2|||f||||t||||||||||2017-02-18 13:41:13.254683|2017-02-18 13:41:13.254683
NCT00794872|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2008-11-19|||January 2007||2007-01-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Chemoreflex Sensitivity in Chronic Kidney Disease|Hyperoxic Chemoreflex Sensitivity in Chronic Kidney Disease|Completed||N/A|65|Actual|RWTH Aachen University|||3||f||||t||||||Samples Without DNA|"~     Measurement of the venous partial pressure of oxygen in blood samples~   "|||2017-02-18 13:41:13.367092|2017-02-18 13:41:13.367092
NCT00794859|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2009-08-03|||October 2008||2008-10-01|August 2009|2009-08-01||||December 2009|Anticipated|2009-12-01||Interventional|SMS||Sorafenib in Previously Treated Malignant Mesothelioma|Trial of Sorafenib in Malignant Mesothelioma Previously Treated With Platinum-based Chemotherapy|Unknown status|Active, not recruiting|Phase 2|54|Anticipated|King's College London||1|||f||||f||||||||||2017-02-18 13:41:13.469417|2017-02-18 13:41:13.469417
NCT00794846|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-04-01|||December 2002||2002-12-01|April 2015|2015-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)|Preference Evaluation of Clarinex Tablets vs. Zyrtec Tablets in Subjects With Symptomatic Allergic Rhinitis|Completed||Phase 4|124|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:41:13.560979|2017-02-18 13:41:13.560979
NCT00794820|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-07-13|2016-07-13||December 2003||2003-12-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Of the 66 participants registered, one participant failed screening and therefore was not evaluable for toxicity or response.|Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline|Fludarabine, Cyclophosphamide, and Multiple Dose Rituximab as Frontline Therapy in Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|66|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:41:13.660276|2017-02-18 13:41:13.660276
NCT00794807|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2008-11-19|||February 2004||2004-02-01|November 2008|2008-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Safety and Tolerability of Repeat Courses of IM Alefacept|A 12-Week Open-Label Followed by 4-Week Double-Blind Study to Determine the Safety and Efficacy of an Extended Course of Alefacept (LFA-3/IgG1 Fusion Protein) in Subjects With Chronic Plaque Psoriasis|Completed||Phase 4|20|Actual|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-02-18 13:41:13.921363|2017-02-18 13:41:13.921363
NCT00794794|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-09-21|||November 2004||2004-11-01|September 2015|2015-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)|A Single-Center, Pediatric, Comparative Taste Test of Desloratadine and Cetirizine Antihistamine Syrup Medications|Completed||Phase 3|204|Actual|Merck Sharp & Dohme Corp.||1|||t||||f||||||||||2017-02-18 13:41:14.028788|2017-02-18 13:41:14.028788
NCT00794781|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-09-03|||June 2008||2008-06-01|September 2014|2014-09-01|February 2015|Anticipated|2015-02-01|December 2014|Anticipated|2014-12-01||Interventional|||A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid Tumors|A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|55|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 13:41:14.118099|2017-02-18 13:41:14.118099
NCT00794768|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-06-19|||November 2002||2002-11-01|June 2015|2015-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)|Preference Evaluation of Clarinex Tablets vs. Allegra Tablets in Subjects With Symptomatic Seasonal Allergic Rhinitis|Completed||Phase 4|118|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:41:14.224472|2017-02-18 13:41:14.224472
NCT00794755|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2011-07-26|||November 2008||2008-11-01|July 2011|2011-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|LOCK||Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin Therapy|A Phase III Pilot RCT (Randomized, Controlled Trial) to Assess the Effectiveness of Low Dose Vitamin K1 (200 Micrograms Per Day) on Improving Anticoagulation Control in Unstable Patients on Warfarin|Completed||Phase 3|100|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 13:41:14.327346|2017-02-18 13:41:14.327346
NCT00794742|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-04-09|||November 2008||2008-11-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Antimicrobial Resistance of Bacteria in Burn Patients|Analyzing the Antimicrobial Resistance Profile of Bacterial Isolates Obtained From Severely Burned Patients|Completed||N/A|32|Actual|Texas Tech University Health Sciences Center|||1||f||||f||||||Samples Without DNA|"~     Bacterial isolates of infected burn wounds~   "|||2017-02-18 13:41:14.438197|2017-02-18 13:41:14.438197
NCT00794729|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2017-01-24|||October 16, 2008||2008-10-16|September 14, 2011|2011-09-14|September 14, 2011||2011-09-14|||||Observational|||Evaluating the Quality of Different Methods of Obtaining Informed Consent|"Sub-Study Evaluating the Quality of Different Methods of Obtaining Informed Consent"|Completed||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:41:14.536328|2017-02-18 13:41:14.536328
NCT00794716|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-06-09|||June 2008||2008-06-01|August 2010|2010-08-01|November 2011|Actual|2011-11-01|March 2010|Actual|2010-03-01||Interventional|||Pharmacokinetics of NRL972 in Patients With Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)|Prospective Single-centre, Open-label Study to Assess the Pharmacokinetics of Cholyl-lysl-fluorescein (NRL972) in Patients With Clinical Evidence for Non-alcoholic Fatty Liver Disease (NAFLD): Supporting the Disease Staging Into Fatty Liver Disease Versus Non-alcoholic Steatohepatitis (NASH)|Completed||Phase 2|125|Actual|Norgine||1|||f||||f||||||||||2017-02-18 13:41:14.81513|2017-02-18 13:41:14.81513
NCT00794703|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2016-03-25|||November 2008||2008-11-01|March 2016|2016-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections|A Multi-center, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of Mycamine® vs Itraconazole Oral Solution for Prophylaxis of Fungal Infections in Patients Undergoing a Hematopoietic Stem Cell Transplant|Completed||Phase 3|288|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-02-18 13:41:14.905982|2017-02-18 13:41:14.905982
NCT00794690|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2009-07-31|||January 2008||2008-01-01|July 2009|2009-07-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|CR-LIVER||Safety Study of Black Cohosh Use by Postmenopausal Women on the Liver|Influence of Black Cohosh (Cimicifuga Racemosa) Use by Postmenopausal Women on Total Hepatic Perfusion and Liver Functions|Completed||N/A|100|Anticipated|Assiut University||1|||f||||f||||||||||2017-02-18 13:41:15.036488|2017-02-18 13:41:15.036488
NCT00794677|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2009-07-31|2009-01-30||June 2006||2006-06-01|July 2009|2009-07-01|September 2008|Actual|2008-09-01|February 2008|Actual|2008-02-01||Interventional|||Effects of Ezetimibe on the Absorption of Oxidized Cholesterol|A Randomized, Double-Blind, Placebo-Controlled, 2-Period, Crossover Study to Evaluate the Effects of Ezetimibe on the Plasma Appearance of 7-Ketocholesterol After an Oral Bolus in Patients With Primary Hypercholesterolemia|Completed||Phase 4|26|Actual|Children's Hospital & Research Center Oakland||2|||f||||f||||||||||2017-02-18 13:41:15.148889|2017-02-18 13:41:15.148889
NCT00794664|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2016-08-01|2013-02-15||January 2009||2009-01-01|August 2016|2016-08-01|October 2010|Actual|2010-10-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis|A Prospective Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis|Completed||Phase 3|58|Actual|Kastle Therapeutics, LLC||2|||f||||t||||||||||2017-02-18 13:41:15.713643|2017-02-18 13:41:15.713643
NCT00794651|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2008-11-19|||January 2009||2009-01-01|November 2008|2008-11-01|June 2009|Anticipated|2009-06-01|May 2009|Anticipated|2009-05-01||Observational|||Osteoarthritis Bedside Testing Kit|Development of a Bedside Pain Assessment Kit for Evaluating Effectiveness of Drugs for Osteoarthritis|Unknown status|Not yet recruiting|N/A|25|Anticipated|Analgesic Solutions|||1||f||||f||||||||||2017-02-18 13:41:17.052962|2017-02-18 13:41:17.052962
NCT00794638|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2010-05-27|||November 2008||2008-11-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||A Phase I Clinical Trial to Assess the Safety of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma|A Multicenter Phase I Clinical Trial to Assess the Safety of Two Consecutive Days of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma|Completed||Phase 1|12|Anticipated|SymBio Pharmaceuticals||1|||f||||t||||||||||2017-02-18 13:41:17.13799|2017-02-18 13:41:17.13799
NCT00794625|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2012-07-13|||November 2008||2008-11-01|July 2012|2012-07-01|April 2013|Anticipated|2013-04-01|November 2012|Anticipated|2012-11-01||Interventional|||Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)|Adjunctive Treatment With Divalproex or Risperidone for Aggression Refractory to Stimulant Monotherapy Among Children With ADHD|Unknown status|Recruiting|Phase 4|270|Anticipated|National Institute of Mental Health (NIMH)||3|||f||||t||||||||||2017-02-18 13:41:17.233672|2017-02-18 13:41:17.233672
NCT00794612|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-12-18|||November 2008||2008-11-01|December 2008|2008-12-01||||November 2008|Actual|2008-11-01||Interventional|||Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.|Safety Dermatological Evaluation: Genital Mucous Irritation - Test in Use - Dermacyd Femina Pocket BR (Lactic Acid).|Completed||Phase 3|30|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:41:17.353056|2017-02-18 13:41:17.353056
NCT00794599|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-04-01|||December 2002||2002-12-01|April 2015|2015-04-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)|Preference Evaluation of Clarinex Tablets vs. Zyrtec Tablets in Subjects With Symptomatic Allergic Rhinitis|Completed||Phase 4|118|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:41:17.444913|2017-02-18 13:41:17.444913
NCT00794586|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2013-12-03||2013-12-03|November 2008||2008-11-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection|A Phase 2, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Fosfomycin/Tobramycin for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa|Completed||Phase 2|120|Anticipated|Gilead Sciences||4|||f||||t||||||||||2017-02-18 13:41:17.533746|2017-02-18 13:41:17.533746
NCT00794573|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2016-03-14|||September 2009||2009-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|EVITA||Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial|Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial|Completed||Phase 3|302|Actual|McGill University||2|||f||||t||||||||||2017-02-18 13:41:17.682064|2017-02-18 13:41:17.682064
NCT00794560|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2014-11-05|2014-06-04||June 2007||2007-06-01|November 2014|2014-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Self-management of Low Molecular Weight Heparin Therapy|Self-management of Heparin Therapy - Drug Use Problems and Compliance With Self-injected Low Molecular Weight Heparin in Ambulatory Care|Completed||Phase 4|154|Actual|University Hospital, Basel, Switzerland||4|||f||||f||||||||||2017-02-18 13:41:17.849998|2017-02-18 13:41:17.849998
NCT00794547|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-08-28|2014-03-31||December 2008||2008-12-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|October 2011|Actual|2011-10-01||Interventional||Thirty-four patients were enrolled (18 in phase I and 16 in phase II).|Phase I/II Calcitriol in Lung Cancer|A Phase I/II Clinical Trial of Intravenous (IV) Calcitriol With Fixed Dose of Cisplatin and Docetaxel in Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|34|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-02-18 13:41:18.292848|2017-02-18 13:41:18.292848
NCT00794534|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-07-26|||January 2012||2012-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:41:18.666712|2017-02-18 13:41:18.666712
NCT00794508|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2016-04-22|2016-03-09||November 2008||2008-11-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional||Pre-treatment|MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID|MND-ADA Transduction of CD34+ Cells From the Bone Marrow Of Children With Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID): Effect of Discontinuation of PEG-ADA and Marrow Cytoreduction With Busulfan|Completed||Phase 2|10|Actual|University of California, Los Angeles||1|||f||||t||||||||No||2017-02-18 13:41:18.712842|2017-02-18 13:41:18.712842
NCT00794495|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-04-01|||December 2002||2002-12-01|April 2015|2015-04-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)|Preference Evaluation of Clarinex Tablets vs. Zyrtec Tablets in Subjects With Symptomatic Allergic Rhinitis|Completed||Phase 4|122|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:41:21.370359|2017-02-18 13:41:21.370359
NCT00794300|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2008-11-19||||||November 2008|2008-11-01||||||||Observational|||Reproducibility of Magnetic Resonance Myocardial Salvage Index|Reproducibility of Myocardial Salvage Index in Acute Myocardial Infarction by Cardiac Magnetic Resonance Imaging|Completed||N/A|||University of Leipzig|||1||f||||f||||||||||2017-02-18 13:41:23.888194|2017-02-18 13:41:23.888194
NCT00794482|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2009-10-07|||March 2008||2008-03-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.|A Multi-centre, Multi-national Open Study in Patients With Hepatic Cirrhosis to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.|Completed||Phase 3|1200|Anticipated|Norgine||1|||f||||t||||||||||2017-02-18 13:41:21.461557|2017-02-18 13:41:21.461557
NCT00794469|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2013-08-01|2009-06-21||December 2008||2008-12-01|November 2008|2008-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Water Induced Thermogenesis in Obese Children|Water Induced Thermogenesis in Obese Children|Completed||N/A|21|Actual|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 13:41:21.553563|2017-02-18 13:41:21.553563
NCT00794456|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-07-07|||September 2009||2009-09-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety|Double Blind, Randomized Study, Controlled by Valeriana Officinalis, of Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Patients With Mild and Moderate Anxiety|Completed||Phase 3|150|Actual|Marjan Industria e Comercio ltda||2|||f||||t||||||||||2017-02-18 13:41:21.774784|2017-02-18 13:41:21.774784
NCT00794443|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2015-04-30|||November 2008||2008-11-01|April 2015|2015-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients|A Multi-center Double-blind Parallel-group Comparison Study in Involutional Osteoporosis Patients to Examine the Efficacy and Safety of ONO-5920/YM529 Monthly Intermittent Formulation With Its Daily Formulation.|Completed||Phase 2/Phase 3|692|Actual|Astellas Pharma Inc||3|||f||||||||||||||2017-02-18 13:41:21.884982|2017-02-18 13:41:21.884982
NCT00794430|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2016-05-04||2015-01-09|December 2008||2008-12-01|January 2015|2015-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain|A Randomised, Double-blind, Placebo-controlled, Multicentre, Parallel Group Study of the Safety, Tolerability and Efficacy of V3381 for up to 13 Weeks in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)|Completed||Phase 2|161|Actual|Vernalis (R&D) Ltd||2|||f||||t||||||||||2017-02-18 13:41:22.013366|2017-02-18 13:41:22.013366
NCT00794417|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2012-08-30||2011-04-17|November 2008||2008-11-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma|A Phase 1/2 Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma|Completed||Phase 1/Phase 2|62|Actual|Regeneron Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:41:22.346337|2017-02-18 13:41:22.346337
NCT00794404|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2016-10-28|||December 2004||2004-12-01|November 2008|2008-11-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Observational|EchoSpA||Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy|Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy in Patients With Uncertain Diagnosis Consulting for Clinical Symptoms Suggestive of Spondylarthropathy|Completed||N/A|489|Actual|Groupe Français d'Etude Génétique des Spondylarthropathies|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|No||2017-02-18 13:41:22.488696|2017-02-18 13:41:22.488696
NCT00794391|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-04-02|||November 2008||2008-11-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)|Effects of a Brief Motivational Intervention on Risky Injection Practices Among Injecting Drug Users|Completed||N/A|219|Actual|Université de Sherbrooke||2|||f||||f||||||||||2017-02-18 13:41:22.571858|2017-02-18 13:41:22.571858
NCT00794378|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-07-03|||November 2004||2004-11-01|July 2015|2015-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)|A Single-Center, Pediatric, Comparative Taste Test of Desloratadine and Cetirizine Antihistamine Syrup Medications|Completed||Phase 3|202|Actual|Merck Sharp & Dohme Corp.||1|||t||||f||||||||||2017-02-18 13:41:22.884416|2017-02-18 13:41:22.884416
NCT00794365|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2010-11-19|2010-11-19||July 2008||2008-07-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Post Marketing Surveillance Study of Champix in Smoking Cessation for Filipino Patients|Post-Marketing Surveillance Study To Observe The Safety And Effectiveness Of Varenicline (Champix) Tablets In Smoking Cessation Among Filipino Subjects|Completed||N/A|330|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:41:22.980478|2017-02-18 13:41:22.980478
NCT00794352|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2017-01-24|||November 17, 2008||2008-11-17|December 9, 2016|2016-12-09||||||||Observational|||Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System|Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the CNS|Recruiting||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:41:23.384464|2017-02-18 13:41:23.384464
NCT00794339|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2014-10-27|||July 2009||2009-07-01|October 2014|2014-10-01|March 2015|Anticipated|2015-03-01|June 2014|Actual|2014-06-01||Interventional|ACRIN 6682||Copper Cu 64-ATSM and PET/CT Scan in Predicting Disease Progression in Patients With Newly-Diagnosed Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Undergoing Chemoradiotherapy Per NCCN Guidelines|Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer|Unknown status|Active, not recruiting|Phase 2|73|Actual|American College of Radiology Imaging Network||1|||f||||t||||||||||2017-02-18 13:41:23.497673|2017-02-18 13:41:23.497673
NCT00794326|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2015-02-26|||October 2008||2008-10-01|September 2014|2014-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|PDOne||Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD|Multicentric, Parallel, Controlled, Randomized, Single-blind Clinical Evaluation of New Low Sodium Peritoneal Dialysis Solution on Patients With Hypertension Treated With Continuous Ambulatory or Automated Peritoneal Dialysis|Completed||Phase 3|140|Anticipated|Fresenius Medical Care Deutschland GmbH||2|||f||||t||||||||||2017-02-18 13:41:23.618535|2017-02-18 13:41:23.618535
NCT00794313|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2012-09-11|||September 2009||2009-09-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease|Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease|Terminated||N/A|4|Actual|Oregon Health and Science University||3||Funding Ended|f||||f||||||||||2017-02-18 13:41:23.773641|2017-02-18 13:41:23.773641
NCT00794287|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-06-03|||January 2009||2009-01-01|June 2015|2015-06-01||||December 2010|Anticipated|2010-12-01||Observational|||Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses|Performance of CAST (Cellular Antigen Stiumulation Test)in Patients With Wasp Venom Allergy. Evaluation of Neutralizing IgG Subclasses|Withdrawn||N/A|0|Actual|University of Zurich|||2||f||||t||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 13:41:23.975362|2017-02-18 13:41:23.975362
NCT00794274|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2013-04-10|||November 2008||2008-11-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis|The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis|Completed||Phase 2/Phase 3|15|Actual|University of Cincinnati||1|||f||||t||||||||||2017-02-18 13:41:24.054075|2017-02-18 13:41:24.054075
NCT00794261|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2010-07-07|||September 2008||2008-09-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|PALM||Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma|Assessment of the Efficacy and Tolerance, and Health Economic Study of a Single Administration of Pegfilgrastim in Lymphoma or Myeloma Patients Treated With Intensive Chemotherapy and Autologous Peripheral Stem Cell Transplantation|Completed||Phase 2|150|Anticipated|Centre Leon Berard||2|||f||||f||||||||||2017-02-18 13:41:24.166177|2017-02-18 13:41:24.166177
NCT00794248|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2015-04-01|||November 2002||2002-11-01|April 2015|2015-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)|Preference Evaluation of Clarinex Tablets vs. Allegra Tablets in Subjects With Symptomatic Seasonal Allergic Rhinitis|Completed||Phase 4|122|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:41:24.48756|2017-02-18 13:41:24.48756
NCT00794235|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2010-01-07|||December 2008||2008-12-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine|Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine|Completed||Phase 2|12|Anticipated|University of Zurich||1|||f||||f||||||||||2017-02-18 13:41:24.577767|2017-02-18 13:41:24.577767
NCT00794222|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-19|2008-11-19|||February 2009||2009-02-01|November 2008|2008-11-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|mobiletype||A Mobile Phone Self-Monitoring Tool to Increase Emotional Self-Awareness and Reduce Depression in Young People|A Randomised Controlled Trial Investigating a Mobile Phone Self-Monitoring Tool (Mobiletype) to Increase Emotional Self-Awareness and Reduce Depressive Symptoms in Young People.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Murdoch Childrens Research Institute||2|||f||||t||||||||||2017-02-18 13:41:24.684542|2017-02-18 13:41:24.684542
NCT00794209|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-17|||March 2003||2003-03-01|November 2008|2008-11-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|LEF-07||Study Evaluating Inhaled AeroLEF Delivered in 4 Aerosol Delivery Devices in Healthy Volunteers|Phase lb, Five Period Crossover, Open-Label Study Evaluating a Single Dose Administration of 3mL or 5mL of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl 500 Mcg/mL), Delivered by up to Four Aerosol Delivery Devices in Healthy Subjects|Completed||Phase 1|9|Actual|YM BioSciences||1|||f||||f||||||||||2017-02-18 13:41:24.782629|2017-02-18 13:41:24.782629
NCT00794196|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-10-01|2016-04-13||October 2008||2008-10-01|October 2016|2016-10-01|November 2012|Actual|2012-11-01|November 2011|Actual|2011-11-01||Interventional|PRODEFAR||Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care|Impact of the Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care on the Compliance to Antidepressants and Patient Wellbeing|Completed||N/A|179|Actual|Fundació Sant Joan de Déu||2|||f||||f||||||||||2017-02-18 13:41:24.890081|2017-02-18 13:41:24.890081
NCT00794183|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2012-06-22|||June 2004||2004-06-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Interventional|BRAVO-CRT||A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval|A Pilot Study of theRelationship Between Atrio-Ventricular Delay and Changes in Biochemical Markers of Chronic Heart Failure During Cardiac Resynchronization Therapy (BRAVO-CRT)|Terminated||Early Phase 1|25|Actual|University of Minnesota - Clinical and Translational Science Institute||3||funding difficulty|f||||f||||||||||2017-02-18 13:41:25.281963|2017-02-18 13:41:25.281963
NCT00794170|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2014-05-09|2012-08-15||August 2008||2008-08-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|I-SIGHT||Interactive Study to Increase Glaucoma Adherence to Treatment|I-SIGHT: Interactive Study to Increase Glaucoma adHerence to Treatment Phase 2: Participant Recruitment & Intervention Delivery and Evaluation|Completed||N/A|312|Actual|Emory University|There may have been a selection bias that contributed to a placebo effect in the control group. The “control” patients may have already been motivated to seek knowledge or involvement in management of glaucoma.|2|||f||||f||||||||||2017-02-18 13:41:25.394841|2017-02-18 13:41:25.394841
NCT00794157|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2011-07-22|2011-07-22||November 2008||2008-11-01|July 2011|2011-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A 12-week Treatment, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol (150 and 300 µg Once Daily [od]) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|347|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:41:25.744968|2017-02-18 13:41:25.744968
NCT00794144|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2010-02-23|2010-01-12||October 2008||2008-10-01|February 2010|2010-02-01||||December 2008|Actual|2008-12-01||Interventional|||Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age||Completed||Phase 2|132|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:41:26.30591|2017-02-18 13:41:26.30591
NCT00794131|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2015-12-11|||November 2008||2008-11-01|March 2015|2015-03-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors|Phase I Study of the Safety, Tolerability,and Tumor-Specific Replication of the Intravenous Administration of Green Fluorescent Protein Encoded Genetically Engineered Attenuated Vaccinia Virus, GL-ONC1, in Patients With Advanced Solid Organ Cancers.|Completed||Phase 1|43|Actual|Genelux Corporation||1|||f||||t||||||||||2017-02-18 13:41:26.619129|2017-02-18 13:41:26.619129
NCT00793754|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2011-10-25|||March 2009||2009-03-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|RATIONAL||Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People|Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People|Completed||Phase 4|30|Actual|Fundacion GESICA||4|||f||||t||||||||||2017-02-18 13:41:37.118289|2017-02-18 13:41:37.118289
NCT00794118|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-04-12|2012-04-12||June 2008||2008-06-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|DOSE||Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)|Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study|Completed||N/A|299|Actual|Pfizer|Protocol did not indicate primary or secondary endpoints and all determination of primary or secondary endpoints were arbitrary.||1||f||||t||||||||||2017-02-18 13:41:26.722133|2017-02-18 13:41:26.722133
NCT00794105|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2008-11-18|||November 2008||2008-11-01|November 2008|2008-11-01||||||||Observational|||Observation of Gas Exchange in the Middle Ear||Unknown status|Not yet recruiting|N/A|||Shaare Zedek Medical Center|||2||f||||f||||||||||2017-02-18 13:41:27.882169|2017-02-18 13:41:27.882169
NCT00794092|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2010-04-07|||November 2008||2008-11-01|April 2010|2010-04-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Magnetic Resonance Imaging of Aortic Aneurysm Instability|Magnetic Resonance Imaging of Aortic Aneurysm Instability|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|University of Edinburgh||1|||f||||f||||||||||2017-02-18 13:41:27.965371|2017-02-18 13:41:27.965371
NCT00794079|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2011-08-02|||June 2007||2007-06-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Omega-3 Fatty Acids and Muscle Protein Synthesis|Omega-3 Fatty Acids and Muscle Protein Synthesis|Completed||N/A|43|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 13:41:28.058107|2017-02-18 13:41:28.058107
NCT00794066|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-11-03|||August 2008||2008-08-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|PARIS||Peripheral Arteriopathy Rate In Stroke|Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients|Active, not recruiting||N/A|1500|Anticipated|University of Erlangen-Nürnberg Medical School|||3||f||||f||||||||||2017-02-18 13:41:28.165861|2017-02-18 13:41:28.165861
NCT00794053|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2009-07-14|||December 2002||2002-12-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer|The Role of Sentinel Lymph Node Biopsy (SLNB) In the Management of Differentiated Thyroid Cancer|Completed||Phase 3|45|Actual|Faculty of Medicine, University of Alexandria||1|||f||||t||||||||||2017-02-18 13:41:28.267283|2017-02-18 13:41:28.267283
NCT00794040|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2017-01-31|||November 17, 2008||2008-11-17|November 22, 2016|2016-11-22|October 20, 2020|Anticipated|2020-10-20|October 9, 2017|Anticipated|2017-10-09||Interventional|||A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation|A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation|Recruiting||Phase 2|160|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:41:28.370461|2017-02-18 13:41:28.370461
NCT00794027|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2013-07-31|||November 2008||2008-11-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|YOGA||The Effects of a Yoga Program in Heart Failure Patients|The Clinical Outcomes Associated With a Modified Yoga Program in Heart Failure|Completed||N/A|20|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 13:41:28.484946|2017-02-18 13:41:28.484946
NCT00794014|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-02-12|||November 2007||2007-11-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion|Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion|Completed||N/A|258|Actual|Samsung Medical Center||2|||f||||||||||||||2017-02-18 13:41:28.588687|2017-02-18 13:41:28.588687
NCT00794001|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-12-09|||October 2007||2007-10-01|December 2016|2016-12-01|December 2021|Anticipated|2021-12-01|December 2020|Anticipated|2020-12-01||Interventional|FITT-STEMI||Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction|Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction (FITT-STEMI): A Multicenter Trial Analyzing the Effects of Systematic Data Feedback on Treatment Quality and Survival Rates.|Recruiting||N/A|50000|Anticipated|St.Bernward Hospital||1|||f||||f||||||||Undecided||2017-02-18 13:41:28.688145|2017-02-18 13:41:28.688145
NCT00793988|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2009-04-02|||October 2008||2008-10-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Vibration-Assisted Anaesthesia|Vibration-Assisted Anaesthesia: A Randomised Controlled Trial to Investigate Whether Vibration Reduces the Pain of Anaesthetic Injection in Eyelid Surgery|Completed||Phase 4|80|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:41:28.81158|2017-02-18 13:41:28.81158
NCT00793975|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-08-16|||January 2005||2005-01-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy|Phase I Study of Weekly Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Monoclonal Antibody IMC-1121B in Patients With Advanced Solid Tumors Who Have Not Responded to Standard Therapy|Completed||Phase 1|37|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 13:41:28.915716|2017-02-18 13:41:28.915716
NCT00793962|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-08-04|||June 2008||2008-06-01|August 2016|2016-08-01|May 2021|Anticipated|2021-05-01|May 2016|Actual|2016-05-01||Interventional|||A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer|A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer|Active, not recruiting||Phase 3|810|Anticipated|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-02-18 13:41:29.02734|2017-02-18 13:41:29.02734
NCT00793936|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2008-11-18|||November 2008||2008-11-01|November 2008|2008-11-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Observational|||Criteria for Choice of Right Double Lumen Tube (DLT)|Criteria for Choice of Right Double Lumen Tube for Lung Surgery|Unknown status|Not yet recruiting|N/A|40|Anticipated|Assaf-Harofeh Medical Center|||1||f||||t||||||||||2017-02-18 13:41:29.131307|2017-02-18 13:41:29.131307
NCT00793923|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-12-18|||January 2008||2008-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|Lucedex||A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD|A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet Age-related Macular Degeneration|Completed||Phase 1/Phase 2|40|Actual|Bay Area Retina Associates||2|||f||||f||||||||||2017-02-18 13:41:29.215823|2017-02-18 13:41:29.215823
NCT00792662|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2010-01-12|||January 2009||2009-01-01|January 2010|2010-01-01|January 2011|Anticipated|2011-01-01|August 2010|Anticipated|2010-08-01||Interventional|||Improving Function, Quality of Life, Glycemia in Diabetics With Dementia|Improving Function, Quality of Life, Glycemia in Diabetics With Dementia|Unknown status|Recruiting|Phase 4|50|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-02-18 13:41:57.872059|2017-02-18 13:41:57.872059
NCT00793910|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2014-07-10|2011-11-21||July 2008||2008-07-01|July 2014|2014-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Oral Gabapentin Versus Placebo for Treatment of Postoperative Pain Following Photorefractive Keratectomy|Oral Gabapentin Versus Placebo for Treatment of Postoperative Pain Following Photorefractive Keratectomy: A Randomized, Double-masked, Single Center, Placebo-controlled Clinical Trial|Completed||N/A|106|Actual|Walter Reed Army Medical Center||2|||f||||||||||||||2017-02-18 13:41:29.328254|2017-02-18 13:41:29.328254
NCT00793897|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-07-12|||April 2009||2009-04-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors|A Phase I Multiple Ascending Dose Study of BMS-754807 in Combination With Paclitaxel and Carboplatin in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|21|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 13:41:29.756628|2017-02-18 13:41:29.756628
NCT00793884|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-10-06|||October 2008||2008-10-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|ELDEP||Emory Latino Diabetes Education Program|Emory Latino Diabetes Education Program|Recruiting||N/A|800|Anticipated|Emory University|||1||f||||f||||||||||2017-02-18 13:41:29.867635|2017-02-18 13:41:29.867635
NCT00793871|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-10-16|2015-04-14||November 2008||2008-11-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|April 2014|Actual|2014-04-01||Interventional|GIST|Safety analysis set included all participants who started study treatment.|Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor|A Single-arm, Open-label, Multi-center, Phase Iv, Efficacy And Safety Study Of Sunitinib Malate In The Treatment Of Chinese Patients With Gastrointestinal Stromal Tumor After Disease Progression On Or Intolerance To Imatinib Mesylate|Completed||Phase 4|60|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:41:29.974367|2017-02-18 13:41:29.974367
NCT00793858|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-06-06|||February 2009||2009-02-01|June 2013|2013-06-01||||September 2009|Anticipated|2009-09-01||Interventional|||A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray|A Pilot Investigation of the Nasal Mucosal Absorption, Retention, and Metabolism of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray When Each Formulation Is Administered to Currently Symptomatic Patients (18 Years or Older) With Documented Perennial Allergic Rhinitis (PAR).|Withdrawn||Phase 4|0|Actual|University of Chicago||6||Cost prohibitive and company withdrew support.|f||||f||||||||||2017-02-18 13:41:30.593597|2017-02-18 13:41:30.593597
NCT00793845|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-11-19|||August 2008||2008-08-01|November 2015|2015-11-01|January 2018|Anticipated|2018-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma|Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma|Active, not recruiting||Phase 2|40|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 13:41:30.686608|2017-02-18 13:41:30.686608
NCT00793832|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-06-27|||July 2007||2007-07-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Supervised Exercise on Physical Fitness and Energy Expenditure in Post Bariatric Surgery Patients|The Effect of Supervised Cardiorespiratory Endurance Exercise Training on Physical Fitness and Energy Expenditure in Roun-en-Y Gastric Bypass and Gastric Banding Surgery Patients.|Completed||N/A|33|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 13:41:30.778525|2017-02-18 13:41:30.778525
NCT00793819|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-02-07|2012-02-07||January 2009||2009-01-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia|A Double-Blind, Placebo-Controlled Phase 2 Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia|Completed||Phase 2|215|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:41:30.88451|2017-02-18 13:41:30.88451
NCT00793806|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2017-02-08|||August 2008||2008-08-01|February 2017|2017-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease|Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease|Completed||N/A|14|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:41:31.309809|2017-02-18 13:41:31.309809
NCT00793793|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2015-08-18|2015-07-03||September 2007||2007-09-01|August 2015|2015-08-01||||January 2011|Actual|2011-01-01||Interventional||Full Analysis Set (FAS): All randomized patients who were dispensed trial medication and were documented to have taken at least 1 dose of trial medication.|Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced|Safety, Antiviral Activity, and Pharmacokinetics of Multiple Rising Oral Doses of BI 201335 NA in Treatment-naïve Patients With Chronic Hepatitis C Infection for 14 Days Monotherapy Followed by Combination With Pegylated Interferon and Ribavirin for an Additional 14 Days (Double-blind, Placebo Controlled), and in Treatment-experienced Patients With Chronic Hepatitis C Infection for 28 Days as Combination Therapy With Pegylated Interferon and Ribavirin (Open-label)|Completed||Phase 1|96|Actual|Boehringer Ingelheim|"Additional secondary endpoints were listed in the original protocol. Those endpoints are of exploratory nature only and were not considered relevant for trial conclusions. For more information see tab “Full Text Review”, section “More Information."|5|||f||||||||||||||2017-02-18 13:41:31.446945|2017-02-18 13:41:31.446945
NCT00793780|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-08-12|2016-06-28||December 2008||2008-12-01|August 2016|2016-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||Overweight women between the ages of 18 and 70 years who met the DSM-IV criteria for schizophrenia or schizoaffective disorder, on the basis of Structured Clinical Interview for DSM-IV. An additional participant dropped out of the study after baseline data was collected.|Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia|Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia|Completed||N/A|24|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:41:36.420604|2017-02-18 13:41:36.420604
NCT00793767|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2009-05-28|||January 2009||2009-01-01|May 2009|2009-05-01||||April 2009|Actual|2009-04-01||Interventional|||Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration|Insulin Resistance and Substrate Metabolism After Acute EPO Administration in Healthy Young Men|Completed||N/A|10|Anticipated|Aarhus University Hospital||2|||f||||f||||||||||2017-02-18 13:41:37.009466|2017-02-18 13:41:37.009466
NCT00793741|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-06-08|||December 2007||2007-12-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness|Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness|Active, not recruiting||N/A|15|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||t||||||||||2017-02-18 13:41:37.229693|2017-02-18 13:41:37.229693
NCT00793728|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2015-08-19|||October 2008||2008-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Prospective Randomized Trial Comparing Two Techniques of Sleeve Gastrectomy|Prospective Randomized Trial Comparing Two Techniques of Sleeve Gastrectomy|Completed||N/A|52|Actual|Hospital Universitari de Bellvitge||2|||f||||f||||||||||2017-02-18 13:41:37.341039|2017-02-18 13:41:37.341039
NCT00793715|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2010-07-22|||July 2010||2010-07-01|June 2010|2010-06-01|June 2013|Anticipated|2013-06-01|June 2012|Anticipated|2012-06-01||Interventional|DECOMPRESS||Laparotomy Versus Percutaneous Puncture in Patients With Abdominal Compartment Syndrome During Acute Pancreatitis|Decompressive Laparotomy With Temporary Abdominal Closure Versus Percutaneous Puncture With Placement of Abdominal Catheter in Patients With Abdominal Compartment Syndrome During Acute Pancreatitis:Multicenter, Randomised, Controlled Study|Unknown status|Recruiting|N/A|100|Anticipated|University of Belgrade||2|||f||||f||||||||||2017-02-18 13:41:37.437288|2017-02-18 13:41:37.437288
NCT00793702|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-01-18|||November 2008||2008-11-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration|An Open Phase I Clinical Trial on the Safety and Risk of Sensitisation by Escalating Doses and Repeated Injections of the rdESAT-6 + rCFP-10 Skin Test Reagent Following Intradermal Administration to Healthy Adults|Completed||Phase 1|42|Actual|Statens Serum Institut||5|||f||||t||||||||||2017-02-18 13:41:37.545029|2017-02-18 13:41:37.545029
NCT00793689|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2009-10-15|||March 2008||2008-03-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Observational|||Perioperative Parathormone Measurement and Sodium Bicarbonate Infusion Test After Total Thyroidectomy|Comparison of the Prognostic Value of Perioperative Parathormone Measurement and Sodium Bicarbonate Infusion Test in the Evaluation of Parathyroid Function After Total Thyroidectomy|Completed||N/A|127|Actual|Aristotle University Of Thessaloniki|||1||f||||||||||||||2017-02-18 13:41:37.652798|2017-02-18 13:41:37.652798
NCT00793676|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-09-29|||September 2008||2008-09-01|September 2015|2015-09-01|October 2016|Anticipated|2016-10-01|May 2016|Anticipated|2016-05-01||Interventional|||Asthma, Inflammation and G Protein-coupled Receptors (GPCR)|G Protein Coupled Receptor (GPCR)Signature as Biomarker of Chronic Pulmonary Inflammatory Diseases and of Therapeutic Follow-up|Recruiting||N/A|310|Anticipated|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-02-18 13:41:37.746858|2017-02-18 13:41:37.746858
NCT00793663|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2011-05-16|||November 2008||2008-11-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|XABP||Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia|1) The Effect of Xenon and Sevoflurane on Hypnosis Monitors. 2) Prevention of Postoperative Nausea and Vomiting. 3) Rescue Treatment of Established Postoperative Nausea and Vomiting. Sevoflurane.|Completed||Phase 4|220|Anticipated|RWTH Aachen University||6|||f||||f||||||||||2017-02-18 13:41:37.876667|2017-02-18 13:41:37.876667
NCT00793650|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-08-17|2012-03-14||May 2005||2005-05-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|October 2009|Actual|2009-10-01||Interventional|||Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study|Combination High Dose Melphalan and Autologous PBSC Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study|Terminated||Phase 1/Phase 2|39|Actual|Emory University||2|||f||||t||||||||||2017-02-18 13:41:38.012792|2017-02-18 13:41:38.012792
NCT00793637|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2009-08-05|||August 2008||2008-08-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|ASLS-Pre||Evaluation of Handling and Possible Complications Related to the Newly Developed Angular Stable Locking System (ASLS)|Prospective Multicenter Case Series to Evaluate Handling and Possible Complications Related to the Angular Stable Locking System in Patients With Proximal and Distal Tibial, Femoral and Humeral Fractures Treated With Intramedullary Nails|Completed||N/A|30|Anticipated|AO Clinical Investigation and Documentation|||1||f||||f||||||||||2017-02-18 13:41:38.429184|2017-02-18 13:41:38.429184
NCT00793624|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2014-06-17|2014-03-28||February 2009||2009-02-01|June 2014|2014-06-01||||December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 48 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (5 µg [2 Actuations of 2.5 ug] and 10 ug [2 Actuations of 5 ug]) Delivered by the Respimat® Inhaler, and 48 Weeks of Twice Daily Foradil® (12 µg) Delivered by the Aerolizer® Inhaler, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|906|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 13:41:38.631025|2017-02-18 13:41:38.631025
NCT00793611|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2011-09-20|2011-08-16||November 2008||2008-11-01|September 2011|2011-09-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Hypnotherapy for Treatment of Overactive Bladder|Hypnotherapy for Treatment of Overactive Bladder: A Feasibility Study|Completed||Phase 2/Phase 3|20|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 13:41:42.837936|2017-02-18 13:41:42.837936
NCT00793598|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2011-03-15|||November 2008||2008-11-01|March 2011|2011-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||CMX001 in Post-transplant Patients With BK Virus Viruria|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of the Safety, Tolerability and Population Pharmacokinetics of CMX001 in Post-Transplant Subjects With BK Virus Viruria|Completed||Phase 1/Phase 2|60|Anticipated|Chimerix||2|||f||||t||||||||||2017-02-18 13:41:43.19792|2017-02-18 13:41:43.19792
NCT00793585|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-04-25|2009-10-28||July 2007||2007-07-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Controlled Study of Uric Acid on the Progression of IgA Nephropathy|A Prospective, Randomized Controlled Study of Uric Acid on the Progression of IgA Nephropathy|Completed||N/A|40|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:41:43.309683|2017-02-18 13:41:43.309683
NCT00792649|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-11-17|||February 2008||2008-02-01|February 2008|2008-02-01||||||||Observational|||Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy||Unknown status|Enrolling by invitation|N/A|200|Anticipated|Johannes Gutenberg University Mainz|||2||f||||f||||||||||2017-02-18 13:41:57.986233|2017-02-18 13:41:57.986233
NCT00793572|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-12-08|||October 2008||2008-10-01|December 2016|2016-12-01||||October 2016|Actual|2016-10-01||Interventional|||Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma|Tandem Autologous HCT/Nonmyeloablative Allogeneic HCT From HLA-Matched Related and Unrelated Donors Followed by Bortezomib Maintenance Therapy for Patients With High-Risk Multiple Myeloma|Active, not recruiting||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 13:41:43.822033|2017-02-18 13:41:43.822033
NCT00793559|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2008-11-18|||November 2008||2008-11-01|November 2008|2008-11-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Terlipressin Administration in Septic Shock Refractory to Catecholamines|Terlipressin Administration in Septic Shock Refractory to Catecholamines Bolus vs. Continuous Drip-Phase II|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 13:41:43.957645|2017-02-18 13:41:43.957645
NCT00793546|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2012-10-04|2012-10-04||February 2009||2009-02-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer|A Phase 2, Randomized, Open-Label Study Of Bosutinib Administered In Combination With Exemestane Versus Exemestane Alone As Second Line Therapy In Postmenopausal Women With Locally Advanced Or Metastatic ER+/PgR+/ErbB2- Breast Cancer|Terminated||Phase 2|42|Actual|Pfizer|Results are not provided because the study was terminated prior to part 2 due to unfavorable risk benefit ratio of the study treatment.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:41:44.059699|2017-02-18 13:41:44.059699
NCT00793520|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2010-06-01|2010-04-15||November 2008||2008-11-01|June 2010|2010-06-01||||April 2009|Actual|2009-04-01||Interventional|||Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia||Terminated||Phase 3|2|Actual|Forest Laboratories|Early termination leading to small numbers of subjects enrolled. Technical problems with MRI equipment resulted in early study termination. No analysis was performed.|2|||f||||f||||||||||2017-02-18 13:41:44.642331|2017-02-18 13:41:44.642331
NCT00793507|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-02-04|||November 2008||2008-11-01|January 2009|2009-01-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Oral Health Care Early Intervention Project|Oral Health Care Early Intervention Project|Completed||N/A|1178|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 13:41:45.016106|2017-02-18 13:41:45.016106
NCT00793494|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-04-12|||January 2009||2009-01-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|POPSII||Efficacy of Probaclac in Irritable Bowel Syndrome in Children Aged 8 to 18 Years|Randomized Controlled Trial of Probaclac Versus Placebo in Children Aged 8 to 18 Years With Irritable Bowel Syndrome|Terminated||Phase 2|44|Actual|St. Justine's Hospital||2||Recruitment impossible|f||||t||||||||||2017-02-18 13:41:45.132504|2017-02-18 13:41:45.132504
NCT00793481|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2017-02-08|||November 2008||2008-11-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy|Diffuse Optical Spectroscopy Measure Microvascular Changes in Metabolic Syndrome and Diabetes Mellitus in Order to Assess Cardiovascular Disease Risk.|Completed||N/A|50|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:41:45.228868|2017-02-18 13:41:45.228868
NCT00793468|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2016-02-11|||December 2008||2008-12-01|February 2016|2016-02-01|December 2008|Anticipated|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Relapse Prevention Study in Newly Abstinent Smokers|A Study to Investigate the Effects of GSK598809 in Newly Abstinent Nicotine-dependent Subjects.|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||2||Study halted prior to enrollment of patients|f||||f||||||||||2017-02-18 13:41:45.326289|2017-02-18 13:41:45.326289
NCT00793455|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2011-10-24|2011-09-01||October 2008||2008-10-01|October 2011|2011-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|UPQUAL||Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders|Using Precision Performance Measurement To Conduct Focused Quality Improvement. Sub-Study 1.|Completed||N/A|628|Actual|Northwestern University|This study does not identify the timing of the intervention that would have the most impact. Mailings occurred 3 months or more after the order was placed, contacting patients sooner may have been more effective.|2|||f||||f||||||||||2017-02-18 13:41:45.452273|2017-02-18 13:41:45.452273
NCT00793442|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2015-11-13|||June 2008||2008-06-01|November 2015|2015-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Endothelium in Severe Sepsis|Endothelial Cell Signaling and Microcirculatory Flow in Severe Sepsis|Recruiting||N/A|600|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||t||||||||||2017-02-18 13:41:46.061669|2017-02-18 13:41:46.061669
NCT00793429|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2008-11-20||||||November 2008|2008-11-01||||||||Interventional|||Safety Study of Prucalopride in Healthy Volunteers|A Double-Blind, Placebo-Controlled, Two-Way Cross-Over in Healthy Volunteers, to Evaluate the Pharmacokinetics, Tolerability and Cardiac Safety of Prucalopride at Steady-State|Completed||Phase 1|||Movetis|||||f||||f||||||||||2017-02-18 13:41:46.17855|2017-02-18 13:41:46.17855
NCT00793416|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-10-28|||November 2008||2008-11-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients|Accuracy of ShuntCheck and MRI in Detection of Shunt Obstruction in Patients Receiving Shunt Patency Test|Withdrawn||Phase 4|0|Actual|NeuroDx Development||1||Loss of study staffing|f||||f||||||||||2017-02-18 13:41:46.24705|2017-02-18 13:41:46.24705
NCT00793403|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-12-31|2012-12-31||January 2008||2008-01-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|New Indices||Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study|"Current Adoption Of Composite Indices In Evaluating Rheumatoid Arthritis Patients: An Observational Study (NEW INDICES Study)"|Completed||N/A|293|Actual|Pfizer|||1||f||||t||||||||||2017-02-18 13:41:46.363361|2017-02-18 13:41:46.363361
NCT00793390|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2017-01-24|||November 17, 2008||2008-11-17|November 15, 2016|2016-11-15||||||||Observational|||Case-Control Study of Inflammatory Breast Cancer in North Africa|A Case-Control Study of Inflammatory Breast Cancer in North Africa|Recruiting||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:41:47.107569|2017-02-18 13:41:47.107569
NCT00792454|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2012-10-25|||October 2008||2008-10-01|October 2012|2012-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Reduction of Mortality Prior to and During the First 90 Days of Dialysis Through a Renal Rehabilitation Program||Unknown status|Recruiting|N/A|80|Anticipated|Maine Medical Center||2|||f||||f||||||||||2017-02-18 13:42:00.725524|2017-02-18 13:42:00.725524
NCT00793377|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-11-18||||||November 2008|2008-11-01|September 2001|Actual|2001-09-01|||||Interventional|||Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer|A Randomized, Multicenter, Open Phase III Study Comparing a Dose-Intensified 8 Week Schedule of Adriamycin and Docetaxel (ADOC) With a Sequential 24 Week Schedule of Adriamycin/Cyclophosphamide Followed by Docetaxel (AC-DOC) Regimen as Preoperative Therapy in Patients With Operable Carcinoma of the Breast (T2-3 N0-2 M0)|Completed||Phase 3|913|Actual|German Breast Group||2|||f||||||||||||||2017-02-18 13:41:47.20095|2017-02-18 13:41:47.20095
NCT00793364|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2009-05-27|||November 2008||2008-11-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Plant Stanol Ester-Containing Spread on Estimated Cardiovascular Risk in Comparison to Mediterranean Diet|Effect of Plant Stanol Ester-Containing Spread Based on Extra Virgin Olive Oil on Estimated Cardiovascular Risk, and Lipid-Inflammatory-Haemostatic Factors in Comparison to Mediterranean Diet: A Randomized, Placebo-Controlled Trial.|Completed||Phase 4|150|Actual|Hellenic Atherosclerosis Society||3|||f||||t||||||||||2017-02-18 13:41:47.30633|2017-02-18 13:41:47.30633
NCT00793351|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-10-17|||September 2008||2008-09-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2013|Actual|2013-11-01||Interventional|||Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation|Allogeneic Hematopoietic Stem Cell Transplantation With Reduced-intensity Conditioning in Children With Neuroblastoma Who Have Failed a Prior Autologous Transplantation|Completed||Phase 2|25|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 13:41:47.415512|2017-02-18 13:41:47.415512
NCT00793338|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-11-18|||November 2008||2008-11-01|November 2008|2008-11-01|February 2011|Anticipated|2011-02-01|November 2010|Anticipated|2010-11-01||Interventional|||Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure|Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|University of New Mexico||1|||f||||t||||||||||2017-02-18 13:41:47.49722|2017-02-18 13:41:47.49722
NCT00793325|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-12-17|2013-12-17||February 2009||2009-02-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Long Term Use of Somatropin in Patients Small for Gestational Age|Special Investigation Of Long Term Use Of Genotropin For SGA (Regulatory Post Marketing Commitment Plan)|Completed||N/A|920|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:41:47.760733|2017-02-18 13:41:47.760733
NCT00793312|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-10-16|||November 2007||2007-11-01|October 2012|2012-10-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Observational|||China Endeavor Registry: A Registry With The Endeavor Zotarolimus Eluting Coronary Stent in China|To Evaluate the 'Real World' Clinical Performance of the Medtronic Endeavor™ Zotarolimus Eluting Coronary Stent System in Chinese Patients, A Prospective, Multicenter Registry|Completed||N/A|2210|Actual|Medtronic Vascular|||1||f||||f||||||||||2017-02-18 13:41:48.254504|2017-02-18 13:41:48.254504
NCT00793299|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2015-04-24|||November 2008||2008-11-01|April 2015|2015-04-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Burden of Cancer in Children: A Pilot Study to Investigate the Impact and Content of Video Illness Narratives|Burden of Cancer in Children: A Pilot Study to Investigate the Impact and Content of Video Illness Narratives|Completed||N/A|11|Actual|University of Rochester||1|||f||||f||||||||||2017-02-18 13:41:48.338752|2017-02-18 13:41:48.338752
NCT00793286|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2008-11-21|||August 2004||2004-08-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Stapler Versus Glue for Laparoscopic Groin Hernia Repair|Stapler Versus Glue for Laparoscopic Groin Hernia Repair|Completed||N/A|80|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 13:41:48.434126|2017-02-18 13:41:48.434126
NCT00793273|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2014-08-13|||November 2008||2008-11-01|May 2014|2014-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.|Evaluation of Glycaemic Control After Initiation of Levemir® in Patients With Type 2 Diabetes Mellitus and Time Period Between Diagnosis of Type 2 Diabetes Mellitus and Insulin Initiation.|Completed||N/A|1074|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:41:48.551863|2017-02-18 13:41:48.551863
NCT00793260|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-11-18|||July 2006||2006-07-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|June 2007|Actual|2007-06-01||Interventional|||Deep Dive Randomized Control Trial|Deep Dive Randomized Control Trial|Completed||N/A|174120|Actual|Health Dialog||2|||f||||f||||||||||2017-02-18 13:41:48.658917|2017-02-18 13:41:48.658917
NCT00793247|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2008-11-18||||||November 2008|2008-11-01||||||||Interventional|||Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)|A Double-Blind, Placebo-Controlled, Cross-Over, Multiple (n=1) Trial to Evaluate the Effects of R093877 in Patients With Chronic Intestinal Pseudo-Obstruction (CIP).|Completed||Phase 2|||Movetis|||||f||||||||||||||2017-02-18 13:41:48.751251|2017-02-18 13:41:48.751251
NCT00793234|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2014-04-04|||December 2008||2008-12-01|April 2014|2014-04-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery|Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery: A Dose-Escalating, Multicenter, Randomised, Active- Controlled Open Label Study|Completed||Phase 2|316|Actual|ThromboGenics||4|||f||||t||||||||||2017-02-18 13:41:48.840862|2017-02-18 13:41:48.840862
NCT00793221|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-06-18|||November 2008||2008-11-01|June 2012|2012-06-01||||July 2011|Actual|2011-07-01||Interventional|CIBELES||Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent|Randomized Comparison Between Sirolimus-eluting and Everolimus-eluting Coronary Stents in Chronic Coronary Occlusions|Completed||Phase 3|207|Actual|Spanish Society of Cardiology||2|||f||||t||||||||||2017-02-18 13:41:48.98952|2017-02-18 13:41:48.98952
NCT00793208|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2013-12-09|||June 2012||2012-06-01|December 2013|2013-12-01|January 2025|Anticipated|2025-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)|Active Immunization of Patients With Non Small Cell Lung Cancer (NSCLC) Using Fibroblasts Transfected With DNA From Autologous Tumor (Phase IB Study)|Recruiting||Phase 1|22|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:41:49.085398|2017-02-18 13:41:49.085398
NCT00792441|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-04-01|||January 2007||2007-01-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2009|Actual|2009-12-01||Interventional|SIMT||Specific Inspiratory Muscle Training (SIMT)in the Patients With Ventilatory Dependence|Effect of Specific Inspiratory Inspiratory Training(SIMT)in the Patients With Ventilatory Dependence on Lung Function and Weaning Outcomes|Active, not recruiting||N/A|20|Anticipated|Khon Kaen University||1|||f||||t||||||||||2017-02-18 13:42:00.815985|2017-02-18 13:42:00.815985
NCT00793195|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-18|2011-11-02|||January 2009||2009-01-01|November 2011|2011-11-01|January 2012|Anticipated|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?|Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? A Pilot Double Blind Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 13:41:49.202114|2017-02-18 13:41:49.202114
NCT00793182|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2009-06-16|||January 2009||2009-01-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|CINOPSIS CT||Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography|A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Optiray 320 mgI/mL and Visipaque 320 mgI/mL on Renal Function in Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography|Terminated||Phase 4|10|Actual|Mallinckrodt||2||Slow enrollment|f||||f||||||||||2017-02-18 13:41:49.309095|2017-02-18 13:41:49.309095
NCT00793169|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-02-19|2010-09-30||September 2007||2007-09-01|February 2015|2015-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery|Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery|Completed||N/A|19|Actual|Northwestern University|Serum rather than plasma lidocaine levels were measured. For lidocaine levels, plasma and serum levels are similar, and serum levels are more routinely reported by reference laboratories. Hence our selection of serum levels for this study.||1||f||||f||||||||||2017-02-18 13:41:49.424853|2017-02-18 13:41:49.424853
NCT00793156|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2010-02-03|||December 2009||2009-12-01|February 2010|2010-02-01|March 2011|Anticipated|2011-03-01|December 2010|Anticipated|2010-12-01||Interventional|AC120-8231||A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)|A Randomized-Withdrawal Phase 3 Study Evaluation the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)|Unknown status|Not yet recruiting|Phase 3|350|Anticipated|Acologix, Inc.||3|||f||||f||||||||||2017-02-18 13:41:49.639701|2017-02-18 13:41:49.639701
NCT00793143|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-08-21|||April 2008||2008-04-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|SLEEVEPASS||Laparoscopic Gastric Bypass Versus Sleeve Gastrectomy to Treat Morbid Obesity|A Randomized Prospective Three-center Study: Laparoscopic Gastric Bypass vs. Laparoscopic Sleeve Gastrectomy in the Treatment of Morbid Obesity|Completed||N/A|240|Actual|Turku University Hospital|||2||f||||f||||||Samples With DNA|"~     Tissue samples~   "|No||2017-02-18 13:41:49.717391|2017-02-18 13:41:49.717391
NCT00793130|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-16|2008-11-18|||November 2008||2008-11-01|November 2008|2008-11-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open Label|The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open Label|Unknown status|Recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||t||||||||||2017-02-18 13:41:49.809904|2017-02-18 13:41:49.809904
NCT00793117|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-15|2012-06-02|||November 2008||2008-11-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|October 2009|Actual|2009-10-01||Interventional|||The Effect of Packing in Post Operative Management of FESS|The Evaluation of Effect of Pva Sponge in Prevention of Complications in Fess|Completed||Phase 4|66|Actual|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-02-18 13:41:49.999793|2017-02-18 13:41:49.999793
NCT00793104|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-11-06|2013-07-12||November 2008||2008-11-01|November 2013|2013-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Evaluation of the CR Plug (Allograft) for the Treatment of a Cartilage Injury in the Knee.|Evaluation of the Composite of Cancellous and Demineralized Bone Plug (CR-Plug) for Repair of Focal Cartilage Lesions in the Femoral Condyle|Terminated||Phase 3|10|Actual|RTI Surgical|"Enrollment was closed early due for 2 factors:~1) Slow enrollment and 2) A potential change in the regulatory pathway for allografts used in cartilage repair~1 patient was lost to follow up, with no data collected at the 24-month visit."|1||Slow enrolment & potential regulatory changes for allograft in cartilage repair|f||||f||||||||||2017-02-18 13:41:50.113534|2017-02-18 13:41:50.113534
NCT00793091|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-11-26|||November 2008||2008-11-01|November 2008|2008-11-01|September 2009|Anticipated|2009-09-01|August 2009|Anticipated|2009-08-01||Interventional|||Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract|A Phase 2, Randomized, Placebo-Controlled, Double-Masked, Multicenter Safety and Efficacy Study of C-KAD Ophthalmic Solution in Patients With Loss of Visual Acuity Due to Age-Related Cataract|Unknown status|Recruiting|Phase 2|80|Anticipated|Chakshu Research, Inc.||2|||f||||f||||||||||2017-02-18 13:41:50.389469|2017-02-18 13:41:50.389469
NCT00793078|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2011-02-28|||January 2009||2009-01-01|January 2011|2011-01-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Arterial Blood Pressure-complexity in Septic Patients|Investigation of Arterial Blood Pressure-complexity and Its Relation to Outcome in Comparison Between Cardiac Surgery Versus Non-cardiac Surgery Septic Patients|Suspended||N/A|72|Anticipated|University Hospital, Bonn|||1|Awaiting decision on financial support by Deutsche Forschungsgemeinschaft (DFG)|f||||f||||||||||2017-02-18 13:41:50.488213|2017-02-18 13:41:50.488213
NCT00793065|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-06-17|||October 2008||2008-10-01|June 2013|2013-06-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Observational|||Evaluating the Effects of EHRs, P4P and Medical Home Redesign in the Hudson Valley|Evaluating the Effects of EHRs, P4P and Medical Home Redesign in the Hudson Valley|Unknown status|Active, not recruiting|N/A|1200|Anticipated|Weill Medical College of Cornell University|||3||f||||f||||||||||2017-02-18 13:41:50.566791|2017-02-18 13:41:50.566791
NCT00793052|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2008-11-16|||November 2008||2008-11-01|November 2008|2008-11-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery|Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery: A Prospective, Double-Blind Study|Unknown status|Active, not recruiting|N/A|80|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 13:41:50.660796|2017-02-18 13:41:50.660796
NCT00793026|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-12-18|||November 2008||2008-11-01|December 2008|2008-12-01||||November 2008|Actual|2008-11-01||Interventional|||Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability|Safety Dermatological Evaluation: Genital Mucous Irritation - Test in Use - Dermacyd Breeze Pocket BR (Lactic Acid).|Completed||Phase 3|30|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:41:50.764683|2017-02-18 13:41:50.764683
NCT00793013|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-08-10|||November 2011||2011-11-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|PRESSURE||Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation|Primary Resuscitation Using Airway Pressure Release Ventilation Improves Recovery From Acute Lung Injury or Adult Respiratory Distress Syndrome and Reduces All Cause Mortality Compared to ARDS Net Low Tidal Volume-Cycled Ventilation.|Recruiting||Phase 2|368|Anticipated|University of Tennessee, Chattanooga||2|||f||||f||||||||||2017-02-18 13:41:50.851964|2017-02-18 13:41:50.851964
NCT00793000|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2011-05-03|||November 2008||2008-11-01|May 2011|2011-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults|A Phase 1 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-04287881 After First Time Administration Of Ascending Single Oral Doses To Healthy Adult Subjects|Completed||Phase 1|80|Actual|Pfizer||10|||f||||f||||||||||2017-02-18 13:41:50.977835|2017-02-18 13:41:50.977835
NCT00792974|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2009-02-04|||October 2008||2008-10-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|||End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)|End-of-Life Fear in Patients With End-Stage Lung Disease: Fears of Death and Dying, Wishes and Needs of Patients With Severe COPD|Unknown status|Recruiting|N/A|199|Anticipated|Philipps University Marburg Medical Center|||1||f||||t||||||||||2017-02-18 13:41:51.1023|2017-02-18 13:41:51.1023
NCT00792961|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-16|2014-04-07|||November 2008||2008-11-01|April 2014|2014-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Real Time Microscopic Imaging During Robot Assisted Prostate Cancer Surgery|In Vivo Confocal Endomicroscopy During da Vinci Robot Assisted Prostatectomy: Feasibility Study|Completed||N/A|10|Actual|Optiscan Pty Ltd||1|||f||||f||||||||||2017-02-18 13:41:51.215929|2017-02-18 13:41:51.215929
NCT00792948|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-16|2016-09-09|||September 2009||2009-09-01|September 2016|2016-09-01||||June 2016|Actual|2016-06-01||Interventional|||Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia|Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) With or Without Allogeneic Stem Cell Transplant in Patients With Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) (A BMT Study)|Active, not recruiting||Phase 2|92|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 13:41:51.320721|2017-02-18 13:41:51.320721
NCT00792935|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2015-12-16|2012-06-28||January 2009||2009-01-01|December 2015|2015-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)|A Phase IIa, Multicenter, Double-Blind, Randomized, Active-Controlled, Parallel-Arm Clinical Trial to Study the Efficacy and Safety of MK-0941 Compared to Sulfonylurea in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy|Completed||Phase 2|143|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:41:54.057938|2017-02-18 13:41:54.057938
NCT00792922|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-04-06|||May 2008||2008-05-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|PRET||Partnership for Rapid Elimination of Trachoma|Research to Programs for Trachoma Elimination: Antibiotic Trial|Completed||Phase 4|20586|Actual|Johns Hopkins University||4|||f||||t||||||||||2017-02-18 13:41:54.405747|2017-02-18 13:41:54.405747
NCT00792909|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-10-11||2009-09-09|December 2008||2008-12-01|October 2016|2016-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A|Vaccination Course in Children Primed and Boosted With Pneumococcal Vaccine GSK 1024850A and in Age-matched Unprimed Children|Completed||Phase 3|172|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:41:54.719645|2017-02-18 13:41:54.719645
NCT00792896|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-16|2008-11-17|||May 2008||2008-05-01|May 2008|2008-05-01||||December 2010|Anticipated|2010-12-01||Interventional|||Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease|A Longitudinal Study That Assessed the Effectiveness of Intervention Toward|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:41:54.841345|2017-02-18 13:41:54.841345
NCT00792883|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-10-26|||October 2007||2007-10-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Observational|PCL07||Clinical Protocol Validation to Identify Prognostic Markers for Critical Care Pediatric Patients|Clinical Protocol Validation to Identify Prognostic Markers for Critical Care Pediatric Patients|Completed||N/A|1000|Actual|Oswaldo Cruz Foundation|||3||f||||t||||||Samples With DNA|"~     DNA extracts from blood or oral swab~   "|||2017-02-18 13:41:54.931263|2017-02-18 13:41:54.931263
NCT00792870|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2012-03-15|||January 2008||2008-01-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of the Shape Up Rhode Island Campaign|Evaluation of the Shape Up Rhode Island Campaign: Study 4 Does Adding Behavioral Weight Control Information to Shape-Up Rhode Island Improve Outcomes?|Completed||N/A|179|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-02-18 13:41:55.027381|2017-02-18 13:41:55.027381
NCT00792857|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2014-09-26|||November 2008||2008-11-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)|Single-Dose, Two-Period, Open Label, Dose Determination, Randomized, Cross-Over Study of CTAP201 Injection and Doxercalciferol (Hectorol) Injection in Subjects With Stage 5 CKD and SHPT on Hemodialysis|Completed||Phase 1|24|Actual|OPKO Health, Inc.||4|||f||||f||||||||||2017-02-18 13:41:55.127628|2017-02-18 13:41:55.127628
NCT00792844|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-11-17|||February 2009||2009-02-01|November 2008|2008-11-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||Comparison of Two Formulations of Bio-K|Comparison of Two Formulations of Lactobacillus Acidophilus and Lactobacillus Casei in the Prevention of Antibiotic-Associated Diarrhea: a Pilot Study|Unknown status|Not yet recruiting|N/A|90|Anticipated|McMaster University||3|||f||||||||||||||2017-02-18 13:41:55.24607|2017-02-18 13:41:55.24607
NCT00792428|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-01-24|||June 2006||2006-06-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|February 2013|Actual|2013-02-01||Interventional|TDCS+OT||Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery|Facilitating Motor Recovery After Stroke Using tDCS|Active, not recruiting||Phase 2/Phase 3|80|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||No||2017-02-18 13:42:00.929723|2017-02-18 13:42:00.929723
NCT00792831|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-05-23|||February 2008||2008-02-01|February 2012|2012-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia|Open Label, Uncontrolled, Pilot, Phase II Study of Histone-deacetylase Inhibitor ITF2357 Administered Orally to Subjects With Chronic Lymphocytic Leukemia (CLL) Refractory/Relapsed After Conventional Chemotherapy or Relapsed After Autologous Bone Marrow Transplantation|Terminated||Phase 2|3|Actual|Italfarmaco||1||"protocol needs complete restructuring in order to make it feasible and to complete the~   enrollment of 23 patients"|f||||t||||||||||2017-02-18 13:41:55.340296|2017-02-18 13:41:55.340296
NCT00792818|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-16|2012-10-27|||December 2008||2008-12-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Efficacy and Safety of Curcuma Domestica Extracts and Ibuprofen in Knee Osteoarthritis|The Efficacy and Safety of Curcuma Domestica Extracts and Ibuprofen for Therapy of Patients With Knee Osteoarthritis, the Randomized Double-blinded Controlled Trial, Multicenter Study|Completed||Phase 3|367|Actual|Mahidol University||2|||f||||t||||||||||2017-02-18 13:41:55.453106|2017-02-18 13:41:55.453106
NCT00792805|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2011-07-22|2011-07-22||November 2008||2008-11-01|July 2011|2011-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD)|A Phase III, 26-week Multicenter Randomized Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol (150 and 300 µg Once Daily [od]) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|563|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:41:55.571036|2017-02-18 13:41:55.571036
NCT00792792|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2017-02-08|||January 2007||2007-01-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Monitoring of Tissue Transfer Flaps by Modulated Imaging|Non-contact, Intra-operative & Post-operative Device, Evaluation of Tissue Transfer Flaps After Reconstructive Surgery.|Recruiting||N/A|200|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:41:55.997358|2017-02-18 13:41:55.997358
NCT00792779|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2009-11-04|||November 2008||2008-11-01|November 2009|2009-11-01|June 2009|Anticipated|2009-06-01|May 2009|Anticipated|2009-05-01||Interventional|||Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty|Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty|Unknown status|Active, not recruiting|N/A|60|Anticipated|Centro Medico Campinas||1|||f||||f||||||||||2017-02-18 13:41:56.12081|2017-02-18 13:41:56.12081
NCT00792766|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2013-09-17|||December 2008||2008-12-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)|Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis|Completed||Phase 1/Phase 2|20|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 13:41:56.209697|2017-02-18 13:41:56.209697
NCT00792753|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2017-02-07|||October 2008||2008-10-01|February 2017|2017-02-01|February 2017|Anticipated|2017-02-01|November 2011|Actual|2011-11-01||Interventional|||"Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study EXCELLA II STUDY"|A Randomized, Single Blind, Consecutive Enrollment Evaluation of the Elixir Novolimus-Eluting Coronary Stent System With Durable Polymer Compared to the Medtronic Endeavor Zotarolimus-Eluting Coronary Stent System in the Treatment Of Patients With De Novo Native Coronary Artery Lesions And A Randomized, Consecutive Enrollment Evaluation of the Elixir Novolimus-Eluting Coronary Stent System With Bioabsorbable Polymer Compared to the Medtronic Endeavor Zotarolimus-Eluting Coronary Stent System in the Treatment Of Patients With De Novo Native Coronary Artery Lesions|Active, not recruiting||N/A|360|Actual|Elixir Medical Corporation||3|||f||||t||||||||No||2017-02-18 13:41:56.318743|2017-02-18 13:41:56.318743
NCT00792740|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2012-02-01|||October 2007||2007-10-01|February 2012|2012-02-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|Chron Disease||Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease|Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease|Terminated||Phase 1/Phase 2|51|Actual|Italfarmaco||2||"As no safety warnings were detected,Interim analysis from the first 40 patients reccomends to~   stop the trial for futility"|f||||t||||||||||2017-02-18 13:41:56.634636|2017-02-18 13:41:56.634636
NCT00792727|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2015-05-12||2015-03-17|September 2007||2007-09-01|May 2015|2015-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Four-Week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee|Completed||Phase 3|380|Actual|Hisamitsu Pharmaceutical Co., Inc.||2|||f||||f||||||||||2017-02-18 13:41:56.74155|2017-02-18 13:41:56.74155
NCT00792714|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-16|2010-01-31|||December 2008||2008-12-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|DPM-PK-102||Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients|Determination of the Pharmacokinetics of Inhaled Mannitol After Single and Multiple Dosing in Cystic Fibrosis Patients|Completed||Phase 1|18|Anticipated|Pharmaxis||1|||f||||f||||||||||2017-02-18 13:41:56.903824|2017-02-18 13:41:56.903824
NCT00792701|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-16|2015-02-05|||November 2008||2008-11-01|February 2015|2015-02-01||||June 2016|Anticipated|2016-06-01||Interventional|||S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer|Phase II ERCC1 and RRM1-Based Adjuvant Therapy Trial in Patients With Stage I Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 2|55|Anticipated|Southwest Oncology Group||2|||f||||f||||||||||2017-02-18 13:41:56.996864|2017-02-18 13:41:56.996864
NCT00792688|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2011-07-22|2011-06-23||October 2008||2008-10-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation|Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to Investigate the Safety and Efficacy of 0.1% and 1.0% Topically Applied GLYC-101, Compared to Placebo, in Patients Undergoing Carbon Dioxide Laser Skin Resurfacing of the Lower Eyelids.|Completed||Phase 2|26|Actual|Glycotex, Inc.||3|||f||||||||||||||2017-02-18 13:41:57.272928|2017-02-18 13:41:57.272928
NCT00792675|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2008-11-17|||January 2003||2003-01-01|November 2008|2008-11-01|November 2007|Actual|2007-11-01|April 2006|Actual|2006-04-01||Interventional|RA&Ex||Effect of Exercise on the Disease Activity of Rheumatoid Arthritis||Completed||N/A|55|Actual|University of Nebraska||1|||f||||f||||||||||2017-02-18 13:41:57.77365|2017-02-18 13:41:57.77365
NCT00792636|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-10-11|2010-10-07||November 2008||2008-11-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period|Assessment of the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet Treatment on Blood Pressure When Administered Intermittently for Six Months for the Acute Treatment of Migraine Attacks, With or Without Aura, in Adults|Completed||Phase 4|407|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:41:58.061564|2017-02-18 13:41:58.061564
NCT00792623|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2016-11-03|||September 2003||2003-09-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).|A Phase III, Open-label, Multi-centre Study to Assess the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM), Given as a Primary Vaccination at 4.5 Months and 6.5 Months Post-transplantation, in Autologous Stem Cell/ Bone Marrow Transplant Recipients Aged 18 Years and Older.|Completed||Phase 2|45|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:41:59.257856|2017-02-18 13:41:59.257856
NCT00792610|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-16|2009-10-05|2009-08-16||August 2007||2007-08-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines|The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines|Completed||N/A|127|Actual|National Taiwan University Hospital|The possible presence of T cell memory among the seronegative patients for HBsAg(+), anti-HBc(+), and anti-HBs(+) could be a concern.|1|||f||||t||||||||||2017-02-18 13:41:59.370988|2017-02-18 13:41:59.370988
NCT00792597|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-03-06|||April 2009||2009-04-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Observational|||Comparison of Three Methods of Hemoglobin Monitoring|Comparison of Three Methods of Hemoglobin Monitoring in Patients Undergoing Spine Revision or Hip Revision Surgery.|Completed||N/A|20|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:41:59.662113|2017-02-18 13:41:59.662113
NCT00792584|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2011-09-09|||November 2008||2008-11-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|SWITCH-EE||Patient Preference, Sleep Quality, and Anxiety/Depression: A Randomized Comparison of Etravirine and Efavirenz|Patient Preference, Sleep Quality, and Anxiety/Depression: A Randomized Comparison of Etravirine and Efavirenz|Completed||N/A|50|Anticipated|University Hospital, Geneva||2|||f||||t||||||||||2017-02-18 13:41:59.755796|2017-02-18 13:41:59.755796
NCT00792571|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2014-05-19||2014-02-11|February 2009||2009-02-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients|An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients.|Completed||Phase 2|18|Actual|Lung Biotechnology PBC||2|||f||||f||||||||||2017-02-18 13:41:59.866691|2017-02-18 13:41:59.866691
NCT00792558|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2015-08-31|||January 2009||2009-01-01|January 2009|2009-01-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Interventional|||Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers|A Phase I Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced or Metastatic Solid Tumors|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 13:41:59.979427|2017-02-18 13:41:59.979427
NCT00792532|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2016-05-18|||July 2003||2003-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Interventional|iMRI||Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes|Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes|Recruiting||Phase 4|100|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 13:42:00.076517|2017-02-18 13:42:00.076517
NCT00792519|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2011-06-20|||February 2009||2009-02-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|KHBS||Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans|Alcohol & HIV in Kenya: Stage 1 Trial of a Peer-Led Alcohol Behavior Intervention|Completed||Phase 1|75|Actual|Brown University||2|||f||||t||||||||||2017-02-18 13:42:00.206836|2017-02-18 13:42:00.206836
NCT00792506|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-05-23|||October 2008||2008-10-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|January 2010|Actual|2010-01-01||Interventional|||Phase II High Pulse Dose Clinical Trial of Orally Administered ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma|Phase II High Pulse Dose Clinical Trial of Orally Administered ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma|Terminated||Phase 2|1|Actual|Italfarmaco||1|||f||||||||||||||2017-02-18 13:42:00.330346|2017-02-18 13:42:00.330346
NCT00792493|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2009-09-23|||December 2008||2008-12-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Tolerability Study With Multiple Ascending Doses of ORM-12741|Phase I Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study With Multiple Ascending Doses of ORM-12741|Completed||Phase 1|51|Actual|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-02-18 13:42:00.435906|2017-02-18 13:42:00.435906
NCT00792480|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2008-11-17|||October 2005||2005-10-01|November 2008|2008-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|WIP||Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial|Does Dietary and Lifestyle Counseling Prevent Excessive Weight Gain During Pregnancy? A Randomized Controlled Trial|Terminated||N/A|100|Actual|Carolinas Medical Center||2||Resident research project limited by restrictions of residency program.|f||||t||||||||||2017-02-18 13:42:00.521583|2017-02-18 13:42:00.521583
NCT00792467|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2012-01-31|||February 2008||2008-02-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma Patients|Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma Patients|Completed||Phase 1/Phase 2|24|Actual|Italfarmaco||1|||f||||t||||||||||2017-02-18 13:42:00.628616|2017-02-18 13:42:00.628616
NCT00791869|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-05-20|||June 2008||2008-06-01|May 2013|2013-05-01|November 2010|Actual|2010-11-01|March 2010|Actual|2010-03-01||Observational|||Pharmacogenetics of Bupropion Metabolism|Pharmacogenetics of Bupropion Metabolism|Completed||N/A|43|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:42:08.857643|2017-02-18 13:42:08.857643
NCT00792415|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2010-04-23|||November 2009||2009-11-01|December 2009|2009-12-01|December 2010|Anticipated|2010-12-01|April 2010|Anticipated|2010-04-01||Observational|||Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool|Validation of a Pediatric Abstinence Syndrome Scoring Tool Utilizing a Standardized Hospital-Based Guideline for Iatrogenic Opioid Dependence|Unknown status|Recruiting|N/A|75|Anticipated|Banner Health|||2||f||||f||||||||||2017-02-18 13:42:01.047418|2017-02-18 13:42:01.047418
NCT00792402|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-17|2011-11-22|||November 2007||2007-11-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Computerized Guideline in Heart Failure: Implementation Process and Impact Evaluation|Implementation Process and Impact of the Heart Failure Electronic Clinical Guideline in the Catalan Health Institute Primary Care Health Board|Completed||N/A|13008|Actual|Jordi Gol i Gurina Foundation|||2||f||||t||||||||||2017-02-18 13:42:01.143057|2017-02-18 13:42:01.143057
NCT00792389|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2008-11-14|||January 2009||2009-01-01|November 2008|2008-11-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Study of the Use of Humidified Warmed Gas and the Effect on Post-Operative Pain in Laparoscopic Cholecystectomies|Randomised Controlled Trail of Warmed Humidified Insufflation Versus Cold Non-Humidified Insufflation in Elective Laparoscopic Cholecystectomies: Does This Reduce Post-Operative Pain?|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Pennine Acute Hospitals NHS Trust||2|||f||||f||||||||||2017-02-18 13:42:01.23067|2017-02-18 13:42:01.23067
NCT00792376|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-08-02|||August 2009||2009-08-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||"NSAIDs in Acute Achilles Tendinopathy: Effect on Pain Control, Leg Stiffness and Functional Recovery in Athletes"|"NSAIDs in Acute Achilles Tendinopathy: Effect on Pain Control, Leg Stiffness and Functional Recovery in Athletes"|Completed||Phase 4|56|Actual|Argentine Tennis Association||2|||f||||f||||||||||2017-02-18 13:42:01.345468|2017-02-18 13:42:01.345468
NCT00792363|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2012-06-12|||November 2008||2008-11-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|December 2010|Actual|2010-12-01||Interventional|||Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations|A Phase II Study of Irinotecan and Panitumumab as 3rd Line Treatment of Patients With Metastatic Colorectal Cancer Without KRAS Mutations|Completed||Phase 2|32|Actual|Vejle Hospital||1|||f||||t||||||||||2017-02-18 13:42:01.454545|2017-02-18 13:42:01.454545
NCT00792350|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2014-05-13|||April 2008||2008-04-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|October 2013|Actual|2013-10-01||Observational|INSIGHT||INSIGHT - Post Marketing Surveillance|International Study With Nexavar About Safety and Efficacy in Carcinoma Hepatocellular Therapy (HCC)|Completed||N/A|791|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a~   "|||2017-02-18 13:42:01.56253|2017-02-18 13:42:01.56253
NCT00792337|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-09-10|||December 2008||2008-12-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids in Asthma|The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids in Asthma|Completed||Phase 3|53|Actual|Mahidol University||2|||f||||f||||||||||2017-02-18 13:42:01.879786|2017-02-18 13:42:01.879786
NCT00792324|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2009-11-17|||June 2008||2008-06-01|November 2009|2009-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125|A Phase III, Double Blind, Mulit-centre, Randomised Placebo Controlled, Pilot Study to Assess the Feasibility of Switching Individuals Receiving Efavirez With Continuing Central Nervous System (CNS) Toxicity to TMC125.|Completed||Phase 3|24|Actual|St Stephens Aids Trust||2|||f||||f||||||||||2017-02-18 13:42:01.985815|2017-02-18 13:42:01.985815
NCT00792311|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2010-03-25|||November 2008||2008-11-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Tsui Test as a Predictor of Bupivacaine Consumption in Labour Epidurals|Tsui Test as a Predictor of Bupivacaine Consumption in Labour Epidurals|Completed||N/A|102|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||1|||f||||f||||||||||2017-02-18 13:42:02.115777|2017-02-18 13:42:02.115777
NCT00792298|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-02-23|2014-08-19||November 2008||2008-11-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)|A Phase IIb, Multicenter, Randomized, Double-Blind Placebo-Controlled, 2-period Adaptive Crossover Polysomnography Study to Evaluate Safety and Efficacy of MK-4305 in Patients With Primary Insomnia|Completed||Phase 2|254|Actual|Merck Sharp & Dohme Corp.||8|||f||||||||||||||2017-02-18 13:42:02.224557|2017-02-18 13:42:02.224557
NCT00792285|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-13|||March 2005||2005-03-01|November 2008|2008-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening|Automated Telephone Outreach With Speech Recognition to Improve Colorectal Cancer Screening: A Randomized Controlled Trial|Completed||N/A|80000|Actual|Harvard Pilgrim Health Care||2|||f||||f||||||||||2017-02-18 13:42:02.868147|2017-02-18 13:42:02.868147
NCT00792272|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-07-19|||June 2008||2008-06-01|July 2013|2013-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients|Prevalence of Aspirin Resistance in Hemodialysis Patients|Completed||N/A|100|Actual|Northwell Health|||1||f||||t||||||||||2017-02-18 13:42:02.978669|2017-02-18 13:42:02.978669
NCT00792259|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2015-06-15|2013-12-12||October 2008||2008-10-01|June 2015|2015-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational||20 Normal Subjects 15 Retinal Disease subjects 13 Glaucoma Subjects|Topcon 3D OCT-1000 Optical Coherence Tomography System|Topcon 3D OCT-1000 Optical Coherence Tomography System for Measurements of Retinal and RNFL Thicknesses: Precision and Agreement Study|Completed||N/A|48|Actual|Topcon Medical Systems, Inc.|||3||f||||f||||||||||2017-02-18 13:42:03.065623|2017-02-18 13:42:03.065623
NCT00792246|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2012-11-09|||December 2008||2008-12-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease|Define the Pharmacokinetics of Oral Voriconazole in Children With Extensive Gastrointestinal Graft Versus Host Disease|Completed||Phase 1|5|Actual|Duke University||2|||f||||f||||||||||2017-02-18 13:42:03.495701|2017-02-18 13:42:03.495701
NCT00792233|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2016-04-13|||June 2009||2009-06-01|April 2016|2016-04-01|October 2015|Actual|2015-10-01|October 2013|Actual|2013-10-01||Interventional|||Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA|Improved Understanding of the Biology and Use of TNF Inhibition in Children With JIA|Completed||Phase 4|137|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||Yes|deidentified subject information and results of testing have already been shared with multiple investigators requesting samples|2017-02-18 13:42:03.604463|2017-02-18 13:42:03.604463
NCT00792220|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2015-05-31|||November 2008||2008-11-01|May 2015|2015-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|MSU||"Mobile Stroke-Unit for Reduction of the Response Time in Ischemic Stroke"|"Mobile Stroke-Unit for Reduction of the Response Time in Ischemic Stroke"|Completed||N/A|200|Anticipated|University Hospital, Saarland||2|||f||||t||||||||||2017-02-18 13:42:03.721169|2017-02-18 13:42:03.721169
NCT00792207|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2009-12-02|||June 2008||2008-06-01|December 2009|2009-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|StepUp||The Role of a Virtual Coach in Improving Adherence to an Activity Program for Overweight Adults|The Role of a Virtual Coach in Improving Adherence to an Activity Program for Overweight Adults|Completed||N/A|70|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:42:03.83332|2017-02-18 13:42:03.83332
NCT00792194|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2015-09-29|||December 2008||2008-12-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Improvement of Aerobic Capacity in Cystic Fibrosis Patients With a One-year Home Training Period|Improvement of Aerobic Capacity in Cystic Fibrosis Patients With a One-year Home Training Period|Completed||N/A|50|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 13:42:03.937752|2017-02-18 13:42:03.937752
NCT00792181|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2008-11-14|||June 2008||2008-06-01|November 2008|2008-11-01||||November 2008|Actual|2008-11-01||Interventional|||To Relieve Pain and Anxiety - an Intervention Study in Ambulance Services|Intervention Study to Relieve Pain and Anxiety in Acute Myocardial Disease Focusing on Treatment With Benzodiazepines(Midazolam)and the Importance of a Caring Relation.|Completed||Phase 1|2800|Anticipated|Sahlgrenska University Hospital, Sweden||4|||f||||t||||||||||2017-02-18 13:42:04.04824|2017-02-18 13:42:04.04824
NCT00792168|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2008-11-14|||November 1996||1996-11-01|November 2008|2008-11-01|December 1998|Actual|1998-12-01|||||Interventional|||Physiologic Monitoring of Antidepressant Treatment Response|Physiologic Monitoring of Antidepressant Treatment Response|Completed||Phase 4|38|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 13:42:04.130875|2017-02-18 13:42:04.130875
NCT00792155|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2016-08-09|||November 2002||2002-11-01|August 2016|2016-08-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Observational|||Polycystic Kidney Disease Data Repository|Autosomal Dominant Polycystic Kidney Disease Data Repository|Recruiting||N/A|500|Anticipated|The Rogosin Institute|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:42:04.237774|2017-02-18 13:42:04.237774
NCT00792142|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2017-02-10|||January 2008||2008-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma|A Phase II Study of Maintenance Treatment With Sequential Bortezomib, Thalidomide and Dexamethasone Following Autologous Peripheral Blood Stem Cell Transplant in Patients With Multiple Myeloma|Active, not recruiting||Phase 2|45|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:42:04.338611|2017-02-18 13:42:04.338611
NCT00792129|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2012-02-14|||April 2004||2004-04-01|February 2012|2012-02-01|June 2009|Actual|2009-06-01|March 2006|Actual|2006-03-01||Observational|||MIS MiLIF Versus Open|A Multi-Center Study to Evaluate MiLIF(R) Versus Open Posterior Unilateral Lumbar Interbody Fusion (TLIF)|Completed||N/A|113|Actual|Zimmer Biomet|||2||f||||f||||||||||2017-02-18 13:42:04.457547|2017-02-18 13:42:04.457547
NCT00792116|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2008-11-18|2008-10-24||February 2008||2008-02-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of Gum Chewing on Math Scores in Adolescents|The Effects of Gum Chewing on Standardized Math Scores in Adolescents|Completed||N/A|108|Actual|Baylor College of Medicine||2|||f||||||||||||||2017-02-18 13:42:04.579728|2017-02-18 13:42:04.579728
NCT00792103|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2016-02-02|2013-02-15||January 2009||2009-01-01|February 2016|2016-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|NP101-008|Per protocol, the intent-to-treat (ITT) population was defined as all subjects who applied and activated at least one NP101 study patch and had at least one post baseline assessment for each migraine symptom (pain, photophobia, phonophobia, and nausea). Of the 183 subjects who applied at least one study patch, 181 subjects met the ITT criteria.|An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months|An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months|Completed||Phase 3|198|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 13:42:04.962365|2017-02-18 13:42:04.962365
NCT00792090|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2008-11-14|||November 2003||2003-11-01|November 2008|2008-11-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Prevention of Cow's Milk Allergy in Children|Use of Fermented Milk in Prevention of Cow's Milk Allergy in New Born and Infant|Completed||N/A|142|Actual|Bledina||2|||f||||t||||||||||2017-02-18 13:42:05.258389|2017-02-18 13:42:05.258389
NCT00792077|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-09-12|||November 2008||2008-11-01|September 2016|2016-09-01||||November 2018|Anticipated|2018-11-01||Interventional|||A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue|A Pilot Open Label Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy Including Lenalidomide on Cancer Related Sleep Disturbances in Chronic Lymphocytic Leukemia (CLL) and Breast Cancer Patients Experiencing Clinically Significant Fatigue|Active, not recruiting||N/A|12|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:42:05.3481|2017-02-18 13:42:05.3481
NCT00792064|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2009-08-24|||February 2009||2009-02-01|August 2009|2009-08-01|July 2014|Anticipated|2014-07-01|December 2013|Anticipated|2013-12-01||Observational|||Systematic Evaluation of Predictors of Quality of Life in the Long-term After Solid Organ Transplantation|Systematic Evaluation of Predictors of Quality of Life in the Long-term After Solid Organ Transplantation- a Prospective Cohort Study|Unknown status|Recruiting|N/A|700|Anticipated|Hannover Medical School|||4||f||||t||||||||||2017-02-18 13:42:05.458223|2017-02-18 13:42:05.458223
NCT00792051|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2014-12-29|||September 2008||2008-09-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children|A Randomised Controlled Trial of the Effectiveness of Vaccinating Children to Reduce Household Transmission of Influenza|Completed||N/A|2800|Anticipated|The University of Hong Kong||2|||f||||t||||||||||2017-02-18 13:42:05.739759|2017-02-18 13:42:05.739759
NCT00791661|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-01-06|2012-09-07||November 2008||2008-11-01|January 2016|2016-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)|A Single Dose Clinical Trial to Study the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-1006 in Japanese Subject With Type 2 Diabetes|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:42:14.467942|2017-02-18 13:42:14.467942
NCT00792038|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2012-08-01|||January 2009||2009-01-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors|Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors|Completed||N/A|88|Actual|University of Aarhus|||2||f||||t||||||Samples With DNA|"~     Full blood~   "|||2017-02-18 13:42:05.853162|2017-02-18 13:42:05.853162
NCT00792025|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2011-05-14|||December 2008||2008-12-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer|A Multicentre Phase II Trial to Determine the Efficacy of the Anti-Tyrosine Kinase Sunitinib (Sutent®) as Second Line Therapy in Patients With Transitional Cell Carcinoma (TCC) of the Urothelium Which Failed or Progressed After First Line Chemotherapy for Advanced or Metastatic Disease|Completed||Phase 2|80|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:42:05.948336|2017-02-18 13:42:05.948336
NCT00792012|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-09-06|||November 2005||2005-11-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma|A Phase I Dose Per Fraction Escalation Study of Hypofractionated Intensity-Modulated Radiation Therapy (Hypo-IMRT) Combining With Temozolomide (TMZ) Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)|Completed||Phase 1|37|Actual|University of Colorado, Denver||1|||f||||t||||||||No||2017-02-18 13:42:06.045484|2017-02-18 13:42:06.045484
NCT00791999|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2012-08-09|2012-06-18||November 2008||2008-11-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Pharmacokinetics and Safety of CDP870 as add-on Medication to MTX in Japanese Active RA Patients Who Have an Incomplete Response to MTX.|Completed||Phase 2/Phase 3|316|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-02-18 13:42:06.159534|2017-02-18 13:42:06.159534
NCT00791986|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2008-11-14|||May 2006||2006-05-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Loaded Breathing Training in Essential Hypertension|Effects of Loaded Breathing Training on Blood Pressure in Essential Hypertensive Patients|Terminated||N/A|30|Actual|Khon Kaen University||3||End of study time and budget permission|f||||t||||||||||2017-02-18 13:42:06.882821|2017-02-18 13:42:06.882821
NCT00791973|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2014-06-06|2014-06-06||November 2008||2008-11-01|June 2014|2014-06-01|May 2010|Actual|2010-05-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen|Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen|Completed||Phase 4|15|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 13:42:06.99756|2017-02-18 13:42:06.99756
NCT00791960|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2010-03-25|||November 2008||2008-11-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting|Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting: A Randomized, Double Blind, Placebo-Controlled Trial|Completed||N/A|149|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-02-18 13:42:07.341374|2017-02-18 13:42:07.341374
NCT00791947|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2011-09-07|||October 2001||2001-10-01|September 2011|2011-09-01|August 2010|Actual|2010-08-01|August 2008|Actual|2008-08-01||Interventional|||A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT|A Nordic Phase II Study of Peripheral T-cell Lymphomas Based on Dose-intensive Induction and High-dose Consolidation With Autologous Stem Cell Rescue|Completed||Phase 2|166|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 13:42:07.454734|2017-02-18 13:42:07.454734
NCT00791934|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2014-07-18|2014-05-06||August 2008||2008-08-01|July 2014|2014-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|DELIVER||Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide|Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide (Kenalog-40)|Completed||Phase 3|63|Actual|Acclarent||1|||f||||f||||||||||2017-02-18 13:42:07.547924|2017-02-18 13:42:07.547924
NCT00791921|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2012-08-05|2012-06-18||November 2008||2008-11-01|August 2012|2012-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Trial to Assess the Efficacy, Pharmacokinetics, and Safety of CDP870 Without Coadministration of MTX in Japanese Active RA Patients in Whom MTX Cannot be Administrated.|Completed||Phase 3|230|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 13:42:07.865541|2017-02-18 13:42:07.865541
NCT00791908|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2015-02-18|2010-08-30||September 2006||2006-09-01|February 2015|2015-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of Electrodessication, Potassium Titanyl Phosphate (KTP) Laser and Pulsed Dye Laser for Treatment of Cherry Angiomata|Comparison of Electrodessication, Potassium Titanyl Phosphate (KTP) Laser and Pulsed Dye Laser for Treatment of Cherry Angiomata|Completed||N/A|15|Actual|Northwestern University|Absence of a cost analysis; all the participants were white; only one set of parameters (ie, for lasers, pulse duration and fluence; and for electrodesiccation, energy level) was used for treatment with each modality.|3|||f||||f||||||||||2017-02-18 13:42:08.350504|2017-02-18 13:42:08.350504
NCT00791895|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2017-01-10|||June 2003||2003-06-01|January 2017|2017-01-01|November 2004|Actual|2004-11-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs|NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) Titrate-To-Target: An Observational Study of the Efficacy of NovoLog® Mix 70/30 in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets on OADs With / Without Once Daily Basal Insulin Therapy|Completed||Phase 4|102|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 13:42:08.619378|2017-02-18 13:42:08.619378
NCT00791882|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2009-11-27|||August 2009||2009-08-01|November 2009|2009-11-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|SST||Social Skills Training in Refractory Schizophrenia|Evaluation of Social Skills Training in Reducing Negative Symptoms in Patients With Refractory Schizophrenia|Unknown status|Recruiting|N/A|92|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:42:08.745492|2017-02-18 13:42:08.745492
NCT00791856|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-04-15|||July 2007||2007-07-01|April 2013|2013-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch|An Open-label, Multiple-dose, Randomized, Two-period Crossover Study to Assess Bioequivalence of the 300 Mcg/Day Testosterone Reduced-size Patch (14 cm2) Relative to the 300 Mcg/Day Testosterone Reference Patch (28 cm2)|Completed||Phase 1|110|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 13:42:08.941408|2017-02-18 13:42:08.941408
NCT00791843|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2013-12-09|||March 2004||2004-03-01|December 2013|2013-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|GHRH||The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure|The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure|Completed||Phase 2|3|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 13:42:09.036616|2017-02-18 13:42:09.036616
NCT00791830|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2013-01-07|||April 2009||2009-04-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|SAFIR||Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan|Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan - a Double Blind Randomised Study|Completed||Phase 3|82|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 13:42:09.137982|2017-02-18 13:42:09.137982
NCT00791817|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-08-04|2011-08-04||August 2005||2005-08-01|August 2011|2011-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study to Evaluate Potential Food Effects|An Open-label, Single Dose, Randomized, Crossover Study to Evaluate Potential Food Effects|Completed||Phase 1|10|Actual|Procter and Gamble||2|||f||||f||||||||||2017-02-18 13:42:09.262558|2017-02-18 13:42:09.262558
NCT00791804|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-14|||February 2004||2004-02-01|November 2008|2008-11-01|December 2004|Actual|2004-12-01|June 2004|Actual|2004-06-01||Interventional|Pain||Phase II Study of Inhaled AeroLEF for Analgesia After ACL Knee Surgery|A Phase II Study Evaluating Inhaled AeroLEF(Liposome-Encapsulated Fentanyl 500mcg/mL)for Post-Operative Pain in Adults After ACL Knee Surgery.|Completed||Phase 2|19|Actual|YM BioSciences||1|||f||||f||||||||||2017-02-18 13:42:09.642837|2017-02-18 13:42:09.642837
NCT00791791|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2012-06-14|||August 2008||2008-08-01|June 2012|2012-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of Surgical Stress Index (SSI) During Sevoflurane/Remifentanil Anesthesia||Completed||N/A|24|Actual|University of Schleswig-Holstein||2|||f||||f||||||||||2017-02-18 13:42:09.757928|2017-02-18 13:42:09.757928
NCT00791778|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2015-08-26|2012-11-01||November 2008||2008-11-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|July 2011|Actual|2011-07-01||Interventional|||Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer|A Double-Blind, Randomized Phase II Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Ovarian Epithelial Cancer or Primary Peritoneal Cancer Patients Who Have Achieved a Complete Clinical Response After Standard Platinum/Taxane Containing Chemotherapy|Completed||Phase 2|246|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:42:09.871596|2017-02-18 13:42:09.871596
NCT00791765|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-14|2014-07-14|2010-09-03||October 2008||2008-10-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Moderate to Severe Plaque Psoriasis With Scalp Involvement|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Treating Scalp Involvement in Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 4|124|Actual|Amgen||2|||f||||||||||||||2017-02-18 13:42:11.349426|2017-02-18 13:42:11.349426
NCT00791752|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2009-06-15|||November 2008||2008-11-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|||||Interventional|||Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017|A Randomized, Single-Blind, Placebo-Controlled, Single-Centre, Phase 1Study in Healthy Volunteers to Assess the Safety, Tolerability andPharmacokinetics of AZD4017 After Single Ascending Oral Doses|Completed||Phase 1|40|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 13:42:11.991497|2017-02-18 13:42:11.991497
NCT00791739|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2014-12-01|||April 2008||2008-04-01|December 2014|2014-12-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia|Open Label Trial Concerning the Effectiveness of Trazodone in the Treatment of Fibromyalgia (Phase I) and Its Augmentation With Pregabalin in Trazodone Partial Responders (Phase II)|Completed||Phase 4|66|Actual|Universidad de Granada||1|||f||||f||||||||||2017-02-18 13:42:12.109196|2017-02-18 13:42:12.109196
NCT00791726|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-07-19|||November 2008||2008-11-01|March 2011|2011-03-01||||||||Observational|||Microperimetry in Macular Edema|Place of Fundus-related Microperimetry in Uveitic Macular Edema|Completed||N/A|30|Anticipated|St. Franziskus Hospital|||1||f||||f||||||||||2017-02-18 13:42:12.225835|2017-02-18 13:42:12.225835
NCT00791713|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-05-18|||March 2006||2006-03-01|January 2009|2009-01-01|July 2006|Actual|2006-07-01|||||Interventional|||A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER|A Randomized, Open-label, Single-center, Crossover Study of the Potential Effects of Paroxetine on the Pharmacokinetics of a Single Dose of Paliperidone Extended-release in Healthy Men|Completed||Phase 1|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:12.31099|2017-02-18 13:42:12.31099
NCT00791700|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-12-21|2015-10-06||April 2009||2009-04-01|December 2016|2016-12-01|July 2019|Anticipated|2019-07-01|April 2015|Actual|2015-04-01||Interventional||The Full Analysis Set (FAS) consisted of all participants who received at least 1 dose of study drug (same as analysis population set [APS] 4).|An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children|An Open-label, Multicenter, Multiple-dose Pharmacokinetic, Safety And Efficacy Trial Of Maraviroc In Combination With Optimized Background Therapy For The Treatment Of Antiretroviral-experienced Ccr5-tropic Hiv-1 Infected Children 2 - <18 Years Of Age|Active, not recruiting||Phase 2|103|Actual|ViiV Healthcare|"Although the Participant Flow Table title indicates Overall Study, the data presented in that table is Subject Discontinuations Through Week 48. The study is ongoing."|1|||f||||t||||||||||2017-02-18 13:42:12.426292|2017-02-18 13:42:12.426292
NCT00791687|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-13|||January 2003||2003-01-01|November 2008|2008-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|RESOX||Prenatal Corticosteroids and Antioxidants in Preterm Infants|Prenatal Corticosteroids Enhance the Antioxidant Defense System in Extremely Low Gestational Age Neonates|Completed||N/A|57|Actual|Fundacion Para La Investigacion Hospital La Fe|||2||f||||f||||||||||2017-02-18 13:42:14.27961|2017-02-18 13:42:14.27961
NCT00791674|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-13|||December 2007||2007-12-01|November 2008|2008-11-01||||||||Observational|||Opiate Sleep Disordered Breathing Study|Sleep Disordered Breathing in Patients With Chronic Pain and Long Term Opiate Therapy|Unknown status|Recruiting|N/A|50|Anticipated|Adelaide Institute for Sleep Health|||1||f||||f||||||||||2017-02-18 13:42:14.376169|2017-02-18 13:42:14.376169
NCT00791648|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-04-12|||July 2009||2009-07-01|April 2016|2016-04-01||||October 2014|Actual|2014-10-01||Interventional|||Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery|Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery|Active, not recruiting||N/A|653|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 13:42:17.916823|2017-02-18 13:42:17.916823
NCT00791635|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-11-10|||September 2008||2008-09-01|November 2016|2016-11-01||||September 2018|Anticipated|2018-09-01||Observational|||Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy|Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy|Recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 13:42:18.028911|2017-02-18 13:42:18.028911
NCT00791622|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-05-17|||January 2006||2006-01-01|April 2010|2010-04-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating QT/QTc Intervals Following Administration of Extended-release Paliperidone and Quetiapine in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|110|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:18.147617|2017-02-18 13:42:18.147617
NCT00791609|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-13|||March 2008||2008-03-01|November 2008|2008-11-01||||||||Observational|||Evaluation the Feasibility of the FOSTI Device|Evaluation the Feasibility of the FOSTI Device Accurately and in a Real Time Way to Differentiate Malignant From Benign Tissue (Performed ex Vivo) in Cancer Surgery|Unknown status|Active, not recruiting|N/A|50|Actual|Optivasive Ltd.|||1||f||||f||||||||||2017-02-18 13:42:18.237135|2017-02-18 13:42:18.237135
NCT00791596|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-13|||January 2005||2005-01-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|June 2005|Actual|2005-06-01||Interventional|||Effectiveness of Ergonomic Intervention|Effectiveness of an Ergonomic Intervention on Work-Related Posture and Low Back Pain in Video Display Terminal Operators: a 3 Year Cross-Over Trial|Completed||Phase 4|200|Actual|University of Bologna||2|||f||||f||||||||||2017-02-18 13:42:18.311471|2017-02-18 13:42:18.311471
NCT00791583|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2012-08-22|||May 2008||2008-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|November 2008|Actual|2008-11-01||Observational|EM CVC MBP||ED Residents MBP During CVC Placement: Sim Lab Based Training|Emergency Medicine Residents Performance in Maximum Barrier Precautions During Central Venous Catheter Placement: Effect of Stimulation-based Training|Completed||N/A|76|Actual|St. Luke's-Roosevelt Hospital Center|||1||f||||f||||||||||2017-02-18 13:42:18.424324|2017-02-18 13:42:18.424324
NCT00791570|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-10-14|||October 2008||2008-10-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy|Histocompatibility Leukocyte Antigen (HLA)-A*2402 and A*0201 Restricted Peptide Vaccine Therapy in Patients With Neovascular Maculopathy|Completed||Phase 1|17|Actual|Osaka University||1|||f||||t||||||||||2017-02-18 13:42:18.586828|2017-02-18 13:42:18.586828
NCT00791557|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-09-27|2013-09-03||October 2008||2008-10-01|September 2016|2016-09-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease|An Open Label Single Center Pilot Study Investigating the Clinical Response and Mechanism of Action of Infliximab in the Treatment of Adults With Inflammatory Bowel Disease Who Have Moderate to Severe Pyoderma Gangrenosum|Completed||N/A|2|Actual|University Hospitals Cleveland Medical Center|Due to timing of the study, only 2 subjects were enrolled.|1|||f||||f||||||||||2017-02-18 13:42:18.837852|2017-02-18 13:42:18.837852
NCT00791544|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2010-08-03|||November 2008||2008-11-01|August 2010|2010-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma|Dose-finding, Safety, Pharmacokinetic and Pharmacodynamic Study of AVE1642, an Anti-Insulin-like Growth Factor-1 Receptor (IGF-1R/CD221) Monoclonal Antibody, Administered as Single Agent and in Combination With Other Anti Cancer Therapies (Sorafenib or Erlotinib) in Patients With Advanced Liver Carcinoma|Terminated||Phase 1/Phase 2|13|Actual|Sanofi||8||"Company decision to discontinue the AVE1642 development program, not due to any safety or~   efficacy concerns"|f||||t||||||||||2017-02-18 13:42:19.050818|2017-02-18 13:42:19.050818
NCT00791531|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2012-04-23|||March 2009||2009-03-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan Volunteers|Phase 1 Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan Volunteers|Completed||Phase 1|25|Actual|KEMRI-Wellcome Trust Collaborative Research Program||1|||f||||f||||||||||2017-02-18 13:42:19.176064|2017-02-18 13:42:19.176064
NCT00791518|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2014-07-24|2010-03-25||December 2008||2008-12-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|LABD||Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy|An Evaluation of Lung Function and Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy|Completed||N/A|1084|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 13:42:19.304512|2017-02-18 13:42:19.304512
NCT00791505|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-13|||July 2002||2002-07-01|November 2008|2008-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Trimethoprim-Sulfamethoxazole Versus Ciprofloxacin in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical Ventilation|Antibiotic Comparison Exacerbation COPD|Completed||Phase 3|170|Actual|University of Monastir||2|||f||||f||||||||||2017-02-18 13:42:19.952379|2017-02-18 13:42:19.952379
NCT00791492|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2012-11-16|2012-11-16||July 2008||2008-07-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|August 2008|Actual|2008-08-01||Interventional|||An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy|An Open-Label Extension Of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy|Completed||Phase 2/Phase 3|86|Actual|Pfizer|Instead of intended endpoint 'heat pain and cooling threshold', results of 'summated 3 score for small nerve fiber function' were reported. Designation of outcomes as primary and secondary was based on study team input as study did not specify this.|1|||f||||f||||||||||2017-02-18 13:42:20.054108|2017-02-18 13:42:20.054108
NCT00790855|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2012-12-03|2012-06-22||November 2008||2008-11-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Bendamustine in Acute Leukemia and MDS|Phase I-II Study of Bendamustine in Patients With Acute Leukemia and High-Risk Myelodysplastic Syndrome (MDS)|Terminated||Phase 1/Phase 2|27|Actual|M.D. Anderson Cancer Center||1||Lack of Response|f||||t||||||||||2017-02-18 13:42:38.74998|2017-02-18 13:42:38.74998
NCT00791479|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2014-12-08|2014-10-03||December 2008||2008-12-01|December 2014|2014-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Participants who received at least one dose of study drug.|Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes|Assessment of Dose-Dependent Effects of LY2189265 on Glycemic Control in Patients With Type 2 Diabetes Treated Only With Lifestyle Interventions|Completed||Phase 2|167|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-02-18 13:42:21.028066|2017-02-18 13:42:21.028066
NCT00791466|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-11-16|||September 2008||2008-09-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2012|Actual|2012-05-01||Interventional|MITCH||Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development|Iodine Supplementation in Pregnant Women Living in Mild-to-moderately Iodine Deficient Areas in India and Thailand: Effects on Pregnancy Outcome and Infant Development|Completed||N/A|829|Actual|Wageningen University||2|||f||||t||||||||||2017-02-18 13:42:23.576665|2017-02-18 13:42:23.576665
NCT00791453|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2009-05-11|||April 2008||2008-04-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|CHEC||Clarksdale Diabetes and Metabolism Clinic CHEC Study|Clarksdale Diabetes and Metabolism Clinic Consumer Health Education Center Study|Completed||N/A|55|Actual|University of Mississippi Medical Center|||1||f||||t||||||Samples Without DNA|"~     No biospecimens are retained~   "|||2017-02-18 13:42:23.844269|2017-02-18 13:42:23.844269
NCT00791440|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2012-12-12|||November 2008||2008-11-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy|Psychosis in Schizophrenia: Mechanisms of Recovery|Completed||N/A|34|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 13:42:23.936832|2017-02-18 13:42:23.936832
NCT00791427|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2015-05-07|||November 2008||2008-11-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|FVF4154s||ERG/EOG Study in AMD Patients Treated With Ranibizumab|ERG/EOG Study in AMD Patients Treated With Ranibizumab|Completed||N/A|10|Actual|Retina Center, Minnesota|||1||f||||||||||||||2017-02-18 13:42:24.041832|2017-02-18 13:42:24.041832
NCT00790582|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2009-03-11|||May 2008||2008-05-01|March 2009|2009-03-01|July 2010|Anticipated|2010-07-01|March 2010|Anticipated|2010-03-01||Interventional|Lithium||A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)|A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Forbes Norris MDA/ALS Research Center||1|||f||||t||||||||||2017-02-18 13:42:24.13353|2017-02-18 13:42:24.13353
NCT00790569|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2013-12-12|2013-12-12||September 2008||2008-09-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||All eligible participants who completed enrollment and were randomized were included in baseline analyses.|Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking|Varenicline Versus Nicotine Replacement for Methadone-Maintained Smokers|Completed||N/A|315|Actual|Butler Hospital||3|||f||||t||||||||||2017-02-18 13:42:24.260359|2017-02-18 13:42:24.260359
NCT00790556|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2016-02-11|2010-09-10||October 2008||2008-10-01|February 2016|2016-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245 (8245-004)(COMPLETED)|A Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245.|Completed||Phase 1|14|Actual|Merck Sharp & Dohme Corp.|Stat. analysis of HGP was not performed as insulin suppression lead to a near complete suppression of HGP in both placebo and MK-8245 treated subjects, making it impossible to determine if MK-8245 could lead to a greater insulin effect than placebo|2|||f||||||||||||||2017-02-18 13:42:25.139581|2017-02-18 13:42:25.139581
NCT00790543|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-03-25|||November 2008||2008-11-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|RS||Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease|Risk Stratification and Identification of Immunogenetic and Microbial Markers of Rapid Disease Progression in Children With Crohn's Disease|Active, not recruiting||N/A|2000|Anticipated|Emory University|||1||f||||f||||||Samples With DNA|"~     At time of enrollment, whole blood for DNA and serum will be collected in all patients.~     Fresh fecal samples will also be requested. For gene expression analysis, biopsy specimens~     will be collected during regularly scheduled endoscopies.~   "|No||2017-02-18 13:42:25.443102|2017-02-18 13:42:25.443102
NCT00790530|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2008-11-11|||June 2006||2006-06-01|November 2008|2008-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|ATO-SR-DM||Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study|Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study|Completed||N/A|1200|Actual|Harvard Pilgrim Health Care||2|||f||||f||||||||||2017-02-18 13:42:25.573278|2017-02-18 13:42:25.573278
NCT00790517|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2015-03-12|||June 2009||2009-06-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|STRIDE||Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)|Reducing Weight and Diabetes Risk in an Underserved Population|Completed||Phase 2|200|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 13:42:25.675651|2017-02-18 13:42:25.675651
NCT00790504|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2008-11-12|||November 2008||2008-11-01|November 2008|2008-11-01||||||||Observational|||Transperineal Ultrasound for the Female Pelvic Floor in Women With Multiple Gestation|Prospective Follow up of the Female Pelvic Floor in Multiple Gestation Using Transperineal Ultrasound|Unknown status|Not yet recruiting|N/A|100|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-02-18 13:42:25.791741|2017-02-18 13:42:25.791741
NCT00790491|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2013-11-06|||October 2007||2007-10-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Automated Guidance Tool for Medical Encounters Addressing Therapeutic Lifestyle Changes (AuGMEnT).|Automated Guidance Tool for Medical Encounters Addressing Therapeutic Lifestyle Changes (AuGMEnT)|Completed||N/A|240|Actual|Griffin Hospital||1|||f||||f||||||||||2017-02-18 13:42:25.876837|2017-02-18 13:42:25.876837
NCT00790478|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2009-12-22|||January 2009||2009-01-01|February 2009|2009-02-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|Melatonin & UC||Melatonin & Ulcerative Colitis|Melatonin and Ulcerative Colitis: A Pilot Clinical Trial|Unknown status|Recruiting|Phase 2|60|Anticipated|Emory University||2|||f||||t||||||||||2017-02-18 13:42:25.970457|2017-02-18 13:42:25.970457
NCT00791414|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2009-03-02|||November 2007||2007-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:42:26.086777|2017-02-18 13:42:26.086777
NCT00791401|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-06-09|||April 2004||2004-04-01|March 2010|2010-03-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function|The Pharmacokinetics of ER OROS Paliperidone in Subjects With Varying Degrees of Impaired Renal Function (Mild, Moderate, and Severe) as Compared to Subjects With Normal Renal Function|Completed||Phase 1|47|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:26.14081|2017-02-18 13:42:26.14081
NCT00791388|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-09-27|2011-08-03||August 2005||2005-08-01|September 2011|2011-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 Days|Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of PG 760564 Administered Twice Daily to Healthy Male and Female Volunteers for 14 Days (27 Doses).|Completed||Phase 1|45|Actual|Procter and Gamble||5|||f||||f||||||||||2017-02-18 13:42:26.248002|2017-02-18 13:42:26.248002
NCT00791375|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2012-04-19|||May 2009||2009-05-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Web-based Physical Activity Intervention for Young Adult Cancer Survivors|Web-based Physical Activity Intervention for Young Adult Cancer Survivors|Completed||N/A|18|Actual|The Miriam Hospital||2|||f||||f||||||||||2017-02-18 13:42:27.172673|2017-02-18 13:42:27.172673
NCT00791362|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2013-07-08|||December 2008||2008-12-01|May 2012|2012-05-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Evaluation Research of a National Accreditation and Improvement Programme for General Practice|Effects and Costs of a National Continuous Improvement Programme on Cardiovascular Diseases in Primary Care|Completed||N/A|1685|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 13:42:27.280934|2017-02-18 13:42:27.280934
NCT00791349|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-06-06|||February 2005||2005-02-01|March 2010|2010-03-01|May 2005|Actual|2005-05-01|||||Interventional|||A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone|A Placebo- and Positive-controlled, Randomized Study Evaluating QT and QTc Intervals Following Administration of Immediate-release Paliperidone in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 1|141|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:27.38061|2017-02-18 13:42:27.38061
NCT00791336|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2015-04-09|||August 2008||2008-08-01|April 2015|2015-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer|A Phase II Trial of the HIV Protease Inhibitor Nelfinavir and Concurrent Radiation and Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer|Terminated||Phase 2|1|Actual|University of Iowa||1||Poor enrollment.|f||||t||||||||||2017-02-18 13:42:27.473933|2017-02-18 13:42:27.473933
NCT00791323|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2011-09-21|2011-08-17||November 2008||2008-11-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy of Ketorolac 0.4% in Prostaglandin Suppression||Completed||Phase 4|9|Actual|Allergan||2|||f||||f||||||||||2017-02-18 13:42:27.585935|2017-02-18 13:42:27.585935
NCT00791310|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2010-12-30|||November 2008||2008-11-01|December 2010|2010-12-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|||Evaluation of MorphoTEP With the FDG Among Patients in Severe Sepsis of Unspecified Etiology|Phase 3b,Evaluation of MorphoTEP With the FDG Among Patients in Severe Sepsis of Unspecified Etiology|Unknown status|Recruiting|Phase 3|30|Anticipated|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-02-18 13:42:27.911223|2017-02-18 13:42:27.911223
NCT00791297|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2015-04-16|||October 2008||2008-10-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914|A Phase 2, Randomized Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914 on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women|Completed||Phase 2|60|Anticipated|Population Council||2|||f||||f||||||||||2017-02-18 13:42:28.166342|2017-02-18 13:42:28.166342
NCT00791284|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-06-06|||August 2004||2004-08-01|March 2010|2010-03-01|December 2004|Actual|2004-12-01|||||Interventional|||A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function|Pharmacokinetics of Paliperidone in Subjects With Moderate Hepatic Impairment as Compared to Subjects With Normal Hepatic Function.|Completed||Phase 1|20|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:28.270769|2017-02-18 13:42:28.270769
NCT00791271|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2015-11-12|||September 2008||2008-09-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion|A Parallel Phase I/II Study of Low Dose Decitabine (5-Aza-Deoxycytidine) With Peginterferon Alfa-2b in Advanced Melanoma|Completed||Phase 1|17|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 13:42:28.357175|2017-02-18 13:42:28.357175
NCT00791258|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2010-09-30|2010-09-02||November 2008||2008-11-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|BP CRUSH||A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure|A Prospective, Open-Label, Titration Study to Evaluate the Efficacy and Safety Safety of AZOR in Multiple Subgroups of Hypertensive Subjects Who Are Non-Responders to Anti-Hypertensive Monotherapy|Completed||Phase 4|999|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 13:42:28.503578|2017-02-18 13:42:28.503578
NCT00791245|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2014-08-07|||January 2006||2006-01-01|August 2014|2014-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Post Market Study of DeNovo NT, Natural Tissue Graft|A Post Market Study of Articular Cartilage Defects of the Knee Treated Wtih DeNovo NT, Natural Tissue Graft|Completed||N/A|25|Actual|Zimmer Orthobiologics, Inc.|||1||f||||||||||||||2017-02-18 13:42:30.91786|2017-02-18 13:42:30.91786
NCT00791232|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-06-06|||March 2003||2003-03-01|March 2010|2010-03-01|June 2003|Actual|2003-06-01|||||Interventional|||A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia|A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Phase 1 Study to Compare the Tolerability of OROS Paliperidone (Extended Release) With Immediate-release (IR) Risperidone in Subjects With Schizophrenia|Completed||Phase 1|113|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:31.008693|2017-02-18 13:42:31.008693
NCT00791219|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2012-03-22||2012-03-22|November 2008||2008-11-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Study Comparing SUBA™-Itraconazole With SPORANOX® (Itraconazole) in the Treatment of Onychomycosis|A Randomized, Double Blind, Multiple-site, Placebo-Controlled Study, Comparing the Efficacy and Safety of SUBA™-Itraconazole Capsules Compared to SPORANOX® (Itraconazole) Capsules in the Treatment of Onychomycosis of the Toenail|Completed||Phase 2|175|Actual|Halcygen Pharmaceuticals Limited||3|||f||||f||||||||||2017-02-18 13:42:31.096655|2017-02-18 13:42:31.096655
NCT00791206|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2013-12-13|||November 2008||2008-11-01|December 2013|2013-12-01|June 2014|Anticipated|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Trial of the Effects of Remote Preconditioning on the Tissue Metabolism During Exercise and Ischemia|Single Blind Randomized Controlled Crossover Trial of the Effects of Remote Preconditioning on the Tissue Metabolism During Exercise and Ischemia|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 13:42:31.21449|2017-02-18 13:42:31.21449
NCT00791193|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-05-17|||March 2007||2007-03-01|April 2010|2010-04-01|May 2007|Actual|2007-05-01|||||Interventional|||A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR|Pharmacokinetic Evaluation of the Relative Bioavailability of Three Paliperidone Extended Release (ER) Formulations With Different in Vitro Release Profiles, and Comparison to Paliperidone Immediate Release (IR), in Healthy Male Subjects|Completed||Phase 1|80|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:31.309551|2017-02-18 13:42:31.309551
NCT00791180|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-09-28|||March 2006||2006-03-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Posterior Lateral Fusion (PLF) With Dynesys|Clinical Outcomes Following Posterior Lateral Fusion With the Dynesys(R) Spinal System|Completed||N/A|38|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 13:42:31.392873|2017-02-18 13:42:31.392873
NCT00791167|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-05-17|||June 2006||2006-06-01|February 2009|2009-02-01|August 2006|Actual|2006-08-01|||||Interventional|||A Study of the Dose Proportionality of Extended Release Paliperidone|Evaluation of the Dose Proportionality of Two Dose Strengths (1.5 and 3 mg) of Extended-release Paliperidone After a Single Administration to Healthy Men|Completed||Phase 1|58|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:31.486056|2017-02-18 13:42:31.486056
NCT00791154|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-10-26||2015-02-02|December 2008||2008-12-01|October 2016|2016-10-01|February 2013|Actual|2013-02-01|June 2012|Actual|2012-06-01||Interventional|||QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer|Amgen Protocol 20060534 - A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer|Completed||Phase 1/Phase 2|204|Actual|NantCell, Inc.||3|||f||||||||||||||2017-02-18 13:42:31.576965|2017-02-18 13:42:31.576965
NCT00791141|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2014-01-22|||August 2008||2008-08-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional|ACCRA-HN||Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer|Multicenter, Open-label Phase II Trial on Post-surgery Chemoradiation in Combination With Cetuximab in Squamous Cell Carcinoma of the Head and Neck With High Risk of Locoregional Recurrence.|Completed||Phase 2|80|Actual|Heinrich-Heine University, Duesseldorf||1|||f||||t||||||||||2017-02-18 13:42:31.790307|2017-02-18 13:42:31.790307
NCT00791128|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-11-01|2016-11-01||October 2008||2008-10-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Study for Pre-Surgical Weight Loss in Type II Diabetes Patients|A Phase II Single-Center, Prospective, Open Label Study of Safety and Efficacy, of the GI Sleeve for Pre-Surgical Weight Loss, in Type II Diabetes Patients|Completed||Phase 2|22|Actual|GI Dynamics||1|||f||||f||||||||Undecided||2017-02-18 13:42:31.917996|2017-02-18 13:42:31.917996
NCT00791115|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-06-21|||June 2008||2008-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Salvage Prostatectomy After Radiotherapy|Salvage Prostatectomy After Radiotherapy: Whole-Mount Histopathological Validation for Tumor-Targeted Salvage HDR Brachytherapy|Active, not recruiting||N/A|16|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 13:42:32.204147|2017-02-18 13:42:32.204147
NCT00791102|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2013-07-08|2013-03-06||January 2010||2010-01-01|July 2013|2013-07-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)|A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial of Topical ASP-1001 (Contrast Media Formulation) in the Prevention of the Signs and Symptoms of the Acute Response to Nasal Allergen Challenge (NAC)|Completed||Phase 2/Phase 3|20|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 13:42:32.310408|2017-02-18 13:42:32.310408
NCT00791089|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-13|||November 2008||2008-11-01|November 2008|2008-11-01|October 2010|Anticipated|2010-10-01|December 2009|Anticipated|2009-12-01||Interventional|||Effects of Fish Oil on Post Ablation Arrhythmias|Effect of Omega-3 Fatty Acids on Short and Long-Term Maintenance of Sinus Rhythm After Radiofrequency Catheter Ablation for Atrial Fibrillation|Unknown status|Recruiting|Phase 4|200|Anticipated|University of Michigan||2|||f||||t||||||||||2017-02-18 13:42:32.642282|2017-02-18 13:42:32.642282
NCT00791076|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2010-03-25|||October 2007||2007-10-01|March 2010|2010-03-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Interventional|||The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients|The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 (Auto-immune) and Post-pancreatectomy Diabetic Patients|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 13:42:32.757278|2017-02-18 13:42:32.757278
NCT00791063|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2013-02-12|||March 2008||2008-03-01|February 2013|2013-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||18F ML-10 for Early Detection of Response of Brain Metastases to WBRT|An Open-Label Study to Evaluate 18F ML-10 as a PET Imaging Radiotracer for Early Detection of Response of Brain Metastases to Whole Brain Radiation Therapy (WBRT)|Completed||Phase 2|10|Actual|Aposense Ltd.||1|||f||||t||||||||||2017-02-18 13:42:32.873959|2017-02-18 13:42:32.873959
NCT00791050|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2008-11-13|||January 2009||2009-01-01|October 2008|2008-10-01|March 2010|Anticipated|2010-03-01|January 2010|Anticipated|2010-01-01||Interventional|||Examine the Effects of Maintaining Body Core Temperature During CABGs|To Examine the Effects on Patients Outcomes of Maintaining Body Core Temperature During CABGs With Thermowrap|Unknown status|Not yet recruiting|N/A|300|Anticipated|Centro Cardiologico Monzino||2|||f||||f||||||||||2017-02-18 13:42:32.977781|2017-02-18 13:42:32.977781
NCT00791037|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-09-06|||October 2008||2008-10-01|September 2016|2016-09-01||||July 2013|Actual|2013-07-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Breast Cancer|Phase I/II Study of Adoptive T Cell Therapy Following In Vivo Priming With a HER-2/Neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine in Patients With Advanced Stage HER2 Overexpressing Breast Cancer|Active, not recruiting||Phase 1/Phase 2|20|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 13:42:33.082343|2017-02-18 13:42:33.082343
NCT00791024|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2015-08-25|||November 2008||2008-11-01|August 2015|2015-08-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Development of a New Method for Analgesia|Phase One Study and Two of a New Method for Local Analgesia|Completed||Phase 1/Phase 2|126|Actual|Hvidovre University Hospital||1|||f||||t||||||||||2017-02-18 13:42:33.194712|2017-02-18 13:42:33.194712
NCT00791011|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2014-03-03|||February 2008||2008-02-01|March 2014|2014-03-01|August 2011|Actual|2011-08-01|July 2010|Actual|2010-07-01||Interventional|||Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat|A Phase 1b Study to Evaluate the Safety and Tolerability of AMG 655 in Combination With Bortezomib or Vorinostat in Subjects With Relapsed or Refractory Lymphoma|Completed||Phase 1|33|Actual|Amgen||7|||f||||||||||||||2017-02-18 13:42:33.287776|2017-02-18 13:42:33.287776
NCT00790998|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2013-11-26|||April 2009||2009-04-01|November 2013|2013-11-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|||Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection|A Single-Dose, Ivermectin-Controlled, Double-Blind, Efficacy, Safety And Tolerability Study Of Orally Administered Moxidectin In Subjects Infected With Onchocerca Volvulus|Completed||Phase 3|1497|Actual|World Health Organization||2|||f||||t||||||||||2017-02-18 13:42:33.416128|2017-02-18 13:42:33.416128
NCT00790985|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2015-10-19|||January 2008||2008-01-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy of Flavocoxid Compared With Naproxen in Subjects With Moderate-severe Osteoarthritis of the Knee|Phase 3. Efficacy of Flavocoxid Compared With Naproxen in Subjects With Moderate-severe Osteoarthritis of the Knee|Completed||N/A|220|Actual|Primus Pharmaceuticals||2|||f||||t||||||||||2017-02-18 13:42:33.535724|2017-02-18 13:42:33.535724
NCT00790972|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-05-19|||June 2007||2007-06-01|May 2016|2016-05-01|June 2013|Anticipated|2013-06-01|June 2010|Anticipated|2010-06-01||Interventional|||The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity|The Efficacy of SinoFresh Nasal and Sinus Care Nasal Spray in Eliminating MRSA From the Nasal Cavity|Withdrawn||N/A|0|Actual|University of Chicago||2||Company went out of business.|f||||f||||||||||2017-02-18 13:42:33.710182|2017-02-18 13:42:33.710182
NCT00790959|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2012-02-21|||October 2007||2007-10-01|February 2012|2012-02-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|SASA!||The SASA! Study: An Evaluation of a Community Intervention to Address Gender-based Violence and Reduce HIV/AIDS Risk in Uganda|The SASA! Study: a Cluster Randomised Controlled Trial of a Community Mobilisation Intervention to Prevention Violence Against Women and Reduce HIV/AIDS Risk in Kampala, Uganda|Unknown status|Recruiting|N/A|800|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-02-18 13:42:33.808923|2017-02-18 13:42:33.808923
NCT00790946|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2010-06-02|||June 2006||2006-06-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|KACT||Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)|Effects of Valsartan on Metabolic Syndrome in Patients With Hypertension|Unknown status|Recruiting|Phase 4|250|Anticipated|Kagoshima University||2|||f||||t||||||||||2017-02-18 13:42:36.279275|2017-02-18 13:42:36.279275
NCT00790933|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2017-01-13|||May 2009||2009-05-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|March 2016|Actual|2016-03-01||Interventional|GEMINI LTS||An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease|A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease|Active, not recruiting||Phase 3|2200|Anticipated|Takeda||1|||f||||t||||||||||2017-02-18 13:42:36.392671|2017-02-18 13:42:36.392671
NCT00790920|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2015-09-17|||December 2008||2008-12-01|September 2015|2015-09-01||||July 2014|Actual|2014-07-01||Interventional|DIAS-3||Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke|A Randomised, Double-blind, Parallel-group Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke|Completed||Phase 3|492|Actual|H. Lundbeck A/S||2|||f||||t||||||||||2017-02-18 13:42:36.545818|2017-02-18 13:42:36.545818
NCT00790907|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-11-30|2011-05-10||February 2009||2009-02-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|FUTURA/OASIS 8||Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)|FondaparinUx Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) (FUTURA). A Prospective Study Evaluating the Safety of Two Regimens of Adjunctive Intravenous UFH During PCI in High Risk Patients With Unstable Angina/Non ST Segment Elevation Myocardial Infarction (UA/NSTEMI) Initially Treated With Subcutaneous Fondaparinux and Referred for Early Coronary Angiography (OASIS 8)|Completed||Phase 4|3235|Actual|GlaxoSmithKline||3|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:42:36.974827|2017-02-18 13:42:36.974827
NCT00790894|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-05-17|||November 2008||2008-11-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|HIT||Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)|Phase II Randomized Trial of Ixabepilone Administered Weekly or Every Three Weeks in Patients With HER-2 Negative Metastatic Breast Cancer Previously Treated With Chemotherapy in the Neo-adjuvant or Adjuvant Setting|Terminated||Phase 2|64|Actual|Hellenic Cooperative Oncology Group||2||The low accrual rate of the study (25% of the expected accrual rate)|f||||f||||||||||2017-02-18 13:42:38.40059|2017-02-18 13:42:38.40059
NCT00790881|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2010-06-25|||October 2008||2008-10-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults|Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Nevirapine in HIV-infected Adults|Completed||Phase 4|36|Anticipated|University of Cape Town||2|||f||||t||||||||||2017-02-18 13:42:38.525292|2017-02-18 13:42:38.525292
NCT00790868|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2013-05-23|||April 2008||2008-04-01|April 2013|2013-04-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|DCSPanic||Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder|Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder|Unknown status|Active, not recruiting|Phase 2|192|Anticipated|Boston University||2|||f||||t||||||||||2017-02-18 13:42:38.636259|2017-02-18 13:42:38.636259
NCT00790842|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2017-01-23|||January 21, 2009|Actual|2009-01-21|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|PrE1003||Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction|A Phase I/II Study of the Tolerability of Lenalidomide and Low Dose Dexamethasone in Previously Treated Multiple Myeloma Patients With Impaired Renal Function|Active, not recruiting||Phase 1/Phase 2|62|Actual|PrECOG, LLC.||3|||f||||t|t|f||||||No|Data is proprietary.|2017-02-18 13:42:38.9868|2017-02-18 13:42:38.9868
NCT00790829|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-08-11|||August 2007||2007-08-01|August 2011|2011-08-01|September 2011|Anticipated|2011-09-01|August 2011|Anticipated|2011-08-01||Interventional|||Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal Surgery|Preemptive Use of Nicotine Patch for Postoperative Pain Relief in Open Abdominal Surgery|Unknown status|Recruiting|N/A|70|Anticipated|Stony Brook University||1|||f||||t||||||||||2017-02-18 13:42:39.318037|2017-02-18 13:42:39.318037
NCT00790816|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2016-10-31|||October 2008||2008-10-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents|An Open-Label Phase Ib Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-Cancer Treatment in Patients With Solid Tumors|Completed||Phase 1|500|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:42:39.433549|2017-02-18 13:42:39.433549
NCT00790803|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2013-07-15|2012-12-20||March 2009||2009-03-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Interventional|||Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema|Vascular Endothelial Growth Factor (VEGF)Blockade With Intravitreal Pegaptnib in Non-Infectious Uveitic Cystoid Macular Edema (CME)|Completed||N/A|5|Actual|Wake Forest University Health Sciences|Implementing screening protocols to catch less progressed CME cases could improve outcomes.|1|||f||||f||||||||||2017-02-18 13:42:39.758682|2017-02-18 13:42:39.758682
NCT00790790|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2012-04-11|2011-08-25||November 2008||2008-11-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study in the Treatment of Osteoarthritis Knee Pain|A Phase 2 Study of the Effects of LY545694, an iGluR5 Antagonist, in the Treatment of Subjects With Osteoarthritis Knee Pain|Completed||Phase 2|147|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 13:42:40.051288|2017-02-18 13:42:40.051288
NCT00790777|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-13|2011-05-17|||March 2007||2007-03-01|January 2009|2009-01-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville|A Single-dose, Open-label, Randomized, 2-way Crossover Pivotal Bioequivalence Study of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville Under Fasted Condition in Healthy Subjects|Completed||Phase 1|72|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:42:41.632646|2017-02-18 13:42:41.632646
NCT00790764|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2014-05-07|||November 2008||2008-11-01|April 2011|2011-04-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI)|Phase II Study for the Transfer of Bone Marrow-Derived Mononuclear and Mesenchymal StemCells Into the Myocardium for the Treatment of Severe Coronary Ischemia|Suspended||Phase 2|60|Anticipated|TCA Cellular Therapy||2||Suspended due to lack of funding.|f||||t||||||||||2017-02-18 13:42:41.714044|2017-02-18 13:42:41.714044
NCT00790751|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2012-06-27|2012-05-25||November 2008||2008-11-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|REVIVE||Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED|A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil (TA-1790) in Subjects With Generalized Erectile Dysfunction|Completed||Phase 3|646|Actual|VIVUS, Inc.||4|||f||||f||||||||||2017-02-18 13:42:41.815067|2017-02-18 13:42:41.815067
NCT00790738|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-06-05|2015-05-21||July 2008||2008-07-01|June 2015|2015-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|T3||Liothyronine (T3) for Bipolar Depression|Randomized Double-Blind Trial of Liothyronine (T3) Augmentation to Treatment as Usual vs Placebo For The Treatment of Bipolar Depression|Completed||Phase 3|11|Actual|Northwell Health|Despite several changes made in order to enhance recruitment during the study period, the study was markedly underpowered. Therefore, no definitive conclusions could be drawn from the data.|2|||f||||t||||||||||2017-02-18 13:42:42.604429|2017-02-18 13:42:42.604429
NCT00790725|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2012-04-24|||November 2008||2008-11-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Proportional Assist Ventilation vs Pressure Support Ventilation|Proportional Assist Ventilation vs. Pressure Support Ventilation in the Management of Patients Referred to a Respiratory Acute Care Unit|Terminated||N/A|12|Actual|Massachusetts General Hospital||2||"The patient population in RACU has changed significantly, we can not find potential subjects~   to recruit. The enrollment rate has reached zero."|f||||f||||||||||2017-02-18 13:42:42.964353|2017-02-18 13:42:42.964353
NCT00790699|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2011-11-16|||August 2009||2009-08-01|December 2009|2009-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port|A Randomized, Parallel, Single Center, Comparison, Pilot Study Evaluating the Safety and Efficacy of Using Symlin Alongside Insulin in a Multiple Injection Port (I-PORT)|Terminated||N/A|31|Actual|Texas Diabetes & Endocrinology, P.A.||2||Lack of patient population|f||||t||||||||||2017-02-18 13:42:43.055948|2017-02-18 13:42:43.055948
NCT00790686|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2014-08-20|||November 2008||2008-11-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|TOTEME||Tolerance and Effectiveness of Ureteral Stents MEMOKATH ® 051 in Chronic Strictures of the Ureter|Study of Tolerance and Effectiveness of Ureteral Stents MEMOKATH ® 051 in the Treatment of Chronic Strictures of the Ureter|Completed||Phase 2|13|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-02-18 13:42:43.158175|2017-02-18 13:42:43.158175
NCT00790673|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-03-31|2015-03-05||July 2009||2009-07-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1|A Phase 1/2, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating the Safety, Tolerability, Biological Activity, and Pharmacokinetics of Orally Administered CF102 in Subjects With Chronic Hepatitis C Genotype 1|Completed||Phase 1/Phase 2|32|Actual|Can-Fite BioPharma||4|||f||||t||||||||||2017-02-18 13:42:43.272998|2017-02-18 13:42:43.272998
NCT00789451|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2010-10-22|||August 2008||2008-08-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||The Effect of Ischaemic-reperfusion on the Endogenous Fibrinolysis in Man|The Effect of Ischaemic-reperfusion on the Endogenous Fibrinolysis in Man|Completed||N/A|12|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-02-18 13:43:20.152577|2017-02-18 13:43:20.152577
NCT00790660|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2015-06-05||2010-02-26|October 2008||2008-10-01|June 2015|2015-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.|A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Multiple Dose Study to Assess the Safety and Tolerability of ASP1941 in Adult Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|61|Actual|Astellas Pharma Inc||5|||f||||f||||||||||2017-02-18 13:42:43.690392|2017-02-18 13:42:43.690392
NCT00790647|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-12-13|2016-09-09||June 2008||2008-06-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|December 2012|Actual|2012-12-01||Interventional|||Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis|Phase II Trial of High-dose Melphalan and Bortezomib and Stem Cell Transplantation in Patients With AL Amyloidosis|Completed||Phase 2|10|Actual|Boston Medical Center||1|||f||||t||||||||No||2017-02-18 13:42:43.801255|2017-02-18 13:42:43.801255
NCT00790634|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-12|||December 2008||2008-12-01|November 2008|2008-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Mechanisms of Fronto-Subcortical Dysfunction: Comparing PD and OCD|Characterizing Mechanisms of Fronto-Subcortical Dysfunction: A Comparison Between Parkinson's Disease and Obsessive-Compulsive Disorder|Unknown status|Not yet recruiting|N/A|100|Anticipated|Sheba Medical Center|||4||f||||f||||||||||2017-02-18 13:42:44.085126|2017-02-18 13:42:44.085126
NCT00790621|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2008-11-12|||September 2007||2007-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:42:44.151041|2017-02-18 13:42:44.151041
NCT00790608|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2011-11-28|||January 2009||2009-01-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)|A Phase II Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus in MRSA Positive Ulcers|Terminated||Phase 2|8|Actual|Nitric BioTherapeutics, Inc||1||Limited recruitment|f||||f||||||||||2017-02-18 13:42:44.196725|2017-02-18 13:42:44.196725
NCT00790595|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2012-07-27|||June 2006||2006-06-01|July 2012|2012-07-01||||July 2009|Actual|2009-07-01||Interventional|||Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy|Phase I, Open Label, Single Center, Multiple Dose, Dose Escalation Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy|Completed||Phase 1|6|Actual|Jonsson Comprehensive Cancer Center||5|||f||||t||||||||||2017-02-18 13:42:44.296187|2017-02-18 13:42:44.296187
NCT00790465|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-12|||November 2008||2008-11-01|November 2008|2008-11-01|November 2010|Anticipated|2010-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Efficacy of Dark Chocolate in Achalasia Patients|Efficacy of Dark Chocolate in Achalasia Patients: Placebo-Controlled Study|Unknown status|Not yet recruiting|Phase 1/Phase 2|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-02-18 13:42:44.410218|2017-02-18 13:42:44.410218
NCT00790452|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2011-11-04|2011-11-04||November 2008||2008-11-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma|A Randomized Phase II Trial of Aspirin for Primary Prophylaxis of Venous Thromboembolism in Glioblastoma|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center|Study terminated early due due to a drug supply issue.|2||Low accrual.|f||||t||||||||||2017-02-18 13:42:44.501837|2017-02-18 13:42:44.501837
NCT00790439|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2014-06-10|||July 2008||2008-07-01|June 2014|2014-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant|Open Randomized Multi-Center Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran (LMW-SD) in Islet Transplantation After Kidney Transplantation (CIT-01B)|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2||Due to funding limitations|f||||t||||||||||2017-02-18 13:42:44.797702|2017-02-18 13:42:44.797702
NCT00790426|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-04-28|||March 2010||2010-03-01|April 2016|2016-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase II Study of TKI258 in Advanced Urothelial Carcinoma|A Phase II Multi-center, Non-randomized, Open Label Study of TKI258 in FGFR3 Mutated and FGFR3 Wild Type Advanced Urothelial Carcinoma|Completed||Phase 2|44|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:42:44.932298|2017-02-18 13:42:44.932298
NCT00790413|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-03-03|||August 2005||2005-08-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Haploidentical Stem Cell Transplantation in Neuroblastoma|High-dose MIBG With Subsequent Transplantation of Haploidentical Stem Cells in Children With Therapy Resistant Neuroblastoma|Active, not recruiting||Early Phase 1|15|Anticipated|Lund University Hospital||1|||f||||||||||||||2017-02-18 13:42:45.075204|2017-02-18 13:42:45.075204
NCT00790400|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2017-01-03|2012-05-23||April 2009||2009-04-01|January 2017|2017-01-01|November 2015|Actual|2015-11-01|June 2011|Actual|2011-06-01||Interventional|EXIST-2||Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)|A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)|Completed||Phase 3|118|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:42:45.285176|2017-02-18 13:42:45.285176
NCT00790387|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2010-03-23|||June 2004||2004-06-01|November 2008|2008-11-01|December 2006|Actual|2006-12-01|December 2005|Actual|2005-12-01||Interventional|||Tirofiban and Enoxaparin in High Risk Coronary Intervention|High Bolus Dose Tirofiban and Enoxaparin Provides Reduced Thrombin Generation and Inflammatory Markers in Patients With High Risk Undergoing Percutaneous Intervention|Completed||Phase 4|60|Actual|The Prince Charles Hospital||2|||f||||f||||||||||2017-02-18 13:42:46.627495|2017-02-18 13:42:46.627495
NCT00790374|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2011-02-28|||January 2009||2009-01-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|October 2010|Actual|2010-10-01||Interventional|STX64PC||BN83495 in Prostate Cancer|A Phase I Dose Escalating Study Evaluating the Pharmacodynamic Profile and Safety of BN83495 in Patients With Prostate Cancer With Evidence of Disease Progression While on Androgen Ablative Therapy|Completed||Phase 1|17|Actual|Ipsen||3|||f||||t||||||||||2017-02-18 13:42:46.740927|2017-02-18 13:42:46.740927
NCT00790361|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2010-06-02|||January 2012||2012-01-01|June 2010|2010-06-01|January 2013|Anticipated|2013-01-01|||||Observational|||The Natural History of Traumatic Spinal Cord Injury Using fMRI, MRS and DTI|Mapping the Natural History of Traumatic Spinal Cord Injury in the Sensorimotor Cortex Using Functional Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging|Unknown status|Not yet recruiting|N/A|20|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||||2017-02-18 13:42:46.848424|2017-02-18 13:42:46.848424
NCT00790348|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-12|||July 2008||2008-07-01|October 2008|2008-10-01||||July 2009|Anticipated|2009-07-01||Observational|||Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes|Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes|Unknown status|Recruiting|N/A|45|Anticipated|Wayne State University|||3||f||||f||||||Samples Without DNA|"~     Serum of patients will be kept for future studies~   "|||2017-02-18 13:42:46.956717|2017-02-18 13:42:46.956717
NCT00790335|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-11-28|||November 2009||2009-11-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|ATTRACT||Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis|Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial|Active, not recruiting||Phase 3|692|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 13:42:47.038907|2017-02-18 13:42:47.038907
NCT00790322|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2010-02-18|||October 2008||2008-10-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Study to Assess the Efficacy and Safety of SBG on Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy With or Without Chemotherapy|Completed||Phase 3|130|Actual|Biotec Pharmacon ASA||2|||f||||f||||||||||2017-02-18 13:42:47.229762|2017-02-18 13:42:47.229762
NCT00790309|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2016-10-31|||December 2008||2008-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Early Diabetes Resolution After Weight Loss Surgery|Hormonal and Inflammatory Parameters Affecting Early Diabetes Resolution Following Weight Loss Surgery|Enrolling by invitation||N/A|60|Anticipated|Vanderbilt University|||2||f||||f||||||Samples With DNA|"~     plasma and serum~   "|||2017-02-18 13:42:47.327563|2017-02-18 13:42:47.327563
NCT00790296|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2011-04-05|2011-01-31||December 2006||2006-12-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue|A Pilot, Randomized Double-Blind Placebo-Controlled Crossover Study of Synthetic Thyrotropin Releasing Hormone (TRH) Administration for the Treatment of Fatigue in Patients With Cancer|Terminated||Phase 2|11|Actual|UConn Health|Limitation: small sample size|2||Interim analyses showed statistically and clinically significant results.|f||||t||||||||||2017-02-18 13:42:47.415615|2017-02-18 13:42:47.415615
NCT00790283|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2009-02-16|||September 2008||2008-09-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|ANSWERS||Assessment of the Numen Stent With Evaluation in a Randomized Study|Assessment of the Numen Stent With Evaluation in a Randomized Study|Unknown status|Recruiting|Phase 2/Phase 3|500|Anticipated|International Biomedical Systems S.p.A.||2|||f||||f||||||||||2017-02-18 13:42:47.705053|2017-02-18 13:42:47.705053
NCT00790270|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2012-10-22|2009-10-19||January 2003||2003-01-01|October 2012|2012-10-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial|Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A Randomized Clinical Trial|Completed||Phase 2|61|Actual|Stony Brook University||3|||f||||f||||||||||2017-02-18 13:42:47.810895|2017-02-18 13:42:47.810895
NCT00790257|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-04-13|||November 2008||2008-11-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Safety and Efficacy Study of Encapsulated Human Islets Allotransplantation to Treat Type 1 Diabetes|A Monocentre Phase 1 Trial to Assess a Monolayer Cellular Device in the Treatment of Type 1 Diabetes|Completed||Phase 1|15|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-02-18 13:42:48.28885|2017-02-18 13:42:48.28885
NCT00790244|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2011-07-03|||October 2007||2007-10-01|November 2008|2008-11-01|October 2022|Anticipated|2022-10-01|October 2012|Anticipated|2012-10-01||Interventional|SSGXX||A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall|A Scandinavian Sarcoma Group Treatment Protocol for Adult Patients With Non-metastatic High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall|Recruiting||Phase 2|188|Anticipated|Oslo University Hospital||4|||f||||t||||||||||2017-02-18 13:42:48.399717|2017-02-18 13:42:48.399717
NCT00790231|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2009-11-19|||October 2008||2008-10-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Effects of Thoracic Epidural Anesthesia on Lower Urinary Tract Function|Effects of Thoracic Epidural Anesthesia on Lower Urinary Tract Function|Completed||N/A|32|Anticipated|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-02-18 13:42:48.539219|2017-02-18 13:42:48.539219
NCT00790218|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2015-02-26|2014-08-12||February 2009||2009-02-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma|A Phase 1-2, Open-label, Dose-escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered CF102 in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|19|Actual|Can-Fite BioPharma||1|||f||||t||||||||||2017-02-18 13:42:48.654222|2017-02-18 13:42:48.654222
NCT00790205|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2016-05-20|2016-03-15||December 2008||2008-12-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|TECOS||Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)|TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control|Completed||Phase 3|14671|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 13:42:49.208963|2017-02-18 13:42:49.208963
NCT00790192|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-03-11|2011-09-01||October 2008||2008-10-01|March 2016|2016-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|PEARL 3||Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.|A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3)|Completed||Phase 3|488|Actual|Sunovion||4|||f||||t||||||||||2017-02-18 13:42:51.763499|2017-02-18 13:42:51.763499
NCT00790179|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-12|||January 2003||2003-01-01|November 2008|2008-11-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty|Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty|Completed||N/A|225|Actual|Northwell Health||3|||f||||t||||||||||2017-02-18 13:42:52.82547|2017-02-18 13:42:52.82547
NCT00790166|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2009-06-23|||October 2008||2008-10-01|June 2009|2009-06-01|March 2010|Anticipated|2010-03-01|October 2009|Anticipated|2009-10-01||Interventional|CIA-6||Effects of Humidity (During CPAP Treatment) on Mucociliary Clearance in Patients With Obstructive Sleep Apnea|Effects of nCPAP With and Without Humidification on: Inspiratory Temperature, Humidity, Saccharine Transit Time, Nasal Lavage and in Vitro Mucus Properties in Patients With Obstructive Sleep Apnea|Terminated||Phase 1/Phase 2|20|Anticipated|Fisher and Paykel Healthcare||3|||f||||||||||||||2017-02-18 13:42:52.956462|2017-02-18 13:42:52.956462
NCT00790153|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2009-04-09|||November 2008||2008-11-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|||||Interventional|||To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension|A Randomized, Open, Two-Way Cross-Over, Single-Centre, Phase I Study to Assess the Counter Regulatory Response During Hypoglycaemia in Healthy Male Volunteers After a Single Oral Dose of AZD1656 Suspension in Comparison With Insulin Infusion|Completed||Phase 1|12|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 13:42:53.055507|2017-02-18 13:42:53.055507
NCT00790140|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-12|||July 2005||2005-07-01|November 2008|2008-11-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery|Randomized Double Blinded Trial to Investigate Effects of an Enteral Nutritional Supplement Enriched With Eicosapentaenoic Acid on Body Composition,Complications,Stress Response,Immune Function & Quality of Life in After Esophagectomy|Unknown status|Recruiting|Phase 4|120|Anticipated|University of Dublin, Trinity College||2|||f||||t||||||||||2017-02-18 13:42:53.159547|2017-02-18 13:42:53.159547
NCT00790127|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2011-05-18||2011-05-13|March 2009||2009-03-01|May 2011|2011-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia|A Multi-National, Blinded, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HQK-1001 in Subjects With Beta Thalassemia Intermedia, Including Hemoglobin E Beta Thalassemia|Completed||Phase 1/Phase 2|21|Actual|HemaQuest Pharmaceuticals Inc.||2|||f||||t||||||||||2017-02-18 13:42:53.267378|2017-02-18 13:42:53.267378
NCT00790114|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2008-11-12|||July 2008||2008-07-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|CYP||Determine the Effect of Multiple Doses of AZD7325, CYP Study|A Phase I Open-Labeled, Fixed Sequence Study to Determine the Effect of Multiple Doses of AZD7325 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)|Completed||Phase 1|24|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:42:53.361604|2017-02-18 13:42:53.361604
NCT00790101|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2011-01-10|||June 2004||2004-06-01|January 2011|2011-01-01|October 2004|Actual|2004-10-01|||||Interventional|||Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation|An 18-Month, Multicenter, Parallel-Group Study to Determine The Relative Efficacy of Risedronate Versus Raloxifene in Subjects Who Have Discontinued Hormone Replacement Therapy (HRT) for Early Intervention in Osteoporosis|Terminated||Phase 4|6|Actual|Sanofi||3|||f||||||||||||||2017-02-18 13:42:53.451906|2017-02-18 13:42:53.451906
NCT00790088|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2012-02-03|||February 2009||2009-02-01|February 2012|2012-02-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Observational|||INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy|International Report on Routine Practice of Sensor-enabled Pump Therapy|Unknown status|Active, not recruiting|N/A|300|Anticipated|Medtronic|||1||f||||f||||||Samples With DNA|"~     capillary blood samples for HbA1c analysis~   "|||2017-02-18 13:42:53.550352|2017-02-18 13:42:53.550352
NCT00790075|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-12|||January 2003||2003-01-01|November 2008|2008-11-01|December 2004|Actual|2004-12-01|June 2004|Actual|2004-06-01||Interventional|||Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children|Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children|Completed||Phase 4|24|Actual|Stony Brook University||1|||f||||f||||||||||2017-02-18 13:42:53.677672|2017-02-18 13:42:53.677672
NCT00790062|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-03-08|2012-05-30||November 2008||2008-11-01|March 2016|2016-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT|Comparison of the Effectiveness of 3 Different Dose Regimens of Oxytocin in Preventing Uterine Atony and Postpartum Hemorrhage During Vaginal Delivery|Completed||Phase 4|1798|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-02-18 13:42:53.78199|2017-02-18 13:42:53.78199
NCT00790049|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2012-04-23|||October 2008||2008-10-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Safety Study of ARRY-371797 in Healthy Subjects||Completed||Phase 1|40|Actual|Array BioPharma||2|||f||||f||||||||||2017-02-18 13:42:54.473504|2017-02-18 13:42:54.473504
NCT00790036|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2016-08-31|||July 2009||2009-07-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|PILLAR2||Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy|A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy|Completed||Phase 3|741|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:42:54.577693|2017-02-18 13:42:54.577693
NCT00790023|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2016-03-10|2012-02-15||November 2008||2008-11-01|March 2016|2016-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis|A Randomized, Multicenter, Double Blind, Placebo Controlled, Parallel Group, Phase III Clinical Trial to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol (160 μg Once Daily and 80 μg Once Daily) for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older.|Completed||Phase 3|707|Actual|Sunovion|This study was not designed or powered for a comparison of the 80mcg dose with the 160mcg dose therefore no statistical comparisons were planned between the two active groups. Publication references to 74 and 148mcg are equivalent to 80 and 160mcg|3|||f||||f||||||||||2017-02-18 13:42:54.917682|2017-02-18 13:42:54.917682
NCT00790010|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2017-01-04|||February 2009||2009-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma|A Phase I Trial of Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma|Active, not recruiting||Phase 1|46|Actual|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-02-18 13:42:57.886439|2017-02-18 13:42:57.886439
NCT00789997|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-03-29|2013-06-04||November 2008||2008-11-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial|TNF-alpha Antagonists for Acute Exacerbations of COPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial|Completed||Phase 2/Phase 3|81|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 13:42:58.020749|2017-02-18 13:42:58.020749
NCT00789984|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2008-11-12||||||November 2008|2008-11-01||||||||Observational|||Corneal Specular Microscopy in Infectious and Noninfectious Uveitis||Completed||Phase 4|||Federal University of São Paulo|||1||f||||t||||||||||2017-02-18 13:43:00.580718|2017-02-18 13:43:00.580718
NCT00789971|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2008-11-12|||March 2007||2007-03-01|November 2008|2008-11-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification|A Comparison of a Single Orbital Floor Injection of Triamcinolone Versus Conventional Steroid and Antibiotic Drops Used Post Operatively in Uneventful Phacoemulsification Surgery|Completed||N/A|150|Actual|Sligo General Hospital||1|||f||||t||||||||||2017-02-18 13:43:00.655744|2017-02-18 13:43:00.655744
NCT00789958|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-10-04|2016-08-02||December 2008||2008-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional||All eligible and analyzable patients that received protocol treatment.|S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct|A Phase II Trial of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed By Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC)|Active, not recruiting||Phase 2|105|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 13:43:00.780322|2017-02-18 13:43:00.780322
NCT00789945|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2013-04-04|||December 2008||2008-12-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|TIME||Timing of Insulin Before Meals Everyday|The Importance of Insulin Timing in Type 1 Diabetes|Completed||N/A|40|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 13:43:03.897368|2017-02-18 13:43:03.897368
NCT00789932|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2013-02-01|||September 2008||2008-09-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|BIACA-2||Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled Trial|Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled Trial|Completed||Phase 1/Phase 2|20|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-02-18 13:43:04.003458|2017-02-18 13:43:04.003458
NCT00789919|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2017-02-08|||March 2002||2002-03-01|November 2008|2008-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Mild Preeclampsia Near Term: Deliver or Deliberate?|Mild Preeclampsia Near Term: Deliver or Deliberate?|Completed||N/A|185|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-02-18 13:43:04.097799|2017-02-18 13:43:04.097799
NCT00789906|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2008-11-12|||July 2008||2008-07-01|November 2008|2008-11-01||||||||Observational|||Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia|Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia|Unknown status|Recruiting|N/A|700|Anticipated|BeerYaakov Mental Health Center|||2||f||||||||||||||2017-02-18 13:43:04.189064|2017-02-18 13:43:04.189064
NCT00789893|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2015-06-10|||November 2008||2008-11-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Study of Vaginal Dilator Use After Pelvic Radiotherapy|A Descriptive Study of Vaginal Dilator Use After Pelvic Radiotherapy|Completed||N/A|115|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 13:43:04.274884|2017-02-18 13:43:04.274884
NCT00789880|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2015-06-02|2012-12-07||December 2008||2008-12-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3|Analysis of the Response of Subjects With Atopic Dermatitis to Oral Vitamin D3 by Measurement of Antimicrobial Peptide Expression in Skin and Saliva|Completed||Phase 2|82|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:43:04.39488|2017-02-18 13:43:04.39488
NCT00789867|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2015-06-02|||November 2008||2008-11-01|August 2009|2009-08-01|December 2010|Actual|2010-12-01|August 2009|Actual|2009-08-01||Interventional|||Single Dose of pGM169/GL67A in CF Patients|Evaluation of Safety and Gene Expression With a Single Dose of pGM169/GL67A Administered to the Nose and Lung of Individuals With Cystic Fibrosis|Completed||Phase 1/Phase 2|27|Actual|Imperial College London||1|||f||||t||||||||||2017-02-18 13:43:06.498971|2017-02-18 13:43:06.498971
NCT00789854|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2012-04-23|2010-08-04||November 2008||2008-11-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|RUBY||Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients|A Randomised, 6-week, Multicentre, Open-label, Rater-blinded Parallel Group Study Comparing Quetiapine Extended Release Monotherapy and Augmentation With Lithium Augmentation in Patients With Treatment Resistant Depression|Completed||Phase 3|688|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 13:43:06.625696|2017-02-18 13:43:06.625696
NCT00789841|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2010-10-25|||September 2008||2008-09-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Gastrointestinal Motility in Patients With Neuroendocrine Tumors|Gastrointestinal Motility in Patients With Neuroendocrine Tumors-Effects of Sandostatin LAR|Completed||N/A|13|Actual|University of Aarhus|||1||f||||f||||||Samples With DNA|"~     Blood samples wich are destroyed after analysis~   "|||2017-02-18 13:43:08.177961|2017-02-18 13:43:08.177961
NCT00789828|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-01-04|2012-03-01||August 2009||2009-08-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|March 2011|Actual|2011-03-01||Interventional|EXIST-1||Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)|A Randomized, Double-blind, Placebo-controlled Study of Everolimus in the Treatment of Patients With Subependymal Giant Cell Astrocytomas (SEGA) Associated With Tuberous Sclerosis Complex (TSC)|Completed||Phase 3|117|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:43:08.297846|2017-02-18 13:43:08.297846
NCT00789815|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2010-04-01|2010-02-03||April 2008||2008-04-01|April 2010|2010-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Bispectral Index-guided Sedation for Flexible Bronchoscopy|Sedation for Flexible Bronchoscopy and Real Time Endobronchial Ultrasound -A Comparison Between Bispectral Index-guided Sedation and Conventional Sedation|Completed||Phase 4|500|Actual|Chang Gung Memorial Hospital|The bronchoscopists were not blinded to sedative procedures. It was difficult to accomplish totally blind conditions. The bronchoscopist would realize which protocol it was when only observing responses of the investigator.|2|||f||||f||||||||||2017-02-18 13:43:09.357386|2017-02-18 13:43:09.357386
NCT00789802|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2014-12-08|2013-06-27||November 2008||2008-11-01|December 2014|2014-12-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC|A Randomized, Controlled Trial of Oral Naproxen and Transdermal Estradiol for Prevention of Unscheduled Bleeding in New Users of Levonorgestrel Intrauterine Contraception|Completed||N/A|129|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 13:43:10.074988|2017-02-18 13:43:10.074988
NCT00789789|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-01-14|||December 2008||2008-12-01|January 2016|2016-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials|Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials|Recruiting||N/A|488|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||1||f||||t||||||Samples With DNA|"~     Blood specimen collection (serum, plasma and whole blood)~   "|||2017-02-18 13:43:10.555176|2017-02-18 13:43:10.555176
NCT00789776|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2016-06-07|||October 2008||2008-10-01|June 2016|2016-06-01||||June 2017|Anticipated|2017-06-01||Interventional|||Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer|A Phase I/II Study Evaluating the Safety and Efficacy of Adding a Single Prophylactic Donor Lymphocyte Infusion (DLI) of Natural Killer Cells Early After Nonmyeloablative, HLA-Haploidentical Hematopoietic Cell Transplantation - A Multi Center Trial|Active, not recruiting||Phase 1/Phase 2|42|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 13:43:10.673055|2017-02-18 13:43:10.673055
NCT00789763|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2012-11-28|||December 2007||2007-12-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma|Open-label, Multicentric Phase I-II Trial to Evaluate the Efficacy and Safety of the Combination of Sorafenib (BAY 43-9006), Gemcitabine and Concurrent Radiotherapy, in Locally Advanced Pancreatic Carcinoma|Completed||Phase 1|12|Actual|Grupo Espanol Multidisciplinario del Cancer Digestivo||1|||f||||f||||||||||2017-02-18 13:43:10.831244|2017-02-18 13:43:10.831244
NCT00789750|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2013-08-27||2013-08-06|April 2009||2009-04-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus|A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 3|562|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:43:10.946081|2017-02-18 13:43:10.946081
NCT00789737|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2014-01-24|2013-12-04||January 2009||2009-01-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Welchol as Monotherapy for Type 2 Diabetes Mellitus|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus|Completed||Phase 3|357|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:43:11.194352|2017-02-18 13:43:11.194352
NCT00789724|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2012-02-21|2010-07-30||November 2008||2008-11-01|September 2010|2010-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|VCU-ART||Anakinra to Prevent Post-infarction Remodeling|Recombinant Human Interleukin-1 Receptor Antagonist, Anakinra, to Prevent Post-infarction Remodeling: the Virginia Commonwealth University Anakinra Remodeling Trial (VCU-ART)|Completed||Phase 3|10|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-02-18 13:43:12.300172|2017-02-18 13:43:12.300172
NCT00789711|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-10-27|||November 2008||2008-11-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|SAFE||An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes|A Multicentre, Open-label, Nonrandomised, Non-interventional, Observational Study to Compare Safety and Effectiveness of Biphasic Insulin Aspart 30 (NovoMix 30) and Insulin Detemir (Levemir) for the Treatment of Diabetes Mellitus|Completed||N/A|3131|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 13:43:12.685991|2017-02-18 13:43:12.685991
NCT00789698|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-05-19|2012-03-27||December 2008||2008-12-01|May 2015|2015-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|PEARL 3 Ext||Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia|A Phase 3 Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Lurasidone in Subjects With Schizophrenia (PEARL 3 Extension Study)|Completed||Phase 3|240|Actual|Sunovion||2|||f||||t||||||||||2017-02-18 13:43:12.800041|2017-02-18 13:43:12.800041
NCT00789685|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2015-05-11|2015-05-11||February 2009||2009-02-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||The safety population was used for summaries of demographic and other baseline characteristics|Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II|A Phase I/II Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of FP-1201 (Recombinant Human Interferon Beta) in the Treatment of Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome.|Completed||Phase 1/Phase 2|37|Actual|Faron Pharmaceuticals Ltd||1|||f||||t||||||||||2017-02-18 13:43:13.786709|2017-02-18 13:43:13.786709
NCT00789672|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-07-07|2010-09-14||January 2009||2009-01-01|July 2016|2016-07-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|ATS14||Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia|A Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia in 8 to 17 Year Olds|Completed||Phase 2|33|Actual|Jaeb Center for Health Research|Without a patching-only control group, no conclusions can be made regarding efficacy, safety, or side effects with this treatment. Placebo controlled trial is needed to see if levodopa can augment occlusion therapy in the treatment of amblyopia.|2|||f||||t||||||||||2017-02-18 13:43:14.230582|2017-02-18 13:43:14.230582
NCT00789659|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2017-02-08|||December 2010||2010-12-01|April 2012|2012-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Incisional Wound Vac in Obese Patients|Incisional Wound Vac in Obese Patients|Withdrawn||N/A|0|Actual|University of Mississippi Medical Center||1||PI did not want to go forward with study at this time|f||||f||||||||||2017-02-18 13:43:15.88038|2017-02-18 13:43:15.88038
NCT00789646|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2008-11-11|||June 2008||2008-06-01|June 2008|2008-06-01|June 2009|Anticipated|2009-06-01|December 2008|Anticipated|2008-12-01||Interventional|||Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients|Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients.|Unknown status|Enrolling by invitation|N/A|32|Anticipated|Mahidol University||2|||f||||f||||||||||2017-02-18 13:43:15.990651|2017-02-18 13:43:15.990651
NCT00789633|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2012-09-25|||November 2008||2008-11-01|September 2012|2012-09-01|December 2013|Anticipated|2013-12-01|December 2011|Actual|2011-12-01||Interventional|||A Phase 3 Study to Compare Efficacy and Safety of Masitinib in Combination With Gemcitabine, to Placebo in Combination With Gemcitabine, in Treatment of Patients With Advanced/Metastatic Pancreatic Cancer|A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled, 2-parallel Group, Phase III Study to Compare Efficacy and Safety of Masitinib 9 mg/kg/Day in Combination With Gemcitabine Compared to Placebo in Combination With Gemcitabine in Treatment of Patients With Advanced/Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 3|320|Anticipated|AB Science||2|||f||||t||||||||||2017-02-18 13:43:16.079744|2017-02-18 13:43:16.079744
NCT00789620|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2011-03-23|||November 2008||2008-11-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effects of Intravenous Lidocaine on Transperitoneal Laparoscopic Urological Surgery|Effects of Intravenous Lidocaine on Transperitoneal Laparoscopic Urological Surgery: A Prospective, Randomised, Placebo Controlled, Double-blind, Phase III Study|Completed||Phase 3|76|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 13:43:16.351492|2017-02-18 13:43:16.351492
NCT00789607|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2016-06-21|||June 2008||2008-06-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|FLIP||Fiducial Localization and Individualized Radiotherapy -Prostate Cancer|Fiducial Localization and Individualized Radiotherapy in Prostate Cancer (FLIP)|Active, not recruiting||Phase 2|60|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 13:43:16.472177|2017-02-18 13:43:16.472177
NCT00789594|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2012-09-19|||April 2009||2009-04-01|September 2012|2012-09-01|March 2013|Anticipated|2013-03-01|June 2012|Actual|2012-06-01||Interventional|LabMon||Improving Laboratory Monitoring in Community Practices: A Randomized Trial|Improving Laboratory Monitoring in Community Practices: A Randomized Trial|Unknown status|Active, not recruiting|N/A|50|Anticipated|VA Boston Healthcare System||4|||f||||f||||||||||2017-02-18 13:43:16.586018|2017-02-18 13:43:16.586018
NCT00789581|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2016-06-01|||January 2009||2009-01-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|TITAN||A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer|Phase III Study of Doxorubicin/Cyclophosphamide (AC) Followed by Ixabepilone vs. AC Followed by Paclitaxel in Patients With Triple-Negative Early-Stage Breast Cancer|Active, not recruiting||Phase 3|614|Actual|SCRI Development Innovations, LLC||2|||f||||t||||||||||2017-02-18 13:43:16.691909|2017-02-18 13:43:16.691909
NCT00789568|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2014-08-11|||October 2008||2008-10-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|January 2009|Actual|2009-01-01||Interventional|||A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects|A Phase 1, Randomized, Placebo- and Active-controlled Crossover Study to Evaluate the Effects of Sapropterin Dihydrochloride Oral Administration on QTc Intervals in Healthy Adult Subjects|Completed||Phase 1|56|Actual|BioMarin Pharmaceutical||4|||f||||f||||||||||2017-02-18 13:43:17.026427|2017-02-18 13:43:17.026427
NCT00789555|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2012-08-08|2012-08-08||November 2008||2008-11-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis|Safety of PATANASE® Nasal Spray in Patients With Perennial Allergic Rhinitis|Completed||Phase 4|1260|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 13:43:17.149928|2017-02-18 13:43:17.149928
NCT00789542|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2014-12-03|||December 2008||2008-12-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Interventional|CLOTS-3||A RCT to Establish the Effectiveness of Intermittent Pneumatic Compression to Prevent Post Stroke DVT|A Randomised Trial to Establish the Effectiveness of Intermittent Pneumatic Compression to Prevent Post Stroke Deep Vein Thrombosis (DVT).|Completed||Phase 3|2876|Actual|University of Edinburgh||2|||f||||t||||||||||2017-02-18 13:43:17.871901|2017-02-18 13:43:17.871901
NCT00789529|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-11|2013-04-22|2011-07-25||September 2008||2008-09-01|April 2013|2013-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Objective Testing of Tear Film Stability|Objective Testing of Tear Film Stability|Completed||N/A|32|Actual|Manhattan Vision Associates||2|||f||||f||||||||||2017-02-18 13:43:17.982603|2017-02-18 13:43:17.982603
NCT00789516|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2013-03-06|||June 2006||2006-06-01|March 2013|2013-03-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Observational|||The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation|The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation|Completed||N/A|60|Actual|Mahidol University|||3||f||||f||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 13:43:18.366533|2017-02-18 13:43:18.366533
NCT00789503|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-12|||November 2004||2004-11-01|November 2008|2008-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Nursing-Home Residents Given Bread Fortified With Vitamin D3|Long-Term Effects of Giving Nursing-Home Residents Bread Fortified With 125 Micrograms (5000 IU) Vitamin D3 Per Daily Serving|Completed||Phase 1/Phase 2|45|Actual|University of Toronto||1|||f||||f||||||||||2017-02-18 13:43:18.451572|2017-02-18 13:43:18.451572
NCT00789490|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-12|2008-11-12|||October 2005||2005-10-01|November 2008|2008-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Relative Bioavailability of Iron and Folic Acid in New Test Supplement|Relative Bioavailability of Iron and Folic Acid From a New Powdered Supplement Compared to a Traditional Tablet in Pregnant Women|Completed||Phase 1|18|Actual|University of Toronto||1|||f||||t||||||||||2017-02-18 13:43:18.543678|2017-02-18 13:43:18.543678
NCT00789477|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2014-08-28|2014-08-28||December 2008||2008-12-01|August 2014|2014-08-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Interventional|DA VINCI|Full analysis set (FAS): included all randomized patients who received any study drug, had baseline assessments, and had at least one (1) post-baseline assessment.|DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact|A Double-Masked, Randomized, Controlled Study of the Safety, Tolerability and Biological Effect of Repeated Intravitreal Administration of VEGF Trap-Eye in Patients With Diabetic Macular Edema (DME)|Completed||Phase 2|221|Actual|Regeneron Pharmaceuticals||5|||f||||f||||||||||2017-02-18 13:43:18.652415|2017-02-18 13:43:18.652415
NCT00789464|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-09-11||||||September 2015|2015-09-01||||||||Interventional|||Probiotics for Girls With Recurring Urinary Tract Infections|H-23187: Probiotic Prophylaxis Against Recurrent Pediatric Urinary Tract Infection|Withdrawn||Phase 2|0|Actual|Baylor College of Medicine||2||Withdrawn by PI|f||||f||||||||||2017-02-18 13:43:20.054418|2017-02-18 13:43:20.054418
NCT00789438|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2010-07-06|2009-10-27||October 2008||2008-10-01|October 2009|2009-10-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Observational|||Evaluation of the Surgical Pleth Index During Spinal and General Anesthesia|The Effects of Sedation and Analgesia on the Surgical Pleth Index (SPI)|Completed||N/A|69|Actual|University of Schleswig-Holstein|||3||f||||f||||||||||2017-02-18 13:43:20.245036|2017-02-18 13:43:20.245036
NCT00789425|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-02-16|||September 2008||2008-09-01|February 2010|2010-02-01|August 2010|Anticipated|2010-08-01|April 2010|Anticipated|2010-04-01||Interventional|||Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women|A Randomised, Double Blind, Parallel Group, 12-month Comparison of a Standardized Olive Extract With Placebo in Postmenopausal Women With Decreased Bone Mineral Density|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|BioActor||2|||f||||f||||||||||2017-02-18 13:43:20.763518|2017-02-18 13:43:20.763518
NCT00789412|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2009-10-27|||August 2008||2008-08-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Observational|||Surgical Stress Index as a Tool for Monitoring Analgesia and/or Sedation in Critically Ill Patients|SSI for Monitoring of Analgesia and Sedation in Critically Ill Patients|Completed||N/A|60|Anticipated|University of Schleswig-Holstein|||2||f||||f||||||||||2017-02-18 13:43:20.874493|2017-02-18 13:43:20.874493
NCT00789399|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2014-10-27|||October 2009||2009-10-01|October 2014|2014-10-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis|A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis|Unknown status|Active, not recruiting|N/A|630|Anticipated|Prairie Education and Research Cooperative||2|||f||||t||||||||||2017-02-18 13:43:20.965204|2017-02-18 13:43:20.965204
NCT00789386|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2009-05-20|||November 2008||2008-11-01|May 2009|2009-05-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|RemiCaps2||The Effect of Remifentanil on Established Capsaicin-Induced Hyperalgesia in Human Volunteers|The Effect of Remifentanil on Established Capsaicin-Induced Hyperalgesia in Human Volunteers|Unknown status|Recruiting|Phase 4|24|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:43:21.0649|2017-02-18 13:43:21.0649
NCT00789373|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-03-10|2011-06-20||November 2008||2008-11-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|June 2010|Actual|2010-06-01||Interventional|||A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer|A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment With Pemetrexed + Cisplatin for Advanced Non-squamous Non-Small Cell Lung Cancer.|Active, not recruiting||Phase 3|939|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:43:21.186609|2017-02-18 13:43:21.186609
NCT00789360|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2009-05-04|||November 2008||2008-11-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Staccato Loxapine Pulmonary Safety in Healthy Volunteers|Pulmonary Safety of Repeat Doses of Staccato® Loxapine for Inhalation in Healthy Volunteers|Completed||Phase 1|30|Anticipated|Alexza Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 13:43:22.953098|2017-02-18 13:43:22.953098
NCT00789347|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2010-04-01|||October 2008||2008-10-01|March 2010|2010-03-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Observational|||Analysis of Cortical Excitability in Neuropathic Pain|Analysis of Cortical Excitability in Neuropathic Pain: an Electrophysiology Study.|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||3||f||||f||||||Samples With DNA|"~     Genomic polymorphism of neurotrophic factors.~   "|||2017-02-18 13:43:23.059411|2017-02-18 13:43:23.059411
NCT00787852|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2014-07-24|2013-07-22||March 2009||2009-03-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional||11 were enrolled but 10 were treated|A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)|A Phase I Study of Dasatinib With Concurrent Chemoradiation for Stage III NSCLC Principal Investigator: Howard Safran, MD.|Terminated||Phase 1|11|Actual|Brown University||2||for efficacy and safety reasons|f||||f||||||||||2017-02-18 13:43:23.153199|2017-02-18 13:43:23.153199
NCT00787839|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-04-06|2014-12-05||June 2009||2009-06-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational||Individuals receiving care at the Atlanta VA Medical Center|Opportunistic Screening for Prediabetes and Early Diabetes in Primary Care|Screening for Prediabetes and Early Diabetes in Primary Care|Completed||N/A|1939|Actual|VA Office of Research and Development|Study in a single healthcare system, in a convenience sample of patients receiving care in a VA primary care clinic, in a population that was largely older, heavier, and predominantly male, and a single OGTT was used as the “gold standard”.||1||f||||f||||||None Retained|"~     blood samples~   "|||2017-02-18 13:43:23.528036|2017-02-18 13:43:23.528036
NCT00787826|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-08-19|||January 2009||2009-01-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|November 2016|Anticipated|2016-11-01||Interventional|||Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine|A Longitudinal Phase 2 Study for the Continued Evaluation of the Safety and Immunogenicity of a Live Francisella Tularensis Vaccine, NDBR 101, Lot 4 in Healthy Adults At-Risk for Exposure to Francisella Tularensis|Enrolling by invitation||Phase 2|1000|Anticipated|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 13:43:23.873693|2017-02-18 13:43:23.873693
NCT00787813|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2008-11-19|||June 2008||2008-06-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|NAC-CC||N-Acetyl Cysteine After Cervical Cerclage|Effect of Oral N-Acetyl Cysteine on Pregnancy Outcome After Cervical Cerclage: a Randomized Controlled Trial|Completed||N/A|100|Anticipated|Assiut University||2|||f||||f||||||||||2017-02-18 13:43:24.054715|2017-02-18 13:43:24.054715
NCT00787800|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-07-02|2013-05-21||November 2008||2008-11-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|RAPTURE||The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock|Reduction And Prevention of Tachyarrhythmias and Shocks Using Reduced Ventricular Pacing With Atrial Algorithms (The RAPTURE Study)|Completed||Phase 4|100|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:43:24.172422|2017-02-18 13:43:24.172422
NCT00789204|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2009-09-21|||May 2008||2008-05-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Postural Re-education in Low Back Pain|"Effectiveness of a Global Posture Reeducation Program for Patients With Low Back Pain"|Completed||Phase 1|100|Actual|University of Bologna||2|||f||||f||||||||||2017-02-18 13:43:30.462703|2017-02-18 13:43:30.462703
NCT00787787|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2013-05-07|||September 2008||2008-09-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer|The CapSul Trial: A Phase II Study of Sunitinib and Capecitabine for the Treatment of Unresectable or Metastatic Hepatocellular Carcinoma (HCC)|Terminated||Phase 2|41|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 13:43:25.136588|2017-02-18 13:43:25.136588
NCT00787774|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2010-03-30|||November 2008||2008-11-01|March 2010|2010-03-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|RAL-dyn||Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression|Integrase Resistance Analysis in Treated Experienced HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression|Unknown status|Recruiting|N/A|20|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-02-18 13:43:25.252173|2017-02-18 13:43:25.252173
NCT00787761|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2012-08-29|2012-07-09||April 2007||2007-04-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|July 2010|Actual|2010-07-01||Interventional|||Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer|Pre-administration of Rabbit Antithymocyte Globulin to Optimize Donor T-Cell Engraftment Following Reduced Intensity Allogeneic Peripheral Blood Progenitor Cell Transplantation From Matched-Related Donors|Completed||Phase 2|24|Actual|Northside Hospital, Inc.||1|||f||||f||||||||||2017-02-18 13:43:25.345826|2017-02-18 13:43:25.345826
NCT00787748|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2012-06-14|||October 2006||2006-10-01|June 2012|2012-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|CORSAIB||COPD and Cardiovascular Risk in the Population|COPD and Cardiovascular Risk in the Population|Completed||N/A|623|Actual|Cimera|||1||f||||t||||||Samples Without DNA|"~     Samples of serum were frozen at -80 ºC~   "|||2017-02-18 13:43:26.061798|2017-02-18 13:43:26.061798
NCT00787735|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-03-08|||January 2004||2004-01-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Improving Delivery of Mental Health Services for Patients With Drug Use and Other Behavioral and Emotional Problems|Services Research: Psychiatric Comorbidity in Drug Abuse|Completed||N/A|380|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 13:43:26.153521|2017-02-18 13:43:26.153521
NCT00789334|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2009-08-21|||November 2008||2008-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:43:26.247678|2017-02-18 13:43:26.247678
NCT00789321|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-08-10|2010-04-30||July 2008||2008-07-01|August 2015|2015-08-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)|A Randomized Clinical Trial to Evaluate the Effects of Multiple Doses of Amlodipine 10 mg on Pedal Edema Measurements in Middle-Aged and Elderly Healthy Subjects and Patient With Hypertension|Completed||Phase 1|47|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:43:28.663739|2017-02-18 13:43:28.663739
NCT00789308|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-08-12|||July 2008||2008-07-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation|Open Randomized Mult-Center Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation (CIT-01A)|Completed||Phase 2|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:43:29.030401|2017-02-18 13:43:29.030401
NCT00789295|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2008-11-10|||March 2004||2004-03-01|October 2008|2008-10-01||||||||Interventional|||Mediterranean Diet and Postprandial Lipemia|Mediterranean vs. Low-Carbohydrate Diet : Which is the Best Dietary Approach for Treating Postprandial Lipid Abnormalities and Improving Glucose Control in Type 2 Diabetic Patients?|Completed||N/A|||Federico II University||2|||f||||f||||||||||2017-02-18 13:43:29.161908|2017-02-18 13:43:29.161908
NCT00789282|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2011-11-23|||February 2008||2008-02-01|November 2011|2011-11-01|December 2012|Anticipated|2012-12-01|February 2012|Anticipated|2012-02-01||Interventional|||Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 Diabetes|Single-blinded, Two-arm, Randomized Clinical Trial of Patients With Type 2 Diabetes Mellitus That Will Compare'Usual Care' With an 'Enhanced Care' Model of Chronic Disease Management That is Based in the Practices of Family Physicians Participating in Primary Care Networks (PCN's).|Unknown status|Recruiting|N/A|306|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 13:43:29.272309|2017-02-18 13:43:29.272309
NCT00789269|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2010-05-26|||January 2009||2009-01-01|September 2009|2009-09-01||||||||Interventional|||Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From a Stroke||Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Fudan University||2|||f||||||||||||||2017-02-18 13:43:29.383495|2017-02-18 13:43:29.383495
NCT00789256|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2013-05-29|2013-05-29||September 2004||2004-09-01|October 2011|2011-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Low Dose Melphalan and Bortezomib for AML and High-Risk MDS|A Pilot Study of Low Dose Melphalan and Bortezomib for Treatment of Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndromes|Completed||N/A|26|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 13:43:29.484707|2017-02-18 13:43:29.484707
NCT00789243|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2010-10-22|||November 2008||2008-11-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||The Effect of Ischaemic-Reperfusion and Ischaemic Preconditioning on the Endogenous Fibrinolysis in Man|The Effect of Ischaemic-Reperfusion and Ischaemic Preconditioning on the Endogenous Fibrinolysis in Man|Completed||N/A|12|Anticipated|University of Edinburgh||3|||f||||f||||||||||2017-02-18 13:43:30.106457|2017-02-18 13:43:30.106457
NCT00789230|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-09|2014-04-03|||January 2006||2006-01-01|April 2014|2014-04-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|HUMP||Mesh Versus Suture Repair for Umbilical Hernias|Mesh Versus Suture Repair for Umbilical Hernias: a Double Blinded, Randomised Controlled Clinical Trial|Unknown status|Active, not recruiting|Phase 3|300|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-02-18 13:43:30.219113|2017-02-18 13:43:30.219113
NCT00789217|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2010-11-26|||December 2008||2008-12-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|March 2010|Actual|2010-03-01||Interventional|||Penicillin Skin Testing in Patients With History of Allergic Reactions to Betalactams|The Comparative Results of Penicillin Testing in Patients With History of Allergic Reactions to Betalactams Between Using In-house Penicillin Test Preparation and Commercial Available Penicillin Testing Kit|Completed||N/A|63|Actual|Chulalongkorn University||3|||f||||f||||||||||2017-02-18 13:43:30.329358|2017-02-18 13:43:30.329358
NCT00789191|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2012-06-26|2010-11-18||November 2008||2008-11-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes|Effect of Detemir and Sitagliptin on Blood Glucose Control in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|222|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 13:43:30.601504|2017-02-18 13:43:30.601504
NCT00789178|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-09|2008-11-10|||December 2008||2008-12-01|November 2008|2008-11-01|April 2010|Anticipated|2010-04-01|October 2009|Anticipated|2009-10-01||Observational|||Cognitive and Memory Function in Patients With Fibromyalgia|Cognitive and Memory Function in Patients With Fibromyalgia and Their Influence on Disability|Unknown status|Not yet recruiting|N/A|80|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||||||2017-02-18 13:43:31.604737|2017-02-18 13:43:31.604737
NCT00789165|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-08|2017-01-08|||December 2009||2009-12-01|January 2017|2017-01-01||||December 2019|Anticipated|2019-12-01||Interventional|||Empiric Quinidine for Asymptomatic Brugada Syndrome|A Prospective Trial Of Empiric Quinidine Therapy For Asymptomatic Brugada Syndrome.|Recruiting||Phase 2/Phase 3|200|Anticipated|International Registry of Asymptomatic Brugada Syndrome||2|||f||||f||||||||||2017-02-18 13:43:31.678912|2017-02-18 13:43:31.678912
NCT00789152|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-05-04|||December 2003||2003-12-01|May 2015|2015-05-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)|The Effects of Desloratadine and Levocetirizine on Nasal Obstruction in Subjects With Induced Allergic Rhinitis in the VCC Assessed Clinically and With Nasal Rhinomanometry and Nasal Flowmetry|Completed||Phase 3|81|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:43:31.805368|2017-02-18 13:43:31.805368
NCT00789139|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-06-18|||October 2008||2008-10-01|June 2015|2015-06-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|RAPID XT||Recurrence of Arrhythmias After Pulmonary Veins Isolation Detected by ICM|Recurrence of Arrhythmias After Pulmonary Veins Isolation Detected by ICM|Completed||Phase 4|47|Actual|Hospital St. Joseph, Marseille, France||1|||f||||t||||||||||2017-02-18 13:43:32.095409|2017-02-18 13:43:32.095409
NCT00789126|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2009-02-18|||October 2008||2008-10-01|February 2009|2009-02-01||||||||Interventional|||Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects|A Phase 1, Randomized, Double-Blind, Single-Dose Escalation Study and Multiple-Dose Escalation Study of VX-509 in Healthy Subjects|Completed||Phase 1|72|Anticipated|Vertex Pharmaceuticals Incorporated|||||||||||||||||||2017-02-18 13:43:32.18254|2017-02-18 13:43:32.18254
NCT00789113|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2015-12-14|2015-01-29||November 2008||2008-11-01|December 2015|2015-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Determination of Absorption and Elimination of Lamotrigine-XR|Determination of Bioavailability and Clearance of Lamotrigine-XR by a Stable Isotope Technique|Completed||Phase 1/Phase 2|12|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 13:43:32.273996|2017-02-18 13:43:32.273996
NCT00789100|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2014-07-15|||February 2009||2009-02-01|July 2014|2014-07-01|February 2011|Actual|2011-02-01|August 2010|Actual|2010-08-01||Observational|||Evaluation of Remote Patient Monitoring.|Evaluation of a Home-based Telemonitor Service|Withdrawn||N/A|0|Actual|Brunel University|||2|Nottingham PCT withdrew for financial reasons|f||||t||||||||||2017-02-18 13:43:32.497249|2017-02-18 13:43:32.497249
NCT00789087|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2008-11-10|||January 2005||2005-01-01|November 2008|2008-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion|Analysis of Clinical and Radiological Results of Two Methods of Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion|Completed||Phase 4|60|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:43:32.596315|2017-02-18 13:43:32.596315
NCT00789074|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2013-11-18|2011-08-04||July 2009||2009-07-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Use of Varenicline for 4-weeks Prior to Quitting|Effects of an Extended Period of Varenicline Use Prior to Quitting Smoking on Post-quitting Urges to Smoke|Completed||Phase 3|101|Actual|Queen Mary University of London||2|||f||||f||||||||||2017-02-18 13:43:32.723757|2017-02-18 13:43:32.723757
NCT00789061|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2008-11-10|||August 2006||2006-08-01|November 2008|2008-11-01|July 2009|Anticipated|2009-07-01|March 2008|Anticipated|2008-03-01||Interventional|||Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation|Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 13:43:33.258172|2017-02-18 13:43:33.258172
NCT00789048|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-09|2011-04-27|||January 2009||2009-01-01|November 2008|2008-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||"The Influence of Operating Table Position Simulating Radiographs on Acetabular Cup Angle During Primary Total Hip Replacement"|"The Influence of Operating Table Position Simulating Radiographs on Acetabular Cup Angle During Primary Total Hip Replacement"|Completed||N/A|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:43:33.359804|2017-02-18 13:43:33.359804
NCT00789035|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2014-05-16|2014-05-16||October 2008||2008-10-01|May 2014|2014-05-01||||October 2009|Actual|2009-10-01||Interventional||The treated set (TS) consisting of all randomised patients who were treated with at least 1 dose of study drug.|12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients|A Phase IIb, Randomized, Parallel Group Safety, Efficacy, and Pharmacokinetics Study of BI 10773 (5 mg, 10 mg and 25 mg) Administered Orally Once Daily Over 12 Weeks Compared Double Blind to Placebo, as Monotherapy, With an Additional Open-label Metformin Arm in Type 2 Diabetic Patients With Insufficient Glycemic Control|Completed||Phase 2|408|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 13:43:33.467434|2017-02-18 13:43:33.467434
NCT00789022|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-09|2008-11-10|||January 2009||2009-01-01|November 2008|2008-11-01||||July 2010|Anticipated|2010-07-01||Observational|||Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment||Unknown status|Not yet recruiting|N/A|80|Anticipated|Shalvata Mental Health Center|||3||f||||f||||||||||2017-02-18 13:43:34.405028|2017-02-18 13:43:34.405028
NCT00789009|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-08|2017-02-04|||November 6, 2008||2008-11-06|February 3, 2017|2017-02-03||||||||Observational|||Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection|Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:43:34.495478|2017-02-18 13:43:34.495478
NCT00788385|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2015-04-13|||June 2009||2009-06-01|April 2015|2015-04-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|||Multi-Center Study of ShuntCheck|Multi-Center Study of ShuntCheck|Withdrawn||Phase 4|0|Actual|NeuroDx Development||1||Insufficient funding|f||||f||||||||||2017-02-18 13:43:45.831895|2017-02-18 13:43:45.831895
NCT00788996|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-09|2008-11-12|||January 2009||2009-01-01|November 2008|2008-11-01|January 2011|Anticipated|2011-01-01|January 2010|Anticipated|2010-01-01||Interventional|BIBE||Reduction of Environmental Tobacco Smoke (ETS) Exposure at Home: the BIBE Study|Effectiveness of a Brief Intervention Opportunistic Targeting Parents Who Smoke to Reduce Exposure to Secondhand Smoke in Babies: STUDY BIBE|Unknown status|Not yet recruiting|Phase 2|552|Anticipated|Jordi Gol i Gurina Foundation||1|||f||||t||||||||||2017-02-18 13:43:34.593792|2017-02-18 13:43:34.593792
NCT00788983|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2013-09-19|||November 2008||2008-11-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Induced Hypoxia Study for Validation of SpO2 Accuracy|Pulse Oximeter Responses to Multiple Levels of Stable Hypoxia|Completed||N/A|12|Actual|Nonin Medical, Inc|||1||f||||f||||||||||2017-02-18 13:43:34.687245|2017-02-18 13:43:34.687245
NCT00788970|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2009-01-12|||January 2009||2009-01-01|January 2009|2009-01-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Shiatsu Adjuvant Therapy And Placebo For Schizophrenia|Shiatsu Adjuvant Therapy And Placebo For Schizophrenia:a Double Blind Study|Unknown status|Not yet recruiting|N/A|150|Anticipated|Herzog Hospital||3|||f||||t||||||||||2017-02-18 13:43:34.768365|2017-02-18 13:43:34.768365
NCT00788957|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-06-23|2015-03-24||October 2008||2008-10-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|February 2012|Actual|2012-02-01||Interventional||Safety analysis set, including participants who received at least one dose of respective investigational product in the corresponding parts of the study.|Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)|A Randomized, Phase 1b/2 Trial of AMG 102 or AMG 479 in Combination With Panitumumab Versus Panitumumab Alone in Subject With Wild-Type KRAS Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|153|Actual|Amgen||4|||f||||||||||||||2017-02-18 13:43:34.887144|2017-02-18 13:43:34.887144
NCT00788944|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2011-01-05|||October 2008||2008-10-01|January 2011|2011-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HCl|An Open-Label Study To Evaluate The Prevalence Of Phenotypic Poor Metabolizers At CYP2D6 Among Venlafaxine-Treated Outpatients With Depression|Completed||Phase 4|971|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:43:37.269576|2017-02-18 13:43:37.269576
NCT00788931|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2012-11-26|||December 2008||2008-12-01|November 2012|2012-11-01||||August 2010|Actual|2010-08-01||Interventional|||A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer|A Phase Ib, Open-label, Two Arm Study of i.v. and Oral Panobinostat (LBH589) in Combination With i.v. Trastuzumab (Herceptin®) and i.v. Paclitaxel as Treatment for Adult Female Patients With HER2 Overexpressing Metastatic Breast Cancer (MBC)|Completed||Phase 1|15|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:43:37.407383|2017-02-18 13:43:37.407383
NCT00788918|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2013-01-10|||November 2008||2008-11-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)|Study of Cerebral Function in Patients With Chronic Hepatitis C Infection Before and After Pegylated Interferon Alfa-2a and Ribavirin Therapy|Completed||N/A|100|Actual|University of Aarhus||4|||f||||t||||||||||2017-02-18 13:43:37.518648|2017-02-18 13:43:37.518648
NCT00788905|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-03-27|||November 2008||2008-11-01|March 2013|2013-03-01|January 2014|Anticipated|2014-01-01|February 2011|Actual|2011-02-01||Interventional|||Comparison of Conventional Dialysis and the Allient System|Uremic Toxin Removal, Blood Cell Kinetics, and Inflammatory Response in Patients Treated With the Allient System|Unknown status|Active, not recruiting|N/A|40|Anticipated|Renal Research Institute||1|||f||||f||||||||||2017-02-18 13:43:37.632693|2017-02-18 13:43:37.632693
NCT00788892|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-07-25||2012-05-16|October 2008||2008-10-01|July 2016|2016-07-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Interventional|||Trial of CPX-351 in Newly Diagnosed Elderly AML Patients|Phase IIB, Multicenter, Randomized, Open Label Trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection Versus Cytarabine and Daunorubicin in Patients With Untreated AML 60-75 Years of Age.|Completed||Phase 2|126|Actual|Celator Pharmaceuticals||2|||f||||t||||||||||2017-02-18 13:43:37.729557|2017-02-18 13:43:37.729557
NCT00788879|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2013-05-07|||February 2003||2003-02-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|TSSC||Tu Salud Si Cuenta Media Campaign|Evaluation of a Media Campaign: Tu Salud Si Cuenta|Completed||N/A|3100|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 13:43:38.072458|2017-02-18 13:43:38.072458
NCT00788866|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2014-10-16|||December 2008||2008-12-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|POM-1||Impact of Maternal Pomegranate Juice on Brain Injury in Infants With Intrauterine Growth Restriction (IUGR)|Impact of Maternal Pomegranate Juice on Brain Injury in Infants With Intrauterine Growth Restriction (IUGR)|Completed||N/A|80|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:43:38.178285|2017-02-18 13:43:38.178285
NCT00788853|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2014-06-23|||November 2008||2008-11-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|DiabCare Asia||A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Indonesia|DiabCare Asia 2008. A Cross-sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia and to Evaluate Perceptions and Practices of Physicians and Patients About Diabetes Management in Asia. DiabCare Asia 2008 - Indonesia|Completed||N/A|1832|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"~     Blood sample~   "|||2017-02-18 13:43:38.29072|2017-02-18 13:43:38.29072
NCT00788840|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2008-11-10|||January 2008||2008-01-01|November 2008|2008-11-01||||August 2009|Anticipated|2009-08-01||Interventional|DEES||Detemir Energy Expenditure Study|A 24-Week, National, Single-Centre, Open-Labelled, Randomised, Parallel-Group Trial Comparing Energy Expenditure With Insulin Detemir Versus NPH Insulin Using a Basal-Bolus Regimen With Insulin Aspart as the Mealtime Insulin in Subjects With Type 2 Diabetes|Unknown status|Recruiting|Phase 4|30|Anticipated|University of Surrey||2|||f||||t||||||||||2017-02-18 13:43:38.393414|2017-02-18 13:43:38.393414
NCT00788827|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-01-21|||November 2008||2008-11-01|July 2011|2011-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant|A Phase I Safety and Tolerability Study Following the Infusion of Autologous Expanded Progeny of an Adult CD34+ Stem Cell Subset (InsulinCytes) to Patients With Type I Diabetes Mellitus and a Successful Renal Transplant|Completed||Phase 1|7|Actual|Imperial College London||1|||f||||t||||||||||2017-02-18 13:43:38.500605|2017-02-18 13:43:38.500605
NCT00788814|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2012-10-15|||June 2008||2008-06-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of Pathways Curriculum for Use With WPD|Women Physical Disability and Depression: Communities Responding Now!|Completed||N/A|80|Actual|Oregon Health and Science University||1|||f||||t||||||||||2017-02-18 13:43:38.61209|2017-02-18 13:43:38.61209
NCT00788801|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2010-11-01|||December 2008||2008-12-01|September 2010|2010-09-01||||March 2009|Actual|2009-03-01||Interventional|||Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain||Completed||Phase 1|11|Actual|Abbott||3|||f||||||||||||||2017-02-18 13:43:38.699971|2017-02-18 13:43:38.699971
NCT00788788|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2008-11-20|||November 2007||2007-11-01|November 2008|2008-11-01||||December 2007|Actual|2007-12-01||Interventional|||Heliox in Experimental Upper Airway Obstruction|PoC Study of Heliox With Helium-Fractions Between 25 and 75% in Experimental Upper Airway Obstruction|Completed||Phase 1/Phase 2|44|Actual|University of Witten/Herdecke||3|||f||||t||||||||||2017-02-18 13:43:38.788784|2017-02-18 13:43:38.788784
NCT00788775|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-10-16|2016-08-22||January 2009||2009-01-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|April 2011|Actual|2011-04-01||Interventional||The analysis dataset is comprised of treated patients.|Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma|A Phase II Study of Nilotinib (AMN107) In TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral or Chronically Sun Damaged Melanoma|Completed||Phase 2|20|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 13:43:38.895159|2017-02-18 13:43:38.895159
NCT00788762|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2014-05-09|||August 2007||2007-08-01|May 2014|2014-05-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Observational|Taxiarchis||Myocilin Variations and Familial Glaucoma in Taxiarchis|Myocilin Variations and Familial Glaucoma in Taxiarchis, A Small Greek Village.|Unknown status|Recruiting|N/A|800|Anticipated|Aristotle University Of Thessaloniki|||1||f||||f||||||Samples With DNA|"~     Myocilin screening was performed from blood or saliva specimens taken from the village. The~     promoter region and exons 1-3 of myocilin were sequenced at the Portland Veterans~     Administration Medical center. Microsatellite marker analysis in the GLC1A region, including~     D1S452, D1S1619, D1S2790 and D1S242 was performed at deCODE (Reykjavik, Iceland).~   "|||2017-02-18 13:43:39.433077|2017-02-18 13:43:39.433077
NCT00788749|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2008-11-10|||May 2004||2004-05-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|February 2008|Actual|2008-02-01||Interventional|||Medical Polypectomy and Predictors of Response|A Proof Of Concept Study to Investigate the Clinical, Histological And Molecular Predictors of Response to Oral and Intranasal Corticosteroid in Nasal Polyposis|Completed||Phase 4|60|Actual|University of Dundee||2|||f||||f||||||||||2017-02-18 13:43:39.516958|2017-02-18 13:43:39.516958
NCT00788736|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-10-25|||September 2008||2008-09-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|September 2016|Actual|2016-09-01||Observational|||Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism|Development and Validation of Clinical Prediction Rules for Bleeding for Patients on Anticoagulant Therapy for Venous Thromboembolism|Completed||N/A|2537|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||Samples With DNA|"~     Subjects may consent to optional DNA and plasma banking~   "|Undecided||2017-02-18 13:43:39.636121|2017-02-18 13:43:39.636121
NCT00788723|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2008-11-10|||July 2008||2008-07-01|November 2008|2008-11-01|May 2009|Anticipated|2009-05-01|March 2009|Anticipated|2009-03-01||Interventional|||Cortical Excitability in Patients With Severe Brain Injury|Cortical Excitability in Patients With Severe Brain Injury|Unknown status|Recruiting|N/A|45|Anticipated|University of Aarhus||3|||f||||f||||||||||2017-02-18 13:43:39.737657|2017-02-18 13:43:39.737657
NCT00788710|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-11-30|2011-06-22||October 2008||2008-10-01|November 2015|2015-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)|A Double-Blind, Placebo-Controlled, Multicenter Trial to Study the Efficacy and Tolerability of MK0663/Etoricoxib in the Treatment of Pain After Abdominal Hysterectomy|Completed||Phase 3|430|Actual|Merck Sharp & Dohme Corp.|11 participants were screened & 10 participants were randomized at site 0028. An audit showed study medication dispensing logs were not kept. These 10 participants were invalidated and excluded from both efficacy & safety analyses.|3|||f||||f||||||||||2017-02-18 13:43:39.856349|2017-02-18 13:43:39.856349
NCT00788697|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2014-08-19||2014-08-18|September 2009||2009-09-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization|Characterization of Focal Liver Lesions With SONOVUE®-Enhanced Ultrasound Imaging: A Phase III, Intrapatient Comparative Study Versus Un-enhanced Ultrasound Imaging Using Histology or Combined Imaging/Clinical Data as Truth Standard|Completed||Phase 3|349|Actual|Bracco Diagnostics, Inc||2|||f||||f||||||||||2017-02-18 13:43:40.372818|2017-02-18 13:43:40.372818
NCT00788684|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2017-01-04|||July 2009||2009-07-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers|A Phase 1 Study Evaluating the Safety of ABT-263 in Combination With Rituximab in Subjects With CD20-positive Lymphoid Malignancies|Active, not recruiting||Phase 1|36|Anticipated|AbbVie||1|||f||||f||||||||||2017-02-18 13:43:40.466386|2017-02-18 13:43:40.466386
NCT00788671|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-09-07|||November 2008||2008-11-01|September 2016|2016-09-01||||November 2017|Anticipated|2017-11-01||Interventional|||Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)|A Phase II Study of the Levonorgestrel Intrauterine Device (Mirena) to Treat Complex Atypical Hyperplasia and Grade 1 Endometrioid Endometrial Carcinoma|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:43:40.686696|2017-02-18 13:43:40.686696
NCT00788658|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-04-12|||December 2008||2008-12-01|April 2016|2016-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|EFI||Cognitive Behaviour Therapy for Patients With IBS|Cognitive Behavior Therapy (CBT) as Compared With Standard Therapy for Patients With IBS and Other Functional Gastrointestinal Disorders|Completed||N/A|100|Actual|Rabin Medical Center||2|||f||||t||||||||||2017-02-18 13:43:40.80399|2017-02-18 13:43:40.80399
NCT00788645|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2010-11-30|||August 2008||2008-08-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||The Use of a Forecasting System for Predicting Exacerbations of COPD|The Use of a Forecasting System for Predicting Exacerbations of COPD: Effect on Symptoms and Hospitalisation and Relevance of Viral Infections|Completed||Early Phase 1|98|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 13:43:40.901072|2017-02-18 13:43:40.901072
NCT00788632|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2013-03-20|||May 2010||2010-05-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|December 2011|Actual|2011-12-01||Interventional|ICOMMIITT||Improving Care of Osteoporosis: Multi-Modal Intervention to Increase Testing and Treatment (ICOMMIITT)|Improving Care of Osteoporosis: Multi-Modal Intervention to Increase Testing and Treatment (ICOMMIITT)|Completed||N/A|12128|Actual|University of Alabama at Birmingham||3|||f||||f||||||||||2017-02-18 13:43:40.9997|2017-02-18 13:43:40.9997
NCT00788619|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2011-11-01|||January 2009||2009-01-01|November 2011|2011-11-01|March 2012|Anticipated|2012-03-01|January 2012|Anticipated|2012-01-01||Interventional|||Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)|Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization|Suspended||Phase 2/Phase 3|250|Anticipated|Johns Hopkins University||2||consent form is being revised|f||||f||||||||||2017-02-18 13:43:41.106149|2017-02-18 13:43:41.106149
NCT00788606|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2016-10-13|||May 2008||2008-05-01|October 2016|2016-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma|Feasibility Study of R-CHOP Plus Bevacizumab in Patients With Diffuse Large B Cell Lymphoma (DLBCL)|Terminated||Phase 2|7|Actual|Royal Marsden NHS Foundation Trust||1||Toxicity and efficacy data from another trial|f||||t||||||||||2017-02-18 13:43:41.201993|2017-02-18 13:43:41.201993
NCT00788593|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2014-01-27|2014-01-27||January 2008||2008-01-01|January 2014|2014-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||Full analysis set (FAS) included all participants who received at least 1 dose of the study medication.|A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)|A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 in Chronic Pancreatitis (CP) Patients With Exocrine Pancreatic Insufficiency (EPI)|Completed||Phase 3|82|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 13:43:41.31222|2017-02-18 13:43:41.31222
NCT00788580|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-08|2015-03-05||||||March 2015|2015-03-01||||||||Interventional|||S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors|S0718: Phase I Study Evaluating The Combination of GW786034 (Pazopanib; NSC-737754; IND-XXXX) and CCI-779 (Temsirolimus; NSC-683864; IND-XXXX) in Patients With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|Southwest Oncology Group||1||Study was discontinued.|f||||||||||||||2017-02-18 13:43:42.015816|2017-02-18 13:43:42.015816
NCT00788567|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-11-02|||June 2005||2005-06-01|November 2015|2015-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants|A Randomized, Open-label Study of the Achievement of a Mycophenolic Acid Therapeutic Window During Treatment With 2 Dosing Regimens of Oral CellCept Administered as a Component of Standard Immunosuppressive Therapy in Patients With Kidney Transplants|Completed||Phase 3|136|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:43:42.09541|2017-02-18 13:43:42.09541
NCT00788554|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-09|2011-08-18|||August 2000||2000-08-01|August 2011|2011-08-01|March 2011|Actual|2011-03-01|March 2004|Actual|2004-03-01||Interventional|LEVEL||LEVEL Trial: Correction of Inguinal Hernia, Endoscopic Versus Lichtenstein|LEVEL Trial: Correction of Inguinal Hernia, Endoscopic Versus Lichtenstein. A Randomised Controlled Clinical Trial.|Completed||Phase 3|660|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-02-18 13:43:42.195023|2017-02-18 13:43:42.195023
NCT00788541|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2012-11-28||2012-11-28|December 2008||2008-12-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension|A Dose-Volume Study of the Safety and IOP-Lowering Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma or Ocular Hypertension|Terminated||Phase 2|197|Actual|Alcon Research||6||Project cancellation|f||||t||||||||||2017-02-18 13:43:42.293708|2017-02-18 13:43:42.293708
NCT00788528|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2011-09-13|||August 2008||2008-08-01|July 2011|2011-07-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|OLE||Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects|Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females|Completed||Phase 2|766|Actual|Shionogi Inc.||1|||f||||f||||||||||2017-02-18 13:43:42.407418|2017-02-18 13:43:42.407418
NCT00788515|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2009-08-27|||November 2008||2008-11-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|REST||Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties|Comparison of the Safety and Efficacy of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties. A 4 Week,Randomized, Double-blind, Comparative, Parallel-group Study.|Terminated||Phase 3|33|Actual|Sanofi||2||"Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary~   insomnia with predominant sleep maintenance problems"|f||||t||||||||||2017-02-18 13:43:42.569197|2017-02-18 13:43:42.569197
NCT00788502|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2010-05-21|||October 2008||2008-10-01|May 2010|2010-05-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Stress Reduction During In Vitro Fertilization|Stress Reduction During In Vitro Fertilization|Unknown status|Recruiting|N/A|45|Anticipated|Stanford University||3|||f||||||||||||||2017-02-18 13:43:42.6729|2017-02-18 13:43:42.6729
NCT00788489|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2011-10-03|||January 2006||2006-01-01|October 2011|2011-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|PETLAB||A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy|A Prospective Study to Evaluate the Role of 2-[18F]Fluoro-2-deoxy-D-glucose (FDG)-Positron Emission Tomography (PET), Breast Magnetic Resonance Imaging (MRI), and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy|Completed||N/A|49|Actual|Ontario Clinical Oncology Group (OCOG)|||1||f||||f||||||||||2017-02-18 13:43:42.765201|2017-02-18 13:43:42.765201
NCT00788476|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2015-01-07|||October 2008||2008-10-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Childhood Cancer Survivor Survey|Needs Assessment Survey in Childhood Cancer Survivors and Their Parents|Completed||N/A|167|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 13:43:42.85254|2017-02-18 13:43:42.85254
NCT00788372|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-06-25|2013-03-21||November 2008||2008-11-01|June 2013|2013-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||An Efficacy and Safety Study of Fentanyl in Participants With Chronic Pain|A Long-Term Study of JNS020QD in Patients With Chronic Pain|Completed||Phase 3|142|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-02-18 13:43:45.907113|2017-02-18 13:43:45.907113
NCT00788463|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2008-11-07|||March 2008||2008-03-01|November 2008|2008-11-01|December 2009|Anticipated|2009-12-01|March 2009|Anticipated|2009-03-01||Interventional|||A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps|A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps|Unknown status|Recruiting|Phase 2|60|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 13:43:42.965549|2017-02-18 13:43:42.965549
NCT00787722|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-09-13|||October 2008||2008-10-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Hematopoietic Stem Cell Transplant in Devic's Disease|Trial of High Dose Immunosuppressive Therapy With Hematopoietic Stem Cell Support in Devic's Disease|Recruiting||Phase 1/Phase 2|40|Anticipated|Northwestern University||1|||f||||f||||||||No||2017-02-18 13:43:43.081667|2017-02-18 13:43:43.081667
NCT00787709|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2008-11-06|||May 2007||2007-05-01|November 2008|2008-11-01|April 2012|Anticipated|2012-04-01|April 2011|Anticipated|2011-04-01||Interventional|Pathways||Translational Obesity Research|Translational Research: Applying Drug Prevention to Obesity Prevention|Unknown status|Recruiting|N/A|2400|Anticipated|University of Southern California||2|||f||||t||||||||||2017-02-18 13:43:43.203392|2017-02-18 13:43:43.203392
NCT00787696|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2011-10-19|||September 2003||2003-09-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Healthy Teen Girls: HIV Risk Reduction|HIV Risk Reduction Among Young Incarcerated Females|Completed||Phase 1/Phase 2|333|Actual|Mississippi State University||2|||f||||f||||||||||2017-02-18 13:43:43.307078|2017-02-18 13:43:43.307078
NCT00787683|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2012-06-25|||October 2008||2008-10-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|Monitor-ICD||Home-Monitoring in Implantable Cardioverter Defibrillator (ICD) Patients|Home-Monitoring in ICD Patients|Unknown status|Active, not recruiting|N/A|416|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:43:43.421206|2017-02-18 13:43:43.421206
NCT00787670|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-02-04|||November 2008||2008-11-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Impact of GBS on CVD in Type 2 Diabetes Mellitus|Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus|Completed||N/A|84|Actual|Duke University||3|||f||||f||||||||||2017-02-18 13:43:43.543667|2017-02-18 13:43:43.543667
NCT00787657|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-10-15|||June 2008||2008-06-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|September 2013|Actual|2013-09-01||Observational|BEACON||Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment|Betaferon Prospective Study on Adherence, Coping and Nursing Support|Completed||N/A|1723|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:43:43.64593|2017-02-18 13:43:43.64593
NCT00787644|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-02-25|2015-01-08||January 2009||2009-01-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|GLITZ||Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)|A Randomized, Placebo-Controlled Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics. (The GLITZ Asthma Study)|Terminated||Phase 2|28|Actual|University of Vermont|Early termination leading to small numbers of subjects analyzed|2||new safety concerns which emerged about pioglitazone during the trial|f||||t||||||||||2017-02-18 13:43:43.787705|2017-02-18 13:43:43.787705
NCT00787631|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-11-06|||December 2008||2008-12-01|October 2008|2008-10-01|December 2010|Anticipated|2010-12-01|January 2010|Anticipated|2010-01-01||Observational|||Analysis of Immunological Reactions to Foods in Birch Pollen-Allergic Patients|Analysis of Immunological Reactions to Pollen-Related Foods in Birch Pollen-Allergic Patients|Unknown status|Not yet recruiting|N/A|30|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-02-18 13:43:44.301418|2017-02-18 13:43:44.301418
NCT00787618|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-08-08|2014-06-25||October 2008||2008-10-01|August 2014|2014-08-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional||Study prematurely terminated, no data available|Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females|A Single-Dose, Open-Label, Parallel Group Study To Evaluate The Pharmacokinetics And Safety Profile Of PROELLEX® (CDB-4124) In Female Subjects With Various Stages Of Impaired Renal Function And In Healthy Female Volunteers|Terminated||Phase 1/Phase 2|6|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with any study data.|3||Increased LFTs|f||||f||||||||||2017-02-18 13:43:44.371735|2017-02-18 13:43:44.371735
NCT00787605|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-09-20|2010-12-20||November 2008||2008-11-01|May 2011|2011-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|ASTRIDE||Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus|An 8-week Study to Evaluate the Efficacy and Safety of Aliskiren HCTZ (300/25 mg) Compared to Amlodipine (10 mg) in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus|Completed||Phase 4|860|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:43:44.728611|2017-02-18 13:43:44.728611
NCT00787592|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2011-06-27|||January 2008||2008-01-01|June 2011|2011-06-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Observational|||SSD vs Collagenase in Pediatric Burn Patients|A Prospective Comparison of Silver Sulfadiazine Cream and Collagenase Ointment for the Treatment of Burns in Children|Unknown status|Active, not recruiting|N/A|100|Actual|Children's Mercy Hospital Kansas City|||2||f||||t||||||||||2017-02-18 13:43:45.21646|2017-02-18 13:43:45.21646
NCT00788450|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-09|2014-01-14|||December 2014||2014-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:43:45.317137|2017-02-18 13:43:45.317137
NCT00788437|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2009-12-15|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:43:45.364608|2017-02-18 13:43:45.364608
NCT00788424|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-10|2015-07-22|||November 2008||2008-11-01|June 2008|2008-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Topical Application of AS101 for the Treatment of Psoriasis|Study of Topical Application of AS101 for the Treatment of Psoriasis|Withdrawn||Phase 2|0|Actual|BioMAS Ltd||2||Sponsor's considerations|f||||f||||||||||2017-02-18 13:43:45.424193|2017-02-18 13:43:45.424193
NCT00788398|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2016-02-10|||June 2009||2009-06-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|January 2015|Actual|2015-01-01||Interventional|FLOW||Fluid Lavage of Open Wounds|Fluid Lavage of Open Wounds (FLOW): A Multi-center, Blinded, Factorial Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures|Completed||N/A|2540|Actual|Greenville Health System||6|||f||||t||||||||||2017-02-18 13:43:45.536212|2017-02-18 13:43:45.536212
NCT00788359|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-12-01|||December 2007||2007-12-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2012|Actual|2012-07-01||Observational|||Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation|Multi-center Trial to Validate Protein Biomarkers of a Pulmonary Exacerbation in Cystic Fibrosis|Completed||N/A|123|Actual|University of Colorado, Denver|||1||f||||f||||||Samples Without DNA|"~     Blood (plasma)~   "|||2017-02-18 13:43:46.580151|2017-02-18 13:43:46.580151
NCT00788346|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2012-12-19|||March 2007||2007-03-01|November 2008|2008-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Reducing the Unnecessary Use of Heavily Marketed Medications: A Randomized Controlled Trial|Reducing Unnecessary Use of Heavily Marketed Medicines: A Randomized Controlled Trial of Computerized Prescribing Alerts and Clinician Education|Completed||N/A|257|Actual|VA Boston Healthcare System||3|||f||||f||||||||||2017-02-18 13:43:46.670207|2017-02-18 13:43:46.670207
NCT00788333|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2012-07-12|||July 2009||2009-07-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer|A Phase I/II Trial of BMS-754807 in Combination With Trastuzumab (Herceptin®) in Subjects With Advanced or Metastatic Her-2-positive Breast Cancer|Completed||Phase 1/Phase 2|40|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 13:43:46.770826|2017-02-18 13:43:46.770826
NCT00788320|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2012-01-18|||October 2008||2008-10-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Vitamin D in Active Tuberculosis (TB) Study|Antimicrobial Peptide LL-37 (Cathelicidin) Production in Active Tuberculosis Disease: Role of Vitamin D Supplementation|Withdrawn||N/A|0|Actual|Atlanta VA Medical Center||2||Inadequate enrollment|f||||f||||||||||2017-02-18 13:43:46.888327|2017-02-18 13:43:46.888327
NCT00788307|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2016-12-20|||July 2009||2009-07-01|December 2016|2016-12-01||||September 2017|Anticipated|2017-09-01||Interventional|||Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy|Phase I Trial of In Situ Gene Therapy for Locally Recurrent Prostate Cancer Following Radiation Therapy Failure Using Sodium/Iodide Symporter and Radioiodine|Recruiting||Phase 1|24|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 13:43:46.989825|2017-02-18 13:43:46.989825
NCT00788294|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2009-07-14|||November 2008||2008-11-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously|Pharmacokinetics And Safety Of A Single Dose Subcutaneous Or Intravenous Administration Of Tanezumab In Healthy Volunteers: An Open-Label, Non-Randomized Phase 1 Study|Completed||Phase 1|76|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:43:47.110315|2017-02-18 13:43:47.110315
NCT00788281|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2008-11-12|||April 2008||2008-04-01|November 2008|2008-11-01|April 2016|Anticipated|2016-04-01|April 2011|Anticipated|2011-04-01||Interventional|||A Multi-Center Randomised Controlled Study to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer||Unknown status|Recruiting|Phase 2|200|Anticipated|Beijing Friendship Hospital||2|||f||||||||||||||2017-02-18 13:43:47.212667|2017-02-18 13:43:47.212667
NCT00788255|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2016-10-17|2016-02-03||October 2008||2008-10-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational||All blood samples for this study were taken from a total cohort of 25 patients|In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography.|In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography.|Completed||N/A|25|Actual|Stanford University|||1||f||||t||||||None Retained|"~     Venous blood~   "|No||2017-02-18 13:43:47.312313|2017-02-18 13:43:47.312313
NCT00788242|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2016-11-22|||January 2009||2009-01-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery|The Effect of Glucose-Insulin-Potassium Infusion on Myocardial Injuries and Cardiac Function in Patients Undergoing Cardiac Surgery|Completed||N/A|200|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 13:43:47.648845|2017-02-18 13:43:47.648845
NCT00788229|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2010-04-01|||November 2008||2008-11-01|April 2010|2010-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome|A Phase II, Randomized, Double-Blind, Clinical Trial to Evaluate the Efficacy and Safety of DHP-101, DHP-300, DHP-500 in Patients With Dry Eye Syndrome|Completed||Phase 2|72|Actual|Dhp Korea Co., Ltd.||4|||f||||t||||||||||2017-02-18 13:43:47.849866|2017-02-18 13:43:47.849866
NCT00788216|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-07-11|||September 2008||2008-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|September 2009|Actual|2009-09-01||Observational|||Development & Validation of Utilities for Health States Relevant to Cervical Cancer Patients|Development and Validation of A Comprehensive Instrument to Determine Utilities for Health States Relevant to Cervical Gynecologic Cancer Patients|Completed||N/A|60|Actual|Duke University|||2||f||||f||||||||||2017-02-18 13:43:47.948745|2017-02-18 13:43:47.948745
NCT00788203|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2011-07-21|||August 2008||2008-08-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Prevention of Childhood Obesity|The Development of an Early Intervention for the Prevention of Childhood Obesity|Completed||Phase 3|130|Actual|Stanford University|||2||f||||||||||||||2017-02-18 13:43:48.057386|2017-02-18 13:43:48.057386
NCT00788190|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2011-04-07|||November 2008||2008-11-01|November 2008|2008-11-01||||||||Interventional|||Treatment of Distal Radius Fractures in Elderly Patients|Treatment of Distal Radius Fractures in Elderly Patients, a Randomized Controlled Trial|Withdrawn||N/A|65|Anticipated|Hand and Upper Limb Clinic, Canada||2||The inclusion/Exclusion criteria was too strict which restricted recruitment|f||||f||||||||||2017-02-18 13:43:48.152422|2017-02-18 13:43:48.152422
NCT00788177|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2011-09-26|||November 2008||2008-11-01|July 2009|2009-07-01|December 2012|Anticipated|2012-12-01|March 2012|Anticipated|2012-03-01||Interventional|||Subretinal Macugen® for Neovascular Age-Related Macular Degeneration|Subretinal Macugen® for Neovascular Age-Related Macular Degeneration (SUMANA)|Unknown status|Recruiting|Phase 3|10|Anticipated|Klinikum Ludwigshafen||1|||f||||f||||||||||2017-02-18 13:43:48.264082|2017-02-18 13:43:48.264082
NCT00788164|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2016-10-27|||November 2008||2008-11-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2017|Anticipated|2017-03-01||Interventional|||Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia|A Phase I Efficacy and Safety Study of HPV16-specific Therapeutic DNA-vaccinia Vaccination in Combination With Topical Imiquimod, in Patients With HPV16+ High Grade Cervical Dysplasia (CIN3)|Recruiting||Phase 1|48|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 13:43:48.360879|2017-02-18 13:43:48.360879
NCT00788151|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2014-09-18|||October 2008||2008-10-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years|Immunogenicity and Safety of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years Previously Vaccinated Against Yellow Fever in Peru|Completed||Phase 2|300|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:43:48.490471|2017-02-18 13:43:48.490471
NCT00788138|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2010-10-08|||October 2008||2008-10-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic Fibrosis||Completed||N/A|30|Anticipated|Atlanta VA Medical Center||2|||f||||f||||||||||2017-02-18 13:43:48.60531|2017-02-18 13:43:48.60531
NCT00788125|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2017-02-10|||September 2008||2008-09-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors|Dasatinib With Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial|Active, not recruiting||Phase 1/Phase 2|143|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:43:48.713475|2017-02-18 13:43:48.713475
NCT00788112|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2013-08-06|||July 2009||2009-07-01|August 2013|2013-08-01|December 2013|Anticipated|2013-12-01|July 2011|Actual|2011-07-01||Interventional|||Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast|A Window Trial of Vorinostat in Patients With Ductal Carcinoma in Situ (DCIS) of the Breast|Unknown status|Active, not recruiting|Phase 1|17|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 13:43:48.84668|2017-02-18 13:43:48.84668
NCT00788099|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2011-06-06|||December 2008||2008-12-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas|Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas|Completed||Phase 1|45|Actual|PharmaMar||2|||f||||f||||||||||2017-02-18 13:43:48.948145|2017-02-18 13:43:48.948145
NCT00788073|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2013-03-22|2013-02-07||November 2008||2008-11-01|March 2013|2013-03-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome|A Double-Blind, Placebo-Controlled, Crossover, Flexible-Dose Evaluation of the Efficacy, Safety and Tolerability of STX209 in the Treatment of Irritability in Subjects With Fragile X Syndrome|Completed||Phase 2|63|Actual|Seaside Therapeutics, Inc.||2|||f||||t||||||||||2017-02-18 13:43:49.049065|2017-02-18 13:43:49.049065
NCT00788060|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-02-12|||October 2008||2008-10-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|Rad/Sutent||A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma|A Single Arm, Phase Ib Study of RAD001 and Sunitinib in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 1|5|Actual|Duke University||1|||f||||f||||||||||2017-02-18 13:43:49.462016|2017-02-18 13:43:49.462016
NCT00788047|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2009-03-05|||November 2008||2008-11-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan|A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon [PF-01913539] On The Single-Dose Pharmacokinetics Of The CYP2D6 Substrate Dextromethorphan In Healthy Subjects|Completed||Phase 1|14|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:43:49.570184|2017-02-18 13:43:49.570184
NCT00788034|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2015-06-22|||October 2008||2008-10-01|December 2012|2012-12-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder|A Double-blind, Randomised, Placebo-controlled, Multicentre, Relapse-prevention Study With Lu AA21004 in Patients With Generalized Anxiety Disorder|Completed||Phase 3|459|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:43:49.671713|2017-02-18 13:43:49.671713
NCT00788021|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2013-11-21|||September 2006||2006-09-01|November 2013|2013-11-01|October 2011|Actual|2011-10-01|January 2011|Actual|2011-01-01||Observational|PIP-01||Protective Immunity Project 01|Characterization of the Impact of Chronic Immunosuppressive Regimens on Protective Immunity Over Time in Renal Transplant Recipients|Completed||N/A|124|Actual|Emory University|||3||f||||t||||||Samples Without DNA|"~     Whole blood, serum, PBMCs~   "|||2017-02-18 13:43:52.172332|2017-02-18 13:43:52.172332
NCT00788008|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-03-23|2014-12-24||November 2008||2008-11-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly|Does Inhalational Anesthesia Accelerate Postoperative Cognitive Decline?|Completed||N/A|200|Actual|Duke University||2|||f||||t||||||||||2017-02-18 13:43:52.273002|2017-02-18 13:43:52.273002
NCT00787995|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-12-05|||October 2008||2008-10-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)|A Multicenter, Multinational, Longitudinal Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)|Terminated||N/A|353|Actual|BioMarin Pharmaceutical|||1||f||||f||||||||||2017-02-18 13:43:52.573964|2017-02-18 13:43:52.573964
NCT00787982|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2009-12-30|||September 2008||2008-09-01|December 2009|2009-12-01|September 2010|Anticipated|2010-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors|Pilot Study Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging and Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Visualase, Inc.||1|||f||||t||||||||||2017-02-18 13:43:52.685043|2017-02-18 13:43:52.685043
NCT00787969|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2016-12-02|||April 2009||2009-04-01|December 2016|2016-12-01||||April 2012|Actual|2012-04-01||Interventional|||Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma|Phase I/II Trial of Rituximab, Cladribine, and Temsirolimus (RCT) Therapy in Newly Diagnosed Mantle Cell Lymphoma (MCL)|Active, not recruiting||Phase 1|74|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 13:43:52.982448|2017-02-18 13:43:52.982448
NCT00787956|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-04-09|||October 2008||2008-10-01|April 2013|2013-04-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Internet Chronic Disease Self-Management Program for Australia|Evaluation of an Internet Chronic Disease Self-Management Program for Australia|Completed||Phase 3|300|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 13:43:53.245488|2017-02-18 13:43:53.245488
NCT00787943|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-04-10|2010-09-24||May 2008||2008-05-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris|A Split-face, Paired-comparison, Pilot Study to Evaluate Safety and Efficacy of Two Topical Benzoyl Peroxide 10.0% Creams for Mild to Moderate Acne Vulgaris|Completed||N/A|10|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 13:43:53.335596|2017-02-18 13:43:53.335596
NCT00787930|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-07-03|2012-12-31||October 2005||2005-10-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Observational|BPD||Bipolar Disorder in Late Life|Bipolar Disorder in Late Life (Evaluation of MRI Hyperintensities and DTI in Bipolar Disorder)|Completed||N/A|19|Actual|Duke University|Acute MRI hypothesis unable to be tested due to high subject response. Five subject scans could not be evaluated by DTI computer program.||2||f||||f||||||Samples With DNA|"~     DNA collected for genetic databank.~   "|||2017-02-18 13:43:53.731149|2017-02-18 13:43:53.731149
NCT00787917|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2011-09-22|2011-07-11||November 2008||2008-11-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)|An Exploratory, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy of Multiple Doses of Omalizumab in Cystic Fibrosis Complicated by Allergic Bronchopulmonary Aspergillosis (ABPA)|Terminated||Phase 4|14|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:43:54.278515|2017-02-18 13:43:54.278515
NCT00787904|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2016-10-21|2015-06-22||December 2006||2006-12-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|June 2011|Actual|2011-06-01||Observational|||Role of T-cells in Post-Menopausal Osteoporosis|The Role of T-cells in Women Undergoing Surgical Menopause|Completed||N/A|19|Actual|Atlanta VA Medical Center|||3||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:43:54.887518|2017-02-18 13:43:54.887518
NCT00787891|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-01-22|2012-07-27||January 2009||2009-01-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients|A Multi-Center, Double-Blind, Parallel-Group Study to Evaluate Short-term Safety and Efficacy and Long-Term Maintenance of Two Dose Levels of Rabeprazole Sodium Delayed-Release Pediatric Bead Formulation in 1- to 11-Year Old Pediatric Subjects With Endoscopically Proven GERD|Completed||Phase 3|127|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-02-18 13:43:55.338634|2017-02-18 13:43:55.338634
NCT00787878|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2017-01-17|||February 2009||2009-02-01|January 2017|2017-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects|Comparison of Safety in Small for Gestational Age (SGA) Subjects Treated With Norditropin® (Somatropin) 5 Years Ago With Untreated SGA Subjects and With Normal Average for Gestational Age (AGA) Subjects|Completed||Phase 3|153|Actual|Novo Nordisk A/S|||3||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 13:43:56.184822|2017-02-18 13:43:56.184822
NCT00787865|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-07|2017-02-14|||April 2008||2008-04-01|February 2017|2017-02-01|April 2026|Anticipated|2026-04-01|April 2021|Anticipated|2021-04-01||Observational|||Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease|Diffusion Tensor Imaging (DTI) as a Tool to Identify Infants With Krabbe Disease in Urgent Need of Treatment|Active, not recruiting||N/A|100|Anticipated|University of Pittsburgh|||4||f||||f||||||||||2017-02-18 13:43:56.28536|2017-02-18 13:43:56.28536
NCT00787579|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2008-11-06|||April 2003||2003-04-01|November 2008|2008-11-01||||April 2008|Actual|2008-04-01||Interventional|||Assessment of Bifocal and Prismatic Bifocal Spectacles for Myopia Control in Children|Assessment of Bifocal and Prismatic Bifocal Spectacles for Myopia Control in Children|Completed||N/A|135|Actual|Essilor International||3|||f||||f||||||||||2017-02-18 13:43:56.388953|2017-02-18 13:43:56.388953
NCT00787566|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2011-07-05|2011-05-24||October 2008||2008-10-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting|A Randomized, Single Administration, Double-blind, Parallel-group Phase 2 Dose Finding Study to Assess the Efficacy, Tolerability, and Safety of TRG (Intranasal Granisetron) in Patients With Chemotherapy-induced Nausea and Vomiting (CINV) Associated With the Administration of Highly Emetogenic Chemotherapy|Completed||Phase 2|68|Actual|Shin Nippon Biomedical Laboratories, Ltd.||3|||f||||||||||||||2017-02-18 13:43:56.503043|2017-02-18 13:43:56.503043
NCT00787553|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2008-11-06|||July 2006||2006-07-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Tinidazole Versus Cefazolin Antibiotic Prophylaxis of Vaginal and Abdominal Hysterectomy|Tinidazole Versus Cefazolin Antibiotic Prophylaxis of Vaginal and Abdominal Hysterectomy|Unknown status|Active, not recruiting|N/A|75|Actual|University of Campinas, Brazil||3|||f||||t||||||||||2017-02-18 13:43:57.211851|2017-02-18 13:43:57.211851
NCT00787540|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2008-11-06|||January 2009||2009-01-01|November 2008|2008-11-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Observational|||Chest Pain, Illness Perception Compliance and Psychosocial Outcome After Coronary Arteriography||Unknown status|Not yet recruiting|N/A|160|Anticipated|Hillel Yaffe Medical Center|||2||f||||||||||||||2017-02-18 13:43:57.317888|2017-02-18 13:43:57.317888
NCT00787527|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-09-02|2014-09-02||November 2008||2008-11-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma|A Phase I/II of Vorinostat Plus CHOP in Untreated T-cell Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|14|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:43:57.406707|2017-02-18 13:43:57.406707
NCT00787514|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2016-05-20|||July 2008||2008-07-01|November 2008|2008-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||FR in Stored Plasma|Measurement of the Folate Receptor in Stored Plasma From Patients With Ovarian Cancer|Completed||N/A|27|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-02-18 13:43:57.750566|2017-02-18 13:43:57.750566
NCT00787501|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-02-02|||June 2008||2008-06-01|February 2016|2016-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|ssrifMRI||Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression|Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression|Completed||Phase 1|98|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:43:57.840372|2017-02-18 13:43:57.840372
NCT00787488|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-11-10|||April 2009||2009-04-01|November 2014|2014-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca|A Pilot Study of Intravenous and Intraperitoneal Chemotherapy Plus Abdominal Hyperthermia to Treat Optimally Debulked and Recurrent Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancers|Withdrawn||N/A|0|Actual|Duke University||1||Study not funded|f||||f||||||||||2017-02-18 13:43:57.969489|2017-02-18 13:43:57.969489
NCT00787475|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-02-02|||September 2008||2008-09-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|NOCHOP||Northern Manhattan Diabetes Community Outreach Project|Northern Manhattan Diabetes Community Outreach Project|Completed||N/A|360|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 13:43:58.06352|2017-02-18 13:43:58.06352
NCT00787462|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2010-09-09|||October 2008||2008-10-01|September 2010|2010-09-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Interventional|||Evaluation of Pregabalin in Idiopathic Small Fiber Neuropathy|Evaluation of Pregabalin in Idiopathic Small Fiber Neuropathy|Suspended||N/A|30|Anticipated|University of Alberta||2||"As a result of restrictive inclusion criteria and a limited pool of suitable subjects with~   SFN, this study has been suspended pending review."|f||||f||||||||||2017-02-18 13:43:58.173281|2017-02-18 13:43:58.173281
NCT00787436|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2013-07-29|||May 2006||2006-05-01|July 2013|2013-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE|Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using Thalidomide|Withdrawn||Phase 3|0|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 13:43:58.28727|2017-02-18 13:43:58.28727
NCT00787423|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2017-01-24|||October 28, 2008||2008-10-28|September 1, 2016|2016-09-01||||||||Observational|||Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population|Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:43:58.392392|2017-02-18 13:43:58.392392
NCT00787410|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2012-06-05|||September 2003||2003-09-01|June 2012|2012-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma|An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma|Completed||Phase 2|23|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:43:58.505579|2017-02-18 13:43:58.505579
NCT00787397|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-01-06|||February 2009||2009-02-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Sleep, Mood, and Behavior Study|Sleep, Mood, and Behavior Study:Transdisciplinary Studies of CBT for Anxiety in Youth|Completed||N/A|51|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:43:58.607992|2017-02-18 13:43:58.607992
NCT00787384|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2010-12-28|||October 2004||2004-10-01|December 2010|2010-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|NILG-HES1-03||Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes|Therapeutic and Biological Effects of Imatinib Mesylate in Primary Hypereosinophilic Syndromes|Completed||Phase 2|25|Actual|Northern Italy Leukemia Group||1|||f||||f||||||||||2017-02-18 13:43:58.791771|2017-02-18 13:43:58.791771
NCT00787371|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-04-09|||June 2005||2005-06-01|April 2015|2015-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)|Study to Confirm Dose Response With PegIntron (SCH 54031) Monotherapy in Patients With Chronic Hepatitis C|Completed||Phase 2|69|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:43:58.900232|2017-02-18 13:43:58.900232
NCT00787358|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2009-06-03|||December 2008||2008-12-01|June 2009|2009-06-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Interventional|SHIFT||A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women|A Randomized, Double-Blind, Placebo Controlled Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women With Intertrochanteric Fracture of the Hip|Withdrawn||Phase 2|50|Anticipated|Zelos Therapeutics||2||Change in company direction|f||||f||||||||||2017-02-18 13:43:58.995248|2017-02-18 13:43:58.995248
NCT00787345|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2010-09-20|||May 2008||2008-05-01|May 2008|2008-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|CVC||Simulation-based Training for Surgery Residents in Aseptic Techniques|General Surgery Residents Education in Maximum Barrier Precautions During Central Venous Catheter Placement: Effect of Simulation-Based Training|Completed||Phase 3|50|Anticipated|St. Luke's-Roosevelt Hospital Center||1|||f||||f||||||||||2017-02-18 13:43:59.097992|2017-02-18 13:43:59.097992
NCT00787332|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-01-06|2012-11-29||September 2008||2008-09-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|HIT||A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome|A Comparative Clinical and Pharmacoeconomic Study Comparing Argatroban® IV vs Desirudin SC for Patients With Suspected Heparin-Induced Thrombocytopenia (HIT)With or Without Thrombosis Syndrome (HIT/TS)|Terminated||Phase 4|16|Actual|Canyon Pharmaceuticals, Inc.|Study stopped early due to poor enrollment.|2||Low enrollment|f||||f||||||||||2017-02-18 13:43:59.213653|2017-02-18 13:43:59.213653
NCT00787319|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-10-08|2013-05-15||January 2010||2010-01-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice|Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice|Completed||N/A|108|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:43:59.638816|2017-02-18 13:43:59.638816
NCT00787306|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2010-06-30|||September 2008||2008-09-01|June 2010|2010-06-01|July 2009|Anticipated|2009-07-01|May 2009|Anticipated|2009-05-01||Interventional|Multi-CHARM||Cardiovascular Health And Risk Modification in Family Health Teams|Multidisciplinary Cariovascular Health And Risk Modification in Family Mealth Teams|Unknown status|Recruiting|Phase 3|480|Anticipated|University of Toronto||2|||f||||f||||||||||2017-02-18 13:44:00.320175|2017-02-18 13:44:00.320175
NCT00786526|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2013-10-29|||March 2008||2008-03-01|October 2013|2013-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Diaphragmatic Function in Ventilated Patients|Ventilator-Induced Diaphragmatic Dysfunction (VIDD) in Critically Ill Patients|Completed||N/A|55|Actual|University Hospital, Montpellier|||1||f||||f||||||||||2017-02-18 13:44:18.06014|2017-02-18 13:44:18.06014
NCT00787293|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2011-02-10|||October 2008||2008-10-01|February 2011|2011-02-01|November 2015|Anticipated|2015-11-01|November 2010|Actual|2010-11-01||Interventional|PTOLEMY-2||Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients|A Multi-center Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients With Heart Failure|Suspended||Phase 2|30|Anticipated|Viacor||1||Company ended operations January 2011|f||||t||||||||||2017-02-18 13:44:00.424985|2017-02-18 13:44:00.424985
NCT00787280|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-02-18|||August 2008||2008-08-01|February 2013|2013-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|DIET||Diet, Imaging and Energy Balance Trial (DIET)|Diet, Imaging and Energy Balance Trial|Completed||N/A|51|Actual|Duke University||2|||f||||f||||||||||2017-02-18 13:44:00.559265|2017-02-18 13:44:00.559265
NCT00787267|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2016-05-31|2014-12-19||September 2008||2008-09-01|May 2016|2016-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|TOP0801|All consented subjects included in baseline analysis.|Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC|Phase II Study of Dasatinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|37|Actual|Duke University||1||Poor accrual|f||||t||||||||||2017-02-18 13:44:00.669728|2017-02-18 13:44:00.669728
NCT00787254|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2012-02-01|2011-02-03||April 2007||2007-04-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs|A Study to Investigate the Preventive Effect of AG-1749 Against the Recurrence of Gastric and Duodenal Ulcers During Long-term Treatment With Nonsteroid Anti-inflammatory Drug|Completed||Phase 3|366|Actual|Takeda|This study was prematurely discontinued due to results available from a parallel study (AG-1749-CCT-351; NCT00762359) demonstrating a preventive effect on ulcer occurrence which impacted the risk/benefit profile.|2|||f||||t||||||||||2017-02-18 13:44:01.042251|2017-02-18 13:44:01.042251
NCT00787241|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-03-17|2011-08-16||September 2002||2002-09-01|March 2014|2014-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Observational|||Platelet Count Trends in Pre-eclamptic Parturients|Platelet Count Trends in Pre-eclamptic Parturients: What is the Predictive Value of an Initial Platelet Count During Labor?|Completed||N/A|445|Actual|Northwestern University|Retrospective trial and obtaining platelet counts was not done per protocol so cannot predict the greatest interval that is acceptable to demonstrate platelet counts greater than 150,000 during labor and delivery.||3||f||||f||||||||||2017-02-18 13:44:02.609857|2017-02-18 13:44:02.609857
NCT00787215|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-08-21|||November 2008||2008-11-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese|A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese: Validation of the Chinese University Diabetes Screening Score|Active, not recruiting||N/A|3000|Anticipated|Chinese University of Hong Kong|||1||f||||||||||||||2017-02-18 13:44:03.133455|2017-02-18 13:44:03.133455
NCT00787202|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-03-06|2012-12-04||December 2008||2008-12-01|March 2013|2013-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.|A Randomized, Placebo Controlled, Double Blind, Parallel Group Multi-Center Study In Order To Investigate Safety And Efficacy Of CP- 690 550 In Subjects With Moderate To Severe Ulcerative Colitis.|Completed||Phase 2|195|Actual|Pfizer|Pharmacokinetic (PK) parameters and their correlation with clinical response and inflammatory biomarkers were not reported as data from future studies were to be pooled for analysis.|5|||f||||f||||||||||2017-02-18 13:44:03.238832|2017-02-18 13:44:03.238832
NCT00787189|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2014-04-07|2009-06-23||August 2007||2007-08-01|April 2014|2014-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Low Level Laser Therapy and Word Recognition in Hearing Impaired Individuals|The Effects of the Erchonia Hearing Laser on Word Recognition in Hearing Impaired Individuals Clinical Study Protocol|Completed||N/A|80|Actual|Erchonia Corporation||2|||f||||t||||||||||2017-02-18 13:44:04.785973|2017-02-18 13:44:04.785973
NCT00787176|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-10-29|||September 2007||2007-09-01|October 2015|2015-10-01|July 2012|Actual|2012-07-01|February 2010|Actual|2010-02-01||Interventional|||The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes|The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes|Terminated||N/A|252|Actual|Northwestern University||4||Study concluded prematurely prior to meeting intended goal recruitment.|f||||f||||||||||2017-02-18 13:44:05.137672|2017-02-18 13:44:05.137672
NCT00787163|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2009-01-21|||September 2008||2008-09-01|November 2008|2008-11-01|December 2013|Anticipated|2013-12-01|September 2011|Anticipated|2011-09-01||Interventional|||Amnioinfusion Initiative|Open Randomized Trial Comparing Perinatal Outcome Following Expectant Management Versus Amnioinfusion in PPROM <25 Wks With Persistent Oligohydramnios|Unknown status|Recruiting|Phase 3|82|Anticipated|Università degli Studi di Brescia||2|||f||||t||||||||||2017-02-18 13:44:05.246834|2017-02-18 13:44:05.246834
NCT00787150|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2013-04-23|2013-01-29||June 2008||2008-06-01|April 2013|2013-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation|A Phase 2b, Randomized, Partially Blind (Open Label Warfarin), Active-Controlled (Warfarin), Multicenter Study, To Evaluate The Safety And Efficacy In 2 Doses Of Apixaban In Comparison To Warfarin, Administered For 12 Weeks In Subjects With NVAF|Completed||Phase 2|222|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 13:44:05.356121|2017-02-18 13:44:05.356121
NCT00787137|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2010-10-15|2010-08-12||December 2008||2008-12-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Single Dose PG102 in Patients With Active Psoriatic Arthritis|A Randomised, Double Blind, Placebo Controlled, Single Ascending Dose, Phase I Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PG102 (Anti-CD40 Monoclonal Antibody) In Patients With Active Psoriatic Arthritis|Terminated||Phase 1|17|Actual|PanGenetics UK Limited|Termination prior to accrual of planned numbers of participants|3||poor recruitment|f||||t||||||||||2017-02-18 13:44:06.232589|2017-02-18 13:44:06.232589
NCT00787124|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2013-12-13|2013-07-24||September 2008||2008-09-01|December 2013|2013-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Transfusions and Nitric Oxide Level in Preterm Infants|Transfusions and Nitric Oxide Level in Preterm Infants|Completed||N/A|8|Actual|Duke University|no AE observed||2||f||||f||||||Samples Without DNA|"~     blood specimens for measurement of SNO-Hb. Samples will be discarded after measurement.~   "|||2017-02-18 13:44:06.803294|2017-02-18 13:44:06.803294
NCT00787111|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2010-02-22|||November 2008||2008-11-01|February 2010|2010-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|EMMA||Extended Management and Measurement of Autism|Extended Management & Measurement of Autism (Emma): An Open-Label, Follow-On Study to Investigate the Safety and Impact on Developmental Trajectory of 18 Months Treatment With Fluoxetine Orally Dissolving Tablet (Odt) In Childhood and Adolescent Autistic Disorder|Terminated||Phase 3|128|Anticipated|Neuropharm||1|||f||||f||||||||||2017-02-18 13:44:07.134297|2017-02-18 13:44:07.134297
NCT00787098|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2009-07-02|||November 2007||2007-11-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Investigating Modes of Progressive Mobility|Investigating Modes of Progressive Mobility|Completed||Phase 2|82|Anticipated|Hill-Rom||2|||f||||f||||||||||2017-02-18 13:44:07.244115|2017-02-18 13:44:07.244115
NCT00787085|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2008-11-06|||September 2001||2001-09-01|November 2008|2008-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|FACES||The Significance of Funguria in Hospitalized Patients|The Significance of Funguria in Hospitalized Patients (FACES)|Completed||N/A|919|Actual|Los Angeles Biomedical Research Institute|||2||f||||t||||||Samples Without DNA|"~     Urine and blood cultures~   "|||2017-02-18 13:44:07.346377|2017-02-18 13:44:07.346377
NCT00787072|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2010-11-30|||October 2008||2008-10-01|November 2010|2010-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||AZD8075 Single Ascending Dose Study|A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of AZD8075 in Healthy Male Volunteers|Terminated||Phase 1|72|Anticipated|AstraZeneca||2||"After reports of turbidity in urine in 4 of 8 volunteers in the 4th cohort, the study was~   halted temporarily."|f||||f||||||||||2017-02-18 13:44:07.444255|2017-02-18 13:44:07.444255
NCT00787059|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2016-04-26||2016-02-18|July 2010||2010-07-01|February 2016|2016-02-01|October 2017|Anticipated|2017-10-01|January 2015|Actual|2015-01-01||Interventional|||AC6 Gene Transfer for CHF|Phase I/II Study AC6 Gene Transfer for Congestive Heart Failure|Active, not recruiting||Phase 1/Phase 2|56|Actual|Hammond, H. Kirk, M.D.||2|||f||||t||||||||Undecided|The trial remains blinded|2017-02-18 13:44:07.535378|2017-02-18 13:44:07.535378
NCT00787033|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2017-01-24|||December 2008||2008-12-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|March 2011|Actual|2011-03-01||Interventional|B0761001||A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies|A Phase 1, Open-Label, Dose Escalation Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies|Completed||Phase 1|46|Actual|Verastem, Inc.||1|||f||||f||||||||||2017-02-18 13:44:10.044503|2017-02-18 13:44:10.044503
NCT00787020|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2015-10-11|2010-10-06||November 2008||2008-11-01|March 2011|2011-03-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Observational|VISION||Ventriculostomies in SAH: ICP Open or Not?|Ventriculostomies in SAH: ICP Open or Not?|Completed||N/A|37|Actual|Duke University|||2||f||||f||||||||||2017-02-18 13:44:10.149742|2017-02-18 13:44:10.149742
NCT00787007|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-06|2012-01-19|||September 2008||2008-09-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers|Randomized, Double-Blind, Single Rising Dose Study of S-equol in Normal Volunteers|Completed||Phase 1|60|Actual|Ausio Pharmaceuticals, LLC||7|||f||||t||||||||||2017-02-18 13:44:10.5531|2017-02-18 13:44:10.5531
NCT00786994|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-08-30|2015-04-02||October 2008||2008-10-01|August 2015|2015-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||ITT|The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses|Randomized, Multicenter, Double Blind Study to Compare the Efficacy and Tolerability of Oleogel-S-10 for 3 Month Versus Placebo Only in Patients With Mild to Moderate Actinic Keratoses Located at the Face and Head Oleogel-S-10 in Actinic Keratoses Trial|Completed||Phase 2|165|Actual|Amryt Pharma||4|||f||||f||||||||||2017-02-18 13:44:10.671998|2017-02-18 13:44:10.671998
NCT00786981|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-08-10|||April 2009||2009-04-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Epidural Steroid Injection Versus Epidural Steroid Injection and Manual Physical Therapy and Exercise in the Management of Lumbar Spinal Stenosis|Epidural Steroid Injection Versus Epidural Steroid Injection and Manual Physical Therapy and Exercise in the Management of Lumbar Spinal Stenosis; a Randomized Clinical Trial|Recruiting||N/A|80|Anticipated|Franklin Pierce University||2|||f||||f||||||||||2017-02-18 13:44:11.325034|2017-02-18 13:44:11.325034
NCT00786968|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2013-02-19|||January 2008||2008-01-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I|An Extension Study of Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis I|Terminated||Phase 1|3|Actual|Dickson, Patricia I., M.D.||1||Due to slow enrolment.|f||||t||||||||||2017-02-18 13:44:11.634506|2017-02-18 13:44:11.634506
NCT00786942|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2010-05-21|||April 2006||2006-04-01|May 2010|2010-05-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Bone Graft Necessity in Opening-Wedge High Tibial Osteotomy|Bone Graft Necessity in Opening-Wedge High Tibial Osteotomy. A Randomized Clinical Trial|Completed||N/A|44|Anticipated|University of Campinas, Brazil||2|||f||||f||||||||||2017-02-18 13:44:11.742226|2017-02-18 13:44:11.742226
NCT00786929|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2009-02-03|||March 2003||2003-03-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|February 2007|Actual|2007-02-01||Interventional|||Acute Pancreatitis and Acute Fluid Collections|Randomized Controlled Trial on Sterile Fluid Collections Management in Acute Pancreatitis|Completed||Phase 4|63|Actual|University Medical Center, Tuzla||2|||f||||f||||||||||2017-02-18 13:44:11.84935|2017-02-18 13:44:11.84935
NCT00786916|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-02-26|2013-01-23||February 2008||2008-02-01|February 2015|2015-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy of IV Lidocaine at Alleviating Pain Associated With Propofol Infusion in Pediatric Patients Undergoing Sedation|Efficacy of Intravenous Lidocaine at Alleviating Pain Associated With Propofol Infusion in Pediatric Patients Undergoing Procedural Sedation|Completed||Phase 4|109|Actual|Akron Children's Hospital|No complications or adverse reactions were associated with either study drug dose.|3|||f||||f||||||||||2017-02-18 13:44:11.953746|2017-02-18 13:44:11.953746
NCT00786903|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-04-02|||November 2008||2008-11-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?|Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?|Completed||N/A|202|Actual|Medical University of Graz|||1||f||||t||||||Samples With DNA|"~     Respiratory secretions, blood, lung tissue~   "|||2017-02-18 13:44:12.397028|2017-02-18 13:44:12.397028
NCT00786890|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-08-21|||November 2008||2008-11-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|JADE-HK2||A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong|A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong: The Joint Asia Diabetes Evaluation (JADE) Program Sub-study 2 (JADE-HK2)|Active, not recruiting||N/A|3000|Anticipated|Chinese University of Hong Kong|||1||f||||||||||||||2017-02-18 13:44:12.483692|2017-02-18 13:44:12.483692
NCT00786877|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-01-15|||August 2009||2009-08-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Cookstove Replacement for Prevention of ALRI and Low Birthweight in Nepal|Cookstove Replacement for Prevention of ALRI and Low Birthweight in Nepal|Completed||Phase 3|4678|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-02-18 13:44:12.573505|2017-02-18 13:44:12.573505
NCT00786864|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2008-11-05|2008-10-14||January 2007||2007-01-01|November 2008|2008-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|LBP||Exercise for Low Back Pain in Children|School-Based Specific Exercise Programme Reduces the Prevalence and Intensity of Low Back Pain in 12-13 Year Old Children: a Randomized Controlled Trial|Completed||N/A|72|Actual|University of Witwatersrand, South Africa|Only 2 schools, in a similar geographic and socioeconomic area were included, and therefore the results may not necessarily be generalized to a larger population|2|||f||||f||||||||||2017-02-18 13:44:12.701354|2017-02-18 13:44:12.701354
NCT00786851|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-08-16|||July 2008||2008-07-01|August 2016|2016-08-01|August 2011|Actual|2011-08-01|July 2010|Actual|2010-07-01||Interventional|||Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)|Salvage Treatment With Lenalidomide and Dexamethaosne(LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)|Completed||Phase 2|33|Actual|Fondazione Italiana Linfomi ONLUS||1|||f||||f||||||||||2017-02-18 13:44:13.130683|2017-02-18 13:44:13.130683
NCT00786838|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2014-03-13|2013-03-29||October 2008||2008-10-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram|A Single-Blind, Multicenter, Placebo-Controlled, Sequential Design Study Evaluating the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram|Completed||Phase 2|76|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 13:44:13.2613|2017-02-18 13:44:13.2613
NCT00786825|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-06-08|||December 2004||2004-12-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|Glycogen||Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla|Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla|Recruiting||N/A|15|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 13:44:14.017309|2017-02-18 13:44:14.017309
NCT00786812|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2014-04-01|||August 2008||2008-08-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|MACS0439||Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase|An Open-label, Multicenter Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase|Completed||Phase 4|89|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:44:14.14354|2017-02-18 13:44:14.14354
NCT00786799|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2012-07-31|2011-09-14||August 2008||2008-08-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Omega-3 Fatty Acids for Autism Treatment|A Randomized, Double-Blind, Placebo-Controlled 12-week Study to Investigate the Effect of Omega-3 Fatty Acids on Hyperactivity in Childhood Autism|Completed||Phase 2|27|Actual|University of California, San Francisco|"Small sample size which results in a limited power to detect small to moderate treatment effects.~Relatively mild level of hyperactivity in both groups."|2|||f||||t||||||||||2017-02-18 13:44:14.255444|2017-02-18 13:44:14.255444
NCT00786786|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-11-02|||August 2008||2008-08-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|||||Observational|||Perceived Barriers to Exercise in Individuals Living With Spinal Cord Injury|Perceived Barriers to Exercise in Individuals Living With Spinal Cord Injury.|Completed||N/A|1000|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:44:14.676815|2017-02-18 13:44:14.676815
NCT00786773|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2010-12-06|||October 2008||2008-10-01|December 2010|2010-12-01|June 2009|Actual|2009-06-01|||||Observational|||Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.|Epidemiological Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment|Completed||N/A|2091|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:44:14.766396|2017-02-18 13:44:14.766396
NCT00786760|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-10-05|||June 2005||2005-06-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Observational|||Natural History of HPV Infection in Men: The HIM Study|Natural History of HPV Infection in Men: The HIM Study|Active, not recruiting||N/A|1431|Actual|H. Lee Moffitt Cancer Center and Research Institute|||2||f||||f||||||Samples With DNA|"~     This study will create a specimen repository with which to test future novel hypotheses~     related to HPV infection among men. To assess other genetic, infectious, or environmental~     factors that may influence acquisition and persistence of HPV infections in men, whole~     blood, serum, exfoliated penile cell samples, and oral cells will be stored in aliquots for~     future analyses as funding becomes available. Using banked specimens preserved for DNA, RNA,~     and protein analyses, we will be able to assess novel biomarkers such as methylation status~     of oncogenic HPV, polymorphisms in genes involved in innate immunity (e.g., TLR genes), and~     mRNA of the E6 and E7 HPV oncoproteins in the future.~   "|||2017-02-18 13:44:14.864324|2017-02-18 13:44:14.864324
NCT00786747|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-12-02|||February 2010||2010-02-01|December 2015|2015-12-01|November 2012|Actual|2012-11-01|October 2011|Actual|2011-10-01||Interventional|||Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities|Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities|Completed||N/A|1164|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 13:44:14.966715|2017-02-18 13:44:14.966715
NCT00786734|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2012-03-28|||August 2008||2008-08-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|May 2009|Actual|2009-05-01||Interventional|||Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)|A Randomized, Open Label, Comparative Study to Evaluate Effect of Pitavastatin for Reduction of Myocardial Damage in Patient Are Scheduled Elective PCI for Stable Angina Pectoris|Withdrawn||Phase 4|0|Actual|JW Pharmaceutical||2|||f||||f||||||||||2017-02-18 13:44:15.095671|2017-02-18 13:44:15.095671
NCT00786721|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2017-02-08|||November 2006||2006-11-01|February 2017|2017-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort|Diffuse Optical Spectroscopy Measurement Technique is Helping Develop More Effective Diagnostic Tools and Therapeutic Regimes for Diabetes, Metabolic Syndrome and Other Mitochondrial Diseases Some Time in the Future|Completed||N/A|9|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:44:15.206504|2017-02-18 13:44:15.206504
NCT00786708|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2014-02-07|||December 2006||2006-12-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|December 2009|Actual|2009-12-01||Observational|||Sensitivity and Specificity of NGAL in an Emergency Room Population|Sensitivity and Specificity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in an Emergency Room Population|Completed||N/A|2304|Actual|Columbia University|||1||f||||f||||||Samples Without DNA|"~     Urine~   "|||2017-02-18 13:44:15.312302|2017-02-18 13:44:15.312302
NCT00786695|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-03-02|||May 2006||2006-05-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ECP||Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP|Esomeprazole as a Diagnostic Test for Gastroesophageal Reflux Disease in Patients With Noncardiac Chest Pain|Completed||N/A|60|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-02-18 13:44:15.423566|2017-02-18 13:44:15.423566
NCT00786682|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2013-09-23|2013-09-23||December 2008||2008-12-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer|A Phase II Study of Docetaxel and Modulation of Autophagy With Hydroxychloroquine for Metastatic Hormone Refractory Prostate Cancer|Terminated||Phase 2|11|Actual|Rutgers, The State University of New Jersey||1||Lack of improved efficacy compared to historical controls, competing studies|f||||f||||||||||2017-02-18 13:44:15.540479|2017-02-18 13:44:15.540479
NCT00786669|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-02-24|||October 2008||2008-10-01|February 2015|2015-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|VITAC||A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors|A Pilot Study of the Addition of Bevacizumab to Vincristine, Oral Irinotecan, and Temozolomide (VOIT Regimen) for Relapsed/Refractory Pediatric Solid Tumors|Completed||Phase 1|13|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 13:44:15.809124|2017-02-18 13:44:15.809124
NCT00786656|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2017-01-24|||November 3, 2008||2008-11-03|May 11, 2015|2015-05-11|May 11, 2015||2015-05-11|||||Observational|||Community Cancer Centers Pilot Patient Survey|NCI Community Cancer Center Pilot Program Patient Survey|Completed||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:44:15.921032|2017-02-18 13:44:15.921032
NCT00786643|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2012-02-28|2011-11-17||February 2006||2006-02-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|GFL||Study of Gamma Interfereon in Metastatic Colorectal Carcinoma|Phase II Study of Gamma Interferon (IFN-γ) Added to Bolus + Infusional 5-Fluorouracil (5-FU) and Leucovorin (LV) +/- Bevacizumab (BV) in Metastatic Colorectal Carcinoma|Completed||Phase 2|48|Actual|Accelerated Community Oncology Research Network|Enrollment to stratum 1 was closed early due to difficulty accruing the required number of patients in this stratum.|2|||f||||t||||||||||2017-02-18 13:44:16.012368|2017-02-18 13:44:16.012368
NCT00786630|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2014-12-19|||November 2007||2007-11-01|December 2014|2014-12-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||Intervention to Reduce Injection Drug Use|Intervention to Reduce Injection Drug Use|Completed||N/A|726|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 13:44:16.84601|2017-02-18 13:44:16.84601
NCT00786617|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-03-18|||December 2007||2007-12-01|March 2015|2015-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||The Efficacy of Nurse-driven, Protocol Guided Ventilator Weaning in a Medical-Surgical Intensive Care Unit (ICU)|The Efficacy of Nurse-driven, Protocol Guided Ventilator Weaning in a Medical-Surgical ICU|Completed||N/A|202|Actual|St. Luke's-Roosevelt Hospital Center|||2||f||||t||||||||||2017-02-18 13:44:16.940889|2017-02-18 13:44:16.940889
NCT00786604|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-11-02|||June 2007||2007-06-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|||||Observational|||Glucose Study, Spinal Cord Injury|Continuous Glucose Monitoring in Individuals With Spinal Cord Injury|Completed||N/A|40|Anticipated|University of California, Irvine|||3||f||||f||||||||||2017-02-18 13:44:17.028689|2017-02-18 13:44:17.028689
NCT00786591|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2012-12-27|||June 2006||2006-06-01|December 2012|2012-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Study of New Biological Markers for Prediction of Severe Acute Pancreatitis|Clinical Evaluation of Novel Biological Markers for the Prediction of Severe Acute Pancreatitis|Completed||N/A|75|Actual|National University Hospital, Singapore|||2||f||||f||||||Samples With DNA|"~     Whole blood; Serum~   "|||2017-02-18 13:44:17.106111|2017-02-18 13:44:17.106111
NCT00786578|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2014-10-23|||January 2010||2010-01-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Evaluation of Skeletal Muscle Lipid Content by Magnetic Resonance Spectroscopy|Evaluation of Intramyocellular Lipid Content (IMCL) in Skeletal Muscle by Magnetic Resonance Spectroscopy|Withdrawn||N/A|0|Actual|University of Minnesota - Clinical and Translational Science Institute|||2|not funded|f||||f||||||Samples Without DNA|"~     blood will be sampled and retained for future metabolic testing as needed~   "|||2017-02-18 13:44:17.200031|2017-02-18 13:44:17.200031
NCT00786565|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-12-07|2009-02-20||January 2004||2004-01-01|December 2011|2011-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Clinical Evaluation of a New Aspheric Intraocular Lens.|Clinical Evaluation of a New Aspheric Intraocular Lens. A Prospective, Multi-Center, Comparative Study.|Completed||Phase 4|75|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 13:44:17.302363|2017-02-18 13:44:17.302363
NCT00786552|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2011-01-19|||November 2008||2008-11-01|January 2011|2011-01-01|November 2013|Anticipated|2013-11-01|November 2012|Anticipated|2012-11-01||Interventional|Panthera||Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer|Phase 2 Trial of Pemetrexed (Alimta™) Combined With Paclitaxel in Patients With Recurrent/Advanced Follicular, Papillary or Anaplastic Thyroid Cancer|Unknown status|Recruiting|Phase 2|47|Anticipated|University of Schleswig-Holstein||1|||f||||||||||||||2017-02-18 13:44:17.866739|2017-02-18 13:44:17.866739
NCT00786539|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2017-02-08|||October 2006||2006-10-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases|Investigation of the Nature and Prevalence of Mitochondria Disease|Completed||N/A|18|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:44:17.964609|2017-02-18 13:44:17.964609
NCT00786513|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2014-04-02|||November 2008||2008-11-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic Therapy|Randomized Double Blind Controlled Trial of the Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic Therapy in Chronic Pseudomonas Aeruginosa Infected Cystic Fibrosis Patients|Completed||Phase 2|134|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 13:44:18.149895|2017-02-18 13:44:18.149895
NCT00786500|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2010-12-03|||February 2007||2007-02-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients|Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients|Completed||Phase 1/Phase 2|24|Actual|Hanoi Medical University||2|||f||||f||||||||||2017-02-18 13:44:18.276566|2017-02-18 13:44:18.276566
NCT00786487|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-07-22|2015-05-29||January 2009||2009-01-01|July 2015|2015-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Training Effects on Skeletal Muscle Fatty Acid Metabolism|Training Effects on Skeletal Muscle Fatty Acid Metabolism|Completed||N/A|33|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||||2017-02-18 13:44:18.387297|2017-02-18 13:44:18.387297
NCT00786474|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-02-08|2016-01-06||July 2009||2009-07-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)|Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery|Completed||Phase 3|1884|Actual|Duke University||2|||f||||t||||||||||2017-02-18 13:44:18.990369|2017-02-18 13:44:18.990369
NCT00786461|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2008-11-05|||March 2007||2007-03-01|November 2008|2008-11-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||The Treatment of Bartholin´s Cyst or Abscess With Silver Nitrate|The Treatment of Bartholin´s Cyst or Abscess With Silver Nitrate|Unknown status|Recruiting|Phase 4|30|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-02-18 13:44:19.669203|2017-02-18 13:44:19.669203
NCT00786448|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2010-04-29|||January 2005||2005-01-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Post Marketing Surveillance Study on Emselex After Launch in Germany|Post-Marketing Surveillance Study Emselex|Completed||Phase 4|5821|Actual|Bayer|||1||f||||f||||||||||2017-02-18 13:44:19.756911|2017-02-18 13:44:19.756911
NCT00786435|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-11-02|||August 2007||2007-08-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|||||Observational|||Carbohydrate Study, Chronic SCI|Carbohydrate Metabolism Impairments in Chronic Human Spinal Cord Injury|Completed||N/A|70|Anticipated|University of California, Irvine|||3||f||||f||||||||||2017-02-18 13:44:19.857778|2017-02-18 13:44:19.857778
NCT00786422|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-10-20|2013-12-20||May 2009||2009-05-01|October 2015|2015-10-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer|The EINSTEIN CYP Cohort Study Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-vein Thrombosis or Pulmonary Embolism Using a Strong CYP 3A4 Inducer|Completed||Phase 2|25|Actual|Bayer||1|||f||||t||||||||||2017-02-18 13:44:19.931472|2017-02-18 13:44:19.931472
NCT00786409|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2013-09-04|||November 2008||2008-11-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|August 2010|Actual|2010-08-01||Interventional|||Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women|Immunogenicity and Safety of the Quadrivalent HPV Vaccine Gardasil in Female Systemic Lupus Erythematosus Patients Aged 9-26|Completed||N/A|27|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 13:44:20.80229|2017-02-18 13:44:20.80229
NCT00786396|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2014-08-18|||July 2004||2004-07-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Connect||Directly Observed Therapy for Community-Released HIV+ Prisoners|Directly Observed Therapy for Community-Released HIV+ Prisoners|Completed||N/A|151|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:44:20.913889|2017-02-18 13:44:20.913889
NCT00786383|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2013-08-16|||February 2006||2006-02-01|August 2013|2013-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy|Phase 1 Study of Every Other Week Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Monoclonal Antibody IMC-1121B in Patients With Advanced Solid Tumors Who Have Not Responded To Standard Therapy|Completed||Phase 1|25|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 13:44:21.024633|2017-02-18 13:44:21.024633
NCT00786370|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2012-02-09|||April 2008||2008-04-01|November 2008|2008-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Dexmedetomidine vs. Propofol for Cataract Surgery|Dexmedetomidine vs. Propofol for Monitored Anesthesia Care During Cataract|Completed||Phase 4|24|Actual|The Cooper Health System||2|||f||||f||||||||||2017-02-18 13:44:21.140326|2017-02-18 13:44:21.140326
NCT00786357|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-06-22|||November 2008||2008-11-01|June 2010|2010-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|SETS-exp||Sleep Enhancement Training Study for Experienced Shiftworkers|Sleep Enhancement Training Study for Experienced Shiftworkers|Completed||Phase 1|32|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 13:44:21.247689|2017-02-18 13:44:21.247689
NCT00786344|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2008-11-04|||November 2004||2004-11-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||USC Well Elderly Study 2|Health Mediating Effects of the Well Elderly Program|Completed||N/A|460|Actual|University of Southern California||2|||f||||t||||||||||2017-02-18 13:44:21.357424|2017-02-18 13:44:21.357424
NCT00786331|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2009-07-31|||July 2007||2007-07-01|July 2009|2009-07-01|December 2009|Anticipated|2009-12-01|July 2009|Anticipated|2009-07-01||Interventional|||Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC|Randomized Phase II Study of Pemetrexed Versus Pemetrexed and Carboplatin as Second Line Chemotherapy in Advanced Non-small-cell Lung Cancer (NSCLC).|Unknown status|Recruiting|Phase 2|230|Anticipated|Gruppo Oncologico Italiano di Ricerca Clinica||2|||f||||t||||||||||2017-02-18 13:44:21.469845|2017-02-18 13:44:21.469845
NCT00786318|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2010-06-18|||September 2008||2008-09-01|June 2010|2010-06-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Ziprasidone vs Standard Therapy for Agitated Patients in the ED|Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department|Unknown status|Active, not recruiting|Phase 4|300|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 13:44:21.612588|2017-02-18 13:44:21.612588
NCT00786305|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2008-11-05|||October 2004||2004-10-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia|Assessment of Efficiency of Nebulized Ceftazidime and Amikacin in Treatment of Ventilator Associated Pneumonia Caused by Pseudomonas Aeruginosa|Completed||Phase 2|40|Actual|Groupe Hospitalier Pitie-Salpetriere||2|||f||||f||||||||||2017-02-18 13:44:21.706281|2017-02-18 13:44:21.706281
NCT00786292|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2012-09-03|||July 2009||2009-07-01|July 2009|2009-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|EVA||Evaluation of Variable Pressure Support Ventilation in the Therapy of Acute Lung Injury|Evaluation of Variable Pressure Support Ventilation in the Therapy of Acute Lung Injury (EVA-Trial)|Completed||N/A|||Technische Universität Dresden||2|||f||||f||||||||||2017-02-18 13:44:21.814211|2017-02-18 13:44:21.814211
NCT00786279|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2016-01-11|||November 2008||2008-11-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|March 2011|Actual|2011-03-01||Interventional|AAAPILOT||Alcohol and Atherosclerosis Pilot Study|Alcohol and Atherosclerosis Pilot Study|Completed||N/A|39|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 13:44:21.910536|2017-02-18 13:44:21.910536
NCT00786266|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-06-22|||November 2008||2008-11-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|SETS-novice||Sleep Enhancement Training Study for Novice Shiftworkers|Sleep Enhancement Training Study for Novice Shiftworkers|Completed||Phase 1|20|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:44:22.025038|2017-02-18 13:44:22.025038
NCT00786253|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2014-10-27|||October 2005||2005-10-01|October 2014|2014-10-01|January 2007|Actual|2007-01-01|||||Interventional|||Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction|A Randomized, Explorative, Double-blind, Double-dummy, Multi-center, Parallel Group Study to Assess Sustainable Efficacy of Once Daily Vardenafil (10 mg) for 12 and 24 Weeks Versus Vardenafil PRN in Men With Mild or Mild to Moderate ED|Completed||Phase 2|236|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:44:22.134135|2017-02-18 13:44:22.134135
NCT00786240|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2010-09-08|||January 2009||2009-01-01|September 2010|2010-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Phase1, Single Dose, Crossover Study to Determine Bioequivalence|A Phase 1, Open-Label, Randomized, Single-Dose, 2-Way Crossover Study To Determine Bioequivalence Of 4 Mg Fesoterodine SR Tablet Between Formulation D And Formulation E(1) In Healthy Subjects.|Completed||Phase 1|37|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:44:22.252361|2017-02-18 13:44:22.252361
NCT00786227|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2013-05-01|||June 2008||2008-06-01|May 2013|2013-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA)|Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA)|Completed||N/A|761|Actual|Stanford University|||1||f||||f||||||||||2017-02-18 13:44:22.356722|2017-02-18 13:44:22.356722
NCT00786214|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2013-06-20|||February 2007||2007-02-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Treatment of Functional Dyspepsia With Acupuncture|Treatment of Functional Dyspepsia With Acupuncture: A Randomized, Blinded, Sham Acupuncture Controlled Study|Completed||N/A|42|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-02-18 13:44:22.449654|2017-02-18 13:44:22.449654
NCT00786201|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-11-24||2012-12-18|December 2008||2008-12-01|November 2015|2015-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)|A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 888 Administered Intravenously in Subjects With Idiopathic Pulmonary Fibrosis|Completed||Phase 2|126|Actual|Centocor, Inc.||4|||f||||t||||||||||2017-02-18 13:44:22.555574|2017-02-18 13:44:22.555574
NCT00786188|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-10-14|2013-07-16||November 2008||2008-11-01|October 2015|2015-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause|A Phase 2, Exploratory, Eight-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Mesafem (Paroxetine Mesylate) Capsules in the Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 2|102|Actual|Noven Therapeutics||2|||f||||f||||||||||2017-02-18 13:44:22.710074|2017-02-18 13:44:22.710074
NCT00786175|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2015-08-21|||October 2008||2008-10-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Survey to Evaluate the Rate of Abnormal Glucose Tolerance Among Hong Kong Chinese Subjects With Coronary Heart Disease|A Cross-sectional Observational Survey to Evaluate the Rate of Diabetes and Glucose Intolerance (Both Diagnosed and Undiagnosed) Among Hong Kong Chinese Subjects With Coronary Heart Disease|Withdrawn||N/A|0|Actual|Chinese University of Hong Kong|||1||f||||t||||||||||2017-02-18 13:44:23.373955|2017-02-18 13:44:23.373955
NCT00786162|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2012-03-14|||April 2007||2007-04-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Blood Pressure Self Management for Hypertension & Prehypertension Using an Internet Enabled, Automated Self Management Program|Blood Pressure Self Management for Hypertension & Prehypertension Using an Internet Enabled, Automated Self Management Program|Completed||N/A|404|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:44:23.465501|2017-02-18 13:44:23.465501
NCT00786149|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2014-09-02|||September 2007||2007-09-01|September 2014|2014-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Improving Varenicline Adherence and Outcomes in Homeless Smokers|Improving Varenicline Adherence and Outcomes in Homeless Smokers|Completed||Phase 3|428|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 13:44:23.563897|2017-02-18 13:44:23.563897
NCT00786136|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2013-04-09|||December 2008||2008-12-01|April 2013|2013-04-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|TRACK-D||Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes|Multicenter Randomized Controlled Study of Rosuvastatin for Prevention of Contrast Induced Acute Kidney Injury in Patients With Diabetes and Slight to Moderate Renal Insufficient|Completed||Phase 4|2998|Actual|Shenyang Northern Hospital||2|||f||||t||||||||||2017-02-18 13:44:23.673346|2017-02-18 13:44:23.673346
NCT00786123|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-03-02|||May 2006||2006-05-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome|Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome: a Randomized Double Blind Placebo Controlled Study|Completed||N/A|40|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-02-18 13:44:23.909639|2017-02-18 13:44:23.909639
NCT00786110|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-05|2009-02-23|||April 2008||2008-04-01|February 2009|2009-02-01|October 2010|Anticipated|2010-10-01|October 2009|Anticipated|2009-10-01||Interventional|PAXO||Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients|Sorafenib Plus Paclitaxel Metronomic Chemotherapy in Adreno-Cortical-Carcinoma Patients Progressing After 1st or 2nd Line Cytotoxic Chemotherapy|Unknown status|Recruiting|Phase 2|30|Anticipated|University of Turin, Italy||1|||f||||t||||||||||2017-02-18 13:44:24.023217|2017-02-18 13:44:24.023217
NCT00786097|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-08-21|||July 2008||2008-07-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix - Compatibility|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix|Completed||Phase 3|53|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:44:24.141643|2017-02-18 13:44:24.141643
NCT00786084|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-09-30|||September 2008||2008-09-01|September 2009|2009-09-01|December 2009|Anticipated|2009-12-01|July 2009|Anticipated|2009-07-01||Observational|PEH||Study of Paraesophageal Hernia Repair With Small Intestine Submucosa|Randomized Prospective Controlled Trial of Paraesophageal Hernia Repair With Small Intestine Submucosa (SIS)|Unknown status|Active, not recruiting|N/A|108|Anticipated|University of Washington|||2||f||||t||||||None Retained|"~     None retained.~   "|||2017-02-18 13:44:24.243076|2017-02-18 13:44:24.243076
NCT00786071|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-03-03|||May 2009||2009-05-01|March 2010|2010-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Metabolic Evaluation of Nutrition in Rett Syndrome|A Systematic Metabolic Approach to the Evaluation of Nutrition in Rett Syndrome According to the Cardiorespiratory Phenotype in Dutch Rett Girls|Completed||N/A|13|Actual|Maastricht University Medical Center|||1||f||||f||||||Samples Without DNA|"~     Whole blood, serum, dried blood spot, leukocytes, erythrocytes, urine.~   "|||2017-02-18 13:44:24.353816|2017-02-18 13:44:24.353816
NCT00786058|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-06-12||||||June 2009|2009-06-01||||||||Expanded Access|||A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003|A Phase III Second Line Trial of Patients With Gemcitabine Resistant Advanced Pancreatic Cancer (CONKO-003)|Approved for marketing||N/A|||CONKO-Studiengruppe|||||f||||||||||||||2017-02-18 13:44:24.451902|2017-02-18 13:44:24.451902
NCT00786045|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2013-04-26|||November 2002||2002-11-01|April 2013|2013-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|FITS||Fitness Intervention Trial for Stroke|Fitness Intervention Tiral for Stroke: Enhancing Walking Endurance Using Home Rehabilitation Programs|Completed||N/A|60|Actual|McGill University||2|||f||||f||||||||||2017-02-18 13:44:24.706347|2017-02-18 13:44:24.706347
NCT00786032|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-01-06|2014-03-26||September 2011||2011-09-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|June 2013|Actual|2013-06-01||Observational|ALS|Participant with ALS age more than 18, living at home within 100 miles of the pariticipating study site, visual acuity of al least 20/80, and communicate non-verbally with their significant other, caregiver and system operator, and with study personnel and demonstrate during the screening phase sufficient EEG interaction for the BCI to operate.|A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients|Cooperative Studies Program (CSP) #567 - A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients|Completed||N/A|27|Actual|VA Office of Research and Development|Some limitations would be the Caregivers willingness and ability to support BCI user. In addition, the caregivers limited availability and the time commitment of the usage of the BCI system.||1||f||||t||||||||||2017-02-18 13:44:24.817805|2017-02-18 13:44:24.817805
NCT00786019|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2016-04-08|||May 2008||2008-05-01|April 2016|2016-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|InsITE||Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes|Influence Of Endothelial Function On Central and Peripheral Causes Of Exercise Impairment In Type 2 Diabetes|Completed||N/A|98|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-02-18 13:44:25.229027|2017-02-18 13:44:25.229027
NCT00786006|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-12-05|||March 2007||2007-03-01|December 2011|2011-12-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer|Randomized Phase II Trial of FOLFIRI3 vs. FOLFOX in Gemcitabine-refractory Advanced Pancreatic Cancer|Completed||Phase 2|61|Actual|Asan Medical Center||2|||f||||f||||||||||2017-02-18 13:44:25.356306|2017-02-18 13:44:25.356306
NCT00785993|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-10-01|||November 2008||2008-11-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Egg-Banking and Ovo-donation|Impact of Egg-Banking in an Ovum-donation Program|Completed||Phase 4|320|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||||||||||||2017-02-18 13:44:25.475903|2017-02-18 13:44:25.475903
NCT00785980|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2012-07-31|2009-09-10||September 2008||2008-09-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin|A One-Directional, Open-Label Drug Interaction Study to Investigate the Effects of Multiple-Dose Ciprofloxacin HCl on the Single-Dose Pharmacokinetics of Quinine in Healthy Volunteers|Completed||Phase 1|24|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 13:44:25.580764|2017-02-18 13:44:25.580764
NCT00785967|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-04-13|||January 2009||2009-01-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|RAG-1/2||Immune Responses in Patients Treated With Raltegravir|Immune Responses to Neo-Antigens in Patients Treated With Raltegravir: Insights on V(D)J Recombination and RAG-1/2 Recombinase Function|Withdrawn||Phase 3|0|Actual|McGill University Health Center||2||Unexpected and severe difficulties in recruitment.|f||||f||||||||||2017-02-18 13:44:26.004508|2017-02-18 13:44:26.004508
NCT00785954|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-08-30||2011-08-30|November 2008||2008-11-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|July 2010|Actual|2010-07-01||Interventional|PROTECTION AMI||Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]|Inhibition of Delta-protein Kinase C for the Reduction of Infarct Size in Acute Myocardial Infarction|Completed||Phase 2|1180|Actual|KAI Pharmaceuticals||4|||f||||t||||||||||2017-02-18 13:44:26.132236|2017-02-18 13:44:26.132236
NCT00785941|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-10-12|||April 2006||2006-04-01|October 2011|2011-10-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available|Phase I Study of Anti-Insulin-Like Growth Factor-I Receptor (IGF-IR) Monoclonal Antibody IMC-A12 Administered Every Other Week in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or for Whom No Standard Therapy is Available|Completed||Phase 1|16|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 13:44:26.368883|2017-02-18 13:44:26.368883
NCT00785928|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-02-11||2010-10-25|October 2008||2008-10-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|||A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy|Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399 in Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy|Completed||Phase 2|158|Actual|Eli Lilly and Company||7|||f||||f||||||||||2017-02-18 13:44:26.482014|2017-02-18 13:44:26.482014
NCT00785915|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2014-10-10|||November 2008||2008-11-01|October 2014|2014-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|JSAD/JMAD||AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects|A Phase I, Single-center, Randomized, Double-blind, Placebo-controlled Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6765 in Healthy Male and Female Japanese and Caucasian Subjects|Completed||Phase 1|40|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:44:26.635128|2017-02-18 13:44:26.635128
NCT00785902|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-02-18||||||February 2011|2011-02-01||||||||Interventional|A||AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation||Withdrawn||Phase 3|||AtriCure, Inc.|||||f||||t||||||||||2017-02-18 13:44:26.729309|2017-02-18 13:44:26.729309
NCT00785889|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2008-11-13|||March 2008||2008-03-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||RCT of Air Insufflation Versus Water Infusion Colonoscopy|A Randomized Controlled Comparison of Warm Water Infusion in Lieu of Air Insufflation vs. Air Insufflation for Aiding Colonoscopy Insertion in Sedated Patients Undergoing Colorectal Cancer (CRC) Screening and Surveillance.|Completed||N/A|56|Actual|East Bay Institute for Research and Education||1|||f||||t||||||||||2017-02-18 13:44:26.873302|2017-02-18 13:44:26.873302
NCT00785876|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2014-05-12|||November 2008||2008-11-01|May 2014|2014-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Implementation of the Low Risk Ankle Rule|Controlled Radiography for Ankle Injury Cases in Kids in the Emergency Department: Implementation of the Low Risk Ankle Rule|Completed||N/A|3000|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 13:44:26.970342|2017-02-18 13:44:26.970342
NCT00785863|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-06-30|||December 2008||2008-12-01|November 2008|2008-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Modulation of Remifentanil-induced Postinfusion Hyperalgesia|Modulation of Remifentanil-induced Analgesia and Postinfusion Hyperalgesia by Parecoxib or Ketorolac in Humans|Completed||Phase 4|16|Actual|Oslo University Hospital||4|||f||||f||||||||||2017-02-18 13:44:27.06802|2017-02-18 13:44:27.06802
NCT00785850|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-03-05|||August 2008||2008-08-01|March 2009|2009-03-01||||September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Safety.|Safety Dermatological Evaluation: Genital Mucous Irritation - Product Tested: Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower.|Completed||Phase 3|31|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:44:27.185776|2017-02-18 13:44:27.185776
NCT00785837|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2008-11-04|||July 2005||2005-07-01|September 2008|2008-09-01|January 2009|Anticipated|2009-01-01|September 2008|Anticipated|2008-09-01||Interventional|hydrotherapy||Effects of Hydrotherapy in Pain and Quality of Sleep's Cycles in Preterm Newborn on Neonatal Intensive Care Units|Effects of Hydrotherapy in Pain and Quality of Sleep's Cycles in Preterm Newborn on Neonatal Intensive Care Units|Unknown status|Recruiting|N/A|8|Anticipated|Universidade Luterana do Brasil||2|||f||||t||||||||||2017-02-18 13:44:27.269907|2017-02-18 13:44:27.269907
NCT00785824|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2013-10-30|||January 2009||2009-01-01|October 2013|2013-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||African-American Bone Metabolism and Lactation Study|A Prospective Cohort Pilot Study of Bone Metabolism in Lactating and Non-lactating Postpartum African-American Women and Healthy Non-pregnant African-American Women|Completed||N/A|58|Actual|University of Pittsburgh|||3||f||||t||||||Samples Without DNA|"~     archival blood serum and plasma~   "|||2017-02-18 13:44:27.368864|2017-02-18 13:44:27.368864
NCT00785811|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-03-15|||October 2008||2008-10-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Chronic Supplementation of L-arginine in the Muscular Performance|Randomized, Double Blind, Placebo Controlled Study of Parallel Groups to Evaluate the Effect of Chronic Supplementation of L-arginine in the Muscular Performance.|Terminated||Phase 4|36|Actual|Sanofi||2||Required by the investigator. The site could not recruit patients anymore.|f||||||||||||||2017-02-18 13:44:27.479001|2017-02-18 13:44:27.479001
NCT00785798|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2016-06-14|2016-06-14||January 2009||2009-01-01|June 2016|2016-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas|A Phase I/II Trial of Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas|Terminated||Phase 1/Phase 2|17|Actual|Yale University||1||sponsor requested|f||||f||||||||||2017-02-18 13:44:27.581211|2017-02-18 13:44:27.581211
NCT00785785|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2016-05-10|2015-10-21||March 2009||2009-03-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|ENESTg1||A Study of Nilotinib Versus Imatinib in GIST Patients|A Randomized, Open Label, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Nilotinib Versus Imatinib in Adult Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 3|644|Actual|Novartis||2|||f||||||||||||||2017-02-18 13:44:27.808792|2017-02-18 13:44:27.808792
NCT00785772|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-10-31|2011-03-29||March 2010||2010-03-01|October 2011|2011-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment|A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment|Terminated||Phase 4|1|Actual|Pfizer|The study was completed with an enrollment of 1 subject because prolongation of the study period or a change in the inclusion criteria (the upper limit of age was deleted) did not lead to further enrollment of subjects.|3||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:44:31.942937|2017-02-18 13:44:31.942937
NCT00785759|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-12-04|||September 2008||2008-09-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|ALZ201||Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers|An Open-label Study to Assess Brain Uptake and Safety of AH110690 (18F) Injection in Subjects With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers|Completed||Phase 2|78|Actual|GE Healthcare||1|||f||||t||||||||||2017-02-18 13:44:32.21537|2017-02-18 13:44:32.21537
NCT00785746|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2013-02-01|||August 2006||2006-08-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Improving Balance in Frail Elderly|Improving Balance in Frail Elderly: A Randomized Clinical Trial of Two Methods to Enhance Strength (Stretch and Strength Versus Core Strength)|Completed||Early Phase 1|60|Actual|McGill University||2|||f||||f||||||||||2017-02-18 13:44:32.295651|2017-02-18 13:44:32.295651
NCT00785733|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-11-30|||November 2008||2008-11-01|November 2010|2010-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART|SMART Way of Treating Asthma. Non-interventional Study to Evaluate Clinical Efficacy of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Patients With Moderate and Severe Asthma|Completed||N/A|1182|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:44:32.387645|2017-02-18 13:44:32.387645
NCT00785720|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-08-21|||August 2008||2008-08-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Photo Avaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower|Completed||Phase 3|26|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:44:32.720514|2017-02-18 13:44:32.720514
NCT00785707|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2016-03-04|||May 2008||2008-05-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|LittlEars||Littlears Auditory Questionnaire: Validation Study in CI Children|Littlears Auditory Questionnaire Validation Study in CI Children With LittlEARS My Diary: Language: North American English|Completed||N/A|31|Actual|Med-El Corporation|||1||f||||f||||||||||2017-02-18 13:44:32.810087|2017-02-18 13:44:32.810087
NCT00785694|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-04-23|||December 2008||2008-12-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Recurrence of Bladder Cancer After Transurethral Resection With Hexvix|Recurrence of Bladder Cancer After Transurethral Resection With Hexvix|Withdrawn||Phase 4|0|Actual|GE Healthcare||2||Rejected ethics approval in UK and Holland|f||||f||||||||||2017-02-18 13:44:32.903403|2017-02-18 13:44:32.903403
NCT00785681|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-08-21|||July 2008||2008-07-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Compatibility|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower|Completed||Phase 3|53|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:44:33.003978|2017-02-18 13:44:33.003978
NCT00785668|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2008-11-04|||November 2007||2007-11-01|November 2008|2008-11-01|February 2008|Actual|2008-02-01|||||Interventional|||A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects|A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects|Completed||Phase 1|10|Actual|Aerovance, Inc.||1|||f||||f||||||||||2017-02-18 13:44:33.101222|2017-02-18 13:44:33.101222
NCT00785655|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-08-21|||July 2008||2008-07-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Compatibility|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower|Completed||Phase 3|53|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:44:33.200125|2017-02-18 13:44:33.200125
NCT00785642|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-03-05|||August 2008||2008-08-01|March 2009|2009-03-01||||September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety.|Safety Dermatological Evaluation: Genital Mucous Irritation - Product Tested: Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid).|Completed||Phase 3|30|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:44:33.29022|2017-02-18 13:44:33.29022
NCT00785629|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2012-09-28|2012-08-27||February 2009||2009-02-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD|A Double Blind Randomized Placebo Controlled Trial of Maintenance of Normal Serum Phosphorus in Chronic Kidney Disease (CKD)|Completed||N/A|148|Actual|Denver Nephrologists, P.C.|Single center study; Modest size of study; pilot study not powered to detect differences among subgroups of actively treated patients|4|||f||||t||||||||||2017-02-18 13:44:33.391983|2017-02-18 13:44:33.391983
NCT00785616|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-07-22|||September 2008||2008-09-01|July 2010|2010-07-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence|A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence|Completed||Phase 4|55|Anticipated|Montefiore Medical Center||1|||f||||f||||||||||2017-02-18 13:44:34.039384|2017-02-18 13:44:34.039384
NCT00785603|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-02-12|||August 2008||2008-08-01|February 2009|2009-02-01|February 2009|Anticipated|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Paroxetines Effect on Tramadols Metabolism and Pharmakodynamics: a Dose Response Study|Paroxetines Effect on Tramadols Metabolism and Pharmakodynamics: a Dose Response Study|Unknown status|Active, not recruiting|Phase 4|12|Actual|University of Southern Denmark||1|||f||||t||||||||||2017-02-18 13:44:34.11997|2017-02-18 13:44:34.11997
NCT00785590|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-08-21|||August 2008||2008-08-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower.|Completed||Phase 3|26|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:44:34.208765|2017-02-18 13:44:34.208765
NCT00785577|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2012-04-30|2011-08-25||November 2008||2008-11-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||A Study for Treatment of Pain in Patients With Diabetic Neuropathy.|A Phase 2 Study of the Effects of LY545694, an iGluR5 Antagonist, in the Treatment of Subjects With Painful Diabetic Neuropathy.|Completed||Phase 2|273|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-02-18 13:44:34.334887|2017-02-18 13:44:34.334887
NCT00785564|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2008-11-04|||November 2007||2007-11-01|November 2008|2008-11-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Observational|||Imaging Cardiac Electrical Remodeling With Electrocardiogram Imaging (ECGI)|Imaging Cardiac Electrical Remodeling With ECGI|Unknown status|Recruiting|N/A|10|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 13:44:38.193247|2017-02-18 13:44:38.193247
NCT00785174|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2008-11-04|||January 2005||2005-01-01|November 2008|2008-11-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Non-Invasive Ventilation Versus Continuous Positive Airway Pressure in Cardiogenic Pulmonary Edema: a Multicentre Study||Completed||Phase 3|200|Actual|University of Monastir||2|||f||||f||||||||||2017-02-18 13:44:46.987374|2017-02-18 13:44:46.987374
NCT00785551|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2012-07-31|||November 2007||2007-11-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment|A Single-Dose, Open-Label Comparative Study of the Pharmacokinetics, Safety,and Tolerability of Oral Quinine Sulfate in Healthy Volunteers and Adults With Mild and Moderate Renal Impairment|Terminated||Phase 1|5|Actual|Mutual Pharmaceutical Company, Inc.||3||poor enrollment|f||||f||||||||||2017-02-18 13:44:38.272211|2017-02-18 13:44:38.272211
NCT00785538|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-06-14|||October 2005||2005-10-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study of IMC-A12 in Patients With Tumors Who No Longer Respond to Treatment or Who No Treatment if Available|Phase I Study of Anti-Insulin-Like Growth Factor-I Receptor (IGF-IR) Monoclonal Antibody IMC-A12 in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or for Whom No Standard Therapy is Available|Completed||Phase 1|24|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 13:44:38.467911|2017-02-18 13:44:38.467911
NCT00785525|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2017-02-15|||February 1997||1997-02-01|October 2016|2016-10-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Interventional|||Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors|Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors|Recruiting||Phase 3|35000|Anticipated|Center for International Blood and Marrow Transplant Research||1|||f||||t||||||||||2017-02-18 13:44:38.579097|2017-02-18 13:44:38.579097
NCT00785512|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2010-08-19|2010-08-19||November 2008||2008-11-01|August 2010|2010-08-01||||August 2009|Actual|2009-08-01||Interventional|||A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy|A Prospective, Randomized, Double-Blind, Placebo Controlled Study of the Long-Term Efficacy of Nebivolol in Hypertensive Patients After Withdrawal of Therapy|Completed||Phase 4|207|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 13:44:38.88743|2017-02-18 13:44:38.88743
NCT00785499|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2012-03-19|||November 2008||2008-11-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|MoMS||Milk Components and Metabolic Syndrome|The Effect of Milk, Whey and Casein on Weight Loss and Risk Markers of Metabolic Syndrome in Overweight Children|Completed||N/A|193|Actual|University of Copenhagen||4|||f||||f||||||||||2017-02-18 13:44:39.339261|2017-02-18 13:44:39.339261
NCT00785486|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2012-08-22|2009-03-11||March 2007||2007-03-01|August 2012|2012-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Drug-Drug Interaction Study of Qualaquin and Midazolam|A Pharmacokinetic Interaction Study Evaluating the Effect of Qualaquin (Quinine Sulfate) Capsules on Midazolam|Completed||Phase 1|24|Actual|Mutual Pharmaceutical Company, Inc.||3|||f||||f||||||||||2017-02-18 13:44:39.436452|2017-02-18 13:44:39.436452
NCT00785473|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-09-02|||January 2008||2008-01-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis|Can Vitamin D Supplementation Prevent Bone Loss in Persons With MS? A Randomised, Placebo-controlled, Single-centre Study|Completed||Phase 4|80|Anticipated|University Hospital of North Norway||2|||f||||f||||||||||2017-02-18 13:44:39.802641|2017-02-18 13:44:39.802641
NCT00785460|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2008-11-04|||January 2008||2008-01-01|November 2008|2008-11-01||||May 2008||2008-05-01||Interventional|||Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers|Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers|Completed||Phase 3|20|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-02-18 13:44:39.909142|2017-02-18 13:44:39.909142
NCT00785447|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-04-24|||March 2008||2008-03-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Comparison of the Efficiency of Mouth-to-nose Breathing With Mouth-to-mouth Breathing|Comparison of the Efficiency of Mouth-to-nose Breathing With Mouth-to-mouth Breathing in Non-paralyzed Adult Patients Under General Anesthesia|Completed||N/A|20|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:44:40.009399|2017-02-18 13:44:40.009399
NCT00785434|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-01-12|||October 2008||2008-10-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD|Phase IV Pilot Study to Examine the Efficacy and Safety of Escitalopram in Doses up to 50 mg for the Treatment of Patients With Major Depressive Disorder (MDD).|Completed||Phase 4|60|Actual|Community Pharmacology Services Ltd||1|||f||||f||||||||||2017-02-18 13:44:40.11596|2017-02-18 13:44:40.11596
NCT00785421|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-01-07|||April 2004||2004-04-01|January 2015|2015-01-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|PROSPECT||Chemotherapy With or Without Enoxaparin in Pancreatic Cancer|A Prospective, Randomized Trial Of Simultaneous Pancreatic Cancer Treatment With Enoxaparin and ChemoTherapy (PROSPECT)|Completed||Phase 2/Phase 3|312|Actual|CONKO-Studiengruppe||2|||f||||t||||||||||2017-02-18 13:44:40.224876|2017-02-18 13:44:40.224876
NCT00785408|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-01-16|||December 2008||2008-12-01|December 2014|2014-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Examine the Safety, Tolerability, and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects|Completed||Phase 2|273|Actual|AstraZeneca||6|||f||||f||||||||||2017-02-18 13:44:40.345168|2017-02-18 13:44:40.345168
NCT00785395|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2011-11-01|||June 2008||2008-06-01|November 2008|2008-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Up-Down Oxytocin Infusion|Up-down Determination of the ED90 of Oxytocin Infusions for the Prevention of Postpartum Uterine Atony in Parturients Undergoing Cesarean Delivery|Completed||Phase 4|40|Actual|IWK Health Centre||1|||f||||t||||||||||2017-02-18 13:44:40.464633|2017-02-18 13:44:40.464633
NCT00785382|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2012-10-30|||January 2009||2009-01-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pregabalin for Postoperative Pain in Women Undergoing Breast Cancer Surgery|A Randomized, Placebo Controlled Trial of Pregabalin for Postoperative Pain in Women Undergoing Breast Cancer Surgery|Completed||Phase 4|62|Actual|IWK Health Centre||2|||f||||t||||||||||2017-02-18 13:44:40.557404|2017-02-18 13:44:40.557404
NCT00785369|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2012-10-02|||August 2008||2008-08-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis|In Vivo Reflectance Confocal Microscopy for Pigmented Lesion Diagnosis: A Multi-center Study|Completed||N/A|441|Actual|Lucid, Inc.||1|||f||||f||||||||||2017-02-18 13:44:40.669674|2017-02-18 13:44:40.669674
NCT00785356|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2014-08-05|2014-06-25||October 2008||2008-10-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Study prematurely terminated|Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids|A Multi-Center, Placebo Controlled, Safety and Efficacy Study of the Selective Progesterone Receptor Modulator Proellex® (CDB-4124) in Anemic, Pre-Menopausal Women With Symptomatic Uterine Fibroids Requiring Hysterectomy|Terminated||Phase 3|8|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with any study data.|3||Repros stopped the study for safety and FDA put the study on hold for safety.|f||||t||||||||||2017-02-18 13:44:40.937956|2017-02-18 13:44:40.937956
NCT00785343|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-12-23|||September 2008||2008-09-01|December 2009|2009-12-01||||||||Interventional|||Study of Robot-assisted Arm Therapy for Acute Stroke Patients|Effectiveness of Adding Robotic Therapy to Conventional Therapy for Acute Stroke Patients With Upper Extremity Paresis|Unknown status|Recruiting|Phase 1|40|Anticipated|Kessler Foundation||2|||f||||t||||||||||2017-02-18 13:44:41.20848|2017-02-18 13:44:41.20848
NCT00785330|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-16|||April 2004||2004-04-01|November 2008|2008-11-01|April 2014|Anticipated|2014-04-01|March 2009|Anticipated|2009-03-01||Interventional|||Allo-hNHL (FluBuCy)|Open, Multicentral, Randomised Phase II Study of Allogene Stem Cell Transplantation After Pretreatment With Fludarabin, Busulfan, Cyclophospahmid and GVHD-Prophylaxis With or Without Rituximab in Patients With Recidivation of High Grade Non-Hodgkin's Lymphoma in Special Risk Situation in the Age of 18 - 65|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||2|||f||||t||||||||||2017-02-18 13:44:41.320795|2017-02-18 13:44:41.320795
NCT00785317|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2008-11-04|||November 2008||2008-11-01|November 2008|2008-11-01|April 2010|Anticipated|2010-04-01|October 2009|Anticipated|2009-10-01||Interventional|BrAVA||Effects of Estradiol on Menopausal Breast|Effects of Oral 1 mg Oestradiol (E2)/ 2 mg of Drospirenone (DRSP) Compared to Oral 1 mg of Oestradiol (E2)/ 0.5 mg Noresthisterone Acetate (NETA)on the Postmenopausal Breast; a Double Blind Randomized Prospective Study|Unknown status|Recruiting|Phase 4|120|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 13:44:41.444686|2017-02-18 13:44:41.444686
NCT00785304|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2014-12-08|||November 2008||2008-11-01|December 2014|2014-12-01|July 2016|Anticipated|2016-07-01|July 2011|Actual|2011-07-01||Observational|||Advanced MRI in Blast-related TBI|ADVANCED MRI IN BLAST-RELATED TBI|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Washington University School of Medicine|||2||f||||t||||||||||2017-02-18 13:44:41.548027|2017-02-18 13:44:41.548027
NCT00785291|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2016-11-14|2015-06-05||October 2008||2008-10-01|November 2016|2016-11-01||||December 2013|Actual|2013-12-01||Interventional||All randomized participants are included in baseline characteristics.|Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer|A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound Nab-paclitaxel or Ixabepilone With or Without Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer|Active, not recruiting||Phase 3|799|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 13:44:41.84855|2017-02-18 13:44:41.84855
NCT00785278|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2008-11-04|||July 2008||2008-07-01|November 2008|2008-11-01|July 2010|Anticipated|2010-07-01|October 2009|Anticipated|2009-10-01||Observational|||Adjusting Wheelchair Set-Up to Minimize Shoulder Joint Forces During Propulsion|Computationally Quantifying Wheelchair Set-Up to Minimize Peak Shoulder Joint Forces Throughout Manual Wheelchair Propulsion: A Pilot Study|Unknown status|Recruiting|N/A|9|Anticipated|Kessler Foundation|||2||f||||f||||||||||2017-02-18 13:44:45.58568|2017-02-18 13:44:45.58568
NCT00785265|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2016-12-29|||August 2007||2007-08-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|November 2015|Actual|2015-11-01||Interventional|||A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation|A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation|Active, not recruiting||N/A|180|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||f||||||||||2017-02-18 13:44:45.672696|2017-02-18 13:44:45.672696
NCT00785252|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-02-04|||September 2008||2008-09-01|February 2011|2011-02-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||EZIO Compared to Central Venous Lines for Emergency Vascular Access|Randomized Study of the EZIO Compared to Central Venous Lines Used for Emergency Vascular Access|Unknown status|Recruiting|Phase 4|50|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 13:44:45.90417|2017-02-18 13:44:45.90417
NCT00785239|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-06-23|||April 2009||2009-04-01|June 2015|2015-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||CryoSpray Ablation(tm)Thoracic Patient Registry|CryoSpray Ablation(tm)Thoracic Patient Registry|Withdrawn||N/A|0|Actual|CSA Medical, Inc.|||1|Business Reasons|f||||f||||||||||2017-02-18 13:44:46.011185|2017-02-18 13:44:46.011185
NCT00785226|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2016-10-14||2015-09-24|November 2008||2008-11-01|October 2016|2016-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||RDEA119 and Sorafenib Combination Dose Escalation Study|A Phase 1/2 Study of the Combination of RDEA119 and Sorafenib in Patients With Advanced Cancer|Completed||Phase 1/Phase 2|62|Actual|Bayer||1|||f||||f||||||||||2017-02-18 13:44:46.120643|2017-02-18 13:44:46.120643
NCT00785213|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2012-07-31|2009-10-20||September 2008||2008-09-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone|An Open-Label Drug-Drug Interaction Study to Investigate the Effects of Steady State Quinine on the Single-Dose Pharmacokinetics of Rosiglitazone Maleate in Healthy Volunteers|Completed||Phase 1|23|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 13:44:46.240843|2017-02-18 13:44:46.240843
NCT00785200|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2013-06-11|||January 2009||2009-01-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|||MRSA Colonization and Control in the Dallas County Jail|MRSA Colonization and Control in the Dallas County Jail|Completed||N/A|4194|Actual|University of Chicago||3|||f||||f||||||||||2017-02-18 13:44:46.658916|2017-02-18 13:44:46.658916
NCT00785187|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2008-11-04|||December 2008||2008-12-01|November 2008|2008-11-01||||February 2009|Anticipated|2009-02-01||Interventional|||Affect of Dose Rate on UVR Induced Skin Erythema|Randomized Open Crossover Study Researching Affect of Dose Rate on UVR Induced Skin Erythema|Unknown status|Not yet recruiting|N/A|40|Anticipated|Goldenhersh, Michael, M.D.||1|||f||||f||||||||||2017-02-18 13:44:46.767914|2017-02-18 13:44:46.767914
NCT00785161|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2016-12-22|||August 2009||2009-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|PICS||Penumbra Imaging Collaborative Study (PICS)|Penumbra Imaging Collaborative Study (PICS): A Multicenter Trial to Assess Outcome of Patients Revascularized by the Penumbra™ System|Active, not recruiting||Phase 4|289|Actual|Penumbra Inc.|||1||f||||f||||||||||2017-02-18 13:44:47.084864|2017-02-18 13:44:47.084864
NCT00785148|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-03-05|||August 2008||2008-08-01|March 2009|2009-03-01||||September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) - Safety|Safety Dermatological Evaluation: Genital Mucous Irritation - Product Tested: Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid).|Completed||Phase 3|31|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:44:47.172371|2017-02-18 13:44:47.172371
NCT00785135|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2015-12-08|||November 2008||2008-11-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria|Effects of Vertical Prism on the Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria: A Randomized, Double-blinded, Placebo-controlled, Cross-over Study|Completed||Phase 3|13|Actual|Vision Specialists of Birmingham||2|||f||||f||||||||||2017-02-18 13:44:47.26289|2017-02-18 13:44:47.26289
NCT00785122|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2013-05-15|||June 2008||2008-06-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|January 2011|Actual|2011-01-01||Interventional|IMA910-101||IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)|An Open Label, Multicenter Phase 1-2 Study to Investigate the Effectiveness, Safety and Immunogenicity of a Monotherapy With Intradermal IMA910 Plus GM-CSF Following Pre-treatment With Low-dose Cyclophosphamide in Advanced Colorectal Carcinoma Patients Who Have Successfully Completed a 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy.|Completed||Phase 1/Phase 2|92|Actual|immatics Biotechnologies GmbH||1|||f||||t||||||||||2017-02-18 13:44:47.363685|2017-02-18 13:44:47.363685
NCT00785109|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-09-22|||January 2010||2010-01-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|08-002||Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification|Vitamin K Containing Nutritional Supplement for Activation of Matrix-GIa-proteins (MGP) and Inhibition of Aortic Valve Calcification Process|Completed||Phase 2/Phase 3|117|Actual|RWTH Aachen University||2|||f||||f||||||||||2017-02-18 13:44:47.509796|2017-02-18 13:44:47.509796
NCT00785096|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-02-09|||January 2009||2009-01-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||How do Patients, Nurses and Physicians Perceive Negative Postoperative Events?|Perception of Surgical Complications - Agreements Among Patients, Nurses and Physicians|Completed||N/A|615|Actual|University of Zurich|||3||f||||t||||||||||2017-02-18 13:44:47.615547|2017-02-18 13:44:47.615547
NCT00785083|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2016-11-16|||September 2008||2008-09-01|November 2016|2016-11-01||||February 2009|Actual|2009-02-01||Interventional|||A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma|A Double-blind, Randomized, Placebo-controlled, Parallel, Time-lagged, Ascending, Multi-centre, Multiple-dose Study to Measure the Magnitude and Time Course of the Effect of FTY720 on FEV1 and Other Pulmonary Function Tests (FVC, FEF25-75%, and FEV1/FVC) in Patients With Moderate Asthma|Completed||Phase 2|36|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:44:47.705283|2017-02-18 13:44:47.705283
NCT00785070|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2009-02-05|||April 2008||2008-04-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Observational|PROSPECT||Pre and Post Orthopedic Surgery Sleep and Cardiac Testing (PROSPECT)|Pre and Post Orthopedic Surgery Sleep and Cardiac Testing (PROSPECT)|Completed||Phase 4|100|Anticipated|Memorial Health System|||1||f||||f||||||||||2017-02-18 13:44:47.81014|2017-02-18 13:44:47.81014
NCT00785057|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-12-02|||November 2008||2008-11-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|SAPIENCE||Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke|A Retrospective, Multi Centre, Non-interventional, Observational Study to Compare Treatment Pattern and Factors That Affect BP Control in Patients With and Without Stroke|Completed||N/A|1000|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:44:47.897636|2017-02-18 13:44:47.897636
NCT00785044|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-04-28|||June 2008||2008-06-01|April 2010|2010-04-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Observational|||Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event|An Open-label, Multicentre, Phase 3 Study to Demonstrate the Prognostic Usefulness of 123I-mIBG Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event During 24 Months Followup|Completed||N/A|471|Actual|GE Healthcare|||1||f||||f||||||||||2017-02-18 13:44:47.991335|2017-02-18 13:44:47.991335
NCT00785031|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2012-06-13|||October 2008||2008-10-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|IRIS||Internet Based Vascular Risk Factor Intervention and Self Management Study|Internet-based Vascular Risk Factor Management for Patients With Clinical Manifest Vascular Disease; a Randomized Controlled Trial|Completed||N/A|330|Actual|UMC Utrecht||2|||f||||f||||||||||2017-02-18 13:44:48.070699|2017-02-18 13:44:48.070699
NCT00785018|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2011-04-21|||November 2008||2008-11-01|May 2009|2009-05-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|VECTOR||In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia|In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia|Completed||N/A|20|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 13:44:48.186051|2017-02-18 13:44:48.186051
NCT00785005|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2012-04-17|||May 2008||2008-05-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|ExPRESS||What Makes Exercise Feel More Difficult to Women With and Without Type 2 Diabetes|Exercise-related Perceived Rate of Exertion at Steady-State Workloads (ExPRESS) in Type 2 Diabetes Mellitus|Completed||N/A|99|Actual|University of Colorado, Denver|||2||f||||t||||||Samples Without DNA|"~     During the first visit, blood will be drawn for measurements of overall health (complete~     blood count and comprehensive metabolic panel), glucose and insulin levels, lipid levels,~     plasma FSH concentration, and HbA1C.~      On two separate visits, blood samples will be drawn from a warmed IV site to measure muscle~     metabolites which change with exercise (e.g., glucose, calcium, lactate, H+, K+, and HCO3-)~     and may be associated with muscle pain or fatigue.~   "|||2017-02-18 13:44:48.294426|2017-02-18 13:44:48.294426
NCT00784992|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2010-10-01|||November 2008||2008-11-01|October 2010|2010-10-01|January 2011|Anticipated|2011-01-01|December 2010|Anticipated|2010-12-01||Interventional|||A Comparison of Endonasal Dacryocystorhinostomy With and Without Silicone Tubes|A Randomised Controlled Trial to Compare Success and Complication Rates in Endonasal Dacryocystorhinostomy Surgery With and Without Silicone Tubes|Unknown status|Recruiting|Phase 4|200|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:44:48.373545|2017-02-18 13:44:48.373545
NCT00784979|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2015-06-22|2014-04-28||January 2002||2002-01-01|June 2015|2015-06-01|April 2012|Actual|2012-04-01|December 2010|Actual|2010-12-01||Interventional|||Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation|Reduction of PRA (Panel Reactive Antibody) in Sensitized Patients Awaiting Live-Donor Renal Transplantation|Completed||Phase 4|26|Actual|Tampa General Hospital||1|||f||||f||||||||||2017-02-18 13:44:48.471758|2017-02-18 13:44:48.471758
NCT00784966|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-04|2014-09-12|||August 2011||2011-08-01|September 2014|2014-09-01|September 2017|Anticipated|2017-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Islet After Kidney Transplant for Type 1 Diabetes|Pancreatic Islet Transplantation in Patients With Type 1 Diabetes Mellitus|Withdrawn||Phase 1/Phase 2|0|Actual|Virginia Commonwealth University||2||University decision.|f||||t||||||||||2017-02-18 13:44:48.692178|2017-02-18 13:44:48.692178
NCT00784953|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2015-11-09|||October 2008||2008-10-01|November 2015|2015-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Real Life Effectiveness in Patients With Not Optimally Controlled Asthma|Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA|Completed||N/A|842|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:44:48.804395|2017-02-18 13:44:48.804395
NCT00784940|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2009-04-24|||June 1998||1998-06-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|March 2005|Actual|2005-03-01||Interventional|||ATAC - Bone Density Sub-Protocol|A Randomised, Double-Blind Trial to Assess the Effects on Bone Mineral Density and Metabolism of Arimidex Alone, Nolvadex Alone, or Arimidex and Nolvadex in Combination, (in Comparison to a Control Group) When Used as Adjuvant Treatment for Breast Cancer in Postmenopausal Women|Completed||Phase 3|308|Actual|AstraZeneca||3|||f||||t||||||||||2017-02-18 13:44:49.047839|2017-02-18 13:44:49.047839
NCT00784927|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-01|2016-08-25|2015-03-23||November 2008||2008-11-01|August 2016|2016-08-01|February 2016|Actual|2016-02-01|October 2013|Actual|2013-10-01||Interventional|||Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma|A Phase 2 Study of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) for Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy|Completed||Phase 2|36|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 13:44:49.143409|2017-02-18 13:44:49.143409
NCT00784914|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-01|2015-09-24|||June 2008||2008-06-01|September 2015|2015-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors|A Pilot Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors|Completed||N/A|12|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 13:44:49.459385|2017-02-18 13:44:49.459385
NCT00784901|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-02|2008-11-10|||August 2008||2008-08-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis Pigmemtosa|Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis Pigmemtosa|Completed||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:44:49.585848|2017-02-18 13:44:49.585848
NCT00784888|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-03-14|||June 2008||2008-06-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|TAMARA||Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy|A Non-Interventional Study Evaluating The Effects Of Aromatase Inhibitor Treatment After 2-3 Years Tamoxifen - As Adjuvant Endocrine Therapy - On Quality Of Life And Safety In Endocrine Responsive Early Stage Postmenopausal Breast Cancer Patients|Completed||Phase 4|344|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:44:49.669048|2017-02-18 13:44:49.669048
NCT00784875|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-01-30|2011-11-17||October 2008||2008-10-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|SLUMBER||An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia|A Phase 2, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study of the Safety and Efficacy of LY2624803 in Outpatients With Insomnia|Completed||Phase 2|643|Actual|Eli Lilly and Company||4|||f||||t||||||||||2017-02-18 13:44:49.964259|2017-02-18 13:44:49.964259
NCT00784862|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2009-05-14|||June 1998||1998-06-01|May 2009|2009-05-01|March 1999|Actual|1999-03-01|||||Interventional|||ATAC - Pharmacokinetics (PK) Sub-Protocol|A Randomised, Double Blind Trial to Assess the Pharmacokinetics of Arimidex Alone, Nolvadex Alone, or Arimidex and Nolvadex in Combination, When Used as Adjuvant Treatment for Breast Cancer in Postmenopausal Women|Completed||Phase 3|9358|Actual|AstraZeneca||3|||f||||t||||||||||2017-02-18 13:44:52.95964|2017-02-18 13:44:52.95964
NCT00784849|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2012-05-17|2012-04-18||November 2004||2004-11-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)|Pilot Trial to Determine the Feasibility of a One Step Sentinel Lymph Node Biopsy Procedure Using Radiolabeled Methylene Blue (IND 70,627)|Completed||Phase 2|62|Actual|Louisiana State University Health Sciences Center in New Orleans||1|||f||||t||||||||||2017-02-18 13:44:53.054651|2017-02-18 13:44:53.054651
NCT00784836|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-04-07|2010-02-17||October 2008||2008-10-01|April 2014|2014-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients|A Multicenter, Open-Label, Immunogenicity and Safety Study of Avonex® (Interferon Beta-1a) 30 mcg Administered Subcutaneously to Subjects With Relapsing Multiple Sclerosis|Terminated||Phase 3|3|Actual|Biogen|Early termination with partial data from 3 subjects, therefore, no statistical analysis performed.|1||Terminated early by Sponsor for business reasons unrelated to safety.|f||||f||||||||||2017-02-18 13:44:53.299496|2017-02-18 13:44:53.299496
NCT00783159|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2011-01-11|||June 2008||2008-06-01|January 2011|2011-01-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|FiAT||Fit in the Aged by Professional Training|The Effect of Different Training Modalities and Vitamin D Supplementation on Functionality in Prefrail Elderly Persons|Completed||N/A|69|Actual|University of Erlangen-Nürnberg Medical School||3|||f||||f||||||||||2017-02-18 13:45:38.199325|2017-02-18 13:45:38.199325
NCT00784823|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2014-02-01|||January 2007||2007-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Mel-Vel||Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma|A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction With High Dose Melphalan as a Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|32|Actual|Hackensack University Medical Center||1|||f||||t||||||||||2017-02-18 13:44:53.524518|2017-02-18 13:44:53.524518
NCT00784810|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-09-22|2011-07-14||February 2009||2009-02-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional|||A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis|A Double-blind, Double-dummy, Parallel Group, Randomised Study to Compare the Efficacy & Tolerability of Oxycodone/Naloxone Prolonged Release (OXN PR) & Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis|Completed||Phase 4|247|Actual|Napp Pharmaceuticals Limited||2|||f||||f||||||||||2017-02-18 13:44:53.632776|2017-02-18 13:44:53.632776
NCT00784797|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-02|2013-11-20|||January 2009||2009-01-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Misopristol Versus Pitocin for Second Trimester Abortion|Comparison Between Misopristol and Pitocin After Mifepristone Preparation for Second Trimeter Abortion|Completed||Phase 4|145|Actual|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 13:44:54.219821|2017-02-18 13:44:54.219821
NCT00784784|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2014-11-07|2011-05-13||November 2008||2008-11-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|Stop-Flu-2||Zanamivir Versus Trivalent Split Virus Influenza Vaccine|A Pilot Study for a Randomized Controlled Trial to Compare Trivalent Split Virus Influenza Vaccine to Seasonal Antiviral Prophylaxis in Healthcare and Other Healthy Adults: Assessment of Zanamivir Versus Vaccine (Stop-Flu-2)|Completed||Phase 3|64|Actual|Mount Sinai Hospital, Canada|Pilot study: Limited number of participants|2|||f||||f||||||||||2017-02-18 13:44:54.332316|2017-02-18 13:44:54.332316
NCT00784771|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2015-11-19|||January 2005||2005-01-01|November 2008|2008-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Hypnotherapeutic Olfactory Conditioning for Posttraumatic Stress Disorder (PTSD)|Hypnotherapeutic Olfactory Conditioning for Chronic Combat-Related Posttraumatic Stress Disorder|Completed||N/A|36|Actual|Herzog Hospital||1|||f||||f||||||||||2017-02-18 13:44:54.754134|2017-02-18 13:44:54.754134
NCT00784758|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-03-08|||February 2009||2009-02-01|March 2011|2011-03-01|July 2011|Anticipated|2011-07-01|April 2011|Anticipated|2011-04-01||Interventional|FAMOUS||Fenzian Asthma Multicenter Outcomes Study|Effect of Fenzian™ Treatment on Symptoms, Pulmonary Function and Albuterol/Salbutamol Use in Patients With Mild to Moderate Persistent Asthma: A Multicenter, Sham-Controlled Clinical Trial|Unknown status|Active, not recruiting|N/A|125|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 13:44:54.849986|2017-02-18 13:44:54.849986
NCT00784745|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2014-05-19|||November 2008||2008-11-01|May 2014|2014-05-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect|Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect|Completed||N/A|21|Actual|University Hospital, Gentofte, Copenhagen||1|||f||||f||||||||||2017-02-18 13:44:54.964838|2017-02-18 13:44:54.964838
NCT00784732|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2016-11-16|||September 2008||2008-09-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber|A Randomized, Partially-blinded, Placebo-controlled, Two-way Crossover, Proof of Concept Study to Compare the Relative Efficacy of CRTh2 Receptor Antagonist, QAV680 Against Placebo in the Treatment of Allergic Rhinitis in an Environmental Exposure Chamber (EEC) Model|Completed||Phase 2|44|Actual|Novartis||3|||f||||f||||||||||2017-02-18 13:44:55.073804|2017-02-18 13:44:55.073804
NCT00784719|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2013-02-27|2012-11-29||November 2008||2008-11-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.|A Phase I/II Prospective, Randomized, Double Masked, Vehicle And Comparator Controlled, Dose Ranging Study Of CP-690,550 In Subjects With Dry Eye Disease.|Completed||Phase 1/Phase 2|327|Actual|Pfizer|In this study, a variance was made in the planned analysis. At the time of data analysis, results from Stage 1 and 2 were combined for efficacy and safety analyses. Hence, results are presented together for both stages.|6|||f||||f||||||||||2017-02-18 13:44:55.214013|2017-02-18 13:44:55.214013
NCT00784706|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-08-26|||October 2008||2008-10-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effect of Combined Therapy on Neglect Syndrome in Stroke Patients|Effect of Combined Therapy on Neglect Syndrome in Stroke Patients|Completed||N/A|30|Actual|Chang Gung Memorial Hospital||3|||f||||f||||||||||2017-02-18 13:44:58.547128|2017-02-18 13:44:58.547128
NCT00784693|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-04-22||2011-03-14|December 2008||2008-12-01|April 2011|2011-04-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis|A Phase 2, 16 Week, Multicenter, Randomized, Double Blind Placebo Controlled, Parallel Group Proof Of Concept Study Evaluating The Efficacy And Safety Of Tanezumab For The Treatment Of Pain Associated With Endometriosis|Terminated||Phase 2|48|Actual|Pfizer||2||"Further recruitment into the study was ceased on 10th December 2009, not attributed to safety.~   All patients recruited in the study completed all study visits."|f||||f||||||||||2017-02-18 13:44:58.812036|2017-02-18 13:44:58.812036
NCT00784680|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2009-04-30|||April 1998||1998-04-01|April 2009|2009-04-01|April 2004|Actual|2004-04-01|||||Interventional|||ATAC - Quality of Life Sub-Protocol|A Randomised, Double-Blind, Parallel Group Trial to Assess Quality of Life With Arimidex Alone, Nolvadex Alone, or Arimidex and Nolvadex in Combination, When Used as Adjuvant Treatment for Breast Cancer in Postmenopausal Women|Completed||Phase 3|308|Actual|AstraZeneca||3|||f||||t||||||||||2017-02-18 13:44:58.940956|2017-02-18 13:44:58.940956
NCT00784667|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2010-11-29|||October 2008||2008-10-01|November 2008|2008-11-01|February 2011|Anticipated|2011-02-01|January 2010|Actual|2010-01-01||Interventional|Dux||Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib|Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab (Erbitux) and Erlotinib (Tarceva) in Patients With Chemotherapy-refractory Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Austin Health||1|||f||||t||||||||||2017-02-18 13:44:59.026827|2017-02-18 13:44:59.026827
NCT00784654|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2015-05-12|2012-07-16||January 2009||2009-01-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17|A Phase III, Double-blind, Placebo-controlled, Randomised Withdrawal, Multicentre, Extension, Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 With Attention- Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|276|Actual|Shire||2|||f||||||||||||||2017-02-18 13:44:59.137459|2017-02-18 13:44:59.137459
NCT00784641|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2013-02-13|||November 2008||2008-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:44:59.990661|2017-02-18 13:44:59.990661
NCT00784615|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2008-11-18|||December 2007||2007-12-01|October 2008|2008-10-01||||||||Observational|||Evaluation of Endocrine and Metabolic Parameters in the New Diagnostic Phenotypes of Polycystic Ovary Syndrome|Descriptive, Transversal Study of Evaluation of Cardiovascular Risks Factors and Prevalence of Metabolic Syndrome in the Different Phenotypes of Women With Polycystic Ovary Syndrome|Unknown status|Recruiting|N/A|80|Anticipated|Universidad Nacional de Córdoba|||5||f||||f||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 13:45:00.078152|2017-02-18 13:45:00.078152
NCT00784602|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2017-02-13|||October 2008||2008-10-01|February 2017|2017-02-01|December 2028|Anticipated|2028-12-01|October 2028|Anticipated|2028-10-01||Observational|||Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes|Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes|Terminated||N/A|301|Actual|William Beaumont Hospitals|||1|Shift in department's research interests|f||||f||||||||No||2017-02-18 13:45:00.213151|2017-02-18 13:45:00.213151
NCT00784589|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2016-11-09|||July 2009||2009-07-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|Rituximab 3||Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus|Comparison Between Monoclonal Antibody CD20 Treatment (Rituximab (mabthéra))and General Corticotherapy Treatment in Patients With Pemphigus|Active, not recruiting||Phase 3|90|Anticipated|University Hospital, Rouen||2|||f||||t||||||||||2017-02-18 13:45:00.308245|2017-02-18 13:45:00.308245
NCT00784576|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2008-12-02|||November 2004||2004-11-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|April 2007|Actual|2007-04-01||Observational|IPDACS||Incidence and Predictors of Delirium After Cardiac Surgery|Incidence and Predictors of Delirium After Cardiac Surgery: A Prospective Observational Cohort Study|Completed||N/A|563|Actual|Medical Universtity of Lodz|||1||f||||f||||||||||2017-02-18 13:45:00.413624|2017-02-18 13:45:00.413624
NCT00784563|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-08-25|2015-01-16||February 2009||2009-02-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Baseline characteristics of subjects.|Effects of Aerobic Exercise in Parkinson's Disease|Effects of Aerobic Exercise in Parkinson's Disease|Completed||N/A|104|Actual|VA Office of Research and Development|We adapted our design in response to recruitment challenges and preliminary results over the course of the study. This uncontrolled study cannot prove efficacy, but provides guidance for a future Phase III study on aerobic exercise in PD.|2|||f||||t||||||||||2017-02-18 13:45:00.521449|2017-02-18 13:45:00.521449
NCT00784550|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-10-11|2010-11-18||December 2008||2008-12-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ADC111114||A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).|A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR DISKUS (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|342|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:45:01.238495|2017-02-18 13:45:01.238495
NCT00784537|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2016-01-25|||September 2008||2008-09-01|January 2016|2016-01-01|January 2016|Anticipated|2016-01-01|January 2015|Actual|2015-01-01||Interventional|HD0801||High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients|Early Salvage With High Dose Chemotherapy and Stem Cell Transplantation in Advanced Stage Hodgkin's Lymphoma Patients With Positive PET After Two Courses of ABVD (PET-2 Positive) and Comparison of RT Versus no RT in PET-2 Negative Patients|Active, not recruiting||Phase 2/Phase 3|520|Actual|Fondazione Italiana Linfomi ONLUS||2|||f||||f||||||||||2017-02-18 13:45:01.995963|2017-02-18 13:45:01.995963
NCT00784524|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-01|2015-04-10|||September 2008||2008-09-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|July 2014|Actual|2014-07-01||Interventional|||Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca|A Phase II Study of Allogeneic Large Multivalent Immunogen (LMI) Vaccine and IL-2 for the Treatment of Stable Metastatic Breast Cancer|Terminated||Phase 2|14|Actual|Masonic Cancer Center, University of Minnesota||1||Slow accrual|f||||t||||||||||2017-02-18 13:45:02.132428|2017-02-18 13:45:02.132428
NCT00784511|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2014-11-13|||July 2008||2008-07-01|November 2014|2014-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Vitamin D, Glucose Control and Insulin Sensitivity in African-Americans|Vitamin D, Glucose Control and Insulin Sensitivity in African-Americans|Completed||Phase 2|100|Actual|Tufts University||2|||f||||f||||||||||2017-02-18 13:45:02.252298|2017-02-18 13:45:02.252298
NCT00784498|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-02|2010-07-31|||November 2008||2008-11-01|November 2008|2008-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Procedural Sedation Using Propofol Versus Midazolam/Ketamine in the Adult Emergency Department|Procedural Sedation for Painful Orthopedic Manipulations With Propofol vs. Midazolam/Ketamine in the Adult Emergency Department|Completed||Phase 4|60|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-02-18 13:45:02.356997|2017-02-18 13:45:02.356997
NCT00784485|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2011-03-08|||February 2009||2009-02-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Non-invasive Measures of Effects of Xolair in Asthma|Non-Invasive Measures of Distal Lung Disease in Asthmatics Before and After Treatment With Omalizumab|Terminated||Phase 4|13|Anticipated|University of California, Los Angeles||1||Terminated due to poor enrollment.|f||||f||||||||||2017-02-18 13:45:02.467429|2017-02-18 13:45:02.467429
NCT00784472|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-07-05|||December 2008||2008-12-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Visceral Pain From the Upper Urinary Tract - a Trial on the Effect of Morphine and Oxycodone in Patients Undergoing PCNL|Visceral Pain Originating From the Upper Urinary Tract - a Randomized Controlled Trial on the Effect of Morphine and Oxycodone in Patients Undergoing Percutaneous Nephrolithotomy (PCNL)|Completed||Phase 3|55|Actual|Fredericia Hosptial||2|||f||||t||||||||||2017-02-18 13:45:02.58227|2017-02-18 13:45:02.58227
NCT00784459|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2013-12-16|2013-06-11||October 2008||2008-10-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|CIA||The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics|Costimulation Inhibition in Asthma|Completed||Phase 2|24|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:45:02.694959|2017-02-18 13:45:02.694959
NCT00784446|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2013-01-04|||April 2008||2008-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2010|Actual|2010-08-01||Interventional|||First-line Therapy of Stage IV Colorectal Cancer|A Phase I/II Study of Capecitabine/Oxaliplatin (XELOX) in Combination With Bevacizumab and Imatinib as First-line Treatment of Patients With Stage IV Colorectal Cancer|Completed||Phase 1/Phase 2|51|Actual|University of Cologne||1|||f||||t||||||||||2017-02-18 13:45:03.09376|2017-02-18 13:45:03.09376
NCT00784433|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2012-02-08|||May 2010||2010-05-01|August 2009|2009-08-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|CASCADE||The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial|Cardiovascular and Metabolic Effects of Moderate Alcohol Consumption in Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|Ben-Gurion University of the Negev||3|||f||||t||||||||||2017-02-18 13:45:03.207845|2017-02-18 13:45:03.207845
NCT00784420|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-11-17|||September 2008||2008-09-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Drug Interaction Study Between Raltegravir And UK-453,061|Open-Label, Randomized, 3-Way Crossover Study To Estimate The Interaction Between Multiple Dose Raltegravir And UK-453,061 In Healthy Subjects|Completed||Phase 1|18|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:45:03.298304|2017-02-18 13:45:03.298304
NCT00784407|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-03|2008-11-03|||February 2008||2008-02-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Thyroid Surgery With the New Harmonic Scalpel: a Prospective Randomized Study|Thyroid Surgery With the New Harmonic Scalpel: a Prospective Randomized Study|Completed||N/A|90|Actual|Hippocration General Hospital||2|||f||||t||||||||||2017-02-18 13:45:03.401226|2017-02-18 13:45:03.401226
NCT00784394|ClinicalTrials.gov processed this data on February 17, 2017|2008-11-01|2016-12-28|||April 2004||2004-04-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Diindolylmethane in Preventing Cancer in Healthy Volunteers|Phase I Ascending Single Dose Pharmacokinetics (PK) and Safety Study of 3,3' Di-indolylmethane (DIM)|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 13:45:03.493343|2017-02-18 13:45:03.493343
NCT00784381|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-11-16|||May 2007||2007-05-01|October 2008|2008-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|Ordoclic-IR||Computer Prescribing System and Impaired Renal Function|Impact of a Counselling System Coupled With a Computer Prescribing System to Optimize the Use of the Drugs for Old Subjects Having Renal Function Impairment|Completed||Phase 3|12|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||||||2017-02-18 13:45:03.595919|2017-02-18 13:45:03.595919
NCT00784368|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2013-06-19|2013-03-21||January 2008||2008-01-01|June 2013|2013-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection|A Pharmacokinetic Study of JK1211 in Patients With Systemic Fungal Infection (SFI) and Patients With Febrile Neutropenia (FN) Suspected of Fungal Infection.|Completed||Phase 3|55|Actual|Janssen Pharmaceutical K.K.||3|||f||||t||||||||||2017-02-18 13:45:03.70324|2017-02-18 13:45:03.70324
NCT00784355|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-08-29|||January 2009||2009-01-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Laparoscopic Cholecystectomy in Idiopathic Pancreatitis|Does Laparoscopic Cholecystectomy Prevent Recurrence in Idiopathic Pancreatitis? A Prospective Multicentre Randomized Study|Recruiting||Phase 2|200|Anticipated|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 13:45:08.991564|2017-02-18 13:45:08.991564
NCT00784342|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-12-12|||July 2008||2008-07-01|December 2012|2012-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Validation of PROMIS Banks With COPD Exacerbations|Validation of PROMIS Banks With COPD Exacerbations|Completed||N/A|188|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||||||2017-02-18 13:45:09.124549|2017-02-18 13:45:09.124549
NCT00784329|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-09-13|||March 2008||2008-03-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|December 2013|Actual|2013-12-01||Interventional|||Pilot Study To Evaluate Optical Frequency Domain Imaging For Diagnosis Of Central Airway Disease|Pilot Study To Evaluate Optical Frequency Domain Imaging For Diagnosis Of Central Airway Disease|Active, not recruiting||N/A|15|Anticipated|Lahey Clinic||1|||f||||f||||||||||2017-02-18 13:45:09.222421|2017-02-18 13:45:09.222421
NCT00784316|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2011-11-23|||August 2007||2007-08-01|November 2011|2011-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery|Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery|Completed||Phase 4|316|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 13:45:09.328241|2017-02-18 13:45:09.328241
NCT00784303|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2014-08-06|||August 2009||2009-08-01|August 2014|2014-08-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|||Evaluating the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology|Phase II, Multicenter, Open-label, Single Arm Trial to Evaluate the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology|Completed||Phase 2|116|Actual|Eisai Inc.||1|||f||||f||||||||||2017-02-18 13:45:09.421925|2017-02-18 13:45:09.421925
NCT00784290|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-03-22|||September 2003||2003-09-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|October 2010|Actual|2010-10-01||Interventional|||Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma|Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|35|Actual|Taiho Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 13:45:09.573068|2017-02-18 13:45:09.573068
NCT00784277|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-01-09|2010-07-22||October 2008||2008-10-01|January 2012|2012-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease|A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Arm, Multicenter Study in Subjects With End-Stage Joint Disease to Compare the Frequency of Constipation Symptoms in SubjectsTreated With Tapentadol IR and Oxycodone IR Using a Bowel Function Patient Diary|Completed||Phase 3|597|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||7|||f||||f||||||||||2017-02-18 13:45:09.677664|2017-02-18 13:45:09.677664
NCT00784264|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2010-01-11|||October 2008||2008-10-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|||||Observational|IMT||A Study on Intima Media Thickness (IMT) in Middle-aged Subjects|A Study on Intima Media Thickness (IMT) in Middle-aged Subjects|Completed||N/A|200|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:45:10.694744|2017-02-18 13:45:10.694744
NCT00784251|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2013-12-10|||July 2008||2008-07-01|December 2013|2013-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Validating PROMIS Instruments in Back and Leg Pain|Validating PROMIS Instruments in Back and Leg Pain|Completed||N/A|226|Actual|University of Washington|||1||f||||f||||||||||2017-02-18 13:45:10.784016|2017-02-18 13:45:10.784016
NCT00784238|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2014-02-07|2014-02-07||April 2008||2008-04-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|Power||Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants|An Open-label, Prospective, Non-Comparative Study to Evaluate Subjective Well-Being and Responses in Patients With Schizophrenia Who Had Switched to Paliperidone Extended-Release Tablets|Completed||Phase 4|289|Actual|Janssen Korea, Ltd., Korea|Some Adverse Events summaries were reported based on estimates due to the fact that they were not prepared in the original study report and the relevant definitions of the data elements were not available for these summaries to be regenerated.|1|||f||||f||||||||||2017-02-18 13:45:10.881116|2017-02-18 13:45:10.881116
NCT00784225|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-12-21|||July 2004||2004-07-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|December 2016|Actual|2016-12-01||Interventional|SEE||S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000|S0000B: Prevention of Cataract and Age-Related Macular Degeneration With Vitamin E and Selenium - SELECT Eye Endpoints (SEE)|Active, not recruiting||Phase 3|2970|Anticipated|Southwest Oncology Group||4|||f||||t||||||||||2017-02-18 13:45:11.47813|2017-02-18 13:45:11.47813
NCT00784212|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-09-21|||October 2008||2008-10-01|September 2016|2016-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy|A Multicenter, Single-blind, Within-subject, Placebo-controlled Proof of Concept Study to Assess the Effect of Single Oral Doses of BGG492 on the Photoparoxysmal EEG Response in Patients With Photosensitive Epilepsy|Completed||Phase 2|13|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:45:11.804408|2017-02-18 13:45:11.804408
NCT00784199|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2013-05-13|||June 2008||2008-06-01|May 2013|2013-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Validating PROMIS Instruments in Depression|Validating PROMIS Instruments in Depression|Completed||N/A|115|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 13:45:11.902242|2017-02-18 13:45:11.902242
NCT00784186|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2014-02-18|||August 2008||2008-08-01|February 2014|2014-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial|Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial|Completed||N/A|120|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-02-18 13:45:11.989924|2017-02-18 13:45:11.989924
NCT00784173|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2008-10-31|||January 2007||2007-01-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Observational|||Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome|Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome|Completed||N/A|2|Actual|Pontificia Universidade Catolica de Sao Paulo|||1||f||||f||||||||||2017-02-18 13:45:12.312712|2017-02-18 13:45:12.312712
NCT00784160|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2009-08-21|||July 2008||2008-07-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- Compatibility|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd PH_DETINBACK Tangerine Mix.|Completed||Phase 3|53|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:45:12.392946|2017-02-18 13:45:12.392946
NCT00784147|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2014-04-17|2014-03-11||August 2008||2008-08-01|April 2014|2014-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|TMB-202|Baseline measures were assessed using the Intent-to-Treat (ITT) population, defined as all randomized patients regardless of whether a dose of study medication was received.|Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1|A Phase 2b, Randomized, Double-Blinded, 48-Week, Multicenter, Dose-Response Study of Ibalizumab Plus an Optimized Background Regimen in Treatment-Experienced Patients Infected With HIV-1(Amended to 24-Weeks)|Completed||Phase 2|113|Actual|TaiMed Biologics Inc.|ACTG Adherence Questionnaire data were incomplete due to insufficient data collection methods. No clinically meaningful information was gained upon review of these results.|2|||f||||t||||||||||2017-02-18 13:45:12.486439|2017-02-18 13:45:12.486439
NCT00784134|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-04-12|||July 2009||2009-07-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|July 2015|Actual|2015-07-01||Interventional|CLEAR III||Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III|Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III|Completed||Phase 3|500|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 13:45:13.279393|2017-02-18 13:45:13.279393
NCT00784121|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2008-12-18|||October 2008||2008-10-01|December 2008|2008-12-01||||November 2008|Actual|2008-11-01||Interventional|||Dermacyd Breeze (Lactic Acid) Pocket BR - Compatibility|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd Breeze Pocket BR.|Completed||Phase 3|54|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:45:13.473813|2017-02-18 13:45:13.473813
NCT00784108|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2017-02-08|||October 2008||2008-10-01|February 2017|2017-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.|Non-contact Imaging Device (Camera) Can Help Improve Treatment for Patients With Basal Cell Carcinoma.|Completed||Phase 1|11|Actual|University of California, Irvine||2|||f||||t||||||||||2017-02-18 13:45:13.560444|2017-02-18 13:45:13.560444
NCT00784095|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2016-03-11|2014-10-03||December 2008||2008-12-01|March 2016|2016-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Outlook Quality of Life Intervention|Outlook: An Intervention to Improve Quality of Life in Serious Illness|Completed||N/A|36|Actual|VA Office of Research and Development|Therefore, due to the small sample size, finding are met with caution. Subjects were not randomized by any condition. As a result, those in the Control arm were more functionally able than the other two arms at baseline.|3|||f||||f||||||||No||2017-02-18 13:45:13.664543|2017-02-18 13:45:13.664543
NCT00784082|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2013-01-30|||May 2009||2009-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Observational|||Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease|Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease|Completed||N/A|62|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"~     Sample with DNA~   "|||2017-02-18 13:45:14.571294|2017-02-18 13:45:14.571294
NCT00784069|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2008-12-18|||October 2008||2008-10-01|December 2008|2008-12-01||||November 2008|Actual|2008-11-01||Interventional|||Dermacyd Breeze (Lactic Acid) Pocket BR - Photo Evaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Breeze Pocket BR.|Completed||Phase 3|27|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:45:14.675349|2017-02-18 13:45:14.675349
NCT00784056|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2009-08-21|||August 2008||2008-08-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Photo Evaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid)|Completed||Phase 3|26|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:45:14.777562|2017-02-18 13:45:14.777562
NCT00784043|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2017-02-03|||March 2004||2004-03-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|February 2017|Actual|2017-02-01||Interventional|||Bilateral Cochlear Implantation in Children With the MED-EL Cochlear Implant|Longitudinal Efficacy in Young Children Implanted Bilaterally With MED-EL COMBI 40+ / PULSARCI100/SONATATI100 Cochlear Implant Systems.|Terminated||N/A|31|Actual|Med-El Corporation||2|||f||||f||||||||||2017-02-18 13:45:14.869961|2017-02-18 13:45:14.869961
NCT00784030|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-03-07|2012-04-25||November 2008||2008-11-01|March 2016|2016-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||High Water Intake to Slow Progression of Polycystic Kidney Disease|The Effect of Water Loading on Urinary Biomarkers|Completed||N/A|23|Actual|New York University School of Medicine|This was a very small study, so larger numbers are needed. Urine cAMP measurement as a surrogate of response to water treatment needs further validation.|2|||f||||f||||||||||2017-02-18 13:45:15.03243|2017-02-18 13:45:15.03243
NCT00784017|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2013-02-26|||October 2008||2008-10-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia|Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia|Completed||Phase 3|199|Actual|medac GmbH||2|||f||||t||||||||||2017-02-18 13:45:15.364567|2017-02-18 13:45:15.364567
NCT00784004|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2014-12-01|||November 2007||2007-11-01|December 2014|2014-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Investigation of Efficiency of Breathing With Different Breathing Patterns|Investigation of Efficiency of Breathing With Different Breathing Patterns in Healthy Volunteers and Patients With Respiratory Failure|Completed||N/A|26|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:45:15.459736|2017-02-18 13:45:15.459736
NCT00783991|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2013-06-05|||April 2009||2009-04-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Investigating the Impact of Mode of Administration on Item Response|Investigating the Impact of Mode of Administration on Item Response|Completed||N/A|800|Actual|Stony Brook University|||4||f||||f||||||||||2017-02-18 13:45:15.560399|2017-02-18 13:45:15.560399
NCT00783978|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-11-16|||September 2009||2009-09-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|APSE||Surfactant Disorders and Chronic Lung Disease|Surfactant Disorders Associated With Chronic Lung Disease in Children.|Completed||N/A|58|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"~     Whole blood, plasma, DNA~   "|||2017-02-18 13:45:15.672719|2017-02-18 13:45:15.672719
NCT00783965|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2016-01-13|2013-07-31||July 2004||2004-07-01|January 2016|2016-01-01|January 2014|Actual|2014-01-01|June 2012|Actual|2012-06-01||Interventional|||Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back|A Phase II Randomized, Double-Blind, Vehicle-Controlled, Crossover Clinical Trial of Tazarotene 0.1% and Vehicle Cream Each Applied Once-Daily for 12 or 24 Months in Subjects With Basal Cell Nevus Syndrome|Completed||Phase 2|34|Actual|Children's Hospital & Research Center Oakland|Non-compliance and large drop-out rates leading to small numbers of data analyzed.|2|||f||||t||||||||||2017-02-18 13:45:15.788353|2017-02-18 13:45:15.788353
NCT00783952|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-09-22|||November 2008||2008-11-01|September 2015|2015-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Validation of Mixed Venous Blood Oxygen Saturation Obtained With a Novel Mathematical Equation|Validation of Mixed Venous Blood Oxygen Saturation Obtained With a Novel Mathematical Equation Using Arterial Oxygen Saturation and Various Local Tissue Oxygen Saturations.|Terminated||N/A|8|Actual|Massachusetts General Hospital||1||Inability to recruit subjects|f||||f||||||||||2017-02-18 13:45:16.238585|2017-02-18 13:45:16.238585
NCT00783939|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2009-03-05|||September 2008||2008-09-01|March 2009|2009-03-01||||September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.|Safety Dermatological Evaluation: Vaginal Mucous Irritation - Product Tested: Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid).|Completed||Phase 3|31|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:45:16.341534|2017-02-18 13:45:16.341534
NCT00783926|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2015-10-07|||July 2008||2008-07-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)|Double Blind, Multi-Center, Phase 1 Study of a Vero Cell-Derived, Whole Virus Clade 2 H5N1 Influenza Vaccine in Healthy Subjects Aged 18 to 45 Years|Completed||Phase 1|422|Actual|Nanotherapeutics, Inc.||2|||f||||t||||||||||2017-02-18 13:45:16.434621|2017-02-18 13:45:16.434621
NCT00783913|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2017-01-24|||October 29, 2008||2008-10-29|October 24, 2011|2011-10-24|October 24, 2011|Actual|2011-10-24|October 24, 2011|Actual|2011-10-24||Interventional|||Using Transcranial Direct Current Stimulation (tDCS) to Enhance the Benefit of Movement Training in Stoke Patients|Enhancing the Beneficial Effects of Upper Extremity Visuomotor Training With tDCS|Completed||N/A|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:45:16.540061|2017-02-18 13:45:16.540061
NCT00783900|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2011-11-23|||January 2007||2007-01-01|November 2011|2011-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Intravenous Administration of Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery|Intravenous Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery|Completed||Phase 4|316|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 13:45:16.636277|2017-02-18 13:45:16.636277
NCT00783887|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2013-08-06|||January 2010||2010-01-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|DCP||Diagnosis of Primary Ciliary Dyskinesia|Molecular Diagnosis of Primary Ciliary Dyskinesia|Completed||N/A|125|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"~     DNA, Serum, White blood cells~   "|||2017-02-18 13:45:16.731885|2017-02-18 13:45:16.731885
NCT00783861|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2008-12-18|||October 2008||2008-10-01|December 2008|2008-12-01||||November 2008|Actual|2008-11-01||Interventional|||Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd Femina Pocket BR.|Completed||Phase 3|54|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:45:16.858387|2017-02-18 13:45:16.858387
NCT00783848|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2013-04-26|||March 2009||2009-03-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Validating PROMIS Instruments in Congestive Heart Failure Patients Receiving a Heart Transplant|Validating PROMIS Instruments in Congestive Heart Failure Patients Receiving a Heart Transplant|Completed||N/A|58|Actual|Duke University|||1||f||||f||||||||||2017-02-18 13:45:16.949842|2017-02-18 13:45:16.949842
NCT00783835|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2013-07-19|2013-03-22||February 2008||2008-02-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|A Multicenter Open Trial to Evaluate the Effectiveness and Quality of Life in Adults With Attention Deficit /Hyperactivity Disorder (ADHD) Treated With Long Acting Methylphenidate (CONCERTA)|Completed||Phase 4|60|Actual|Janssen-Cilag Farmaceutica Ltda.||1|||f||||f||||||||||2017-02-18 13:45:17.044951|2017-02-18 13:45:17.044951
NCT00783822|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-11-08|||November 2008||2008-11-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|January 2011|Actual|2011-01-01||Interventional|TIME||Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients|Behavioral and Psychosocial Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients: a Multicenter Study|Completed||N/A|265|Actual|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-02-18 13:45:17.356971|2017-02-18 13:45:17.356971
NCT00783809|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-04-26|||October 2008||2008-10-01|April 2012|2012-04-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|MOONSTRIP||Measurement of Optic Nerve Sheath in Traumatic Raised Intracranial Pressure|Measurement of Optic Nerve Sheath in Traumatic Raised Intracranial Pressure|Unknown status|Active, not recruiting|N/A|560|Anticipated|McMaster University|||1||f||||f||||||||||2017-02-18 13:45:17.461391|2017-02-18 13:45:17.461391
NCT00783796|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2014-10-31|2011-11-29||October 2008||2008-10-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional|SPIRIT SV||SPIRIT Small Vessel Registry|Spirit Small Vessel Registry (SPIRIT SV)|Completed||Phase 3|150|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 13:45:17.624261|2017-02-18 13:45:17.624261
NCT00783783|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-12-10|||November 2008||2008-11-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||CYP2D6 Pharmacogenetics in Risperidone-Treated Children|CYP2D6 PHARMACOGENETICS IN RISPERIDONE-TREATED CHILDREN AND ADOLESCENTS WITH PSYCHIATRIC OR NEURODEVELOPMENTAL DISORDERS|Completed||N/A|47|Actual|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||Samples With DNA|"~     DNA from blood, buccal swab, or saliva~   "|||2017-02-18 13:45:19.236077|2017-02-18 13:45:19.236077
NCT00783770|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2011-05-16|||July 2005||2005-07-01|May 2011|2011-05-01||||March 2007|Actual|2007-03-01||Observational|||Maternal and Infant Cord Blood Monosaccharide Content|Comparison of Monosaccharide Content of Maternal and Umbilical Venous Cord Blood in Term and Preterm Pregnancies|Completed||N/A|48|Actual|Arkansas Children's Hospital Research Institute|||3||f||||f||||||Samples Without DNA|"~     plasma will be stored~   "|||2017-02-18 13:45:19.333888|2017-02-18 13:45:19.333888
NCT00783757|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2017-01-09|||August 2008||2008-08-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|December 2014|Actual|2014-12-01||Interventional|||TOBI to Monitor Response to Neoadjuvant Therapy in Breast Cancer|Functional Metabolic Near-infrared Tomographic Optical Breast Imaging (TOBI) to Monitor Response to Neoadjuvant Therapy in Breast Cancer|Active, not recruiting||Phase 1|24|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||No||2017-02-18 13:45:19.401094|2017-02-18 13:45:19.401094
NCT00783744|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2009-09-25|||December 2001||2001-12-01|September 2009|2009-09-01||||August 2003|Actual|2003-08-01||Interventional|LAPTOP||Insulin Glargine Combination Therapies in Type II Diabetics|28-week, Open, Randomized, Multinational, Multicenter Clinical Trial to Compare Efficacy and Safety of Combination Therapy of Glimepiride Plus Metformin Plus HOE901 Insulin Analogue Versus a Two-injection Conventional Therapy With Premixed Insulin NPH 30/70 Bid in Type 2 Diabetes Mellitus Patients Poorly Controlled With Oral Antidiabetic Drug Treatment.|Completed||Phase 3|375|Actual|Sanofi||2|||f||||||||||||||2017-02-18 13:45:19.504438|2017-02-18 13:45:19.504438
NCT00783731|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2011-07-25|||October 2008||2008-10-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|October 2010|Actual|2010-10-01||Interventional|||Low Dose of Midazolam is Superior to Conventional Dose for Rapid Sequence Intubation in Emergency Department (ED)||Completed||N/A|||Seoul National University Hospital||1|||f||||||||||||||2017-02-18 13:45:19.610633|2017-02-18 13:45:19.610633
NCT00783718|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2014-06-19|2014-06-19||January 2009||2009-01-01|June 2014|2014-06-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|GEMINI I|Baseline characteristics are provided for the Induction Phase Safety Population, defined as all participants, in both Cohort 1 and Cohort 2, who received any amount of study drug in the Induction Phase (Weeks 0-6), according to the actual study drug received.|Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis|A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients With Moderate to Severe Ulcerative Colitis|Completed||Phase 3|895|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 13:45:19.708711|2017-02-18 13:45:19.708711
NCT00782964|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2009-12-23|||October 2008||2008-10-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|||||Observational|DRIA||Antidepressant Incomplete Response Depression|Assessment of Therapeutic Strategies in Unipolar Depression With Incomplete Response to a Antidepressant Treatment in Regular Clinical Practicing.|Completed||N/A|364|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:45:42.058235|2017-02-18 13:45:42.058235
NCT00783705|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2015-07-28|2015-04-29||November 2008||2008-11-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia|Phase IIb Randomized Comparative Study of the Efficacy and Safety of Myo-inositol Versus Placebo in Smokers With Bronchial Dysplasia|Completed||Phase 2|85|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:45:22.703817|2017-02-18 13:45:22.703817
NCT00783692|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2014-06-19|2014-06-19||December 2008||2008-12-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|GEMINI II|The Induction Phase Safety Population, defined as all participants, in both Cohort 1 and Cohort 2, who received any amount of study drug in the Induction Phase (Weeks 0 to 6), according to the actual study drug received.|Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease|A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease|Completed||Phase 3|1116|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 13:45:24.000311|2017-02-18 13:45:24.000311
NCT00783679|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-04-24|||November 2009||2009-11-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Feasibility and Accuracy of Exhaled CO2 to Measure Cardiac Output in Ventilated Patients Without Tracheal Intubation|Determining the Feasibility and Accuracy of Exhaled CO2 to Measure Cardiac Output in Ventilated Patients Without Tracheal Intubation|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||1||Understaffing and inadequate funding|f||||f||||||||||2017-02-18 13:45:30.090627|2017-02-18 13:45:30.090627
NCT00783666|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2009-08-21|||August 2008||2008-08-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Photo Evaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd PH_DETINBACK Tangerine Mix|Completed||Phase 3|26|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:45:30.202561|2017-02-18 13:45:30.202561
NCT00783653|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2013-09-20|||August 2008||2008-08-01|September 2013|2013-09-01||||July 2013|Actual|2013-07-01||Interventional|||Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years|Phase I/II Clinical Study of SU11248 (Sutent) Combined With Standard Chemotherapy With Cytosine Arabinoside and Daunorubicin in Patients With FLT3 Mutated AML Over 60 Years of Age|Completed||Phase 1/Phase 2|22|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-02-18 13:45:30.288955|2017-02-18 13:45:30.288955
NCT00783640|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2008-12-18|||October 2008||2008-10-01|December 2008|2008-12-01||||November 2008|Actual|2008-11-01||Interventional|||Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Femina Pocket BR.|Completed||Phase 3|27|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:45:30.393224|2017-02-18 13:45:30.393224
NCT00783627|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2011-02-22|||November 2006||2006-11-01|February 2011|2011-02-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Observational|DREPANOPEC||Sickle Cell Disease and Endothelial Progenitor Cells (EPCs)|Evaluation of Angiogenic Potential in Sickle Cell Disease. CARACTERIZATION of Endothelial Progenitor Cells|Completed||N/A|66|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:45:30.481898|2017-02-18 13:45:30.481898
NCT00783614|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-31|2012-10-03|2012-01-16||October 2008||2008-10-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Aspirin and Antiretroviral Therapy in HIV Infected Patients|The Effect of Aspirin and Antiretroviral Therapy on Cardiovascular Risk in HIV Infected Patients: A Pilot Study|Terminated||Phase 2|22|Actual|Minneapolis Medical Research Foundation||4||Lack of funding|f||||f||||||||||2017-02-18 13:45:30.58893|2017-02-18 13:45:30.58893
NCT00783601|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-10-15|||October 2004||2004-10-01|October 2015|2015-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||MK0524 Asthma POC Study (0524-008)(COMPLETED)|A Multicenter, Randomized, Double Blind, Crossover Study Comparing the Effect of MK0524 With Placebo and Concomitant Administration of MK0524 Plus Montelukast in Adult Patients With Chronic Asthma|Completed||Phase 2|130|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:45:31.109879|2017-02-18 13:45:31.109879
NCT00783588|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2008-10-30|||May 2007||2007-05-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Phase I Extension Trial of Repeated Infusions of ISF35|A Phase 1B Extension Trial to Allow Repeat Dosing of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35) in Subjects Previously Treated in MDACC Protocol 2004-0914|Completed||Phase 1|4|Actual|Memgen, LLC|||||f||||t||||||||||2017-02-18 13:45:31.212584|2017-02-18 13:45:31.212584
NCT00783575|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2015-08-21|||October 2002||2002-10-01|August 2015|2015-08-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease|Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease|Withdrawn||N/A|0|Actual|Medical College of Wisconsin|||1|PI has left institution|f||||t||||||Samples With DNA|"~     DNA extraction, serology~   "|||2017-02-18 13:45:31.326891|2017-02-18 13:45:31.326891
NCT00783562|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2008-10-30|||October 2007||2007-10-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Preventive Intervention in Nursery School Teachers|Effectiveness of an Extension-Oriented Exercise Program in Preventing Neck and Low Back Complaints in Nursery School Teachers|Completed||Phase 1|71|Actual|University of Bologna||2|||f||||f||||||||||2017-02-18 13:45:31.434253|2017-02-18 13:45:31.434253
NCT00783549|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-10-26|||September 2008||2008-09-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.|A Study in Healthy Volunteers of Single Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Compound Alone and When Co-administered With Sitagliptin|Completed||Phase 1|76|Actual|GlaxoSmithKline||5|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:45:31.747972|2017-02-18 13:45:31.747972
NCT00783367|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2017-01-24|||July 2008||2008-07-01|January 2017|2017-01-01||||December 2013|Actual|2013-12-01||Interventional|||Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas|Phase 2 Trial of Lenalidomide (Revlimid)-Dexamethasone + Rituximab in Recurrent Small B-Cell Non-Hodgkin Lymphomas (NHL) Resistant to Rituximab|Active, not recruiting||Phase 2|25|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 13:45:34.525376|2017-02-18 13:45:34.525376
NCT00783536|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2009-06-01|||November 2008||2008-11-01|June 2009|2009-06-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|DOTAR||A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis|An Randomized, Open Label, Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate With DMARD Therapy in Subjects With Active Early Rheumatoid Arthritis|Withdrawn||Phase 4|402|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:45:31.856549|2017-02-18 13:45:31.856549
NCT00783523|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2013-08-06|||March 2008||2008-03-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Influence of MMP on Brain AVM Hemorrhage|Influence of Matrix Metalloproteinase on Brain Arteriovenous Malformation Hemorrhage|Completed||Phase 1|33|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:45:31.961946|2017-02-18 13:45:31.961946
NCT00783510|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2017-01-13|||July 2008||2008-07-01|January 2017|2017-01-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|STRIVE||Juvenile Idiopathic Arthritis (JIA) Registry|A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE|Active, not recruiting||N/A|800|Anticipated|AbbVie|||2||f||||f||||||||||2017-02-18 13:45:32.081631|2017-02-18 13:45:32.081631
NCT00783497|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-12-16|||October 2005||2005-10-01|December 2015|2015-12-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Observational|||Evaluating the Relationship Between Stress, Ethnicity, and Blood Pressure|Stress, Blood Pressure, & Ethnicity|Completed||N/A|203|Actual|University of California, San Diego|||2||f||||t||||||Samples With DNA|"~     Serum, urine~   "|||2017-02-18 13:45:32.294822|2017-02-18 13:45:32.294822
NCT00783484|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2009-05-28|||October 2008||2008-10-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects|A Double-Blind (3rd Party Open), Placebo-Controlled, Crossover, Dose Escalating Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539, To Assess The Potential Of PF-03716539 To Inhibit CYP3A4 (In Vivo) And To Evaluate The Drug Interaction Potential Between PF-03716539 And Darunavir Or Maraviroc In Healthy Adult Subjects|Completed||Phase 1|37|Actual|Pfizer||6|||f||||f||||||||||2017-02-18 13:45:32.382371|2017-02-18 13:45:32.382371
NCT00783471|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2010-06-15|||November 2008||2008-11-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|DOPERLO||Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)|Docetaxel Combined With Pulsatile Erlotinib (Tarceva®) In Patients With Metastatic Non Small Cell Lung Cancer (NSCLC) (DOPERLO)|Terminated||Phase 2|51|Actual|Hellenic Cooperative Oncology Group||2||"The low accrual rate of the study (30% of the expected accrual rate)/Low efficacy in both~   treatment arms."|f||||f||||||||||2017-02-18 13:45:32.515526|2017-02-18 13:45:32.515526
NCT00783458|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-06-29|||December 2004||2004-12-01|June 2015|2015-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)|A Preference Evaluation of Nasonex® Nasal Spray (Unscented) vs. Flonase® Nasal Spray (Scented) in Subjects With Symptomatic Allergic Rhinitis (AR) - Single-Dose Cross-over|Completed||Phase 4|100|Actual|Merck Sharp & Dohme Corp.||2|||t||||f||||||||||2017-02-18 13:45:32.632365|2017-02-18 13:45:32.632365
NCT00783445|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2014-03-10|||December 2008||2008-12-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Evaluating the Effectiveness of a Community Exercise Program to Reduce the Risk of Metabolic Syndrome Among Black Americans|Community Exercise and Metabolic Syndrome in Black Families|Completed||Phase 3|204|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 13:45:32.736703|2017-02-18 13:45:32.736703
NCT00783432|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2009-10-01|2008-12-29||July 2006||2006-07-01|October 2009|2009-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis|Active-Controlled Trial of the Safety and Tolerability of a MP03-33 in Patients With Chronic Allergic or Nonallergic Rhinitis|Completed||Phase 3|862|Actual|Meda Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:45:32.856689|2017-02-18 13:45:32.856689
NCT00783419|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2016-04-22|||March 2007||2007-03-01|April 2016|2016-04-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Observational|||Rate of Pelvic Inflammatory Disease at St. Michael's Hospital|Rate of Pelvic Inflammatory Disease and Tubo-ovarian Abscess at SMH|Completed||N/A|55|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-02-18 13:45:34.073795|2017-02-18 13:45:34.073795
NCT00783406|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2010-10-27||2009-03-24|October 2008||2008-10-01|October 2010|2010-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|A7881010||Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.|A Phase 2A, Double Blind (3rd Party Open), 4 Way Cross-Over, Placebo Controlled Study To Investigate The Pharmacokinetics, Safety, Toleration And Efficacy Of Single Inhaled Doses Of PF-00610355 In Moderate COPD Patients.|Completed||Phase 2|20|Anticipated|Pfizer||4|||f||||f||||||||||2017-02-18 13:45:34.158712|2017-02-18 13:45:34.158712
NCT00783393|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-04-08|||May 2003||2003-05-01|April 2015|2015-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)|SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma|Completed||Phase 2|32|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 13:45:34.285635|2017-02-18 13:45:34.285635
NCT00783380|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2008-10-31|||October 2005||2005-10-01|October 2008|2008-10-01|March 2008|Actual|2008-03-01|July 2006|Actual|2006-07-01||Interventional|||Influenza Vaccination in Immunocompromized Patients|Double Blind Randomized Comparison of a Subunit- and a Virosomal Influenza Vaccine in Immunocom-Promized Patients|Completed||Phase 4|304|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 13:45:34.395746|2017-02-18 13:45:34.395746
NCT00783354|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-05-11|||April 2003||2003-04-01|May 2015|2015-05-01|April 2004|Actual|2004-04-01|February 2004|Actual|2004-02-01||Interventional|ATTITUD||A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)|"A Pilot, Multicenter, Double-blind Randomized Study for Comparison of Aerius® Continuous Treatment Versus Aerius® PRN Regimen on Chronic Idiopathic Urticaria Patient Quality of Life"|Completed||Phase 4|129|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:45:34.683446|2017-02-18 13:45:34.683446
NCT00783341|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2009-07-16|||November 2008||2008-11-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously|An Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously as 6-Day Continuous Infusions to Healthy Subjects|Completed||Phase 1|25|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 13:45:34.793819|2017-02-18 13:45:34.793819
NCT00783328|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2011-06-22|||November 2008||2008-11-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors|A Clinical Phase 1 Safety And Pharmacokinetic/Pharmacodynamic Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors|Completed||Phase 1|13|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 13:45:34.891088|2017-02-18 13:45:34.891088
NCT00783315|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2009-05-11|||January 2008||2008-01-01|April 2009|2009-04-01||||February 2011|Anticipated|2011-02-01||Interventional|POWER||Evaluating Weight Loss Programs for Obese People at Risk for Heart Disease (The POWER Study)|Practice-Based Opportunities for Weight Reduction Trial at Johns Hopkins|Unknown status|Active, not recruiting|Phase 3|390|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||t||||||||||2017-02-18 13:45:34.995962|2017-02-18 13:45:34.995962
NCT00783302|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2014-12-09|2014-11-04||September 2008||2008-09-01|December 2014|2014-12-01|April 2011|Actual|2011-04-01|October 2010|Actual|2010-10-01||Observational|||Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care|A Prospective, Multi-Center Registry Study for Clinical Outcome in Subjects Undergoing Coronary Computed Tomography Angiography (CCTA) Examination (VISIPAQUE Registry Study)|Completed||N/A|885|Actual|GE Healthcare|||1||f||||f||||||||||2017-02-18 13:45:35.110178|2017-02-18 13:45:35.110178
NCT00783289|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-08-20||2012-06-28|November 2008||2008-11-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|MEDI-563||A Phase 2a Study to Evaluate the Safety and Tolerability of MEDI-563 in Adults With Asthma|A Phase 2a, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Tolerability of Multiple-dose Subcutaneous Administration of MEDI-563, a Humanized Anti-interleukin-5 Receptor Alpha Monoclonal Antibody, in Adults With Asthma|Completed||Phase 2|25|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 13:45:35.47685|2017-02-18 13:45:35.47685
NCT00783276|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2016-07-13|||October 2008||2008-10-01|July 2016|2016-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||An fMRI Study of SYN115 in Cocaine Dependent Subjects|An fMRI Study of SYN115 in Cocaine Dependent Subjects|Completed||Early Phase 1|26|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 13:45:35.576795|2017-02-18 13:45:35.576795
NCT00783263|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-01-19|2011-08-10||November 2008||2008-11-01|January 2015|2015-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)|A Multicenter, Randomized, Double-Blind, Titration Study to Evaluate the Efficacy and Safety of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia at Risk for Coronary Heart Disease|Completed||Phase 3|440|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:45:35.67956|2017-02-18 13:45:35.67956
NCT00783250|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-07-16|||September 2008||2008-09-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|August 2011|Actual|2011-08-01||Interventional|||Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Patients|Effect of Bronchodilators on Respiratory Mechanics in COPD Patients With Poor Reversibility|Terminated||Phase 4|20|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2||Problems with data collection|f||||t||||||||||2017-02-18 13:45:36.380757|2017-02-18 13:45:36.380757
NCT00783237|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-04-15|||December 2003||2003-12-01|April 2015|2015-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)|Onset of Action of Mometasone Furoate Nasal Spray vs. Placebo in Induced Allergic Rhinitis|Completed||Phase 4|340|Actual|Merck Sharp & Dohme Corp.||2|||t||||f||||||||||2017-02-18 13:45:36.490343|2017-02-18 13:45:36.490343
NCT00783224|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-05-04|2010-04-15||September 2005||2005-09-01|May 2015|2015-05-01|December 2005|Actual|2005-12-01|November 2005|Actual|2005-11-01||Interventional|||A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)|Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis|Completed||Phase 3|351|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:45:36.583234|2017-02-18 13:45:36.583234
NCT00783211|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-04-27|||August 2004||2004-08-01|April 2015|2015-04-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)|A Placebo Controlled Study of the Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. in the Treatment of Subjects With Symptomatic Seasonal Allergic Rhinitis (SAR)|Completed||Phase 4|722|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:45:37.111469|2017-02-18 13:45:37.111469
NCT00783198|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-12-16|2014-04-25||September 2009||2009-09-01|December 2015|2015-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adult Subjects With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma|Completed||Phase 2/Phase 3|565|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 13:45:37.202854|2017-02-18 13:45:37.202854
NCT00783185|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2010-01-11|||January 2006||2006-01-01|October 2008|2008-10-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment|Dual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis|Completed||Phase 1|50|Anticipated|University of Konstanz||2|||f||||f||||||||||2017-02-18 13:45:37.97235|2017-02-18 13:45:37.97235
NCT00783172|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2013-02-11|||January 2009||2009-01-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|August 2010|Actual|2010-08-01||Interventional|||Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer|OGF & Gemcitabine: Novel Treatment for Pancreatic Cancer Phase I, A Safety and Toxicity Study|Terminated||Phase 1|4|Actual|Penn State University||1||Problems with IRB|f||||t||||||||||2017-02-18 13:45:38.078168|2017-02-18 13:45:38.078168
NCT00783146|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-04-06|||August 2004||2004-08-01|April 2015|2015-04-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)|A Placebo Controlled Study of the Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. in the Treatment of Subjects With Symptomatic Seasonal Allergic Rhinitis (SAR)|Completed||Phase 4|728|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:45:38.309782|2017-02-18 13:45:38.309782
NCT00783133|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-04-01|||November 2002||2002-11-01|April 2015|2015-04-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)|Preference Evaluation of Clarinex Tablets vs. Allegra Tablets in Subjects With Symptomatic Seasonal Allergic Rhinitis|Completed||Phase 4|131|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:45:38.410884|2017-02-18 13:45:38.410884
NCT00783120|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2013-11-01|||January 2008||2008-01-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|RESIS||Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia|Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia - a Multicenter Study|Completed||N/A|197|Actual|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||2|||f||||t||||||||||2017-02-18 13:45:38.505383|2017-02-18 13:45:38.505383
NCT00783107|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-12-10|||October 2007||2007-10-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)|Clinical Investigation of Aerosol Immunotherapy in COPD: A Phase I Placebo-Controlled Dose Escalation/Deescalation Trial of Aerosol Cyclosporine (CyIS) in Patients With Gold Stage III Chronic Obstructive Pulmonary Disease|Completed||Phase 1|8|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:45:38.610193|2017-02-18 13:45:38.610193
NCT00783094|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2011-03-18|2010-06-25||November 2008||2008-11-01|March 2011|2011-03-01|April 2010|Actual|2010-04-01|June 2009|Actual|2009-06-01||Interventional|||Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Evaluate the Efficacy and Safety of Tadalafil Once-a-Day Dosing for 12 Weeks Followed by an Open-Label Extension to Evaluate the Long-Term Safety and Efficacy of Tadalafil in Japanese Men With Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 2|422|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 13:45:38.734393|2017-02-18 13:45:38.734393
NCT00783081|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-03-21|||November 2008||2008-11-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication||Completed||Phase 2|387|Actual|Kowa Research Institute, Inc.||5|||f||||t||||||||||2017-02-18 13:45:40.886951|2017-02-18 13:45:40.886951
NCT00783068|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2010-11-04|||August 2008||2008-08-01|October 2008|2008-10-01|August 2010|Actual|2010-08-01|December 2009|Actual|2009-12-01||Interventional|||Anti-inflammatory Effects of GTS-21 After LPS|The Effect of the Alpha-7 Nicotinic AChR Agonist GTS-21 on Inflammation and End-organ Dysfunction During Human Endotoxemia|Completed||N/A|12|Actual|Radboud University||2|||f||||t||||||||||2017-02-18 13:45:41.025994|2017-02-18 13:45:41.025994
NCT00783055|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2008-10-30|||March 2005||2005-03-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Autonomy Among Physically Frail Older People in Nursing Homes|Autonomy Among Physically Frail Older People in Nursing Homes: a Study Protocol for an Intervention Study|Completed||N/A|66|Actual|University of Southern Denmark||1|||f||||f||||||||||2017-02-18 13:45:41.138817|2017-02-18 13:45:41.138817
NCT00783042|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2009-06-29|||October 2008||2008-10-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|||||Interventional|||Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements|A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Transthoracic Doppler Echocardiography Method as a Non-Invasive Method for Coronary Function Measurements; Ability to Detect Short-Term Statin Effects in Patients With Increased Cardiovascular Risk|Completed||Early Phase 1|80|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:45:41.247086|2017-02-18 13:45:41.247086
NCT00783029|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2012-02-06|||October 2008||2008-10-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Measurement of the Eye's Blood Vessels Using the Dynamic Vessel Analyzer (DVA)|Reproducibility of Dynamic Vessel Analyzer Measurements and Establishment of Standards|Completed||N/A|87|Actual|Penn State University|||1||f||||f||||||||||2017-02-18 13:45:41.357393|2017-02-18 13:45:41.357393
NCT00783016|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2011-07-25|||October 2008||2008-10-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|||Effect of Pain Control on the Diagnosis of Acute Appendicitis on the Diagnostic Accuracy of General Surgeon||Completed||Phase 4|234|Anticipated|Seoul National University Hospital||2|||f||||||||||||||2017-02-18 13:45:41.449266|2017-02-18 13:45:41.449266
NCT00783003|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2016-10-26|||November 2008||2008-11-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects|A Single Centre, Randomised, Placebo-controlled, Four-way Cross Over Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of GSK233705 and GW642444 as Monotherapies and in Combination in Healthy Japanese Subjects|Completed||Phase 1|16|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:45:41.738647|2017-02-18 13:45:41.738647
NCT00782990|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2008-11-04|||January 2001||2001-01-01|November 2008|2008-11-01|June 2007|Actual|2007-06-01|October 2004|Actual|2004-10-01||Interventional|||A 3 Year Follow-up Prospective Open Randomized Trial of TVT Versus Colposuspension for Primary Stress Incontinence|A Three Year Follow-up Prospective Open Randomized Trial of Tension-Free Vaginal Tape and Colposuspension for Primary Urodynamic Stress Incontinence|Completed||Phase 4|50|Actual|Hospital Severo Ochoa||2|||f||||||||||||||2017-02-18 13:45:41.851522|2017-02-18 13:45:41.851522
NCT00782977|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2012-12-19|||November 2008||2008-11-01|May 2011|2011-05-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Apneic Oxygenation Via Nasal Cannulae Prevents Arterial Hypoxemia|Oxygenation Via Nasal Cannulae Prevents Arterial Hypoxemia During the Apneic Period in Paralyzed Patients|Completed||N/A|90|Anticipated|University of Manitoba||3|||f||||f||||||||||2017-02-18 13:45:41.958343|2017-02-18 13:45:41.958343
NCT00782951|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-09-11|||July 2007||2007-07-01|September 2015|2015-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Comparison of Analgesic Efficacy Between a Single Dose of ORG 28611, Morphine, and Placebo After Dental Impaction Surgery (Study P05800)|A Randomized, Double-blind, Active and Placebo Controlled Trial to Compare the Relative Analgesic Efficacy and Safety of a Single Intravenous Dose of ORG 28611 3 mcg/kg, Morphine Sulfate 0.12 mg/kg, and Placebo in Patients Experiencing Moderate to Severe Pain After Dental Impaction Surgery.|Terminated||Phase 2|11|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:45:42.191498|2017-02-18 13:45:42.191498
NCT00782938|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2010-01-13|||May 2008||2008-05-01|October 2008|2008-10-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Observational|||The Role of Serum Anticholinergic Activity in ACVB Patients|Serum Anticholinergic Activity (SAA) and BIS-EEG as Potential Markers for Cognitive Ability and/or the Anticholinergic Medication in ACVB Patients|Completed||N/A|100|Anticipated|Heidelberg University|||2||f||||f||||||||||2017-02-18 13:45:42.282092|2017-02-18 13:45:42.282092
NCT00782925|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2014-12-01|||October 2008||2008-10-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|PRESLO||An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare Workers|An Educational and Exercise Program as Secondary Prevention of Recurrent Lower Back Pain in Healthcare Workers: A Randomized, Controlled, 2-year Follow-up Study.|Completed||N/A|351|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 13:45:42.367497|2017-02-18 13:45:42.367497
NCT00782912|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-04-20|||November 2008||2008-11-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|PPADS||Postpartum Anemia and Postpartum Depression|Is Postpartum Anemia an Independent Risk Factor for Development of Postpartum Depression?|Completed||N/A|103|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 13:45:42.471229|2017-02-18 13:45:42.471229
NCT00782899|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2010-12-08|||October 2008||2008-10-01|December 2009|2009-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|4D||Four Dimensions in Schizophrenia|Prospective Observational Study About Progress of Subjective Well-being Sensation in Schizophrenic Patients|Completed||N/A|320|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:45:42.558683|2017-02-18 13:45:42.558683
NCT00782886|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2011-01-25|||April 2008||2008-04-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer|Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer|Completed||N/A|75|Anticipated|Pathfinder Therapeutics|||1||f||||t||||||||||2017-02-18 13:45:42.698034|2017-02-18 13:45:42.698034
NCT00782873|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2008-10-29|||March 2008||2008-03-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Observational|||Balanced Propofol Sedation During Upper Endoscopy in Morbidly Obese Patients|Balanced Propofol Sedation During Upper Endoscopy in Morbidly Obese Patients: Assessment of Cardiopulmonary Parameters|Completed||N/A|65|Actual|Research Associates of New York, LLP|||1||f||||f||||||||||2017-02-18 13:45:42.796468|2017-02-18 13:45:42.796468
NCT00782860|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2009-03-30||||||March 2009|2009-03-01||||||||Observational|||Early Pregnancy Failure: Factors Affecting Successful Medical Termination Treatment||Completed||N/A|||Western Galilee Hospital-Nahariya|||2||f||||||||||||||2017-02-18 13:45:42.8841|2017-02-18 13:45:42.8841
NCT00782847|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2008-10-30|||July 2004||2004-07-01|October 2008|2008-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|DiaNe||Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy|A Prospective Controlled Randomized Multicenter Trial to Evaluate the Effect of a Structurized Multifactorial Behavior Modifying Consultation and Support Programme DiaNe for People With Diabetic Nephropathy|Completed||Phase 3|125|Actual|DiaNe HCM GmbH||2|||f||||f||||||||||2017-02-18 13:45:42.957065|2017-02-18 13:45:42.957065
NCT00782834|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2013-04-15|2010-12-17||July 2008||2008-07-01|April 2013|2013-04-01|October 2009|Actual|2009-10-01|July 2008|Actual|2008-07-01||Interventional|07060|"Screened:~Started: 15 patients Completed: 14 patients Comments: 1 patient deemed ineligible due to arrhythmia.~Treatment Phase:~Started: 14 patients Completed: 13 patients Comments: 1 patient on extensive pathology review was found to have a solitary fibrous tumor, not GIST."|Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST)|Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib|Terminated||Phase 2|13|Actual|Fox Chase Cancer Center|The study failed to meet its accrual goals. Study terminated prior to accruing 17 subjects due to futility of meeting endpoint.|1||Stopped early for futility, unable to meet accrual goals|f||||f||||||||||2017-02-18 13:45:43.070506|2017-02-18 13:45:43.070506
NCT00782821|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2015-12-14|2015-10-20||September 2008||2008-09-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients|Targeted Therapy for High Immunologic Risk Renal Transplant Recipients: A Prospective, Randomized, Open-Label Pilot Study of B-Cell Depleting Therapy in Combination With Anti-Thymocyte Globulin [Rabbit] (Thymoglobulin®, Genzyme), Tacrolimus (Prograf®, Astellas), Mycophenolate Mofetil (CellCept®, Roche) and Corticosteroid Minimization|Completed||Phase 4|40|Actual|University of Cincinnati||4|||f||||f||||||||||2017-02-18 13:45:43.392921|2017-02-18 13:45:43.392921
NCT00782808|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-09-25|||March 2009||2009-03-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Observational|||Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV||Completed||N/A|60|Actual|South East Asia Research Collaboration with Hawaii|||2||f||||f||||||||||2017-02-18 13:45:44.100787|2017-02-18 13:45:44.100787
NCT00782795|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-06-06|||November 2008||2008-11-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality|Phase II Study of Chronic Pancreatitis and the Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality|Completed||Phase 2|60|Actual|University of Michigan||2|||f||||t||||||||Undecided|Decision will be made once the study results are produced.|2017-02-18 13:45:44.398506|2017-02-18 13:45:44.398506
NCT00782782|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-26|2008-10-28|||August 2008||2008-08-01|October 2008|2008-10-01|December 2011|Anticipated|2011-12-01|December 2009|Anticipated|2009-12-01||Observational|||Vascular Sensitivity to Adrenergic Agonists in Patients With CHF and in Healthy Subjects|Effect of Medications on Vascular Response in Patients With CHF and in Healthy Subjects|Unknown status|Active, not recruiting|N/A|80|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples Without DNA|"~     samples for norepinephrine and PRA will be retained~   "|||2017-02-18 13:45:44.522227|2017-02-18 13:45:44.522227
NCT00782769|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-07-20||2011-08-16|September 2008||2008-09-01|July 2016|2016-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Safety Extension Study of DR-OXY-301|A Multicenter, Parallel-Group Extension Study to Evaluate the Safety of Two Doses of DR-3001 in Women With Overactive Bladder|Completed||Phase 3|240|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 13:45:44.615011|2017-02-18 13:45:44.615011
NCT00782756|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-07-25|||October 2008||2008-10-01|July 2016|2016-07-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma|A Phase II Study of Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma|Active, not recruiting||Phase 2|40|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:45:44.842091|2017-02-18 13:45:44.842091
NCT00782743|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2015-09-22|||February 2008||2008-02-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Comparison of Phenprocoumon and Acetylsalicylic Acid (ASA)|Prospective Comparison of Phenprocoumon (Marcumar) and Acetylsalicylic Acid (ASA)With Regard to the Progress of Valvular and Coronary Calcification|Completed||N/A|157|Actual|RWTH Aachen University|||2||f||||f||||||Samples Without DNA|"~     Biomarkers for inflammation, measuring of inhibitors of calcification~   "|||2017-02-18 13:45:44.946377|2017-02-18 13:45:44.946377
NCT00782730|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2013-06-11|||October 2008||2008-10-01|June 2013|2013-06-01||||December 2009|Actual|2009-12-01||Observational|||Assessment of Third Trimester Post-void Residual and Validation of Bladder Scanner in Pregnancy and Post-partum|Assessment of Third Trimester Post-void Residual Along With Determining Validity of the Bladder Scanner in the Third Trimester of Pregnancy and Postpartum|Completed||N/A|35|Actual|West Virginia University|||1||f||||f||||||||||2017-02-18 13:45:45.079132|2017-02-18 13:45:45.079132
NCT00782717|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2012-10-22|2011-08-17||November 2008||2008-11-01|October 2012|2012-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients|A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle Following Cataract Surgery in Diabetic Retinopathy Patients|Completed||Phase 2|263|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:45:45.172738|2017-02-18 13:45:45.172738
NCT00782704|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2015-02-09|||October 2008||2008-10-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Development and Validation of a Morbidity Index for Complications in Minor and Major Abdominal Surgery|Development and Validation of a Morbidity Index for Complications in Minor and Major Abdominal Surgery|Completed||N/A|219|Actual|University of Zurich|||3||f||||t||||||||||2017-02-18 13:45:45.571937|2017-02-18 13:45:45.571937
NCT00782691|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2008-10-29|||July 2008||2008-07-01|October 2008|2008-10-01||||December 2009|Anticipated|2009-12-01||Observational|||Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.|Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.|Unknown status|Recruiting|N/A|15|Anticipated|Radboud University|||1||f||||||||||Samples With DNA|"~     Head-and-neck cancer patients will undergo a therapeutic lymph node dissection of the~     cervical nodes. This treatment is given whether the patient is enrolled in the study or not.~     Histological specimens of cancer patients are always stored for possible future refference~     in the routine clinical practice.~   "|||2017-02-18 13:45:45.675791|2017-02-18 13:45:45.675791
NCT00782665|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-28|||July 2008||2008-07-01|October 2008|2008-10-01|July 2010|Anticipated|2010-07-01|June 2010|Anticipated|2010-06-01||Interventional|||Myometrial Biopsy for the Detection of Infection|Myometrial Biopsy for the Detection of Infection|Unknown status|Recruiting|N/A|1000|Anticipated|The Woman's Hospital of Texas||2|||f||||f||||||||||2017-02-18 13:45:45.770336|2017-02-18 13:45:45.770336
NCT00782652|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-09-08|||March 2006||2006-03-01|September 2016|2016-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients|The Effects of Nitric Oxide for Inhalation on Survival or the Need for Dialysis or a Right Ventricular Assistance Device (RVAD) in Right Ventricular Infarction Patients|Terminated||Phase 2|3|Actual|Mallinckrodt||2||Slow enrollment|f||||t||||||||||2017-02-18 13:45:45.879705|2017-02-18 13:45:45.879705
NCT00782639|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2012-01-24|2011-06-29||March 2009||2009-03-01|January 2012|2012-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|RECARE||Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients|RECARE (REnal Safety Following the Intra-Arterial Administration of Iopamidol vs. Iodixanol During Coronary AngiogRaphy in DiabEtic Patients)|Terminated||Phase 4|23|Actual|Bracco Diagnostics, Inc|This study was terminated early due to low enrollment. Only 1 patient in the Iopamiro-370 group had CIN (per all 3 definitions [first 3 secondary outcome measures] of CIN); therefore, no formal analyses were performed.|2||This study was terminated early due to slow enrollment.|f||||f||||||||||2017-02-18 13:45:46.151361|2017-02-18 13:45:46.151361
NCT00782626|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2015-12-30|2015-12-30||June 2009||2009-06-01|December 2015|2015-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas|A Phase II Study of Everolimus (RAD001) for Children With Chemotherapy and/or Radiation-Refractory Progressive or Recurrent Low-Grade Gliomas|Completed||Phase 2|23|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:45:46.613008|2017-02-18 13:45:46.613008
NCT00782613|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2009-01-29|||November 2008||2008-11-01|January 2009|2009-01-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis|Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Wafety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic|Terminated||Phase 2|30|Anticipated|Synvista Therapeutics, Inc||2||Study has been termination early due to financial contraints.|f||||f||||||||||2017-02-18 13:45:46.961657|2017-02-18 13:45:46.961657
NCT00782600|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2009-06-05|||July 2008||2008-07-01|June 2009|2009-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers|A Phase 1, Randomized, 4-Period, 4-Sequence Cross-Over Study Of The Pharmacokinetics Of 3 Durations Of Release Of A Controlled Release Formulation And A Single Dose Of An Immediate Release Oral Suspension Of CE-224,535 In Normal Healthy Volunteers|Completed||Phase 1|16|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:45:47.062127|2017-02-18 13:45:47.062127
NCT00782587|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2010-02-05|||October 2008||2008-10-01|February 2010|2010-02-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|IPOP||Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer|Phase I Safety and Tolerability Study of Immediate Post-Operative Intravesical Instillation of Chemophase® (Recombinant Human Hyaluronidase in Combination With Mitomycin) in Patients With Non-Muscle-Invasive Bladder Cancer|Completed||Phase 1|14|Actual|Halozyme Therapeutics||1|||f||||f||||||||||2017-02-18 13:45:47.174094|2017-02-18 13:45:47.174094
NCT00782574|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-12-27|||November 2008||2008-11-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|February 2012|Actual|2012-02-01||Interventional|||Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients|A Phase I Open Label, Multi Centre Study of AZD2281 Administered Orally in Combination With Cisplatin, to Assess the Safety and Tolerability in Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|59|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 13:45:47.285991|2017-02-18 13:45:47.285991
NCT00782561|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2009-07-14|||April 2008||2008-04-01|July 2009|2009-07-01|March 2011|Anticipated|2011-03-01|June 2010|Anticipated|2010-06-01||Interventional|||Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)|A Phase I, Open-Label Study of the Safety and Pharmacokinetics of FG-3019 in Adolescent and Adult Subjects With Steroid-Resistant Focal Segmental Glomerulosclerosis|Terminated||Phase 1|12|Anticipated|FibroGen||1|||f||||f||||||||||2017-02-18 13:45:47.399291|2017-02-18 13:45:47.399291
NCT00782548|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2008-10-29|||May 2004||2004-05-01|October 2008|2008-10-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults|A Phase IV, Comparative, Randomized, Double Blind, Single-Dose, 2-Way Crossover Study to Evaluate the Pharmacokinetics and Safety of Alpharma Branded Products Division (KADIAN)and Ligand Pharmaceuticals Inc. (Avinza) 30 mg Morphine Sulfate Sustained-Release Capsules in Healthy Adult Volunteers Under Fed Conditions|Completed||Phase 4|40|Actual|Alpharma Pharmaceuticals LLC, a subsidiary of Pfizer Inc.||2|||f||||||||||||||2017-02-18 13:45:47.502224|2017-02-18 13:45:47.502224
NCT00782535|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2011-11-17||2010-08-18|December 2008||2008-12-01|November 2011|2011-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)|EVALUATION OF THE SAFETY AND EFFICACY OF TREATMENT WITH SINGLE DOSES OF CHF 4226 pMDI IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE A Multicenter, Randomized, Double-Blind,Placebo-Controlled, 5-Way Crossover Study|Completed||Phase 2|20|Actual|Chiesi Pharmaceuticals Inc.||5|||f||||f||||||||||2017-02-18 13:45:47.601966|2017-02-18 13:45:47.601966
NCT00782522|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2012-03-26|||April 2009||2009-04-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Effect Study of an Eccentric Training Program and Stretching for Patients With Chronical Rotator Cuff Tendinopathy|Effect Study of an Eccentric Training Program and Stretching for Patients With Chronical Rotator Cuff Tendinopathy|Completed||N/A|69|Actual|University Ghent||2|||f||||f||||||||||2017-02-18 13:45:47.709664|2017-02-18 13:45:47.709664
NCT00782509|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-06-17|2014-03-28||February 2009||2009-02-01|June 2014|2014-06-01||||September 2010|Actual|2010-09-01||Interventional|||12 / 48 wk Pivotal PFT vs PBO in COPD II|Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 48 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (5 mcg [2 Actuations of 2.5 mcg] and 10 mcg [2 Actuations of 5 mcg]) Delivered by the Respimat® Inhaler, in Patients With Chronic Obstructive Pulmonary Disease (COPD|Completed||Phase 3|644|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 13:45:47.843013|2017-02-18 13:45:47.843013
NCT00782496|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2016-01-29|2010-09-27||November 2008||2008-11-01|January 2016|2016-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Glucose Meter Study|A New Contour Blood Glucose Monitoring System With High Frequency Testing Patients|Completed||N/A|211|Actual|Ascensia Diabetes Care||2|||f||||f||||||||||2017-02-18 13:45:52.942329|2017-02-18 13:45:52.942329
NCT00782483|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-06-19|2014-01-06||October 2008||2008-10-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Personalized Interactive Laser Therapy of Port Wine Stain|Personalized Interactive Laser Therapy of Port Wine Stain - Study 2|Terminated||N/A|6|Actual|University of Arkansas|PI relocated and protocol was terminated, and no subject returned for treatment under protocol.|1||PI moved out of state.|f||||t||||||||||2017-02-18 13:45:53.48412|2017-02-18 13:45:53.48412
NCT00782470|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-10-31|||December 2007||2007-12-01|October 2014|2014-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A|A Prospective, Non-interventional, Multi-center, Open-label Study to Evaluate the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Subjects With Severe Hemophilia A Receiving Prophylaxis and On-demand Treatment Regimen|Completed||N/A|38|Actual|Bayer|||3||f||||f||||||||||2017-02-18 13:45:53.687657|2017-02-18 13:45:53.687657
NCT00782457|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2015-03-17|||January 2002||2002-01-01|October 2008|2008-10-01|December 2010||2010-12-01|February 2007|Actual|2007-02-01||Interventional|||Prospective Randomised Study Comparing Laparoscopic Versus Open Surgery in Patients With Rectal Cancer||Completed||Phase 3|200|Anticipated|Hospital Universitario Virgen de la Arrixaca||2|||f||||||||||||||2017-02-18 13:45:53.812542|2017-02-18 13:45:53.812542
NCT00782444|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2016-08-15|||January 2009||2009-01-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|CAOS||Computer Navigation vs Conventional Technique in Knee Arthroplasty|Computer Navigation vs Conventional Technique in Knee Arthroplasty. A Prospective, Randomised, Clinical and Radiostereometric Trial|Active, not recruiting||N/A|200|Anticipated|Haukeland University Hospital||2|||f||||t||||||||||2017-02-18 13:45:53.899896|2017-02-18 13:45:53.899896
NCT00782431|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2015-10-07||2009-10-29|November 2008||2008-11-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|||Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older|Phase 3 Double Blind Clinical Study of Effectiveness and Safety of Vero Cell-Derived, Trivalent, Seasonal Influenza Vaccine in Adults Aged 50 Years and Older|Completed||Phase 3|3195|Anticipated|Nanotherapeutics, Inc.||2|||f||||t||||||||||2017-02-18 13:45:54.011421|2017-02-18 13:45:54.011421
NCT00782418|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-11-03|2010-03-19||September 2008||2008-09-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)|A Randomized Clinical Trial to Study Glucose Dependent Insulin Secretion Methodologies in Healthy Lean Male Subjects|Completed||Phase 1|27|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 13:45:54.13993|2017-02-18 13:45:54.13993
NCT00782405|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2011-04-18|||October 2008||2008-10-01|April 2011|2011-04-01||||April 2011|Actual|2011-04-01||Interventional|||Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With Mirtazapine|Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With Mirtazapine|Completed||Phase 3|40|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-02-18 13:45:54.678605|2017-02-18 13:45:54.678605
NCT00782392|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2011-05-16|||January 2007||2007-01-01|May 2011|2011-05-01||||June 2007|Actual|2007-06-01||Observational|||Bioavailability and Dosing of a Monosaccharide Supplement in Adults|Bioavailability and Dosing of an Oral Monosaccharide Supplement in Adults and Effects on Resting Brain Activity|Completed||N/A|15|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 13:45:54.791934|2017-02-18 13:45:54.791934
NCT00782379|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2013-10-28|2013-03-18||October 2008||2008-10-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|April 2011|Actual|2011-04-01||Interventional|||Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer|A Phase II Trial of Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients With Hematologic Malignancies|Completed||Phase 2|20|Actual|Northside Hospital, Inc.||1|||f||||f||||||||||2017-02-18 13:45:54.867487|2017-02-18 13:45:54.867487
NCT00782366|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2011-04-25|||March 2008||2008-03-01|April 2011|2011-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|PGT||Predictive Genetic Risk Assessment Trial|Proof-of-Principle Trial of Communication to Patients Receiving Predictive Genetic Risk Assessment|Completed||N/A|26|Actual|Mayo Clinic|||2||f||||f||||||||||2017-02-18 13:45:55.585309|2017-02-18 13:45:55.585309
NCT00782353|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2012-11-12|||October 2008||2008-10-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection|A Phase 1, Randomized, Double-Blind, Ascending Multiple-Dose Study of the Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Chronic Hepatitis C Infection|Completed||Phase 1|35|Actual|Hoffmann-La Roche||3|||f||||f||||||||||2017-02-18 13:45:55.701498|2017-02-18 13:45:55.701498
NCT00782340|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-04-22|2014-03-18||September 2008||2008-09-01|April 2014|2014-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|NOH301||A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa|Phase III, Multi-Center, Study to Assess the Clinical Effect of Droxidopa in Subjects With Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency or Non-Diabetic Neuropathy and Symptomatic NOH|Completed||Phase 3|263|Actual|Chelsea Therapeutics||2|||f||||f||||||||||2017-02-18 13:45:55.822174|2017-02-18 13:45:55.822174
NCT00782327|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2015-06-02|||June 2009||2009-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers|Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers|Recruiting||Phase 3|174|Anticipated|University Hospital, Ghent||2|||f||||t||||||||||2017-02-18 13:45:56.823967|2017-02-18 13:45:56.823967
NCT00782314|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2009-07-23|||April 2008||2008-04-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|||||Observational|||Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice|Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice|Completed||N/A|400|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:45:56.938982|2017-02-18 13:45:56.938982
NCT00782301|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2012-01-18|||March 2009||2009-03-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients|A Multicenter, Randomized, Open, Comparative Trial Of Maraviroc Versus Etravirine Each In Combination With Darunavir/Ritonavir And Raltegravir For The Treatment Of Antiretroviral-Experienced HIV-1 Subjects Co-Infected With Hepatitis C And/Or Hepatitis B|Withdrawn||Phase 4|0|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-02-18 13:45:57.056589|2017-02-18 13:45:57.056589
NCT00782288|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-09-01|2015-10-14||August 2010||2010-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Phase II Study of Digitoxin to Treat Cystic Fibrosis|Phase II Study of Digitoxin to Treat Cystic Fibrosis|Completed||Phase 2|24|Actual|Johns Hopkins University|Steady states of digitoxin were not achieved in subjects until relatively late the in 28 day treatment period. This would suggest that it may require a much longer treatment course to meaningfully effect inflammation in the airways.|3|||f||||t||||||||||2017-02-18 13:45:57.193768|2017-02-18 13:45:57.193768
NCT00782275|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-08-29|||January 2009||2009-01-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|July 2016|Actual|2016-07-01||Interventional|||Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma|A Phase II Trial of Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|40|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:45:58.422851|2017-02-18 13:45:58.422851
NCT00782262|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-29|||April 2005||2005-04-01|October 2008|2008-10-01||||January 2009|Anticipated|2009-01-01||Interventional|||Weight Loss Effects on Heart and Blood Vessel Function in Obesity|Effects of Obesity and Diet Induced Weight Loss on Cardiovascular Risk Factors, Vascular and Ventricular Structure and Function in Obese Men|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|University of Adelaide||3|||f||||t||||||||||2017-02-18 13:45:58.527193|2017-02-18 13:45:58.527193
NCT00782249|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-12-04|||October 2005||2005-10-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy|Prospective Randomized Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy|Unknown status|Recruiting|N/A|45|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 13:45:58.615602|2017-02-18 13:45:58.615602
NCT00782236|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2016-03-03|||June 2006||2006-06-01|March 2016|2016-03-01|October 2009|Actual|2009-10-01|November 2007|Actual|2007-11-01||Interventional|||Comparison of Straumann BoneCeramic vs. Allograft Bone in Extraction Sockets|Comparison of an Alloplast (Straumann Bone Ceramic) to an Allograft of Freeze Dried Bone (FDBA) for Preservation of the Alveolar Ridge Following Tooth Extraction: a Prospective, Randomized, Controlled Clinical Study|Terminated||Phase 4|13|Actual|Institut Straumann AG||2||Lack of enrollment|f||||f||||||||No||2017-02-18 13:45:58.722641|2017-02-18 13:45:58.722641
NCT00782223|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2008-10-29|||July 2008||2008-07-01|October 2008|2008-10-01||||December 2008|Anticipated|2008-12-01||Observational|||Assessment of Digital Radiograph Measurements of Hip,Spine and Lower Limbs|Assessment of Hip, Spine and Lower Limbs Digital Radiograph Measurements in Pediatric Population: Using PACS Integrated Computer Software (TraumaCad From OrthoCrat)|Unknown status|Active, not recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||5||f||||f||||||||||2017-02-18 13:45:58.829906|2017-02-18 13:45:58.829906
NCT00782210|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-06-03|2014-03-28||November 2008||2008-11-01|March 2014|2014-03-01||||September 2010|Actual|2010-09-01||Interventional|||12 / 48 Week Pivotal PFT vs PBO in COPD I|Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 48 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (5 mcg [2 Actuations of 2.5 mcg] and 10 mcg [2 Actuations of 5 mcg]) Delivered by the Respimat® Inhaler, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|625|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 13:45:58.930617|2017-02-18 13:45:58.930617
NCT00782197|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-30|2010-10-01|||January 2008||2008-01-01|October 2010|2010-10-01||||||||Interventional|||Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA|Efficacy and Safety of the Infiltration of Autologous Plasma Rich in Growth Factors (PRGF) in the Symptomatic Treatment of Knee Osteoarthritis|Completed||Phase 4|240|Anticipated|Biotechnology Institute IMASD||2|||f||||f||||||||||2017-02-18 13:46:01.913695|2017-02-18 13:46:01.913695
NCT00782184|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2015-10-12|2011-09-22||November 2008||2008-11-01|October 2015|2015-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)|A Randomized, Double-Blind, Active-Controlled Study of Patients With Primary Hypercholesterolemia and High Cardiovascular Risk and Not Adequately Controlled With Atorvastatin: A Comparison of Switching to a Combination Tablet Ezetimibe/Simvastatin Versus Doubling the Baseline Dose of Atorvastatin|Completed||Phase 3|250|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:46:02.038563|2017-02-18 13:46:02.038563
NCT00782171|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2012-06-06|||July 2004||2004-07-01|June 2012|2012-06-01|February 2010|Actual|2010-02-01|October 2006|Actual|2006-10-01||Interventional|||Evaluation of Immediate Versus Delayed Loading of Dental Implants With a Modified Surface|Immediate and Delayed Loading of 4.1 mm and 4.8 mm Implants in the Posterior Mandible & Maxilla: A Controlled Randomized Study of Single or 2-4 Unit Restorations Loaded Immediately After Surgery or Four Weeks After Surgery|Completed||Phase 4|285|Actual|Institut Straumann AG||2|||f||||f||||||||||2017-02-18 13:46:02.683861|2017-02-18 13:46:02.683861
NCT00782158|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2017-02-04|||October 25, 2008||2008-10-25|January 24, 2017|2017-01-24||||||||Observational|||Hepatitis B and HIV Co-Infection in Patients in Uganda|Hepatitis B and HIV Co-Infection in Uganda|Completed||N/A|11000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:46:02.806043|2017-02-18 13:46:02.806043
NCT00782145|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2011-07-11|||June 2008||2008-06-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families|HSCT-CHESS to Enhance Hematopoietic Transplant Recovery|Completed||Phase 3|198|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-02-18 13:46:02.905874|2017-02-18 13:46:02.905874
NCT00782132|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-04-22|||November 2006||2006-11-01|April 2016|2016-04-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Observational|||Access to Infertility Services: Clinic Perspective|Access to Infertility Services in Ontario for Couples in Which One or Both Partners is HIV-Positive|Completed||N/A|23|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-02-18 13:46:03.026022|2017-02-18 13:46:03.026022
NCT00782119|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-29|||June 2008||2008-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:46:03.098344|2017-02-18 13:46:03.098344
NCT00782106|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2016-04-21|||December 2006||2006-12-01|October 2010|2010-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously|Phase 1/2 Determination of the Dose of Recominant Human Hyaluronidase (rHuPH20) Required Enabling Up to 600 mg/kg Bodyweight of IGIV, 10% to be Administered Subcutaneously in a Single Infusion Site in Subjects With Primary Immunodeficiency (PID)|Completed||Phase 1/Phase 2|11|Actual|Baxalta US Inc.||2|||f||||f||||||||||2017-02-18 13:46:03.148163|2017-02-18 13:46:03.148163
NCT00782093|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2012-10-11|||October 2008||2008-10-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration||Completed||Phase 1|63|Actual|Ophthotech Corporation||1|||f||||f||||||||||2017-02-18 13:46:03.240688|2017-02-18 13:46:03.240688
NCT00782080|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-29|2014-03-12|||July 2008||2008-07-01|March 2014|2014-03-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHD|Efficacy and Safety of St. John´s Wort/Valerian Extract (Sedariston Concentrate) Versus Placebo in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|155|Actual|Johannes Gutenberg University Mainz||2|||f||||t||||||||||2017-02-18 13:46:03.317306|2017-02-18 13:46:03.317306
NCT00782067|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2016-09-01|||October 2008||2008-10-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia|A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease|Active, not recruiting||Phase 2|116|Actual|Novartis||1|||f||||f||||||||||2017-02-18 13:46:03.428432|2017-02-18 13:46:03.428432
NCT00782054|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-10-27|||September 2006||2006-09-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of Post Burn Rehabilitation Population for Itch Control|Evaluation of Provase in the Post Burn Rehabilitation Population for Itch Control and Moisturization Properties|Completed||Phase 4|23|Actual|Swiss-American Products, Inc||2|||f||||t||||||||||2017-02-18 13:46:03.770883|2017-02-18 13:46:03.770883
NCT00781157|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2013-05-22|||January 2008||2008-01-01|May 2013|2013-05-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Phenylephrine for Spinal Induced Hypotension|Up-down Determination of the ED90 of Phenylephrine for Spinal Induced Hypotension in Parturients Undergoing Cesarean Delivery|Completed||Phase 4|66|Actual|IWK Health Centre||1|||f||||t||||||||||2017-02-18 13:46:29.107461|2017-02-18 13:46:29.107461
NCT00782041|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2009-09-14|||January 2003||2003-01-01|September 2009|2009-09-01||||August 2003|Actual|2003-08-01||Interventional|||Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer|Phase II Study of Oxaliplatin in Combination With 5-fluorouracil (5-FU) and Folinic Acid (FA) in Patients Who Have Failed First-line Treatment for Locally Advanced or Metastatic Cervical Cancer.|Terminated||Phase 2|11|Actual|Sanofi||1||protocol violation|f||||f||||||||||2017-02-18 13:46:03.895605|2017-02-18 13:46:03.895605
NCT00782028|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-28|||October 2008||2008-10-01|October 2008|2008-10-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Integrating Well-Woman and Well-Baby Care to Improve Parenting and Family Wellness|Integrating Well-Woman and Well-Baby Care to Improve Parenting and Family Wellness|Unknown status|Not yet recruiting|N/A|170|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 13:46:03.993819|2017-02-18 13:46:03.993819
NCT00782015|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2009-12-07|||October 2008||2008-10-01|December 2009|2009-12-01|November 2010|Anticipated|2010-11-01|December 2009|Anticipated|2009-12-01||Interventional|||Effects of Almonds on Vascular Reactivity in Patients With Coronary Artery Disease|Effects of Almonds on Vascular Reactivity and Biomarkers of Inflammation, Oxidative Stress and Endothelial Function in Patients With Coronary Artery Disease|Unknown status|Active, not recruiting|N/A|40|Anticipated|Tufts University||1|||f||||f||||||||||2017-02-18 13:46:04.080249|2017-02-18 13:46:04.080249
NCT00782002|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2010-09-29|||July 2006||2006-07-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|||Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy|Phase 1 Study of Weekly Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) Monoclonal Antibody IMC-18F1 in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or For Whom No Standard Therapy is Available|Completed||Phase 1|27|Actual|ImClone LLC||1|||f||||t||||||||||2017-02-18 13:46:04.174551|2017-02-18 13:46:04.174551
NCT00781989|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2011-09-29|||September 2008||2008-09-01|September 2011|2011-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Ultrasonography as a Biomarker in Early Rheumatoid Arthritis|Qualification of Ultrasonography as a Biomarker of Prognosis and Response to Treatment in Early Rheumatoid Arthritis|Completed||N/A|101|Actual|Imperial College London|||1||f||||f||||||Samples With DNA|"~     whole blood / serum~   "|||2017-02-18 13:46:04.280781|2017-02-18 13:46:04.280781
NCT00781976|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2010-03-30|||November 2008||2008-11-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Antiviral Activity of AZD7295 in HCV Carriers|A Randomised, DB, PC Study to Determine the PK, Safety and Tolerability Profile and Antiviral Activity of Multiple Oral Doses of AZD7295 in Otherwise Healthy Male and Female Hepatitis C Carriers With Compensated Liver Disease|Completed||Phase 1|31|Actual|Arrow Therapeutics||2|||f||||t||||||||||2017-02-18 13:46:04.371723|2017-02-18 13:46:04.371723
NCT00781963|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2015-04-06|2014-09-17||May 2010||2010-05-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|||Implementing Sleep Interventions for Older Veterans|Implementing Sleep Interventions for Older Veterans|Completed||N/A|519|Actual|VA Office of Research and Development|The study sample was predominantly older male veterans, so results may not be generalizable to older women.|3|||f||||f||||||||||2017-02-18 13:46:04.469139|2017-02-18 13:46:04.469139
NCT00781950|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2016-10-27|2014-12-04||October 2008||2008-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|March 2011|Actual|2011-03-01||Interventional|FLAXPAD||Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease|A Double Blind, Randomized, Placebo Controlled, Study for Assessment of Dietary Flaxseed on Improving Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease|Completed||Phase 2/Phase 3|110|Actual|St. Boniface General Hospital Research Centre||2|||f||||t||||||||||2017-02-18 13:46:04.84004|2017-02-18 13:46:04.84004
NCT00781937|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2016-12-15|2011-09-01||October 2008||2008-10-01|December 2016|2016-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance|Effect of Liraglutide on Long-term Weight Maintenance and Additional Weight Loss Induced by a 4 to 12 Week Low Calorie Diet in Obese Subjects; A 56 Week Randomised, Double-blind, Placebo Controlled, Parallel Group, Multicentre Trial With a 12 Week Follow-up Period|Completed||Phase 3|422|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 13:46:05.191829|2017-02-18 13:46:05.191829
NCT00781924|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2011-08-04|||January 2008||2008-01-01|August 2009|2009-08-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Observational|||Interventional Sonography Guided by Image Fusion|Interventional Sonography Guided by Image Fusion|Completed||N/A|60|Anticipated|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-02-18 13:46:06.810889|2017-02-18 13:46:06.810889
NCT00781911|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-08-12||2010-09-01|February 2009||2009-02-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|July 2011|Actual|2011-07-01||Interventional|||A Study of IMC-A12 in Islet Cell Cancer|A Phase 2, Multicenter, Two Tier Study of IMC-A12 in Combination With Depot Octreotide in Patients With Metastatic, Well or Moderately Differentiated Carcinoid or Islet Cell Carcinoma|Completed||Phase 2|43|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 13:46:06.891538|2017-02-18 13:46:06.891538
NCT00781898|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-09-07|||June 2008||2008-06-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site|Prevention of Relapse to Opioid Addiction Using Depot Naltrexone|Completed||Phase 2/Phase 3|308|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 13:46:07.007789|2017-02-18 13:46:07.007789
NCT00781885|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-04-13||2012-04-13|January 2009||2009-01-01|April 2012|2012-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients|A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients|Completed||Phase 2|19|Actual|Lung Biotechnology PBC||1|||f||||f||||||||||2017-02-18 13:46:07.263784|2017-02-18 13:46:07.263784
NCT00781872|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-28|||October 2006||2006-10-01|October 2008|2008-10-01||||December 2009|Anticipated|2009-12-01||Interventional|||Mesenchymal Stem Cells for the Treatment of MS|Explorative Trial to Investigate the Migration Ability of Mesenchymal Bone Marrow Stem Cells (MSC) in the Central Nervous System (CNS) Following Their Intrathecal Administration in Severe Cases of Multiple Sclerosis (MS)|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 13:46:07.36954|2017-02-18 13:46:07.36954
NCT00781859|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2014-12-02|2012-12-20||December 2008||2008-12-01|April 2014|2014-04-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.|A Randomized, Placebo Controlled, Double-masked, Multicenter Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion|Completed||Phase 3|326|Actual|ThromboGenics||2|||f||||t||||||||||2017-02-18 13:46:07.465187|2017-02-18 13:46:07.465187
NCT00781846|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2015-02-12|||October 2008||2008-10-01|February 2015|2015-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)|A Phase I Trial of Oral Deforolimus (AP23573; MK-8669), an mTOR Inhibitor, in Combination With Bevacizumab for Patients With Advanced Cancers|Completed||Phase 1|17|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:46:07.897434|2017-02-18 13:46:07.897434
NCT00781833|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-01-19|||October 2008||2008-10-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord Injury|Case Study Testing the Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord Injury|Terminated||N/A|1|Actual|The Alfred E. Mann Foundation for Scientific Research||1||Participation of single subject enrolled was terminated.|f||||f||||||||||2017-02-18 13:46:08.009414|2017-02-18 13:46:08.009414
NCT00781820|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2013-06-09|||October 2008||2008-10-01|June 2013|2013-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste|A Double-blind, Randomized, Multicenter, Placebo- Controlled Phase 3 Trial to Prove the Superiority of Bifonazole vs. Placebo After 4 Weeks of Onychomycosis Treatment/ as a Follow-up of a 2 Weeks Treatment of Non-surgical Nail Ablation of Diseased Nail Matrix With 40% Urea Paste|Completed||Phase 3|693|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:46:08.123576|2017-02-18 13:46:08.123576
NCT00781807|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2009-08-24|||November 2008||2008-11-01|August 2009|2009-08-01|April 2014|Anticipated|2014-04-01|October 2013|Anticipated|2013-10-01||Interventional|||Rehabilitation and Outcome for Patients on LVAD Support|Multi-module Rehabilitation for Patients on LVAD Support - Impact on Long-term Outcomes|Unknown status|Recruiting|N/A|80|Anticipated|Hannover Medical School||1|||f||||t||||||||||2017-02-18 13:46:08.275572|2017-02-18 13:46:08.275572
NCT00781794|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2009-07-21|||January 2009||2009-01-01|July 2009|2009-07-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients|A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of Single Oral Doses of NSA-789 on Auditory P50 Suppression in Nonsmoking Patients With Stabilized Schizophrenia|Terminated||Phase 1|30|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 13:46:08.391864|2017-02-18 13:46:08.391864
NCT00781781|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2015-02-03|||July 2008||2008-07-01|October 2008|2008-10-01|December 2011|Actual|2011-12-01|August 2008|Actual|2008-08-01||Interventional|||Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning|Multicenter, Openlabel, Phase II Intergroups (GELTAMO/GETH) Trial, on the Use of Alemtuzumab for Unrelated Donor Reduced Intensity Conditioning Allogenic Transplant in Hematological Malignancies Patients|Terminated||Phase 2|34|Actual|CABYC||2||Inability to recruit the number of patients established in the study protocol (34 of 40)|f||||f||||||||||2017-02-18 13:46:08.49286|2017-02-18 13:46:08.49286
NCT00781768|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2011-09-13|||August 2003||2003-08-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|October 2008|Actual|2008-10-01||Interventional|||Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea|A Prospective, Randomized Phase III Trial of Oral Ondansetron and Dexamethasone Versus Oral Ondansetron, Dexamethasone and Apreptant (MK-869)for the Prevention of N/V Associated With Highly Emetogenic Preparative Regimens Prior to Stem Cell Transplantation.|Completed||Phase 4|180|Actual|Loyola University||2|||f||||f||||||||||2017-02-18 13:46:08.615128|2017-02-18 13:46:08.615128
NCT00781755|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2015-06-03||||||December 2008|2008-12-01||||||||Interventional|||Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal|Phase 4 Study of Treating Schizophrenic Smokers Using Varenicline and Behavioral Intervention: Effects on Craving, Cues and Withdrawal|Withdrawn||Phase 4|0|Actual|VA Boston Healthcare System||2||"Study design was altered such that a treatment component was removed through the VA IRB. We~   did not and will not begin this clinical trial."|f||||f||||||||||2017-02-18 13:46:08.711491|2017-02-18 13:46:08.711491
NCT00781742|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-07-16||2012-02-21|October 2008||2008-10-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||AZD6765 Severe Major Depressive Disorder (MDD) IV|A Phase IIb, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Efficacy and Safety Study of Adjunctive AZD6765 in Subjects With Severe Major Depressive Disorder (MDD) and a History of Poor Response to Antidepressants|Completed||Phase 2|152|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 13:46:08.820124|2017-02-18 13:46:08.820124
NCT00781729|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-28|||September 2004||2004-09-01|August 2008|2008-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Yoga for Kyphosis Trial|Phase 2 Study of Yoga for Excess Thoracic Curvature.|Completed||Phase 2|118|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 13:46:08.952711|2017-02-18 13:46:08.952711
NCT00781716|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-28|||October 2008||2008-10-01|October 2008|2008-10-01|May 2011|Anticipated|2011-05-01|May 2011|Anticipated|2011-05-01||Interventional|CREST-MI||Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China|Comparison of Safety and Efficacy of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction and Analysis of Current Status of Emergency PCI Green Channel for Patients With ST Elevation Myocardial Infarction in China|Unknown status|Not yet recruiting|N/A|1020|Anticipated|Beijing Chao Yang Hospital||2|||f||||f||||||||||2017-02-18 13:46:09.054816|2017-02-18 13:46:09.054816
NCT00781703|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2014-07-14|||February 2008||2008-02-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|June 2012|Actual|2012-06-01||Interventional|DIAMOND||Evaluation of a Natural Experiment to Improve Statewide Depression Care in Minnesota (MN)|DIAMOND Study: Evaluation of a Natural Experiment to Improve Statewide Depression Care in MN|Completed||N/A|2631|Actual|HealthPartners Institute||1|||f||||f||||||||||2017-02-18 13:46:09.153171|2017-02-18 13:46:09.153171
NCT00781690|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2010-02-15|||September 2008||2008-09-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|RHODES||Reduction of Heparin Dose in Dialysis With Evodial System|Pilot, Prospective, Multicenter, Open and Non-randomised Study: Definition of an Index of Anti Xa Value at the End of Hemodialysis Treatment.|Completed||Phase 4|60|Anticipated|Gambro Lundia AB||1|||f||||f||||||||||2017-02-18 13:46:09.242324|2017-02-18 13:46:09.242324
NCT00781677|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2010-01-11|||May 2008||2008-05-01|January 2010|2010-01-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Observational|||Using Neuroimaging to Investigate Major Depressive Disorder|Using Neuroimaging to Investigate Neurobiological Correlates of Treatment Resistance Associated With Co-morbid Anxiety in Major Depressive Disorder|Unknown status|Recruiting|N/A|50|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-02-18 13:46:09.375193|2017-02-18 13:46:09.375193
NCT00781664|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-11-19|||October 2008||2008-10-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Cumulative Irritation Test|21-Day Cumulative Irritation Test|Completed||Phase 1|44|Actual|Pfizer||9|||f||||f||||||||||2017-02-18 13:46:09.463638|2017-02-18 13:46:09.463638
NCT00780793|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-02-01|||September 2008||2008-09-01|October 2008|2008-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|STRASS||Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study|Effect of TNF-blocker Injections Spacing on Rheumatoid Arthritis Inflammatory Activity in Patients in Clinical Remission or Low Disease Activity|Completed||Phase 4|250|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:46:09.570084|2017-02-18 13:46:09.570084
NCT00780780|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-10-27|||July 2007||2007-07-01|August 2008|2008-08-01|October 2008|Anticipated|2008-10-01|August 2008|Actual|2008-08-01||Interventional|NEVANAC||Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema|A Randomized Parallel, Masked to Evaluate the Efficacy of Triamcinolone Associated With Nepafenac (Nevanac) Compared With Intravitreal Injection of Triamcinolone for Treatment of Clinically Significant Diabetic Macular Edema|Unknown status|Active, not recruiting|Phase 3|40|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 13:46:09.6786|2017-02-18 13:46:09.6786
NCT00781651|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-28|||October 2007||2007-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:46:09.783281|2017-02-18 13:46:09.783281
NCT00781638|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2012-04-02|||October 2008||2008-10-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis|Open Uncontrolled Investigation to Assess the Efficacy and Safety of Adacolumn® Granulocytes, Monocytes / Macrophage Apheresis Device in Children and Adolescents With Active Ulcerative Colitis|Completed||N/A|24|Actual|Otsuka Frankfurt Research Institute GmbH||1|||f||||f||||||||||2017-02-18 13:46:09.929228|2017-02-18 13:46:09.929228
NCT00781625|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-29|||October 2008||2008-10-01|October 2008|2008-10-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Probiotics as a Prophylactic Aid in Women With Recurrent Urinary Tract Infections (UTI's)|Probiotics/Lactobacillus as a Prophylactic Aid in Recurrent Bacterial Cystitis in Women. A Randomized, Prospective, Double-Blinded, Placebo Controlled, Multi-Center Study.|Unknown status|Recruiting|N/A|120|Anticipated|University Hospital, Akershus||3|||f||||t||||||||||2017-02-18 13:46:10.023397|2017-02-18 13:46:10.023397
NCT00781612|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-11-01|||October 2008||2008-10-01|November 2016|2016-11-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||An Extension Study of Trastuzuma Emtansine in Patients Previously Treated With Trastuzuma Emtansine|An Open-Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 (T-DM1) Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Treated With the Equivalent T-DM1 Regimen in a Genentech and/or F. Hoffmann-La Roche Ltd.-Sponsored T-DM1 Study|Enrolling by invitation||Phase 2|500|Anticipated|Genentech, Inc.||1|||f||||||||||||||2017-02-18 13:46:10.143368|2017-02-18 13:46:10.143368
NCT00781599|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-06-27|2012-04-19||October 2008||2008-10-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers|Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers|Completed||N/A|72|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 13:46:10.569213|2017-02-18 13:46:10.569213
NCT00781586|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2013-11-20|||October 2007||2007-10-01|November 2013|2013-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy of ONE A DAY Weightsmart Advanced Versus Caffeine and Placebo on Energy Expenditure, Thermogenesis and Perceived Energy Levels in Women.|A Randomized, Single Center, Double-blind, Three-way Crossover Trial to Evaluate the Efficacy of ONE A DAY Weightsmart Advanced Versus Caffeine and Placebo on Energy Expenditure, Thermogenesis and Perceived Energy Levels in Women.|Completed||Phase 4|22|Actual|Bayer||3|||f||||f||||||||||2017-02-18 13:46:11.030352|2017-02-18 13:46:11.030352
NCT00781573|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2013-11-01|||September 2008||2008-09-01|November 2013|2013-11-01|March 2014|Anticipated|2014-03-01|March 2013|Actual|2013-03-01||Interventional|SCORE||Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)|Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)|Unknown status|Active, not recruiting|N/A|280|Anticipated|North Texas Veterans Healthcare System||2|||f||||t||||||||||2017-02-18 13:46:11.144086|2017-02-18 13:46:11.144086
NCT00781560|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2009-08-06|||October 2008||2008-10-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|||||Observational|CRE NIS||Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal|A Cross-sectional Study to Survey the Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the Rate of Patients (on Treatment) Achieving the Hyperlipidaemia Treatment Goal With Crestor 5mg to 10mg for 8 Weeks|Completed||N/A|2575|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:46:11.272379|2017-02-18 13:46:11.272379
NCT00781547|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-28|||January 1999||1999-01-01|October 2008|2008-10-01|May 2005|Actual|2005-05-01|September 2003|Actual|2003-09-01||Interventional|GHDM||Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus||Completed||Phase 3|40|Actual|Göteborg University||2|||f||||f||||||||||2017-02-18 13:46:11.39095|2017-02-18 13:46:11.39095
NCT00781534|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2010-02-18|||September 2003||2003-09-01|February 2010|2010-02-01|September 2008|Actual|2008-09-01|December 2004|Actual|2004-12-01||Interventional|||A Clinical Trial of Ginseng in Diabetes|A Clinical Trial of Ginseng for Glucose Intolerance|Completed||Early Phase 1|19|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-02-18 13:46:11.494125|2017-02-18 13:46:11.494125
NCT00781521|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2008-10-28|||November 2002||2002-11-01|October 2008|2008-10-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children|A Pilot, Multicenter, Open Label, Non Comparative Study of the Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media Twice Daily for Seven Days in Children With Tympanostomy Tubes|Completed||Phase 3|96|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 13:46:11.605324|2017-02-18 13:46:11.605324
NCT00781508|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2014-06-23|2013-04-22||December 2006||2006-12-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Effects of Viagra on Heart Function in Patients With Heart Failure|Single Dose Sildenafil in Heart Failure Patients Improves 6-minute Walk Test by a Reduction in Left Ventricular Filling Pressure|Completed||Phase 4|10|Actual|MetroHealth Medical Center|The study was limited by the small number of participants. Additionally, the inclusion criterion of a systolic pulmonary artery pressure of > 40 mmHg was no longer present in the majority of patients at the time they presented for study.|2|||f||||f||||||||||2017-02-18 13:46:11.702969|2017-02-18 13:46:11.702969
NCT00781495|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2011-07-11|||December 2008||2008-12-01|September 2009|2009-09-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Determinants of Insulin-induced Weight Gain in Type 2 Diabetes Mellitus|Determinants of Insulin-induced Weight Gain in Type 2 Diabetes Mellitus|Unknown status|Recruiting|N/A|75|Anticipated|Radboud University|||1||f||||f||||||||||2017-02-18 13:46:12.08753|2017-02-18 13:46:12.08753
NCT00781482|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-02-25||||||February 2016|2016-02-01||||||||Interventional|||Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem|Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem|Withdrawn||Phase 4|0|Actual|Kettering Health Network||1||Sponsor elected not to conduct study at this time.|f||||f||||||||||2017-02-18 13:46:12.195679|2017-02-18 13:46:12.195679
NCT00781469|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2015-05-27|||November 2008||2008-11-01|September 2011|2011-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood|A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood|Completed||N/A|29|Actual|Imperial College London|||3||f||||f||||||Samples With DNA|"~     Blood and synovium~   "|||2017-02-18 13:46:12.301575|2017-02-18 13:46:12.301575
NCT00781456|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2016-12-12|2014-08-19||January 2009||2009-01-01|December 2016|2016-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||Intent-to-treat population includes all randomly assigned and treated participants who had at least 1 week of postbaseline migraine data.|A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy of DR-105 Compared to Placebo For the Management of Menstrually-Related Migraine Headaches.|Completed||Phase 2|109|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 13:46:12.392412|2017-02-18 13:46:12.392412
NCT00781443|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2010-05-04||2010-05-04|December 2008||2008-12-01|May 2010|2010-05-01||||November 2009|Actual|2009-11-01||Interventional|||A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma|A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma|Completed||Phase 2|29|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 13:46:13.083431|2017-02-18 13:46:13.083431
NCT00781430|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2012-05-10|||April 2009||2009-04-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease|An Open-Label, Single-Dose, Parallel-Group Study Of The Pharmacokinetics And Safety Of Neratinib In Subjects With Chronic Hepatic Impairment And In Matched Healthy Adults|Completed||Phase 1|27|Actual|Puma Biotechnology, Inc.||1|||f||||f||||||||||2017-02-18 13:46:13.174996|2017-02-18 13:46:13.174996
NCT00781417|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2012-02-04|||October 2008||2008-10-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|POSH-D||Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease|Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease|Completed||N/A|48|Actual|Atlanta VA Medical Center||2|||f||||f||||||||||2017-02-18 13:46:13.259942|2017-02-18 13:46:13.259942
NCT00781404|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2013-02-15|||October 2008||2008-10-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Interventional|PROMISE||Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI|Myocardial Protection During reperfusión in Patients With Acute Coronary Syndrome With ST Segment Elevation Submitted to Primary Angioplasty: Effect of Intracoronary Adenosine on Infarct Size and Ventricular Remodeling.|Completed||Phase 3|201|Actual|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||f||||||||||2017-02-18 13:46:13.365107|2017-02-18 13:46:13.365107
NCT00781391|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2015-03-12|2015-02-05||November 2008||2008-11-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|EngageAFTIMI48||Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation|A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)|Completed||Phase 3|21105|Actual|Daiichi Sankyo Inc.||3|||f||||t||||||||||2017-02-18 13:46:13.541387|2017-02-18 13:46:13.541387
NCT00781378|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2008-10-28|||June 2002||2002-06-01|October 2008|2008-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China|Efficacy and Safety Evaluation of Low Dosage of Recombinant Tissue Plasminogen Activator (rt-PA) in the Treatment of Pulmonary Thromboembolism: A Multi-Center, Randomized Controlled Trial in China|Completed||Phase 4|118|Actual|Beijing Chao Yang Hospital||2|||f||||t||||||||||2017-02-18 13:46:26.316503|2017-02-18 13:46:26.316503
NCT00781365|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2014-06-12|2014-02-27||March 2009||2009-03-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|Hyperlink||Home Blood Pressure Telemonitoring and Case Management to Control Hypertension|Home Blood Pressure Telemonitoring and Case Management to Control Hypertension|Completed||N/A|450|Actual|HealthPartners Institute||2|||f||||t||||||||||2017-02-18 13:46:26.470951|2017-02-18 13:46:26.470951
NCT00781352|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-06-28|||November 1998||1998-11-01|June 2016|2016-06-01|March 2007|Actual|2007-03-01|November 2003|Actual|2003-11-01||Interventional|||Nitrous Oxide and Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study|Nitrous Oxide Does Not Increase the Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study|Completed||Phase 3|408|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-02-18 13:46:27.314514|2017-02-18 13:46:27.314514
NCT00781339|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-28|2011-09-06||2011-09-06|October 2008||2008-10-01|September 2011|2011-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients|A Phase IIa Open Label Study to Evaluate the Safety and Antimicrobial Effects of NVC-422 on Bacteriuria in Chronically Catheterized Subjects|Completed||Phase 2|20|Actual|NovaBay Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:46:27.435121|2017-02-18 13:46:27.435121
NCT00781326|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-08-05|2016-03-22||August 2008||2008-08-01|August 2016|2016-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression|Treatment of Depression Occurring in the Setting of Cerebrovascular Risk -- A Pilot Study|Terminated||Phase 4|9|Actual|University of Pittsburgh|Study was terminated for administrative reasons at the end of Phase I (open label antidepressant treatment). No subjects entered Phase II (Nimodipine vs Placebo).|1||Final cost of study medication was significantly greater than initial estimate,|f||||f||||||||||2017-02-18 13:46:27.547853|2017-02-18 13:46:27.547853
NCT00781313|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-07-19|||June 2008||2008-06-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|January 2009|Actual|2009-01-01||Observational|||Disaster Preparedness Among Families Caring for Children With Diabetes|Pre-hurricane Disaster Preparedness: A Survey in Pediatric Type 1 Diabetes|Completed||N/A|142|Actual|Baylor College of Medicine|||1||f||||f||||||||No||2017-02-18 13:46:27.867165|2017-02-18 13:46:27.867165
NCT00781300|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-10-27|||March 2006||2006-03-01|October 2008|2008-10-01|February 2007|Actual|2007-02-01|November 2006|Actual|2006-11-01||Interventional|||Intraocular Pressure With Loteprednol and Dexamethasone|A Randomized Clinical Trial Comparing the Intraocular Pressure Changes With the Use of Loteprednol and Dexamethasone After Pterygium Surgery|Completed||Phase 4|35|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 13:46:27.953326|2017-02-18 13:46:27.953326
NCT00781287|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2013-08-08|||February 2009||2009-02-01|August 2013|2013-08-01|October 2013|Anticipated|2013-10-01|February 2012|Actual|2012-02-01||Interventional|UW PIC 330||Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1|Impact of Raltegravir (Isentress/MK-0518) - Containing Regimens on HIV-1 Infected CD4+ T-Cells During Acute and Early HIV-1 Infection: A Randomized, Controlled Study Comparing Standard Antiretroviral Therapy to Standard Therapy Plus Raltegravir|Terminated||Phase 4|10|Actual|University of Washington||2||Enrollment too slow.|f||||f||||||||||2017-02-18 13:46:28.068216|2017-02-18 13:46:28.068216
NCT00781274|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2014-04-16|2012-06-05||December 2008||2008-12-01|April 2014|2014-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy|A Phase 3 Study of MP-424 in Combination With Peginterferon Alfa-2b and Ribavirin (RBV) in Subjects With (Genotype 1) Hepatitis C Who Did Not Respond to Previous Treatment|Completed||Phase 3|32|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-02-18 13:46:28.201616|2017-02-18 13:46:28.201616
NCT00781261|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2013-01-11|||August 2009||2009-08-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|BONES||Osteonecrosis of the Hip and Bisphosphonate Treatment|A Randomised Controlled Trial of Bisphosphonate Therapy in Osteonecrosis of the Hip|Unknown status|Recruiting|Phase 2|120|Anticipated|University of Sydney||2|||f||||f||||||||||2017-02-18 13:46:28.45823|2017-02-18 13:46:28.45823
NCT00781248|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-26|2009-03-24|||September 2008||2008-09-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy Study of the NG Shield, a Device Intended to Reduce Pain and Discomfort Level Related to Nasogasstric Tube Usage|Evaluation of Safety and Efficacy of the NasoGastric Shield (NG Shield) in Healthy Subjects With Indwelling Nasogastric Tube|Completed||Phase 2|24|Anticipated|Nanovibronix||2|||f||||t||||||||||2017-02-18 13:46:28.572666|2017-02-18 13:46:28.572666
NCT00781222|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-10-27|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:46:28.667708|2017-02-18 13:46:28.667708
NCT00781209|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-26|2008-10-27|||October 2008||2008-10-01|October 2008|2008-10-01|December 2010|Anticipated|2010-12-01|October 2009|Anticipated|2009-10-01||Interventional|||The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases|A Phase II Trial Evaluating the Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 13:46:28.714742|2017-02-18 13:46:28.714742
NCT00781196|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2009-08-03|||May 2008||2008-05-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|PIGO||Folic Acid Supplementation in Phenytoin Induced Gingival Overgrowth|Effect of Low Dose Oral Folic Acid Supplementation on Phenytoin Induced Gingival Overgrowth: A Randomized Double Blind Controlled Trial.|Completed||Phase 3|120|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 13:46:28.821859|2017-02-18 13:46:28.821859
NCT00781183|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-12-20|||January 2009||2009-01-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Does Pulmonary Rehabilitation Change Self-Selected And Maximum Sustainable Walking Speed In Patients With Lung Disease?|Does Pulmonary Rehabilitation Change The Self-Selected And Maximum Sustainable Walking Speed In Patients With Symptomatic Lung Disease?|Completed||N/A|64|Actual|West Park Healthcare Centre||1|||f||||f||||||||||2017-02-18 13:46:28.920767|2017-02-18 13:46:28.920767
NCT00781170|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2009-05-27|||May 2000||2000-05-01|May 2009|2009-05-01||||||||Interventional|||Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma|Dose-Reduced Allogeneic Stem Cell Transplantation as Induction of a Graft-Versus-Myeloma-Effect After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma Stage II/III|Completed||Phase 2|20|Anticipated|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-02-18 13:46:29.027404|2017-02-18 13:46:29.027404
NCT00780130|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-27|||May 2008||2008-05-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||SPARQ and Core Proprioception|The Relationship of Core Stability to Core Proprioception|Completed||N/A|20|Actual|Logan College of Chiropractic|||1||f||||f||||||||||2017-02-18 13:46:45.177766|2017-02-18 13:46:45.177766
NCT00781144|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-10-27|||August 2007||2007-08-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Determination of Forces Used in Palpatory Diagnosis|The Effect of Experience and Gender on the Palpatory Forces Exerted by Novice and Experienced Osteopaths in Australia|Completed||N/A|82|Actual|Nova Southeastern University|||3||f||||f||||||||||2017-02-18 13:46:29.216459|2017-02-18 13:46:29.216459
NCT00781131|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2013-05-22|||May 2008||2008-05-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01||Interventional|||Trial of Pregabalin for Post-operative Pain in Women Undergoing Abdominal Hysterectomy|A Randomized, Placebo Controlled Trial of Pregabalin for Post-operative Pain in Women Undergoing Abdominal Hysterectomy|Completed||Phase 4|101|Actual|IWK Health Centre||3|||f||||t||||||||||2017-02-18 13:46:29.311575|2017-02-18 13:46:29.311575
NCT00781118|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-09-26||2015-06-22|December 2008||2008-12-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|January 2014|Actual|2014-01-01||Interventional|ALERTS||AngelMed for Early Recognition and Treatment of STEMI|AngelMed for Early Recognition and Treatment of STEMI|Active, not recruiting||Phase 3|1020|Anticipated|Angel Medical Systems||2|||f||||t||||||||Yes|When we have completed review with the FDA, the IPD will will be made available.|2017-02-18 13:46:29.4232|2017-02-18 13:46:29.4232
NCT00781105|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-05-03|||August 2008||2008-08-01|May 2012|2012-05-01||||September 2010|Actual|2010-09-01||Interventional|Chinese PAC||Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B|An Open-label, Multicenter, Phase IV Study to Evaluate the Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B|Completed||Phase 4|2200|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:46:29.613423|2017-02-18 13:46:29.613423
NCT00781092|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-09-19|||October 2008||2008-10-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral Eyes|A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral Eyes|Completed||Phase 4|30|Actual|Durrie Vision||2|||f||||f||||||||||2017-02-18 13:46:29.706334|2017-02-18 13:46:29.706334
NCT00781079|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2015-04-06|2014-09-18||April 2008||2008-04-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional|PEER|Veteran patients of MHICM teams|Do Consumer Providers Enhance Recovery?|Promoting Recovery Using Mental Health Consumer Providers|Completed||N/A|285|Actual|VA Office of Research and Development|1. cluster randomized trial - teams may have exerted influence on the findings. 2. analyses were intent-to-treat, but about half the veterans in the PS group did not receive any PS services. 3. the study involved a small number of peers (n=6)|2|||f||||t||||||||||2017-02-18 13:46:29.814581|2017-02-18 13:46:29.814581
NCT00781066|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-10-27|||January 2007||2007-01-01|October 2008|2008-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|CCT||Controlled Cord Traction During Third Stage of Labor|Controlled Cord Traction During Third Stage of Labor: Pilot Trial|Completed||Phase 3|200|Actual|Universidad de la Republica||2|||f||||t||||||||||2017-02-18 13:46:30.386965|2017-02-18 13:46:30.386965
NCT00781053|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2013-02-08|||July 2008||2008-07-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study|Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study With P144 Topical Adminsitration for Skin Fibrosis in Patients With Systemic Sclerosis|Completed||Phase 2|38|Actual|ISDIN||1|||f||||f||||||||||2017-02-18 13:46:30.493789|2017-02-18 13:46:30.493789
NCT00781040|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-04-19|||December 2006||2006-12-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients|Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients|Recruiting||N/A|270|Anticipated|Kuopio University Hospital|||1||f||||f||||||||No||2017-02-18 13:46:30.603873|2017-02-18 13:46:30.603873
NCT00781027|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2010-05-19|||December 2008||2008-12-01|May 2010|2010-05-01||||May 2010|Actual|2010-05-01||Interventional|||Fuchs' Torsional Phaco Study|Fuchs' Endothelial Dystrophy and Cataract Surgery: Can Torsional Phacoemulsification Decrease the Risk for Corneal Decompensation|Completed||Phase 4|50|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:46:30.722592|2017-02-18 13:46:30.722592
NCT00781001|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2013-07-29|||July 2008||2008-07-01|July 2013|2013-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy|Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy|Completed||Phase 1/Phase 2|17|Actual|Center for Medicinal Cannabis Research||4|||f||||t||||||||||2017-02-18 13:46:30.818113|2017-02-18 13:46:30.818113
NCT00780988|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2012-01-21||||||January 2012|2012-01-01||||||||Interventional|||Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer|A Pilot Study to Assess the Safety and Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination Prior to Autologous Hematopoietic and Immune Cell Rescue in Metastatic Colorectal Cancer|Withdrawn||Phase 1|0|Actual|Stanford University|||||f||||||||||||||2017-02-18 13:46:30.93375|2017-02-18 13:46:30.93375
NCT00780975|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2017-01-03|||February 2005||2005-02-01|January 2017|2017-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer|A Phase II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Aplidin® as a 3-hour IV Infusion Every 2 Weeks, in Relapsing or Refractory Patients With Androgen-independent Prostate Adenocarcinoma..|Terminated||Phase 2|8|Actual|PharmaMar||1||Poor recruitment|f||||f||||||||||2017-02-18 13:46:31.029507|2017-02-18 13:46:31.029507
NCT00780962|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-10-27|||October 2007||2007-10-01|October 2008|2008-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients|N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients|Unknown status|Recruiting|Phase 2/Phase 3|800|Anticipated|Beth Israel Deaconess Medical Center|||||f||||t||||||||||2017-02-18 13:46:31.146571|2017-02-18 13:46:31.146571
NCT00780949|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-08-02|||January 2009||2009-01-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|PLAC||Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease|Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease|Completed||N/A|110|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:46:31.241379|2017-02-18 13:46:31.241379
NCT00780936|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2008-11-21|||October 2007||2007-10-01|November 2008|2008-11-01|July 2008||2008-07-01|||||Interventional|||Effects of a Peripheral Nerve Block on Biomarkers of Pain and Inflammation|Effect of Peripheral Nerve Block on Inflammatory and Nociceptive Biomarkers in a UV-B Burn Model in Humans|Completed||N/A|15||Stanford University|||||f||||||||||||||2017-02-18 13:46:31.346056|2017-02-18 13:46:31.346056
NCT00780923|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2013-03-25|||January 2009||2009-01-01|March 2013|2013-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effect of Continuous Positive Airway Pressure Treatment on Inflammation in Patients With Obstructive Sleep Apnea|A Longitudinal Study of Short-Term Effects of CPAP Treatment on Airway and Systemic Inflammation in Patients With Obstructive Sleep Apnea|Completed||N/A|43|Actual|Kyoto University, Graduate School of Medicine||1|||f||||t||||||||||2017-02-18 13:46:31.421883|2017-02-18 13:46:31.421883
NCT00780910|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2014-04-16|2012-06-05||November 2008||2008-11-01|April 2014|2014-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy|A Phase 3 Study of MP-424 in Combination With Peginterferon Alfa-2b and Ribavirin in Subjects With Genotype 1 Hepatitis C Who Relapsed After Previous Treatment|Completed||Phase 3|109|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-02-18 13:46:31.524604|2017-02-18 13:46:31.524604
NCT00780897|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-10-27|||March 2005||2005-03-01|October 2008|2008-10-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Observational|GéNIOP||Premature Ovarian Failure (Genetic and Physiopathologic Analysis)|Premature Ovarian Failure : Genetic and Physiopathologic Analysis|Unknown status|Recruiting|N/A|87|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"~     One ovarian biopsy during the protocol to evaluate ovocytes number and transcriptome~     analysis.~   "|||2017-02-18 13:46:31.7785|2017-02-18 13:46:31.7785
NCT00780884|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-26|2015-06-21|||April 2008||2008-04-01|June 2015|2015-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients|Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients|Completed||N/A|21|Actual|HaEmek Medical Center, Israel||1|||f||||t||||||||||2017-02-18 13:46:31.862099|2017-02-18 13:46:31.862099
NCT00780858|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-25|2015-05-05|||October 2008||2008-10-01|May 2015|2015-05-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Observational|LP||Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI|GnRH Antagonist Prevention of Premature Luteinization in Patients Undergoing IUI|Completed||N/A|662|Actual|IVI Madrid|||2||f||||f||||||||||2017-02-18 13:46:31.967044|2017-02-18 13:46:31.967044
NCT00780845|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2008-11-03|||January 2003||2003-01-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)|AKIN (Acute Kidney Injury Network): Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft Surgery|Completed||N/A|817|Actual|Hospital de Base|||2||f||||f||||||||||2017-02-18 13:46:34.373699|2017-02-18 13:46:34.373699
NCT00780832|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-02-23|||May 2008||2008-05-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder|Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder|Terminated||N/A|8|Actual|IWK Health Centre||2||Insufficient elligible patients available in a reasonable time frame.|f||||f||||||||||2017-02-18 13:46:34.488682|2017-02-18 13:46:34.488682
NCT00780819|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2013-05-13|||October 2008||2008-10-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|July 2009|Actual|2009-07-01||Interventional|BZS||Borderzone Sampling|Does Borderzone Contrast Enhancement on Intraoperative MRI During High Grade Glioma Resection Correlate With Residual Tumor?|Completed||N/A|10|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-02-18 13:46:34.603089|2017-02-18 13:46:34.603089
NCT00780806|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2011-08-22|||October 2008||2008-10-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults|An Open-Label Safety And Blood Collection Study In Mnb Rlp2086 Vaccinated Healthy Adult Volunteers For Immunological Assay Development|Completed||Phase 1/Phase 2|60|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||t||||||||||2017-02-18 13:46:34.698658|2017-02-18 13:46:34.698658
NCT00780767|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2012-08-15|||September 2008||2008-09-01|October 2008|2008-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|ART-MPE||Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism|Angiojet Rheolytic Thrombectomy In Case of Massive Pulmonary Embolism A Prospective Single Center Feasibility and Safety Pilot Trial|Completed||Phase 2|10|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-02-18 13:46:34.798478|2017-02-18 13:46:34.798478
NCT00780754|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-26|2008-10-27|||April 2007||2007-04-01|October 2008|2008-10-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia|Effect of 5α Reductase Inhibitor Dutasteride on the Prevention of the Prostate Cancer in Men With High Grade Intraepithelial Neoplasia of the Prostate|Unknown status|Recruiting|Phase 3|200|Anticipated|Kaunas University of Medicine||2|||f||||f||||||||||2017-02-18 13:46:34.904024|2017-02-18 13:46:34.904024
NCT00780741|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-05-19|2012-08-23||October 2008||2008-10-01|May 2016|2016-05-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|NLD3||Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old|A Randomized Trial Comparing Immediate Probing in an Office Setting With Deferred Probing in a Facility Setting for Treatment of Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old|Completed||Phase 3|220|Actual|Jaeb Center for Health Research|"Conclusions not definitive--would need larger sample size.~Participants with bilateral NLDO excluded, so results not generalizable to bilateral cases.~Actual costs may vary by region and payer.~Did not include costs of follow up visits."|2|||f||||t||||||||||2017-02-18 13:46:35.017895|2017-02-18 13:46:35.017895
NCT00780728|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2009-11-12||||||November 2009|2009-11-01||||||||Interventional|||Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial Hypertension|Addition of Sildenafil to Bosentan Monotherapy in Patients With Pulmonary Arterial Hypertension (PAH)|Withdrawn||Phase 3|||University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 13:46:37.947227|2017-02-18 13:46:37.947227
NCT00780715|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2016-01-07|||December 2008||2008-12-01|January 2016|2016-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|ROAD||Response To Oral Agents in Diabetes (ROAD)- Pilot Study|Response To Oral Agents in Diabetes (ROAD)- Pilot Study|Completed||Phase 4|29|Actual|University of Dundee||4|||f||||f||||||||||2017-02-18 13:46:38.033483|2017-02-18 13:46:38.033483
NCT00780702|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2017-01-24|||May 8, 2008||2008-05-08|February 27, 2014|2014-02-27|April 16, 2013|Actual|2013-04-16|April 16, 2013|Actual|2013-04-16||Interventional|||Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients|Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients|Completed||Phase 1|200|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 13:46:38.139428|2017-02-18 13:46:38.139428
NCT00780676|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2015-07-16|2015-06-10||June 2009||2009-06-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||Individuals who were positive for more than one predictor were assigned to the marker arm for which they had the highest percentile positivity.|Personalized Treatment Selection for Metastatic Breast Cancer|Personalized Treatment Selection for Metastatic Breast Cancer|Terminated||Phase 2|97|Actual|M.D. Anderson Cancer Center|Study terminated according to early stopping rules.|4||Closed early for futility.|f||||f||||||||||2017-02-18 13:46:38.2449|2017-02-18 13:46:38.2449
NCT00780663|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-27|2011-06-13|||October 2008||2008-10-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma|A Phase 2, Multi-Center, Open Label Study Evaluating the Efficacy and Safety of Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma|Completed||Phase 2|25|Anticipated|Cylene Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:46:38.659946|2017-02-18 13:46:38.659946
NCT00780650|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2017-02-09|||May 2009||2009-05-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine|Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine|Active, not recruiting||Early Phase 1|56|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 13:46:38.763031|2017-02-18 13:46:38.763031
NCT00780637|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-07-14|||October 2008||2008-10-01|July 2016|2016-07-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|P1A3C||Brachial Artery t-PA Release in Heart Transplant Recipients|Characterization of Brachial Arterial t-PA Release, Vasodilator Function, and Vascular Compliance and Correlation With Fibrinolytic Balance, Oxidative Stress, and Inflammation Measures in Heart Transplant Recipients (SCCOR Project 1, Aim 3C)|Withdrawn||N/A|0|Actual|Vanderbilt University||1||Bradykinin Shortage, SCCOR expired prior to BK availability, lack of enrollment.|t||||t||||||||||2017-02-18 13:46:38.862191|2017-02-18 13:46:38.862191
NCT00780624|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-04-20|||January 2008||2008-01-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Nasal Intermittent Positive Pressure Ventilation In Newborn Infants With Respiratory Distress Syndrome|Nasal Intermittent Positive Pressure Ventilation In Newborn Infants With Respiratory Distress Syndrome|Completed||N/A|100|Actual|Third Military Medical University||2|||f||||t||||||||Undecided||2017-02-18 13:46:39.149324|2017-02-18 13:46:39.149324
NCT00780611|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2015-03-16|||November 2008||2008-11-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|GCC0832||Investigating the Improvement in 4D CT Images Using AV Biofeedback|Investigating the Improvement in 4D CT Images Using Audiovisual Biofeedback: An Intra-fraction and an Inter-fraction Evaluation.|Completed||N/A|25|Actual|University of Maryland|||1||f||||t||||||||||2017-02-18 13:46:39.251855|2017-02-18 13:46:39.251855
NCT00780598|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2012-06-27|||October 2009||2009-10-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|OPAL||Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML|The OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects With Treatment Refractory or Relapsed Acute Myeloid Leukemia|Completed||Phase 2|76|Actual|Chroma Therapeutics||1|||f||||t||||||||||2017-02-18 13:46:39.355063|2017-02-18 13:46:39.355063
NCT00780585|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2014-12-18|||April 2007||2007-04-01|December 2014|2014-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED)|A Multi-center Cardiac Safety Study of Subjects Who Participated in Organon Sponsored Phase 1 and Phase 2 Completed and Discontinued Trials With Org 24448|Completed||N/A|95|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:46:39.499993|2017-02-18 13:46:39.499993
NCT00780572|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2015-11-18|2015-10-15||December 2008||2008-12-01|November 2015|2015-11-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|VA ADE||Implementation of Real-time ADE Surveillance and Decision Support|Implementation of Real-Time ADE Surveillance and Decision Support|Completed||N/A|595|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 13:46:39.59016|2017-02-18 13:46:39.59016
NCT00780559|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2017-01-24|||November 1, 2009|Actual|2009-11-01|January 2017|2017-01-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|INMED||Improving Neuropathy and Mobility in People With Early Diabetes|Improving Neuropathy and Mobility in Subjects With Early Diabetes|Active, not recruiting||Phase 2|142|Anticipated|VA Office of Research and Development||2|||f||||f||||||||No||2017-02-18 13:46:39.876892|2017-02-18 13:46:39.876892
NCT00780546|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2008-10-24|||October 2008||2008-10-01|October 2008|2008-10-01|July 2009|Anticipated|2009-07-01|May 2009|Anticipated|2009-05-01||Observational|||Spatial Epidemiology of Tuberculosis (TB) Infection|Spatial Epidemiology of Tuberculosis Infection|Unknown status|Not yet recruiting|N/A|1000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:46:39.986326|2017-02-18 13:46:39.986326
NCT00780533|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2008-10-24|||August 2008||2008-08-01|October 2008|2008-10-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Observational|||Changes in and Determinants of Movement Performance, Functional Status, and Health-Related Quality of Life After Stroke Rehabilitation|Changes in and Determinants of Movement Performance, Functional Status, and Health-Related Quality of Life After Stroke Rehabilitation|Unknown status|Active, not recruiting|N/A|70|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-02-18 13:46:40.084587|2017-02-18 13:46:40.084587
NCT00780520|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2008-10-24|||June 2007||2007-06-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Effect of Glutamine on Systemic Inflammation During Human Experimental Endotoxemia|The Effect of Glutamine Infusion on the Inflammatory Response and HSP-70 in BMNCs During Human Experimental|Completed||N/A|8|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:46:40.167856|2017-02-18 13:46:40.167856
NCT00779818|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||October 2008||2008-10-01|October 2008|2008-10-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Electrical Acupuncture and Laser Therapy for Low Back Pain|Electrical Acupuncture and Laser Therapy for Low Back Pain|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 13:46:48.887886|2017-02-18 13:46:48.887886
NCT00780507|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2013-05-29|||August 2007||2007-08-01|May 2013|2013-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Fecal Biomarker Study for Patients With Ulcerative Colitis|Fecal Biomarker Study for Patients From a Once Daily Study for Efficacy in a Ulcerative Colitis Maintenance Study|Completed||Phase 3|89|Actual|Warner Chilcott|||2||f||||f||||||None Retained|"~     Human feces protein biomarkers Enrollment is number of specimens rather than number of~     subjects~   "|||2017-02-18 13:46:40.266017|2017-02-18 13:46:40.266017
NCT00780494|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2012-09-03|||February 2009||2009-02-01|September 2012|2012-09-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma|A Phase II Study of Capecitabine, Carboplatin, and Bevacizumab for Metastatic or Unresectable Gastroesophageal Junction and Gastric Adenocarcinoma|Unknown status|Recruiting|Phase 2|35|Anticipated|Stanford University||1|||f||||t||||||||||2017-02-18 13:46:40.407743|2017-02-18 13:46:40.407743
NCT00780481|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-07-14|||January 2007||2007-01-01|July 2016|2016-07-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|P1A3B||Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation|Characterization of Brachial Arterial t-PA Release, Vasodilator Function, and Vascular Compliance and Correlation With Fibrinolytic Balance, Oxidative Stress, and Inflammation Measures (SCCOR Project 1 Aim 3B)|Terminated||N/A|13|Actual|Vanderbilt University||1||Lack of enrollment due to strict inclusion/exclusion criteria. Bradykinin shortage|t||||t||||||||||2017-02-18 13:46:40.507799|2017-02-18 13:46:40.507799
NCT00780468|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2014-03-26|||October 2008||2008-10-01|March 2014|2014-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Pilot Study to Evaluate a Revised Method of Assessing Food in a Commercial Weight Management Program Format|A Pilot Study to Evaluate a Revised Method of Assessing Food in a Commercial Weight Management Program Format|Completed||N/A|134|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 13:46:40.608294|2017-02-18 13:46:40.608294
NCT00780455|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-05-08|2013-01-22||October 2008||2008-10-01|May 2015|2015-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Rehabilitation Study in MS Patients|Multicenter, Open Label, Randomized and Parallel Group Phase IV Pilot Study Evaluating the Effectiveness of Functional Rehabilitation Protocol in RRMS Patients Treated With Betaferon®|Terminated||Phase 4|4|Actual|Bayer|Due to the very low number of patients enrolled in the study, no statistical report was done. Study was early terminated.|2|||f||||f||||||||||2017-02-18 13:46:40.705312|2017-02-18 13:46:40.705312
NCT00780442|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-24|||September 2006||2006-09-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals|D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals|Completed||Phase 2|28|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 13:46:41.337498|2017-02-18 13:46:41.337498
NCT00780429|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2008-10-24|||June 2006||2006-06-01|October 2008|2008-10-01||||||||Observational|||Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients|Evaluation of Pharmacokinetic and Pharmacodynamic Parameters in Renal Transplant Patients Receiving Mycophenolic Acid and Stable for at Least 3 Months|Unknown status|Active, not recruiting|N/A|54|Actual|IRCCS Policlinico S. Matteo|||3||f||||f||||||||||2017-02-18 13:46:41.438412|2017-02-18 13:46:41.438412
NCT00780416|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2014-04-16|2012-06-05||November 2008||2008-11-01|April 2014|2014-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C|A Phase 3 Study of MP-424 in Combination With Peginterferon Alfa-2b and Ribavirin, in Treatment-Naïve Subjects With Genotype 1 Hepatitis C|Completed||Phase 3|189|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 13:46:41.517251|2017-02-18 13:46:41.517251
NCT00780403|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-09-21|2010-02-17||August 2005||2005-08-01|September 2015|2015-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)|A Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications|Completed||Phase 4|220|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:46:41.965741|2017-02-18 13:46:41.965741
NCT00780390|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2014-12-19|||January 2008||2008-01-01|December 2014|2014-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|CRPS||Autonomic Dysfunction and Spinal Cord Stimulation in Complex Regional Pain Syndrome|Autonomic Dysfunction and Spinal Cord Stimulator in Complex Regional Pain Syndrome|Terminated||Phase 4|10|Actual|Vanderbilt University||2||Lack of enrollment and discontinued funding|f||||f||||||||||2017-02-18 13:46:42.191427|2017-02-18 13:46:42.191427
NCT00780377|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2009-06-24|||October 2008||2008-10-01|June 2009|2009-06-01|May 2011|Anticipated|2011-05-01|January 2011|Anticipated|2011-01-01||Interventional|P1A4D||Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients|The Effects of Cardiac Innervation on Intra-Coronary t-PA Release|Unknown status|Recruiting|N/A|100|Anticipated|Vanderbilt University||1|||t||||t||||||||||2017-02-18 13:46:42.30523|2017-02-18 13:46:42.30523
NCT00780364|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2015-05-29|||March 2008||2008-03-01|June 2012|2012-06-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Observational|||Sour Taste and Cold Temperature in Dysphagia|Sour Taste and Cold Temperature Effects on Pharyngeal Transit Time After Ischemic Stroke:Anatomic and Functional Bases.|Terminated||N/A|30|Actual|UPECLIN HC FM Botucatu Unesp|||1||f||||f||||||||||2017-02-18 13:46:42.398419|2017-02-18 13:46:42.398419
NCT00780351|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2009-10-21|||October 2008||2008-10-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|||||Observational|||Dosing Vancomycin in Patients on Sustained Low Efficiency Daily Hemodiafiltration (SLEDD-f)|Pharmacokinetics and Dosing of Vancomycin in Sustained Low Efficiency Daily Hemodiafiltration (SLEDD-f)|Completed||N/A|15|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     serum~   "|||2017-02-18 13:46:42.488397|2017-02-18 13:46:42.488397
NCT00780338|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2015-05-08|2014-11-04||June 2008||2008-06-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|January 2013|Actual|2013-01-01||Interventional|AGTO||Enhancing Prevention Capacity With Developmental Assets and Getting to Outcomes|Enhancing Prevention Capacity With Developmental Assets and Getting to Outcomes|Completed||Phase 2|376|Actual|RAND||2|||f||||f||||||||||2017-02-18 13:46:42.605462|2017-02-18 13:46:42.605462
NCT00779415|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-02-26|||July 2008||2008-07-01|February 2015|2015-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Long Term Prognosis of MRI Diagnosed Partial Thickness Tears of the Rotator Cuff|Long Term Prognosis of MRI Diagnosed Partial Thickness Tears of the Rotator Cuff|Completed||N/A|10|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-02-18 13:46:59.073386|2017-02-18 13:46:59.073386
NCT00780325|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2014-02-05|||October 2008||2008-10-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition|A Single Center, Double-blind, Placebo-controlled Phase I Single-dose Cross-over Study in Healthy Subjects to Investigate the Inhibitory Effect of CG100649, Celecoxib, Naproxen, and Acetazolamide on the Activity of Cyclooxygenases (COX-1, COX-2) and Carbonic Anhydrases (CA-I, CA-II)|Terminated||Phase 1|26|Actual|University of Pennsylvania||6||"A total of three parts were planned for this study. The sponsor funded only Part 1, so that~   neither Part 2 nor Part 3 of this study has been conducted."|f||||f||||||||||2017-02-18 13:46:43.229452|2017-02-18 13:46:43.229452
NCT00780312|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2013-07-01|||December 2008||2008-12-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|HOHF||Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer|Physiotherapy Versus no Physiotherapy to Patients Suffering From Head and Neck Cancer Undergoing Radiotherapy Treatment|Completed||Phase 2|97|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:46:43.360168|2017-02-18 13:46:43.360168
NCT00780299|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-06-23|||October 2008||2008-10-01|June 2016|2016-06-01|November 2016|Anticipated|2016-11-01|June 2016|Actual|2016-06-01||Interventional|Hyperdia||Hemodynamic Efficiency of an Hemodialysis Treatment With High Permeability in Post-resuscitation Shock|Hemodynamic Efficiency of an Hemodialysis Treatment With High Permeability (HDHP) During the Early Period of Post-resuscitation Shock|Active, not recruiting||Phase 3|38|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:46:43.65929|2017-02-18 13:46:43.65929
NCT00780286|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2015-04-14|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:46:43.764581|2017-02-18 13:46:43.764581
NCT00780273|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2014-08-18|2014-03-17||September 2008||2008-09-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in Anterior Part of Mandible and Restored With Fixed Prostheses|Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in the Anterior Part of the Mandible and Restored With Fixed Prostheses: a Randomized, Split-mouth, Masked, Prospective, Open, Comparison, Monocenter Trial|Completed||Phase 4|19|Actual|Dentsply International||2|||f||||f||||||||||2017-02-18 13:46:43.8154|2017-02-18 13:46:43.8154
NCT00780260|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2013-12-10|||May 2007||2007-05-01|December 2013|2013-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Case Management Alternatives for African American Women at High Risk for HIV|Case Management Alternatives for African American Women at High Risk for HIV|Completed||Phase 3|562|Actual|Nova Southeastern University||2|||f||||f||||||||||2017-02-18 13:46:44.073313|2017-02-18 13:46:44.073313
NCT00780247|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2008-10-24|||July 2008||2008-07-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|Alaska/Hawaii||Environmental Influences on Vitamin D Status|Environmental Influences on Vitamin D Status|Completed||N/A|50|Actual|Creighton University|||2||f||||f||||||||||2017-02-18 13:46:44.16762|2017-02-18 13:46:44.16762
NCT00780234|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-09-30|||August 2009||2009-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|June 2016|Actual|2016-06-01||Interventional|||Pioglitazone for Lung Cancer Chemoprevention|Pioglitazone for Lung Cancer Chemoprevention|Active, not recruiting||Phase 2|391|Anticipated|VA Office of Research and Development||2|||f||||t||||||||No||2017-02-18 13:46:44.258845|2017-02-18 13:46:44.258845
NCT00780221|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2008-10-24|||October 2008||2008-10-01|October 2008|2008-10-01|December 2010|Anticipated|2010-12-01|October 2010|Anticipated|2010-10-01||Observational|CRP-Han||C-Reactive Protein (CRP) Gene Variants and Coronary Artery Disease in a Chinese Han Population|CRP Gene Variants and Coronary Artery Disease in a Chinese Han Population|Unknown status|Recruiting|N/A|1000|Anticipated|Fudan University|||2||f||||t||||||Samples With DNA|"~     Blood sample will be examined and DNA variants be analyzed.~   "|||2017-02-18 13:46:44.36993|2017-02-18 13:46:44.36993
NCT00780208|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2009-08-14|||April 2007||2007-04-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD|The Evaluation of the Safety and Efficacy of the Methylphenidate Patch in Former Stimulant Users With ADHD|Completed||N/A|20|Anticipated|Medical University of South Carolina||1|||f||||f||||||||||2017-02-18 13:46:44.456312|2017-02-18 13:46:44.456312
NCT00780195|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2014-12-10|||July 1998||1998-07-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|November 2000|Actual|2000-11-01||Interventional|||Metabolic Adaptations to Diabetes in African Americans|Metabolic Adaptations to Diabetes|Completed||N/A|16|Actual|Vanderbilt University||4|||f||||f||||||||||2017-02-18 13:46:44.655133|2017-02-18 13:46:44.655133
NCT00780182|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2010-02-01|||October 2008||2008-10-01|February 2010|2010-02-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers|An Open-Label, Randomized, 3-Way Crossover, Single-Dose Study in Healthy Volunteers Comparing the Bioavailability of CMX001 (HDP-Cidofovir Conjugate) Delivered as a Tablet Formulation vs a Solution Formulation and the Effect of Food on CMX001 Bioavailability|Completed||Phase 1|24|Anticipated|Chimerix||1|||f||||t||||||||||2017-02-18 13:46:44.754058|2017-02-18 13:46:44.754058
NCT00780169|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2013-05-09|||October 2008||2008-10-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|May 2011|Actual|2011-05-01||Interventional|||Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer|A Phase I Study of Sorafenib (Nexavar®) in Combination With FOLFIRI as First Line Therapy for Metastatic Colorectal Cancer|Completed||Phase 1|16|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-02-18 13:46:44.841612|2017-02-18 13:46:44.841612
NCT00780156|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2013-09-27|||November 2008||2008-11-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|ITALIC||The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontinuation of Clopidogrel|The ITALIC Study Is There A LIfe for DES After Discontinuation of Clopidogrel : The ITALIC Study|Terminated||N/A|1235|Actual|French Cardiology Society|||1|"No more information will be given. No consequences on security and treatment of patients:~   standard therapy is already performed for all patients."|f||||t||||||||||2017-02-18 13:46:44.94965|2017-02-18 13:46:44.94965
NCT00780143|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2014-10-27|||November 2007||2007-11-01|November 2013|2013-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia|Phase I/II Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia|Terminated||Phase 1/Phase 2|35|Anticipated|PharmaMar||1||Poor recruitment|f||||f||||||||||2017-02-18 13:46:45.056797|2017-02-18 13:46:45.056797
NCT00780117|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2012-07-25|||June 2008||2008-06-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Observational|Currarino||Characterization of At-risk Population for Pre-sacral Tumor in CURRARINO Syndrome|Characterization of At-risk Population and Prognosis Factors for SACRO-coccygeal Teratoma in CURRARINO Syndrome. A Clinical, Molecular and Pathological Study.|Completed||N/A|57|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"~     Pathological tumoral tissue analysis after surgical removal · Annual serum alpha-foeto~     protein level monitoring~   "|||2017-02-18 13:46:45.268155|2017-02-18 13:46:45.268155
NCT00780104|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-06-07|||July 2007||2007-07-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|UPCC 02407||Sirolimus in Combination With MEC in High Risk Myeloid Leukemias|A Prospective Single Institution Pilot Study Evaluating the Pharmacokinetics of Sirolimus in Combination With MEC (Mitoxantrone + Etoposide + Cytarabine) in Patients With High Risk Leukemias|Completed||Phase 1|15|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 13:46:45.363019|2017-02-18 13:46:45.363019
NCT00780091|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2010-08-11|||May 2008||2008-05-01|August 2010|2010-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|OPTIMON||Optimisation of Monitoring for Clinical Research Studies|Evaluation of Efficacy and Cost of Two Monitoring Strategies for Public Clinical Research - OPTIMON: Optimisation of Monitoring for Clinical Research Studies|Completed||N/A|1800|Anticipated|University Hospital, Bordeaux|||2||f||||t||||||||||2017-02-18 13:46:45.474336|2017-02-18 13:46:45.474336
NCT00780078|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2017-01-03|||October 2008||2008-10-01|December 2016|2016-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|EVAKIN||Clinical Evaluation of Swallowing Disorders as a Predictor of Extubation Failure|Clinical Evaluation by Physical Therapist of Swallowing Disorders as a Predictor of Extubation Failure in Patients Intubated Orotracheally for Over 6 Days|Completed||N/A|160|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-02-18 13:46:45.586225|2017-02-18 13:46:45.586225
NCT00779246|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2012-02-16|2011-08-01||June 2008||2008-06-01|February 2012|2012-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections|Cost-Effectiveness of Chlorhexidine Bathing vs. Active Surveillance Cultures to Prevent Acquisition of Methicillin-resistant Staphylococcus Aureus and Other Hospital-Acquired Infections: A Pilot Study|Completed||N/A|1518|Actual|Christiana Care Health Services|"Single-center, single-unit study limits generalizability~MRSA acquisition rates lower during both intervention groups than expected, resulting in under-powering of study~Baseline rate of acquisition of colonization unknown"|2|||f||||f||||||||||2017-02-18 13:46:45.69882|2017-02-18 13:46:45.69882
NCT00779233|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||September 2004||2004-09-01|October 2008|2008-10-01|October 2004|Actual|2004-10-01|September 2004|Actual|2004-09-01||Interventional|||Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions|A Study to Compare the Relative Bioavailability of Ranbaxy and GlaxoSmithKline Formulation of Zidovudine Tablets 300 mg in Healthy Adult Volunteers Under Fasting Conditions.|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:46:46.082931|2017-02-18 13:46:46.082931
NCT00779220|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-03-24|||October 2008||2008-10-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|February 2010|Actual|2010-02-01||Interventional|||A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis|A Randomized, Double-blind, Parallel-group, Study to Evaluate the Efficacy, Safety and PK/PD of Ocrelizumab in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy|Terminated||Phase 2|152|Actual|Chugai Pharmaceutical||4|||f||||f||||||||||2017-02-18 13:46:46.18532|2017-02-18 13:46:46.18532
NCT00779207|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-23|||November 2006||2006-11-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Weight Loss and Exercise on Liver and Muscle Fat in Obese Elderly|Effect of Weight Loss and Exercise on Intrahepatic and Intramyocellular Fat in Obese Older Adults|Completed||Phase 3|20|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 13:46:46.301533|2017-02-18 13:46:46.301533
NCT00779194|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-10-12|||October 2008||2008-10-01|October 2016|2016-10-01||||December 2015|Actual|2015-12-01||Interventional|Rapamune||Prospective Study of Rapamycin for the Treatment of SLE|Prospective Study of Rapamycin for the Treatment of SLE|Completed||Phase 2|40|Actual|State University of New York - Upstate Medical University||4|||f||||t||||||||||2017-02-18 13:46:46.416003|2017-02-18 13:46:46.416003
NCT00779181|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-12-16|||October 2008||2008-10-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension|A Phase 2, Dose-Ranging Study of the Safety and Efficacy of ADX415 Immediate-Release in the Treatment of Essential Hypertension|Completed||Phase 2|80|Actual|Addrenex Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 13:46:46.517264|2017-02-18 13:46:46.517264
NCT00780065|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-24|||September 2008||2008-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:46:46.623403|2017-02-18 13:46:46.623403
NCT00780052|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-24|2016-09-23|||September 2002||2002-09-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|UPCC 04701||Infusional C-myb ASODN in Advanced Hematologic Malignancies|Infusional C-myb Antisense Oligodeoxynucleotide in Advanced Hematological Malignancies|Completed||Phase 1|13|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 13:46:46.667953|2017-02-18 13:46:46.667953
NCT00780039|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-05-19|||October 2003||2003-10-01|May 2015|2015-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)|Phase II, Open-Label, Study of CAELYX and Carboplatin Intermediate Platinum-Sensitive (6-12 Months Treatment-free Interval) Relapsed Epithelial Ovarian Cancer.|Completed||Phase 2|58|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:46:46.761999|2017-02-18 13:46:46.761999
NCT00780026|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2011-10-18|||July 2008||2008-07-01|October 2011|2011-10-01|July 2012|Anticipated|2012-07-01|December 2011|Anticipated|2011-12-01||Interventional|||Intraoperative Glucose Control in Liver Transplant|Effect Of Intraoperative Strict Glycemic Control During Liver Transplantation On Postoperative Morbidity And Mortality|Unknown status|Recruiting|N/A|180|Anticipated|University of Michigan||2|||f||||f||||||||||2017-02-18 13:46:46.855117|2017-02-18 13:46:46.855117
NCT00780013|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-23|||May 2002||2002-05-01|October 2008|2008-10-01|June 2002|Actual|2002-06-01|May 2002|Actual|2002-05-01||Interventional|||Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions|Crossover Bioavailability Study on Metformin Formulations Comparing Metformin Hydrochloride Liquid 500 mg/5mL of Ranbaxy Laboratories With GlucophageA® 1000 mg Tablets of Bristol-Myers Squibb in Healthy, Adult, Male and Female Volunteers Under Fed Conditions, Following a 1000 mg Dose|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:46:46.958632|2017-02-18 13:46:46.958632
NCT00780000|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-10-12||2010-09-10|April 2008||2008-04-01|October 2015|2015-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer|Phase 2 Clinical Trial of Intravenous Alvespimycin [KOS-1022] in Patients With Her2 Positive Breast Cancer|Terminated||Phase 2|4|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 13:46:47.061683|2017-02-18 13:46:47.061683
NCT00779987|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-12-02|||October 2008||2008-10-01|October 2008|2008-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Autologous Serum Efficacy Study in Patients With Severe Dry Eye|Autologous Serum Efficacy Study in Patients With Severe Dry Eye|Completed||Phase 2|12|Actual|University of Chile||2|||f||||t||||||||||2017-02-18 13:46:47.151231|2017-02-18 13:46:47.151231
NCT00779974|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-02-25|||August 2008||2008-08-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Electromyography Evaluation of Subscapularis Function After Total Shoulder Arthroplasty|Electromyography Evaluation of Subscapularis Function After Total Shoulder|Completed||N/A|32|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-02-18 13:46:47.257479|2017-02-18 13:46:47.257479
NCT00779961|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||April 2008||2008-04-01|October 2008|2008-10-01|April 2013|Anticipated|2013-04-01|April 2011|Anticipated|2011-04-01||Interventional|||An Investigation for the Optimal Timing of a Cleft Palate Repair|An Investigation for the Optimal Timing of a Cleft Palate Repair|Unknown status|Recruiting|Early Phase 1|320|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 13:46:47.366522|2017-02-18 13:46:47.366522
NCT00779948|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-08-05|||December 2008||2008-12-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|January 2012|Actual|2012-01-01||Observational|DIFINE||Dynamic Internal Fixation of Femoral Neck Fractures|Dynamic Internal Fixation of Femoral Neck Fractures|Completed||N/A|171|Actual|Aesculap AG|||2||f||||f||||||||||2017-02-18 13:46:47.66702|2017-02-18 13:46:47.66702
NCT00779935|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-04-15|||October 2004||2004-10-01|April 2015|2015-04-01|February 2007|Actual|2007-02-01|October 2005|Actual|2005-10-01||Interventional|||Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)|Baseline Serum Vascular Endothelial Growth Factor (VEGF) Concentration as Predictive Factor of Response to Infliximab (Remicade) Therapy in Patients With Active Ankylosing Spondylitis Despite Conventional Treatment: a Multicenter Pilot Study|Completed||Phase 4|44|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:46:47.766877|2017-02-18 13:46:47.766877
NCT00779922|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-10-10|||November 2008||2008-11-01|October 2016|2016-10-01||||September 2012|Actual|2012-09-01||Interventional|||Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function||Completed||Phase 2|39|Actual|Poitiers University Hospital||1|||f||||f||||||||||2017-02-18 13:46:47.853434|2017-02-18 13:46:47.853434
NCT00779909|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2012-08-02|||December 2008||2008-12-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|May 2011|Actual|2011-05-01||Interventional|||Dose-dependent Anti-inflammatory Effects of Vitamin D in a Human Gingivitis Model|Dose-dependent Anti-inflammatory Effects of Vitamin D in a Human Gingivitis Model|Completed||N/A|35|Actual|Boston University||4|||f||||f||||||||||2017-02-18 13:46:47.943736|2017-02-18 13:46:47.943736
NCT00779896|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2008||2008-10-01|October 2008|2008-10-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study|Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study|Unknown status|Recruiting|Phase 1/Phase 2|15|Anticipated|McGill University||1|||f||||f||||||||||2017-02-18 13:46:48.051788|2017-02-18 13:46:48.051788
NCT00779883|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||June 2006||2006-06-01|October 2008|2008-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)|A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)|Completed||Phase 1|9|Actual|Memgen, LLC||1|||f||||t||||||||||2017-02-18 13:46:48.149132|2017-02-18 13:46:48.149132
NCT00779870|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-03-25|||October 2008||2008-10-01|June 2011|2011-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Airway Smooth Muscle and Asthma Severity|Evaluating the Role of Oxidant/Anti-oxidant Balance and the Relationship of Asthma Severity on Airway Smooth Muscle Proliferation, Migration and Cytokine Release.|Completed||N/A|52|Actual|Imperial College London|||4||f||||f||||||Samples With DNA|"~     endobronchial biopsies and cultured airway smooth muscle cells~   "|||2017-02-18 13:46:48.269111|2017-02-18 13:46:48.269111
NCT00779857|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2013-05-31|2013-02-11||September 2008||2008-09-01|May 2013|2013-05-01|October 2011|Actual|2011-10-01|October 2009|Actual|2009-10-01||Interventional|EXCLUDE|70 patients treated with AtriClip LAA Exclusion System|AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery|Exclusion of the Left Atrial Appendage With the AtriClip LAA Exclusion Device in Patients Undergoing Concomitant Cardiac Surgery|Completed||Phase 2|70|Actual|AtriCure, Inc.||1|||f||||t||||||||||2017-02-18 13:46:48.375616|2017-02-18 13:46:48.375616
NCT00779844|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-09-22|||December 2008||2008-12-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|LoopObese||Anesthesic Propofol and Remifentanil Requirements in Obese Patients|Intravenous Anesthesia in Obese Patients: Propofol and Remifentanil Requirements|Terminated||Phase 4|63|Actual|Hopital Foch||2||difficulty in recruiting|f||||f||||||||||2017-02-18 13:46:48.669749|2017-02-18 13:46:48.669749
NCT00779831|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||June 2004||2004-06-01|October 2008|2008-10-01|December 2004|Actual|2004-12-01|June 2004|Actual|2004-06-01||Interventional|||Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions|Comparative, Randomized, Single Dose, 2 Way Crossover Bioavailability Study of Ranbaxy and Warner - Lambert (Sudafed ® 12 Hour) 120 mg Pseudoephedrine Hydrochloride Extended - Release Tablets in Healthy Adult Volunteers Under Fasting Conditions.|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:46:48.777108|2017-02-18 13:46:48.777108
NCT00776958|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2014-07-30|||July 2008||2008-07-01|July 2014|2014-07-01||||July 2014|Actual|2014-07-01||Observational|||Lynne Cohen Consortium Project: Multi-Center Database/Registry|Multi - Center Database/Registry of Subjects at High Risk for Ovarian or Breast Cancer - A Lynne Cohen Consortium Project|Completed||N/A|176|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:47:44.420265|2017-02-18 13:47:44.420265
NCT00779805|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||June 2004||2004-06-01|October 2008|2008-10-01|October 2004|Actual|2004-10-01|June 2004|Actual|2004-06-01||Interventional|||Bioequivalence Study of Pseudoephedrine HCl 120 mg ER Tablets Under Fed Conditions|An Open Label, Balanced, Randomised, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Bioavailability Study on Pseudoephedrine Hydrochloride Formulations Comparing Pseudoephedrine Hydrochloride 120 mg ER Tablets of Ranbaxy Laboratories With Sudafed 120 mg ER Tablets of Pfizer Consumer Health Care in Healthy, Adult, Human Subjects Under Fed Conditions.|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:46:48.986894|2017-02-18 13:46:48.986894
NCT00779792|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||September 2008||2008-09-01|August 2008|2008-08-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|WA+TR_1||Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation|Comparison of Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Experimentally Induced Skin Irritation|Unknown status|Active, not recruiting|Phase 4|36|Actual|Odense University Hospital||1|||f||||t||||||||||2017-02-18 13:46:49.091347|2017-02-18 13:46:49.091347
NCT00779779|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2010-11-24|2010-06-29||November 2008||2008-11-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants|Reactogenicity and Safety of Two Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus Vaccine, Rotarix™ When Administered in Sri Lankan Infants Aged at Least 6 Weeks at the Time of First Vaccination.|Completed||Phase 4|522|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:46:49.206041|2017-02-18 13:46:49.206041
NCT00779766|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-09-08|2012-04-12||October 2008||2008-10-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|September 2011|Actual|2011-09-01||Interventional|||Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects|Efficacy, Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects|Completed||Phase 3|6081|Actual|GlaxoSmithKline|At the time of the event-triggered analysis at Month 24, some safety results remain blinded and are not presented here since the study is still ongoing. These results will be updated once they become available.|2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:46:49.501917|2017-02-18 13:46:49.501917
NCT00779753|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2013-08-01|||July 2008||2008-07-01|August 2013|2013-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Determination of Lysine Requirement in the Parenterally Fed Neonate|Determination of Lysine Requirement in the Parenterally Fed Neonate|Completed||N/A|6|Actual|The Hospital for Sick Children||1|||f||||t||||||||||2017-02-18 13:46:52.63429|2017-02-18 13:46:52.63429
NCT00779740|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-05-04|||February 2005||2005-02-01|May 2015|2015-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)|Clinical Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray|Completed||Phase 3|102|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:46:52.73649|2017-02-18 13:46:52.73649
NCT00779727|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-10-23|||October 1999||1999-10-01|September 2008|2008-09-01|June 2004||2004-06-01|||||Interventional|||Post-Cesarean Wound Drainage is Not Necessary in Women at Increased Risk of Hemorrhage||Terminated||Phase 4|||University of Zurich|||||f||||||||||||||2017-02-18 13:46:52.828371|2017-02-18 13:46:52.828371
NCT00779714|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2008||2008-10-01|October 2008|2008-10-01|April 2013|Anticipated|2013-04-01|October 2012|Anticipated|2012-10-01||Interventional|ChemoSensMM||Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC|Prospectively Randomized Phase III Study of an Individualized Sensitivity-Directed Combination Chemotherapy Versus DTIC as First-Line Treatment in Stage IV Metastatic Melanoma|Unknown status|Recruiting|Phase 3|360|Anticipated|University of Wuerzburg||2|||f||||t||||||||||2017-02-18 13:46:52.906677|2017-02-18 13:46:52.906677
NCT00779701|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-10-31|2015-05-22||March 2007||2007-03-01|October 2016|2016-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation|Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation|Completed||Phase 4|27|Actual|Temple University||1|||f||||f||||||||||2017-02-18 13:46:53.049028|2017-02-18 13:46:53.049028
NCT00779688|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2011-02-09|||November 2008||2008-11-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|September 2009|Actual|2009-09-01||Observational|||A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers|Endoscopic Retrograde CholangioPancreatography Endomicroscopy Registry Outcomes Database|Completed||N/A|130|Actual|Mauna Kea Technologies|||1||f||||f||||||||||2017-02-18 13:46:53.255324|2017-02-18 13:46:53.255324
NCT00779675|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-10-30|2012-09-27||October 2008||2008-10-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|October 2011|Actual|2011-10-01||Observational|REALITY||Assessment of Long-Term Infliximab for Psoriasis (P05319)|Real-World Assessment of Long-Term Infliximab Therapy for Psoriasis|Completed||N/A|660|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:46:55.686662|2017-02-18 13:46:55.686662
NCT00779662|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||February 2008||2008-02-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||The Prevalence of Rheumatic Heart Disease in School Children in Fiji|The Prevalence of Rheumatic Heart Disease in School Children in Fiji|Unknown status|Active, not recruiting|N/A|2000|Anticipated|Queensland Institute of Medical Research|||1||f||||||||||||||2017-02-18 13:46:56.179872|2017-02-18 13:46:56.179872
NCT00779649|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2009-10-29|||September 2008||2008-09-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|LUSTER||MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial|MoviPrep® Versus HalfLytely® for Colon Cleansing: An Investigator-blinded, Randomized Trial.|Completed||Phase 4|220|Anticipated|Research Associates of New York, LLP||2|||f||||f||||||||||2017-02-18 13:46:56.248464|2017-02-18 13:46:56.248464
NCT00779636|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-04-27|||July 2003||2003-07-01|April 2015|2015-04-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)|Efficacy and Safety of Desloratadine 10 mg Daily vs. Placebo in Subjects With Allergic Airway Disease During the Pollen Season|Completed||Phase 4|506|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:46:56.547973|2017-02-18 13:46:56.547973
NCT00779623|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2008-10-23|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:46:56.636794|2017-02-18 13:46:56.636794
NCT00779610|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||October 2008||2008-10-01|October 2008|2008-10-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||The Effects of Passive and Active Vibration Therapy on Grip Strength and Myoelectric Activity|The Effects of Passive and Active Vibration Therapy on Grip Strength and Myoelectric Activity|Unknown status|Recruiting|Phase 1|40|Anticipated|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 13:46:56.683213|2017-02-18 13:46:56.683213
NCT00779597|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2010-08-26|||October 2008||2008-10-01|October 2008|2008-10-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Improvement of Self Management for Oncologic Patients With Pain|Improvement of Self Management Skills for Oncologic Patients With Pain Through a Trans Institutional Nursing Intervention: a Cluster Randomized Multi Center Study|Completed||N/A|208|Anticipated|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-02-18 13:46:56.767888|2017-02-18 13:46:56.767888
NCT00779584|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-02-25|||October 2008||2008-10-01|February 2015|2015-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Phase 1 Dose-escalation Study of a Cell Cycle Inhibitor With and Without Gemcitabine in Patients With Solid Tumors or Lymphoma (Study P05248)|A Phase 1 Dose-Escalation Study of SCH 900776 as Monotherapy and in Combination With Gemcitabine in Subjects With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|45|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:46:56.878467|2017-02-18 13:46:56.878467
NCT00779571|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2014-10-09|||October 2008||2008-10-01|October 2014|2014-10-01|February 2012|Actual|2012-02-01|September 2011|Actual|2011-09-01||Interventional|FEMIN||The Female Health Dietary Intervention Study|Treatment of PCOS (Polycystic Ovary Syndrome)in Morbidly Obese Women - A Randomized Controlled Prospective Dietary Intervention Study|Completed||N/A|61|Actual|The Hospital of Vestfold||2|||f||||f||||||||||2017-02-18 13:46:56.976691|2017-02-18 13:46:56.976691
NCT00779558|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-06-10|2015-05-28||November 2005||2005-11-01|June 2015|2015-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Heparin and the Reduction of Thrombosis (HART) Trial|Heparin and Catheter-related Thrombosis in Neonates and Infants Following Cardiac Surgery|Completed||N/A|90|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 13:46:57.085226|2017-02-18 13:46:57.085226
NCT00779545|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-04-08|||April 2004||2004-04-01|April 2015|2015-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)|Dose Finding and Dose Regimen Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis|Completed||Phase 2|455|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 13:46:57.571049|2017-02-18 13:46:57.571049
NCT00779532|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-09-23|||May 2008||2008-05-01|September 2015|2015-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802)|A Randomized, Double-blind, Placebo and Positive Controlled, Parallel Group Trial to Investigate the Effect of Multiple Doses of NOMAC-E2 on QT/QTc Interval in Healthy Women|Completed||Phase 1|189|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:46:57.669495|2017-02-18 13:46:57.669495
NCT00779519|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2011-06-08||2010-07-15|February 2009||2009-02-01|June 2011|2011-06-01||||December 2009|Actual|2009-12-01||Interventional|||Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss|A Prospective, Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multiple Dose, Multicenter Study to Assess Safety and Tolerability of TTP435 in Obese (Class 1-2) Subjects Over 8 Weeks of Treatment|Completed||Phase 2|100|Actual|vTv Therapeutics||2|||f||||f||||||||||2017-02-18 13:46:57.759378|2017-02-18 13:46:57.759378
NCT00779506|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2011-10-19|2010-05-20||November 2008||2008-11-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|QUENCH||Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)|A 8-week, Multi-Centre, Open-label, Non-comparative, Phase IV Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR) With Daily Dose 400mg-800mg in the Treatment of Acute Schizophrenic Patients|Completed||Phase 4|96|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:46:57.867049|2017-02-18 13:46:57.867049
NCT00779493|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-03-10|||November 2008||2008-11-01|March 2015|2015-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|CuTIBS||Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial|Study Title: Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial|Completed||Phase 4|17|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-02-18 13:46:58.211008|2017-02-18 13:46:58.211008
NCT00779480|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-06-14|||January 2009||2009-01-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)|Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia|Terminated||Phase 1|14|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1||Failure to demonstrate a tolerable dose that had potential for efficacy.|f||||t||||||||||2017-02-18 13:46:58.317239|2017-02-18 13:46:58.317239
NCT00779467|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2014-06-04|||October 2008||2008-10-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Epidural Neostigmine for Labor Pain|Epidural Neostigmine Dose Response for the Treatment of Labor Pain|Completed||N/A|157|Actual|Wake Forest University Health Sciences||4|||f||||t||||||||||2017-02-18 13:46:58.472229|2017-02-18 13:46:58.472229
NCT00779454|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-06-06|||September 2008||2008-09-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma|Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma|Active, not recruiting||Phase 2|70|Anticipated|Vejle Hospital||2|||f||||t||||||||||2017-02-18 13:46:58.739086|2017-02-18 13:46:58.739086
NCT00779441|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||August 2005||2005-08-01|October 2008|2008-10-01|November 2005|Actual|2005-11-01|September 2005|Actual|2005-09-01||Interventional|||Bioequivalence Study of Zolpidem 10 mg Tablets Under Fed Conditions|An Open Label, Relative Bioavailability Study of 10 mg Zolpidem Tablet Under Non-Fasting Conditions|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:46:58.849795|2017-02-18 13:46:58.849795
NCT00779428|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-09-23||2015-09-23|July 2006||2006-07-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating Tanespimycin|Phase 2 Clinical Trial of Tanespimycin in Patients With Advanced Malignancies After Failure of Previous Anti-cancer Therapy Regimens Who Have Participated on a Prior Protocol Investigating Tanespimycin|Completed||Phase 2|6|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 13:46:58.961584|2017-02-18 13:46:58.961584
NCT00779402|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-04-21|||September 2001||2001-09-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|August 2006|Actual|2006-08-01||Interventional|PROTECT||Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer|Autologous PAP-loaded Dendritic Cell Vaccine (APC8015, Provenge [TM]) in Patients With Non-metastatic Prostate Cancer Who Experience PSA Elevation Following Radical Prostatectomy: a Randomized, Controlled, Double-blind Trial|Completed||Phase 3|176|Actual|Dendreon||2|||f||||||||||||||2017-02-18 13:46:59.18562|2017-02-18 13:46:59.18562
NCT00779389|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-01-12|||January 2009||2009-01-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family|Comparison of Biomarker Modulation by Inhibition of EGFR and/or Src Family Kinases Using Erlotinib and Dasatinib in Head and Neck Lung Cancers|Completed||Phase 1|58|Actual|University of Pittsburgh||4|||f||||f||||||||||2017-02-18 13:46:59.314769|2017-02-18 13:46:59.314769
NCT00779376|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||February 2005||2005-02-01|October 2008|2008-10-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|||Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Ranbaxy and GlaxoSmithKline (Retrovir ® ) 300 mg Zidovudine Tablets in Healthy Adult Volunteers Under Fed Conditions|Completed||N/A|68|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:46:59.431126|2017-02-18 13:46:59.431126
NCT00779363|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-09-21|||June 2004||2004-06-01|April 2013|2013-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Prospective, Clinical Trial of the TANTALUS® System in Treatment of Obese to Morbidly Obese Patients|A Prospective Clinical Trial of the TANTALUS System In Treatment of Obese to Morbidly Obese Patients|Completed||N/A|14|Actual|MetaCure (USA), Inc.||1|||f||||t||||||||||2017-02-18 13:46:59.531454|2017-02-18 13:46:59.531454
NCT00779350|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||August 2005||2005-08-01|October 2008|2008-10-01|October 2005|Actual|2005-10-01|August 2005|Actual|2005-08-01||Interventional|||Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting Conditions|A Study to Compare the Relative Bioavailability of Ranbaxy and Pfizer Formulations of Sertraline 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions.|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:46:59.635673|2017-02-18 13:46:59.635673
NCT00779337|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2012-05-21|||October 2008||2008-10-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|EPL||Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas|Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas|Completed||Phase 1|8|Actual|Queensland Institute of Medical Research||1|||f||||f||||||||||2017-02-18 13:46:59.7456|2017-02-18 13:46:59.7456
NCT00779324|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2014-08-11||2014-07-27|August 2009||2009-08-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study|A Multi-Center, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic Traumatic Brain Injury Irritability and Aggression: A Replication Study|Completed||N/A|168|Actual|Carolinas Healthcare System||2|||f||||t||||||||||2017-02-18 13:46:59.843909|2017-02-18 13:46:59.843909
NCT00779311|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2011-10-31|2011-09-09||October 2008||2008-10-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer|A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer|Terminated||Phase 1|8|Actual|Accelerated Community Oncology Research Network|Early termination due to the MTD determined to be Dose Level 1, leading to a small number of subjects analyzed.|1||Dose limiting toxicity at the lowest planned dose level.|f||||f||||||||||2017-02-18 13:46:59.977751|2017-02-18 13:46:59.977751
NCT00779298|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-23||||||October 2008|2008-10-01||||||||Observational|||Effect of Commercial Rye Whole-Meal Bread on Postprandial Blood Glucose and Gastric Emptying in Healthy Subjects|Effect of Commercial Rye Whole-Meal Bread on Postprandial Blood Glucose and Gastric Emptying in Healthy Subjects|Completed||N/A|||Lund University Hospital|||1||f||||t||||||||||2017-02-18 13:47:00.841684|2017-02-18 13:47:00.841684
NCT00779285|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-06-18|2010-02-11||February 2006||2006-02-01|June 2015|2015-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)|Cardiac Safety Profile of Caelyx Therapy in Anthracyclin Pretreated Metastatic Breast Cancer Patients.|Terminated||Phase 4|1|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:47:00.913464|2017-02-18 13:47:00.913464
NCT00779272|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||September 2008||2008-09-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases|Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases|Completed||N/A|184|Anticipated|University of Zurich|||2||f||||f||||||||||2017-02-18 13:47:01.1065|2017-02-18 13:47:01.1065
NCT00779259|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2009-10-20|2009-05-27||August 2007||2007-08-01|October 2009|2009-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Drug - Drug Interaction Study Between Quinine Sulfate and Theophylline|A Pharmacokinetic Drug-Drug Interaction Study to Evaluate the Effect of Steady-State Quinine Sulfate on the Pharmacokinetics of Single-Dose Theophylline in Healthy Adult Males|Completed||Phase 1|24|Actual|Mutual Pharmaceutical Company, Inc.||3|||f||||f||||||||||2017-02-18 13:47:01.195432|2017-02-18 13:47:01.195432
NCT00779168|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-09-29|||September 2008||2008-09-01|September 2016|2016-09-01||||July 2017|Anticipated|2017-07-01||Interventional|||White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy|A Phase Ib Trial of Mushroom Powder in Biochemically Recurrent Prostate Cancer|Active, not recruiting||Phase 1|36|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:47:01.882579|2017-02-18 13:47:01.882579
NCT00779155|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2011-07-07|2011-05-13||August 2007||2007-08-01|July 2011|2011-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of Magnetic Fields for Treatment of Parkinson's Disease|A Double-blind, Sham-stimulation Controlled Study of the Application of Magnetic Fields Using the Jacobson Resonator for the Treatment of Parkinson's Disease.|Completed||Phase 2|12|Actual|pico-tesla Magnetic Therapies, LLC||2|||f||||t||||||||||2017-02-18 13:47:02.002136|2017-02-18 13:47:02.002136
NCT00776204|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2011-04-19|||May 2008||2008-05-01|April 2011|2011-04-01|February 2011|Actual|2011-02-01|July 2009|Actual|2009-07-01||Interventional|OCTDESI||The Optical Coherence Tomography Drug Eluting Stent Investigation|The Optical Coherence Tomography Drug Eluting Stent Investigation(OCTDESI)|Completed||N/A|60|Actual|Boston Scientific Corporation||3|||f||||t||||||||||2017-02-18 13:47:53.891892|2017-02-18 13:47:53.891892
NCT00779142|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2014-06-27|2014-05-27||September 2011||2011-09-01|June 2014|2014-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Patients with Recalcitrant Diabetic Macular Edema|Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies|Evaluation of the Utility of Intravitreal Methotrexate in Patients With Recalcitrant Diabetic Macular Edema in an Open Label, Nonrandomized, Uncontrolled, Interventional Pilot Trial|Terminated||N/A|2|Actual|Wake Forest University Health Sciences||1||recent research indicates Lucentis to be an effictive treatment|f||||f||||||||||2017-02-18 13:47:02.336|2017-02-18 13:47:02.336
NCT00779129|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-09-29|||March 2003||2003-03-01|September 2015|2015-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)|Phase II Trial of Caelyx and Cyclophosphamide in Metastatic Breast Cancer|Completed||Phase 2|70|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:47:02.571637|2017-02-18 13:47:02.571637
NCT00779116|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-04-06|2010-02-17||September 2005||2005-09-01|April 2015|2015-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)|A Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications|Completed||Phase 4|217|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:47:02.671506|2017-02-18 13:47:02.671506
NCT00779103|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-06-08|||September 2004||2004-09-01|June 2015|2015-06-01|April 2012|Actual|2012-04-01|August 2011|Actual|2011-08-01||Interventional|||Histrelin Subcutaneous Implant in Children With Central Precocious Puberty|Phase III, Open-Label Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Children With Central Precocious Puberty|Completed||Phase 3|36|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:47:02.906939|2017-02-18 13:47:02.906939
NCT00779090|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2007||2007-10-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|||Functional Residual Capacity (FRC) Guided Alveolar Recruitment Strategy|The Influence of a Functional Residual Capacity Guided Alveolar Recruitment Strategy After Open Endotracheal Suctioning on Oxygenation and Regional Ventilation|Completed||Phase 4|59|Actual|University of Luebeck||4|||f||||f||||||||||2017-02-18 13:47:03.006296|2017-02-18 13:47:03.006296
NCT00779077|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2009-04-22|||January 2009||2009-01-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Cystic Fibrosis (CF) Flow Rates Study|An Open, Observational, Non-Interventional Study of Inspiratory Flow Rates and Volumes in Subjects With Cystic Fibrosis Inhaling Via a Spirometer With the High Resistance RS01 Dry Powder Inhaler Device in Series|Completed||N/A|25|Actual|Pharmaxis|||1||f||||f||||||||||2017-02-18 13:47:03.097155|2017-02-18 13:47:03.097155
NCT00779064|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2014-12-23|||July 2004||2004-07-01|December 2014|2014-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status|BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status|Completed||Phase 2|36|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:47:03.172423|2017-02-18 13:47:03.172423
NCT00779051|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||August 2005||2005-08-01|October 2008|2008-10-01|October 2005|Actual|2005-10-01|September 2005|Actual|2005-09-01||Interventional|||Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions|An Open Label, Relative Bioavailability Study of 10 mg Zolpidem Tablet Under Fasting Conditions|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:03.284766|2017-02-18 13:47:03.284766
NCT00779038|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2014-04-22|2013-01-10||August 2008||2008-08-01|April 2014|2014-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy Study of Fentanyl Iontophoretic Transdermal System (ITS) for Management of Moderate to Severe Acute Pain in Participants Who Have Undergone Elective Spine or Orthopedic Surgery|Clinical Outcome Study in Postoperative Pain Management to Demonstrate the Efficacy and Safety of IONSYS (Fentanyl ITS Iontophoretic Transdermal System) in Daily Clinical Practice and to Assess Its Convenience (IPAC)|Terminated||Phase 4|13|Actual|Janssen Cilag N.V./S.A.|No efficacy results were reported because the study was prematurely terminated, following the worldwide voluntary withdrawal of Fentanyl Iontophoretic Transdermal System (IONSYS) by Janssen-Cilag.|1||Stopped prematurely in 2008 due to IONSYS withdrawal off the market globally|f||||f||||||||||2017-02-18 13:47:03.386024|2017-02-18 13:47:03.386024
NCT00779025|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2011-10-04|2011-03-30||January 2008||2008-01-01|October 2011|2011-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Safety Evaluation of Personal Lubricant Product When Used by Couples in Home-use Conditions|A Safety Evaluation of Personal Lubricant Product When Used by Couples in Home-use Conditions|Completed||N/A|82|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-02-18 13:47:03.669135|2017-02-18 13:47:03.669135
NCT00779012|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-04-28|||October 2004||2004-10-01|April 2015|2015-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)|Post-Registration Open-Label, Non-Comparative, Multicenter Study of Rate of Efficacy and Tolerance of the Use of Anti-TNF Chimeric Monoclonal Antibodies (Remicade) in Treatment of Patients With Active Ankylosing Spondylitis|Completed||Phase 4|42|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:47:03.943539|2017-02-18 13:47:03.943539
NCT00778999|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2014-11-14|2009-06-23||October 2006||2006-10-01|November 2014|2014-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|Xpect||Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696)|A Randomized, Open-Label Clinical Trial to Identify Predictive Factors for Controlled Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH in GnRH Antagonist Regimen With or Without Oral Contraceptive Scheduling|Completed||Phase 4|442|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:47:04.048127|2017-02-18 13:47:04.048127
NCT00778986|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2010-09-29|||March 2009||2009-03-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Effects of Remote Patient Monitoring on Heart Failure Management|Effects of Remote Patient Monitoring on Heart Failure Management: A Randomized Controlled Trial|Completed||N/A|100|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:47:04.389195|2017-02-18 13:47:04.389195
NCT00777712|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2017-01-20|||September 2008||2008-09-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|December 2018|Anticipated|2018-12-01||Observational|WoundVac||Mechanisms Underlying Impaired Diabetic Wound Healing|Mechanisms Underlying Impaired Diabetic Wound Healing|Recruiting||N/A|300|Anticipated|Ohio State University|||6||f||||f||||||Samples With DNA|"~     Blood, Wound Vac Sponge.~   "|||2017-02-18 13:47:27.756912|2017-02-18 13:47:27.756912
NCT00778973|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2008-10-23|||August 2005||2005-08-01|October 2008|2008-10-01|October 2005|Actual|2005-10-01|September 2005|Actual|2005-09-01||Interventional|||Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed Conditions|A Study to Compare the Relative Bioavailability of Ranbaxy and Pfizer Formulation of Sertraline 100 mg Tablets in Healthy Adult Volunteers Under Fed Conditions.|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:04.495268|2017-02-18 13:47:04.495268
NCT00778960|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-07-09|||January 2009||2009-01-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.|Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.|Completed||N/A|102|Actual|Oregon Health and Science University||4|||f||||f||||||||||2017-02-18 13:47:04.605068|2017-02-18 13:47:04.605068
NCT00778947|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-05-16|||November 2008||2008-11-01|October 2008|2008-10-01||||September 2009|Anticipated|2009-09-01||Interventional|HARMONIC001||Single Centre Study to Compare Harmonic Scalpel to Conventional Diathermy in Free Tissue Transfer Breast Reconstruction|Comparison of Harmonic Scalpel to Conventional Diathermy in Free Tissue Transfer for Breast Reconstruction|Withdrawn||N/A|0|Actual|St Andrew's Centre for Plastic Surgery||2||Study abandoned and was never started|f||||||||||||||2017-02-18 13:47:04.708903|2017-02-18 13:47:04.708903
NCT00778934|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2011-10-04|||December 2007||2007-12-01|October 2011|2011-10-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||In-Home Use Study to Evaluate Use of an Intimate Health Product in Females|A Single-blind, Multi-center, In-home Use Study to Evaluate Sexual Enhancement Effects of Product PD-F-5394 in Females|Completed||N/A|79|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||f||||||||||2017-02-18 13:47:04.803489|2017-02-18 13:47:04.803489
NCT00778921|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-09-20|2010-12-13||October 2008||2008-10-01|February 2011|2011-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone|A Randomized, Eight Week Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren / Amlodipine (150/10 mg and 300/10 mg) in Comparison With Amlodipine 10 mg in Patients With Essential Hypertension Not Adequately Responsive to Amlodipine 10 mg Monotherapy|Completed||Phase 3|847|Actual|Novartis||3|||f||||f||||||||||2017-02-18 13:47:04.906793|2017-02-18 13:47:04.906793
NCT00778908|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2012-08-17|||January 2008||2008-01-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Interventional|||Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma|Late-Course Accelerated Hyperfractionated IMRT Versus Conventionally Fractionated IMRT in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: A Prospective Randomized Clinical Trial|Completed||Phase 2/Phase 3|120|Actual|Guangxi Medical University||2|||f||||t||||||||||2017-02-18 13:47:05.330809|2017-02-18 13:47:05.330809
NCT00778895|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2016-10-07|2012-12-19||November 2008||2008-11-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control|Clinical Study in Children, 6 Months to 3 Years of Age, to Assess the Immunogenicity and Safety of Two Dose Levels of Thimerosal-free Fluviral® Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control|Completed||Phase 2|390|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:47:05.459543|2017-02-18 13:47:05.459543
NCT00778882|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-02-10|||January 2007||2007-01-01|February 2016|2016-02-01|October 2022|Anticipated|2022-10-01|October 2008|Actual|2008-10-01||Interventional|||Gene Therapy for Chronic Granulomatous Disease in Korea|An Open-label, Uncontrolled, Single Center, Phase I/II Trial to Assess the Safety and Efficacy of Autologous Hematopoietic Stem Cells Transduced With MT-gp91 Retroviral Vector in gp91 Defective Chronic Granulomatous Disease Patients|Active, not recruiting||Phase 1/Phase 2|2|Actual|ViroMed Co., Ltd. dba VM BioPharma||1|||f||||f||||||||||2017-02-18 13:47:06.473027|2017-02-18 13:47:06.473027
NCT00778869|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-23|2015-06-08|2010-02-17||August 2005||2005-08-01|June 2015|2015-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)|Whole Human Genome Oligo Microarray Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment Compared to Healthy Controls|Completed||Phase 4|10|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:47:06.571945|2017-02-18 13:47:06.571945
NCT00778856|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-03-26|||September 2008||2008-09-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|VCA-01||Hand Transplantation for the Reconstruction of Below the Elbow Amputations|Hand Transplantation for the Reconstruction of Below the Elbow Amputations|Terminated||N/A|19|Actual|Emory University||1||Principal Investigator relocated to another institution|f||||t||||||||||2017-02-18 13:47:06.790713|2017-02-18 13:47:06.790713
NCT00778843|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-05-02|||October 2008||2008-10-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C|Efficacy and Safety of Viusid as Antioxidant and Immunomodulator Nutritional Supplement in Patients With Chronic Hepatitis C and Non-responders to Standard Antiviral Therapy. A Randomized and Double Blind Controlled Trial|Completed||Phase 3|60|Actual|Catalysis SL||2|||f||||f||||||||||2017-02-18 13:47:06.886081|2017-02-18 13:47:06.886081
NCT00778830|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-04-28|2015-04-28||February 2009||2009-02-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|APEC|Intention-to-treat (ITT) population consisted of all the enrolled subjects who received at least one dose of study treatment.|Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)|An Asia Pacific Non-randomized, Open-label Phase II Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab (Erbitux) or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)|Completed||Phase 1/Phase 2|289|Actual|Merck KGaA||2|||f||||f||||||||||2017-02-18 13:47:07.001408|2017-02-18 13:47:07.001408
NCT00777738|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-01-17|||October 2008||2008-10-01|October 2008|2008-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|WM2||Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia|A Phase IIA Trial Testing the Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia|Completed||Phase 2|34|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:47:27.553911|2017-02-18 13:47:27.553911
NCT00778817|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2014-03-28|2013-08-30||December 2008||2008-12-01|December 2013|2013-12-01|March 2014|Actual|2014-03-01|May 2012|Actual|2012-05-01||Interventional|||IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery|Multi-Institutional Phase II Study of IMC-A12, a Recombinant Human IgG1 Monoclonal Antibody Directed at the Type I Insulin-Like Growth Factor Receptor IGF1R, in Adrenocortical Carcinoma: IMC-A12 With Mitotane vs Mitotane Alone|Terminated||Phase 2|20|Actual|National Cancer Institute (NCI)|After the treatment of 20 subjects, a protocol defined interim analysis was completed for safety and futility. The trial was permanently halted based on futility concerns.|1||The trial was permanently halted due to futility concerns.|f||||t||||||||||2017-02-18 13:47:07.732812|2017-02-18 13:47:07.732812
NCT00778804|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||July 2004||2004-07-01|October 2008|2008-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Preventing Heart Disease in Underserved Patients|Preventing Heart Disease in Underserved Patients|Completed||N/A|465|Actual|Temple University||2|||f||||t||||||||||2017-02-18 13:47:08.103506|2017-02-18 13:47:08.103506
NCT00778791|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||April 2004||2004-04-01|October 2008|2008-10-01|July 2004|Actual|2004-07-01|April 2004|Actual|2004-04-01||Interventional|||Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions|The Objective of This Study is to Compare the Relative Bioavailability of Metformin HC1 750 mg Extended-Release Tablets (Ranbaxy) With That of Glucophage® XR 750 mg Tablets (Bristol Myers Squibb) in Healthy, Adult, Subjects Under Fasting Conditions.|Completed||N/A|60|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:08.213065|2017-02-18 13:47:08.213065
NCT00778778|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||May 2005||2005-05-01|October 2008|2008-10-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions|Blinded, Comparative, Randomized, Single-Dose, Three Way Crossover Bioavailability Study of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg Cefprozil Tablets in Healthy Adult Volunteers Under Fasting Conditions.|Completed||N/A|27|Actual|Ranbaxy Inc.||3|||f||||t||||||||||2017-02-18 13:47:08.311211|2017-02-18 13:47:08.311211
NCT00778765|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||September 2002||2002-09-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Ranbaxy and Parke-Davis (Neurontin®) 400 mg Gabapentin Capsules in Healthy Adult Volunteers Under Fed Conditions|Completed||N/A|24|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:08.415815|2017-02-18 13:47:08.415815
NCT00778752|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-05-12|||April 2009||2009-04-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma|Dose-finding Study of Lenalidomide as Maintenance Therapy in Multiple Myeloma After Allogeneic Stem Cell Transplantation|Completed||Phase 1/Phase 2|24|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-02-18 13:47:08.515049|2017-02-18 13:47:08.515049
NCT00778739|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||June 2005||2005-06-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|June 2005|Actual|2005-06-01||Interventional|||Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions|A Two-Way Crossover, Open-Label, Single-Dose, Fed, Bioequivalence Study of Cefprozil 250 mg/5 mL Oral Suspension Versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) in Normal Healthy Non-Smoking Male and Female Subjects|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:08.612743|2017-02-18 13:47:08.612743
NCT00778726|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||September 2004||2004-09-01|October 2008|2008-10-01|December 2004|Actual|2004-12-01|October 2004|Actual|2004-10-01||Interventional|||Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions|Single Dose Two-Way Crossover Fasted Bioequivalence Study of Benazepril HCl/ Hydrochlorothiazide 20 mg/ 25 mg Tablets in Healthy Volunteers|Completed||N/A|42|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:08.708307|2017-02-18 13:47:08.708307
NCT00778713|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||March 2003||2003-03-01|October 2008|2008-10-01|April 2003|Actual|2003-04-01|March 2003|Actual|2003-03-01||Interventional|||Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions|A Bioequivalence Study of Test and Reference Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Non-Fasting Conditions|Completed||N/A|33|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:08.804906|2017-02-18 13:47:08.804906
NCT00778700|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-03-13||2010-06-17|October 2008||2008-10-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis|A Double-Blind, Randomized, Vehicle-Controlled Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis|Completed||Phase 2|199|Actual|Incyte Corporation||4|||f||||f||||||||||2017-02-18 13:47:08.904693|2017-02-18 13:47:08.904693
NCT00778687|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2013-12-22|||October 2008||2008-10-01|December 2013|2013-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Heart Rate Variability Change After Liver Transplantation|Effects of Liver Transplantation on the Heart Rate Variability in Patients With End-Stage Liver Disease|Completed||N/A|30|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:47:09.014269|2017-02-18 13:47:09.014269
NCT00778674|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2004||2004-10-01|October 2008|2008-10-01|December 2004|Actual|2004-12-01|October 2004|Actual|2004-10-01||Interventional|||Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions|Single Dose Two-Way Crossover Fed Bioequivalence Study of Benazepril HCl/ Hydrochlorothiazide 20 mg/ 25 mg Tablets in Healthy Volunteers|Completed||N/A|30|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:09.082021|2017-02-18 13:47:09.082021
NCT00778661|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2002||2002-10-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Ranbaxy and GlaxoSmithKline (Augmentin®) 400 mg Amoxicillin (as the Trihydrate)/57 mg Clavulanic Acid (as the Potassium Salt) Chewable Tablets in Healthy Adult Volunteers Following Administration of a Two Tablet Dose Under Fasting Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:09.190137|2017-02-18 13:47:09.190137
NCT00778648|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2010-09-09|2010-09-09||September 2008||2008-09-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms|Effectiveness of an Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms|Completed||N/A|543|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:47:09.297986|2017-02-18 13:47:09.297986
NCT00778622|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2013-08-19|2013-06-14||November 2009||2009-11-01|August 2013|2013-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional||Baseline population consisted of: all participants enrolled into one of three body weight arms, normal, overweight or obese, based on body mass index at screening; and who were assigned to treatment with Glucophage XR. This population was used for analysis of demographics.|Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients|The Relationship Between Baseline Body Weight and Glycemic Control Following Metformin Extended-Release Tablets (Glucophage XR) Monotherapy in Chinese Patients With Newly Diagnosed Type 2 Diabetes|Completed||Phase 4|371|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 13:47:09.843062|2017-02-18 13:47:09.843062
NCT00778609|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-01-13|||December 2008||2008-12-01|January 2016|2016-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache|A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group, 2-arm Study to Show Superiority of the Oral Contraceptive SH T00658ID Over Microgynon on Hormone Withdrawal-associated Symptoms After 6 Cycles of Treatment|Completed||Phase 3|449|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:47:10.935506|2017-02-18 13:47:10.935506
NCT00778596|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-05-24|||February 2009||2009-02-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Prednisolone Priming Study in Patients With Chronic Hepatitis B|A Randomized, Double Blind Controlled Trial to Evaluate the Therapeutic Effect of Telbivudine With or Without Prednisolone Priming in Patients With Chronic Hepatitis B|Unknown status|Recruiting|Phase 4|160|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-02-18 13:47:11.124831|2017-02-18 13:47:11.124831
NCT00778583|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||September 2003||2003-09-01|October 2008|2008-10-01|December 2003|Actual|2003-12-01|October 2003|Actual|2003-10-01||Interventional|||Bioequivalence Study of Nitrofurantoin 100 mg Capsules Under Fed Conditions|An Open Label, Randomised, Two-Treatment, Four-Period, Two-Sequence, Single-Dose, Crossover, Fully Replicated Bioavailability Study on Nitrofurantoin Formulations Comparing Nitrofurantoin 100 mg Capsules of Ranbaxy Laboratories With Macrobid 100 mg Capsules in Healthy, Adult, Human Subjects Under Fed Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:11.239995|2017-02-18 13:47:11.239995
NCT00778570|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2014-11-28|||February 2007||2007-02-01|November 2014|2014-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Advanced Surface Ablation (ASA) vs Laser-Assisted In Situ Keratomileusis (LASIK)|A Combined Retrospective and Prospective Chart Review Analysis of Visual Outcomes Following Excimer Laser Vision Correction|Recruiting||N/A|4000|Anticipated|Ottawa Hospital Research Institute|||2||f||||f||||||||||2017-02-18 13:47:11.346951|2017-02-18 13:47:11.346951
NCT00778557|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||June 2005||2005-06-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|June 2005|Actual|2005-06-01||Interventional|||Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions|A Three-Way Crossover, Blinded, Single-Dose, Fasting, Bioequivalence Study of One Test Formulation of Cefprozil 250 mg/5 mL Oral Suspension Versus Two Reference Formulation of Cefzil TM Powder for Oral Suspension (250 mg/5 mL) in Normal Healthy Non-Smoking Male and Female Subjects|Completed||N/A|35|Actual|Ranbaxy Inc.||3|||f||||t||||||||||2017-02-18 13:47:11.458539|2017-02-18 13:47:11.458539
NCT00778544|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||June 2006||2006-06-01|October 2008|2008-10-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions|Randomized, Open-Label, 2 - Way Crossover, Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg- 42.9 mg/ 5 mL Oral Suspension and Augmentin ES-600 (Reference) Following a 600 mg- 42.9 mg Dose in Healthy Subjects Under Fed Conditions.|Completed||N/A|48|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:11.569648|2017-02-18 13:47:11.569648
NCT00778531|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2014-11-18|||September 2007||2007-09-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Protocol for the Post-approval Study of ArteFill® for Correction of Nasolabial Folds|Protocol for the Post-approval Study of ArteFill® for Correction of Nasolabial Folds|Completed||Phase 4|1008|Actual|Suneva Medical, Inc.||1|||f||||f||||||||||2017-02-18 13:47:11.681835|2017-02-18 13:47:11.681835
NCT00778518|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2009-10-09|||July 2008||2008-07-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).|Phase IIb Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of ARX201 Following Repeated Dosing to Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).|Completed||Phase 2|36|Anticipated|Ambrx, Inc.||3|||f||||f||||||||||2017-02-18 13:47:11.77432|2017-02-18 13:47:11.77432
NCT00778505|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-09-22|||October 2008||2008-10-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|LoopPed||Use of Closed-loop Anesthesia in Pediatric Patients|Target-Controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by the Index Bispectral: Comparison in Pediatric Patients Between Manual Perfusion and Automated Perfusion|Terminated||Phase 4|45|Actual|Hopital Foch||2||difficulty in recruiting|f||||f||||||||||2017-02-18 13:47:11.882025|2017-02-18 13:47:11.882025
NCT00778492|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||May 2008||2008-05-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|October 2008|Anticipated|2008-10-01||Observational|||Thrombelastogram in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery|Thrombelastogram and Predicting Microvascular Bleeding in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery|Unknown status|Recruiting|N/A|60|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 13:47:11.985387|2017-02-18 13:47:11.985387
NCT00778479|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-03-19|||October 2008||2008-10-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Evaluation of the Safety of Sepraspray in Open Abdominal Surgery|Evaluation of the Safety of Sepraspray in Open Abdominal Surgery|Terminated||N/A|155|Actual|Sanofi||2||Terminated by Sponsor: see details below|f||||t||||||||||2017-02-18 13:47:12.082281|2017-02-18 13:47:12.082281
NCT00778466|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||February 2006||2006-02-01|October 2008|2008-10-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions|A Study to Compare the Relative Bioavailability of Ranbaxy and Bristol Myers Squibb Formulations of Metformin 1000 mg Tablets in Healthy Adult Volunteers Under Fed Conditions|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:12.246118|2017-02-18 13:47:12.246118
NCT00778453|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-05|2012-07-31|||August 2008||2008-08-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Relative Effects and Predictive Models of Contemporary Upper Limb Training Programs in Stroke Patients|Relative Effects and Predictive Models of Contemporary Upper Limb Training Programs in Stroke Patients Delivered in Hospital-based and Home-based Settings|Completed||N/A|150|Actual|Chang Gung Memorial Hospital||6|||f||||f||||||||||2017-02-18 13:47:12.35094|2017-02-18 13:47:12.35094
NCT00778440|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2009-08-06|||January 2009||2009-01-01|August 2009|2009-08-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Observational|LESIONAT||Risk Level of Suffering From Traffic Injury in Primary Health Care: LESIONAT Project|Risk Level of Suffering From Traffic Injury in Primary Health Care: LESIONAT Project|Unknown status|Enrolling by invitation|N/A|1540|Anticipated|Jordi Gol i Gurina Foundation|||1||f||||t||||||||||2017-02-18 13:47:12.462722|2017-02-18 13:47:12.462722
NCT00778427|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||February 2006||2006-02-01|October 2008|2008-10-01|April 2006|Actual|2006-04-01|February 2006|Actual|2006-02-01||Interventional|||Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions|A Study to Compare the Relative Bioavailability of Ranbaxy and Bristol Myers Squibb Formulations of Metformin 1000 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:12.545|2017-02-18 13:47:12.545
NCT00778414|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||June 2006||2006-06-01|October 2008|2008-10-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg - 42.9 mg/ 5 mL Oral Suspension Under Fasting Conditions|Randomized, Open - Label, 2 - Way Crossover, Bioequivalence Study of Amoxicillin-Clavulanic Acid 600mg - 42.9 mg/ 5 mL Oral Suspension and Augmentin ES - 600 (Reference) Following a 600 mg - 42.9 mg Dose in Healthy Subjects Under Fasting Conditions|Completed||N/A|48|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:12.638332|2017-02-18 13:47:12.638332
NCT00778401|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2002||2002-10-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 800 mg Gabapentin Tablets Under Fasting Condition|Completed||N/A|28|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:12.736811|2017-02-18 13:47:12.736811
NCT00778388|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2012-10-18|||September 2008||2008-09-01|October 2012|2012-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers|Against Pseudomonas Aeruginosa in Healthy Volunteers|Completed||Phase 1|157|Actual|Valneva Austria GmbH||5|||f||||t||||||||||2017-02-18 13:47:12.836215|2017-02-18 13:47:12.836215
NCT00778375|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-06-15|2016-01-28||October 2008||2008-10-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)|Clofarabine Plus Low-Dose Cytarabine Induction Followed by Consolidation of Clofarabine Plus Low-Dose Cytarabine Alternating With Decitabine in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)|Completed||Phase 2|122|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 13:47:12.955344|2017-02-18 13:47:12.955344
NCT00778362|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||January 2006||2006-01-01|October 2008|2008-10-01|December 2012|Anticipated|2012-12-01|October 2008|Anticipated|2008-10-01||Observational|||Splenic Function After Spleen-Preserving Distal Pancreatectomy With Excision of Splenic Artery and Vein|Splenic Function After Spleen-Preserving Distal Pancreatectomy With Excision of Splenic Artery and Vein|Unknown status|Active, not recruiting|N/A|40|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:47:15.595944|2017-02-18 13:47:15.595944
NCT00778349|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||April 2002||2002-04-01|October 2008|2008-10-01|July 2002|Actual|2002-07-01|May 2002|Actual|2002-05-01||Interventional|||A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal|A Randomized, Three-Treatment, Three-Period, Six-Sequence, Single-Dose, Crossover Pharmacokinetic Study on Metformin Hydrochloride Solution 100 mg/mL of Ranbaxy Laboratories Comparing the Pharmacokinetic Profile of Metformin Under Fasting Condition, After a Low Fat Meal and After a High Fat Meal in Healthy, Adult, Human Male Subjects.|Completed||N/A|34|Actual|Ranbaxy Inc.||3|||f||||t||||||||||2017-02-18 13:47:15.68387|2017-02-18 13:47:15.68387
NCT00778336|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2014-10-08|2011-02-22||January 2007||2007-01-01|October 2014|2014-10-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Observational|||A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters|Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters|Completed||N/A|452|Actual|Boston Scientific Corporation|Non randomized observational registry||4||f||||f||||||||||2017-02-18 13:47:15.778375|2017-02-18 13:47:15.778375
NCT00778323|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-09|2011-02-24|||September 2007||2007-09-01|November 2008|2008-11-01|April 2009|Actual|2009-04-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Trial of Remote Preconditioning in Patients Undergoing Cervical Decompression Surgery|Effects of Remote Ischemic Preconditioning on Biochemical Markers and Neurological Outcomes in Patients Undergoing Elective Cervical Decompression Surgery|Completed||Phase 1/Phase 2|51|Actual|Xijing Hospital||1|||f||||t||||||||||2017-02-18 13:47:16.354077|2017-02-18 13:47:16.354077
NCT00778310|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2012-06-08|2012-04-26||November 2008||2008-11-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Neuroimaging of the Effects of Concerta in the Treatment of ADHD|Functional Neuroimaging of Acute Concerta Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): Differences Across Development|Completed||Phase 4|76|Actual|The University of Texas Health Science Center at San Antonio|No typically developing control group compared to either the adult or child group.|2|||f||||f||||||||||2017-02-18 13:47:16.461672|2017-02-18 13:47:16.461672
NCT00778297|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2012-05-18|||November 2007||2007-11-01|May 2012|2012-05-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine|Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine With 6 Mcg HA/Strain/Dos Antigen Content|Completed||N/A|234|Actual|Omninvest Vaccine Manufacturing, Researching and Trading Ltd.||2|||f||||t||||||||||2017-02-18 13:47:17.065756|2017-02-18 13:47:17.065756
NCT00777699|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2012-02-02|||August 2008||2008-08-01|February 2012|2012-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors|A Phase 1 Dose-Escalation Study of XL765 in Combination With Erlotinib in Subjects With Solid Tumors|Completed||Phase 1|80|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:47:27.888811|2017-02-18 13:47:27.888811
NCT00778284|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2002||2002-10-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Ranbaxy and GlaxoSmithKline (Augmentin®) 400 mg Amoxicillin (as the Trihydrate)/57 mg Clavulanic Acid (as the Potassium Salt) Chewable Tablets in Healthy Adult Volunteers Following Administration of a Two Tablet Dose Under Fed Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:17.164353|2017-02-18 13:47:17.164353
NCT00778271|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||September 2002||2002-09-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Bioequivalence Study of Gabapentin 400 mg Capsules Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Ranbaxy and Park:-Davis (Neurontin®) 400 mg Gabapentin Capsules in Healthy Adult Volunteers Under Fasting Conditions|Completed||N/A|26|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:17.267134|2017-02-18 13:47:17.267134
NCT00778258|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-03-29|2015-12-17||August 2008||2008-08-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||All Enrolled|Study of Milk Allergy and Tolerance in Children|Dietary Intervention in Milk Allergy and Tolerance Development|Completed||Phase 2|170|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-02-18 13:47:17.3913|2017-02-18 13:47:17.3913
NCT00778245|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||May 2005||2005-05-01|October 2008|2008-10-01|October 2005|Actual|2005-10-01|June 2005|Actual|2005-06-01||Interventional|||Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions|An Open - Label, Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg Cefprozil Tablets in Healthy Adult Volunteers Under Fed Conditions.|Completed||N/A|26|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:19.989892|2017-02-18 13:47:19.989892
NCT00778232|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2002||2002-10-01|October 2008|2008-10-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions|A Relative Bioavailability Study of 800 mg Gabapentin Tablets Under Non-Fasting Conditions|Completed||N/A|22|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:20.101206|2017-02-18 13:47:20.101206
NCT00778219|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2009-12-14|||October 2008||2008-10-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Comparison of Heart Rate Variability Among Tracheal Intubation Methods|Comparison of Autonomic Stimulation Among Different Tracheal Intubation Methods -- Using Non-invasive Heart Rate Variability Spectral Power as an Indicator|Completed||N/A|60|Anticipated|National Taiwan University Hospital|||3||f||||t||||||||||2017-02-18 13:47:20.200148|2017-02-18 13:47:20.200148
NCT00778206|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-05-05|||September 2008||2008-09-01|May 2016|2016-05-01|September 2023|Anticipated|2023-09-01|September 2023|Anticipated|2023-09-01||Observational|PKUDOS||PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry|PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry|Recruiting||N/A|3500|Anticipated|BioMarin Pharmaceutical|||2||f||||f||||||||||2017-02-18 13:47:20.302994|2017-02-18 13:47:20.302994
NCT00778193|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2008-10-22|||October 2007||2007-10-01|October 2008|2008-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Lesions2||Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers|A Randomized, Blinded, Placebo-Controlled Study of the Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on Gastroduodenal Healing|Completed||Phase 4|125|Actual|Research Associates of New York, LLP||5|||f||||f||||||||||2017-02-18 13:47:20.507386|2017-02-18 13:47:20.507386
NCT00778180|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2005||2005-10-01|October 2008|2008-10-01|November 2005|Actual|2005-11-01|October 2005|Actual|2005-10-01||Interventional|||Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions|A Study to Compare the Relative Bioavailability of Ranbaxy and Aventis Formulations of Furosemide 80 mg Tablets in Healthy Adult Volunteers Under Fasted Condition.|Completed||N/A|44|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:20.628962|2017-02-18 13:47:20.628962
NCT00778167|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2014-05-06|2013-01-15||October 2008||2008-10-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase I/Randomized Phase II Study of the Anti-IGF-1R Monoclonal Antibody IMC-A12 in Combination With Erlotinib Compared With Erlotinib Alone in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|18|Actual|National Cancer Institute (NCI)|Phase I of the study was completed but because of concerns about the achievable dose intensity at the maximum tolerated dose (MTD), the expansion into a randomized phase II study comparing full-dose erlotinib with the combination was cancelled.|2|||f||||||||||||||2017-02-18 13:47:20.730405|2017-02-18 13:47:20.730405
NCT00778154|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2013-06-03|||January 2004||2004-01-01|June 2013|2013-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate|A Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Long-Term Alendronate or Risedronate|Completed||N/A|105|Actual|Warner Chilcott|||4||f||||f||||||Samples Without DNA|"~     bone biopsies~   "|||2017-02-18 13:47:21.211944|2017-02-18 13:47:21.211944
NCT00778141|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||April 2004||2004-04-01|October 2008|2008-10-01|June 2004|Actual|2004-06-01|April 2004|Actual|2004-04-01||Interventional|||Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions|A Relative Bioavailability Study of Metformin HCl 750 mg XR Tablets Under Non-Fasting Conditions.|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:21.308116|2017-02-18 13:47:21.308116
NCT00778128|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2010-09-03|||October 2008||2008-10-01|September 2010|2010-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour|A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour|Completed||Phase 1|26|Actual|Clavis Pharma||2|||f||||f||||||||||2017-02-18 13:47:21.415441|2017-02-18 13:47:21.415441
NCT00778115|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||November 2004||2004-11-01|October 2008|2008-10-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions|A Relative Bioavailability Study of Loperamide HCl 2 mg and Simethicone 125 mg Tablets to Imodium® Advanced Caplets Under Fasting Condition|Completed||N/A|26|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:21.544059|2017-02-18 13:47:21.544059
NCT00778102|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2016-11-01|2015-07-10||October 2008||2008-10-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Intent-to-Treat (ITT) Population: All randomized participants. Participants were analyzed according to which treatment group they were randomized, regardless of the treatment actually received.|A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.|A Multicentre Randomised Phase II Study to Assess the Safety and Resectability in Patients With Initially Unresectable Liver Metastases Secondary to Colorectal Cancer Receiving First-line Treatment Either With mFOLFOX-6 Plus Bevacizumab or FOLFOXIRI Plus Bevacizumab (OLIVIA)|Completed||Phase 2|80|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:47:21.65031|2017-02-18 13:47:21.65031
NCT00778089|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2010-03-19|||July 2008||2008-07-01|March 2010|2010-03-01|December 2010|Anticipated|2010-12-01|September 2008|Anticipated|2008-09-01||Interventional|||Open-Label Study to Evaluate the Immunogenicity of Bovine Collagen in ArteFill® by Skin Testing|Open-Label Study to Evaluate the Immunogenicity of Bovine Collagen in ArteFill® by Skin Testing|Terminated||Phase 1|498|Actual|Suneva Medical, Inc.||1||Closed incomplete due to Artes Medical Closing|f||||f||||||||||2017-02-18 13:47:22.791672|2017-02-18 13:47:22.791672
NCT00778076|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2009-03-31|||July 2008||2008-07-01|March 2009|2009-03-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||The Impact of Hyaluronic Acid Injections on Osteoarthritic Knee Mechanics|The Biomechanical Impact of Intra-Articular Hyaluronic Acid in Knee Osteoarthritis Patients: A Randomized, Double Blind, Placebo Controlled Study|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|University of Western Ontario, Canada||2|||f||||f||||||||||2017-02-18 13:47:22.896834|2017-02-18 13:47:22.896834
NCT00778063|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2013-03-14|||March 2009||2009-03-01|March 2013|2013-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|PED-DEX||Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients|Intranasal Dexmedetomidine Decreases Emergence Delirium in Pediatric Patients After Sevoflurane Based General Anesthesia|Unknown status|Recruiting|N/A|80|Anticipated|Ochsner Health System||2|||f||||t||||||||||2017-02-18 13:47:23.014154|2017-02-18 13:47:23.014154
NCT00778050|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||October 2002||2002-10-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of 600 mg Amoxicillin Dispersible Tablets vs 400 mg/ 5 mL Amoxil ® for Oral Suspension Under Fasting Conditions.|Completed||N/A|26|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:23.137228|2017-02-18 13:47:23.137228
NCT00778037|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||September 2006||2006-09-01|October 2008|2008-10-01|November 2006|Actual|2006-11-01|September 2006|Actual|2006-09-01||Interventional|||Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-Treatment, Two-Sequence, Two-Period, Single-Dose, Crossover, Bioavailability Study Comparing Cyclobenzaprine Hydrochloride 10 mg Tablet of Ohm Labs Inc (A Subsidiary of Ranbaxy Pharmaceuticals Inc USA.) With Flexeril® 10 mg Tablet (Containing Cyclobenzaprine Hydrochloride 10 mg) Manufactured by Merck & Co Inc., USA and Distributed by McNeil Consumer & Speciality Pharmaceuticals, in Healthy, Adult, Male, Human Subjects Under Fasting Condition.|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:23.2418|2017-02-18 13:47:23.2418
NCT00778024|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2009-12-11|||August 2003||2003-08-01|December 2009|2009-12-01|December 2003|Actual|2003-12-01|October 2003|Actual|2003-10-01||Interventional|||Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions|The Objective of This Randomized, Single-dose, Two-way Evaluation is to Compare the Bioequivalence of a Test Fluoxetine HCL Formulation (Ranbaxy Laboratories Limited, Lot No. 6320101) to an Equivalent Oral Dose of the Commercially Available Fluoxetine HCL (Prozac®, Dista Products Company, Lot No 6RK57M) in a Test Population of 36 Adult Subjects Under Fasting Conditions.|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:23.348903|2017-02-18 13:47:23.348903
NCT00778011|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2012-06-27|||November 2005||2005-11-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Uncomplicated Nausea and Vomiting in the Emergency Department|Ondansetron 4 mg vs. 2 mg vs. Metoclopramide 10 mg for Nausea and Vomiting in the Emergency Department: A Randomized, Double-Blind Clinical Trial|Completed||Phase 4|137|Actual|WellSpan Health||3|||f||||f||||||||||2017-02-18 13:47:23.45278|2017-02-18 13:47:23.45278
NCT00777998|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2015-05-12|||August 2008||2008-08-01|May 2015|2015-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma|Autologous-Allogeneic Tandem Stem Cell Transplantation and Maintenance Therapy With Thalidomide/ DLI for Patients With Multiple Myeloma (MM) and Age < _60 Years: A Phase II-study|Active, not recruiting||Phase 2|221|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-02-18 13:47:23.570884|2017-02-18 13:47:23.570884
NCT00777985|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2014-05-20|||December 2007||2007-12-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|BOSAS||Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea|Cardiovascular Consequences of Obstructive Sleep Apnea (OSA): Role of Endothelin and Preventive Effects of Bosentan|Completed||Phase 2|19|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-02-18 13:47:23.694081|2017-02-18 13:47:23.694081
NCT00777972|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-22|2008-10-22|||March 2003||2003-03-01|October 2008|2008-10-01|April 2003|Actual|2003-04-01|March 2003|Actual|2003-03-01||Interventional|||Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions|A Bioequivalence Study of Test and Reference Fosinopril Sodium/ Hydrochlorothiazide 20/12.5 mg Tablets Under Fasting Conditions|Completed||N/A|34|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:23.805374|2017-02-18 13:47:23.805374
NCT00777959|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2015-08-18|||October 2008||2008-10-01|August 2015|2015-08-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)|A Phase II Randomized, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus (Ridaforolimus) in Men With Asymptomatic, Metastatic Castrate-resistant Prostate Cancer|Completed||Phase 2|22|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 13:47:23.913194|2017-02-18 13:47:23.913194
NCT00777725|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2011-07-20|||January 2009||2009-01-01|July 2011|2011-07-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Observational|||Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Left and/or Right Sided Heart Failure|Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Left and/or Right Sided Heart Failure|Completed||N/A|125|Actual|Monash University|||4||f||||f||||||Samples Without DNA|"~     Blood samples for fibrotic biomarkers.~   "|||2017-02-18 13:47:27.662745|2017-02-18 13:47:27.662745
NCT00777946|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2011-06-30|2010-12-13||October 2008||2008-10-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone|A Randomized, Eight-week Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren / Amlodipine (300/5 mg and 300/10 mg) in Comparison With Aliskiren 300 mg in Patients With Essential Hypertension Not Adequately Responsive to Aliskiren 300 mg Monotherapy|Completed||Phase 3|818|Actual|Novartis||3|||f||||f||||||||||2017-02-18 13:47:24.034194|2017-02-18 13:47:24.034194
NCT00777933|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2011-04-21|||July 2000||2000-07-01|April 2011|2011-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation|Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation|Completed||N/A|131|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 13:47:24.591174|2017-02-18 13:47:24.591174
NCT00777920|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-01-29|||November 2008||2008-11-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|ABS-LT||Study of Ambrisentan in Subjects With Pulmonary Hypertension|ABS-LT: A Phase 3, Long-Term, Open Label, Multicenter Safety Study of Ambrisentan in Subjects With Pulmonary Hypertension|Active, not recruiting||Phase 3|300|Anticipated|Gilead Sciences||1|||f||||t||||||||||2017-02-18 13:47:24.695517|2017-02-18 13:47:24.695517
NCT00777907|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-08-05|||October 2008||2008-10-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|November 2014|Actual|2014-11-01||Interventional|COCOA||Complete Occlusion of Coilable Aneurysms|Complete Occlusion of Coilable Aneurysms|Completed||Phase 3|13|Actual|Chestnut Medical Technologies||2|||f||||f||||||||||2017-02-18 13:47:24.839485|2017-02-18 13:47:24.839485
NCT00777894|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-04-14|||November 2008||2008-11-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|||Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|External Beam Radiotherapy for Unresectable Hepatocellular Carcinoma. A Multicenter Phase I/II Trial.|Completed||Phase 1/Phase 2|18|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||No||2017-02-18 13:47:25.012863|2017-02-18 13:47:25.012863
NCT00777868|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2012-06-20|||October 2007||2007-10-01|June 2012|2012-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis||Completed||Phase 2|135|Actual|Dow Pharmaceutical Sciences||4|||f||||||||||||||2017-02-18 13:47:25.124282|2017-02-18 13:47:25.124282
NCT00777855|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2013-05-08|2013-01-14||November 2008||2008-11-01|May 2013|2013-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.|The Effects of Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers.|Completed||N/A|10|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 13:47:25.36755|2017-02-18 13:47:25.36755
NCT00777842|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-12-29|||November 2008||2008-11-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery|Silencing the c-Myc Gene Using Third Generation Antisense Restenosis Therapy|Terminated||N/A|19|Actual|Cook||1||In this feasibility study device did not perform as well as expected.|f||||||||||||||2017-02-18 13:47:25.660919|2017-02-18 13:47:25.660919
NCT00777829|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-12-08|||September 2008||2008-09-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Memory Consolidation in Pharmacologically Enhanced Naps|Understanding Memory Consolidation by Studying Pharmacologically Enhanced Naps.|Completed||N/A|30|Actual|University of California, San Diego||5|||f||||t||||||||||2017-02-18 13:47:25.745243|2017-02-18 13:47:25.745243
NCT00777816|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2015-12-28|||February 2009||2009-02-01|December 2015|2015-12-01||||October 2014|Actual|2014-10-01||Interventional|||Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis|A Blinded, Placebo-controlled, Study of the Safety and Pharmacokinetics of XOMA 052 Administered to Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis|Suspended||Phase 2|18|Anticipated|XOMA (US) LLC||2|||f||||f||||||||||2017-02-18 13:47:25.851963|2017-02-18 13:47:25.851963
NCT00777803|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-03-07|2012-01-23||November 2008||2008-11-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|Head2Head||NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines|A Prospective, Multicenter, Randomized, Rater- and Subject-Blind, Parallel Group Trial to Investigate the Non-Inferiority of NT 201, Free of Complexing Proteins, in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines|Completed||Phase 3|381|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-02-18 13:47:25.954095|2017-02-18 13:47:25.954095
NCT00777790|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2014-01-21|2008-12-02||February 2004||2004-02-01|January 2014|2014-01-01|April 2005|Actual|2005-04-01|April 2004|Actual|2004-04-01||Interventional|||Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents|Antibody Responses to a Booster Dose of an Experimental Tetravalent (A, C, Y, and W-135) Meningococcal Diphtheria Toxoid Conjugate Vaccine, Menactra® in Adolescents Who Previously Received Menomune® or Menactra®|Completed||Phase 2|241|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 13:47:26.516631|2017-02-18 13:47:26.516631
NCT00777777|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-21|||August 2008||2008-08-01|October 2008|2008-10-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|eSVS||The eSVS (TM) Mesh External Saphenous Vein Support Trial|The eSVS(TM)Mesh External Saphenous Vein Support Trial|Unknown status|Recruiting|Phase 2|120|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-02-18 13:47:27.015966|2017-02-18 13:47:27.015966
NCT00777764|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-11-25|2010-08-19||August 2008||2008-08-01|November 2016|2016-11-01||||March 2009|Actual|2009-03-01||Interventional|||The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)|The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)|Completed||Phase 4|60|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 13:47:27.126934|2017-02-18 13:47:27.126934
NCT00777751|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-11-23|||October 2008||2008-10-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Observational|||Radiation Therapy and Cardiac Enzymes|Radiation Therapy and Cardiac Biomarkers|Active, not recruiting||N/A|30|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:47:27.468227|2017-02-18 13:47:27.468227
NCT00777686|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2012-03-29|||August 2008||2008-08-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Measuring Non-Enhancing Glioblastoma Progression|Quantifying Progression of Non-Enhancing Tumor in Patients With Recurrent Glioblastoma Treated With Antiangiogenic Agents|Completed||N/A|7|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:47:27.993657|2017-02-18 13:47:27.993657
NCT00777673|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2013-01-03|||October 2008||2008-10-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|January 2013|Anticipated|2013-01-01||Interventional|||Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.|Neoadjuvant Weekly Nab-paclitaxel (Abraxane®) Plus Carboplatin Followed By Doxorubicin Plus Cyclophosphamide With Bevacizumab Added Concurrently To Chemotherapy For Palpable And Operable Triple Negative Invasive Breast Cancer|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|University of Tennessee Cancer Institute||1|||f||||t||||||||||2017-02-18 13:47:28.112242|2017-02-18 13:47:28.112242
NCT00777647|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2017-02-07|||May 2008||2008-05-01|February 2017|2017-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effect of Carbonated Soft Drinks on the Body Weight|Effect of Carbonated Soft Drinks on Body Weight, Fat Distribution and Metabolic Risk Factors|Completed||N/A|60|Actual|Aarhus University Hospital||4|||f||||f||||||||||2017-02-18 13:47:28.209283|2017-02-18 13:47:28.209283
NCT00777634|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2012-04-23|2012-03-09||June 2005||2005-06-01|April 2012|2012-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Follow-Up Extension to the Family Study of Binge Eating Disorder|Follow-Up Extension to the Family Study of Binge Eating Disorder|Completed||N/A|268|Actual|Mclean Hospital|||2||f||||f||||||||||2017-02-18 13:47:28.310798|2017-02-18 13:47:28.310798
NCT00777621|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-02-11|||April 2008||2008-04-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|CREG||Caloric Restriction, Exercise, and Glucoregulation in Humans|Caloric Restriction, Exercise, and Glucoregulation in Humans|Completed||N/A|69|Actual|St. Louis University||3|||f||||f||||||||||2017-02-18 13:47:28.758215|2017-02-18 13:47:28.758215
NCT00777608|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2015-08-11|2011-01-27||December 2008||2008-12-01|August 2015|2015-08-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial, With Placebo Run-In, and an Open-Label Treatment Period, to Evaluate the Performance of the CogState Computerized Neuropsychological Battery and the ADAS-Cog in Generally Cholinesterase-naive AD Patients|Completed||Phase 1|106|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:47:28.860082|2017-02-18 13:47:28.860082
NCT00777595|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2009-03-26|||October 2008||2008-10-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CT14||Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers|A Randomized, Double Blind, Single Dose, Positive and Placebo Controlled, Crossover Study of the Effects of Inhaled Carmoterol, at the Proposed Therapeutic and Supratherapeutic Doses, on the QTc Intervals in Healthy Subjects|Completed||Phase 1|47|Actual|Chiesi Farmaceutici S.p.A.||4|||f||||f||||||||||2017-02-18 13:47:29.227691|2017-02-18 13:47:29.227691
NCT00777582|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-12-27|||October 2008||2008-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|February 2009|Actual|2009-02-01||Interventional|||Phase I Comparative Bioavailability Study|A Phase I, Randomised, 2 Period Cross Over Study to Determine the Comparative Bioavailability of Two Different Oral Formulations of AZD2281 in Cancer Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|228|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 13:47:29.416586|2017-02-18 13:47:29.416586
NCT00777569|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2017-01-13|||March 2005||2005-03-01|December 2008|2008-12-01|November 2006|Actual|2006-11-01|September 2006|Actual|2006-09-01||Interventional|||Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine|Study 2: Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine|Completed||Phase 2|66|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 13:47:29.533412|2017-02-18 13:47:29.533412
NCT00777556|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-09-14|2012-09-14||October 2008||2008-10-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Emergency Contraception Actual Use Study|Plan B® 1.5 Emergency Contraception Actual Use Study in Adolescents|Completed||Phase 3|343|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 13:47:29.644736|2017-02-18 13:47:29.644736
NCT00777543|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-11-12|||November 2008||2008-11-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Increasing Ferulic Acid Bioavailability in Bran|The Effect of Pre-treatment of Bran on the Bioavailability of Ferulic Acid and Other Bioactive Compounds From Wholegrain Breads Enriched in Bran|Unknown status|Active, not recruiting|N/A|8|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:47:30.173611|2017-02-18 13:47:30.173611
NCT00777530|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-22|||April 2008||2008-04-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects|Ascending Single-Dose Of The Safety, Tolerability, And Pharmacokinetics Of Bosutinib Administered Orally With Multiple Doses Of Ketoconazole To Healthy Adult Subjects.|Completed||Phase 1|48|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:47:30.303463|2017-02-18 13:47:30.303463
NCT00777517|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2009-08-26|||November 2008||2008-11-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Bioequivalence Study On Pediatric Appropriate Formulation|An Open Label, Randomized, Single Dose, Two-Way Crossover Bioequivalence Study Comparing A Pediatric Appropriate Formulation To A 10 Mg Commercial Atorvastatin Calcium Tablet Formulation In Healthy Subjects|Completed||Phase 1|76|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:47:30.397119|2017-02-18 13:47:30.397119
NCT00777504|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2011-09-15|||October 2008||2008-10-01|September 2011|2011-09-01|April 2012|Anticipated|2012-04-01|January 2012|Anticipated|2012-01-01||Interventional|||Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors|Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors|Unknown status|Recruiting|Phase 4|30|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 13:47:30.525397|2017-02-18 13:47:30.525397
NCT00776971|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2008-10-21|||November 2007||2007-11-01|August 2008|2008-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Carbonated Soft Drinks on Appetite-Regulation|Carbonated Soft Drinks May Alter Appetite Sensation and Appetite-Regulating Hormone Level and Lead to Increased Energy Intake.|Completed||N/A|24|Actual|Aarhus University Hospital||4|||f||||f||||||||||2017-02-18 13:47:44.330052|2017-02-18 13:47:44.330052
NCT00777491|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-09-28|||December 2008||2008-12-01|September 2016|2016-09-01||||January 2018|Anticipated|2018-01-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery|A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy|Active, not recruiting||Phase 2|64|Anticipated|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 13:47:30.63725|2017-02-18 13:47:30.63725
NCT00777478|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-02-02|||December 2008||2008-12-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|May 2012|Anticipated|2012-05-01||Interventional|sutent-capiri||Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer|A Phase I Dose Escalation Study With Sunitinib (SutentR) in Combination With Capecitabine and Irinotecan (Capiri) in Previously Treated Patients With Advanced Colorectal Cancer|Unknown status|Recruiting|Phase 1|32|Anticipated|Radboud University||1|||f||||t||||||||||2017-02-18 13:47:30.761195|2017-02-18 13:47:30.761195
NCT00777465|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2014-05-19|||January 2003||2003-01-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Acute Kidney Injury After Cardiac Surgery Based on KDIGO Criteria|Prognostic Value of Acute Kidney Injury After Cardiac Surgery According to Kidney Disease: Improving Global Outcomes Definition and Staging (KDIGO) Criteria|Completed||N/A|2804|Actual|Hospital de Base|||4||f||||f||||||||||2017-02-18 13:47:30.859309|2017-02-18 13:47:30.859309
NCT00777452|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2008-10-21|||March 2005||2005-03-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer|A Prospective Quality of Life Study in Men With Clinically Localized Prostate Carcinoma Treated With Different Treatment Modalities|Completed||N/A|93|Actual|Samsung Medical Center|||4||f||||t||||||||||2017-02-18 13:47:30.955528|2017-02-18 13:47:30.955528
NCT00777439|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-08-17|||October 2008||2008-10-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Domperidone for Refractory Gastrointestinal Disorders|An Investigational New Drug Program for the Use of Domperidone in the Treatment of Refractory Gastroesophageal Reflux Disease and Other Gastrointestinal Motility Disorders|Recruiting||N/A|75|Anticipated|Arnold, George, M.D.||1|||f||||t||||||||||2017-02-18 13:47:31.060696|2017-02-18 13:47:31.060696
NCT00777426|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2014-09-25|||September 2008||2008-09-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Observational|||HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia||Completed||N/A|60|Actual|South East Asia Research Collaboration with Hawaii|||3||f||||t||||||Samples Without DNA|"~     PBMC, Plasma, Urine~   "|||2017-02-18 13:47:31.194995|2017-02-18 13:47:31.194995
NCT00777413|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||November 2002||2002-11-01|October 2008|2008-10-01|January 2003|Actual|2003-01-01|November 2002|Actual|2002-11-01||Interventional|||Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions|Single Dose Two-Way Crossover Fed Bioequivalence Study of Minocycline 100 mg Capsules in Healthy Volunteers|Completed||N/A|24|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:31.302943|2017-02-18 13:47:31.302943
NCT00777400|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2013-05-13|||December 2008||2008-12-01|May 2013|2013-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells|A Pilot Trial to Assess the Effect of CNI Conversion to Efalizumab in T Regulatory Cells in Renal Transplantation|Withdrawn||Phase 1/Phase 2|0|Actual|University of California, San Francisco||1||"New safety information reported in the post-marketing setting with efalizumab for treatment of~   chronic plaque psoriasis and trial conduct feasibility issues."|f||||t||||||||||2017-02-18 13:47:31.41835|2017-02-18 13:47:31.41835
NCT00777387|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2014-01-06|||August 2008||2008-08-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Randomized Controlled Trial Comparing Slow-freezing to Vitrification of Oocytes|Cryopreservation of Oocytes: A Randomized Controlled Trial Comparing Slow-freezing to Vitrification|Terminated||N/A|14|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2||Studies emerged that demonstrated the superiority of vitrification|f||||f||||||||||2017-02-18 13:47:31.531948|2017-02-18 13:47:31.531948
NCT00777374|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2011-01-31|||October 2008||2008-10-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|ZU-SkinSIT-003||Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration|Single Center Phase I/IIa, Placebo Controlled, Randomized, Double-blind Preseasonal Study to Assess Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration|Completed||Phase 2|97|Actual|University of Zurich||2|||f||||t||||||||||2017-02-18 13:47:31.64738|2017-02-18 13:47:31.64738
NCT00777361|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2010-11-17|||October 2008||2008-10-01|November 2010|2010-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|MB||Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers|An Open, Two Period, Single Dose, Phase I Study of the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics Following Oral Administration of [14C]-AZD3480 and the Pharmacokinetics of AZD3480 Following Intravenous Administration to Healthy Male Volunteers With Different CYP2D6 Genotype|Terminated||Phase 1|9|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:47:31.756048|2017-02-18 13:47:31.756048
NCT00777348|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2009-04-07|||November 2007||2007-11-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|AERIA||To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol|Clinical Trial to Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol in Comparison to the Single Components and Placebo in Adults With Exercise Induced Asthma Randomised, Placebo-Controlled, Double-Blind, Crossover, Multicentre Study|Completed||Phase 2|62|Actual|MEDA Pharma GmbH & Co. KG||4|||f||||t||||||||||2017-02-18 13:47:31.863641|2017-02-18 13:47:31.863641
NCT00777179|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-08-29|2011-04-27||October 2008||2008-10-01|August 2016|2016-08-01|December 2011|Actual|2011-12-01|January 2010|Actual|2010-01-01||Interventional|||Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy|Randomized, Double-blinded, Placebo-controlled Phase II Study of Vandetanib (ZactimaTM) Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy|Completed||Phase 2|117|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:47:37.255239|2017-02-18 13:47:37.255239
NCT00777335|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2015-10-27|2012-01-06||February 2009||2009-02-01|October 2015|2015-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer|A Randomized Phase II, Open-label Multicenter Trial of Panobinostat Monotherapy in Women With HER2 Positive Locally Recurrent or Metastatic Breast Cancer|Terminated||Phase 2|4|Actual|Translational Research in Oncology|The recruitment rate has shown to be very low worldwide. In total, 4 patients only were recruited, instead of the 132 initially targeted. Due to the very small number of subjects randomized in this study, only descriptive analyses have been made.|2||Very low recruitement rate.|f||||f||||||||||2017-02-18 13:47:31.983394|2017-02-18 13:47:31.983394
NCT00777322|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2011-07-20|||October 2008||2008-10-01|April 2009|2009-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|T-Cat||T-Cat Laser & Cross-linking for Keratoconus|Pilot Study of Excimer Laser Topography-Computer Assisted Treatment (T-Cat) Combined With Corneal Collagen Cross-linking With Riboflavin and UV Light|Completed||N/A|15|Actual|Moorfields Eye Hospital NHS Foundation Trust||1|||f||||t||||||||||2017-02-18 13:47:32.55843|2017-02-18 13:47:32.55843
NCT00777309|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2013-02-22||2013-02-06|September 2008||2008-09-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)|A Randomized Phase 2 Study of Erlotinib Plus ARQ 197 Versus Erlotinib Plus Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|167|Actual|ArQule||2|||f||||f||||||||||2017-02-18 13:47:32.66926|2017-02-18 13:47:32.66926
NCT00777296|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-11-17||2016-11-17|February 2007||2007-02-01|September 2015|2015-09-01|February 2010|Actual|2010-02-01|February 2008|Actual|2008-02-01||Interventional|||Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™)|Phase 1b/2a Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) In Cystic Fibrosis Patients With Chronic Infections Due To Pseudomonas Aeruginosa.|Completed||Phase 1/Phase 2|||Insmed Incorporated||4|||f||||t||||||||||2017-02-18 13:47:32.808774|2017-02-18 13:47:32.808774
NCT00777283|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2015-03-06|||September 2008||2008-09-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:47:32.926762|2017-02-18 13:47:32.926762
NCT00777270|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2008-10-21|||September 2005||2005-09-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|July 2007|Actual|2007-07-01||Interventional|||Continuous Versus Interrupted Sutures for Repair of Episiotomy or Second Degree Tears: a Randomised Controlled Trial|Continuous Versus Interrupted Sutures for Repair of Episiotomy or Second Degree Tears: a Randomised Controlled Trial|Completed||N/A|445|Actual|Hospital Universitario Principe de Asturias||2|||f||||t||||||||||2017-02-18 13:47:32.981018|2017-02-18 13:47:32.981018
NCT00777257|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2014-01-21|2009-09-24||April 2005||2005-04-01|January 2014|2014-01-01|September 2007|Actual|2007-09-01|March 2007|Actual|2007-03-01||Interventional|||Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine|Immunogenicity and Safety of Meningococcal (Groups A, C, Y, and W-135) Diphtheria Toxoid Conjugate Vaccine (Menactra®) in Adolescents in the US When Administered Concomitantly With Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap Vaccine)|Completed||Phase 4|1345|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 13:47:33.166212|2017-02-18 13:47:33.166212
NCT00777244|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2013-11-08|||April 2008||2008-04-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|December 2013|Anticipated|2013-12-01||Interventional|ADIUVO||Efficacy of Adjuvant Mitotane Treatment (ADIUVO)|Efficacy of Adjuvant Mitotane Treatment in Prolonging Recurrence-free Survival in Patients With Adrenocortical Carcinoma at Low-intermediate Risk of Recurrence|Unknown status|Recruiting|Phase 3|200|Anticipated|University of Turin, Italy||2|||f||||t||||||||||2017-02-18 13:47:33.885672|2017-02-18 13:47:33.885672
NCT00777231|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-09-12||2012-10-31|January 2005||2005-01-01|September 2016|2016-09-01|August 2013|Actual|2013-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies|1)Mixed Chimerism to Treat Sickle Cell Disease: Extended Protocol 2)Mixed Chimerism to Treat Non-Malignant Disorders of the Hematopoietic Stem Cell 3)Transplantation of Allogeneic Bone Marrow Enriched for Graft Facilitating Cells in the Treatment of Aplastic Anemia|Completed||Phase 1/Phase 2|9|Actual|University of Louisville||3|||f||||t||||||||||2017-02-18 13:47:34.02638|2017-02-18 13:47:34.02638
NCT00777218|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2010-06-23|||August 2007||2007-08-01|June 2010|2010-06-01|July 2011|Anticipated|2011-07-01|December 2010|Anticipated|2010-12-01||Interventional|||Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine|Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine|Unknown status|Recruiting|N/A|90|Anticipated|University of South Alabama||3|||f||||f||||||||||2017-02-18 13:47:34.131704|2017-02-18 13:47:34.131704
NCT00777205|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2015-04-06|2014-12-30||February 2010||2010-02-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|DIAL-UP|Fifty-six of the patients randomized to the telephone-based peer support intervention were excluded from main study analyses because of an unforeseen disruption in their 6-month intervention that was unrelated to patient characteristics.|Improving Depression Management Through Peer Support|Improving Depression Management Through Peer Support|Completed||N/A|443|Actual|VA Office of Research and Development|56 of the patients randomized to the telephone-based peer support intervention were excluded from main study analyses because of an unforeseen disruption in their 6-month intervention that was unrelated to patient characteristics.|2|||f||||t||||||||||2017-02-18 13:47:34.242338|2017-02-18 13:47:34.242338
NCT00777192|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-02-18|||August 2008||2008-08-01|February 2016|2016-02-01||||August 2017|Anticipated|2017-08-01||Observational|||Longitudinal Study of Symptoms in Colorectal Cancer|Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer|Active, not recruiting||N/A|500|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Serum and cell samples will also be collected during chemotherapy for analysis of cytokines~     and their relationship to symptom production.~   "|||2017-02-18 13:47:37.146707|2017-02-18 13:47:37.146707
NCT00777166|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2014-03-13|||December 2005||2005-12-01|March 2014|2014-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia|Phase 4 Study of Oxytocin Used During Cesarean Section|Completed||Phase 4|103|Actual|Uppsala University||2|||f||||f||||||||||2017-02-18 13:47:37.96147|2017-02-18 13:47:37.96147
NCT00777153|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-11-07|2012-04-03||October 2008||2008-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|April 2010|Actual|2010-04-01||Interventional|REGAL||Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma|A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone|Completed||Phase 3|423|Actual|AstraZeneca||3|||f||||t||||||||||2017-02-18 13:47:38.232105|2017-02-18 13:47:38.232105
NCT00777140|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-07-04|||September 2008||2008-09-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|TANDEM-1||Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion|Double-blind, Randomized, Placebo Controlled, Dose-finding Phase 2 Clinical Trial of Intravenous Deferoxamine in Patients With Acute Ischemic Stroke Treated With Tissue Plasminogen Activator|Completed||Phase 2|62|Actual|Germans Trias i Pujol Hospital||2|||f||||t||||||||||2017-02-18 13:47:39.178381|2017-02-18 13:47:39.178381
NCT00777127|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2013-01-31|||December 2008||2008-12-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|LEIDA||Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses|Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp (LEIDA)|Completed||Phase 4|258|Actual|MEDA Pharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 13:47:39.284759|2017-02-18 13:47:39.284759
NCT00777114|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2011-03-08|||October 2008||2008-10-01|March 2011|2011-03-01||||November 2011|Anticipated|2011-11-01||Interventional|||Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy|Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy|Unknown status|Recruiting|Phase 1|25|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-02-18 13:47:39.413558|2017-02-18 13:47:39.413558
NCT00777101|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-06-22||2012-04-17|February 2009||2009-02-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|March 2011|Actual|2011-03-01||Interventional|||Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer|A Phase 2 Randomized Open-Label Study of Neratinib Versus Lapatinib Plus Capecitabine For The Treatment Of ErbB-2 Positive Locally Advanced Or Metastatic Breast Cancer|Active, not recruiting||Phase 2|233|Actual|Puma Biotechnology, Inc.||2|||f||||t||||||||||2017-02-18 13:47:39.712871|2017-02-18 13:47:39.712871
NCT00777088|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-11-17|||October 2008||2008-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|PUFS||Pipeline for Uncoilable or Failed Aneurysms|Pipeline for Uncoilable or Failed Aneurysms|Completed||N/A|135|Actual|Medtronic Neurovascular Clinical Affairs||1|||f||||f||||||||||2017-02-18 13:47:40.03122|2017-02-18 13:47:40.03122
NCT00777075|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2008-10-21|||July 2003||2003-07-01|October 2008|2008-10-01|November 2005||2005-11-01|||||Interventional|||L-Arginine and Erectile Dysfunction|Oral Administration of L-Arginine in Patients With Erectile Dysfunction|Completed||Phase 4|57||Hannover Medical School||2|||f||||f||||||||||2017-02-18 13:47:40.139901|2017-02-18 13:47:40.139901
NCT00777062|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2014-06-30|2013-12-12||July 2009||2009-07-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|July 2012|Actual|2012-07-01||Interventional|||VIVITROL as a Treatment for Cocaine and Alcohol Dependence|A Phase II, Randomized, Double-Blind Pilot Trial of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension) for the Treatment of Cocaine and Alcohol Dependence|Completed||Phase 2|80|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 13:47:40.236047|2017-02-18 13:47:40.236047
NCT00777049|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-07-14|2016-05-26||February 2009||2009-02-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer|A Phase II, Open-label Multicenter Trial of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 2|54|Actual|Translational Research in Oncology|In Arm II, low recruitment resulted in insufficient data (and enrollment was stopped). In Arm I, the required number of tumor responses was not reached. Unable to determine efficacy (small sample); secondary objectives also removed from the protocol.|2|||f||||f||||||||No||2017-02-18 13:47:40.644226|2017-02-18 13:47:40.644226
NCT00777036|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2017-01-27|||February 2009||2009-02-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2016|Actual|2016-09-01||Interventional|||A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib|A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib|Active, not recruiting||Phase 2|139|Anticipated|Bristol-Myers Squibb||3|||f||||t||||||||||2017-02-18 13:47:41.396481|2017-02-18 13:47:41.396481
NCT00777023|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2012-02-21|2012-01-16||October 2008||2008-10-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Study of Gabapentin Extended Release (G-ER)in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women.|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 3|565|Actual|Depomed||3|||f||||f||||||||||2017-02-18 13:47:41.795835|2017-02-18 13:47:41.795835
NCT00777010|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2017-01-27|||September 2008||2008-09-01|January 2017|2017-01-01|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Energy Metabolism and Cognitive Aging|Energy Metabolism and Cognitive Aging|Recruiting||N/A|60|Anticipated|University of Cincinnati||2|||f||||f||||||||No||2017-02-18 13:47:42.496695|2017-02-18 13:47:42.496695
NCT00776997|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2013-11-22|2012-04-25||November 2008||2008-11-01|November 2013|2013-11-01|September 2011|Actual|2011-09-01|December 2010|Actual|2010-12-01||Interventional|||LINX Reflux Management System Clinical Study Protocol|LINX Reflux Management System Clinical Study Protocol|Completed||N/A|100|Actual|Torax Medical Incorporated||1|||f||||f||||||||||2017-02-18 13:47:42.620928|2017-02-18 13:47:42.620928
NCT00776984|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2014-09-09|2012-07-20||October 2008||2008-10-01|September 2014|2014-09-01||||July 2011|Actual|2011-07-01||Interventional|||Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)|A Phase III Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (5 mcg/Day) Over 48 Weeks as add-on Controller Therapy on Top of Usual Care in Patients With Severe Persistent Asthma|Completed||Phase 3|453|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:47:42.947832|2017-02-18 13:47:42.947832
NCT00776945|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-06-05|||January 2009||2009-01-01|November 2013|2013-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|fPAM||Feasibility and Functionality of fPAM Imaging in Melanoma|Determine the Feasibility and Functionality of fPAM Imaging for the in Vivo Characterization and Early Diagnosis of Melanoma|Terminated||N/A|2|Actual|Washington University School of Medicine|||1|no funding|f||||f||||||Samples Without DNA|"~     Tissue biopsies may be performed if locoregional recurrence validated by clinical~     examination.~   "|||2017-02-18 13:47:44.53922|2017-02-18 13:47:44.53922
NCT00776932|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2015-05-26|||June 2007||2007-06-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|August 2011|Actual|2011-08-01||Observational|JRPIT||Chronic Knee Pain Study|Disparity in Joint Replacement: Pathway to Intervention|Completed||N/A|852|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 13:47:44.622615|2017-02-18 13:47:44.622615
NCT00776919|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-21|2016-10-11|2011-12-21||October 2008||2008-10-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne|A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of A Clindamycin / Benzoyl Peroxide Gel Versus Clindamycin Gel Versus Benzoyl Peroxide Gel Versus Vehicle Gel In Subjects With Acne Vulgaris|Completed||Phase 3|1315|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:47:44.71932|2017-02-18 13:47:44.71932
NCT00776906|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-01-19|||October 2008||2008-10-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Advance® 18PTX® Balloon Catheter Study|Advance® 18PTX® Balloon Catheter Study: Treatment of Lesions in Superficial Femoral Artery/Popliteal Artery With a Paclitaxel-coated Balloon|Completed||N/A|150|Actual|Cook||2|||f||||||||||||||2017-02-18 13:47:46.283204|2017-02-18 13:47:46.283204
NCT00776373|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-19|2016-06-07|||January 2007||2007-01-01|June 2016|2016-06-01||||December 2009|Actual|2009-12-01||Interventional|UPCC 25406||Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies|A Phase I/II, Open-label Single Institution Study Evaluating Rapamycin in Combination With High-dose Etoposide and Cytarabine in Relapsed or Refractory Aggressive Lymphoid Malignancies|Terminated||Phase 1/Phase 2|4|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 13:47:46.370685|2017-02-18 13:47:46.370685
NCT00776360|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2015-04-06|||December 2008||2008-12-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Effect of Oxytocin on the Gastric Emptying|The Effect of Oxytocin on Gastric Emptying in Patients With Gastro Paresis|Completed||Early Phase 1|12|Actual|Skane University Hospital||2|||f||||t||||||||||2017-02-18 13:47:46.479329|2017-02-18 13:47:46.479329
NCT00776347|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-10-14|||October 2008||2008-10-01|October 2015|2015-10-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)|Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)|Completed||N/A|24|Actual|Osaka University||1|||f||||f||||||||||2017-02-18 13:47:46.589509|2017-02-18 13:47:46.589509
NCT00776334|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-20|||October 2002||2002-10-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|November 2002|Actual|2002-11-01||Interventional|||Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions|The Objective of This Study is to Compare the Relative Bioavailability of Fosinopril Sodium 40 mg Tablets (Ranbaxy Laboratories Limited, Lot No. 1238312) With That of Monopril® (Bristol-Myers Squibb, Lot No. 1D47960), in Healthy Adult Subjects Under Fasting Conditions.|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:46.700037|2017-02-18 13:47:46.700037
NCT00776321|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-20|||September 2006||2006-09-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia|A Placebo Controlled, Double Blind, Randomised, 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia|Completed||Phase 2|142|Actual|Karo Bio AB||3|||f||||t||||||||||2017-02-18 13:47:46.797689|2017-02-18 13:47:46.797689
NCT00776893|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:47:46.892772|2017-02-18 13:47:46.892772
NCT00776880|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2009-12-22|||January 2009||2009-01-01|November 2009|2009-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|ASAINPA||Does American Society of Anesthesiologists (ASA) Physical Status Scale Enough in Patients Assessment|Reevaluating the American Society of Anesthesiologists (ASA) Physical Status System in Patients Assessment and Compared With a New Scale of Physical-psycho-social Gauge Raised by Our Institution|Completed||N/A|1500|Actual|Nanjing Medical University|||2||f||||t||||||||||2017-02-18 13:47:46.944298|2017-02-18 13:47:46.944298
NCT00776867|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-09-19|||October 2008||2008-10-01|September 2016|2016-09-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors|Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors|Active, not recruiting||Phase 1|36|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:47:47.03489|2017-02-18 13:47:47.03489
NCT00776854|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-18|2008-10-20|||November 2008||2008-11-01|October 2008|2008-10-01|November 2009|Anticipated|2009-11-01|July 2009|Anticipated|2009-07-01||Interventional|||Bioburden Reduction of Diabetic Foot Ulcer|Noveon Laser Treatment to Effect Bioburden Reduction or Elimination in Diabetic Foot Ulcer: A Davice Performance Clinical Study|Unknown status|Not yet recruiting|Phase 1|20|Anticipated|Nomir Medical Technologies||1|||f||||||||||||||2017-02-18 13:47:47.129907|2017-02-18 13:47:47.129907
NCT00776841|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-19|2010-11-02|||September 2008||2008-09-01|November 2010|2010-11-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||A Phase 1 Single and Multiple-Dose Study of Aramchol in Healthy Male Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Escalating Single and Multiple-Dose Study of Aramchol in Healthy Male Volunteers|Completed||Phase 1|41|Actual|Galmed Medical Reserch||7|||f||||t||||||||||2017-02-18 13:47:47.204309|2017-02-18 13:47:47.204309
NCT00776451|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2009-06-02|||November 2008||2008-11-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Observational|||Usability of the PreView PHP for Home Use in Intermediate AMD Patients|Usability of the PreView PHP for Home Use in Intermediate Age Related Macular Degeneration Patients|Completed||N/A|66|Anticipated|Notal Vision Ltd|||1||f||||t||||||||||2017-02-18 13:47:51.690381|2017-02-18 13:47:51.690381
NCT00776828|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-18|2013-12-15|||November 2006||2006-11-01|December 2013|2013-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|CILON-T||The Efficacy of CILostazol ON Ischemic Complications After DES Implantation|Influence of CILostazol-based Triple Anti-platelet Therapy ON Ischemic Complication After Drug-eluting stenT Implantation|Completed||Phase 4|960|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 13:47:47.51515|2017-02-18 13:47:47.51515
NCT00776815|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:47:47.628336|2017-02-18 13:47:47.628336
NCT00776802|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-19|2013-06-21|||July 2008||2008-07-01|June 2013|2013-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|GCS-100LE||GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Phase 1/2 Study of GCS-100 in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B Cell Lymphoma|Withdrawn||Phase 1/Phase 2|0|Actual|La Jolla Pharmaceutical Company||1||Lack of funding|f||||f||||||||||2017-02-18 13:47:47.6772|2017-02-18 13:47:47.6772
NCT00776789|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2014-01-10|2010-06-01||August 2008||2008-08-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Early Skin to Skin Contact on Breast Feeding Behaviour in Term Newborns: A Randomized Controlled Trial|Effect of Early Skin to Skin Contact on Breast Feeding Behaviour in Term Newborns: A Randomized Controlled Trial|Completed||N/A|41|Actual|All India Institute of Medical Sciences, New Delhi|This study evaluated breast feeding behaviour of term neonates with only one video, which may not have been an accurate marker of feeding behavior.There could a possibility of inadvertent bias at the time of intervention.|2|||f||||f||||||||||2017-02-18 13:47:47.803936|2017-02-18 13:47:47.803936
NCT00776776|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-21|||April 2005||2005-04-01|August 2008|2008-08-01|April 2010|Anticipated|2010-04-01|April 2007|Actual|2007-04-01||Observational|FABS||Follow-up of Adolescent Bariatric Surgery|Follow-up of Adolescent Bariatric Surgery|Unknown status|Enrolling by invitation|N/A|180|Anticipated|Children's Hospital Medical Center, Cincinnati|||2||f||||f||||||||||2017-02-18 13:47:48.220741|2017-02-18 13:47:48.220741
NCT00776763|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2011-07-20|||October 2008||2008-10-01|October 2008|2008-10-01|December 2010|Actual|2010-12-01|October 2009|Actual|2009-10-01||Interventional|KIA-ProRet||Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab|The Profile of the Growth Factors and Other Mediators of Angiogenesis in the Ocular Fluids in Proliferative Retinopathies (AMD and PDR) Before and After the Intravitreal Administration of Bevacizumab (Avastin) as an Anti-VEGF Blocker|Completed||Phase 2|150|Anticipated|Ophthalmological Association Edelweiss||1|||f||||||||||||||2017-02-18 13:47:48.304735|2017-02-18 13:47:48.304735
NCT00776750|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||September 2003||2003-09-01|October 2008|2008-10-01|May 2004||2004-05-01|May 2004||2004-05-01||Interventional|||Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients|Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients|Completed||Phase 4|407|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-02-18 13:47:48.402028|2017-02-18 13:47:48.402028
NCT00776737|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-18|2017-01-24|||October 16, 2008||2008-10-16|January 14, 2011|2011-01-14|January 14, 2011||2011-01-14|||||Observational|||Studies of Measures of Attention|Studies of Measures of Attention|Completed||N/A|36|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:47:48.488584|2017-02-18 13:47:48.488584
NCT00776724|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-19|2012-11-15|||November 2008||2008-11-01|November 2012|2012-11-01|May 2013|Anticipated|2013-05-01|March 2013|Anticipated|2013-03-01||Interventional|TaiNAC||Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm|A Randomized Phase III Study of Docetaxel/ Epirubicin Versus Tailored Regimens as Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm|Unknown status|Recruiting|Phase 3|272|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:47:48.583368|2017-02-18 13:47:48.583368
NCT00776711|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-18|2017-01-24|||October 16, 2008||2008-10-16|January 14, 2011|2011-01-14|January 14, 2011|Actual|2011-01-14|January 14, 2011|Actual|2011-01-14||Interventional|||Vaccine for Prevention of Bird Flu|An Open-Label, Randomized Phase I Study in Healthy Adults of 4 Prime-Boost Schedules With Monovalent Influenza Subunit Virion (H5N1) Vaccine (Sanofi Pasteur, Inc), Administered Alone or Following Recombinant DNA Plasmid (H5) Vaccine (VRC, NIAID)|Completed||Phase 1|60|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:47:48.696728|2017-02-18 13:47:48.696728
NCT00776698|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-11-01|||April 2009||2009-04-01|November 2016|2016-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.|An Open Label Study to Establish the Preferred Dose and to Assess Safety and Overall Response Rate of Avastin in Combination With Concomitant Thoracic Radiation and Chemotherapy (Cisplatin and Etoposide) in Locally Advanced Unresectable Non-squamous Non-small Cell Lung Cancer.|Completed||Phase 1|1|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:47:48.790328|2017-02-18 13:47:48.790328
NCT00776685|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2011-06-24|||May 2007||2007-05-01|December 2010|2010-12-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|Adventure||Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse|Cognitive Behavioral Interventions That Target Personality Risk for Substance Abuse and Mental Illness: Delivery by Educational Professionals|Completed||Phase 2/Phase 3|3190|Actual|King's College London||4|||f||||t||||||||||2017-02-18 13:47:48.889108|2017-02-18 13:47:48.889108
NCT00776672|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-20|||October 2002||2002-10-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|October 2002|Actual|2002-10-01||Interventional|||Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions|The Objective of This Study is to Compare the Relative Bioavailability of Fosinopril Sodium 40 mg Tablets (Ranbaxy Laboratories Limited, Lot No. 1238312) With That of Monopril® in Healthy Adult Subjects Under Non-Fasting Conditions|Completed||N/A|24|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:48.996667|2017-02-18 13:47:48.996667
NCT00776659|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2013-09-12|2013-09-12||December 2008||2008-12-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin|An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin|Terminated||N/A|39|Actual|Pfizer|Study was terminated due to slow enrollment and observational nature of the study. Low number of participants enrolled was not sufficient to conduct the planned analysis. Study was not terminated due to safety concerns.||1|See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:47:49.096488|2017-02-18 13:47:49.096488
NCT00776646|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||May 2006||2006-05-01|October 2008|2008-10-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|||Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two- Sequence, Single-Dose, Crossover Bioavailability Study Comparing Hydrochlorothiazide 50 mg Tablet of Ohm Laboratories (A Subsidiary of Ranbaxy Pharmaceuticals USA) With Hydrochlorothiazide 50 mg Tablet of IVAX Pharmaceuticals in Healthy, Adult, Human, Male Subjects Under Fasting Condition|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:49.387329|2017-02-18 13:47:49.387329
NCT00776633|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-08-29|||September 2008||2008-09-01|August 2014|2014-08-01|September 2014|Anticipated|2014-09-01|December 2013|Actual|2013-12-01||Interventional|ISAR-TRIPLE||Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation|Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting|Unknown status|Active, not recruiting|Phase 4|614|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 13:47:49.484267|2017-02-18 13:47:49.484267
NCT00776620|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||July 2003||2003-07-01|October 2008|2008-10-01|September 2003|Actual|2003-09-01|August 2003|Actual|2003-08-01||Interventional|||Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions|A Relative Bioavailability Study of Glimepiride 1 MG Tablets Under Fed Conditions|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:49.598024|2017-02-18 13:47:49.598024
NCT00776607|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||April 2007||2007-04-01|September 2008|2008-09-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|LIT||Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)|Randomized, Controlled, Parallel-Group Prospective Study to Investigate the Clinical Effectiveness of Early Insulin Treatment in Patients With Latent Autoimmune Diabetes in Adults|Unknown status|Recruiting|N/A|200|Anticipated|Abertawe Bro Morgannwg University NHS Trust||2|||f||||t||||||||||2017-02-18 13:47:49.701284|2017-02-18 13:47:49.701284
NCT00776594|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-09-12|2015-07-29||October 2008||2008-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|December 2014|Actual|2014-12-01||Interventional|||Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy|Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy|Completed||Phase 2|102|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 13:47:49.821255|2017-02-18 13:47:49.821255
NCT00776581|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2009-09-17|||January 2009||2009-01-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|POPIC||Ten-year Practice of Labor Pain Control in China|A Ten-year Practice of Labor Pain Control in China|Completed||N/A|40000|Actual|Nanjing Medical University|||4||f||||t||||||||||2017-02-18 13:47:50.377775|2017-02-18 13:47:50.377775
NCT00776568|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||February 2008||2008-02-01|October 2008|2008-10-01||||August 2009|Anticipated|2009-08-01||Interventional|||Treatment of Refractory Angina Pectoris by Shock Wave Therapy|Extracorporeal Shock Wave Therapy (ESWT) for the Treatment of Refractory Angina Pectoris|Unknown status|Active, not recruiting|Phase 3|60|Actual|Universal Research Group||2|||f||||t||||||||||2017-02-18 13:47:50.484052|2017-02-18 13:47:50.484052
NCT00776555|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-03-03|2010-05-05||November 2008||2008-11-01|June 2010|2010-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution|A Single-Blind, Randomized Study of the Comparative Drug Likeability and Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as a Solution|Terminated||Phase 1|3|Actual|Shire|Shire decided to cancel this study on march 31, 2009 due to changes in business priorities. The study termination was not related to any data or safety concerns.|2||The study was stopped by the sponsor based on a non-safety related business priority decision.|f||||f||||||||||2017-02-18 13:47:50.695405|2017-02-18 13:47:50.695405
NCT00776542|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||October 2002||2002-10-01|October 2008|2008-10-01|January 2003|Actual|2003-01-01|November 2002|Actual|2002-11-01||Interventional|||Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions|Single Dose Two-Way Crossover Fasted Bioequivalence Study of Minocycline 100 mg Capsules in Healthy Volunteers|Completed||N/A|28|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:51.01249|2017-02-18 13:47:51.01249
NCT00776529|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2009-01-28|||October 2008||2008-10-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Combination of Strength and Sensorimotor Training|Randomized Controlled Trial of Two Combinations of Strength and Sensorimotor Training: Effects on Strength, Power and Balance|Completed||Phase 1|30|Actual|University of Applied Sciences of Western Switzerland||2|||f||||f||||||||||2017-02-18 13:47:51.112755|2017-02-18 13:47:51.112755
NCT00776516|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2013-07-01|||October 2008||2008-10-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers|A Phase 1, Open-Label, Drug Interaction Study to Evaluate the Effect of Repeat Doses of Rifampin on the Single-Dose Pharmacokinetics of Mirabegron (YM178)|Completed||Phase 1|24|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 13:47:51.20236|2017-02-18 13:47:51.20236
NCT00776503|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2014-03-19|||May 2008||2008-05-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|GFMVOR2007||Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia|A Phase I/II Study of Vorinostat in Combination With Low Dose Ara-C for Patients With Intermediate-2 or High Risk Myelodysplastic Syndromes|Completed||Phase 1/Phase 2|52|Actual|Groupe Francophone des Myelodysplasies||2|||f||||t||||||||||2017-02-18 13:47:51.311507|2017-02-18 13:47:51.311507
NCT00776490|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||July 2003||2003-07-01|October 2008|2008-10-01|September 2003|Actual|2003-09-01|August 2003|Actual|2003-08-01||Interventional|||Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions|A Relative Bioavailability Study of Glimepiride 1 MG Tablets Under Fasting Conditions|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:51.428921|2017-02-18 13:47:51.428921
NCT00776477|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-19|2008-10-20|||December 2007||2007-12-01|October 2008|2008-10-01||||December 2008|Anticipated|2008-12-01||Interventional|||The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease||Unknown status|Recruiting|Phase 3|300|Anticipated|China National Center for Cardiovascular Diseases||2|||f||||||||||||||2017-02-18 13:47:51.525651|2017-02-18 13:47:51.525651
NCT00776464|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-18|2008-10-20|||November 2008||2008-11-01|October 2008|2008-10-01|January 2010|Anticipated|2010-01-01|November 2009|Anticipated|2009-11-01||Interventional|||Treating Onychomychosis||Unknown status|Not yet recruiting|Phase 2/Phase 3|60|Anticipated|Nomir Medical Technologies||1|||f||||||||||||||2017-02-18 13:47:51.615848|2017-02-18 13:47:51.615848
NCT00776438|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2015-06-16|||September 2007||2007-09-01|June 2015|2015-06-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines|Evaluation of the Cellular, Humoral and Mucosal Immune Response in Adults and Elderly Subjects Vaccinated Either With an Inactivated Influenza Vaccine Administered Via the Intradermal Route or an Inactivated Influenza Vaccine Administered Via the Intramuscular Route|Completed||Phase 2|160|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 13:47:51.940643|2017-02-18 13:47:51.940643
NCT00776425|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-10-01|||March 2007||2007-03-01|October 2015|2015-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study of the Quality of Life and Treatment Response to Once Weekly NeoRecormon (Epoetin Beta) Treatment in Anemic Patients With Solid and Lymphoid Malignancies.|QUALITY OF LIFE BENEFIT IN ANEMIC CANCER PATIENTS TREATED WITH NEORECORMON (EPOETIN BETA): QUALITY OF LIFE TREATMENT RESPONSE AND CLINICAL EVALUATION OF ONCE-WEEKLY DOSING|Completed||Phase 4|125|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:47:52.060074|2017-02-18 13:47:52.060074
NCT00776412|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-18|2017-01-27|||October 16, 2008||2008-10-16|January 19, 2017|2017-01-19||||||||Observational|||Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults|Biomarkers of Inflammation, Coagulation, and Endothelial Function in HIV-Infected Adults|Recruiting||N/A|375|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:47:52.176083|2017-02-18 13:47:52.176083
NCT00776399|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2015-07-28|||October 2008||2008-10-01|July 2015|2015-07-01|August 2017|Anticipated|2017-08-01|April 2017|Anticipated|2017-04-01||Interventional|||Radiofrequency Ablation in Resectable Colorectal Lung Metastasis|Radiofrequency Ablation in Resectable Colorectal Lung Metastasis: A Phase-II Clinical Trial|Active, not recruiting||Phase 2|70|Anticipated|Mie University||1|||f||||t||||||||||2017-02-18 13:47:52.282373|2017-02-18 13:47:52.282373
NCT00776386|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-19|2008-10-20|||July 2008||2008-07-01|July 2008|2008-07-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Observational|||Determinants and Practical Significance of Change in Motor Ability, Functional Performance, and HRQOL After Stroke|Determinants and Practical Significance of Change in Motor Ability, Functional Performance, and HRQOL After Distributed Constraint-Induced Therapy in Stroke|Unknown status|Active, not recruiting|N/A|70|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-02-18 13:47:52.412468|2017-02-18 13:47:52.412468
NCT00776308|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2012-01-23|||October 2008||2008-10-01|January 2012|2012-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|MBI||Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery|Molecular Breast Imaging in the Preoperative Evaluation of Women With Biopsy Proven Breast Cancer|Completed||N/A|98|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 13:47:52.495516|2017-02-18 13:47:52.495516
NCT00776295|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2013-01-16|2011-10-04||May 2007||2007-05-01|January 2013|2013-01-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer|Phase II Trial of Autologous Peripheral Blood Hematopoietic Cell Transplantation (PBHCT) Followed by Dendritic Cell p53 Vaccination and Adoptive T Cell Transfer in Patients With Limited Stage Small Cell Lung Cancer|Terminated||Phase 2|2|Actual|H. Lee Moffitt Cancer Center and Research Institute|Early termination of trial due to small number of subjects thus leading to unreliabe data|1||Low accrual|f||||t||||||||||2017-02-18 13:47:52.592259|2017-02-18 13:47:52.592259
NCT00776282|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||July 2006||2006-07-01|October 2008|2008-10-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions|An Open Label, Balanced, Randomized, Two-Treatment, Two-Sequence, Two-Period, Single-Dose, Crossover, Bioavailability Study on Loratadine Formulations Comparing Loratadine 10 mg Orally Disintegrating Tablets of Ohm Laboratories, Inc. (A Subsidiary of Ranbaxy Pharmaceuticals Inc) With Claritin® Reditabs® 10 mg Tablet (Containing Loratadine 10 mg) of Schering- Plough Healthcare Product Inc, in Healthy, Adult, Male, Human Subjects Under Fed Condition|Completed||N/A|80|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:52.84105|2017-02-18 13:47:52.84105
NCT00776269|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||October 2008||2008-10-01|September 2008|2008-09-01||||||||Interventional|||Comparison of Argon Laser and Radiofrequency in Trichiasis Treatment|Comparison the Result of Argon Laser and Radiofrequency in Trichiasis Treatment of Patients Referred to Labbafinejad Oculoplastic Clinic|Unknown status|Recruiting|N/A|||Shahid Beheshti University of Medical Sciences||1|||f||||f||||||||||2017-02-18 13:47:52.947232|2017-02-18 13:47:52.947232
NCT00776256|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-18|2008-10-20|||February 2007||2007-02-01|October 2008|2008-10-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Effects of Oligofructose and Barley on Satiety and Energy Intake|The Effect of Meal Replacement Bars Containing Different Types of Fibres (Oligofructose and/or Barley) on Satiety and Energy Intake|Completed||N/A|24|Actual|Unilever R&D||4|||f||||f||||||||||2017-02-18 13:47:53.034485|2017-02-18 13:47:53.034485
NCT00776243|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2010-05-10|||October 2008||2008-10-01|October 2009|2009-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Short-term Effect of Intensive Insulin Therapy on Incretin Secretion|Short-term Effect of Intensive Insulin Therapy on Incretin Secretion|Completed||N/A|30|Anticipated|The Catholic University of Korea|||2||f||||f||||||Samples Without DNA|"~     plasma serum~   "|||2017-02-18 13:47:53.147325|2017-02-18 13:47:53.147325
NCT00776230|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2016-03-29|2013-12-05||September 2008||2008-09-01|March 2016|2016-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling|Immunogenicity of a Commercial Batch of the Japanese Encephalitis Vaccine IC51 up to Twenty-four Months Post Filling. An Open-label, Multicenter, Phase 3 Study|Completed||Phase 3|304|Actual|Valneva Austria GmbH||3|||f||||f||||||||||2017-02-18 13:47:53.250523|2017-02-18 13:47:53.250523
NCT00776217|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||June 2006||2006-06-01|October 2008|2008-10-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions|An Open Label, Balanced, Randomized, Two-Treatment, Two-Sequence, Two-Period, Single-Dose, Crossover, Bioavailability Study on Loratadine Formulations Comparing Loratadine 10 mg Orally Disintegrating Tablets of Ohm Laboratories, Inc. (A Subsidiary of Ranbaxy Pharmaceuticals Inc) With Claritin® Reditabs 10 mg Tablet (Containing Loratadine 10 mg) of Schering- Plough Healthcare Product Inc, in Healthy, Adult, Male, Human Subjects Under Fasting Condition|Completed||N/A|80|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:53.799368|2017-02-18 13:47:53.799368
NCT00776191|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2015-06-03|||September 2008||2008-09-01|June 2015|2015-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|NephropaedPD01||Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism|Randomized, Multicenter Cross-over Study in Investigating the Effect of Bicarbonate-based Solutions (Physioneal 35 vs. 40) on Protein Metabolism in Children and Adolescents on Chronic Peritoneal Dialysis|Terminated||Phase 4|5|Actual|University of Erlangen-Nürnberg Medical School||2||al study sites stoped on 15/05/2012 because of insufficient recrutement.|f||||f||||||||||2017-02-18 13:47:54.004291|2017-02-18 13:47:54.004291
NCT00776178|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-18|2017-01-24|||October 8, 2008||2008-10-08|March 15, 2016|2016-03-15||||||||Observational|||Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health|Feasibility Study: Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health|Completed||N/A|68|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:47:54.113529|2017-02-18 13:47:54.113529
NCT00776165|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2010-02-01|||October 2007||2007-10-01|February 2010|2010-02-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)|A Phase 3 Randomized Controlled Open Label Comparative Multicentric Trial To Compare The Safety And Efficacy of Indigenous Recombinant Human Granulocyte Colony Stimulating Factor (rhG-CSF) With Neupogen In Patients on Myelosuppressive Therapy for Non Myeloid Malignancies.|Completed||Phase 3|126|Anticipated|Shantha Biotechnics Limited||2|||f||||f||||||||||2017-02-18 13:47:54.209363|2017-02-18 13:47:54.209363
NCT00776152|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-20|2008-10-20|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:47:54.314524|2017-02-18 13:47:54.314524
NCT00776139|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||October 2004||2004-10-01|October 2008|2008-10-01|December 2004|Actual|2004-12-01|October 2004|Actual|2004-10-01||Interventional|||Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions|An Open Label, Randomized, Single-Center, Single-Dose, Two-Treatment, Two-Period, Crossover Bioavailability Study Comparing Cetirizine Hydrochloride 10 mg Tablet of Ohm Laboratories Inc. (A Subsidiary of Ranbaxy, Inc) With Zyrtec® Cetirizine Hydrochloride, 10 mg Tablet of Pfizer Labs (Division of Pfizer Inc.) in Healthy, Adult, Human Subjects Under Fasting Condition|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:54.359831|2017-02-18 13:47:54.359831
NCT00776126|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2016-07-01|||October 2008||2008-10-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|NRR||Digital Breast Tomosynthesis Preference Study|Radiologists' Preference Study - Digital Breast Tomosynthesis|Completed||N/A|51|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 13:47:54.466554|2017-02-18 13:47:54.466554
NCT00776113|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-17|||August 2003||2003-08-01|October 2008|2008-10-01|December 2003|Actual|2003-12-01|September 2003|Actual|2003-09-01||Interventional|||Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions|An Open Label, Balanced, Randomised, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Bioavailability Study on Carvedilol Formulations Comparing Carvedilol 12.5 mg Tablets of Ranbaxy Laboratories With Coreg® 12.5 mg Tablets of Glaxosmithkline in Healthy, Adult, Human Subjects Under Fasting Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:54.565694|2017-02-18 13:47:54.565694
NCT00776100|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2016-08-12|||October 2008||2008-10-01|August 2016|2016-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer|A Randomized Phase II Study of Oligometastatic Stage IV Non-Small Cell Lung Cancer (NSCLC) Treated With Systemic Therapy Plus Either Radiotherapy to All Sites of Gross Residual Disease or No Radiotherapy|Completed||Phase 2|3|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 13:47:54.75946|2017-02-18 13:47:54.75946
NCT00776087|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2015-08-24|||July 2008||2008-07-01|August 2015|2015-08-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|EuroEco||European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)|European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)|Recruiting||Phase 4|416|Anticipated|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-02-18 13:47:55.022284|2017-02-18 13:47:55.022284
NCT00776074|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2010-06-17|||June 2006||2006-06-01|June 2010|2010-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.|3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients With Uterine Fibroids|Completed||Phase 2|80|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:47:55.170059|2017-02-18 13:47:55.170059
NCT00776048|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2010-06-23|||January 2007||2007-01-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Validation of an Obstacle Course Used in Patients With Muscle Tightness|The Validation of a New Method to Evaluate the Effects of Chemoneurolytic Intervention on Balance and Community Ambulation in Spastic Hemiplegic Patients|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Kessler Foundation|||2||f||||f||||||||||2017-02-18 13:47:55.284429|2017-02-18 13:47:55.284429
NCT00776035|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2016-05-03|||January 2008||2008-01-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Sex and Obesity: Effects on Heart Failure Study|Sex and Obesity Effects on Myocardial Blood Flow and Metabolism|Active, not recruiting||N/A|10|Anticipated|Washington University School of Medicine|||1||f||||f||||||Samples With DNA|"~     Non diagnostic genetic samples~   "|||2017-02-18 13:47:55.370894|2017-02-18 13:47:55.370894
NCT00776022|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2010-03-01|||April 2005||2005-04-01|March 2010|2010-03-01|June 2005|Actual|2005-06-01|April 2005|Actual|2005-04-01||Interventional|||Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions|An Open Label, Randomized, Single-center, Single-dose, Two-treatment, Two-period, Crossover Bioavailability Study Comparing Cetirizine Hydrochloride 10 mg Tablet of Ohm Laboratories Inc. (A Subsidiary of Ranbaxy, Inc) With Zyrtec® Cetirizine Hydrochloride, 10 mg Tablet of Pfizer Labs (Division of Pfizer Inc.) in Healthy, Adult, Human Subjects Under Fed Condition|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:55.476127|2017-02-18 13:47:55.476127
NCT00775099|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-16|||September 2005||2005-09-01|October 2008|2008-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Combustion Derived Air Pollution and Vascular Function|The Effects of Combustion-Derived Air Pollution on Vascular Vasomotor and Fibrinolytic Function in Healthy Volunteers (Diesel Exposure)|Completed||N/A|16|Actual|University of Edinburgh||4|||f||||f||||||||||2017-02-18 13:48:14.358076|2017-02-18 13:48:14.358076
NCT00776009|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2011-06-06|2010-12-13||October 2008||2008-10-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.|A Randomized, Multi-center, Double-blind, Placebo-controlled, Cross-over Study Evaluating the Safety and Efficacy of Dex-Methylphenidate Extended Release 30 mg vs. 20 mg as Measured by SKAMP-Combined Scores in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.|Completed||Phase 4|165|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:47:55.577108|2017-02-18 13:47:55.577108
NCT00775996|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||August 2003||2003-08-01|October 2008|2008-10-01|November 2003|Actual|2003-11-01|September 2003|Actual|2003-09-01||Interventional|||Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions|The Objective of This Study Was to Compare the Single-Dose Relative Bioavailability of Ranbaxy and Abbott (Tranxene® T-Tab®) 15 mg Clorazepate Dipotassium Tablets Under Fasting Conditions.|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:47:58.63764|2017-02-18 13:47:58.63764
NCT00775983|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-10-18|2013-05-07||October 2008||2008-10-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|DvL|Of 72 eligible and enrolled participants, 3 were excluded from analysis because they did not receive an abortion (2 in the Same-day Dilapan-S group, and 1 in the Overnight laminaria group).|Dilapan Versus Laminaria|Same-day Dilapan Versus Overnight Laminaria for Cervical Preparation for Early Second-trimester Surgical Abortion|Completed||N/A|72|Actual|University of California, San Francisco|-inadequate power to compare complications directly between study groups. Procedure time was chosen as a proxy for procedural difficulty and thus potential complications|2|||f||||t||||||||||2017-02-18 13:47:58.7386|2017-02-18 13:47:58.7386
NCT00775970|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||May 2008||2008-05-01|October 2008|2008-10-01||||||||Interventional|||Walking, Spontaneous Physical Activity and Lipid Oxidation After Dietary Treatment of Obesity|Influence of Walking on Spontaneous Physical Activity and on Lipid Oxidation Following Dietary Treatment of Obesity|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Tours||2|||f||||f||||||||||2017-02-18 13:47:59.138027|2017-02-18 13:47:59.138027
NCT00775957|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2010-09-27|||October 2008||2008-10-01|September 2010|2010-09-01||||||||Observational|||Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma|Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma|Terminated||N/A|35|Anticipated|University of Oklahoma|||2|Terminated by institutional review board|f||||t||||||||||2017-02-18 13:47:59.240276|2017-02-18 13:47:59.240276
NCT00775944|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2012-09-26|2012-07-25||February 2009||2009-02-01|September 2012|2012-09-01|September 2010|Actual|2010-09-01|February 2010|Actual|2010-02-01||Interventional|PORTSSS||Trial Comparing Different Methods of Support With Stopping Smoking (PORTSSS/Stop Together Trial)|Trial Comparing Different Methods of Support With Stopping Smoking Offered Through The National Health Service (NHS) Smoking Helpline|Completed||Phase 4|2591|Actual|University of Nottingham||4|||f||||f||||||||||2017-02-18 13:47:59.348512|2017-02-18 13:47:59.348512
NCT00775931|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2015-04-22|||August 2008||2008-08-01|April 2015|2015-04-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Allogeneic Transplantation For Severe Osteopetrosis|Allogeneic Hematopoietic Stem Cell Transplantation For Severe Osteopetrosis|Active, not recruiting||Phase 2/Phase 3|23|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-02-18 13:48:00.315333|2017-02-18 13:48:00.315333
NCT00775918|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||June 2005||2005-06-01|October 2008|2008-10-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Bioequivaelnce Study of Doxycycline Monohydrate 100mg Tablets Under Fed Conditions|Single Dose Two-Way Crossover Fed Bioequivalence Study of Doxycycline Monohydrate 100 mg Tablets in Healthy Volunteers|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:00.46193|2017-02-18 13:48:00.46193
NCT00775905|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-16|||July 2005||2005-07-01|October 2008|2008-10-01|October 2005|Actual|2005-10-01|August 2005|Actual|2005-08-01||Interventional|||Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions|The Objective of This Study Was to Compare the Rate and Extent of Absorption of Ranbaxy Amlodipine 10 mg Tablet to That of Norvasc® 10 mg Tablet After a Single, One Tablet Dose in Fasted Subjects.|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:00.566866|2017-02-18 13:48:00.566866
NCT00775892|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2011-08-07|||September 2008||2008-09-01|August 2011|2011-08-01||||May 2010|Actual|2010-05-01||Interventional|||SeriACL™ Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair|A Multi-Center Open Label Study to Evaluate the SeriACL™ Device (Gen IB) for Primary Anterior Cruciate Ligament Repair|Completed||Phase 1/Phase 2|30|Anticipated|Serica Technologies, Inc.||1|||f||||t||||||||||2017-02-18 13:48:00.676852|2017-02-18 13:48:00.676852
NCT00775879|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2013-05-17|||March 2006||2006-03-01|May 2013|2013-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|SIZE||Interest of the Induction With Target-controlled Inhalation of Sevoflurane on Spikes Wave Occurrence|Interest of the Induction With Target-controlled Inhalation of Sevoflurane on Spikes Wave Occurrence|Completed||N/A|34|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 13:48:00.770116|2017-02-18 13:48:00.770116
NCT00775866|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-12-28|||October 2006||2006-10-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|May 2015|Actual|2015-05-01||Interventional|||MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy|MRI - Guided Biopsy for Suspicion of Locally Recurrent Prostate Cancer After External Beam Radiotherapy|Active, not recruiting||N/A|90|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 13:48:00.860052|2017-02-18 13:48:00.860052
NCT00775853|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2017-02-10|||October 15, 2008||2008-10-15|November 29, 2016|2016-11-29||||||||Observational|||Biomarkers of Risk of Parkinson Disease|Biomarkers of Risk of Parkinson Disease|Active, not recruiting||N/A|88|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:48:00.963681|2017-02-18 13:48:00.963681
NCT00775840|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2010-06-17|||January 2008||2008-01-01|June 2010|2010-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.|"Candesartan Added Therapy for Treatment Optimization of Symptomatic Heart Failure With Diastolic Dysfunction in Diabetic and Hypertensive Patients A Randomized, Placebo-controlled, Double-blind, Parallel-group and Multicenter Clinical Phase III Study Investigating the Effects on NT-proBNP Over 6 Months"|Completed||Phase 3|22|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:48:01.061578|2017-02-18 13:48:01.061578
NCT00775827|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||November 2002||2002-11-01|October 2008|2008-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions|A Randomised, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Bioavailability Study on Fenofibrate Formulations Comparing Fenofibrate 160 mg Tablets of Ranbaxy Laboratories With Tricor 160 mg Tablets of in Healthy, Adult, Human Subjects Under Fasting Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:01.230767|2017-02-18 13:48:01.230767
NCT00775814|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-08-06|||October 2006||2006-10-01|August 2012|2012-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.|Double-blind, Randomized Trial to Investigate the Antihypertensive and Metabolic Effects of Candesartan in Insulin-resistant Obese Patients With a Hypertension Not Adequately Controlled by Previous ß-blocker or Calcium Channel Blocker|Completed||Phase 4|188|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:48:01.343474|2017-02-18 13:48:01.343474
NCT00775801|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2016-07-28|||September 2008||2008-09-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|August 2016|Anticipated|2016-08-01||Interventional|FLD||Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease|An IDE Study of the Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease|Active, not recruiting||N/A|300|Anticipated|AxioMed Spine Corporation||2|||f||||t||||||||||2017-02-18 13:48:01.483711|2017-02-18 13:48:01.483711
NCT00775788|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-11-17|||June 2008||2008-06-01|October 2008|2008-10-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Autologous Fat Grafting to the Breast|Autologous Fat Grafting to the Breast|Unknown status|Recruiting|N/A|50|Anticipated|Louisiana State University Health Sciences Center in New Orleans||6|||f||||f||||||||||2017-02-18 13:48:01.605917|2017-02-18 13:48:01.605917
NCT00775775|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-10-02|||May 2003||2003-05-01|October 2009|2009-10-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Fatigue, Sleep Disorders and Endocrine Abnormalities in TBI Patients|The Relationship Between Fatigue, Sleep Disorders and Endocrine Abnormalities Following Traumatic Brain Injury|Unknown status|Recruiting|N/A|50|Anticipated|Kessler Foundation|||1||f||||f||||||||||2017-02-18 13:48:01.729463|2017-02-18 13:48:01.729463
NCT00775762|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||November 2008||2008-11-01|October 2008|2008-10-01|December 2010|Anticipated|2010-12-01|January 2009|Anticipated|2009-01-01||Interventional|||Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events||Unknown status|Not yet recruiting|Phase 3|213|Anticipated|Catholic University of the Sacred Heart||3|||f||||t||||||||||2017-02-18 13:48:01.814509|2017-02-18 13:48:01.814509
NCT00775749|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2011-10-25|||April 2009||2009-04-01|October 2011|2011-10-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Transdermal Nicotine in Female Patients at High Risk for Post Operative Nausea and/or Vomiting (PONV)|Transdermal Nicotine in Female Patients at High Risk for PONV|Withdrawn||N/A|560|Anticipated|Ochsner Health System||2||The study is not feasible with the number of subjects needed to complete it.|f||||t||||||||||2017-02-18 13:48:02.119722|2017-02-18 13:48:02.119722
NCT00775736|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2017-01-10|||October 2008||2008-10-01|January 2017|2017-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|Mix2Mix||Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin|Observational Study Evaluating Safety in Patients With Type 2 Diabetes Treated With NovoMix® 30 or NovoMix® 50 or NovoMix®70 (Biphasic Insulin Aspart)|Completed||N/A|611|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:48:02.24939|2017-02-18 13:48:02.24939
NCT00775723|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-30|||January 2008||2008-01-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Melatonin Production Delay in Preterm Infants|Term-Born Infants at 9 and 12 Months of Age: A Randomized Controlled Trial|Completed||Phase 1/Phase 2|46|Actual|Tel Aviv University|||1||f||||f||||||||||2017-02-18 13:48:02.366548|2017-02-18 13:48:02.366548
NCT00775710|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2011-06-21|||March 2006||2006-03-01|October 2008|2008-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Clinical Trial Assessing Two Protocols to Withdraw Non-invasive Ventilation in Hypercapnic Respiratory Failure|A Randomized Controlled Trial Comparing Two Protocols to Withdraw Non-invasive Ventilation (NIV) After an Episode of Hypercapnic Respiratory Failure|Completed||Phase 4|128|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 13:48:02.450256|2017-02-18 13:48:02.450256
NCT00775697|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2013-06-18|||September 2009||2009-09-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Montelukast in Children With Wheezing|Montelukast Effects on Pulmonary Function in Children With Wheezing Aged Less Than 2 Years|Unknown status|Enrolling by invitation|Phase 4|40|Anticipated|Universita di Verona||1|||f||||t||||||||||2017-02-18 13:48:02.549883|2017-02-18 13:48:02.549883
NCT00775684|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2013-01-31|||October 2008||2008-10-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass|A Randomized, Controlled Trial Comparing the Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass in Patients With Impaired Fasting Glucose or Early Type 2 Diabetes|Completed||N/A|47|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-02-18 13:48:02.658466|2017-02-18 13:48:02.658466
NCT00775671|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2012-09-23|2012-09-23||October 2008||2008-10-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome|Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome|Completed||Phase 4|46|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:48:02.785849|2017-02-18 13:48:02.785849
NCT00775658|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||January 2008||2008-01-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Olopatadine Eye Drops and Allergy Skin Testing|Effect of Olopatadine Hydrochloride 0.2% Ophthalmic Solution on Epicutaneous Skin Prick Testing With Histamine and Saline|Completed||N/A|24|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:48:03.195698|2017-02-18 13:48:03.195698
NCT00775645|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2014-01-13|||September 2009||2009-09-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|January 2012|Actual|2012-01-01||Interventional|||S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy|S0715: Randomized Placebo-Controlled Trial of Acetyl-L-Carnitine (ALC) for the Prevention of Taxane Induced Neuropathy Phase III|Completed||Phase 3|437|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 13:48:03.321803|2017-02-18 13:48:03.321803
NCT00775632|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-06-21|||October 2008||2008-10-01|June 2016|2016-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants|A Phase II Randomized Study Comparing Low Dose Alemtuzumab and Cyclosporine With Standard of Care for the Prevention of Chronic Extensive GVHD for Patients Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) for Hematological Malignancies|Completed||Phase 2|78|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 13:48:03.944847|2017-02-18 13:48:03.944847
NCT00775619|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-17|||September 2003||2003-09-01|October 2008|2008-10-01|December 2003|Actual|2003-12-01|September 2003|Actual|2003-09-01||Interventional|||Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions|An Open Label, Balanced, Randomised, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Bioavailability Study on Carvedilol Formulations Comparing Carvedilol 12.5 mg Tablets of Ranbaxy Laboratories With Coreg® 12.5 mg Tablets of Glaxosmithkline in Healthy, Adult, Human Subjects Under Fed Conditions|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:04.050904|2017-02-18 13:48:04.050904
NCT00775606|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2014-05-30|2013-06-28||October 2008||2008-10-01|May 2014|2014-05-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease|A Phase 4 Study of the Effect on Immune Reconstitution of a Lopinavir/Ritonavir-Based Versus an Efavirenz-based HAART (Highly Active Antiretroviral Therapy) Regimen in Antiretroviral-Naïve Subjects With Advanced HIV Disease|Terminated||Phase 4|15|Actual|Rush University Medical Center|Study was terminated due to the slow recruitment and the small number of subjects.|2||Study stopped 12/2010 due to poor enrollment. Only 15 of 60 needed enrolled.|f||||f||||||||||2017-02-18 13:48:04.148608|2017-02-18 13:48:04.148608
NCT00775593|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2015-03-15|2014-06-10||December 2008||2008-12-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|AML1107||Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia|An Open Label Phase II Trial of Clofarabine and Temsirolimus in Older Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)|Completed||Phase 2|60|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-02-18 13:48:04.584887|2017-02-18 13:48:04.584887
NCT00775580|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-17|||May 2005||2005-05-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|May 2005|Actual|2005-05-01||Interventional|||Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions|Single Dose Two-Way Crossover Fasted Bioequivalence Study of Atenolol 100 mg Capsules in Healthy Volunteers|Completed||N/A|36|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:04.874284|2017-02-18 13:48:04.874284
NCT00775567|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2011-08-09|||January 2008||2008-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|MEF||Effect of Fructose on Colonic Microflora|Colonic Microbial and Clinical Adaptation to Large Doses of Fructose|Completed||N/A|45|Actual|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||t||||||||||2017-02-18 13:48:04.980638|2017-02-18 13:48:04.980638
NCT00775554|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2015-10-13|||September 2008||2008-09-01|October 2008|2008-10-01||||August 2009|Anticipated|2009-08-01||Interventional|||Comparison Study of Using Ultrasound Guidance for Hematoma Blocks vs. Traditional Approach|"Are Ultrasound-guided Hematoma Blocks for Distal Forearm Fractures Superior to the Landmark-guided Method for Hematoma Blocks?"|Withdrawn||N/A|0|Actual|St. Luke's-Roosevelt Hospital Center||2||no participants enrolled|f||||t||||||||||2017-02-18 13:48:05.091444|2017-02-18 13:48:05.091444
NCT00775541|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2012-06-15|||October 2007||2007-10-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Hyperglycemia and Oxidative Stress in the Human Brain With Diabetes|Hyperglycemia and Oxidative Stress in the Human Brain With Diabetes|Terminated||N/A|5|Actual|University of Kansas Medical Center||1||Insufficient dose for MRI scanning|f||||t||||||||||2017-02-18 13:48:05.202853|2017-02-18 13:48:05.202853
NCT00775528|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2010-10-25|2010-09-09||April 2009||2009-04-01|October 2010|2010-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|An Open Label, Multi-center, Study to Assess the Safety and Tolerability of Pancrelipase Delayed Release Capsules in Infants and Children Less Than 7 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|Completed||Phase 3|19|Actual|Solvay Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:48:05.317485|2017-02-18 13:48:05.317485
NCT00775515|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2011-04-29|||October 2008||2008-10-01|April 2011|2011-04-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||Laparoscopic Prostatectomy for Chronic Prostatitis|Laparoscopic Prostatectomy for Chronic Prostatitis|Unknown status|Recruiting|Phase 2|100|Anticipated|The Krongrad Institute||1|||f||||f||||||||||2017-02-18 13:48:05.598749|2017-02-18 13:48:05.598749
NCT00775502|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2016-06-14|||October 2008||2008-10-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Interventional|||Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma|Open-Label, Multi-Center, Dose Escalation Phase 1/2 Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Subjects With Previously Treated Multiple Myeloma|Terminated||Phase 1|23|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1||lack of efficacy in Multiple myeloma|f||||f||||||||||2017-02-18 13:48:05.70489|2017-02-18 13:48:05.70489
NCT00775489|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2011-01-04|||January 2010||2010-01-01|October 2008|2008-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Nasal Steroids in Controlled Glaucoma|The Effect of Beclomethasone Nasal Spray on Intraocular Pressure in Ocular Hypertension or Controlled Glaucoma|Completed||N/A|19|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:48:05.812249|2017-02-18 13:48:05.812249
NCT00775476|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2013-12-12|||March 2009||2009-03-01|December 2013|2013-12-01|June 2019|Anticipated|2019-06-01|October 2017|Anticipated|2017-10-01||Interventional|NAC||Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine|Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine|Suspended||Phase 1/Phase 2|478|Anticipated|State University of New York - Upstate Medical University||3||"Funds from original NIH grant, AT4332, have been exhausted. While new funding is thought with~   revised study design, no new patients will be recruited."|f||||t||||||||||2017-02-18 13:48:05.917591|2017-02-18 13:48:05.917591
NCT00775294|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2011-05-11|||May 2008||2008-05-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|May 2009|Actual|2009-05-01||Interventional|||Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal Tissue|A Phase IV, Open Label Study in Healthy Male Subjects to Investigate the Extent of Maraviroc Exposure in Blood, Saliva, Seminal Fluid, and Rectal Mucosal Tissue Following Single and Multiple Dosing of Maraviroc|Completed||Phase 1|14|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 13:48:11.538512|2017-02-18 13:48:11.538512
NCT00775463|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2014-01-31|2014-01-31||May 2009||2009-05-01|January 2014|2014-01-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Interventional|DISTOL-1|Baseline demographics and characteristics were summarized for subjects who received at least one dose of study drug. One subject in the treprostinil diethanolamine treatment group was randomized, withdrew consent and exited the study prior to taking any study medication and is not included in the summary.|Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine|DISTOL-1: Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: A Randomized, Double-blind, Placebo-controlled, Multicenter Study|Completed||Phase 2|148|Actual|United Therapeutics||2|||f||||f||||||||||2017-02-18 13:48:06.029513|2017-02-18 13:48:06.029513
NCT00775450|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-12-05|2011-07-14||October 2008||2008-10-01|December 2013|2013-12-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Influenza Vaccine Revaccination in Ambulatory Elderly Subjects|Safety and Immunogenicity of Revaccination With Influenza Vaccine in Ambulatory Elderly Subjects Previously Vaccinated With Fluzone ID, Fluzone HD, and Fluzone® IM|Completed||Phase 2|807|Actual|Sanofi||5|||f||||f||||||||||2017-02-18 13:48:07.230692|2017-02-18 13:48:07.230692
NCT00775437|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2015-12-17|2015-12-17||March 2009||2009-03-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use|Compassionate Use Study of Adalimumab in Children 2 to < 4 Years Old or Age 4 and Above Weighing Less Than 15 kg With Active Juvenile Idiopathic Arthritis (JIA)|Completed||Phase 3|32|Actual|AbbVie||1|||f||||f||||||||||2017-02-18 13:48:08.432418|2017-02-18 13:48:08.432418
NCT00775424|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2016-08-24|||September 2008||2008-09-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection|A PHASE Ib PARTIALLY RANDOMIZED PILOT STUDY INTENDED TO EVALUATE THE SAFETY AND IMMUNOLOGICAL EFFECTS OF HIV-1 DNA IMMUNIZATION (PENNVAX-B) WITH OR WITHOUT CO-ADMINISTRATION OF CONSTRUCTS CONTAINING DNA ENCODING FOR THE EXPRESSION OF EITHER IL-12 OR IL-15 IN HIV INFECTED INDIVIDUALS|Completed||Phase 1|38|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 13:48:09.882499|2017-02-18 13:48:09.882499
NCT00775411|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-08-01|2012-08-01||November 2008||2008-11-01|August 2012|2012-08-01|April 2010|Actual|2010-04-01|November 2009|Actual|2009-11-01||Interventional|||Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)||Completed||Phase 2|44|Actual|Allergan||1|||f||||f||||||||||2017-02-18 13:48:09.994058|2017-02-18 13:48:09.994058
NCT00775398|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-06-06|||November 2008||2008-11-01|June 2012|2012-06-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Observational|MOSAIC||Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters.|A Phase 4, Multicenter, Open-Label, Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® (Thrombin, Topical U.S.P [Bovine Origin]) on Coagulation Parameters|Completed||N/A|553|Actual|Pfizer|||4||f||||f||||||None Retained|"~     Whole blood~   "|||2017-02-18 13:48:10.233163|2017-02-18 13:48:10.233163
NCT00775385|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2016-08-09|||April 2009||2009-04-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|April 2013|Actual|2013-04-01||Interventional|TASTE||TAilored Post-Surgical Therapy in Early Stage NSCLC|Randomized Phase II/III Adjuvant Trial Evaluating Feasibility of Standard (A) vs. Customized Treatment (B) in Stage II or Stage IIIA Non-N2, Non-squamous Non Small Cell Lung Cancer (NSCLC).|Active, not recruiting||Phase 2/Phase 3|152|Actual|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||t||||||||||2017-02-18 13:48:10.377308|2017-02-18 13:48:10.377308
NCT00775372|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-17|||September 2005||2005-09-01|October 2008|2008-10-01|December 2005|Actual|2005-12-01|October 2005|Actual|2005-10-01||Interventional|||Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions|An Open Label, Balanced, Randomised, Two-Treatment, Four-Period, Two- Sequence, Single-Dose, Crossover Fully Replicated, Bioavailability Study on Clarithromycin Formulations Comparing Clarithromycin 250 mg/5 mL Powder for Oral Suspension of Ranbaxy Laboratories With Biaxin® Granules 250 mg/5 mL Oral Suspension in Healthy, Adult,Human, Male Subjects Under Fed Conditions.|Completed||N/A|40||Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:10.612249|2017-02-18 13:48:10.612249
NCT00775359|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||August 2002||2002-08-01|October 2008|2008-10-01|October 2002|Actual|2002-10-01|September 2002|Actual|2002-09-01||Interventional|||Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Relative Bioavailability Study of Ranbaxy and Abbott (TriCor®) 160 mg Fenofibrate Tablets in Healthy Adult Volunteers Under Fed Conditions|Completed||N/A|24|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:10.722344|2017-02-18 13:48:10.722344
NCT00775346|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2014-08-05|2010-03-15||August 2008||2008-08-01|August 2014|2014-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||A Multi-Center Study to Assess the Performance of Saturation Patterns.|A Multi-Center Study to Assess the Performance of the Saturation Pattern Detection (SPD) Software Algorithm.|Completed||N/A|92|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-02-18 13:48:10.834813|2017-02-18 13:48:10.834813
NCT00775333|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||December 2003||2003-12-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|||||Observational|||Nerve Entrapment in Diabetic Patients|Clinical Outcomes of Surgical Release Among Diabetic Patients With Carpal Tunnel Syndrome. A Prospective Study With Matched Controls|Completed||N/A|67|Actual|Skane University Hospital|||2||f||||f||||||||||2017-02-18 13:48:11.040376|2017-02-18 13:48:11.040376
NCT00775320|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2016-05-12|||October 2008||2008-10-01|May 2016|2016-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET|Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-fluorothymidine Positron Emission Tomography|Terminated||N/A|13|Actual|University of Oklahoma|||1|Study closed by institutional review board|f||||t||||||Samples Without DNA|"~     Tissue from brain tumor~   "|||2017-02-18 13:48:11.138696|2017-02-18 13:48:11.138696
NCT00775307|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2016-03-09|||November 2008||2008-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Adjuvant Pazopanib in Stage I NSCLC|A Randomized, Double-blind, Placebo-controlled Phase II-III Multi-centre Study to Evaluate the Effect of Adjuvant Pazopanib (GW786034) Versus Placebo on Post-surgical Disease-free Survival in Patients With Stage I Non Small Cell Lung Cancer and Tumor Size Equal or Inferior to 5 cm.|Active, not recruiting||Phase 2/Phase 3|140|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||t||||||||||2017-02-18 13:48:11.2351|2017-02-18 13:48:11.2351
NCT00775281|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2010-04-25|||October 2006||2006-10-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.|Mediators of Neurogenic Inflammation in the Urinary Tract as Key Factors in the Painful Bladder Syndrome / Interstitial Cystitis and Bladder Dysfunction|Completed||N/A|45|Anticipated|University Hospital Inselspital, Berne|||3||f||||f||||||Samples With DNA|"~     cold cut bladder biopsies~   "|||2017-02-18 13:48:11.637885|2017-02-18 13:48:11.637885
NCT00775268|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2017-01-24|||September 29, 2008||2008-09-29|October 23, 2014|2014-10-23|October 23, 2014|Actual|2014-10-23|||||Interventional|||18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma|A Pilot Study of 18F Fluorothymidine (FLT) PET/CT in Lymphoma|Terminated||Phase 1/Phase 2|31|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 13:48:11.732413|2017-02-18 13:48:11.732413
NCT00775255|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-16|||September 2005||2005-09-01|October 2008|2008-10-01|December 2005|Actual|2005-12-01|September 2005|Actual|2005-09-01||Interventional|||Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions|An Open Label, Balanced, Randomised, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioavailability Study on Clarithromycin Formulations Comparing Clarithromycin 250 mg/5 mL Powder for Oral Suspension of Ranbaxy Laboratories With Biaxin® Granules 250 mg/5 mL Oral Suspension in Healthy, Adult, Human, Male Subjects Under Fasting Conditions.|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:11.855242|2017-02-18 13:48:11.855242
NCT00775242|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-08-21|||April 2007||2007-04-01|August 2009|2009-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.|Comparative Efficacy and Safety Study of Three Different Doses of a Formulation Composed of Crystalline Estradiol and Progesterone Microspheres, Indicated for Monthly IM Injection for the Treatment ot Climacteric Symptoms.|Completed||Phase 2/Phase 3|103|Actual|Centro A.F. de Estudios Tecnologicos, S.A.||1|||f||||f||||||||||2017-02-18 13:48:12.160767|2017-02-18 13:48:12.160767
NCT00775229|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2014-01-31|2013-10-09||August 2008||2008-08-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Naltrexone in the Treatment of Trichotillomania|A Double-blind, Placebo-controlled Study of Naltrexone in Trichotillomania|Completed||Phase 2|51|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 13:48:12.269425|2017-02-18 13:48:12.269425
NCT00775216|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-05-21|||October 2008||2008-10-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Project Diabetes: Prescription for Healthy Living|Project Diabetes: Prescription for Healthy Living|Terminated||N/A|13|Actual|Vanderbilt University||2||grant funding ended and lack of sufficient participants to complete trial|f||||f||||||||||2017-02-18 13:48:12.689528|2017-02-18 13:48:12.689528
NCT00775203|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2012-04-24|2010-02-25||June 2007||2007-06-01|April 2012|2012-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.|A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.|Completed||Phase 3|412|Actual|Labopharm Inc.||2|||f||||||||||||||2017-02-18 13:48:12.789102|2017-02-18 13:48:12.789102
NCT00775190|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2014-05-15|||October 2008||2008-10-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives|Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives|Terminated||N/A|9|Actual|William Beaumont Hospitals||2||unale to recruit , progress report not filed by PI|f||||f||||||||||2017-02-18 13:48:13.585287|2017-02-18 13:48:13.585287
NCT00775177|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-17|2008-10-17|||June 2005||2005-06-01|October 2008|2008-10-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions|Single Dose Two-Way Crossover Fasted Bioequivalence Study of Doxycycline Monohydrate 100 mg Tablets in Healthy Volunteers|Completed||N/A|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:13.695654|2017-02-18 13:48:13.695654
NCT00775164|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-08-30|||January 2009||2009-01-01|August 2012|2012-08-01|February 2011|Anticipated|2011-02-01|December 2010|Anticipated|2010-12-01||Interventional|||Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study|Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study|Withdrawn||Phase 4|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Inadequate enrollment|f||||t||||||||||2017-02-18 13:48:13.805869|2017-02-18 13:48:13.805869
NCT00775151|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-16|||July 2005||2005-07-01|October 2008|2008-10-01|November 2005|Actual|2005-11-01|August 2005|Actual|2005-08-01||Interventional|||Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions|The Objective of This Study Was to Compare the Rate and Extent of Absorption of Ranbaxy Amlodipine 10 mg Tablet to That of Norvasc® 10 mg Tablet After a Single, One Tablet Dose in Fed State Subjects.|Completed||N/A|40|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:13.917455|2017-02-18 13:48:13.917455
NCT00775138|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-09-29||2016-09-29|June 2008||2008-06-01|September 2016|2016-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Determine the Safety and Tolerability of Arikace™ Versus Placebo in Patients Who Have Bronchiectasis.|A Placebo Controlled, Randomized, Parallel Cohort, Safety And Tolerability Study Of 2 Dose Levels Of Liposomal Amikacin For Inhalation (Arikace™) In Patients With Bronchiectasis Complicated By Chronic Infection Due To Pseudomonas Aeruginosa|Completed||Phase 1/Phase 2|64|Actual|Insmed Incorporated||3|||f||||t||||||||||2017-02-18 13:48:14.029122|2017-02-18 13:48:14.029122
NCT00775125|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2010-12-16|||June 2008||2008-06-01|December 2010|2010-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.|A Phase I, Open-label, Randomized, 2-way Crossover Trial in 40 Healthy Subjects to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.|Completed||Phase 1|40|Actual|Tibotec BVBA|||||f||||||||||||||2017-02-18 13:48:14.174069|2017-02-18 13:48:14.174069
NCT00775112|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-16|||July 2004||2004-07-01|October 2008|2008-10-01||||September 2006||2006-09-01||Interventional|||Randomized Evaluation of a Positioning Pillow for Lumbar Puncture in Paediatric Hematology-Oncology|Randomized Evaluation of a Positioning Pillow for Lumbar Puncture in Paediatric Hematology-Oncology|Completed||N/A|124|Actual|Centre Leon Berard||2|||f||||f||||||||||2017-02-18 13:48:14.259164|2017-02-18 13:48:14.259164
NCT00775086|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2011-06-06|||May 2004||2004-05-01|April 2010|2010-04-01|August 2004|Actual|2004-08-01|||||Interventional|||Bioequivalence Study of Patches With Different Equilibration Profiles|A Definitive Bioequivalence Study of ORTHO EVRA Exhibiting Faster Equilibration Profile and Currently Marketed ORTHO EVRA in Healthy Female Volunteers|Completed||Phase 1|42|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:48:14.465222|2017-02-18 13:48:14.465222
NCT00775073|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-04-27|||October 2008||2008-10-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|January 2011|Actual|2011-01-01||Interventional|||Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001|Antiangiogenic Treatment of Advanced or Metastatic Hepatocellular Cancer (HCC) - An Open Label, Stratified, Single-arm Phase II Study of Bevacizumab and RAD001|Completed||Phase 2|33|Actual|Treiber, Gerhard||1|||f||||t||||||||||2017-02-18 13:48:14.550423|2017-02-18 13:48:14.550423
NCT00775060|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-04-06|||September 2009||2009-09-01|April 2016|2016-04-01|September 2024|Anticipated|2024-09-01|September 2024|Anticipated|2024-09-01||Observational|||Maastricht IBS Cohort|Maastricht IBS Cohort: Phenotypical and Genotypical Characterization of Patients With Irritable Bowel Syndrome.|Recruiting||N/A|600|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||No||2017-02-18 13:48:14.665476|2017-02-18 13:48:14.665476
NCT00775047|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-16|||August 2006||2006-08-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|PAD||Pharmacist-Administered Injections for Contraception|Pharmacist-Administered Injections of Depo-Medroxyprogesterone Acetate for Contraception: A Pilot Randomized Controlled Trial|Completed||N/A|50|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 13:48:14.757231|2017-02-18 13:48:14.757231
NCT00775034|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2014-12-04|||November 2008||2008-11-01|December 2014|2014-12-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|DREAM||Drainage Versus Sealant in Double Blinded Monocentric Open Incisional Hernia Repair|Drainage Versus Sealant in Double Blinded Monocentric Open Incisional Hernia Repair|Unknown status|Recruiting|Phase 4|100|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:48:14.864665|2017-02-18 13:48:14.864665
NCT00775021|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2015-05-05|2011-02-07||August 2008||2008-08-01|May 2015|2015-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Clinical Comparison of Two Daily Disposable Contact Lenses.||Completed||N/A|123|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 13:48:15.058361|2017-02-18 13:48:15.058361
NCT00775008|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2009-03-02|||October 2008||2008-10-01|March 2009|2009-03-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Media Effects Study on Health-Related Content||Completed||Early Phase 1|40|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 13:48:15.373971|2017-02-18 13:48:15.373971
NCT00774995|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-09-27|2011-05-26||November 2008||2008-11-01|September 2016|2016-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.|Study to Evaluate the Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With GSK Biologicals' Engerix™-B Vaccine, Approximately 20 Years Ago.|Completed||Phase 4|49|Actual|GlaxoSmithKline|A decrease in the specificity of the anti-HB ELISA assay had been observed in some studies for low levels of antibody (10-100 mIU/mL).The table shows updated results following complete retesting and reanalysis|4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:48:15.463173|2017-02-18 13:48:15.463173
NCT00774982|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-07-16|||December 2008||2008-12-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients|Pilot, Randomized, Open-Label, Two-Way Crossover Comparative Bioavailability Study of 40 mg Delayed Release Oral 6Mercaptopurine Versus 100 mg Purinethol in Patients With Crohns Disease|Completed||Phase 1|12|Actual|Teva GTC||2|||f||||f||||||||||2017-02-18 13:48:16.093725|2017-02-18 13:48:16.093725
NCT00774969|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-16|||October 2007||2007-10-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease|Phase 1 Study to Evaluate the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri-Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease|Completed||Phase 1|19|Actual|S.L.A. Pharma AG||1|||f||||t||||||||||2017-02-18 13:48:16.359834|2017-02-18 13:48:16.359834
NCT00774956|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-03-19|||September 2008||2008-09-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Shoulder Training: Muscle Recruitment Patterns and the Effect of an Exercise Program|Shoulder Training: Muscle Recruitment Patterns and the Effect of an Exercise Program|Completed||N/A|77|Actual|University Ghent||2|||f||||f||||||||||2017-02-18 13:48:16.458985|2017-02-18 13:48:16.458985
NCT00774943|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-04-05|||December 2008||2008-12-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of AMG 557 in Adults With Systemic Lupus Erythematosus|A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|58|Actual|Amgen||2|||f||||||||||||||2017-02-18 13:48:16.553271|2017-02-18 13:48:16.553271
NCT00774930|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-12-28|2015-08-05||May 2009||2009-05-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|May 2013|Actual|2013-05-01||Interventional|ELECT|Intent-to-treat (ITT) population: All randomised subjects (regardless of whether the subjects received or adhered to the allocated treatment group). Subjects from the ITT population were analysed under the randomised treatment group.|An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome|A Double Blind, Randomized Placebo Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome|Completed||Phase 3|115|Actual|Ipsen|None specified.|2|||f||||t||||||||||2017-02-18 13:48:16.690989|2017-02-18 13:48:16.690989
NCT00774917|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-06-22|||October 2008||2008-10-01|June 2009|2009-06-01|March 2010|Anticipated|2010-03-01|September 2009|Anticipated|2009-09-01||Interventional|NAUTIC||Numen Stent Assessment Using OCT Technique in a Single Center Study|Numen Stent Assessment Using OCT Technique in a Single Center Study|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|International Biomedical Systems S.p.A.||1|||f||||f||||||||||2017-02-18 13:48:17.729824|2017-02-18 13:48:17.729824
NCT00774904|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-17|||April 2007||2007-04-01|October 2008|2008-10-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Adiponectin and Insulin Resistance in Diabetic Nephropathy|Adiponectin is Positively Associated With Insulin Resistance in Subjects With Type 2 Diabetic Nephropathy and Effects by Angiotensin Type 1 Receptor Blocker Losartan|Completed||N/A|80|Actual|Health Science Center of Xi’an Jiaotong University|||||f||||||||||||||2017-02-18 13:48:17.844526|2017-02-18 13:48:17.844526
NCT00774891|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-02-16|||October 2008||2008-10-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography|Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography|Withdrawn||N/A|0|Actual|Lahey Clinic|||1|difficulty enrolling patients into this study|f||||f||||||||||2017-02-18 13:48:17.930227|2017-02-18 13:48:17.930227
NCT00774878|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2011-03-02|||October 2008||2008-10-01|March 2011|2011-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer|Multicenter, Randomized, Open Label Study Evaluating an Anti Insulin-like Growth Factor-1 Receptor (IGF-1R/CD221) Monoclonal Antibody, AVE1642, Administered Every 4 Weeks in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer|Terminated||Phase 2|18|Actual|Sanofi||2||"Company decision to discontinue the AVE1642 development program, not due to any safety or~   efficacy concerns"|f||||f||||||||||2017-02-18 13:48:18.035217|2017-02-18 13:48:18.035217
NCT00774865|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2013-10-07|||June 2008||2008-06-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|June 2012|Actual|2012-06-01||Observational|ZEUSFUPCTA||Long Term Follow-up of Robotic Assisted Surgical Revascularization|Long Term Follow-up of Robotic Assisted Surgical Revascularization With CT Angiography|Unknown status|Enrolling by invitation|N/A|150|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-02-18 13:48:18.14349|2017-02-18 13:48:18.14349
NCT00774852|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-01-15|2014-08-18||November 2008||2008-11-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|December 2012|Actual|2012-12-01||Interventional|ACCESS|Intent-to-treat sample|Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis|A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis|Completed||Phase 2|137|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 13:48:18.25483|2017-02-18 13:48:18.25483
NCT00774839|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-08-09|||October 2008||2008-10-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients|A Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients|Completed||N/A|62|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 13:48:19.801206|2017-02-18 13:48:19.801206
NCT00774826|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2011-02-14|||December 2005||2005-12-01|February 2011|2011-02-01|March 2014|Anticipated|2014-03-01|September 2010|Actual|2010-09-01||Interventional|||Multicentric Study, Three Randomized Arms (R−CVP vs R−CHOP vs R−FM),for Patients With Stage II−IV Follicular Lymphoma|Phase III Multicentric IIL Study, Three Randomized Arms (R−CVP vs R−CHOP vs R−FM),for Treatment of Patients With Stage II−IV Follicular Lymphoma|Unknown status|Active, not recruiting|Phase 3|534|Actual|Fondazione Italiana Linfomi ONLUS||3|||f||||f||||||||||2017-02-18 13:48:19.91068|2017-02-18 13:48:19.91068
NCT00774813|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2008-10-16|||October 2007||2007-10-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Nexalin Therapy for the Treatment of Depressive Symptoms|Phase II Study Using Nexalin Therapy for the Treatment of Depressive Symptoms Associated With Mild to Moderate Depression Episodes|Completed||Phase 2|120|Actual|Kalaco Scientific, Inc.||3|||f||||f||||||||||2017-02-18 13:48:20.09566|2017-02-18 13:48:20.09566
NCT00774800|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-08-25|2010-04-27||October 2008||2008-10-01|August 2014|2014-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||All participants who received at least 1 dose of Humalog, Humulin-R, or recombinant human hyaluronidase PH20 (rHuPH20).|Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus|Phase II Study Evaluating Pharmacokinetics and Postprandial Glycemic Response of Subcutaneously Injected Humalog and Humulin R With/Without Co-Injected Recombinant Human Hyaluronidase Following Liquid Meal in Type1 Diabetes Mellitus Patients|Completed||Phase 2|22|Actual|Halozyme Therapeutics||1|||f||||f||||||||||2017-02-18 13:48:22.54963|2017-02-18 13:48:22.54963
NCT00774787|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-10-03|2010-09-30||October 2008||2008-10-01|October 2016|2016-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses|A Randomized, Open-label, Assessor-blinded, Split-face Study of Imiquimod 5% Cream Applied After Cryotherapy of Actinic Keratoses|Completed||Phase 4|27|Actual|Rigel Dermatology|Open label; small patient number; planned secondary endpoint of change in only lesions treated with cryotherapy (baseline) not determinable as only all lesions (baseline + new) consistently captured.|2|||f||||f||||||||||2017-02-18 13:48:23.060224|2017-02-18 13:48:23.060224
NCT00774774|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2011-04-22|||January 2009||2009-01-01|September 2008|2008-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|GRIPMASK||Face Masks for Preventing Influenza Transmission|a Randomized Controlled Trial Evaluating the Effectiveness and the Safety of Surgical Masks Wared by the Index Patient for Preventing Secondary Transmission of Influenza A in Households|Completed||Phase 4|372|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:48:23.42957|2017-02-18 13:48:23.42957
NCT00774761|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-05-10||2013-05-10|November 2008||2008-11-01|May 2013|2013-05-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease|A Randomized, Multiple-Dose,Double-Blind,Crossover Trial to Assess the Systemic Exposure of Fluticasone Propionate (FP)/Formoterol Fumarate (FF) Fixed-Dose Combination in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|97|Actual|Dey||5|||f||||f||||||||||2017-02-18 13:48:23.600125|2017-02-18 13:48:23.600125
NCT00774748|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-01-04|2011-04-08||August 2008||2008-08-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Once Weekly Subcutaneous Ports for the Administration of Anticoagulants|Once Weekly Subcutaneous Ports for the Administration of Anticoagulants - A Prospective Pharmacokinetic and Clinical Utilization Study|Completed||N/A|21|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 13:48:23.861339|2017-02-18 13:48:23.861339
NCT00774735|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2010-09-09|||October 2008||2008-10-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||GSK1349572 Drug Interaction Study With Protease Inhibitors|A Phase I, Open Label, Randomized, Two Period, One-way Two Sequence Crossover Study to Evaluate the Effect of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK1349572 Pharmacokinetics in Healthy Adult Subjects (ING111405).|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:48:24.149021|2017-02-18 13:48:24.149021
NCT00774722|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-06-04|||September 2006||2006-09-01|June 2013|2013-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy|Phase 2 Study Evaluation of Topical 10% Metronidazole Ointment for the Reduction of Pain After Haemorrhoidectomy|Completed||Phase 2/Phase 3|59|Actual|S.L.A. Pharma AG||2|||f||||f||||||||||2017-02-18 13:48:24.259357|2017-02-18 13:48:24.259357
NCT00774709|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-09-27|||October 2008||2008-10-01|September 2013|2013-09-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Observational|KaRen||Karolinska-Rennes (KaRen) Prospective Study of Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction|Ancillary Study of the Registry Karolinska-Rennes (KaRen) : Prospective Study of Dyssynchrony in Heart Failure With Preserved Ejection Fraction|Completed||N/A|90|Actual|French Cardiology Society|||1||f||||t||||||||||2017-02-18 13:48:24.35748|2017-02-18 13:48:24.35748
NCT00774696|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-16|||December 2002||2002-12-01|October 2008|2008-10-01|February 2003|Actual|2003-02-01|December 2002|Actual|2002-12-01||Interventional|||Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions|The Objective of This Study is to Compare the Relative Bioavailability of Clarithromycin 500 mg Tablets (Ranbaxy Laboratories Limited) With That of BIAXIN® 500 mg Tablets in Healthy, Adult Subjects Under Non-Fasting Conditions.|Completed||N/A|24||Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:24.446058|2017-02-18 13:48:24.446058
NCT00774683|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2011-10-21|||August 2008||2008-08-01|October 2011|2011-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women|A Phase IV, Open-Label, Single-Sequence Pilot Study to Characterize the Pharmacokinetics of a 400mg Oral Dose of Raltegravir in the Cervicovaginal Fluids of HIV-Infected Women|Completed||N/A|1|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"~     blood specimens and cervicovaginal fluids~   "|||2017-02-18 13:48:24.551602|2017-02-18 13:48:24.551602
NCT00774657|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-02-16|||September 2008||2008-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Ventricular Remodeling In Patients With Aortic Stenosis Assessed Echocardiography|Patterns Of Left Ventricular Remodeling In Patients With Aortic Stenosis Assessed By Two-Dimensional And Three-Dimensional Echocardiography|Withdrawn||N/A|0|Actual|Lahey Clinic|||1|Unable to identify and recruit suitable study subjects|f||||f||||||||||2017-02-18 13:48:24.661426|2017-02-18 13:48:24.661426
NCT00774644|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-11-17|||December 2002||2002-12-01|October 2008|2008-10-01|February 2003|Actual|2003-02-01|January 2003|Actual|2003-01-01||Interventional|||Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.|The Objective of This Study is to Compare the Relative Bioavailability of Clarithromycin 500 mg Tablets (Ranbaxy Laboratories Limited) With That of BIAXIN® 500 mg Tablets in Healthy, Adult Subjects Under Fasting Conditions.|Completed||N/A|33|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:24.753006|2017-02-18 13:48:24.753006
NCT00774631|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-09-14|||March 2009||2009-03-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|IHPOTOTAM||IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis|Mild Induced Hypothermia to Treat Severe Community Acquired Meningitis in Adults Admitted to Intensive Care Unit|Terminated||Phase 4|98|Actual|Assistance Publique - Hôpitaux de Paris||2||The sponsor stoppes the study for the security problem.|f||||f||||||||||2017-02-18 13:48:24.857121|2017-02-18 13:48:24.857121
NCT00774618|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-03-20|||October 2008||2008-10-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Evaluation of Surgical Treatment on Pain and Disability for Chronic, Non-healing Rib Fracture|Prospective Trial of Operative Management of Rib Fracture Non-Union|Completed||Phase 4|34|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 13:48:24.962955|2017-02-18 13:48:24.962955
NCT00774605|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-01-22|||December 2008||2008-12-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Solution And A Varenicline Patch Applied To The Skin|A Phase 1, Open-Label, Nonrandomized, Single Dose Study To Characterize The Pharmacokinetics Of A Varenicline (CP-526,555) Transdermal Solution And A Varenicline Transdermal Delivery System Applied To The Skin Of Adult Smokers|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:48:25.071035|2017-02-18 13:48:25.071035
NCT00774592|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2015-06-02|||September 2004||2004-09-01|June 2015|2015-06-01|December 2018|Anticipated|2018-12-01|December 2008|Actual|2008-12-01||Interventional|||HIV Risk Reduction in Youth in the Bahamas|Adolescent Risk Reduction in the Bahamas-Peers and Parents|Active, not recruiting||N/A|1360|Actual|Wayne State University||7|||f||||f||||||||||2017-02-18 13:48:25.173503|2017-02-18 13:48:25.173503
NCT00774579|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2015-06-03|||March 2008||2008-03-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|March 2009|Actual|2009-03-01||Observational|||The Effect of Growth Hormone Replacement on Liver Fat|Growth Hormone Replacement in Adults With Growth Hormone Deficiency (GHD) - The Effect on Liver Fat.|Completed||N/A|30|Actual|Imperial College London|||2||f||||f||||||Samples Without DNA|"~     plasma, serum, leucocytes, 24-hour urine~   "|||2017-02-18 13:48:25.290267|2017-02-18 13:48:25.290267
NCT00774566|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2014-12-07|||October 2008||2008-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|FreezeAF||PV-Isolation With the Cryoballoon Versus RF:a Randomized Controlled Prospective Non-inferiority Trial (FreezeAF)|A Comparison of Isolating the Pulmonary Veins With the Cryoballoon Catheter Versus Radiofrequency Segmental Isolation:a Randomized Controlled Prospective Non-inferiority Trial|Completed||Phase 4|322|Actual|Staedtisches Klinikum Karlsruhe||2|||f||||f||||||||||2017-02-18 13:48:25.390182|2017-02-18 13:48:25.390182
NCT00774553|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2010-01-14|||October 2008||2008-10-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|||||Interventional|||To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin|A Randomized, Single-Blind, Placebo-Controlled, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Multiple Ascending Oral Doses of AZD1656 in Subjects With T2DM Treated With Metformin|Completed||Phase 1|70|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 13:48:25.504328|2017-02-18 13:48:25.504328
NCT00774540|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2015-04-22|||August 2008||2008-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|Knemikro01||Acute Pain and Inflammation After Surgery|Acute Pain and Role of Ketolorac in Inflammatory Mediators After Knee Arthroscopy Evaluated by Microdialysis|Completed||Phase 4|40|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 13:48:25.604713|2017-02-18 13:48:25.604713
NCT00774527|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-12|2011-02-16|||March 2003||2003-03-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|February 2010|Actual|2010-02-01||Interventional|CyFluCyATG||Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT|Randomized Comparison of Cyclophosphamide Versus Cyclophosphamide Plus Fludarabine In Addition To Anti-Thymocyte Globulin for the Conditioning Therapy in Allogeneic Hematopoietic Cell Transplantation for Bone Marrow Failure Syndrome|Completed||Phase 3|82|Actual|Cooperative Study Group A for Hematology||1|||f||||f||||||||||2017-02-18 13:48:25.717598|2017-02-18 13:48:25.717598
NCT00774514|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-04-08|||October 2008||2008-10-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Cardiovascular Effects of Nitrogen Dioxide Exposure|The Cardiovascular Effects of Nitrogen Dioxide Exposure|Completed||N/A|12|Anticipated|University of Edinburgh||2|||f||||f||||||||||2017-02-18 13:48:26.031506|2017-02-18 13:48:26.031506
NCT00774501|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-02-17|||October 2008||2008-10-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy|A Pilot Study to Assess the Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy|Completed||N/A|10|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:48:26.132296|2017-02-18 13:48:26.132296
NCT00774488|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-16|||January 2006||2006-01-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Acute Effects of Glucose Dependent Insulinotropic Polypeptide (GIP) on Subcutaneous Adipose Tissue||Completed||N/A|17|Actual|German Institute of Human Nutrition||6|||f||||t||||||||||2017-02-18 13:48:26.234892|2017-02-18 13:48:26.234892
NCT00774475|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-23|||November 2008||2008-11-01|October 2008|2008-10-01|January 2011|Anticipated|2011-01-01|November 2010|Anticipated|2010-11-01||Interventional|DANTE||Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition|Optimization of Antiplatelet Therapy With Clopidogrel on the Basis of the Extent of Platelet Inhibition in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy Undergoing PCI With Stent Implantation|Unknown status|Not yet recruiting|Phase 3|442|Anticipated|University of Florence||2|||f||||f||||||||||2017-02-18 13:48:26.316284|2017-02-18 13:48:26.316284
NCT00774462|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-12-10|||January 2008||2008-01-01|December 2007|2007-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|FORCE||Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis|FORCE: Rituximab (CD 20+-B Cell-depleting Monoclonal Antibody) for the Treatment of Refractory Inflammatory Myopathies With Specific Antibodies and Refractory Myasthenia Gravis|Completed||Phase 2|30|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 13:48:26.437377|2017-02-18 13:48:26.437377
NCT00774449|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2011-07-19|||July 2009||2009-07-01|July 2009|2009-07-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Characterization of Bronchiolitis-obliterans Syndrome (BOS) Following Lung Transplantation|Characterization of Bronchiolitis-obliterans Syndrome (BOS) Following Lung Transplantation|Unknown status|Recruiting|N/A|261|Anticipated|Hannover Medical School|||1||f||||t||||||Samples Without DNA|"~     bronchoalveolar lavage, transbronchial biopsies, blood samples~   "|||2017-02-18 13:48:26.546103|2017-02-18 13:48:26.546103
NCT00774436|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-11-01|||October 2008||2008-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Focal Cryoablation in Low-Risk Prostate Cancer|A Phase II Study of Focal Cryoablation in Low-Risk Prostate Cancer|Active, not recruiting||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:48:26.644159|2017-02-18 13:48:26.644159
NCT00774423|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2013-02-13|||January 2006||2006-01-01|September 2011|2011-09-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|ASIRI||Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)|Multicentric, Randomized, Double-blind Study Versus Placebo, With Two Parallel Groups Treated to Evaluate the Efficacy and the Tolerance of Riluzole in Children and Young Adults (6 to 20 Years of Age) With SMA. (Type II and Type III)|Completed||Phase 2/Phase 3|141|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:48:26.747071|2017-02-18 13:48:26.747071
NCT00774397|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2015-10-14|2015-07-03||October 2008||2008-10-01|October 2015|2015-10-01||||November 2011|Actual|2011-11-01||Interventional||Treated set: The treated set (TS) included all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment, whether randomised or not|Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)|Antiviral Effect, Safety and Pharmacokinetics of BI 201335 NA in Hepatitis C Virus Genotype 1 Infected Treatment-naïve and Treatment-experienced Patients for 24 Weeks as Combination Therapy With Pegylated Interferon-alpha 2a and Ribavirin (Double-blinded, Randomised, Placebo-controlled, Phase II)|Completed||Phase 2|719|Actual|Boehringer Ingelheim||7|||f||||||||||||||2017-02-18 13:48:26.898296|2017-02-18 13:48:26.898296
NCT00774384|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-11-14|||September 2009||2009-09-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Regulation of Mucosal Immune Response to Systemic MenB Vaccine|A Phase II, Open Label, Randomised, Single Centre Study To Evaluate The Importance Of Naturally Induced Immune Regulation On The Mucosal Immune Response To Meningococcal Serogroup B Outer Membrane Vesicle (Omv) Vaccine When Administered Intramuscularly To Adults & Adolescents|Completed||Phase 2|9|Actual|University Hospitals Bristol NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:48:30.764092|2017-02-18 13:48:30.764092
NCT00774371|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2011-09-16|||January 2005||2005-01-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|SHAPE||Weight Reduction Intervention for Breast Cancer Survivors|The Survivors' Health And Physical Exercise Study|Completed||N/A|253|Actual|University of California, San Diego||1|||f||||f||||||||||2017-02-18 13:48:30.871451|2017-02-18 13:48:30.871451
NCT00774358|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-09-02|||October 2008||2008-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|WAS||Interleukin-2 Treatment for Wiskott-Aldrich Syndrome|Reinstituting Natural Killer Cell Cytotoxicity and Cytoskeletal Dynamics in Wiskott-Aldrich Syndrome With IL-2 Therapy|Completed||Phase 1|9|Actual|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-02-18 13:48:30.986398|2017-02-18 13:48:30.986398
NCT00774345|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-10-03|||January 2009||2009-01-01|October 2016|2016-10-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia Following Second-Line Therapy (The Continuum Trial)|Active, not recruiting||Phase 3|317|Actual|Celgene Corporation||2|||f||||t||||||||||2017-02-18 13:48:31.137996|2017-02-18 13:48:31.137996
NCT00774332|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-15|||June 2006||2006-06-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|June 2006|Actual|2006-06-01||Interventional|||A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL|A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL|Unknown status|Recruiting|Phase 2|37|Anticipated|Cooperative Study Group A for Hematology||1|||f||||f||||||||||2017-02-18 13:48:31.691576|2017-02-18 13:48:31.691576
NCT00774319|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-04-10|||December 2008||2008-12-01|April 2012|2012-04-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|Condor||TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer|A Randomised Study of TPF as Neoadjuvant Chemotherapy Followed by Concomitant Chemoradiotherapy (CRT) With Conventional Radiotherapy (RT) Versus Concomitant CRT With Accelerated RT in Patients With Locally Advanced Head and Neck Squamous Cell Cancer (HNSCC) in Good Condition. The Condor Study. A Study of the Dutch Head and Neck Cancer Group (DHNCG).|Unknown status|Recruiting|Phase 2|70|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 13:48:31.790129|2017-02-18 13:48:31.790129
NCT00774306|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2014-11-19|2014-11-19||April 2009||2009-04-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Antiepileptic Drugs and Vascular Risk Markers|The Effects of Antiepileptic Drugs on Serum Lipids and Inflammation in Patients With Subarachnoid Hemorrhage|Terminated||N/A|52|Actual|Thomas Jefferson University|"Study terminated due to 1) change in clinical practice; 2) inadequate recruitment and follow-up.~Number of pts providing full data was <15% of goal. Because of this, any analysis of data was considered futile, and no analyses were performed."|4||study no longer consistent with current clinical practice|f||||f||||||||||2017-02-18 13:48:31.904573|2017-02-18 13:48:31.904573
NCT00774293|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2008-10-16|||September 2004||2004-09-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|June 2007|Actual|2007-06-01||Interventional|OMEO||Homoeopathic Association in Aortic Valve Surgery|Preliminary Study of a Homoeopathic Association in Patients Undergoing Aortic Valve Surgery.|Completed||Phase 4|92|Actual|BOIRON||2|||f||||f||||||||||2017-02-18 13:48:32.475582|2017-02-18 13:48:32.475582
NCT00774280|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2011-02-10|||May 2002||2002-05-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|BuCyvsBUFlu||Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen|Randomized Comparison of Once-daily Intravenous Busulfan Plus Cyclophosphamide Versus Fludarabine as a Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Leukemia and Myelodysplastic Syndrome|Completed||Phase 3|130|Actual|Cooperative Study Group A for Hematology||2|||f||||t||||||||||2017-02-18 13:48:32.569458|2017-02-18 13:48:32.569458
NCT00774267|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2014-03-10|2013-10-30||January 2009||2009-01-01|March 2014|2014-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Study Evaluating Changes In Mammographic Breast Density|Evaluation Of Changes In Mammographic Breast Density Associated With Bazedoxifene Acetate/Conjugated Estrogens, Raloxifene And Placebo In Postmenopausal Women: An Ancillary Study Of Protocol 3115A1-303-WW|Completed||N/A|507|Actual|Pfizer|||4||f||||f||||||||||2017-02-18 13:48:32.684036|2017-02-18 13:48:32.684036
NCT00774254|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2017-01-24|||October 14, 2008||2008-10-14|September 26, 2016|2016-09-26||||||||Observational|||Reactions to Disease Risk Information|Participant Reactions to Disease Risk Information|Completed||N/A|132|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:48:33.180151|2017-02-18 13:48:33.180151
NCT00774241|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2016-11-01|||January 2010||2010-01-01|November 2016|2016-11-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer|An Open Label Study of the Effect of First Line Combination Treatment With Avastin and Docetaxel on Disease Response in Patients With Metastatic Breast Cancer|Withdrawn||Phase 4|0|Actual|Hoffmann-La Roche||1||Study was put on hold then out of Medical Plan therefore cancelled|f||||||||||||||2017-02-18 13:48:33.403871|2017-02-18 13:48:33.403871
NCT00774228|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-08-07|||November 2008||2008-11-01|August 2009|2009-08-01||||||||Interventional|||I-ZIP Ocular Bandage Pivotal Study|Clinical Evaluation of the I-ZIP® Ocular Bandage as a Protective Ocular Bandage in Subjects Undergoing Clear Corneal Cataract Surgery With IOL Implantation: A Pivotal Study|Completed||N/A|||Ocular Therapeutix, Inc.||2|||f||||||||||||||2017-02-18 13:48:33.492196|2017-02-18 13:48:33.492196
NCT00774215|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2010-01-25|||October 2007||2007-10-01|October 2008|2008-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Evaluation of the Avaulta Procedure for the Correction of Pelvic Organ Prolapse - Results at 1 Year|Retrospective Cohort of the Avaulta Vaginal Mesh Procedure as a Treatment of Pelvic Organ Prolapse|Completed||N/A|103|Anticipated|Atlantic Health System|||1||f||||f||||||||||2017-02-18 13:48:33.576107|2017-02-18 13:48:33.576107
NCT00774202|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2017-01-31|||November 2003||2003-11-01|January 2017|2017-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP|A Rand. Trial Comp Higher Doses of Rituximab (Rituxan) With Standard Doses of Rituxan in Combination With CVP (Cyclophosphamide, Vincristine, and Prednisone) in Patients With Chronic ITP Who Have Failed/Relapsed After Rituxan Treatment|Completed||Phase 2/Phase 3|17|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 13:48:33.665999|2017-02-18 13:48:33.665999
NCT00774189|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-16|||July 2003||2003-07-01|October 2008|2008-10-01|November 2003|Actual|2003-11-01|August 2003|Actual|2003-08-01||Interventional|||Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions|An Open Label, Balanced, Randomised, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover Bioavailability Study on Clarithromycin Formulations, Comparing Clarithromycin 250 mg Tablets of Ranbaxy Laboratories With Biaxin 250 mg Tablets of Abbott Laboratories in Healthy, Adult, Human Subjects Under Fasting Conditions|Completed||Phase 1|32|Actual|Ranbaxy Inc.||2|||f||||t||||||||||2017-02-18 13:48:33.780901|2017-02-18 13:48:33.780901
NCT00774176|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-08-03|||June 2004||2004-06-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|PA-SCOPE||Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations|Pennsylvania Study of Chronic Obstructive Pulmonary Exacerbations (PA-SCOPE)|Completed||N/A|1000|Anticipated|Temple University|||3||f||||t||||||Samples With DNA|"~     Ancillary studies collect blood specimens for gene expression and genetic factors.~   "|||2017-02-18 13:48:33.874604|2017-02-18 13:48:33.874604
NCT00774163|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-12-15|2012-06-13||February 2010||2010-02-01|December 2016|2016-12-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|||Safety of Lactobacillus Reuteri in Healthy Volunteers|Phase 1: Safety of Lactobacillus Reuteri in Healthy Volunteers|Completed||Phase 1|45|Actual|Tulane University||2|||f||||f||||||||||2017-02-18 13:48:33.97481|2017-02-18 13:48:33.97481
NCT00774150|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2014-07-17|||October 2008||2008-10-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|CATS||Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study|Transdisciplinary Studies of CBT for Anxiety in Youth|Completed||N/A|194|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:48:34.838749|2017-02-18 13:48:34.838749
NCT00774137|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2015-02-02|||April 2007||2007-04-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Observational|||Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery|Phase IV Multi Center Validation Study of Novel Biomarkers of Acute Kidney Injury After Cardiac Surgery|Completed||N/A|1550|Actual|Yale University|||1||f||||f||||||Samples With DNA|"~     Urine, plasma, buffy coat (optional)~   "|||2017-02-18 13:48:34.944559|2017-02-18 13:48:34.944559
NCT00774124|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2015-11-02|||August 2007||2007-08-01|November 2015|2015-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Improving Outcomes in Underserved Women With GDM|Improving Outcomes in Underserved Women With GDM|Completed||N/A|57|Actual|Temple University||2|||f||||f||||||||||2017-02-18 13:48:35.04753|2017-02-18 13:48:35.04753
NCT00774111|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2009-06-04|||October 2008||2008-10-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||GSK1349572 Drug Interaction Study With Etravirine|A Phase I, Open Label, Two Period, Single Fixed-Sequence Crossover Study to Evaluate the Effect of Etravirine on GSK1349572 Pharmacokinetics in Healthy Adult Subjects (ING111603)|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:48:35.153761|2017-02-18 13:48:35.153761
NCT00774098|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2010-03-31|||January 2007||2007-01-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Improving Glycogen Liver Content Will Improve Post-operative Liver Function in Patients Undergoing Major Liver Resections|Improving Glycogen Liver Content Will Improve Post-operative Liver Function in Patients Undergoing Major Liver Resections|Completed||N/A|60|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-02-18 13:48:35.252136|2017-02-18 13:48:35.252136
NCT00774085|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2012-04-26|||November 2004||2004-11-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|e-STAR||An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone|Electronic Schizophrenia Treatment Adherence Registry|Completed||Phase 4|408|Actual|Janssen Cilag N.V./S.A.|||1||f||||f||||||||||2017-02-18 13:48:35.34231|2017-02-18 13:48:35.34231
NCT00774072|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-16|2014-12-03|||October 2008||2008-10-01|December 2014|2014-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization|Nasal Inhalation of Tobramycin by the Pari Sinus Nebulizer in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization in the Upper Airways|Completed||Phase 2|9|Actual|University of Jena||2|||f||||t||||||||||2017-02-18 13:48:35.437295|2017-02-18 13:48:35.437295
NCT00774059|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-15|||January 2009||2009-01-01|October 2008|2008-10-01|January 2011|Anticipated|2011-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Evaluation of Safety and Performance of the Orbix Breast Lift System|Phase 1 Study to Evaluate the Safety and Performance of the Orbix Breast Lift System|Unknown status|Not yet recruiting|Phase 1|5|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-02-18 13:48:35.54536|2017-02-18 13:48:35.54536
NCT00774046|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-01-16|2012-12-17||December 2002||2002-12-01|January 2014|2014-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML|High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for Therapy-Related Myelodysplastic Syndrome/Therapy -Related Acute Myeloid Leukemia|Completed||Phase 2|32|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 13:48:35.637212|2017-02-18 13:48:35.637212
NCT00774033|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-07-25|||December 2008||2008-12-01|March 2012|2012-03-01|May 2012|Actual|2012-05-01|February 2012|Actual|2012-02-01||Interventional|ENSEM||Epidermal Cells Delivery and Acute Burns|A Randomized Trial Comparing Recell® Autologous Epidermal Cells Harvesting Kits Versus Classic Skin Grafts for the Treatment of Acute Burn in Adults and Children|Terminated||Phase 3|51|Actual|Assistance Publique - Hôpitaux de Paris||2||Not enough patients included|f||||f||||||||||2017-02-18 13:48:35.947168|2017-02-18 13:48:35.947168
NCT00774020|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-04-23|||October 2008||2008-10-01|April 2012|2012-04-01||||January 2011|Actual|2011-01-01||Interventional|||Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)|A 6 Months, Open-Label Phase IV Study to Confirm the Safety and Efficacy of Single Intravenous Dose of 5 mg Zoledronic Acid for the Patients of Paget's Disease of Bone (PDB) in China|Completed||Phase 4|9|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:48:36.054771|2017-02-18 13:48:36.054771
NCT00774007|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-15|||September 2004||2004-09-01|October 2008|2008-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome|Effect of Mesalazine on Low Grade Mucosal Inflammation in Irritable Bowel Syndrome. A Pilot Double Blind Placebo Controlled Study.|Completed||Phase 2/Phase 3|20|Actual|SOFAR S.p.A.||2|||f||||t||||||||||2017-02-18 13:48:36.158041|2017-02-18 13:48:36.158041
NCT00773994|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2015-07-28|||May 2008||2008-05-01|July 2015|2015-07-01||||July 2015|Actual|2015-07-01||Interventional|||Pilot Study Evaluating Characteristic Closure Patterns of the Normal Velopharyngeal Portal|Pilot Study Evaluating Characteristic Closure Patterns of the Normal Velopharyngeal Portal|Completed||N/A|4|Actual|Children's Hospital of Pittsburgh||1|||f||||f||||||||||2017-02-18 13:48:36.267118|2017-02-18 13:48:36.267118
NCT00773799|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2008-10-15|||October 2008||2008-10-01|October 2008|2008-10-01|January 2014|Anticipated|2014-01-01|October 2009|Anticipated|2009-10-01||Observational|MOSAR||Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community|Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community|Unknown status|Not yet recruiting|N/A|1200|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-02-18 13:48:38.433905|2017-02-18 13:48:38.433905
NCT00773981|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-11-03|||October 2008||2008-10-01|October 2008|2008-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Transrectal Vacuum Assisted Drainage: A New Method of Treating Anastomotic Leakage After Rectal Resection|"Transrectal Vacuum Assisted Drainage: A NEW METHOD OF TREATING ANASTOMOTIC LEAKAGE AFTER RECTAL RESECTION. A Prospective Randomized Multicenter Study in Cooperation With The Danish Colorectal Cancer Group"|Unknown status|Recruiting|Phase 3|60|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 13:48:36.369336|2017-02-18 13:48:36.369336
NCT00773968|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-03-04|2016-03-04||September 2008||2008-09-01|March 2016|2016-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|ORION|Safety population included all participants who entered the study and received at least one dose of methoxy polyethylene glycol-epoetin beta.|A Study of Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal Anemia|A Single Arm, Open Label Study to Assess the Efficacy, Safety and Tolerability of Once Monthly Administration of Subcutaneous C.E.R.A. for the Maintenance of Haemoglobin Levels in Pre-Dialysis Patients With Chronic Renal Anaemia|Completed||Phase 3|140|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:48:36.466926|2017-02-18 13:48:36.466926
NCT00773955|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-04-23|2013-02-13||November 2008||2008-11-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|October 2009|Actual|2009-10-01||Interventional|||R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer|A Phase II Study of AT-101 in Recurrent Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:48:36.889608|2017-02-18 13:48:36.889608
NCT00773942|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2009-10-30|||November 2007||2007-11-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries|Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries|Completed||N/A|637|Actual|University of Illinois at Chicago||3|||f||||f||||||||||2017-02-18 13:48:37.184524|2017-02-18 13:48:37.184524
NCT00773929|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2010-04-23|||January 2009||2009-01-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced Cancer|A Multicenter Phase I Clinical and Pharmacokinetic Study of Oral TAK-593 in Subjects With Nonhematologic Advanced Cancer|Completed||Phase 1|60|Anticipated|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:48:37.30981|2017-02-18 13:48:37.30981
NCT00773916|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2009-08-14|||March 2006||2006-03-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|||The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder||Completed||Phase 4|130|Anticipated|Federal University of Rio Grande do Sul||1|||f||||t||||||||||2017-02-18 13:48:37.397596|2017-02-18 13:48:37.397596
NCT00773903|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2008-11-24|||December 2008||2008-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:48:37.498065|2017-02-18 13:48:37.498065
NCT00773890|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-05-07|||July 2008||2008-07-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||TRF-1101 Assessment in Sickle Cell Disease|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Activity of TRF-1101 on Microvascular Blood Flow, Vascular Endothelial Injury, and Vasoocclusive Pain in Patients With Sickle Cell Disease|Terminated||Phase 1/Phase 2|80|Anticipated|TRF Pharma, Inc||2||"Study was stopped due to perceived futility because the baseline pain score in first 40~   patients was too low to be able demonstrate an improvement"|f||||t||||||||||2017-02-18 13:48:37.545072|2017-02-18 13:48:37.545072
NCT00773877|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-15|||October 2008||2008-10-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients|Comparison of RNFL Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients|Unknown status|Recruiting|N/A|400|Anticipated|Yonsei University|||2||f||||t||||||||||2017-02-18 13:48:37.642991|2017-02-18 13:48:37.642991
NCT00773864|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2008-10-15|||October 2008||2008-10-01|October 2008|2008-10-01|January 2014|Anticipated|2014-01-01|October 2009|Anticipated|2009-10-01||Observational|MOSAR||Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers|Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community- the Role of Healthcare Workers|Unknown status|Not yet recruiting|N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-02-18 13:48:37.726156|2017-02-18 13:48:37.726156
NCT00773851|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-04-21|||April 2005||2005-04-01|April 2016|2016-04-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Interventional|||Transfacial Sutures Versus Stapler for Mesh Fixation in Laparoscopic Ventral Hernia Repair|Mesh Shrinkage Following Transfacial Suturing Versus Stapler for Mesh Fixation in Laparoscopic Ventral Hernia Repair: a Prospective, Randomised Blinded Study|Completed||N/A|36|Actual|Medtronic - MITG||2|||f||||f||||||||||2017-02-18 13:48:37.979902|2017-02-18 13:48:37.979902
NCT00773838|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2016-04-22|||December 2008||2008-12-01|April 2016|2016-04-01|April 2012|Actual|2012-04-01|May 2011|Actual|2011-05-01||Interventional|||Study of Vorinostat (MK0683), an HDAC Inhibitor, in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (0683-095 AMJ)|An International, Multicenter, Open-Label Study of Vorinostat (MK0683) in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|143|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 13:48:38.09104|2017-02-18 13:48:38.09104
NCT00773825|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2015-06-17|||February 2007||2007-02-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|EPIGEN||Genomic Imprinting and Assisted Reproductive Technologies|Assessment of the Risk of Imprinting Defects in Children Born Following Assisted Reproductive Technologies (ART)|Completed||N/A|542|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||Samples With DNA|"~     whole blood (serum, ADN) and placenta samples~   "|||2017-02-18 13:48:38.200636|2017-02-18 13:48:38.200636
NCT00773812|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2017-01-11|||July 2007||2007-07-01|January 2017|2017-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders|Neuronal Nicotinic Receptor Modulation in the Treatment of Autism: A Pilot Trial of Mecamylamine|Completed||Phase 1|20|Actual|Ohio State University||2|||f||||f||||||||||2017-02-18 13:48:38.308734|2017-02-18 13:48:38.308734
NCT00773786|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2015-05-19|2013-05-29||October 2008||2008-10-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)|A Double-Blind, Crossover Study to Assess the Effects of Nebulized Brovana Added to Tiotropium on FEV1, Hyperinflation, and Exercise Endurance Capacity in COPD|Completed||Phase 4|20|Actual|Saint Francis Care||2|||f||||f||||||||||2017-02-18 13:48:38.539765|2017-02-18 13:48:38.539765
NCT00773773|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2017-02-06|||October 2008||2008-10-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer|A Study to Assess if a Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer|Active, not recruiting||N/A|500|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:48:38.831228|2017-02-18 13:48:38.831228
NCT00773760|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2009-08-04|||October 2008||2008-10-01|August 2009|2009-08-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Observational|||MOR and COMT SNP Polymorphism and Pain|Does mu Opioid Receptor (MOR) and Catechol-O-methyltransferase (COMT) Genes Polymorphism Correlate of Clinical Postoperative Pain and Response to Analgesics|Unknown status|Recruiting|N/A|100|Anticipated|East Tallinn Central Hospital|||1||f||||t||||||Samples With DNA|"~     blood~   "|||2017-02-18 13:48:38.926681|2017-02-18 13:48:38.926681
NCT00773747|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2015-08-20|||December 2008||2008-12-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|September 2011|Actual|2011-09-01||Interventional|||Study of Vorinostat (MK-0683) an HDAC Inhibitor, or Placebo in Combination With Bortezomib in Patients With Multiple Myeloma (MK-0683-088 AMN)|An International, Multicenter, Randomized, Double-Blind Study of Vorinostat (MK0683) or Placebo in Combination With Bortezomib in Patients With Multiple Myeloma|Completed||Phase 3|637|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 13:48:39.024728|2017-02-18 13:48:39.024728
NCT00773734|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2016-10-27|2014-10-22||September 2008||2008-09-01|October 2016|2016-10-01|May 2015|Actual|2015-05-01|August 2009|Actual|2009-08-01||Interventional||The intent-to-treat (ITT) population consisted of all randomized participants.|Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)|A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)|Completed||Phase 2|352|Actual|Celgene Corporation||6|||f||||t||||||||||2017-02-18 13:48:39.174423|2017-02-18 13:48:39.174423
NCT00773721|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-09-26|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:48:44.902917|2017-02-18 13:48:44.902917
NCT00773708|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2015-03-10|||March 2009||2009-03-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product|Pilot Study to Assess the Role of Immune Activation and Apoptosis as a Marker for Treatment Intensification With Raltegravir in Hiv-infected Patients on Antiretroviral Therapy With Long-term Viral Suppression and Unfavourable Immunologic Response (Discordant Patients: v+i-)|Completed||Phase 4|57|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 13:48:44.946085|2017-02-18 13:48:44.946085
NCT00773695|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-08-01|||November 2008||2008-11-01|August 2016|2016-08-01|January 2023|Anticipated|2023-01-01|January 2023|Anticipated|2023-01-01||Interventional|||A Study of Avastin (Bevacizumab) in Combination With Neoadjuvant Treatment Regimens in Patients With Primary HER2 Negative Breast Cancer|A Multicenter, Randomized, ph II Clinical Trial to Evaluate the Effect of Avastin in Combination With Neoadj Treatment Regimens on the Molecular and Metabolic Characteristics and Changes in the Primary Tumors With Ref to the Obtained Responses in Patients With Large Primary HER2 Neg Breast Cancers|Active, not recruiting||Phase 2|150|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:48:45.068749|2017-02-18 13:48:45.068749
NCT00773682|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2011-11-16|||June 2008||2008-06-01|September 2008|2008-09-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|mdph||Efficacy and Tolerability of Mud Packs Therapy in Osteoarthritis of the Hand|Efficacy and Tolerability of Mud Packs Therapy in Osteoarthritis of the Hands: a One Year Follow-up|Completed||Phase 4|60|Actual|University of Siena||1|||f||||f||||||||||2017-02-18 13:48:45.186342|2017-02-18 13:48:45.186342
NCT00773669|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2013-05-30|||October 2008||2008-10-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|March 2011|Actual|2011-03-01||Observational|||Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007|Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007|Completed||N/A|24|Actual|Summa Health System|||1||f||||f||||||||||2017-02-18 13:48:45.368971|2017-02-18 13:48:45.368971
NCT00773656|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-02-26|||October 2008||2008-10-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|EPOPA||Patients Overexposed for a Prostate Adenocarcinoma|Surveillance of the Cohort of Patients Overexposed in a Course of Conformational Radiotherapy for a Prostate Adenocarcinoma in Jean MONNET Hospital, Epinal, France. Epinal: Patients Overexposed for a Prostate Adenocarcinoma|Completed||N/A|249|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"~     White cells, serum and DNA~   "|||2017-02-18 13:48:45.43711|2017-02-18 13:48:45.43711
NCT00773643|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-07-25|||April 2008||2008-04-01|July 2016|2016-07-01||||April 2020|Anticipated|2020-04-01||Interventional|||Osteogenic Profiling of Tissue From Children With Craniosynostosis|Osteogenic Profiling of Tissue From Children With Craniosynostosis|Recruiting||N/A|50|Anticipated|Children's Hospital of Pittsburgh||1|||f||||f||||||||||2017-02-18 13:48:45.543269|2017-02-18 13:48:45.543269
NCT00773630|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2011-09-08|||December 2008||2008-12-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions||Completed||Phase 1|44|Actual|Otsuka Frankfurt Research Institute GmbH||4|||f||||f||||||||||2017-02-18 13:48:45.661671|2017-02-18 13:48:45.661671
NCT00773617|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2013-04-22|||March 2009||2009-03-01|April 2013|2013-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Testing an Alternative Therapy for Bulimia Nervosa|Integrative Cognitive Affective Therapy for Bulimia Nervosa (ICAT)|Completed||N/A|80|Actual|Neuropsychiatric Research Institute, Fargo, North Dakota||2|||f||||t||||||||||2017-02-18 13:48:45.752915|2017-02-18 13:48:45.752915
NCT00773604|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-08-05|||June 2008||2008-06-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|STN DBS||Deep Brain Stimulation in Patients With Dystonia|Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) in Patients With Dystonia|Completed||Phase 1/Phase 2|22|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 13:48:45.854165|2017-02-18 13:48:45.854165
NCT00773591|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2015-03-27|||March 2010||2010-03-01|March 2015|2015-03-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|Snoring||Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders|Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders (Snoring Study)|Withdrawn||Phase 2|0|Actual|Merz Pharmaceuticals GmbH||2||"The BfArM (CA)approved the trial in Nov 2008. However, the responsible EC refused approval in~   March 2009."|f||||f||||||||||2017-02-18 13:48:45.94631|2017-02-18 13:48:45.94631
NCT00773578|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2009-02-12|||October 2007||2007-10-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Observational|NOLN||Exhaled Nitric Oxide and Nasal Lavage Fluid|Impact of Environmental Tobacco Smoke on Exhaled Nitric Oxide and on Biomarkers of Nasal Inflammation in Atopic Asthmatic Children|Completed||N/A|49|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"~     Whole blood~   "|||2017-02-18 13:48:46.042164|2017-02-18 13:48:46.042164
NCT00773565|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-08-22|||October 2008||2008-10-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Identification of Novel Targets for Regulation of Adipose Tissue Mass|Identification of Novel Targets for Regulation of Adipose Tissue Mass|Completed||N/A|62|Actual|Heidelberg University||1|||f||||f||||||||||2017-02-18 13:48:46.144324|2017-02-18 13:48:46.144324
NCT00773552|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-12-05|||November 2008||2008-11-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder|Randomized Double Blinded Placebo-controlled Trial of the Once Daily 5mg Dose of Solifenacin Succinate vs. Placebo in Inner City Women Ages 20-45 With Overactive Bladder|Withdrawn||Phase 4|0|Actual|Stamford Hospital||2||Investigator Left Institution|f||||f||||||||||2017-02-18 13:48:46.249361|2017-02-18 13:48:46.249361
NCT00773539|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2008-10-14|||July 2008||2008-07-01|October 2008|2008-10-01|August 2009|Anticipated|2009-08-01|February 2009|Anticipated|2009-02-01||Interventional|CRYO-RF||A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy|Safety and Efficacy of Transvenous Pulmonary Isolation for the Treatment of Atrial Fibrillation: A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy|Unknown status|Recruiting|Phase 4|78|Anticipated|Herz-Zentrums Bad Krozingen||3|||f||||t||||||||||2017-02-18 13:48:46.354856|2017-02-18 13:48:46.354856
NCT00773526|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-11-01|||November 2008||2008-11-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.|An Open Label Dose-escalation Study to Evaluate Safety, Pharmacokinetics and Anti-tumor Activity of RO5126766, a Dual Raf and MEK Inhibitor, Administered Orally as Monotherapy in Patients With Advanced Tumors|Completed||Phase 1|52|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:48:46.445225|2017-02-18 13:48:46.445225
NCT00773513|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-11-01|||December 2008||2008-12-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)|A Randomized, Controlled, Open-Label, Multi-Centre, Parallel-Group Study To Assess All-Cause Mortality And Cardiovascular Morbidity In Patients With Chronic Kidney Disease On Dialysis And Those Not On Renal Replacement Therapy Under Treatment With MIRCERA® Or Reference ESAs.|Active, not recruiting||Phase 4|2828|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:48:46.53457|2017-02-18 13:48:46.53457
NCT00773500|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2012-02-27|||September 2008||2008-09-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Observational|BWHCERT5E||Impact of Vendor Systems on Ambulatory Medication Safety|Impact of Vendor Systems on Ambulatory Medication Safety|Completed||N/A|20|Actual|Weill Medical College of Cornell University|||2||f||||f||||||||||2017-02-18 13:48:49.170745|2017-02-18 13:48:49.170745
NCT00773487|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-07-24|||October 2008||2008-10-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Influence of Diesel Exhaust Particles (DEP) With and Without Organic Compounds on the Allergic Inflammation in Asthmatic Subjects|Influence of Diesel Exhaust Particles (DEP) With and Without Organic Compounds on the Allergic Inflammation in Asthmatic Subjects|Completed||N/A|15|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f||||||||||||||2017-02-18 13:48:49.264481|2017-02-18 13:48:49.264481
NCT00773474|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2016-01-21|2015-12-15||October 2008||2008-10-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Lonafarnib in Metastatic Breast Cancer|A Phase II Study of Lonafarnib in Patients With Metastatic Breast Cancer|Terminated||Phase 2|29|Actual|Hoosier Cancer Research Network||1||funding terminated|f||||t||||||||||2017-02-18 13:48:49.376703|2017-02-18 13:48:49.376703
NCT00773461|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-06-09|2015-12-29||October 2008||2008-10-01|June 2016|2016-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional||Intent-to-Treat (ITT) Population: The ITT population included all randomized participants who received at least one infusion of study treatment; Per Protocol (PP) Population: The PP population included all participants in the ITT population who adhered to the protocol.|A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.|A Randomized, Double Blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With DMARD Therapy, in Patients With Active Rheumatoid Arthritis and Inadequate Response to Current DMARD Therapy|Completed||Phase 3|209|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:48:50.117262|2017-02-18 13:48:50.117262
NCT00773448|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2015-07-02|||September 2008||2008-09-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SOME||Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism|Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism: an Open Randomized Controlled Trial Using a Comprehensive Abdomen/Pelvis Computed Tomography|Completed||N/A|862|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 13:48:50.858746|2017-02-18 13:48:50.858746
NCT00773435|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2015-11-30|||November 2008||2008-11-01|December 2008|2008-12-01|August 2009|Anticipated|2009-08-01|May 2009|Anticipated|2009-05-01||Interventional|||Effects of Echinacea in Children|Assessing the in Vivo Effect of Echinacea Purpurea on Markers of Immune Activities in Children|Withdrawn||N/A|0|Actual|University of Washington||2||Decided to conduct study in adults first|f||||t||||||||||2017-02-18 13:48:51.167587|2017-02-18 13:48:51.167587
NCT00773422|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2016-11-22|||January 2008||2008-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse|The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse|Completed||Phase 2|30|Actual|Yale University||3|||f||||t||||||||||2017-02-18 13:48:51.272386|2017-02-18 13:48:51.272386
NCT00773409|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-09-14|||October 2008||2008-10-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)|A Prospective Study Evaluating the Incidence of Nephrogenic Systemic Fibrosis in Patients With Stages 4 to 5 Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents Within the Past 10 Years|Completed||N/A|405|Actual|Bracco Diagnostics, Inc|||1||f||||f||||||Samples Without DNA|"~     fixed tissue samples and tissue sample for testing of GBCA.~   "|||2017-02-18 13:48:51.382948|2017-02-18 13:48:51.382948
NCT00773383|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2013-06-19|2011-03-31||November 2008||2008-11-01|June 2013|2013-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.|An Open-label Study to Determine the Effect of R1507 Plus Tarceva (Erlotinib) on Progression-free Survival in Patients With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) With Progressive Disease After Clinical Benefit to Second or Third Line Tarceva Monotherapy.|Terminated||Phase 2|35|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:48:51.471197|2017-02-18 13:48:51.471197
NCT00773370|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-08-11|2016-02-26||January 2009||2009-01-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|February 2014|Actual|2014-02-01||Interventional|APA-Stroke||Adaptive Physical Activity for Chronic Stroke|Adaptive Physical Activity for Chronic Stroke|Completed||Phase 1|76|Actual|VA Office of Research and Development||2|||f||||f||||||||No||2017-02-18 13:48:51.905233|2017-02-18 13:48:51.905233
NCT00773357|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2016-11-22|||October 2008||2008-10-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Modeling Stress-precipitated Smoking Behavior for Medication Development|Modeling Stress-precipitated Smoking Behavior for Medication Development|Recruiting||Phase 2|240|Anticipated|Yale University||3|||f||||t||||||||||2017-02-18 13:48:52.574795|2017-02-18 13:48:52.574795
NCT00773344|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2015-10-12||2010-09-10|December 2005||2005-12-01|October 2015|2015-10-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin|Phase 1/2 Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin|Completed||Phase 1/Phase 2|25|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 13:48:52.696462|2017-02-18 13:48:52.696462
NCT00773331|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-11-01|||July 2009||2009-07-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.|An Open Label Randomized Controlled Study to Compare the Efficacy and Safety of Once Every 4 Weeks Administration of Mircera Versus Short-acting Epoetin for the Maintenance of Hemoglobin Levels in Dialysis Patients With Chronic Renal Anemia.|Completed||Phase 3|281|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:48:52.80733|2017-02-18 13:48:52.80733
NCT00773318|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-03-02|||April 2008||2008-04-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer|SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer|Terminated||N/A|30|Actual|Lawson Health Research Institute||1||"1 patient has been enrolled. No complications reported. The research team decided to terminate~   the clinical trial due to insufficient patients' accrual."|f||||f||||||||||2017-02-18 13:48:52.917001|2017-02-18 13:48:52.917001
NCT00773305|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-12-26|||October 2008||2008-10-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|November 2010|Actual|2010-11-01||Observational|||Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer|Chart Review of the Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer|Completed||N/A|200|Actual|Summa Health System|||1||f||||f||||||||||2017-02-18 13:48:53.039984|2017-02-18 13:48:53.039984
NCT00773292|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2013-04-12|||August 2006||2006-08-01|April 2013|2013-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|HAM05||Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)|The HAM Ciclosporin Study : an Observational Trial of Therapy in Early or Progressing HAM/TSP|Completed||Phase 2/Phase 3|7|Actual|Imperial College London||1|||f||||t||||||||||2017-02-18 13:48:53.119398|2017-02-18 13:48:53.119398
NCT00773279|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2013-10-14|||September 2008||2008-09-01|October 2013|2013-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics|A Multi-centre, Randomised, Open-label, Cross-over Study to Explore Effectiveness, Safety, and Preference of a New Disposable Pen PDS290 Versus FlexPen® in Subjects With Type 1 or Type 2 Diabetes|Completed||Phase 3|242|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 13:48:53.230216|2017-02-18 13:48:53.230216
NCT00773266|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-09-26|||September 2006||2006-09-01|September 2012|2012-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Intraocular Position of Secondary Iris-Fixated IOLs in Aphakic Eyes|Intraocular Architecture of Secondary Implanted Anterior Chamber Iris-Fixated Lenses in Aphakic Eyes Evaluated With Anterior Segment Optical Coherence Tomography|Completed||N/A|16|Actual|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-02-18 13:48:53.597417|2017-02-18 13:48:53.597417
NCT00773084|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2015-05-11|||September 2008||2008-09-01|March 2011|2011-03-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|ARID-HF||Aliskiren and Renin Inhibition in Diastolic Heart Failure|Aliskiren and Renin Inhibition in Diastolic Heart Failure in Mexican Americans|Withdrawn||N/A|0|Actual|Texas Tech University Health Sciences Center||1||Difficulty in recruiting patients and then the PI left the institution|f||||f||||||||||2017-02-18 13:48:55.659294|2017-02-18 13:48:55.659294
NCT00773253|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2011-09-09|2011-02-15||April 2008||2008-04-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|October 2010|Actual|2010-10-01||Interventional|||Botox for Cervical Dystonia Following EMG Mapping|Pre-injection, Multi-channel EMG Mapping to Optimize Botulinum Toxin Type A Efficacy in Cervical Dystonia.|Completed||Phase 4|10|Actual|University of California, San Francisco|One patient received single channel injection, but did not get multi-channel injection because the frontalis test showed immunity to botulinum toxin indicating no possibility of clinical benefit. This is an exclusion criterion.|2|||f||||f||||||||||2017-02-18 13:48:53.682018|2017-02-18 13:48:53.682018
NCT00773240|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2011-08-27|||April 2008||2008-04-01|August 2011|2011-08-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment|A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment Initiated in the Grass Pollen Season in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis|Completed||Phase 3|276|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-02-18 13:48:54.075947|2017-02-18 13:48:54.075947
NCT00773227|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2015-11-19|||April 2004||2004-04-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|July 2015|Actual|2015-07-01||Interventional|OPMD||Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts|Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts|Completed||Phase 2|30|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:48:54.170624|2017-02-18 13:48:54.170624
NCT00773214|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2015-02-05|||April 2008||2008-04-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|||Inter Individual Variation in Weight Loss Response to Exercise|Identification and Characterization of Individual Variability in Exercise-induced Weight Loss: Biological and Behavioral Markers of Success.|Completed||N/A|22|Actual|Norwegian University of Science and Technology||1|||f||||t||||||||||2017-02-18 13:48:54.282915|2017-02-18 13:48:54.282915
NCT00773201|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-07-25|||February 2008||2008-02-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|Generepol||Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation|Identification of the Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation at a Pharmacological and Physiological Stimulus in an Apparently Normal Population|Completed||Phase 1|997|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 13:48:54.398245|2017-02-18 13:48:54.398245
NCT00773188|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2016-11-01|||December 2008||2008-12-01|November 2016|2016-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.|A Single-arm, Open-label, Multicenter Feasibility Trial of Bevacizumab Given in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Locally Advanced Unresectable Non-squamous, Non-small Cell Lung Cancer|Completed||Phase 1|6|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:48:54.505599|2017-02-18 13:48:54.505599
NCT00773175|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2011-12-02|||October 2008||2008-10-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|PEDs-II||Subcutaneous Rehydration Compared to Intravenous Rehydration|Subcutaneous Rehydration With Hylenex Compared to Intravenous Rehydration in Infants and Young Children With Mild to Moderate Dehydration|Completed||Phase 4|186|Anticipated|Halozyme Therapeutics||2|||f||||f||||||||||2017-02-18 13:48:54.616166|2017-02-18 13:48:54.616166
NCT00773162|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-02-24|||October 2008||2008-10-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Flushing in Social Anxiety Disorder on Seroquel|A Single-center, Randomized, Double-blind, Phase III Comparison of the Efficacy and Safety of Quetiapine Fumarate (Oral Extended Release Tablets) to Placebo in Social Phobia Patients and Changes in Their Vasodilatory Response to Methyl-Nicotinate|Completed||Phase 3|21|Actual|START Clinic for Mood and Anxiety Disorders||2|||f||||f||||||||||2017-02-18 13:48:54.75519|2017-02-18 13:48:54.75519
NCT00773149|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2012-07-25|||October 2006||2006-10-01|February 2011|2011-02-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Interventional|Campath||Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia|Phase I/II Study of Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia (ALL) or ALL in Relapse.|Completed||Phase 1/Phase 2|12|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:48:54.851042|2017-02-18 13:48:54.851042
NCT00773136|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-03-20|2013-06-22||February 2008||2008-02-01|March 2014|2014-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes|Effect of Bimatoprost (Lumigan) in Gel Suspension Applied to the Eyelashes on Eyelash Growth|Completed||N/A|21|Actual|University of Miami|A larger and longer term study would help assess the incidence of ocular side effects related to the Bimatoprost. This randomized controlled study evaluated patients after only 6 weeks of application of the drug.|1|||f||||f||||||||||2017-02-18 13:48:54.955925|2017-02-18 13:48:54.955925
NCT00773123|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-15|||October 2008||2008-10-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.||Unknown status|Recruiting|N/A|300|Anticipated|Yonsei University|||2||f||||t||||||||||2017-02-18 13:48:55.209386|2017-02-18 13:48:55.209386
NCT00773110|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-05-27|||December 2008||2008-12-01|May 2010|2010-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study of Albumin to Reduce Inflammation Following Surgery|Scavenging Free Haemoglobin Attenuates the Systemic Inflammatory Response Following Surgery|Terminated||Phase 2|232|Actual|Imperial College London||2||Recruitment under target, Finding|f||||t||||||||||2017-02-18 13:48:55.29389|2017-02-18 13:48:55.29389
NCT00773097|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2014-02-12|2013-07-17||October 2008||2008-10-01|February 2014|2014-02-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional||A total of 39 subjects completed the 52 weeks of the study.|Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma|Study of the MUC1 Peptide - Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma|Completed||Phase 2|46|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:48:55.410399|2017-02-18 13:48:55.410399
NCT00772551|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2010-08-13|||June 2008||2008-06-01|August 2010|2010-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Raltegravir and Ezetimibe PK Study|Evaluation of the Pharmacokinetics and Safety of Raltegravir and Ezetimibe When Co-administered to Male and Female Healthy Volunteers|Completed||Phase 1|26|Actual|St Stephens Aids Trust||2|||f||||f||||||||||2017-02-18 13:49:06.420312|2017-02-18 13:49:06.420312
NCT00773071|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-06-07|||April 2008||2008-04-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers|Added-value of SPECT/CT in Patients Undergoing Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) for Gynecological Cancers|Completed||N/A|15|Actual|Lawson Health Research Institute||1|||f||||t||||||||||2017-02-18 13:48:55.76834|2017-02-18 13:48:55.76834
NCT00773058|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-02-17|||December 2008||2008-12-01|January 2009|2009-01-01||||April 2009|Anticipated|2009-04-01||Interventional|||Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)|Effect of Treatment With Stress-Doses Glucocorticoid on Mortality in Patients With ARDS and Relative Adrenal Insufficiency|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|Southeast University, China||4|||f||||f||||||||||2017-02-18 13:48:55.890432|2017-02-18 13:48:55.890432
NCT00773045|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-15|||April 2006||2006-04-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|August 2006|Actual|2006-08-01||Observational|PIJNICU2||Pain Measurement and Pain Management in the Intensive Care Unit(ICU)|Pain Measurement and Pain Management in the ICU|Completed||N/A|190|Actual|St. Antonius Hospital|||1||f||||f||||||||||2017-02-18 13:48:55.982022|2017-02-18 13:48:55.982022
NCT00773032|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-15|||October 2008||2008-10-01|October 2008|2008-10-01||||June 2009|Anticipated|2009-06-01||Interventional|||Age-Dependent Memory Benefits From Pharmacologically Enhanced Naps?||Unknown status|Recruiting|N/A|||University of California, San Diego||3|||f||||||||||||||2017-02-18 13:48:56.083718|2017-02-18 13:48:56.083718
NCT00773019|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2009-06-09|||November 2004||2004-11-01|June 2009|2009-06-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Observational|||SynchroMed II Post-Approval Study|SynchroMed II Programmable Drug Infusion System Post-Approval Study|Completed||Phase 4|84|Actual|MedtronicNeuro|||1||f||||f||||||||||2017-02-18 13:48:56.179801|2017-02-18 13:48:56.179801
NCT00773006|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2011-10-03|||February 2008||2008-02-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|June 2010|Actual|2010-06-01||Observational|CAPCIR||Canadian Anticoagulant Percutaneous Coronary Intervention Registry|Canadian Prospective, Observational Study on the Use of LMWH in the Setting of Percutaneous Coronary Intervention|Completed||N/A|747|Actual|University of Alberta|||3||f||||f||||||||||2017-02-18 13:48:56.252095|2017-02-18 13:48:56.252095
NCT00772993|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-15|2008-10-15|||October 2008||2008-10-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma|Efficacy of RNFL / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma|Unknown status|Recruiting|N/A|400|Anticipated|Yonsei University|||4||f||||t||||||||||2017-02-18 13:48:56.341478|2017-02-18 13:48:56.341478
NCT00772980|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2010-06-30|||November 2008||2008-11-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus|A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus|Completed||Phase 3|400|Anticipated|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-02-18 13:48:56.421588|2017-02-18 13:48:56.421588
NCT00772967|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2015-10-16|2009-11-19||June 2008||2008-06-01|October 2015|2015-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)|A Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Analgesic Effects of Naproxen and Ultracet in a Walking Model of Osteoarthritis Knee Pain|Completed||Phase 1|22|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 13:48:56.561746|2017-02-18 13:48:56.561746
NCT00772954|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-04-19|2012-03-13||March 2006||2006-03-01|April 2012|2012-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity|A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of the Safety, Tolerability and Immunogenicity of Two Doses of a Clostridium Difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Adult Volunteers (18 - 55 Years)|Terminated||Phase 1|36|Actual|Sanofi|This study was terminated early in light of issues with CTM stability. All other study procedures and visits were performed per protocol.|3||Issues with CTM stability.|f||||f||||||||||2017-02-18 13:48:57.172314|2017-02-18 13:48:57.172314
NCT00772941|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2014-01-28|2013-12-09||February 2009||2009-02-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)|Drug Use Investigation Of Champix (Regulatory Post Marketing Commitment Plan)|Completed||N/A|3939|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:48:57.811172|2017-02-18 13:48:57.811172
NCT00772928|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2012-01-30|2009-09-23||October 2003||2003-10-01|January 2012|2012-01-01|November 2006|Actual|2006-11-01|May 2006|Actual|2006-05-01||Interventional|||Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™|Immunogenicity Assessment of Pentacel™ (Hybrid CP20/20/5/3DT-mIPV//PRP-T) When Given at Different Times From or Concurrently With a Pneumococcal Conjugate Vaccine|Completed||Phase 3|1167|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:48:58.420915|2017-02-18 13:48:58.420915
NCT00772915|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-12|2016-10-10|2012-06-26||December 2008||2008-12-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|March 2011|Actual|2011-03-01||Interventional|||Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma|"A Phase II Trial of Revlimid® and On Demand Dexamethasone Dosing in Patients With Newly Diagnosed Symptomatic Multiple Myeloma"|Active, not recruiting||Phase 2|39|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 13:48:59.228891|2017-02-18 13:48:59.228891
NCT00772902|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2011-11-18|||October 2008||2008-10-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|ROCKET II||ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial|A Phase 4, Open Label, Randomized, Controlled Study to Assess the Effect on Lipid Profile of Switching a Stable HAART Regimen of Fixed Dose Abacavir/Lamivudine (Kivexa) Plus Lopinavir/Ritonavir (Kaletra), to Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Plus Lopinavir/Ritonavir (Kaletra) in Adult HIV-1 Infected Subjects With Raised Cholesterol|Completed||Phase 4|85|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 13:48:59.572095|2017-02-18 13:48:59.572095
NCT00772889|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2016-10-06|2012-03-29||October 2008||2008-10-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly|Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly|Completed||Phase 3|971|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:48:59.701275|2017-02-18 13:48:59.701275
NCT00772876|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2012-11-21|||December 2008||2008-12-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies|An Open Label, Multicenter Phase I Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies|Completed||Phase 1|39|Actual|Piramal Enterprises Limited||1|||f||||f||||||||||2017-02-18 13:49:01.207465|2017-02-18 13:49:01.207465
NCT00772863|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2009-10-28|||September 2003||2003-09-01|October 2009|2009-10-01||||June 2008|Actual|2008-06-01||Interventional|Tax-Over||Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer|The Evaluation of Efficacy and Safety of Subsequent Cisplatin and Docetaxel Regimen In The First Line Treatment of Advanced Epithelial Ovarian Cancer|Completed||Phase 2|37|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:49:01.309557|2017-02-18 13:49:01.309557
NCT00772850|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2010-07-14|||October 2008||2008-10-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|SRC||Rotator Cuff Injury in Antegrade Locked Nailing for Humeral Fractures|Sonographic Evaluation of Rotator Cuff Injury in Antegrade Locked Nailing for Humeral Fractures|Completed||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:49:01.419426|2017-02-18 13:49:01.419426
NCT00772837|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-11-09|||August 2006||2006-08-01|November 2009|2009-11-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|EEHPDS||Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms|Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms.|Completed||N/A|370|Actual|Aga Khan University||2|||f||||f||||||||||2017-02-18 13:49:01.530595|2017-02-18 13:49:01.530595
NCT00772824|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-08-10|||December 2007||2007-12-01|August 2009|2009-08-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients|Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients- A Prospective, Randomised, Single Blind, Three Arm, Phase Four Prevention Trial|Unknown status|Recruiting|Phase 4|30|Anticipated|Banaras Hindu University||3|||f||||f||||||||||2017-02-18 13:49:01.64404|2017-02-18 13:49:01.64404
NCT00772811|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-05|2011-02-16|||July 2001||2001-07-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|Flu-Mel||Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma|Allogeneic Non-Myeloablative Stem Cell Transplantation Using Fludarabine and Melphalan Conditioning Regimen for Chronic Lymphocytic Leukemia, Lymphoma, and Multiple Myeloma|Completed||Phase 2|38|Actual|Cooperative Study Group A for Hematology||1|||f||||t||||||||||2017-02-18 13:49:01.75532|2017-02-18 13:49:01.75532
NCT00772798|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2008-10-14|||June 2007||2007-06-01|October 2008|2008-10-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer|A Phase I/II Non-Comparative Study of Paclitaxel Plus Carboplatin in Combination With Vorinostat in Patient With Advanced, Recurrent, Epithelial Ovarian Cancer|Unknown status|Recruiting|Phase 2|70|Anticipated|Herlev Hospital||1|||f||||t||||||||||2017-02-18 13:49:01.878254|2017-02-18 13:49:01.878254
NCT00772785|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2013-01-25||2011-01-05|September 2008||2008-09-01|October 2012|2012-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|PRO-809||Study of Probuphine in Patients With Opioid Dependence|An Open-label, Multi-center Extension Study of Probuphine in Patients With Opioid Dependence|Terminated||Phase 3|16|Actual|Titan Pharmaceuticals||1||This study was terminated for reasons not related to efficacy or safety|f||||t||||||||||2017-02-18 13:49:01.980617|2017-02-18 13:49:01.980617
NCT00772772|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2015-01-06|2011-03-10||March 2008||2008-03-01|January 2015|2015-01-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Vitamin D Repletion in Chronic Kidney Disease|The Effect of Vitamin D3 Repletion in Chronic Kidney Disease Stage 3|Completed||Early Phase 1|12|Actual|Rockefeller University||1|||f||||f||||||||||2017-02-18 13:49:02.097099|2017-02-18 13:49:02.097099
NCT00772759|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-05-04|||October 2008||2008-10-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|||||Interventional|||Assess Safety, Tolerability and PK of AZD3199 in Japanese|A Phase I, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Centre Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Japanese Healthy Men|Completed||Phase 1|27|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 13:49:02.334428|2017-02-18 13:49:02.334428
NCT00772746|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2008-10-14|||March 2006||2006-03-01|October 2008|2008-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|CBT||Cognitive Behavioral Therapy in Panic Disorder|Effectiveness of Specific Model of Cognitive-Behavioral Therapy in Panic Disorder Patients With Agoraphobia|Completed||N/A|50|Actual|Universidade Federal do Rio de Janeiro|||1||f||||t||||||None Retained|"~     None retained~   "|||2017-02-18 13:49:02.457427|2017-02-18 13:49:02.457427
NCT00772733|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2011-02-21|||October 2008||2008-10-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|KOSMOS||A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment|A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment|Completed||N/A|936|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:49:02.562381|2017-02-18 13:49:02.562381
NCT00772720|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2010-03-30|||March 2010||2010-03-01|March 2010|2010-03-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|RALMET-VOLHCB||Effects of Raltegravir (Isentress®) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy Volunteers|Study on the Effects of Raltegravir (Isentress®) on Lipid and Carbohydrate Metabolism and Mitochondrial Function in Healthy Volunteers|Unknown status|Recruiting|Phase 1|14|Anticipated|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-02-18 13:49:02.662381|2017-02-18 13:49:02.662381
NCT00772707|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-08-31|2012-08-01||September 2008||2008-09-01|August 2012|2012-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Multi‐Center Investigation of Patient Acceptability of OPTI‐FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)|A 30 Day, Multi‐Centered, Open Label Study To Determine Comfort and Overall Contact Lens Wearing Experience Using OPTI‐FREE RepleniSH® MPDS as Compared to COMPLETE®MPS Easy Rub™ or ReNu MultiPlus® in Daily Wear Soft Contact Lens Patients|Completed||N/A|114|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:49:02.757995|2017-02-18 13:49:02.757995
NCT00772694|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2008-10-23|||September 2008||2008-09-01|October 2008|2008-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|GCT||Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy|Sorafenib (NEXAVAR) Monotherapy in Patients With Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy|Unknown status|Recruiting|Phase 2|20|Anticipated|Fondation Wygrajmy Zdrowie||1|||f||||t||||||||||2017-02-18 13:49:03.003089|2017-02-18 13:49:03.003089
NCT00772681|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2009-12-04|||October 2004||2004-10-01|December 2009|2009-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Tax-Nazo||Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma|Phase IV Clinical Study Evaluating The Efficacy of Chemoradiotherapy Following Neoadjuvant Treatment With Docetaxel and Cisplatin in Indifferentiated and Non-keratinized Squamous Cell Carcinoma of Nasopharynx|Completed||Phase 4|57|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:49:03.107314|2017-02-18 13:49:03.107314
NCT00772668|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-12|2016-12-14|2013-01-18||September 2008||2008-09-01|December 2016|2016-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Treating Patients With Stage III or Stage IV Follicular Lymphoma or Marginal Zone Lymphoma|Pilot Study of RCVELP as First Line Therapy for Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL)|Terminated||N/A|3|Actual|University of Miami|This study was terminated early due to lack of funding. All patients were removed from the study. No results were analyzed.|1||Funding|f||||t||||||||||2017-02-18 13:49:03.21283|2017-02-18 13:49:03.21283
NCT00772655|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2012-07-31|||October 2007||2007-10-01|July 2012|2012-07-01|June 2015|Anticipated|2015-06-01|June 2010|Actual|2010-06-01||Interventional|||Zevalin® First Line in Follicular Lymphoma|Multicenter European Pilot Study of 90Yttrium-Ibritumomab Tiuxetan as First Line Therapy for Stage III - IV Follicular Lymphoma (and Selected Patients With Extended Stage II) Followed by Consolidation Rituximab for Patients in Complete Remission But With Persistent Molecular Disease|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-02-18 13:49:03.467824|2017-02-18 13:49:03.467824
NCT00772642|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-11|2017-01-24|||October 8, 2008||2008-10-08|September 10, 2010|2010-09-10|September 10, 2010||2010-09-10|||||Observational|||Immune Parameters in the Cord Blood of Newborns Exposed to Malaria in the Womb|Profiling Immunological Parameters in the Cord Blood of Neonates Exposed to Plasmodium Falciparum in Utero|Completed||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:49:03.579776|2017-02-18 13:49:03.579776
NCT00772629|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2014-01-21|2009-03-16||January 2004||2004-01-01|January 2014|2014-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults|Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults Who Were Either Previously Vaccinated With Unconjugated Meningococcal Polysaccharide (Serogroups A, C or Serogroups A, C, Y, and W-135) Vaccine or Not Vaccinated With Meningococcal Vaccine|Terminated||Phase 2|18|Actual|Sanofi|Enrollment was terminated before the planned sample size was achieved because the principal investigator and the Sponsor decided that sufficient sera had been obtained to meet the secondary objective of the study.|2||See detailed description for termination reason|f||||f||||||||||2017-02-18 13:49:03.66487|2017-02-18 13:49:03.66487
NCT00772616|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-11|2016-09-22|||September 2008||2008-09-01|September 2016|2016-09-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||Influence of Intraoperative Analgesia on the Postoperative Morphine Consumption|Influence of Intraoperative Analgesia (Sufentanil Administered According to the Usual Criteria or Remifentanil Administered by a Closed-loop System Using Bispectral Index as the Controller) on the Postoperative Morphine Consumption|Completed||Phase 4|60|Actual|Hopital Foch||2|||f||||f||||||||||2017-02-18 13:49:04.054821|2017-02-18 13:49:04.054821
NCT00772603|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2013-12-23|2013-04-09||November 2008||2008-11-01|December 2013|2013-12-01|November 2010|Actual|2010-11-01|April 2010|Actual|2010-04-01||Interventional|PROSPER1||Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures|Phase III Study to Evaluate the Efficacy and Safety of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Seizures|Completed||Phase 3|366|Actual|Supernus Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 13:49:04.158823|2017-02-18 13:49:04.158823
NCT00772590|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2012-07-23|2012-05-06||March 2009||2009-03-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional|CORAL||Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response|Randomised Double-blind Placebo Controlled Study to Measure the Effect of Antiretroviral Therapy (ART) Intensification With Raltegravir and/or Hyper-immune Bovine Colostrum on CD4+ T Cell Count in ART Treated, HIV-1 Infected Individuals With Suboptimal CD4+ T Cell Responses|Completed||Phase 4|75|Actual|Kirby Institute|Effect of interventions only measured in peripheral blood|4|||f||||f||||||||||2017-02-18 13:49:05.327613|2017-02-18 13:49:05.327613
NCT00772577|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2011-03-08|2010-12-07||August 2008||2008-08-01|March 2011|2011-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|ATTAIN||Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension|An 8-Week Prospective, Multicenter, Randomized, Double-Blind, Active Control, Parallel Group Study to Evaluate the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension|Completed||Phase 4|386|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:49:05.90404|2017-02-18 13:49:05.90404
NCT00772564|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-11|2012-05-25|||August 2008||2008-08-01|May 2012|2012-05-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||The Use of Statins for Myocardial Death Prevention|The Use of Statins for Myocardial Death Prevention: From Cell to Bedside|Completed||Phase 4|25|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-02-18 13:49:06.322253|2017-02-18 13:49:06.322253
NCT00772538|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2014-07-30|2012-07-25||October 2008||2008-10-01|July 2014|2014-07-01||||July 2011|Actual|2011-07-01||Interventional|||Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)|A Phase III Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (5 mcg/Day) Over 48 Weeks as add-on Controller Therapy on Top of Usual Care in Patients With Severe Persistent Asthma|Completed||Phase 3|459|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:49:06.530073|2017-02-18 13:49:06.530073
NCT00772525|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2016-01-28||2016-01-28|September 2008||2008-09-01|January 2016|2016-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis|A Double-blind, Placebo-controlled, Randomized Crossover, Activity Study of Single Oral Doses of 50 mg and 400 mg Nerispirdine on Visual Function in Patients With Multiple Sclerosis|Completed||Phase 2|31|Actual|Sanofi||6|||f||||t||||||||||2017-02-18 13:49:07.710118|2017-02-18 13:49:07.710118
NCT00772512|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2010-03-17|||November 2008||2008-11-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study Of The Effect Of PF-04802540 On Sleep Measures|Subject- And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, 3-Way Crossover Study To Study Effects Of PF-04802540 On Polysomnography Endpoints In Healthy Volunteers|Completed||Phase 1|13|Actual|Taisho Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-02-18 13:49:07.821479|2017-02-18 13:49:07.821479
NCT00772499|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2008-10-14|||November 2002||2002-11-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|VIOS||Vascular Improvement With Olmesartan Medoxomil Study|Vascular Improvement With Olmesartan Medoxomil Study|Completed||Phase 4|100|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:49:07.931756|2017-02-18 13:49:07.931756
NCT00772486|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2010-11-18|||September 2008||2008-09-01|November 2010|2010-11-01||||April 2011|Anticipated|2011-04-01||Interventional|||A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL|A Phase 1b Study of Repeated Doses of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35) in Combination With Fludarabine, Cyclophosphamide and Rituximab (FCR) in Subjects With Chronic Lymphocytic Leukemia (CLL)|Unknown status|Active, not recruiting|Phase 1|12|Anticipated|Memgen, LLC||1|||f||||t||||||||||2017-02-18 13:49:08.043853|2017-02-18 13:49:08.043853
NCT00772473|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2009-05-22|||February 2008||2008-02-01|May 2009|2009-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine|Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine|Completed||N/A|34|Actual|Clinvest|||1||f||||f||||||None Retained|"~     saliva~   "|||2017-02-18 13:49:08.161391|2017-02-18 13:49:08.161391
NCT00772460|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-09-18|||October 2008||2008-10-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|HDV||Comparison of a New Patient Warming System Using Polymer Conductive Warming With Forced Air Warming During Surgery|Comparison of a New Patient Warming System Using Polymer Conductive Warming With Forced Air Warming During Surgery|Completed||Phase 3|80|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:49:08.262889|2017-02-18 13:49:08.262889
NCT00772447|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-02-23|2011-09-09||September 2008||2008-09-01|February 2015|2015-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||One patient was randomized but did not receive any study drug, so the patient was not included in FAS(full analysis set) population analysis.|China Registration Study in Patients With Skin Infections|A Phase 3, Multicentre, Randomised, Investigator-blinded, Parallel-groupStudy of the Safety and Efficacy of Intravenous Daptomycin (Cubicin®)Compared With That of Comparator (Vancomycin or Vancomycin Followed by Semi-synthetic Penicillin-cloxacillin) in the Treatment of Chinese Subjects With cSSSI|Completed||Phase 3|265|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:49:08.364055|2017-02-18 13:49:08.364055
NCT00772434|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2011-11-17|||September 2008||2008-09-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument|Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument|Completed||N/A|412|Actual|Rockefeller University|||1||f||||f||||||||||2017-02-18 13:49:09.188339|2017-02-18 13:49:09.188339
NCT00772421|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2012-01-27|||January 2009||2009-01-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|SANTE RR||Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Rhythm|Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Rhythm (SANTE RR)|Completed||N/A|29|Actual|MedtronicNeuro|||2||f||||t||||||||||2017-02-18 13:49:09.27423|2017-02-18 13:49:09.27423
NCT00772408|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2013-02-27|||August 2006||2006-08-01|October 2008|2008-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis|Relationship Between TLR2 Polymorphism and Pulmonary Tuberculosis|Completed||N/A|300|Actual|Chang Gung Memorial Hospital|||2||f||||t||||||Samples With DNA|"~     peripheral blood leukocyte DNA and plasma~   "|||2017-02-18 13:49:09.374504|2017-02-18 13:49:09.374504
NCT00772395|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2014-09-18|||April 2006||2006-04-01|September 2014|2014-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|PREVENT||Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty|Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty. A Randomized, Double-blind, Placebo-controlled, Parallel-group Study|Completed||Phase 4|78|Actual|Danderyd Hospital||2|||f||||f||||||||||2017-02-18 13:49:09.484935|2017-02-18 13:49:09.484935
NCT00772382|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2014-09-05|2014-04-10||December 2008||2008-12-01|September 2014|2014-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia|A Phase III, Multi-center, Open Label, Flexible Dose, Long Term Safety Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia|Completed||Phase 3|116|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-02-18 13:49:09.606754|2017-02-18 13:49:09.606754
NCT00772369|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2014-01-20|2010-03-15||September 2003||2003-09-01|January 2014|2014-01-01|April 2005|Actual|2005-04-01|April 2004|Actual|2004-04-01||Observational|||Retrospective Survey of Safety of Fourth Dose Pentacel® in Children|Retrospective Safety Survey of Selected Events in the 6 Months Following the 4th Dose of the Pentacel® Vaccination Series in Children|Completed||Phase 4|3214|Actual|Sanofi|||1||f||||f||||||||||2017-02-18 13:49:10.305003|2017-02-18 13:49:10.305003
NCT00772356|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2016-03-01|||January 2008||2008-01-01|June 2010|2010-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I Diabetes|A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I Diabetes|Completed||N/A|14|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:49:10.650664|2017-02-18 13:49:10.650664
NCT00772343|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2013-09-06||2012-06-28|February 2009||2009-02-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|July 2011|Actual|2011-07-01||Interventional|||Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection|A Phase II Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of A Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection (CDI)|Completed||Phase 2|116|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 13:49:10.749966|2017-02-18 13:49:10.749966
NCT00772330|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2017-01-10|||October 2007||2007-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:49:10.890329|2017-02-18 13:49:10.890329
NCT00772317|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2016-01-11|||July 2008||2008-07-01|January 2016|2016-01-01|December 2021|Anticipated|2021-12-01|December 2016|Anticipated|2016-12-01||Interventional|STAR||A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)|A Multicenter Clinical Study of the Sonablate® 450 (Sonablate) for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)|Active, not recruiting||N/A|117|Actual|SonaCare Medical||1|||f||||t||||||||||2017-02-18 13:49:10.934371|2017-02-18 13:49:10.934371
NCT00772304|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2010-02-23|2009-12-03||October 2008||2008-10-01|February 2010|2010-02-01||||November 2008|Actual|2008-11-01||Interventional|||Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis||Completed||Phase 4|102|Actual|Alcon Research|Small sample size. The severity of symptoms experienced by patients may have masked their ability to detect taste and smell.|1|||f||||f||||||||||2017-02-18 13:49:11.052613|2017-02-18 13:49:11.052613
NCT00772291|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2011-08-18|||May 2007||2007-05-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|pregabalin||Chronic Pain Management After Herniorraphy|Chronic Pain Management After Herniorraphy:Pregabalin vs Placebo. A Double-blinded Randomised Controlled Clinical Trial.|Completed||Phase 3|140|Anticipated|Erasmus Medical Center||2|||f||||t||||||||||2017-02-18 13:49:11.318373|2017-02-18 13:49:11.318373
NCT00772278|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2014-10-25|||January 2009||2009-01-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Comparing Carotid Stenting With Endarterectomy in Severe Asymptomatic Carotid Stenosis|A Randomized Evaluation of Short Term and Long Term Outcome After Endovascular Repair by Stenting of Carotid Artery Stenosis in Patients With Severe (70% and Higher) Asymptomatic Carotid Stenosis|Unknown status|Recruiting|Phase 4|500|Anticipated|Carmel Medical Center||2|||f||||t||||||||||2017-02-18 13:49:11.422914|2017-02-18 13:49:11.422914
NCT00772265|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2012-12-26|||September 2010||2010-09-01|December 2012|2012-12-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects|A Randomized Single Center Double Blind 2 Period Crossover Glucose Clamp Study to Test for Bioequivalence Between 2 Recombinant Human Isophane Insulins Wockhardt's Human Isophane Insulin Injection100IU/ml With Novolin N in Healthy Subjects|Completed||Phase 1|56|Actual|Wockhardt||2|||f||||f||||||||||2017-02-18 13:49:11.529923|2017-02-18 13:49:11.529923
NCT00772252|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2010-06-28|||August 2008||2008-08-01|June 2010|2010-06-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Observational|||Oxidative Stress and Microcirculation in Patient With Hepatic Failure Undergoing Liver Support Treatment|Oxidative Stress and Microcirculation in Patient With Hepatic Failure Undergoing Liver Support Treatment|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:49:11.63182|2017-02-18 13:49:11.63182
NCT00772239|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2011-04-23|||October 2008||2008-10-01|April 2011|2011-04-01||||August 2010|Actual|2010-08-01||Interventional|ROTEM||Perioperative Coagulation Management in Cardiac Surgery.|Perioperative Coagulation Management in Cardiac Surgery. Rotem Versus Standard Pratctice. A Randomized Trial.|Terminated||N/A|100|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-02-18 13:49:11.735182|2017-02-18 13:49:11.735182
NCT00772226|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2012-09-09|||September 2008||2008-09-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Use of Music as Pain Therapy in Patients Undergoing Laparoscopic Cholecystectomy in a Day Care Unit|The Use of Music as Pain Therapy in Patients Undergoing Laparoscopic Cholecystectomy in a Day Care Unit|Completed||Phase 3|204|Actual|Randers Regional Hospital||2|||f||||f||||||||||2017-02-18 13:49:11.833715|2017-02-18 13:49:11.833715
NCT00772213|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2013-10-29|||February 2003||2003-02-01|October 2013|2013-10-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|MIGTS||The Multifunctional Image Guided Therapy Suite (MIGTS) in Emergency Multiple Trauma Care|The Impact of a Multifunctional Image Guided Therapy Suite (MIGTS) on Emergency Multiple Trauma Care - a Controlled Clinical Pilot Study|Completed||N/A|168|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 13:49:11.9293|2017-02-18 13:49:11.9293
NCT00772200|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2016-10-14|||September 2008||2008-09-01|October 2016|2016-10-01||||January 2100|Anticipated|2100-01-01||Observational|||Neuropsychological and Behavioral Testing in Younger Patients With Cancer|Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer|Recruiting||N/A|755|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-02-18 13:49:12.053077|2017-02-18 13:49:12.053077
NCT00772187|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2010-09-21|||October 2007||2007-10-01|July 2010|2010-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Intraoperative and Postoperative Analgesia for Laparoscopic Surgery.|Intraoperative and Postoperative Analgesia for Laparoscopic Surgery.|Completed||Phase 4|40|Anticipated|Rambam Health Care Campus||2|||f||||||||||||||2017-02-18 13:49:15.089126|2017-02-18 13:49:15.089126
NCT00772174|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2010-07-01|||January 2007||2007-01-01|July 2010|2010-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|PRISMA||Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes|Double-blind, Randomized, Multicenter, Parallel-Group Study to Evaluate the Effects of Pioglitazone on Metabolic Syndrome in Patients With Type 2 Diabetes Treated With Metformin|Completed||Phase 3|418|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:49:15.183564|2017-02-18 13:49:15.183564
NCT00772161|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-01-20|||October 2008||2008-10-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|MPH-Kinetics||Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD)|A Single-Center, Single-Blind, Randomized, Oral Dose Cross-Over Study in Prepuberal Boys With ADHD to Investigate Efficacy and Bioequivalence of 20 mg Ritalin LA Compared to 20 mg Medikinet Retard After Treatment With o.d. Doses Over 7 Days Each.|Completed||Phase 1/Phase 2|24|Actual|University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 13:49:15.298097|2017-02-18 13:49:15.298097
NCT00772148|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2015-06-02|2015-05-12||October 2008||2008-10-01|June 2015|2015-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients|A Phase 2, Open-Label, Multi-Center, Randomized Trial to Demonstrate the Pharmacokinetics of LCP-Tacro™ Tablets Once Daily and Prograf® Capsules Twice Daily in Adult De Novo Liver Transplant Patients|Completed||Phase 2|58|Actual|Veloxis Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:49:15.416614|2017-02-18 13:49:15.416614
NCT00772135|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2008-10-14|||September 2008||2008-09-01|October 2008|2008-10-01|April 2009|Anticipated|2009-04-01|February 2009|Anticipated|2009-02-01||Interventional|||Reversibility by Sildenafil of Exercise-Induced Abnormal Right Ventricular Pressure Response in ASD and VSD-Operated Patients|Pulmonary Hypertension in Adolescents and Adults With Congenital Heart Disease|Unknown status|Recruiting|N/A|15|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-02-18 13:49:16.449191|2017-02-18 13:49:16.449191
NCT00772122|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2008-10-14|||January 2000||2000-01-01|October 2008|2008-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage|Controlled Trial in Women With Recurrent Miscarriage of G-CSF Versus Placebo|Completed||Phase 4|68|Actual|University of Florence||2|||f||||t||||||||||2017-02-18 13:49:16.540219|2017-02-18 13:49:16.540219
NCT00772109|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2016-04-12|2011-07-16||October 2008||2008-10-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults|Lot Consistency, Immunogenicity, and Safety Study of Three Lots of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® Administered Intramuscularly in Adult Subjects Aged 18 to 64 Years|Completed||Phase 3|4292|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 13:49:16.662146|2017-02-18 13:49:16.662146
NCT00772096|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2015-03-09|||October 2008||2008-10-01|March 2015|2015-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Septic Encephalopathy and Late Cognitive Dysfunction|Septic Encephalopathy and Late Cognitive Dysfunction in Patients With Sepsis - the Role of Inflammation|Completed||Phase 4|50|Actual|University Hospital, Basel, Switzerland||2|||f||||||||||||||2017-02-18 13:49:17.767644|2017-02-18 13:49:17.767644
NCT00772083|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2010-08-10|||November 2008||2008-11-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors|Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors|Completed||N/A|400|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-02-18 13:49:17.855807|2017-02-18 13:49:17.855807
NCT00772070|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2014-01-21|2009-03-26||March 2003||2003-03-01|January 2014|2014-01-01|May 2004|Actual|2004-05-01|August 2003|Actual|2003-08-01||Interventional|||Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine|Antibody Responses to a Reduced Dose of Menomune® in Children Who Previously Received an Experimental Tetravalent (A, C, Y, and W-135) Meningococcal Diphtheria Toxoid Conjugate Vaccine, TetraMenD|Completed||Phase 2|173|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:49:17.951085|2017-02-18 13:49:17.951085
NCT00772057|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-12-18|||October 2004||2004-10-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Beta-blockers for Prevention Of Growth Of Small Esophageal Varices In Cirrhosis: An Randomized Controlled Trial (RCT)|Early Primary Prophylaxis With Beta-Blockers In Prevention Of Growth Of Small Esophageal Varices In Cirrhosis: A Randomized Controlled Trial|Completed||N/A|164|Actual|Govind Ballabh Pant Hospital||2|||f||||f||||||||||2017-02-18 13:49:18.694284|2017-02-18 13:49:18.694284
NCT00772044|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2010-03-31|||November 2008||2008-11-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|AERO||Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea|Randomized, Double-blind Study to Compare Safety and Effectiveness of the ProventTM Professional Sleep Apnea Therapy Device to Sham for the Non-invasive Treatment of OSAH|Completed||Phase 4|250|Anticipated|Ventus Medical, Inc.||2|||f||||f||||||||||2017-02-18 13:49:18.804917|2017-02-18 13:49:18.804917
NCT00772031|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2012-01-20|2011-10-18||October 2008||2008-10-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|CMTT||NINDS CRC Chronic Migraine Treatment Trial|NINDS Clinical Research Collaboration Chronic Migraine Treatment Trial|Completed||Phase 3|191|Actual|The EMMES Corporation||2|||f||||t||||||||||2017-02-18 13:49:18.936413|2017-02-18 13:49:18.936413
NCT00772018|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-12|2012-02-01|||May 2008||2008-05-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Quality of Life and Symptom Management in Patients With Bladder Cancer|A Qualitative Study of Patients With Non-Invasive Bladder Cancer|Completed||N/A|28|Actual|Baylor College of Medicine|||1||f||||f||||||||||2017-02-18 13:49:19.588621|2017-02-18 13:49:19.588621
NCT00772005|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-06-21|2011-03-31||September 2008||2008-09-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia|A 24-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil (150, 200, and 250 mg/ Day) as Adjunctive Therapy in Adults With Schizophrenia|Completed||Phase 2|287|Actual|Teva Pharmaceutical Industries||4|||f||||t||||||||||2017-02-18 13:49:19.727474|2017-02-18 13:49:19.727474
NCT00771992|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2010-08-03|||October 2008||2008-10-01|August 2010|2010-08-01|June 2010|Actual|2010-06-01|October 2009|Actual|2009-10-01||Interventional|||Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma|Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma|Completed||N/A|15|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f||||||||||||||2017-02-18 13:49:27.306486|2017-02-18 13:49:27.306486
NCT00771979|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2009-06-17|||November 2008||2008-11-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|||||Interventional|||Relative Bioavailability of Phase II and Phase III Formulations of AZD0530|A Phase I, Randomised, Open-Label, Cross-Over, Single Centre Study in Healthy Volunteers to Determine the Relative Bioavailability of the Phase III Tablet Formulation to the Phase II Tablet Formulation of AZD0530|Completed||Phase 1|18|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:49:27.398608|2017-02-18 13:49:27.398608
NCT00771966|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2012-10-19|||October 2008||2008-10-01|October 2012|2012-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Radical Prostatectomy and Perioperative Fluid Therapy|Radical Prostatectomy and Perioperative Fluid Therapy|Completed||Phase 4|44|Actual|Rigshospitalet, Denmark||2|||f||||||||||||||2017-02-18 13:49:27.487948|2017-02-18 13:49:27.487948
NCT00771953|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-06-13|2013-05-28||November 2008||2008-11-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|May 2012|Actual|2012-05-01||Interventional|||0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer|0822GCC Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients|Completed||Phase 2|109|Actual|University of Maryland|This study is limited by the relatively low numbers and the hetereogeneity between concurrent treatments (docetaxel vs. pemetrexed). However, in analyses stratified by docetaxel and pemetrexed, results for an affect of apricoxib were still null.|2|||f||||t||||||||||2017-02-18 13:49:27.575668|2017-02-18 13:49:27.575668
NCT00771940|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-02-02|||October 2008||2008-10-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Peripheral Metabolic Effects of Ghrelin|Peripheral Metabolic Effects of Intra Arterial Ghrelin Infusion in Healthy Controls|Completed||Phase 1|8|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-02-18 13:49:27.961814|2017-02-18 13:49:27.961814
NCT00771927|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2014-10-17|2013-03-08||October 2008||2008-10-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|PASS|Baseline characteristics refer to the Safety Set (SS). Safety Set includes all patients who have signed a data consent form, provided Baseline characteristic data, and received treatment at least once.|Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures|Post-Authorization Safety Study to Evaluate the Long-Term Safety and Tolerability of Vimpat® (Lacosamide) as Add-On Therapy in Epilepsy Patients With Partial-Onset Seizures Who Are Uncontrolled on Current Therapy|Completed||N/A|1005|Actual|UCB Pharma|||2||f||||f||||||||||2017-02-18 13:49:28.053099|2017-02-18 13:49:28.053099
NCT00771914|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2012-10-31|2011-10-10||November 2008||2008-11-01|October 2012|2012-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Effects of Omega-3 Fatty Acids on Aspirin Resistance|The Effects of Omega-3 Fatty Acids on Aspirin Resistance|Completed||Phase 1/Phase 2|27|Actual|University of Rochester||4|||f||||t||||||||||2017-02-18 13:49:31.976813|2017-02-18 13:49:31.976813
NCT00771901|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-04-28|||February 2008||2008-02-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|TUDCA/PBA||Effect of Endoplasmic Reticulum Stress on Metabolic Function|Effect of Endoplasmic Reticulum Stress on Metabolic Function|Completed||N/A|101|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-02-18 13:49:32.560996|2017-02-18 13:49:32.560996
NCT00771888|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2008-11-12|||April 2008||2008-04-01|November 2008|2008-11-01|August 2009|Anticipated|2009-08-01|October 2008|Actual|2008-10-01||Interventional|LOCKCYST-ext||Open-Label Extension of LOCKCYST Trial|Open-Label Extension of the LOCKCYST Trial, LOCKCYST: Long Acting Lnareotide as as Volume Reducing Treatment of Polycystic Livers|Unknown status|Active, not recruiting|Phase 2/Phase 3|54|Anticipated|Radboud University||1|||f||||f||||||||||2017-02-18 13:49:32.676156|2017-02-18 13:49:32.676156
NCT00771875|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2015-12-17|2015-10-27||September 2008||2008-09-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Randomized Trial for Mixed Acute Rejection|B-Cell Targeted Therapy for Acute Renal Allograft Rejection With an Antibody Mediated Component: A Prospective, Randomized, Open-Label Study|Completed||Phase 2|30|Actual|University of Cincinnati||3|||f||||t||||||||||2017-02-18 13:49:32.788193|2017-02-18 13:49:32.788193
NCT00771862|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-14|2016-04-07|||October 2008||2008-10-01|April 2016|2016-04-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks|Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks|Active, not recruiting||Phase 4|18|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-02-18 13:49:33.733921|2017-02-18 13:49:33.733921
NCT00771849|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-13|2016-04-12|2009-03-16||August 2003||2003-08-01|April 2016|2016-04-01|May 2004|Actual|2004-05-01|March 2004|Actual|2004-03-01||Interventional|||Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children|Antibody Responses for Serogroup C After One Dose of an Experimental Tetravalent (A, C, Y, and W-135) Meningococcal Diphtheria Toxoid Conjugate Vaccine Versus a Non-meningococcal Control Vaccine in Children Who Have Previously Received a Monovalent Meningococcal C Conjugate Vaccine|Completed||Phase 2|103|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:49:33.843927|2017-02-18 13:49:33.843927
NCT00771836|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-10-14|||July 2004||2004-07-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|AHR||Airway Reactivity in Children Before and After BMT Bone Marrow Transplantation|Airway Reactivity in Children Before and After Bone Marrow Transplantation|Completed||N/A|39|Actual|Rambam Health Care Campus|||1||f||||f||||||None Retained|"~     Not retained~   "|||2017-02-18 13:49:34.300614|2017-02-18 13:49:34.300614
NCT00771823|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2010-08-13|||May 2008||2008-05-01|August 2010|2010-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers|A Placebo Controlled Study of the Impact on Insulin Sensitivity and Lipid Profile of Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers|Completed||Phase 1|16|Actual|St Stephens Aids Trust||2|||f||||f||||||||||2017-02-18 13:49:34.384932|2017-02-18 13:49:34.384932
NCT00771641|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2014-01-23||||||January 2014|2014-01-01|November 2013|Actual|2013-11-01|August 2002|Actual|2002-08-01||Interventional|||Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck|Phase III Randomized Comparison of Radiotherapy Fractionation in Advanced Squamous Cell Carcinoma of the Head and Neck: Twice-Daily Hyperfractionation vs Split-Course Accelerated Hyperfractionation vs Accelerated Fractionation With Concomitant Boost vs Standard Fractionation|Completed||Phase 3|1113|Actual|Radiation Therapy Oncology Group||4|||f||||t||||||||||2017-02-18 13:49:41.446375|2017-02-18 13:49:41.446375
NCT00771810|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-10-11|2013-02-25||October 2008||2008-10-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer|Ph IIb Study Evaluating the Safety & Efficacy of TXA127 in the Reduction of Incidence and Severity of Thrombocytopenia in Patients Receiving Combination Gemcitabine and Platinum Therapy for Ovarian, Fallopian Tube, or Peritoneal Carcinoma|Terminated||Phase 2|34|Actual|Tarix Pharmaceuticals|Feasibility considerations (e.g., slow patient enrollment and lower incidence of Grade 3-4 thrombocytopenia than planned) necessitated early termination of the study after 34 patients had been enrolled.|3||Insufficient incidence of thrombocytopenia in control population|f||||f||||||||||2017-02-18 13:49:34.49239|2017-02-18 13:49:34.49239
NCT00771797|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-09-22|||October 2008||2008-10-01|September 2015|2015-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment|Clinical Study to Assess the Clinical Efficacy of Flavanol-rich Cocoa on Vascular Function in Diabetic Patients With PAOD|Withdrawn||Phase 2|0|Actual|RWTH Aachen University||2||investigator took study to university hospital duesseldorf|f||||f||||||||||2017-02-18 13:49:35.859161|2017-02-18 13:49:35.859161
NCT00771784|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-08-21|||July 2008||2008-07-01|August 2012|2012-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Effects of Tracheal Intubation on Ventilation With a Laryngeal Mask During Percutaneous Dilatation Tracheostomy|Effects of Short- and of Long-term Tracheal Intubation on Ventilation With a Laryngeal Mask During Percutaneous Dilatation Tracheostomy.|Completed||N/A|60|Actual|University of Padova|||2||f||||t||||||||||2017-02-18 13:49:35.968343|2017-02-18 13:49:35.968343
NCT00771771|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2014-02-24|||December 2008||2008-12-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|June 2012|Actual|2012-06-01||Interventional|||Early Supported Discharge After Stroke in Bergen|Early Supported Discharge After Stroke in Bergen. An RCT Looking at the Collaboration Between Hospital Service and Primary Health Care.|Completed||N/A|306|Actual|Haukeland University Hospital||3|||f||||f||||||||||2017-02-18 13:49:36.059931|2017-02-18 13:49:36.059931
NCT00771758|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2014-04-24|2010-12-08||September 2008||2008-09-01|April 2014|2014-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis|A Randomized, Double-Blind, Placebo- and Oxycodone Immediate Release (IR)-Controlled Study of Tapentadol IR for the Treatment of Acute Pain Caused by Vertebral Compression Fractures Associated With Osteoporosis|Completed||Phase 3|108|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC|Insufficient number of participants enrolled to meet proposed sample size, so that statistical inferences could not be made.|3|||f||||f||||||||||2017-02-18 13:49:36.195114|2017-02-18 13:49:36.195114
NCT00771745|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-12-15|2013-01-18||September 2008||2008-09-01|December 2015|2015-12-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients|Prospective, Single Center, Pilot Study of Pretransplant Thymoglobulin Administration and Early Corticosteroid Withdrawal in Living Donor Renal Transplant Recipients Under Mycophenolate Mofetil (MMF) and Tacrolimus Immunosuppression|Completed||Phase 4|11|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 13:49:38.237398|2017-02-18 13:49:38.237398
NCT00771732|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-10-10|||May 2008||2008-05-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Using Light Therapy to Treat Toe Nail Fungus|Noveon Laser Treatment of Onychomycosis: A Device Performance Clinical Study|Unknown status|Recruiting|Phase 2|40|Anticipated|Nomir Medical Technologies||2|||f||||t||||||||||2017-02-18 13:49:38.627993|2017-02-18 13:49:38.627993
NCT00771719|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-07-27|||October 2008||2008-10-01|July 2012|2012-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia|Open-Label Exploratory, Multiple-Dose Study of Ceftobiprole to Evaluate the Pharmacokinetics and Broncho-Alveolar Penetration in Adults With Ventilator-Associated Pneumonia|Terminated||Phase 1|1|Actual|Basilea Pharmaceutica||1||Study closed due to lack of enrollment; challenging patient population.|f||||f||||||||||2017-02-18 13:49:38.737127|2017-02-18 13:49:38.737127
NCT00771706|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-04-19|||January 2006||2006-01-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux|Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux|Withdrawn||Phase 3|0|Actual|Massachusetts Eye and Ear Infirmary||2||This study was not activated, no data was collected.|f||||f||||||||||2017-02-18 13:49:38.840506|2017-02-18 13:49:38.840506
NCT00771693|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2010-11-04|||May 2007||2007-05-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)|Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With NIDDM: a Placebo-controlled Dose-response Study With Insulin Aspart (Novorapid®)|Completed||Phase 4|18|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-02-18 13:49:38.9497|2017-02-18 13:49:38.9497
NCT00771680|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-10-26|||October 2008||2008-10-01|October 2016|2016-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes|Evaluation of Effectiveness and Safety of Levemir® (Insulin Detemir), NovoMix® (Biphasic Insulin Aspart) and/or NovoRapid® (Insulin Aspart) in Insulin naïve Subjects With Type 2 Diabetes.|Completed||N/A|10408|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:49:39.060408|2017-02-18 13:49:39.060408
NCT00771667|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2013-03-26|2011-10-10||December 2008||2008-12-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy|A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Ustekinumab Therapy in Subjects With Moderately to Severely Active Crohn's Disease Previously Treated With TNF Antagonist Therapy|Completed||Phase 2|526|Actual|Centocor, Inc.||10|||f||||t||||||||||2017-02-18 13:49:39.187583|2017-02-18 13:49:39.187583
NCT00771654|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-08-30|||February 2009||2009-02-01|August 2012|2012-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Phentermine/Gastric Band Weight Loss Study|Does the Addition of Phentermine Increase Weight Loss in the Obese After Gastric Band Operation?|Withdrawn||N/A|0|Actual|Carolinas Healthcare System||2||Low enrollment|f||||t||||||||||2017-02-18 13:49:41.350727|2017-02-18 13:49:41.350727
NCT00771628|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2009-07-10|||January 2008||2008-01-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Flex-It Stylet to Malleable Stylet for GlideScope Intubation: A Randomized Controlled Trial|Comparison of Flex-It Stylet to Malleable Stylet for GlideScope Intubation: A Randomized Controlled Trial|Completed||N/A|80|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 13:49:41.559245|2017-02-18 13:49:41.559245
NCT00771615|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2016-10-06|2013-12-19||October 2008||2008-10-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years|A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age|Completed||Phase 2|469|Actual|GlaxoSmithKline||9|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:49:41.683129|2017-02-18 13:49:41.683129
NCT00771602|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-05-27|2011-04-04||August 2008||2008-08-01|May 2015|2015-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Alemtuzumab + Rituximab Consolidation in CLL|A Randomized Trial of Rituximab vs Alemtuzumab vs Alemtuzumab + Rituximab as Consolidation Therapy for Patients With Chronic Lymphocytic Leukemia (CLL) With Evidence of Residual Disease Following Prior Chemo(Immuno)Therapy|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||3||Lack of accrual.|f||||f||||||||||2017-02-18 13:49:44.576565|2017-02-18 13:49:44.576565
NCT00771589|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2008-10-10|||May 2008||2008-05-01|October 2008|2008-10-01|April 2009|Anticipated|2009-04-01|January 2009|Anticipated|2009-01-01||Interventional|||Active Knee Prosthesis Study for Improvement of Locomotion for Above Knee Amputees|The Active Knee Prosthesis Will be Tested to Evaluate How Well it Improves the Gait Symmetry and Reduces the Metabolic Cost of an Amputee During Walking. The Prosthesis Will be Attached to the Socket of the Amputee.|Unknown status|Recruiting|N/A|10|Anticipated|Providence VA Medical Center||1|||f||||t||||||||||2017-02-18 13:49:44.934661|2017-02-18 13:49:44.934661
NCT00771576|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2013-07-29|||September 2006||2006-09-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||PET Scan Imaging of Beta Cell Mass|PET Scan Imaging of Pancreatic Beta Cell Mass With DTBZ|Completed||N/A|30|Actual|Columbia University|||3||f||||t||||||None Retained|"~     Blood~   "|||2017-02-18 13:49:45.047776|2017-02-18 13:49:45.047776
NCT00771563|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2013-06-27|||June 2008||2008-06-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|SYRINGES||Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)|Low Molecular Weight Heparin in Advanced Non Small Cell Lung Cancer (NSCLC): a Randomized Open Label Phase III Study Evaluating the Effect of Enoxaparin (Clexane) on Survival and Symptom Control in Patients With Stage IIIB and IV NSCLC Undergoing a Cisplatin Based First Line Chemotherapy: the SYRINGES Trial|Completed||Phase 3|104|Actual|University Hospital, Antwerp||2|||f||||f||||||||||2017-02-18 13:49:45.144762|2017-02-18 13:49:45.144762
NCT00771537|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2013-06-28|2013-04-07||November 2006||2006-11-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||HIV Testing & Womens Attitudes on HIV Vaccine Trials|HIV Testing & Womens Attitudes on HIV Vaccine Trials|Completed||Phase 3|2031|Actual|Indiana University||16|||f||||t||||||||||2017-02-18 13:49:45.273213|2017-02-18 13:49:45.273213
NCT00771524|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-07-27|||April 2009||2009-04-01|July 2012|2012-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone|Open-Label, Pharmacokinetic Study of the Penetration of Ceftobiprole Into Bone|Completed||Phase 1|22|Actual|Basilea Pharmaceutica||2|||f||||f||||||||||2017-02-18 13:49:46.743016|2017-02-18 13:49:46.743016
NCT00771511|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2013-02-06|||October 2010||2010-10-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Cervical Capsaicin for Labor Induction and Pain Relief|Cervical Capsaicin for Labor Induction and Pain Relief|Withdrawn||Phase 4|0|Actual|Columbia University||2||PI left the institution.|f||||t||||||||||2017-02-18 13:49:46.840497|2017-02-18 13:49:46.840497
NCT00771498|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-05-15|||November 2008||2008-11-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|A06-295||An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin|An Evaluation of the Pharmacological Interaction of Lopinavir 800mg - Ritonavir 200mg Combination and Rifampin in Subjects Presenting Tuberculosis, With Contraindication for Antiretroviral Regimens Including Efavirenz|Completed||Phase 4|30|Actual|Oswaldo Cruz Foundation||1|||f||||f||||||||||2017-02-18 13:49:46.92706|2017-02-18 13:49:46.92706
NCT00771485|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-02-08|||September 2008||2008-09-01|February 2012|2012-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Efficacy of Bowel Preparation Before Colonoscopy|Study of Efficacy of Bowel Preparation Before Colonoscopy|Completed||Phase 2|148|Actual|C.B. Fleet Company, Inc.||2|||f||||f||||||||||2017-02-18 13:49:47.038082|2017-02-18 13:49:47.038082
NCT00771472|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-04-02|2012-05-30||August 2008||2008-08-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)|Phase I Clinical Study of MK-0683 in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL)|Completed||Phase 1|10|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:49:47.13714|2017-02-18 13:49:47.13714
NCT00771459|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2011-06-22|||October 2008||2008-10-01|October 2008|2008-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Local Infiltration Analgesia in Major Spine Surgery With Ropivacaine Versus Placebo|Lokal Infiltrations Analgesi Med Ropivakain 0,5 % Versus Placebo Ved Rygkirurgi for Spinalstenose: et Prospektivt Randomiseret, Dobbeltblindet, Placebo-kontrolleret Studie|Completed||Phase 4|48|Anticipated|Hvidovre University Hospital||2|||f||||||||||||||2017-02-18 13:49:47.483581|2017-02-18 13:49:47.483581
NCT00771446|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2013-04-05||2012-07-24|October 2008||2008-10-01|April 2013|2013-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ELAD||Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency|Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) in Patients With Acute on Chronic Hepatitis (AOCH)|Completed||Phase 1/Phase 2|18|Actual|Vital Therapies, Inc.||2|||f||||t||||||||||2017-02-18 13:49:47.578723|2017-02-18 13:49:47.578723
NCT00771251|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-11-02|||May 2008||2008-05-01|November 2015|2015-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)|A Study of Golimumab (CNTO148) Monotherapy in Patients With Active Rheumatoid Arthritis|Completed||Phase 3|311|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-02-18 13:49:50.756577|2017-02-18 13:49:50.756577
NCT00771433|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2011-05-12|||October 2007||2007-10-01|December 2008|2008-12-01||||May 2011|Actual|2011-05-01||Interventional|||G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer|Evaluation of the Efficacy of Adding Daily G-CSF (Granulocyte Colony Stimulating Factor) for Prevention of Hematologic Toxicity Due to Neoadjuvant or Adjvuant Chemotherapy in Breast Cancer|Completed||Phase 2|120|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:49:47.688998|2017-02-18 13:49:47.688998
NCT00771420|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-07-19|||October 2008||2008-10-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis|A Double-blind, Placebo-controlled, Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CAM-3001 in Patients With Rheumatoid Arthritis.|Completed||Phase 1|38|Actual|MedImmune LLC||7|||f||||t||||||||||2017-02-18 13:49:47.857356|2017-02-18 13:49:47.857356
NCT00771407|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-08-25|2013-08-20||December 2008||2008-12-01|August 2015|2015-08-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|PriSm|The Baseline Analysis population is the 113 subjects in the Intent To Treat population.|Parastomal Reinforcement With Strattice|A Prospective, Multicenter, Randomized, Controlled, Third-party Blinded Study of Strattice Fascial Inlay for Parastomal Reinforcement in Patients Undergoing Surgery for Permanent Abdominal Wall Ostomies|Completed||Phase 4|120|Actual|LifeCell||2|||f||||f||||||||||2017-02-18 13:49:47.975426|2017-02-18 13:49:47.975426
NCT00771394|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2013-02-13|||October 2008||2008-10-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of Solifenacin Succinate as Add-on Therapy for Overactive Bladder (OAB) Symptoms in Men Treated for Benign Prostatic Hyperplasia (BPH) With Tamsulosin Hydrochloride|Completed||Phase 4|638|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 13:49:48.851037|2017-02-18 13:49:48.851037
NCT00771381|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-10-01|||November 2008||2008-11-01|March 2012|2012-03-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer|A Phase II Pre-Treatment Hypoxia PET Imaging Study Using 18F-FAZA in Patients With Invasive Duct Carcinoma of the Breast|Unknown status|Recruiting|Phase 2|30|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 13:49:48.972759|2017-02-18 13:49:48.972759
NCT00771368|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-01-18|||January 2009||2009-01-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Reduction of Bacteria in MRSA Positive Ulcers|A Clinical Trial on the Reduction of Bacteria (Including MRSA) in MRSA Positive Ulcers and Lesions|Terminated||Phase 1/Phase 2|20|Anticipated|Nitric BioTherapeutics, Inc||1||limited recruitment|f||||f||||||||||2017-02-18 13:49:49.072882|2017-02-18 13:49:49.072882
NCT00771355|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2011-03-28|||August 2008||2008-08-01|March 2011|2011-03-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|||In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy|In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy|Terminated||N/A|40|Anticipated|Massachusetts General Hospital|||4|Lack of study staff.|f||||f||||||||||2017-02-18 13:49:49.15525|2017-02-18 13:49:49.15525
NCT00771342|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2010-02-02|||December 2008||2008-12-01|February 2010|2010-02-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)|A Blinded Placebo Controlled Single Cross-over Clinical Trial to Evaluate Fungicidal Activity With Topical Application of 1% Gaseous Nitric Oxide in Subjects With Moderate to Severe Tinea Pedis (Athlete's Foot)|Completed||Phase 2|50|Anticipated|Nitric BioTherapeutics, Inc||2|||f||||f||||||||||2017-02-18 13:49:49.233842|2017-02-18 13:49:49.233842
NCT00771329|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2013-09-12|||October 2008||2008-10-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB023 (Anti-TWEAK) Administered to Subjects With Rheumatoid Arthritis.|Completed||Phase 1|53|Actual|Biogen||2|||f||||t||||||||||2017-02-18 13:49:49.328364|2017-02-18 13:49:49.328364
NCT00771316|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-10-01|2010-04-22||December 2008||2008-12-01|October 2015|2015-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)|A Phase 3, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of MK0826 and Meropenem in Patients With Complicated Urinary Tract Infection|Terminated||Phase 3|6|Actual|Merck Sharp & Dohme Corp.|The reason for early termination: Study was terminated early due to feasibility issues including slow enrollment.|2||feasibility and low enrollment|f||||||||||||||2017-02-18 13:49:49.422613|2017-02-18 13:49:49.422613
NCT00771303|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-05-27|||September 2008||2008-09-01|May 2015|2015-05-01|April 2016|Anticipated|2016-04-01|January 2016|Anticipated|2016-01-01||Observational|||Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study|Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study|Recruiting||Phase 3|300|Anticipated|University Hospital, Geneva|||1||f||||t||||||Samples Without DNA|"~     Nt-pro BNP measurement~   "|||2017-02-18 13:49:49.743581|2017-02-18 13:49:49.743581
NCT00771290|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2012-11-13|||March 2008||2008-03-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Comparision of Air Versus CO2 for Distention During Sigmoidoscopy|Prospective,Randomized Trial Comparing Colonic Distension After Intra-operative Sigmoidoscopy Using Ambient Air or Carbon Dioxide|Terminated||N/A|54|Actual|Columbia University||1|||f||||f||||||||||2017-02-18 13:49:49.862127|2017-02-18 13:49:49.862127
NCT00771277|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2015-04-06|2014-09-05||September 2008||2008-09-01|August 2014|2014-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||All families were National Guard families. The veterans were divided between mild and moderate TBI with co-morbid PTSD and 1 to 5 years post-injury. Patients were all male except for one wife. All were Caucasian. Ages of patients ranged from mid 20s to mid 40s.|Team Based Initiative Support|Team Based Initiative Support|Completed||N/A|6|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 13:49:50.14363|2017-02-18 13:49:50.14363
NCT00771264|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-04-13|2010-08-26||September 2008||2008-09-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|SUmiT||Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms||Completed||Phase 4|220|Actual|Uroplasty, Inc||2|||f||||||||||||||2017-02-18 13:49:50.390212|2017-02-18 13:49:50.390212
NCT00771238|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-08-25|2015-03-23||November 2008||2008-11-01|August 2015|2015-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||ICU patients in a high acuity Medical / Surgical ICU. Patients had a low Braden Pressure Ulcer Risk Score|Pilot Study of Incidence and Change in Existing Pressure Ulcers: TC500 Bed Compared With Standard Beds|A Pilot Study of Pressure Ulcer Incidence and Change in Existing Pressure Ulcers Comparing Subjects Placed on the TC500 Bed With Standard Beds in the 850-SICU Unit|Completed||N/A|52|Actual|Hill-Rom||2|||f||||f||||||||||2017-02-18 13:49:51.08678|2017-02-18 13:49:51.08678
NCT00771225|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2010-02-02|||November 2008||2008-11-01|October 2008|2008-10-01|November 2013|Anticipated|2013-11-01|November 2012|Anticipated|2012-11-01||Interventional|||National,Multicentric Randomised Study of the Correction of Genital Prolapse With Fascial Repair or Mesh-Prolift|A National Multicentric Randomised Study of the Correction of Genital Prolapse With Fascial Repair or Mesh (Prolift)|Unknown status|Active, not recruiting|Phase 4|180|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:49:51.392321|2017-02-18 13:49:51.392321
NCT00771212|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2014-05-22|||October 2007||2007-10-01|May 2014|2014-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Observational Study on the Patients With Pain Medications|Observational Study on the Patients With Pain Medications|Completed||Phase 4|2636|Actual|Johnson & Johnson Taiwan Ltd|||1||f||||||||||||||2017-02-18 13:49:51.504676|2017-02-18 13:49:51.504676
NCT00771199|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2014-09-16|||October 2008||2008-10-01|September 2014|2014-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain|An Open-label, Multicenter Study to Evaluate the Safety/Tolerability and Clinical Utility of Low-dose TTS-Fentanyl D-TRANS in Taiwan Patients With Cancer Pain|Completed||Phase 4|14|Actual|Janssen-Cilag Ltd.||1|||f||||f||||||||||2017-02-18 13:49:51.599943|2017-02-18 13:49:51.599943
NCT00771186|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2010-06-16|||January 2008||2008-01-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Intraoperative Laryngeal Electromyography (LEMG) in Children With Vocal Fold Immobility: a Longitudinal Study|Intraoperative Laryngeal Electromyography (LEMG) in Children With Vocal Fold Immobility: a Longitudinal Study|Completed||N/A|40|Anticipated|Massachusetts Eye and Ear Infirmary|||1||f||||f||||||||||2017-02-18 13:49:51.70369|2017-02-18 13:49:51.70369
NCT00771173|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-08-22|2015-04-20||August 2008||2008-08-01|August 2016|2016-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|CATH||CATHETER ANALGESIA TRIAL Phenazopyrdine vs. Placebo: a Randomized Controlled Trial|THE CAT(H) STUDY CATHETER ANALGESIA TRIAL Phenazopyrdine vs. Placebo: a Randomized Controlled Trial A CREST 2010 Project|Completed||Phase 4|258|Actual|Loyola University|One limitation of our study was inconsistent collection of our primary outcome data. Nursing staff and house staff failed to collect VAS scores consistently.|2|||f||||f||||||||Undecided||2017-02-18 13:49:51.791267|2017-02-18 13:49:51.791267
NCT00771160|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2015-04-21|||September 2004||2004-09-01|April 2015|2015-04-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)|MK0476 Phase III Long-term Study -Perennial Allergic Rhinitis-|Completed||Phase 3|120|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:49:52.261921|2017-02-18 13:49:52.261921
NCT00771147|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-06-14|||June 2008||2008-06-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|||||Observational|PONDIAC||A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®|Prospective Open-label Non-interventional, Non-controlled Multi Observational and Pharmaco-economic Phase IV Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ® as Well as Effectiveness, Safety and Direct Medical Costs of Nexavar® Treatment Under Daily-life Treatment Conditions|Completed||N/A|71|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a~   "|||2017-02-18 13:49:52.358124|2017-02-18 13:49:52.358124
NCT00771134|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2014-05-14||2014-05-14|December 2008||2008-12-01|May 2014|2014-05-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression|Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Quetiapine-Referenced, Fixed-Dose Study of Lu AA39959 in the Treatment of Depression in Patients With Bipolar I or II Disorder|Terminated||Phase 2|105|Actual|H. Lundbeck A/S||3||Study was previously suspended and is now terminated|f||||f||||||||||2017-02-18 13:49:52.465425|2017-02-18 13:49:52.465425
NCT00771121|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-10|2008-10-10||||||October 2008|2008-10-01||||||||Interventional|||Effect of Moisturizing Creams on Skin Barrier Function||Unknown status|Recruiting|Phase 4|||ACO Hud Nordic AB||2|||f||||f||||||||||2017-02-18 13:49:52.58164|2017-02-18 13:49:52.58164
NCT00771108|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2011-09-02|||May 2006||2006-05-01|September 2011|2011-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|ED||Exercise Dose and Nonalcoholic Fatty Liver Disease|Exercise Dose and Nonalcoholic Fatty Liver Disease|Completed||N/A|33|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:49:52.661599|2017-02-18 13:49:52.661599
NCT00771095|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2008-10-09|||January 2008||2008-01-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|POD||Pounds Off Digitally Study: A Podcasting Weight Loss Intervention|Pounds Off Digitally Study: A Podcasting Weight Loss Intervention|Completed||Phase 1|94|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 13:49:52.775293|2017-02-18 13:49:52.775293
NCT00771082|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-06-05|||January 2003||2003-01-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Osteoarthritis and Body Composition: Evaluation of Systematic Mediators|Osteoarthritis and Body Composition: Evaluation of Systematic Mediators|Terminated||N/A|1033|Actual|National Institute on Aging (NIA)|||1||f||||f||||||Samples Without DNA|"~     Banked serum and urine samples~   "|||2017-02-18 13:49:52.877926|2017-02-18 13:49:52.877926
NCT00771069|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-12-02|||November 2008||2008-11-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|CRYSTAL-CO||Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension|A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With DM Related Complication and Hypertension.|Completed||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:49:52.977355|2017-02-18 13:49:52.977355
NCT00770887|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2011-08-09|||May 2010||2010-05-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|SAD||Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate|Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate: A Pilot Observational Study of Feasibility and Acceptability|Completed||N/A|50|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 13:49:56.03112|2017-02-18 13:49:56.03112
NCT00771056|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-08-18|2015-12-17||July 2008||2008-07-01|August 2016|2016-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Hydroxychloroquine in Untreated B-CLL Patients|Phase II Study to Evaluate the Tolerability and Efficacy of Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients With Hydroxychloroquine.|Terminated||Phase 2|23|Actual|Northwell Health||1||study suspended while data is reviewed for safety and efficacy.|f||||f||||||||No|There is no plan to contact each individual patient (participant in the trial) and inform hem/her of results of this trial as it affects each one of them.|2017-02-18 13:49:53.074296|2017-02-18 13:49:53.074296
NCT00771043|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2009-07-29|||November 2008||2008-11-01|July 2009|2009-07-01|June 2010|Anticipated|2010-06-01|August 2009|Anticipated|2009-08-01||Interventional|PRTOECT||A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a|Optical Coherence Tomography as a Measure of Neuroprotection in Patients With Relapsing-Remitting Multiple Sclerosis Receiving Natalizumab or Interferon Beta-1a|Withdrawn||Phase 4|50|Anticipated|Biogen||2||Sponsor decision to withdraw study at this time.|f||||f||||||||||2017-02-18 13:49:53.304672|2017-02-18 13:49:53.304672
NCT00771030|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-10-31||2015-12-14|November 2008||2008-11-01|October 2016|2016-10-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|||Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 827 in Subjects With Rheumatoid Arthritis|A Randomized, Double-blind, Placebo-controlled, Ascending Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 827 in Subjects With Rheumatoid Arthritis|Completed||Phase 1/Phase 2|40|Actual|Amgen||2|||f||||||||||||||2017-02-18 13:49:53.390352|2017-02-18 13:49:53.390352
NCT00771017|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2013-08-16|||July 2008||2008-07-01|August 2013|2013-08-01||||April 2010|Anticipated|2010-04-01||Interventional|||Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer|A Randomized, Phase II Trial of Brief Androgen-Ablation Combined With Cell-based CG1940/CG8711 Immunotherapy For Prostate Cancer in Patients With Non-Metastatic, Biochemically Relapsed Prostate Cancer|Withdrawn||Phase 2|0|Actual|Eastern Cooperative Oncology Group||2|||f||||||||||||||2017-02-18 13:49:53.488563|2017-02-18 13:49:53.488563
NCT00771004|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-07-01|||August 2006||2006-08-01|July 2010|2010-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.|Pilot Trial Studying the Effects of Pioglitazone in Comparison to Placebo on Myocardial Function and Oxidative Stress in Patients With Type II Diabetes and Insulin Resistance Undergoing Elective PTCA. A Randomized Double-blinded Phase II Study.|Completed||Phase 2|63|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:49:53.600186|2017-02-18 13:49:53.600186
NCT00770991|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-02-11|2016-02-11||December 2005||2005-12-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)|A Pilot Study To Investigate the Biological Modulation of Familial Adenomatous Polyposis (FAP) by Lyophilized Black Raspberries|Completed||Phase 1|34|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 13:49:53.722817|2017-02-18 13:49:53.722817
NCT00770978|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-07-27|||November 2008||2008-11-01|July 2012|2012-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU|Open-Label, Parallel Group, Multiple-dose Study of Ceftobiprole to Evaluate the Plasma Pharmacokinetics in Adults in Intensive Care Units|Completed||Phase 1|33|Actual|Basilea Pharmaceutica||2|||f||||f||||||||||2017-02-18 13:49:54.139154|2017-02-18 13:49:54.139154
NCT00770965|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-03-30|2015-02-02||September 2008||2008-09-01|March 2015|2015-03-01||||September 2009|Actual|2009-09-01||Interventional|||Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis|Phase II Single Dose, Randomized, Double-blind, Multi-center, Parallel-group, Placebo-controlled Study to Assess the Efficacy of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis|Completed||Phase 2|80|Actual|Novartis||4|||f||||f||||||||||2017-02-18 13:49:54.356908|2017-02-18 13:49:54.356908
NCT00770952|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-07-01|||December 2006||2006-12-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.|Effects of Pioglitazone in Combination With Glimepiride in Comparison to Glimepiride Monotherapy on Metabolic Control in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|91|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:49:54.903601|2017-02-18 13:49:54.903601
NCT00770939|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2011-10-07|||July 2008||2008-07-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of the Effect of Vivostat Platelet Rich Fibrin(PRF) in the Treatment of Diabetic Foot Ulcers|A Cohort Study to Evaluate the Effect of Vivostat Platelet Rich Fibrin on Diabetic Foot Ulcers.|Completed||Phase 4|60|Anticipated|Vivostat||1|||f||||f||||||||||2017-02-18 13:49:55.035872|2017-02-18 13:49:55.035872
NCT00770926|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-05-19|||September 2006||2006-09-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|August 2009|Actual|2009-08-01||Interventional|LWBW||Reducing Disparities in Diabetes Risk Through Lifestyle Changes in Community Settings|Physical Activity and Diet to to Reduce Disparities in Diabetes Risk|Completed||N/A|230|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:49:55.129045|2017-02-18 13:49:55.129045
NCT00770913|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-04-16|2011-09-13||October 2008||2008-10-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|||Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis|Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis|Completed||Phase 2/Phase 3|337|Actual|Eisai Inc.|"In the Participant flow section, there is only one Reason for Not Completed per participant reported, even if there were multiple reasons."|3|||f||||||||||||||2017-02-18 13:49:55.238525|2017-02-18 13:49:55.238525
NCT00770900|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-12-17|||September 2008||2008-09-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)|Prospective, Randomized, Double-blind, Study to Evaluate the Eosinophils Activation Parameters and Phagocyte Function in Patients With Persistent Asthma Treated With Montelukast|Completed||Phase 4|83|Actual|University of Brasilia||2|||f||||||||||||||2017-02-18 13:49:55.923066|2017-02-18 13:49:55.923066
NCT00770874|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2017-02-03|||September 2008||2008-09-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Interventional|||Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer|Phase III Study of S-1 + Cisplatin Compared With Single-agent Cisplatin in Stage IVB, Recurrent, or Persistent Carcinoma of the Cervix|Completed||Phase 3|375|Actual|Taiho Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 13:49:56.362495|2017-02-18 13:49:56.362495
NCT00770861|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-12-21|2010-11-09||September 2008||2008-09-01|December 2010|2010-12-01||||November 2009|Actual|2009-11-01||Interventional|||A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients|A Multicenter, Prospective, Randomized, Double-blind, Placebo-Controlled, Dose-Titration Study of Nebivolol Monotherapy in Hispanic Patients With Stage 1 or Stage 2 Hypertension|Completed||Phase 4|277|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 13:49:56.476064|2017-02-18 13:49:56.476064
NCT00770848|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2014-02-06||2013-04-15|November 2008||2008-11-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|January 2011|Actual|2011-01-01||Interventional|||AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer|A Phase 1b/2 Study to Assess the Safety and Efficacy of AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer|Completed||Phase 1/Phase 2|162|Actual|Amgen||4|||f||||||||||||||2017-02-18 13:49:56.968277|2017-02-18 13:49:56.968277
NCT00770835|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2011-07-11|||March 2009||2009-03-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|SPLENDOR||Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.|Effects of Pioglitazone on Endothelial Progenitor Cells in Type 2 Diabetic Patients With Vascular Complications - The SPLENDOR Study.|Completed||Phase 4|39|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:49:57.081118|2017-02-18 13:49:57.081118
NCT00770822|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-01-11|||April 2007||2007-04-01|December 2013|2013-12-01|December 2017|Anticipated|2017-12-01|July 2013|Actual|2013-07-01||Interventional|SetPace||Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer|A Multicenter Clinical Study of the Sonablate® 500 (SB-500) for the Treatment of Localized (T1c/T2a) Prostate Cancer With HIFU|Active, not recruiting||N/A|466|Anticipated|SonaCare Medical||2|||f||||t||||||||||2017-02-18 13:49:57.205906|2017-02-18 13:49:57.205906
NCT00770809|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-11-01|2015-05-07||December 2008||2008-12-01|November 2016|2016-11-01||||January 2014|Actual|2014-01-01||Interventional|||Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery|Randomized Phase III Trial of Paclitaxel +Trastuzumab + Lapatinib Versus Paclitaxel + Trastuzumab as Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer|Active, not recruiting||Phase 3|305|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 13:49:57.340062|2017-02-18 13:49:57.340062
NCT00770796|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-10-15|||April 2006||2006-04-01|October 2015|2015-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Statins for Prevention of Contrast Induced Nephropathy|Usefulness of Atorvastatin (80 mg) in Prevention of Contrast-Induced Nephropathy in Patients With Chronic Renal Disease|Completed||Phase 4|304|Actual|Ospedale Misericordia e Dolce||2|||f||||t||||||||||2017-02-18 13:50:01.398923|2017-02-18 13:50:01.398923
NCT00770783|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2013-10-28|||February 2005||2005-02-01|October 2013|2013-10-01|May 2014|Anticipated|2014-05-01|September 2013|Actual|2013-09-01||Interventional|||Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression|Efficacy of Magnetic Seizure Therapy (MST) in Refractory Major Depression|Unknown status|Active, not recruiting|Phase 3|30|Anticipated|University Hospital, Bonn||2|||f||||f||||||||||2017-02-18 13:50:01.491194|2017-02-18 13:50:01.491194
NCT00770770|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-05-08|2015-04-17||May 2009||2009-05-01|May 2015|2015-05-01||||October 2013|Actual|2013-10-01||Interventional|FAVOR||Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina|A Randomized, Double-masked, Pilot Study of the Safety and Efficacy of 0.5 µg/Day and 0.2 µg/Day Iluvien™ (Fluocinolone Acetonide Intravitreal Insert) 0.19 mg in Subjects With Macular Edema Secondary to Retinal Vein Occlusion|Terminated||Phase 2|20|Actual|Alimera Sciences||2|||f||||f||||||||||2017-02-18 13:50:01.590573|2017-02-18 13:50:01.590573
NCT00770757|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-01-28|2015-12-17||February 2009||2009-02-01|January 2016|2016-01-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||CC-4047 (Pomalidomide) for Graft vs. Host Disease|A Phase 2, Open-Label, Single-Arm, Pilot Study of Safety and Efficacy of CC-4047 (Pomalidomide) in Patients With Advanced Chronic Graft-Versus-Host Disease Developing After Allogeneic Hematological Stem Cell Transplantation|Completed||Phase 2|13|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 13:50:02.46394|2017-02-18 13:50:02.46394
NCT00770744|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-11-07|||September 2008||2008-09-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy of Lu 31-130 in Patients With Schizophrenia|A Randomised, Double-blind, Parallel-group, Active-controlled, Flexible Dose Study Exploring the Efficacy and Safety of 12 Weeks Treatment With Lu 31-130 in Patients With Schizophrenia|Completed||Phase 2|93|Actual|H. Lundbeck A/S||2|||f||||t||||||||||2017-02-18 13:50:02.924892|2017-02-18 13:50:02.924892
NCT00770731|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2013-02-12|||September 2008||2008-09-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study of Temsirolimus, Topotecan, and Bortezomib|A Phase I Study of Temsirolimus, Topotecan, and Bortezomib in Patients With Advanced Malignancy|Completed||Phase 1|80|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 13:50:03.056515|2017-02-18 13:50:03.056515
NCT00770718|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2011-11-22|||April 2008||2008-04-01|November 2011|2011-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage|A Comparison of Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma for Anticoagulation Reversal in Warfarin-Associated Acute Intracranial Hemorrhage: A Dose Ranging Pilot Study|Terminated||Phase 1|2|Actual|University of Utah||3||poor enrollment|f||||t||||||||||2017-02-18 13:50:03.172137|2017-02-18 13:50:03.172137
NCT00770705|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2008-10-09|||October 2008||2008-10-01|October 2008|2008-10-01||||January 2012|Anticipated|2012-01-01||Interventional|||Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery|Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery|Unknown status|Not yet recruiting|Phase 2|62|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-02-18 13:50:03.282434|2017-02-18 13:50:03.282434
NCT00770692|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-10-24|2012-10-24||October 2008||2008-10-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)|A Phase III Study of SEP-190 (Eszopiclone) in Patients With Insomnia|Completed||Phase 3|369|Actual|Eisai Inc.||4|||f||||||||||||||2017-02-18 13:50:03.389552|2017-02-18 13:50:03.389552
NCT00770679|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2009-08-03|||July 2007||2007-07-01|August 2009|2009-08-01|June 2010|Anticipated|2010-06-01|January 2010|Anticipated|2010-01-01||Interventional|||Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging|Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging|Unknown status|Recruiting|N/A|24|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 13:50:04.112846|2017-02-18 13:50:04.112846
NCT00770666|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2008-10-09|||September 2005||2005-09-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Combination Medications vs. Patch Alone for Medically-Ill Smokers|Flexibly-Dosed Combination Pharmacotherapy Versus Standard-Dosed Nicotine Patch Alone for Smokers With Medical Illness|Completed||Phase 4|127|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 13:50:04.417771|2017-02-18 13:50:04.417771
NCT00770653|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-09-13|2010-09-13||April 2007||2007-04-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.|Effects of a Pioglitazone/Metformin Fixed Combination in Comparison to Metformin in Combination With Glimepiride on Diabetic Dyslipidemia|Completed||Phase 3|305|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:50:04.537702|2017-02-18 13:50:04.537702
NCT00770640|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-08-31|||August 2008||2008-08-01|August 2010|2010-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PIOren||Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.|Comparison of the Effects of Pioglitazone vs. Placebo When Given in Addition to Standard Insulin Treatment in Patients With Type 2 Diabetes Mellitus and Renal Failure|Completed||Phase 2|40|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:50:05.66901|2017-02-18 13:50:05.66901
NCT00770627|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-04-12|||October 2008||2008-10-01|April 2010|2010-04-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|||Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children|A Randomized , Controlled, Doulbe Blind Placebo Trial To Evaluate The Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children|Unknown status|Enrolling by invitation|Phase 4|160|Anticipated|Laboratoires URGO||2|||f||||f||||||||||2017-02-18 13:50:05.802095|2017-02-18 13:50:05.802095
NCT00770614|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-05-06|||March 2004||2004-03-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Hydration and Contrast-Induced Nephropathy in Primary Angioplasty|Hydration and Contrast-Induced Nephropathy in Primary Angioplasty. A Randomized, Placebo Controlled, Trial.|Completed||Phase 4|450|Actual|Ospedale Misericordia e Dolce||3|||f||||t||||||||||2017-02-18 13:50:05.893361|2017-02-18 13:50:05.893361
NCT00770601|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-05-03|||January 2009||2009-01-01|May 2012|2012-05-01||||February 2011|Actual|2011-02-01||Interventional|||Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease|A Multi-Center, Open Label, 24-Month Treatment Study to Establish the Safety, Tolerability, Efficacy, Pharmacokinetics of Canakinumab (Anti-IL-1 Beta Antibody) in Patients With NOMID / CINCA Syndrome|Terminated||Phase 3|6|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:50:05.992816|2017-02-18 13:50:05.992816
NCT00770588|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-01-15|2012-01-17||September 2008||2008-09-01|August 2012|2012-08-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|INFORM||Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)|A Placebo-Controlled, Multicentre, Randomised, Parallel Group, Trial to Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (StageIIIB/IV) Non Small Cell Lung Cancer (NSCLC) Chinese Patients Who HaveNot Experienced Disease Progression or Unacceptable Toxicity During Front Line Standard Platinum-Based Chemotherapy|Completed||Phase 4|296|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:50:06.111059|2017-02-18 13:50:06.111059
NCT00770575|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-07-01|||June 2005||2005-06-01|July 2010|2010-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease|Double Blinded Study of the Effects of Pioglitazone in Combination With Atorvastatin in Comparison to Atorvastatin Treatment Alone on Intima-Media Thickness in Patients at Risk for Vascular Complications|Completed||Phase 2|148|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:50:06.639789|2017-02-18 13:50:06.639789
NCT00770562|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2014-10-21|2014-06-26||July 2005||2005-07-01|October 2014|2014-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)|A Randomized, Open-label Study of First-line Treatment With Dexamethasone or Dexamethasone Plus MabThera on Sustained Treatment Response in Adult Patients With Idiopathic Thrombocytopenic Purpura|Completed||Phase 3|103|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:50:06.964427|2017-02-18 13:50:06.964427
NCT00770536|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-09-25|||January 2009||2009-01-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|January 2012|Actual|2012-01-01||Interventional|||AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR|A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer|Completed||Phase 1|103|Actual|Amgen||2|||f||||f||||||||||2017-02-18 13:50:07.626925|2017-02-18 13:50:07.626925
NCT00770523|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-05|2011-06-08|||December 2003||2003-12-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Observational|||Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells|Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients With Hematologic Malignancies|Completed||Phase 2|52|Actual|Cooperative Study Group A for Hematology|||1||f||||f||||||||||2017-02-18 13:50:07.768326|2017-02-18 13:50:07.768326
NCT00770510|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-12-28|2012-12-28||September 2008||2008-09-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)|A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia|Completed||Phase 2/Phase 3|192|Actual|Eisai Inc.||5|||f||||f||||||||||2017-02-18 13:50:07.862252|2017-02-18 13:50:07.862252
NCT00770497|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-07-01|||March 2007||2007-03-01|July 2010|2010-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.|Effect of Pioglitazone Compared to a Combination Therapy With Ramipril and to a Ramipril Monotherapy on Low Grade Inflammation and Vascular Function in Patients With Increased Cardiovascular Risk and an Activated Inflammation. A Randomized Double-blinded Phase II Study.|Completed||Phase 2|172|Actual|Takeda||3|||f||||f||||||||||2017-02-18 13:50:08.595527|2017-02-18 13:50:08.595527
NCT00770471|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2012-05-01|||June 2009||2009-06-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I/II Trial of Temozolomide and ABT-888 in Subjects With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1/Phase 2|24|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 13:50:09.118156|2017-02-18 13:50:09.118156
NCT00770458|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2010-01-04|||June 2008||2008-06-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Observational|||Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker|Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker|Completed||N/A|1000|Anticipated|Sequenom, Inc.|||1||f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 13:50:09.231971|2017-02-18 13:50:09.231971
NCT00770445|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2010-08-17|||May 2008||2008-05-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|PIOcomb||Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.|Impact of Pioglitazone, Metformin and the Combination of Both on Cardiovascular Risk in Insulin-treated Patients With Type 2 Diabetes - The PIOcomb Study|Completed||Phase 4|121|Actual|Takeda||3|||f||||f||||||||||2017-02-18 13:50:09.344175|2017-02-18 13:50:09.344175
NCT00770432|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-02-20|2009-06-24||November 2007||2007-11-01|February 2015|2015-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study Comparing PEG 3350 Laxative to Placebo in the Treatment of Occasional Constipation (Study CL2007-12)(P08216)|A Randomized, Placebo-Controlled, Double-Blind, Trial of Polyethylene Glycol 3350 Laxative for the Treatment of Occasional Constipation.|Completed||Phase 4|203|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:50:09.49732|2017-02-18 13:50:09.49732
NCT00770419|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-05-27|||May 2008||2008-05-01|May 2015|2015-05-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Observational|||Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers|Perception of Caregiver Burden|Withdrawn||N/A|0|Actual|Rutgers, The State University of New Jersey|||1|Slow accrual|f||||t||||||||||2017-02-18 13:50:09.770439|2017-02-18 13:50:09.770439
NCT00770406|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2009-08-03|||January 2009||2009-01-01|August 2009|2009-08-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence|Intravesikal Instillation af Botulinum Toxin Type A Til Patienter Med Urge Urininkontinens|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Glostrup University Hospital, Copenhagen||1|||f||||f||||||||||2017-02-18 13:50:09.881335|2017-02-18 13:50:09.881335
NCT00770393|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2008-10-09|||February 2002||2002-02-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|June 2005|Actual|2005-06-01||Interventional|||Laryngeal Preservation in Pyriform Sinus Carcinoma|Randomized Phase III Trial Comparing Induction Chemotherapy Followed by Radiotherapy to Concomitant Chemoradiotherapy for Laryngeal Preservation in T3MO Pyriform Sinus Carcinoma|Completed||Phase 2/Phase 3|71|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-02-18 13:50:09.966761|2017-02-18 13:50:09.966761
NCT00770380|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2011-09-15|||June 2007||2007-06-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|HypnoRelapse||Hypnosis for Smoking Relapse Prevention|Hypnosis for Smoking Relapse Prevention|Completed||Phase 3|139|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 13:50:10.084669|2017-02-18 13:50:10.084669
NCT00770367|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2011-12-02|2010-07-08||October 2008||2008-10-01|December 2011|2011-12-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes|Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes|Completed||Phase 4|36|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 13:50:10.393009|2017-02-18 13:50:10.393009
NCT00770354|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2009-08-07|||September 2008||2008-09-01|August 2009|2009-08-01|August 2011|Anticipated|2011-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer|A Phase II, Randomised, Open-Label, Multicentre Study of AS1402 in Combination With Letrozole as First Line Treatment in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer|Terminated||Phase 2|110|Anticipated|Antisoma Research||2|||f||||t||||||||||2017-02-18 13:50:10.813459|2017-02-18 13:50:10.813459
NCT00770341|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2015-08-06|2011-05-17||September 2008||2008-09-01|August 2015|2015-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)|A Phase III Randomized, Open-labeled Clinical Trial of MK-3009 (Daptomycin) in Patients With Skin and Soft Tissue Infections, Septicemia and Right-sided Infective Endocarditis Caused by MRSA|Completed||Phase 3|122|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 13:50:10.93114|2017-02-18 13:50:10.93114
NCT00770328|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2009-01-27|||May 2003||2003-05-01|January 2009|2009-01-01|June 2009|Anticipated|2009-06-01|May 2009|Anticipated|2009-05-01||Interventional|||The Effects of Pentoxifylline on PAI-1 in an Obese Population|The Effects of Pentoxifylline on PAI-1 in an Obese Population|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:50:11.63135|2017-02-18 13:50:11.63135
NCT00770315|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-09|2016-10-07|2014-04-25||September 2009||2009-09-01|October 2016|2016-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adult Subjects With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma|Completed||Phase 2/Phase 3|784|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-02-18 13:50:11.747844|2017-02-18 13:50:11.747844
NCT00770302|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-07-08|||October 2008||2008-10-01|July 2009|2009-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin|An Open Label, Pharmacokinetic Study of Single and Multiple Doses of 5 mg Saxagliptin in Healthy Chinese Subjects Living in China|Completed||Phase 1|34|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:50:12.43521|2017-02-18 13:50:12.43521
NCT00770107|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-06-22|||June 2004||2004-06-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Thiamine Supplementation to Improve Cardiac Function in Patients With Congestive Heart Failure|Thiamine Supplementation to Improve Cardiac Function in Patients With Congestive Heart Failure on Long-term Treatment With Diuretic Drugs|Completed||N/A|12|Anticipated|Luzerner Kantonsspital||2|||f||||||||||||||2017-02-18 13:50:18.142172|2017-02-18 13:50:18.142172
NCT00770289|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2012-08-01|2012-06-06||May 2008||2008-05-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|B2411003||Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)|Open Label, Observational, Non-interventional Study for the Evaluation of Remission Rates in Patients With MDD Under Treatment With Various Anti-depressives|Completed||N/A|851|Actual|Pfizer|Protocol did not indicate primary or secondary endpoints and designation of endpoints as primary or secondary endpoints was arbitrary.||1||f||||f||||||||||2017-02-18 13:50:12.533191|2017-02-18 13:50:12.533191
NCT00770276|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-03-09|||January 2005||2005-01-01|March 2013|2013-03-01|January 2017|Anticipated|2017-01-01|January 2015|Anticipated|2015-01-01||Observational|MOS||Mannheim Obesity Study|Mannheim Obesity Pilot Study: Evaluation of Metabolic Und Cardiovascular Risk in Obesity|Unknown status|Recruiting|N/A|120|Anticipated|Universitätsmedizin Mannheim|||2||f||||f||||||||||2017-02-18 13:50:12.830919|2017-02-18 13:50:12.830919
NCT00770263|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2015-06-02|||May 2009||2009-05-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Erlotinib and Temsirolimus for Solid Tumors|Phase I Study of Erlotinib and Temsirolimus in Resistant Solid Malignancies|Completed||Phase 1|46|Actual|Washington University School of Medicine||5|||f||||f||||||||||2017-02-18 13:50:12.933121|2017-02-18 13:50:12.933121
NCT00770250|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2010-11-30|||September 2008||2008-09-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|||||Observational|SYMPTOMES||National Survey on Asthma|A Mirror Assessment of the Words Used By Patients and Physicians to Express Asthma Symptoms, According To the Patient's Level of Asthma Control In General Medicine|Completed||N/A|1704|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:50:13.089861|2017-02-18 13:50:13.089861
NCT00770237|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2011-09-12|||October 2008||2008-10-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia|Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia|Completed||N/A|44|Anticipated|University of Maryland||1|||f||||f||||||||||2017-02-18 13:50:14.579585|2017-02-18 13:50:14.579585
NCT00770224|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-10-10|||April 2009||2009-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|||S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma|A Phase II Study of Iodine-131-Labeled Tositumomab in Combination With Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Rituximab Therapy for Patients With Advanced Stage Follicular Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 2|87|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 13:50:14.690507|2017-02-18 13:50:14.690507
NCT00770211|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2011-10-05|2011-08-09||October 2008||2008-10-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines|A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Investigate the Efficacy and Safety of IncobotulinumtoxinA (Xeomin), Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines.|Completed||Phase 3|271|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-02-18 13:50:15.013704|2017-02-18 13:50:15.013704
NCT00770198|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2008-10-08|||January 2005||2005-01-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|January 2007|Actual|2007-01-01||Observational|||sgp130 in Chronic Human Liver Disease|Study of IL-6 Transsignaling in Chronic Human Liver Disease|Completed||N/A|129|Actual|Erasme University Hospital|||2||f||||f||||||Samples Without DNA|"~     plasma, liver biopsies, and peripheral blood mononuclear cell culture medium.~   "|||2017-02-18 13:50:15.419621|2017-02-18 13:50:15.419621
NCT00770185|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-11-25|||August 2008||2008-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|March 2012|Actual|2012-03-01||Interventional|||Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer|A Phase II Study of Ridaforolimus in Patients With Metastatic And/Or Locally Advanced Recurrent Endometrial Cancer|Completed||Phase 2|35|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 13:50:15.50669|2017-02-18 13:50:15.50669
NCT00770172|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2011-05-12|||October 2007||2007-10-01|December 2008|2008-12-01||||May 2011|Actual|2011-05-01||Interventional|||G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy|Moderate Persistent Neutropenia: Comparison of Administration of G-CSF (Granulocyte Colony Stimulating Factor) 1 Day Out of 2 Versus Traditional Schedules to Maintain Dose Intensity. Phase III Multicenter Study in Patients With Solid Tumors Receiving Chemotherapy|Completed||Phase 3|140|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:50:15.771645|2017-02-18 13:50:15.771645
NCT00770159|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-02-04|||November 2004||2004-11-01|January 2016|2016-01-01|November 2005|Actual|2005-11-01|June 2005|Actual|2005-06-01||Interventional|||A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)|A Double-Blind, Placebo-Controlled, Once-Weekly, Multiple-Dose Study to Investigate the Safety, Tolerability, Plasma Concentration Profile and Effects on Biochemical Markers of Bone Resorption of MK0822 in Healthy Postmenopausal Female Subjects|Completed||Phase 1|78|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:50:15.874215|2017-02-18 13:50:15.874215
NCT00770146|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-08-01|2013-02-15||November 2008||2008-11-01|August 2016|2016-08-01|October 2010|Actual|2010-10-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) as Add-on Therapy in High Risk Hypercholesterolemic Patients|Completed||Phase 3|158|Actual|Kastle Therapeutics, LLC||2|||f||||t||||||||||2017-02-18 13:50:15.988057|2017-02-18 13:50:15.988057
NCT00770133|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-11-22||2011-04-26|February 2010||2010-02-01|November 2013|2013-11-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.|A Multi-center, Double-masked, Randomized, Placebo-controlled Evaluation of the Onset and Duration of Action of KetoNaph Ophthalmic Solution in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis.|Completed||Phase 3|133|Actual|Bausch & Lomb Incorporated||4|||f||||f||||||||||2017-02-18 13:50:17.711629|2017-02-18 13:50:17.711629
NCT00770120|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-04-16|||December 2008||2008-12-01|April 2013|2013-04-01|June 2013|Anticipated|2013-06-01|May 2013|Anticipated|2013-05-01||Interventional|||S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery|Phase II Trial of mTOR Inhibitor, Everolimus (RAD001), in Malignant Pleural Mesothelioma (MPM)|Unknown status|Active, not recruiting|Phase 2|55|Anticipated|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 13:50:17.811342|2017-02-18 13:50:17.811342
NCT00770094|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-08-04|||October 2008||2008-10-01|August 2009|2009-08-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|VBLWL-001||Multi Laser Platform Comparison Study for LASIK|A Prospective, Randomized, Multi Center Clinical Comparison Of Fellow Eyes Undergoing Lasik Using The Amo/Visx Customvue™ , The Bausch And Lomb Zyoptix And Planoscan And The Wavelight Allegretto Wave™ Wavefront Guided And Wavefront Optimized Excimer Laser Systems|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|Durrie Vision||3|||f||||f||||||||||2017-02-18 13:50:18.253775|2017-02-18 13:50:18.253775
NCT00770081|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-01-02||2013-01-02|September 2008||2008-09-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)|A 28-week Extension to a 24-week Multicenter, Randomized, Double-blind, Active-controlled Clinical Trial to Evaluate the Safety and Tolerability of Vildagliptin (50 mg qd) Versus Sitagliptin (25 mg qd) in Patients With Type 2 Diabetes and Severe Renal Insufficiency|Completed||Phase 3|75|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:50:18.368451|2017-02-18 13:50:18.368451
NCT00770068|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2015-04-09|||July 2006||2006-07-01|October 2008|2008-10-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Examining the Link Between Depression and Seasonal Allergies|Seasonality of Depression and Airborne Allergens|Unknown status|Active, not recruiting|N/A|250|Anticipated|University of Maryland|||2||f||||t||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:50:18.704605|2017-02-18 13:50:18.704605
NCT00770055|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2011-01-27|||November 2001||2001-11-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|February 2010|Actual|2010-02-01||Interventional|||Internet Use Among Women With Recurrent Metastatic Breast Cancer|Internet Use Among Women With Recurrent Breast Cancer|Completed||N/A|70|Actual|Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-02-18 13:50:18.810707|2017-02-18 13:50:18.810707
NCT00770042|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-11-30|||October 2008||2008-10-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil|A Phase I, Single-Centre, Open-Label, Randomized, One-sequence Crossover, Three-Group Study to Evaluate the Effect of Ketoconazole, Ritonavir and Erythromicin on the Safety and Pharmacokinetics of Avanafil (TA-1790) in Healthy Male Subjects|Completed||Phase 1|44|Actual|VIVUS, Inc.||3|||f||||f||||||||||2017-02-18 13:50:18.904291|2017-02-18 13:50:18.904291
NCT00770029|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-02-21|2011-08-09||October 2008||2008-10-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Safety of IncobotulinumtoxinA (Xeomin), Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines. No. 2|Completed||Phase 3|276|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-02-18 13:50:19.014812|2017-02-18 13:50:19.014812
NCT00770016|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2010-10-25|||January 2010||2010-01-01|October 2010|2010-10-01|January 2011|Anticipated|2011-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism|Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism|Terminated||N/A|0|Actual|University of Aarhus||1||no longer interested in doing the study|f||||t||||||||||2017-02-18 13:50:19.417213|2017-02-18 13:50:19.417213
NCT00770003|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2015-08-13|||September 2008||2008-09-01|August 2015|2015-08-01|February 2010|Actual|2010-02-01|March 2009|Actual|2009-03-01||Interventional|||Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848|A Double-blind, Placebo Controlled, Randomized, Parallel Group Study to Investigate the Tolerability, Safety, Pharmacodynamics and Pharmacokinetics of Repeated Weekly Doses of AZD8848 Administered Intranasally to Seasonal Allergic Rhinitis Patients|Completed||Phase 1|103|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:50:19.527196|2017-02-18 13:50:19.527196
NCT00769990|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2011-07-01|||September 2008||2008-09-01|July 2011|2011-07-01|April 2010|Actual|2010-04-01|November 2009|Actual|2009-11-01||Interventional|||Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases|Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life|Withdrawn||Phase 1/Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||1||No patient accrual.|f||||t||||||||||2017-02-18 13:50:19.634786|2017-02-18 13:50:19.634786
NCT00769964|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-06-24|||September 2008||2008-09-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||VA111913 TS: First in Human Study|A First in Human Study Consisting of a Two-Part, Double-Blind, Placebo-Controlled, Escalating Single and Multiple Dose Study of VA111913 TS in Adult Non-Pregnant Women Volunteers With a Single Dose, Open, Fed vs. Fasting Crossover Phase|Completed||Phase 1|98|Actual|Vantia Ltd|||||f||||||||||||||2017-02-18 13:50:19.749335|2017-02-18 13:50:19.749335
NCT00769951|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2015-10-01|||February 2008||2008-02-01|October 2015|2015-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer|The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients|Completed||N/A|46|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||||||2017-02-18 13:50:19.84341|2017-02-18 13:50:19.84341
NCT00769938|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-01-12|||December 2008||2008-12-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|WOEST||WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)|What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing|Completed||Phase 4|573|Actual|R&D Cardiologie||2|||f||||t||||||||||2017-02-18 13:50:19.955432|2017-02-18 13:50:19.955432
NCT00769925|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2012-01-06|||November 2008||2008-11-01|January 2012|2012-01-01|February 2012|Anticipated|2012-02-01|January 2012|Anticipated|2012-01-01||Interventional|||Assessing Different Methods of Anxiety Care in Pediatric Settings|Improving Care for Anxiety in Pediatric Settings|Unknown status|Active, not recruiting|N/A|52|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-02-18 13:50:20.076803|2017-02-18 13:50:20.076803
NCT00769912|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2014-08-28|||October 2008||2008-10-01|January 2011|2011-01-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||Evaluation of of a Prefixed 50% N2O- 50%O2 Mixture in Legal Abortion Under Local Analgesia|Evaluation of of a Prefixed 50% N2O- 50%O2 Mixture in Legal Abortion Under Local Analgesia|Completed||Phase 3|71|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 13:50:20.188211|2017-02-18 13:50:20.188211
NCT00769899|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-03-17|||October 2008||2008-10-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|JSAD||AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects|A Phase I,Single-Center,Randomised,Double-Blind,Placebo-Controlled Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7325 in Healthy Male Japanese Subjects|Completed||Phase 1|48|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 13:50:20.284897|2017-02-18 13:50:20.284897
NCT00769886|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-11-22||2009-12-17|October 2008||2008-10-01|November 2013|2013-11-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.|A Multi-Center, Double-Masked, Randomized, Vehicle and Active Controlled Evaluation of the Onset and Duration of Action of KetoNaph Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis|Completed||Phase 3|144|Actual|Bausch & Lomb Incorporated||4|||f||||f||||||||||2017-02-18 13:50:20.395582|2017-02-18 13:50:20.395582
NCT00769873|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-06-23|||October 2006||2006-10-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Anticoagulation Post Laparoscopic Splenectomy|Effect of Anticoagulation in Reducing the Incidence of Splenic/Portal Vein Thrombosis Post-Laparoscopic Splenectomy Protocol Number: 5698|Terminated||Phase 2|35|Actual|University of Alberta||2||"Recruitment was slower than anticipated. Insufficient funding to expand to multi-centered~   trial."|f||||f||||||||||2017-02-18 13:50:20.492245|2017-02-18 13:50:20.492245
NCT00769860|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-11-22|2016-11-22||September 2008||2008-09-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Arimoclomol in Sporadic Inclusion Body Myositis|Safety and Tolerability Trial of Arimoclomol for Sporadic Inclusion Body Myositis|Completed||Phase 2/Phase 3|24|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 13:50:20.622566|2017-02-18 13:50:20.622566
NCT00769847|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-05-29|||September 2008||2008-09-01|May 2015|2015-05-01|September 2013|Anticipated|2013-09-01|July 2009|Actual|2009-07-01||Observational|||Endoscopic Treatment for Isolated, Single Suture Craniosynostosis|Endoscopic Treatment for Isolated, Single Suture Craniosynostosis|Withdrawn||N/A|0|Actual|University of Utah|||1|Study was withdrawn due to lack of resources.|f||||f||||||||||2017-02-18 13:50:21.281009|2017-02-18 13:50:21.281009
NCT00769834|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-04-28|||January 2010||2010-01-01|April 2009|2009-04-01|April 2011|Anticipated|2011-04-01|December 2010|Anticipated|2010-12-01||Observational|||Disc Edema in Patients With Chronic Kidney Disease|Incidence and Causes of Disc Edema in Patients With Chronic Kidney Disease|Withdrawn||N/A|323|Anticipated|University of Mississippi Medical Center|||1|Study withdrawn due to logistic reasons and will be re-organized at a later date|f||||f||||||||||2017-02-18 13:50:21.374643|2017-02-18 13:50:21.374643
NCT00769821|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2012-12-11|||February 2007||2007-02-01|December 2012|2012-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||The Impact of Lymphedema on Breast Cancer Survivors|The Impact of Lymphedema on Local and Overall Functioning|Completed||N/A|145|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:50:21.484844|2017-02-18 13:50:21.484844
NCT00769808|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-05-30|||August 2008||2008-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:50:21.596385|2017-02-18 13:50:21.596385
NCT00769795|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-10-06|||October 2008||2008-10-01|October 2015|2015-10-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer|Phase II Study of Neoadjuvant IMC-A12 Combined With Androgen Deprivation Prior to Prostatectomy|Completed||Phase 2|29|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 13:50:21.660525|2017-02-18 13:50:21.660525
NCT00769782|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-09-27|||October 2008||2008-10-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|GISTs||Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor|Phase II Multicenter Clinical Trial on Surgery for Patients With Resectable Hepatic Metastasis From Gastrointestinal Stromal Tumors (GISTs)|Completed||Phase 2|6|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||t||||||||||2017-02-18 13:50:21.772093|2017-02-18 13:50:21.772093
NCT00769769|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-08-22|||October 2008||2008-10-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Comparing Delivery Methods of Cognitive Behavioral Therapy for Depressed African-American Dementia Caregivers|Telephone CBT for Depressed African-American Dementia Caregivers|Completed||Phase 3|106|Actual|Florida State University||2|||f||||t||||||||||2017-02-18 13:50:22.00764|2017-02-18 13:50:22.00764
NCT00769756|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2008-10-08|||April 2006||2006-04-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|April 2007|Actual|2007-04-01||Observational|||Evaluation of Three New Strategies to Fight Obesity in Families|Evaluation of Three New Strategies to Fight Obesity in Families|Completed||N/A|261|Actual|University of Magdeburg|||3||f||||f||||||Samples Without DNA|"~     blood samples~   "|||2017-02-18 13:50:22.111398|2017-02-18 13:50:22.111398
NCT00769730|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2009-08-02|||January 2008||2008-01-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication|Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication|Completed||N/A|25|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||Samples With DNA|"~     serum~   "|||2017-02-18 13:50:22.200872|2017-02-18 13:50:22.200872
NCT00769717|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-08-26|||October 2008||2008-10-01|August 2009|2009-08-01|May 2011|Anticipated|2011-05-01|May 2011|Anticipated|2011-05-01||Interventional|||Evaluation of a Health at Every Size vs a Behavioral Weight Loss Approach for Obese Women|Comparative Health Improvements and Rate of Relapse in Weight-Centered vs. Wellness-Centered Interventions for Obese Women|Unknown status|Active, not recruiting|Phase 2/Phase 3|80|Anticipated|The Reading Hospital and Medical Center||2|||f||||f||||||||||2017-02-18 13:50:22.295941|2017-02-18 13:50:22.295941
NCT00769704|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-06-14|2015-09-22||April 2009||2009-04-01|June 2016|2016-06-01|September 2014|Actual|2014-09-01|February 2013|Actual|2013-02-01||Interventional|||Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma|A Randomized Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Treatment With OncoVEX^GM-CSF Compared to Subcutaneously Administered GM-CSF in Melanoma Patients With Unresectable Stage IIIb, IIIc and IV Disease|Completed||Phase 3|437|Actual|BioVex Limited||2|||f||||t||||||||||2017-02-18 13:50:22.407462|2017-02-18 13:50:22.407462
NCT00584064|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-07-20||||||July 2016|2016-07-01||||||||Expanded Access|||Emergency/Compassionate Use PFO Occluder||Available||N/A|||St. Jude Medical|||||||||||||||||||2017-02-18 14:55:43.623385|2017-02-18 14:55:43.623385
NCT00769691|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-03-07|||April 2008||2008-04-01|October 2008|2008-10-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Observational|||Monitoring of Cerebral Blood Flow Autoregulation Using Near Infrared Spectroscopy|Cerebral Autoregulation Monitoring in Adults Undergoing Cardiac Surgery: Comparison of Near Infrared Spectroscopy With Transcranial Doppler|Completed||N/A|225|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 13:50:23.721845|2017-02-18 13:50:23.721845
NCT00769678|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-04-16|||October 2008||2008-10-01|April 2013|2013-04-01||||May 2012|Actual|2012-05-01||Interventional|||Stimulation of the Diaphragm in Patients With Severe Heart Failure Following Heart Surgery|Biventricular Pacing and Stimulation of the Diaphragm in Patients With Severe Heart Failure Following Heart Surgery (Epiphrenic II Pilot Trial)|Completed||N/A|33|Actual|Luzerner Kantonsspital||1|||f||||||||||||||2017-02-18 13:50:23.822874|2017-02-18 13:50:23.822874
NCT00769665|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-01-31|||October 2008||2008-10-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||A 2-week Clinical Comparison of SYSTANE® Ultra to Sensitive Eyes Rewetting Drops in Contact Lens Wearing Patients.||Completed||N/A|47|Actual|Alcon Research|||2||f||||f||||||||||2017-02-18 13:50:23.934616|2017-02-18 13:50:23.934616
NCT00769652|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-11-15|2013-11-15||October 2006||2006-10-01|November 2013|2013-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer|The Influence of Changes in Body Composition on Quality of Life in Cancer Patients and The Impact of Medical Nutrition Therapy by a Registered Dietitian on Outcome|Terminated||N/A|8|Actual|Rutgers, The State University of New Jersey||2||slow accrual|f||||f||||||||||2017-02-18 13:50:24.035424|2017-02-18 13:50:24.035424
NCT00769626|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2011-07-15|||September 2008||2008-09-01|October 2008|2008-10-01|May 2010|Actual|2010-05-01|September 2009|Actual|2009-09-01||Interventional|||Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy|Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy: A Randomized Clinical Trial|Terminated||Phase 3|15|Actual|Intermountain Health Care, Inc.||2||Unable to recruit patients|f||||f||||||||||2017-02-18 13:50:24.417506|2017-02-18 13:50:24.417506
NCT00769613|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-12-17|||August 2008||2008-08-01|August 2010|2010-08-01||||August 2014|Anticipated|2014-08-01||Interventional|||Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections|Emergency Access to C.V. pp65 / IE-1 Specific Cytotoxic T Lymphocytes for Recipients of Allogeneic Stem Cell Transplants With Persistant or Therapy Refractory Infections|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 13:50:24.526105|2017-02-18 13:50:24.526105
NCT00769600|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-10-12|||November 2008||2008-11-01|October 2016|2016-10-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|Itraconazole||A Randomized Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous Non-Small Cell Lung Cancer|A Randomized Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous Non-Small Cell Lung Cancer|Terminated||Phase 2|23|Actual|Sidney Kimmel Comprehensive Cancer Center||2||Low accrual.|f||||t||||||||||2017-02-18 13:50:24.646783|2017-02-18 13:50:24.646783
NCT00769587|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-04-25|||June 2007||2007-06-01|April 2016|2016-04-01|October 2012|Actual|2012-10-01|May 2011|Actual|2011-05-01||Interventional|||Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis|Phase II Study of Thalidomide in Mastocytosis|Completed||Phase 2|20|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||t||||||||||2017-02-18 13:50:24.742723|2017-02-18 13:50:24.742723
NCT00769574|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2014-08-28|||June 2008||2008-06-01|August 2014|2014-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.|Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.|Completed||N/A|143|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 13:50:24.841684|2017-02-18 13:50:24.841684
NCT00769561|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-12-04|2013-05-24||August 2008||2008-08-01|December 2013|2013-12-01|April 2011|Actual|2011-04-01|July 2010|Actual|2010-07-01||Interventional|||Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders|Comparison of a Biofeedback-Based Cognitive Behavioral Treatment and Occlusal Splint Therapy for Temporomandibular Disorders. A Randomized Clinical Trial.|Completed||Phase 2/Phase 3|58|Actual|Philipps University Marburg Medical Center||2|||f||||t||||||||||2017-02-18 13:50:24.942387|2017-02-18 13:50:24.942387
NCT00769548|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-12-30|||April 1995||1995-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|April 2001|Actual|2001-04-01||Interventional|||Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer|A PHASE III TRIAL COMPARING WHOLE PELVIC IRRADIATION FOLLOWED BY A CONEDOWN BOOST TO BOOST IRRADIATION ONLY AND COMPARING NEOADJUVANT TO ADJUVANT TOTAL ANDROGEN SUPPRESSION (TAS)|Completed||Phase 3|1322|Actual|Radiation Therapy Oncology Group||4|||f||||t||||||||||2017-02-18 13:50:25.557134|2017-02-18 13:50:25.557134
NCT00769535|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2013-04-26|||January 2006||2006-01-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|HSP70||Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma|Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma|Completed||N/A|600|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||||2017-02-18 13:50:25.68259|2017-02-18 13:50:25.68259
NCT00769522|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-09-30|||September 2008||2008-09-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|July 2011|Actual|2011-07-01||Interventional|||FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia|Phase III Trial of Combined Immunochemotherapy With Fludarabine, Cyclophosphamide and Rituximab (FCR) Versus Bendamustine and Rituximab (BR) in Patients With Previously Untreated Chronic Lymphocytic Leukaemia|Active, not recruiting||Phase 3|564|Actual|German CLL Study Group||2|||f||||t||||||||No||2017-02-18 13:50:25.788174|2017-02-18 13:50:25.788174
NCT00769509|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2015-07-20|||March 2009||2009-03-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Energy Expenditure Assessment of Premature Infants|Energy Expenditure Assessment of Preterm Infant With Very Low Birth Weight Fed With Human Milk or Preterm Formula|Completed||Phase 4|25|Actual|Oswaldo Cruz Foundation||2|||f||||t||||||||||2017-02-18 13:50:25.93788|2017-02-18 13:50:25.93788
NCT00768963|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-07-24|||October 2008||2008-10-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Ranibizumab for the Inhibition of Neovascularization in Pterygia|Ranibizumab for the Inhibition of Neovascularization in Pterygia|Completed||Phase 1|10|Actual|Bascom Palmer Eye Institute||2|||f||||f||||||||||2017-02-18 13:50:39.623411|2017-02-18 13:50:39.623411
NCT00769496|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-01-21|||January 2005||2005-01-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||BAY 77-1931 Long-term Extension From Phase II Study|A Long-term, Open Label Extension, Non-controlled Study to Assess the Efficacy and Safety of BAY 77-1931 (Lanthanum Carbonate) for Hyperphosphatemia in Patients Undergoing Hemodialysis|Completed||Phase 2|145|Actual|Bayer||1|||f||||f||||||||||2017-02-18 13:50:26.05885|2017-02-18 13:50:26.05885
NCT00769483|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-11-22|||November 2008||2008-11-01|November 2016|2016-11-01||||November 2018|Anticipated|2018-11-01||Interventional|||MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer|A Phase I/ Randomized Phase II Study of Gemcitabine Plus Erlotinib Plus MK-0646; Gemcitabine Plus MK-0646 and Gemcitabine Plus Erlotinib for Patients With Advanced Pancreatic Cancer (IISP#33337)|Active, not recruiting||Phase 1/Phase 2|100|Anticipated|M.D. Anderson Cancer Center||5|||f||||t||||||||||2017-02-18 13:50:26.164844|2017-02-18 13:50:26.164844
NCT00769470|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-01-20|||April 2009||2009-04-01|January 2016|2016-01-01||||November 2013|Actual|2013-11-01||Interventional|||Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery|A Multicenter, Open Label, Randomized Phase II Trial of Presurgical Treatment With Single-Agent Trastuzumab (H) or Lapatinib (Ty) or the Combination of Trastuzumab and Lapatinib (H+Ty), Followed by Six Cycles of Docetaxel (T) and Carboplatin (C) With Trastuzumab (TCH) or Lapatinib (TCTy) or the Combination of Trastuzumab and Lapatinib (TCHTy) in Patients With HER2/Neu-Amplified Operable Breast Cancer|Completed||Phase 2|18|Actual|Translational Oncology Research International||3|||f||||t||||||||||2017-02-18 13:50:26.295168|2017-02-18 13:50:26.295168
NCT00769457|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-05-25|||September 2008||2008-09-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|OptiLink-HF||OptiLink HF Study: Optimization of Heart Failure Management Using Medtronic OptiVol Fluid Status Monitoring and CareLink Network|OptiLink HF Study (Optimization of Heart Failure Management Using Medtronic OptiVol® Fluid Status Monitoring and Medtronic CareLink® Network)|Completed||Phase 4|1002|Actual|Medtronic Bakken Research Center||2|||f||||t||||||||No||2017-02-18 13:50:26.432271|2017-02-18 13:50:26.432271
NCT00769431|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2013-07-24|||May 2008||2008-05-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer|FOCUS GROUP EVALUATION OF PROSTATE CANCER SYMPTOM MANAGEMENT EDUCATION MATERIALS|Completed||N/A|7|Actual|Baylor College of Medicine||1|||f||||f||||||||||2017-02-18 13:50:26.547395|2017-02-18 13:50:26.547395
NCT00769418|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2015-08-18|||September 2004||2004-09-01|August 2015|2015-08-01|September 2006|Actual|2006-09-01|December 2004|Actual|2004-12-01||Interventional|||Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)|A Double-Blind, Randomized, Placebo-Controlled, Multi-Panel, Multiple Oral Dose Study, to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0822 in Healthy Male and Postmenopausal Female Subjects|Completed||Phase 1|62|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:50:26.662002|2017-02-18 13:50:26.662002
NCT00769405|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-08-29|||February 2008||2008-02-01|August 2016|2016-08-01||||December 2015|Actual|2015-12-01||Interventional|||Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer|Phase III Study Evaluating the Use of Systemic Chemotherapy and Chemohyperthemia Intraperitoneal Preoperatively (CHIP) and After Maximum Resection of Peritoneal Carcinomatosis Originating With Colorectal Cancer|Completed||Phase 3|264|Actual|UNICANCER||2|||f||||||||||||||2017-02-18 13:50:26.756549|2017-02-18 13:50:26.756549
NCT00769392|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2012-05-09|||September 2008||2008-09-01|May 2012|2012-05-01|October 2012|Anticipated|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection|Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection|Unknown status|Active, not recruiting|N/A|100|Anticipated|Lahey Clinic||4|||f||||f||||||||||2017-02-18 13:50:26.893738|2017-02-18 13:50:26.893738
NCT00769379|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2017-02-16|||November 2008||2008-11-01|December 2016|2016-12-01||||March 2019|Anticipated|2019-03-01||Interventional|||Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy|A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy and Radiation Therapy Alone for Women With HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy|Active, not recruiting||Phase 3|2000|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 13:50:29.396795|2017-02-18 13:50:29.396795
NCT00769366|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2008-10-07|||May 2005||2005-05-01|September 2008|2008-09-01||||December 2009|Anticipated|2009-12-01||Interventional|STEP-IN-AMI||Randomized, Controlled Study on Short-Term Psychotherapy After Acute Myocardial Infarction|Randomized, Controlled Study on Short-Term Psychotherapy After Acute Myocardial Infarction: The Step-in-AMI Trial (Short TErm Psychotherapy IN Acute Myocardial Infarction)|Unknown status|Recruiting|N/A|92|Anticipated|San Filippo Neri General Hospital||2|||f||||f||||||||||2017-02-18 13:50:31.38229|2017-02-18 13:50:31.38229
NCT00769353|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-05-20|||January 2008||2008-01-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness|Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness|Completed||N/A|90|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:50:31.463901|2017-02-18 13:50:31.463901
NCT00769340|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2008-10-08|||August 2008||2008-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:50:31.563426|2017-02-18 13:50:31.563426
NCT00769327|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2015-01-27|||February 2009||2009-02-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|CML0408||Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia|Front-line Treatment of Philadelphia Positive (Ph Pos), BCRABL Positive, Chronic Myeloid Leukemia (CML) With Two Tyrosine Kinase Inhibitors (TKI) (Nilotinib and Imotinib) A Phase II Exploratory Multicentric Centre.|Completed||Phase 2|129|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-02-18 13:50:31.618973|2017-02-18 13:50:31.618973
NCT00769314|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2012-11-21|2011-10-26||May 2007||2007-05-01|November 2012|2012-11-01|August 2009|Actual|2009-08-01|November 2008|Actual|2008-11-01||Interventional|LIP||Phase 3 Clinical Study for the Treatment of Cold Sore|A Randomised, Double-Blind, Single Dose, One-Day Early Administration, Multicentre Study Comparing the Efficacy and Safety of Acyclovir Lauriad® 50 mg Muco-adhesive Buccal Tablet to Matching Placebo, in the Treatment of Herpes Labialis in Immunocompetent Patients.|Completed||Phase 3|1727|Actual|Onxeo||2|||f||||f||||||||||2017-02-18 13:50:31.753786|2017-02-18 13:50:31.753786
NCT00769301|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2011-06-29|||November 2008||2008-11-01|June 2011|2011-06-01|December 2014|Anticipated|2014-12-01|December 2011|Anticipated|2011-12-01||Observational|||Symptom Clusters in Cancer Patients and Their Caregivers- a Longitudinal Study|Advancing the Science of Symptom Management and Support for Cancer Patients and Their Caregivers|Unknown status|Active, not recruiting|N/A|500|Anticipated|Oslo University Hospital|||2||f||||t||||||Samples With DNA|"~     DNA analyses for genotyping subgroups of patients based on their experience with pain,~     fatigue, sleep disturbance and depression will test the hypothesis that gene polymorphisms~     within the selected candidate genes will exhibit significant differences in frequency~     distribution among the different patient subgroups that are identified through cluster~     analysis.~   "|||2017-02-18 13:50:32.69097|2017-02-18 13:50:32.69097
NCT00769288|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2014-01-06|||July 2009||2009-07-01|January 2014|2014-01-01||||December 2013|Actual|2013-12-01||Interventional|||FAU in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study of Intravenously Administered FAU (1-(2'-Deoxy-2'-Fluoro-B-D-arabinofuranosyl) Uracil, NSC#678515) in Patients With Advanced Solid Tumors|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:50:32.790846|2017-02-18 13:50:32.790846
NCT00769275|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2008-10-08|||August 2000||2000-08-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Observational|DIAD||Detection of Ischemia in Asymptomatic Diabetics|Detection of Ischemia in Asymptomatic Diabetics|Completed||N/A|1123|Actual|Yale University|||2||f||||t||||||Samples Without DNA|"~     blood~   "|||2017-02-18 13:50:32.914967|2017-02-18 13:50:32.914967
NCT00769262|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2016-10-03|||January 2009||2009-01-01|October 2016|2016-10-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Weaning Thermoregulatory Support in Preterm Neonates|Effect of Conservative Weaning of Thermoregulatory Support on Weight Gain and Length of Stay in Preterm Neonates|Withdrawn||N/A|0|Actual|University of Missouri-Columbia||2||insufficient funds|f||||f||||||||No||2017-02-18 13:50:33.009243|2017-02-18 13:50:33.009243
NCT00769249|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2015-03-17|||February 2008||2008-02-01|March 2015|2015-03-01||||December 2010|Anticipated|2010-12-01||Observational|||Positive Changes in Quality of Life of Older Cancer Patients and Their Caregivers|Correlates of Post-Traumatic Growth in Cancer Patients and Their Partners|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||||||2017-02-18 13:50:33.113229|2017-02-18 13:50:33.113229
NCT00769236|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2014-08-27|||June 2008||2008-06-01|August 2014|2014-08-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease|Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease|Completed||N/A|160|Actual|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-02-18 13:50:33.200233|2017-02-18 13:50:33.200233
NCT00769223|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2014-10-13|||February 1993||1993-02-01|October 2014|2014-10-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Observational|||Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer|Pre-Operative Gleason Score and PSA and Clinical Stage in Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer|Recruiting||N/A|3500|Anticipated|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 13:50:33.303968|2017-02-18 13:50:33.303968
NCT00769210|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-03-29|||May 2005||2005-05-01|March 2016|2016-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure|The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure|Completed||Early Phase 1|12|Actual|University of Utah||1|||f||||f||||||||||2017-02-18 13:50:33.403549|2017-02-18 13:50:33.403549
NCT00769197|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-08|2009-04-28|||June 2008||2008-06-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Optic Discs in Children With Cerebral Palsy|Optic Nerve Head Morphology in Children With Perinatal Onset Static Encephalopathy|Completed||N/A|61|Actual|University of Mississippi Medical Center|||2||f||||f||||||||||2017-02-18 13:50:33.509914|2017-02-18 13:50:33.509914
NCT00769184|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-07-22|2014-11-14||October 2008||2008-10-01|July 2015|2015-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional||Fifteen patients with localized chronic plaque psoriasis (less than or equal to 6% BSA and PGA score greater than or equal to 3) were enrolled. Eleven patients completed the study. Three patients were removed due to an adverse event, and 1 patient was lost to follow-up after week 2.|Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis|A Steroid-Sparing Effect of Supplemental LCD Treatment in Patients With Moderate-to-Severe Localized Psoriasis Lesions: a Pilot Study.|Completed||N/A|15|Actual|NeoStrata Company, Inc.|This was a bilateral study in which 15 subjects total were recruited and randomized to receive both interventions simultaneously by dividing treatment arms to each side of the body.|2|||f||||t||||||||||2017-02-18 13:50:33.605904|2017-02-18 13:50:33.605904
NCT00769171|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2014-12-17|||October 2005||2005-10-01|December 2014|2014-12-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|DRAGON||Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)|A Prospective, Randomized, Double-blinded, Multi-center Trial Assessing the Safety and Efficacy of Intravenous Administration BAY12-8039 (Moxifloxacin) 400mg Every 24 h Compared to Intravenous Ceftriaxone 2g Every 24h and Metronidazole 500mg Every 12h for the Treatment of Patients With Complicated Intra-abdominal Infections|Completed||Phase 3|364|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:50:33.93278|2017-02-18 13:50:33.93278
NCT00769158|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2012-02-03|||October 2008||2008-10-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study|Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study|Completed||Phase 1|4|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 13:50:34.066474|2017-02-18 13:50:34.066474
NCT00769145|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-07-24|||October 2008||2008-10-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|August 2011|Actual|2011-08-01||Interventional|||Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery|Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery|Completed||Phase 1|5|Actual|Bascom Palmer Eye Institute||1|||f||||f||||||||||2017-02-18 13:50:34.178479|2017-02-18 13:50:34.178479
NCT00768573|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2015-04-27|||January 2008||2008-01-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Taste Test of a New Formulation of Sildenafil (Revatio)|A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio®|Completed||Phase 1|4|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:50:47.630446|2017-02-18 13:50:47.630446
NCT00769132|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-09-03|2008-10-30||August 2007||2007-08-01|September 2015|2015-09-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, 4-Period, Crossover Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With Hypercholesterolemia|Completed||Phase 1|26|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 13:50:34.2936|2017-02-18 13:50:34.2936
NCT00769119|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2012-08-14|2012-01-24||September 2008||2008-09-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|NEPAL||A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis|A Phase II, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy of 28 Day Oral Administration of AZD9668 in Patients With Bronchiectasis|Completed||Phase 2|38|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:50:34.740021|2017-02-18 13:50:34.740021
NCT00769106|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-04-13|||June 2008||2008-06-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|HCC-CIK||Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer|A Randomized Controlled Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients With Hepatocellular Carcinoma Who Underwent Radical Resection.|Completed||Phase 3|200|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:50:35.626886|2017-02-18 13:50:35.626886
NCT00769093|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2014-11-17|||October 2008||2008-10-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy|Pilot Study to Compare Dynamic MR Imaging Changes in Patients With Recurrent High Grade Glioma, Receiving an Antiangiogenic Drug, Bevacizumab, Versus Dexamethasone. Dual Agent MR Imaging Study, Using Gadolinium and Ferumoxytol (Code 7228)|Terminated||Phase 1|6|Actual|OHSU Knight Cancer Institute||2||Inadequate enrollment|f||||t||||||||||2017-02-18 13:50:35.725856|2017-02-18 13:50:35.725856
NCT00769080|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2011-11-28|||September 2008||2008-09-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|||||Observational|ARI NIS||The Performance of Patient Support Program in Early Stage Breast Cancer|A Prospective, Multicentre, Controlled, Observational Study to Evaluate the Performance of Patient Support Programme (PSP) in Improving Patient Adherence With Adjuvant Aromatase Inhibitors (AI) Medication for Postmenopausal, Early Stage Breast Cancer|Completed||N/A|524|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 13:50:35.851442|2017-02-18 13:50:35.851442
NCT00769067|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-09-22|2015-07-27||November 2008||2008-11-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|October 2010|Actual|2010-10-01||Interventional||Intent-to-treat (ITT) population included all randomized participants with study drug assignment designated according to initial randomization, regardless of treatment received.|A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen|A Randomized Phase 2 Trial Of Pf-00299804 Versus Erlotinib For The Treatment Of Advanced Non-small Cell Lung Cancer After Failure Of At Least One Prior Chemotherapy Regimen|Completed||Phase 2|188|Actual|Pfizer||2|||f||||||||||||||2017-02-18 13:50:35.974193|2017-02-18 13:50:35.974193
NCT00769054|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2010-07-08|||October 2008||2008-10-01|October 2008|2008-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Local Infiltration Analgesia With Ropivacaine in Posterior Vaginal Wall Prolapse:a Randomized, Double-Blind Study|Lokal Infiltrations Analgesi Med Ropivakain 1 % Versus Placebo VED Vaginale Descensusoperationer: ET Prospektivt Randomiseret, Dobbeltblindet, Placebo- Kontrolleret Studie|Completed||Phase 4|48|Anticipated|Hvidovre University Hospital||2|||f||||||||||||||2017-02-18 13:50:37.045739|2017-02-18 13:50:37.045739
NCT00769041|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2011-01-05|||October 2008||2008-10-01|January 2011|2011-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Thorough EKG Safety Study of TA-1790 (Avanafil)|A Blinded, Randomized Crossover Trial to Define the ECG Effects of TA-1790 (Avanafil) Using a Single Clinical and a Supratherapeutic Dose Compared to Placebo and Moxifloxacin in Healthy Men: A Thorough ECG Trial|Completed||Phase 1|57|Actual|VIVUS, Inc.||4|||f||||f||||||||||2017-02-18 13:50:37.137296|2017-02-18 13:50:37.137296
NCT00769028|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2011-08-16|||December 2008||2008-12-01|August 2011|2011-08-01|September 2011|Anticipated|2011-09-01|February 2011|Actual|2011-02-01||Interventional|||AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis|A Double-Blind Placebo-Controlled Pilot Study of Safety and Tolerability of AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Daval International Limited||2|||f||||t||||||||||2017-02-18 13:50:37.230996|2017-02-18 13:50:37.230996
NCT00769015|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2014-11-13|2014-10-09||June 2009||2009-06-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional|VITAL||Low Vision Depression Prevention Trial for Age Related Macular Degeneration|Low Vision Depression Prevention Trial for Age Related Macular Degeneration|Completed||Phase 3|188|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 13:50:37.3379|2017-02-18 13:50:37.3379
NCT00769002|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-08-26|||September 2008||2008-09-01|August 2013|2013-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|Pro00000226||PET-CT Scans in Healthy Volunteers After Flu Vaccination|Impact of Bilateral Priming on Response to Unilateral Flu Vaccination|Completed||N/A|16|Actual|Hackensack University Medical Center||2|||f||||t||||||||||2017-02-18 13:50:38.156695|2017-02-18 13:50:38.156695
NCT00768989|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2012-02-22|2011-10-19||November 2008||2008-11-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|SPARTAN||Phase IIB Pilot of Atazanavir + Raltegravir|A Multicenter, Randomized, Open-Label, Active-Controlled Pilot Study to Evaluate the Safety and Antiretroviral Activity of Unboosted Atazanavir BID Plus Raltegravir BID and Boosted Atazanavir QD in Combination With Tenofovir/Emtricitabine QD in Treatment Naive HIV-Infected Subjects|Terminated||Phase 2|167|Actual|Bristol-Myers Squibb||2||"Efficacy endpoint met, but overall experimental dosing regimen not considered optimal to~   support further clinical development in this population."|f||||f||||||||||2017-02-18 13:50:38.277645|2017-02-18 13:50:38.277645
NCT00768976|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-05-22|||October 2008||2008-10-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Study of Patient Satisfaction With the Cancer Clinical Trial Experience|Study of Patient Satisfaction With the Cancer Clinical Trial Experience|Completed||N/A|100|Actual|Summa Health System|||1||f||||f||||||||||2017-02-18 13:50:39.554289|2017-02-18 13:50:39.554289
NCT00768950|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-08-13|||January 2008||2008-01-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|SPONDILENDO||The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides|The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides|Completed||N/A|65|Actual|Carol Davila University of Medicine and Pharmacy|||1||f||||t||||||||||2017-02-18 13:50:39.728655|2017-02-18 13:50:39.728655
NCT00768937|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2010-11-08|||September 2008||2008-09-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma|Sorafenib as Inhibitor of Collateral Tumor Vessel Growth During Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma (HCC)- a Pilot Trial to Evaluate Safety and Biological Response|Completed||Phase 1/Phase 2|22|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-02-18 13:50:39.841157|2017-02-18 13:50:39.841157
NCT00768924|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-09-28|||March 2007||2007-03-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Observational|||CopiOs(TM) Bone Void Filler in the Post-Harvest Iliac Crest|CopiOs(TM) Bone Void Filler in the Post-Harvest Iliac Crest|Completed||N/A|35|Actual|Zimmer Biomet|||1||f||||||||||||||2017-02-18 13:50:39.953546|2017-02-18 13:50:39.953546
NCT00768911|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2010-10-26|||October 2008||2008-10-01|October 2010|2010-10-01|June 2011|Anticipated|2011-06-01|October 2010|Anticipated|2010-10-01||Interventional|||CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme|Phase 1, Open Label, Multi-Center Study To Evaluate The Safety And Tolerability of CT-322 Administered In Combination With Focal Brain Radiotherapy And Temozolomide To Subjects With Newly Diagnosed Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|Adnexus, A Bristol-Myers Squibb R&D Company||1|||f||||f||||||||||2017-02-18 13:50:40.042763|2017-02-18 13:50:40.042763
NCT00768898|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2012-03-19|2009-09-21||August 2008||2008-08-01|March 2012|2012-03-01||||September 2008|Actual|2008-09-01||Observational|||Defining the Conjunctival Staining Method: Instillation Volume and Time Course to Assess Staining With Lissamine Green||Completed||N/A|30|Actual|Alcon Research|||3||f||||f||||||||||2017-02-18 13:50:40.156975|2017-02-18 13:50:40.156975
NCT00768885|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2013-03-15|||September 2008||2008-09-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||Comparative Study of the Wearing Satisfaction of Two Soft Contact Lens Designs.|Comparative Study of the Wearing Satisfaction of Two Soft Contact Lens Designs|Completed||N/A|64|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 13:50:40.48525|2017-02-18 13:50:40.48525
NCT00768872|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-10-13|||October 2008||2008-10-01|October 2016|2016-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|ADR-SCS||Spinal Cord Stimulation Research Study|Neuro Ambulatory Data Recorder (ADR) Spinal Cord Stimulation (SCS) Study|Completed||N/A|66|Actual|MedtronicNeuro|||1||f||||f||||||||||2017-02-18 13:50:40.570562|2017-02-18 13:50:40.570562
NCT00768859|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-05-10|||September 2008||2008-09-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|August 2011|Actual|2011-08-01||Interventional|TRAIN||Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study|Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study|Completed||Phase 2|111|Actual|The Netherlands Cancer Institute||1|||f||||t||||||||||2017-02-18 13:50:40.649428|2017-02-18 13:50:40.649428
NCT00768846|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2008-10-11|||September 2008||2008-09-01|October 2008|2008-10-01|June 2011|Anticipated|2011-06-01|May 2010|Anticipated|2010-05-01||Interventional|ZEPPELIN||Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World|Randomized Comparison of Zotarolimus- and Everolimus-Eluting Stents for Coronary Treatment|Unknown status|Recruiting|Phase 4|2600|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 13:50:40.759277|2017-02-18 13:50:40.759277
NCT00768833|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2014-08-20|||October 2008||2008-10-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|Carriage||Study Evaluating the Nasopharyngeal Carriage in Healthy Children|Nasopharyngeal Carriage in Children After Introduction of General Pneumococcal Immunization in Germany|Completed||N/A|242|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:50:40.870415|2017-02-18 13:50:40.870415
NCT00768820|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-01-28|||May 2001||2001-05-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|VCFS||The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome|The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors|Recruiting||Phase 4|400|Anticipated|The Chaim Sheba Medical Center||1|||f||||t||||||||||2017-02-18 13:50:40.96308|2017-02-18 13:50:40.96308
NCT00768807|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2012-05-04|||October 2009||2009-10-01|May 2012|2012-05-01|September 2010|Actual|2010-09-01|October 2009|Actual|2009-10-01||Interventional|||Structural and Functional Left Ventricular Remodelling in Patients With Obstructive Sleep Apnea|Structural and Functional Left Ventricular Remodelling in Patients With Obstructive Sleep Apnea|Completed||N/A|450|Actual|Associação Fundo de Incentivo à Pesquisa||2|||f||||f||||||||||2017-02-18 13:50:41.071188|2017-02-18 13:50:41.071188
NCT00768794|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-05-30|||July 2006||2006-07-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|||Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy|A Trial Using Acidophilus for the Treatment and Prevention of Oral Candidiasis in Head and Neck Cancer Patients Undergoing Radiation Therapy|Completed||N/A|5|Actual|Summa Health System||1|||f||||f||||||||||2017-02-18 13:50:41.163798|2017-02-18 13:50:41.163798
NCT00768781|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-05-28|||November 2008||2008-11-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|||Mindfulness-Based Approaches to Insomnia|Augmenting Behavior Therapy for Insomnia With Mindfulness Meditation|Completed||Phase 2|54|Actual|Rush University Medical Center||3|||f||||f||||||||||2017-02-18 13:50:41.263223|2017-02-18 13:50:41.263223
NCT00768768|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-03-10|||October 2008||2008-10-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Iontophoretic Application of Terbinafine Gel to the Large Toe Nail|A Study of Skin/Nail Sensation and the Pharmacokinetics of the Uptake of Terbinafine in the Great Toe Nail and Systemically Following Treatment With the Electrokinetic Transungual System (ETS)-Terbinafine Gel in Healthy Normal Voluneteers|Completed||Phase 1|40|Anticipated|Transport Pharmaceuticals||5|||f||||f||||||||||2017-02-18 13:50:41.375124|2017-02-18 13:50:41.375124
NCT00767429|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2010-07-26|||August 2008||2008-08-01|July 2010|2010-07-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|field||Development of an Acceleration Based Fall Risk Detector|Development of an Acceleration Based Fall Risk Detector|Unknown status|Recruiting|N/A|100|Anticipated|Maastricht University Medical Center||1|||f||||t||||||||||2017-02-18 13:51:08.074519|2017-02-18 13:51:08.074519
NCT00768755|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-10-06|2012-03-01||January 2009||2009-01-01|October 2015|2015-10-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer|Randomized Phase 2 Study Of Cisplatin/Pemetrexed With Or Without Axitinib (AG-013736) As First-Line Treatment For Patients With Non-Squamous Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|180|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 13:50:41.495928|2017-02-18 13:50:41.495928
NCT00768742|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2013-11-22|||September 2008||2008-09-01|November 2013|2013-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|FAST||Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study|Clinical Study to Assess the Safety and Effectiveness of VizAblate(tm) Intrauterine Ultrasound-guided RF Ablation (IUUSgRFA) of Submucosal and Intramural Uterine Fibroids on the Reduction of Pictorial Blood Loss Assessment Scores|Withdrawn||N/A|0|Actual|Gynesonics||1||study revised and reinitiated under another protocol|f||||f||||||||||2017-02-18 13:50:43.166868|2017-02-18 13:50:43.166868
NCT00768729|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2013-02-14|||May 2009||2009-05-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation|Immunosuppression Minimization to Single Drug Therapy With Sirolimus (Rapamune) in Pediatric Transplantation|Completed||Phase 1|7|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 13:50:43.258183|2017-02-18 13:50:43.258183
NCT00768716|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2008-10-07|||September 2008||2008-09-01|October 2008|2008-10-01|April 2011|Anticipated|2011-04-01|December 2010|Anticipated|2010-12-01||Interventional|||Effect of Race/Ethnicity and Genes on Acetaminophen Pharmacokinetics|Effect of Race/Ethnicity and Genes on Acetaminophen Pharmacokinetics|Unknown status|Recruiting|Phase 4|200|Anticipated|Tufts University||2|||f||||f||||||||||2017-02-18 13:50:43.3782|2017-02-18 13:50:43.3782
NCT00768703|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2016-11-01|||October 2008||2008-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Percutaneous Endoscopic Tracheal Plug/Unplug for CDH|Percutaneous Endoscopic Tracheal Plug/Unplug for Congenital Diaphragmatic Hernia|Active, not recruiting||Phase 1/Phase 2|10|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 13:50:43.479222|2017-02-18 13:50:43.479222
NCT00768690|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2010-10-11|||October 2008||2008-10-01|September 2010|2010-09-01||||February 2009|Actual|2009-02-01||Interventional|||A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333||Completed||Phase 1|45|Actual|Abbott||5|||f||||||||||||||2017-02-18 13:50:43.594398|2017-02-18 13:50:43.594398
NCT00768677|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2008-10-07|||July 2003||2003-07-01|September 2008|2008-09-01||||||||Interventional|||Topiramate for Binge Eating Disorder Among Adolescents|Open-Label Study of Topiramate for Binge Eating Disorder and Bulimia Nervosa Among Adolescents|Completed||N/A|||The Zucker Hillside Hospital|||||f||||f||||||||||2017-02-18 13:50:43.700791|2017-02-18 13:50:43.700791
NCT00768664|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-06-01||2011-06-03|November 2008||2008-11-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|May 2010|Actual|2010-05-01||Interventional|||Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer|Clinical Phase 2 Multicenter Trial Of PF-00299804 In Patients With Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck|Completed||Phase 2|69|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:50:43.788621|2017-02-18 13:50:43.788621
NCT00768651|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-05-29|2015-05-10||October 2008||2008-10-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional||Patients with evidence of early graft insufficiency following a period of insulin independence after one or more islet infusions for c-peptide negative type 1 diabetes participated in the study.|Incretin Effect and Use After Clinical Islet Transplantation|Pilot Study of Safety and Efficacy of Combined Use of Dipeptidyl-peptidase Inhibitor (Sitagliptin) and Proton Pump Inhibitor (Pantoprazole) to Prevent Beta-cell Apoptosis and Promote Islet Regeneration in Islet Transplant Recipients With Early Graft Dysfunction|Completed||Phase 2|8|Actual|University of Alberta|The major weaknesses of the study are the small sample size and the lack of a control group.|1|||f||||f||||||||||2017-02-18 13:50:43.901885|2017-02-18 13:50:43.901885
NCT00768638|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-04-28|||October 2008||2008-10-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|SARP||Study of Atorvastatin Dose Dependent Reduction of Proteinuria|The Renal Protective Effects of Low-dose and High-dose Atorvastatin in Patients With Glomerular Disease and Proteinuria: a Randomized Controlled Double Blinded Study|Completed||Phase 4|23|Actual|Laval University||2|||f||||f||||||||||2017-02-18 13:50:44.277689|2017-02-18 13:50:44.277689
NCT00768625|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2008-10-07|||April 2005||2005-04-01|October 2008|2008-10-01|December 2012|Anticipated|2012-12-01|March 2011|Anticipated|2011-03-01||Observational|ERA||Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea|Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea|Unknown status|Recruiting|N/A|2000|Anticipated|Associacao Fundo de Incentivo a Psicofarmcologia|||1||f||||f||||||||||2017-02-18 13:50:44.37997|2017-02-18 13:50:44.37997
NCT00768612|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-01-28|||November 2008||2008-11-01|January 2013|2013-01-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia|A Randomized, Double-Blind, Risperidone-Reference, Parallel-Group, Safety, and Tolerability Study of Vabicaserin (SCA-136) in Japanese Subjects With Acute Exacerbation of Schizophrenia|Withdrawn||Phase 2|0|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||t||||||||||2017-02-18 13:50:44.464456|2017-02-18 13:50:44.464456
NCT00768599|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-12-05|2012-12-05||March 2008||2008-03-01|December 2012|2012-12-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||A Study of Econazole Foam 1% in Athlete's Foot|A Multi-Center Randomized, Evaluator-Blinded, Vehicle Controlled, Parallel Group Comparison Study of the Safety and Efficacy of Econazole Nitrate Foam 1%, Econazole Nitrate 1% Cream, and Foam Vehicle in Subjects With Tinea Pedis|Completed||Phase 2|135|Actual|AmDerma||3|||f||||f||||||||||2017-02-18 13:50:44.557479|2017-02-18 13:50:44.557479
NCT00768586|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2008-10-14|||February 2008||2008-02-01|September 2008|2008-09-01||||||||Observational|fVEP||Analysis of the Early Development of the Visual Function in Extreme Premature Infants Under 28th Weeks of Gestation|Analysis of the Early Development of the Visual Function in Extreme Premature Infants Under 28th Weeks of Gestation. - A Prospective Study to Identify Normal Values of Flash Visual Evoked Potentials in This Population|Unknown status|Recruiting|N/A|40|Anticipated|Medical University of Vienna|||1||f||||f||||||||||2017-02-18 13:50:45.219021|2017-02-18 13:50:45.219021
NCT00768560|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-05-13|2009-09-28||January 2008||2008-01-01|May 2015|2015-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study|Evaluation of the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of BAY A1040 CR Tablet on High Dose Administration in Patients With Essential Hypertension.|Completed||Phase 2|35|Actual|Bayer||3|||f||||f||||||||||2017-02-18 13:50:47.734339|2017-02-18 13:50:47.734339
NCT00768547|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2011-07-21|||August 2008||2008-08-01|August 2008|2008-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Risk Stratification in Acutely Admitted Medical Patients|Risk Stratification in Acutely Admitted Medical Patients|Completed||N/A|5900|Actual|Ribe County Hospital|||2||f||||f||||||||||2017-02-18 13:50:48.565793|2017-02-18 13:50:48.565793
NCT00768534|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-10-05|||October 2008||2008-10-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media|Microbiological Analysis Of Spontaneous Draining Acute Otitis Media Including Serotype Distribution Of Pneumococcal Isolates|Completed||N/A|2138|Actual|Pfizer|||1||f||||f||||||Samples Without DNA|"~     Middle ear fluid and anasopharyngeal swab~   "|||2017-02-18 13:50:48.636905|2017-02-18 13:50:48.636905
NCT00768521|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2015-07-22|2014-08-01||September 2008||2008-09-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)|A Randomized, Placebo Controlled, Crossover Study to Evaluate the Effects of Tolterodine Tartrate on Urodynamic Parameters in Patients With Overactive Bladder|Completed||Phase 1|20|Actual|Merck Sharp & Dohme Corp.|The analysis presented includes all patients. An analysis excluding patients who were misdosed yielded different results with a similar conclusion and are not presented.|4|||f||||||||||||||2017-02-18 13:50:48.716749|2017-02-18 13:50:48.716749
NCT00768508|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2013-03-14|||September 2008||2008-09-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Combined Pharmacotherapies for Alcoholism|Combined Pharmacotherapies for Alcoholism|Completed||Phase 3|300|Actual|University of Virginia||4|||f||||t||||||||||2017-02-18 13:50:49.168996|2017-02-18 13:50:49.168996
NCT00768495|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-06-02|||October 2008||2008-10-01|June 2009|2009-06-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|CLI-Pre/Post||Hyperspectral Imaging Pre and Post Endovascular Intervention|Evaluation of the Success of Endovascular Peripheral Revascularization for the Treatment of Chronic Limb Ischemia by Measuring OxyHb and DeoxyHb Using a New Hyperspectral Imaging Device (OxyVu).|Unknown status|Recruiting|N/A|60|Anticipated|HyperMed|||1||f||||f||||||||||2017-02-18 13:50:49.284282|2017-02-18 13:50:49.284282
NCT00768482|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-01-25||2011-01-05|September 2008||2008-09-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PRO-810||A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence|A Single Cross-Over, Open-Label Study of the Relative Bioavailability of Probuphine Versus Buprenorphine Sublingual Tablets at Steady State in Patients With Opioid Dependence|Terminated||Phase 3|9|Actual|Titan Pharmaceuticals||1||This study was terminated for reasons not related to efficacy or safety|f||||t||||||||||2017-02-18 13:50:49.379255|2017-02-18 13:50:49.379255
NCT00768469|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-05-10|||October 2008||2008-10-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study Evaluating Safety And Tolerability, Solid Tumor|A Phase 1 Study Of Neratinib (HKI-272) In Combination With Paclitaxel In Subjects With Solid Tumors|Completed||Phase 1|10|Actual|Puma Biotechnology, Inc.||1|||f||||t||||||||||2017-02-18 13:50:49.4839|2017-02-18 13:50:49.4839
NCT00768456|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2011-06-22|||October 2008||2008-10-01|July 2008|2008-07-01|December 2010|Actual|2010-12-01|October 2009|Actual|2009-10-01||Interventional|||Local Infiltration Analgesia With Ropivacaine Versus Placebo in Vaginal Hysterectomy: a Randomized, Double-Blind Study|Lokal Infiltrations Analgesi Med Ropivakain 0,5 % Versus Placebo VED Vaginal Hysterektomi: ET Prospektivt Randomiseret, Dobbeltblind ET, Placebo-kontrolleret Studie|Completed||Phase 4|48|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 13:50:49.583069|2017-02-18 13:50:49.583069
NCT00768443|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2010-12-06|||September 2008||2008-09-01|December 2010|2010-12-01|February 2009|Actual|2009-02-01|||||Observational|PHENIX||Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)|Epidemiological Study to Assess the Symptom Patterns and Management Strategies in Patients Consulting With Persistent GERD Symptoms in Primary Care|Completed||N/A|2674|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:50:49.680984|2017-02-18 13:50:49.680984
NCT00768430|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-12-27|2013-09-05||November 2008||2008-11-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Optimization of IV Ketamine for Treatment Resistant Depression|Optimization of Intravenous Ketamine for Treatment-Resistant Depression: A Randomized, Placebo-Controlled, Triple-masked, Clinical Trial|Completed||Phase 2|73|Actual|Baylor College of Medicine|Limitations of our trial include stringent enrollment criteria due to concerns about ketamine’s psychoactive effects and abuse liability. A proportion of screened patients (17.2%) refused or were unable to tolerate psychotropic washout.|2|||f||||t||||||||||2017-02-18 13:50:49.793651|2017-02-18 13:50:49.793651
NCT00768417|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2013-11-15|||April 2006||2006-04-01|November 2013|2013-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Availability of Lipids in Almonds in Healthy Individuals|Mastication of Almonds: Effects of Lipid Bioaccessibility, Appetite, and Hormone Response|Completed||N/A|20|Actual|Purdue University|||1||f||||t||||||Samples With DNA|"~     Plasma, feces~   "|||2017-02-18 13:50:50.138241|2017-02-18 13:50:50.138241
NCT00768404|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2009-11-30|||October 2008||2008-10-01|November 2009|2009-11-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment|A Phase I, Open-Label, Parallel-Group, Single Dose, Non-Randomized Study To Compare The Pharmacokinetics Of Each Individual Component (Topiramate And Phentermine) Of The Combination Product VI-0521 In Subjects With Mild, Moderate And Severe Renal Impairment To Subjects With Normal Renal Function|Completed||Phase 1|32|Actual|VIVUS, Inc.||1|||f||||f||||||||||2017-02-18 13:50:50.252898|2017-02-18 13:50:50.252898
NCT00768391|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2011-06-27|||December 2006||2006-12-01|June 2011|2011-06-01|January 2010|Actual|2010-01-01|March 2009|Actual|2009-03-01||Interventional|||Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available|Phase I Study of Anti-Platelet Derived Growth Factor Receptor Alpha (PDGFRa) Monoclonal Antibody IMC-3G3 in Patients With Advanced Solid Tumors Who No Longer Respond to Standard Therapy or for Whom no Standard Therapy is Available|Completed||Phase 1|20|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 13:50:50.358703|2017-02-18 13:50:50.358703
NCT00768378|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2012-06-27|||July 2008||2008-07-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Efficacy Study of BrainPort® Balance Device in Peripheral Vestibular Dysfunction.|A Controlled Clinical Study to Evaluate the Safety and Efficacy of the BrainPort® Balance Device When Used to Improve Balance in Subjects With Peripheral Vestibular Dysfunction|Completed||N/A|147|Actual|Wicab||2|||f||||f||||||||||2017-02-18 13:50:50.459411|2017-02-18 13:50:50.459411
NCT00768365|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2008-10-07|||October 2007||2007-10-01|September 2008|2008-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|adrenal||Cardiovascular Risk in Patients With Non-Functional Adrenal Incidentaloma|Cardiovascular Risk in Patients With Non-Functional Adrenal Incidentaloma: Myth or Reality?|Completed||N/A|105|Actual|Istanbul University|||3||f||||f||||||||||2017-02-18 13:50:50.590653|2017-02-18 13:50:50.590653
NCT00768352|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2008-10-07|||February 2008||2008-02-01|October 2008|2008-10-01|June 2009|Anticipated|2009-06-01|February 2009|Anticipated|2009-02-01||Interventional|||Educational Intervention for Optimizing Adolescent Mental Health Screening and Treatment in Pediatric Residency|An Educational Intervention for Optimizing Adolescent Mental Health Screening Skills and Treatment in Pediatric Residency|Unknown status|Recruiting|N/A|50|Anticipated|Brooke Army Medical Center||1|||f||||||||||||||2017-02-18 13:50:50.695441|2017-02-18 13:50:50.695441
NCT00768339|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2011-07-12|||September 2008||2008-09-01|July 2011|2011-07-01|September 2011|Anticipated|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas|AEG35156-204: A Phase 1-2, Multicenter, Open-Label Study of the X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas|Terminated||Phase 1/Phase 2|25|Actual|Aegera Therapeutics||1||Slow recruitment|f||||f||||||||||2017-02-18 13:50:50.847336|2017-02-18 13:50:50.847336
NCT00768326|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-11-07|||March 2007||2007-03-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy of Lu 31-130 in Patients With Schizophrenia|A Double-blind, Randomised, Parallel-group, Placebo-controlled Study of the Safety, Tolerability and Efficacy Following Sequential Dose Regimens of Lu 31-130 to Patients With Schizophrenia|Completed||Phase 2|280|Actual|H. Lundbeck A/S||6|||f||||t||||||||||2017-02-18 13:50:51.126301|2017-02-18 13:50:51.126301
NCT00768313|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2010-05-14|||September 2008||2008-09-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Phase IV Comparing Rods of Yield Strengths to Correct Adolescent Idiopathic Scoliosis.|A Multi-Centre Randomized Phase IV Clinical Trial Comparing Rods of Varying Yield Strengths and Their Ability to Hold Correction of Adolescent Idiopathic Scoliosis.|Terminated||Phase 4|0|Actual|Queen's University||2||lack of enrollment|f||||f||||||||||2017-02-18 13:50:51.247821|2017-02-18 13:50:51.247821
NCT00768300|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2014-02-27|2013-07-15||December 2008||2008-12-01|February 2014|2014-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|ARTEMIS-IPF|Full Analysis Set: participants who were randomized and treated|(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF|ARTEMIS-IPF: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group, Event Driven Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects With Early Idiopathic Pulmonary Fibrosis (IPF)|Terminated||Phase 3|494|Actual|Gilead Sciences||2||Lack of efficacy|f||||t||||||||||2017-02-18 13:50:51.365616|2017-02-18 13:50:51.365616
NCT00768287|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-12-13|||January 2009||2009-01-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|November 2011|Actual|2011-11-01||Interventional|||Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B|Phase I/II/III Pharmacokinetic and Outcome Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B|Active, not recruiting||Phase 2/Phase 3|77|Actual|Aptevo Therapeutics||1|||f||||t||||||||||2017-02-18 13:50:53.396803|2017-02-18 13:50:53.396803
NCT00768274|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2016-07-21||2013-10-28|September 2008||2008-09-01|July 2016|2016-07-01||||August 2009|Actual|2009-08-01||Interventional|||Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol|A Safety, Pharmacokinetic, and Pharmacodynamic Assessment of 28-Day Oral Dosing of RVX000222 in Healthy Subjects and Subjects With Low High Density Lipoprotein (HDL)|Completed||Phase 1/Phase 2|72|Actual|Resverlogix Corp||3|||f||||||||||||||2017-02-18 13:50:53.512322|2017-02-18 13:50:53.512322
NCT00768261|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2012-07-19|||November 2004||2004-11-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Corticolimbic Degeneration and Treatment of Dementia|Corticolimbic Degeneration and Treatment of Dementia|Completed||Phase 4|39|Actual|Washington University School of Medicine||4|||f||||f||||||||||2017-02-18 13:50:53.618453|2017-02-18 13:50:53.618453
NCT00768248|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2011-09-13|||October 2008||2008-10-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Naval Medical Center San Diego (NMCSD) - Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain|Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain|Terminated||N/A|2|Actual|University of California, San Diego||2||No longer enrolling patients, not enough enrollment|f||||f||||||||||2017-02-18 13:50:53.72916|2017-02-18 13:50:53.72916
NCT00768235|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2008-10-07|||March 2007||2007-03-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Yoga Program in Respiratory Function|Influence of Yoga Program in Respiratory Function of Older Women|Completed||Phase 1/Phase 2|36|Actual|Catholic University of Brasília||2|||f||||t||||||||||2017-02-18 13:50:53.839284|2017-02-18 13:50:53.839284
NCT00768222|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-07|2011-08-29|2011-06-27||October 2008||2008-10-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery|Pilot Evaluation of Cosmetic Outcome and Surgical Site Infection Rates of Coated VICRYL* Plus Antibacterial (Polyglactin 910) Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery|Completed||Phase 4|101|Actual|Ethicon, Inc.||2|||f||||f||||||||||2017-02-18 13:50:53.954839|2017-02-18 13:50:53.954839
NCT00768209|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-11-30|||October 2008||2008-10-01|November 2009|2009-11-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment|A Phase I, Open Label, Single-Dose Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment and In Healthy Control Subjects|Completed||Phase 1|18|Actual|VIVUS, Inc.||1|||f||||f||||||||||2017-02-18 13:50:54.467888|2017-02-18 13:50:54.467888
NCT00720694|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-07-22|||June 2006||2006-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:07:15.423649|2017-02-18 14:07:15.423649
NCT00768196|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2010-12-06|||September 2008||2008-09-01|December 2010|2010-12-01|February 2009|Actual|2009-02-01|||||Observational|Preedom||Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients|Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients|Completed||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:50:54.582065|2017-02-18 13:50:54.582065
NCT00768183|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||May 2006||2006-05-01|October 2008|2008-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of KADIAN 100 mg When Dosed With Alcohol Under Fasting and Fed Conditions Compared to Water|A Phase 1, Single-Center, Open-Label, Drug Interaction Study to Evaluate the Effect of Alcohol Ingestion on the Pharmacokinetics of Alpharma Branded Products Division Inc. (KADIAN) Morphine Sulfate Extended-Release Capsules in Healthy Adult Volunteers Under Fasting and Fed Conditions and Relative Bioavailability Assessment of an Immediate Release Morphine Solution|Completed||Phase 1|32|Actual|Alpharma Pharmaceuticals LLC, a subsidiary of Pfizer Inc.||4|||f||||||||||||||2017-02-18 13:50:54.65993|2017-02-18 13:50:54.65993
NCT00768170|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2015-07-02|||September 2008||2008-09-01|July 2015|2015-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028)|A Open-Label, Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK0633 in Japanese Asthmatic Children Aged 12 to Less Than 16 Years|Completed||Phase 1|10|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:50:54.762373|2017-02-18 13:50:54.762373
NCT00768157|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-02-06|||April 2007||2007-04-01|February 2009|2009-02-01|August 2010|Anticipated|2010-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma|Efficacy of Antiviral Therapy With Lamivudine or Entecavir After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:50:54.84052|2017-02-18 13:50:54.84052
NCT00768144|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2016-06-13|2014-06-05||September 2008||2008-09-01|June 2016|2016-06-01|February 2013|Actual|2013-02-01|May 2012|Actual|2012-05-01||Interventional||The analysis dataset is comprised of all enrolled patients.|Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma|A Phase II Trial of Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma|Completed||Phase 2|36|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 13:50:54.95649|2017-02-18 13:50:54.95649
NCT00768131|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2015-10-26|||October 2008||2008-10-01|October 2015|2015-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel|A Randomized Phase II Trial to Assess the Predictive Value of Increased EGFR Copy Number by FISH in Patients With Advanced / Metastatic NSCLC Treated With Cetuximab and Carboplatin / Paclitaxel|Withdrawn||Phase 2|0|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 13:50:55.2983|2017-02-18 13:50:55.2983
NCT00768118|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-04|2014-06-10|2014-04-10||April 2008||2008-04-01|June 2014|2014-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants|A Pilot Study of Biomarker Alterations By Nutritional Agents|Completed||N/A|11|Actual|Barbara Ann Karmanos Cancer Institute|The study has small numbers, it was a proof-of-concept study only to demonstrate that agents taken orally can alter biomarkers, similar to the results obtained from in vitro studies, it was to open doors for future studies.|1|||f||||t||||||||||2017-02-18 13:50:55.414879|2017-02-18 13:50:55.414879
NCT00768105|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2010-12-02|||September 2008||2008-09-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin|A Randomized, Single-Blind, Placebo-Controlled, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Multiple Ascending Oral Doses of AZD1656 in Subjects With T2DM Treated With Insulin|Completed||Phase 1|24|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 13:50:55.840375|2017-02-18 13:50:55.840375
NCT00768079|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-07-14||2016-07-14|February 2009||2009-02-01|July 2016|2016-07-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|MEDI-563||A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered MEDI-563|A Phase 2, Multicenter, Randomized, Double-blind, Placebocontrolled Study to Evaluate the Safety and Efficacy of Intravenously Administered MEDI-563, A Humanized Anti-interleukin-5 Receptor Alpha Monoclonal Antibody, on Asthma Control Following Acute Exacerbations in Adults|Completed||Phase 2|110|Actual|MedImmune LLC||3|||f||||f||||||||||2017-02-18 13:50:55.933788|2017-02-18 13:50:55.933788
NCT00768066|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2015-11-09|2014-01-17||August 2008||2008-08-01|November 2015|2015-11-01|September 2013|Actual|2013-09-01|August 2012|Actual|2012-08-01||Interventional|TAC-HFT|This is the number of patients who were randomized and received the study product injection.|The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)|A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Transendocardial Injection of Autologous Human Cells (Bone Marrow or Mesenchymal) in Patients With Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction.|Completed||Phase 1/Phase 2|65|Actual|University of Miami||3|||f||||t||||||||||2017-02-18 13:50:56.263839|2017-02-18 13:50:56.263839
NCT00768053|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-07-28|2011-03-24||October 2008||2008-10-01|July 2011|2011-07-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|Rainbow||Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients|Open-Label Study To Evaluate The EULAR-RAID Score, Rheumatoid Arthritis Impact Of Disease Score, In Rheumatoid Arthritis Patients Eligible To Etanercept And Who Will Receive Etanercept|Completed||Phase 4|108|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:50:57.940575|2017-02-18 13:50:57.940575
NCT00768040|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2012-02-02|2012-02-02||September 2008||2008-09-01|February 2012|2012-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema|A Randomized, Double-masked, Placebo-controlled, add-on Study to Assess the Efficacy of Oral Aliskiren 300 mg Once Daily for Diabetic Macular Edema|Terminated||Phase 2|39|Actual|Novartis|This study was terminated early due to low recruitment of patients. The study lacked power against the original objective of statistically significance for changes in central retinal thickness due to the much reduced sample size.|2||Inadequate enrollment|f||||f||||||||||2017-02-18 13:50:58.518284|2017-02-18 13:50:58.518284
NCT00768027|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-06-02|||August 2008||2008-08-01|June 2009|2009-06-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Observational|HBOT||Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System|Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System|Suspended||N/A|60|Anticipated|HyperMed|||1|Seeking additional funds|f||||f||||||||||2017-02-18 13:50:58.931868|2017-02-18 13:50:58.931868
NCT00768014|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-05|2008-10-06|||March 2008||2008-03-01|October 2008|2008-10-01|December 2010|Anticipated|2010-12-01|July 2008|Anticipated|2008-07-01||Observational|TENS||fMRI Measurements on Pain Relief Methods in First Stage Labor Pain|fMRI Measurements on the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Acupuncture Points Verses Spontaneous Normal Vaginal Delivery to Relief of Labor Pain|Unknown status|Recruiting|N/A|60|Anticipated|Chang Gung Memorial Hospital|||3||f||||t||||||||||2017-02-18 13:50:59.029752|2017-02-18 13:50:59.029752
NCT00768001|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2012-01-30|||June 2008||2008-06-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Genetic Analysis of Liver Cancer|Genetic Analysis of Liver Cancer|Terminated||N/A|41|Actual|Stanford University|||1|low accrual|f||||||||||Samples With DNA|"~     tumor sample~   "|||2017-02-18 13:50:59.113761|2017-02-18 13:50:59.113761
NCT00767988|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2015-09-11||||||September 2015|2015-09-01||||||||Interventional|||Probiotics in Girls With Spina Bifida|Probiotics Improvement of Gastrointestinal and Genitourinary Health in Girls With Spina Bifida (H-23245)|Withdrawn||Phase 2|0|Actual|Baylor College of Medicine||2||Withdrawn by PI|f||||f||||||||||2017-02-18 13:50:59.184483|2017-02-18 13:50:59.184483
NCT00767975|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-11-25|||January 2008||2008-01-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|LTBI_prison||Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison|Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison|Completed||Phase 3|2384|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:50:59.290835|2017-02-18 13:50:59.290835
NCT00767962|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2015-08-21|||February 2009||2009-02-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Prospective Randomised Study of Efficacy, Safety and Costs of Talc Pleurodesis Under Medical Thoracoscopy and Pleurodesis Under Video-assisted Thoracoscopy Surgery for Recurrent Primary Spontaneous Pneumothorax|A Prospective Randomised Study of Efficacy, Safety and Costs of Talc Pleurodesis Under Medical Thoracoscopy and Pleurodesis Under Video-assisted Thoracoscopy Surgery for Recurrent Primary Spontaneous Pneumothorax|Completed||N/A|62|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 13:50:59.39612|2017-02-18 13:50:59.39612
NCT00767949|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2012-04-13|||October 2008||2008-10-01|April 2012|2012-04-01|August 2012|Anticipated|2012-08-01|July 2010|Actual|2010-07-01||Interventional|||Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration|A Phase 1, Dose-Escalating, Multi-Center, Study of iSONEP (Sonepcizumab [LT1009]) Administered as an Intravitreal Injection to Subjects With Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|Unknown status|Active, not recruiting|Phase 1|15|Actual|Lpath, Inc.||1|||f||||f||||||||||2017-02-18 13:50:59.492662|2017-02-18 13:50:59.492662
NCT00767936|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-06-28|||March 2008||2008-03-01|June 2016|2016-06-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Observational|||Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma|Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma|Terminated||N/A|135|Actual|Stanford University|||1||f||||||||||Samples Without DNA|"~     blood~   "|||2017-02-18 13:50:59.599336|2017-02-18 13:50:59.599336
NCT00767923|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-06-02|||July 2008||2008-07-01|June 2009|2009-06-01|February 2010|Anticipated|2010-02-01|February 2009|Actual|2009-02-01||Observational|LOA||Validation of OxyVu for Assessing Level of Amputation With Comparison to Other Modalities|Clinical Validation of HyperMed OxyVu Tissue Oximeter for Assessing Level of Amputation With Comparison to Other Modalities|Unknown status|Active, not recruiting|N/A|20|Actual|HyperMed|||1||f||||f||||||||||2017-02-18 13:50:59.686928|2017-02-18 13:50:59.686928
NCT00767910|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-01-04|||March 2007||2007-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:50:59.785865|2017-02-18 13:50:59.785865
NCT00767897|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2016-08-18|||November 2011||2011-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients|The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients|Active, not recruiting||N/A|72|Actual|Indiana University|||4||f||||t||||||||||2017-02-18 13:51:00.043561|2017-02-18 13:51:00.043561
NCT00767884|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2014-02-18|||October 2008||2008-10-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|PRP||Effect of Panretinal Photocoagulation on Optic Nerve Head Topography|Effect of Panretinal Photocoagulation on Optic Nerve Head Topography and Nerve Fiber Layer Parameters|Terminated||N/A|9|Actual|University of Nebraska|||1|Low subject recruitment|f||||f||||||||||2017-02-18 13:51:00.158948|2017-02-18 13:51:00.158948
NCT00767871|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2011-07-21|||March 2007||2007-03-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|August 2007|Actual|2007-08-01||Interventional|||Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder|Changes of Cerebral Glucose Metabolism Associated With the Fear Network Activity Before and After 12 Weeks of Escitalpram Treatment in Panic Disorder|Completed||Phase 4|46|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 13:51:00.270829|2017-02-18 13:51:00.270829
NCT00767858|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2017-01-24|||September 24, 2008||2008-09-24|February 24, 2016|2016-02-24|February 24, 2016||2016-02-24|||||Observational|||Cultural Congruence in International Genetics Research|Cultural Congruence in International Genetics Research: Perceptions of Opportunities and Challenges Among Researchers|Terminated||N/A|45|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:51:00.383263|2017-02-18 13:51:00.383263
NCT00767845|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-04|2016-11-07|||June 2006||2006-06-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Symptom Management in African-American Men With Localized Prostate Cancer|PROSTATE CANCER SYMPTOM MANAGEMENT FOR LOW LITERACY MEN|Withdrawn||N/A|0|Actual|Baylor College of Medicine||||No subjects were enrolled here or at UCSF.|f||||f||||||||||2017-02-18 13:51:00.471961|2017-02-18 13:51:00.471961
NCT00761865|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-08-03|2013-12-03||October 2008||2008-10-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Lateral Ankle Sprain Study|Lateral Ankle Sprain Study|Terminated||N/A|34|Actual|University of Rochester||2||low enrollment|f||||f||||||||||2017-02-18 13:53:09.662946|2017-02-18 13:53:09.662946
NCT00767832|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2009-11-06|||August 2008||2008-08-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.|Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.|Completed||N/A|60|Anticipated|Stanford University|||1||f||||||||||None Retained|"~     Venous blood~   "|||2017-02-18 13:51:00.575592|2017-02-18 13:51:00.575592
NCT00767819|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2016-12-30|||March 2008||2008-03-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Treatment of Patients With RAD001 Who Have Progressive Sarcoma|Multicenter, Triple-arm, Single-stage, Phase II Trial to Determine the Preliminary Efficacy and Safety of RAD001 in Patients With Histological Evidence of Progressive or Metastatic Bone or Soft Tissue Sarcomas|Active, not recruiting||Phase 2|71|Actual|Novartis||3|||f||||||||||||||2017-02-18 13:51:00.664244|2017-02-18 13:51:00.664244
NCT00767806|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2010-09-30|2010-06-24||September 2008||2008-09-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study for Patient With Chronic Low Back Pain|Effect of Duloxetine 60 mg Once Daily Versus Placebo in Patients With Chronic Low Back Pain|Completed||Phase 3|401|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:51:00.789629|2017-02-18 13:51:00.789629
NCT00767793|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2015-10-01|||September 2008||2008-09-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650)|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Ascending Dose Study of INS117548 Ophthalmic Solution in Subjects With Bilateral Ocular Hypertension or Early Primary Open Angle Glaucoma|Completed||Phase 1|84|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 13:51:02.463427|2017-02-18 13:51:02.463427
NCT00767780|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-05|||October 2006||2006-10-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||The Effect of a New Biomechanical Device||Completed||N/A|200|Anticipated|Assaf-Harofeh Medical Center|||5||f||||f||||||||||2017-02-18 13:51:02.552657|2017-02-18 13:51:02.552657
NCT00767767|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-01-22|||October 2008||2008-10-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|May 2011|Actual|2011-05-01||Interventional|||The Effect of Intravenous Anesthetics on Fear Learning and Memory|The Effect of Intravenous Anesthetics on Fear Learning and Memory|Unknown status|Active, not recruiting|N/A|90|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 13:51:02.644184|2017-02-18 13:51:02.644184
NCT00767754|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2011-07-21|||January 2007||2007-01-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|June 2007|Actual|2007-06-01||Interventional|||Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder|Phase 4 Study of Panic Disorder That Expresses to Change of Cerebral Glucose Metabolism After 12 Week of Paroxetine Treatment|Completed||Phase 4|37|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 13:51:02.748886|2017-02-18 13:51:02.748886
NCT00767741|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-04|2013-04-03|||November 2010||2010-11-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Evaluation of the Effects of Heating or Massaging or Vibrating at the Vicinity of the Insulin Delivery Site|Evaluation of the Effects of Heating or Massaging or Vibrating at the Vicinity of the Insulin Delivery Site|Completed||N/A|100|Actual|Insuline Medical Ltd.||1|||f||||f||||||||||2017-02-18 13:51:02.844816|2017-02-18 13:51:02.844816
NCT00767728|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2009-12-21|||December 2004||2004-12-01|December 2009|2009-12-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative Colitis|Completed||Phase 3|256|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 13:51:02.943868|2017-02-18 13:51:02.943868
NCT00767715|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||October 2004||2004-10-01|October 2008|2008-10-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Study in the Treatment of Acute Mania|A Randomized Open Label Study on the Efficacy, Tolerability, and Total Costs of Olanzapine Versus Conventional Antipsychotics in the Treatment of Acute Mania in Sweden|Terminated||Phase 4|11|Actual|Eli Lilly and Company||2||Trial discontinued due to low enrollment|f||||f||||||||||2017-02-18 13:51:03.056107|2017-02-18 13:51:03.056107
NCT00767702|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2017-01-24|||September 18, 2008||2008-09-18|August 8, 2012|2012-08-08|August 8, 2012||2012-08-08|||||Observational|||Use of Population Descriptors in Human Genetic Research|Exploring the Use of Population Descriptors in Human Genetic Research|Completed||N/A|18|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:51:03.170974|2017-02-18 13:51:03.170974
NCT00767689|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-08-03|||May 2008||2008-05-01|August 2009|2009-08-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy||Unknown status|Recruiting|N/A|96|Anticipated|John H. Stroger Hospital||2|||f||||f||||||||||2017-02-18 13:51:03.250337|2017-02-18 13:51:03.250337
NCT00767676|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-04|2014-06-26|2013-10-09||October 2008||2008-10-01|June 2014|2014-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Contact Sensitization Potential of 828 Ointment|Evaluation of the Contact Sensitization Potential of 828 Ointment in Normal Healthy Adults|Completed||Phase 1|259|Actual|Healthpoint||1|||f||||f||||||||||2017-02-18 13:51:03.349695|2017-02-18 13:51:03.349695
NCT00767663|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2015-10-29|||October 2008||2008-10-01|October 2015|2015-10-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|P3||Persantin Preceding Elective PCI|Does Pretreatment With Persantin Reduce Periprocedural Troponin-I Release in Patients Undergoing Elective Single Vessel PCI|Completed||Phase 4|30|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 13:51:03.571963|2017-02-18 13:51:03.571963
NCT00767650|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2017-01-24|||September 23, 2008||2008-09-23|June 28, 2011|2011-06-28|June 28, 2011||2011-06-28|||||Observational|||Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia|Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia|Completed||N/A|7|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:51:03.677993|2017-02-18 13:51:03.677993
NCT00767637|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2014-06-19|||June 2005||2005-06-01|June 2014|2014-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone|Open Label, Non-controlled Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone in Patients With Hyperphosphatemia Receiving Dialysis|Completed||Phase 2|14|Actual|Bayer||1|||f||||f||||||||||2017-02-18 13:51:03.75804|2017-02-18 13:51:03.75804
NCT00767624|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-10-10|2016-08-05||December 2008||2008-12-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional||Intent to treat|TRIAD - Treatment of Insomnia and Depression|Improving Depression Outcome by Adding Insomnia Therapy to Antidepressants|Completed||Phase 2/Phase 3|150|Actual|Stanford University|Our results do not inform clinical guidelines for any single antidepressant medication.|2|||f||||t||||||||No||2017-02-18 13:51:03.858905|2017-02-18 13:51:03.858905
NCT00767611|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-04|2012-05-09|||October 2008||2008-10-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|||||Observational|||Molecular Markers of Human Sperm Function|Molecular Markers of Human Sperm Function|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:51:04.413542|2017-02-18 13:51:04.413542
NCT00767598|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2008-10-06|||December 2007||2007-12-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|CYP3APDE5I||The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects|The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors(PDE5I) in Male Subjects|Completed||Phase 1|21|Actual|Inje University||3|||f||||t||||||||||2017-02-18 13:51:04.505242|2017-02-18 13:51:04.505242
NCT00767585|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-07-02|||August 2008||2008-08-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|||||Observational|||An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice|An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice|Completed||N/A|560|Anticipated|AstraZeneca|||8||f||||f||||||||||2017-02-18 13:51:04.615766|2017-02-18 13:51:04.615766
NCT00767572|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-10-11|2012-11-09||August 2008||2008-08-01|October 2013|2013-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Statins and Endothelial Function in Patients With Coarctation of the Aorta|Effects of Statins on Endothelial Function in Patients With Coarctation of the Aorta|Terminated||Phase 4|12|Actual|University of California, San Francisco|All patients were enrolled and completed the study interventions and assessments. Technical problems with measurements may have led to some unreliable data.|2||low enrollment|f||||t||||||||||2017-02-18 13:51:04.716668|2017-02-18 13:51:04.716668
NCT00767559|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-09-23|||November 2008||2008-11-01|September 2011|2011-09-01|October 2012|Anticipated|2012-10-01|October 2011|Anticipated|2011-10-01||Interventional|DVT||Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery|Prophylaxis Against Thromboembolic Disease Following Orthopaedic Surgeries on Extremities|Unknown status|Active, not recruiting|N/A|330|Anticipated|The New England Baptist Hospital||3|||f||||t||||||||||2017-02-18 13:51:04.96842|2017-02-18 13:51:04.96842
NCT00767546|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-05|2008-10-06|||May 2009||2009-05-01|October 2008|2008-10-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients|Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients|Unknown status|Not yet recruiting|Phase 1|40|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-02-18 13:51:05.099049|2017-02-18 13:51:05.099049
NCT00767533|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-07-20|||October 2008||2008-10-01|July 2016|2016-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Immunobiology of Cancer|Immunobiology of Cancer|Terminated||N/A|84|Actual|Stanford University|||1|PI left|f||||t||||||Samples With DNA|"~     peripheral blood mononuclear cells~   "|||2017-02-18 13:51:05.181441|2017-02-18 13:51:05.181441
NCT00767520|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2013-02-22|2012-05-08||February 2009||2009-02-01|July 2012|2012-07-01|December 2012|Actual|2012-12-01|March 2011|Actual|2011-03-01||Interventional|||Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer|A Randomized, Double-Blind, Multi-Center Phase II Trial of Exemestane (AromasinÂ®) Plus Dasatinib Versus Exemestane Plus Placebo in Advanced Estrogen Receptor-Positive Breast Cancer After Disease Progression on a Non-Steroidal Aromatase Inhibitor (NSAI)|Completed||Phase 2|155|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:51:05.276235|2017-02-18 13:51:05.276235
NCT00767507|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2014-02-21|2013-04-23||October 2008||2008-10-01|February 2014|2014-02-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|Bridge|This is the Safety Population: Includs both Stage I and Stage II patients who received any study drug and were classified according to the actual treatment received. Stage I (open-label) patients were analyzed based on the dose they received; Stage II (randomized) patients were analyzed based on the actual treatment, cangrelor or placebo, received.|Maintenance of Platelet Inhibition With Cangrelor|BRIDGE: Maintenance of Platelet inihiBition With cangRelor After dIscontinuation of ThienopyriDines in Patients Undergoing surGEry|Completed||Phase 2|221|Actual|The Medicines Company||2|||f||||t||||||||||2017-02-18 13:51:06.490338|2017-02-18 13:51:06.490338
NCT00767494|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2012-09-18|||October 2008||2008-10-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT||Terminated||Phase 3|17|Actual|Alcon Research||4||Project Cancelled|f||||f||||||||||2017-02-18 13:51:07.370462|2017-02-18 13:51:07.370462
NCT00767481|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2012-07-18|||October 2008||2008-10-01|November 2011|2011-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT||Terminated||Phase 3|6|Actual|Alcon Research||3||Project Cancelled|f||||f||||||||||2017-02-18 13:51:07.471681|2017-02-18 13:51:07.471681
NCT00767468|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-04|2012-05-22|||October 2008||2008-10-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|February 2010|Actual|2010-02-01||Interventional|||Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis|A Phase IB Study of Sorafenib for Patient With Locally Advanced or Metastatic Hepatocellular Carcinoma and Child's B Cirrhosis|Terminated||Phase 1|6|Actual|UNC Lineberger Comprehensive Cancer Center||2||Funding unavailable|f||||t||||||||||2017-02-18 13:51:07.571487|2017-02-18 13:51:07.571487
NCT00767455|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-04|2014-01-29|2013-10-09||October 2008||2008-10-01|January 2014|2014-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Cumulative Irritation Potential of 828 Ointment|Evaluation of the Cumulative Irritation Potential of 828 Ointment in a Population of Normal Healthy Subjects|Completed||Phase 1|59|Actual|Healthpoint||1|||f||||f||||||||||2017-02-18 13:51:07.747283|2017-02-18 13:51:07.747283
NCT00767442|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-12-14|||December 2008||2008-12-01|December 2009|2009-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Least Invasive Nonlinear Light Microscopy|Least Invasive Nonlinear Light Microscopy|Unknown status|Recruiting|N/A|10|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-02-18 13:51:07.991124|2017-02-18 13:51:07.991124
NCT00767416|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-07-18||2016-07-18|October 2008||2008-10-01|July 2016|2016-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|MEDI-559||A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children|A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-559, a Live Attenuated Intranasal Vaccine Against Respiratory Syncytial Virus in Healthy 1 to <24 Month-Old Children|Completed||Phase 1/Phase 2|116|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 13:51:08.187526|2017-02-18 13:51:08.187526
NCT00767403|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2012-04-02|||January 2010||2010-01-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Internet Intervention for Childhood Encopresis|An Internet Intervention for Childhood Constipation and Encopresis|Completed||N/A|290|Actual|University of Virginia||3|||f||||||||||||||2017-02-18 13:51:10.75873|2017-02-18 13:51:10.75873
NCT00767390|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2015-10-12|||October 2008||2008-10-01|October 2015|2015-10-01||||||||Observational|Human Patch||CARTO 3 Human Patch Study|CARTO 3 ACL Patches Effectiveness Over Prolonged Clinical Case|Withdrawn||Phase 1/Phase 2|0|Actual|Biosense Webster, Inc.|||1|The required results were obtained through alternate methodology|f||||f||||||||||2017-02-18 13:51:10.870359|2017-02-18 13:51:10.870359
NCT00767377|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2013-10-12|||May 2007||2007-05-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|July 2012|Actual|2012-07-01||Interventional|||Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC|Phase II Trial of Epirubicin, Oxaliplatin and 5-day 5-fluorouracil in Patients With Advanced and Metastatic Gastric Cancer|Completed||Phase 2|163|Actual|Fudan University||1|||f||||f||||||||||2017-02-18 13:51:10.955212|2017-02-18 13:51:10.955212
NCT00767364|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2014-06-11|2014-03-18||July 2009||2009-07-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|October 2012|Actual|2012-10-01||Interventional|||Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome|Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome: A Pilot Study|Completed||Phase 1|8|Actual|Children's Hospital of Michigan|The small sample size makes generalization of the study data difficult.|2|||f||||t||||||||||2017-02-18 13:51:11.065445|2017-02-18 13:51:11.065445
NCT00767351|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2010-07-22|||October 2008||2008-10-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||Variation in Serum Levels of Metformin in Patients With Reduced Renal Function|Intraindividual Variation of Serum Metformin in a Cohort of Patients With Type 2 DM and Moderately Reduced Renal Function|Completed||N/A|30|Anticipated|Skane University Hospital|||1||f||||f||||||||||2017-02-18 13:51:11.564866|2017-02-18 13:51:11.564866
NCT00767338|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-06-24|2012-12-12||May 2010||2010-05-01|June 2013|2013-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|VIA||Microsurgical Varicocelectomy Versus No Surgery in Men With a Palpable Varicocele and an Abnormal Semen Analysis|A Prospective, Randomized, Study of Microsurgical Varicocelectomy Versus Observation in the Treatment of Male Partners With a Palpable Varicocele and an Abnormal Semen Analysis|Terminated||Phase 3|3|Actual|Yale University||4||"The DSMB recommended stopping the study because of concerns about the dismal recruitment, the~   drain on network resources, and the need for a study redesign."|f||||t||||||||||2017-02-18 13:51:11.648199|2017-02-18 13:51:11.648199
NCT00767325|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2013-06-24|2013-03-13||December 2008||2008-12-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography|Multi-Center, Open Label Study to Assess Early Response to Abatacept With Background Methotrexate Using Power Doppler Ultrasonography in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate|Completed||Phase 3|104|Actual|Bristol-Myers Squibb|Power Doppler ultrasonography values from 1 site (8 participants were excluded due to technical and quality issues with PDUS scoring and compliance issues.)|1|||f||||f||||||||||2017-02-18 13:51:12.33354|2017-02-18 13:51:12.33354
NCT00767312|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2017-01-24|||September 24, 2008||2008-09-24|January 5, 2017|2017-01-05||||||||Observational|||Analysis of HIV-1 Replication During Antiretroviral Therapy|Analysis of HIV-1 Replication During Antiretroviral Therapy|Enrolling by invitation||N/A|43|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:51:12.790479|2017-02-18 13:51:12.790479
NCT00767299|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2015-04-08||2015-04-08|December 2008||2008-12-01|April 2015|2015-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of Arzoxifene to Treat Korean Women With Osteoporosis|Effects of Arzoxifene on Bone Mineral Density in Korean Postmenopausal Women With Osteoporosis|Completed||Phase 2|91|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:51:12.886339|2017-02-18 13:51:12.886339
NCT00767286|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-04|2014-01-27||||||July 2011|2011-07-01|November 2003|Actual|2003-11-01|||||Interventional|||Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer|A PHASE III TRIAL OF THE USE OF LONG TERM TOTAL ANDROGEN SUPPRESSION FOLLOWING NEOADJUVANT HORMONAL CYTOREDUCTION AND RADIOTHERAPY IN LOCALLY ADVANCED CARCINOMA OF THE PROSTATE|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:51:12.98264|2017-02-18 13:51:12.98264
NCT00767273|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2012-06-07|||October 2006||2006-10-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx|Pilot Study to Investigate the Role of Metabolic Imaging in Predicting Tumor Response and Outcome After Therapy for Pancreatic Cancer|Completed||N/A|30|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 13:51:13.094269|2017-02-18 13:51:13.094269
NCT00767260|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2014-09-06|||March 2008||2008-03-01|September 2014|2014-09-01|March 2015|Anticipated|2015-03-01|March 2012|Actual|2012-03-01||Interventional|||Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus|Autologous Bone Marrow Mononuclear Cell Infusion With Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 1/Phase 2|82|Actual|Fuzhou General Hospital||4|||f||||t||||||||||2017-02-18 13:51:13.179562|2017-02-18 13:51:13.179562
NCT00767247|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2010-12-02|||May 2008||2008-05-01|December 2010|2010-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|ATACA||Analysis of Antihypertensive Treatment Efficacy|Analysis of Antihypertensive Treatment Efficacy|Terminated||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:51:13.291145|2017-02-18 13:51:13.291145
NCT00767234|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-07-06|||August 2008||2008-08-01|July 2016|2016-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Permission to Collect Blood Over Time for Research|Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers|Terminated||N/A|104|Actual|Stanford University|||1|Accrual issues - Low Accrual|f||||t||||||Samples Without DNA|"~     blood~   "|||2017-02-18 13:51:13.389451|2017-02-18 13:51:13.389451
NCT00767221|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-05|2009-04-20|||October 2005||2005-10-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study|Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study|Completed||Phase 2|20|Anticipated|Pharmalink AB||1|||f||||f||||||||||2017-02-18 13:51:13.477659|2017-02-18 13:51:13.477659
NCT00767208|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-06|2009-05-19|||January 2005||2005-01-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|May 2006|Actual|2006-05-01||Interventional|||Diabetes and Metabolic Postprandial Responses|Comparison of Postprandial Metabolic Responses Between Type 2 Diabetic and Healthy Overweight Subjects|Completed||N/A|24||Centre de Recherche en Nutrition Humaine Rhone-Alpe||2|||f||||f||||||||||2017-02-18 13:51:13.582015|2017-02-18 13:51:13.582015
NCT00767195|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2010-06-06|||July 2008||2008-07-01|June 2010|2010-06-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Power Spectral Analysis of Breath Sound in Pulmonary Edema|Power Spectral Analysis of Lung Sounds Detected at Bilateral Lung Bases in Patients With Cardiogenic and Non-cardiogenic Pulmonary Edema|Unknown status|Recruiting|N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan|||3||f||||t||||||||||2017-02-18 13:51:13.671841|2017-02-18 13:51:13.671841
NCT00767182|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-03-22|||August 2008||2008-08-01|March 2016|2016-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|VOLUPLA||Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers|Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers - Monocentric Prospective Cohort|Completed||N/A|40|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"~     plasma and serum samples~   "|No||2017-02-18 13:51:13.761454|2017-02-18 13:51:13.761454
NCT00767169|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-12-09|||October 2008||2008-10-01|December 2013|2013-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Bisphosphonate-coated Dental Implants||Completed||Phase 2|16|Actual|University Hospital, Linkoeping||1|||f||||f||||||||||2017-02-18 13:51:14.077977|2017-02-18 13:51:14.077977
NCT00767156|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||October 2008||2008-10-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|November 2008|Anticipated|2008-11-01||Interventional|SBanti-aging||Effects of Oral and Topical Sea Buckthorn Oil Treatments on Skin Aging|Subjective and Instrumental Evaluation of the Effects of Treatments With Two Sea Buckthorn Oil Products on Cutaneous Aging|Unknown status|Not yet recruiting|N/A|60|Anticipated|Institute of Skin and Product Evaluation, Italy||4|||f||||f||||||||||2017-02-18 13:51:14.173721|2017-02-18 13:51:14.173721
NCT00767130|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-03|||January 2007||2007-01-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|SIM||DNA Diagnostic System for Statin Safety and Efficacy|DNA Diagnostic System for Statin Safety and Efficacy|Unknown status|Recruiting|N/A|750|Anticipated|Genomas, Inc|||3||f||||f||||||Samples With DNA|"~     DNA extracted from blood samples~   "|||2017-02-18 13:51:14.283482|2017-02-18 13:51:14.283482
NCT00767117|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-06-08|||September 2008||2008-09-01|May 2010|2010-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.|A Phase I, Open-label, Randomized Cross-over, 2-period, 2-way Interaction Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Subjects.|Completed||Phase 1|16|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:51:14.390354|2017-02-18 13:51:14.390354
NCT00767104|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-14|||October 2008||2008-10-01|October 2008|2008-10-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris|A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris|Unknown status|Recruiting|N/A|40|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 13:51:14.486662|2017-02-18 13:51:14.486662
NCT00767091|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2012-04-23|||March 2009||2009-03-01|March 2009|2009-03-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|CHoPA-I||Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentric Trial|Completed||Phase 3|40|Actual|University Hospital, Lille||2|||f||||f||||||||||2017-02-18 13:51:14.620186|2017-02-18 13:51:14.620186
NCT00767065|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||January 2009||2009-01-01|September 2008|2008-09-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|EXACCT||Early Cardiac Computed Tomography (CT) In Patients Admitted With Acute Chest Pain|The Role of Early X-Ray Cardiac Computed Tomography in Patients Admitted With Acute Chest Pain|Unknown status|Not yet recruiting|N/A|250|Anticipated|Chelsea and Westminster NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:51:14.741905|2017-02-18 13:51:14.741905
NCT00767052|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2009-06-29|||September 2008||2008-09-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|||||Interventional|||Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236|A Randomised Single Centre Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral Multiple Ascending Daily Doses of AZD1236 Tablet by a Single-Blind, Placebo-Controlled, and Single Dose Relative Bioavailability of the Oral Suspension and Oral Tablet Formulations by an Open Cross-Over in Healthy Japanese Men|Completed||Phase 1|48|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 13:51:14.851303|2017-02-18 13:51:14.851303
NCT00767039|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2011-09-28|2011-04-27||January 2005||2005-01-01|October 2008|2008-10-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|CAST||Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants|Phase 4 Study of Curosurf (Poractant) and Survanta (Beractant) Surfactant Treatment in Very Premature Infants With Respiratory Distress Syndrome.|Terminated||Phase 4|52|Actual|Boston Medical Center|The primary limitations are the small number of patients, the high rate of chronic lung disease in the beractant group and the open-label design of the study.|2||Slow recruitment,changes in protocols, larger than anticipated differences|f||||f||||||||||2017-02-18 13:51:14.95171|2017-02-18 13:51:14.95171
NCT00767026|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-06-21|||January 2008||2008-01-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||COPE Intervention for Parents of Children With Epilepsy|COPE Intervention for Parents of Children With Epilepsy|Completed||Phase 1|88|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 13:51:15.601852|2017-02-18 13:51:15.601852
NCT00710736|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-09-28|||June 2008||2008-06-01|September 2012|2012-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer||Completed||Phase 1|29|Actual|Array BioPharma||1|||f||||f||||||||||2017-02-18 14:10:37.272604|2017-02-18 14:10:37.272604
NCT00767013|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-04-16|||May 2007||2007-05-01|April 2013|2013-04-01||||December 2013|Anticipated|2013-12-01||Interventional|||Preoperative Assessment of Aortic Valve Stenosis and Coronary Artery Disease|Preoperative Assessment of Aortic Valve Stenosis and Coronary Artery Disease: Dual-source Computed Tomography Compared With Invasive Coronary Angiography and Transthoracic Echocardiography|Unknown status|Recruiting|N/A|65|Anticipated|Luzerner Kantonsspital||1|||f||||t||||||||||2017-02-18 13:51:15.716516|2017-02-18 13:51:15.716516
NCT00767000|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2015-02-02|2012-06-19||October 2008||2008-10-01|February 2015|2015-02-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)|A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Range Finding Clinical Trial of MK0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin|Terminated||Phase 2|813|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 13:51:15.82927|2017-02-18 13:51:15.82927
NCT00766987|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2017-01-09|||April 2007||2007-04-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|CADRE||Cardiac FDG PET Viability Registry|Ontario Provincial Registry Project for Cardiac Viability Assessment Using FDG PET|Recruiting||N/A|2000|Anticipated|Ottawa Heart Institute Research Corporation|||1||f||||f||||||||No||2017-02-18 13:51:17.17545|2017-02-18 13:51:17.17545
NCT00766974|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||October 2008||2008-10-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Compression Aided Management of Edema in Patients With C3 Venous Disease|Compression Versus Anti-Embolism Stockings in Patients With Leg Edema: Objective Investigation of Interface Compression and Edema Measurements, Clinical Outcomes, and Quality of Life.|Unknown status|Recruiting|Phase 4|40|Anticipated|BSN Medical Inc||2|||f||||f||||||||||2017-02-18 13:51:17.290918|2017-02-18 13:51:17.290918
NCT00766961|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-12-21|||April 2007||2007-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy|Randomized Comparison of Trans-catheter Arterial Embolization (TAE) and Surgery in Patients With Major Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy|Recruiting||N/A|184|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 13:51:17.404319|2017-02-18 13:51:17.404319
NCT00766948|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-11-21|||August 2008||2008-08-01|November 2016|2016-11-01|August 2030|Anticipated|2030-08-01|August 2030|Anticipated|2030-08-01||Observational|||The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry|The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry|Active, not recruiting||N/A|100|Anticipated|Scripps Translational Science Institute|||1||f||||f||||||Samples With DNA|"~     Blood or Saliva~   "|||2017-02-18 13:51:17.537333|2017-02-18 13:51:17.537333
NCT00766935|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-02|||November 2007||2007-11-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Observational|||The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device|The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device|Completed||N/A|30|Actual|ImpediMed Limited|||2||f||||f||||||||||2017-02-18 13:51:17.62781|2017-02-18 13:51:17.62781
NCT00766909|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-11-07|||March 2008||2008-03-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|June 2010|Actual|2010-06-01||Interventional|CSATAC||Diabetogenicity of Cyclosporine and Tacrolimus|Diabetogenicity of Cyclosporine and Tacrolimus|Completed||Phase 4|18|Actual|University of Aarhus||3|||f||||t||||||||||2017-02-18 13:51:17.729859|2017-02-18 13:51:17.729859
NCT00766896|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-06-20|||July 2009||2009-07-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|PLARAS||Platelet Hyperreactivity to Aspirin and Stroke|Platelet Hyperreactivity to Aspirin and Stroke: A Prospective Study With Clinical Outcomes|Completed||Phase 4|203|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 13:51:17.851157|2017-02-18 13:51:17.851157
NCT00766883|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2017-01-24|||September 29, 2008||2008-09-29|May 23, 2016|2016-05-23|December 15, 2010|Actual|2010-12-15|December 15, 2010|Actual|2010-12-15||Interventional|||Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant|A Phase II Clinical Trial to Determine the Effectiveness of Problem Solving Education in Caregivers and Patients During Allogeneic HSCT|Completed||Phase 2|195|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:51:17.973838|2017-02-18 13:51:17.973838
NCT00766870|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2010-09-28|||September 2008||2008-09-01|September 2010|2010-09-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder|A Randomised, Double-blind, Parallel-group, Placebo-controlled, and Active-referenced Study Evaluating the Efficacy and Safety of Three Fixed Dose Regimens of Lu AA34893 in the Treatment of Major Depressive Disorder|Terminated||Phase 2|35|Actual|H. Lundbeck A/S||5||Study was previously paused and is now terminated|f||||f||||||||||2017-02-18 13:51:18.075144|2017-02-18 13:51:18.075144
NCT00766857|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2015-12-08|||May 2009||2009-05-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure|The Effect of Exenatide Compared to Insulin Glargine on Cardiac Function and Metabolism in Type 2 Diabetic Patients With Congestive Heart Failure: a Randomized Comparator-controlled Trial|Completed||Phase 4|27|Actual|VU University Medical Center||2|||f||||f||||||||||2017-02-18 13:51:18.184515|2017-02-18 13:51:18.184515
NCT00766844|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-01-21|||April 2008||2008-04-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|||Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm|Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage Using MTS Trial System 3510|Completed||Phase 1|12|Actual|University of Illinois at Chicago||1|||f||||t||||||||||2017-02-18 13:51:18.290146|2017-02-18 13:51:18.290146
NCT00766831|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-09-13|2013-06-19||October 2008||2008-10-01|September 2013|2013-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain|Hydromorphone OROS in Korean Cancer Patients: Evaluation of Its Clinical Usefulness in Improvement of Sleep Disturbance|Completed||Phase 4|190|Actual|Janssen Korea, Ltd., Korea||1|||f||||t||||||||||2017-02-18 13:51:18.401807|2017-02-18 13:51:18.401807
NCT00766818|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-05-11|||January 2007||2007-01-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet|The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet: A Longitudinal Investigation in the Second and Third Trimesters Including Empiric Dosage Adjustment|Completed||Phase 1|12|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 13:51:18.864463|2017-02-18 13:51:18.864463
NCT00766805|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||October 2002||2002-10-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|Secondary||Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis|Endoscopic Variceal Ligation Plus Propranolol And Isosorbide Mononitrate Versus Endoscopic Variceal Ligation Alone For Secondary Prophylaxis Of Variceal Bleeding: A Randomized Controlled Trial|Completed||N/A|177|Actual|Govind Ballabh Pant Hospital||2|||f||||f||||||||||2017-02-18 13:51:18.955998|2017-02-18 13:51:18.955998
NCT00766792|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-30|||December 2005||2005-12-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard Dialysis|Removal of Uremic Toxins With Nocturnal Dialysis Versus Standard Dialysis|Completed||N/A|15|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:51:19.054945|2017-02-18 13:51:19.054945
NCT00766779|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2015-04-02|||January 2010||2010-01-01|April 2015|2015-04-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||HCT Versus CT in Elderly AML|Randomized Phase III Study Comparing Conventional Chemotherapy to Low Dose Total Body Irradiation-Based Conditioning and HCT From Related and Unrelated Donors as Consolidation Therapy for Older Patients With AML in 1st Complete Remission|Recruiting||Phase 3|231|Anticipated|European Group for Blood and Marrow Transplantation||2|||f||||t||||||||||2017-02-18 13:51:19.150125|2017-02-18 13:51:19.150125
NCT00766766|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-09-05|||September 2002||2002-09-01|September 2013|2013-09-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||Reduction of Environmental Tobacco Smoke (ETS) Exposure In Pediatric Cancer Patients|Reduction of Environmental Tobacco Smoke (ETS) Exposure In Pediatric Cancer Patients|Completed||N/A|166|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-02-18 13:51:19.364764|2017-02-18 13:51:19.364764
NCT00766753|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2013-11-18|||December 2006||2006-12-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|February 2014|Anticipated|2014-02-01||Interventional|||Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas|A Phase I/II Evaluation of Vaccination With Type 1 Dendritic Cells Pulsed With Multiple Peptides in the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 13:51:19.465957|2017-02-18 13:51:19.465957
NCT00766740|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||October 2007||2007-10-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|ATTEMPT||Long Term Clinical Efficacy of Thrombectomy Devices in Acute ST Elevation Myocardial Infarction|Individual-Patient-Data Pooled-Analysis Comparing Long Term Clinical Outcome in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention With or Without Prior Thrombectomy|Completed||Phase 4|2686|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-02-18 13:51:19.577082|2017-02-18 13:51:19.577082
NCT00766727|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2011-07-01|||October 2008||2008-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:51:19.694776|2017-02-18 13:51:19.694776
NCT00766714|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||January 2000||2000-01-01|October 2008|2008-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Efficacy Study of the Embryo Transfer Catheter|The Efficacy of the Embryo Transfer Catheter in IVF and ICSI is Operator-Dependent: a Randomized Clinical Trial|Completed||N/A|1446|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:51:19.739029|2017-02-18 13:51:19.739029
NCT00766701|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||January 2003||2003-01-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Spectroscopic Evaluation of Cervical Neoplasia|Pivotal Study for Assessment of Cervical Neoplasia Using Fluorescence and Reflectance Spectroscopy|Completed||N/A|1599|Actual|Guided Therapeutics|||1||f||||t||||||Samples With DNA|"~     histology slides~   "|||2017-02-18 13:51:19.831595|2017-02-18 13:51:19.831595
NCT00766688|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-04-15||2016-04-15|October 2008||2008-10-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia|A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AVE5530 When Added to Ongoing Stable Statin Therapy at High Doses in Patients With Severe Primary Hypercholesterolemia|Terminated||Phase 3|643|Actual|Sanofi||3||AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy|f||||f||||||||||2017-02-18 13:51:19.928054|2017-02-18 13:51:19.928054
NCT00766675|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-05-29|2013-02-18||October 2008||2008-10-01|May 2013|2013-05-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain|Ultracet (Tramadol HCL [37.5 mg]/Acetaminophen [325 mg]) Combination Tablets in the Treatment of the Pain of Fibromyalgia|Completed||Phase 4|80|Actual|Johnson & Johnson Taiwan Ltd||1|||f||||f||||||||||2017-02-18 13:51:20.11241|2017-02-18 13:51:20.11241
NCT00766662|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||October 2006||2006-10-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Intermittent Preventive Treatment in Infant in Mali||Completed||N/A|||University of Bamako||2|||f||||f||||||||||2017-02-18 13:51:20.759238|2017-02-18 13:51:20.759238
NCT00766649|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2014-04-07|2013-04-15||October 2008||2008-10-01|April 2014|2014-04-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Interventional|SIRGA||Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD|Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral Geographic Atrophy Associated With Age-Related Macular Degeneration|Completed||Phase 1/Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 13:51:20.865463|2017-02-18 13:51:20.865463
NCT00766636|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-04-18|2015-08-19||September 2008||2008-09-01|August 2015|2015-08-01||||November 2012|Actual|2012-11-01||Interventional||One participant in Gemcitabine + Erlotinib with Radiation did not receive any treatment.|Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy|A Randomized Phase II Study of Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy for Patients With Resectable Adenocarcinoma of the Pancreas|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center||2||Slow Accrual|f||||t||||||||||2017-02-18 13:51:21.238646|2017-02-18 13:51:21.238646
NCT00766623|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2009-09-28|||October 2008||2008-10-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|EMPEF||Elucidation and Monitoring Postprandial Endothelial Function|Elucidation and Monitoring Postprandial Endothelial Function|Completed||N/A|20|Anticipated|Wageningen University||6|||f||||f||||||||||2017-02-18 13:51:21.630528|2017-02-18 13:51:21.630528
NCT00766597|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2015-12-28|2015-11-12||August 2009||2009-08-01|December 2015|2015-12-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional||The HIV-1 infected antiretroviral therapy experienced participants With CCR5-tropic virus who started treatment in Step II|Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents|Phase I/II Open-Label Study to Evaluate the PK, Safety, Tolerability and Antiviral Activity of Vicriviroc, a Novel CCR5 Antagonist in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents|Completed||Phase 1/Phase 2|9|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Study was terminated early with Merck's announcement on July 15, 2010 on the discontinuation of the development of Vicriviroc, with 4 participants given study drug and only 1 participant reached Week 24.|1|||f||||||||||||||2017-02-18 13:51:21.748872|2017-02-18 13:51:21.748872
NCT00766584|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-02-19|||January 2003||2003-01-01|February 2016|2016-02-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|SYNAPSE||Autonomic Nervous System Activity, Aging and Sleep Apnea/Hypopnea|Autonomic Nervous System Activity, Aging and Sleep Apnea/Hypopnea in a Prospective Cohort of Subjects Aged 67 Years|Active, not recruiting||N/A|852|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|No||2017-02-18 13:51:22.130159|2017-02-18 13:51:22.130159
NCT00766571|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2017-02-16|||September 29, 2008||2008-09-29|February 15, 2017|2017-02-15||||||||Observational|||Clinical and Genetic Studies of VACTERL Association|Clinical and Genetic Studies of VACTERL Association|Completed||N/A|304|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:51:22.240861|2017-02-18 13:51:22.240861
NCT00766558|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||November 2008||2008-11-01|September 2008|2008-09-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Observational|||The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered Population|Study of the Efficacy of Written Emotional Disclosure on Eating Disorder Pathology|Unknown status|Not yet recruiting|N/A|50|Anticipated|Penn State University|||4||f||||t||||||||||2017-02-18 13:51:22.330839|2017-02-18 13:51:22.330839
NCT00766545|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2009-01-08|||April 1992||1992-04-01|January 2009|2009-01-01|March 1997|Actual|1997-03-01|March 1997|Actual|1997-03-01||Interventional|CSPS||Cilostazol Stroke Prevention Study : A Placebo-Controlled Double-Blind Trial for Secondary Prevention of Cerebral Infarction.|Cilostazol Stroke Prevention Study : A Placebo-Controlled Double-Blind Trial for Secondary Prevention of Cerebral Infarction.|Completed||Phase 3|1095|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-02-18 13:51:22.41352|2017-02-18 13:51:22.41352
NCT00766532|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2012-09-13|2012-07-06||January 2009||2009-01-01|September 2012|2012-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?|Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?|Completed||Phase 4|12|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 13:51:22.500844|2017-02-18 13:51:22.500844
NCT00766519|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-11-18|||February 2009||2009-02-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|EVOLUTION||Effect of Intraoperative Volume Optimization on Outcome After Intrabdominal Surgery|Effect of Intraoperative Volume Optimization on Outcome After Intrabdominal Surgery: a Multicenter, Randomized, Double-blind, Comparative Study|Completed||Phase 4|104|Actual|University Hospital, Lille||2|||f||||f||||||||||2017-02-18 13:51:22.711395|2017-02-18 13:51:22.711395
NCT00766506|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-03-14|2013-01-21||May 2008||2008-05-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic Surgery|Comparison of Ionsys and Routine Care With Morphine IV (Intravenous) PCA in the Management of Early Post-operative Mobilisation, Ability to Mobilise and in Time to Fitness For Discharge|Terminated||Phase 4|108|Actual|Janssen-Cilag Ltd.|Study was temporarily stopped due to an issue with a batch of drug outside the study and later permanently stopped.|2||Product class one recall|f||||f||||||||||2017-02-18 13:51:22.83329|2017-02-18 13:51:22.83329
NCT00766493|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2016-08-22|2012-06-28||January 2009||2009-01-01|August 2016|2016-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|EMBOLDEN||GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)|GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (GORE EMBOLDEN)|Completed||Phase 3|250|Actual|W.L.Gore & Associates||1|||f||||t||||||||||2017-02-18 13:51:23.468965|2017-02-18 13:51:23.468965
NCT00766480|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2013-08-23|||January 2007||2007-01-01|July 2009|2009-07-01||||March 2010|Anticipated|2010-03-01||Interventional|||Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus|An Investigational Study of Chemoradiosensitivity Prediction With Genetic Profiling of Esophageal Biopsy for Squamous Cell Carcinoma of the Esophagus|Unknown status|Recruiting|N/A|160|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:51:24.094977|2017-02-18 13:51:24.094977
NCT00766467|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-06-17|2016-03-04||September 2008||2008-09-01|June 2016|2016-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas|A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment|Completed||Phase 2|81|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 13:51:24.236689|2017-02-18 13:51:24.236689
NCT00766454|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2017-01-17|||November 1998||1998-11-01|October 2015|2015-10-01||||January 2010|Actual|2010-01-01||Observational|||Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer|Metabolic Genotypes and Oncogenic Damage in Breast Cancer|Completed||N/A|1104|Actual|Wake Forest University Health Sciences|||1||f||||t||||||||||2017-02-18 13:51:24.954993|2017-02-18 13:51:24.954993
NCT00766441|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2010-01-11|||August 2008||2008-08-01|October 2008|2008-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan|Sitagliptin Versus Sulphonylurea Based Treatments in Muslim Patients With Type 2 Diabetes During Ramadan|Terminated||Phase 4|22|Actual|University of Manchester||2||inadequate recruitment|f||||t||||||||||2017-02-18 13:51:25.054335|2017-02-18 13:51:25.054335
NCT00766233|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-01-15|||January 2008||2008-01-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|January 2016|Actual|2016-01-01||Interventional|||Optimal Application Dose of Superficial Hyperthermia|Phase III Study for Analysis of the Optimal Application Dose of Superficial Hyperthermia|Active, not recruiting||Phase 3|17|Actual|Universitätsmedizin Mannheim||2|||f||||f||||||||||2017-02-18 13:51:28.104694|2017-02-18 13:51:28.104694
NCT00766415|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2014-01-27|2010-11-30||November 2008||2008-11-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|||||Interventional|Biopsy|One patient randomised to the placebo group voluntarily discontinued from the study after randomisation before receiving any investigational product. This patient is excluded from the analysis.|14729-D9831C00002- 1 Month Biopsy Study|A Double-blind, Placebo-controlled, Randomised, Parallel Group Phase IIa Study to Evaluate the Histological Changes, Cellularity, Clinical Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|52|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 13:51:25.16923|2017-02-18 13:51:25.16923
NCT00766402|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2014-10-14|||October 2008||2008-10-01|October 2014|2014-10-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)|A Study to Evaluate the Clinical Benefits of Tramadol/Acetaminophen (Ultracet®) vs. Diclofenac (Voltaren®) in the Treatment of Pain in Patients With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)|Terminated||Phase 4|8|Actual|Johnson & Johnson Taiwan Ltd||2|||f||||f||||||||||2017-02-18 13:51:25.875381|2017-02-18 13:51:25.875381
NCT00766389|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-03|2008-10-03|||October 2008||2008-10-01|October 2008|2008-10-01|February 2009|Anticipated|2009-02-01|December 2008|Anticipated|2008-12-01||Observational|||Retinal Nerve Fiber Layer Thickness Analysis With Cirrus HD OCT Versus Stratus Optical Coherence Tomography (OCT)|Retinal Nerve Fiber Layer Thickness Analysis With Cirrus HD OCT Versus Stratus OCT|Unknown status|Recruiting|N/A|200|Anticipated|Yonsei University|||2||f||||f||||||||||2017-02-18 13:51:25.980197|2017-02-18 13:51:25.980197
NCT00766376|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-01-06|2010-01-06||July 2007||2007-07-01|January 2010|2010-01-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Safety and Efficacy Evaluation of Erbium Treatment|Safety and Efficacy Evaluation of Fractional Erbium Treatment|Unknown status|Active, not recruiting|N/A|151|Actual|Palomar Medical Technologies, Inc.||1|||f||||f||||||||||2017-02-18 13:51:26.068332|2017-02-18 13:51:26.068332
NCT00766363|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-04-18|2011-06-16||October 2008||2008-10-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Phase 1b Safety Study of Three Different Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo in Patients With Mild to Moderate Probable Alzheimer's Disease|Completed||Phase 1|49|Actual|FORUM Pharmaceuticals Inc||4|||f||||f||||||||||2017-02-18 13:51:26.307095|2017-02-18 13:51:26.307095
NCT00766350|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2014-12-01|||November 2008||2008-11-01|December 2014|2014-12-01|October 2010|Actual|2010-10-01|March 2010|Actual|2010-03-01||Interventional|||Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of Fibromyalgia|A Randomized, Pilot Clinical Trial to Assess the Comparative Efficacy and Tolerability of Quetiapine XR Versus Amitriptyline for the Treatment of Patients With Fibromyalgia|Completed||Phase 4|90|Actual|Universidad de Granada||2|||f||||f||||||||||2017-02-18 13:51:27.190781|2017-02-18 13:51:27.190781
NCT00766337|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2013-01-08|||December 2008||2008-12-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|EMERALD||Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration|A Phase 2, Randomized, Masked, Controlled Clinical Study to Assess the Safety and Efficacy of Lucentis® Plus Sirolimus Versus Lucentis® Plus Placebo in Patients With Sub-Foveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|Terminated||Phase 2|62|Actual|Santen Inc.||3|||f||||f||||||||||2017-02-18 13:51:27.302212|2017-02-18 13:51:27.302212
NCT00766324|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2014-05-13||2014-05-13|September 2007||2007-09-01|May 2014|2014-05-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||PHA-739358 for Treatment of Hormone Refractory Prostate Cancer|A Phase II Study of PHA-739358 in Patients With Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|118|Actual|Nerviano Medical Sciences||2|||f||||f||||||||||2017-02-18 13:51:27.404659|2017-02-18 13:51:27.404659
NCT00766311|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-01-05|||January 2008||2008-01-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|XRCISL||Aerobic and Strengthening Exercise for Acute Leukemia|Aerobic and Strengthening Exercise for Acute Leukemia|Completed||N/A|20|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 13:51:27.505795|2017-02-18 13:51:27.505795
NCT00766298|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2009-03-25|||June 2004||2004-06-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|SHELL||Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight Loss|Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight Loss|Unknown status|Active, not recruiting|N/A|102|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 13:51:27.613074|2017-02-18 13:51:27.613074
NCT00766285|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2015-07-30||||||December 2009|2009-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||High Dose Influenza in Immunosuppressed Subjects|Safety and Immunogenicity of High Dose Baculovirus-Expressed Recombinant Trivalent HA Influenza Vaccine in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: Phase II Double-Blind Trial|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 13:51:27.716752|2017-02-18 13:51:27.716752
NCT00766272|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-09-19|||June 2008||2008-06-01|September 2013|2013-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Lokomat Training Effects on MS Gait Abnormalities|Gait Rehabilitation for Multiple Sclerosis Using Robot-assisted Body-weight-supported Treadmill Training (Lokomat)|Terminated||Phase 1/Phase 2|20|Actual|VA Office of Research and Development||1||Study re-designed|f||||f||||||||||2017-02-18 13:51:27.815993|2017-02-18 13:51:27.815993
NCT00766259|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-02|||July 2009||2009-07-01|October 2008|2008-10-01|June 2012|Anticipated|2012-06-01|June 2011|Anticipated|2011-06-01||Observational|||Relationship of Staphylococcal Colonization to Infection|Relationship of Staphylococcal Colonization to Infection|Unknown status|Not yet recruiting|N/A|4400|Anticipated|Veterans BioMedical Research Institute|||6||f||||f||||||None Retained|"~     only bacterial strains collected~   "|||2017-02-18 13:51:27.908516|2017-02-18 13:51:27.908516
NCT00766246|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-04-18|||October 2008||2008-10-01|April 2016|2016-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase II Avastin Trial for Stage IIIB/IV NSCLC|A Multicenter, Open-Label, Randomized, Phase II Trial of Docetaxel, Carboplatin and Bevacizumab as First-Line Treatment, Followed by Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Second-Line Treatment of Stage IIIB or IV Non-Small Cell Lung Cancer|Terminated||Phase 2|125|Actual|Pharmatech||2||Withdrawal of funding support|f||||t||||||||Yes||2017-02-18 13:51:27.988651|2017-02-18 13:51:27.988651
NCT00766220|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-12-28|||October 2009||2009-10-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver|Phase II Randomized Study of SIR-Spheres, Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Metastases to the Liver|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||2||Slow Accrual and withdrawn/exclusion of 2 participants.|f||||t||||||||||2017-02-18 13:51:28.207824|2017-02-18 13:51:28.207824
NCT00766207|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2011-05-11|||October 2008||2008-10-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|April 2010|Actual|2010-04-01||Interventional|PREVENT||Electronic Notification of Teratogenic Risks|Preconception Risk Evaluation Via Electronic Medical Record Notification of Teratogenic Risks|Completed||N/A|2593|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:51:30.686732|2017-02-18 13:51:30.686732
NCT00766194|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2013-09-10|||May 2007||2007-05-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Nasopharyngeal Pressure Measurement During Neonatal Nasal Respiratory Support|Nasopharyngeal Pressure Measurement During Neonatal Nasal Respiratory Support|Terminated||N/A|20|Actual|University of Utah|||1|slow enrollment|f||||f||||||||||2017-02-18 13:51:30.813446|2017-02-18 13:51:30.813446
NCT00766181|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2010-05-24|||October 2008||2008-10-01|November 2008|2008-11-01|April 2009|Anticipated|2009-04-01|February 2009|Anticipated|2009-02-01||Observational|||Satisfaction With Pediatric Intravenous Catheter Placement in the Emergency Department|An Evaluation of Parent and Nurse Satisfaction Associated With Pediatric Peripheral Intravenous Catheter Placement Using Standard of Care vs. ZingoTM in the Emergency Department|Terminated||N/A|200|Anticipated|Anesiva, Inc.|||2|Product withdrawn from distribution|f||||f||||||||||2017-02-18 13:51:30.88795|2017-02-18 13:51:30.88795
NCT00766168|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-06-12|||January 2008||2008-01-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|PVS-07-07||High Refractive Index Material 510(k)|Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.|Completed||N/A|76|Actual|Paragon Vision Sciences||2|||f||||f||||||||||2017-02-18 13:51:30.984919|2017-02-18 13:51:30.984919
NCT00766155|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-10-11|||August 2008||2008-08-01|October 2016|2016-10-01||||September 2011|Actual|2011-09-01||Interventional|PETACC-6||Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer|Preoperative Chemoradiotherapy and Postoperative Chemotherapy With Capecitabine and Oxaplatin vs.Capecitabine Alone in Locally Advanced Rectal Cancer (PETACC-6)|Completed||Phase 3|1094|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 13:51:31.095014|2017-02-18 13:51:31.095014
NCT00766142|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2009-07-07|||May 2007||2007-05-01|July 2009|2009-07-01||||December 2009|Anticipated|2009-12-01||Interventional|||Combination Chemotherapy and Cetuximab in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer|Clinical Phase II Study Evaluating Systemic Chemotherapy in Combination With Cetuximab as Adjuvant Treatment in Patients With Completely Surgically Resected Peritoneal Carcinomatosis of Colorectal Origin|Unknown status|Recruiting|Phase 2|46|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:51:31.199826|2017-02-18 13:51:31.199826
NCT00766129|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2011-07-04|||February 2008||2008-02-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|April 2011|Actual|2011-04-01||Interventional|||Comparison of Safety and Efficacy of Two Different Drug Eluting Stents Implanted Into Saphenous Vein Grafts|Comparison of Safety and Efficacy of Drug Eluting Stents : TAXUS (Boston Scientific) vs. LUC-Chopin (Balton, Poland) Implanted Into Saphenous Vein Grafts. Study With Serial Intravascular Ultrasounds.|Unknown status|Active, not recruiting|Phase 3|50|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||f||||||||||2017-02-18 13:51:31.292717|2017-02-18 13:51:31.292717
NCT00766116|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-10-25|||July 2005||2005-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2015|Actual|2015-06-01||Interventional|||Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)|A Phase I/II Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed AML|Active, not recruiting||Phase 1/Phase 2|50|Actual|University of California, San Diego||1|||f||||t||||||||||2017-02-18 13:51:31.382965|2017-02-18 13:51:31.382965
NCT00766103|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-10-19|||December 2006||2006-12-01|October 2016|2016-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.|The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.|Completed||N/A|8|Actual|Tampere University Hospital||1|||f||||||||||||||2017-02-18 13:51:31.509108|2017-02-18 13:51:31.509108
NCT00766090|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-10-26|2013-06-06||October 2008||2008-10-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma|A Multi-Centre, Randomized, Double Blind Cross-over Study to Assess the Non-inferiority of GW685698X 200mcg Once Daily and 100mcg Twice Daily in Adult and Adolescent Patients With Asthma|Completed||Phase 2|190|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:51:31.614033|2017-02-18 13:51:31.614033
NCT00766077|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2010-04-12|||September 2008||2008-09-01|April 2010|2010-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Bone Geometry, Strength, and Biomechanical Changes in Runners With a History of Stress Fractures|Bone Geometry, Strength, and Biomechanical Changes in Runners With a History of Stress Fractures|Completed||N/A|32|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 13:51:32.778396|2017-02-18 13:51:32.778396
NCT00766064|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-08-22|||September 2008||2008-09-01|August 2016|2016-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)|Effects of Paliperidone in Posttraumatic Stress Disorder (PTSD)|Withdrawn||Phase 4|0|Actual|Yale University||1|||f||||f||||||||||2017-02-18 13:51:32.855718|2017-02-18 13:51:32.855718
NCT00765869|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2008-10-02|||July 2008||2008-07-01|October 2008|2008-10-01|February 2009|Anticipated|2009-02-01|December 2008|Anticipated|2008-12-01||Interventional|||Randomised Controlled Trial of a Literacy Sensitive Decision Aid for Bowel Cancer Screening|A Randomised Controlled Trial of a Bowel Cancer Screening Decision Aid for Adults With Low Education and Literacy|Unknown status|Recruiting|N/A|555|Anticipated|University of Sydney||3|||f||||f||||||||||2017-02-18 13:51:37.227727|2017-02-18 13:51:37.227727
NCT00766051|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2016-11-14|2011-04-04||November 2007||2007-11-01|November 2016|2016-11-01|March 2010|Actual|2010-03-01|June 2008|Actual|2008-06-01||Interventional|NBOTI||A Study of Neurophysiologically Based Occupational Therapy Intervention (NBOTI) for Feeding in the NCCU.|The Efficacy of Neurophysiologically Based Occupational Therapy Intervention in the Neonatal Intensive Care Unit: An Exploratory Study|Completed||N/A|10|Actual|University of Utah|The limitation of this study is that the effectiveness of the neurophysiologically based occupational therapy intervention applies to the diagnostic groups of the infants that participated in this study.|2|||f||||f||||||||||2017-02-18 13:51:32.956264|2017-02-18 13:51:32.956264
NCT00766038|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-12-31|||September 2008||2008-09-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|Growth-TBI||Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.|A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.|Completed||Phase 2|63|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 13:51:33.393887|2017-02-18 13:51:33.393887
NCT00766025|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2009-02-27|||September 2008||2008-09-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|||||Interventional|||Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving Rosuvastatin|A Phase I, Open Label, Parallel Group, Single and Multiple Dose Study in Taiwanese Subjects Identified as CYP2C19 Poor Metabolizers or Extensive Metabolizers Receiving 20 Milligrams of Rosuvastatin Calcium|Completed||Phase 1|50|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:51:33.517258|2017-02-18 13:51:33.517258
NCT00766012|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2009-08-24|||September 2008||2008-09-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|||||Interventional|||Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects|A Phase I, Single-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Oral Doses of AZD2066 in Japanese Healthy Male Subjects|Completed||Phase 1|132|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:51:33.834677|2017-02-18 13:51:33.834677
NCT00765999|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2013-01-11|||October 2008||2008-10-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation|An Open-Label, Long-Term Safety Study of Oral Linaclotide Administered to Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation|Completed||Phase 3|1557|Actual|Forest Laboratories||1|||f||||f||||||||||2017-02-18 13:51:33.950009|2017-02-18 13:51:33.950009
NCT00765986|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2014-10-02|||October 2008||2008-10-01|October 2014|2014-10-01|October 2015|Anticipated|2015-10-01|September 2015|Anticipated|2015-09-01||Observational|||Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy|A Study to See if a New Type of Imaging Can Help Our Understanding of the Course of Non-small Cell Lung Cancer in Patients Undergoing Treatment With Radiotherapy or Chemoradiotherapy|Unknown status|Recruiting|N/A|30|Anticipated|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 13:51:34.166888|2017-02-18 13:51:34.166888
NCT00765973|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2015-06-02|||September 2008||2008-09-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors|A Phase 1 Study of Topotecan Liposomes Injection (TLI) in Subjects With Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors|Active, not recruiting||Phase 1|50|Anticipated|Spectrum Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 13:51:34.283414|2017-02-18 13:51:34.283414
NCT00765960|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2011-08-11|||September 2008||2008-09-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Observational|iLASIK||Evaluation of Outcomes Using the Amo Advanced CustomVue Ilasik Procedure|Evaluation of Outcomes Using the Amo Advanced CustomVue Ilasik Procedure|Terminated||N/A|0|Actual|Medical University of South Carolina|||1|Prinicipal Investigator separating employment from University.|f||||f||||||||||2017-02-18 13:51:34.39201|2017-02-18 13:51:34.39201
NCT00765947|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2011-03-08|2010-12-13||September 2008||2008-09-01|March 2011|2011-03-01|August 2009||2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension|A Twenty-four Week, Open-label, Non-comparative, Multi-center Study to Assess the Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension.|Completed||Phase 4|256|Actual|Novartis||1|||f||||f||||||||||2017-02-18 13:51:34.483363|2017-02-18 13:51:34.483363
NCT00765934|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2010-05-17|||November 2009||2009-11-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Influence of Rapydan on Clinical Chemistry and Hematology Measurements|Does Rapydan Influence Routine Clinical Chemistry and Hematology Measurements?|Completed||N/A|25|Anticipated|LabNoord||1|||f||||t||||||||||2017-02-18 13:51:34.759194|2017-02-18 13:51:34.759194
NCT00765921|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-12-01|||June 2008||2008-06-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|February 2016|Actual|2016-02-01||Interventional|||Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma|A Phase I Single Center Study of Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma|Completed||Phase 1|40|Actual|Massachusetts Eye and Ear Infirmary||2|||f||||f||||||||No||2017-02-18 13:51:34.871981|2017-02-18 13:51:34.871981
NCT00765908|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2008-10-02|||October 2008||2008-10-01|August 2008|2008-08-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Ischaemic Pre-Conditioning in Elective Percutaneous Coronary Intervention (PCI) Patients|Ischaemic Pre-Conditioning in Elective PCI Patients - Attenuation of Subsequent Ischaemia in a Validated Animal Model|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 13:51:34.981198|2017-02-18 13:51:34.981198
NCT00765895|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2015-04-15|2014-04-09||January 2009||2009-01-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|NORIG||Nortriptyline for Idiopathic Gastroparesis|Nortriptyline for Idiopathic Gastroparesis: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial (NORIG)|Completed||Phase 3|130|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 13:51:35.077515|2017-02-18 13:51:35.077515
NCT00765882|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-12-19|2012-09-28||September 2008||2008-09-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks in Patients With Chronic Constipation|Completed||Phase 3|633|Actual|Forest Laboratories||3|||f||||||||||||||2017-02-18 13:51:36.405097|2017-02-18 13:51:36.405097
NCT00765856|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2015-06-10|||October 2008||2008-10-01|June 2015|2015-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects|An Open-Label Safety and Tolerability Study of Immediate-Release and Extended-Release Oxymorphone in Opioid-Tolerant Pediatric Subjects With Chronic Pain.|Terminated||Phase 3|27|Actual|Endo Pharmaceuticals||1||Terminated new protocol developed which incorporated Pharmacokinetics|f||||f||||||||||2017-02-18 13:51:37.352251|2017-02-18 13:51:37.352251
NCT00765843|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2014-06-19|2014-04-28||October 2008||2008-10-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain|A Randomized Controlled Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain|Completed||N/A|77|Actual|Rosalind Franklin University of Medicine and Science||3|||f||||f||||||||||2017-02-18 13:51:37.482042|2017-02-18 13:51:37.482042
NCT00765830|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-01-02||2013-01-02|September 2008||2008-09-01|January 2013|2013-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)|A 28 Week Extension to a 24 Week Multi-center, Randomized, Double-blind Clinical Trial to Evaluate the Safety and Tolerability of Vildagliptin (50 mg qd) Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency|Completed||Phase 3|349|Actual|Novartis||2|||f||||t||||||||||2017-02-18 13:51:37.918456|2017-02-18 13:51:37.918456
NCT00765817|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-10-21|2011-01-04||October 2008||2008-10-01|October 2016|2016-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||One subject per group withdrew from the study prior to the first dose of study medication and therefore are not part of the baseline or subsequent analysis.|Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus|A Randomized Trial Comparing Exenatide With Placebo in Subjects With Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemic Medications|Completed||Phase 3|261|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:51:38.097424|2017-02-18 13:51:38.097424
NCT00765804|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2010-08-27||2010-08-20|October 2008||2008-10-01|August 2010|2010-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye|Evaluation of Dexamethasone Phosphate Delivered by Ocular Iontophoresis for Treatment of Dry Eye in the Controlled Adverse Environment Model|Completed||Phase 2|89|Actual|Eyegate Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 13:51:39.198374|2017-02-18 13:51:39.198374
NCT00765791|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-12-17|||December 2008||2008-12-01|December 2013|2013-12-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|2B/Not 2B||Shoulder Function After Level IIB Neck Dissection: A Randomized Controlled Study|Shoulder Function After Level IIB Neck Dissection: A Randomized Controlled|Unknown status|Enrolling by invitation|Early Phase 1|32|Anticipated|University of Alberta||2|||f||||t||||||||||2017-02-18 13:51:39.328204|2017-02-18 13:51:39.328204
NCT00765778|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-15|||October 2008||2008-10-01|October 2008|2008-10-01|January 2014|Anticipated|2014-01-01|October 2009|Anticipated|2009-10-01||Observational|||Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community|Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community:the Role of Family Members and Caregivers in Dissemination of MDR in Rehabilitation Centers|Unknown status|Not yet recruiting|N/A|400|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-02-18 13:51:39.437566|2017-02-18 13:51:39.437566
NCT00765765|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-11-06|2013-11-06||February 2009||2009-02-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer|Phase I/II Study of Ixabepilone in Combination With the Autophagy Inhibitor Hydroxychloroquine for the Treatment of Patients With Metastatic Breast Cancer|Terminated||Phase 1/Phase 2|6|Actual|Rutgers, The State University of New Jersey||1||Slow accrual|f||||f||||||||||2017-02-18 13:51:39.539732|2017-02-18 13:51:39.539732
NCT00765752|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2013-01-18|||November 2007||2007-11-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Cortical GABA Concentrations in Insomnia|The Association of Cortical GABA Concentrations in Subjects With Primary Insomnia and Depression in Partial Remission With Residual Insomnia|Completed||N/A|23|Actual|Yale University|||2||f||||f||||||||||2017-02-18 13:51:39.850456|2017-02-18 13:51:39.850456
NCT00765739|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-01-23|||October 2008||2008-10-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|NMES||The Effect of Neuromuscular Electrical Stimulation (NMES)|The Effect of Neuromuscular Electrical Stimulation (NMES) in Inducing Muscle Hypertrophy and Improvement in Muscle Torque Output Within the Quadriceps Muscle of Elderly People|Completed||Phase 2|23|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 13:51:39.947227|2017-02-18 13:51:39.947227
NCT00765726|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2011-12-16|2011-12-16||February 2009||2009-02-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Study Evaluating The Safety Of Xyntha In Usual Care Settings|A Postauthorization Safety Surveillance Study Of Xyntha In Usual Care Settings|Terminated||Phase 4|12|Actual|Pfizer|The study was discontinued because the sponsor had ongoing studies collecting similar safety data.|1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:51:40.050413|2017-02-18 13:51:40.050413
NCT00765713|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-04-01|||October 2008||2008-10-01|September 2008|2008-09-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|SAHS-ICD||Sleep Apnea-hypopnea Syndrome (SAHS) and Ventricular Arrhythmias|Sleep Apnea-hypopnea Syndrome and Ventricular Arrhythmias in Patients With Systolic Ventricular Dysfunction and Implantable Cardioverter-defibrillator. Incidence and Effect of CPAP Treatment|Completed||Phase 4|224|Actual|Hospital Universitario La Paz||2|||f||||f||||||||||2017-02-18 13:51:40.306164|2017-02-18 13:51:40.306164
NCT00765700|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2013-09-20||2013-09-17|September 2008||2008-09-01|September 2013|2013-09-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study to Assess the Efficacy and Safety of Ketotransdel™ (Ketoprofen Topical Cream 10%) in the Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury.|Completed||Phase 3|364|Actual|Imprimis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 13:51:40.413218|2017-02-18 13:51:40.413218
NCT00764348|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-09-06||||||September 2011|2011-09-01||||||||Observational|||Evaluation of Wound Biofilm in Acute and Chronic Wounds|Evaluation of Wound Biofilm in Acute and Chronic Wounds|Withdrawn||N/A|0|Actual|Southwest Regional Wound Care Center|||1|withdrawn as MSU approval obained|f||||f||||||Samples With DNA|"~     traumatic, diabetic foot ulcer, decubitus ulcer, venous leg ulcer~   "|||2017-02-18 13:52:13.822488|2017-02-18 13:52:13.822488
NCT00765687|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2013-12-08|||August 2008||2008-08-01|December 2011|2011-12-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|BLEST||Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates|A Multi-center Observational Clinical Study of Screening of Non-small-cell Lung Cancer With Bone Metastasis and Efficacy and Safety of Those Receiving Bisphosphonates|Completed||Phase 4|432|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-02-18 13:51:40.530188|2017-02-18 13:51:40.530188
NCT00765674|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2011-04-15|2011-01-12||September 2008||2008-09-01|April 2011|2011-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension|An 8 Week, Double-blind, Randomized, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate to Severe Hypertension|Completed||Phase 3|1191|Actual|Novartis||4|||f||||f||||||||||2017-02-18 13:51:40.635113|2017-02-18 13:51:40.635113
NCT00765661|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2015-05-18|2014-07-09||September 2008||2008-09-01|May 2015|2015-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients|A Phase 2, Open-Label, Multi-Center, Randomized Trial To Demonstrate The Pharmacokinetics Of LCP-Tacro™ Tablets Once Daily and Prograf® Capsules Twice Daily In Adult De Novo Kidney Transplant Patients|Completed||Phase 2|63|Actual|Veloxis Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:51:41.279402|2017-02-18 13:51:41.279402
NCT00765648|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2014-12-11|2011-07-18||October 2008||2008-10-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|CLUE||Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department|A Phase IV, Randomized Trial to Determine the Efficacy and Safety of Cardene Intravenous (I.V.) Versus Labetalol for Management of Hypertensive Emergencies in the Emergency Department Setting|Completed||Phase 4|226|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 13:51:42.031941|2017-02-18 13:51:42.031941
NCT00765635|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-02|||September 2008||2008-09-01|October 2008|2008-10-01||||October 2008|Actual|2008-10-01||Interventional|||Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal|Randomized, Placebo-Controlled Evaluation of Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal|Completed||Phase 4|90|Actual|Hospital Clinic of Barcelona||3|||f||||t||||||||||2017-02-18 13:51:42.67411|2017-02-18 13:51:42.67411
NCT00765622|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-02|||April 2007||2007-04-01|August 2008|2008-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Assessment of Pelvic Floor Function in Elderly|Assessment of Pelvic Floor Function in Women With Urinary Incontinence|Completed||N/A|153|Actual|Catholic University of Brasília|||2||f||||t||||||Samples Without DNA|"~     Women~   "|||2017-02-18 13:51:42.7853|2017-02-18 13:51:42.7853
NCT00765609|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-02|||December 2008||2008-12-01|September 2008|2008-09-01|March 2009|Anticipated|2009-03-01|February 2009|Anticipated|2009-02-01||Observational|||To Evaluate the Paediatric Analgesia Slide|To Evaluate the Paediatric Analgesia Slide, a New Device Developed to Assist Parents in Administering Paracetamol to Children at Home|Unknown status|Not yet recruiting|N/A|140|Anticipated|County Durham and Darlington NHS Foundation Trust|||2||f||||f||||||||||2017-02-18 13:51:42.881663|2017-02-18 13:51:42.881663
NCT00765596|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2011-11-15|||January 2005||2005-01-01|November 2011|2011-11-01||||December 2006|Actual|2006-12-01||Observational|||Ghrelin Changes After Roux-en-Y Gastric Bypass|Ghrelin Changes After Roux-en-Y Gastric Bypass: Does Gastric Pouch vs. Gastric Remnant Feeding Affect Secretion?|Completed||N/A|14|Actual|Vanderbilt University|||2||f||||f||||||Samples With DNA|"~     plasma, tissues~   "|||2017-02-18 13:51:42.984814|2017-02-18 13:51:42.984814
NCT00765583|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2011-09-20|||November 2005||2005-11-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Determine How Long Restylane® Will Last After Initial Treatment With 2 Different Re-treatment Schedules.|A Randomized, Evaluator-Blind, Multi-Center, Comparison of the Efficacy and Persistence of Correction of Nasolabial Folds With Restylane® Using Two Different Re-Treatment Schedules|Completed||Phase 4|75|Actual|Medicis Aesthetics, Inc.||1|||f||||f||||||||||2017-02-18 13:51:43.094503|2017-02-18 13:51:43.094503
NCT00765570|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2015-04-29|2015-02-16||February 2003||2003-02-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy|Treatment of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy A Phase II Randomized Trial|Terminated||Phase 2|12|Actual|Summa Health System||2||Accrual too slow - would not enroll enough subjects to determine outcome|f||||f||||||||||2017-02-18 13:51:43.206348|2017-02-18 13:51:43.206348
NCT00765557|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-10-02||||||October 2008|2008-10-01||||||||Expanded Access|||Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome|Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome|Available||N/A|||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 13:51:43.619228|2017-02-18 13:51:43.619228
NCT00765544|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-09-19|||September 2008||2008-09-01|September 2013|2013-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Targeted Lower Extremity Joint Training|Robot-assisted Ankle Rehabilitation for Multiple Sclerosis (Anklebot)|Terminated||Phase 1/Phase 2|10|Actual|VA Office of Research and Development||3||Study re-design|f||||t||||||||||2017-02-18 13:51:43.714198|2017-02-18 13:51:43.714198
NCT00765531|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-10-30||||||October 2008|2008-10-01||||||||Expanded Access|||Hypercalciuria and Calcium Stone Disease in Caucasian Patients|Hypercalciuria and Calcium Stone Disease in Caucasian Patients|Available||N/A|||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 13:51:43.824923|2017-02-18 13:51:43.824923
NCT00765518|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-06-29||2016-06-23|September 2008||2008-09-01|June 2016|2016-06-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Interventional|||Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)|Intramyocardial Delivery of Autologous Bone Marrow Cells in Patients With Heart Failure Due to Dilated Cardiomyopathy|Completed||Phase 2|40|Actual|Vericel Corporation||2|||f||||t||||||||||2017-02-18 13:51:43.899392|2017-02-18 13:51:43.899392
NCT00765505|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2016-10-24|||July 2004||2004-07-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|MIRA||Muscle Lipid and Insulin Resistance in the Elderly|Muscle Lipid and Insulin Resistance in the Elderly|Active, not recruiting||N/A|300|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:51:44.012269|2017-02-18 13:51:44.012269
NCT00456456|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03|||October 2006||2006-10-01|April 2007|2007-04-01||||||||Observational|||The Daily Habits Survey|The Daily Habits Survey|Unknown status|Recruiting|N/A|300||American University|||||f||||||||||||||2017-02-18 15:43:24.948895|2017-02-18 15:43:24.948895
NCT00765492|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2009-06-25|||October 2008||2008-10-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|||||Interventional|||AZD8529 Multiple Ascending Dose Study in Healthy Subjects|A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8529 When Given as Single and Multiple Ascending Oral Doses in Healthy Subjects|Completed||Phase 1|47|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:51:44.115037|2017-02-18 13:51:44.115037
NCT00765479|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2013-09-19|||December 2006||2006-12-01|August 2009|2009-08-01|July 2013|Actual|2013-07-01|September 2011|Actual|2011-09-01||Interventional|||Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer|Randomized Placebo-Controlled Adjuvant Study of Prevention of Prostate Cancer Recurrence After Radical Prostatectomy by Soy Protein Isolate|Completed||Phase 2/Phase 3|284|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:51:44.203595|2017-02-18 13:51:44.203595
NCT00765466|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2008-10-21|||October 2007||2007-10-01|September 2008|2008-09-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||A Phase II Open Label, Multi-Center Study With AVR118 in Anorectic Patients With Recurrent or Advanced Malignancies|A Phase II Open Label, Multi-Center Study With AVR118 in Anorectic Patients With Recurrent or Advanced Malignancies|Unknown status|Recruiting|Phase 2|30|Anticipated|McGill University||1|||f||||t||||||||||2017-02-18 13:51:44.31582|2017-02-18 13:51:44.31582
NCT00765453|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2015-08-06|||March 2008||2008-03-01|August 2015|2015-08-01|March 2018|Anticipated|2018-03-01|March 2014|Actual|2014-03-01||Interventional|REGEN-AMI||Bone Marrow Derived Adult Stem Cells for Acute Anterior Myocardial Infarction|Randomised Controlled Clinical Trial of the Use of Autologous Bone Marrow Derived Progenitor Cells to Salvage Myocardium in Patients With Acute Anterior Myocardial Infarction|Active, not recruiting||Phase 2|100|Anticipated|Barts & The London NHS Trust||2|||f||||t||||||||||2017-02-18 13:51:44.402679|2017-02-18 13:51:44.402679
NCT00765440|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2015-02-08|||July 2007||2007-07-01|February 2015|2015-02-01|April 2011|Actual|2011-04-01|July 2009|Actual|2009-07-01||Interventional|||Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract|Role of Peri-operative Immunonutrition in Cancers of the Higher Aero-digestive Tract|Completed||Phase 3|311|Actual|Centre Antoine Lacassagne||3|||f||||f||||||||||2017-02-18 13:51:44.516038|2017-02-18 13:51:44.516038
NCT00765427|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2009-03-27|||September 2008||2008-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers|A Phase 1a, Repeat-Dose Escalation Study to Investigate the Safety and Tolerability of a 7-Day Repeated Dose of Retinoid QLT091001 in Healthy Volunteers|Completed||Phase 1|18|Anticipated|QLT Inc.||1|||f||||t||||||||||2017-02-18 13:51:44.628046|2017-02-18 13:51:44.628046
NCT00765414|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-02|2014-02-04|||April 2003||2003-04-01|February 2014|2014-02-01|August 2006|Actual|2006-08-01|April 2006|Actual|2006-04-01||Interventional|||Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.|An Open-Label Extension Study of the Long-Term Safety and Efficacy of Recombinant Human Acid α-Glucosidase (rhGAA) Given as Enyzme Replacement Therapy to a Single Patient With Pompe Disease (Glycogen Storage Disease Type II) Who Were Previously Enrolled in Genzyme-Sponsored Enzyme Replacement Therapy Studies|Completed||Phase 2|1|Actual|Sanofi||1|||f||||t||||||||||2017-02-18 13:51:44.710716|2017-02-18 13:51:44.710716
NCT00765401|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-09-30|||November 2008||2008-11-01|September 2008|2008-09-01||||||||Observational|||An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients|An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients|Unknown status|Not yet recruiting|N/A|42|Anticipated|Penn State University|||4||f||||f||||||||||2017-02-18 13:51:44.816291|2017-02-18 13:51:44.816291
NCT00765388|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2014-01-27|2011-09-19||October 2008||2008-10-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|DK188OS||A Randomised Cross-over Study With Two 1-piece Urostomy Bags.|A Comparative, Randomised, Crossover Study With 2 Urostomy Bags Among 30 Urostomy-operated Persons in UK|Completed||Phase 4|27|Actual|Coloplast A/S||2|||f||||f||||||||||2017-02-18 13:51:44.915988|2017-02-18 13:51:44.915988
NCT00765375|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-04-28|2012-08-29||September 2008||2008-09-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of the Use of Botox on Acne|Double-Blind, Randomized, Placebo-Controlled Study to Determine the Safety and the Efficacy of Using Botulinum Neurotoxin Type A Injections for Subjects With Mild to Moderate Acne Vulgaris|Terminated||Phase 2|5|Actual|DeNova Research|Study terminated after 5 subjects|1||Investigator decision|f||||t||||||||||2017-02-18 13:51:45.46104|2017-02-18 13:51:45.46104
NCT00765362|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-05-10|2010-06-16||January 2000||2000-01-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Mobile - Bearing Knee Study|Encore Mobile - Bearing Knee Study #200|Completed||Phase 3|419|Actual|Encore Medical, L.P.||1|||f||||f||||||||||2017-02-18 13:51:45.708438|2017-02-18 13:51:45.708438
NCT00765349|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2015-10-07|||May 2008||2008-05-01|October 2015|2015-10-01||||||||Observational|||Clinical Observational Study Investigating the Role of Diastolic Dysfunction in Determining Abnormal Cardiorespiratory Exercise Testing Parameters in Patients Undergoing Major Surgery||Recruiting||N/A|30|Anticipated|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||f||||||||||2017-02-18 13:51:45.969951|2017-02-18 13:51:45.969951
NCT00765336|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-11-02|2011-09-28||November 2006||2006-11-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Examine the Effects of Minocycline Extended-Release Tablets on Sperm Production in Human Males.|A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of Minocycline Extended-Release Tablets on Spermatogenesis in Human Males|Completed||Phase 4|180|Actual|Medicis Pharmaceutical Corporation||2|||f||||t||||||||||2017-02-18 13:51:46.058741|2017-02-18 13:51:46.058741
NCT00765323|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2013-09-20||2012-03-05|September 2008||2008-09-01|September 2013|2013-09-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly|Phase III, Open-Label, Multicenter International Study to Evaluate the Efficacy and Safety of an Octreotide Implant vs. Sandostatin LAR Depot in Patients With Acromegaly|Terminated||Phase 3|169|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:51:46.436197|2017-02-18 13:51:46.436197
NCT00765310|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-11-22|||April 2009||2009-04-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2011|Actual|2011-11-01||Interventional|||Lipoic Acid and Prevention of Heart Disease|The Role of R-alpha Lipoic Acid in Prevention of Atherosclerotic Vascular Disease|Active, not recruiting||Phase 2/Phase 3|100|Anticipated|Oregon State University||2|||f||||t||||||||||2017-02-18 13:51:46.658608|2017-02-18 13:51:46.658608
NCT00765297|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-07-26|||September 2007||2007-09-01|July 2010|2010-07-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|stumble||Identify Subjects at Risk for Falling Using Acceleration Based Gait Analysis System|Identify Subjects at Risk for Falling Using Acceleration Based Gait Analysis System|Unknown status|Recruiting|Early Phase 1|100|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 13:51:46.77005|2017-02-18 13:51:46.77005
NCT00765284|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-06-29|||December 2007||2007-12-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Effect of Niaspan on Cholesterol in Men|Effect of Niaspan on Parameters of Reverse Cholesterol Transport and HDL-C Subclasses in Male Subjects With Low HDL-C Levels|Completed||N/A|15|Anticipated|KineMed|||2||f||||f||||||Samples With DNA|"~     Stool, urine, and blood samples will be taken and analyzed as part of the study.~   "|||2017-02-18 13:51:46.864423|2017-02-18 13:51:46.864423
NCT00765271|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2009-11-17|||May 2008||2008-05-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects|A Study Investigating Plasma Abacavir and Its Intracellular Anabolite Carbovir-triphosphate Pharmacokinetics in the Absence and in the Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects.|Completed||Phase 1|29|Actual|St Stephens Aids Trust||2|||f||||f||||||||||2017-02-18 13:51:46.957163|2017-02-18 13:51:46.957163
NCT00765258|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2013-08-19|||January 2008||2008-01-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|May 2012|Actual|2012-05-01||Observational|||Utility of CT Fluoroscopy Guidance During Percutaneous Sacroplasty With Quality of Life Assessment|Utility of CT Fluoroscopy Guidance During Percutaneous Sacroplasty With Quality of Life Assessment|Completed||N/A|14|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 13:51:47.206118|2017-02-18 13:51:47.206118
NCT00765245|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-03-10|2015-02-27||October 2008||2008-10-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma|A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab as Maintenance Therapy Following Standard Chemotherapy for Patients With High/High-intermediate Risk Diffuse Large B-Cell Lymphoma|Completed||Phase 2|44|Actual|Vanderbilt-Ingram Cancer Center|"Pre-specified Outcomes Measures data were not collected as anticipated in original protocol, thus results will not be reported."|2|||f||||t||||||||||2017-02-18 13:51:47.298314|2017-02-18 13:51:47.298314
NCT00765232|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-12-21|2011-11-18||October 2008||2008-10-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy|The Efficacy of Continuous Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy: a Double Blinded Randomized Placebo Controlled Trial.|Completed||Phase 4|111|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:51:48.12517|2017-02-18 13:51:48.12517
NCT00765219|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2015-07-21|||May 2008||2008-05-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|December 2013|Actual|2013-12-01||Interventional|||Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care|Treating Late-life GAD in Primary Care: Enhancing Outcomes and Translational Value|Completed||N/A|222|Anticipated|Baylor College of Medicine||3|||f||||f||||||||||2017-02-18 13:51:48.459602|2017-02-18 13:51:48.459602
NCT00765206|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-02-20|2009-08-28||May 2008||2008-05-01|February 2015|2015-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)|Randomized, Crossover Pharmacodynamic Study Comparing the Effects of Zegerid® (20 mg Omeprazole/Sodium Bicarbonate) and Prilosec OTC® Tablets (20 Mg-equivalent Omeprazole)|Completed||Phase 3|60|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:51:48.579529|2017-02-18 13:51:48.579529
NCT00765193|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2010-04-14|2009-06-27||May 2008||2008-05-01|April 2010|2010-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|TBSE||The Impact of Total Body Skin Examination on Skin Cancer Detection|The Impact of Total Body Skin Examination on Skin Cancer Detection|Completed||N/A|14381|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 13:51:48.839284|2017-02-18 13:51:48.839284
NCT00765180|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2015-11-17|||January 2007||2007-01-01|November 2015|2015-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Comparison of Transparent Retractable Extension Device and Narrow Band Imaging on Colorectal Adenoma Detection||Completed||N/A|200|Actual|Showa Inan General Hospital||2|||f||||f||||||||||2017-02-18 13:51:49.16477|2017-02-18 13:51:49.16477
NCT00765167|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2008-10-02|||November 2007||2007-11-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Training and Calibration of Dental Examiners|Training and Calibration of Dental Examiners|Completed||Phase 3|18|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-02-18 13:51:49.256711|2017-02-18 13:51:49.256711
NCT00765154|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2010-10-29|||October 2008||2008-10-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||NNRTI/PI Toxicity Switch to Darunavir Study|Phase IV, Two-arm, Open-label, Single-centre Randomised Pilot Study to Assess the Feasibility of Immediate or Deferred Switching of HIV-infected Individuals Intolerant of Efavirenz, Ritonavir-boosted Lopinavir or Ritonavir-boosted Darunavir|Terminated||Phase 4|12|Actual|St Stephens Aids Trust||2||Difficulties in recruitment due to a change in the nature of practice.|f||||f||||||||||2017-02-18 13:51:49.357102|2017-02-18 13:51:49.357102
NCT00765141|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-11-24|||June 2008||2008-06-01|November 2015|2015-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host Microbe Scientific Study|A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host Microbe Scientific Study|Withdrawn||N/A|0|Actual|Southwest Regional Wound Care Center|||1|No participants enrolled per PI discretion|f||||t||||||Samples With DNA|"~     The samples can include material such as wound debridement, removed orthopedic implants,~     removed catheters or shunts, excised tonsils, amputated tissue, sputum, stool, or other~     excretions.~   "|||2017-02-18 13:51:49.461004|2017-02-18 13:51:49.461004
NCT00765128|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-12-21|2011-11-18||October 2008||2008-10-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy|The Efficacy of Continuous Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy: a Double Blinded Randomized Placebo Controlled Trial|Completed||Phase 4|17|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:51:49.551108|2017-02-18 13:51:49.551108
NCT00765115|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-09-30|||July 2006||2006-07-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.|Assessment of LY450139-Mediated Inhibition of Amyloid Beta Formation Determined by 13C6-Leucine In Healthy Subjects|Completed||Phase 1|27|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 13:51:49.871583|2017-02-18 13:51:49.871583
NCT00765102|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-03-30|2012-09-26||September 2008||2008-09-01|March 2016|2016-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Trial of Romidepsin and Bortezomib for Multiple Myeloma|A Phase II Trial of Romidepsin and Bortezomib for Multiple Myeloma Patients With Relapsed or Refractory Disease|Terminated||Phase 2|32|Actual|Celgene Corporation||1||There was a change in the Sponsor's research strategy; safety concerns were not a factor.|f||||f||||||||||2017-02-18 13:51:49.976283|2017-02-18 13:51:49.976283
NCT00765089|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-02-11|||December 2005||2005-12-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Bipolar Radiofrequency Ablation -Role in Prevention of Postoperative Atrial Fibrillation|Bipolar Radiofrequency Ablation -Role in Prevention of Postoperative Atrial Fibrillation|Completed||Phase 4|35|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:51:50.75656|2017-02-18 13:51:50.75656
NCT00765076|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-10-06|2012-03-08||October 2008||2008-10-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older|Observer-blind Immunogenicity Study of GSK Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects|Completed||Phase 3|192|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:51:50.852658|2017-02-18 13:51:50.852658
NCT00765063|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-12-01|2011-08-11||October 2008||2008-10-01|December 2011|2011-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)|A 6 Month, Prospective, Open-Label Multiple Center Extension Trial To Evaluate The Long Term Safety And Sustained Efficacy Of Fragmin In The Treatment Of Chronic Foot Ulcers In Diabetic Patients With Peripheral Arterial Occlusive Disease|Completed||Phase 2/Phase 3|62|Actual|Pfizer|Study enrollment was terminated before planned number of participants was obtained. Although randomized participants were allowed to complete entire course of therapy according to protocol and study status was therefore designated as completed.|1|||f||||f||||||||||2017-02-18 13:51:54.610554|2017-02-18 13:51:54.610554
NCT00765050|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2014-04-04|||January 2009||2009-01-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF|A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF|Terminated||Phase 1/Phase 2|13|Actual|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 13:51:55.272921|2017-02-18 13:51:55.272921
NCT00765037|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-08-03|2009-06-08||August 2008||2008-08-01|August 2010|2010-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Retrospective Encore Reverse Shoulder Prosthesis Study|Post Market Study on the Efficacy of the Encore Reverse Shoulder Prosthesis in a Small Group of Subjects|Completed||Phase 4|19|Actual|Encore Medical, L.P.|||1||f||||f||||||||||2017-02-18 13:51:55.410183|2017-02-18 13:51:55.410183
NCT00765024|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-06-18|||July 2008||2008-07-01|September 2008|2008-09-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Ivermectin Versus Albendazole for Chronic Strongyloidiasis|Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis|Unknown status|Enrolling by invitation|Phase 3|72|Anticipated|Mahidol University||3|||f||||f||||||||||2017-02-18 13:51:55.633529|2017-02-18 13:51:55.633529
NCT00765011|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2011-02-12|||October 2008||2008-10-01|February 2011|2011-02-01|May 2014|Anticipated|2014-05-01|February 2014|Anticipated|2014-02-01||Interventional|||TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer|A Phase II Trial With Radiotherapy Plus Cetuximab to Evaluate Specific Survival Free of Laryngectomy in Patients With Resectable and Locally Advanced Larynx Cancer, After Treatment With TPF|Unknown status|Recruiting|Phase 2|92|Anticipated|Grupo Español de Tratamiento de Tumores de Cabeza y Cuello||2|||f||||f||||||||||2017-02-18 13:51:55.740221|2017-02-18 13:51:55.740221
NCT00764998|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2010-08-19|||October 2008||2008-10-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Interventional|||Influenza Vaccine in HIV|A Controlled Trial to Assess the Immunogenicity and Efficacy of Three Vaccine Dosing Strategies in HIV Infected Adults|Completed||Phase 3|285|Actual|Ottawa Hospital Research Institute||2|||f||||||||||||||2017-02-18 13:51:55.866427|2017-02-18 13:51:55.866427
NCT00764985|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2010-07-01|||June 2008||2008-06-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Observational|E-STOP||Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis|E-STOP Registry: A Registry for the Evaluation of Syncope,Its Diagnosis, Treatment, Outcome and Prognosis Using Our SELF-Pathway|Completed||N/A|540|Anticipated|St. Luke's-Roosevelt Hospital Center|||1||f||||f||||||||||2017-02-18 13:51:55.996989|2017-02-18 13:51:55.996989
NCT00764972|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-10-17|||October 2007||2007-10-01|October 2008|2008-10-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer|A Phase IB/II Trial of Combination of Vinorelbine With Sorafenib (BAY 43-9006) as First-Line Treatment in Patients With Metastatic Breast Cancer|Unknown status|Recruiting|Phase 1/Phase 2|36|Anticipated|McGill University||1|||f||||t||||||||||2017-02-18 13:51:56.077775|2017-02-18 13:51:56.077775
NCT00764959|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-02-08|||October 2007||2007-10-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Retrospective Study of the Linear™ Hip|Post-Market Study of the Linear™ Hip System|Terminated||Phase 4|200|Anticipated|Encore Medical, L.P.|||1|Enrollment and data collection insufficient to continue study.|f||||f||||||||||2017-02-18 13:51:56.176395|2017-02-18 13:51:56.176395
NCT00764946|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2015-07-06|2012-02-13||October 2008||2008-10-01|July 2015|2015-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)|A Phase III Open-Label Single Arm Study to Evaluate the Safety, Tolerability, and Efficacy of MK0518/Raltegravir in a Diverse Cohort of HIV-Infected Patients|Completed||Phase 3|209|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 13:51:56.279475|2017-02-18 13:51:56.279475
NCT00764933|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2010-06-01|||January 2008||2008-01-01|January 2010|2010-01-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Structured Information During the Intensive Care Unit Stay|A Randomized Controlled Multi Center Study to Evaluate the Efficacy of a Structured Information Program During ICU Stay|Completed||N/A|211|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-02-18 13:51:57.185374|2017-02-18 13:51:57.185374
NCT00764920|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2017-02-08|||October 2008||2008-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Skin Imaging With Technologies in Development|Non-invasive Imaging Modalities for Assessment of Normal and Lesional Skin|Recruiting||N/A|350|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:51:57.279217|2017-02-18 13:51:57.279217
NCT00764907|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2009-07-07|||November 2002||2002-11-01|July 2009|2009-07-01||||October 2007|Anticipated|2007-10-01||Interventional|||Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia|A Randomized Trial of the I-BFM-SG for the Management of Childhood Non-B Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 3|4000|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 13:51:57.396621|2017-02-18 13:51:57.396621
NCT00764894|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-02-08|||October 2007||2007-10-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Foundation Knee Study - Retrospective|Post-Market Study of the Foundation Knee System|Terminated||Phase 4|200|Anticipated|Encore Medical, L.P.|||1|Enrollment and data collection insufficient to continue study.|f||||f||||||||||2017-02-18 13:51:57.521178|2017-02-18 13:51:57.521178
NCT00764881|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2014-12-08|2011-07-28||January 2009||2009-01-01|December 2014|2014-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effects of SH T00658ID on Libido|Multi-center, Double-blind, Randomized Study to Investigate the Impact of a Sequential Oral Contraceptive Containing Estradiol Valerate and Dienogest (SH T00658ID) Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (Microgynon) Over 6 Treatment Cycles on Alleviating Complaints of Reduced Libido in Women With Acquired Female Sexual Dysfunction (FSD) Associated With Oral Contraceptive Use|Completed||Phase 3|217|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:51:57.643911|2017-02-18 13:51:57.643911
NCT00764868|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2014-01-10|2011-01-31||October 2008||2008-10-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study|A Phase III, Open-Label, Extension, Multi-Center, Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Adolescents Aged 13-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|269|Actual|Shire||1|||f||||f||||||||||2017-02-18 13:52:00.29157|2017-02-18 13:52:00.29157
NCT00764855|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-05-04|||October 2008||2008-10-01|May 2012|2012-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Validation of the Effect of Propofol and Opiates Closed-loop Administration Device During Anesthesia and Sedation|Validation of the Effect of Propofol and Opiates Closed-loop Administration Device During Anesthesia and Sedation|Completed||N/A|180|Actual|University Hospital, Ghent|||1||f||||f||||||||||2017-02-18 13:52:00.634768|2017-02-18 13:52:00.634768
NCT00764842|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-02-08|||January 2008||2008-01-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Efficacy of the CLP® Hip - Retrospective|Post-Market Study: The Efficacy of the CLP® Hip|Terminated||Phase 4|61|Actual|Encore Medical, L.P.|||1|Enrollment and data collection insufficient to continue study.|f||||f||||||||||2017-02-18 13:52:00.735781|2017-02-18 13:52:00.735781
NCT00764829|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2012-02-13|||September 2008||2008-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Blood Samples to Evaluate Biomarkers of Donor Chimerism|Blood Samples to Evaluate Biomarkers of Donor Chimerism|Completed||N/A|80|Anticipated|Fred Hutchinson Cancer Research Center|||1||f||||f||||||Samples With DNA|"~     plasma,DNA~   "|||2017-02-18 13:52:00.838075|2017-02-18 13:52:00.838075
NCT00764816|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2011-06-22|||October 2008||2008-10-01|June 2011|2011-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4|Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4|Completed||N/A|9|Actual|Indiana University||2|||f||||f||||||||||2017-02-18 13:52:00.931674|2017-02-18 13:52:00.931674
NCT00764803|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-03-09|||January 2008||2008-01-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Observational|||3DKnee™ System vs. the MJS Knee System|Post-Market Study: The Efficacy of the 3DKnee™ System vs. the MJS Knee System|Terminated||Phase 4|27|Actual|Encore Medical, L.P.|||2|Corporate decision to discontinue distribution of MJS Knee.|f||||f||||||||||2017-02-18 13:52:01.053831|2017-02-18 13:52:01.053831
NCT00764790|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-10-11|2010-02-25||October 2008||2008-10-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children|Immunogenicity and Safety of GSK Biologicals' Thimerosal-free TIV Flu Vaccine Versus a Licensed Comparator in Children|Completed||Phase 3|3317|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:52:01.171726|2017-02-18 13:52:01.171726
NCT00764777|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2013-01-24|||December 2008||2008-12-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|September 2010|Actual|2010-09-01||Interventional|BRAVISSIMO||Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions|Physician Initiated Multi-center Belgian-Italian-Dutch Trial Investigating Abbott Vascular Iliac Stents in the Treatment of TASC A, B, C & D Iliac Lesions|Completed||Phase 4|325|Actual|Flanders Medical Research Program||1|||f||||f||||||||||2017-02-18 13:52:02.296318|2017-02-18 13:52:02.296318
NCT00764764|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-10-03|||May 2008||2008-05-01|July 2009|2009-07-01||||May 2008|Actual|2008-05-01||Interventional|||Study of the Effect of Neck Treatment on Shoulder Impingement|Shoulder Impingement: A By-Product of Cervical Spine Dysfunction?|Terminated||Phase 1|30|Anticipated|CAMC Health System||2||PI left institution|f||||t||||||||||2017-02-18 13:52:02.406973|2017-02-18 13:52:02.406973
NCT00764751|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2013-10-18|||September 2008||2008-09-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris|LEO 19123 Cream in the Treatment of Psoriasis Vulgaris|Completed||Phase 2|51|Actual|LEO Pharma||3|||f||||f||||||||||2017-02-18 13:52:02.50995|2017-02-18 13:52:02.50995
NCT00703313|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2009-02-04|||May 2008||2008-05-01|February 2009|2009-02-01||||June 2008|Actual|2008-06-01||Interventional|||Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators||Completed||Phase 4|72|Anticipated|Santen Inc.||3|||f||||f||||||||||2017-02-18 14:13:40.561458|2017-02-18 14:13:40.561458
NCT00764738|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2013-03-18|||October 2008||2008-10-01|March 2013|2013-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration|Study Investigating High Resolution OCT, Multifocal ERG and Microperimetry Outcomes of Monthly vs As Needed Ranibizumab in Neovascular Age-Related Macular Degeneration|Completed||Phase 2/Phase 3|45|Actual|Retina Macula Institute||2|||f||||t||||||||||2017-02-18 13:52:02.613983|2017-02-18 13:52:02.613983
NCT00764725|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2008-12-22|||December 2002||2002-12-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|April 2007|Actual|2007-04-01||Interventional|SWEFOT||Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)|A Prospective Randomized, Open, Multi-Center Trial Comparing TNF-Blockade + MTX to MTX+SSZ+HCQ in Patients With Early RA With an Inadequate Response to MTX|Completed||Phase 4|487|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 13:52:02.713132|2017-02-18 13:52:02.713132
NCT00764712|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-03-09|||February 2008||2008-02-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery Patients|Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery Patients|Completed||N/A|120|Actual|Charles University, Czech Republic||3|||f||||f||||||||||2017-02-18 13:52:02.815496|2017-02-18 13:52:02.815496
NCT00764699|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2015-05-14|||October 2008||2008-10-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Increlex® on Children With Crohn Disease|Effect of Increlex® on Children With Crohn Disease|Terminated||Phase 2/Phase 3|3|Actual|Nationwide Children's Hospital||1||PI left institution|f||||f||||||||||2017-02-18 13:52:02.931132|2017-02-18 13:52:02.931132
NCT00764686|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2009-09-28|||June 2008||2008-06-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||A Study Investigating an Exercise and Education Programme for Individuals With Ankylosing Spondylitis|A Study Investigating an Exercise and Education Programme for Individuals With Ankylosing Spondylitis.|Completed||Phase 3|18|Anticipated|University College Dublin||2|||f||||t||||||||||2017-02-18 13:52:03.041282|2017-02-18 13:52:03.041282
NCT00764673|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-02-08|2010-11-19||October 2006||2006-10-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||The 3DKnee™ System: A Post-Market Study|The 3DKnee™ System: A Post-Market Study|Completed||Phase 4|71|Actual|Encore Medical, L.P.||1|||f||||f||||||||||2017-02-18 13:52:03.154648|2017-02-18 13:52:03.154648
NCT00764660|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-07-20|2016-06-07||February 2009||2009-02-01|July 2016|2016-07-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|OD-H||Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718)|A Prospective, Double-Blind, Placebo-Controlled Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Subjects With Alcohol Dependence.|Terminated||Phase 2|141|Actual|Merck Sharp & Dohme Corp.||2||"Based on the outcome of a planned interim analysis, the study was stopped early due to~   futility."|f||||f||||||||||2017-02-18 13:52:03.472604|2017-02-18 13:52:03.472604
NCT00764647|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-02-03|||March 2006||2006-03-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|September 2011|Actual|2011-09-01||Interventional|||Education Program for Family Caregivers|Evaluation of Education Program for Family Caregivers of Frail Elders|Active, not recruiting||N/A|42|Actual|CAMC Health System||1|||f||||f||||||||||2017-02-18 13:52:04.151456|2017-02-18 13:52:04.151456
NCT00764634|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-11-28||2011-06-29|September 2008||2008-09-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B|A Phase 2, Randomized, Double Blind, Placebo-Controlled, Multicenter Study to Evaluate Safety, Dosing Schedule and Antibody Kinetics of Recombinant Botulinum Vaccine A/B, rBV A/B-40, in Healthy Adults|Completed||Phase 2|440|Actual|DynPort Vaccine Company LLC, A CSC Company||4|||f||||t||||||||||2017-02-18 13:52:04.264593|2017-02-18 13:52:04.264593
NCT00764621|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2014-11-03|||October 2008||2008-10-01|November 2014|2014-11-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Health Economic Evaluation of Primovist-enhanced Liver MRI|Multi-center, Randomized Comparison Study to eVALUatE Outcomes and Resource Needs of Imaging and Treatment Following Primovist-enhanced MRI of the Liver in Comparison to Extracellular Contrast Media (ECCM)-Enhanced MRI and Contrast-enhanced Computed Tomography (CT) in Patients With a History of Colorectal Cancer and Known or Suspected Metachronous Liver Metastases.|Completed||Phase 4|360|Actual|Bayer||3|||f||||f||||||||||2017-02-18 13:52:04.391164|2017-02-18 13:52:04.391164
NCT00764608|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-11-24|||June 2008||2008-06-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Study of the Human Skin Microbiome|Study of the Human Skin Microbiome|Withdrawn||N/A|0|Actual|Southwest Regional Wound Care Center|||1|No Participants enrolled, per PI discretion|f||||t||||||Samples With DNA|"~     The subjects' samples will be analyzed using DNA methods in order to identify the types of~     microbes present on the swabs. Other substances such as proteins, RNA, and other metabolites~     may also be analyzed. DNA or other molecular components of the sample will be extracted.~     Alternately, microbes in the sample can be cultured directly. The samples will be explored~     using molecular analyses. The backbone of the analyses will be shotgun metagenomic~     sequencing and 16S rDNA amplicon sequencing. The results of these analyses will be used to~     identify and describe the microbiome of the skin.~   "|||2017-02-18 13:52:04.543404|2017-02-18 13:52:04.543404
NCT00764595|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-09-27|||October 2008||2008-10-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|GISTs||Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor|Phase II Multicenter Clinical Trial on Imatinib Treatment for Patients With Resectable Hepatic Metastasis From Gastrointestinal Stromal Tumors (GISTs)|Completed||Phase 2|5|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||t||||||||||2017-02-18 13:52:04.627206|2017-02-18 13:52:04.627206
NCT00764582|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2009-08-24|||September 2008||2008-09-01|August 2009|2009-08-01||||March 2009|Anticipated|2009-03-01||Interventional|||Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery|A Randomized, Observer-masked, Parallel-group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmic Solution in Subjects Undergoing Corneal Transplant Surgery|Terminated||Phase 4|60|Anticipated|Santen Inc.||2||Study terminated due to lack of enrollment.|f||||f||||||||||2017-02-18 13:52:04.797343|2017-02-18 13:52:04.797343
NCT00764569|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2017-02-08|||November 2008||2008-11-01|February 2017|2017-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||The Investigation of a Fluorescence/Elastic Scattering Spectroscopy (F-ESS) Device for Oral Tissue Characterization|a Non-invasive Device for the Detection, Diagnosis and Screening of Oral Pathology|Completed||N/A|77|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 13:52:04.908874|2017-02-18 13:52:04.908874
NCT00764556|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2009-10-13|||May 2008||2008-05-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|IPS2008||Phase II Study of Safety and Feasibility of Intensive Blood Glucose Control With Insulin on Acute Medical Wards|Phase II Study of Safety and Feasibility of Intensive Blood Glucose Control With Insulin on Acute Medical Wards|Completed||Phase 2|20|Actual|St George's, University of London||1|||f||||t||||||||||2017-02-18 13:52:05.006576|2017-02-18 13:52:05.006576
NCT00764543|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-10-01||||||October 2008|2008-10-01||||||||Expanded Access|||Ambulatory Blood Pressure Measurement in Children With Congenital Urine Flow Obstruction|Ambulatory Blood Pressure Measurement in Children With Congenital Urine Flow Obstruction|Available||N/A|||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 13:52:05.115431|2017-02-18 13:52:05.115431
NCT00764530|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-01-19|||November 2003||2003-11-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Cementless Alumina-Alumina Total Hip and Hybrid|Keramos Ceramic/Ceramic Total Hip System|Completed||Phase 3|342|Actual|Encore Medical, L.P.||2|||f||||f||||||||||2017-02-18 13:52:05.1901|2017-02-18 13:52:05.1901
NCT00764517|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-11-28||2016-11-28|August 2008||2008-08-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|January 2015|Actual|2015-01-01||Interventional|||Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma|Phase II Study of Vorinostat (SAHA), Cladribine, and Rituximab (SCR) in Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, and Relapsed B Cell Non-Hodgkin Lymphoma|Active, not recruiting||Phase 2|66|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 13:52:05.48809|2017-02-18 13:52:05.48809
NCT00764504|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-03-21|2010-11-19||October 2002||2002-10-01|March 2011|2011-03-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|RSP||Reverse Shoulder Prosthesis Study|Encore Reverse Shoulder Prosthesis|Completed||Phase 3|516|Actual|Encore Medical, L.P.||3|||f||||f||||||||||2017-02-18 13:52:05.618459|2017-02-18 13:52:05.618459
NCT00763685|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2012-01-29|||June 2010||2010-06-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Study to Evaluate the Efficacy of Pre-operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery|Double-Blind, Randomized, Placebo -Controlled Study to Evaluate the Efficacy of Pre-operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery|Terminated||Phase 4|40|Actual|East Tallinn Central Hospital||3||"The gynecological laparoscopic surgery transition to day surgery made following the study~   protocol not possible."|f||||f||||||||||2017-02-18 13:52:06.348372|2017-02-18 13:52:06.348372
NCT00763672|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2013-03-26|||November 2008||2008-11-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|MOMA||MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim Study|Impact of a Single Second-trimester Plasma sFlt-1 and/or Urinary PlGF Assay on Maternofetal Morbidity/Mortality|Completed||N/A|1040|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:52:06.505027|2017-02-18 13:52:06.505027
NCT00763659|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2012-07-19|||May 2008||2008-05-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|LUTEGA||Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)|Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)|Completed||N/A|172|Actual|University of Jena||3|||f||||f||||||||||2017-02-18 13:52:06.780085|2017-02-18 13:52:06.780085
NCT00763646|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-10-20|||April 2007||2007-04-01|September 2008|2008-09-01||||December 2010|Anticipated|2010-12-01||Interventional|||Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma|Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma|Unknown status|Recruiting|Phase 2|30|Anticipated|McGill University||1|||f||||t||||||||||2017-02-18 13:52:06.871065|2017-02-18 13:52:06.871065
NCT00763633|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2008-12-30|||January 2008||2008-01-01|September 2008|2008-09-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||B6 Treatment for Nausea and Vomiting in Pregnancy|Vitamin B6 Concentration and Treatment in Nausea and Vomiting of Pregnancy|Unknown status|Recruiting|Phase 4|150|Anticipated|Showa University||2|||f||||t||||||||||2017-02-18 13:52:06.967425|2017-02-18 13:52:06.967425
NCT00763620|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-09-22|||February 2009||2009-02-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Mini-LBA||Assessment of the Diagnostic Capacity of the Mini-broncho Alveolar Lavage Performed Through a Suction Catheter|Assessment of the Diagnostic Capacity of a New Sampling Technique for Lower Respiratory Tract Culture for Patients With Acute Infectious Pneumonia Admitted in Intensive Care Unit and Non Intubated.|Completed||N/A|36|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 13:52:07.077898|2017-02-18 13:52:07.077898
NCT00763607|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-09-01|||November 2007||2007-11-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|February 2008|Actual|2008-02-01||Observational|||Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)|Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Radically Resected Non Small Cell Lung Cancer|Completed||N/A|454|Anticipated|Istituto Clinico Humanitas|||1||f||||f||||||Samples With DNA|"~     Paraffine embedded tumor sections~   "|||2017-02-18 13:52:07.19217|2017-02-18 13:52:07.19217
NCT00763594|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-08-31|||September 2008||2008-09-01|August 2015|2015-08-01|December 2017|Anticipated|2017-12-01|May 2016|Anticipated|2016-05-01||Interventional|LURIPP||Linköping University Relational and Interpersonal Psychotherapy Project|Randomized Controlled Trial of Interpersonal and Brief Relational Psychotherapy for Major Depressive Disorder.|Recruiting||Phase 2|120|Anticipated|Linkoeping University||2|||f||||f||||||||||2017-02-18 13:52:07.287064|2017-02-18 13:52:07.287064
NCT00763581|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2017-01-31|||April 2008||2008-04-01|January 2017|2017-01-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Observational|||Personal Adherence Evaluation of Medication Use for Adult Bipolar Disorder Patients|Personal Adherence Evaluation of Individuals Receiving Treatment for Bipolar Disorder (PAE in BD)|Completed||N/A|20|Actual|Case Western Reserve University|||1||f||||t||||||||||2017-02-18 13:52:07.425543|2017-02-18 13:52:07.425543
NCT00763568|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2008-09-26|||August 2006||2006-08-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C|Study of a 4-Week Lead-In With Nitazoxanide Followed By 36 Weeks of Nitazoxanide Plus Peginterferon Alfa-2a in the Treatment of Chronic Hepatitis C|Completed||Phase 2|40|Actual|Romark Laboratories L.C.||1|||f||||f||||||||||2017-02-18 13:52:07.522493|2017-02-18 13:52:07.522493
NCT00763555|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2012-01-06||2010-10-16|September 2008||2008-09-01|January 2012|2012-01-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis|A Multicenter, Randomized, Vehicle-controlled, Efficacy and Safety Study of CD2027 3µg/g Oily Spray Applied Twice Daily for 8 Weeks in Subjects With Plaque-type Psoriasis|Completed||Phase 2|88|Actual|Galderma||2|||f||||||||||||||2017-02-18 13:52:07.650326|2017-02-18 13:52:07.650326
NCT00763542|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2013-11-03|||July 2008||2008-07-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|July 2011|Actual|2011-07-01||Interventional|||Combined Treatment for Patients With Comorbid Substance Use Disorders and Post-traumatic Stress Disorder (PTSD): an Integration of Cognitive-behavioral Treatment (CBT) and Trauma-focused Structured Writing Therapy|A Randomized Controlled Trial Comparing (1) a Combined Treatment of CBT for Substance Use Disorders (SUD) and Trauma-focused Structured Writing Therapy With (2) CBT for SUD Alone in Patients With Comorbid SUD and PTSD|Completed||Phase 2|130|Actual|VU University of Amsterdam||2|||f||||f||||||||||2017-02-18 13:52:07.758843|2017-02-18 13:52:07.758843
NCT00764491|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2013-09-19|||July 2003||2003-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:52:07.862291|2017-02-18 13:52:07.862291
NCT00764478|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-11-24|2015-03-26||April 2012||2012-04-01|November 2015|2015-11-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional||Randomized participants who received at least one dose of trial medication|Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691)|A Phase 3b, Multicenter, Double-Blind, Fixed-Dose, Parallel-Group, Three Week Placebo Controlled Trial Evaluating the Safety and Efficacy of Asenapine in Subjects With Bipolar 1 Disorder Experiencing an Acute Manic or Mixed Episode (Protocol P05691 [Formerly 041044])|Completed||Phase 3|367|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:52:07.935937|2017-02-18 13:52:07.935937
NCT00764465|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-01-27|2015-03-24||October 2008||2008-10-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||An Interaction Study to Assess Drug Levels in Healthy Adult Subjects|Steady State Pharmacokinetics (PK) of Fosamprenavir (FPV) Alone or in Combination With Low Dose Ritonavir (/r) (1400mg BID, 1400mg/100mg QD or 700/100mg BID) and the Chemokine Receptor 5 (CCR5) Entry Inhibitor Maraviroc (MVC) 300mg BID in Healthy Volunteers|Completed||Phase 2|45|Actual|Garden State Infectious Disease Associates, PA|Data for primary outcomes are not available per intervention . Values reported as means are uncertain measure type (data no longer available).|6|||f||||f||||||||||2017-02-18 13:52:09.539505|2017-02-18 13:52:09.539505
NCT00764452|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2012-05-03|||February 2006||2006-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:52:10.336224|2017-02-18 13:52:10.336224
NCT00764439|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-07-06|||October 2008||2008-10-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pilot Study of a New Nicotine Replacement Therapy|Pilot Study on Usage Patterns of a Novel Nicotine Replacement Therapy - A Multi-Center, Open, 3-Week Randomized Low Intervention Study of Two Different Directions for Use in Smokers Motivated to Quit|Completed||Phase 2|258|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-02-18 13:52:10.388348|2017-02-18 13:52:10.388348
NCT00764426|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-10-01|||June 2004||2004-06-01|October 2008|2008-10-01||||||||Interventional|||Alcohol, Inflammation and Atherosclerosis|Clinical Study of the Effect of Different Alcoholic and Non-Alcoholic Beverages on Markers of Inflammation|Completed||N/A|72|Actual|European Research Advisory Board||2|||f||||f||||||||||2017-02-18 13:52:10.499807|2017-02-18 13:52:10.499807
NCT00764413|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2014-11-21|||April 2009||2009-04-01|February 2014|2014-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Chronotherapy in Acute Multiple Sclerosis (MS) Attack|Treatment With Methylprednisolone in Acute Exacerbations of Multiple Sclerosis: Enhanced Effect With Nighttime Treatment?|Terminated||N/A|57|Actual|Sykehuset Innlandet HF||2||Low inclusion frequency and not enough human resources for completing study|f||||f||||||||||2017-02-18 13:52:10.612247|2017-02-18 13:52:10.612247
NCT00764400|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2012-05-18|||August 2008||2008-08-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|June 2012|Anticipated|2012-06-01||Interventional|||Treatment for Word Retrieval Impairments in Aphasia|Communication Outcomes for Naming Treatments in Aphasia|Unknown status|Recruiting|Phase 1|16|Anticipated|Old Dominion University||2|||f||||f||||||||||2017-02-18 13:52:10.724446|2017-02-18 13:52:10.724446
NCT00764387|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2014-12-04|||March 2008||2008-03-01|December 2014|2014-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.|Contrast-enhanced MRI Examination of Cerebral Neoplastic Enhancing Lesions: Comparison of Diagnostic Efficacy of Gd-DOTA 0.5M and Gadobutrol 1.0 M at 0.1 mmol/kg Body Weight: Intraindividual Comparison Clinical Study.|Completed||Phase 4|166|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:52:13.230523|2017-02-18 13:52:13.230523
NCT00764374|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2014-10-28|||August 2008||2008-08-01|October 2014|2014-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia|A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia|Completed||Phase 3|412|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 13:52:13.333804|2017-02-18 13:52:13.333804
NCT00764361|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-03-08|2012-02-24||January 2009||2009-01-01|March 2012|2012-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers|A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of NanoDOX™ Hydrogel(1.0% Doxycycline Monohydrate)in Diabetic Adult Subjects With Lower Extremity Ulcers Compared to Placebo Hydrogel.|Completed||Phase 2|15|Actual|Nanotherapeutics, Inc.|enrollment stopped before reaching the initial 40 subjects anticipated due to slow enrollment of subjects|2|||f||||t||||||||||2017-02-18 13:52:13.445307|2017-02-18 13:52:13.445307
NCT00764335|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2010-06-22||||||June 2010|2010-06-01|July 2009|Actual|2009-07-01|||||Observational|||Treatment and Rehabilitation of Patients With Hip Arthroplasty to Regain Walk and Work Efficiency and Quality of Life|Treatment and Rehabilitation of Patients With Hip Arthroplasty to Regain Walk and Work Efficiency and Quality of Life|Completed||N/A|40||Norwegian University of Science and Technology|||4||f||||f||||||||||2017-02-18 13:52:13.908651|2017-02-18 13:52:13.908651
NCT00764322|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2013-11-01|||June 2008||2008-06-01|November 2013|2013-11-01|August 2015|Anticipated|2015-08-01|March 2010|Actual|2010-03-01||Interventional|||Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen|Validating CYP2D6 Genotype-Guided Tamoxifen Therapy for a Multiracial U.S. Population|Unknown status|Active, not recruiting|N/A|501|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 13:52:13.988101|2017-02-18 13:52:13.988101
NCT00764309|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2012-01-30|2012-01-30||January 2009||2009-01-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|June 2010|Actual|2010-06-01||Interventional|||Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis|An Open Label Study to Evaluate the Safety of Dasatinib in the Treatment of Scleroderma Pulmonary Interstitial Fibrosis|Completed||Phase 1/Phase 2|47|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 13:52:14.122764|2017-02-18 13:52:14.122764
NCT00764296|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-09-06|||December 2006||2006-12-01|September 2011|2011-09-01||||||||Observational|||Collection of Samples for the Evaluation of Wound Biofilm in Acute and Chronic Wounds|Collection of Samples for the Evaluation of Wound Biofilm in Acute and Chronic Wounds|Completed||N/A|34|Actual|Southwest Regional Wound Care Center|||1||f||||t||||||Samples With DNA|"~     The debridement sample will be processed to extract DNA for 16s rDNA evaluation in order to~     determine the microbial population of the sample using a more sensitive means than standard~     culture.~   "|||2017-02-18 13:52:14.832136|2017-02-18 13:52:14.832136
NCT00764283|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2009-04-14|||November 2008||2008-11-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||The Prevention of Postoperative Epidural Catheter Migration: a Comparison of Three Types of Dressing|The Prevention of Postoperative Epidural Catheter Migration: a Comparison of Three Types of Dressing|Completed||N/A|200|Anticipated|University Ghent||3|||f||||f||||||||||2017-02-18 13:52:14.933844|2017-02-18 13:52:14.933844
NCT00764270|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2016-11-22|||August 2011||2011-08-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|November 2011|Actual|2011-11-01||Interventional|||The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease|The Role of R-alpha Lipoic Acid in Treatment of Atherosclerotic Vascular Disease|Active, not recruiting||Phase 2/Phase 3|50|Anticipated|Oregon State University||2|||f||||t||||||||||2017-02-18 13:52:15.034347|2017-02-18 13:52:15.034347
NCT00764257|ClinicalTrials.gov processed this data on February 17, 2017|2008-10-01|2011-12-19|||October 2004||2004-10-01|December 2011|2011-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||PREVELLE Shape (CX002) Dermal Filler Protocol|A Multicenter, Evaluator-Masked Study to Assess the Efficacy and Safety of Mentor's CX002 Dermal Filler Medical Device, When Applied as an Intradermal Implant for the Correction of Facial Wrinkles and Lip Augmentation (CX002 Dermal Filler Protocol)|Completed||Phase 3|||Mentor Worldwide, LLC||2|||f||||t||||||||||2017-02-18 13:52:15.148634|2017-02-18 13:52:15.148634
NCT00764244|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-03-23|||January 2005||2005-01-01|November 2014|2014-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|VITRILASE||Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema|VITRILASE Study: Prospective Randomized Trial Comparing the Effect of Laser, Vitrectomy and Intravitreal Triamcinolone Injection for Diabetic Macular Edema|Completed||Phase 3|72|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-02-18 13:52:15.248649|2017-02-18 13:52:15.248649
NCT00764231|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2012-02-07|||October 2008||2008-10-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)|A Pilot Study of a Home-based Exercise Intervention for Patients With AML|Completed||Phase 2|40|Actual|Toronto Rehabilitation Institute||2|||f||||f||||||||||2017-02-18 13:52:15.369342|2017-02-18 13:52:15.369342
NCT00764218|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-09-30|||March 2001||2001-03-01|January 2001|2001-01-01|December 2008|Anticipated|2008-12-01|December 2003|Anticipated|2003-12-01||Interventional|SAS-HTA||Cardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea Syndrome|Cardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea Syndrome : Role of Hypertension|Unknown status|Recruiting|Early Phase 1|300|Anticipated|University Hospital, Grenoble||4|||f||||t||||||||||2017-02-18 13:52:15.483136|2017-02-18 13:52:15.483136
NCT00764205|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-09-30|||November 2006||2006-11-01|September 2008|2008-09-01|November 2010|Anticipated|2010-11-01|November 2009|Anticipated|2009-11-01||Observational|||Randomized Trial of Prehospital Tropin Levels in Acute Coronary Syndrome (ACS)|Randomized Trial of Prehospital Troponin Assessment Using the i-STAT Blood Analyzer|Unknown status|Active, not recruiting|N/A|1200|Anticipated|Redmond Fire Department Medic One|||2||f||||f||||||||||2017-02-18 13:52:15.597279|2017-02-18 13:52:15.597279
NCT00764192|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2009-01-12|||October 2006||2006-10-01|January 2009|2009-01-01|October 2007|Actual|2007-10-01|February 2007|Actual|2007-02-01||Interventional|||Influence of Hemodialysis on Endothel-Depending Dilatation of Peripheral Arteries|Angiologic Study of the Influence of Hemodialysis on Endothelial Function|Completed||N/A|14|Actual|RWTH Aachen University||1|||f||||f||||||||||2017-02-18 13:52:15.680756|2017-02-18 13:52:15.680756
NCT00764179|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-10-04|||March 2008||2008-03-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|Proneonat||"Effects (Long Term Analysis) of an Hyperproteinic Nutrition on Neonates With Intra-uterine Growth Delay : a Prospective, Multicentric , Randomized, Double Blind Study (Proneonat)"|"Effects (Long Term Analysis) of an Hyperproteinic Nutrition on Neonates With Intra-uterine Growth Delay : a Prospective, Multicentric , Randomized, Double Blind Study (Proneonat)"|Terminated||N/A|93|Actual|Nantes University Hospital||2||difficulties of recruitment, high number of patients lost to follow-up|f||||f||||||||||2017-02-18 13:52:15.788433|2017-02-18 13:52:15.788433
NCT00764166|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-09-30|||June 2003||2003-06-01|September 2008|2008-09-01|November 2010|Anticipated|2010-11-01|November 2009|Anticipated|2009-11-01||Interventional|RisingPSA||A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel|Non-Metastatic High-Risk Prostate Cancer Patients With Biochemical Relapse Only After Local Treatment. A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel|Unknown status|Active, not recruiting|Phase 3|254|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:52:15.88116|2017-02-18 13:52:15.88116
NCT00549276|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2007-10-23|||May 2006||2006-05-01|May 2006|2006-05-01|November 2006|Actual|2006-11-01|||||Observational|||Randomized Comparison of Curved Cutter Stapler and Linear Stapler||Completed||N/A|||Samsung Medical Center|||60||f||||t||||||||||2017-02-18 15:09:08.055334|2017-02-18 15:09:08.055334
NCT00764153|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2014-10-22|||October 2002||2002-10-01|October 2014|2014-10-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Hemiarthroplasty or Internal Fixation for Displaced Femoral Neck Fractures - 5 Years Follow up|Hemiarthroplasty or Internal Fixation for Displaced Femoral Neck Fractures - 5 Years Follow up|Completed||N/A|222|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 13:52:15.989322|2017-02-18 13:52:15.989322
NCT00764140|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2013-04-17|||January 2007||2007-01-01|April 2013|2013-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Tumor Growth Factors in Hepatocellular Carcinoma|Insulin-like Growth Factors (IGF) Axis (IGFs, Its Binding Proteins,Receptors), Transforming Growth Factor Alpha and Beta 1 and Epidermal Growth Factor in the Urine and Serum of Patients With Hepatocellular Carcinoma.|Completed||N/A|400|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||2||f||||f||||||Samples Without DNA|"~     Blood and/or urine~   "|||2017-02-18 13:52:16.097077|2017-02-18 13:52:16.097077
NCT00764127|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2013-01-30|||February 2008||2008-02-01|January 2013|2013-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||The Development of an Eating Laboratory for Overweight Adolescents|The Development of an Eating Laboratory for Overweight Adolescents|Completed||N/A|36|Actual|New York State Psychiatric Institute|||3||f||||t||||||Samples Without DNA|"~     10 cc (2 teaspoons) of blood will be drawn during the screening assessment to screen for~     medical illness.~      60 cc (12 teaspoons) of blood will be drawn from an indwelling IV catheter during the~     single-item meal to assay for meal-related hormones (ghrelin, leptin,cholecystokinin,~     insulin, peptideY). Bariatric surgery participants may have an additional 20 cc of blood~     taken to measure glucose responses to the meal.~   "|||2017-02-18 13:52:16.20763|2017-02-18 13:52:16.20763
NCT00764114|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2013-05-03|||November 2006||2006-11-01|February 2011|2011-02-01|April 2013|Actual|2013-04-01|August 2012|Actual|2012-08-01||Interventional|DTS||Comparison of Two Antimicrobial Therapy Duration for Spondylodiscitis|Comparison of Two Antimicrobial Therapy Duration (6 Weeks Versus 12 Weeks)for Spondylodiscitis|Completed||Phase 4|351|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:52:16.378873|2017-02-18 13:52:16.378873
NCT00764101|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2011-07-07|||September 2008||2008-09-01|July 2011|2011-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Attentional Bias Modification in Patients With Posttraumatic Stress Disorder|Effects of Attentional Bias Modification on Attentional Bias and Symptoms of Posttraumatic Stress Disorder|Completed||Phase 2|80|Anticipated|PsyQ||2|||f||||f||||||||||2017-02-18 13:52:16.652129|2017-02-18 13:52:16.652129
NCT00764088|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-11-24|||August 2007||2007-08-01|November 2015|2015-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||A Retrospective Analysis of Patients With Full Thickness Wounds on a Case by Case Basis|A Retrospective Analysis of Patients With Full Thickness Wounds on a Case by Case Basis|Completed||N/A|4|Actual|Southwest Regional Wound Care Center|||1||f||||t||||||||||2017-02-18 13:52:16.763935|2017-02-18 13:52:16.763935
NCT00764075|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-07-06|||October 2008||2008-10-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|EK138/08||Guided Placement of CRT-Leads|CT and 3D-Echocardiography Placement of CRT-Leads|Completed||N/A|132|Anticipated|RWTH Aachen University||3|||f||||f||||||||||2017-02-18 13:52:16.860563|2017-02-18 13:52:16.860563
NCT00764062|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-09-30|||September 2005||2005-09-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|ODAMOX||Amoxicillin Susceptibility of Oral Streptococci After a 3-Day or a 7-Day Amoxicillin Therapy|Randomized Controlled Trial Short Antibiotic Therapy (3-Day) Versus Long Antibiotic Therapy (7-Day) in Odontology-Stomatology: Impact on the Resistance of Oral Streptococci|Terminated||Phase 4|81|Actual|Assistance Publique - Hôpitaux de Paris||2||The trial was stopped earlier than planned because of the slow accrual rate.|f||||f||||||||||2017-02-18 13:52:16.968828|2017-02-18 13:52:16.968828
NCT00764049|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-02-24|||June 2009||2009-06-01|February 2015|2015-02-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|DACAR||Single Pass Albumin Dialysis in Patients With Cirrhosis|Prospective Pilot Study Assessing Safety and Efficacy of Single Pass Albumin Dialysis in Patients With Acute on Chronic Liver Failure|Completed||Phase 1/Phase 2|11|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:52:17.08157|2017-02-18 13:52:17.08157
NCT00764036|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2011-07-14|||October 2008||2008-10-01|February 2009|2009-02-01|September 2011|Anticipated|2011-09-01|August 2011|Anticipated|2011-08-01||Interventional|ARTIC-M33/2||Study of Artesunate in Metastatic Breast Cancer|Prospective Open Uncontrolled Phase I Study of Compatibility, Safety&Pharmacokinetics of Artesunate, a Semisynthetic Derivative of Artemisinin From the Chinese Herb Artemisia Annua in Patients With Metastatic/Locally Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|Heidelberg University||1|||f||||t||||||||||2017-02-18 13:52:17.194472|2017-02-18 13:52:17.194472
NCT00764023|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-11-24|||March 2008||2008-03-01|November 2015|2015-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host-Microbe Scientific Study|A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune,or Host-Microbe Scientific Study|Completed||N/A|97|Actual|Southwest Regional Wound Care Center|||2||f||||t||||||Samples With DNA|"~     The intent of this protocol is to salvage human-related material that is normally destined~     for destruction, so it can be used in infection-related scientific studies~   "|||2017-02-18 13:52:17.305661|2017-02-18 13:52:17.305661
NCT00764010|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-06-30|||May 1997||1997-05-01|September 2008|2008-09-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|DOIT||Diet and Omega-3 Intervention Trial on Atherosclerosis|Diet and Omega-3 Intervention Trial on Atherosclerosis|Completed||Phase 3|563|Actual|Oslo University Hospital||4|||f||||t||||||||||2017-02-18 13:52:17.401147|2017-02-18 13:52:17.401147
NCT00763997|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2008-09-29|||February 2004||2004-02-01|September 2008|2008-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages|Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation|Completed||N/A|80|Actual|Ruhr University of Bochum||4|||f||||f||||||||||2017-02-18 13:52:17.504963|2017-02-18 13:52:17.504963
NCT00763984|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-01-14|||October 2007||2007-10-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women|PERL 4: Promoting Effective Recovery From Labor|Completed||Phase 3|432|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 13:52:17.614921|2017-02-18 13:52:17.614921
NCT00763971|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2014-06-06|2012-02-27||October 2008||2008-10-01|August 2013|2013-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17|A Phase III, Randomised, Double-Blind, Multicentre, Parallel-Group, Placebo- and Active-Controlled, Dose-Optimisation Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|336|Actual|Shire||3|||f||||||||||||||2017-02-18 13:52:17.742189|2017-02-18 13:52:17.742189
NCT00763958|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2012-05-01|2011-02-04||May 2008||2008-05-01|May 2012|2012-05-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||Relapse Prevention to Reduce HIV Among Women Prisoners|Relapse Prevention to Reduce HIV Among Women Prisoners|Completed||Phase 4|44|Actual|University of Alabama at Birmingham|Slow recruitment with poor retention. Transient population that was difficult to effectively track.|2|||f||||t||||||||||2017-02-18 13:52:18.786929|2017-02-18 13:52:18.786929
NCT00763945|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2009-09-17|||March 2006||2006-03-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|ADMIRE||Infarction Register|Aachen Digital Myocardial Infarction Register|Completed||N/A|5000|Anticipated|RWTH Aachen University|||1||f||||f||||||||||2017-02-18 13:52:19.198068|2017-02-18 13:52:19.198068
NCT00763932|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2014-02-04|||April 2003||2003-04-01|February 2014|2014-02-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies|A Multicenter, Open-Label Extension Study of the Long-Term Safety and Efficacy of Recombinant Human Acid α-Glucosidase (rhGAA) in Patients With Pompe Disease (Glycogen Storage Disease Type II) Who Were Previously Enrolled in Genzyme-Sponsored Enzyme Replacement Therapy Studies|Completed||Phase 2|7|Actual|Sanofi||1|||f||||t||||||||||2017-02-18 13:52:19.296728|2017-02-18 13:52:19.296728
NCT00763919|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2014-10-09|2011-10-24||July 2008||2008-07-01|October 2014|2014-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder|Customized Adherence Enhancement in Bipolar Disorder (CAE in BD)|Completed||N/A|43|Actual|Case Western Reserve University||1|||f||||t||||||||||2017-02-18 13:52:19.404477|2017-02-18 13:52:19.404477
NCT00763906|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2008-09-30|||November 2004||2004-11-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|November 2006|Actual|2006-11-01||Interventional|CATECHOFLOU||Norepinephrine Weaning in Septic Patients|Continuous Administration of Norepinephrine Assisted by Fuzzy Logic Assisted Control in Septic Shock Patients|Completed||Phase 4|40|Actual|Association pour le Développement de la Recherche et de l'Enseignement en Médecine d'Urgence||2|||f||||t||||||||||2017-02-18 13:52:20.142918|2017-02-18 13:52:20.142918
NCT00763893|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2015-11-03|||September 2008||2008-09-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|January 2014|Actual|2014-01-01||Interventional|MARFANSARTAN||Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome|Multicenter, Randomised, Double Blind Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome|Terminated||Phase 3|303|Actual|Assistance Publique - Hôpitaux de Paris||2||"A similar publication has been released, suggesting a beneficial effect of sartans, and only~   15 patients remained to be seen for their visit at 36 months."|f||||t||||||||||2017-02-18 13:52:20.235711|2017-02-18 13:52:20.235711
NCT00763880|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2013-11-18|||November 2005||2005-11-01|November 2013|2013-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Hematoma Block as an Adjunct to Procedural Sedation for Forearm Fracture Reduction|Hematoma Blocks in Forearm Fractures: An Effective Adjunct to Procedural Sedation?|Terminated||Phase 4|89|Actual|Rhode Island Hospital||2||Recruitment was taking longer than originally anticipated.|f||||t||||||||||2017-02-18 13:52:20.35268|2017-02-18 13:52:20.35268
NCT00763867|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2014-07-14|2013-04-04||September 2008||2008-09-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|RELAX||Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study)|Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX)|Completed||Phase 3|216|Actual|Duke University||2|||f||||t||||||||||2017-02-18 13:52:20.474262|2017-02-18 13:52:20.474262
NCT00763841|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-01-19|||September 1999||1999-09-01|November 2009|2009-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations|A Pilot Study Using Transcranial Magnetic Stimulation (TMS) to Investigate the Role of the Temporal Cortex in Schizophrenic Patients With Auditory Hallucinations|Completed||Phase 1|18|Anticipated|The University of New South Wales||2|||f||||f||||||||||2017-02-18 13:52:21.772663|2017-02-18 13:52:21.772663
NCT00763828|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-08-18|||February 2017||2017-02-01|August 2016|2016-08-01|August 2018|Anticipated|2018-08-01|February 2018|Anticipated|2018-02-01||Interventional|CHIPAHA||Can Hypothermia be Incorporated Into Primary Angioplasty for Heart Attack?|Can Hypothermia be Incorporated Into Primary Angioplasty for Heart Attack?|Not yet recruiting||Phase 1|20|Anticipated|Life Recovery Systems||1|||f||||t||||||||||2017-02-18 13:52:21.873465|2017-02-18 13:52:21.873465
NCT00763815|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-10-14|2016-08-18||September 2008||2008-09-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|GETGOAL-P|Safety population included all randomized patients who were exposed to at least 1 dose of study drug, regardless of the amount of treatment administered.|GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone|A Randomized, Double-blind, Placebo-controlled, 2-arm Parallel-group, Multicenter Study With a 24-week Main Treatment Period and an Extension Assessing the Efficacy and Safety of AVE0010 on Top of Pioglitazone in Patients With Type 2 Diabetes Not Adequately Controlled With Pioglitazone|Completed||Phase 3|484|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 13:52:22.007201|2017-02-18 13:52:22.007201
NCT00763802|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2014-04-04|||September 2007||2007-09-01|April 2014|2014-04-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Observational|CPM||Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2|Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2|Completed||N/A|400|Actual|Association for Innovation and Biomedical Research on Light and Image|||1||f||||||||||||||2017-02-18 13:52:23.30479|2017-02-18 13:52:23.30479
NCT00763789|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-01-05|||August 2008||2008-08-01|January 2010|2010-01-01|September 2010|Anticipated|2010-09-01|||||Interventional|||Local Anaesthesia and Remifentanil Sedation Versus Total Intravenous Anaesthesia for Hysteroscopic Surgery in an Ambulatory Surgery Department.|Local Anaesthesia and Remifentanil Sedation Versus Total Intravenous Anaesthesia for Hysteroscopic Surgery in an Ambulatory Surgery Department. A Randomized Clinical Trial.|Unknown status|Recruiting|N/A|96|Anticipated|Copenhagen University Hospital at Herlev||2|||f||||||||||||||2017-02-18 13:52:23.394065|2017-02-18 13:52:23.394065
NCT00763776|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2014-02-26|||July 2008||2008-07-01|January 2011|2011-01-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|SECCI||Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector|Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector : Randomized Comparative Study.|Terminated||N/A|27|Actual|Assistance Publique - Hôpitaux de Paris||2||difficulty for the patient recruiting|f||||f||||||||||2017-02-18 13:52:23.487759|2017-02-18 13:52:23.487759
NCT00763763|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2011-10-04|||December 2004||2004-12-01|October 2011|2011-10-01|January 2010|Actual|2010-01-01|October 2007|Actual|2007-10-01||Interventional|AFR07||Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive|Study to Evaluate Efficacy and Safety of Glivec® in Combination With Vincristine and Dexamethasone in Patients With Lymphoid Blast Crisis CML or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Relapse or Refractory|Completed||Phase 2|55|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:52:23.599906|2017-02-18 13:52:23.599906
NCT00763750|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2014-06-18|2013-05-09||October 2008||2008-10-01|June 2014|2014-06-01|July 2012|Actual|2012-07-01|June 2011|Actual|2011-06-01||Interventional|||BrUOG-Brain-223:A Study of PPX (CT-2103), Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors (CTI # CT2103)|BrUOG-Brain-223-A Phase II Study of PPX (CT-2103), Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors (CTI # CT2103) Principal Investigator: Howard Safran, M.D.|Completed||Phase 2|25|Actual|Brown University||1|||f||||t||||||||||2017-02-18 13:52:23.716801|2017-02-18 13:52:23.716801
NCT00763737|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-12-14|||August 2010||2010-08-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2018|Anticipated|2018-07-01||Interventional|TOTAL moderate||Randomized Controlled Trial of Fetoscopic Endoluminal Tracheal Occlusion With a Balloon Versus Expectant Management During Pregnancy in Fetuses With Left Sided Congenital Diaphragmatic Hernia and Moderate Pulmonary Hypoplasia.|Randomized Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) Versus Expectant Management During Pregnancy in Fetuses With Left Sided and Isolated Congenital Diaphragmatic Hernia and Moderate Pulmonary Hypoplasia.|Recruiting||N/A|196|Anticipated|University Hospital, Gasthuisberg||2|||f||||t||||||||||2017-02-18 13:52:23.991669|2017-02-18 13:52:23.991669
NCT00763724|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-03-09|||June 2008||2008-06-01|March 2010|2010-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults|A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults From a Large U.S. Managed Care Population|Completed||N/A|254432|Actual|Eli Lilly and Company|||7||f||||f||||||||||2017-02-18 13:52:24.141796|2017-02-18 13:52:24.141796
NCT00763711|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2012-01-09|||June 2008||2008-06-01|January 2012|2012-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|NG||Injectable Bulking Agent Needle Guide|Injectable Bulking Agent Needle Guide|Terminated||Phase 1|17|Actual|Carbon Medical Technologies||1|||f||||f||||||||||2017-02-18 13:52:24.221855|2017-02-18 13:52:24.221855
NCT00763698|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2011-09-28|2011-07-26||October 2008||2008-10-01|September 2011|2011-09-01|May 2010|Actual|2010-05-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead|QuickFlex Micro Model 1258T Left Heart Pacing Lead|Completed||N/A|86|Actual|St. Jude Medical||1|||f||||f||||||||||2017-02-18 13:52:24.328731|2017-02-18 13:52:24.328731
NCT00763529|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2008-10-14|||January 2003||2003-01-01|October 2008|2008-10-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Elocon vs Fluticasone in Localized Psoriasis (P03197)(COMPLETED)|Elocon vs Fluticasone in Localized Psoriasis|Completed||Phase 4|245|Actual|Schering-Plough||2|||f||||f||||||||||2017-02-18 13:52:24.635682|2017-02-18 13:52:24.635682
NCT00763516|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2017-01-23|||February 2009||2009-02-01|January 2017|2017-01-01|September 2040|Anticipated|2040-09-01|September 2039|Anticipated|2039-09-01||Interventional|PC02||Proton Radiation for Resectable Carcinoma of the Pancreas|A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas|Active, not recruiting||N/A|8|Actual|University of Florida||1|||f||||t||||||||||2017-02-18 13:52:24.727973|2017-02-18 13:52:24.727973
NCT00763503|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2012-01-06||2010-10-13|September 2008||2008-09-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis|Pharmacokinetic and Pharmacodynamic Study of CD 2027 3µg/g Oily Spray Applied Twice Daily for 3 Weeks Under Conditions of Maximized Use in Adults With Plaque-type Psoriasis|Completed||Phase 2|26|Actual|Galderma||1|||f||||||||||||||2017-02-18 13:52:24.856482|2017-02-18 13:52:24.856482
NCT00763490|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-11-03|2015-01-05||December 2008||2008-12-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|March 2013|Actual|2013-03-01||Interventional|||Trial Of Double Umbilical Cord Blood Transplantation|Trial Of Double Umbilical Cord Blood Transplantation|Completed||Phase 2|20|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 13:52:24.969343|2017-02-18 13:52:24.969343
NCT00763477|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2010-07-26|||April 2010||2010-04-01|July 2010|2010-07-01|April 2011|Anticipated|2011-04-01|February 2011|Anticipated|2011-02-01||Interventional|ghrelin||Ghrelin in Cystic Fibrosis|The Effect of Ghrelin on Appetite and Immune Function in Patients With Cystic Fibrosis|Unknown status|Recruiting|N/A|20|Anticipated|Papworth Hospital||1|||f||||t||||||||||2017-02-18 13:52:25.253495|2017-02-18 13:52:25.253495
NCT00763464|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2011-07-06|||October 2006||2006-10-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|FEMCAD||Coronary Artery Disease (CAD) in Postmenopausal Women|Coronary Artery Disease in Postmenopausal Women. Comparison of Myocardial Szintigraphy With Sress-Echocardiography and Stress-MRI.|Completed||N/A|100|Anticipated|RWTH Aachen University||1|||f||||f||||||||||2017-02-18 13:52:25.362602|2017-02-18 13:52:25.362602
NCT00763256|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-07-10|2012-03-05||May 2006||2006-05-01|July 2015|2015-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||The Effect of Periodontal Treatment and the Use of Dentifrice on Glycaemic Control in Diabetics|The Effect of Periodontal Treatment and the Use of Dentifrice on Glycaemic Control in Diabetics|Completed||Phase 3|33|Actual|Colgate Palmolive||2|||f||||t||||||||||2017-02-18 13:52:31.56297|2017-02-18 13:52:31.56297
NCT00763451|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-10-21|2016-08-18||September 2008||2008-09-01|October 2016|2016-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|GETGOAL-F1|Safety population included all randomized patients who were exposed to at least 1 dose of study drug, regardless of the amount of treatment administered.|GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, 24-week Study Followed by an Extension Assessing the Efficacy and Safety of AVE0010 in Two Titration Regimens on Top of Metformin in Patients With Type 2 Diabetes Not Adequately Controlled With Metformin|Completed||Phase 3|484|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 13:52:25.470188|2017-02-18 13:52:25.470188
NCT00763438|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-30|2016-11-07|||November 2007||2007-11-01|November 2016|2016-11-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|||Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia|A Prospective, Open-label, Single-arm, Multinational, Multi-centre, Flexible-dose, Extension Study of the SCoP 99824 With Sertindole for Patients Suffering From Schizophrenia|Completed||Phase 4|18|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-02-18 13:52:26.992097|2017-02-18 13:52:26.992097
NCT00763425|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-11-17|||September 2008||2008-09-01|November 2015|2015-11-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|COLD||Prospective Randomized Comparison of Cold Snare Polypectomy and Conventional Polypectomy||Completed||N/A|200|Actual|Showa Inan General Hospital||2|||f||||f||||||||||2017-02-18 13:52:27.09984|2017-02-18 13:52:27.09984
NCT00763412|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2013-01-28|||November 2006||2006-11-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis|Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis|Completed||N/A|40|Anticipated|Arbelaez, Ana Maria||2|||f||||t||||||||||2017-02-18 13:52:27.211129|2017-02-18 13:52:27.211129
NCT00763399|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-07-16|||October 2008||2008-10-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Probiotics on Intestinal Bacterial Population and Immune Modulation|Phase 4 Study of Probiotics on Intestinal Bacterial Population and Immune Modulation|Completed||Phase 4|300|Anticipated|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-02-18 13:52:27.376982|2017-02-18 13:52:27.376982
NCT00763386|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-05-25|2011-12-13||June 2001||2001-06-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Compare the NexGen LPS and LPS-Flex Knee Implants|Prospective Randomized Multicenter Study of NexGen LPS-Flex Knee|Completed||N/A|331|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:52:27.632827|2017-02-18 13:52:27.632827
NCT00763373|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2008-09-29|||November 2006||2006-11-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Observational|||Unnecessary IV Antibiotic Days Using General Criteria for Antibiotic Switch|Unnecessary IV Antibiotic Days Using General Criteria for Antibiotic Switch|Completed||Phase 3|187|Actual|Sorlandet Hospital HF|||2||f||||f||||||||||2017-02-18 13:52:28.139601|2017-02-18 13:52:28.139601
NCT00763360|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-12-20|2011-12-20||May 2008||2008-05-01|December 2011|2011-12-01||||September 2010|Actual|2010-09-01||Interventional|||To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.|To Compare the Ability of DiscoVisc® Ophthalmic Viscosurgical Device (OVD) to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.|Completed||Phase 4|184|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 13:52:28.260995|2017-02-18 13:52:28.260995
NCT00763347|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-05-18|||November 2006||2006-11-01|May 2012|2012-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus|A Phase 2, Double-Blind Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate Treatment With SYR-619 in Subjects With Type 2 Diabetes|Terminated||Phase 2|82|Actual|Takeda||6||Voluntarily terminated based on preliminary non-clinical findings.|f||||f||||||||||2017-02-18 13:52:28.776423|2017-02-18 13:52:28.776423
NCT00763321|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-01-08|2013-11-01||September 2008||2008-09-01|January 2014|2014-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)|A Phase 3, Open-Label Period Followed by a Randomized, Double-blind Placebo-controlled Study of the Analgesic Efficacy of Extended-release Hydrocodone/Acetaminophen (Vicodin CR) Compared to Placebo in Subjects With Chronic Low Back Pain|Completed||Phase 3|287|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 13:52:28.912187|2017-02-18 13:52:28.912187
NCT00763308|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2008-09-26|||April 2009||2009-04-01|September 2008|2008-09-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||A Web-Based Cardiovascular Intervention for the Workplace|Fast Track Program to Create a Web-Based Cardiovascular Intervention for the Workplace|Unknown status|Not yet recruiting|Phase 1|300|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||f||||||||||2017-02-18 13:52:29.429798|2017-02-18 13:52:29.429798
NCT00763295|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-28|2012-10-25|||May 2008||2008-05-01|October 2012|2012-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?|Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?|Completed||N/A|53|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 13:52:29.534471|2017-02-18 13:52:29.534471
NCT00763282|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-04-06|2014-11-24||November 2008||2008-11-01|October 2014|2014-10-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional||For the SM+MI arm there was 1 death (post-randomization, pre-data collection) which accounts for the discrepency between starting participants (72) and baseline participants (71) for that group.|Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)|Self-Management to Prevent Ulcers in Veterans With Spinal Cord Injury|Completed||N/A|144|Actual|VA Office of Research and Development|The study was underpowered because of difficulties encountered with recruitment and retention. Delivering an adequate “dose” of the treatments and site coordinator fidelity to the MI intervention were also limitations.|2|||f||||t||||||||||2017-02-18 13:52:29.630891|2017-02-18 13:52:29.630891
NCT00763269|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-03-05|2010-08-24||September 2008||2008-09-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Efficacy of a Toothpaste to Reduce Sensitivity|The Efficacy of a Toothpaste to Reduce Sensitivity|Completed||Phase 3|626|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-02-18 13:52:31.12579|2017-02-18 13:52:31.12579
NCT00763243|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-05-02|||August 2008||2008-08-01|April 2012|2012-04-01|August 2012|Anticipated|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||Pilot Study of the Feasibility and Efficacy of Working Memory Training in Children With Cochlear Implants|Pilot Study of the Feasibility and Efficacy of Working Memory Training in Children With Cochlear Implants|Unknown status|Active, not recruiting|N/A|10|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 13:52:32.03961|2017-02-18 13:52:32.03961
NCT00763230|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-04-29|||April 2008||2008-04-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study of Transcranial Direct Current Stimulation (tDCS) to Treat Depression|A Sham-controlled Study of Transcranial Direct Current Stimulation (tDCS) as a Treatment for Depression|Completed||Phase 2/Phase 3|68|Anticipated|The University of New South Wales||2|||f||||f||||||||||2017-02-18 13:52:32.143049|2017-02-18 13:52:32.143049
NCT00763217|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-05-12|||June 2005||2005-06-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2009|Actual|2009-06-01||Observational|biostroke||Clinical Biological and Pharmacological Factors Influencing Stroke Outcome|Characterization of Clinical, Biological and Pharmacological Markers of Stroke Outcome|Completed||N/A|550|Actual|University Hospital, Lille|||1||f||||f||||||Samples Without DNA|"~     whole blood and serum~   "|||2017-02-18 13:52:32.249202|2017-02-18 13:52:32.249202
NCT00763204|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2008-10-22|||February 2008||2008-02-01|October 2008|2008-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test|A Phase I, Randomized, Observer-Blind, Single-Center, Vehicle- and Comparator-Controlled, Initial Dose-Ranging Study to Assess the Antipsoriatic Efficacy of Different Concentrations of AN2728 Cream in a Psoriasis Plaque Test|Completed||Phase 1|12|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 13:52:32.344576|2017-02-18 13:52:32.344576
NCT00763191|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2012-12-07|||June 2008||2008-06-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Analysis of Oculo-motor Deficiencies Associated With FMR1 Gene Expression (Genetic Abnormality Predisposing to a Neurodegenerative Disease)|Analysis of Oculo-motor Deficiencies Associated With FMR1 Gene Expression (Genetic Abnormality Predisposing to a Neurodegenerative Disease)|Terminated||N/A|27|Actual|Nantes University Hospital||1||departure of the principal investigator and nobody else was able to continue this study.|f||||f||||||||||2017-02-18 13:52:32.464548|2017-02-18 13:52:32.464548
NCT00763178|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2015-04-21|||February 2007||2007-02-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|April 2009|Actual|2009-04-01||Interventional|||Effects of Duloxetine on Fear Conditioning in Posttraumatic Stress Disorder (PTSD)|Effects of Duloxetine on Fear Conditioning in PTSD|Completed||Early Phase 1|26|Actual|Yale University||1|||f||||f||||||||||2017-02-18 13:52:32.550426|2017-02-18 13:52:32.550426
NCT00763165|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2008-09-30|||November 2000||2000-11-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Periodontal Disease and Cardiovascular Disease|Periodontal Disease and Cardiovascular Disease|Unknown status|Active, not recruiting|Phase 3|438|Actual|Colgate Palmolive||2|||f||||t||||||||||2017-02-18 13:52:32.653922|2017-02-18 13:52:32.653922
NCT00763152|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2015-10-13|||September 2008||2008-09-01|October 2015|2015-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||CMT-07-08: The PROstate Bed Evaluation Study|The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed|Completed||N/A|12|Actual|Varian Medical|||1||f||||f||||||||||2017-02-18 13:52:32.752299|2017-02-18 13:52:32.752299
NCT00763139|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-11-12|2014-05-21||April 2009||2009-04-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|September 2012|Actual|2012-09-01||Interventional|||Inflammation and Insulin Resistance in Rheumatoid Arthritis|Inflammation and Insulin Resistance in Rheumatoid Arthritis|Completed||N/A|34|Actual|Vanderbilt University|Study relatively small, but efficiently designed. Crossover design has the advantage of comparing changes in the same patient and the disadvantage that subtle, undetected carryover effects may occur. 8 week drug exposure shorter than most trials.|2|||f||||t||||||||||2017-02-18 13:52:32.853604|2017-02-18 13:52:32.853604
NCT00763126|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-28|2008-09-29|||October 2008||2008-10-01|September 2008|2008-09-01||||October 2009|Anticipated|2009-10-01||Interventional|||Does Having a Spouse Present During Epidural Analgesia Affect Stress Levels in the Parturient and Her Spouse?|The Effect of the Presence of a Spouse on the Parturient's and Her Spouse's Stress Level During Epidural Analgesia During Labor as Measured by Salivary Amylase|Unknown status|Not yet recruiting|N/A|200|Anticipated|Rabin Medical Center||2|||f||||||||||||||2017-02-18 13:52:35.611975|2017-02-18 13:52:35.611975
NCT00763113|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-07-12|||June 2007||2007-06-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Prospective Randomized Study on Vanguard Cruciate Retaining Versus Vanguard High Flex Posterior Stabilized Total Knee System in the Early Range of Motion|A Prospective Randomized Study on Vanguard Cruciate Retaining Versus Vanguard High Flex Posterior Stabilized Total Knee System in the Early Range of Motion|Completed||N/A|173|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:52:35.730173|2017-02-18 13:52:35.730173
NCT00763100|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-01-05|||May 2008||2008-05-01|January 2011|2011-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|BIRADS||Efficacy of Tomosynthesis in the BIRADS 3 Population|The Efficacy of Tomosynthesis in the BIRADS 3 Population Including Surveillance of Patients in the Treatment or Post-Treatment for Breast Cancer|Completed||N/A|690|Anticipated|WellSpan Health|||1||f||||t||||||||||2017-02-18 13:52:35.820335|2017-02-18 13:52:35.820335
NCT00763087|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-03-10|||September 2008||2008-09-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet|Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet|Completed||Phase 1|43|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 13:52:35.907695|2017-02-18 13:52:35.907695
NCT00763074|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2008-12-11|||April 2006||2006-04-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Exercise and Diet in Type 2 Diabetic Women|Clinical Trial of Exercise and Diet in Type 2 Diabetic Women|Completed||N/A|70|Actual|Eulji University Hospital||4|||f||||t||||||||||2017-02-18 13:52:36.020644|2017-02-18 13:52:36.020644
NCT00763061|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-02-23|2009-04-28||May 2006||2006-05-01|February 2010|2010-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension|A Twelve-Week, Double Masked, Parallel Group, Study of Travoprost 0.004% Compared to Timolol 0.5% in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 4|111|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:52:36.114855|2017-02-18 13:52:36.114855
NCT00763048|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-06-10|2010-08-19||March 2008||2008-03-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Collection of Gingival Crevicular Fluid From Periodontitis Patients|Collection of Gingival Crevicular Fluid From Periodontitis Patients|Completed||Phase 3|39|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-02-18 13:52:36.695907|2017-02-18 13:52:36.695907
NCT00763035|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-07-28|||January 2009||2009-01-01|April 2010|2010-04-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)|Comparison of Dobutamine and Regadenoson Stress CMR|Terminated||Phase 4|40|Anticipated|Wake Forest University Health Sciences||2||Potential participants with COPD/asthma unwilling to participate.|f||||f||||||||||2017-02-18 13:52:37.477931|2017-02-18 13:52:37.477931
NCT00763022|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-11-08|||November 2003||2003-11-01|November 2012|2012-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Study of the Safety and Efficacy of TAK-559 Compared to Placebo in the Treatment of Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|302|Actual|Takeda||3|||f||||f||||||||||2017-02-18 13:52:37.586973|2017-02-18 13:52:37.586973
NCT00763009|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-11-08|||September 2002||2002-09-01|November 2012|2012-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Persantine: Variation in Response Trial|Persantine: Variation in Response Trial|Terminated||Phase 4|7|Actual|UConn Health||1||Limited numbers of patients qualified for trial|f||||t||||||||||2017-02-18 13:52:37.687729|2017-02-18 13:52:37.687729
NCT00762996|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-05-05|2008-10-24||August 2007||2007-08-01|May 2015|2015-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Clinical Evaluation of Two Daily Disposable Contact Lenses||Completed||N/A|65|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||f||||||||||2017-02-18 13:52:37.799784|2017-02-18 13:52:37.799784
NCT00762983|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-02-12|||March 2008||2008-03-01|February 2015|2015-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)|Claritin® Tablet 10 mg, Claritin® RediTabs® 10 mg, Claritin® Dry Syrup 1% Drug Use Investigation (Pediatrics)|Completed||N/A|1003|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:52:38.084583|2017-02-18 13:52:38.084583
NCT00762970|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-05-04|2015-07-01||April 2007||2007-04-01|May 2016|2016-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||Baseline summary was conducted on all subjects who randomized in the study.|Controlling Myopia Progression With Soft Contact Lenses||Completed||N/A|150|Actual|Johnson & Johnson Vision Care, Inc.||3|||f||||f||||||||||2017-02-18 13:52:38.182786|2017-02-18 13:52:38.182786
NCT00762957|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-02-24|||November 2004||2004-11-01|February 2012|2012-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Study of the Safety and Efficacy of a Combination of TAK-559 and Metformin Compared to Placebo and Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus|Terminated||Phase 3|15|Actual|Takeda||3||Hepatic Safety Signal Identified.|f||||f||||||||||2017-02-18 13:52:38.669279|2017-02-18 13:52:38.669279
NCT00762944|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-10-17|||September 2005||2005-09-01|October 2011|2011-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Total Temporomandibular Joint Replacement System Post Approval Study|Total Temporomandibular Joint Replacement System Post Approval Study|Completed||N/A|92|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 13:52:38.77997|2017-02-18 13:52:38.77997
NCT00762931|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-03-12|||September 2008||2008-09-01|March 2015|2015-03-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Neurostimulation for the Relief of Acute Bronchoconstriction|Neurostimulation for the Relief of Acute Bronchoconstriction|Completed||Phase 2|25|Actual|ElectroCore LLC||1|||f||||f||||||||||2017-02-18 13:52:38.868181|2017-02-18 13:52:38.868181
NCT00762918|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-02-19|||March 2008||2008-03-01|February 2010|2010-02-01|September 2008|Anticipated|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis|Vitamin D and Its Non-Classic Roles in Cystic Fibrosis|Withdrawn||Phase 3|0|Actual|Children's Hospital of Philadelphia||1||Recruitment|f||||t||||||||||2017-02-18 13:52:38.977746|2017-02-18 13:52:38.977746
NCT00762905|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-01-11|||April 2006||2006-04-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Trial of MedLogic LiquiBand Laparoscopic Versus Dermabond in the Closure of Surgical Incisions|A Prospective, Randomised, Controlled, Double-masked, Multi-center Clinical Trial of MedLogic LiquiBand Laparoscopic Versus Dermabond in the Closure of Surgical Incisions|Completed||N/A|460|Anticipated|MedLogic Global Limited||2|||f||||f||||||||||2017-02-18 13:52:39.076341|2017-02-18 13:52:39.076341
NCT00762892|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-12-19|2014-12-19||January 2009||2009-01-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|RAN||Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients|A Pilot Study--randomized, Prospective, Single Site Trial Evaluating Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients|Completed||Phase 4|33|Actual|The University of Texas Health Science Center, Houston|Limitations are the relatively small sample size and loss to follow-up. Medical records of patients that were lost to follow up was reviewed to ensure that no SAE occurred. We also attempted multiple times to contact patients.|2|||f||||f||||||||||2017-02-18 13:52:39.175635|2017-02-18 13:52:39.175635
NCT00762879|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2017-01-04|||April 2008||2008-04-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|January 2014|Actual|2014-01-01||Observational|Spine QCT||Spine Quantitative Computed Tomography (QCT)|Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children|Active, not recruiting||N/A|127|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||Samples Without DNA|"~     urine~   "|||2017-02-18 13:52:39.853203|2017-02-18 13:52:39.853203
NCT00762866|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-06-08|||September 2008||2008-09-01|June 2015|2015-06-01|December 2022|Anticipated|2022-12-01|December 2020|Anticipated|2020-12-01|2 Weeks|Observational [Patient Registry]|PGPP||Psychiatric Genotype/Phenotype Project Repository|Psychiatric Genotype/Phenotype Project|Enrolling by invitation||N/A|300|Anticipated|Vanderbilt University|||3||f||||f||||||Samples With DNA|"~     Blood, urine, saliva~   "|||2017-02-18 13:52:39.950437|2017-02-18 13:52:39.950437
NCT00751023|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2011-08-04|||February 2009||2009-02-01|November 2009|2009-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Modafinil in Methamphetamine Dependence|Effects of Modafinil in Methamphetamine Dependence|Completed||Phase 4|60|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 13:56:49.367883|2017-02-18 13:56:49.367883
NCT00762853|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-02-16|2010-08-19||May 2008||2008-05-01|August 2010|2010-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Development of Clinical Method to Triclosan Retention in Plaque Following Brushing|Development of Clinical Method to Triclosan Retention in Plaque Following Brushing|Completed||Phase 3|20|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-02-18 13:52:40.048708|2017-02-18 13:52:40.048708
NCT00762840|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2009-06-04|||October 2006||2006-10-01|June 2009|2009-06-01||||April 2010|Anticipated|2010-04-01||Interventional|||Safety and Efficacy of the Apexum Ablator|Clinical Study to Evaluate the Safety and Efficacy of the Apexum Ablator in Subjects With Periapical Lesions Associated With Root Canal Infection|Unknown status|Recruiting|N/A|100|Anticipated|Apexum Ltd.||2|||f||||f||||||||||2017-02-18 13:52:40.411932|2017-02-18 13:52:40.411932
NCT00762827|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-06-24|||November 2005||2005-11-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Impact of Reducing Inflammation on Vascular Function in the Metabolic Syndrome|The Impact of Reducing Inflammation on Vascular Function in the Metabolic Syndrome|Completed||Phase 2/Phase 3|150|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:52:40.520581|2017-02-18 13:52:40.520581
NCT00762814|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2009-06-24|||May 2008||2008-05-01|June 2009|2009-06-01|June 2009|Anticipated|2009-06-01|March 2009|Anticipated|2009-03-01||Interventional|||The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease|The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease|Terminated||Early Phase 1|4|Actual|Washington University School of Medicine||1||There was no funding for the device to be used in the study.|f||||t||||||||||2017-02-18 13:52:40.624334|2017-02-18 13:52:40.624334
NCT00762801|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-10-24|||September 2008||2008-09-01|October 2016|2016-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects|Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects|Withdrawn||N/A|0|Actual|University of North Texas Health Science Center|||1|Principal Investigator left institution.|f||||t||||||||No||2017-02-18 13:52:40.72751|2017-02-18 13:52:40.72751
NCT00762788|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-06-01|2014-09-11||February 2007||2007-02-01|June 2015|2015-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Clinical Trial of Several Contact Lenses in Extended Wear||Completed||N/A|350|Actual|Johnson & Johnson Vision Care, Inc.|Cautions for results: low completed enrollment numbers and number of non-neophytes lower than required per protocol. Arms not gender matched; Proportion of neophytes/non-neophytes not balanced; High rate of drop-out among subjects enrolled.|6|||f||||||||||||||2017-02-18 13:52:40.82805|2017-02-18 13:52:40.82805
NCT00762775|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2014-12-10|||November 2008||2008-11-01|December 2014|2014-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|PTH Modified||The Interaction Between Calcium and Vitamin D Intake|The Interaction Between Calcium and Vitamin D Intake|Completed||N/A|78|Actual|Winthrop University Hospital||4|||f||||f||||||||||2017-02-18 13:52:41.593962|2017-02-18 13:52:41.593962
NCT00762762|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-04-02|2012-04-02||March 2006||2006-03-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Investigate Plaque and Gingival Index|Investigate Plaque and Gingival Index|Completed||Phase 3|46|Actual|Colgate Palmolive||2|||f||||t||||||||||2017-02-18 13:52:41.70842|2017-02-18 13:52:41.70842
NCT00762749|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-10-04|||September 2008||2008-09-01|October 2011|2011-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study to Evaluate Diphenhydramine in Children and Adolescents|An Open-Label, Single-Dose Study Evaluating the Pharmacokinetics of Diphenhydramine in Children and Adolescents|Completed||Phase 1|36|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||f||||||||||2017-02-18 13:52:42.148372|2017-02-18 13:52:42.148372
NCT00762736|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-02-27|||July 2004||2004-07-01|February 2012|2012-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus|A Phase II, Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study of the Efficacy, Safety, and Tolerability of Pioglitazone HCl (ACTOS™) in Combination With TAK-536 in Subjects With Type II Diabetes|Completed||Phase 2|704|Actual|Takeda||6|||f||||f||||||||||2017-02-18 13:52:42.262379|2017-02-18 13:52:42.262379
NCT00762723|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-03-26|2014-02-10||February 2008||2008-02-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Clinical Outcomes of the Trinica(R) Anterior Lumbar Plate: Fixed Screws vs. Variable Screws|A Comparison of Clinical Outcomes Comparing Fixed-angle, Variable-angle, and Hybrid Screw Configuration for the Trinica(R) Anterior Lumbar Plate System|Terminated||N/A|19|Actual|Zimmer Biomet||3||Study was stopped due to slow enrollment|f||||f||||||||||2017-02-18 13:52:42.457321|2017-02-18 13:52:42.457321
NCT00762710|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2013-08-05|||January 2009||2009-01-01|August 2013|2013-08-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Study of the Medication Prazosin for Alcohol Dependence|Clinical Trial of the Adrenergic Alpha-1 Antagonist Prazosin for Alcohol Dependence|Unknown status|Recruiting|Phase 2|150|Anticipated|Seattle Institute for Biomedical and Clinical Research||2|||f||||t||||||||||2017-02-18 13:52:43.00274|2017-02-18 13:52:43.00274
NCT00762697|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-11-24|||June 2007||2007-06-01|November 2015|2015-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Obtaining and Storing Blood Samples and Debridement Samples for Wound Related Research|Obtaining and Storing Blood Samples and Debridement Samples for Wound Related Research|Completed||N/A|20|Actual|Southwest Regional Wound Care Center|||1||f||||t||||||Samples With DNA|"~     Analytical methods used to examine the blood or debridement can investigate morphological,~     molecular, immunological, cellular, viral, biochemical, chemical, genetic, and/or~     transcriptional components of the samples~   "|||2017-02-18 13:52:43.120596|2017-02-18 13:52:43.120596
NCT00762684|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-11-08|||November 2004||2004-11-01|November 2012|2012-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Study of the Safety and Efficacy of TAK-559 Compared to Placebo in the Treatment of Patients With Type 2 Diabetes Mellitus|Terminated||Phase 3|8|Actual|Takeda||2||Hepatic safety signal identified.|f||||f||||||||||2017-02-18 13:52:43.203543|2017-02-18 13:52:43.203543
NCT00762671|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2008-09-29|||May 1999||1999-05-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus|Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus|Completed||Phase 2/Phase 3|60|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 13:52:43.300694|2017-02-18 13:52:43.300694
NCT00762658|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2008-10-22|||November 2007||2007-11-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test|A Phase I, Randomized, Observer-Blind, Single-Center, Vehicle- and Comparator-Controlled, Initial Dose-Ranging Study to Assess the Antipsoriatic Efficacy of Different Concentrations of AN2728 Ointment in a Psoriasis Plaque Test|Completed||Phase 1|12|Actual|Pfizer||6|||f||||f||||||||||2017-02-18 13:52:43.400079|2017-02-18 13:52:43.400079
NCT00762645|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-03-12|2010-01-07||February 2007||2007-02-01|March 2010|2010-03-01||||May 2008|Actual|2008-05-01||Interventional|||Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)|A Twelve-Week, Double Masked, Parallel Group, Primary-Therapy Pilot Study of the Safety and Efficacy of Travoprost 0.004% Compared to Pilocarpine 1% in Patients With Chronic Angle-Closure Glaucoma|Completed||Phase 4|30|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:52:43.517784|2017-02-18 13:52:43.517784
NCT00762632|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2012-08-07|||December 2007||2007-12-01|August 2012|2012-08-01||||June 2012|Actual|2012-06-01||Interventional|||Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia|An Open-label Phase I/II (Proof of Concept) Trial of an Combination of Nilotinib (AMN 107) and RAD001 in Patients With Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|40|Anticipated|Technische Universität München||1|||f||||t||||||||||2017-02-18 13:52:43.842205|2017-02-18 13:52:43.842205
NCT00762619|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-01-04|2010-08-24||April 2007||2007-04-01|January 2011|2011-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Clinical Study to Examine Brushing on Dental Implants|Clinical Study to Examine Brushing on Dental Implants|Completed||Phase 3|105|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-02-18 13:52:43.952388|2017-02-18 13:52:43.952388
NCT00762606|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-10-26|2011-06-07||September 2008||2008-09-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Phaco Versus Small Incision Cataract Surgery (SICS) Health Economic Study|A Twelve-Months, Single-Masked, Parallel Group, Health Economic Study of Phacoemulsification Versus Small Incision Cataract Surgery (SICS) in Chinese Patients With Senile Cataract.|Completed||N/A|106|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:52:45.683142|2017-02-18 13:52:45.683142
NCT00762593|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2008-10-16|||January 2006||2006-01-01|October 2008|2008-10-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|KEAT F1||Trial Evaluating Transvaginal Electrical Stimulation With a Home Use Programmable Device for Urinary Stress Incontinence|A Multicenter Double Blind Randomized Placebo Controlled Trial Evaluating Transvaginal Electrical Stimulation With a Home Use Programmable Device for Urinary Stress Incontinence|Unknown status|Active, not recruiting|Phase 2|150|Actual|Akontis||2|||f||||t||||||||||2017-02-18 13:52:46.220901|2017-02-18 13:52:46.220901
NCT00762580|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-11-03|||January 2006||2006-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|MOON||Features to Predict Success With Nonoperative Treatment of Patients With Rotator Cuff Tears|Features to Predict Success With Nonoperative Treatment of Patients With Rotator Cuff Tears|Active, not recruiting||N/A|380|Anticipated|Vanderbilt University|||1||f||||t||||||||Yes|De Identified data from this cohort is only available to members of the MOON Shoulder Consortium. The member must provide a description of the use of the data to the research coordinator. The data request is then presented to the MOON consortium. A unanimous agreement of the plan by the consortium must be received prior to receiving the data.|2017-02-18 13:52:46.316993|2017-02-18 13:52:46.316993
NCT00762567|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-10-04|||September 2008||2008-09-01|October 2011|2011-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Phenylephrine Pediatric Pharmacokinetic Study|An Open-Label, Single-Dose Study Evaluating the Pharmacokinetics of Phenylephrine in Children and Adolescents|Completed||Phase 1|36|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||f||||||||||2017-02-18 13:52:46.439745|2017-02-18 13:52:46.439745
NCT00762554|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2008-09-29|||October 2008||2008-10-01|September 2008|2008-09-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Depodur vs Fentanyl Infusion for Post-C/S Analgesia|A Comparison of Single Dose Depodur With Fentanyl Infusion for Post-Cesarean Section Analgesia|Unknown status|Not yet recruiting|N/A|300|Anticipated|Goodman, Evan, M.D.||3|||f||||t||||||||||2017-02-18 13:52:46.544447|2017-02-18 13:52:46.544447
NCT00762541|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2013-08-22||2013-08-07|October 2006||2006-10-01|August 2013|2013-08-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Moderate to High Myopia|A Prospective Multicenter Trial To Evaluate The Safety And Effectiveness Of The MEL 80 Excimer Laser Using LASIK (Laser In Situ Keratomileusis) For The Correction Of > -7.00 D to -12.00 D Of Myopia With Up To -6.00 D Of Astigmatism, and Maximum MRSE of ≤ -12.00 D|Completed||N/A|129|Actual|Carl Zeiss Meditec, Inc.||1|||f||||t||||||||||2017-02-18 13:52:46.641647|2017-02-18 13:52:46.641647
NCT00762528|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-08-27|2012-03-05||February 2009||2009-02-01|August 2015|2015-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Compare Anti-inflammatory Dentifrices|Compare Anti-inflammatory Dentifrices|Completed||Phase 4|49|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-02-18 13:52:46.751203|2017-02-18 13:52:46.751203
NCT00762515|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-12-14|2010-08-19||February 2008||2008-02-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Clinical Study to Evaluate the Treatment of Gingivitis of Two Toothpastes|Clinical Study to Evaluate the Treatment of Gingivitis of Two Toothpastes|Completed||Phase 3|44|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-02-18 13:52:47.301087|2017-02-18 13:52:47.301087
NCT00762502|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-05-06|2014-03-28||June 2007||2007-06-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Senofilcon A Toric Lenses to Balafilcon A Toric Lenses Over Extended Wear Period|Comparison of Senofilcon A Toric Lenses to Balafilcon A Toric Lenses Over Extended Wear Period|Completed||N/A|112|Actual|Johnson & Johnson Vision Care, Inc.||3|||f||||f||||||||||2017-02-18 13:52:47.670338|2017-02-18 13:52:47.670338
NCT00762489|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2011-04-28|||October 2008||2008-10-01|April 2011|2011-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Comparison of Three Methods of Taking Temperatures in the Well Baby Nursery|Comparison of Temporal Artery, Axillary, and Rectal Temperatures in Newborn Patients in the Well Baby Nursery.|Completed||N/A|104|Actual|Christiana Care Health Services||2|||f||||f||||||||||2017-02-18 13:52:48.112464|2017-02-18 13:52:48.112464
NCT00762476|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-03-21|2012-02-08||August 2008||2008-08-01|March 2012|2012-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses|A MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II EFFICACY TRIAL OF AV LOTION (FORMULA NO. 3804-250A) FOR THE PREVENTION OF COLD ILLNESS IN HUMAN SUBJECTS|Completed||Phase 2|411|Actual|The Dial Corporation||2|||f||||f||||||||||2017-02-18 13:52:48.216711|2017-02-18 13:52:48.216711
NCT00762463|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2011-07-26|2011-06-17||July 2009||2009-07-01|July 2011|2011-07-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis|A 6-Week, Randomized, Double-Blind, Parallel-Group Study To Evaluate The Symptomatic Effects And Safety Of Celecoxib 200mg QD Compared To Diclofenac 75mg SR QD In Chinese Patients With Ankylosing Spondylitis, With 6-Week Extension Phase Treatment On Celecoxib 400 Mg QD Or Maintaining Double-Blind Phase Therapy|Completed||Phase 3|240|Actual|Pfizer|The protocol does not specify time points for secondary endpoints; these are described in the statistical analysis plan.|2|||f||||f||||||||||2017-02-18 13:52:48.721763|2017-02-18 13:52:48.721763
NCT00762450|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-03-05|2010-12-14||April 2008||2008-04-01|March 2012|2012-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect on Bacterial Glycolytic Acid Formation on Plaque|Effect on Bacterial Glycolytic Acid Formation on Plaque|Completed||Phase 3|6|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-02-18 13:52:49.945633|2017-02-18 13:52:49.945633
NCT00762437|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-27|2011-06-16|||January 2008||2008-01-01|May 2009|2009-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Non-Invasive Cooling of Fat Cells||Completed||N/A|240|Anticipated|Zeltiq Aesthetics||1|||f||||f||||||||||2017-02-18 13:52:50.401134|2017-02-18 13:52:50.401134
NCT00762424|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-12-16|2013-12-16||June 2007||2007-06-01|December 2014|2014-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|Flowmax|results not available|Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis|Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis|Completed||N/A|53|Actual|WellSpan Health||2|||f||||f||||||||||2017-02-18 13:52:50.496243|2017-02-18 13:52:50.496243
NCT00762411|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-01-28|2013-11-06||September 2008||2008-09-01|January 2015|2015-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|IDENTITY-2||Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo|Effect of LY450139 a y-Secretase Inhibitor, on the Progression of Alzheimer's Disease as Compared With Placebo|Completed||Phase 3|1111|Actual|Eli Lilly and Company|All dosing for 4-week post-study drug cessation timeframe outcome measures stopped after protocol-specified interim review showed dose-dependent cognitive/functional worsening for LY450139 participants. No assessments made during 32-week follow up.|2|||f||||t||||||||||2017-02-18 13:52:50.98764|2017-02-18 13:52:50.98764
NCT00762398|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2008-09-29|||September 2008||2008-09-01|September 2008|2008-09-01|July 2009|Anticipated|2009-07-01|December 2008|Anticipated|2008-12-01||Observational|||Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients|Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients|Unknown status|Enrolling by invitation|N/A|100|Anticipated|University of California, Irvine|||1||f||||f||||||Samples With DNA|"~     Blood sample for the measurement of Hct, and ABG~   "|||2017-02-18 13:52:53.533174|2017-02-18 13:52:53.533174
NCT00762385|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-05-05|2008-12-05||August 2007||2007-08-01|May 2015|2015-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Clinical Comparison of Two Silicone-Hydrogel Contact Lenses||Completed||N/A|97|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 13:52:53.673835|2017-02-18 13:52:53.673835
NCT00762372|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-08-16|||February 2008||2008-02-01|August 2011|2011-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane)|Phase 2/3 Clinical Study With BLM-240 in Adult Surgery Patients That Need General Anesthesia|Completed||Phase 2/Phase 3|216|Actual|Baxter Healthcare Corporation||3|||f||||f||||||||||2017-02-18 13:52:53.923857|2017-02-18 13:52:53.923857
NCT00762359|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-02-01|2011-02-03||May 2007||2007-05-01|February 2012|2012-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers|A Study to Investigate the Preventive Effect of AG-1749 Against the Recurrence of Gastric And Duodenal Ulcers During Long-Term Treatment With Low Dose Aspirin.|Terminated||Phase 3|461|Actual|Takeda|On September 2008, the Efficacy and Safety Evaluation Committee recommended that this study be discontinued based on the interim analysis.|2||AG-1749 superior to Gefarnate in ulcer prevention|f||||t||||||||||2017-02-18 13:52:54.055571|2017-02-18 13:52:54.055571
NCT00762346|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2013-12-08|||September 2008||2008-09-01|December 2011|2011-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis|Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis|Completed||Phase 4|156|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-02-18 13:52:58.228273|2017-02-18 13:52:58.228273
NCT00762333|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-10-05|||June 2007||2007-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Circulating Markers for Ischemic Heart Disease|Circulating Markers for Ischemic Heart Disease|Recruiting||N/A|550|Anticipated|UConn Health|||1||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 13:52:58.32363|2017-02-18 13:52:58.32363
NCT00762320|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2014-02-05|2013-11-14||October 2008||2008-10-01|February 2014|2014-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Comparison of Liquid Kaletra and Low Dose Kaletra Tablets|Comparison of Liquid Kaletra and Low Dose Kaletra Tablets in HIV-Positive Children|Completed||N/A|8|Actual|Phoenix Children's Hospital|Early termination leading to small number of subjects analyzed.|1|||f||||f||||||||||2017-02-18 13:52:58.427352|2017-02-18 13:52:58.427352
NCT00762307|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-27|2012-01-04|||January 2007||2007-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Non-invasive Cooling of Subcutaneous Fat||Completed||N/A|192|Actual|Zeltiq Aesthetics||1|||f||||f||||||||||2017-02-18 13:52:58.806387|2017-02-18 13:52:58.806387
NCT00762294|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-12-14|||May 2007||2007-05-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Anastrozole and Letrozole|Effect Of Anastrozole And Letrozole On Bone Turnover Markers And Bone Mineral Density In Postmenopausal Women With Primary Breast Cancer: A Pilot Study|Completed||N/A|25|Actual|UConn Health|||1||f||||f||||||||||2017-02-18 13:52:58.888646|2017-02-18 13:52:58.888646
NCT00762281|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-08-09|||July 2004||2004-07-01|August 2012|2012-08-01|October 2008|Actual|2008-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Effectiveness Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Hyperopia|A Prospective, Randomized, Multicenter Trial To Evaluate The Safety And Effectiveness Of The MEL 80 Excimer Laser Using LASIK (Laser In Situ Keratomileusis) For The Correction Of ≤ +6.0 D Of Hyperopia With Or Without Astigmatism Of +0.50 D To +3.50 D And MRSE ≤ +6.50 D|Completed||N/A|189|Actual|Carl Zeiss Meditec, Inc.||1|||f||||t||||||||||2017-02-18 13:52:59.184482|2017-02-18 13:52:59.184482
NCT00762268|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-08-25|2014-06-17||September 2008||2008-09-01|August 2014|2014-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||Individuals entering the treatment phase of the study.|A Trial of SAMe for Treatment-Resistant Bipolar Depression|Intermittent-Dose Oral SAMe (S-adenosyl-L-methionine) in Persistent and Treatment-Refractory Bipolar Depression: A Double-Blind Pilot Trial With an Optional Open-label Follow-up|Completed||N/A|17|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 13:52:59.298265|2017-02-18 13:52:59.298265
NCT00762255|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2013-07-24|||September 2008||2008-09-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma|A Phase I Trial of Vorinostat in Combination With Bevacizumab and Irinotecan in Recurrent Glioblastoma|Completed||Phase 1|19|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-02-18 13:52:59.670416|2017-02-18 13:52:59.670416
NCT00762242|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-12-08|||May 2007||2007-05-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|||Metabolomic Profiling of Novel Mediators of Vascular Function|Metabolomic Profiling of Novel Mediators of Vascular Function|Terminated||N/A|48|Actual|Brigham and Women's Hospital|||1|Study enrollment was no adequate.|f||||t||||||Samples Without DNA|"~     plasma samples for assays of novel biomarkers~   "|||2017-02-18 13:52:59.785424|2017-02-18 13:52:59.785424
NCT00762229|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2013-06-12|2013-04-17||July 2007||2007-07-01|June 2013|2013-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe)|Prospective Evaluation of LDL Levels in Patients Converted From Zetia (Ezetimibe)10 mg to 5 mg|Completed||N/A|39|Actual|Bronx VA Medical Center||2|||f||||t||||||||||2017-02-18 13:52:59.881877|2017-02-18 13:52:59.881877
NCT00762216|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-10-26|2010-04-14||May 2008||2008-05-01|May 2010|2010-05-01||||June 2009|Actual|2009-06-01||Interventional|||Rotational Stability of the AcrySof® Toric|Rotational Stability of the AcrySof® Toric|Completed||N/A|71|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:53:00.313775|2017-02-18 13:53:00.313775
NCT00762190|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-11-08|||November 2003||2003-11-01|November 2012|2012-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus|A Multicenter, Double-Blind, Placebo-Controlled, Randomized Study of the Safety of TAK-559 in the Treatment of Patients With Type 2 Diabetes Mellitus|Terminated||Phase 3|348|Actual|Takeda||2||Hepatic safety signal identified.|f||||f||||||||||2017-02-18 13:53:00.520884|2017-02-18 13:53:00.520884
NCT00762177|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2011-02-22|2010-12-14||May 2008||2008-05-01|February 2011|2011-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Investigate Oral Bacteria in Adult Population|Investigate Oral Bacteria in Adult Population|Completed||Phase 3|24|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-02-18 13:53:00.634313|2017-02-18 13:53:00.634313
NCT00762164|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2013-04-19|2013-04-16||March 2007||2007-03-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol|Comparative Efficacy of a Vytorin 10/80 Tablet Split Into 4 (Estimated Dose Ezetimibe 2.5 + Simvastatin 20) Versus Simvastatin 20 Milligrams on LDL Cholesterol|Completed||Phase 4|34|Actual|Bronx VA Medical Center||2|||f||||f||||||||||2017-02-18 13:53:01.7517|2017-02-18 13:53:01.7517
NCT00762151|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-06-22|||November 2007||2007-11-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste|Clinical Research Study to Investigate the Anti-Plaque Effect of a Prototype Toothpaste Containing an Anacor Material Via the MGMPI Method|Completed||Phase 1|18|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 13:53:02.120879|2017-02-18 13:53:02.120879
NCT00762138|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2014-02-25|||September 2008||2008-09-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|TAPS||The AutoloGel™ Post-Market Surveillance (TAPS) Program|The AutoloGel™ Post-Market Surveillance (TAPS) Program|Terminated||N/A|131|Actual|Cytomedix||1||Discontinued due to favorable results|f||||t||||||||||2017-02-18 13:53:02.426922|2017-02-18 13:53:02.426922
NCT00762125|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-12-01|||December 2005||2005-12-01|December 2014|2014-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Subgroups of Fibromyalgia Syndrome (FMS): Symptoms, Beliefs, and Tailored Treatment|Subgroups of Fibromyalgia Syndrome (FMS): Symptoms, Beliefs, and Tailored Treatment|Completed||Phase 2|266|Actual|University of Washington||4|||f||||||||||||||2017-02-18 13:53:02.537843|2017-02-18 13:53:02.537843
NCT00762112|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-11-08|||November 2003||2003-11-01|November 2012|2012-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus|A Long-Term, Open-Label, Phase 3a Safety Study of Oral TAK-559 (32 mg QD) in the Treatment of Patients With Type 2 Diabetes Mellitus|Terminated||Phase 3|316|Actual|Takeda||1||Hepatic safety signal identified.|f||||f||||||||||2017-02-18 13:53:02.641703|2017-02-18 13:53:02.641703
NCT00762099|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2011-04-07|||May 2009||2009-05-01|April 2011|2011-04-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|RCT||Perioperative Pregabalin Use, Rehabilitation, Pain Outcomes and Anxiety Following Hip Surgery|The Short and Long Term Effects of Perioperative Pregabalin Use on Functional Rehabilitation, Pain Outcomes and Anxiety Following Total Hip Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.|Unknown status|Recruiting|Phase 4|184|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 13:53:02.741022|2017-02-18 13:53:02.741022
NCT00762086|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-28|2012-08-27|2012-07-23||March 2009||2009-03-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Safety and Efficacy Study of a New Intermittent Pneumatic Compression Device to Treat Patients With Peripheral Arterial Disease (PAD) Stage II|A Prospective, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of a New Intermittent Pneumatic Compression Device on Initial Claudication Distance in Patients With Peripheral Arterial Disease Stage II.|Completed||N/A|67|Actual|Mego Afek Ltd.||2|||f||||f||||||||||2017-02-18 13:53:02.861281|2017-02-18 13:53:02.861281
NCT00761878|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2009-07-03|||December 2007||2007-12-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of the PlasmaJet Neutral Argon Plasma System to Treat Skin Ageing|Evaluation of the PlasmaJet Neutral Argon Plasma System for Skin Regeneration and Comparison With the Rhytec Portrait PSR Plasma System|Completed||N/A|35|Actual|Plasma Surgical Inc||1|||f||||f||||||||||2017-02-18 13:53:09.372501|2017-02-18 13:53:09.372501
NCT00484042|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2007-06-07|||January 2006||2006-01-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Observational|||Activation of Polyamine Catabolism in Patients With Acute Pancreatitis||Completed||N/A|||University of Tampere|||||f||||t||||||||||2017-02-18 15:33:41.385798|2017-02-18 15:33:41.385798
NCT00762073|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-09-02|2015-08-03||November 2008||2008-11-01|March 2014|2014-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||The Safety Analysis Set, defined as all randomized participants who received at least one dose of double-blind study drug. Treatment group assignment was the treatment actually received. One participant in the medium dose group was enrolled and randomized then withdrew consent and did not receive study drug.|Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis|Oral Viscous Budesonide Suspension (MB-7) in Subjects With Eosinophilic Esophagitis: A Randomized, Placebo-Controlled, Dose-Ranging Study in Children and Adolescents|Completed||Phase 2|82|Actual|Shire||4|||f||||f||||||||||2017-02-18 13:53:03.262515|2017-02-18 13:53:03.262515
NCT00762060|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-03-17|||November 2006||2006-11-01|December 2014|2014-12-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Observational|MISS||Multicenter Infection Surveillance Study Following Colorectal Procedures|Phase IV Multicenter Infection Surveillance Study Following Colorectal Procedures|Completed||N/A|289|Actual|Halyard Health|||2||f||||f||||||||||2017-02-18 13:53:04.477819|2017-02-18 13:53:04.477819
NCT00762047|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2013-07-29|||June 2004||2004-06-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||A Prospective, Multi-center, Randomized, Blinded Study to Evaluate Durasphere FI for the Treatment of Fecal Incontinence|Phase 2 IDE Study of Durasphere FI in the Treatment of Fecal Incontinence|Terminated||Phase 2|90|Actual|Carbon Medical Technologies||2|||f||||f||||||||||2017-02-18 13:53:04.582763|2017-02-18 13:53:04.582763
NCT00762034|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-11-16|2013-03-28||December 2008||2008-12-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|April 2012|Actual|2012-04-01||Interventional||All randomized participants.|A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer|Randomized, Open-Label, Phase 3 Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer|Completed||Phase 3|939|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 13:53:04.693001|2017-02-18 13:53:04.693001
NCT00762021|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-11-24|2010-09-30||December 2006||2006-12-01|November 2010|2010-11-01||||August 2009|Actual|2009-08-01||Interventional|||Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens||Completed||N/A|104|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:53:06.913765|2017-02-18 13:53:06.913765
NCT00762008|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-10-05|||December 2005||2005-12-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure|Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure|Recruiting||N/A|500|Anticipated|UConn Health|||1||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 13:53:07.268666|2017-02-18 13:53:07.268666
NCT00761995|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-07-17|||February 2009||2009-02-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension||Completed||Phase 4|200|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:53:07.372897|2017-02-18 13:53:07.372897
NCT00761982|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-28|2011-11-27|||September 2008||2008-09-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.|Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment|Completed||Phase 1/Phase 2|20|Anticipated|Hospital Universitario Central de Asturias||1|||f||||f||||||||||2017-02-18 13:53:07.469085|2017-02-18 13:53:07.469085
NCT00761969|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-28|2015-11-12|2015-09-29||December 2004||2004-12-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|PID-PAB||Prevention of Ischemic Events in Patients With Peripheral Arterial Disease|Prevention of Ischemic Events in Patients With Peripheral Arterial Disease by the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice|Completed||Phase 4|1455|Actual|KRKA|||2||f||||t||||||Samples With DNA|"~     blood (16 ml) for analysis of inflammatory markers (from serum) and genotyping, to be~     correlated with clinical outcomes.~      Anonymity of patients is proveded by coding the samples and the patients clinical records.~   "|||2017-02-18 13:53:07.578509|2017-02-18 13:53:07.578509
NCT00761956|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-06-12|2012-04-02||September 2004||2004-09-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Compare the NexGen CR and CR-Flex Knee Implants|Prospective Randomized Multicenter Study of NexGen CR-Flex Knee|Completed||N/A|189|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:53:08.023676|2017-02-18 13:53:08.023676
NCT00761943|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-07-21|||December 2006||2006-12-01|July 2015|2015-07-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Observational|||Correlating Clinical Disease State With Color Doppler Ultrasound|"Adhesive Capsulitis-Correlating Clinical Disease State With Color Doppler Ultrasound"|Completed||N/A|30|Actual|Vanderbilt University|||1||f||||t||||||||||2017-02-18 13:53:08.437804|2017-02-18 13:53:08.437804
NCT00761930|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2013-08-08|2010-08-19||March 2008||2008-03-01|August 2013|2013-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Compare the Clinical Efficacy of Prototype Toothpastes.|Compare the Clinical Efficacy of Prototype Toothpastes.|Completed||Phase 3|103|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-02-18 13:53:08.533764|2017-02-18 13:53:08.533764
NCT00761917|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-03-30|||June 2008||2008-06-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Observational|||Diagnostic Evaluation of the Tear Film|Analysis of the Tear Film Lipid Layer|Completed||N/A|229|Actual|TearScience, Inc.|||2||f||||f||||||||||2017-02-18 13:53:09.04949|2017-02-18 13:53:09.04949
NCT00761904|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-05-03|||December 2010||2010-12-01|May 2010|2010-05-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|SAMPLES||The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians|A Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples|Unknown status|Not yet recruiting|N/A|660|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:53:09.152424|2017-02-18 13:53:09.152424
NCT00761891|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-12-04|||May 2007||2007-05-01|December 2015|2015-12-01|January 2010|Actual|2010-01-01|May 2008|Actual|2008-05-01||Interventional|||Validation of an Assay to Measure Cyclooxygenase-1 Activity|Validation of an Ex Vivo Cyclooxygenase-1 Catalytic Assay in Humans|Completed||N/A|60|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:53:09.25884|2017-02-18 13:53:09.25884
NCT00453596|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2007-03-28||||||March 2007|2007-03-01||||||||Observational|||Analysis of Implantation Failure and Establishment of Therapy for Implantation Failure||Unknown status|Recruiting|N/A|||Yamaguchi University Hospital|||||f||||||||||||||2017-02-18 15:44:54.409159|2017-02-18 15:44:54.409159
NCT00761852|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2008-09-29|||May 1999||1999-05-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Signaling Mechanisms and Vascular Function in Diabetes Mellitus|Signaling Mechanisms and Vascular Function in Diabetes Mellitus|Completed||Phase 2/Phase 3|30|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 13:53:09.988062|2017-02-18 13:53:09.988062
NCT00761839|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2015-05-05|||July 2008||2008-07-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Does Use of a Wound After-care Summary Improve Patient Satisfaction and Time to Wound Healing?|Does Use of a Wound After-care Summary Improve Patient Satisfaction and Time to Wound Healing?|Withdrawn||N/A|0|Actual|VA Office of Research and Development||2||"Study was withdrawn because of a problem with the software used for generating the aftercare~   summary."|f||||f||||||||||2017-02-18 13:53:10.082854|2017-02-18 13:53:10.082854
NCT00761826|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2013-08-22||2013-08-07|January 2007||2007-01-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Mixed Astigmatism|A Prospective Multicenter Trial To Evaluate The Safety And Effectiveness Of The MEL 80 Excimer Laser Using LASIK (Laser In Situ Keratomileusis) For The Correction Of Naturally Occuring Mixed Astigmatism Up To 6.0 D|Completed||N/A|126|Actual|Carl Zeiss Meditec, Inc.||1|||f||||t||||||||||2017-02-18 13:53:10.179176|2017-02-18 13:53:10.179176
NCT00761813|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-06-13|||March 2009||2009-03-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Using Alternative Implants for the Surgical Treatment of Hip Fractures (The FAITH Study)|Fixation Using Alternative Implants for the Treatment of Hip Fractures: A Multi-Centre Randomized Trial Comparing Sliding Hip Screws and Cancellous Screws on Revision Surgery Rates and Quality of Life in the Treatment of Femoral Neck Fractures|Completed||Phase 3|1079|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 13:53:10.282115|2017-02-18 13:53:10.282115
NCT00761800|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-29|2009-05-28|||May 2008||2008-05-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Dermacyd Teen Care Tangerina Mix - Compatibility|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermal Irritability, Dermal Sensitivity) of Dermacyd Teen Care Tangerina Mix .|Completed||Phase 3|51|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:53:10.415536|2017-02-18 13:53:10.415536
NCT00761787|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2009-03-05|||May 2005||2005-05-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|CARGOII||Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY|Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY|Completed||N/A|800|Anticipated|XDx|||1||f||||f||||||Samples Without DNA|"~     venous blood whole blood white blood cells~   "|||2017-02-18 13:53:10.494508|2017-02-18 13:53:10.494508
NCT00761774|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2017-02-08|||November 2008||2008-11-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam|An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Used at a Flexible Dose up to a Maximum of 200 mg/Day in Subjects Aged 16 Years or Older Suffering From Epilepsy.|Active, not recruiting||Phase 3|108|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 13:53:10.595552|2017-02-18 13:53:10.595552
NCT00761761|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-03-14|2015-02-19||October 2008||2008-10-01|March 2016|2016-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Sensoril(Ashwaganhda)for Bipolar Disorder|Sensoril® (Ashwagandha) - A Standardized Extract From a Medicinal Plant - (Withania Somnifera) for Cognitive Enhancement in Persons With Bipolar Disorder: A Parallel Group, Randomized Double Blind, and Placebo Controlled Study|Completed||Phase 3|60|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:53:10.762997|2017-02-18 13:53:10.762997
NCT00761748|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-11-29|2010-03-08||September 2008||2008-09-01|November 2012|2012-11-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Comparison of Two Urostomy Bags (2-piece).|A Comparative, Randomised, Crossover Study With SenSura Uro 2-piece Versus ConvaTec 2-piece Among 30 Urostomy-operated Persons in Germany|Completed||Phase 3|30|Actual|Coloplast A/S||2|||f||||f||||||||||2017-02-18 13:53:11.199791|2017-02-18 13:53:11.199791
NCT00761735|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-09-11|2013-10-28||July 2007||2007-07-01|September 2015|2015-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2)|Assessment of the Safety, Efficacy, Tolerability and Pharmacokinetics of PEG-Intron® Plus REBETOL® in Pediatric Patients With Chronic Hepatitis C|Completed||Phase 3|94|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 13:53:11.636575|2017-02-18 13:53:11.636575
NCT00761722|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-12-14|||August 2008||2008-08-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|RACE||Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma|A Phase I, Dose-Ranging Study to Evaluate the Pharmacokinetics and Safety of Azacitidine Administered Subcutaneously (SC) and as Different Oral Formulations in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML), Lymphoma, and Multiple Myeloma|Completed||Phase 1|31|Actual|Celgene Corporation||2|||f||||f||||||||||2017-02-18 13:53:12.080027|2017-02-18 13:53:12.080027
NCT00761709|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-07-11||2014-07-10|July 2009||2009-07-01|July 2014|2014-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 2|104|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 13:53:12.203947|2017-02-18 13:53:12.203947
NCT00761696|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-06-19|||September 2008||2008-09-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies|A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies|Completed||Phase 1|94|Actual|Infinity Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:53:12.300561|2017-02-18 13:53:12.300561
NCT00761683|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2009-09-08|||October 2008||2008-10-01|September 2009|2009-09-01||||||||Observational|ESIS||Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS|Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSIS|Terminated||N/A|105|Anticipated|AstraZeneca|||1|"Anticipated number of patients not achieved. All Patients recruited in the study completed all~   study visits."|f||||f||||||||||2017-02-18 13:53:12.403861|2017-02-18 13:53:12.403861
NCT00346411|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2006-06-28||||||May 2006|2006-05-01||||||||Observational|||Health Outcomes in Rheumatoid Arthritis|Health Outcomes in Rheumatoid Arthritis|Unknown status|Recruiting|N/A|260||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:26:07.734268|2017-02-18 16:26:07.734268
NCT00761670|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-12-08|||September 2008||2008-09-01|December 2010|2010-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|AMIMIND||Efficacy Study on Cognitive Functions in Schizophrenic Patients|Comparative Efficacy of Amisulpride vs Risperidone on Cognitive Functions in Patients With Chronic Schizophrenia|Completed||Phase 4|37|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:53:12.493807|2017-02-18 13:53:12.493807
NCT00761657|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-01-28|||November 2008||2008-11-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Phase 2 Study of FG-4592 in Subjects With Anemia and Chronic Kidney Disease Not Requiring Dialysis|A Randomized, Single-blind, Placebo-controlled, 4-Week Treatment Study of the Safety and Biologic Activity of Escalating Multiple Oral Doses of FG-4592 in Subjects With Chronic Kidney Disease Not Requiring Dialysis|Completed||Phase 2|117|Actual|FibroGen||7|||f||||t||||||||||2017-02-18 13:53:12.593059|2017-02-18 13:53:12.593059
NCT00761644|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-09-06|||August 2008||2008-08-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Doxil, Bevacizumab and Temsirolimus Trial|A Phase I Trial of Doxil, Bevacizumab and Temsirolimus|Completed||Phase 1|200|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:53:12.718948|2017-02-18 13:53:12.718948
NCT00761631|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-05-30|2011-07-15||December 2008||2008-12-01|May 2013|2013-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years|A Phase 3, Open Label Trial Evaluating the Safety,Tolerability and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine in Healthy Children Aged 15 Months to 17 Years in the United States|Completed||Phase 3|1200|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:53:13.012156|2017-02-18 13:53:13.012156
NCT00761618|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-11-23|||March 2009||2009-03-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||Intrapleural Catheter Daily Versus Three Times a Week Drainage|Effectiveness of Daily Versus Three Times a Week Drainage After Placement of Intrapleural Catheters for the Palliative Management of Pleural Effusions Associated With Malignancies|Active, not recruiting||Phase 3|280|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 13:53:15.558754|2017-02-18 13:53:15.558754
NCT00761605|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-09-03|2014-01-24||April 2008||2008-04-01|September 2014|2014-09-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|PASS||Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants|An Open-label Prospective, Non-comparative Study to Evaluate the Subjective Experiences Upon Transition to Paliperidone Extended Release(ER) in Subjects With Schizophrenia|Completed||Phase 4|387|Actual|Janssen Korea, Ltd., Korea|Some Adverse Events summaries were reported based on estimates due to the fact that they were not prepared in the original study report and the relevant definitions of the data elements were not available for these summaries to be regenerated.|1|||f||||f||||||||||2017-02-18 13:53:15.706695|2017-02-18 13:53:15.706695
NCT00761592|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-10-25|2009-01-30||July 2006||2006-07-01|October 2013|2013-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm||Completed||Phase 4|65|Actual|Allergan|This was a pilot study.|2|||f||||f||||||||||2017-02-18 13:53:16.176881|2017-02-18 13:53:16.176881
NCT00761579|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-05-01|2014-01-16||April 2008||2008-04-01|May 2014|2014-05-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|PERFECT||Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission|An Open-Label Prospective, Non-Comparative Study To Explore The Tolerability, Safety and Effectiveness Upon Transition to Paliperidone Slow-Release Tablet in Schizophrenic Patients|Completed||Phase 4|190|Actual|Janssen Korea, Ltd., Korea|Some Adverse Events summaries were reported based on estimates due to the fact that they were not prepared in the original study report and the relevant definitions of the data elements were not available for these summaries to be regenerated.|1|||f||||f||||||||||2017-02-18 13:53:16.734205|2017-02-18 13:53:16.734205
NCT00761566|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2013-08-14|||October 2008||2008-10-01|August 2013|2013-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Effect of Remote Preconditioning on the Exercise Performance of the Elite Swimmers|Double Blind Randomized Controlled Trial of the Effect of Remote Preconditioning on the Exercise Performance of the Elite Swimmers|Completed||Phase 2|24|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 13:53:17.302468|2017-02-18 13:53:17.302468
NCT00761553|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-01-16|||October 2005||2005-10-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||Dietary Supplements and Exercise in Aging Adults||Completed||N/A|49|Actual|Purdue University||4|||f||||||||||||||2017-02-18 13:53:17.399772|2017-02-18 13:53:17.399772
NCT00761540|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2017-01-25|||October 2008||2008-10-01|January 2017|2017-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo|A Dose Escalation Study to Investigate the Pharmacokinetics, Tolerability and Safety of Liraglutide After Multiple s.c. Doses in Healthy Chinese Male Subjects|Completed||Phase 1|37|Actual|Novo Nordisk A/S||6|||f||||f||||||||||2017-02-18 13:53:17.488879|2017-02-18 13:53:17.488879
NCT00761527|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2015-07-15|2011-11-04||March 2008||2008-03-01|July 2015|2015-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)|Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Desloratadine Syrup Among Filipino Pediatric Patients|Completed||N/A|2980|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:53:17.604279|2017-02-18 13:53:17.604279
NCT00761514|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2009-10-23|2009-08-26||November 2006||2006-11-01|October 2009|2009-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|VIVIR||Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira|Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira as Their First Anti-TNF Monoclonal Antibody (VIVIR)|Terminated||Phase 4|14|Actual|Abbott|This study was terminated early due to lack of enrollment. Only 7 subjects completed 24 weeks of treatment. That number is too small to provide reliable data on the effectiveness of the treatment.|1||The study was terminated due to low enrollment.|f||||f||||||||||2017-02-18 13:53:17.862116|2017-02-18 13:53:17.862116
NCT00761332|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-06-20|||February 2008||2008-02-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Back Pain in Patients With Severe Osteoporosis|An Observational Study to Assess Back Pain in Patients With Severe Osteoporosis Treated With Teriparatide Versus Antiresorptives|Completed||N/A|650|Actual|Eli Lilly and Company|||2||f||||f||||||||||2017-02-18 13:53:20.944922|2017-02-18 13:53:20.944922
NCT00761501|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2010-12-07|||September 2008||2008-09-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E|Phase I, Open-label, Randomized, 3-way Crossover Study to Assess Relative Bioavailability of Single Oral Dose of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E in Healthy Volunteers|Completed||Phase 1|38|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 13:53:18.127463|2017-02-18 13:53:18.127463
NCT00761488|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2015-05-08||||||January 2010|2010-01-01||||||||Interventional|||Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric||Withdrawn||Phase 4|0|Actual|Alcon Research||1||Primary Investigator resigned from hospital|f||||||||||||||2017-02-18 13:53:18.236369|2017-02-18 13:53:18.236369
NCT00761475|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-10-27|||February 2009||2009-02-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|December 2012|Actual|2012-12-01||Interventional|PRIMA||Primary Mesh Closure of Abdominal Midline Wounds|Primary Mesh Closure of Abdominal Midline Wounds; a Prospective Randomized Multicenter Trial|Completed||Phase 3|480|Actual|Erasmus Medical Center||3|||f||||t||||||||||2017-02-18 13:53:18.329545|2017-02-18 13:53:18.329545
NCT00761462|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-07-13|2008-12-19||October 1999||1999-10-01|July 2015|2015-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||BAY 0 9867 Cipro Pediatric Use Study (QUIP)|A Prospective, Open-label, Non-randomized, Naturalistic, Long-term Safety Surveillance, Observational Study of Either Ciprofloxacin (Either as Oral Suspension, Oral Tablets or Sequential IV Followed by Oral Therapy or Purely IV Therapy) or a Non-quinolone Antibiotic (Either as Oral Suspension, Oral Tablets or Sequential IV Followed by Oral Therapy or Purely IV Therapy) in the Treatment of Pediatric Patients With Infectious Diagnoses|Completed||Phase 3|1029|Actual|Bayer|The study was not randomized or blinded; the demographic and baseline infection characteristics were not comparable for the treatment groups; the long term followup times were different for the two groups (5 year versus 2 years).|2|||f||||t||||||||||2017-02-18 13:53:18.461028|2017-02-18 13:53:18.461028
NCT00761449|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2012-04-26|||October 2007||2007-10-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5|A Multicentre Phase II Study of the Efficacy and Safety of Lenalidomide in High-risk Myeloid Disease (High-risk MDS and AML) With a Karyotype Including Del(5q) or Monosomy 5|Completed||Phase 2|28|Actual|Nordic MDS Group||1|||f||||t||||||||||2017-02-18 13:53:19.619513|2017-02-18 13:53:19.619513
NCT00761436|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-11-27|||February 2000||2000-02-01|November 2014|2014-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pilot Study of Safety and Efficacy of Spheramine|Stereotactic Intrastriatal Implantation of Spheramine in Advanced Parkinson's Disease Patients: A Pilot Study of Tolerability and Efficacy.|Terminated||Phase 2|6|Actual|Bayer||1||Study was completed, only life long extended follow-up phase was discontinued after 12 years|f||||f||||||||||2017-02-18 13:53:19.902172|2017-02-18 13:53:19.902172
NCT00761423|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-12-05|||August 2008||2008-08-01|December 2011|2011-12-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|PRICT||The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial|The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial|Completed||Phase 4|81|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:53:19.992716|2017-02-18 13:53:19.992716
NCT00761410|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-06-17|||October 2004||2004-10-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|February 2010|Actual|2010-02-01||Interventional|||A Study to Determine the Performance of the Press Fit Condylar (P.F.C.) Sigma RP-F Knee System|A Prospective, Non-Comparative Multi Centre Study to Evaluate the Clinical Performance of the DePuy Press Fit Condylar (P.F.C.) Sigma Rotating Platform High Flexion Knee.|Terminated||Phase 4|170|Actual|DePuy International||1||Study was terminated early due to prolonged recruitment period.|f||||f||||||||||2017-02-18 13:53:20.097335|2017-02-18 13:53:20.097335
NCT00761397|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-06-14|||September 2008||2008-09-01|June 2016|2016-06-01||||September 2017|Anticipated|2017-09-01||Observational|||Adherence to Swallowing Exercises in Head and Neck Cancer|Adherence to Swallowing Exercises in Head and Neck Cancer|Active, not recruiting||N/A|350|Anticipated|M.D. Anderson Cancer Center|||2||f||||t||||||||||2017-02-18 13:53:20.205884|2017-02-18 13:53:20.205884
NCT00761384|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-02-18|||April 2008||2008-04-01|April 2015|2015-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|HITT||High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma|A Prospective Study With Individually Adjusted High Dose 90Y-Ibritumomab Tiuxetan Treatment With Peripheral Blood Stem Cells Support to Improve Outcome for Patients With Refractory/Recurrent B-cell Lymphoma, Stage II-IV|Completed||Phase 1/Phase 2|7|Actual|Lund University Hospital||1|||f||||f||||||||||2017-02-18 13:53:20.312201|2017-02-18 13:53:20.312201
NCT00761371|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-04-09|||August 2002||2002-08-01|April 2015|2015-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients|Exploratory Evaluation of Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients Treated With HAART (CD4+ ≥ 200 Cells mm3): An Open Labeled, Non-comparative Study|Completed||Phase 4|52|Actual|MEDA Pharma GmbH & Co. KG||1|||f||||||||||||||2017-02-18 13:53:20.411015|2017-02-18 13:53:20.411015
NCT00761358|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2010-11-21|||September 2008||2008-09-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia|To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia, Focusing on the Assessment of Subjective Symptoms|Completed||Phase 3|820|Anticipated|Zeria Pharmaceutical||2|||f||||f||||||||||2017-02-18 13:53:20.540616|2017-02-18 13:53:20.540616
NCT00761345|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-11-23|2015-01-22||September 2008||2008-09-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional||Patients with locally advanced or metastatic pancreatic cancer confined to the abdomen and an ECOG performance status (PS) of 0-1 who had received 0-1 prior regimens (without Gemcitabine or Erlotinib) and no prior radiotherapy were eligible|Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer|Phase I Study of Low-Dose Fractionated Radiotherapy as a Chemosensitizer for Gemcitabine and Erlotinib in Patients With Locally Advanced or Limited Metastatic Pancreatic Cancer|Completed||Phase 1|27|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-02-18 13:53:20.635336|2017-02-18 13:53:20.635336
NCT00761046|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-12-02|||October 2008||2008-10-01|December 2011|2011-12-01||||||||Observational|||Retrospective Study on Cenos Stem With BoneMaster HA|Retrospective Study on Cenos Stem With BoneMaster HA|Withdrawn||N/A|0|Actual|Zimmer Biomet|||1|No data have been obtained at all in this time.|f||||f||||||||||2017-02-18 13:53:31.691616|2017-02-18 13:53:31.691616
NCT00761319|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-04-20|2012-03-30||October 2008||2008-10-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health|An Evaluation of the Ocular Surface Health in Subjects Using TRAVATAN Z® Ophthalmic Solution Versus XALATAN® Ophthalmic Solution|Completed||Phase 3|705|Actual|Alcon Research|The subjective nature of the OSDI may not be sensitive enough to detect the effects of preservatives on the corneal surface. The measurement and quantification of OSD remains a considerable clinical challenge. (Pflugfelder and Baudoin, 2011)|2|||f||||f||||||||||2017-02-18 13:53:21.084621|2017-02-18 13:53:21.084621
NCT00761306|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2013-12-23|2013-10-28||June 2007||2007-06-01|December 2013|2013-12-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional||Age and Sex: all-patients-treated set (APTS) - all patients who took at least one dose of Vortioxetine in Study NCT00761306 / 11492C; MADRS and HAM-D-24: full-analysis set (FAS) = 74 - all patients in the APTS who had at least one valid Baseline and one valid post-Baseline assessment of the MADRS total score in Study NCT00761306 / 11492C.|Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults|A Long-term, Open-label Study Evaluating the Safety and Tolerability of [Vortioxetine] Lu AA21004 in Patients With Major Depressive Disorder|Completed||Phase 2|74|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-02-18 13:53:21.414709|2017-02-18 13:53:21.414709
NCT00761280|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2014-11-04|2014-08-07||December 2008||2008-12-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|SAPPHIRE|The Intent-to-treat population includes all participants randomized.|Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma|Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.|Terminated||Phase 3|27|Actual|Isarna Therapeutics GmbH|Early termination of the study leading to recruitment of 27 of 180 planned subjects and incomplete collection of data. Survival results are based on post-study collection of additional survival data under a protocol amendment.|2||Unable to recruit the projected patient number. All analyses are descriptive, only.|f||||t||||||||||2017-02-18 13:53:21.704935|2017-02-18 13:53:21.704935
NCT00761267|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2017-02-09|||February 2009||2009-02-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis|A Prospective, Open-label Study To Assess The Pharmacokinetics, Safety & Efficacy Of Anidulafungin When Used To Treat Children With Invasive Candidiasis, Including Candidemia|Recruiting||Phase 3|60|Anticipated|Pfizer||1|||f||||t||||||||No||2017-02-18 13:53:23.318433|2017-02-18 13:53:23.318433
NCT00761254|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-09-11|||August 2008||2008-08-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Domperidone for Relief of Gastrointestinal Disorders|Oral Domperidone for Relief of Gastrointestinal Disorders in Patients Who Failed Standard Therapy|Terminated||N/A|42|Actual|Carle Physician Group||1||PI withdrew due to increased responsibilities in clinical department.|f||||f||||||||||2017-02-18 13:53:23.482961|2017-02-18 13:53:23.482961
NCT00761241|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2010-05-25|||September 2008||2008-09-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT|A Phase II Protocol in Borderline Resectable Pancreatic Cancer Using Gemcitabine/Docetaxel Chemotherapy and An Oxaliplatin-Based Chemoradiation.|Completed||Phase 2|40|Anticipated|Benaroya Research Institute||1|||f||||f||||||||||2017-02-18 13:53:23.733654|2017-02-18 13:53:23.733654
NCT00761228|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2015-08-06|||July 2010||2010-07-01|April 2013|2013-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|NH001-2||Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury|A Double-blind, Placebo-controlled, Randomized Study of the Safety and Efficacy of NH001 in Improving the Functional Outcome of Patients in a Vegetative State or Minimally Conscious State Following a Severe Traumatic Brain Injury|Suspended||Phase 2|76|Anticipated|NeuroHealing Pharmaceuticals Inc.||2|||f||||t||||||||||2017-02-18 13:53:23.833584|2017-02-18 13:53:23.833584
NCT00761215|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-05-18|2014-07-15||September 2008||2008-09-01|May 2016|2016-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional||All randomized participants who received study drug.|Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections|A Phase 2 Multi-Center, Randomized, Double-Blind, Non-Controlled Study Comparing the Safety, Tolerance, and Efficacy of TR-701 in Patients With Complicated Skin and Skin Structure Infections|Completed||Phase 2|192|Actual|Trius Therapeutics LLC||3|||f||||f||||||||||2017-02-18 13:53:23.950058|2017-02-18 13:53:23.950058
NCT00761202|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-10-25|2010-01-12||August 2007||2007-08-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms||Completed||Phase 4|50|Actual|Allergan||2|||f||||f||||||||||2017-02-18 13:53:24.55357|2017-02-18 13:53:24.55357
NCT00761189|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-01-22|2014-01-22||February 2008||2008-02-01|January 2014|2014-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|PANDORA||PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia|An Open Label, Prospective, Non-comparative Study to Evaluate Flexible Dose of Paliperidone Extended-Release and Clinical Response in the Treatment of Subjects With Schizophrenia|Completed||Phase 4|491|Actual|Janssen Korea, Ltd., Korea|Some Adverse Events summaries were reported based on estimates due to the fact that they were not prepared in the original study report and the relevant definitions of the data elements were not available for these summaries to be regenerated.|1|||f||||f||||||||||2017-02-18 13:53:25.021637|2017-02-18 13:53:25.021637
NCT00761176|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2015-11-30|2015-10-26||July 2008||2008-07-01|November 2015|2015-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers|A Controlled Study Comparing Basic Wound Care to the Provant® Therapy System as an Adjunct to Basic Wound Care for Wound Surface Area Reduction in Diabetic Plantar Foot Wounds|Terminated||N/A|8|Actual|Regenesis Biomedical, Inc.||2||Protocol Violations noted for 6 of 8 patients|f||||f||||||||||2017-02-18 13:53:25.45095|2017-02-18 13:53:25.45095
NCT00761163|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-01-16|||February 2007||2007-02-01|January 2013|2013-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||The Body's Response to Aerobic Versus Resistance Exercise||Completed||N/A|25|Actual|Purdue University||3|||f||||||||||||||2017-02-18 13:53:25.816292|2017-02-18 13:53:25.816292
NCT00761150|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-01-09|2013-11-01||September 2008||2008-09-01|January 2014|2014-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)|A Phase 3, Open-Label Period Followed by a Randomized, Double-blind, Placebo-controlled Study of the Analgesic Efficacy of Extended-release Hydrocodone/Acetaminophen (Vicodin CR) Compared to Placebo in Subjects With Chronic Low Back Pain|Completed||Phase 3|308|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 13:53:25.911275|2017-02-18 13:53:25.911275
NCT00761137|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2015-09-22|2011-08-05||March 2008||2008-03-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|NH004-2||Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients|A Two-Phase, Double Blind, Placebo-Controlled, Randomized, Crossover Study of the Safety and Efficacy of Intra-Oral NH004 Films for the Short-Term Relief of Sialorrhea Symptoms in Parkinson's Disease Patients|Completed||Phase 2|19|Actual|NeuroHealing Pharmaceuticals Inc.||4|||f||||t||||||||||2017-02-18 13:53:26.499468|2017-02-18 13:53:26.499468
NCT00761124|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-26|2016-07-05|||April 2003||2003-04-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|April 2017|Anticipated|2017-04-01||Interventional|PSA||Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men|Informed Decision-Making Regarding PSA Screening|Active, not recruiting||Phase 2|1006|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-02-18 13:53:26.784141|2017-02-18 13:53:26.784141
NCT00761111|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2008-10-07|||June 2007||2007-06-01|October 2008|2008-10-01||||May 2008|Anticipated|2008-05-01||Interventional|||Could a Simple Information Booklet Modify Low Back Pain Patients Beliefs After Lumbar Discectomy?|Could a Simple Information Booklet Modify Low Back Pain Patients Beliefs After Lumbar Discectomy?|Unknown status|Active, not recruiting|Phase 3|140|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:53:26.890804|2017-02-18 13:53:26.890804
NCT00761098|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-01-03|||May 2005||2005-05-01|January 2011|2011-01-01|August 2010|Anticipated|2010-08-01|May 2010|Anticipated|2010-05-01||Interventional|||Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)|A Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis|Unknown status|Recruiting|Phase 4|80|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 13:53:26.978105|2017-02-18 13:53:26.978105
NCT00761085|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-07-18|||January 2008||2008-01-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MSCD||Methadone in Pediatric and Adult Sickle Cell Patients|Methadone in Pediatric and Adult Sickle Cell Patients|Recruiting||N/A|54|Anticipated|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:53:27.084299|2017-02-18 13:53:27.084299
NCT00761072|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-03-05|||July 2008||2008-07-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Remifentanil Propofol Infusion in Pediatric Spinal Surgery|An Evaluation of RemifentanilPropofol Infusion in Pediatric Spinal Surgery|Completed||N/A|12|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 13:53:27.196494|2017-02-18 13:53:27.196494
NCT00761059|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2009-02-24|||October 2008||2008-10-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|Glucose FG||Analgesic Efficacy of Oral Glucose in Preterm Neonates During Suctioning|Prospective, Placebo-Controlled Blinded Clinical Trial to Study the Efficacy of Orally Administered Glucose 20% for Relieving Pain During Nasopharyngeal Suctioning in Preterm Infants > 1500g Under CPAP-Therapy|Unknown status|Recruiting|N/A|40|Anticipated|University of Cologne||2|||f||||f||||||||||2017-02-18 13:53:27.294212|2017-02-18 13:53:27.294212
NCT00760279|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2008-09-25|||September 2005||2005-09-01|September 2008|2008-09-01||||||||Interventional|||An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates|An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates Pediatric Pharmacology Research Unit, Children's Hospital of Michigan|Completed||Phase 1|16|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||t||||||||||2017-02-18 13:53:27.38531|2017-02-18 13:53:27.38531
NCT00760266|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-03-31|2010-12-22||September 2008||2008-09-01|March 2011|2011-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ACTION||Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population|An 8-week Randomized, Double-blind, Parallel-group, Multi-center, Active-controlled Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren HCTZ (300/25 mg) Compared to HCTZ (25 mg) in Older Patients With Stage 2 Systolic Hypertension|Completed||Phase 4|451|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:53:27.475419|2017-02-18 13:53:27.475419
NCT00760253|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2009-12-14|||September 2008||2008-09-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Observational|||Compare the Side Effects and Difference Awake Level of Three TCI Propofol Formula in TVOR Patients|Compare the Side Effects and Differences Awake Level of Propofol by Using Three TCI Formula of Anesthesia in TVOR Patients|Completed||N/A|118|Actual|National Taiwan University Hospital|||3||f||||f||||||||||2017-02-18 13:53:27.848083|2017-02-18 13:53:27.848083
NCT00760240|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2010-04-23|||September 2008||2008-09-01|April 2010|2010-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Ability of Patients With Low Vision to Properly Instill Eye Drops|Objective Evaluation of the Ability of Patients With Decreased Vision or Restricted Visual Fields to Properly Instill Eye Drops|Completed||N/A|200|Anticipated|Mid-Atlantic Glaucoma Experts|||2||f||||f||||||||||2017-02-18 13:53:27.950745|2017-02-18 13:53:27.950745
NCT00760227|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-09-27|||January 2003||2003-01-01|September 2011|2011-09-01||||December 2007|Actual|2007-12-01||Interventional|||Testing the Effectiveness of Child and Parent-Targeted Health Promotion Interventions in Pediatric Stem Cell Transplantation|Testing the Effectiveness of Child and Parent-Targeted Health Promotion Interventions in Pediatric Stem Cell Transplantation|Completed||N/A|189|Actual|St. Jude Children's Research Hospital||3|||f||||f||||||||||2017-02-18 13:53:28.046785|2017-02-18 13:53:28.046785
NCT00760214|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-11-08|2011-03-24||January 2008||2008-01-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension|A Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Ramipril in Subjects With Essential Hypertension|Completed||Phase 3|885|Actual|Takeda||3|||f||||f||||||||||2017-02-18 13:53:28.164271|2017-02-18 13:53:28.164271
NCT00543595|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-05-21|||August 2004||2004-08-01|May 2015|2015-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)||Completed||Phase 2|154|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:15.682392|2017-02-18 15:11:15.682392
NCT00761033|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-12-06|||October 2008||2008-10-01|December 2016|2016-12-01||||||||Interventional|||Music to Reduce Pain and Anxiety in the Pediatric Emergency Department|Music to Reduce Pain and Anxiety in the Pediatric Emergency Department: a Randomized Controlled Trial of Children 3-6 Years Undergoing Intravenous Placement|Completed||N/A|42|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 13:53:31.769411|2017-02-18 13:53:31.769411
NCT00761020|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2010-06-02|||September 2008||2008-09-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|April 2009|Actual|2009-04-01||Interventional|||Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection|Analysis of Anti-Plasmodium Falciparum Merozoite Surface Protein 1 Antigen Specific Antibodies in a Human Malaria Challenge Using Mefloquine Prophylaxis to Confirm Assay Sensitivity and Establish Key Antibody Kinetic Parameters|Completed||Phase 1|31|Anticipated|Walter Reed Army Institute of Research (WRAIR)||2|||f||||t||||||||||2017-02-18 13:53:31.867616|2017-02-18 13:53:31.867616
NCT00761007|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-03-20|2010-09-08||July 2008||2008-07-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|IRIS||Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)|Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Evaluate the Effect of a 4-week Treatment With Oral Doses of Ibodutant (Code: MEN15596) in Irritable Bowel Syndrome (IBS).|Completed||Phase 2|554|Actual|Menarini Group||4|||f||||f||||||||||2017-02-18 13:53:31.976201|2017-02-18 13:53:31.976201
NCT00760994|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-01-14|||January 2009||2009-01-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|COPE||Reducing Alcohol Use & Post-traumatic Stress Disorder (PTSD) With Cognitive Restructuring & Experiential Acceptance|Reducing Alcohol Use & PTSD w/ Cognitive Restructuring & Experiential Acceptance|Completed||N/A|133|Actual|Seattle Institute for Biomedical and Clinical Research||3|||f||||t||||||||||2017-02-18 13:53:32.88014|2017-02-18 13:53:32.88014
NCT00760981|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2010-02-17|||September 2008||2008-09-01|February 2010|2010-02-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease|A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 13:53:33.007022|2017-02-18 13:53:33.007022
NCT00760968|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-06-09|||August 2007||2007-08-01|June 2010|2010-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral TAK-783 in the Treatment of the Signs and Symptoms in Subjects With Rheumatoid Arthritis|Completed||Phase 2|224|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:53:33.101769|2017-02-18 13:53:33.101769
NCT00760955|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-06-20||2016-06-20|September 2006||2006-09-01|June 2016|2016-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Study to Evaluate the Efficacy and Safety of 3 Doses of TAK-583 in Subjects With Mild to Moderate Diabetic Peripheral Neuropathy|Completed||Phase 2|338|Actual|Takeda||4|||f||||t||||||||||2017-02-18 13:53:33.24542|2017-02-18 13:53:33.24542
NCT00760942|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-12-09|||October 2008||2008-10-01|December 2013|2013-12-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|||Liquid Preterm Formula Versus Powdered Human Milk Fortifier in VLBW Infants|Randomized Study of a Liquid High-Calorie Preterm Formula Versus Powdered Human Milk Fortifier in Very-Low Birthweight Infants|Completed||N/A|84|Actual|University of Oklahoma||2|||f||||t||||||||||2017-02-18 13:53:33.586561|2017-02-18 13:53:33.586561
NCT00760929|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-11-01||2016-07-26|November 2008||2008-11-01|November 2016|2016-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).|A Randomized, Placebo Controlled Study to Determine the Effect of Two Dose Schedules of R1507 or Placebo, Both in Combination With Erlotinib (Tarceva®), on Progression-free Survival in Patients With Advanced Non-small Cell Lung Cancer With Disease Progression After First or Second Line Chemotherapy|Completed||Phase 2|167|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 13:53:33.678861|2017-02-18 13:53:33.678861
NCT00760916|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-01-29|||December 2008||2008-12-01|January 2013|2013-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)|FREEDOM DR: An International, Multi-Center, 12-Week, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study Followed by a 12-Week Open-Label Extension Study to Assess the Efficacy, Safety, and Dose Response of UT-15C SR in Subjects With Pulmonary Hypertension|Withdrawn||Phase 3|0|Actual|United Therapeutics||4||Study stopped prior to subject enrollment.|f||||f||||||||||2017-02-18 13:53:33.850077|2017-02-18 13:53:33.850077
NCT00760903|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2017-01-04|||June 2003||2003-06-01|January 2017|2017-01-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Observational|||Magnetic Resonance (MR) Spectroscopy and Diffusion Tensor Imaging in Determining Brain Injury and Subsequent Clinical Outcome in Patients of Moderate Brain Trauma||Withdrawn||N/A|0|Actual|University of Michigan|||5|Study was not started due to PI concentrating on other studies|f||||f||||||||No||2017-02-18 13:53:33.992828|2017-02-18 13:53:33.992828
NCT00760890|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2008-09-25|||June 2001||2001-06-01|September 2008|2008-09-01|October 2005|Actual|2005-10-01|June 2005|Actual|2005-06-01||Interventional|BFe01B1||Iron and the Breast-Fed Infant: Iron Status and Two Regimens of Iron Supplementation|Iron and the Breast-Fed Infant: Iron Status and Two Regimens of Iron Supplementation|Completed||N/A|171|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||||||||||||2017-02-18 13:53:34.104028|2017-02-18 13:53:34.104028
NCT00760877|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-10-04|2016-07-01||June 2009||2009-06-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)|An Open Label, Randomized Study of Nilotinib vs. Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Patients With Evidence of Persistent Leukemia by RQ-PCR.|Completed||Phase 3|207|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:53:34.214063|2017-02-18 13:53:34.214063
NCT00760864|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-06-09|||August 2004||2004-08-01|June 2010|2010-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of Oral TAK-715 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis|Completed||Phase 2|432|Actual|Takeda||4|||f||||f||||||||||2017-02-18 13:53:34.934948|2017-02-18 13:53:34.934948
NCT00760851|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2011-03-17|||September 2008||2008-09-01|February 2011|2011-02-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|SIPPY II||Yogurt Study in Children 2-4 Years Old Attending Daycare|Study to Investigate the Potential of Probiotics II|Completed||Phase 3|190|Anticipated|Georgetown University||2|||f||||t||||||||||2017-02-18 13:53:35.042763|2017-02-18 13:53:35.042763
NCT00760838|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-06-25|2013-10-22||March 2009||2009-03-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|February 2011|Actual|2011-02-01||Interventional|AZISAST||AZISAST Study: AZIthromycin in Severe ASThma Study|The AZIthromycin in Severe ASThma (AZISAST) Study: a Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Efficacy, Safety and Cost-effectiveness of Azithromycin as add-on Therapy in Adult Subjects With Severe Persistent Asthma, Who Remain Inadequately Controlled Despite GINA (2006) Step 4 or 5 Therapy|Completed||Phase 4|109|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:53:35.147986|2017-02-18 13:53:35.147986
NCT00760825|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-06-16|||March 2012||2012-03-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|||A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children|An Open Label Post Licensure Trial to Evaluate the Safety and Immunogenicity of Indigenously Manufactured Killed Bivalent (O1 and O139) Whole Cell Oral Cholera Vaccine(Shanchol™)|Completed||Phase 4|200|Actual|International Vaccine Institute||1|||f||||t||||||||||2017-02-18 13:53:35.891436|2017-02-18 13:53:35.891436
NCT00760812|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-02-19|||April 2007||2007-04-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|May 2013|Actual|2013-05-01||Interventional|||Comparing Parent-Implemented Interventions for Toddlers With Autism Spectrum Disorders|Effects of Parent-Implemented Intervention for Toddlers With Autism Spectrum (The ESI Study)|Completed||N/A|82|Actual|Florida State University||2|||f||||t||||||||||2017-02-18 13:53:36.005013|2017-02-18 13:53:36.005013
NCT00760799|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-05-01|||March 2007||2007-03-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Randomized Study of Anular Repair With the Xclose Tissue Repair System|Randomized Study of Anular Repair With the Xclose Tissue Repair System|Completed||Phase 4|750|Actual|Anulex Technologies, Inc.||2|||f||||f||||||||||2017-02-18 13:53:36.11571|2017-02-18 13:53:36.11571
NCT00760786|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2008-09-25|||July 2008||2008-07-01|September 2008|2008-09-01||||February 2010|Anticipated|2010-02-01||Interventional|||Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque|Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque: Serial Virtual Histology Intravascular Ultrasound Analysis|Unknown status|Recruiting|N/A|60|Anticipated|Samsung Medical Center||4|||f||||t||||||||||2017-02-18 13:53:36.249433|2017-02-18 13:53:36.249433
NCT00760773|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-12-08|||April 2009||2009-04-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|||Impact of Emergency Department Probiotic Treatment of Diarrheal Illness on Daycare Attendance|Impact of Emergency Department Probiotic Treatment of Diarrheal Illness on Daycare Attendance: Randomized Controlled Trial and Economic Analysis|Terminated||Phase 2|132|Actual|The Hospital for Sick Children||3||Funding ended and fewer than required number of patients enrolled.|f||||t||||||||||2017-02-18 13:53:36.359725|2017-02-18 13:53:36.359725
NCT00760760|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-03-14|||September 2008||2008-09-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|September 2014|Actual|2014-09-01||Interventional|PUFA-ATI||n-3 Polyunsaturated Fatty Acids in Obesity|Impact of n-3 Polyunsaturated Fatty Acids on Adipose Tissue Inflammation in Morbidly Obese Patients|Completed||Phase 2|55|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:53:36.471122|2017-02-18 13:53:36.471122
NCT00760747|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-08-02|2011-08-02||September 2008||2008-09-01|August 2011|2011-08-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|ADHD SWITCH||Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)|A Randomized, Controlled, Open-Label Comparison Study of the Efficacy and Safety of Slow Transitioning Compared With Fast Transitioning From a Stimulant Medication to Atomoxetine in Pediatric and Adolescent Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 4|112|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:53:36.579883|2017-02-18 13:53:36.579883
NCT00760734|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2015-01-01|||September 2008||2008-09-01|January 2015|2015-01-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Interventional|||Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)|HBOT in Chronic Traumatic Brain Injury/Post Concussion Syndrome and TBI/PTSD Pilot Trial|Completed||Phase 1|30|Actual|Louisiana State University Health Sciences Center in New Orleans||2|||f||||t||||||||||2017-02-18 13:53:37.353366|2017-02-18 13:53:37.353366
NCT00760721|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-11-23|||September 2006||2006-09-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||Increasing Hepatitis B Screening Among Korean Church Attendees|Increasing Hepatitis B Screening Among Korean Church Attendees (Component Project) Program Project Title: Liver Cancer Control Interventions for Asian Americans|Completed||Phase 3|1123|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 13:53:37.466354|2017-02-18 13:53:37.466354
NCT00760708|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-01-16|||September 2005||2005-09-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Circulating Adenosine Levels Before and After Intravenous (IV) Persantine|Circulating Adenosine Levels Before and After Intravenous (IV) Persantine|Terminated||N/A|221|Actual|UConn Health|||1|Persantine is no longer being used at UCHC for pharmacological stress testing|f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 13:53:37.570518|2017-02-18 13:53:37.570518
NCT00760695|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-05-08|||October 2008||2008-10-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa|Cannabinoid CB1 Receptor Agonist Treatment in Severe Chronic Anorexia Nervosa|Completed||Phase 3|24|Actual|Odense University Hospital||2|||f||||t||||||||||2017-02-18 13:53:37.664919|2017-02-18 13:53:37.664919
NCT00368004|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2017-01-24|||July 28, 2006||2006-07-28|April 15, 2013|2013-04-15|April 15, 2013||2013-04-15|||||Observational|||Family Studies of Uveal Coloboma|Family Studies of Uveal Coloboma|Terminated||N/A|100|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:30.502609|2017-02-18 16:18:30.502609
NCT00760682|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-05-23|||June 2008||2008-06-01|May 2012|2012-05-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Hyperbaric Oxygen Treatment of Mandibular Osteoradionecrosis. A Randomized Clinical Study|Hyperbaric Oxygen Treatment of Mandibular Osteoradionecrosis. A Randomized Clinical Study|Unknown status|Recruiting|Phase 2|114|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:53:37.775193|2017-02-18 13:53:37.775193
NCT00760669|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-09-25|2013-06-06||May 2007||2007-05-01|September 2013|2013-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational||Baseline characteristics were performed on safety analysis set. Data presented only for 1055 participants as they were part of safety analysis set. Safety analysis set included all participants who received at least 1 dose of study medication.|An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants|Post Marketing Surveillance of Remicade in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Patients|Completed||Phase 4|1061|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-02-18 13:53:37.889521|2017-02-18 13:53:37.889521
NCT00760656|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-10-12|||April 2007||2007-04-01|October 2016|2016-10-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|SJLIFE||Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer|Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer|Recruiting||N/A|8000|Anticipated|St. Jude Children's Research Hospital|||2||f||||f||||||Samples With DNA|"~     Control Participants - Storage of Biological Specimens~      Blood, serum and urine:~      A peripheral blood order will be placed in MILLI by a member of the clinical staff and the~     control participant will have 23cc of peripheral blood (6cc each in 3 NaHeparin tube, 5cc in~     red top) collected for the study. The collected peripheral blood sample will be stored in~     the institutional tissue bank. The sample will be tagged accordingly and will be only~     released to fulfill future objectives of the SJLIFE protocol.~   "|||2017-02-18 13:53:38.257034|2017-02-18 13:53:38.257034
NCT00760643|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-05-01|||December 2011||2011-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:53:38.561117|2017-02-18 13:53:38.561117
NCT00760630|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-09-03|||December 2009||2009-12-01|September 2010|2010-09-01|April 2012|Anticipated|2012-04-01|October 2011|Anticipated|2011-10-01||Interventional|MASES||Measurements to Assess Severity of Epicardial Stenoses|Simultaneous Measurements Of Pressure Gradient, Blood Flow and Percentage Area Stenosis Of Coronary Epicardial Lesions To Assess Severity Of Epicardial Stenosis And Myocardial Infarction|Suspended||Early Phase 1|76|Anticipated|University of Cincinnati||1||IRB Approval on study expired May 28, 2009|f||||f||||||||||2017-02-18 13:53:38.60862|2017-02-18 13:53:38.60862
NCT00760617|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-10-11|2012-03-29||October 2008||2008-10-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older|Observer-blind Safety and Immunogenicity Study of GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A When Administered to Elderly Subjects.|Completed||Phase 3|526|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:53:38.725327|2017-02-18 13:53:38.725327
NCT00760604|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-08-10|||September 2008||2008-09-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer|A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Patients With Locally Advanced Esophageal Cancer|Terminated||Phase 3|4|Actual|Weill Medical College of Cornell University||2||Closed due to slow patient accrual.|f||||f||||||||||2017-02-18 13:53:40.13902|2017-02-18 13:53:40.13902
NCT00760591|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2008-09-25|||September 2008||2008-09-01|September 2008|2008-09-01||||||||Observational|||Change of Neutrophil Gelatinase-Associated Lipocalin(NGAL) Following Sodium Phosphate Bowel Preparation(Pilot Study)|Change of Neutrophil Gelatinase-Associated Lipocalin(NGAL) Following Sodium Phosphate Bowel Preparation(Pilot Study)|Unknown status|Recruiting|N/A|30|Anticipated|Soon Chun Hyang University|||1||f||||f||||||None Retained|"~     Serum, Urine~   "|||2017-02-18 13:53:40.243711|2017-02-18 13:53:40.243711
NCT00760578|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-03-19|2013-03-19||September 2008||2008-09-01|March 2013|2013-03-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator|A Phase 2A, Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Two Dose Levels of Mitoglitazone™ in Type 2 Diabetic Patients|Completed||Phase 2|86|Actual|Metabolic Solutions Development Company||4|||f||||f||||||||||2017-02-18 13:53:40.32793|2017-02-18 13:53:40.32793
NCT00760565|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-11-01|||September 2008||2008-09-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).|A Randomized, Double-Blind, Multiple-Ascending Dose, Placebo-Controlled, Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO4905417 Following Intravenous Infusion in Healthy Volunteers and Patients With Peripheral Arterial Disease|Completed||Phase 1|72|Actual|Hoffmann-La Roche||12|||f||||||||||||||2017-02-18 13:53:40.971518|2017-02-18 13:53:40.971518
NCT00760552|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-04-06|2014-12-03||November 2009||2009-11-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Trial of Low and High Intensity Strategies to Maintain BP Control|Trial of Low And High Intensity Strategies to Maintain Blood Pressure Control|Completed||N/A|249|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:53:41.097303|2017-02-18 13:53:41.097303
NCT00760539|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2014-07-14||2014-07-10|June 2008||2008-06-01|July 2014|2014-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Travoprost/Timolol BAC-free|A Six-Week, Multi-Center, Double-Masked, Safety and Efficacy Study of Travoprost 0.004%/Timolol 0.5% BAC-free Compared to Travoprost 0.004%/Timolol 0.5% in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|87|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:53:41.562852|2017-02-18 13:53:41.562852
NCT00760526|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-09-02|2012-10-26||September 2010||2010-09-01|September 2016|2016-09-01|January 2012|Actual|2012-01-01|June 2011|Actual|2011-06-01||Interventional|||Randomized Trial to Assess Efficacy and Safety of Continuous Glucose Monitoring in Children 4-<10 Years With T1DM|A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children (4 to <10 Year Olds)|Completed||Phase 3|146|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-02-18 13:53:41.673098|2017-02-18 13:53:41.673098
NCT00760513|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2016-04-14|||November 2009||2009-11-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids|The Effects of Purified n-3 Fatty Acids on Serum Fibrosis Markers and Cardiovascular Risk Markers in a Randomized Placebo Controlled Trial in Patients With Non Alcoholic Fatty Liver Disease|Active, not recruiting||Phase 2|100|Anticipated|University Hospital Southampton NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:53:42.434517|2017-02-18 13:53:42.434517
NCT00760500|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2015-02-16|||January 2004||2004-01-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational|||Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China|Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China|Completed||N/A|13201|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||Samples Without DNA|"~     Nasopharyngeal specimen taken by swab~   "|||2017-02-18 13:53:42.548907|2017-02-18 13:53:42.548907
NCT00760487|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-01-12|2009-09-22||October 2006||2006-10-01|January 2012|2012-01-01||||June 2008|Actual|2008-06-01||Interventional|||Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens||Completed||Phase 4|120|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:53:42.647644|2017-02-18 13:53:42.647644
NCT00760474|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-06-22|2012-03-07||January 2009||2009-01-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||An fMRI Study Of Brain Response In Patients With Fibromyalgia|A Double-Blind, Placebo-Controlled Cross-Over Study In Fibromyalgia Subjects To Examine Effects Of Pregabalin On Brain Response To Mechanical Pain As Assessed By Functional Magnetic Resonance Imaging, Proton Magnetic Resonance Spectroscopy And Subjective Ratings|Completed||Phase 1|27|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:53:42.890197|2017-02-18 13:53:42.890197
NCT00760461|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-06-21|||October 2008||2008-10-01|June 2016|2016-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Domperidone in Refractory Gastroparesis|Domperidone in Refractory Gastroparesis|Terminated||Phase 2|30|Anticipated|Yale University||1||Subjects currently unable to receive drug from dispensing pharmacy.|f||||f||||||||||2017-02-18 13:53:43.729925|2017-02-18 13:53:43.729925
NCT00760448|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2017-01-26|||April 2004||2004-04-01|January 2017|2017-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia|Trial Investigating the Hypoglycaemic Response to Single Doses of Insulin Detemir and NPH Insulin in Subjects With Type 1 Diabetes|Completed||Phase 1|25|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 13:53:43.822565|2017-02-18 13:53:43.822565
NCT00760435|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-11-12|2014-05-19||March 2009||2009-03-01|November 2014|2014-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease|Infliximab (Remicade®) Plus Intravenous Immunoglobulin (IVIG) for the Primary Treatment of Patients With Acute Kawasaki Disease|Completed||Phase 3|196|Actual|University of California, San Diego|The major limitation of our study was the low rate of treatment-resistance in the placebo arm (11%, compared to historical IVIG resistance rates of 20%), which decreased our power to detect a difference in the primary outcome measure.|2|||f||||t||||||||||2017-02-18 13:53:43.918955|2017-02-18 13:53:43.918955
NCT00760422|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2012-04-19|||December 2008||2008-12-01|August 2008|2008-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|NIR||Clinical Evaluation of NIR (Non-Invasive Infrared) Thermometer Performance||Completed||N/A|500|Anticipated|Medisim Ltd|||2||f||||t||||||||||2017-02-18 13:53:44.516116|2017-02-18 13:53:44.516116
NCT00760409|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-12-05|||September 2008||2008-09-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI|Prospective Study Differentiating Recurrent Brain Tumor Versus Radiation Injury Using Magnetic Resonance (MR) Spectroscopy, Diffusion Tensor Imaging and Diffusion Weighted Imaging on 3T(Tesla) MR Scanner|Active, not recruiting||N/A|50|Anticipated|University of Michigan|||2||f||||t||||||||No||2017-02-18 13:53:44.598146|2017-02-18 13:53:44.598146
NCT00760396|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2009-04-06|||September 2008||2008-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||Multiple-Dose Study of VGX-1027 in Healthy Subjects|A Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety and Pharmacokinetics of VGX-1027 in Healthy Subjects|Completed||Phase 1|40|Actual|VGX Pharmaceuticals, LLC||4|||f||||f||||||||||2017-02-18 13:53:44.688398|2017-02-18 13:53:44.688398
NCT00760383|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-12-01|2014-04-17||June 2008||2008-06-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation|Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation|Completed||N/A|60|Actual|University of Oregon||2|||f||||t||||||||||2017-02-18 13:53:44.786343|2017-02-18 13:53:44.786343
NCT00760370|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-12-06|||December 2008||2008-12-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer|Bone Retention of Bisphosphonate (Zometa) in Patients With Multiple Myeloma or Breast Cancer With Metastases to Bone|Completed||Phase 2|60|Actual|Vejle Hospital||1|||f||||t||||||||||2017-02-18 13:53:45.210553|2017-02-18 13:53:45.210553
NCT00760357|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-11-24|||April 2007||2007-04-01|November 2015|2015-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||A Retrospective Analysis of Patients With Full Thickness Wounds in Limbs With Critical Ischemia|A Retrospective Analysis of Patients With Full Thickness Wounds in Limbs With Critical Ischemia|Completed||N/A|190|Actual|Southwest Regional Wound Care Center|||1||f||||t||||||Samples With DNA|"~     Once the patients are identified that have a full thickness wound on a limb clearly~     identified as having critical limb ischemia, these patients will be evaluated. The data that~     will be extracted from each chart will include patient's age, patient's gender, number of~     office visits, presence of diabetes, presence of osteomyelitis, type and amount of~     antibiotic administered, number of hyperbaric oxygen treatments, and if the wound healed.~   "|||2017-02-18 13:53:45.313074|2017-02-18 13:53:45.313074
NCT00760344|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-06-20||2016-06-20|March 2007||2007-03-01|June 2016|2016-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate Treatment With SYR-472 in Subjects With Type 2 Diabetes|Completed||Phase 2|386|Actual|Takeda||6|||f||||f||||||||||2017-02-18 13:53:45.407845|2017-02-18 13:53:45.407845
NCT00760331|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2008-09-25|||June 2008||2008-06-01|September 2008|2008-09-01|July 2028|Anticipated|2028-07-01|||||Observational|TCF2||Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function|A Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function|Recruiting||N/A|100|Anticipated|University Hospital, Limoges|||1||f||||f||||||||||2017-02-18 13:53:45.860946|2017-02-18 13:53:45.860946
NCT00760318|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2008-09-25|||November 2005||2005-11-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|October 2007|Actual|2007-10-01||Interventional|Keppra||Keppra for Cervical Dystonia|Prospective Double Blind Evaluation of Levetiracetam (Keppra) for the Treatment of Cervical Dystonia|Suspended||Phase 2|17|Actual|University of South Florida||1||Sponsor decided to stop enrollment to review data.|f||||f||||||||||2017-02-18 13:53:45.950597|2017-02-18 13:53:45.950597
NCT00760305|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-05-23|||October 2004||2004-10-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|Pro-self||Pro-self Pain Management in Norway|Pro-self - a Nursing Intervention to Support and Educate Cancer Patients and Their Caregivers so That the Patient Can Stay Home|Completed||N/A|167|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 13:53:46.053716|2017-02-18 13:53:46.053716
NCT00760292|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2008-09-25|||May 2008||2008-05-01|June 2008|2008-06-01|April 2011|Anticipated|2011-04-01|December 2009|Anticipated|2009-12-01||Observational|GenVarT2DM||Genetic Variants and Phenotypic Characteristics of Patients With T2DM|Genetic Variants and Phenotypic Characteristics of Patients With T2DM|Unknown status|Active, not recruiting|N/A|2000|Anticipated|Odense University Hospital|||2||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 13:53:46.165935|2017-02-18 13:53:46.165935
NCT00760201|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-04-18|||August 2008||2008-08-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Observational|HospExe||Qualitative Analysis of Hospital Executives, Physician Administrators, and Hospital Legal Counsels' Perceptions of End-of-Life Care|Analysis of Hospital Executives, Physician Administrators, and Hospital Legal Counsels� Perceptions of End-of-Life Care|Completed||N/A|14|Anticipated|VA Office of Research and Development|||1||f||||f|||||||"~     Qualitative Analysis~   "|||2017-02-18 13:53:46.244436|2017-02-18 13:53:46.244436
NCT00760188|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-12-13|||July 2004||2004-07-01|November 2011|2011-11-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|||Prospective Data Collection on Cementless Oxford Partial Knee|Prospective Clinical Evaluation of the Cementless Oxford Partial Knee|Withdrawn||N/A|0|Actual|Zimmer Biomet|||1|No patients recruited into study.|f||||f||||||||||2017-02-18 13:53:46.333278|2017-02-18 13:53:46.333278
NCT00760175|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2015-05-26|||October 2008||2008-10-01|May 2015|2015-05-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients|A Randomized, Controlled Trial Comparing Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients|Completed||N/A|85|Actual|University of Alberta||2|||f||||t||||||||||2017-02-18 13:53:46.432829|2017-02-18 13:53:46.432829
NCT00760162|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2011-08-02|||August 2007||2007-08-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|Probiotics||Pilot-Scale Clinical Trials of Kibow Biotics® in Chronic Kidney Failure|Pilot-Scale Clinical Trials of Kibow Biotics® (a Patented and Proprietary Probiotic Formulation) in Chronic Kidney Failure|Completed||N/A|180|Actual|Kibow Biotech Inc.|||6||f||||t||||||||||2017-02-18 13:53:46.557612|2017-02-18 13:53:46.557612
NCT00760149|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2013-09-06|||July 2010||2010-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|High RIF||Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis|Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania.|Completed||Phase 2|150|Actual|Radboud University||3|||f||||t||||||||||2017-02-18 13:53:46.658203|2017-02-18 13:53:46.658203
NCT00760136|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2008-10-23|||August 2006||2006-08-01|September 2008|2008-09-01|July 2009|Anticipated|2009-07-01|||||Observational|||The Role of Quadriceps Contraction in Patellar Repositioning - a Computed Tomography Study|The Role of Quadriceps Contraction in Patellar Repositioning-a Computed Tomography Study|Unknown status|Recruiting|Early Phase 1|150|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:53:46.778697|2017-02-18 13:53:46.778697
NCT00760123|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2014-08-22|||May 2005||2005-05-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Lymphedema Prevention in Breast Cancer|Lymphedema Prevention in Breast Cancer: a Simple Blind, Randomized, Prospective Clinical Trial of the Efficacy of Physical Therapy|Completed||N/A|120|Actual|University of Alcala||2|||f||||t||||||||||2017-02-18 13:53:46.869238|2017-02-18 13:53:46.869238
NCT00760110|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-25|2008-09-30|||November 1997||1997-11-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||A Cohort Study of Morning Home Blood Pressure Measurement in Type 2 Diabetic Patients|Usefulness of Home Blood Pressure Measurement in the Morning in Type 2 Diabetic Patients: Long-Term Results of a Prospective Longitudinal Study|Completed||N/A|400|Actual|Nagaoka Red Cross Hospital|||2||f||||f||||||||||2017-02-18 13:53:46.972635|2017-02-18 13:53:46.972635
NCT00760097|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-02-04|||September 2007||2007-09-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|aTDCS||Adjunctive Transcranial Direct Current Stimulation for Cognition in Major Depression|Adjunctive Transcranial Direct Current Stimulation for Cognition in Major Depression|Completed||Phase 4|18|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-02-18 13:53:47.082878|2017-02-18 13:53:47.082878
NCT00760084|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2011-08-03|2009-08-05||July 2005||2005-07-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|September 2005|Actual|2005-09-01||Interventional|||Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|An Expanded Access Protocol to Administer Decitabine to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Completed||Phase 2|10|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 13:53:47.193842|2017-02-18 13:53:47.193842
NCT00760071|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-04-14|||July 2006||2006-07-01|April 2010|2010-04-01|September 2009|Actual|2009-09-01|October 2008|Actual|2008-10-01||Observational|||Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)|Evaluation of Morphological and Functional Magnetic Resonance Imaging (MRI) for Early Diagnosis of Lung Changes in Children (0-6 Years) With Cystic Fibrosis (CF)|Completed||N/A|30|Anticipated|German Cancer Research Center|||2||f||||t||||||||||2017-02-18 13:53:47.529723|2017-02-18 13:53:47.529723
NCT00639093|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-06-25|2009-07-30||March 2008||2008-03-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||A Virtual Arm to Stop Smoking|A Virtual Arm to Stop Smoking. A Comparative Study|Completed||N/A|91|Actual|Universite du Quebec en Outaouais||2|||f||||f||||||||||2017-02-18 14:36:05.891424|2017-02-18 14:36:05.891424
NCT00760058|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-05-08|||June 2008||2008-06-01|March 2010|2010-03-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOL|Visual Outcome and Visual Quality After Bilateral Implantation of the AcrySof® IQ IOL Compared to MI60® and Tecnis® IOL|Withdrawn||Phase 4|0|Actual|Alcon Research||3||Enrollment not initiated for study.|f||||f||||||||||2017-02-18 13:53:47.635303|2017-02-18 13:53:47.635303
NCT00760045|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-01-05|||August 2008||2008-08-01|January 2010|2010-01-01||||October 2008|Actual|2008-10-01||Interventional|||Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time||Completed||Phase 2|40|Anticipated|Alcon Research||4|||f||||f||||||||||2017-02-18 13:53:47.732048|2017-02-18 13:53:47.732048
NCT00760032|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-12-04||||||December 2012|2012-12-01||||||||Interventional|||Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients|Association of Serum Levels of Lipopolysaccharide Binding Protein (LBP) With the Evolution of Pro- and Anti-inflammatory Cytokines, and the Development of Severe Infectious Events in Cirrhotic Patients|Withdrawn||Phase 4|0|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2||was not possible to measure LBP levels because we cannot found the kit|f||||t||||||||||2017-02-18 13:53:47.826061|2017-02-18 13:53:47.826061
NCT00760019|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-08-14|||August 2005||2005-08-01|August 2013|2013-08-01|February 2011|Actual|2011-02-01|October 2009|Actual|2009-10-01||Interventional|||Inflammation and Vascular Function in Atherosclerosis|Inflammation and Vascular Function in Atherosclerosis|Completed||Phase 2/Phase 3|44|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 13:53:47.928638|2017-02-18 13:53:47.928638
NCT00760006|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-08-06|||May 2008||2008-05-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Preoperative Antibiotics Study|Efficacy of Preoperative Prophylactic Antibiotics in Preventing Complications in the Primary Repair of Cleft Palates|Completed||Phase 2|91|Actual|Children's Hospital of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:53:48.033256|2017-02-18 13:53:48.033256
NCT00759993|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-09-06|||September 2008||2008-09-01|September 2012|2012-09-01|March 2013|Anticipated|2013-03-01|June 2012|Actual|2012-06-01||Interventional|||Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.|A 6 Week, Blinded, Randomized, Controlled Pilot Study to Evaluate the Safety and Efficacy of Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.|Terminated||Phase 2|60|Anticipated|State University of New York - Upstate Medical University||2||inability to recruit and retain|f||||f||||||||||2017-02-18 13:53:48.143152|2017-02-18 13:53:48.143152
NCT00759980|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2011-03-22|||October 2008||2008-10-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Transfusing Neonates Based on Platelet Mass|Transfusing Neonates Based on Platelet Mass in the Neonatal Intensive Care Unit: A Randomized Pilot Study|Completed||N/A|50|Anticipated|Christiana Care Health Services|||2||f||||f||||||||||2017-02-18 13:53:48.242005|2017-02-18 13:53:48.242005
NCT00759967|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-07-11|||September 2007||2007-09-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Conventional Hemodialysis vs. Short Daily Hemodialysis (6 Days / Week) and Mechanisms of Blood Pressure Control|Randomized Cross-over Study of Short Daily Hemodialysis Compared to Conventional Hemodialysis to Determine the Mechanisms of Hypertension Control|Completed||Phase 3|22|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 13:53:48.334705|2017-02-18 13:53:48.334705
NCT00759954|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-08-13|2008-12-01||September 2004||2004-09-01|August 2010|2010-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesauce|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Study Comparing the Bioavailability of a Morphine Sulfate Sustained Release Capsule 1 x 200mg to KADIAN 2 x 100mg Capsules Administered Orally as a Sprinkle on Applesauce|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||f||||||||||2017-02-18 13:53:48.444361|2017-02-18 13:53:48.444361
NCT00759941|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-12-11|2012-07-12||October 2007||2007-10-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin|A Comparison of Brinzolamide Ophthalmic Suspension, 1% (Azopt) TID vs. Placebo TID Added to Latanoprost Ophthalmic Solution, 0.005% (Xalatan) in Patients With Elevated IOP on a Prostaglandin|Completed||Phase 4|86|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:53:48.941565|2017-02-18 13:53:48.941565
NCT00759928|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2014-07-01|||October 2008||2008-10-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|September 2013|Actual|2013-09-01||Interventional|||PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors|Pharmacokinetic Trial of Sorafenib and Erlotinib in Patients With Refractory Solid Tumors|Completed||Phase 1|48|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 13:53:49.267179|2017-02-18 13:53:49.267179
NCT00759915|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-08-13|2008-12-05||August 2006||2006-08-01|August 2010|2010-08-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions|A Randomized Two-way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Formulation of KADIAN (2 x 10mg) Capsules Compared to a KADIAN 20 mg Capsule in Healthy Adult Subjects Under Fed Conditions|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||||||||||||2017-02-18 13:53:49.38261|2017-02-18 13:53:49.38261
NCT00759902|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-08-13|2008-12-05||August 2006||2006-08-01|August 2010|2010-08-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions|A Randomized Two-way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Formulation of KADIAN (2 x 10mg) Capsules Compared to a KADIAN 20 mg Capsule in Healthy Adult Subjects Under Fasted Conditions|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||||||||||||2017-02-18 13:53:49.826293|2017-02-18 13:53:49.826293
NCT00759889|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2017-01-11|||March 2007||2007-03-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Obtaining and Storing Standard of Care Wound Biopsies for Immediate or Future Wound-Related Scientific Study|Obtaining and Storing Standard of Care Wound Biopsies for Immediate or Future Wound Related Scientific Study|Recruiting||N/A|5|Anticipated|Southwest Regional Wound Care Center|||1||f||||t||||||Samples With DNA|"~     Wound edge biopsies that are obtained through standard of care protocols will be subjected~     to additional microscopic and molecular analyses following the completion of standard~     medical assessment.~   "|||2017-02-18 13:53:50.258702|2017-02-18 13:53:50.258702
NCT00759876|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-08-13|||July 2008||2008-07-01|August 2013|2013-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD)|A Phase 2a Extension Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy|Terminated||Phase 2|36|Actual|PTC Therapeutics||1|||f||||f||||||||||2017-02-18 13:53:50.365572|2017-02-18 13:53:50.365572
NCT00759863|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2010-02-22|2009-06-22||August 2006||2006-08-01|February 2010|2010-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|Lifezig||LifeZig Personalized Reminiscence Video With Slideshows and Music for Individuals With Alzheimer's and Dementia|LifeZig System for Individuals With Alzheimer's Disease|Completed||Phase 2|242|Actual|Photozig, Inc.||2|||f||||||||||||||2017-02-18 13:53:50.483508|2017-02-18 13:53:50.483508
NCT00759850|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2008-09-24|||October 2003||2003-10-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|October 2005|Actual|2005-10-01||Interventional|PASEO||Drug Eluting Stent (DES) in Primary Angioplasty|PaclitAxel or Sirolimus-Eluting Stent vs Bare Metal Stent in Primary Angioplasty (PASEO) Randomized Trial|Completed||Phase 2/Phase 3|270|Actual|San Giuseppe Moscati Hospital||3|||f||||f||||||||||2017-02-18 13:53:53.207777|2017-02-18 13:53:53.207777
NCT00759837|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2009-07-15|||October 2008||2008-10-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects|An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of Bosutinib in Subjects With Chronic Hepatic Impairment and in Matched Healthy Adults|Completed||Phase 1|27|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:53:53.311935|2017-02-18 13:53:53.311935
NCT00759824|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-02-11|||September 2008||2008-09-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide|A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide|Completed||Phase 2|64|Actual|European Lung Cancer Working Party||1|||f||||t||||||||||2017-02-18 13:53:53.407502|2017-02-18 13:53:53.407502
NCT00759811|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-03-29|2009-09-04||December 2007||2007-12-01|March 2013|2013-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|METIS||METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)|METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure: Randomized Double-blind, Placebo-controlled Trial (METIS Trial)|Completed||Phase 2/Phase 3|50|Actual|Instituto de Cardiologia do Rio Grande do Sul||2|||f||||t||||||||||2017-02-18 13:53:53.520661|2017-02-18 13:53:53.520661
NCT00759798|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-09-30|||August 2008||2008-08-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)|Prospective Identification of Significant Prognostic Factors in Patients Treated With Fludarabine, Cyclophosphamide, and Rituximab (FCR) as Initial Therapy for Chronic Lymphocytic Leukemia.|Active, not recruiting||Phase 2|300|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:53:53.919337|2017-02-18 13:53:53.919337
NCT00759785|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-04-24|||October 2008||2008-10-01|April 2015|2015-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of Dalotuzumab (MK0646) in Breast Cancer Patients (0646-013)|A Study to Establish Proof-of-Biology for MK0646 in Breast Cancer|Completed||Phase 1|48|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 13:53:54.044328|2017-02-18 13:53:54.044328
NCT00759772|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2017-01-09|||September 2008||2008-09-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa|The Role of PTH in Low Bone Mass in Anorexia Nervosa|Active, not recruiting||Phase 2|23|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:53:54.137724|2017-02-18 13:53:54.137724
NCT00759759|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-08-13|2008-12-05||September 2004||2004-09-01|August 2010|2010-08-01|October 2004|Actual|2004-10-01|September 2004|Actual|2004-09-01||Interventional|||Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Study Comparing the Bioavailability of a Morphine Sulfate Sustained Release Capsule 1 x 200mg to KADIAN 2 x 100mg Capsules Under Fasting Conditions|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||||||||||||2017-02-18 13:53:54.457353|2017-02-18 13:53:54.457353
NCT00759746|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2016-03-01|||October 2009||2009-10-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|COMPASS||Childhood Obesity Treatment: A Maintenance Approach|Childhood Obesity Treatment: A Maintenance Approach|Completed||N/A|482|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 13:53:54.942297|2017-02-18 13:53:54.942297
NCT00759733|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-08-04|||July 2008||2008-07-01|August 2010|2010-08-01|December 2011|Anticipated|2011-12-01|July 2011|Anticipated|2011-07-01||Observational|||Evaluation Cardiac Function With Echo and BNP in Obstetrical Patients With/Without Cardiac Disease|Prospective Cohort Evaluation of Cardiac Function With Echocardiography and Serum B-type Natriuretic Peptide (BNP) in Obstetrical Patients With and Without a History of Cardiac Disease|Unknown status|Not yet recruiting|N/A|40|Anticipated|State University of New York - Upstate Medical University|||2||f||||f||||||||||2017-02-18 13:53:55.274276|2017-02-18 13:53:55.274276
NCT00759720|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-02-01|||November 2003||2003-11-01|February 2012|2012-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|ORIGAMI||Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Study of the Safety and Efficacy of a Combination of TAK-559 and Glyburide Compared to Placebo and Glyburide in the Treatment of Patients With Type 2 Diabetes Mellitus|Terminated||Phase 3|447|Actual|Takeda||3||Potential hepatic safety signal|f||||f||||||||||2017-02-18 13:53:55.410785|2017-02-18 13:53:55.410785
NCT00759707|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-08-15|||April 2006||2006-04-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Endothelial Function in Lower Extremity Bypass Grafts|Endothelial Function in Lower Extremity Bypass Grafts|Completed||N/A|19|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 13:53:55.537419|2017-02-18 13:53:55.537419
NCT00759694|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2014-10-16|||October 1999||1999-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:53:55.64281|2017-02-18 13:53:55.64281
NCT00759681|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-12-20|2012-10-31||September 2008||2008-09-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|StEPS||ArterX Surgical Sealant, A Randomized Prospective Multicenter Trial|A Prospective, Multi-center, Randomized Study to Evaluate the Safety and Efficacy of ArterX Vascular Sealant.|Completed||Phase 3|217|Actual|Tenaxis Medical, Inc.|There were no significant trial limitations.|2|||f||||t||||||||||2017-02-18 13:53:55.692477|2017-02-18 13:53:55.692477
NCT00759668|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2011-01-05|2010-10-12||May 2007||2007-05-01|January 2011|2011-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Visual Function and Patient Satisfaction After Bilateral Implantation of AcrySof Natural ReSTOR (Model SN60D3) or AcrySof Natural Monofocal (Model SN60AT)||Completed||N/A|35|Actual|Alcon Research|Visual acuity data were collected in different units (i.e. c, twentieth, decimal, Jaeger) and were converted to LogMAR after inclusion in the database. This led to inevitable approximations of the data.|2|||f||||f||||||||||2017-02-18 13:53:56.100443|2017-02-18 13:53:56.100443
NCT00759655|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-02-03|2010-12-14||June 2009||2009-06-01|February 2011|2011-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age|An Open-Label Study To Evaluate The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age In Usual Care Settings|Terminated||Phase 3|1|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 13:53:56.535324|2017-02-18 13:53:56.535324
NCT00759642|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-02-23|||March 2009||2009-03-01|December 2013|2013-12-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy|Phase II Trial of Lapatinib in Women With Hormone Receptor Positive (ER and/or PR +) HER-2 Negative Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|University of Kansas Medical Center||1|||f||||t||||||||||2017-02-18 13:53:56.862703|2017-02-18 13:53:56.862703
NCT00759629|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2008-09-24|||May 2001||2001-05-01|September 2008|2008-09-01|August 2005|Actual|2005-08-01|January 2005|Actual|2005-01-01||Interventional|Brave-2||Beyond 12 Hours Reperfusion AlternatiVe Evaluation Trial|An International, Multicenter, Randomized Trial Assessing the Value of Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting > 12 Hours From Onset of Symptoms|Completed||Phase 4|365|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 13:53:57.123744|2017-02-18 13:53:57.123744
NCT00759616|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-02-11|||April 2003||2003-04-01|February 2012|2012-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Outcome Analysis of the Oxford Partial Knee Arthroplasty|Outcome Analysis of the Oxford Partial Knee Arthroplasty|Completed||N/A|156|Actual|Zimmer Biomet||1|||f||||f||||||||||2017-02-18 13:53:57.244887|2017-02-18 13:53:57.244887
NCT00759603|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-07-27|2015-07-27||September 2008||2008-09-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia|Lenalidomide in Combination With Rituximab as Treatment for Patients With Relapsed Chronic Lymphocytic Leukemia - RV-CLL-PI-0292|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 13:53:57.337004|2017-02-18 13:53:57.337004
NCT00759590|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-10-19|||September 2008||2008-09-01|October 2015|2015-10-01||||March 2015|Actual|2015-03-01||Observational|||Comparison of Two Methods to Estimate the Lung Recruitment|Comparisons of Two Methods to Estimate the Lung Recruitment|Recruiting||N/A|30|Anticipated|Policlinico Hospital|||1||f||||f||||||||||2017-02-18 13:53:57.635908|2017-02-18 13:53:57.635908
NCT00759577|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-10-05|2011-11-18||September 2008||2008-09-01|October 2015|2015-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||"Feasibility of At-home Titration of Solifenacin"|"Feasibility of At-home Titration of Solifenacin 5 and 10mg and Effect on Symptoms and Quality of Life in a Typical OAB Population"|Terminated||Phase 4|36|Actual|New York University School of Medicine|Early termination leading to small numbers of subjects analyzed; Technical problems with measurement leading to unreliable or uninterpretable data.|1||difficulty with enrollment|f||||t||||||||||2017-02-18 13:53:57.743691|2017-02-18 13:53:57.743691
NCT00759564|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2016-02-10|2015-12-11||November 2008||2008-11-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function|An Open-label, 2-way Crossover Study To Investigate The Pharmacokinetics, Safety And Tolerability Of Iv Cp-70429 And Oral Pf-03709270 In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function|Completed||Phase 1|29|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 13:53:57.925535|2017-02-18 13:53:57.925535
NCT00759551|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-06-17|||August 2004||2004-08-01|June 2010|2010-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study of the Efficacy, Safety, and Tolerability of TAK-536 in Patients With Mild to Moderate Uncomplicated Essential Hypertension|Completed||Phase 2|555|Actual|Takeda||7|||f||||f||||||||||2017-02-18 13:53:59.753786|2017-02-18 13:53:59.753786
NCT00759538|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-07-30|||July 2007||2007-07-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|July 2007|Actual|2007-07-01||Observational|||Effect of Early Pulmonary Rehabilitation After Lung Transplantation|Effect of Early Pulmonary Rehabilitation After Lung Transplantation in Patients With a Prolonged Length of Stay on the Waiting List and Hospitalization After Transplantation|Completed||N/A|120|Actual|Hannover Medical School|||1||f||||f||||||||||2017-02-18 13:53:59.862339|2017-02-18 13:53:59.862339
NCT00759525|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-09-14|2013-08-15||February 2002||2002-02-01|September 2016|2016-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||Cross Over study|The Role of Mineralocorticoid Receptors in Vascular Function|The Role of Mineralocorticoid Receptors in Vascular Function|Completed||Phase 2/Phase 3|15|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 13:53:59.965606|2017-02-18 13:53:59.965606
NCT00759512|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2009-02-02|||August 2003||2003-08-01|February 2009|2009-02-01||||August 2005|Actual|2005-08-01||Interventional|||Effects of Therapeutic Touch on Osteoarthritis of the Knee||Completed||N/A|60|Actual|University of Toledo Health Science Campus||2|||f||||f||||||||||2017-02-18 13:54:00.427848|2017-02-18 13:54:00.427848
NCT00759317|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2014-07-01|||June 2001||2001-06-01|July 2014|2014-07-01|September 2002|Actual|2002-09-01|August 2002|Actual|2002-08-01||Interventional|Ven Nls I||Physiologic Monitoring of Antidepressant Treatment Response|Physiologic Monitoring of Antidepressant Medication Effects in Normal Controls Subjects I|Completed||Phase 4|37|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 13:54:03.992718|2017-02-18 13:54:03.992718
NCT00759499|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2017-01-11|||January 2007||2007-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Obtaining and Storing Wound Debridment Samples For Immediate or Future Wound-Related Scientific Study|Obtaining and Storing Wound Debridment Samples for Immediate or Future Wound-Related Scientific Study|Enrolling by invitation||N/A|829|Anticipated|Southwest Regional Wound Care Center|||1||f||||f||||||Samples With DNA|"~     The intent of this protocol is to salvage wound material that is normally destined for~     destruction, so it can be used in wound-related scientific studies~   "|No||2017-02-18 13:54:00.522577|2017-02-18 13:54:00.522577
NCT00759486|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-07-25|||October 2005||2005-10-01|July 2016|2016-07-01||||October 2020|Anticipated|2020-10-01||Observational|||Pediatric Facial Fracture Study|Pediatric Facial Fracture Growth and Development Study|Recruiting||N/A|1000|Anticipated|Children's Hospital of Pittsburgh|||1||f||||t||||||||||2017-02-18 13:54:00.631559|2017-02-18 13:54:00.631559
NCT00759473|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-03-14|2013-05-21||September 2008||2008-09-01|March 2016|2016-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||D-Cycloserine Facilitation of Cocaine - Cue Extinction|D-Cycloserine Facilitation of Cocaine - Cue Extinction|Completed||Phase 2|79|Actual|Medical University of South Carolina||5|||f||||t||||||||||2017-02-18 13:54:00.728937|2017-02-18 13:54:00.728937
NCT00759460|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-09-19|||March 2007||2007-03-01|September 2013|2013-09-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia|An Exploratory Study Conducted as an add-on to Clinical Trial 11286, to Evaluate the Metabolic Effect of up to 12 Weeks Treatment With Sertindole and Olanzapine in Patients With Schizophrenia|Completed||Phase 3|250|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:54:01.367049|2017-02-18 13:54:01.367049
NCT00759447|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2008-09-24|||December 2007||2007-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:54:01.479337|2017-02-18 13:54:01.479337
NCT00759434|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2014-12-02|||March 2004||2004-03-01|December 2014|2014-12-01||||August 2009|Actual|2009-08-01||Interventional|||A New Method of Surgically Treating Varicose Veins and Venous Ulcers - a Study to Assess Clinical and Economic Value|A Dual Centre, Randomised Controlled Trial of the Clinical and Cost Effectiveness of Endovenous Laser Therapy (EVLT) in the Treatment of Varicose Veins and Venous Ulcers|Unknown status|Active, not recruiting|N/A|260|Anticipated|University of Hull||2|||f||||f||||||||||2017-02-18 13:54:01.537456|2017-02-18 13:54:01.537456
NCT00759421|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2013-09-13|||October 2006||2006-10-01|September 2013|2013-09-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Exploratory Cognition Study of Sertindole in Patients With Schizophrenia|An Exploratory Cognition Study Conducted as an add-on to Clinical Trial 11286, to Evaluate the Neurocognitive Effects of 12 Weeks Treatment With Sertindole and Olanzapine in Patients With Schizophrenia|Completed||Phase 3|96|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 13:54:01.646429|2017-02-18 13:54:01.646429
NCT00759408|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-05-03|||February 1999||1999-02-01|April 2010|2010-04-01|June 2011|Anticipated|2011-06-01|October 2010|Anticipated|2010-10-01||Interventional|||The Role of Endothelin in Pulmonary Hypertension|The Role of Endothelin in Pulmonary Hypertension|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 13:54:01.764911|2017-02-18 13:54:01.764911
NCT00759395|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-10-10|2012-10-10||January 2009||2009-01-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)|An Investigation of the Antidepressant Efficacy of a Selective, High, Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder|Completed||Phase 2|22|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 13:54:01.882095|2017-02-18 13:54:01.882095
NCT00759382|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-08-09|||July 2008||2008-07-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|||Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.|Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.|Recruiting||N/A|340|Anticipated|European Lung Cancer Working Party|||1||f||||t||||||||Undecided||2017-02-18 13:54:02.357288|2017-02-18 13:54:02.357288
NCT00759369|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-02-24|||September 2008||2008-09-01|February 2012|2012-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Water as Therapy in Autosomal Dominant Polycystic Kidney Disease|Completed||N/A|11|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 13:54:02.485112|2017-02-18 13:54:02.485112
NCT00759356|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-08-13|2008-12-05||August 2004||2004-08-01|August 2010|2010-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Study Comparing the Bioavailability of a Morphine Sulfate Sustained Release Capsule 1 x 200mg to KADIAN 2 x 100mg Capsules Under Fed Conditions|Completed||Phase 1|36|Actual|Actavis Inc.||2|||f||||||||||||||2017-02-18 13:54:02.591522|2017-02-18 13:54:02.591522
NCT00759343|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2016-03-14|||June 2008||2008-06-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Stone Centre Urine and Serum Bank|Stone Centre Urine and Serum Bank|Active, not recruiting||N/A|500|Anticipated|University of British Columbia|||2||f||||f||||||Samples With DNA|"~     Urine and serum of stone-forming individuals and non-stone forming controls will be banked~     for analysis of protein biomarkers and predisposing factors. Ureteral stents removed from~     patients that would otherwise be discarded will be processed and stored to assess for~     bacterial and biofilm adherence.~      Serum and Urine specimens will be collected, de-identified, and banked/retained.~   "|||2017-02-18 13:54:03.056426|2017-02-18 13:54:03.056426
NCT00759330|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-08-12|2016-05-13||October 2007||2007-10-01|June 2016|2016-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|LBP||Flurbiprofen Tape for Treatment of Chronic Low Back Pain|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Flurbiprofen Tape for Treatment of Chronic Low Back Pain|Completed||Phase 2|127|Actual|Teikoku Pharma USA||4|||f||||f||||||||||2017-02-18 13:54:03.159913|2017-02-18 13:54:03.159913
NCT00607568|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2011-12-09|||June 2006||2006-06-01|December 2011|2011-12-01|September 2009|Actual|2009-09-01|August 2007|Actual|2007-08-01||Interventional|||Atomoxetine Effects in Humans|Atomoxetine Effects in Humans|Completed||Phase 1/Phase 2|10|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:47:38.354134|2017-02-18 14:47:38.354134
NCT00759304|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-08-10|||January 2001||2001-01-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|PROOF||Evaluation of Aging, Autonomic Nervous System Activity and Cardiovascular Events|Evaluation of Aging, Autonomic Nervous System Activity and Cardiovascular Events on a Prospective Cohort of Subjects Aged 65 Years|Active, not recruiting||N/A|1011|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples With DNA|"~     Serum, DNA~   "|No||2017-02-18 13:54:04.103469|2017-02-18 13:54:04.103469
NCT00759291|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-09-14|||April 2006||2006-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome|The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome|Active, not recruiting||Phase 2/Phase 3|60|Anticipated|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 13:54:04.199441|2017-02-18 13:54:04.199441
NCT00759278|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2008-09-24|||August 2008||2008-08-01|September 2008|2008-09-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Observational|||Comparison Fetal Hemodynamic Measurements Antihypertensive Versus Control|A Comparison of Fetal Hemodynamic Measurements Between Pregnant Women Taking Anti-Hypertensive Medication and Controls|Unknown status|Not yet recruiting|N/A|60|Anticipated|State University of New York - Upstate Medical University|||2||f||||f||||||||||2017-02-18 13:54:04.308053|2017-02-18 13:54:04.308053
NCT00759265|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-10-06|||May 2006||2006-05-01|July 2010|2010-07-01|January 2011|Actual|2011-01-01|February 2010|Actual|2010-02-01||Interventional|||Improving Mobility in Diabetic Patients Through Resistance Training|Improving Mobility in Diabetic Patients Through Resistance Training|Completed||N/A|160|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:54:04.413743|2017-02-18 13:54:04.413743
NCT00759252|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-08-27|||February 2008||2008-02-01|August 2015|2015-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|PRISM-PC||Perceptions Regarding Investigational Screening for Memory Problems in Primary Care|Perceptions Regarding Investigational Screening for Memory Problems in Primary Care: The PRISM-PC Study|Completed||N/A|954|Actual|Indiana University|||1||f||||f||||||||||2017-02-18 13:54:04.520414|2017-02-18 13:54:04.520414
NCT00759239|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2016-11-18|||September 2008||2008-09-01|January 2012|2012-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension||Completed||Phase 4|36|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:54:04.611525|2017-02-18 13:54:04.611525
NCT00759226|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2008-09-25|||July 2002||2002-07-01|September 2008|2008-09-01|August 2007|Actual|2007-08-01|July 2005|Actual|2005-07-01||Interventional|CONKO-101||Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer|An Open Labeled Phase 2 Study of Gemcitabine in Combination With Cisplatin, 5-FU (24h CI) and Folinic Acid in Patients With Inoperable Esophageal Cancer|Completed||Phase 2|92|Actual|CONKO-Studiengruppe||1|||f||||t||||||||||2017-02-18 13:54:04.911177|2017-02-18 13:54:04.911177
NCT00759213|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2012-02-16|||December 2007||2007-12-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|November 2008|Actual|2008-11-01||Observational|||Discharge Planning Assessment of Family Needs|Discharge Planning Assessment of Family Needs and Concerns at the Time of Infant's Discharge in the NICU|Completed||N/A|250|Actual|Christiana Care Health Services|||1||f||||f||||||||||2017-02-18 13:54:05.009742|2017-02-18 13:54:05.009742
NCT00759200|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2016-11-15|||October 2008||2008-10-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients|An Open-label, Randomized, Multicenter, Active-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of Albinterferon Alfa 2b Administered Every 4 Weeks Plus Ribavirin in Interferon Alfa-naïve Patients With Genotype 2/3 Chronic Hepatitis C|Completed||Phase 2|525|Anticipated|Novartis||5|||f||||||||||||||2017-02-18 13:54:05.087704|2017-02-18 13:54:05.087704
NCT00759187|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2010-02-24|2008-10-16||January 2008||2008-01-01|November 2008|2008-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluate Clinical Research From Commerical Oral Care Products|Evaluate Clinical Research From Commerical Oral Care Products|Completed||Phase 3|25|Actual|Colgate Palmolive||3|||f||||f||||||||||2017-02-18 13:54:05.256794|2017-02-18 13:54:05.256794
NCT00759174|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-08-08|2013-08-08||November 2008||2008-11-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION|"Case Crossover Study of PDE5 Inhibitor Exposure as a Potential Trigger Factor for Acute NAION"|Completed||N/A|673|Actual|Pfizer|Potential for bias from inaccuracies in recall of exposure and exposure-based enrollment were evaluated. Although these sources of bias cannot be excluded, they were unlikely to have substantially affected the primary results.||1||f||||f||||||||||2017-02-18 13:54:05.712112|2017-02-18 13:54:05.712112
NCT00759161|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-02-09||2011-02-09|November 2007||2007-11-01|February 2011|2011-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis|A Double-Blind, Randomized Bilateral Study of the Safety and Efficacy of AN2728 Ointment, 5%, Versus Ointment Vehicle in the Treatment of Patients With Plaque Type Psoriasis|Completed||Phase 2|35|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:54:06.179865|2017-02-18 13:54:06.179865
NCT00759148|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-02-23|2011-02-23||October 2008||2008-10-01|February 2011|2011-02-01||||March 2010|Actual|2010-03-01||Interventional|||Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis||Completed||Phase 3|1179|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:54:06.292489|2017-02-18 13:54:06.292489
NCT00759135|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-06-12||2010-08-30|May 2007||2007-05-01|June 2012|2012-06-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)|Phase 2 Multicenter Randomized Two Dose Level and Non-Inferiority Clinical Evaluation of Transrectal Administration of NX-1207 for the Treatment of BPH|Completed||Phase 2|85|Actual|Nymox Corporation||3|||f||||f||||||||||2017-02-18 13:54:06.629433|2017-02-18 13:54:06.629433
NCT00759122|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2008-09-23|||November 2002||2002-11-01|September 2008|2008-09-01|December 2005|Actual|2005-12-01|November 2005|Actual|2005-11-01||Interventional|||Electroencephalography (EEG) Biomarkers of Response in Depression|EEG Biomarkers of Response in Depression|Completed||Phase 4|44|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 13:54:06.764385|2017-02-18 13:54:06.764385
NCT00310739|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-11-06||||||April 2005|2005-04-01||||||||Observational|||Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury||Unknown status|Recruiting|N/A|||Hamamatsu University|||||f||||||||||||||2017-02-18 16:38:48.856864|2017-02-18 16:38:48.856864
NCT00759109|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2015-06-08|2011-03-24||March 2002||2002-03-01|June 2015|2015-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)|Long-term Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation: a Multicenter Study of Hepatocellular Carcinoma Prevention in Patients Non-responders to Combined Therapy With Alpha Interferon + Ribavirin or Peginterferon Alpha + Ribavirin or to Interferon Monotherapy|Completed||Phase 3|150|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:54:06.867202|2017-02-18 13:54:06.867202
NCT00759096|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2010-01-25|2009-09-11||May 2007||2007-05-01|January 2010|2010-01-01||||July 2008|Actual|2008-07-01||Interventional|||Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL|Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL|Completed||Phase 4|30|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:54:07.460271|2017-02-18 13:54:07.460271
NCT00759083|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2011-11-08|||September 2008||2008-09-01|November 2011|2011-11-01||||September 2009|Actual|2009-09-01||Interventional|||Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients|Bivalirudin PCI Registry in HIT/HITTS Patients|Completed||Phase 4|150|Actual|The Medicines Company||1|||f||||f||||||||||2017-02-18 13:54:07.649972|2017-02-18 13:54:07.649972
NCT00759070|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-02-21|||September 2008||2008-09-01|February 2013|2013-02-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|LIPOTAR-07||Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism|Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism in ARV-naive HIV-infected Subjects|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 13:54:07.747174|2017-02-18 13:54:07.747174
NCT00759057|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-06-26|||March 2003||2003-03-01|June 2012|2012-06-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|||A Clinical Study of the Dynesys(R) Spinal System|A Clinical Study of the Dynesys(R) Spinal System As a Non-fusion Device for Spinal Stabilization|Terminated||Phase 3|399|Actual|Zimmer Biomet||2||PMA not approved. FDA granted permission to close the study.|f||||f||||||||||2017-02-18 13:54:07.850051|2017-02-18 13:54:07.850051
NCT00759044|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-10-13|||March 2008||2008-03-01|October 2015|2015-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function|Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function|Completed||N/A|90|Actual|Association for Innovation and Biomedical Research on Light and Image|||2||f||||||||||||||2017-02-18 13:54:07.970607|2017-02-18 13:54:07.970607
NCT00759031|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-04-11|2008-10-16||February 2008||2008-02-01|April 2012|2012-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Investigation of Dental Plaque and Gingival Index|Investigation of Dental Plaque and Gingival Index|Completed||Phase 3|19|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-02-18 13:54:08.055338|2017-02-18 13:54:08.055338
NCT00759018|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2015-10-20||||||October 2015|2015-10-01||||||||Expanded Access|||Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD|Expanded Access of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD|No longer available||N/A|||Mesoblast, Ltd.|||||||||||||||||||2017-02-18 13:54:08.425334|2017-02-18 13:54:08.425334
NCT00759005|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2008-09-23|||March 2007||2007-03-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Stress on Heroin-Related Memory Retrieval||Completed||N/A|||National Institute on Drug Dependence, China||1|||f||||||||||||||2017-02-18 13:54:08.742481|2017-02-18 13:54:08.742481
NCT00758992|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-03-11|||October 2006||2006-10-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages|Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages|Completed||N/A|14|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 13:54:08.835156|2017-02-18 13:54:08.835156
NCT00758979|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2014-03-05|||November 2002||2002-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:54:08.932448|2017-02-18 13:54:08.932448
NCT00758966|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2012-11-27||2012-11-27|September 2008||2008-09-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder|A Proof-of-Concept, Multicenter, Randomized, Double-Blind, Parallel Study of Naltrexone Sustained-Release (SR) and/or Fluoxetine Therapy in the Treatment of Subjects With Obsessive-Compulsive Disorder (OCD)|Terminated||Phase 2|8|Actual|Orexigen Therapeutics, Inc||3||Sponsor Decision- Financial Considerations|f||||f||||||||||2017-02-18 13:54:08.983958|2017-02-18 13:54:08.983958
NCT00758953|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-03-02||2010-01-11|February 2007||2007-02-01|March 2012|2012-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pain Associated With Endometriosis||Completed||Phase 2|66|Actual|Lumara Health, Inc.||4|||f||||f||||||||||2017-02-18 13:54:09.10975|2017-02-18 13:54:09.10975
NCT00758940|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2015-05-08||||||January 2010|2010-01-01||||||||Interventional|||Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL|A Six-months, Open-labelled Clinical Assessment of Visual Function After Bilateral Implantation of Arcysof ReSTOR Multifocal Intra-ocular Lens|Withdrawn||Phase 4|0|Actual|Alcon Research||1||Primary Investigator resigned from Hospital|f||||f||||||||||2017-02-18 13:54:09.271653|2017-02-18 13:54:09.271653
NCT00758927|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2009-08-03|||July 2009||2009-07-01|August 2009|2009-08-01|July 2010|Anticipated|2010-07-01|April 2010|Anticipated|2010-04-01||Interventional|||The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients|The Effects of OMACOR on the LDL Sub-fraction in Korean Type 2 Diabetic Patients With Combined Hyperlipidemia|Unknown status|Recruiting|Phase 4|70|Anticipated|Inje University||2|||f||||t||||||||||2017-02-18 13:54:09.364988|2017-02-18 13:54:09.364988
NCT00758914|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2008-09-23|||May 1997||1997-05-01|September 2008|2008-09-01||||August 2001|Actual|2001-08-01||Interventional|||Vitamin E and Infection in the Elderly|Vitamin E and Infection in the Elderly|Completed||N/A|||Tufts University|||||f||||t||||||||||2017-02-18 13:54:09.480711|2017-02-18 13:54:09.480711
NCT00758901|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-12-02|||November 2003||2003-11-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||ROCC Knee Data Collection|A Prospective, Multicentre Study Evaluating the Clinical Performance of the ROCC Knee Prosthesis|Terminated||N/A|200|Actual|Zimmer Biomet|||1|Site Decision|f||||f||||||||||2017-02-18 13:54:09.572208|2017-02-18 13:54:09.572208
NCT00758888|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2009-07-23|||September 2008||2008-09-01|September 2008|2008-09-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Effect of Orthopedic Blocking on Cervical Spine Flexion and Extension Strength|Effect of Orthopedic Blocking on Cervical Spine Flexion and Extension Strength|Unknown status|Recruiting|N/A|30|Anticipated|Logan College of Chiropractic||3|||f||||f||||||||||2017-02-18 13:54:09.686188|2017-02-18 13:54:09.686188
NCT00758875|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-02-11|||July 2006||2006-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:54:09.783373|2017-02-18 13:54:09.783373
NCT00758862|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-12-19|||December 2008||2008-12-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo|The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo|Completed||Phase 2|20|Actual|LEO Pharma||1|||f||||f||||||||||2017-02-18 13:54:09.837097|2017-02-18 13:54:09.837097
NCT00758849|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2008-09-30|||September 2008||2008-09-01|September 2008|2008-09-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|Foehn||Fipamezole in Neurogenic Orthostatic Hypotension|A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the Effect of Fipamezole on Neurogenic Orthostatic Hypotension in Patients With Multiple System Atrophy or Parkinson's Disease|Unknown status|Not yet recruiting|Phase 2|24|Anticipated|Juvantia Pharma Ltd||2|||f||||f||||||||||2017-02-18 13:54:09.930045|2017-02-18 13:54:09.930045
NCT00758836|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2015-07-09|2014-07-18||December 2008||2008-12-01|July 2015|2015-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)|A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK0974 Co-administered With Ibuprofen or Acetaminophen in Patients With Migraine With or Without Aura|Completed||Phase 2|683|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:54:10.041599|2017-02-18 13:54:10.041599
NCT00758823|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2009-10-23|||August 2008||2008-08-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Randomized Controlled Trial Comparing Efficacy and Tolerance of Four Pediculicides|Randomized Controlled Trial Comparing Efficacy and Tolerance of Four Pediculicides Acting Mechanically With Reference Product Acting Chemically (Prioderm)|Completed||N/A|750|Anticipated|Omega Pharma||1|||f||||t||||||||||2017-02-18 13:54:10.801031|2017-02-18 13:54:10.801031
NCT00758810|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2009-06-16|||October 2006||2006-10-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|OLIMPIC||Impact at One Year of a Secondary Prevention Educational Program on Cardiovascular Risk Factors|Impact at One Year of a Secondary Prevention Educational Program on Cardiovascular Risk Factors, Daily Physical Activity, Dietary Habits and Blood Glucose and Fatty Acids in Coronary Syndromes Patients|Completed||N/A|354|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||||||2017-02-18 13:54:10.912444|2017-02-18 13:54:10.912444
NCT00758797|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2014-05-22|||April 2008||2008-04-01|May 2014|2014-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Novel Treatment for Metastatic Melanoma|In Situ Photoimmunotherapy: A Tumor Directed Treatment for Advanced Melanoma With Cutaneous Metastases|Terminated||Phase 1|7|Actual|Northwestern University||1||Study was not renewed during annual Northwestern Cancer Center review.|f||||t||||||||||2017-02-18 13:54:11.023067|2017-02-18 13:54:11.023067
NCT00758784|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2013-01-03||2011-09-02|August 2008||2008-08-01|January 2013|2013-01-01||||June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease||Completed||Phase 2|38|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 13:54:11.134588|2017-02-18 13:54:11.134588
NCT00758771|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2014-01-22|2014-01-22||October 2007||2007-10-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|GIST||Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents|Using State-of-the-art Rheological Methods to Characterize CF Sputum and the Effects of Mucoactive Agents: A Pilot Study|Completed||N/A|38|Actual|University of California, San Francisco|||2||f||||f||||||Samples Without DNA|"~     Sputum~   "|||2017-02-18 13:54:11.225702|2017-02-18 13:54:11.225702
NCT00758758|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-08-09|2013-05-09||December 2001||2001-12-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||Performance of the Hedrocel(R) Cervical Fusion Device|Performance of the Hedrocel(R) Cervical Fusion Device|Completed||Phase 3|231|Actual|Zimmer Biomet||8|||f||||f||||||||||2017-02-18 13:54:11.517944|2017-02-18 13:54:11.517944
NCT00758745|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2014-08-15|2011-07-01||January 2006||2006-01-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Randomized Contralateral Clinical Trial With Single-piece (SN60WF) vs. Three Piece (MA60AC) AcrySof Intraocular Lenses (IOLs) on Development of Posterior Chamber Opacification (PCO).||Completed||N/A|81|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:54:12.518603|2017-02-18 13:54:12.518603
NCT00758732|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2015-09-25|||October 2005||2005-10-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma|A Multicenter Randomized Phase II Study of Docetaxel/Carboplatin Versus Docetaxel/Pegylated Liposomal Doxorubicin as Second Line Treatment in Patients With Platinum Sensitive Disease|Terminated||Phase 2|34|Actual|Hellenic Oncology Research Group||2||Poor accrual|f||||||||||||||2017-02-18 13:54:12.813535|2017-02-18 13:54:12.813535
NCT00758719|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2016-02-26|||September 2008||2008-09-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System|A Prospective Multicenter Lumbar Spine Fusion Study to Evaluate the Effectiveness of the Biomet Lumbar Spinal Fusion System|Completed||N/A|53|Actual|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-02-18 13:54:12.933081|2017-02-18 13:54:12.933081
NCT00749294|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-08-06|||June 2008||2008-06-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Anogenital Wart Burden and Cost of Illnesses|Measurement of Anogenital Wart Burden, and Cost of Illnesses in Bangkok|Completed||N/A|150|Anticipated|Mahidol University|||1||f||||f||||||||||2017-02-18 13:57:21.336022|2017-02-18 13:57:21.336022
NCT00758706|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2015-04-14|2011-07-25||September 2008||2008-09-01|April 2015|2015-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|BICO||A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients|A Double-blind, Randomised, Placebo-controlled, Parallel Group Multi-centre Phase IIa Study to Assess the Effects on Biomarkers in Induced Sputum, Bood and Uine of AZD1236 Administered as Oral Tablet in Moderate to Severe COPD Patients During a 6 Week Period.|Completed||Phase 2|55|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:54:13.036947|2017-02-18 13:54:13.036947
NCT00758693|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2012-01-10|||October 2008||2008-10-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)|Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia: A Phase II Study|Withdrawn||Phase 2|0|Actual|University of Kentucky||1||Funding was withdrawn due to insufficient accrual|f||||f||||||||||2017-02-18 13:54:16.063449|2017-02-18 13:54:16.063449
NCT00758680|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2016-02-04|2012-07-24||August 2008||2008-08-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)|A Multiple Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-1006.|Terminated||Phase 1|112|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-02-18 13:54:16.185177|2017-02-18 13:54:16.185177
NCT00758667|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2014-12-08|2013-12-23||January 2005||2005-01-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|August 2008|Actual|2008-08-01||Interventional||Participants with capsular contracture after breast implants that elected to have capsule removed and implant exchanged; followup for recurrence of capsulsar contracture|Chemically Assisted Capsulectomy-A New Clinical Approach|Chemically Assisted Capsulectomy-A New Clinical Approach|Terminated||N/A|20|Actual|Vanderbilt University||2||preliminary analysis showed no difference|f||||f||||||||||2017-02-18 13:54:17.527424|2017-02-18 13:54:17.527424
NCT00758654|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-03-28|||January 2007||2007-01-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Strain-Encoded Cardiac Magnetic Resonance Imaging for Dobutamine Stress Testing|Strain-Encoded Cardiac Magnetic Resonance Imaging as an Adjunct for Dobutamine Stress Testing.|Completed||N/A|320|Actual|Heidelberg University|||2||f||||f||||||||||2017-02-18 13:54:17.882699|2017-02-18 13:54:17.882699
NCT00758641|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2016-06-16|||September 2009||2009-09-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Platelet Rich Plasma to Treat Plantar Fasciitis|Use of PRP to Treat Plantar Fasciitis, Blinded and Randomized as a Multi Center Study|Completed||Phase 4|115|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:54:17.986167|2017-02-18 13:54:17.986167
NCT00758628|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2009-09-03|||August 2008||2008-08-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.|Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.|Completed||Phase 4|50|Anticipated|Bp Consulting, Inc||2|||f||||f||||||||||2017-02-18 13:54:18.098085|2017-02-18 13:54:18.098085
NCT00758615|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-12-04|||September 2008||2008-09-01|December 2013|2013-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Pilot Evaluation of a Walking School Bus Program|Pilot and Feasibility Evaluation of a Walking School Bus Program Intervention for Elementary School Students|Completed||N/A|149|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-02-18 13:54:18.192106|2017-02-18 13:54:18.192106
NCT00758602|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2014-07-08|2014-07-08||September 2008||2008-09-01|July 2014|2014-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional||Intent-to-Treat (ITT) population: all randomized patients who received at least one dose ofthe treatment-group specific medication.|A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.|A Randomized, Open Label Study Comparing the Effect of CellCept Combined With Low Dose Versus Standard Dose Tacrolimus, and Corticosteroids, on Kidney Function in Renal Transplantation Patients|Completed||Phase 4|210|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 13:54:18.298969|2017-02-18 13:54:18.298969
NCT00758589|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2014-01-24|2013-07-01||September 2008||2008-09-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|||||Interventional|OLIVE||One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids|A Double-blind, Randomised, Parallel Group, Multicentre Phase IIb, Placebo-Controlled, 1 Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids|Completed||Phase 2|368|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 13:54:19.031303|2017-02-18 13:54:19.031303
NCT00758576|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2010-12-06|2010-10-08||February 2008||2008-02-01|December 2010|2010-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||ReSTOR Natural +3.0D Study In Japan|ReSTOR Natural +3.0D (Diopter) Study In Japan|Completed||N/A|64|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 13:54:20.130182|2017-02-18 13:54:20.130182
NCT00758563|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2008-11-20|2008-10-16||March 2008||2008-03-01|November 2008|2008-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Train New Examiners Via Modified Gingival Margin Plaque|Train New Examiners Via Modified Gingival Margin Plaque|Completed||Phase 3|15|Actual|Colgate Palmolive||2|||f||||t||||||||||2017-02-18 13:54:20.36065|2017-02-18 13:54:20.36065
NCT00758550|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2010-03-04|2009-08-13||April 2007||2007-04-01|March 2010|2010-03-01||||June 2008|Actual|2008-06-01||Interventional|||Visual Function After Bilateral Implantation of AcrySof® Toric|Visual Function After Bilateral Implantation of AcrySof® Toric|Completed||Phase 4|60|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:54:20.711638|2017-02-18 13:54:20.711638
NCT00758537|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2009-07-13|||January 2007||2007-01-01|July 2009|2009-07-01|October 2008||2008-10-01|||||Observational|||Tryptophan Metabolism in Kidney Disease||Completed||N/A|80|Anticipated|Charite University, Berlin, Germany|||4||f||||||||||||||2017-02-18 13:54:21.075564|2017-02-18 13:54:21.075564
NCT00758524|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-05-31||2012-05-31|September 2008||2008-09-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Finding Study to Evaluate the Efficacy and Safety of LCI699, a New Experimental Antihypertensive Drug, in Patients With Essential Hypertension|A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Finding Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo After 8 Weeks Treatment in Patients With Essential Hypertension|Completed||Phase 2|526|Actual|Novartis||6|||f||||f||||||||||2017-02-18 13:54:21.171639|2017-02-18 13:54:21.171639
NCT00758511|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-11-13|||January 2009||2009-01-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|PAMINA||Pain Reactivity to Non-Pharmacological Interventions Across Repeated Routine Heel-Sticks in Preterm Infants in a Neonatal Intensive Care Unit|Pain Reactivity to Non-pharmacological Interventions Across Repeated Routine Heel-Sticks in Preterm Infants in a Neonatal Intensive Care Unit|Completed||Early Phase 1|71|Actual|University of Basel||3|||f||||f||||||||||2017-02-18 13:54:21.282177|2017-02-18 13:54:21.282177
NCT00758498|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-07-12|2010-04-30||September 2008||2008-09-01|July 2013|2013-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder|A 3-Day, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Armodafinil Treatment (50 and 150 mg/Day) in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder|Completed||Phase 3|427|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-02-18 13:54:21.406375|2017-02-18 13:54:21.406375
NCT00758485|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2015-08-04|2013-03-11||October 2008||2008-10-01|August 2015|2015-08-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)|A Randomized, Safety-assessor Blinded Trial Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in Adult Subjects Scheduled for Surgery Requiring Profound Neuromuscular Blockade|Completed||Phase 3|140|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:54:22.789641|2017-02-18 13:54:22.789641
NCT00758472|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2012-05-04|||March 2005||2005-03-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||ReCap Total Hip Resurfacing Prospective Data Collection|ReCap Total Hip Resurfacing Prospective Data Collection|Terminated||N/A|82|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 13:54:23.170915|2017-02-18 13:54:23.170915
NCT00758459|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-07-25|2011-07-25||September 2008||2008-09-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|||||Interventional|CERA||Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients|A 6 Week Double-Blind, Placebo-controlled, Randomised, Parallel Group Phase IIa Study to Assess the Tolerability/Safety and Efficacy of AZD1236as an Oral Tablet in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|74|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:54:23.283973|2017-02-18 13:54:23.283973
NCT00758446|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-03-12|||September 2008||2008-09-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis|A Double-blind, Randomized, Placebo-controlled, Cross-over, Allergen Challenge Study to Evaluate the Efficacy, Safety and Tolerability of BLX-028914 in Subjects With Allergic Rhinitis|Completed||Phase 2|36|Actual|Dart NeuroScience, LLC||3|||f||||f||||||||||2017-02-18 13:54:23.838306|2017-02-18 13:54:23.838306
NCT00758433|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-06-08|||September 2008||2008-09-01|June 2011|2011-06-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Civamide Patch Safety, Tolerability and PK Study|Randomized, Double-Blind, Placebo-Controlled Evaluation of the Tolerability of Two Civamide (Zucapsaicin) Patch Strengths Compared to Placebo Patch in Healthy Volunteers|Completed||Phase 1|39|Actual|Winston Laboratories||3|||f||||f||||||||||2017-02-18 13:54:23.932687|2017-02-18 13:54:23.932687
NCT00758420|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2015-02-19|2014-01-06||October 2008||2008-10-01|February 2015|2015-02-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|Pilot|Treated patients with a week 8 study assessment.|Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence|A Randomized, Single Blind, Placebo Controlled, Multicenter Study to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for the Treatment of Symptomatic, Visible Varicose Veins With Saphenofemoral Junction (SFJ) Incompetence.|Completed||Phase 2/Phase 3|77|Actual|BTG International Inc.||2|||f||||f||||||||||2017-02-18 13:54:24.045101|2017-02-18 13:54:24.045101
NCT00758407|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-24|2010-01-12|||August 2006||2006-08-01|January 2010|2010-01-01||||January 2010|Actual|2010-01-01||Interventional|EMF||Methylphenidate Treatment of Cancer-Related Fatigue|Placebo Controlled Double Blind Study With Methylphenidate in Treatment of Adults With Cancer-Related Fatigue|Completed||Phase 2/Phase 3|66|Anticipated|Medice Arzneimittel Pütter GmbH & Co KG||2|||f||||f||||||||||2017-02-18 13:54:24.534546|2017-02-18 13:54:24.534546
NCT00758394|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-08-08|2008-10-16||September 2007||2007-09-01|August 2013|2013-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Clinical Study to Compare Dental Plaque Control|Clinical Study to Compare Dental Plaque Control|Completed||Phase 3|29|Actual|Colgate Palmolive||4|||f||||f||||||||||2017-02-18 13:54:24.649852|2017-02-18 13:54:24.649852
NCT00758381|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2008-10-09|||August 2007||2007-08-01|October 2008|2008-10-01|August 2009|Anticipated|2009-08-01|August 2008|Anticipated|2008-08-01||Interventional|MAPS||Metastatic Advanced Pancreas Sorafenib|A Randomized Phase II Study of Gemcitabine/Cisplatin With or Without Sorafenib to Evaluate the Efficacy and Safety in Patients With Locally Advanced or Metastatic Pancreatic Cancer. MAPS Trial|Unknown status|Recruiting|Phase 2|114|Anticipated|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente||2|||f||||f||||||||||2017-02-18 13:54:25.224991|2017-02-18 13:54:25.224991
NCT00758368|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-07-21|||March 2009||2009-03-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease|Comparison of Continuous and Pulsatile Apomorphine Administration in Parkinson's Disease Complicated by Levodopa-induced Dyskinesia|Withdrawn||Phase 2|24|Anticipated|Oregon Health and Science University||2||Inadequate support to conduct the study|f||||f||||||||||2017-02-18 13:54:25.348652|2017-02-18 13:54:25.348652
NCT00758355|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2016-07-18|||March 2008||2008-03-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2013|Actual|2013-12-01||Observational|||Data Collection on ReCap/Magnum in Total Hip Replacement and Resurfacing|A Prospective, Multicentre Study Evaluating the Clinical Performance of the ReCap/Magnum in Total Hip Replacement and Resurfacing|Completed||N/A|150|Actual|Zimmer Biomet|||2||f||||f||||||||||2017-02-18 13:54:25.462487|2017-02-18 13:54:25.462487
NCT00758342|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2010-02-23|2009-09-10||May 2006||2006-05-01|February 2010|2010-02-01||||March 2008|Actual|2008-03-01||Interventional|||Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)|A Double-Masked, Parallel-Group, Efficacy and Safety Study of Brinzolamide 1.0% (AZOPT) as Adjunctive Therapy to Travoprost 0.004% (TRAVATAN) in Patients With Chronic Angle-Closure Glaucoma|Terminated||Phase 4|37|Actual|Alcon Research||2||difficulty of enrolling patients|f||||f||||||||||2017-02-18 13:54:25.549058|2017-02-18 13:54:25.549058
NCT00758329|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-12-05|||April 2004||2004-04-01|November 2011|2011-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Retrospective Data Review of ReCap Total Hip Resurfacing|Retrospective Data Review of ReCap Total Hip Resurfacing|Withdrawn||N/A|0|Actual|Zimmer Biomet|||1|No further contact with the site|f||||f||||||||||2017-02-18 13:54:25.846587|2017-02-18 13:54:25.846587
NCT00758316|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2017-02-09|||September 2008||2008-09-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions|A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions|Completed||Phase 3|120|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-02-18 13:54:25.935744|2017-02-18 13:54:25.935744
NCT00758303|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2013-08-29||2013-08-22|September 2007||2007-09-01|August 2013|2013-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Evaluate the Lipid Regulating Effects of TRIA-662|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multi-Center Study to Evaluate the Lipid Regulating Effects of TRIA-662|Completed||Phase 2/Phase 3|211|Actual|Cortria Corporation||3|||f||||t||||||||||2017-02-18 13:54:26.042998|2017-02-18 13:54:26.042998
NCT00758290|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2008-11-20|2008-10-16||May 2008||2008-05-01|November 2008|2008-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Clinical Study to Evaluate Dental Plaque|Clinical Study to Evaluate Dental Plaque|Completed||Phase 3|23|Actual|Colgate Palmolive||2|||f||||f||||||||||2017-02-18 13:54:26.144245|2017-02-18 13:54:26.144245
NCT00758277|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-06-22|||May 2007||2007-05-01|August 2009|2009-08-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|Keppra-2||Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients|Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients|Completed||Phase 3|201|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 13:54:26.673666|2017-02-18 13:54:26.673666
NCT00758264|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2016-10-06||2009-09-09|October 2008||2008-10-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration|Immunogenicity & Safety Study of GSK Biologicals' Meningococcal Vaccine GSK134612 When Co-administered With GSK Biologicals' Pneumococcal Vaccine GSK1024850A in Healthy 12-23-month-old Children Previously Primed With GSK1024850A|Completed||Phase 3|363|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:54:26.79758|2017-02-18 13:54:26.79758
NCT00758251|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2010-12-08|||September 2008||2008-09-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment|Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment|Completed||N/A|80|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:54:26.919264|2017-02-18 13:54:26.919264
NCT00758238|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2008-09-23|||September 2008||2008-09-01|September 2008|2008-09-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|myBP||Development and Pilot-Testing of a Patient Self Management Approach for Hypertension Using Personal Electronic Health Records|Evidence-Based Development and Initial Evaluation of a Facilitated Patient Self Management e Health Strategy Intervention for Hypertension|Unknown status|Not yet recruiting|N/A|120|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 13:54:27.021084|2017-02-18 13:54:27.021084
NCT00758225|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2011-05-30|||September 2008||2008-09-01|May 2011|2011-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)|A Phase II Open-label Extension Study to Obtain Long-term Safety, Tolerability and Efficacy Data of Idebenone in the Treatment of Duchenne Muscular Dystrophy - Extension to Study SNT-II-001|Completed||Phase 2|21|Anticipated|Santhera Pharmaceuticals||1|||f||||t||||||||||2017-02-18 13:54:27.121123|2017-02-18 13:54:27.121123
NCT00758212|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2008-10-08|||November 2008||2008-11-01|September 2008|2008-09-01|April 2009|Anticipated|2009-04-01|January 2009|Anticipated|2009-01-01||Interventional|||Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem|Influenza Vaccination at a Reduced Dose of 1:10 Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 13:54:27.218411|2017-02-18 13:54:27.218411
NCT00758199|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2012-03-14|||July 2008||2008-07-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery|Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery|Completed||Phase 4|49|Actual|Bp Consulting, Inc||3|||f||||f||||||||||2017-02-18 13:54:27.330909|2017-02-18 13:54:27.330909
NCT00758186|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-23|2008-09-23|||October 2004||2004-10-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Randomized Trial of Colonic Stents as a Bridge to Surgery|Endoscopic Stenting and Elective Surgery Versus Emergency Surgery for Left-Sided Malignant Colonic Obstruction: A Prospective Randomized Trial.|Completed||Phase 3|40|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-02-18 13:54:27.435844|2017-02-18 13:54:27.435844
NCT00758173|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-08-23|||February 2008||2008-02-01|September 2008|2008-09-01||||||||Observational|||Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom|A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Prostate Cancer in East Anglia, Trent and West Midlands|Unknown status|Recruiting|N/A|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:54:27.54662|2017-02-18 13:54:27.54662
NCT00758160|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-03-10|2013-09-05||March 2008||2008-03-01|March 2014|2014-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|From Immediate-release MPH to OROS MPH: The Impact Upon Family of Children and Adolescents With ADHD|Completed||Phase 4|296|Actual|Johnson & Johnson Taiwan Ltd||1|||f||||f||||||||||2017-02-18 13:54:27.643031|2017-02-18 13:54:27.643031
NCT00607009|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-02-04|||July 2006||2006-07-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Project ALIVE (A Lifestyle Intervention Via Email)|Email-Based Diet and Activity Promotion in Worksites|Completed||N/A|797|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 14:47:52.290647|2017-02-18 14:47:52.290647
NCT00758147|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2008-09-22|||November 2008||2008-11-01|September 2008|2008-09-01|June 2010|Anticipated|2010-06-01|November 2009|Anticipated|2009-11-01||Interventional|||Force Feedback Joystick in Upper Limb Rehabilitation Following Stroke|Assessment of Force Feedback Joystick in Upper Limb Rehabilitation Following Stroke|Unknown status|Not yet recruiting|N/A|30|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-02-18 13:54:28.069071|2017-02-18 13:54:28.069071
NCT00758134|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-05-27|||July 2008||2008-07-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients|Prospective Phase II Trial Evaluating Efficacy of Trastuzumab Therapy in HER2 FISH Positive and/or HER2 Mutation Positive, Pretreated, Non-Small Cell Lung Cancer Patients (MO20509)|Terminated||Phase 2|9|Actual|Istituto Clinico Humanitas||1||Insufficient accrual|f||||f||||||||||2017-02-18 13:54:28.173486|2017-02-18 13:54:28.173486
NCT00758121|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2009-11-04|||November 2008||2008-11-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|CORRELATE-HF||Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients|CORRELATE-HF: Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients|Terminated||N/A|56|Actual|Boston Scientific Corporation|||1|"Inappropriate therapy associated with certain right ventricular (RV) lead complications may~   occur more frequently if the Respiratory Sensor is programmed On"|f||||f||||||||||2017-02-18 13:54:28.271521|2017-02-18 13:54:28.271521
NCT00758108|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-20|2017-01-24|||September 11, 2008||2008-09-11|April 29, 2015|2015-04-29|April 29, 2015||2015-04-29|||||Observational|||Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions|WAGR Syndrome and Other 11p Contiguous Gene Deletions: Clinical Characterization and Correlation With Genotype|Completed||N/A|197|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:54:28.365401|2017-02-18 13:54:28.365401
NCT00758095|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-11-20|||December 2006||2006-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:54:28.456361|2017-02-18 13:54:28.456361
NCT00758082|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2010-03-10|||July 2008||2008-07-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|TELFIT||Reinforcement of the Impact of a Functional Insulin Therapy Training Course by Telemonotoring With a PDA-phone in Type 1 Diabetic Patients. The TELFIT Study Patients|Reinforcement of the Impact of a Functional Insulin Therapy Training Course by Telemonotoring With a PDA-phone in Type 1 Diabetic Patients. The TELFIT Study|Completed||Phase 3|62|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-02-18 13:54:28.511484|2017-02-18 13:54:28.511484
NCT00758069|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2015-08-03|2009-08-17||July 2005||2005-07-01|August 2015|2015-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)|Phase II Study on Sitagliptin -Assessment of Glucose-lowering Effects|Completed||Phase 2|80|Actual|Merck Sharp & Dohme Corp.|Reported overdoses, regardless of association with reported adverse events, were considered as serious adverse events in this study. The patients for whom the event of overdose was reported had no concomitant AEs with the overdose.|3|||f||||f||||||||||2017-02-18 13:54:28.619204|2017-02-18 13:54:28.619204
NCT00758056|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-08-23|||February 2008||2008-02-01|September 2008|2008-09-01||||||||Observational|||Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom|A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Endometrial Cancer in East Anglia, Oxford Trent and West Midlands|Unknown status|Recruiting|N/A|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:54:29.060635|2017-02-18 13:54:29.060635
NCT00758043|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2013-09-30|2011-06-22||October 2008||2008-10-01|June 2011|2011-06-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response|A Randomized Study of Stopping Treatment at 24 Weeks or Continuing Treatment to 48 Weeks in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response While Receiving Telaprevir, Peginterferon Alfa2a (Pegasys®) and Ribavirin (Copegus®)|Completed||Phase 3|540|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||t||||||||||2017-02-18 13:54:29.156562|2017-02-18 13:54:29.156562
NCT00758030|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-06-06|||March 2004||2004-03-01|March 2010|2010-03-01|July 2004|Actual|2004-07-01|||||Interventional|||Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults.|A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose Study to Evaluate and Compare the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Subjects.|Completed||Phase 1|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 13:54:30.559221|2017-02-18 13:54:30.559221
NCT00758017|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2011-06-21|||January 2009||2009-01-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Efficacy of Different Acupuncture Methods for Chronic Low Back Pain|Efficacy of Different Acupuncture Methods for Chronic Low Back Pain|Completed||N/A|150|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:54:30.649886|2017-02-18 13:54:30.649886
NCT00758004|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2009-11-16|||October 2008||2008-10-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Bioequivalence Study Of Pediatric Appropriate Formulation|An Open Label, Randomized, Single Dose, Two-Way Crossover Bioequivalence Study Comparing A New 80 Mg (2x40 mg) Pediatric Appropriate Formulation To A 80 Mg Commercial Atorvastatin Calcium Tablet Formulation In Healthy Subjects|Completed||Phase 1|76|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:54:30.755994|2017-02-18 13:54:30.755994
NCT00757991|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-08-23|||February 2008||2008-02-01|September 2008|2008-09-01||||||||Observational|||Blood Samples From Healthy Volunteers for Genetic Studies in the East Anglia Region of the United Kingdom|A Population Based Control Collection for Genetic Studies in East Anglia|Unknown status|Recruiting|N/A|4000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:54:30.878741|2017-02-18 13:54:30.878741
NCT00757978|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2008-12-17|||January 2006||2006-01-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms|Phase 4 Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms in Patients Using Clozapine. A Randomized, Double-Blind, Placebo Controled Study|Completed||Phase 4|22|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 13:54:30.980902|2017-02-18 13:54:30.980902
NCT00757965|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-08-23|||February 2008||2008-02-01|September 2008|2008-09-01||||||||Observational|||Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom|A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Colorectal Cancer in East Anglia|Unknown status|Recruiting|N/A|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:54:31.093549|2017-02-18 13:54:31.093549
NCT00757952|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2016-03-28|||November 2007||2007-11-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction|Early Detection of Epithelial Ovarian Cancer Using Exhaled Breath Markers: GC/FT-ICR Mass Spectrometry and Canine Olfaction.|Completed||N/A|109|Actual|Pine Street Foundation|||1||f||||f||||||||||2017-02-18 13:54:31.194266|2017-02-18 13:54:31.194266
NCT00757939|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2015-08-10|||September 2008||2008-09-01|August 2015|2015-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)|A Two-Part Cross-Sectional and Longitudinal Study to Assess Regional Cerebral Blood Flow by Dynamic Arterial Spin Labeling as an Alzheimer's Disease Biomarker as Compared to FDG-PET in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects|Completed||Phase 1|40|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 13:54:31.296611|2017-02-18 13:54:31.296611
NCT00757926|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2010-02-02|||September 2009||2009-09-01|February 2010|2010-02-01|September 2010|Anticipated|2010-09-01|August 2010|Anticipated|2010-08-01||Interventional|||Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants|Phase I/II, Randomized, Double-blind, Placebo-controlled, Staged Dosage Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 3-dose Series of Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV] Administered to Healthy Indian Infants Concurrently With Other Standard EPI Vaccines|Withdrawn||Phase 1/Phase 2|240|Anticipated|Shantha Biotechnics Limited||2||Replaced with an alternate study|f||||t||||||||||2017-02-18 13:54:31.390813|2017-02-18 13:54:31.390813
NCT00757913|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2010-02-23|||September 2008||2008-09-01|February 2010|2010-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||n-3 Enriched Nutrition Therapy and Postoperative Cognitive Dysfunction After Cardiac Surgery|The Effect of n-3 Enriched Nutrition Therapy on Postoperative Cognitive Dysfunction and Delirium After Elective Cardiac Surgery|Terminated||Phase 4|400|Anticipated|University Hospital, Basel, Switzerland||2||Insufficient recruitment rate|f||||||||||||||2017-02-18 13:54:31.494838|2017-02-18 13:54:31.494838
NCT00757900|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2008-10-08|||April 2008||2008-04-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy of Influenza Vaccine in HIV Infected Adults|Efficacy of Influenza Vaccine in HIV Infected Adults|Completed||Phase 4|507|Actual|University of Witwatersrand, South Africa||2|||f||||f||||||||||2017-02-18 13:54:31.585893|2017-02-18 13:54:31.585893
NCT00757887|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2010-11-08|||October 2009||2009-10-01|October 2009|2009-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Re-exposure of EHMI-8 Human Volunteers to Live Malaria Sporozoites|Re-exposure of EHMI-8 Human Volunteers to Live Malaria Sporozoites|Completed||N/A|15|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 13:54:31.690927|2017-02-18 13:54:31.690927
NCT00757874|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2015-09-05|||April 2006||2006-04-01|September 2015|2015-09-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus|A Double Blind Phase II Study Comparing Safety and Efficacy of Tacrolimus Versus Topical Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus.|Completed||Phase 2|56|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-02-18 13:54:31.800862|2017-02-18 13:54:31.800862
NCT00757848|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2012-08-14|2012-01-24||October 2008||2008-10-01|August 2012|2012-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|INCA||A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis|A Phase II, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy of 28 Day Oral Administration of AZD9668 in Patients With Cystic Fibrosis|Completed||Phase 2|56|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:54:31.917562|2017-02-18 13:54:31.917562
NCT00757835|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-05-09|||May 2008||2008-05-01|May 2014|2014-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG|24-hour IOP Control With the Travoprost/Timolol Fixed Combination Compared With the Latanoprost/Timolol Fixed Combination, When Both Are Dosed in the Evening in Patients With Exfoliative Glaucoma|Completed||Phase 4|40|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-02-18 13:54:32.587726|2017-02-18 13:54:32.587726
NCT00757822|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2016-04-07|2015-09-28||December 2009||2009-12-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|December 2013|Actual|2013-12-01||Interventional|PONV||Prevention of Postoperative Nausea and Vomiting (PONV) in Surgical Patients|Prevention of Postoperative Nausea and Vomiting in Surgical Patients|Completed||N/A|216|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:54:32.687775|2017-02-18 13:54:32.687775
NCT00757809|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2012-05-10|||October 2008||2008-10-01|May 2012|2012-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study Evaluating The Tolerability Of Multiple Doses Of HKI-272|A Blinded, Randomized, Multiple-Dose, Parallel Group Study to Characterize the Occurrence of Mild to Moderate Diarrhea After Administration of Neratinib Either 240-mg Once Daily or 120-mg Twice Daily for 14 Days to Healthy Subjects|Completed||Phase 1|50|Actual|Puma Biotechnology, Inc.||2|||f||||f||||||||||2017-02-18 13:54:33.377398|2017-02-18 13:54:33.377398
NCT00757796|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2008-09-21|||October 2008||2008-10-01|September 2008|2008-09-01||||||||Observational|||Obstructive Sleep Apnea Syndrome and Attention Executive Function Disturbances|Obstructive Sleep Apnea Syndrome and Attention Executive Function Disturbances|Unknown status|Not yet recruiting|N/A|80|Anticipated|Assaf-Harofeh Medical Center|||1||f||||||||||||||2017-02-18 13:54:33.468007|2017-02-18 13:54:33.468007
NCT00757614|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-08-23|||February 2008||2008-02-01|April 2010|2010-04-01||||||||Observational|||Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom|A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Cancer in East Anglia, Trent and West Midlands|Unknown status|Recruiting|N/A|14000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:54:38.963358|2017-02-18 13:54:38.963358
NCT00757783|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2015-11-30|2010-08-12||October 2008||2008-10-01|November 2015|2015-11-01|July 2012|Actual|2012-07-01|August 2009|Actual|2009-08-01||Interventional|||Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment|A Multicenter, Open-label, Randomized Study to Assess the Metabolics, Efficacy, and Safety of Once-daily Darunavir Versus Atazanavir in HIV-infected Treatment-naive Adult Patients|Completed||Phase 4|68|Actual|Tibotec, Inc|65 subjects were enrolled/treated in the main study. 3 subjects were enrolled, randomized, not treated and excluded from analyses (n=68). An additional 18 subjects were enrolled in a substudy extension and excluded from the main analyses.|2|||f||||||||||||||2017-02-18 13:54:33.596982|2017-02-18 13:54:33.596982
NCT00757770|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2016-09-06|||August 2003||2003-08-01|September 2016|2016-09-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine|Study to Assess the Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine in Terms of Immunogenicity and Safety When Given to Healthy Infants at 2 and 4 Months of Age|Completed||Phase 3|854|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:54:34.342925|2017-02-18 13:54:34.342925
NCT00757757|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2013-02-09||2013-02-09|September 2008||2008-09-01|February 2013|2013-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases|A Phase I/II Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MCS110 in Patients With Prostate Cancer and Bone Metastases|Terminated||Phase 1/Phase 2|3|Actual|Novartis||1|||f||||f||||||||||2017-02-18 13:54:36.893421|2017-02-18 13:54:36.893421
NCT00757744|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2011-05-16|||September 2007||2007-09-01|May 2011|2011-05-01|September 2010|Actual|2010-09-01|January 2010|Actual|2010-01-01||Interventional|||Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China|Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China|Completed||Phase 3|45|Actual|Yale University||2|||f||||f||||||||||2017-02-18 13:54:36.997326|2017-02-18 13:54:36.997326
NCT00757731|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-07-10|||September 2006||2006-09-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||FMS European Long-Term Study|A European Phase III, Multicentre, Double-blind, Randomised, Monotherapy, 12-month Study of Milnacipran for the Treatment of the Fibromyalgia Syndrome|Completed||Phase 3|490|Actual|Pierre Fabre Medicament||3|||f||||||||||||||2017-02-18 13:54:37.106783|2017-02-18 13:54:37.106783
NCT00757718|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2009-09-04|||December 2008||2008-12-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Sleep Disordered Breathing and Gestational Hypertension|Sleep Disordered Breathing and Gestational Hypertension|Completed||N/A|26|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-02-18 13:54:37.211377|2017-02-18 13:54:37.211377
NCT00757705|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-02-05|2014-02-05||March 2008||2008-03-01|February 2014|2014-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia|An Open-label Prospective Trial to Evaluate the Tolerability, Safety and Maintained Efficacy of a Transition to Paliperidone ER in Subjects With Schizophrenia Previously Unsuccessfully Treated With Other Oral Antipsychotics|Completed||Phase 4|299|Actual|Johnson & Johnson Taiwan Ltd|Some Adverse Events summaries were reported based on estimates due to the fact that they were not prepared in the original study report and the relevant definitions of the data elements were not available for these summaries to be regenerated.|1|||f||||f||||||||||2017-02-18 13:54:37.321779|2017-02-18 13:54:37.321779
NCT00757692|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2013-02-19|||January 2009||2009-01-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.|A Phase II Randomised Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.|Completed||Phase 2|74|Actual|British Columbia Cancer Agency||2|||f||||f||||||||||2017-02-18 13:54:37.875484|2017-02-18 13:54:37.875484
NCT00757679|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-07-10|||September 2006||2006-09-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran|Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran. An Exploratory Placebo-controlled Clinical Trial in Fibromyalgia Out-patients|Completed||Phase 2|153|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-02-18 13:54:37.994788|2017-02-18 13:54:37.994788
NCT00757666|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-02-23|||October 2008||2008-10-01|February 2011|2011-02-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|APPROPRIATE||APPROPRIATE - Rate Adaptive Pacing Sensor|Assessment of Proper Physiologic Response With Rate Adaptive Pacing Driven by Minute Ventilation or Accelerometer|Terminated||Phase 4|1000|Anticipated|Boston Scientific Corporation||2||Difficulty in enrollment; higher than planned patient attrition and data attrition|f||||f||||||||||2017-02-18 13:54:38.092887|2017-02-18 13:54:38.092887
NCT00757653|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2014-03-05|||October 2003||2003-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:54:38.204362|2017-02-18 13:54:38.204362
NCT00757640|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-20|2008-09-20|||September 2008||2008-09-01|September 2008|2008-09-01|September 2015|Anticipated|2015-09-01|September 2010|Anticipated|2010-09-01||Interventional|CHOLEGAS||Gastrectomy Plus Prophylactic Cholecystectomy in Gastric Cancer Surgery|The CHOLEGAS Study: Multicentric Randomized, Double-Blinded, Controlled Trial of Gastrectomy Plus Prophylactic Cholecystectomy Versus Gastrectomy Only, in Adults Submitted to Gastric Cancer Surgery With Curative Intent.|Unknown status|Recruiting|Phase 4|150|Anticipated|Italian Research Group for Gastric Cancer||2|||f||||f||||||||||2017-02-18 13:54:38.269245|2017-02-18 13:54:38.269245
NCT00757627|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2015-08-13|2010-01-04||December 2007||2007-12-01|August 2015|2015-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)|Patient-reported Outcomes With Etoricoxib in Real Life|Completed||Phase 4|500|Actual|Merck Sharp & Dohme Corp.|Open-labeled, non-controlled|1|||f||||||||||||||2017-02-18 13:54:38.390006|2017-02-18 13:54:38.390006
NCT00754728|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2010-04-01|||July 2007||2007-07-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|November 2008|Actual|2008-11-01||Interventional|||"JACTAX Trial Drug Eluting Stent Trial"|"JACTAX Trial Drug Eluting Stent Trial"|Completed||N/A|103|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-02-18 13:55:31.535252|2017-02-18 13:55:31.535252
NCT00757601|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2016-02-04|2012-07-31||April 2008||2008-04-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)|A Single Dose Clinical Trial to Study the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK1006.|Completed||Phase 1|25|Actual|Merck Sharp & Dohme Corp.||12|||f||||f||||||||||2017-02-18 13:54:39.067887|2017-02-18 13:54:39.067887
NCT00757588|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2015-05-08|2011-08-10||November 2008||2008-11-01|May 2015|2015-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin|A Multicenter, Randomized, Double-Blind, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Insulin Alone or on Insulin in Combination With Metformin|Completed||Phase 3|455|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 13:54:40.870204|2017-02-18 13:54:40.870204
NCT00757575|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2012-03-26|||February 2008||2008-02-01|March 2012|2012-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan|Epidemiological Surveillance Network Study To Assess the Disease of Pneumonia in Infants and Children in Japan|Completed||N/A|28511|Actual|Pfizer|||1||f||||t||||||||||2017-02-18 13:54:42.3093|2017-02-18 13:54:42.3093
NCT00757562|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2015-04-27|||November 2002||2002-11-01|April 2015|2015-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)|Multiple-Dose Safety and Tolerance Study of Desloratadine in Atopic Pediatric Subjects and Pediatric Subjects With Chronic Idiopathic Urticaria, Ages >=2 to <12 Years, Who Are Poor Metabolizers of Desloratadine|Completed||Phase 3|97|Actual|Merck Sharp & Dohme Corp.||2|||t||||f||||||||||2017-02-18 13:54:42.407829|2017-02-18 13:54:42.407829
NCT00757549|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2014-08-25|||September 2008||2008-09-01|August 2014|2014-08-01||||August 2011|Actual|2011-08-01||Interventional|||3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx|Comparison of FLT and FDG PET in the Evaluation of Response to Cetuximab, Cisplatin and Radiation Therapy in Advanced Head and Neck Malignancies or Response to Standard Chemo-radiotherapy in Esophageal Malignancies|Unknown status|Active, not recruiting|Early Phase 1|30|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 13:54:42.496208|2017-02-18 13:54:42.496208
NCT00757536|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2016-01-24|||May 2006||2006-05-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Primary Vitrectomy With Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment|Primary Vitrectomy Combined With 360° Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment (V.E.E. Study)|Completed||N/A|60|Actual|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||2|||f||||f||||||||No||2017-02-18 13:54:42.598111|2017-02-18 13:54:42.598111
NCT00757523|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2011-07-11|||September 2008||2008-09-01|July 2011|2011-07-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris|A Multi-center, Randomized, Evaluator-blind, Parallel-group Evaluation of the Efficacy, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Topical Treatment of Facial Acne Vulgaris|Completed||Phase 4|400|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:54:42.700268|2017-02-18 13:54:42.700268
NCT00757510|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2014-12-08|||January 2008||2008-01-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|CHDRR||Congenital Heart Disease Research Registry|Congenital Heart Disease Research Registry|Terminated||N/A|861|Actual|Emory University|||1|Insufficient funding|f||||f||||||Samples With DNA|"~     Blood and serum collected from Registry subjects will be cryopreserved for potential future~     genetic and/or protein-based studies.~   "|||2017-02-18 13:54:42.831709|2017-02-18 13:54:42.831709
NCT00757497|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-20|2017-01-24|||September 17, 2008||2008-09-17|August 18, 2015|2015-08-18|August 18, 2015|Actual|2015-08-18|||||Interventional|||Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia|Safety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)|Terminated||Phase 1|20|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:54:42.925935|2017-02-18 13:54:42.925935
NCT00757484|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2015-12-15|2015-05-27||September 2008||2008-09-01|May 2015|2015-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational||This was a chart review study. 37 participants were not analyzed because the data in their chart was not available.|Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery|Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery|Completed||N/A|528|Actual|University of Rochester|||1||f||||f||||||||||2017-02-18 13:54:43.03192|2017-02-18 13:54:43.03192
NCT00757471|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2016-01-24|||August 2008||2008-08-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Brillant Blue Versus Indocyanine Green for Macular Hole Surgery|Membranepeeling With Brillant Blue Versus Membranepeeling With Indocyanine Green for Patients With Idiopathic Macular Holes.|Completed||N/A|60|Actual|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||2|||f||||f||||||||||2017-02-18 13:54:43.302413|2017-02-18 13:54:43.302413
NCT00757458|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2008-09-22|||December 2008||2008-12-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Evaluation of Bacterial and Fungal Contamination During Propofol Continuous Infusion|Evaluation of Bacterial and Fungal Contamination During Propofol Continuous Infusion in Patients Undergoing General Anesthesia|Unknown status|Not yet recruiting|N/A|652|Anticipated|University of Sao Paulo||4|||f||||t||||||||||2017-02-18 13:54:43.414161|2017-02-18 13:54:43.414161
NCT00757445|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2008-09-22|||January 1997||1997-01-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Treatment Results on Patients With Debridement and Prosthesis Retention in the Hip|Treatment Results on Patients With Debridement and Prosthesis Retention in the Hip 1997-2007|Completed||N/A|105|Actual|Sorlandet Hospital HF|||1||f||||f||||||||||2017-02-18 13:54:43.524082|2017-02-18 13:54:43.524082
NCT00757432|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-04-08|||September 2007||2007-09-01|April 2011|2011-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Recovery After Robotic Urogynecological Surgery: The Patient's Perspective|Recovery After Robotic Urogynecological Surgery: The Patient's Perspective|Completed||N/A|22|Actual|University of Rochester|||1||f||||f||||||||||2017-02-18 13:54:43.597224|2017-02-18 13:54:43.597224
NCT00757419|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2010-12-06|||September 2008||2008-09-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||AZD3355 Dose-escalation Study in Healthy Males|A Phase 1 Single Centre Single-blind Randomised Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD3355 After Administration of Single Ascending Doses and Multiple Repeated Doses in Healthy Male Volunteers|Completed||Phase 1|54|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:54:43.669505|2017-02-18 13:54:43.669505
NCT00757406|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2009-04-14|||August 2008||2008-08-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|||Assessment of Unilateral Lymphoedema of the Leg|Assessment of Unilateral Lymphoedema of the Leg|Completed||N/A|45|Anticipated|ImpediMed Limited|||2||f||||t||||||||||2017-02-18 13:54:43.774294|2017-02-18 13:54:43.774294
NCT00757393|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-09-05|||September 2008||2008-09-01|September 2013|2013-09-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis|Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis|Unknown status|Recruiting|Phase 3|28|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 13:54:43.864097|2017-02-18 13:54:43.864097
NCT00757380|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2016-01-24|||July 2008||2008-07-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Trypan Blue Versus Brillant Blue for Epiretinal Membranes|Membranepeeling With Trypan Blue Versus Membranpeeling With Brillant Blue for Patients With Idiopathic Epiretinal Membranes|Completed||N/A|60|Actual|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||2|||f||||f||||||||||2017-02-18 13:54:43.9968|2017-02-18 13:54:43.9968
NCT00757367|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-12-13|||July 2008||2008-07-01|December 2013|2013-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Trial to Determine How Long Insulin and FDKP (the Molecule That Forms Technosphere Particles) Stays in the Lungs of Healthy Individuals After Inhalation of Technosphere® Insulin (TI) Powder Using Bronchoalveolar Lavage (BAL)|A Phase 1, Open-Label, Controlled Clinical Trial to Determine the Pulmonary Residence Time of Insulin and Fumaryl Diketopiperazine, Utilizing Bronchoalveolar Lavage, After Administration of Technosphere® Insulin Inhalation Powder in Healthy Subjects|Completed||Phase 1|13|Actual|Mannkind Corporation||1|||f||||||||||||||2017-02-18 13:54:44.109108|2017-02-18 13:54:44.109108
NCT00757354|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2015-06-22|||June 2012||2012-06-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty|A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty|Completed||N/A|77|Actual|Zimmer Biomet||1|||f||||t||||||||||2017-02-18 13:54:44.207978|2017-02-18 13:54:44.207978
NCT00757341|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2009-04-24|||December 2008||2008-12-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606|An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]-Labeled Bosutinib in Healthy Male Subjects|Completed||Phase 1|6|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:54:44.308576|2017-02-18 13:54:44.308576
NCT00757328|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2009-02-16|||July 2008||2008-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|||||Observational|EPIDEP||Treatment Clinical Practice in Bipolar Depression in Spain|EPIDEP. Epidemiologic Study in Bipolar Depression: Evaluation of the Usual Clinical Practice of Psychiatrists in Spain|Completed||N/A|378|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:54:44.605625|2017-02-18 13:54:44.605625
NCT00757315|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-03-27|||September 2008||2008-09-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|September 2009|Actual|2009-09-01||Interventional|||NdYag Laser for Acne Keloidalis Nuchae|Prospective, Controlled Study of the Efficacy of NdYag for Acne Keloidalis Nuchae|Unknown status|Active, not recruiting|N/A|20|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-02-18 13:54:44.712972|2017-02-18 13:54:44.712972
NCT00757302|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2015-09-29|||September 2008||2008-09-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|||Intraoperative Gamma Camera for Breast Cancer Surgery|Evaluation of a New Intraoperative Gamma Camera for the Sentinel Lymph Node Procedure in Breast Cancer|Completed||Phase 3|110|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 13:54:44.824827|2017-02-18 13:54:44.824827
NCT00757289|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2011-09-27|||August 2007||2007-08-01|September 2011|2011-09-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|||Platelet-rich-plasma Treating Tennis Elbow|Use of Platelet-rich-plasma to Treat Tennis Elbow, A Blinded and Randomized Single Center Study|Completed||N/A|106|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:54:44.935511|2017-02-18 13:54:44.935511
NCT00757276|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2014-12-12|||June 2008||2008-06-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study|Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study|Completed||N/A|50|Actual|University Hospital, Basel, Switzerland|||1||f||||||||||Samples Without DNA|"~     bood sampling~   "|||2017-02-18 13:54:45.040057|2017-02-18 13:54:45.040057
NCT00757263|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-08-23|||February 2008||2008-02-01|September 2008|2008-09-01||||||||Observational|||Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom|A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Ovarian Cancer in East Anglia, Oxford, Trent and West Midlands|Unknown status|Recruiting|N/A|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:54:45.163994|2017-02-18 13:54:45.163994
NCT00757250|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2012-02-27|||September 2008||2008-09-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy|A Phase I Evaluation of the Safety and Biologic Activity of TXA127 in HIV-Infected Subjects With CD4+ T-Lymphocyte Counts Less Than 250 Per mm3 Who Have Responded to HAART|Terminated||Phase 1|13|Actual|US Biotest, Inc.||5||Difficulty recruiting subjects to dosing cohort 5.|f||||t||||||||||2017-02-18 13:54:45.257866|2017-02-18 13:54:45.257866
NCT00757237|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2011-06-07|2011-04-08||August 2008||2008-08-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Interventional|||Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa|An Open-Label, Randomized, Phase 3 Trial to Evaluate the Efficacy and Safety of Aztreonam for Inhalation Solution (AZLI) Versus Tobramycin Inhalation Solution (TIS) in an Intermittent Aerosolized Antibiotic Regimen in Subjects With Cystic Fibrosis Followed by an Open-Label, Single Arm Extension (European Union [EU] Only)|Completed||Phase 3|274|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 13:54:45.384645|2017-02-18 13:54:45.384645
NCT00757224|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-21|2008-09-22|||October 2008||2008-10-01|September 2008|2008-09-01|October 2009|Anticipated|2009-10-01|November 2008|Anticipated|2008-11-01||Interventional|||Parental Education on Passive Smoke Exposure and Respiratory Diseases in Infants||Unknown status|Not yet recruiting|N/A|150|Anticipated|Assaf-Harofeh Medical Center||3|||f||||||||||||||2017-02-18 13:54:46.639542|2017-02-18 13:54:46.639542
NCT00757211|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-08-23|||February 2008||2008-02-01|September 2008|2008-09-01||||||||Observational|||Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom|A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Breast Cancer in East Anglia|Unknown status|Recruiting|N/A|6000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 13:54:46.732136|2017-02-18 13:54:46.732136
NCT00757198|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2013-09-11|||September 2008||2008-09-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|REMISYD||Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.|Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.|Completed||Phase 4|90|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 13:54:46.829161|2017-02-18 13:54:46.829161
NCT00757185|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2016-07-01|||February 2008||2008-02-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Compromised Microcirculation in Women With Polycystic Ovary Syndrome|Compromised Microcirculation in Women With Polycystic Ovary Syndrome|Completed||Early Phase 1|28|Actual|Yale University||2|||f||||||||||||||2017-02-18 13:54:46.927951|2017-02-18 13:54:46.927951
NCT00757172|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2016-02-10|2014-07-25||January 2009||2009-01-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|November 2011|Actual|2011-11-01||Interventional||All registered participants who have met the eligibility criteria.|Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction|A Phase II Study of Neoadjuvant Therapy With Cisplatin, Docetaxel, Panitumumab Plus Radiation Therapy Followed by Surgery in Patients With Locally Advanced Adenocarcinoma of the Distal Esophagus|Completed||Phase 2|70|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 13:54:47.052814|2017-02-18 13:54:47.052814
NCT00757159|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-22|2012-01-16|||August 2008||2008-08-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study on Regenerative Treatment of Intra-bony Defects|Randomised, Clinical Controlled Study on Treatment of Intra-bony Defects With Enamel Matrix Protein (Emdogain®) vs. Nanocrystalline Hydroxyapatite (Ostim®)|Completed||Phase 4|56|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-02-18 13:54:47.915708|2017-02-18 13:54:47.915708
NCT00757146|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2010-06-22|||March 2006||2006-03-01|June 2010|2010-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Neonatal Intensive Care (NICU) Course and Hospital Outcome of Infants With BPD Treated Using Inhaled Nitric Oxide|NICU Course and Hospital Outcome of Infants With Bronchopulmonary Dysplasia Treated Using Inhaled Nitric Oxide|Completed||N/A|18|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 13:54:48.02222|2017-02-18 13:54:48.02222
NCT00757133|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2014-12-04|||November 2008||2008-11-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PRIMAAT||Prevention of Incisional Hernia by Mesh Augmentation After Midline Laparotomy for Aortic Aneurysm Treatment|Prevention of Incisional Hernia by Mesh Augmentation After Midline Laparotomy for Aortic Aneurysm Treatment.|Completed||N/A|120|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:54:48.111705|2017-02-18 13:54:48.111705
NCT00757120|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2012-09-14|||October 2007||2007-10-01|September 2012|2012-09-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Observational|||Biomarkers and Genetic Factors Related to Emphysema|SCCOR: Alveolar and Airway Mechanisms for COPD Project 3: Membrane-Type 1 Matrix Metalloproteinase and Extracellular Matrix Metalloproteinase Inducer in Cigarette Smoke-Induced Lung Inflammation and Emphysema Pathogenesis|Unknown status|Active, not recruiting|N/A|145|Actual|Washington University School of Medicine|||2||f||||t||||||Samples With DNA|"~     Blood cells, serum, extracted RNA and DNA, lung fluid~   "|||2017-02-18 13:54:48.221207|2017-02-18 13:54:48.221207
NCT00757107|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2016-03-11|||October 2011||2011-10-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|October 2014|Actual|2014-10-01||Interventional|||Taperloc Versus Taplerloc Microplasty|Clinical Evaluation of Taperloc Total Hip System With Two Different Stem Lengths|Completed||N/A|60|Actual|University Hospital, Linkoeping||2|||f||||t||||||||Yes||2017-02-18 13:54:48.31137|2017-02-18 13:54:48.31137
NCT00757094|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2010-02-24|||September 2008||2008-09-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Observational|||Safety and Feasibility of Fasting While Receiving Chemotherapy|Safety and Feasibility of Fasting While Receiving Chemotherapy|Completed||N/A|12|Actual|King Fahad Medical City|||1||f||||f||||||||||2017-02-18 13:54:48.423445|2017-02-18 13:54:48.423445
NCT00757081|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2013-02-06|||June 2008||2008-06-01|May 2009|2009-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study to Evaluate the Effect of Injection Lypolysis (Lipodissolve) Treatments to Reduce Body Fat|Metabolic And Structural Effects Of Phosphatidylcholine And Deoxycholate Injections On Subcutaneous Fat|Completed||N/A|20|Actual|BodyAesthetic Research Center||1|||f||||f||||||||||2017-02-18 13:54:48.511953|2017-02-18 13:54:48.511953
NCT00757068|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2015-05-26|||September 2007||2007-09-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|STARTS||Strategies to Avoid Returning to Smoking|Addressing Postpartum Mood and Weight Concerns to Sustain Smoking Cessation|Completed||N/A|300|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:54:48.615276|2017-02-18 13:54:48.615276
NCT00757055|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-11-24|||December 2012||2012-12-01|November 2014|2014-11-01|January 2014|Anticipated|2014-01-01|November 2013|Anticipated|2013-11-01||Interventional|||If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure|If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure|Withdrawn||Phase 2|0|Actual|St Vincent's University Hospital, Ireland||2||Difficulty recruit pts with PSHF HR > 70 & high BNP.|f||||f||||||||||2017-02-18 13:54:48.725166|2017-02-18 13:54:48.725166
NCT00757042|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2011-05-19|||October 2008||2008-10-01|May 2011|2011-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Safety Study of AMG 157 in Healthy Subjects and Subjects With Atopic Dermatitis|A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 157 in Healthy Subjects and Subjects With Moderate to Severe Atopic Dermatitis|Completed||Phase 1|78|Actual|Amgen||2|||f||||||||||||||2017-02-18 13:54:49.060977|2017-02-18 13:54:49.060977
NCT00757029|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-10-04|||October 2005||2005-10-01|December 2010|2010-12-01|August 2010|Actual|2010-08-01|August 2008|Actual|2008-08-01||Interventional|NETADHD||Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)|Association Between Norepinephrine Transporter Polymorphism and Response of Methylphenidate|Completed||Phase 4|150|Anticipated|Hallym University Medical Center||1|||f||||f||||||||||2017-02-18 13:54:49.160759|2017-02-18 13:54:49.160759
NCT00757016|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2008-09-19|||October 2004||2004-10-01|September 2008|2008-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Injection Treatment of Corticosteroid to Pelvic Ligament Insertions on Women With Longlasting Backpain After Pregnancy|Injection Treatment of Slow-Release Corticosteroid to the Sacrospinous Ligament Insertions on Women With Long-Lasting Low Back Pain Starting in Pregnancy.|Completed||N/A|38|Actual|Sundsvall Hospital||2|||f||||t||||||||||2017-02-18 13:54:49.262308|2017-02-18 13:54:49.262308
NCT00757003|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-04-13|||October 2001||2001-10-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|||To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease|A Clinical Study of the TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Diseases for Non-Surgical Candidates Under the Physician Sponsored IDE.|Completed||Phase 3|100|Actual|Stanford University||1|||f||||||||||||||2017-02-18 13:54:49.377643|2017-02-18 13:54:49.377643
NCT00756990|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2015-09-30|||November 2005||2005-11-01|September 2015|2015-09-01|August 2011|Actual|2011-08-01|March 2009|Actual|2009-03-01||Interventional|||Depot Naltrexone Treatment of Opioid Dependent Parolees|Depot Naltrexone Treatment of Opioid Dependent Parolees|Completed||N/A|61|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 13:54:49.480402|2017-02-18 13:54:49.480402
NCT00756977|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-08-09|2013-02-19||August 2008||2008-08-01|August 2013|2013-08-01||||November 2008|Actual|2008-11-01||Interventional||Intent to Treat population|BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy|BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy|Completed||Phase 3|394|Actual|Braintree Laboratories||2|||f||||f||||||||||2017-02-18 13:54:49.588435|2017-02-18 13:54:49.588435
NCT00756964|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2012-08-01|2011-11-23||October 2008||2008-10-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|RasbAKI||Lowering Serum Uric Acid to Prevent Acute Kidney Injury|Effect of Rasburicase on Acute Kidney Injury, Kidney Function, the Incidence of Renal Replacement Therapy and All-cause Mortality Following Cardiac Surgery.|Completed||Phase 2|26|Actual|University of Florida|The limitation of the pilot study is that it was not powered to provide definite answers, an inherent limitation attributed to the absence of similar studies.|2|||f||||t||||||||||2017-02-18 13:54:50.203981|2017-02-18 13:54:50.203981
NCT00756951|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2009-11-20|||September 2008||2008-09-01|December 2008|2008-12-01||||||||Interventional|SCV-07 OM||Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer|A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Safety and Efficacy of SC-07 for the Delay to Onset of Severe Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck.|Completed||Phase 2|59||SciClone Pharmaceuticals||3|||f||||t||||||||||2017-02-18 13:54:50.551314|2017-02-18 13:54:50.551314
NCT00756938|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2015-01-14|2014-01-16||March 2009||2009-03-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)|A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With Hypertension|Completed||Phase 3|101|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 13:54:50.688435|2017-02-18 13:54:50.688435
NCT00756925|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2011-08-04|||February 2009||2009-02-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Gender and Neural Substrates of Stress and Craving|Exploring Gender Differences in the Neural Substrates of Stress Induced Drug Craving|Completed||N/A|20|Anticipated|Medical University of South Carolina|||2||f||||t||||||||||2017-02-18 13:54:51.703623|2017-02-18 13:54:51.703623
NCT00756912|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2014-07-10|||September 2008||2008-09-01|July 2014|2014-07-01||||November 2008|Actual|2008-11-01||Interventional|||A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors|A Phase I, Open-Label, Dose Escalation Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors|Terminated||Phase 1|30|Actual|Eisai Inc.||1||"This study was terminated in November 2008 due to a business decision (resources)."|f||||f||||||||||2017-02-18 13:54:51.792938|2017-02-18 13:54:51.792938
NCT00756899|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2012-10-25|||July 2008||2008-07-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|VDS||Vitamin D Deficiency and Low Bone Mineral Content in Children|The Relationship Between Vitamin D Deficiency and Low Bone Mineral Content in Children|Completed||N/A|45|Actual|University of Massachusetts, Worcester|||2||f||||f||||||||||2017-02-18 13:54:51.886911|2017-02-18 13:54:51.886911
NCT00756886|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-02-26|2012-05-31||September 2008||2008-09-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study|Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study|Completed||N/A|73|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 13:54:51.983852|2017-02-18 13:54:51.983852
NCT00756873|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2008-09-19|||October 2008||2008-10-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Etoricoxib in Ear Nose Throat Surgery|Analgesic Efficacy and Safety of Etoricoxib in Ear Nose Throat Surgery|Unknown status|Not yet recruiting|Phase 3|90|Anticipated|University of Regensburg||3|||f||||f||||||||||2017-02-18 13:54:52.530811|2017-02-18 13:54:52.530811
NCT00756860|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-05-31|||May 2008||2008-05-01|May 2012|2012-05-01|September 2009|Actual|2009-09-01|August 2008|Actual|2008-08-01||Interventional|||A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)|A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®) on Phosphate Binding in Healthy Volunteers|Completed||Phase 1|66|Actual|Amgen||2|||f||||||||||||||2017-02-18 13:54:52.636621|2017-02-18 13:54:52.636621
NCT00244491|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2015-08-10|||September 2002||2002-09-01|August 2015|2015-08-01|August 2003||2003-08-01|||||Interventional|||The Care Transitions Intervention|The Care Transitions Intervention|Completed||N/A|1400||University of Colorado, Denver|||||f||||||||||||||2017-02-18 17:01:08.749664|2017-02-18 17:01:08.749664
NCT00756847|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-04-09|||September 2008||2008-09-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional|||Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Combination With Paclitaxel and Carboplatin in Subjects With Solid Tumors|Completed||Phase 1|52|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:54:52.724904|2017-02-18 13:54:52.724904
NCT00756834|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-19|||November 2006||2006-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:54:52.840861|2017-02-18 13:54:52.840861
NCT00756821|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2012-10-23|||October 2008||2008-10-01|October 2012|2012-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|BforSMA||A Pilot Study of Biomarkers for Spinal Muscular Atrophy|A Pilot Study of Biomarkers for Spinal Muscular Atrophy|Completed||N/A|130|Actual|New England Research Institutes|||2||f||||f||||||Samples With DNA|"~     Whole blood, plasma, PBMCs, and urine~   "|||2017-02-18 13:54:53.101721|2017-02-18 13:54:53.101721
NCT00756808|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-02-06|||October 2007||2007-10-01|February 2014|2014-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?|Is Tuberculin Skin Testing Effective in Screening for Latent TB in Elderly Residents of Nursing Homes? Comparison With a New IFN-y Based Assay|Completed||N/A|135|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 13:54:53.222623|2017-02-18 13:54:53.222623
NCT00756795|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2010-08-31|||February 2009||2009-02-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|I-PAP||Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study)|Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study)|Terminated||Early Phase 1|0|Actual|University of Nebraska||1||PI chose not to continue with this unfunded study|f||||f||||||||||2017-02-18 13:54:53.303343|2017-02-18 13:54:53.303343
NCT00756782|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2012-03-01|||October 2008||2008-10-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma|Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of TAC-101 in Combination With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma|Withdrawn||Phase 2|0|Actual|Taiho Oncology, Inc.||2||Terminated due to safety concerns.|f||||f||||||||||2017-02-18 13:54:53.405391|2017-02-18 13:54:53.405391
NCT00756769|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-08-14|||April 2003||2003-04-01|August 2016|2016-08-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|SLEIGH||Systemic Lupus Erythematosus in Gullah Health|Systemic Lupus Erythematosus in Gullah Health|Recruiting||N/A|750|Anticipated|Medical University of South Carolina|||3||f||||f||||||||||2017-02-18 13:54:53.504642|2017-02-18 13:54:53.504642
NCT00756756|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2008-09-19|||June 2007||2007-06-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||The Effect of Granulocyte Colony Stimulating Factor (G-CSF) on Myocardial Function After Acute Anterior Myocardial Infarction, a Prospective Double Blind Randomized Placebo Controlled Study|The Effect of Granulocyte Colony Stimulating Factor (G-CSF) on Myocardial Function After Acute Anterior Myocardial Infarction, a Prospective Double Blind Randomized Placebo Controlled Study|Completed||N/A|20|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-02-18 13:54:53.594771|2017-02-18 13:54:53.594771
NCT00756743|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2010-03-17|||September 2008||2008-09-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers|A Phase I Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-04802540 After Multiple Oral Dose Administration To Healthy Adult Volunteers|Completed||Phase 1|40|Actual|Taisho Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 13:54:53.704449|2017-02-18 13:54:53.704449
NCT00756730|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2012-10-23|2012-02-21||September 2008||2008-09-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|LARD||Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r|Randomized, Open-label Study of Switch From Lopinavir/Ritonavir (LPV/r) or Fosamprenavir/Ritonavir (FPV/r) to Either Once Daily Atazanavir/Ritonavir (ATV/r) or Once Daily Darunavir/Ritonavir (DRV/r) (Plus Background Nucleoside Reverse Transcriptase Inhibitors) in Patients Experiencing Triglyceride Elevations While Receiving LPV/r or FPV/r.|Completed||Phase 4|49|Actual|Community Research Initiative of New England||2|||f||||||||||||||2017-02-18 13:54:53.814491|2017-02-18 13:54:53.814491
NCT00756717|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2015-04-01|||May 2008||2008-05-01|April 2015|2015-04-01|May 2018|Anticipated|2018-05-01|May 2015|Anticipated|2015-05-01||Interventional|MK-0752||Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer|A Pilot Study of MK-0752 in Combination With Tamoxifen or Letrozole in Patients With Early Stage Breast Cancer Prior to Surgery|Active, not recruiting||N/A|22|Actual|Loyola University||1|||f||||t||||||||||2017-02-18 13:54:54.598715|2017-02-18 13:54:54.598715
NCT00756704|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-11-02|||September 2008||2008-09-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Effectiveness of Smoking Cessation Guidelines in the Emergency Department|The Effectiveness of Smoking Cessation Guidelines in the Emergency Department|Completed||N/A|789|Actual|University of Iowa||2|||f||||t||||||||||2017-02-18 13:54:54.704474|2017-02-18 13:54:54.704474
NCT00756691|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-06-04|||October 2008||2008-10-01|June 2014|2014-06-01|November 2014|Anticipated|2014-11-01|October 2014|Anticipated|2014-10-01||Observational|||A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA|A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA|Unknown status|Recruiting|N/A|30|Anticipated|AHS Cancer Control Alberta|||2||f||||f||||||||||2017-02-18 13:54:54.808945|2017-02-18 13:54:54.808945
NCT00756678|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2011-09-22|2011-09-22||September 2008||2008-09-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Acceptability of Two Lubricant Eye Drops||Completed||Phase 4|51|Actual|Allergan||2|||f||||f||||||||||2017-02-18 13:54:54.909244|2017-02-18 13:54:54.909244
NCT00756665|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-05-10|||July 2008||2008-07-01|May 2016|2016-05-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|PASS||Prostate Active Surveillance Study|Canary Prostate Active Surveillance Study|Recruiting||N/A|2300|Anticipated|University of Washington|||1||f||||t||||||Samples With DNA|"~     serum, plasma, white cells, DNA, urine, prostate tissue~   "|||2017-02-18 13:54:55.185207|2017-02-18 13:54:55.185207
NCT00120640|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2012-09-18|||July 2005||2005-07-01|September 2012|2012-09-01||||||||Interventional|||Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate||Withdrawn||N/A|0|Actual|Yale University||||funding|f||||||||||||||2017-02-18 17:35:52.094442|2017-02-18 17:35:52.094442
NCT00756652|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2017-02-07|||November 2006||2006-11-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|MGPAS||Mentor MemoryGel Post-Approval Study|MemoryGel Silicone Gel-Filled Breast Implant Post-Approval Study|Active, not recruiting||N/A|43046|Actual|Mentor Worldwide, LLC|||2||f||||f||||||||||2017-02-18 13:54:55.311471|2017-02-18 13:54:55.311471
NCT00756639|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2017-02-16|||June 2008|Actual|2008-06-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium|Prophylactic Cranial Irradiation (PCI) for Patients With Small Cell Carcinoma of the Urothelium|Recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:54:55.401917|2017-02-18 13:54:55.401917
NCT00756626|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2010-10-01|||October 2008||2008-10-01|October 2010|2010-10-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|FYCS||Feeding Young Children Study: Bottle Weaning Intervention|Feeding Young Children Study (FYCS)- a Randomized Control Trial of a Bottle Weaning Intervention Aimed at Reducing the Risk of Overweight in Low Income Multi-ethnic Toddlers.|Unknown status|Active, not recruiting|Phase 3|464|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-02-18 13:54:55.528243|2017-02-18 13:54:55.528243
NCT00756613|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2017-02-02|||February 1, 2008|Actual|2008-02-01|February 2017|2017-02-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|VADT-F||The VA Diabetes Trial Follow-up Study (VADT-FS)|CSP #465FS - VA Diabetes Trial Long Term Follow-up Study|Active, not recruiting||N/A|1350|Anticipated|VA Office of Research and Development|||1||f||||t||||||||Undecided||2017-02-18 13:54:55.63089|2017-02-18 13:54:55.63089
NCT00756600|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-11-02|||October 2006||2006-10-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|GAS||A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants|A Multi-site Randomised Controlled Trial Comparing Regional and General Anaesthesia for Effects on Neurodevelopmental Outcome and Apnoea in Infants|Active, not recruiting||Phase 4|720|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 13:54:55.721696|2017-02-18 13:54:55.721696
NCT00756587|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2008-10-30|||December 2003||2003-12-01|September 2008|2008-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Cup Versus Bottle Feeding for Late Preterm Infants|Cup Versus Bottle Feeding for Hospitalized Late Preterm Infants in Egypt|Completed||N/A|60|Actual|Cairo University||2|||f||||f||||||||||2017-02-18 13:54:55.857461|2017-02-18 13:54:55.857461
NCT00756574|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2009-07-15|2009-07-15||October 2008||2008-10-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Randomized Control Trial to Study the Efficacy of the Surgical Mask Versus the N95 Respirator to Prevent Influenza|A Randomized Control Trial of Surgical Masks vs N95 Respirators to Prevent Influenza in Health Care Workers|Completed||N/A|447|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 13:54:55.959764|2017-02-18 13:54:55.959764
NCT00756561|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-05-10|2010-11-08||September 2008||2008-09-01|May 2016|2016-05-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Observational|HOP-2A||HOP-2A - Intratesticular Hormone Levels|Intratesticular Hormone Levels in Healthy Young Men|Completed||N/A|10|Actual|University of Washington|Early termination of study leading to data analysis of the first ten of eleven men receiving aspirations.||1||f||||f||||||Samples Without DNA|"~     serum blood, testicular tissue~   "|||2017-02-18 13:54:56.353554|2017-02-18 13:54:56.353554
NCT00756548|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-12-03|2013-02-19||August 2008||2008-08-01|December 2013|2013-12-01||||November 2008|Actual|2008-11-01||Interventional||Intent-to-treat population|BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy|BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy|Completed||Phase 3|386|Actual|Braintree Laboratories||2|||f||||f||||||||||2017-02-18 13:54:56.614487|2017-02-18 13:54:56.614487
NCT00756535|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2008-09-19|||October 2008||2008-10-01|September 2008|2008-09-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Exercise Training in a Geriatric Hospital Ward||Unknown status|Not yet recruiting|N/A|160|Anticipated|Health Center of the City of Joensuu||2|||f||||f||||||||||2017-02-18 13:54:57.242097|2017-02-18 13:54:57.242097
NCT00756522|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2012-09-14|||October 2007||2007-10-01|September 2012|2012-09-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Observational|||Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation|Specialized Center of Clinically Oriented Research: Alveolar and Airway Mechanisms for COPD. Detection: Lung Imaging and Profiling (Project 1)|Unknown status|Enrolling by invitation|N/A|63|Actual|Washington University School of Medicine|||1||f||||t||||||Samples With DNA|"~     Plasma, serum, isolated RNA and DNA, and lung tissue~   "|||2017-02-18 13:54:57.345919|2017-02-18 13:54:57.345919
NCT00756509|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2016-12-28|||August 2008||2008-08-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib|An Open-label, Multi-center, Single-arm Study to Evaluate the Efficacy of Nilotinib in Adult Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line Treatment|Active, not recruiting||Phase 4|44|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:54:57.439944|2017-02-18 13:54:57.439944
NCT00756496|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2009-06-29|||November 2006||2006-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:54:57.549421|2017-02-18 13:54:57.549421
NCT00756483|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-19|||October 2008||2008-10-01|September 2008|2008-09-01|October 2009|Anticipated|2009-10-01|March 2009|Anticipated|2009-03-01||Observational|||Stability Plus - Outcomes From Extended Continuum of Care|Study the Effects of Pre- and Post-Operative Resistive Exercise in Total Arthroplasty Patients Using the Stability Plus Exercise System|Unknown status|Not yet recruiting|N/A|200|Anticipated|Stability Plus, LLC|||4||f||||t||||||||||2017-02-18 13:54:57.603761|2017-02-18 13:54:57.603761
NCT00756470|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-11-04|2014-10-30||October 2008||2008-10-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Phase II Neoadjuvant in Inflammatory Breast Cancer|A Phase II Study of Neoadjuvant Lapatinib Plus Chemotherapy (Sequential FEC75 and Paclitaxel) in Women With Inflammatory Breast Cancer Whose Tumors Overexpress ErbB2 (Her2/Neu)|Terminated||Phase 2|15|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 13:55:00.050902|2017-02-18 13:55:00.050902
NCT00050297|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-03|2012-06-06||||||June 2012|2012-06-01|February 2004|Actual|2004-02-01|||||Interventional|||YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer||Terminated||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:01:57.177357|2017-02-18 18:01:57.177357
NCT00756457|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-06-30|2013-02-14||July 2007||2007-07-01|June 2014|2014-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Bracing and Strengthening for Posterior Tibial Tendon Dysfunction|The Effect of Bracing and Strengthening Exercises on Posterior Tibial Tendon Dysfunction|Completed||Phase 2|39|Actual|Ithaca College||2|||f||||f||||||||||2017-02-18 13:55:00.441019|2017-02-18 13:55:00.441019
NCT00756444|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2014-03-28|2013-10-23||October 2008||2008-10-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck|A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck (Amended Version 20-March-2009)|Completed||Phase 2|67|Actual|Amgen||2|||f||||t||||||||||2017-02-18 13:55:01.112719|2017-02-18 13:55:01.112719
NCT00756431|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-12-05|||January 2004||2004-01-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures|Prospective Randomized Double Blinded Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures|Withdrawn||N/A|0|Actual|Zimmer Biomet||2||No data so far|f||||f||||||||||2017-02-18 13:55:01.891798|2017-02-18 13:55:01.891798
NCT00756418|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2015-04-24|||June 2003||2003-06-01|April 2015|2015-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)|A Randomized Open-Label Comparative Study of Montelukast Versus Theophylline Added to Inhaled Corticosteroid in Pediatric Patients With Bronchial Asthma|Completed||Phase 4|84|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:55:02.006834|2017-02-18 13:55:02.006834
NCT00756405|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2010-04-29|||March 2007||2007-03-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Dietary Antioxidants on Cardiovascular Risk Factors|Potential Health Benefits of Dietary Antioxidants From Supplements v. Foods|Completed||N/A|90|Anticipated|Stanford University||3|||f||||||||||||||2017-02-18 13:55:02.115732|2017-02-18 13:55:02.115732
NCT00756392|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-07-14|||October 2008||2008-10-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer|MR Spectroscopy in Localized Prostate Cancer|Completed||N/A|10|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 13:55:02.215301|2017-02-18 13:55:02.215301
NCT00756379|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-11-02|||March 2009||2009-03-01|November 2016|2016-11-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|Century||Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease|Randomized Trial of Comprehensive Lifestyle Modifications, Optimal Pharmacological Treatment and PET Imaging for Detection and Management of Stable Coronary Artery Disease|Recruiting||Phase 3|1300|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||No||2017-02-18 13:55:02.326341|2017-02-18 13:55:02.326341
NCT00756366|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2017-01-09|||July 2005||2005-07-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|PET-OSA||CPAP Therapy in Patients With Heart Failure and Obstructive Sleep Apnea.|Effects of Continuous Positive Airway Pressure Therapy on Myocardial Energetics and Sympathetic Nerve Function in Patients With Heart Failure and Obstructive Sleep Apnea.|Completed||Phase 1|67|Actual|Ottawa Heart Institute Research Corporation||3|||f||||f||||||||||2017-02-18 13:55:02.451938|2017-02-18 13:55:02.451938
NCT00756353|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-04-14|||June 2006||2006-06-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||"Survey of Buprenorphine Use Among Out of Care Population in France (P04933)(COMPLETED)"|Out of Care Patient Survey|Completed||N/A|600|Actual|Indivior Inc.|||2||f||||f||||||||||2017-02-18 13:55:02.570759|2017-02-18 13:55:02.570759
NCT00756340|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2015-10-13|||July 2008||2008-07-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors|A Phase I Trial of RAD001 (Everolimus) and Avastin(R) (Bevacizumab) in Children With Recurrent Solid Tumors|Completed||Phase 1|16|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 13:55:02.659|2017-02-18 13:55:02.659
NCT00756327|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2009-08-14|||August 2007||2007-08-01|August 2009|2009-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||AquaLase Capsule Wash for Pediatric Eyes|AquaLase Capsule Wash for Pediatric Eyes|Completed||N/A|20|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 13:55:02.768158|2017-02-18 13:55:02.768158
NCT00756314|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2010-10-06|2010-09-09||July 2008||2008-07-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|APA||Contraceptive Counseling Following an Abortion|Effectiveness of Contraceptive Counseling of Women Following an Abortion in Recife, Brasil: a Randomized Controlled Intervention Study.|Completed||N/A|246|Actual|Instituto Materno Infantil Prof. Fernando Figueira|"The time of the follow up of six months after the abortion, not having the possibility to evaluate the effectiveness of the measurement in longer term.~However, this decision may have contributed to overestimate the intervention effect."|2|||f||||t||||||||||2017-02-18 13:55:02.850496|2017-02-18 13:55:02.850496
NCT00756301|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2012-06-05|||June 2009||2009-06-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Cutaneous Administration of Local Anesthetic for Spine Injection Procedures|Cutaneous Administration of Local Anesthetic for Spine Injection Procedures: A Prospective Randomized Controlled Trial of Patient Preferred Method|Completed||N/A|55|Actual|Stanford University||3|||f||||||||||||||2017-02-18 13:55:03.278122|2017-02-18 13:55:03.278122
NCT00756288|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2016-08-29|||March 2016||2016-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses|A Randomized Controlled Paired Comparison of Photo-therapy With a Topical Retinoid Cream Pretreatment Versus PDT Alone for Actinic Keratoses|Withdrawn||N/A|0|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 13:55:03.383834|2017-02-18 13:55:03.383834
NCT00756275|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-06-24|||January 2009||2009-01-01|February 2009|2009-02-01|March 2013|Anticipated|2013-03-01|March 2012|Anticipated|2012-03-01||Interventional|VARSUD||Varenicline and Motivational Advice for Smokers With Substance Use Disorders|Varenicline and Motivational Advice for Smokers With SUD|Unknown status|Recruiting|N/A|274|Anticipated|Brown University||2|||f||||t||||||||||2017-02-18 13:55:03.48214|2017-02-18 13:55:03.48214
NCT00756262|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-09-24|||March 2003||2003-03-01|September 2014|2014-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|VRE||Probiotic Lactobacillus GG to Eliminate VRE Colonization|Probiotic Lactobacillus GG to Eliminate VRE Colonization|Terminated||Phase 1|11|Actual|Tufts Medical Center||2||Insufficient recruitment, no additional funding available|f||||t||||||||||2017-02-18 13:55:03.81827|2017-02-18 13:55:03.81827
NCT00756249|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2010-09-24|||October 2007||2007-10-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke|Randomised, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of Lu AA24493 in Acute Ischemic Stroke|Completed||Phase 1|16|Actual|H. Lundbeck A/S||6|||f||||t||||||||||2017-02-18 13:55:03.911355|2017-02-18 13:55:03.911355
NCT00756236|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2014-12-02|||October 2008||2008-10-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement|A Comparison of the Effect of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Oklahoma||3|||f||||t||||||||||2017-02-18 13:55:04.031267|2017-02-18 13:55:04.031267
NCT00756223|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2013-11-20|||November 2008||2008-11-01|November 2013|2013-11-01||||October 2010|Actual|2010-10-01||Interventional|||Phase I Study of BI 831266 in Patients With Advanced Solid Tumours|An Open-label Phase I Single Dose Escalation Trial of Two Dosing Schedules of BI 831266 Administered Intravenously Over 24 h Continuously in Patients With Advanced Solid Tumours|Completed||Phase 1|25|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 13:55:04.141297|2017-02-18 13:55:04.141297
NCT00756210|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18||||||September 2008|2008-09-01||||||||Interventional|||Lifestyle and Obesity||Completed||N/A|||University College of Antwerp|||||f||||||||||||||2017-02-18 13:55:04.237824|2017-02-18 13:55:04.237824
NCT00756197|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2015-08-06|||October 2008||2008-10-01|August 2015|2015-08-01|September 2009|Anticipated|2009-09-01|March 2009|Anticipated|2009-03-01||Interventional|CSALGI2||CryoSpray Ablation(TM)to Determine Safety and Feasibility in Radiation Induced Proctitis|A Single Center Pilot Study of CryoSpray Ablation(TM) to Determine Safety and Feasibility in Radiation Induced Proctitis (CSA LGI-2)|Withdrawn||Phase 4|0|Actual|CSA Medical, Inc.||2||Considering more robust design.|f||||f||||||||||2017-02-18 13:55:04.316394|2017-02-18 13:55:04.316394
NCT00756184|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-19|2011-09-27|||September 2007||2007-09-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Value of an Intervention to Enhance Adherence in Glaucoma Patients|1-year Randomized Control Trial Investigating the Value of an Intervention to Enhance Adherence in Glaucoma Patients Receiving Prostaglandin Monotherapy and in Patients Who Are Candidates for Adjunctive Therapy|Completed||Phase 4|107|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-02-18 13:55:04.443586|2017-02-18 13:55:04.443586
NCT00756171|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2012-12-17|||September 2008||2008-09-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|COPE||Colesevelam Versus Placebo in Cholestatic Pruritus|Colesevelam Versus Placebo in Cholestatic Pruritus. A Double-blind, Placebo-controlled Study|Completed||Phase 2/Phase 3|38|Actual|Foundation for Liver Research||2|||f||||t||||||||||2017-02-18 13:55:04.55267|2017-02-18 13:55:04.55267
NCT00756158|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2010-07-14|||August 2008||2008-08-01|July 2010|2010-07-01|July 2011|Anticipated|2011-07-01|||||Observational|||Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in ADHD|Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention-deficit Hyperactivity Disorder|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"~     The subjects will receive blood withdrawal. The blood sample will be used for establishing~     lymphoblastoid cell lines, which will be used for molecular genetic experiments~   "|||2017-02-18 13:55:04.66418|2017-02-18 13:55:04.66418
NCT00756145|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2015-05-13|||September 2008||2008-09-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Use of Low Molecular Weight Heparin in Hemodiafiltration|The Use of Low Molecular Weight Heparin in Hemodiafiltration|Completed||Phase 4|15|Actual|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 13:55:04.778133|2017-02-18 13:55:04.778133
NCT00756132|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-10-31|||August 2008||2008-08-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|Cyto-Cog||Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca|Role of Inflammatory Markers in Predicting Disease Recurrency and Cognitive Performance in Women With High Risk and Locally Advanced Breast Cancer|Active, not recruiting||N/A|120|Actual|University Health Network, Toronto|||4||f||||f||||||||||2017-02-18 13:55:04.893208|2017-02-18 13:55:04.893208
NCT00756119|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-05-30|||December 2006||2006-12-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Measurement of Cardiac Output and Blood Volumes Using Transonic Ultrasound Dilution Technology|Measurement of Cardiac Output and Blood Volumes Using Transonic Ultrasound Dilution Technology - Clinical Evaluation and Validation|Completed||N/A|26|Actual|Transonic Systems Inc.|||1||f||||f||||||||||2017-02-18 13:55:04.9856|2017-02-18 13:55:04.9856
NCT00756106|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2014-02-06|||July 2008||2008-07-01|February 2014|2014-02-01||||September 2011|Actual|2011-09-01||Observational|||MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma|Quantitative Assessment of the Early and Late Effects of Radiation and Chemotherapy on Glioblastoma Using Multiple MRI Techniques|Terminated||N/A|16|Actual|Massachusetts General Hospital|||1|Funding ended|f||||t||||||||||2017-02-18 13:55:05.068938|2017-02-18 13:55:05.068938
NCT00756093|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-01-31|2009-09-25||September 2008||2008-09-01|January 2012|2012-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops||Completed||N/A|20|Actual|Alcon Research||4|||f||||f||||||||||2017-02-18 13:55:05.176939|2017-02-18 13:55:05.176939
NCT00756080|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2010-03-08|||September 2008||2008-09-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||"Effects of Oral Citrulline on Protein Metabolism in Healthy Humans: a Prospective, Randomized, Double-blind , Cross-over Study (Citrugrêle)"|"Effects of Oral Citrulline on Protein Metabolism in Healthy Humans: a Prospective, Randomized, Double-blind , Cross-over Study"|Completed||Phase 1|12|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-02-18 13:55:05.471261|2017-02-18 13:55:05.471261
NCT00756067|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2017-01-09|||September 2008||2008-09-01|January 2017|2017-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Evaluation of Pneumococcal Vaccine Formulations in Elderly|A Study to Evaluate GSK Biologicals' Candidate Formulations of Pneumococcal Vaccines (GSK2189241A) in Elderly Subjects.|Completed||Phase 1|168|Actual|GlaxoSmithKline||7|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:55:05.565582|2017-02-18 13:55:05.565582
NCT00756041|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-02-27|||September 2005||2005-09-01|February 2012|2012-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy|An Open-Label, Multi-Center Study to Evaluate the Safety of Long-Term Administration of TAK-128 in Subjects With Mild to Moderate Diabetic Peripheral Neuropathy|Terminated||Phase 2|221|Actual|Takeda||1||Lack of Efficacy.|f||||f||||||||||2017-02-18 13:55:05.681432|2017-02-18 13:55:05.681432
NCT00756028|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-01-12|||January 2009||2009-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|KvL||Short Versus Long Protocol for IVF and IVF+ICSI|Short Versus Long IVF-treatment. A Prospective, Consecutive and Randomized Comparative Study|Completed||Phase 4|1099|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 13:55:05.780508|2017-02-18 13:55:05.780508
NCT00756015|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-10-11|||November 2007||2007-11-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Post-op Rehabilitation's Influence on Tendon Healing & Clinical Outcomes Following Arthroscopic Rotator Cuff Repair|Healing After Arthroscopic Rotator Cuff Repair: A Prospective, Randomized Trial of Early Range of Motion Versus Immobilization|Completed||N/A|150|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 13:55:05.901634|2017-02-18 13:55:05.901634
NCT00756002|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2010-05-31|2009-04-03||August 2007||2007-08-01|May 2010|2010-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia|A Randomized, Double-Blind, Placebo-Controlled, Polysomnography Plus Outpatient Study to Determine the Safety and Efficacy of 4 mg Ramelteon in Adults With Chronic Insomnia|Completed||Phase 3|259|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:55:06.02079|2017-02-18 13:55:06.02079
NCT00755989|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18|||December 2008||2008-12-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds|A Phase 3, Single-Centered, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Trial of Morphine Sulfate Gel 0.1% in Patients With Stage 2-3 Wounds|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|Banner Health||2|||f||||t||||||||||2017-02-18 13:55:07.617186|2017-02-18 13:55:07.617186
NCT00755976|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-13|2014-12-30|||August 2007||2007-08-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma|Phase II Trial of the Multi-Drug Resistance Protein Modulating Agent Sulindac in Combination With Epirubicin in Patients With Advanced Melanoma|Completed||Phase 2|32|Actual|Cancer Trials Ireland||1|||f||||||||||||||2017-02-18 13:55:07.72076|2017-02-18 13:55:07.72076
NCT00755963|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2011-07-20|||May 2009||2009-05-01|July 2010|2010-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal Women|The Influence of Hormone Replacement Therapy on the Cerebral Serotonin-1A Receptor Distribution and Mood in Postmenopausal Women|Completed||Phase 4|30|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-02-18 13:55:07.832889|2017-02-18 13:55:07.832889
NCT00755950|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-06-07|||October 2008||2008-10-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|November 2011|Actual|2011-11-01||Interventional|||Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis|A Multicentre, Double-blind, Randomized, Placebo-controlled, Phase II/III Study to Evaluate the Safety and Efficacy of 280 mg and 420 mg Silymarin TID (Legalon® Capsules) Administered for Four Weeks in Subjects With Acute Viral Hepatitis With a Four Week Follow-up Period|Terminated||Phase 2/Phase 3|70|Actual|University of Maryland||3||Low enrollment|f||||t||||||||||2017-02-18 13:55:07.929523|2017-02-18 13:55:07.929523
NCT00755937|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2015-05-26|2008-09-29||February 2002||2002-02-01|May 2015|2015-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|RemiTRAC®||Remicade® Crohn's Disease Registry Across Canada (Study P02793)|Remicade® Treatment Registry Across Canada in Crohn's Disease|Terminated||N/A|556|Actual|Merck Sharp & Dohme Corp.|This was an observational study. There were no imposed interventions from the Sponsor including imposing specific duration of treatment or data collection beyond the standard of care.||1|Satisfied a post-marketing commitment to Canadian Health Authorities.|f||||f||||||||||2017-02-18 13:55:08.052677|2017-02-18 13:55:08.052677
NCT00755924|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-11-25|||June 2008||2008-06-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|August 2009|Actual|2009-08-01||Interventional|||Prospective Randomized Clinical Trial Evaluating the Impact of Vinegar on High Density Lipoprotein||Completed||Phase 1|114|Actual|HealthPartners Institute||1|||f||||f||||||||||2017-02-18 13:55:08.407876|2017-02-18 13:55:08.407876
NCT00755911|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-05-28|2013-01-07||June 2008||2008-06-01|May 2015|2015-05-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy|Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy|Completed||Phase 1/Phase 2|24|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 13:55:08.485174|2017-02-18 13:55:08.485174
NCT00755898|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18|||December 2003||2003-12-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Urinary Excretion of Acetylamantadine by Cancer Patients|Urinary Excretion of Acetylamantadine by Cancer Patients|Completed||Phase 2|150|Actual|University of Manitoba||2|||f||||f||||||||||2017-02-18 13:55:08.923599|2017-02-18 13:55:08.923599
NCT00755885|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2017-01-25|||October 2008||2008-10-01|January 2017|2017-01-01|June 4, 2016|Actual|2016-06-04|June 4, 2016|Actual|2016-06-04||Interventional|||Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer|A Cancer Research UK Phase I/II Open Label Study to Evaluate the Safety, Endocrine Effects and Anti-tumour Activity of Abiraterone Acetate (CB7630) in Patients With Oestrogen (ER) or Androgen Receptor (AR) Positive Advanced or Metastatic Breast Carcinoma|Completed||Phase 1/Phase 2|77|Actual|Cancer Research UK||1|||f||||||||||||||2017-02-18 13:55:09.022296|2017-02-18 13:55:09.022296
NCT00592046|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-18|||May 2005||2005-05-01|July 2012|2012-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Phase I Trial of ZIO-101 in Hematologic Cancers|A Phase I Trial of ZIO-101 in Hematologic Cancers|Completed||Phase 1|12|Actual|Ziopharm||1|||f||||t||||||||||2017-02-18 14:53:22.077865|2017-02-18 14:53:22.077865
NCT00755872|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2011-10-07|||November 2007||2007-11-01|October 2011|2011-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate|Influence of a High-fat Meal on the Bioavailability of a Two Different Formulations of Risedronate|Completed||Phase 1|76|Actual|Warner Chilcott||4|||f||||t||||||||||2017-02-18 13:55:09.119364|2017-02-18 13:55:09.119364
NCT00755859|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18|||May 1998||1998-05-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|December 2004|Actual|2004-12-01||Interventional|||"Steroids and Azathioprine Versus Steroids Alone in IgAN"|Corticosteroids and Azathioprine Versus Corticosteroids Alone in IgA Nephropathy: a Randomized Controlled Trial.|Completed||Phase 4|206|Actual|A. Manzoni Hospital||2|||f||||t||||||||||2017-02-18 13:55:09.226207|2017-02-18 13:55:09.226207
NCT00755846|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-02-01|2011-06-08||March 2005||2005-03-01|February 2012|2012-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Comparison Study to Determine the Efficacy and Safety of SYR110322 in Patients With Type 2 Diabetes, Who Are Either Receiving No Current Treatment or Currently Treated With Diet and Exercise, Sulfonylurea, Metformin or a Combination of Sulfonylurea and Metformin|Completed||Phase 2|265|Actual|Takeda||6|||f||||f||||||||||2017-02-18 13:55:09.579768|2017-02-18 13:55:09.579768
NCT00755833|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-10-27|||September 2008||2008-09-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months|A Prospective, Multicentre, Open Label, Un-controlled , Observational, 12-month Study in Subjects Using: NovoMix® 50 (Biphasic Insulin Aspart 50) for Treatment of Type 2 Diabetes Mellitus in Slovenia|Completed||N/A|270|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:55:11.290847|2017-02-18 13:55:11.290847
NCT00755820|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2012-10-25|||January 2008||2008-01-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Food Exposure Therapy in Anorexia Nervosa|Food Exposure Therapy in Anorexia Nervosa|Completed||N/A|32|Actual|New York State Psychiatric Institute|||3||f||||f||||||||||2017-02-18 13:55:11.394481|2017-02-18 13:55:11.394481
NCT00755807|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2011-11-04|2011-06-13||October 2008||2008-10-01|November 2011|2011-11-01|November 2010|Actual|2010-11-01|August 2010|Actual|2010-08-01||Interventional|||Duloxetine for Multiple Sclerosis Pain|Duloxetine in Patients With Central Neuropathic Pain Due to Multiple Sclerosis.|Completed||Phase 3|239|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 13:55:11.525205|2017-02-18 13:55:11.525205
NCT00755794|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-05-13|||June 2006||2006-06-01|May 2016|2016-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|SAS||The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)|An 8 Week Multicenter, Open-label, Observational Study to Evaluate the Effectiveness of Adding Montelukast Sodium 10 mg Per Day to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma|Completed||Phase 3|800|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 13:55:13.528784|2017-02-18 13:55:13.528784
NCT00755781|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-09-13|||September 2008||2008-09-01|September 2012|2012-09-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|CIS001||Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation|A Multi-Center, Randomized, Controlled Study to Demonstrate the Efficacy and Safety of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation|Completed||Phase 3|284|Actual|APT Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 13:55:13.624948|2017-02-18 13:55:13.624948
NCT00755768|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2008-09-18|||January 2006||2006-01-01|September 2008|2008-09-01|September 2006|Actual|2006-09-01|||||Interventional|||More Time Better Outcome - a Randomised Trial to Investigate the Effect of More Dietetic Time in Dialysis Patients|More Time Better Outcome - a Randomised Trial to Investigate the Effect of More Dietetic Time on Phosphate Levels in End Stage Renal Failure Patients|Completed||N/A|75||Royal Free Hampstead NHS Trust|||||f||||f||||||||||2017-02-18 13:55:13.758857|2017-02-18 13:55:13.758857
NCT00755755|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2012-12-11|2012-07-26||October 2008||2008-10-01|December 2012|2012-12-01|August 2010|Actual|2010-08-01|March 2010|Actual|2010-03-01||Interventional|PEARLI||PGL4001 Versus Placebo in Uterine Myomas|A Phase III, Randomized, Parallel Group, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of PGL4001 (Ulipristal) Versus Placebo for Pre-Operative Treatment of Symptomatic Uterine Myomas|Completed||Phase 3|241|Actual|PregLem SA||3|||f||||t||||||||||2017-02-18 13:55:13.860795|2017-02-18 13:55:13.860795
NCT00755742|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2011-09-21|||November 2008||2008-11-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Lifestyle Intervention Targetting Obesity and Insulin Resistance in Chronic Hepatitis C|Evaluation of the Impact of a Combined Program of Diet, Exercise and Behavior Modification on the Insulin Resistance and Adipokine Profile in Obese Patients With Current and Cured Chronic Hepatitis C.|Completed||N/A|24|Actual|University Health Network, Toronto||4|||f||||t||||||||||2017-02-18 13:55:14.567293|2017-02-18 13:55:14.567293
NCT00755729|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18|||November 2006||2006-11-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Effect of the Preoperative Oral Carbohydrate Attenuating Immediate Postoperative Insulin Resistance on PI3K Dependent Signaling Pathway|The Effect of the Preoperative Oral Carbohydrate Attenuating Immediate Postoperative Insulin Resistance on PI3K Dependent Signaling Pathway|Completed||Phase 4|32|Actual|Shanghai Changzheng Hospital||2|||f||||t||||||||||2017-02-18 13:55:14.680552|2017-02-18 13:55:14.680552
NCT00755716|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2016-10-26||2012-06-20|April 2006||2006-04-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|December 2008|Actual|2008-12-01||Interventional|||Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study|Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study|Completed||Phase 3|84|Actual|UConn Health||3|||f||||f||||||||No||2017-02-18 13:55:14.789209|2017-02-18 13:55:14.789209
NCT00755703|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-12-31|||October 2008||2008-10-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|September 2009|Actual|2009-09-01||Interventional|||Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.|A Phase I, Dose-Ranging Safety and Immunogenicity Study of an Adenovirus-vectored Intranasal, Pandemic (Hemagglutinin H5) Influenza Vaccine, ADhVN1203/04.H5, in Healthy Adults|Completed||Phase 1|48|Actual|Altimmune, Inc.||4|||f||||t||||||||||2017-02-18 13:55:14.904805|2017-02-18 13:55:14.904805
NCT00048009|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2005-06-23||||||May 2005|2005-05-01||||||||Interventional|||Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids||Completed||Phase 2|||Hoffmann-La Roche|||||||||||||||||||2017-02-18 18:03:21.126126|2017-02-18 18:03:21.126126
NCT00755690|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2014-02-17|||September 2008||2008-09-01|February 2014|2014-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease|Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease|Completed||N/A|32|Actual|University of British Columbia||3|||f||||f||||||||||2017-02-18 13:55:15.017944|2017-02-18 13:55:15.017944
NCT00755677|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-03-20|||March 2007||2007-03-01|March 2012|2012-03-01|July 2008|Actual|2008-07-01|January 2008|Actual|2008-01-01||Interventional|||Exploring the Health Benefits Associated With Daily Pulse Consumption in Individuals With Peripheral Arterial Disease|Exploring the Health Benefits Associated With Daily Pulse Consumption in Individuals With Peripheral Arterial Disease|Completed||Early Phase 1|26|Actual|St. Boniface General Hospital Research Centre||1|||f||||f||||||||||2017-02-18 13:55:15.133557|2017-02-18 13:55:15.133557
NCT00755664|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2015-06-04|||July 2007||2007-07-01|June 2015|2015-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly|Effects of Low-dose B-vitamins Supplementation on Plasma Homocysteine and Framingham Risk Score: Double Blind Randomized Controlled Trial in Healthy Chinese Elderly|Completed||Phase 3|390|Actual|Peking University||2|||f||||t||||||||||2017-02-18 13:55:15.278513|2017-02-18 13:55:15.278513
NCT00755651|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18|||January 2003||2003-01-01|September 2008|2008-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy|Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy|Completed||N/A|180|Actual|Royal Free Hampstead NHS Trust||2|||f||||f||||||||||2017-02-18 13:55:15.395856|2017-02-18 13:55:15.395856
NCT00755638|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2009-07-10|||September 2008||2008-09-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ACE-031 (ActRIIB-IgG1) in Healthy, Postmenopausal Volunteers|Completed||Phase 1|48|Actual|Acceleron Pharma, Inc.||1|||f||||f||||||||||2017-02-18 13:55:15.50371|2017-02-18 13:55:15.50371
NCT00755599|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2008-09-18|||September 2008||2008-09-01|September 2008|2008-09-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|EASE||Eisenhower's Alternative Speculum Examination|The EASE Trial: Eisenhower's Alternative Speculum Examination|Unknown status|Active, not recruiting|N/A|1200|Anticipated|Eisenhower Army Medical Center||2|||f||||f||||||||||2017-02-18 13:55:15.58496|2017-02-18 13:55:15.58496
NCT00755586|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2009-08-17|||January 2009||2009-01-01|August 2009|2009-08-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Stem Cell Therapy to Improve the Muscle Function of Patients With Partly Denervated Muscles of the Arm|Autologous Bone Marrow Transplantation for Muscle Improvement in Traumatic Brachial Plexus Injuries|Unknown status|Recruiting|Phase 1/Phase 2|18|Anticipated|Leiden University Medical Center||3|||f||||f||||||||||2017-02-18 13:55:15.686736|2017-02-18 13:55:15.686736
NCT00755573|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2010-08-19|||October 2008||2008-10-01|July 2009|2009-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|CPP||Pain and Chronic Pancreatitis - Clinical End Experimental Studies|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical and Experimental Pilot Study of Pregabalin in Patients With Chronic Pancreatitis|Completed||Phase 2/Phase 3|64|Actual|Aalborg Universitetshospital||2|||f||||t||||||||||2017-02-18 13:55:15.793853|2017-02-18 13:55:15.793853
NCT00755560|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-02-18|||September 2008||2008-09-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2015|Actual|2015-07-01||Interventional|||Treatment of Asymptomatic Toxocariasis With Albendazole in Children|Treatment of Asymptomatic Toxocariasis With Albendazole in Children. A Prospective, Randomized, Placebo-controlled Clinical Trial|Active, not recruiting||Phase 3|50|Anticipated|Hospital de Niños R. Gutierrez de Buenos Aires||2|||f||||t||||||||Undecided||2017-02-18 13:55:15.906762|2017-02-18 13:55:15.906762
NCT00755547|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-03-27|||April 2008||2008-04-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|POWER||A Study of the Effects of Exercise Intensity on Insulin Sensitivity in Overweight Youth|Physical Activity for Overweight Youth at Risk for Type 2 Diabetes Mellitus (POWER) Trial|Completed||Phase 4|120|Actual|University of Manitoba||3|||f||||||||||||||2017-02-18 13:55:16.018276|2017-02-18 13:55:16.018276
NCT00755534|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-02-12|||November 2008||2008-11-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC|A Parallel Phase II Study With Irinotecan/Cetuximab (Until PD) Followed by XELOX/Cetuximab (Until PD) vs the Reverse Sequence in Metastatic CRC With Previous Benefit on Irinotecan/Bevacizumab Based Therapy|Terminated||Phase 2|68|Actual|Hellenic Oncology Research Group||2||Due to poor accrual|f||||f||||||||||2017-02-18 13:55:16.131913|2017-02-18 13:55:16.131913
NCT00755521|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2012-08-09|||September 2008||2008-09-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|October 2010|Actual|2010-10-01||Interventional|||Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia|Study Proposal - A Randomized Double-blinded Study Comparing Adding Etoricoxib Versus Placebo to Female Patients With Fibromyalgia-analysis of Organic and Psychiatric Measures|Unknown status|Recruiting|Phase 4|80|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-02-18 13:55:16.255804|2017-02-18 13:55:16.255804
NCT00755508|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-02-27|||November 2005||2005-11-01|February 2012|2012-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With Insomnia|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Proof-of-Concept Study to Evaluate the Safety and Efficacy of ROZEREM™ Taken in Combination With Gabapentin for the Treatment of Subjects With Chronic Insomnia|Completed||Phase 2|378|Actual|Takeda||5|||f||||f||||||||||2017-02-18 13:55:16.358226|2017-02-18 13:55:16.358226
NCT00755495|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-02-27|||July 2006||2006-07-01|February 2012|2012-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Proof-of-Concept Study to Evaluate the Safety and Efficacy of Ramelteon Taken in Combination With Doxepin for the Treatment of Subjects With Chronic Insomnia|Completed||Phase 2|472|Actual|Takeda||4|||f||||f||||||||||2017-02-18 13:55:16.475871|2017-02-18 13:55:16.475871
NCT00327405|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2006-05-17||||||January 2006|2006-01-01||||||||Observational|||Results of Ocular Compression and Suture Release in Trabeculectomy and Combined Surgery|A Retrospective Study of Surgical Outcomes.|Completed||N/A|||University of Cincinnati|||||f||||||||||||||2017-02-18 16:32:15.760987|2017-02-18 16:32:15.760987
NCT00755482|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18|||January 2006||2006-01-01|September 2008|2008-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee|Randomised, Placebo Controlled Trial to Examine the Effect of Aquamin F on NSAID Dose Reduction in Subjects With Osteoarthritis of the Knee.|Completed||Phase 1/Phase 2|29|Actual|Marigot Ltd.||2|||f||||f||||||||||2017-02-18 13:55:16.594483|2017-02-18 13:55:16.594483
NCT00755469|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-12-03|||September 2008||2008-09-01|December 2013|2013-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Post-conditioning to Reduce Infarct Size|"Modification of Reperfusion by Post-Conditioning Reduces Infarct Size in Acute Myocardial Infarction"|Completed||N/A|43|Actual|Minneapolis Heart Institute Foundation||1|||f||||f||||||||||2017-02-18 13:55:16.889459|2017-02-18 13:55:16.889459
NCT00755456|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-03-25|||January 2008||2008-01-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)|Phase 2 Study of the Effect of a Peritoneal Dialysis Solution Containing Glucose (1.5%) and L-carnitine (0.1%) on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis|Unknown status|Recruiting|Phase 2|80|Anticipated|Iperboreal Pharma Srl||2|||f||||f||||||||||2017-02-18 13:55:16.999247|2017-02-18 13:55:16.999247
NCT00755443|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18|||February 2003||2003-02-01|September 2008|2008-09-01|December 2005|Actual|2005-12-01|September 2004|Actual|2004-09-01||Interventional|DIABETES||Sirolimus-Eluting Stent Versus Standard Stent in Diabetic|A Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients|Completed||Phase 4|160|Actual|Hospital San Carlos, Madrid||2|||f||||t||||||||||2017-02-18 13:55:17.123034|2017-02-18 13:55:17.123034
NCT00755430|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2008-09-18|||January 2009||2009-01-01|September 2008|2008-09-01|December 2012|Anticipated|2012-12-01|||||Observational|||Structural and Functional Connectivity in Autism Spectrum Disorders|Structural and Functional Connectivity in Autism Spectrum Disorders by Using Diffusion Spectrum Imaging and Functional Magnetic Resonance Imaging Studies|Unknown status|Not yet recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"~     The subjects will receive blood withdrawal. The blood sample will be used for establishing~     lymphoblastoid cell lines, which will be used for molecular genetic experiments.~   "|||2017-02-18 13:55:17.221026|2017-02-18 13:55:17.221026
NCT00755417|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-02-03|2011-12-21||September 2008||2008-09-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 3|541|Actual|Depomed||3|||f||||f||||||||||2017-02-18 13:55:17.312041|2017-02-18 13:55:17.312041
NCT00755404|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2013-03-25|||June 2007||2007-06-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Interventional|||Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)|Phase 2 Study of the Effect of a Peritoneal Dialysis Solution Containing Glucose (1.5%) and L-Carnitine (0.1%) on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis|Unknown status|Recruiting|Phase 2|20|Anticipated|Iperboreal Pharma Srl||2|||f||||f||||||||||2017-02-18 13:55:18.15476|2017-02-18 13:55:18.15476
NCT00755391|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2012-10-25|||February 2008||2008-02-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Cognitive Behavioral Therapy for Adolescents With Bulimia|Cognitive Behavioral Therapy for Adolescents With Bulimia|Completed||N/A|8|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 13:55:18.266698|2017-02-18 13:55:18.266698
NCT00755378|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-18|2009-03-25|||September 2008||2008-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|||||Interventional|SAD||AZD8529 Single Ascending Dose Study|Phase I, Single-Center, Randomized, Double-Blind, Placebo Controlled Single-Ascending Dose, First Time Into Man Study to Assess the Safety, Tolerability, and PK of AZD8529 in Healthy Subjects Part B: A Randomized, Open Label Study to Assess the Effect of Food on AZD 8529|Completed||Phase 1|58|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:55:18.370671|2017-02-18 13:55:18.370671
NCT00755365|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2008-09-17|||January 2003||2003-01-01|September 2008|2008-09-01|September 2008|Anticipated|2008-09-01|December 2007|Actual|2007-12-01||Observational|||Intraoperative Angioembolization in the Management of Pelvic Fracture-Related Hemodynamic Instability|Intraoperative Angioembolization in the Management of Pelvic Fracture-Related Hemodynamic Instability|Unknown status|Active, not recruiting|N/A|15|Anticipated|Penn State University|||1||f||||f||||||||||2017-02-18 13:55:18.473382|2017-02-18 13:55:18.473382
NCT00755352|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-04-02|||November 2002||2002-11-01|April 2015|2015-04-01|April 2005|Actual|2005-04-01|June 2003|Actual|2003-06-01||Interventional|||A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.|Efficacy of WelChol as an Add-on to Pravastatin Therapy|Completed||Phase 4|67|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:55:18.571057|2017-02-18 13:55:18.571057
NCT00755339|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2017-01-24|||September 15, 2008||2008-09-15|October 25, 2016|2016-10-25|October 25, 2016||2016-10-25|||||Observational|||Role of the Sensory Experience in Generating Motor Tics in Tourette Syndrome|Understanding the Anatomy and Physiology of the Sensory Experience and Its Role in Generating Tics in Tourette Syndrome|Completed||N/A|54|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:55:18.681995|2017-02-18 13:55:18.681995
NCT00755326|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2013-02-19|||April 2007||2007-04-01|February 2013|2013-02-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|TCM-OAK||Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee|Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee|Completed||Phase 2|120|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 13:55:18.779755|2017-02-18 13:55:18.779755
NCT00755313|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-05-12|||May 2007||2007-05-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|September 2012|Actual|2012-09-01||Observational|||Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer|Effects of Chemotherapy on Brain Structure and Function|Active, not recruiting||N/A|81|Actual|University of California, San Francisco|||1||f||||t||||||||||2017-02-18 13:55:18.887299|2017-02-18 13:55:18.887299
NCT00589498|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2013-11-01|||December 2005||2005-12-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Fat Gain and Cardiovascular Disease Mechanisms|Fat Gain and Cardiovascular Disease Mechanisms|Completed||Phase 3|69|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:54:09.711084|2017-02-18 14:54:09.711084
NCT00755300|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2011-08-11|||June 2006||2006-06-01|August 2011|2011-08-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Observational|||Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical Techniques|Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical Techniques|Completed||N/A|15|Actual|University of California, Davis|||2||f||||f||||||||||2017-02-18 13:55:18.998108|2017-02-18 13:55:18.998108
NCT00755287|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-07-27||2016-07-26|November 2008||2008-11-01|July 2016|2016-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.|A Multicenter, Randomized, Open-label, Active-controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin-naïve Type 2 Diabetic Patients Inadequately Controlled With Metformin and Sulphonylurea Combination Therapy|Completed||Phase 3|1072|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 13:55:19.108549|2017-02-18 13:55:19.108549
NCT00755274|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2016-04-12|2010-02-01||September 2008||2008-09-01|April 2016|2016-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®|Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2008-2009 Formulation)|Completed||Phase 4|32|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:55:19.484331|2017-02-18 13:55:19.484331
NCT00755261|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-05-07|2015-04-15||September 2008||2008-09-01|May 2015|2015-05-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Phase II Study of Doxorubicin and Avastin® in Sarcoma.|Phase II Study of Doxorubicin and Avastin® for Patients With Advanced Soft-tissue Sarcomas.|Terminated||Phase 2|4|Actual|Sidney Kimmel Comprehensive Cancer Center||1||The study has been terminated due to low accrual.|f||||t||||||||||2017-02-18 13:55:20.098222|2017-02-18 13:55:20.098222
NCT00755248|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2008-09-16|||January 2007||2007-01-01|September 2008|2008-09-01|January 2011|Anticipated|2011-01-01|||||Observational|||Coronary Artery Bypass Grafting: Factors Related to Late Events and Saphenous Graft Patency|Coronary Artery Bypass Grafting: Factors Related to Late Events and Saphenous Graft Patency|Unknown status|Recruiting|N/A|300|Anticipated|Centro Cardiologico Monzino|||1||f||||f||||||Samples With DNA|"~     Plasma,serum, whole blood~   "|||2017-02-18 13:55:22.692824|2017-02-18 13:55:22.692824
NCT00755235|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2013-04-05|2011-07-22||April 2009||2009-04-01|April 2013|2013-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Feasibility of Depression Care Management by E-mail|Pilot Trial of Depression Care Management by Electronic Secure Messaging|Completed||N/A|208|Actual|Group Health Cooperative|Findings apply only to patients who choose to communicate by online messaging.|2|||f||||f||||||||||2017-02-18 13:55:22.797266|2017-02-18 13:55:22.797266
NCT00755222|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2016-09-07|2011-01-18||August 2008||2008-08-01|July 2016|2016-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease|A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effectiveness of AA4500 Administered Two Times a Week for Up to Three Treatment Cycles (2 x 3) in Subjects With Peyronie's Disease|Completed||Phase 2|147|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:55:23.176412|2017-02-18 13:55:23.176412
NCT00755209|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2013-11-20|||October 2008||2008-10-01|November 2013|2013-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Tranexamic Acid for Preventing Progressive Intracranial Haemorrhage in Traumatic Brain Injury|Tranexamic Acid for Preventing Progressive Intracranial Haemorrhage in Adults With Traumatic Brain Injury; a Randomised, Double-blinded, Placebo-controlled Trial|Completed||Phase 3|238|Actual|Khon Kaen University||1|||f||||f||||||||||2017-02-18 13:55:23.651129|2017-02-18 13:55:23.651129
NCT00755196|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2011-02-09||2011-02-09|September 2008||2008-09-01|February 2011|2011-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis|A Double-Blind, Randomized, 12 Week, Bilateral Study of the Safety and Efficacy of AN2728 Ointment, 5%, Versus Ointment Vehicle in the Treatment of Patients With Plaque Type Psoriasis|Completed||Phase 2|30|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 13:55:23.96451|2017-02-18 13:55:23.96451
NCT00755183|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-03-15||2012-03-15|July 2008||2008-07-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction|A Single-Center, Double-Masked, Randomized, Vehicle Controlled Study to Evaluate the Safety and Efficacy of Testosterone 0.03% Ophthalmic Solution Compared to Vehicle for the Treatment of Meibomian Gland Dysfunction|Completed||Phase 2|60|Actual|ORA, Inc.||2|||f||||f||||||||||2017-02-18 13:55:24.071181|2017-02-18 13:55:24.071181
NCT00755170|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-10-03|||November 2008||2008-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer|A Phase II Study of the Combination of Metronomic Vinorelbine and Bevacizumab as 2nd Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|48|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 13:55:24.173137|2017-02-18 13:55:24.173137
NCT00755157|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-10-06|||April 2008||2008-04-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer|A Phase II Study of the Combination of Metronomic Docetaxel and Bevacizumab as 2nd Line Treatment in Patients With Small Cell Lung Cancer (SCLC)|Withdrawn||Phase 2|0|Actual|University Hospital of Crete||1|||f||||f||||||||||2017-02-18 13:55:24.287242|2017-02-18 13:55:24.287242
NCT00755144|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-02-11|||April 2007||2007-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:55:24.405012|2017-02-18 13:55:24.405012
NCT00755131|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2010-01-25|2009-11-05||September 2008||2008-09-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction|Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction|Completed||N/A|75|Actual|Federico II University||2|||f||||f||||||||||2017-02-18 13:55:24.470213|2017-02-18 13:55:24.470213
NCT00751010|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-10-10|||September 2008||2008-09-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Relationship: Interstitial Cystitis & Vulvodynia-Part 2|Relationship: Interstitial Cystitis & Vulvodynia-Part 2|Completed||N/A|127|Anticipated|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 13:56:49.468477|2017-02-18 13:56:49.468477
NCT00755118|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-10-06|||October 2008||2008-10-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc|Phase II Study Of Weekly Administration Oxaliplatin Plus 5-Fu/Lv (Aio Regimen) Plus Bevacizumab, Alternative With Irinotecan Plus 5-Fu/Lv(Aio Regimen) Plus Cetuximab, As Salvage Treatment In Pretreated Patients With Mcrc|Terminated||Phase 2|24|Actual|University Hospital of Crete||1||Due to poor Accrual|f||||f||||||||||2017-02-18 13:55:24.909507|2017-02-18 13:55:24.909507
NCT00755105|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2011-08-04|2008-12-30||September 1998||1998-09-01|August 2011|2011-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Measurements of Body Iron Excretion of Healthy Adults|Body Iron Excretion of Healthy Adults as Measured by Isotope Dilution|Completed||N/A|77|Actual|USDA Grand Forks Human Nutrition Research Center|||1||f||||f||||||||||2017-02-18 13:55:25.097695|2017-02-18 13:55:25.097695
NCT00755092|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2009-02-10|||September 2008||2008-09-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|DINAM||Effect of Doula in Nulliparas and Multiparas|Analgesic Efficacy of Doula in Nulliparous and Multiparous Women|Completed||N/A|150|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 13:55:25.437775|2017-02-18 13:55:25.437775
NCT00755079|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2015-02-24|2014-06-16||April 2007||2007-04-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|August 2012|Actual|2012-08-01||Interventional|||Use of an Oral Beta-2 Agonist in Persons With Spinal Cord Injury|A Randomized, Double-blind, Placebo-controlled Parallel Group Trial to Determine the Effect of an Oral Beta-2 Agonist on Respiratory Muscle Strength in Spinal Cord Injury|Completed||Phase 2/Phase 3|40|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 13:55:25.538275|2017-02-18 13:55:25.538275
NCT00755066|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2008-09-25||||||September 2008|2008-09-01||||||||Interventional|||Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE|The Effect of Intranasal Corticosteroid on the Immune Response Following Nasal Allergen Challenge in Patients Suffering From Seasonal Allergic Rhinitis|Completed||N/A|48|Actual|Medical University of Vienna||2|||f||||||||||||||2017-02-18 13:55:25.866715|2017-02-18 13:55:25.866715
NCT00755053|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-08-04|||September 2008||2008-09-01|July 2015|2015-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparative Efficacy of Ovule vs Tablet|An Investigator-blinded, Active-controlled Phase 3 Study to Prove the Non-inferior Efficacy of a Clotrimazole Ovule (500 mg) Versus a Clotrimazole Vaginal Tablet (500 mg) in Vaginal Candidiasis|Completed||Phase 3|466|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:55:25.961023|2017-02-18 13:55:25.961023
NCT00755040|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-10-14|2016-10-14||October 2008||2008-10-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|December 2014|Actual|2014-12-01||Interventional|||Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder|Randomized Placebo Controlled Double Blind Study of Restasis Versus Placebo in Primary Prevention of Ocular GVHD After Allogeneic Stem Cell Transplantation|Completed||Phase 3|164|Actual|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-02-18 13:55:26.076732|2017-02-18 13:55:26.076732
NCT00755027|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-08-07|||September 2008||2008-09-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Rasagiline and Apathy in Parkinson's Disease|A Randomised Placebo-controlled Trial of Rasagiline in Parkinson Disease Patients With Symptoms of Apathy|Completed||Phase 4|40|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||1|||f||||t||||||||||2017-02-18 13:55:26.688556|2017-02-18 13:55:26.688556
NCT00755014|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2008-09-17|||September 2007||2007-09-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|March 2008|Actual|2008-03-01||Interventional|||Study Effect of Red Wine Consumption on Endothelial Progenitor Cells and Endothelial Function|Taipei Veterans General Hospital|Completed||Phase 1|40|Actual|Taipei Veterans General Hospital, Taiwan||1|||f||||f||||||||||2017-02-18 13:55:26.797987|2017-02-18 13:55:26.797987
NCT00755001|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2012-02-29|||May 2007||2007-05-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Clinical Study on BiHapro Total Hip System With Different Surface Coatings|Clinical Study on BiHapro Total Hip System With Different Surface Coatings|Terminated||N/A|40|Actual|Zimmer Biomet|||2|The site decided to stop the study|f||||f||||||||||2017-02-18 13:55:26.895562|2017-02-18 13:55:26.895562
NCT00754988|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-11-03||2016-11-01|October 2008||2008-10-01|November 2016|2016-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.|A Multicenter, Randomized, Double-dummy, Placebo and Active-controlled Study to Assess the Safety, Tolerability and Effect of Taspoglutide on Glycemic Control Compared to Sitagliptin and Placebo in Patients With Type II Diabetes Mellitus Inadequately Controlled With Metformin.|Completed||Phase 3|666|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 13:55:27.00215|2017-02-18 13:55:27.00215
NCT00754975|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2010-08-05|||January 2008||2008-01-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|May 2009|Actual|2009-05-01||Interventional|||JACTAX LD Drug Eluting Stent Trial|A Clinical Trial Comparing the Performance of the JACTAX LD DES With the TAXUS™ Libertè™ DES|Completed||N/A|130|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 13:55:27.253617|2017-02-18 13:55:27.253617
NCT00754962|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2008-09-17|||December 2006||2006-12-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Bioequivalency Study of Protriptyline 10 mg Tablets Under Fasted Conditions|A Single Dose, 2-Period, 2-Way Crossover Bioequivalency Study of Protriptyline Tablets 10 mg Under Fasted Conditions|Completed||N/A|38|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 13:55:27.354089|2017-02-18 13:55:27.354089
NCT00754949|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2014-03-03||||||March 2014|2014-03-01||||||||Interventional|||Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis|A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical and Anti-Microbial Efficacy and Safety of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone in the Treatment of Subjects With Blepharoconjunctivitis|Withdrawn||Phase 3|0|Actual|InSite Vision||3|||f||||f||||||||||2017-02-18 13:55:27.440989|2017-02-18 13:55:27.440989
NCT00754936|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2011-02-18|||May 2007||2007-05-01|February 2011|2011-02-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|ERP||Treatment Response of Geriatric Depression|ERPs, Cognitive Dysfunction and Treatment Response of Geriatric Depression|Unknown status|Recruiting|N/A|120|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-02-18 13:55:27.533127|2017-02-18 13:55:27.533127
NCT00754923|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2014-05-14|2014-04-15||October 2008||2008-10-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of Single Agent Sorafenib in Non-small Cell Lung Cancer Patients Who Never Smoked or Were Former Light Smokers.|Terminated||Phase 2|11|Actual|Ohio State University Comprehensive Cancer Center|The study was discontinued, after withdrawal from the sponsor due to slow accrual. The discovery of EGFR mutations changed the scope of the trial.|1|||f||||t||||||||||2017-02-18 13:55:27.64291|2017-02-18 13:55:27.64291
NCT00754910|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2010-02-02|||December 2008||2008-12-01|June 2009|2009-06-01||||October 2010|Anticipated|2010-10-01||Interventional|||Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease|Immunobiology of Photodynamic Therapy in Lung Cancer Patients|Unknown status|Recruiting|N/A|236|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:55:27.865886|2017-02-18 13:55:27.865886
NCT00754897|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2009-09-14|||November 2008||2008-11-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Feasibility Study for PANDAS|Feasibility Study for Pediatric NeuroDevelopmental Assessment Study (PANDAS)|Completed||N/A|72|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 13:55:27.97704|2017-02-18 13:55:27.97704
NCT00754884|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-12-03|||October 2008||2008-10-01|December 2015|2015-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|CALFI||Calcitonin in the Treatment of Fibromyalgia|Phase IV Study of Nasal Salmon Calcitonin in the Treatment of Symptoms and Signs of Fibromyalgia|Withdrawn||Phase 4|0|Actual|Unidad de Investigacion en Enfermedades Cronico-Degenerativas||2||Study drug was not longer available in our country.|f||||f||||||||||2017-02-18 13:55:28.072829|2017-02-18 13:55:28.072829
NCT00754871|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-01-26|||September 2008||2008-09-01|January 2015|2015-01-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Pharmacodynamic Characterization of Dienogest|A Double-blind, Randomized, Dose-controlled Study to Evaluate Pharmacodynamic Properties of Four Oral Doses of Dienogest (DNG) in 100 Healthy Young Female Volunteers Over a Period of Two Cycles up to a Maximum of 72 Days|Completed||Phase 1|102|Actual|Bayer||4|||f||||f||||||||||2017-02-18 13:55:28.198752|2017-02-18 13:55:28.198752
NCT00754858|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2014-11-26|||October 2008||2008-10-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|May 2010|Actual|2010-05-01||Interventional|||Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer|Phase II Study of Camtobell Inj.(Belotecan) in Combination With Cisplatin in Patients With Previously Untreated, Extensive-stage Small-cell Lung Cancer|Completed||Phase 2|42|Actual|Yonsei University||1|||f||||f||||||||||2017-02-18 13:55:28.309989|2017-02-18 13:55:28.309989
NCT00754845|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2017-01-10|||October 2004||2004-10-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|July 2015|Actual|2015-07-01||Interventional|||Letrozole in Treating Women With Primary Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy|A Double Blind Randomization to Letrozole or Placebo for Women Previously Diagnosed With Primary Breast Cancer Completing Five Years of Adjuvant Aromatase Inhibitor Either as Initial Therapy or After Tamoxifen (Including Those in The MA.17 Study)|Active, not recruiting||Phase 3|1918|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 13:55:28.423558|2017-02-18 13:55:28.423558
NCT00754832|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2012-01-20|2011-09-09||September 2005||2005-09-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|September 2008|Actual|2008-09-01||Interventional|||American Ginseng Treatment for Multiple Sclerosis Related Fatigue|A Double-blinded, Placebo-controlled Crossover Pilot Study of American Ginseng Treatment for Multiple Sclerosis Related Fatigue|Completed||Phase 2|56|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 13:55:28.770171|2017-02-18 13:55:28.770171
NCT00754819|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2009-10-07|||April 2008||2008-04-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|COOL||Targeting Inflammation in Acute Coronary Syndrome Using Colchicine|Colchicine Compared With Placebo to Reduce Hs-CRP in Patients With Acute Coronary Syndromes- Targeting Inflammation in Atherosclerosis Trial|Completed||Phase 2/Phase 3|80|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 13:55:29.065659|2017-02-18 13:55:29.065659
NCT00754806|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2008-09-17|||February 2007||2007-02-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Observational|||Prospective Randomized Comparison of Clinical Results of Hand Assisted Laparoscopic Splenectomies and Open Splenectomies|Prospective Randomized Study Between Open and Hand Assisted Splenectomies|Completed||N/A|27|Actual|Istanbul University|||2||f||||t||||||||||2017-02-18 13:55:29.157229|2017-02-18 13:55:29.157229
NCT00754793|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2013-12-16|2012-06-13||January 2009||2009-01-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|August 2010|Actual|2010-08-01||Interventional|SFPAT||Sinusitis and Facial Pain Disorders Anti-Depression Trial|Sinusitis and Facial Pain Disorders Anti-Depression Trial|Terminated||Phase 4|3|Actual|University of Washington||2||poor recruitment|f||||f||||||||||2017-02-18 13:55:29.229601|2017-02-18 13:55:29.229601
NCT00754780|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2012-03-15|||September 2000||2000-09-01|March 2012|2012-03-01||||August 2004|Actual|2004-08-01||Interventional|||Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1|Phase II Clinical Trial of Pirfenidone for the Treatment of Patients With Neurofibromatosis Type I|Completed||Phase 2|24|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 13:55:29.615279|2017-02-18 13:55:29.615279
NCT00754767|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-12-15|||June 2006||2006-06-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|||L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer|Pilot Study of L-Carnitine Supplementation in the Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Metastatic Breast Cancer|Completed||N/A|2|Actual|HealthPartners Institute||2|||f||||f||||||||||2017-02-18 13:55:29.708942|2017-02-18 13:55:29.708942
NCT00754754|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2011-07-26|||September 2008||2008-09-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Brain Retraction Monitoring Sensor Study|Brain Retraction Monitoring Sensor|Completed||N/A|40|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 13:55:29.818971|2017-02-18 13:55:29.818971
NCT00754741|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-04-21|2015-03-23||July 2008||2008-07-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|April 2010|Actual|2010-04-01||Interventional|MIDAS||Multi-arm Intervention Diabetes Adherence Study|Phase III Clinical Trial of the Effectiveness of Adherence Data and Motivational Interviewing to Improve Medication Adherence and Both Glycated Hemoglobin and Cholesterol Control|Completed||Phase 3|1692|Actual|Henry Ford Health System||3|||f||||t||||||||||2017-02-18 13:55:29.91423|2017-02-18 13:55:29.91423
NCT00754715|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2008-12-12|||September 2008||2008-09-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers|A Phase I, Single-Centre, Randomised, Double-Blind, Placebo-Controlled Parallel-Group Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2516 in Young and Elderly Healthy Volunteers After Oral Single Ascending Doses|Completed||Phase 1|72|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:55:31.637656|2017-02-18 13:55:31.637656
NCT00754702|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-09-25|||October 2008||2008-10-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer|Vinorelbine Metronomic Plus Lapatinib as Salvage Therapy for Patients With Overexpressing HER-2 Metastatic Breast Cancer. A Multicenter Phase II Study|Terminated||Phase 2|16|Actual|University Hospital of Crete||1||Poor accrual|f||||f||||||||||2017-02-18 13:55:31.728736|2017-02-18 13:55:31.728736
NCT00754689|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-05-13|||September 2008||2008-09-01|May 2016|2016-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes|A Multicenter, Double Blind, Placebo Controlled Randomized Study of the Efficacy and Safety of Two Rimonabant/Metformin Combinations for Reducing A1C in the Treatment of Patients With Type 2 Diabetes Mellitus Who Are Not on Current Drug Therapy.|Withdrawn||Phase 3|0|Actual|Sanofi||5||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 13:55:31.841656|2017-02-18 13:55:31.841656
NCT00754676|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2011-12-05|||October 2004||2004-10-01|December 2011|2011-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Endoscopic Stenting for Chronic Abdominal Pain|Randomized Single Blind Trial of Endoscopic Stenting for Chronic Pancreatitis-Associated Abdominal Pain|Completed||N/A|2|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 13:55:31.955624|2017-02-18 13:55:31.955624
NCT00754663|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2008-09-17|||May 2008||2008-05-01|September 2008|2008-09-01|November 2009|Anticipated|2009-11-01|September 2009|Anticipated|2009-09-01||Interventional|BETA||Exercise Training in Patients With Cardioverter-Defibrillators|BETA: Beneficial Effects of Exercise Training in Patients With Implantable Cardioverter-Defibrillators|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-02-18 13:55:32.03419|2017-02-18 13:55:32.03419
NCT00754650|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2014-05-27|2014-05-27||September 2008||2008-09-01|May 2014|2014-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||Intent-to-treat population: All participants who received at least 1 administration of the study drug.|A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic Leukemia|ML21206 - Bevacizumab in Chronic Lymphocytic Leukemia: A Proof of Concept Study|Completed||Phase 2|2|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:55:32.141656|2017-02-18 13:55:32.141656
NCT00754637|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-01-25|||December 2009||2009-12-01|January 2012|2012-01-01|June 2023|Anticipated|2023-06-01|December 2022|Anticipated|2022-12-01||Observational|MTT||Microplasty Tibial Tray Data Collection|Microplasty Tibial Tray Multi-Center Data Collection|Withdrawn||N/A|0|Actual|Zimmer Biomet|||1|The study was withdrawn because it no longer fit the business need.|f||||f||||||||||2017-02-18 13:55:32.356655|2017-02-18 13:55:32.356655
NCT00754624|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2014-10-09|2014-07-22||May 2004||2004-05-01|October 2014|2014-10-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial|"A Four-year, Safety and Tolerability, Open-Label, Follow on Trial Evaluating Technosphere® Insulin in Subjects With Type 2 Diabetes Mellitus."|Completed||Phase 2|229|Actual|Mannkind Corporation||1|||f||||||||||||||2017-02-18 13:55:32.658336|2017-02-18 13:55:32.658336
NCT00754611|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2010-02-03|||December 2008||2008-12-01|February 2010|2010-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||The Evolution and Management of Migraine Recurrence Beyond 24 Hours|The Evolution and Management of Migraine Recurrence Beyond 24 Hours: A Prospective Study of Tertiary Care Center Patients|Unknown status|Active, not recruiting|N/A|100|Anticipated|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-02-18 13:55:33.111019|2017-02-18 13:55:33.111019
NCT00754598|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-17|||July 2006||2006-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:55:33.195686|2017-02-18 13:55:33.195686
NCT00754585|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2010-11-16|||August 2008||2008-08-01|November 2010|2010-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||The Effectiveness of the Logic Back™Support.|The Effectiveness of the Logic Back™Support in Promoting a Comfortable Neutral Low Back Position, Reduced Muscular Effort, Improved Performance, and Decreased Postural Shifts in Seating.|Completed||Early Phase 1|24|Anticipated|Canadian Memorial Chiropractic College|||1||f||||f||||||||||2017-02-18 13:55:33.244598|2017-02-18 13:55:33.244598
NCT00754572|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-05-13|2014-06-23||February 2009||2009-02-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Intention to treat (ITT) population: All participants who received at least one dose of study drug and who had at least one effectiveness measurement performed after baseline.|A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis|A Single-arm, Open-label Study of the Safety and Reduction of Signs and Symptoms During Treatment With Tocilizumab in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis|Completed||Phase 3|418|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:55:33.363707|2017-02-18 13:55:33.363707
NCT00754559|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2016-01-14|2014-04-07||August 2008||2008-08-01|January 2016|2016-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||All treated participants were included in the safety population as well as the intent to-treat (ITT) population.|A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis.|"Effectiveness After Four and Twentyfour Weeks and Safety of Tocilizumab in Patients With Active RA"|Completed||Phase 3|286|Actual|Hoffmann-La Roche|Nonserious adverse events presented in this record include all adverse events reported during the study, not just nonserious events.|1|||f||||||||||||||2017-02-18 13:55:33.965351|2017-02-18 13:55:33.965351
NCT00748930|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-02-12|||September 2006||2006-09-01|February 2015|2015-02-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Observational|||The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)|The Canadian ATTRACT Follow-up Program|Terminated||N/A|13|Actual|Merck Sharp & Dohme Corp.|||1|Challenging data collection|f||||f||||||||||2017-02-18 13:57:27.089605|2017-02-18 13:57:27.089605
NCT00754546|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2013-05-28|2009-08-03||August 2008||2008-08-01|May 2013|2013-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|ARFEET||Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPD|Effects of Arformoterol on Exercise Endurance Time and Breathlessness in COPD: Cycle Ergometer vs. Treadmill|Completed||Phase 4|20|Actual|Dartmouth-Hitchcock Medical Center|Study completed with no reported adverse effects. One limitation of the study is frequent exercise tests involving 7 visits for each participant|2|||f||||t||||||||||2017-02-18 13:55:35.037504|2017-02-18 13:55:35.037504
NCT00754533|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2011-09-07|||September 2008||2008-09-01|October 2008|2008-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|FRAXIO||Continuous Versus Interval Training in Patients With Coronary Artery Disease: FRAXIO Study|Influence of Different Exercise Training Programs in Patients With Coronary Artery Disease on Cardiac and Respiratory Parameters|Completed||N/A|64|Anticipated|University Hospital, Limoges||2|||f||||f||||||||||2017-02-18 13:55:35.384593|2017-02-18 13:55:35.384593
NCT00752804|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2015-06-02|||September 2008||2008-09-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Uremic Toxins in the ICU: Patients After Cardiac Surgery|Study of the Kinetics of Uremic Toxins in the ICU Patients With Acute Renal Failure, in Order to Optimize the Dialysis Dose: Patients After Cardiac Surgery|Recruiting||N/A|12|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 13:55:35.485226|2017-02-18 13:55:35.485226
NCT00752791|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-08-13|2012-04-16||October 2008||2008-10-01|August 2012|2012-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.|A Phase 2 Study of the Safety and Efficacy of Hematide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Subjects Previously Treated With Epoetin|Completed||Phase 2|59|Actual|Takeda||1|||f||||f||||||||||2017-02-18 13:55:35.595874|2017-02-18 13:55:35.595874
NCT00752778|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-11-09|||December 2008||2008-12-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri|MRI Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri|Terminated||Phase 4|8|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-02-18 13:55:36.012727|2017-02-18 13:55:36.012727
NCT00752765|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-06-02|||September 2008||2008-09-01|May 2012|2012-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||The Effects of Bariatric Surgery Weight Loss on Knee Pain in Patients With Osteoarthritis of the Knee|The Effects of Bariatric Surgery Weight Loss on Knee Pain in Patients With Osteoarthritis of the Knee|Completed||N/A|30|Anticipated|Penn State University|||1||f||||t||||||||||2017-02-18 13:55:36.11049|2017-02-18 13:55:36.11049
NCT00752752|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2012-04-02|||September 2008||2008-09-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|MARATHON-MRI||The Acute Cardiovascular Effects of Marathon Running Using Magnetic Resonance Imaging|The Acute Cardiovascular Effects of Marathon Running Using Magnetic Resonance Imaging|Completed||N/A|25|Actual|William Beaumont Hospitals|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:55:36.207101|2017-02-18 13:55:36.207101
NCT00752739|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2012-08-13|||August 2002||2002-08-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Selenium in Treating Patients With Prostate Cancer|Phase II Chemoprevention Trial of Selenium and Prostate Cancer (Watchful Waiting With Selenium Trial)|Completed||Phase 2|220|Anticipated|University of Arizona||3|||f||||||||||||||2017-02-18 13:55:36.301498|2017-02-18 13:55:36.301498
NCT00754520|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2016-04-07|||May 2009||2009-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:55:36.416696|2017-02-18 13:55:36.416696
NCT00754507|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-04-02|||November 2002||2002-11-01|April 2015|2015-04-01|April 2005|Actual|2005-04-01|June 2003|Actual|2003-06-01||Interventional|||A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.|Efficacy of WelChol as an Add-on to Atorvastatin Therapy|Completed||Phase 4|65|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:55:36.471638|2017-02-18 13:55:36.471638
NCT00754494|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2014-12-22|2014-04-23||July 2008||2008-07-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|October 2012|Actual|2012-10-01||Interventional|||Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma|A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting EGF Receptor Signaling in Aberrant Crypt Foci of the Colon|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 13:55:36.582967|2017-02-18 13:55:36.582967
NCT00754481|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2015-07-29|||January 2005||2005-01-01|July 2015|2015-07-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||Hypothermia for Cardiac Arrest in Paediatrics|Hypothermia for Cardiac Arrest in Paediatrics (HypCAP) - Pilot Study|Completed||Phase 2|38|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 13:55:37.547202|2017-02-18 13:55:37.547202
NCT00754468|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-10-06|2014-06-09||February 2009||2009-02-01|October 2015|2015-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|ESODOI||Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.|A STUDY OF CRYOSPRAY ABLATIONTM USING SURGICAL RESECTION SPECIMENS TO DETERMINE TREATMENT EFFECT, DEPTH OF INJURY, AND SIDE EFFECTS IN THE ESOPHAGUS (CSA Depth 3)|Completed||Phase 4|7|Actual|CSA Medical, Inc.|single center, small number of subjects|2|||f||||t||||||||||2017-02-18 13:55:37.659859|2017-02-18 13:55:37.659859
NCT00754455|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2013-07-16||2013-07-16|September 2008||2008-09-01|July 2013|2013-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Evaluate the Safety and Immunogenicity of a Seasonal Influenza VLP Vaccine (Recombinant) in Healthy Adults|A Phase 2a Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) in Healthy Adults|Completed||Phase 2|317|Actual|Novavax||4|||f||||t||||||||||2017-02-18 13:55:38.238833|2017-02-18 13:55:38.238833
NCT00754442|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2014-05-13|2013-01-17||February 2007||2007-02-01|February 2014|2014-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|1hydroxylase||Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism|Clinical and Molecular Characterization of Suspected Partial 25-hydroxyvitamin D-1-alpha-hydroxylase Deficiency|Completed||N/A|20|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 13:55:38.361221|2017-02-18 13:55:38.361221
NCT00748865|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-01-31|2009-09-25||July 2008||2008-07-01|January 2012|2012-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Acute Comfort and Blur of Systane Ultra and Systane||Completed||N/A|20|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:57:29.567628|2017-02-18 13:57:29.567628
NCT00754429|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2013-10-22|||June 2004||2004-06-01|October 2013|2013-10-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)|The Effect of Losartan Versus Amlodipine-based Antihypertensive Therapy on Atherosclerotic Inflammatory Markers and Cerebrovascular Regulation in Ischemic Stroke Patients|Completed||Phase 4|40|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||||||||||||2017-02-18 13:55:38.758504|2017-02-18 13:55:38.758504
NCT00754416|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-06-04|||March 2003||2003-03-01|May 2015|2015-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||S.E.S Shoulder Arthroplasty Data Collection|A Prospective, Multicentre Study Evaluating the Clinical Performance of the S.E.S Shoulder Prosthesis|Terminated||N/A|100|Actual|Zimmer Biomet|||1|Product no more sold|f||||f||||||||||2017-02-18 13:55:39.017945|2017-02-18 13:55:39.017945
NCT00754403|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2010-07-01|||July 2005||2005-07-01|July 2010|2010-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effects on Glycemic Control With Concomitantly Administered Pioglitazone HCl and Metformin HCl Extended Release (Fortamet®) in Subjects With Type 2 Diabetes|Completed||Phase 4|312|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:55:39.129481|2017-02-18 13:55:39.129481
NCT00754390|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2011-05-31|2008-12-17||November 2005||2005-11-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effects of Calcium and Phytate on Zinc Absorption|Effects of Calcium and Phytate on Zinc Absorption|Completed||N/A|17|Actual|USDA Grand Forks Human Nutrition Research Center||1|||f||||f||||||||||2017-02-18 13:55:39.255515|2017-02-18 13:55:39.255515
NCT00754377|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-04-27|2014-08-29||January 2008||2008-01-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|July 2008|Actual|2008-07-01||Observational||No descriptive information was collected from subjects.|Developing a Practice-Based Learning and Improvement Quality Improvement (QI) Systems Impact Assessment Questionnaire|Developing a PBLI QI Systems Impact Assessment Questionnaire|Completed||N/A|92|Actual|VA Office of Research and Development|While necessary limitations for initial assessment tool development, concerns will be addressed in the multi-site trial of the curriculum, including assessment of the training manual and codebooks that were developed during this project.||2||f||||f||||||||||2017-02-18 13:55:39.55394|2017-02-18 13:55:39.55394
NCT00754364|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2014-01-28|||October 2008||2008-10-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|May 2014|Anticipated|2014-05-01||Interventional|||Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients|A Randomized Phase II Study of Progression Free Survival Comparing Gemcitabine (1000 mg/m2 Infusion) Versus Carboplatin (AUC5 Infusion) Plus Alimta (500 mg/m2 Infusion) as First-line Chemotherapy in Elderly Patients With Locally Advanced (Stage IIIb) or Metastatic (Stage IV) Non Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|108|Anticipated|Istituto Clinico Humanitas||2||low enrollment rate|f||||f||||||||||2017-02-18 13:55:39.860922|2017-02-18 13:55:39.860922
NCT00754351|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2012-06-26|||September 2008||2008-09-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer|Docetaxel, Gemcitabine and Bevacizumab as Salvage Therapy for Metastatic Breast Cancer|Completed||Phase 2|48|Actual|University Hospital of Crete||1|||f||||f||||||||||2017-02-18 13:55:39.961947|2017-02-18 13:55:39.961947
NCT00754338|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-17|2010-09-28|2010-03-26||January 2008||2008-01-01|September 2010|2010-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens|Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens|Completed||N/A|76|Actual|University of Waterloo||4|||f||||f||||||||||2017-02-18 13:55:40.085028|2017-02-18 13:55:40.085028
NCT00754325|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-05-25|2016-05-16||September 2008||2008-09-01|May 2016|2016-05-01|January 2014|Actual|2014-01-01|November 2011|Actual|2011-11-01||Interventional||Intent To Treat (ITT) Population; all randomized participants|Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor|Phase II Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor|Completed||Phase 2|100|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:55:40.825718|2017-02-18 13:55:40.825718
NCT00754312|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2010-02-02|||June 2008||2008-06-01|February 2010|2010-02-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer|A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer|Withdrawn||Phase 1|30|Anticipated|Syndax Pharmaceuticals||3||This study has been transfered from a sponsored trial to an investigator initiated trial.|f||||f||||||||||2017-02-18 13:55:41.493509|2017-02-18 13:55:41.493509
NCT00754299|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2011-08-05|||October 2010||2010-10-01|September 2008|2008-09-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Observational|nicotine||Smoking Cessation in Nonunion, Malunion, Osseous Infection|Outcome of a Prospective Protocol for Smoking Cessation in Nonunion, Malunion, Osseous Infection, and Infected Nonunion Patients|Withdrawn||N/A|60|Anticipated|Penn State University|||1|Study could not get funding; research never initiated.|f||||f||||||||||2017-02-18 13:55:41.595701|2017-02-18 13:55:41.595701
NCT00754286|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2010-03-04|||July 2008||2008-07-01|March 2010|2010-03-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer|A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer|Unknown status|Recruiting|N/A|132|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-02-18 13:55:41.685501|2017-02-18 13:55:41.685501
NCT00754273|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2011-03-22|||September 2008||2008-09-01|March 2011|2011-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|MRSA||An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS|Prospective Evaluation Of Protected Alveolar Lavage (PAL) Staphylococcus Aurues Resistance Patterns|Completed||N/A|1250|Anticipated|University of Kentucky|||1||f||||f||||||||||2017-02-18 13:55:41.905177|2017-02-18 13:55:41.905177
NCT00754260|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-12-10|||March 2008||2008-03-01|December 2015|2015-12-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Caffeine Reduction and Overactive Bladder Symptoms|Caffeine Reduction Education And Overactive Bladder Symptoms|Active, not recruiting||N/A|110|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-02-18 13:55:42.00171|2017-02-18 13:55:42.00171
NCT00754247|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2010-10-18|||March 2006||2006-03-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars|A Prospective, Randomized, Investigator-blinded, Placebo-controlled, Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars|Completed||Phase 4|30|Actual|University of Miami||3|||f||||f||||||||||2017-02-18 13:55:42.104094|2017-02-18 13:55:42.104094
NCT00754234|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2011-06-01|2008-12-30||September 2007||2007-09-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Iron Bioavailability From MyPyramid Menus|Iron Bioavailability From MyPyramid Menus|Completed||N/A|16|Actual|USDA Grand Forks Human Nutrition Research Center||1|||f||||f||||||||||2017-02-18 13:55:42.226399|2017-02-18 13:55:42.226399
NCT00754221|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2011-05-31|||May 2008||2008-05-01|May 2011|2011-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia|A Multi-center, Long-term, Open-label Extension Study of [S,S]-Reboxetine (PNU-165442G) Administered Once Daily in Patients With Fibromyalgia|Terminated||Phase 3|390|Actual|Pfizer||1||"This study has been terminated early as the esreboxetine development program is being~   discontinued. There are no safety or efficacy concerns."|f||||t||||||||||2017-02-18 13:55:42.420314|2017-02-18 13:55:42.420314
NCT00754208|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2009-05-28|||October 2008||2008-10-01|May 2009|2009-05-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children|Long Acting Stimulant Treatment of ADHD in Young Children|Unknown status|Recruiting|Phase 4|15|Anticipated|University of Nebraska||1|||f||||f||||||||||2017-02-18 13:55:42.624427|2017-02-18 13:55:42.624427
NCT00754195|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2015-02-19|||September 2008||2008-09-01|February 2015|2015-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Insertion Distance of Thoracic Epidural Catheters in the Context of Thoracotomy Procedures.|Influence of Catheter Insertion Distance on the Quality of Thoracic Epidural Analgesia in the Context of Thoracotomy Procedures.|Completed||N/A|120|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||3|||f||||f||||||||||2017-02-18 13:55:42.727968|2017-02-18 13:55:42.727968
NCT00754182|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2010-05-03|||September 2008||2008-09-01|March 2009|2009-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|SCSvsSG||Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision|Comparison of Esthetic Results Between Subcuticular Suture and Synthetic Glue in Thyroidectomy Incision: a RCT|Completed||N/A|100|Actual|Azienda Ospedaliera - Universitaria di Modena||2|||f||||f||||||||||2017-02-18 13:55:42.848815|2017-02-18 13:55:42.848815
NCT00754169|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2017-01-24|||September 5, 2008||2008-09-05|January 9, 2013|2013-01-09|January 9, 2013||2013-01-09|||||Observational|||Warfighter Head Injury Study|Warfighter Head Injury Study a Comprehensive, Multidisciplinary Research Evaluation|Terminated||N/A|314|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:55:42.950646|2017-02-18 13:55:42.950646
NCT00754156|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2014-02-15|2013-07-15||September 2008||2008-09-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ABRA||ABRA Abdominal Closure System in Open Abdomen Management|A Prospective, Controlled Evaluation of ABRA Abdominal Wall Closure System in Combination With V.A.C. Therapy Compared to V.A.C. Alone in the Management of Open Abdomen|Completed||Phase 4|14|Actual|University of Kentucky|"Limited by small sample size, and lack of closely matched patient groups.~Limited by product change from the original VAC to the ABThera system mid study.~Limited by a significant learning curve in application and use of the ABRA device."|2|||f||||f||||||||||2017-02-18 13:55:43.050382|2017-02-18 13:55:43.050382
NCT00754143|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2011-01-10|||March 2008||2008-03-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy|A Randomized, Double-blind, Placebo-Controlled, Phase 1 Study of Safety, Pharmacokinetics and Pharmacodynamics of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy on Background ACEi and/or ARB Therapy|Completed||Phase 1|36|Anticipated|FibroGen||3|||f||||t||||||||||2017-02-18 13:55:46.245387|2017-02-18 13:55:46.245387
NCT00754130|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-02-23|2012-08-31||September 2008||2008-09-01|February 2015|2015-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).|A Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-0941 in Japanese Patients With Type 2 Diabetes|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 13:55:46.367578|2017-02-18 13:55:46.367578
NCT00754117|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2017-02-07|||May 2008|Actual|2008-05-01|February 2017|2017-02-01|December 8, 2012|Actual|2012-12-08|December 2010|Actual|2010-12-01||Observational|||Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)|Early Response Assessment in Patients With Diffuse Large B-cell Lymphoma Using 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)|Completed||N/A|8|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 13:55:47.14442|2017-02-18 13:55:47.14442
NCT00754104|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2011-01-17|||September 2008||2008-09-01|January 2009|2009-01-01||||December 2008|Actual|2008-12-01||Interventional|||Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors|A Phase 1, Open Label Study of ABT-869 in Combination With Tarceva in Subjects With Advanced Non-hematologic Malignancy|Withdrawn||Phase 1|0|Actual|Abbott||1|||f||||||||||||||2017-02-18 13:55:47.300815|2017-02-18 13:55:47.300815
NCT00754091|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2015-04-14|||June 2008||2008-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:55:47.539841|2017-02-18 13:55:47.539841
NCT00754078|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2016-07-04|||September 2008||2008-09-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy|A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy|Active, not recruiting||Phase 2|58|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 13:55:47.584914|2017-02-18 13:55:47.584914
NCT00730093|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2009-08-05|||August 2008||2008-08-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||The Absorption of Vitamin B12 Among Healthy Pregnant Women|The Absorption of Vitamin B12 Among Healthy Pregnant Women|Completed||N/A|27|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 14:03:51.161248|2017-02-18 14:03:51.161248
NCT00754065|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2013-07-15|2012-05-10||September 2008||2008-09-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)|A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group, 2-arm Study to Show Superiority of the Oral Contraceptive SH T00658ID Over Ortho Tri-Cyclen Lo on Hormone Withdrawal-associated Symptoms After 6 Cycles of Treatment.|Completed||Phase 3|409|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:55:47.724023|2017-02-18 13:55:47.724023
NCT00754052|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2008-12-10|||September 2008||2008-09-01|December 2008|2008-12-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17|A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17|Terminated||Phase 3|192|Anticipated|Eisai Inc.||3||Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns.|f||||||||||||||2017-02-18 13:55:50.693701|2017-02-18 13:55:50.693701
NCT00754039|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2015-04-02|||February 2003||2003-02-01|April 2015|2015-04-01|March 2004|Actual|2004-03-01|September 2003|Actual|2003-09-01||Interventional|||Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol|The Effects of the Combination of Welchol and Tricor Compared to TriCor Alone in Patients With Mixed Hyperlipidemia|Completed||Phase 4|129|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:55:50.808912|2017-02-18 13:55:50.808912
NCT00754026|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2010-05-27|||September 2008||2008-09-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Insertion Distance of Interscalene Perineural Catheters in the Context of Shoulder Surgery.|Influence of the Insertion Distance on Loss of Sensation Produced by Interscalene Perineural Catheters in the Context of Shoulder Surgery.|Completed||N/A|60|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-02-18 13:55:50.919069|2017-02-18 13:55:50.919069
NCT00754013|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2013-01-11|2011-07-21||September 2008||2008-09-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10|A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10|Terminated||Phase 3|9|Actual|Eisai Inc.|Due to the study terminating early,only 9 subjects were enrolled and these subjects receive only limited exposure to study medications with no subject reaching his/her maximum targeted dose. Therefore,the planned efficacy criteria were not analyzed.|2||Sufficient evidence of efficacy not met.|f||||t||||||||||2017-02-18 13:55:51.015978|2017-02-18 13:55:51.015978
NCT00754000|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2012-04-27|||July 2008||2008-07-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|||||Observational|AIM||The AIM Study: Assessing the Impact of Margin Reduction|The AIM Study: Assessing the Impact of Margin Reduction|Completed||N/A|82|Actual|Varian Medical|||1||f||||f||||||||||2017-02-18 13:55:51.553186|2017-02-18 13:55:51.553186
NCT00753987|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2013-08-30|||March 2006||2006-03-01|August 2013|2013-08-01|January 2007|Actual|2007-01-01|July 2006|Actual|2006-07-01||Interventional|||Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis|Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis|Completed||Phase 1|13|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-02-18 13:55:51.661882|2017-02-18 13:55:51.661882
NCT00753974|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2012-11-15|||June 2008||2008-06-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Studying Cardiac Tissue in Patients With Heart Failure|Biologic Commonalities Associated With Degeneration in Function of Cardiac, Skeletal and Respiratory Muscles in Patients With Heart Failure.|Unknown status|Enrolling by invitation|N/A|150|Anticipated|University of Kentucky||1|||f||||f||||||||||2017-02-18 13:55:51.764483|2017-02-18 13:55:51.764483
NCT00753961|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2017-01-25|||September 2008||2008-09-01|January 2017|2017-01-01|April 2010|Actual|2010-04-01|March 2009|Actual|2009-03-01||Interventional|||Effect Of The Consumption Of Fermented Dairy Drink On Common Infections In Shift-Workers|EFFECT OF THE CONSUMPTION OF FERMENTED DAIRY DRINK ON COMMON INFECTIONS IN SHIFT-WORKERS|Completed||N/A|1340|Actual|Danone Research||2|||f||||t||||||||||2017-02-18 13:55:51.86226|2017-02-18 13:55:51.86226
NCT00753948|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2014-07-02|2013-09-27||December 2006||2006-12-01|May 2014|2014-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Exhaled Levels of Nitric Oxide|The Effect of Nitric Oxide on Pulmonary Resistances and Blood Pressure in Persons With Tetraplegia|Completed||Phase 2/Phase 3|23|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 13:55:51.954999|2017-02-18 13:55:51.954999
NCT00753935|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2010-10-12|||June 2006||2006-06-01|October 2010|2010-10-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|||Aspirin Resistance in Coronary Artery Disease|Evaluation of Aspirin Resistance at a Molecular Level in Aspirin-Treated Patients With Coronary Artery Disease|Unknown status|Active, not recruiting|N/A|160|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 13:55:52.417617|2017-02-18 13:55:52.417617
NCT00753922|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2014-03-21|2013-06-12||September 2000||2000-09-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||All enrolled subjects are included|Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses|Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses in Patients Who Are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction or Revision|Completed||Phase 3|1008|Actual|Mentor Worldwide, LLC|Adverse events were not coded according to the MedDRA dictionary, rather they were collected as Complications in alignment with the 2006 FDA Guidance for Industry and FDA Staff – Saline, Silicone Gel, and Alternative Breast Implants.|4|||t||||f||||||||||2017-02-18 13:55:52.547534|2017-02-18 13:55:52.547534
NCT00753909|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2016-10-03|||November 2008||2008-11-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer|Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer|Completed||Phase 2|50|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 13:55:53.268419|2017-02-18 13:55:53.268419
NCT00753610|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2008-09-15|||January 2007||2007-01-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|EPC||Endothelial Progenitor Cells in Cervical Cancer Patients Receiving Chemoradiation|Effect of Concurrent Chemoradiation on Circulating Endothelial Progenitor Cells in Cervical Cancer|Unknown status|Recruiting|N/A|30|Anticipated|Mackay Memorial Hospital|||1||f||||t||||||||||2017-02-18 13:56:01.542004|2017-02-18 13:56:01.542004
NCT00753896|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2015-04-20|2012-02-14||October 2008||2008-10-01|March 2015|2015-03-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin|Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin|Completed||Phase 3|134|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:55:53.398958|2017-02-18 13:55:53.398958
NCT00753883|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2008-09-16|||July 2006||2006-07-01|September 2008|2008-09-01||||May 2008|Actual|2008-05-01||Interventional|||Ezetrol Post-Marketing Study|A Randomized, Open-Labeled, Parallel Group Comparison Study to Evaluate the Efficacy, Safety of Ezetimibe Alone Versus Statin in the Treatment of Hypercholesterolemia|Completed||Phase 4|40|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 13:55:53.794499|2017-02-18 13:55:53.794499
NCT00753870|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2011-04-14|||August 2008||2008-08-01|April 2011|2011-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers|Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers|Terminated||Phase 1|2|Actual|University of North Carolina, Chapel Hill||1||Lack of funding|f||||f||||||||||2017-02-18 13:55:53.887215|2017-02-18 13:55:53.887215
NCT00753857|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2008-09-16|||October 2006||2006-10-01|September 2008|2008-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Drug Facts Box: Helping Consumers Understand Drugs for Risk Reduction|The Drug Facts Box: Helping Consumers Understand Drugs for Risk Reduction|Completed||Phase 3|260|Actual|White River Junction VAMC||2|||f||||f||||||||||2017-02-18 13:55:53.992255|2017-02-18 13:55:53.992255
NCT00753844|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2012-04-04|||November 2006||2006-11-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer|Tumor Vaccine Therapy Against Advanced Esophageal Cancer Using HLA-A*2402 Restricted Epitope Peptides Drived From URLC10|Completed||Phase 1|7|Actual|Kinki University||1|||f||||||||||||||2017-02-18 13:55:54.086275|2017-02-18 13:55:54.086275
NCT00753831|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2012-07-11|||January 2009||2009-01-01|July 2012|2012-07-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy of Aurosling in Frontalis Sling Suspension Surgery|Randomized, Double Blind, Active Controlled Study of the Efficacy, Surgical Outcome and Complications of Silicone Rod Sling in Frontalis Sling Suspension Surgery|Completed||Phase 4|16|Actual|Aurolab||1|||f||||t||||||||||2017-02-18 13:55:54.173207|2017-02-18 13:55:54.173207
NCT00752726|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2013-02-28|2010-07-21||September 2008||2008-09-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Orlistat in Body Composition|The Effects of Weight Reduction With Orlistat vs. Placebo on Changes in Body Composition|Completed||Phase 4|131|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 13:55:54.277809|2017-02-18 13:55:54.277809
NCT00752713|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2008-09-15|||January 2007||2007-01-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|137-2005||Strain-Encoded Magnetic Resonance Imaging in Acute Myocardial Infarction|Strain-Encoded Magnetic Resonance Imaging for Evaluation of Left Ventricular Function and Acute Myocardial Infarction|Completed||N/A|48|Actual|RWTH Aachen University|||2||f||||f||||||||||2017-02-18 13:55:54.90908|2017-02-18 13:55:54.90908
NCT00752700|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2014-12-04|||January 2009||2009-01-01|December 2014|2014-12-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|REINFORCE||Resistance Exercise Training For Radically Treated Respiratory Cancer|Resistance Training in Radically Treated Respiratory Cancer Patients: a Prospective Randomized Multicenter Study|Completed||N/A|113|Actual|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 13:55:55.214917|2017-02-18 13:55:55.214917
NCT00752687|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2010-10-19|||September 2008||2008-09-01|September 2010|2010-09-01||||May 2009|Actual|2009-05-01||Interventional|||A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults||Completed||Phase 1|100|Actual|Abbott||2|||f||||||||||||||2017-02-18 13:55:55.324465|2017-02-18 13:55:55.324465
NCT00752674|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2008-09-11|||August 2006||2006-08-01|September 2008|2008-09-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||Neuromuscular Balance in Low Back Pain|The Effectiveness of Neuromuscular Balance in Low Back Pain|Completed||Phase 4|12|Actual|Fortaleza University||1|||f||||t||||||||||2017-02-18 13:55:55.422666|2017-02-18 13:55:55.422666
NCT00752661|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-05-16|||June 2007||2007-06-01|August 2010|2010-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||An Exploratory Study of Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back Pain|An Exploratory Study of an Active Ingredient of JNS013-tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back Pain|Completed||Phase 2|119|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 13:55:55.51257|2017-02-18 13:55:55.51257
NCT00752648|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2010-04-26|||July 2008||2008-07-01|April 2010|2010-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend Capsule|A Phase I, Open-label, 3-way Crossover Trial in Healthy Subjects to Compare the Bioavailability of a Single Oral Dose of TMC435350 Formulated as 2 Different Solid Formulations to That of a Single Oral Dose of TMC435350 Formulated as a Powder Blend Capsule.|Completed||Phase 1|24|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:55:55.598697|2017-02-18 13:55:55.598697
NCT00752635|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-05-18|||September 2004||2004-09-01|April 2010|2010-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris|Comparison of Efficacy and Safety of Tricilest (Norgestimate-ethinyl Estradiol) and Diane-35 (Cyproterone Acetate-ethinyl Estradiol) in the Treatment of Acne Vulgaris|Completed||Phase 4|48|Actual|Johnson & Johnson Taiwan Ltd|||||f||||||||||||||2017-02-18 13:55:55.686105|2017-02-18 13:55:55.686105
NCT00753818|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2008-09-16||||||September 2008|2008-09-01||||||||Interventional|||Developmental Effects of Infant Formula Supplemented With LCPUFA||Completed||N/A|||Mead Johnson Nutrition||4|||f||||||||||||||2017-02-18 13:55:55.783167|2017-02-18 13:55:55.783167
NCT00753805|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2008-09-15|||August 2004||2004-08-01|June 2008|2008-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Dietetic Effects of Mare's Milk in Patients With Atopic Dermatitis|Dietetic Effects of Oral Intervention With Mare's Milk on the SCORAD, Faecal Microbiota and Immunological Parameters in Patients With Atopic Dermatitis|Completed||N/A|23|Actual|University of Jena||1|||f||||t||||||||||2017-02-18 13:55:55.868853|2017-02-18 13:55:55.868853
NCT00753792|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2011-06-01|||November 2008||2008-11-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Interventional|||Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse|Multicenter, Randomized, Double Blind, Clinical Trial to Compare the Clinical and Radiological Efficacy of Equivalent Doses of Methylprednisolone Administered Orally or Intravenously in Patients With Multiple Sclerosis During Relapse|Completed||Phase 4|49|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 13:55:55.962255|2017-02-18 13:55:55.962255
NCT00753779|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-16|2015-04-02|||November 2002||2002-11-01|April 2015|2015-04-01|April 2005|Actual|2005-04-01|June 2003|Actual|2003-06-01||Interventional|||A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks.|Efficacy of WelChol® as an Add-on to Simvastatin Therapy|Completed||Phase 4|72|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:55:56.083434|2017-02-18 13:55:56.083434
NCT00753766|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2014-10-20|2014-09-19||October 2005||2005-10-01|October 2014|2014-10-01|September 2008|Actual|2008-09-01|December 2007|Actual|2007-12-01||Interventional|||Multifactorial Pre-operative Intervention in Diabetes Mellitus|Multifactorial Pre-Operative Intervention in Diabetes Mellitus|Completed||N/A|1|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 13:55:56.192309|2017-02-18 13:55:56.192309
NCT00753753|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2015-06-24|||February 2008||2008-02-01|June 2015|2015-06-01|November 2009|Actual|2009-11-01|October 2008|Actual|2008-10-01||Observational|VERIFRENCHY||VerifyNow French Registry|Evaluation of the Occurence of Thrombotic and Bleeding Events After Coronary Angioplasty With Stent According to Aspirin and Clopidogrel Platelet Reactivity Assessed by a Point of Care Assay in the Cathlab (the Verifynow French Registry)|Completed||N/A|1001|Actual|Association Pour le Développement des Soins Cardiologiques de la ville de Chartres|||1||f||||t||||||||||2017-02-18 13:55:56.506615|2017-02-18 13:55:56.506615
NCT00753740|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2014-07-09||2012-02-24|September 2008||2008-09-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.|A Phase II Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of Maintenance IT-101 in Platinum Sensitive Ovarian Cancer Patients Who Received 4-6 Cycles of a 2nd Line Platinum-Based Regimen Without Disease Progression.|Terminated||Phase 2|1|Actual|Cerulean Pharma Inc.||3||Poor trial recruitment|f||||t||||||||||2017-02-18 13:55:56.595195|2017-02-18 13:55:56.595195
NCT00753727|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-14|2011-06-21|||September 2008||2008-09-01|December 2010|2010-12-01|March 2016|Anticipated|2016-03-01|March 2012|Anticipated|2012-03-01||Interventional|SUNXRT||Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma|A Phase IB/II Study of Sunitinib in Combination With Neoadjuvant Radiation in Patients With Resectable Soft-tissue Sarcoma|Unknown status|Recruiting|Phase 1/Phase 2|26|Anticipated|Australasian Sarcoma Study Group||1|||f||||t||||||||||2017-02-18 13:55:56.711531|2017-02-18 13:55:56.711531
NCT00753714|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2016-08-30|2012-08-29||October 2008||2008-10-01|August 2016|2016-08-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|ZELIG||Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine|Phase II, Randomised, Double-blind, Two-arm, Parallel Study of Vandetanib (ZACTIMA™ , ZD6474) Plus Gemcitabine (Gemzar® ) or Gemcitabine Plus Placebo as First Line Treatment of Advanced (Stage IIIB or IV) Non Small Cell Lung Cancer (NSCLC) Elderly Patients.|Completed||Phase 2|124|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 13:55:56.815997|2017-02-18 13:55:56.815997
NCT00753688|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2013-08-15|2011-11-17||October 2008||2008-10-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|November 2010|Actual|2010-11-01||Interventional|PALETTE||Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy|A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy|Completed||Phase 3|369|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 13:55:57.367557|2017-02-18 13:55:57.367557
NCT00753675|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2016-08-29|2013-09-27||October 2008||2008-10-01|August 2016|2016-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|VANGOGH|Patient screened 180 Patient Randomized 174 (1 never treated) Sceening failures 6 Patient Treated 173 (ITT=165 ; 8 excluded from ITT due to missing postbaseline assesment)|Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer|A Randomized, Multicentre, Phase II, Parallel-Group Trial of Vandetanib Monotherapy or Vandetanib in Combination With Gemcitabine Versus Gemcitabine Plus Vandetanib Matching Placebo in Subjects With Advanced Biliary Tract Cancer (Gallbladder Cancer, Cancer of the Extrahepatic Bile Duct, Intrahepatic Cholangiocarcinoma and Ampullary Carcinoma)|Completed||Phase 2|174|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 13:55:59.051739|2017-02-18 13:55:59.051739
NCT00753662|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-14|2011-09-12|||November 2008||2008-11-01|September 2011|2011-09-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|TMS in AD||Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease|Phase 2 (Feasibility) Study of Transcranial Magnetic Stimulation as Additional Therapy to Drug Treatment in Patients With Alzheimer's Disease|Unknown status|Recruiting|Phase 2|45|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||t||||||||||2017-02-18 13:56:00.177535|2017-02-18 13:56:00.177535
NCT00753649|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2016-10-06|2016-10-06||September 2008||2008-09-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants|Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Infanrix Hexa Vaccine in Healthy Infants|Completed||Phase 4|224|Actual|GlaxoSmithKline|None reported.|2|||f||||||||||||||2017-02-18 13:56:00.305063|2017-02-18 13:56:00.305063
NCT00753636|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-13|2013-04-29|2011-01-13||April 2008||2008-04-01|April 2013|2013-04-01|February 2010|Actual|2010-02-01|June 2009|Actual|2009-06-01||Interventional|||Parkinson's Disease Isradipine Safety Study|Phase II Safety and Tolerability of Isradipine (A Potential Neuroprotective Agent) in Patients With Parkinson's Disease- Stage II|Completed||Phase 2|31|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 13:56:00.748094|2017-02-18 13:56:00.748094
NCT00753623|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2016-10-26|2013-11-01||September 2008||2008-09-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Clinical Management of Neuropathic Pain With Ramelteon|Clinical Management of Neuropathic Pain With Ramelteon|Terminated||N/A|23|Actual|Massachusetts General Hospital|Problems with recruitment and termination of the study consequently resulted in uninterpretable data.|2||Recruitment did not accrue as expected.|f||||f||||||||||2017-02-18 13:56:01.10435|2017-02-18 13:56:01.10435
NCT00740038|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-09-11|||August 2006||2006-08-01|August 2011|2011-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Support for People Undergoing Chemotherapy|Study of Stress Management and Exercise Intervention During Cancer Chemotherapy|Completed||Phase 2/Phase 3|471|Actual|H. Lee Moffitt Cancer Center and Research Institute||4|||f||||f||||||||||2017-02-18 14:00:08.513842|2017-02-18 14:00:08.513842
NCT00753597|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2013-02-05|||September 2008||2008-09-01|February 2013|2013-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|RADS||Rescue of Steroidogenic Capacity in Adrenocortical Failure Study (RADS)|Immunotherapeutic Rescue of Steroidogenic Function in Autoimmune Adrenocortical Failure: Pilot Study|Completed||Phase 4|6|Actual|Newcastle University||1|||f||||t||||||||||2017-02-18 13:56:01.638265|2017-02-18 13:56:01.638265
NCT00753571|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2009-12-29|||January 2008||2008-01-01|September 2008|2008-09-01|October 2010|Anticipated|2010-10-01|December 2008|Anticipated|2008-12-01||Interventional|||Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response|Cistanche Total Glycosides Treatment for Amyotrophic Lateral Sclerosis: A Randomized Control Trial Study Assessing Clinical Response|Unknown status|Recruiting|Phase 2|40|Anticipated|Peking University||2|||f||||f||||||||||2017-02-18 13:56:01.73644|2017-02-18 13:56:01.73644
NCT00753558|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2010-09-19|||November 2008||2008-11-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae|A Randomized,Double-Blind,Placebo-Controled Trial of Selective Digestive Decontamination Using Oral Gentamicin and Oral Polymyxin E for Eradication of Carbapenem-Resistant Klebsiella Pneumoniae Carriage|Completed||N/A|||Soroka University Medical Center||2|||f||||t||||||||||2017-02-18 13:56:01.84271|2017-02-18 13:56:01.84271
NCT00753545|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2013-02-06|2012-12-07||August 2008||2008-08-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|June 2010|Actual|2010-06-01||Interventional|||Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer|Phase II Randomised, Double Blind, Multicentre Study to Assess the Efficacy of AZD2281 in the Treatment of Patients With Platinum Sensitive Relapsed Serous Ovarian Cancer Following Treatment With Two or More Platinum Containing Regimens|Completed||Phase 2|265|Actual|AstraZeneca|For OM DoR: The subset of patients evaluable for response who responded to study treatment.Values in results table may be under-estimates as some patients had not progressed at final analysis,so true duration is likely to be greater than in database.|2|||f||||f||||||||||2017-02-18 13:56:01.94515|2017-02-18 13:56:01.94515
NCT00753532|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2014-12-05|||November 2007||2007-11-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Neuroprotective and Cardioprotective Effects Of Palm Vitamin E Tocotrienols|A Double Blind Placebo Controlled Study On The Neuroprotective And Anti-Atherogenic Effects Of Palm TocotrienolRich Fraction(Palm Vitamin E)|Completed||Phase 2|241|Actual|University of Science Malaysia||2|||f||||t||||||||||2017-02-18 13:56:05.100892|2017-02-18 13:56:05.100892
NCT00753519|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-13|2012-10-14|2012-08-31||September 2008||2008-09-01|October 2012|2012-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Transcranial Magnetic Stimulation to Treat Parkinson's Disease|Intermittent Theta-Burst Transcranial Magnetic Stimulation (TBS) for the Treatment of Parkinson Disease|Completed||Phase 1/Phase 2|28|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 13:56:05.417119|2017-02-18 13:56:05.417119
NCT00753506|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2012-02-27|2011-08-22||August 2008||2008-08-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Artemisinin to Reduce The Symptoms of Schizophrenia|Double-Blind Trial of Artemisinin to Reduce The Symptoms of Schizophrenia|Completed||N/A|66|Actual|Sheppard Pratt Health System||2|||f||||t||||||||||2017-02-18 13:56:06.119021|2017-02-18 13:56:06.119021
NCT00753493|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2012-07-12|||August 2008||2008-08-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients|Phase I Pharmacokinetic and Safety Study of Intravenous Topiramate in Adult Patients|Completed||Phase 1|20|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 13:56:06.513008|2017-02-18 13:56:06.513008
NCT00753480|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2008-11-06|||September 2008||2008-09-01|November 2008|2008-11-01||||||||Interventional|||A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of D4064A Administered Intravenously to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer After a Platinum-Containing Regimen|Suspended||Phase 1|56|Anticipated|Genentech, Inc.|||||f||||||||||||||2017-02-18 13:56:06.618281|2017-02-18 13:56:06.618281
NCT00753467|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2010-10-20|||September 2008||2008-09-01|September 2008|2008-09-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B|Protocol Title: A Phase II Open-labeled Study to Determine the Safety and Preliminary Efficacy of Interferon-gamma 1b (IFN-γ 1b) in Patients With Chronic Hepatitis B Who Are HBV DNA Positive|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|Huntington Medical Research Institutes||3|||f||||t||||||||||2017-02-18 13:56:06.708669|2017-02-18 13:56:06.708669
NCT00753454|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2014-08-26|2012-05-10||September 2008||2008-09-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|Dose Flex II||Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)|A Phase IIIb, Multi-center Open-label, Follow-up Study to Evaluate the Safety and Efficacy of Certolizumab Pegol Administered Concomitantly With Methotrexate in Patients With Active Rheumatoid Arthritis Who Participated in C87077.|Completed||Phase 3|168|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 13:56:07.074071|2017-02-18 13:56:07.074071
NCT00753441|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2013-05-20|||September 2008||2008-09-01|May 2013|2013-05-01|January 2016|Anticipated|2016-01-01|September 2015|Anticipated|2015-09-01||Interventional|STENTBY||Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head|Endoscopic Biliary Stenting on Demand Versus Surgical Biliary Bypass for Palliation of Patients With Advanced Cancer of the Pancreatic Head: STENTBY - A Randomized Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Heidelberg University||2|||f||||t||||||||||2017-02-18 13:56:07.821455|2017-02-18 13:56:07.821455
NCT00753428|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2014-09-16|||November 2008||2008-11-01|September 2014|2014-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Community-based Evaluation of a Pilot PMTCT Project in Kafue District|CIDRZ 1236 - Community-based Evaluation of a Pilot PMTCT Project in Kafue District: Impact of HAART to Prevent Pediatric AIDS in Rural Zambia.|Completed||N/A|4129|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"~     Finger/Heel pricks will be performed for Dried Blood Spot Cards.~   "|||2017-02-18 13:56:07.932888|2017-02-18 13:56:07.932888
NCT00728767|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2011-04-13|||January 2008||2008-01-01|August 2009|2009-08-01|December 2009|Actual|2009-12-01|November 2008|Actual|2008-11-01||Interventional|||Brief Intervention for Heavy Drinkers|Brief Intervention for Heavy Drinkers - a Randomized Controlled Trial|Completed||Phase 3|772|Actual|University of Southern Denmark||2|||f||||t||||||||||2017-02-18 14:04:21.024364|2017-02-18 14:04:21.024364
NCT00753415|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2015-02-26|2014-03-19||August 2008||2008-08-01|February 2015|2015-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)|A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors|Completed||Phase 1|37|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-02-18 13:56:08.065489|2017-02-18 13:56:08.065489
NCT00753402|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2015-05-26|||February 2012||2012-02-01|May 2015|2015-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|Epi||The Effects of Epinephrine in Endotoxemia in Normal Volunteers|The Effects of Epinephrine in Endotoxemia in Normal Volunteers|Completed||Phase 1|37|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 13:56:09.71483|2017-02-18 13:56:09.71483
NCT00753389|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2008-09-15|||September 2008||2008-09-01|September 2008|2008-09-01|March 2009|Anticipated|2009-03-01|||||Observational|PORC||Muscle Relaxants and Post-Anesthesia Complications|Epidemiologic Study on Short and Long-Term Effects of Anesthesia With Muscle Relaxants (Epidemiologische Untersuchung Kurz- Und längerfristiger Auswirkungen Der Anästhesie Mit Muskelrelaxanzien)|Unknown status|Recruiting|N/A|20000|Anticipated|Technische Universität München|||1||f||||||||||||||2017-02-18 13:56:09.82472|2017-02-18 13:56:09.82472
NCT00753363|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2016-12-08|2014-10-15||April 2007||2007-04-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2012|Actual|2012-11-01||Interventional|IRIS||Exercise and Inflammation in the Elderly|Exercise, Inflammation and Pro-thrombotic Modulators in the Elderly|Active, not recruiting||N/A|119|Actual|VA Office of Research and Development||2|||f||||t||||||||No||2017-02-18 13:56:09.938614|2017-02-18 13:56:09.938614
NCT00753350|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2013-03-01|||September 2008||2008-09-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|SENSATE||METHOD (Minimally Invasive, Endoscopically-delivered, Tolerable by Human Individuals, Non-morbid Obesity Device) Study|An Open-label, Single-center, Feasibility Study Designed to Evaluate the Safety and Tolerability of Sensate™ Anchored Gastric Device in Subjects With Non-morbid Obesity|Completed||Phase 1|15|Actual|Sensate LLC||1|||f||||f||||||||||2017-02-18 13:56:10.482718|2017-02-18 13:56:10.482718
NCT00753337|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2016-03-07|2012-02-10||October 2008||2008-10-01|February 2016|2016-02-01|September 2013|Actual|2013-09-01|February 2011|Actual|2011-02-01||Interventional|ACTIVE||The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study|The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study Using the Medtronic Assurant Cobalt Iliac Balloon-Expandable Stent System|Completed||N/A|123|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-02-18 13:56:10.583651|2017-02-18 13:56:10.583651
NCT00753324|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2016-03-25|||May 2009||2009-05-01|March 2016|2016-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia|Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia (Impact of HAART to Prevent Pediatric AIDS in Rural Zambia).|Completed||Phase 4|284|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 13:56:10.92628|2017-02-18 13:56:10.92628
NCT00753311|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2011-10-07|||July 2009||2009-07-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|November 2010|Actual|2010-11-01||Interventional|||Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.|A Randomized, Double Blind, Controlled Versus Placebo in Parallel Groups, Study to Evaluate the Efficacy of 10 mg Lyophilized Oral Rizatriptan in the Acute Treatment of Migraine in Patients With Unilateral Trigeminal Autonomic Symptoms.|Completed||Phase 4|80|Actual|IRCCS San Raffaele||2|||f||||f||||||||||2017-02-18 13:56:11.023782|2017-02-18 13:56:11.023782
NCT00753298|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2012-09-27|2009-04-06||January 2007||2007-01-01|September 2012|2012-09-01||||March 2008|Actual|2008-03-01||Interventional|||A Randomized, Fully-blinded Parallel Groups Study of Catheter Materials Used for Clean Intermittent Catheterisation|A Multi-centre, Double-blind, Randomized, Parallel Groups Study Comparing PVC and Polyolefin-based Elastomer (POBE) as Catheter Materials, Outcomes Will be Measured by Subject Perception.|Completed||N/A|195|Actual|Wellspect HealthCare||2|||f||||f||||||||||2017-02-18 13:56:11.124957|2017-02-18 13:56:11.124957
NCT00753285|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2014-11-03||2014-09-15|September 2008||2008-09-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Renal Denervation in Patients With Refractory Hypertension|Renal Denervation in Patients With Refractory Hypertension|Completed||N/A|35|Actual|Medtronic Vascular||1|||f||||f||||||||||2017-02-18 13:56:11.665928|2017-02-18 13:56:11.665928
NCT00753272|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2016-09-20|2012-04-26||September 2008||2008-09-01|September 2016|2016-09-01|January 2011|Actual|2011-01-01|June 2010|Actual|2010-06-01||Interventional|||Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older|Observer-blind Superior Efficacy Trial With GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A in Elderly Subjects|Completed||Phase 3|43695|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:56:11.797253|2017-02-18 13:56:11.797253
NCT00753259|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2010-04-19|||June 2006||2006-06-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|AFClinic||Atrial Fibrillation (AF) Clinic to Improve the Treatment of Patients With Atrial Fibrillation.|The Effect of a Nurse-driven ICT-supported Disease Management Program to Improve the Treatment of Patients With Atrial Fibrillation.|Completed||N/A|712|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:56:14.324659|2017-02-18 13:56:14.324659
NCT00753246|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2012-11-30|||August 2007||2007-08-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|||||Interventional|||Nimotuzumab in Adults With Glioblastoma Multiforma|Phase-III Study of Standard Radiotherapy Plus Concomitant and Adjuvant OSAG 101 (Theraloc®) Plus Temozolomide vs. Standard Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Patient With Newly Diagnosed, Histologically Confirmed Glioblastoma Multiforme Grade IV|Completed||Phase 3|150|Anticipated|Oncoscience AG||2|||f||||t||||||||||2017-02-18 13:56:14.433241|2017-02-18 13:56:14.433241
NCT00753233|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2017-01-24|||September 5, 2008||2008-09-05|January 25, 2012|2012-01-25|January 25, 2012||2012-01-25|||||Observational|||Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy|Long Term Follow Up of Children and Adolescents Diagnosed With Hypertrophic Cardiomyopathy: Identification of Risk Factors That Predict Arrhythmia Events|Completed||N/A|145|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:56:14.544969|2017-02-18 13:56:14.544969
NCT00753220|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2014-11-03|2013-07-25||August 2009||2009-08-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|CRITICAL||Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer|A Phase I/IIa Trial of Combined Cryotherapy and Intra-tumoral Immunotherapy With Autologous Immature Dendritic Cells (VDC2008) in Chemo-naïve Men With Prostatic Adenocarcinoma and Limited Metastases to Lymph Nodes and/or Bone|Terminated||Phase 1/Phase 2|7|Actual|Bostwick Laboratories||1||Withdrew the IND with the FDA.|f||||f||||||||||2017-02-18 13:56:14.626461|2017-02-18 13:56:14.626461
NCT00753207|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-13|2016-02-12|||October 2007||2007-10-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|November 2008|Actual|2008-11-01||Interventional|||Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30|An Open-Label Phase I Study of Fixed Dose Lapatinib in Combination With an Escalating Dose of Epirubicin in Metastatic Breast Cancer|Completed||Phase 1|10|Actual|Cancer Trials Ireland||1|||f||||||||||||||2017-02-18 13:56:15.020015|2017-02-18 13:56:15.020015
NCT00753194|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2008-09-15|||March 2005||2005-03-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|March 2006|Actual|2006-03-01||Observational|NHS||False Positive Results in Newborn Hearing Screening|False-Positive Results in Newborn Hearing Screening: Possible Causes|Completed||N/A|1110|Actual|Federal University of São Paulo|||2||f||||f||||||||||2017-02-18 13:56:15.13911|2017-02-18 13:56:15.13911
NCT00753181|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2009-04-24|||August 2008||2008-08-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes|Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes|Completed||Phase 3|60|Actual|Abbott Nutrition||3|||f||||f||||||||||2017-02-18 13:56:15.230778|2017-02-18 13:56:15.230778
NCT00753168|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2009-01-06|||September 2008||2008-09-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma|A Randomized, Parallel-Group, Multi-Center, Investigator-Masked, Active-and Placebo-Controlled, Phase 1-2 Evaluation of the Safety and Efficacy of OT-730 Ophthalmic Solution in Reducing the Intraocular Pressure in Subjects With Ocular Hypertension or Open-Angle Glaucoma|Completed||Phase 1/Phase 2|48|Anticipated|Othera Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:56:15.335477|2017-02-18 13:56:15.335477
NCT00753155|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2008-09-15|||January 2002||2002-01-01|September 2008|2008-09-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|Ergo-LTx||Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Lung Transplantation (Ergo-LTx)|Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Lnug Transplantation|Unknown status|Active, not recruiting|N/A|89|Actual|Hannover Medical School||1|||f||||t||||||||||2017-02-18 13:56:15.444474|2017-02-18 13:56:15.444474
NCT00753142|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2014-07-07|2014-07-07||March 2004||2004-03-01|July 2014|2014-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises|Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises|Completed||N/A|28|Actual|Emory University||3|||f||||t||||||||||2017-02-18 13:56:15.521719|2017-02-18 13:56:15.521719
NCT00753129|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2010-05-03|||October 2008||2008-10-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Head Elevation in Prone Position|Influence of Head Elevation in Prone Position on Gas Exchange and Lung Mechanics in Patients With ALI/ARDS|Completed||Phase 2|20|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:56:16.252821|2017-02-18 13:56:16.252821
NCT00753116|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2012-11-02|||September 2008||2008-09-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension|Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension|Completed||Phase 1|20|Anticipated|Medtronic Vascular||1|||f||||t||||||||||2017-02-18 13:56:16.349026|2017-02-18 13:56:16.349026
NCT00753103|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2008-09-15|||January 2003||2003-01-01|September 2008|2008-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|ACTIVE||Anti-Cytokine Therapy for Vasculitis|Phase II Pilot Cohort Study to Investigate the Safety and Efficacy of Infliximab as Additional Therapy in the Treatment if Anti-Neutrophil Cytoplasm Antibody Associated Vasculitis|Completed||Phase 2|37|Actual|University Hospital Birmingham NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 13:56:16.440595|2017-02-18 13:56:16.440595
NCT00753090|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2016-02-16|||June 2009||2009-06-01|February 2016|2016-02-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Vanguard™ Deep Dish Rotating Platform Knee Clinical Evaluation|Vanguard™ Deep Dish Rotating Platform Knee Clinical Evaluation|Active, not recruiting||Phase 4|329|Actual|Zimmer Biomet||2|||f||||f||||||||Undecided||2017-02-18 13:56:16.561312|2017-02-18 13:56:16.561312
NCT00753077|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-14|2011-09-02|||August 2008||2008-08-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Observational|||Three Dimensional Morphology of Upper Respiratory Tract and Mandibular Position on Obstructive Sleep Apnea||Completed||N/A|20|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:56:16.668117|2017-02-18 13:56:16.668117
NCT00753064|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-14|2008-09-15|||September 2006||2006-09-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||AScVS and/ or Prazosin for Scorpion Envenomation|Comparative Study of Efficacy of Antiscorpion Venom Serum(AScVS)vs Prazosin in the Management of Severe Scorpion(Mesobuthus Tamulus Concanesis Pocock)Envenomation and Evaluation of Effects of the Combination of AScVS + Prazosin Therapy.|Completed||Phase 3|81|Actual|Haffkine Bio-Pharmaceutical Corporation Ltd.||3|||f||||f||||||||||2017-02-18 13:56:16.743771|2017-02-18 13:56:16.743771
NCT00753051|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2012-05-04|||June 2008||2008-06-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|TCRS||Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)|Treatment of Clozapine-resistant Schizophrenia : Comparison Between Augmentation With Haloperidol and Electroconvulsive Therapy|Completed||N/A|18|Actual|Khon Kaen University||2|||f||||f||||||||||2017-02-18 13:56:16.871224|2017-02-18 13:56:16.871224
NCT00753038|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2014-11-03|||August 2008||2008-08-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|July 2011|Actual|2011-07-01||Interventional|||Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma|Phase 2 Study of Intravenous Administration of a Wild-Type Reovirus (REOLYSIN®) in Combination With Paclitaxel and Carboplatin in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck.|Completed||Phase 2|14|Actual|Oncolytics Biotech||1|||f||||f||||||||||2017-02-18 13:56:16.978416|2017-02-18 13:56:16.978416
NCT00753025|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-15|||October 2006||2006-10-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|June 2007|Actual|2007-06-01||Interventional|||Autologous Bone Marrow For Lower Extremity Ischemia Treating|Randomized Double Blind Placebo-Controlled Research Of Treatment Efficiency For Patients With Lower Extremity Arteriosclerosis Obliterans By Autologous Transplantation Of Bone Marrow Progenitor Cells|Completed||Phase 2|42|Actual|Clinical Center of Cellular Technologies, Russia||3|||f||||t||||||||||2017-02-18 13:56:17.076066|2017-02-18 13:56:17.076066
NCT00753012|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2012-08-22|2012-05-02||April 2008||2008-04-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults|An In Depth Cardiovascular Study of Lisdexamfetamine (LDX; Vyvanse) in Healthy and Treated Hypertensive Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 4|24|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:56:17.17663|2017-02-18 13:56:17.17663
NCT00752999|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2012-04-26|||November 2008||2008-11-01|April 2012|2012-04-01|March 2010|Anticipated|2010-03-01|November 2009|Anticipated|2009-11-01||Interventional|SOLEIL||Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of R935788 in Systemic Lupus Erythematosus Patients With Active Disease|Withdrawn||Phase 2|0|Actual|Rigel Pharmaceuticals||2||Study was withdrawn for business reasons before study start.|f||||t||||||||||2017-02-18 13:56:17.640741|2017-02-18 13:56:17.640741
NCT00752986|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2016-10-11|2014-09-15||December 2008||2008-12-01|October 2016|2016-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ZACFAST|No data were analyzed due to the premature study interruption and sample of patients was too low.|ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial|A Randomized,Double-blind,Parallel-group,Multicentre,Phase II Study to Evaluate the Safety and Pharmacological Activity of the Combination of Vandetanib (100 or 300 MG/Daily or Placebo)With Fulvestrant (Loading Dose)in Postmenopausal Advanced BC Patients|Terminated||Phase 2|39|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 13:56:17.74852|2017-02-18 13:56:17.74852
NCT00752973|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2014-07-14|2014-02-19||September 2008||2008-09-01|July 2014|2014-07-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice|Phase II, Multi-Center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis|Completed||Phase 2/Phase 3|12|Actual|Taro Pharmaceuticals USA||1|||f||||f||||||||||2017-02-18 13:56:18.322635|2017-02-18 13:56:18.322635
NCT00752960|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2008-09-12|||January 2007||2007-01-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|DIMS||DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics|DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics|Unknown status|Recruiting|N/A|1000|Anticipated|Genomas, Inc|||5||f||||f||||||Samples With DNA|"~     DNA extracted from whole blood~   "|||2017-02-18 13:56:18.624712|2017-02-18 13:56:18.624712
NCT00752947|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2009-03-10|||September 2008||2008-09-01|March 2009|2009-03-01|May 2010|Anticipated|2010-05-01|March 2010|Anticipated|2010-03-01||Interventional|||Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors|Multi-Centre, Prospective, Open Label, Randomized Trial to Assess the Efficacy and Safety of Moxifloxacin Versus Levofloxacin Plus Metronidazole in the Treatment of Community-Acquired Pneumonia With Aspiration Factors|Unknown status|Recruiting|Phase 4|186|Anticipated|Beijing Hospital||2|||f||||t||||||||||2017-02-18 13:56:18.829683|2017-02-18 13:56:18.829683
NCT00752934|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2011-04-17|||October 2010||2010-10-01|September 2008|2008-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Does Oral Baclofen Improve Care and Comfort in Spastic Children in Nursing Homes?||Unknown status|Recruiting|Phase 4|20|Anticipated|Shaare Zedek Medical Center||2|||f||||||||||||||2017-02-18 13:56:18.946965|2017-02-18 13:56:18.946965
NCT00752921|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2008-09-15|||September 2008||2008-09-01|September 2008|2008-09-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache|Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-02-18 13:56:19.033792|2017-02-18 13:56:19.033792
NCT00752908|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2012-04-10|||February 2008||2008-02-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Tissue Penetration of Antibiotics in Obesity|Tissue Penetration of Antibiotics in Obesity|Completed||N/A|30|Actual|Washington University School of Medicine|||2||f||||f||||||Samples Without DNA|"~     plasma, interstitial fluid~   "|||2017-02-18 13:56:19.138258|2017-02-18 13:56:19.138258
NCT00752895|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-13|2016-12-20|2015-09-28||September 2008||2008-09-01|November 2016|2016-11-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional||All randomized participants|American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL|A Phase III Randomized, Double-Blind, Placebo Controlled Trial of North American Ginseng Extract (CVT-E002; COLD-fX®) to Prevent Respiratory Infection and Reduce Antibiotic Use in Patients With Chronic Lymphocytic Leukemia|Completed||Phase 3|293|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-02-18 13:56:19.238153|2017-02-18 13:56:19.238153
NCT00752882|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-01-18||||||January 2011|2011-01-01|June 2009|Anticipated|2009-06-01|||||Interventional|||Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration|Comparison of Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration|Unknown status|Not yet recruiting|Phase 2|24|Anticipated|University Hospital, Clermont-Ferrand|||||f||||||||||||||2017-02-18 13:56:20.243954|2017-02-18 13:56:20.243954
NCT00752869|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-15|2013-02-25|||September 2008||2008-09-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|DUT/T||Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement|"Dutasteride in Men Receiving Testosterone Therapy: Impact on Serum PSA, Testosterone, DHT Levels and Prostate Volume: Implications for Prostate Safety"|Completed||Phase 4|24|Actual|The Miriam Hospital||2|||f||||t||||||||||2017-02-18 13:56:20.344802|2017-02-18 13:56:20.344802
NCT00752505|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2011-06-07||2011-06-07|August 2008||2008-08-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.|A Phase 2 Randomized Double-Blind Placebo-Controlled Crossover Study Assessing The Ability Of Esreboxetine (PNU-165442g) To Improve Cognitive Function In Fibromyalgia Patients.|Completed||Phase 2|89|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:56:22.773997|2017-02-18 13:56:22.773997
NCT00752856|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-13|2014-03-31|||September 2008||2008-09-01|March 2014|2014-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients|Nucleoside-Sparing Combination Therapy With Lopinavir/Ritonavir (LPV/r) + Raltegravir (RAL) vs. Efavirenz (EFV) + Tenofovir Disoproxil Fumarate + Emtricitabine (TDF/FTC) in Antiretroviral-Naïve Patients|Completed||Phase 2|50|Actual|California Collaborative Treatment Group||2|||f||||t||||||||||2017-02-18 13:56:20.47079|2017-02-18 13:56:20.47079
NCT00752843|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2012-02-15|||September 2008||2008-09-01|February 2012|2012-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers|A Phase I, Open-Label, Fixed-Sequence Study to Determine the Effect of Single and Multiple Oral Doses of CORLUX (TM) (Mifepristone) on the Pharmacokinetics of a Single Oral Dose of Fluvastatin (a CYP2C9 Probe) in Healthy Volunteers|Completed||Phase 1|20|Actual|Corcept Therapeutics||1|||f||||t||||||||||2017-02-18 13:56:20.587252|2017-02-18 13:56:20.587252
NCT00752830|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2008-10-28|||September 2008||2008-09-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328|A Phase I, Open, Randomized, Single-Dose, Two-Treatment (Fed Versus Fasting), Two-Period Cross-Over Single-Centre Study to Evaluate the Effect of Food on the Pharmacokinetics of AZD0328 Following Oral Administration (Capsule) in Healthy Male Subjects|Completed||Phase 1|14|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:56:20.693152|2017-02-18 13:56:20.693152
NCT00752817|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2008-10-06|||September 2008||2008-09-01|October 2008|2008-10-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|LAC||Creating a Proficiency-Based Virtual Reality Simulation Training Programme for Laparoscopic Assisted Colectomy|Creating and Implementing a Proficiency-Based Progression Virtual Reality Training Programme for Higher Surgical Trainees for Laparoscopic Assisted Sigmoid Colectomy.|Unknown status|Recruiting|N/A|16|Anticipated|Royal College of Surgeons, Ireland||2|||f||||t||||||||||2017-02-18 13:56:20.792188|2017-02-18 13:56:20.792188
NCT00752622|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2015-07-01|2011-06-23||November 2008||2008-11-01|July 2015|2015-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|OPTIMIST||Treatment With Infliximab in a Medical Setting (Study P05587)|Optimization of Treatment With Infliximab in a Medical Setting|Terminated||Phase 4|100|Actual|Merck Sharp & Dohme Corp.|Due to early study termination, no statistical analysis was performed for the interventional part of this study, therefore, endpoints dedicated to this phase of the study have not been analyzed.|2||"Factors that led to termination: recruitment challenges and a lower incidence of flares than~   estimated, causing a high risk of the study being underpowered."|f||||f||||||||||2017-02-18 13:56:20.927072|2017-02-18 13:56:20.927072
NCT00752609|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-06-26|2012-04-16||September 2008||2008-09-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.|A Phase 2 Study of the Safety and Efficacy of Hematide Injection for the Maintenance Treatment of Anemia in Subjects With Chronic Renal Failure Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa|Completed||Phase 2|102|Actual|Takeda||1|||f||||f||||||||||2017-02-18 13:56:21.324301|2017-02-18 13:56:21.324301
NCT00752596|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2017-01-31|||September 2005||2005-09-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient|Compassionate Use Study to Assess the Long Term Safety of 125 mg Per Day of Oral Azimilide Dihydrochloride in One Patient Following Termination of the SHIELD Open-label Study 2001060|Completed||Phase 2|1|Actual|Forest Laboratories||1|||f||||f||||||||||2017-02-18 13:56:21.970768|2017-02-18 13:56:21.970768
NCT00752583|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2014-12-04|||September 2008||2008-09-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||Peritoneal Dialysis Versus Haemodialysis|Clinical Study in Order to Quantify Solute Removal in Peritoneal Dialysis Versus Haemodialysis|Unknown status|Recruiting|N/A|75|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:56:22.063318|2017-02-18 13:56:22.063318
NCT00752570|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-08-14||2015-07-13|November 2008||2008-11-01|August 2015|2015-08-01|June 2012|Actual|2012-06-01|September 2010|Actual|2010-09-01||Interventional|||A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma|A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma|Completed||Phase 2|144|Actual|Amgen||2|||f||||||||||||||2017-02-18 13:56:22.166324|2017-02-18 13:56:22.166324
NCT00752557|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2015-06-15|||December 2008||2008-12-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD|A Phase 2, Multicenter, Randomized, Active-controlled, Parallel-group, Dose-finding And Safety Study Of Recombinant Human Bone Morphogenetic Protein-2 (Rhbmp-2)/Calcium Phosphate Matrix (Cpm) In Subjects With Decreased Bone Mineral Density|Completed||Phase 2|50|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 13:56:22.362511|2017-02-18 13:56:22.362511
NCT00752544|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2010-04-26|||August 2008||2008-08-01|April 2010|2010-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers|Phase I, Double-blind, Randomized, Placebo-controlled Trial to Examine the Safety, Tolerability and Plasma Pharmacokinetics of Ascending Oral Doses of TMC435350 After Single and Repeated Dosing in Healthy Japanese Male Subjects|Completed||Phase 1|30|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-02-18 13:56:22.502185|2017-02-18 13:56:22.502185
NCT00752531|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2013-03-21|||December 2003||2003-12-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness of Home Automated Telemanagement in Chronic Obstructive Pulmonary Disorder|Evaluation of Home Automated Telemanagement in COPD|Completed||N/A|280|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 13:56:22.581873|2017-02-18 13:56:22.581873
NCT00752518|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-05-16|||May 2004||2004-05-01|April 2010|2010-04-01|January 2006|Actual|2006-01-01|||||Interventional|||A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients|A Phase I/II Study of JNJ-26866138 (Bortezomib) in Japanese Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|35|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 13:56:22.68976|2017-02-18 13:56:22.68976
NCT00752492|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2011-04-19|||September 2008||2008-09-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|June 2010|Actual|2010-06-01||Interventional|||Acceleration of Recovery From General Anesthesia - Efficacy of Isocapnic Hyperpnoea in Obese Patients Undergoing Isoflurane Anesthesia|Acceleration of Recovery From General Anesthesia - Efficacy of Isocapnic Hyperpnoea in Obese Patients Undergoing Isoflurane Anesthesia|Completed||N/A|44|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 13:56:22.870691|2017-02-18 13:56:22.870691
NCT00752479|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-04-08|||May 2008||2008-05-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance|Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance|Terminated||Phase 1/Phase 2|4|Actual|Mario Negri Institute for Pharmacological Research||2||Necessity of major revision of the protocol|f||||f||||||||||2017-02-18 13:56:22.963323|2017-02-18 13:56:22.963323
NCT00752466|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-05-17|||March 2003||2003-03-01|April 2010|2010-04-01|March 2004|Actual|2004-03-01|||||Interventional|||A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately|A Drug Interaction Study of the Pharmacokinetics of Flunarizine and Topiramate (RWJ-17021-000) During Mono- and Concomitant Therapy|Completed||Phase 1|75|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:56:23.07023|2017-02-18 13:56:23.07023
NCT00752453|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2015-06-02|||September 2008||2008-09-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Uremic Toxins in the Intensive Care Units (ICU): Patients With Lactate Acidosis|Study of the Kinetics of Uremic Toxins in the ICU Patients With Acute Renal Failure, in Order to Optimize the Dialysis Dose: Patients With Lactate Acidosis|Recruiting||N/A|12|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 13:56:23.163777|2017-02-18 13:56:23.163777
NCT00752440|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2008-09-15|||August 2006||2006-08-01|September 2008|2008-09-01|July 2009|Anticipated|2009-07-01|November 2008|Anticipated|2008-11-01||Interventional|||Inspiratory Muscle Training in Patients With Autonomic Neuropathic|Inspiratory Muscle Training in Patients With Autonomic Neuropathic: a Randomized Trial|Unknown status|Recruiting|Phase 4|24|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||1|||f||||t||||||||||2017-02-18 13:56:23.274958|2017-02-18 13:56:23.274958
NCT00752427|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-06-06|||June 2004||2004-06-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|||||Interventional|||24-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophrenia|R076477-SCH-702: a 24 Week Open-Label Extension to R076477-SCH-302|Completed||Phase 3|86|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:56:23.369432|2017-02-18 13:56:23.369432
NCT00752414|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2008-12-22|||July 2008||2008-07-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients|Phase 1b, Randomized, Single-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MP-376 Inhalation Solution Administered for 5 Days to Chronic Bronchitis Patients|Completed||Phase 1|20|Anticipated|Forest Laboratories||2|||f||||f||||||||||2017-02-18 13:56:23.462946|2017-02-18 13:56:23.462946
NCT00752401|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2014-01-20|||May 2009||2009-05-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|VITA-D||Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients|VITA-D: Cholecalciferol Substitution in Vitamin D Deficient Kidney Transplant Recipients: A Randomized, Placebo-controlled Study to Evaluate the Posttransplant Outcome|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 13:56:23.574287|2017-02-18 13:56:23.574287
NCT00752388|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2013-11-18|||November 2008||2008-11-01|November 2013|2013-11-01||||November 2008|Actual|2008-11-01||Observational|||Non-interventional Observational Study on WHO-5 Questionnaire Application in Parkinson's Disease|Application of the WHO-5 Well-being Index (WHO-5) as a Screening Instrument for Depression in Parkinson's Disease|Completed||N/A|1588|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 13:56:23.69469|2017-02-18 13:56:23.69469
NCT00752375|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-01-14|||February 2009||2009-02-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Antibiotic Prophylaxis in Children With Pyelonephritis|A Randomized Controlled Trial of Antibiotic Prophylaxis in Children With Pyelonephritis in the Abscence of Vesicoureteral Reflux|Withdrawn||Phase 3|0|Actual|University of Alberta||2||No participants|f||||f||||||||||2017-02-18 13:56:26.674197|2017-02-18 13:56:26.674197
NCT00752362|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-11-19|||March 2006||2006-03-01|November 2015|2015-11-01||||May 2008|Actual|2008-05-01||Interventional|||Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)|PercutAneous INTervention With Biodegradable- Polymer Based Paclitaxel-eluting, Sirolimus-eluting, or Bare Stents for the Treatment of de Novo Coronary Lesions.|Completed||Phase 4|280|Actual|Sahajanand Medical Technologies Pvt. Ltd.||3|||f||||t||||||||||2017-02-18 13:56:26.778261|2017-02-18 13:56:26.778261
NCT00752349|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-12||||||September 2008|2008-09-01||||||||Expanded Access|||To Evaluate Oral Phase Swallowing Function Using Submental Ultrasound|To Evaluate Oral Phase Swallowing Function Using Submental Ultrasound|Available||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 13:56:26.906354|2017-02-18 13:56:26.906354
NCT00752336|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2008-09-12|||January 2002||2002-01-01|September 2008|2008-09-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|Ergo-HTx||Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation|Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation|Unknown status|Active, not recruiting|N/A|87|Actual|Hannover Medical School||1|||f||||t||||||||||2017-02-18 13:56:26.978582|2017-02-18 13:56:26.978582
NCT00752323|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2016-09-29|||August 2008||2008-08-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma|Fluorescence-Guided Detection of Malignant Gliomas: A Dose Ranging Study Using 5-Aminolevulinic Acid (ALA) Induced Protoporphyrin (PpIX) in a Multicenter Phase II Clinical Trial|Recruiting||Phase 2|120|Anticipated|Case Comprehensive Cancer Center||4|||f||||t||||||||||2017-02-18 13:56:27.060148|2017-02-18 13:56:27.060148
NCT00751946|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2010-09-24|||March 2006||2006-03-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|GIRLS||Girls In Recovery From Life Stress (GIRLS) Study|Girls In Recovery From Life Stress (GIRLS) Study|Completed||Phase 2|70|Actual|UConn Health||2|||f||||t||||||||||2017-02-18 13:56:33.80929|2017-02-18 13:56:33.80929
NCT00752310|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-06-08|||April 2008||2008-04-01|April 2010|2010-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet|A Phase I, Open-label, Randomized, Crossover Trial in Healthy Subjects Receiving DRV Combined With RTV Low Dose to Compare the Oral Bioavailability of DRV Suspension to That of DRV 300 mg Tablet Under Fasted and Fed Conditions, and to Assess Multiple Dose Pharmacokinetics of the DRV Suspension|Completed||Phase 1|23|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:56:27.184329|2017-02-18 13:56:27.184329
NCT00752297|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2011-09-01||2011-05-03|June 2007||2007-06-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|PT-03a||Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows|"A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Single-Dose Pivotal Trial to Demonstrate the Safety and Efficacy of PurTox® for the Treatment of Glabellar Rhytides (Frown Lines)"|Completed||Phase 3|402|Actual|Mentor Worldwide, LLC||2|||f||||f||||||||||2017-02-18 13:56:27.269244|2017-02-18 13:56:27.269244
NCT00752284|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2008-12-05|||June 2006||2006-06-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|coronrct||Safety of Coronectomy vs Excision of Wisdom Teeth|Randomized Controlled Trial of Safety of Coronectomy Versus Excision of Wisdom Teeth|Completed||N/A|349|Actual|The University of Hong Kong||2|||f||||f||||||||||2017-02-18 13:56:27.380457|2017-02-18 13:56:27.380457
NCT00752271|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2009-12-17|||May 2008||2008-05-01|December 2009|2009-12-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Observational|||AMS Study: Inflammatory and Biomechanical Contributors to Arthritis Development Following Arthroscopic Meniscectomy|Inflammatory and Biomechanical Contributors to Arthritis Development Following Arthroscopic Meniscectomy|Terminated||N/A|32|Anticipated|National Institute on Aging (NIA)|||2||f||||f||||||||||2017-02-18 13:56:27.483881|2017-02-18 13:56:27.483881
NCT00752258|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-09-01||2011-09-01|February 2008||2008-02-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|PT-03c||A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows|"A Phase III, Multi-Center, Long-Term, Repeat-Treatment, Open-Label, Single-Arm Trial to Demonstrate the Safety of Repeat Treatment With PurTox® for the Treatment of Glabellar Rhytides (Frown Lines)"|Completed||Phase 3|576|Actual|Mentor Worldwide, LLC||1|||f||||f||||||||||2017-02-18 13:56:27.573646|2017-02-18 13:56:27.573646
NCT00752245|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2015-06-02|||September 2008||2008-09-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Uremic Toxins in the Intensive Care Unit (ICU): Patients With Sepsis|Study of the Kinetics of Uremic Toxins in the ICU Patients With Acute Renal Failure, in Order to Optimize the Dialysis Dose: Patients With Sepsis/Multi-organ Failure|Recruiting||N/A|12|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 13:56:27.886952|2017-02-18 13:56:27.886952
NCT00752232|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-11-30|2014-05-09||December 2008||2008-12-01|November 2015|2015-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease|A Phaseiia, Multicenter, Randomized, Third-party Unblinded, Adjuvant And Placebo-controlled, Multiple Ascending Dose, Safety, Tolerability And Immunogenicity Trial Of Acc-001 And Qs-21 Adjuvant In Japanese Subjects With Mild To Moderate Alzheimer's Disease.|Completed||Phase 2|40|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 13:56:28.027384|2017-02-18 13:56:28.027384
NCT00752219|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2009-12-01|||March 2009||2009-03-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections|A Prospective, Multicenter, Double-blind, Randomized, Comparative Study to Estimate the Safety, Tolerability and Efficacy of NXL104/Ceftazidime Plus Metronidazole vs. Meropenem in the Treatment of Complicated Intra-abdominal Infections in Hospitalized Adults|Completed||Phase 2|200|Anticipated|Novexel Inc||2|||f||||f||||||||||2017-02-18 13:56:29.912918|2017-02-18 13:56:29.912918
NCT00752206|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2016-10-12|||March 2009||2009-03-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|December 2016|Anticipated|2016-12-01||Interventional|||A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung|A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Cross-over, Phase II.5 Study of Saracatinib (AZD0530), a Selective Src Kinase Inhibitor, In Patients With Recurrent Osteosarcoma Localized to the Lung|Active, not recruiting||Phase 2|88|Anticipated|Sarcoma Alliance for Research through Collaboration||2|||f||||t||||||||||2017-02-18 13:56:30.257451|2017-02-18 13:56:30.257451
NCT00752193|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-06-03|||October 2008||2008-10-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety and Efficacy of a Vaginally Administered Probiotic Lactobacilli Delivery System.|Safety and Efficacy of a Vaginally Administered Probiotic Lactobacilli Delivery System|Recruiting||N/A|206|Anticipated|University Ghent||2|||f||||f||||||||||2017-02-18 13:56:30.395181|2017-02-18 13:56:30.395181
NCT00752180|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2012-12-26|||August 2008||2008-08-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics|A Single Dose,Single Centre,Double Blind,Crossover Study Comparing the Pharmacokinetic Profiles of Wockhardt's Insulin Human Injection, Soluble (Recombinant DNA Origin) for Injection and Actrapid in Type 1 Diabetics|Completed||Phase 1|28|Actual|Wockhardt||2|||f||||f||||||||||2017-02-18 13:56:30.505354|2017-02-18 13:56:30.505354
NCT00752167|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2016-05-10|||February 2007||2007-02-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Diagnosis of Exercise-induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes|Diagnosis of EIB and Asthma in NCAA Division I Athletes|Completed||N/A|74|Actual|University of Arizona|||2||f||||f||||||||No||2017-02-18 13:56:30.617082|2017-02-18 13:56:30.617082
NCT00752154|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2010-07-01|||January 2010||2010-01-01|September 2008|2008-09-01|January 2011|Anticipated|2011-01-01|December 2010|Anticipated|2010-12-01||Interventional|||Curcumin in Rheumatoid Arthritis|Curcumin in Rheumatoid Arthritis - ACross-Over Pilot Study|Unknown status|Recruiting|Early Phase 1|40|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-02-18 13:56:30.715086|2017-02-18 13:56:30.715086
NCT00752141|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-09-22|||September 2008||2008-09-01|September 2011|2011-09-01||||October 2008|Actual|2008-10-01||Interventional|||Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers|Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers|Completed||Phase 1|153|Actual|Watson Pharmaceuticals||3|||f||||||||||||||2017-02-18 13:56:30.806748|2017-02-18 13:56:30.806748
NCT00752128|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2013-04-18|2011-10-31||August 2008||2008-08-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|October 2010|Actual|2010-10-01||Observational|R-Int||RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population|RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population|Completed||N/A|2349|Actual|Medtronic Vascular|The data collection in this registry was limited to the collection of MACE (death, myocardial infarction (Q- and non-Q-wave), emergent cardiac bypass surgery and TLR) and stent thrombosis events.||1||f||||t||||||||||2017-02-18 13:56:30.90823|2017-02-18 13:56:30.90823
NCT00752115|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2011-09-05|||February 2007||2007-02-01|April 2009|2009-04-01|December 2010|Actual|2010-12-01|March 2009|Actual|2009-03-01||Interventional|||Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer|Randomized Phase II Study of Combination Chemotherapy With Sildenafil Plus Carboplatin and Weekly Paclitaxel in Patients With Previously Untreated Advanced Non-small Cell Lung Cancer|Completed||Phase 2/Phase 3|120|Anticipated|Hamamatsu University||2|||f||||t||||||||||2017-02-18 13:56:31.172966|2017-02-18 13:56:31.172966
NCT00752102|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2016-08-17|||September 2008||2008-09-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|VCOR||Vitamin D and Coronary Calcification Study|A Phase IV, Randomized, Single-center Study of the Effects of Calcitriol and Paricalcitol on Vascular Calcification in Chronic Kidney Disease Stages 3 and 4|Completed||Phase 4|123|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 13:56:31.291051|2017-02-18 13:56:31.291051
NCT00752089|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2016-10-17|2011-09-07||September 2007||2007-09-01|May 2016|2016-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model|Exploratory Evaluation of an Experimental Fluoride Dentifrice Formulation Using an in Situ Remineralization/Fluoride Uptake Model|Completed||Phase 2|20|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 13:56:31.398605|2017-02-18 13:56:31.398605
NCT00752076|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2009-11-25|||April 2008||2008-04-01|November 2009|2009-11-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|EGFR||Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment|Detection of Epithelial Growth Factor Receptor (EGFR) Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 13:56:31.747946|2017-02-18 13:56:31.747946
NCT00752063|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2008-09-12|||September 2007||2007-09-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|SECOX||Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma|A Phase IIa Trial of Sorafenib With Capecitabine and Oxaliplatin in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|52|Anticipated|The University of Hong Kong||1|||f||||t||||||||||2017-02-18 13:56:31.851812|2017-02-18 13:56:31.851812
NCT00752050|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-09-01||2011-05-03|November 2007||2007-11-01|September 2011|2011-09-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|PT-03b||Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows|"A Phase 3, Multi-Center Trial to Demonstrate the Safety and Efficacy of Repeat Treatment With PurTox® for the Treatment of Glabellar Rhytides (Frown Lines)"|Completed||Phase 3|699|Actual|Mentor Worldwide, LLC||2|||f||||f||||||||||2017-02-18 13:56:31.958068|2017-02-18 13:56:31.958068
NCT00752037|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-12|2011-07-19|||September 2008||2008-09-01|September 2008|2008-09-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients|Safety and Efficacy of Lopinavir/Ritonavir in Combination With Raltegravir in HIV-infected Patients|Completed||Phase 4|30|Actual|Saint Michael's Medical Center||1|||f||||f||||||||||2017-02-18 13:56:32.075411|2017-02-18 13:56:32.075411
NCT00752024|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-09-12|||September 2008||2008-09-01|September 2008|2008-09-01|December 2010|Anticipated|2010-12-01|September 2010|Anticipated|2010-09-01||Interventional|SATIH||Stereotactic Aspiration and Thrombolysis of Intracerebral Hemorrhage: a Prospective Controlled Study|Stereotactic Aspiration and Thrombolysis of Intracerebral Hemorrhage: a Prospective Controlled Study（SATIH）|Unknown status|Not yet recruiting|N/A|60|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-02-18 13:56:32.276562|2017-02-18 13:56:32.276562
NCT00752011|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2012-10-16|||June 2008||2008-06-01|October 2012|2012-10-01||||October 2012|Actual|2012-10-01||Interventional|||Phase I Study of TAS-106 in Combo With Carboplatin|Phase I Dose Escalating Study Of Tas-106 In Combination With Carboplatin In Patients With Solid Tumors|Completed||Phase 1|45|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:56:32.39638|2017-02-18 13:56:32.39638
NCT00751998|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2013-02-04|2011-03-16||November 2006||2006-11-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|April 2008|Actual|2008-04-01||Interventional|||Spy II Clinical Registry|A Clinical Registry to Assess Performance and Clinical Utility of the SpyGlass Direct Visualization System|Completed||Phase 4|297|Actual|Boston Scientific Corporation||1|||f||||||||||||||2017-02-18 13:56:32.516663|2017-02-18 13:56:32.516663
NCT00751985|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-04-13|||September 2008||2008-09-01|May 2009|2009-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Web-based Ultra-brief Intervention for Heavy Drinkers Trial|Web-based Ultra-brief Intervention for Heavy Drinkers - a Randomized Controlled Trial Comparing Personalized Normative Feedback With Self-help Material|Completed||Phase 3|1380|Actual|University of Southern Denmark||3|||f||||t||||||||||2017-02-18 13:56:33.028506|2017-02-18 13:56:33.028506
NCT00751972|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-09-20|2013-03-15||August 2008||2008-08-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2010|Actual|2010-08-01||Interventional|ADVANCE||Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure|Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure|Completed||N/A|140|Actual|HeartWare, Inc.||1|||f||||t||||||||||2017-02-18 13:56:33.142422|2017-02-18 13:56:33.142422
NCT00751959|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-07-18|||April 2009||2009-04-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|NINSAPP||Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks|Surfactant Application During Spontaneous Breathing With CPAP or During Mechanical Ventilation in the Therapy of IRDS in Premature Infants < 27 Weeks|Completed||N/A|213|Actual|University of Cologne||2|||f||||t||||||||||2017-02-18 13:56:33.686368|2017-02-18 13:56:33.686368
NCT00322504|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-01-06|||January 2006||2006-01-01|November 2006|2006-11-01|September 2006||2006-09-01|||||Interventional|||Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility Study||Completed||N/A|10||University of New Mexico|||||f||||||||||||||2017-02-18 16:34:33.603622|2017-02-18 16:34:33.603622
NCT00751933|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-04-10|2015-04-10||October 2008||2008-10-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|October 2009|Actual|2009-10-01||Interventional|||Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis|A Controlled Study of Salmonella Ty21a and Cholera/ ETEC-vaccine and the Role of Oats in Daily Diet as a New Treatment in Patients With Mild or Moderate Ulcerative Colitis.|Terminated||Phase 2|3|Actual|Haukeland University Hospital||4||Lack of patients compatible with the protocol´s criteria|f||||f||||||||||2017-02-18 13:56:33.934647|2017-02-18 13:56:33.934647
NCT00751920|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-01-04|||August 2008||2008-08-01|January 2016|2016-01-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Comparative Evaluation of MRI and MDCT for the Detection of Metastic Pulmonary Nodules|Comparative Evaluation of MRI and MDCT for the Detection of Metastic Pulmonary Nodules|Terminated||Phase 3|1|Actual|The Hospital for Sick Children||1||"The sponsor-investigator relocated to a different institution and was not able to continue the~   study."|f||||f||||||||||2017-02-18 13:56:34.200707|2017-02-18 13:56:34.200707
NCT00751907|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2010-09-27|||June 2006||2006-06-01|September 2010|2010-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|CAPP||Cerebral and Peripheral Perfusion Pilot Study|Impact of Atorvastatin on Cerebral Perfusion and Endothelial Function|Completed||Phase 2|16|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 13:56:34.30665|2017-02-18 13:56:34.30665
NCT00751894|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2011-01-18||||||January 2011|2011-01-01||||||||Interventional|MEG-5||Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)|Haematopoietic Progenitor Cell Mobilization in Children With Malignancies: Evaluation of Pegfilgrastim at 200µg/kg After Chemotherapy|Unknown status|Not yet recruiting|Phase 2|30|Anticipated|University Hospital, Clermont-Ferrand|||||f||||||||||||||2017-02-18 13:56:34.422503|2017-02-18 13:56:34.422503
NCT00751881|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-05-27|2013-04-16||August 2008||2008-08-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|April 2012|Actual|2012-04-01||Interventional|TOWER||An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis|A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis|Completed||Phase 3|1169|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 13:56:34.552737|2017-02-18 13:56:34.552737
NCT00751868|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2014-12-16|||September 2008||2008-09-01|December 2014|2014-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|GIM9||FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC|NEO-ADIXERN (NEO-ADjuvant IXabepilone in Breast Cancer). A Feasibility Study of Dose-dense FEC With G-CSF Support Followed by Dose-dense Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in Breast Cancer|Completed||Phase 2|47|Actual|Consorzio Oncotech||1|||f||||t||||||||||2017-02-18 13:56:37.552252|2017-02-18 13:56:37.552252
NCT00751855|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-07-26|||July 2008||2008-07-01|October 2010|2010-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Cortisol Augmentation of Prolonged Exposure Therapy|Cortisol Augmentation of Prolonged Exposure Therapy|Completed||N/A|11|Actual|Bronx VA Medical Center||2|||f||||f||||||||||2017-02-18 13:56:37.66812|2017-02-18 13:56:37.66812
NCT00751842|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-10-09|||September 2008||2008-09-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT|A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus (USA)|Terminated||Phase 3|331|Actual|Diamyd Therapeutics AB||3||"Based on other clinical trial results it was unlikely the study would meet the efficacy~   endpoints"|f||||t||||||||||2017-02-18 13:56:37.839254|2017-02-18 13:56:37.839254
NCT00751829|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2008-09-11|||July 2003||2003-07-01|September 2008|2008-09-01|February 2005|Actual|2005-02-01|October 2004|Actual|2004-10-01||Interventional|||Isolated Systolic Hypertension in the Elderly and Very Elderly|Comparison of the Efficacy of Olmesartan Medoxomil Versus Nitrendipine on Systolic Blood Pressure in Elderly and Very Elderly Patients With Isolated Systolic Hypertension|Completed||Phase 3|417|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:56:37.977143|2017-02-18 13:56:37.977143
NCT00751816|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-12-08|||June 2008||2008-06-01|December 2015|2015-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Head & Neck Cancer Survivorship: Physical and Functional Status|Head & Neck Cancer Survivorship: Physical and Functional Status|Completed||Phase 1|23|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 13:56:38.07785|2017-02-18 13:56:38.07785
NCT00751803|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-11-12||2014-04-30|August 2008||2008-08-01|November 2014|2014-11-01||||May 2009|Actual|2009-05-01||Interventional|||BI 44370 TA in Acute Migraine Attack|A Randomised, Double-blind, Placebo- and Active Comparator-controlled, Five Parallel Groups Study to Investigate the Efficacy and Safety of BI 44370 TA (50 mg, 200 mg, and 400 mg) Administered Orally Once During an Acute Migraine Attack of Moderate or Severe Intensity|Completed||Phase 2|416|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-02-18 13:56:38.202291|2017-02-18 13:56:38.202291
NCT00751790|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2014-07-17|2009-12-21||July 2006||2006-07-01|August 2012|2012-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer|A Multicenter, Open, Non-comparative, Phase III Study on the Efficacy, Pharmacokinetics and Safety of Two Injections of Triptorelin Embonate 22.5 mg 6-month Formulation in Patients With Advanced Prostate Cancer.|Completed||Phase 3|120|Actual|Debiopharm International SA||1|||f||||f||||||||||2017-02-18 13:56:38.526189|2017-02-18 13:56:38.526189
NCT00751777|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2014-03-17|2014-01-30||September 2008||2008-09-01|March 2014|2014-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||Intent-to-Treat (ITT) Population: all study subjects who were consented, randomized, and had a baseline serology|Traveler's Diarrhea (TD) Automated Process|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Immunogenicity and Safety of a Two Vaccination Regimen With an LT Vaccine Patch in Healthy Adults|Completed||Phase 2|120|Actual|Intercell USA, Inc.||2|||f||||f||||||||||2017-02-18 13:56:38.775736|2017-02-18 13:56:38.775736
NCT00751764|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2010-09-15|||November 2008||2008-11-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study Evaluating The Excretion Of Moxidectin Into The Breast Milk Of Lactating, Non-Breastfeeding Women|An Open-Label, Single-Dose Study to Evaluate the Excretion of Moxidectin Into the Breast Milk of Lactating, Non-breastfeeding Women.|Completed||Phase 1|12|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:56:39.151941|2017-02-18 13:56:39.151941
NCT00318877|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2012-12-12|||May 2006||2006-05-01|December 2012|2012-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Sports to Prevent Obesity|Sports to Prevent Obesity Randomized Trial|Completed||N/A|79|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 16:35:50.602282|2017-02-18 16:35:50.602282
NCT00751751|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2008-09-11|||June 2003||2003-06-01|September 2008|2008-09-01|June 2005|Actual|2005-06-01|April 2005|Actual|2005-04-01||Interventional|||Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly|Comparison of the Efficacy of Olmesartan Medoxomil Versus Losartan on Diastolic Blood Pressure in Elderly and Very Elderly Patients With Essential Hypertension.|Completed||Phase 3|441|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 13:56:39.239126|2017-02-18 13:56:39.239126
NCT00751738|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2017-01-31|||October 2002||2002-10-01|January 2017|2017-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)|A Multi-center, Open-label, Follow-up Study to Assess the Long-term Safety of 125 mg Per Day of Oral Azimilide Dihydrochloride in Patients With an Implantable Cardioverter Defibrillator|Completed||Phase 3|330|Actual|Forest Laboratories||1|||f||||f||||||||||2017-02-18 13:56:39.343306|2017-02-18 13:56:39.343306
NCT00751712|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2016-03-28|||May 2006||2006-05-01|March 2016|2016-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|CerebralOx||Cerebral Oximetric Monitoring of the Posterior Circulation|Cerebral Oximetric Monitoring of the Posterior Circulation in Neonates and Infants During Complex Aortic Arch Reconstruction.|Completed||N/A|13|Actual|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||No||2017-02-18 13:56:39.677964|2017-02-18 13:56:39.677964
NCT00751699|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2013-04-15|||March 2007||2007-03-01|April 2013|2013-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers|A Randomized, Open-label, Multiple Dose, Parallel Group Study to Evaluate 5 ASA and N Ac 5 ASA Pharmacokinetics Following Administration of Oral Doses of Asacol 2.4 g/Day and Lialda 2.4 g/Day for 7 Days in Healthy Volunteers|Completed||Phase 1|37|Actual|Warner Chilcott||3|||f||||f||||||||||2017-02-18 13:56:39.772714|2017-02-18 13:56:39.772714
NCT00751686|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2013-02-14|||July 2008||2008-07-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece|To Estimate the Burden of Rotavirus Gastroenteritis (RV GE) in Children < 5 Years of Age in Greece|Completed||N/A|128|Actual|GlaxoSmithKline|||1||f||||||||||Samples Without DNA|"~     Stool sample~   "|||2017-02-18 13:56:39.865175|2017-02-18 13:56:39.865175
NCT00751673|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2016-07-18|||January 2006||2006-01-01|July 2016|2016-07-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Observational|||TESS Shoulder Arthroplasty Data Collection|A Prospective, Multicentre Study Evaluating the Clinical Performance of the T.E.S.S Anatomic and Reverse Shoulder Prostheses|Active, not recruiting||N/A|600|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 13:56:39.97322|2017-02-18 13:56:39.97322
NCT00751660|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-03-07|||September 2008||2008-09-01|March 2012|2012-03-01||||March 2013|Anticipated|2013-03-01||Interventional|Pan Can||Screening Methods in Finding Lung Cancer Early in Current or Former Smokers|Early Detection of Lung Cancer - A Pan Canadian Study|Unknown status|Active, not recruiting|N/A|2504|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-02-18 13:56:40.084356|2017-02-18 13:56:40.084356
NCT00751647|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2014-02-13|||December 2008||2008-12-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|July 2012|Actual|2012-07-01||Interventional|CSREP||Cystic Fibrosis Core Strengthening and Respiratory Exercise Program|Cystic Fibrosis Core Strengthening and Respiratory Exercise Program (CSREP)|Completed||Phase 2|6|Actual|Children's Hospitals and Clinics of Minnesota||1|||f||||f||||||||||2017-02-18 13:56:40.195168|2017-02-18 13:56:40.195168
NCT00751634|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2013-04-30|2012-01-09||January 2009||2009-01-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Temperature Control in Central Fever in the Neuro-ICU|Temperature Control in Central Fever in the Neuro-ICU|Completed||Phase 4|20|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 13:56:40.291775|2017-02-18 13:56:40.291775
NCT00751621|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2014-03-05|2012-12-19||August 2008||2008-08-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)|A Multicenter Extension Study of the Efficacy, Tolerability, and Safety of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency (IgPro20 EU Extension Study)|Completed||Phase 3|40|Actual|CSL Behring||1|||f||||f||||||||||2017-02-18 13:56:40.69024|2017-02-18 13:56:40.69024
NCT00751608|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2016-09-22|||September 2006||2006-09-01|September 2016|2016-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients|A Randomized, Double-blind, Placebo-controlled Ascending Dose Study to Evaluate the Effect of APL180 on Endothelial Function in Patients With Familial Hypercholesterolemia|Withdrawn||Phase 2|0|Actual|Novartis||3|||f||||f||||||||||2017-02-18 13:56:41.185437|2017-02-18 13:56:41.185437
NCT00751595|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2016-03-03|||September 2008||2008-09-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|ISS T-002||Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine|A Phase II Randomized, Open Label, Immunogenicity and Safety Trial of the Vaccine Based on the Recombinant Biologically Active HIV-1 Tat Protein in Anti-Tat Negative HIV-1 Infected HAART-treated Adult Subjects.|Completed||Phase 2|168|Actual|Istituto Superiore di Sanità||2|||f||||t||||||||||2017-02-18 13:56:41.297159|2017-02-18 13:56:41.297159
NCT00751582|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-17|2016-03-20|||July 1998||1998-07-01|September 2008|2008-09-01|November 1998|Actual|1998-11-01|November 1998|Actual|1998-11-01||Interventional|||Effective Means to Address Moderately Malnourished Children|Effective Means to Address Moderately Malnourished Children Within BINP Communities|Completed||N/A|300|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-02-18 13:56:41.4306|2017-02-18 13:56:41.4306
NCT00751569|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-11|||September 2008||2008-09-01|September 2008|2008-09-01|September 2009|Anticipated|2009-09-01|||||Observational|||microRNA Profile in Umbilical Cord Blood NK Cells|microRNA Profile in Umbilical Cord Blood NK Cells|Unknown status|Recruiting|N/A|5|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     Umbilical cord blood~   "|||2017-02-18 13:56:41.54498|2017-02-18 13:56:41.54498
NCT00751556|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2014-04-18|||February 2008||2008-02-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Single/Multiple Dose Bioavailability Trial|An Open Label, Randomized, Two-Way Crossover Trial to Determine the Pharmacokinetic Profile of an Extended Release Naproxen Sodium Tablet Relative to Aleve Tablets Following Single and Multiple Dose Administration in Healthy Adult Subjects|Completed||Phase 1|32|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:56:41.65044|2017-02-18 13:56:41.65044
NCT00751543|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2010-06-28|||January 2008||2008-01-01|June 2010|2010-06-01||||December 2010|Anticipated|2010-12-01||Interventional|||The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy|The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy|Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 13:56:41.760695|2017-02-18 13:56:41.760695
NCT00751530|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2012-07-31|2010-07-22||March 2008||2008-03-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|||||Observational|BRAVO||BRAVO: Background Regimen of Raltegravir on Virologic Outcome|Outcomes of Early Raltegravir Experience: Comparison of Virologic Response in Regimens Not Containing a Protease Inhibitor in the Antiretroviral Background Regimen Versus a Protease Inhibitor in the Background Regimen|Completed||N/A|442|Actual|Community Research Initiative of New England|||2||f||||f||||||||||2017-02-18 13:56:41.859868|2017-02-18 13:56:41.859868
NCT00751517|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2008-09-11||||||September 2008|2008-09-01||||||||Interventional|||Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides|Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides. A Randomized Controlled Trial.|Unknown status|Active, not recruiting|Phase 2|||University of Parma||2|||f||||f||||||||||2017-02-18 13:56:42.296126|2017-02-18 13:56:42.296126
NCT00751504|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2013-01-23|||September 2008||2008-09-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Quetiapine in the Treatment of Psychotic Depression - a Pilot Study|Quetiapine in the Treatment of Psychotic Depression - a Pilot Study|Completed||Phase 3|16|Actual|Ruhr University of Bochum||1|||f||||t||||||||||2017-02-18 13:56:42.408322|2017-02-18 13:56:42.408322
NCT00751491|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2009-05-05|||September 2008||2008-09-01|May 2009|2009-05-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|RACE||Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)|Randomized Comparison of Adenosin Intracoronary Infusion and Clopidogrel Pretreatment on Myonecrosis Occurence in Elective PCI|Unknown status|Recruiting|Phase 3|60|Anticipated|University of Roma La Sapienza||3|||f||||f||||||||||2017-02-18 13:56:42.506242|2017-02-18 13:56:42.506242
NCT00751478|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2013-09-13|||March 2007||2007-03-01|September 2013|2013-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)|A Randomized, Double-Blind, Triple-Dummy, Single-Dose, Four-Way Crossover Study to Determine the Relative Bioavailability, Pharmacodynamic Effects, and Safety of Equivalent Doses of Whole and Crushed ALO-01 Versus Morphine IR in Opioid Experienced, Non-Dependent Subjects|Completed||Phase 1/Phase 2|32|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:56:42.613675|2017-02-18 13:56:42.613675
NCT00751465|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-09-10|||November 2008||2008-11-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Dysfunctional Attention Processes in Fear of Blushing: Specificity and Changeability|Clinical Specificity of Dysfunctional Habitual Attention Processes in Fear of Blushing and Their Changeability|Completed||N/A|82|Actual|Technische Universität Dresden||3|||f||||t||||||||||2017-02-18 13:56:42.720827|2017-02-18 13:56:42.720827
NCT00751452|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2011-01-18|||April 2008||2008-04-01|January 2011|2011-01-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Observational|||Citrulline Allo. Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in Children|Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in Children|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital, Clermont-Ferrand|||2||f||||||||||||||2017-02-18 13:56:42.835379|2017-02-18 13:56:42.835379
NCT00751439|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2010-06-10|||June 2008||2008-06-01|June 2010|2010-06-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Observational|||Verification of Pulse Oximetry in Neonatal Population|Verification of Pulse Oximetry in Neonatal Population|Completed||N/A|25|Anticipated|Children's Hospitals and Clinics of Minnesota|||1||f||||f||||||||||2017-02-18 13:56:42.92607|2017-02-18 13:56:42.92607
NCT00751426|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2008-09-11|||August 1999||1999-08-01|August 2008|2008-08-01|May 2002|Actual|2002-05-01|February 2002|Actual|2002-02-01||Observational|||Treatment of Hepatitis C in Psychiatric Patients|Treatment of Chronic Hepatitis c With Interferon-Alpha 2a and Ribavirin: a Comparison of Patients With Psychiatric Disorders and Controls|Completed||Phase 4|81|Actual|Charite University, Berlin, Germany|||||f||||t||||||||||2017-02-18 13:56:43.106199|2017-02-18 13:56:43.106199
NCT00751413|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-05-29|||August 2008||2008-08-01|May 2015|2015-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Plasma Levels of MK0633 in Children Ages 6-12 (0633-023)|A Multicenter, Open-Label, Single Dose Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 6 to Less Than 12 Years|Completed||Phase 1|22|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 13:56:43.209217|2017-02-18 13:56:43.209217
NCT00751400|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2015-08-12|2011-01-03||July 2008||2008-07-01|August 2015|2015-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Naproxen Sodium Extended-Release Actual Use Study|An Open Label, Actual Use Study in Consumers Taking an Extended-Release Over the Counter NSAID in a Naturalistic Setting|Completed||Phase 3|497|Actual|Bayer|No control group, detailed data collected for up to 10 days during 1 month followup, data recall by subjects may vary|1|||f||||f||||||||||2017-02-18 13:56:43.304543|2017-02-18 13:56:43.304543
NCT00751387|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-11|2010-11-27|||November 2008||2008-11-01|November 2010|2010-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia|Australian Descriptive Epidemiology Study of Severity of Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS) and Exposure to Biological Disease Modifying Anti-rheumatic Drugs (bDMARDs)|Completed||N/A|559|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 13:56:43.785737|2017-02-18 13:56:43.785737
NCT00751374|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-10|||September 2008||2008-09-01|September 2008|2008-09-01|October 2014|Anticipated|2014-10-01|October 2014|Anticipated|2014-10-01||Interventional|||Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis|Prospective, Randomized, Open-Label Study of Topical Antibiotic Prophylaxis at the Catheter Exit Site: Continuous Daily Gentamicin Cream Versus Cyclical Gentamicin Cream and Mupirocin 2% Cream Alternating at Monthly Basis.|Unknown status|Not yet recruiting|Phase 4|500|Anticipated|Kwong Wah Hospital||2|||f||||t||||||||||2017-02-18 13:56:44.026223|2017-02-18 13:56:44.026223
NCT00751361|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-10|||November 1998||1998-11-01|September 2008|2008-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|ART||Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial|Prospective, Randomized, Controlled Clinical Study Evaluating the Efficacy of Rheopheresis for Dry Age-Related Macular Degeneration Dry AMD Treatment With Rheopheresis Trial - ART|Completed||Phase 4|52|Actual|Apheresis Research Institute||2|||f||||t||||||||||2017-02-18 13:56:44.135127|2017-02-18 13:56:44.135127
NCT00751348|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-09-27||2010-07-02|October 2008||2008-10-01|September 2016|2016-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136|Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136|Completed||Phase 3|475|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:56:44.239631|2017-02-18 13:56:44.239631
NCT00751335|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2009-06-22|||August 2006||2006-08-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||ThermoSmart® Versus Conventional Humidification in Continuous Positive Airway Pressure (CPAP)|Prospective, Randomized, Double-Blind Cross-Over Study Comparing ThermoSmart® to Conventional Heated Humidity in Patients Suing Continuous Positive Airway Pressure|Completed||N/A|79|Actual|Fisher and Paykel Healthcare||2|||f||||f||||||||||2017-02-18 13:56:44.368312|2017-02-18 13:56:44.368312
NCT00751322|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2012-01-27|||August 2008||2008-08-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|July 2010|Actual|2010-07-01||Interventional|TRALI2||Transfusion-Induced Alterations of Pulmonary and Immune Function in Mechanically Ventilated Patients|Project 2 (Mayo): Transfusion-Induced Alterations of Pulmonary and Immune Function in Mechanically Ventilated Patients|Completed||N/A|100|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 13:56:44.477706|2017-02-18 13:56:44.477706
NCT00751309|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-12-17|||April 2004||2004-04-01|December 2008|2008-12-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Observational|LARGO||Lung Allograft Rejection Gene Expression Observational (LARGO) Study|Lung Allograft Rejection Gene Expression Observational (LARGO) Study|Terminated||N/A|2044|Actual|XDx|||1|Restructuring and refocus of company.|f||||f||||||Samples Without DNA|"~     venous blood plasma~   "|||2017-02-18 13:56:44.590501|2017-02-18 13:56:44.590501
NCT00751296|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-05-12|2015-12-29||August 2006||2006-08-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|Rev-CLL||Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)|A Phase 2 Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 2|27|Actual|University Health Network, Toronto|Original study protocol used a starting lenalidomide dose of 10mg OD for 21days of a 28-day cycle, escalating weekly by 5mg to a target of 25mg daily. Toxicities reported with the first two enrolled patients lead to the current protocol amendment.|1||Seven years of follow-up & final analysis done in Dec 2012.|f||||t||||||||||2017-02-18 13:56:44.723928|2017-02-18 13:56:44.723928
NCT00751283|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2013-08-12|||August 2007||2007-08-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|||Radiofrequency for the Treatment of Peripheral Vascular Occlusive Disease of the Lower Extremities|Minnow Medical GRST Peripheral Catheter System First-in-Man Study Radiofrequency for the Treatment of Peripheral Vascular Occlusive Disease of the Lower Extremities|Withdrawn||Phase 2/Phase 3|0|Actual|Vessix Vascular, Inc||1||Data was inconclusive|f||||t||||||||||2017-02-18 13:56:45.048045|2017-02-18 13:56:45.048045
NCT00751270|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2016-03-02|||November 2005||2005-11-01|March 2016|2016-03-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|BrTK01||Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas|A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas|Completed||Phase 1|15|Actual|Advantagene, Inc.||2|||f||||t||||||||||2017-02-18 13:56:45.150924|2017-02-18 13:56:45.150924
NCT00751257|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2012-09-11|||December 2006||2006-12-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||N-Acetylcysteine and Smoking Reduction|A Randomized Controlled Trial of Oral N-acetylcysteine for Smoking Reduction: a Pilot Study|Completed||Phase 2|33|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 13:56:45.268496|2017-02-18 13:56:45.268496
NCT00751244|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2010-09-24|||January 2005||2005-01-01|September 2010|2010-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|MOMS||Mothers Overcoming and Managing Stress|Breaking the Cycle for Women With Behavioral Problems and Crime|Completed||Phase 2|147|Actual|UConn Health||3|||f||||f||||||||||2017-02-18 13:56:45.369732|2017-02-18 13:56:45.369732
NCT00751231|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2012-06-26|||December 2008||2008-12-01|June 2012|2012-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|INNOVATE-PCI||A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI|A Randomized, Double-Blind, Active-Controlled Trial to Evaluate Intravenous and Oral PRT060128, a Selective and Reversible P2Y12 Inhibitor, vs Clopidogrel, as a Novel Antiplatelet Therapy in Patients Undergoing Non-Urgent PCI|Completed||Phase 2|652|Actual|Portola Pharmaceuticals||4|||f||||t||||||||||2017-02-18 13:56:45.496883|2017-02-18 13:56:45.496883
NCT00751218|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2015-05-04|||May 2004||2004-05-01|May 2015|2015-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)|A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (CIU)|Completed||Phase 4|174|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 13:56:45.669789|2017-02-18 13:56:45.669789
NCT00751205|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2014-10-27|||August 2008||2008-08-01|October 2014|2014-10-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Interventional|||Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)|(REASON) Double-blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl-l-carnitine in the Prevention of Sagopilone-induced Peripheral Neuropathy.|Completed||Phase 2|150|Actual|Bayer||2|||f||||f||||||||||2017-02-18 13:56:45.778084|2017-02-18 13:56:45.778084
NCT00751192|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-10-08|||October 2007||2007-10-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Peru||Completed||N/A|||NGO Via Libre||2|||f||||f||||||||||2017-02-18 13:56:45.907646|2017-02-18 13:56:45.907646
NCT00751179|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2015-06-03|2012-02-23||November 2008||2008-11-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Rocuronium Plus Sugammadex Versus Succinylcholine Alone in Participants Undergoing Short Surgical Procedures (19.4.319)(P05700 AM2)(COMPLETED)|A Multi-center, Randomized, Parallel Group, Comparative, Active Controlled, Safety Assessor Blinded Trial in Adult Subjects Comparing Rocuronium Plus Sugammadex Versus Succinylcholine Alone in Subjects Undergoing Short Surgical Procedures in Out-patient Surgicenters|Completed||Phase 3|161|Actual|Merck Sharp & Dohme Corp.|The potassium change from baseline interval included most/all of the intubation/surgical period for the sug but not the suc or roc analysis. AE reporting interval included the entire intubation/surgery period for the suc but not the roc-sug group.|2|||f||||f||||||||||2017-02-18 13:56:46.008794|2017-02-18 13:56:46.008794
NCT00751166|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2015-05-04|||March 2004||2004-03-01|May 2015|2015-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)|A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (CIU)|Terminated||Phase 4|149|Actual|Merck Sharp & Dohme Corp.||3||Study could not be re-supplied with study medication in a timely manner.|f||||f||||||||||2017-02-18 13:56:46.466847|2017-02-18 13:56:46.466847
NCT00751153|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-10-08|||March 2008||2008-03-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment|Open Label Phase 4, 48 Week Pilot Study of the Antiviral Efficacy and Tolerability of the Combination of Isentress™ and ReyatazTM When Substituted for Current Antiviral Regimen in Patients With Viral Suppression But Who Are Experiencing Adverse Events Related to Their Current Antiviral Regimen.|Unknown status|Recruiting|Phase 4|40|Anticipated|Peter J. Ruane, M.D., Inc.||1|||f||||f||||||||||2017-02-18 13:56:46.557532|2017-02-18 13:56:46.557532
NCT00751140|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2012-12-04|2012-12-04||September 2008||2008-09-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection|Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract|Completed||Phase 2|20|Actual|H. Lee Moffitt Cancer Center and Research Institute|The sample size was small because it was a single institution study. It was thus underpowered to achieve a cancer-specific endpoint pertaining to the oncological merit of performing a modified RPLND in the context of UUT-UC.|1|||f||||t||||||||||2017-02-18 13:56:46.654989|2017-02-18 13:56:46.654989
NCT00751127|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2011-03-24|||January 1993||1993-01-01|September 2008|2008-09-01|February 1994|Actual|1994-02-01|February 1994|Actual|1994-02-01||Interventional|||A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension|A 6-month, Randomized, Double-masked Comparison of Latanoprost (PhXA41) With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension. A Multi-centre Study in the United States.|Completed||Phase 3|268|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:56:46.905716|2017-02-18 13:56:46.905716
NCT00751114|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2012-09-03|2012-07-06||November 2008||2008-11-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|EASIE||Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients|Superiority Study of Insulin Glargine Over Sitagliptin in Insulin-naïve Patients With Type 2 Diabetes Treated With Metformin and Not Adequately Controlled|Completed||Phase 4|515|Actual|Sanofi||2|||f||||||||||||||2017-02-18 13:56:47.137367|2017-02-18 13:56:47.137367
NCT00751101|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-05-12|||August 2007||2007-08-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|March 2012|Actual|2012-03-01||Interventional|||Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer|Pilot Study of Nicotine Patches to Reduce Hand-Foot Syndrome Associated With Capecitabine Chemotherapy in Patients With Metastatic Breast Cancer|Active, not recruiting||N/A|24|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 13:56:47.990641|2017-02-18 13:56:47.990641
NCT00751088|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2013-02-26|||September 2008||2008-09-01|July 2009|2009-07-01||||||||Interventional|||A Randomized Controlled Study Comparing Three Single-incision Devices for Female Urinary Stress Incontinence|A Comparison Among Three Single-incision Devices for the Treatment of Female Urinary Genuine Stress Incontinence: a Randomized Controlled Study.|Completed||Phase 4|||University Magna Graecia||4|||f||||||||||||||2017-02-18 13:56:48.251751|2017-02-18 13:56:48.251751
NCT00751075|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2015-06-29|||December 2003||2003-12-01|June 2015|2015-06-01|June 2004|Actual|2004-06-01|May 2004|Actual|2004-05-01||Interventional|||Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)|Efficacy and Safety of 200 mcg QD or 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) vs Amoxicillin vs Placebo as Primary Treatment of Subjects With Acute Rhinosinusitis|Completed||Phase 3|981|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:56:48.369714|2017-02-18 13:56:48.369714
NCT00751062|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-10|||November 1992||1992-11-01|September 2008|2008-09-01|December 1993|Actual|1993-12-01|December 1993|Actual|1993-12-01||Interventional|||A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia|A 6-Month, Randomized, Double-Masked Comparison of PhXA41 With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension. A Multi-Centre Study in Scandinavia|Completed||Phase 3|267|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:56:48.470386|2017-02-18 13:56:48.470386
NCT00751049|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-10|||December 1992||1992-12-01|September 2008|2008-09-01|December 1993|Actual|1993-12-01|December 1993|Actual|1993-12-01||Interventional|||A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom|A 6-Month, Randomized, Double-Masked Comparison of PhXA41 With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension. A Multi-Centre Study in the United Kingdom|Completed||Phase 3|294|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:56:48.596595|2017-02-18 13:56:48.596595
NCT00751036|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2014-02-25|2013-10-29||June 2009||2009-06-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|MACS0375||Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg|Randomized Phase III Trial Comparing Nilotinib 800mg to Imatinib 800 mg for the Treatment of Patients With Advanced and/or Metastatic Gastrointestinal Stromal Tumors Refractory to Imatinib 400 mg|Terminated||Phase 3|94|Actual|Novartis|Patients were limited (planned 300, Actual 94). Early termination of study; not sufficient power to test the original primary hypothesis with respect to PFS. Only descriptive analyses were carried out for this study.|2|||f||||f||||||||||2017-02-18 13:56:48.729226|2017-02-18 13:56:48.729226
NCT00750997|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-09-23|||November 2007||2007-11-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Hypertonic Modulation of Inflammation Following Injury|Hypertonic Modulation of Inflammation Following Injury|Terminated||N/A|119|Actual|National Institute of General Medical Sciences (NIGMS)|||2|Enrollment in the clinical trial was stopped for futility|f||||t||||||Samples Without DNA|"~     plasma~   "|||2017-02-18 13:56:49.571286|2017-02-18 13:56:49.571286
NCT00750984|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-09-30|||September 2008||2008-09-01|September 2016|2016-09-01|February 2017|Anticipated|2017-02-01|July 2013|Actual|2013-07-01||Interventional|||A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing|A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing|Active, not recruiting||N/A|49|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 13:56:49.680787|2017-02-18 13:56:49.680787
NCT00750971|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2011-07-20|||August 2008||2008-08-01|August 2009|2009-08-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|ASSIST||Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)|An Open-Label, Phase II Multicenter Cohort Study of Immunoablation With Cyclophosphamide and Antithymocyte-Globulin and Transplantation of Autologous Cd34-Enriched Hemapoietic Stem Cells Versus Currently Available Immunosuppressive/Immunomodulatory Therapy for Treatment of Refractory Systemic Lupus Erythematosus|Unknown status|Recruiting|Phase 2|30|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 13:56:49.780279|2017-02-18 13:56:49.780279
NCT00750958|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-10|||June 2008||2008-06-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|PREVENT||PREVENT - Prospective Rhythm Event Surveillance in the ER With NetGuard|PREVENT - Prospective Rhythm Event Surveillance in the ER With NetGuard|Completed||N/A|287|Actual|Datascope Patient Monitoring||1|||f||||t||||||||||2017-02-18 13:56:49.886805|2017-02-18 13:56:49.886805
NCT00750945|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2009-09-25|||September 2008||2008-09-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Treadmill and Music Cueing for Gait Training in Mild to Moderate Parkinson's Disease|Treadmill and Music Cueing for Gait Training in Mild to Moderate Parkinson's Disease: a Preliminary Study|Completed||N/A|30|Actual|Chulalongkorn University||3|||f||||t||||||||||2017-02-18 13:56:49.985186|2017-02-18 13:56:49.985186
NCT00750932|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-11-13|||January 2008||2008-01-01|November 2008|2008-11-01||||||||Observational|Pro-Muco||Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis|Study of the Biodistribution of PMN Serine Proteases in Sputum of Patients Affected by Cystic Fibrosis: Towards New Anti-Inflammatory Therapies|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Tours|||3||f||||t||||||Samples With DNA|"~     Whole blood Sputum~   "|||2017-02-18 13:56:50.087288|2017-02-18 13:56:50.087288
NCT00750919|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2015-07-02|2014-05-22||October 2008||2008-10-01|July 2015|2015-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)|A Twenty-six Weeks, Open-label Extension Trial to Evaluate Safety and Efficacy of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia Who Completed Clinical Trial Protocol 21106|Terminated||Phase 3|184|Actual|Merck Sharp & Dohme Corp.|This study was terminated due to the Sponsor's decision not to continue development of esmertazapine for this indication.|1||"This trial was stopped prematurely due to the Sponsor's decision not to continue the~   development of esmertazapine for this indication."|f||||f||||||||||2017-02-18 13:56:50.166278|2017-02-18 13:56:50.166278
NCT00750906|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2013-03-06|||October 2008||2008-10-01|March 2013|2013-03-01||||||||Observational|||ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes|The Muscle Biochemical, Serum Potassium and Cardiovascular Changes After Succinylcholine in Patients Undergoing Electroconvulsive Therapy.|Suspended||N/A|20|Anticipated|University of California, San Francisco|||1|Study on hold since 2009. Awaiting FDA approval of Sugammdex to complete second arm of study.|f||||f||||||||||2017-02-18 13:56:50.505974|2017-02-18 13:56:50.505974
NCT00750893|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2014-10-23|2011-01-28||September 2008||2008-09-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants|Safety of GlaxoSmithKline Biologicals' Oral Live Attenuated Human Rotavirus Vaccine, Rotarix™ or Rotarix™ Liquid Formulation (Oral Suspension or Prefilled Syringe) When Administered According to the Prescribing Information in Korea|Completed||N/A|3111|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 13:56:50.590308|2017-02-18 13:56:50.590308
NCT00750880|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2015-06-29|2014-07-15||September 2008||2008-09-01|June 2015|2015-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Inten-to-Treat (ITT) population: all participants included in the study who received at least 1 dose of study medication.|An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.|International Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy.|Completed||Phase 3|1681|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 13:56:51.065016|2017-02-18 13:56:51.065016
NCT00750867|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2015-09-28|2013-12-26||June 2008||2008-06-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|September 2009|Actual|2009-09-01||Interventional|||Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins|Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins|Completed||Phase 2|9|Actual|University of Massachusetts, Worcester|The main study limitation is its small size and open label character.|1|||f||||f||||||||||2017-02-18 13:56:54.741749|2017-02-18 13:56:54.741749
NCT00750854|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-02-11|||November 2003||2003-11-01|February 2016|2016-02-01|April 2004|Actual|2004-04-01|February 2004|Actual|2004-02-01||Interventional|||Efficacy & Safety Study of Natural Eggshell Membrane (NEM) for the Treatment of Joint & Connective Tissue Disorders|A Double Arm Study to Evaluate the Effectiveness of NEM Compositions for the Treatment of Joint and Connective Tissue Pain|Completed||N/A|28|Actual|ESM Technologies, LLC||2|||f||||f||||||||No||2017-02-18 13:56:55.009101|2017-02-18 13:56:55.009101
NCT00750841|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-09-22|||September 2008||2008-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|July 2009|Actual|2009-07-01||Interventional|||Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours|A Phase I, Open Label, Non-Randomised Study to Assess the Effect of Rifampicin on the Pharmacokinetics of Multiple Oral Doses of Cediranib (AZD2171, RECENTIN™), in Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|88|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:56:55.122022|2017-02-18 13:56:55.122022
NCT00750828|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2008-09-10|||January 2004||2004-01-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Observational|||Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry Mouth|Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry Mouth|Completed||N/A|28|Actual|Hacettepe University|||1||f||||t||||||||||2017-02-18 13:56:55.433917|2017-02-18 13:56:55.433917
NCT00750815|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2013-12-03|2013-09-23||September 2008||2008-09-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional||Overall Survival by disease risk stratification: 54 participants with cytogenetics and fluorescence in situ hybridisation (FISH) results available for risk stratification. All other measures: 58 Participants.|Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)|An Open Label Phase I/II Study of the Safety and Efficacy of Cyclophosphamide, Bortezomib (VELCADE), Pegylated Liposomal Doxorubicin (DOXIL), and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|58|Actual|H. Lee Moffitt Cancer Center and Research Institute|Trial closed early after 58 patients were enrolled due to slow accrual and shortage of pegylated liposomal doxorubicin. Only 54 participants had cytogenetics and fluorescence in situ hybridisation (FISH) results available for risk stratification.|2|||f||||t||||||||||2017-02-18 13:56:55.522518|2017-02-18 13:56:55.522518
NCT00750802|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2009-06-25|||September 2008||2008-09-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|||||Interventional|||A Sedation/Cognition/EEG Study Using AZD6280 and Comparator|A Phase 1, Single Centre, Single Dose, Double-Blind, Double-Dummy, Four-Way Crossover, Placebo-Controlled, Randomized Study to Investigate the Effects of AZD6280 on Sedation, Cognition and EEG in Comparison With Lorazepam in Healthy Male Volunteers|Completed||Phase 1|17|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 13:56:56.343224|2017-02-18 13:56:56.343224
NCT00750789|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2008-09-10|||September 2008||2008-09-01|September 2008|2008-09-01||||November 2008|Anticipated|2008-11-01||Interventional|||The Effect of Dates on Plasma Lipids, Oxidative Stress and the Atherogenicity of Serum in Healthy Adults||Unknown status|Not yet recruiting|Phase 4|10|Anticipated|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-02-18 13:56:56.444058|2017-02-18 13:56:56.444058
NCT00750776|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2013-04-14|||August 2003||2003-08-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|||||Observational|KvaliMed||KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment|KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment|Terminated||N/A|212|Anticipated|Psychiatric Centre Rigshospitalet|||1|Due to lack of financial support|f||||f||||||||||2017-02-18 13:56:56.544306|2017-02-18 13:56:56.544306
NCT00750763|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2009-08-24|||January 2008||2008-01-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Tolerability, Efficacy and Mucosal Inflammation Associated With Orally Administered Colon Cleansing for Colonoscopy|A Prospective Audit of Tolerability, Mucosal Cleansing Efficacy and Mucosal Abnormalities Associated With Standard Orally Administered Colon Cleansing Preparations for Colonoscopy|Completed||Phase 4|676|Actual|Fremantle Hospital and Health Service||3|||f||||f||||||||||2017-02-18 13:56:56.655241|2017-02-18 13:56:56.655241
NCT00750750|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2015-04-20|||January 2003||2003-01-01|April 2015|2015-04-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)|Efficacy and Safety of 200 mcg QD or 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) vs Amoxicillin vs Placebo as Primary Treatment of Subjects With Acute Rhinosinusitis|Completed||Phase 2|981|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 13:56:56.774053|2017-02-18 13:56:56.774053
NCT00750737|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-10|2016-08-22|2015-12-01||June 2008||2008-06-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)|Phase III Clinical Trial of Oral Posaconazole 3 Times/Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) for Prevention of Invasive Fungal Infections In Patients With Hematologic Malignancies & Hematopoietic Stem Cell Transplant|Completed||Phase 3|46|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 13:56:56.878307|2017-02-18 13:56:56.878307
NCT00750724|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2010-05-25|||July 2008||2008-07-01|July 2009|2009-07-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|GoOn MRI||"Efficacy Study of Go On in Magnetic Resonance Imaging (MRI) Improvement in Osteoarthritis (OA) Knee"|Phase 3 Study GoON and MRI Improvement in OA Knee|Completed||Phase 3|60|Actual|Khon Kaen University||2|||f||||t||||||||||2017-02-18 13:56:57.308161|2017-02-18 13:56:57.308161
NCT00750711|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-15|||March 2008||2008-03-01|September 2008|2008-09-01||||January 2010|Anticipated|2010-01-01||Interventional|||Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters|Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-02-18 13:56:57.431377|2017-02-18 13:56:57.431377
NCT00750698|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2011-03-17|||August 2008||2008-08-01|February 2010|2010-02-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Patients With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib|A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Patients With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib|Completed||Phase 2|70|Anticipated|Syndax Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:56:57.509942|2017-02-18 13:56:57.509942
NCT00750685|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2014-12-17||2014-12-17|March 2007||2007-03-01|December 2014|2014-12-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Interventional|||Study of the Mentor Becker Expander/Breast Implant in Subjects Who Are Undergoing Primary Breast Reconstruction|Study of the Safety and Effectiveness of the Mentor Becker Expander/Breast Implant in Subjects Who Are Undergoing Primary Breast Reconstruction|Terminated||Phase 3|315|Actual|Mentor Worldwide, LLC||1||Sponsor Terminated|t||||f||||||||||2017-02-18 13:56:57.623193|2017-02-18 13:56:57.623193
NCT00750672|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2012-07-11|||August 2008||2008-08-01|July 2012|2012-07-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Observational|||Follow-up Care After Treatment for Endometrial Cancer|Follow-up After Primary Therapy for Endometrial Cancer; Implementation of a Cancer Care Ontario Guideline: A Pilot Evaluation Study.|Completed||N/A|20|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 13:56:57.717032|2017-02-18 13:56:57.717032
NCT00750659|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2016-04-19|||July 2009||2009-07-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Nilotinib Pre and Post Allogeneic Stem Cell Transplantation|Open-label Trial of Nilotinib in Patients With Advanced (>CP1) Chronic Myeloid Leukemia or Ph+ Acute Lymphatic Leukemia Pre- and Post- Allogeneic Stem Cell Transplantation.|Completed||Phase 2|24|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 13:56:57.996198|2017-02-18 13:56:57.996198
NCT00750646|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-09|||September 2008||2008-09-01|September 2008|2008-09-01|August 2009|Anticipated|2009-08-01|March 2009|Anticipated|2009-03-01||Observational|||Observational Study of How Patients Take Eye Drops|The Relationship Between Glaucoma Medication Self-Efficacy, Outcome Expectations, Eye Drop Tech., Adherence and IOP.|Unknown status|Recruiting|N/A|220|Anticipated|Robin, Alan L., M.D.|||1||f||||t||||||||||2017-02-18 13:56:58.101123|2017-02-18 13:56:58.101123
NCT00750633|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2012-11-29||2012-11-28|June 2008||2008-06-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Phase III Study of an Otic Formulation in Acute Otitis Externa||Completed||Phase 3|990|Actual|Alcon Research||3|||f||||t||||||||||2017-02-18 13:56:58.212749|2017-02-18 13:56:58.212749
NCT00750620|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-09-04|||September 2008||2008-09-01|September 2013|2013-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment|A Phase 1, Open-Label, Single-Dose, Parallel-Group Study to Assess the Effect of Mild, Moderate and Severe Renal Impairment on the Pharmacokinetics of YM178|Completed||Phase 1|33|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-02-18 13:56:58.307201|2017-02-18 13:56:58.307201
NCT00750594|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2012-06-04|||April 2008||2008-04-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Patent Foramen Ovale in Children With Migraine Headaches|Patent Foramen Ovale in Children With Migraine Headaches|Completed||N/A|109|Actual|University of Utah|||2||f||||f||||||||||2017-02-18 13:56:58.417065|2017-02-18 13:56:58.417065
NCT00750581|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2016-08-17|||August 2008||2008-08-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants|An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants- A Randomized Pilot Study|Terminated||Phase 2/Phase 3|9|Actual|University of Calgary||2||Study medication was no longer available for study|f||||t||||||||||2017-02-18 13:56:58.514209|2017-02-18 13:56:58.514209
NCT00750568|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-09|||October 2007||2007-10-01|August 2008|2008-08-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Observational|||Intravenous Terbutaline in Severe Status Asthmaticus|Pharmacokinetics and Pharmacodynamics of Terbutaline Given as a Continuous Intravenous Infusion in Severe Status Asthmaticus|Unknown status|Enrolling by invitation|N/A|36|Anticipated|Wayne State University|||3||f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 13:56:58.61951|2017-02-18 13:56:58.61951
NCT00750555|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2012-10-10|||September 2008||2008-09-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer|Phase II Study of Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer|Terminated||Phase 2|4|Actual|Geisinger Clinic||1||Dr. Amy Law left Geisinger Health System. 4 patients enrolled|f||||f||||||||||2017-02-18 13:56:58.724876|2017-02-18 13:56:58.724876
NCT00750529|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2014-07-04|||November 2008||2008-11-01|July 2014|2014-07-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Alzheimer and Sleep|Effects of Galantamine and Donépézil on the Amount and the Quality oh the Sleep in Patients Suffering From Alzheimer Disease.|Completed||Phase 1|15|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:56:58.836628|2017-02-18 13:56:58.836628
NCT00750516|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2009-06-24|||September 2008||2008-09-01|June 2009|2009-06-01||||||||Observational|||Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet|Lactic Acid Levels In Hypotensive Patients Without(Standard) and With Tourniquet|Suspended||N/A|100|Anticipated|State University of New York - Upstate Medical University|||1|Insufficient patient enrolled|f||||f||||||||||2017-02-18 13:56:58.949005|2017-02-18 13:56:58.949005
NCT00750503|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-09|||June 2007||2007-06-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Workplace Tobacco Cessation And Oral Cancer Screening Study|Workplace Tobacco Cessation And Oral Cancer Screening Study|Completed||Phase 3|104|Actual|Tata Memorial Hospital|||||f||||t||||||||||2017-02-18 13:56:59.036113|2017-02-18 13:56:59.036113
NCT00750477|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2016-02-11|||December 2004||2004-12-01|February 2016|2016-02-01|May 2006|Actual|2006-05-01|January 2006|Actual|2006-01-01||Interventional|OPTION||Efficacy & Safety Study Evaluating Natural Eggshell Membrane (NEM) in the Treatment of Osteoarthritis|A Multi-Center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of Natural Eggshell Membrane (NEM) in the Treatment of Pain & Stiffness Associated With Moderate Osteoarthritis of the Knee|Completed||N/A|67|Actual|ESM Technologies, LLC||2|||f||||f||||||||No||2017-02-18 13:56:59.125636|2017-02-18 13:56:59.125636
NCT00750464|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2009-10-12|||November 2008||2008-11-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|||||Observational|||Collection of Raw Data of Thermal Imaging for the Purpose of Developing a Device for Early Detection of Breast Cancer|Collection of Raw Data of Thermal Imaging for the Purpose of Developing a Device for Early Detection of Breast Cancer|Completed||N/A|575|Actual|Real Imaging Ltd.|||1||f||||f||||||||||2017-02-18 13:56:59.237229|2017-02-18 13:56:59.237229
NCT00750451|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2009-03-19|||January 2006||2006-01-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Low Molecular Weight Heparin in Recurrent Implantation Failure|Empirical Low Molecular Weight Heparin Administration in the Luteal Phase in Patients With Recurrent Implantation Failures: a Randomized Open Labeled Trial|Completed||N/A|||V.K.V. American Hospital, Istanbul||2|||f||||||||||||||2017-02-18 13:56:59.311722|2017-02-18 13:56:59.311722
NCT00750438|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2016-11-18|||September 2008||2008-09-01|July 2009|2009-07-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|||Effect of Fibre Products on Appetite and Weight|Increased Short Chain Fatty Acids in the Colon Are Associated With Improved Energy Homeostasis and Insulin Sensitivity.|Completed||N/A|58|Actual|Imperial College London||3|||f||||t||||||||||2017-02-18 13:56:59.409851|2017-02-18 13:56:59.409851
NCT00750425|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2011-03-09|||August 2008||2008-08-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|April 2009|Actual|2009-04-01||Interventional|||Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours|A Phase I, Open Label, Non-Randomised Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Multiple Oral Doses of Cediranib (AZD2171, RECENTINÔ), in Patients With Advanced Solid Tumours|Completed||Phase 1|46|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:56:59.509882|2017-02-18 13:56:59.509882
NCT00749476|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2011-06-06|2010-01-29||April 2008||2008-04-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX|Reformulated BeneFIX Efficacy and Safety After Conversion From a pdFIX|Completed||Phase 4|1|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:57:18.604146|2017-02-18 13:57:18.604146
NCT00750412|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2011-10-17|||March 2009||2009-03-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||An Assessment of Voluntary Adolescent Mental Health Screening and Referral in a Children's Hospital Emergency Department|An Assessment of Voluntary Adolescent Mental Health Screening and Referral in a Children's Hospital Emergency Department|Completed||N/A|112|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-02-18 13:56:59.602928|2017-02-18 13:56:59.602928
NCT00750399|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2012-04-25|||October 2008||2008-10-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma|An Open Label Study to Evaluate the Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma|Completed||Phase 1|10|Actual|The New York Eye Cancer Center||1|||f||||f||||||||||2017-02-18 13:56:59.698441|2017-02-18 13:56:59.698441
NCT00750386|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2011-05-20|||January 2008||2008-01-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas|Dose Dense Administration of Paclitaxel and Carboplatin Combination as 1st Line Treatment in Patients With Ovarian Carcinoma|Completed||Phase 1/Phase 2|50|Anticipated|Hellenic Oncology Research Group||1|||f||||||||||||||2017-02-18 13:56:59.819047|2017-02-18 13:56:59.819047
NCT00750373|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2015-04-06|2012-06-29||September 2006||2006-09-01|April 2015|2015-04-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|EASE||Early Surgery Versus Conventional Treatment in Infective Endocarditis|A Randomized Comparison of Early Surgery Versus Conventional Treatment Strategy in Patients With High Embolic Risk of Infective Endocarditis|Completed||Phase 4|76|Actual|Asan Medical Center|The EASE trial was a limited study in scope, in that it included patients with severe valvular disease and large vegetations, and excluded those with major stroke, prosthetic valve endocarditis or aortic abscess.|2|||f||||f||||||||||2017-02-18 13:56:59.936176|2017-02-18 13:56:59.936176
NCT00750360|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2016-11-03|2008-12-23||October 2003||2003-10-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.|Study to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals' Influenza Split Vaccine FLUARIX™ Administered According to the Prescribing Information in Korean Subjects Aged More Than 6 Months of Age at the Time of Vaccination|Completed||Phase 4|883|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:57:00.355047|2017-02-18 13:57:00.355047
NCT00750347|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2011-01-18|||September 2008||2008-09-01|January 2011|2011-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Antagonistic Interaction CB1-paracetamol|Evaluation of the Interaction of Rimonabant (Antagonist of CB1 Receptor) on the Analgesic Effect of Paracetamol in Intravenous Administration|Completed||Phase 1|24|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:57:01.08398|2017-02-18 13:57:01.08398
NCT00750334|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2015-05-19|||September 2008||2008-09-01|May 2015|2015-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)|A Phase I, Open-Label, Dose-Finding and Food Effect Study of Oral Clofarabine in Previously Treated Adult Patients With Myelodysplastic Syndromes (MDS)|Terminated||Phase 1|2|Actual|Sanofi||2||Terminated to focus on comparable trial, CLOMDS02507|f||||f||||||||||2017-02-18 13:57:01.184245|2017-02-18 13:57:01.184245
NCT00750321|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-09||||||September 2008|2008-09-01||||||||Interventional|||Placebo Transcutaneous Electrical Nerve Stimulation (TENS)||Completed||N/A|||University of Iowa||3|||f||||||||||||||2017-02-18 13:57:01.294987|2017-02-18 13:57:01.294987
NCT00750308|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2014-12-08|2010-01-06||December 2006||2006-12-01|December 2014|2014-12-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional||We provide baseline data for those 18 subjects who completed all four treatment arms and whose data are analyzed in this crossover study.|Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i|Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi|Completed||N/A|27|Actual|Vanderbilt University||12|||f||||f||||||||||2017-02-18 13:57:01.371678|2017-02-18 13:57:01.371678
NCT00750295|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2013-10-16|||February 2007||2007-02-01|August 2011|2011-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis|An Open Label, Multiple Dose, Time-lagged, Switch Study to Evaluate the Safety, Tolerability and Activity of Escalating SBR759 Doses in Patients With Chronic Kidney Disease on Hemodialysis|Completed||Phase 1/Phase 2|60|Actual|Novartis||7|||f||||f||||||||||2017-02-18 13:57:02.124649|2017-02-18 13:57:02.124649
NCT00750282|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2014-07-15|2014-06-16||August 2008||2008-08-01|July 2014|2014-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||"dropout in Part A occurred due to pre-treatment AEs.~dropouts in Part B occurred due to withdrawal of consent."|Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers|An Open-label, Non-randomized, Multi-center Study to Optimize Image Assessment and Evaluate the Efficacy and Safety of BAY 94-9172 (ZK 6013443) Positron Emission Tomography (PET) for Detection/Exclusion of Cerebral Amyloid Beta in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers|Completed||Phase 2|422|Actual|Piramal Imaging SA||1|||f||||f||||||||||2017-02-18 13:57:02.238554|2017-02-18 13:57:02.238554
NCT00750269|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2015-10-13|||February 2009||2009-02-01|October 2015|2015-10-01||||September 2014|Actual|2014-09-01||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer|Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients|Active, not recruiting||Phase 1/Phase 2|110|Anticipated|Radiation Therapy Oncology Group||9|||f||||t||||||||||2017-02-18 13:57:03.132097|2017-02-18 13:57:03.132097
NCT00750256|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2012-03-15|||July 2008||2008-07-01|February 2011|2011-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects|A Phase I, Randomized, Single-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 13:57:03.308476|2017-02-18 13:57:03.308476
NCT00750243|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-10-04||2010-09-17|September 2008||2008-09-01|October 2010|2010-10-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation|A Double-Blind, Randomized, Active Comparator Study of LT-NS001 Versus Naprosyn for Seven Days in Healthy Subjects With Endoscopic Evaluation|Completed||Phase 1|120|Actual|Logical Therapeutics||2|||f||||f||||||||||2017-02-18 13:57:03.407667|2017-02-18 13:57:03.407667
NCT00750230|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2016-02-11|||October 2003||2003-10-01|February 2016|2016-02-01|January 2004|Actual|2004-01-01|December 2003|Actual|2003-12-01||Interventional|||Pilot Study of the Efficacy & Safety of Natural Eggshell Membrane (NEM) for Joint & Connective Tissue Disorders|A Single Arm Pilot Study to Evaluate the Effectiveness of Eggshell Membrane Compositions for the Treatment of Pain Associated With Connective Tissue and Joints|Completed||N/A|11|Actual|ESM Technologies, LLC||1|||f||||f||||||||No||2017-02-18 13:57:03.497899|2017-02-18 13:57:03.497899
NCT00750217|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-09|||August 2008||2008-08-01|August 2008|2008-08-01|May 2009|Anticipated|2009-05-01|February 2009|Anticipated|2009-02-01||Interventional|||Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches|Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches: A Study on Practicability With Patients Maintained With Daily Dosages Between 60mg and 100mg Methadone.|Unknown status|Recruiting|Phase 4|10|Anticipated|Psychiatric University Hospital, Zurich||1|||f||||t||||||||||2017-02-18 13:57:03.617301|2017-02-18 13:57:03.617301
NCT00750204|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-09|||July 2008||2008-07-01|September 2008|2008-09-01|July 2010|Anticipated|2010-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Airway Pressure Release Ventilation in Acute Lung Injury|Airway Pressure Release Ventilation in Acute Lung Injury|Unknown status|Recruiting|Phase 3|40|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 13:57:03.710799|2017-02-18 13:57:03.710799
NCT00750191|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2013-11-20|2013-09-13||September 2007||2007-09-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Placebo-controlled Trial of Transdiscal Radiofrequency Annuloplasty|A Randomized, Placebo-controlled Trial of Transdiscal Radiofrequency Annuloplasty for Treatment of Discogenic Lower Back Pain|Completed||Phase 1|64|Actual|Baylis Medical Company||2|||f||||t||||||||||2017-02-18 13:57:03.829051|2017-02-18 13:57:03.829051
NCT00750178|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2015-08-18|||November 2004||2004-11-01|August 2015|2015-08-01|November 2005|Actual|2005-11-01|August 2005|Actual|2005-08-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)|A Phase I Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer|Completed||Phase 1|30|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 13:57:04.259135|2017-02-18 13:57:04.259135
NCT00750165|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2008-09-10|||May 2007||2007-05-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Auto Continuous Positive Airway Pressure (CPAP) Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)|Auto CPAP Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome.|Completed||Phase 3|30|Actual|Fisher and Paykel Healthcare||1|||f||||t||||||||||2017-02-18 13:57:04.354597|2017-02-18 13:57:04.354597
NCT00750152|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2013-04-15|2012-02-08||September 2008||2008-09-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris|A Phase 3 Double-Blind, Randomized, Placebo-Controlled,Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-500 in Subjects With Tinea Cruris|Completed||Phase 3|334|Actual|Merz Pharmaceuticals, LLC||2|||f||||f||||||||||2017-02-18 13:57:04.465262|2017-02-18 13:57:04.465262
NCT00750139|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-04-19|2012-02-13||August 2008||2008-08-01|April 2013|2013-04-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis|A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-500 in Subjects With Tinea Pedis|Completed||Phase 3|707|Actual|Merz Pharmaceuticals, LLC||4|||f||||f||||||||||2017-02-18 13:57:04.932549|2017-02-18 13:57:04.932549
NCT00750126|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2011-01-18|||April 2007||2007-04-01|January 2011|2011-01-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|RICE||Allogeneic Hematopoietic Stem Cell Transplantation|Feasibility Study on Allogeneic Hematopoietic Stem Cell Transplantation Following Fludarabine-Busulfan-ALS-based Reduced-intensity Conditioning in Children With Hematological Malignancy or Solid Tumor Not Responding to Standard Therapy or for Which the Indication for Allograft is Maintained But Cannot be Carried Out Due to the Toxicity Involved in Myeloablative Conditioning.|Unknown status|Recruiting|Phase 2|30|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:57:05.771071|2017-02-18 13:57:05.771071
NCT00750113|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2014-12-04|||October 2007||2007-10-01|December 2014|2014-12-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.|A Multicenter Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control and Beyond: Comparison of Two Treatment Strategies.|Completed||Phase 4|405|Actual|Bayer||3|||f||||f||||||||||2017-02-18 13:57:05.883029|2017-02-18 13:57:05.883029
NCT00750100|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2010-10-08|||September 2007||2007-09-01|September 2008|2008-09-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|||Low Dose hCG in the Late Follicular Phase|Among ICSI Patients Undergoing Antagonist Protocols With Recombinant FSH, Does Replacement of Recombinant FSH by 200 IU of hCG in the Late Follicular Phase Compared With Continuing Recombinant FSH, Result in a Similar Number of Oocytes?|Completed||Phase 4|70|Actual|Universitair Ziekenhuis Brussel||2|||f||||f||||||||||2017-02-18 13:57:06.036464|2017-02-18 13:57:06.036464
NCT00750087|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2010-02-04|||August 2008||2008-08-01|February 2010|2010-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR|Non-interventional Study to Observe Treatment Efficacy in Maintaining Symptoms Control in Patients With Schizophrenia, Treated With Seroquel XR|Completed||N/A|578|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:57:06.147325|2017-02-18 13:57:06.147325
NCT00750074|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-09-09|||November 2007||2007-11-01|September 2008|2008-09-01||||September 2008|Anticipated|2008-09-01||Observational|||Slope of the Pressure-Time Waveform Predicts Resistance and Compliance in Mechanically Ventilated Subjects|Slope of the Pressure-Time Waveform Predicts Respiratory System Resistance and Elastance in Mechanically Ventilated Subjects|Unknown status|Recruiting|N/A|12|Anticipated|University of Iowa|||1||f||||f||||||||||2017-02-18 13:57:06.276727|2017-02-18 13:57:06.276727
NCT00750061|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-30|2015-04-28|2015-01-06||August 2008||2008-08-01|April 2015|2015-04-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy and Safety of Lithium Carbonate in the Treatment of Chronic Spinal Cord Injuries|Efficacy and Safety pf Lithium Carbonate in the Treatment of Chronic Spinal Cord Injuries: a Double-Blind, Randomized, Placebo-Controlled Clinical Trial|Completed||Phase 2|40|Actual|China Spinal Cord Injury Network||2|||f||||t||||||||||2017-02-18 13:57:06.366757|2017-02-18 13:57:06.366757
NCT00750048|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2012-01-26|||September 2008||2008-09-01|January 2012|2012-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Impact of Naloxone on the Analgesic Effect of Paracetamol in Healthy Volunteers|Impact of Naloxone on the Analgesic Effect of Paracetamol in Healthy Volunteers|Completed||Phase 1|12|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 13:57:06.886387|2017-02-18 13:57:06.886387
NCT00750035|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2008-10-23|||January 1996||1996-01-01|September 2008|2008-09-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Total Versus Subtotal Hysterectomy:a Randomised, Prospective Multicentre Study of the Effect on Urinary, Sexual and Bowel Function||Completed||N/A|279|Actual|St George's Healthcare NHS Trust||2|||f||||t||||||||||2017-02-18 13:57:06.994408|2017-02-18 13:57:06.994408
NCT00750022|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2009-09-18|||January 2008||2008-01-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Feasibility of Integrating Indirect Calorimetry (IC) Technology in Primary Care|Feasibility Study of Integrating IC Technology With the WatchWT Comprehensive Weight Reduction Program.|Completed||N/A|75|Actual|Colorado Center for Chronic Care Innovations, Inc.||2|||f||||f||||||||||2017-02-18 13:57:07.10539|2017-02-18 13:57:07.10539
NCT00750009|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2013-08-20|||April 2008||2008-04-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial|Preparatory Aid to Improve Decision Making About Cancer Clinical Trials (PRE-ACT)|Completed||Phase 3|583|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 13:57:07.200029|2017-02-18 13:57:07.200029
NCT00749996|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2016-01-26|2014-04-24||November 2006||2006-11-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|||Herniectomy Versus Herniectomy With a Spinal Stabilization System for the Treatment of Complex Disc Disease|Herniectomy vs. Herniectomy With a Spinal Stabilization System for the Treatment of Complex Disc Disease|Completed||Phase 4|165|Actual|Medtronic Spinal and Biologics|The current study was limited by not reaching the target enrollment. Because of the low patient recruitment rate, despite major efforts by the investigators and sponsor, enrollment was stopped prematurely.|2|||f||||f||||||||||2017-02-18 13:57:07.353498|2017-02-18 13:57:07.353498
NCT00749983|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2012-10-01|||June 2009||2009-06-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Creatine Supplementation in Women With Knee Osteoarthritis and Fibromyalgia||Completed||N/A|60|Actual|University of Sao Paulo||2|||f||||||||||||||2017-02-18 13:57:07.844195|2017-02-18 13:57:07.844195
NCT00749970|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2010-12-08|||July 2008||2008-07-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|SWN-K||Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia|Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia|Completed||N/A|100|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 13:57:07.938732|2017-02-18 13:57:07.938732
NCT00749957|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2016-04-07|2015-11-30||December 2008||2008-12-01|April 2016|2016-04-01|December 2027|Anticipated|2027-12-01|September 2014|Actual|2014-09-01||Interventional|||Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis|A Multiple-Site, Phase 1/2, Safety and Efficacy Trial of a Recombinant Adeno-associated Virus Vector Expressing RPE65 (rAAV2-CB-hRPE65) in Patients With Leber Congenital Amaurosis Type 2|Active, not recruiting||Phase 1/Phase 2|12|Actual|Applied Genetic Technologies Corp||2|||f||||t||||||||||2017-02-18 13:57:08.039023|2017-02-18 13:57:08.039023
NCT00749944|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-09|2010-08-24|2010-07-07||September 2008||2008-09-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo|An Experimental Medicine, Randomized, Double-Blind Study Assessing Neuropsychiatric Symptoms In Quitting Smokers Treated With Varenicline Tartrate Or Placebo|Completed||Phase 4|110|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:57:08.66434|2017-02-18 13:57:08.66434
NCT00749931|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-07|2014-05-26|2014-05-26||October 2008||2008-10-01|May 2014|2014-05-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|Pivotal||MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery|MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery|Completed||N/A|664|Actual|Dune Medical Devices||2|||f||||f||||||||||2017-02-18 13:57:10.708174|2017-02-18 13:57:10.708174
NCT00749918|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2008-10-16|||January 2007||2007-01-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Vitamin D Deficiency and Vitamin D Supplementation on Glucose Metabolism|Improved Insulin Sensitivity With Therapeutic Vitamin D Replacement in Pre-Diabetic Vitamin D Deficient Individuals|Completed||N/A|12|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 13:57:11.077485|2017-02-18 13:57:11.077485
NCT00749905|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-07-21|||January 2009||2009-01-01|July 2010|2010-07-01||||July 2009|Anticipated|2009-07-01||Interventional|||Low Fiber Diet for Bowel Preparation for Colon Capsule Examination|A Prospective Randomized Controlled Investigator-blinded Study of Low Fiber Diet for Bowel Preparation for Colon Capsule Examination|Terminated||Phase 2|75|Anticipated|Sheba Medical Center||2||was not able to recruit enough patients|f||||f||||||||||2017-02-18 13:57:11.182546|2017-02-18 13:57:11.182546
NCT00749892|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-11-10|||June 2008||2008-06-01|November 2016|2016-11-01||||September 2018|Anticipated|2018-09-01||Interventional|||Neoadjuvant Erlotinib (Tarceva) in Transitional Cell Carcinoma|A Phase II Exploratory Study of Pre-Operative Treatment With Erlotinib (Tarceva) in Muscle Invasive or Recurrent Transitional Cell Carcinoma Requiring Cystectomy|Active, not recruiting||Phase 2|42|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 13:57:11.330507|2017-02-18 13:57:11.330507
NCT00749879|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2010-02-10|||August 2008||2008-08-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Crossover Study of the Safety and PK Properties of Proellex®|A Phase I, Open-Label, Randomized, Single-Center, Unblinded, Single-Dose, Five-Way Crossover Study of the Safety and PK Properties of Proellex®|Completed||Phase 1|17|Actual|Repros Therapeutics Inc.||5|||f||||f||||||||||2017-02-18 13:57:11.445195|2017-02-18 13:57:11.445195
NCT00749866|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-08-09|||May 2007||2007-05-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Long Term Nebulised Gentamicin in Patients With Bronchiectasis|Can Long Term Nebulised Gentamicin Reduce The Bacterial Burden, Break the Vicious Cycle of Inflammation and Improve Quality of Life in Patients With Bronchiectasis|Completed||Phase 4|60|Actual|University of Edinburgh||2|||f||||f||||||||||2017-02-18 13:57:11.534608|2017-02-18 13:57:11.534608
NCT00749853|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2015-05-03|||May 2015||2015-05-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|May 2015|Actual|2015-05-01||Interventional|||Efficacy of Ovarian Stimulation Based on FSHR Genotype Status|Prospective, Randomized Open Trial to Evaluate the Efficacy of an Ovarian Stimulation Protocol Based on FSH Receptor Genotype|Suspended||Phase 3|165|Anticipated|Medical University of Vienna||2||PI left the institution|f||||f||||||||||2017-02-18 13:57:11.632565|2017-02-18 13:57:11.632565
NCT00749840|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-02-12|||April 2008||2008-04-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Attitudes and Beliefs and the Steps of HIV Care|Attitudes and Beliefs and the Steps of HIV Care|Completed||N/A|200|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:57:11.74016|2017-02-18 13:57:11.74016
NCT00749827|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-04-19||||||April 2016|2016-04-01||||||||Interventional|CIN||Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN)|Exploring the Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy|Withdrawn||Phase 4|0|Actual|Memorial University of Newfoundland||2||No funding received|f||||f||||||||Undecided||2017-02-18 13:57:11.844169|2017-02-18 13:57:11.844169
NCT00749814|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2008-09-08|||October 2008||2008-10-01|August 2008|2008-08-01||||December 2010|Anticipated|2010-12-01||Interventional|||Sleep Disturbances in Hospitalized Children||Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||||||||||||2017-02-18 13:57:11.947206|2017-02-18 13:57:11.947206
NCT00749801|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2008-09-08|||May 2007||2007-05-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Geneferm Nattokinase|A Randomized, Double-Blind, Placebo-Controlled, Parallel Comparison Study to Evaluate the Efficacy and Safety of Oral Administration of Nattokinase (From GeneFerm Biotechnology Co., Ltd.) Taken by Dyslipidemia Patients|Completed||N/A|47|Actual|Chi Mei Medical Hospital||3|||f||||f||||||||||2017-02-18 13:57:12.053676|2017-02-18 13:57:12.053676
NCT00749788|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-01-31||2013-01-31|December 2006||2006-12-01|January 2013|2013-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study Evaluating the Efficacy and Safety of JTT-302 Administered Daily for Four Weeks in Subjects With Low HDL-C Levels|Completed||Phase 2|150|Actual|Akros Pharma Inc.||3|||f||||f||||||||||2017-02-18 13:57:12.158568|2017-02-18 13:57:12.158568
NCT00749775|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-11-20|2013-11-20||June 2008||2008-06-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|ESSENCE||Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)|Eplerenone Observational Study Of Safety And Efficacy Evaluation To Normalize Blood Pressure For Clinical Effectiveness|Completed||N/A|3338|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 13:57:12.253825|2017-02-18 13:57:12.253825
NCT00749762|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2015-05-01|||October 2002||2002-10-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Pulmonary Function During Prone and Supine Positioning in NICU Infants Requiring Assisted Ventilation|Pulmonary Function During Prone and Supine Positioning in Neonatal Intensive Care Unit (NICU) Infants Requiring Assisted Ventilation|Withdrawn||N/A|0|Actual|University of Utah|||1|Computers/hardware for data collection/storage are outdated and unserviceable.|f||||f||||||||||2017-02-18 13:57:15.052776|2017-02-18 13:57:15.052776
NCT00749749|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-04-29|||September 2008||2008-09-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of the CollaRx Bupivacaine Implant Compared to the ON-Q Painbuster Following Abdominal Hysterectomy|A Phase II, Randomized, Single-dose, Unblinded Study to Compare the Efficacy and Safety of the CollaRx Bupivacaine Implant With the ON-Q PainBuster Post-op Pain Relief System in Women Following Abdominal Hysterectomy|Completed||Phase 2|27|Actual|Innocoll||2|||f||||f||||||||||2017-02-18 13:57:15.126851|2017-02-18 13:57:15.126851
NCT00749736|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-03-28|||July 2008||2008-07-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4.|The Role of Vitamin D in Immune Function in Patients With CKD Stages 3 and 4.|Completed||Phase 4|100|Actual|Indiana University||3|||f||||t||||||||||2017-02-18 13:57:15.238231|2017-02-18 13:57:15.238231
NCT00749723|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-07-07|||February 2006||2006-02-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|January 2013|Actual|2013-01-01||Interventional|HIT-REZ-2005||Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children|Therapy-Optimization Trial and Phase II Study for the Treatment of Relapsed or Refractory of Primitive Neuroectodermal Brain Tumors and Ependymomas in Children and Adolescents|Active, not recruiting||Phase 2/Phase 3|160|Anticipated|University Hospital, Bonn||4|||f||||t||||||||||2017-02-18 13:57:15.346043|2017-02-18 13:57:15.346043
NCT00749710|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2008-09-08|||September 2008||2008-09-01|September 2008|2008-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Blood Loss and Complications of Internal Fixation of Femoral Neck Fractures in Patients Treated With Clopidogrel|Blood Loss and Complications of Internal Fixation of Femoral Neck Fractures in Patients Treated With Clopidogrel|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-02-18 13:57:15.7201|2017-02-18 13:57:15.7201
NCT00749697|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2008-09-08|||May 2008||2008-05-01|September 2008|2008-09-01|July 2010|Anticipated|2010-07-01|January 2010|Anticipated|2010-01-01||Interventional|||Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases|Investigating Absorbed Radiation Dose Delivered to Differentiated Thyroid Cancer Metastases Following Administration of Fixed Activity of Radioactive Iodine|Unknown status|Recruiting|N/A|10|Anticipated|Royal Marsden NHS Foundation Trust|||||f||||f||||||||||2017-02-18 13:57:15.81227|2017-02-18 13:57:15.81227
NCT00749684|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2015-10-16|2010-10-22||December 1996||1996-12-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)|Efficacy and Safety of High-dose Treatment With the Immunomodulator Interferon-α-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma.|Completed||N/A|138|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:57:15.908375|2017-02-18 13:57:15.908375
NCT00749671|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2016-08-26|2015-09-20||October 2007||2007-10-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Bispectral Index Monitoring During Testing in the Electrophysiology Lab|To Assess the Utility of BIS Monitoring in the Administration of Moderate Sedation in Patients Undergoing Implantable Cardioverter -Defibrillator (ICD) Implantation With Defibrillatory Threshold (DFT) Testing|Terminated||N/A|20|Actual|Baystate Medical Center||2||Lack of enrollment|f||||f||||||||No||2017-02-18 13:57:16.175172|2017-02-18 13:57:16.175172
NCT00749658|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-06-23|||November 2008||2008-11-01|June 2016|2016-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|ChanBan||Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence|Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence|Completed||Phase 2/Phase 3|10|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-02-18 13:57:16.562151|2017-02-18 13:57:16.562151
NCT00749645|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-07|2016-06-21|||October 2006||2006-10-01|October 2014|2014-10-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|FANG30-RA||Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients|Clinical Phase II Pilot Study of the Efficacy of FANG(30) to Treat Active Rheumatoid Arthritis in Adult Patients|Completed||Phase 2|60|Actual|Universidad Austral de Chile||2|||f||||t||||||||Yes|All these data has been accepted for publication in Clinical Rheumatology|2017-02-18 13:57:16.688356|2017-02-18 13:57:16.688356
NCT00749632|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2009-10-13||2009-10-13|July 2007||2007-07-01|October 2009|2009-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|FP1097-002||A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence|An Open-Label, Dose Escalating Study to Evaluate the Safety of Intravaginal Oxybutynin in Subjects With Urge Urinary Incontinence|Completed||Phase 2|45|Actual|FemmePharma Global Healthcare, Inc.||3|||f||||f||||||||||2017-02-18 13:57:16.812136|2017-02-18 13:57:16.812136
NCT00749619|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-07|2008-09-08|||May 2007||2007-05-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?||Completed||Phase 3|||Western Galilee Hospital-Nahariya||3|||f||||f||||||||||2017-02-18 13:57:16.931623|2017-02-18 13:57:16.931623
NCT00749606|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2014-12-15|||September 2008||2008-09-01|May 2013|2013-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Study to Promote Weight Loss in Primary Care Practices|Weight Loss in Primary Care: a Translation of the Diabetes Prevention Program|Completed||N/A|257|Actual|State University of New York - Upstate Medical University||2|||f||||t||||||||||2017-02-18 13:57:17.027636|2017-02-18 13:57:17.027636
NCT00749593|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2012-06-08|||August 2004||2004-08-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|June 2007|Actual|2007-06-01||Observational|CaHASE||Study of UK Adults With Congenital Adrenal Hyperplasia.|Cross-Sectional Multi-Centre Study of UK Adults With Congenital Adrenal Hyperplasia.|Completed||N/A|25|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||t||||||||||2017-02-18 13:57:17.127911|2017-02-18 13:57:17.127911
NCT00749580|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2014-12-02|2014-03-27||November 2008||2008-11-01|June 2014|2014-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen|A Pilot, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Raltegravir Versus NRTIs as a Backbone in HIV-Infected Patients Switched From a Stable Boosted PI Regimen|Completed||N/A|46|Actual|University of South Florida|This is a pilot study and has a small sample size.|2|||f||||f||||||||||2017-02-18 13:57:17.223524|2017-02-18 13:57:17.223524
NCT00749567|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2015-09-25|||July 2008||2008-07-01|September 2015|2015-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer|Combination of Erlotinib (Tarceva®) and Bevacizumab (Avastin®) as Second-line Treatment in Locally Advanced / Metastatic, Non-squamous, Non-small Cell Lung Cancer (NSCLC) Patients: A Phase II Study|Terminated||Phase 2|13|Actual|Hellenic Oncology Research Group||1||Poor accrual|f||||f||||||||||2017-02-18 13:57:17.866539|2017-02-18 13:57:17.866539
NCT00749554|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-06-04|||April 2008||2008-04-01|June 2010|2010-06-01||||August 2010|Anticipated|2010-08-01||Interventional|TD-RCT-002||Trial of Disc Biacuplasty to Treat Chronic Discogenic Low Back Pain|Blinded Randomised Placebo-Controlled Trial of TransDiscal Biacuplasty for Patients With Mechanical Low Back Pain of Disc Origin|Terminated||Phase 4|40|Anticipated|Baylis Medical Company||2||Primary Investigator Retired.|f||||f||||||||||2017-02-18 13:57:17.997273|2017-02-18 13:57:17.997273
NCT00749541|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-07|2010-12-15|||November 2008||2008-11-01|September 2008|2008-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Vitamin d Levels and Coronary Catheterization|25 Hydroxy Vitamin d Levels in Patients Undergoing an Elective Coronary Catheterization|Completed||N/A|100|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||Samples Without DNA|"~     blood samples~   "|||2017-02-18 13:57:18.110237|2017-02-18 13:57:18.110237
NCT00749528|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2012-03-14|||September 2007||2007-09-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Evaluation of Toxic Metals, Trace Elements and Total Antioxidant Activity in Children With Recurrent Wheezing|Sectional Prospective Randomised Study of Evaluation Toxic Metals, Trace Elements Status and Total Antioxidant Activity in Children With Recurrent Wheezing.|Completed||N/A|95|Actual|Kecioren Education and Training Hospital|||2||f||||f||||||Samples Without DNA|"~     Group 1: Children with recurrent wheezing. Plasma and Hair specimen are retined Group 2:~     Healthy children. Plasma and Hair specimen are retined~   "|||2017-02-18 13:57:18.201466|2017-02-18 13:57:18.201466
NCT00749515|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-12-01|||March 2008||2008-03-01|December 2010|2010-12-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Pilot Study for Patients With Poor Response to Deferasirox|Pilot Pharmacokinetic Study In Patients With Inadequate Response To Deferasirox (Exjade)|Completed||Phase 4|15|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-02-18 13:57:18.294171|2017-02-18 13:57:18.294171
NCT00749502|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-07-23|||September 2008||2008-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|September 2011|Actual|2011-09-01||Interventional|||A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)|A Phase I Study of MK-4827 in Patients With Advanced Solid Tumors or Hematologic Malignancies|Completed||Phase 1|113|Actual|Tesaro, Inc.||4|||f||||f||||||||||2017-02-18 13:57:18.40673|2017-02-18 13:57:18.40673
NCT00749489|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2014-06-24|||November 2008||2008-11-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Improving Pain and Function in Hip Fracture|Improving Pain and Function in Hip Fracture|Completed||Phase 3|164|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 13:57:18.497621|2017-02-18 13:57:18.497621
NCT00749463|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2012-07-06|2010-04-23||February 2009||2009-02-01|July 2012|2012-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment|Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment|Completed||Phase 4|300|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-02-18 13:57:18.801748|2017-02-18 13:57:18.801748
NCT00749450|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-06|2012-04-23|||March 2008||2008-03-01|April 2012|2012-04-01||||March 2013|Anticipated|2013-03-01||Interventional|||Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer|Short Course Oncology Therapy - A Study of Adjuvant Chemotherapy in Colorectal Cancer|Unknown status|Recruiting|Phase 3|9500|Anticipated|Cancer Research UK, Glasgow||2|||f||||t||||||||||2017-02-18 13:57:19.550559|2017-02-18 13:57:19.550559
NCT00749437|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-06|2012-06-13|||October 2008||2008-10-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer|Feasibility of 3-D Conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage, Node Negative Breast Cancer Patients Using Acculoc Fiducial Markers: A Phase I Trial|Completed||Phase 1|34|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 13:57:19.661066|2017-02-18 13:57:19.661066
NCT00749424|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-02-03|||January 2004||2004-01-01|February 2010|2010-02-01|April 2009|Actual|2009-04-01|May 2005|Actual|2005-05-01||Interventional|CACTUS||The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.|"CORONARY BIFURCATIONS: APPLICATION OF THE CRUSHING TECHNIQUE USING SIROLIMUS-ELUTING STENTS - The CACTUS Trial"|Completed||Phase 4|350|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 13:57:19.747793|2017-02-18 13:57:19.747793
NCT00749411|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2017-01-13||2010-02-05|November 2008||2008-11-01|January 2017|2017-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, 4-week Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Repeat Inhaled Doses of the Combination of GSK233705 and GW642444 Administered Once-daily in Subjects With COPD|Completed||Phase 2|61|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:57:19.85487|2017-02-18 13:57:19.85487
NCT00749398|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-07-15|2011-08-31||September 2007||2007-09-01|July 2015|2015-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|PHODYPSO||Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)|Atlas of the Evolution of Psoriasis Lesions Under Remicade® : A Dynamic Standardized Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab|Completed||N/A|133|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:57:19.98423|2017-02-18 13:57:19.98423
NCT00749385|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2008-12-19|||August 2008||2008-08-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels|A Randomized, Open-Label, 4-Way Crossover Study to Evaluate Naproxen and Esomeprazole Plasma Levels in Healthy Subjects Following Oral Administration of PN 400, Enteric-Coated Naproxen 500mg Plus Enteric-Coated Esomeprazole 20mg, Enteric-Coated Naproxen 500mg Alone, and Enteric-Coated Esomeprazole 20mg Alone.|Completed||Phase 1|40|Actual|POZEN||4|||f||||f||||||||||2017-02-18 13:57:20.554051|2017-02-18 13:57:20.554051
NCT00749372|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-11-04|||September 2008||2008-09-01|November 2010|2010-11-01|June 2011|Anticipated|2011-06-01|January 2011|Anticipated|2011-01-01||Interventional|T2*MRI||MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions|T2* Cardiac MRI Screening of Highly Transfused Patients With Myelodysplastic Syndrome|Unknown status|Recruiting|N/A|50|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 13:57:20.662178|2017-02-18 13:57:20.662178
NCT00749359|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-11-04|||July 2008||2008-07-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||PAXIL CR Bioequivalence Study|An Open-label, Randomized, Single Dose, Two-period Crossover Study to Demonstrate Bioequivalence Between the Controlled Release Paroxetine Tablet (37.5 mg) Manufactured at Cidra and Mississauga|Completed||Phase 1|166|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:57:20.75828|2017-02-18 13:57:20.75828
NCT00749346|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2011-09-26|||May 2008||2008-05-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer|An Open Label Pilot Study of NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer|Completed||Phase 1/Phase 2|42|Anticipated|NovoCure Ltd.||1|||f||||f||||||||||2017-02-18 13:57:20.866424|2017-02-18 13:57:20.866424
NCT00749333|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2009-04-29|||August 2008||2008-08-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.|A Phase I, Randomised, Double Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Oral Doses of AZD8566 in Healthy Volunteers|Completed||Phase 1|108|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:57:20.999333|2017-02-18 13:57:20.999333
NCT00749320|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-12-20|||September 2008||2008-09-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)|Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Antiangiogenic and Targeted Therapies of Metastatic Renal Cell Carcinoma|Active, not recruiting||N/A|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No|No plan to share IPD|2017-02-18 13:57:21.107796|2017-02-18 13:57:21.107796
NCT00749307|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2009-11-24|||June 2008||2008-06-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients|Effects of Supplementation With Algal Triacylglycerols Versus Placebo on Heart Rate Variability in Elderly Patients|Completed||Phase 2/Phase 3|50|Anticipated|Campus Bio-Medico University||2|||f||||f||||||||||2017-02-18 13:57:21.218483|2017-02-18 13:57:21.218483
NCT00318864|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2006-04-25|||June 2002||2002-06-01|April 2006|2006-04-01|July 2005||2005-07-01|||||Interventional|||Biological CVD Risk Factors in Older Depressed Patients|Stress, the HPA and Health in Aging|Completed||N/A|70||Stanford University|||||f||||||||||||||2017-02-18 16:35:50.709035|2017-02-18 16:35:50.709035
NCT00749281|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-07-07|||September 2008||2008-09-01|August 2009|2009-08-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Observational|||Neutrophil Gelatinase-associated Lipocalin Concentration in Coronary Artery Disease|Neutrophil Gelatinase-associated Disease: a Potential Biomarker of the Severity of Coronary Artery Disease|Completed||N/A|73|Actual|Cardiovascular Research Society, Greece|||2||f||||t||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 13:57:21.42427|2017-02-18 13:57:21.42427
NCT00749268|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2015-09-09|2013-10-14||October 2008||2008-10-01|September 2015|2015-09-01|November 2012|Actual|2012-11-01|December 2011|Actual|2011-12-01||Interventional||"1 inguinal pt assigned to receive AbsorbaTack was treated with ProTack and one patient assigned to receive ProTack received AbsorbaTack. These patients are included in the intent to treat population above, but were omitted from the safety population."|AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair|Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair: A Prospective, Randomized Comparison to Evaluate the Incidence of Post-operative Pain Associated With Absorbable Fixation (AbsorbaTack) vs Conventional Fixation (ProTack) Following Laparoscopic Hernia Repair|Completed||Phase 4|216|Actual|Medtronic - MITG||2|||f||||f||||||||||2017-02-18 13:57:21.533106|2017-02-18 13:57:21.533106
NCT00749255|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-01-17|||May 2008||2008-05-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|||||Observational|||Collect Breast Cancer Patients' Digital Mammography Images With Corresponding Reports for the Development of Software|R2 Case Collection|Terminated||N/A|200|Anticipated|WellSpan Health|||1|not enough personnel to conduct study at site|f||||f||||||||||2017-02-18 13:57:22.30958|2017-02-18 13:57:22.30958
NCT00749242|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2014-12-13|||December 2007||2007-12-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|TRAUMAA1-2-3||Comparative Study of Balloon Kyphoplasty and Conservative Treatment|Prospective Randomized Study Comparing Balloon Kyphoplasty and Conservative Treatment in Acute Traumatic Vertebral Fractures, Types A1, A2, AND A3.1 According to the Magerl Classification (STIC 3)|Completed||Phase 4|41|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:57:22.394135|2017-02-18 13:57:22.394135
NCT00749229|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2017-01-03|||December 2007||2007-12-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|TRAUMAA3B1C1||Feasibility Study of Balloon Kyphoplasty in Traumatic Vertebral Fractures Needing Surgical Fixation|Prospective Cohort Study on the Feasibility and Reliability of 'Open' Balloon Kyphoplasty in Types A3.2, A3.3, B1 and C1 MAGERL Classification Vertebral Fractures(STIC 4)|Terminated||Phase 4|17|Actual|Assistance Publique - Hôpitaux de Paris||1||the number of patients recruited at present is sufficient for analysis.|f||||f||||||||||2017-02-18 13:57:22.503761|2017-02-18 13:57:22.503761
NCT00749216|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2010-05-27||2010-05-27|September 2008||2008-09-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease|Multiple-Dose Safety in Japanese Subjects With Mild-to-Moderate Alzheimer's Disease|Completed||Phase 2|33|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 13:57:22.611065|2017-02-18 13:57:22.611065
NCT00749203|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-12-10|||January 2009||2009-01-01|December 2012|2012-12-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|KetPTSD||Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)|Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder|Unknown status|Recruiting|Phase 2|40|Anticipated|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 13:57:22.716328|2017-02-18 13:57:22.716328
NCT00749190|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2014-05-16|2014-05-16||August 2008||2008-08-01|May 2014|2014-05-01||||October 2009|Actual|2009-10-01||Interventional||Treated Set (TS) consisting of all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|BI 10773 add-on to Metformin in Patients With Type 2 Diabetes|A Phase II, Randomized, Parallel Group Safety, Efficacy, and Pharmacokinetics Study of BI 10773 (1 mg, 5 mg, 10 mg, 25 mg, and 50 mg) Administered Orally Once Daily Over 12 Weeks Compared Double Blind to Placebo With an Additional Open-label Sitagliptin Arm in Type 2 Diabetic Patients With Insufficient Glycemic Control Despite Metformin Therapy|Completed||Phase 2|495|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 13:57:22.850014|2017-02-18 13:57:22.850014
NCT00749177|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-03-04|||November 2008||2008-11-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|B2W||Blending Two Worlds: Traditional Aboriginal Healing Strategies for Depression and Anxiety|Blending Two Worlds: Traditional Aboriginal Healing Strategies for Depression and Anxiety. Possible Options for Children, Youth and Families|Terminated||N/A|4|Actual|Fraser Health||3||Primary investigator left program: unable to recruit a replacement|f||||f||||||||||2017-02-18 13:57:24.355601|2017-02-18 13:57:24.355601
NCT00749164|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2009-08-10|||September 2009||2009-09-01|August 2009|2009-08-01|August 2012|Anticipated|2012-08-01|February 2012|Anticipated|2012-02-01||Interventional|MSCGVHD||Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment|Allogeneic Mesenchymal Stem Cell Infusion for Treatment Of Steroid Resistant GVHD|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-02-18 13:57:24.475758|2017-02-18 13:57:24.475758
NCT00749151|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2010-11-17|||December 2002||2002-12-01|November 2010|2010-11-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|QUITLINE||Effectiveness of the American Lung Association Reactive Anti-Smoking Telephone Help Line in Illinois|A Randomized Controlled Trial on the Effectiveness of the American Lung Association Reactive Anti-Smoking Telephone Help Line in Illinois|Completed||N/A|990|Actual|Southern Illinois University||2|||f||||t||||||||||2017-02-18 13:57:24.562441|2017-02-18 13:57:24.562441
NCT00749138|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2010-03-07|||November 2008||2008-11-01|March 2010|2010-03-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Interventional|||Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy|Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy|Completed||Phase 1|18|Anticipated|Bader, Ted, M.D.||1|||f||||f||||||||||2017-02-18 13:57:24.674224|2017-02-18 13:57:24.674224
NCT00749125|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-03-18|||July 2001||2001-07-01|March 2013|2013-03-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||fMRI Studies of Emotional Brain Circuitry in People With Major Depression|fMRI Studies of Emotional Circuitry in Major Depression|Completed||N/A|100|Actual|National Institute of Mental Health (NIMH)||2|||f||||f||||||||||2017-02-18 13:57:24.786655|2017-02-18 13:57:24.786655
NCT00749112|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2010-08-27|||August 2008||2008-08-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias|Low Doses of Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias|Completed||Phase 2/Phase 3|19|Actual|Hospital Universitario Dr. Jose E. Gonzalez||1|||f||||f||||||||||2017-02-18 13:57:24.891767|2017-02-18 13:57:24.891767
NCT00749099|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-07|2013-02-20|||April 2007||2007-04-01|February 2013|2013-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum)|092206: Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum) From PANCRECARB® (Pancrelipase), Delayed Release Capsules, Buffered and Enteric-Coated Microspheres|Terminated||N/A|11|Actual|Digestive Care, Inc.||2||No longer required study by FDA for NDA approval.|f||||t||||||||||2017-02-18 13:57:25.006606|2017-02-18 13:57:25.006606
NCT00749086|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2014-12-13|||December 2007||2007-12-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|OSTEO+6||Comparison of Balloon Kyphoplasty and Vertebroplasty in Subacute Osteoporotic Vertebral Fractures|Prospective Randomized Study of Balloon Kyphoplasty and Vertebroplasty in Subacute (Older Than 6 Weeks) Osteoporotic Vertebral Fractures (STIC2)|Completed||Phase 4|97|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 13:57:25.112472|2017-02-18 13:57:25.112472
NCT00749073|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-04-02|2013-01-18||September 2008||2008-09-01|April 2013|2013-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Vertos MILD™ Preliminary Patient Evaluation Study|A Single-center, Prospective, Clinical Study to Assess the Clinical Application and Outcomes of Minimally Invasive Lumbar Decompression With the MILD™ Devices in Patients With Symptomatic Central Foraminal Lumbar Spinal Stenosis.|Completed||N/A|10|Actual|Vertos Medical, Inc.|Small pilot series with short follow-up. Procedure experience of investigator limited. Minimal information available regarding appropriate patient selection, thus patient pool confined to complex cases wait-listed for more aggressive laminectomy.|1|||f||||f||||||||||2017-02-18 13:57:25.2183|2017-02-18 13:57:25.2183
NCT00749060|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2014-12-13|||December 2007||2007-12-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|OSTEO-6||Comparison of Balloon Kyphoplasty, Vertebroplasty and Conservative Management in Acute Osteoporotic Vertebral Fractures|Prospective Randomized Comparative Study of Balloon Kyphoplasty,Vertebroplasty and Conservative Management in Acute Osteoporotic Vertebral Fractures of Less Than 6 Weeks|Completed||N/A|48|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||f||||||||||2017-02-18 13:57:25.463525|2017-02-18 13:57:25.463525
NCT00749047|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2009-09-15|||September 2008||2008-09-01|September 2009|2009-09-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|||How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?|A Study on the Anti-proteinuric Effects of Pioglitazone in Patients With Type 2 Diabetes.|Unknown status|Active, not recruiting|Phase 4|12|Anticipated|Christchurch Hospital||1|||f||||f||||||||||2017-02-18 13:57:25.582826|2017-02-18 13:57:25.582826
NCT00749034|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2010-05-19|||September 2008||2008-09-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers|Phase I Open Label, Randomized, Controlled, Dose-Escalation Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers Stratified for History of BCG-Vaccination|Completed||Phase 1|80|Actual|Vakzine Projekt Management GmbH||2|||f||||f||||||||||2017-02-18 13:57:25.688519|2017-02-18 13:57:25.688519
NCT00749021|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2012-10-03|||September 2008||2008-09-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments|A Phase I Study to Evaluate the Efficacy and Safety of Treating Subfoveal Pigment Epithelial Detachment Associated With Choroidal Neovascularization With Anti-vascular Endothelial Growth Factor Fragment, Ranibizumab.|Completed||Phase 1|40|Actual|Southern California Desert Retina Consultants, MC||4|||f||||f||||||||||2017-02-18 13:57:25.793423|2017-02-18 13:57:25.793423
NCT00749008|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2014-02-24|||September 2008||2008-09-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Study of Generalized Movements for Early Prediction of Cerebral Palsy|Early Prediction of Cerebral Palsy in Preterm Infants and Term Infants Using Detection of Generalized Movements|Completed||N/A|63|Actual|Hawaii Pacific Health|||2||f||||t||||||||||2017-02-18 13:57:25.908213|2017-02-18 13:57:25.908213
NCT00748995|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-08-24|||August 2010||2010-08-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|July 2014|Actual|2014-07-01||Observational|||Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study|CSP #566 - Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study|Active, not recruiting||N/A|817|Anticipated|VA Office of Research and Development|||1||f||||t||||||None Retained|"~     No Biospecimens were collected~   "|No||2017-02-18 13:57:26.000687|2017-02-18 13:57:26.000687
NCT00748982|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-06-22|2011-01-25||August 2008||2008-08-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction|A Single-centre, Single-blind, Randomised, Placebo-controlled Phase IIa Study to Investigate the Effect of AZD1305 Given as an Intravenous (iv) Infusion on Left Ventricular Performance in Patients With Left Ventricular Dysfunction|Completed||Phase 2|16|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:57:26.113794|2017-02-18 13:57:26.113794
NCT00748969|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2014-11-19|2014-10-30||November 2008||2008-11-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Clinical Trial of Growth Hormone in MPS I, II, and VI|Phase II/III, Randomized, Clinical Trial of the Effects of Nutropin AQ® on Growth and Bone Metabolism in Children With MPS I, II, and VI and Short Stature|Terminated||Phase 2/Phase 3|2|Actual|Los Angeles Biomedical Research Institute||2||Insufficient recruitment.|f||||f||||||||||2017-02-18 13:57:26.475905|2017-02-18 13:57:26.475905
NCT00748956|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2012-12-10|||January 2010||2010-01-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|NPY||Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers|Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers|Completed||Phase 2|10|Actual|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||||2017-02-18 13:57:26.85883|2017-02-18 13:57:26.85883
NCT00748943|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2008-09-11|||March 2007||2007-03-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Clinical and Microbiological Effects of a Mouthwash Containing Chlorine Dioxide|The Clinical Effects of a Mouthwash Containing Chlorine Dioxide on Oral Malodor and Salivary Periodontal and Malodorous Bacteria Using for 7days|Completed||Phase 1|15|Actual|Tokyo Medical and Dental University||1|||f||||f||||||||||2017-02-18 13:57:26.993642|2017-02-18 13:57:26.993642
NCT00691431|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2011-06-01|||May 2004||2004-05-01|June 2008|2008-06-01|November 2005||2005-11-01|||||Interventional|||IntraLase vs Hansatome Flaps in LASIK|Comparison of the IntraLaser Femtosecond Laser and Hansatome Mechanical Keratome for Laser In Situ Keratomileusis|Completed||N/A|51||Stanford University|||||f||||||||||||||2017-02-18 14:18:02.783438|2017-02-18 14:18:02.783438
NCT00746525|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2017-01-19|||September 2008||2008-09-01|January 2017|2017-01-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Non-Invasive Brain Signal Training to Induce Motor Control Recovery After Stroke|Non-Invasive Brain Signal Training to Induce Motor Control Recovery After Stroke|Completed||N/A|8|Actual|Louis Stokes VA Medical Center||1|||f||||f||||||||||2017-02-18 13:57:27.179998|2017-02-18 13:57:27.179998
NCT00746512|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2015-05-07|2010-12-17||September 2008||2008-09-01|May 2015|2015-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)|A Randomized, Double-Blind, Parallel Group, Placebo Controlled Study to Access the Effects of Oral Prednisone on Clinical Efficacy and the Power Doppler Ultrasound Signal of Synovium in Patients With Rheumatoid Arthritis|Completed||Phase 1|45|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 13:57:27.290098|2017-02-18 13:57:27.290098
NCT00746499|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-10-12|||September 2008||2008-09-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Pharmacokinetic Study of Raltegravir in Healthy Premenopausal Women.|A Phase 1, Open-Label Study, Investigating First-Dose and Steady-State Pharmacokinetics of Raltegravir in the Genital Tract of HIV Uninfected Women|Completed||Phase 1|7|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 13:57:27.807812|2017-02-18 13:57:27.807812
NCT00746486|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2017-02-07|||February 2009||2009-02-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)|Double-blind, Randomised, Placebo-controlled, Multi-centre Phase III Clinical Study Comparing the Combination of Ursodeoxycholic Acid Capsules Plus Budesonide Capsules to Ursodeoxycholic Acid Capsules Plus Placebo in the Treatment of Primary Biliary Cirrhosis|Terminated||Phase 3|62|Actual|Dr. Falk Pharma GmbH||2||Study stopped based on the recommendation of the IDMC after a planned Interim Analysis|f||||f||||||||||2017-02-18 13:57:27.914817|2017-02-18 13:57:27.914817
NCT00746473|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-03|||August 2004||2004-08-01|September 2008|2008-09-01|October 2005|Actual|2005-10-01|||||Observational|||Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART|Assessment of Cytokine Values in Serum and by Specific cDNA Amplification and Detection Using RT-PCR in HIV-1 Infected Individuals With and Without Highly Active Anti-Retroviral Therapy (HAART)|Completed||N/A|73|Actual|UPECLIN HC FM Botucatu Unesp|||4||f||||t||||||||||2017-02-18 13:57:28.024777|2017-02-18 13:57:28.024777
NCT00746460|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2014-01-10|||June 2008||2008-06-01|January 2014|2014-01-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||The Healthy Options Feasibility Study|"The Effectiveness of CVD Risk Profiles When Used by Allied Health Care Providers (HCP) Within a Groupe de Médecine de Famille: The Healthy Options Feasibility Study."|Completed||N/A|50|Actual|McGill University||1|||f||||f||||||||||2017-02-18 13:57:28.11459|2017-02-18 13:57:28.11459
NCT00746447|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-06-25|||May 2005||2005-05-01|June 2012|2012-06-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|||Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)|Double-blind, Double-dummy, Randomised, Multicentre, 12-months, Comparative Study of the Efficacy and Tolerability of Once Daily 3.0 g Mesalazine Granules vs. Once Daily 1.5 g Mesalazine Granules vs. Three Times Daily 0.5 g Mesalazine Granules for Maintenance of Remission in Patients With Ulcerative Colitis|Completed||Phase 3|648|Actual|Dr. Falk Pharma GmbH||3|||f||||f||||||||||2017-02-18 13:57:28.223368|2017-02-18 13:57:28.223368
NCT00746434|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2016-12-02|||November 2008||2008-11-01|October 2016|2016-10-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|||A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis|A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis|Withdrawn||Phase 2|0|Actual|AstraZeneca||2||Study withdrawn due to business decisions. No subjects were treated.|f||||t||||||||||2017-02-18 13:57:28.352359|2017-02-18 13:57:28.352359
NCT00746421|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2014-03-31|2013-09-13||January 2010||2010-01-01|March 2014|2014-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder|Phase IV Study of Quetiapine XR Aimed at Disability and Cognitive Impairments.|Terminated||Phase 4|32|Actual|Emory University|We were unable to perform the pre-planned primary and secondary statistical analyses between group comparisons as the groups sizes were too small to compare meaningfully.|2||Sponsor withdrew funding|f||||t||||||||||2017-02-18 13:57:28.45143|2017-02-18 13:57:28.45143
NCT00746408|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2009-06-15|||January 2009||2009-01-01|June 2009|2009-06-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Observational|||Tailored Internet Information Supply for Patients|Study of the Quality of Self-Diagnosis by Headache Patients Getting Tailored Internet Information|Unknown status|Recruiting|N/A|500|Anticipated|Health & Life Sciences University, Tryol|||4||f||||t||||||||||2017-02-18 13:57:29.075383|2017-02-18 13:57:29.075383
NCT00748917|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-05-31|||May 2010||2010-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:57:29.197762|2017-02-18 13:57:29.197762
NCT00748904|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2011-01-03|||June 2008||2008-06-01|January 2011|2011-01-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Rifaximin Versus Lactulose in Renal Failure|A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Progressive Renal Failure|Unknown status|Recruiting|Phase 4|70|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 13:57:29.247236|2017-02-18 13:57:29.247236
NCT00748891|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-06-30|||August 2008||2008-08-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|February 2010|Actual|2010-02-01||Interventional|||DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)|Exploratory Open-Label, Non-randomised, Single Centre Methodology Study Comparing DCE-CT and DCE-MRI as Markers of Changes in Vascular Activity Mediated by a Positive Control Agent [Cediranib (Recentin™; AZD2171), a Potent Inhibitor of VEGF-driven Angiogenesis] in Patients With Advanced Solid Tumour|Completed||Phase 1|35|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 13:57:29.360717|2017-02-18 13:57:29.360717
NCT00748878|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-10-11|||June 2008||2008-06-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Observational|||Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation)|Platelet Function During ECMO|Completed||N/A|5|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 13:57:29.471178|2017-02-18 13:57:29.471178
NCT00748852|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-01-31||2013-01-31|January 2007||2007-01-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety Study of JTT-302 in Subjects With Low HDL-C Levels|An Eight Week, Open-label Extension Study Evaluating the Safety of JTT-302 Administered Once Daily in Subjects With Low HDL-C Levels Who Have Completed the Treatment Phase of Study AT302-U-06-003|Completed||Phase 2|103|Actual|Akros Pharma Inc.||1|||f||||f||||||||||2017-02-18 13:57:29.837643|2017-02-18 13:57:29.837643
NCT00748839|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-11-22|||March 2009||2009-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|Score-TIH||Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical|Heparin-Induced Thrombocytopenia : Development and Validation of a Predictive Clinical Score: a Prospective Multicenter Study Under the Auspices of the French Haemostasis and Thrombosis Study Group (GEHT)in Cooperation With the French Association of Regional PharmacoVigilance Center (AFCRPV)|Completed||N/A|2700|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||Samples Without DNA|"~     blood sample~   "|||2017-02-18 13:57:29.93662|2017-02-18 13:57:29.93662
NCT00748826|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-09-02|2011-12-22||August 2002||2002-08-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Remicade Safety Line (Study P03236)(COMPLETED)|Remicade Safety Line|Completed||N/A|576|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:57:30.075828|2017-02-18 13:57:30.075828
NCT00748813|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2016-11-30|||June 2008||2008-06-01|December 2011|2011-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009|A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Sub|Completed||Phase 2|133|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:57:30.334831|2017-02-18 13:57:30.334831
NCT00748800|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2009-02-05|||September 2004||2004-09-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|May 2007|Actual|2007-05-01||Interventional|||An Affect Management Intervention for Juvenile Offenders|An Affect Management Intervention for Juvenile Offenders|Completed||Phase 1|95|Actual|Rhode Island Hospital||2|||f||||f||||||||||2017-02-18 13:57:30.454392|2017-02-18 13:57:30.454392
NCT00748787|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2011-06-07|||October 2008||2008-10-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents|Multicenter, Double Blind, Randomized, Controlled With Placebo, to Evaluate the Effect of the Treatment With Plantago Ovata Husk in the Incidence of the Remission of Metabolic Syndrome in Children and Adolescents Between 10 to 16 Years Old.|Terminated||Phase 2|19|Actual|Rottapharm Spain||2||"It was very difficult to fulfill the inclusion criteria, therefore the expected time of~   inclusion was delayed so much time."|f||||f||||||||||2017-02-18 13:57:30.575847|2017-02-18 13:57:30.575847
NCT00748774|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-01-05|||May 2008||2008-05-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Brain Tumor Patient-Caregiver Congruence, MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT)|Primary Brain Tumor Patient and Caregiver Congruence in Symptom Report Using the M.D. Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT)|Completed||N/A|115|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 13:57:30.700629|2017-02-18 13:57:30.700629
NCT00748761|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2014-12-16|||June 2008||2008-06-01|December 2014|2014-12-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder|Cognitive-Behavioral Therapy & Glutamatergic Neurometabolites in Pediatric OCD|Unknown status|Active, not recruiting|N/A|108|Anticipated|University of California, Los Angeles||3|||f||||f||||||||||2017-02-18 13:57:30.816335|2017-02-18 13:57:30.816335
NCT00748748|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2012-07-03|||February 2010||2010-02-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Lactobacillus Probiotic on Healthy Adults|Effect of Lactobacillus Probiotic on Healthy Adults|Completed||Phase 1|20|Actual|Fargo VA Medical Center||1|||f||||f||||||||||2017-02-18 13:57:30.93388|2017-02-18 13:57:30.93388
NCT00748735|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-07|2008-09-08||||||January 2008|2008-01-01||||||||Observational|||Left Ventricular Lead Position in Cardiac Resynchronization Therapy|Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy by Myocardial Deformation Imaging|Completed||N/A|55|Actual|RWTH Aachen University|||1||f||||f||||||||||2017-02-18 13:57:31.035347|2017-02-18 13:57:31.035347
NCT00748722|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2008-09-07|||September 2008||2008-09-01|September 2008|2008-09-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Observational|DIEP||Pre-Operative Imaging of Abdominal Wall Perforators Using CT Angiography|Pre-Operative Imaging of Abdominal Wall Perforators Using CT Angiography for DIEP Breast Reconstruction|Unknown status|Active, not recruiting|N/A|20|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||||||2017-02-18 13:57:31.147112|2017-02-18 13:57:31.147112
NCT00748709|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-08|2013-11-05|2013-08-08||October 2008||2008-10-01|November 2013|2013-11-01||||November 2010|Actual|2010-11-01||Interventional|||Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.|An Open Label Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification or EFGR Activating Mutations.|Terminated||Phase 2|20|Actual|Boehringer Ingelheim|Due to early study termination, only data on the primary efficacy endpoint were summarized, no CIs were produced and efficacy and safety results were presented for the overall population rather than by tumor category.|1|||f||||||||||||||2017-02-18 13:57:31.263808|2017-02-18 13:57:31.263808
NCT00748696|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2012-02-20|||December 2006||2006-12-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Combined Effects of Resistance Training and Nutritional Supplements in the Treatment of Sarcopenia|Combined Effects of Resistance Training and Nutritional Supplements in the Treatment of Sarcopenia|Terminated||Phase 3|2|Actual|Centre Hospitalier Universitaire de Nice||4|||f||||f||||||||||2017-02-18 13:57:31.611673|2017-02-18 13:57:31.611673
NCT00748683|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2009-12-14|||September 2008||2008-09-01|September 2008|2008-09-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|||Development of an Integrated Health Care Environment for Elderly With RFID Technology|Development of an Integrated Health Care Environment for Elderly With RFID Technology|Completed||Early Phase 1|15|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 13:57:31.728135|2017-02-18 13:57:31.728135
NCT00543179|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2007-10-11|||October 2007||2007-10-01|October 2007|2007-10-01||||||||Interventional|||Treatment of the Dumping Syndrome With Lanreotide Autogel®|Treatment of the Dumping Syndrome With Lanreotide Autogel®|Unknown status|Recruiting|Phase 4|||Radboud University|||||f||||t||||||||||2017-02-18 15:11:24.034917|2017-02-18 15:11:24.034917
NCT00748670|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2008-09-05|||September 1999||1999-09-01|September 2008|2008-09-01||||October 2006|Actual|2006-10-01||Interventional|||Treatment With Fixture Microthread™ in Patients With Poor Bone Quality and no Teeth in the Upper Jaw, When Using Two-Stage Surgery|An Open, Prospective, Multicenter Study to Evaluate Treatment of Edentulous Upper Jaws With an Implant-Supported Prosthesis Retained by Astra Tech Dental Implants, Fixture Micro-Macro in Patients With Poor Bone Quality|Terminated||N/A|23|Actual|Dentsply Sirona Implants||1||"Decision to modify the product under study as a result of feedback regarding subjective~   feeling during installation procedure. For more info, see brief summary."|f||||f||||||||||2017-02-18 13:57:31.816096|2017-02-18 13:57:31.816096
NCT00748657|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-11-14|2015-05-27||September 2008||2008-09-01|August 2016|2016-08-01||||January 2013|Actual|2013-01-01||Interventional||Eligibile and treatmed patients|Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary|A Phase II Trial of NCI-Supplied Agent: Bevacizumab (rhuMAB VEGF) (NSC# 704865) for Recurrent Sex Cord-Stromal Tumors of the Ovary|Active, not recruiting||Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 13:57:31.916965|2017-02-18 13:57:31.916965
NCT00748644|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-08-02|||October 2008||2008-10-01|January 2012|2012-01-01|June 2013|Actual|2013-06-01|March 2013|Actual|2013-03-01||Interventional|MAINRITSAN||Efficacy Study of Two Treatments in the Remission of Vasculitis|MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis|Completed||Phase 3|117|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:57:32.352111|2017-02-18 13:57:32.352111
NCT00748631|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-03-23|||October 2007||2007-10-01|November 2014|2014-11-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Interventional|KYPHOK||Treatment of Malignant Vertebral Fractures With Percutaneous Balloon Kyphoplasty.|"Assessment of Percutaneous Balloon Kyphoplasty in the Treatment of Malignant Vertebral Fractures (Multiple Myeloma and Osteolytic Metastases) : Observational Study"|Terminated||N/A|60|Actual|Assistance Publique - Hôpitaux de Paris||1||the data collected are enough to obtain a qualitative analysis.|f||||f||||||||||2017-02-18 13:57:32.464318|2017-02-18 13:57:32.464318
NCT00748618|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-09-05|||October 2008||2008-10-01|September 2008|2008-09-01|March 2010|Anticipated|2010-03-01|October 2009|Anticipated|2009-10-01||Interventional|||Vitamin D Replacement After Kidney Transplant|Vitamin D Replacement After Kidney Transplant|Unknown status|Not yet recruiting|Phase 1/Phase 2|144|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-02-18 13:57:32.570607|2017-02-18 13:57:32.570607
NCT00748605|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-09-13|||June 2007||2007-06-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet|A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0 or 1600 mg/Day of S-2367 Administered Orally Once Daily With an Initial 6-Week Low Calorie Diet in Obese Males and Females|Completed||Phase 2|842|Actual|Shionogi Inc.||3|||f||||f||||||||||2017-02-18 13:57:32.684494|2017-02-18 13:57:32.684494
NCT00748592|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2009-02-11|||January 2009||2009-01-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia|PD 0200390 Dose-Ranging Trial: A Randomized, Double-Blind, Placebo-Controlled, 4-Way Crossover, Multicenter Polysomnography Trial Of PD 0200390 In Elderly Subjects With Primary Insomnia|Withdrawn||Phase 2|0|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:57:32.887368|2017-02-18 13:57:32.887368
NCT00748579|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-10-07|2010-07-30||September 2008||2008-09-01|October 2015|2015-10-01|July 2009|Actual|2009-07-01|November 2008|Actual|2008-11-01||Interventional|||Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency|A Phase II Open-Label Study to Investigate the Effects of CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen Consumption, and Myocardial Efficiency in Patients With Heart Failure and Left Ventricular Systolic Dysfunction|Terminated||Phase 2|2|Actual|Cytokinetics|Inadequate enrollment led to early termination of study and insufficient number of patients for analysis.|2||"Decision to discontinue due to challenges of trial design and constraints on enrolling~   eligible and consenting patients."|f||||t||||||||||2017-02-18 13:57:32.999142|2017-02-18 13:57:32.999142
NCT00748566|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-04-29|2013-04-29||December 2008||2008-12-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome|A One-Year, Phase IV, Open-Label, Non-Comparative Trial Of The Effect Of Ziprasidone HCL On Metabolic Syndrome Risk Factors In Patients With Psychotic Disorders|Terminated||Phase 4|172|Actual|Pfizer|The study was prematurely terminated by sponsor due to changes in organizational strategy and resources, not due to safety concerns.|1||See Detailed Description|f||||f||||||||||2017-02-18 13:57:33.451808|2017-02-18 13:57:33.451808
NCT00748553|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2016-09-14|||September 2008||2008-09-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|VA||A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer|A Phase I/II Clinical Trial of the Hypomethylating Agent Azacitidine (Vidaza) With the Nanoparticle Albumin Bound Paclitaxel (Abraxane) in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer|Completed||Phase 1/Phase 2|30|Actual|University of Utah||1|||f||||f||||||||||2017-02-18 13:57:34.233605|2017-02-18 13:57:34.233605
NCT00748540|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-03-09||2016-03-09|December 2007||2007-12-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|VSBRW||Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses|Clinical Trial of the Vibrant Soundbridge as a Treatment for Conductive and Mixed Hearing Losses, Using Direct Round Window Cochlear Stimulation.|Completed||N/A|50|Actual|Med-El Corporation||1|||f||||f||||||||||2017-02-18 13:57:34.34582|2017-02-18 13:57:34.34582
NCT00748527|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-07-09|||July 2007||2007-07-01|September 2008|2008-09-01|November 2010|Actual|2010-11-01|December 2009|Actual|2009-12-01||Interventional|||Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Cancer Research UK Randomised, Multicentre, Phase II Trial of the DNAhypomethylating Agent, 5-Aza-2'-Deoxycytidine (Decitabine) Given Intravenously in Combination With Carboplatin, Versus Carboplatin Alone Given 4 Weekly in Patients With Progressive, Advanced Ovarian Cancer|Terminated||Phase 2|134|Anticipated|National Cancer Institute (NCI)||2||"The study was withdrawn due to certain adverse events [hypersensitivity]."|f||||||||||||||2017-02-18 13:57:34.474264|2017-02-18 13:57:34.474264
NCT00536900|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2014-07-16|||June 2004||2004-06-01|July 2014|2014-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Clinical Trial of Abstinence-Linked Money Management|Abstinence-Linked Money Management|Completed||Phase 2|90|Actual|Yale University||2|||f||||t||||||||||2017-02-18 15:12:44.008718|2017-02-18 15:12:44.008718
NCT00748514|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2008-10-06|||June 1995||1995-06-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||A Capsular Incision and Biochemical Recurrence After Radical Perineal Prostatectomy|Impact of a Capsular Incision on Biochemical Recurrence After Radical Perineal Prostatectomy|Completed||N/A|266|Actual|Samsung Medical Center|||1||f||||t||||||Samples Without DNA|"~     prostate gland~   "|||2017-02-18 13:57:34.607021|2017-02-18 13:57:34.607021
NCT00748501|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2012-10-30||2012-10-30|September 2008||2008-09-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|ALS||Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)|A Phase 2 Repeat-Dosing Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis|Completed||Phase 2|45|Actual|Sangamo Therapeutics||2|||f||||f||||||||||2017-02-18 13:57:34.699384|2017-02-18 13:57:34.699384
NCT00748488|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-01-27|||September 2008||2008-09-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ParkFit||Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease|The ParkFit Study; Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease|Completed||Phase 3|700|Actual|Radboud University||2|||f||||t||||||||||2017-02-18 13:57:34.811478|2017-02-18 13:57:34.811478
NCT00748475|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-02-19|||September 2008||2008-09-01|February 2013|2013-02-01||||May 2010|Actual|2010-05-01||Interventional|||Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus|Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus|Completed||N/A|12|Actual|University of Konstanz||1|||f||||f||||||||||2017-02-18 13:57:34.95156|2017-02-18 13:57:34.95156
NCT00748462|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-01-24|||July 2008||2008-07-01|January 2014|2014-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CO2||Fractional CO2 Treatment of Acne Scars in Asians|Clinical Quality Assurance Study: Fractional CO2 Treatment of Acne Scars in Asians|Completed||Phase 4|12|Actual|Mahidol University||1|||f||||t||||||||||2017-02-18 13:57:35.027994|2017-02-18 13:57:35.027994
NCT00748449|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-09-09|||June 2008||2008-06-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|COLO-TDM||Colonography Versus Colonoscopy in High Risk Patient|Acceptability and Effectiveness of Colonography Compared to Colonoscopy for the Detection of Advanced Adenomas in Patients at High Risk for Colorectal Cancer|Terminated||N/A|39|Actual|Assistance Publique - Hôpitaux de Paris||2||No more inclusions|f||||f||||||||||2017-02-18 13:57:35.127585|2017-02-18 13:57:35.127585
NCT00748436|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2009-05-06|||September 2008||2008-09-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy Study of Betahistine on Body Weight in Obese Female Subjects|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Female Subjects|Completed||Phase 2|187|Actual|OBEcure Ltd.||3|||f||||t||||||||||2017-02-18 13:57:35.232378|2017-02-18 13:57:35.232378
NCT00748423|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-08-01|||December 2008||2008-12-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|INOSTA||Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study)|Bicentric Study of the Effect of Inhaled Nitric Oxide Compared to Placebo in Acute Chest Syndrome of Adult Sickle Cell Patients|Completed||Phase 2/Phase 3|100|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 13:57:35.35365|2017-02-18 13:57:35.35365
NCT00748410|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2017-01-31|||January 2009||2009-01-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis|An Open Label, 7-day Repeat Dose Study to Evaluate the Pharmacodynamics of SB-656933-AAA in Patients With Ulcerative Colitis.|Terminated||Phase 2|3|Actual|GlaxoSmithKline||1||SB-656933 is no longer being developed for ulcerative colitis.|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:57:35.465936|2017-02-18 13:57:35.465936
NCT00748397|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2008-09-05|||January 1999||1999-01-01|September 2008|2008-09-01||||December 2007|Actual|2007-12-01||Interventional|||Evaluation of Treatment With Fixture Microthread™ in Patients Missing All Teeth in the Upper Jaw, When Using One-Stage Surgery|An Open, Prospective, Multicenter Study to Evaluate Treatment of Edentulous Upper Jaws With Fixed Detachable Bridges Retained by Astra Tech Dental Implants, Fixture Micro-Macro|Terminated||N/A|54|Actual|Dentsply Sirona Implants||1||"Decision to modify the product under study as a result of feedback regarding subjective~   feeling during installation procedure. For more info, see brief summary."|f||||f||||||||||2017-02-18 13:57:35.567632|2017-02-18 13:57:35.567632
NCT00748384|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-05-14|||February 2009||2009-02-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Observational|UU2||Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients|Usability of the Foresee Home in Intermediate Age Related Macular Degeneration Patients|Completed||N/A|30|Actual|Notal Vision Ltd|||2||f||||f||||||||||2017-02-18 13:57:35.74195|2017-02-18 13:57:35.74195
NCT00748371|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-12-04|||June 2004||2004-06-01|December 2015|2015-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration|Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration|Terminated||Phase 4|150|Anticipated|Vanderbilt University||3||Funding issue|f||||f||||||||||2017-02-18 13:57:35.859661|2017-02-18 13:57:35.859661
NCT00748358|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-09-17|||March 2008||2008-03-01|September 2008|2008-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|PROSUT||An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer|An Open Label Phase II Study of Oral Treatment With Sunitinib (SUTENT) in Patients Suffering From Hormone Refractory Prostate Cancer After Progression With Docetaxel Based Regimen|Completed||Phase 2|50|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:57:35.973973|2017-02-18 13:57:35.973973
NCT00748345|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-12-15|||February 2009||2009-02-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|Caspo-brûlés||Pharmacokinetics of Caspofungin in Burn Patients|Pharmacokinetics of Caspofungin in Burn Patients|Completed||Phase 2/Phase 3|2|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:57:36.082306|2017-02-18 13:57:36.082306
NCT00748332|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2012-08-21|||March 2008||2008-03-01|June 2009|2009-06-01|August 2012|Actual|2012-08-01|June 2011|Actual|2011-06-01||Interventional|||Protein-energy Oral Supplementation Enriched With Omega-3 Fatty Acids in Cardiac Cachexia|Effects of a Protein-energy Oral Supplement Enriched With Omega-3 Fatty Acids Compared to a Standard Protein-energy Supplement in Cardiac Cachexia|Terminated||Phase 3|6|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 13:57:36.190365|2017-02-18 13:57:36.190365
NCT00748319|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-08-21|||March 2009||2009-03-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|KIR||Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma|Analysis of Killer Immunoglobulin-like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T-cell Lymphomas (Mycosis Fungoid and Sézary Syndrome) in Patients With Erythroderma or Erythematous Patches/Plaques.|Completed||N/A|495|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 13:57:36.297445|2017-02-18 13:57:36.297445
NCT00748306|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-10-11|||December 2008||2008-12-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study in Mild Asthmatic Patients|A Randomised, Double-blind, Placebo-controlled, 2-period Cross-over Study to Evaluate the Effect of Treatment With GSK2190915 on the Allergen-induced Asthmatic Response in Subjects With Mild Asthma|Completed||Phase 2|19|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:57:36.40939|2017-02-18 13:57:36.40939
NCT00748293|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2008-09-05|||September 2008||2008-09-01|September 2008|2008-09-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet|Achievement of Better Examinee Compliance on Colon Cleansing Before Colonoscopy Without Sacrificing Cleansing Effect - A Multi-Center Endoscopist-Blinded Randomized Trial Using Commercialized Low-Residue Diet|Unknown status|Recruiting|N/A|224|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:57:36.528836|2017-02-18 13:57:36.528836
NCT00748280|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2011-06-22|||April 2008||2008-04-01|June 2011|2011-06-01|September 2013|Anticipated|2013-09-01|September 2008|Actual|2008-09-01||Interventional|VPT||Vital Pulp Therapy to Treat Irreversible Pulpitis|Pulpotomy Versus Root Canal Therapy to Treat Irreversible Pulpitis in Human Permanent Molars: A Multicenter Randomized Non-inferiority Trial.|Unknown status|Active, not recruiting|Phase 3|615|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 13:57:36.635595|2017-02-18 13:57:36.635595
NCT00748267|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-03-03|||August 2008||2008-08-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast Cancer|Use of Pre-Operative Hypnosis to Reduce Post-Operative Pain and Anesthesia Related Side-Effects|Completed||N/A|20|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 13:57:36.744406|2017-02-18 13:57:36.744406
NCT00748254|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2016-10-17|||February 2008||2008-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis|Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis|Recruiting||Early Phase 1|120|Anticipated|University of Michigan||2|||f||||f||||||||No||2017-02-18 13:57:36.842193|2017-02-18 13:57:36.842193
NCT00748241|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-01-12|2011-08-23||September 2000||2000-09-01|January 2012|2012-01-01||||August 2008|Actual|2008-08-01||Interventional|||Study to Evaluate Implant Survival Rate of Astra Tech Fixture ST in the Posterior Maxilla With One-stage Surgery and Early Loading|An Open Prospective Study to Evaluate the Survival Rate and Marginal Bone Response of Astra Tech Dental Implants, Fixture ST, in Patients With Tooth Loss in the Posterior Maxilla.|Completed||N/A|19|Actual|Dentsply Sirona Implants||1|||f||||f||||||||||2017-02-18 13:57:36.96255|2017-02-18 13:57:36.96255
NCT00748228|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2015-06-11|||November 2004||2004-11-01|June 2015|2015-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Dopamine in Orthostatic Tolerance|Dopamine in Orthostatic Tolerance|Terminated||N/A|22|Actual|Vanderbilt University||3||This study is being replaced by another protocol.|f||||f||||||||||2017-02-18 13:57:37.228597|2017-02-18 13:57:37.228597
NCT00748215|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2014-08-14|||February 2009||2009-02-01|August 2014|2014-08-01||||August 2014|Actual|2014-08-01||Interventional|||Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan|Phase II, Randomized, Double Blind Comparison of CASAD vs. Placebo for the Treatment and Prevention of Diarrhea in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|100|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 13:57:39.740735|2017-02-18 13:57:39.740735
NCT00748202|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2011-01-18|||September 2008||2008-09-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|PASSION||Berinert P Study of Subcutaneous Versus Intravenous Administration|Pharmacokinetics Berinert P Study of Subcutaneous Versus Intravenous Administration in Subjects With Moderate Hereditary Angioedema - The Passion Study|Completed||Phase 3|24|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-02-18 13:57:39.853683|2017-02-18 13:57:39.853683
NCT00748189|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-03-22|2013-11-14||December 2008||2008-12-01|March 2016|2016-03-01|June 2022|Anticipated|2022-06-01|March 2013|Actual|2013-03-01||Interventional|COMPLEMENT 1||Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia|A Phase III, Open Label, Randomized, Multicenter Trial of Ofatumumab Added to Chlorambucil Versus Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 3|447|Actual|Novartis||2|||f||||f||||||||||2017-02-18 13:57:39.992493|2017-02-18 13:57:39.992493
NCT00748176|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2009-12-14|||July 2008||2008-07-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||The Relationship of Abdominal Circumference and Trunk Length With the Level of Spinal Anesthesia in Obstetric Patients|The Relationship of Abdominal Circumference and Trunk Length With the Level of Spinal Anesthesia in Obstetric Patients|Completed||N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:57:41.961709|2017-02-18 13:57:41.961709
NCT00748163|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-08-31|||August 2008||2008-08-01|August 2011|2011-08-01||||||||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer|Phase II Study of ABI-007 Plus Sunitinib as First Line Treatment for Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||1||Study has been abandoned for lack of available funding.|||||t||||||||||2017-02-18 13:57:42.057809|2017-02-18 13:57:42.057809
NCT00747929|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-09-13|||June 2007||2007-06-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet|A Double-Blind, Multi-Center, Randomized, Parallel-Group, Yearlong Study to Assess the Efficacy and Safety of 0, 800, or 1600 mg/Day of S-2367 Administered Orally Once Daily With a Reduced Calorie Diet in Obese Males and Females|Completed||Phase 2|724|Actual|Shionogi Inc.||3|||f||||f||||||||||2017-02-18 13:57:48.105835|2017-02-18 13:57:48.105835
NCT00748150|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-01-04|||July 2008||2008-07-01|January 2012|2012-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects|A Phase II, Open-Label, Uncontrolled, Single Center Study to Evaluate Safety and Immunogenicity of Flu Vaccine Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly Subjects|Completed||Phase 2|143|Actual|Novartis||1|||f||||f||||||||||2017-02-18 13:57:42.169993|2017-02-18 13:57:42.169993
NCT00748137|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2010-02-05|||March 2008||2008-03-01|August 2009|2009-08-01|January 2011|Anticipated|2011-01-01|October 2010|Anticipated|2010-10-01||Interventional|||Bolus Insulin Card Calculator Randomised Controlled Study|Bolus Insulin Card Calculator Randomised Controlled Study|Unknown status|Recruiting|N/A|150|Anticipated|John Hunter Children's Hospital||2|||f||||f||||||||||2017-02-18 13:57:42.283233|2017-02-18 13:57:42.283233
NCT00748124|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2014-09-04||2013-02-22|August 2008||2008-08-01|September 2014|2014-09-01|April 2011|Actual|2011-04-01|September 2010|Actual|2010-09-01||Interventional|||PleuraSeal Pivotal Study (US)|A Prospective Multicenter Randomized Clinical Study to Evaluate the PleuraSeal Sealant System as an Adjunct to Standard Closure Techniques for Control of Visceral Pleural Air Leaks Following Elective Pulmonary Resection Via Open Thoracotomy|Terminated||Phase 3|230|Actual|Integra LifeSciences Corporation||2||Interim analysis results were not supportive of primary endpoint|f||||f||||||||||2017-02-18 13:57:42.400853|2017-02-18 13:57:42.400853
NCT00748111|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-12-15|||August 2008||2008-08-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|TIDE||Thrombus and Inflammation Study in Sudden Cardiac DEath|Thrombus and Inflammation in Sudden Cardiac DEath|Completed||N/A|380|Actual|Assistance Publique - Hôpitaux de Paris||4|||f||||f||||||||||2017-02-18 13:57:42.48656|2017-02-18 13:57:42.48656
NCT00748098|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2013-07-15|2011-04-21||October 2008||2008-10-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance|Study RXP110908, a Polysomnography Study of GSK1838262 (XP13512) Extended Release Tablets Versus Placebo in the Treatment of Restless Legs Syndrome (RLS) and Associated Sleep Disturbance|Completed||Phase 3|136|Actual|XenoPort, Inc.||2|||f||||f||||||||||2017-02-18 13:57:42.671662|2017-02-18 13:57:42.671662
NCT00748085|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2015-06-30|2014-06-16||October 2008||2008-10-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|ICEtheMAD||CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)|A Multi-Center Study of CryoSpray Ablation(tm)in Malignant Airway Disease to Determine, Safety, and Tissue Effect in the Lung (ICE the MAD)|Terminated||N/A|5|Actual|CSA Medical, Inc.||1||Business Reasons|f||||t||||||||||2017-02-18 13:57:43.499322|2017-02-18 13:57:43.499322
NCT00748072|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2014-12-30|2014-12-30||August 2008||2008-08-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy|1-deamino 8-d-arginine Vasopressin in Percutaneous Ultrasound-guided Renal Biopsy: a Randomized Controlled Trial|Completed||Phase 4|162|Actual|University of Bari|A possible limitation of the study is the single-center design of the study, which could reduce the generalizability of our results and their external validity.|2|||f||||f||||||||||2017-02-18 13:57:43.795936|2017-02-18 13:57:43.795936
NCT00748059|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2016-10-14|||December 1996||1996-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Pathophysiology of Orthostatic Hypotension|The Pathophysiology of Orthostatic Hypotension|Active, not recruiting||Phase 1|25|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 13:57:44.301207|2017-02-18 13:57:44.301207
NCT00748046|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2014-06-24|||August 2008||2008-08-01|June 2014|2014-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton|Phase 1, Open-label, Single Ascending-dose Study to Assess Safety, Pharmacokinetics, Biodistribution and Radiation Dosimetry of Intravenous Doses of Alpharadin™ Injection (Radium-223 Chloride) in Patients With HRPC and Skeletal Metastases|Completed||Phase 1|10|Actual|Bayer||1|||f||||f||||||||||2017-02-18 13:57:44.43622|2017-02-18 13:57:44.43622
NCT00746395|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2016-11-07|2013-08-15||April 2008||2008-04-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy|Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy|Completed||Phase 4|45|Actual|University of South Alabama|Study participant enrollment met per protocol requirement.|2|||f||||f||||||||||2017-02-18 13:57:44.549028|2017-02-18 13:57:44.549028
NCT00746382|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2016-11-30|||November 2008||2008-11-01|October 2016|2016-10-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|||A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)|A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis|Withdrawn||Phase 2|0|Actual|AstraZeneca||2||Study withdrawn due to business decisions. No subjects were treated.|f||||f||||||||||2017-02-18 13:57:44.942844|2017-02-18 13:57:44.942844
NCT00746369|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2013-11-18|||October 2008||2008-10-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|IMARA||IMARA, Adapting SiHLE for Detained African American Adolescent Females|IMARA, Adapting SiHLE for Detained African American Adolescent Females|Completed||N/A|188|Actual|Emory University||2|||f||||f||||||||||2017-02-18 13:57:45.061923|2017-02-18 13:57:45.061923
NCT00746356|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2013-02-20|2011-07-24||August 2008||2008-08-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds|A Clinical Evaluation of the Current™ Radio Frequency (RF) Implantable Cardioverter Defibrillator (ICD) Models 2215/1215 and Promote™ RF Cardiac Resynchronization Therapy Defibrillator (CRT-D) Model 3215 Pulse Generators|Completed||N/A|128|Actual|St. Jude Medical||2|||f||||f||||||||||2017-02-18 13:57:45.183217|2017-02-18 13:57:45.183217
NCT00746343|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2013-12-11|||September 2008||2008-09-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|MedRisk||Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study|Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study|Completed||N/A|122|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 13:57:45.495743|2017-02-18 13:57:45.495743
NCT00196001|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-02-16|||July 2005||2005-07-01|February 2006|2006-02-01||||||||Observational|||ACTH Stimulation and G Protein|G Protein Expression in Response to ACTH Stimulation Testing|Unknown status|Recruiting|N/A|40||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 17:13:29.058417|2017-02-18 17:13:29.058417
NCT00746330|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2011-06-03|2010-11-21||August 2008||2008-08-01|June 2011|2011-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma|A Randomized, Double-blind, Double-dummy, Multi-centre, 4-way Cross-over Study to Compare the Single Dose Bronchodilatory Effect of Formoterol Fumarate in Combination With Mometasone Furoate Delivered Via Pressurized Metered Dose Inhaler (pMDI) to Placebo Delivered Via pMDI in Children Aged 5-11 Years Old With Persistent Asthma|Completed||Phase 2|32|Actual|Novartis||4|||f||||||||||||||2017-02-18 13:57:45.612377|2017-02-18 13:57:45.612377
NCT00746317|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2012-10-15|||September 2008||2008-09-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2010|Actual|2010-10-01||Interventional|||A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)|A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 Administered Weekly in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC)|Completed||Phase 1|27|Actual|Chugai Pharmaceutical||1|||f||||f||||||||||2017-02-18 13:57:46.706052|2017-02-18 13:57:46.706052
NCT00746304|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2008-08-31|||September 2007||2007-09-01|September 2007|2007-09-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Observational|||Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin|Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin|Completed||N/A|164|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-02-18 13:57:46.816771|2017-02-18 13:57:46.816771
NCT00746291|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2012-07-09|||June 2008||2008-06-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Heart Rate Variability (HRV) Among Children With Brain Damage|Assessment of Autonomic Nervous System With Analysis of Heart Rate Variability in Children With Brain Damage.|Terminated||N/A|80|Actual|Alyn Pediatric & Adolecent Rehabilitation Center||3|||f||||f||||||||||2017-02-18 13:57:46.913871|2017-02-18 13:57:46.913871
NCT00746278|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2010-02-25|||September 2008||2008-09-01|May 2008|2008-05-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional|||A Random Clinical Trial (RCT) of the Impact of Electrocoagulation on Ovarian Reserve|A Random Clinical Trial of the Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst|Completed||Phase 4|180|Actual|Shandong Provincial Hospital||3|||f||||t||||||||||2017-02-18 13:57:47.020504|2017-02-18 13:57:47.020504
NCT00746265|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2013-08-05|||September 2008||2008-09-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|November 2011|Actual|2011-11-01||Interventional|MYH||Behavioral Treatment for Weight Loss|Acceptance-based Behavior Treatment: An Innovative Weight Control|Completed||N/A|128|Actual|Drexel University||2|||f||||t||||||||||2017-02-18 13:57:47.132686|2017-02-18 13:57:47.132686
NCT00746252|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2012-06-19|||June 2008||2008-06-01|June 2012|2012-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|PAMS||Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder|Investigating Metabolic Side Effects of Antipsychotic Medications in Children|Completed||N/A|40|Anticipated|University of Maryland||2|||f||||t||||||||||2017-02-18 13:57:47.24179|2017-02-18 13:57:47.24179
NCT00748033|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-09-27|||August 2008||2008-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:57:47.352681|2017-02-18 13:57:47.352681
NCT00748020|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2008-09-05|||January 2003||2003-01-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|||Narrow-Band UVB-Therapy in Psoriasis|Narrow-Band UVB-Therapy in Psoriasis: Randomised Double-Blind Comparison of Erythematogenic and Suberythematogenic Irradiation Regimens|Completed||Phase 4|109|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 13:57:47.396047|2017-02-18 13:57:47.396047
NCT00748007|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2012-11-27|||January 2008||2008-01-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy of Rivastigmine in Patients With Down Syndrome|Efficacy of Rivastigmine in Patients With Down Syndrome|Completed||N/A|14|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 13:57:47.489472|2017-02-18 13:57:47.489472
NCT00747994|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2010-07-12|||September 2007||2007-09-01|July 2010|2010-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|PAGET||Genetic Study of Families Affected by Paget's Disease of Bone|Genetic Study of Families Affected by Paget's Disease of Bone|Completed||N/A|83|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"~     collection of extracted DNA, RNA and serum samples and urinary samples~   "|||2017-02-18 13:57:47.605564|2017-02-18 13:57:47.605564
NCT00747981|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-12-14|||May 2008||2008-05-01|August 2011|2011-08-01|October 2011|Actual|2011-10-01|April 2010|Actual|2010-04-01||Interventional|SICE||Thoracic Computed Tomography Scan for Diagnosis of Aspirated Foreign Bodies.|Management and Assessment of Thoracic CT Scan for Diagnosis of Aspirated Foreign Bodies in Children|Completed||N/A|311|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 13:57:47.705628|2017-02-18 13:57:47.705628
NCT00747968|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2011-06-29|||February 2010||2010-02-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|November 2010|Actual|2010-11-01||Interventional|||The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET|The Effect of the GLP-1 Analogue Exenatide on Glucose Metabolism in the CNS and Heart During Hyperglycemia in Type-2 Diabetic Patients Assessed by PET|Completed||Phase 2/Phase 3|8|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 13:57:47.80625|2017-02-18 13:57:47.80625
NCT00747955|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2017-01-24|||August 28, 2008||2008-08-28|April 1, 2016|2016-04-01||||||||Observational|||Evaluation of Assessments of Motor Performance, Physical Impairments and Functional Abilities|Evaluation of Assessments of Motor Performance, Physical Impairments and Functional Abilities|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 13:57:47.913364|2017-02-18 13:57:47.913364
NCT00747942|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-09-05|||October 2006||2006-10-01|September 2008|2008-09-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|STAM||Support for Increased Physical Activity (Stöd Till Aktivare Motion)|Intervention Program for Physically Inactive and Overweight Immigrant Women From the Middle East and Latin America Living in Sweden|Unknown status|Active, not recruiting|N/A|234|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 13:57:48.006907|2017-02-18 13:57:48.006907
NCT00747227|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2011-10-06|2011-03-04||December 2006||2006-12-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)|Clinical Evaluation of a Modified Light Transmission IOL|Completed||Phase 3|250|Actual|Abbott Medical Optics||2|||f||||f||||||||||2017-02-18 13:58:00.947587|2017-02-18 13:58:00.947587
NCT00747916|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2015-06-23|2014-07-02||August 2008||2008-08-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||"Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space(ICE PLS)"|"A Pilot Study of the Safety, Efficacy, and Side Effects of Interventional Cryotherapy for the Eradication of Disease in the Pleural Space (ICE PLS)"|Terminated||Phase 4|3|Actual|CSA Medical, Inc.||1||Business Reasons|f||||f||||||||||2017-02-18 13:57:48.455961|2017-02-18 13:57:48.455961
NCT00747903|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-05|2014-01-09|||February 2008||2008-02-01|July 2009|2009-07-01||||December 2010|Anticipated|2010-12-01||Interventional|||Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer|Investigation of the Effectiveness of Non-Coherent Blue Light in Intralesional Photodynamic of Basal Cell Carcinoma|Unknown status|Recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:57:48.753197|2017-02-18 13:57:48.753197
NCT00747890|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2011-10-31|||September 2008||2008-09-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Surgical Treatment of Mild Obstructive Sleep Apnea|The Effects of Surgical Treatment on Mild Obstructive Sleep Apnea and Its Co-morbidities|Unknown status|Recruiting|N/A|100|Anticipated|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 13:57:48.846354|2017-02-18 13:57:48.846354
NCT00747877|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-08-09|||April 2008||2008-04-01|June 2009|2009-06-01||||April 2012|Anticipated|2012-04-01||Interventional|||High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy|Myeloma X Relapse (Intensive): A Phase III Study to Determine the Role of a Second Autologous Stem Cell Transplant as Consolidation Therapy in Patients With Relapsed Multiple Myeloma Following Prior High-dose Chemotherapy and Autologous Stem Cell Rescue.|Unknown status|Recruiting|Phase 3|460|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:57:48.937913|2017-02-18 13:57:48.937913
NCT00747864|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2010-07-21|||April 2006||2006-04-01|July 2010|2010-07-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Observational|||Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life|Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life|Completed||N/A|106|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 13:57:49.106669|2017-02-18 13:57:49.106669
NCT00747851|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2016-06-21|||October 2003||2003-10-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Necrotizing Enterocolitis (NEC) & Platelet-Activating Factor (PAF)-Stimulated Protein Translation in Premature Infants|Necrotizing Enterocolitis (NEC) & Platelet-Activating Factor (PAF)-Stimulated Protein Translation in Premature Infants|Recruiting||N/A|388|Anticipated|University of Utah|||1||f||||f||||||||||2017-02-18 13:57:49.178435|2017-02-18 13:57:49.178435
NCT00747838|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-05-24|||September 2008||2008-09-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Observational|STAR||A Multicenter Data Registry for Outcomes From Surgical Treatment of Atrial Arrhythmias|Surgical Treatment for Atrial Arrhythmia Registry (STAR Outcomes)|Terminated||N/A|106|Actual|Virginia Commonwealth University|||1|Low enrollment.|f||||f||||||||||2017-02-18 13:57:49.276|2017-02-18 13:57:49.276
NCT00747825|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2011-10-07|||December 2009||2009-12-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma|A Phase I Study Evaluating the Safety, Pharmacokinetics, Tissue Distribution, and Determination of Radiation Dosimetry for 131-I-MIP-1145|Terminated||Phase 1|12|Anticipated|Molecular Insight Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:57:49.368905|2017-02-18 13:57:49.368905
NCT00747812|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2012-06-28|2012-06-28||May 2006||2006-05-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|November 2008|Actual|2008-11-01||Interventional|PRISM UK||Study of Occipital Nerve Stimulation for Drug Refractory Migraine|A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Occipital Nerve Stimulation for Drug Refractory Migraine|Terminated||Phase 2|11|Actual|Boston Scientific Corporation|Insufficient data collected from limited number of implanted subjects.|2||Sponsor closed enrollment early based on interim data from the PRISM US Pivotal Study.|f||||f||||||||||2017-02-18 13:57:49.46759|2017-02-18 13:57:49.46759
NCT00747799|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-12-08|||January 2009||2009-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|May 2011|Actual|2011-05-01||Interventional|||Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)|Phase II Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Are Failure of Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)|Completed||Phase 2|54|Actual|Sun Yat-sen University||1|||f||||||||||||||2017-02-18 13:57:49.868148|2017-02-18 13:57:49.868148
NCT00747786|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-10-07|||December 2008||2008-12-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Observational|||Non Interventional Post Marketing Programme in Neuroendocrine Tumours|"An Observational, Multicentre, Open Label, Non Interventional Programme to Assess the Long-Term Safety and Efficacy of Somatuline Autogel in the Treatment of Neuroendocrine Tumours When Administered by Patients or Their Partners (Home Injection Group) or Administered by Healthcare Professionals"|Completed||N/A|40|Actual|Ipsen|||1||f||||f||||||||||2017-02-18 13:57:49.972127|2017-02-18 13:57:49.972127
NCT00747773|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2014-01-08|||November 2007||2007-11-01|January 2014|2014-01-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|CSAir 1||Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung|A Study Of Cryospray Ablationtm Using Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung|Completed||Phase 4|21|Actual|CSA Medical, Inc.||1|||f||||t||||||||||2017-02-18 13:57:50.051577|2017-02-18 13:57:50.051577
NCT00747760|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-09-10|||December 2005||2005-12-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|July 2006|Actual|2006-07-01||Observational|TSHR||TSH Receptor Mutations Among a Consanguineous Community|The Prevalence of TSH Receptor Mutation Among the Arab Population of Israel|Completed||N/A|209|Actual|HaEmek Medical Center, Israel|||2||f||||f||||||Samples With DNA|"~     Blood samples were taken with EDTA and Genomic DNA was extracted from peripheral mononuclear~     cells using the Blood Amp Kit (QIAGEN Inc., Valencia, CA)~   "|||2017-02-18 13:57:50.142989|2017-02-18 13:57:50.142989
NCT00746707|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2011-12-17|||September 2008||2008-09-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Biologic Glue for First Degree Perineal Tears|Randomized Control Trial for the Comparison of Biologic Glue Versus Suturing for First Degree Perineal Tears|Completed||N/A|102|Actual|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 13:58:12.656554|2017-02-18 13:58:12.656554
NCT00747747|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2012-03-12|2011-12-05||November 2007||2007-11-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|January 2009|Actual|2009-01-01||Interventional|SToSS||Sinuclean's Treatment Of Sinusitis' Symptoms|Safety and Efficacy (for Symptoms Remission) of the Treatment of the Acute Episode of Sinusitis With Ecballium Elaterium (SINUclean DM® Nasal Spray) as Co-adjuvant of the Antibiotic Therapy: Comparative, Prospective, Randomized, Open Study.|Completed||Phase 4|49|Actual|Galsor S.r.l.|Clinical diagnosis could not be confirmed before treatment start due to logistics problems to make cranial MRI in due time.|3|||f||||f||||||||||2017-02-18 13:57:50.243351|2017-02-18 13:57:50.243351
NCT00747734|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2011-04-18|||September 2008||2008-09-01|April 2011|2011-04-01||||||||Interventional|||A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of MNRP1685A, a Human IgG1 Antibody, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|35|Actual|Genentech, Inc.|||||f||||||||||||||2017-02-18 13:57:51.030077|2017-02-18 13:57:51.030077
NCT00747721|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2009-04-20|||September 2008||2008-09-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|DEX PK||Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU|Pharmacokinetics of Intravenous Dexmedetomidine for Prolonged Infusion in Critically Ill, Ventilated Patients in Intensive Care Unit; an Open, Non-Randomised, Single Centre Study|Completed||Phase 1|13|Actual|Orion Corporation, Orion Pharma||1|||f||||f||||||||||2017-02-18 13:57:51.113281|2017-02-18 13:57:51.113281
NCT00747708|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-10-08|||August 2005||2005-08-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|REGEN-IHD||Bone Marrow Derived Adult Stem Cells for Chronic Heart Failure|Randomised Control Trial to Compare the Effects of G-CSF and Autologous Bone Marrow Progenitor Cells Infusion on the Quality of Life and Left Ventricular Function in Patients With Heart Failure Secondary to Ischaemic Heart Disease|Completed||Phase 2/Phase 3|148|Actual|Barts & The London NHS Trust||3|||f||||t||||||||||2017-02-18 13:57:51.199796|2017-02-18 13:57:51.199796
NCT00747695|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2011-01-07|||March 2008||2008-03-01|January 2011|2011-01-01|September 2009|Actual|2009-09-01|||||Interventional|||A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive|A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With GERD 1 to 11 Years Old, Inclusive|Completed||Phase 1|31|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:57:51.329801|2017-02-18 13:57:51.329801
NCT00747682|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2010-06-22|||July 2006||2006-07-01|June 2010|2010-06-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Observational|||Cerebral Perfusion, Oxygenation, Electrical Activity|Alterations in Cerebral Perfusion, Oxygenation, Electrical Activity, and Markers of Cerebral Damage Associated With Cerebro-spinal Fluid Reservior Aspiration in Neonates With Post Hemorrhagic Hydrocephalus|Completed||N/A|30|Anticipated|University of Utah|||1||f||||f||||||||||2017-02-18 13:57:51.422129|2017-02-18 13:57:51.422129
NCT00747669|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-03-22|||September 2008||2008-09-01|March 2012|2012-03-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Pharmacokinetic Study of Synera™ in Neonates and Infants|A Pharmacokinetic Study of Synera™ (Lidocaine 70 mg and Tetracaine 70 mg Topical Patch) to Evaluate the Systemic Exposure to Lidocaine and Tetracaine in Neonates and Infants|Suspended||Phase 4|11|Anticipated|ZARS Pharma Inc.||1||Difficulty with enrollment|f||||f||||||||||2017-02-18 13:57:51.511501|2017-02-18 13:57:51.511501
NCT00747656|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-05-07|||February 2009||2009-02-01|May 2013|2013-05-01|May 2013|Anticipated|2013-05-01|March 2013|Actual|2013-03-01||Observational|PREDICT||Prehospital Evaluation and Economic Analysis of Different Coronary Syndrome Treatment Strategies - PREDICT|The Impact of Prehospital 12 Lead ECG With Advanced Emergency Department Notification on Time to In-hospital Reperfusion Strategy in Patients With Acute ST Segment Elevation Myocardial Infarction - A Prospective Study|Unknown status|Active, not recruiting|N/A|400|Anticipated|St. Joseph's Healthcare Hamilton|||4||f||||f||||||||||2017-02-18 13:57:51.602473|2017-02-18 13:57:51.602473
NCT00747643|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-11-21|2011-07-27||September 2008||2008-09-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement|Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement|Completed||N/A|163|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-02-18 13:57:51.725815|2017-02-18 13:57:51.725815
NCT00747630|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2012-12-14|||May 2006||2006-05-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)|Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome|Terminated||Early Phase 1|99|Actual|Texas Tech University Health Sciences Center||1||This project was not a clinical trial requiring registration|f||||f||||||||||2017-02-18 13:57:52.156941|2017-02-18 13:57:52.156941
NCT00747617|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2016-02-09|2011-08-04||September 2007||2007-09-01|February 2016|2016-02-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Interventional|||Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)|Theca Cell Function in Women With Polycystic Ovary Syndrome|Completed||Phase 3|25|Actual|University of California, San Diego||2|||f||||t||||||||No||2017-02-18 13:57:52.265618|2017-02-18 13:57:52.265618
NCT00747604|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2015-04-02|||June 2006||2006-06-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex|Increlex® (Mecasermin [rDNA Origin] Injection) Growth Forum Database - IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex|Terminated||N/A|1378|Actual|Ipsen|||1|Shortage of Increlex supply|f||||t||||||||||2017-02-18 13:57:52.646688|2017-02-18 13:57:52.646688
NCT00747591|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2010-07-21|||November 2002||2002-11-01|July 2010|2010-07-01|April 2005|Actual|2005-04-01|February 2005|Actual|2005-02-01||Observational|||Urine Concentration of S100B in Extremely Premature Infants|Correlation of Urine Concentration of S100B in Extremely Premature Infants With Gestational Age and Severity of Intraventricular Hemorrhage|Completed||N/A|68|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 13:57:52.746674|2017-02-18 13:57:52.746674
NCT00747578|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-09-05|||September 2008||2008-09-01|September 2008|2008-09-01||||||||Observational|||Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan|Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan|Unknown status|Recruiting|N/A|300|Anticipated|Taichung Veterans General Hospital|||3||f||||||||||||||2017-02-18 13:57:52.825824|2017-02-18 13:57:52.825824
NCT00747565|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2013-02-27|2009-08-14||November 2004||2004-11-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Effectiveness of a Multifocal Intraocular Lens (IOL)|Clinical Evaluation of the Tecnis Multifocal Intraocular Lens (IOL), Model ZM900, Original Study (DIOL-101-TCNS); Clinical Evaluation of the Tecnis Multifocal Intraocular Lens, Model ZM900, Expansion Study (DIOL-104-TCNS)|Completed||N/A|470|Actual|Abbott Medical Optics|Results from the original study (DIOL-101-TCNS) and the expansion study (DIOL-104-TCNS) were analyzed together. The original study enrolled both multifocal and monofocal control subjects; the expansion study enrolled additional multifocal subjects.|2|||f||||f||||||||||2017-02-18 13:57:52.923984|2017-02-18 13:57:52.923984
NCT00747552|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2010-01-22|2009-07-21||January 2006||2006-01-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|April 2008|Actual|2008-04-01||Observational|||Intra-Abdominal Hypertension in Neonatal Intensive Care Patients|Intra-Abdominal Hypertension in Neonatal Intensive Care Patients|Completed||N/A|30|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 13:57:53.548981|2017-02-18 13:57:53.548981
NCT00747539|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2016-05-11|||July 2008||2008-07-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy|Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy|Completed||N/A|330|Actual|University of California, Los Angeles|||2||f||||t||||||Samples Without DNA|"~     Urine samples will be collected.~   "|||2017-02-18 13:57:53.774454|2017-02-18 13:57:53.774454
NCT00747526|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-07-05|||December 2007||2007-12-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive|A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabeprazole in Pediatric Subjects With GERD 1 to 11 Months Old, Inclusive|Completed||Phase 1|51|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-02-18 13:57:53.908671|2017-02-18 13:57:53.908671
NCT00747513|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2012-05-31|||September 2009||2009-09-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||A Multi-component Program to Reduce Obesity in Children|A Multi-component Program to Improve Lifestyle Habits and Reduce Obesity in Children|Completed||N/A|3600|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 13:57:54.072547|2017-02-18 13:57:54.072547
NCT00747500|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-04-22|||July 2008||2008-07-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Observational|||Non Interventional Post Marketing Programme in Acromegaly|"An Observational, Multicentre, Open Label, Non Interventional Programme to Assess the Long-term Safety and Efficacy of Somatuline® Autogel® in the Treatment of Acromegaly When Administered by Patients or Their Partners (Home Injection Group) or Administered by Healthcare Professionals."|Completed||N/A|42|Actual|Ipsen|||1||f||||f||||||||||2017-02-18 13:57:54.19651|2017-02-18 13:57:54.19651
NCT00747487|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-05-24|||November 2007||2007-11-01|May 2013|2013-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|RHODOS||Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy|A Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Patients With Leber's Hereditary Optic Neuropathy|Completed||Phase 2|85|Actual|Santhera Pharmaceuticals||2|||f||||t||||||||||2017-02-18 13:57:54.289629|2017-02-18 13:57:54.289629
NCT00747474|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-02-13|2012-01-05||September 2008||2008-09-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors|A Phase 1 Open-Label, Sequential Dose Escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Lipotecan® (TLC388 HCl for Injection) When Administered to Patients With Advanced Solid Tumors|Completed||Phase 1|54|Actual|Taiwan Liposome Company||1|||f||||t||||||||||2017-02-18 13:57:54.432271|2017-02-18 13:57:54.432271
NCT00747461|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2015-08-11|2015-06-04||October 2008||2008-10-01|August 2015|2015-08-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|ICEtheBAD||"Interventional Cryotherapy for the Eradication of Benign Airway Disease (ICE the BAD)"|"Assessment of the Safety, Side Effects and Efficacy of Interventional Cryotherapy for the Eradication of Benign Airway Disease(ICE THE BAD)"|Terminated||Phase 4|5|Actual|CSA Medical, Inc.||1||Business Reasons|f||||f||||||||||2017-02-18 13:57:55.240923|2017-02-18 13:57:55.240923
NCT00747448|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2016-02-01|||May 2009||2009-05-01|February 2016|2016-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||CryoSpray Ablation (TM) GI Patient Registry|CryoSpray Ablation (TM) GI Patient Registry|Completed||N/A|199|Actual|CSA Medical, Inc.|||1||f||||f||||||||No||2017-02-18 13:57:55.4954|2017-02-18 13:57:55.4954
NCT00747435|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2016-03-04|||February 2007||2007-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:57:55.601787|2017-02-18 13:57:55.601787
NCT00747422|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-10-15|||July 2008||2008-07-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Wrinkles Around the Eyes|Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Periorbital Wrinkles|Completed||N/A|100|Actual|Ulthera, Inc||1|||f||||f||||||||||2017-02-18 13:57:55.648928|2017-02-18 13:57:55.648928
NCT00747409|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-09-04|||July 2004||2004-07-01|September 2008|2008-09-01|June 2009|Anticipated|2009-06-01|March 2009|Anticipated|2009-03-01||Interventional|||Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes|Randomized, Long-Term Study About the Effects of Analogue Versus Human Insulin Based Regimens (Insulin Detemir and Aspart Versus NPH- and Regular Human Insulin) on Metabolic Control and Myocardial Function in People With Type 2 Diabetes.|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Munich Municipal Hospital||2|||f||||t||||||||||2017-02-18 13:57:55.881431|2017-02-18 13:57:55.881431
NCT00747396|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2016-11-30|||September 2000||2000-09-01|November 2016|2016-11-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|BEIP||The Bucharest Early Intervention Project|The Bucharest Early Intervention Project: Effects of Early Psychosocial Deprivation on Mental Health in Adolescence|Active, not recruiting||N/A|136|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 13:57:56.000612|2017-02-18 13:57:56.000612
NCT00745966|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-10-03|||July 2008||2008-07-01|September 2008|2008-09-01||||September 2008|Actual|2008-09-01||Observational|POLE||Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder|A 8-Week, Multicenter, Open-Label, Observational Study of Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder|Completed||N/A|1000|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 13:58:17.805767|2017-02-18 13:58:17.805767
NCT00747383|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2012-12-04|||September 2008||2008-09-01|September 2008|2008-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|MSD-GLP1||How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.|Influence of Improving Glycaemic Control on Glucagon-Like-Peptide-1 Response to an Oral Glucose Load. Comparison of Sulphonylurea With DPP-4 Inhibition.|Completed||N/A|74|Actual|The Royal Bournemouth Hospital||2|||f||||t||||||||||2017-02-18 13:57:56.110529|2017-02-18 13:57:56.110529
NCT00747370|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2008-09-04|||January 2002||2002-01-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||Dynamic MRI of the Behaviour of Female Pelvic Floor|The Suitability of Dynamic MRI for Pelvic Floor, Bladder Neck and Midurethra|Completed||Early Phase 1|74|Actual|Kuopio University Hospital||3|||f||||f||||||||||2017-02-18 13:57:56.224203|2017-02-18 13:57:56.224203
NCT00747357|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2016-02-18|||September 2008||2008-09-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|September 2012|Actual|2012-09-01||Interventional|INDICOR||INDICOR The Paclitaxel-Eluting PTCA-Balloon Catheter in Combination With a Cobalt-Chromium Stent|The Paclitaxel-Eluting PTCA-Balloon Catheter in Combination With a Cobalt-Chromium Stent to Treat Coronary Artery Disease in a Real World Scenario|Completed||Phase 3|97|Actual|Heart Centre Rotenburg||2|||f||||t||||||||||2017-02-18 13:57:56.324465|2017-02-18 13:57:56.324465
NCT00747344|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2013-03-22|2012-09-05||December 2008||2008-12-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|||A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis|Completed||Phase 3|121|Actual|Centocor, Inc.||4|||f||||t||||||||||2017-02-18 13:57:56.443059|2017-02-18 13:57:56.443059
NCT00747331|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2009-04-10|||September 2008||2008-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass|Fenoldopam Prophylaxis of Splanchnic Organs Underperfusion During Cardiopulmonary Bypass: a Randomized, Controlled Trial.|Completed||Phase 4|80|Anticipated|IRCCS Policlinico S. Donato||2|||f||||f||||||||||2017-02-18 13:57:56.935658|2017-02-18 13:57:56.935658
NCT00747318|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2011-06-08||2011-06-08|September 2008||2008-09-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005|A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005, Incorporating Amendment 1 and 2|Completed||Phase 3|280|Actual|SkyePharma AG||1|||f||||f||||||||||2017-02-18 13:57:59.462009|2017-02-18 13:57:59.462009
NCT00747305|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2015-10-21|||October 2008||2008-10-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery|Biomarkers of Tumor Angiogenesis and Response to Sunitinib Maleate in Renal Cell Carcinoma|Terminated||Phase 1|17|Actual|Medical University of South Carolina||1||Study terminated early due to low accrual.|f||||t||||||||||2017-02-18 13:57:59.618753|2017-02-18 13:57:59.618753
NCT00747292|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-09-04|||December 2007||2007-12-01|September 2008|2008-09-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery|Randomised Controlled Trial Comparing the Effects of Epidural, Spinal and PCA in Patients Undergoing Laparoscopic Colectomy.|Unknown status|Recruiting|Phase 1/Phase 2|99|Anticipated|Minimal Access Therapy Training Unit||3|||f||||f||||||||||2017-02-18 13:57:59.731225|2017-02-18 13:57:59.731225
NCT00747279|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-09-08|||June 2007||2007-06-01|September 2008|2008-09-01||||||||Interventional|||Comparison of Two Strategies for Glycemic Control in Acute Ischemic Stroke|Comparison of Two Strategies for Glycemic Control in Acute Ischemic Stroke|Unknown status|Recruiting|Phase 4|70|Anticipated|Hospital Sao Domingos||2|||f||||f||||||||||2017-02-18 13:57:59.842211|2017-02-18 13:57:59.842211
NCT00746239|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-09-14|2015-06-18||August 2008||2008-08-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety|Ramelteon for Sleep Initiation Insomnia in Panic Disorder Who Are Also on Escitalopram for Anxiety: A Double Blind, Randomized Clinical Trial|Terminated||N/A|11|Actual|Penn State University||2||Funding for continuation was not received.|f||||||||||||||2017-02-18 13:57:59.936856|2017-02-18 13:57:59.936856
NCT00746226|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-02|||March 2006||2006-03-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|June 2006|Actual|2006-06-01||Interventional|||Probiotics for Birch Pollen Allergy|Probiotic Intervention for Children With Birch Pollen Allergy|Completed||Phase 1/Phase 2|47|Actual|Danisco||2|||f||||f||||||||||2017-02-18 13:58:00.178971|2017-02-18 13:58:00.178971
NCT00746213|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2009-06-03|||July 2008||2008-07-01|June 2009|2009-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Chronic Pain After Thoracotomy, an Incidence Study|Chronic Pain After Thoracotomy, an Incidence Study|Completed||N/A|1340|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-02-18 13:58:00.484352|2017-02-18 13:58:00.484352
NCT00746200|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2010-05-10|||October 2008||2008-10-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Acupuncture for Chronic Constipation|Randomised Controlled Trial of Acupuncture for Patients With Chronic Constipation|Completed||Phase 3|80|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:58:00.571955|2017-02-18 13:58:00.571955
NCT00747266|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2008-09-04|||March 2007||2007-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 13:58:00.693991|2017-02-18 13:58:00.693991
NCT00747253|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-10-05|||August 2008||2008-08-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors|AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors|Completed||Phase 1|10|Actual|Monteris Medical||1|||f||||t||||||||||2017-02-18 13:58:00.741899|2017-02-18 13:58:00.741899
NCT00747240|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2015-05-11|||February 2002||2002-02-01|July 2014|2014-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression|Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression And The Incidence Of Chronic Lung Disease (Cld) In Very Low Birth Weight Infants|Completed||N/A|139|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 13:58:00.852847|2017-02-18 13:58:00.852847
NCT00747214|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2014-04-22|2014-01-16||November 2004||2004-11-01|April 2014|2014-04-01|November 2006|Actual|2006-11-01|September 2006|Actual|2006-09-01||Interventional||Baseline analysis population is equal to the per protocol population defined as the subset of intent to treat population with no major protocol deviations including entry criteria and use of restricted medications and with study drug compliance of at least 75% during Days 1 to 42.|A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA|A Multicenter, Randomized, Blinded Study Comparing the Effect of CRx-102 Plus DMARD Therapy to That of Placebo Plus DMARD Therapy on Serum C Reactive Protein (CRP) and Cytokines in Subjects With RA|Completed||Phase 2|59|Actual|Zalicus||2|||f||||f||||||||||2017-02-18 13:58:01.44198|2017-02-18 13:58:01.44198
NCT00747201|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-04|2014-05-21|||September 2009||2009-09-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites|Implementing Chronic Care Management for Bipolar Disorder|Completed||N/A|384|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 13:58:01.81837|2017-02-18 13:58:01.81837
NCT00747188|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2008-09-03|||February 2006||2006-02-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|July 2007|Actual|2007-07-01||Interventional|PBL||The Impact of Problem-Based Learning (PBL) and Lecturing|The Impact of Problem-Based Learning (PBL) and Lecturing on the Behavior and Attitudes of Iranian Nursing Students: a Randomised Controlled Trial (RCT)|Completed||N/A|||University of Tasmania||2|||f||||t||||||||||2017-02-18 13:58:01.926959|2017-02-18 13:58:01.926959
NCT00747175|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2010-12-02|||August 2008||2008-08-01|December 2010|2010-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|MAD||A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes|A Randomized, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Multiple Ascending Oral Doses of AZD1656 in T2DM Subjects|Completed||Phase 1|52|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 13:58:02.018303|2017-02-18 13:58:02.018303
NCT00747162|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-11-26|||August 2008||2008-08-01|November 2013|2013-11-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Muscle Oxygenation and Skin Pigmentation|Correlation Between Muscle Oxygenation and Skin Pigmentation|Withdrawn||Phase 4|0|Actual|Emory University||1||incorporated into other study|f||||f||||||||||2017-02-18 13:58:02.128087|2017-02-18 13:58:02.128087
NCT00747149|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2011-08-29|2010-08-06||May 2008||2008-05-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|ADAPT||A Diabetes Study to Treat A Population Previously Not at Target|12-week, Open-label, Multi-center, Prospective Study Evaluating the Effect of Individualizing Starting Doses of Rosuvastatin According to Baseline LDL (Low Density Lipoprotein)-Cholesterol Levels on Achieving Cholesterol Targets in Type 2 Diabetic Patients|Completed||Phase 4|598|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 13:58:02.225878|2017-02-18 13:58:02.225878
NCT00747136|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-04-12|||August 2008||2008-08-01|April 2011|2011-04-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Observational|||WavSTAT® Optical Biopsy System to Target Esophageal Biopsies|A Prospective Evaluation of the WavSTAT® Optical Biopsy System to Target Esophageal Biopsies: An Adjunctive Tool to Assist the Endoscopist to Identify Dysplasia or Cancer|Terminated||N/A|47|Actual|SpectraScience|||1|Study has been terminated for inadequate results|f||||t||||||Samples Without DNA|"~     esophageal biopsies will be collected.~   "|||2017-02-18 13:58:03.263434|2017-02-18 13:58:03.263434
NCT00747123|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2016-10-25||2012-09-11|September 2008||2008-09-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma|A Phase 2a, Multi-Center, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of ACE-011 (hActRIIA-IgG1) in Patients With Osteolytic Lesions of Multiple Myeloma|Completed||Phase 2|30|Actual|Celgene Corporation||4|||f||||t||||||||||2017-02-18 13:58:03.347947|2017-02-18 13:58:03.347947
NCT00747110|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-06-25|||October 2007||2007-10-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|August 2008|Actual|2008-08-01||Interventional|||Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)|Double-blind, Double-dummy, Randomised, Multi-centre, Comparative Phase III Clinical Study on the Efficacy and Tolerability of an 8 Week Oral Treatment With 9 mg Budesonide or 3 g Mesalazine in Patients With Active Ulcerative Colitis|Completed||Phase 3|343|Actual|Dr. Falk Pharma GmbH||2|||f||||t||||||||||2017-02-18 13:58:03.468348|2017-02-18 13:58:03.468348
NCT00747097|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2011-02-09|||September 2008||2008-09-01|February 2011|2011-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|ECHO||Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study|Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study|Completed||Phase 2|43|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-02-18 13:58:03.585003|2017-02-18 13:58:03.585003
NCT00747084|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2015-10-06|||December 2007||2007-12-01|October 2015|2015-10-01|December 2015|Anticipated|2015-12-01|December 2012|Actual|2012-12-01||Interventional|||Can Simple and Inexpensive Techniques Enhance Patient Comfort|Can Simple and Inexpensive Techniques Enhance Patient Comfort in Sedation Risk-free Screening and Surveillance Colonoscopy?|Terminated||Phase 1/Phase 2|82|Actual|VA Office of Research and Development||2||"Instruments necessary to continue project have been removed via medical center staff.~   Therefore, the project cannot continue until they have been replaced."|f||||f||||||||||2017-02-18 13:58:03.681476|2017-02-18 13:58:03.681476
NCT00747071|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-08-27|||September 2011||2011-09-01|June 2011|2011-06-01|November 2013|Anticipated|2013-11-01|November 2012|Anticipated|2012-11-01||Interventional|||Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies|Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies|Withdrawn||Phase 2/Phase 3|0|Actual|Hadassah Medical Organization||2||Sponsors decision|f||||t||||||||||2017-02-18 13:58:03.792859|2017-02-18 13:58:03.792859
NCT00747058|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2010-01-07|||August 2008||2008-08-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects|A Double Blind (3rd Party Open), Randomized, Placebo Controlled, Dose Escalating Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects|Completed||Phase 1|28|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 13:58:03.891089|2017-02-18 13:58:03.891089
NCT00747045|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2014-12-02|||August 2008||2008-08-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients|A Prospective Single Blind Controlled Study to Assess the Efficacy of a Lung Protective Ventilation Strategy in the Prevention of Reperfusion Lung Injury Following PTE|Completed||N/A|128|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 13:58:03.99193|2017-02-18 13:58:03.99193
NCT00747032|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2012-05-04|||September 2010||2010-09-01|May 2012|2012-05-01|April 2011|Anticipated|2011-04-01|February 2011|Anticipated|2011-02-01||Interventional|||To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis|Multi-Center, Double-Blind, Randomized, Vehicle-controlled, Parallel-Group Study Comparing NYC-0462 Ointment To a Vehicle Control|Withdrawn||Phase 3|0|Actual|Nycomed||2||Study withdrawn due to business decisions. No subjects were treated.|f||||f||||||||||2017-02-18 13:58:04.096137|2017-02-18 13:58:04.096137
NCT00747019|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2009-06-30|||December 2008||2008-12-01|June 2009|2009-06-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Prosocial Behavior and Exercise Among Older Adults|Prosocial Behavior and Exercise Among Older Adults|Unknown status|Recruiting|N/A|80|Anticipated|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 13:58:04.181039|2017-02-18 13:58:04.181039
NCT00747006|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2014-10-21|2014-07-22||September 2008||2008-09-01|October 2014|2014-10-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional||Randomized Subjects. Patients were randomly assigned to various carbohydrate loads (0%, 50%, 100%, 150% or 200%). The 100% carbohydrate load was determined based upon their standard insulin dose for their normal meal.|Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake|A Phase 2, Single-Center, Open-Label, Pharmacodynamic Clinical Trial to Evaluate the Effect of Technosphere® Insulin Inhalation Powder Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Postprandial Glucose Levels in Subjects With Type 1 and Type 2 Diabetes Mellitus Ingesting Meals With Varied Carbohydrate Content|Terminated||Phase 2|18|Actual|Mannkind Corporation|- Early termination of trial leading to small numbers of subjects analyzed.|2||Business reasons|f||||||||||||||2017-02-18 13:58:04.28925|2017-02-18 13:58:04.28925
NCT00746993|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2012-12-11|||October 2008||2008-10-01|December 2012|2012-12-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|||Randomized Controlled Trial of Structured Contraceptive Counseling in Adult Women|Structured Contraceptive Counseling--A Randomized Controlled Trial|Completed||N/A|250|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 13:58:05.154568|2017-02-18 13:58:05.154568
NCT00746980|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-06-13|||August 2008||2008-08-01|June 2016|2016-06-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Efalizumab in the Treatment of Alopecia, Phase II|Efalizumab in the Treatment of Alopecia Totalis/Universalis in Young Adults, Phase II|Withdrawn||Phase 2|0|Actual|Northwestern University||1||Newly identified safety concerns have changed the risk and benefit considerations|f||||t||||||||||2017-02-18 13:58:05.259757|2017-02-18 13:58:05.259757
NCT00746967|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-09-03|||January 2003||2003-01-01|September 2008|2008-09-01|February 2004|Actual|2004-02-01|||||Interventional|||An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder|An Open-Label, Multi-Center Extension Study To Evaluate The Safety, Toleration And Sustained Efficacy Of Oral Sildenafil Administered To Women Who Have Been Diagnosed With Female Sexual Arousal Disorder|Completed||Phase 2|267|Actual|Pfizer||1|||f||||||||||||||2017-02-18 13:58:05.370972|2017-02-18 13:58:05.370972
NCT00746954|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-02-16|2013-11-05||September 2008||2008-09-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|CSA treatment||Buspirone as a Potential Treatment for Recurrent Central Apnea|Buspirone as a Potential Treatment for Recurrent Central Apneas|Terminated||Phase 3|8|Actual|VA Office of Research and Development|"VA population turned out to have a high number of heart failure patients who had psychiatric co-morbidity or were empirically treated with antidepressants, precluding participation.~There were not enrolled enough participants."|3||Patient recruitment and Funding inadequate to finish trial|f||||t||||||||||2017-02-18 13:58:05.771788|2017-02-18 13:58:05.771788
NCT00746941|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2014-07-02|2013-01-03||January 2009||2009-01-01|July 2014|2014-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)|A Randomized, Rater-Blinded Study to Explore the Effect of Mefloquine in Subjects With Progressive Multifocal Leukoencephalopathy (PML)|Terminated||Phase 1/Phase 2|37|Actual|Biogen|From ongoing analysis, it became clear, based on conditional power calculations, that the study would not reach its primary endpoint, a decrease of JC viral load in CSF with mefloquine treatment; therefore, the study was terminated early.|2||Primary endpoint not achieved|f||||f||||||||||2017-02-18 13:58:06.059259|2017-02-18 13:58:06.059259
NCT00746928|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2008-09-03|||September 2005||2005-09-01|September 2008|2008-09-01|October 2008|Anticipated|2008-10-01|July 2007|Actual|2007-07-01||Interventional|||Cardiovascular Consequences of Intermittent Hypoxia in Healthy Subjects|Cardiovascular Consequences of Intermittent Hypoxia in Healthy Subjects|Unknown status|Active, not recruiting|N/A|12|Actual|University Hospital, Grenoble||1|||f||||f||||||||||2017-02-18 13:58:07.823261|2017-02-18 13:58:07.823261
NCT00746915|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2009-06-03|||March 2009||2009-03-01|June 2009|2009-06-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Phase I Study Evaluating The Safety And Efficacy of a Device for Collection of Electrical Bioimpedance Data|A Prospective, Single-Center, Phase I Study Evaluating the Safety and Initial Efficacy of the Epidetect Device for Collection of Bioimpedance Data of Human Tissues in Patients Undergoing Elective Pain Relief Treatment of Lumbar Epidural Steroid Injection Under Fluoroscopy|Unknown status|Recruiting|Phase 1|20|Anticipated|ImpediGuide Ltd||1|||f||||t||||||||||2017-02-18 13:58:07.913773|2017-02-18 13:58:07.913773
NCT00746902|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2014-11-06|||June 2008||2008-06-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional|RHOOSAS||Study of the Relationships Between Refractory Hypertension, Overweight/Obesity and Sleep Apnea Syndrome|Study of the Relationships Between Refractory Hypertension, Overweight/Obesity and Sleep Apnea Syndrome|Completed||Phase 3|62|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-02-18 13:58:08.003561|2017-02-18 13:58:08.003561
NCT00745953|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2009-08-17|||August 2007||2007-08-01|August 2009|2009-08-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Regression of Fatty Heart by Valsartan Therapy|Regression of Fatty Heart by Valsartan Therapy|Unknown status|Recruiting|Phase 4|28|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 13:58:17.88509|2017-02-18 13:58:17.88509
NCT00746889|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2010-07-29|2010-04-05||March 2004||2004-03-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee Osteoarthritis|Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee Osteoarthritis: A Randomized Placebo-Controlled Clinical Trial|Completed||N/A|79|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 13:58:08.103267|2017-02-18 13:58:08.103267
NCT00746876|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2016-04-18|||September 2009||2009-09-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|December 2012|Actual|2012-12-01||Interventional|HEMIUNIBIPOL||Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures.|Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures. A Randomized Trial of RSA Measurements of Acetabular Wear.|Completed||N/A|28|Actual|Sykehuset Asker og Baerum||2|||f||||f||||||||||2017-02-18 13:58:08.471048|2017-02-18 13:58:08.471048
NCT00746863|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2010-06-15|2010-03-19||January 2007||2007-01-01|June 2010|2010-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Randomized Control Trial to Assess Postoperative Pain After Sling Placement|Injection of 0.125% Marcaine During Mid-Urethral Sling Placement for Pain Relief: A Randomized Control Trial|Completed||N/A|42|Actual|University of North Carolina, Chapel Hill|Our exclusion criteria were strict, and as such, results presented here may have limited generalizability. Other limitations include that we can only address operations performed under general anesthesia.|2|||f||||f||||||||||2017-02-18 13:58:08.582607|2017-02-18 13:58:08.582607
NCT00746850|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2011-10-12|||September 2008||2008-09-01|September 2008|2008-09-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|HAC||Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis|Randomized, Double-blind, Controlled Trial of Harmonic(H) Versus Monopolar Diathermy (M) for Laparoscopic Cholecystectomy (LC) for Acute Cholecystitis (AC) in Adults.|Completed||N/A|42|Actual|University of Bologna||2|||f||||f||||||||||2017-02-18 13:58:09.247847|2017-02-18 13:58:09.247847
NCT00746837|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2010-11-30|||August 2008||2008-08-01|November 2010|2010-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||AZD5672 Absolute Bioavailability Study|A Phase I Study to Assess Absolute Bioavailability of AZD5672 at Steady-state in Healthy Volunteers|Completed||Phase 1|26|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:58:09.583086|2017-02-18 13:58:09.583086
NCT00746824|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2012-08-31|||August 2008||2008-08-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals.|TM30339: A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel, Repeated Subcutaneous Dose-range Study Designed to Determine the Weight Loss in Obese Subjects.|Terminated||Phase 2|192|Actual|7TM Pharma A/S||6||The IND was withdrawn.|f||||f||||||||||2017-02-18 13:58:09.688089|2017-02-18 13:58:09.688089
NCT00746811|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2010-01-26|||January 2010||2010-01-01|January 2010|2010-01-01|October 2010|Anticipated|2010-10-01|July 2010|Anticipated|2010-07-01||Interventional|||Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia|A Double-blind, Randomized, Placebo-controlled, Two-period Crossover Trial to Assess the Effects of 4 g/d P-OM3 on LDL-C and Other Aspects of the Fasting Lipid Profile in Subjects With Primary Hypercholesterolemia|Unknown status|Recruiting|Phase 4|32|Anticipated|Provident Clinical Research||2|||f||||f||||||||||2017-02-18 13:58:09.798004|2017-02-18 13:58:09.798004
NCT00746798|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-03-17|2011-09-27||October 2008||2008-10-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|WinVax004||Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults|Randomized, Modified, Double-blind, Placebo-controlled, Phase II, Dose-ranging Study of the Safety and Immunogenicity of Single Dose ChimeriVax-WN02 Vaccine in Healthy Adults.|Completed||Phase 2|479|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 13:58:09.909599|2017-02-18 13:58:09.909599
NCT00746785|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2014-01-30|2013-11-15||September 2002||2002-09-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|May 2010|Actual|2010-05-01||Interventional|||A New Pharmacotherapy for Alcohol Dependence: Olanzapine|A New Pharmacotherapy for Alcohol Dependence: Olanzapine|Completed||Phase 3|304|Actual|The Mind Research Network||3|||f||||f||||||||||2017-02-18 13:58:10.753761|2017-02-18 13:58:10.753761
NCT00746772|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2010-09-07|||April 2006||2006-04-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy of Purslane in Treatment of Oral Lichen Planus|Treatment of Oral Lichen Planus Lesions|Completed||Phase 2|37|Actual|Qazvin University Of Medical Sciences||2|||f||||f||||||||||2017-02-18 13:58:11.200913|2017-02-18 13:58:11.200913
NCT00746759|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2015-06-02|||February 2010||2010-02-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Observational|AEGIS IDE||Airway Epithelium Gene Expression: AEGIS IDE|Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS IDE|Completed||N/A|1331|Actual|Allegro Diagnostics, Corp.|||1||f||||f||||||Samples With DNA|"~     Cells, Blood~   "|||2017-02-18 13:58:11.327627|2017-02-18 13:58:11.327627
NCT00746746|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2011-01-12|||June 2008||2008-06-01|September 2008|2008-09-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Interventional|||A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma|A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b (PEG-Intron)and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Ochsner Health System||1|||f||||t||||||||||2017-02-18 13:58:11.47022|2017-02-18 13:58:11.47022
NCT00746733|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2009-11-18|2009-10-14||September 2008||2008-09-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC|A Phase I, Open-Label, Randomized, Four Period Crossover Drug Interaction Study to Evaluate the Pharmacokinetic Profiles of VYVANSE™ and ADDERALL XR When Each is Administered Alone and in Combination With the Proton Pump Inhibitor Prilosec OTC™ in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Shire||2|||f||||||||||||||2017-02-18 13:58:11.594365|2017-02-18 13:58:11.594365
NCT00746720|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-05-02|||May 2006||2006-05-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|July 2009|Actual|2009-07-01||Interventional|||Modulation of the Surgical Inflammatory Response by Etoricoxib|Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral Versus Central|Terminated||Phase 2|23|Actual|University of Erlangen-Nürnberg Medical School||4||Patient recruitment difficulties|f||||t||||||||||2017-02-18 13:58:12.503173|2017-02-18 13:58:12.503173
NCT00537589|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2007-10-03|||December 2004||2004-12-01|September 2007|2007-09-01|August 2006|Actual|2006-08-01|||||Interventional|UGA||Ultrasound Guided Arthrocentesis|Randomized Control Trial of Ultrasound-Guided Peripheral Arthrocentesis|Completed||N/A|132|Actual|Carolinas Healthcare System||2|||f||||f||||||||||2017-02-18 15:13:44.76272|2017-02-18 15:13:44.76272
NCT00746694|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2015-08-26|2010-12-21||October 2007||2007-10-01|August 2015|2015-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)|Epidemiological Study to Assess the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Pegylated Liposomal Doxorubicin|Completed||N/A|154|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:58:12.756791|2017-02-18 13:58:12.756791
NCT00746681|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-12-18|||December 2005||2005-12-01|December 2009|2009-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder|A Phase 2, 26 Week, Multicentre, Randomized Double Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy and Safety of Tolterodine, Pregabalin and a Tolterodine-Pregabalin Combination for Idiopathic Overactive Bladder|Completed||Phase 2|188|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 13:58:12.971669|2017-02-18 13:58:12.971669
NCT00746668|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2015-02-24|2014-12-22||August 2008||2008-08-01|February 2015|2015-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Multi-Center Study of Reading Rehabilitation in Macular Disease|A Multi-Center Study of Reading Rehabilitation in Macular Disease|Completed||N/A|36|Actual|VA Office of Research and Development||7|||f||||f||||||||||2017-02-18 13:58:13.100479|2017-02-18 13:58:13.100479
NCT00746655|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-12-23|||July 2009||2009-07-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||SBRT + TACE for Primary Hepatocellular Carcinoma|A Study of Stereotactic Body Radiation Therapy (SBRT) in Combination With Cisplatin Transcatheter Arterial Chemoembolization (TACE) for Primary Hepatocellular Carcinoma (HCC)|Withdrawn||N/A|0|Actual|University of Pittsburgh||1||Unable to recruit|f||||t||||||||||2017-02-18 13:58:13.652755|2017-02-18 13:58:13.652755
NCT00746642|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2009-06-02|||October 2009||2009-10-01|June 2009|2009-06-01|October 2010|Anticipated|2010-10-01|May 2010|Anticipated|2010-05-01||Interventional|||Use of Mellitor Sensor for Continuous Glucose Monitoring - An Ex-Vivo Study|Use of Mellitor Sensor for Continuous Glucose Monitoring - An Ex-Vivo Study|Unknown status|Not yet recruiting|N/A|20|Anticipated|Mellitor||2|||f||||f||||||||||2017-02-18 13:58:13.775169|2017-02-18 13:58:13.775169
NCT00746629|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2015-05-19|||May 2008||2008-05-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|FOCUS||Familial Overweight: Comparing Use of Strategies|Behavioral Skill Adherence in Pediatric Obesity Treatment|Completed||N/A|72|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-02-18 13:58:13.87441|2017-02-18 13:58:13.87441
NCT00746616|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2013-04-02||2013-03-21|June 2007||2007-06-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Durom(R) Hip Resurfacing System Multicenter Trial|Durom(R) Hip Resurfacing System Multicenter Trial|Completed||Phase 3|40|Actual|Zimmer Biomet||1|||f||||f||||||||||2017-02-18 13:58:13.980251|2017-02-18 13:58:13.980251
NCT00746603|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2013-07-17|||January 2008||2008-01-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors|A Feasibility Study to Evaluate the Safety of Simvastatin in Young Adults Treated for Hodgkin's Disease|Terminated||N/A|18|Actual|Columbia University||1||Poor enrollment|f||||t||||||||||2017-02-18 13:58:14.079194|2017-02-18 13:58:14.079194
NCT00746590|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2016-05-03|2016-05-03||September 2008||2008-09-01|May 2016|2016-05-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma|A Phase 2 Study of the Anti-tumour Activity and Safety of Prolarix™ in Hepatocellular Carcinoma (HCC)|Terminated||Phase 2|1|Actual|BTG International Inc.||1||Study terminated prematurely by sponsor for business reason. One patient was enrolled.|f||||f||||||||Yes||2017-02-18 13:58:14.172947|2017-02-18 13:58:14.172947
NCT00746577|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2012-02-21|||August 2008||2008-08-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Organizational Factors Influencing Practice Improvement in Community Based Care|Organizational Factors Influencing Practice Improvement in Community Based|Completed||N/A|910|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 13:58:14.414292|2017-02-18 13:58:14.414292
NCT00746564|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-11-01|2015-04-13||September 2008||2008-09-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|February 2011|Actual|2011-02-01||Interventional||All patients implanted with the Confirm Device.|Study of New Implantable Loop Recorder|Confirm Implantable Cardiac Monitor Study|Completed||N/A|75|Actual|St. Jude Medical||1|||f||||f||||||||||2017-02-18 13:58:14.49469|2017-02-18 13:58:14.49469
NCT00746551|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-02-11|2015-01-15||September 2008||2008-09-01|February 2015|2015-02-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|EIVF||Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment|Low Dose Intravenous Versus Oral Iron for Iron Deficiency Anemia Starting Late in Pregnancy: A Randomized Controlled Trial|Completed||Phase 4|80|Actual|Mahidol University||2|||f||||t||||||||||2017-02-18 13:58:14.838655|2017-02-18 13:58:14.838655
NCT00746538|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-03|2008-09-03|||January 2008||2008-01-01|July 2008|2008-07-01|July 2009|Anticipated|2009-07-01|March 2009|Anticipated|2009-03-01||Interventional|||Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent|Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent: A Randomized Control Trial|Unknown status|Recruiting|Phase 4|80|Anticipated|Khon Kaen University||2|||f||||f||||||||||2017-02-18 13:58:15.216948|2017-02-18 13:58:15.216948
NCT00746187|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-03-14|2014-03-12||December 2002||2002-12-01|March 2016|2016-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study to Compare Marginal Bone Loss Around Implants From Two Dental Implant Systems.|An Open, Randomized Study to Compare Two Dental Implant Systems With Regard to Changes in Marginal Bone Level.|Completed||N/A|36|Actual|Dentsply Sirona Implants||2|||f||||f||||||||||2017-02-18 13:58:15.338875|2017-02-18 13:58:15.338875
NCT00746174|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2008-09-02|||February 2004||2004-02-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|March 2007|Actual|2007-03-01||Interventional|||Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving Rosiglitazone|Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving Rosiglitazone|Completed||Phase 4|24|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 13:58:15.626115|2017-02-18 13:58:15.626115
NCT00743353|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2009-01-29|||August 2008||2008-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|K5||Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5|An Exploratory, Multi-Center, Open Label, Non-Randomized Study of F-18 RGD-K5|Completed||Early Phase 1|16|Anticipated|Siemens Molecular Imaging||1|||f||||f||||||||||2017-02-18 13:59:07.884411|2017-02-18 13:59:07.884411
NCT00746161|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-03|||April 2002||2002-04-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of Double Tract Reconstruction After Total Gastrectomy in Patients With Gastric Cancer|A Prospective Randomized Controlled Trial Comparing Double Tract Method With Roux-en-Y Method After Total Gastrectomy in Patients With Gastric Cancer|Completed||Phase 3|44|Actual|Wakayama Medical University||2|||f||||t||||||||||2017-02-18 13:58:15.742742|2017-02-18 13:58:15.742742
NCT00746148|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2012-12-03|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|REPOS||Reflexology's Effect on Polycystic Ovary Syndrome: A Pilot Study|Reflexology's Effect on Polycystic Ovary Syndrome (REPOS): A Pilot Study|Unknown status|Not yet recruiting|Phase 3|140|Anticipated|University of Nottingham||2|||f||||f||||||||||2017-02-18 13:58:16.074949|2017-02-18 13:58:16.074949
NCT00746135|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2016-10-21|||November 2007||2007-11-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|October 2010|Actual|2010-10-01||Interventional|TRI-V||TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study|TRI-V Resynchronization in Paced Heart Failure Patients With ICD Indication.|Completed||N/A|40|Actual|St. Jude Medical||3|||f||||f||||||||||2017-02-18 13:58:16.17535|2017-02-18 13:58:16.17535
NCT00746122|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2016-08-22|||September 2009||2009-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2013|Actual|2013-07-01||Interventional|IMPROVE||Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair|Can Emergency Endovascular Aneurysm Repair (eEVAR) Improve the Survival From Ruptured Abdominal Aortic Aneurysm?|Completed||N/A|613|Actual|Imperial College London||2|||f||||t||||||||||2017-02-18 13:58:16.291102|2017-02-18 13:58:16.291102
NCT00746109|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2011-01-03|||September 2008||2008-09-01|January 2011|2011-01-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Study of Wound Packing After Superficial Skin Abscess Drainage|Randomized Clinical Trial of Wound Packing Following Incision and Drainage of Superficial Skin Abscesses in the Pediatric Emergency Department|Completed||Phase 4|60|Anticipated|New York University School of Medicine||2|||f||||t||||||||||2017-02-18 13:58:16.457824|2017-02-18 13:58:16.457824
NCT00746096|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2014-06-12|2014-04-08||September 2008||2008-09-01|June 2014|2014-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||58 and 57 pts were assigned to IKH-01 or placebo group, and 57 and 56 pts started study drug adminitstration. Five pts in the IKH-01 group were excluded from FAS due to no available data of efficacy but include safety set and 1 pts placebo group was exculded from FAS and safety analysis population because of no visti after the drug administration.|Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea|Phase 3, Placebo Controlled, Randomized, Double-blinded, Nonsteroidal Antiinflammatory Drug add-on Clinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Primary Dysmenorrhea.|Completed||Phase 3|115|Actual|Nobelpharma||2|||f||||t||||||||||2017-02-18 13:58:16.561718|2017-02-18 13:58:16.561718
NCT00746083|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-02|||April 2001||2001-04-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|July 2005|Actual|2005-07-01||Interventional|||Challenge!, a Health Promotion/ Obesity Prevention Program for Teens|Randomized Controlled Trial for Health Promotion/ Obesity Prevention Targeting Low-Income, Urban, African-American Adolescents|Completed||N/A|235|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 13:58:16.911723|2017-02-18 13:58:16.911723
NCT00746070|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2010-05-03|||January 2007||2007-01-01|April 2010|2010-04-01|January 2013|Anticipated|2013-01-01|December 2009|Anticipated|2009-12-01||Observational|TAIPAI||Postoperative Cardiovascular Index Change of Primary Aldosteronism|Postoperative Cardiovascular Index Change of Primary Aldosteronism|Unknown status|Enrolling by invitation|N/A|300|Actual|National Taiwan University Hospital|||2||f||||f||||||||||2017-02-18 13:58:17.032613|2017-02-18 13:58:17.032613
NCT00746057|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2013-09-27|||May 2006||2006-05-01|September 2013|2013-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft (Protocol DPRC Array)|Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft.|Terminated||N/A|134|Actual|Nantes University Hospital||1||The number of included patients is sufficient.|f||||f||||||||||2017-02-18 13:58:17.139165|2017-02-18 13:58:17.139165
NCT00746044|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2009-05-14|||February 2008||2008-02-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Observational|COVOL||Measurement of MRP2 Function Using Urinary Coproporphyrins|Evaluation of the Ratio of Urinary Coproporphyrins I and III as a Potential Biomarker of MRP2 Function in Man|Completed||N/A|40|Actual|University Hospital, Tours|||1||f||||f||||||Samples With DNA|"~     24h urine DNA~   "|||2017-02-18 13:58:17.22678|2017-02-18 13:58:17.22678
NCT00746031|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2010-10-22|||December 2008||2008-12-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids|Novel Magnetic Resonance Imaging Strategies as a Non-invasive Biomarker of Vascular and Extracellular Matrix Morphology in Women With Uterine Fibroids.|Completed||Phase 4|30|Actual|University of Edinburgh||3|||f||||f||||||||||2017-02-18 13:58:17.308615|2017-02-18 13:58:17.308615
NCT00746018|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-08-30|||August 2008||2008-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy|Evaluation of Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy|Active, not recruiting||N/A|39|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 13:58:17.41014|2017-02-18 13:58:17.41014
NCT00746005|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-30|2011-01-11|||October 2008||2008-10-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy of Fish Oil Supplementation on Cognition in MCI Patients and the Influence of the APOE4 Allele|Challenge Study: The Efficacy of Fish Oil Supplementation on Cognitive Performance in MCI Patients and the Influence of the APOE-epsilon4 Allele|Completed||N/A|40|Anticipated|Wageningen University||2|||f||||f||||||||||2017-02-18 13:58:17.50607|2017-02-18 13:58:17.50607
NCT00745992|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2008-09-02|||October 2008||2008-10-01|September 2008|2008-09-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Observational|||Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients|Voriconazole Therapeutic Drug Monitoring and CYP2C19 Genetic Polymorphisms in Taiwanese Patients|Unknown status|Not yet recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     plasma~   "|||2017-02-18 13:58:17.700381|2017-02-18 13:58:17.700381
NCT00032695|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-28|2006-05-12||||||November 2005|2005-11-01||||||||Interventional|||Treatment of AIDS Vacuolar Myelopathy With Methionine||Completed||Phase 3|56||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:07:15.678357|2017-02-18 18:07:15.678357
NCT00745940|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2014-02-27|2013-06-28||November 2009||2009-11-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||We initially had 57 MBCT Intervention group participants and 48 Control group participants. 29 participants (28%) did not complete the study – 17 prior to their respective arm starting and 8 during the intervention. Thus, for our analysis we had 38 in each arm.|Mindfulness-Based Cognitive Therapy Intervention to Treat Depression in Individuals With a Traumatic Brain Injury|A Multi-site, Randomized, Controlled Trial of a Mindfulness-based Cognitive Therapy Intervention for Treating Depression in a Traumatic Brain Injury Population.|Completed||N/A|105|Actual|Lakehead University|It is not possible to generalize our findings to the general population of people with a traumatic brain injury. Participants self-selected. Some did not complete the intervention. The control group was a “wait-list” control group.|2|||f||||f||||||||||2017-02-18 13:58:17.994776|2017-02-18 13:58:17.994776
NCT00745927|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2012-08-13|||June 2008||2008-06-01|August 2012|2012-08-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Application of CO2 Insufflations in Colonoscopy Randomized Trial|Application of CO2 Insufflations in Colonoscopy Examination-A Single-blinded Randomized Trial|Unknown status|Recruiting|N/A|400|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:58:18.43627|2017-02-18 13:58:18.43627
NCT00745914|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2017-01-07|||September 2008||2008-09-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients|A Randomized Placebo-Controlled Study to Evaluate the Efficacy of Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Inducing Carotid Atherosclerotic Plaque Regression in Diabetic End-Stage Renal Disease Patients|Completed||N/A|22|Actual|The University of Hong Kong||2|||f||||t||||||||No||2017-02-18 13:58:18.54131|2017-02-18 13:58:18.54131
NCT00745901|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2011-06-08|2010-04-22||May 2008||2008-05-01|April 2010|2010-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females|An Open Label Study to Evaluate Cycle Control With Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) and Yaz (Drospirenone/Ethinyl Estradiol) in Healthy Sexually Active Females|Completed||Phase 4|355|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC|||||f||||||||||||||2017-02-18 13:58:18.657854|2017-02-18 13:58:18.657854
NCT00745888|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2009-09-04|||May 2007||2007-05-01|August 2009|2009-08-01||||||||Observational|||Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit|Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit|Unknown status|Recruiting|Phase 3|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples Without DNA|"~     blood sample~   "|||2017-02-18 13:58:19.730602|2017-02-18 13:58:19.730602
NCT00745875|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2012-04-26|2012-04-26||August 2008||2008-08-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study|A Phase II, Double-blind, Placebo Controlled, Randomised Study to Assess the Efficacy and Safety of ZD4054 (Zibotentan) in Combination With Pemetrexed (Alimta®) vs. Pemetrexed Alone in Patients With Non-small Cell Lung Cancer Who Have Failed One Prior Platinum-based Chemotherapy Regimen|Completed||Phase 2|66|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 13:58:19.830707|2017-02-18 13:58:19.830707
NCT00745862|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2013-07-23|||August 2008||2008-08-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma|Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma|Completed||N/A|118|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 13:58:20.231908|2017-02-18 13:58:20.231908
NCT00745849|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2008-08-29|||June 2005||2005-06-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-Blind, Placebo Controlled Trial|Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-Blind, Placebo Controlled Trial|Completed||N/A|43|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 13:58:20.329547|2017-02-18 13:58:20.329547
NCT00745836|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-02|||January 2005||2005-01-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|||||Interventional|||Effects of Atorvastatin on Adiponectin Levels and Insulin Sensitivity In Hypercholesterolemic Patients||Completed||Phase 4|||Gachon University Gil Medical Center||1|||f||||t||||||||||2017-02-18 13:58:20.435806|2017-02-18 13:58:20.435806
NCT00745823|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-10-01|2012-03-06||September 2008||2008-09-01|October 2015|2015-10-01|May 2011|Actual|2011-05-01|October 2010|Actual|2010-10-01||Interventional|||A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)|A Phase III Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Once Daily Raltegravir (MK0518) Versus Twice Daily Raltegravir, Each in Combination With TRUVADA™, in Treatment-Naïve HIV Infected Patients|Terminated||Phase 3|775|Actual|Merck Sharp & Dohme Corp.|The study was terminated before the 96-week efficacy analysis. Adverse event data were collected for the entire treatment period up to a maximum of Week 108, which defines the Overall Study period.|2||"Primary efficacy analysis at Week 48 did not demonstrate non-inferiority of raltegravir 800 mg~   once daily versus raltegravir 400 mg twice daily"|f||||t||||||||||2017-02-18 13:58:20.532281|2017-02-18 13:58:20.532281
NCT00745810|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2011-10-13|||August 2008||2008-08-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Observational|||Anesthetic Management and Remote Reperfusion Injuries|The Effects of Anesthetic Management on Oxidative Injuries After Cardiopulmonary Bypass|Completed||N/A|40|Actual|National Taiwan University Hospital|||1||f||||f||||||None Retained|"~     whole blood and plasma~   "|||2017-02-18 13:58:21.206916|2017-02-18 13:58:21.206916
NCT00745797|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2014-01-27|||April 2008||2008-04-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PCI||Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy|Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy：A Multi-center Randomized Phase ⅢTrial|Terminated||Phase 3|5|Actual|Chinese Society of Lung Cancer||2||this trial enroll extremely slow and No funding support|f||||t||||||||||2017-02-18 13:58:21.411513|2017-02-18 13:58:21.411513
NCT00745784|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2011-08-17|||January 2009||2009-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Prolonged Grief in Young Bereaved Spouses and Partners|Lost to Cancer: Prolonged Grief in Young Bereaved Spouses and Partners|Completed||N/A|60|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 13:58:21.518766|2017-02-18 13:58:21.518766
NCT00745771|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2009-03-19|||October 2007||2007-10-01|March 2009|2009-03-01|November 2008|Actual|2008-11-01|February 2008|Actual|2008-02-01||Interventional|||Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness|Multiple Dose, Double-Blind, Double-Dummy, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness From Exercise|Completed||Phase 2|168|Actual|IDEA AG||2|||f||||f||||||||||2017-02-18 13:58:21.625274|2017-02-18 13:58:21.625274
NCT00745758|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2008-09-02|||May 2008||2008-05-01|September 2008|2008-09-01|September 2008|Anticipated|2008-09-01|||||Observational|||The Factors Cause Vasospasm After Aneurysmal Subarachnoid Hemorrhage|The Factors Cause Vasospasm After Aneurysmal Subarachnoid Hemorrhage|Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"~     CSF~   "|||2017-02-18 13:58:21.715476|2017-02-18 13:58:21.715476
NCT00745745|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2013-07-26|||August 2008||2008-08-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|June 2011|Actual|2011-06-01||Interventional|SPICE||Septal Positioning of Ventricular Implanted Cardioverter Defibrillator (ICD) Leads|Septal Positioning of Ventricular ICD Leads|Completed||N/A|299|Actual|St. Jude Medical||2|||f||||f||||||||||2017-02-18 13:58:21.802234|2017-02-18 13:58:21.802234
NCT00745732|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2014-03-12|||October 2008||2008-10-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)|A Phase I Dose-Escalation and Safety Study of ZD6474 (ZACTIMA) Used In Combination With Radiation Therapy for Patients With Inoperable/Unresectable Non-Small Cell Lung Cancer|Terminated||Phase 1|3|Actual|M.D. Anderson Cancer Center||1||Sponsor withdrew support.|f||||f||||||||||2017-02-18 13:58:21.923841|2017-02-18 13:58:21.923841
NCT00745719|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2017-01-14|||March 2007||2007-03-01|January 2017|2017-01-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||Parathyroidectomy in Endstage Renal Disease|A Pilot Study to Evaluate the Efficacy of Total Parathyroidectomy in Retarding Cardiovascular Calcification in End-stage Renal Disease Patients|Completed||Phase 4|62|Actual|The University of Hong Kong||1|||f||||t||||||||No||2017-02-18 13:58:22.043371|2017-02-18 13:58:22.043371
NCT00745706|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-03-10|||September 2008||2008-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|April 2014|Actual|2014-04-01||Interventional|DISCERN-AF||Discerning Symptomatic and Asymptomatic Episodes Pre and Post Radiofrequency Ablation of Atrial Fibrillation|Discerning Symptomatic and Asymptomatic Episodes Pre and Post Radiofrequency Ablation of Atrial Fibrillation|Completed||N/A|50|Actual|Ottawa Heart Institute Research Corporation||1|||f||||f||||||||||2017-02-18 13:58:22.154154|2017-02-18 13:58:22.154154
NCT00745693|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-04|||March 2008||2008-03-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin|The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin|Completed||N/A|15|Actual|University of Edinburgh||4|||f||||f||||||||||2017-02-18 13:58:22.265246|2017-02-18 13:58:22.265246
NCT00745680|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2011-01-20|||October 2007||2007-10-01|January 2011|2011-01-01|October 2011|Anticipated|2011-10-01|||||Observational|||Speckle Tracking Imaging and Realtime 3 Dimensional Echocardiograhy to Study LV Function and Remodeling After Acute Myocardial Infarction (AMI)|Morphodynamic Study of Left Ventricular Remodeling With Possible Mechanisms for Pharmacologic Therapy: Assessment by Real-time 3-dimensional Echocardiography and 2-dimensional Speck Tracking Imaging.|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 13:58:22.388931|2017-02-18 13:58:22.388931
NCT00745667|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-02|||July 1999||1999-07-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|LAMA||The LAMA Trial: Laparoscopic Correction of Perforated Peptic Ulcer Versus Open Correction|The LAMA Trial: Laparoscopic Correction of Perforated Peptic Ulcer Versus Open Correction by Upper Laparotomy|Completed||N/A|109|Actual|Erasme University Hospital||2|||f||||f||||||||||2017-02-18 13:58:22.479549|2017-02-18 13:58:22.479549
NCT00745654|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2008-11-03|||July 2008||2008-07-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Chronic Pain After Lung Transplantation, an Incidence Study|Chronic Pain After Lung Transplantation, an Incidence Study|Completed||N/A|111|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-02-18 13:58:22.633967|2017-02-18 13:58:22.633967
NCT00745641|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2009-08-05|||September 2008||2008-09-01|March 2009|2009-03-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Abdominal Computed Tomography and the Blood Reactive Oxygen Species Level|Effect of Abdominal X-ray Computed Tomography Examination on the Blood Reactive Oxygen Species Level|Withdrawn||N/A|60|Anticipated|National Taiwan University Hospital|||1|"because of the presence of unexpected administrative barrier to interfere the collection of~   case"|f||||f||||||None Retained|"~     only peripheral blood will be collected for measurement of reactive oxygen species.~   "|||2017-02-18 13:58:22.712273|2017-02-18 13:58:22.712273
NCT00745628|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-02|||May 2008||2008-05-01|May 2008|2008-05-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|CCS-CHD||Chinese Cohort Study of Coronary Heart Disease|Cross-Sectional Investigation of Secondary Prevention on Coronary Heart Disease and Generalization of Standardized Secondary Prevention in Chinese Coronary Heart Disease Patients|Unknown status|Recruiting|N/A|10000|Anticipated|Ministry of Science and Technology of the People´s Republic of China|||1||f||||t||||||||||2017-02-18 13:58:22.79486|2017-02-18 13:58:22.79486
NCT00745615|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-12-01|||December 2006||2006-12-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients|[An Active Extension of LAQ/5062 Study. A Multinational, Multi-center, Randomized, Double-blind, Parallel-group Study, to Evaluate the Safety, Tolerability and Efficacy of Two Doses (0.3mg and 0.6mg) of Laquinimod,] Orally Administered in Relapsing Remitting (R-R) Multiple Sclerosis (MS) Subjects Followed by an Open Label Phase of Laquinimod 0.6 mg Daily.|Active, not recruiting||Phase 2|211|Actual|Teva Pharmaceutical Industries||1|||f||||t||||||||||2017-02-18 13:58:22.873231|2017-02-18 13:58:22.873231
NCT00745602|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2010-02-17|||October 2007||2007-10-01|September 2008|2008-09-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||The Effect of Atrial Fibrillation Hemodynamics on Regulation of Cerebral Blood Flow|The Effect of Atrial Fibrillation Hemodynamics on Regulation of Cerebral Blood Flow|Unknown status|Recruiting|N/A|10|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 13:58:23.002956|2017-02-18 13:58:23.002956
NCT00745589|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2017-01-07|||July 2008||2008-07-01|January 2017|2017-01-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||Sevelamer Hydrochloride in Peritoneal Dialysis Patients|Use of Sevelamer Hydrochloride to Control Hyperphosphatemia and Reduce Calcification Burden in the Poor Peritoneal Dialysis Patients|Completed||N/A|60|Actual|The University of Hong Kong||2|||f||||t||||||||No||2017-02-18 13:58:25.443563|2017-02-18 13:58:25.443563
NCT00745576|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2010-02-05|||October 2008||2008-10-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered|An Open-label, Nonrandomized Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Verapamil Immediate Release (IR) and a Single Dose of SAM-531 When Co-administered Orally to Healthy Young Adult Subjects|Completed||Phase 1|14|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:58:25.603087|2017-02-18 13:58:25.603087
NCT00745563|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-30|2011-06-08|||October 2008||2008-10-01|December 2008|2008-12-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Intra-uterine Slow-Release Insemination on Pregnancy Rate in Women Designated for Artificial Insemination|Testing the Effect of Intra-uterine Slow-Release Insemination (SRI) on the Pregnancy Rate in Women Designated for Artificial Insemination|Completed||N/A|100|Anticipated|Fertiligent||1|||f||||t||||||||||2017-02-18 13:58:25.699315|2017-02-18 13:58:25.699315
NCT00745550|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2012-04-19|||August 2008||2008-08-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis|A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis|Completed||Phase 1/Phase 2|55|Actual|S*BIO||1|||f||||f||||||||||2017-02-18 13:58:25.796376|2017-02-18 13:58:25.796376
NCT00745537|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-05-27|||April 2008||2008-04-01|May 2015|2015-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|T-BOOM||T- BOOM Teens--Building Options and Opportunities for Moms|Teens--Building Options and Opportunities for Moms|Completed||N/A|23|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-02-18 13:58:25.901435|2017-02-18 13:58:25.901435
NCT00745524|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2012-05-16|||February 2008||2008-02-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|||||Observational|||Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations|Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations|Completed||N/A|1910|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 13:58:26.005983|2017-02-18 13:58:26.005983
NCT00745511|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2009-06-07|||March 2009||2009-03-01|June 2009|2009-06-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)|A Randomized, Multi-Center, Double Blind, 3 Arm, Phase I/II Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)|Unknown status|Recruiting|Phase 1/Phase 2|96|Anticipated|Ora Bio Ltd.||3|||f||||t||||||||||2017-02-18 13:58:26.097281|2017-02-18 13:58:26.097281
NCT00745498|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-11-17|2012-06-06||June 2008||2008-06-01|November 2015|2015-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|IBDV||Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy|Efficacy Study of Pre- and Intra-operative Intravitreal Bevacizumab Injection on Postoperative Vitreous Hemorrhage After Diabetic Vitrectomy|Completed||N/A|126|Actual|Seoul National University Bundang Hospital||3|||f||||t||||||||||2017-02-18 13:58:26.207244|2017-02-18 13:58:26.207244
NCT00745485|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2012-02-01|||August 2008||2008-08-01|February 2012|2012-02-01||||July 2010|Actual|2010-07-01||Interventional|LISA||Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid|A Phase IV Study of the Safety and Feasibility of Rooms-based Infusion of Zoledronic Acid for Women With Post-menopausal Osteoporosis|Completed||Phase 4|186|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:58:26.831508|2017-02-18 13:58:26.831508
NCT00745472|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-02|||October 2007||2007-10-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Observational|||Auditory Evoked Potentials and Experimental Pain|The Amplitude of Auditory Evoked Potentials and the Intensity of Experimental Pain Stimulation in Healthy Volunteers|Completed||N/A|20|Actual|Odense University Hospital|||2||f||||f||||||||||2017-02-18 13:58:26.948114|2017-02-18 13:58:26.948114
NCT00745459|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2010-11-08|||September 2008||2008-09-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Interventional|||Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy|Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy (Open-label Study)|Completed||Phase 3|100|Anticipated|Nihon Pharmaceutical Co., Ltd||1|||f||||t||||||||||2017-02-18 13:58:27.028051|2017-02-18 13:58:27.028051
NCT00745446|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-04|||September 2007||2007-09-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation|The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation|Completed||N/A|18|Actual|University of Edinburgh||3|||f||||f||||||||||2017-02-18 13:58:27.12191|2017-02-18 13:58:27.12191
NCT00745433|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2016-03-02|||January 2008||2008-01-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|REPAMET 2||Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide|REPAMET 2: Observational Study of the Switch From Metformin Monotherapy to Bitherapy With Metformin and Repaglinide|Completed||N/A|906|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 13:58:27.222665|2017-02-18 13:58:27.222665
NCT00745420|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-05-17|||August 2008||2008-08-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|July 2015|Actual|2015-07-01||Interventional|SCURT||Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)|Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children With Severe Sickle Cell Disease (BMT CTN #0601)|Active, not recruiting||Phase 2|39|Actual|Medical College of Wisconsin||1|||f||||t||||||||Yes|Findings will be published in a manuscript.|2017-02-18 13:58:27.325923|2017-02-18 13:58:27.325923
NCT00744380|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2016-08-04|2016-03-09||August 2008||2008-08-01|August 2016|2016-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Dexmedetomidine Versus Midazolam for Facilitating Extubation|Dexmedetomidine vs. Midazolam for Facilitating Extubation in Medical and Surgical ICU Patients: A Randomized, Double-Blind Study|Completed||N/A|23|Actual|University of Colorado, Denver||2|||f||||f||||||||Yes|Publication|2017-02-18 13:58:27.467885|2017-02-18 13:58:27.467885
NCT00744367|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-08-03||2016-07-26|October 2008||2008-10-01|August 2016|2016-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Effect of Taspoglutide on Glycemic Control Compared to Placebo in Patients With Type II Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone|Completed||Phase 3|326|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 13:58:28.126212|2017-02-18 13:58:28.126212
NCT00744354|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2015-10-07|||October 2008||2008-10-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|December 2011|Actual|2011-12-01||Interventional|||Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase 1 Dose Escalation Study of Bortezomib (Velcade®), Pegylated Liposomal Doxorubicin (Doxil®), and Vorinostat (Suberoylanilide Hydromaxic Acid, Saha, Zolinzatm) in Patients With Relapse/Refractory Multiple Myeloma|Terminated||Phase 1|32|Actual|UNC Lineberger Comprehensive Cancer Center||1||Drugs unavailable|f||||t||||||||||2017-02-18 13:58:28.549068|2017-02-18 13:58:28.549068
NCT00744341|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2010-09-16|||February 2009||2009-02-01|September 2010|2010-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure|A Double-Blind, Placebo-Controlled, Randomized, Multi-Center, Dose-Finding Study of SLV320, a Selective A1 Adenosine Receptor Antagonist, to Evaluate the Effect on Renal Function and Safety in Subjects Hospitalized With Acute Decompensated Heart Failure and Renal Dysfunction (Reno-Defend 1)|Terminated||Phase 2|46|Actual|Solvay Pharmaceuticals||5||This study was stopped 29OCT2009 due to strategic drug development considerations|f||||t||||||||||2017-02-18 13:58:28.676686|2017-02-18 13:58:28.676686
NCT00744328|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2014-10-20|2014-10-13||August 2008||2008-08-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|E2SERT||Postpartum Depression: Transdermal Estradiol Versus Sertraline|Postpartum Depression: Transdermal Estradiol Versus Sertraline|Terminated||Phase 4|85|Actual|Northwestern University||3||Recruitment Issues|f||||t||||||||||2017-02-18 13:58:28.88437|2017-02-18 13:58:28.88437
NCT00744315|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2008-10-14|||November 2007||2007-11-01|July 2008|2008-07-01|May 2009|Anticipated|2009-05-01|July 2008|Actual|2008-07-01||Interventional|THEANGIOGEN||Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy|Induced Angiogenesis by Genic Therapy With VEGF165 in Advanced Ischemic Cardiomyopathy - Historical Controlled Trial|Unknown status|Recruiting|Phase 2|20|Anticipated|Instituto de Cardiologia do Rio Grande do Sul||1|||f||||t||||||||||2017-02-18 13:58:29.574148|2017-02-18 13:58:29.574148
NCT00744302|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2015-05-20|||April 2006||2006-04-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.|Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.|Completed||Phase 2|180|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 13:58:29.679921|2017-02-18 13:58:29.679921
NCT00744289|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-06-14|||September 2008||2008-09-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|HAVIT||Hepatitis B Acceptability and Vaccination Incentive Trial|A Randomised Controlled Trial to Evaluate the Effectiveness of a Small Financial Incentive After the Second and Third Dose of a Hepatitis B Vaccine, on Vaccine Completion in People Who Inject Drugs|Completed||N/A|204|Actual|Kirby Institute||2|||f||||f||||||||||2017-02-18 13:58:29.79336|2017-02-18 13:58:29.79336
NCT00744276|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2010-05-25||2010-05-25|January 2007||2007-01-01|May 2010|2010-05-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|FP1198-001||A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Multicenter Evaluation of the Use of Topically Administered Danazol Versus Placebo in Subjects With Pain Associated With Fibrocystic Breast Disease|Completed||Phase 2|60|Anticipated|FemmePharma Global Healthcare, Inc.||6|||f||||f||||||||||2017-02-18 13:58:29.903518|2017-02-18 13:58:29.903518
NCT00744263|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2014-10-01|2014-10-01||September 2008||2008-09-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|CAPITA|Safety population included all participants who received study vaccine and who had any safety data.|Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults|A Phase 4, Randomized, Placebo-Controlled Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine Efficacy in Prevention of Vaccine-Serotype Pneumococcal Community-Acquired Pneumonia and Invasive Pneumococcal Disease|Completed||Phase 4|84496|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 13:58:30.074499|2017-02-18 13:58:30.074499
NCT00744250|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2013-02-20|||August 2008||2008-08-01|February 2013|2013-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control|Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control in Patients With Pancreatic Insufficiency|Terminated||Phase 4|3|Actual|Digestive Care, Inc.||1||No longer required study by FDA for NDA approval.|f||||f||||||||||2017-02-18 13:58:32.922783|2017-02-18 13:58:32.922783
NCT00744237|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2011-06-30|2011-06-30||August 2008||2008-08-01|June 2011|2011-06-01||||July 2010|Actual|2010-07-01||Interventional|||Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients|Glycemic Effects of Nebivolol Compared With Metoprolol Extended Release and Compared With Hydrochlorothiazide In Hypertensive Patients With Type 2 Diabetes Mellitus: A Pilot Study|Completed||Phase 4|231|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 13:58:33.0372|2017-02-18 13:58:33.0372
NCT00744224|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2010-01-12|||February 2009||2009-02-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|PREDEX||PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide|Prednisolone-induced Impairment of Glucose Metabolism and Beta-cell Dysfunction and the Protective Effects of Exenatide: a Single-center, Randomized, Double-blind, Placebo-controlled Crossover Study in Healthy Volunteers|Completed||N/A|8|Anticipated|VU University Medical Center||3|||f||||f||||||||||2017-02-18 13:58:33.642122|2017-02-18 13:58:33.642122
NCT00744211|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2014-11-05|||July 2008||2008-07-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|June 2011|Actual|2011-06-01||Observational|||Proteolytic Enzyme Induction Within the Human Myocardial Interstitium|Proteolytic Enzyme Induction Within the Human Myocardial Interstitium|Completed||N/A|30|Anticipated|VA Office of Research and Development|||2||f||||t||||||Samples Without DNA|"~     Myocardial interstitial fluid~   "|||2017-02-18 13:58:33.738282|2017-02-18 13:58:33.738282
NCT00744198|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-04-05|||August 2012||2012-08-01|April 2013|2013-04-01||||August 2014|Anticipated|2014-08-01||Interventional|||Autologous Versus Synthetic Versus Biological Sling for Trans-obturator Correction of Urinary Stress Incontinence|A Comparison in Terms of Efficacy and Safety Among Three Different Materials for Trans-obturator Correction of Urinary Stress Incontinence: Autologous, Synthetic and Biological Sling|Unknown status|Recruiting|Phase 4|8|Anticipated|University Magna Graecia||3|||f||||||||||||||2017-02-18 13:58:33.832407|2017-02-18 13:58:33.832407
NCT00744185|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2012-07-18|||October 2008||2008-10-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|HEMANGIOMA||Propranolol in Capillary Hemangiomas|Double Blind, Randomised, Placebo-controlled Study of Propranolol in Infantile Capillary Hemangiomas|Terminated||Phase 2/Phase 3|14|Actual|University Hospital, Bordeaux||2||Study halted prematurely due to some difficulties in recruitment of patients|f||||t||||||||||2017-02-18 13:58:33.936333|2017-02-18 13:58:33.936333
NCT00744172|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2014-11-17|||January 2006||2006-01-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|December 2006|Actual|2006-12-01||Interventional|Finhyst 2006||Finhyst 2006: Study on Morbidity of Hysterectomies in Finland|Finhyst 2006: Incidence, Methods, Complications and Effect on Quality of Life of Hysterectomies in Finland in 2006|Completed||N/A|5279|Actual|Society for Gynecological Surgery in Finland||3|||f||||t||||||||||2017-02-18 13:58:34.051178|2017-02-18 13:58:34.051178
NCT00745407|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2008-09-02|||January 2005||2005-01-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|||||Interventional|||Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients||Completed||Phase 4|||Gachon University Gil Medical Center||1|||f||||t||||||||||2017-02-18 13:58:34.145913|2017-02-18 13:58:34.145913
NCT00745394|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2008-09-02|||April 2008||2008-04-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|August 2008|Anticipated|2008-08-01||Observational|NIRS||Validation of Near Infrared Spectroscopy (NIRS) During Heart-Lung Bypass in Children|Validation of Somatic and Cerebral Near Infrared Spectroscopy (NIRS) During Cardiopulmonary Bypass In Pediatric Patients: A Prospective Clinical Study|Unknown status|Recruiting|N/A|10|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-02-18 13:58:34.241681|2017-02-18 13:58:34.241681
NCT00745381|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-08-15|||August 2008||2008-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors|Gastroenteropancreatic and Unknown Primary Neuroendocrine Registry A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors|Active, not recruiting||N/A|300|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     All participants will be invited to provide a DNA (blood sample) and tissue sample for the~     purposes of developing a tissue repository. Blood samples will be collected. Expected~     accrual is 150 patients per year. Patients who donate blood and/or tissue samples are~     considered evaluable for protocol; however, it is preferred that both are obtained.~   "|||2017-02-18 13:58:34.321805|2017-02-18 13:58:34.321805
NCT00745368|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2012-09-07|2012-07-25||September 2008||2008-09-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women|Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women|Completed||N/A|28|Actual|University of Rochester|Due to limited sample size and large intersubject variability, more study comparing male and female GT concentrations is needed.|1|||f||||f||||||||||2017-02-18 13:58:34.625703|2017-02-18 13:58:34.625703
NCT00745355|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2016-11-07|||August 2008||2008-08-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Quality of Life in Patients With Bladder Cancer|A Prospective Study of Quality of Life in Patients With Bladder Cancer|Active, not recruiting||N/A|550|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 13:58:34.923494|2017-02-18 13:58:34.923494
NCT00745342|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-09-09|||March 1999||1999-03-01|September 2016|2016-09-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Optimizing Adherence and Glycemia in Youth With New Insulin-dependent Diabetes Mellitus (IDDM)|Optimizing Adherence and Glycemia in Youth With New IDDM|Completed||N/A|105|Actual|Joslin Diabetes Center||2|||f||||t||||||||||2017-02-18 13:58:35.042908|2017-02-18 13:58:35.042908
NCT00745329|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2008-09-02|||October 2008||2008-10-01|September 2008|2008-09-01||||||||Observational|||The Effect of Infliximab on Sperm Quality|The Effect of Infliximab,Adalimumab, Azathioprines and 5-Aminosalicylate on Semen Quality in Men With Inflammatory Bowel Disease|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-02-18 13:58:35.142467|2017-02-18 13:58:35.142467
NCT00745316|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-01-07||2015-11-19|February 2009||2009-02-01|January 2016|2016-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|POSEIDON||Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Tolerability of Oral Tonapofylline in Patients With Heart Failure and Renal Insufficiency|Terminated||Phase 2|34|Actual|Biogen||6||Company Decision|f||||t||||||||||2017-02-18 13:58:35.216177|2017-02-18 13:58:35.216177
NCT00745303|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2008-09-01|||May 2002||2002-05-01|September 2008|2008-09-01|March 2004|Actual|2004-03-01|May 2003|Actual|2003-05-01||Observational|||Effect of Tai Chi Chuan on Autonomic Nervous Modulation in Aged Subjects|Effect of Tai Chi Chuan on Autonomic Nervous Modulation, Blood Lipid and Cytokines Production in Aged Subjects|Completed||N/A|50|Actual|Taipei Veterans General Hospital, Taiwan|||2||f||||f||||||Samples Without DNA|"~     Blood sample obtained from each subject was withdrawn for the quantitative measurements of~     total cholesterol (TC), high-density lipoprotein--cholesterol (HDL-C), high-density~     lipoprotein--cholesterol (LDL-C), triglyceride (TG), fasting blood sugar (FBS), and uric~     acid (UA). The immunoenzymometric assays for the quantitative measurement of tumor necrosis~     factor-α (TNF-α) and interferon-γ (IFN-γ) in the serum were also performed on the blood~     sample from each subject.~   "|||2017-02-18 13:58:35.355896|2017-02-18 13:58:35.355896
NCT00745290|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2013-07-03|2011-11-23||August 2008||2008-08-01|July 2013|2013-07-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|TKA||A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty|A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Active Control Study to Evaluate the Safety and Efficacy of a Single Intraoperative Administration of SKY0402 For Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty|Completed||Phase 3|245|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 13:58:35.457488|2017-02-18 13:58:35.457488
NCT00745277|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2012-11-28|||August 2008||2008-08-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||High and Low Dose Treatment of Carbidopa in Parkinson's Disease|A Randomized Controlled Trial of Four Week Outpatient Treatment of Parkinson's Disease Comparing High and Low Dose Carbidopa.|Completed||Phase 2|12|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 13:58:36.088907|2017-02-18 13:58:36.088907
NCT00745264|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2009-03-19|||October 2007||2007-10-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise|Multi-Centre, Open-Label, Two Segment, Parallel Group Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise|Completed||Phase 1|80|Actual|IDEA AG||4|||f||||||||||||||2017-02-18 13:58:36.200164|2017-02-18 13:58:36.200164
NCT00745251|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2012-09-05|2012-07-31||August 2008||2008-08-01|September 2012|2012-09-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults|Completed||Phase 1/Phase 2|45|Actual|VIVUS, Inc.||2|||f||||f||||||||||2017-02-18 13:58:36.296255|2017-02-18 13:58:36.296255
NCT00745238|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2012-08-10|||June 2008||2008-06-01|September 2008|2008-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Cardiovascular Consequences of NIV Withdrawal in Patients With Myotonic Dystrophy|Four Weeks Withdrawal of Non-invasive Ventilation (NIV) in Patients With Myotonic Dystrophy: Cardiovascular, Metabolic and Daytime Vigilance Induced Changes|Unknown status|Recruiting|N/A|35|Anticipated|University Hospital, Grenoble||1|||f||||f||||||||||2017-02-18 13:58:36.707079|2017-02-18 13:58:36.707079
NCT00745225|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2017-01-07|||February 2006||2006-02-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|PPAR||Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients|Targeting Peroxisome Proliferator-Activated Receptor-Gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?|Completed||Phase 4|160|Actual|The University of Hong Kong||2|||f||||t||||||||||2017-02-18 13:58:36.809107|2017-02-18 13:58:36.809107
NCT00745212|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-01|2013-11-06|||June 2008||2008-06-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Observational|STRATHEGE||Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women|Prospective Multicentric Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women With a Risk of Thromboembolism and/or a Risk of Placental Vascular Complication, Strategy Determined With a Risk Score.|Completed||N/A|2280|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||t||||||||||2017-02-18 13:58:36.923933|2017-02-18 13:58:36.923933
NCT00745199|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2009-08-17|||May 2008||2008-05-01|August 2009|2009-08-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus|Phase II Study of the Effect of Oral Cromolyn Sodium on Uremic Pruritus and Serum Tryptase Levels of Hemodialysed Patients|Completed||Phase 2|62|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-02-18 13:58:37.011428|2017-02-18 13:58:37.011428
NCT00745186|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2015-06-17|||August 2007||2007-08-01|June 2015|2015-06-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers|A Randomized, Open Label, Four Way Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics and Safety After Intramuscular (IM) Administration of Mayne Glucagon for Injection With Glucagen® (Novo Nordisk) in Healthy Volunteers.|Completed||Phase 1|28|Actual|Hospira, Inc.||2|||f||||f||||||||||2017-02-18 13:58:37.259514|2017-02-18 13:58:37.259514
NCT00745173|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2009-02-11|||September 2008||2008-09-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study Evaluating Premarin and Bazedoxifene Potential Interaction|An Open-Label, Single/Multiple Dose Non-Randomized, 3-Period, Crossover Study To Determine The Potential Drug Interaction Of Conjugated Estrogens (CE) On Bazedoxifene In Healthy Postmenopausal Women.|Completed||Phase 1|30|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 13:58:37.3687|2017-02-18 13:58:37.3687
NCT00745160|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2011-03-29|||August 2008||2008-08-01|March 2011|2011-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes|Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes|Completed||N/A|115|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     blood sample for DNA analysis~   "|||2017-02-18 13:58:37.45943|2017-02-18 13:58:37.45943
NCT00745147|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-31|2010-05-03|||July 2008||2008-07-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||Comparison of TCM and Laxatives for Adults With Chronic Constipation|Comparison of Chinese Herbal Formula and Lactulose for Adults With Chronic Constipation-a Randomized ,Double-Blind, Controlled Trial|Completed||Phase 3|93|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 13:58:37.565175|2017-02-18 13:58:37.565175
NCT00745134|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-03-30|||August 2008||2008-08-01|March 2016|2016-03-01||||July 2017|Anticipated|2017-07-01||Interventional|||Curcumin With Pre-operative Capecitabine and Radiation Therapy Followed by Surgery for Rectal Cancer|A Randomized Double Blinded Study of Curcumin With Pre-operative Capecitabine and Radiation Therapy Followed by Surgery for Rectal Cancer|Active, not recruiting||Phase 2|45|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 13:58:37.698068|2017-02-18 13:58:37.698068
NCT00745121|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2016-03-23|||August 2008||2008-08-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Study Evaluating ASTRA TECH Implant System, OsseoSpeed™ Implants in the Upper Jaw in Women With Osteoporosis|An Open, Prospective, Non-randomized, Controlled, Multicenter Study to Evaluate Clinical Outcome of the ASTRA TECH Implant System, OsseoSpeed™ Implant in Women Over 60 Years of Age With Osteoporosis/Osteopenia|Active, not recruiting||N/A|58|Actual|Dentsply Sirona Implants||2|||f||||f||||||||||2017-02-18 13:58:37.817721|2017-02-18 13:58:37.817721
NCT00744133|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2014-08-07|||March 2009||2009-03-01|July 2014|2014-07-01|November 2011|Actual|2011-11-01|December 2010|Actual|2010-12-01||Interventional|||Malaria Challenge With NF54 Strain|An Interventional Plasmodium Falciparum Malaria Challenge Model Utilizing the NF54 Strain of Parasite Transmitted by Aseptic A. Stephensi Mosquitoes to Healthy Malaria-Naïve Adult Volunteers|Completed||Phase 1|37|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 13:58:56.454527|2017-02-18 13:58:56.454527
NCT00745108|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2014-05-22|||October 2001||2001-10-01|May 2014|2014-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|THEBES||Tibolone Endometrium Study (Study 32972)(P06470)|A Multinational, Multicenter, Randomized, Double-blind, Parallel Group, Active Controlled, Comparative Trial, to Assess the Endometrial Histological Profile Following Treatment With Tibolone (Org OD14) Versus Conjugated Estrogen (CE) Plus Medroxyprogesterone Acetate (MPA) in Postmenopausal Women|Completed||Phase 3|32|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 13:58:37.920474|2017-02-18 13:58:37.920474
NCT00745095|ClinicalTrials.gov processed this data on February 17, 2017|2008-09-02|2014-07-02|2014-04-18||March 2009||2009-03-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage|Efficacy and Safety of Bowel Preparations for Colonoscopy in SCI|Completed||Phase 4|360|Actual|VA Office of Research and Development||6|||f||||f||||||||||2017-02-18 13:58:38.013542|2017-02-18 13:58:38.013542
NCT00745069|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2011-05-17|||July 2004||2004-07-01|April 2010|2010-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis|4-Week Randomized Multicenter DB, Placebo- and Active-controlled, Parallel-group, Forced-titration Phase 2B Study of Efficacy and Safety With CG5503 Prolonged Release (PR) to 233 mg BID and Oxycodone PR to 20 mg BID vs Placebo in Subjects With Moderate to Severe Chronic Pain of Knee Osteoarthritis|Completed||Phase 2|670|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 13:58:38.643022|2017-02-18 13:58:38.643022
NCT00745056|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2015-06-01|||August 2008||2008-08-01|June 2015|2015-06-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|WHIMS-ECHO||Examining the Relationship Between Hormone Therapy and Cognitive Function (The WHIMS-ECHO Study)|Women's Health Initiative Memory Study--Epidemiology of Cognitive Health Outcomes|Active, not recruiting||N/A|2922|Actual|Wake Forest University Health Sciences|||1||f||||t||||||||||2017-02-18 13:58:38.731168|2017-02-18 13:58:38.731168
NCT00745043|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2008-08-29|||May 2005||2005-05-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|BOLD||Beta-Blocker in Chronic Obstructive Pulmonary Disease (COPD) Study|Do Beta-Blockers Affect the Use of Beta-Agonist Inhalers in COPD?|Completed||N/A|11|Actual|Waikato Hospital||4|||f||||f||||||||||2017-02-18 13:58:38.825279|2017-02-18 13:58:38.825279
NCT00745030|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2011-04-18|2010-10-12||June 2008||2008-06-01|April 2011|2011-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism|Efficacy and Tolerability of Ramelteon in Patients With REM Behavior Disorder and Parkinsonism: A Placebo Controlled, Double Blind, Randomized, Prospective Pilot Study|Terminated||N/A|3|Actual|Northwestern University||2||Low subject recruitment and enrollment.|f||||t||||||||||2017-02-18 13:58:38.927015|2017-02-18 13:58:38.927015
NCT00745017|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-08-29|||July 2001||2001-07-01|August 2008|2008-08-01||||July 2006|Actual|2006-07-01||Interventional|||Stress Generation and Recurrent Depression: The Role of Differential Treatment Response|Stress Generation and Recurrent Depression: The Role of Differential Treatment Response|Completed||Phase 1|72|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-02-18 13:58:39.298616|2017-02-18 13:58:39.298616
NCT00745004|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2012-01-23|||January 2009||2009-01-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)|"Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D): Identifying the Responder"|Completed||Phase 4|150|Actual|University of Nottingham||2|||f||||f||||||||||2017-02-18 13:58:39.408688|2017-02-18 13:58:39.408688
NCT00744991|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2010-10-25||2010-10-25|September 2008||2008-09-01|October 2010|2010-10-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma|A Phase 2, Open-Label, Multicenter Study of Single-Agent Enzastaurin in Patients With Relapsed Cutaneous T-Cell Lymphoma|Completed||Phase 2|25|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 13:58:39.512308|2017-02-18 13:58:39.512308
NCT00744978|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2011-10-12|2011-10-12||July 2009||2009-07-01|October 2011|2011-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease|A Phase 2 Multicenter, Double-Blind, Placebo-Controlled, Crossover Trial of Varenicline Tartrate (CP-526,555) in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|66|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 13:58:39.743932|2017-02-18 13:58:39.743932
NCT00744965|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2017-01-25|||August 2008||2008-08-01|January 2017|2017-01-01|January 2016|Actual|2016-01-01|January 2013|Actual|2013-01-01||Interventional|||Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo|A Randomized Controlled Clinical Trial of Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo|Completed||Phase 4|395|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 13:58:40.776556|2017-02-18 13:58:40.776556
NCT00744952|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-11-11|||August 2008||2008-08-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis|VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-vessel Vasculitis (Takayasu's Arteritis):Development as Clinical Trial Outcome Measures|Recruiting||N/A|36|Anticipated|University of Pennsylvania|||1||f||||t||||||||||2017-02-18 13:58:40.88386|2017-02-18 13:58:40.88386
NCT00744939|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2014-09-17|2014-07-29||November 2008||2008-11-01|September 2014|2014-09-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Observational|||Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist|Prospective Non-randomized Observational (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Magnevist® Injection in Patients With Moderate Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.|Completed||Phase 4|168|Actual|Bayer|Bayer HealthCare was informed about the release from the postmarketing surveillance (PMS) for Magnevist with a letter dated 02 JUN 2011. As a consequence Bayer HealthCare stopped enrollment for this study on 01 AUG 2011.||1||f||||f||||||Samples Without DNA|"~     Serum creatinine must be obtained within 6 weeks of the administration of Magnevist, or as~     currently recommended by the American College of Radiology. At the Baseline within 48 hrs.~     pre-injection a chemistry panel will be obtained in all patients after intravenous access~     has been obtained.~   "|||2017-02-18 13:58:41.009439|2017-02-18 13:58:41.009439
NCT00744926|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-07-26||2016-07-26|August 2008||2008-08-01|July 2016|2016-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.|A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Effect of Taspoglutide Compared to Placebo, in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise|Completed||Phase 3|373|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 13:58:42.820034|2017-02-18 13:58:42.820034
NCT00744913|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2013-08-14|||August 2008||2008-08-01|August 2013|2013-08-01|March 2010|Anticipated|2010-03-01|February 2010|Anticipated|2010-02-01||Interventional|||Study of Nicotine Replacement Therapy in Pregnancy|Randomized, Controlled Open-Label Study of Nicotine Replacement Therapy in Pregnancy|Withdrawn||Phase 3|0|Actual|The Hospital for Sick Children||2||Discontinued due to difficulty in recruitment|f||||t||||||||||2017-02-18 13:58:42.965552|2017-02-18 13:58:42.965552
NCT00744900|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2009-07-24|||September 2008||2008-09-01|July 2009|2009-07-01||||||||Interventional|GFPC 07-01||Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)|A Phase II Trial With Pemetrexed Plus Cisplatin as First Line Chemotherapy for Advanced Non - Small Cell Lung Cancer (NSCLC) Patients With Measurable Asymptomatic Brain Metastasis (GFPC 07-01/METAL).|Completed||Phase 2|45|Actual|University Hospital, Brest||1|||f||||t||||||||||2017-02-18 13:58:43.062672|2017-02-18 13:58:43.062672
NCT00744887|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2011-06-08|||August 2008||2008-08-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.|Phase I, Open-label, Randomized, 3-way Crossover Trial to Assess the Pharmacokinetics of Darunavir (DRV) Given Once-daily With Different Doses of Ritonavir in Healthy Subjects.|Completed||Phase 1|21|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-02-18 13:58:43.178564|2017-02-18 13:58:43.178564
NCT00744874|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2012-12-11|2012-07-25||October 2007||2007-10-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|September 2009|Actual|2009-09-01||Interventional|MAP-PAF||Ablation of the Pulmonary Veins for Paroxysmal Afib|Multi-Array Ablation of the Pulmonary Veins for Paroxysmal Atrial Fibrillation|Completed||Phase 4|55|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||f||||||||||2017-02-18 13:58:43.282534|2017-02-18 13:58:43.282534
NCT00744861|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2013-07-23|||September 2008||2008-09-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|EXO-SPINE||Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery|EXO-SPINE: A Prospective, Multi-center, Double-blind, Randomized, Placebo Controlled Pivotal Study of Ultrasound as Adjunctive Therapy for Increasing Posterolateral Fusion Success Following Single Level Posterior Instrumented Lumbar Surgery|Terminated||N/A|310|Actual|Bioventus LLC||2||Terminated following interim analysis|f||||f||||||||||2017-02-18 13:58:43.772441|2017-02-18 13:58:43.772441
NCT00744848|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2013-07-03|2011-11-23||August 2008||2008-08-01|July 2013|2013-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy|Phase 3, Multicenter, Randomized, Double-Blind, Parallel-group, Active-control Study to Evaluate the Safety and Efficacy of a Single Administration of SKY0402 for Prolonged Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy|Completed||Phase 3|204|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 13:58:43.89258|2017-02-18 13:58:43.89258
NCT00744835|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2012-06-04|||August 2006||2006-08-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|August 2007|Actual|2007-08-01||Interventional|||Atrial Fibrillation Ablation Pilot Study|Atrial Fibrillation Ablation Pilot Study- Study Number AFI-20|Completed||Phase 1|53|Actual|Medtronic Atrial Fibrillation Solutions||1|||f||||t||||||||||2017-02-18 13:58:44.466233|2017-02-18 13:58:44.466233
NCT00744822|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-08-28|||March 2006||2006-03-01|December 2005|2005-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Vibration Response Imaging (VRI) in Lung Transplant Recipients|Vibration Response Imaging (VRI) in Lung Transplant Recipients|Completed||N/A|55|Actual|Hannover Medical School|||1||f||||t||||||||||2017-02-18 13:58:44.57075|2017-02-18 13:58:44.57075
NCT00744809|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2011-06-08|||August 2008||2008-08-01|March 2010|2010-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.|A Phase I, Double-blind, Double-dummy, Randomized, Placebo Controlled and Active Controlled Trial to Evaluate the Effect of TMC278 25 mg Daily at Steady-state and the Effect of Efavirenz (EFV) 600 mg Daily at Steady-state on the QT/QTc Interval, in 2 Randomized Panels of Healthy Volunteers|Completed||Phase 1|120|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-02-18 13:58:44.661056|2017-02-18 13:58:44.661056
NCT00744796|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2008-08-29|||December 2006||2006-12-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|DSAEK||Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty|Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) in Patients With Corneal Endothelial Cell Dysfunction: Clinical Outcomes and Diagnostic Imaging Analysis|Unknown status|Recruiting|N/A|200|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 13:58:44.748001|2017-02-18 13:58:44.748001
NCT00744770|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2010-04-26|||October 2008||2008-10-01|April 2010|2010-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.|A Phase I, Open-label, Single-sequence Drug-drug Interaction Trial in Subjects on Stable Methadone Maintenance Therapy, to Investigate the Potential Interaction Between TMC278 25 mg q.d. and Methadone, at Steady-state.|Completed||Phase 1|13|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 13:58:44.850139|2017-02-18 13:58:44.850139
NCT00744757|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2013-08-26|2013-03-19||August 2008||2008-08-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|September 2010|Actual|2010-09-01||Interventional|||An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)|A Phase II Multi-center Study of 5-AZA-2'-Deoxycytidine (Decitabine) Single Agent in Taiwanese Patients With Myelodysplastic Syndrome (MDS)|Completed||Phase 2|37|Actual|Johnson & Johnson Taiwan Ltd||1|||f||||f||||||||||2017-02-18 13:58:44.94936|2017-02-18 13:58:44.94936
NCT00744744|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2012-02-01|||May 2008||2008-05-01|February 2012|2012-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Health-Related Quality of Life in Patients With Bladder Cancer|A CROSS-SECTIONAL STUDY OF PATIENT-REPORTED OUTCOMES FOR BLADDER CANCER PATIENTS WITH NON-INVASIVE DISEASE|Completed||N/A|138|Actual|Baylor College of Medicine|||1||f||||f||||||||||2017-02-18 13:58:45.753241|2017-02-18 13:58:45.753241
NCT00744731|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2013-06-10||2013-01-15|January 2009||2009-01-01|June 2013|2013-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures|The Open Label Extension Portion of the Study Entitled A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects With Partial Onset Seizures.|Completed||Phase 3|403|Actual|SK Life Science||2|||f||||||||||||||2017-02-18 13:58:45.863467|2017-02-18 13:58:45.863467
NCT00744718|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-11-15|||August 2008||2008-08-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|August 2015|Actual|2015-08-01||Interventional|||Bevacizumab and Carboplatin for Patients With Ovarian Cancer|Bevacizumab and Carboplatin for Patients With Platin Resistant Epithelial Ovarian Cancer. A Phase II Study.|Completed||Phase 2|73|Actual|Vejle Hospital||1|||f||||t||||||||||2017-02-18 13:58:45.967172|2017-02-18 13:58:45.967172
NCT00744705|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2008-08-29|||September 2008||2008-09-01|August 2008|2008-08-01|December 2008|Anticipated|2008-12-01|November 2008|Anticipated|2008-11-01||Observational|||Normative Database of the Retinal Nerve Fiber Layer Thickness Measured by the Cirrus HD OCT in Asians|Normative Database of the Retinal Nerve Fiber Layer Thickness Measured by the Cirrus HD OCT in Asians|Unknown status|Not yet recruiting|N/A|200|Anticipated|Yonsei University|||1||f||||t||||||||||2017-02-18 13:58:46.058124|2017-02-18 13:58:46.058124
NCT00744692|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2014-07-23|2014-07-23||October 2008||2008-10-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|December 2012|Actual|2012-12-01||Interventional||22 subjects undergoing umbilical cord blood transplant|Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders|A Pilot Study of Reduced Intensity Conditioning in Pediatric Patients <21 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood Transplantation|Completed||Phase 1|22|Actual|Duke University||1|||f||||f||||||||||2017-02-18 13:58:46.152|2017-02-18 13:58:46.152
NCT00744679|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2015-02-06|||November 2008||2008-11-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State|An Assessment of the Steady-State Pharmacokinetic and Pharmacodynamic Profile of Tysabri 300 mg Following at Least 12 Monthly Infusions|Completed||Phase 4|20|Actual|Biogen||1|||f||||f||||||||||2017-02-18 13:58:46.475452|2017-02-18 13:58:46.475452
NCT00744666|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2009-08-04|||September 2008||2008-09-01|August 2009|2009-08-01|July 2010|Anticipated|2010-07-01|June 2010|Anticipated|2010-06-01||Interventional|IVTA:PRE-TREAT||IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids|IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids|Unknown status|Recruiting|Phase 4|70|Anticipated|Hotel Dieu Hospital||2|||f||||f||||||||||2017-02-18 13:58:46.580246|2017-02-18 13:58:46.580246
NCT00744653|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2014-06-18|2011-03-22||October 2008||2008-10-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.|Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.|Terminated||Phase 2|17|Actual|Copenhagen University Hospital at Herlev|Early termination due to too few objective respondes using the primary endpoint.|1||Primary endpoint measure not suitable for evaluation|f||||t||||||||||2017-02-18 13:58:46.693199|2017-02-18 13:58:46.693199
NCT00744640|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2010-01-11|||October 2005||2005-10-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|GEMOXEL||Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma|Gemcitabine, Oxaliplatin and Capecitabine (GEMOXEL) for Patients With Advanced Pancreatic Adenocarcinoma (APC): A Phase I/II Study|Completed||Phase 1/Phase 2|46|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-02-18 13:58:46.965903|2017-02-18 13:58:46.965903
NCT00744627|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2014-01-28|2013-10-25||September 2008||2008-09-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of a Single Dose of Lu AA21004 in Acute Treatment of Adults With Generalized Anxiety Disorder|Completed||Phase 3|301|Actual|Takeda||2|||f||||f||||||||||2017-02-18 13:58:47.09084|2017-02-18 13:58:47.09084
NCT00744614|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2010-10-19|||November 2007||2007-11-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients|Use Of Capnography As Surrogate Measure Of PC02 In Medical ICU Patients|Terminated||N/A|70|Anticipated|Lahey Clinic|||1|"Principal Investigator (central contact) has left the organization and requests the study be~   terminated"|f||||f||||||||||2017-02-18 13:58:48.930885|2017-02-18 13:58:48.930885
NCT00744601|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-12-31|||April 2007||2007-04-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Observational|||Impulsivity, Neural Deficits and Cocaine Addiction|Impulsivity, Neural Deficits, and Relapse in Cocaine Addiction|Completed||N/A|90|Actual|University of Texas Southwestern Medical Center|||2||f||||f||||||Samples With DNA|"~     urine, blood, plasma, and erythrocytes~   "|||2017-02-18 13:58:49.042094|2017-02-18 13:58:49.042094
NCT00744588|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-01-02|||August 2007||2007-08-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|August 2011|Actual|2011-08-01||Observational|||Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism|Stress, HPA Dysfunction, and Relapse in Alcoholism|Completed||N/A|75|Actual|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples With DNA|"~     serum plasma whole blood urine~   "|||2017-02-18 13:58:49.147605|2017-02-18 13:58:49.147605
NCT00744575|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2010-10-08|||August 2008||2008-08-01|January 2009|2009-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Assessment of a Specific Neurophysiological Brain Pattern in Patients Suffering From Chronic Back Pain|Assessment of a Specific Neurophysiological Brain Pattern in Patients Suffering From Chronic Back Pain|Completed||N/A|72|Anticipated|University Hospital Freiburg|||2||f||||f||||||||||2017-02-18 13:58:49.256553|2017-02-18 13:58:49.256553
NCT00744562|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-09-16|||August 2008||2008-08-01|September 2016|2016-09-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors|A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors|Completed||Phase 1|42|Actual|OncoMed Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:58:49.357411|2017-02-18 13:58:49.357411
NCT00188981|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-19|||June 2003||2003-06-01|April 2007|2007-04-01|June 2008|Anticipated|2008-06-01|||||Observational|||Dutch Prediction of Psychosis Study|Dutch Prediction of Psychosis Study|Unknown status|Active, not recruiting|N/A|120||UMC Utrecht|||||f||||f||||||||||2017-02-18 17:15:59.986995|2017-02-18 17:15:59.986995
NCT00744549|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2015-07-14|||May 2008||2008-05-01|July 2015|2015-07-01||||December 2013|Actual|2013-12-01||Interventional|||Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance|The Impact of Antioxidants on MRI Markers of Cell Proliferation and Hypoxia Among Men on Active Surveillance With Early Stage Prostate Cancer|Suspended||Phase 2|40|Anticipated|University Health Network, Toronto||2||Study is currently on hold and recruitment may resume in the future|f||||f||||||||||2017-02-18 13:58:49.44539|2017-02-18 13:58:49.44539
NCT00744536|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2012-12-11|||January 2008||2008-01-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|REMMYDYS||Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat Higher Risk Myelodysplastic Syndromes|"Revlimid®, and Metronomic Melphalan in the Management of Higher Risk Myelodysplastic Syndromes (MDS) and CMML: a Phase 2 Study"|Completed||Phase 2|20|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-02-18 13:58:49.552156|2017-02-18 13:58:49.552156
NCT00744523|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-01-28|2010-03-10||September 2007||2007-09-01|January 2016|2016-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|ARMOUR||Proximal Protection With The Mo.Ma Device During Carotid Stenting|ARMOUR: Proximal Protection With The Mo.Ma Device During Carotid Stenting|Completed||N/A|262|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-02-18 13:58:49.674852|2017-02-18 13:58:49.674852
NCT00744510|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2012-12-03|||December 2012||2012-12-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|March 2013|Anticipated|2013-03-01||Interventional|REPOS||Reflexology's Effect on Polycystic Ovary Syndrome (PCOS)|Reflexology's Effect on Polycystic Ovary Syndrome (REPOS): A Pilot Study|Unknown status|Not yet recruiting|Phase 3|140|Anticipated|University of Nottingham||2|||f||||f||||||||||2017-02-18 13:58:50.679241|2017-02-18 13:58:50.679241
NCT00744497|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2016-08-23|2013-11-15||October 2008||2008-10-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|August 2012|Actual|2012-08-01||Interventional|READY|All participants who were randomized to receive any treatment|Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer|A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined With Dasatinib to Docetaxel Combined With Placebo in Castration-Resistant Prostate Cancer|Completed||Phase 3|1930|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 13:58:50.797649|2017-02-18 13:58:50.797649
NCT00744484|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2012-01-05|||February 2008||2008-02-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|May 2009|Actual|2009-05-01||Interventional|||A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary Disease|A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary Disease (COPD)-a Comparison of Water Based and Land Based Group Training|Completed||N/A|22|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-02-18 13:58:55.204026|2017-02-18 13:58:55.204026
NCT00744471|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2011-04-25||2011-04-14|November 2008||2008-11-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Tanezumab in Osteoarthritis Of The Hip|A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Osteoarthritis Of The Hip|Completed||Phase 3|627|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 13:58:55.526446|2017-02-18 13:58:55.526446
NCT00744458|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2010-05-26|||August 2008||2008-08-01|August 2009|2009-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|TAHADIRA||Treat Arterial Hypertension and Diabetes in Rural Africa|A Prospective Randomised Trial Comparing Three Interventions to Improve Treatment Adherence Among Patients With Arterial Hypertension or Diabetes in Rural Cameroon (TAHADIRA-trial 1)|Completed||N/A|223|Actual|Cooperation Afrique||3|||f||||t||||||||||2017-02-18 13:58:55.719771|2017-02-18 13:58:55.719771
NCT00744445|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2008-08-29|||October 1993||1993-10-01|August 2008|2008-08-01|August 1998|Actual|1998-08-01|August 1998|Actual|1998-08-01||Interventional|||Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity|Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity|Completed||Phase 2|46|Actual|Sunnybrook Health Sciences Centre||3|||f||||f||||||||||2017-02-18 13:58:55.8255|2017-02-18 13:58:55.8255
NCT00744419|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2015-12-01|||May 2009||2009-05-01|December 2015|2015-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants|A Multicenter, Open-label, Single and Multiple Dose Pharmacokinetic Study of IV Pantoprazole in Preterm Infants and Infants 0-11 Months With a Clinical Diagnosis of Gastroesophageal Reflux Disease (GERD) or the Need for Acid Suppression|Completed||Phase 1|24|Actual|University of Louisville||1|||f||||t||||||||||2017-02-18 13:58:55.92503|2017-02-18 13:58:55.92503
NCT00744406|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-08-29|||July 2003||2003-07-01|August 2008|2008-08-01||||September 2006|Actual|2006-09-01||Interventional|||Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression|Patient Dimensions as Predictors of Response, Relapse and Recurrence Following Cognitive-Behavioral Therapy, Interpersonal Psychotherapy and Pharmacotherapy Treatment of Patients With Major Depression.|Completed||Phase 2|72|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-02-18 13:58:56.035811|2017-02-18 13:58:56.035811
NCT00744393|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-29|2015-03-17|||October 2008||2008-10-01|March 2015|2015-03-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||The Effect of Sodium Oxybate on Sleep Architecture|The Effect of Sodium Oxybate on Sleep Architecture in Critically Ill Patients: A Double-Blind, Crossover Pilot Study|Withdrawn||Phase 2|0|Actual|Tufts Medical Center||2||Sponsor pulled funding secondary to economy issues|f||||f||||||||||2017-02-18 13:58:56.146105|2017-02-18 13:58:56.146105
NCT00744159|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2008-08-28|||January 2006||2006-01-01|August 2008|2008-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Prospective Comparison of Immunological Benefit of Laparoscopic Colectomy|Prospective Comparative Study of Immunological Benefit Between Laparoscopic Colectomy and Open Colectomy|Completed||N/A|84|Actual|Samsung Medical Center|||2||f||||f||||||||||2017-02-18 13:58:56.256914|2017-02-18 13:58:56.256914
NCT00744146|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2010-09-16|||September 2008||2008-09-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||First Time in Human Study of Protexia|Phase I, Randomized, Controlled, Third-party Double-blind, Dose Escalating Study of Protexia Administered Intramuscularly at One or Two Time Points in Healthy Human Volunteers|Completed||Phase 1|33|Actual|PharmAthene, Inc.||5|||f||||t||||||||||2017-02-18 13:58:56.350528|2017-02-18 13:58:56.350528
NCT00744120|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2013-12-19|||October 2003||2003-10-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Lymphoma Follow-up|Lymphoma Follow-up Protocol|Completed||N/A|51|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||f||||||Samples Without DNA|"~     Blood serum~   "|||2017-02-18 13:58:56.563095|2017-02-18 13:58:56.563095
NCT00744107|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2009-08-04|||August 2008||2008-08-01|April 2009|2009-04-01|September 2010|Anticipated|2010-09-01|July 2010|Anticipated|2010-07-01||Interventional|||Cobra II Study: Use of the Cobra™ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery Disease|The Cobra II Study: Use of the Cobra™ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery Disease|Unknown status|Active, not recruiting|Phase 2|258|Anticipated|Medlogics Device Corporation||1|||f||||t||||||||||2017-02-18 13:58:56.649826|2017-02-18 13:58:56.649826
NCT00744094|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2015-09-22|||January 2007||2007-01-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Resistance Training in Elderly|The Influence of Resistance Training on Body Composition and Muscle Characteristics in Healthy Elderly|Completed||Phase 1/Phase 2|26|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:58:56.747597|2017-02-18 13:58:56.747597
NCT00744081|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-08-28|||July 2004||2004-07-01|August 2008|2008-08-01||||December 2007|Anticipated|2007-12-01||Interventional|||Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)|Open-Label Multicenter Trial of Glivec® (Imatinib Mesylate, Formerly Known as STI571) in Combination With Chemotherapy (MTC) in Patients With Refractory or Relapsed Acute Myeloid Leukemia (AML)|Unknown status|Recruiting|Phase 2|130|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 13:58:56.838979|2017-02-18 13:58:56.838979
NCT00744068|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2016-11-23|||April 2006||2006-04-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|||Four Models of Telephone Support for Stimulant Recovery|Four Models of Telephone Support for Stimulant Recovery|Completed||N/A|302|Actual|University of California, Los Angeles||5|||f||||t||||||||||2017-02-18 13:58:56.995113|2017-02-18 13:58:56.995113
NCT00744055|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2016-03-18|2015-10-27||January 2009||2009-01-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Veterans|Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).|The Use of Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).|Completed||Phase 3|96|Actual|Yale University||2|||f||||t||||||||||2017-02-18 13:58:57.292267|2017-02-18 13:58:57.292267
NCT00744042|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2016-01-25|2011-05-15||September 2008||2008-09-01|January 2016|2016-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)|A Multicenter, Open-Label Study of the Safety, Tolerability and Pharmacology of Asfotase Alfa in up to 10 Severely Affected Patients With for the Treatment of Severely Affected Patients With Infantile Hypophosphatasia (HPP)|Completed||Phase 1/Phase 2|11|Actual|Alexion Pharma GmbH||1|||f||||t||||||||||2017-02-18 13:58:57.70773|2017-02-18 13:58:57.70773
NCT00744029|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-08-29|||February 2004||2004-02-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|December 2005|Actual|2005-12-01||Interventional|BASS||Reduction of Prehospital Delays in Stroke and Transient Ischaemic Attack (TIA)|Population-Based Intervention to Reduce Prehospital Delays in Patients With Stroke and Transient Ischaemic Attack|Completed||N/A|1388|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 13:58:58.166497|2017-02-18 13:58:58.166497
NCT00744016|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2009-12-21|||December 2004||2004-12-01|December 2009|2009-12-01|October 2007|Actual|2007-10-01|May 2007|Actual|2007-05-01||Interventional|||Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative Colitis|Completed||Phase 3|305|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 13:58:58.271203|2017-02-18 13:58:58.271203
NCT00744003|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-11-15|||July 2008||2008-07-01|November 2013|2013-11-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||An Observational Study of Early Coagulopathy, or Clotting Disorder, in Injured Patients|Early Trauma Induced Coagulopathy (ETIC): A Pilot Study to Determine Its Definition and Risk Factors|Withdrawn||N/A|0|Actual|Emory University|||1|PI no longer at Emory; no participants enrolled, study not conducted|f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 13:58:58.380933|2017-02-18 13:58:58.380933
NCT00743990|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2010-05-07|||October 2008||2008-10-01|August 2009|2009-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough|Effect of a Medicated Topical Therapy, Petrolatum, and No Treatment on Nocturnal Cough and Congestion for Children With Upper Respiratory Infections|Completed||N/A|143|Actual|Penn State University||3|||f||||t||||||||||2017-02-18 13:58:58.460493|2017-02-18 13:58:58.460493
NCT00743977|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-08-28|||August 2008||2008-08-01|August 2008|2008-08-01||||November 2008|Anticipated|2008-11-01||Interventional|||Bioequivalence of Phenazopyridine HCl in Healthy Volunteers|2 Treatment, 2 Period, Randomized, Single Blinded, Crossover Bioequivalence of Phenazopyridine HCl in 24 Healthy Volunteers|Unknown status|Active, not recruiting|N/A|24|Actual|Universal Enterprises||2|||f||||t||||||||||2017-02-18 13:58:58.559687|2017-02-18 13:58:58.559687
NCT00743964|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2010-01-13|||April 2008||2008-04-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)|A Randomized Phase II Study of Combination Chemotherapy With Epirubicin , Cisplatin and Capecitabine (ECX) or Cisplatin and Capecitabine (CX) in Advanced Gastric Cancer|Completed||Phase 2|91|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 13:58:58.658148|2017-02-18 13:58:58.658148
NCT00743951|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2016-03-29|||January 2007||2007-01-01|March 2016|2016-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Feasibility Study: Effect of Patient Decision Aids for Total Joint Replacement on Surgical Referrals|Feasibility Study: Does Screening Plus Patient Decision Aids Reduce Unnecessary Surgical Referrals for Total Joint Arthroplasty in Practices With Long Waiting Lists for Surgical Consults?|Completed||Phase 3|142|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||No||2017-02-18 13:58:58.754235|2017-02-18 13:58:58.754235
NCT00743938|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2015-09-23||2015-09-23|March 2009||2009-03-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|August 2010|Actual|2010-08-01||Interventional|||A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC|A Double-Blind, Randomized, Parallel Two-Arm Phase II Trial of BMS-690514 Versus Erlotinib in Previously Treated NSCLC Patients|Completed||Phase 2|141|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 13:58:58.876637|2017-02-18 13:58:58.876637
NCT00741858|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2015-07-08|2015-06-15||April 2003||2003-04-01|July 2015|2015-07-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Duragen Versus Duraguard in Chiari Surgery|Prospective Randomized Study of Duragen vs. Duraguard in Chiari Surgery|Completed||Phase 3|34|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-02-18 13:59:36.617263|2017-02-18 13:59:36.617263
NCT00743925|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2014-01-30||2012-01-31|July 2008||2008-07-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|FRANCIS-ACS||FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes|FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes|Completed||Phase 2|625|Actual|Anthera Pharmaceuticals||2|||f||||f||||||||||2017-02-18 13:58:59.019501|2017-02-18 13:58:59.019501
NCT00743912|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2009-12-21|||September 2008||2008-09-01|December 2009|2009-12-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers|A Phase 1, Single Arm, Open-Label Study to Evaluate the Effect of Rifaximin 550 MG Tablets TID on the Pharmacokinetics of Orally Administered Midazolam in Healthy Male and Female Volunteers|Completed||Phase 1|24|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-02-18 13:58:59.160921|2017-02-18 13:58:59.160921
NCT00743899|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-12-08|||January 2009||2009-01-01|December 2013|2013-12-01|June 2016|Anticipated|2016-06-01|June 2013|Actual|2013-06-01||Interventional|SMART-CASE||Conservative Versus Aggressive Revascularization in Patients With Intermediate Lesions Undergoing Percutaneous Coronary Intervention With Angiography Guidance Alone|Conservative Versus Aggressive Revascularization in Patients With Intermediate Lesions Undergoing Percutaneous Coronary Intervention With Angiography Guidance Alone (SMART-CASE)|Unknown status|Active, not recruiting|N/A|899|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-02-18 13:58:59.254587|2017-02-18 13:58:59.254587
NCT00743886|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2011-07-10|||January 2008||2008-01-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear|Influence of PRGF on Healing of MCL Tear - Randomized-Double-Blind-Placebo Control Trail|Withdrawn||Phase 2/Phase 3|50|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-02-18 13:58:59.420076|2017-02-18 13:58:59.420076
NCT00743873|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2011-07-10|||January 2008||2008-01-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation|PRP Treatment for Medial Retinaculum Tear - Randomized-Double-Blind-Placebo Control Trail|Completed||Phase 2/Phase 3|50|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-02-18 13:58:59.518717|2017-02-18 13:58:59.518717
NCT00743860|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2016-11-15|||September 2008||2008-09-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848|A Study to Evaluate the Pharmacokinetics of the Enteric-Coated Micronized Free Base Formulation of Darapladib [SB-480848] and Its Metabolites in Healthy Volunteers.|Completed||Phase 1|20|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:58:59.775786|2017-02-18 13:58:59.775786
NCT00743847|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2009-02-20|||March 2009||2009-03-01|February 2009|2009-02-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia|A Phase 2 6-Week, Double-Blind, Placebo-Controlled, Multicenter Trial Of Varenicline Tartrate (CP-526,555) For Cognitive Impairment In Subjects With Schizophrenia|Withdrawn||Phase 2|0|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 13:58:59.876894|2017-02-18 13:58:59.876894
NCT00743834|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-09-03|||September 2008||2008-09-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)|Cost-Effectiveness of Adding Web-Based CBT to Luvox CR for OCD|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Rogers Center for Research & Training, Inc.||1|||f||||f||||||||||2017-02-18 13:58:59.980017|2017-02-18 13:58:59.980017
NCT00743821|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2014-05-05|||October 2008||2008-10-01|May 2014|2014-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|Eye-TRAC||Eye-Tracking Rapid Attention Computation|Eye-Tracking Rapid Attention Computation|Completed||N/A|426|Actual|Brain Trauma Foundation|||2||f||||f||||||||||2017-02-18 13:59:00.091393|2017-02-18 13:59:00.091393
NCT00743808|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2015-11-30|||December 2006||2006-12-01|August 2013|2013-08-01|September 2010|Actual|2010-09-01|May 2008|Actual|2008-05-01||Observational|||Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes|Improving Hypertension Control in Individuals With Diabetes|Completed||N/A|11510|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-02-18 13:59:00.182719|2017-02-18 13:59:00.182719
NCT00743795|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-10-11||2012-06-06|October 2008||2008-10-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|July 2009|Actual|2009-07-01||Interventional|||Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Comparing 24 or 48 Weeks of GS 9190, in Combination With Peginterferon Alfa 2a and Ribavirin, to 48 Weeks of Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic Hepatitis C Virus (HCV) Infection (GS-US-196-0103)|Completed||Phase 2|252|Actual|Gilead Sciences||3|||f||||t||||||||||2017-02-18 13:59:00.286253|2017-02-18 13:59:00.286253
NCT00743782|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2017-01-24|||August 22, 2008||2008-08-22|April 7, 2014|2014-04-07|April 7, 2014|Actual|2014-04-07|April 7, 2014|Actual|2014-04-07||Interventional|||Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism|Comparing Pump vs. Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism|Completed||Early Phase 1|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 13:59:00.480211|2017-02-18 13:59:00.480211
NCT00743769|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2015-03-19|||April 2008||2008-04-01|March 2015|2015-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Phase 1 Study of the Safety and Tolerability of the Intravenous Administration of Thymosin Beta 4 and Its Pharmacokinetics After Single and Multiple Doses in Healthy Volunteers|Completed||Phase 1|60|Actual|RegeneRx Biopharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 13:59:00.587257|2017-02-18 13:59:00.587257
NCT00743756|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2014-06-07|||April 2006||2006-04-01|June 2014|2014-06-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|||Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM)|Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With T2Dm|Terminated||N/A|38|Actual|Emory University||3||slow patient enrollment|f||||f||||||||||2017-02-18 13:59:00.698246|2017-02-18 13:59:00.698246
NCT00743743|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2015-08-21|||September 2008||2008-09-01|August 2015|2015-08-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|||Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease|Randomized, Placebo-controlled Clinical Trial of Resveratrol Supplement Effects on Cognition, Function and Behavior in Patients With Mild-to-moderate Alzheimer's Disease|Withdrawn||Phase 3|0|Actual|Medical College of Wisconsin||2||PI has left institution|f||||t||||||||||2017-02-18 13:59:00.80907|2017-02-18 13:59:00.80907
NCT00743730|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2016-09-26|2015-11-04||June 2005||2005-06-01|September 2016|2016-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|PNCA||Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay|Outcomes And Parent Satisfaction Associated With Parent/Nurse Controlled Analgesia In Pediatric Patients With Developmental Delay|Completed||N/A|94|Actual|Medical College of Wisconsin||3|||f||||f||||||||||2017-02-18 13:59:00.923921|2017-02-18 13:59:00.923921
NCT00743717|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-05-21|2013-02-27||February 2004||2004-02-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of the Safety and Effectiveness of the Kinamed Gem Ceramic Femoral Component for Total Knee Replacement|Clinical Trial on the Zirconia Femoral Component for the Gem Total Knee System|Completed||Phase 2|4|Actual|Kinamed Incorporated||2|||f||||f||||||||||2017-02-18 13:59:01.448704|2017-02-18 13:59:01.448704
NCT00743704|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2009-04-18|||August 2008||2008-08-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Novel Noninvasive Techniques to Study Neutrophil Airway Inflammation in an Ozone Challenge Model|Novel Noninvasive Techniques to Study Neutrophil Airway Inflammation in an Ozone Challenge Model|Completed||N/A|15|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f||||||||||||||2017-02-18 13:59:01.835349|2017-02-18 13:59:01.835349
NCT00743691|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2009-02-05|||April 2009||2009-04-01|February 2009|2009-02-01|October 2010|Anticipated|2010-10-01|April 2010|Anticipated|2010-04-01||Interventional|||Impact Study of Community Based Treatment of Neonatal Infection by Health Extension Workers on Neonatal Mortality|Impact of Strengthened Health Extension Program and Community Based Treatment of Neonatal Infections on Neonatal Mortality in Oromia and South Nation and Nationalities & People Region(SNNPR), Ethiopia|Unknown status|Not yet recruiting|N/A|660000|Anticipated|Save the Children||2|||f||||t||||||||||2017-02-18 13:59:01.944329|2017-02-18 13:59:01.944329
NCT00743678|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-06-13|||June 2008||2008-06-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis|A Phase II Study of Neoadjuvant FOLFOX6 Plus Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis|Completed||Phase 2|73|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-02-18 13:59:02.065258|2017-02-18 13:59:02.065258
NCT00743665|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-09-12|||June 2007||2007-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Quality of Life And Psychological Symptoms In Children With Cyclic Vomiting Syndrome (CVS)|Quality of Life And Psychological Symptoms In Children With Cyclic Vomiting Syndrome|Active, not recruiting||N/A|75|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 13:59:02.172411|2017-02-18 13:59:02.172411
NCT00743652|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2012-03-13|2011-09-09||January 2009||2009-01-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.|A Phase 3, Open Label Trial Evaluating the Safety, Immunogenicity and Impact of 13-valent Pneumococcal Conjugate Vaccine in Alaskan Native Children.|Completed||Phase 3|373|Actual|Pfizer||5|||f||||t||||||||||2017-02-18 13:59:02.282465|2017-02-18 13:59:02.282465
NCT00743639|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-08-28|||July 2005||2005-07-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|SDILCM||Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy|Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells for Dilated Cardiomyopathy: Randomized Clinical Trial|Completed||Phase 2/Phase 3|30|Actual|Instituto de Cardiologia do Rio Grande do Sul||1|||f||||t||||||||||2017-02-18 13:59:04.492157|2017-02-18 13:59:04.492157
NCT00743626|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-08-28|||December 2006||2006-12-01|August 2008|2008-08-01|January 2011|Anticipated|2011-01-01|December 2008|Anticipated|2008-12-01||Interventional|||Pap Smear Research Study|Evaluation of the Role of Human Papillomavirus Testing and p16 Expression in the Management of Patients Undergoing Cervical Cancer Screening|Unknown status|Recruiting|N/A|1712|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 13:59:04.603093|2017-02-18 13:59:04.603093
NCT00743613|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2008-09-02|||February 2005||2005-02-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Observational|PREPARED||Predicting Peripheral Arterial Disease in Men With Erectile Dysfunction|Predicting Peripheral Arterial Disease in Men With Erectile Dysfunction|Completed||N/A|175|Actual|Bruton Avenue Family Practice|||1||f||||f||||||||||2017-02-18 13:59:04.715169|2017-02-18 13:59:04.715169
NCT00743600|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2016-11-08|||September 2005||2005-09-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Ultrasound Evaluation of the Rotator Cable and Associated Structures.|Ultrasound Evaluation of the Rotator Cable and Associated Structures.|Completed||N/A|123|Actual|University of Michigan||2|||f||||f||||||||Yes||2017-02-18 13:59:04.825613|2017-02-18 13:59:04.825613
NCT00743587|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2010-03-10|||September 2008||2008-09-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb|A Randomized, Double-Blind, Placebo And Active Controlled Methodology Study Investigating The Effects Of Tramadol And Naproxen On The Pain Thresholds Of Patients With Severe Pain Due To Osteoarthritis Of The Thumb|Completed||Phase 1|36|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 13:59:04.937076|2017-02-18 13:59:04.937076
NCT00743574|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2013-06-20|2013-02-15||August 2008||2008-08-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||the number of participants for analysis was determined by the number who completed the study.|Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)|Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)|Completed||N/A|36|Actual|Yale University|No limitations|1|||f||||t||||||||||2017-02-18 13:59:05.051422|2017-02-18 13:59:05.051422
NCT00743561|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2012-04-27|||June 2008||2008-06-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA)|Study of the Performance of Ambulatory Nocturnal Polygraphy in the Diagnosis of Sleep Apnea in Multiple System Atrophy|Completed||N/A|30|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-02-18 13:59:05.382887|2017-02-18 13:59:05.382887
NCT00743548|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2010-11-12|||August 2008||2008-08-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Comparing the Inter-dental Brush to Dental Floss|Comparison of Inter-dental Brush to Dental Floss for Reduction of Plaque and Bleeding in Areas With Intact Papilla: A Clinical Trial|Completed||Phase 3|32|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 13:59:05.492337|2017-02-18 13:59:05.492337
NCT00743535|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2013-04-05|||February 2008||2008-02-01|April 2013|2013-04-01||||February 2013|Actual|2013-02-01||Interventional|||Anterior Defect Correction With Mesh Plus Treatment of Stress Incontinence With Transobturator or Transvaginal Approach|A Comparison in Terms of Efficacy and Safety Between Transobturator and Transvaginal Tape Performed at the Same Time of Anterior Defect Correction With Mesh|Terminated||Phase 4|15|Actual|University Magna Graecia||2||Low recruitment rate.|f||||||||||||||2017-02-18 13:59:05.592405|2017-02-18 13:59:05.592405
NCT00743522|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-28|2015-06-04|||September 2008||2008-09-01|June 2015|2015-06-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|PROVIDE||Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication|Programming Implantable Cardioverter Defibrillators (ICDs) in Patients With Primary Prevention Indication to Prolong Time to First Shock|Completed||Phase 4|1670|Actual|St. Jude Medical|||2||f||||t||||||||||2017-02-18 13:59:05.698991|2017-02-18 13:59:05.698991
NCT00743509|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2015-08-31|2013-04-04||August 2008||2008-08-01|August 2015|2015-08-01|September 2012|Actual|2012-09-01|April 2010|Actual|2010-04-01||Interventional|OCR||A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma|A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma|Completed||Phase 2|49|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-02-18 13:59:05.799004|2017-02-18 13:59:05.799004
NCT00743496|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2016-08-17|||August 2008||2008-08-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma|A Phase I Trial Of The Humanized Anti-GD2 Antibody (HU14.18K322A) In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma|Active, not recruiting||Phase 1|50|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 13:59:06.303356|2017-02-18 13:59:06.303356
NCT00743483|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2014-11-17|2014-11-05||August 2008||2008-08-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency|An Open Label, Exploratory Study on the Effect of rhBSSL on the Fat Absorption in Patients With Cystic Fibrosis and Pancreatic Insufficiency|Completed||Phase 2|15|Actual|Swedish Orphan Biovitrum||1|||f||||f||||||||||2017-02-18 13:59:06.413504|2017-02-18 13:59:06.413504
NCT00743470|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2010-10-29|||August 2008||2008-08-01|September 2010|2010-09-01||||October 2008|Actual|2008-10-01||Interventional|||A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects|A Comparison of the Bioavailability of Rifabutin With and Without Lopinavir/Ritonavir in Healthy Adult Subjects|Terminated||Phase 1|15|Actual|Abbott||2|||f||||||||||||||2017-02-18 13:59:06.68063|2017-02-18 13:59:06.68063
NCT00743457|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2012-10-12|||August 2008||2008-08-01|October 2012|2012-10-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Observational|||Study of Ultrasound of the Eye for Children With Suspected Shunt Failure|Pediatric Ocular Ultrasound for VPS Failure|Completed||N/A|36|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-02-18 13:59:06.781996|2017-02-18 13:59:06.781996
NCT00743444|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-07-17|2011-03-16||February 2007||2007-02-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||TLESR-impedance Study in Patients|A Double-blind, Placebo Controlled, Randomized, Two Centre Phase IIA Pharmacodynamic Cross-over Study to Assess the Effect of AZD3355, 65 mg Bid, on Transient Lower Esophageal Sphincter Relaxations (TLESRs) in GERD Patients With an Incomplete Response to PPI Treatment|Completed||Phase 2|27|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 13:59:06.886331|2017-02-18 13:59:06.886331
NCT00743431|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2015-03-26|2010-05-21||February 2005||2005-02-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)|Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (PPE).|Completed||N/A|224|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:59:07.145791|2017-02-18 13:59:07.145791
NCT00743418|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2008-08-27|||June 2007||2007-06-01|August 2008|2008-08-01||||December 2012|Anticipated|2012-12-01||Interventional|SenTra||Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease|The Use of Advanced Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease and Related Cognitive Disorders|Unknown status|Recruiting|Phase 1/Phase 2|300|Anticipated|Tel-Aviv Sourasky Medical Center||3|||f||||||||||||||2017-02-18 13:59:07.37074|2017-02-18 13:59:07.37074
NCT00743405|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2009-05-29|||May 2008||2008-05-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects|Single-Blind, Randomised, Placebo Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects|Completed||Phase 1|30|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 13:59:07.47318|2017-02-18 13:59:07.47318
NCT00743392|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-11-15|||July 2008||2008-07-01|November 2013|2013-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||HPV Infections in Older Women|HPV Infections in Older Women|Completed||N/A|503|Actual|University of Washington|||1||f||||f||||||Samples With DNA|"~     Vaginal swab samples for HPV DNA testing~   "|||2017-02-18 13:59:07.568934|2017-02-18 13:59:07.568934
NCT00743379|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2015-05-05|||August 2008||2008-08-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors|A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors|Completed||Phase 1/Phase 2|71|Actual|Threshold Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:59:07.65698|2017-02-18 13:59:07.65698
NCT00743366|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-02-04|||August 2008||2008-08-01|February 2013|2013-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Quetiapine on Marijuana Withdrawal and Relapse|Effect of Quetiapine on Marijuana Withdrawal and Relapse|Completed||Phase 2|20|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 13:59:07.780291|2017-02-18 13:59:07.780291
NCT00743340|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-01-25|||November 2005||2005-11-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine|A Rollover Protocol to Provide Subjects Completing the FTC-203 Study in South Africa With Continued Access to Emtricitabine|Active, not recruiting||Phase 2|50|Actual|Gilead Sciences||1|||f||||f||||||||||2017-02-18 13:59:07.981249|2017-02-18 13:59:07.981249
NCT00743327|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2012-08-03|||October 2008||2008-10-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|ADT||Androgen Deprivation Therapy Study|Metabolic and Cardiovascular Complications in Men With Prostate Cancer Undergoing Long-term Androgen Deprivation Therapy|Terminated||N/A|1|Actual|National Institutes of Health Clinical Center (CC)|||3|No Participants completed study|f||||f||||||Samples Without DNA|"~     Serum, Muscle biopsy specimens~   "|||2017-02-18 13:59:08.079499|2017-02-18 13:59:08.079499
NCT00743314|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2016-10-12|||September 2008||2008-09-01|April 2016|2016-04-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer|Integration of SPECT/CT Lymphoscintigraphy Into Breast Cancer Radiation for LymphaticSparing|Completed||N/A|30|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 13:59:08.352345|2017-02-18 13:59:08.352345
NCT00743301|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2008-08-27|||August 2008||2008-08-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|February 2009|Anticipated|2009-02-01||Interventional|A305||The Effect of Palm Olein, Olive Oil and Lard and on Risk Markers of Cardiovascular Disease|Effects of Palm Olein Versus Olive Oil on Blood Lipids, Lipoproteins and Novel Risk Markers of Cardiovascular Disease|Unknown status|Recruiting|N/A|45|Anticipated|University of Copenhagen||3|||f||||f||||||||||2017-02-18 13:59:08.450218|2017-02-18 13:59:08.450218
NCT00743288|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2014-04-24|2014-01-21||July 2008||2008-07-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma|A Phase I/II Study of Oral Melphalan Combined With LBH589 for Patients With Relapsed or Refractory Multiple Myeloma (MM)|Completed||Phase 1/Phase 2|40|Actual|Oncotherapeutics||1|||f||||f||||||||||2017-02-18 13:59:08.545935|2017-02-18 13:59:08.545935
NCT00743275|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2016-04-12|2010-02-01||August 2008||2008-08-01|April 2016|2016-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination|Immunogenicity and Safety Among Adults of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (Intramuscular Route)|Completed||Phase 4|120|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 13:59:09.001635|2017-02-18 13:59:09.001635
NCT00743262|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-08-25|2010-08-02||April 2008||2008-04-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|August 2008|Actual|2008-08-01||Interventional|||Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis|Second Amendment on Phase I Trial NO7VEG 'Assessment of a Next Generation Indwelling Provox Voice Rehabilitation System (Vega)': Vega Siri Addendum.|Completed||Phase 1/Phase 2|15|Actual|Atos Medical AB|Provox ActiValve users have short device life with normal indwelling prostheses (and hence use the Provox ActiValve). Therefore, the device life measured in this patient group is very short and not representative of the normal Provox Vega user.|1|||f||||f||||||||||2017-02-18 13:59:09.657067|2017-02-18 13:59:09.657067
NCT00743249|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-04-03|2013-02-22||October 2008||2008-10-01|April 2013|2013-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional||This reporting group includes all randomized participants for whom stent insertion was successfully completed (57).|Punctal Plug Study to Determine the Safety and Retention Times of Various Lengths of Canalicular Stents in Volunteers|A Three-Month Safety Study to Determine the Retention Times of Side-Arm Canalicular Stents|Completed||N/A|60|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 13:59:09.881064|2017-02-18 13:59:09.881064
NCT00743236|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-06-04|||August 2008||2008-08-01|June 2013|2013-06-01||||June 2009|Actual|2009-06-01||Interventional|||Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer|A Phase III Multi-Institutional Randomized Clinical Trial: Effect of Type of Ischemia - Warm vs Cold During Partial Nephrectomy - on Renal Function|Completed||Phase 3|1|Actual|Wake Forest University Health Sciences||2|||f||||||||||||||2017-02-18 13:59:10.222447|2017-02-18 13:59:10.222447
NCT00743223|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2008-08-27|||October 2006||2006-10-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|||||Observational|||The Frequency Forward Head Posture in Subjects With Temporomandibular Disorder|The Frequency Forward Head Posture in Subjects With Temporomandibular Disorder|Completed||N/A|100|Actual|Federal University of Mato Grosso do Sul|||2||f||||f||||||||||2017-02-18 13:59:10.339774|2017-02-18 13:59:10.339774
NCT00743210|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2014-07-14|||January 2010||2010-01-01|July 2014|2014-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Oral L-Citrulline and ADMA in Pregnancy|Phase 1 Study of Oral L-citrulline on ADMA/L-arginine and Endothelial-dependent Vascular Function in Pregnancy.|Completed||Phase 1|41|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 13:59:10.447606|2017-02-18 13:59:10.447606
NCT00743197|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-11-30|2011-09-13||May 2008||2008-05-01|November 2011|2011-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Women With Chest Pain and Normal Coronary Arteries Study|Women With Chest Pain and Normal Coronary Arteries Study: A Randomized Study of Medical Treatment and Therapeutic Lifestyle Changes|Terminated||N/A|3|Actual|Northwestern University|Study terminated due to departure of PI; all work including analyses ceased upon departure.In addition,study end points were based on changes b/w groups treatment vs. usual care) at 12 mo follow up- none of the subjects completed the Mo 12 visit.|2||Terminated due to departure of PI from institution.|f||||f||||||||||2017-02-18 13:59:10.542218|2017-02-18 13:59:10.542218
NCT00743184|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-12-02|||September 2008||2008-09-01|August 2013|2013-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Trial of the Safety and Efficacy of Ozarelix in Patients With Benign Prostatic Hyperplasia (BPH)|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Ozarelix, in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)|Terminated||Phase 2|860|Anticipated|Spectrum Pharmaceuticals, Inc||3|||f||||f||||||||||2017-02-18 13:59:10.916479|2017-02-18 13:59:10.916479
NCT00743171|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2008-08-27|||January 2000||2000-01-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Long-Term Study On Home Spirometry After Lung Transplantation|Long-Term Study On Home Spirometry After Lung Transplantation|Completed||N/A|152|Actual|Hannover Medical School|||3||f||||f||||||||||2017-02-18 13:59:11.027838|2017-02-18 13:59:11.027838
NCT00742183|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-04-06|2010-06-03||August 2008||2008-08-01|October 2010|2010-10-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®|An Open, Parallel, Randomized, Comparative, Multi-centre Investigation in US Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene® in the Treatment of Partial Thickness Burns.|Completed||Phase 4|100|Actual|Molnlycke Health Care AB||2|||f||||f||||||||||2017-02-18 13:59:11.140074|2017-02-18 13:59:11.140074
NCT00742170|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-10-15|2014-10-15||August 2007||2007-08-01|October 2014|2014-10-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Transdermal Electroacupuncture for Opioid Detoxification|Transdermal Electroacupuncture for Opioid Detoxification|Completed||Phase 1/Phase 2|48|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 13:59:11.524369|2017-02-18 13:59:11.524369
NCT00742157|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-08-15|||March 2003||2003-03-01|August 2011|2011-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)|An Open-label Evaluation of the Long-term Efficacy and Safety of a Standardized Regimen of Growth Hormone, Glutamine and a Modified Diet in the Treatment of Patients With Short Bowel Syndrome|Terminated||Phase 4|30|Anticipated|University of Nebraska||1||Lack of Enrollment|f||||f||||||||||2017-02-18 13:59:12.005942|2017-02-18 13:59:12.005942
NCT00742144|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2012-05-31|||September 2008||2008-09-01|February 2011|2011-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia|An Open-label Phase I Study of Ofatumumab (GSK1841157) in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 13:59:12.103542|2017-02-18 13:59:12.103542
NCT00742131|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-11-30|||March 2005||2005-03-01|November 2016|2016-11-01|August 2011|Actual|2011-08-01|May 2008|Actual|2008-05-01||Interventional|||A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors|A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors|Completed||Phase 1|40|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:59:12.199966|2017-02-18 13:59:12.199966
NCT00742118|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2015-09-29|||February 2008||2008-02-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|February 2016|Anticipated|2016-02-01||Interventional|||Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable Bowel|Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the entérique Nervous System During the Syndrome of the Irritable Bowel|Recruiting||N/A|200|Anticipated|Centre Hospitalier Universitaire de Nice||3|||f||||f||||||||||2017-02-18 13:59:12.301332|2017-02-18 13:59:12.301332
NCT00742105|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-06-20|||November 2008||2008-11-01|June 2016|2016-06-01||||March 2010|Actual|2010-03-01||Interventional|||Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan|A Phase I Study of BGT226, Administered Orally in Adult Patients With Advanced Solid Tumor in Japan|Completed||Phase 1|21|Actual|Novartis||1|||f||||f||||||||||2017-02-18 13:59:12.412352|2017-02-18 13:59:12.412352
NCT00742092|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2014-03-05|||August 2008||2008-08-01|March 2014|2014-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Miglustat in Cystic Fibrosis|Single Center, Double-blind, Randomized, Placebo-controlled, Two-period/Two-treatment Crossover Study Investigating the Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation|Completed||Phase 2|11|Actual|Actelion||2|||f||||f||||||||||2017-02-18 13:59:12.502562|2017-02-18 13:59:12.502562
NCT00742079|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-09-03|2014-08-11||September 2006||2006-09-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia|Pilot Study of Pretreatment D-cycloserine for CBT-assessment of Paranoid Delusions in Schizophrenia|Completed||Phase 4|21|Actual|Massachusetts General Hospital|The cross-over design of this study produced results that are difficult to interpret due to a significant order effect. Larger and longer trials are needed to assess whether this treatment may benefit patients with medication resistant delusions.|2|||f||||f||||||||||2017-02-18 13:59:12.600851|2017-02-18 13:59:12.600851
NCT00742066|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-03-16|||March 2008||2008-03-01|March 2011|2011-03-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Role of AT1-receptor Blockers in Insulin-induced Vasodilation.|Insulin-induced Microvascular Activity in Patients With Essential Hypertension: a Possible Role for Angiotensin II AT1-receptor Blockers.|Unknown status|Active, not recruiting|N/A|32|Anticipated|Maastricht University Medical Center||3|||f||||f||||||||||2017-02-18 13:59:13.158324|2017-02-18 13:59:13.158324
NCT00742053|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-07-11|2012-04-25||June 2008||2008-06-01|July 2016|2016-07-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Electrocardiogram (ECG) Guided Peripherally Inserted Central Catheter (PICC) Placement|A Study of Electrocardiogram (ECG) Guidance for Placement of Peripherally Inserted Central Catheters (PICC)|Terminated||N/A|7|Actual|C. R. Bard|The study was terminated early due to poor enrollment.|1||Enrollment rate was too slow.|f||||f||||||||No||2017-02-18 13:59:13.26547|2017-02-18 13:59:13.26547
NCT00742040|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2008-08-26|||August 2008||2008-08-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Rapid Versus Prolonged Inpatient Up-Titration of Captopril|Rapid Versus Prolonged Inpatient Up-Titration of Captopril: A Randomized Clinical Trial|Unknown status|Recruiting|Phase 2|50|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 13:59:13.49005|2017-02-18 13:59:13.49005
NCT00742027|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-01-16|||September 2008||2008-09-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Phase II Study of Oral Panobinostat in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma|A Phase II Study of Oral Panobinostat in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma After High-dose Chemotherapy With Autologous Stem Cell.|Completed||Phase 2|129|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:59:13.593538|2017-02-18 13:59:13.593538
NCT00742014|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2013-12-13|||August 2008||2008-08-01|December 2013|2013-12-01||||June 2014|Anticipated|2014-06-01||Interventional|||The Assessment of Right Ventricular Contractility in Response to Sildenafil|The Assessment of Right Ventricular Contractility in Response to Sildenafil in Pediatric Patients With Pulmonary Arterial Hypertension|Suspended||Phase 3|10|Anticipated|The Hospital for Sick Children||1||absorption of oral sildenafil not consistent|f||||f||||||||||2017-02-18 13:59:13.752069|2017-02-18 13:59:13.752069
NCT00742001|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-03-15|||September 2008||2008-09-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|IMPROVE||Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival|IMPROVE: Inactivation of Whole Blood With Mirasol (R): Performance in Red Blood Cells, Platelets and Plasma Investigation|Terminated||Phase 1|12|Actual|Terumo BCTbio||3||"An endpoint difference between 3 energies was not observed. Correlations between recovery and~   ATP were established, and will be used for a Whole Blood system."|f||||f||||||||||2017-02-18 13:59:14.010691|2017-02-18 13:59:14.010691
NCT00741988|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2013-03-29|2013-01-23||September 2008||2008-09-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2010|Actual|2010-09-01||Interventional|||Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer|Phase II Trial of Ixabepilone and Carboplatin With or Without Bevacizumab in Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer|Completed||Phase 2|82|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 13:59:14.123792|2017-02-18 13:59:14.123792
NCT00741975|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2012-04-12|||April 2007||2007-04-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|Project TRAC||Affect Management Intervention for Early Adolescents Wtih Mental Health Problems|Affect Management Intervention for Early Adolescents With Mental Health Problems|Completed||Phase 1|138|Actual|Rhode Island Hospital||2|||f||||f||||||||||2017-02-18 13:59:14.633313|2017-02-18 13:59:14.633313
NCT00741962|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2009-05-11|||August 2008||2008-08-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study on the Effects of VR-3 Herbal Blend Intake on Acute and Chronic Stress in Healthy Adults|A Pilot Double-Blind Crossover Study on the Effects of VR-3 Herbal Blend Intake on Acute and Chronic Stress and Their Biomarkers in Healthy Adults|Completed||N/A|20|Anticipated|NEMA Research, Inc.||2|||f||||||||||||||2017-02-18 13:59:14.734433|2017-02-18 13:59:14.734433
NCT00741949|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2011-08-25|||September 2008||2008-09-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|SEDA-FIBRO||Broncho-alveolar Lavage Under Noninvasive Ventilation With Propofol TCI in Patient With AHRF|Fiberoptic Bronchoscopy With Broncho-alveolar Lavage Under Noninvasive Ventilation With Propofol Target Controled Infusion in Patient With Acute Hypoxemic Respiratory Failure. A Randomized Controlled Study : SEDA-FIBRO.|Completed||Phase 3|46|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 13:59:14.823011|2017-02-18 13:59:14.823011
NCT00741936|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-05-23|2011-08-02||July 2008||2008-07-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||An Effectiveness and Safety Study of Chinese Herbal Medicine for Functional Constipation|Chinese Herbal Medicine for Functional Constipation: A Randomized, Double-blind, Placebo Controlled Trial|Completed||Phase 2|120|Actual|Hong Kong Baptist University||2|||f||||t||||||||||2017-02-18 13:59:14.939689|2017-02-18 13:59:14.939689
NCT00743158|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2009-08-19|||August 2008||2008-08-01|August 2009|2009-08-01||||||||Observational|Ztr||Transfer Impedance in Cystic Fibrosis|Transfer Impedance in Cystic Fibrosis (Ztr)|Unknown status|Recruiting|N/A|40|Anticipated|Boston Children’s Hospital|||1||f||||||||||||||2017-02-18 13:59:15.680728|2017-02-18 13:59:15.680728
NCT00743145|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-10-25|||May 2008||2008-05-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana|Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana|Completed||Phase 2|49|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 13:59:15.750678|2017-02-18 13:59:15.750678
NCT00743132|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2010-01-22|||April 2008||2008-04-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Observational|StV 11-2008||Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection|Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection|Completed||N/A|569|Actual|University of Zurich|||2||f||||f||||||||||2017-02-18 13:59:15.85663|2017-02-18 13:59:15.85663
NCT00743119|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-02-04|||June 2008||2008-06-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|October 2009|Actual|2009-10-01||Interventional|||Characterization of the Analgesic Effects of Oral THC and Smoked Marijuana in Non-treatment Seeking Marijuana Smokers|Characterization of the Analgesic Effects of Oral THC and Smoked Marijuana in Non-treatment Seeking Marijuana Smokers|Completed||Phase 2|26|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 13:59:15.948434|2017-02-18 13:59:15.948434
NCT00743106|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-09-13|2016-06-20||September 2002||2002-09-01|September 2016|2016-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery|The Effect of Fenoldopam on Renal Function in Solitary Partial Nephrectomy Surgery|Terminated||N/A|90|Actual|The Cleveland Clinic||2||Executive committee determined to close study after interim analysis.|f||||f||||||||||2017-02-18 13:59:16.05912|2017-02-18 13:59:16.05912
NCT00743093|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-09-06|2013-03-18||August 2008||2008-08-01|September 2013|2013-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||Baseline characteristics were collected on all subjects at screening and included: race, ethnicity, gender, age, weight, and height. The number of participants included in the analysis (276) is based on the safety population, which includes any subject that took at least one dose of study medication.|Aminotransferase Trends During Prolonged Acetaminophen Dosing|Aminotransferase Trends During Prolonged Therapeutic Acetaminophen Dosing|Completed||Phase 4|398|Actual|Denver Health and Hospital Authority|This study was limited to healthy volunteers. The ingestion of each dose of study drug and use of other medications was self-reported.|2|||f||||t||||||||||2017-02-18 13:59:16.4434|2017-02-18 13:59:16.4434
NCT00743080|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2010-11-02|||January 2008||2008-01-01|August 2008|2008-08-01|January 2010||2010-01-01|||||Interventional|||Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators|GYNAECARE MORCELLEX Tissue Morcellator vs. ROTOCUT GI Tissue Morcellator: a Randomized Controlled Study|Completed||Phase 4|||University Magna Graecia||2|||f||||||||||||||2017-02-18 13:59:16.849827|2017-02-18 13:59:16.849827
NCT00743067|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-10-14|||August 2006||2006-08-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors|A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors|Completed||Phase 1|37|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:59:16.946675|2017-02-18 13:59:16.946675
NCT00743054|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2015-05-19|||July 2008||2008-07-01|May 2015|2015-05-01|August 2011|Actual|2011-08-01|August 2009|Actual|2009-08-01||Observational|||microRNA Expression in Renal Cell Carcinoma|microRNA Expression in Renal Cell Carcinoma|Completed||N/A|50|Actual|Sun Yat-sen University|||1||f||||t||||||Samples With DNA|"~     The tumor tissues and tumor adjacent tissues will be collected when patients receive renal~     cell carcinoma resection.~      The blood and urine will be collected before patients receive operation. And the blood and~     urine of some healthy volunteers will be collected as the control group.~   "|||2017-02-18 13:59:17.030641|2017-02-18 13:59:17.030641
NCT00743041|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2010-05-28|||December 2008||2008-12-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||The Effect of EFT on Psychological States in a Veterans Population|The Effect of EFT (Emotional Freedom Techniques) on Psychological States in a Veterans Population: A Randomized Controlled Trial|Completed||Early Phase 1|100|Anticipated|Soul Medicine Institute||2|||f||||f||||||||||2017-02-18 13:59:17.121508|2017-02-18 13:59:17.121508
NCT00743028|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2010-10-06|||August 2008||2008-08-01|September 2010|2010-09-01||||August 2010|Actual|2010-08-01||Interventional|||Assess the Oral Bioavailability of New ABT-263 Formulations|A Single Dose Study Evaluating the Oral Bioavailability and Pharmacokinetics of the Capsule Formulation of ABT-263 in Subjects With Cancer|Completed||Phase 1|36|Actual|Abbott||6|||f||||||||||||||2017-02-18 13:59:17.233372|2017-02-18 13:59:17.233372
NCT00743015|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-10-31|||September 2008||2008-09-01|October 2013|2013-10-01||||March 2009|Actual|2009-03-01||Interventional|||Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks|Relative Bioavailability Following Single Oral Administration of 200 mg of BI 44370 During and Between Migraine Attacks in Male and Female Migraine Patients. An Open-label, Fixed-sequence, Two-period Study With Intraindividual Comparison|Completed||Phase 1|19|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 13:59:17.344164|2017-02-18 13:59:17.344164
NCT00743002|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-06-13||2013-06-04|August 2008||2008-08-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione|A Multi-center, Double-blind, Randomized, Placebo-controlled Study of TT223 in Patients With Type 2 Diabetes Treated With Metformin and/or TZD|Completed||Phase 2|87|Actual|Transition Therapeutics||2|||f||||f||||||||||2017-02-18 13:59:17.429618|2017-02-18 13:59:17.429618
NCT00742989|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2008-08-27|||May 2005||2005-05-01|August 2008|2008-08-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||Effect of Osteopathic Lymphatic Treatment on Plasma Volume, Protein Concentration and Albumin Concentration.|The Short-Term Effect of Osteopathic Lymphatic Treatment on Blood Cell Count, Plasma Protein, and Blood Pressure: A Pilot Study in a Cross-Over Design|Completed||N/A|15|Actual|Kansas City University of Medicine and Biosciences||2|||f||||f||||||||||2017-02-18 13:59:17.650482|2017-02-18 13:59:17.650482
NCT00742976|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2010-01-19|||June 2008||2008-06-01|June 2008|2008-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|Le-Na||Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients|Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention and Weight in Type 2 Diabetic Patients|Completed||Phase 4|24|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 13:59:17.757015|2017-02-18 13:59:17.757015
NCT00742963|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2015-03-27|||August 2008||2008-08-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma|A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma|Completed||Phase 1/Phase 2|102|Actual|Threshold Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:59:17.861003|2017-02-18 13:59:17.861003
NCT00742950|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-06-24|||August 2008||2008-08-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|CINPHA||Refractive Change Induced by 2.8-mm Corneal Incision|Study of Refractive Change Induced by 2.8-mm Corneal Incisions for Cataract Surgery|Completed||N/A|108|Anticipated|Hospital Universitario Ramon y Cajal||3|||f||||t||||||||||2017-02-18 13:59:17.973146|2017-02-18 13:59:17.973146
NCT00742937|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2009-07-28|||July 2007||2007-07-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Impact of Maternal Supplementation With Dual Megadose of Vitamin A|Impact of Supplementation With Dual Megadose of Vitamin A in the Post-partum About Vitamin A Levels in Breast Milk, Serum Levels of Vitamin A and Iron in the Binomial Mother-son and Growth and Morbidity of Children Under 6 Months|Completed||Phase 2/Phase 3|239|Actual|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||t||||||||||2017-02-18 13:59:18.075042|2017-02-18 13:59:18.075042
NCT00742924|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2014-06-04|2014-06-04||August 2008||2008-08-01|June 2014|2014-06-01||||April 2012|Actual|2012-04-01||Interventional|||Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma|Feasibility and Dose Discovery Analysis of Zoledronic Acid With Concurrent Chemotherapy in the Treatment of Newly Diagnosed Metastatic Osteosarcoma|Completed||Phase 1|24|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 13:59:18.190003|2017-02-18 13:59:18.190003
NCT00742911|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2014-10-29|||July 2008||2008-07-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver|Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver|Completed||Phase 1|21|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 13:59:19.360449|2017-02-18 13:59:19.360449
NCT00742898|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2009-09-14|||April 2007||2007-04-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Evaluation of Opt-Out Rapid HIV Testing in the Emergency Department|Non-targeted Opt-out Rapid HIV Screening in the Emergency Department: a Controlled Clinical Trial|Completed||N/A|120000|Anticipated|Denver Health and Hospital Authority||2|||f||||f||||||||||2017-02-18 13:59:19.473755|2017-02-18 13:59:19.473755
NCT00742885|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2016-10-11|2013-12-20||September 2008||2008-09-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine|Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine GSK 1557484A.|Completed||Phase 2|100|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:59:19.598071|2017-02-18 13:59:19.598071
NCT00742872|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-02-27|2013-02-27||September 2008||2008-09-01|February 2013|2013-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome|A Prospective Double-Blind Placebo-Controlled Trial of Mosapride in Patients With Constipation-Predominant Irritable Bowel Syndrome|Terminated||Phase 3|41|Actual|American University of Beirut Medical Center|High placebo response rate, high dropout rate.|2||Poor recruitment, high drop out rate|f||||f||||||||||2017-02-18 13:59:20.727787|2017-02-18 13:59:20.727787
NCT00742859|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-11-30||2016-11-30|October 2008||2008-10-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|EXPLORE-Xa||Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin|A PHASE 2, RANDOMIZED, PARALLEL GROUP, DOSE FINDING, MULTICENTER, MULTINATIONAL STUDY OF THE SAFETY, TOLERABILITY AND PILOT EFFICACY OF THREE BLINDED DOSES OF THE ORAL FACTOR Xa INHIBITOR BETRIXABAN COMPARED WITH OPEN LABEL DOSE-ADJUSTED WARFARIN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (EXPLORE Xa)|Completed||Phase 2|508|Actual|Portola Pharmaceuticals||4|||f||||t||||||||||2017-02-18 13:59:21.035111|2017-02-18 13:59:21.035111
NCT00742846|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2015-02-25|||August 2008||2008-08-01|February 2015|2015-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effects of Intra-articular Versus Subacromial Steroid Injections on Clinical Outcomes in Adhesive Capsulitis|Effects of Intra-articular Versus Subacromial Steroid Injections on Clinical Outcomes in Adhesive Capsulitis|Withdrawn||N/A|0|Actual|Milton S. Hershey Medical Center||4||No enrollment|f||||f||||||||||2017-02-18 13:59:21.270121|2017-02-18 13:59:21.270121
NCT00742833|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2009-09-02||||||September 2009|2009-09-01||||||||Interventional|||A Phase II Study of KUC-7483 in Patients With Overactive Bladder|A Randomized, Double Blind, Placebo Controlled, Phase II Study of KUC-7483 in Patients With Overactive Bladder|Completed||Phase 2|400|Anticipated|Kissei Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 13:59:21.395607|2017-02-18 13:59:21.395607
NCT00742820|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2009-02-06|||August 2008||2008-08-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers|Randomized, Controlled, 3-Arm, Open Label, Cross-Over Bioequivalence Study Comparing Liquid PhosLo vs. PhosLo Gelcaps Using Calcium Citrate as a Positive Control in Healthy Volunteers|Completed||Phase 1|46|Actual|Fresenius Medical Care North America||3|||f||||f||||||||||2017-02-18 13:59:21.497887|2017-02-18 13:59:21.497887
NCT00742807|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2014-12-04|||August 2008||2008-08-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Pain Evaluation During Follicle Aspiration: Comparison of Two Sedation Protocols|Pain Evaluation During Follicle Aspiration: Comparison of Two Sedation Protocols|Unknown status|Recruiting|Phase 4|300|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 13:59:21.614683|2017-02-18 13:59:21.614683
NCT00742794|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2010-08-18|||August 2008||2008-08-01|September 2008|2008-09-01|August 2010|Actual|2010-08-01|||||Observational|ZU-HVA-001||Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)|Frequency of Hymenoptera-stings in Patients Under and After Allergen-specific Immunotherapy: a Retrospective Data-analysis Considering Socio-economic Aspects|Completed||Phase 4|200|Anticipated|University of Zurich|||1||f||||t||||||||||2017-02-18 13:59:21.71896|2017-02-18 13:59:21.71896
NCT00742781|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-07-08|2013-01-23||May 2009||2009-05-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|CTSA||Vitamin D Supplementation in Crohn's Patients|"Vitamin D and Crohn's Disease From the Bench to the Clinic"|Completed||Phase 1|21|Actual|Penn State University|The main limitation of the study was the lack of placebo control and the small size of the study.|1|||f||||f||||||||||2017-02-18 13:59:21.803851|2017-02-18 13:59:21.803851
NCT00742768|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2009-03-09|||June 2008||2008-06-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Absorption of Vitamin K2|Comparison of Absorption of Vitamin K2 Human Study Gelpell|Completed||N/A|16|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:59:22.27779|2017-02-18 13:59:22.27779
NCT00742755|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2016-08-17|||September 2003||2003-09-01|February 2016|2016-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Increasing Adherence to Follow-up of Breast Abnormalities in Low-Income Korean American Women|Increasing Adherence to Follow-up of Breast Abnormalities in Low-Income Korean American Women|Completed||N/A|160|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 13:59:22.376267|2017-02-18 13:59:22.376267
NCT00742742|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2015-02-04|||March 2009||2009-03-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|WIMS||Walnut Intervention on Metabolic Syndrome (WIMS)|The Effects of Walnut Supplement on Cardio-Metabolic Risk Factors in Patients With Metabolic Syndrome|Completed||Phase 2/Phase 3|189|Actual|Chinese Academy of Sciences||2|||f||||f||||||||||2017-02-18 13:59:22.481942|2017-02-18 13:59:22.481942
NCT00742729|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2016-07-28|||September 2004||2004-09-01|November 2010|2010-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Increasing Colorectal Cancer Screening Among Filipino Americans|Increasing Colorectal Cancer Screening Among Filipino Americans|Completed||N/A|906|Actual|Jonsson Comprehensive Cancer Center||3|||f||||f||||||||||2017-02-18 13:59:22.589904|2017-02-18 13:59:22.589904
NCT00742716|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2014-10-30||2014-10-30|October 2008||2008-10-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease|An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis|Completed||Phase 2|41|Actual|OPKO Health, Inc.||4|||f||||f||||||||||2017-02-18 13:59:22.696228|2017-02-18 13:59:22.696228
NCT00742703|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2009-03-06|||August 2008||2008-08-01|March 2009|2009-03-01||||||||Interventional|||Study of the Effects of a Mineralized Water Ingestion Upon Lipidic Absorption Mechanisms|Study of the Effects of a Mineralized Water Ingestion Upon Lipidic Absorption Mechanisms|Completed||N/A|12|Anticipated|Multimed||2|||f||||f||||||||||2017-02-18 13:59:22.804916|2017-02-18 13:59:22.804916
NCT00742690|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2014-10-11|||May 2005||2005-05-01|October 2014|2014-10-01|March 2015|Anticipated|2015-03-01|December 2014|Anticipated|2014-12-01||Interventional|||Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome|Terlipressin Given As I.V. Boluses Vs Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome (Hrs): Preliminary Results Of A Randomized Controlled Clinical Study.|Unknown status|Recruiting|Phase 2/Phase 3|70|Anticipated|University of Padova||2|||f||||f||||||||||2017-02-18 13:59:22.897285|2017-02-18 13:59:22.897285
NCT00742677|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2013-09-19|||January 2007||2007-01-01|July 2009|2009-07-01||||March 2008|Anticipated|2008-03-01||Interventional|||Feeding Schedules After Surgery in Patients With Gynecologic Cancer|Early Oral Feeding After a Gynaecologic Oncologic Laparotomy: A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|180|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 13:59:23.007848|2017-02-18 13:59:23.007848
NCT00742664|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-08-04|||September 2008||2008-09-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project|Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project|Completed||Phase 1/Phase 2|24|Anticipated|University of South Florida||2|||f||||f||||||||||2017-02-18 13:59:23.118816|2017-02-18 13:59:23.118816
NCT00742638|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2008-08-26|||March 2008||2008-03-01|August 2008|2008-08-01|August 2010|Anticipated|2010-08-01|May 2010|Anticipated|2010-05-01||Interventional|||To Evaluate the Efficiency and Safety of Quetiapine Fumarate in the Treatment of Acute Manic Patients With Bipolar Disorder.|An Open Label, Randomised, Valproate-Controlled Study to Evaluate the Efficiency and Safety of Quetiapine Fumarate in the Treatment of Acute Manic Patients With Bipolar Disorder.|Unknown status|Recruiting|N/A|70|Anticipated|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-02-18 13:59:23.229139|2017-02-18 13:59:23.229139
NCT00742625|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-27|2014-09-04|2013-01-02||September 2008||2008-09-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|July 2010|Actual|2010-07-01||Interventional|||Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|Dose Escalation and Phase II Study of Bortezomib (IND #58443) Added to Standard Daunorubicin and Cytarabine Therapy for Patients With Previously Untreated Acute Myeloid Leukemia Age 60-75 Years|Completed||Phase 1/Phase 2|95|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:59:25.768339|2017-02-18 13:59:25.768339
NCT00742612|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-02-09|||February 2009||2009-02-01|July 2009|2009-07-01|April 2010|Anticipated|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy|A Study of the Effect of ARC1779 Injection on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy|Terminated||Phase 2|100|Anticipated|Archemix Corp.||2||Enrollment slower than expected|f||||t||||||||||2017-02-18 13:59:26.614887|2017-02-18 13:59:26.614887
NCT00742599|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-11-08|||September 2008||2008-09-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy|Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy (Randomized, Double-blind, Parallel-assignment , Placebo-controlled Study)|Completed||Phase 3|80|Anticipated|Nihon Pharmaceutical Co., Ltd||2|||f||||t||||||||||2017-02-18 13:59:26.741679|2017-02-18 13:59:26.741679
NCT00742586|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-10-14|||July 2008||2008-07-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Autonomic Failure Patients for RNA Blood Sampling|Identification of Autonomic Failure Patients, Controls and Blood Sampling for Pilot Study|Completed||N/A|30|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 13:59:26.835412|2017-02-18 13:59:26.835412
NCT00742573|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-12-08|||August 2008||2008-08-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics|Improving the Effectiveness of Treatment for Depression in Hispanics|Unknown status|Active, not recruiting|Phase 2|170|Anticipated|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 13:59:26.923228|2017-02-18 13:59:26.923228
NCT00742560|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-10-24|||August 2008||2008-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|December 2013|Actual|2013-12-01||Interventional|||A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma|A Phase 1b/2, Multicenter, Open-label, Dose-escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed Multiple Myeloma|Completed||Phase 2|101|Actual|AbbVie||3|||f||||t||||||||||2017-02-18 13:59:27.055421|2017-02-18 13:59:27.055421
NCT00742547|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-12-10|||October 2008||2008-10-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|DIANA||Type 2 Diabetes Mellitus: New Approaches to Optimize Medical Care in General Practice|DIANA - Diabetes Mellitus: Neue Wege Der Optimierung Der allgemeinärztlichen Betreuung|Completed||N/A|204|Actual|German Cancer Research Center||2|||f||||f||||||||||2017-02-18 13:59:27.186094|2017-02-18 13:59:27.186094
NCT00742534|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2011-12-27|||August 2008||2008-08-01|December 2011|2011-12-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants|Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants|Withdrawn||Phase 1|0|Actual|Vanderbilt University||1||Study never began|f||||t||||||||||2017-02-18 13:59:27.310979|2017-02-18 13:59:27.310979
NCT00742521|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2015-06-09|||March 2001||2001-03-01|June 2015|2015-06-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q.3|Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Question 3|Completed||N/A|22|Actual|Vanderbilt University||4|||f||||f||||||||||2017-02-18 13:59:27.404699|2017-02-18 13:59:27.404699
NCT00742508|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-10-11|2010-05-17||August 2008||2008-08-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure|A Study to Evaluate the Safety and Tolerability of SK&F-105517-D in Patients With Chronic Heart Failure- An Open-label Study to Evaluate the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SK&F-105517-D in Patients With Chronic Heart Failure (Phase I/II Study)|Completed||Phase 1|41|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:59:27.535799|2017-02-18 13:59:27.535799
NCT00742495|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2012-10-23|||March 2009||2009-03-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|BCX1777-108||Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.|A Phase I/II Pharmacokinetic Study of Intravenous and Oral Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non-Hodgkin's Lymphoma.|Terminated||Phase 1/Phase 2|2|Actual|Mundipharma Research Limited||1||Slow Recruitment|f||||t||||||||||2017-02-18 13:59:29.017856|2017-02-18 13:59:29.017856
NCT00742482|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2009-02-16|||January 2003||2003-01-01|February 2009|2009-02-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy|A Phase III Study With Freeze Dried HL10, Three Dosages of 200 mg/kg Ideal Body Weight Versus Standard Therapy in ALI/ARDS Patients|Terminated||Phase 3|418|Actual|LEO Pharma||||"A 300 patient safety analysis by the Data Monitoring Committee showed a trend towards higher~   mortality in the treatment group."|f||||t||||||||||2017-02-18 13:59:29.120209|2017-02-18 13:59:29.120209
NCT00742469|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-24|2009-12-21|||June 2005||2005-06-01|December 2009|2009-12-01|April 2007|Actual|2007-04-01|September 2005|Actual|2005-09-01||Interventional|||Rifaximin for Prevention of Travellers' Diarrhea|A Randomized,Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Rifaximin for the Prevention of Travellers' Diarrhea|Completed||Phase 3|210|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 13:59:29.230708|2017-02-18 13:59:29.230708
NCT00742456|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-02-22|||January 2009||2009-01-01|February 2011|2011-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Microvascular Dilatation After Endogenous Induced Hyperinsulinemia|Insulin-induced Microvascular Dilatation During a Physiological Stimulus - Studies in Hypertension and Obesity.|Completed||N/A|48|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:59:29.326285|2017-02-18 13:59:29.326285
NCT00742443|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-03-02|||December 2008||2008-12-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|Revise||Juvista in Scar Revision Surgery of Disfiguring Scars|A Double Blind, Within Patient, Placebo Controlled Trial to Assess the Efficacy of Juvista (Avotermin) in Conjunction With Scar Revision Surgery for the Improvement of Disfiguring Scars.|Completed||Phase 3|350|Anticipated|Renovo||3|||f||||f||||||||||2017-02-18 13:59:29.434487|2017-02-18 13:59:29.434487
NCT00742430|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2012-02-11|||February 2009||2009-02-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|||||Observational|||Resistance on Antithrombotic Drugs in Ischemic Heart Disease|Assessment of Aspirin and Clopidogrel Resistance in Ischemic Heart Disease Using Multiplate Function Analyser and it's Correlation With Major Adverse Cardiac Events|Completed||N/A|141|Actual|University of Zagreb|||2||f||||f||||||||||2017-02-18 13:59:29.794558|2017-02-18 13:59:29.794558
NCT00742417|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-05-05|2015-12-03||July 2007||2007-07-01|May 2016|2016-05-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional||The baseline analysis population included all randomized subjects who received at least one plasma exchange session or one sham procedure.|Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid|Phase II Study to Evaluate the Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid, and Its Effects in Patients With Mild-moderate Alzheimer's Disease.|Completed||Phase 2|42|Actual|Grifols Biologicals Inc.||2|||f||||f||||||||||2017-02-18 13:59:29.920677|2017-02-18 13:59:29.920677
NCT00742404|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-12-17|||July 2008||2008-07-01|June 2010|2010-06-01||||July 2010|Anticipated|2010-07-01||Interventional|||Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma|A Phase II Study of Pegylated Liposomal Doxorubicin, Bortezomib and Dexamethasone (DVD) for Patients With Newly Diagnosed Multiple Myeloma (MM)|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 13:59:30.686277|2017-02-18 13:59:30.686277
NCT00742391|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2015-02-18|2012-02-21||September 2008||2008-09-01|March 2012|2012-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations|A Multi-center, Randomized, Parallel Group, Double-blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, 0.05% In Patients With Actinic Keratoses ON Non-head Locations (REGION-I)|Completed||Phase 3|255|Actual|Peplin||2|||f||||f||||||||||2017-02-18 13:59:30.808939|2017-02-18 13:59:30.808939
NCT00742378|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2008-09-22|||September 2008||2008-09-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|October 2008|Anticipated|2008-10-01||Observational|||Discriminating Ability of the Cirrus High Definition (HD) Optical Coherence Tomography (OCT) for Glaucoma|Discriminating Ability of the Cirrus HD OCT for Glaucoma|Unknown status|Recruiting|N/A|200|Anticipated|Yonsei University|||2||f||||t||||||||||2017-02-18 13:59:31.198125|2017-02-18 13:59:31.198125
NCT00742365|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2015-04-09|||November 2007||2007-11-01|January 2011|2011-01-01|September 2015|Anticipated|2015-09-01|April 2010|Actual|2010-04-01||Observational|||Predicting Effectiveness of Light Treatment for Winter Seasonal Affective Disorder|Predicting Light Treatment's Effectiveness on Reducing Depression and Cardiovascular Risk in Seasonal Affective Disorder|Unknown status|Active, not recruiting|N/A|80|Anticipated|University of Maryland|||2||f||||t||||||||||2017-02-18 13:59:31.298857|2017-02-18 13:59:31.298857
NCT00742352|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2008-09-08|||September 2008||2008-09-01|August 2008|2008-08-01||||||||Observational|||PET FDG Assessment of Change in Atherosclerotic Plaques After Chemotherapy||Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||t||||||||||2017-02-18 13:59:31.409967|2017-02-18 13:59:31.409967
NCT00742339|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2014-10-11|||May 2005||2005-05-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome|Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome (HRS): An Open Multicentric Randomized Study|Terminated||Phase 2/Phase 3|49|Actual|University of Padova||2||"Decision of independent monitoring committee: Risk of non-response to treatment significantly~   higher in midodrine group than in terlipressin group."|f||||f||||||||||2017-02-18 13:59:31.481307|2017-02-18 13:59:31.481307
NCT00742326|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-10-26|2014-04-10||August 2008||2008-08-01|October 2016|2016-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections|Pioglitazone for Hepatic Steatosis in HIV/HCV Co-infection|Terminated||Phase 4|13|Actual|National Institutes of Health Clinical Center (CC)|The study failed to enroll to the originally established sample size due to slow enrollment.|2||Enrollment stopped prior to complete enrollment due to slow accrual|f||||t||||||||No|Decision will be made at the time of request|2017-02-18 13:59:31.590892|2017-02-18 13:59:31.590892
NCT00742313|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-02-17|2013-11-08||June 2009||2009-06-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effect on Bleeding When Using FloSeal Matrix™ in Subjects Undergoing Endoscopic Vein Harvest (EVH)|Effect on Bleeding When Using FloSeal Matrix™ in Subjects Undergoing Endoscopic Vein Harvest (EVH)|Terminated||Phase 4|50|Actual|Duke University|This study was terminated early|2||No statistical differences on study endpoints between groups.|f||||f||||||||||2017-02-18 13:59:32.123473|2017-02-18 13:59:32.123473
NCT00742300|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2008-11-21|||January 1998||1998-01-01|November 2008|2008-11-01||||||||Interventional|ASTRAD||Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases|Phase I/II Open-Label Monocentric Clinical Trial for Induction of Tolerance With CD34-Enriched Autologous Hematopoietic Stem Cell Transplantation After High-Dose Chemotherapy With Cyclophosphamide and Rabbit-Antithymocyte Globulin for Refractory Autoimmune Diseases|Unknown status|Active, not recruiting|Phase 1/Phase 2|||Charite University, Berlin, Germany||1|||f||||f||||||||||2017-02-18 13:59:32.428113|2017-02-18 13:59:32.428113
NCT00742287|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2011-10-28|||February 2009||2009-02-01|October 2011|2011-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|INC001||Cardiovascular Effects of Oligomeric Procyanidins (OPCs) in Smokers|The Effects of Oligomeric Procyanidins (OPCs) on Vascular Function, Biomarkers of Oxidative Stress and Inflammation in Smokers: a Pilot Study|Completed||N/A|28|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 13:59:32.534181|2017-02-18 13:59:32.534181
NCT00742274|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2013-11-08|2013-03-14||August 2008||2008-08-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|February 2012|Actual|2012-02-01||Interventional|ADSORB||A European Study on Medical Management Versus TAG Device + Medical Management for Acute Uncomplicated Type B Dissection|A Randomized European Study Comparing Endoluminal Stent Grafting and Best Medical Therapy (BMT) to BMT Alone in the Treatment of Acute Uncomplicated Type B Aortic Dissection|Completed||N/A|61|Actual|W.L.Gore & Associates||2|||f||||t||||||||||2017-02-18 13:59:32.639481|2017-02-18 13:59:32.639481
NCT00742261|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2016-10-11|||August 2008||2008-08-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study to Investigate the Bioavailability of Two Forms of GSK1363089 in Subjects With Solid Tumors|An Open-label, Randomized, Two-way Balanced Crossover Study to Investigate the Bioavailability of Two Forms ofGSK1363089 in Subjects With Solid Tumors|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 13:59:33.429479|2017-02-18 13:59:33.429479
NCT00742248|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2008-08-26|||September 2004||2004-09-01|August 2008|2008-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)|Double Blind, Double Dummy, Multicentre, Randomised, Placebo- Controlled, Crossover Design Clinical Trial of 12 μg (Single Dose and Repeated Doses) Formoterol Fumarate Administered Via pMDI With HFA-134a Propellant or DPI (Aerolizertm Inhaler) in Patients With Partially Reversible COPD|Completed||Phase 2|54|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||||2017-02-18 13:59:33.532308|2017-02-18 13:59:33.532308
NCT00742235|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-03-15|2013-06-05||July 2007||2007-07-01|March 2016|2016-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects|hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects|Completed||N/A|99|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 13:59:33.654728|2017-02-18 13:59:33.654728
NCT00742222|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-05-16|||May 2008||2008-05-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|EXIBT||Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer|Electronic Xoft Intersociety Brachytherapy Trial|Completed||Phase 4|63|Actual|Xoft, Inc.||1|||f||||t||||||||||2017-02-18 13:59:34.046074|2017-02-18 13:59:34.046074
NCT00742209|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2013-07-15|2011-07-25||August 2008||2008-08-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||Intent to Treat population|Prevention Study in Adult Patients Suffering From Migraine Headaches|Study MPX111381: A Dose-ranging Study Evaluating the Efficacy, Safety and Tolerability of GSK1838262 (XP13512) in the Prophylactic Treatment of Migraine Headache|Completed||Phase 2|526|Actual|XenoPort, Inc.||5|||f||||f||||||||||2017-02-18 13:59:34.17507|2017-02-18 13:59:34.17507
NCT00742196|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-26|2008-08-26|||September 2008||2008-09-01|August 2008|2008-08-01|March 2009|Anticipated|2009-03-01|December 2008|Anticipated|2008-12-01||Observational|||Retinal Nerve Fiber Layer Thickness Measurement on Parapapillary Atrophy With the Cirrus High-Definition (HD) Optical Coherence Tomography (OCT)|Retinal Nerve Fiber Layer Thickness Measurement on Parapapillary Atrophy With|Unknown status|Not yet recruiting|N/A|30|Anticipated|Yonsei University|||2||f||||t||||||||||2017-02-18 13:59:36.018955|2017-02-18 13:59:36.018955
NCT00741923|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2012-06-14|||November 2007||2007-11-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Consuming Beans for One Month on Blood Lipids, Satiety, Intake Regulation and Body Weight|Beans and Potatoes in the Regulation of Food Intake and Risk Factors for Chronic Diseases. Effect of Consuming Beans for One Month on Blood Lipids, Satiety, Intake Regulation and Body Weight|Completed||N/A|14|Actual|University of Toronto||1|||f||||f||||||||||2017-02-18 13:59:36.110744|2017-02-18 13:59:36.110744
NCT00741910|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2012-08-22|||July 2003||2003-07-01|August 2012|2012-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|CD06||Extension Study of Semapimod 60 mg IV x 3 Days|Extension Study of CNI-1493 for Treatment of Moderate to Severe Crohn's Disease|Completed||Phase 2|15|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-02-18 13:59:36.220063|2017-02-18 13:59:36.220063
NCT00741897|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2009-09-14|||March 2002||2002-03-01|September 2009|2009-09-01||||December 2003|Actual|2003-12-01||Interventional|||Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis|A Monitored Release Study On The Efficacy And Safety of Fexofenadine (Telfast®) 30mg Pediatric Tablets On Filipino Children Aged 6 To 11 for The Relief of Perennial And Intermittent Allergic Rhinitis.|Completed||Phase 4|264|Actual|Sanofi||1|||f||||||||||||||2017-02-18 13:59:36.331346|2017-02-18 13:59:36.331346
NCT00741884|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-04-21|||August 2010||2010-08-01|April 2015|2015-04-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation|A Phase 2, Seven Week, Double-Blind, Placebo Controlled, Randomized, Parallel Group Study To Evaluate The Safety And Efficacy Of Three Doses Of A Controlled Release Formulation Of Varenicline For Smoking Cessation|Withdrawn||Phase 2|0|Actual|Pfizer||5|||f||||t||||||||||2017-02-18 13:59:36.43038|2017-02-18 13:59:36.43038
NCT00741871|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2012-04-19|||July 2008||2008-07-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies|A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies|Completed||Phase 1|35|Actual|S*BIO||1|||f||||f||||||||||2017-02-18 13:59:36.524129|2017-02-18 13:59:36.524129
NCT00741845|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2012-03-05|||June 2008||2008-06-01|March 2012|2012-03-01||||June 2009|Actual|2009-06-01||Interventional|||Prevention of Persistence of Bacterial Vaginosis|Prevention of Persistence of Bacterial Vaginosis: The Effects of High Dose Intravaginal Metronidazole|Terminated||Phase 3|117|Actual|Embil Pharmaceutical Co. Ltd||3||"Terminated for site documentation and monitoring issues - not safety, study drug, or adverse~   event issues."|f||||||||||||||2017-02-18 13:59:36.968741|2017-02-18 13:59:36.968741
NCT00741832|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2008-11-13|||March 2008||2008-03-01|November 2008|2008-11-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients|The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in COPD Patients|Unknown status|Recruiting|N/A|11|Anticipated|Khon Kaen University||2|||f||||t||||||||||2017-02-18 13:59:37.054115|2017-02-18 13:59:37.054115
NCT00741819|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-23|2013-01-16|2012-05-17||September 2008||2008-09-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects|An Open Label, Multi-center Study Evaluating the Safety of Long-term Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.|Completed||Phase 4|73|Actual|United Therapeutics|Small, open-label study without comparison arm.|1|||f||||f||||||||||2017-02-18 13:59:37.162706|2017-02-18 13:59:37.162706
NCT00741806|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-03-01|||August 2008||2008-08-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|GHB-CS03||Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults|Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults|Completed||Phase 1|32|Actual|AVIR Green Hills Biotechnology AG||2|||f||||t||||||||||2017-02-18 13:59:37.861428|2017-02-18 13:59:37.861428
NCT00741793|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2016-12-21|||February 2002||2002-02-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|April 2018|Anticipated|2018-04-01||Observational|BioTRAC||Biologic Treatment Registry Across Canada|BioTRAC (BIOLOGIC TREATMENT REGISTRY ACROSS CANADA)|Recruiting||Phase 4|3000|Anticipated|Janssen Inc.|||1||f||||f||||||||||2017-02-18 13:59:37.957513|2017-02-18 13:59:37.957513
NCT00741780|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-03-19|||June 2006||2006-06-01|March 2015|2015-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).|Long-term Observational Follow-up Study of a Multicenter, Randomized, Double-blind, Placebo-controlled, Comparative Trial of AMD3100 (240µg/kg) Plus G-CSF (10µg/kg) Versus G-CSF (10µg/kg) Plus Placebo to Mobilize and Collect ≥ 6X 10^6 CD34+ Cells/kg in Multiple Myeloma Patients for Autologous Transplantation|Completed||N/A|164|Actual|Sanofi|||2||f||||f||||||||||2017-02-18 13:59:38.057627|2017-02-18 13:59:38.057627
NCT00741767|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-10-05|||August 2008||2008-08-01|October 2015|2015-10-01|February 2012|Actual|2012-02-01|September 2010|Anticipated|2010-09-01||Interventional|AQuOS-COPD||The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD|The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD (Advair and Quality of Sleep in COPD)|Withdrawn||N/A|0|Actual|Northwestern University||2||Study subject enrollment difficulties|f||||f||||||||||2017-02-18 13:59:38.160612|2017-02-18 13:59:38.160612
NCT00741754|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2009-03-30|||June 2005||2005-06-01|August 2008|2008-08-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|EUWSFDAR||Evaluation of the Unstimulated Whole Saliva Flow During and After Radiotherapy, With the Use HcT20|Evaluation of the Unstimulated Whole Saliva Flow During and After Radiotherapy, With the Use of Lauryl-Diethylene-Glycol-Ether Sodium Sulfate Associated With Calcium Hydroxide (hCt20).|Completed||Phase 2|31|Actual|UPECLIN HC FM Botucatu Unesp||1|||f||||t||||||||||2017-02-18 13:59:38.274841|2017-02-18 13:59:38.274841
NCT00741741|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2010-10-22|||July 2008||2008-07-01|October 2010|2010-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||TMC278-TiDP15-C150: Trial to Examine Safety, Tolerability and Plasma Pharmacokinetics of Multiple Doses of TMC278LA.|Phase I, Double Blind, Randomized, Placebo-controlled Trial to Examine the Safety, Tolerability and Plasma Pharmacokinetics of Multiple (Monthly) Intramuscular and Subcutaneous Doses of TMC278LA.|Terminated||Phase 1|20|Actual|Tibotec Pharmaceuticals, Ireland||||Strategic decision|f||||f||||||||||2017-02-18 13:59:38.386292|2017-02-18 13:59:38.386292
NCT00741728|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2011-12-08|||June 2008||2008-06-01|December 2011|2011-12-01|December 2019|Anticipated|2019-12-01|June 2012|Anticipated|2012-06-01||Observational|PPSIII||Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population|Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population. The Paris Prospective Study III|Recruiting||N/A|10000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||t||||||Samples With DNA|"~     Blood samples and DNA taken from fresh blood~   "|||2017-02-18 13:59:38.475101|2017-02-18 13:59:38.475101
NCT00741715|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-04-15||2016-04-15|August 2008||2008-08-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia|"A Multicenter, Randomized, Placebo-controlled, Factorial Design, 12-month Study to Evaluate the Efficacy and Safety of AVE5530 25 mg/Day and 50 mg/Day Co-administered With All Registered Atorvastatin Strengths Ranging From 10 mg to 80 mg in Patients With Primary Hypercholesterolemia"|Terminated||Phase 3|1736|Actual|Sanofi||15||AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy|f||||f||||||||||2017-02-18 13:59:38.604364|2017-02-18 13:59:38.604364
NCT00741702|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2012-05-15|||September 2001||2001-09-01|May 2012|2012-05-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|DREAM3||Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples|Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples|Completed||N/A|95|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 13:59:38.729601|2017-02-18 13:59:38.729601
NCT00741689|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-12-02|||August 2008||2008-08-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers|A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Ascending Oral Doses of AZD1656 in Japanese Healthy Male Volunteers|Completed||Phase 1|36|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 13:59:38.826484|2017-02-18 13:59:38.826484
NCT00741676|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2008-12-30|||August 2008||2008-08-01|August 2008|2008-08-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Comparison of the Laparoscopy-Assisted Distal Gastrectomy and Open Distal Gastrectomy for Advanced Gastric Cancer|Comparison of the Laparoscopy-Assisted Distal Gastrectomy(LADG) and Open Distal Gastrectomy (ODG) for Advanced Gastric Cancer (Stage Ib and II).|Unknown status|Recruiting|Phase 1|124|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-02-18 13:59:38.922185|2017-02-18 13:59:38.922185
NCT00741663|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2008-09-24|||April 2005||2005-04-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|SVSSF||Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)|Phase 4 Study on the Comparison Between Combined Versus Sequential Diuretic Treatment of Moderate Ascites in Nonazotemic Patients With Cirrhosis|Completed||Phase 4|100|Anticipated|University of Padova||2|||f||||f||||||||||2017-02-18 13:59:39.030568|2017-02-18 13:59:39.030568
NCT00741650|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2015-02-25|||September 2008||2008-09-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|October 2011|Actual|2011-10-01||Interventional|Ibedrift||Ibedrift- A Trial Comparing a New Approach to Musculoskeletal Pain Consisting of Education and Peer Involvement to Treatment as Usual|Ibedrift- Health Related Coping. A Randomized Controlled Trial Comparing a Worksite Educational Intervention With or Without Referral to Treatment as Usual.|Completed||Phase 2/Phase 3|2097|Actual|Uni Research||3|||f||||f||||||||||2017-02-18 13:59:39.13156|2017-02-18 13:59:39.13156
NCT00741637|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2012-03-29|||July 2010||2010-07-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults|A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Single Dose Regimen of Live Attenuated Oral Cholera Vaccine (Choleragarde®) in HIV-Seropositive Adults in Thailand|Completed||Phase 2|32|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-02-18 13:59:39.23695|2017-02-18 13:59:39.23695
NCT00741624|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2009-06-02|||September 2008||2008-09-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Pain Reduce Following Refractive Surgery|Mitigating Pain Following Refractive Surgery|Completed||Phase 2|2|Actual|FORSIGHT Vision3||1|||f||||t||||||||||2017-02-18 13:59:39.349852|2017-02-18 13:59:39.349852
NCT00741611|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2012-09-26|2012-08-27||July 2008||2008-07-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|MAGELLAN||Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation|A Randomized Controlled Trial of Radiofrequency Ablation for the Treatment of Paroxysmal Atrial Fibrillation Using the Bard High Density Mesh Ablation System (MAGELLAN)|Terminated||Phase 3|44|Actual|C. R. Bard|Due to the study’s early termination and enrollment of only 7 randomized patients, predefined study endpoints were not evaluable. Treated patients were followed through 12 months postprocedure and data were summarized where possible.|2||Business reasons|f||||t||||||||||2017-02-18 13:59:39.454296|2017-02-18 13:59:39.454296
NCT00741598|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2015-08-04|||September 2008||2008-09-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder|The Efficacy and Safety of Galantamine for Dysfunction in Bipolar Disorder|Completed||Phase 4|55|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 13:59:40.018915|2017-02-18 13:59:40.018915
NCT00741585|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-10-24|||January 2008||2008-01-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|HYGIA||Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment|Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment|Recruiting||Phase 4|18000|Anticipated|University of Vigo||2|||f||||t||||||||||2017-02-18 13:59:40.142355|2017-02-18 13:59:40.142355
NCT00741572|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2009-09-23|||August 2008||2008-08-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Observational|||Individual Sensitivity for Interstitial Lung Diseases|Individual Sensitivity for Interstitial Lung Diseases|Completed||N/A|100|Anticipated|Maastricht University Medical Center|||2||f||||f||||||Samples With DNA|"~     The patients will be asked to donate 5L exhaled air and 20 ml blood.~   "|||2017-02-18 13:59:40.354702|2017-02-18 13:59:40.354702
NCT00741559|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-05-12|||March 2008||2008-03-01|May 2014|2014-05-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Combined Role of Position Emission Tomography (PET) and Magnetoencephalography (MEG) in Nonlesional Epilepsy|Combined Role of PET and MEG in Nonlesional Epilepsy in Pediatric Population|Completed||Phase 3|59|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-02-18 13:59:40.456019|2017-02-18 13:59:40.456019
NCT00741546|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2008-08-25|||March 2007||2007-03-01|August 2008|2008-08-01||||September 2010|Anticipated|2010-09-01||Observational|||Association of Low Vitamin D Levels With Mortality in Patients With Reduced Left Ventricular Function Referred to Cardiac Surgery|Association of Low Vitamin D Levels With Mortality in Patients With Reduced Left Ventricular Function Referred to Cardiac Surgery|Unknown status|Enrolling by invitation|N/A|160|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||t||||||||||2017-02-18 13:59:40.560937|2017-02-18 13:59:40.560937
NCT00741533|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-11-17|||February 2008||2008-02-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|November 2008|Actual|2008-11-01||Observational|||Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital|Quality of Life in Thai Women Diagnosed Cervical Cancer at King Chulalongkorn Memorial Hospital|Completed||N/A|172|Actual|Chulalongkorn University|||1||f||||f||||||||||2017-02-18 13:59:40.654209|2017-02-18 13:59:40.654209
NCT00741520|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-10-27|||August 2008||2008-08-01|August 2008|2008-08-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|OSA-NORMO||Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients|Cardiovascular Impact of Obstructive Sleep Apnea in Normotensive Patients and the Effects of Continuous Positive Airway Pressure|Completed||Phase 4|36|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 13:59:40.732246|2017-02-18 13:59:40.732246
NCT00741507|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2009-07-14|||September 2008||2008-09-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|UNADAREW||Unhealthy Alcohol Drinking and Anesthetic Requirement in Women|Unhealthy Alcohol Drinking and Anesthetic Requirement in General Anesthesia in Women|Completed||N/A|200|Actual|Nanjing Medical University||5|||f||||t||||||||||2017-02-18 13:59:40.83493|2017-02-18 13:59:40.83493
NCT00741143|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-23|2008-08-25|||August 2007||2007-08-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Iron Fortified Wheat Flour on Cognition and Iron Status in Indian School Children|Effect of Iron Fortified Wheat Flour on Cognition and Iron Status in Indian School Children|Completed||N/A|194|Actual|St. John's Research Institute||2|||f||||f||||||||||2017-02-18 13:59:48.506287|2017-02-18 13:59:48.506287
NCT00741494|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-12-26|||August 2008||2008-08-01|December 2010|2010-12-01||||December 2010|Actual|2010-12-01||Interventional|||Effectiveness of the Use of the PICSI Dish (Hyaluronan Microdot) in the Selection of Sperm for Intracytoplasmic Sperm Injection (ICSI)|Effectiveness of the Use of the PICSI Dish (Hyaluronan Microdot) in the Selection of Sperm for Intracytoplasmic Sperm Injection (ICSI) for Patients Having a Low Versus High Proportion of Hyaluronan Binding Sperm (HBA)|Completed||N/A|801|Actual|Biocoat||5|||f||||f||||||||||2017-02-18 13:59:40.945527|2017-02-18 13:59:40.945527
NCT00741481|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2011-02-23|||June 2006||2006-06-01|February 2011|2011-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|earlyPETmCRC||PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome.|Evaluation of Prognostic and Predictive Value of PETSCAn in ColoRectal Cancer (CRC)|Completed||N/A|40|Anticipated|Jules Bordet Institute|||1||f||||f||||||||||2017-02-18 13:59:41.060199|2017-02-18 13:59:41.060199
NCT00741468|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-08-20|2014-07-03||July 2008||2008-07-01|August 2014|2014-08-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional||All subjects enrolled|Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects|An Open-Label, Multiple-Dose, Non-Randomized Study to Assess the Drug-Drug Interactions of Proellex® (CDB-4124) With Cytochrome P450 Isoenzymes CYP1A2, 2C9, 2C19, 2D6, and 3A4 in Healthy Female Subjects|Completed||Phase 1|18|Actual|Repros Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 13:59:41.169448|2017-02-18 13:59:41.169448
NCT00741455|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-05-04|||June 2004||2004-06-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|January 2014|Actual|2014-01-01||Interventional|||Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies|Non-Myeloablative Chemotherapy Followed by HLA-Matched Related Allogeneic Stem Cell Transplantation for Hematologic Malignancies|Active, not recruiting||N/A|22|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 13:59:41.438724|2017-02-18 13:59:41.438724
NCT00741442|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-01-07||2014-01-07|July 2008||2008-07-01|January 2014|2014-01-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout|Randomized, Double-Blind, Multicenter,Placebo-Controlled, Dose Ranging, Efficacy and Safety Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout|Completed||Phase 2|3|Actual|Ardea Biosciences, Inc.||4|||f||||f||||||||||2017-02-18 13:59:41.567233|2017-02-18 13:59:41.567233
NCT00741429|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2014-12-01|||May 2007||2007-05-01|December 2014|2014-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||A 2-Month Safety Follow-Up Trial|A 2-Month Safety Follow-up Trial of Subjects From MannKind Protocols MKC-TI-009, MKC-TI-102, MKC-TI-103 and MKC-TI-030|Completed||Phase 3|649|Actual|Mannkind Corporation|||2||f||||||||||||||2017-02-18 13:59:41.666189|2017-02-18 13:59:41.666189
NCT00741416|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2011-06-30|||June 2008||2008-06-01|June 2011|2011-06-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Observational|IHS||Biorepository: Indiana Health Study|Collection and Storage of Human Biological Materials (Blood Sample) and Linked Phenotypic Information (Health History) for Research Purposes|Unknown status|Recruiting|N/A|1400|Anticipated|Fairbanks Institute|||2||f||||t||||||Samples With DNA|"~     70ml of whole blood: 3-10 ml EDTA tubes for collection of whole blood 3-10 ml SST tubes (red~     tops) for collection of serum 2-3ml PAXgene tubes for collection of RNA A minimum of 1 EDTA~     and 1 SST tube is required for enrollment into the study.~   "|||2017-02-18 13:59:42.147558|2017-02-18 13:59:42.147558
NCT00741403|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-12-28|||August 2008||2008-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies|An Open Label, Dose-Escalation Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Cancer Patients|Completed||Phase 1|39|Actual|Cornerstone Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 13:59:42.262551|2017-02-18 13:59:42.262551
NCT00741390|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2010-03-05|2009-09-02||August 2008||2008-08-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose|Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose When Using Different Currently Marketed Lancing Devices and Lancets|Completed||N/A|250|Actual|Becton, Dickinson and Company||4|||f||||f||||||||||2017-02-18 13:59:42.382643|2017-02-18 13:59:42.382643
NCT00741377|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2013-02-15|||January 2009||2009-01-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients|A Phase Ib/II Multicenter Dose-determination Study, With an Adaptive, Randomized, Placebo-controlled, Double-blind Phase II, Using Various Repeated IV Doses of BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients With Prior Skeletal-related Event|Completed||Phase 1|28|Actual|Novartis||1|||f||||||||||||||2017-02-18 13:59:42.92618|2017-02-18 13:59:42.92618
NCT00741364|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2011-09-29|||September 2008||2008-09-01|September 2011|2011-09-01|July 2012|Anticipated|2012-07-01|February 2012|Anticipated|2012-02-01||Interventional|DProstate||Vitamin D Effects on Prostate Pathology|Randomized Trial of the Effects of Vitamin D on Prostate Cancer-associated Lesions and on Vitamin D Metabolites in Prostate|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|University of Toronto||3|||f||||f||||||||||2017-02-18 13:59:43.056443|2017-02-18 13:59:43.056443
NCT00741351|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2011-09-07|||December 2007||2007-12-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|Neuromorfeo||Anesthesiological Strategies in Elective Craniotomy|Anesthesiological Strategies in Elective Craniotomy: Randomized, Equivalence, Open Trial|Completed||Phase 3|411|Actual|Azienda Ospedaliera San Gerardo di Monza||3|||f||||t||||||||||2017-02-18 13:59:43.179368|2017-02-18 13:59:43.179368
NCT00741338|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-06-02|2014-06-02||September 2008||2008-09-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||Analysis population included all enrolled participants, including 1 participant who was screen failure.|Immune Tolerance Study With Aldurazyme® (Laronidase)|A Trial of Antigen-specific Immune Tolerance Induction in Mucopolysaccharidosis I (MPS I) Patients Initiating Enzyme Replacement Therapy With Aldurazyme® (Laronidase)|Completed||Phase 1/Phase 2|7|Actual|Sanofi|Study was discontinued on September 10,2013 due to changing standards of care for this population, practical infeasibility of routinely monitoring plasma CsA in clinical setting, inconclusive results of interim analysis and not due to safety concern.|2|||f||||t||||||||||2017-02-18 13:59:43.324402|2017-02-18 13:59:43.324402
NCT00740974|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2008-08-22||||||August 2008|2008-08-01||||||||Observational|||Allergy and Asthma Following Children Who Were Fed Supplemented Infant Formula||Completed||N/A|||Mead Johnson Nutrition|||||f||||||||||||||2017-02-18 13:59:54.09766|2017-02-18 13:59:54.09766
NCT00741325|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2014-02-10|||June 2006||2006-06-01|February 2014|2014-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).|Long-term Observational Follow-up Study of a Multicenter, Randomized, Double-blind, Placebo-controlled, Comparative Trial of AMD3100 (240µg/kg) Plus G-CSF (10µg/kg) Versus G-CSF (10µg/kg) Plus Placebo to Mobilize and Collect ≥ 5X 10^6 CD34+ Cells/kg in Non-Hodgkin's Lymphoma Patients for Autologous Transplantation|Completed||N/A|178|Actual|Sanofi|||2||f||||f||||||||||2017-02-18 13:59:43.747295|2017-02-18 13:59:43.747295
NCT00741312|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2011-01-20|||October 2008||2008-10-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|October 2010|Actual|2010-10-01||Interventional|||Influence of Physical Exercise on Endothelial Function in Pregnant Women|Influence of Physical Exercise on Endothelial Function in Pregnant Women: Randomized Clinical Trial|Completed||Phase 1/Phase 2|64|Anticipated|Universidad del Valle, Colombia||2|||f||||f||||||||||2017-02-18 13:59:43.843072|2017-02-18 13:59:43.843072
NCT00741299|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2012-07-25|||August 2007||2007-08-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Observational|||A Study of the Association Between Tobacco Smoking and Bipolar Affective Disorder|Association Between Tobacco Smoking and Bipolar Affective Disorder.Clinico-epidemiological, Cross-sectional, Retrospective Study.|Completed||N/A|100|Actual|Tirat Carmel Mental Health Center|||1||f||||f||||||||||2017-02-18 13:59:43.941586|2017-02-18 13:59:43.941586
NCT00741286|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2011-08-04|2010-08-03||November 2006||2006-11-01|August 2010|2010-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|ECLIPse||Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler|Study for the Multi-Center Placebo-Controlled Double-Blind Clinical Trial for the Evaluation of the Effect of Cilostazol on Pulsatility Index of Transcranial Doppler in the Acute Lacunar Infarction Patients|Completed||Phase 4|203|Actual|Inje University||2|||f||||f||||||||||2017-02-18 13:59:44.028987|2017-02-18 13:59:44.028987
NCT00741273|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2014-08-08|2014-06-27||October 2008||2008-10-01|August 2014|2014-08-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional||ITT and Safety populations were the same|Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults|An Open-label, Two-stage, Dose-escalation, Parallel Group Study to Evaluate the Safety and Pharmacokinetics Profile of Proellex® (CDB-4124) in Female Patients With Impaired Hepatic Function and Healthy Adult Volunteers|Completed||Phase 1|16|Actual|Repros Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 13:59:44.448311|2017-02-18 13:59:44.448311
NCT00741260|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2016-06-22||2013-01-28|December 2008||2008-12-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|November 2010|Actual|2010-11-01||Interventional|||Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer|A Phase 1/2, Open-Label Study Of Neratinib (HKI-272) In Combination With Capecitabine In Subjects With Solid Tumors And ErbB-2 Positive Metastatic Or Locally Advanced Breast Cancer|Active, not recruiting||Phase 1/Phase 2|105|Actual|Puma Biotechnology, Inc.||1|||f||||f||||||||||2017-02-18 13:59:44.889513|2017-02-18 13:59:44.889513
NCT00741247|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2009-06-23|||August 2008||2008-08-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA|Minimally Invasive Mediastinal Staging of Potentially Operable Lung Cancer With Endobronchial Ultrasound Guided Transbronchial Needle Aspiration(EBUS-TBNA) and Transesophageal Aspiration Using Ultrasonic Bronchoscope (EUS-B-FNA)|Completed||N/A|150|Actual|National Cancer Center, Korea||1|||f||||t||||||||||2017-02-18 13:59:45.044037|2017-02-18 13:59:45.044037
NCT00741234|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2012-04-19|||April 2007||2007-04-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine|A Phase I Dose Escalation Study of Oral SB939 When Administered Thrice Weekly (Every Other Day) for 3 Weeks in a 4-week Cycle in Patients With Advanced Malignancies|Completed||Phase 1|85|Actual|S*BIO||3|||f||||f||||||||||2017-02-18 13:59:45.136347|2017-02-18 13:59:45.136347
NCT00741221|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-10-03|||June 2008||2008-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer|Pemetrexed Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|50|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 13:59:45.248615|2017-02-18 13:59:45.248615
NCT00741208|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2011-06-03|||August 2008||2008-08-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Modification of Asthma With Soy Isoflavone|Modification of Asthma With Soy Isoflavone|Completed||N/A|20|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 13:59:45.358992|2017-02-18 13:59:45.358992
NCT00741195|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2016-10-03|||April 2008||2008-04-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer|Docetaxel Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC|Completed||Phase 2|50|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 13:59:45.471124|2017-02-18 13:59:45.471124
NCT00741182|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2015-03-17|||October 2008||2008-10-01|August 2009|2009-08-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Effect of PTH(1-34) Treatment on Fracture Healing in Vivo|Effect of PTH(1-34) Treatment on Fracture Healing in Vivo|Withdrawn||Phase 2|0|Actual|Glostrup University Hospital, Copenhagen||4|||f||||t||||||||||2017-02-18 13:59:47.97695|2017-02-18 13:59:47.97695
NCT00741169|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2013-04-17|||June 2008||2008-06-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.|Phase I, Open-label, 3-way Crossover Trial in Healthy Volunteers to Determine the Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.|Completed||Phase 1|21|Actual|Tibotec Pharmaceuticals, Ireland||6|||f||||f||||||||||2017-02-18 13:59:48.087314|2017-02-18 13:59:48.087314
NCT00741156|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2015-11-16|2013-07-26||July 2008||2008-07-01|November 2015|2015-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution|The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution After the Bidirectional Cavopulmonary Connection|Completed||Phase 3|12|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-02-18 13:59:48.199477|2017-02-18 13:59:48.199477
NCT00526175|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2016-01-16|||June 2001||2001-06-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||LAL-BR/2001: Study Treatment to Low Risk ALL|LAL-BR/2001: Study Treatment to Low Risk ALL|Completed||Phase 4|150|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:18:09.861093|2017-02-18 15:18:09.861093
NCT00741130|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2008-08-25|||July 2008||2008-07-01|August 2008|2008-08-01|January 2009|Anticipated|2009-01-01|October 2008|Anticipated|2008-10-01||Observational|||Corrected Measurement of the Retinal Nerve Fiber Layer Thickness by Optic Disc Configuration With the Cirrus HD OCT|Corrected Measurement of the Retinal Nerve Fiber Layer Thickness by Optic Disc Configuration With the Cirrus HD OCT|Unknown status|Recruiting|N/A|50|Anticipated|Yonsei University|||2||f||||t||||||||||2017-02-18 13:59:48.609963|2017-02-18 13:59:48.609963
NCT00741117|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2013-03-05|||October 2011||2011-10-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Conjugated Hyperbilirubinemia and Pulse Oximetry|The Influence of Conjugated Hyperbilirubinemia on Pulse Oximetric Accuracy in Liver Disease|Terminated||N/A|4|Actual|Emory University||3||Study stopped due to insufficient personnel required to conduct trial.|f||||f||||||||||2017-02-18 13:59:48.703327|2017-02-18 13:59:48.703327
NCT00741104|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2017-01-02|2009-06-11||January 2008||2008-01-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|REQUEST||A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)|A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients|Completed||Phase 4|363|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 13:59:48.818106|2017-02-18 13:59:48.818106
NCT00741091|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2011-08-22|2011-06-02||December 2008||2008-12-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|CABANA||A Carotid Stenting Boston Scientific Surveillance Program|A Carotid Stenting Boston Scientific Surveillance Program Carotid WALLSTENT Monorail Endoprosthesis FilterWire EZ™ Embolic Protection System|Completed||Phase 4|1097|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 13:59:49.328463|2017-02-18 13:59:49.328463
NCT00741078|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-28|||December 2004||2004-12-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|||||Interventional|||Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension|Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension|Completed||Phase 4|||Gachon University Gil Medical Center||1|||f||||t||||||||||2017-02-18 13:59:50.149295|2017-02-18 13:59:50.149295
NCT00741065|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-25|2010-02-10|||September 2008||2008-09-01|February 2010|2010-02-01|February 2010|Anticipated|2010-02-01|June 2009|Anticipated|2009-06-01||Interventional|DESWT||DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting|DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting|Unknown status|Active, not recruiting|N/A|10|Anticipated|Cardiac Regeneration Technologies, LLC||1|||f||||f||||||||||2017-02-18 13:59:50.22997|2017-02-18 13:59:50.22997
NCT00741052|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2011-07-11|||July 2007||2007-07-01|August 2008|2008-08-01|June 2010|Actual|2010-06-01|October 2008|Actual|2008-10-01||Interventional|||Ciprofloxacin Multiple Dose for Adult Cholera|Randomized, Double Blind, Controlled Clinical Trial to Evaluate the Efficacy of Multiple-dose Ciprofloxacin With Single Dose Azithromycin Therapy for Adults With Cholera Due to Multiply Resistant Strains of V. Cholerae O1 or O139|Completed||Phase 3|218|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||f||||||||||2017-02-18 13:59:50.318424|2017-02-18 13:59:50.318424
NCT00741039|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-10-19|2015-10-19||August 2008||2008-08-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older|Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older|Completed||Phase 2|126|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 13:59:50.624698|2017-02-18 13:59:50.624698
NCT00741026|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2014-07-11|2012-11-29||August 2008||2008-08-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|||A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers|A Double-blind, Placebo-controlled, Crossover Study Examining the Acute Effects of Olanzapine on Plasma Leptin, Glucose Tolerance and Free Fatty Acids in Healthy Volunteers|Completed||N/A|15|Actual|Milton S. Hershey Medical Center|One episode of orthostatic hypotension requiring unblinding. One individual with emesis after glucose challenge and that individual's glucose tolerance data were unavailable analysis.|2|||f||||t||||||||||2017-02-18 13:59:50.94682|2017-02-18 13:59:50.94682
NCT00741013|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2014-04-22|2009-08-04||March 2007||2007-03-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Quantifying Airway Inflammation With Radiologic Tests|Imaging Biomarkers of Pulmonary Inflammation|Completed||Early Phase 1|22|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 13:59:51.442291|2017-02-18 13:59:51.442291
NCT00741000|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2008-08-22|||July 2008||2008-07-01|August 2008|2008-08-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|CSEROM||Cervical Stairstep and Effects on Range of Motion (ROM)|The Effects of Cervical Stairstep on Cervical Range of Motion|Unknown status|Recruiting|Phase 1|50|Anticipated|Logan College of Chiropractic||1|||f||||f||||||||||2017-02-18 13:59:51.969752|2017-02-18 13:59:51.969752
NCT00740987|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-02-10|||October 2007||2007-10-01|December 2014|2014-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|CIREA2||Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)|Evaluation of Intermittent Pneumatic Compression Associated With Elastic Stockings and Anticoagulant Prophylaxis Versus Anticoagulant Prophylaxis Alone on Venous Thromboembolism Incidence in ICU Patients Without High Risk of Bleeding|Completed||Phase 3|621|Actual|University Hospital, Brest||2|||f||||||||||||||2017-02-18 13:59:52.0644|2017-02-18 13:59:52.0644
NCT00739986|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2012-08-22|||October 2002||2002-10-01|August 2012|2012-08-01|August 2004|Actual|2004-08-01|June 2004|Actual|2004-06-01||Interventional|CD04||Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo|A Randomized, Double-Blind, Placebo-controlled Study of CNI-1493 for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment vs. Placebo|Completed||Phase 2|152|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:59:52.193273|2017-02-18 13:59:52.193273
NCT00739973|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-06-02|2011-01-13||September 2008||2008-09-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension|An 8-week Double-blind, Multicenter, Randomized, Multifactorial, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination With Amlodipine in Patients With Essential Hypertension|Completed||Phase 3|2694|Actual|Novartis||9|||f||||f||||||||||2017-02-18 13:59:52.337864|2017-02-18 13:59:52.337864
NCT00740961|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-10-01|||March 2008||2008-03-01|October 2015|2015-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer|The Vulnerable Elders Survey Study of Older Cancer Patients|Terminated||N/A|63|Actual|Case Comprehensive Cancer Center|||2|low accrual|f||||t||||||Samples Without DNA|"~     Approximately 13mls of blood will be drawn at each of the three time-points for testing for~     biologic correlates of frailty (pre study, mid-study and post-study).~   "|||2017-02-18 13:59:54.173281|2017-02-18 13:59:54.173281
NCT00740948|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-03-04|||March 2008||2008-03-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Interventional|TEARS||Tolerance and Efficacy of Rituximab in Sjogren's Disease|Tolerance and Efficacy of Rituximab in Sjogren's Disease|Completed||Phase 2/Phase 3|122|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-02-18 13:59:54.297184|2017-02-18 13:59:54.297184
NCT00740935|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2013-10-18|||May 2007||2007-05-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|IVANHOE||Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.|Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.|Completed||Phase 4|7204|Actual|University Hospital, Brest||1|||f||||t||||||||||2017-02-18 13:59:54.433319|2017-02-18 13:59:54.433319
NCT00740922|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2011-06-06|||July 1999||1999-07-01|April 2010|2010-04-01|April 2001|Actual|2001-04-01|||||Observational|||Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers|A Multicenter Clinical Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers|Completed||N/A|563|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||||||||||||||||2017-02-18 13:59:54.540211|2017-02-18 13:59:54.540211
NCT00740909|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-06-19|||November 2008||2008-11-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|CBT for TTM||Cognitive Behavioral Therapy for Trichotillomania|Cognitive Behavioral Therapy for Trichotillomania|Completed||Phase 1/Phase 2|38|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 13:59:54.650425|2017-02-18 13:59:54.650425
NCT00740896|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2009-04-07|||June 2008||2008-06-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Acute Effects of Smoking on Airway Dendritic Cells|Acute Effects of Smoking on Airway Dendritic Cells|Completed||N/A|16|Actual|University of Rostock||2|||f||||f||||||||||2017-02-18 13:59:54.763364|2017-02-18 13:59:54.763364
NCT00740883|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2017-01-11|||July 2007||2007-07-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2015|Actual|2015-10-01||Interventional|PADIS EP||"Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. PADIS-PE Study."|"Eighteen Months of Oral Anticoagulant Therapy Versus Placebo After 6 Six Months of Anticoagulation for a First Episode of Idiopathic Pulmonary Embolism: a Multicentre Double-blind Randomized Controlled Trial. PADIS-PE Study."|Completed||Phase 3|374|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-02-18 13:59:54.858142|2017-02-18 13:59:54.858142
NCT00740870|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2016-10-31|||January 2007||2007-01-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|May 2015|Actual|2015-05-01||Interventional|Melody IDE||Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Original IDE Cohort|Implantation of the Medtronic Melody Transcatheter Pulmonary Valve in Patients With Dysfunctional RVOT Conduits: A Feasibility Study|Active, not recruiting||N/A|150|Actual|Medtronic Cardiovascular||1|||f||||f||||||||||2017-02-18 13:59:54.963312|2017-02-18 13:59:54.963312
NCT00740857|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2011-06-01|2009-10-30||August 2008||2008-08-01|June 2011|2011-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study Comparing the Efficacy of Two Ibuprofen Formulations|A Study Comparing the Efficacy of Two Ibuprofen Formulations|Completed||Phase 4|211|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 13:59:55.071127|2017-02-18 13:59:55.071127
NCT00740844|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2012-02-13|||November 2007||2007-11-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Interventional|CIREA1||Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk|Evaluation of Intermittent Pneumatic Compression (IPC) of the Lower Limbs Associated With Elastic Stockings (ES) Compared to ES Alone on Venous Thromboembolism Incidence in Patients With High Bleeding Risk Hospitalized in Intensive Medical Care Units|Completed||Phase 3|408|Actual|University Hospital, Brest||2|||f||||||||||||||2017-02-18 13:59:55.742992|2017-02-18 13:59:55.742992
NCT00740831|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2012-12-13|2012-07-26||August 2008||2008-08-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|PEARLII||PGL4001 Versus GnRH-agonist in Uterine Myomas|A Phase III, Randomised, Parallel Group, Double-blind, Double-dummy, Active Comparator-controlled, Multicenter Study to Assess the Efficacy and Safety of PGL4001 vs GnRH-agonist for Pre-operative Ttt of Symptomatic Uterine Myomas|Completed||Phase 3|301|Actual|PregLem SA||3|||f||||t||||||||||2017-02-18 13:59:55.854696|2017-02-18 13:59:55.854696
NCT00740818|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2008-08-22|||July 2008||2008-07-01|August 2008|2008-08-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Logan Basic and Dysmenorrhea|A Pilot Study: Logan Basic Technique and Auxiliary Abdominal Contacts for Reducing Symptomatology of Primary Dysmenorrhea|Unknown status|Recruiting|Phase 2|30|Anticipated|Logan College of Chiropractic||3|||f||||f||||||||||2017-02-18 13:59:56.934684|2017-02-18 13:59:56.934684
NCT00740805|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2017-02-09|||August 2008||2008-08-01|February 2017|2017-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma|A Phase I Study of ABT-888 in Combination With Cyclophosphamide in Solid Tumors or Non-Hodgkin Lymphoma|Active, not recruiting||Phase 1|90|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 13:59:57.038648|2017-02-18 13:59:57.038648
NCT00740792|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2012-08-07|2012-05-15||August 2008||2008-08-01|August 2012|2012-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies|Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Azelastine Hydrochloride Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis.|Completed||Phase 3|776|Actual|Meda Pharmaceuticals||4|||f||||f||||||||||2017-02-18 13:59:57.187573|2017-02-18 13:59:57.187573
NCT00173485|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||June 2005||2005-06-01|June 2005|2005-06-01|June 2009||2009-06-01|||||Observational|||The Study of Infection and Cell Inflammation in Peritoneal Dialysate||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.279335|2017-02-18 17:19:33.279335
NCT00740779|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-01-23|2012-01-23||September 2008||2008-09-01|January 2012|2012-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.|A Multi-Center, Double-Blind, Placebo-Controlled Investigation of Silodosin in the Treatment of Subjects With Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome|Completed||Phase 2|153|Actual|Watson Pharmaceuticals||3|||f||||f||||||||||2017-02-18 13:59:57.878766|2017-02-18 13:59:57.878766
NCT00740766|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2009-06-04|||June 1998||1998-06-01|June 2009|2009-06-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Perinatal Outcomes in Nutritionally Monitored Obese Pregnant Women|Perinatal Outcomes in Nutritionally Monitored Obese Pregnant Women|Completed||N/A|257|Actual|Jamaica Hospital Medical Center||2|||f||||f||||||||||2017-02-18 13:59:58.411313|2017-02-18 13:59:58.411313
NCT00740753|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2016-03-28|||August 2004||2004-08-01|March 2016|2016-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|Y-90HDE||Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option|A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma|Enrolling by invitation||N/A|400|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 13:59:58.521414|2017-02-18 13:59:58.521414
NCT00740740|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2008-08-22|||June 2007||2007-06-01|August 2008|2008-08-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||Biomarkers of Aneurysm Wall Strength|Biological and Biochemical Markers of Aneurysm Wall Degradation; Towards Non-Invasive Wall Strength Analysis.|Unknown status|Recruiting|N/A|50|Anticipated|Radboud University|||3||f||||f||||||Samples With DNA|"~     whole blood, serum, white cells, urine, tissue~   "|||2017-02-18 13:59:58.620348|2017-02-18 13:59:58.620348
NCT00740727|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2009-09-10|2009-03-03||February 2009||2009-02-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||EASI Access II --- Follow-up Study to the EASI Access Trial|Enzymatically Augmented Subcutaneous Infusion (EASI) Access II Trial|Completed||Phase 1|18|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 13:59:58.713546|2017-02-18 13:59:58.713546
NCT00740714|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2012-12-24|2012-07-24||December 2008||2008-12-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|QE3||Effects of Coenzyme Q10 (CoQ) in Parkinson Disease|Effects of Coenzyme Q10 in Parkinson Disease - Phase III|Terminated||Phase 3|600|Actual|Weill Medical College of Cornell University|The planned interim analysis for futility based on the first 300 subjects has reached the pre-specified termination criterion.|3||"The investigational drug is unlikely to demonstrate efficacy over placebo for this indication.~   However, no safety issues were discovered."|f||||t||||||||||2017-02-18 13:59:58.986399|2017-02-18 13:59:58.986399
NCT00740701|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-09-16|||April 2000||2000-04-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|||Effects of Transcranial Magnetic Stimulation to the Cerebellum on Cognition|fMRI and TMS Analysis of Cerebellar Cognitive Function|Enrolling by invitation||N/A|188|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 14:00:00.573934|2017-02-18 14:00:00.573934
NCT00740688|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2008-08-21|||June 2008||2008-06-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Basic and Balance: Logan Basic Technique on Bilateral Weight Balance|The Effects of Logan Basic Technique on Bilateral Weight Balance|Completed||Phase 2|75|Anticipated|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 14:00:00.659016|2017-02-18 14:00:00.659016
NCT00740675|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2011-01-05|||April 2008||2008-04-01|January 2011|2011-01-01|February 2011|Anticipated|2011-02-01|August 2009|Actual|2009-08-01||Interventional|||Ambulatory Medication Reconciliation Following Hospital Discharge|"Ambulatory Medication Reconciliation Following Hospital Discharge: Project 4 From Center for Education and Research on Therapeutics (CERT) on Health Information Technology"|Unknown status|Active, not recruiting|N/A|912|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 14:00:00.745666|2017-02-18 14:00:00.745666
NCT00740662|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2012-12-19|||January 2008||2008-01-01|December 2012|2012-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Intraoperative Measuring of Small Bowel Length Compared to Measuring by Magnetic Resonance Imaging (MRI) in Morbid Obese Patients|Prospective Study for the Quantification of a Compensatory Increase in Small Bowel Length After Roux-en-Y Gastric Bypass in Morbid Obese Patients by Pre- and Postoperative Length-Measuring With MRI Compared to Intraoperative Length-Measuring|Terminated||N/A|7|Actual|University Hospital Inselspital, Berne|||1|Recruiting problems|f||||f||||||||||2017-02-18 14:00:00.868938|2017-02-18 14:00:00.868938
NCT00740649|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2009-03-30|||October 2008||2008-10-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of HSD-016|Single Ascending Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of HSD-016 Administered Orally To Healthy Japanese Male Subjects|Completed||Phase 1|74|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:00:00.993427|2017-02-18 14:00:00.993427
NCT00740636|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2016-07-01|2015-10-20||August 2008||2008-08-01|June 2016|2016-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer|Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer|Completed||Phase 2|92|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:00:01.096881|2017-02-18 14:00:01.096881
NCT00740623|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2013-01-15||2013-01-15|January 2009||2009-01-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects With Partial Onset Seizures.|Completed||Phase 3|547|Actual|SK Life Science||3|||f||||||||||||||2017-02-18 14:00:01.55016|2017-02-18 14:00:01.55016
NCT00740610|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2014-01-03||2014-01-03|August 2008||2008-08-01|January 2014|2014-01-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)|A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Activity of GS 9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)|Completed||Phase 2|124|Actual|Gilead Sciences||5|||f||||t||||||||||2017-02-18 14:00:01.676254|2017-02-18 14:00:01.676254
NCT00172978|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-10-26||||||April 2005|2005-04-01||||||||Observational|||Indications and Related Factors for Caesarean Delivery, 1996 to 2002.||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.662071|2017-02-18 17:19:36.662071
NCT00740597|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2014-06-12|2014-06-12||July 2008||2008-07-01|June 2014|2014-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma|Phase II Study of Preoperative Intensity-Modulated Radiation Therapy for Soft-Tissue Sarcomas|Terminated||Phase 2|1|Actual|City of Hope Medical Center|Study closed 05/12/2010 (opened 7/25/2008): No patients were accrued and treated per protocol in nearly two years (2 patients were screened). The study was terminated by the IRB when the PI decided not to continue. Protocol objectives were not met.|1||No patients were enrolled on the study|f||||t||||||||||2017-02-18 14:00:01.829069|2017-02-18 14:00:01.829069
NCT00740584|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-07-05|2012-04-03||August 2008||2008-08-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.|Assessment of Local Retention and Duration of Activity of SPL7013 Following Vaginal Application of 3% SPL7013 Gel (VivaGel) in Healthy Volunteers|Completed||Phase 1/Phase 2|12|Actual|Starpharma Pty Ltd||1|||f||||f||||||||||2017-02-18 14:00:02.079043|2017-02-18 14:00:02.079043
NCT00740571|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2009-02-04|||September 2008||2008-09-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|Off-label||Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer|A Randomised Controlled Trial in the Palliative Setting Regarding Off-Label Medication: Investigating the Efficiency of Amitriptyline Versus Pregabalin From a Societal Perspective|Unknown status|Recruiting|Phase 3|130|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 14:00:02.322783|2017-02-18 14:00:02.322783
NCT00740558|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2008-08-26|||July 2004||2004-07-01|August 2008|2008-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Heart Rate Variability Modulation Following a Manipulation in Pain Free Patients Versus Patients in Pain|Heart Rate Variability Modulation Following a Manipulation in Pain Free Patients Versus Patients in Pain|Completed||N/A|53|Actual|Universite du Quebec a Montreal||2|||f||||t||||||||||2017-02-18 14:00:02.435597|2017-02-18 14:00:02.435597
NCT00740545|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2015-03-04|||April 2007||2007-04-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2013|Actual|2013-09-01||Interventional|PREFIX||Prevention of Unexplained Recurrent Abortion by Enoxaparine|Essai thérapeutique randomisé Multicentrique en Double Insu, Comparant l'énoxaparine 40mg Versus Placebo, en Une Injection Sous-cutanée Quotidienne, Dans Les Fausses Couches spontanées récurrentes inexpliquées|Terminated||Phase 3|258|Actual|University Hospital, Brest||2||Stopped for futility|f||||t||||||||||2017-02-18 14:00:02.547773|2017-02-18 14:00:02.547773
NCT00740532|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2010-09-01|||October 2007||2007-10-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|March 2008|Actual|2008-03-01||Observational|||Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients|Observational Study Assessing Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients|Completed||N/A|11|Actual|Istituto Clinico Humanitas|||1||f||||f||||||Samples With DNA|"~     Paraffine embedded tumor sections~   "|||2017-02-18 14:00:02.644328|2017-02-18 14:00:02.644328
NCT00740519|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2017-02-02|||September 2008||2008-09-01|February 2017|2017-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|SOLVE™||Observational Study on Safety of Self-titration of Once Daily Levemir®|Evaluation on Safety of Self-titration in Insulin naïve People With Type 2 Diabetes Treated With Levemir® (Insulin Detemir) and Oral Antidiabetic Agents|Completed||N/A|882|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:00:02.740328|2017-02-18 14:00:02.740328
NCT00740506|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2017-01-24|||August 20, 2008||2008-08-20|July 13, 2009|2009-07-13|July 13, 2009|Actual|2009-07-13|July 13, 2009|Actual|2009-07-13||Interventional|||Behavioral and Environmetal Factors and Time to Delivery|Behavioral and Environmental Factors and Time to Delivery|Completed||Phase 4|510||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:00:02.854046|2017-02-18 14:00:02.854046
NCT00740493|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2017-01-11|||July 2007||2007-07-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|PADIS TVP||Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)|"Eighteen Months of Oral Anticoagulant Therapy Versus Placebo After 6 Six Months of Anticoagulation for a First Episode of Idiopathic Proximal Deep Vein Thrombosis: a Multicentre Double-Blind Randomized Controlled Trial. PADIS-TVP Study."|Completed||Phase 3|104|Actual|University Hospital, Brest||2|||f||||t||||||||||2017-02-18 14:00:02.952233|2017-02-18 14:00:02.952233
NCT00740480|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2009-08-20|2009-07-15||April 2008||2008-04-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Study of the ENTact Septal Staple System for Tissue Approximation During Septoplasty|A Prospective, Non-Randomized, Limited-Use Evaluation of the ENTact Septal Staple System for Tissue Approximation During Septoplasties|Completed||N/A|25|Actual|ENTrigue Surgical, Inc.|||1||f||||f||||||||||2017-02-18 14:00:03.069882|2017-02-18 14:00:03.069882
NCT00740467|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2010-01-27|||January 2008||2008-01-01|July 2009|2009-07-01||||January 2010|Anticipated|2010-01-01||Interventional|||Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders|Allograft of Hematopoietic Stem Cells With Reduced-intensity Conditioning From a HLA-haploidentical Family Donor: Phase II Study of Combined Immunosuppression Before and After Transplantation|Unknown status|Recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:00:03.292093|2017-02-18 14:00:03.292093
NCT00740454|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2010-12-27|||January 2006||2006-01-01|December 2010|2010-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|EDVIGE||Single Complete Compression Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy and Postpartum|Diagnostic Exclusion Value of a Negative Single Distal and Proximal Lower Limb Veins Compression Ultrasonography in Pregnant and Post-partum Women With a Clinically Suspected Deep Vein Thrombosis|Completed||N/A|200|Anticipated|University Hospital, Brest|||1||f||||f||||||||||2017-02-18 14:00:03.397084|2017-02-18 14:00:03.397084
NCT00740441|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2009-09-24|||August 2008||2008-08-01|September 2009|2009-09-01|March 2010|Anticipated|2010-03-01|September 2009|Anticipated|2009-09-01||Interventional|||A Phase II Study of AS1411 in Renal Cell Carcinoma|A Phase II, Open Label, Single Arm Study of AS1411 in Patients With Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Antisoma Research||1|||||||f||||||||||2017-02-18 14:00:03.520307|2017-02-18 14:00:03.520307
NCT00740428|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2009-12-04|||March 2008||2008-03-01|December 2009|2009-12-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|||Pelvic Floor Exercises During Gestation in the Prevention of Urinary Incontinence and Pelvic Floor Muscle Dysfunction|The Effectiveness of Pelvic Floor Exercises During Gestation in the Prevention of Urinary Incontinence and Pelvic Floor Muscle Dysfunction.|Completed||Phase 2/Phase 3|48|Anticipated|UPECLIN HC FM Botucatu Unesp||1|||f||||f||||||||||2017-02-18 14:00:03.629752|2017-02-18 14:00:03.629752
NCT00740415|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2016-03-15|||June 2007||2007-06-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|May 2011|Actual|2011-05-01||Interventional|ManteauRiBVD||Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma|First-line Treatment of Mantle Cell Lymphoma of Old Patients . Evaluate the Efficacy, Toxicity, and Molecular Prognostic Factors of Velcade®) in Association With Chemotherapy and Immunotherapy With Rituximab|Completed||Phase 2|39|Actual|French Innovative Leukemia Organisation||1|||f||||t||||||||No||2017-02-18 14:00:03.735623|2017-02-18 14:00:03.735623
NCT00740402|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-22|2010-04-15|||January 2008||2008-01-01|August 2008|2008-08-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Observational|||Motor Learning of a Planning Task in Stroke Patients: the Maze Paradigm Measured Through Time and Error as Variables|Motor Learning of a Planning Task in Stroke Patients|Completed||N/A|20|Actual|Faculdades Metropolitanas Unidas|||1||f||||t||||||None Retained|"~     no biospecimens are to be retained~   "|||2017-02-18 14:00:03.858503|2017-02-18 14:00:03.858503
NCT00740389|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2011-06-08|||September 2008||2008-09-01|April 2010|2010-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.|A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.|Completed||Phase 1|18|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 14:00:03.946281|2017-02-18 14:00:03.946281
NCT00740376|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2017-01-06|||August 2008||2008-08-01|January 2017|2017-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|MBK||Uniglide™ Mobile Bearing Unicondylar Knee System vs the Uniglide™ Fixed Bearing Unicondylar Knee System|A Prospective, Comparative, Randomized, Double Blind, Multi-center Study of the Uniglide™ Mobile Bearing Unicondylar Knee System vs. Uniglide™ Fixed Bearing Unicondylar Knee System|Terminated||Phase 3|47|Actual|Corin||2||enrollment closed|f||||t||||||||||2017-02-18 14:00:04.051322|2017-02-18 14:00:04.051322
NCT00740363|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-09-21|||September 2008||2008-09-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Sitagliptin in Renal Transplant Recipients|The Effect of Sitagliptin Treatment on Glucose Metabolism and Endothelial Function in Renal Transplant Recipients - JANUVIA-08|Completed||Phase 4|25|Actual|University of Oslo School of Pharmacy||2|||f||||f||||||||||2017-02-18 14:00:04.166852|2017-02-18 14:00:04.166852
NCT00740350|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2008-08-22|||March 2007||2007-03-01|August 2008|2008-08-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Logan Basic During Pregnancy on Labor and Childbirth|Does the Logan Basic Protocol for Chiropractic Care During Pregnancy Reduce Labor Time and Increase the Ease of Labor and Childbirth?|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Logan College of Chiropractic||1|||f||||f||||||||||2017-02-18 14:00:04.273436|2017-02-18 14:00:04.273436
NCT00740337|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2012-09-14|||October 2007||2007-10-01|September 2012|2012-09-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Observational|||Factors That Affect the Development of COPD Symptoms|Specialized Center of Clinically Oriented Research: Alveolar and Airway Mechanisms of COPD. Airway Determinants: Innate Immune Signaling (Project 4)|Unknown status|Enrolling by invitation|N/A|82|Actual|Washington University School of Medicine|||2||f||||t||||||Samples With DNA|"~     Plasma, serum, isolated RNA and DNA, lung tissue~   "|||2017-02-18 14:00:04.360301|2017-02-18 14:00:04.360301
NCT00740324|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2010-11-08|||August 2008||2008-08-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men|Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men During Endoscopy|Completed||Phase 3|30|Anticipated|Nihon Pharmaceutical Co., Ltd||3|||f||||t||||||||||2017-02-18 14:00:04.453086|2017-02-18 14:00:04.453086
NCT00740311|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2010-06-01|||November 2007||2007-11-01|June 2010|2010-06-01|May 2011|Anticipated|2011-05-01|November 2010|Anticipated|2010-11-01||Interventional|||Filling of Tooth Sockets With MBCP Gel TM Versus Technical Without Filling|Comparative Clinical Study of the Prevention of the Reduction of Alveolar Crest by Alveoli Filling With an Injectable Calcium Phosphate After Extraction of Mandibular Molar or Pre Molar|Unknown status|Recruiting|N/A|||Nantes University Hospital||2|||f||||||||||||||2017-02-18 14:00:04.556121|2017-02-18 14:00:04.556121
NCT00740298|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2013-10-08|||July 2008||2008-07-01|October 2013|2013-10-01|July 2014|Anticipated|2014-07-01|July 2013|Actual|2013-07-01||Interventional|||Thermal Analgesia in Newborns|Thermal Analgesia in Newborns|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Chicago||2|||f||||f||||||||||2017-02-18 14:00:04.645761|2017-02-18 14:00:04.645761
NCT00740285|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-08-21|||April 2004||2004-04-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|April 2006|Actual|2006-04-01||Interventional|||Effectiveness and Safety of Lidocaine for Scleroderma|Effectiveness and Safety of Lidocaine for Scleroderma. Randomized Double-Blind Clinical Trial|Completed||Phase 2/Phase 3|26|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:00:04.740686|2017-02-18 14:00:04.740686
NCT00740272|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-10-17|||March 2008||2008-03-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|Alternative||Af Ablation In Brady-Tachy Syndrome|Af Ablation In Brady-Tachy Syndrome|Terminated||N/A|38|Actual|St. Jude Medical||2||Slow recruitment|f||||f||||||||||2017-02-18 14:00:04.846092|2017-02-18 14:00:04.846092
NCT00740259|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-20|||September 2004||2004-09-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol|Is Flunarizine a Cheap, Well-Tolerated and Long-Acting Atypical Antipsychotic? A Randomized Double-Blind Flexible-Dose Clinical Trial Versus Haloperidol for the Treatment of Schizophrenia|Completed||Phase 4|70|Actual|Ambulatório de Bipolaridade|||||f||||f||||||||||2017-02-18 14:00:04.945596|2017-02-18 14:00:04.945596
NCT00740246|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2008-08-21|||June 2005||2005-06-01|August 2008|2008-08-01||||||||Interventional|||Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia|A Multi-Center, Randomized, Blinded, Placebo Controlled, Cross-Over Study to Investigate the Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia|Completed||Phase 3|||Luitpold Pharmaceuticals|||||||||f||||||||||2017-02-18 14:00:05.241837|2017-02-18 14:00:05.241837
NCT00740233|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2014-03-26|||June 2008||2008-06-01|February 2009|2009-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|PROCAIM||Web-Based Survey of Pain, Stress and Complementary and Alternative Medicine||Completed||N/A|2300|Actual|University of California, Los Angeles|||1||f||||f||||||||||2017-02-18 14:00:05.340306|2017-02-18 14:00:05.340306
NCT00740220|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2016-04-29|2009-02-13||September 2006||2006-09-01|April 2016|2016-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|6MWT||Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation|Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation|Completed||N/A|97|Actual|Wake Forest University Health Sciences|Study was conducted in a Pulmonary Rehabilitation Population and may not be generalizable.||1||f||||f||||||||Undecided|Data could only be shared if requestor had IRB approval and funding to re-contact all participants for permission.|2017-02-18 14:00:05.432096|2017-02-18 14:00:05.432096
NCT00740207|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-05-05|2010-09-13||September 2008||2008-09-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA|A Phase IV Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral Digital Subtraction Angiography (DSA)|Completed||Phase 4|33|Actual|Bracco Diagnostics, Inc||2|||f||||f||||||||||2017-02-18 14:00:05.683136|2017-02-18 14:00:05.683136
NCT00740194|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2011-08-29|||August 2008||2008-08-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|December 2008|Actual|2008-12-01||Interventional|||Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men|Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men.|Completed||Phase 1/Phase 2|20|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 14:00:06.201021|2017-02-18 14:00:06.201021
NCT00740181|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2014-07-27|2013-05-14||August 2008||2008-08-01|July 2014|2014-07-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|||Decitabine, Cytarabine, GCSF for Refractory AML/MDS|A Phase II Study With Decitabine, Low Dose Cytarabine and G-CSF in High-risk Myelodysplastic Syndromes, Refractory Acute Myeloid Leukemia or Acute Myeloid Leukemia in Patients With Significant Co-morbidities.|Terminated||Phase 2|9|Actual|Brown University||1||Lack of efficacy|f||||t||||||||||2017-02-18 14:00:06.313481|2017-02-18 14:00:06.313481
NCT00740168|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2016-01-20|||May 2007||2007-05-01|January 2016|2016-01-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Observational|BevaRet||Bevacizumab Treatment and Retinal Vessel Monitoring|Analysis of Retinal Vessel Reaction and Monitoring of Circulation Parameters During Bevacizumab Therapy|Completed||N/A|20|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-02-18 14:00:06.576225|2017-02-18 14:00:06.576225
NCT00740155|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-03-02|||August 2008||2008-08-01|March 2015|2015-03-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults|Safety and Immunogenicity of Bivalent and Tetravalent Formulations of Dengue Vaccine Candidates in Healthy Flavivirus-Naïve Adults Aged 18 to 45 Years|Completed||Phase 2|154|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 14:00:06.688151|2017-02-18 14:00:06.688151
NCT00740142|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2009-06-25|||September 2008||2008-09-01|December 2008|2008-12-01|August 2010|Anticipated|2010-08-01|May 2010|Anticipated|2010-05-01||Interventional|||Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy|Efficacy of Combined Oral L-Ornithine-L-Aspartate and Oral Lactulose in Patients With Hepatic Encephalopathy|Unknown status|Recruiting|Phase 4|34|Anticipated|Mahidol University||2|||f||||t||||||||||2017-02-18 14:00:06.822238|2017-02-18 14:00:06.822238
NCT00740129|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2016-11-15|||October 2008||2008-10-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Re-treatment of Patients With Paget's Disease Using Zoledronic Acid|An Open Label, Reclast®/Aclasta®, Re-treatment of Relapsed Patients With Paget's Disease of Bone Who Participated in the CZOL446K2304 and CZOL446K2305 Core Registration Studies|Completed||Phase 4|6|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:00:06.937348|2017-02-18 14:00:06.937348
NCT00740116|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-06-26|||March 2008||2008-03-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Tranexamic Acid in Surgery of Advanced Ovarian Cancer|Tranexamic Acid in Surgery of Advanced Ovarian Cancer - a Prospective Randomized Double Blind Placebo Controlled Study|Completed||Phase 4|100|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-02-18 14:00:07.067479|2017-02-18 14:00:07.067479
NCT00740103|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-08-22|||December 2002||2002-12-01|August 2012|2012-08-01|September 2004|Actual|2004-09-01|July 2004|Actual|2004-07-01||Interventional|CD05||Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease|Long-term Study of Semapimod (CNI-1493) for Treatment of Moderate to Severe Crohn's Disease With Reference to Study CNI-1493-CD-04, 1 or 3 Days' Treatment vs. Placebo|Completed||Phase 2|119|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:00:07.201523|2017-02-18 14:00:07.201523
NCT00740090|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2017-01-24|||August 11, 2008||2008-08-11|June 9, 2009|2009-06-09||||June 9, 2009|Actual|2009-06-09||Interventional|||Malaria Vaccine for Children in Mali|Phase 1, Randomized, Double-Blind, Dose-Escalating Study of the Safety, Reactogenicity, and Immunogenicity of the AMA1-C1/Alhydrogel+CPG 7909 Vaccine for Plasmodium Falciparum Malaria in Children in Mali|Completed||Phase 1|200||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:00:07.364757|2017-02-18 14:00:07.364757
NCT00740077|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2009-02-06|||August 2008||2008-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Bioavailability of Flavonoids and Phenolic Acids From Cranberry Juice Cocktail in Healthy Older Adults|Bioavailability of Flavonoids and Phenolic Acids From Cranberry Juice Cocktail in Healthy Older Adults|Completed||N/A|10|Actual|Tufts University||1|||f||||t||||||||||2017-02-18 14:00:07.463812|2017-02-18 14:00:07.463812
NCT00740064|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2009-01-27|||May 2008||2008-05-01|January 2009|2009-01-01|November 2009|Anticipated|2009-11-01|August 2009|Anticipated|2009-08-01||Interventional|SHIELD||Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects|A Pilot Study of Highly Active Antiretroviral Therapy Using Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Antiretroviral Naive HIV-Infected Subjects|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Denver Infectious Disease Consultants, PLLC||1|||f||||t||||||||||2017-02-18 14:00:07.56213|2017-02-18 14:00:07.56213
NCT00740051|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2014-06-17|2011-08-03||August 2008||2008-08-01|December 2013|2013-12-01||||August 2010|Actual|2010-08-01||Interventional||Number of participants and other baseline values taken from interim analysis.|A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate|A Randomised, db, Placebo-controlled, Parallel Group Efficacy and Safety Study of BI 1356 (5mg), Administered Orally Once Daily for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients With Insufficient Glycaemic Control for Whom Metformin Therapy is Inappropriate (Intolerability or Contraindication)|Completed||Phase 3|227|Actual|Boehringer Ingelheim|Primary analysis (at interim) was rerun using final study database|3|||f||||||||||||||2017-02-18 14:00:07.679516|2017-02-18 14:00:07.679516
NCT00740025|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2010-10-12|||January 2006||2006-01-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|QD vs BID||Once Daily vs Twice Daily Administration of Gonadotropins in Assisted Reproductive Technologies (ART)|A Prospective Randomized Study of QD vs BID Dosing in ART|Completed||N/A|200|Anticipated|Virginia Center for Reproductive Medicine|||2||f||||f||||||||||2017-02-18 14:00:08.626913|2017-02-18 14:00:08.626913
NCT00740012|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-09-25|||March 2007||2007-03-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Glycemic Rises After Waking Up In Response To An Alarm Clock In Type 1-Diabetic Patients Analysed With Continuous Glucose Monitoring (GlucoDay®)|Blutzucker-Nachtprofile Mit Wecker Und Selbstmessungen gegenüber Fremdmessungen Durch Spezialisiertes Pflegepersonal: Eine Analyse Mittels Kontinuierlichem Glukose-Monitoring (Glucoday®)|Completed||N/A|32|Anticipated|Diabeteszentrum Bad Lauterberg im Harz||4|||f||||f||||||||||2017-02-18 14:00:08.720228|2017-02-18 14:00:08.720228
NCT00739999|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2010-08-19|2010-03-15||December 2008||2008-12-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia|A 8-Week, Open-Label, Phase 1 Study To Evaluate Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Atorvastatin In Children And Adolescents With Heterozygous Familial Hypercholesterolemia|Completed||Phase 1|39|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:00:08.898659|2017-02-18 14:00:08.898659
NCT00739960|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2013-06-10|||August 2008||2008-08-01|June 2013|2013-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|STAR||Safety Study of Abatacept to Treat Refractory Sarcoidosis|Sarcoidosis, Trial of Abatacept in Refractory Disease (STAR). A Prospective Open-Label Trial of Abatacept in Progressive Sarcoidosis|Terminated||Phase 2|1|Actual|University of Chicago||1||Funding has been pulled|f||||t||||||||||2017-02-18 14:00:12.406884|2017-02-18 14:00:12.406884
NCT00739947|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2014-07-25|||October 2008||2008-10-01|July 2014|2014-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears|A Prospective Study To Evaluate Surgical Outcomes In Subjects With Full-Thickness Rotator Cuff Tears Treated By Means Of A Double-Row Arthroscopic Repair|Completed||N/A|162|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:00:12.499758|2017-02-18 14:00:12.499758
NCT00739934|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-01-26|2010-09-17||December 2008||2008-12-01|January 2011|2011-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection|An Open-Label, Intravenous To Oral Switch, Multiple Dose Study To Evaluate The Pharmacokinetics, Safety And Tolerability Of Voriconazole In Immunocompromised Children Aged 2 To <12 Years Who Are At High Risk For Systemic Fungal Infection|Completed||Phase 2|40|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:00:12.620697|2017-02-18 14:00:12.620697
NCT00739921|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-06-30|||June 2006||2006-06-01|June 2014|2014-06-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA|PCR Analysis of Nasal Polyps for Fungal DNA|Unknown status|Recruiting|N/A|260|Anticipated|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 14:00:13.612159|2017-02-18 14:00:13.612159
NCT00739908|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2012-06-26|2012-02-14||September 2008||2008-09-01|June 2012|2012-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|CX157-200||A Study of CX157 (TriRima) for the Treatment of Depression|A Randomized, Double-Blind, Placebo-Controlled Parallel-Group, Assessment of the Efficacy, Safety and Tolerability of CX157 (TriRima) 60mg Three Times a Day (TID) in Subjects With Major Depressive Disorder|Completed||Phase 2|285|Actual|CeNeRx BioPharma Inc.|Subjects were asked to take 6 capsules 3 times a day for 6 weeks. Non-adherence with the study medication was high based on the population PK data. This likely contributed to the results in CX157 treatment group.|2|||f||||t||||||||||2017-02-18 14:00:13.720544|2017-02-18 14:00:13.720544
NCT00739895|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-10-02|||June 2007||2007-06-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Assessment of Cardiac Involvement of Common Cold in High Performing Athletes by Cardiac Magnetic Resonance Imaging (MRI)|Left Ventricular Dilatation in Athletes With Common Colds; a Cardio-vascular MRI Study|Terminated||N/A|100|Anticipated|University of Calgary|||1||f||||t||||||||||2017-02-18 14:00:14.569006|2017-02-18 14:00:14.569006
NCT00739882|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2014-01-26|2010-06-28||April 2008||2008-04-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TRUST||TRUST Study: Raptiva ® in Hand & Foot Psoriasis|A Phase IV Multicentre, Randomised, Double-blind, Placebo Controlled, Trial to Evaluate the Safety and Efficacy of Raptiva ® in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis Involving Hands and/or Feet, With or Without Pustules.|Terminated||Phase 4|76|Actual|Merck KGaA|Following the recommendation of the European Medicines Agency (EMEA) to suspend the marketing authorization of Raptiva® and the subsequent premature termination of this trial analysis of efficacy-related endpoints was not performed|2||"The study was terminated after the European Medicines Agency recommended to suspend the~   marketing authorisation of Raptiva in the European Union"|f||||||||||||||2017-02-18 14:00:14.673811|2017-02-18 14:00:14.673811
NCT00739869|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-10-16|||May 2004||2004-05-01|October 2015|2015-10-01|March 2007|Actual|2007-03-01|April 2006|Actual|2006-04-01||Observational|WHIMS-MRI||Evaluating the Effects of Hormone Replacement Therapy on Brain Function (The WHIMS-MRI Study)|Effects of Hormone Therapy on Subclinical Neurological Pathology-The WHIMS-MRI Collaborative Study|Completed||N/A|1426|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||||||2017-02-18 14:00:15.939177|2017-02-18 14:00:15.939177
NCT00739856|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-21|||January 2005||2005-01-01|August 2008|2008-08-01||||December 2005|Actual|2005-12-01||Interventional|||Use of Electroconvulsive Therapy (ECT) in Chronic, Severe, Treatment Resistant Posttraumatic Stress Disorder|Efficacy of ECT in Chronic, Severe, Antidepressant- And CBT-Refractory Posttraumatic Stress Disorder: An Open, Prospective Study|Completed||N/A|20|Actual|Government Medical College Srinagar||1|||f||||f||||||||||2017-02-18 14:00:16.037345|2017-02-18 14:00:16.037345
NCT00739843|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2016-10-31|||November 2007||2007-11-01|October 2016|2016-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients|Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients|Terminated||N/A|55|Actual|University of Chicago|||1||f||||t||||||||||2017-02-18 14:00:16.120962|2017-02-18 14:00:16.120962
NCT00690677|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-01-16|||June 2008||2008-06-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Phase II Trial of LBH589 in Refractory Colorectal Cancer|Phase II Trial of LBH589 in Refractory Colorectal Cancer|Completed||Phase 2|29|Actual|Swedish Medical Center||1|||f||||f||||||||||2017-02-18 14:18:18.84933|2017-02-18 14:18:18.84933
NCT00739830|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-06-30|||August 2008||2008-08-01|June 2015|2015-06-01|July 2012|Actual|2012-07-01|February 2011|Actual|2011-02-01||Interventional|||Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)|A Randomized Phase II Trial of Ridaforolimus (AP23573; MK-8669) Compared to Progestin or Chemotherapy in Female Adult Patients With Advanced Endometrial Carcinoma|Completed||Phase 2|130|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:00:16.209121|2017-02-18 14:00:16.209121
NCT00739817|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2009-08-15|||July 2010||2010-07-01|August 2009|2009-08-01||||||||Observational|||Screening for Primary Ciliary Dyskinesia Using Nasal Nitric Oxide|Screening for Primary Ciliary Dyskinesia Using Nasal Nitric Oxide|Unknown status|Not yet recruiting|N/A|6000|Anticipated|Ziv Hospital|||1||f||||||||||||||2017-02-18 14:00:16.317913|2017-02-18 14:00:16.317913
NCT00739791|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-09-12|||September 2003||2003-09-01|September 2012|2012-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer|Pilot Trial of Gene Expression Modulation by Intervention With Nutrition and Lifestyle|Completed||N/A|34|Anticipated|University of California, San Francisco||1|||f||||||||||||||2017-02-18 14:00:16.405353|2017-02-18 14:00:16.405353
NCT00739778|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-12-16|||August 2008||2008-08-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of a Novel Sweetener on the pH of Dental Plaque.|Effect of a Novel Sweetener on the pH of Dental Plaque.|Completed||Phase 2|24|Anticipated|Cargill||1|||f||||f||||||||||2017-02-18 14:00:16.497881|2017-02-18 14:00:16.497881
NCT00739765|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2016-01-25|2015-09-08||April 2008||2008-04-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|March 2013|Actual|2013-03-01||Interventional|||Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder|Psychotherapies for Chronic Post-Traumatic Stress Disorder|Completed||Phase 3|110|Actual|New York State Psychiatric Institute|Limited generalizability of unmedicated sample; incomplete therapist fidelity rating; limited sample size.|3|||f||||t||||||||No||2017-02-18 14:00:16.580356|2017-02-18 14:00:16.580356
NCT00739752|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-21|||June 2003||2003-06-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|June 2007|Actual|2007-06-01||Interventional|||Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics|Interventions to Increase HBV Vaccinations in STD Clinics|Completed||N/A|1749|Actual|Indiana University||7|||f||||t||||||||||2017-02-18 14:00:17.27966|2017-02-18 14:00:17.27966
NCT00739739|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-03-16||2011-03-16|August 2008||2008-08-01|March 2011|2011-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis|A Phase 2, 12 Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Proof Of Concept Study Evaluating The Efficacy And Safety Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis/Painful Bladder Syndrome.|Completed||Phase 2|161|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:00:17.406544|2017-02-18 14:00:17.406544
NCT00739713|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2010-06-24|||September 2008||2008-09-01|February 2009|2009-02-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|DESB||Effects of Sea Buckthorn Oil on Dry Eye|Effects of Sea Buckthorn Oil on Dry Eye|Unknown status|Active, not recruiting|N/A|80|Anticipated|University of Turku||2|||f||||f||||||||||2017-02-18 14:00:17.551933|2017-02-18 14:00:17.551933
NCT00739700|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2017-01-23|||June 2007|Actual|2007-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2009|Actual|2009-12-01||Observational|NIBP vs IABP||Non-invasive Blood Pressure (BP) Monitoring Compared to A-Line BP Monitoring|Accuracy and Precision of Oscillometric Blood Pressure Monitoring in the Arm, Calf and Thighs of Medical ICU Patients When Compared to Invasive Arterial Blood Pressure Monitoring|Completed||N/A|116|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||Yes|A requestor must have local IRB approval and funding to support a request of this data. It will be provided de-identified and shared authorship is required.|2017-02-18 14:00:17.656171|2017-02-18 14:00:17.656171
NCT00739687|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2009-01-29|||August 2008||2008-08-01|January 2009|2009-01-01|October 2009|Anticipated|2009-10-01|August 2009|Anticipated|2009-08-01||Interventional|BENEFICIAL||Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart Failure|A Double-Blind, Placebo-Controlled, Randomized Trial Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart Failure|Terminated||Phase 2|100|Anticipated|Synvista Therapeutics, Inc||2||Study has been termination early due to financial constraints.|f||||f||||||||||2017-02-18 14:00:17.743437|2017-02-18 14:00:17.743437
NCT00739674|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-10-09|2010-07-14||February 2008||2008-02-01|October 2015|2015-10-01|January 2010|Actual|2010-01-01|July 2009|Actual|2009-07-01||Interventional|||SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)|Randomized Open-label Trial to Evaluate the Effectiveness of Diet Management With a Losartan Titration Regimen Versus Losartan Titration Regimen Alone on Blood Pressure Reduction in Hypertensives.|Completed||Phase 3|992|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:00:17.855267|2017-02-18 14:00:17.855267
NCT00739661|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2012-04-02|2012-02-10||December 2008||2008-12-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission|Completed||Phase 2|104|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 14:00:19.090048|2017-02-18 14:00:19.090048
NCT00739648|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2012-01-31|2011-09-04||October 2008||2008-10-01|December 2011|2011-12-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients|Phase 2, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Efficacy of MP-376 Inhalation Solution Administered for 5 Days Every 28 Days to Prevent Acute Exacerbations in High Risk COPD Patients|Completed||Phase 2|322|Actual|Forest Laboratories||2|||f||||t||||||||||2017-02-18 14:00:19.525121|2017-02-18 14:00:19.525121
NCT00739635|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2016-02-03|||September 2008||2008-09-01|February 2016|2016-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|EASE||Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus|A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus|Completed||Phase 3|411|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-02-18 14:00:20.135789|2017-02-18 14:00:20.135789
NCT00739622|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2010-04-26|||July 2008||2008-07-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.|A Phase I, Open-label Drug-drug Interaction Trial to Investigate the Effect of TMC278 25 mg q.d. on the Steady State Pharmacokinetics of Ethinylestradiol and Norethindrone, in Healthy Women|Completed||Phase 1|18|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 14:00:20.266863|2017-02-18 14:00:20.266863
NCT00739609|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-05-29|||August 2008||2008-08-01|May 2015|2015-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|D-1MT||IDO Inhibitor Study for Relapsed or Refractory Solid Tumors|A Phase I Study of Indoximod [1-methyl-D-tryptophan (D-1MT)] in Patients With Relapsed or Refractory Solid Tumors|Terminated||Phase 1|17|Actual|NewLink Genetics Corporation||1||Lack of enrollment.|f||||t||||||||||2017-02-18 14:00:20.356872|2017-02-18 14:00:20.356872
NCT00739596|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-21|2016-09-20|2010-12-14||July 2008||2008-07-01|February 2011|2011-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|ATLAAST||Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans|An 8 Week Prospective, Multicenter, Randomized, Double-Blind, Active Control, Parallel Group Study to Evaluate the Efficacy and Safety of Aliskiren HCTZ Versus Amlodipine in African American Patients With Stage 2 Hypertension|Completed||Phase 4|332|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:00:20.469818|2017-02-18 14:00:20.469818
NCT00739583|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2013-06-05|2010-03-09||August 2008||2008-08-01|June 2013|2013-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|site marking||Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions|Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions|Completed||Phase 4|20|Actual|Johns Hopkins University|"Non-standardization of the amount of ink used to mark each site.~The use of only one type of marking pen.~No measurement of the amount of pressure use to apply the skin cleaning solutions.~Potential subjectivity of surgeons viewing initials"|2|||f||||f||||||||||2017-02-18 14:00:21.110784|2017-02-18 14:00:21.110784
NCT00739570|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-22|||June 2008||2008-06-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||The Effect of Manipulations of the Lumbar Spine on Six Different Outcome Measures|The Effect of Manipulations of the Lumbar Spine on Six Different Outcome Measures.|Completed||N/A|20|Actual|Universite du Quebec a Montreal||2|||f||||f||||||||||2017-02-18 14:00:21.526785|2017-02-18 14:00:21.526785
NCT00739557|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-12-03|||August 2008||2008-08-01|December 2015|2015-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||A Pilot Study to Evaluate the Systemic Inflammatory Response of Thoracoabdominal Aortic Aneurysm Repair.|A Pilot Study to Evaluate the Systemic Inflammatory Response of Thoracoabdominal Aortic Aneurysm Repair.|Withdrawn||N/A|0|Actual|The University of Texas Health Science Center, Houston|||1|Investigator left the institution, another PI has not been named.|f||||f||||||Samples Without DNA|"~     Blood and saliva samples will be obtained for the purposes of this study and will be~     maintained until complete analysis of the samples for all patients is complete.~   "|||2017-02-18 14:00:21.639659|2017-02-18 14:00:21.639659
NCT00739544|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-20|||August 2008||2008-08-01|August 2008|2008-08-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Chronic Pain After Operation for Breast Cancer|Examination of Healthy Female Subjects in the Project: Disposing Factors for Chronic Pain After Operation for Breast Cancer|Unknown status|Enrolling by invitation|Early Phase 1|20|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-02-18 14:00:21.733359|2017-02-18 14:00:21.733359
NCT00739531|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-08-20|||October 2007||2007-10-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Measuring Exhaled Nitric Oxide (eNO) Using the Apieron INSIGHT System and the Aerocrine NIOX System|Measuring the Fractional Concentration of Exhaled Nitric Oxide (eNO) Using the Apieron INSIGHT System and the Aerocrine NIOX System|Completed||N/A|150|Anticipated|Apieron|||1||f||||f||||||||||2017-02-18 14:00:21.842103|2017-02-18 14:00:21.842103
NCT00739518|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2016-06-29|||October 2004||2004-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams|Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies|Active, not recruiting||N/A|500|Anticipated|University of Michigan||1|||f||||f||||||||No||2017-02-18 14:00:21.941485|2017-02-18 14:00:21.941485
NCT00739505|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-05-27|||August 2008||2008-08-01|May 2014|2014-05-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)|A Multicenter, Open-Label, Dose Escalating Study of the Safety, Tolerability and Pharmacology of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)|Completed||Phase 1|6|Actual|Alexion Pharma GmbH||2|||f||||t||||||||||2017-02-18 14:00:22.046049|2017-02-18 14:00:22.046049
NCT00739492|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-12-05|||June 2008||2008-06-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||Testing Strategies for Weight Loss, II||Completed||Phase 1/Phase 2|66|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-02-18 14:00:22.160865|2017-02-18 14:00:22.160865
NCT00739479|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2012-10-25|||August 2008||2008-08-01|August 2008|2008-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||CCRC: Effects of Partially Hydrolyzed Whey Peptides (PHWP) On Weight Loss In Individuals With The Metabolic Syndrome (METS)|CCRC: Effects of Partially Hydrolyzed Whey Peptides (PHWP) On Weight Loss In Individuals With The Metabolic Syndrome (METS)|Completed||N/A|35|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 14:00:22.26413|2017-02-18 14:00:22.26413
NCT00739466|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2016-01-17|||September 2008||2008-09-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|BLAST||Biorest Liposomal Alendronate With Stenting sTudy (BLAST)|Intravenous Liposomal Alendronate Infusion in Subjects Undergoing Bare Metal Coronary Stent Implantation|Completed||Phase 2|226|Actual|BIOrest Ltd.||3|||f||||f||||||||||2017-02-18 14:00:22.368348|2017-02-18 14:00:22.368348
NCT00739453|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2011-12-21|||October 2008||2008-10-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)|A Phase I Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®) in Patients With Advanced Solid Tumors|Completed||Phase 1|95|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 14:00:22.490892|2017-02-18 14:00:22.490892
NCT00017810|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-13|2005-12-08||||||April 2001|2001-04-01||||||||Interventional|||The Healthy Life Choices Project in HIV-Positive Patients||Unknown status|Recruiting|Phase 1|||National Institute of Nursing Research (NINR)|||||f||||||||||||||2017-02-18 18:10:23.339465|2017-02-18 18:10:23.339465
NCT00739440|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2013-08-06|||August 2008||2008-08-01|August 2013|2013-08-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Randomized Controlled Trial to Compare Two Anti-scorpion Serums|Randomized Controlled Trial to Evaluate Efficiency and Safety of the Polyvalent Antiscorpion Serum of Birmex Versus Other Commercial Serum|Completed||Phase 4|120|Actual|Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.||2|||f||||f||||||||||2017-02-18 14:00:22.60077|2017-02-18 14:00:22.60077
NCT00739414|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2014-04-16|||July 2008||2008-07-01|March 2010|2010-03-01||||November 2009|Actual|2009-11-01||Interventional|||Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors|A Phase IA, Dose-escalating Study of LBH589 Administered Intravenously in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|14|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:00:22.693458|2017-02-18 14:00:22.693458
NCT00739401|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2011-09-29||2011-09-17|May 2006||2006-05-01|September 2011|2011-09-01|July 2013|Anticipated|2013-07-01|July 2008|Actual|2008-07-01||Interventional|||Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm|Endologix Powerlink® Suprarenal Proximal Cuff|Unknown status|Active, not recruiting|Phase 2|44|Actual|Endologix||1|||f||||t||||||||||2017-02-18 14:00:22.798257|2017-02-18 14:00:22.798257
NCT00739388|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2013-04-09|||July 2008||2008-07-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|January 2010|Actual|2010-01-01||Interventional|||Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy|5-Azacytidine to Treat Acute Myeloid Leukemia in Elderly or Frail Patients Not Suitable for Intensive Chemotherapy. A Multicenter Phase II Trial.|Completed||Phase 2|47|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||||2017-02-18 14:00:22.912259|2017-02-18 14:00:22.912259
NCT00739375|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2013-12-12|||September 2011||2011-09-01|December 2013|2013-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.|The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.|Completed||Phase 1|50|Actual|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-02-18 14:00:23.05454|2017-02-18 14:00:23.05454
NCT00739362|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2017-01-24|||August 1, 2008||2008-08-01|January 11, 2017|2017-01-11|January 5, 2017|Actual|2017-01-05|January 5, 2017|Actual|2017-01-05||Interventional|||Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment|The Effects of Transcranial Direct Current Stimulation (TDCS) on Food Intake and Weight Loss|Completed||Phase 2|148|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 14:00:23.138476|2017-02-18 14:00:23.138476
NCT00739349|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2016-05-26||2015-04-29|August 2008||2008-08-01|June 2015|2015-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye|A Phase II, Multi-Center, Double-Masked, Randomized Study of NOVA22007 0.05% and 0.1% Cyclosporine Ophthalmic Cationic Emulsions Compared to Vehicle for the Treatment of the Signs and Symptoms of Dry Eye|Completed||Phase 2|132|Actual|Santen SAS||3|||f||||t||||||||||2017-02-18 14:00:23.26134|2017-02-18 14:00:23.26134
NCT00739336|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-08-11|2015-06-01||July 2008||2008-07-01|August 2016|2016-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Diabetes Prevention and Control in the Workplace: A Pilot Study|Diabetes Prevention and Control in the Workplace: A Pilot Study|Completed||N/A|45|Actual|State University of New York - Upstate Medical University||2|||f||||f||||||||||2017-02-18 14:00:23.359297|2017-02-18 14:00:23.359297
NCT00739323|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-07-16|||December 2006||2006-12-01|July 2014|2014-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|EPC||Impaired Wound Healing in Diabetic Foot Ulceration|Impaired Wound Healing in Diabetic Foot Ulceration|Completed||N/A|137|Actual|Beth Israel Deaconess Medical Center|||1||f||||t||||||||||2017-02-18 14:00:23.736352|2017-02-18 14:00:23.736352
NCT00739310|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-08-24|2015-04-20||August 2008||2008-08-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|October 2010|Actual|2010-10-01||Interventional||Patients who completed 12 months of prospective therapy|Study Assessing High-Frequency Chest Wall Oscillation (HFCWO) in Preventing Pulmonary Exacerbations|A Pilot Study to Assess the Efficacy and Effectiveness of High-Frequency Chest Wall Oscillation (HFCWO) in Preventing Pulmonary Exacerbations in Children With Muscle Weakness and Restrictive Lung Disease CR-0088|Completed||N/A|29|Actual|Hill-Rom|Study design was sub-optimal due to lack of control group and lack of randomization|1|||f||||f||||||||||2017-02-18 14:00:23.819407|2017-02-18 14:00:23.819407
NCT00739297|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-05-28|2010-01-14||July 2008||2008-07-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)|A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma|Completed||Phase 1|68|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 14:00:24.031904|2017-02-18 14:00:24.031904
NCT00739284|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-20|||August 2008||2008-08-01|August 2008|2008-08-01||||August 2008|Anticipated|2008-08-01||Interventional|JJVsPCN08||A Prospective Comparison Between Ureteral Stent and Nephrostomy Tube for an Urgent Drainage of Obstructed Kidney||Unknown status|Recruiting|N/A|60|Anticipated|Rabin Medical Center||2|||f||||t||||||||||2017-02-18 14:00:24.64|2017-02-18 14:00:24.64
NCT00739271|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-21|||October 2005||2005-10-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|||Early Enteral Feeding After Intestinal Anastomosis|Early Enteral Feeding After Intestinal Anastomosis|Completed||N/A|82|Actual|Christian Medical College and Hospital, Ludhiana, India||2|||f||||f||||||||||2017-02-18 14:00:24.72094|2017-02-18 14:00:24.72094
NCT00739258|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2012-01-20|||April 2008||2008-04-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison|Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison and Set up the Notional Halfway Home in Union Area of Medical Facility|Completed||N/A|700|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||3||f||||f||||||||||2017-02-18 14:00:24.815354|2017-02-18 14:00:24.815354
NCT00739245|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-08-20|||||||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:00:24.896548|2017-02-18 14:00:24.896548
NCT00737451|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2012-03-26|||March 2008||2008-03-01|September 2009|2009-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Association of Thyroid Autoimmunity and Chronic Urticaria|Association of Thyroid Autoimmunity and Chronic Urticaria in Taiwan|Completed||N/A|155|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-02-18 14:00:59.913453|2017-02-18 14:00:59.913453
NCT00739232|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2009-07-31|||September 2008||2008-09-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HSD-016|Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HSD-016 Administered Orally to Healthy Subjects|Completed||Phase 1|74|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:00:24.946215|2017-02-18 14:00:24.946215
NCT00739219|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2009-01-19|||December 2006||2006-12-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|Outcomes||Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)|Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO) Using the Apieron NO Analyzer|Terminated||Phase 4|260|Actual|Apieron||2||Study terminated due to lack of care guidelines in the protocol.|f||||f||||||||||2017-02-18 14:00:25.034083|2017-02-18 14:00:25.034083
NCT00739206|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2010-06-15|||August 2008||2008-08-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.|A Multicenter, Open Label, Efficacy and Safety Study of Parenteral SAR97276A in the Treatment of Symptomatic Uncomplicated and Severe Malaria in Adults and Children|Terminated||Phase 2|113|Actual|Sanofi||3||"In accordance with protocol's predefined criteria and Data Monitoring Committee recommendation~   due to insufficient level of efficacy"|f||||t||||||||||2017-02-18 14:00:25.165716|2017-02-18 14:00:25.165716
NCT00739193|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-10-23|||August 2008||2008-08-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure|A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure|Withdrawn||Phase 2|75|Anticipated|Prism Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:00:25.275569|2017-02-18 14:00:25.275569
NCT00739180|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2012-11-02|||November 2007||2007-11-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes|Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes|Completed||N/A|45|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 14:00:25.354734|2017-02-18 14:00:25.354734
NCT00739167|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-10-14|||April 2008||2008-04-01|October 2015|2015-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer|A Quality of Life Study for Patients With Primary or Metastatic Liver Cancer Who Are Treated With Radioembolization (Y90 Microspheres) or Transcatheter Arterial Embolization (TACE)|Completed||N/A|74|Actual|Northwestern University|||3||f||||t||||||||||2017-02-18 14:00:25.448917|2017-02-18 14:00:25.448917
NCT00739154|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-08-20|||November 2008||2008-11-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Observational|||Protective Effect of Phenytoin on Glaucoma|Clinical Cohort Study of Association Between Steady State Phenytoin Treatment and Better Clinical Parameters of Glaucoma|Unknown status|Not yet recruiting|N/A|200|Anticipated|Rabin Medical Center|||3||f||||f||||||||||2017-02-18 14:00:25.743002|2017-02-18 14:00:25.743002
NCT00739141|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-12-07|||August 2008||2008-08-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.|A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.|Recruiting||Phase 2|80|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:00:25.85599|2017-02-18 14:00:25.85599
NCT00739128|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-04-14|||February 2009||2009-02-01|April 2011|2011-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Response to Hepatitis B Vaccine in Celiac Disease Patients|Intradermal Immunization Against Hepatitis B Virus in Celiac Disease- a Randomized Controlled Trial|Terminated||N/A|210|Anticipated|Shaare Zedek Medical Center||2||"Believed that a better study was to compare the response to engerix B vs Sci-B-Vac vaccine in~   this patient group."|f||||f||||||||||2017-02-18 14:00:25.982907|2017-02-18 14:00:25.982907
NCT00739115|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-08-25|||September 2008||2008-09-01|August 2015|2015-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study|The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study|Completed||N/A|13|Actual|Hawaii Pacific Health||2|||f||||t||||||||||2017-02-18 14:00:26.096407|2017-02-18 14:00:26.096407
NCT00739102|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2014-03-28|2013-07-08||August 2008||2008-08-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|May 2011|Actual|2011-05-01||Interventional|STROLL|Modified Intent-To-Treat (ITT) Population|S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease|S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease (STROLL)|Completed||N/A|250|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 14:00:26.207576|2017-02-18 14:00:26.207576
NCT00739089|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2017-01-23|||August 2008||2008-08-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Presep and Vascath Interaction Study|A Pilot Study to Compare the Interaction Between Central Venous Mixed Venous Oxygen Saturation Catheters and Central Venous Hemodialysis Catheters|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences|||1|Study stopped due to a lack of enrollment.|f||||f||||||||Yes|de-identified data would have been shared with any other investigator with a local IRB approved protocol to evaluate de-identified patient data|2017-02-18 14:00:26.724005|2017-02-18 14:00:26.724005
NCT00739076|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-04-01|||August 2007||2007-08-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|VRHTrauma||Pain Control After Trauma|Pain Control After Trauma|Completed||N/A|184|Actual|University of Washington||3|||f||||f||||||||||2017-02-18 14:00:26.821805|2017-02-18 14:00:26.821805
NCT00739063|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2012-02-10|2011-12-21||July 2008||2008-07-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer|Study of Erlotinib, Small Molecule Targeting Epidermal Growth Factor Receptor (EGFR) in Treatment of Patients w/EGFR-overexpressing 'Triple Receptor-negative' Metastatic Carcinoma of Breast That Progressed on Anthracyclines and Taxanes|Terminated||Phase 2|11|Actual|M.D. Anderson Cancer Center||1||Poor Accrual|f||||f||||||||||2017-02-18 14:00:26.923481|2017-02-18 14:00:26.923481
NCT00739050|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-09-03|2010-08-26||September 2007||2007-09-01|September 2015|2015-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)|Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus|Terminated||Phase 4|4|Actual|Merck Sharp & Dohme Corp.|The Investigator was not able to recruit the required patients and was not able to get the necessary equipment. The protocol was terminated for Administrative Reasons.|2|||f||||||||||||||2017-02-18 14:00:27.177829|2017-02-18 14:00:27.177829
NCT00739037|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2009-08-03|||August 2008||2008-08-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease|A Randomized, Single Dose, Placebo-Controlled, 2 Period Crossover Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAZ 417 in Cerebrospinal Fluid, When Administered Orally to Subjects With Alzheimer's Disease|Terminated||Phase 1|10|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:00:27.476133|2017-02-18 14:00:27.476133
NCT00739024|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2012-08-22|2011-07-22||April 2008||2008-04-01|August 2012|2012-08-01|September 2010|Actual|2010-09-01|April 2009|Actual|2009-04-01||Interventional|||A Study of a Melatonin Receptor Agonist to Prevent Migraine|A Randomized, Double-blind Placebo-controlled, Parallel Group Study to Study the Efficacy and Tolerability of Ramelteon (Rozerem) in the Prophylaxis of Migraine|Terminated||Phase 2|18|Actual|Swedish Medical Center|Early termination leading to small numbers of subjects analyzed|2||Recruitment slow and administrative reasons|f||||f||||||||||2017-02-18 14:00:27.572501|2017-02-18 14:00:27.572501
NCT00739011|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-12-07|||August 2008||2008-08-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Validation of HC250 and HC240 Series.|Validation of Customer Requirements for the HC244/HC254|Completed||N/A|40|Anticipated|Fisher and Paykel Healthcare||1|||f||||f||||||||||2017-02-18 14:00:27.93281|2017-02-18 14:00:27.93281
NCT00738998|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2017-02-02|||June 2008||2008-06-01|February 2017|2017-02-01||||June 2018|Anticipated|2018-06-01||Interventional|||Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer|Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors|Active, not recruiting||N/A|102|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:00:28.030279|2017-02-18 14:00:28.030279
NCT00738985|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-03-23|||November 2009||2009-11-01|March 2015|2015-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors|Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Patients With Mixed Hyperlipidemia and Two or More Risk Factors to Cardiovascular Disease.|Withdrawn||Phase 4|0|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||2||The study was cancelled due to budget limitations|f||||f||||||||||2017-02-18 14:00:28.146806|2017-02-18 14:00:28.146806
NCT00738972|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2013-08-17|2013-07-20||January 2008||2008-01-01|August 2013|2013-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)|Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients.|Terminated||Phase 3|12|Actual|Fundación Lindavista del Corazón AC|This study was terminated early and due to sample size it was not possible to perform further statistical analyses.|4||"Study terminated early due to sample size, not possible to perform further statistical~   analysis."|f||||||||||||||2017-02-18 14:00:28.245663|2017-02-18 14:00:28.245663
NCT00738959|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2008-10-28|||June 2008||2008-06-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese|A Phase I, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0328 in Healthy Young Japanese and Caucasian Male Volunteers After Oral Single and Multiple Ascending Doses|Completed||Phase 1|64|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:00:28.609957|2017-02-18 14:00:28.609957
NCT00738946|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2010-06-03|||August 2008||2008-08-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|IPTc/ITNs||A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African Children|A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African Children|Completed||N/A|6000|Anticipated|London School of Hygiene and Tropical Medicine||1|||f||||t||||||||||2017-02-18 14:00:28.697803|2017-02-18 14:00:28.697803
NCT00738933|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-02-11|||April 2008||2008-04-01|February 2011|2011-02-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Dietary Phytosterols and Human Aortic Valve|Effects of Dietary Plant Sterols and Stanols on Sterol Composition and Structure of the Human Aortic Valve|Unknown status|Recruiting|N/A|60|Anticipated|Helsinki University||3|||f||||f||||||||||2017-02-18 14:00:28.809227|2017-02-18 14:00:28.809227
NCT00738920|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-05-16|||August 2010||2010-08-01|May 2016|2016-05-01|August 2017|Anticipated|2017-08-01|June 2016|Anticipated|2016-06-01||Interventional|||Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome|Self Administered CBT for IBS: A Multisite Trial|Active, not recruiting||Phase 2/Phase 3|462|Actual|State University of New York at Buffalo||3|||f||||t||||||||Undecided||2017-02-18 14:00:28.910952|2017-02-18 14:00:28.910952
NCT00738907|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-09-23|||November 2006||2006-11-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Observational|||Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.|Assessment of Beta Cell Mass by PET Scans With [11C] DTBZ in Longstanding Type 1 Diabetes|Completed||N/A|18|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||||||2017-02-18 14:00:29.009675|2017-02-18 14:00:29.009675
NCT00738894|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-04-21|||August 2008||2008-08-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|HLX 06-03||GORE® HELEX® Septal Occluder / GORE® Septal Occluder for Patent Foramen Ovale (PFO) Closure in Stroke Patients - The Gore REDUCE Clinical Study|GORE® HELEX® Septal Occluder / GORE® Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients With Patent Foramen Ovale (PFO)|Active, not recruiting||Phase 3|664|Anticipated|W.L.Gore & Associates||2|||f||||t||||||||||2017-02-18 14:00:29.092492|2017-02-18 14:00:29.092492
NCT00451659|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-03-21|||February 2005||2005-02-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Observational|||Characterization of Recently Deployed Veterans|Characterization of Recently Deployed Veterans|Completed||Phase 3|500||Tuscaloosa Research & Education Advancement Corporation|||||f||||f||||||||||2017-02-18 15:45:33.96801|2017-02-18 15:45:33.96801
NCT00738881|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2015-10-06|2013-11-27||October 2008||2008-10-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2011|Actual|2011-12-01||Interventional|MARVEL||Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer|MARVEL: Marker Validation of Erlotinib in Lung Cancer- A Phase III Biomarker Validation Study of Second-Line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Randomized to Pemetrexed Versus Erlotinib|Terminated||Phase 3|23|Actual|National Cancer Institute (NCI)||2||Slow accrual|f||||||||||||||2017-02-18 14:00:29.272311|2017-02-18 14:00:29.272311
NCT00738868|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2011-05-12|||October 2007||2007-10-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery|Re-irradiation and Stereotactic Cetuximab in Patients With Recurrent Carcinoma of the Head and Neck|Completed||Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:00:32.586603|2017-02-18 14:00:32.586603
NCT00738855|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-11-25|||February 2006||2006-02-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Clinical Impacts of Oral Gastrografin Follow Through in Adhesive Small Bowel Obstruction (SBO)|Clinical Impacts of Oral Gastrografin Follow Through in Adhesive Small Bowel Obstruction (SBO).|Completed||N/A|100|Actual|Mansoura University||2|||f||||t||||||||||2017-02-18 14:00:32.688948|2017-02-18 14:00:32.688948
NCT00738842|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2010-12-02|||May 2008||2008-05-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Uric Acid Study in Healthy Male Volunteers|A Randomised, Double-Blind, Two-Period Crossover Study to Assess the Effect of AZD6140 on Uric Acid Levels in Healthy Male Volunteers|Completed||Phase 1|24|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:00:32.804564|2017-02-18 14:00:32.804564
NCT00738829|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2013-08-29|||October 2008||2008-10-01|August 2013|2013-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL|Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide Followed by Rituximab/Lenalidomide in Untreated Chronic Lymphocytic Leukemia (CLL) - a Dose-finding Study With Concomitant Evaluation of Safety and Efficacy.|Completed||Phase 1/Phase 2|45|Actual|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||t||||||||||2017-02-18 14:00:32.903309|2017-02-18 14:00:32.903309
NCT00738816|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-20|2010-12-13|||April 2009||2009-04-01|December 2010|2010-12-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|||Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic Department|The Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic Department.|Completed||N/A|108|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 14:00:33.049916|2017-02-18 14:00:33.049916
NCT00738803|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2009-02-05|||June 2007||2007-06-01|February 2009|2009-02-01|April 2010|Anticipated|2010-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement|Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement|Unknown status|Recruiting|N/A|100|Anticipated|Tennessee Orthopedic Alliance||1|||f||||f||||||||||2017-02-18 14:00:33.143179|2017-02-18 14:00:33.143179
NCT00738790|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2010-04-14|||November 2003||2003-11-01|April 2010|2010-04-01|November 2013|Anticipated|2013-11-01|November 2010|Anticipated|2010-11-01||Interventional|||Preoperative Radiotherapy and Local Excision in Rectal Cancer|The Randomised Study of Preoperative Radiotherapy and Local Excision for Radiosensitive Rectal Cancer|Unknown status|Recruiting|Phase 3|102|Anticipated|Polish Colorectal Cancer Study Group||2|||f||||t||||||||||2017-02-18 14:00:33.252524|2017-02-18 14:00:33.252524
NCT00738777|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-05-10|||July 2008||2008-07-01|May 2016|2016-05-01|June 2020|Anticipated|2020-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer|A Randomized, Prospective Trial of 2-6 Weeks Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer: Anastrozole +/- Fulvestrant or Tamoxifen Exposure - Response in Molecular Profile (AFTER-study).|Recruiting||Phase 2|250|Anticipated|The Netherlands Cancer Institute||4|||f||||f||||||||||2017-02-18 14:00:33.357242|2017-02-18 14:00:33.357242
NCT00738764|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-01-05|||July 2008||2008-07-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Trial of PDL192 in Subjects With Advanced Solid Tumors|A Phase 1, Multicenter, Open-Label, Dose Escalation Trial of PDL192 in Subjects With Advanced Solid Tumors|Completed||Phase 1|30|Actual|Abbott||6|||f||||f||||||||||2017-02-18 14:00:33.496274|2017-02-18 14:00:33.496274
NCT00738751|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2015-02-03|||November 2008||2008-11-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|August 2013|Actual|2013-08-01||Interventional|||Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers|Phase I Study of LBH589 in Combination With Erlotinib for Advanced Aerodigestive Tract Cancers (CLBH5889CUS11T)|Completed||Phase 1|44|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 14:00:33.607865|2017-02-18 14:00:33.607865
NCT00738738|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-11-30|||January 2009||2009-01-01|November 2012|2012-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)|A Phase 3, 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder|Withdrawn||Phase 3|0|Actual|Pfizer||1||Please see Detailed Description for termination reason.|f||||f||||||||||2017-02-18 14:00:33.720831|2017-02-18 14:00:33.720831
NCT00738725|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-01-26|||January 2008||2008-01-01|October 2013|2013-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population|A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population Combining Targeted and Unsupervised Biological Measurements With Non-Invasive Imaging Modalities to Identify Biomarkers That Predict Near Term (1-3-years) Outcomes|Completed||N/A|7687|Actual|BG Medicine, Inc|||3||f||||f||||||Samples With DNA|"~     Serum, plasma, RNA and DNA~   "|||2017-02-18 14:00:33.833497|2017-02-18 14:00:33.833497
NCT00738712|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-12-15|||May 2011||2011-05-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams|Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams|Active, not recruiting||N/A|20|Anticipated|University of Michigan||1|||f||||t||||||||No||2017-02-18 14:00:33.928718|2017-02-18 14:00:33.928718
NCT00682773|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-08-02|||September 2006||2006-09-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Interventional|||Enhancing the Safety of Warfarin in Nursing Homes|Enhancing the Safety of Warfarin in Nursing Homes|Completed||N/A|26|Anticipated|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-02-18 14:21:15.452361|2017-02-18 14:21:15.452361
NCT00738699|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2015-04-24||2013-11-18|September 2008||2008-09-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|December 2011|Actual|2011-12-01||Interventional|FAR-122||An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer|A Randomized, Double Blind, Placebo-Controlled Study of the Efficacy and Safety oF MORAb-003(Farletuzumab) in Combination With Paclitaxel Therapy in Subjects With Platinum-Resistant or Refractory Relapsed Ovarian Cancer|Terminated||Phase 2|412|Actual|Morphotek||2||study did not meet pre-specified criteria for continuation following interim futility analysis|f||||t||||||||||2017-02-18 14:00:34.235015|2017-02-18 14:00:34.235015
NCT00738686|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-08-20|||June 2004||2004-06-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|AUTAX||Austrian Multivessel Taxus-Stent Registry|Austrian Multivessel Taxus-Stent Registry|Completed||Phase 4|441|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-02-18 14:00:34.393996|2017-02-18 14:00:34.393996
NCT00738673|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-12-12|2012-12-12||July 2008||2008-07-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer|An Open-Label, Multi-Centre, Uncontrolled, Exploratory Trial Investigating Degarelix One-Month Dosing Regimen as Second-Line Hormonal Treatment After PSA-Failure in GnRH Agonist Treated Patients With Prostate Cancer|Completed||Phase 2|37|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:00:34.532481|2017-02-18 14:00:34.532481
NCT00738660|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2008-08-19|||February 2007||2007-02-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|START1DM||Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy|Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy|Completed||Phase 3|30|Actual|Postgraduate Institute of Medical Education and Research||1|||f||||f||||||||||2017-02-18 14:00:35.540212|2017-02-18 14:00:35.540212
NCT00738647|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2011-11-04|||May 2007||2007-05-01|November 2011|2011-11-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Assessment of a New Resin-based Composite Filling Material|Assessment of a New Resin-based Composite Restorative Material|Active, not recruiting||N/A|72|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 14:00:35.650136|2017-02-18 14:00:35.650136
NCT00738634|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-07-18|||July 2008||2008-07-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|IN2SHAPE||IN2SHAPE: A Study of Physical Activity and Depressive Symptoms in Adolescence|IN2SHAPE Intervention to Stay Healthy and Physical Everyday: A Randomised Controlled Trial for the Feasibility and Effectiveness of a Self-motivated Physical Activity Intervention on the Mental Health of Adolescents.|Completed||N/A|26|Actual|Australian National University||3|||f||||||||||||||2017-02-18 14:00:35.739013|2017-02-18 14:00:35.739013
NCT00738621|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2013-12-18|||July 2008||2008-07-01|August 2008|2008-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients|A Comparison of Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients|Completed||Phase 4|100|Actual|Scott and White Hospital & Clinic||2|||f||||t||||||||||2017-02-18 14:00:35.846959|2017-02-18 14:00:35.846959
NCT00738608|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2009-09-17|||June 2006||2006-06-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Observational|||Etoricoxib as a Pre-emptive Analgesic in Therapeutic Arthroscopy|Etoricoxib as a Pre-emptive Analgesic in Therapeutic Arthroscopy|Completed||N/A|66|Anticipated|Marienkrankenhaus Soest|||2||f||||f||||||||||2017-02-18 14:00:35.96222|2017-02-18 14:00:35.96222
NCT00738595|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2009-05-28|||August 2008||2008-08-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.|Phase II Multicentre, Randomised, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation, Effect on it Own and in Combination With Open Label Nicotine Replacement Therapy.|Completed||Phase 2|400|Anticipated|Evotec Neurosciences GmbH||4|||f||||f||||||||||2017-02-18 14:00:36.056525|2017-02-18 14:00:36.056525
NCT00738582|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-11-13||2013-11-18|December 2008||2008-12-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|June 2011|Actual|2011-06-01||Interventional|Amatuximab||An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma|An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma|Completed||Phase 2|89|Actual|Morphotek||1|||f||||t||||||||||2017-02-18 14:00:36.166634|2017-02-18 14:00:36.166634
NCT00738569|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-03-23|||July 2008||2008-07-01|March 2016|2016-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen|A Pilot Study to Assess the Downregulation of HIV-1 Associated Chronic Inflammation in Patients With Limited Immunologic Responses When Raltegravir is Added to a Virologically Suppressed HAART Regimen|Completed||N/A|30|Actual|National Jewish Health||1|||f||||f||||||||||2017-02-18 14:00:36.294152|2017-02-18 14:00:36.294152
NCT00738556|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2009-01-28|||January 2003||2003-01-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Spot Drug-Eluting Stenting for Long Coronary Stenoses|Spot Drug-Eluting vs Full Cover Stenting for Long Coronary Stenoses: a Randomized Clinical Study|Completed||N/A|179|Actual|Cardiovascular Research Society, Greece||2|||f||||t||||||||||2017-02-18 14:00:36.391403|2017-02-18 14:00:36.391403
NCT00738543|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2013-06-18|2009-07-17||August 2008||2008-08-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Povidone-iodine Against Sodium Hypochlorite as Skin Antiseptics|Comparative Study of 10% Povidone-iodine Against 10% Sodium Hypochlorite as Skin Antiseptics in Human Volunteers.|Completed||Phase 3|48|Actual|Universidad de Guanajuato||1|||f||||f||||||||||2017-02-18 14:00:36.710247|2017-02-18 14:00:36.710247
NCT00738530|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-05-16|2016-03-22||June 2004||2004-06-01|May 2016|2016-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Intent-to-treat population (ITT) included all participants randomized into the study.|A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy|A Randomised, Double-blind Study to Evaluate the Efficacy and Safety of Avastin Plus Roferon Compared With Placebo Plus Roferon on Overall Survival and Tumor Assessment in Nephrectomised Patients With Metastatic Clear Cell Renal Cell Carcinoma|Completed||Phase 3|649|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:00:37.01921|2017-02-18 14:00:37.01921
NCT00037193|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Acute Regulation of Parathyroid Hormone by Dietary Phosphate|Acute Regulation of Parathyroid Hormone by Dietary Phosphate|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:06:05.672398|2017-02-18 18:06:05.672398
NCT00738517|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-05-10|||September 2008||2008-09-01|May 2016|2016-05-01|December 2011|Anticipated|2011-12-01|June 2011|Anticipated|2011-06-01||Interventional|||Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction|Immunoadsorption With Subsequent Immunoglobulin Substitution for Patients With Heart Failure After Myocardial Infarction|Withdrawn||Phase 1/Phase 2|0|Actual|University Medicine Greifswald||2||PI left center|f||||f||||||||||2017-02-18 14:00:37.989844|2017-02-18 14:00:37.989844
NCT00738504|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2008-08-19|||June 2008||2008-06-01|August 2008|2008-08-01||||||||Observational|||Intensive Insulin Therapy and Acute Kidney Injury. Analysis Using RIFLE Criteria.|INTENSIVE INSULIN THERAPY REALLY REDUCES THE INCIDENCE OF ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS? An Analysis Using the RIFLE Criteria for Definition of Acute Kidney Injury.|Completed||N/A|337||Hospital Sao Domingos|||4||f||||t||||||||||2017-02-18 14:00:38.110521|2017-02-18 14:00:38.110521
NCT00738491|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-12-01|||August 2008||2008-08-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Effects of Ambient Air Pollution Exposure in Patients With Stable Angina Pectoris During Normal Daily Activities|Effects of Ambient Air Pollution Exposure in Patients With Stable Angina Pectoris During Normal Daily Activities|Terminated||N/A|1|Actual|University of Edinburgh|||2|Study performed in alternative location (Beijing China)|f||||f||||||Samples Without DNA|"~     Plasma samples Serum samples~   "|||2017-02-18 14:00:38.199283|2017-02-18 14:00:38.199283
NCT00738478|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2009-02-17|||February 2006||2006-02-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients|Phase III Study for the Significance of Nasogastric Decompression Tube After Curative Distal Gastrectomy for Gastric Cancer Patients|Completed||Phase 3|180|Actual|Wakayama Medical University||2|||f||||t||||||||||2017-02-18 14:00:38.306757|2017-02-18 14:00:38.306757
NCT00738452|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-09-30|||August 2008||2008-08-01|September 2016|2016-09-01||||November 2017|Anticipated|2017-11-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy|A Phase I Trial of Radioimmunotherapy (Y-90-Mx-DTPA-cT84.66) After Completion of Radiation Therapy Alone, or Radiation Therapy Plus Systemic Therapy in Unresectable or Medically Inoperable, Non-metastatic CEA-Producing Stage I-IIIB Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1|10|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:00:38.404572|2017-02-18 14:00:38.404572
NCT00738439|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-08-31|||October 2008||2008-10-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|PON||Multi-Center Prospective Evaluation of Operative Versus Nonoperative Treatment for Adult Spinal Deformity|Multi-Center Prospective Evaluation of Operative Versus Nonoperative Treatment for Adult Spinal Deformity: Differentiating Clinical and Radiographic Features and Evaluation of Treatment Outcomes|Enrolling by invitation||N/A|936|Anticipated|International Spine Study Group Foundation|||2||f||||f||||||||||2017-02-18 14:00:38.51391|2017-02-18 14:00:38.51391
NCT00738426|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2014-04-01|2014-02-25||October 2007||2007-10-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Study of Low Level Laser Therapy for Body Contouring|A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia ML Scanner (MLS) on Body Contouring of the Waist, Hips and Thighs Clinical Study Protocol|Completed||N/A|72|Actual|Erchonia Corporation||2|||f||||f||||||||||2017-02-18 14:00:38.605391|2017-02-18 14:00:38.605391
NCT00738413|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2010-11-04|||August 2008||2008-08-01|November 2010|2010-11-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both|An Iron Balance Study Comparing Deferasirox, Deferoxamine and the Combination of Both Drugs|Unknown status|Recruiting|Phase 1/Phase 2|6|Anticipated|Weill Medical College of Cornell University||3|||f||||t||||||||||2017-02-18 14:00:38.998775|2017-02-18 14:00:38.998775
NCT00738400|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-11-12|2010-11-26||November 2008||2008-11-01|November 2015|2015-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome|Double-blind, Placebo Controlled, Randomized Study of Vardenafil to Determine Efficacy on Erectile Dysfunction (ED) in Men With ED and Metabolic Syndrome (ED-METABOLIC)|Completed||Phase 4|150|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:00:39.318884|2017-02-18 14:00:39.318884
NCT00738387|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-12-29||2012-05-01|December 2008||2008-12-01|May 2012|2012-05-01||||December 2010|Actual|2010-12-01||Interventional|ATTRACT-2||A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer|A Phase III, Randomized, Double-blind, Placebo-controlled Multi-center Study of ASA404 in Combination With Docetaxel in Second-line Treatment of Patients With Locally Advanced or Metastatic (Stage IIIb/IV) Non-small Cell Lung Cancer (NSCLC)|Terminated||Phase 3|900|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:00:39.841931|2017-02-18 14:00:39.841931
NCT00738374|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2015-02-12|2014-12-19||November 2008||2008-11-01|February 2015|2015-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||All enrolled participants.|A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.|A Study of Chlorambucil Plus MabThera as Induction Therapy Followed in Responders by Maintenance Therapy Versus Observation on Response Rate in Patients >=60 Years With Previously Untreated Chronic Lymphocytic Leukemia|Completed||Phase 2|97|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:00:40.127674|2017-02-18 14:00:40.127674
NCT00738361|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-01-14|2015-10-28||August 2008||2008-08-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|July 2012|Actual|2012-07-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery|A Phase 2 Study Of Weekly Infusion Nab-paclitaxel (Paclitaxel Protein-bound Particles for Injectable Suspension) In Patients With Unresectable And Metastatic Uveal Melanoma|Completed||Phase 2|4|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:00:41.137545|2017-02-18 14:00:41.137545
NCT00738348|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-06-06|||April 2007||2007-04-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|KMS||Effect of Perioperative Sivelstat Administration for Liver Resection|Effect of Perioperative Sivelstat Administration for Liver Resection|Completed||N/A|50|Actual|Kochi University||2|||f||||t||||||||||2017-02-18 14:00:41.471934|2017-02-18 14:00:41.471934
NCT00735215|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2009-12-21|||October 2008||2008-10-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|||||Observational|||Faslodex Registry: Fulvestrant in Current Clinical Practice|Faslodex Registry: a Belgian Observational Study to Evaluate the Use of Fulvestrant in Current Clinical Practice|Completed||N/A|200|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:01:54.591426|2017-02-18 14:01:54.591426
NCT00738335|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2012-10-02|||January 2009||2009-01-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases|A Phase I Open-Label, Dose-Finding Study to Evaluate the Safety and Efficacy of Concurrent Radiosurgery and Erlotinib Administration in Non-Small Cell Lung Cancer Patients With Brain Metastases|Withdrawn||Phase 1|0|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 14:00:41.575117|2017-02-18 14:00:41.575117
NCT00738322|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2009-06-29|||July 2008||2008-07-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|||||Interventional|||To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects|A Single-Centre, Single-Blind, Randomised, Placebo-Controlled, Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD1305 in Healthy Male Japanese Subjects|Completed||Phase 1|36|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:00:41.688176|2017-02-18 14:00:41.688176
NCT00738309|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-04-18|||May 2006||2006-05-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|PSK||Prospective Study of Scheuermann's Kyphosis|Prospective Study of Scheuermann's Kyphosis|Completed||N/A|147|Actual|Setting Scoliosis Straight Foundation|||2||f||||f||||||||||2017-02-18 14:00:41.974494|2017-02-18 14:00:41.974494
NCT00738296|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2015-06-23|||April 2005||2005-04-01|August 2008|2008-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|VYCTOR||Vytorin on Carotid Intima-media Thickness and Overall Rigidity|Vytorin on Carotid Intima-media Thickness and Overall Rigidity|Completed||Phase 4|90|Actual|Hospital Regional 1o de Octubre||3|||f||||||||||||||2017-02-18 14:00:42.073315|2017-02-18 14:00:42.073315
NCT00738283|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2015-07-23|2012-09-24||September 2008||2008-09-01|July 2015|2015-07-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Observational|||Zinc and Copper Absorption in Neonates With Bilious Losses|Zinc and Copper Absorption in Neonates With Bilious Losses|Completed||N/A|17|Actual|Baylor College of Medicine|Only 10 infants achieved a majority of enteral feeds with the ostomy in place, of which only 7 were fully enterally fed at the time of the study. This is a mixed group, but nonetheless representative of infants with small intestinal ostomies.||1||f||||f||||||Samples Without DNA|"~     Blood, stool, gastric residuals, and urine~   "|||2017-02-18 14:00:42.167714|2017-02-18 14:00:42.167714
NCT00738257|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2010-05-14|||June 2000||2000-06-01|May 2010|2010-05-01||||December 2004|Actual|2004-12-01||Interventional|SMART||A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.|A 2 Year Prospective, Multicentre, Open-label, Randomised, Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients (With a PTH > 150pg/ml) on a Ciclosporin A and Glucocorticoid Based Immunosuppressive Regimen.|Completed||Phase 4|126|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:00:42.383555|2017-02-18 14:00:42.383555
NCT00738244|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2011-09-23|||November 2007||2007-11-01|September 2011|2011-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Effectiveness of Hearing-aid Based Wind-noise Algorithm|Methods of Wind Noise Suppression in Hearing Aids|Completed||N/A|60|Anticipated|University of Iowa|||2||f||||f||||||||||2017-02-18 14:00:42.475642|2017-02-18 14:00:42.475642
NCT00738231|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2009-06-18|||September 2007||2007-09-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|May 2008|Actual|2008-05-01||Interventional|||Training Methods for a Doctrine Of Life With Healthy Heart|Two Distinct Training Methods for Healthy Heart in Low Social and Economical Society|Unknown status|Enrolling by invitation|N/A|498|Actual|Eskisehir Osmangazi University||2|||f||||f||||||||||2017-02-18 14:00:42.573206|2017-02-18 14:00:42.573206
NCT00738218|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-08-19|||October 2005||2005-10-01|August 2008|2008-08-01||||February 2007|Actual|2007-02-01||Interventional|CORE-64||Diagnostic Accuracy of Multi-Detector Spiral Computed Tomography Angiography Using 64 Detectors|"Coronary Evaluation Using Multi-Detector Spiral Computed Tomography Angiography Using 64 Detectors: CORE-64 Study"|Completed||N/A|405|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 14:00:42.695224|2017-02-18 14:00:42.695224
NCT00738205|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-03-10|||June 2007||2007-06-01|March 2014|2014-03-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Observational|||Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector|Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector When Administering Saizen® Growth Hormone to Children With Growth Disorders|Completed||N/A|834|Actual|Merck KGaA|||2||f||||||||||||||2017-02-18 14:00:42.798615|2017-02-18 14:00:42.798615
NCT00738192|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2009-03-10|||July 2008||2008-07-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|CARAN||Comparison of Analgesic Efficacy of Fentanyl, Sufentanil and Butorphanol After Remifentanil Anesthesia|Comparison of Analgesic Efficacy of Fentanyl, Sufentanil and Butorphanol After Remifentanil Anesthesia in Gynecological Laparoscopic Surgeries|Completed||Phase 4|150|Actual|Nanjing Medical University||3|||f||||t||||||||||2017-02-18 14:00:42.909165|2017-02-18 14:00:42.909165
NCT00738179|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-02-04|||September 2008||2008-09-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|SAVE||Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease|Sleep Apnea cardioVascular Endpoints Study - Investigating the Effectiveness of Treatment With CPAP vs Standard Care in Reducing CV Morbidity and Mortality in Patients With Co-existing CV Disease and Moderate-severe Obstructive Sleep Apnea.|Unknown status|Active, not recruiting|Phase 3|2500|Anticipated|Adelaide Institute for Sleep Health||2|||f||||t||||||||||2017-02-18 14:00:43.029617|2017-02-18 14:00:43.029617
NCT00738166|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-07-27|||October 2007||2007-10-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|OrgTrace||Content, Bioavailability and Health Effects of Trace Elements and Bioactive Components in Organic Agricultural Systems||Completed||N/A|18|Actual|University of Copenhagen||3|||f||||||||||||||2017-02-18 14:00:43.154263|2017-02-18 14:00:43.154263
NCT00738153|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-08-13|||June 2008||2008-06-01|August 2014|2014-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes|Efficacy and Safety Study of Levemir® (Insulin Detemir) to Treat Type 1 and 2 Diabetes Mellitus|Completed||N/A|798|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:00:43.256462|2017-02-18 14:00:43.256462
NCT00729547|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2008-08-04|||September 2006||2006-09-01|September 2006|2006-09-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|neurofeedback||The Therapeutic Efficacy of Neurofeedback in Depression|The Therapeutic Efficacy of Frontal EEG Asymmetry Neurofeedback in Depression|Completed||N/A|24|Actual|Korea University||2|||f||||f||||||||||2017-02-18 14:04:07.842599|2017-02-18 14:04:07.842599
NCT00738140|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2013-07-09|||September 2007||2007-09-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors|Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors|Completed||Phase 2|15|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:00:43.365614|2017-02-18 14:00:43.365614
NCT00738127|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2008-08-19|||October 1992||1992-10-01|August 2008|2008-08-01|October 2004|Actual|2004-10-01|June 2004|Actual|2004-06-01||Interventional|ADTPD||Safety Study of Surgical Technique to Treat Acute Dorsal Trans-Scaphoid Perilunate Dislocations|Surgical Techniques for Acute Dorsal Trans-Scaphoid Perilunate Dislocations|Completed||N/A|801|Actual|The Second Hospital of Qinhuangdao||2|||f||||t||||||||||2017-02-18 14:00:43.47584|2017-02-18 14:00:43.47584
NCT00738114|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2013-11-20|||August 2008||2008-08-01|November 2013|2013-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Diabetes in the Perioperative Period|Type 2 Diabetes in the Perioperative Period: Prevalence and Clinical Outcome|Completed||N/A|3184|Actual|Emory University|||2||f||||f||||||||||2017-02-18 14:00:43.592744|2017-02-18 14:00:43.592744
NCT00738101|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-09-19|||September 2008||2008-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants|Compassionate Use of an Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Infants|Recruiting||N/A|15|Anticipated|Baylor College of Medicine||1|||f||||t||||||||Yes||2017-02-18 14:00:43.694115|2017-02-18 14:00:43.694115
NCT00738088|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2008-08-18|||June 2007||2007-06-01|August 2008|2008-08-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Variation in Sulphonylurea Response in Type 2 Diabetes|The Use of Glycaemic Response to Sulphonylureas as a Tool to Investigate Type 2 Diabetes Pathophysiology|Unknown status|Enrolling by invitation|Phase 4|80|Anticipated|NHS Tayside||1|||f||||f||||||||||2017-02-18 14:00:43.824417|2017-02-18 14:00:43.824417
NCT00738075|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2008-08-19|||October 2008||2008-10-01|August 2008|2008-08-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Observational|||Automatic Recognition of Freezing of Gait Episodes|Online Automatic Recognition of Freezing of Gait Episodes|Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||||||2017-02-18 14:00:43.923577|2017-02-18 14:00:43.923577
NCT00738062|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-04-22|2014-03-18||January 2008||2008-01-01|April 2014|2014-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|NOH303|Omits 1 patient who randomized into the study in error and did not receive study drug.|Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)|An Open-label Study, to Assess the Long-term Safety and Clinical Benefit of Droxidopa in Subjects With PAF, Dopamine Beta Hydroxylase Deficiency or Non-diabetic Neuropathy and Symptomatic Neurogenic Orthostatic Hypotension|Completed||Phase 3|103|Actual|Chelsea Therapeutics||2|||f||||f||||||||||2017-02-18 14:00:44.034446|2017-02-18 14:00:44.034446
NCT00738049|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-07-25|2013-01-25||June 2009||2009-06-01|July 2014|2014-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|Darusentan||Darusentan Effect on PET Uptake Heterogeneity|A Phase 2, Investigator-Initiated, Feasibility Study to Evaluate the Mechanisms of Coronary Endothelial Dysfunction Imaged As Resting Myocardial Perfusion Heterogeneity After Endothelin Receptor Blockade With Darusentan|Completed||Phase 2|40|Actual|The University of Texas Health Science Center, Houston|The trial was stopped after 20 enrollments as the manufacturer of darusentan halted further development of the drug after a negative phase 3 trial in resistant hypertension.|2|||f||||f||||||||||2017-02-18 14:00:45.436042|2017-02-18 14:00:45.436042
NCT00738036|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-09-29|||April 2008||2008-04-01|September 2015|2015-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Acute Pain Episodes in Patients Under Opioid Maintenance Therapy : Clinical Management and Long Term Effects|Acute Pain Episodes in Patients Under Opioid Maintenance Therapy : Clinical Management and Long Term Effects|Completed||N/A|151|Actual|University Hospital, Toulouse|||2||f||||f||||||||||2017-02-18 14:00:45.813269|2017-02-18 14:00:45.813269
NCT00738023|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-12-18|2014-12-18||March 2004||2004-03-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes|Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes|Completed||Phase 4|36|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:00:45.896829|2017-02-18 14:00:45.896829
NCT00738010|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-09-16|||April 2005||2005-04-01|September 2008|2008-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|NMES||Effectiveness of Kneehab in Strengthening Quadriceps in Rehabilitation Post Anterior Cruciate Ligament (ACL) Reconstruction|The Effectiveness of Kneehab in Strengthening the Quadriceps of Patients in Rehabilitation After Anterior Cruciate Ligament Reconstruction|Completed||Phase 3|131|Actual|Bio-Medical Research, Ltd.||3|||f||||f||||||||||2017-02-18 14:00:46.205746|2017-02-18 14:00:46.205746
NCT00737997|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2014-11-18|||December 2006||2006-12-01|November 2014|2014-11-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Early Morphine Administration on the Development of Acute Opioid Tolerance During Pediatric Scoliosis Surgery|Effect of Early Administration of Morphine on the Development of Acute Opioid Tolerance During Infusion of Remifentanil for Pediatric Scoliosis Surgery|Completed||Phase 3|40|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 14:00:46.316814|2017-02-18 14:00:46.316814
NCT00737984|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-04-19|||August 2008||2008-08-01|October 2009|2009-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Improving the Pregnancy Rate With Endometrial Sampling Before Intrauterine Insemination|Improving the Pregnancy Rate With Endometrial Sampling Before Intrauterine Insemination|Terminated||N/A|9|Actual|McGill University Health Center||2||Because very low number of patients were enrolled|f||||f||||||||||2017-02-18 14:00:46.414913|2017-02-18 14:00:46.414913
NCT00737971|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-04-29|||August 2008||2008-08-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|ATEMD||Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema|A Randomized, Parallel Group, Masked Clinical Study to Evaluate the Efficacy of Triamcinolone and Bevacizumab Through Intravitreal Injection With Individual or Simultaneous Drugs to Treatment of Diabetic Macular Edema|Completed||Phase 4|142|Actual|Federal University of São Paulo||3|||f||||f||||||||Yes|data presented in several congresses: ARVO 2010-- poster ARVO 2011, WOC BERLIN 2010, WOC ABU DABHI 2012 (partial data) CBO 2014 (final data)|2017-02-18 14:00:46.52396|2017-02-18 14:00:46.52396
NCT00737958|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2010-03-30|||August 2008||2008-08-01|July 2008|2008-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||The Effects of Diesel Exhaust Inhalation On Exercise Capacity In Patients With Stable Angina Pectoris|The Effects of Diesel Exhaust Inhalation On Exercise Capacity In Patients With Stable Angina Pectoris|Completed||N/A|19|Actual|University of Edinburgh|||1||f||||f||||||Samples Without DNA|"~     Plasma samples Serum samples~   "|||2017-02-18 14:00:46.638701|2017-02-18 14:00:46.638701
NCT00737945|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-06-21|||August 2006||2006-08-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Observational|||Prognostic Value of Endothelial Dysfunction and Coronary Complexity|Incremental Significance of Endothelial Function Assessed by Reactive Hyperemia Peripheral Arterial Tonometry to Improve Risk Stratification in High Risk Patients for Cardiovascular Events|Unknown status|Active, not recruiting|N/A|500|Anticipated|Kumamoto University|||1||f||||f||||||||||2017-02-18 14:00:46.955331|2017-02-18 14:00:46.955331
NCT00737932|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2015-03-19|||May 2010||2010-05-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Laquinimod Phase IIa Study in Active Crohn's Disease|A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohorts, Dose Range Finding Study to Evaluate the Safety, Tolerability and Clinical Effect of Escalating Doses of Laquinimod in Active Moderate to Severe Crohn's Disease.|Completed||Phase 2|180|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 14:00:47.041525|2017-02-18 14:00:47.041525
NCT00737919|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2011-02-09|||May 2006||2006-05-01|August 2008|2008-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Influence of Dietary Plant Sterols and Plant Stanols on Cholesterol and Plant Sterol Levels in Atheromatous Plaques|The Influence of Dietary Plant Sterols and Plant Stanols on Cholesterol and Plant Sterol Levels in Atheromatous Plaques|Completed||N/A|30|Anticipated|Helsinki University||2|||f||||f||||||||||2017-02-18 14:00:47.183713|2017-02-18 14:00:47.183713
NCT00737906|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2015-08-25|||October 2007||2007-10-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Surgical Reduction of the Inferior Turbinates for Nasal Obstruction|Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study|Terminated||Phase 4|30|Actual|ArthroCare Corporation||1|||f||||f||||||||||2017-02-18 14:00:47.289526|2017-02-18 14:00:47.289526
NCT00737893|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2017-01-18|||June 2008||2008-06-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|EPO||Erythropoietin to Enhance Erection Recovery in Men Following Radical Prostatectomy|Erythropoietin to Enhance Erection Recovery in Men Following Radical Prostatectomy|Recruiting||Phase 2|50|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:00:47.415041|2017-02-18 14:00:47.415041
NCT00737880|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-08-19|||July 2001||2001-07-01|August 2008|2008-08-01|December 2005|Actual|2005-12-01|January 2004|Actual|2004-01-01||Interventional|||Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation|A Prospective Randomized Multicenter Trial Comparing Histidine-Tryptophane-Ketoglutarate (HTK) Versus University of Wisconsin (UW) Perfusion Solution in Clinical Pancreas Transplantation|Completed||Phase 4|68|Actual|Medical University Innsbruck||2|||f||||f||||||||||2017-02-18 14:00:47.553923|2017-02-18 14:00:47.553923
NCT00737867|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2011-04-01|||September 2007||2007-09-01|April 2011|2011-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer|Vinorelbine Plus Gemcitabine (VG) Versus Vinorelbine Plus Carboplatin (VC) in Advanced Non-small Cell Lung Cancer. An Open Randomized Multicenter Phase III Trial From Norwegian Lung Cancer Study Group (NLCG)|Completed||Phase 3|444|Anticipated|The Norwegian Lung Cancer Study Group||2|||f||||f||||||||||2017-02-18 14:00:47.665076|2017-02-18 14:00:47.665076
NCT00737854|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2008-12-09|||May 2008||2008-05-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|May 2010|Anticipated|2010-05-01||Interventional|TOLP||Free Soft Tissue Graft in Treatment of Oral Lichen Planus|Free Soft Tissue Graft in Treatment of Oral Lichen Planus|Unknown status|Recruiting|Phase 1|20|Anticipated|Qazvin University Of Medical Sciences||1|||f||||t||||||||||2017-02-18 14:00:47.800034|2017-02-18 14:00:47.800034
NCT00737841|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2008-08-19|||January 2006||2006-01-01|August 2008|2008-08-01|September 2008|Anticipated|2008-09-01|August 2008|Anticipated|2008-08-01||Interventional|PBIBS||Effect of Bifidobacterium on Irritable Bowel Syndrome|Effect of Bifidobacterium on Irritable Bowel Syndrome|Unknown status|Recruiting|N/A|50|Anticipated|Tohoku University||2|||f||||f||||||||||2017-02-18 14:00:47.91069|2017-02-18 14:00:47.91069
NCT00737828|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2014-05-20|||August 2008||2008-08-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|June 2013|Actual|2013-06-01||Interventional|||Cardiopulmonary Exercise Testing and Preoperative Risk Stratification|A Randomised Controlled Trial of the Utility of Cardiopulmonary Exercise (CPX) Testing for Preoperative Risk Stratification to Guide Perioperative Care and Thereby Reduce Postoperative Morbidity|Completed||N/A|228|Actual|University College London Hospitals||2|||f||||f||||||||||2017-02-18 14:00:48.021671|2017-02-18 14:00:48.021671
NCT00737815|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-06-18|||June 2007||2007-06-01|June 2012|2012-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Randomized Crossover Study of Magnesium Supplementation|Magnesium Supplements, Plasma Inflammatory Markers, and Gene Expression in Overweight Individuals With Metabolic Syndrome: a Randomized , Controlled Crossover Trial|Completed||N/A|14|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:00:48.150948|2017-02-18 14:00:48.150948
NCT00737802|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-12-28|||February 2008||2008-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter|In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter|Recruiting||N/A|100|Anticipated|Northwell Health|||3||f||||f||||||||No||2017-02-18 14:00:48.262018|2017-02-18 14:00:48.262018
NCT00737789|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-03-03|||November 2008||2008-11-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.|Multicentre, Controlled, Randomised, Investigator-Blinded, Comparative Study of Oral Mesalazine 4g Once Daily Versus Mesalazine 4g in Two Divided Doses in Patients With Active Ulcerative Colitis.|Completed||Phase 3|206|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:00:48.374123|2017-02-18 14:00:48.374123
NCT00736541|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2008-08-15|||July 2004||2004-07-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|April 2007|Actual|2007-04-01||Interventional|NAC||N-Acetylcysteine in Liver Transplantation|Investigation of the Efficacy of N-Acetylcysteine (NAC) to Protect Against Hepato-Renal Ischemia-Reperfusion Injury in Patients Undergoing Orthotopic Liver Transplantation|Completed||N/A|100|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:01:20.670668|2017-02-18 14:01:20.670668
NCT00737776|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2016-10-27|||May 2008||2008-05-01|October 2016|2016-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|UPGRADE||Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes|NovoMix® 30 UPGRADE (NovoMix® 30 Use for Progressed Glycemic Control in Realistic Administration to DiabEtes Mellitus): A Multicentre, Open Label, Nonrandomised, Non-interventional, Observational, Efficacy and Safety Study in Patients Using Biphasic Insulin Aspart 30 (NovoMix® 30) for the Treatment of Diabetes Mellitus|Completed||N/A|1068|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:00:48.56168|2017-02-18 14:00:48.56168
NCT00737763|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2014-05-09|||October 2008||2008-10-01|May 2014|2014-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|BRiTE||Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab|Beta Cell Rescue in New Onset Type 1 Diabetes Mellitus With the LFA-1 Antibody Efalizumab|Withdrawn||Phase 2|0|Actual|Emory University||2||drug withdrawn from market|f||||t||||||||||2017-02-18 14:00:48.689678|2017-02-18 14:00:48.689678
NCT00737750|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2008-08-27|||April 2005||2005-04-01|August 2008|2008-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|NMES||Effectiveness of Kneehab in Strengthening the Quadriceps of Patients Post Anterior Cruciate Ligament (ACL) Reconstruction|Phase III Study in Patients Undergoing Rehabilitation Post-Surgical Reconstruction of the Anterior Cruciate Ligament (ACL)|Completed||Phase 3|131|Actual|Bio-Medical Research, Ltd.||3|||f||||f||||||||||2017-02-18 14:00:48.800944|2017-02-18 14:00:48.800944
NCT00737737|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-16|2015-04-09|2015-04-09||August 2008||2008-08-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|September 2013|Actual|2013-09-01||Interventional|||Hormone Function in Men Treated for Pain With Opioids or Placebo|Effects of Chronic Musculoskeletal Pain and Opioidergic Versus Placebo Interventions on Neuroendocrine Function in Men|Completed||Phase 4|8|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 14:00:48.938111|2017-02-18 14:00:48.938111
NCT00737724|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-19|2015-03-24|||March 2008||2008-03-01|March 2015|2015-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment|Efficacy of Simultaneous Versus Sequential Antiretroviral Therapy and Antituberculosis Treatment in Patients With AIDS and Active Tuberculosis. Open, Randomized and Controlled, Multisite Clinical Trial.|Terminated||N/A|63|Actual|Instituto Nacional de Enfermedades Respiratorias||2||Other published trials showed definitive expected superiority of Group 1|f||||t||||||||||2017-02-18 14:00:49.488524|2017-02-18 14:00:49.488524
NCT00737711|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-04-26|2016-03-08||July 2008||2008-07-01|April 2016|2016-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||Safety population included all participants who receive at least one dose of study medication.|A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy.|A Single Arm, Open Label Study to Assess the Efficacy, Safety and Tolerability of Two Weekly Administration of Intravenous Methoxy Polyethylene Glycol-epoetin Beta (MIRCERA) for the Treatment of Chronic Renal Anemia in Dialysis Patients Not Currently Treated With Erythropoietin-stimulating Agent (ESA).|Completed||Phase 4|189|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:00:49.621651|2017-02-18 14:00:49.621651
NCT00737698|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-02-17|||January 2007||2007-01-01|August 2008|2008-08-01|October 2010|Actual|2010-10-01|October 2008|Actual|2008-10-01||Interventional|||Comparison of Repetitive Magnetic Stimulation (rMS) and Exercise Versus no Active Treatment on Quadriceps Function in Chronic Obstructive Pulmonary Disease (COPD)|Is the Anaerobic Quadriceps Muscle Phenotype in Chronic Obstructive Pulmonary Disease Mediated by Reduced Muscle Concentrations of Peroxisome Proliferator-Activated Receptors Alpha and Delta?|Completed||N/A|71|Actual|Imperial College London||3|||f||||f||||||||||2017-02-18 14:00:50.250362|2017-02-18 14:00:50.250362
NCT00737685|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-03-23|||January 2006||2006-01-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Interventional|||Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)|Fludarabine, Cyclophosphamide Plus Thymoglobulin Conditioning Regimen for Unrelated Bone Marrow (or Mobilized Peripheral Blood) Transplantation in Severe Aplastic Anemia|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|The Korean Society of Pediatric Hematology Oncology||1|||f||||f||||||||||2017-02-18 14:00:50.357777|2017-02-18 14:00:50.357777
NCT00737672|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2014-10-14|2014-02-06||September 2008||2008-09-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|May 2011|Actual|2011-05-01||Interventional|REVISE||GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis|GORE VIABAHN® Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise Arteriovenous Grafts at the Venous Anastomosis in Hemodialysis Patients|Completed||Phase 3|293|Actual|W.L.Gore & Associates||2|||f||||t||||||||||2017-02-18 14:00:50.480012|2017-02-18 14:00:50.480012
NCT00737659|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2010-03-25|||August 2008||2008-08-01|December 2008|2008-12-01|August 2013|Anticipated|2013-08-01|August 2011|Anticipated|2011-08-01||Interventional|MMF||CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients|Phase IV, Open-Label, Multicenter, Randomized Study Comparing Mycophenolate Mofetil (MMF) Dose Adjustment Based on Blood MPA Concentration to Standard Care Treatment With MMF in Renal Transplant Recipients Receiving Tacrolimus|Unknown status|Recruiting|Phase 4|138|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 14:00:54.517522|2017-02-18 14:00:54.517522
NCT00737646|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2012-12-14|||July 2009||2009-07-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Interventional|||Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics|Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics|Completed||N/A|5066|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-02-18 14:00:54.632931|2017-02-18 14:00:54.632931
NCT00737633|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2012-09-05|2012-07-31||August 2008||2008-08-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults|An Open-Label, Non-Randomized Multicenter Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Providing and Maintaining Glycemic Control in Type 2 Diabetic Adults|Terminated||Phase 2|101|Actual|VIVUS, Inc.||2||Limited regulatory value to uncontrolled trials. No safety/efficacy concerns.|f||||f||||||||||2017-02-18 14:00:54.745683|2017-02-18 14:00:54.745683
NCT00737620|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2012-10-29|||March 2008||2008-03-01|December 2011|2011-12-01||||November 2011|Actual|2011-11-01||Interventional|||Evaluation of Heparin Bonded Vascular Graft Versus Standard Graft in Prosthetic Arteriovenous Access for Hemodialysis|Evaluation of Heparin Bonded Vascular Graft Versus Standard Graft in Prosthetic Arteriovenous Access for Hemodialysis|Completed||Phase 4|160|Actual|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-02-18 14:00:55.109311|2017-02-18 14:00:55.109311
NCT00737607|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2008-08-18|||January 2008||2008-01-01|August 2008|2008-08-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|MEDLLSS||Clinical Outcome Study of Minimally Invasive Decompression for Lumbar Spinal Stenosis|Clinical Study of Microendoscopic Decompressive Laminotomy for Treatment of Lumbar Spinal Stenosis|Unknown status|Recruiting|N/A|60|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-02-18 14:00:55.204149|2017-02-18 14:00:55.204149
NCT00737594|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-02-16|2016-02-16||July 2008||2008-07-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional||Study was terminated early, data was not analyzed.|Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension|A Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension|Terminated||Phase 2|9|Actual|Sucampo Pharma Americas, LLC||3||Failure to enroll a suitable number of qualified subjects.|f||||t||||||||||2017-02-18 14:00:55.299271|2017-02-18 14:00:55.299271
NCT00737581|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2017-01-30|||August 2008||2008-08-01|January 2017|2017-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Spinal Cord Stimulation Research Study|Posture Responsive Spinal Cord Stimulation Research Study|Completed||N/A|20|Actual|MedtronicNeuro|||1||f||||f||||||||||2017-02-18 14:00:55.53691|2017-02-18 14:00:55.53691
NCT00737568|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-02-09|2012-11-15||September 2008||2008-09-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|November 2011|Actual|2011-11-01||Interventional|||Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine|A Phase 3b, Randomized, Double-Blind, Double-Dummy Study Evaluating the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus Emtricitabine Plus Tenofovir DF Fixed-Dose Combination Therapy in Subjects With Chronic Hepatitis B Who Are Resistant to Lamivudine|Completed||Phase 3|280|Actual|Gilead Sciences|There were no limitations affecting the analysis or results.|2|||f||||t||||||||||2017-02-18 14:00:55.622067|2017-02-18 14:00:55.622067
NCT00737555|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-02-14|||August 2006||2006-08-01|February 2012|2012-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours|A Phase 1b Dose-escalation Study to Evaluate the Safety and Tolerability of the Addition of the Aminopeptidase Inhibitor CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours|Completed||Phase 1|23|Actual|Chroma Therapeutics||1|||f||||t||||||||||2017-02-18 14:00:57.215614|2017-02-18 14:00:57.215614
NCT00737542|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2009-11-25||||||August 2008|2008-08-01||||||||Interventional|||Local Lidocaine Infiltration for Pain Management Post Cesarean Delivery.|A Prospective Randomized Double-blind, Placebo-controlled Study of the Effect of Preoperative Analgesia With Local Lidocaine Infiltration for Pain Management Post Cesarean Delivery.|Unknown status|Not yet recruiting|N/A|||Soroka University Medical Center||2|||f||||||||||||||2017-02-18 14:00:57.329191|2017-02-18 14:00:57.329191
NCT00737529|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-11-30|2013-06-28||December 2008||2008-12-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|October 2012|Actual|2012-10-01||Interventional|EMERGE|The baseline characteristics are from the participants assesed within the Intent to Treat Population (ITT). The ITT population was defined as all enrolled participants who received at least one dose of study drug. The ITT population was the primary analysis population used for all efficacy analyses.|"A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The EMERGE Trial"|A Phase 2, Multicenter, Single-Arm, Open-Label Study To Determine The Efficacy And Safety Of Single-Agent Lenalidomide (Revlimid®) In Patients With Mantel Cell NHL Who Have Relapsed Or Progressed After Treatment With Bortezomib Or Refractory To Bortezomib|Active, not recruiting||Phase 2|134|Actual|Celgene Corporation||1|||f||||t||||||||||2017-02-18 14:00:57.44109|2017-02-18 14:00:57.44109
NCT00737516|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2013-06-12||2013-06-04|January 2000||2000-01-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation|A Centralized Cord Blood Registry to Facilitate Allogeneic, Unrelated Donor Umbilical Cord Blood Transplantation|Completed||Phase 2|3621|Actual|National Marrow Donor Program||1|||f||||t||||||||||2017-02-18 14:00:58.45053|2017-02-18 14:00:58.45053
NCT00737503|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-16|2011-06-25|||September 2008||2008-09-01|August 2008|2008-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab|Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab|Completed||Phase 4|4550|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||2|||f||||t||||||||||2017-02-18 14:00:58.570235|2017-02-18 14:00:58.570235
NCT00737490|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2014-07-31|||June 2005||2005-06-01|April 2013|2013-04-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|Devise-CRT||Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT)|Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT)|Completed||N/A|40|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:00:58.678622|2017-02-18 14:00:58.678622
NCT00737477|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-06-17|2016-06-17||September 2008||2008-09-01|June 2016|2016-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|MISTRAL|Intent-to-Treat (ITT) Population: All participants who received at least one dose of Mircera and provided at least one Hb evaluation between Weeks 0 to 24, and for whom any follow-up information was available.|A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis|A Single Arm, Open-Label, Multicentre Study to Assess the Maintenance of Haemoglobin Levels With Once Monthly Subcutaneous Administration of C.E.R.A (Continuous Erythropoietin Receptor Activator) in Patients With Chronic Kidney Disease on Peritoneal Dialysis|Completed||Phase 3|96|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:00:58.778455|2017-02-18 14:00:58.778455
NCT00737464|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-03-30|2016-02-25||August 2008||2008-08-01|March 2016|2016-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||Safety population included all enrolled participants who received at least one dose of study medication.|A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.|A Single Arm, Open Label Study to Assess the Efficacy, Safety and Tolerability of Once-monthly Administration of Intravenous MIRCERA for the Maintenance of Haemoglobin Levels in Dialysis Patients With Chronic Renal Anaemia|Completed||Phase 4|132|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:00:59.319466|2017-02-18 14:00:59.319466
NCT00737438|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-01-04|2016-01-04||August 2008||2008-08-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma|A Phase II Study of Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma|Completed||Phase 2|22|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:01:00.054101|2017-02-18 14:01:00.054101
NCT00737425|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2008-10-27|||September 2008||2008-09-01|October 2008|2008-10-01||||||||Interventional|||Safety and Efficacy Study of Pain Shield Device to Treat Subjects Following Laparoscopic-Assisted Abdominal Surgery|Evaluation of Safety and Efficacy of the PainShield Device for the Treatment of Subjects Who Underwent Laparoscopic-Assisted Abdominal Surgery|Unknown status|Recruiting|Phase 4|80|Anticipated|Shaare Zedek Medical Center||2|||f||||||||||||||2017-02-18 14:01:00.337162|2017-02-18 14:01:00.337162
NCT00737412|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2010-01-19|||April 2008||2008-04-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults|A Double-blind, Randomized, Placebo Controlled, Multicenter Study of the Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults.|Completed||Phase 3|277|Actual|Bio-K Plus International Inc.||2|||f||||t||||||||||2017-02-18 14:01:00.635748|2017-02-18 14:01:00.635748
NCT00737399|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2016-01-14|||September 2008||2008-09-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|April 2018|Anticipated|2018-04-01||Interventional|||Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)|Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)|Recruiting||Early Phase 1|14|Anticipated|Soul Medicine Institute||1|||f||||f||||||||||2017-02-18 14:01:00.750848|2017-02-18 14:01:00.750848
NCT00737386|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2011-08-15|||September 2009||2009-09-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Frequency of Parasite Infection in Hyraxes and Sandflies During Outbreak of Leishmania Tropica Epidemic in The West Bank||Unknown status|Enrolling by invitation|N/A|600|Anticipated|Hadassah Medical Organization|||1||f||||f||||||None Retained|"~     Blood samples~   "|||2017-02-18 14:01:00.882386|2017-02-18 14:01:00.882386
NCT00737373|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-09-18|||August 2007||2007-08-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|December 2009|Actual|2009-12-01||Interventional|||Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer|A Multicenter, Randomised Phase II Trial on the Therapy of Advanced Gastric Cancer or Adenocarcinoma of the Esophagogastric Junction in Patients Older Than 65 Years With Specific Regard of Quality of Life and Pharmacogenetic Risk Profile|Completed||Phase 2|143|Actual|Krankenhaus Nordwest||2|||f||||f||||||||||2017-02-18 14:01:00.957065|2017-02-18 14:01:00.957065
NCT00737360|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-18|2012-08-02|2012-04-20||August 2008||2008-08-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Interventional|||Phase II Study of TAS-106 to Treat Head and Neck Cancer|Phase II Study of TAS-106 in Patients With Recurrent or Metastatic Head and Neck Cancer Refractory to Platinum Based Chemotherapy|Terminated||Phase 2|27|Actual|Taiho Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-02-18 14:01:01.088791|2017-02-18 14:01:01.088791
NCT00737347|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2008-08-18|||September 2003||2003-09-01|August 2008|2008-08-01|April 2008|Actual|2008-04-01|March 2007|Actual|2007-03-01||Interventional|||Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone|Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone|Completed||Phase 3|39|Actual|Northwestern University||3|||f||||f||||||||||2017-02-18 14:01:01.443795|2017-02-18 14:01:01.443795
NCT00737334|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2009-11-09|||September 2008||2008-09-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||EEG, Cerebral Oximetry, and Arterial to Jugular Venous Lactate to Assess Cerebral Ischemia During Carotid Endarterectomy|A Comparison of the EEGo Monitor, BIS Monitor, and FORE-SIGHT Cerebral Oximeter With Arterial to Jugular Venous Lactate Difference to Assess Cerebral Ischemia During Carotid Endarterectomy|Completed||N/A|40|Anticipated|University of Manitoba||1|||f||||f||||||||||2017-02-18 14:01:01.562779|2017-02-18 14:01:01.562779
NCT00737321|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2017-02-08|||August 2008||2008-08-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|||Mechanisms Regulating Wound Vascularization|Mechanisms Regulating Wound Vascularization|Active, not recruiting||N/A|80|Anticipated|Ohio State University|||2||f||||f||||||Samples With DNA|"~     All participnts with wounds will have 3 mm punch biopsy performed twice or three times in~     the whole study period.Obtained tissue sample will be processed immidiately and frozen in~     liquid nitrogen.The tissue sample will transport to research lab for genomic analysis.~   "|||2017-02-18 14:01:01.677834|2017-02-18 14:01:01.677834
NCT00737308|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-17|2015-05-14|||June 2008||2008-06-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Properties and Clinical Performance of Zirconia-based Dental Ceramics|Properties and Clinical Performance of Zirconia-based Dental Ceramics|Completed||N/A|20|Actual|Mahidol University||1|||f||||f||||||||||2017-02-18 14:01:01.790193|2017-02-18 14:01:01.790193
NCT00737295|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2010-11-15|||May 2008||2008-05-01|November 2010|2010-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Ultrasound for Diagnosis of Biliary Dyskinesia|Study to Investigate the Role of Ultrasound for Diagnosis of Biliary Dyskinesia|Terminated||N/A|25|Actual|Texas Tech University Health Sciences Center||1||PI left institution, study interest wained-so stopped.|f||||f||||||||||2017-02-18 14:01:01.901702|2017-02-18 14:01:01.901702
NCT00737282|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-08-05|2014-06-25||October 2008||2008-10-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Study prematurely terminated|Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids|A Phase III, Open-Label, Parallel, Randomized, Multicenter Study Evaluating the Safety of 25 And 50 mg Proellex® (CDB-4124) in the Treatment of Premenopausal Women With Symptomatic Uterine Fibroids|Terminated||Phase 3|175|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with any study data.|2||Repros stopped study for safety and FDA put study on hold.|f||||t||||||||||2017-02-18 14:01:02.001827|2017-02-18 14:01:02.001827
NCT00735956|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2010-08-19|||September 2008||2008-09-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|PARTNER||PARTNER Recruitment and Brief Intervention Pilot Study|PARTNER: The Underage Drinking: Building Health Care System Research|Completed||Phase 1/Phase 2|300|Anticipated|Duke University||1|||f||||f||||||||||2017-02-18 14:01:34.989879|2017-02-18 14:01:34.989879
NCT00737269|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2013-03-01|||June 2008||2008-06-01|March 2013|2013-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||A Complicated Skin and Soft-tissue Infection Patient Registry|A Prospective, Multi-center, Observational Registry Involving Patients Hospitalized With Complicated Skin and Soft Tissue Infections (cSSTI) for IV Antibiotic Therapy|Completed||Phase 4|1081|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC|||1||f||||||||||||||2017-02-18 14:01:02.248134|2017-02-18 14:01:02.248134
NCT00737256|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2012-09-06|||August 2008||2008-08-01|September 2012|2012-09-01|May 2014|Anticipated|2014-05-01|May 2013|Anticipated|2013-05-01||Interventional|||A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence|A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence|Unknown status|Recruiting|Phase 2|44|Anticipated|Denver Research Institute||2|||f||||t||||||||||2017-02-18 14:01:02.332999|2017-02-18 14:01:02.332999
NCT00737243|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-07-07|2015-10-07||August 2008||2008-08-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional||252 patients who had successful assays.|Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site|A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site|Completed||Phase 2|289|Actual|SCRI Development Innovations, LLC|The focus of this study was to evaluate the ability of the 92-gene assay to successfully predict tumor tissue of origin, not to assess one particular treatment|2|||f||||f||||||||||2017-02-18 14:01:02.451319|2017-02-18 14:01:02.451319
NCT00737230|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2013-08-23|||April 2007||2007-04-01|June 2009|2009-06-01|July 2012|Actual|2012-07-01|September 2010|Actual|2010-09-01||Interventional|||Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis|Effective Management of Radiation-induced Bowel Injury: A Randomized Controlled Trial|Completed||N/A|250|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:01:02.810996|2017-02-18 14:01:02.810996
NCT00737217|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2013-06-24|||March 2006||2006-03-01|June 2013|2013-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease|Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease|Completed||N/A|74|Actual|University of Michigan|||2||f||||f||||||||||2017-02-18 14:01:02.898797|2017-02-18 14:01:02.898797
NCT00737204|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-06-11|2013-03-13||June 2008||2008-06-01|March 2013|2013-03-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Interventional|||Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS|Armodafinil Treatment for Fatigue in HIV+ Patients|Completed||Phase 4|70|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 14:01:02.983486|2017-02-18 14:01:02.983486
NCT00737191|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2012-03-07|||August 2008||2008-08-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain|Analgesic Effect of Olanzapine in Cancer Pain: A Double-Blind Randomized Placebo-Controlled Parallel Group Pilot Study|Withdrawn||N/A|0|Actual|Mayo Clinic||3||No accrual; No patients enrolled|f||||t||||||||||2017-02-18 14:01:03.530102|2017-02-18 14:01:03.530102
NCT00737178|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-09-18|2012-12-31||July 2008||2008-07-01|September 2014|2014-09-01|August 2011|Actual|2011-08-01|October 2009|Actual|2009-10-01||Interventional|||Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion|A Randomized Trial of Immediate Versus Delayed Insertion of the Copper T380A Following Medication Abortion|Completed||Phase 4|156|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 14:01:03.632344|2017-02-18 14:01:03.632344
NCT00737165|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2013-10-30|||July 2006||2006-07-01|October 2013|2013-10-01|March 2011|Actual|2011-03-01|December 2009|Actual|2009-12-01||Interventional|NOCOMIT-J||A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J)|A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J)|Completed||N/A|1951060|Actual|Japan Foundation for Neuroscience and Mental Health||2|||f||||t||||||||||2017-02-18 14:01:04.056129|2017-02-18 14:01:04.056129
NCT00737152|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-07-19|||July 2011||2011-07-01|July 2011|2011-07-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|ASI-DMII||Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus|Phase II, Open-Label Study to Assess the Cardiovascular Side Effects and Efficacy for Reducing Blood Glucose Level in Type II Diabetes Mellitus Patients Being Treated With RAS 130 With or Without Diet and Exercise|Unknown status|Not yet recruiting|Phase 2|460|Anticipated|American Scitech International||1|||f||||f||||||||||2017-02-18 14:01:04.166399|2017-02-18 14:01:04.166399
NCT00737139|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2012-08-29|||September 2008||2008-09-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study Comparing Peri-articular Injection of Bupivacaine With and Without Epinephrine|A Prospective, Randomized, Double-Blind Controlled Clinical Trial to Evaluate the Post-Operative Blood Loss and Transfusion Rate Following Total Joint Arthroplasty With Intra-articular Injection of Bupivacaine and Epinephrine|Terminated||N/A|33|Actual|Rush University Medical Center||2||"Prohibitively expensive and efficacy of tranexamic acid rendered topic clinically less~   relevant."|f||||f||||||||||2017-02-18 14:01:04.358239|2017-02-18 14:01:04.358239
NCT00737126|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2008-08-18|||January 2004||2004-01-01|August 2008|2008-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Folic Acid Administration in the Progression of Microalbuminuria|Folic Acid Administration Reduces the Progression of Microalbuminuria|Completed||N/A|40|Actual|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||f||||||||||2017-02-18 14:01:04.465596|2017-02-18 14:01:04.465596
NCT00737113|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2014-03-18|||September 2008||2008-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|May 2012|Actual|2012-05-01||Interventional|||Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant|Recombinant Human Growth Hormone(RH-GH) For Accelerating Immune Reconstitution In Pediatric and Adult Patients Undergoing Allogeneic Stem Cell Transplantation|Terminated||Phase 1|14|Actual|Duke University||1||Study was terminated early due to low accrual.|f||||f||||||||||2017-02-18 14:01:04.566391|2017-02-18 14:01:04.566391
NCT00737100|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2014-05-07|2011-03-21||September 2008||2008-09-01|January 2014|2014-01-01||||April 2010|Actual|2010-04-01||Interventional|||Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis|A Randomized, Double-blind, Placebo-controlled Parallel Group Study to Investigate the Safety and Efficacy of Two Doses of Tiotropium Bromide (2.5 mcg and 5 mcg) Administered Once Daily Via the Respimat Device for 12 Weeks in Patients With Cystic Fibrosis.|Completed||Phase 2|510|Actual|Boehringer Ingelheim||3|||t||||||||||||||2017-02-18 14:01:04.686749|2017-02-18 14:01:04.686749
NCT00737087|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-04-20|||November 2007||2007-11-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|October 2013|Actual|2013-10-01||Interventional|||Long-term Clinical Effectiveness of the Delta Xtend Reverse Total Shoulder|A Multi-centred, Non-comparative, Non-randomised, Open, Post Marketing Investigation to Look at the Long-term Clinical Efficacy of the Delta Xtend Reverse Total Shoulder Used in the Treatment of Shoulders With Rotator Cuff Deficiencies.|Terminated||N/A|144|Actual|DePuy International||1||Study was stopped due to low follow-up compliance at study sites.|f||||f||||||||||2017-02-18 14:01:06.476556|2017-02-18 14:01:06.476556
NCT00737074|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2008-08-15|||January 2002||2002-01-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Observational|||Macular Hole in Diabetic Retinopathy|Macular Hole in Proliferative Diabetic Retinopathy With Fibrovascular Proliferation|Completed||N/A|23|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 14:01:06.576341|2017-02-18 14:01:06.576341
NCT00737061|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2013-02-07|2009-08-26||November 2002||2002-11-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|December 2005|Actual|2005-12-01||Interventional|EASE||Safety & Efficacy Study of the Adiana System for Women Who Desire Permanent Birth Control (Sterilization)|A Multi-Center, Prospective Evaluation of the Adiana System for Transcervical Sterilization Using Electrothermal Energy in Women Aged 18-45 - The EASE Trial|Terminated||N/A|770|Actual|Hologic, Inc.|At the time of analysis, 481 completed 3 years. Due to the cumulative nature of the analysis, subjects may be lost to follow-up at one time and return to follow-up at a subsequent point. All subjects who have not withdrawn consent will be followed.|1||Product Pre-Market Approval withdrawn|f||||t||||||||||2017-02-18 14:01:06.66769|2017-02-18 14:01:06.66769
NCT00737048|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2016-03-29|2013-03-25||March 2008||2008-03-01|March 2016|2016-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain|A Double-Blind Comparative Study of JNS013 in Patients With Post-Tooth-Extraction Pain|Completed||Phase 3|328|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-02-18 14:01:07.113701|2017-02-18 14:01:07.113701
NCT00737035|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-08-05|||July 2008||2008-07-01|August 2015|2015-08-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Effectiveness of a Web-based Intervention for Guardians of Children Whose One Parent Has Murdered the Other|Testing an IHCA for Guardians of Survivors of Intraparental Homicide|Withdrawn||N/A|0|Actual|University of Virginia||2||Recruitment difficulties|f||||t||||||||||2017-02-18 14:01:08.125078|2017-02-18 14:01:08.125078
NCT00737022|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2008-08-14|||May 2005||2005-05-01|July 2006|2006-07-01|December 2006|Actual|2006-12-01|July 2006|Actual|2006-07-01||Observational|||Macular Appearance After Diabetic Vitrectomy|Macular Appearance After Diabetic Vitrectomy for Fibrovascular Proliferation -An Optical Coherence Tomography Study|Completed||N/A|108|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 14:01:10.571687|2017-02-18 14:01:10.571687
NCT00737009|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2011-06-21|||August 2008||2008-08-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment|An Observational Study of Adherence to Adjuvant Anastrozole Therapy in Postmenopausal Patients With Early Breast Cancer Over One Year Follow-up.|Completed||N/A|259|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:01:10.654573|2017-02-18 14:01:10.654573
NCT00736996|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-12-10|2015-11-06||November 2008||2008-11-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|POEM||Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)|Pioglitazone and Exercise Effects on Older Adults With MCI and Metabolic Syndrome|Completed||Phase 2|78|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-02-18 14:01:10.748675|2017-02-18 14:01:10.748675
NCT00736983|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2012-04-16|||September 2008||2008-09-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|Adafi||Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's|Adalimumab for the Treatment of Perianal Fistulas in Crohn's Disease More Effective Alone or Combined to Ciprofloxacin|Completed||Phase 3|76|Actual|Foundation for Liver Research||2|||f||||f||||||||||2017-02-18 14:01:11.532674|2017-02-18 14:01:11.532674
NCT00736970|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-08-26|||July 2008||2008-07-01|August 2015|2015-08-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|||Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)|A Phase II Trial of Oral Deforolimus (AP23573; MK-8669), an mTOR Inhibitor, in Combination With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer|Completed||Phase 2|34|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:01:11.645776|2017-02-18 14:01:11.645776
NCT00736957|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-06-23|2013-03-25||May 2008||2008-05-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||A Long-term Efficacy and Safety Study of Tramadol Hydrochloride Plus Acetaminophen (JNS013) in Japanese Participants With Chronic Pain|A Study of a Long-term Administration of JNS013 in Patients With Chronic Pain|Completed||Phase 3|219|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-02-18 14:01:11.965958|2017-02-18 14:01:11.965958
NCT00736944|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-04-03|2013-11-18||October 2008||2008-10-01|April 2016|2016-04-01|August 2020|Anticipated|2020-08-01|August 2010|Actual|2010-08-01||Interventional|||Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer|Trial to Determine the CR Rate at the Primary Tumor Site After 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head & Neck Carcinoma Treated With Definitive Concurrent Cisplatin & Radiation Therapy|Active, not recruiting||Phase 2|30|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 14:01:12.533651|2017-02-18 14:01:12.533651
NCT00736931|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2012-05-25|||July 2008||2008-07-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam|Randomized, Comparative, Double-blind, Placebo-controlled, Triple-dummy, Four-way Cross-over Study to Investigate Neurocognitive Effects of Brivaracetam in Healthy Subjects|Completed||Phase 1|20|Actual|UCB Pharma||4|||f||||f||||||||||2017-02-18 14:01:13.571968|2017-02-18 14:01:13.571968
NCT00736918|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2014-01-14|||June 2006||2006-06-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|June 2011|Actual|2011-06-01||Interventional|ACTION-J||RCT of Post-Suicide Attempt Case Management (ACTION-J)|A Randomized Controlled Multicenter Trial of Post-Suicide Attempt Case Management for the Prevention of Further Attempts in Japan (ACTION-J)|Completed||Phase 3|914|Actual|Japan Foundation for Neuroscience and Mental Health||2|||f||||t||||||||||2017-02-18 14:01:13.67827|2017-02-18 14:01:13.67827
NCT00736905|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2010-04-26|||June 2008||2008-06-01|April 2010|2010-04-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.|Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function|Completed||Phase 1|32|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 14:01:13.812914|2017-02-18 14:01:13.812914
NCT00736892|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2012-09-13|||September 2008||2008-09-01|September 2012|2012-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|ALIEN||Incidence of Acute Lung Injury: The Alien Study|Acute Lung Injury: Epidemiology and Natural History. The ALIEN Study|Completed||N/A|282|Actual|Villar, Jesus, M.D.|||1||f||||f||||||||||2017-02-18 14:01:13.904747|2017-02-18 14:01:13.904747
NCT00736879|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2015-09-23|2014-02-05||September 2008||2008-09-01|September 2015|2015-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||All randomized participants who took at least one dose of double-blind study medication were included in the analysis.|Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise|Completed||Phase 3|497|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:01:14.01867|2017-02-18 14:01:14.01867
NCT00736866|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2010-07-08|||August 2008||2008-08-01|August 2008|2008-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|ACT||The Acetylcysteine for Contrast-Induced Nephropathy Trial|A Pragmatic Randomized Clinical Trial Evaluating the Effect of Acetylcysteine for Contrast-induced Nephropathy|Completed||Phase 3|2300|Anticipated|Hospital do Coracao||2|||f||||f||||||||||2017-02-18 14:01:15.691862|2017-02-18 14:01:15.691862
NCT00736853|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2013-07-22|2013-04-12||June 2008||2008-06-01|July 2013|2013-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||An Efficacy and Safety Study of Acetaminophen Plus Tramadol Hydrochloride (JNS013) in Participants With Chronic Pain|A Phase 3 Study of JNS013 in Patients With Chronic Pain|Completed||Phase 3|321|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-02-18 14:01:15.804139|2017-02-18 14:01:15.804139
NCT00736840|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2012-02-15|2011-06-16||August 2008||2008-08-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|MBT||BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis|Pivotal Study to Evaluate the Efficacy and Safety of the BreathID® System for Detection of Cirrhosis Using the ¹³C-methacetin Breath Test(MBT)|Completed||Phase 3|414|Actual|Exalenz Bioscience LTD.|Technical problems caused the termination of 2 subjects who did not complete breath test. Liver biopsy, 1 patient refused and others had signs of HCC thus disqualified.|1|||f||||t||||||||||2017-02-18 14:01:17.087304|2017-02-18 14:01:17.087304
NCT00736827|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2015-12-02|||August 2008||2008-08-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Observational|BICUK||BK Virus and Renal Dysfunction in Postoperative/Posttraumatic Critically Ill Patients|BK Virus and Renal Dysfunction in Postoperative/Posttraumatic Critically Ill Patients|Completed||N/A|51|Actual|University of Ulm|||2||f||||f||||||Samples With DNA|"~     Whole blood, serum, white blood cells; urine~   "|||2017-02-18 14:01:17.362293|2017-02-18 14:01:17.362293
NCT00736814|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2011-02-23|||June 2008||2008-06-01|August 2009|2009-08-01||||||||Interventional|||First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|Genotype-driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy|Unknown status|Recruiting|Phase 2|117|Anticipated|National Cancer Institute (NCI)||5|||f||||||||||||||2017-02-18 14:01:17.466226|2017-02-18 14:01:17.466226
NCT00736801|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2008-08-20|||September 2005||2005-09-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma|Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma|Completed||N/A|35|Actual|University of Rostock||1|||f||||f||||||||||2017-02-18 14:01:17.578813|2017-02-18 14:01:17.578813
NCT00736788|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2010-12-08|||August 2008||2008-08-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers|A Phase 1, Single-Centre, Randomised, Double-Blind (Within Panels), Placebo-Controlled Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1704 After Administration of Oral Single Ascending Doses in Healthy Japanese Male and Non-Fertile Female Volunteers|Terminated||Phase 1|16|Actual|AstraZeneca||2||"AZD1704 has essentially similar PK profile in Japanese subjects as in Caucasians. One of the~   main purposes of the study has thereby been achieved."|f||||t||||||||||2017-02-18 14:01:17.687927|2017-02-18 14:01:17.687927
NCT00736775|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2010-10-26|||August 2008||2008-08-01|October 2010|2010-10-01||||May 2010|Actual|2010-05-01||Interventional|||A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease|A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous MABT5102A Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|56|Actual|Genentech, Inc.|||||f||||||||||||||2017-02-18 14:01:17.783209|2017-02-18 14:01:17.783209
NCT00736762|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2008-08-15|||February 2008||2008-02-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Effects of Global Postural re-Education Program|Effects of Global Postural re-Education Program on the Biomechanical Characteristics of the Elderly Balance.|Completed||N/A|30|Actual|University of the State of Santa Catarina||1|||f||||f||||||||||2017-02-18 14:01:17.873465|2017-02-18 14:01:17.873465
NCT00736749|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-10-14|||May 2008||2008-05-01|October 2016|2016-10-01||||January 2100|Anticipated|2100-01-01||Observational|||Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies|Umbrella Long-Term Follow-Up Protocol|Recruiting||N/A|4485|Anticipated|Children's Oncology Group|||1||f||||||||||||||2017-02-18 14:01:17.975989|2017-02-18 14:01:17.975989
NCT00736736|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2008-08-14|||March 2008||2008-03-01|June 2008|2008-06-01||||July 2008|Actual|2008-07-01||Interventional|||Effects of Hip Abductor and External Rotator Strength Training in Patients With Patellofemoral Pain Syndrome||Completed||N/A|85|Actual|National Taiwan University Hospital||3|||f||||||||||||||2017-02-18 14:01:18.6409|2017-02-18 14:01:18.6409
NCT00013962|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-03|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Vitamin D Metabolism and the Williams Syndrome|Vitamin D Metabolism and the Williams Syndrome|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:00.03303|2017-02-18 18:11:00.03303
NCT00736723|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2016-11-24|2015-12-02||August 2008||2008-08-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Observational|NICUPS|surveyed daily for sepsis, organ dysfunctions and shock|NT-proBNP in ICU Postoperative/Posttraumatic Patients With Shock|NT-proBNP in Postoperative/Posttraumatic Critically Ill Patients With Severe SIRS/Sepsis and Shock|Completed||N/A|51|Actual|University of Ulm|Myocardial depression has not been verified in our patients by a low cardiac index or by echocardiography||2||f||||f||||||Samples With DNA|"~     Whole blood, serum, white blood cells~   "|Yes||2017-02-18 14:01:18.741883|2017-02-18 14:01:18.741883
NCT00736710|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2012-12-04|||December 2008||2008-12-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||rTMS Effects on Smoking Cessation and Cognition in Schizophrenia|Effects of rTMS on Smoking Cessation and Cognitive Outcomes in Outpatients With Schizophrenia Treated With Transdermal Nicotine Patch|Completed||N/A|15|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 14:01:19.097297|2017-02-18 14:01:19.097297
NCT00736697|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2011-02-14|||November 2008||2008-11-01|February 2011|2011-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin|An Open-Label, Randomized, Single-Dose, Parallel-Group Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Moxidectin Administered Orally to Healthy Subjects|Completed||Phase 1|54|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:01:19.204177|2017-02-18 14:01:19.204177
NCT00736684|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2011-02-10|||November 2007||2007-11-01|February 2011|2011-02-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|PROGAINT-ES||Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures|Proximal Femoral Nail Antirotation™ (PFNA) Versus Gamma Nail 3™ (Gamma3) for Intramedullary Nailing of Unstable Trochanteric Fractures - a Multicenter Randomized Controlled Trial|Completed||Phase 4|440|Anticipated|AO Clinical Investigation and Documentation||2|||f||||t||||||||||2017-02-18 14:01:19.299836|2017-02-18 14:01:19.299836
NCT00736671|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-03-02|||July 2006||2006-07-01|March 2016|2016-03-01|August 2010|Actual|2010-08-01|April 2010|Actual|2010-04-01||Observational|||Striatal and Extra-striatal Mechanisms of Falling in Parkinson's Disease|Striatal and Extra-striatal Mechanisms of Falling in Parkinson's Disease|Completed||N/A|88|Actual|University of Michigan|||2||f||||f||||||||No||2017-02-18 14:01:19.412597|2017-02-18 14:01:19.412597
NCT00736658|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2009-09-29|||June 2008||2008-06-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|||||Interventional|JMAD||AZD1386 Japanese Multiple Ascending Dosing Study|A Phase I, Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1386 in Healthy Japanese Young and Elderly Subjects After Oral Multiple Doses.|Completed||Phase 1|32|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:01:19.501567|2017-02-18 14:01:19.501567
NCT00736645|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-10-17|||August 2008||2008-08-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer|A Randomized, Double Blind, Placebo Controlled Clinical Trial of L-SeMet Supplementation and Finasteride Treatment of Patients With Prostate Cancer Prior to Robotic Prostatectomy/Brachytherapy|Completed||Phase 2|55|Actual|Roswell Park Cancer Institute||4|||f||||t||||||||||2017-02-18 14:01:19.603139|2017-02-18 14:01:19.603139
NCT00736632|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2015-06-01|||May 2006||2006-05-01|June 2015|2015-06-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Vitamin D, Insulin Resistance, and Cardiovascular Disease|Vitamin D, Insulin Resistance, and Cardiovascular Disease|Recruiting||N/A|90|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 14:01:19.714042|2017-02-18 14:01:19.714042
NCT00736619|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2016-08-09|||August 2008||2008-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)|Phase I Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)|Completed||Phase 1|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:01:19.842083|2017-02-18 14:01:19.842083
NCT00736606|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2010-11-30|||August 2008||2008-08-01|November 2010|2010-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy Volunteers|A Phase I, Single Centre, Open-Label Study to Assess the Pharmacokinetics of Both AZD9056 (Steady State) and Simvastatin (Single Dose) When Co-Administered in Healthy Volunteers|Completed||Phase 1|12|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:01:19.954712|2017-02-18 14:01:19.954712
NCT00736593|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2009-04-23|||September 2008||2008-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||A Study Evaluating Nexagon™ in the Treatment of Skin Wounds.|A Phase 1 Randomized, Prospective, Within-Subject, Double-Blind, Vehicle-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability and Clinical Effect of Nexagon™ in Full-Thickness Punch Wounds|Completed||Phase 1|43|Anticipated|CoDa Therapeutics Inc.||1|||f||||t||||||||||2017-02-18 14:01:20.054267|2017-02-18 14:01:20.054267
NCT00736580|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2012-12-18|2012-12-18||June 2008||2008-06-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Glove Perforation When Using Blunt Verses Sharp Needles in Cesarean Delivery|Glove Perforation When Using Blunt vs. Sharp Needles in Cesarean Delivery|Completed||N/A|240|Actual|West Virginia University||2|||f||||f||||||||||2017-02-18 14:01:20.159853|2017-02-18 14:01:20.159853
NCT00736567|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-10-27|||May 2008||2008-05-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|||||Observational|||Evaluation of a Diagnostic Enteric Card for Management of Diarrhea|Evaluation of a Diagnostic Enteric Card for Management of Diarrhea in a Clinical Site in Fortaleza, Brazil|Completed||N/A|436|Actual|PATH|||1||f||||f||||||Samples Without DNA|"~     Stool samples are retained for future research.~   "|||2017-02-18 14:01:20.514799|2017-02-18 14:01:20.514799
NCT00736554|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-01-04|||July 2008||2008-07-01|January 2011|2011-01-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Observational|CA-MRSA||What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?|Prevalence of MRSA in Skin and Soft Tissue Infections in Two Ontario Emergency Departments.|Completed||N/A|152|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-02-18 14:01:20.588037|2017-02-18 14:01:20.588037
NCT00736528|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2009-02-23|||August 2008||2008-08-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers|An Investigator And Subject-Blind, Phase 1 Study To Characterize The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Multiple Doses Of PF-04447943 In Healthy Elderly Subjects|Terminated||Phase 1|10|Actual|Pfizer||4||See Detailed Description for termination reason.|f||||f||||||||||2017-02-18 14:01:20.778936|2017-02-18 14:01:20.778936
NCT00736515|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2010-08-19|||October 2008||2008-10-01|August 2010|2010-08-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|CODMS||Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes|Phase 4 Study of Comparison of Combination Therapy of Gliclazide MR and Basal Insulin With Pre-mix Insulin Monotherapy for the Patients With Type 2 Diabetes Mellitus|Unknown status|Recruiting|Phase 4|160|Anticipated|Servier (Tianjin) Pharmaceutical Co. LTD.||2|||f||||t||||||||||2017-02-18 14:01:20.890968|2017-02-18 14:01:20.890968
NCT00736502|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-02-03|2012-07-30||September 2008||2008-09-01|February 2014|2014-02-01||||July 2011|Actual|2011-07-01||Observational||Treated set|PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.|Longterm Efficacy and Safety of NVP-based HAART in HIV-1 Positive Patients in the Daily Clinical Practice.|Completed||N/A|280|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:01:21.021077|2017-02-18 14:01:21.021077
NCT00736489|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-15|2014-05-08|2010-11-30||August 2008||2008-08-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199|A Phase II, Double-blind, Placebo-controlled, Randomised, 6-way Cross-over, Single-dose Study to Investigate the Local and Systemic Effects of 3 Doses of Inhaled AZD3199 (a β2-agonist) Compared to Formoterol in Asthmatic Patients|Completed||Phase 2|37|Actual|AstraZeneca||6|||f||||f||||||||||2017-02-18 14:01:21.319618|2017-02-18 14:01:21.319618
NCT00736476|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2011-12-07|||October 2008||2008-10-01|December 2011|2011-12-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults|Phase I/II, Randomized, Observer-blind, Placebo-controlled, Single-Center Study of the Tolerability, Immunogenicity, and Efficacy of an Novartis' Investigational H. Pylori Vaccine in H. Pylori-Negative Adults|Completed||Phase 1|63|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:01:22.823474|2017-02-18 14:01:22.823474
NCT00736463|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-07-20|||January 2005||2005-01-01|August 2008|2008-08-01||||January 2012|Anticipated|2012-01-01||Interventional|||Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)|Effects of High Dose Simvastatin vs. Atorvastatin on Baseline Lipoprotein Profiles, Apo-A-1 and C Reactive Protein|Unknown status|Recruiting|Phase 4|80|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:01:23.098229|2017-02-18 14:01:23.098229
NCT00736450|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2012-10-11|||July 2008||2008-07-01|October 2012|2012-10-01|October 2022|Anticipated|2022-10-01|October 2022|Anticipated|2022-10-01||Interventional|||Oblimersen Sodium and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma|Investigator Initiated Pilot Study of Microarray Directed Therapy for Diffuse Large B-cell Lymphoma Using Genasense With CHOP-R|Terminated||N/A|37|Actual|University of Nebraska||1||Manufacturer is no longer making the drug.|f||||t||||||||||2017-02-18 14:01:23.211981|2017-02-18 14:01:23.211981
NCT00736437|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2008-08-14|||August 1999||1999-08-01|August 2008|2008-08-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis|Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis|Completed||Phase 2|417|Actual|Medivir||2|||f||||f||||||||||2017-02-18 14:01:23.345014|2017-02-18 14:01:23.345014
NCT00736424|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2014-01-10|||June 2008||2008-06-01|January 2014|2014-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|SUDEP||Brain Stimulation for Epilepsy Long Term Follow-up|Brain Stimulation for Epilepsy Long Term Follow-up|Completed||N/A|9|Actual|MedtronicNeuro|||1||f||||t||||||||||2017-02-18 14:01:23.446725|2017-02-18 14:01:23.446725
NCT00736411|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-10-27|||August 2008||2008-08-01|October 2015|2015-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||In Vitro Fertilization (IVF) and Acupuncture for Infertility|IVF and Acupuncture for Infertility: A Randomized Controlled Trail|Terminated||N/A|320|Actual|Pacific Fertility Center||2||"Adjustments to ensure clear outcomes and scientific merit integrated. Study closed at 14~   subjects. New protocol submitted to IRB."|f||||t||||||||||2017-02-18 14:01:23.541699|2017-02-18 14:01:23.541699
NCT00736398|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2013-04-01|||August 2008||2008-08-01|April 2013|2013-04-01||||||||Observational|FACT||Fusion Assessment Clinical Trial|Fusion Assessment Clinical Trial (FACT)|Completed||N/A|50|Anticipated|Flexuspine, Inc.|||1||f||||f||||||||||2017-02-18 14:01:23.653503|2017-02-18 14:01:23.653503
NCT00736385|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-12-05|2015-03-17||April 2009||2009-04-01|December 2016|2016-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|NAFLD||Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)|Hyperinsulinemia and Insulin Resistance in Nonalcoholic Fatty Liver Disease. Metformin for the Treatment of Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Trial|Terminated||Phase 4|11|Actual|Duke University|Study was terminated early due to difficulties with enrollment.|2|||f||||f||||||||||2017-02-18 14:01:23.751591|2017-02-18 14:01:23.751591
NCT00736372|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2013-03-21|||June 2008||2008-06-01|March 2013|2013-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer|A Phase Ib Trial of PX-12 Administered as a 72-Hour Infusion Every 21 Days in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer That is Refractory to Standard Treatment|Completed||Phase 1|14|Actual|Cascadian Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 14:01:24.433962|2017-02-18 14:01:24.433962
NCT00736346|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2008-08-14|||October 2005||2005-10-01|August 2008|2008-08-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|MADONA||Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain|Efficacy of Three Treatment Modalities for Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain|Unknown status|Recruiting|N/A|204|Anticipated|Universite du Quebec a Montreal||4|||f||||f||||||||||2017-02-18 14:01:24.546325|2017-02-18 14:01:24.546325
NCT00034957|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2012-02-14||||||February 2012|2012-02-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)||Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-02-18 18:06:41.338335|2017-02-18 18:06:41.338335
NCT00736333|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-10-31|2011-06-13||November 2006||2006-11-01|October 2014|2014-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)|Observational Program of Caelyx in MBC - Prevention and Treatment of PPE and Infusion Reactions|Completed||N/A|167|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:01:24.665801|2017-02-18 14:01:24.665801
NCT00736320|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2016-11-07|||November 2009||2009-11-01|November 2016|2016-11-01||||May 2020|Anticipated|2020-05-01||Interventional|HD16||HD16 for Early Stage Hodgkin Lymphoma|HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET|Active, not recruiting||Phase 3|1150|Actual|University of Cologne||2|||f||||t||||||||||2017-02-18 14:01:24.946475|2017-02-18 14:01:24.946475
NCT00736307|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-07-14|||October 2007||2007-10-01|April 2010|2010-04-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) Patients|Transplantation of Ex-Vivo Expanded Human Limbal Epithelial Stem Cells (LSC) on Amniotic Membrane (AM) for Limbal Stem Cell Deficiency (LSCD)|Completed||Phase 1/Phase 2|10|Actual|Royan Institute||1|||f||||t||||||||||2017-02-18 14:01:25.055739|2017-02-18 14:01:25.055739
NCT00736294|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-07-27|||July 2008||2008-07-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|PREFACE||Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter|Prevention of Atrial Fibrillation by the Prescription of Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter|Terminated||Phase 3|198|Actual|Centre Hospitalier Universitaire de Saint Etienne||2||Difficulty to include patients|f||||t||||||||||2017-02-18 14:01:25.16759|2017-02-18 14:01:25.16759
NCT00736281|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2016-06-16|||October 2008||2008-10-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Sublingual Immunotherapy for Food Allergy|Sublingual Immunotherapy for Food Allergy|Terminated||N/A|31|Actual|University of Missouri-Columbia||2||Due to recently published research, this is no longer a novel study.|f||||t||||||||||2017-02-18 14:01:25.295786|2017-02-18 14:01:25.295786
NCT00736268|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-08-06|||August 2008||2008-08-01|August 2014|2014-08-01||||May 2013|Actual|2013-05-01||Interventional|||Coping Skills for Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their Caregivers|Telephone-based Intervention for Patients With COPD and Their Caregivers|Completed||N/A|746|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:01:25.400982|2017-02-18 14:01:25.400982
NCT00736255|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-07-22|2011-08-17||December 2007||2007-12-01|July 2016|2016-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study|Lis-dexamphetamine (LDX/SPD489)as a Treatment for Smoking Cessation in Nicotine Dependent Individuals With ADHD|Completed||N/A|32|Actual|Duke University|Limitations of the study: 1. Our sample size was quite small and this can realistically only be considered a pilot trial. 2.We did not collect systematic follow-up data on our sample after the end of treatment.3.the duration of our trial was short.|2|||f||||f||||||||||2017-02-18 14:01:25.512177|2017-02-18 14:01:25.512177
NCT00736242|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-02-02|2012-12-21||December 2005||2005-12-01|February 2015|2015-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)|Treatment of Chronic Hepatitis C in HIV-infected Patients With PegIntron Pen and Rebetol According to German Law (§ 67 Abs 6 AMG)|Completed||N/A|232|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:01:26.010587|2017-02-18 14:01:26.010587
NCT00736229|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-11-19|2013-06-04||August 2008||2008-08-01|November 2014|2014-11-01|August 2012|Actual|2012-08-01|June 2011|Actual|2011-06-01||Interventional|||Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients|Intensive Exenatide Therapy in Hyperglycemic Patients Admitted to the Coronary Intensive Care Unit|Completed||Phase 4|40|Actual|Saint Luke's Health System|Modest number of patients enrolled, not powered to examine the effects of exenatide on hard clinical outcomes, no randomization, differences in baseline glucose levels and duration of therapy.|1|||f||||t||||||||||2017-02-18 14:01:26.394679|2017-02-18 14:01:26.394679
NCT00736216|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-03-17|||July 2008||2008-07-01|March 2015|2015-03-01||||July 2009|Actual|2009-07-01||Observational|||Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults|Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults|Withdrawn||Phase 1|0|Actual|Case Comprehensive Cancer Center|||1|PI left the institution|f||||t||||||||||2017-02-18 14:01:26.977971|2017-02-18 14:01:26.977971
NCT00736203|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2013-02-06|||July 2008||2008-07-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|MPVS||Memory and Picture Viewing Study|Memory and Picture Viewing Study|Completed||N/A|116|Actual|Duke University|||1||f||||f||||||Samples With DNA|"~     saliva, blood~   "|||2017-02-18 14:01:27.084647|2017-02-18 14:01:27.084647
NCT00736190|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2011-11-30|2011-07-07||August 2008||2008-08-01|November 2011|2011-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection|A Phase IV Study to Evaluate the Efficacy, Safety and Tolerability of Tenofovir DF in Asian-American Adults With Chronic Hepatitis B Infection|Completed||Phase 4|90|Actual|Gilead Sciences||1|||f||||f||||||||||2017-02-18 14:01:27.175781|2017-02-18 14:01:27.175781
NCT00736177|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-04-08|||August 2008||2008-08-01|February 2009|2009-02-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Comparison of Transfers of Fresh and Thawed Embryos in Patients With Prior Failed Embryo Transfer Cycles|Comparison of Transfers of Fresh and Thawed Embryos in Patients With Prior Failed Embryo Transfer Cycles|Withdrawn||N/A|0|Actual|Fertility Center of Las Vegas||2||No recruitment|f||||f||||||||||2017-02-18 14:01:30.051853|2017-02-18 14:01:30.051853
NCT00736164|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2012-02-03|||August 2008||2008-08-01|February 2012|2012-02-01||||June 2012|Anticipated|2012-06-01||Interventional|||Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer|A Randomized, Double Blind, Placebo Controlled Clinical Trial of Supplementation of L-Selenomethionine in Patients With Prostate Cancer Prior to Prostatectomy or Brachytherapy (Se Pre-Prostatectomy/Pre-Brachytherapy Trial)|Withdrawn||Phase 2|0|Actual|Roswell Park Cancer Institute||2||No accrual|f||||||||||||||2017-02-18 14:01:30.170355|2017-02-18 14:01:30.170355
NCT00639080|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2011-07-21|||March 2008||2008-03-01|August 2009|2009-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Necessity for Lipid Lowering Therapy in Type 2 Diabetes Patients|Necessity for Lipid Lowering Therapy in Type 2 Diabetes Patients|Completed||N/A|25|Actual|Endocrine Research Society|||1||f||||f||||||||||2017-02-18 14:36:06.256561|2017-02-18 14:36:06.256561
NCT00736151|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2009-08-06|||May 2004||2004-05-01|August 2009|2009-08-01||||April 2007|Actual|2007-04-01||Interventional|||Phase II Dose Titration Study in Patients With Neuropathic Pain|A Phase II, Multicentre, Pilot, Randomised, Double Blind Placebo Controlled Dose Titration Study to Evaluate the Safety, Maximum Tolerated Dose and Preliminary Evidence of Efficacy of Orally Administered Ralfinamide at Four Doses (80, 160, 240 and 320 mg/Day) in Patients With Neuropathic Pain|Completed||Phase 2|272|Actual|Newron||2|||f||||||||||||||2017-02-18 14:01:30.269622|2017-02-18 14:01:30.269622
NCT00736138|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-12-10|||June 2007||2007-06-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Hyperpronation and Foot Pain|Effect of Training and Pellots in Treatment of Foot Pain Caused by Hyperpronation|Completed||N/A|50|Actual|Northern Orthopaedic Division, Denmark||2|||f||||||||||||||2017-02-18 14:01:30.402266|2017-02-18 14:01:30.402266
NCT00736125|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2013-04-17|2013-03-05||December 2007||2007-12-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|September 2009|Actual|2009-09-01||Interventional|||A Study to Determine if Carbon Dioxide Lavage During Total Knee Surgery Reduces Intraoperative Embolic Events|A Comparison of Intraoperative Embolic Events During Total Knee Arthroplasty Performed With CarboJet Assisted Versus Standard Orthopedic Techniques: A Pilot Study|Completed||Phase 2|20|Actual|Kinamed Incorporated||2|||f||||f||||||||||2017-02-18 14:01:30.486823|2017-02-18 14:01:30.486823
NCT00736112|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2016-09-29|||October 2008||2008-10-01|September 2016|2016-09-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|FATA||Food Allergy - Tubes - Adenoids (FATA) Trial|A New Approach to Otitis Media With Effusion (OME)|Withdrawn||N/A|0|Actual|University of Missouri-Columbia||3||The investigator left the institution|f||||t||||||||No||2017-02-18 14:01:31.082542|2017-02-18 14:01:31.082542
NCT00736099|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-06-18|2011-12-21||August 2008||2008-08-01|December 2013|2013-12-01||||December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM|A 78 Week Open Label Extension to Trials Assessing the Safety and Efficacy of BI 1356 (5 mg) as Monotherapy or in Combination With Other Antidiabetic Medications in Type 2 Diabetic Patients.|Completed||Phase 3|2122|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:01:31.229288|2017-02-18 14:01:31.229288
NCT00736086|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2008-08-14|||March 2006||2006-03-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Observational|||RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System|A Post-Market, Prospective, Multi-Center, Study to Evaluate Safety and Efficacy of the StarClose™ Vascular Closure System in Patients Who Are Ambulated Early Post-Diagnostic Catheterization|Completed||Phase 4|165|Actual|Abbott Vascular|||1||f||||t||||||||||2017-02-18 14:01:33.336009|2017-02-18 14:01:33.336009
NCT00736073|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-06-18|2012-11-15||August 2007||2007-08-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|August 2010|Actual|2010-08-01||Interventional|||A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis|A Randomized, Double-Blind, Prospective Trial of Oral Administration of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis|Completed||N/A|73|Actual|Duke University|Unable to control for pre-procedure dosing|2|||f||||f||||||||||2017-02-18 14:01:33.659289|2017-02-18 14:01:33.659289
NCT00736060|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-08-25|||May 2008||2008-05-01|August 2011|2011-08-01|November 2008|Actual|2008-11-01|||||Observational|||Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever|Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom|Completed||N/A|60|Anticipated|HaEmek Medical Center, Israel|||2||f||||f||||||||||2017-02-18 14:01:34.06155|2017-02-18 14:01:34.06155
NCT00736047|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2009-10-29|||August 2008||2008-08-01|October 2009|2009-10-01||||October 2009|Actual|2009-10-01||Interventional|||Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.|A Double Blind, Placebo-controlled, Multi-centre Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of Repeated s.c Administrations of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.|Completed||Phase 2|200|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:01:34.161962|2017-02-18 14:01:34.161962
NCT00736034|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2010-03-26|2010-03-04||September 2008||2008-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment|A Single-Center, Open-Label Study to Assess the Efficacy of SharpPS™-Gold in Elderly Subjects With Memory Impairment|Completed||Phase 4|18|Actual|Enzymotec||1|||f||||||||||||||2017-02-18 14:01:34.263018|2017-02-18 14:01:34.263018
NCT00736021|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2010-03-21|||September 2008||2008-09-01|September 2008|2008-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Treatment of Post-traumatic Stress Disorder With High Doses of Escitalopram|Post-marketing, Twelve Weeks, Open Label Study of up to 40 mg. Escitalopram in Chronic PTSD|Completed||N/A|38|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 14:01:34.471641|2017-02-18 14:01:34.471641
NCT00736008|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-08-25|||May 2008||2008-05-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Thrombophilic Risk Factors in Pediatric Patients Diagnosed at the Ha'Emek Medical Center|The Study Will Summarize the Clinical and Laboratory Data of All the Pediatric Patients Diagnosed With Thrombotic Events at the Pediatric Hematology Unit|Completed||N/A|100|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-02-18 14:01:34.583241|2017-02-18 14:01:34.583241
NCT00735995|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-04-11|||August 2008||2008-08-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway|Effectiveness of Group and Individual Treatment of Childhood Anxiety Disorders in Community Clinics. A Randomized Controlled Trial.|Completed||Phase 2|165|Actual|Regionsenter for barn og unges psykiske helse||3|||f||||f||||||||||2017-02-18 14:01:34.676395|2017-02-18 14:01:34.676395
NCT00735969|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-10-10|2014-06-16||August 2008||2008-08-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Patients 18 years of age and older with chronic hepatitis C genotype 1 who have not been successfully treated with a standard course of Peginterferon and ribavirin.|High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype 1 Infection Who Have Failed to Respond or Relapsed After Standard Therapy|Completed||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 14:01:34.786209|2017-02-18 14:01:34.786209
NCT00005219|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||April 1988||1988-04-01|May 2000|2000-05-01|March 1990||1990-03-01|||||Observational|||Predicting Physical Activity Change: an Epidemiologic Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:20.21889|2017-02-18 18:15:20.21889
NCT00735943|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-08-26|2011-07-21||November 2008||2008-11-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Macugen Observational Study|Macugen Observational Study|Terminated||N/A|22|Actual|Pfizer|Outcome measures were not designated as primary or secondary measures as this study was an observational non-interventional study.||1|See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:01:35.091|2017-02-18 14:01:35.091
NCT00735930|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-04-01|||August 2008||2008-08-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|March 2013|Actual|2013-03-01||Interventional|||Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase 1 Trial of Flavopiridol in Combination With Lenalidomide in Patients With Relapsed or Refractory B-Cell CLL/SLL|Completed||Phase 1|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:01:35.437436|2017-02-18 14:01:35.437436
NCT00735917|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-04-25|2013-10-07||October 2008||2008-10-01|June 2013|2013-06-01|October 2012|Actual|2012-10-01|April 2011|Actual|2011-04-01||Interventional|||Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer|A Phase II Trial of AZD0530 in Previously Treated Metastatic Pancreas Cancer|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:01:35.560207|2017-02-18 14:01:35.560207
NCT00735904|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-11-30|2012-11-30||December 2008||2008-12-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer|Phase 2 Trial Of AG-013736 As First-Line Treatment For Patients With Squamous Non-Small Cell Lung Cancer Receiving Treatment With Cisplatin And Gemcitabine|Completed||Phase 2|38|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:01:35.905266|2017-02-18 14:01:35.905266
NCT00735891|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2016-09-21|||December 2008||2008-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|||A Trial for Treatment of Stage IIIB or IV Non-Small Cell Lung Cancer|Multicenter, Open-Label, Randomized, Phase II Trial of Docetaxel, Carboplatin and Bevacizumab as First-Line Treatment, Followed by Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Second Line Treatment of Stage IIIB or IV NSCLC|Completed||Phase 2|2|Actual|Milton S. Hershey Medical Center||3|||f||||t||||||||||2017-02-18 14:01:36.259601|2017-02-18 14:01:36.259601
NCT00735878|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2009-04-29|||September 2004||2004-09-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|December 2008|Anticipated|2008-12-01||Interventional|||Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer|A Phase I/II Pharmacokinetic and Pharmacodynamic Study of ABT-751 in Combination With Carboplatin in Patients With Advanced Lung Cancer|Terminated||Phase 1/Phase 2|33|Anticipated|Dartmouth-Hitchcock Medical Center||1||"It was decided to close the study to further enrollment based on data from a similar study~   using ABT-751 and Pemetrexed that did not show efficacy."|f||||t||||||||||2017-02-18 14:01:36.387312|2017-02-18 14:01:36.387312
NCT00735865|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2009-05-22|||July 2003||2003-07-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion|Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion|Completed||N/A|55|Actual|Lahey Clinic||4|||f||||f||||||||||2017-02-18 14:01:36.646072|2017-02-18 14:01:36.646072
NCT00735852|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2016-10-12|||December 2008||2008-12-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women|A Prospective Single Centre, Single Arm, Open Label Study of the Long Term Use of a LHRA Agonist (Decapeptyl SR, 11.25mg) in Combination With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women|Completed||Phase 4|31|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-02-18 14:01:36.747928|2017-02-18 14:01:36.747928
NCT00735839|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-12-18|2012-05-23||March 2008||2008-03-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Single Dose of Merck S. Aureus Vaccine (V710) in Healthy Male Japanese Subjects|Completed||Phase 1|40|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:01:36.851184|2017-02-18 14:01:36.851184
NCT00735826|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2011-12-02|||March 2009||2009-03-01|December 2011|2011-12-01||||December 2012|Anticipated|2012-12-01||Interventional|||A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Stage I-III Non-Small Cell Lung Cancer|A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Stage I-III Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|N/A|10|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 14:01:37.188086|2017-02-18 14:01:37.188086
NCT00735813|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2012-09-04|||April 2008||2008-04-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia|A Randomised Study of Taurolock for the Locking of Tunneled Central Venous Catheters in Children With Malignant Diseases.|Completed||Phase 3|129|Actual|Aarhus University Hospital||2|||f||||f||||||||||2017-02-18 14:01:37.286124|2017-02-18 14:01:37.286124
NCT00735800|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-05-04|||February 2008||2008-02-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Telephone Support for Dementia Caregivers|Psychosocial Telephone Intervention for Dementia Caregivers|Completed||Phase 2|250|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-02-18 14:01:37.407509|2017-02-18 14:01:37.407509
NCT00735787|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2010-10-11|2010-09-01||August 2008||2008-08-01|October 2010|2010-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet|Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet|Completed||Phase 4|81|Actual|Abbott|Based on one investigator's non-compliance with the protocol at one site, ITT analyses were conducted in a smaller number of subjects that excluded all 9 subjects from this one site.|2|||f||||f||||||||||2017-02-18 14:01:37.535153|2017-02-18 14:01:37.535153
NCT00735774|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2009-11-23|||August 2008||2008-08-01|November 2009|2009-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Suitability of 11C-ORM-13070 as a PET Tracer|Suitability of 11C-ORM-13070 as a Positron Emission Tomography Tracer; an Open Study in Healthy Males|Completed||Phase 1|18|Actual|Orion Corporation, Orion Pharma||1|||f||||f||||||||||2017-02-18 14:01:38.546231|2017-02-18 14:01:38.546231
NCT00639067|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2014-05-15|||June 2008||2008-06-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|||Breath Test for Early Detection of Lung Cancer|Breath Test Assay for the Adjunctive Detection of Lung Cancer|Completed||N/A|215|Actual|Menssana Research, Inc.|||4||f||||f||||||||||2017-02-18 14:36:06.350449|2017-02-18 14:36:06.350449
NCT00735761|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2008-08-14|||December 2006||2006-12-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients|A Randomized, Double-Blind, Active-Controlled, Subject Initiated Study Comparing ME-609 to Acyclovir Cream for Treatment of Recurrent Herpes Simplex Labialis in Immunocompromised Patients|Completed||Phase 3|201|Actual|Medivir||2|||f||||f||||||||||2017-02-18 14:01:38.643177|2017-02-18 14:01:38.643177
NCT00735748|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-12-04|||March 2008||2008-03-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Comparison of Tramadol Orally Versus an Optimized Dose of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery|Comparison of the Therapeutic Efficacy and Side Effects of Tramadol Per os (Tradonal Odis® Orodispersible Tablets) Versus an Optimised Dosis of Intravenous Tramadol for Postoperative Pain Relief in Ambulatory Surgery.|Unknown status|Recruiting|Phase 4|200|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 14:01:38.733571|2017-02-18 14:01:38.733571
NCT00735735|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2014-03-11|||February 2009||2009-02-01|March 2014|2014-03-01||||January 2012|Actual|2012-01-01||Interventional|||Measurement of Substance P in Saliva of Low Back Pain Patients|Study of the Measurement of Substance P in the Saliva of Patients With Low Back Pain|Suspended||N/A|40|Anticipated|Kovacs Foundation||1|||f||||t||||||||||2017-02-18 14:01:38.839337|2017-02-18 14:01:38.839337
NCT00735722|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2016-03-31|||July 2009||2009-07-01|March 2016|2016-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|AFMAZE-CABG||A(f)MAZE-CABG Study|A Prospective Randomized Trial Comparing Freedom From Atrial Fibrillation at One Year Post CABG in Patients Undergoing Concomitant Left Atrial Ablation Using HIFU Versus CABG in Patients With Persistent or Long Standing Persistent AF|Terminated||N/A|188|Actual|St. Jude Medical||2||Insufficient recruitment|f||||t||||||||||2017-02-18 14:01:38.925178|2017-02-18 14:01:38.925178
NCT00735709|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2013-10-25|2013-10-25||August 2008||2008-08-01|October 2013|2013-10-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder|A Randomized, Double-blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 3 Doses of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder|Completed||Phase 3|560|Actual|Takeda||4|||f||||f||||||||||2017-02-18 14:01:39.066596|2017-02-18 14:01:39.066596
NCT00735696|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-12-17|2014-12-17||January 2009||2009-01-01|December 2014|2014-12-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Interventional||Modified intent to treat population (mITT): All participants who received any quantity of study drug.|A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer|A Phase 2, Open-label Study of IMC-1121B in Combination With Paclitaxel and Carboplatin as First-line Therapy in Patients With Stage IIIB/IV Non-small Cell Lung Cancer|Completed||Phase 2|41|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 14:01:42.207602|2017-02-18 14:01:42.207602
NCT00735683|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-05-29|||September 2008||2008-09-01|May 2015|2015-05-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety|Double-Blind, Randomized, Placebo-Controlled, 12-Week Study of the Safety and Efficacy of ATHX-105 Phosphate for the Treatment of Obesity|Withdrawn||Phase 2|0|Actual|Athersys, Inc||6|||f||||f||||||||||2017-02-18 14:01:42.679362|2017-02-18 14:01:42.679362
NCT00735670|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2016-10-07|2013-04-03||June 2008||2008-06-01|October 2016|2016-10-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional||Participants meeting eligibility criteria for the final protocol version.|Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury|Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury|Completed||N/A|34|Actual|University of Michigan|Difficulties with recruitment and high rate of withdrawal (57%) resulted in a very small sample. As such, results must be taken with caution given low power in this study.|2|||f||||t||||||||||2017-02-18 14:01:42.770787|2017-02-18 14:01:42.770787
NCT00735657|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-02-24|||August 2008||2008-08-01|February 2010|2010-02-01|December 2010|Anticipated|2010-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle|Anesthesia for PPV Using Insulin Needle|Unknown status|Recruiting|N/A|120|Anticipated|King Khaled Eye Specialist Hospital||2|||f||||t||||||||||2017-02-18 14:01:43.276133|2017-02-18 14:01:43.276133
NCT00735644|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-04-01|2014-06-25||August 2008||2008-08-01|April 2015|2015-04-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional||The baseline analysis population represents the participants who have received the trial vaccine or control vaccine (safety analysis set). Data on participants were analyzed and presented according to the vaccine they actually received.|Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines|Lot-to-lot Consistency, Bridging, and Safety Trial of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines|Completed||Phase 3|1200|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 14:01:43.404507|2017-02-18 14:01:43.404507
NCT00735631|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-12-06|||June 2008||2008-06-01|December 2011|2011-12-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Evaluation of the Accuracy, Safety and Robustness of a Single-input-single-output (SISO) Model-based Predictive Closed-loop System to Guide Patient-individualized ICU Sedation|Evaluation of the Accuracy, Safety and Robustness of a Single-input-single-output (SISO) Model-based Predictive Closed-loop System to Guide Patient-individualized ICU Sedation.|Completed||Phase 4|36|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 14:01:44.54832|2017-02-18 14:01:44.54832
NCT00735618|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2011-11-15|2009-03-03||June 2008||2008-06-01|November 2011|2011-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Relaxation and Heart Rate Variability|Pilot Study on the Effects of a Brief Relaxation Program on Heart Rate Variability in Cancer Patients|Completed||N/A|20|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:01:44.799292|2017-02-18 14:01:44.799292
NCT00735605|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2010-01-12|||September 2006||2006-09-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Comparative Study Between Surgical and Non Surgical Treatment of Anismus in Patients|Comparative Study Between Surgical and Non Surgical Treatment of Anismus in Patients With Symptoms of Obstructed Defecation|Completed||N/A|60|Actual|Mansoura University||3|||f||||t||||||||||2017-02-18 14:01:45.052079|2017-02-18 14:01:45.052079
NCT00735592|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-08-25|||March 2008||2008-03-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Value of Radiological Follow up in Children Hospitalized With Lobar Pneumonia|The Study Intend to Evaluate the Usefulness of Performing a Follow up X Rays in Children Admitted With Lobar Pneumonia.|Completed||N/A|200|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-02-18 14:01:45.169352|2017-02-18 14:01:45.169352
NCT00735579|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2017-02-07|||July 2008||2008-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Observational|INWOUND||Wound Healing Abnormalities in Major Abdominal Surgery|Incidence of Wound-healing-abnormalities in Major Abdominal Surgery - Association With Factors of Coagulation|Recruiting||N/A|260|Anticipated|Klinikum St. Georg gGmbH|||1||f||||f||||||Samples Without DNA|"~     1) serum samples for measurement of coagulation factors~   "|||2017-02-18 14:01:45.267844|2017-02-18 14:01:45.267844
NCT00735566|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-10-16|||April 2006||2006-04-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|July 2008|Actual|2008-07-01||Observational|||Antiangiogenic Factors in Gastric Cancer|The Role of Endogenous Antiangiogenic Factors in Gastric Cancer Progression|Completed||N/A|240|Actual|National Cancer Center, Korea|||1||f||||f||||||Samples Without DNA|"~     Serum for protein assay using ELISA~   "|||2017-02-18 14:01:45.378936|2017-02-18 14:01:45.378936
NCT00735553|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-08-05|2014-06-25||August 2008||2008-08-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Study prematurely terminated|Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids|A Phase III, Three-arm, Parallel Design, Placebo-controlled, Randomized, Double-blind, Multicenter Study Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in the Treatment of Premenopausal Women With Symptomatic Uterine Fibroids|Terminated||Phase 3|77|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with any study data.|3||Repros stopped the study for safety and FDA put the study on hold for safety.|f||||t||||||||||2017-02-18 14:01:45.472467|2017-02-18 14:01:45.472467
NCT00735540|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-08-30|||May 2008||2008-05-01|August 2015|2015-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Clinical Diagnosis of Teenagers Admitted to Pediatric Departments|The Purpose of This Study is to Analyze the Clinical Characteristics of Teenagers Admitted to Pediatric Departments|Completed||N/A|1389|Actual|HaEmek Medical Center, Israel|||3||f||||t||||||||||2017-02-18 14:01:45.740935|2017-02-18 14:01:45.740935
NCT00735527|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2009-05-04|||May 2008||2008-05-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|INLOR||Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children|Intra-Nasal vs. Intra-Venous Lorazepam for Control of Acute Seizures in Children: Prospective Open Labeled Randomized Equivalence Trial|Completed||Phase 3|140|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 14:01:45.850321|2017-02-18 14:01:45.850321
NCT00735514|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-10-01|||July 2008||2008-07-01|October 2015|2015-10-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Observational|||Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer|Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers|Completed||Phase 1|83|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||||||2017-02-18 14:01:45.962058|2017-02-18 14:01:45.962058
NCT00735501|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-10-28|||March 2008||2008-03-01|October 2014|2014-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes|Safety of Levemir® (Insulin Detemir) Treatment in Patients With Type 2 Diabetes|Completed||N/A|314|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:01:46.081908|2017-02-18 14:01:46.081908
NCT00735488|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2015-08-30|||May 2008||2008-05-01|August 2015|2015-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Sickle Cell Anemia Screening and Prevention in Northern Israel|Summary of the Data From the Prevention Programme for Hemoglobinopathies in Northern Israel|Completed||N/A|69|Actual|HaEmek Medical Center, Israel|||2||f||||t||||||||||2017-02-18 14:01:46.185087|2017-02-18 14:01:46.185087
NCT00735475|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-07-17|2011-07-03||October 2008||2008-10-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine|A Phase IV, Randomized, Observer-Blind, Multi-Center, Non Inferiority Comparison of the Immune Response of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Inactivated Split-Virion Influenza Vaccine in Adults Aged Greater Than or Equal to 65 Years|Completed||Phase 4|1268|Actual|Seqirus||2|||f||||||||||||||2017-02-18 14:01:46.318559|2017-02-18 14:01:46.318559
NCT00735462|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2011-06-21|2011-04-24||August 2008||2008-08-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts|A Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts|Completed||Phase 3|511|Actual|Graceway Pharmaceuticals, LLC|There was a high percentage of lost to follow up in this study. Since the disease studied in this study can be wait and watch, typically a high lost to follow up rate were seen in these kind of trials.|3|||f||||f||||||||||2017-02-18 14:01:47.059377|2017-02-18 14:01:47.059377
NCT00735449|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-11-13|2011-10-17||July 2008||2008-07-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects|Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects|Completed||Phase 4|204|Actual|Allergan||2|||f||||||||||||||2017-02-18 14:01:47.635051|2017-02-18 14:01:47.635051
NCT00735436|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2013-02-04|2012-12-31||December 2008||2008-12-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|July 2011|Actual|2011-07-01||Interventional|||A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)|Phase II Trial for Patients With Glioblastoma Multiforme (GBM) Treated With Gliadel Followed by Avastin Plus Irinotecan|Terminated||Phase 2|18|Actual|Duke University||1||Study enrollment was halted due to slow accrual.|f||||f||||||||||2017-02-18 14:01:48.00781|2017-02-18 14:01:48.00781
NCT00735423|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-14|2017-01-24|||August 2008||2008-08-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Infant Diet Effects on Brain Function and Language Processing (fMRI)|Effects of Neonatal Diet on Language, Neurocognitive Functions at Eight Years Old: fMRI, ERP and Standardized Behavioral Measures|Active, not recruiting||N/A|100|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:01:48.323822|2017-02-18 14:01:48.323822
NCT00735228|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-08-15|||August 2008||2008-08-01|August 2008|2008-08-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|KMS||Tight Glycemic Control by Artificial Pancreas|Benefit of Tight Glycemic Control in Surgical Patients: Prospective Randomized Clinical Trial|Unknown status|Recruiting|N/A|400|Anticipated|Kochi University||2|||f||||t||||||||||2017-02-18 14:01:54.471336|2017-02-18 14:01:54.471336
NCT00735410|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-11-30|||June 2008||2008-06-01|November 2011|2011-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009|A Phase III, Multicenter, Uncontrolled, Open-label Study to Evaluate Safety and Immunogenicity of Preservative Free, Inactivated Split Influenza Vaccine, Using the Strain Composition 2008/2009 When Administered to Adult and Elderly Subjects|Completed||Phase 3|134|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:01:48.41822|2017-02-18 14:01:48.41822
NCT00735397|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-02-11|2015-09-16||October 2008||2008-10-01|February 2016|2016-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures|An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures|Completed||Phase 3|1218|Actual|Eisai Inc.||1|||f||||t||||||||||2017-02-18 14:01:48.53682|2017-02-18 14:01:48.53682
NCT00735384|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2017-01-12|||September 2006||2006-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Muscle Force Assessment in the Intensive Care Unit and in Primary Myopathies|Application of Methodology of Non-invasive Stimulated Muscle Force Assessment to ICU Patients and Patients With Primary Myopathies to Characterize Their Muscle Weakness - Extension of the Study Protocol: 2008 to 2018|Recruiting||N/A|80|Anticipated|University Hospital, Basel, Switzerland|||2||f||||f||||||||||2017-02-18 14:01:49.79606|2017-02-18 14:01:49.79606
NCT00735371|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2011-06-21|2010-02-01||October 2008||2008-10-01|June 2011|2011-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Phase III, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled, Forced-dose Titration, Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Adolescents Aged 13-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|314|Actual|Shire||4|||f||||f||||||||||2017-02-18 14:01:49.917658|2017-02-18 14:01:49.917658
NCT00735358|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-10-04|||September 2005||2005-09-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||Comparison of Endoscopic Injection of Conventional and Double Doses Cyanoacrylate for Gastric Variceal Hemorrhage||Completed||Phase 4|105|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-02-18 14:01:50.618564|2017-02-18 14:01:50.618564
NCT00735345|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-03-06|||August 2008||2008-08-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma|Chemotherapy Induction and Chemoradiotherapy Combined With Cetuximab Respectively in Patients With Non-Metastatic Esophageal Carcinoma: A Multicentric Phase II Study|Terminated||Phase 2|50|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1||because of safety concerns the study was terminated prematurely|f||||f||||||||||2017-02-18 14:01:50.708661|2017-02-18 14:01:50.708661
NCT00735332|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2010-08-04|||August 2008||2008-08-01|August 2010|2010-08-01|October 2010|Anticipated|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma|A Phase IIa Study of TLN-232 as Second-line Therapy for Patients With Metastatic Melanoma|Terminated||Phase 2|49|Anticipated|Thallion Pharmaceuticals||1||License termination.|f||||f||||||||||2017-02-18 14:01:50.904122|2017-02-18 14:01:50.904122
NCT00735319|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-01-11|||September 2008||2008-09-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|TcB RCT||Transcutaneous Bilirubinometers in the Community|Transcutaneous Bilirubinometers in the Community and the Reduction of Morbidity Associated to Jaundice: A Clustered Randomized Controlled Trial.|Completed||N/A|10000|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 14:01:51.006073|2017-02-18 14:01:51.006073
NCT00735306|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-05-22|2011-10-14||July 2008||2008-07-01|April 2015|2015-04-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|TART||Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma|A Phase I/II Trial of Radiation, Avastin and Tarceva for Resectable or Locally Advanced Pancreatic Adenocarcinoma|Completed||Phase 1|12|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:01:51.115143|2017-02-18 14:01:51.115143
NCT00735293|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-09-17|||April 2007||2007-04-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|VASER AxHH||VASER Treatment of Axillary Hyperhidrosis/Bromidrosis|The Use of the VASER System in the Treatment of Axillary Hyperhidrosis and/or Axillary Bromidrosis|Completed||Phase 4|13|Actual|Commons Aesthetic Plastic Surgery||1|||f||||f||||||||||2017-02-18 14:01:51.435472|2017-02-18 14:01:51.435472
NCT00735280|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-01-03|||August 2008||2008-08-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|ISAR-REACT-3A||Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI|Non-randomized, Open-label, Historical Control, Single Group Assignment Trial of a Reduced Dose of Unfractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions|Completed||Phase 4|2505|Actual|Deutsches Herzzentrum Muenchen||1|||f||||f||||||||||2017-02-18 14:01:51.553143|2017-02-18 14:01:51.553143
NCT00735267|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-11-09||2010-08-25|October 2008||2008-10-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)|A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder|Terminated||Phase 3|468|Actual|Pfizer||1||Please see Detailed Description for termination reason.|f||||f||||||||||2017-02-18 14:01:51.665146|2017-02-18 14:01:51.665146
NCT00735254|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2010-01-18|||July 2008||2008-07-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|July 2009|Actual|2009-07-01||Interventional|||Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars|Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars|Completed||Early Phase 1|20|Anticipated|The Cleveland Clinic||4|||f||||t||||||||||2017-02-18 14:01:51.849302|2017-02-18 14:01:51.849302
NCT00735241|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-05-21|||July 2008||2008-07-01|May 2015|2015-05-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|FAST||FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma|Pilot Study of FOLFOX6 Plus Sir-Spheres® Microspheres (Chemo-radiotherapy) in Combination With Bevacizumab (Avastin) as a First Line Treatment in Patients With Nonresectable Liver Metastases From Primary Colorectal Carcinoma|Withdrawn||Phase 2/Phase 3|0|Actual|Sirtex Medical||1||Withdrawn by the study sponsor.|f||||t||||||||||2017-02-18 14:01:54.337715|2017-02-18 14:01:54.337715
NCT00735189|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-06-23|||November 2007||2007-11-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?|Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician? A Prospective Randomized Trial|Completed||Phase 4|96|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 14:01:54.68734|2017-02-18 14:01:54.68734
NCT00735176|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-10-05|||September 2008||2008-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|July 2018|Anticipated|2018-07-01||Interventional|NORCAT||The Norwegian Cervical Arthroplasty Trial|Treatment of Cervical Radiculopathy With Arthroplasty Compared With Discectomy With Fusion and Cage (ACDF. Clinical, Radiological and Biomechanical Aspects. A Randomized Multicenter Study.|Active, not recruiting||N/A|146|Anticipated|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-02-18 14:01:54.786462|2017-02-18 14:01:54.786462
NCT00735163|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2009-04-15|||September 2008||2008-09-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|Aldea _01||Blood Glucose Control With A Software-Algorithm In Intensive Care Unit (ICU) Patients|Mono-Centric, Open, Non-Controlled Study To Investigate The Feasibility Of Blood Glucose Control With The Software-Algorithm eMPC (Enhanced Model Predictive Control) In ICU Patients|Completed||N/A|20|Actual|B. Braun Melsungen AG||1|||f||||f||||||||||2017-02-18 14:01:54.896243|2017-02-18 14:01:54.896243
NCT00735150|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-10-08|||March 2008||2008-03-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk|Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk|Completed||N/A|34|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:01:54.999487|2017-02-18 14:01:54.999487
NCT00735137|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2009-11-02|||August 2008||2008-08-01|November 2009|2009-11-01|February 2012|Anticipated|2012-02-01|October 2011|Anticipated|2011-10-01||Interventional|||Randomized Study of Pessary Versus Standard Management in Women With Increased Chance of Premature Birth|Randomized Study of Pessary vs Standard Management in Women With Increased Chance of Premature Birth|Unknown status|Recruiting|Phase 3|2780|Anticipated|King's College Hospital NHS Trust||4|||f||||t||||||||||2017-02-18 14:01:55.108856|2017-02-18 14:01:55.108856
NCT00735124|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-06-13|||November 2008||2008-11-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2009|Actual|2009-12-01||Interventional|||Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy|An Investigation of Post-Operative Pain Scores and Analgesic Requirements After Ambulatory Inguinal Herniorrhaphy With Pre-Operative Gabapentin Therapy|Suspended||Phase 2/Phase 3|240|Anticipated|University of Oklahoma||2||Need amendments in application process and require IBD number from FDA|f||||t||||||||||2017-02-18 14:01:55.453421|2017-02-18 14:01:55.453421
NCT00735111|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2013-01-15|||February 2008||2008-02-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?|Do Self-Rated Karnofsky Performance Status (KPS) Scores Correlate With Health-Care-Provider-Rated Scores?|Completed||N/A|200|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 14:01:55.576608|2017-02-18 14:01:55.576608
NCT00735098|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2013-02-04|||January 2009||2009-01-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effects of Home-Based Rehabilitation Treatments Among Persons With Symptomatic Knee Osteoarthritis|The Effects of Home-Based Rehabilitation Treatments Among Persons With Symptomatic Knee Osteoarthritis.|Completed||N/A|44|Actual|University of Zululand||4|||f||||||||||||||2017-02-18 14:01:55.685124|2017-02-18 14:01:55.685124
NCT00735085|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2011-09-09||2011-09-09|April 2009||2009-04-01|September 2011|2011-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.|A Randomized, Double Blind, Placebo-Controlled Dose Escalation Study to Investigate the Safety and Pharmacokinetics After Single and Multiple Doses of SLV334 in Sequential Cohorts of Patients With Moderate and Severe Traumatic Brain Injury|Terminated||Phase 2|57|Actual|Abbott||2||This study was stopped 20 May 2010 due to strategic considerations|f||||t||||||||||2017-02-18 14:01:55.790895|2017-02-18 14:01:55.790895
NCT00735072|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-06-13|2011-06-05||September 2008||2008-09-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|||Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure|Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure|Completed||Phase 4|45|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:01:55.913898|2017-02-18 14:01:55.913898
NCT00735059|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2009-08-20|||August 2008||2008-08-01|August 2009|2009-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures|Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures|Completed||N/A|14|Anticipated|EXcorLab GmbH||2|||f||||f||||||||||2017-02-18 14:01:56.351124|2017-02-18 14:01:56.351124
NCT00735046|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2011-01-13|||April 2008||2008-04-01|July 2008|2008-07-01|April 2010|Actual|2010-04-01|||||Observational|KORDIAL||Cognitive Behavioural Therapy of Early Dementia|Cognitive Behavioural Resource-based Therapy of Early Dementia in the Everyday Setting|Completed||N/A|200|Anticipated|Technische Universität München|||2||f||||t||||||None Retained|"~     not required~   "|||2017-02-18 14:01:56.462134|2017-02-18 14:01:56.462134
NCT00735033|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-08-18||||||May 2008|2008-05-01||||||||Interventional|||The Effects of the Swiss Ball on Cerebral Vascular Accident|The Effects of the Swiss Ball on Patients With Hemiplegia Due to Cerebral Vascular Accident|Completed||N/A|||Fortaleza University|||||f||||t||||||||||2017-02-18 14:01:56.571087|2017-02-18 14:01:56.571087
NCT00735020|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-01-23|||June 2008||2008-06-01|January 2014|2014-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines|A Phase I, Observer-Blind, Randomized, Single-Center Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines in Healthy Adults Aged 18 to 39 Years.|Completed||Phase 1|72|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:01:56.652128|2017-02-18 14:01:56.652128
NCT00734812|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2013-01-23|||May 2008||2008-05-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Laparoscopic Supracervical Hysterectomy Versus Total Laparoscopic Hysterectomy|LSH vs. TLH, A Randomized Single Blind Trial|Withdrawn||Phase 3|0|Actual|Brigham and Women's Hospital||2||Study was withdrawn prior to any enrollment.|f||||f||||||||||2017-02-18 14:02:00.626724|2017-02-18 14:02:00.626724
NCT00735007|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2013-10-21|2010-07-14||July 2008||2008-07-01|October 2013|2013-10-01||||January 2009|Actual|2009-01-01||Interventional|||12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.|International, Multicenter, Single-arm, Open-label, 12-week Phase IIIb Study to Evaluate RebiSmart™ Suitability for Self Injection of Rebif® New Formulation (RNF) in Multidose Cartridges in Patients With Relapsing Form of Multiple Sclerosis (RMS)|Completed||Phase 3|106|Actual|EMD Serono||1|||f||||f||||||||||2017-02-18 14:01:56.764856|2017-02-18 14:01:56.764856
NCT00734994|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2015-06-01|2011-08-01||April 2008||2008-04-01|June 2015|2015-06-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer|Pilot Study of External Hyperthermia and Intravesical Mitomycin-C To Treat Recurrent Bladder Cancer After Resection and Standard Adjuvant Therapy|Completed||Early Phase 1|15|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:01:57.561486|2017-02-18 14:01:57.561486
NCT00734981|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2011-06-22|||January 2012||2012-01-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Observational|||Efficacy Evaluation of a Novel Diagnostic Assay Which is the Basis for Seaforia Diagnostic System|Efficacy Evaluation of a Novel Diagnostic Assay Which is the Basis for Seaforia Diagnostic System|Unknown status|Not yet recruiting|N/A|60|Anticipated|Lotus Bio Inc.|||1||f||||t||||||None Retained|"~     Semen~   "|||2017-02-18 14:01:57.897598|2017-02-18 14:01:57.897598
NCT00734968|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-08-17|2016-05-20||May 2008||2008-05-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence|Does Prophylaxis With Macrobid Reduce the Incidence of Urinary Tract Infection in Patients Who Receive a Sub-Urethral Sling for the Treatment of Stress Urinary Incontinence: Randomized, Double Blinded Placebo Controlled Clinical Trial|Completed||Phase 4|161|Actual|University of Missouri-Columbia||2|||f||||t||||||||Undecided||2017-02-18 14:01:57.985621|2017-02-18 14:01:57.985621
NCT00734955|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-08-01|||May 2006||2006-05-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients|An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients|Recruiting||N/A|530|Anticipated|Duke University||3|||f||||t||||||||||2017-02-18 14:01:58.42386|2017-02-18 14:01:58.42386
NCT00734942|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-12-22|||January 2009||2009-01-01|August 2008|2008-08-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|||Development and Implementation of Evidence-Based Family-Oriented Support for Young Carers and Their Families in Germany|Improved Health-Related Quality of Life for Young Carers and Their Families in Germany on the Basis of Evidence-Based Family-Oriented Support|Unknown status|Not yet recruiting|N/A|150|Anticipated|University of Witten/Herdecke||2|||f||||f||||||||||2017-02-18 14:01:58.527447|2017-02-18 14:01:58.527447
NCT00734929|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-02-12|2011-04-07||September 2007||2007-09-01|January 2016|2016-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy|A Comparison of the Combination of Aprepitant and Dexamethasone Versus the Combination of Ondansetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Craniotomy|Completed||Phase 4|115|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:01:58.647941|2017-02-18 14:01:58.647941
NCT00734916|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2010-02-03|||August 2008||2008-08-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Immune Modulation by Parenteral Lipids|Immune Modulation by Omega-3 Versus Omega-6 Based Parenteral Lipids in Healthy Volunteers|Completed||N/A|8|Anticipated|Radboud University||3|||f||||f||||||||||2017-02-18 14:01:59.231727|2017-02-18 14:01:59.231727
NCT00734903|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-12-15|||October 2010||2010-10-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|March 2015|Actual|2015-03-01||Interventional|WPR||A Randomized Controlled Trial on Women's Substance Abuse Treatment|A Randomized Controlled Trial on Women's Substance Abuse Treatment|Active, not recruiting||Phase 2|66|Anticipated|VA Office of Research and Development||2|||f||||t||||||||No||2017-02-18 14:01:59.32967|2017-02-18 14:01:59.32967
NCT00734890|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-03-14|||March 2008||2008-03-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma|Phase I Study of Vandetanib (ZD 6474) and Bevacizumab Combination Therapy Evaluating the VEGF and EGF Signal Transduction Pathways in Adults With Solid Tumors and Lymphomas|Completed||Phase 1|18|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 14:01:59.455762|2017-02-18 14:01:59.455762
NCT00734877|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-10-06|||July 2008||2008-07-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|TT4B||UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma|UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Ages 65 and Under: A Trial Enrolling Subjects to Standard Total Therapy 3 (S-TT3)|Recruiting||Phase 3|400|Anticipated|University of Arkansas||2|||f||||t||||||||||2017-02-18 14:01:59.566662|2017-02-18 14:01:59.566662
NCT00734864|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2012-11-20|||June 2009||2009-06-01|November 2012|2012-11-01|June 2012|Anticipated|2012-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma|Phase I Study of Dasatinib Plus Protracted Temozolomide in Recurrent Malignant Glioma|Withdrawn||Phase 1|0|Actual|Duke University||2||Study drug supplier withdrew support for the study. Study was withdrawn from the Duke IRB.|f||||f||||||||||2017-02-18 14:01:59.703364|2017-02-18 14:01:59.703364
NCT00734851|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-11-18|2015-09-21||December 2008||2008-12-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|September 2014|Actual|2014-09-01||Interventional|||Multimodality Phase II Study in Prostate Cancer|Multimodality Therapy for Recurrent High Risk Prostate Cancer: A Phase II Study|Terminated||Phase 2|36|Actual|Duke University||1||Dose Limiting Toxicities|f||||t||||||||||2017-02-18 14:01:59.815137|2017-02-18 14:01:59.815137
NCT00734838|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-12-19|||January 2006||2006-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy|Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy|Recruiting||N/A|162|Anticipated|Duke University||2|||f||||t||||||||||2017-02-18 14:02:00.41338|2017-02-18 14:02:00.41338
NCT00734825|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-06-27|||November 2006||2006-11-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|November 2008|Actual|2008-11-01||Interventional|||Emergency Department CT Scanning for Appendicitis|Emergency Department CT Scanning for Appendicitis: IV Contrast vs. IV and Oral Contrast|Completed||N/A|244|Actual|WellSpan Health||2|||f||||f||||||||||2017-02-18 14:02:00.521596|2017-02-18 14:02:00.521596
NCT00734799|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-08-11|2014-02-03||January 2008||2008-01-01|August 2015|2015-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study|Treating Co-Morbid Sleep Difficulties in Veterans With PTSD: A Pilot Study|Completed||N/A|22|Actual|Durham VA Medical Center||2|||f||||f||||||||||2017-02-18 14:02:00.741113|2017-02-18 14:02:00.741113
NCT00734786|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-22|||August 2008||2008-08-01|August 2008|2008-08-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles|Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles. Study # CLN 08-003.|Withdrawn||Phase 1/Phase 2|15|Anticipated|Phytotox SA||1||Study cancelled.|f||||f||||||||||2017-02-18 14:02:01.25014|2017-02-18 14:02:01.25014
NCT00734773|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-05-16|||November 2008||2008-11-01|May 2012|2012-05-01||||||||Interventional|||Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL|A Pilot Study Incorporating Motexafin Gadolinium (MGd) Into High-dose Methotrexate (MTX)-Based Chemo-immunotherapy and Radiation for Patients With Newly Diagnosed Primary CNS Lymphoma|Withdrawn||Early Phase 1|0|Actual|Northwestern University||1||Lack of funding|f||||t||||||||||2017-02-18 14:02:01.359405|2017-02-18 14:02:01.359405
NCT00734760|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-08-12|||February 2001||2001-02-01|August 2008|2008-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|PROMOTION||An Intervention to Reduce Prehospital Delay to Treatment in Acute Coronary Syndrome|Reducing Prehospital Delay in Acute Myocardial Infarction|Completed||N/A|3522|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:02:01.481234|2017-02-18 14:02:01.481234
NCT00734747|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-12-30|2015-05-15||May 2008||2008-05-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|May 2011|Actual|2011-05-01||Interventional||All subjects consented for enrollment|Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD)|Evaluation of the Medigus SRS Endoscopic Stapling System for the Treatment of Gastro-Esophageal Reflux Disease (GERD)|Completed||Phase 3|72|Actual|Medigus Ltd||1|||f||||f||||||||||2017-02-18 14:02:01.596801|2017-02-18 14:02:01.596801
NCT00734734|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-12-21|2015-12-21||June 2008||2008-06-01|December 2015|2015-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||Baseline analysis population was defined as all participants who were enrolled.|Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009|A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD® Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009, When Administered to Elderly Subjects|Completed||Phase 2|64|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:02:01.975005|2017-02-18 14:02:01.975005
NCT00734721|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2008-08-13|||December 2007||2007-12-01|August 2008|2008-08-01||||December 2008|Anticipated|2008-12-01||Interventional|FIVA||Assessment of Psychological Strain and Perioperative Fear in Intravitreal Injections|Fear of Intravitreal Injection - Assessment of Psychological Strain and Potential Contributing Factors|Unknown status|Recruiting|Phase 2|60|Anticipated|University Hospital Tuebingen||4|||f||||f||||||||||2017-02-18 14:02:02.228162|2017-02-18 14:02:02.228162
NCT00734708|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-06-14|||August 2008||2008-08-01|June 2012|2012-06-01||||March 2010|Actual|2010-03-01||Interventional|||Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)||Completed||Phase 3|328|Actual|Kaken Pharmaceutical||2|||f||||f||||||||||2017-02-18 14:02:02.333589|2017-02-18 14:02:02.333589
NCT00734695|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2010-02-28|||July 2009||2009-07-01|February 2010|2010-02-01|February 2010|Anticipated|2010-02-01|November 2009|Anticipated|2009-11-01||Interventional|||Comparing the Use of Vitamin c (Ascorbic Acid) in Eye Burn in Subconjunctival Injection to Topical or Oral Treatment.|The Effect of Subconjunctival Vitamin c on Recovery Rate and End Result From Eye Burn.|Withdrawn||Phase 1|20|Anticipated|The Baruch Padeh Medical Center, Poriya||3||couldn't recruit patients|f||||f||||||||||2017-02-18 14:02:02.468771|2017-02-18 14:02:02.468771
NCT00734682|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-01-05|||August 2008||2008-08-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas|A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas|Completed||Phase 1|34|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 14:02:02.583029|2017-02-18 14:02:02.583029
NCT00734669|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-10-24|||July 2008||2008-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|January 2016|Actual|2016-01-01||Observational|||Risk of Hypoglycemia in Type 2 Diabetes|Risk of Hypoglycemia in Type 2 Diabetes - Effects of Glibenclamide and Exercise on Cardiovascular, Hormonal, and Metabolic Parameters|Completed||N/A|12|Actual|University of Giessen|||1||f||||f||||||||No||2017-02-18 14:02:02.699513|2017-02-18 14:02:02.699513
NCT00734656|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-03-26|2011-10-27||March 2007||2007-03-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|October 2010|Actual|2010-10-01||Interventional|||Pharmacogenetics of Alcohol: Treatment Implications|Subjective and Physiological Effects of Alcohol: Role of Genetic Variation and Adrenal Hormones|Completed||N/A|94|Actual|UConn Health||4|||f||||f||||||||||2017-02-18 14:02:02.789953|2017-02-18 14:02:02.789953
NCT00734643|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2017-02-10|||June 2006||2006-06-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Family Adaptation Study Following the Diagnosis of Hypoplastic Left Heart Syndrome in a Newborn|Family Stress, Coping and Outcomes Following the Diagnosis of Hypoplastic Left Heart Syndrome in a Newborn|Active, not recruiting||N/A|130|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 14:02:03.271575|2017-02-18 14:02:03.271575
NCT00734630|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2011-03-31|2011-03-31||August 2008||2008-08-01|March 2011|2011-03-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Nebivolol Added To Antihypertensive Treatment With Lisinopril or Losartan in Patients With Hypertension.|Completed||Phase 4|491|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 14:02:03.365808|2017-02-18 14:02:03.365808
NCT00734617|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-07-02|2011-02-03||August 2007||2007-08-01|February 2011|2011-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|CON NIC II||Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II|Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II|Completed||Phase 3|479|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:02:04.009874|2017-02-18 14:02:04.009874
NCT00015561|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-20|2006-09-01|||September 1996||1996-09-01|September 2006|2006-09-01|August 2001||2001-08-01|||||Observational|||Pesticides--Health Fertility and Reproductive Risk||Completed||N/A|1803||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:43.820384|2017-02-18 18:10:43.820384
NCT00734604|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-10-21|2010-09-20||August 2008||2008-08-01|October 2010|2010-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.|A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction.|Completed||Phase 3|378|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-02-18 14:02:04.383985|2017-02-18 14:02:04.383985
NCT00734591|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-09-24|2012-09-24||August 2008||2008-08-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|FUSE||Follow-Up Study for Exubera|An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials|Completed||N/A|7439|Actual|Pfizer|Detection and/or reporting bias possible in continuous analysis (presented here) of lung cancer mortality and lung cancer incidence endpoints. Study had insufficient power to draw clear statistical conclusions due to small number of events.||2||f||||f||||||||||2017-02-18 14:02:06.729679|2017-02-18 14:02:06.729679
NCT00734578|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-02-10|2010-10-22||September 2008||2008-09-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of SPD503 in Combination With Psychostimulants|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose Optimization Study Evaluating the Efficacy and Safety of SPD503 in Combination With Psychostimulants in Children and Adolescents Aged 6-17 Years With a Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|461|Actual|Shire||3|||f||||f||||||||||2017-02-18 14:02:07.668072|2017-02-18 14:02:07.668072
NCT00734565|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-02-06|||July 2008||2008-07-01|February 2012|2012-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b|A Phase I, Single-arm, Single-center Study to Investigate Safety and Reactogenicity of Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b in Healthy Children Aged 16 - 20 Months and Infants Aged 2 - 4 Months|Completed||Phase 1|40|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:02:08.638619|2017-02-18 14:02:08.638619
NCT00734552|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2015-05-20|||October 2007||2007-10-01|May 2015|2015-05-01|May 2010|Actual|2010-05-01|October 2009|Actual|2009-10-01||Interventional|||Study to Evaluate the Protective Effect of α-Keto Acid With Low-protein Diet on Renal Function in PD Patients|Randomized, Open-Label, Prospective Study to Evaluate the Protective Effect of α-Keto Acid With Low-protein Diet on Residual Renal Function (RRF) in Peritoneal Dialysis Patients|Completed||N/A|100|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 14:02:08.738462|2017-02-18 14:02:08.738462
NCT00734539|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2014-07-27|2014-06-17||November 2008||2008-11-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|December 2011|Actual|2011-12-01||Interventional||Infants who received at least 1 dose of study drug (Modified Intent-to-Treat population)|Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight|Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants < 750 Grams Birth|Completed||Phase 3|362|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:02:08.855748|2017-02-18 14:02:08.855748
NCT00734526|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-11-04|||December 2008||2008-12-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma|A Phase I Study of Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma|Completed||Phase 1|18|Actual|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-02-18 14:02:09.949841|2017-02-18 14:02:09.949841
NCT00734513|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-11-23|||January 2003||2003-01-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Partner-Assisted Emotional Disclosure for GI Cancer|Partner Assisted Emotional Disclosure for GI Cancer|Completed||N/A|300|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:02:10.068763|2017-02-18 14:02:10.068763
NCT00734500|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-11-16|2011-08-31||January 2008||2008-01-01|November 2012|2012-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Anidulafungin PK in Infants and Toddlers|Anidulafungin PK in Infants and Toddlers|Completed||Phase 1|15|Actual|Duke University||1|||f||||||||||||||2017-02-18 14:02:10.182503|2017-02-18 14:02:10.182503
NCT00734487|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-07-19|||June 2008||2008-06-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|A2ASDOCT||AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study|Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study|Completed||N/A|470|Actual|Duke University|||2||f||||f||||||||Yes|"All findings resulting from the A2A SDOCT study will be prepared for publication in peer-reviewed journals and posted on PubMed Central once accepted.~We are supportive of efforts by publishers and professional societies to develop technologies for on-line publishing of entire experimental datasets. We will archive experimental results and findings from the proposed project for at least the duration of the project, and make the underlying datasets available to other researchers upon request."|2017-02-18 14:02:10.406452|2017-02-18 14:02:10.406452
NCT00734474|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-03-31|2014-10-03||August 2008||2008-08-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|June 2011|Actual|2011-06-01||Interventional||All randomized participants.|A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin|A Phase 2/3, Placebo-Controlled, Efficacy and Safety Study of Once-Weekly, Subcutaneous LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin|Completed||Phase 2/Phase 3|1202|Actual|Eli Lilly and Company||9|||f||||t||||||||||2017-02-18 14:02:10.561023|2017-02-18 14:02:10.561023
NCT00734461|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-03-30||2016-03-30|August 2007||2007-08-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse|A Single-Center, Randomized, Double-Blind, Active- and Placebo-Controlled Crossover Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse|Completed||Phase 2|14|Actual|Pain Therapeutics||7|||f||||f||||||||||2017-02-18 14:02:16.735201|2017-02-18 14:02:16.735201
NCT00734448|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2014-06-12|||November 2013||2013-11-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Myo-inositol Administration in Gestational Diabetes|Effect of Myo-inositol Administration on Insulin Sensitivity in Gestational Diabetes Patients by Continuous Glucose Monitoring System (CGMS)|Unknown status|Recruiting|N/A|30|Anticipated|University of Messina||1|||f||||f||||||||||2017-02-18 14:02:16.996023|2017-02-18 14:02:16.996023
NCT00731055|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-05-16|2014-02-19||February 2008||2008-02-01|April 2016|2016-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effects of Varenicline on Cigarette Self Administration|Effects of Varenicline on Cigarette Self Administration|Completed||Phase 2|16|Actual|New York State Psychiatric Institute||4|||f||||t||||||||||2017-02-18 14:03:29.615105|2017-02-18 14:03:29.615105
NCT00734435|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-11-27||2012-11-27|September 2008||2008-09-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects|A Proof of Concept, Multi-Center, Randomized, Double-Blind, Parallel, Placebo-Controlled, Study of Zonisamide Sustained Release (SR) 360 mg Versus Placebo in the Prevention of Weight Gain Associated With Olanzapine Therapy for Psychosis|Terminated||Phase 2|26|Actual|Orexigen Therapeutics, Inc||2||Sponsor Decision- Financial Considerations|f||||f||||||||||2017-02-18 14:02:17.098225|2017-02-18 14:02:17.098225
NCT00734422|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2011-08-03|||July 2008||2008-07-01|May 2011|2011-05-01|July 2010|Actual|2010-07-01|June 2009|Actual|2009-06-01||Interventional|||Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants|Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants|Completed||Phase 2/Phase 3|67|Actual|VU University of Amsterdam||2|||f||||f||||||||||2017-02-18 14:02:17.217803|2017-02-18 14:02:17.217803
NCT00734409|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2013-03-21|2012-08-10||May 2008||2008-05-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|COST_2||Combining Objective and Subjective Sedation Assessment Tools|Combining Objective and Subjective Sedation Assessment Tools - Second Study|Completed||N/A|300|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:02:17.323805|2017-02-18 14:02:17.323805
NCT00734396|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2013-01-04|||February 2009||2009-02-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|Measure||Mesenchymal Stem Cells and Subclinical Rejection|Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Allograft Rejection After Renal Transplantation|Completed||Phase 1/Phase 2|15|Actual|Leiden University Medical Center||1|||f||||f||||||||||2017-02-18 14:02:17.73567|2017-02-18 14:02:17.73567
NCT00734383|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-07-11|||April 2005||2005-04-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Propofol Cardioprotection for Type II Diabetics|PRO-TECT II: Propofol Cardioprotection for Type II Diabetics|Completed||Phase 2/Phase 3|137|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 14:02:17.834491|2017-02-18 14:02:17.834491
NCT00734370|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2013-03-20|||October 2008||2008-10-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|June 2011|Actual|2011-06-01||Interventional|||Virtual Reality Exposure Therapy in Agoraphobic Participants|Virtual Reality Exposure Therapy in Agoraphobic Participants|Completed||Phase 2/Phase 3|55|Actual|VU University of Amsterdam||3|||f||||f||||||||||2017-02-18 14:02:17.941899|2017-02-18 14:02:17.941899
NCT00734357|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2014-06-12|||October 2009||2009-10-01|June 2014|2014-06-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients|Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients|Completed||N/A|413|Actual|University of Michigan||2|||f||||||||||||||2017-02-18 14:02:18.042986|2017-02-18 14:02:18.042986
NCT00734344|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-04-25|2016-01-05||September 2008||2008-09-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection|Pilot Study of Raltegravir/Tenofovir/Emtricitabine Versus Efavirenz/Tenofovir/Emtricitabine for Adults With Acute HIV-1 Infection: Exploring the Role of Integrase Inhibition in Early HIV Pathogenesis|Completed||N/A|18|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:02:18.157516|2017-02-18 14:02:18.157516
NCT00734331|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-08-13|||September 2008||2008-09-01|August 2008|2008-08-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Observational|||Micro Ribonucleic Acid (RNA) as Cholinergic Tone and Inflammatory Regulator in Inflammatory Bowel Disease||Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||f||||||Samples With DNA|"~     serum, colonic tissue, whole blood~   "|||2017-02-18 14:02:19.200682|2017-02-18 14:02:19.200682
NCT00734318|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2012-08-09|||September 2008||2008-09-01|August 2012|2012-08-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma|A Double Blind, Double Dummy, Randomised, Multicentre, Four Arm Parallel Group Study to Assess the Efficacy and Safety of FlutiForm® pMDI 250/10µg (2 Puffs Bid) vs Fluticasone pMDI 250µg (2 Puffs Bid) Plus Formoterol pMDI 12µg (2 Puffs Bid) Administered Concurrently in Adult Subjects With Severe Persistent, Reversible Asthma.|Completed||Phase 3|1667|Actual|Mundipharma Research Limited||4|||f||||f||||||||||2017-02-18 14:02:19.289632|2017-02-18 14:02:19.289632
NCT00734305|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-08-30|2016-07-12||July 2008||2008-07-01|August 2016|2016-08-01|September 2013|Actual|2013-09-01|May 2010|Actual|2010-05-01||Interventional|||Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment|A Phase I and Pharmocologic Study of MM-121 in Patients With Refractory Advanced Solid Tumors|Completed||Phase 1|44|Actual|Merrimack Pharmaceuticals||1|||f||||t||||||||No||2017-02-18 14:02:19.406213|2017-02-18 14:02:19.406213
NCT00734292|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2010-08-24||2010-08-24|September 2008||2008-09-01|August 2010|2010-08-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma|A Randomized, Placebo-controlled, Double-blind, Crossover, Single-dose Exposure Study to Evaluate the Early Bronchodilating Effect of FlutiForm 100/10 µg HFA pMDI and FlutiForm 250/10 µg HFA pMDI, Compared to Placebo in Adult Subjects With Mild to Moderate Asthma|Completed||Phase 2|39|Anticipated|SkyePharma AG||3|||f||||f||||||||||2017-02-18 14:02:20.17969|2017-02-18 14:02:20.17969
NCT00734279|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-11-30|||March 2006||2006-03-01|August 2008|2008-08-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Follicle-Stimulating Hormone (FSH) and the Onset of Puberty|Follicle-Stimulating Hormone (FSH) and the Onset of Puberty|Completed||N/A|11|Actual|University of Utah||4|||f||||f||||||||||2017-02-18 14:02:20.290074|2017-02-18 14:02:20.290074
NCT00734266|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2013-03-05|||April 2007||2007-04-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Changes in Leukotrienes During Cardiac Surgery in Patients With Chronic Obstructive Pulmonary Disease|Changes in Leukotrienes During Cardiac Surgery in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|20|Actual|Massachusetts General Hospital|||2||f||||t||||||||||2017-02-18 14:02:20.425955|2017-02-18 14:02:20.425955
NCT00734253|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-10-06||2014-05-02|August 2008||2008-08-01|May 2014|2014-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 2b Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Patients With Nephropathy Due to Type 2 Diabetes|Completed||Phase 2|317|Actual|NephroGenex, Inc.||3|||f||||t||||||||||2017-02-18 14:02:20.51798|2017-02-18 14:02:20.51798
NCT00734240|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-07-28|||July 2008||2008-07-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Tolerability of Single and Multiple Doses of ISIS 353512 in Healthy Volunteers|Double Blind, Placebo-Controlled, Dose-Escalation, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 353512 Administered Intravenously and Subcutaneously to Healthy Volunteers|Completed||Phase 1|103|Actual|Ionis Pharmaceuticals, Inc.||16|||f||||f||||||||||2017-02-18 14:02:20.739334|2017-02-18 14:02:20.739334
NCT00734227|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2008-08-13|||July 1996||1996-07-01|July 2008|2008-07-01|July 2006|Actual|2006-07-01|October 2003|Actual|2003-10-01||Interventional|||TIPS Versus Portacaval Shunt for Acute Bleeding Varices in Cirrhosis|TIPS Versus Portacaval Shunt for Acute Bleeding Varices in Cirrhosis|Completed||N/A|153|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 14:02:20.848781|2017-02-18 14:02:20.848781
NCT00734214|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-04-07|2012-05-11||March 2008||2008-03-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Hypotonic Versus Isotonic Parenteral (HIP) Fluid Trial|Hypotonic Versus Isotonic Parenteral Fluids in Children - a Randomized Controlled Trial|Completed||Phase 3|258|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 14:02:20.956624|2017-02-18 14:02:20.956624
NCT00734201|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2011-07-21|||October 2008||2008-10-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of Low Doses of V24343 in Obese Subjects|A Double-blind, Placebo-controlled, Parallel Group Study of the Effect of V24343 on Blood Pressure and Weight in Obese Subjects|Completed||Phase 1|32|Actual|Vernalis (R&D) Ltd||1|||f||||f||||||||||2017-02-18 14:02:21.336175|2017-02-18 14:02:21.336175
NCT00734188|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2011-07-12|||January 2009||2009-01-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma|A Multi-Center, Open-Label, Phase I, Dose-Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma|Completed||Phase 1|21|Anticipated|Pain Therapeutics||1|||f||||f||||||||||2017-02-18 14:02:21.433461|2017-02-18 14:02:21.433461
NCT00734175|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2009-08-05|||September 2008||2008-09-01|September 2008|2008-09-01||||December 2008|Actual|2008-12-01||Interventional|||Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine|Phase I Inpatient Study of the Safety and Immunogenicity of Live Influenza A Vaccine H6N1 (6-2) AA ca Recombinant (A/Teal/Hong Kong/W312/1997 (H6N1) x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H6N1 Infection in the Event of a Pandemic|Completed||Phase 1|22|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||f||||||||||2017-02-18 14:02:21.530169|2017-02-18 14:02:21.530169
NCT00734162|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-13|2016-07-20|2012-10-08||December 2008||2008-12-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|March 2011|Actual|2011-03-01||Interventional|||Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection|A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents With Chronic Hepatitis B Infection|Completed||Phase 3|106|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 14:02:21.664715|2017-02-18 14:02:21.664715
NCT00734149|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-03-21|2013-02-11||July 2004||2004-07-01|March 2016|2016-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|MVP||Bortezomib With Melphalan and Prednisone for Multiple Myeloma|A Prospective Study of Bortezomib in Combination With Melphalan and Prednisone for Patients With Previously Untreated Multiple Myeloma|Completed||Phase 2|45|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:02:29.460471|2017-02-18 14:02:29.460471
NCT00734136|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2009-02-17|||May 2005||2005-05-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|July 2005|Actual|2005-07-01||Interventional|||Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome|Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome|Terminated||N/A|100|Actual|Lahey Clinic||2||Insufficient findings for data analysis|f||||f||||||||||2017-02-18 14:02:29.772578|2017-02-18 14:02:29.772578
NCT00734123|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-08-13|||April 2008||2008-04-01|August 2008|2008-08-01|May 2013|Anticipated|2013-05-01|April 2009|Anticipated|2009-04-01||Interventional|PRIMARIA||Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.|Early Detection of Atherosclerosis in the Primary Care Setting: a Randomized Trial to Assess the Efficacy of a Novel Strategy in the Primary Prevention of Cardiovascular Diseases.|Unknown status|Recruiting|Phase 4|2948|Anticipated|Hospital Arnau de Vilanova||2|||f||||t||||||||||2017-02-18 14:02:29.881057|2017-02-18 14:02:29.881057
NCT00734110|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-06-05|||July 2000||2000-07-01|June 2015|2015-06-01|June 2010|Actual|2010-06-01|April 2009|Actual|2009-04-01||Interventional|||Long-term Study of The Press Fit Condylar (P.F.C.) Sigma Total Knee Replacement System|Multi-Centre Clinical Study of the P.F.C.® Sigma Total Knee System|Terminated||Phase 4|723|Actual|DePuy International||1||"The study achieved the stated objective to record pre & post operative outcomes at a minimum 5~   years."|f||||f||||||||||2017-02-18 14:02:29.997986|2017-02-18 14:02:29.997986
NCT00734097|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2012-09-10|2009-09-25||November 2007||2007-11-01|August 2012|2012-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|NEON||A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)|An Open Label, Multicentre Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)|Completed||Phase 4|314|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:02:30.311609|2017-02-18 14:02:30.311609
NCT00734084|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-06-05|||June 2001||2001-06-01|June 2015|2015-06-01|April 2008|Actual|2008-04-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Evaluate the DePuy Minimally Invasive Unicompartmental Knee|A Prospective, Non-Comparative Multi-centre Study to Evaluate the Safety and Performance of the DePuy Minimally Invasive (Preservation) Unicompartmental Knee and Instrumentation.|Terminated||Phase 4|247|Actual|DePuy International||1||"After a review of status, request of investigators & since similar data was available from~   other sources"|f||||f||||||||||2017-02-18 14:02:30.654372|2017-02-18 14:02:30.654372
NCT00734071|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2013-10-25|2013-10-25||June 2008||2008-06-01|October 2013|2013-10-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of Single Dose of Lu AA21004 in Acute Treatment of Adults With Generalized Anxiety Disorder|Completed||Phase 3|304|Actual|Takeda||2|||f||||f||||||||||2017-02-18 14:02:30.765327|2017-02-18 14:02:30.765327
NCT00734058|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-08-12|||December 2008||2008-12-01|August 2008|2008-08-01|June 2012|Anticipated|2012-06-01|January 2012|Anticipated|2012-01-01||Interventional|SAAF-T||SOLAR & ATRILAZE Atrial Fibrillation Trial|Atrial Fibrillation Treatment Using Laser Ablation of Cardiac Tissue During Concomitant Cardiac Surgery|Unknown status|Not yet recruiting|Phase 3|90|Anticipated|EndoPhotonix, Inc.||1|||f||||f||||||||||2017-02-18 14:02:32.503723|2017-02-18 14:02:32.503723
NCT00734045|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-12-08|||February 2008||2008-02-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|WB-13||Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples|Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples|Completed||N/A|450|Anticipated|Nanogen, Inc.|||2||f||||f||||||||||2017-02-18 14:02:32.615035|2017-02-18 14:02:32.615035
NCT00734032|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-10-26||2010-02-05|August 2008||2008-08-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients|A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients- A Multicenter, Randomized, Double-blind, Placebo-controlled Study of SB-480848 to Evaluate the Efficacy and Safety -|Completed||Phase 2|107|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:02:32.708451|2017-02-18 14:02:32.708451
NCT00734019|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2017-01-30|||October 2005||2005-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Survivorship of the Press Fit Condylar (P.F.C.) Sigma Fixed Bearing Knee With a Cobalt Chrome Tibial Tray|A Prospective, Non-comparative, Multicentre, Multinational Study to Determine the Survivorship of the P.F.C. Fixed Bearing Knee System Using a Moderately Cross-linked Polyethylene Insert and a Cobalt Chrome Tibial Tray.|Active, not recruiting||Phase 4|650|Actual|DePuy International||1|||f||||f||||||||||2017-02-18 14:02:32.838085|2017-02-18 14:02:32.838085
NCT00734006|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-05-06|||July 2008||2008-07-01|May 2015|2015-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Cortico-cortical Connectivity During Midazolam Sedation in Humans; a TMS/EEG Study|Cortico-cortical Connectivity During Midazolam Sedation in Humans; a TMS/EEG Study|Completed||N/A|20|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-02-18 14:02:32.94935|2017-02-18 14:02:32.94935
NCT00733993|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-01-05|||April 2008||2008-04-01|January 2016|2016-01-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Caffeine and Cocaine|Experiment 1: Adenosine Receptor A2A Antagonists and Cocaine Dependence|Completed||Phase 1/Phase 2|67|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 14:02:33.046167|2017-02-18 14:02:33.046167
NCT00733980|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-08-30||2011-03-17|October 2008||2008-10-01|August 2012|2012-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder|A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed With Major Depressive Disorder|Completed||Phase 2|150|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:02:33.173596|2017-02-18 14:02:33.173596
NCT00733967|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2012-07-25|||January 2008||2008-01-01|July 2012|2012-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Varenicline-Methamphetamine Interaction Study (2008)|A Human Laboratory Assessment of the Safety and Potential Efficacy of Varenicline In Methamphetamine-Dependent Volunteers Receiving Methamphetamine|Withdrawn||Phase 1|0|Actual|Baylor College of Medicine||2||No longer active|f||||t||||||||||2017-02-18 14:02:33.294198|2017-02-18 14:02:33.294198
NCT00733954|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2014-04-28|2009-04-30||August 2007||2007-08-01|April 2014|2014-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis|A Comparison Between Clobetasol Propionate (Clobex®) Spray and Clobetasol Propionate Ointment With Regard to Efficacy, Safety, Subject Satisfaction and Duration of Response in Moderate to Severe Plaque Psoriasis|Completed||Phase 4|250|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||||2017-02-18 14:02:33.406508|2017-02-18 14:02:33.406508
NCT00733941|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-05-26|||September 2008||2008-09-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Interval Training in Young Healthy Individuals|Interval Training: Training, Detraining and Retraining; an Interventional Study|Completed||N/A|24|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 14:02:34.047104|2017-02-18 14:02:34.047104
NCT00733928|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2016-05-27|||October 1999||1999-10-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|May 2005|Actual|2005-05-01||Interventional|||The Press Fit Condylar (P.F.C.) Sigma Metal-backed Versus All-poly|Randomised Prospective Comparison of P.F.C All-polyethylene Versus Metal-backed Tibial Component. A Clinical, Radiological and Roentgen Stereophotogrammetric Analysis (RSA) Study.|Completed||Phase 4|67|Actual|DePuy International||2|||f||||f||||||||||2017-02-18 14:02:34.158174|2017-02-18 14:02:34.158174
NCT00733915|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2016-08-01|||March 2002||2002-03-01|August 2016|2016-08-01|October 2014|Actual|2014-10-01|September 2007|Actual|2007-09-01||Interventional|||Long-term Study of the DePuy Low Contact Stress (LCS) Complete Total Knee System|A Prospective, Non-Comparative Study to Evaluate the Performance of the DePuy Low Contact Stress (LCS) Complete Mobile-bearing Total Knee System.|Completed||Phase 4|241|Actual|DePuy International||1|||f||||f||||||||||2017-02-18 14:02:34.270024|2017-02-18 14:02:34.270024
NCT00733902|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2011-01-04||2010-12-21|September 2008||2008-09-01|January 2011|2011-01-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Tanezumab in Osteoarthritis of the Knee|A Phase 3 Randomized, Double Blind, Placebo-Controlled Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Osteoarthritis Of The Knee|Completed||Phase 3|697|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 14:02:34.368728|2017-02-18 14:02:34.368728
NCT00733889|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2013-02-19|||December 2006||2006-12-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma|Phase II, Multicentre, Uncontrolled Pilot Study to Evaluate Safety and Efficacy of the Combination of Cetuximab and Chemotherapy (Docetaxel, Cisplatin, 5-fluorouracil) as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy (Cisplatin) Plus Cetuximab in Patients With a Locoregional Esophageal Carcinoma|Completed||Phase 2|50|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1|||f||||f||||||||||2017-02-18 14:02:34.540717|2017-02-18 14:02:34.540717
NCT00733876|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2014-08-05|||August 2008||2008-08-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|May 2010|Actual|2010-05-01||Interventional|||Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery|Phase I Clinical Trial, Dose-escalating Intra-aortic Infusion of Allogeneic , Bone Marrow-derived Multipotent Stromal Cells to Prevent and Treat Post-operative Acute Kidney Injury in Patients Who Require On-pump Cardiac Surgery|Completed||Phase 1|15|Anticipated|AlloCure Inc.||1|||f||||t||||||||||2017-02-18 14:02:34.64425|2017-02-18 14:02:34.64425
NCT00733863|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2010-05-10|||July 2008||2008-07-01|May 2010|2010-05-01||||February 2010|Actual|2010-02-01||Interventional|||Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.|A 52-week,Multi-center,Randomized,Double-blind,Placebo-controlled,Parallel Group Study in Patients With Mild Alzheimer's Disease to Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106|Completed||Phase 2|27|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:02:34.739036|2017-02-18 14:02:34.739036
NCT00733850|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-06-17|||August 2008||2008-08-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer|A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection Plus Gemcitabine (G+K) Versus Gemcitabine in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|85|Actual|KangLaiTe USA||2|||f||||t||||||||||2017-02-18 14:02:34.845592|2017-02-18 14:02:34.845592
NCT00733837|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-12-17|||July 2008||2008-07-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Cervical Multifidus Muscle Function||Completed||Phase 1|30|Anticipated|Logan College of Chiropractic||1|||f||||f||||||||||2017-02-18 14:02:35.19324|2017-02-18 14:02:35.19324
NCT00733824|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2016-11-09|2016-07-18||November 2008||2008-11-01|November 2016|2016-11-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma|A Phase I/II Study of Intravenous AMD3100 Added to a Mobilization Regimen of G-CSF to Increase the Number of Autologous Peripheral Blood Stem Cells Collected From Patients With Lymphoma|Completed||Phase 1/Phase 2|61|Actual|Washington University School of Medicine||5|||f||||f||||||||||2017-02-18 14:02:35.298966|2017-02-18 14:02:35.298966
NCT00733811|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-08-12|||September 2000||2000-09-01|July 2008|2008-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|SEQDFPDFO||Efficacy Study of the Use of Sequential DFP-DFO Versus DFP|Phase IV Study of the Use of Sequential DFP-DFO Versus DFP in Thalassemia Major Patients|Completed||Phase 4|213|Actual|Azienda Ospedaliera V. Cervello||2|||f||||t||||||||||2017-02-18 14:02:36.510715|2017-02-18 14:02:36.510715
NCT00733798|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2009-05-08||||||May 2009|2009-05-01||||||||Interventional|||A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma|A Phase 1/2, Multi-Center, Safety and Efficacy Study Evaluating Intravenously Administered 131I-TM601 in Patients With Progressive and/or Recurrent Malignant Melanoma|Terminated||Phase 1/Phase 2|58|Anticipated|TransMolecular||1||For Strategic Reasons|f||||f||||||||||2017-02-18 14:02:36.652489|2017-02-18 14:02:36.652489
NCT00733785|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-05-31|||August 2008||2008-08-01|March 2011|2011-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|Rosi XR||PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers|A Two Cohort Study in Healthy Volunteers to Characterise the Pharmacokinetic Properties of the Rosiglitazone XR Formulation Manufactured at the GlaxoSmithKline Crawley Facility.|Completed||Phase 1|60|Actual|GlaxoSmithKline||7|||f||||f||||||||||2017-02-18 14:02:36.76461|2017-02-18 14:02:36.76461
NCT00733772|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-02-04|||March 2009||2009-03-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|FIMS||Flaxseed Intervention on Metabolic Syndrome|The Effects of Flaxseed Supplement on Cardio-metabolic Risk Factors in Patients With Metabolic Syndrome|Completed||Phase 2/Phase 3|189|Actual|Chinese Academy of Sciences||2|||f||||f||||||||||2017-02-18 14:02:36.869884|2017-02-18 14:02:36.869884
NCT00733759|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-08-12||||||August 2008|2008-08-01||||||||Observational|||Contrast Echocardiography in Patients With Pulmonary Arteriovenous Malformations (PAVMs)|The Evaluation of Intra-Cardiac Shunts in Patients With Pulmonary Arteriovenous Malformations|Unknown status|Active, not recruiting|N/A|45|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 14:02:36.97128|2017-02-18 14:02:36.97128
NCT00733746|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2017-01-24|||April 2009||2009-04-01|January 2017|2017-01-01||||November 2015|Actual|2015-11-01||Interventional|||Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery|A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients With Operable Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|123|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 14:02:37.038864|2017-02-18 14:02:37.038864
NCT00733733|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-08-12|||January 2008||2008-01-01|August 2008|2008-08-01|June 2010|Anticipated|2010-06-01|January 2010|Anticipated|2010-01-01||Interventional|ATG||Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor|A Prospective, Randomized, Open, Multicenter Study to Evaluate the Efficacy and Tolerability of Induction Therapy With a Single High-Dose Anti-T-Lymphocyte Globulin (ATG) in Renal Transplant Patients With a Kidney From a Non-Heart-Beating Donor and Tacrolimus, Mycophenolate Mofetil, and Steroids as Basic Immunosuppression.|Unknown status|Recruiting|Phase 3|180|Anticipated|Radboud University||2|||f||||f||||||||||2017-02-18 14:02:37.173989|2017-02-18 14:02:37.173989
NCT00733720|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2017-01-11|||August 2008||2008-08-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Buprenorphine Naltrexone-P1 A-Cocaine|Attenuation of Opioid Effects of Three Different Doses of Sublingual Buprenorphine / Naloxone by Oral Naltrexone in Healthy Volunteers|Completed||Phase 1|8|Anticipated|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-02-18 14:02:37.285491|2017-02-18 14:02:37.285491
NCT00733707|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2016-03-16|||August 2008||2008-08-01|March 2016|2016-03-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders|Improving Adherence With Oral Contraceptives Using Daily Text Messaging Reminders|Completed||N/A|82|Actual|Planned Parenthood League of Massachusetts||2|||f||||f||||||||||2017-02-18 14:02:37.379153|2017-02-18 14:02:37.379153
NCT00733694|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-12-17|||April 2000||2000-04-01|December 2015|2015-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|DRAGON||Outcome Study of Total Knee Arthroplasty in Asian Patients|Clinical Evaluation of the Low Contact Stress (LCS) Classic and Universal Mobile-bearing Total Knee System. The Asian LCS User Group - 'The Dragon Knee Study'|Completed||Phase 4|607|Actual|DePuy International||1|||f||||f||||||||||2017-02-18 14:02:37.473681|2017-02-18 14:02:37.473681
NCT00733681|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-01-21|||March 2004||2004-03-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|February 2014|Actual|2014-02-01||Interventional|TC3||The Press Fit Condylar (P.F.C.) Sigma Rotating Platform (RP) TC3 Revision Knee in Revision Knee Arthroplasty|A Prospective, Non-comparative Study to Evaluate the Performance of the DePuy P.F.C. Sigma Rotating Platform TC3 Knee Prosthesis in Revision Knee Arthroplasty.|Terminated||Phase 4|181|Actual|DePuy International||1||Subjects were no longer able to remain compliant with follow-up intervals|f||||f||||||||||2017-02-18 14:02:37.774374|2017-02-18 14:02:37.774374
NCT00733668|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2009-03-24|||March 2006||2006-03-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|UNIQUE||Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder|An Open-Label, Non-Comparative, Multi-Centre, Phase II Prospective Trial to Assess the Efficacy of Quetiapine Fumarate Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) in SSRI-Resistant Major Depressive Disorder.|Completed||Phase 2|||AstraZeneca||1|||f||||f||||||||||2017-02-18 14:02:37.888071|2017-02-18 14:02:37.888071
NCT00733655|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-05-28|||September 2008||2008-09-01|August 2008|2008-08-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia||Active, not recruiting||N/A|50|Anticipated|Imperial College London|||1||f||||||||||Samples Without DNA|"~     Histological samples~   "|||2017-02-18 14:02:37.992816|2017-02-18 14:02:37.992816
NCT00733642|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2009-07-24|||August 2008||2008-08-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease|An Open Label, Single Dose Escalation Study Of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease|Completed||Phase 1|15|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:02:38.071696|2017-02-18 14:02:38.071696
NCT00733629|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2008-08-12||||||August 2008|2008-08-01||||||||Observational|||Study of Endothelial Cells in Patients With Hereditary Haemorrhagic Telangiectasia|In Vitro Studies pf Endothelial Cells Derived From HHT Patients|Unknown status|Active, not recruiting|N/A|100|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 14:02:38.181697|2017-02-18 14:02:38.181697
NCT00733616|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2013-02-19|||November 2008||2008-11-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status|Phase II Study of Adjusted-dose Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status.|Completed||Phase 2|44|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1|||f||||f||||||||||2017-02-18 14:02:38.248252|2017-02-18 14:02:38.248252
NCT00733603|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-01-12|||June 2008||2008-06-01|January 2010|2010-01-01|May 2009|Anticipated|2009-05-01|February 2009|Anticipated|2009-02-01||Interventional|IC03||Physical Therapy in Women With Interstitial Cystitis|A Single-Blinded Randomized Multi-Center Trial to Evaluate the Efficacy and Durability of Myofascial Tissue Manipulation in Women With Interstitial Cystitis/Painful Bladder Syndrome|Unknown status|Active, not recruiting|N/A|88|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 14:02:38.347428|2017-02-18 14:02:38.347428
NCT00733590|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2016-03-14|||June 2003||2003-06-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|PROSe-ICD||Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention|Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention (PROSe-ICD)|Recruiting||N/A|1500|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"~     Whole blood drawn at 6-12 month intervals~   "|||2017-02-18 14:02:38.476187|2017-02-18 14:02:38.476187
NCT00733577|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-10-27|||August 2008||2008-08-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing.|A Single-blinded Randomized, Placebo-controlled, Staggered-parallel, Escalating-dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral SB756050 Administered for 6 Days to Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|48|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:02:38.581702|2017-02-18 14:02:38.581702
NCT00733564|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2009-03-30|||August 2008||2008-08-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|EDAUC||Evaluation of Different Anesthesia for Uterine Curettage|Evaluation of the Anesthetic Efficacy of Propofol,Sevoflurane and Paracervical Block for Uterine Curettage|Completed||N/A|150|Anticipated|Nanjing Medical University||3|||f||||t||||||||||2017-02-18 14:02:38.690178|2017-02-18 14:02:38.690178
NCT00733551|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2017-01-31|||September 2008||2008-09-01|January 2017|2017-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.|A Randomized, Double-blind, Ascending Dose Trial to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics, of Repeat Doses of Motilin Receptor Agonist GSK962040 in Male and Female Healthy Volunteers|Completed||Phase 1|31|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:02:38.798556|2017-02-18 14:02:38.798556
NCT00733538|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2012-03-23|||December 2004||2004-12-01|February 2009|2009-02-01|November 2012|Anticipated|2012-11-01|November 2009|Actual|2009-11-01||Interventional|IFM-01-04||Stage I Multiple Myeloma Treatment|Stage I Multiple Myeloma Treatment|Unknown status|Active, not recruiting|Phase 4|350|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 14:02:38.913596|2017-02-18 14:02:38.913596
NCT00733525|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2014-05-23|||September 2000||2000-09-01|May 2014|2014-05-01|August 2005|Actual|2005-08-01|April 2005|Actual|2005-04-01||Interventional|||Effectiveness of Stepped Care Versus Best Available Care for Bulimia Nervosa|Stepped Care vs Best Available Care for Bulimia Nervosa|Completed||N/A|293|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 14:02:39.018133|2017-02-18 14:02:39.018133
NCT00733512|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2010-04-14|2010-03-24||June 2007||2007-06-01|April 2010|2010-04-01||||March 2008|Actual|2008-03-01||Observational|||Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)|Surgeon Experience ReSTOR Aspheric +4 Intraocular Lens (IOL)|Completed||Phase 4|146|Actual|Alcon Research|||1||f||||||||||||||2017-02-18 14:02:39.132671|2017-02-18 14:02:39.132671
NCT00733499|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-09-23|2014-03-22||September 2006||2006-09-01|September 2015|2015-09-01|November 2020|Anticipated|2020-11-01|October 2009|Actual|2009-10-01||Interventional||The number of participants in the intent to treat population (All eligible subjects, admitted to the study that receive the allocated treatment, and have at least one usable post-treatment assessment).|A Study to Determine the Difference in Low Contact Stress (LCS) Duofix Versus Low Contact Stress (LCS) Porocoat Knee Systems|A Prospective, Randomised, Single Blinded Study Comparing the Pain, Biological Fixation and Outcomes of Patients With LCS Complete Duofix or LCS Porocoat Knee Systems|Active, not recruiting||Phase 4|206|Actual|DePuy International||2|||f||||f||||||||||2017-02-18 14:02:39.357116|2017-02-18 14:02:39.357116
NCT00733486|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-06-08|||August 2005||2005-08-01|June 2015|2015-06-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Evaluate the Performance of the DePuy Low Contact Stress (LCS®) Complete Anterior-Posterior Glide (APG) Mobile Bearing Knee|A Prospective, Non-Comparative Study to Evaluate the Performance of the DePuy Low Contact Stress (LCS®) Complete Anterior-Posterior Glide (AP Glide) Mobile Bearing Knee System in Primary Knee Arthroplasty|Terminated||Phase 4|233|Actual|DePuy International||1||"The study was terminated at 2 years as investigators were unable to continue participation in~   the study."|f||||f||||||||||2017-02-18 14:02:39.751424|2017-02-18 14:02:39.751424
NCT00733473|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2011-12-17|||September 2007||2007-09-01|December 2011|2011-12-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing|Phase 4 Study of Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing|Completed||Phase 4|100|Actual|Kecioren Education and Training Hospital||2|||f||||f||||||||||2017-02-18 14:02:39.96724|2017-02-18 14:02:39.96724
NCT00733460|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2013-06-06|||March 2008||2008-03-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET|A Phase I Study to Evaluate the Safety, Biodistribution and Radiation Dosimetry of BFPET as a Potential Myocardial Perfusion Imaging (MPI) Agent for PET|Completed||Phase 1|12|Actual|Fluoropharma, Inc.||1|||f||||f||||||||||2017-02-18 14:02:40.079592|2017-02-18 14:02:40.079592
NCT00733447|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2015-07-28|||March 2010||2010-03-01|July 2015|2015-07-01|May 2014|Anticipated|2014-05-01|August 2013|Actual|2013-08-01||Expanded Access|||SynCardia Freedom Driver System Study|SynCardia Freedom Driver System Study|Approved for marketing||N/A|||SynCardia Systems. Inc.|||||||||t||||||||||2017-02-18 14:02:40.190958|2017-02-18 14:02:40.190958
NCT00733434|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2009-10-26|||July 2008||2008-07-01|October 2009|2009-10-01|July 2010|Anticipated|2010-07-01|July 2009|Anticipated|2009-07-01||Interventional|PGE1HNM||The Use of Prostaglandin E1 in Head and Neck Microsurgery|Phase 4 Study of Postoperative Prostaglandin E1 in Head and Neck Microsurgery|Unknown status|Recruiting|Phase 4|242|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 14:02:40.26774|2017-02-18 14:02:40.26774
NCT00733421|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-01-15|2009-12-07||October 2008||2008-10-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Anti-inflammatory Analgesics on Pain Following Hallux Valgus Surgery|The Effect of Anti-inflammatory Analgesics on Bone Repair, Pain and Gastro-intestinal Side Effects After Hallux Valgus Surgery; a Prospective Randomised Double-blind Placebo Controlled Study.|Completed||Phase 4|100|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 14:02:40.386164|2017-02-18 14:02:40.386164
NCT00733408|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-11-04|||April 2008||2008-04-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic Breast Cancer|Combined Targeted Therapies for Triple Negative Advanced Breast Cancer - A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib|Active, not recruiting||Phase 2|63|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 14:02:40.865841|2017-02-18 14:02:40.865841
NCT00733395|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-08-11|||August 2008||2008-08-01|August 2008|2008-08-01||||August 2008|Anticipated|2008-08-01||Interventional|||Hood to Coast Injury Study|Comparison of Two Juice Drinks in Preventing the Symptoms of Muscle Pain Among Runners|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:02:41.14913|2017-02-18 14:02:41.14913
NCT00733382|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-08-11|||February 2008||2008-02-01|August 2008|2008-08-01|August 2009|Anticipated|2009-08-01|December 2008|Anticipated|2008-12-01||Interventional|||Effect of Dexamethasone on Migraine Headache|The Effect of Dexamethasone in the Attack of Migraine Headache and to Prevent of Its Relapse After Discharge From Emergency Department: a Randomized, Double-Blind, Controlled Trial.|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|Shiraz University of Medical Sciences||2|||f||||f||||||||||2017-02-18 14:02:41.233666|2017-02-18 14:02:41.233666
NCT00733369|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2016-08-01|2014-03-22||November 2007||2007-11-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|August 2010|Actual|2010-08-01||Interventional||Study protocol was designed and executed on using ‘knees’ as study units. Out of 106 enrolled knees, 11 knees were removed from analysis for following reasons: 8 protocol violations [bilaterals accrued at site bilaterals not allowed; used 1st knee operated upon] (4 inv, 4 control); 2 ltfu (1 inv, 1 control); 1 missing outcome (1 inv, 0 control).|A Study to Compare the Press Fit Condylar (P.F.C.) Sigma Rotating-platform High-flexion (RP-F) Versus the Press Fit Condylar (P.F.C.) Sigma Rotating-platform (RP) Knee Implants|A Prospective, Single Blinded, Multi-centre Randomised Controlled Trial Comparing the Post Operative Range of Motion of the P.F.C. Sigma RP-F Knee With the P.F.C. Sigma RP Knee in Primary Total Knee Arthroplasty.|Terminated||Phase 4|106|Actual|DePuy International||2||"This study was closed for the reason of slow recruitment with only 16% of the target subjects~   recruited over a 29 month period."|f||||f||||||||||2017-02-18 14:02:41.342046|2017-02-18 14:02:41.342046
NCT00733356|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2011-04-06|||July 2008||2008-07-01|April 2011|2011-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|VBHR||The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading|The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading|Completed||Phase 4|42|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 14:02:42.742661|2017-02-18 14:02:42.742661
NCT00733343|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-10-26|||February 2008||2008-02-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|April 2015|Actual|2015-04-01||Interventional|Serve-HF||Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure|Treatment of Sleep-Disordered Breathing With Predominant Central Sleep Apnea by Adaptive Servo Ventilation in Patients With Heart Failure|Completed||Phase 4|1325|Actual|ResMed||2|||f||||t||||||||||2017-02-18 14:02:42.865066|2017-02-18 14:02:42.865066
NCT00733330|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2014-07-29|2014-03-24||January 2005||2005-01-01|July 2014|2014-07-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional||86 subjects were enrolled, but 2 were intraoperatively excluded and did not receive surgery. Gender data is unavailable on one MiTKR subject.|Minimally Invasive Total Knee Replacement - Navigated Versus Non-navigated Study|Computer Assisted Navigation in Minimally Invasive Total Knee Arthroplasty: Comparing the Alignment Achieved Using the DePuy Ci Minimally Invasive (Mi) Versus the DePuy Non Navigated Conventional Total Knee Arthroplasty.|Terminated||Phase 4|86|Actual|DePuy International||2||"A sample size recalculation indicated an increase from 154 to 1500 subjects was required so~   the study stopped as new target was considered unfeasible."|f||||f||||||||||2017-02-18 14:02:43.484718|2017-02-18 14:02:43.484718
NCT00733317|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2011-12-17|||September 2007||2007-09-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Budesonide for Emergency Treatment of Acute Wheezing in Children|Phase 4 Study of Budesonide for Emergency Treatment of Acute Wheezing in Children|Completed||Phase 4|100|Actual|Kecioren Education and Training Hospital||2|||f||||f||||||||||2017-02-18 14:02:44.535771|2017-02-18 14:02:44.535771
NCT00733304|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-04-14||2012-03-01|June 2008||2008-06-01|April 2015|2015-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||An Extension to Study MD7108240|An Extension Study to Protocol MD7108240: Pazopanib Eye Drops in Subjects With Neovascular Age-related Macular Degeneration|Completed||Phase 2|99|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 14:02:44.649884|2017-02-18 14:02:44.649884
NCT00733291|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2011-12-21|2009-04-10||January 2008||2008-01-01|December 2011|2011-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)||Completed||N/A|64|Actual|Alcon Research||4|||f||||f||||||||||2017-02-18 14:02:44.764785|2017-02-18 14:02:44.764785
NCT00733278|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2014-07-16|2013-10-08||November 2007||2007-11-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Intrauterine Contraceptive Device (IUD) Placement at Time of C-Section|Acceptability and Technical Feasibility of Insertion of a Copper IUD at Time of Elective C-section: A Pilot Study|Completed||Phase 4|7|Actual|Los Angeles Biomedical Research Institute|Pilot study involving only seven subjects, which limits generalizability of findings.|1|||f||||f||||||||||2017-02-18 14:02:45.274528|2017-02-18 14:02:45.274528
NCT00733265|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2010-12-02|||February 2007||2007-02-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers|Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers|Completed||Phase 1|24|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:02:45.520356|2017-02-18 14:02:45.520356
NCT00733252|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-12|2015-10-01|||April 2008||2008-04-01|October 2015|2015-10-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Observational|||Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease|Optical Coherence Tomography of Human Airways|Withdrawn||Phase 1|0|Actual|Case Comprehensive Cancer Center|||1|Low interest|f||||t||||||Samples Without DNA|"~     Fresh Bronchi from 10 subjects undergoing pneumonectomy or lobectomy for malignant and~     benign processes will be obtained from the UHCMC Pathology Department as discarded tissue~     from fresh specimens~   "|||2017-02-18 14:02:45.63132|2017-02-18 14:02:45.63132
NCT00733239|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2012-04-16|||August 2008||2008-08-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|OMDD2||Drug Discrimination in Methadone-Maintained Humans Study 2|Drug Discrimination in Methadone-Maintained Humans Study 2|Completed||Phase 1|15|Actual|University of Arkansas||1|||f||||t||||||||||2017-02-18 14:02:45.729407|2017-02-18 14:02:45.729407
NCT00733226|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2014-07-04|2009-12-16||August 2007||2007-08-01|July 2014|2014-07-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing|Phase IV Study of Effect of OM-85 BV (Broncho-Vaxom) on Wheezing Related Morbidity in Children With Recurrent Wheezing|Completed||Phase 4|80|Actual|Kecioren Education and Training Hospital|Main shortcoming of our study is the small sample size. This might have hampered the appearance of some statistically meaningful differences such as wheezing attacks that require steroid treatment, rate and duration of hospitalizations.|2|||f||||f||||||||||2017-02-18 14:02:45.834815|2017-02-18 14:02:45.834815
NCT00733213|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2009-10-13|||January 2008||2008-01-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|||||Observational|||Depiction of Prostate Cancer Treatment Alternatives in Greece|Depiction of Prostate Cancer Treatment Alternatives in Greece|Completed||N/A|310|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:02:46.317133|2017-02-18 14:02:46.317133
NCT00733200|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2009-12-10||||||August 2008|2008-08-01||||||||Interventional|||Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?|Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?|Completed||N/A|||Huazhong University of Science and Technology||1|||f||||t||||||||||2017-02-18 14:02:46.405645|2017-02-18 14:02:46.405645
NCT00733187|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2013-02-07|||February 2009||2009-02-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869|A Pharmacokinetic Study to Evaluate the Effect of Food on the Oral Bioavailability and Effect of Diurnal Variation on the Pharmacokinetics of ABT-869|Completed||Phase 1|34|Actual|AbbVie||1|||f||||f||||||||||2017-02-18 14:02:46.487674|2017-02-18 14:02:46.487674
NCT00733174|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2008-08-11|||March 2004||2004-03-01|August 2008|2008-08-01||||January 2009|Anticipated|2009-01-01||Interventional|||Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance|Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance|Unknown status|Recruiting|Phase 4|60|Anticipated|Denver Research Institute||2|||f||||t||||||||||2017-02-18 14:02:46.583512|2017-02-18 14:02:46.583512
NCT00733161|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2010-07-06|||August 2008||2008-08-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effect of Passive Exercise on Systemic Endothelial Function in Elderly Patients With Chronic Heart Failure|Effect of Passive Exercise on Systemic Endothelial Function in Elderly Patients With Chronic Heart Failure|Completed||Phase 4|30|Actual|Kyoto University||2|||f||||||||||||||2017-02-18 14:02:46.677199|2017-02-18 14:02:46.677199
NCT00733148|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-07|||July 2004||2004-07-01|August 2008|2008-08-01|April 2005|Actual|2005-04-01|January 2005|Actual|2005-01-01||Observational|||Correlation Between the Interstitial and Arterial Glucose in Post Surgery Patients|Randomised Trial to Investigate the Correlation Between the Interstitial and Arterial Blood Concentrations of Glucose During Subcutaneous Microdialysis Glucose Monitoring in Post Surgery Patients at the Intensive Care Unit.|Completed||N/A|40|Actual|Medical University of Graz|||2||f||||t||||||||||2017-02-18 14:02:46.782061|2017-02-18 14:02:46.782061
NCT00733135|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-08-14|2014-06-05||October 2008||2008-10-01|August 2015|2015-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++)|Determination of Safety and Effectiveness of the SilverHawk™ Peripheral Plaque Excision System for Calcium (SilverHawk LS-C) and the SpiderFX™ Embolic Protection Device for the Treatment of Calcified Peripheral Arterial Disease in the Superficial Femoral and/or the Popliteal Arteries (DEFINITIVE Ca++)|Completed||Phase 2/Phase 3|133|Actual|Medtronic Endovascular||1|||f||||f||||||||||2017-02-18 14:02:46.895334|2017-02-18 14:02:46.895334
NCT00733122|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2011-01-13|||October 2009||2009-10-01|January 2011|2011-01-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)|Evaluation of Tolerability and Immunogenicity of GARDASIL in Healthy Females, Between 16 and 26 Years of Age, in India.|Suspended||Phase 3|600|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:02:47.295999|2017-02-18 14:02:47.295999
NCT00733109|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-01-08|||March 2003||2003-03-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|July 2006|Actual|2006-07-01||Interventional|CIN2||Management of Cervical Intraepithelial Neoplasia Grade 2|Management of Cervical Intraepithelial Neoplasia Grade 2|Completed||Phase 4|90|Actual|Universidade Cidade de Sao Paulo||2|||f||||t||||||||||2017-02-18 14:02:47.384179|2017-02-18 14:02:47.384179
NCT00733096|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2012-10-05|2012-08-24||August 2008||2008-08-01|September 2010|2010-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy||Completed||Phase 2/Phase 3|84|Actual|Johns Hopkins University|Subjects who failed to obtain benefit were unblinded after 1-month, which limits conclusions regarding long-term efficacy.|3|||f||||f||||||||||2017-02-18 14:02:47.495529|2017-02-18 14:02:47.495529
NCT00733083|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2008-08-08|||September 2008||2008-09-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|DOM||A Comparative Study With Parenteral Oxycodone, Morphine and Dexamethasone in Postoperative Pain in Paediatric Patients|A Comparative Study With Pre-Emptive Parenteral Oxycodone, Morphine and Dexamethasone in the Treatment of Postoperative Pain in Paediatric Patients 4 to 12 Years of Age|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Turku||4|||f||||f||||||||||2017-02-18 14:02:47.940041|2017-02-18 14:02:47.940041
NCT00733070|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-10|2013-07-06|||August 2008||2008-08-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study to Evaluate the Safety and Efficacy of the CiTop™ ExPander™ Guidewire for Crossing Chronic Total Occlusions in Coronary Arteries|A Multicenter Multinational Study to Evaluate the Safety and Efficacy of the CiTop™ ExPander™ Guidewire for Crossing Chronic Total Occlusions in Coronary Arteries|Terminated||N/A|30|Anticipated|Ovalum||1||no interest to develop the product|f||||f||||||||||2017-02-18 14:02:48.052431|2017-02-18 14:02:48.052431
NCT00733057|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-08-11|||August 2003||2003-08-01|August 2008|2008-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Minocycline for the Treatment of Early-Phase Schizophrenia|A Double Blind Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia|Completed||Phase 3|70|Actual|Shalvata Mental Health Center||2|||f||||f||||||||||2017-02-18 14:02:48.282063|2017-02-18 14:02:48.282063
NCT00733044|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2013-05-06|||September 2007||2007-09-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|November 2011|Actual|2011-11-01||Interventional|||Cost-effectiveness of Multidisciplinary Management of Tinnitus|Cost-effectiveness of Multidisciplinary Management of Tinnitus at a Specialised Tinnitus Centre|Completed||N/A|492|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 14:02:48.394301|2017-02-18 14:02:48.394301
NCT00733031|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2010-12-09|||August 2008||2008-08-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918|A Phase I, Open-Label, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6918 Administered Daily as a Single Agent and in Combination Treatment in Adult Patients With Refractory Solid Malignancies|Terminated||Phase 1|75|Anticipated|AstraZeneca||3||"PK results demonstrate low and variable plasma concentrations so that achieving therapeutic~   concentrations is unlikely."|f||||f||||||||||2017-02-18 14:02:48.504848|2017-02-18 14:02:48.504848
NCT00733018|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2017-01-27|||December 2007||2007-12-01|January 2017|2017-01-01|July 2009|Actual|2009-07-01|June 2008|Actual|2008-06-01||Interventional|Foodgene||Nutrigenomics Diet Intervention Study Comparing Effects of Western and Balanced Diet in Healthy Subjects|Health Risk Assessment of Dietary Carbohydrates in Chronic Disease Development|Completed||N/A|40|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-02-18 14:02:48.628416|2017-02-18 14:02:48.628416
NCT00733005|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2014-11-07|2009-10-13||July 2008||2008-07-01|November 2014|2014-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)|Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Relief of Nasal Congestion Associated With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 3|324|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:02:48.746457|2017-02-18 14:02:48.746457
NCT00732992|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2011-03-15|2010-10-27||August 2008||2008-08-01|March 2011|2011-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies|Phase 1 Study Of Sunitinib (SU011248) In Combination With Pemetrexed In Patients With Advanced Solid Malignancies In Japan|Completed||Phase 1|12|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:02:49.103536|2017-02-18 14:02:49.103536
NCT00732979|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2013-05-16|||March 2008||2008-03-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|IVC CLAMP||Infrahepatic Inferior Vena Cava Clamping During Hepatectomy|IVC CLAMP: Infrahepatic Inferior Vena Cava Clamping During Hepatectomy - A Randomized Controlled Trial|Completed||N/A|152|Actual|Heidelberg University||2|||f||||t||||||||||2017-02-18 14:02:49.774648|2017-02-18 14:02:49.774648
NCT00732966|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-10|2008-08-11|||September 2008||2008-09-01|August 2008|2008-08-01||||September 2009|Anticipated|2009-09-01||Interventional|||Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?|Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?|Unknown status|Not yet recruiting|N/A|30|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 14:02:49.867093|2017-02-18 14:02:49.867093
NCT00732953|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2014-06-07|||February 2009||2009-02-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|January 2010|Actual|2010-01-01||Interventional|||Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries|Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries - a Randomized Clinical Trial.|Completed||Phase 2/Phase 3|120|Actual|University of Ulm||2|||f||||f||||||||||2017-02-18 14:02:49.961792|2017-02-18 14:02:49.961792
NCT00732940|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2013-08-01|2011-04-07||October 2008||2008-10-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|October 2009|Actual|2009-10-01||Interventional|||Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)|A Phase 2, Multi-Center, Randomized, Open Label, Trial to Evaluate the Safety, Tolerability, and Biological Activity of 2 Dosing Schedules of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)|Terminated||Phase 2|56|Actual|Human Genome Sciences Inc.||2||Sponsor terminated study for business reasons.|f||||t||||||||||2017-02-18 14:02:50.082416|2017-02-18 14:02:50.082416
NCT00732927|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-07|||July 2002||2002-07-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|July 2006|Actual|2006-07-01||Interventional|PARVO||Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion|Parnaparin Versus Aspirin in the Treatment of Retinal Vein Occlusion. A Randomized, Double Blind, Controlled Study|Terminated||Phase 3|67|Actual|Università degli Studi dell'Insubria||2||slow recruitment rate|f||||f||||||||||2017-02-18 14:02:51.109029|2017-02-18 14:02:51.109029
NCT00732914|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2014-04-22|||January 2009||2009-01-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Sequential Study to Treat Renal Cell Carcinoma|A Phase III Randomized Sequential Open-Label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Sunitinib Versus Sunitinib Followed by Sorafenib in the Treatment of First-Line Advanced / Metastatic Renal Cell Carcinoma|Completed||Phase 3|272|Actual|Sponsor GmbH||2|||f||||f||||||||||2017-02-18 14:02:51.211194|2017-02-18 14:02:51.211194
NCT00732901|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2016-04-22|||June 2008||2008-06-01|April 2016|2016-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Clinical Neurobiology of Serotonin and Addiction|Project 1: Clinical Neurobiology of Serotonin and Addiction|Completed||Phase 2/Phase 3|160|Actual|Virginia Commonwealth University||3|||f||||t||||||||||2017-02-18 14:02:51.313823|2017-02-18 14:02:51.313823
NCT00732888|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2013-12-17|||November 2008||2008-11-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers|Effect of Calcium Supplements on Nilotinib Hydrochloride Pharmacokinetics in Healthy Volunteers (CAMN107DUS10T) (UPCI 08-077)|Completed||Phase 1|14|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:02:51.433623|2017-02-18 14:02:51.433623
NCT00732875|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-04-10|2009-06-02||August 2006||2006-08-01|April 2015|2015-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)|A Placebo-controlled, Double-blinded, Randomized Clinical Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methotrexate Treatment (Open-label Extension Part)|Completed||Phase 3|92|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:02:51.539564|2017-02-18 14:02:51.539564
NCT00732862|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2014-12-10|||February 1998||1998-02-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|March 2000|Actual|2000-03-01||Interventional|||Metabolic Adaptation to Diabetes|Metabolic Adaptation to Diabetes|Completed||N/A|15|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:02:51.816287|2017-02-18 14:02:51.816287
NCT00732849|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-08|||June 2002||2002-06-01|July 2008|2008-07-01|November 2007|Actual|2007-11-01|September 2002|Actual|2002-09-01||Interventional|||The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery|The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery - A Prospective, Randomized, Clinical Trial.|Completed||Phase 4|600|Actual|Jagiellonian University||4|||f||||f||||||||||2017-02-18 14:02:51.912619|2017-02-18 14:02:51.912619
NCT00732836|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2016-02-04|||June 2008||2008-06-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Hepatic Arterial Infusion (HAI) of Abraxane|Phase I Trial of Hepatic Arterial Infusion of Abraxane With a Pharmacokinetic Study in Advanced Solid Cancer Patients With Predominant Hepatic Metastases|Completed||Phase 1|64|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 14:02:52.011577|2017-02-18 14:02:52.011577
NCT00732823|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-10-29|||July 2005||2005-07-01|August 2008|2008-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Compression Device Safety Study|A Phase II Randomized Study to Evaluate the Safety of the Compression Test Device Using Intermittent Pneumatic Compression Mode in Subjects With Venous Insufficiency and Oedema|Completed||Phase 2|16|Actual|ConvaTec Inc.||4|||f||||f||||||||||2017-02-18 14:02:52.136707|2017-02-18 14:02:52.136707
NCT00732810|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-08-04|||July 2008||2008-07-01|August 2015|2015-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)|A Randomized Phase 2 Study of SCH 727965 in Subjects With Advanced Breast and Non Small Cell Lung (NSCLC) Cancers|Completed||Phase 2|97|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 14:02:52.235299|2017-02-18 14:02:52.235299
NCT00732797|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2011-08-11|||October 2008||2008-10-01|January 2010|2010-01-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||A Trial of Booklet Based Self Management of Dizziness|Evaluation of the Cost-effectiveness of Booklet-based Self-management of Dizziness in Primary Care, With and Without Expert Telephone Support|Completed||Phase 2|337|Actual|University of Southampton||3|||f||||f||||||||||2017-02-18 14:02:52.33668|2017-02-18 14:02:52.33668
NCT00732784|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2013-12-17|||November 2008||2008-11-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Calcium on Gleevec Pharmacokinetics (PK) in Healthy Volunteers|Effect of Calcium Supplements on Imatinib Mesylate (Gleevec®) Pharmacokinetics in Healthy Volunteers (CSTI571BUS 280) (UPCI 08-072)|Completed||Phase 1|11|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:02:52.440577|2017-02-18 14:02:52.440577
NCT00732771|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2009-08-25|||June 2008||2008-06-01|August 2009|2009-08-01||||May 2009|Actual|2009-05-01||Interventional|||Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism|A Pilot, Single-blind, Forced-titration Study to Assess the Hemodynamic and Hormonal Effects, Safety and Tolerability of the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism|Completed||Phase 2|12|Anticipated|Novartis||1|||f||||||||||||||2017-02-18 14:02:52.551586|2017-02-18 14:02:52.551586
NCT00732758|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-11-30|2015-09-22||October 2008||2008-10-01|November 2015|2015-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|Vitamin D RCT||Defining Vitamin D Insufficiency in School Age Children: A Randomized Placebo Controlled Trial of Vitamin D3|Defining Vitamin D Insufficiency in School Age Children: A Randomized Placebo Controlled Trial of Vitamin D3|Completed||Phase 1|157|Actual|University of Pittsburgh|No limitations.|2|||f||||f||||||||||2017-02-18 14:02:52.645218|2017-02-18 14:02:52.645218
NCT00732745|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-09|2011-08-19|||October 2008||2008-10-01|August 2011|2011-08-01||||June 2010|Actual|2010-06-01||Interventional|||Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction|Phase I/II Study of the Combination of Oxaliplatin / Docetaxel and ZACTIMA for the Treatment of Advanced Cancers of the Esophagus and Gastroesophageal Junction|Terminated||Phase 1|9|Actual|Case Comprehensive Cancer Center||2||Lost funding for Phase II portion of study|f||||t||||||||||2017-02-18 14:02:55.767556|2017-02-18 14:02:55.767556
NCT00732732|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2011-08-05|||September 2008||2008-09-01|August 2011|2011-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Controlled Trial of Plantain Powder in Infantile Diarrhea|A Controlled Trail of Plantain Powder (Green Banana) in Infantile Diarrhea.|Terminated||N/A|200|Anticipated|Augusta University||2||"Closed by US IRB due to lack of an adequate system for continuing review by the Indian IRB. No~   subjects enrolled in US."|f||||f||||||||||2017-02-18 14:02:55.875102|2017-02-18 14:02:55.875102
NCT00732719|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-10-29|||October 2004||2004-10-01|August 2008|2008-08-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Compression Device Safety Study on Edema|A Phase II Non-Comparative Study Evaluating the Effects of the Compression Test Device on Oedema|Completed||Phase 2|12|Actual|ConvaTec Inc.||7|||f||||f||||||||||2017-02-18 14:02:55.976385|2017-02-18 14:02:55.976385
NCT00732706|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2008-08-11|||August 2008||2008-08-01|August 2008|2008-08-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|FNB||Femoral Nerve Block: Anatomical Insertion Point - A Prospective Randomised Double-Blind Controlled Trial|Femoral Nerve Block: Anatomical Insertion Point - A Prospective Randomised Double-Blind Controlled Trial|Unknown status|Not yet recruiting|N/A|60|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 14:02:56.086723|2017-02-18 14:02:56.086723
NCT00732693|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2008-08-11|||February 2002||2002-02-01|August 2008|2008-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure|Comparison of Standard and Physiologic Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure and the Assessment of Skeletal, Cardiovascular and Reproductive Parameters|Completed||Phase 4|42|Actual|University of Edinburgh||2|||f||||f||||||||||2017-02-18 14:02:56.199564|2017-02-18 14:02:56.199564
NCT00732680|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2016-03-18|2013-11-13||December 2008||2008-12-01|March 2016|2016-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome|Prospective Case Series Evaluating Short and Long Term Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome|Terminated||Phase 1/Phase 2|9|Actual|Mayo Clinic|No study data was collected in the study. The Lead investigator moved to a new medical center; the study was stopped when he left.|1||Lead investigator moved to a new medical center; study was stopped when he left.|f||||f||||||||||2017-02-18 14:02:56.32791|2017-02-18 14:02:56.32791
NCT00732654|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2012-03-29|||August 2008||2008-08-01|March 2012|2012-03-01|June 2015|Anticipated|2015-06-01|June 2010|Actual|2010-06-01||Interventional|||The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy|The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 14:02:56.553493|2017-02-18 14:02:56.553493
NCT00732641|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-10-08|2011-10-27||December 2000||2000-12-01|October 2015|2015-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7)|Phase III Randomized, Prospective Multi-center Trial of PEG-Interferon α-2b as a Maintenance Therapy, Compared to Observation, in Patients With Multiple Myeloma Who Responded to Induction Therapy (Protocol No P01972)|Completed||Phase 3|244|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 14:02:56.866063|2017-02-18 14:02:56.866063
NCT00732628|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2009-02-20|||January 2008||2008-01-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|||||Observational|||Evaluating Outcomes in the Placement of Boomerang Percutaneous Device|Technical and Clinical Outcomes Following Placement of Boomerang Percutaneous Closure Device After Cerebral Angiography or Neurointerventional Procedures|Terminated||N/A|200|Anticipated|University of Michigan|||1|Physician is no longer associated with the Univ. of Michigan Medical Center|f||||f||||||||||2017-02-18 14:02:57.53703|2017-02-18 14:02:57.53703
NCT00732615|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-11-10|2015-02-20||December 2008||2008-12-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|REPLACE||Use of NPSP558 in the Treatment of Hypoparathyroidism|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH[1-84]) for the Treatment of Adults With Hypoparathyroidism|Completed||Phase 3|124|Actual|Shire||2|||f||||t||||||||||2017-02-18 14:02:57.636274|2017-02-18 14:02:57.636274
NCT00732602|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2009-02-12|||January 2008||2008-01-01|February 2009|2009-02-01||||August 2008|Actual|2008-08-01||Interventional|||The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes|The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes|Completed||N/A|8|Actual|University Hospital, Gentofte, Copenhagen||3|||f||||f||||||||||2017-02-18 14:02:58.425706|2017-02-18 14:02:58.425706
NCT00732589|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2009-11-17|||August 2008||2008-08-01|August 2008|2008-08-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|SSNB||SSNB in Hemiplegic Shoulder Pain|Suprascapular Nerve Block in Hemiplegic Shoulder Pain.|Completed||Phase 2|0|Anticipated|Chulalongkorn University||2|||f||||f||||||||||2017-02-18 14:02:58.737364|2017-02-18 14:02:58.737364
NCT00732576|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2009-03-09|||January 2008||2008-01-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Omega-3 Fatty Acids and Menaquinone-7 on Thrombotic Tendency|Effects of Omega-3 Fatty Acids and Menaquinone-7 on Thrombotic Tendency|Completed||N/A|57|Actual|Maastricht University Medical Center||8|||f||||f||||||||||2017-02-18 14:02:58.851545|2017-02-18 14:02:58.851545
NCT00728780|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2012-09-27|||August 2008||2008-08-01|September 2012|2012-09-01||||September 2008|Actual|2008-09-01||Interventional|||Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.||Completed||Phase 1|32|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:04:20.919152|2017-02-18 14:04:20.919152
NCT00732563|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-09|2017-02-03|||July 16, 2008|Actual|2008-07-16|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|June 29, 2012|Actual|2012-06-29||Interventional|||Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery|Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer|Active, not recruiting||N/A|100|Actual|Roswell Park Cancer Institute||1|||f||||t|f|f||||||||2017-02-18 14:02:58.962867|2017-02-18 14:02:58.962867
NCT00732550|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-03|2016-04-13|||July 2008||2008-07-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Comparison of Single Trocar Cholecystectomy to Standard Laparoscopic Cholecystectomy|Comparison of Single Trocar Cholecystectomy to Standard Laparoscopic Cholecystectomy|Active, not recruiting||N/A|20|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 14:02:59.061207|2017-02-18 14:02:59.061207
NCT00732537|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2008-08-08|||March 1999||1999-03-01|August 2008|2008-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Inhaled Nitric Oxide by Oxygen Hood in Neonates|Inhaled Nitric Oxide in Neonates With Elevated A-aDO2 Gradients Not Requiring Mechanical Ventilation|Completed||Phase 4|8|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:02:59.158229|2017-02-18 14:02:59.158229
NCT00732524|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2008-08-11|||September 2004||2004-09-01|August 2008|2008-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA|Combination of Sulfonylureas and Insulin Glargine as Safety Net Outpatient Therapy for Unstable Diabetes and Impending Diabetic Ketoacidosis (DKA)|Completed||Phase 4|80|Actual|John H. Stroger Hospital||2|||f||||t||||||||||2017-02-18 14:02:59.277761|2017-02-18 14:02:59.277761
NCT00732511|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2011-02-09|||April 2008||2008-04-01|February 2011|2011-02-01|April 2009|Anticipated|2009-04-01|December 2008|Anticipated|2008-12-01||Interventional|||Coreg CR, Blood Vessel Stiffness and Blood Vessel Function|Effect of Coreg CR on BP, Endothelial Function, Exhaled Nitric Oxide, and Nitric Oxide Production and Oxidation|Unknown status|Recruiting|Phase 4|40|Anticipated|State University of New York - Downstate Medical Center||2|||f||||f||||||||||2017-02-18 14:02:59.390859|2017-02-18 14:02:59.390859
NCT00732498|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-09|2016-11-10|||May 2006||2006-05-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL|Phase II Trial Of Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy After Cytoreduction With ESHAP Chemotherapy In Patients With Relapsed Follicular Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 2|52|Anticipated|University of Arizona||1|||f||||t||||||||||2017-02-18 14:02:59.509573|2017-02-18 14:02:59.509573
NCT00732485|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2012-12-10|||August 2008||2008-08-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate|The Role of Mitochondrial Oxidation on Insulin Resistance in Burn Patients Treated With Fenofibrate|Withdrawn||Phase 2/Phase 3|0|Actual|The University of Texas Medical Branch, Galveston||2||Principal Investigator Changed|f||||t||||||||||2017-02-18 14:02:59.648885|2017-02-18 14:02:59.648885
NCT00732472|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2016-10-11|2014-01-02||October 2008||2008-10-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days|A Randomised, Double-blind, Placebo-controlled, Dose Ascending, 2-cohort, Parallel Group Study to Examine the Safety, Tolerability and Pharmacokinetics of Once-daily Inhaled Doses of GSK573719 Formulated With the Excipient Magnesium Stearatein COPD Subjects for 7 Days|Completed||Phase 2|37|Actual|GlaxoSmithKline|Subject 303 and Subject 317 correspond to the same participant who was randomized and dosed on two separate occasions. This participant has been counted as two separate participants on all the outputs.|1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:02:59.781504|2017-02-18 14:02:59.781504
NCT00732459|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-09|2008-08-15|||January 2007||2007-01-01|August 2008|2008-08-01|December 2008|Anticipated|2008-12-01|July 2008|Actual|2008-07-01||Observational|||Clinical Trial of Electro-Acupuncture Preconditioning in Patients Underwent Heart Valve Replacement Surgery|Clinical Trial of The Myocardial Protective Effects of Repeated Electroacupuncture Preconditioning in Heart Valve Replacement Surgery|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Xijing Hospital|||2||f||||t||||||||||2017-02-18 14:03:02.061403|2017-02-18 14:03:02.061403
NCT00732446|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2011-06-21|||August 2008||2008-08-01|August 2008|2008-08-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|BRA-07-02||Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis|An Evaluation of the Safety and Efficacy of the Administration of a Fixed Combination of Moxifloxacin 0.5% and Dexamethasone 0.1% Eye Drops Compared With the Individual Administration of Moxifloxacin 0.5% and Dexamethasone 0.1% in the Treatment of Bacterial Ocular Inflammation and Infection (Blepharitis and/or Keratitis and/or Conjunctivitis)|Completed||Phase 3|100|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:03:02.166057|2017-02-18 14:03:02.166057
NCT00732433|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-10-31|||June 2000||2000-06-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|April 2017|Anticipated|2017-04-01||Interventional|||Digital Mammography: Computer-Aided Breast Cancer Diagnosis|Digital Mammography: Computer-Aided Breast Cancer Diagnosis|Active, not recruiting||N/A|500|Anticipated|University of Michigan||1|||f||||t||||||||||2017-02-18 14:03:02.279795|2017-02-18 14:03:02.279795
NCT00732420|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-11|2013-07-30|||September 2008||2008-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors|A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of Two Schedules of Oral Topotecan in Combination With Pazopanib in Subjects With Advanced Solid Tumors|Completed||Phase 1|50|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:03:02.388019|2017-02-18 14:03:02.388019
NCT00732407|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-10|2008-08-11|||September 2008||2008-09-01|August 2008|2008-08-01||||September 2009|Anticipated|2009-09-01||Interventional|||Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)|Effect of Aliskiren on Arterial Stiffness and Platelet Function in Patients With Type 2 Diabetes Mellitus, a Comparison With Losartan|Unknown status|Not yet recruiting|N/A|40|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 14:03:02.499193|2017-02-18 14:03:02.499193
NCT00732394|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2008-08-08|||August 2008||2008-08-01|August 2008|2008-08-01|January 2010|Anticipated|2010-01-01|August 2009|Anticipated|2009-08-01||Interventional|||A Comparative Study: Non-Surgical Spinal Decompression and Spinal Manipulative Therapy- Utilizing a Quantifiable Musculoskeletal Functional Assessment Risk Analysis Tool (MSDR®) in Patients With Chronic Low Back Pain|This is a Study is for the Purpose of Quantifying Function of the Back and Lower Extremities, and to Assess the Inter-Regional Biomechanical Relationships of the Neck, Upper Extremities, Back, and Lower Extremities in Patients Suffering From Chronic Low Back Pain.|Unknown status|Recruiting|N/A|200|Anticipated|MedAppraise, Inc.||1|||f||||t||||||||||2017-02-18 14:03:02.612972|2017-02-18 14:03:02.612972
NCT00732381|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-05-27|2009-10-07||August 2008||2008-08-01|May 2015|2015-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)|Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Relief of Nasal Congestion Associated With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 3|351|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:03:02.711609|2017-02-18 14:03:02.711609
NCT00732368|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-05-04|||May 2005||2005-05-01|May 2015|2015-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)|A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis|Completed||Phase 3|98|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:03:03.082939|2017-02-18 14:03:03.082939
NCT00732355|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2016-02-29|||March 2009||2009-03-01|February 2016|2016-02-01|September 2010|Actual|2010-09-01|February 2010|Actual|2010-02-01||Observational|SyphPoc||Syph-Check Syphilis Antibody Point of Care (POC) Test|One-Step Syphilis Point of Care Test for Rapid Immunoassay Screening of Antibodies to Treponema Pallidum|Terminated||N/A|400|Actual|Healthcare Providers Direct, Inc.|||2|insufficient patient populations|f||||f||||||||No||2017-02-18 14:03:03.177763|2017-02-18 14:03:03.177763
NCT00732342|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-08-17|||February 2008||2008-02-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|Duration||Contingency Management Treatment Duration|Contingency Management Treatment Duration|Completed||Phase 2|310|Actual|UConn Health||4|||f||||f||||||||||2017-02-18 14:03:03.286225|2017-02-18 14:03:03.286225
NCT00732329|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-02-10|||August 2008||2008-08-01|February 2015|2015-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|ERGODEM||Effectiveness of Home Based Occupational Therapy for Dementia.|Effectiveness of an Optimized Home Based Occupational Therapy for Patients With Dementia.|Completed||N/A|160|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-02-18 14:03:03.392028|2017-02-18 14:03:03.392028
NCT00732316|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2012-07-16|||April 2008||2008-04-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|December 2009|Actual|2009-12-01||Interventional|||Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome|HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION AFTER REDUCED INTENSITY CONDITIONING OF BUSULFAN, FLUDARABINE, AND ANTI-THYMOCYTE GLOBULIN FOR ADULT PATIENTS WITH HEMATOLOGIC MALIGNANCIES AND MYELODYSPLASTIC SYNDROME - A PHASE 2 STUDY|Completed||Phase 2|54|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 14:03:03.50405|2017-02-18 14:03:03.50405
NCT00732303|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-03-23|2016-02-24||January 2009||2009-01-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer|A Phase II Study of Concurrent Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer: Hoosier Oncology Group LUN08-129|Terminated||Phase 2|8|Actual|Hoosier Cancer Research Network||1||Study terminated due to withdrawal of pharmaceutical funding|f||||t||||||||||2017-02-18 14:03:03.633327|2017-02-18 14:03:03.633327
NCT00732290|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2013-03-22|||February 2009||2009-02-01|March 2013|2013-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|PLATINE||Investigation of Drug-drug Interaction Between Clopidogrel and Fluoxetine|Investigation of Drug-drug Interaction Between Clopidogrel and Fluoxetine|Completed||Phase 1|10|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-02-18 14:03:03.949434|2017-02-18 14:03:03.949434
NCT00732277|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-05-05|||April 2008||2008-04-01|May 2016|2016-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|StePS||Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis - a Randomised Pilot Study|Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis (Steroids in Paediatric Sepsis, StePS) - a Randomised Pilot Study|Completed||Phase 2|21|Actual|University Hospital Southampton NHS Foundation Trust||2|||f||||t||||||||No||2017-02-18 14:03:04.062719|2017-02-18 14:03:04.062719
NCT00732264|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-10-17|||July 2008||2008-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:03:04.208739|2017-02-18 14:03:04.208739
NCT00732251|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2012-03-26|||August 2008||2008-08-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Allopurinol Maintenance Study for Bipolar Disorder|An Open Label, Naturalistic Study With Allopurinol Augmentation for Prevention of Mania in Bipolar Disorder|Completed||Phase 4|15|Actual|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-02-18 14:03:04.263516|2017-02-18 14:03:04.263516
NCT00732238|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-01-21|2014-10-28||July 2007||2007-07-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Multifaceted Treatment of Catheter-related Urinary Tract Infection|Multifaceted Treatment of Catheter-related Urinary Tract Infection|Completed||Phase 2|61|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:03:04.370515|2017-02-18 14:03:04.370515
NCT00732225|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-06-30|2010-03-31||May 2007||2007-05-01|June 2010|2010-06-01||||February 2008|Actual|2008-02-01||Interventional|||DisCoVisc Comparative Evaluation|A Prospective, Non-randomized Comparison of DisCoVisc to Dispersive and Cohesive Ophthalmic Viscosurgical Devices (OVDs) in Non-eventful Cataract Surgery|Completed||Phase 3|173|Actual|Alcon Research|At the time of surgery, patients were assigned to a study group based on the availability of study Ophthalmic Viscosurgical Devices (OVDs).|5|||f||||f||||||||||2017-02-18 14:03:04.96041|2017-02-18 14:03:04.96041
NCT00732212|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2016-01-28|||February 2009||2009-02-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Doppler Ultrasound Probe for Blood Flow Detection in Severe Upper Gastrointestinal Hemorrhage|Doppler Ultrasound Probe for Blood Flow Detection in Severe UGI Bleed|Completed||N/A|236|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:03:05.750689|2017-02-18 14:03:05.750689
NCT00732199|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-10-09|||October 2008||2008-10-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Determinants of Age Related Breathing Instability During Non-Rapid-Eye-Movement (NREM) Sleep|Determinants of Age-specific Breathing Instability During Sleep|Completed||N/A|92|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:03:05.866849|2017-02-18 14:03:05.866849
NCT00732186|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-02-16|||August 2009||2009-08-01|November 2009|2009-11-01|February 2011|Anticipated|2011-02-01|February 2011|Anticipated|2011-02-01||Interventional|||Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia|Phase Ib Study Evaluating the Safety and Exploring the Molecular and Cytogenetic Response of Combination Therapy With Dasatinib and Ipilimumab in Patients With Chronic or Accelerated Phase Chronic Myeloid Leukemia|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:03:05.992058|2017-02-18 14:03:05.992058
NCT00732173|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2013-02-07|||July 2008||2008-07-01|February 2013|2013-02-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer|Survivors of Uterine Cancer Empowered By Exercise and Healthy Diet (SUCCEED)|Completed||N/A|74|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 14:03:06.100764|2017-02-18 14:03:06.100764
NCT00732160|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2014-07-08|||September 2008||2008-09-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|September 2012|Actual|2012-09-01||Interventional|||Aldosterone and Glucose Homeostasis|Aldosterone and Glucose Homeostasis|Completed||N/A|68|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:03:06.210048|2017-02-18 14:03:06.210048
NCT00732147|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2012-06-02|||April 2009||2009-04-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM|Effects of Pramlintide on Endogenous Production of VLDL-Triglyceride and Glucose in the Post Prandial State in Type 2 Diabetes Mellitus|Withdrawn||N/A|0|Actual|University of Maryland||2||Sponsor could not fund.|f||||f||||||||||2017-02-18 14:03:06.320318|2017-02-18 14:03:06.320318
NCT00732134|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-08|||March 2008||2008-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:03:06.430144|2017-02-18 14:03:06.430144
NCT00732121|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-06-25|||August 2008||2008-08-01|February 2009|2009-02-01|August 2010|Anticipated|2010-08-01|June 2010|Anticipated|2010-06-01||Interventional|||Bone Turnover in Type 2 Diabetes Patients|Effects of Sitagliptin On Markers of Bone Turnover in Patients With Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 4|20|Anticipated|University of Vermont||2|||f||||f||||||||||2017-02-18 14:03:06.48221|2017-02-18 14:03:06.48221
NCT00732108|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-03-04|||November 2008||2008-11-01|March 2015|2015-03-01||||August 2011|Anticipated|2011-08-01||Interventional|||Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness|Efficacy of Topiramate in Patients Wih Migraine-Associated Dizziness|Withdrawn||N/A|0|Actual|University of California, San Francisco||2||No subjects enrolled|f||||t||||||||||2017-02-18 14:03:06.592291|2017-02-18 14:03:06.592291
NCT00732095|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-12-13|||March 2008||2008-03-01|December 2010|2010-12-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|PSC3||Promoting Self-Change From Alcohol Problems: Mechanisms of Change in a Community-Based Intervention|Promoting Self-Change From Alcohol Problems: Mechanisms of Change in a Community-Based Intervention|Completed||Phase 3|283|Actual|Nova Southeastern University||1|||f||||f||||||||||2017-02-18 14:03:06.703242|2017-02-18 14:03:06.703242
NCT00732082|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2013-06-11|||February 2009||2009-02-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|February 2010|Actual|2010-02-01||Interventional|||Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer|Phase I Study of Soluble LAG-3 (IMP321) and Gemcitabine in Patients With Advanced Pancreas Cancer|Terminated||Phase 1|18|Actual|Washington University School of Medicine||5||Company manufacturing study drug was unable to continue production.|f||||f||||||||||2017-02-18 14:03:06.819772|2017-02-18 14:03:06.819772
NCT00732069|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2013-06-22|2012-07-18||August 2008||2008-08-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis|Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 2|Completed||Phase 2|19|Actual|Vanderbilt University||6|||f||||t||||||||||2017-02-18 14:03:06.970646|2017-02-18 14:03:06.970646
NCT00732056|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-12-22|||July 2008||2008-07-01|December 2015|2015-12-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|||A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer|A Phase I/II Study of GRN163L in Combination With Paclitaxel and Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 1|24|Actual|Geron Corporation||1|||f||||f||||||||||2017-02-18 14:03:07.379576|2017-02-18 14:03:07.379576
NCT00732043|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2012-03-15|||December 2007||2007-12-01|March 2012|2012-03-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer|A 48-Month Extension to the Randomized, Double-blind, Placebo-Controlled Study of the Effects of Pomegranate Extract on Rising Prostate-Specific Antigen Levels in Men Following Primary Therapy for Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|Roll International Corporation||3|||f||||t||||||||||2017-02-18 14:03:07.487785|2017-02-18 14:03:07.487785
NCT00732030|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-03-25|2009-04-29||June 2007||2007-06-01|March 2010|2010-03-01||||March 2009|Actual|2009-03-01||Interventional|||Low Cylinder Toric|Evaluation of the Acrysof Toric Model SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.03 Diopters (D)|Completed||Phase 4|26|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 14:03:07.603003|2017-02-18 14:03:07.603003
NCT00732017|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2008-08-06|||February 2004||2004-02-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Effects Of High Voltage Pulsed Current On Post-Traumatic Injuries|Effects Of High Voltage Pulsed Current On Ankle Post-Traumatic Injuries|Completed||N/A|28|Actual|Universidad Industrial de Santander||3|||f||||t||||||||||2017-02-18 14:03:07.851114|2017-02-18 14:03:07.851114
NCT00732004|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2009-06-30|||August 2008||2008-08-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Time Course Comparison of Contact Lens Maintenance Systems for Hydrogel Lenses||Completed||N/A|132|Anticipated|University of Melbourne||3|||f||||||||||||||2017-02-18 14:03:07.978414|2017-02-18 14:03:07.978414
NCT00731991|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2009-07-31|||August 2008||2008-08-01|August 2008|2008-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Art and Surface Electromyography (EMG)|The Effects of Active Release Technique and Proprioceptive Neurological Facilitation on Surface EMGs of Hypertonic Upper Trapezius Musculature|Completed||Phase 1/Phase 2|30|Anticipated|Logan College of Chiropractic||3|||f||||f||||||||||2017-02-18 14:03:08.074637|2017-02-18 14:03:08.074637
NCT00731978|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2009-10-28|||September 2008||2008-09-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|NIRF||NIRF Trial: Near-Infrared Spectroscopy for Intraoperative Restriction of Fluids Trial|Near-Infrared Spectroscopy for Intraoperative Restriction of Fluids Trial A Prospective Randomized Study of Near-infrared Spectroscopy Directed Fluid Therapy vs Standard Fluid Therapy in Patients Undergoing Open Elective Colorectal Surgery|Completed||N/A|27|Actual|Hutchinson Technology Inc||2|||f||||t||||||||||2017-02-18 14:03:08.169863|2017-02-18 14:03:08.169863
NCT00731965|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2014-07-29|||May 2008||2008-05-01|July 2014|2014-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|VAART||Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis|Multicenter Randomized Clinical Trial in Patients With Juvenile Idiopathic Arthritis: Safety and Efficacy of Vaccination With Live Attenuated Measles, Mumps, Rubella Vaccine|Completed||Phase 4|140|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 14:03:08.268935|2017-02-18 14:03:08.268935
NCT00731952|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2011-02-02|||June 2006||2006-06-01|February 2011|2011-02-01|January 2012|Anticipated|2012-01-01|April 2011|Anticipated|2011-04-01||Interventional|||Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer|Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|University of Virginia||1|||f||||f||||||||||2017-02-18 14:03:08.377217|2017-02-18 14:03:08.377217
NCT00731939|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2014-03-07|2013-09-27||November 2007||2007-11-01|March 2014|2014-03-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||Titan® One Touch Release Inflatable Penile Prosthesis|Titan® One Touch Release Inflatable Penile Prosthesis|Completed||N/A|124|Actual|Coloplast A/S||1|||f||||f||||||||||2017-02-18 14:03:08.487578|2017-02-18 14:03:08.487578
NCT00731926|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-08-10|||September 2007||2007-09-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Antioxidant on Endurance Performance in Healthy Men|Effect of Antioxidant on Endurance Performance in Healthy Men -Double Blind Randomized Placebo and Active Controlled Trial-|Completed||Phase 2/Phase 3|69|Actual|Seoul National University Hospital||3|||f||||f||||||||||2017-02-18 14:03:09.439939|2017-02-18 14:03:09.439939
NCT00731913|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-03-17|||July 2007||2007-07-01|March 2015|2015-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||A Comparison of Monosyn and Monocryl Sutures in Surgical Wounds|A Randomized, Prospective Trial Evaluating Surgeon-Preference in Selection of Absorbable Suture Material|Completed||N/A|48|Actual|Tufts Medical Center|||2||f||||t||||||||||2017-02-18 14:03:09.53581|2017-02-18 14:03:09.53581
NCT00731900|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-08|||April 2007||2007-04-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Pharmacogenetic Study for Topiramate-Induced Cognitive Dysfunction||Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-02-18 14:03:09.644406|2017-02-18 14:03:09.644406
NCT00731887|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2014-01-07|||June 2011||2011-06-01|December 2013|2013-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|LBO||Large Burn Outcome Study|Assessment of the Treatment of the Severely Burned With Anabolic Agents on Improved Wound Healing, Recovery and Rehabilitation: Large Burn Outcome Study|Withdrawn||N/A|0|Actual|The University of Texas Medical Branch, Galveston|||1|Personnel involved in this protocol are no longer associated with this study|f||||f||||||Samples Without DNA|"~     Blood and urine collected for this study will be retained for possible re-analysis if needed~     for the duration of the study.~   "|||2017-02-18 14:03:09.720118|2017-02-18 14:03:09.720118
NCT00731874|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-12-21|2015-12-21||August 2008||2008-08-01|December 2015|2015-12-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|TIMELY||Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status|Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status by Biopsy and mRNA Profiles (TIMELY Study)|Terminated||Phase 4|34|Actual|Weill Medical College of Cornell University|The population reported is small because the study was stopped early due to the increase in late antibody mediated rejection (occurring after month 15) that was seen in Arm 2 (target tacrolimus trough 3 to 5 ng/mL).|2||A higher rate of late rejection was seen in the low tacrolimus arm.|f||||f||||||||||2017-02-18 14:03:09.797332|2017-02-18 14:03:09.797332
NCT00731861|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2014-09-10|||May 2005||2005-05-01|September 2014|2014-09-01|August 2010|Actual|2010-08-01|September 2008|Actual|2008-09-01||Interventional|||Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors|Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors|Completed||Phase 1|28|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 14:03:10.206083|2017-02-18 14:03:10.206083
NCT00731848|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2012-03-15|||February 2008||2008-02-01|March 2012|2012-03-01|January 2015|Anticipated|2015-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer|An Open-label Extension Study of the Effects of Pomegranate Extract on Rising Prostate-specific Antigen Levels in Men Following Primary Therapy for Prostate Cancer.|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Roll International Corporation||1|||f||||t||||||||||2017-02-18 14:03:10.313644|2017-02-18 14:03:10.313644
NCT00731835|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-03-10|||July 2008||2008-07-01|March 2016|2016-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone|Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone? A Randomized Controlled Trial|Terminated||N/A|4|Actual|University of Pittsburgh||2||slow enrollment|f||||t||||||||||2017-02-18 14:03:10.417599|2017-02-18 14:03:10.417599
NCT00731822|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2016-10-26|2013-06-12||August 2008||2008-08-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)|Study HZC111348, a Repeat-dose Study of GW685698/GW642444 Inhalation Powder Versus Placebo in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|60|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:03:10.53268|2017-02-18 14:03:10.53268
NCT00731809|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-03|2008-12-22|||April 2008||2008-04-01|February 2008|2008-02-01|October 2010|Anticipated|2010-10-01|April 2010|Anticipated|2010-04-01||Interventional|||Evaluation of PET CT in the Management of Patients With Crohn's Disease.|Evaluation of PET CT in the Management of Patients With Crohn's Disease.|Unknown status|Recruiting|Phase 4|50|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-02-18 14:03:10.949655|2017-02-18 14:03:10.949655
NCT00731796|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2011-03-05|||September 2007||2007-09-01|March 2011|2011-03-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|FOM||Testing of a Functional Outcome Measure for Those With Visual Field Defects|Testing of a Functional Outcome Measure for Those With Visual Field Defects|Suspended||N/A|190|Anticipated|NovaVision, Inc.|||4|Lack of funding|f||||f||||||||||2017-02-18 14:03:11.044675|2017-02-18 14:03:11.044675
NCT00731783|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2012-04-23|2011-03-02||July 2008||2008-07-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|SuDS||Staphylococcus Aureus Decolonization Study|Household vs. Individual Approach to Decolonization of Community-acquired Methicillin-resistant Staphylococcus Aureus.|Completed||N/A|183|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 14:03:11.156877|2017-02-18 14:03:11.156877
NCT00731770|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-08|||September 2008||2008-09-01|August 2008|2008-08-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Comparing Fluticasone-Salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep|TITLE: Double-Blinded, Double-Dummy, Study Comparing Fluticasone-Salmeterol to Placebo in Patients With COPD and Associated Poor Sleep or Daytime Somnolence.|Unknown status|Not yet recruiting|Phase 4|15|Anticipated|Penn State University||2|||f||||f||||||||||2017-02-18 14:03:11.609183|2017-02-18 14:03:11.609183
NCT00731757|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2009-07-21|||May 2009||2009-05-01|July 2009|2009-07-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis|A Phase II, Multi-Center, Open Label Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis|Withdrawn||Phase 2|20|Anticipated|Wright State University||1|||||||t||||||||||2017-02-18 14:03:11.719467|2017-02-18 14:03:11.719467
NCT00731744|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-08|||January 2007||2007-01-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|February 2007|Actual|2007-02-01||Interventional|||Generation of Dendritic Cell Precursors From Cord Blood Stem Cells|Generation of Dendritic Cell Precursors From Cord Blood Stem Cells|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 14:03:11.817611|2017-02-18 14:03:11.817611
NCT00731731|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2016-12-08|2015-04-28||July 2009||2009-07-01|November 2016|2016-11-01||||February 2014|Actual|2014-02-01||Interventional|||Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid [SAHA]), Temozolomide, and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma|Active, not recruiting||Phase 1/Phase 2|125|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:03:11.909018|2017-02-18 14:03:11.909018
NCT00731718|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-08-08|||June 2007||2007-06-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Control of Head Lice Infestations in Children and Adults|Control of Head Lice in Children and Adults|Completed||N/A|543|Actual|Larada Sciences, Inc.||1|||f||||t||||||||||2017-02-18 14:03:13.308396|2017-02-18 14:03:13.308396
NCT00731705|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2014-09-18|||January 2007||2007-01-01|September 2014|2014-09-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells|In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells|Withdrawn||N/A|0|Actual|Indiana University|||1||f||||t||||||Samples Without DNA|"~     peripheral blood, apheresis samples~   "|||2017-02-18 14:03:13.416518|2017-02-18 14:03:13.416518
NCT00731692|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-04-13|||July 2008||2008-07-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|INFORMS||FTY720 in Patients With Primary Progressive Multiple Sclerosis|A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis|Completed||Phase 3|969|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:03:13.520242|2017-02-18 14:03:13.520242
NCT00731679|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-06-30|2014-06-30||July 2008||2008-07-01|June 2014|2014-06-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|TARGET 1|The analysis population was the intent-to-treat population, defined as subjects who received at least 1 dose of study drug.|Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)|A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin 550 mg TID in the Treatment of Subjects With Non-Constipation Irritable Bowel Syndrome|Completed||Phase 3|623|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 14:03:13.820454|2017-02-18 14:03:13.820454
NCT00731666|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2013-09-27|2013-09-27||December 2007||2007-12-01|September 2013|2013-09-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)|Prospective, Non-randomized, Multi-center Clinical Trial to Assess the Effectiveness of the Coloplast Titan® IPP at Maintaining or Increasing Penile Length After Implantation|Completed||N/A|40|Actual|Coloplast A/S||1|||f||||f||||||||||2017-02-18 14:03:14.545955|2017-02-18 14:03:14.545955
NCT00731653|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2013-10-24|2013-10-24||July 2008||2008-07-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)|An Open-Label Extension Study to Assess the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder|Completed||Phase 2|81|Actual|Massachusetts General Hospital|This was an open-label study. Conclusions regarding the efficacy of the combination study drug were not made.|1|||f||||f||||||||||2017-02-18 14:03:14.842806|2017-02-18 14:03:14.842806
NCT00731640|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-03-19|2009-09-09||June 2007||2007-06-01|March 2010|2010-03-01||||May 2008|Actual|2008-05-01||Interventional|||Contralateral ReSTOR / Monofocal or Phakic Eye|Clinical Outcomes With AcrySof ReSTOR Aspheric Apodized Diffractive Intraocular Lens (IOL) in One Eye and a Contralateral Monofocal IOL or Phakic Eye|Completed||Phase 4|52|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 14:03:15.081741|2017-02-18 14:03:15.081741
NCT00731627|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2014-06-24|||January 2007||2007-01-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|September 2013|Actual|2013-09-01||Interventional|STASH||Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial|Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial|Completed||Phase 3|803|Actual|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 14:03:15.464748|2017-02-18 14:03:15.464748
NCT00731614|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-06-01|2015-03-03||November 2008||2008-11-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|September 2011|Actual|2011-09-01||Interventional||Participants are adults with a single limb amputation who report current phantom limb pain.|Cognitive Behavior Therapy (CBT) and Mirror Training for Phantom Limb Pain|Psychosocial and Visual Feedback Intervention for Phantom Limb Pain|Completed||N/A|59|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:03:15.566529|2017-02-18 14:03:15.566529
NCT00731601|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2009-04-06|||May 2008||2008-05-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|PPI||Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding|Phase 4 Study of Intravenous Proton Pump Inhibitor in Patients With Peptic Ulcer Bleeding After Successful Endoscopic Therapy- a Prospective Randomized Comparative Trial|Completed||Phase 4|120|Actual|Lotung Poh-Ai Hospital||2|||f||||t||||||||||2017-02-18 14:03:16.117117|2017-02-18 14:03:16.117117
NCT00731588|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2014-12-23|||June 2008||2008-06-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Red Blood Cell (RBC) Survival Following Transfusion in Infants|Red Blood Cell Survival Following Transfusion in Infants|Completed||Phase 2|140|Actual|University of Iowa||2|||f||||t||||||||||2017-02-18 14:03:16.231471|2017-02-18 14:03:16.231471
NCT00731575|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2011-08-11|||June 2007||2007-06-01|August 2011|2011-08-01||||May 2016|Anticipated|2016-05-01||Interventional|VINKU2||Viral Inception of Asthma: Prospective Study From Infancy to School-age|Viral Inception of Asthma: Prospective Study From Infancy to School-age.|Unknown status|Active, not recruiting|N/A|200|Anticipated|University of Turku||1|||f||||t||||||||||2017-02-18 14:03:16.342952|2017-02-18 14:03:16.342952
NCT00731562|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-01-07|||July 2008||2008-07-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation|Phase 1, Open-Label, Randomized, Single-Dose, Two-Way Crossover Study To Evaluate The Effect Of Food On The Oral Bioavailability Of A Varenicline Controlled Release Formulation In Healthy Adult Smokers|Completed||Phase 1|24|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:03:16.455134|2017-02-18 14:03:16.455134
NCT00731549|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2014-11-14|2014-11-04||December 2008||2008-12-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ASPIRE||Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia|A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia|Completed||Phase 3|1081|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||t||||||||||2017-02-18 14:03:16.626521|2017-02-18 14:03:16.626521
NCT00731536|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2013-10-14|||October 2008||2008-10-01|October 2013|2013-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands|A Retrospective Review of Reports of Hepatosplenic T-cell Lymphoma in the Dutch National Database of Pathology (Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief [PALGA]), a Database of Pathology Results for The Netherlands|Completed||Phase 4|15|Actual|Centocor Ortho Biotech Services, L.L.C.|||1||f||||f||||||||||2017-02-18 14:03:21.769751|2017-02-18 14:03:21.769751
NCT00731523|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2011-02-03|||July 2008||2008-07-01|February 2011|2011-02-01||||August 2008|Actual|2008-08-01||Interventional|||Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects.|An Open-label, Single-dose, Parallel-group Study to Compare the Pharmacokinetics of FTY720 and Metabolites in Subjects With Severe Renal Impairment With That in Matched Healthy Control Subjects|Completed||Phase 1|18|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:03:21.883105|2017-02-18 14:03:21.883105
NCT00731510|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2009-05-06|||June 2008||2008-06-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|October 2008|Anticipated|2008-10-01||Interventional|||MEDEX Hidden Valley 2008|MEDEX Hidden Valley 2008|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Medical Expeditions Ltd||2|||f||||f||||||||||2017-02-18 14:03:21.988486|2017-02-18 14:03:21.988486
NCT00731497|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-07|||September 2004||2004-09-01|August 2008|2008-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|SODIS_Bolivia||Solar Water Disinfection Intervention Trial in Bolivia|Solar Water Disinfections: Randomized Intervention Trial|Completed||Phase 3|1163|Actual|University of California, Berkeley||2|||f||||f||||||||||2017-02-18 14:03:22.094579|2017-02-18 14:03:22.094579
NCT00731484|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-03-14|2011-04-06||July 2008||2008-07-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Validation of TearLab Osmometer - Human Factor Usability Report|Validation of TearLab Osmometer - Human Factor Usability Report|Completed||N/A|233|Actual|TearLab Corporation|As recruitment came from the general clinical population, only 19 subjects were classified as having Sjögren's Syndrome, and few of the subjects had severe dry eye. Therefore, the upper range is lower than we have observed in the following studies.||1||f||||f||||||||Yes|The data was used in the FDA 510(K) submission.|2017-02-18 14:03:22.206682|2017-02-18 14:03:22.206682
NCT00731471|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2011-03-25|||August 2008||2008-08-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV|A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Are Infected With HIV|Completed||Phase 1|24|Anticipated|University of Oxford||2|||f||||t||||||||||2017-02-18 14:03:22.417974|2017-02-18 14:03:22.417974
NCT00731458|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2013-09-04|||May 2007||2007-05-01|September 2013|2013-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Prospective Comparison of Cirrus Versus Stratus Ocular Coherence Tomography for Different Retinal Pathology.|Prospective Comparison of Cirrus and Stratus Optical Coherence Tomography for Quantifying Retinal Thickness|Completed||N/A|60|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 14:03:22.723965|2017-02-18 14:03:22.723965
NCT00731445|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2012-06-29|||July 2008||2008-07-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|||Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)|Phase I/II Dose Escalation, Pharmacokinetic, Safety, and Efficacy Study of Oral Z-208 in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|43|Anticipated|Zeria Pharmaceutical|||||f||||t||||||||||2017-02-18 14:03:22.802705|2017-02-18 14:03:22.802705
NCT00731432|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2011-07-19|||August 2008||2008-08-01|August 2008|2008-08-01||||||||Interventional|||Herbal Periodontal Patch (THPP) for Gingival Inflammation in Diabetics|The Effect Of A Transmucosal Herbal Periodontal Patch (THPP) on Gingival Inflammation in Diabetic Patients|Suspended||Phase 2|60|Anticipated|Izun Pharma Ltd||2||Failure to recruit|f||||f||||||||||2017-02-18 14:03:22.899975|2017-02-18 14:03:22.899975
NCT00731419|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-05|||June 2007||2007-06-01|May 2007|2007-05-01|August 2009|Anticipated|2009-08-01|May 2009|Anticipated|2009-05-01||Interventional|||Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant Jaundice|Distal Malignant Biliary Obstruction: A Prospective Randomised Trial Comparing Metal and Plastic Stents in Palliation of Symptomatic Jaundice|Unknown status|Recruiting|Phase 4|100|Anticipated|University of Cape Town||2|||f||||f||||||||||2017-02-18 14:03:23.011618|2017-02-18 14:03:23.011618
NCT00731393|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-09-14|||October 2003||2003-10-01|September 2016|2016-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04|To Determine the Immunogenicity and Reactogenicity of a Thiomersal Free Trivalent Influenza Split Vaccine 2003/2004 or of GSK Biologicals' Standard Formulation Influsplit SSW®/Fluarix™ 2003/2004 in Children Aged From 6 Months Until 6 Years|Completed||Phase 3|157|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:03:23.122444|2017-02-18 14:03:23.122444
NCT00731380|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-06-21|||July 2008||2008-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer|Phase I Trial of ABI-007 (Abraxane) Plus Cisplatin Plus 5-Fluorouracil (APF) as Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With Locally Advanced Squamous Cell Cancers of the Head and Neck (HNSCC)|Completed||Phase 1|12|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 14:03:23.249641|2017-02-18 14:03:23.249641
NCT00731367|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2009-02-02|||October 2005||2005-10-01|February 2009|2009-02-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites|A Phase IIIb, Randomized Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites.|Completed||Phase 3|73|Actual|ConvaTec Inc.||2|||f||||f||||||||||2017-02-18 14:03:23.364172|2017-02-18 14:03:23.364172
NCT00731354|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2011-06-06|||July 2007||2007-07-01|June 2011|2011-06-01|April 2009|Actual|2009-04-01|September 2008|Actual|2008-09-01||Interventional|Contra-Lateral||VASER-Assisted Lipoplasty Compared With Suction-Assisted Lipoplasty|A Multi-Center, Prospective, Randomized, Single-Blind, Controlled Clinical Trial Comparing VASER-Assisted Lipoplasty and Suction-Assisted Lipoplasty.|Completed||Phase 4|21|Anticipated|Sound Surgical Technologies, LLC.||2|||f||||f||||||||||2017-02-18 14:03:23.467215|2017-02-18 14:03:23.467215
NCT00731341|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2011-10-25|2010-08-12||July 2008||2008-07-01|October 2011|2011-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata|Feasibility Study of Hysteroscopic Cryoablation Treatment of Symptomatic Uterine Fibroids in Women Who do Not Desire Further Pregnancies|Completed||N/A|3|Actual|Galil Medical|Due to the nature of this feasibility study, a very small number of participants was evaluated.|1|||f||||f||||||||||2017-02-18 14:03:23.579624|2017-02-18 14:03:23.579624
NCT00731328|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-08|2015-12-29|||April 2008||2008-04-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome|HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION AFTER REDUCED INTENSITY CONDITIONING OF BUSULFAN, FLUDARABINE, AND ANTI-THYMOCYTE GLOBULIN FOR PATIENTS WITH BONE MARROW FAILURE SYNDROME - A PHASE 2 STUDY|Completed||Phase 2|15|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 14:03:23.85191|2017-02-18 14:03:23.85191
NCT00731315|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-03-05|||August 2008||2008-08-01|March 2015|2015-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|UTI-Kiosk||Computer-Assisted Treatment of Urinary Tract Infection in Emergency Departments and Community Health Centers|Computer-Assisted Treatment in the Management of Adult Female Patients With Symptoms of Urinary Tract Infection in Emergency Departments and Community Health Centers: A Randomized Trial|Terminated||N/A|200|Actual|University of California, San Francisco||4||"Funding Period ended, did not reach full sample size due to limited numbers of eligible~   patients"|f||||t||||||||||2017-02-18 14:03:23.949197|2017-02-18 14:03:23.949197
NCT00731302|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2016-10-31|||April 2005||2005-04-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Aspirin Resistance in Systemic Lupus Erythematosus (SLE)|Vascular Damage in Systemic Lupus Erythematosus (SLE)|Active, not recruiting||Phase 1|120|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 14:03:24.058076|2017-02-18 14:03:24.058076
NCT00731289|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-07|||July 2003||2003-07-01|August 2008|2008-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Gait Patterns After Intraarticular Treatment of Patients With Osteoarthritis of the Knee|Efficacy and Safety of Intra-Articular Injections of Durolane® in the Treatment of Osteoarthritis in the Knee|Completed||Phase 4|60|Actual|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-02-18 14:03:24.165876|2017-02-18 14:03:24.165876
NCT00731276|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-03-22|||June 2008||2008-06-01|March 2016|2016-03-01||||||||Interventional|||Irinotecan in Treating Asian Patients With Solid Tumors|Phase I Study to Investigate Genotype-based Dose Individualization of Irinotecan in Asian Cancer Patients|Active, not recruiting||Phase 1|18|Actual|National Cancer Centre, Singapore||1|||f||||f||||||||No||2017-02-18 14:03:24.273992|2017-02-18 14:03:24.273992
NCT00731263|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2012-07-10|||July 2008||2008-07-01|July 2012|2012-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of Tor Kinase Inhibitor in Advanced Tumors|A Phase I/II, Open-Label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Tor Kinase Inhibitor AZD8055 Administered Orally to Patients With Advanced Solid Tumours.|Completed||Phase 1|64|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:03:24.37516|2017-02-18 14:03:24.37516
NCT00731250|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2011-05-19|||July 2008||2008-07-01|February 2011|2011-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model|A Randomised, Double-blind, Placebo-controlled Study to Assess the Effect of Oral, Single Dose SB-705498 in a Validated Intranasal Capsaicin Challenge Model in Healthy Volunteers|Completed||Phase 1|45|Actual|GlaxoSmithKline||7|||f||||f||||||||||2017-02-18 14:03:24.476503|2017-02-18 14:03:24.476503
NCT00731042|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2012-01-24|2009-01-23||March 2008||2008-03-01|January 2012|2012-01-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects|A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects|Completed||Phase 4|33|Actual|3M||2|||f||||f||||||||||2017-02-18 14:03:29.894703|2017-02-18 14:03:29.894703
NCT00731237|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2009-10-15|||October 2008||2008-10-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|March 2009|Actual|2009-03-01||Observational|EXCEED||XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery|XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery|Completed||N/A|2517|Actual|Abbott Vascular|||1||f||||f||||||||||2017-02-18 14:03:24.590396|2017-02-18 14:03:24.590396
NCT00731224|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2013-03-28|||July 2008||2008-07-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|CARE||Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.|A 24-week, Multi-center, Open-label Evaluation of Compliance and Tolerability of the Once-daily 10 cm² Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease.|Completed||Phase 4|380|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:03:24.952438|2017-02-18 14:03:24.952438
NCT00731211|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-05-18|2014-12-16||September 2008||2008-09-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|May 2011|Actual|2011-05-01||Interventional||All eligible patients|Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma|A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab|Completed||Phase 2|57|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 14:03:25.105624|2017-02-18 14:03:25.105624
NCT00731198|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2010-08-31|2009-09-14||August 2008||2008-08-01|November 2009|2009-11-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)|Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During ERCP: a Prospective, Multicenter Randomized Controlled Trial|Completed||Phase 3|650|Actual|Changhai Hospital||2|||f||||t||||||||||2017-02-18 14:03:25.429659|2017-02-18 14:03:25.429659
NCT00731185|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-05-14|||September 2003||2003-09-01|May 2015|2015-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)|A Multi-center, Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety of Mometasone Furoate Nasal Spray (MFNS) in the Post Surgical Treatment of Nasal Polyposis|Completed||Phase 3|162|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:03:25.81862|2017-02-18 14:03:25.81862
NCT00731172|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2009-03-01|||September 2008||2008-09-01|March 2009|2009-03-01|July 2011|Anticipated|2011-07-01|July 2010|Anticipated|2010-07-01||Interventional|Cop1CD||A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease|A Pilot Single Center,Randomized,Double Blind Placebo Controlled Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Inducing Remission in Patients With Moderately Active Crohn's Disease.|Unknown status|Recruiting|Phase 2|50|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-02-18 14:03:25.912995|2017-02-18 14:03:25.912995
NCT00731159|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-07|||July 2008||2008-07-01|July 2008|2008-07-01|July 2009|Anticipated|2009-07-01|January 2009|Anticipated|2009-01-01||Observational|||Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment|Sperm Capacitation Assay as a Tool to Predict Sperm Potential to Fertilize in IVF Treatment|Unknown status|Recruiting|N/A|50|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-02-18 14:03:26.030487|2017-02-18 14:03:26.030487
NCT00731146|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-05|||August 2008||2008-08-01|August 2008|2008-08-01|July 2009|Anticipated|2009-07-01|February 2009|Anticipated|2009-02-01||Interventional|||Effects of Technique on the Local Anesthetic Dose Required for Interscalene Brachial Plexus Block|Effects of Ultrasound Guidance on the Minimum Effective Anesthetic Volume Required for Interscalene Brachial Plexus Block Versus Nerve Stimulator Guidance|Unknown status|Recruiting|N/A|80|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 14:03:26.130897|2017-02-18 14:03:26.130897
NCT00731133|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2012-01-20|2011-11-02||August 2008||2008-08-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Open-Label Disulfiram for Methamphetamine Dependence|Open-Label Pilot Study of Disulfiram for Methamphetamine Dependence|Completed||Phase 1/Phase 2|15|Actual|University of Arkansas|Large dropout so few participants had data throughout the trial. No control group so cannot determine whether side effects were related to disulfiram or an artifact of participation.|1|||f||||t||||||||||2017-02-18 14:03:26.243513|2017-02-18 14:03:26.243513
NCT00731120|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2013-10-25|2013-10-25||June 2008||2008-06-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses of Lu AA21004 in Acute Treatment of Adults With Generalized Anxiety Disorder|Completed||Phase 3|457|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:03:26.51174|2017-02-18 14:03:26.51174
NCT00731107|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-07|||September 2008||2008-09-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||XCEL Bladeless Trocar Versus Veress Needle: A Randomised Controlled Trial Comparing These Two Entry Techniques in Gynaecological Laparoscopic Surgery.|XCEL Bladeless Trocar Versus Veress Needle: A Randomised Controlled Trial Comparing These Two Entry Techniques in Gynaecological Laparoscopic Surgery.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Southern Health||2|||f||||t||||||||||2017-02-18 14:03:28.144362|2017-02-18 14:03:28.144362
NCT00731094|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-04-06|2014-09-18||June 2010||2010-06-01|March 2014|2014-03-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||The VA-STRIDE Study|Expert System-Based Feedback in Sedentary Overweight Veterans|Completed||N/A|232|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:03:28.258233|2017-02-18 14:03:28.258233
NCT00731081|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2014-02-04|||March 2007||2007-03-01|February 2014|2014-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme®|Observational Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme|Completed||N/A|8|Actual|Sanofi|||1||f||||f||||||Samples Without DNA|"~     urine and plasma oligosaccharides~   "|||2017-02-18 14:03:29.43806|2017-02-18 14:03:29.43806
NCT00731068|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2013-10-23|||February 2007||2007-02-01|October 2013|2013-10-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears|PRP as a Treatment for ACHILLES Tendon Tears - Randomized-Double-Blind-Placebo Control Trail|Completed||Phase 2/Phase 3|50|Actual|Meir Medical Center||2|||f||||t||||||||||2017-02-18 14:03:29.521722|2017-02-18 14:03:29.521722
NCT00731029|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-07|||September 2002||2002-09-01|August 2008|2008-08-01||||April 2003|Actual|2003-04-01||Interventional|||Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03|Comparative Vaccination Study of the Reactogenicity and Immunogenicity of a Thiomersal-Free Formulation of Influsplit SSW® 2002/2003 Versus the Standard Formulation of Influsplit SSW® 2002/2003 in Individuals Over 18 Years|Completed||Phase 3|239|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 14:03:30.210507|2017-02-18 14:03:30.210507
NCT00731016|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2013-07-04|||October 2008||2008-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid|Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid|Completed||Phase 2|15|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 14:03:30.311995|2017-02-18 14:03:30.311995
NCT00731003|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2014-11-11|||April 2009||2009-04-01|November 2014|2014-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||The Effect of Serotonergic Modulation on Intestinal Permeability and Visceral Hypersensitivity in Healthy Individuals and Irritable Bowel Syndrome (IBS) Patients|The Effect of Serotonergic Modulation on Intestinal Permeability and Visceral Hypersensitivity in Healthy Individuals and IBS Patients|Completed||N/A|60|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-02-18 14:03:30.40284|2017-02-18 14:03:30.40284
NCT00730990|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-12-02|||May 2008||2008-05-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase I, Healthy Volunteer Positron Emission Tomography Study|A8801007 A Phase I, Healthy Volunteer Qualification Of Ligand [C 11] PF 04621053 And Randomized Determination Of H3 Receptor Occupancy Of PF 03654746, Using PET|Completed||Phase 1|10|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:03:30.507901|2017-02-18 14:03:30.507901
NCT00730977|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2009-09-17|||August 2008||2008-08-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device|A Pilot Study to Investigate the Tolerability of Inhaled Dry Powder Mannitol (IDPM) Administered Via a Novel Dry Powder Inhaler Device in Healthy Individuals and Subjects With Bronchiectasis.|Completed||Phase 1/Phase 2|15|Actual|Pharmaxis||1|||f||||f||||||||||2017-02-18 14:03:30.608422|2017-02-18 14:03:30.608422
NCT00730964|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-05-09|2012-04-05||May 2008||2008-05-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|OSSAR||A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice.|A Post-marketing Surveillance Study of the Occurrence of Serious Adverse Reactions Among Patients Who Receive Optison in Routine Medical Practice|Completed||Phase 4|1039|Actual|GE Healthcare||1|||f||||t||||||||||2017-02-18 14:03:30.704779|2017-02-18 14:03:30.704779
NCT00730951|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-07-30|||June 2007||2007-06-01|July 2015|2015-07-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation|The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation|Completed||Phase 2|18|Actual|St. Michael's Hospital, Toronto||5|||f||||f||||||||||2017-02-18 14:03:30.928381|2017-02-18 14:03:30.928381
NCT00730938|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-07|||February 2008||2008-02-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery|The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery|Completed||N/A|45|Actual|Presbyterian Church East Africa Kikuyu Hospital||2|||f||||f||||||||||2017-02-18 14:03:31.016924|2017-02-18 14:03:31.016924
NCT00730925|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2014-02-24|2013-08-09||June 2008||2008-06-01|February 2014|2014-02-01||||January 2012|Actual|2012-01-01||Interventional|||Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients|A Phase II Single-arm Trial of BIBW 2992 in Demographically and Genotypically Selected NSCLC|Completed||Phase 2|41|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:03:31.126612|2017-02-18 14:03:31.126612
NCT00730912|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-09-01|2010-06-03||June 2008||2008-06-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539)|Protocol for Post-approval Commitment Study of Loratadine for PPK Analysis in Japanese Pediatric and Adults Patients|Completed||Phase 4|261|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:03:31.634858|2017-02-18 14:03:31.634858
NCT00730899|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2008-08-04|||May 2008||2008-05-01|August 2008|2008-08-01|June 2011|Anticipated|2011-06-01|January 2011|Anticipated|2011-01-01||Observational|||Association Study of Gene Polymorphisms With Cardiac Performance|Observational Association Study of G Protein Polymorphisms With Cardiac Performance in Coronary Artery Disease Patients Undergoing Coronary Artery Bypass Grafting|Unknown status|Recruiting|N/A|500|Anticipated|University Hospital, Essen|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 14:03:32.085931|2017-02-18 14:03:32.085931
NCT00730886|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-09-13|||July 2008||2008-07-01|September 2012|2012-09-01||||July 2011|Actual|2011-07-01||Interventional|||ExAblate Treatment of Uterine Fibroids for Fertility Enhancement|A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared With Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy|Terminated||Phase 4|2|Actual|InSightec||2|||f||||f||||||||||2017-02-18 14:03:32.171042|2017-02-18 14:03:32.171042
NCT00730873|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2008-08-07||||||August 2008|2008-08-01||||||||Interventional|||Fatty Liver and Obstructive Sleep Apnea|Fatty Liver and Obstructive Sleep Apnea|Completed||N/A|||Assaf-Harofeh Medical Center||1|||f||||||||||||||2017-02-18 14:03:32.277386|2017-02-18 14:03:32.277386
NCT00730860|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2012-11-23|||December 2008||2008-12-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE|Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation Associated With Postoperative Transhepatic Arterial Chemoembolization——a Prospective Randomized Clinical Trial|Unknown status|Recruiting|N/A|140|Anticipated|Southwest Hospital, China||2|||f||||t||||||||||2017-02-18 14:03:32.380323|2017-02-18 14:03:32.380323
NCT00730496|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2010-11-04|||January 2008||2008-01-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Injection of Day 2 Embryo Culture Supernatant Into the Uterine Cavity Didn't Improve Implantation and Pregnancy Rates|Injection of Day 2 Embryo Culture Supernatant Into the Uterine Cavity Didn't Improve Implantation and Pregnancy Rates of Day 3 Embryo Transfer: a Randomized Clinical Trial in Patients Who Underwent in Vitro Fertilization- Embryo Transfer.|Completed||Phase 1|90|Actual|Shen-Zhen City Maternity and Child Healthcare Hospital||2|||f||||t||||||||||2017-02-18 14:03:44.903802|2017-02-18 14:03:44.903802
NCT00730847|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2012-11-21|2012-11-21||September 2008||2008-09-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Evaluate Safety of a Vaccine Against Cervical Cancer (HPV-16/18 L1/AS04) in Healthy Filipino Females Aged 10 Yrs & Above|Post-marketing Surveillance Study to Monitor Safety of Vaccination (Accor to Prescribing Information) With GlaxoSmithKline Biologicals' Human Papillomavirus Vaccine (HPV-16/18 L1/AS04) in Healthy Filipino Females (3,000; Aged >/= 10 Yrs)|Terminated||Phase 4|596|Actual|GlaxoSmithKline||1||GSK received exemption from PDFDA on conduct of this post-marketing surveillance (PMS) study|f||||||||||||||2017-02-18 14:03:32.494571|2017-02-18 14:03:32.494571
NCT00730834|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2009-08-24|||June 2007||2007-06-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|CALM||Customized Acoustic Stimulation for Long Term Medical Benefit for the Relief of Tinnitus and Hyperacusis|Phase 4 Study of Use of a Customized Acoustic Stimulus to Reduce the Disturbing Symptoms of Tinnitus and Hyperacusis|Unknown status|Active, not recruiting|Phase 4|53|Actual|Neuromonics, Inc.||1|||f||||f||||||||||2017-02-18 14:03:32.792993|2017-02-18 14:03:32.792993
NCT00730821|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2009-08-20|||January 2007||2007-01-01|August 2009|2009-08-01||||August 2009|Actual|2009-08-01||Interventional|||Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors|A Combination Phase I Open Label Dose Escalation Study of Concomitant Administration of BIBW 2992 With BIBF 1120 in Patients With Advanced Solid Tumors|Completed||Phase 1|28|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-02-18 14:03:32.880619|2017-02-18 14:03:32.880619
NCT00730808|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2010-05-18|||December 2008||2008-12-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before Surgery|Efficacy and Tolerability of a Preoperative Oral Nutritional Supplement (PreOP Booster) vs. Placebo in Surgical Patients (Pilot Study)|Completed||N/A|20|Actual|Fresenius Kabi||2|||f||||||||||||||2017-02-18 14:03:32.97868|2017-02-18 14:03:32.97868
NCT00730795|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2008-08-07|||January 2004||2004-01-01|August 2008|2008-08-01||||December 2004|Actual|2004-12-01||Interventional|||Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults|A Phase I Open Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Recombinant Mycobacterium Tuberculosis Vaccine, Mtb72F With AS02A Adjuvant, When Administered Intramuscularly to Healthy PPD-Negative Adults|Completed||Phase 1|12|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:03:33.077793|2017-02-18 14:03:33.077793
NCT00730782|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2008-08-07|||November 2005||2005-11-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|September 2007|Actual|2007-09-01||Interventional|||Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers|Assessment of the Safety and Immunogenicity of Three Formulations of the Recombinant Pichia Pastoris Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]), Blood-Stage Malaria Vaccine in Healthy Dutch Adult Volunteers : a Phase 1, Single- Blind, Randomised, Dose-Escalating, Unicentre Trial|Completed||Phase 1|56|Actual|European Malaria Vaccine Initiative||3|||f||||f||||||||||2017-02-18 14:03:33.182602|2017-02-18 14:03:33.182602
NCT00730769|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2011-09-19|||March 2004||2004-03-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients|Phase IV.II Pilot Study of Treatment of Cytomegalovirus Infection With a Brief Induction With Ganciclovir i.v. Followed by Valganciclovir Oral in Solid Organ Transplant Patients.|Completed||Phase 4|21|Actual|Hospital Universitari de Bellvitge||1|||f||||t||||||||||2017-02-18 14:03:33.282388|2017-02-18 14:03:33.282388
NCT00730756|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2014-06-12|2009-10-13||March 2008||2008-03-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis|A Pilot, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Efficacy and Safety of Once-daily Intranasal Administration of Fluticasone Furoate Nasal Spray 110 mcg for 4 Weeks in Adults and Adolescents With Irritant (Non-Allergic) Rhinitis|Completed||Phase 2|102|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:03:33.397837|2017-02-18 14:03:33.397837
NCT00730743|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-02-02|||May 2008||2008-05-01|February 2015|2015-02-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Study on Clinical Outcome of Vascular Inflow Occlusion in Open Liver Resection|Open Liver Resection With or Without Vascular Inflow Occlusion: a Randomized Control Trial|Completed||N/A|126|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 14:03:34.088782|2017-02-18 14:03:34.088782
NCT00730730|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2016-03-07|2010-11-11||November 2007||2007-11-01|February 2016|2016-02-01|August 2012|Actual|2012-08-01|February 2009|Actual|2009-02-01||Interventional|||The Complete® Self-Expanding Stent and Stent Delivery System Registry|The Medtronic Complete® Self-Expanding Stent and Stent Delivery System Registry: a Non-randomized Prospective, Multicenter, Consecutive Registry|Completed||N/A|50|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-02-18 14:03:34.179947|2017-02-18 14:03:34.179947
NCT00730717|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2009-07-21|||May 2009||2009-05-01|July 2009|2009-07-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum|Multi Center, Open Label Pilot Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum|Withdrawn||Phase 2|20|Anticipated|Wright State University||2|||f||||t||||||||||2017-02-18 14:03:34.437144|2017-02-18 14:03:34.437144
NCT00730704|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-11-02|||May 2009||2009-05-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|HPV Acceptance||Acceptance of Human Papillomavirus Vaccination in Postpartum Women|Acceptance of Human Papillomavirus Vaccination in Postpartum Women|Completed||N/A|150|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 14:03:34.547163|2017-02-18 14:03:34.547163
NCT00730691|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2013-10-25|2013-10-25||June 2008||2008-06-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Fixed-Dose Study Comparing the Efficacy and Safety of 3 Doses of Lu AA21004 in Acute Treatment of Adults With Generalized Anxiety Disorder|Completed||Phase 3|781|Actual|Takeda||5|||f||||f||||||||||2017-02-18 14:03:34.65164|2017-02-18 14:03:34.65164
NCT00730678|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-08-11|||July 1998||1998-07-01|August 2016|2016-08-01|March 2034|Anticipated|2034-03-01|December 2033|Anticipated|2033-12-01||Observational|||Pharmacogenetic Determinants Of Treatment Response In Children|Pharmacogenetic Determinants Of Treatment Response In Children|Recruiting||N/A|8800|Anticipated|St. Jude Children's Research Hospital|||1||f||||f||||||Samples With DNA|"~     DNA or RNA for genetic testing will typically be obtained simultaneously with blood that is~     drawn for clinical reasons.~   "|||2017-02-18 14:03:37.516025|2017-02-18 14:03:37.516025
NCT00730665|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2011-07-12||2011-06-07|January 2008||2008-01-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)|A Parallel-Group, Randomized, Double-Blind, Multi-Center Dose Response Study To Evaluate The Efficacy And Safety Of PF-00885706, A 5-HT4 Receptor Partial Agonist, As Add-On Therapy To Esomeprazole For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD) Who Have A Poor Response To Proton Pump Inhibitor (PPI) Treatment|Terminated||Phase 2|81|Actual|Pfizer||5||This study has been placed on clinical hold by the sponsor due to operational reasons.|f||||t||||||||||2017-02-18 14:03:37.631469|2017-02-18 14:03:37.631469
NCT00730652|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2010-04-21|||May 2009||2009-05-01|April 2010|2010-04-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|MDX1411-02||Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma|A Phase I, Open-Label, Multicenter, Dose-escalation, Multidose Study of MDX-1411 Administered Every 7 Days in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma|Withdrawn||Phase 1|34|Anticipated|Bristol-Myers Squibb||1||Sponsor Decision|f||||f||||||||||2017-02-18 14:03:37.796637|2017-02-18 14:03:37.796637
NCT00730639|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2016-03-24|2016-02-22||January 2009||2009-01-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|February 2013|Actual|2013-02-01||Interventional|MDX1106-03|All treated participants.|A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies|A Phase 1, Open-Label, Multicenter, Multidose, Dose Escalation Study of BMS-936558 (Nivolumab) in Subjects With Selected Advanced or Recurrent Malignancies|Active, not recruiting||Phase 1|395|Actual|Bristol-Myers Squibb||5|||f||||t||||||||||2017-02-18 14:03:37.939652|2017-02-18 14:03:37.939652
NCT00730626|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2009-06-19|||August 2008||2008-08-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|PRO||Dose Response Study of a Fermented Yogurt on the Immune System and Gut Health|Dose Response Study of the Impact of a Yogurt Containing Bifidobacterium Lactis BB-12 and Lactobacillus Acidophilus LA-5 on the Immune System and Gut Health.|Completed||N/A|58|Actual|Laval University||3|||f||||f||||||||||2017-02-18 14:03:43.447765|2017-02-18 14:03:43.447765
NCT00730613|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2011-08-11|||February 2002||2002-02-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma|Pilot Feasibility and Safety Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Genetically-Modified Autologous CD8+ T Cell Clones|Completed||N/A|3|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:03:43.766876|2017-02-18 14:03:43.766876
NCT00730600|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2008-08-06|||June 2007||2007-06-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Effect of THAI Traditional Massage on Bone Markers|Acute Changes in Biochemical Markers of Bone Resorption and Formation After THAI Traditional Massage|Completed||N/A|30|Actual|Mahidol University||1|||f||||f||||||||||2017-02-18 14:03:43.860736|2017-02-18 14:03:43.860736
NCT00730587|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-01-06||||||January 2016|2016-01-01||||||||Observational|||Study of Body Composition Methodology in Young Children (InfantPod)|Development of a Body Composition Method for Infants and Children|Withdrawn||N/A|0|Actual|Arkansas Children's Hospital Research Institute|||1|This study will not be conducted. A new study is replacing this one.|f||||f||||||Samples Without DNA|"~     Urine will be collected from all study participants.~   "|||2017-02-18 14:03:43.971659|2017-02-18 14:03:43.971659
NCT00730574|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2014-09-08|||July 2008||2008-07-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|March 2011|Actual|2011-03-01||Interventional|||Examining B12 Deficiency Associated With C677T Mutation on MTHFR Gene in Terms of Commonness and Endothelial Function|Examining the Commonness of the C677T Mutation in the MTHFR Gene in Subjects With B12 Deficiency and the Influence of the B12 Deficiency Combined With the C677T Mutation on the MTHFR Gene on Endothelial Function.|Terminated||N/A|100|Actual|Carmel Medical Center||2||completed patient rectuitment|f||||f||||||||||2017-02-18 14:03:44.054214|2017-02-18 14:03:44.054214
NCT00730561|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-08-07|||March 2006||2006-03-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy|Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy in Patients With Diabetes Mellitus Type 2:A Randomized Controlled Trial.|Completed||N/A|20|Actual|Hospital Universitario Dr. Jose E. Gonzalez||2|||f||||f||||||||||2017-02-18 14:03:44.153586|2017-02-18 14:03:44.153586
NCT00730548|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2017-02-14|||November 2007||2007-11-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|April 2011|Actual|2011-04-01||Interventional|ConnectOptiVol||Compare Remote Patient Management and Standard Care in CRT-D and ICD-patients to Assess the Effect on Heart Failure|Clinical Evaluation to Assess the Effect of the Combination of a Pre-Defined Management Pathway to Reduce Fluid Overload in Cardiac Decompensation With Carelink Remote Management, Connexus Remote Telemetry and the OptiVol Early Warning System on Health Care Utilization|Completed||N/A|180|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||No||2017-02-18 14:03:44.255442|2017-02-18 14:03:44.255442
NCT00730535|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2011-04-21|||August 2006||2006-08-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients|Exploring Predictors of Symptoms Relapse After Discontinuation of Successful Treatment With a Tolterodine Prolonged Release Capsules (4 mg, Once Daily) in Overactive Bladder Patients: A Prospective Randomized Multicenter Trial|Completed||Phase 4|173|Actual|Samsung Medical Center||3|||f||||t||||||||||2017-02-18 14:03:44.366121|2017-02-18 14:03:44.366121
NCT00730522|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-07-31|||July 2008||2008-07-01|July 2012|2012-07-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence|Vigabatrin for Treatment of Methamphetamine Dependence: A Phase II Study|Terminated||Phase 2|57|Actual|Catalyst Pharmaceuticals, Inc.||2||To conserve remaining capital, Sponsor decided to terminate the study early.|f||||f||||||||||2017-02-18 14:03:44.492386|2017-02-18 14:03:44.492386
NCT00730509|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2008-08-04|||April 2004||2004-04-01|May 2008|2008-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Effects of 5-Methyltetrahydrofolate and Vitamin B12 Supplemetation on Red Cell Membrane in Children With Cystic Fibrosis|Preliminary Evidences of Active Form of Folic Acid and Vitamin B12 Supplementation to Ameliorate Cell Membrane in Children With Cystic Fibrosis|Completed||N/A|31|Actual|Universita di Verona||1|||f||||f||||||||||2017-02-18 14:03:44.603997|2017-02-18 14:03:44.603997
NCT00730483|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2014-10-01|||February 2009||2009-02-01|October 2014|2014-10-01|June 2015|Anticipated|2015-06-01|December 2014|Anticipated|2014-12-01||Interventional|||Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors|Treatment of Patients With Hepatic Neuroendocrine Metastases Using Drug-Eluting Bead Embolization|Unknown status|Active, not recruiting|N/A|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 14:03:45.001872|2017-02-18 14:03:45.001872
NCT00730470|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-07-28|||August 2008||2008-08-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors|A Phase I, Open-label, Dose-Finding Study to Assess the Safety and Tolerability of U3-1287 (AMG 888), a Human Monoclonal Antibody Targeting HER3 in Patients With Advanced Solid Tumors.|Completed||Phase 1|60|Anticipated|U3 Pharma GmbH||1|||f||||f||||||||||2017-02-18 14:03:45.119868|2017-02-18 14:03:45.119868
NCT00730457|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2014-09-22|||July 2008||2008-07-01|September 2014|2014-09-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine|A Two Part Study to Investigate the Safety and Immunogenicity of the VAX125 Influenza Vaccine in Healthy Adults Age 18-49 Years Part I: Phase I, Open-Label, Escalating Dose-Ranging Study Part II: Phase II, Double-Blind Placebo-Controlled Study|Completed||Phase 1|56|Actual|VaxInnate Corporation||1|||f||||t||||||||||2017-02-18 14:03:45.218119|2017-02-18 14:03:45.218119
NCT00730444|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2009-11-05||||||November 2009|2009-11-01||||||||Expanded Access|||Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma|Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma|Approved for marketing||N/A|||GE Healthcare|||||||||||||||||||2017-02-18 14:03:45.324705|2017-02-18 14:03:45.324705
NCT00730431|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-04-22|||July 2008||2008-07-01|April 2015|2015-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)|A Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IDX184 After Oral Administration in Healthy Subjects|Completed||Phase 1|48|Anticipated|Merck Sharp & Dohme Corp.||7|||f||||f||||||||||2017-02-18 14:03:45.422892|2017-02-18 14:03:45.422892
NCT00730418|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2010-08-25|||January 2007||2007-01-01|August 2010|2010-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia|A Prospective Study for the Effects of Chronic Use of Doxazosin on Alpha 1-adrenergic Receptors in Men With Benign Prostatic Hyperplasia|Completed||N/A|25|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-02-18 14:03:45.522069|2017-02-18 14:03:45.522069
NCT00730405|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-08-09||2012-06-28|July 2008||2008-07-01|August 2012|2012-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the Efficacy and Safety of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis|Completed||Phase 2|584|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-02-18 14:03:45.649614|2017-02-18 14:03:45.649614
NCT00730392|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-05|||October 2002||2002-10-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||Etanercept in New Onset Type 1 Diabetes|"ENBREL® (Etanercept) Administration to Patients Newly Diagnosed With Type 1 Diabetes Mellitus: Feasibility-Safety Study (Study)"|Completed||Phase 1/Phase 2|18|Actual|University at Buffalo||1|||f||||t||||||||||2017-02-18 14:03:45.877823|2017-02-18 14:03:45.877823
NCT00730379|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-02-09|||July 2008||2008-07-01|February 2015|2015-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004)|A Phase I Study of Ridaforolimus (MK8669) and MK0646 in Patients With Advanced Cancer|Completed||Phase 1|87|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:03:45.982304|2017-02-18 14:03:45.982304
NCT00730366|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2010-09-12|||March 2004||2004-03-01|September 2010|2010-09-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa|New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa.|Completed||Phase 3|2766|Actual|Institute of Tropical Medicine, Belgium||3|||f||||f||||||||||2017-02-18 14:03:46.095065|2017-02-18 14:03:46.095065
NCT00730353|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2011-04-21|||August 2008||2008-08-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Sutent + Taxol for Advanced Esophageal Cancer|A Phase II Study of Sunitinib Malate (Sutent®) With Paclitaxel (Taxol®) in Patients With Advanced Esophageal Cancer|Completed||Phase 2|28|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-02-18 14:03:46.216304|2017-02-18 14:03:46.216304
NCT00730340|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2010-06-14|||August 2008||2008-08-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Closure Method Study Following Tonsillectomy in Children|Decreased Morbidity With Closure of the Tonsillar Fossae|Completed||Early Phase 1|14|Actual|University of Oklahoma||2|||f||||f||||||||||2017-02-18 14:03:46.494342|2017-02-18 14:03:46.494342
NCT00730327|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-10-08|2015-08-27||June 2008||2008-06-01|October 2015|2015-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||The baseline analysis population consisted of the Intent-to-Treat (ITT) population. All baseline characteristics were calculated at the screening visit.|A Study of BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese Subjects|Safety and Effectiveness of the BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese Subjects|Completed||N/A|448|Actual|Apollo Endosurgery, Inc.||2|||f||||f||||||||||2017-02-18 14:03:46.614435|2017-02-18 14:03:46.614435
NCT00730314|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-06-21|||August 2008||2008-08-01|June 2016|2016-06-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells|Phase I/II Trial Of Hematopoietic Stem Cell Transplant (HSCT) For Children With A Genetic Disease Of Blood Cells Without An HLA-Matched Sibling Donor|Completed||Phase 1/Phase 2|25|Actual|Children's Hospital Los Angeles||2|||f||||t||||||||No||2017-02-18 14:03:47.718562|2017-02-18 14:03:47.718562
NCT00730106|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2010-10-18|||May 2008||2008-05-01|October 2010|2010-10-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Observational|||Endoscopic Findings in Patients With Typical Gastroesophageal Reflux Disease (GERD) Symptoms|Endoscopic Findings in Taiwan Patients Presenting With Characteristic Symptoms of Gastroesophageal Reflux Disease|Completed||N/A|1000|Anticipated|Lotung Poh-Ai Hospital|||2||f||||t||||||||||2017-02-18 14:03:51.0701|2017-02-18 14:03:51.0701
NCT00730301|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-05|||July 2007||2007-07-01|August 2008|2008-08-01||||September 2008|Anticipated|2008-09-01||Interventional|EUROPT||EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous Emphysema|A Multi-Center, Prospective, Clinical Trial Designed to Study the Efficacy of One-Way Valve Implantation Based on a New Treatment Algorithm in Patients With Heterogeneous Emphysema|Unknown status|Recruiting|Phase 4|20|Anticipated|LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology||1|||f||||t||||||||||2017-02-18 14:03:47.832396|2017-02-18 14:03:47.832396
NCT00730288|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2012-04-13|||August 2006||2006-08-01|April 2012|2012-04-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Interventional|||Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects|Safety of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects Previously Immunised With an Investigational Dengue or Yellow Fever Vaccine|Completed||Phase 2|35|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 14:03:47.932232|2017-02-18 14:03:47.932232
NCT00730275|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-08-07|2011-12-21||July 2008||2008-07-01|August 2015|2015-08-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)|A Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sitagliptin in Adolescents|Completed||Phase 1|35|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 14:03:48.049532|2017-02-18 14:03:48.049532
NCT00730262|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2009-12-29|||August 2008||2008-08-01|December 2009|2009-12-01|June 2010|Anticipated|2010-06-01|April 2010|Anticipated|2010-04-01||Interventional|||Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme|A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme|Terminated||Phase 2|40|Anticipated|Thallion Pharmaceuticals||1||Lack of efficacy|f||||f||||||||||2017-02-18 14:03:48.59917|2017-02-18 14:03:48.59917
NCT00730249|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2010-01-12|||September 2008||2008-09-01|January 2010|2010-01-01||||January 2010|Actual|2010-01-01||Interventional|QUMEA||Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA|Quality Assurance of Administering Methylphenidate in Adults With ADHD|Completed||Phase 3|150|Anticipated|Medice Arzneimittel Pütter GmbH & Co KG||2|||f||||f||||||||||2017-02-18 14:03:48.710895|2017-02-18 14:03:48.710895
NCT00730236|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2014-01-15|2013-01-18||December 2007||2007-12-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|September 2010|Actual|2010-09-01||Interventional|||A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)|A Phase III Study of Microsomal Triglyceride Transfer Protein (MTP) Inhibitor AEGR-733 in Patients With Homozygous Familial Hypercholesterolemia on Current Lipid-lowering Therapy|Completed||Phase 3|29|Actual|Aegerion Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-02-18 14:03:48.915376|2017-02-18 14:03:48.915376
NCT00730223|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2013-02-12|||March 2004||2004-03-01|February 2013|2013-02-01|August 2009|Actual|2009-08-01|March 2006|Actual|2006-03-01||Interventional|||Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors|Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors|Completed||Phase 1|33|Actual|Vanderbilt University||1|||f||||t||||||||||2017-02-18 14:03:49.53118|2017-02-18 14:03:49.53118
NCT00730210|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-10-23|||June 2008||2008-06-01|October 2012|2012-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|HypoPTH||Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life|Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life|Completed||Phase 2|62|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:03:49.625725|2017-02-18 14:03:49.625725
NCT00730197|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2008-08-07|||February 2007||2007-02-01|August 2008|2008-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg|Single-Dose Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets(40 mg; Mylan) and Sular® Extended Release Tablets (40 mg; First Horizon) in Healthy Volunteers|Completed||Phase 1|48|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:03:49.738759|2017-02-18 14:03:49.738759
NCT00730184|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-07|||February 2007||2007-02-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Does Potassium Bicarbonate Improve the Effect of Dietary Protein on Bone and Muscle?|Does Potassium Bicarbonate Improve the Effect of Dietary Protein on Bone and Muscle?|Completed||N/A|23|Actual|Tufts University||2|||f||||f||||||||||2017-02-18 14:03:50.047658|2017-02-18 14:03:50.047658
NCT00730171|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2013-01-07|||September 2008||2008-09-01|January 2013|2013-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation|An Open-label, Long-term Safety Study of Oral Linaclotide Administered to Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation|Completed||Phase 3|1743|Actual|Ironwood Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 14:03:50.16369|2017-02-18 14:03:50.16369
NCT00730158|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2016-02-16|||December 2008||2008-12-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer|A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer|Recruiting||Phase 2|165|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:03:50.38177|2017-02-18 14:03:50.38177
NCT00730145|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2010-02-16|||September 2008||2008-09-01|February 2010|2010-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis|A Phase I, Open-Label, Single Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of PD-0332334 In Subjects Receiving Chronic Hemodialysis|Completed||Phase 1|8|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:03:50.495909|2017-02-18 14:03:50.495909
NCT00730132|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-06-23|2010-06-30||January 2008||2008-01-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)|Observational Study of Approaches to Lipid-lowering Therapy in Russian Patients With Coronary Heart Disease (<<Treat to Goal>>)|Completed||N/A|712|Actual|Merck Sharp & Dohme Corp.|||3||f||||t||||||||||2017-02-18 14:03:50.6073|2017-02-18 14:03:50.6073
NCT00730119|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-04-02|||October 2001||2001-10-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Observational|||Evaluation Of The GE Monitor Product Line|Evaluation Of The GE Monitor Product Line|Completed||N/A|1500|Anticipated|GE Healthcare|||3||f||||f||||||||||2017-02-18 14:03:50.982502|2017-02-18 14:03:50.982502
NCT00730080|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2014-12-08|||July 2008||2008-07-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|March 2015|Anticipated|2015-03-01||Observational|||Sapropterin in Individuals With Phenylketonuria|Effects of Sapropterin on Brain and Cognition in Individuals With Phenylketonuria|Unknown status|Active, not recruiting|N/A|44|Actual|Washington University School of Medicine|||2||f||||f||||||||||2017-02-18 14:03:51.259711|2017-02-18 14:03:51.259711
NCT00730067|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-08-22|||June 2012||2012-06-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension|Sildenafil for COPD-associated Pulmonary Hypertension. A Randomized Double Blinded Placebo Controlled Study.|Withdrawn||Phase 4|0|Actual|University of Aarhus||2||As a single center, it was not possible to recruit enough patients with pulmonary hypertension|f||||t||||||||||2017-02-18 14:03:51.382614|2017-02-18 14:03:51.382614
NCT00730054|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2011-07-03|||February 2005||2005-02-01|August 2008|2008-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|Remiclon||Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers|Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers|Completed||Phase 1/Phase 2|12|Actual|Oslo University Hospital||4|||f||||f||||||||||2017-02-18 14:03:51.494171|2017-02-18 14:03:51.494171
NCT00730041|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2010-01-06|2009-08-07||November 2007||2007-11-01|January 2010|2010-01-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|Pillar-CPAP||Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea|Randomized Placebo-Controlled Study of the Pillar® Palatal Implant System With CPAP|Terminated||Phase 4|51|Actual|Medtronic Xomed, Inc.|The study was underpowered for this comparison as only half the planned enrollment occurred. Also, changes occurred with the sleep stage and position as well as the masks used between the two PSGs, which may have affected some of the results.|2||Medtronic acquisition of Restore Medical, business decision|f||||f||||||||||2017-02-18 14:03:51.721122|2017-02-18 14:03:51.721122
NCT00730028|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-02-18|2016-02-18||April 2009||2009-04-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||All participants enrolled in the protocol are included in the baseline analysis population.|Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus|Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 2|1310|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 14:03:52.222626|2017-02-18 14:03:52.222626
NCT00730015|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-12-19|2012-09-28||August 2008||2008-08-01|December 2012|2012-12-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Trial of Linaclotide in Patients With Chronic Constipation|A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide Administered Orally for 12 Weeks Followed by a 4-Week Randomized Withdrawal Period in Patients With Chronic Constipation|Completed||Phase 3|643|Actual|Ironwood Pharmaceuticals, Inc.||3|||f||||||||||||||2017-02-18 14:03:53.440268|2017-02-18 14:03:53.440268
NCT00730002|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-12-10|||March 2008||2008-03-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|September 2014|Actual|2014-09-01||Interventional|||Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus|Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus|Completed||N/A|66|Actual|University of Michigan||4|||f||||f||||||||||2017-02-18 14:03:54.29878|2017-02-18 14:03:54.29878
NCT00729989|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2008-08-07|||August 2008||2008-08-01|August 2008|2008-08-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Efficacy and Safety of Gastric Suctioning During Neonatal Resuscitation|Efficacy and Safety of Gastric Suctioning During Neonatal Resuscitation- A Randomized Clinical Trial|Unknown status|Not yet recruiting|N/A|5000|Anticipated|University of Iowa||2|||f||||t||||||||||2017-02-18 14:03:54.408548|2017-02-18 14:03:54.408548
NCT00729976|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2011-04-04|||September 2008||2008-09-01|March 2010|2010-03-01|June 2011|Anticipated|2011-06-01|December 2010|Anticipated|2010-12-01||Interventional|||Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.|Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.|Unknown status|Recruiting|Phase 4|40|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 14:03:54.507973|2017-02-18 14:03:54.507973
NCT00729963|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2013-04-09|||January 2004||2004-01-01|April 2013|2013-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients|Efficacy of Sibutramine-induced Weight Loss vs. Continuous Positive Airway Pressure (CPAP) in the Treatment of Obese Patients With Obstructive Sleep Apnea|Completed||Phase 4|45|Actual|Laval University||2|||f||||t||||||||||2017-02-18 14:03:54.604927|2017-02-18 14:03:54.604927
NCT00729950|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2010-04-23|||July 2003||2003-07-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|October 2005|Actual|2005-10-01||Interventional|||Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma|An Open-Label Pharmacokinetic and Safety Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma|Completed||Phase 1|92|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:03:54.69289|2017-02-18 14:03:54.69289
NCT00729937|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2015-01-29|2014-04-17||April 2009||2009-04-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional||The baseline analysis population is the per protocol population. All participants who met enrollment criteria, had none of the exclusion criteria, completed at least 75% of the first 5 days of antimicrobial therapy, and had physical follow-up at the Test of Cure (TOC) visit were included in the per protocol population.|"Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus STOP MRSA"|"Strategies Using Off-Patent Antibiotics for Methicillin-Resistant Staphylococcus Aureus (STOP MRSA) - A Phase IIB, Multi-Center, Randomized, Double-Blind Clinical Trial"|Completed||Phase 2/Phase 3|2265|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 14:03:54.807681|2017-02-18 14:03:54.807681
NCT00729924|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2015-03-02|2014-05-27||August 2008||2008-08-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|February 2011|Actual|2011-02-01||Interventional|||Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid|Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid|Completed||Phase 2/Phase 3|40|Actual|Vanderbilt University|There were no limitations to this trial.|1|||f||||f||||||||||2017-02-18 14:03:58.976774|2017-02-18 14:03:58.976774
NCT00006511|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-20|2016-02-17|||September 2000||2000-09-01|January 2006|2006-01-01|August 2005|Actual|2005-08-01|||||Observational|||Chromosome 5Q Gene Variants and Asthma-Related Traits||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:27.915285|2017-02-18 18:12:27.915285
NCT00729911|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-10-17|||October 2008||2008-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|||Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD|Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICD/CRTD|Active, not recruiting||Phase 4|120|Anticipated|Texas Cardiac Arrhythmia Research Foundation||2|||f||||f||||||||||2017-02-18 14:03:59.285656|2017-02-18 14:03:59.285656
NCT00729898|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2016-10-27|||March 2008||2008-03-01|October 2016|2016-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes|Safety of NovoMix® 30 (Biphasic Insulin Aspart) Treatment in Patients With Type 2 Diabetes|Completed||N/A|243|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:03:59.388803|2017-02-18 14:03:59.388803
NCT00729885|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2008-08-07|||November 2006||2006-11-01|August 2008|2008-08-01||||August 2008|Anticipated|2008-08-01||Interventional|||Visual Feedback Goggle for Positional Vertigo Treatment|Visual Feedback Goggle For The Treatment Of Benign Paroxysmal Positional Vertigo in a Randomized Single-Blind Study|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|Vertigone Inc.||2|||f||||f||||||||||2017-02-18 14:03:59.495287|2017-02-18 14:03:59.495287
NCT00729872|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2009-09-09|||July 2008||2008-07-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis|A Phase 2a Randomized, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects With Moderately Active Ulcerative Colitis|Completed||Phase 1/Phase 2|60|Anticipated|ActoGeniX N.V.||6|||f||||t||||||||||2017-02-18 14:03:59.60498|2017-02-18 14:03:59.60498
NCT00729859|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-09-12|2011-06-02||December 2008||2008-12-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|CEP-1||CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men|Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men Title Changed With New Protocol (12/14/09): Hormonal Regulation of HDL-C in Men|Completed||Phase 2|31|Actual|University of Washington||3|||f||||f||||||||||2017-02-18 14:03:59.83545|2017-02-18 14:03:59.83545
NCT00729846|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2016-03-21|2016-02-01||May 2006||2006-05-01|March 2016|2016-03-01|July 2009|Actual|2009-07-01|August 2008|Actual|2008-08-01||Interventional|||Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)|Combination Bevacizumab and Verteporfin (Standard and Reduced Fluence)in the Treatment of Neovascular Age-Related Macular Degeneration|Completed||Phase 2|22|Actual|California Retina Consultants||2|||f||||f||||||||||2017-02-18 14:04:01.068492|2017-02-18 14:04:01.068492
NCT00729833|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2014-05-21|2014-04-11||September 2008||2008-09-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|August 2011|Actual|2011-08-01||Interventional||Full Analysis Set: All enrolled participants who received at least 1 dose of figitumumab plus sunitinib.|Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors|Phase 1, Open Label, Sequential Cohort, Dose Escalation Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors|Terminated||Phase 1|45|Actual|Pfizer|This study was terminated prematurely. Subsequently, ADA samples were not assayed and the pharmacokinetics of sunitinib plus its metabolite were not analyzed.|1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:04:01.399956|2017-02-18 14:04:01.399956
NCT00729820|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2008-08-07|||August 2008||2008-08-01|June 2008|2008-06-01||||||||Observational|||The Influence of Personality on Two Aspects of Cognitive Performance: Processing Speed, and Accuracy.|The Influence of Personality on Two Aspects of Cognitive Performance: Processing Speed, and Accuracy.|Unknown status|Not yet recruiting|N/A|30|Anticipated|BeerYaakov Mental Health Center|||1||f||||||||||||||2017-02-18 14:04:02.727489|2017-02-18 14:04:02.727489
NCT00729807|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-07|2016-08-30|2015-12-17||July 2008||2008-07-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma|Treatment of Melanoma With Wild-type p53 and Detectable S100B Using Pentamidine: a Phase II Trial With Correlative Biomarker Endpoints|Completed||Phase 2|6|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 14:04:02.789583|2017-02-18 14:04:02.789583
NCT00729794|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-11-18|||September 2008||2008-09-01|November 2016|2016-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|VSE-2||Vasopressin, Epinephrine, and Steroids for Cardiac Arrest|Vasopressin, Epinephrine, and Corticosteroids for Inhospital Cardiac Arrest: A Multicenter Randomized Controlled Trial|Completed||Phase 3|300|Actual|University of Athens||2|||f||||t||||||||||2017-02-18 14:04:03.046087|2017-02-18 14:04:03.046087
NCT00729781|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2011-12-01|2011-08-23||April 2008||2008-04-01|December 2011|2011-12-01|January 2011|Actual|2011-01-01|November 2009|Actual|2009-11-01||Interventional|NVC||Study of Polyester Implants for the Treatment of External Nasal Valve Collapse (NVC)|Open Label, Baseline Controlled Study to Evaluate the Use of Polyethylene Terephthalate (PET) Implants for the Treatment of External Nasal Valve Collapse and Cosmetic Contour Deformity|Terminated||Phase 1/Phase 2|45|Actual|Medtronic Xomed, Inc.||1||Strategic Business Decision|f||||f||||||||||2017-02-18 14:04:03.17586|2017-02-18 14:04:03.17586
NCT00729768|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-02|2009-03-12||||||March 2009|2009-03-01||||||||Interventional|||A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation|A Phase II/III, Randomized, Open-Label, Active Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Efalizumab Compared With Cyclosporine, Both in Combination With Mycophenolate Mofetil and Corticosteroids, As an Immunosuppressant Regimen in De Novo Renal Transplantation|Withdrawn||Phase 2/Phase 3|200|Anticipated|Genentech, Inc.||2|||f||||||||||||||2017-02-18 14:04:03.635612|2017-02-18 14:04:03.635612
NCT00729755|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-06-27|||August 2008||2008-08-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Creatine Augmentation Treatment in Major Depressive Disorder Subjects|Efficacy and Safety of Augmentation of Creatine for the Patients With Major Depressive Disorder|Completed||N/A|59|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:04:03.739335|2017-02-18 14:04:03.739335
NCT00729742|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2016-04-01|||February 2009||2009-02-01|April 2016|2016-04-01|May 2011|Actual|2011-05-01|June 2010|Actual|2010-06-01||Interventional|||Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008)|A Phase 1b, Multicenter Trial to Evaluate Molecular Determinants of Response to Erlotinib and MK0646 in Advanced Non-Small-Cell Lung Cancer|Completed||Phase 1|49|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:04:03.846379|2017-02-18 14:04:03.846379
NCT00729729|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-03|2012-08-27|||July 2008||2008-07-01|August 2008|2008-08-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|PCA 1||Pharmacokinetic Study for PCA Derivate Formulations|Phase 4, Three Way Cross-over, Pharmacokinetic Study for PCA Derivate Formulations in Healthy Subjects|Completed||Phase 4|30|Anticipated|Hadassah Medical Organization||3|||f||||t||||||||||2017-02-18 14:04:03.952445|2017-02-18 14:04:03.952445
NCT00729716|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-04-16|||May 2008||2008-05-01|March 2012|2012-03-01|May 2015|Anticipated|2015-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Comparison of BioCart™II With Microfracture for Treatment of Cartilage Defects of the Femoral Condyle|Phase II Study to Investigate the Efficacy and Safety of BioCart™II in the Treatment of Symptomatic Cartilage Defects of the Femoral Condyle in Comparison With Microfracture|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|ProChon Biotech Ltd||2|||f||||f||||||||||2017-02-18 14:04:04.04821|2017-02-18 14:04:04.04821
NCT00729703|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2015-01-12|||June 2006||2006-06-01|January 2015|2015-01-01|October 2013|Actual|2013-10-01|December 2011|Actual|2011-12-01||Interventional|OPTION||Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications|Optimal Antitachycardia Therapy in ICD Patients Without Pacing Indications|Completed||Phase 4|462|Actual|LivaNova||2|||f||||t||||||||||2017-02-18 14:04:04.179356|2017-02-18 14:04:04.179356
NCT00729690|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-11-20|2012-10-18||August 2008||2008-08-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement|Effects of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Total Knee Replacement (TKA)|Completed||Phase 3|48|Actual|Rush University Medical Center||3|||f||||f||||||||||2017-02-18 14:04:04.513076|2017-02-18 14:04:04.513076
NCT00729677|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-10-05|2009-09-15||June 2005||2005-06-01|October 2015|2015-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Observational|||Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin|Prevalence of Delayed Nausea and Vomiting in Patients Being Treated With Oxaliplatin-based Regimens (mFOLFOX6 or FOLFOX7) for Colorectal Cancer|Completed||N/A|64|Actual|Beth Israel Medical Center|This was a convenience sample of patients seen at 2 medical centers. Subjects were restricted to those who could complete Quality of Life forms in Spanish or English.||1||f||||f||||||||||2017-02-18 14:04:05.013495|2017-02-18 14:04:05.013495
NCT00729664|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2015-09-03|||February 2009||2009-02-01|September 2015|2015-09-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Anti-PDL1||Multiple Ascending Dose (MDX1105-01)|A Phase 1, Multidose Study of BMS-936559 (MDX-1105) Administered Every 14 Days in Subjects With Selected Advanced or Recurrent Solid Tumors|Completed||Phase 1|281|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-02-18 14:04:05.298315|2017-02-18 14:04:05.298315
NCT00729651|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-07-21|2010-02-05||March 2008||2008-03-01|July 2015|2015-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)|A Prospective, Randomized, Open-label, Active-controlled Study to Evaluate the Efficacy and Safety of Fosamax Plus D in Postmenopausal Osteoporotic Women|Completed||Phase 4|343|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:04:05.443956|2017-02-18 14:04:05.443956
NCT00729638|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2014-08-07|||June 2008||2008-06-01|August 2014|2014-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma|An Open-Label Phase I Study of the Safety of and Efficacy of RAD001 in Combination With Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma|Completed||Phase 1|28|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:04:06.522128|2017-02-18 14:04:06.522128
NCT00729625|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2016-05-20|||April 2005||2005-04-01|April 2005|2005-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Air Muscle and Task Practice in Upper Limb Stroke Rehab|Air Muscle and Task Practice in Upper Limb Stroke Rehab|Completed||Early Phase 1|24|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 14:04:06.640264|2017-02-18 14:04:06.640264
NCT00729612|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-04-28|2016-04-28||August 2008||2008-08-01|April 2016|2016-04-01||||December 2011|Actual|2011-12-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|Phase II Trial of Abraxane Plus Carboplatin for Advanced NSCLC for Patients at Risk of Bleeding From VEGF Directed Therapies|Active, not recruiting||Phase 2|63|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:04:06.730897|2017-02-18 14:04:06.730897
NCT00729599|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2009-03-03|||July 2008||2008-07-01|March 2009|2009-03-01||||August 2008|Actual|2008-08-01||Interventional|Cepacol Teen||Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.|Single Site Study, Phase III, for Safety Dermatological Evaluation: Basic Acceptability With Odontological Follow up - Cepacol Teen.|Completed||Phase 3|31|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:04:06.98856|2017-02-18 14:04:06.98856
NCT00729586|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2017-01-31|||September 2008||2008-09-01|January 2017|2017-01-01||||January 2017|Anticipated|2017-01-01||Interventional|||Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer|A Randomized Phase II Trial of Temsirolimus (NCI-Supplied Agent, NSC # 683864) or the Combination of Hormonal Therapy Plus Temsirolimus in Women With Advanced, Persistent, or Recurrent Endometrial Carcinoma|Active, not recruiting||Phase 2|84|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 14:04:07.082735|2017-02-18 14:04:07.082735
NCT00729573|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-03-08|||November 2009||2009-11-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Bone Mineral Density Substudy - An Ancillary Study to MTN-003|Phase 2B Safety and Effectiveness Study of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate Tablet and Emtricitabine/Tenofovir Disoproxil Fumarate Tablet for the Prevention of HIV Infection in Women|Completed||N/A|518|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Urine and blood samples~   "|||2017-02-18 14:04:07.457244|2017-02-18 14:04:07.457244
NCT00729560|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2014-09-05|2014-05-27||July 2008||2008-07-01|September 2014|2014-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|PCOS||Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome|Determination if Pharmacologic Blockade of Androgen Action Decreases Renal Clearance of D-Chiro-Inositol (DCI), Increases the Circulating Concentration of DCI, and Enhances Insulin-Stimulated Release of the D-chiro-inositol-containing Inositolphosphoglycan (DCI-IPG) Mediator in Obese Women With Polycystic Ovary Syndrome (PCOS)|Terminated||N/A|8|Actual|Virginia Commonwealth University||2||Lack of recruitment|f||||f||||||||||2017-02-18 14:04:07.5819|2017-02-18 14:04:07.5819
NCT00729534|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2017-01-24|||August 1, 2008||2008-08-01|May 29, 2013|2013-05-29|May 29, 2013||2013-05-29|||||Observational|||Research Participants Perceptions of Their Experience in Clinical Studies|Research Participant Perception of Care Project: Part 1: Focus Groups of Research Participants and Research Professionals to Identify Key Dimensions of the Research Participant Experience|Completed||N/A|14|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:04:07.954872|2017-02-18 14:04:07.954872
NCT00729521|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-02-03|2014-09-15||July 2007||2007-07-01|February 2015|2015-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional||Average annual population over residents over 65 years of age.|Dissemination of Injury Interventions|Facilitating Dissemination of Injury Interventions: A Randomized Controlled Trial|Completed||N/A|35037|Actual|Medical College of Wisconsin|E coding of injuries can be incomplete, but 99.7% of records with a diagnostic code in the range 800-995.89 had an E code. We may have included more than one admission for the same fall, but we excluded admissions from an acute care facility.|3|||f||||f||||||||||2017-02-18 14:04:08.216421|2017-02-18 14:04:08.216421
NCT00729508|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2009-07-07|||August 2008||2008-08-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects|A Double-Blind, Randomised, Placebo-Controlled Study to Evaluate the Efficacy of Cat-PAD in Cat Allergic Subjects Following Challenge to Cat Allergen in an Environmental Exposure Chamber.|Completed||Phase 2|120|Anticipated|Circassia Limited||5|||f||||f||||||||||2017-02-18 14:04:08.617191|2017-02-18 14:04:08.617191
NCT00729495|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2009-05-12|||July 2008||2008-07-01|May 2009|2009-05-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib|Phase I, Randomized, Open-Label, 2-Way Crossover Study to Evaluate Relative Bioavailability of Single Oral Dose of Celecoxib Administered as Marketed Product, or Overencapsulated Capsule in Healthy Volunteers|Completed||Phase 1|80|Anticipated|POZEN||2|||f||||f||||||||||2017-02-18 14:04:08.728341|2017-02-18 14:04:08.728341
NCT00729482|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2013-12-31|2013-12-31||July 2008||2008-07-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|September 2011|Actual|2011-09-01||Interventional||Baseline analysis was based on all enrolled patients.|RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment|A Phase II Study of RAD001 (Everolimus) in Patients With Fluoropyrimidine and Platinum-refractory Advanced Gastric Cancer|Completed||Phase 2|54|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 14:04:08.84225|2017-02-18 14:04:08.84225
NCT00729469|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2013-05-21|2013-03-19||July 2008||2008-07-01|March 2013|2013-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity|Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity, Symptoms of Vulvar and Vaginal Atrophy (VVA), Associated With Menopause: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing Oral Ospemifene 60 mg Dose With Placebo in Postmenopausal Women|Completed||Phase 3|919|Actual|Shionogi Inc.||2|||||||||||||||||2017-02-18 14:04:09.105343|2017-02-18 14:04:09.105343
NCT00729456|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2008-08-04|||April 2003||2003-04-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|April 2006|Actual|2006-04-01||Interventional|ESP||Evaluation of Education in the Secondary Prevention of Foot Ulceration in Diabetes|Evaluation of Education in the Secondary Prevention of Foot Ulceration in Diabetes|Completed||N/A|172|Actual|Nottingham University Hospitals NHS Trust||2|||f||||f||||||||||2017-02-18 14:04:10.026921|2017-02-18 14:04:10.026921
NCT00729443|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2008-11-10|||July 2008||2008-07-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|SAD||Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy Volunteers|A Single-Centre, Placebo-Controlled, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD3241 Following Administration of Single Ascending (Part A) and Fractionated Ascending (Part B) Oral Doses to Young Healthy Volunteers|Completed||Phase 1|64|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:04:10.134688|2017-02-18 14:04:10.134688
NCT00729430|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2015-01-26|||August 2008||2008-08-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|October 2013|Actual|2013-10-01||Interventional|Omega-REMODEL||Evaluating a Heart Magnetic Resonance Imaging (MRI) Procedure and the Effect of Fish Oil Supplementation in People Who Have Recently Had a Heart Attack (The PROSPECT-CMR Study)|Prognostic, Anti-arrhythmic, and Ventricular Remodeling Effects of High Dose Fish Oil in Patients With a Recent Myocardial Infarction|Completed||Phase 3|374|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 14:04:10.224514|2017-02-18 14:04:10.224514
NCT00729417|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2008-08-06|||August 2008||2008-08-01|August 2008|2008-08-01||||August 2010|Anticipated|2010-08-01||Observational|||Obstetrical Risk Factors for the Development of Urinary and/or Fecal Incontinence|Obstetrical Risk Factors for the Development of Urinary and/or Fecal Incontinence|Unknown status|Not yet recruiting|N/A|300|Anticipated|Maaynei Hayesha Medical Center|||1||f||||f||||||||||2017-02-18 14:04:10.334873|2017-02-18 14:04:10.334873
NCT00729404|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2014-11-27|||August 2008||2008-08-01|November 2014|2014-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene|Multicenter, Open-label, Randomized, Uncontrolled Study to Evaluate Inhibition of Ovulation of Two Transdermal Patch Formulations Containing 0.55 mg EE and Either 1.05 or 2.1 mg GSD in Healthy Young Female Vol. Over a Period of 3 Treatment Cycles|Terminated||Phase 2|17|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:04:10.398178|2017-02-18 14:04:10.398178
NCT00729391|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2011-05-12|||September 2008||2008-09-01|April 2011|2011-04-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|WC-WHC||Women-Focused HIV Prevention in the Western Cape|Women-Focused HIV Prevention in the Western Cape|Unknown status|Active, not recruiting|Phase 3|720|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||f||||||||||2017-02-18 14:04:10.513446|2017-02-18 14:04:10.513446
NCT00729378|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-02-24|||April 2007||2007-04-01|February 2012|2012-02-01|August 2012|Anticipated|2012-08-01|April 2012|Anticipated|2012-04-01||Interventional|||Jump-In - Building Better Bones|Exercise and Bone Development in Young Girls|Unknown status|Recruiting|N/A|400|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 14:04:10.6221|2017-02-18 14:04:10.6221
NCT00729170|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2012-06-29|||October 2006||2006-10-01|June 2012|2012-06-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||Milk Supplementation and Energy Balance.|Impact of Milk Supplementation on Body Composition, Bone Density and Satiety in Women Following a Weight Loss Program.|Completed||N/A|41|Actual|Laval University||1|||f||||t||||||||||2017-02-18 14:04:13.962408|2017-02-18 14:04:13.962408
NCT00729365|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2015-02-24|2014-12-30||July 2008||2008-07-01|February 2015|2015-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PREVENTKD||PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)|Nocturnal Hypertension and Prevention of Microalbuminuria in Type 1 Diabetes|Terminated||Phase 3|65|Actual|Northwestern University|"The study was terminated prematurely because of new information from the literature from other studies showing that this study could not be successful.~Only 59 patients were screened and consented and 46 were found acceptable who were randomized."|3||Data from other studies showed that study could not be completef successfully|f||||t||||||||||2017-02-18 14:04:10.716974|2017-02-18 14:04:10.716974
NCT00729352|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2014-09-25|||August 2008||2008-08-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|October 2011|Actual|2011-10-01||Observational|||Lung Mucus Hypersecretion and NQO1|Dependency of O3-Induced Lung Mucus Hypersecretion on NQO1|Completed||N/A|60|Actual|National Institute of Environmental Health Sciences (NIEHS)|||2||f||||f||||||Samples With DNA|"~     Bronchoalveolar lavage specimens.~   "|||2017-02-18 14:04:11.432904|2017-02-18 14:04:11.432904
NCT00729339|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2009-05-12|||June 2008||2008-06-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Role of Mosapride in Patients With Gastroesophageal Reflux Disease|Role of Mosapride in Patients With Gastroesophageal Reflux Disease|Completed||Phase 4|114|Actual|Lotung Poh-Ai Hospital||2|||f||||t||||||||||2017-02-18 14:04:11.519123|2017-02-18 14:04:11.519123
NCT00729326|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2015-03-20|2010-10-12||August 2008||2008-08-01|March 2015|2015-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione|Comparison of the Effect of Exenatide vs. Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione|Completed||Phase 4|83|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:04:11.629762|2017-02-18 14:04:11.629762
NCT00729313|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-06-18|||April 2000||2000-04-01|June 2012|2012-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae|A Phase III Multicentre Randomised Double-blind Comparative Study of Efficacy and Safety of Lanreotide 30 mg Versus Placebo for Treatment of Patients With Digestive Fistulae|Completed||Phase 3|111|Actual|Ipsen||2|||f||||f||||||||||2017-02-18 14:04:12.459031|2017-02-18 14:04:12.459031
NCT00729300|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-08-17|||April 2006||2006-04-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study of the Relationship Between Disulfiram and Cocaine Self-administration.|Laboratory Models of Cocaine Self-administration|Terminated||Phase 1/Phase 2|60|Actual|National Institute on Drug Abuse (NIDA)||2||Project moved to new university|f||||t||||||||No||2017-02-18 14:04:12.587426|2017-02-18 14:04:12.587426
NCT00729287|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-05-10|||September 2009||2009-09-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|SELEBLAT||Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer|Phase III Randomized Chemoprevention Study of Selenium on the Recurrence of Non-invasive Bladder Cancer|Completed||Phase 3|276|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-02-18 14:04:12.687805|2017-02-18 14:04:12.687805
NCT00729274|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-09-04|||November 2011||2011-11-01|September 2015|2015-09-01|April 2014|Anticipated|2014-04-01|May 2012|Anticipated|2012-05-01||Interventional|||HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL|HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL|Withdrawn||N/A|0|Actual|Laval University||2||Was not approved by funding organization|f||||f||||||||||2017-02-18 14:04:12.791456|2017-02-18 14:04:12.791456
NCT00729261|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-04-27|||August 2004||2004-08-01|August 2008|2008-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Prospective Trial of Elective Extubation in Brain Injured Patients.|A Prospective Trial of Elective Extubation in Brain Injured Patients Meeting Extubation Criteria for Ventilatory Support.|Completed||Phase 1|16|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:04:12.894112|2017-02-18 14:04:12.894112
NCT00729248|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2013-05-23|2010-08-25||July 2008||2008-07-01|May 2013|2013-05-01|January 2010|Actual|2010-01-01|July 2009|Actual|2009-07-01||Observational|||The Differential Effects of 3 Different Immunosuppressive|The Differential Effects of 3 Different Immunosuppressive Agents, Tacrolimus Mycophenolate Mofetil and Sirolimus on the Generation of Tregs and DCregs in in Vitro MLR and T Cell Activation Assays|Completed||N/A|12|Actual|Northwestern University|||1||f||||t||||||Samples With DNA|"~     White Cells.~   "|||2017-02-18 14:04:12.999591|2017-02-18 14:04:12.999591
NCT00729235|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2011-12-21|||May 2006||2006-05-01|June 2010|2010-06-01|November 2011|Actual|2011-11-01|December 2008|Actual|2008-12-01||Interventional|BITAC||Biventricular Tachycardias Outcome Trial|Biventricular Tachycardias Outcome Trial|Completed||Phase 4|481|Actual|LivaNova||2|||f||||t||||||||||2017-02-18 14:04:13.217832|2017-02-18 14:04:13.217832
NCT00729222|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2015-10-19|||November 2008||2008-11-01|October 2015|2015-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Hemodynamic Effects of Rolofylline Injectable Emulsion in the Treatment of Patients With Heart Failure|Completed||Phase 2|60|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:04:13.532261|2017-02-18 14:04:13.532261
NCT00729209|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-04-23|||July 2008||2008-07-01|April 2012|2012-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of ARRY-371797 in Patients With Rheumatoid Arthritis||Completed||Phase 1|28|Actual|Array BioPharma||3|||f||||f||||||||||2017-02-18 14:04:13.632289|2017-02-18 14:04:13.632289
NCT00729196|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2011-01-31|||July 2005||2005-07-01|January 2011|2011-01-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|Two-for-2||A Trial of Two Diets for Weight and Diabetes Management|A Trial of Two Diets for Weight and Diabetes Management|Completed||N/A|80|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 14:04:13.742533|2017-02-18 14:04:13.742533
NCT00729183|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2015-12-11|||October 2008||2008-10-01|December 2015|2015-12-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||BMD Efficacy and Safety of Odanacatib in Postmenopausal Women (0822-031)|A Phase III Randomized, Placebo-Controlled Study to Evaluate the Effect of Odanacatib (MK0822) on Bone Mineral Density (BMD) and Overall Safety, and to Estimate the Effect of Odanacatib (MK0822) on Bone Micro-architecture in Postmenopausal Women Treated With Vitamin D|Completed||Phase 3|214|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:04:13.851125|2017-02-18 14:04:13.851125
NCT00004643|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||February 1995||1995-02-01|March 1999|1999-03-01||||||||Interventional|||Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus||Completed||Phase 2|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:24.056433|2017-02-18 18:16:24.056433
NCT00729157|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2015-06-01|||August 2008||2008-08-01|December 2014|2014-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy|A Phase II Study of Single Agent Intravenous (IV) VEGF Trap in Patients With Poor Prognostic Recurrent and/or Metastatic Thyroid Cancer After RAI Therapy|Completed||Phase 2|41|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:04:14.074492|2017-02-18 14:04:14.074492
NCT00729144|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2011-01-09|||June 2008||2008-06-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|ABBI||Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial|Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial|Completed||N/A|133|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||t||||||||||2017-02-18 14:04:14.206208|2017-02-18 14:04:14.206208
NCT00729131|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2014-09-25|||August 2008||2008-08-01|September 2014|2014-09-01|February 2012|Actual|2012-02-01|January 2010|Actual|2010-01-01||Observational|||Functional Implications of TNF|Functional Implications of TNF|Completed||N/A|10|Actual|National Institute of Environmental Health Sciences (NIEHS)|||2||f||||f||||||Samples With DNA|"~     Bronchoalveolar lavage specimens.~   "|||2017-02-18 14:04:14.319752|2017-02-18 14:04:14.319752
NCT00729118|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-06|2016-03-16|||September 2008||2008-09-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma|Vorinostat (SAHA) and Lenalidomide After Autologous Transplant for Patients With Multiple Myeloma|Active, not recruiting||Phase 1|19|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:04:14.446773|2017-02-18 14:04:14.446773
NCT00729092|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2016-04-26|||May 2008||2008-05-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Observational|||Additional Positron Emission Tomography (PET) Scan of Brain in Patients Undergoing PET Scan for Diseases Unrelated to Brain|Additional (Positron Emission Tomography)PET Scan of Brain in Patients Undergoing PET Scan for Diseases Unrelated to Brain|Completed||N/A|100|Actual|Rush University Medical Center|||1||f||||f||||||||||2017-02-18 14:04:14.576842|2017-02-18 14:04:14.576842
NCT00729079|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-10-08|||December 2008||2008-12-01|March 2013|2013-03-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|DPP||Diabetes Prevention Program Pilot Study|Virtual Translation of Diabetes Prevention to Primary Care: A Pilot Study|Completed||N/A|36|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 14:04:14.669508|2017-02-18 14:04:14.669508
NCT00729053|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2009-01-08|||June 2004||2004-06-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|||Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma|A Phase 2, Multi-Center, Randomized, Open-Label Study of Two Dose Levels of IMOxine® (IMO-2055 for Injection) in Patients With Metastatic or Locally Recurrent Clear Cell Renal Carcinoma|Completed||Phase 2|224|Anticipated|Idera Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 14:04:14.784312|2017-02-18 14:04:14.784312
NCT00729040|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2009-01-27|||January 2008||2008-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||Enhancing Adherence by Building Online Communities|Enhancing Adherence to an Internet-Mediated Walking Program by Building Online Communities|Completed||Phase 1/Phase 2|324|Actual|Robert Wood Johnson Foundation||2|||f||||f||||||||||2017-02-18 14:04:14.89529|2017-02-18 14:04:14.89529
NCT00729027|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2016-04-15||2016-04-15|July 2008||2008-07-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia|A Multicenter, Double-blind, Randomized, 12-month, Placebo-controlled Study to Evaluate the Lipid-lowering Effect, Safety and Tolerability of AVE5530 25 mg/Day and 50mg/Day When Added to Ongoing Stable Statin Therapy (HMG-CoA Reductase Inhibitors) in Patients With Primary Hypercholesterolemia|Terminated||Phase 3|1015|Actual|Sanofi||3||AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy|f||||f||||||||||2017-02-18 14:04:15.006919|2017-02-18 14:04:15.006919
NCT00729014|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2008-08-01|||May 2008||2008-05-01|May 2008|2008-05-01||||September 2008|Anticipated|2008-09-01||Observational|||A Study of Drug-Induced Kidney Disease|A Study of Drug-Induced Kidney Disease|Unknown status|Recruiting|N/A|2000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 14:04:15.147309|2017-02-18 14:04:15.147309
NCT00729001|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2016-09-15|||November 2000||2000-11-01|September 2016|2016-09-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.|Phase II, Double-blind, Randomized, Placebo-controlled Study of 2 Doses of GSK Biologicals' Live Attenuated Human Rotavirus Vaccine at Different Virus Concentrations (10 5.2 and 10 6.4 Ffu) in Healthy Infants Following a 0, 2 Month Schedule and Previously Uninfected With Human Rotavirus.|Completed||Phase 2|529|Actual|GlaxoSmithKline||3|||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:04:15.247963|2017-02-18 14:04:15.247963
NCT00728988|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-09-29|2011-04-25||September 2008||2008-09-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|ALPACS||Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome|A Prospective Randomized, Open-Label, Parallel-Group Comparative Study: Atorvastatin Pre-Treatment Versus Usual Care In Asian Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention|Completed||Phase 4|499|Actual|Pfizer|Defective high-sensitivity C reactive protein reagents showed instability and 20% average positive bias in results, affecting only change from baseline in CRP. Analyses were performed on all samples; results include affected and unaffected samples.|2|||f||||f||||||||||2017-02-18 14:04:15.417249|2017-02-18 14:04:15.417249
NCT00728975|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2010-05-26|||June 2008||2008-06-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||The Bowel Research Collaborative Data Tracking System Implementation Study|The Bowel Research Collaborative Data Tracking System Implementation Study|Completed||N/A|390|Anticipated|British Columbia Cancer Agency|||13||f||||f||||||||||2017-02-18 14:04:15.98419|2017-02-18 14:04:15.98419
NCT00728962|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-01-13|2009-06-26||March 2005||2005-03-01|January 2015|2015-01-01|October 2009|Actual|2009-10-01|May 2006|Actual|2006-05-01||Observational|Fireball||A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading.|A Prospective, Observational Study of Osseotite Certain IOL (Immediate Occlusal Loading) Implants in Immediate Occlusal Loading of Short Span Fixed Restorations|Completed||N/A|75|Actual|Zimmer Biomet|||1||f||||t||||||||||2017-02-18 14:04:16.093282|2017-02-18 14:04:16.093282
NCT00728949|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-03-02||2010-09-14|August 2008||2008-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|March 2012|Actual|2012-03-01||Interventional|||A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer|Phase 2 Randomized, Multicenter Study of IMC-A12 as a Single Agent or in Combination With Antiestrogens in Postmenopausal Women With Hormone Receptor-Positive Advanced or Metastatic Breast Cancer After Progression on Antiestrogen Therapy|Completed||Phase 2|93|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:04:16.454825|2017-02-18 14:04:16.454825
NCT00728936|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2012-05-15|||September 2007||2007-09-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 in Hepatitis C-infected Patients|A Phase 1, Multi-center, Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 in Hepatitis C-infected Patients Unresponsive to Standard Treatment With Pegylated Interferon and Ribavirin|Completed||Phase 1|40|Actual|Idera Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 14:04:16.574718|2017-02-18 14:04:16.574718
NCT00728923|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-03-30|2011-08-29||August 2008||2008-08-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Interventional|||Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)|Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)|Completed||Phase 2|9|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-02-18 14:04:16.691291|2017-02-18 14:04:16.691291
NCT00728910|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2016-01-28|2012-11-29||June 2008||2008-06-01|January 2016|2016-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|CENTAUR||Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study|Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study|Completed||Phase 2|25|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-02-18 14:04:16.926624|2017-02-18 14:04:16.926624
NCT00728897|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2012-03-15|||July 2008||2008-07-01|February 2011|2011-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules.|An Open Label, Randomised, Single Dose, Three-way Crossover Study to Investigate the Relative Bioavailability of a 100mg Capsule Compared to Four 25mg GSK598809 Capsules and the Effect of Food on the Pharmacokinetics of the 100mg Capsule in Healthy Male and Female Volunteers.|Completed||Phase 1|16|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 14:04:17.259687|2017-02-18 14:04:17.259687
NCT00728884|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-05-14|2009-07-07||October 2005||2005-10-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|July 2009|Actual|2009-07-01||Observational|PrevailMulti||Study of Certain Prevail Implants Used to Treat All Types of Edentulism in the Maxilla and Mandible|Observational Study of Certain Prevail Implant System in Maxillary and Mandibular Regions|Completed||N/A|162|Actual|Zimmer Biomet|||1||f||||t||||||||||2017-02-18 14:04:17.350289|2017-02-18 14:04:17.350289
NCT00728871|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2008-08-05|||December 2005||2005-12-01|August 2008|2008-08-01|December 2011|Anticipated|2011-12-01|January 2006|Anticipated|2006-01-01||Interventional|||The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis|The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and CIN Patients and Their Prognosis|Unknown status|Recruiting|N/A|600|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-02-18 14:04:17.59784|2017-02-18 14:04:17.59784
NCT00728858|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-08-01|||April 2006||2006-04-01|April 2008|2008-04-01|February 2007|Actual|2007-02-01|December 2006|Actual|2006-12-01||Observational|||The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients|An Open-Label, Randomized Clinical Study to Evaluate the Efficacy, Safety and Genetic Polymorphism of Hypoca(Barnidipine)and Adalat OROS(Nifedipine) in Mild to Moderate Hypertensive Patients|Completed||N/A|43|Actual|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"~     Extract DNA from buffy coat. Test drug concentration in plasma.~   "|||2017-02-18 14:04:17.68464|2017-02-18 14:04:17.68464
NCT00728845|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2013-09-18|2013-09-18||June 2008||2008-06-01|September 2013|2013-09-01|December 2016|Anticipated|2016-12-01|July 2011|Actual|2011-07-01||Interventional|||Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer|(NJ 1508) Modulation of Autophagy With Hydroxychloroquine in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced/Recurrent Non-Small Cell Lung Cancer - A Phase I/II Study|Terminated||Phase 1/Phase 2|8|Actual|Rutgers, The State University of New Jersey||2||Slow accrual|f||||f||||||||||2017-02-18 14:04:17.766316|2017-02-18 14:04:17.766316
NCT00728832|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2008-08-12|||May 2002||2002-05-01|August 2008|2008-08-01||||February 2003|Actual|2003-02-01||Interventional|||A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery|A Phase 1 Study to Evaluate the Effects of Lidocaine/Epinephrine Test Dose Administration on the Pharmacokinetic Profile of a Single Dose of Thoracic Extended-Release Epidural Morphine in Patients Undergoing Major Upper Abdominal Surgery|Completed||Phase 1|39|Actual|EKR Therapeutics, Inc||5|||f||||t||||||||||2017-02-18 14:04:18.270907|2017-02-18 14:04:18.270907
NCT00728819|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-06-13|||August 2008||2008-08-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters|Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters|Completed||N/A|340|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 14:04:20.642771|2017-02-18 14:04:20.642771
NCT00728806|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-05-21|||October 2007||2007-10-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Biomarker for Peritoneal Ultrafiltration Failure|Biomarker for Early Detection and Intervention of Peritoneal Ultrafiltration Failure|Completed||N/A|40|Actual|Sun Yat-sen University|||1||f||||t||||||Samples Without DNA|"~     peritoneal tissue will be collected at the time of peritoneal dialysis catheter insertion or~     extubation. Serum and dialysate samples will be collected for protein analysis.~   "|||2017-02-18 14:04:20.749488|2017-02-18 14:04:20.749488
NCT00728793|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2011-11-17|||August 2008||2008-08-01|November 2011|2011-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors|A Phase I Open-Label, Multiple Dose, Sequential Dose Escalation Study to Investigate the Safety and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced and Refractory Solid Tumors|Completed||Phase 1|25|Actual|Curis, Inc.||1|||f||||f||||||||||2017-02-18 14:04:20.827386|2017-02-18 14:04:20.827386
NCT00006510|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-20|2016-07-28|||September 2000||2000-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Identification of an Asthma Susceptibility Gene on 3P||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:27.985723|2017-02-18 18:12:27.985723
NCT00728754|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-01-13|2009-06-26||March 2005||2005-03-01|January 2015|2015-01-01|April 2011|Actual|2011-04-01|July 2007|Actual|2007-07-01||Interventional|Cliffhanger||A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.|A Prospective, Randomized-controlled Multicenter Study of the Osseotite Certain Lateralized Implant in Short-span Fixed Bridge Cases for Preservation of Crestal Bone|Completed||N/A|61|Actual|Zimmer Biomet||2|||f||||t||||||||||2017-02-18 14:04:21.141641|2017-02-18 14:04:21.141641
NCT00728741|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2017-01-24|||August 1, 2008||2008-08-01|May 26, 2010|2010-05-26|May 26, 2010||2010-05-26|||||Observational|||Brain Activity During Strategic Planning|Functional Neuro-Imaging of Strategy Use During Human Behavior|Completed||N/A|16|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:04:21.561137|2017-02-18 14:04:21.561137
NCT00728728|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2016-12-19|2016-12-19||December 2009||2009-12-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|March 2015|Actual|2015-03-01||Interventional|||Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia|Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia|Completed||Phase 2|88|Actual|VA Office of Research and Development||2|||f||||t||||||||Undecided||2017-02-18 14:04:21.651088|2017-02-18 14:04:21.651088
NCT00728715|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-07-31|||January 2004||2004-01-01|July 2008|2008-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy of Budesonide-Formoterol in Bronchiectasis|Clinical Efficacy and Safety of Budesonide and Formoterol in the Management of Non-Cystic Fibrosis Bronchiectasis|Completed||N/A|40|Anticipated|Hospital General de Requena||2|||f||||f||||||||||2017-02-18 14:04:24.535743|2017-02-18 14:04:24.535743
NCT00728702|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2008-08-05|||July 2008||2008-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:04:24.650485|2017-02-18 14:04:24.650485
NCT00728689|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-06-22|2009-06-10||August 2008||2008-08-01|September 2010|2010-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase I Trial of an Investigational Small Pox Medication|A Phase I Randomized, Double-Blind, Crossover, Exploratory Study of the Pharmacokinetics of a Single Oral Dose of Form I Versus Form V Capsules of the Anti-Orthopoxvirus Compound ST-246® in Fed Normal Healthy Volunteers|Completed||Phase 1|12|Actual|SIGA Technologies||2|||f||||t||||||||||2017-02-18 14:04:24.710171|2017-02-18 14:04:24.710171
NCT00728676|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2013-01-17|||August 2008||2008-08-01|January 2013|2013-01-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Observational|||Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors|Pilot Study to Evaluate the Effects of Kuvan on Adult Individuals With Phenylketonuria With Measurable Maladaptive Behaviors|Completed||N/A|10|Actual|University of Southern California|||1||f||||f||||||||||2017-02-18 14:04:25.406143|2017-02-18 14:04:25.406143
NCT00728663|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2013-04-09|||June 2008||2008-06-01|April 2013|2013-04-01|April 2010|Actual|2010-04-01|September 2009|Actual|2009-09-01||Interventional|||Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer|Docetaxel and Cetuximab in Patients With Docetaxel-resistant Hormone-refractory Prostate Cancer (HRPC). A Multicenter Phase II Trial|Completed||Phase 2|35|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||||2017-02-18 14:04:25.488316|2017-02-18 14:04:25.488316
NCT00728650|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2012-02-06|||October 2003||2003-10-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|October 2010|Actual|2010-10-01||Observational|||A Retrospective Review of Malignant Liver Tumors|A Retrospective Review of Malignant Liver Tumors|Completed||N/A|228|Actual|University of Oklahoma|||1||f||||f||||||||||2017-02-18 14:04:25.631309|2017-02-18 14:04:25.631309
NCT00728637|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2013-05-14|||January 2005||2005-01-01|May 2013|2013-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|FIT-Heart||Evaluating the Effectiveness of a Family Heart Health Educational Program (The FIT-Heart Study)|Effectiveness of a Family Heart Health Intervention Trial (FIT Heart I)|Completed||N/A|501|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 14:04:25.732399|2017-02-18 14:04:25.732399
NCT00728624|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-04|2010-08-26|||November 2008||2008-11-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|EGAST 2008||Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns|Expert Group On Antibiotic Susceptibility Testing [EGAST] 2008: A Non-Interventional, Multicenter In-Vitro Study To Evaluate The Prevalence Of Beta-Lactamase Producing Strains Among Clinical Isolates Obtained From Hospital In-Patients And Comparison Of Antimicrobial Susceptibility Using Disc-Diffusion Method|Completed||Early Phase 1|2039|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:04:25.843261|2017-02-18 14:04:25.843261
NCT00728611|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-03|2011-07-10|||January 2008||2008-01-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee|PRP as a Treatment for Knee Osteoarthritis - Randomized-double-blind-placebo Control Trail.|Completed||Phase 2/Phase 3|60|Anticipated|Meir Medical Center||3|||f||||t||||||||||2017-02-18 14:04:25.954138|2017-02-18 14:04:25.954138
NCT00728598|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2008-08-05|||January 1998||1998-01-01|August 2008|2008-08-01|December 1998|Actual|1998-12-01|December 1998|Actual|1998-12-01||Observational|||Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis|Vitreous Levels of Patients With Proliferative Diabetic Retinopathy.|Completed||N/A|30|Actual|National Taiwan University Hospital|||3||f||||||||||Samples Without DNA|"~     Vitreous sample and blood sample~   "|||2017-02-18 14:04:26.056473|2017-02-18 14:04:26.056473
NCT00728585|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-05|2013-05-30|||January 2009||2009-01-01|May 2013|2013-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant|A Group-Wide Double-Blind Randomized Placebo-Controlled Trial of Palifermin to Prevent Chemotherapy and/or Radiotherapy Induced Oral Mucositis in Children Undergoing Autologous or Allogeneic Hematopoietic Stem Cell Transplantation|Withdrawn||Phase 2|0|Actual|Children's Oncology Group||2||Withdrawn due to lack of drug supply|f||||f||||||||||2017-02-18 14:04:26.146003|2017-02-18 14:04:26.146003
NCT00728572|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2016-09-14|||July 2008||2008-07-01|September 2016|2016-09-01|July 2009|Actual|2009-07-01|November 2008|Actual|2008-11-01||Interventional|||Logan Basic Technique Measured by Surface Electromyography (EMG)|The Effect of Logan Basic Technique Apex Contact Adjustment on the Motor Recruitment Pattern in the Erector Spinae.|Completed||Phase 1/Phase 2|45|Actual|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 14:04:26.265223|2017-02-18 14:04:26.265223
NCT00623363|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-11-06||2011-04-04|April 2007||2007-04-01|November 2015|2015-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease||Completed||Phase 2|27|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 14:41:45.505155|2017-02-18 14:41:45.505155
NCT00728559|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2011-02-02|||September 2010||2010-09-01|August 2008|2008-08-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Evaluation of Local Anlagesia Into the Trocar Site During Operative Laparosocpy|Evaluation of Local Anlagesia Into the Trocar Site During Operative Laparosocpy|Unknown status|Not yet recruiting|N/A|120|Anticipated|The Baruch Padeh Medical Center, Poriya||3|||f||||t||||||||||2017-02-18 14:04:26.355049|2017-02-18 14:04:26.355049
NCT00728546|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2012-12-26|||June 2008||2008-06-01|November 2012|2012-11-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||NAT2 in Re-challenge of INH in Patients With Hepatitis|The Application of the N-acetyltransferase 2 (NAT2) Genotyping in Re-challenge Protocol of Isoniazid (INH) Titration in Patients With Anti-TB Medications-induced Hepatitis|Unknown status|Recruiting|Phase 4|100|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 14:04:26.460405|2017-02-18 14:04:26.460405
NCT00728533|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2011-03-17||||||March 2011|2011-03-01||||||||Interventional|||Open-Label, Randomised Parallel-Group Study|The Rationale of the Study is to Demonstrate That Degarelix Given at Three-month Dosing Intervals Will Produce and Maintain Androgen Deprivation in Prostate Cancer Patients Through Immediate and Prolonged Testosterone Suppression, and to Provide Confirmatory Evidence of the Safety of Degarelix.|Withdrawn||Phase 3|0|Actual|Ferring Pharmaceuticals||2||Terminated due to awaiting data from Phase II study.|f||||t||||||||||2017-02-18 14:04:26.565336|2017-02-18 14:04:26.565336
NCT00728520|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-08-05|||July 2008||2008-07-01|August 2008|2008-08-01|June 2012|Anticipated|2012-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy|A Phase II Trial With Azacitidine Single Agent in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Who Are Ineligible for Standard Induction Therapy: A Department of Veterans Affairs Multi-Site Study|Unknown status|Recruiting|Phase 2|40|Anticipated|Kansas City Veteran Affairs Medical Center||1|||f||||t||||||||||2017-02-18 14:04:26.654693|2017-02-18 14:04:26.654693
NCT00728507|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2013-04-01|||November 2009||2009-11-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|||Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis|A Phase II Randomized, Open-label Trial of a Rifapentine Plus Moxifloxacin-Based Regimen for Intensive Phase Treatment of Smear-Positive Pulmonary Tuberculosis|Unknown status|Active, not recruiting|Phase 2|216|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:04:26.758032|2017-02-18 14:04:26.758032
NCT00728494|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-07-20|2008-12-05||October 2005||2005-10-01|July 2015|2015-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)|Evaluation of Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron / Rebetol in Conjunction With a Patient Assistance Program - Non Interventional Observational Study.|Completed||N/A|99|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:04:26.877168|2017-02-18 14:04:26.877168
NCT00728481|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2016-01-12|2012-10-05||May 2008||2008-05-01|January 2016|2016-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis|The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis|Completed||Phase 2/Phase 3|51|Actual|Mayo Clinic|"The index endoscopy was obtained solely for clinical reasons and could have been done as long as 18 months prior to study enrollment.~A single question on the dysphagia questionnaire was used to assess dysphagia symptom response."|2|||f||||t||||||||||2017-02-18 14:04:27.49309|2017-02-18 14:04:27.49309
NCT00728468|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2014-08-01|||September 2008||2008-09-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|October 2010|Actual|2010-10-01||Interventional|||A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients|A Phase 1, Open Label, Single Arm Trial To Evaluate The Effect Of PF- 00299804 On The Pharmacokinetics Of Dextromethorphan In Patients With Advanced Malignant Solid Tumors|Completed||Phase 1|16|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:04:28.075267|2017-02-18 14:04:28.075267
NCT00728455|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2014-10-16|||July 2008||2008-07-01|October 2014|2014-10-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers|Single Subcutaneous Dose Rising Study to Investigate the Safety, Tolerability, Efficacy and Pharmacokinetics of NNC 0070-0002-0349 in Overweight/Obese Male Subjects|Withdrawn||Phase 1|0|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-02-18 14:04:28.187839|2017-02-18 14:04:28.187839
NCT00728442|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2013-09-02|||December 2008||2008-12-01|September 2013|2013-09-01|April 2011|Actual|2011-04-01|April 2010|Actual|2010-04-01||Interventional|OncoDoc2||Impact of OncoDoc2 on Guideline Compliance in the Management of Breast Cancer|Impact of the OncoDoc2 Decision Support System on Compliance of Multidisciplinary Staff Meeting Decisions With Clinical Practice Guidelines in the Management of Non-metastatic Breast Cancer.|Completed||N/A|816|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:04:28.297286|2017-02-18 14:04:28.297286
NCT00728429|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-02|2012-07-12|||June 2008||2008-06-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Aerobic Exercise in Patients Receiving Chemotherapy for Cancer|CCCWFU 99108 - Effect of Exercise Training in Patients Receiving Anthracycline Drugs - A Pilot Study|Terminated||N/A|1|Actual|Wake Forest University Health Sciences||2||slow accrual|f||||f||||||||||2017-02-18 14:04:28.406753|2017-02-18 14:04:28.406753
NCT00728416|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-07-27|2009-10-09||August 2008||2008-08-01|July 2016|2016-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)|Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Relief of Nasal Congestion Associated With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 3|333|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:04:28.512901|2017-02-18 14:04:28.512901
NCT00728403|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-07-30|||September 2008||2008-09-01|July 2015|2015-07-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes|Long Term Metabolic and Therapeutic Effects of Combined Treatment of American Ginseng (Panax Quinquefolius L.) Extract and Korean Red Ginseng (Steamed Panax C.A. Meyer) Extract in the Treatment of Type 2 Diabetes|Active, not recruiting||Phase 2|120|Anticipated|St. Michael's Hospital, Toronto||3|||f||||f||||||||||2017-02-18 14:04:28.877505|2017-02-18 14:04:28.877505
NCT00004559|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-09|2016-03-15|||March 1999||1999-03-01|November 2005|2005-11-01|February 2002|Actual|2002-02-01|||||Interventional|||Fatty Acid Antiarrhythmia Trial (FAAT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:16:33.514371|2017-02-18 18:16:33.514371
NCT00728390|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2013-10-07|||July 2008||2008-07-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|August 2011|Actual|2011-08-01||Interventional|||A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks|Phase 1 Targeted Combination Trial Of PF-00299804 And CP-751,871 In Patients With Advanced Solid Tumors|Completed||Phase 1|74|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:04:28.981548|2017-02-18 14:04:28.981548
NCT00728377|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-02|2016-10-24|||July 2007||2007-07-01|October 2016|2016-10-01|November 2012|Actual|2012-11-01|November 2011|Actual|2011-11-01||Interventional|||An Exercise Intervention to Prevent Gestational Diabetes|An Exercise Intervention to Prevent Recurrent GDM|Completed||N/A|488|Actual|University of Massachusetts, Amherst||2|||f||||t||||||||||2017-02-18 14:04:29.096376|2017-02-18 14:04:29.096376
NCT00728364|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-04-10|||October 2008||2008-10-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Observational|||Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy|A Case Finding Study for Anderson-Fabry Disease Among Patients With Chronic Kidney Disease Not on Renal Replacement Therapy|Completed||N/A|4353|Actual|Klinikum Wels-Grieskirchen|||1||f||||f||||||||||2017-02-18 14:04:29.204307|2017-02-18 14:04:29.204307
NCT00728351|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2013-01-02||2013-01-02|June 2008||2008-06-01|January 2013|2013-01-01||||February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)|A Multicenter, Double-blind, Randomized Study to Compare the Efficacy of 24 Weeks Treatment With Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) Versus Metformin Monotherapy (1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy.|Completed||Phase 3|317|Actual|Novartis||2|||f||||t||||||||||2017-02-18 14:04:29.289269|2017-02-18 14:04:29.289269
NCT00728338|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-08-07|||June 2003||2003-06-01|August 2008|2008-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides|Effect of Docosahexenoic Acid (22:6n-3, DHA) Supplementation on Risk Factors for Cardiovascular Disease in Hyperlipidemic Men|Completed||N/A|40|Actual|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-02-18 14:04:29.46113|2017-02-18 14:04:29.46113
NCT00728325|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2013-12-04|||May 2008||2008-05-01|December 2013|2013-12-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Impact of Supported Employment Versus Standard Vocational Rehabilitation in Veterans With Post-traumatic Stress Disorder|The Impact of Supported Employment Versus Standard Vocational Rehabilitation in Veterans With PTSD|Unknown status|Active, not recruiting|N/A|100|Anticipated|Tuscaloosa Research & Education Advancement Corporation||2|||f||||f||||||||||2017-02-18 14:04:29.583493|2017-02-18 14:04:29.583493
NCT00728312|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-06-25|||August 2009||2009-08-01|June 2015|2015-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial|Double-blind Placebo Controlled Trial of Aripiprazole for Amphetamine|Withdrawn||Phase 4|0|Actual|VA Office of Research and Development||2||PI left the VA.|f||||f||||||||||2017-02-18 14:04:29.6856|2017-02-18 14:04:29.6856
NCT00728299|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-08-04|||September 2003||2003-09-01|August 2008|2008-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||The Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness|The Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness|Completed||N/A|384|Actual|Radiant Research||2|||f||||f||||||||||2017-02-18 14:04:29.78476|2017-02-18 14:04:29.78476
NCT00728286|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-10-07|||October 2008||2008-10-01|October 2015|2015-10-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Observational|||Assessment of Thrombogenicity in Acute Coronary Syndrome|Assessment of Platelet-dependent Thrombosis in Patients With Acute Coronary Syndromes Using an ex Vivo Arterial Injury Model|Completed||N/A|90|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||t||||||||||2017-02-18 14:04:29.881971|2017-02-18 14:04:29.881971
NCT00728273|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2008-12-03|||January 2007||2007-01-01|November 2008|2008-11-01|June 2007|Actual|2007-06-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy of Multiple Micronutrient Fortified Biscuits and Deworming in Vietnamese School Children|Efficacy of Multiple Micronutrient Fortified Biscuits and Deworming on Reducing Anemia Prevalence, and Improving Micronutrient Status, Cognitive Function, and Growth in Vietnamese School Children|Completed||Phase 2|510|Actual|Neys-van Hoogstraten Foundation, The Netherlands||4|||f||||f||||||||||2017-02-18 14:04:29.983967|2017-02-18 14:04:29.983967
NCT00728260|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-02-10|2015-01-07||July 2005||2005-07-01|February 2015|2015-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational||Children 2 through 10 years of age who received Menactra vaccine within Kaiser Permanente during the study period.|36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds|Post-licensure Safety Surveillance Study of Routine Use of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in Recipients 2 to 10 Years of Age.|Completed||N/A|1421|Actual|Sanofi|||1||f||||f||||||||||2017-02-18 14:04:30.097298|2017-02-18 14:04:30.097298
NCT00728247|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2010-09-17|||July 2008||2008-07-01|September 2010|2010-09-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Objective Kinematic Correlates of Palpatory Diagnosis|Objective Kinematic Correlates of Palpatory Diagnosis|Completed||N/A|10|Anticipated|Michigan State University||1|||f||||f||||||||||2017-02-18 14:04:30.683158|2017-02-18 14:04:30.683158
NCT00728234|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-08-06|||January 2000||2000-01-01|July 2008|2008-07-01|July 2006|Actual|2006-07-01|December 2002|Actual|2002-12-01||Observational|||Analysis of Correlation of Amplitude-Integrated EEG and Neurodevelopmental Outcome in Preterm Infants|Analysis of Amplitude-Integrated Electroencephalography and Its Predictive Value for Neurodevelopmental Outcome in Preterm Infants Born Below 30 Weeks Gestational Age|Completed||N/A|284|Actual|Medical University of Vienna|||1||f||||f||||||||||2017-02-18 14:04:30.764738|2017-02-18 14:04:30.764738
NCT00728221|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2017-01-05|||November 2007||2007-11-01|January 2017|2017-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|ESGC||Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation|Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation|Completed||Phase 2|17|Actual|St. Michael's Hospital, Toronto||4|||f||||f||||||||||2017-02-18 14:04:30.873575|2017-02-18 14:04:30.873575
NCT00728208|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-06-09|||July 2008||2008-07-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||GSK372475 PK Study in Healthy Volunteers|A Placebo-controlled, Single-blind, Randomised, Parallel Group, 28-day Repeat Dose Study to Investigate the Tolerability, Safety and Steady State Pharmacokinetics of GSK372475 in Healthy Young and Elderly, Male and Female Subjects|Completed||Phase 1|66|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:04:30.985593|2017-02-18 14:04:30.985593
NCT00728195|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2014-03-25|||November 2008||2008-11-01|March 2014|2014-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia|A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of JNJ-37822681 Administered Twice Daily in Subjects With Schizophrenia|Completed||Phase 2|498|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||5|||f||||t||||||||||2017-02-18 14:04:31.099545|2017-02-18 14:04:31.099545
NCT00728182|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2013-08-09|2013-05-08||August 2008||2008-08-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|ENACT||Evaluating Neuroprotection in Aneurysm Coiling Therapy|A Phase II, Multicenter, Randomized, Fasting, Double-Blind, Placebo-Controlled, Safety, Tolerability and Efficacy Study Evaluating a Single Dose of Intravenous NA-1 in Male and Female Patients Undergoing Endovascular Repair of Brain Aneurysms|Completed||Phase 2|185|Actual|NoNO Inc.||2|||f||||t||||||||||2017-02-18 14:04:31.27106|2017-02-18 14:04:31.27106
NCT00728169|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2009-09-17|||July 2008||2008-07-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Developing Asthma Interventions Using Community Based Research|Feasibility of Developing an Effective Asthma Intervention Using CBPR Methods|Completed||N/A|62|Anticipated|Meharry Medical College|||1||f||||t||||||||||2017-02-18 14:04:31.989574|2017-02-18 14:04:31.989574
NCT00728156|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2015-10-07|||August 2009||2009-08-01|October 2015|2015-10-01|April 2012|Actual|2012-04-01|December 2010|Actual|2010-12-01||Interventional|||Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)|Assessment of Platelet-dependent Thrombosis by an ex Vivo Arterial Injury Model: a Placebo Controlled Trial of Clopidogrel as Antiplatelet Therapy in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease|Completed||Phase 4|90|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-02-18 14:04:32.082443|2017-02-18 14:04:32.082443
NCT00728143|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2008-08-04|||August 1989||1989-08-01|August 2008|2008-08-01|November 1989|Actual|1989-11-01|November 1989|Actual|1989-11-01||Interventional|||Blood Glucose Response to Highly Viscous Polysaccharide Enriched Biscuits in Healthy and Diabetic Subjects|Therapeutic Trials of Low Glycemic Index Foods and Dietary Fiber in the Management of Diabetes, Hyperlipidemia and Renal Disease|Completed||N/A|19|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 14:04:32.212259|2017-02-18 14:04:32.212259
NCT00728130|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2014-12-12|2013-05-29||May 2008||2008-05-01|December 2014|2014-12-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients|Prospective Study to Assess the Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Patients With Carcinoma of the Upper Aerodigestive Tract|Completed||Phase 1|22|Actual|Southern Illinois University||1|||f||||f||||||||||2017-02-18 14:04:32.307623|2017-02-18 14:04:32.307623
NCT00728117|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-11-08|||July 2008||2008-07-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants|Should Very Low Birth Weight Infants Receive Enteral Nutrition During Indomethacin or Ibuprofen Treatment of a Patent Ductus Arteriosus? A Multi-Center Randomized Controlled Trial|Completed||N/A|177|Actual|University of California, San Francisco||4|||f||||t||||||||||2017-02-18 14:04:32.620891|2017-02-18 14:04:32.620891
NCT00728104|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2017-02-03|||October 2007||2007-10-01|February 2017|2017-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)|Co-Enzyme Q10, L-Carnitine and Amitriptyline Usage in Cyclic Vomiting Syndrome (CVS): A Research Study|Withdrawn||N/A|0|Actual|Medical College of Wisconsin|||4|No funding|f||||f||||||||||2017-02-18 14:04:32.733609|2017-02-18 14:04:32.733609
NCT00728091|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-04-26||2016-04-26|July 2008||2008-07-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|AQUARIST1||A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia|A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Satavaptan (SR121463B) Versus Placebo in Patients With Dilutional Hyponatremia Due to the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)|Terminated||Phase 3|2|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 14:04:32.828142|2017-02-18 14:04:32.828142
NCT00728078|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2009-02-06|||July 2008||2008-07-01|February 2009|2009-02-01|July 2011|Anticipated|2011-07-01|July 2009|Anticipated|2009-07-01||Interventional|LDT-RFA||Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2/Phase 3|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 14:04:32.926269|2017-02-18 14:04:32.926269
NCT00728065|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2009-02-17|||December 2007||2007-12-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||The Effects of Salvia Hispanica-Enriched Foods on Glycemic and Insulinemic Responses and Subjective Satiety|The Effects of Salvia Hispanica-Enriched Foods on Glycemic and Insulinemic Responses and Subjective Satiety|Completed||N/A|30|Anticipated|St. Michael's Hospital, Toronto||10|||f||||f||||||||||2017-02-18 14:04:33.040848|2017-02-18 14:04:33.040848
NCT00728052|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2012-03-15|||June 2008||2008-06-01|February 2011|2011-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers.|A Placebo-controlled, Single-blind, Randomised, Human Volunteer Study Investigating the Tolerability and Pharmacokinetics of Escalating Single Oral Doses (75mg and Above) of GSK598809 in Otherwise Healthy Volunteers.|Completed||Phase 1|1|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:04:33.137594|2017-02-18 14:04:33.137594
NCT00728039|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-09-12|||April 2007||2007-04-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Quality of Life (QOL), Coping and Psychological Symptoms in Children and Adolescents With Cyclic Vomiting Syndrome|Quality of Life, Coping and Psychological Symptoms in Children and Adolescents With Cyclic Vomiting Syndrome|Active, not recruiting||N/A|120|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 14:04:33.231759|2017-02-18 14:04:33.231759
NCT00727857|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2011-07-27|2009-08-28||June 2007||2007-06-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.|A Phase 3b, Double-Blind, Randomized Study to Determine the Efficacy and Safety of Pioglitazone HCl and Metformin HCl Fixed-Dose Combination Therapy Compared to Pioglitazone HCl Monotherapy and to Metformin HCl Monotherapy in the Treatment of Subjects With Type 2 Diabetes|Completed||Phase 3|600|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:04:35.287927|2017-02-18 14:04:35.287927
NCT00728026|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-07-20|||June 2008||2008-06-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea|Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome, Irritable Bowel Syndrome, Postural Orthostatic Tachycardia Syndrome, Functional Abdominal Pain or Chronic Nausea|Active, not recruiting||N/A|50|Anticipated|Medical College of Wisconsin|||5||f||||f||||||||||2017-02-18 14:04:33.304423|2017-02-18 14:04:33.304423
NCT00728013|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2008-08-22|||December 2006||2006-12-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|December 2008|Anticipated|2008-12-01||Interventional|CHILLAS||China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome|China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome|Unknown status|Recruiting|N/A|1600|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-02-18 14:04:33.383143|2017-02-18 14:04:33.383143
NCT00728000|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2009-04-24|||August 2008||2008-08-01|April 2009|2009-04-01|August 2010|Anticipated|2010-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma|Phase II Study Of Neoadjuvant Chemotherapy With Gemcitabine, Oxaliplatin And Erlotinib (Gemoxt) In Borderline Resectable Pancreatic Adenocarcinoma|Withdrawn||Phase 2|20|Anticipated|University of Cincinnati||1||study withdrawn due to lack of enrollment|f||||f||||||||||2017-02-18 14:04:33.491647|2017-02-18 14:04:33.491647
NCT00727987|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2013-05-22|||May 2008||2008-05-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy|A Study of Golimumab (CNTO 148) Administered in Combination With Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis|Completed||Phase 3|269|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-02-18 14:04:33.802545|2017-02-18 14:04:33.802545
NCT00727974|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2017-01-30|||January 2008||2008-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines|Genetic Analysis of Children With Cyclic Vomiting Syndrome and Migraines|Recruiting||N/A|880|Anticipated|Medical College of Wisconsin|||2||f||||t||||||Samples With DNA|"~     5 ml of blood will be drawn through venipucture from the study subjects, their biological~     parents and siblings when available. In addition, 4 ml of blood will be drawn for serologic~     testing.~   "|||2017-02-18 14:04:33.991829|2017-02-18 14:04:33.991829
NCT00727961|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-04-29|2009-01-29||November 2004||2004-11-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)|Obligatory Post-Registration Open-Label, Non-Comparative Multicenter Study of Efficacy and Tolerance Rate of Caelyx as Monotherapy in Patients With Epithelial Ovarian Cancer, Resistant to Previous Platinum Therapy.|Completed||Phase 4|58|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:04:34.106432|2017-02-18 14:04:34.106432
NCT00727948|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2011-04-21|||July 2008||2008-07-01|June 2010|2010-06-01|December 2011|Anticipated|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy|The Impact of the Anti-Platelet Agent Aspirin on Angiogenesis Proteins in Women With Breast Cancer|Unknown status|Active, not recruiting|Early Phase 1|35|Anticipated|University of Vermont||1|||f||||t||||||||||2017-02-18 14:04:34.383642|2017-02-18 14:04:34.383642
NCT00727935|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2008-08-04|||October 2006||2006-10-01|August 2008|2008-08-01||||July 2007|Actual|2007-07-01||Interventional|LiRoPep||Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep)|Comparison Of The Analgesia Obtained By Infiltration Of Lidocaïne 1% And Ropivacaïne 0,75% Versus Placebo For The Joinings Of Episiotomies Among Parturients Under Epidural Analgesia|Completed||Phase 4|165|Actual|University Hospital, Angers||3|||f||||t||||||||||2017-02-18 14:04:34.472501|2017-02-18 14:04:34.472501
NCT00727922|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-12-15|||June 2008||2008-06-01|July 2011|2011-07-01|April 2011|Actual|2011-04-01|January 2010|Actual|2010-01-01||Interventional|MnDPDP-K04||Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity|Evaluation of Mangafodipir Protective Activity Against Oxaliplatin Neurotoxicity|Completed||Phase 2|23|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 14:04:34.571316|2017-02-18 14:04:34.571316
NCT00727909|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2014-06-04|2013-09-09||May 2009||2009-05-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||All Study Participants|Evaluation of Open-canal Behind-the-Ear Hearing Aids and Traditional In-the-ear Hearing Aids.|Evaluation of Open-Ear Canal and Traditional Custom-Fit Hearing Aids|Completed||N/A|290|Actual|VA Office of Research and Development|No limitations or caveats to report.|1|||f||||f||||||||||2017-02-18 14:04:34.685094|2017-02-18 14:04:34.685094
NCT00727896|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-06-24|||August 2008||2008-08-01|March 2011|2011-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||"Information Technology Methodology for Patient Motivation in Diabetes Management."|"Reinforcement of Adherence to Prescription Recommendations in Diabetic Patients Using Short Message Service (SMS)- A Pilot Study"|Completed||Phase 1|200|Anticipated|India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals||2|||f||||t||||||||||2017-02-18 14:04:34.944728|2017-02-18 14:04:34.944728
NCT00727883|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2010-12-09|||July 2007||2007-07-01|December 2010|2010-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|SOSTA||Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients|Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients|Completed||N/A|190|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:04:35.074676|2017-02-18 14:04:35.074676
NCT00727870|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-03-01|||July 2008||2008-07-01|March 2012|2012-03-01|June 2012|Anticipated|2012-06-01|October 2011|Actual|2011-10-01||Interventional|||Evaluation of Preferences of Consumers and Clinicians for the Management of Shave Biopsy Sites With a PolyMem Formulation Dressing or Current Standard of Care.|A Single Site, Three Arm, Open Label Comparative Preference Study to Evaluate the Preference of Consumers and Health Care Professionals for the Use of Shapes by PolyMem Wound Dressings and Shapes by PolyMem Silver Wound Dressings, Each Compared to Antibiotic Ointment Covered With a Band-aid Type Dressing (Current Standard of Practice) and to Each Other in the Post-biopsy Management of Shave Biopsies. Each Participant Serves as Own Control. A Blinded Third Party Physician Will Evaluate and Compare the Wounds Based on Photos Taken at the Various Follow-up Points..|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|Ferris Mfg. Corp.||3|||f||||f||||||||||2017-02-18 14:04:35.156814|2017-02-18 14:04:35.156814
NCT00727844|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2016-02-12|2013-09-10||July 2008||2008-07-01|May 2014|2014-05-01|November 2014|Actual|2014-11-01|October 2012|Actual|2012-10-01||Interventional||2 patients excluded in immediate start group before receiving any linezolid owing to baseline neuropathy|Linezolid to Treat Extensively-Drug Resistant Tuberculosis|A Phase 2a, Randomized, 2-Arm, Open-Label, Clinical Trial of the Efficacy of Linezolid Combined With Antituberculous Therapy in Subjects With Extensively Drug-Resistant (XDR) Pulmonary Tuberculosis|Completed||Phase 2|41|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Small sample size|2|||f||||t||||||||||2017-02-18 14:04:36.841031|2017-02-18 14:04:36.841031
NCT00727831|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2014-01-24|||July 2008||2008-07-01|January 2014|2014-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma|Phase I Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients With Primary Central Nervous Lymphoma (PCNSL)|Completed||Phase 1/Phase 2|4|Actual|University College, London||1|||f||||t||||||||||2017-02-18 14:04:37.436988|2017-02-18 14:04:37.436988
NCT00727818|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-07-31|||May 2006||2006-05-01|July 2008|2008-07-01|February 2007||2007-02-01|||||Interventional|||A Split-Blind Clinical Investigation to Compare the Performance and Safety of Inion GTR™ Biodegradable Membrane System to Resorbable Bilayer Bio-Gide®-Membrane of Geistlich Biomaterials in Enhancing Bone Regeneration After Removal of Wisdom Teeth.||Completed||Phase 4|||University of Zurich|||||f||||||||||||||2017-02-18 14:04:37.575449|2017-02-18 14:04:37.575449
NCT00727805|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-10-04|||October 2003||2003-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:04:37.646463|2017-02-18 14:04:37.646463
NCT00727792|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2017-01-21|||January 2009||2009-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Refinement and Assessment of New MRI Technologies for Thoracic/ Cardiovascular Exams|Refinement and Assessment of New MRI Technologies for Thoracic/ Cardiovascular Exams|Enrolling by invitation||N/A|100|Actual|University of Michigan||2|||f||||f||||||||No||2017-02-18 14:04:37.695211|2017-02-18 14:04:37.695211
NCT00727779|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-02-13|||January 2008||2008-01-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome|Mechanisms by Which Strength Training Ameliorates the Metabolic Syndrome|Completed||N/A|50|Actual|East Tennessee State University||2|||f||||t||||||||||2017-02-18 14:04:37.802516|2017-02-18 14:04:37.802516
NCT00727766|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2014-11-10|||January 2009||2009-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|September 2012|Actual|2012-09-01||Interventional|||Oral Clofarabine for Acute Myeloid Leukemia|Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older With Acute Myeloid Leukemia|Completed||Phase 1|25|Actual|Washington University School of Medicine||6|||f||||t||||||||||2017-02-18 14:04:37.917097|2017-02-18 14:04:37.917097
NCT00727753|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-05-27|||July 2008||2008-07-01|May 2015|2015-05-01|October 2013|Actual|2013-10-01|December 2012|Actual|2012-12-01||Observational|||VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)|Effects of Vascular Endothelial Growth Factor Antagonism With Ranibizumab or Bevacizumab in Patients With Neovascular Macular Degeneration|Completed||Phase 4|54|Actual|University of Zurich|||3||f||||f||||||||||2017-02-18 14:04:38.033771|2017-02-18 14:04:38.033771
NCT00727740|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-11-23|2016-08-24||August 2005||2005-08-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis|A Prospective, Multicenter, Randomized, Double-blind Controlled Study to Determine Whether a Single Dose of Intraduodenal Indomethacin Can Decrease the Incidence and Severity of Post-ERCP Pancreatitis|Completed||N/A|117|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:04:38.146513|2017-02-18 14:04:38.146513
NCT00727727|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2009-02-24|||March 2008||2008-03-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)|Stabilization on, or Change-Over to the Non-Ergot Dopamine Agonist Piribedil in Patients With Morbus Parkinson - a Post Marketing Surveillance Study in Private Practices.|Completed||N/A|750|Anticipated|Desitin Arzneimittel GmbH|||1||f||||f||||||||||2017-02-18 14:04:38.442486|2017-02-18 14:04:38.442486
NCT00727714|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2016-04-13|2015-11-17||April 2008||2008-04-01|April 2016|2016-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|LIS||Lung Function and Inflammatory Markers in Cement Dust Exposed Workers: A Cross-shifts Study|Circulating Inflammatory Markers, Exhaled NO and Lung Function in Cement Production Workers; a Cross-shifts Study|Completed||N/A|95|Actual|Sykehuset Telemark|||1||f||||f||||||Samples With DNA|"~     Whole blood serum~   "|No|The individual data is no longer available, due to regulations in Norway requiering individual data to be deleted 5 years after the study was compleeted.|2017-02-18 14:04:38.550975|2017-02-18 14:04:38.550975
NCT00727701|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-06-25|||July 2008||2008-07-01|June 2015|2015-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of Individualized Wound Prevention Instruction to Prevent Venous Ulcer Development|Does Use of a Wound After-care Summary for Patients With a History of Venous Ulcers Lower Recurrence Rate?|Terminated||Phase 1|72|Anticipated|VA Office of Research and Development||3||"Study delayed for over a year by research shutdown at Seattle VA and other issues. Study~   designer moved to Ann Arbor in the interim, so the study was closed."|f||||f||||||||||2017-02-18 14:04:38.888784|2017-02-18 14:04:38.888784
NCT00726648|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-09-02||2009-08-26|July 2008||2008-07-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||CDP323 Biomarker Study|Double-blind, Placebo-controlled, Randomized, Parallel-group Study in Subjects With Relapsing Forms of Multiple Sclerosis to Evaluate the Effects of Different CDP323 Doses on Biomarker Patterns as Well as on Safety and Tolerability.|Completed||Phase 1/Phase 2|71|Actual|UCB Pharma||5|||f||||t||||||||||2017-02-18 14:04:39.00213|2017-02-18 14:04:39.00213
NCT00726635|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2009-02-15|||August 2008||2008-08-01|July 2008|2008-07-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies|Assessment of the Impact of Preoperative Stress Reduction on Psychological, Physiological and Immunological Parameters in Women With Gynecological Malignancies - Prospective Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|60|Anticipated|Rabin Medical Center||3|||f||||f||||||||||2017-02-18 14:04:39.109915|2017-02-18 14:04:39.109915
NCT00726622|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-09-23|2016-08-11||August 2008||2008-08-01|August 2016|2016-08-01||||October 2013|Actual|2013-10-01||Interventional||All patients that were randomized to a treatment arm were available for baseline characteristics. Four patients from Arm 1: Open laparotomy and rectal resection and one patient from Arm 2: Laparoscopic-assisted rectal resection are not shown because of patient refusal or improper consent.|Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer|A Phase III Prospective Randomized Trial Comparing Laparoscopic-Assisted Resection Versus Open Resection for Rectal Cancer|Active, not recruiting||Phase 3|486|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 14:04:39.237089|2017-02-18 14:04:39.237089
NCT00726609|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-02-16|2009-08-13||January 2006||2006-01-01|February 2015|2015-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641)|Post-marketing Surveillance (PMS) Management of Invasive Mycosis With Posaconazole|Completed||N/A|214|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:04:40.269811|2017-02-18 14:04:40.269811
NCT00726596|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-12-16|||August 2008||2008-08-01|December 2015|2015-12-01|October 2016|Anticipated|2016-10-01|February 2014|Actual|2014-02-01||Interventional|||Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer|NJ 1808: Autophagic Cell Death With Hydroxychloroquine in Patients With Hormone-Dependent Prostate-Specific Antigen Progression After Local Therapy For Prostate Cancer.|Active, not recruiting||Phase 2|64|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 14:04:40.620345|2017-02-18 14:04:40.620345
NCT00727688|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-12-19|||August 2006||2006-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:04:40.722834|2017-02-18 14:04:40.722834
NCT00727675|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-06-28|||August 2008||2008-08-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2014|Actual|2014-07-01||Interventional|CPODAT||Chronic Pain and Opioid Dependence Assessment and Treatment|Chronic Pain and Opioid Dependence Assessment and Treatment|Completed||N/A|15|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:04:40.768842|2017-02-18 14:04:40.768842
NCT00727662|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2015-04-13|||June 2008||2008-06-01|April 2015|2015-04-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||A Yoga and Wellness Program for Breast Cancer Survivors With Persistent Fatigue|Iyengar Yoga for Breast Cancer Survivors With Persistent Fatigue|Completed||N/A|72|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 14:04:40.876313|2017-02-18 14:04:40.876313
NCT00727649|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2015-03-18|2015-01-23||July 2008||2008-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|FIRM||Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence|Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence|Completed||Phase 2/Phase 3|80|Actual|VA Office of Research and Development|Please note that the data on those lost to follow-up limits our ability to conclude differences between the two interventions.|2|||f||||f||||||||||2017-02-18 14:04:40.99247|2017-02-18 14:04:40.99247
NCT00727636|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-05-03|2011-05-03||July 2008||2008-07-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|June 2010|Actual|2010-06-01||Interventional|HPV||Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy|Pilot Study of Immunogenicity and Tolerability to the Quadrivalent Human Papillomavirus Virus-like Particle (VLP) Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy Compared to Healthy Children and Youth Adult Females|Completed||N/A|53|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 14:04:43.918985|2017-02-18 14:04:43.918985
NCT00727623|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-08-07|||July 2007||2007-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in Belgium|Prospective Observational Study to Assess Predictors of in Hospital Mortality in STEMI Patients Admitted in Belgian Hospitals|Recruiting||N/A|5000|Anticipated|Universiteit Antwerpen|||1||f||||f||||||||||2017-02-18 14:04:44.337215|2017-02-18 14:04:44.337215
NCT00727610|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2011-02-15|||May 2008||2008-05-01|February 2011|2011-02-01||||||||Observational|||Development of a Screening Strategy for Community-based Adverse Drug Related Events in the Emergency Department|Development of a Screening Strategy for Community-based Adverse Drug Related Events in the Emergency Department|Completed||N/A|1588|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 14:04:44.423945|2017-02-18 14:04:44.423945
NCT00727597|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2013-06-28|2012-08-28||July 2008||2008-07-01|June 2013|2013-06-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|SUPPoRT||A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT|A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT|Completed||Phase 3|101|Actual|Georgetown University||2|||f||||t||||||||||2017-02-18 14:04:44.514866|2017-02-18 14:04:44.514866
NCT00727584|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2013-08-23|||November 2007||2007-11-01|June 2009|2009-06-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|||Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression|SCORAD: A Randomised Feasibility Study of Single Fraction Radiotherapy Compared to Multi-fraction Radiotherapy in Patients With Metastatic Spinal Cord Compression|Completed||N/A|100|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:04:44.892386|2017-02-18 14:04:44.892386
NCT00727571|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2014-07-18|2009-10-29||September 2006||2006-09-01|July 2014|2014-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||LEARN-6™: A Prospective, Observational Nursing Home Study|Prospective Observational Study to Evaluate Physical Performance and Quality of Life in Older Long Stay Nursing Home Residents With Chronic Kidney Disease With and Without Anemia|Completed||N/A|815|Actual|Amgen|21 subjects could not be classified into the defined groups because of missing lab values at enrollment||4||f||||||||||None Retained|"~     N/A (None Retained)~   "|||2017-02-18 14:04:45.21707|2017-02-18 14:04:45.21707
NCT00727558|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-05-05|2009-09-24||July 2008||2008-07-01|May 2015|2015-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Comparison of Daily Disposable Contact Lenses.||Completed||N/A|248|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||||||||||||2017-02-18 14:04:45.849496|2017-02-18 14:04:45.849496
NCT00727545|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2008-08-04|||March 2006||2006-03-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Effect of Rice Fortification With Iron on Anemia Among Children|Effect of Weekly Rice Fortification With Iron on Frequency of Anemia and Hemoglobin Concentration Among Children Attending Public Day Care Centers From Rio de Janeiro|Completed||Phase 2/Phase 3|385|Actual|Universidade Federal do Rio de Janeiro||1|||f||||t||||||||||2017-02-18 14:04:46.311695|2017-02-18 14:04:46.311695
NCT00727532|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2013-07-17|||July 2008||2008-07-01|July 2013|2013-07-01|June 2015|Anticipated|2015-06-01|October 2011|Actual|2011-10-01||Interventional|||Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer|Correlation of Pathologic Findings After Neo-adjuvant Sorafenib With Results of Diffusion-Weighted Magnetic Resonance Imaging in Patients With Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma|Terminated||N/A|9|Actual|Northwestern University||1||Low Accrual|f||||t||||||||||2017-02-18 14:04:46.399134|2017-02-18 14:04:46.399134
NCT00727519|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-27|2010-03-22|||July 2008||2008-07-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|||||Interventional|||The Effect of Pomegranate Juice on Oxidative Stress in Hemodialysis Patients|A Randomized Clinical Trial for Estimating the Effects of Pomegranate Juice Consumption by Hemodialysis Patients on Oxidative Stress, Infections, Cardiovascular Events and Mortality|Completed||Phase 3|||Western Galilee Hospital-Nahariya||2|||f||||f||||||||||2017-02-18 14:04:46.502468|2017-02-18 14:04:46.502468
NCT00727506|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2016-09-30|2013-08-08||July 2008||2008-07-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|January 2011|Actual|2011-01-01||Interventional||For Phase I part, all patients who were treated with at least one dose of the study medication. For Phase II part, all patients who were randomized and have taken at least one dose of the study medication.|BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma|Phase I/II Trial of BIBW 2992 (Afatinib) in Treating Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|151|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 14:04:46.603595|2017-02-18 14:04:46.603595
NCT00727493|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-08-01|||January 2004||2004-01-01|August 2008|2008-08-01|April 2010|Anticipated|2010-04-01|January 2010|Anticipated|2010-01-01||Interventional|OPOZAHN||Osteoporosis and Dental Implant|Evaluation of the Influence of Alendronate on Wound Healing After Dental Implants in Patients With Osteoporosis|Unknown status|Recruiting|Phase 4|45|Anticipated|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-02-18 14:04:48.463905|2017-02-18 14:04:48.463905
NCT00727480|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-06-01|||September 2002||2002-09-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|July 2008|Actual|2008-07-01||Interventional|||Finger Imaging to Detect Blood Flow in the Fingertips|Finger Imaging and Biometric System|Terminated||N/A|13|Actual|University of Michigan||1||No longer acruing data for this study.|f||||f||||||||||2017-02-18 14:04:48.57411|2017-02-18 14:04:48.57411
NCT00727467|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-12-30|||September 2008||2008-09-01|August 2008|2008-08-01|March 2009|Anticipated|2009-03-01|December 2008|Anticipated|2008-12-01||Interventional|||A Randomised Controlled Trial (RCT) to Evaluate Use of an Individual Auditory Cueing Device's (IACD's) on Freezing and Gait in People With Parkinson's Disease (PD)|A Randomised Controlled Trial Evaluating the Effect of an Individual Auditory Cueing Device on Freezing and Gait Speed in People With Parkinson's Disease|Unknown status|Not yet recruiting|Phase 1/Phase 2|47|Anticipated|University of Dublin, Trinity College||2|||f||||t||||||||||2017-02-18 14:04:48.670407|2017-02-18 14:04:48.670407
NCT00727454|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-11-14|||July 2007||2007-07-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|OSA-MRI||Effects of Continuous Positive Airway Pressure (CPAP) in Heart Remodeling by Magnetic Resonance Imaging (MRI)|Effects of Continuous Positive Airway Pressure on Heart Remodeling in Patients With Obstructive Sleep Apnea: A Randomized Study With Cardiovascular Magnetic Resonance Imaging|Terminated||Phase 4|24|Actual|University of Sao Paulo||2||Difficulty of recruiting patients and cost limitations.|f||||f||||||||||2017-02-18 14:04:48.785956|2017-02-18 14:04:48.785956
NCT00727441|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2017-01-11|||July 2008||2008-07-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery|A Randomized Three-arm Neoadjuvant and Adjuvant Feasibility and Toxicity Study of a GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine Administered Either Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Patients With Surgically Resected Adenocarcinoma of the Pancreas|Active, not recruiting||N/A|87|Anticipated|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 14:04:48.888991|2017-02-18 14:04:48.888991
NCT00727428|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2012-06-14|||August 2008||2008-08-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' FluLaval® TF|Immunogenicity and Safety Study of GSK Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral®, Thimerosal-free (FluLaval® TF), in Adults 18 to 60 Years of Age.|Completed||Phase 1|110|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 14:04:49.000721|2017-02-18 14:04:49.000721
NCT00727415|ClinicalTrials.gov processed this data on February 17, 2017|2008-08-01|2016-08-16|||February 2008||2008-02-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|LLC0606||Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy|A Prospective Multicenter Pilot Trial to Evaluate the Efficacy of a Treatment With Fludarabine, Cyclophosphamide, Lenalidomide (FCL) for Advanced Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients.|Completed||Phase 1/Phase 2|52|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||No||2017-02-18 14:04:49.098224|2017-02-18 14:04:49.098224
NCT00727402|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-02-13|2010-11-09||October 2006||2006-10-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|January 2009|Actual|2009-01-01||Observational|LASH||Longitudinal Evaluation of Silicone Hydrogel (LASH) Study|The Longitudinal Evaluation of Silicone Hydrogel (LASH) Contact Lens Study|Completed||N/A|205|Actual|National Eye Institute (NEI)|||1||f||||f||||||Samples Without DNA|"~     tear samples contact lenses bacteria isolated from contact lenses~   "|||2017-02-18 14:04:49.218209|2017-02-18 14:04:49.218209
NCT00727389|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-31|||April 2007||2007-04-01|July 2008|2008-07-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|Incapacity||Prevention of Functional Decline of Aged Women|The Influence of the Support Group on the Functional Incapacity in the Prevention of Functional Decline of Aged Women.|Completed||N/A|31|Actual|Academia Cearense de Odontologia||1|||f||||t||||||||||2017-02-18 14:04:49.627553|2017-02-18 14:04:49.627553
NCT00727376|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2011-08-04|||March 2008||2008-03-01|January 2010|2010-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Evaluation of Polyflex Stenting in Esophageal Cancer Patients|Clinical Evaluation of Polyflex Stenting in Esophageal Cancer Patients Undergoing Chemotherapy and/or Radiation Therapy|Completed||N/A|26|Anticipated|University of Louisville|||1||f||||f||||||||||2017-02-18 14:04:49.722362|2017-02-18 14:04:49.722362
NCT00727181|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-10-17|||November 2007||2007-11-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||An Observational, Prospective Evaluation of the Trifecta™ Valve|An Observational, Prospective Evaluation of the Trifecta™ Valve|Completed||N/A|120|Anticipated|St. Jude Medical||1|||f||||t||||||||||2017-02-18 14:04:54.095197|2017-02-18 14:04:54.095197
NCT00727363|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2011-06-21|||August 2008||2008-08-01|June 2011|2011-06-01|August 2011|Anticipated|2011-08-01|June 2011|Actual|2011-06-01||Interventional|C3P||Prophylactic Probiotics in Premature Infants|Prophylactic Probiotics for the Prevention of Sepsis and NEC in Premature Infants in Colombia. A Randomized Double-Blind, Multicenter Trial|Terminated||Phase 3|751|Actual|Colombian Neonatal Research Network||2||We are underpowered to find a difference in the primary outcome.|f||||t||||||||||2017-02-18 14:04:49.81449|2017-02-18 14:04:49.81449
NCT00727350|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2008-08-01|||March 2007||2007-03-01|August 2008|2008-08-01|December 2012|Anticipated|2012-12-01|March 2012|Anticipated|2012-03-01||Interventional|||Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.|Phase II Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.|Unknown status|Recruiting|Phase 2|44|Anticipated|AZ-VUB||1|||f||||f||||||||||2017-02-18 14:04:49.925975|2017-02-18 14:04:49.925975
NCT00727337|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-01-12|2014-10-22||January 2009||2009-01-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|LACE||Supplementing Hearing Aids With Computerized Auditory Training|Supplementing Hearing Aids With Computerized Auditory Training|Completed||N/A|279|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 14:04:50.016883|2017-02-18 14:04:50.016883
NCT00727324|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2012-03-30|||May 2006||2006-05-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis|A Pilot, Open-label, Multi-center Clinical Trial to Investigate the Safety and Efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis.|Completed||Phase 2|22|Actual|AM-Pharma||1|||f||||t||||||||||2017-02-18 14:04:50.556953|2017-02-18 14:04:50.556953
NCT00727311|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-10-08|2010-12-22||August 2005||2005-08-01|October 2015|2015-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Real-life Surveillance Study of Patients With Chronic Hepatitis C Treated With PegIntron Injector and Rebetol (Study P04538)(COMPLETED)|Treatment of Chronic Hepatitis C With PegIntron Injector and Rebetol (Post Marketing Surveillance Study)|Completed||N/A|2302|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:04:50.709128|2017-02-18 14:04:50.709128
NCT00727298|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-11-30|2012-08-10||February 2006||2006-02-01|November 2015|2015-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|REMission||Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)|Post Marketing Surveillance Study of the Labeled Use of Remicade® (Infliximab) in Patients With Chronic Inflammatory Diseases|Completed||N/A|4485|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:04:51.047786|2017-02-18 14:04:51.047786
NCT00727285|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2013-08-16|||February 2008||2008-02-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Observational|||Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies|CF Leukocyte Genes as Biomarkers for Novel Therapies|Completed||N/A|60|Actual|National Jewish Health|||1||f||||t||||||||||2017-02-18 14:04:51.628837|2017-02-18 14:04:51.628837
NCT00727272|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2010-01-11|2009-11-24||February 2004||2004-02-01|January 2010|2010-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions|A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions|Completed||Phase 1|27|Actual|Mutual Pharmaceutical Company, Inc.||3|||f||||f||||||||||2017-02-18 14:04:51.727199|2017-02-18 14:04:51.727199
NCT00727259|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-04-07|2009-06-18||October 2004||2004-10-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|SATISFACTION||Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)|Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C|Completed||N/A|1995|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:04:52.334456|2017-02-18 14:04:52.334456
NCT00727246|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2013-06-10|||March 2009||2009-03-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||CDP-Choline and Working Memory After TBI: A Neuroimaging Study|CDP-Choline and Working Memory After TBI: A Neuroimaging Study.|Completed||Phase 2|20|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:04:52.559062|2017-02-18 14:04:52.559062
NCT00727233|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2017-01-24|||July 8, 2008||2008-07-08|May 4, 2012|2012-05-04|June 16, 2011|Actual|2011-06-16|June 16, 2011|Actual|2011-06-16||Interventional|||Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas|Phase I Trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, Nexavar) in Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas|Completed||Phase 1|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:04:52.677117|2017-02-18 14:04:52.677117
NCT00727220|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2012-04-01|||January 2004||2004-01-01|April 2012|2012-04-01||||||||Observational|||Prospective Study of the Impact of Insulin Pump Therapy in Young Children With Type 1 Diabetes|A Prospective Study of the Impact of CSII Therapy in Young Children With Type 1 DM|Unknown status|Active, not recruiting|N/A|50|Anticipated|Indiana University|||2||f||||f||||||||||2017-02-18 14:04:52.784548|2017-02-18 14:04:52.784548
NCT00727207|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-12-13|||May 2008||2008-05-01|December 2012|2012-12-01|September 2014|Anticipated|2014-09-01|May 2011|Actual|2011-05-01||Interventional|||Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy|Phase II Trial on Efficacy of mTOR Inhibitor RAD001 as Maintenance Therapy for Patients Above 60 Years in Mantle Cell Lymphoma After First and Second Line Chemotherapy|Terminated||Phase 2|35|Anticipated|Technische Universität München||1||Lack of participations (8 of 25)|f||||||||||||||2017-02-18 14:04:52.876694|2017-02-18 14:04:52.876694
NCT00727194|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2016-12-19|2016-03-22||October 2008||2008-10-01|December 2016|2016-12-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Interventional|||Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis|A Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Multi-Center Study of Eculizumab in Patients With Generalized Myasthenia Gravis (gMG) Who Have Moderate to Severe Muscle Weakness Despite Treatment With Immunosuppressants|Terminated||Phase 2|14|Actual|Alexion Pharmaceuticals|"Small sample size limited ability to detect intercohort differences. Carryover effect from Treatment Period (TP) 1 warrants cautious interpretation of TP 2 data.~Study terminated early; 13 patients received eculizumab or placebo in TP2."|2|||f||||t||||||||||2017-02-18 14:04:52.998478|2017-02-18 14:04:52.998478
NCT00451438|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-03-21|||January 2007||2007-01-01|January 2007|2007-01-01|March 2007||2007-03-01|||||Observational|||Investigation of Muscle Activity Pattern of Gluteus Medius and Tensor Fascia Lata in Patients With PFPS||Completed||N/A|30||National Taiwan University Hospital|||||f||||f||||||||||2017-02-18 15:45:37.469747|2017-02-18 15:45:37.469747
NCT00727168|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2008-08-01|||November 2007||2007-11-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Screening for Glaucoma in Namil Area, South Korea|Epidemiologic Study for the Prevalence of Glaucoma in Namil Area, Geumsan City, South Korea|Completed||N/A|1532|Actual|Korean Glaucoma Society|||1||f||||t||||||||||2017-02-18 14:04:54.190922|2017-02-18 14:04:54.190922
NCT00727155|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2009-07-09|||September 2008||2008-09-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|ACCESS||Adjusting to Chronic Conditions Using Education Support and Skills|Improving Quality Of Life For Chronically Ill Patients Using Education Support And Skills; A Randomized Controlled Mental Trial|Completed||N/A|3|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:04:54.275753|2017-02-18 14:04:54.275753
NCT00727142|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-08-08|||July 2008||2008-07-01|July 2008|2008-07-01|July 2012|Anticipated|2012-07-01|August 2011|Actual|2011-08-01||Interventional|||Conservative Versus Surgical Management of Idiopathic Normal Pressure Hydrocephalus (INPH)|Conservative Versus Surgical Management of Idiopathic Normal Pressure Hydrocephalus|Terminated||N/A|14|Actual|University College London Hospitals||2||observed benefit of treatment larger than expected|f||||f||||||||||2017-02-18 14:04:54.367087|2017-02-18 14:04:54.367087
NCT00727129|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2008-09-25|||July 2004||2004-07-01|September 2008|2008-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms|Placebo-Controlled, Randomized, Double-Blind, Multicenter Study, to Demonstrate the Efficacy of 12 Weeks of Treatment With USL-221 on Moderate to Severe Vasomotor Symptoms and Vulvar/Vaginal Atrophy in Postmenopausal Patients|Completed||Phase 3|495|Actual|Upsher-Smith Laboratories|||||||||||||||||||2017-02-18 14:04:54.474597|2017-02-18 14:04:54.474597
NCT00727116|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-02-06|||January 2008||2008-01-01|February 2015|2015-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Pennsylvania Abusive Head Trauma Prevention Program|Pennsylvania Abusive Head Trauma Prevention Program|Completed||N/A|949609|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 14:04:54.560151|2017-02-18 14:04:54.560151
NCT00727103|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2011-06-02|||July 2008||2008-07-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia|Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia - a Double Blind, Placebo Controlled Trial|Terminated||Phase 4|10|Actual|State University of New York - Upstate Medical University||2||Slow recruitment, high drop-out rate in both arms|f||||t||||||||||2017-02-18 14:04:54.657295|2017-02-18 14:04:54.657295
NCT00727090|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2013-04-30|2010-07-21||August 2008||2008-08-01|April 2013|2013-04-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients|Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients|Terminated||Phase 4|6|Actual|Northwestern University||2||Enrollment below goal.|f||||f||||||||||2017-02-18 14:04:54.890013|2017-02-18 14:04:54.890013
NCT00727077|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-04-07|||June 2006||2006-06-01|April 2015|2015-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)|Treatment of Chronic Hepatitis C in Children With Intron Vial or Pen and Rebetol According to German Law (§ 67 Abs 6 AMG)|Terminated||N/A|3|Actual|Merck Sharp & Dohme Corp.|||1|"Study halted due to low recruitment. The 3 participants at time of termination transferred~   into study P04538 (NCT00727077). See NCT00727077 for details/results."|f||||f||||||||||2017-02-18 14:04:55.386913|2017-02-18 14:04:55.386913
NCT00727064|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2010-05-26|2009-08-31||June 2008||2008-06-01|May 2010|2010-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects|A Randomized, Open-Label, Two-Period, Parallel Group, Crossover Study to Evaluate the Pharmacokinetics of Venlafaxine Extended-Release and DVS SR in Healthy Subjects Who Are Extensive or Poor Cytochrome P450 2D6 Substrate Metabolizers|Completed||Phase 1|14|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:04:55.478405|2017-02-18 14:04:55.478405
NCT00727051|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2014-08-15|||June 2007||2007-06-01|August 2014|2014-08-01||||July 2014|Actual|2014-07-01||Observational|||Comparison of Coronary CT Angiography With Conventional Coronary Angiography in Liver and Lung Transplant Candidates|Comparison of Coronary CT Angiography With Conventional Coronary Angiography in Liver and Lung Transplant Candidates.|Suspended||N/A|20|Anticipated|University of California, San Francisco|||1|No funding|f||||t||||||||||2017-02-18 14:04:55.910239|2017-02-18 14:04:55.910239
NCT00727038|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2010-07-26||||||July 2008|2008-07-01||||||||Interventional|NVG||Lucentis for New Onset Neovascular Glaucoma|Randomized Controlled Trial of Lucentis in the Management of New Onset Neovascular Glaucoma|Withdrawn||Phase 1/Phase 2|30|Anticipated|University of Illinois at Chicago||2||Company withdrew funding/sponsorship|f||||f||||||||||2017-02-18 14:04:56.003465|2017-02-18 14:04:56.003465
NCT00727025|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2013-05-17|2012-02-24||July 2005||2005-07-01|May 2013|2013-05-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Randomized Controlled Trial of Subcuticular Skin Closure Versus Steri-strip S Closure|Closing Linear Incisions in Plastic Surgery: A Randomized Clinical Trial Comparing a New Coaptive Film Device Versus Standard Subcuticular Sutures for Scar Quality, Patient Comfort, and Closure Time|Completed||N/A|51|Actual|Dartmouth-Hitchcock Medical Center|"patients not blinded~surgeons rated photographs of scars, while the patients were rating their actual scars.~All patients were caucasian"|1|||f||||t||||||||||2017-02-18 14:04:56.290287|2017-02-18 14:04:56.290287
NCT00727012|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-07-12|||June 2008||2008-06-01|July 2011|2011-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|MITRAL||Multicenter International Trial Ring AnnulopLasty|Multicenter International Trial Ring AnnulopLasty|Completed||N/A|180|Actual|St. Jude Medical||1|||f||||f||||||||||2017-02-18 14:04:56.556357|2017-02-18 14:04:56.556357
NCT00726999|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2011-01-03|2010-08-19||June 2006||2006-06-01|January 2011|2011-01-01|May 2009|Actual|2009-05-01|July 2008|Actual|2008-07-01||Interventional|||Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion|Perioperative Use of Gabapentin To Decrease Opioid Requirements in Pediatric Spinal Fusion Patients|Completed||N/A|63|Actual|Medical College of Wisconsin||2|||f||||t||||||||||2017-02-18 14:04:56.653194|2017-02-18 14:04:56.653194
NCT00726804|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-08-18|||March 2008||2008-03-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|SPARTA||Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis|Discontinuation of TNF-alpha Inhibitors in Spondylarthritis Patients With Low Disease Activity, and Re-initiation of Therapy if Disease Flares|Terminated||Phase 4|7|Actual|Glostrup University Hospital, Copenhagen||1||It was not possible to recruit patients|f||||t||||||||||2017-02-18 14:04:59.670287|2017-02-18 14:04:59.670287
NCT00726986|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2014-11-05|2014-07-08||July 2008||2008-07-01|November 2014|2014-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Sorafenib in Conjunction With Chemotherapy and as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer|Terminated||Phase 2|18|Actual|Case Comprehensive Cancer Center|This study was terminated after enrolling 18 patients on the basis of excessive toxicity observed and preliminary efficacy data showing that study was unlikely to meet primary end point.|1||Extreme toxicity|f||||t||||||||||2017-02-18 14:04:57.066622|2017-02-18 14:04:57.066622
NCT00726973|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2012-05-09|||December 2006||2006-12-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)|A Pilot Study With Reduced Fluence Photodynamic Therapy With Visudyne Ranibizumab VS. Ranibizumab Only to Treat Exudative AMD|Withdrawn||N/A|0|Actual|Lahey Clinic||2||Unable to recruit study participants|f||||f||||||||||2017-02-18 14:04:57.484481|2017-02-18 14:04:57.484481
NCT00726960|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2008-07-30|||January 2008||2008-01-01|July 2008|2008-07-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers|Modulation of Opiate Reward by NK1 Antagonism: A Laboratory-Based Proof of Concept Study|Unknown status|Active, not recruiting|Phase 1|60|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-02-18 14:04:57.602195|2017-02-18 14:04:57.602195
NCT00726947|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-05-23|||December 2002||2002-12-01|May 2016|2016-05-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Ultrasound Elasticity Imaging of Venous Thrombi|Aging Venous Thrombi With Ultrasound Elasticity Imaging|Completed||Early Phase 1|254|Actual|University of Michigan||2|||f||||f||||||||No||2017-02-18 14:04:57.730537|2017-02-18 14:04:57.730537
NCT00726934|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2017-02-07|||September 2007||2007-09-01|February 2017|2017-02-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients|The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients|Completed||N/A|149|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 14:04:57.835942|2017-02-18 14:04:57.835942
NCT00726921|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2008-07-31|||August 2008||2008-08-01|July 2008|2008-07-01|August 2011|Anticipated|2011-08-01|August 2009|Anticipated|2009-08-01||Observational|||Imaging Modalities in Detection of Coronary Artery Disease in End-Stage Renal Disease Patients|Detection of Significant Coronary Artery Disease in Nephropathy Patients Utilizing Coronary CTA and Real Time Perfusion DSE: Comparison With Quantitative Coronary Angiography and Patient Outcome|Unknown status|Not yet recruiting|N/A|75|Anticipated|University of Nebraska|||1||f||||t||||||||||2017-02-18 14:04:57.95529|2017-02-18 14:04:57.95529
NCT00726908|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2012-06-14|||April 2007||2007-04-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|QuEST||Intramuscular Lipid and Insulin Action:Ethnic Aspects|Intramuscular Lipid and Insulin Action:Ethnic Aspects|Completed||N/A|69|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-02-18 14:04:58.061915|2017-02-18 14:04:58.061915
NCT00726895|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2010-01-11|2009-11-24||May 2004||2004-05-01|January 2010|2010-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions|A Randomized, Two-way Crossover Design Used to Compare the Dose Proportionality of Quinine Sulfate Capsules, 324 mg Following a Single Oral Dose of 1 x 324 mg Capsule Versus 2 x 324 mg Capsules in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:04:58.155146|2017-02-18 14:04:58.155146
NCT00726882|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2014-12-29|2014-12-29||August 2008||2008-08-01|December 2014|2014-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies|A Follow-up Study to Assess the Evolution and Persistence of Resistance to ABT-333 After Discontinuation of ABT-333 Therapy in HCV Genotype-1 Infected Subjects Who Participated in Phase 1, 2, or 3 ABT-333 Clinical Studies|Completed||Phase 2|35|Actual|AbbVie||1|||f||||||||||||||2017-02-18 14:04:58.544438|2017-02-18 14:04:58.544438
NCT00726869|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2012-08-22|||May 2008||2008-05-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies.|A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies.|Terminated||Phase 1|28|Actual|Abbott||4||Enrollment has been halted|f||||t||||||||||2017-02-18 14:04:58.805163|2017-02-18 14:04:58.805163
NCT00726856|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-04-15|||May 2007||2007-05-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)|A Retrospective Survey to Evaluate the Effectiveness and Safety of Dual Inhibition Lipid-lowering Regimen in the Treatment of Dyslipidemic Patients in Normal Practice|Completed||N/A|1200|Anticipated|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:04:59.018431|2017-02-18 14:04:59.018431
NCT00726843|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-04-06|||July 2008||2008-07-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of Yoga for the Treatment of Pediatric Headaches|Evaluation of Yoga for the Treatment of Pediatric Headaches|Terminated||N/A|7|Actual|Medical College of Wisconsin||2||Enrollment proceeded too slowly to conduct study as RCT.|f||||f||||||||||2017-02-18 14:04:59.125336|2017-02-18 14:04:59.125336
NCT00726830|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-11-09|2012-11-09||March 2009||2009-03-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer|"A Randomized Comparison of Oral Methadone as a First-Switch Opioid Versus Opioid Switching Between Sustained-Release Morphine and Oxycodone for Oncology-Hematology Outpatients With Pain Management Problems: The Simply Rotate Study"|Terminated||N/A|1|Actual|M.D. Anderson Cancer Center||2||Low Accrual.|f||||t||||||||||2017-02-18 14:04:59.227651|2017-02-18 14:04:59.227651
NCT00726817|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2008-07-31|||December 2007||2007-12-01|July 2008|2008-07-01||||February 2008|Actual|2008-02-01||Interventional|||The Effects of Butyrate Enemas on Visceral Perception|The Effects of Butyrate Enemas on Visceral Perception|Completed||N/A|11|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-02-18 14:04:59.578642|2017-02-18 14:04:59.578642
NCT00726791|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2011-07-21|||April 2008||2008-04-01|July 2011|2011-07-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy of rTMS (Repetitive Transcranial Magnetic Stimulation) on Patients With Somatoform Pain Disorder|Efficacy of rTMS (Repetitive Transcranial Magnetic Stimulation) on Patients With Somatoform Pain Disorder|Withdrawn||N/A|10|Actual|Samsung Medical Center||1||patient did not enroll|f||||t||||||||||2017-02-18 14:04:59.766063|2017-02-18 14:04:59.766063
NCT00726778|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-03-15|||May 2004||2004-05-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Observational|AMERICO||Admixture Mapping of Ethnic and Racial Insulin Complex Outcomes|Admixture Mapping of Ethnic and Racial Insulin Complex Outcomes|Completed||N/A|360|Anticipated|University of Alabama at Birmingham|||1||f||||f||||||Samples With DNA|"~     Three 5-ml blood samples will be obtained from each subject and sent to the Laboratory Core~     of the General Clinical Research Center to establish EBV lymphoblastoid cell lines and for~     DNA extraction. EBV lines will be kept at UAB for future genetic analysis. Extracted DNA~     will be sent to Dr. Mark Shriver at the Pennsylvania State University for genotyping of the~     ancestry informative markers (AIMs).~   "|||2017-02-18 14:04:59.8743|2017-02-18 14:04:59.8743
NCT00726765|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2016-01-20|||June 2008||2008-06-01|January 2016|2016-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain (Study P05320)(COMPLETED)|Observational Trial on the Value of Diagnostic Criteria in the Diagnosis of Spinal Spondyloarthropathies in Patients With Chronic Low Back Pain|Completed||N/A|1090|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:04:59.963623|2017-02-18 14:04:59.963623
NCT00726752|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2012-05-17|2012-02-25||July 2008||2008-07-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study In Patients With Advanced Solid Tumor|A Phase 1 Study In Patients With Advanced Solid Tumor To Evaluate The Pharmacokinetics And Safety Of AG-013736 At Single Doses Of 5 mg, 7 mg And 10 mg, And At Multiple Doses|Completed||Phase 1|6|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:05:00.172349|2017-02-18 14:05:00.172349
NCT00726739|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2012-11-07|2012-08-29||June 2008||2008-06-01|November 2012|2012-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma|A Randomized Phase II Study of IL-2 With or Without an Allogeneic Large Multivalent Immunogen (LMI) Vaccine for the Treatment of Stage IV Melanoma|Terminated||Phase 2|21|Actual|Masonic Cancer Center, University of Minnesota||3||Pre-planned analysis established it unlikely study would meet primary objective.|f||||t||||||||||2017-02-18 14:05:00.56773|2017-02-18 14:05:00.56773
NCT00726726|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2008-11-04|||August 2008||2008-08-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Drug Interaction Study With a Potential Alzheimer's Disease Compound|Effect of Concomitant Administration of BMS-708163 on the Pharmacokinetics of Midazolam, Warfarin, Caffeine, Omeprazole and Dextromethorphan in Healthy Male Subjects by Administration of a Modified Cooperstown Cocktail|Completed||Phase 1|22|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 14:05:01.320182|2017-02-18 14:05:01.320182
NCT00726713|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2013-07-26|2013-05-02||June 2008||2008-06-01|July 2013|2013-07-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)|A 24 Week, Double-blind, Placebo-controlled, Multisite Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)|Completed||Phase 4|214|Actual|Pamlab, Inc.|Adverse Event reporting detailed in the “Other Adverse Events” section was provided only with specificity to the affected Organ System. Additional detail for the “Other Adverse Events” was not available at the time of reporting.|2|||f||||f||||||||||2017-02-18 14:05:01.453308|2017-02-18 14:05:01.453308
NCT00726700|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-31|2013-08-01|||May 2004||2004-05-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|||||Interventional|||Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma|Randomized Phase II Study About the Application of Pegfilgrastim (Neulasta) at Day 2 or Day 4 Within the Treatment in Patients With Aggressive Non-Hodgkin's Lymphoma Aged 61 to 80 Years With 6 or 8 Cycles of Chemotherapy With CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) at 14-day Intervals (CHOP-14), Both With or Without the Monoclonal Anti-CD20 Antibody Rituximab|Completed||Phase 2|109|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:05:02.238536|2017-02-18 14:05:02.238536
NCT00726687|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2012-07-18|||June 2008||2008-06-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors|Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1/Phase 2|7|Actual|Ziopharm||1|||f||||f||||||||||2017-02-18 14:05:02.398916|2017-02-18 14:05:02.398916
NCT00726674|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2012-03-07|||August 2008||2008-08-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|Lapas II||Basal Insulin for Type 2 Diabetes Patients Treated in Outpatient Clalit Clinics|Lantus for Diabetic Patients Treated in Clalit Outpatient Clinics|Completed||N/A|1229|Actual|Sanofi|||1||f||||f||||||||||2017-02-18 14:05:02.525544|2017-02-18 14:05:02.525544
NCT00726661|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2016-05-23|2016-04-05||June 2008||2008-06-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|VIRGO|Baseline characteristics was analyzed for all enrolled participants in respective individual groups (CT Cohort and HT Cohort); therefore, the data for 'mean age' for total population is not applicable for this study.|An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)|An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer|Completed||Phase 4|1287|Actual|Genentech, Inc.|||2||f||||||||||Samples With DNA|"~     Whole blood and tissue~   "|||2017-02-18 14:05:02.631629|2017-02-18 14:05:02.631629
NCT00726583|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2011-10-27|||June 2008||2008-06-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Phase I Trial of Oral PX-866|A Phase I Trial of Oral PX-866 (a PI-3K Inhibitor) in Patients With Advanced Solid Tumors|Completed||Phase 1|90|Anticipated|Cascadian Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 14:05:03.326426|2017-02-18 14:05:03.326426
NCT00726570|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2013-11-04|||August 2008||2008-08-01|November 2013|2013-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|TEGLeg||Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs|Effects of Sequential Compression Devices on Coagulation Parameters Assessed by TEG® in Patients Undergoing Major Abdominal Surgery|Terminated||N/A|40|Actual|University of Parma||2||Failed to reach the expected enrollment rates by the end of 2010|f||||f||||||||||2017-02-18 14:05:03.427807|2017-02-18 14:05:03.427807
NCT00726557|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2015-10-08|2010-04-15||October 2005||2005-10-01|October 2015|2015-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|SUPPORT||Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)|Quality Assurance of HCV-therapy With PegIntron® Plus Rebetol® in Drug-substituted Patients - SUPPORT Project Post-Marketing Surveillance Study|Completed||N/A|246|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:03.555543|2017-02-18 14:05:03.555543
NCT00726544|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2009-11-24|||December 2008||2008-12-01|November 2009|2009-11-01|March 2011|Anticipated|2011-03-01|December 2010|Anticipated|2010-12-01||Interventional|||Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy|A Randomized, Double-blind, Placebo Controlled, Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy|Terminated||Phase 2|100|Anticipated|Archemix Corp.||4||Enrollment into study was slower than expected.|f||||t||||||||||2017-02-18 14:05:03.886311|2017-02-18 14:05:03.886311
NCT00726531|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2010-07-07|||June 2008||2008-06-01|July 2010|2010-07-01|May 2013|Anticipated|2013-05-01|May 2011|Anticipated|2011-05-01||Interventional|ProAct65+||Promoting Physical Activity in the Over 65s|Multi-centre Cluster Randomised Trial Comparing a Community Group Exercise Programme With Home Based Exercise With Usual Care for Over 65s in Primary Care|Unknown status|Recruiting|Phase 3|1200|Anticipated|University College, London||3|||f||||t||||||||||2017-02-18 14:05:04.007065|2017-02-18 14:05:04.007065
NCT00726505|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2016-10-14|||June 2009||2009-06-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|MOA||Renal Mechanism of Action/Splay vs. TmG|Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 1|1|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:05:04.115492|2017-02-18 14:05:04.115492
NCT00726492|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2008-07-29|||June 2001||2001-06-01|July 2008|2008-07-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||An Examination of the Value of Shortwave Diathermy and Hydrotherapy for Patients With Osteoarthritis of Their Knees|A Randomised Controlled Trial Evaluating the Effects of Shortwave Diathermy and Hydrotherapy for Patients With Osteoarthritis of Their Knees|Completed||N/A|77|Actual|University College Dublin||4|||f||||f||||||||||2017-02-18 14:05:04.215124|2017-02-18 14:05:04.215124
NCT00726479|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2014-03-26|||August 2008||2008-08-01|March 2014|2014-03-01||||September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis|A Phase II, Randomised, Double-blind, Placebo-controlled and Parallel Group Study to Evaluate the Safety and Efficacy of Four Weeks Treatment of 7.5 mg b.i.d, 15 mg q.d and 15 mg b.i.d. BIBW 2948 BS (Inhalation Powder, Hard Capsule for HandiHaler®) in Patients With COPD Associated With Chronic Bronchitis.|Withdrawn||Phase 2|0|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:05:04.317943|2017-02-18 14:05:04.317943
NCT00726466|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2015-07-06|||March 2008||2008-03-01|July 2015|2015-07-01||||||||Interventional|SEIRA||Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration|A Phase I Study of the Inhibition of LFA-1 to Intercellular Adhesion Molecule-1 (ICAM-1) Using Subcutaneous Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (SEIRA)|Withdrawn||Phase 1|0|Actual|Vitreous -Retina- Macula Consultants of New York||1||Lack of recruitment|||||f||||||||||2017-02-18 14:05:04.427613|2017-02-18 14:05:04.427613
NCT00726453|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2016-04-21|2012-01-31||July 2008||2008-07-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|January 2011|Actual|2011-01-01||Interventional|R-US||The Medtronic RESOLUTE US Clinical Trial|A Clinical Evaluation of the Medtronic Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries With a Reference Vessel Diameter of 2.25 mm to 4.2mm|Completed||N/A|1516|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-02-18 14:05:04.562502|2017-02-18 14:05:04.562502
NCT00726440|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2012-02-08|||February 2008||2008-02-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaemic Control in Type 1 Diabetic Patients?|Are the Continous Glucose Monitoring Systems Able to Improve Long Term Glycaemic Control in Type 1 Diabetic Patients With Poor Metabolic Control?|Completed||N/A|180|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||3|||f||||f||||||||||2017-02-18 14:05:07.927524|2017-02-18 14:05:07.927524
NCT00726427|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2010-12-02|||July 2008||2008-07-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers|A Randomized, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction After Single Ascending Oral Doses of AZD1656 in Healthy Male Subjects|Completed||Phase 1|32|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:05:08.064521|2017-02-18 14:05:08.064521
NCT00726414|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2010-01-13|2009-12-04||December 2005||2005-12-01|January 2010|2010-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg|A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg Under Fasting and Fed Conditions|Completed||Phase 1|22|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:05:08.160933|2017-02-18 14:05:08.160933
NCT00726401|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2010-10-07|||May 2008||2008-05-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis|A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis|Completed||Phase 2|200|Anticipated|Afexa Life Sciences Inc||2|||f||||f||||||||||2017-02-18 14:05:08.706842|2017-02-18 14:05:08.706842
NCT00726388|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2009-04-17|||September 2008||2008-09-01|April 2009|2009-04-01|May 2009|Anticipated|2009-05-01|April 2009|Anticipated|2009-04-01||Interventional|||An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain|An Open-Label, Multiple-Dose, Multiple-Day, Non-Randomized, Single-Arm Safety Study Of Repeat-Doses Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain|Unknown status|Active, not recruiting|Phase 3|850|Anticipated|Javelin Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:05:08.829183|2017-02-18 14:05:08.829183
NCT00724984|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-02-27|2014-02-27||July 2008||2008-07-01|February 2014|2014-02-01||||November 2012|Actual|2012-11-01||Interventional|PCYC-0403||Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma|Phase I/II Dose-Escalation Study of the Pan-Histone Deacetylase (HDAC) Inhibitor PCI-24781 in Lymphoma|Completed||Phase 1/Phase 2|55|Actual|Pharmacyclics LLC.||1|||f||||f||||||||||2017-02-18 14:05:19.068397|2017-02-18 14:05:19.068397
NCT00726375|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2015-12-04|2014-07-08||May 2008||2008-05-01|December 2015|2015-12-01|September 2014|Actual|2014-09-01|July 2013|Actual|2013-07-01||Interventional|||The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease|The Use of Etanercept (Enbrel) as Sole Treatment for Grade I Acute Graft Versus Host Disease|Completed||Phase 3|34|Actual|University of Michigan Cancer Center|Due to difficulties obtaining approval for insurance coverage of the study drug, only 34 of 50 patients were enrolled. The study was terminated prematurely and findings were reported for 34 patients.|1|||f||||t||||||||||2017-02-18 14:05:09.002847|2017-02-18 14:05:09.002847
NCT00726362|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2010-12-02|||December 2007||2007-12-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia|To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia|Completed||N/A|3270|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:05:09.37371|2017-02-18 14:05:09.37371
NCT00726349|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-05-04|||May 2008||2008-05-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|TRIOS||Transfusion Requirements in Orthopedic Surgery (PHASE 2)|Transfusion Requirements in Orthopedic Surgery (Phase 2): A Prospective Observational Evaluation of the Optimal Transfusion Trigger.|Completed||N/A|305|Actual|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-02-18 14:05:09.471407|2017-02-18 14:05:09.471407
NCT00726336|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2010-10-14||2010-10-14|August 2008||2008-08-01|October 2010|2010-10-01||||October 2008|Actual|2008-10-01||Interventional|||GSK1349572 Drug Interaction With Tenofovir|A Phase I, Open Label, Single Sequence,Drug Interaction Study Evaluating Plasma GSK1349572 and Tenofovir Pharmacokinetics in Healthy Adult Subjects (ING111604)|Completed||Phase 1|16|Anticipated|GlaxoSmithKline||1|||||||||||||||||2017-02-18 14:05:09.567767|2017-02-18 14:05:09.567767
NCT00726323|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-11-30||2012-03-01|June 2006||2006-06-01|November 2016|2016-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)|A Phase 2 Study of the c-Met RTK Inhibitor GSK1363089 (Formerly XL880) in Subjects With Papillary Renal-Cell Carcinoma|Completed||Phase 2|74|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:05:09.671224|2017-02-18 14:05:09.671224
NCT00726310|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-03-14|||May 2000||2000-05-01|February 2012|2012-02-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Observational|||Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability|A Multicenter Prospective Patient Outcome Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability|Completed||N/A|205|Actual|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-02-18 14:05:09.794767|2017-02-18 14:05:09.794767
NCT00726297|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2012-12-18|||January 2005||2005-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:05:09.901069|2017-02-18 14:05:09.901069
NCT00726284|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-03-14|||April 2004||2004-04-01|February 2012|2012-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|SPO||Spine Patient Outcomes Registry for Biomet/EBI|BIOMET/EBI Spine Patient Outcomes Registry|Completed||N/A|651|Actual|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-02-18 14:05:09.951025|2017-02-18 14:05:09.951025
NCT00726271|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-30|||June 2008||2008-06-01|July 2008|2008-07-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Pilot Study of Dietary Modification of Appetite Set Point in Obesity|A Pilot 6 Week Study of the Feasibility and Acceptability of Dietary Modification With the Goal of Changing the Appetite Set Point in People Taking Medications That Cause Weight Gain Through Increased Appetite.|Unknown status|Enrolling by invitation|N/A|50|Anticipated|State University of New York - Upstate Medical University||1|||f||||f||||||||||2017-02-18 14:05:10.049821|2017-02-18 14:05:10.049821
NCT00726258|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2014-08-27|||March 2008||2008-03-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Association of Intravenous Ketamine With Thoracic Epidural Analgesia: Effects on Pain and Respiratory Function Following Thoracotomy.|Association of Intravenous Ketamine With Thoracic Epidural Analgesia: Effects on Pain and Respiratory Function Following Thoracotomy.|Terminated||N/A|21|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 14:05:10.160918|2017-02-18 14:05:10.160918
NCT00726245|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-07-10|||January 2008||2008-01-01|July 2011|2011-07-01|March 2011|Actual|2011-03-01|February 2009|Actual|2009-02-01||Interventional|||Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear|PRP as a Treatment for Acute Muscle Tears - Randomized-double-blind-placebo Control Trail.|Completed||Phase 2/Phase 3|50|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-02-18 14:05:10.272909|2017-02-18 14:05:10.272909
NCT00726232|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-10-25|2012-01-20||July 2008||2008-07-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|June 2010|Actual|2010-06-01||Interventional|||Study to Determine the Safety and Efficacy of Ruxolitinib (INCB018424) in Patients With Polycythemia Vera or Essential Thrombocythemia|An Open-Label Study to Determine the Safety and Efficacy of INCB018424 in Patients With Advanced Polycythemia Vera or Essential Thrombocythemia Refractory to Hydroxyurea|Active, not recruiting||Phase 2|73|Actual|Incyte Corporation||3|||f||||f||||||||||2017-02-18 14:05:10.374923|2017-02-18 14:05:10.374923
NCT00726219|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-02-09|||December 2008||2008-12-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Insertion Distance of Femoral Perineural Catheters in the Context of Major Knee Surgery.|Influence of the Insertion Distance on Loss of Sensation Produced by Femoral Perineural Catheters in the Context of Major Knee Surgery.|Completed||N/A|72|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||f||||||||||2017-02-18 14:05:12.371116|2017-02-18 14:05:12.371116
NCT00726206|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2014-08-27|||July 2008||2008-07-01|August 2014|2014-08-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Correlation Between the Analysis of the Rapid Cortical Oscillations, the General Movements of the Preterm's and the Cerebral Palsy|Correlation Between the Analysis of the Rapid Cortical Oscillations, the General Movements of the Preterm's and the Cerebral Palsy|Completed||N/A|44|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 14:05:12.46496|2017-02-18 14:05:12.46496
NCT00725322|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-06-04|||December 2007||2007-12-01|June 2012|2012-06-01|January 2013|Anticipated|2013-01-01|October 2012|Anticipated|2012-10-01||Interventional|||Subcutaneous Botulinum Toxin for Cutaneous Allodynia|Subcutaneous Botulinum Toxin for Cutaneous Allodynia|Unknown status|Active, not recruiting|N/A|70|Anticipated|Stanford University||2|||f||||||||||||||2017-02-18 14:05:28.948202|2017-02-18 14:05:28.948202
NCT00726193|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-03-14|||June 2006||2006-06-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Study to Analyze the Effects of EBI OsteoGen™ on the Surgical Reconstruction of Tibia Non-unions|A Prospective Randomized Multi - Center Clinical Outcomes Collection Study To Analyze The Effect Of Ebi Osteogen™ Direct Current Stimulator On The Surgical Reconstruction Of Tibia Nonunions|Terminated||N/A|4|Actual|Zimmer Biomet|||2|Slow enrollment|f||||f||||||||Undecided||2017-02-18 14:05:12.568599|2017-02-18 14:05:12.568599
NCT00726180|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2013-08-09|2013-03-08||July 2008||2008-07-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|||Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer|Evaluation of the Use of Trastuzumab to Induce Increased ER Expression in ER-Negative/Low, Her-2/Neu Positive Breast Cancer|Terminated||Phase 1/Phase 2|1|Actual|University of Michigan Cancer Center||1||Due to low enrollment|f||||t||||||||||2017-02-18 14:05:12.673227|2017-02-18 14:05:12.673227
NCT00726167|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-10-03|||September 2008||2008-09-01|October 2016|2016-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Serum Procalcitonin Study in the Management of Ventilated Patients|Clinical Utility of Serum Procalcitonin in the Management of Ventilator-Associated Pneumonia|Completed||N/A|29|Actual|University of Missouri-Columbia|||1||f||||f||||||||No||2017-02-18 14:05:12.877918|2017-02-18 14:05:12.877918
NCT00726154|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-01-10|||June 2009||2009-06-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Rhythms||Pilot Study of the Effects of Circadian Rhythms on the Treatment of Bipolar I Depression.|Rhythmicity as a Moderator of Treatment Outcomes of Bipolar I Depression -Pilot Study|Withdrawn||N/A|0|Actual|University of Pittsburgh||2||This study did not receive funding|f||||f||||||||||2017-02-18 14:05:12.985219|2017-02-18 14:05:12.985219
NCT00726141|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-30|||October 2004||2004-10-01|July 2008|2008-07-01|October 2007|Actual|2007-10-01|January 2005|Actual|2005-01-01||Interventional|BRISC||Brief Interventions on Smoking for Hormonal Contraceptive Users|Brief Interventions on Smoking for Hormonal Contraceptive Users|Completed||N/A|699|Actual|University of Luebeck||1|||f||||f||||||||||2017-02-18 14:05:13.093246|2017-02-18 14:05:13.093246
NCT00726128|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-03-14|||August 1998||1998-08-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|VueLock||Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System|A Multi-Center Prospective Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System|Completed||N/A|371|Actual|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-02-18 14:05:13.178504|2017-02-18 14:05:13.178504
NCT00726115|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2009-07-29|||August 2008||2008-08-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531|Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Dose of SAM-531 Administered Orally To Healthy Young and Elderly Subjects|Completed||Phase 1|56|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:05:13.339614|2017-02-18 14:05:13.339614
NCT00726102|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-04-26|||November 2008||2008-11-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|May 2012|Actual|2012-05-01||Interventional|||Development and Health of Rural Chinese Children Fed Meat as a Daily Complementary Food From 6-18 Mos of Age|Development and Health of Rural Chinese Children Fed Meat as a Daily Complementary Food From 6-18 Mos of Age|Completed||N/A|1488|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-02-18 14:05:13.584312|2017-02-18 14:05:13.584312
NCT00726076|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2013-12-10|||July 2008||2008-07-01|December 2013|2013-12-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Managing Epilepsy Well- WebEase Project|Managing Epilepsy Well: Self-Management Intervention Research-Coordinating Center|Completed||N/A|194|Actual|Emory University||2|||f||||f||||||||||2017-02-18 14:05:13.699561|2017-02-18 14:05:13.699561
NCT00726063|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2015-01-13|2013-11-19||April 2008||2008-04-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|CollegeBowl|Nanotite implants = 239 Osseotite implants = 246|A Prospective Study Evaluating the Performance of Nanotite Osseotite Implants When Placed by Graduate Student Programs|A Prospective Randomized-controlled Evaluation of Nanotite and Osseotite Surfaced Implant Performance in Graduate Student Programs|Completed||N/A|241|Actual|Zimmer Biomet||2|||f||||t||||||||||2017-02-18 14:05:13.807673|2017-02-18 14:05:13.807673
NCT00726050|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2017-01-24|||July 28, 2008||2008-07-28|April 29, 2010|2010-04-29|April 29, 2010||2010-04-29|||||Observational|||Brain Activity in Time Discrimination and Sensory Input|The Relationship Between Temporal Discrimination and Cortical Excitability in Humans|Completed||N/A|4|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:05:14.142397|2017-02-18 14:05:14.142397
NCT00726037|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-08-23|2013-04-26||October 2008||2008-10-01|August 2016|2016-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer|A Pilot Study Evaluating the Efficacy of Regulatory T-cell (T-reg) Suppression by Denileukin Diftitox (Ontak) in Metastatic Pancreatic Cancer|Terminated||Phase 2|7|Actual|Loyola University|This study was prematurely terminated, because the study drug Ontak is no longer supplied by the manufacturer for this study. Data is not analyzed for any outcome measures.|1||Collaborator withdrew support due to a drug supply interruption.|f||||t||||||||No||2017-02-18 14:05:14.440409|2017-02-18 14:05:14.440409
NCT00726024|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2012-12-18|||July 2002||2002-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:05:14.674515|2017-02-18 14:05:14.674515
NCT00726011|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-10-22|||July 2008||2008-07-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|December 2011|Actual|2011-12-01||Interventional|TEC-006OL||Tetrodotoxin Open-label Efficacy and Safety Continuation Study|A Multicentre, Open-label, Long-term Efficacy and Safety Continuation Study of Subcutaneous Tetrodotoxin (TTX) for Moderate to Severe Cancer-related Pain|Completed||Phase 3|113|Actual|Wex Pharmaceuticals Inc.||1|||f||||f||||||||||2017-02-18 14:05:14.718494|2017-02-18 14:05:14.718494
NCT00725998|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-10-17||||||July 2008|2008-07-01||||||||Observational|ECAP||Longitudinal Study Of The Evoked Compound Action Potential Measured In Children Cochlear Implant Users|Longitudinal Study Of The Evoked Compound Action Potential Measured In Children Cochlear Implant Users|Completed||N/A|||University of Sao Paulo|||1||f||||||||||||||2017-02-18 14:05:14.821421|2017-02-18 14:05:14.821421
NCT00724529|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-01-21|||June 2007||2007-06-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Post Marketing Surveillance of Remicade|Post Marketing Surveillance of Remicade in Inflammatory Bowel Disease (IBD)|Completed||Phase 4|938|Actual|Janssen Korea, Ltd., Korea|||3||f||||||||||||||2017-02-18 14:05:50.428988|2017-02-18 14:05:50.428988
NCT00725985|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2013-08-02|2013-06-11||December 2008||2008-12-01|August 2013|2013-08-01|April 2012|Actual|2012-04-01|July 2011|Actual|2011-07-01||Interventional|ORACLE MS|The intent-to-treat (ITT) population included all randomized participants who received at least 1 dose of ITP study medication (cladribine or placebo).|Oral Cladribine in Early Multiple Sclerosis (MS)|A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS|Completed||Phase 3|617|Actual|EMD Serono|Due to early termination of trial, efficacy data presented from core double blind ITP only. Due to low number of participants entering OLMP and LTFU period and the reduced duration, only descriptive safety data from OLMP and LTFU are presented.|3|||f||||t||||||||||2017-02-18 14:05:14.91376|2017-02-18 14:05:14.91376
NCT00725972|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2010-03-09|||July 2008||2008-07-01|March 2010|2010-03-01||||May 2011|Anticipated|2011-05-01||Interventional|||Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures|Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures.|Unknown status|Recruiting|N/A|200|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:05:17.158525|2017-02-18 14:05:17.158525
NCT00725959|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2012-01-26|||September 2008||2008-09-01|July 2009|2009-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Online Social Networking for HIV Prevention|Online Social Networking for HIV Prevention|Unknown status|Recruiting|Phase 1/Phase 2|6204|Anticipated|Colorado School of Public Health||2|||f||||f||||||||||2017-02-18 14:05:17.268179|2017-02-18 14:05:17.268179
NCT00725946|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-05-30|||February 2008||2008-02-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT|A Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT|Terminated||Early Phase 1|7|Actual|Stanford University||1|||f||||||||||||||2017-02-18 14:05:17.363675|2017-02-18 14:05:17.363675
NCT00725933|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2017-01-05|||June 2008||2008-06-01|January 2017|2017-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Administration of BIIB028 to Subjects With Solid Tumors|A Phase 1, Multicenter, Open-Label, Dose Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of BIIB028 Administered to Subjects With Advanced Solid Tumors|Completed||Phase 1|43|Actual|Biogen||1|||f||||f||||||||||2017-02-18 14:05:17.452807|2017-02-18 14:05:17.452807
NCT00725920|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-08-05|2010-06-01||January 2007||2007-01-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Placebo Controled Clinical Trial Using Topiramate To Treat Posttraumatic Stress Disorder (PTSD) Patients.|Randomized Clinical Trial to Study the Topiramate Efficacy for Posttraumatic Disorder Treatment|Completed||Phase 4|35|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:05:17.549033|2017-02-18 14:05:17.549033
NCT00725907|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-07-10|||January 2008||2008-01-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Treatment of ATFL Tears With PRP|Treatment of ATFL Tears After Ankle Sprains With PRP|Completed||N/A|30|Anticipated|Meir Medical Center||2|||f||||||||||||||2017-02-18 14:05:18.041613|2017-02-18 14:05:18.041613
NCT00725894|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2013-11-15|||November 2007||2007-11-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Observational|PLN||Pediatric Locking Nail for the Treatment of Femoral Fractures in Children|A Prospective Multi-Center Clinical Outcomes Study To Assess The Safety and Effectiveness Of The Pediatric Locking Nail For Treatment Of Femoral Fractures In Children|Completed||N/A|33|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 14:05:18.134079|2017-02-18 14:05:18.134079
NCT00725881|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2011-07-01||2011-06-14|August 2008||2008-08-01|July 2011|2011-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication|A Randomized, Double-Blinded, Placebo-Controlled Phase 1/2 Dose-Range-Finding Study to Evaluate the Safety, Efficacy and PK of Multiple Once Daily Intravenous Doses of TSC in Patients With Intermittent Claudication|Completed||Phase 1/Phase 2|48|Actual|Diffusion Pharmaceuticals LLC||9|||f||||t||||||||||2017-02-18 14:05:18.234855|2017-02-18 14:05:18.234855
NCT00725868|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-30|2011-08-25|||September 2007||2007-09-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention|Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.|Completed||N/A|170|Anticipated|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 14:05:18.352674|2017-02-18 14:05:18.352674
NCT00725855|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2008-07-30|||August 2008||2008-08-01|July 2008|2008-07-01|April 2009|Anticipated|2009-04-01|March 2009|Anticipated|2009-03-01||Interventional|P50||A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients|A Single-Center, Double-Blind, Placebo-Controlled, Randomized Blocks Study Investigating the Effect of 4 Dosages (1 mg, 5 mg, 15 mg, 50 mg) of MEM 3454 on P50 Sensory Gating and Mismatch Negativity (MMN) in Patients With Schizophrenia|Unknown status|Not yet recruiting|Phase 2|12|Anticipated|Memory Pharmaceuticals||5|||f||||f||||||||||2017-02-18 14:05:18.457539|2017-02-18 14:05:18.457539
NCT00725842|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2015-09-18|2012-06-13||January 2009||2009-01-01|September 2015|2015-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|RE-CHUT||Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)|Relapse Rate and Predictive Factors in the Treatment of Hepatitis C in Common Clinical Practice|Terminated||N/A|97|Actual|Merck Sharp & Dohme Corp.|Due to low enrollment some planned analyses were not performed.||1|Low enrollment|f||||f||||||||||2017-02-18 14:05:18.575388|2017-02-18 14:05:18.575388
NCT00725829|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-02-09|||June 2008||2008-06-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects|Effects of Simvastatin Versus Simvastatin Combined With Ezetimibe on Blood Coagulation in Patients With Acute Coronary Events: Relationship With Cholesterol-Lowering and Anti-Inflammatory Properties|Unknown status|Recruiting|N/A|100|Anticipated|Jagiellonian University||2|||f||||f||||||||||2017-02-18 14:05:18.829239|2017-02-18 14:05:18.829239
NCT00724997|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2009-12-07|||March 2007||2007-03-01|December 2009|2009-12-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|GHBCS-01||Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers|Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers|Completed||Phase 1|48|Actual|AVIR Green Hills Biotechnology AG||5|||f||||t||||||||||2017-02-18 14:05:18.939318|2017-02-18 14:05:18.939318
NCT00724971|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-02-14|||July 2008||2008-07-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study Evaluating The Safety And Tolerability Of Combination Therapy Inotuzumab Ozogamicin (CMC-544) And Rituximab|A Phase 1 Study Of Inotuzumab Ozogamicin (CMC-544) Administered In Combination With Rituximab In Subjects With B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1|10|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 14:05:20.582543|2017-02-18 14:05:20.582543
NCT00724958|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-10-01|2011-07-13||December 2004||2004-12-01|October 2015|2015-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)|Real Life Dosing Regimen of Remicade in Austria in Crohn's Disease - Program Extension|Completed||N/A|348|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:20.696323|2017-02-18 14:05:20.696323
NCT00724945|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-05-05|2009-09-25||July 2008||2008-07-01|May 2015|2015-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Two Soft Bifocal Contact Lenses||Completed||N/A|113|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||||||||||||2017-02-18 14:05:21.266235|2017-02-18 14:05:21.266235
NCT00724932|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2015-02-26|2013-03-14||July 2008||2008-07-01|February 2015|2015-02-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional||The Baseline Analysis Population consisted of randomized participants who received investigational medicinal product (IMP). Four participants randomized to Sugammadex did not receive IMP and three participants randomized to receive Neostigmine did not receive IMP.|Comparison of Sugammadex With Neostigmine During Laparoscopic Cholecystectomy or Appendectomy (P05699)|A Multi-center, Randomized, Parallel-group, Comparative, Active-controlled, Safety-assessor Blinded Trial in Adult Subjects Comparing the Efficacy and Safety of Sugammadex (SCH 900616, ORG 25969) Administered at 1-2 PTC With Neostigmine Administered at Reappearance of T2 in Subjects Undergoing Laparoscopic Cholecystectomy or Appendectomy Under Propofol Anesthesia|Completed||Phase 3|140|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 14:05:21.5581|2017-02-18 14:05:21.5581
NCT00725816|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-03-14|||August 2006||2006-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:05:22.597842|2017-02-18 14:05:22.597842
NCT00725803|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2014-06-11||2014-01-03|April 2008||2008-04-01|June 2014|2014-06-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV|A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Activity of GS-9450, a Caspase Inhibitor, in Subjects With Chronic Hepatitis C (GS-US-227-0102)|Completed||Phase 2|33|Actual|Gilead Sciences||4|||f||||f||||||||||2017-02-18 14:05:22.64783|2017-02-18 14:05:22.64783
NCT00725790|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-28|||August 2008||2008-08-01|July 2008|2008-07-01|September 2009|Anticipated|2009-09-01|August 2009|Anticipated|2009-08-01||Interventional|SCI||A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury|Multi-Centre, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury|Unknown status|Not yet recruiting|Phase 4|350|Anticipated|China Rehabilitation Research Center||2|||f||||||||||||||2017-02-18 14:05:22.773707|2017-02-18 14:05:22.773707
NCT00725777|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2012-02-16|||July 2008||2008-07-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Treatment of Non-falciparum Malaria|Efficacy and Safety of Artemether Lumefantrine Combination Therapy for the Treatment of Malaria Due to Plasmodium Ovale, Plasmodium Malariae, and Mixed Plasmodium Infections in Gabon|Completed||N/A|40|Actual|Albert Schweitzer Hospital||1|||f||||f||||||||||2017-02-18 14:05:22.884639|2017-02-18 14:05:22.884639
NCT00725764|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-10-26||2010-02-05|August 2007||2007-08-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck|A Phase 2 Study of the MET RTK Inhibitor GSK1363089 (Formerly XL880) in Subjects With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|14|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:05:22.994808|2017-02-18 14:05:22.994808
NCT00725751|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-10-01|2012-03-23||September 2007||2007-09-01|October 2015|2015-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)|Evaluation of Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Patients With/Without Substitution Therapy in Austria|Completed||N/A|353|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:05:23.111114|2017-02-18 14:05:23.111114
NCT00725738|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-29|||May 2008||2008-05-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|TRACIA||Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction: TRACIA STUDY.|Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction: TRACIA Study.|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|National Heart Institute, Mexico||1|||f||||f||||||||||2017-02-18 14:05:23.464572|2017-02-18 14:05:23.464572
NCT00725725|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-11-01|2016-08-10||July 2008||2008-07-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)|A Multi-center, Double-blind, Fixed Dose Trial Examining the Efficacy and Safety of Org 25935 Versus Placebo as Augmentation to Cognitive Behavioral Therapy in Subjects With Panic Disorder|Terminated||Phase 2|46|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:05:23.583028|2017-02-18 14:05:23.583028
NCT00725712|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-10-11||2010-08-12|March 2007||2007-03-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study of GSK1363089 in Metastatic Gastric Cancer|A Phase 2 Study of GSK1363089 (XL880) Administered Orally to Subjects With Metastatic Gastric Cancer|Completed||Phase 2|74|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:05:24.396369|2017-02-18 14:05:24.396369
NCT00725699|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2011-03-05|||June 2008||2008-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:05:24.599319|2017-02-18 14:05:24.599319
NCT00725686|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-10-05|||February 2007||2007-02-01|October 2012|2012-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)|"A Phase I Open-Label, Dose Escalation Trial Of REDD14NP Delivered By A Single Intravitreal Injection To Patients With Choroidal Neovascularization (CNV) Secondary To Exudative Age-Related Macular Degeneration (Wet AMD)."|Completed||Phase 1|54|Actual|Quark Pharmaceuticals||1|||f||||t||||||||||2017-02-18 14:05:24.644581|2017-02-18 14:05:24.644581
NCT00725673|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2009-11-09|||September 2007||2007-09-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Observational|||Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.|Determination of Risk Factors for Developing Osteoporosis in COPD GOLD II Patients. A Case Control Study to Identify Possible Risk Factors for Developing Osteoporosis in COPD GOLD II Patients.|Completed||N/A|106|Actual|Catharina Ziekenhuis Eindhoven|||2||f||||t||||||Samples Without DNA|"~     Whole blood~   "|||2017-02-18 14:05:24.767913|2017-02-18 14:05:24.767913
NCT00725660|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2008-07-29|||September 2008||2008-09-01|July 2008|2008-07-01||||||||Observational|||Pre-Eclampsia Prediction By Doppler Screening Of Uterine Arteries And Angiogenic Factors In Second Trimester Of Pregnancy||Unknown status|Not yet recruiting|N/A|3000|Anticipated|Shaare Zedek Medical Center|||1||f||||||||||||||2017-02-18 14:05:24.851436|2017-02-18 14:05:24.851436
NCT00725647|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2009-09-17|||May 2005||2005-05-01|September 2009|2009-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies|A Study of the Value of Plasma N-terminal proBNP Concentrations for Diagnosing Patent Ductus Arteriosus in Preterm Babies.|Completed||N/A|102|Actual|St George's, University of London|||1||f||||f||||||||||2017-02-18 14:05:25.083281|2017-02-18 14:05:25.083281
NCT00725634|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-01-23|||September 2008||2008-09-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2010|Actual|2010-12-01||Interventional|P05538||A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma|A Phase 1 Study of AV-299 (Formerly SCH 900105) Administered by IV Infusion as Monotherapy in Advanced Solid Tumors, Lymphomas, or Multiple Myeloma or in Combination With Erlotinib in Advanced Solid Tumors|Completed||Phase 1|41|Actual|AVEO Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 14:05:25.176399|2017-02-18 14:05:25.176399
NCT00725621|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-02|2011-07-08||March 2004||2004-03-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED)|Real Life Dosing Regimen of Remicade in Austria, Monitored Over 9 Consecutive Infusions in Rheumatoid Arthritis Therapy|Completed||N/A|516|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:25.308643|2017-02-18 14:05:25.308643
NCT00725608|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-04-26|2011-10-18||May 2008||2008-05-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)|Evaluation of Transfer From Subutex or Other Treatment for Opioid Drug Dependence to Suboxone: Acceptability, Safety and Impact on Medication Dispensing|Completed||N/A|339|Actual|Indivior Inc.|||1||f||||f||||||||||2017-02-18 14:05:25.840153|2017-02-18 14:05:25.840153
NCT00725595|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-08-25|||August 2008||2008-08-01|August 2008|2008-08-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Treatment of Cheyne Stocks Respiration With Adaptive Servo Ventilation and Bilevel Ventilators in Patients With Chronic Heart Failure||Unknown status|Recruiting|Phase 4|12|Anticipated|Nanjing Medical University|||1||f||||t||||||||||2017-02-18 14:05:26.111625|2017-02-18 14:05:26.111625
NCT00725582|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2009-06-01|||September 2008||2008-09-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma|The Effects of IMA-026 on Allergen-Induced Airway Responses and Airway Inflammation in Subjects With Mild Atopic Asthma|Completed||Phase 1|24|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:05:26.212404|2017-02-18 14:05:26.212404
NCT00725569|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2009-10-18|||August 2008||2008-08-01|October 2008|2008-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Homeopathy for Post-operative (C. Section) Recovery|Effect of Homeopathic Drugs Bellis Perennis ו- Staphysagria on the Post-operative Recovery, of Women Undergoing Cesarean Section- (an Exploratory) Double Blind, Placebo Controlled Study|Completed||Phase 2/Phase 3|90|Anticipated|Shaare Zedek Medical Center||3|||f||||f||||||||||2017-02-18 14:05:26.309927|2017-02-18 14:05:26.309927
NCT00725556|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-31|||March 2006||2006-03-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|||The Development of Autistic Children Based on Mothers´Response in Autism Behavior Checklist|The Development of Autistic Children Based on Mother´s Response in Autism Behavior Checklist|Completed||Phase 1/Phase 2|11|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 14:05:26.414836|2017-02-18 14:05:26.414836
NCT00725543|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-28|2011-06-13||June 2004||2004-06-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)|Remicade Therapy in Ankylosing Spondylitis: Investigation of Real Life Regimen in Austria Over 9 Consecutive Infusions|Completed||N/A|358|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:26.522961|2017-02-18 14:05:26.522961
NCT00725530|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-07-19|2009-09-25||March 2008||2008-03-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation of Deposits on Contact Lenses Worn Extended Wear||Completed||N/A|54|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:05:26.832826|2017-02-18 14:05:26.832826
NCT00725517|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-31|||December 2005||2005-12-01|July 2008|2008-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange|Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange in Continuous Ambulatory Peritoneal Dialysis Patients, Compare to 2.5% Dianeal Peritoneal Dialysis Solution.|Completed||Phase 4|2|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-02-18 14:05:27.05602|2017-02-18 14:05:27.05602
NCT00725504|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-06-21|||September 2008||2008-09-01|June 2012|2012-06-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Effect of IV Lidocaine Infusions on Pain|Effect of IV Lidocaine Infusions on Pain|Completed||N/A|22|Actual|Stanford University||1|||f||||||||||||||2017-02-18 14:05:27.165375|2017-02-18 14:05:27.165375
NCT00725491|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-11-18|2009-12-17||May 2007||2007-05-01|November 2014|2014-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)|A Phase III, Multi-center, Open-label, Randomized Study to Assess the Efficacy and Safety of Org 37462 Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for IVF or ICSI, Using a Long Protocol of Triptorelin as a Reference Treatment.|Completed||Phase 3|259|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:05:27.256633|2017-02-18 14:05:27.256633
NCT00725478|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2010-03-30|||January 2008||2008-01-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|PIR-001/K||SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease|Stabilization on, or Change-over to the Non-ergot Dopamine Agonist Piribedil in Patients With Morbus Parkinson - a Post Marketing Surveillance Study in Parkinson Clinic Ambulances and Larger Private Practices.|Completed||N/A|250|Actual|Desitin Arzneimittel GmbH|||1||f||||f||||||||||2017-02-18 14:05:27.57389|2017-02-18 14:05:27.57389
NCT00725465|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2012-03-07|||January 2006||2006-01-01|March 2012|2012-03-01||||||||Observational|||Prospective Evaluation of Combined Laparoscopy With CO2 Intraoperative Colonoscopy Treatment for Colorectal Lesions|Prospective Evaluation of Combined Laparoscopy With CO2 Intraoperative Colonoscopy Treatment for Colorectal Lesions|Unknown status|Recruiting|N/A|30|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 14:05:27.656705|2017-02-18 14:05:27.656705
NCT00725452|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-07-15|2011-06-13||October 2006||2006-10-01|July 2015|2015-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)|Real Life Treatment Regimen of Remicade (Infliximab) in Austria, Monitored Over 5 Years in Plaque Psoriasis Therapy|Completed||N/A|26|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:27.730993|2017-02-18 14:05:27.730993
NCT00725439|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-09-23|||September 2004||2004-09-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|July 2005|Actual|2005-07-01||Interventional|||An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne|An Open Label Pilot Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment of Moderate to Severe Facial Acne|Completed||Phase 2|16|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:05:28.012355|2017-02-18 14:05:28.012355
NCT00725426|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2009-04-24|||July 2008||2008-07-01|April 2009|2009-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Rifampin on Bosutinib When Both Are Given to Healthy People|A Study to Examine the Potential Effect of Rifampin on the Pharmacokinetics of Bosutinib When Administered Concomitantly to Healthy Subjects|Completed||Phase 1|24|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:05:28.181548|2017-02-18 14:05:28.181548
NCT00725413|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2015-02-06|||November 2001||2001-11-01|February 2015|2015-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)|A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)|Completed||Phase 4|210|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:05:28.260653|2017-02-18 14:05:28.260653
NCT00725400|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2011-07-19|||February 2010||2010-02-01|July 2011|2011-07-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma|Phase II Open Label Comparative Study of Cetuximab and Radiation Therapy Vs Surgery Before or After Radiation Therapy in Patients With Stage II to IV Colorectal Carcinoma|Withdrawn||Phase 2|450|Anticipated|American Scitech International||2||"Study is withdrawn due to unavailability of eligible subject population. We will request the~   sponsors to extend the time for enrollment."|f||||f||||||||||2017-02-18 14:05:28.347648|2017-02-18 14:05:28.347648
NCT00725387|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-09-21|||August 2007||2007-08-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy|Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy|Recruiting||N/A|100|Anticipated|Stanford University|||1||f||||t||||||||||2017-02-18 14:05:28.464925|2017-02-18 14:05:28.464925
NCT00725374|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-05-22|||December 2002||2002-12-01|May 2014|2014-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|STEM||A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469)|A Exploratory, Double-blind, Randomized, Placebo-controlled Trial to Investigate the Tissue Specific Effects of 2.5 mg Tibolone on Breast Cancer in Postmenopausal Women, in Particular on Breast Tissue Proliferation.|Completed||Phase 3|102|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:05:28.551359|2017-02-18 14:05:28.551359
NCT00725361|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-11-02|||June 2008||2008-06-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma).|A Pilot Study to Evaluate the Efficacy of Ambrisentan in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis.|Completed||N/A|20|Actual|Stanford University||1|||f||||||||||||||2017-02-18 14:05:28.642069|2017-02-18 14:05:28.642069
NCT00725348|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-09-23|||April 2004||2004-04-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|March 2005|Actual|2005-03-01||Interventional|||An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis|An Open-Label, Multi-Center Pilot Trial to Assess the Efficacy and Safety of Oral R115866 in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis|Completed||Phase 2|19|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:05:28.74142|2017-02-18 14:05:28.74142
NCT00725335|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2012-11-23|||September 2008||2008-09-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|||Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy|The Effect of Ischemia/Reperfusion Injuries Elicited by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Excision:A Multicenter Prospective Randomized Controlled Trial|Completed||N/A|498|Actual|Southwest Hospital, China||2|||f||||t||||||||||2017-02-18 14:05:28.839196|2017-02-18 14:05:28.839196
NCT00441948|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-02-27|||May 2007||2007-05-01|February 2007|2007-02-01|April 2008||2008-04-01|||||Interventional|||Enhanced Safety Laser Hair Removal System|Peterio™ – an Add-on Device for Enhanced Safety of Aesthetic Laser Treatments.|Unknown status|Not yet recruiting|N/A|10||Scilex Ltd.|||||f||||f||||||||||2017-02-18 15:49:22.92319|2017-02-18 15:49:22.92319
NCT00725309|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2012-09-14|||November 2007||2007-11-01|September 2012|2012-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Observational|||Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease|Specialized Center of Clinically Oriented Research: Alveolar and Airway Mechanisms for COPD: Genetic Determinants: Elastin Quality and Quantity (Project 2)|Unknown status|Active, not recruiting|N/A|255|Actual|Washington University School of Medicine|||1||f||||t||||||Samples With DNA|"~     Plasma, serum, isolated RNA and DNA, lung tissue (obtained from other substudies)~   "|||2017-02-18 14:05:29.049993|2017-02-18 14:05:29.049993
NCT00725296|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-10-13|2011-07-01||December 2004||2004-12-01|October 2015|2015-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)|Remicade Therapy in Psoriatic Arthritis: Investigation of Real Life Regimen in Austria Over 9 Consecutive Infusions|Completed||N/A|178|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:29.141938|2017-02-18 14:05:29.141938
NCT00725283|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2016-07-28|||October 2008||2008-10-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)|Study of GSK2130579A Tumor-Antigen-Specific Cancer Immunotherapeutic as Post-consolidation Therapy in Adult Patients With Acute Myeloid Leukemia|Completed||Phase 1|34|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-02-18 14:05:29.416794|2017-02-18 14:05:29.416794
NCT00725270|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-03-12|||April 1998||1998-04-01|March 2014|2014-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Treatment of Schizoaffective Disorder Using Mifepristone|Treatment of Schizoaffective Disorder Using Mifepristone|Terminated||Phase 2/Phase 3|14|Actual|Stanford University||2||Lack of funding.|f||||||||||||||2017-02-18 14:05:31.933173|2017-02-18 14:05:31.933173
NCT00725257|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-28|||June 2004||2004-06-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Dietary Control of Type 2 Diabetes: Low-Carbohydrate Mediterranean Diet Versus Low-Fat Diet|Effect of a Low-Carbohydrate Mediterranean Diet or Low-Fat Diet in Newly-Diagnosed Type 2 Diabetic Patients|Completed||N/A|215|Actual|Second University of Naples||2|||f||||f||||||||||2017-02-18 14:05:32.068764|2017-02-18 14:05:32.068764
NCT00725244|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-10-16|||May 2005||2005-05-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|November 2007|Actual|2007-11-01||Interventional|||Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias|A Randomized Prospective Study of Endoscopy Bipolar Eletrocoagulation and Argon Plasma Coagulation of Chronic Rectal Bleeding From Radiation Telangiectasias|Completed||Phase 4|30|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:05:32.168896|2017-02-18 14:05:32.168896
NCT00725231|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-05-04|||February 2008||2008-02-01|May 2012|2012-05-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|A-CHOP-14||Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP|Phase III Study of CHOP-14 Plus or Minus Alemtuzumab in Peripheral T-cell Lymphoma of the Elderly|Unknown status|Recruiting|Phase 3|274|Anticipated|University of Göttingen||2|||f||||t||||||||||2017-02-18 14:05:32.278633|2017-02-18 14:05:32.278633
NCT00725218|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-08-05|||May 2008||2008-05-01|May 2008|2008-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|FAUCOP||Flurbiprofen Axetil for Uterine Contraction Pain|Phase IV Study of Flurbiprofen Axetil for Uterine Contraction Pain After Abortion|Completed||Phase 4|97|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 14:05:32.391891|2017-02-18 14:05:32.391891
NCT00725205|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-10-07|2011-10-10||March 2006||2006-03-01|October 2015|2015-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)|Patient Compliance During PegIntron (Injection Pen) and Rebetol Combination Therapy in Chronic Hepatitis C|Completed||N/A|294|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:32.502718|2017-02-18 14:05:32.502718
NCT00725192|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2011-04-06|||July 2008||2008-07-01|April 2011|2011-04-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|Hypnosis||Sleep-directed Hypnosis As A Complement To Cognitive Processing Therapy (CPT) In Treating Posttraumatic Stress Disorder (PTSD)|Sleep-directed Hypnosis As A Complement To CPT In Treating PTSD|Unknown status|Active, not recruiting|N/A|50|Anticipated|Center for Trauma Recovery, St Louis||2|||f||||f||||||||||2017-02-18 14:05:32.723616|2017-02-18 14:05:32.723616
NCT00725179|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2011-09-08|||August 2008||2008-08-01|September 2011|2011-09-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Observational|||Treatment of Acetaminophen Toxicity With N-acetylcysteine|Treatment of Acetaminophen Toxicity With Intravenous vs Oral N-acetylcysteine: A Retrospective Review|Completed||N/A|130|Anticipated|Akron Children's Hospital|||2||f||||f||||||||||2017-02-18 14:05:32.83484|2017-02-18 14:05:32.83484
NCT00725166|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2009-06-09|||October 2008||2008-10-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|CERA||Human Muscle Gene Expression Profiles in Young and Old Men|Human Muscle Gene Expression Profiles in Young and Old Men|Completed||N/A|41|Actual|Centre Hospitalier Universitaire de Saint Etienne|||2||f||||f||||||Samples With DNA|"~     Serum, muscle~   "|||2017-02-18 14:05:32.92343|2017-02-18 14:05:32.92343
NCT00725153|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-07-20|2009-09-25||March 2008||2008-03-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of Deposits on Contact Lenses Worn Daily Wear||Completed||N/A|55|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:05:33.234026|2017-02-18 14:05:33.234026
NCT00725140|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2015-05-29|||June 2008||2008-06-01|May 2015|2015-05-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Observational|START||Standardized sTudy With Almotriptan in eaRly Treatment of Migraine|Standardized sTudy With Almotriptan in eaRly Treatment of Migraine, START. An International, Open-label, Single Arm, Effectiveness and Safety Study of Almotriptan in Primary Care Setting|Completed||N/A|501|Actual|Almirall, S.A.|||1||f||||t||||||||||2017-02-18 14:05:33.478867|2017-02-18 14:05:33.478867
NCT00725127|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-10-24|||October 2008||2008-10-01|October 2016|2016-10-01|June 2021|Anticipated|2021-06-01|December 2020|Anticipated|2020-12-01||Interventional|CARING||Chronotherapy With Low-dose Aspirin for Primary Prevention|Chronotherapy With Low-dose Aspirin for Primary Prevention of Cardiovascular Events in Subjects With Impaired Fasting Glucose or Diabetes (CARING Study).|Recruiting||Phase 4|3200|Anticipated|University of Vigo||2|||f||||t||||||||Undecided||2017-02-18 14:05:33.590131|2017-02-18 14:05:33.590131
NCT00374595|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2012-06-18|||April 2006||2006-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Vascular Risk After Kidney Transplantation|Vascular Risk After Kidney Transplantation|Completed||N/A|342|Actual|University of Nebraska|||1||f||||t||||||||||2017-02-18 16:15:53.833408|2017-02-18 16:15:53.833408
NCT00725114|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-07-07|||April 2008||2008-04-01|August 2012|2012-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|TEC-006||Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain|A Multicentre , Randomized, Double-blind, Placebo-controlled, Parallel-design Trial of the Efficacy and Safety of Subcutaneous Tetrodotoxin (TTX) for Moderate to Severe Inadequately Controlled Cancer-related Pain|Completed||Phase 3|165|Actual|Wex Pharmaceuticals Inc.||2|||f||||f||||||||||2017-02-18 14:05:33.806031|2017-02-18 14:05:33.806031
NCT00725101|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-11-29|2012-04-27||June 2008||2008-06-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|REFLECTIONS||Fibromyalgia Health Outcome Study on Cost of Treatments|Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (The REFLECTIONS Study)|Completed||N/A|1700|Actual|Eli Lilly and Company|||1||f||||f||||||||||2017-02-18 14:05:33.933617|2017-02-18 14:05:33.933617
NCT00725088|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-08-22|||December 2006||2006-12-01|July 2008|2008-07-01|December 2010|Anticipated|2010-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Study of Rehabilitation Therapy on Patients After Acute Myocardial Infarction|Study of Rehabilitation Therapy on Patients After Acute Myocardial Infarction|Unknown status|Recruiting|N/A|300|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-02-18 14:05:34.775363|2017-02-18 14:05:34.775363
NCT00725075|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-10-19|2016-10-19||April 2007||2007-04-01|October 2016|2016-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|GIANT||Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)|A Multi-center, Double-blind, Flexible-dose Efficacy Trial With Org 25935 Versus Placebo as add-on Therapy in Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia Treated With a Stable Dose of a Second Generation Antipsychotic (GIANT)|Completed||Phase 2|215|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:05:34.877313|2017-02-18 14:05:34.877313
NCT00725062|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2012-11-06|||June 2008||2008-06-01|November 2012|2012-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant|Phase I-II Dose Escalation Study of CD4+CD25+ Cells in Adult Patients Undergoing HLA-Identical Sibling Donor Peripheral Blood Progenitor Cell Transplantation|Terminated||Phase 1|3|Actual|Masonic Cancer Center, University of Minnesota||1||Slow accrual.|f||||t||||||||||2017-02-18 14:05:35.636998|2017-02-18 14:05:35.636998
NCT00725049|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2015-01-13|2013-08-06||February 2009||2009-02-01|January 2015|2015-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Romeo||An Evaluation of Integration Success and Maintenance of Short Implants in Maxillas Needing Sinus Augmentation|A Prospective, Multicenter, Randomized Multicenter Study of Short Implants Used to Obviate the Need for Sinus Augmentation: an Assessment of Clinical Outcomes and Resource Allocation.|Completed||N/A|37|Actual|Zimmer Biomet||2|||f||||t||||||||||2017-02-18 14:05:35.763173|2017-02-18 14:05:35.763173
NCT00725036|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-29|2013-11-21|||September 2002||2002-09-01|November 2013|2013-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes|A 24-month Multicentre, Open-label, Randomised, Parallel Group, Long Term Safety Trial Comparing Intensive Treatment of Pulmonary Inhaled Human Insulin With Insulin Aspart Administered s.c., Both in Combination With NPH, in Subjects With Type 1 Diabetes|Completed||Phase 3|305|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:05:36.169097|2017-02-18 14:05:36.169097
NCT00725023|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2011-09-13|||August 2008||2008-08-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Use of TPD Heat Lamp for Tennis Elbow Pain - a Randomized-controlled Trial|A Randomized Double-blind Study to Assess the Use of TDP© Heat-lamp as an Effective Therapy for Tennis Elbow Pain (Lateral Epicondylitis Pain)|Terminated||Phase 2/Phase 3|116|Anticipated|Queen's University||2||Slow accrual|f||||f||||||||||2017-02-18 14:05:36.267849|2017-02-18 14:05:36.267849
NCT00725010|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-08|2010-10-22||April 2007||2007-04-01|September 2015|2015-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)|Temodal (TMZ) in Concomitant Radiochemotherapy Followed by Sequential TMZ Chemotherapy in Newly Diagnosed Glioblastoma Multiforme Patients - an Observational Program|Completed||N/A|64|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:36.375773|2017-02-18 14:05:36.375773
NCT00724919|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-08-07|||December 2003||2003-12-01|August 2008|2008-08-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Observational|||A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli|Association of Antibiotic Utilization Measures and Control of Extended-Spectrum β-Lactamases (ESBLs) (A Post-Intervention Surveillance Study)|Completed||N/A|256|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 14:05:36.639502|2017-02-18 14:05:36.639502
NCT00724906|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2010-02-02|||July 2010||2010-07-01|February 2010|2010-02-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|POET-2||Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor|Evaluation of the Diagnostic Accuracy and Safety of 123 I-ALTROPANE® as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes (POET-2)|Unknown status|Not yet recruiting|Phase 3|240|Anticipated|Alseres Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 14:05:36.726537|2017-02-18 14:05:36.726537
NCT00724893|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-07-20|2013-07-29||August 2005||2005-08-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423)|Pegetron® Redipen™ Prospective Optimal Weight-based Dosing Response Program|Completed||N/A|2430|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:05:36.838965|2017-02-18 14:05:36.838965
NCT00724880|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-28|||June 2006||2006-06-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.|Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery. A Prospective Randomized Controlled Study|Completed||Phase 4|135|Actual|Catharina Ziekenhuis Eindhoven||3|||f||||||||||||||2017-02-18 14:05:38.162802|2017-02-18 14:05:38.162802
NCT00619775|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2008-12-05|||April 2004||2004-04-01|December 2008|2008-12-01|October 2005|Actual|2005-10-01|||||Interventional|CREATE||Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial|Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial|Completed||Phase 3|419|Actual|ev3||1|||f||||t||||||||||2017-02-18 14:43:06.603989|2017-02-18 14:43:06.603989
NCT00724867|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-03-10|2015-11-19||August 2008||2008-08-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States|A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed the Phase 3 Protocol HGS1006-C1056 in the United States|Completed||Phase 3|268|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 14:05:38.322176|2017-02-18 14:05:38.322176
NCT00724854|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-02-06|2010-12-23||August 2006||2006-08-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|APEGIN||Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427)|Evaluation of Rapid Virological Response in HCV Patients Treated With PegIntron and Ribavirin - APEGIN Trial|Completed||N/A|1146|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:05:41.713903|2017-02-18 14:05:41.713903
NCT00724841|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-07-20||2013-08-28|June 2008||2008-06-01|July 2016|2016-07-01|August 2010|Actual|2010-08-01|July 2008|Actual|2008-07-01||Interventional|||A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma|A Multi-Center, Open-Label, Phase I/II Study of GEM1777 in Combination With Temozolomide Administered Every 4 Weeks to Patients With Metastatic Melanoma|Terminated||Phase 1/Phase 2|1|Actual|Teva Pharmaceutical Industries||6||Study terminated prematurely due to financial contraints.|f||||f||||||||||2017-02-18 14:05:42.389064|2017-02-18 14:05:42.389064
NCT00724828|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-07-29|||May 2005||2005-05-01|July 2008|2008-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Study Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino Children|An Evaluation of Streptococcus Pneumoniae Serotype Carriage Rate For Nasopharyngeal Carriage in Filipino Children Attending Well Baby Clinic in Hospitals and Primary Care Centers|Completed||N/A|500|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||t||||||||||2017-02-18 14:05:44.871732|2017-02-18 14:05:44.871732
NCT00724815|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2016-02-02|2013-02-15||January 2009||2009-01-01|February 2016|2016-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|NP101-007|Per protocol, the safety population was defined as subjects who applied a study patch. In each treatment group there were subjects who were randomized but not treated (NP101=31, placebo patch=30) and are therefore not included in the safety population.|The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine|The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study|Completed||Phase 3|530|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 14:05:44.978255|2017-02-18 14:05:44.978255
NCT00724802|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2011-06-20|||March 2008||2008-03-01|June 2011|2011-06-01||||August 2008|Actual|2008-08-01||Interventional|||Oral Glyceryl Triacetate (GTA) in Newborns With Canavan|Oral Glyceryl Triacetate (GTA) in Newborns With Canavan|Unknown status|Recruiting|N/A|1|Anticipated|Shaare Zedek Medical Center||1|||f||||||||||||||2017-02-18 14:05:45.496772|2017-02-18 14:05:45.496772
NCT00724789|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2015-07-13|||November 2000||2000-11-01|July 2015|2015-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)|An Open-label, Observational Trial to Monitor the Incidence of Congenital Malformations in Infants of Women With an Ongoing Pregnancy After Controlled Ovarian Hyperstimulation Using Puregon® (recFSH)/Orgalutran® (Ganirelix) Followed by IVF/ICSI, or a Long Protocol With a GnRH Agonist as Historical Controls.|Completed||N/A|2066|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:05:45.59309|2017-02-18 14:05:45.59309
NCT00724776|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2010-08-10|||July 2008||2008-07-01|August 2010|2010-08-01||||July 2009|Actual|2009-07-01||Interventional|||Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients|A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Escalating Single Dose of Albinterferon Alfa 2b (Alb-IFN), Recombinant Human Albumin-interferon Alfa Fusion Protein in Japanese Chronic Hepatitis C Patients.|Completed||Phase 1|30|Anticipated|Novartis||1|||f||||f||||||||||2017-02-18 14:05:45.687025|2017-02-18 14:05:45.687025
NCT00724763|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-29|||July 2008||2008-07-01|July 2008|2008-07-01||||July 2009|Anticipated|2009-07-01||Interventional|Acupuncture||The Effect of Acupuncture on Blood Pressure and Heart Rate Variability (HRV)|The Effect of Acupuncture on Blood Pressure and HRV|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 14:05:45.7867|2017-02-18 14:05:45.7867
NCT00724750|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-24|2015-07-27||July 2006||2006-07-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Comparison of Two Methods of Negative Pressure Wound Therapy|Prospective Randomized Control Trial Comparing Two Methods of Negative Pressure Wound Therapy: Gauze Suction Versus Vacuum Assisted Closure Device|Completed||N/A|87|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 14:05:45.885509|2017-02-18 14:05:45.885509
NCT00724737|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2011-08-04|||July 2006||2006-07-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|July 2011|Actual|2011-07-01||Interventional|||Presurgical Planning With Functional MRI (fMRI) Mapping of Motor Cortex in Patients With Cerebral Tumors|Presurgical Planning With Motion Corrected fMRI Mapping of Motor Cortex in Patients With Cerebral Tumors|Completed||Early Phase 1|80|Anticipated|University of Michigan||1|||f||||f||||||||||2017-02-18 14:05:46.531731|2017-02-18 14:05:46.531731
NCT00724724|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-26|2011-02-23|||August 2008||2008-08-01|February 2011|2011-02-01|August 2011|Anticipated|2011-08-01|June 2011|Anticipated|2011-06-01||Interventional|ESCAPE||The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial|The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial|Unknown status|Recruiting|Phase 4|1000|Anticipated|Peking Union Medical College Hospital||2|||f||||t||||||||||2017-02-18 14:05:46.628094|2017-02-18 14:05:46.628094
NCT00724711|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-05-22|2012-03-28||July 2008||2008-07-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|SWIFT||Safety and Efficacy Study of Switching From Epzicom to Truvada|A Prospective, Randomized, Open Label Phase IV Study to Evaluate the Rationale of Switching From Fixed Dose Abacavir (ABC)/Lamivudine (3TC) to Fixed Dose Tenofovir DF (TDF)/Emtricitabine (FTC) in Virologically Suppressed, HIV-1 Infected Patients Maintained on a Ritonavir Boosted Protease Inhibitor Containing Antiretroviral Regimen|Completed||Phase 4|312|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 14:05:46.807789|2017-02-18 14:05:46.807789
NCT00372047|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-06-02||||||June 2008|2008-06-01||||||||Observational|||Evaluation of Excessive UV Irradiation on Skin Aging by Multiphoton Laser Imaging and Biophysical Methods||Unknown status|Not yet recruiting|Phase 1/Phase 2|||University of Jena|||||f||||||||||||||2017-02-18 16:17:00.673649|2017-02-18 16:17:00.673649
NCT00724698|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2016-01-22|2009-05-28||October 2005||2005-10-01|January 2016|2016-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|Aerius||Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria|Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Desloratadine Tablet Among Filipino Patients|Completed||N/A|3011|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:47.994617|2017-02-18 14:05:47.994617
NCT00724685|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-02-07|||January 2008||2008-01-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Interest of Continuous Ropivacaine Administration Through an Elastomeric Pump (Pain Buster) for the Surgery of Latissimus Dorsi and Serratus Micro Anastomotic Flaps|Interest of Continuous Ropivacaine Administration Through an Elastomeric Pump (Pain Buster ) for the Surgery of Latissimus Dorsi and Serratus Micro Anastomotic Flaps|Terminated||Phase 4|34|Actual|Nantes University Hospital||2|||f||||||||||||||2017-02-18 14:05:48.194177|2017-02-18 14:05:48.194177
NCT00724672|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-05-29|||September 2008||2008-09-01|May 2015|2015-05-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Observational|||A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)|Whole Human Genome Oligo Microarray Analysis of the Peripheral Blood Mononuclear Cells of Patients With Rheumatoid Arthritis During Different Forms of Anti-Tumor Necrosis-Alpha Treatments.|Withdrawn||N/A|0|Actual|Merck Sharp & Dohme Corp.|||4||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 14:05:48.286705|2017-02-18 14:05:48.286705
NCT00724659|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-05-01|||September 2004||2004-09-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|August 2010|Actual|2010-08-01||Interventional|||Pre and Post Arthrogram Ultrasound Images of Joints|An Evaluation of Pre and Post Arthrogram Ultrasound Images of Joints: Does Arthrography Have a Role in Ultrasonography?|Completed||N/A|9|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 14:05:48.388186|2017-02-18 14:05:48.388186
NCT00724646|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2009-09-14|||February 2009||2009-02-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Observational|||Perspectives on End-of-Life Care for Medically-Fragile Children and Young Adults|Direct Care Staff and Parents'/Legal Guardians' Perspectives on End-of-Life Care in a Long-Term Care Facility for Medically Fragile and Intellectually Disabled Pediatric and Young Adult Residents|Completed||N/A|125|Anticipated|Akron Children's Hospital|||2||f||||f||||||||||2017-02-18 14:05:48.485286|2017-02-18 14:05:48.485286
NCT00724633|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-01-19|||November 2011||2011-11-01|January 2012|2012-01-01|November 2014|Anticipated|2014-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients|Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients: a Randomized Controlled Trial.|Unknown status|Recruiting|Phase 3|150|Anticipated|Lawson Health Research Institute||3|||f||||t||||||||||2017-02-18 14:05:48.582936|2017-02-18 14:05:48.582936
NCT00724620|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-07-25|||June 2005||2005-06-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)|Open Multicenter Study of Combination Therapy With Weight-Based PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1. Impact of the Combination Therapy on Sustained Virological Response and Tolerability, in These Patients.|Completed||Phase 4|103|Actual|Schering-Plough||3|||f||||f||||||||||2017-02-18 14:05:48.682568|2017-02-18 14:05:48.682568
NCT00724607|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2017-01-25|||May 6, 2008|Actual|2008-05-06|January 2017|2017-01-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|BIO||Brain Injury Outcomes (BIO) Study|Validation of Brief Objective Neurobehavioral Detectors of Mild TBI|Active, not recruiting||N/A|300|Anticipated|VA Office of Research and Development|||3||f||||f||||||Samples With DNA|"~     Tissue samples are requested for 1.) current laboratory measures, 2.) current genomic,~     immunologic, angiogenic and endocrine measures, and 3.) future unknown measures.~   "|Undecided||2017-02-18 14:05:48.789011|2017-02-18 14:05:48.789011
NCT00724594|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2015-05-08|2015-01-09||August 2008||2008-08-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|||Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)|Safety of N-acetylcysteine in Maternal Chorioamnionitis|Completed||Phase 1/Phase 2|46|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 14:05:48.907201|2017-02-18 14:05:48.907201
NCT00724581|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-07-28|||August 2008||2008-08-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|PASCART||Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer|Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer: A Controlled, Randomized, Double Blinded Trial|Unknown status|Not yet recruiting|Phase 4|275|Anticipated|Aarhus University Hospital||1|||f||||t||||||||||2017-02-18 14:05:49.789551|2017-02-18 14:05:49.789551
NCT00724568|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2016-06-14|2014-09-03||May 2008||2008-05-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|April 2009|Actual|2009-04-01||Interventional|RVDD|A total of 74 patients were enrolled in this phase 1/2 study. 2 patients were not evaluable for the Dose Limiting Toxicity (DLT) and therefore only 72 are included in the baseline analysis population.|Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma|A Multi-Institutional Phase I/II Study of Revlimid® (Lenalidomide), Velcade® (Bortezomib), Dexamethasone, and Doxil®, (RVDD) Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|74|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 14:05:49.885244|2017-02-18 14:05:49.885244
NCT00724555|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2014-01-30|||February 2008||2008-02-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|ASPIRE||Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities|Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities|Completed||N/A|2005|Anticipated|Georgetown University|||1||f||||f||||||||||2017-02-18 14:05:50.138847|2017-02-18 14:05:50.138847
NCT00724542|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-08-22|||July 2008||2008-07-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|EIIGETPCHD||Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.|Evaluation of Lifestyle and Therapeutic Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.|Unknown status|Recruiting|N/A|1600|Anticipated|Ministry of Science and Technology of the People´s Republic of China||2|||f||||t||||||||||2017-02-18 14:05:50.329581|2017-02-18 14:05:50.329581
NCT00724516|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2012-05-18|||June 2007||2007-06-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography|Evaluation Of A Novel Breast Compression Paddle For Wire Localization In Mammography|Completed||N/A|10|Actual|University of Michigan||1|||f||||||||||||||2017-02-18 14:05:50.5321|2017-02-18 14:05:50.5321
NCT00724503|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2017-01-27|||August 2006||2006-08-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|June 2016|Actual|2016-06-01||Interventional|SIRFLOX||FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer|Randomised Comparative Study Of Folfox6m Plus Sir-Spheres® Microspheres Versus Folfox6m Alone As First Line Treatment In Patients With Nonresectable Liver Metastases From Primary Colorectal Carcinoma|Completed||N/A|532|Actual|Sirtex Medical||2|||f||||t||||||||||2017-02-18 14:05:50.836584|2017-02-18 14:05:50.836584
NCT00724490|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-07-28|||February 2004||2004-02-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|September 2007|Actual|2007-09-01||Interventional|||Unilateral Deep Brain Stimulation (DBS) of the Nucleus (Nucl.) Accumbens (Acc.) in Patients With Treatment Resistant Obsessive Compulsive Disorder (OCD)|Unilateral Deep Brain Stimulation of the Nucleus Accumbens in Patients With Treatment Resistant Obsessive Compulsive Disorder|Completed||N/A|16|Actual|University of Cologne||1|||f||||f||||||||||2017-02-18 14:05:51.090745|2017-02-18 14:05:51.090745
NCT00724477|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-28|2009-11-24||October 2007||2007-10-01|September 2015|2015-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)|PRAGMATIC (This is the True Official Title of the Protocol for This Study)|Completed||N/A|1663|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:51.194304|2017-02-18 14:05:51.194304
NCT00724464|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-10-16|2011-10-04||December 2007||2007-12-01|October 2015|2015-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Efficacy of PegIntron (Peginterferon Alfa-2b) and Rebetol (Ribavirin) in Treatment-naïve Subjects With Chronic Hepatitis C in Clinical Practice in Greece (Study P05209)|A Greek Observational Study on Relapse Rate and Sustained Virological Response in Naive CHC Patients, Treated With Pegylated Interferon Alpha-2b and Ribavirin in Daily Clinical Practice|Completed||N/A|332|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:51.402622|2017-02-18 14:05:51.402622
NCT00724451|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-24|2012-10-05||July 2008||2008-07-01|September 2015|2015-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)|Prospective, Observational, Multicentre Study Evaluating HCV Patients Characteristics of Eligibility and Disease Management in Real Clinical Practice|Completed||N/A|1128|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:51.72041|2017-02-18 14:05:51.72041
NCT00724438|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-09-04|||July 2008||2008-07-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|August 2009|Actual|2009-08-01||Observational|||Pharmacokinetics of Implanon in Obese Women|Pharmacokinetics of Implanon in Obese Women|Completed||N/A|18|Actual|University of Chicago|||2||f||||f||||||Samples With DNA|"~     whole blood, serum, plasma~   "|||2017-02-18 14:05:52.096298|2017-02-18 14:05:52.096298
NCT00724425|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-04-14|||July 2008||2008-07-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Phase 1 Dose Escalation Study of IPI-493|A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of IPI-493 Orally Administered to Patients With Advanced Malignancies|Terminated||Phase 1|53|Actual|Infinity Pharmaceuticals, Inc.||1||"Drug exposure of retaspimycin HCl was superior to IPI-493, Infinity will focus exclusively on~   retaspimycin"|f||||f||||||||||2017-02-18 14:05:52.199385|2017-02-18 14:05:52.199385
NCT00724412|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-01-31|||April 2008||2008-04-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye||Completed||Phase 4|279|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:05:52.289442|2017-02-18 14:05:52.289442
NCT00724399|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-12-15|||January 2006||2006-01-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Preventive Health Practices in Women|Preventive Health Practices in Women|Completed||N/A|1418|Actual|University of Michigan|||2||f||||f||||||||No||2017-02-18 14:05:52.374993|2017-02-18 14:05:52.374993
NCT00724386|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-03-06|||June 1999||1999-06-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|October 2005|Actual|2005-10-01||Interventional|||Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer|A Phase I Study of Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine With Filgrastim Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer|Completed||Phase 1|26|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 14:05:52.468219|2017-02-18 14:05:52.468219
NCT00724373|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-24|2010-05-06||November 2007||2007-11-01|September 2015|2015-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)|Retrospective Data Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol|Completed||N/A|442|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:52.570413|2017-02-18 14:05:52.570413
NCT00724360|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-10-04|||November 2006||2006-11-01|October 2013|2013-10-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|||Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)|A Phase II Trial Evaluating the Safety and the Efficacy of Trastuzumab in Relapsed/Refractory HER2 Positive B-acute Lymphoblastic Leukemia Patients.|Terminated||Phase 2|15|Actual|Nantes University Hospital||||Difficulties of recruitment|f||||||||||||||2017-02-18 14:05:52.828429|2017-02-18 14:05:52.828429
NCT00724347|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2015-01-15|2014-11-03||July 2008||2008-07-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CINT|Hearing impaired with hearing aids|PC-Based Rehabilitation of Auditory Function|PC-based Rehabilitation of Auditory Function|Completed||N/A|18|Actual|VA Office of Research and Development|Five publications describing the new tests that we developed have appeared.|1|||f||||f||||||||||2017-02-18 14:05:52.932229|2017-02-18 14:05:52.932229
NCT00724334|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-02-17||2016-02-17|July 2008||2008-07-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis|An Open-Label Study to Evaluate the Long-Term Effects of Orally Administered SAR302503 in Patients With Primary or Secondary Myelofibrosis|Completed||Phase 1/Phase 2|42|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:05:53.403708|2017-02-18 14:05:53.403708
NCT00724321|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-17|||July 2008||2008-07-01|September 2015|2015-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude|Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction With Exercise at High Altitude|Withdrawn||Phase 1|0|Actual|Loma Linda University||1||"PI has left the institution. We are unable to locate any study records to determine if~   subjects were enrolled."|f||||f||||||||||2017-02-18 14:05:53.510804|2017-02-18 14:05:53.510804
NCT00724308|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-04-06|2014-07-10||November 2009||2009-11-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|October 2012|Actual|2012-10-01||Interventional|TeleQuit MH||Telephone Care Coordination for Smokers in VA Mental Health Clinics|Telephone Care Coordination for Smokers in Mental Health Clinics|Completed||N/A|1206|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:05:53.617169|2017-02-18 14:05:53.617169
NCT00724295|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-02-03|||April 2005||2005-04-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)|PEG Intron/REBETOL Combination Therapy Special Investigation -Investigation on the Safety and Efficacy of PegIntron and REBETOL Combination Therapy in Patients With Chronic Hepatitis C-|Completed||N/A|1077|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:54.055877|2017-02-18 14:05:54.055877
NCT00724282|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-10-15|2015-09-10||April 2008||2008-04-01|October 2015|2015-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Treatment of Insomnia and Glucose Metabolism|Double-blind Placebo-controlled Study of the Effects of Eszopiclone on Glucose Tolerance, Insulin Secretion, and Insulin Action in Adults With Chronic Insomnia|Completed||Phase 4|20|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 14:05:54.146896|2017-02-18 14:05:54.146896
NCT00724269|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-09-28|||October 2009||2009-10-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Comparison of OPTI-FREE RepleniSH and ReNu Multi-Plus Lens Care Regimens on Corneal Epithelium||Completed||N/A|20|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:05:54.426087|2017-02-18 14:05:54.426087
NCT00724256|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-02-15|||July 2006||2006-07-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|STUTI||Short-term Antibiotic Therapy for Pyelonephritis in Childhood|Randomised Controlled Trial on Efficacy and Safety of Short Term Versus Long Term Antibiotic Therapy for Pyelonephritis in Childhood.|Terminated||Phase 3|36|Actual|IRCCS Burlo Garofolo||2||other upcoming studies; patients refusal of invasive follow up (DMSA)|f||||t||||||||||2017-02-18 14:05:54.522733|2017-02-18 14:05:54.522733
NCT00724243|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-09-03|2010-01-28||January 2006||2006-01-01|September 2015|2015-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)|Remicade Treatment Registry in Rheumatoid Arthritis I|Completed||N/A|33|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:54.649799|2017-02-18 14:05:54.649799
NCT00724230|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-02-02|||February 2006||2006-02-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)|"PegIntron/REBETOL Combination Therapy Designated Drug Use Investigation -Investigation on the Safety and Efficacy of PegIntron and REBETOL Combination Therapy in Patients With Chronic Hepatitis C Excluding Those With IFN Naive Low Viral Load and Genotype 1 and High Viral Load-"|Completed||N/A|505|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:05:54.871183|2017-02-18 14:05:54.871183
NCT00724217|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-07-28|||July 2008||2008-07-01|July 2008|2008-07-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|SPPP||Standard Process 21 Day Purification Program Project|The Effects of the Standard Process 21 Day Purification Program, on Serum Lipids, C-Reactive Protein, Homocystine, Blood Pressure, and Heart Rate Variability in Normal Weight and Overweight Participants Who Have Total Cholesterol Levels Over 180.|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 14:05:54.957192|2017-02-18 14:05:54.957192
NCT00724204|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2008-07-28|||April 2006||2006-04-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|P010||Safety Assessment of Lactobacillus Salivarius CECT5713 in 6 Months Old Children|Functional Evaluation of a Follow on Formula Supplemented With Lactobacillus Salivarius CECT5713|Completed||Phase 1|80|Actual|Puleva Biotech||2|||f||||t||||||||||2017-02-18 14:05:55.061567|2017-02-18 14:05:55.061567
NCT00724191|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-06-21|||September 1999||1999-09-01|June 2016|2016-06-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)|Quantitation of Human Brain Tumor Therapy Response by MR|Active, not recruiting||Early Phase 1|190|Anticipated|University of Michigan||1|||f||||f||||||||No||2017-02-18 14:05:55.162029|2017-02-18 14:05:55.162029
NCT00724178|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2010-01-14|||July 2003||2003-07-01|January 2010|2010-01-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||The Effect of Vitamin D and Calcium on Bone in Pediatric HIV|The Effect of Vitamin D and Calcium on Bone in Pediatric HIV|Completed||Phase 2/Phase 3|59|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 14:05:55.278797|2017-02-18 14:05:55.278797
NCT00724165|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-02-04|||September 2006||2006-09-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Seamos Activas: Increasing Physical Activity Among Latinas|Seamos Activas: Increasing Physical Activity Among Latinas|Completed||Phase 2|106|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 14:05:55.393428|2017-02-18 14:05:55.393428
NCT00724152|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-04-16|2015-01-06||February 2009||2009-02-01|April 2015|2015-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional||Period 1 and Period 2|Cognitive Behavioral Therapy (CBT) for Tinnitus|Cognitive-behavioral Therapy for Tinnitus|Completed||Phase 1/Phase 2|33|Actual|VA Office of Research and Development|"During Period 2 only two participants (one completer) were randomized to standard care and only four participants (3 completers) were randomized Cognitive Behavioral Therapy."|3|||f||||f||||||||||2017-02-18 14:05:55.492263|2017-02-18 14:05:55.492263
NCT00724139|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-27|2008-07-28|||January 2008||2008-01-01|July 2008|2008-07-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||The Effect of Training With Custom-Made Biomechanical Perturbation Platform on Kinetics, Kinematics and Electromyography in Knee Osteoarthritis Patients||Unknown status|Recruiting|N/A|15|Anticipated|HaEmek Medical Center, Israel||1|||f||||||||||||||2017-02-18 14:05:56.117727|2017-02-18 14:05:56.117727
NCT00724126|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-26|2014-06-30|2014-06-30||July 2008||2008-07-01|June 2014|2014-06-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|TARGET 2|The analysis population was the intent-to-treat population, defined as subjects who received at least 1 dose of study drug. Two randomized subjects (1 in each group) did not receive study drug and were not included in the intent-to-treat population.|Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)|A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin 550 mg TID in the Treatment of Subjects With Non-Constipation Irritable Bowel Syndrome|Completed||Phase 3|637|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 14:05:56.215619|2017-02-18 14:05:56.215619
NCT00724113|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2017-01-03|||February 2009||2009-02-01|May 2014|2014-05-01|July 2014|Actual|2014-07-01|August 2013|Actual|2013-08-01||Interventional|CAPSULITE||ARTHRO Distension Plus Intensive Mobilisation in Shoulder Capsulitis|Evaluation of the Effectiveness of ARTHRO -Distension Plus Intensive Mobilisation in Shoulder Capsulitis|Completed||Phase 3|66|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:05:56.875689|2017-02-18 14:05:56.875689
NCT00724100|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-08-26|||September 2008||2008-09-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors|A Phase 1, Dose Escalation Study of the Safety and Pharmacokinetics of ALB 109564(a) Administered Intravenously Every 3 Weeks to Subjects With Advanced Solid Tumors|Terminated||Phase 1|46|Actual|Albany Molecular Research, Inc.||1||Sponsor's decision|f||||f||||||||||2017-02-18 14:05:56.992682|2017-02-18 14:05:56.992682
NCT00724087|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-09-04|||July 2008||2008-07-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Sleep Loss and Energy Metabolism in People With Family History of Type 2 Diabetes.|Sleep, Energy Metabolism and Diabetes Risk.|Completed||N/A|12|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 14:05:57.07974|2017-02-18 14:05:57.07974
NCT00724074|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-07-25||||||July 2008|2008-07-01||||||||Interventional|||The Use of Continuous Wound Infusion Analgesia in Total Knee Arthroplasty|The Use of Continuous Wound Infusion Analgesia in Total Knee Arthroplasty|Unknown status|Not yet recruiting|N/A|20|Anticipated|Capital Health, Canada||2|||f||||t||||||||||2017-02-18 14:05:57.177446|2017-02-18 14:05:57.177446
NCT00724061|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-26|2013-11-25|2013-11-25||September 2008||2008-09-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL|Pilot Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy in Cutaneous T-Cell Lymphoma|Terminated||N/A|7|Actual|Northwestern University|Only 7 patients were enrolled before the study was terminated by the Data Monitoring Committee due to poor accrual. Accrual was limited by a worldwide psoralen shortage and well as the exclusion of patients with prior UV light exposure.|1||Closed early due to poor accrual.|f||||t||||||||||2017-02-18 14:05:57.279851|2017-02-18 14:05:57.279851
NCT00724048|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-07-20||2013-02-19|October 2008||2008-10-01|July 2016|2016-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|HART||A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease|A Multi-center, North American, Randomized, Double-blind, Parallel Group Study Comparing Three Doses of ACR16 Versus Placebo for the Symptomatic Treatment of Huntington Disease (HART)|Completed||Phase 2/Phase 3|227|Actual|Teva Pharmaceutical Industries||4|||f||||t||||||||||2017-02-18 14:05:57.77418|2017-02-18 14:05:57.77418
NCT00724035|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2009-07-14|||May 2008||2008-05-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Ultrasound-Guided Axillary or Infraclavicular Nerve Block for Upper Limb Surgery|Onset Time of Brachial Plexus Anesthesia With the Axillary or Infraclavicular Approach Under Real-Time Ultrasound Guidance: a Randomized Controlled Trial|Completed||Phase 4|52|Anticipated|University of Parma||2|||f||||f||||||||||2017-02-18 14:05:57.898277|2017-02-18 14:05:57.898277
NCT00724022|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-09-30|||June 2008||2008-06-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|Harmony||Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation|Triple Arm, Prospectively Randomized Multi Centre Study Phase IV to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation in Non-risk Patients|Completed||Phase 4|600|Anticipated|University Hospital Freiburg||3|||f||||f||||||||||2017-02-18 14:05:58.031044|2017-02-18 14:05:58.031044
NCT00724009|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-01-30|2014-01-30||December 2007||2007-12-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2010|Actual|2010-09-01||Interventional|||Clofarabine Bone Marrow Cytoreduction|Clofarabine Bone Marrow Cytoreduction : Feasibility of Induction as a Bridge to Allogeneic Stem Cell Transplantation for Patients With Relapsed or Refractory Acute Leukemias, Myelodysplastic Syndromes, and Advanced Myeloproliferative Diseases.|Completed||Phase 2|29|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 14:05:58.179504|2017-02-18 14:05:58.179504
NCT00723996|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-12-15|||September 2003||2003-09-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Preventive Health Behavior in Women|Preventive Health Behavior in Women|Completed||N/A|254|Actual|University of Michigan|||3||f||||f||||||||No||2017-02-18 14:05:58.45974|2017-02-18 14:05:58.45974
NCT00723983|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2016-02-02|||November 2008||2008-11-01|February 2016|2016-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|NP101-011||Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period|A Phase I, Open Label, Single-Dose, Four-Way Crossover Study Comparing the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) With an Oral Formulation of Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period|Completed||Phase 1|23|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-02-18 14:05:58.549568|2017-02-18 14:05:58.549568
NCT00723970|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-02-07|||June 2007||2007-06-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression|Seroquel XR for the Treatment of Peri and Postmenopausal Women With Major Depressive Disorder: Impact on Mood, Physical Symptoms, Sleep and Quality of Life|Completed||Phase 4|40|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 14:05:58.643831|2017-02-18 14:05:58.643831
NCT00723567|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2009-02-18|||February 2008||2008-02-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||A Novel Mutation of the Spectrin Gene|Case Report: A Novel Mutation of the Spectrin Gene in a Family of Northern European Descent Is Associated With Three Different Phenotypes|Completed||N/A|12|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 14:06:10.609431|2017-02-18 14:06:10.609431
NCT00723957|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2016-02-09|2011-06-20||December 2008||2008-12-01|February 2016|2016-02-01|August 2011|Actual|2011-08-01|May 2010|Actual|2010-05-01||Interventional|||A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer|A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Patients With Advanced Non-small Cell Lung Cancer|Completed||Phase 2|260|Actual|R-Pharm||2|||f||||f||||||||||2017-02-18 14:05:58.76163|2017-02-18 14:05:58.76163
NCT00723944|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-01-13|2009-06-26||February 2005||2005-02-01|January 2015|2015-01-01|May 2011|Actual|2011-05-01|April 2007|Actual|2007-04-01||Interventional|RadioCity||A Study of the Performance of Certain Prevail Implants Used in Short Fixed Cases|A Prospective, Randomized-controlled Multicenter Study of the Osseotite Certain Lateralized Implanting Short-span Fixed Bridge Cases for Preservation of Crestal Bone|Completed||N/A|102|Actual|Zimmer Biomet||2|||f||||t||||||||||2017-02-18 14:05:59.618347|2017-02-18 14:05:59.618347
NCT00723931|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-11-02|2010-11-09||June 2006||2006-06-01|November 2015|2015-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||PegIntron Injection Surveillance Plan (Study P04123)|PegIntron Injection Surveillance Plan|Completed||N/A|1267|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:06:00.068266|2017-02-18 14:06:00.068266
NCT00723918|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2011-01-11|||April 2009||2009-04-01|January 2011|2011-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy|NARC 011: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Methadone and Combination of Methadone and SAB378 in HIV-associated Painful Peripheral Neuropathy|Terminated||Phase 2|0|Actual|Washington University School of Medicine||3||Withdrawal of pharmaceutical support from Novartis - no participants randomized|f||||t||||||||||2017-02-18 14:06:00.318971|2017-02-18 14:06:00.318971
NCT00723905|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-01-14|||August 2005||2005-08-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|RemiTRAC||Remicade Infusion Management Program|Remicade Infusion Management Program|Completed||Phase 4|1630|Actual|Janssen Inc.|||1||f||||f||||||||||2017-02-18 14:06:00.456236|2017-02-18 14:06:00.456236
NCT00723892|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-10-29|2010-08-25||July 2005||2005-07-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)|Observatory on Treatment Adhesion in Patients Suffering From Hepatitis C Chronic Treated With ViraferonPeg® Injected / Rebetol® in Conjunction With a Psychotherapeutic Assistance Program|Completed||N/A|614|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:06:00.54338|2017-02-18 14:06:00.54338
NCT00723879|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-11-02|||October 2004||2004-10-01|November 2015|2015-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)|Evaluation of Adherence Rate in Patients Receiving PegIntron / Rebetol (Weight Based) for Hepatitis C in Conjunction With a Patient Assistance Program.|Terminated||N/A|115|Actual|Merck Sharp & Dohme Corp.|||1|"Because of slow recruitment; Despite the study was started long time ago (Oct 2004), we have~   not reached the projected number of patients (150 patients)"|f||||f||||||||||2017-02-18 14:06:00.897738|2017-02-18 14:06:00.897738
NCT00723866|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-07-29|||December 2005||2005-12-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for Poststroke Upper Extremity Spasticity|Combined Botulinum Toxin Type A With Modified Constraint-Induced Movement Therapy for Chronic Stroke Patients With Upper Extremity Spasticity|Completed||N/A|32|Actual|Kaohsiung Veterans General Hospital.||2|||f||||t||||||||||2017-02-18 14:06:00.983086|2017-02-18 14:06:00.983086
NCT00723853|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-09-04|||April 2008||2008-04-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|REACH-OUT||REACH-OUT: Chicago Children's Diabetes Prevention Program|REACH-OUT: Chicago Children's Diabetes Prevention Program|Completed||N/A|131|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 14:06:01.087485|2017-02-18 14:06:01.087485
NCT00723840|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-07-29|2011-03-31||September 2006||2006-09-01|July 2015|2015-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|COSMO||Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560)|Assessment of the Social Cost of Crohn's Disease (COsto Sociale Della Malattia di CrOhn - COSMO): Economic and Quality of Life Aspects|Completed||N/A|245|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:06:01.18725|2017-02-18 14:06:01.18725
NCT00723827|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-01-19|2012-12-05||March 2008||2008-03-01|January 2015|2015-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)|Temodal (Temozolomide) Post Marketing Surveillance Protocol|Completed||N/A|682|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:06:01.486841|2017-02-18 14:06:01.486841
NCT00722813|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2013-11-20|||October 2006||2006-10-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Observational|||Cost Effectiveness and Utility of Computed Tomography Angiography (CTA) and Cardiac Cath|Cost Effectiveness and Utility of Coronary Artery Computed Tomography Angiography (CTA) in Screening for Coronary Artery Disease|Completed||N/A|31|Actual|University of Michigan|||1||f||||t||||||||||2017-02-18 14:06:02.05664|2017-02-18 14:06:02.05664
NCT00722800|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2014-01-16|2013-05-06||October 2008||2008-10-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||One subject was excluded because she was regularly taking ibuprofen. The other subject changed her mind about study participation.|A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS|A Single-Center, Randomized Double-Blind, Parallel-Group Study to Examine the Safety and Efficacy of YAZ Compared With Placebo In The Treatment Of Hidradenitis Suppurativa|Terminated||Phase 2|4|Actual|Massachusetts General Hospital|Very small sample size.|2||Poor recruitment|f||||f||||||||||2017-02-18 14:06:02.162647|2017-02-18 14:06:02.162647
NCT00722774|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-11-07||||||July 2008|2008-07-01||||September 2008|Actual|2008-09-01||Interventional|||Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine|Phase I Inpatient Study of the Safety and Immunogenicity of Live Influenza A Vaccine H2N2 (A/Ann Arbor/6/60 ca Recombinant), a Live Attenuated Virus Vaccine Candidate for Prevention of Influenza H2N2 Infection in the Event of a Pandemic|Completed||Phase 1|22|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||f||||||||||2017-02-18 14:06:02.608409|2017-02-18 14:06:02.608409
NCT00722761|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2013-01-29|2012-12-17||April 2009||2009-04-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne|A Single-Center, Randomized Double-Blind, Parallel-Group Study to Examine the Safety and Efficacy Of YAZ Compared With Placebo In The Treatment Of Moderate Truncal Acne Vulgaris|Completed||Phase 3|30|Actual|Massachusetts General Hospital|Early termination leading to small number of subjects analyzed|2|||f||||f||||||||||2017-02-18 14:06:02.740128|2017-02-18 14:06:02.740128
NCT00722748|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-11-21|||June 2007||2007-06-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Genomic Investigation of Cardiovascular Diseases|The Genebank at Scripps Clinic Registry|Active, not recruiting||N/A|15000|Anticipated|Scripps Translational Science Institute|||1||f||||f||||||Samples With DNA|"~     Cardiac Catheterization Patients~      Blood will be collected from the patients that will undergo heart catheterization for~     establishing a gene bank registry. Informed consent will take place prior to cardiac~     catheterization. 38 cc of blood collected will be processed to create a repository of DNA,~     RNA, and lymphoblastoid cell-line immortalization on selected patient populations, plasma~     and serum. The DNA will be amplified in certain patient populations to preserve the~     quantity.~   "|||2017-02-18 14:06:03.17684|2017-02-18 14:06:03.17684
NCT00722735|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2009-06-10|||October 2008||2008-10-01|October 2008|2008-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|FLUT||Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)|A Double-Blind, Double-Dummy, Prospective, Randomized Multiple-Site Study of Oral Finafloxacin 300 mg b.i.d. Versus Oral Ciprofloxacin 250 mg b.i.d. in Patients With Lower Uncomplicated UTI (uUTI) With a Treatment Duration of 3 Days|Completed||Phase 2|36|Anticipated|MerLion Pharmaceuticals GmbH||2|||f||||t||||||||||2017-02-18 14:06:03.283141|2017-02-18 14:06:03.283141
NCT00722722|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2016-04-28|2015-04-21||June 2008||2008-06-01|April 2016|2016-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates|The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates|Completed||Phase 2|18|Actual|Mayo Clinic||3|||f||||f||||||||||2017-02-18 14:06:03.402745|2017-02-18 14:06:03.402745
NCT00722709|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2010-01-12|||September 2008||2008-09-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Intraperitoneal Local Anaesthetic in Colonic Surgery|Randomised Double Blind Trial to Investigate the Effects of Intraperitoneal Local Anaesthetic Following Colonic Surgery.|Completed||Phase 1|60|Anticipated|University of Auckland, New Zealand||2|||f||||t||||||||||2017-02-18 14:06:03.843058|2017-02-18 14:06:03.843058
NCT00722696|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2008-07-24|||July 2008||2008-07-01|July 2008|2008-07-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Metabolic Effects of Eccentric Endurance Training|Metabolic Effects of Eccentric Endurance Training|Unknown status|Not yet recruiting|N/A|35|Anticipated|Vorarlberg Institute for Vascular Investigation and Treatment||1|||f||||f||||||||||2017-02-18 14:06:03.955626|2017-02-18 14:06:03.955626
NCT00722683|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-10-17|||April 2001||2001-04-01|September 2011|2011-09-01||||August 2010|Actual|2010-08-01||Interventional|||Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts|Characterization of Breast Masses Using a New Method of Ultrasound Contrast Agent Imaging in 3D Mapping of Vascular Anomalies|Completed||N/A|50|Anticipated|University of Michigan||1|||f||||t||||||||||2017-02-18 14:06:04.044059|2017-02-18 14:06:04.044059
NCT00722670|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2013-05-07|||June 2007||2007-06-01|May 2013|2013-05-01|August 2010|Actual|2010-08-01|February 2009|Actual|2009-02-01||Interventional|||Pregnant Women's CoOp|Woman-Focused HIV Prevention With Pregnant African-Americans|Completed||Phase 1|100|Actual|RTI International||2|||f||||f||||||||||2017-02-18 14:06:04.135479|2017-02-18 14:06:04.135479
NCT00722657|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2008-07-23|||April 2006||2006-04-01|May 2008|2008-05-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Observational|||Social-Economics Profile of the Asthmatic Patients Attended at Nucleus of Integrated Medical Care|Social-Economics Profile of the Asthmatic Patients Attended at Nucleus of Integrated Medical Care|Completed||N/A|40|Actual|Fortaleza University|||1||f||||t||||||None Retained|"~     None Retained - no samples retained~   "|||2017-02-18 14:06:04.246158|2017-02-18 14:06:04.246158
NCT00723814|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-27|2008-07-28||||||July 2008|2008-07-01||||||||Observational|||Blood Pressure Monitor Clinical Test||Completed||N/A|||Andon Health Co., Ltd|||||f||||||||||||||2017-02-18 14:06:04.325827|2017-02-18 14:06:04.325827
NCT00723801|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-09-08|2014-08-15||October 2007||2007-10-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome|Effects of Losartan vs Atenolol on Aortic Stiffness and Diastolic Function in Adults With Marfan Syndrome|Completed||Phase 3|40|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 14:06:04.394191|2017-02-18 14:06:04.394191
NCT00723788|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-11-14|2014-11-05||August 2008||2008-08-01|November 2014|2014-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||Patient referral from Emergency Department for suspected appendicitis with ultrasound and/or CT imaging request (0800 hr – 1700 hr)|Magnetic Resonance Imaging (MRI) of Appendicitis in Children|Magnetic Resonance Evaluation of Appendicitis in Children Aged 8-18|Completed||N/A|21|Actual|Children's Research Institute||1|||f||||f||||||||||2017-02-18 14:06:04.742791|2017-02-18 14:06:04.742791
NCT00723775|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2012-06-21|||July 2008||2008-07-01|June 2012|2012-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||GSK706769/KALETRA Drug-drug Interaction Study|Phase I, Open Label Drug-drug Interaction Study in Healthy Volunteers to Evaluate the Effect of KALETRA (Lopinavir-ritonavir) on GSK706769 Pharmacokinetics and to Evaluate the Pharmacokinetics of a New Oral Formulation of GSK706769|Completed||Phase 1|17|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:06:04.965747|2017-02-18 14:06:04.965747
NCT00723762|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2011-03-08|||February 2009||2009-02-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|||Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients|Valproic Acid-associated Hypoalbuminemia in Medically Fragile Pediatric and Young Adult Patients in a Long Term Care Facility Part 1: Potential Mechanism for Decreased Albumin Synthesis|Completed||N/A|90|Anticipated|Akron Children's Hospital|||3||f||||f||||||Samples Without DNA|"~     Serum and urine samples from patients receiving VPA.~   "|||2017-02-18 14:06:05.067432|2017-02-18 14:06:05.067432
NCT00372034|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-03|2009-04-06|||July 2006||2006-07-01|April 2009|2009-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Effect of Punctal Plugs on Tear Volume and Osmolality||Completed||N/A|20||The University of New South Wales|||||f||||||||||||||2017-02-18 16:17:00.745078|2017-02-18 16:17:00.745078
NCT00723749|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-04-26|2012-01-11||March 2008||2008-03-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)|Post-marketing Surveillance Study (Paper-AWB) for GPs and Clinics: Treatment of Opioid-dependent Patients With SUBOXONE® 2 mg / 8 mg Sublingual Tablets - Acceptability and Safety Data From a Real Life Scenario.|Completed||N/A|384|Actual|Indivior Inc.|||1||f||||t||||||||||2017-02-18 14:06:05.177978|2017-02-18 14:06:05.177978
NCT00723736|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-04-09|2009-06-18||December 2007||2007-12-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)|Non-Interventional Study of the Safe Use of Aerius in Pediatric Patients With Allergic Rhinitis or Chronic Idiopathic Urticaria.|Completed||N/A|100|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:06:05.432864|2017-02-18 14:06:05.432864
NCT00723723|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-08-11|||January 2008||2008-01-01|August 2015|2015-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)|Compliance With LDL-Lowering Therapy For Secondary Prevention of Coronary Heart Disease in Real Life Practice|Completed||N/A|555|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:06:05.684647|2017-02-18 14:06:05.684647
NCT00723710|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-08-24|2013-08-21||April 2006||2006-04-01|August 2015|2015-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)|Guidelines to the Intron A® Health Management Program II: A Nursing Support Program for Patients With High-Risk Melanoma Receiving High Dose Intron A Therapy|Completed||N/A|299|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:06:05.773366|2017-02-18 14:06:05.773366
NCT00723697|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2011-04-14|2011-04-14||May 2007||2007-05-01|July 2010|2010-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|OPUS R||Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)|Etude Observationnelle Prospective de l'Utilisation en Situation Reelle; Prospective Real Situation Observational Study of Subutex® or Its Buprenorphine High Dose Generic (BHD) in the Replacement Treatment of Major Opiate Dependence: Following Parameters With Respect to Misuse and Pharmacovigilance|Completed||N/A|1307|Actual|Indivior Inc.|||1||f||||f||||||||||2017-02-18 14:06:06.030233|2017-02-18 14:06:06.030233
NCT00723684|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-28|2013-03-07|||July 2008||2008-07-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|July 2012|Actual|2012-07-01||Interventional|PANther||Project Attention Deficit Hyperactivity Disorder (ADHD) and Electroencephalography (EEG)-Neurofeedback THERapy|ADHD and EEG-neurofeedback. A Single-blind Randomized Placebo-controlled Treatment Study.|Completed||N/A|63|Actual|Radboud University||2|||f||||t||||||||||2017-02-18 14:06:06.361395|2017-02-18 14:06:06.361395
NCT00723671|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-12-10|||November 2006||2006-11-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|April 2013|Actual|2013-04-01||Interventional|||Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus||Completed||N/A|66|Actual|University of Michigan||1|||f||||||||||||||2017-02-18 14:06:08.826087|2017-02-18 14:06:08.826087
NCT00723658|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-26|2015-03-05|||September 2008||2008-09-01|March 2015|2015-03-01||||May 2010|Actual|2010-05-01||Interventional|||S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia|S0629, Observational Study of Asymptomatic Waldenstrom's Macroglobulinemia and Phase II Study of Tandem Autologous Transplant and Maintenance Treatment for Patients With Symptomatic Disease|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||2||lack of accrual|f||||t||||||||||2017-02-18 14:06:08.924703|2017-02-18 14:06:08.924703
NCT00723645|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-11-26|2012-03-23||April 2008||2008-04-01|November 2015|2015-11-01|February 2011|Actual|2011-02-01|April 2010|Actual|2010-04-01||Observational|FAST-4||Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)|Rate and Predictors of Relapse in the Treatment of Hepatitis C in Real-life Clinical Practice in Spanish Hospitals (FAST-4)|Completed||N/A|279|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:06:09.067081|2017-02-18 14:06:09.067081
NCT00723632|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-10-01|2011-11-11||September 2005||2005-09-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)|Cost of Treatment of Chronic Hepatitis C Using Combination of Peginterferon α-2b Plus Ribavirin|Completed||N/A|901|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:06:09.256701|2017-02-18 14:06:09.256701
NCT00723619|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2010-02-16|||June 2007||2007-06-01|July 2008|2008-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|LUNOKID-Studie||Investigation of Lungfunction Normal Values in Children and Adolescent in Germany (Spirometry, Ultrasonic Pneumography and Exhaled NO)|Investigation of Lungfunction Normal Values in Children and Adolescent in Germany|Completed||N/A|2007|Actual|Marien Hospital Wesel|||1||f||||f||||||||||2017-02-18 14:06:09.478063|2017-02-18 14:06:09.478063
NCT00723606|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-06-30|2010-07-29||September 2008||2008-09-01|June 2015|2015-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation|A Randomized, Open Label, Rater Blind, Flexible Dose Multi-Center Study Comparing The Efficacy And Safety Of Intramuscular Ziprasidone With Haloperidol For Three Days In Patients With Agitation Of Schizophrenia|Completed||Phase 3|376|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:06:09.618138|2017-02-18 14:06:09.618138
NCT00723593|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2017-01-24|||July 23, 2008||2008-07-23|February 4, 2013|2013-02-04|February 4, 2013||2013-02-04|||||Observational|||Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host Disease|Natural History and Pathophysiology of Gastrointestinal Graft Versus Host Disease|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:06:10.256474|2017-02-18 14:06:10.256474
NCT00723580|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2015-07-28|2010-09-22||May 2008||2008-05-01|July 2015|2015-07-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Actigraphic Analysis of Treatment Response|Actigraphic Analysis of Treatment Response in a Six Year Old Girl With Kabuki Syndrome|Completed||N/A|1|Actual|Child Psychopharmacology Institute|This single case study has limited generalizability in that these results may not apply to others. The methods explored, however, may apply to others and Single-subject repeated measurements can provide valuable clinical and scientific data.|1|||f||||f||||||||||2017-02-18 14:06:10.341888|2017-02-18 14:06:10.341888
NCT00723554|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2013-03-27|2013-01-14||July 2008||2008-07-01|March 2013|2013-03-01|April 2011|Actual|2011-04-01|August 2010|Actual|2010-08-01||Interventional|INHALE-15||Iloprost Power Disc-15 in Pulmonary Arterial Hypertension|A Phase IIIb, Multicenter, Open-label Study of Patients With Pulmonary Arterial Hypertension Treated With Iloprost(Inhalation)Evaluating Safety and Inhalation Times When Converting From Power Disc-6 (PD-6) to Power Disc-15 (PD-15) With the I-neb® AAD®|Terminated||Phase 3|63|Actual|Actelion||1||sponsor's decision|f||||f||||||||||2017-02-18 14:06:10.727469|2017-02-18 14:06:10.727469
NCT00723541|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2017-01-11|||January 2008||2008-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Breast Lesion Analysis for Tomosynthesis Mammography|Tomosynthesis Mammography: Computer-Aided Analysis of Breast Lesions|Recruiting||Early Phase 1|800|Anticipated|University of Michigan||1|||f||||f||||||||No||2017-02-18 14:06:11.760592|2017-02-18 14:06:11.760592
NCT00723528|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2014-04-22|2013-12-02||March 2008||2008-03-01|April 2014|2014-04-01|March 2010|Actual|2010-03-01|January 2009|Actual|2009-01-01||Interventional||"N (number of participants analyzed) signifies the participants evaluable for this measure."|An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis|A Placebo-Controlled Double-Blind Comparative Study of CNTO1275 in Patients With Plaque Type Psoriasis|Completed||Phase 3|158|Actual|Janssen Pharmaceutical K.K.||7|||f||||f||||||||||2017-02-18 14:06:11.884039|2017-02-18 14:06:11.884039
NCT00723515|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2008-07-24|||February 2007||2007-02-01|July 2008|2008-07-01|October 2007|Actual|2007-10-01|June 2007|Actual|2007-06-01||Interventional|||Therapeutic Effect of Two Fluoride Varnishes on White Spot Lesions: a Clinical Study|Therapeutic Effect of Two Fluoride Varnishes on White Spot Lesions: a Clinical Study|Completed||Phase 4|45|Actual|University of Pernambuco||2|||f||||f||||||||||2017-02-18 14:06:13.728708|2017-02-18 14:06:13.728708
NCT00723502|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2009-06-15|||September 2008||2008-09-01|October 2008|2008-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|FLASH||Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients|An Open-Label, Randomized, Multicenter, Two-Arms Efficacy and Safety Study of 14 Days Treatment With Finafloxacin 400 mg b.i.d. Plus Amoxicillin 1000 mg b.i.d.Versus Finafloxacin 400 mg b.i.d. Plus Esomeprazole 40 mg b.i.d. in Patients With Helicobacter Pylori Infection|Completed||Phase 2|30|Anticipated|MerLion Pharmaceuticals GmbH||2|||f||||t||||||||||2017-02-18 14:06:13.844679|2017-02-18 14:06:13.844679
NCT00723489|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2013-12-11|2013-07-16||August 2008||2008-08-01|December 2013|2013-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis|A Study of the Systemic and Cutaneous Immune Responses to Yellow Fever Vaccination in Atopic Dermatitis Subjects|Completed||Phase 1/Phase 2|82|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 14:06:14.184562|2017-02-18 14:06:14.184562
NCT00723476|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-05-19|||September 2005||2005-09-01|May 2015|2015-05-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Family Centered Advanced Care Planning for Adolescents With HIV/AIDS and Their Families|Family Centered Advanced Care Planning (FCACP)|Completed||N/A|82|Actual|Children's Research Institute||2|||f||||t||||||||||2017-02-18 14:06:15.002213|2017-02-18 14:06:15.002213
NCT00723463|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-11-01|||June 2006||2006-06-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|June 2016|Actual|2016-06-01||Interventional|||Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue|Retrospective - Prospective - Study to Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissues at 3T MRI|Completed||Early Phase 1|200|Actual|University of Michigan||1|||f||||f||||||||No||2017-02-18 14:06:15.114865|2017-02-18 14:06:15.114865
NCT00723450|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-11-18|2014-03-27||July 2008||2008-07-01|November 2016|2016-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients|The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age|Completed||Phase 3|301|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:06:15.235047|2017-02-18 14:06:15.235047
NCT00723437|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2008-07-25|||January 2005||2005-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|January 2007|Actual|2007-01-01||Interventional|||Evaluation of the Efficacy of Acitretin Therapy for Nail Psoriasis|Evaluation of Nail Psoriasis Severity Index (NAPSI) and Modified Napsi in Patients With Nail Psoriasis Treated With Acitretin|Completed||Phase 4|36|Actual|Istituti Fisioterapici Ospitalieri||1|||f||||f||||||||||2017-02-18 14:06:16.68988|2017-02-18 14:06:16.68988
NCT00723424|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2010-11-30|||July 2008||2008-07-01|November 2010|2010-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin|An Open-label Study to Assess the Effect of AZD5672 at Steady State on the Pharmacokinetics of Digoxin Following Single Dose Administration in Healthy Volunteers|Completed||Phase 1|24|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:06:16.801188|2017-02-18 14:06:16.801188
NCT00723411|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2011-10-07|||July 2008||2008-07-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)|A Phase III, 3-Arm, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Impact of Diamyd on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus (EU)|Terminated||Phase 3|334|Actual|Diamyd Therapeutics AB||3||The primary endpoint at 15 months was not met.|f||||t||||||||||2017-02-18 14:06:16.915543|2017-02-18 14:06:16.915543
NCT00723398|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2013-01-30|||March 2009||2009-03-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention|Combination of Low Dose Antiestrogens With Omega-3 Fatty Acids for Prevention of Hormone-independent Breast Cancer|Unknown status|Active, not recruiting|N/A|372|Anticipated|Milton S. Hershey Medical Center||5|||f||||f||||||||||2017-02-18 14:06:17.091491|2017-02-18 14:06:17.091491
NCT00723385|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2015-04-07|||July 2008||2008-07-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effects of Vitamin D on Lipids|Effects of Vitamin D on Lipids|Completed||N/A|130|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:06:17.205509|2017-02-18 14:06:17.205509
NCT00722982|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-11-21|||July 2008||2008-07-01|November 2014|2014-11-01|July 2015|Anticipated|2015-07-01|May 2012|Actual|2012-05-01||Observational|||Migration Pattern of C-stem AMT Versus Exeter in Total Hip Arthroplasty|Migration Pattern of C-stem AMT Versus Exeter in Total Hip Arthroplasty|Unknown status|Active, not recruiting|N/A|70|Actual|Oslo University Hospital|||2||f||||f||||||||||2017-02-18 14:06:24.801785|2017-02-18 14:06:24.801785
NCT00723359|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2013-07-16|||August 2008||2008-08-01|July 2013|2013-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma|A Phase I Dose Escalation Study to Evaluate Maximum Tolerated Dose (MTD), Pharmacokinetics (PK), and Safety of BT062 in Subjects With Relapsed or Relapsed/Refractory Multiple Myeloma|Completed||Phase 1|32|Actual|Biotest Pharmaceuticals Corporation||1|||f||||||||||||||2017-02-18 14:06:17.335295|2017-02-18 14:06:17.335295
NCT00723346|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2012-01-10|||January 2006||2006-01-01|January 2012|2012-01-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Interventional|GRASPALL||Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia|Administration of Allogenic of Red Blood Cells Loaded L Asparaginase in Acute Lymphoblastic Leukemia Relapse.|Completed||Phase 1/Phase 2|25|Actual|ERYtech Pharma||4|||f||||t||||||||||2017-02-18 14:06:17.440311|2017-02-18 14:06:17.440311
NCT00723333|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2009-10-08|||May 2008||2008-05-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Bone Marrow Transplant Chart Review for RIC|Chart Review of Reduced Intensity Conditioning (RIC) Allogeneic Transplants in Elderly Patients With Myelofibrosis.|Completed||N/A|30|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 14:06:17.549479|2017-02-18 14:06:17.549479
NCT00723320|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-08-22|||February 2008||2008-02-01|July 2008|2008-07-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|EALIPPCA||Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis|Effect of Atorvastatin and Lifestyle Intervention on Progression of Carotid Intima-Media Thickness in Chinese People Without Manifest Atherosclerotic Disease|Unknown status|Recruiting|N/A|1200|Anticipated|Ministry of Science and Technology of the People´s Republic of China||4|||f||||t||||||||||2017-02-18 14:06:17.670944|2017-02-18 14:06:17.670944
NCT00723307|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2012-12-07|||February 2009||2009-02-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CAMERA||Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study|A Randomised Placebo-controlled Trial of Metformin on Progression of Carotid Atherosclerosis in Non-diabetic Patients With Cardiovascular Disease Treated With Conventional Risk Reducing Agents|Completed||Phase 4|173|Actual|University of Glasgow||2|||f||||f||||||||||2017-02-18 14:06:17.781688|2017-02-18 14:06:17.781688
NCT00723294|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2016-06-06|||September 2008||2008-09-01|June 2016|2016-06-01||||September 2013|Actual|2013-09-01||Interventional|||Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer|A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma|Active, not recruiting||Phase 2|99|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 14:06:17.885946|2017-02-18 14:06:17.885946
NCT00723281|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2014-08-15|||January 2007||2007-01-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|July 2010|Actual|2010-07-01||Observational|||Comparison of CT Angiography With Conventional Angiography and Intravascular Ultrasound in Heart Transplant Patients|Comparison of CT Angiography With Conventional Angiography and Intravascular Ultrasound in Heart Transplant Patients|Completed||N/A|18|Anticipated|University of California, San Francisco|||1||f||||t||||||||||2017-02-18 14:06:18.006588|2017-02-18 14:06:18.006588
NCT00723268|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2008-07-28|||May 2007||2007-05-01|July 2008|2008-07-01||||August 2008|Anticipated|2008-08-01||Interventional|||Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae|Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Mashhad University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:06:18.101356|2017-02-18 14:06:18.101356
NCT00723255|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2016-11-14|2015-05-11||September 2008||2008-09-01|November 2016|2016-11-01||||July 2011|Actual|2011-07-01||Interventional|||Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Combination Bevacizumab (NCI-Supplied Agent: NSC #70486) and Temsirolimus (CCI-779, NCI-Supplied Agent, NSC #683864) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Active, not recruiting||Phase 2|53|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:06:18.222637|2017-02-18 14:06:18.222637
NCT00723242|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2008-07-24|||April 2002||2002-04-01|July 2008|2008-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||The Role of Dendritic Cells in Hepatitis C Infection||Completed||N/A|||University College, London|||||f||||||||||||||2017-02-18 14:06:18.816707|2017-02-18 14:06:18.816707
NCT00723229|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2010-07-20|||August 2008||2008-08-01|July 2010|2010-07-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation|A Randomized, Cross-Over Study to Evaluate the Suppressive Effect of Acyclovir on Rapidly Cleared Herpes Simplex Virus Type 2 Genital Reactivation Episodes in Herpes Simplex Virus-2 Seropositive Adults|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|University of Washington||2|||f||||f||||||||||2017-02-18 14:06:18.895111|2017-02-18 14:06:18.895111
NCT00723216|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2010-04-02|||March 2007||2007-03-01|April 2010|2010-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery|Multicenter, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Enoxaparin Sodium (RP54563) 20mg Bid for 14 Days for Prevention of Venous Thromboembolism in Patients With Curative Abdominal Cancer Surgery. Physical Prophylaxis Only Arm [Intermittent Pneumatic Compression (IPC)] Will be Used as an Indicator of Event Rates.|Completed||Phase 3|151|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:06:19.200523|2017-02-18 14:06:19.200523
NCT00723203|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2014-09-03|2014-06-12||April 2008||2008-04-01|September 2014|2014-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia|A Phase II Study of LBH589, a Novel Histone Deacetylase Inhibitor, in Relapsed and Refractory Adult Patients With Acute Leukemia (AL) or in Newly Diagnosed Patients Over the Age of 60|Terminated||Phase 2|16|Actual|City of Hope Medical Center|There were no responses observed in the first 12 evaluable patients accrued to the first stage of the two-stage Optimum design of Simon. As a result the study was terminated due to a lack of efficacy.|1||Terminated early due to a lack of efficacy|f||||t||||||||||2017-02-18 14:06:19.30143|2017-02-18 14:06:19.30143
NCT00722995|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2015-06-01|||January 2008||2008-01-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|SLEEVE||Surgical Treatment for Morbid Obesity by Sleeve Gastrectomy Versus Gastric Bypass|Surgical Treatment for Morbid Obesity by Sleeve Gastrectomy Versus Gastric Bypass. Study Comparing Complications, Efficacy and Quality of Life.|Active, not recruiting||N/A|280|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:06:24.680429|2017-02-18 14:06:24.680429
NCT00723190|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2012-01-24|2011-09-20||January 2008||2008-01-01|September 2011|2011-09-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|An Open-Label, Chronic Exposure Evaluation of the Safety of CLONICEL (Clonidine HCl Sustained Release) in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|303|Actual|Shionogi Inc.|Efficacy results need to be reviewed in the context that the study is an open-label/non-placebo controlled study. No formal statistical testing of efficacy results has been done. No adjustments have been made to account for drop-outs or missing data.|1|||f||||f||||||||||2017-02-18 14:06:19.642208|2017-02-18 14:06:19.642208
NCT00723177|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-10-11|2015-03-23||October 2008||2008-10-01|October 2016|2016-10-01|June 2012|Actual|2012-06-01|April 2010|Actual|2010-04-01||Interventional|AV411||Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal|The Safety, Tolerability and Preliminary Efficacy of AV411, a Glial Activation Inhibitor, in Heroin Abusers Under Conditions of Morphine Maintenance and Withdrawal|Completed||Phase 2|30|Actual|New York State Psychiatric Institute||3|||f||||f||||||||Yes|Data have been published in a peer-reviewed journal.|2017-02-18 14:06:20.135926|2017-02-18 14:06:20.135926
NCT00723164|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2008-07-25|||October 2005||2005-10-01|July 2008|2008-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Premedication on Sevoflurane Induction|Low Dose Fentanyl/Midazolam Improves Sevoflurane Induction in Adults|Completed||N/A|80|Actual|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-02-18 14:06:20.63023|2017-02-18 14:06:20.63023
NCT00723151|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2010-10-29|||July 2005||2005-07-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Effects of Intensity of Early Communication Intervention|Effects of Intensity of Early Communication Intervention|Completed||Phase 2|70|Anticipated|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:06:20.750386|2017-02-18 14:06:20.750386
NCT00723125|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2014-10-14|2014-07-17||September 2008||2008-09-01|October 2014|2014-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer|Q3week Carboplatin With Weekly Abraxaneä And Avastin + Subsequent Dose-Dense Ac With Avastin As Neoadjuvant Therapy In Resectable And Unresectable (Stage Iia-Iiib) Her2-Negative Breast Cancer|Completed||Phase 2|60|Actual|Brown University||2|||f||||t||||||||||2017-02-18 14:06:20.870699|2017-02-18 14:06:20.870699
NCT00723112|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2010-11-22|||February 2007||2007-02-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||The Role of Erythropoietin in Myelodysplastic Syndrome|The Role of Erythropoietin in Myelodysplastic Syndrome|Completed||N/A|8|Actual|University of Utah|||2||f||||f||||||||||2017-02-18 14:06:21.730207|2017-02-18 14:06:21.730207
NCT00723099|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2017-02-14|||June 2008||2008-06-01|February 2017|2017-02-01||||September 2017|Anticipated|2017-09-01||Interventional|||Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer|Transplantation of Umbilical Cord Blood in Patients With Hematological Malignancies Using a Reduced-Intensity Preparative Regimen (A Multi-center Trial Coordinated by the FHCRC)|Suspended||Phase 2|85|Anticipated|Fred Hutchinson Cancer Research Center||2||interim analysis|f||||t||||||||||2017-02-18 14:06:21.842368|2017-02-18 14:06:21.842368
NCT00723086|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2009-09-30|||May 2005||2005-05-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer|An Extension Multicenter Phase II Open Label Non-comparative Trial of RP56976 Administered Every Three Weeks in Combination With Daily Prednisolone for Metastatic Hormone Refractory Prostate Cancer.|Completed||Phase 2|16|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:06:21.992285|2017-02-18 14:06:21.992285
NCT00723073|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2010-08-25|2010-06-07||January 2008||2008-01-01|August 2010|2010-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia|Evaluation of Caspofungin or Micafungin as Empiric Antifungal Therapy in Adult Patients With Persistent Febrile Neutropenia: A Retrospective, Observational, Sequential Cohort Analysis|Completed||N/A|323|Actual|Brigham and Women's Hospital|Retrospective, observational, sequential cohort study conducted at a single center. Only adult patients were treated at our institution, so these results cannot be extrapolated to a pediatric population.||2||f||||f||||||||||2017-02-18 14:06:22.087154|2017-02-18 14:06:22.087154
NCT00723060|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2011-08-05|||September 2008||2008-09-01|August 2011|2011-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder|Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder (Randomized, Double-blind, Multi-center Study)|Completed||Phase 4|176|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:06:22.793953|2017-02-18 14:06:22.793953
NCT00723047|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2011-09-02|||November 2003||2003-11-01|September 2011|2011-09-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|Fibrin glue||Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial|Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial|Completed||Phase 3|77|Actual|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||1|||f||||f||||||||||2017-02-18 14:06:22.950531|2017-02-18 14:06:22.950531
NCT00723021|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2012-12-27|2012-12-27||July 2008||2008-07-01|December 2012|2012-12-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|||PF-04191834 Single Dose Bronchodilatory Study In Asthma.|A Phase 2a, Randomised, Double-Blind (3rd Party Open), Double-Dummy, Placebo And Active Controlled 5-Way Crossover Study To Assess The Bronchodilatory Action, Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04191834 In Asthmatic Patients.|Completed||Phase 2|15|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 14:06:23.234344|2017-02-18 14:06:23.234344
NCT00723008|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2013-02-19|2012-10-09||May 2007||2007-05-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|CES||Cranial Electrotherapy Stimulation in Burned Patients|Effect of Cranial Electrotherapy Stimulation on PTSD in Burned Outpatients|Completed||Phase 2|20|Actual|United States Army Institute of Surgical Research|This study had a high study turn-over rate, which led to small data group analysis. All subjects enrolled were active military service men. This made civilian and female comparison impossible. The PI also changed during study course.|2|||f||||f||||||||||2017-02-18 14:06:24.078371|2017-02-18 14:06:24.078371
NCT00722969|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2009-03-02|||November 2007||2007-11-01|March 2009|2009-03-01|April 2009|Anticipated|2009-04-01|November 2008|Anticipated|2008-11-01||Interventional|||Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer|A Phase II Study of Erlotinib and Sorafenib in Patients With Locally Advanced and/or Metastatic (Stage IIIb or IV) Non Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy|Unknown status|Active, not recruiting|Phase 2|48|Anticipated|Free University Medical Center||1|||f||||f||||||||||2017-02-18 14:06:24.904736|2017-02-18 14:06:24.904736
NCT00722956|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2010-11-30|||July 2008||2008-07-01|November 2010|2010-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin|A Phase I, Single Centre, Open-label Study to Assess the Pharmacokinetics of Both AZD5672 (Steady-state) and Atorvastatin (Single Dose) When Co Administered in Healthy Volunteers|Completed||Phase 1|12|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:06:25.023099|2017-02-18 14:06:25.023099
NCT00722943|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2013-02-06|||July 2008||2008-07-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|DMT||Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study|Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study|Completed||N/A|46|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 14:06:25.136866|2017-02-18 14:06:25.136866
NCT00722930|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2008-07-25|||April 2008||2008-04-01|July 2008|2008-07-01|April 2013|Anticipated|2013-04-01|April 2011|Anticipated|2011-04-01||Interventional|GOTEL-FL1LC||Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma|Consolidation Treatment With Y90-Ibritumomab Tiuxetan In Patients With High-Risk Follicular Lymphoma With Either Partial Or Complete Response To R-Chop Induction Chemotherapy|Unknown status|Recruiting|Phase 2|38|Anticipated|Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas||1|||f||||f||||||||||2017-02-18 14:06:25.247922|2017-02-18 14:06:25.247922
NCT00722917|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-06-20||2016-06-20|July 2008||2008-07-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus|A Phase II, Randomized, Double-Blind, Placebo-and Active-Controlled, Multi-center Study to Determine the Efficacy and Safety of TAK-379 in Subjects With Type 2 Diabetes|Terminated||Phase 2|323|Actual|Takeda||5||Animal Toxicity Findings|f||||f||||||||||2017-02-18 14:06:25.366043|2017-02-18 14:06:25.366043
NCT00722904|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2013-10-04|||June 2007||2007-06-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|July 2009|Actual|2009-07-01||Observational|||Evaluation of Vascular Pathology With 3D, Time-Resolved Phase Contrast Magnetic Resonance Imaging (MRI)|Evaluation of Vascular Pathology With 3D, Time-Resolved Phase Contrast MRI|Completed||N/A|40|Anticipated|University of California, San Francisco|||2||f||||t||||||||||2017-02-18 14:06:25.495254|2017-02-18 14:06:25.495254
NCT00722891|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2010-11-12|||July 2008||2008-07-01|November 2010|2010-11-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Ocular Responses to Short and Long-term Lens Wear|Ocular Responses to Acute and Chronic Lens Wear|Completed||Phase 4|30|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:06:25.594707|2017-02-18 14:06:25.594707
NCT00722878|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-09-07|||July 2008||2008-07-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung Disease|Early Onset and Progression of Primary Ciliary Dyskinesia Lung Disease Prior to 10 Years of Age|Active, not recruiting||N/A|48|Anticipated|University of North Carolina, Chapel Hill|||1||f||||t||||||Samples With DNA|"~     Approximately 2 teaspoons of blood and a small amount of urine (if the child is able to~     urinate in a cup) will be collected and held at the specimen bank located at Denver~     Children's Hospital. These samples will be used to help identify markers that may predict~     the clinical course of PCD.~   "|||2017-02-18 14:06:25.69804|2017-02-18 14:06:25.69804
NCT00722865|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2016-12-17|||September 2008||2008-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma|Avastin (Bevacizumab) in Combination With ABVD for the Treatment of Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma|Active, not recruiting||Phase 2|36|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:06:25.811372|2017-02-18 14:06:25.811372
NCT00722852|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2009-10-02|||June 2008||2008-06-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee|Multicentre, Randomized, Double-blind, Placebo-controlled Study of Safety and Efficacy of Epicutaneously Applied Diractin® (Ketoprofen in Transfersome® Gel) for the Treatment of Osteoarthritis of the Knee|Completed||Phase 3|555|Actual|IDEA AG||2|||f||||f||||||||||2017-02-18 14:06:25.911518|2017-02-18 14:06:25.911518
NCT00722839|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-25|2012-06-21|||December 2006||2006-12-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants|A Phase I Dose Escalation Study of Peptide Vaccines With Activity Against Human Cytomegalovirus|Completed||Phase 1|68|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 14:06:26.058425|2017-02-18 14:06:26.058425
NCT00722826|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-05-29|||June 2007||2007-06-01|May 2015|2015-05-01||||June 2009|Actual|2009-06-01||Observational|||Tetralogy of Fallot Seed Grant|MRI Assessment of Right Ventricular Function in Patients After Repair of Tetralogy of Fallot|Completed||N/A|82|Actual|University of California, San Francisco|||1||f||||t||||||||||2017-02-18 14:06:26.155185|2017-02-18 14:06:26.155185
NCT00722644|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2017-01-10|||September 1999||1999-09-01|July 2008|2008-07-01|August 2007||2007-08-01|||||Interventional|||Cognitive Behavioral Stress Management for HIV+ Drug Abusers|Cognitive Behavioral Treatment of HIV+ Drug Abusers|Completed||Phase 1|450||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 14:06:26.306001|2017-02-18 14:06:26.306001
NCT00722631|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2012-09-26|||May 2007||2007-05-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2009|Actual|2009-04-01||Interventional|||Anti-Inflammatory Effects of Pioglitazone|Detection of Plaque Inflammation and Visualization of Anti-Inflammatory Effects of Pioglitazone on Plaque Inflammation in Subjects With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus by FDG-PET/CT|Completed||N/A|70|Actual|Kurume University||2|||f||||t||||||||||2017-02-18 14:06:26.394851|2017-02-18 14:06:26.394851
NCT00722228|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-07-24||||||July 2008|2008-07-01||||||||Interventional|||Allogeneic Whole Cell Cancer Vaccine for Metastatic Epithelial Tumors||Unknown status|Not yet recruiting|Phase 1/Phase 2|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 14:06:36.906978|2017-02-18 14:06:36.906978
NCT00722618|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2016-11-22|||September 2007||2007-09-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||Communication With in Vitro Fertilization (IVF) Patients About Risks|Improving Communication With IVF Patients About Risks Such as Multiple Births|Completed||N/A|264|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:06:26.503759|2017-02-18 14:06:26.503759
NCT00722605|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2013-01-23|||July 2008||2008-07-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer|The Use of Multiple Respiration-Correlated Cone Beam CT Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer.|Completed||Phase 1/Phase 2|16|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:06:26.607823|2017-02-18 14:06:26.607823
NCT00722592|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2014-12-18||2012-03-07|September 2008||2008-09-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|September 2010|Actual|2010-09-01||Interventional|PRECEDENT||Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)|A Randomized Phase II Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil/Caelyx) in Combination, Versus PLD Alone, in Subjects With Platinum-Resistant Ovarian Cancer|Completed||Phase 2|162|Actual|Endocyte||2|||f||||t||||||||||2017-02-18 14:06:26.718809|2017-02-18 14:06:26.718809
NCT00722579|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2010-06-11|||July 2008||2008-07-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|December 2008|Actual|2008-12-01||Interventional|PRESILLION||A Study of the Presillion Stent in de Novo Coronary Lesions|A Non-Randomized, Multi-Center, Single-Arm Safety Study of the Presillion Stent in de Novo Native Coronary Artery Lesions|Completed||Phase 3|101|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 14:06:26.836459|2017-02-18 14:06:26.836459
NCT00722566|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-10-06|2011-08-30||July 2008||2008-07-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma|An Open-Label Randomized Study of Subcutaneous and Intravenous VELCADE in Subjects With Previously Treated Multiple Myeloma|Completed||Phase 3|222|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 14:06:26.9547|2017-02-18 14:06:26.9547
NCT00722553|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2013-05-08|2012-04-30||July 2008||2008-07-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|April 2011|Actual|2011-04-01||Interventional|||Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder|A Phase 2, Single-Arm Study of Pralatrexate in Patients With Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder|Completed||Phase 2|30|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||||||||||||2017-02-18 14:06:30.158185|2017-02-18 14:06:30.158185
NCT00722540|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2017-02-06|||July 2008||2008-07-01|February 2017|2017-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083|Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NCC126-0083 in Healthy Male Japanese Subjects.|Completed||Phase 1|40|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-02-18 14:06:30.745692|2017-02-18 14:06:30.745692
NCT00722527|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2016-10-05|||July 2006||2006-07-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Molecular Biology of Polycythemia and Thrombocytosis|Molecular Biology of Polycythemia and Thrombocytosis|Recruiting||N/A|200|Anticipated|University of Utah|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 14:06:30.85782|2017-02-18 14:06:30.85782
NCT00722514|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-08-14|||July 1998||1998-07-01|July 2008|2008-07-01|July 2001||2001-07-01|February 2001||2001-02-01||Interventional|||Evaluation of a Patient Education Program for Ankylosing Spondylitis|Evaluation of a Patient Education Program for Ankylosing Spondylitis|Completed||N/A|||Rehazentrum Bad Eilsen||2|||f||||||||||||||2017-02-18 14:06:30.972606|2017-02-18 14:06:30.972606
NCT00722501|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2009-04-24|||August 2008||2008-08-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study Evaluating the Safety and Pharmacokinetics of Ascending Single IV Doses of ERB-257|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ERB-257 Administered Intravenously as a 30-Minute Infusion to Healthy Subjects|Completed||Phase 1|48|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:06:31.064705|2017-02-18 14:06:31.064705
NCT00722488|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2013-11-15|||June 2008||2008-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma|An Open-Label, Dose Escalation, Phase I Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma|Completed||Phase 1|56|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 14:06:31.154708|2017-02-18 14:06:31.154708
NCT00722475|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2014-11-05|||August 2008||2008-08-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage|A Randomized, Placebo-controlled, Double-blind Trial of Intravenous Immunoglobulin for Women With Unexplained Secondary Recurrent Miscarriage|Completed||Phase 3|82|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 14:06:31.240329|2017-02-18 14:06:31.240329
NCT00722462|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-07-07|||August 2008||2008-08-01|July 2015|2015-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|AcuIVF||The Effect of Acupuncture on Pregnancy Rates in Women Undergoing Embryo Transfer|The Effect of Acupuncture on Pregnancy Rates in Women Undergoing Embryo Transfer After in Vitro Fertilization: A Prospective Randomized Sham-controlled Trial|Terminated||Phase 4|30|Actual|Ottawa Fertility Centre||3||Recent abstract publication questioning the need for our study|f||||f||||||||||2017-02-18 14:06:31.34715|2017-02-18 14:06:31.34715
NCT00722436|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2017-02-10|2016-09-16||July 2008||2008-07-01|February 2017|2017-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Tranexamic Acid for Craniofacial Surgery|Tranexamic Acid for the Reduction of Allogeneic Blood Exposure in Infants and Children Having Craniofacial Surgery|Terminated||Phase 4|20|Actual|University of Pittsburgh|Study terminated because two studies published during the trial demonstrated efficacy of tranexamic acid at a lower dose.|2||Study dose changed based on recent publications|f||||f||||||||No|We stopped the study early because emerging data came out that demonstrated benefit with significantly lower doses than our study. We were compelled to stop enrolling.|2017-02-18 14:06:31.445444|2017-02-18 14:06:31.445444
NCT00722423|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-09-16|2015-03-24||May 2009||2009-05-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|July 2013|Actual|2013-07-01||Interventional|HCV||An Integrated Care Model for Improving Hepatitis C Virus Patient Outcomes|An Integrated Care Model for Improving HCV Patient Outcomes|Completed||N/A|364|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:06:31.847245|2017-02-18 14:06:31.847245
NCT00722410|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-07-24|||September 2008||2008-09-01|July 2008|2008-07-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia|Safety and Efficacy Study of Eradication of Carbapenem Resistant Klebsiella Pneumonia From the Gastrointestinal Tract by Probiotics.|Unknown status|Not yet recruiting|Phase 1/Phase 2|60|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||||2017-02-18 14:06:32.49407|2017-02-18 14:06:32.49407
NCT00722397|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-06-03|||August 2008||2008-08-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||TODAY Genetics Study|Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Genetics Study|Completed||N/A|2654|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||Samples With DNA|"~     Collect 27 mL of blood to send (1) for extraction of DNA to the NIDDK Central Repository and~     (2) for measurement of glucose, C-peptide, and autoantibody analysis to a central blood~     laboratory.~   "|||2017-02-18 14:06:32.617149|2017-02-18 14:06:32.617149
NCT00722384|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-07-24|||August 2004||2004-08-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5|An Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5 by Single Intravitreal Injection in Patients With Wet Age-Related Macular Degeneration|Completed||Phase 1|15|Actual|OPKO Health, Inc.||5|||f||||f||||||||||2017-02-18 14:06:32.720764|2017-02-18 14:06:32.720764
NCT00722371|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2015-03-23|2011-09-09||September 2008||2008-09-01|March 2015|2015-03-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|||MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)|A Multicenter, Randomized, Double-Blind Study of the Co-Administration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 3|1615|Actual|Merck Sharp & Dohme Corp.||7|||f||||f||||||||||2017-02-18 14:06:32.834384|2017-02-18 14:06:32.834384
NCT00722358|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-06-15||2011-06-15|December 2008||2008-12-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects|Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Antiviral Activity and Safety, Tolerability, and Pharmacokinetics of BMS-650032 in Subjects Infected With Hepatitis C Virus Genotype 1|Completed||Phase 2|15|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:06:34.796631|2017-02-18 14:06:34.796631
NCT00722345|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-07-24|||June 2005||2005-06-01|June 2005|2005-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Exercise Consultation in Obese Youth|Can Exercise Consultation Increase Activity Levels and Improve Metabolic Markers in Obese Adolescents? A Pilot Study.|Completed||N/A|33|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-02-18 14:06:34.897783|2017-02-18 14:06:34.897783
NCT00722332|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2013-10-30|||February 2008||2008-02-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients|Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients|Completed||Phase 4|9|Actual|Cangene Corporation||1|||f||||f||||||||||2017-02-18 14:06:34.990329|2017-02-18 14:06:34.990329
NCT00722319|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-08-11|||March 2009||2009-03-01|January 2010|2010-01-01|October 2011|Anticipated|2011-10-01|July 2010|Actual|2010-07-01||Observational|WAR-STENT||Ongoing WARfarin and Coronary STENTing|Ongoing WARfarin and Coronary STENTing. A Multi-center, Prospective Registry on Antithrombotic Treatment.|Unknown status|Active, not recruiting|N/A|1000|Anticipated|War-Stent Investigators|||1||f||||f||||||||||2017-02-18 14:06:35.092358|2017-02-18 14:06:35.092358
NCT00722306|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-02-03|||May 2008||2008-05-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers|A Phase One Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers|Completed||Phase 1|6|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:06:35.202657|2017-02-18 14:06:35.202657
NCT00722293|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2014-09-11|||July 2008||2008-07-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|June 2012|Actual|2012-06-01||Interventional|||A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors|A Phase I, Open-label, Study of the Safety, Pharmacokinetics, and Pharmacodynamics Dose Escalation of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors|Completed||Phase 1|111|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 14:06:35.298891|2017-02-18 14:06:35.298891
NCT00722280|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2016-02-09|||December 2008||2008-12-01|February 2016|2016-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Human Upper Extremity (Hand and Forearm) Allotransplantation|The Pittsburgh Protocol in Human Upper Extremity Allotransplantation|Enrolling by invitation||N/A|300|Anticipated|University of Pittsburgh||1|||f||||t||||||||No||2017-02-18 14:06:35.414128|2017-02-18 14:06:35.414128
NCT00722267|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2009-07-24|||July 2008||2008-07-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|||||Observational|||European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients|Patient Perception of Symptom Variability. A Cross-sectional Study of Patients With Severe COPD.|Completed||N/A|7400|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:06:35.536299|2017-02-18 14:06:35.536299
NCT00722254|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2016-03-17|||June 2006||2006-06-01|March 2016|2016-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder|Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder|Terminated||N/A|15|Actual|University of Utah|||2|This study was stopped due to poor enrollment numbers|f||||f||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 14:06:36.72009|2017-02-18 14:06:36.72009
NCT00722241|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-07-24|||May 2008||2008-05-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System|Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System|Completed||N/A|53|Actual|DexCom, Inc.|||1||f||||f||||||||||2017-02-18 14:06:36.817085|2017-02-18 14:06:36.817085
NCT00722215|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-07-23|||May 2006||2006-05-01|August 2006|2006-08-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Endothelin Receptor Antagonism in Proteinuric Nephropathy|The Systemic & Renal Effects of Endothelin Receptor Antagonism in Proteinuric Nephropathy|Completed||Phase 1|22|Actual|University of Edinburgh||3|||f||||f||||||||||2017-02-18 14:06:36.980247|2017-02-18 14:06:36.980247
NCT00722202|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2009-04-24|||October 2008||2008-10-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study Evaluating the Safety and Pharmacokinetics (PK) of Ascending Single IV Doses of ERB-257 in Healthy Japanese Males|Ascending Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of ERB-257 Administered Intravenously as a 30-Minute Infusion to Healthy Japanese Male Subjects|Completed||Phase 1|48|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:06:37.200205|2017-02-18 14:06:37.200205
NCT00722189|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2015-03-18|||July 2008||2008-07-01|March 2015|2015-03-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Observational|||Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses|Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization|Completed||N/A|900|Actual|Bayer|||1||f||||f||||||||||2017-02-18 14:06:37.295487|2017-02-18 14:06:37.295487
NCT00722176|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2010-06-27|||June 2008||2008-06-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020|A Six-Week, Randomized, Double-Blind, Parallel Group Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 Compared To Risperidone|Completed||Phase 2|220|Anticipated|BioLineRx, Ltd.||3|||f||||t||||||||||2017-02-18 14:06:37.387198|2017-02-18 14:06:37.387198
NCT00722163|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-07-23|||September 2007||2007-09-01|July 2008|2008-07-01|March 2013|Anticipated|2013-03-01|May 2009|Anticipated|2009-05-01||Interventional|PSTEP||A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis|A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis|Unknown status|Recruiting|Early Phase 1|330|Anticipated|Ontario Mental Health Foundation||3|||f||||f||||||||||2017-02-18 14:06:37.514057|2017-02-18 14:06:37.514057
NCT00722150|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-01-24|||July 2008||2008-07-01|January 2011|2011-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|ARC II||Artemisinin Resistance in Cambodia II|Artemisinin Resistance in Cambodia II|Completed||N/A|143|Actual|Armed Forces Research Institute of Medical Sciences, Thailand||3|||f||||t||||||||||2017-02-18 14:06:37.620909|2017-02-18 14:06:37.620909
NCT00722137|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2017-01-03|2014-11-08||May 2008||2008-05-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|January 2014|Actual|2014-01-01||Interventional||The population consisted of all randomized participants.|Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma|A Randomized, Open-Label, Multicentre Phase 3 Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma Who Are Not Eligible for a Bone Marrow Transplant|Active, not recruiting||Phase 3|487|Actual|Takeda||2|||f||||||||||||||2017-02-18 14:06:37.743098|2017-02-18 14:06:37.743098
NCT00722124|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-08-05|2011-08-05||September 2008||2008-09-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence|S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence|Completed||Phase 2/Phase 3|150|Actual|Mayo Clinic||3|||f||||f||||||||||2017-02-18 14:06:39.057238|2017-02-18 14:06:39.057238
NCT00722111|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2013-09-27|||February 2011||2011-02-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Exercise for Swallowing Problems After Stroke|Rehabilitation Exercise for Dysphagia Subsequent to Stroke|Completed||N/A|200|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 14:06:39.562621|2017-02-18 14:06:39.562621
NCT00722098|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2013-07-05|||June 2008||2008-06-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|April 2011|Actual|2011-04-01||Interventional|||Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients|Melanoma Peptide-Loaded Dendritic Cell Vaccine in HLA-A*0201 Patients With Stage IV Melanoma: A Phase II Randomized Trial to Compare Vaccination With and Without Cyclophosphamide Treatment.|Terminated||Phase 2|9|Actual|Baylor Research Institute||2||Early termination due to lesser accrual, and data analysis not done.|f||||t||||||||||2017-02-18 14:06:39.673183|2017-02-18 14:06:39.673183
NCT00722085|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-07-23|||January 2008||2008-01-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Observational|||Amniotic Fluid Sludge in Cerclage Patients as an Indicator for Increased Risk of Preterm Delivery and Neonatal Outcome.|Amniotic Fluid Sludge in Cerclage Patients as an Indicator for Increased Risk of Preterm Delivery and Neonatal Outcome.|Completed||N/A|177|Actual|Center For Maternal Fetal Medicine|||1||f||||t||||||||||2017-02-18 14:06:39.784508|2017-02-18 14:06:39.784508
NCT00722072|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2015-10-20|2011-08-04||July 2008||2008-07-01|October 2015|2015-10-01|July 2012|Actual|2012-07-01|July 2010|Actual|2010-07-01||Interventional|||Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy|A Phase II Open-Label Study of Sorafenib Plus Fulvestrant as Salvage Therapy for Hormone Receptor Positive Metastatic Breast Cancer Failing Prior Aromatase Inhibitor Treatment|Terminated||Phase 2|12|Actual|OHSU Knight Cancer Institute||1|||f||||||||||||||2017-02-18 14:06:39.87837|2017-02-18 14:06:39.87837
NCT00722059|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2014-01-31|||April 2006||2006-04-01|January 2014|2014-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography|Assessment of Emerging Technology: Comparison of Breast Tomosynthesis and Digital Mammography in the Evaluation of Heterogeneously Dense and Extremely Dense Breasts|Completed||Early Phase 1|50|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 14:06:40.144228|2017-02-18 14:06:40.144228
NCT00722046|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2016-04-08||2012-10-08|December 2008||2008-12-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease|A Phase 2 Multicenter, Randomized, Double Blind, Placebo-Controlled Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease|Completed||Phase 2|198|Actual|Pfizer||6|||f||||t||||||||||2017-02-18 14:06:40.33466|2017-02-18 14:06:40.33466
NCT00722033|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-08-13|||August 2008||2008-08-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|ELECTROPREM||Common Neonatal Procedures Could Affect the aEEG in <30 Weeks of Gestational Age Preterms|Effect of Common Neonatal Procedures Over the Amplitude- Integrated Electroencephalography Register in <30 Weeks Preterms.|Unknown status|Not yet recruiting|Phase 2|10|Anticipated|Pontificia Universidad Catolica de Chile||1|||f||||f||||||||||2017-02-18 14:06:40.479423|2017-02-18 14:06:40.479423
NCT00722020|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-10-22|2015-08-25||July 2008||2008-07-01|October 2015|2015-10-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional||Pediatric patients admitted with diagnosis of Asthma|HFCWO in Hospitalized Asthmatic Children|High Frequency Chest Wall Oscillation in Hospital Management of Asthmatic Children|Completed||N/A|43|Actual|Hill-Rom||2|||f||||f||||||||||2017-02-18 14:06:40.600236|2017-02-18 14:06:40.600236
NCT00722007|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2017-01-05|||April 2008||2008-04-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|PASNew||Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)|Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)|Completed||Phase 4|160|Actual|Corin||1|||f||||t||||||||||2017-02-18 14:06:40.916748|2017-02-18 14:06:40.916748
NCT00721994|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2017-01-05|||May 2008||2008-05-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Observational|PAS:IDE||Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects|Cormet Resurfacing Hip System Post PMA Approval Study (PMA #P050016)Pre-market (IDE) Study Group 10 Year Follow-Up With Metal Ion and Renal Function Data Collection Clinical Investigation Plan|Active, not recruiting||N/A|350|Anticipated|Corin|||1||f||||t||||||Samples With DNA|"~     blood specimens for metal ion testing and renal function testing~   "|||2017-02-18 14:06:41.034092|2017-02-18 14:06:41.034092
NCT00721981|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2010-12-09|||April 2009||2009-04-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|||||Observational|||An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy|A Non-interventional Study for Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy. With Special Focus on Patients Who Are in Transition From First Line to Second Line Treatment|Terminated||N/A|120|Anticipated|AstraZeneca|||1|Low Recruitment|f||||f||||||||||2017-02-18 14:06:41.150518|2017-02-18 14:06:41.150518
NCT00721968|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2014-02-04|2013-04-18||March 2007||2007-03-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract|A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Clinical Investigation Of The Trabecular Micro-Bypass Stent Model GTS400 In Conjunction With Cataract Surgery|Completed||Phase 3|62|Actual|Glaukos Corporation|There are no limitations and caveats to report|2|||f||||t||||||||||2017-02-18 14:06:41.406809|2017-02-18 14:06:41.406809
NCT00721955|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2008-10-22|||July 2008||2008-07-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|AMDC-004-302||Staccato® Loxapine Treatment of Agitation in Bipolar Disorder Patients|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Efficacy and Safety Study of Staccato® Loxapine for Inhalation in Patients With Bipolar I Disorder and Acute Agitation|Completed||Phase 3|300|Anticipated|Alexza Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 14:06:41.811004|2017-02-18 14:06:41.811004
NCT00721929|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2012-12-04|||October 2003||2003-10-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2010|Actual|2010-07-01||Interventional|||Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI|Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRI|Completed||N/A|16|Actual|University of Michigan||1|||f||||||||||||||2017-02-18 14:06:41.929024|2017-02-18 14:06:41.929024
NCT00721916|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2012-10-31|||July 2008||2008-07-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|||Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer|Randomized Phase II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) Versus 5-FU, l-LV and Oxaliplatin Combination Therapy (mFOLFOX6) in Patients With Untreated Metastatic Colorectal Cancer|Completed||Phase 2|107|Actual|Taiho Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-02-18 14:06:42.028148|2017-02-18 14:06:42.028148
NCT00721903|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2016-05-03|||March 2000||2000-03-01|May 2016|2016-05-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies|3D Breast Ultrasound In Predicting Response to Breast Cancer Therapies|Completed||N/A|88|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 14:06:42.138207|2017-02-18 14:06:42.138207
NCT00721890|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2013-10-22|||June 2008||2008-06-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|DBGT-OC-CR||Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma|Phase II Study: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma|Completed||Phase 2|16|Actual|Centre Hospitalier Universitaire de Québec, CHU de Québec||1|||f||||t||||||||||2017-02-18 14:06:42.250954|2017-02-18 14:06:42.250954
NCT00721877|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-24|2014-10-07|||August 2008||2008-08-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Resveratrol in Healthy Adult Participants|Clinical Study of Resveratrol on Drug and Carcinogen Metabolizing Enzymes|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:06:42.362055|2017-02-18 14:06:42.362055
NCT00721864|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-08-05|||May 2006||2006-05-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)|The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)|Completed||N/A|10|Actual|University of Utah|||1||f||||f||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 14:06:42.475314|2017-02-18 14:06:42.475314
NCT00721851|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2011-06-21|||April 2008||2008-04-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||320-slice Coronary Computed Tomography (CT) Angiography|Coronary Artery Imaging With 320-slice Computed Tomography|Completed||N/A|30|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-02-18 14:06:42.584316|2017-02-18 14:06:42.584316
NCT00721838|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-08-18|||February 2009||2009-02-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|Teen LABS||Dietary Intake and Eating Behaviors in Adolescents Who Undergo Bariatric Surgery|Dietary Intake and Eating Behaviors in Adolescents Who Undergo Bariatric Surgery|Completed||N/A|160|Actual|University of Pennsylvania|||2||f||||f||||||||||2017-02-18 14:06:42.674085|2017-02-18 14:06:42.674085
NCT00721825|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2008-07-23|||January 2008||2008-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|TIERS||Study of NeuroAid In Enhancing Recovery After Stroke|A Double-Blinded, Placebo-Controlled, Randomized Phase II Pilot Study to Investigate the Potential Efficacy of a Traditional Chinese Medicine NeuroAid In Enhancing Recovery After Stroke (TIERS)|Completed||Phase 2|40|Actual|Moleac Pte Ltd.||2|||f||||f||||||||||2017-02-18 14:06:42.771566|2017-02-18 14:06:42.771566
NCT00721812|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2010-03-17||2010-03-17|September 2008||2008-09-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686|A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 After Single and Repeated Oral Dosing in Healthy Volunteers Using a Dose-Escalating, Randomized, Placebo-Controlled Study Design|Completed||Phase 1|87|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 14:06:42.871907|2017-02-18 14:06:42.871907
NCT00721799|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2017-02-09|||February 2008|Actual|2008-02-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|December 2014|Actual|2014-12-01||Interventional|||F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients|F-18 Fluorothymidine (FLT) PET Imaging for Early Evaluation of Response to Chemoradiation Therapy in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)|Active, not recruiting||Phase 2|50|Anticipated|University of Iowa||1|||f||||t||||||||Yes|Data will be shared through clinicaltrials.gov and in provision with the filed data sharing plan for the grant|2017-02-18 14:06:42.974326|2017-02-18 14:06:42.974326
NCT00721786|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2015-05-21|||September 2008||2008-09-01|May 2015|2015-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|TC4||Internet Stop Smoking Study - Phase VI|Internet Health Research Center: Smoking, Latinos, and the Web|Completed||N/A|18154|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 14:06:43.083495|2017-02-18 14:06:43.083495
NCT00721773|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2015-05-18|||September 2008||2008-09-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients|Effects of Benazepril,Valsartan or Combination of Both on Residual Renal Function in Peritoneal Dialysis Patients|Completed||N/A|200|Actual|Sun Yat-sen University||4|||f||||t||||||||||2017-02-18 14:06:43.192225|2017-02-18 14:06:43.192225
NCT00721760|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2013-01-14||2010-12-20|July 2008||2008-07-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|SAVE-HIP2||Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery|A Multinational, Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Hip Fracture Surgery|Completed||Phase 3|1003|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:06:43.31251|2017-02-18 14:06:43.31251
NCT00721747|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2012-03-15|||January 2008||2008-01-01|March 2012|2012-03-01|January 2015|Anticipated|2015-01-01|January 2011|Actual|2011-01-01||Interventional|||Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer|Phase II, Open, Not Randomized Clinical Trial, to Evaluate the Sequential Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in her2 Negative Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 2|83|Anticipated|Grupo Oncológico Gallego||1|||f||||t||||||||||2017-02-18 14:06:43.472433|2017-02-18 14:06:43.472433
NCT00721734|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-01-08|2015-11-02||November 2008||2008-11-01|January 2016|2016-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function|Phase 2 Study of the Safety and Pharmacokinetics of Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function|Completed||Phase 2|50|Actual|Onyx Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:06:43.602113|2017-02-18 14:06:43.602113
NCT00721721|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-07-28|||October 2003||2003-10-01|August 2008|2008-08-01|May 2009|Actual|2009-05-01|July 2005|Actual|2005-07-01||Interventional|GenSalt||Analyzing Genetic Factors Involved in Blood Pressure Changes Due to Salt and Potassium Intake (The GenSalt Study)|Genetic Epidemiology Network of Salt Sensitivity|Completed||Phase 3|1906|Actual|National Heart, Lung, and Blood Institute (NHLBI)||1|||f||||t||||||||||2017-02-18 14:06:46.729646|2017-02-18 14:06:46.729646
NCT00721708|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2009-12-14|||April 2007||2007-04-01|December 2009|2009-12-01|July 2008|Actual|2008-07-01|October 2007|Actual|2007-10-01||Interventional|||Pharmacokinetics of Carnosine|Pharmacokinetics of Carnosine|Completed||N/A|4|Actual|Tufts University||4|||f||||f||||||||||2017-02-18 14:06:46.830543|2017-02-18 14:06:46.830543
NCT00721695|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2014-07-16||2011-06-17|May 2008||2008-05-01|July 2014|2014-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.|Randomized, Controlled, Double-Masked, Multicenter, Exploratory Study of the Clinical Benefit and Safety of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR) Using a Coaxial Phacoemulsification Process|Completed||Phase 1/Phase 2|60|Actual|Omeros Corporation||3|||f||||f||||||||||2017-02-18 14:06:46.933138|2017-02-18 14:06:46.933138
NCT00721682|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2013-10-23|||November 2008||2008-11-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|ANTALPED||Evaluation of Acute Pain in Maltreated Children|Evaluation of Acute Pain in Maltreated Children : a Prospective, Multicentric and Controlled Study|Completed||N/A|78|Actual|Nantes University Hospital|||2||f||||f||||||||||2017-02-18 14:06:47.059663|2017-02-18 14:06:47.059663
NCT00721669|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2013-09-12|||June 2008||2008-06-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors|A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors|Completed||Phase 1|60|Actual|ImmunoGen, Inc.||1|||f||||||||||||||2017-02-18 14:06:47.152699|2017-02-18 14:06:47.152699
NCT00721656|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2009-03-16||||||March 2009|2009-03-01||||||||Interventional|||Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes|A Randomized, Double Blind, Placebo Controlled, Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes|Completed||Phase 2|80|Anticipated|Kissei Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 14:06:47.239152|2017-02-18 14:06:47.239152
NCT00721643|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2009-08-24|||July 2008||2008-07-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|March 2009|Actual|2009-03-01||Interventional|||Absorption Kinetics of Polyphenols in Angel's Plant (Angelica Keiskei)|Absorption Kinetics of Polyphenols in Angel's Plant (Angelica Keiskei)|Unknown status|Active, not recruiting|Early Phase 1|10|Actual|Tufts University||2|||f||||f||||||||||2017-02-18 14:06:47.338568|2017-02-18 14:06:47.338568
NCT00721630|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-07-11|||July 2008||2008-07-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer|Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer|Completed||Phase 2|24|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:06:47.428275|2017-02-18 14:06:47.428275
NCT00721617|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-07-23|2015-05-11||April 2009||2009-04-01|July 2015|2015-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|FFAADA|All subjects|FFA Hypertension and Inflammation in Lean and Obese Subjects|Free Fatty Acids-Induced Hypertension, Endothelial Dysfunction, Inflammation, Insulin Resistance, and Autonomic Dysfunction in Lean and Obese Subjects|Completed||N/A|12|Actual|Emory University|A larger sample size and inclusion of subjects from different ethnicities would be required to generalize the results of this study. Study used healthy volunteers--outcomes cannot be applied to patients with diabetes mellitus or insulin resistance|2|||f||||t||||||||||2017-02-18 14:06:47.539213|2017-02-18 14:06:47.539213
NCT00721604|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2009-07-31|||July 2008||2008-07-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Observational|||Fluid Responsiveness Prediction at the Bedside|Prediction of Volume Expansion Effectiveness in Hypotensive Critically Ill Patients.|Completed||N/A|30|Anticipated|Fondazione Poliambulanza Istituto Ospedaliero|||1||f||||f||||||||||2017-02-18 14:06:48.115529|2017-02-18 14:06:48.115529
NCT00721591|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-10-31|||March 2005||2005-03-01|October 2016|2016-10-01|July 2014|Actual|2014-07-01|January 2013|Actual|2013-01-01||Observational|||Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy|Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy|Completed||N/A|14|Actual|University of Chicago|||2||f||||f||||||Samples Without DNA|"~     Plasma from subjects to obtain concentrations of heparin will be retained~   "|||2017-02-18 14:06:48.227578|2017-02-18 14:06:48.227578
NCT00721578|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2011-01-06|2010-07-28||April 2009||2009-04-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections|An Observational Study Of Patients Receiving Therapy For Systemic Fungal Infections|Completed||N/A|23|Actual|Pfizer|"Primary and Secondary outcome measured were arbitrarily defined as they were not defined in the protocol.~This study was terminated prematurely due to slow recruitment rate leading to a small (23) number of subjects analyzed."||1||f||||f||||||||||2017-02-18 14:06:48.333031|2017-02-18 14:06:48.333031
NCT00721565|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2015-05-09|||April 2006||2006-04-01|May 2015|2015-05-01|August 2008|Actual|2008-08-01|February 2008|Actual|2008-02-01||Interventional|BEAT||An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial; Pilot Study)|An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial)|Completed||Phase 1|49|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 14:06:48.783526|2017-02-18 14:06:48.783526
NCT00721552|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2012-06-28|||October 2008||2008-10-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|SPHINX||Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome|Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism and Beta-Cell Dysfunction in Males With the Metabolic Syndrome X: A Randomized, Placebo-controlled, Double-blind Intervention Study With a 2x2 Factorial Design|Completed||N/A|82|Actual|VU University Medical Center||6|||f||||f||||||||||2017-02-18 14:06:48.895054|2017-02-18 14:06:48.895054
NCT00721539|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-11-02|2014-11-18||September 2010||2010-09-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract|A Pilot Study Assessing Transoral Robotic Surgery (TORS) For Oral And Laryngopharyngeal Benign And Malignant Lesions Using The da Vinci® Robotic Surgical System|Terminated||N/A|9|Actual|Stanford University|Early termination leading to small numbers of subjects analyzed secondary to low accrual of subjects.|1||Low Accrual|f||||t||||||||No||2017-02-18 14:06:51.353429|2017-02-18 14:06:51.353429
NCT00721526|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2013-01-28|||August 2009||2009-08-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder|Disulfiram Combined With Lorazepam for Treatment of Patients With Alcohol Dependence and Primary or Secondary Anxiety Disorder|Completed||Phase 4|45|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 14:06:51.626374|2017-02-18 14:06:51.626374
NCT00721513|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2015-10-22|||September 2008||2008-09-01|October 2015|2015-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer|Phase II Study to Evaluate the Efficacy and Toxicity of Multimodality Treatment With Induction Taxotere/Cisplatin?5-FU (TPF) Chemotherapy Followed by Concomitant Cetuximab and Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Active, not recruiting||Phase 2|46|Anticipated|Wake Forest University Health Sciences||1|||f||||t||||||||||2017-02-18 14:06:51.724887|2017-02-18 14:06:51.724887
NCT00721500|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2015-05-05|2010-05-07||June 2008||2008-06-01|May 2015|2015-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||All enrolled and completed subjects were included in the baseline summary.|A Comparison of Two Daily Disposable Contact Lenses.|An Evaluation of the Lens Fit of Narafilcon A Soft Contact Lenses|Completed||N/A|25|Actual|Johnson & Johnson Vision Care, Inc.||4|||f||||||||||||||2017-02-18 14:06:51.83929|2017-02-18 14:06:51.83929
NCT00721487|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2014-07-21|||July 2008||2008-07-01|July 2014|2014-07-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Observational|||Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections|A Case Series of Investigator-Identified Fluconazole Failures: Outcome Characterization of Patients Who Fail to Respond to Fluconazole Treatment of Severe Infections Caused by Candida Albicans|Completed||N/A|28|Actual|CPL Associates|||1||f||||f||||||||||2017-02-18 14:06:52.180186|2017-02-18 14:06:52.180186
NCT00721305|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2011-09-30|||August 2008||2008-08-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|LIVE||Lovastatin: Immunomodulatory Value Evaluation|Antiretroviral Effect of Lovastatin on HIV-1-infected Individuals Without Highly Active Antiretroviral Therapy (HAART): A Phase-II Randomized Clinical Trial (RCT)|Completed||Phase 2|112|Actual|Universidad de Antioquia||2|||f||||t||||||||||2017-02-18 14:06:58.748184|2017-02-18 14:06:58.748184
NCT00721474|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2009-02-05|||September 2008||2008-09-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects|An Open-Label, Randomized, Single-Dose, 2-Period Crossover Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects|Completed||Phase 1|24|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:06:52.281616|2017-02-18 14:06:52.281616
NCT00721461|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2015-08-03|||July 2005||2005-07-01|August 2015|2015-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Test the Tolerability of an Investigational Electroporation Device in Healthy Adults (V930-001)|Probe Study of the Tolerability of an Investigational Electroporation Device, MedPulser (Trademark) DNA Delivery System (DDS) in Healthy Adults 18 to 35 Years of Age|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:06:52.364394|2017-02-18 14:06:52.364394
NCT00721448|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2010-12-02|||June 2008||2008-06-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers|A Two-Cohort, Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Chinese Volunteers Living in China|Completed||Phase 1|24|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:06:52.654063|2017-02-18 14:06:52.654063
NCT00721435|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2017-01-22|||April 2002||2002-04-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|December 2014|Actual|2014-12-01||Interventional|||Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions|Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions|Completed||N/A|183|Actual|University of Michigan||2|||f||||f||||||||No||2017-02-18 14:06:52.739378|2017-02-18 14:06:52.739378
NCT00721422|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2010-02-16|||August 2008||2008-08-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.|A Phase 1, Open-Label, Single Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of PD 0332334 In Subjects With Various Degrees Of Renal Function|Terminated||Phase 1|16|Actual|Pfizer||4||Please see Detailed Description for termination reason.|f||||f||||||||||2017-02-18 14:06:52.841573|2017-02-18 14:06:52.841573
NCT00721409|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-07-08|2015-03-04||September 2008||2008-09-01|July 2016|2016-07-01|July 2018|Anticipated|2018-07-01|November 2013|Actual|2013-11-01||Interventional|||Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer|Phase 1/2, Open-Label, Randomized Study Of The Safety, Efficacy, And Pharmacokinetics Of Letrozole Plus PD 0332991 (Oral CDK 4/6 Inhibitor) And Letrozole Single Agent For The First-Line Treatment Of ER Positive, HER2 Negative Advanced Breast Cancer In Postmenopausal Women|Active, not recruiting||Phase 1/Phase 2|177|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:06:53.221829|2017-02-18 14:06:53.221829
NCT00721396|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2015-03-17|2015-02-18||August 2008||2008-08-01|March 2015|2015-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules|A Phase 2b, Open Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules.|Completed||Phase 2|1885|Actual|Novartis||4|||f||||t||||||||||2017-02-18 14:06:56.141507|2017-02-18 14:06:56.141507
NCT00721383|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2014-12-30|||May 2007||2007-05-01|December 2014|2014-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|TRAC||Telephone Resources and Assistance for Caregivers (TRAC)|Clinical Trial to Enhance Caregiver Physical Activity|Completed||N/A|211|Actual|Rush University Medical Center||2|||f||||t||||||||||2017-02-18 14:06:57.678635|2017-02-18 14:06:57.678635
NCT00721370|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2013-02-14|||July 2008||2008-07-01|February 2013|2013-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer|Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer|Completed||Phase 1|12|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 14:06:57.786991|2017-02-18 14:06:57.786991
NCT00721357|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2015-07-29|2015-01-08||August 2008||2008-08-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|July 2012|Actual|2012-07-01||Observational|||Skeletal Muscle Properties and the Metabolic Cost of Walking Post-stroke|Skeletal Muscle Properties and the Metabolic Cost of Walking Post-Stroke|Completed||Phase 2|30|Actual|VA Office of Research and Development|||2||f||||f||||||None Retained|"~     None retained~   "|||2017-02-18 14:06:57.898688|2017-02-18 14:06:57.898688
NCT00721344|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2012-06-12|||April 2008||2008-04-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration.|A Phase 1, Randomized, Double-Blind, Cross-Over, Placebo- and Active-Controlled Cardiac Safety Study of Therapeutic and Supratherapeutic Doses of Fumaryl Diketopiperazine Administered as Technosphere® Inhalation Powder in Healthy Subjects|Completed||Phase 1|48|Actual|Mannkind Corporation||4|||f||||||||||||||2017-02-18 14:06:58.438091|2017-02-18 14:06:58.438091
NCT00721331|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-09-24|||July 2008||2008-07-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers|A Phase I, Single-Center, Randomized, Vehicle-Controlled Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers|Completed||Phase 1|20|Anticipated|Zalicus||5|||f||||f||||||||||2017-02-18 14:06:58.54856|2017-02-18 14:06:58.54856
NCT00721318|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2008-07-23|||May 2008||2008-05-01|July 2008|2008-07-01|May 2010|Anticipated|2010-05-01|May 2009|Anticipated|2009-05-01||Observational|||A Prevalence Study of Chronic Widespread Pain (CWP) Among Patients With Rheumatoid Arthritis (RA) and Control Population in Tallinn and Harjumaa County|A Prevalence Study of Chronic Widespread Pain (CWP) Among Patients With Rheumatoid Arthritis (RA) and Control Population Matched by Gender, Age and Place of Residence in Tallinn and Harjumaa County|Unknown status|Active, not recruiting|N/A|6000|Anticipated|Estonian Society for Rheumatology|||2||f||||f||||||||||2017-02-18 14:06:58.657881|2017-02-18 14:06:58.657881
NCT00721279|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-23|2014-05-19|2009-10-22||September 2007||2007-09-01|May 2014|2014-05-01||||October 2008|Actual|2008-10-01||Observational||SAF - Safety Analysis Set|Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome|Sifrol Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary RLS|Completed||N/A|549|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:06:58.899341|2017-02-18 14:06:58.899341
NCT00721266|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-04|2016-11-01|||June 2008||2008-06-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.|An Open Label, Dose-escalation Study to Evaluate Safety, Pharmacokinetics and Tumor Growth Control Rate of RO5083945, a Glycoengineered Antibody Against EGFR, in Patients With Metastatic and/or Locally Advanced Malignant EGFR+ Solid Tumors.|Completed||Phase 1|102|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:06:59.630586|2017-02-18 14:06:59.630586
NCT00721253|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2010-03-04|2009-09-18||July 2007||2007-07-01|March 2010|2010-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Visual Outcomes of Subjects Bilaterally Implanted With ReSTOR Aspheric +4 vs. Tecnis or Acri.LISA|Visual Outcomes of Subjects Bilaterally Implanted With ReSTOR Aspheric +4 vs. Tecnis Multifocal Intraocular Lens (IOL) or Acri.LISA IOL|Completed||Phase 4|42|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 14:06:59.724763|2017-02-18 14:06:59.724763
NCT00721240|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2010-02-16|||February 2006||2006-02-01|July 2008|2008-07-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Investigation to Identify Predictors of Response to a Treatment With Montelukast|Investigation to Identify Predictors of Response to a Treatment With Montelukast|Completed||Phase 4|50|Anticipated|Marien Hospital Wesel||1|||f||||f||||||||||2017-02-18 14:07:00.171544|2017-02-18 14:07:00.171544
NCT00721227|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2010-09-01|2010-07-21||April 2008||2008-04-01|September 2010|2010-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates|Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates|Completed||N/A|15|Actual|Ethicon Endo-Surgery||2|||f||||f||||||||||2017-02-18 14:07:00.317588|2017-02-18 14:07:00.317588
NCT00721214|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-02-03|2015-04-29||July 2008||2008-07-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Out of the 16 evaluable patients, 12 were able to proceed to transplant.|5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome|A Phase II Study of the Use of 5-Azacytidine as Pre-Transplant Cytoreduction Prior to Allogeneic Stem Cell Transplantation for High Risk Myelodysplastic Syndromes|Completed||Phase 2|16|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-02-18 14:07:00.823263|2017-02-18 14:07:00.823263
NCT00721201|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2011-05-26|||November 2008||2008-11-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Glucocorticoid Receptor Antagonism in Subclinical Cushings|A Pilot Study of the Effect of a Glucocorticoid Receptor Antagonist in Patients With Subclinical Cushings|Completed||Phase 1/Phase 2|6|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||t||||||||||2017-02-18 14:07:01.170275|2017-02-18 14:07:01.170275
NCT00721188|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2015-04-28|2011-02-23||January 2006||2006-01-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|July 2008|Actual|2008-07-01||Interventional|||Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients|Single-Dose Pharmacokinetics of Venofer (Iron Sucrose Injection) in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients Receiving or Not Receiving Erythropoiesis Stimulating Agents (ESA's)|Completed||Phase 2|11|Actual|Luitpold Pharmaceuticals||1|||f||||||||||||||2017-02-18 14:07:01.265689|2017-02-18 14:07:01.265689
NCT00721175|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2011-11-21|2011-08-23||November 2007||2007-11-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma|Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Unresectable Complex Hilar Cholangiocarcinoma; a Randomized Controlled Trial|Completed||Phase 4|108|Actual|Khon Kaen University||2|||f||||f||||||||||2017-02-18 14:07:01.62267|2017-02-18 14:07:01.62267
NCT00721162|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2016-08-24|2014-05-16||August 2008||2008-08-01|August 2016|2016-08-01|August 2015|Actual|2015-08-01|May 2012|Actual|2012-05-01||Interventional||All participants who received any amount of study drug.|Study of Ramucirumab in Ovarian Cancer|A Phase 2, Non-randomized, Open-label, Multicenter Study of IMC-1121B in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|60|Actual|Eli Lilly and Company||1|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 14:07:02.106691|2017-02-18 14:07:02.106691
NCT00721149|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2013-12-03|2013-02-08||September 2008||2008-09-01|December 2013|2013-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|AFTX||NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study|NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study|Terminated||Phase 3|10|Actual|Biosense Webster, Inc.|Because of early study termination, the study did not reach its targeted enrollment and study data analysis was not fully conducted, thus study results may not be interpretable.|1||"Enrollment stopped after CDRH Advisory Panel (Nov 20, 2008) recommended NAVISTAR® THERMOCOOL®~   catheter approval."|f||||f||||||||||2017-02-18 14:07:02.540988|2017-02-18 14:07:02.540988
NCT00721136|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2012-10-02|||September 2007||2007-09-01|October 2012|2012-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation|Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation|Completed||N/A|104|Actual|Johns Hopkins University||4|||f||||f||||||||||2017-02-18 14:07:02.950571|2017-02-18 14:07:02.950571
NCT00720928|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2008-07-28|||July 2008||2008-07-01|July 2008|2008-07-01|May 2010|Anticipated|2010-05-01|December 2009|Anticipated|2009-12-01||Interventional|||Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease|A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's Disease|Unknown status|Recruiting|Phase 4|15|Anticipated|Asan Medical Center||1|||f||||t||||||||||2017-02-18 14:07:10.715659|2017-02-18 14:07:10.715659
NCT00721123|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2013-11-05|2013-07-17||August 2005||2005-08-01|November 2013|2013-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||All-exposure population: All patients who entered the study and received at least one dose of tocilizumab at any time. Baseline was defined as the first dose of study drug, whether that occurred in the WA17822 study or the WA18695 study.|A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis|Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in WA17822|Completed||Phase 3|538|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:07:03.226448|2017-02-18 14:07:03.226448
NCT00721110|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2011-08-18|||July 2008||2008-07-01|August 2011|2011-08-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Lidocaine and Ketamine in Abdominal Surgery|Effects of Perioperative Lidocaine and Ketamine Infusions on Acute Functional Recovery After Abdominal Hysterectomy|Terminated||N/A|64|Actual|Outcomes Research Consortium||4|||f||||f||||||||||2017-02-18 14:07:04.563441|2017-02-18 14:07:04.563441
NCT00721097|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2013-09-27|||June 2008||2008-06-01|September 2013|2013-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|EXPRESA||Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics|Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics|Terminated||N/A|40|Actual|Nantes University Hospital|||1|Number of included patients is sufficient.|f||||t||||||||||2017-02-18 14:07:04.675209|2017-02-18 14:07:04.675209
NCT00721084|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2013-09-04|||July 2008||2008-07-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Fitness and Sleep in People With Family History of Type 2 Diabetes.|Sleep, Energy Metabolism and Diabetes Risk|Completed||N/A|30|Actual|University of Chicago|||2||f||||f||||||||||2017-02-18 14:07:04.841501|2017-02-18 14:07:04.841501
NCT00721071|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2013-08-30|||December 2006||2006-12-01|August 2013|2013-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis|Diagnostic Utility of Induced Sputum Using Hypertonic Saline to Evaluate Airway Infection and Inflammation in Cystic Fibrosis|Completed||Phase 2|95|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-02-18 14:07:04.936118|2017-02-18 14:07:04.936118
NCT00721058|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2010-01-04|||August 2008||2008-08-01|January 2010|2010-01-01||||October 2009|Actual|2009-10-01||Interventional|||Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer.|Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer.|Completed||N/A|60|Anticipated|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-02-18 14:07:05.043416|2017-02-18 14:07:05.043416
NCT00721045|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2015-05-19|||August 2008||2008-08-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|June 2011|Actual|2011-06-01||Interventional|||A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure|A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure|Completed||Phase 2|60|Actual|Mesoblast, Ltd.||6|||f||||t||||||||||2017-02-18 14:07:05.150528|2017-02-18 14:07:05.150528
NCT00721032|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2012-04-26|||June 2012||2012-06-01|April 2012|2012-04-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia|Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia|Unknown status|Not yet recruiting|N/A|70|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:07:05.332657|2017-02-18 14:07:05.332657
NCT00721019|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2013-09-04|||July 2008||2008-07-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Sleep Loss and Glucose Metabolism in People With Family History of Type 2 Diabetes.|Sleep, Energy Metabolism and Diabetes Risk.|Completed||N/A|11|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 14:07:05.419962|2017-02-18 14:07:05.419962
NCT00721006|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2014-05-07|||June 2008||2008-06-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|MESENDO||Phase II Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia|Phase II Safety/Efficacy Study of A Combination Stem Cell Therapy That Develops Mature Stable Vessel Formation in Ischemic Limbs|Completed||Phase 2|35|Actual|TCA Cellular Therapy||2|||f||||t||||||||||2017-02-18 14:07:05.53017|2017-02-18 14:07:05.53017
NCT00720993|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2009-04-22|||August 2008||2008-08-01|February 2009|2009-02-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Observational|CRC screening||Colorectal Cancer Screening Validation Study|"Altered Gene Expression in Colorectal Smears of Individuals With Colon Cancer"|Unknown status|Enrolling by invitation|N/A|165|Anticipated|IntelliGeneScan, Inc.|||2||f||||f||||||Samples Without DNA|"~     Rectal smears (cytology brush) samples and RNA recovered from such materials.~   "|||2017-02-18 14:07:05.629697|2017-02-18 14:07:05.629697
NCT00720980|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-07-21|||May 2008||2008-05-01|May 2008|2008-05-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Observational|||Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy|Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy|Completed||N/A|6|Actual|Henry Ford Health System|||1||f||||f||||||||||2017-02-18 14:07:05.717669|2017-02-18 14:07:05.717669
NCT00720967|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-07-22|||November 2008||2008-11-01|July 2008|2008-07-01|November 2012|Anticipated|2012-11-01|November 2011|Anticipated|2011-11-01||Interventional|SeRenaD-CPB||Preop Hemodialysis or Intraop Ultrafiltration for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery|Influence of Preoperative Hemodialysis or Intraoperative Modified Ultrafiltration on Postoperative Outcome for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery: Randomized, Controlled, Multicenter Clinical Trial|Unknown status|Not yet recruiting|Phase 3|450|Anticipated|University Hospital, Geneva||3|||f||||f||||||||||2017-02-18 14:07:05.805291|2017-02-18 14:07:05.805291
NCT00720954|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-07-22|||January 2006||2006-01-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy|Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy For Diagnosis of Patients With Pleural Effusions: A Randomized Control Trial|Completed||N/A|124|Actual|Eskisehir Osmangazi University||2|||f||||||||||||||2017-02-18 14:07:05.936254|2017-02-18 14:07:05.936254
NCT00720941|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-08-15|2013-01-04||August 2008||2008-08-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2012|Actual|2012-05-01||Interventional|COMPARZ||Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma|Study VEG108844, A Study of Pazopanib Versus Sunitinib in the Treatment of Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma|Active, not recruiting||Phase 3|927|Actual|Novartis||2|||f||||t||||||||||2017-02-18 14:07:06.063967|2017-02-18 14:07:06.063967
NCT00720915|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2016-12-12|||September 2008||2008-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|DODS||D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months|A Cohort Study to Test That There is a Low Risk of Recurrent VTE in Patients With a First Episode of Unprovoked VTE Who Stop Anticoagulant Therapy After 3 Months of Treatment in Response to Negative D-dimer Testing|Completed||N/A|410|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 14:07:10.826288|2017-02-18 14:07:10.826288
NCT00720902|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2013-05-14|||February 2007||2007-02-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|March 2010|Actual|2010-03-01||Interventional|||Adult Growth Hormone Deficiency and Cardiovascular Risk|Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas|Terminated||N/A|8|Actual|Columbia University||2||poor enrollment|f||||f||||||||||2017-02-18 14:07:10.942264|2017-02-18 14:07:10.942264
NCT00720889|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2013-09-04|||July 2008||2008-07-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Glucose Metabolism and Sleep in People With Family History of Type 2 Diabetes.|Sleep, Energy Metabolism and Diabetes Risk.|Completed||N/A|20|Actual|University of Chicago|||2||f||||f||||||||||2017-02-18 14:07:11.049089|2017-02-18 14:07:11.049089
NCT00720876|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2016-08-23|||July 2008||2008-07-01|August 2016|2016-08-01||||October 2017|Anticipated|2017-10-01||Interventional|||Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma|A Phase II Study of Vorinostat (Suberoylanilide Hydroxamic Acid) Plus Rituximab in Indolent Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 2|33|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:07:11.137111|2017-02-18 14:07:11.137111
NCT00720850|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-09-26|||April 2008||2008-04-01|September 2013|2013-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|LENAMAINT||Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)|Lenalidomide Maintenance Therapy in Patients With MDS or AML With Cytogenetic Abnormalities Involving Monosomy 5 or del5q After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|Terminated||Phase 2|10|Actual|Technische Universität Dresden||1||"Low recruitment, scientific rationale not applicable anymore to all patients and possible~   induction of GvHD by the study drug"|f||||f||||||||||2017-02-18 14:07:11.24737|2017-02-18 14:07:11.24737
NCT00720837|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2012-10-10|||July 2008||2008-07-01|October 2012|2012-10-01||||October 2012|Actual|2012-10-01||Interventional|||Magnetic Resonance Temperature Imaging & Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors|Pilot Study Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging (MRTI) and Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors|Terminated||N/A|6|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f||||||||||2017-02-18 14:07:11.364902|2017-02-18 14:07:11.364902
NCT00720824|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-07-22|||June 2007||2007-06-01|July 2008|2008-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Reduction of Immunization Discomfort in Children|Reduction of Immunization Discomfort in 4-6 Year Old Children: A Randomized Clinical Trial.|Completed||N/A|42|Actual|Berberich, F. Ralph, M.D.||2|||f||||f||||||||||2017-02-18 14:07:11.47099|2017-02-18 14:07:11.47099
NCT00720811|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2012-03-15|||October 2009||2009-10-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs|Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs|Completed||N/A|6456|Actual|Mbarara University of Science and Technology||2|||f||||t||||||||||2017-02-18 14:07:11.576287|2017-02-18 14:07:11.576287
NCT00720798|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2014-09-26|2014-06-10||September 2005||2005-09-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||All-exposure population: All participants who entered this study and received at least 1 dose of tocilizumab in either this extension study or in a core study.|An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies|Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in MRA Core Studies|Completed||Phase 3|2067|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:07:11.943402|2017-02-18 14:07:11.943402
NCT00720785|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2017-01-27|||July 17, 2008||2008-07-17|January 19, 2017|2017-01-19|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Natural Killer Cells and Bortezomib to Treat Cancer|Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK TRAIL Cytotoxicity With Bortezomib|Recruiting||Phase 1|61|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:07:13.938766|2017-02-18 14:07:13.938766
NCT00720772|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2009-12-16|||July 2008||2008-07-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||Intravenous Sodium Thiosulfate on Coronary Calcification in Patients on Hemodialysis|The Treatment Effect of Intravenous Sodium Thiosulfate on Coronary Calcification in Patients on Hemodialysis|Completed||Phase 2|50|Anticipated|Ramathibodi Hospital||2|||f||||f||||||||||2017-02-18 14:07:14.051426|2017-02-18 14:07:14.051426
NCT00720759|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2014-01-21|2013-10-07||July 2009||2009-07-01|January 2014|2014-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Improving Stroke Rehabilitation: Spacing Effect and D-cycloserine|Improving Stroke Rehabilitation: Spacing Effect and D-cycloserine|Completed||Phase 2|24|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 14:07:14.160279|2017-02-18 14:07:14.160279
NCT00720733|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2015-03-05|||September 2008||2008-09-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|IRISS||Intervention for (Those) Recently Informed of Seropositive Status (IRISS)|A Positive Affect Intervention for Those Recently Diagnosed With HIV|Completed||N/A|160|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:07:15.111118|2017-02-18 14:07:15.111118
NCT00720720|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2010-04-02||||||July 2008|2008-07-01||||||||Interventional|PHYTOPLAQUES||Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque|Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque|Terminated||N/A|0|Actual|French Cardiology Society||2||Recruitment and organizational difficulties|f||||t||||||||||2017-02-18 14:07:15.22201|2017-02-18 14:07:15.22201
NCT00720707|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-22|2008-07-22|||April 2006||2006-04-01|July 2008|2008-07-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Coronally Advanced Flap in Combination With Acellular Dermal Matrix and Enamel Matrix Derivatives for Root Coverage|Coronally Advanced Flap in Combination With Acellular Dermal Matrix With or Without Enamel Matrix Derivatives for Root Coverage|Completed||Phase 4|18|Actual|Tabriz University||2|||f||||t||||||||||2017-02-18 14:07:15.318643|2017-02-18 14:07:15.318643
NCT00720681|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2016-03-28|||August 2008||2008-08-01|March 2016|2016-03-01|January 2012|Actual|2012-01-01|June 2009|Actual|2009-06-01||Observational|HUMERUS||Plating of Humeral Shaft Fractures in Multiple Trauma Patients.|Plating of Acute Humeral Diaphyseal Fractures Via an Anterior Lateral Approach in Multiple Trauma Patients.|Completed||N/A|96|Actual|OhioHealth|||1||f||||f||||||||No||2017-02-18 14:07:15.473613|2017-02-18 14:07:15.473613
NCT00720668|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2009-02-06|||June 2006||2006-06-01|February 2009|2009-02-01|May 2010|Anticipated|2010-05-01|March 2009|Anticipated|2009-03-01||Observational|HBV-HCC||The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma|The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|200|Anticipated|Sun Yat-sen University|||1||f||||t||||||||||2017-02-18 14:07:15.545722|2017-02-18 14:07:15.545722
NCT00720655|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2014-01-21|||August 2005||2005-08-01|January 2014|2014-01-01||||December 2006|Actual|2006-12-01||Interventional|||Effects of Fatty and Lean Fish Intake on Cardiovascular Risk Factors in Subjects With Coronary Heart Disease|Effects of Fatty and Lean Fish Intake on Cardiovascular Risk Factors in Subjects With Coronary Heart Disease|Completed||N/A|33|Actual|University of Eastern Finland||3|||f||||f||||||||||2017-02-18 14:07:15.660921|2017-02-18 14:07:15.660921
NCT00720642|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2012-09-11|||July 2006||2006-07-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|I-PET||Percutaneous Excision Trial|Percutaneous Excision Trial (I-Pet): A Multi-Center Clinical Study Of The Intact Breast Lesion Excision System (Bles) To Demonstrate That A Definitive Diagnosis Can Be Made From The Tissue Sample Collected With The Intact Bles.|Completed||N/A|1170|Actual|Intact Medical Corporation|||2||f||||f||||||Samples Without DNA|"~     Breast lesion tissue~   "|||2017-02-18 14:07:15.767175|2017-02-18 14:07:15.767175
NCT00720629|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2014-07-10|2014-05-01||December 2007||2007-12-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||First Stage: Study Treatment. All participants.|Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation|A Phase II Study of Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation|Terminated||Phase 2|8|Actual|H. Lee Moffitt Cancer Center and Research Institute|Study closed early during the first stage, did not proceed to the second stage comparison as planned. Investigators exercised right to close the study prematurely for lack of efficacy, although no protocol-defined end points had been met.|2|||f||||t||||||||||2017-02-18 14:07:15.869788|2017-02-18 14:07:15.869788
NCT00720616|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2013-02-18|||October 2010||2010-10-01|February 2013|2013-02-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.|Effects of a Fixed Low Dose Growth Hormone Therapy on Insulin Sensitivity, Metabolic Profile, Adipocyte IGF-I and Insulin Signalling, Intramyocellular and Intrahepatic Lipids, and Cortisol Metabolism in Subjects With Metabolic Syndrome.|Withdrawn||N/A|0|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 14:07:16.217817|2017-02-18 14:07:16.217817
NCT00720603|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2015-03-19||||||March 2015|2015-03-01||||||||Expanded Access|EAP||This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.|Expanded Acess Study of Plerixafor and G-CSF for the Mobilization and Collection of Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease or Multiple Myeloma|No longer available||N/A|||Sanofi|||||||||||||||||||2017-02-18 14:07:16.349806|2017-02-18 14:07:16.349806
NCT00720590|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-08-29|||November 2003||2003-11-01|July 2008|2008-07-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors|Effect of HIV-1 Protease Inhibitors on Endothelial Function and Glucose Metabolism in Normal, HIV-Uninfected Subjects: Atazanavir or Lopinavir/Ritonavir or Placebo|Completed||N/A|30|Actual|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||t||||||||||2017-02-18 14:07:16.440919|2017-02-18 14:07:16.440919
NCT00720577|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2008-07-22|||December 2005||2005-12-01|July 2008|2008-07-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|LEAP||Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.|Two-Part,Multicenter,Randomized,Double-Blind,Placebo-Controlled,Study to Evaluate the Effect of Simvastatin,Losartan,and Pioglitazone on Cardiovascular Disease Biomarkers in Lower Extremity Atherosclerotic Plaque Excised From Patients w/PAD|Completed||Early Phase 1|164|Actual|ev3||3|||f||||f||||||||||2017-02-18 14:07:16.546419|2017-02-18 14:07:16.546419
NCT00720564|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2010-08-09|||April 2008||2008-04-01|August 2010|2010-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma|A Phase I Study of the Combination of Radiation Therapy (RT), Arsenic Trioxide (ATO) and Temozolomide (TMZ) in Patients With Newly-Diagnosed Glioblastoma Multiforme (GBM)|Completed||Phase 1|18|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:07:16.647936|2017-02-18 14:07:16.647936
NCT00720551|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2009-02-12|||June 2008||2008-06-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Calibration and Validation of the STISIM Driving Simulator|Calibration and Validation of the STISIM Driving Simulator: Simulated Driving Performance Under the Influence of Alcohol (0.05%, 0.08% AND 0.11%), and Placebo|Completed||N/A|27|Actual|Utrecht Institute for Pharmaceutical Sciences||1|||f||||f||||||||||2017-02-18 14:07:16.745541|2017-02-18 14:07:16.745541
NCT00720538|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-10-25|||August 2008||2008-08-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|September 2011|Actual|2011-09-01||Interventional|TALIBDP||Thalidomide in Pediatric Inflammatory Bowel Diseases.|Randomized Controlled Double-blind Vs. Placebo Multicentre Study on the Safety and Effectiveness of Thalidomide in the Treatment of Refractory Crohn's Disease and Ulcerative Colitis.|Completed||Phase 3|84|Actual|IRCCS Burlo Garofolo||2|||f||||t||||||||||2017-02-18 14:07:16.82735|2017-02-18 14:07:16.82735
NCT00720525|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2011-07-15|||April 2008||2008-04-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|||||Observational|||Pulsatile and Steady State Hemodynamics in Diastolic Heart Failure|Diagnostic Value of Measures of Pulsatile Versus Steady State Hemodynamics in Diastolic Heart Failure|Completed||N/A|362|Actual|Klinikum Wels-Grieskirchen|||2||f||||f||||||||||2017-02-18 14:07:16.945068|2017-02-18 14:07:16.945068
NCT00372021|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2006-10-11|||January 2003||2003-01-01|November 2002|2002-11-01||||||||Interventional|||Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy||Completed||Phase 1/Phase 2|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:00.899617|2017-02-18 16:17:00.899617
NCT00720512|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2015-03-10|||June 2008||2008-06-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|February 2013|Actual|2013-02-01||Interventional|BEBYP||Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab|AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III STUDY OF SECOND-LINE CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS WHO HAVE RECEIVED FIRST-LINE CHEMOTHERAPY PLUS BEVACIZUMAB.|Terminated||Phase 3|184|Actual|Gruppo Oncologico del Nord-Ovest||2|||f||||||||||||||2017-02-18 14:07:17.033078|2017-02-18 14:07:17.033078
NCT00720499|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2015-07-20|2015-06-19||July 2008||2008-07-01|July 2015|2015-07-01||||February 2009|Actual|2009-02-01||Interventional|||Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Randomised, Double-blind, Cross-over Study to Assess the Efficacy and Safety of 4 Weeks of Once Daily Treatment of 2 Doses of Orally Inhaled BI 1744 CL, Each in Fixed Dose Combination (FDC) With 5 Microgram Tiotropium Bromide (Delivered by the Respimat® Inhaler) in Patients With COPD|Completed||Phase 2|141|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:07:17.285677|2017-02-18 14:07:17.285677
NCT00720486|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2014-03-26|||June 2008||2008-06-01|March 2014|2014-03-01|February 2012|Actual|2012-02-01|August 2011|Actual|2011-08-01||Interventional|||Effectiveness of Anger Management Treatment in Reducing Anger-Related Behaviors in Female Juvenile Offenders|Anger Management Treatment for Female Juvenile Offenders|Completed||N/A|75|Actual|Drexel University||2|||f||||t||||||||||2017-02-18 14:07:18.539837|2017-02-18 14:07:18.539837
NCT00720473|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2017-01-30|2013-11-26||April 2006||2006-04-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional||Baseline scans were available for 37 participants, 23 BPD subjects and 14 for healthy controls. One participant had missing scan data, and twenty one participants with a BPD diagnosis had baseline MADRS scores available.|Lamotrigine Therapy in Geriatric Bipolar Depression|Lamotrigine Therapy in the Treatment of Geriatric Bipolar Depression: An Evaluation of Markers of Cerebral Energy Metabolism|Completed||N/A|69|Actual|Mclean Hospital|Limited data was available for associating changes in MADRS scores with metabolite changes (22 regions from 11 participants with BPD).|2|||f||||t||||||||||2017-02-18 14:07:18.639835|2017-02-18 14:07:18.639835
NCT00720460|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2017-01-24|||July 16, 2008||2008-07-16|December 22, 2016|2016-12-22||||||||Observational|||Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Normal Volunteers|Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Healthy Volunteers|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:07:19.189823|2017-02-18 14:07:19.189823
NCT00720447|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2013-08-01|||November 2008||2008-11-01|July 2011|2011-07-01||||November 2010|Anticipated|2010-11-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma|Phase II Study of Low Intensity Allogeneic Transplantation in Mantle Cell Lymphoma|Unknown status|Not yet recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:07:19.288024|2017-02-18 14:07:19.288024
NCT00720434|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2013-06-18|2013-06-18||August 2008||2008-08-01|June 2013|2013-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection|A Phase 2, Randomized, Placebo Controlled, Dose Ranging Study To Evaluate Peginterferon Alfa 2a (Pegasys®) And Ribavirin (Copegus®) With And Without PF-00868554 In Subjects Chronically Infected With Hepatitis C Virus|Completed||Phase 2|35|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:07:19.390909|2017-02-18 14:07:19.390909
NCT00720421|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2010-12-08|||June 2008||2008-06-01|November 2008|2008-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.|A Phase 1, Single Centre, Single Dose, Double-blind, Double-dummy, Four-way Crossover, Placebo-controlled, Randomized Study to Investigate the Effects of AZD7325 on Sedation, Cognition and Electroencephalogram (EEG) in Comparison With Lorazepam in Healthy Male Volunteers.|Completed||Phase 1|16|Anticipated|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:07:20.530129|2017-02-18 14:07:20.530129
NCT00720408|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2009-09-14|||December 2007||2007-12-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.|A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF and Extended Release (XL) Tacrolimus /MMF and Steroid Withdraw in de Novo Liver Transplant Recipients.|Completed||Phase 3|48|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:07:20.650126|2017-02-18 14:07:20.650126
NCT00720395|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2015-05-06|||August 2005||2005-08-01|March 2009|2009-03-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Observational|||Identifying Predictors of Bipolar Disorder Relapse During Pregnancy and the Postpartum Period|Predictors of Postpartum Relapse in Women With Bipolar Disorder|Withdrawn||N/A|0|Actual|National Institute of Mental Health (NIMH)|||1|Withdrawn [Funding was never granted for this study. No participants were ever enrolled.]|f||||t||||||Samples Without DNA|"~     Plasma, serum, and urine samples are processed and stored at each study visit.~   "|||2017-02-18 14:07:20.76005|2017-02-18 14:07:20.76005
NCT00720382|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2015-05-04|2009-11-06||March 2007||2007-03-01|May 2015|2015-05-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis|Active Controlled Trial of the Safety and Tolerability of MP 03-036 (Astepro 0.15%) in Patients With Perennial Allergic Rhinitis|Completed||Phase 3|703|Actual|Meda Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:07:20.862818|2017-02-18 14:07:20.862818
NCT00720369|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2013-11-26|2011-09-20||July 2008||2008-07-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|CoQ10||CoQ10 in Geriatric Bipolar Depression|Oral Administration of CoQ10 and Phosphorus-31 Magnetization Transfer Magnetic Resonance Spectroscopy in Geriatric Bipolar Disorder and Healthy Older Adults|Completed||N/A|42|Actual|Mclean Hospital||2|||f||||t||||||||||2017-02-18 14:07:21.770381|2017-02-18 14:07:21.770381
NCT00720356|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2016-05-31|||March 2009||2009-03-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma|A Phase II Study of Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma Without MGMT Promoter Methylation|Active, not recruiting||Phase 2|50|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 14:07:22.183579|2017-02-18 14:07:22.183579
NCT00720343|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2016-03-23|2016-03-23||February 2009||2009-02-01|March 2016|2016-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||Data per arm is not available. Columbia will never have access to this data.|Effect of Oral Choline Supplementation on Postoperative Pain|Effect of Oral Choline Supplementation on Postoperative Pain|Terminated||Phase 4|54|Actual|Columbia University||2||PI left the institution.|f||||t||||||||||2017-02-18 14:07:22.305671|2017-02-18 14:07:22.305671
NCT00720330|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2010-03-17|||July 2008||2008-07-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain|The Effect of Thoracolumbar Paravertebral Block or Intravenous Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain After Inguinal Herniorrhaphy|Terminated||N/A|22|Actual|Outcomes Research Consortium||3||Enrollment challenges prohibited study progression.|f||||f||||||||||2017-02-18 14:07:22.542636|2017-02-18 14:07:22.542636
NCT00720317|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2010-09-15|||May 2008||2008-05-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Diabetic Retinopathy and Sickle Trait|Diabetic Retinopathy and Sickle Cell Trait|Completed||N/A|48|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 14:07:22.648122|2017-02-18 14:07:22.648122
NCT00720304|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2015-11-25|||November 2007||2007-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck|A Phase II Study of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Erlotinib, in Combination With Docetaxel and Radiation in Locally Advanced Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|37|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:07:22.736249|2017-02-18 14:07:22.736249
NCT00720291|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2010-01-21|||February 2006||2006-02-01|January 2010|2010-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Inflammation and Treatment of Bacterial Vaginosis Near Term|Inflammation and Treatment of Bacterial Vaginosis Near Term|Unknown status|Recruiting|N/A|520|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 14:07:22.876042|2017-02-18 14:07:22.876042
NCT00720278|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2010-02-19|2009-09-23||August 2007||2007-08-01|February 2010|2010-02-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies|Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 and MP03-33 Compared to Placebo in Patients With Seasonal Allergic Rhinitis|Completed||Phase 3|526|Actual|Meda Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:07:22.989791|2017-02-18 14:07:22.989791
NCT00720265|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2008-07-18|||February 2006||2006-02-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients|A PHASE III, Randomized, Open-Label, Comparative, Multi - Center Study to Assess the Safety and Efficacy of Prograf® (Tacrolimus) and MR4 (Modified Release Tacrolimus) in de Novo Kidney Transplant Recipients|Completed||Phase 3|135|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:07:23.82559|2017-02-18 14:07:23.82559
NCT00720252|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2015-03-20|||July 2008||2008-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Can Ultrasound Replace Amniocentesis for Confirming Fetal Lung Maturation Among Premature Fetuses?|Can Ultrasound Replace Amniocentesis for Confirming Fetal Lung Maturation Among Premature Fetuses?|Terminated||N/A|10|Actual|HaEmek Medical Center, Israel||1||TECHNICAL ISSUES|f||||||||||||||2017-02-18 14:07:23.934645|2017-02-18 14:07:23.934645
NCT00720239|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2013-02-20|||February 2008||2008-02-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|September 2009|Actual|2009-09-01||Interventional|||Taliderm Dressing for Venous Ulcers|Safety and Wound Healing Efficacy of the TalidermR Wound Dressing a Poly-N-acetyl Glucosamine-derived Membrane Material in Humans With Venous Stasis Ulcers: a Pilot Study.|Completed||Early Phase 1|50|Actual|Medical University of South Carolina||4|||f||||t||||||||||2017-02-18 14:07:24.018119|2017-02-18 14:07:24.018119
NCT00720226|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2013-04-01|||July 2008||2008-07-01|April 2013|2013-04-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Efficacy of Losartan in Preventing Progression of COPD|Efficacy of Losartan in Preventing Progression of COPD|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:07:24.103418|2017-02-18 14:07:24.103418
NCT00720213|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2009-11-09|||August 2008||2008-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:07:24.207384|2017-02-18 14:07:24.207384
NCT00720200|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2014-09-13|||June 2008||2008-06-01|September 2014|2014-09-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||ICU Family Communication Study|A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit|Completed||Phase 3|593|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 14:07:24.25372|2017-02-18 14:07:24.25372
NCT00720174|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2016-05-16|||June 2008||2008-06-01|May 2016|2016-05-01||||January 2013|Actual|2013-01-01||Interventional|||Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma|A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:07:24.365244|2017-02-18 14:07:24.365244
NCT00720161|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2011-09-28|||November 2006||2006-11-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Metformin in Children With Motor Deficit|Metformin in Children With Motor Deficit|Completed||N/A|42|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||t||||||||||2017-02-18 14:07:24.507671|2017-02-18 14:07:24.507671
NCT00720148|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2014-08-25|||February 2008||2008-02-01|August 2014|2014-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Phase I Trial of Bortezomib and Sunitinib|Phase IB Dose Escalation Study of Bortezomib (VELCADE) Administered Weekly for 4 Weeks and Sunitinib (SU-011248) Administered Daily for 4 Weeks Followed by a 14 Day Rest in Patients With Refractory Solid Tumors|Completed||Phase 1|30|Actual|Emory University||1|||f||||f||||||||||2017-02-18 14:07:24.617546|2017-02-18 14:07:24.617546
NCT00720135|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2015-06-03|||January 2008||2008-01-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma|A Phase I Study of De-Immunized DI-Leu16-IL2 Immunocytokine in Patients With B-Cell Non-Hodgkin Lymphoma|Completed||Phase 1|9|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:07:24.80663|2017-02-18 14:07:24.80663
NCT00720122|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-02-28|2012-01-27||July 2008||2008-07-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|814||Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Anorexia Nervosa|Effects of Recombinant Human Insulin Like Growth Factor-1 (rhIGF-1) on Bone Metabolism in Adolescent Girls With Anorexia Nervosa|Completed||Phase 2|28|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:07:24.936194|2017-02-18 14:07:24.936194
NCT00720109|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2016-09-08|2016-09-08||July 2008||2008-07-01|September 2016|2016-09-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Interventional||Since all patients were enrolled under induction therapy and later risk stratified, all patients are grouped under the treatment induction group, including the three ineligible patients.|Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib NSC# 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2/Phase 3|63|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:07:25.222231|2017-02-18 14:07:25.222231
NCT00720096|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2013-12-13|2010-10-15||July 2008||2008-07-01|December 2013|2013-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan|A Pilot Prospective Trial Of Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan In Recurrent Or Persistent Ovarian Cancer Within 12 Months Of Platinum-Based Chemotherapy|Terminated||N/A|4|Actual|H. Lee Moffitt Cancer Center and Research Institute|Due to limited sample size, we were unable to make definitive conclusions in this trial.|2||Funds for this project have been spent, and it is thereby terminated.|f||||t||||||||||2017-02-18 14:07:26.695005|2017-02-18 14:07:26.695005
NCT00720083|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2015-11-14|2013-03-22||November 2008||2008-11-01|November 2015|2015-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||All eligible patients.|Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer|A Randomized Phase II Trial of Chemoradiotherapy Versus Chemoradiotherapy and Vandetanib for High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 2|34|Actual|Radiation Therapy Oncology Group|This study terminated early with 34 subjects accrued out of 170 planned, therefore no analyses were performed.|2||Withdrawal of drug supply.|f||||t||||||||||2017-02-18 14:07:27.303376|2017-02-18 14:07:27.303376
NCT00720070|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2013-08-23|||September 2007||2007-09-01|December 2008|2008-12-01||||August 2012|Anticipated|2012-08-01||Interventional|||PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer|A Multi-centre Randomised Phase III Trial Comparing PET-CT Guided Watch and Wait Policy Versus Planned Neck Dissection for the Management of Locally Advanced (N2/N3) Nodal Metastases in Patients With Head and Neck Squamous Cancer|Unknown status|Recruiting|Phase 3|560|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:07:27.915433|2017-02-18 14:07:27.915433
NCT00720057|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-08-12|2011-01-03||June 2008||2008-06-01|August 2015|2015-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain.|A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of an Extended Release Naproxen Sodium Tablet in Postsurgical Dental Pain|Completed||Phase 3|312|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:07:28.024203|2017-02-18 14:07:28.024203
NCT00720031|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2008-07-22|||November 2000||2000-11-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones|Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones|Completed||Phase 1/Phase 2|16|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-02-18 14:07:28.538832|2017-02-18 14:07:28.538832
NCT00720018|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2016-02-02|||June 2008||2008-06-01|February 2016|2016-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|NP101-006||Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers|A Phase I, Single Center, Open Label, Single-Dose, Five-Period Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) in Healthy Volunteers|Completed||Phase 1|4|Actual|Teva Pharmaceutical Industries||5|||f||||f||||||||||2017-02-18 14:07:28.630577|2017-02-18 14:07:28.630577
NCT00720005|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2010-10-01|||September 2007||2007-09-01|October 2010|2010-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Evaluation of the Aspheric ReSTOR IOL After Routine Cataract Extraction|Evaluation of the Aspheric ReSTOR IOL After Routine Cataract Extraction|Completed||Phase 4|20|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 14:07:28.728027|2017-02-18 14:07:28.728027
NCT00719992|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2008-07-18|||April 2006||2006-04-01|July 2008|2008-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Diagnostic Value of HS-CRP in Stable Angina.|Diagnostic Value of HS-CRP in Stable Angina Patients With Positive Exercise Test as Compared With Coronary Angiography.|Completed||N/A|97|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:07:28.830243|2017-02-18 14:07:28.830243
NCT00719979|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2014-03-18|||September 2009||2009-09-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|May 2011|Actual|2011-05-01||Interventional|||Effectiveness of a Technology Assisted Behavioral Intervention in Assisting People With Major Depressive Disorder|Integrated Telemental Health Intervention for Depression in Primary Care|Completed||Phase 1|102|Actual|Northwestern University||3|||f||||t||||||||||2017-02-18 14:07:28.931292|2017-02-18 14:07:28.931292
NCT00719966|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2016-12-20|||June 2008||2008-06-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Observational|||Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer|Effect of Aromatase Inhibitor Therapy for Breast Cancer on Endothelial Function|Active, not recruiting||N/A|150|Anticipated|Mayo Clinic|||2||f||||t||||||||||2017-02-18 14:07:29.041077|2017-02-18 14:07:29.041077
NCT00719953|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2010-04-18|2010-01-10||August 2008||2008-08-01|July 2008|2008-07-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|Cognitex001||Study to Assess the Efficacy of Cognitex|A Single-Center, Open-label Study to Assess the Efficacy of Cognitex in Elderly Subjects With Memory Impairment|Completed||Phase 4|30|Actual|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 14:07:29.162235|2017-02-18 14:07:29.162235
NCT00719758|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2008-10-09|||June 2008||2008-06-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Drug-Drug Interaction Study of TRK-100STP|TRK-100STP Pharmacokinetic Study in Healthy Volunteers - Evaluation of Pharmacokinetic Interaction Between TRK-100STP and Kremezin|Completed||Phase 1|24|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 14:07:35.2392|2017-02-18 14:07:35.2392
NCT00719940|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2008-07-18|||October 2000||2000-10-01|June 2008|2008-06-01|November 2006|Actual|2006-11-01|October 2004|Actual|2004-10-01||Interventional|TCP||Tinnitus Treatment by Structured Cognitive Behavioral Therapy|Randomized Controlled Clinical Trial of Efficacy and Safety of Individual Cognitive Behavioral Therapy (CBT) Within the Setting of the Structured Therapy Program sTCP (Structured Tinnitus Care Program) in Patients With Tinnitus Aurium|Completed||Phase 4|286|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-02-18 14:07:29.35863|2017-02-18 14:07:29.35863
NCT00719927|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2009-02-05|||June 2008||2008-06-01|June 2008|2008-06-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Comadres Weight Loss Pilot Program|Comadres Weight Loss Pilot Program|Unknown status|Active, not recruiting|N/A|45|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-02-18 14:07:29.471428|2017-02-18 14:07:29.471428
NCT00719914|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-07-24|2012-07-24||November 2007||2007-11-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|IC TITAN||A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks|IntraCoronary Treatment With Integrilin To Improve ANgiographic Outcomes (IC TITAN - TIMI 47) Trial|Terminated||Phase 2|31|Actual|Brigham and Women's Hospital|Early termination due to poor enrollment.|2||Poor enrollment|f||||t||||||||||2017-02-18 14:07:32.016685|2017-02-18 14:07:32.016685
NCT00719901|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2015-01-09|2013-08-08||July 2008||2008-07-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|April 2011|Actual|2011-04-01||Interventional||One patient withdrew prior to beginning treatment and was replaced, thus, will be excluded in all analysis.|Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase I/II Trial of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma|Terminated||Phase 1/Phase 2|11|Actual|National Cancer Institute (NCI)|This trial was terminated due to slow accrual and the drug supply of Obatoclax during the phase I; therefore, the phase II portion will never open. No results from the phase II portion are available.|1||"This trial was terminated due to slow accrual and the drug supply of Obatoclax during the~   phase I; therefore, the phase II portion will never open."|f||||||||||||||2017-02-18 14:07:32.389683|2017-02-18 14:07:32.389683
NCT00719888|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2017-01-11|||November 2005||2005-11-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease|Transplantation of Umbilical Cord Blood for Patients With Hematological Diseases With Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloablative Preparative Regimen|Recruiting||Phase 2|75|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 14:07:32.717095|2017-02-18 14:07:32.717095
NCT00719875|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2009-06-05|||December 2008||2008-12-01|June 2009|2009-06-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer|A Dose-Escalating and Phase II Clinical Trial of the Histone Deacetylase (HDAC) Inhibitor Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA, ZolinzaTM) in Combination With Capecitabine (XelodaTM) Using a New Weekly Dose Regimen for Advanced Breast Cancer|Unknown status|Recruiting|Phase 1/Phase 2|47|Anticipated|Yale University||1|||f||||f||||||||||2017-02-18 14:07:32.866369|2017-02-18 14:07:32.866369
NCT00719862|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2010-01-27|2009-09-30||August 2007||2007-08-01|January 2010|2010-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies|Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-036 in Patients With Seasonal Allergic Rhinitis|Completed||Phase 3|481|Actual|Meda Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:07:32.981917|2017-02-18 14:07:32.981917
NCT00719849|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2014-02-18|||November 2005||2005-11-01|February 2014|2014-02-01|December 2009|Actual|2009-12-01|November 2008|Actual|2008-11-01||Interventional|||Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease|Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematological Malignancies Using a Non-Myeloablative Preparative Regimen|Terminated||Phase 2|13|Actual|Fred Hutchinson Cancer Research Center||2||"A new protocol was developed to replace this protocol in 2008, with removal of ATG and~   extension of MMF duration."|f||||f||||||||||2017-02-18 14:07:33.8756|2017-02-18 14:07:33.8756
NCT00719836|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-20|2012-04-19|||August 2008||2008-08-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies|A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies|Completed||Phase 1/Phase 2|76|Actual|S*BIO||1|||f||||f||||||||||2017-02-18 14:07:34.048149|2017-02-18 14:07:34.048149
NCT00719823|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2016-05-03|||August 2008||2008-08-01|May 2016|2016-05-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Maraviroc Compassionate Use|Maraviroc Compassionate Use|Withdrawn||Phase 3|0|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-02-18 14:07:34.136422|2017-02-18 14:07:34.136422
NCT00719810|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2014-06-30|2010-01-07||June 2008||2008-06-01|June 2014|2014-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections|A Randomized, Double-Blind, Multicenter Study of the Safety and Efficacy of RX 3341 Compared With Tigecycline for the Treatment of Complicated Skin and Skin Structure Infections|Completed||Phase 2|150|Actual|Melinta Therapeutics, Inc.||3|||f||||f||||||||||2017-02-18 14:07:34.237376|2017-02-18 14:07:34.237376
NCT00719797|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2015-03-10|||July 2008||2008-07-01|March 2015|2015-03-01||||May 2011|Actual|2011-05-01||Interventional|TRIBE||Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer|A PHASE III RANDOMIZED TRIAL OF FOLFOXIRI + BEVACIZUMAB VERSUS FOLFIRI + BEVACIZUMAB AS FIRST- LINE TREATMENT FOR METASTATIC COLORECTAL CANCER|Completed||Phase 3|509|Actual|Gruppo Oncologico del Nord-Ovest||2|||f||||t||||||||||2017-02-18 14:07:34.660948|2017-02-18 14:07:34.660948
NCT00719784|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-20|2017-02-08|||July 2008||2008-07-01|February 2017|2017-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Vibration Response Imaging in the Diagnosis of Pulmonary Disease|Vibration Response Imaging in the Diagnosis of Pulmonary Disease - an Exploratory Study|Completed||N/A|25|Actual|Singapore General Hospital||1|||f||||f||||||||||2017-02-18 14:07:35.009741|2017-02-18 14:07:35.009741
NCT00719771|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2014-05-20|||January 2008||2008-01-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Global® AP™ Total Shoulder Arthroplasty|A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty|Completed||N/A|64|Actual|DePuy Orthopaedics||1|||f||||f||||||||||2017-02-18 14:07:35.122733|2017-02-18 14:07:35.122733
NCT00719745|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2008-07-18|||February 2006||2006-02-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients|A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf® (Tacrolimus) and MR4 (Modified Release Tacrolimus) in de Novo Liver Transplant Recipients|Completed||Phase 3|74|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:07:35.358601|2017-02-18 14:07:35.358601
NCT00719732|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2010-03-04|2009-09-18||September 2007||2007-09-01|March 2010|2010-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3|Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3|Completed||Phase 4|218|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 14:07:35.465821|2017-02-18 14:07:35.465821
NCT00719719|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2017-01-24|||July 16, 2008||2008-07-16|November 17, 2016|2016-11-17||||||||Observational|||Cause of Unexplained Anaphylaxis|Studies in the Pathogenesis of Idiopathic Anaphylaxis|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:07:35.679369|2017-02-18 14:07:35.679369
NCT00719706|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-06-13|2012-06-13||August 2008||2008-08-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder|The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder: A Randomized, Placebo-Controlled Trial of Acetyl-L-Carnitine and Alpha-Lipoic Acid for the Treatment of Bipolar Depression|Completed||Phase 2|40|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 14:07:35.788773|2017-02-18 14:07:35.788773
NCT00719693|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-09-27|||July 2008||2008-07-01|September 2012|2012-09-01||||September 2008|Actual|2008-09-01||Interventional|||Assessment of the Effect of Food on ABT-143 Bioavailability||Completed||Phase 1|115|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:07:36.315043|2017-02-18 14:07:36.315043
NCT00719680|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2014-03-05|2012-11-27||June 2008||2008-06-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)|A Multicenter Extension Study of the Efficacy, Tolerability, and Safety of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency (PID)|Completed||Phase 3|21|Actual|CSL Behring||1|||f||||||||||||||2017-02-18 14:07:36.432898|2017-02-18 14:07:36.432898
NCT00719667|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-20|2011-10-17|||July 2008||2008-07-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|GOPCABE||German Off Pump Coronary Artery Bypass in Elderly Study|German Off Pump Coronary Artery Bypass in Elderly Study|Completed||Phase 3|2000|Anticipated|German Off Pump Coronary Artery Bypass in Elderly Study Group||1|||f||||t||||||||||2017-02-18 14:07:36.874774|2017-02-18 14:07:36.874774
NCT00719654|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-07-18|||August 2007||2007-08-01|July 2008|2008-07-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Observational|||Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia|Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia|Unknown status|Recruiting|N/A|150|Anticipated|Medical University of South Carolina|||2||f||||f||||||Samples With DNA|"~     Blood plasma and a portion of placenta is retained~   "|||2017-02-18 14:07:36.965499|2017-02-18 14:07:36.965499
NCT00719641|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-19|2017-01-24|||July 11, 2008||2008-07-11|September 21, 2016|2016-09-21|September 21, 2016|Actual|2016-09-21|September 21, 2016|Actual|2016-09-21||Interventional|||Experimental Device to Improve Colonoscopy|A Trial of Segmental Stiffening Wires to Improve the Efficiency and Patient Tolerability of Colonoscopy|Completed||Phase 1/Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:07:37.056119|2017-02-18 14:07:37.056119
NCT00719628|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-21|2009-04-06|||September 2008||2008-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Depth of Anaesthesia and Cognitive Dysfunction|Depth of Anaesthesia and Presence of Postoperative Cognitive Dysfunction|Completed||N/A|70|Actual|Rigshospitalet, Denmark|||1||f||||t||||||||||2017-02-18 14:07:37.15619|2017-02-18 14:07:37.15619
NCT00719615|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2015-06-02|2010-01-27||March 2008||2008-03-01|March 2010|2010-03-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Observational|||Assess Vitamin D Levels in Those With & Without Thyroid Cancer|The Relationship Between Vitamin D and Thyroid Cancer|Completed||N/A|111|Actual|University of Nebraska|The trial limitations include that it was mostly done on Caucasian subjects; the controls were those with thyroid nodules not subjects without any thyroid disease; the sample size was small; & a small number of Vit D assays used different methods.||3||f||||f||||||Samples With DNA|"~     Whole blood.~   "|||2017-02-18 14:07:37.233867|2017-02-18 14:07:37.233867
NCT00719602|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-09-16|||August 2009||2009-08-01|September 2016|2016-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART|P1060 Substudy Comparing Differences in Malaria Parasitemia by Real Time Quantitative PCR in HIV-Infected Infants and Children on PI-Based HAART Versus NNRTI-Based HAART|Completed||Early Phase 1|105|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group||2|||f||||t||||||||||2017-02-18 14:07:37.652761|2017-02-18 14:07:37.652761
NCT00719589|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2010-03-23|||July 2008||2008-07-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Outcomes of Pudendal InterStim|Outcomes of Pudendal InterStim|Completed||N/A|84|Actual|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 14:07:37.770986|2017-02-18 14:07:37.770986
NCT00719576|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-11-02|||July 2008||2008-07-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|SUMMIT||A Comparison Between the Performance of Chondrocytes Versus Microfracture Technique on Knee Symptoms|A Prospective Randomized Open-label Parallel-group Multi-center Study to Demonstrate the Superiority of Matrix-induced Autologous Chondrocyte Implantation (MACI®) Versus Arthroscopic Microfracture for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle Including the Trochlea.|Completed||Phase 3|144|Actual|Vericel Corporation||2|||f||||t||||||||||2017-02-18 14:07:38.062786|2017-02-18 14:07:38.062786
NCT00719563|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2016-12-19|2014-07-14||October 2008||2008-10-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|August 2011|Actual|2011-08-01||Interventional|||American Ginseng in Treating Patients With Fatigue Caused by Cancer|The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Placebo-Controlled Phase III Study|Completed||Phase 3|364|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 14:07:38.21631|2017-02-18 14:07:38.21631
NCT00619567|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2013-12-09|||September 2007||2007-09-01|December 2013|2013-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Cognitive Stimulation Program in AIDS|Pilot Study of an Internet-Based Cognitive Stimulation Program in AIDS|Completed||Phase 1|60|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:43:13.17432|2017-02-18 14:43:13.17432
NCT00719550|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-11-13||2013-04-15|February 2009||2009-02-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|November 2010|Actual|2010-11-01||Interventional|||AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer|A Multicenter, Double-Blind, 3-Arm, Phase 1b/2 Study in Subjects With Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Adenocarcinoma to Evaluate the Safety and Efficacy of First-line Treatment With Epirubicin, Cisplatin, and Capecitabine(ECX) Plus AMG 102|Completed||Phase 1/Phase 2|130|Actual|Amgen||4|||f||||||||||||||2017-02-18 14:07:40.183681|2017-02-18 14:07:40.183681
NCT00719537|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-01-16|||July 2008||2008-07-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia|Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia in Patients With a Prior History of Preeclampsia: A Prospective, Randomized Clinical Trial|Terminated||N/A|3|Actual|William Beaumont Hospitals||2||inability to find qualifying participants|f||||t||||||||||2017-02-18 14:07:40.453924|2017-02-18 14:07:40.453924
NCT00719524|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-03-08|||July 2008||2008-07-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor|An Open-label, Non-randomized, Dose Evaluation, Safety and Pharmacokinetics Phase I Study of AVE8062 in Combination With Platinum Salts (Cisplatin or Carboplatin) and Taxanes (Docetaxel or Paclitaxel), Every 3 Weeks, in Patients With Advanced Solid Tumors.|Completed||Phase 1|71|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:07:40.564302|2017-02-18 14:07:40.564302
NCT00719511|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-02-16|||February 2008||2008-02-01|February 2011|2011-02-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration|Single Center Phase I/IIa, Placebo Controlled, Randomized, Double-blind, Dose-response Study to Assess the Optimal Dose as Well as Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration|Completed||Phase 2|132|Anticipated|University of Zurich||4|||f||||f||||||||||2017-02-18 14:07:40.665208|2017-02-18 14:07:40.665208
NCT00719498|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-05-16|||November 2003||2003-11-01|April 2010|2010-04-01|July 2004|Actual|2004-07-01|||||Interventional|||Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)|Early High-dose Erythropoietin Therapy and Hypothermia After Out-of-hospital Cardiac Arrest: A Matched Control Study|Completed||Phase 3|20|Actual|Janssen Cilag S.A.S.|||||f||||||||||||||2017-02-18 14:07:40.757468|2017-02-18 14:07:40.757468
NCT00719485|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2009-02-05|||April 2009||2009-04-01|July 2008|2008-07-01|February 2011|Anticipated|2011-02-01|February 2011|Anticipated|2011-02-01||Interventional|||A Study on the Use of Educational Programs Prior to Lumbar Spinal Surgery|A Prospective Randomized Control Trial Assessing the Effect of Two Different Educational Programs on Functional Outcome and Quality of Life Scores for Patients Having Posterior Decompressive Lumbar Spinal Surgery for Degenerative Conditions of the Lumbar Spine|Unknown status|Not yet recruiting|N/A|70|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 14:07:40.844395|2017-02-18 14:07:40.844395
NCT00719472|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-07-11|2012-05-24||July 2008||2008-07-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|RATE||A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE)|A Phase III Multicenter, Open-label Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma|Completed||Phase 3|451|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 14:07:40.934425|2017-02-18 14:07:40.934425
NCT00719459|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2015-06-17|||June 2008||2008-06-01|June 2015|2015-06-01||||July 2008|Actual|2008-07-01||Interventional|||Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer|A Randomized, Open-Label, Single-Dose, Parallel-Design, Bioequivalence Study of Hospira Iron Sucrose Injection Compared to Venofer® Injection USP in Healthy Subjects.|Completed||Phase 1|60|Actual|Hospira, Inc.||2|||f||||f||||||||||2017-02-18 14:07:41.352894|2017-02-18 14:07:41.352894
NCT00719446|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2015-08-31|||October 2007||2007-10-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|ALTOS||Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials|Patient Outcomes 6 and 12 Months After ALTA, OMEGA, EDEN and SAILS ARDS Network Trials|Completed||N/A|922|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 14:07:41.456028|2017-02-18 14:07:41.456028
NCT00719433|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-04-19|||July 2008||2008-07-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Functional Recovery in Stroke Patients With Task-Specific Robot-Aided Arm Therapy|Functional Recovery in Stroke Patients With Task-Specific Robot-Aided Arm Therapy|Completed||Phase 2/Phase 3|76|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 14:07:41.558881|2017-02-18 14:07:41.558881
NCT00719420|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2008-07-18|||April 2006||2006-04-01|July 2008|2008-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia|A Randomized Clinical Trial to Examine the Efficacy of a Clarithromycin-, Amoxicillin-, and Metronidazole-Based Regimen to Eradicate Helicobacter Pylori Infections in Pasto, Colombia|Completed||Phase 3|151|Actual|University of North Texas Health Science Center||2|||f||||f||||||||||2017-02-18 14:07:41.673661|2017-02-18 14:07:41.673661
NCT00719407|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2012-11-07|||January 2010||2010-01-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|September 2011|Actual|2011-09-01||Interventional|NEAT||Neonatal Erythropoietin in Asphyxiated Term Newborns|Neonatal Erythropoietin in Asphyxiated Term Newborns: a Phase I Trial|Completed||Phase 1|24|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 14:07:41.789124|2017-02-18 14:07:41.789124
NCT00719394|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2009-07-08|||March 2008||2008-03-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males|Ascending Single-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSI-136 Administered Orally to Healthy Japanese Male Subjects and Healthy Japanese Elderly Male Subjects|Completed||Phase 1|72|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:07:41.903842|2017-02-18 14:07:41.903842
NCT00719381|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2012-06-13|||January 2008||2008-01-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Pioglitazone on Inflammation in Cystic Fibrosis|Effect of Pioglitazone on Sputum Biomarkers of Inflammation and Lung Epithelial Repair in Cystic Fibrosis|Completed||Phase 1|24|Anticipated|University of Southern California||2|||f||||t||||||||||2017-02-18 14:07:42.004202|2017-02-18 14:07:42.004202
NCT00719368|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2014-04-04|||January 2006||2006-01-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Neurophysiological Characterization of Postherniotomy Pain|Quantitative Sensory Testing in Persistent Postherniotomy Pain Patients|Completed||N/A|48|Actual|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-02-18 14:07:42.11377|2017-02-18 14:07:42.11377
NCT00719355|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-02-07|2012-05-15||June 2005||2005-06-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Polestriding Versus Walking for Subjects With Poor Leg Circulation|Polestriding Versus Walking for PAD Rehabilitation|Completed||Phase 2|146|Actual|University of Illinois at Chicago|Due to the small number of women in the trial, results cannot be generalized to women.|2|||f||||f||||||||||2017-02-18 14:07:42.206501|2017-02-18 14:07:42.206501
NCT00719342|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-11-13|||July 2008||2008-07-01|November 2014|2014-11-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Breathing a Mixture of 92% Oxygen (O2) + 8% Carbon Dioxide (CO2) on Flicker Induced Blood Flow Changes in Ocular Perfusion|Effect of Breathing a Mixture of 92% O2 + 8% CO2 on Flicker Induced Blood Flow Changes in Ocular Perfusion|Completed||N/A|24|Actual|Medical University of Vienna||1|||f||||||||||||||2017-02-18 14:07:42.67156|2017-02-18 14:07:42.67156
NCT00719329|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2012-03-28|2011-08-10||August 2008||2008-08-01|March 2012|2012-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Impact of Chlorhexidine Cleansing on Bacteria Colonizing the Umbilical Cord of Infants in Bangladesh|Bacterial Colonization of the Neonatal Umbilical Cord and Impact of 4.0% Chlorhexidine Cleansing on the Bacteriological Profile of the Umbilical Cord of Newborns in Sylhet District, Bangladesh|Completed||N/A|1931|Actual|Johns Hopkins Bloomberg School of Public Health|Not all possible swab data were available for each baby due to staff leave/holiday, unplanned work stoppage, child/mother absent/moved/died, swab collected but not processed - these reasons did not differ between the groups|3|||f||||f||||||||||2017-02-18 14:07:42.770847|2017-02-18 14:07:42.770847
NCT00719316|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2010-01-13|||July 2008||2008-07-01|July 2008|2008-07-01|January 2010|Anticipated|2010-01-01|July 2009|Anticipated|2009-07-01||Interventional|MSNA||Aliskiren and Muscle Sympathetic Nerve Activity|Effect of Aliskiren on Muscle Sympathetic Nerve Activity (MSNA) in Hypertensive Patients With Chronic Kidney Disease|Unknown status|Recruiting|Phase 4|30|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-02-18 14:07:43.271382|2017-02-18 14:07:43.271382
NCT00719303|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2016-02-09|||June 2012||2012-06-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|September 2017|Anticipated|2017-09-01||Interventional|||Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?|Recruiting||Phase 3|1070|Anticipated|Gynecologic Oncology Group||2|||f||||f||||||||||2017-02-18 14:07:43.522084|2017-02-18 14:07:43.522084
NCT00719290|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2015-08-18|||July 2008||2008-07-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Primary Angle Closure Glaucoma and Aqueous Dynamics|A Randomised Comparative Study of the Effects of Cataract Extraction With Lens Implant Alone Versus Cataract Extraction With Lens Implant and Goniosynechialysis on Outflow Facility in Patients With Primary Angle Closure Glaucoma.|Completed||N/A|24|Actual|Guy's and St Thomas' NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 14:07:45.150711|2017-02-18 14:07:45.150711
NCT00719277|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2009-05-04|||December 2006||2006-12-01|May 2009|2009-05-01|September 2009|Anticipated|2009-09-01|July 2009|Anticipated|2009-07-01||Interventional|PULSE||Feasibility Study: Sleuth Monitoring System|Pilot Clinical Study of the Sleuth Implantable ECG Monitoring System|Unknown status|Active, not recruiting|N/A|40|Anticipated|Transoma Medical||1|||f||||f||||||||||2017-02-18 14:07:45.261364|2017-02-18 14:07:45.261364
NCT00719264|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2015-05-27|2014-04-04||November 2008||2008-11-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer|A Randomized, Open-label, Multi-center Phase II Study to Compare Bevacizumab Plus RAD001 Versus Interferon Alfa-2a Plus Bevacizumab for the First-line Treatment of Patients With Metastatic Clear Cell Carcinoma of the Kidney|Completed||Phase 2|365|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:07:45.360234|2017-02-18 14:07:45.360234
NCT00719251|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2009-03-04|||March 2004||2004-03-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Effects of High Voltage Pulsed Current (HVPC) and Low Level Laser Therapy (LLLT) on Wound Healing in Diabetic Ulcers|Effects of High Voltage Pulsed Current and Low Level Laser Therapy on Wound Healing in Diabetic Ulcers.|Completed||N/A|28|Actual|Universidad Industrial de Santander||3|||f||||t||||||||||2017-02-18 14:07:46.418781|2017-02-18 14:07:46.418781
NCT00719238|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2008-07-18|||January 2007||2007-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||A Pilot Study to Promote Maternal and Infant Oral Health|A Pilot Study to Promote Maternal and Infant Oral Health|Completed||N/A|121|Actual|UConn Health||2|||f||||f||||||||||2017-02-18 14:07:46.546676|2017-02-18 14:07:46.546676
NCT00719225|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-07-13||||||July 2011|2011-07-01||||||||Expanded Access|||A Belatacept Compassionate Use Study for Patients With a Kidney Transplant|Belatacept for Renal Allograft Recipients: A Compassionate Use Program|Approved for marketing||N/A|||Bristol-Myers Squibb|||||||||f||||||||||2017-02-18 14:07:46.74668|2017-02-18 14:07:46.74668
NCT00719212|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2015-12-08|2015-10-22||January 2009||2009-01-01|December 2015|2015-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer|A Multicenter Open Label Phase II Study of the Efficacy and Safety of AMG 479, a Fully Human Monoclonal Antibody Against Insulin-like Growth Factor Type 1 Receptor (IGF-1R) as Second Line Therapy in Patients With Recurrent Platinum Sensitive Ovarian Cancer|Completed||Phase 2|61|Actual|Translational Research in Oncology||1|||f||||t||||||||||2017-02-18 14:07:46.849294|2017-02-18 14:07:46.849294
NCT00719199|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-10-21|||January 2009||2009-01-01|October 2013|2013-10-01|August 2011|Actual|2011-08-01|April 2011|Actual|2011-04-01||Interventional|||Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer|Open-label Phase 1b Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer Who Have Progressed Following Chemotherapy for Advanced or Metastatic Disease|Terminated||Phase 1|21|Actual|EMD Serono||1||Sponsor will discontinue further development of EMD 1201081|f||||f||||||||||2017-02-18 14:07:47.48306|2017-02-18 14:07:47.48306
NCT00619554|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2008-02-20|||July 2007||2007-07-01|February 2008|2008-02-01||||August 2007|Actual|2007-08-01||Observational|||A Study on the Intraject Instructions for Use|Zogenix Intraject Instructions for Use Pilot Study|Completed||N/A|19|Actual|Zogenix, Inc.|||1||f||||f||||||||||2017-02-18 14:43:15.639774|2017-02-18 14:43:15.639774
NCT00719186|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2014-05-12|2014-03-25||February 2009||2009-02-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PPCOSII||Pregnancy in Polycystic Ovary Syndrome II|A 20 Week Double-Blind Randomized Trial of Clomiphene Citrate and Letrozole for the Treatment of Infertility in Women With Polycystic Ovary Syndrome|Completed||Phase 3|750|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:07:47.758451|2017-02-18 14:07:47.758451
NCT00719173|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-05-17|||August 2005||2005-08-01|May 2012|2012-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer|Evaluating the Effect of Aprepitant on Cyclophosphamide Pharmacokinetics|Completed||N/A|19|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 14:07:48.306657|2017-02-18 14:07:48.306657
NCT00719160|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2012-11-30|2012-01-26||January 2005||2005-01-01|November 2012|2012-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effect of Protein on Calcium Absorption and Gastric Acid Production|Dietary Protein's Effect on Gastric pH and Calcium Absorption|Completed||Phase 4|12|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:07:48.412844|2017-02-18 14:07:48.412844
NCT00719147|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-09-26|||July 2001||2001-07-01|September 2011|2011-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone|Avascular Necrosis of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone|Completed||N/A|170|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 14:07:48.669116|2017-02-18 14:07:48.669116
NCT00719134|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2015-04-08|2015-02-10||September 2008||2008-09-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache|The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache|Completed||Phase 4|76|Actual|Beth Israel Deaconess Medical Center|Patients were not asked whether or not they thought the pill they took was maxalt or placebo. Thus, it is not possible to determine their actual level of expectation.|6|||f||||f||||||||||2017-02-18 14:07:48.781601|2017-02-18 14:07:48.781601
NCT00719121|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-09-23|||November 2006||2006-11-01|July 2008|2008-07-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Study on Anti-inflammatory Effects of Topical R115866 Gel|Placebo-Controlled, Investigator Blinded, Explorative Trial to Evaluate the Anti-inflammatory Effect of Multiple Topical Applications of R115866 Gel (0.35%) in Two Models of Cutaneous Inflammation in Healthy Male Subjects|Completed||Phase 1|12|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 14:07:49.029516|2017-02-18 14:07:49.029516
NCT00719108|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-12-26|||July 2008||2008-07-01|December 2012|2012-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.|Randomized,Single Center,Double Blind,Two-period,Crossover Glucose Clamp Trial to Test Bioequivalence Between Two Recombinant Human Soluble Insulins - Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects|Completed||Phase 1|42|Actual|Wockhardt||2|||f||||f||||||||||2017-02-18 14:07:49.130698|2017-02-18 14:07:49.130698
NCT00719095|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-04-12|||April 2006||2006-04-01|July 2008|2008-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effective Treatment for Prescription Opioid Abuse|Effective Treatment for Prescription Opioid Abuse|Completed||Phase 2|105|Actual|University of Vermont Medical Center||3|||f||||f||||||||||2017-02-18 14:07:49.241659|2017-02-18 14:07:49.241659
NCT00719082|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-01-26|||July 2008||2008-07-01|January 2016|2016-01-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Observational|||Fall Prevention:Dynamic Posturographic Measurements in the Geriatric Population|Fall Prevention:Dynamic Posturographic Measurements in the Geriatric Population|Withdrawn||N/A|0|Actual|Carrick Institute for Graduate Studies|||1|Lack of Funding|f||||t||||||||No||2017-02-18 14:07:49.353581|2017-02-18 14:07:49.353581
NCT00719069|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2008-07-21|||April 2008||2008-04-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke|A Double-Blind, Placebo-Controlled, Randomized, Single-Dose, 2-Period Crossover Study of the Pharmacodynamics of Orally Administered PSI-697 in Healthy Subjects Who Smoke|Completed||Phase 1|30|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:07:49.442058|2017-02-18 14:07:49.442058
NCT00719056|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-18|||August 2004||2004-08-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|December 2005|Actual|2005-12-01||Interventional|||Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty|Efficacy of Teicoplanin for the Prevention of Surgical Site Infections After Total Hip or Knee Arthroplasty: A Prospective, Open-Label Randomized Study|Completed||Phase 4|616|Actual|University of Athens||2|||f||||f||||||||||2017-02-18 14:07:49.5187|2017-02-18 14:07:49.5187
NCT00719043|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2016-09-09|2013-12-19||July 2008||2008-07-01|September 2016|2016-09-01|February 2011|Actual|2011-02-01|April 2010|Actual|2010-04-01||Interventional|||Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years|A Trial to Evaluate the Safety and Immunogenicity of Monovalent H5N1 Vaccine in Adults >=18 Yrs of Age|Completed||Phase 2|841|Actual|GlaxoSmithKline||7|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:07:49.659174|2017-02-18 14:07:49.659174
NCT00719030|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2016-07-28|||February 2009||2009-02-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|April 2010|Actual|2010-04-01||Interventional|||A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy|A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy|Completed||N/A|25|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-02-18 14:07:52.446627|2017-02-18 14:07:52.446627
NCT00719017|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2013-04-05|||September 2007||2007-09-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery|Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery: a Randomized Controlled Study.|Unknown status|Recruiting|Phase 4|24|Anticipated|University Magna Graecia||3|||f||||t||||||||||2017-02-18 14:07:52.582714|2017-02-18 14:07:52.582714
NCT00719004|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2016-04-06|||February 2008||2008-02-01|April 2016|2016-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Sonographic Features of Normal Soft Tissues of the Feet|Sonographic Features of Normal Soft Tissues of the Feet|Completed||N/A|10|Actual|University of Michigan||1|||f||||f||||||||No||2017-02-18 14:07:52.706433|2017-02-18 14:07:52.706433
NCT00718991|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2015-03-06|||July 2008||2008-07-01|March 2015|2015-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|EXCELLENT-BTK||EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study|A Physician Initiated Prospective Multicenter Study on Excimer Laser Recanalisation in the Treatment of Long Infrapopliteal Lesions in Patients With Critical Limb Ischemia|Terminated||Phase 2/Phase 3|14|Actual|Flanders Medical Research Program||1||too slow enrollment|f||||f||||||||||2017-02-18 14:07:52.816826|2017-02-18 14:07:52.816826
NCT00718978|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2008-09-05|||June 2003||2003-06-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|July 2004|Actual|2004-07-01||Interventional|||Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS)|Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS) Based on Esterified Hyaluronic Acid Scaffold: Our Experience|Completed||N/A|11|Actual|University of Roma La Sapienza||3|||f||||f||||||||||2017-02-18 14:07:52.929301|2017-02-18 14:07:52.929301
NCT00718965|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2016-04-15||2016-04-15|July 2008||2008-07-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia|A Double-blind, Randomized, 12-month, Placebo-controlled, Parallel Group, Fixed-dose Study to Evaluate the Efficacy and Safety of AVE5530 25mg/Day and AVE5530 50 mg/Day in Patients With Primary Hypercholesterolemia|Terminated||Phase 3|826|Actual|Sanofi||3||AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy|f||||f||||||||||2017-02-18 14:07:53.040197|2017-02-18 14:07:53.040197
NCT00718952|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2010-02-11|||July 2008||2008-07-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|EVALUATION||The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension|Multi-centre, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Treatment of Pulmonary Arterial Hypertension With Vardenafil in China|Completed||Phase 3|60|Anticipated|Tongji University||2|||f||||t||||||||||2017-02-18 14:07:53.151571|2017-02-18 14:07:53.151571
NCT00718939|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-10-19|||July 2008||2008-07-01|October 2016|2016-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Rheos® Diastolic Heart Failure Trial|Rheos® Diastolic Heart Failure Trial|Completed||N/A|6|Actual|CVRx, Inc.||2|||f||||f||||||||||2017-02-18 14:07:53.288294|2017-02-18 14:07:53.288294
NCT00718926|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2008-07-18|||August 2008||2008-08-01|May 2008|2008-05-01|March 2010|Anticipated|2010-03-01|December 2008|Anticipated|2008-12-01||Observational|||The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients|The Evaluation of Thiol Redox Status in Conjunctiva of Dry Eye Patients|Unknown status|Not yet recruiting|N/A|50|Anticipated|Meiji University of Oriental Medicine|||4||f||||t||||||Samples Without DNA|"~     After application of anethesia eyedrops, nitrocel membrane is put ocular surface. Then,~     removed the membrane. This method is commonly used clinically.~   "|||2017-02-18 14:07:53.40196|2017-02-18 14:07:53.40196
NCT00718913|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2015-05-14|||April 2008||2008-04-01|May 2015|2015-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer|A Phase II Trial of Postoperative Chemotherapy and Chemo-radiotherapy for Resected Adenocarcinoma of the Stomach and Gastro-esophageal Junction|Completed||Phase 2|40|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 14:07:53.498329|2017-02-18 14:07:53.498329
NCT00718887|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-01-04|2012-10-17||July 2008||2008-07-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|December 2009|Actual|2009-12-01||Interventional|||Suboptimal Responders to Adefovir Switching to Entecavir|A Comparative Study of the Week 12 Antiviral Efficacy and Safety of Switching to Entecavir vs. Continuing Adefovir Treatment in Adults With Chronic Hepatitis B and Suboptimal Response to Adefovir|Completed||Phase 4|228|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:07:53.644753|2017-02-18 14:07:53.644753
NCT00718874|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2012-04-18|||June 2008||2008-06-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PRIMO||A Specialized Diet for the Unique Metabolic Characteristics of Peripubertal African American Girls|Dietary Intervention to Improve Insulin Dynamics During the Pubertal Transition|Completed||N/A|30|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 14:07:54.171734|2017-02-18 14:07:54.171734
NCT00718861|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2014-10-02|2013-11-08||May 2008||2008-05-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||The intent-to-treat (ITT) population included all patients who were enrolled in the extension study at Visit 12. This included patients who were randomized to Z9 and Z6P3 groups.|3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs|A 3-year, Multicenter, Double-blind, Randomized, Placebo-controlled Extension to CZOL446H2301E1 to Evaluate the Efficacy and Long Term Safety of 6 and 9 Years Zoledronic Acid Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 3|190|Actual|Novartis||2|||f||||t||||||||||2017-02-18 14:07:54.278834|2017-02-18 14:07:54.278834
NCT00718848|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2015-10-13|||July 2008||2008-07-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Impact of In-centre Nocturnal Hemodialysis on Ventricular Remodeling and Function in End-stage Renal Disease|Impact of In-centre Nocturnal Hemodialysis on Ventricular Remodeling and Function in End-stage Renal Disease|Completed||N/A|67|Actual|St. Michael's Hospital, Toronto|||2||f||||f||||||Samples Without DNA|"~     Serum and plasma.~   "|||2017-02-18 14:07:55.120163|2017-02-18 14:07:55.120163
NCT00718835|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2014-02-20|||June 2007||2007-06-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Incentive-based Smoking Cessation for Methadone Patients|Incentive-based Smoking Cessation for Methadone Patients|Completed||Phase 2|170|Anticipated|University of Vermont Medical Center||2|||f||||f||||||||||2017-02-18 14:07:55.21645|2017-02-18 14:07:55.21645
NCT00718822|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2008-07-18|||August 2006||2006-08-01|July 2008|2008-07-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Interventional|||Outcome of Embryo Culture at Two Oxygen Tensions|Does Reduced Oxygen Tension in Embryo Culture Influence Clinical Outcome of ICSI Cycles? A Prospective Randomized Trial|Completed||N/A|647|Actual|University Clinical Centre, Maribor||2|||f||||f||||||||||2017-02-18 14:07:55.326501|2017-02-18 14:07:55.326501
NCT00718809|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2015-06-05|2015-05-15||June 2008||2008-06-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|August 2010|Actual|2010-08-01||Interventional|||Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer|Phase II Trial of AZD0530 for Patients With Relapsed/Refractory Thymic Malignancies (Thymoma and Thymic Carcinoma)|Terminated||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:07:55.419254|2017-02-18 14:07:55.419254
NCT00006404|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2014-03-25|||September 2000||2000-09-01|May 2009|2009-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Nutrition in Pregnancy, Birth Weight, and Childhood Asthma||Completed||N/A|||Harvard Pilgrim Health Care|||||f||||||||||||||2017-02-18 18:12:44.571642|2017-02-18 18:12:44.571642
NCT00718796|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2010-05-14|||April 2008||2008-04-01|May 2010|2010-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|Cardio pilot||Naturopathic Treatment for the Prevention of Cardiovascular Disease|Naturopathic Treatment for the Prevention of Cardiovascular Disease: a Pragmatic Randomized Controlled Trial|Completed||Phase 3|300|Anticipated|The Canadian College of Naturopathic Medicine||2|||f||||t||||||||||2017-02-18 14:07:56.175881|2017-02-18 14:07:56.175881
NCT00718783|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-12-13|||April 2007||2007-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Molecular Analysis of Retinoblastoma|Molecular Analysis of Retinoblastoma|Completed||N/A|41|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||Samples With DNA|"~     -  Each tumor sample will be immediately transferred to a sterile cryovial and flash~          frozen in liquid nitrogen.~        -  White blood cells will be isolated from the blood sample as a source of genomic DNA.~   "|||2017-02-18 14:07:58.72387|2017-02-18 14:07:58.72387
NCT00718770|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-12-16|2013-08-02||November 2008||2008-11-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression|Rexinoid Therapy for Poorly Differentiated Thyroid Cancer: A Pilot Clinical Trial and Correlation to Retinoid and PPARy Receptor Expression|Completed||Early Phase 1|10|Actual|University of Colorado, Denver|Small numbers of participants with higher than expected numbers of patients not eligible and who could not complete trial due to lack of efficacy or drug side effects|1|||f||||t||||||||||2017-02-18 14:07:58.834883|2017-02-18 14:07:58.834883
NCT00718757|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-08-26|||January 2005||2005-01-01|August 2013|2013-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies|A Phase I Trial Using Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies|Completed||Phase 1|4|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 14:07:59.070548|2017-02-18 14:07:59.070548
NCT00718744|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2010-08-04|||June 2008||2008-06-01|August 2010|2010-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units|Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units|Completed||Phase 2|30|Actual|Laboratorios Leti, S.L.||1|||f||||f||||||||||2017-02-18 14:07:59.189088|2017-02-18 14:07:59.189088
NCT00718731|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2010-04-01|||March 2008||2008-03-01|April 2010|2010-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study GSI-136 in Healthy Young and Healthy Elderly Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSI 136 Administered Orally to Healthy Young and Healthy Elderly Subjects|Completed||Phase 1|80|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:07:59.294857|2017-02-18 14:07:59.294857
NCT00718718|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-01-29||2011-09-15|August 2008||2008-08-01|January 2016|2016-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy|A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, Dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 2|187|Actual|Centocor, Inc.||7|||f||||t||||||||||2017-02-18 14:07:59.398465|2017-02-18 14:07:59.398465
NCT00718705|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-12-27|||July 2008||2008-07-01|May 2011|2011-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|PREMYC||Reduction of Spontaneous Prematurity by Antibiotic Treatment (Josamycin)|Reduction of Spontaneous Prematurity: Impact of Antibiotic Treatment (Josamycin) in Case of Positive PCR for Ureaplasma Spp and/or Mycoplasma Hominis in Amniotic Fluid|Completed||Phase 3|3200|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:07:59.765699|2017-02-18 14:07:59.765699
NCT00718692|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2016-10-25||2015-11-25|July 2008||2008-07-01|October 2016|2016-10-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)|A Multi-centre, Single Intravenous Dose, Exploratory Dose-finding, Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) in RhD Positive, Non-splenectomized Adult Subjects.|Completed||Phase 2|61|Actual|Symphogen A/S||1|||f||||t||||||||No||2017-02-18 14:07:59.884394|2017-02-18 14:07:59.884394
NCT00718679|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-18|2010-02-10|||July 2008||2008-07-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|IVN-CAT-001B||Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial|Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial|Completed||Phase 1|20|Anticipated|University of Zurich||2|||f||||f||||||||||2017-02-18 14:08:00.046911|2017-02-18 14:08:00.046911
NCT00718666|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-08-08||2013-12-05|October 2008||2008-10-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|November 2013|Actual|2013-11-01||Interventional|||The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers|Long Term Antibody Persistence Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Administered as 1 or 2 Doses to Healthy Toddlers at 9-12 Months of Age and as a Booster Dose at 5 Years Post-primary Vaccination|Completed||Phase 2|387|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:08:00.151275|2017-02-18 14:08:00.151275
NCT00718653|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2009-02-27|||September 2004||2004-09-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Antioxidants on Human Macular Pigments|Effects of Antioxidants on Human Macular Pigments|Completed||N/A|40|Actual|National Eye Institute (NEI)||2|||f||||f||||||||||2017-02-18 14:08:00.312551|2017-02-18 14:08:00.312551
NCT00718484|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-01-29|||August 2008||2008-08-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|April 2012|Actual|2012-04-01||Interventional|PICASSO||A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma|A Phase II Multicenter, Parallel Group, Randomized Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Subjects With Unresectable or Metastatic Soft-tissue Sarcoma|Unknown status|Active, not recruiting|Phase 2|67|Actual|Ziopharm||2|||f||||f||||||||||2017-02-18 14:08:03.691844|2017-02-18 14:08:03.691844
NCT00718640|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-09-25|2013-06-21||October 2007||2007-10-01|September 2013|2013-09-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney Function|Safety and Efficacy of Velcade in Relapsed and/or Refractory Multiple Myeloma Patients With Impaired Renal Function|Terminated||Phase 2|10|Actual|Janssen-Ortho Inc., Canada|Participants’ recruitment was limited due to pre-defined criteria of renal disease and requirement of repeated evaluation of creatinine clearance. Due to insufficient number of participants the outcome measure data was not analyzed.|1||Study stopped due to lagging enrolment.|f||||f||||||||||2017-02-18 14:08:00.455114|2017-02-18 14:08:00.455114
NCT00718627|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-02-05|||July 2008||2008-07-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders|Open, Prospective, Uncontrolled, Multicentre Study to Evaluate The Safety and Efficacy of Multiple Applications of Liver Cell Suspension Into The Portal Vein in Children With Urea Cycle Disorders (UCDs)|Completed||Phase 2|12|Actual|Cytonet GmbH & Co. KG||1|||f||||t||||||||||2017-02-18 14:08:00.816944|2017-02-18 14:08:00.816944
NCT00718614|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-11-24|||June 2007||2007-06-01|November 2014|2014-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-dependent Diabetes Mellitus (IDDM)|Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With IDDM|Terminated||N/A|80|Anticipated|Medical University of Vienna||4|||f||||t||||||||||2017-02-18 14:08:00.928505|2017-02-18 14:08:00.928505
NCT00718601|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-12-22|||July 2008||2008-07-01|December 2015|2015-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma|A Phase I Study of GRN163L in Combination With Bortezomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|40|Anticipated|Geron Corporation||1|||f||||f||||||||||2017-02-18 14:08:01.0401|2017-02-18 14:08:01.0401
NCT00718588|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2012-03-06|||July 2008||2008-07-01|March 2012|2012-03-01||||December 2009|Actual|2009-12-01||Interventional|||A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial, With a Single Ascending-Dose Stage Followed by a Multiple Ascending-Dose Stage, of the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous MTRX1011A in Patients With Rheumatoid Arthritis|Terminated||Phase 1|66|Actual|Genentech, Inc.||1||"Study had completed enrollment but drug injection was halted due to an unacceptable incidence~   of rash."|f||||||||||||||2017-02-18 14:08:01.154722|2017-02-18 14:08:01.154722
NCT00718575|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-07-24|||August 2008||2008-08-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|June 2010|Actual|2010-06-01||Interventional|||The Effects of Glucose/Ischemic Preconditioning on Reperfusion Injury in Deceased-Donor Liver Transplantation|A Prospective, Randomized Trial to Investigate the Effects of Glucose/ Ischemic Preconditioning Donor Pre-treatment on Reperfusion Injury in Deceased-Donor Liver Transplantation|Terminated||Phase 3|50|Actual|University Health Network, Toronto||2||too few patients meeting current eligibility criteria|f||||f||||||||||2017-02-18 14:08:01.239939|2017-02-18 14:08:01.239939
NCT00718562|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-11-16|||September 2008||2008-09-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib|A Multi-center Phase II Study to Evaluate the Efficacy and Safety of AMN107 (Nilotinib) in Patients With Gastrointestinal Stromal Tumors Who Have Progressed on or Are Intolerant to Both Imatinib and Sunitinib|Completed||Phase 2|35|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:08:01.346689|2017-02-18 14:08:01.346689
NCT00718549|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-11-01|||July 2009||2009-07-01|November 2016|2016-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-cell Chronic Lymphocytic Leukemia|A Randomized, Open Label Study to Assess the Effect of Maintenance Treatment With MabThera vs no Treatment, After Induction With MabThera, Cladribine and Cyclophosphamide on Progression-free Survival in Previously Untreated Patients With Progressive B-CLL. The Trial Conducted With PALG Sites|Completed||Phase 3|128|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:08:01.677516|2017-02-18 14:08:01.677516
NCT00718536|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2009-04-08|||August 2008||2008-08-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy|Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy|Completed||Phase 4|15|Anticipated|Germans Trias i Pujol Hospital||1|||f||||f||||||||||2017-02-18 14:08:01.798725|2017-02-18 14:08:01.798725
NCT00718523|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2015-12-08|2015-10-22||January 2009||2009-01-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|September 2013|Actual|2013-09-01||Interventional|||Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer|A Randomized, Double-blind, Placebo Controlled, Multi-center, Phase II Study of Adding AMG 479, a Fully Human Monoclonal Antibody Against Insulin-like Growth Factor Type 1 Receptor (IGF-1R) to First Line Chemotherapy in Patients With Optimally Debulked ( < 1 cm ) Epithelial Ovarian Cancer|Terminated||Phase 2|170|Actual|Translational Research in Oncology||2||The steering committee of the TRIO014 study has taken the decision to stop the TRIO014 trial.|f||||t||||||||||2017-02-18 14:08:01.948363|2017-02-18 14:08:01.948363
NCT00718510|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2013-12-09|||September 2009||2009-09-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|July 2011|Actual|2011-07-01||Interventional|||L-arginine in Treatment as Usual in Schizophrenia|A Randomised, Double-blind, Cross-over, Placebo Controlled, Adjunctive-treatment of L-arginine Added to Treatment-as-usual (TAU) in Schizophrenia|Completed||N/A|13|Actual|University of Alberta||1|||f||||t||||||||||2017-02-18 14:08:03.502823|2017-02-18 14:08:03.502823
NCT00718497|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-03-01|||August 2007||2007-08-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population|Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population|Completed||N/A|25|Actual|Drexel University|||1||f||||f||||||||||2017-02-18 14:08:03.598106|2017-02-18 14:08:03.598106
NCT00006403|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2016-05-12|||July 2000||2000-07-01|March 2005|2005-03-01|June 2004|Actual|2004-06-01|||||Observational|||Inflammation: Correlates and Prognosis in Framingham||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:44.646522|2017-02-18 18:12:44.646522
NCT00718471|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2012-12-17|||August 2008||2008-08-01|December 2012|2012-12-01|August 2010|Actual|2010-08-01|March 2010|Actual|2010-03-01||Interventional|ATOLL||STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH)|Acute STEMI Treated With Primary Angioplasty and Intravenous 0.5 mg/kg Lovenox or UFH to Lower Ischemic and Bleeding Events|Completed||Phase 3|910|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:08:03.819546|2017-02-18 14:08:03.819546
NCT00718458|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2015-10-28|||August 2007||2007-08-01|October 2015|2015-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|BCI||EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)|EEG-Based Brain-Computer Interface Project for Individuals With ALS|Recruiting||N/A|150|Anticipated|Drexel University|||2||f||||f||||||||||2017-02-18 14:08:03.930957|2017-02-18 14:08:03.930957
NCT00718445|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-06-23|||March 2008||2008-03-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Pennsylvania Consortium: Clinical Database|Pennsylvania Consortium: Clinical Database|Terminated||N/A|25|Actual|Drexel University|||1|Terminated due to lack of funding and support staff|f||||f||||||||||2017-02-18 14:08:04.04461|2017-02-18 14:08:04.04461
NCT00718432|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-06-24|||April 2008||2008-04-01|June 2009|2009-06-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||An Interventional Study of Geriatric Frailty, Osteoporosis, and Depression|Interventional Study of Geriatric Frailty, Osteoporosis, and Depression in a Community Based Randomized Trial.|Completed||N/A|406|Actual|National Health Research Institutes, Taiwan||3|||f||||t||||||||||2017-02-18 14:08:04.138287|2017-02-18 14:08:04.138287
NCT00718419|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2012-09-07||2011-06-13|July 2008||2008-07-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|September 2010|Actual|2010-09-01||Interventional|||A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma|An Open Label, Multicenter Phase 2 Study of Single-Agent Enzastaurin HCl in Previously Treated Waldenstrom's Macroglobulinemia or Multiple Myeloma|Completed||Phase 2|46|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:08:04.460214|2017-02-18 14:08:04.460214
NCT00718406|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2008-07-16||||||August 2002|2002-08-01||||||||Interventional|||Pain Relief of Metoprolol Versus Metoprolol Plus Morphine in Acute Chest Pain||Completed||Phase 4|||Sahlgrenska University Hospital, Sweden||2|||f||||||||||||||2017-02-18 14:08:04.57069|2017-02-18 14:08:04.57069
NCT00718393|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2011-03-24|||June 2007||2007-06-01|March 2011|2011-03-01|September 2008|Anticipated|2008-09-01|April 2008|Anticipated|2008-04-01||Observational|||Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS)|Compassionate Use of Ceftriaxone in Patients With ALS|Withdrawn||N/A|5|Anticipated|Drexel University|||1|No further patient to be enrolled. This was a 1 patient compassionate use protocol.|f||||f||||||||||2017-02-18 14:08:04.659985|2017-02-18 14:08:04.659985
NCT00718380|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2012-07-13|||September 2008||2008-09-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Phase 1 Study of ABT-869 in Subjects With Solid Tumors|An Open Label, Phase I Study Evaluating Pharmacokinetics, Safety, and Tolerability of ABT-869 in Subjects With Solid Tumors|Completed||Phase 1|18|Actual|Abbott||4|||f||||||||||||||2017-02-18 14:08:04.736999|2017-02-18 14:08:04.736999
NCT00718367|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-01-13|||March 2008||2008-03-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|||||Observational|||Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens|Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens|Completed||N/A|||National University Hospital, Singapore|||1||f||||||||||||||2017-02-18 14:08:04.828403|2017-02-18 14:08:04.828403
NCT00718354|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-05-12|||July 2008||2008-07-01|May 2015|2015-05-01|August 2010|Actual|2010-08-01|January 2010|Actual|2010-01-01||Interventional|GASTRANOX||Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT|Randomized, Phase III-b, Multi-centre, Open-label, Parallel Study of Enoxaparin (Low Molecular Weight Heparin) Given Concomitantly With Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Gastric and Gastro-oesophageal Cancer|Completed||Phase 3|740|Actual|Thrombosis Research Institute||2|||f||||t||||||||||2017-02-18 14:08:04.915597|2017-02-18 14:08:04.915597
NCT00718341|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2010-05-05|||June 2008||2008-06-01|May 2010|2010-05-01||||February 2009|Actual|2009-02-01||Interventional|||Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients|A Multi-centre, Randomized, Double-blind, Placebo Controlled, Two-period, Crossover Proof-of-concept Study in Male Patients With Fragile X Syndrome to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of AFQ056|Completed||Phase 2|30|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:08:05.050424|2017-02-18 14:08:05.050424
NCT00718328|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2011-12-14|||October 2008||2008-10-01|December 2011|2011-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Simvastatin For Intracerebral Hemorrhage Study|Simvastatin For Intracerebral Hemorrhage Study|Terminated||Phase 2|1|Actual|Johns Hopkins University||2||Poor recruitment, trial terminated|f||||t||||||||||2017-02-18 14:08:05.158496|2017-02-18 14:08:05.158496
NCT00718315|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-01-09|2015-01-09||April 2009||2009-04-01|January 2015|2015-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Intention to treat (ITT) population covered all participants who had at least one application of study drug and who had at least one post-treatment assessment, irrespective of compliance extent with protocol criteria.|A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.|A Randomized, Open Label Study to Compare the Use of the Dermatological Creams Verutex, Eritex and Fisiogel in the Management of Skin Rash Associated With Tarceva Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer.|Completed||Phase 3|201|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 14:08:05.280009|2017-02-18 14:08:05.280009
NCT00718302|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2013-03-05|||June 2008||2008-06-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures|Ankle Fracture Plating: A Multicenter Randomized Trial Comparing Lateral and Antiglide Plating in Displaced Lateral Malleolus Fractures|Completed||N/A|249|Actual|Boston Medical Center||1|||f||||t||||||||||2017-02-18 14:08:06.147151|2017-02-18 14:08:06.147151
NCT00718289|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2008-07-17|||March 2007||2007-03-01|July 2008|2008-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes|Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes|Completed||Phase 4|25|Actual|Ospedale Regionale di Locarno||2|||f||||f||||||||||2017-02-18 14:08:06.256443|2017-02-18 14:08:06.256443
NCT00718276|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2011-12-22|||March 2008||2008-03-01|December 2011|2011-12-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Pharmacokinetic Study: Effect of 25(OH)D and Vitamin D3 on Serum 25(OH)D|Pharmacokinetic Study in Healthy Postmenopausal Women to Compare Supplementation of Vitamin D3 to 25(OH)D|Completed||Phase 1|35|Actual|University of Zurich||2|||f||||t||||||||||2017-02-18 14:08:06.357496|2017-02-18 14:08:06.357496
NCT00718263|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-09-21|||April 2008||2008-04-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|PHCHBS-WD4070||Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)|Extension Study to a Phase III Multi-center, Open-label, Randomized Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|Recruiting||Phase 3|90|Anticipated|Novartis||2|||f||||||||||||||2017-02-18 14:08:06.470513|2017-02-18 14:08:06.470513
NCT00718250|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2008-07-16|||May 2008||2008-05-01|July 2008|2008-07-01|February 2012|Anticipated|2012-02-01|May 2011|Anticipated|2011-05-01||Interventional|RFUSIN2-AML1||Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2|A Phase I Study of Lentivirus Transduced Acute Myeloid Leukaemic Cells (AML) Expressing B7.1 (CD80) and IL-2 for the Potential Enhancement of Graft Versus Leukaemia(GvL) Effect in Poor Prognosis AML|Unknown status|Recruiting|Phase 1|24|Anticipated|King's College Hospital NHS Trust||4|||f||||t||||||||||2017-02-18 14:08:06.656227|2017-02-18 14:08:06.656227
NCT00718237|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-05-13|2010-06-23||August 2008||2008-08-01|May 2015|2015-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)|A Phase III Randomized, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of V260 in Healthy Infants in Japan|Completed||Phase 3|762|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:08:06.766534|2017-02-18 14:08:06.766534
NCT00718224|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-01-14||2010-12-20|July 2008||2008-07-01|January 2013|2013-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|SAVE-KNEE||Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery|A Multinational, Multicenter, Randomized, Double-blind Study Comparing the Efficacy and Safety of Semuloparin (AVE5026) With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery|Completed||Phase 3|1150|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:08:07.396599|2017-02-18 14:08:07.396599
NCT00718211|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2008-07-18|||May 2006||2006-05-01|July 2008|2008-07-01||||||||Observational|||A Retrospective Clinical Records Review of Patients Diagnosed With Gastrointestinal Stromal Tumour at Two Tertiary Institutes in Singapore|A Retrospective Clinical Records Review of Patients Diagnosed With Gastrointestinal Stromal Tumour at Two Tertiary Institutes in Singapore.|Unknown status|Recruiting|N/A|||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 14:08:07.545512|2017-02-18 14:08:07.545512
NCT00718198|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2009-02-10|||March 2006||2006-03-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Observational|||Effects of a Computerized Physician Order Entry (CPOE)-Based Inpatient Insulin Protocol on Glycemic Outcomes|Effects of a Computerized Physician Order Entry (CPOE)-Based Inpatient Insulin Protocol on Glycemic Outcomes|Completed||N/A|413|Actual|John H. Stroger Hospital|||2||f||||f||||||||||2017-02-18 14:08:07.633729|2017-02-18 14:08:07.633729
NCT00718185|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-03-11|||May 2008||2008-05-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Observational|||Pharmacokinetics and Pharmacdynamics of Sildenafil|The Pharmacokinetics and Pharmacodynamics of Sildenafil in Pediatric and Adult Patients|Terminated||N/A|9|Actual|Children's Hospital of Philadelphia|||1|Similar study completed.|f||||f||||||Samples Without DNA|"~     Blood specimens~   "|||2017-02-18 14:08:07.728087|2017-02-18 14:08:07.728087
NCT00718172|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2017-01-24|||July 11, 2008||2008-07-11|August 19, 2014|2014-08-19|August 19, 2014|Actual|2014-08-19|||||Interventional|||Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C|Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C|Completed||Phase 1|81|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:08:07.834448|2017-02-18 14:08:07.834448
NCT00718159|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2012-02-10|||August 2008||2008-08-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia|Phase 1 Study of LY573636-sodium in Patients With Essential Thrombocythemia and Acute Myeloid Leukemia|Completed||Phase 1|45|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:08:07.946467|2017-02-18 14:08:07.946467
NCT00718146|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2014-01-16|||June 2008||2008-06-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation|Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (Intramuscular Route)|Completed||Phase 2|130|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:08:08.063374|2017-02-18 14:08:08.063374
NCT00718133|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2010-09-13|||December 2008||2008-12-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|August 2009|Actual|2009-08-01||Interventional|||The Effect of Air Pollution on Lung Health Among Children Living in Haifa Bay Region, Israel|The Effect of Air Pollution on Lung Health Among Children Living in Haifa Bay Region, Israel.|Completed||N/A|15|Actual|Carmel Medical Center||1|||f||||f||||||||||2017-02-18 14:08:08.168394|2017-02-18 14:08:08.168394
NCT00718120|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2016-10-26|2009-07-16||July 2008||2008-07-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years|Immunogenicity and Safety Study of a Single Injection of GSK Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral® (2008 - 2009 Season) in Adults Aged 18 to 60 Years and Over 60 Years.|Completed||Phase 3|110|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:08:08.284126|2017-02-18 14:08:08.284126
NCT00718107|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-03-01|||June 2005||2005-06-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology|Satisfaction Survey for ALS Patients Comparing Rooms With and Without Assistive Technology|Terminated||N/A|5|Actual|Drexel University|||1|"The study was discontinued due to low enrollment. A survey has been implemented in place of a~   formal study."|f||||f||||||||||2017-02-18 14:08:08.751769|2017-02-18 14:08:08.751769
NCT00718094|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2017-01-17|||March 2008||2008-03-01|January 2017|2017-01-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|||Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis|A Phase IIa Pilot Study to Determine the Safety of an Oral Dose of Green Tea Extract (Polyphenon E®) and Provide Preliminary Evidence to Support Its Efficacy in Ulcerative Colitis|Completed||Phase 2|20|Actual|University of Louisville||3|||f||||t||||||||||2017-02-18 14:08:08.834161|2017-02-18 14:08:08.834161
NCT00718081|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-12-18|2013-10-18||August 2008||2008-08-01|December 2014|2014-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery|A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery|Completed||Phase 2|88|Actual|AcelRx Pharmaceuticals, Inc.||3|||f||||||||||||||2017-02-18 14:08:08.955875|2017-02-18 14:08:08.955875
NCT00718068|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2010-07-26|||October 2008||2008-10-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|ASPIC||Safety of Continuous Potassium Chloride Infusion in Critical Care|Assessing the Safety of a Continuous Potassium Chloride Infusion in Critical Care: A Randomised Controlled Trial|Completed||Phase 4|160|Actual|The Queen Elizabeth Hospital||2|||f||||f||||||||||2017-02-18 14:08:09.45218|2017-02-18 14:08:09.45218
NCT00718055|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2009-02-09|||November 2006||2006-11-01|February 2009|2009-02-01||||||||Observational|||Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients|MR Skanning Med Leverspecifikt Oralt Kontraststof Sammenlignet Med CT Skanning Hos Colorectalcancer Patienter Med Levermetastaser|Withdrawn||Phase 4|50|Anticipated|Copenhagen University Hospital at Herlev|||1||f||||||||||||||2017-02-18 14:08:09.562282|2017-02-18 14:08:09.562282
NCT00718042|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2012-03-02|2011-12-16||June 2008||2008-06-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of Chagas Blood Screening and Confirmatory Assays|Evaluation of ABBOTT PRISM Chagas Assay and Chagas Confirmatory Assay|Completed||N/A|41862|Actual|Abbott Diagnostics Division||2|||f||||f||||||||||2017-02-18 14:08:09.646481|2017-02-18 14:08:09.646481
NCT00718029|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2008-07-23|||July 2008||2008-07-01|July 2008|2008-07-01||||July 2009|Anticipated|2009-07-01||Observational|||Cerebrospinal Fluid (CSF) Raltegravir Substudy|MK: Raltegravir Concentrations in Cerebrospinal Fluid|Unknown status|Enrolling by invitation|N/A|15|Anticipated|University of California, San Diego|||1||f||||||||||Samples With DNA|"~     CSF, PBMC, plasma~   "|||2017-02-18 14:08:10.605009|2017-02-18 14:08:10.605009
NCT00718016|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-03-01|||December 2004||2004-12-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient|Assessment of the Cyberlink Control System for Use by the ALS Patient|Terminated||N/A|1|Actual|Drexel University|||1|New protocol was developed based on preliminary results from this study.|f||||f||||||||||2017-02-18 14:08:10.688043|2017-02-18 14:08:10.688043
NCT00718003|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-03-01|||May 2005||2005-05-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).|Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).|Terminated||N/A|10|Actual|Drexel University|||1|Terminated due to difficulty enrolling subjects.|f||||f||||||||||2017-02-18 14:08:10.769464|2017-02-18 14:08:10.769464
NCT00717990|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-10-06|||April 2008||2008-04-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment|A Phase II Study of Irinotecan, Capecitabine and Avastin in Patients With Metastatic Colorectal Cancer, Who Have Progressed After 1ST Line Therapy With Folfox/Avastin.|Terminated||Phase 2|15|Actual|University Hospital of Crete||1||Poor Accrual|f||||f||||||||||2017-02-18 14:08:10.857379|2017-02-18 14:08:10.857379
NCT00717977|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-09-02|2010-08-02||July 2008||2008-07-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Continuous Glucose Sensor Profiles in Non-Diabetic Subjects|A Study to Assess Continuous Glucose Sensor Profiles in Healthy Non-Diabetic Subjects|Completed||Phase 4|74|Actual|Jaeb Center for Health Research||1|||f||||t||||||||||2017-02-18 14:08:10.969802|2017-02-18 14:08:10.969802
NCT00717951|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-24|||May 2008||2008-05-01|May 2008|2008-05-01|May 2010|Anticipated|2010-05-01|December 2009|Anticipated|2009-12-01||Interventional|||A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer|A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 2|120|Actual|Academy Military Medical Science, China||2|||f||||t||||||||||2017-02-18 14:08:11.774845|2017-02-18 14:08:11.774845
NCT00717938|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-09-13|||June 2008||2008-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|RASTEN||A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer|A Randomized Phase III Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer|Active, not recruiting||Phase 3|390|Anticipated|Lund University Hospital||2|||f||||f||||||||||2017-02-18 14:08:11.875243|2017-02-18 14:08:11.875243
NCT00717925|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-12-07|||March 2007||2007-03-01|December 2015|2015-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating Safety and Tolerability of Inotuzumab Ozogamicin (CMC-544) in Japanese Patients With B-cell Non-Hodgkin's Lymphoma (NHL)|A Phase 1 Study Of CMC-544 Administered As A Single Agent In Subjects With B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1|13|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||t||||||||||2017-02-18 14:08:12.003023|2017-02-18 14:08:12.003023
NCT00717912|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2008-07-17|||July 2008||2008-07-01|July 2008|2008-07-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup|Determination of the Glycemic Index and the Insulinemic Index of a Sweetener|Unknown status|Recruiting|N/A|6|Anticipated|Routin SA||3|||f||||t||||||||||2017-02-18 14:08:12.09277|2017-02-18 14:08:12.09277
NCT00717899|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2010-09-13|||December 2008||2008-12-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|August 2009|Actual|2009-08-01||Interventional|||The Effect of Air Pollution on Lung Health Among School Children Living in Haifa Bay Region|The Effect of Air Pollution on Lung Health Among School Children Living in Haifa Bay Region|Completed||N/A|1200|Anticipated|Carmel Medical Center||1|||f||||f||||||||||2017-02-18 14:08:12.202232|2017-02-18 14:08:12.202232
NCT00717886|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-10-19|2015-10-19||June 2008||2008-06-01|October 2015|2015-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Upper Extremity Lymphatic Mapping for Breast Cancer Patients|Upper Extremity Lymphatic Mapping for Breast Cancer Patients: A Pilot Study|Completed||N/A|13|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:08:12.316945|2017-02-18 14:08:12.316945
NCT00717873|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-08-25|2015-08-25||June 2008||2008-06-01|August 2015|2015-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of High-Frequency Chest Wall Oscillation|Evaluation of High-Frequency Chest Wall Oscillation Using the Vest Airway Clearance System Compared to Conventional Chest Physical Therapy at Barnes-Jewish Hospital|Completed||Phase 4|330|Actual|Hill-Rom||2|||f||||f||||||||||2017-02-18 14:08:12.534258|2017-02-18 14:08:12.534258
NCT00717860|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-03-04|2011-07-28||August 2008||2008-08-01|March 2016|2016-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)|A Multicenter, Double-Blind, Comparative Study of MK0991 (Caspofungin) Versus Micafungin in Adult Japanese Patients With Deep-seated Candida or Aspergillus Infections|Completed||Phase 3|121|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:08:12.812654|2017-02-18 14:08:12.812654
NCT00717847|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2013-12-10|||February 2006||2006-02-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib|A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib|Completed||N/A|||National University Hospital, Singapore|||2||f||||||||||||||2017-02-18 14:08:13.232596|2017-02-18 14:08:13.232596
NCT00717834|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-17|2015-10-07|||June 2008||2008-06-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine|A Blinded Phase 1/2 Dose Escalation Study to Assess Safety and Immunogenicity and Investigate the Optimal Dose Level of a Formalin-Treated, UV-Inactivated, Vero Cell-Derived Ross River Virus (RRV) Vaccine in Healthy Volunteers Aged 18 to 40 Years|Completed||Phase 1/Phase 2|400|Anticipated|Nanotherapeutics, Inc.||8|||f||||t||||||||||2017-02-18 14:08:13.315994|2017-02-18 14:08:13.315994
NCT00717821|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2013-10-07|||October 2008||2008-10-01|October 2013|2013-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study of Once Monthly Intravenous or Subcutaneous Mircera in Patients With Chronic Kidney Disease on Hemodialysis.|A Randomized, Controlled, Open Label, French Multicenter Parallel Group Study to Compare the Hemoglobin Maintenance With Once Monthly Administration of Mircera Versus Epoetin Beta or Darbepoetin Alfa in Patients With Chronic Kidney Disease on Hemodialysis|Completed||Phase 3|421|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:08:13.419787|2017-02-18 14:08:13.419787
NCT00717808|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2015-05-27|||September 2008||2008-09-01|September 2011|2011-09-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)|A Phase 1, Blinded, Randomised, Crossover Pilot Study to Investigate the Safety, Tolerability and Pharmacokinetics of Tranilast in Patients With Rheumatoid Arthritis on Methotrexate|Withdrawn||Phase 1|0|Actual|Imperial College London||2||Due to unforeseen circumstances this study will not now start.|f||||f||||||||||2017-02-18 14:08:13.595071|2017-02-18 14:08:13.595071
NCT00717795|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-07-25|||June 2008||2008-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Physical Activity Intervention for Lung Cancer Survivors|Physical Activity Intervention for Lung Cancer Survivors|Active, not recruiting||N/A|52|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:08:13.706441|2017-02-18 14:08:13.706441
NCT00717782|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2008-07-17|||January 2003||2003-01-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||Pain Relief for Thrombosed External Haemorrhoids|Randomized Clinical Trial of Botulinum Toxin Injection for Pain Relief in Patients With Thrombosed External Haemorrhoids|Completed||Phase 4|30|Actual|University of Palermo||2|||f||||f||||||||||2017-02-18 14:08:13.8124|2017-02-18 14:08:13.8124
NCT00717769|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-10-19||2011-04-04|July 2008||2008-07-01|October 2015|2015-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis|Completed||Phase 2|270|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 14:08:13.925124|2017-02-18 14:08:13.925124
NCT00717756|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2014-06-26|2014-02-20||January 2009||2009-01-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial|Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial|Completed||Phase 2|41|Actual|Brown University||1|||f||||t||||||||||2017-02-18 14:08:14.044588|2017-02-18 14:08:14.044588
NCT00717743|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2010-04-07|||March 2007||2007-03-01|April 2010|2010-04-01||||||||Observational|||T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)|T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)|Completed||N/A|||National University Hospital, Singapore|||1||f||||||||||||||2017-02-18 14:08:14.329034|2017-02-18 14:08:14.329034
NCT00717730|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-07-27|||January 2010||2010-01-01|July 2015|2015-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Folic Acid and Vitamin B12 in Young Indian Children|Routine Administration of Folic Acid and Vitamin B12 to Prevent Childhood Infections in Young Indian Children|Completed||Phase 2|1000|Actual|Centre For International Health||4|||f||||t||||||||||2017-02-18 14:08:14.417793|2017-02-18 14:08:14.417793
NCT00717717|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2015-10-26|||November 2006||2006-11-01|October 2015|2015-10-01|February 2012|Actual|2012-02-01|February 2010|Actual|2010-02-01||Interventional|PACT||A Clinical Controlled Trial on the Effect of Physical Activity After Cancer Treatment (PACT)|Physical Activity After Cancer Treatment (PACT)- A Clinical Controlled Trial on the Effect of a One-year Physical Activity Program for Cancer Patients Following Cytostatic Treatment|Completed||N/A|214|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 14:08:14.549232|2017-02-18 14:08:14.549232
NCT00717704|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-05-29|||July 2008||2008-07-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Solid Tumors Using Ixabepilone and Dasatinib|A Phase I Study of Ixabepilone Combined With Dasatinib in Patients With Solid Tumors|Completed||Phase 1|19|Actual|Washington Hospital Center||1|||f||||t||||||||||2017-02-18 14:08:14.652923|2017-02-18 14:08:14.652923
NCT00006402|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2008-01-18|||August 2000||2000-08-01|January 2008|2008-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Observational|||Lifestyle, Adiposity and Cardiovascular Health in Youths||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:44.724025|2017-02-18 18:12:44.724025
NCT00717691|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-04-27|||July 2008||2008-07-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial|Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial|Completed||N/A|50|Actual|Dynasplint Systems, Inc.||2|||f||||t||||||||||2017-02-18 14:08:14.758764|2017-02-18 14:08:14.758764
NCT00717678|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-12-16|||December 2007||2007-12-01|December 2015|2015-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients|A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF and Extended Release (XL) Tacrolimus /MMF in de Novo Kidney Transplant Recipients|Completed||Phase 3|73|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-02-18 14:08:14.874262|2017-02-18 14:08:14.874262
NCT00717665|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2011-06-24|||June 2007||2007-06-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Self-monitoring of Blood Pressure in Primary Care|Self-monitoring of Blood Pressure in Primary Care in Older Diabetic Patients With Uncontrolled Systolic Hypertension|Completed||N/A|110|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-02-18 14:08:14.987682|2017-02-18 14:08:14.987682
NCT00717652|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2010-10-22|||July 2008||2008-07-01|July 2008|2008-07-01||||July 2008|Anticipated|2008-07-01||Interventional|melasma||Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma|Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In The Treatment Of Facial Melasma, Taking As Reference The Product Triluma ® (Hidroquinone, Fluoncinolone And Tretinoin).|Suspended||Phase 2/Phase 3|110|Anticipated|Azidus Brasil||2|||f||||f||||||||||2017-02-18 14:08:15.10148|2017-02-18 14:08:15.10148
NCT00717639|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2011-08-05|||May 2008||2008-05-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Vasovist Magnetic Resonance Angiography (MRA) in Peripheral Arterial Occlusive Disease|Determination of Diagnostic Accuracy and Added Value of Vasovist®-Enhanced Peripheral MRA in Comparison to Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients With Peripheral Artery Disease|Terminated||Phase 4|150|Anticipated|Heidelberg University||1||Required contrast media (Vasovist) withdrawn from market|f||||f||||||||||2017-02-18 14:08:15.218348|2017-02-18 14:08:15.218348
NCT00717626|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-12-17|||July 2008||2008-07-01|December 2013|2013-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A|Pilot Study of Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A|Completed||Phase 2|14|Actual|The Hospital for Sick Children||1|||f||||t||||||||||2017-02-18 14:08:15.329538|2017-02-18 14:08:15.329538
NCT00717613|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2011-11-07|||July 2007||2007-07-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2009|Actual|2009-10-01||Observational|||Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting|Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting|Completed||N/A|50|Anticipated|Baylor College of Medicine|||1||f||||f||||||||||2017-02-18 14:08:15.434355|2017-02-18 14:08:15.434355
NCT00717600|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2008-07-16|||January 2008||2008-01-01|July 2008|2008-07-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|BERP||Bacteriuria Eradication Through Probiotics|Bacteriuria Eradication Through Probiotics|Unknown status|Enrolling by invitation|Phase 1|10|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:08:15.737312|2017-02-18 14:08:15.737312
NCT00717587|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-01-09|||June 2008||2008-06-01|January 2009|2009-01-01||||July 2010|Anticipated|2010-07-01||Interventional|||Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer|A Histopathologic and Imaging Study of Renal Cell Carcinoma Vasculature in the Setting of Sunitinib Therapy Prior to Cytoreductive Nephrectomy|Unknown status|Recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:08:15.849165|2017-02-18 14:08:15.849165
NCT00717574|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-06-13|||March 2008||2008-03-01|June 2012|2012-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|N20||Addition of Nitrous Oxide and Its Effects on Depth of Anesthesia|Addition of Nitrous Oxide to a Sevoflurane or Propofol Based Anesthetic and Its Effects on Depth of Anesthesia Indices (N20)|Completed||N/A|42|Actual|University of Oklahoma||2|||f||||t||||||||||2017-02-18 14:08:15.955331|2017-02-18 14:08:15.955331
NCT00717561|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-11-02|||February 2008||2008-02-01|October 2014|2014-10-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia|A National, Prospective, Randomized, Open Label Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin vs IV Ceftriaxone + IV Azithromycin Followed by PO Amoxicilline/Clavulanate and PO Clarithromycin in Subjects With Community-acquired Pneumonia|Completed||Phase 3|60|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:08:16.094328|2017-02-18 14:08:16.094328
NCT00717548|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-11-02|||June 2008||2008-06-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy of Narrative Exposure Therapy (NET) in Treating Women After Human Trafficking or Forced Prostitution|The Effectiveness of Narrative Exposure Therapy in Treating Women After Trafficking and Forced Prostitution|Completed||N/A|10|Actual|University of Konstanz||1|||f||||f||||||||||2017-02-18 14:08:16.235203|2017-02-18 14:08:16.235203
NCT00717535|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2013-04-25|||August 2005||2005-08-01|April 2013|2013-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Studying Umbilical Cord Blood From African-American Donors|Investigation of the Total Nucleated Cell Yield of Cord Blood Units Collected From African-American Donors in Correlation With Gestational and Other Health Variables|Withdrawn||N/A|0|Actual|Barbara Ann Karmanos Cancer Institute|||1|Funding unavailable|f||||t||||||None Retained|"~     Cord blood unit (CBU)will be collected in utero and transported to the Stem Cell Processing~     Laboratory. The volume of the CBU will be measured and cell count will be obtained.~   "|||2017-02-18 14:08:16.336212|2017-02-18 14:08:16.336212
NCT00717522|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2013-03-06|2013-03-06||August 2008||2008-08-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma|A Phase 2, Multicenter, Open-label, Single Arm, Two-stage Study to Evaluate the Efficacy and Safety of CC-4047 (Pomalidomide) in Patients With Advanced Soft Tissue Sarcomas Who Have Relapsed or Are Refractory to Systemic Anticancer Therapy|Terminated||Phase 2|7|Actual|Celgene||1||"Study enrollment was terminated due to a corporate strategic decision unrelated to patient~   safety."|f||||t||||||||||2017-02-18 14:08:16.437612|2017-02-18 14:08:16.437612
NCT00717509|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2009-06-09|||October 2007||2007-10-01|June 2009|2009-06-01|October 2009|Anticipated|2009-10-01|January 2009|Actual|2009-01-01||Observational|||Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia|Cross-Sectional Study of the Association Between Multiple Genetic Polymorphisms and the Metabolic Side Effects in Patients With Schizophrenia Taking Clozapine More Than 1 Year|Unknown status|Recruiting|N/A|150|Anticipated|Seoul National Hospital|||1||f||||t||||||Samples With DNA|"~     peripheral blood~   "|||2017-02-18 14:08:16.774185|2017-02-18 14:08:16.774185
NCT00717496|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2013-01-04|||April 2005||2005-04-01|July 2008|2008-07-01|August 2006|Actual|2006-08-01|May 2006|Actual|2006-05-01||Interventional|||Telephone Support Intervention to Improve Breastfeeding|Telephone Support Intervention to Improve Breastfeeding Rates in Low-Income Women|Completed||N/A|339|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 14:08:16.877822|2017-02-18 14:08:16.877822
NCT00717483|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-07-19|||July 2008||2008-07-01|July 2016|2016-07-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Observational|||BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes|BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes|Completed||N/A|108|Actual|Baylor College of Medicine|||1||f||||f||||||||No||2017-02-18 14:08:16.994435|2017-02-18 14:08:16.994435
NCT00717470|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2015-06-12|||May 2008||2008-05-01|June 2015|2015-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|OSAKA||A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection|A Multicenter, Four Arm, Randomized, Open Label Clinical Study Investigating Optimized Dosing in a Prograf®-/Advagraf®-Based Immunosuppressive Regimen in Kidney Transplant Subjects (OSAKA Study)|Completed||Phase 4|1252|Actual|Astellas Pharma Inc||4|||f||||t||||||||||2017-02-18 14:08:17.098803|2017-02-18 14:08:17.098803
NCT00717457|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-11-01||2016-07-20|July 2008||2008-07-01|November 2016|2016-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.|Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|1189|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 14:08:17.38024|2017-02-18 14:08:17.38024
NCT00717444|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2013-07-23|||September 2008||2008-09-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|HAPI||Healthy Activities for Prize Incentives|Healthy Activities for Prize Incentives|Completed||Phase 1|75|Actual|UConn Health||2|||f||||f||||||||||2017-02-18 14:08:17.760381|2017-02-18 14:08:17.760381
NCT00717431|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-03-28|||January 2008||2008-01-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|METTLE||A Multicenter Study of Hippocampal Electrical Stimulation (HS, in Mesial Temporal Lobe Epilepsy|Medical vs Electrical Therapy for Temporal Lobe Epilepsy|Terminated||Phase 3|8|Actual|University of Calgary||2||insufficient enrolment|f||||t||||||||||2017-02-18 14:08:17.855004|2017-02-18 14:08:17.855004
NCT00717418|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2011-12-05|2011-12-05||September 2004||2004-09-01|December 2011|2011-12-01|August 2008|Actual|2008-08-01|August 2006|Actual|2006-08-01||Observational|||Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease||Completed||N/A|781|Actual|Allergan|Due to actual dry eye treatment used, data were not interpretable by separate treatment arms. Hence, Outcomes are only reported as a single group.||1||f||||||||||||||2017-02-18 14:08:17.951336|2017-02-18 14:08:17.951336
NCT00717405|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-07-05|2015-12-01||October 2008||2008-10-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|April 2010|Actual|2010-04-01||Interventional||Intent to treat population (ITT): Included all enrolled participants who had at least 1 post baseline assessment.|A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.|An Open Label Study to Assess the Rate of Pathological Complete Response in Patients With Primary Inflammatory HER2-positive Breast Cancer Treated With Avastin + Herceptin Based Chemotherapy|Completed||Phase 2|52|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:08:18.325033|2017-02-18 14:08:18.325033
NCT00717392|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2013-02-28|||September 2008||2008-09-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|June 2011|Actual|2011-06-01||Observational|||Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders|Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders|Completed||N/A|40|Actual|Sheba Medical Center|||4||f||||f||||||||||2017-02-18 14:08:21.170412|2017-02-18 14:08:21.170412
NCT00717379|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2009-04-13|||May 2007||2007-05-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation|Open-Label, Randomized, Multicenter, Parallel-Group Efficacy and Safety Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation|Completed||Phase 4|50|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:08:21.264939|2017-02-18 14:08:21.264939
NCT00717366|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-07-01|||July 2008||2008-07-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||A Study of Intravenous Mircera for the Treatment of Anemia in Pediatric Patients on Hemodialysis|An Open Label Multi-center, Multiple Dose Study to Determine the Optimum Starting Dose of Intravenous MIRCERA for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis|Completed||Phase 2|64|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:08:21.385837|2017-02-18 14:08:21.385837
NCT00717353|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-01-13|||October 2005||2005-10-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Observational|||Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype|Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype|Unknown status|Active, not recruiting|N/A|||National University Hospital, Singapore|||1||f||||||||||||||2017-02-18 14:08:21.573633|2017-02-18 14:08:21.573633
NCT00717340|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2012-06-27|||February 2009||2009-02-01|June 2012|2012-06-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer|A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer|Completed||Phase 1|18|Actual|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:08:21.817726|2017-02-18 14:08:21.817726
NCT00717327|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2009-06-24|||July 2008||2008-07-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Adolescent Knowledge of Their Medications|Medication Reconciliation List and Adolescent Functional Health Literacy|Completed||N/A|384|Anticipated|Brooke Army Medical Center|||1||f||||t||||||||||2017-02-18 14:08:21.929421|2017-02-18 14:08:21.929421
NCT00717314|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2014-09-23|2014-06-04||May 2008||2008-05-01|September 2014|2014-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Per-Protocol (PP) population: all participants who received at least 1 dose of the treatment-group specific medication who did not dropout from the study prematurely.|A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.|A Randomized, Open Label Study Comparing the Effect of CellCept Combined With 2 Regimens of Reduced Calcineurin Inhibitors on Kidney Function in Liver Transplant Patients|Completed||Phase 4|87|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:08:22.022419|2017-02-18 14:08:22.022419
NCT00717301|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2015-06-10|||September 2008||2008-09-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury|Accuracy of S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury|Completed||N/A|1252|Actual|University of Rochester|||2||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:08:22.540156|2017-02-18 14:08:22.540156
NCT00717288|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2011-08-30|2011-07-20||July 2008||2008-07-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir|Transitioning Post-cardiothoracic Surgery Patients From Intravenous Insulin to the Subcutaneous Route With Insulin Detemir.|Completed||Phase 4|82|Actual|Ohio State University||3|||f||||t||||||||||2017-02-18 14:08:22.648074|2017-02-18 14:08:22.648074
NCT00717275|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-09-14|2012-07-10||September 2008||2008-09-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Study of Temozolomide to Treat Newly Diagnosed Brain Metastases|A Phase II Study of Temozolomide (TMZ) Following Stereotactic Radiosurgery (SRS) for Patients With Newly Diagnosed Brain Metastases|Terminated||Phase 2|3|Actual|University of Florida|This single center study was terminated early due to slow accrual; therefore, statistical analysis of the 3 participants was not done.|1||Slow accrual.|f||||t||||||||||2017-02-18 14:08:23.153527|2017-02-18 14:08:23.153527
NCT00717262|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2009-01-15|||May 2008||2008-05-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Phase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects|A Phase 1, Double-Blind, Placebo Controlled, Repeat-Dose Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Volunteers|Completed||Phase 1|41|Anticipated|HemaQuest Pharmaceuticals Inc.||2|||f||||f||||||||||2017-02-18 14:08:23.390502|2017-02-18 14:08:23.390502
NCT00717249|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2016-04-20|2016-04-20||August 2007||2007-08-01|April 2016|2016-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||All subjects that were dispensed a study lens.|Vistakon Investigational Contact Lenses Worn for Daily Wear||Completed||N/A|529|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:08:23.487707|2017-02-18 14:08:23.487707
NCT00717236|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-03-02|2011-03-10||July 2008||2008-07-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|REALISTIC||Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis|A Phase IIIb Multicenter Study With a 12-week Double-blind, Placebo-controlled, Randomized Period Followed by an Open-label, Extension Phase Evaluating Safety/Efficacy of Certolizumab Pegol Given to Patients With Active Rheumatoid Arthritis.|Completed||Phase 3|1648|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 14:08:24.258819|2017-02-18 14:08:24.258819
NCT00717223|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-16|2016-07-19|||June 2007||2007-06-01|July 2016|2016-07-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Observational|||A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes|A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes|Completed||N/A|110|Actual|Baylor College of Medicine|||1||f||||f||||||||No||2017-02-18 14:08:26.297802|2017-02-18 14:08:26.297802
NCT00717210|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2008-07-16|||June 1999||1999-06-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|February 2005|Actual|2005-02-01||Interventional|NOA-04||Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide|NOA-04 Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide|Completed||Phase 3|318|Actual|Neuro-Oncology Working Group of the German Cancer Society||2|||f||||t||||||||||2017-02-18 14:08:26.405595|2017-02-18 14:08:26.405595
NCT00717197|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2013-06-24|2013-02-18||July 2008||2008-07-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|March 2012|Actual|2012-03-01||Interventional|||Study of Capecitabine to Treat Recurrent High Grade Gliomas|Pilot Study to Determine Therapeutic Response of Oral Capecitabine (Xeloda) in Recurrent High Grade Gliomas (HGGs) by Establishing the Radiographic Response Rate Using Modified Macdonald Criteria|Completed||Phase 2|30|Actual|University of Florida||1|||f||||t||||||||||2017-02-18 14:08:26.533024|2017-02-18 14:08:26.533024
NCT00717184|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2010-04-07|||May 2007||2007-05-01|April 2010|2010-04-01||||||||Interventional|||A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma|A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma|Completed||Phase 1|||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 14:08:26.830189|2017-02-18 14:08:26.830189
NCT00717171|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2009-01-08|||July 2006||2006-07-01|January 2009|2009-01-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Efficacy of the SurgiStim3 Electrical Stimulation Device in Persons Undergoing Anterior Cruciate Ligament Repair|Efficacy of the SurgiStim3 Electrical Stimulation Device in Persons Undergoing Anterior Cruciate Ligament Repair|Terminated||Phase 4|100|Anticipated|VQ OrthoCare||2||Low enrollment|f||||f||||||||||2017-02-18 14:08:26.917951|2017-02-18 14:08:26.917951
NCT00717158|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-14|||May 2001||2001-05-01|August 2007|2007-08-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|ICAN||Lifestyle Intervention's Impact on Health Care Costs|Evaluating Healthcare Utilization, Costs and Health-Related Outcomes of a Medical Nutrition Therapy Intervention on Obese Patients With Type 2 Diabetes - A Pilot Study|Completed||N/A|147|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 14:08:27.019909|2017-02-18 14:08:27.019909
NCT00717145|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2011-10-07|||July 2008||2008-07-01|October 2011|2011-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Food Effects on the Relative Bioavailability of Different Dosages of Risedronate|Food Effects on the Relative Bioavailability of a Risedronate 20 mg Delayed-release [DR] Tablet and to Compare the 20 mg DR Tablet to 35 mg DR and 35 mg Immediate-release Tablets|Completed||Phase 1|94|Actual|Warner Chilcott||4|||f||||f||||||||||2017-02-18 14:08:27.131477|2017-02-18 14:08:27.131477
NCT00359580|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||September 18, 1997||1997-09-18|September 26, 2016|2016-09-26||||||||Observational|||Genetic Studies in the Amish and Mennonites|Genetic Studies in the Amish and Mennonites|Completed||N/A|157|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:50.117619|2017-02-18 16:21:50.117619
NCT00717132|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2016-08-16|||October 2007||2007-10-01|August 2016|2016-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Cost-effectiveness of Family Based Pediatric Obesity Treatment|Cost-effectiveness of Family Based Pediatric Obesity Treatment|Completed||N/A|50|Actual|State University of New York at Buffalo||2|||f||||f||||||||Yes|Data will be submitted|2017-02-18 14:08:27.227154|2017-02-18 14:08:27.227154
NCT00717119|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-09-12|||April 2008||2008-04-01|July 2008|2008-07-01|August 2008|Actual|2008-08-01|||||Observational|||Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.|Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.|Completed||N/A|6356|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:08:27.330817|2017-02-18 14:08:27.330817
NCT00717106|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2009-05-04|||July 2008||2008-07-01|May 2009|2009-05-01||||||||Observational|OBSERV-ECG||Observational Study of the Sleuth Implantable ECG Monitoring System|Observational Study of the Sleuth Implantable ECG Monitoring System|Unknown status|Enrolling by invitation|N/A|250|Anticipated|Transoma Medical|||1||f||||f||||||||||2017-02-18 14:08:27.416872|2017-02-18 14:08:27.416872
NCT00717093|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2015-06-30|2010-04-15||August 2008||2008-08-01|June 2015|2015-06-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use|A Randomized, Multicenter, Double Blind, Placebo Controlled Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use|Completed||Phase 4|432|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:08:27.505106|2017-02-18 14:08:27.505106
NCT00717080|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-01-24|||July 2008||2008-07-01|October 2009|2009-10-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|ACO||The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction|Role of Capsular Tension Ring in Anterior Capsular Contraction in Retinitis Pigmentosa Patients|Completed||Phase 4|40|Actual|Aurolab||2|||f||||t||||||||||2017-02-18 14:08:27.994381|2017-02-18 14:08:27.994381
NCT00717067|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2010-11-10|2009-11-16||July 2008||2008-07-01|November 2010|2010-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function|An Open-Label, Parallel Group, Single And Multiple Dose Study To Evaluate The Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function|Completed||Phase 4|30|Actual|ViiV Healthcare||5|||f||||f||||||||||2017-02-18 14:08:28.104196|2017-02-18 14:08:28.104196
NCT00717054|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2014-05-01|2014-03-05||February 2008||2008-02-01|September 2013|2013-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting|A Randomized, Double-blind Comparison of Oral Aprepitant Alone vs Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting|Completed||N/A|115|Actual|Drexel University||2|||f||||t||||||||||2017-02-18 14:08:29.71444|2017-02-18 14:08:29.71444
NCT00717041|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2015-06-12|2015-05-22||May 2008||2008-05-01|June 2015|2015-06-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Observational|||Epidemiology of Depression, Anxiety, and Cognitive Impairment|Epidemiology of Depression, Anxiety, and Cognitive Impairment Among Emergency Department Patients|Completed||N/A|1206|Actual|University of Rochester|"Single center, limited generalizability~Large proportion of individuals lost to follow up~ED visit may have heightened symptoms~Validity of instruments in the ED setting is unknown"||1||f||||f||||||||||2017-02-18 14:08:30.063875|2017-02-18 14:08:30.063875
NCT00717028|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-14|||September 2005||2005-09-01|September 2005|2005-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Functional Endoscopic Evaluation of Swallowing|Achados da avaliação videoendoscópica da deglutição em crianças Com Paralisia Cerebral.|Completed||N/A|9|Actual|Fortaleza University|||1||f||||f||||||||||2017-02-18 14:08:30.386071|2017-02-18 14:08:30.386071
NCT00717015|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2012-04-02|||November 2005||2005-11-01|April 2012|2012-04-01||||||||Observational|||Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer|Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer|Completed||N/A|||National University Hospital, Singapore|||1||f||||||||||||||2017-02-18 14:08:30.467855|2017-02-18 14:08:30.467855
NCT00717002|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-12-10|||February 2008||2008-02-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study|Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study|Completed||N/A|||National University Hospital, Singapore|||2||f||||f||||||||||2017-02-18 14:08:30.551202|2017-02-18 14:08:30.551202
NCT00716989|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2010-12-22|||November 2008||2008-11-01|December 2010|2010-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|LBP003||Pathophysiological Study of Characteristics of the Changes in the Cutaneous Immune System After Intradermal Antigen Injections|LBP003: Characteristics of the Changes in the Cutaneous Immune System After Intradermal Antigen Injections|Terminated||N/A|36|Actual|Hospices Civils de Lyon||1||"Third group realisation has not been necessary regarding the results of the first two groups~   (no sufficient modifications in the immune response)"|f||||t||||||||||2017-02-18 14:08:30.637362|2017-02-18 14:08:30.637362
NCT00716976|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2016-01-04||2014-04-14|June 2008||2008-06-01|January 2016|2016-01-01||||September 2012|Actual|2012-09-01||Interventional|||Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy|A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children|Active, not recruiting||Phase 3|131|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 14:08:30.730439|2017-02-18 14:08:30.730439
NCT00716963|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2015-04-30|2015-04-14||July 2008||2008-07-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?|Does a Lipophilic Steroid Inhaled After an Early Allergic Reaction Affect the Late Reaction?|Completed||Phase 4|7|Actual|McMaster University||3|||f||||f||||||||||2017-02-18 14:08:30.93758|2017-02-18 14:08:30.93758
NCT00716781|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-14|||July 2004||2004-07-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Observational|||Management of Infants Born to Group B Streptococcus Positive Mothers.|Management of Infants Born to Group B Streptococcus Positive Mothers: Laboratory Tests vs Physical Examination|Completed||N/A|16394|Actual|IRCCS Burlo Garofolo|||2||f||||f||||||||||2017-02-18 14:08:34.325008|2017-02-18 14:08:34.325008
NCT00716950|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-16|||July 2008||2008-07-01|July 2008|2008-07-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients|Evaluation of Antihypertensive Activity of Valsartan and Amlodipine Compared to Losartan and Amlodipine Through Ambulatory Blood Pressure Monitoring in Moderate Hypertensive Patients in a Randomized, Controlled, Double-Blind Study|Unknown status|Recruiting|Phase 4|187|Anticipated|University of Pavia||2|||f||||t||||||||||2017-02-18 14:08:31.269023|2017-02-18 14:08:31.269023
NCT00716937|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2014-12-15|||September 2007||2007-09-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Karydakis Procedure Versus Excision With Healing by Secondary Intention (EHSI) in Sacrococcygeal Pilonidal Sinus|Recurrence, Complications, Work-off Date, Healing Time and Patients Willingness in Karydakis Technique for Treatment of Sacrococcygeal Pilonidal Sinus Versus Excision With Healing by Secondary Intention (EHSI)Technique|Completed||Phase 4|321|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:08:31.362629|2017-02-18 14:08:31.362629
NCT00716924|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2009-09-24|||May 2004||2004-05-01|September 2009|2009-09-01||||February 2006|Actual|2006-02-01||Interventional|CASTLE||CASTLE (Clopidogrel And Serum Troponin Level Elevation)|Clopidogrel 600 mg and 300 mg as a Loading Dose Prior to Percutaneous Coronary Intervention And Serum Troponin Level Elevation: A Pilot Study|Completed||Phase 3|155|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 14:08:31.470854|2017-02-18 14:08:31.470854
NCT00716911|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2015-06-03|||January 2000||2000-01-01|June 2015|2015-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant|CMV Specific Cellular Immunity in Recipients of Allogeneic Bone Marrow Transplantation: Association of CMV-Specific HLA-Peptide Tetramer Binding With Cytotoxic T-Cell Function, CMV Infection and Other Clinical Events|Completed||N/A|100|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:08:31.567082|2017-02-18 14:08:31.567082
NCT00716898|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2016-04-14|||February 2009||2009-02-01|April 2016|2016-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients|Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients Compared to Patients With Unstable Angina Pectoris; The Possible Role of Heparanase|Completed||N/A|25|Actual|Shaare Zedek Medical Center|||2||f||||t||||||||||2017-02-18 14:08:31.667996|2017-02-18 14:08:31.667996
NCT00716885|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-14|||September 2008||2008-09-01|May 2008|2008-05-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Observational|OXIS-PACING||The Effect of Left Ventricular Filling Pressure on Pulmonary Clearance of Free Radical Loaded White Blood Cells and Platelets in Congestive Heart Failure Patients Before and After Biventricular Pacing|The Effect of Left Ventricular Filling Pressure on Pulmonary Clearance of Free Radical Loaded White Blood Cells and Platelets in Congestive Heart Failure Patients Before and After Biventricular Pacing|Unknown status|Not yet recruiting|N/A|20|Anticipated|VU University Medical Center|||2||f||||t||||||Samples Without DNA|"~     Bloodsamples~   "|||2017-02-18 14:08:31.758635|2017-02-18 14:08:31.758635
NCT00716872|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-02-24|||July 2008||2008-07-01|February 2010|2010-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|SHUTi-C||Improving the Sleep of Cancer Patients Using an Internet-Based Program|Evaluating Internet-Based Interventions for Insomnia in Cancer Patients|Completed||N/A|22|Anticipated|University of Virginia||4|||f||||f||||||||||2017-02-18 14:08:31.848839|2017-02-18 14:08:31.848839
NCT00716859|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2011-01-31|2010-11-01||July 2008||2008-07-01|January 2011|2011-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.|A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study Evaluating The Efficacy And Safety Of Latanoprost And Timolol In Pediatric Subjects With Glaucoma.|Completed||Phase 3|139|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:08:32.198818|2017-02-18 14:08:32.198818
NCT00716846|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2011-09-05|||June 2006||2006-06-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|H-17-21||Effects of Statins on the Pharmacokinetics for Midazolam in Healthy Volunteers|Effects of Three Statins, Simvastatin, Atorvastatin, and Pitavastatin, on the Pharmacokinetics for Midazolam in Healthy Volunteers|Completed||N/A|11|Actual|Hamamatsu University||3|||f||||f||||||||||2017-02-18 14:08:32.837723|2017-02-18 14:08:32.837723
NCT00716833|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2015-01-15|||February 2006||2006-02-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|EPPA||Etoricoxibe - Preemptive and Postoperative Analgesia for Abdominal and Thoracic Surgery|Etoricoxibe - Preemptive and Postoperative Analgesia for Abdominal and Thoracic Surgery|Terminated||Phase 3|87|Actual|Ludwig-Maximilians - University of Munich||2||poor recruitment|f||||t||||||||||2017-02-18 14:08:32.937506|2017-02-18 14:08:32.937506
NCT00716820|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2016-08-29|2016-08-29||May 2008||2008-05-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).|Special Investigation For Gist Of Sutent (Regulatory Post Marketing Commitment Plan).|Completed||N/A|480|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:08:33.054413|2017-02-18 14:08:33.054413
NCT00716807|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2016-05-19|2013-08-13||January 2008||2008-01-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||Co-investigators have spent many hours with computer-support personnel trying to locate data on the deceased investigators' computer, but could find nothing other than the gender and treatment assignment for 46 enrolled participants.|Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain|Modeling Kappa Opioid Analgesic Mechanisms in Chronic Orofacial Pain Disorders|Terminated||N/A|46|Actual|University of California, San Francisco|Dr. Robert Gear led this study and maintained data on his computer. Co-investigators have spent many hours trying to locate data on the deceased investigators' computer, but could find nothing other than the minimal results data entered here.|4||Unable to recruit a sufficient number of subjects.|f||||t||||||||||2017-02-18 14:08:33.787071|2017-02-18 14:08:33.787071
NCT00716794|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2011-03-08|||July 2008||2008-07-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Phase I/II Study of HE3235 in Patients With Prostate Cancer|A Phase I/II, Open-Label, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Potential Activity of HE3235 When Administered Orally to Patients With Prostate Cancer|Completed||Phase 1/Phase 2|64|Actual|Harbor Therapeutics||1|||f||||f||||||||||2017-02-18 14:08:34.215962|2017-02-18 14:08:34.215962
NCT00716768|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-01-31|||October 2007||2007-10-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|January 2014|Anticipated|2014-01-01||Interventional|||Trial of Laparoscopic Compared to Open Inguinal Hernia Repair in Children Younger Than 3 Years|Randomized Controlled Trial of Laparoscopic Compared to Open Inguinal Hernia Repair in Children Younger Than 3 Years of Age|Unknown status|Recruiting|N/A|152|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:08:34.418278|2017-02-18 14:08:34.418278
NCT00716755|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2016-02-25|||October 2009||2009-10-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.|The Minimal Effective Dose of Antipsychotic Medication in Older Patients With Schizophrenia: a PET Study.|Completed||N/A|45|Actual|Centre for Addiction and Mental Health||1|||f||||t||||||||No||2017-02-18 14:08:34.520965|2017-02-18 14:08:34.520965
NCT00716742|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2011-11-30|2011-11-30||September 2004||2004-09-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Observational|||Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)||Completed||N/A|1099|Actual|Allergan|Data for 2-year and 3-year follow-up not interpretable due to extremely high drop out rates.||1||f||||||||||||||2017-02-18 14:08:34.63942|2017-02-18 14:08:34.63942
NCT00716729|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2010-10-18|||July 2009||2009-07-01|July 2008|2008-07-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Observational|||Development of Outcome-measures for Physically Active Patients With Hip and Groin Pain|Development of Outcome-measures for Physically Active Patients With Hip and Groin Pain|Completed||N/A|150|Anticipated|Amager Hospital|||1||f||||f||||||||||2017-02-18 14:08:34.993121|2017-02-18 14:08:34.993121
NCT00716716|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2015-03-19|||April 2008||2008-04-01|March 2015|2015-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase I/IIa Study of FIXFc in Hemophilia B Patients|A Phase I/IIa Safety and Pharmacokinetic Study of Intravenous FIXFc in Previously Treated Hemophilia B Patients|Completed||Phase 1|10|Actual|Biogen||1|||f||||t||||||||||2017-02-18 14:08:35.072171|2017-02-18 14:08:35.072171
NCT00716703|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-15|||November 2003||2003-11-01|July 2008|2008-07-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||CT Scan Using IV Contrast Alone for Pediatric Appendicitis|CT Scan Using IV Contrast Alone for Pediatric Appendicitis|Completed||N/A|250|Actual|University of Rochester||1|||f||||f||||||||||2017-02-18 14:08:35.186737|2017-02-18 14:08:35.186737
NCT00716690|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2016-02-18|||July 2008||2008-07-01|February 2016|2016-02-01|June 2020|Anticipated|2020-06-01|January 2020|Anticipated|2020-01-01||Interventional|||Multi Donor Mismatched Stem Cell Transplantation (MDT)|Enhancement of Hematopoietic Stem Cell Engraftment by Multi Donor Stem Cell Transplantation (MDT) From 2 Mismatched Donors, a Phase I-II Open Study|Recruiting||Phase 1/Phase 2|10|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 14:08:35.296232|2017-02-18 14:08:35.296232
NCT00716677|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-12-31|||October 2009||2009-10-01|December 2012|2012-12-01|December 2010|Anticipated|2010-12-01|October 2010|Anticipated|2010-10-01||Observational|||Dysfunctional Breathing in Difficult Asthma.|Ambulatory Respiratory Inductance Plethysmography (RIP). Can it be Used to Help Identify Dysfunctional Breathing in Difficult Asthma?|Withdrawn||N/A|0|Actual|Royal Brompton & Harefield NHS Foundation Trust|||2|Life shirt technology no longer available|f||||f||||||||||2017-02-18 14:08:35.411536|2017-02-18 14:08:35.411536
NCT00716664|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2009-03-10|||March 2007||2007-03-01|July 2008|2008-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Do Musculoskeletal Techniques Improve Forced Expiratory Volume in One Second in Adults With Cystic Fibrosis?|Pilot Study: Do Physiotherapy Musculoskeletal Techniques Improve Forced Expiratory Volume in One Second in Adults With Cystic Fibrosis?|Completed||N/A|20|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 14:08:35.505719|2017-02-18 14:08:35.505719
NCT00716651|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2012-06-14|||July 2008||2008-07-01|June 2012|2012-06-01||||July 2010|Actual|2010-07-01||Interventional|MEPOCHUSS||Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome|A Phase II, Single Center Open Label, Prospective Trial to Evaluate the Efficacy and Safety of Mepolizumab for Patients With Refractory or Relapsing Churg Strauss Syndrome|Completed||Phase 2|10|Actual|University of Schleswig-Holstein||1|||f||||t||||||||||2017-02-18 14:08:35.612544|2017-02-18 14:08:35.612544
NCT00716638|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-10-31|||July 2008||2008-07-01|October 2013|2013-10-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Trauma-focused CBT Versus EMDR in the Treatment of Posttraumatic Stress Disorder|Trauma-focused CBT vs. EMDR in the Treatment of Posttraumatic Stress Disorder|Unknown status|Recruiting|Phase 2/Phase 3|90|Anticipated|VU University of Amsterdam||2|||f||||f||||||||||2017-02-18 14:08:35.695644|2017-02-18 14:08:35.695644
NCT00716625|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2016-11-17|2016-08-29||June 2008||2008-06-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational||In total, 1674 participants were enrolled in the study. Of the 1674 participants, 1 participant was excluded from the baseline analysis because the safety was not assessable.|Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)|Special Investigation For RCC Of Sutent (Regulatory Post Marketing Commitment Plan).|Completed||N/A|1674|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:08:35.879404|2017-02-18 14:08:35.879404
NCT00716612|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-01-24|||January 2009||2009-01-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|COSMIC||Does Coenzyme Q 10 Supplementation Reduce Muscle Pain Caused by Statins? (Cholesterol Lowering Medications)|Effect of Coenzyme Q 10 Supplementation on Myalgia Induced by HMG-CoA Reductase Inhibitors|Completed||N/A|37|Actual|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 14:08:37.073066|2017-02-18 14:08:37.073066
NCT00716599|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-15|||January 2008||2008-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Training in Fever Case Management With Rapid Diagnostic Tests (RDTs) for Malaria in Uganda|Effectiveness and Safety of Training in Fever Case Management Incorporating Rapid Diagnostic Tests (RDTs) for Malaria at Peripheral Health Centers in Uganda|Completed||N/A|14000|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:08:37.182612|2017-02-18 14:08:37.182612
NCT00716586|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2014-12-12|||October 2005||2005-10-01|December 2014|2014-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration|Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration|Unknown status|Recruiting|Phase 4|70|Anticipated|University of Illinois at Chicago||1|||f||||f||||||||||2017-02-18 14:08:37.286134|2017-02-18 14:08:37.286134
NCT00716573|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-03-08|||July 2008||2008-07-01|December 2010|2010-12-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|COREV||Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure|COREV : A Multi-center, Randomized, Open-label Study Evaluating the Efficacy on Renal Function of Everolimus in Heart Transplant Recipients With Established Chronic Renal Failure|Unknown status|Active, not recruiting|Phase 4|206|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 14:08:37.393836|2017-02-18 14:08:37.393836
NCT00716560|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2016-10-19|||May 2005||2005-05-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin|Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin|Terminated||N/A|8|Actual|Thomas Jefferson University|||1|Administratively terminated.|f||||f||||||||||2017-02-18 14:08:37.507019|2017-02-18 14:08:37.507019
NCT00716547|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2009-10-15|||May 2008||2008-05-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA)|Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Study of Safety and Efficacy of Two Dosages of Epicutaneously Applied Diractin® (Ketoprofen in Transfersome® Gel) for the Treatment of Osteoarthritis of the Knee|Completed||Phase 3|1399|Actual|IDEA AG||4|||f||||f||||||||||2017-02-18 14:08:37.620234|2017-02-18 14:08:37.620234
NCT00716534|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-04-19||2013-04-04|June 2008||2008-06-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)|A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of Carboplatin/Paclitaxel in Combination With ABT-869 Versus Carboplatin/Paclitaxel Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) as First-Line Treatment|Completed||Phase 2|145|Actual|AbbVie||3|||f||||||||||||||2017-02-18 14:08:37.739843|2017-02-18 14:08:37.739843
NCT00716521|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2009-04-22|||July 2008||2008-07-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers|Subject- And Investigator-Blinded, Sponsor-Open, Randomized, Single-Dose, Placebo-Controlled, 3-Way Crossover Study To Study Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers|Completed||Phase 1|11|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:08:37.87497|2017-02-18 14:08:37.87497
NCT00716508|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2013-09-17|||September 2008||2008-09-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Surgical Treatment for Acute Patella Tendon Rupture|Surgical Treatment for Acute Patella Tendon Rupture: a Prospective, Randomized Study Comparing Transpatellar Suture Tunnels Method vs. Suture Anchors.|Terminated||Phase 4|3|Actual|Emory University||2||Our PI left our institutions as we could not longer continue.|f||||f||||||||||2017-02-18 14:08:37.976021|2017-02-18 14:08:37.976021
NCT00716495|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2016-04-21|||June 2008||2008-06-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Pharmacodynamic Study of a New Formulation, AGI - 101H Vaccine in the Treatment of Advanced Melanoma|A Phase I/IIa, Open-label Bridging Safety and Pharmacodynamic Study of a New Formulation of 6 Month Extended Dosing With AGI - 101H Vaccine in the Treatment of Patients With Advanced Melanoma|Terminated||Phase 1/Phase 2|5|Actual|AGIRx Ltd.||1||problems in funding|f||||t||||||||||2017-02-18 14:08:38.071835|2017-02-18 14:08:38.071835
NCT00716482|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-09-02|2013-04-04||July 2008||2008-07-01|September 2013|2013-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|BE1|"There were 1681 started participants and 1562 completed participants. Reasons for rejected participants are listed in participant flow section"|Ultrasound Elastography of Breast Lesions|Assessment of the Clinical Value of SuperSonic Shear Wave Elastography in the Ultrasonic Evaluation of Breast Lesions|Completed||N/A|1681|Actual|SuperSonic Imagine|"follow up on BI-RADS 2 lesions was not performed~operators knew the BI-RADS score of the lesion before performing SWE~more BI-RADS 3 and 4 lesions were recruited because of the study design"||1||f||||f||||||||||2017-02-18 14:08:38.177614|2017-02-18 14:08:38.177614
NCT00716469|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2015-04-14|||July 2008||2008-07-01|April 2015|2015-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|PDT||Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas|Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using Intratumoral Delivery of Non-coherent Light for Photoactivation of LS11 in Children With Plexiform Neurofibromas|Terminated||Phase 1|7|Actual|Children's Hospital of Philadelphia||1||The study is terminated due to expiration of study materials.|f||||t||||||||||2017-02-18 14:08:38.640894|2017-02-18 14:08:38.640894
NCT00716456|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2015-04-13|2015-03-31||July 2008||2008-07-01|April 2015|2015-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||"Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed Acquired Resistance to Erlotinib"|"A Phase I/II Trial of Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed Acquired Resistance to Erlotinib"|Completed||Phase 1/Phase 2|21|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:08:38.753127|2017-02-18 14:08:38.753127
NCT00716443|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2012-09-21|2009-09-25||July 2008||2008-07-01|September 2012|2012-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections|Open-Label, Randomized, Split-Face Study to Evaluate the Efficacy, Safety and Subject Satisfaction of Pain Management During and After Restylane® Dermal Filler Injections for the Correction of Nasolabial Folds|Terminated||Phase 4|51|Actual|Galderma Laboratories, L.P.||2||Sponsor decision|f||||f||||||||||2017-02-18 14:08:39.2722|2017-02-18 14:08:39.2722
NCT00716430|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2008-07-15|||August 2007||2007-08-01|July 2008|2008-07-01|February 2009|Anticipated|2009-02-01|December 2008|Anticipated|2008-12-01||Interventional|EQUIP-ACS||European Quality Improvement Programme for Acute Coronary Syndromes|Improving the Management of Non-ST Elevation Acute Coronary Syndrome: Systematic Evaluation of a Quality Improvement Programme|Unknown status|Recruiting|N/A|3500|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 14:08:42.187264|2017-02-18 14:08:42.187264
NCT00716209|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2014-03-03|||September 2012||2012-09-01|March 2014|2014-03-01||||December 2014|Anticipated|2014-12-01||Observational|||Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers|Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers|Unknown status|Active, not recruiting|N/A|||National University Hospital, Singapore|||1||f||||||||||||||2017-02-18 14:08:47.070544|2017-02-18 14:08:47.070544
NCT00716417|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2014-06-03|2013-08-08||July 2008||2008-07-01|August 2013|2013-08-01||||July 2010|Actual|2010-07-01||Interventional|||Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours|A Phase Ib Open Label Study to Assess the Safety, Tolerability and Pharmacokinetics of Continuous Dosing With BIBW 2992 Combined With Two Different Regimens of Backbone Chemotherapy: Cisplatin Combined With 5 Fluorouracil and Cisplatin Combined With Paclitaxel in Patients With Advanced Solid Tumors.|Completed||Phase 1|47|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:08:42.547123|2017-02-18 14:08:42.547123
NCT00716404|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2010-02-03|||April 2008||2008-04-01|February 2010|2010-02-01||||||||Observational|PROVIDE||Post-Market Observational Study of Intra-Renal Drug Delivery|Post-Market Observational Study of Intra-Renal Drug Delivery|Withdrawn||N/A|1000|Anticipated|FlowMedica, Inc.|||1|FlowMedica was purchased by AngioDynamics. Study will be re-started by AngioDynamics.|f||||f||||||||||2017-02-18 14:08:45.429704|2017-02-18 14:08:45.429704
NCT00716391|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2011-02-12|||July 2008||2008-07-01|February 2011|2011-02-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer.|Open Label Randomized, Multi-centre Phase III Trial of TPF Plus Conc. Treatment With Cisplatin and Radiotherapy Versus Conc. Cetuximab and Radiotherapy in Locally Advanced, Unresectable Head and Neck Cancer.|Unknown status|Recruiting|Phase 3|458|Anticipated|Grupo Español de Tratamiento de Tumores de Cabeza y Cuello||2|||f||||f||||||||||2017-02-18 14:08:45.540791|2017-02-18 14:08:45.540791
NCT00716378|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2017-01-24|||July 11, 2008||2008-07-11|November 15, 2010|2010-11-15|November 15, 2010|Actual|2010-11-15|November 15, 2010|Actual|2010-11-15||Interventional|||Teenage Passenger Influences on Driving Performance of Teenage Drivers|Teenage Passenger Influences on the Simulated Driving Performance of Teenage Drivers|Completed||N/A|36|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:08:45.688818|2017-02-18 14:08:45.688818
NCT00716365|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2011-08-15|||January 2008||2008-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|January 2009|Actual|2009-01-01||Interventional|USF-Hemostasis||USF Hemostasis: USage of HemCon for Femoral Hemostasis After Percutaneous Procedures|USF Hemostasis: USage of HemCon for Femoral Hemostasis After Percutaneous|Completed||Phase 4|278|Actual|Meir Medical Center||1|||f||||||||||||||2017-02-18 14:08:45.770356|2017-02-18 14:08:45.770356
NCT00716352|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2008-07-15|||March 2004||2004-03-01|July 2008|2008-07-01|November 2005|Actual|2005-11-01|||||Interventional|||Prospective Registry of Outcomes and Management of Acute Ischaemic Syndromes|Prospective Registry of Outcomes and Management of Acute Ischaemic Syndromes|Completed||N/A|1340|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||||||||||||2017-02-18 14:08:45.879436|2017-02-18 14:08:45.879436
NCT00716339|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-14||||||July 2008|2008-07-01||||||||Interventional|||Pseudophakic Accommodation||Completed||N/A|40||Medical University of Vienna||2|||f||||||||||||||2017-02-18 14:08:46.206029|2017-02-18 14:08:46.206029
NCT00716326|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-12-17|||January 2007||2007-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||The Use of Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Pain of Predominantly Peripheral Neuropathic Origin|The Use of Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Pain of Predominantly Peripheral Neuropathic Origin|Completed||N/A|115|Anticipated|Norwegian Fund for Postgraduate Training in Physiotherapy||2|||f||||f||||||||||2017-02-18 14:08:46.296698|2017-02-18 14:08:46.296698
NCT00716313|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-15|||December 2007||2007-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:08:46.396458|2017-02-18 14:08:46.396458
NCT00716300|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2009-02-17|||July 2008||2008-07-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Observational|||High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome|Functional Studies of High Density Lipoprotein in the Metabolic Syndrome|Unknown status|Recruiting|N/A|30|Anticipated|The University of Western Australia|||2||f||||t||||||Samples With DNA|"~     DNA plasma~   "|||2017-02-18 14:08:46.444851|2017-02-18 14:08:46.444851
NCT00716287|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2014-01-13|||March 2007||2007-03-01|January 2014|2014-01-01||||December 2014|Anticipated|2014-12-01||Observational|||Characterisation of Gene Variants in the Angiogenic Pathway|Characterisation of Gene Variants in the Angiogenic Pathway|Unknown status|Active, not recruiting|N/A|||National University Hospital, Singapore|||1||f||||||||||||||2017-02-18 14:08:46.526697|2017-02-18 14:08:46.526697
NCT00716274|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2016-08-24|||September 2008||2008-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Effects of Atomoxetine on Brain Activation During Attention and Reading Tasks in Patients With ADHD & Comorbid Dyslexia|Neurophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Dyslexia: Functional Magnetic Resonance Imaging (fMRI) Measures of Brain Activation During Attention and Reading Tasks Pre- and Post-Atomoxetine Treatment|Completed||Phase 4|110|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:08:46.600817|2017-02-18 14:08:46.600817
NCT00716261|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-15|||January 2008||2008-01-01|July 2008|2008-07-01|November 2009|Anticipated|2009-11-01|September 2009|Anticipated|2009-09-01||Interventional|||Bio-Feedback to Improving Stability in Elderly Population|Using Bio-Feedback for Improving Stability in Walking and Everyday Activity|Unknown status|Active, not recruiting|N/A|||Tel-Aviv Sourasky Medical Center|||||f||||t||||||||||2017-02-18 14:08:46.717248|2017-02-18 14:08:46.717248
NCT00716248|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-01-04|||January 2007||2007-01-01|September 2009|2009-09-01||||December 2011|Anticipated|2011-12-01||Interventional|||Bucillamine Study of Holding Remission After Infliximab Dose-off|The Bucillamine Study of Holding Remission After Infliximab Dose-off in Patients With Rheumatoid Arthritis Receiving Methotrexate|Unknown status|Active, not recruiting|Phase 4|40|Anticipated|Saitama Medical University||2|||f||||||||||||||2017-02-18 14:08:46.806157|2017-02-18 14:08:46.806157
NCT00716235|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2009-01-15|||January 2009||2009-01-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities|Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities|Unknown status|Recruiting|N/A|160|Anticipated|Sheba Medical Center|||4||f||||f||||||||||2017-02-18 14:08:46.896724|2017-02-18 14:08:46.896724
NCT00716222|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2009-01-20|||May 2008||2008-05-01|January 2009|2009-01-01|May 2009|Anticipated|2009-05-01|||||Observational|SOM||Hormonal and Metabolic Consequences of Sleep Disorders in Young Obese Patients|Hormonal and Metabolic Consequences of Sleep Disorders in Young Obese Patients|Unknown status|Recruiting|N/A|70|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||3||f||||t||||||||||2017-02-18 14:08:46.990041|2017-02-18 14:08:46.990041
NCT00716196|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2012-09-11|||March 2005||2005-03-01|September 2012|2012-09-01|July 2008|Actual|2008-07-01|April 2007|Actual|2007-04-01||Observational|||A Prospective Study of Thin Prep Versus Papanicolau in Suspected Malignant Lesions During Endoscopic Ultrasound (EUS)|A Prospective Study of Thin Prep Versus Papanicolau in Suspected Malignant Lesions During EUS|Completed||N/A|||Indiana University|||1||f||||f||||||||||2017-02-18 14:08:47.153408|2017-02-18 14:08:47.153408
NCT00716183|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2009-05-22|||July 2008||2008-07-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|July 2008|Actual|2008-07-01||Interventional|||Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis|Phase 2/3 Evaluation of Three Lactobacilli Strains Isolated From Human Milk for the Treatment of Infectious Mastitis During the Lactation Period|Completed||Phase 2/Phase 3|300|Actual|Universidad Complutense de Madrid||4|||f||||t||||||||||2017-02-18 14:08:47.23228|2017-02-18 14:08:47.23228
NCT00716170|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-11-27|||July 2008||2008-07-01|April 2009|2009-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia|The Role of GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia|Completed||N/A|10|Actual|Herlev Hospital|||1||f||||t||||||Samples With DNA|"~     Blood plasma and leucocytes~   "|||2017-02-18 14:08:47.340863|2017-02-18 14:08:47.340863
NCT00716157|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2014-12-03|||October 2004||2004-10-01|December 2014|2014-12-01|September 2011|Actual|2011-09-01|August 2008|Actual|2008-08-01||Observational|||Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation|A Prospective Study to Evaluate the Incidence and Patterns of Nausea and Vomiting in Patients Receiving Combined Chemotherapy and Radiation|Completed||N/A|40|Anticipated|Thomas Jefferson University|||1||f||||f||||||||||2017-02-18 14:08:47.456192|2017-02-18 14:08:47.456192
NCT00716144|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2011-09-23|||June 2006||2006-06-01|September 2011|2011-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis|A Randomized, Evaluator-Blind, Placebo-Controlled, Parallel-Group Dose-Ranging Study of the Safety and Efficacy of Oral R115866 and R115866 Placebo in the Treatment of Plaque Psoriasis|Completed||Phase 2|176|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 14:08:47.551988|2017-02-18 14:08:47.551988
NCT00716131|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2017-01-05|||April 2007||2007-04-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Amyotrophic Lateral Sclerosis (ALS) Tissue Donation Program|ALS Tissue Donation Program|Completed||N/A|205|Actual|Drexel University|||4||f||||f||||||Samples With DNA|"~     Blood (Serum and DNA) Urine (Serum and DNA) CSF Blood specimens and tissue specimens (from~     brain, spinal cord, gastrointestinal tract, skeletal muscle and peripheral nerve)~   "|No|The purpose of this protocol is to collect and bank tissue specimens.|2017-02-18 14:08:47.816748|2017-02-18 14:08:47.816748
NCT00716118|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2011-01-05|||July 2008||2008-07-01|January 2011|2011-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|WCFC||Oocyte Cryopreservation: The Impact of Cryopreservation on the Meiotic Spindle and Mitochondria of Human Oocytes.|Oocytes Cryopreservation: The Impact of Cryopreservation on the Meiotic Spindle and Mitochondria of Human Oocytes.|Completed||N/A|20|Anticipated|West Coast Fertility Centers|||1||f||||t||||||||||2017-02-18 14:08:47.913216|2017-02-18 14:08:47.913216
NCT00716105|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2015-05-18|||August 2008||2008-08-01|October 2014|2014-10-01|February 2015|Actual|2015-02-01|July 2010|Actual|2010-07-01||Interventional|||Effect of the Level of Dietary Protein on Infant Growth|Effect of the Level of Dietary Protein on Infant Growth and Body Composition in the First Year of Life|Completed||N/A|405|Actual|Nestlé||3|||f||||f||||||||||2017-02-18 14:08:48.010746|2017-02-18 14:08:48.010746
NCT00716092|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2014-06-18|2011-05-13||July 2008||2008-07-01|January 2014|2014-01-01||||November 2008|Actual|2008-11-01||Interventional|||The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients|A 4-week, Randomized, Double Blind, Double Dummy, Placebo Controlled, Parallel Group Study Comparing the Influence of BI 1356 (5 mg) and Sitagliptin (100 mg) Administered Orally Once Daily on Various Biomarkers in Type 2 Diabetic Patients|Completed||Phase 2|121|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 14:08:48.113632|2017-02-18 14:08:48.113632
NCT00716079|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-11-19|2013-08-21||September 2008||2008-09-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|INTERACT2||The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial|An International Randomised Controlled Trial to Establish the Effects of Early Intensive Blood Pressure Lowering in Patients With Intracerebral Haemorrhage.|Completed||N/A|2839|Actual|The George Institute||2|||f||||t||||||||||2017-02-18 14:08:48.900902|2017-02-18 14:08:48.900902
NCT00716066|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2017-02-07|||June 2008||2008-06-01|February 2017|2017-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy|High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + Thymoglobulin Followed by Syngeneic or Autologous Hematopoietic Cell Transplantation for Patients With Autoimmune Neurologic Diseases|Recruiting||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 14:08:49.773148|2017-02-18 14:08:49.773148
NCT00716053|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2010-01-14|||December 2008||2008-12-01|January 2010|2010-01-01|December 2009||2009-12-01|December 2009||2009-12-01||Interventional|||Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema|Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema|Withdrawn||Phase 3|225|Anticipated|Aeris Therapeutics||2|||f||||t||||||||||2017-02-18 14:08:49.940504|2017-02-18 14:08:49.940504
NCT00716040|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-15|||March 2008||2008-03-01|July 2008|2008-07-01|November 2008|Anticipated|2008-11-01|September 2008|Anticipated|2008-09-01||Interventional|SPIAH-Q||Social-Psychological Intervention to Improve Adherence to HAART|Effectiveness of a Social-Psychological Intervention to Improve Adherence to Antiretroviral Drug Regimens for AIDS: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|121|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 14:08:50.034587|2017-02-18 14:08:50.034587
NCT00716027|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2010-09-28|||July 2008||2008-07-01|July 2008|2008-07-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Applying Social Comparison Theory to Behavioral Weight Loss: Does Modifying Group Membership Improve Outcome?|Applying Social Comparison Theory to Behavioral Weight Loss: Does Modifying Group Membership Improve Outcome?|Completed||N/A|80|Anticipated|The Miriam Hospital||2|||f||||t||||||||||2017-02-18 14:08:50.137827|2017-02-18 14:08:50.137827
NCT00006323|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-02|2016-05-12|||September 1999||1999-09-01|March 2005|2005-03-01|July 2004|Actual|2004-07-01|||||Observational|||Neurobehavioral Consequences of Sleep Apnea in Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:57.646532|2017-02-18 18:12:57.646532
NCT00716014|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-15|2008-11-18|||January 2008||2008-01-01|November 2008|2008-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita|A Single-Center, Placebo-Controlled, Rising Dose to Tolerance and Safety Study of TD101, an siRNA Designed for Treatment of Pachyonychia Congenita|Completed||Phase 1|1|Anticipated|Pachyonychia Congenita Project||2|||f||||t||||||||||2017-02-18 14:08:50.232268|2017-02-18 14:08:50.232268
NCT00716001|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2008-07-11|||July 2008||2008-07-01|July 2008|2008-07-01||||June 2009|Anticipated|2009-06-01||Interventional|||Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure||Unknown status|Not yet recruiting|Phase 4|||Osaka General Medical Center||2|||f||||f||||||||||2017-02-18 14:08:50.330383|2017-02-18 14:08:50.330383
NCT00715988|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2014-01-11|||October 2007||2007-10-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|September 2012|Actual|2012-09-01||Interventional|||Methadone Pharmacokinetics and Cardiac Effects in Newborns|Safety and Single Dose Population Pharmacokinetics and Bioavailability of Methadone and Its Enantiomers in Newborns and Young Infants At 29-48 Weeks Post Menstrual Age|Unknown status|Active, not recruiting|Phase 1|4|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 14:08:50.41082|2017-02-18 14:08:50.41082
NCT00715975|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2010-08-31|||July 2008||2008-07-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|halobetasol||Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis|Clinical Trial of Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis Plate, and as Comparator the Product Psorex (Clobetasol Propionate).|Completed||Phase 2/Phase 3|140|Anticipated|Azidus Brasil||2|||f||||f||||||||||2017-02-18 14:08:50.516934|2017-02-18 14:08:50.516934
NCT00715962|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-02-23|2016-01-22||January 2010||2010-01-01|February 2016|2016-02-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional||Participants were 100 patients aged 65 years or older admitted to the medical wards of the Birmingham Veterans Affairs Medical Center (BVAMC).|Efficacy and Safety of a Hospital Walking Program for Older Adults|Efficacy and Safety of a Hospital Walking Program for Older Adults|Completed||Phase 2|100|Actual|VA Office of Research and Development|Study may not be generalizable as subjects mostly male and not demented or delirious. Study sample is small and needs to be replicated in a larger cohort.|2|||f||||t||||||||Yes|Persons interested in obtaining the dataset will be asked to complete a data sharing agreement and procure IRB approval from their institution. At that time a de-identified dataset will be provided to them.|2017-02-18 14:08:50.625556|2017-02-18 14:08:50.625556
NCT00715949|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2015-04-14|2013-07-29||December 2005||2005-12-01|April 2015|2015-04-01|June 2014|Actual|2014-06-01|December 2007|Actual|2007-12-01||Observational|||Neurocognitive Evaluation of Mild Traumatic Brain Injury in the Hospitalized Pediatric Population|Neurocognitive Evaluation of Minor Traumatic Brain Injury in the Hospitalized Pediatric Population|Completed||N/A|120|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 14:08:51.661456|2017-02-18 14:08:51.661456
NCT00715936|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2011-07-06|||July 2009||2009-07-01|December 2010|2010-12-01|April 2012|Anticipated|2012-04-01|March 2012|Anticipated|2012-03-01||Interventional|PEDS||The Pakistan Early Childhood Development Scale Up Trial|Phase 1 Study on the Integration of Early Childhood Interventions in a Primary Care Health Service in Sindh, Pakistan|Unknown status|Recruiting|Phase 2/Phase 3|1500|Anticipated|Aga Khan University||4|||f||||t||||||||||2017-02-18 14:08:51.884843|2017-02-18 14:08:51.884843
NCT00715923|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2015-12-01|||November 2007||2007-11-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Modified Consent Form Utility|CTSA Utility of Modified Consent Forms in Clinical Research: Fraga Tea Study|Terminated||N/A|30|Anticipated|University of California, Davis||2||funding|f||||f||||||||||2017-02-18 14:08:51.988108|2017-02-18 14:08:51.988108
NCT00715910|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2014-11-20|2014-04-25||July 2008||2008-07-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional||The overall number of baseline subjects correspond to the subjects at Year 1 persistence phase and another cohort of subjects (naive control group) which was offered a dose of Nimenrix vaccine at Year 5 within the same study.|The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults|Long-term Antibody Persistence of GSK Biologicals' MenACWY-TT Vaccine Versus Menactra® in Healthy Adolescents/Adults Aged 10-25 Years and Booster Response to MenACWY-TT Vaccine Administered at 5 Years Post-primary Vaccination|Completed||Phase 2|818|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-02-18 14:08:52.097488|2017-02-18 14:08:52.097488
NCT00715897|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2011-12-23|||August 2008||2008-08-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|October 2010|Actual|2010-10-01||Interventional|||Hyperbaric Oxygen Therapy Induced Neuroplasticity in Post Stroke Patients Suffering Chronic Neurological Deficiencies||Completed||N/A|74|Actual|Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-02-18 14:08:53.474611|2017-02-18 14:08:53.474611
NCT00715884|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2013-12-17|2011-02-25||July 2008||2008-07-01|December 2013|2013-12-01|September 2014|Anticipated|2014-09-01|March 2010|Actual|2010-03-01||Interventional|ELITE||Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems|A Prospective, Single-Blind, Randomized, Multi-Center Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE).|Unknown status|Active, not recruiting|N/A|678|Actual|Cordis Corporation|The study was terminated early by the Sponsor for business reasons. Hence the data was under powered for hypothesis testing. No definitive conclusions can be made from this data.|2|||f||||t||||||||||2017-02-18 14:08:53.591766|2017-02-18 14:08:53.591766
NCT00715871|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-11-17|||February 2008||2008-02-01|November 2014|2014-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Clinical Study of Smoke-Break Liquid Cigarettes|Phase II Study to Measure Effectiveness and to Monitor Side Effects of Smoke-Break Nicotine Delivery Device|Completed||Phase 2|52|Actual|Smoke-Break, Inc.||1|||f||||f||||||||||2017-02-18 14:08:54.804773|2017-02-18 14:08:54.804773
NCT00715858|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2009-02-03|||May 2008||2008-05-01|February 2009|2009-02-01|October 2009|Anticipated|2009-10-01|August 2009|Anticipated|2009-08-01||Interventional|||A Pilot Study of Inflammatory Markers in Alzheimer's Disease|A Pilot Study Comparing Inflammatory Biomarkers in Blood and CSF in Patients With Alzheimer's Disease and Age-Matched Controls|Unknown status|Recruiting|Phase 3|21|Anticipated|McMaster University||5|||f||||f||||||||||2017-02-18 14:08:54.917391|2017-02-18 14:08:54.917391
NCT00715650|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-02-10|2014-10-06||December 2008||2008-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|June 2012|Actual|2012-06-01||Interventional|||Benefits Counseling to Preserve Function Among Disability Applicants|Benefits Counseling to Preserve Function Among Disability Applicants|Completed||Phase 2|92|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:08:58.014677|2017-02-18 14:08:58.014677
NCT00715845|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-10-25|||April 2008||2008-04-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|April 2010|Actual|2010-04-01||Interventional|||Carbon Dioxide Insufflation on Cerebral Microemboli|Effects of Carbon Dioxide Insufflation on Cerebral Microemboli During Cardiopulmonary Bypass: A Randomised Trial Correlating Embolic Load & Neurologic Outcomes.|Terminated||Phase 2/Phase 3|20|Actual|University Health Network, Toronto||1||ran out of funding|f||||f||||||||||2017-02-18 14:08:55.039288|2017-02-18 14:08:55.039288
NCT00715832|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2009-08-25|||May 2008||2008-05-01|August 2009|2009-08-01|February 2015|Anticipated|2015-02-01|February 2010|Anticipated|2010-02-01||Interventional|||A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer|A Phase I Vaccine Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer|Unknown status|Recruiting|Phase 1|25|Anticipated|Southern Cancer Center||1|||f||||t||||||||||2017-02-18 14:08:55.154457|2017-02-18 14:08:55.154457
NCT00715819|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2009-02-17|||April 2008||2008-04-01|February 2009|2009-02-01||||December 2009|Anticipated|2009-12-01||Observational|||Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma|Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma|Unknown status|Recruiting|N/A|30|Anticipated|Stanford University|||||f||||||||||||||2017-02-18 14:08:55.25518|2017-02-18 14:08:55.25518
NCT00715806|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2011-06-21|||June 2008||2008-06-01|November 2009|2009-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|CLAUSTRO||Claustrophobia and Magnetic Resonance Imaging|Reduction of Claustrophobia During Magnetic Resonance Imaging: Randomized, Controlled Trial|Completed||N/A|174|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 14:08:55.340883|2017-02-18 14:08:55.340883
NCT00715793|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-08-12|||June 2008||2008-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|May 2015|Actual|2015-05-01||Interventional|UPCI-07-008||Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma|Phase I/II Trial of the Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|39|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:08:55.555376|2017-02-18 14:08:55.555376
NCT00715780|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2016-11-04|||June 2008||2008-06-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents|Observational Safety and Efficacy Study in Subjects Using Insulin for the Treatment of Type 2 Diabetes Mellitus Failing on Oral Anti-diabetic Agents|Completed||N/A|1667|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:08:55.667029|2017-02-18 14:08:55.667029
NCT00715767|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2010-10-13|||January 2009||2009-01-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|BLSinBotswana||Basic Life Support (BLS) and Barriers to Cross-Cultural Education|Correlation of Cognitive and Technical Skills Assessment for Basic Life Support and Identification of Barriers to Cross-Cultural Education|Completed||N/A|215|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 14:08:55.784523|2017-02-18 14:08:55.784523
NCT00715754|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2015-05-01|2009-07-21||September 2006||2006-09-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|FEMA||Antecedents of Obesity: Fetal Measures of Adiposity|"Antecedents of Obesity: Fetal Measures of Adiposity, A Plan for Obesity Disaster Management"|Completed||N/A|47|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 14:08:55.870457|2017-02-18 14:08:55.870457
NCT00715741|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2010-02-02|2009-08-11||June 2008||2008-06-01|February 2010|2010-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Does High Intraoperative Inspired Oxygen Reduce Postoperative Arterial Oxygen Saturation?|Does High Intraoperative Inspired Oxygen Reduce Postoperative Arterial Oxygen Saturation?|Completed||Phase 2/Phase 3|100|Actual|University of Utah|This data for this outcome measure is identical|4|||f||||f||||||||||2017-02-18 14:08:56.071948|2017-02-18 14:08:56.071948
NCT00715728|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2009-06-18|||June 2008||2008-06-01|June 2009|2009-06-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Efficacy of Warming Device During Surgery|Efficacy of a New Intraoperative Resistive Warming Device|Unknown status|Recruiting|N/A|30|Anticipated|Outcomes Research Consortium|||2||f||||f||||||||||2017-02-18 14:08:56.707734|2017-02-18 14:08:56.707734
NCT00715715|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2012-04-18|||April 2008||2008-04-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients|A Pilot Study of Adefovir Dipivoxil Alone and After Prednisone Priming for the Treatment of Asian Patients With HBeAg-positive Chronic Hepatitis B|Withdrawn||N/A|0|Actual|Maimonides Medical Center||2||Withdrawn studies.|f||||f||||||||||2017-02-18 14:08:56.790118|2017-02-18 14:08:56.790118
NCT00715702|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2009-04-28|||July 2008||2008-07-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety Study of AZD5672 in Renally Impaired Subjects|An Open-Label, Single-Centre, Parallel Group, Phase I Study To Compare the Pharmacokinetics of AZD5672 Single Dose in Patients With Renal Impairment and Healthy Volunteers|Completed||Phase 1|40|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:08:57.049083|2017-02-18 14:08:57.049083
NCT00715689|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2017-02-06|||July 2008||2008-07-01|February 2017|2017-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083|Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC126-0083 in Growth Hormone Deficient Adults (GHDA)|Completed||Phase 2|33|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-02-18 14:08:57.153643|2017-02-18 14:08:57.153643
NCT00715676|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2009-12-07|2009-09-16||March 2007||2007-03-01|December 2009|2009-12-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|2MD-3H-2B||Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density|A Phase 2, Double-blind, Randomized, Placebo-Controlled, Daily-dose, Proof-of-concept Study of a Vitamin D Compound in Postmenopausal Women With Osteopenia|Completed||Phase 2|157|Actual|Deltanoid Pharmaceuticals||3|||f||||t||||||||||2017-02-18 14:08:57.276689|2017-02-18 14:08:57.276689
NCT00715663|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2016-12-12|||February 2007||2007-02-01|December 2016|2016-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes|A Multi-center, Prospective, Non-interventional Evaluation of Efficacy, Safety and Convenience of Using NovoMix® 30 FlexPen® as Monotherapy, or in Combination With OHA, in Treatment of Type 2 Diabetic Patients in Routine Clinical Practice: A Post-Marketing Surveillance Study|Completed||N/A|1584|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:08:57.904106|2017-02-18 14:08:57.904106
NCT00715637|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2010-10-12|||June 2007||2007-06-01|October 2010|2010-10-01||||June 2010|Anticipated|2010-06-01||Interventional|||Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study|Phase III Open-Label Randomized Study of Amonafide L-Malate in Combination With Cytarabine Compared to Daunorubicin in Combination With Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- The ACCEDE Study|Unknown status|Active, not recruiting|Phase 3|420|Anticipated|Antisoma Research||2|||f||||t||||||||||2017-02-18 14:08:58.638831|2017-02-18 14:08:58.638831
NCT00715624|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-10-14|2016-08-18||July 2008||2008-07-01|October 2016|2016-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|GETGOAL-L|Safety population included all randomized patients who were exposed to at least 1 dose of study drug, regardless of the amount of treatment administered.|GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin|A Randomized, Double-blind, Placebo-controlled, 2-arm Parallel-group, Multicenter Study With a 24-week Main Treatment Period and an Extension Assessing the Efficacy and Safety of AVE0010 in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin|Completed||Phase 3|496|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:08:58.901388|2017-02-18 14:08:58.901388
NCT00715611|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-11-23|||July 2008||2008-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma|Phase II Toxicity Study of Pleurectomy/Decortication, (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma|Recruiting||Phase 2|81|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:09:00.186937|2017-02-18 14:09:00.186937
NCT00715598|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2012-05-07|||June 2008||2008-06-01|May 2012|2012-05-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Observational|PQAS||Cognitive Testing for the Pain Quality Assessment Scale (PQAS)|Cognitive Testing for the Pain Quality Assessment Scale (PQAS)|Completed||N/A|213|Actual|University of Washington|||2||f||||f||||||||||2017-02-18 14:09:00.376923|2017-02-18 14:09:00.376923
NCT00715585|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-06-11|||June 2008||2008-06-01|June 2013|2013-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|DiNES||Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care|Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care|Completed||N/A|150|Actual|Vanderbilt University||3|||f||||t||||||||||2017-02-18 14:09:00.478729|2017-02-18 14:09:00.478729
NCT00715572|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2008-07-14|||March 2002||2002-03-01|July 2008|2008-07-01|May 2004|Actual|2004-05-01|February 2004|Actual|2004-02-01||Interventional|||Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone|Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone in the Treatment of Primary Hypothyroidism|Completed||N/A|36|Actual|I.M. Sechenov First Moscow State Medical University||2|||f||||f||||||||||2017-02-18 14:09:00.585936|2017-02-18 14:09:00.585936
NCT00715559|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2011-06-23|2011-04-18||July 2008||2008-07-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Cysteamine Therapy for Major Depressive Disorder|An Open-Label Study of Cysteamine Bitartrate in Treatment-Resistant Major Depression|Terminated||N/A|3|Actual|Murrough, James, M.D.||1||Change in resources available for study procedures.|f||||f||||||||||2017-02-18 14:09:00.681945|2017-02-18 14:09:00.681945
NCT00715546|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2011-06-21|||October 2007||2007-10-01|March 2009|2009-03-01|November 2011|Anticipated|2011-11-01|August 2011|Anticipated|2011-08-01||Interventional|AADSCTPL||Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy|Phase 1 Study of Autologous-Derived Stem Cell Transplantation in Patients With Lipodystrophy|Unknown status|Active, not recruiting|Phase 1|5|Actual|Irmandade Santa Casa de Misericórdia de Porto Alegre||1|||f||||t||||||||||2017-02-18 14:09:01.107815|2017-02-18 14:09:01.107815
NCT00715533|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2014-06-23|||July 2008||2008-07-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|1000Plus||3 Tesla (3T) Stroke Medical Radiologic Technology (MRT) for Examining Mismatch in 1000+|3T Stroke MRT for Examining Mismatch in the CSB of the Charité Universitätsmedizin Berlin (3Tesla in 1000+)|Completed||N/A|1500|Actual|Charite University, Berlin, Germany|||1||f||||f||||||||||2017-02-18 14:09:01.200338|2017-02-18 14:09:01.200338
NCT00715520|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2017-01-30|||April 2007||2007-04-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Neurobiological Principles Applied to the Rehabilitation of Stroke Patients|Neurobiological Principles Applied to the Rehabilitation of Stroke Patients|Completed||N/A|26|Actual|Emory University||3|||f||||f||||||||||2017-02-18 14:09:01.299765|2017-02-18 14:09:01.299765
NCT00715507|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-08-08|||July 2003||2003-07-01|August 2016|2016-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Evaluation of Drug Display in Critical Care Setting|Evaluation of Drug Display in Critical Care Setting|Completed||N/A|200|Anticipated|University of Utah|||2||f||||t||||||||||2017-02-18 14:09:01.427622|2017-02-18 14:09:01.427622
NCT00715494|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2015-11-04|||July 2008||2008-07-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|September 2009|Actual|2009-09-01||Interventional|RETURN||A Pilot Study of Rehabilitation Among Intensive Care Unit (ICU) Survivors: the RETURN Trial|Returning to Everyday Tasks Utilizing Rehabilitation Networks (RETURN)|Active, not recruiting||Phase 1|130|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:09:01.530804|2017-02-18 14:09:01.530804
NCT00715481|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2015-02-09|||June 2008||2008-06-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|November 2008|Actual|2008-11-01||Observational|RIACE||Renal Insufficiency And Cardiovascular Events|Reduced Estimated Glomerular Filtration Rate (eGFR)and Prediction of Cardiovascular Disease and Renal Outcome in Subjects With Type 2 Diabetes: Italian Multicenter Study|Completed||N/A|15628|Actual|Diabetic Nephropathy Study Group|||1||f||||f||||||||||2017-02-18 14:09:01.655319|2017-02-18 14:09:01.655319
NCT00715468|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2014-12-11|||August 2007||2007-08-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Observational|||Prospective, 6 Month, Open Label, Conversion Study From Mycophenolate Mofetil (MMF) to PRMYFORTIC*|Prospective, 6 Month, Open Label, Conversion Study From MMF to MYFORTIC* Evaluating the Severity of GI Symptoms and MPA Metabolite as a Surrogate Marker of MYFORTIC|Completed||N/A|59|Actual|Maisonneuve-Rosemont Hospital|||1||f||||f||||||||||2017-02-18 14:09:01.775804|2017-02-18 14:09:01.775804
NCT00714155|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-06-13|||July 2006||2006-07-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Outcomes and Patient Satisfaction After Colpocleisis for Pelvic Organ Prolapse|Outcomes and Patient Satisfaction After Colpocleisis for Pelvic Organ Prolapse|Completed||N/A|48|Actual|University of Rochester|||3||f||||f||||||||||2017-02-18 14:09:27.341999|2017-02-18 14:09:27.341999
NCT00715455|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2013-05-29|||October 2007||2007-10-01|May 2013|2013-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|REVERSAL-PCI||Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI|Phase 2a, Multi-Center, Open Label, Randomized, Feasibility/Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Subjects Undergoing Elective PCI After Pretreatment With Clopidogrel and Aspirin|Completed||Phase 2|26|Actual|Regado Biosciences, Inc.||3|||f||||t||||||||||2017-02-18 14:09:01.863061|2017-02-18 14:09:01.863061
NCT00715442|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-09-19|||June 2008||2008-06-01|September 2016|2016-09-01||||June 2018|Anticipated|2018-06-01||Interventional|||Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)|Phase II Non-Randomized Pre-Surgical Study Evaluating Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC) Who Are Eligible for Cytoreductive Nephrectomy|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:09:01.992588|2017-02-18 14:09:01.992588
NCT00715429|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-01-14|||August 2007||2007-08-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Vitamin D for Painful Nocturnal Leg Cramps|Nocturnal Leg Cramps in the Elderly: Randomized Controlled Trial of Ergocalciferol (Vitamin D2) for a Painful and Distressing Problem|Terminated||N/A|29|Actual|University of Wisconsin, Madison||2||"We exhausted potential candidates before reaching goal of 70; recruited 29, 29 completed the~   study"|f||||t||||||||||2017-02-18 14:09:02.122924|2017-02-18 14:09:02.122924
NCT00715416|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2008-07-11|||June 2004||2004-06-01|January 2006|2006-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents|Balloon Angioplasty vs. Primary Stenting of Femoropopliteal Arteries Using Self-Expandable Nitinol Stents - a Randomized Controlled Trial|Completed||Phase 4|76|Actual|Vienna General Hospital||2|||f||||f||||||||||2017-02-18 14:09:02.242613|2017-02-18 14:09:02.242613
NCT00715403|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2014-11-24|2014-11-14||October 2004||2004-10-01|November 2014|2014-11-01||||September 2009|Actual|2009-09-01||Interventional||Treated set which comprised of all patients who received at least one dose of Nintedanib in both their previous Nintedanib trial and in this extension trial|A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120|Extension Study to Establish Safety, Pharmacokinetics and Efficacy of BIBF 1120 in Patients With Previous Clinical Benefit From BIBF 1120|Completed||Phase 1|41|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:09:02.384661|2017-02-18 14:09:02.384661
NCT00715390|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2012-12-13|2009-04-03||October 2004||2004-10-01|December 2012|2012-12-01|August 2006|Actual|2006-08-01|August 2005|Actual|2005-08-01||Observational|||Dysrhythmias During General Anesthesia in Children|Dysrhythmias During General Anesthesia in Children|Completed||N/A|234|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 14:09:05.421689|2017-02-18 14:09:05.421689
NCT00715377|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2015-08-21|||June 2007||2007-06-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Anticholinergic Burden in Schizophrenia|Anticholinergic Burden in Schizophrenia|Terminated||N/A|2|Actual|Centre for Addiction and Mental Health||1||Insufficient subject accrual|f||||f||||||||||2017-02-18 14:09:05.646047|2017-02-18 14:09:05.646047
NCT00715364|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2011-09-02|||August 2009||2009-08-01|September 2011|2011-09-01|September 2010|Anticipated|2010-09-01|June 2010|Anticipated|2010-06-01||Interventional|REGENESIS||REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients|A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients|Withdrawn||Phase 2|30|Anticipated|Stem Cell Therapeutics Corp.||2|||f||||t||||||||||2017-02-18 14:09:05.754736|2017-02-18 14:09:05.754736
NCT00715351|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-11-23|||May 2007||2007-05-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes|Efficacy and Safety of Glycaemic Control of Levemir® or Insulatard® in Patients With Type 2 Diabetes|Completed||N/A|342|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 14:09:05.867464|2017-02-18 14:09:05.867464
NCT00715338|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2009-01-27|||June 2008||2008-06-01|January 2009|2009-01-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Observational|||Effects of Oxygen on Lung Tissue During Anesthesia|Effects of Oxygen on Lung Tissue During Anesthesia|Unknown status|Active, not recruiting|N/A|40|Anticipated|Vanderbilt University|||1||f||||t||||||None Retained|"~     serum~   "|||2017-02-18 14:09:05.969787|2017-02-18 14:09:05.969787
NCT00715325|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-13|2008-09-17|||October 2008||2008-10-01|September 2008|2008-09-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Interventional|||ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy|Evaluation of Safety and Efficacy of a New Colonoscope, ProtectiScope CS, to Diagnose Large Bowel Diseases|Unknown status|Not yet recruiting|Phase 1/Phase 2|200|Anticipated|Stryker GI Ltd.||1|||f||||f||||||||||2017-02-18 14:09:06.055546|2017-02-18 14:09:06.055546
NCT00715312|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2008-07-14|||February 2008||2008-02-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study|Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study.|Completed||N/A|43|Actual|Malaysia Palm Oil Board||1|||f||||f||||||||||2017-02-18 14:09:06.143916|2017-02-18 14:09:06.143916
NCT00715299|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2015-02-17|2014-12-03||June 2005||2005-06-01|February 2015|2015-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||Individuals greater than 6 months post stroke, 18-80 years of age. Subjects who have experienced more than one stroke will be accepted only if all strokes are on the same side of the brain.|Locomotor Training (Walking Therapy) Post Stroke|Mechanisms of Response to Locomotor Training After Stroke|Completed||N/A|38|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 14:09:08.648505|2017-02-18 14:09:08.648505
NCT00715286|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2008-07-14|||November 2001||2001-11-01|July 2008|2008-07-01|June 2009|Anticipated|2009-06-01|April 2007|Anticipated|2007-04-01||Interventional|||Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study|Neoadjuvant Chemotherapy (NACT) Followed by Interval Debulking Surgery vs Upfront Surgery Followed by Chemotherapy (CT) in Advanced Epithelial Ovarian Carcinoma (EOC): A Prospective Randomized Study|Unknown status|Recruiting|Phase 3|180|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 14:09:08.902086|2017-02-18 14:09:08.902086
NCT00715273|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2015-12-01|||June 2001||2001-06-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|CPC||Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication|Carotid Plaque Composition by Magnetic Resonance Imaging During Lipid Lowering Therapy|Active, not recruiting||Phase 4|217|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 14:09:08.998408|2017-02-18 14:09:08.998408
NCT00715260|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2008-07-14|||December 2007||2007-12-01|July 2008|2008-07-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Observational|ITCH Registry||An Observational Study of Pruritus Amongst Hemodialysis Patients|A Multicenter, Prospective, Observational Study of Pruritus Amongst Hemodialysis Patients: The ITCH National Registry|Unknown status|Active, not recruiting|N/A|80|Anticipated|Acologix, Inc.|||1||f||||f||||||||||2017-02-18 14:09:09.120224|2017-02-18 14:09:09.120224
NCT00715247|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-10-05|||July 2006||2006-07-01|October 2016|2016-10-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes|Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes|Recruiting||N/A|700|Anticipated|University of Utah|||2||f||||f||||||Samples With DNA|"~     Whole blood and bone marrow aspirate~   "|||2017-02-18 14:09:09.479968|2017-02-18 14:09:09.479968
NCT00715234|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-06-21|||October 2007||2007-10-01|June 2013|2013-06-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients|Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients|Completed||N/A|4807|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 14:09:09.601869|2017-02-18 14:09:09.601869
NCT00715221|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2010-04-02|||July 2007||2007-07-01|April 2010|2010-04-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Observational|||Multi-Tracer Pet Quantitation of Insulin Action|Multi-Tracer Pet Quantitation of Insulin Action|Unknown status|Recruiting|N/A|30|Anticipated|University of Pittsburgh|||3||f||||f||||||Samples Without DNA|"~     Aliquotted blood samples~   "|||2017-02-18 14:09:09.709261|2017-02-18 14:09:09.709261
NCT00715208|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2013-04-26|2012-02-03||September 2008||2008-09-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma|A Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (Bortezomib) in Combination With Rituximab, Cyclophosphamide, and Prednisone With or Without Doxorubicin Followed by Rituximab Maintenance in Patients With Relapsed Follicular Lymphoma.|Completed||Phase 2|55|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||||||||||||2017-02-18 14:09:09.80028|2017-02-18 14:09:09.80028
NCT00715195|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2013-12-18|||September 2007||2007-09-01|November 2013|2013-11-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|Aquavip||Improving Quality of Life of Fibromyalgia Patients|Evaluation of Improving Quality of Life of Fibromyalgia Patients Treated With a Plurifocal Program : a Controlled Study With 12 Months Monitoring.|Completed||N/A|115|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:09:10.73227|2017-02-18 14:09:10.73227
NCT00715182|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2013-01-15|||July 2008||2008-07-01|January 2013|2013-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer|A Phase I/II Multi-center, Open Label Study of TKI258 Administered Orally on an Intermittent Schedule in Adult Patients With Advanced or Metastatic Renal Cell Cancer (RCC)|Completed||Phase 1|87|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:09:10.843097|2017-02-18 14:09:10.843097
NCT00715169|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2008-07-14|||August 2005||2005-08-01|July 2008|2008-07-01||||April 2006|Actual|2006-04-01||Interventional|||Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease|Phase 2 A, Double-Blind, Randomized, Placebo-Controlled Trial Measuring the Effects of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease|Completed||Phase 2|108|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 14:09:10.952115|2017-02-18 14:09:10.952115
NCT00715156|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2012-02-20|||July 2008||2008-07-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|October 2009|Actual|2009-10-01||Observational|||Role of Recombinants in Peach Allergy|Classification of Different Forms of Peach Allergy and the Role of Recombinant Allergens in the Diagnosis|Completed||N/A|148|Actual|Niguarda Hospital|||2||f||||f||||||Samples With DNA|"~     Blood sample~   "|||2017-02-18 14:09:11.0307|2017-02-18 14:09:11.0307
NCT00715143|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2015-02-09|||June 2008||2008-06-01|February 2015|2015-02-01|December 2023|Anticipated|2023-12-01|December 2023|Anticipated|2023-12-01||Interventional|||Post Approval Study: NOVATION Ceramic Articulation Hip System|Post Approval Study: NOVATION Ceramic Articulation Hip System A Multi-Center, Open-Label Study to Evaluate the Mid and Long-Term Safety and Effectiveness of the Exactech NOVATION Ceramic Articulation Hip System|Recruiting||Phase 4|125|Anticipated|Exactech||1|||f||||f||||||||||2017-02-18 14:09:11.127815|2017-02-18 14:09:11.127815
NCT00715130|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2011-12-06|||September 2005||2005-09-01|December 2011|2011-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|MOVE'M||Move and Moderate in Balance|Move and Moderate in Balance (MOVE'M): A TREC Worksite Health Study|Completed||N/A|31|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 14:09:11.241357|2017-02-18 14:09:11.241357
NCT00715117|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-05-29|2011-08-04||July 2008||2008-07-01|May 2013|2013-05-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|LDN-Ped||The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease|The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease|Completed||Phase 2|14|Actual|Penn State University|This was a pseudo-crossover trial where 6 subjects received placebo for 8 wks then were crossed over to active drug for 8 wks to increase the N treated with active drug. A smaller cohort of subjects on placebo were for safety & toxicity comparison.|2|||f||||t||||||||||2017-02-18 14:09:11.342394|2017-02-18 14:09:11.342394
NCT00715104|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2015-04-14|2015-02-27||July 2008||2008-07-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|NeoACT||Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer|An Open Label, Phase 2 Trial of Immunotherapy With Sipuleucel-T (Provenge®) as Neoadjuvant Treatment in Men With Localized Prostate Cancer|Completed||Phase 2|42|Actual|Dendreon||2|||f||||t||||||||||2017-02-18 14:09:12.140195|2017-02-18 14:09:12.140195
NCT00714142|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2008-09-02|||August 2008||2008-08-01|September 2008|2008-09-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Renal Blood Flow Measurement With Positron Emission Tomography (PET)|Renal Blood Flow Measurement With PET|Unknown status|Recruiting|Phase 2|30|Anticipated|Proportional Technologies, Inc.||3|||f||||t||||||||||2017-02-18 14:09:27.432401|2017-02-18 14:09:27.432401
NCT00715091|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2014-08-22|||September 2008||2008-09-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ENRADAS||Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis|Effects of NSAIDs on RAdiographic Damage in Ankylosing Spondylitis (ENRADAS) - a Prospective Randomised Controlled Trial|Completed||Phase 4|180|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 14:09:13.296838|2017-02-18 14:09:13.296838
NCT00715078|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-04-21|2014-02-19||August 2008||2008-08-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|May 2012|Actual|2012-05-01||Interventional|ProACT||To Evaluate Sipuleucel-T Manufactured With Different Concentrations of Prostate Adenocarcinoma (PA2024) Antigen|A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen|Completed||Phase 2|122|Actual|Dendreon||3|||f||||t||||||||||2017-02-18 14:09:13.452234|2017-02-18 14:09:13.452234
NCT00715065|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-01-07|||June 2010||2010-06-01|January 2013|2013-01-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Observational|||fMRI in Blood Phobia Syncope|Neuroimaging in Blood Phobia Syncope|Withdrawn||N/A|0|Actual|Vanderbilt University|||2|Could not get funding for fMRI studies at this time.|f||||f||||||||||2017-02-18 14:09:14.876132|2017-02-18 14:09:14.876132
NCT00715052|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-14|2013-05-06|||August 2008||2008-08-01|October 2008|2008-10-01||||June 2012|Actual|2012-06-01||Interventional|||The Effect of Hyperbaric Oxygen Therapy on Patients Suffering From Neurologic Deficiency Due Traumatic Brain Injury||Completed||N/A|60|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 14:09:14.990166|2017-02-18 14:09:14.990166
NCT00715039|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2008-10-01|||October 2003||2003-10-01|October 2008|2008-10-01|May 2004|Actual|2004-05-01|||||Interventional|||Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder|A 4-Week, Double-Blind, Randomized, Multicenter, Fixed Dose, Placebo-Controlled, Parallel Group Study of Lorazepam and Paroxetine in Patients With Generalized Anxiety Disorder: Assessment of a New Instrument Intended to Capture Rapid Onset|Completed||N/A|169|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:09:15.094985|2017-02-18 14:09:15.094985
NCT00715026|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-11-25|2013-11-13||April 2009||2009-04-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Trilogy AB Acetabular Hip System Post Approval Study|Multicenter Post Approval Study of the Trilogy AB(R) Acetabular System|Terminated||Phase 4|31|Actual|Zimmer Biomet|A business decision unrelated to device performance led to the early termination of the study and withdrawal of the study device(s) from the US market. Early termination of the study limits the usefulness of the available data.|1||Sponsor business decision unrelated to clinical performance.|f||||f||||||||||2017-02-18 14:09:15.256882|2017-02-18 14:09:15.256882
NCT00715013|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2011-09-14|||July 2008||2008-07-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma|Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma Multiforme Prior to and After Secondary Resection: an Open-label Phase I/II Trial.|Completed||Phase 1/Phase 2|9|Actual|University of Zurich||1|||f||||f||||||||||2017-02-18 14:09:15.523084|2017-02-18 14:09:15.523084
NCT00715000|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2013-04-24|||July 2008||2008-07-01|April 2013|2013-04-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|SROPREMA||Oral Versus Intravenous Rehydration for Prevention of Dehydration in Premature Babies, During the First Days of Life.|Prevention of Dehydration in Premature Babies Between 32 and 34+6 Gestational Age, Weighing Between 1700 and 2200 g, During the First Days of Life, Using Oral Rehydration Solution in Alternative to Intravenous Infusion|Completed||Phase 4|49|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:09:15.625613|2017-02-18 14:09:15.625613
NCT00714987|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-09-16|||January 2009||2009-01-01|September 2009|2009-09-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Observational|||The EVLW for Set the Positive End Expiratory Pressure (PEEP) in the Acute Respiratory Distress Syndrome (ARDS)|Predictive Value of the Extra-Vascular Lung Water (EVLW) for the Alveolar Recruitment in the Acute Respiratory Distress Syndrome ( ARDS ).|Withdrawn||N/A|40|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||||||2017-02-18 14:09:15.7396|2017-02-18 14:09:15.7396
NCT00714974|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2008-07-08|||February 2000||2000-02-01|July 2008|2008-07-01|October 2007|Actual|2007-10-01|February 2003|Actual|2003-02-01||Interventional|||A Prospective, Randomized, Blinded Study of BIS Analysis in ICU Patients Requiring Neuromuscular Blocking Agents|A Prospective, Randomized, Blinded Study of BIS Analysis in ICU Patients Requiring Neuromuscular Blocking Agents|Completed||N/A|56|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 14:09:15.816941|2017-02-18 14:09:15.816941
NCT00714961|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2009-03-24|||February 2003||2003-02-01|March 2009|2009-03-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|CLARITY-TIMI28||Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction|A Randomized, Double-Blind, Placebo-Controlled Trial Comparing Clopidogrel Plus Acetylsalicylic Acid (ASA) Versus ASA Alone in Subjects With Acute ST Elevation Myocardial Infarction (STEMI) Treated With Fibrinolytic Therapy|Completed||Phase 3|3491|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:09:15.921374|2017-02-18 14:09:15.921374
NCT00714948|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2015-10-18|2015-04-14||July 2008||2008-07-01|October 2015|2015-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma|Phase II Study of Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma|Terminated||Phase 2|2|Actual|Memorial Sloan Kettering Cancer Center|Early termination leading to no subjects analyzed. Only two participants were enrolled and treated on this study. Neither completed the study as they both came off due to adverse events.|1||Lack of accrual|f||||||||||||||2017-02-18 14:09:16.061962|2017-02-18 14:09:16.061962
NCT00714935|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2015-11-03|||April 2008||2008-04-01|November 2015|2015-11-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Shared Decision-making: Effects on Cardiac Risk Factor Modification Behavior|Effects of a Decision Aid for Patients With Coronary Artery Disease on Cardiac Risk Factor Modification Behavior and Health Outcomes|Completed||N/A|363|Actual|Oslo University Hospital||3|||f||||f||||||||||2017-02-18 14:09:16.309872|2017-02-18 14:09:16.309872
NCT00714922|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2010-09-14|||October 2007||2007-10-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Comparison of Photorefractive Keratectomy (PRK) and Sub-Bowman's Keratomileusis (SBK)|Comparison of Photorefractive Keratectomy (PRK) and Sub-Bowman's Keratomileusis (SBK): Assessment of Visual Function and Patient Satisfaction|Completed||N/A|60|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 14:09:16.435939|2017-02-18 14:09:16.435939
NCT00714909|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2011-02-22|||November 2008||2008-11-01|February 2011|2011-02-01|May 2012|Anticipated|2012-05-01|November 2011|Anticipated|2011-11-01||Observational|CAVECCAS||Determination of Predictive Value of Echography Doppler Abnormalities|CAVECCAS Value of Risk Factors for Symptomatic Catheter Related Thrombosis in Patients With Breast Cancer Treated With Adjuvant Chemotherapy|Unknown status|Recruiting|N/A|600|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 14:09:16.530814|2017-02-18 14:09:16.530814
NCT00714896|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-05-25|||April 2007||2007-04-01|May 2013|2013-05-01|August 2009|Actual|2009-08-01|June 2008|Actual|2008-06-01||Interventional|INSPIRE||Interventions for Smoking Among Persons in Recovery|A Stepped-Care Intervention for Current and Former Smokers in Outpatient Chemical Dependency Treatment|Completed||N/A|75|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:09:16.628561|2017-02-18 14:09:16.628561
NCT00714883|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2012-10-24|||June 2008||2008-06-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|November 2009|Actual|2009-11-01||Interventional|NEVO RES-II||Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions|A Prospective, Multi-Center Study of the Conor Cobalt Chromium Reservoir Based Stent (NevoTM) With Sirolimus Elution in Native Coronary Artery Lesions (NEVO RES-II)|Terminated||Phase 2|3|Actual|Cordis Corporation||1||"The NEVO™ stent will not be commercialized. Cordis decided to close the study after 3 years.~   This decision took the absence of safety signals into account."|f||||t||||||||||2017-02-18 14:09:16.79503|2017-02-18 14:09:16.79503
NCT00714870|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-05-29|2013-03-28||February 2008||2008-02-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Pediatric Quality of Life Among Population With Body Mass Index (BMI) Greater Than or Equal to 85%|Pediatric Quality of Life Among Population With BMI Greater Than or Equal to 85%: Impact of a Behavioral Intervention Program|Completed||N/A|76|Actual|Steward St. Elizabeth's Medical Center of Boston, Inc.||1|||f||||t||||||||||2017-02-18 14:09:17.043442|2017-02-18 14:09:17.043442
NCT00714857|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-01-02|||October 2007||2007-10-01|January 2014|2014-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Dex-Pop-PK||Population Pharmacokinetics of Dexmedetomidine in ICU Patients|Population Pharmacokinetics of Dexmedetomidine in ICU Patients|Completed||Phase 2/Phase 3|21|Actual|University of Turku||1|||f||||f||||||||||2017-02-18 14:09:17.407856|2017-02-18 14:09:17.407856
NCT00714844|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-07|||January 2007||2007-01-01|April 2008|2008-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Insulin Detemir and Waist Circumference|Waist Circumference Reduction After Insulin Detemir Treatment in Type 2 Diabetes Patients Previously Treated With NPH Insulin|Completed||N/A|20|Actual|University of Roma La Sapienza|||1||f||||f||||||||||2017-02-18 14:09:17.502176|2017-02-18 14:09:17.502176
NCT00714831|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2008-07-11|||September 2008||2008-09-01|July 2008|2008-07-01|December 2010|Anticipated|2010-12-01|September 2010|Anticipated|2010-09-01||Interventional|||Referral From Primary Health Care Centers to a Physical Activity Program. A Randomized Controlled Trial|Referral From Primary Health Care Centers to a Physical Activity Program: Establishing Long-Term Adherence? A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|424|Anticipated|Jordi Gol i Gurina Foundation||2|||f||||t||||||||||2017-02-18 14:09:17.571217|2017-02-18 14:09:17.571217
NCT00714818|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-11-21|||August 2008||2008-08-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness|Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness: Impact on Knowledge, Risk Perception, Perceived Control and Internalized Stigma.|Completed||Phase 3|13|Actual|University of British Columbia||3|||f||||f||||||||||2017-02-18 14:09:17.672574|2017-02-18 14:09:17.672574
NCT00714805|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2017-01-05|||January 2007||2007-01-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|GIDysmotility||Non-Invasive Measurement of Gastrointestinal (GI) Motility in Patients With Amyotrophic Lateral Sclerosis (ALS)|Non-Invasive Measurement of GI Motility in Patients With ALS|Completed||N/A|41|Actual|Drexel University|||2||f||||f||||||||||2017-02-18 14:09:17.784692|2017-02-18 14:09:17.784692
NCT00714792|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2009-06-10|||June 2008||2008-06-01|June 2009|2009-06-01||||||||Observational|||Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?|Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?|Unknown status|Recruiting|N/A|20|Anticipated|University of Rochester|||2||f||||f||||||Samples Without DNA|"~     Urine specimen~   "|||2017-02-18 14:09:17.881269|2017-02-18 14:09:17.881269
NCT00714779|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-07|||January 2000||2000-01-01|July 2008|2008-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Fluoxetine vs. Brief Psychotherapy for Major Depression|Fluoxetine vs. Brief Psychotherapy in the Treatment of Major Depression - a Randomized Comparative Study|Completed||N/A|85|Actual|University of Turku||2|||f||||f||||||||||2017-02-18 14:09:17.967104|2017-02-18 14:09:17.967104
NCT00714766|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2009-02-13|||July 2008||2008-07-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Heat Stress and Volume Administration|Heat Stress and Volume Administration|Completed||N/A|10|Anticipated|Rigshospitalet, Denmark||1|||f||||t||||||||||2017-02-18 14:09:18.07737|2017-02-18 14:09:18.07737
NCT00714753|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-06-03|||August 2008||2008-08-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer|Pilot Evaluation of High Dose-Rate Brachytherapy ± Image-Guided Intensity Modulated Hypofractionated External Radiotherapy for Localized Prostate Cancer|Completed||Phase 2|5|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:09:18.16756|2017-02-18 14:09:18.16756
NCT00714740|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-05-18|||June 2008||2008-06-01|May 2014|2014-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude|Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude|Completed||Phase 4|49|Actual|University of Zurich||1|||f||||f||||||||||2017-02-18 14:09:18.266424|2017-02-18 14:09:18.266424
NCT00714727|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-07-11|||July 2008||2008-07-01|September 2009|2009-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|SPAMDA||Set Point Acupuncture for Migraines Using a Digital Assistant|Set Point Acupuncture for Migraines Using a Digital Assistant|Completed||Phase 1|50|Actual|Memorial Medical Center||1|||f||||f||||||||||2017-02-18 14:09:18.358205|2017-02-18 14:09:18.358205
NCT00713752|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-09-25|||February 2008||2008-02-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais||Completed||N/A|494|Actual|South East Asia Research Collaboration with Hawaii|||1||f||||t||||||||||2017-02-18 14:09:33.439472|2017-02-18 14:09:33.439472
NCT00714714|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2012-02-14|2009-04-01||January 2008||2008-01-01|February 2012|2012-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.|An Investigator-Blind, Phase 4 Study Assessing the Facial Irritation Potential of Two Acne Treatment Products Using a Split-Face Model|Completed||Phase 4|25|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-02-18 14:09:18.459831|2017-02-18 14:09:18.459831
NCT00714701|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2016-09-09|||June 2008||2008-06-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|CAPS4||Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)|Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)|Completed||N/A|900|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||9||f||||f||||||Samples With DNA|"~     blood, pancreatic juices~   "|||2017-02-18 14:09:18.732603|2017-02-18 14:09:18.732603
NCT00714688|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2014-04-24|2010-04-02||February 2008||2008-02-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder|A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS Methylphenidate (54 and 72 mg/Day) in Adults With Attention Deficit/Hyperactivity Disorder|Completed||Phase 3|279|Actual|Janssen-Cilag International NV|Study was not designed to statistically compare the 54 mg with the 72 mg dose. Study medication was not titrated to the assigned dose as in clinical practice. This could have differentially affected treatment emergence of AEs and patient retention.|3|||f||||f||||||||||2017-02-18 14:09:19.009038|2017-02-18 14:09:19.009038
NCT00714675|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2013-12-29|||December 2009||2009-12-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|CIPROAGE||Citrulline and Protein Metabolism in the Malnourished Elderly People|Citrulline Supplementation in Elderly Malnourished and Hospitalised Subjects: Effects on Protein Metabolism|Completed||N/A|27|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:09:19.689686|2017-02-18 14:09:19.689686
NCT00714662|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-11|||June 2008||2008-06-01|July 2008|2008-07-01|March 2009|Anticipated|2009-03-01|February 2009|Anticipated|2009-02-01||Interventional|||High Flux Hemodialysis Thrice Versus Once|Effects of Different Frequencies of High-Flux Membranes on Blood Pressure, Fluid Balance, and Indices of Nutrition, Inflammation, and Dialysis Adequacy in Chronic Hemodialysis Patients - Comparisons Between Thrice vs Once Weekly|Unknown status|Recruiting|Phase 3|80|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 14:09:19.800969|2017-02-18 14:09:19.800969
NCT00714649|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-11-13|||July 2008||2008-07-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|CHIRON||Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery|Neoadjuvant Cetuximab Monotherapy Followed by Surgery in Squamous Cell Carcinoma of Head and Neck: Phase I/II Study|Completed||Phase 1/Phase 2|34|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-02-18 14:09:20.050869|2017-02-18 14:09:20.050869
NCT00714636|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2010-06-15|||October 2006||2006-10-01|June 2010|2010-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|CSF||Cerebrospinal Fluid Repository|Cerebrospinal Fluid Repository|Completed||N/A|200|Anticipated|Drexel University|||2||f||||f||||||Samples With DNA|"~     Cerebrospinal Fluid from Lumbar Puncture.~   "|||2017-02-18 14:09:20.160255|2017-02-18 14:09:20.160255
NCT00714623|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-12-20|||March 2005||2005-03-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||The SCRIPPS DES REAL WORLD Registry|A Prospective Registry for the Use of CypherTM Sirolimus-Eluting Stents In Patients With Coronary Artery Disease Treated With Percutaneous Coronary Interventions at Scripps Clinic|Completed||N/A|859|Actual|Scripps Health|||1||f||||t||||||||||2017-02-18 14:09:20.25215|2017-02-18 14:09:20.25215
NCT00714610|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-02-03|||August 2007||2007-08-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Serum Metal Ion Concentrations Following Primary Hip Arthroplasty|Serum Metal Ion Concentrations Following Unilateral Versus Bilateral Large Head Metal on Metal Primary Hip Arthroplasty|Completed||N/A|39|Actual|University of Utah|||1||f||||t||||||Samples Without DNA|"~     Blood will be drawn for analysis.~   "|||2017-02-18 14:09:20.348715|2017-02-18 14:09:20.348715
NCT00714597|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-01-14||2010-12-20|July 2008||2008-07-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|SAVE-VEMED||Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility|A Multinational, Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Primary Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility|Terminated||Phase 3|421|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:09:20.448195|2017-02-18 14:09:20.448195
NCT00714584|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2011-05-18|||May 2003||2003-05-01|April 2010|2010-04-01|June 2003|Actual|2003-06-01|||||Interventional|||Pharmacokinetics of Naltrexone Following Intravenous and Oral Routes of Administration in Healthy Volunteers|Pharmacokinetics of Naltrexone Hydrochloride (HCl) Following Intravenous (i.v.) and Oral Routes of Administration in Healthy Subjects|Completed||Phase 1|18|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 14:09:20.606609|2017-02-18 14:09:20.606609
NCT00714571|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2016-11-03|2016-11-03||July 2008||2008-07-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||"One participant from MST Healthy older adults Stage 1 excluded after study completion due to ongoing chemotherapy treatment (undisclosed during study).~One participant from MST MCI Stage 1 excluded due to being diagnosed with Alzheimer's dementia within 1 month of completing study"|Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI)|Behavioral and Neuroimaging Changes After Cognitive Rehab in TBI and MCI|Completed||Phase 1|82|Actual|VA Office of Research and Development||6|||f||||f||||||||||2017-02-18 14:09:20.695662|2017-02-18 14:09:20.695662
NCT00714558|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2011-05-18|||April 2003||2003-04-01|April 2010|2010-04-01|May 2003|Actual|2003-05-01|||||Interventional|||Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy Volunteers|Pharmacokinetics of Fentanyl Citrate Following Intravenous (i.v.) and Oral Routes of Administration in Healthy Subjects|Completed||Phase 1|18|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 14:09:21.295893|2017-02-18 14:09:21.295893
NCT00712647|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-09-25|||May 1985||1985-05-01|September 2012|2012-09-01|June 2005|Actual|2005-06-01|December 2004|Actual|2004-12-01||Interventional|CARET||Carotene and Retinol Efficacy Trial|Caret and Retinol Efficacy Trial: The Caret Coordinating Center|Completed||Phase 4|18314|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 14:09:55.761398|2017-02-18 14:09:55.761398
NCT00714545|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-12-20|||April 2006||2006-04-01|December 2012|2012-12-01|December 2015|Anticipated|2015-12-01|April 2015|Anticipated|2015-04-01||Interventional|||SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents|Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents. Short Title: Scripps V|Unknown status|Recruiting|Phase 4|60|Anticipated|Scripps Health||1|||f||||t||||||||||2017-02-18 14:09:21.391436|2017-02-18 14:09:21.391436
NCT00714532|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-07-09|||April 2007||2007-04-01|July 2013|2013-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Smoking Reduction and Cessation Interventions for Chinese|A Stage-Based Scheduled Smoking Intervention for Chinese|Completed||N/A|298|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:09:21.498206|2017-02-18 14:09:21.498206
NCT00714519|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-08-29|||July 2008||2008-07-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Feasibility Study of the Execution of an Efficacy Trial in the Nursing Home Setting|A Phase II Feasibility Study of Xenaderm® Ointment Exploring Design Issues for Phase III Efficacy in Partial-Thickness Wounds|Withdrawn||Phase 2|0|Actual|Healthpoint||2||"The study was terminated due to the inability to enroll subjects. No subjects were or ever~   will be enrolled into this study."|f||||f||||||||||2017-02-18 14:09:21.610698|2017-02-18 14:09:21.610698
NCT00714506|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2016-01-12|||March 2008||2008-03-01|January 2016|2016-01-01||||December 2009|Actual|2009-12-01||Interventional|||Effects of a Weight Reduction and Lifestyle Program in Older Adults|Effects of a Weight Reduction and Lifestyle Program in Older Adults|Completed||N/A|36|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:09:21.721372|2017-02-18 14:09:21.721372
NCT00714493|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-08-29|2011-01-14||July 2008||2008-07-01|August 2013|2013-08-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||RESTART C0168Z05 Rheumatoid Arthritis Study|A Phase 4, Multicenter, Open-Label, Assessor-Blinded Switch Study of the Efficacy and Safety of Infliximab (REMICADE) in Patients With Active Rheumatoid Arthritis Who Are Responding Inadequately to Etanercept (ENBREL) or Adalimumab (HUMIRA).|Completed||Phase 4|203|Actual|Centocor Ortho Biotech Services, L.L.C.||1|||f||||f||||||||||2017-02-18 14:09:21.820689|2017-02-18 14:09:21.820689
NCT00714480|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2011-08-02|||July 2008||2008-07-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment|Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment|Completed||N/A|3|Actual|Swedish Medical Center||3|||f||||t||||||||||2017-02-18 14:09:22.333475|2017-02-18 14:09:22.333475
NCT00714467|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-05-26|||August 2004||2004-08-01|May 2013|2013-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Expert System and Family Assisted Interventions for Chinese Smokers|Expert System and Family Assisted Interventions for Chinese Smokers|Completed||N/A|1280|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:09:22.439059|2017-02-18 14:09:22.439059
NCT00714454|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2008-07-11||||||July 2008|2008-07-01||||||||Interventional|||5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris|5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris: A Double-Blind, Placebo Controlled Trial|Completed||N/A|||University of Miami||2|||f||||f||||||||||2017-02-18 14:09:22.541626|2017-02-18 14:09:22.541626
NCT00714441|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-04-17|||July 2008||2008-07-01|April 2012|2012-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|REDEEM||Reducing Distress and Improving Self-Care in Diabetes|Reducing Distress and Improving Self-Care in Diabetes|Completed||N/A|392|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-02-18 14:09:22.632445|2017-02-18 14:09:22.632445
NCT00714428|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2015-09-03|||April 2009||2009-04-01|September 2015|2015-09-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Observational|TBIQOL||Development of Quality of Life Tool for TBI|Development of a Quality of Life Tool for Deployment Related TBI|Completed||N/A|485|Actual|VA Office of Research and Development|||3||f||||f||||||None Retained|"~     None retained~   "|||2017-02-18 14:09:22.742843|2017-02-18 14:09:22.742843
NCT00714415|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2017-01-30|||January 2008||2008-01-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||Registry For Patients Treated With BeneFix In Usual Care Setting In Germany|Pharmacovigilance Evaluation Of Benefix (Registered) In Germany And Austria|Completed||N/A|82|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:09:22.842049|2017-02-18 14:09:22.842049
NCT00714402|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2011-05-17|||August 2008||2008-08-01|January 2009|2009-01-01||||||||Observational|||Procalcitonin Level and Kinetics in Children With Bacterial Infections|Procalcitonin Level as a Prognostic Marker and Its' Kinetics in Children With Bacterial Infections|Completed||N/A|50|Anticipated|Shaare Zedek Medical Center|||1||f||||||||||None Retained|"~     whole blood~   "|||2017-02-18 14:09:22.96712|2017-02-18 14:09:22.96712
NCT00714389|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2013-01-31|2010-01-05||February 2008||2008-02-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Uroflow Measurements in Healthy Volunteers|Uroflow Measurements in Healthy Volunteers|Completed||N/A|12|Actual|University of Rochester|Limited number of participants||1||f||||f||||||||||2017-02-18 14:09:23.077267|2017-02-18 14:09:23.077267
NCT00714376|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2012-10-30|||May 2008||2008-05-01|October 2012|2012-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|TAX1||Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients|Phase II Single Center Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients With an Early Rising PSA Following Radical Prostatectomy|Terminated||Phase 2|6|Actual|Centre Hospitalier Universitaire de Québec, CHU de Québec||1||Prematurely terminated due to financial considerations|f||||t||||||||||2017-02-18 14:09:23.452512|2017-02-18 14:09:23.452512
NCT00714363|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2010-10-15|||October 2007||2007-10-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of LASIK and SBK|Comparison of Laser-Assisted in Situ Keratomeleusis (LASIK) vs Sub-Bowman's Keratomileusis (SBK): Assessment of Visual Function and Patient Satisfaction|Completed||N/A|40|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 14:09:23.564808|2017-02-18 14:09:23.564808
NCT00714350|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-12-11|||July 2007||2007-07-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Evaluation of Information Displays A Paper & Pencil, Computer, Simulator, and ICU Based Study|Evaluation of Information Displays A Paper & Pencil, Computer, Simulator, and ICU Based Study|Completed||N/A|32|Actual|University of Utah|||2||f||||t||||||||||2017-02-18 14:09:23.656866|2017-02-18 14:09:23.656866
NCT00613275|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2016-06-14|||July 2005||2005-07-01|June 2016|2016-06-01|September 2011|Actual|2011-09-01|June 2010|Actual|2010-06-01||Interventional|||Patient Navigation in the Safety Net:CONNECTeDD|Patient Navigation in the Safety Net:CONNECTeDD|Completed||Phase 4|4038|Actual|Boston Medical Center||1|||f||||t||||||||||2017-02-18 14:45:41.579195|2017-02-18 14:45:41.579195
NCT00714337|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2010-12-08|||June 2008||2008-06-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Formulation and Food Effect Study of AZD1386 in Healthy Volunteers|A Phase I, Single-Centre, Randomised, Open-Label, Five-Way Cross-Over Formulation- and Food-Effect Study in Healthy Volunteers to Assess the Pharmacokinetics of AZD1386 After Single Doses of Two Oral Solid Formulations and an Oral Solution|Completed||Phase 1|12|Anticipated|AstraZeneca||5|||f||||f||||||||||2017-02-18 14:09:23.744067|2017-02-18 14:09:23.744067
NCT00714324|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2009-01-02|||July 2008||2008-07-01|January 2009|2009-01-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Observational|||Simplified Nutritional Screening for Patient Use|Validation of Nutritional Screening for Patient Use|Unknown status|Recruiting|N/A|2200|Anticipated|University of Southampton|||2||f||||f||||||||||2017-02-18 14:09:23.828355|2017-02-18 14:09:23.828355
NCT00714311|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2015-02-04|2015-02-04||October 2004||2004-10-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder|A Randomized-Controlled Trial of Transference-Focused Psychotherapy vs. Treatment by Experienced Community Psychotherapists for Borderline Personality Disorder|Completed||N/A|104|Actual|University Hospital Muenster||2|||f||||f||||||||||2017-02-18 14:09:23.913579|2017-02-18 14:09:23.913579
NCT00714298|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-11|||May 2006||2006-05-01|July 2008|2008-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Diagnostic Value of Heart-Fatty Acid Binding Protein and Ischemia Modified Albumin as Biochemical Markers on Non ST Segment Elevation Acute Coronary Syndrome at the Emergency Room.|Analyse en médecine d'Urgence d'Une stratégie d'Utilisation combinée de Deux Marqueurs Biologiques Dans le Diagnostic de Syndrome Coronaire Aigu Non ST+: étude Des Performances de la Heart-Fatty Acid Binding Protein et de l' Ischemia Modified Albumin dès la première Heure de Prise en Charge|Completed||N/A|700|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-02-18 14:09:24.310678|2017-02-18 14:09:24.310678
NCT00714285|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-10-11|2013-07-11||July 2008||2008-07-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.|Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate GSK 2115160A in Adults.|Completed||Phase 1|420|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:09:24.422799|2017-02-18 14:09:24.422799
NCT00714272|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-07-11|||April 2008||2008-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:09:25.476299|2017-02-18 14:09:25.476299
NCT00714259|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-06-18|||July 2008||2008-07-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies|UAB 0775 Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Protocol From HLA Matched Related Donors for The Treatment of Patients With Low Grade B Cell Malignancies|Terminated||Phase 2/Phase 3|5|Actual|University of Alabama at Birmingham||1||Accrual goals could not be met within a timely manner|f||||t||||||||||2017-02-18 14:09:25.529618|2017-02-18 14:09:25.529618
NCT00714246|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2017-01-26|||October 2008|Actual|2008-10-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|May 2013|Actual|2013-05-01||Interventional|||Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer|Phase I/II Study of Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1/Phase 2|6|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||Undecided|Once study is completed we will provide updates to data|2017-02-18 14:09:25.640267|2017-02-18 14:09:25.640267
NCT00714233|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2015-04-29|2011-04-08||August 2002||2002-08-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|April 2004|Actual|2004-04-01||Interventional|||Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)|Treatment of Polycystic Ovary Syndrome (POS) in Overweight Adolescents|Completed||Phase 3|43|Actual|University of Rochester||4|||f||||f||||||||||2017-02-18 14:09:25.760338|2017-02-18 14:09:25.760338
NCT00714220|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2015-10-28|||November 2006||2006-11-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)|Quantitative Measurement of Nutritional Substrate Utilization in Patients With ALS|Terminated||N/A|107|Actual|Drexel University|||3|Lack of funding and support staff.|f||||f||||||||||2017-02-18 14:09:26.421189|2017-02-18 14:09:26.421189
NCT00714207|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2008-07-10|||July 2002||2002-07-01|July 2008|2008-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Evaluation of Adolescent Smoking Cessation Programs|Evaluation of Adolescent Smoking Cessation Programs|Completed||N/A|407|Actual|Johns Hopkins University||4|||f||||f||||||||||2017-02-18 14:09:26.507648|2017-02-18 14:09:26.507648
NCT00714194|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2015-05-06|||July 2008||2008-07-01|May 2015|2015-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|ICUDelirium||Effect of Daily Interruption of Continuous Sedation on Delirium, Sleep Perception in Intensive Care Unit (ICU) Patients|The Effect of Daily Interruption of Continuous Sedation on the Occurrence of Delirium and Perception of Sleep in ICU Patients|Completed||Early Phase 1|52|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:09:26.713923|2017-02-18 14:09:26.713923
NCT00714181|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-11|2016-02-17|||June 2008||2008-06-01|February 2016|2016-02-01|June 2013|Actual|2013-06-01|July 2011|Actual|2011-07-01||Interventional|||Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Hydroxychloroquine in Combination With Temozolomide in Patients With Advanced Solid Tumors|Completed||Phase 1|38|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 14:09:26.817568|2017-02-18 14:09:26.817568
NCT00714168|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2015-12-23|2013-01-06||March 2008||2008-03-01|December 2015|2015-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|Step-Up||Evaluating the Effectiveness of a Stepped-Care Approach to Long-Term Weight Loss (The Step-Up Study)|The Effect of a Stepped-care Approach to Long-term Weight Loss|Completed||N/A|363|Actual|University of Pittsburgh|This study was not designed to test for weight loss equivalency between conditions. This study is unable to determined if an alternative intensity or frequency of intervention steps would be more or less effective for weight loss.|2|||f||||t||||||||||2017-02-18 14:09:26.914614|2017-02-18 14:09:26.914614
NCT00714129|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2015-12-01|||September 2007||2007-09-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|LINC||De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver Disease|De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver Disease|Active, not recruiting||N/A|60|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:09:27.529043|2017-02-18 14:09:27.529043
NCT00714116|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-12-20|||February 2009||2009-02-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus|An Ascending Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of SBI-087 Administered To Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|30|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:09:27.639865|2017-02-18 14:09:27.639865
NCT00714103|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2016-10-12|||June 2008||2008-06-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||8-Chloro-Adenosine in Chronic Lymphocytic Leukemia|A Phase I Study of 8-Chloro-Adenosine in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma|Completed||Phase 1|11|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 14:09:27.734917|2017-02-18 14:09:27.734917
NCT00714090|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-07-18|||May 2008||2008-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression|Repetitive Transcranial Magnetic Stimulation Efficacy for Major Resistant Depression Compared or Associated With Venlafaxine : a Multicentric Study.|Completed||Phase 3|170|Actual|Club rTMS et Psychiatrie||3|||f||||t||||||||||2017-02-18 14:09:27.995205|2017-02-18 14:09:27.995205
NCT00714077|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2016-02-15|||April 2008||2008-04-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|January 2018|Anticipated|2018-01-01||Observational|||Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer|Prospective Randomized Phase III Study of Concurrent Capecitabine and Radiotherapy With or Without Oxaliplatin as Adjuvant Treatment for Stage II and III Rectal Cancer|Recruiting||Phase 3|570|Anticipated|Chinese Academy of Medical Sciences|||2||f||||t||||||||||2017-02-18 14:09:28.123948|2017-02-18 14:09:28.123948
NCT00714064|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2014-07-09|||June 2006||2006-06-01|July 2014|2014-07-01|July 2011|Actual|2011-07-01|February 2011|Actual|2011-02-01||Interventional|PneuMum||PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers|PneuMum: A Randomised Controlled Trial of Pneumococcal Polysaccharide Vaccination for Aboriginal and Torres Strait Islander Mothers to Protect Their Babies From Ear Disease|Completed||Phase 3|227|Actual|Menzies School of Health Research||3|||f||||t||||||||||2017-02-18 14:09:28.259141|2017-02-18 14:09:28.259141
NCT00714051|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-10-02|2014-09-26||October 2008||2008-10-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|February 2012|Actual|2012-02-01||Interventional|||Fall Prevention Program for Older Adults|Fall Prevention Program for Older Adults|Completed||Phase 1/Phase 2|55|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:09:28.376411|2017-02-18 14:09:28.376411
NCT00714038|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2011-03-08|||May 2008||2008-05-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||CARE - Quality Improvement in Asthma Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.|CARE - Quality Development in Asthma in General Practice|Completed||N/A|2122|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:09:29.005308|2017-02-18 14:09:29.005308
NCT00714025|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-01-23|||November 2008||2008-11-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|April 2009|Actual|2009-04-01||Interventional|||A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy|A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma After Failure of Platinum-based Chemotherapy|Completed||Phase 2|40|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-02-18 14:09:29.181811|2017-02-18 14:09:29.181811
NCT00714012|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2016-08-18|||October 2004||2004-10-01|August 2016|2016-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Evaluation of Information Displays-A Paper, Computer and Simulator Based Study|Evaluation of Information Displays-A Paper, Computer and Simulator Based Study|Completed||N/A|200|Anticipated|University of Utah|||1||f||||t||||||||||2017-02-18 14:09:29.284336|2017-02-18 14:09:29.284336
NCT00713999|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2008-07-11|||August 2001||2001-08-01|July 2008|2008-07-01|September 2003|Actual|2003-09-01|April 2002|Actual|2002-04-01||Interventional|FGS/MGS/STI||Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar|Study of Reproductive Health in Rural Madagascar With Emphasis on Urogenital Schistosomiasis and Sexually Transmitted Infections|Completed||N/A|680|Actual|University of Aarhus||1|||f||||t||||||||||2017-02-18 14:09:29.383351|2017-02-18 14:09:29.383351
NCT00713986|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2008-07-11|||March 2006||2006-03-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|October 2007|Actual|2007-10-01||Interventional|||Non-Pharmacologic Interventions to Relief Pain in Healthy Newborns Submitted to Vaccination to Hepatitis B|Non-Pharmacologic Interventions to Relief Pain in Healthy Newborns Submitted to Vaccination to Hepatitis B: a Comparison Between Skin-to-Skin Contact, Glucose 25% and Both of Them|Completed||Phase 3|640|Actual|Federal University of São Paulo||4|||f||||f||||||||||2017-02-18 14:09:29.493505|2017-02-18 14:09:29.493505
NCT00713973|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2008-10-17|||June 2007||2007-06-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|||||Observational|||Comparative Study Between Thrombosis Prophylaxis Protocols|Comparative Study Between American and Brazilian Protocols for Deep Venous Thrombosis Prophylaxis: a New Proposal|Completed||N/A|212|Actual|UPECLIN HC FM Botucatu Unesp|||3||f||||t||||||||||2017-02-18 14:09:29.591089|2017-02-18 14:09:29.591089
NCT00713960|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2012-01-13|||April 2008||2008-04-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||CARE - Quality Improvement in Cardiovascular Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.|CARE - Quality Development in Cardiovascular Disease in General Practice|Completed||N/A|2193|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:09:29.686103|2017-02-18 14:09:29.686103
NCT00713947|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-04-20|||April 2008||2008-04-01|April 2015|2015-04-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Interventional|Aspylori||Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control|Comparative Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control on the Gastric Lesions Induced by the Aspirin With the Low Dose Among Patients Treated With the Long Course|Withdrawn||Phase 4|0|Actual|Assistance Publique - Hôpitaux de Paris||3||no inclusion|f||||t||||||||||2017-02-18 14:09:29.973901|2017-02-18 14:09:29.973901
NCT00713934|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2011-10-01|||January 2008||2008-01-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Autologous Bone Marrow Stem Cells in Cirrhosis Patients|Autologous Transplantation of Bone Marrow Derived CD 133 Positive Stem Cell and Mono Nuclear Cell (MNC) Transplantation in Patients With Decompensate Cirrhosis: Randomized Clinical Trial|Completed||Phase 1/Phase 2|7|Actual|Royan Institute||2|||f||||t||||||||||2017-02-18 14:09:30.094885|2017-02-18 14:09:30.094885
NCT00713921|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-12-11|||February 2008||2008-02-01|December 2012|2012-12-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients|Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients|Unknown status|Recruiting|N/A|20|Anticipated|Saint Thomas Health Services||1|||f||||t||||||||||2017-02-18 14:09:30.205151|2017-02-18 14:09:30.205151
NCT00713908|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2009-12-15|||November 2007||2007-11-01|December 2009|2009-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Voiding Dysfunction in the Postoperative Period Following Placement of the TVT|Voiding Dysfunction in the Postoperative Period Following Placement of the TVT|Terminated||N/A|2|Actual|University of Rochester|||1|"The Co-Principal Investigator has moved and is no longer interested in continuing this study~   at this site."|f||||f||||||||||2017-02-18 14:09:30.301267|2017-02-18 14:09:30.301267
NCT00713895|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-09|||August 2001||2001-08-01|June 2008|2008-06-01|August 2005|Actual|2005-08-01|January 2004|Actual|2004-01-01||Interventional|||Treating Chinese Smokers With Interactive Expert System|Treating Chinese Smokers With Interactive Expert System|Completed||N/A|363|Actual|University of California, San Francisco||2|||f||||||||||||||2017-02-18 14:09:30.383722|2017-02-18 14:09:30.383722
NCT00713882|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-03-10|||April 2008||2008-04-01|March 2009|2009-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors|Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors|Completed||N/A|130|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 14:09:30.490975|2017-02-18 14:09:30.490975
NCT00713869|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2011-01-05|||April 2006||2006-04-01|January 2011|2011-01-01|April 2011|Anticipated|2011-04-01|November 2009|Anticipated|2009-11-01||Observational|Slow-freeze||Oocyte Cryopreservation: Evaluation of an Oocyte Freezing and Thawing Technique|Evaluation of the Affects of an Oocyte Freezing and Thawing Technique in Patients Undergoing In-vitro Fertilization (IVF)|Unknown status|Active, not recruiting|N/A|50|Anticipated|West Coast Fertility Centers|||2||f||||t||||||||||2017-02-18 14:09:30.585145|2017-02-18 14:09:30.585145
NCT00713856|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2010-10-15|||November 2007||2007-11-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Comparison of Conventional and Custom Photorefractive Keratectomy (PRK)|Comparison of Conventional and Custom With Iris Registration PRK Ablations: Assessment of Visual Function and Patient Satisfaction|Completed||N/A|44|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 14:09:30.681127|2017-02-18 14:09:30.681127
NCT00713843|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2015-03-16|||September 2008||2008-09-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|May 2013|Actual|2013-05-01||Interventional|NECKproject||Effectiveness of Manual Therapy in Patients With Neck Pain.|Effectiveness of Manual Therapy and Physical Therapy in Patients With Subacute and Chronic Non-specific Neck Pain. A Randomized Controlled Trial.|Completed||N/A|180|Actual|Radboud University||2|||f||||t||||||||||2017-02-18 14:09:30.776947|2017-02-18 14:09:30.776947
NCT00713830|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2016-10-21|2016-08-18||July 2008||2008-07-01|October 2016|2016-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|GETGOAL-S|Safety population included all randomized patients who were exposed to at least 1 dose of study drug, regardless of the amount of treatment administered.The one patient in the placebo group who received Lixisenatide was described in the Lixisenatide group.|GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea|A Randomized, Double-blind, Placebo-controlled, 2-arm Parallel-group, Multicenter 24-week Study Followed by an Extension Assessing the Efficacy and Safety of AVE0010 on Top of a Sulfonylurea in Patients With Type 2 Diabetes Not Adequately Controlled With Sulfonylurea|Completed||Phase 3|859|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:09:30.902206|2017-02-18 14:09:30.902206
NCT00713817|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2012-07-11|2012-07-11||March 2007||2007-03-01|July 2012|2012-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain|A Multicentre, Open Label, Follow on Study to Assess the Maintenance of Effect, Tolerance and Safety of Sativex® in the Treatment of Subjects With Neuropathic Pain. This Will be Followed by a Randomised-withdrawal Phase (Part B) for a Subset of Patients|Completed||Phase 3|19|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:09:32.445776|2017-02-18 14:09:32.445776
NCT00713804|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-07-11|||July 2008||2008-07-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||Impact of Genetic Counseling for Individuals With Mental Illness|Genetic Counseling for Individuals With Mental Illness: Impact on Knowledge, Risk Perception, Perceived Control and Internalized Stigma.|Completed||Phase 3|120|Actual|University of British Columbia||3|||f||||f||||||||||2017-02-18 14:09:32.996285|2017-02-18 14:09:32.996285
NCT00713791|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2010-11-10|||June 2008||2008-06-01|November 2010|2010-11-01|August 2008|Actual|2008-08-01|||||Interventional|||Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.|A Phase I, Randomised, Single-blind, Single-centre, Incomplete-block Crossover, Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets|Completed||Phase 1|20|Anticipated|AstraZeneca||1|||f||||||||||||||2017-02-18 14:09:33.106633|2017-02-18 14:09:33.106633
NCT00713778|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-08-15|||November 2003||2003-11-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst|The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Exc|Completed||Phase 4|192|Actual|Shandong Provincial Hospital||3|||f||||t||||||||||2017-02-18 14:09:33.217136|2017-02-18 14:09:33.217136
NCT00713765|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2014-08-12|||December 2008||2008-12-01|August 2014|2014-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic Interaction Between AZD3480 and Donepezil|A Double-blind, Randomised, Cross-over, Placebo-controlled Study of Repeated Oral Doses of AZD3480 and a Single Dose of Donepezil to Evaluate the Pharmacokinetic Interaction Between AZD3480 and Donepezil in Healthy Extensive and Poor Metabolisers of CYP2D6|Terminated||Phase 1|33|Actual|AstraZeneca||1||Ended prematurely - The trial never commenced.|f||||f||||||||||2017-02-18 14:09:33.330221|2017-02-18 14:09:33.330221
NCT00713739|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-04-25|||January 2008||2008-01-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2010|Actual|2010-12-01||Interventional|MET||Alfuzosin for Medical Expulsion Therapy of Ureteral Stones|Evaluation of Alfuzosin as Medical Expulsion Therapy for Ureteral Stones|Unknown status|Recruiting|Phase 3|240|Anticipated|United States Naval Medical Center, San Diego||4|||f||||t||||||||||2017-02-18 14:09:33.521623|2017-02-18 14:09:33.521623
NCT00713726|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-10|||January 2006||2006-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants|Post-Operatory Analgesia in Newborn Infants: a Comparative Study of Fentanyl Versus Tramadol|Completed||Phase 3|160|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:09:33.622068|2017-02-18 14:09:33.622068
NCT00713713|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2009-07-31|||July 2008||2008-07-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|VITALI||Effect of Different Ventilatory Strategies on Cardiac Function in Patients With Acute Respiratory Failure|Hemodynamic Impact of Low and High Tidal Volume Mechanical Ventilation in Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS) Patients|Completed||N/A|16|Anticipated|Fondazione Poliambulanza Istituto Ospedaliero||1|||f||||f||||||||||2017-02-18 14:09:33.712461|2017-02-18 14:09:33.712461
NCT00713700|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2016-06-08|2013-10-25||August 2008||2008-08-01|June 2016|2016-06-01|January 2017|Anticipated|2017-01-01|October 2011|Actual|2011-10-01||Interventional|ADO II||AMPLATZER Duct Occluder II Clinical Study|Closure of Patent Ductus Arteriosus With the AMPLATZER DUCT Occluder II|Active, not recruiting||N/A|192|Actual|St. Jude Medical||1|||f||||t||||||||||2017-02-18 14:09:33.813959|2017-02-18 14:09:33.813959
NCT00713687|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-08-09|||August 2008||2008-08-01|July 2008|2008-07-01|December 2011||2011-12-01|||||Interventional|GemOx-PDT||Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma|Sequential Combination of Chemotherapy With Gemcitabine/Oxaliplatin and Photodynamic Therapy in Advanced Cholangiocarcinoma|Withdrawn||Phase 2|0|Actual|Technische Universität München||1||recruiting failed|f||||f||||||||||2017-02-18 14:09:34.187492|2017-02-18 14:09:34.187492
NCT00713674|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2010-01-11|||March 2008||2008-03-01|July 2008|2008-07-01|February 2009|Anticipated|2009-02-01|February 2009|Actual|2009-02-01||Interventional|SJMRSA||Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx|Comparison of Decolonization of MRSA Using Theraworx|Withdrawn||N/A|60|Anticipated|St. John's Health System, Missouri||3||Lack of patient recruitment.|f||||f||||||||||2017-02-18 14:09:34.2946|2017-02-18 14:09:34.2946
NCT00713661|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-05-04|2011-12-20||June 2008||2008-06-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)|Non-randomised, Open, Multi-center Trial Evaluating Feasibility and Safety of TachoSil® Application on a Colorectal Anastomosis.|Completed||Phase 2|25|Actual|Nycomed||1|||f||||t||||||||||2017-02-18 14:09:34.402895|2017-02-18 14:09:34.402895
NCT00713648|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2015-11-25|2014-01-22||August 2008||2008-08-01|November 2015|2015-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency|A Multi-Centre, Open-Label, Single-Arm and Multiple Dosing Trial on Efficacy and Safety of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Subjects With Congenital Factor XIII Deficiency|Completed||Phase 3|41|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 14:09:34.887562|2017-02-18 14:09:34.887562
NCT00713635|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2016-05-05|||December 2010||2010-12-01|May 2016|2016-05-01|January 2016|Actual|2016-01-01|November 2014|Actual|2014-11-01||Observational|||Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome|The Prenatal Effects of Congenital Heart Disease on Neurodevelopmental Outcome|Completed||N/A|51|Actual|Columbia University|||4||f||||f||||||||||2017-02-18 14:09:35.444734|2017-02-18 14:09:35.444734
NCT00713622|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2015-11-02|||June 2008||2008-06-01|November 2015|2015-11-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate|A Multicentre, Randomised, Active Comparator, Parallel Group Study To Compare The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate|Completed||Phase 4|2|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 14:09:35.539433|2017-02-18 14:09:35.539433
NCT00713609|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-02-23||2010-09-07|June 2008||2008-06-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne|A Multi-center, Randomized, Double-blind, Vehicle-Controlled, Phase 2 Study of the Safety and Efficacy of Benzoyl Peroxide/Clindamycin Gel and Tazarotene Cream When Used in Combination in the Treatment of Acne Vulgaris|Completed||Phase 2|591|Actual|GlaxoSmithKline||6|||f||||f||||||||||2017-02-18 14:09:35.650843|2017-02-18 14:09:35.650843
NCT00713596|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2016-03-18|2012-04-19||July 2008||2008-07-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study Evaluating Benefit of Using Fibrin Glue in Septorhinoplasty|The Use of Fibrin Sealant During Septorhinoplasty: Short and Long Term Benefits|Terminated||N/A|25|Actual|Mayo Clinic|Study was terminated due to principal investigator leaving the institution.|3||Lead investigator moved to a new medical center; study was stopped when he left.|f||||t||||||||||2017-02-18 14:09:35.788915|2017-02-18 14:09:35.788915
NCT00713583|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-03-01|||January 2008||2008-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence|Contingency Management Plus Levodopa/Carbidopa for Treatment of Cocaine Dependence|Completed||Phase 2|160|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-02-18 14:09:36.232046|2017-02-18 14:09:36.232046
NCT00713570|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2010-12-10|||August 2006||2006-08-01|December 2010|2010-12-01||||July 2012|Anticipated|2012-07-01||Observational|||Explore the Nature Factors Relevant to Learning-Pioneering Natural Factors That Influences Science Learning II|the Cognitive Ability Dose Associate With COMT, 5HT6, BDNF and Biological Systemic Pathway Candidate Genes in General Population|Unknown status|Recruiting|N/A|2800|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 14:09:36.344051|2017-02-18 14:09:36.344051
NCT00713557|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-10-12|||March 2005||2005-03-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Observational|||Shanghai Registry of Acute Coronary Events|Phase 4 Study to Compare Different Therapeutic Strategies for Patients With ACS|Terminated||N/A|20000|Anticipated|Shanghai Jiao Tong University School of Medicine|||6|"devices applied in the study were no more available in the market, and medical intervention~   section was completed."|f||||t||||||||||2017-02-18 14:09:36.457021|2017-02-18 14:09:36.457021
NCT00713544|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2011-08-26|2010-07-22||July 2008||2008-07-01|August 2011|2011-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ESCAPE||A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis|A Randomised, Double Blind, Placebo Controlled, Phase IIb Dose Ranging Study (With Open-label Etanercept Treatment Group) to Investigate Efficacy, Safety and Pharmacokinetics of AZD5672 Administered for 12 Weeks to Rheumatoid Arthritis Patients Receiving Methotrexate.|Completed||Phase 2|373|Actual|AstraZeneca|Hybrid ACR, ACRn, individual ACR components, Erythrocyte sedimentation rate (ESR), Short-form-36 (SF-36), Rheumatoid Arthritis Quality of Life (RAQoL) and Patient Insight Questionnaire (PIQ) did not provide extra information so are not presented|6|||f||||f||||||||||2017-02-18 14:09:36.584751|2017-02-18 14:09:36.584751
NCT00713531|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2015-05-27|||July 2008||2008-07-01|May 2015|2015-05-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Observational|||Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand||Completed||N/A|992|Actual|South East Asia Research Collaboration with Hawaii|||1||f||||f||||||Samples Without DNA|"~     Plasma, CD4, HIV-RNA~   "|||2017-02-18 14:09:37.538782|2017-02-18 14:09:37.538782
NCT00713518|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-10-10||2012-10-05|November 2009||2009-11-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|November 2010|Actual|2010-11-01||Interventional|MONET||Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).|Phase II Open Label Multicenter, Prospective, Randomized, Age Related Macular Degeneration, Comparator Controlled Study Evaluating PF-04523655 Versus Ranibizumab In The Treatment Of Subjects With Choroidal Neovascularization (MONET Study).|Completed||Phase 2|152|Actual|Quark Pharmaceuticals||5|||f||||f||||||||||2017-02-18 14:09:37.630234|2017-02-18 14:09:37.630234
NCT00713505|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2010-10-11|||May 2008||2008-05-01|October 2010|2010-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction|A Behavioral Intervention Trial for Parents of Childhood Cancer Survivors With Neurobehavioral Late Effects|Completed||N/A|56|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 14:09:37.779889|2017-02-18 14:09:37.779889
NCT00713492|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2017-01-24|||July 7, 2008||2008-07-07|December 5, 2016|2016-12-05|December 31, 2019|Anticipated|2019-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Computer-Assisted Self-Administration of Ethanol|Computer-Assisted Self-Administration of Ethanol (CASE) in Humans|Recruiting||N/A|320|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:09:38.086112|2017-02-18 14:09:38.086112
NCT00713479|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2013-12-19|2013-03-26||July 2008||2008-07-01|December 2013|2013-12-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional||This is a crossover design wherein each subject completed both the sugar pill treatment condition and the varenicline(medication under study) condition. Two subjects in the placebo condition did not complete the first component of the trial.|An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers|A Human Laboratory Assessment of the Safety and Potential Efficacy of Varenicline in Methamphetamine-dependent Volunteers Receiving Methamphetamine|Completed||Phase 1|8|Actual|University of California, Los Angeles|Small sample size|2|||f||||t||||||||||2017-02-18 14:09:38.197876|2017-02-18 14:09:38.197876
NCT00713466|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-30|||August 2007||2007-08-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|CLIPP||The Use of Computer-Assisted Learning Pediatrics Program (CLIPP) in the Pediatric Clerkship|The Use of Computer-Assisted Learning Pediatrics Program (CLIPP) in the Pediatric Clerkship|Completed||N/A|198|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 14:09:38.519676|2017-02-18 14:09:38.519676
NCT00713453|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2015-03-21|||January 2007||2007-01-01|March 2015|2015-03-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Muscle Response to Enzyme Replacement Therapy in Pompe Disease|Muscle Response to Enzyme Replacement Therapy in Pompe Disease|Recruiting||N/A|16|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 14:09:38.604541|2017-02-18 14:09:38.604541
NCT00713440|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-08-05|||July 2008||2008-07-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Incretin Physiology Associated With Steroid Hormone Treatment|Incretin Physiology and Beta-Cell Function Before and After Treatment With Steroid Hormone in Healthy Individuals|Completed||N/A|10|Actual|Glostrup University Hospital, Copenhagen||1|||f||||t||||||||||2017-02-18 14:09:38.699577|2017-02-18 14:09:38.699577
NCT00713427|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2009-08-31|||July 2007||2007-07-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction|A Multi-Center, Single Arm, Prospective Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction|Completed||N/A|70|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-02-18 14:09:38.811199|2017-02-18 14:09:38.811199
NCT00713414|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2017-01-24|||July 9, 2008||2008-07-09|September 21, 2016|2016-09-21|September 21, 2016||2016-09-21|||||Observational|||Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia|Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia and Other Focal Dystonias|Completed||N/A|37|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:09:38.910724|2017-02-18 14:09:38.910724
NCT00713401|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2014-02-10||2014-01-03|February 2008||2008-02-01|February 2014|2014-02-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Safety Study of Tecadenoson to Treat Atrial Fibrillation|An Open-Label, Sequential-Group, Dose-Escalation Study To Evaluate The Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous Tecadenoson Alone and in Combination With a Beta-Blocker in Adults With Rapid Atrial Fibrillation (CVT 4129)|Completed||Phase 2|21|Actual|Gilead Sciences||5|||f||||f||||||||||2017-02-18 14:09:39.001461|2017-02-18 14:09:39.001461
NCT00713375|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-10|||April 2008||2008-04-01|July 2008|2008-07-01||||April 2008|Anticipated|2008-04-01||Observational|||Time Frequency Analysis of Electrocardiogram and Blood Pressure in Intracranial Hemorrhage Patients|Multiscale Entropy and Time-Frequency Analysis of Electrocardiogram and Blood Pressure in Patients With Spontaneous Intracranial Hemorrhage|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"~     Whole blood. Cerebral spinal fluids~   "|||2017-02-18 14:09:39.207063|2017-02-18 14:09:39.207063
NCT00712634|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2009-12-18|||November 1997||1997-11-01|December 2009|2009-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Cytomegalovirus Vaccine in Healthy Participants|A Phase I Dose Escalation Study of Lipopeptide Vaccines With Activity Against Human Cytomegalovirus|Completed||Phase 1|46|Anticipated|City of Hope Medical Center||2|||f||||||||||||||2017-02-18 14:09:55.854019|2017-02-18 14:09:55.854019
NCT00713362|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-12-13|||April 2008||2008-04-01|November 2012|2012-11-01|September 2013|Anticipated|2013-09-01|November 2012|Actual|2012-11-01||Interventional|||Chest Tube Drainage or Thoracoscopic Surgery for Failed Aspiration of Spontaneous Pneumothorax|Comparison of Chest Tube Drainage Versus Thoracoscopic Surgery for Unsuccessful Aspiration of Primary Spontaneous Pneumothorax: a Prospective Randomized Trial|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 14:09:39.301617|2017-02-18 14:09:39.301617
NCT00713349|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-10-09|2013-10-09||June 2008||2008-06-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing|A Randomized, Evaluator Blinded, Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing of Induced Thermal Wounds|Completed||Phase 2|25|Actual|Healthpoint||2|||f||||f||||||||||2017-02-18 14:09:39.407187|2017-02-18 14:09:39.407187
NCT00713336|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2010-09-27|||June 2008||2008-06-01|September 2010|2010-09-01|November 2008|Actual|2008-11-01|||||Interventional|||Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval|A Phase I, Double-blind, Double-dummy, Placebo-controlled, Randomised, Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval Compared to Placebo, Using AVELOX (Moxifloxacin) as a Positive Control, in Healthy Volunteers Aged 18 to 45 Years.|Completed||Phase 1|40|Anticipated|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:09:39.640134|2017-02-18 14:09:39.640134
NCT00713323|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2012-08-16|2012-07-11||October 2005||2005-10-01|August 2012|2012-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.|A Multicentre, Open Label, Follow on Study to Assess the Maintenance of Effect, Tolerance and Safety of Sativex® in the Treatment of Subjects With Neuropathic Pain. This Will be Followed by a Randomised-withdrawal Phase (Part B) for a Subset of Patients.|Completed||Phase 3|380|Actual|GW Pharmaceuticals Ltd.||1|||f||||f||||||||||2017-02-18 14:09:39.752866|2017-02-18 14:09:39.752866
NCT00713310|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-04-03|2012-03-06||December 2008||2008-12-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis|Study to Assess the Safety and Efficacy of Asacol® (1.2 to 4.8 g/Day) Administered as 400 mg Delayed-release Tablets Given Every 12 Hours for 6 Weeks to Children and Adolescents With Mildly-to-Moderately Active Ulcerative Colitis|Completed||Phase 3|83|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 14:09:40.354738|2017-02-18 14:09:40.354738
NCT00713297|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-09|||September 2007||2007-09-01|June 2008|2008-06-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Observational|||Implementation of a Novel Computerized Physician Order Entry System|Implementation of a Novel Computerized Physician Order Entry System to Reduce Medication Errors|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 14:09:40.927104|2017-02-18 14:09:40.927104
NCT00713284|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-08-01|||May 2007||2007-05-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|MYFIIRP||Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic|A Pilot Study to Evaluate the Safety and Efficacy of Mycophenolate Sodium (Myfortic®) in Combination With Sirolimus (Rapamune®) in Stable Renal Allograft Recipients|Completed||Phase 4|13|Actual|California Pacific Medical Center Research Institute||1|||f||||f||||||||||2017-02-18 14:09:41.034254|2017-02-18 14:09:41.034254
NCT00713271|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2014-04-09|||August 2008||2008-08-01|April 2014|2014-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|AZD3199MAD||Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men|A Phase I, Randomised, Double-blind, Placebo-controlled, Parallel-group, Single-centre Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD3199 (a B2-agonist) Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men|Completed||Phase 1|27|Anticipated|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:09:41.14991|2017-02-18 14:09:41.14991
NCT00713258|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-05-04|2011-07-28||April 2008||2008-04-01|May 2012|2012-05-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)|A 24-week, International, Multi Centre, Randomised, Double-blind, Double-dummy, Parallel Group, Phase IV Clinical Trial Investigating Changes in Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) Treated With Either 100 µg PTH(1-84) Daily or 70 mg Alendronate Weekly|Terminated||Phase 4|75|Actual|Nycomed|Early termination leading to small number of subjects analyzed.|2||Slow enrolment|f||||f||||||||||2017-02-18 14:09:41.258161|2017-02-18 14:09:41.258161
NCT00713245|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-12-03|||May 2008||2008-05-01|December 2013|2013-12-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Long Term Follow up Study in Late-onset Pompe Disease|A Long Term Follow up Study in Late-onset Pompe Disease|Recruiting||N/A|70|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 14:09:41.661169|2017-02-18 14:09:41.661169
NCT00713232|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-09|||May 2007||2007-05-01|May 2007|2007-05-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Observational|||The Construction of a Chinese Picture Naming Test and Its Preliminary Normative Data|The Construction of a Chinese Picture Naming Test and Its Preliminary Normative Data|Completed||N/A|522|Actual|National Taiwan University Hospital|||2||f||||f||||||||||2017-02-18 14:09:41.757351|2017-02-18 14:09:41.757351
NCT00713219|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2015-04-21|2015-04-07||July 2008||2008-07-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer|Phase II Study of Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity -Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer|Completed||Phase 2|14|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:09:41.852005|2017-02-18 14:09:41.852005
NCT00713206|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2015-01-13|2013-08-06||September 2006||2006-09-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|||Prospective Study of NanoTite Implants Placed Into Fresh Sinus-Lift Augmentation Sites (VSSL)|A Prospective, Randomized-Controlled, Multicenter Study of NanoTite Implants Placed Into Fresh Sinus Lift Augmentation Sites|Completed||N/A|92|Actual|Zimmer Biomet||2|||f||||t||||||||||2017-02-18 14:09:42.10025|2017-02-18 14:09:42.10025
NCT00713193|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2017-01-13|||November 2007||2007-11-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)|A Multi-Center, Randomized Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in the Initial Therapy of Thrombotic Thrombocytopenic Purpura (TTP)|Active, not recruiting||Phase 3|62|Anticipated|Ohio State University||2|||f||||t||||||||Yes|data being evaluated and reviewed, manuscript in preparation for final report to FDA|2017-02-18 14:09:42.469697|2017-02-18 14:09:42.469697
NCT00713180|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2015-06-24|||August 2008||2008-08-01|August 2008|2008-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Determinants of Pterygium Occurrence and Recurrence in a Rural African Population|Determinants of Pterygium Occurrence and Recurrence in a Rural African Population|Completed||N/A|355|Anticipated|Anguria, Peter, M.D.||2|||f||||t||||||||||2017-02-18 14:09:42.790257|2017-02-18 14:09:42.790257
NCT00713167|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2009-05-20|||July 2008||2008-07-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|GSE||The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL)|Randomized, Cross-Over, Double Blind, Placebo-Controlled Study of Grape Seed Extract in Treating Patients With Mild Hyperlipidemia|Completed||Phase 2/Phase 3|55|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:09:42.884279|2017-02-18 14:09:42.884279
NCT00713154|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-10|||April 2007||2007-04-01|July 2008|2008-07-01|September 2008|Anticipated|2008-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy|A Phase II, Double-Blind Placebo-Controlled, Parallel Group Study of the Safety and Preliminary Efficacy of MTS-01, for the Prevention of Alopecia Induced by Whole Brain Radiotherapy|Terminated||Phase 2|16|Actual|Mitos Pharmaceuticals||2||Major planned study protocol modifications|f||||f||||||||||2017-02-18 14:09:42.99123|2017-02-18 14:09:42.99123
NCT00713141|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-10|2010-08-30|||November 2004||2004-11-01|August 2010|2010-08-01||||||||Observational|||Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer|Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer|Completed||N/A|30||National University Hospital, Singapore|||1||f||||||||||||||2017-02-18 14:09:43.081524|2017-02-18 14:09:43.081524
NCT00713128|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2011-04-11|||April 2008||2008-04-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy|Prospective Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy|Completed||N/A|50|Anticipated|Steward St. Elizabeth's Medical Center of Boston, Inc.|||1||f||||f||||||||||2017-02-18 14:09:43.157831|2017-02-18 14:09:43.157831
NCT00713115|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2008-07-09|||June 2008||2008-06-01|June 2008|2008-06-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Prospective Randonmized Comparison of Needlescopic Versus Conventional Laparoscopic Adrenalectomy|Prospective Randonmized Comparison of Needlescopic Versus Conventional Laparoscopic Adrenalectomy for Benign Adrenal Tumors Less Than 5 cm in Diameter|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 14:09:43.247597|2017-02-18 14:09:43.247597
NCT00713102|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2016-10-03|||January 2008||2008-01-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Surgical and Medical Emergencies on Board of European Aircraft Carriers|Surgical and Medical Emergencies on Board of European Aircraft Carriers|Completed||N/A|10189|Actual|Ruhr University of Bochum|||1||f||||t||||||||||2017-02-18 14:09:43.458153|2017-02-18 14:09:43.458153
NCT00713089|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-01-07|||March 2006||2006-03-01|January 2014|2014-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development|A 2 Year Prospective Study of Stool Microbiota in Two Diverse Cohorts of Asian (Singaporean and Indonesian) Newborns and Its Influence on Allergy Development|Completed||N/A|74|Actual|National University Hospital, Singapore|||2||f||||f||||||Samples With DNA|"~     Stools samples will be collected between 72 to 120 hours (or 3 to 5 days) and at 1, 3 and 12~     months of age.~   "|||2017-02-18 14:09:43.552244|2017-02-18 14:09:43.552244
NCT00713076|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-08-18|||October 2007||2007-10-01|July 2008|2008-07-01||||March 2008|Actual|2008-03-01||Interventional|||Wettability of Contact Lenses With a Multi-Purpose Solution||Completed||N/A|30|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 14:09:43.646484|2017-02-18 14:09:43.646484
NCT00713063|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2015-01-29|||April 2006||2006-04-01|January 2015|2015-01-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Behavioral Exercise Intervention for Smoking Cessation|Behavioral Exercise Intervention for Smoking Cessation|Completed||Phase 2|61|Actual|Butler Hospital||2|||f||||f||||||||||2017-02-18 14:09:43.7424|2017-02-18 14:09:43.7424
NCT00713050|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-06-10|||August 2007||2007-08-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Speech and Language Therapy After Stroke|Neurophysiological Measurement in Aphasia Treatment|Terminated||N/A|34|Actual|University of Chicago||2||Protocol expired; PI retired|f||||f||||||||||2017-02-18 14:09:43.838168|2017-02-18 14:09:43.838168
NCT00713037|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2017-02-02|||June 2008||2008-06-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas|Hypoxia-PET and IMPT Dose Painting in Patients With Chordomas: A Pilot Study|Completed||N/A|20|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:09:43.942619|2017-02-18 14:09:43.942619
NCT00713024|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2010-06-28|||January 2008||2008-01-01|June 2010|2010-06-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Patterns of Cerebral Activation to Innocuous and Noxious Heat Stimulations in Neuropathic Pain|Patterns of Cerebral Activation to Innocuous and Noxious Heat Stimulations in Neuropathic Pain|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-02-18 14:09:44.048098|2017-02-18 14:09:44.048098
NCT00713011|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2012-11-14|||November 2008||2008-11-01|November 2012|2012-11-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|CARDINAL||Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients|Randomized Open-label 2-arm Parallel Design Comparator Study of the Effect of Adalat® XL® Compared to Diltiazem on Proteinuria and Blood Pressure in Patients With Diabetes and Mild to Moderate Hypertension When Used as an Add on to Avalide®|Withdrawn||Phase 3|0|Actual|Bayer||2||"Study was stopped by sponsor prior to first patient assignment to groups due to operational~   reasons."|f||||f||||||||||2017-02-18 14:09:44.135596|2017-02-18 14:09:44.135596
NCT00712998|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2009-05-17|||May 2008||2008-05-01|March 2008|2008-03-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Observational|||X-Ray Computed Tomography and Blood Reactive Oxygen Species Level|Effect of X-Ray Computed Tomography Examination on the Blood Reactive Oxygen Species Level in Apparently Healthy Adults|Terminated||N/A|60|Anticipated|National Taiwan University Hospital|||3|Beacuse of unexpected administrative barriers, only 5 cases were enrolled in a year.|f||||f||||||None Retained|"~     only peripheral blood will be collected for measurement of reactive oxygen species.~   "|||2017-02-18 14:09:44.235238|2017-02-18 14:09:44.235238
NCT00712985|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2014-03-24|2013-06-11||September 2005||2005-09-01|March 2014|2014-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|CTIBL|18 patients signed consent & 1 withdrew due to family not wishing her to continue with trial.|Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)|Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)|Completed||Phase 3|18|Actual|Milton S. Hershey Medical Center|18 patients were able to be enrolled in this trial & only 13 were able to be analyzed. This was an insufficient number to analyze/interpret data.|1|||f||||f||||||||||2017-02-18 14:09:44.31038|2017-02-18 14:09:44.31038
NCT00712972|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2009-07-16|||July 2008||2008-07-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Evaluation of the Medial Parapatellar Knee Injection Technique|Evaluation of the Effectiveness of the Medial Parapatellar Knee Injection Technique|Completed||N/A|45|Anticipated|Oklahoma State University Center for Health Sciences|||1||f||||t||||||||||2017-02-18 14:09:44.56654|2017-02-18 14:09:44.56654
NCT00712959|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-04-01|2014-02-18||June 2008||2008-06-01|April 2014|2014-04-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose|Immune Responses in Adults to Revaccination With Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (ADACEL®) 10 Years After a Previous Dose|Completed||Phase 4|769|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 14:09:44.669634|2017-02-18 14:09:44.669634
NCT00712946|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-04-27|||March 2006||2006-03-01|March 2010|2010-03-01|December 2010|Actual|2010-12-01|||||Observational|Barosleep||Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages|Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages|Completed||N/A|103|Actual|GE Healthcare|||2||f||||t||||||||||2017-02-18 14:09:45.419611|2017-02-18 14:09:45.419611
NCT00712933|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2017-01-19|||May 2008||2008-05-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057|A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B™)a Fully Human Monoclonal Anti-BLyS Antibody in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed the Phase 3 Protocol HGS1006-C1056 or HGS1006-C1057|Completed||Phase 3|738|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 14:09:45.50761|2017-02-18 14:09:45.50761
NCT00712920|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-06-06|2009-09-30||January 2007||2007-01-01|June 2011|2011-06-01||||May 2008|Actual|2008-05-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies|Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 and MP03-33 in Patients With Perennial Allergic Rhinitis|Completed||Phase 3|581|Actual|Meda Pharmaceuticals|Standard deviations for primary endpoint are not available.|3|||f||||f||||||||||2017-02-18 14:09:48.156415|2017-02-18 14:09:48.156415
NCT00712907|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2008-07-09|||February 2003||2003-02-01|July 2008|2008-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow|Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow|Completed||N/A|12|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 14:09:49.264662|2017-02-18 14:09:49.264662
NCT00712894|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-09-20|||December 2006||2006-12-01|September 2012|2012-09-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Interventional|EDUCATE-AMI||Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction|Reversal of No-reflow/Slow-flow During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction--a Prospective Randomized Study Comparing Intracoronary Infusion of Diltiazem, Verapamil and Nitroglycerin|Completed||Phase 4|102|Actual|Fudan University||3|||f||||t||||||||||2017-02-18 14:09:49.359903|2017-02-18 14:09:49.359903
NCT00712881|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2016-02-05|||October 2008||2008-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|||Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Patients With HER2-Positive Breast Cancer|Prospective, Open-Label, Randomized Study of Combination Therapy of MYOCET® Plus Cyclophosphamide and Trastuzumab Versus Free Doxorubicin Plus Cyclophosphamide Alone, Each Followed by Docetaxel and Trastuzumab, in Neoadjuvant Setting in Treatment-Naive Patients With HER2-Positive Breast Cancer|Completed||Phase 2|126|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 14:09:49.478447|2017-02-18 14:09:49.478447
NCT00712868|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-07-17|||June 2008||2008-06-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|LACTAFEM||Acceptability of Lactacyd Femina|Safety Dermatological Evaluation: Acceptability With Gynaecological Follow up Lactacyd Femina|Completed||Phase 4|559|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:09:49.59387|2017-02-18 14:09:49.59387
NCT00712855|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-10-26|||June 2008||2008-06-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|HCC||A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma|A Phase 1B, Multi-center, Open Label, Dose Escalation Study of Mapatumumab ([HGS1012], a Fully-human Monoclonal Antibody to TRAIL-R1) in Combination With Sorafenib as a First Line Therapy in Subjects With Advanced Hepatocellular Carcinoma|Completed||Phase 1|23|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:09:49.682758|2017-02-18 14:09:49.682758
NCT00712842|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-07-19|||January 2007||2007-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|||Neurovascular Coupling in Patients With Early Stage Diabetes Retinopathy|Neurovascular Coupling in Patients With Early Stage Diabetes Retinopathy|Completed||N/A|100|Actual|Medical University of Vienna|||2||f||||t||||||||||2017-02-18 14:09:49.792087|2017-02-18 14:09:49.792087
NCT00712439|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-06-06|||April 2006||2006-04-01|June 2011|2011-06-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy|Completed||Phase 2|147|Actual|Depomed||2|||f||||f||||||||||2017-02-18 14:09:58.566526|2017-02-18 14:09:58.566526
NCT00712829|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-10-07|||May 2008||2008-05-01|October 2011|2011-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents|A Phase I Study Evaluating the Safety, Pharmacokinetics, Tissue Distribution, Metabolism of Small Molecule Inhibitors of Prostate Specific Membrane Antigen: Determination of I-123 Radiation Dosimetry for 123-I-MIP-1072 and 123-I-MIP-1095|Completed||Phase 1|12|Anticipated|Molecular Insight Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 14:09:50.099782|2017-02-18 14:09:50.099782
NCT00712816|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-03-19|||July 2008||2008-07-01|March 2012|2012-03-01|May 2012|Anticipated|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Use of Cold and Compression Therapy With Total Knee Replacement Patients|Investigating the Use of a Cryopneumatic Therapy Device in Primary Total Knee Arthroplasty Patients|Unknown status|Active, not recruiting|Phase 4|224|Anticipated|CoolSystems, Inc.||2|||f||||f||||||||||2017-02-18 14:09:50.197036|2017-02-18 14:09:50.197036
NCT00712803|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-12-31|||December 2008||2008-12-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy Adults|A Phase I Dose Comparison Study of the Safety and Immunogenicity of rDEN3-3'Ddelta30, a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 3|Completed||Phase 1|29|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 14:09:50.319303|2017-02-18 14:09:50.319303
NCT00712790|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-01-04|||June 2008||2008-06-01|January 2016|2016-01-01|April 2014|Actual|2014-04-01|June 2009|Actual|2009-06-01||Interventional|||Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)|Phase I/II Study of SIR-Spheres Plus Sorafenib as First Line Treatment in Patients With Non-Resectable Primary Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|35|Actual|Singapore Clinical Research Institute||1|||f||||f||||||||||2017-02-18 14:09:50.43279|2017-02-18 14:09:50.43279
NCT00712777|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-11-20|||March 2008||2008-03-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor Polymorphism|Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor Polymorphism|Withdrawn||N/A|0|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 14:09:50.5491|2017-02-18 14:09:50.5491
NCT00712764|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2008-07-08|||January 2005||2005-01-01|December 2006|2006-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Role of Adenosine in the Control of Choroidal Blood Flow During Changes in Ocular Perfusion Pressure.|Role of Adenosine in the Control of Choroidal Blood Flow During Changes in Ocular Perfusion Pressure.|Completed||N/A|20|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 14:09:50.650724|2017-02-18 14:09:50.650724
NCT00712751|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-09-26|||June 2008||2008-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Sexual Health of Rectal Cancer Patients|The Sexual Health of Rectal Cancer Patients: A Pilot Study|Active, not recruiting||N/A|192|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:09:50.74411|2017-02-18 14:09:50.74411
NCT00712738|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2017-01-24|||June 20, 2008||2008-06-20|September 22, 2010|2010-09-22|September 22, 2010|Actual|2010-09-22|September 22, 2010|Actual|2010-09-22||Interventional|||Oral Nifedipine to Treat Iron Overload|A Trial of Oral Nifedipine for the Treatment of Iron Overload|Completed||Phase 1|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:09:50.854364|2017-02-18 14:09:50.854364
NCT00712725|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2015-01-23|2010-10-22||July 2008||2008-07-01|January 2015|2015-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||MK3207 for Treatment of Acute Migraines (3207-005)|A Phase IIb, Multicenter, Randomized, Double-blind, Placebo-Controlled Dose-finding Study of MK3207 in the Treatment of Acute Migraine|Completed||Phase 2|676|Actual|Merck Sharp & Dohme Corp.||7|||f||||||||||||||2017-02-18 14:09:50.97682|2017-02-18 14:09:50.97682
NCT00712712|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2009-12-13|||October 2007||2007-10-01|July 2009|2009-07-01||||December 2010|Anticipated|2010-12-01||Interventional|||Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer|Evaluation of the Effectiveness of the Radiofrequency Ablation for Reducing Refractory Pain From Bone Metastases|Unknown status|Recruiting|Phase 2|63|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:09:53.054292|2017-02-18 14:09:53.054292
NCT00712699|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2013-08-10||2013-08-10|June 2008||2008-06-01|August 2013|2013-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With ADHD|Placebo vs. Extended Release Stimulant Crossover Trial in Preschoolers With ADHD|Completed||N/A|27|Actual|Baystate Medical Center||2|||f||||f||||||||||2017-02-18 14:09:53.147943|2017-02-18 14:09:53.147943
NCT00712686|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2013-11-07|||June 2000||2000-06-01|June 2010|2010-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia|A Multicenter, Double-Blind, Randomized, Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia|Completed||Phase 3|690|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-02-18 14:09:53.253231|2017-02-18 14:09:53.253231
NCT00712673|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-10-24|2016-08-18||June 2008||2008-06-01|October 2016|2016-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|GETGOAL-M|Safety population included all randomized patients who were exposed to at least 1 dose of study drug, regardless of the amount of treatment administered.|GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter 24-week Study Followed by an Extension Assessing the Efficacy and Safety of AVE0010 on Top of Metformin in Patients With Type 2 Diabetes Not Adequately Controlled With Metformin|Completed||Phase 3|680|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 14:09:53.363189|2017-02-18 14:09:53.363189
NCT00712660|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2013-03-31|||November 2008||2008-11-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|November 2009|Actual|2009-11-01||Interventional|||Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia|ITAREPS Trial: A Prospective Randomized Double-blind Controlled Study in IT-aided Mobile Phone-based Relapse Prevention Program in Schizophrenia.|Completed||N/A|146|Actual|Prague Psychiatric Center||2|||f||||f||||||||||2017-02-18 14:09:55.626984|2017-02-18 14:09:55.626984
NCT00006322|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-02|2016-03-15|||July 1999||1999-07-01|March 2005|2005-03-01|June 2003|Actual|2003-06-01|||||Observational|||Birth Weight Effect on Blood Pressure in Late Childhood||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:57.713765|2017-02-18 18:12:57.713765
NCT00712621|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2009-11-20|||February 2010||2010-02-01|November 2009|2009-11-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination|Phase II Two Arm Randomized Controlled Clinical Trial to Study Quality of Life and Survival of Breast Cancer Patients After Completion of Chemotherapy or Radiation Therapy or Surgery or Any Combination Therapy in Stage I to IV Carcinoma|Withdrawn||Phase 2|460|Anticipated|American Scitech International||2||"Study is withdrawn due to unavailability of eligible subject population. We will request the~   sponsors to extend the time for enrollment."|f||||f||||||||||2017-02-18 14:09:55.961099|2017-02-18 14:09:55.961099
NCT00712608|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2010-01-26|||August 2008||2008-08-01|April 2009|2009-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||The Evaluation of Cow's Milk Formula - Study B|The Evaluation of Cow's Milk Formula - Study B|Completed||N/A|399|Anticipated|Mead Johnson Nutrition||3|||f||||f||||||||||2017-02-18 14:09:56.070441|2017-02-18 14:09:56.070441
NCT00712595|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2009-04-22|||January 2007||2007-01-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|January 2007|Actual|2007-01-01||Interventional|Mifemyo||Mifepristone for Treatment of Uterine Fibroids|Mifepristone 5 mg Versus 10 mg for the Treatment of Uterine Leiomyomata. A Randomized, Double Blinded Clinical Trial.|Completed||Phase 2/Phase 3|200|Actual|Mediterranea Medica S. L.||2|||f||||t||||||||||2017-02-18 14:09:56.204436|2017-02-18 14:09:56.204436
NCT00712582|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2017-01-11|||July 2008||2008-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma|Risk-Adapted Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma|Active, not recruiting||Phase 2|101|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 14:09:56.319517|2017-02-18 14:09:56.319517
NCT00712569|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2015-02-05|||June 2008||2008-06-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Observational|||Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety|Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety|Completed||N/A|85|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 14:09:56.425762|2017-02-18 14:09:56.425762
NCT00712556|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-09|2013-02-25|||May 2008||2008-05-01|February 2013|2013-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||PET Study in Patients With Non-Hodgkin Lymphoma|Positron Emission Tomography Study in Patients With Non-Hodgkin Lymphoma|Completed||Phase 1|55|Actual|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-02-18 14:09:56.524453|2017-02-18 14:09:56.524453
NCT00712543|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-08-19|2011-04-07||June 2009||2009-06-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Preference Study Comparing Kristalose® and Liquid Lactulose|A Preference Study Comparing Kristalose® and Liquid Lactulose in the Treatment of Constipation|Completed||Phase 4|50|Actual|Cumberland Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:09:56.650963|2017-02-18 14:09:56.650963
NCT00712530|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-04|2013-02-19|2013-02-19||January 2005||2005-01-01|February 2013|2013-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|GIHU004||Single DermaVir Immunization in HIV-1 Infected Patients on HAART|A Phase I Study to Evaluate the Tolerability and Safety of LC002, a DermaVir Vaccine, in HIV-1-infected Subjects Currently Under Treatment With Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1|9|Actual|Genetic Immunity|This is a Phase I small sample study that was not powered for the secondary efficacy endpoints.|3|||f||||t||||||||||2017-02-18 14:09:57.320982|2017-02-18 14:09:57.320982
NCT00712517|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-07-18|||September 2010||2010-09-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Propofol Versus Volatile Anesthesia in Post Operative Pain Management|Do Patients Anesthetized With Propofol Have Less Pain Than Those Anesthetized With Volatile?|Terminated||N/A|90|Actual|The Cleveland Clinic||2||Enrolling of participants has halted and the results are being gathered|f||||f||||||||No||2017-02-18 14:09:57.933231|2017-02-18 14:09:57.933231
NCT00712504|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-11-07|||July 2004||2004-07-01|November 2008|2008-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer|A Phase 1 Safety And Pharmacokinetic Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Solid Tumors|Completed||Phase 1|49|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:09:58.048132|2017-02-18 14:09:58.048132
NCT00712491|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2013-01-08|||September 2008||2008-09-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|||Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration|A Phase 1/2, Randomized Clinical Study to Assess the Safety and Efficacy of Sirolimus in Patients With Newly Diagnosed, Treatment-Naive Sub-Foveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|Terminated||Phase 1/Phase 2|20|Actual|Santen Inc.||2|||f||||f||||||||||2017-02-18 14:09:58.150214|2017-02-18 14:09:58.150214
NCT00712478|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-03-03|||September 2007||2007-09-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|INTENSE3MIX||Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes|Observational Study on Efficacy of Intensification of Insulin Therapy to at Least 3 Daily Injections in Type 2 Diabetes|Completed||N/A|114|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:09:58.254064|2017-02-18 14:09:58.254064
NCT00712465|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2010-12-02|||August 2008||2008-08-01|December 2010|2010-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||An Interaction Study With Digoxin and AZD1305|A Phase I, Randomised, Open, Single-centre, Three-period Crossover Study to Evaluate the Effect of AZD1305 on the Pharmacokinetics of Digoxin After Repeated Oral Administration of AZD1305 and Digoxin to Young Healthy Male Volunteers|Completed||Phase 1|18|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:09:58.352802|2017-02-18 14:09:58.352802
NCT00712452|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2013-05-13|||June 2008||2008-06-01|May 2013|2013-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|IROCHIM||Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve|Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve.|Terminated||N/A|19|Actual|Assistance Publique - Hôpitaux de Paris||3||problems of insuffisant recruitment|f||||f||||||||||2017-02-18 14:09:58.453223|2017-02-18 14:09:58.453223
NCT00712426|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2016-02-10||2016-02-10|September 2009||2009-09-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|December 2014|Actual|2014-12-01||Interventional|CREST-E||Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)|Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)|Terminated||Phase 3|553|Actual|Massachusetts General Hospital||2||"Results of an interim analysis showed that it was unlikely that creatine was effective in~   slowing loss of function in early symptomatic Huntington's Disease."|f||||t||||||||||2017-02-18 14:09:58.665843|2017-02-18 14:09:58.665843
NCT00712413|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2017-02-08|||August 2008||2008-08-01|February 2017|2017-02-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori|Pilot Study Assessing the Safety, Tolerability, Compliance and Efficacy of Twice Daily Dosed Pylera Plus Omeprazole as a First Line Treatment of Helicobacter Pylori Infection|Withdrawn||Phase 3|0|Actual|Forest Laboratories||1||Sponsor's decision|f||||f||||||||||2017-02-18 14:09:58.82838|2017-02-18 14:09:58.82838
NCT00712400|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2012-01-24|||June 2005||2005-06-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects|Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects|Completed||N/A|24|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 14:09:58.93082|2017-02-18 14:09:58.93082
NCT00712387|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-02-23|||July 2008||2008-07-01|February 2009|2009-02-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Trial of Proficiency- Based Simulation Training for General Surgical Trainees|A National, Prospective,Randomised, Single Blinded Controlled Trial of Proficiency- Based Simulation Training for General Surgical Trainees|Unknown status|Active, not recruiting|N/A|24|Anticipated|Royal College of Surgeons, Ireland||2|||f||||f||||||||||2017-02-18 14:09:59.020514|2017-02-18 14:09:59.020514
NCT00712374|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2009-09-21|||September 2008||2008-09-01|September 2009|2009-09-01|July 2012|Anticipated|2012-07-01|December 2011|Anticipated|2011-12-01||Interventional|||Evaluation of the Public Health Impact of Seasonal Intermittent Preventive Treatment (IPT) in Children in Senegal|Evaluation of the Public Health Impact and Cost Effectiveness of Seasonal Intermittent Preventive Treatment in Children in Senegal|Unknown status|Enrolling by invitation|Phase 4|100000|Anticipated|London School of Hygiene and Tropical Medicine||1|||f||||t||||||||||2017-02-18 14:09:59.131394|2017-02-18 14:09:59.131394
NCT00712361|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-12-04|||July 2008||2008-07-01|December 2009|2009-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||A Comparative Study of the SoftTouch Non-Invasive Finger-Mounted Device|A Comparative Clinical Trial to Assess the Accuracy of the SoftTouch. A Novel Non-invasive Device for Measuring Peripheral Blood Glucose, Carbon Dioxide, pH, Hemoglobin, Hematocrit, SpO2, Peripheral Pulse and Blood Pressure.|Completed||N/A|70|Actual|Cnoga Medical Ltd.||1|||f||||t||||||||||2017-02-18 14:09:59.218702|2017-02-18 14:09:59.218702
NCT00712348|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-05-30|2014-04-30||December 2008||2008-12-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|||Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase|A Phase 3 Multicenter, Open-label, Switchover Trial to Assess the Safety and Efficacy of Plant Cell Expressed Recombinant Human Glucocerebrosidase in Patients With Gaucher Disease Treated With Imiglucerase|Completed||Phase 3|31|Actual|Protalix||1|||f||||t||||||||||2017-02-18 14:09:59.336279|2017-02-18 14:09:59.336279
NCT00712335|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-04-18|2011-11-16||February 2007||2007-02-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||The Effects of Montelukast on Smokers With Asthma|The Effects of Montelukast on Sputum Cells and Inflammatory Markers in Smokers With Asthma|Completed||Phase 4|105|Actual|Inje University|It is difficult attaining representative gender ratios (i.e., representative of the general population) when conducting a smoking study in Korea, as smoking by females is still considered culturally taboo.|5|||f||||t||||||||||2017-02-18 14:09:59.874517|2017-02-18 14:09:59.874517
NCT00712322|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2015-01-22|||October 2008||2008-10-01|January 2015|2015-01-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||2 Week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Yrs) With Neurogenic Detrusor Overactivity|A 14-day, Open-label, Multicenter, Dose-escalating, Sequential Cohort Study to Evaluate Pharmacodynamics (Urodynamics) and Pharmacokinetics, Clinical Efficacy, Tolerability and Safety, Following Multiple Doses (mg/kg/Day) of Darifenacin Liquid Oral Suspension Given b.i.d. (Twice Daily) in Children, Ages 2 - 15 Years, With Neurogenic Detrusor Overactivity|Suspended||Phase 2|9|Actual|Warner Chilcott||4||Due to extremely difficult enrollment.|f||||t||||||||||2017-02-18 14:10:00.790239|2017-02-18 14:10:00.790239
NCT00712309|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2009-02-09|||February 2007||2007-02-01|February 2009|2009-02-01||||June 2010|Anticipated|2010-06-01||Interventional|ETAP||Endovascular Treatment of Popliteal Artery - Balloon Angioplasty Versus Primary Stenting|Endovascular Treatment of Atherosclerotic Popliteal Artery Lesions - Balloon Angioplasty Versus Primary Stenting|Unknown status|Recruiting|N/A|250|Anticipated|Herz-Zentrums Bad Krozingen||2|||f||||t||||||||||2017-02-18 14:10:01.054082|2017-02-18 14:10:01.054082
NCT00712296|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-12-29|||August 2008||2008-08-01|December 2009|2009-12-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Effectiveness of Chinese Herbal Therapy for Asthma|Center for Chinese Herbal Therapy for Asthma. Project #2-Clinical Effect of a Chinese Herbal Therapy in Human Asthma-Phase II|Suspended||Phase 2|50|Anticipated|Icahn School of Medicine at Mount Sinai||3|||f||||t||||||||||2017-02-18 14:10:01.148649|2017-02-18 14:10:01.148649
NCT00712283|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2009-12-04|||July 2008||2008-07-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers|A Single Center, Randomized, Double-blind, Placebo-controlled, Parallel Group Design Study to Investigate the Effect of 12,5 mg, 25 mg, 50 mg and 75 mg Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers|Completed||Phase 1|64|Anticipated|Merz Pharmaceuticals GmbH||4|||f||||||||||||||2017-02-18 14:10:01.26944|2017-02-18 14:10:01.26944
NCT00712270|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-02-25|||April 2005||2005-04-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|December 2008|Actual|2008-12-01||Interventional|BEST||Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia|A Randomized Double-blind Trial of Aripiprazole and Risperidone in Schizophrenia: An Evaluation of Neuroimaging, Neuropsychological, and Pharmacogenomic Markers of Differential Treatment Response|Terminated||Phase 4|21|Actual|Kettering Health Network||3||Study terminated due to failure to meet sufficient enrollment for valid analysis|f||||f||||||||No||2017-02-18 14:10:01.365821|2017-02-18 14:10:01.365821
NCT00712257|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2014-06-02|||November 2007||2007-11-01|June 2014|2014-06-01|August 2009|Actual|2009-08-01|September 2008|Actual|2008-09-01||Interventional|SALVAGE||Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis|A Prospective, Multicenter Trial to Evaluate the Safety and Performance of Spectranetics Laser With Adjunct PTA and GORE VIABAHN Endoprosthesis for the Treatment of SFA Instent Restenosis.|Terminated||N/A|27|Actual|VIVA Physicians||1||Due to safety concerns|f||||t||||||||||2017-02-18 14:10:01.492808|2017-02-18 14:10:01.492808
NCT00712244|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2010-09-10|2009-04-27||October 2007||2007-10-01|September 2010|2010-09-01||||April 2009|Actual|2009-04-01||Interventional|||DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus|DisCoVisc Versus Competitor|Completed||Phase 4|112|Actual|Alcon Research||4|||f||||f||||||||||2017-02-18 14:10:01.599877|2017-02-18 14:10:01.599877
NCT00712231|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-08|||January 2008||2008-01-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Limitations of Using a Sheimpflug Image-Based Device for Measuring Anterior Chamber Depth in Pseudophakic Eyes|To Assess the Degree of Agreement of Anterior Chamber Depth Measurements by 2 Optical Devices (Pentacam and IOLMaster) and Compare Them With Contact Ultrasound A-Scan in Phakic and Pseudophakic Eyes.|Completed||N/A|184|Actual|Far Eastern Memorial Hospital|||2||f||||f||||||None Retained|"~     no specimen~   "|||2017-02-18 14:10:02.450678|2017-02-18 14:10:02.450678
NCT00712218|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2012-02-01|||December 2008||2008-12-01|February 2012|2012-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|LION||Lymphadenectomy In Ovarian Neoplasms|Randomized, Multicentre Trial for Lymphadenectomy In Ovarian Neoplasms|Active, not recruiting||Phase 3|640|Anticipated|Philipps University Marburg Medical Center||2|||f||||t||||||||||2017-02-18 14:10:02.534012|2017-02-18 14:10:02.534012
NCT00712205|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2009-08-12|||August 2008||2008-08-01|August 2009|2009-08-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Vitamin D for the Treatment of Severe Asthma|Asthma and Vitamin D (a Clinical Pilot Study)|Unknown status|Enrolling by invitation|Phase 4|20|Anticipated|Kantonsspital Baselland Bruderholz||2|||f||||f||||||||||2017-02-18 14:10:02.696161|2017-02-18 14:10:02.696161
NCT00712192|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-08|||January 2007||2007-01-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Endoscopic Saphenous Vein Harvest for Coronary Artery Bypass Grafting|The Impact on Endothelial Function and Integrity by Endoscopic Saphenous Vein Harvest for Coronary Artery Bypass Grafting|Completed||N/A|34|Actual|Far Eastern Memorial Hospital||1|||f||||t||||||||||2017-02-18 14:10:02.802341|2017-02-18 14:10:02.802341
NCT00712179|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2016-04-07|2016-03-09||July 2008||2008-07-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|October 2011|Actual|2011-10-01||Observational|||Understanding Different Parameters in Locomotor Training (a Type of Walking Training) for Person After a Stroke|Developing Evidence-based Parameter Selection for Locomotor Training|Completed||N/A|49|Actual|VA Office of Research and Development|||1||f||||f||||||||Undecided||2017-02-18 14:10:02.880456|2017-02-18 14:10:02.880456
NCT00712166|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2010-11-19|2010-09-10||May 2008||2008-05-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|AIR-CF4||Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa|A Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysine For Inhalation in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa (AIR-CF4)|Completed||Phase 3|160|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 14:10:03.137543|2017-02-18 14:10:03.137543
NCT00712153|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2010-08-05|||November 2006||2006-11-01|July 2008|2008-07-01||||November 2007|Actual|2007-11-01||Observational|||Follow-up of Coronary Artery Bypass Graft Patency by Multislice Computed Tomography|Follow-up of Coronary Artery Bypass Graft Patency by Multislice Computed Tomography|Completed||N/A|36|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-02-18 14:10:03.936864|2017-02-18 14:10:03.936864
NCT00712140|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-09-01|||October 2007||2007-10-01|November 2008|2008-11-01||||October 2011|Anticipated|2011-10-01||Interventional|||Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer|Persephone: Duration of Trastuzumab With Chemotherapy in Women With Early Stage Breast Cancer: Six Months Versus Twelve|Unknown status|Recruiting|Phase 3|4000|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:10:04.012287|2017-02-18 14:10:04.012287
NCT00712127|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-02-18|||June 2006||2006-06-01|February 2011|2011-02-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|RENEW||Re-energize With Nutrition, Exercise and Weight Loss|Preventing Adverse Effects In Class II and Class III Obesity|Completed||N/A|310|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 14:10:04.126843|2017-02-18 14:10:04.126843
NCT00712114|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-06|2011-06-11|||July 2008||2008-07-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid Arthritis|A Phase I/II, Open Label, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Potential Anti-Inflammatory Activity of HE3286 When Administered Orally for 29 Days to Patients With Rheumatoid Arthritis on a Stable Dose of Methotrexate|Completed||Phase 1/Phase 2|14|Actual|Harbor Therapeutics||3|||f||||f||||||||||2017-02-18 14:10:04.234721|2017-02-18 14:10:04.234721
NCT00712101|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-04-19|||July 2008||2008-07-01|August 2009|2009-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|AIDA STEMI||Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction|Prospective Randomized Controlled Clinical Study to Compare Abciximab-bolus i.v. Versus i.c. in Primary PCI in Patients With Acute ST-elevation Myocardial Infarction|Completed||Phase 3|1912|Anticipated|University of Leipzig||2|||f||||t||||||||||2017-02-18 14:10:04.346546|2017-02-18 14:10:04.346546
NCT00712088|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-03-10|||July 2008||2008-07-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Project ICARE: Intervening for Community Awareness, Respect, & Empowerment|Project ICARE: Intervening for Community Awareness, Respect, & Empowerment - Behavioral Intervention to Reduce Sexual Risk Behavior of African American Men Who Have Sex With Men|Completed||N/A|275|Anticipated|Centers for Disease Control and Prevention||2|||f||||||||||||||2017-02-18 14:10:04.463408|2017-02-18 14:10:04.463408
NCT00712075|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2015-05-12|2015-04-15||July 2008||2008-07-01|May 2015|2015-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|FROPS||Functional Rehabilitation for Older Patients With Schizophrenia|Functional Rehabilitation for Older Patients With Schizophrenia (FROPS)|Terminated||N/A|107|Actual|VA Office of Research and Development|"Early termination leading to small sample size and loss of follow-up data.~No 50% CBSST comparison group without mobile computer to test efficacy of shorter treatment alone."|3||Loss of funding|f||||t||||||||||2017-02-18 14:10:04.570839|2017-02-18 14:10:04.570839
NCT00712062|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-09-16|||February 2009||2009-02-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma|Pilot Study to Determine Therapeutic Response of Pemetrexed (Alimta) in Recurrent or Progressive Primary Central Nervous System Lymphoma (PCNSL) by Establishing the Radiographic Response Rate Using Modified Macdonald Criteria|Withdrawn||Phase 2|0|Actual|University of Florida||1||Lack of accrual|f||||t||||||||||2017-02-18 14:10:05.192658|2017-02-18 14:10:05.192658
NCT00712049|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-07-20|||June 2008||2008-06-01|July 2011|2011-07-01||||||||Interventional|NASCIT||Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)|Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)-A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|200|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:10:05.300328|2017-02-18 14:10:05.300328
NCT00712036|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2015-01-08|||June 2008||2008-06-01|January 2015|2015-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Entry Into Comprehensive Methadone Treatment Via Interim Maintenance|Entry Into Comprehensive Methadone Treatment Via Interim Maintenance|Completed||N/A|230|Actual|Friends Research Institute, Inc.||3|||f||||t||||||||||2017-02-18 14:10:05.4052|2017-02-18 14:10:05.4052
NCT00712023|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2009-09-27|||July 2007||2007-07-01|April 2008|2008-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Forced-air Warming and Circulating-water Mattress in Preventing Heat Loss During Vascular Surgery|Effect of Forced-air Warming and Circulating-water Mattress in Preventing Heat Loss During Vascular Surgery|Completed||Phase 2|44|Actual|Mahidol University||2|||f||||f||||||||||2017-02-18 14:10:05.527574|2017-02-18 14:10:05.527574
NCT00712010|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2013-07-12|2013-04-09||July 2008||2008-07-01|July 2013|2013-07-01|April 2011|Actual|2011-04-01|July 2009|Actual|2009-07-01||Interventional|OPTI-PROT|Participants were recruited amoung the Nestlé Research Center staff.|Metabolic Effect of High-protein Meals in Men|Acute Metabolic Effect of the Protein Quality of a High-protein Meal Replacement in Healthy Men|Completed||N/A|25|Actual|Nestlé||7|||f||||f||||||||||2017-02-18 14:10:05.648245|2017-02-18 14:10:05.648245
NCT00711997|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2013-09-29|2012-08-14||August 2009||2009-08-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer|Phase 1/2a, Dose-Escalation, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Intratumoral Administration of DTA-H19 in Patients With Unresectable Pancreatic Cancer|Completed||Phase 1/Phase 2|9|Actual|BioCancell Ltd.||1|||f||||f||||||||||2017-02-18 14:10:06.110336|2017-02-18 14:10:06.110336
NCT00711984|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-07-25|||February 2004||2004-02-01|July 2011|2011-07-01||||||||Interventional|||Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Trial in Patients With Advanced Atherosclerosis|Comparison of Stenting Versus Best Medical Therapy for Treatment of Ostial Renal Artery Stenosis: a Randomized Controlled Trial in Patients With Advanced Atherosclerosis.|Unknown status|Recruiting|Phase 4|120|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:10:06.555025|2017-02-18 14:10:06.555025
NCT00711971|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2013-01-22|||September 2008||2008-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Interventional|||Does Fish Oil Prevent Depression in Pregnancy and Postpartum?|Does EPA or DHA Prevent Depressive Symptoms in Pregnancy and Postpartum?|Completed||Phase 2/Phase 3|126|Actual|University of Michigan||3|||f||||t||||||||||2017-02-18 14:10:06.654583|2017-02-18 14:10:06.654583
NCT00711958|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2016-10-21|||November 2004||2004-11-01|October 2016|2016-10-01|December 2005|Actual|2005-12-01|July 2005|Actual|2005-07-01||Interventional|||Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients|Double-blind, Randomized, Multicenter, Clinical Phase III Study to Evaluate the Efficacy and Safety of HX575 for the Treatment of Chemotherapy Associated Anemia in Cancer Patients|Completed||Phase 3|105|Actual|Sandoz||2|||f||||f||||||||No||2017-02-18 14:10:06.750047|2017-02-18 14:10:06.750047
NCT00711945|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-08|||March 2008||2008-03-01|July 2008|2008-07-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Observational|GROWTH1||Growth Relapse and Outcomes With Therapy 1|"Growth Relapse and Outcomes With Therapy 1:Factors Determining Poor Outcomes in Pediatric Crohns Disease"|Unknown status|Recruiting|N/A|300|Anticipated|European Society of Pediatric Gastroenterology, Hepatology and Nutrition|||1||f||||t||||||Samples Without DNA|"~     Serum for antiglycan antibodies stool for calprotectin~   "|||2017-02-18 14:10:06.874832|2017-02-18 14:10:06.874832
NCT00711932|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2013-09-10|||August 2008||2008-08-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Observational|||The Effect of TRA-8 on Ovarian Cancer Tissue|Death Receptor-Mediated Apoptosis and Therapy Strategies in Ovarian Cancer|Completed||N/A|478|Actual|University of Alabama at Birmingham|||1||f||||t||||||||||2017-02-18 14:10:06.958003|2017-02-18 14:10:06.958003
NCT00711919|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-09-09|||July 2007||2007-07-01|September 2009|2009-09-01||||December 2009|Anticipated|2009-12-01||Interventional|PEACE||Pitavastatin on Carotid Intima-media Thickness|Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-Lowering Therapy|Unknown status|Active, not recruiting|N/A|300|Anticipated|Kyoto Prefectural University of Medicine||2|||f||||f||||||||||2017-02-18 14:10:07.04816|2017-02-18 14:10:07.04816
NCT00711906|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2016-01-15|||February 2009||2009-02-01|January 2016|2016-01-01|September 2010|Actual|2010-09-01|February 2010|Actual|2010-02-01||Interventional|||Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy|The Role of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria And Its Effects in Pregnancy|Terminated||Phase 3|352|Actual|Institute of Tropical Medicine, Belgium||4||Malaria prev. fell in the study area, so we cannot evaluate the primary endpoint|f||||f||||||||||2017-02-18 14:10:07.168827|2017-02-18 14:10:07.168827
NCT00711893|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2013-03-11|||June 2008||2008-06-01|March 2013|2013-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|FASt-IBP||Feature Assessment Study for Indications Based Programming|Feature Assessment Study for Indications Based Programming|Completed||N/A|301|Actual|Guidant Corporation|||1||f||||f||||||||||2017-02-18 14:10:07.290809|2017-02-18 14:10:07.290809
NCT00711880|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2013-06-13|2012-07-19||May 2002||2002-05-01|June 2013|2013-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.|A Double Blind, Randomised, Placebo Controlled Parallel Group Study of Cannabis Based Medicine Extract (CBME), in the Treatment of Peripheral Neuropathic Pain Characterised by Allodynia.|Completed||Phase 3|125|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:10:07.516219|2017-02-18 14:10:07.516219
NCT00711867|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-12-09|2009-10-28||July 2008||2008-07-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Intraoperative Warming Devices|Intraoperative Warming: Comparison of Performance of the Dynatherm Medical vitalHeat™ Temperature Management System (vH2) and the Arizant Bair Hugger System|Completed||Phase 3|55|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:10:08.301633|2017-02-18 14:10:08.301633
NCT00711854|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2014-08-04|||January 2009||2009-01-01|August 2014|2014-08-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|||Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection|Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole (TMP-SMX) Plus Rifampicin With a Regimen of Linezolid in the Treatment of Infections Caused by Methicillin-resistant Staphylococcus Aureus (MRSA)|Completed||Phase 4|150|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 14:10:08.584264|2017-02-18 14:10:08.584264
NCT00711841|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-03-16|||July 2011||2011-07-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|COHELLP||Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome|Postpartum Dexamethasone for Women With Class I HELLP Syndrome: a Double-blind, Placebo-controled, Randomized Clinical Trial|Active, not recruiting||Phase 4|400|Anticipated|Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||t||||||||||2017-02-18 14:10:08.697029|2017-02-18 14:10:08.697029
NCT00711828|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2016-04-13|2015-01-16||August 2008||2008-08-01|March 2016|2016-03-01||||November 2013|Actual|2013-11-01||Interventional|||Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma|A Phase 2 Clinical Trial of Rituximab, Cyclophosphamide, Bortezomib (VELCADE), and Dexamethasone (R-CYBOR-D) in Relapsed Low Grade and Mantle Cell Lymphoma|Active, not recruiting||Phase 2|21|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:10:08.809698|2017-02-18 14:10:08.809698
NCT00711815|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-08-04|||January 2007||2007-01-01|August 2011|2011-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||A Study to Identify Markers in Blood and Tissue of HPV Clearance|Biomarkers of HPV Clearance: A Prospective Study|Completed||N/A|197|Actual|University of Alabama at Birmingham|||1||f||||t||||||Samples With DNA|"~     Whole blood, cervical cells~   "|||2017-02-18 14:10:09.112911|2017-02-18 14:10:09.112911
NCT00711802|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-01-05|2015-05-27||July 2008||2008-07-01|January 2016|2016-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||All participants who received at least 1 dose of study drug|Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections|An Evaluation of the Safety, Efficacy and Pharmacokinetics of Daptomycin in Pediatric Subjects Aged One to Seventeen Years With Complicated Skin and Skin Structure Infections Caused by Gram-Positive Pathogens|Completed||Phase 4|396|Actual|Cubist Pharmaceuticals LLC||2|||f||||f||||||||||2017-02-18 14:10:09.208814|2017-02-18 14:10:09.208814
NCT00711789|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2011-06-22|||February 2010||2010-02-01|January 2009|2009-01-01||||February 2013|Anticipated|2013-02-01||Interventional|ASK-IT||Angiotensin in Septic Kidney Injury Trial|A Pilot Crossover Randomised Controlled Trial of Angiotensin II in Critically Ill Patients With Severe Sepsis and Acute Renal Failure|Unknown status|Recruiting|Phase 2|12|Anticipated|Austin Health||2|||f||||f||||||||||2017-02-18 14:10:13.044855|2017-02-18 14:10:13.044855
NCT00711776|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2013-03-21|||April 2008||2008-04-01|March 2013|2013-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers|Bioequivalence Study of Aciclovir 5% Cream - Bioequivalence Study of Aciclovir Cream Between Current and New Formulation in Japanese Healthy Volunteers -|Completed||Phase 1|27|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:10:13.403316|2017-02-18 14:10:13.403316
NCT00711763|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-05-04|||July 2008||2008-07-01|April 2011|2011-04-01|September 2011|Anticipated|2011-09-01|April 2011|Actual|2011-04-01||Observational|||Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants|Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants|Suspended||N/A|1|Anticipated|Louisiana State University Health Sciences Center Shreveport|||1|failure to recruit more patients and lack of supporting personnel.|f||||f||||||||||2017-02-18 14:10:13.501285|2017-02-18 14:10:13.501285
NCT00711750|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-08|||January 2008||2008-01-01|July 2008|2008-07-01||||||||Observational|||Immediate Maintained Cannulation of a Newly Implanted Prosthetic Arteriovenous Access for Acute Hemodialysis||Unknown status|Recruiting|N/A|39|Anticipated|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-02-18 14:10:13.60121|2017-02-18 14:10:13.60121
NCT00711737|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-06-15|||September 2008||2008-09-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months|Open-label Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months|Completed||N/A|27|Actual|Changi General Hospital|||1||f||||f||||||||||2017-02-18 14:10:13.677146|2017-02-18 14:10:13.677146
NCT00711724|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2010-06-21|||July 2007||2007-07-01|June 2010|2010-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD|Comparison of Self and Clinician Administered Rating Scales in Patients With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|50|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-02-18 14:10:13.760774|2017-02-18 14:10:13.760774
NCT00711711|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2011-04-13|||June 2008||2008-06-01|April 2011|2011-04-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||Manual Lymphatic Drainage Following Total Knee Arthroplasty Surgery|Outcome of Manual Lymphatic Drainage Following Total Knee Arthroplasty Surgery|Completed||N/A|60|Actual|Haute Ecole Cantonale Vaudoise de Santé||2|||f||||f||||||||||2017-02-18 14:10:13.848553|2017-02-18 14:10:13.848553
NCT00711698|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-06-06|||September 2007||2007-09-01|August 2009|2009-08-01||||September 2009|Anticipated|2009-09-01||Interventional|||Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC)|PCA for Pain Control in Adults With Sickle Cell Disease in the Emergency Department (ED) Decreases Admission Rates Over Standard Bolus Therapy|Withdrawn||Phase 2|0|Actual|Johns Hopkins University||2||technical difficulties coordinating study|f||||f||||||||||2017-02-18 14:10:13.955665|2017-02-18 14:10:13.955665
NCT00711321|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-04|2010-05-26|||November 2008||2008-11-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Long-term Safety and Tolerability of AFFITOPE AD02|Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD02 Applied During AFFiRiS 002|Completed||N/A|23|Actual|Affiris AG|||2||f||||t||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:10:22.584605|2017-02-18 14:10:22.584605
NCT00711685|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-08|||January 2007||2007-01-01|July 2008|2008-07-01||||December 2007|Actual|2007-12-01||Interventional|||Topical Vancomycin in Prevention of Methicillin-Resistant Staphylococcal Related Mediastinitis in Patients Receiving Coronary Artery Bypass Graft|Topical Vancomycin in Prevention of Methicillin-Resistant Staphylococcal Related Mediastinitis in Patients Receiving Coronary Artery Bypass Graft|Completed||N/A|50|Anticipated|Far Eastern Memorial Hospital|||||f||||t||||||||||2017-02-18 14:10:14.059151|2017-02-18 14:10:14.059151
NCT00711672|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2015-06-02|||July 2008||2008-07-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Study of the Therapeutic Use of Language in Patients With Metastatic Colorectal Cancer|Critical Negotiations: Narrative Agreement, Negotiation, and Register Use in Encounters Between Patients With Metastatic Colorectal Carcinoma and Their Oncologists|Completed||N/A|5|Actual|Hematology and Oncology Associates of NE Pennsylvania|||2||f||||t||||||||||2017-02-18 14:10:14.159651|2017-02-18 14:10:14.159651
NCT00711659|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2013-11-25|||June 2007||2007-06-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|Head to Toe||Standardizing Educational Opportunities on the Complete Pediatric Physical Exam|Standardizing Educational Opportunities on the Complete Pediatric Physical Exam|Completed||N/A|519|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 14:10:14.273103|2017-02-18 14:10:14.273103
NCT00711646|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2013-06-13|2012-07-11||June 2002||2002-06-01|June 2013|2013-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.|A Double Blind, Randomised, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Cannabis Based Medicine 1:1 THC:CBD Compared With Placebo for the Treatment of Spasticity in Patients With Multiple Sclerosis.|Completed||Phase 3|189|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:10:14.364991|2017-02-18 14:10:14.364991
NCT00711633|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-04|2008-07-04|||December 2002||2002-12-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|February 2005|Actual|2005-02-01||Interventional|||Evaluation of Safety, Tolerance and Effects on the Intestinal Flora of a New Fermented Milk for Preterm Infants|Evaluation of a Fermented Formula Without Live Bacteria for Preterm Infants: Effects on Microbiota Species and Intestinal Inflammatory Markers|Completed||N/A|58|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:10:14.963937|2017-02-18 14:10:14.963937
NCT00711620|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2011-06-13|||May 2008||2008-05-01|October 2009|2009-10-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|ETASS||Efficacy of Thymosin alpha1 for Severe Sepsis|Multicenter, Randomized, Controlled Study to Evaluate the Efficacy of Thymosin alpha1 in Patients With Severe Sepsis|Completed||N/A|366|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 14:10:15.075074|2017-02-18 14:10:15.075074
NCT00711607|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2015-08-18|||May 2007||2007-05-01|August 2015|2015-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)|A Combined Multiple Dose and Single Dose Trial to Assess the Pharmacokinetic Profile of NOMAC, E2 and E1 After Oral Administration of NOMAC-E2 in Healthy Female Volunteers|Completed||Phase 1|25|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:10:15.186145|2017-02-18 14:10:15.186145
NCT00711594|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2015-01-13|2013-08-08||April 2008||2008-04-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Until the snapshot for CTR|LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib|Phase I/II Open Label Trial of Continuous Once Daily Oral Treatment With BIBW 2992 - Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib.|Completed||Phase 2|74|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:10:15.370173|2017-02-18 14:10:15.370173
NCT00711581|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2014-04-09|||August 2008||2008-08-01|June 2008|2008-06-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Evaluation of Laparoscopic Internal Retractor Device|Evaluation of the Efficacy and Safety of the Endograb: A Laparoscopic Internal Retractor Device|Completed||N/A|10|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 14:10:16.712172|2017-02-18 14:10:16.712172
NCT00711568|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2013-03-29|||October 2001||2001-10-01|March 2013|2013-03-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||A Clinical Trial of Magnetic Stimulation in Depression|A Clinical Trial of Magnetic Stimulation in Depression|Completed||Phase 2|48|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 14:10:16.806383|2017-02-18 14:10:16.806383
NCT00711555|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2009-08-06|2009-06-11||November 2005||2005-11-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Emend for Multiple-day Emetogenic Chemotherapy|An Open Label Phase II Study of Aprepitant for Multi-day Moderately-high to Highly Emetogenic Chemotherapy Regimens|Completed||Phase 2|22|Actual|University of Illinois at Chicago||1|||f||||f||||||||||2017-02-18 14:10:16.920309|2017-02-18 14:10:16.920309
NCT00711542|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2017-01-11|||September 2008||2008-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|REPAIR-ACS||Effects of Intracoronary Progenitor Cell Therapy on Coronary Flow Reserve After Acute MI|Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute Coronary Syndrome: REPAIR - ACS|Terminated||Phase 1/Phase 2|31|Actual|Johann Wolfgang Goethe University Hospital||2||Slow recruitment|f||||f||||||||||2017-02-18 14:10:17.159044|2017-02-18 14:10:17.159044
NCT00711529|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2013-05-14|2012-03-05||July 2008||2008-07-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||Of the 13 women randomized to the hypnotherapy arm, 2 women were ineligible and therefore not included in analysis. Two women were unable to initate treatment and did not submit diaries. Two women lost their diaries, leaving 7 diaries for analysis. Of the 14 women randomized to receive gabapentin, 6 dropped out and did not submit diaries.|Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes.|Comparison of Hypnotherapy Versus Gabapentin in the Treatment of Hot Flashes in Breast Cancer Survivors or Women at Risk of Developing Breast Cancer.|Completed||Phase 3|27|Actual|Women and Infants Hospital of Rhode Island|We were unable to meet recruitment goals because of 1) lower-than-anticipated rate of referrals, and 2) subjects' unwillingness to randomization. This resulted in small numbers that limit interpretation of results.|2|||f||||t||||||||||2017-02-18 14:10:17.290608|2017-02-18 14:10:17.290608
NCT00711516|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2013-07-12|2010-09-30||September 2008||2008-09-01|July 2013|2013-07-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance|Double-Blind, Placebo-Controlled, Functional Neuroimaging Study of Armodafinil (200 mg/Day) on Prefrontal Cortical Activation in Patients With Residual Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea|Completed||Phase 4|40|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 14:10:18.002024|2017-02-18 14:10:18.002024
NCT00711503|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2012-08-31|||January 2009||2009-01-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|AIDA||Anti-Interleukin-1 in Diabetes Action|A Randomised Clinical Trial of the Effect of Interleukin-1 Receptor Antagonism on the Insulin Production in Patients With New Onset Type 1 Diabetes|Completed||Phase 2/Phase 3|69|Actual|Steno Diabetes Center||2|||f||||t||||||||||2017-02-18 14:10:19.411352|2017-02-18 14:10:19.411352
NCT00711490|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-08|2016-09-22|2011-05-10||July 2008||2008-07-01|September 2016|2016-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|SDME||Sirolimus to Treat Diabetic Macular Edema|Pilot Study of the Evaluation of Sirolimus in the Treatment of Diabetic Macular Edema|Completed||Phase 1/Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 14:10:19.546425|2017-02-18 14:10:19.546425
NCT00711477|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2015-01-05|2014-10-08||September 2008||2008-09-01|December 2014|2014-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||Randomized subjects|A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects|Naltrexone Sustained Release (SR) 32 mg and Bupropion Sustained Release (SR) 360 mg Combination Therapy in Functional Magnetic Resonance Imaging (fMRI) Changes in Overweight or Obese Subjects|Completed||Phase 2|46|Actual|Orexigen Therapeutics, Inc||2|||f||||f||||||||||2017-02-18 14:10:19.876987|2017-02-18 14:10:19.876987
NCT00711464|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-07-05|||May 2008||2008-05-01|August 2011|2011-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|InO||A Dose-response Study of Modafinil Effects on Cognition in Healthy Adults and in Schizophrenia Patients|A Dose-response Study of Modafinil Effects on Cognition in Healthy Adults and in Schizophrenia Patients.|Completed||Phase 4|40|Actual|University of California, Davis||3|||f||||f||||||||||2017-02-18 14:10:20.652795|2017-02-18 14:10:20.652795
NCT00711451|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-07-12|||July 2008||2008-07-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|February 2011|Actual|2011-02-01||Interventional|||Manual and Expressed Placental Removal at Cesarean Delivery and Its Effects on Various Cardiac Indices|Manual and Expressed Placental Removal at Planned Cesarean Delivery and Its Effects on Various Cardiac Indices as Measured By Continuous Wave Doppler Ultrasonography|Terminated||N/A|19|Actual|William Beaumont Hospitals||2||unable to recruit patients|f||||f||||||||||2017-02-18 14:10:20.768798|2017-02-18 14:10:20.768798
NCT00711438|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2008-07-07|||April 2006||2006-04-01|October 2006|2006-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|BIS-PhIInm||Pilot Randomized Controlled Trial of a Breathlessness Intervention Service for Chronic Obstructive Pulmonary Disease|Phase II Pilot Pragmatic Single-Blinded Fast Track Randomised Controlled Trial of the Breathlessness Intervention Service Versus Standard Care for Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|13|Actual|Cambridge University Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 14:10:20.878508|2017-02-18 14:10:20.878508
NCT00711425|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2013-08-22|2011-06-07||February 2004||2004-02-01|August 2013|2013-08-01||||January 2010|Actual|2010-01-01||Interventional||Per protocol analysis presented, this includes implants loaded 0 to 56 days from implant placement (134 implants in 44 patients).|Study on OsseoSpeed™ Implants in Patients Missing 2-5 Teeth in the Posterior Lower Jaw, Restored With Permanent Teeth Attached 6-7 Weeks Later|An Open, Prospective Study to Evaluate Implant Stability, Marginal Bone Adaptation and the Survival Rate of Astra Tech Dental Implant System, Fixture Osseospeed™, in Patients With Tooth Loss in the Posterior Mandible in an Early Loading Protocol.|Completed||N/A|45|Actual|Dentsply Sirona Implants||1|||f||||f||||||||||2017-02-18 14:10:21.009715|2017-02-18 14:10:21.009715
NCT00711412|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-05|2016-11-16|||October 2005||2005-10-01|November 2016|2016-11-01|February 2019|Anticipated|2019-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer|A Phase II Study of Capecitabine and Oxaliplatin With Radiation for Esophageal and Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 2|45|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 14:10:21.530674|2017-02-18 14:10:21.530674
NCT00711399|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-09-13|||September 2008||2008-09-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Observational|||Assessment of Cough and Wheeze With Breath Sound Documenting Device|Use of Objective Cough Counting and Breath Sounds Documenting Device, to Assess the Severity and Duration of Cough and Wheeze in Children and Adults Suffer From Acute or Chronic Respiratory Disease.|Completed||N/A|55|Actual|Carmel Medical Center|||1||f||||t||||||||||2017-02-18 14:10:21.652328|2017-02-18 14:10:21.652328
NCT00711386|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2012-03-30|||May 2008||2008-05-01|March 2012|2012-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||GSK706769 Repeat Dose Study|A Double-Blind, Randomized, Placebo-Controlled, Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK706769 in Healthy Male and Female Subjects|Completed||Phase 1|40|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:10:21.768917|2017-02-18 14:10:21.768917
NCT00711373|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2016-04-14|||June 1998||1998-06-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|HandCTA||Vascularized Composite Allotransplantation of the Hand|Vascularized Composite Allotransplantation of the Hand|Recruiting||Phase 2|20|Anticipated|Christine M. Kleinert Institute for Hand and Microsurgery||1|||f||||t||||||||No||2017-02-18 14:10:21.875801|2017-02-18 14:10:21.875801
NCT00711360|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2012-09-25|||July 2008||2008-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|January 2012|Actual|2012-01-01||Interventional|HomeCARE II||Monitoring of Fluid Status in Heart Failure Patients by Intrathoracic Impedance Measurement (HomeCARE II)|Monitoring of Fluid Status in Heart Failure Patients by Intrathoracic Impedance Measurement|Completed||Phase 4|303|Actual|Biotronik SE & Co. KG||1|||f||||f||||||||||2017-02-18 14:10:22.023318|2017-02-18 14:10:22.023318
NCT00711347|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2010-08-04|2009-09-09||June 2007||2007-06-01|August 2010|2010-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Intraoperative Floppy Iris Syndrome||Completed||Phase 4|28|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:10:22.159871|2017-02-18 14:10:22.159871
NCT00711308|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2009-02-12|||April 2005||2005-04-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Tinzaparin in the Treatment of the Acute Pulmonary Embolism|Long Term Subcutaneous Tinzaparin Compared With Tinzaparin and Oral Anticoagulants in the Treatment of the Acute Pulmonary Embolism|Completed||Phase 4|102|Actual|Complejo Hospitalario Xeral-Calde||2|||f||||f||||||||||2017-02-18 14:10:22.685388|2017-02-18 14:10:22.685388
NCT00711295|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2015-10-07|||August 2008||2008-08-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|July 2009|Actual|2009-07-01||Interventional|||Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups|An Open-Label Phase 3 Study to Assess the Safety and Immunogenicity of a Vero Cell-Derived Whole Virus H5N1 Influenza Vaccine in an Adult and Elderly Population as Well as in Specified Risk Groups|Completed||Phase 3|3583|Actual|Nanotherapeutics, Inc.||6|||f||||t||||||||||2017-02-18 14:10:22.809241|2017-02-18 14:10:22.809241
NCT00711282|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-06-26|||December 2005||2005-12-01|June 2014|2014-06-01||||June 2011|Actual|2011-06-01||Interventional|||Study of Bone Preservation When OsseoSpeed™ Implants Are Placed Immediately Following Tooth Extraction|A Prospective, Randomized, Controlled Study to Evaluate Buccal Bone Preservation Using Fixture MicroThread™ OsseoSpeed™ Placed in Fresh Extraction Sockets the Maxilla.|Completed||N/A|104|Actual|Dentsply Sirona Implants||2|||f||||f||||||||||2017-02-18 14:10:22.98459|2017-02-18 14:10:22.98459
NCT00711269|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-06-11|||July 2008||2008-07-01|June 2012|2012-06-01||||||||Interventional|||Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia|Randomized, Placebo-controlled, Double-blind, Parallel-group, Confirmatory Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia <Phase III Study>|Completed||Phase 3|440|Anticipated|Sumitomo Dainippon Pharma Co., Ltd.||4|||f||||||||||||||2017-02-18 14:10:23.095383|2017-02-18 14:10:23.095383
NCT00711256|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2008-07-07|||July 2008||2008-07-01|April 2008|2008-04-01|November 2008|Anticipated|2008-11-01|August 2008|Anticipated|2008-08-01||Interventional|sunscreen||Sunscreen: Persistence of Sun Protection Factor and the Influence on Vitamin D|Sunscreen Removal by Clothing Meassured in Vivo. Sun Protection Factor Persistence During a Day Indoor Without Physical Activity. Does Sunscreen Reduce Vitamin D?|Unknown status|Recruiting|N/A|80|Anticipated|Bispebjerg Hospital||4|||f||||f||||||||||2017-02-18 14:10:23.193523|2017-02-18 14:10:23.193523
NCT00711243|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-05|2016-10-19|||March 2005||2005-03-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor|A Phase I/II Study of Taxotere, Oxaliplatin, and 5- Fluorouracil|Active, not recruiting||Phase 1/Phase 2|58|Actual|Northwestern University||5|||f||||t||||||||||2017-02-18 14:10:23.292174|2017-02-18 14:10:23.292174
NCT00711230|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-04|2013-02-19|||April 2008||2008-04-01|February 2013|2013-02-01|January 2015|Anticipated|2015-01-01|December 2011|Actual|2011-12-01||Interventional|GIEU006||Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients|A Phase II Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Safety, Tolerability, Immunogenicity, and Antiretroviral Activity of DermaVir Patch (LC002) in Treatment-Naïve HIV-1-Infected Patients|Unknown status|Active, not recruiting|Phase 2|36|Actual|Genetic Immunity||6|||f||||t||||||||||2017-02-18 14:10:23.414977|2017-02-18 14:10:23.414977
NCT00711217|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2011-11-01|||June 2008||2008-06-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of a Medical Food for Chronic Wounds|Evaluation of a Medical Food for Chronic Wounds|Completed||Phase 3|271|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-02-18 14:10:23.553965|2017-02-18 14:10:23.553965
NCT00711204|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2012-12-06|||January 2008||2008-01-01|December 2012|2012-12-01||||June 2009|Actual|2009-06-01||Interventional|||Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease|A 12-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease|Withdrawn||Phase 4|0|Actual|Eisai Inc.||2||No patients were enrolled in the study.|f||||||||||||||2017-02-18 14:10:23.710854|2017-02-18 14:10:23.710854
NCT00711191|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2013-11-26|2012-05-03||June 2008||2008-06-01|November 2013|2013-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas|A Phase 1 Dose Escalation Open Label Study Of CP-870,893 In Combination With Gemcitabine In Patients With Chemotherapy-Naïve Surgically Incurable Pancreatic Cancer|Completed||Phase 1|22|Actual|Hoffmann-La Roche||1|||f||||f||||||||||2017-02-18 14:10:23.820375|2017-02-18 14:10:23.820375
NCT00711178|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2010-11-01|||June 2008||2008-06-01|March 2008|2008-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)||Completed||N/A|150|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||||2017-02-18 14:10:24.691683|2017-02-18 14:10:24.691683
NCT00711165|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2008-07-03|||August 2005||2005-08-01|July 2008|2008-07-01|August 2006|Actual|2006-08-01|April 2006|Actual|2006-04-01||Interventional|||Mometasone and Markers of Airway Inflammation|The Effects of Mometasone on Markers of Airway Inflammation|Completed||Phase 4|12|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 14:10:24.791241|2017-02-18 14:10:24.791241
NCT00711152|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2015-09-05|||February 2008||2008-02-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|JADE-MOS||Community Health Worker Reduces Care Utilization|Inclusion Of a Community Health Worker in a Collaborative Diabetes Care Program Reduces Health Care Utilization (JADE)|Completed||Phase 4|661|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 14:10:24.895186|2017-02-18 14:10:24.895186
NCT00711139|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-04|2010-05-26|||June 2008||2008-06-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Long-term Safety and Tolerability of AFFITOPE AD01|Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS 001|Completed||N/A|22|Actual|Affiris AG|||2||f||||t||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:10:25.213097|2017-02-18 14:10:25.213097
NCT00711126|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2016-11-15|||October 2008||2008-10-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection|A Single-centre, Open-label, Sequential, Dose-ascending Study to Examine Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Intravenous, Inhaled and Oral Doses of GW642444 in Healthy Male Subjects|Completed||Phase 1|9|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:10:25.316887|2017-02-18 14:10:25.316887
NCT00711113|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-01-09|2013-08-22||December 2003||2003-12-01|January 2014|2014-01-01||||September 2011|Actual|2011-09-01||Interventional||Per protocol analysis presented, this includes implants loaded 0 to 56 days from implant placement (80 implants in 32 patients).|Study on OsseoSpeed™ Implants Replacing 2-5 Teeth in the Posterior Upper Jaw, Restored With Provisional Teeth Attached 6-7 Weeks Later|An Open, Prospective Study to Evaluate Implant Stability, Marginal Bone Adaptation and the Survival Rate of Astra Tech Dental Implant System, Fixture Osseospeed™, in Patients With Tooth Loss in the Posterior Maxilla in an Early Loading Protocol.|Completed||N/A|47|Actual|Dentsply Sirona Implants||1|||f||||f||||||||||2017-02-18 14:10:25.455323|2017-02-18 14:10:25.455323
NCT00711100|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2016-11-15|2013-10-17||August 2008||2008-08-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers|Preference, Health Effects and Efficacy of Four Oral Tobacco Products for Smoking Cessation|Completed||Phase 2|104|Actual|University of Minnesota - Clinical and Translational Science Institute||5|||f||||t||||||||No||2017-02-18 14:10:25.724314|2017-02-18 14:10:25.724314
NCT00711087|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2015-09-11|2015-09-11||July 2007||2007-07-01|September 2015|2015-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)|Botulinum Toxin A Treatment of Detrusor External Sphincter Dyssynergia During Early Spinal Cord Injury (Protocol #H-20344)|Terminated||Phase 2|1|Actual|Baylor College of Medicine||2||Funds no longer available|f||||f||||||||||2017-02-18 14:10:26.1158|2017-02-18 14:10:26.1158
NCT00711074|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2009-04-08|||June 2008||2008-06-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|||||Interventional|||Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers|An Open-Label, Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics Following a Single Oral Dose of [14C]AZD5672 in Healthy Male Volunteers|Completed||Phase 1|4|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:10:26.446496|2017-02-18 14:10:26.446496
NCT00711061|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2009-02-09|||June 2008||2008-06-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy|Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy.|Completed||N/A|24|Actual|Children's Mercy Hospital Kansas City|||2||f||||f||||||||||2017-02-18 14:10:26.556782|2017-02-18 14:10:26.556782
NCT00711048|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2009-08-27|||June 2008||2008-06-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|||||Interventional|||Esophageal Hypersensitivity Study in Healthy Volunteers|A Phase I, Two Centre, Double-blind, Randomized, Cross-over Study to Evaluate AZD1386 in Single Doses of 30 mg and 95 mg Compared to Placebo in a Multimodal Experimental Pain Model on Esophageal Sensitivity and Development of Sensitization in Healthy Male Volunteers|Completed||Phase 1|45|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:10:26.656223|2017-02-18 14:10:26.656223
NCT00711035|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-03-25||2014-03-03|November 2008||2008-11-01|March 2016|2016-03-01|August 2013|Actual|2013-08-01|October 2012|Actual|2012-10-01||Interventional|CHALLAH||Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)|Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation Or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)|Completed||Phase 1/Phase 2|50|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:10:26.770061|2017-02-18 14:10:26.770061
NCT00711022|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-07-04|2014-03-12||May 2005||2005-05-01|May 2014|2014-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study on ASTRA TECH Implant System, OsseoSpeed™ Implants in Patients Missing All Teeth in the Upper Jaw, Restored With Provisional Teeth Within 24 Hours|An Open, Prospective, Multicenter Study to Evaluate the Outcome of ASTRA TECH Implant System, OsseoSpeed™ Implants, in Patients With Totally Edentulous Maxillas and Poor Bone Quality and Quantity in an Immediate Loading Protocol.|Completed||N/A|51|Actual|Dentsply Sirona Implants||1|||f||||f||||||||||2017-02-18 14:10:26.897503|2017-02-18 14:10:26.897503
NCT00711009|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2012-02-13|2010-11-16||July 2008||2008-07-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|November 2009|Actual|2009-11-01||Interventional|PROGRESS||Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)|A Randomized, Open-label Study of Lopinavir/Ritonavir 400/100 mg Tablet Twice Daily + Co-formulated Emtricitabine/Tenofovir Disoproxil Fumarate 200/300 mg Once Daily Versus Lopinavir/Ritonavir 400/100 mg Tablet Twice Daily + Raltegravir 400 mg Twice Daily in Antiretroviral Naive, HIV-1 Infected Subjects|Completed||Phase 3|206|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:10:27.143435|2017-02-18 14:10:27.143435
NCT00710996|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2010-01-29|2009-09-18||January 2008||2008-01-01|January 2010|2010-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Blue Light Intraocular Lenses (IOLs) and Photostress|Blue Light Intraocular Lenses (IOLs) and Photostress|Completed||N/A|58|Actual|Alcon Research|||3||f||||f||||||||||2017-02-18 14:10:31.843269|2017-02-18 14:10:31.843269
NCT00710983|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2013-11-14|||July 2008||2008-07-01|November 2013|2013-11-01|January 2015|Anticipated|2015-01-01|June 2014|Anticipated|2014-06-01||Interventional|||Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth|Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth|Unknown status|Active, not recruiting|N/A|||Bandim Health Project||2|||f||||f||||||||||2017-02-18 14:10:32.211605|2017-02-18 14:10:32.211605
NCT00710970|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2013-07-22|2012-12-27||January 2007||2007-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment|H-16848 - Phase II Pilot Study With Correlative Markers of Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy|Completed||Phase 2|28|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:10:32.305719|2017-02-18 14:10:32.305719
NCT00710957|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2013-11-14|||April 2008||2008-04-01|November 2013|2013-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Vitamin D and Physical Function in Older Adults|Role of Vitamin D Status on Physical Function and Falls in Adults of Advanced Age|Completed||N/A|1100|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 14:10:32.582114|2017-02-18 14:10:32.582114
NCT00710749|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2012-09-27|2011-03-18||July 2008||2008-07-01|September 2012|2012-09-01||||April 2009|Actual|2009-04-01||Interventional|||The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects|An Open Prospective Multicenter Study Comparing the Urine Flow Measurements of Standard Clinic Flow Measurements vs Comercially Available Portable Digital Flow Meters and a Disposable Flow Meter in a Crossover and Randomized Order on Male BPH Subjects|Completed||N/A|60|Actual|Wellspect HealthCare||2|||f||||f||||||||||2017-02-18 14:10:36.982528|2017-02-18 14:10:36.982528
NCT00710944|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2014-06-26|2014-03-12||April 2005||2005-04-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|June 2008|Actual|2008-06-01||Interventional|||Study to Compare Survival for ASTRA TECH Implant System, OsseoSpeed™ Implants Following Immediate Loading in Extraction Sockets Versus Immediate Loading in Healed Ridges|An Open, Prospective, Controlled Study in the Maxilla to Evaluate Clinical Outcome of ASTRA TECH Implant System, OsseoSpeed™ Implants in Single Tooth Replacement Using an Immediate Loading Protocol in Extraction Sockets and Healed Ridges.|Completed||N/A|132|Actual|Dentsply Sirona Implants||3|||f||||f||||||||||2017-02-18 14:10:32.668289|2017-02-18 14:10:32.668289
NCT00710931|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-12-05|2011-10-04||October 2008||2008-10-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1|Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1|Completed||Phase 4|35|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 14:10:33.220557|2017-02-18 14:10:33.220557
NCT00710905|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2011-11-21|2011-10-04||October 2009||2009-10-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Visual Function With Contralateral AcrySof® ReSTOR® Aspheric SN6AD1 and SN6AD3|Visual Function With Contralateral AcrySof® ReSTOR® Aspheric SN6AD1 and SN6AD3|Terminated||Phase 4|50|Actual|Alcon Research||1||Postmarket study terminated as the SN6AD3 is no longer promoted.|f||||f||||||||||2017-02-18 14:10:33.415348|2017-02-18 14:10:33.415348
NCT00710892|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2016-10-06|||December 2008||2008-12-01|October 2016|2016-10-01|July 2026|Anticipated|2026-07-01|November 2011|Actual|2011-11-01||Interventional|CASPALLO||CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene|CASPALLO: A Phase I Study Evaluating the Use of Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation|Active, not recruiting||Phase 1|10|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:10:33.627029|2017-02-18 14:10:33.627029
NCT00710879|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2011-12-07|2011-01-14||July 2008||2008-07-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Evaluation of a Multi-Purpose Solution|A Study to Evaluate the Clinical Performance of a Multi-Purpose Solution.|Completed||N/A|180|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 14:10:33.739156|2017-02-18 14:10:33.739156
NCT00710866|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-07|2011-07-11|2011-07-11||August 2008||2008-08-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|TITRE||Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity||Completed||Phase 3|262|Actual|British Columbia Centre for Disease Control||2|||f||||t||||||||||2017-02-18 14:10:34.192218|2017-02-18 14:10:34.192218
NCT00710853|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2009-07-09|||May 2008||2008-05-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Qigong, Tai Chi and Yoga Practice in Older Adults|Effects of Qigong, Tai Chi and Yog Practice on Indicators of Health and Quality of Life in Older Adults|Completed||N/A|50|Anticipated|Bastyr University||3|||f||||f||||||||||2017-02-18 14:10:34.766499|2017-02-18 14:10:34.766499
NCT00710840|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-05-14|2015-03-18||June 2008||2008-06-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|February 2011|Actual|2011-02-01||Interventional|||Effectiveness of Minimally Invasive Total Knee Replacement in Improving Rehabilitation and Function|Functional Outcomes Following Minimally Invasive Total Knee Arthroplasty|Completed||Phase 2|44|Actual|University of Colorado, Denver|Small sample size; Relatively short follow-up time|2|||f||||||||||||||2017-02-18 14:10:34.871561|2017-02-18 14:10:34.871561
NCT00710827|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-11-22|||October 2008||2008-10-01|November 2012|2012-11-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks|A 54 Week Treatment, Randomized, Multi Center, Double Blind, Placebo Controlled Study to Assess the Safety and Efficacy of NEBIDO 1000 mg (4 ml) in Elderly Men With Symptomatic Late Onset Hypogonadism (SLOH)|Withdrawn||Phase 4|0|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:10:35.31297|2017-02-18 14:10:35.31297
NCT00710814|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-10-16|2015-08-11||April 2008||2008-04-01|October 2015|2015-10-01|July 2014|Actual|2014-07-01|August 2012|Actual|2012-08-01||Interventional|||Trial of Leptin Administration After Roux-en-Y Gastric Bypass|Effects of Leptin on Body Weight and Neuroendocrine Axes After Gastric Bypass|Completed||Phase 1/Phase 2|31|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 14:10:35.662642|2017-02-18 14:10:35.662642
NCT00710801|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2011-09-14|||May 2005||2005-05-01|September 2011|2011-09-01||||||||Observational|||Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation|Randomized, Open-label Study to Evaluate the Hepatitis C Virus (HCV) Burden in Patients Receiving Cyclosporine (Neoral or CSA) Versus Tacrolimus (Prograf) in de Novo Liver Recipients Receiving Mycophenolate Sodium (Myfortic): Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation|Completed||N/A|40|Anticipated|University of Alberta|||1||f||||||||||Samples With DNA|"~     Serum Tissue~   "|||2017-02-18 14:10:36.044782|2017-02-18 14:10:36.044782
NCT00710788|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2013-02-09|||January 2007||2007-01-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|Independent||Reduce Cardiovascular Calcifications to Reduce QT Interval in Dialysis|Interventional, Multicenter, Prospective, Randomized Trial to Slow Down the Progression of Cardiovascular Calcifications to Reduce QTd in Incident Dialysis Patients|Completed||N/A|360|Actual|Azienda Sanitaria ASL Avellino 2||2|||f||||t||||||||||2017-02-18 14:10:36.134163|2017-02-18 14:10:36.134163
NCT00710775|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2009-10-09|||November 2007||2007-11-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|HLT||Heart Leaflet Technologies Valve Study|Temporary Intra-operative Placement of HLT Percutaneous Aortic Valve|Unknown status|Recruiting|N/A|7|Anticipated|Centro Cardiologico Monzino||1|||f||||f||||||||||2017-02-18 14:10:36.26786|2017-02-18 14:10:36.26786
NCT00710762|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2016-07-13|2014-11-14||March 2006||2006-03-01|July 2016|2016-07-01|March 2014|Actual|2014-03-01|September 2008|Actual|2008-09-01||Interventional||"Treated set consist of all patients who received at least 1 dose of nintedanib or placebo.~Note: 43 patients were included in the analyses instead of 44 patients in nintedanib arm as one patient was excluded after drug administration due to important protocol violation."|A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer|A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer|Completed||Phase 2|89|Actual|Boehringer Ingelheim|Data from all randomised patients collected upto NOV’08 were included in all above sections,unless stated otherwise.5 patients continued on BIBF1120 after database lock(DBL)-NOV’08 upto Mar’14,but due to limited data no further analyses were done.|2|||f||||||||||||||2017-02-18 14:10:36.387681|2017-02-18 14:10:36.387681
NCT00710723|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-07-03|||October 2005||2005-10-01|January 2008|2008-01-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Vitrification Versus Slow Freezing of Human Day 3 Embryos|Vitrification Versus Slow Freezing of Human Day 3 Embryos|Unknown status|Active, not recruiting|N/A|901|Actual|University Hospital, Gasthuisberg||2|||f||||||||||||||2017-02-18 14:10:37.375021|2017-02-18 14:10:37.375021
NCT00710710|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2014-04-30||2014-04-30|August 2006||2006-08-01|April 2014|2014-04-01||||October 2008|Actual|2008-10-01||Interventional|||Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer|An Open, Randomised, Clinical Phase II Trial in Patients With Unresectable Advanced Pancreatic Cancer Investigating the Efficacy, Safety, and Pharmacokinetics of BI 2536 Administered in Repeated 3-week Cycles as a Single i.v. Dose of 200 mg on Day 1 or as 60 mg Doses on Days 1, 2, and 3|Completed||Phase 2|89|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:10:37.472208|2017-02-18 14:10:37.472208
NCT00710697|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2009-09-23|||June 2008||2008-06-01|September 2009|2009-09-01|July 2009|Anticipated|2009-07-01|March 2009|Anticipated|2009-03-01||Interventional|||Cardiac Safety Assessment Study of Picoplatin in Solid Tumors|A Phase 1 Study of Picoplatin in Subjects With Advanced Non-Hematological Malignancies With Emphasis on Cardiac Repolarization|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|Poniard Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:10:37.57642|2017-02-18 14:10:37.57642
NCT00710684|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2012-03-15||2011-03-17|July 2008||2008-07-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|May 2010|Actual|2010-05-01||Interventional|||A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease|Study AZ3110866, a Fixed Dose Study of SB-742457 Versus Placebo When Added to Existing Donepezil Treatment in Subjects With Mild-to-moderate Alzheimer's Disease|Completed||Phase 2|684|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:10:37.68538|2017-02-18 14:10:37.68538
NCT00710671|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2016-02-29|||March 2008||2008-03-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Psychosocial Needs of YMSM|Psychosocial Needs of HIV+ Young Men Who Have Sex With Men (YMSM)|Completed||N/A|254|Actual|Westat|||2||f||||t||||||||||2017-02-18 14:10:37.87809|2017-02-18 14:10:37.87809
NCT00710658|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2013-05-22|||May 2006||2006-05-01|May 2013|2013-05-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|WebChoice||Internet Support for Cancer Patients|A Randomized Clincial Trial to Evaluate the Effects of an Internett-based Support System for Cancer Patients on Symptom Distress, Depression, and Quality of Life.|Completed||N/A|325|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 14:10:38.183572|2017-02-18 14:10:38.183572
NCT00710645|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-11-20|||April 2003||2003-04-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Lido Workset Study|Assessment of Spasticity in MS Patients Using a Lido Workset|Completed||N/A|31|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 14:10:38.296369|2017-02-18 14:10:38.296369
NCT00710632|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2013-09-16|||September 2007||2007-09-01|July 2009|2009-07-01||||August 2008|Anticipated|2008-08-01||Interventional|||Screening to Predict Weight Loss in Patients With Cancer|Predicting Weight Loss in People With Cancer: Development of a Screening Tool|Unknown status|Active, not recruiting|N/A|220|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:10:38.402547|2017-02-18 14:10:38.402547
NCT00710619|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2016-11-16|||June 2008||2008-06-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|DOSE||Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX|Dosing Observational Study in Hemophilia Subjects With Inhibitors: A Phase IV Diary Study in Subjects Prescribed NovoSeven® as First Line on Demand Therapy for Acute Bleeding Episodes|Completed||N/A|52|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:10:38.498355|2017-02-18 14:10:38.498355
NCT00710606|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-04-14|2013-08-22||June 2008||2008-06-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®|Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®|Completed||N/A|40|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 14:10:38.603813|2017-02-18 14:10:38.603813
NCT00710593|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-10-26|||February 2008||2008-02-01|October 2012|2012-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Impact of an HPV Vaccine in HIV-Infected Young Women|Immunogenicity, Safety, Tolerability, and Behavioral Consequences of an HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women|Completed||Phase 2|99|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 14:10:39.047703|2017-02-18 14:10:39.047703
NCT00710580|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2013-01-10||2011-08-23|July 2008||2008-07-01|January 2013|2013-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|350|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 14:10:39.172475|2017-02-18 14:10:39.172475
NCT00710567|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2016-10-20|||July 2008||2008-07-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2012|Actual|2012-01-01||Interventional|||Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS|Evaluation of the Safety and Effectiveness of the DuraHeart™ Left Ventricular Assist System in Patients Awaiting Transplantation|Terminated||N/A|66|Actual|Terumo Heart Inc.||1||Insufficient enrollment|f||||f||||||||No||2017-02-18 14:10:39.3179|2017-02-18 14:10:39.3179
NCT00710554|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2014-01-20|2012-07-11||August 2005||2005-08-01|January 2014|2014-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia|A Double Blind, Randomized, Placebo Controlled, Parallel Group Study of Sativex® in the Treatment of Subjects With Peripheral Neuropathic Pain, Associated With Allodynia|Completed||Phase 3|246|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:10:39.460108|2017-02-18 14:10:39.460108
NCT00710541|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-08-12|||October 2004||2004-10-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|July 2011|Actual|2011-07-01||Interventional|||Non-invasive Ventilation in Severe Chronic Obstructive Pulmonary Disease(COPD)|Non-invasive Ventilation in Patients With Severe Chronic Obstructive Pulmonary Disease and Lung Emphysema (COPD)|Terminated||N/A|195|Actual|Deutsche Lungenstiftung e.V.||2||The publication of a national guideline on NPPV precluded further recruitment.|f||||t||||||||||2017-02-18 14:10:40.271476|2017-02-18 14:10:40.271476
NCT00710528|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2012-08-29|||June 2008||2008-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|December 2011|Actual|2011-12-01||Interventional|||Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies|A Phase 1 Sequential Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of CAL-101 in Patients With Select, Relapsed or Refractory Hematologic Malignancies|Completed||Phase 1|192|Actual|Gilead Sciences||1|||f||||f||||||||||2017-02-18 14:10:40.383641|2017-02-18 14:10:40.383641
NCT00710515|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2014-08-12|||July 2008||2008-07-01|August 2014|2014-08-01|June 2010|Actual|2010-06-01|April 2009|Actual|2009-04-01||Interventional|||Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies|A Phase I, Open-Label Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies|Completed||Phase 1|30|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:10:40.492151|2017-02-18 14:10:40.492151
NCT00710502|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2009-12-14|||January 2009||2009-01-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Transvaginal NOTES Cholecystectomy: Phase I/II Mexico Clinical Trial|Transvaginal Natural Orifice Translumenal and Endoscopic Surgery (NOTES) Cholecystectomy vs. Laparoscopic Cholecystectomy: Phase I/II Clinical Trial|Completed||Phase 1/Phase 2|40|Anticipated|North Texas Veterans Healthcare System||3|||f||||f||||||||||2017-02-18 14:10:40.588196|2017-02-18 14:10:40.588196
NCT00710489|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2015-04-15|||May 2008||2008-05-01|April 2015|2015-04-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|||Potential Research Study Participant Registry|Potential Research Study Participant Registry|Recruiting||N/A|200|Anticipated|University of California, Davis|||1||f||||f||||||||||2017-02-18 14:10:40.695707|2017-02-18 14:10:40.695707
NCT00710476|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-07-02|||August 2006||2006-08-01|January 2008|2008-01-01||||||||Interventional|||Effect of the Number of Inseminated Spermatozoa on Subsequent Human Embryonic Development in Vitro|Effect of the Number of Inseminated Spermatozoa on Subsequent Human Embryonic Development in Vitro|Completed||N/A|82|Actual|University Hospital, Gasthuisberg||2|||f||||f||||||||||2017-02-18 14:10:40.79414|2017-02-18 14:10:40.79414
NCT00710463|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2008-07-03|||May 2003||2003-05-01|July 2008|2008-07-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Observational|||Evaluation of the Role of Nocturnal Non-Invasive Ventilation in Pulmonary Rehabilitation|Evaluation of the Role of Nocturnal Non-Invasive Ventilation in Pulmonary Rehabilitation|Completed||N/A|80|Actual|Deutsche Lungenstiftung e.V.|||2||f||||f||||||||||2017-02-18 14:10:40.882009|2017-02-18 14:10:40.882009
NCT00710450|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2011-09-22|||May 2008||2008-05-01|September 2011|2011-09-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|||Effect of Montelukast on Basophils, In-vitro|The Effect of Montelukast In-vitro on Basophil Histamine and Leukotriene, IL-4 Adn IL-13 Release in Subjects With Allergic Rhinitis or Allergic Asthma|Unknown status|Active, not recruiting|N/A|15|Anticipated|Creighton University|||2||f||||f||||||Samples Without DNA|"~     Supernatents from stimulation assays will be kept for batch assay.~   "|||2017-02-18 14:10:40.986537|2017-02-18 14:10:40.986537
NCT00710437|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-07-06|||April 2005||2005-04-01|July 2012|2012-07-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Observational|||Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy Surgery|Effects of Dexmedetomidine on the Intraoperative Electroencephalogram During Endarterectomy Surgery|Completed||N/A|22|Actual|University of California, Davis|||2||f||||f||||||||||2017-02-18 14:10:41.079682|2017-02-18 14:10:41.079682
NCT00710424|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2012-07-31|2012-06-26||July 2005||2005-07-01|July 2012|2012-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy|A Double Blind, Randomized, Placebo Controlled, Parallel Group Study of Sativex in the Treatment of Subjects With Pain Due to Diabetic Neuropathy|Completed||Phase 3|297|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:10:41.190178|2017-02-18 14:10:41.190178
NCT00710411|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2015-12-16|||April 2009||2009-04-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Observational|IRAMST||Inflammatory Response After Muscle and Skeleton Trauma|Inflammatory Response in Polytraumatized Patients|Completed||N/A|48|Actual|University of Ulm|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, white cells, and tissues will be retained.~   "|||2017-02-18 14:10:42.144037|2017-02-18 14:10:42.144037
NCT00710398|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2011-07-19|||July 2008||2008-07-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|May 2010|Actual|2010-05-01||Interventional|||"Improving Diet, Exercise And Lifestyle (IDEAL) for Women Study"|"The Impact of Higher Dairy and Dietary Protein on the Quality of Hypoenergetic diet-and Exercise-induced Weight Loss in Pre-menopausal, Overweight and Obese Young Women"|Completed||N/A|90|Anticipated|McMaster University||3|||f||||f||||||||||2017-02-18 14:10:42.247531|2017-02-18 14:10:42.247531
NCT00710385|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-10-11|2011-08-19||September 2007||2007-09-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Abuse Liability of Suboxone Versus Subutex|Reinforcing Effects of Intravenous Buprenorphine Versus Buprenorphine/Naloxone in Buprenorphine-maintained Intravenous Drug Users (P05207)|Completed||Phase 3|19|Actual|New York State Psychiatric Institute|The stringent criteria for enrollment, qualification and retention in this trial were highly selective for a certain subpopulation of opioid-dependent individuals.|7|||f||||f||||||||Yes|Data have been published in a peer-reviewed journal.|2017-02-18 14:10:42.37336|2017-02-18 14:10:42.37336
NCT00710372|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2010-11-11|||June 2008||2008-06-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|July 2009|Actual|2009-07-01||Interventional|||Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension|A Double Blind, Randomized, Placebo Controlled, Parallel Group, Dose-Titration Phase II Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Efficacy of an Anti-Angiotensin II Vaccine (CYT006-AngQb) in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 2|83|Actual|Cytos Biotechnology AG||2|||f||||f||||||||||2017-02-18 14:10:42.734298|2017-02-18 14:10:42.734298
NCT00710359|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2010-08-13|||April 2008||2008-04-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Cobalamin Status in Young Children With Gastrointestinal Symptoms or Feeding Problems|Cobalamin Status in Young Children With Gastrointestinal Symptoms or Feeding Problems|Completed||N/A|100|Anticipated|Haukeland University Hospital||2|||f||||f||||||||||2017-02-18 14:10:42.831779|2017-02-18 14:10:42.831779
NCT00710346|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2017-01-24|||June 30, 2008||2008-06-30|September 1, 2016|2016-09-01|September 1, 2016||2016-09-01|||||Observational|||Establishment of Fibroid Tissue Bank|Establishment of a Fibroid Tissue Bank|Terminated||N/A|43|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:10:42.954979|2017-02-18 14:10:42.954979
NCT00710333|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2010-03-08|||July 2008||2008-07-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|RN1001-0093||Safety of Juvista When Administered Following Excision of Ear Lobe Keloids|A Single-centre, Double Blind, Randomised, Tolerance Study to Investigate the Safety of Juvista 500ng/100µL/Linear cm When Administered Following Excision of Ear Lobe Keloids.|Completed||Phase 1/Phase 2|10|Anticipated|Renovo||2|||f||||f||||||||||2017-02-18 14:10:43.054267|2017-02-18 14:10:43.054267
NCT00710320|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-03|2010-02-03|||July 2008||2008-07-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Temperature Changes During Induction of General Anesthesia in Pediatric Patients|Temperature Changes During Induction of General Anesthesia in Pediatric Patients|Completed||N/A|44|Actual|University of Oklahoma|||1||f||||t||||||||||2017-02-18 14:10:43.150614|2017-02-18 14:10:43.150614
NCT00710307|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2010-09-09|||October 2008||2008-10-01|September 2010|2010-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|EPIGROW||Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study)|Descriptive, Cross-sectional and Prospective Epidemiology Study, on the Identification of Insulin-like Growth Factor-1 Status in Idiopathic Short Stature Children (EPIGROW Study)|Completed||Phase 4|275|Actual|Ipsen|||1||f||||||||||Samples With DNA|"~     Whole blood will be collected. The blood sample will be kept as long as necessary and for a~     maximum of 5 years.~   "|||2017-02-18 14:10:43.263628|2017-02-18 14:10:43.263628
NCT00710294|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2011-10-28|||August 2005||2005-08-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|DEBuT-HET||Device Based Therapy in Hypertension Extension Trial|DEBuT - HET: Device Based Therapy in Hypertension Extension Trial: Long-Term Follow-Up Trial for Patients Who Completed the DEBuT-HT Study|Completed||N/A|50|Anticipated|CVRx, Inc.||1|||f||||f||||||||||2017-02-18 14:10:43.359374|2017-02-18 14:10:43.359374
NCT00710281|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2013-09-17|||March 2008||2008-03-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|||Analysis Of Intracranial Artery Lesions Using 2-D/3D Phase Contrast MR|Hemodynamic Analysis Of Intracranial Artery And Associated Lesions Using 2-D/3D Phase Contrast MR Angiography Focused On Wall Shear Stress Measurement|Withdrawn||N/A|0|Actual|Lahey Clinic||1||Investigator is no longer at study site|f||||f||||||||||2017-02-18 14:10:43.464071|2017-02-18 14:10:43.464071
NCT00710268|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2015-01-13|||June 2008||2008-06-01|January 2015|2015-01-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|||Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours|A Phase I, Open Label, Dual Centre Study To Assess The Safety And Tolerability Of AZD2281 In Combination With Bevacizumab (Avastin®) In Patients With Advanced Solid Tumours|Completed||Phase 1|18|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 14:10:43.577791|2017-02-18 14:10:43.577791
NCT00710255|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2016-10-27|||October 2007||2007-10-01|October 2016|2016-10-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Observational|||Role of Leukotrienes and Adenosine in Hyperpnea-induced Bronchospasm|Role of Leukotrienes and Adenosine in Hyperpnea-induced Bronchospasm Determined by Dynamic Analysis of Exhaled Breath Condensate.|Completed||N/A|8|Actual|University of Vermont|||1||f||||f||||||||||2017-02-18 14:10:43.689807|2017-02-18 14:10:43.689807
NCT00710242|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2009-05-18|||April 2007||2007-04-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Study to Assess Safety and Efficacy of DF01 in Reducing Prolonged Labor|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Assess the Safety and Efficacy or Pre-Treatment With DF01 During Late Pregnancy in Reducing Prolonged Labor|Completed||Phase 2|263|Actual|Dilafor AB||2|||f||||f||||||||||2017-02-18 14:10:43.789585|2017-02-18 14:10:43.789585
NCT00710229|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-06-08|||July 2008||2008-07-01|June 2010|2010-06-01||||December 2011|Anticipated|2011-12-01||Interventional|MANTA||Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration|A Randomized Observer and Subject Masked Trial Comparing the Visual Outcome After Treatment With Ranibizumab or Bevacizumab in Patients With Neovascular Age-related Macular Degeneration Multicenter Anti VEGF Trial in Austria (MANTA)|Unknown status|Recruiting|Phase 3|320|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||2|||f||||f||||||||||2017-02-18 14:10:43.898438|2017-02-18 14:10:43.898438
NCT00710216|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2009-04-16||||||April 2009|2009-04-01||||||||Interventional|EVD||Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B|Randomized, Open-Label, Phase IV Trial in Nucleus(t)id-Naive Patients With Chronic Hepatitis B to Examine the Effect of Telbivudine Compared to Lamivudine on the Early Dynamics and Kinetics of Viral Suppression (Early-Viral-Dynamics Study)|Withdrawn||Phase 4|40|Anticipated|University of Ulm||2||Sponsor withdraw|f||||f||||||||||2017-02-18 14:10:44.001942|2017-02-18 14:10:44.001942
NCT00710203|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2015-04-06|2011-06-07||July 2008||2008-07-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|DPN||Dermatosis Papulosa Nigra|Efficacy of a 585 nm Pulsed Dye Laser (PDL) for the Treatment of Dermatosis Papulosa Nigra, and Compare it to Therapy With Curettage and Electrodesiccation.|Completed||N/A|10|Actual|University of California, Davis||4|||f||||f||||||||||2017-02-18 14:10:44.120143|2017-02-18 14:10:44.120143
NCT00710190|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-10-19|||July 2003||2003-07-01|October 2016|2016-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|DEBuT-HT||Device Based Therapy in Hypertension Trial|A Study of Baroreflex Hypertension Therapy in Refractory Hypertension|Completed||N/A|46|Actual|CVRx, Inc.||1|||f||||f||||||||||2017-02-18 14:10:44.535493|2017-02-18 14:10:44.535493
NCT00710177|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2017-01-16|||January 2006||2006-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|PPHN||PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn|Prostaglandin G/H Synthase-1 (PTGS1) Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn (PPHN)|Recruiting||N/A|120|Anticipated|Medical College of Wisconsin|||2||f||||f||||||Samples With DNA|"~     whole blood, meconium~   "|No||2017-02-18 14:10:44.65291|2017-02-18 14:10:44.65291
NCT00710164|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-05-27|||September 2008||2008-09-01|September 2009|2009-09-01||||July 2010|Anticipated|2010-07-01||Interventional|||Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke||Unknown status|Recruiting|Phase 2/Phase 3|130|Anticipated|Fudan University||2|||f||||t||||||||||2017-02-18 14:10:44.759733|2017-02-18 14:10:44.759733
NCT00708799|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-05-04|||November 2007||2007-11-01|May 2015|2015-05-01|November 2015|Anticipated|2015-11-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy of Macrolide Immunomodulation in Severe Sepsis.|Efficacy of Macrolide Immunomodulation in Severe Sepsis|Terminated||Phase 2|100|Anticipated|VA Office of Research and Development||2||Safety evaluation due to recent publications.|f||||f||||||||||2017-02-18 14:10:56.497903|2017-02-18 14:10:56.497903
NCT00710151|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2015-04-22|||July 2008||2008-07-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Observational|||Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors|Neurotoxicity in Primary Central Nervous System Lymphoma: An International, Collaborative, Observational Study of Cognition in Long-Term Survivors|Terminated||N/A|80|Actual|OHSU Knight Cancer Institute|||1||f||||t||||||||||2017-02-18 14:10:44.87553|2017-02-18 14:10:44.87553
NCT00710138|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2010-08-13|||June 2008||2008-06-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Cobalamin Status in Young Children With Developmental Delay|Cobalamin Status in Young Children With Developmental Delay and Regression|Completed||N/A|100|Anticipated|Haukeland University Hospital||2|||f||||f||||||||||2017-02-18 14:10:44.970878|2017-02-18 14:10:44.970878
NCT00710125|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2014-08-04|||January 2008||2008-01-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety Study of GPX-150 in Patients With Solid Tumors|Phase 1 Study and Dose Seeking Study of an Intravenous Formulation of the Anthracycline Analog GPX-150 in Patients With Solid Tumors|Completed||Phase 1|27|Actual|Gem Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:10:45.097655|2017-02-18 14:10:45.097655
NCT00710112|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2016-08-23|||June 2006||2006-06-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|CLD||Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants|Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants|Recruiting||N/A|900|Anticipated|Medical College of Wisconsin|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 14:10:45.192176|2017-02-18 14:10:45.192176
NCT00710099|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2011-10-05|||July 2008||2008-07-01|October 2011|2011-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|INFLUX-VS||Effect of Oral Sildenafil With Digital Therapeutic Iontophoresis of Sodium Nitroprussiate in Healthy Volunteers|Effect of Oral Sildenafil With Digital Therapeutic Iontophoresis of Sodium Nitroprussiate on Cutaneous Blood Flow in Healthy Volunteers|Completed||N/A|40|Anticipated|University Hospital, Grenoble||2|||f||||f||||||||||2017-02-18 14:10:45.316468|2017-02-18 14:10:45.316468
NCT00710086|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2009-09-17|||July 2008||2008-07-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|IRELAN||Intravenous Remifentanil for Labor Analgesia|Remifentanil Intravenous Patient-controlled Labor Analgesia for Nulliparous Women|Completed||Phase 4|1000|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 14:10:45.422209|2017-02-18 14:10:45.422209
NCT00710073|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2008-07-02|||May 2006||2006-05-01|July 2008|2008-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Sono-Electro-Magnetic Therapy for Refractory Chronic Pelvic Pain Syndrome|Sono-Electro-Magnetic Therapy for the Treatment of Chronic Pelvic Pain Syndrome: A Pilot Study|Completed||N/A|12|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 14:10:45.537901|2017-02-18 14:10:45.537901
NCT00710060|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2013-11-01|||September 2002||2002-09-01|July 2008|2008-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations|NIMH Collaborative HIV/STD Prevention Trial|Completed||Phase 3|18147|Actual|RTI International||2|||f||||t||||||||||2017-02-18 14:10:45.638307|2017-02-18 14:10:45.638307
NCT00710047|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-11-10|||June 2008||2008-06-01|November 2010|2010-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Food Effect Study of a Single Dose of ZD4054 (Zibotentan)|A Randomised, Open-label, Single-centre, Crossover Study in Healthy Male Volunteers to Assess the Effect of Food on the Pharmacokinetics of a 10 mg Single Oral Dose of ZD4054 (Zibotentan)|Completed||Phase 1|30|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:10:45.766791|2017-02-18 14:10:45.766791
NCT00710034|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2014-12-11|||April 2010||2010-04-01|December 2014|2014-12-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine|Oral Tobacco as a Harm Reduction Product: Study 2 - Efficacy of Oral Tobacco Products Compared to Medicinal Nicotine for Smoking Cessation and Among Non-abstainers, for Reduction in Cigarette Smoking|Completed||Phase 2|390|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 14:10:45.855362|2017-02-18 14:10:45.855362
NCT00710021|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-11-07|2014-01-09||November 2008||2008-11-01|November 2015|2015-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Modified Intent-to-Treat|Vitamin D3 in Systemic Lupus Erythematosus|Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)|Completed||Phase 2|57|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 14:10:46.175851|2017-02-18 14:10:46.175851
NCT00710008|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2008-08-19|||February 2006||2006-02-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|RECO1||Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans|Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans|Completed||N/A|26|Actual|Landsteiner Institut||1|||f||||f||||||||||2017-02-18 14:10:47.986769|2017-02-18 14:10:47.986769
NCT00709995|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-11-30||2010-12-09|June 2008||2008-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|February 2010|Actual|2010-02-01||Interventional|||A Study for Participants With Metastatic Renal Cell Carcinoma|Dose Finding and Randomized, Multicenter, Placebo-Controlled, Phase 2 Study of Enzastaurin and Sunitinib Versus Placebo and Sunitinib in Patients With Metastatic Renal Cell Carcinoma|Active, not recruiting||Phase 2|122|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:10:48.084658|2017-02-18 14:10:48.084658
NCT00709982|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2011-06-06|||May 2005||2005-05-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.|An Open-label Pharmacokinetic Drug Interaction Study of Folic Acid and 250 Mcg NGM/35 Mcg EE (ORTHO-CYCLEN) in Healthy Women..|Completed||Phase 1|47|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:10:48.191517|2017-02-18 14:10:48.191517
NCT00709969|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2008-07-02|||July 2002||2002-07-01|July 2008|2008-07-01|February 2003|Actual|2003-02-01|||||Interventional|||Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria|Open Label, Multicenter Study for Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets (6-Dose Regimen) in African Infants and Children in the Treatment of Acute Uncomplicated Falciparum Malaria|Completed||Phase 3|310|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:10:48.272363|2017-02-18 14:10:48.272363
NCT00709956|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-09-10|2010-10-07||July 2008||2008-07-01|March 2015|2015-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|PROWESS 15||Iloprost Power 15 in Pulmonary Arterial Hypertension|A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients With Symptomatic Pulmonary Arterial Hypertension|Completed||Phase 3|64|Actual|Actelion||2|||f||||f||||||||||2017-02-18 14:10:48.37904|2017-02-18 14:10:48.37904
NCT00709930|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2009-03-30|||December 2007||2007-12-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension|Randomized Placebo-Controlled Trial of Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Field in Mild and Moderate Essential Hypertension|Completed||Phase 2|20|Anticipated|Kyoto University||2|||f||||t||||||||||2017-02-18 14:10:48.862218|2017-02-18 14:10:48.862218
NCT00709917|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-03-02|||March 2007||2007-03-01|March 2016|2016-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|REPAMET||Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes|Observational Study Investigating the Efficacy of Switching From Metformin Monotherapy to a Dual Therapy of Metformin and Repaglinide on Glycaemic Control in Type 2 Diabetes|Completed||N/A|2171|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:10:48.958681|2017-02-18 14:10:48.958681
NCT00709904|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2013-06-06||2011-03-07|June 2008||2008-06-01|June 2013|2013-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|SAVE-HIP3||Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery|A Multinational, Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of AVE5026 With Placebo for the Extended Prevention of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery|Completed||Phase 3|469|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:10:49.113317|2017-02-18 14:10:49.113317
NCT00709891|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2015-02-05|2015-01-20||May 2008||2008-05-01|February 2015|2015-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Eligible population: All participants who met the study inclusion/exclusion criteria, had not been enrolled in the study previously, and had not withdrawn consent before undergoing any study procedures. Of the enrolled population, 321 participants did not meet these criteria.|Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease|Evaluation of the Cobas® 4800 HPV Test for the Detection of High-grade Cervical Disease in Women Undergoing Routine Cervical Cancer Screening|Completed||N/A|47208|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:10:49.253602|2017-02-18 14:10:49.253602
NCT00709878|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-02-24|2010-08-27||April 2008||2008-04-01|February 2015|2015-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors|Histological Characterization and Differentiation of Rash From Other EGFR Inhibitors|Completed||N/A|32|Actual|Northwestern University|Small sample size||4||f||||f||||||Samples With DNA|"~     Skin tissue biopsies.~   "|||2017-02-18 14:10:49.498241|2017-02-18 14:10:49.498241
NCT00709865|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-12-10||2015-12-10|July 2008||2008-07-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|TRIDENT-1||Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency|Completed||Phase 2/Phase 3|420|Actual|Biogen||4|||f||||t||||||||||2017-02-18 14:10:52.4423|2017-02-18 14:10:52.4423
NCT00709852|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-12-08|2011-08-19||June 2008||2008-06-01|December 2014|2014-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging|A Multicenter, Randomized, Double-blind, Crossover, Phase 3 Study to Determine the Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients Referred for Contrast-enhanced MRI of the Central Nervous System (CNS)|Completed||Phase 3|402|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:10:52.983589|2017-02-18 14:10:52.983589
NCT00709839|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2011-05-31|||June 2008||2008-06-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Rapid Effects of Hydrocortisone on Glucose-induced Insulin Secretion in Healthy Humans|Rapid Effects of Hydrocortisone on Glucose-induced Insulin Secretion in Healthy Humans|Completed||Phase 4|10|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-02-18 14:10:55.308604|2017-02-18 14:10:55.308604
NCT00709826|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2012-10-08|2012-06-18||August 2008||2008-08-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|June 2010|Actual|2010-06-01||Interventional|||APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer|APRiCOT-P (Apricoxib in Combination Oncology Treatment - Pancreas): Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Gemcitabine and Erlotinib in the Treatment of Patients With Advanced Pancreatic Cancer|Completed||Phase 2|109|Actual|Tragara Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 14:10:55.619959|2017-02-18 14:10:55.619959
NCT00709813|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2011-07-03|||December 2003||2003-12-01|March 2009|2009-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients|Including Patient Preferences in Symptom Management of Cancer Patients: A Randomized Clinical Trial|Completed||N/A|145|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 14:10:56.173246|2017-02-18 14:10:56.173246
NCT00709800|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2009-02-11|||August 2007||2007-08-01|February 2009|2009-02-01||||September 2008|Actual|2008-09-01||Interventional|||Pandemic Influenza Plasmid DNA Vaccines (Needle)|A Phase 1, Double-Blinded Study to Evaluate the Safety, Tolerability, and Immunogenicity of Pandemic Influenza Plasmid DNA Vaccines|Completed||Phase 1|56|Actual|Vical||5|||f||||t||||||||||2017-02-18 14:10:56.274384|2017-02-18 14:10:56.274384
NCT00709787|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-11-09|||June 2008||2008-06-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management|Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management|Completed||Phase 4|899|Actual|Pfizer|||1||||||f||||||||||2017-02-18 14:10:56.394208|2017-02-18 14:10:56.394208
NCT00709306|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-04-09|||March 2006||2006-03-01|April 2014|2014-04-01|June 2010|Actual|2010-06-01|June 2008|Actual|2008-06-01||Interventional|||The Skin Savvy Study: A Behavioral Skin Cancer Prevention Intervention|The Skin Savvy Study: A Behavioral Skin Cancer Prevention Intervention|Completed||Phase 1|200|Actual|Fox Chase Cancer Center||4|||f||||f||||||||||2017-02-18 14:11:08.422259|2017-02-18 14:11:08.422259
NCT00708786|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-06-30|||April 2004||2004-04-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Ventricular Arrhythmias Incidence According to Sleep Apnea Syndrome in Implantable Cardioverter-Defibrillator (ICD) Patients|Ventricular Arrhythmias Incidence According to Sleep Apnea Syndrome in ICD Patients|Completed||Phase 4|755|Anticipated|LivaNova||1|||f||||t||||||||||2017-02-18 14:10:56.602128|2017-02-18 14:10:56.602128
NCT00708773|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2017-01-03|||February 2006||2006-02-01|January 2017|2017-01-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors|A Phase I Genotype-Directed Dose-Escalation Study of Irinotecan (NSC616348, CPT-11, Camptosar) in Patients With Advanced Solid Tumors|Completed||Phase 1|68|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 14:10:56.721294|2017-02-18 14:10:56.721294
NCT00708760|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2012-03-06|||April 2007||2007-04-01|March 2012|2012-03-01|September 2014|Anticipated|2014-09-01|June 2014|Anticipated|2014-06-01||Observational|||Moderate Sedation Educational Software|Moderate Sedation Education Software|Unknown status|Active, not recruiting|N/A|80|Anticipated|University of Utah|||2||f||||t||||||||||2017-02-18 14:10:56.822037|2017-02-18 14:10:56.822037
NCT00708747|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-07-01|||July 1996||1996-07-01|July 2008|2008-07-01|September 2003|Actual|2003-09-01|June 2001|Actual|2001-06-01||Interventional|||Biseko Versus Albumin in Systemic Inflammatory Response Syndrome (SIRS) Patients|Biseko Versus Albumin in the Treatment of High Risk Patients With Systemic Inflammatory Response Syndrome - a Randomized Controlled Trial|Completed||Phase 4|40|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:10:56.92139|2017-02-18 14:10:56.92139
NCT00708734|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2014-10-21|2014-10-01||July 2008||2008-07-01|October 2014|2014-10-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional||age over 50 and gender|Exercise Intervention to Reduce Postural Instability in Osteoarthritis|Exercise Intervention to Reduce Postural Instability in Osteoarthritis|Completed||N/A|10|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 14:10:57.035542|2017-02-18 14:10:57.035542
NCT00708721|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-01-15|||March 2008||2008-03-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia|Phase I/II Study of Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia (Dysplastic Type) Patients Who Have Failed Hypomethylating Therapy|Completed||Phase 1/Phase 2|12|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:10:57.268059|2017-02-18 14:10:57.268059
NCT00708708|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2015-07-24|2014-12-19||June 2008||2008-06-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational||Safety analysis set included all participants with available post-baseline safety data.|Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings|A Prospective Non-interventional Study (Nis) Of The Routine Use Of Etanercept In The Long-term Treatment Of Patients With Plaque-type Psoriasis In Everyday Practice: An Efficacy, Safety, And Health Economic Evaluation|Completed||Phase 4|926|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:10:57.399259|2017-02-18 14:10:57.399259
NCT00708695|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-03-01|||May 2008||2008-05-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|MemphisY17||Age-17 Follow-up of Home Visiting Intervention|Age-17 Follow-up of Home Visiting Intervention|Completed||N/A|1138|Actual|University of Colorado, Denver|||4||f||||t||||||Samples With DNA|"~     Spit samples will be taken.~   "|||2017-02-18 14:10:59.106237|2017-02-18 14:10:59.106237
NCT00708682|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2011-10-24|2011-01-28||July 2008||2008-07-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico|A Phase 3, Open Label, Single Arm Trial Evaluating the Safety, Tolerability, and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Mexico|Completed||Phase 3|225|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:10:59.224298|2017-02-18 14:10:59.224298
NCT00708669|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2014-11-04|||March 2008||2008-03-01|April 2012|2012-04-01||||September 2013|Actual|2013-09-01||Interventional|J-DESsERT®||Japan-Drug Eluting Stents Evaluation; a Randomized Trial|A Japanese Prospective, Randomized, Multi-center Trial Comparing the TAXUS Stent and the CYPHER Stent in Patients With Coronary Artery Disease Eligible for PCI.|Completed||N/A|3500|Anticipated|Associations for Establishment of Evidence in Interventions||2|||f||||t||||||||||2017-02-18 14:11:00.21223|2017-02-18 14:11:00.21223
NCT00708656|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2010-09-16|||October 2006||2006-10-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|CODA||The Colitis Once Daily Asacol Study|A Randomized, Single-Blind Study to Assess Efficacy and Safety of Dosing Mesalazine 800 mg Tablets (Asacol®) at 2.4 g Once Daily Versus Divided Doses 3 Times Daily for 12 Months in Maintenance of Remission of Ulcerative Colitis.|Completed||Phase 3|213|Actual|Cardiff and Vale University Health Board||2|||f||||t||||||||||2017-02-18 14:11:00.434459|2017-02-18 14:11:00.434459
NCT00708643|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-05-05|2010-11-01||June 2008||2008-06-01|May 2015|2015-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Clinical Performance of a New Daily Disposable Contact Lens Worn in an Established Contact Lens Wearing Population||Completed||N/A|80|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||||||||||||2017-02-18 14:11:00.594898|2017-02-18 14:11:00.594898
NCT00708630|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2012-07-26|||June 2008||2008-06-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination|The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination|Completed||N/A|100|Actual|University of Auckland, New Zealand||2|||f||||f||||||||||2017-02-18 14:11:01.162015|2017-02-18 14:11:01.162015
NCT00708617|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-01-22|||September 2008||2008-09-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|FIBROMAF||FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liver Disease|Non Invasive Diagnostic Methods for Fibrosis in Alcoholic Liver Disease : FIBROSCAN Validation and Comparison of Fibrotest - FIBROSCAN Association With FIBROSCAN Alone|Completed||N/A|227|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 14:11:01.269382|2017-02-18 14:11:01.269382
NCT00708604|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2014-07-02|||August 2005||2005-08-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes|Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes Using a Sirolimus/Tacrolimus/MMF-Based Immunosuppressive Regimen|Completed||Phase 1|3|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:11:01.369328|2017-02-18 14:11:01.369328
NCT00708591|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2014-01-16|||October 2004||2004-10-01|January 2014|2014-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Rapamycin Plus Ketoconazole in Advanced Cancers|A Phase Ib Study Administering Rapamycin (Sirolimus) With Ketoconazole in Patients With Advanced Malignancies|Completed||Phase 1|57|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 14:11:01.483237|2017-02-18 14:11:01.483237
NCT00708578|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2011-01-24|||May 2008||2008-05-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)|Insulin Glargine Combined With Sulfonylurea Versus Metformin in Patients With Type 2 Diabetes: A Randomized, Controlled Trial.|Completed||Phase 4|99|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 14:11:01.583413|2017-02-18 14:11:01.583413
NCT00708565|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2008-07-01|||July 2008||2008-07-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High Altitude|Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High Altitude|Unknown status|Recruiting|Phase 1|50|Anticipated|VA Loma Linda Health Care System|||||f||||f||||||||||2017-02-18 14:11:01.686888|2017-02-18 14:11:01.686888
NCT00708552|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2012-05-31||2012-02-23|July 2008||2008-07-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease|Study AZ3110865, a Study Comparing SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease|Completed||Phase 2|576|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 14:11:01.792782|2017-02-18 14:11:01.792782
NCT00708539|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2008-07-01|||April 2006||2006-04-01|July 2008|2008-07-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.|A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.|Unknown status|Recruiting|Phase 4|2686|Anticipated|Nordica Fertility Clinic||2|||f||||t||||||||||2017-02-18 14:11:02.115554|2017-02-18 14:11:02.115554
NCT00709774|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2008-07-02|||July 2008||2008-07-01|June 2008|2008-06-01||||June 2010|Anticipated|2010-06-01||Interventional|||Right Ventricular Septal Pacing for the Prevention of Left Ventricular Dysfunction in Patients With Atrio-Ventricular Block|Right Ventricular Septal Pacing for the Prevention of Left Ventricular Dysfunction in Patients With Atrio-Ventricular Block|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Osaka General Medical Center||1|||f||||||||||||||2017-02-18 14:11:02.225588|2017-02-18 14:11:02.225588
NCT00709761|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-09-09|2011-10-13||July 2008||2008-07-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|January 2011|Actual|2011-01-01||Interventional|||Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC|LPT 111111- A Single-arm, Multicenter Phase II Study to Evaluate The Combination of Weekly Nanoparticle Albumin Bound Paclitaxel (Nab-Paclitaxel or ABRAXANE®) and Lapatinib (TYKERB®) in Women With No More Than One Prior Treatment for ErbB2 Overexpressing Metastatic Breast Cancer|Active, not recruiting||Phase 2|60|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:11:02.295617|2017-02-18 14:11:02.295617
NCT00709748|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2008-07-02|||February 2008||2008-02-01|July 2008|2008-07-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|E-STIM||E-STIM Trial: Comparing the Efficacy of the Empi Select TENS to a Control for the Treatment of Chronic Lower Back Pain|The E-STIM Trial: A Randomized, Double-Blind, Multicenter Trial Comparing the Efficacy of the Empi Select Transcutaneous Electrical Nerve Stimulation (TENS) to a Control for the Treatment of Chronic Lower Back Pain|Unknown status|Recruiting|N/A|300|Anticipated|Empi, A DJO Company||2|||f||||f||||||||||2017-02-18 14:11:02.70488|2017-02-18 14:11:02.70488
NCT00709735|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2010-04-27|||May 2007||2007-05-01|April 2010|2010-04-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|||A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol|A Psychophysiologic Study of Weakening Traumatic Combat Memories With Post-Reactivation Propranolol|Unknown status|Recruiting|Phase 4|66|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:11:02.83325|2017-02-18 14:11:02.83325
NCT00709722|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2016-11-13|2016-04-13||October 2003||2003-10-01|July 2008|2008-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional||ITT population|Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis|Safety and Efficacy Study on Deoxyspergualin (NKT-01) in Patients With Uncontrolled Lupus Nephritis Receiving Oral Corticosteroids and Prior Treatment of Standard Immunosuppressive Therapy|Completed||Phase 1/Phase 2|21|Actual|Nippon Kayaku Co.,Ltd.||1|||f||||f||||||||||2017-02-18 14:11:02.940892|2017-02-18 14:11:02.940892
NCT00709709|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2014-11-13|||June 2006||2006-06-01|July 2008|2008-07-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|EVASCAN||Medical Evaluation of Scanner in Coronary Syndrome|Medical and Economic Medical Evaluation of Scan Multislice of Coronary Artery in Exploration of Stable Coronary Syndrome. Comparison With Quantitative Coronarography|Completed||N/A|1500|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 14:11:03.416868|2017-02-18 14:11:03.416868
NCT00709696|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-07-09|||April 2008||2008-04-01|July 2015|2015-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Human Laboratory Study Of Varenicline in Smokers|Human Laboratory Study Of Varenicline in Smokers|Completed||N/A|6|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 14:11:03.520059|2017-02-18 14:11:03.520059
NCT00709683|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-03-04|||May 2008||2008-05-01|March 2016|2016-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®|An Observational Study Evaluating the Safety and Efficacy of the Treatment With Biphasic Insulin Aspart (NovoMix® 30 FlexPen®) in the Treatment of Type 2 Diabetics After Failing on Basal/ Intermediate Mono or Combination Therapy|Completed||N/A|216|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:11:03.636672|2017-02-18 14:11:03.636672
NCT00709670|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2013-09-17|||September 2008||2008-09-01|July 2008|2008-07-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|PEPSI||ComParative Diagnostic Study Between Multislice Computed Tomography (MSCT) and Stress Echography in Coronarin Patients.|ComParative Diagnostic Study Between MSCT and Stress Echography in Patients Presenting With Suspected Acute Coronary Syndrome Without ST Segment Elevation.|Completed||N/A|217|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 14:11:03.739763|2017-02-18 14:11:03.739763
NCT00709657|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-11-13|||March 2008||2008-03-01|November 2014|2014-11-01|November 2011|Actual|2011-11-01|July 2010|Actual|2010-07-01||Interventional|||The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion|The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion|Terminated||N/A|8|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-02-18 14:11:03.855422|2017-02-18 14:11:03.855422
NCT00709644|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2011-06-06|||April 2005||2005-04-01|March 2010|2010-03-01|August 2005|Actual|2005-08-01|||||Interventional|||Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.|A Pivotal Bioequivalence Study of 250 Mcg NGM/25 Mcg EE With or Without Folic Acid in Healthy Female Subjects|Completed||Phase 1|54|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:11:03.961744|2017-02-18 14:11:03.961744
NCT00709631|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2015-02-24|||December 2006||2006-12-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|June 2009|Actual|2009-06-01||Observational|ULCERE||Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers|Prospective Evaluation of the Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers|Completed||N/A|155|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 14:11:04.053809|2017-02-18 14:11:04.053809
NCT00709618|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2014-06-30|2012-12-13||June 2008||2008-06-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects|A Phase II, Single-Arm, Multi-Center Study Evaluating the Combination of Vinorelbine and Lapatinib in Women With ErbB2 Overexpressing Metastatic Breast Cancer|Terminated||Phase 2|44|Actual|GlaxoSmithKline|The study was terminated due to low screening and a low enrollment rate after 3 years.|||"Evolving standard of care practices in this disease setting was limiting enrolment and leading~   to a delay in delivering this study information to the public."|f||||f||||||||||2017-02-18 14:11:04.139396|2017-02-18 14:11:04.139396
NCT00709605|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-28|2017-01-24|||June 25, 2008||2008-06-25|May 20, 2014|2014-05-20|May 20, 2014|Actual|2014-05-20|May 20, 2014|Actual|2014-05-20||Interventional|||Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection|A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity of a Multiclade Recombinant HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP In Uninfected Adults Randomized to Needle or Biojector Methods of Intramuscular Injection|Completed||Phase 1|31|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:11:04.713723|2017-02-18 14:11:04.713723
NCT00709592|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-10-31|2015-02-01||July 2008||2008-07-01|October 2016|2016-10-01|September 2020|Anticipated|2020-09-01|February 2014|Actual|2014-02-01||Interventional||Subjects able to proceed to transplant.|Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT|Reduced Intensity Myeloablative Total Body Irradiation and Thymoglobulin Followed by Allogeneic Peripheral Blood Stem Cell Transplantation|Active, not recruiting||Phase 2|42|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 14:11:04.811601|2017-02-18 14:11:04.811601
NCT00709579|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2008-07-03|||June 2008||2008-06-01|July 2008|2008-07-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids|Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids|Unknown status|Active, not recruiting|Phase 3|60|Anticipated|Pierre Fabre Dermo Cosmetique||2|||f||||t||||||||||2017-02-18 14:11:05.46889|2017-02-18 14:11:05.46889
NCT00709566|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-07-22|||April 2008||2008-04-01|July 2010|2010-07-01|December 2010|Anticipated|2010-12-01|September 2010|Anticipated|2010-09-01||Interventional|EMPART||EMPART - Exercise and Manual Physiotherapy Arthritis Research Trial|The Effectiveness of Exercise Therapy and Manual Therapy in Hip Osteoarthritis - A Multicentre Randomised Controlled Trial|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|Royal College of Surgeons, Ireland||3|||f||||f||||||||||2017-02-18 14:11:05.58735|2017-02-18 14:11:05.58735
NCT00709553|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-09-27|||July 2008||2008-07-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Drug Interaction Study to Asses Multiple Doses of ZD4054 (Zibotentan)|A Randomised, Open-label, Crossover, Phase I Study to Assess the Effect of Multiple Oral Doses of ZD4054 (Zibotentan) on the Pharmacokinetics of a CYP450 3A Probe (Midazolam) in Healthy Male Subjects|Completed||Phase 1|12|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:11:05.703847|2017-02-18 14:11:05.703847
NCT00709540|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2008-12-08|||January 2008||2008-01-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacodynamics of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women|Completed||Phase 1|40|Anticipated|Acceleron Pharma, Inc.||1|||f||||t||||||||||2017-02-18 14:11:05.807954|2017-02-18 14:11:05.807954
NCT00709527|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2012-06-14|||July 2008||2008-07-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration|A Phase 1 Ascending Dose And Parallel Group Trial To Establish The Safety, Tolerability AND Pharmacokinetic Profile Of Multiple Intravitreous Injections Of ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Multiple Doses Of Lucentis® 0.5 mg/Eye, Or With One Induction Dose Of Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration|Completed||Phase 1|60|Actual|Ophthotech Corporation||1|||f||||||||||||||2017-02-18 14:11:05.897299|2017-02-18 14:11:05.897299
NCT00709514|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-07-08|||December 2008||2008-12-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|April 2011|Actual|2011-04-01||Interventional|||Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers|A Phase II, Double-blind, Placebo-controlled Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers|Completed||Phase 2|41|Actual|Oneness Biotech Co., Ltd.||2|||f||||f||||||||||2017-02-18 14:11:05.996468|2017-02-18 14:11:05.996468
NCT00709501|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-10-19|||July 2009||2009-07-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Disseminating Effective Habits for Long-Term Weight Loss|Disseminating Effective Habits for Long-Term Weight Loss|Completed||N/A|100|Actual|Penn State University||2|||f||||f||||||||||2017-02-18 14:11:06.095934|2017-02-18 14:11:06.095934
NCT00708123|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2013-04-18|2010-09-14||November 2007||2007-11-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||In Situ Caries of Fluoride Toothpastes|Comparison of the Clinical Efficacy From the Retention Phase of Fluoride Delivery of Fluoride Toothpastes Using an in Situ Caries Model|Completed||Phase 3|60|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-02-18 14:11:30.643072|2017-02-18 14:11:30.643072
NCT00709488|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2012-11-14|||June 2008||2008-06-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)|A Phase 1 Study to Evaluate the Safety and Effectiveness of Using the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Who Are Candidates for Interventional Therapy|Completed||Phase 1|12|Actual|Light Sciences Oncology||1|||f||||f||||||||||2017-02-18 14:11:06.207533|2017-02-18 14:11:06.207533
NCT00709475|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-10-27|||May 2008||2008-05-01|October 2016|2016-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|LevSafeQD||Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus|Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus|Completed||N/A|747|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:11:06.330582|2017-02-18 14:11:06.330582
NCT00709462|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-07-23|||March 2004||2004-03-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)|A Phase I, Open-Label, Dose-Escalation, Multidose Study of CDX-1307, a Mannose Receptor-Targeted hCG-β Vaccine, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX-1307-01)|Completed||Phase 1|48|Anticipated|Celldex Therapeutics||1|||f||||f||||||||||2017-02-18 14:11:06.442798|2017-02-18 14:11:06.442798
NCT00709449|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2009-11-30|||May 2008||2008-05-01|November 2009|2009-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects|An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects|Completed||Phase 2/Phase 3|60|Anticipated|Medical University of Vienna||3|||f||||t||||||||||2017-02-18 14:11:06.540792|2017-02-18 14:11:06.540792
NCT00709436|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2012-01-10|||June 2008||2008-06-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery|Randomized, Multiple-center, Double-blind, Placebo-controlled Study of the Safety and Analgesic Efficacy of Repeated Dosing of PMI-150 (Intranasal Ketamine) to Treat Acute Post-operative Pain Following Orthopedic Trauma, Injury, or Surgery.|Completed||Phase 3|250|Actual|Hospira, Inc.||2|||f||||f||||||||||2017-02-18 14:11:06.647921|2017-02-18 14:11:06.647921
NCT00709423|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2008-07-02|||March 2007||2007-03-01|June 2008|2008-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effects of Moxaverine and Placebo on Ocular Blood Flow|A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow|Completed||Phase 2|16|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 14:11:06.775628|2017-02-18 14:11:06.775628
NCT00709410|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2012-03-29|||January 2009||2009-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|February 2009|Actual|2009-02-01||Interventional|||Mass Oral Cholera Vaccination in Zanzibar|Mass Oral Cholera Vaccination in High-risk Populations in Zanzibar: Assessment of Effectiveness and Herd Protection|Completed||N/A|51151|Actual|International Vaccine Institute||1|||f||||f||||||||||2017-02-18 14:11:06.86756|2017-02-18 14:11:06.86756
NCT00709397|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-07-29|||June 2008||2008-06-01|July 2010|2010-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy|HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy|Terminated||N/A|3|Actual|Brigham and Women's Hospital|||1|lack of accrual|f||||f||||||Samples With DNA|"~     Peripheral blood mononuclear cells will be tested for HIV-1 DNA levels. The cell pellets~     obtained from each of the samples will be tested for 1) total HIV-1 DNA and 2-LTR circles~     using real-time quantitative PCR and 2) integrated proviral DNA using Alu real-time nested~     PCR.~   "|||2017-02-18 14:11:06.976291|2017-02-18 14:11:06.976291
NCT00709384|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2009-09-18|||January 2006||2006-01-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Prevention of Atrial Tachycardia After a Right Atriotomy II|Prevention of Atrial Tachycardia After a Right Atriotomy II|Completed||Phase 2|14|Actual|Aarhus University Hospital Skejby||1|||f||||f||||||||||2017-02-18 14:11:07.074612|2017-02-18 14:11:07.074612
NCT00709371|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-29|2012-11-27||2012-11-26|July 2008||2008-07-01|November 2012|2012-11-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity|A Phase IIB, Multi-Center, Dose-Parallel, Randomized, Double-Blind, Monotherapy and Placebo-Controlled Safety and Efficacy Study of Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity|Completed||Phase 2|729|Actual|Orexigen Therapeutics, Inc||6|||f||||f||||||||||2017-02-18 14:11:07.176029|2017-02-18 14:11:07.176029
NCT00709358|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2011-12-26|||May 2008||2008-05-01|May 2011|2011-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|EVAMICA||Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections|Health Economic Evaluation of Rapid Detection of Bacteraemia and Fungemia by Real Time PCR for Cases of Febrile Neutropenia, Suspicion of Endocarditis and Severe Sepsis in Intensive Care Units|Completed||Phase 4|2000|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:11:07.314757|2017-02-18 14:11:07.314757
NCT00709345|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2015-04-16|||July 2006||2006-07-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Behavioral Intervention to Reduce Novel Antipsychotic Medication Health Risks|Effectiveness of a Cognitive Behavioral Treatment for Reducing Atypical Antipsychotic Medication Health Risks in People With Serious Mental Illness|Completed||Phase 1/Phase 2|333|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-02-18 14:11:07.422885|2017-02-18 14:11:07.422885
NCT00709332|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2011-06-06|||January 2005||2005-01-01|April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.|An Open-label Pharmacokinetic Drug Interaction Study of Folic Acid and 250 Mcg NGM/35 Mcg E E (ORTHO-CYCLEN) in Healthy Women.|Completed||Phase 1|47|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:11:07.532972|2017-02-18 14:11:07.532972
NCT00709319|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-08-25|2011-07-27||July 2005||2005-07-01|August 2016|2016-08-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Observational|Vitrectomy-D||Evaluation of Vitrectomy for Diabetic Macular Edema|Evaluation of Vitrectomy for Diabetic Macular Edema Study|Completed||N/A|87|Actual|Jaeb Center for Health Research|||1||f||||f||||||||||2017-02-18 14:11:07.624144|2017-02-18 14:11:07.624144
NCT00709293|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2013-06-17|||July 2008||2008-07-01|June 2013|2013-06-01||||May 2009|Anticipated|2009-05-01||Interventional|||Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients|Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients|Withdrawn||N/A|0|Actual|University of California, Los Angeles||2||Insufficient funding|f||||f||||||||||2017-02-18 14:11:08.524521|2017-02-18 14:11:08.524521
NCT00709280|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2013-02-11|||April 2009||2009-04-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|ISIS||Infant Study of Inhaled Saline in Cystic Fibrosis|Infant Study of Inhaled Saline in Cystic Fibrosis|Completed||N/A|321|Actual|CF Therapeutics Development Network Coordinating Center||2|||f||||t||||||||||2017-02-18 14:11:08.629016|2017-02-18 14:11:08.629016
NCT00709267|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2011-06-06|||October 2004||2004-10-01|April 2010|2010-04-01|December 2004|Actual|2004-12-01|||||Interventional|||Bioavailability Study of Folic Acid in Healthy Women|A Randomized, Open Label Absolute Bioavailability Study of Folic Acid.|Completed||Phase 1|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:11:08.771062|2017-02-18 14:11:08.771062
NCT00709254|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2008-07-02|||December 2001||2001-12-01|July 2008|2008-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|LEF-2495||Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects|Phase I, 3-Period, Fasting, Bioavailability, Safety Assessment and PK Study Evaluating Single Dose Administration of i.v. Fentanyl (200 µg) and Single and Multiple Doses of 3 mL of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl 500 µg/mL) Administered in Normal Healthy Subjects|Completed||Phase 1|12|Actual|YM BioSciences||3|||f||||f||||||||||2017-02-18 14:11:08.85643|2017-02-18 14:11:08.85643
NCT00709241|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2014-10-22|||December 2007||2007-12-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|PANIC||Psychosocial Patterns and Prognosis in Patients With Heart Failure|Prognostic Value of Negative Affectivity in Patients With Heart Failure|Completed||N/A|325|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"~     serum, urine.~   "|||2017-02-18 14:11:08.96734|2017-02-18 14:11:08.96734
NCT00709228|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-01-14|2009-11-09||May 2006||2006-05-01|January 2015|2015-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)|PREDICT - Prospective Observational Study Of A Cohort Of Naïve Patients With Chronic Hepatitis C Infected With Hepatitis C Virus Genotype 1 Low Viral Load (HCV LVL G1) And Treated With Peg-Intron 1.5 ug/Kg/Week Plus Rebetol 800-1200 mg/Day Who Achieved A Negative HCV-RNA At Week 4 and at Week 24|Completed||N/A|496|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||Samples With DNA|"~     Blood sample for PCR~   "|||2017-02-18 14:11:09.057058|2017-02-18 14:11:09.057058
NCT00709215|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2009-01-08|||June 2008||2008-06-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia|A Phase I/II Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia|Unknown status|Recruiting|Phase 1/Phase 2|44|Anticipated|OncoVista, Inc.||1|||f||||t||||||||||2017-02-18 14:11:09.4409|2017-02-18 14:11:09.4409
NCT00709202|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-12-14|||July 2008||2008-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|May 2016|Actual|2016-05-01||Interventional|||Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain in Adolescents and Young Adults|The Attenuation of Second Generation Antipsychotic Induced Weight Gain in Adolescents and Adults Using Betahistine: A Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|39|Actual|Nathan Kline Institute for Psychiatric Research||2|||f||||f||||||||No||2017-02-18 14:11:09.546465|2017-02-18 14:11:09.546465
NCT00709189|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2011-06-06|||May 2005||2005-05-01|April 2010|2010-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.|A Pivotal Bioequivalence Study of 250 Mcg NGM/35 Mcg EE With or Without Folic Acid in Healthy Female Subjects.|Completed||Phase 1|53|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:11:09.660107|2017-02-18 14:11:09.660107
NCT00709176|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-02-10|||June 2005||2005-06-01|October 2013|2013-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|FOCUS-Triage||Outcomes of Triaged Family Care in Advanced Cancer|Outcomes of Triaged Family Care in Advanced Cancer|Completed||N/A|484|Actual|University of Michigan||3|||f||||t||||||||||2017-02-18 14:11:09.756839|2017-02-18 14:11:09.756839
NCT00709163|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2008-07-02|||December 2003||2003-12-01|June 2008|2008-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Nesiritide - Dilated Cardiomyopathy|Nesiritide as an Adjunctive Therapy for Children With Dilated Cardiomyopathy Admitted to the Intensive Care Unit|Completed||N/A|20|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:11:09.901992|2017-02-18 14:11:09.901992
NCT00709150|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2013-07-25|||March 2005||2005-03-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|MDDP||Collaborative Depression Care Management in Treating Depressed Low-income Hispanics With Diabetes|Multifaceted Depression Diabetes Program for Hispanics|Completed||Phase 4|387|Actual|University of Southern California||2|||f||||t||||||||||2017-02-18 14:11:09.998927|2017-02-18 14:11:09.998927
NCT00709137|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-05-27|||October 2008||2008-10-01|May 2014|2014-05-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension|Randomized Trial of Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension|Withdrawn||N/A|0|Actual|VA Salt Lake City Health Care System||2||lack of enrollment|f||||t||||||||||2017-02-18 14:11:10.102714|2017-02-18 14:11:10.102714
NCT00709124|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-04-13|2015-03-30||June 2008||2008-06-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|NMES||Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness|Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness|Completed||Phase 2|36|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:11:10.22484|2017-02-18 14:11:10.22484
NCT00709111|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-01-04|2011-07-26||January 2009||2009-01-01|January 2016|2016-01-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression|A Pilot Trial of Maraviroc for Treatment of Subjects on Antiretroviral Therapy With Suboptimal CD4 T-cell Count Recovery Despite Sustained Virologic Suppression|Completed||N/A|34|Actual|AIDS Clinical Trials Group||1|||f||||t||||||||||2017-02-18 14:11:10.595282|2017-02-18 14:11:10.595282
NCT00709098|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-09-10|2012-09-27||September 2008||2008-09-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PROWESS 15 Ext||Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension|A Multicenter, Double-blind, Randomized Study Comparing the Safety and Tolerability of Iloprost Inhalation Solution Delivered by I-neb Utilizing Power Disc-15 and Power Disc-6 in Patients With Symptomatic Pulmonary Arterial Hypertension|Completed||Phase 3|49|Actual|Actelion||2|||f||||f||||||||||2017-02-18 14:11:11.362551|2017-02-18 14:11:11.362551
NCT00709085|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2009-11-23|||April 2008||2008-04-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)|Functional Genomics and Proteomics Towards and Understanding of Cell Signaling and Diseases--- Genomic and Proteomic Analyses of Liver Cells During Hepatitis Virus Infections and Cell Therapy (4/4)|Unknown status|Recruiting|N/A|320|Anticipated|National Taiwan University Hospital|||2||f||||f||||||Samples With DNA|"~     liver tissue (non-tumor part)~   "|||2017-02-18 14:11:12.113303|2017-02-18 14:11:12.113303
NCT00709072|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2010-04-22|||February 2009||2009-02-01|June 2009|2009-06-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Follow-up of Children After Stuttering Treatment|Relapse Following the Lidcombe Program for Preschool Children Who Stutter|Unknown status|Recruiting|Phase 2|180|Anticipated|University of Sydney||2|||f||||f||||||||||2017-02-18 14:11:12.287299|2017-02-18 14:11:12.287299
NCT00709059|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-11-03|2010-12-22||December 2004||2004-12-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|PRACTICE||Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)|A Non-interventional Phase IV Survey to Assess the Antiviral Effectiveness of PegIntron® and Rebetol® Treatment According to the Stage of Liver Fibrosis in Previously Untreated Patients With Genotype 1/4/5/6 Chronic Hepatitis C (CHC) (PRACTICE)|Completed||N/A|538|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:11:12.384041|2017-02-18 14:11:12.384041
NCT00709046|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2010-01-11|||January 2008||2008-01-01|January 2010|2010-01-01||||January 2010|Anticipated|2010-01-01||Interventional|||High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment|High Dose Versus Standard Dose Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Hemostasis: A Prospective Randomized Comparative Study|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 14:11:12.585796|2017-02-18 14:11:12.585796
NCT00709033|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-07-20|||July 2009||2009-07-01|July 2016|2016-07-01|April 2027|Anticipated|2027-04-01|May 2012|Actual|2012-05-01||Interventional|ATECRAB||T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL|Phase I Study Of The Administration Of Peripheral Activated T-Cells and EBV Specific CTLs Expressing CD19 Chimeric Receptors For Advanced B-Cell Non-Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia (ATECRAB)|Active, not recruiting||Phase 1|3|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:11:12.696877|2017-02-18 14:11:12.696877
NCT00709020|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2015-06-03|||June 2008||2008-06-01|June 2015|2015-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors|A Translational Breast Cancer Prevention Trial of Mushroom Powder in Postmenopausal Breast Cancer Survivors|Completed||Phase 1|16|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:11:12.808807|2017-02-18 14:11:12.808807
NCT00709007|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-04-14|||July 2008||2008-07-01|March 2009|2009-03-01|July 2011|Anticipated|2011-07-01|July 2010|Anticipated|2010-07-01||Interventional|DAART+||Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India|Evaluating the Role of Directly Administered Antiretroviral Therapy (DAART) in Conjunction With Opiate Substitution in Delivery of Highly Active Antiretroviral Therapy to HIV-1-infected Injecting Drug Users (IDUs) in Chennai, India|Withdrawn||Phase 2/Phase 3|0|Actual|Johns Hopkins University||2||"No participants satisfied eligibility criteria and were enrolled into the study since July~   2008."|f||||f||||||||||2017-02-18 14:11:12.919477|2017-02-18 14:11:12.919477
NCT00708994|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2016-12-01|||April 2008||2008-04-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|THC-Gamma||Cannabinoids, Neural Synchrony, and Information Processing|Cannabinoids, Psychosis, Neural Synchrony, and Information Processing|Active, not recruiting||Phase 1|36|Anticipated|Yale University||2|||f||||||||||||||2017-02-18 14:11:13.007983|2017-02-18 14:11:13.007983
NCT00708981|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-09-30|||May 2007||2007-05-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)|Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)|Completed||Phase 4|120|Actual|John H. Stroger Hospital||2|||f||||t||||||||||2017-02-18 14:11:13.101354|2017-02-18 14:11:13.101354
NCT00708968|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2015-06-15|||September 2001||2001-09-01|July 2008|2008-07-01|December 2005|Actual|2005-12-01|October 2005|Actual|2005-10-01||Interventional|||Prostate Cancer: Family Care for Patients and Spouses|Prostate Cancer: Family Care for Patients and Spouses|Completed||N/A|263|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 14:11:13.200523|2017-02-18 14:11:13.200523
NCT00708955|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-02|2017-01-24|||June 25, 2008||2008-06-25|November 23, 2016|2016-11-23||||||||Observational|||Evaluation and Treatment of People With Eye Diseases|Evaluation and Treatment Protocol for Potential Research Participants With Ocular Diseases|Active, not recruiting||N/A|2141|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:11:13.313889|2017-02-18 14:11:13.313889
NCT00708942|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2013-04-17|2013-03-04||January 2009||2009-01-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1|A Randomized Phase II Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) in Patients With Low-grade Cervical Intraepithelial Neoplasia (CIN1)|Terminated||Phase 2|83|Actual|Photocure|Slow recruitment lead to early terminaiton of the second part of the trial, including arms 4 and 5, after enrolment of 13 patients. No formal statistical analysis conducted on this part of the data.|5||"Slow recruitment, study stopped with only 13 of 70 patients included in second part of the~   study"|f||||f||||||||||2017-02-18 14:11:13.397512|2017-02-18 14:11:13.397512
NCT00605709|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-07-24|||March 2008||2008-03-01|July 2012|2012-07-01||||July 2008|Anticipated|2008-07-01||Interventional|||Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma||Withdrawn||Phase 2|0|Actual|Berg, LLC||4|||f||||t||||||||||2017-02-18 14:48:23.819484|2017-02-18 14:48:23.819484
NCT00708929|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2013-03-15|||June 2009||2009-06-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?|Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?|Completed||N/A|100|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 14:11:16.616685|2017-02-18 14:11:16.616685
NCT00708916|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2012-12-10|||June 2008||2008-06-01|December 2012|2012-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients|Clinical and Immune-modulating Effects of CC-10004 in Discoid Lupus Erythematosus|Completed||Phase 1/Phase 2|10|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 14:11:16.71904|2017-02-18 14:11:16.71904
NCT00708903|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2012-05-10|||May 2008||2008-05-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)|A Single Dose, Crossover, Placebo- and Moxifloxacin-Controlled Study of the Effects of HKI-272 on Cardiac Repolarization in Healthy Adult Subjects|Completed||Phase 1|60|Actual|Puma Biotechnology, Inc.||3|||f||||f||||||||||2017-02-18 14:11:16.825976|2017-02-18 14:11:16.825976
NCT00708890|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2014-04-15|||September 2008||2008-09-01|April 2014|2014-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|TSF_Norway||Twelve Step Based Self-help Groups for Substance Related Disorders|Twelve Step Based Self-help Groups for Substance Related Disorders - A Randomized Controlled Trial on a Detoxification Center|Completed||N/A|140|Actual|Sorlandet Hospital HF||2|||f||||f||||||||||2017-02-18 14:11:16.922069|2017-02-18 14:11:16.922069
NCT00708877|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-07-23|2011-12-13||March 2007||2007-03-01|July 2013|2013-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Liver Transplantation for Cholangiocarcinoma|Liver Transplantation for Cholangiocarcinoma|Terminated||N/A|5|Actual|University of Utah||1||"study procedures have become standard of care as patients seeking Model for End-Stage Liver~   Disease (MELD) exception points for cholangiocarcinoma"|f||||t||||||||||2017-02-18 14:11:17.02025|2017-02-18 14:11:17.02025
NCT00708851|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-04-02|2014-11-13||April 2007||2007-04-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional||12 participants with bilateral, symmetrical plaque psorasis|NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study|A Clinical Evaluation of Safety & Efficacy of Adding an At-home Topical LCD Solution Regimen to Standard Narrowband UVB Phototherapy Administered 3 Times Weekly to Adults With Generalized Plaque Psoriasis.|Completed||N/A|12|Actual|NeoStrata Company, Inc.|This is a bilateral pilot study including 12 subjects. Subjects will apply the liquor carbonis distillate (LCD) solution to one half of their body, while receiving narrow-band ultraviolet B (NB-UVB) light therapy across their whole body.|2|||f||||f||||||||||2017-02-18 14:11:17.235742|2017-02-18 14:11:17.235742
NCT00708838|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2008-07-01|||January 2002||2002-01-01|July 2008|2008-07-01|February 2007|Actual|2007-02-01|January 2006|Actual|2006-01-01||Observational|||Levels of Circulating T Cells Expressing VLA-1 Collagen Receptors|VLA-1 Receptors on Peripheral T Cells in Ischemic Heart Disease Patients|Completed||N/A|151|Actual|Sheba Medical Center|||5||f||||f||||||None Retained|"~     Blood samples isolated from patients included in the study and anallysed by FACS~   "|||2017-02-18 14:11:17.499137|2017-02-18 14:11:17.499137
NCT00708825|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2008-06-30|||January 2008||2008-01-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Reverse-Loop Upper Arm Arteriovenous Graft|Reverse-Loop Upper Arm Arteriovenous Graft for Chronic Hemodialysis|Suspended||N/A|7|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||Samples Without DNA|"~     prosthetic vascular graft (ePTFE)~   "|||2017-02-18 14:11:17.788718|2017-02-18 14:11:17.788718
NCT00708812|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-21|2011-07-20|||July 2007||2007-07-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer|Paclitaxel Plus Carboplatin (TC) Versus TC Plus Endostar in Patients With Advanced Non-small Cell Lung Cancer(NSCLC): a Randomized, Double-blind, Placebo-controlled, Multicentre Study|Completed||Phase 2|126|Actual|Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-02-18 14:11:17.871428|2017-02-18 14:11:17.871428
NCT00708526|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-08-19|2009-01-30||March 2008||2008-03-01|August 2016|2016-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea|Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea|Completed||Phase 2|22|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 14:11:17.978137|2017-02-18 14:11:17.978137
NCT00708513|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-10-18|||December 2003||2003-12-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|Cellsaver||Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.|Phase I/II Evaluation of Intraoperative Autotransfusion Filtration for Major Surgical Oncology Operations|Completed||N/A|98|Actual|University of Louisville|||1||f||||t||||||||||2017-02-18 14:11:18.333247|2017-02-18 14:11:18.333247
NCT00708500|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-09-24|2011-05-13||August 2008||2008-08-01|September 2015|2015-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)|A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin|Completed||Phase 3|404|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 14:11:18.433736|2017-02-18 14:11:18.433736
NCT00708487|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-29|2008-07-01|||August 1999||1999-08-01|June 2008|2008-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|Oxygen||Live Births With Low Oxygen Blastocyst Culture|A Controlled Randomized Trial Evaluating the Effect of Lowered Incubator Oxygen Tension on Live Births in a Predominantly Blastocyst Transfer Program|Completed||N/A|230|Actual|Texas Health Resources||2|||f||||t||||||||||2017-02-18 14:11:19.219395|2017-02-18 14:11:19.219395
NCT00708474|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2012-02-29|||June 2008||2008-06-01|February 2012|2012-02-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||OsseoFit™ Prospective Data Collection|OsseoFit™ Porous Tissue Matrix™ Prospective Data Collection|Withdrawn||N/A|0|Actual|Zimmer Biomet||2||Planning new study protocol|f||||f||||||||||2017-02-18 14:11:19.329387|2017-02-18 14:11:19.329387
NCT00703300|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2014-11-06|||June 2008||2008-06-01|September 2014|2014-09-01|October 2014|Actual|2014-10-01|March 2010|Actual|2010-03-01||Interventional|||Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia|Phase I Study of Decitabine (Dacogen) and Bortezomib (Velcade) in Acute Myeloid Leukemia|Completed||Phase 1|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:13:40.652989|2017-02-18 14:13:40.652989
NCT00708461|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-06-17|2011-12-13||January 2006||2006-01-01|June 2013|2013-06-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Interventional|HealthWorks||Environmental Intervention for Weight Gain Prevention|Environmental Intervention for Weight Gain Prevention|Completed||N/A|1747|Actual|University of Minnesota - Clinical and Translational Science Institute|The recruitment goal of 6 sites represents only 3% of those initially contacted for participation, or 16% of eligible and interested sites. The design limits power due to the small sample size at the group level.|2|||f||||t||||||||||2017-02-18 14:11:19.427945|2017-02-18 14:11:19.427945
NCT00708448|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2017-02-15|||January 2008||2008-01-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients|Development of an Integrated Molecular Biomarker ofEarly Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients Using Imaging Assessments and Genomic Modeling|Active, not recruiting||N/A|26|Actual|University of Utah||1|||f||||t|f|f||||||||2017-02-18 14:11:19.822014|2017-02-18 14:11:19.822014
NCT00708435|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-01-01|2013-06-07||June 2008||2008-06-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||The Intention-to-treat population comprised all subjects who were (1) eligible for the study and had (2) signed informed consent and were randomized to 1 of the 2 treatment groups regardless of whether the subjects received study product. In the ITT population, subjects were analyzed “as randomized”.|Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy|An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Coumarin Derivatives in Subjects With Acute Major Bleeding|Completed||Phase 3|216|Actual|CSL Behring||2|||f||||||||||||||2017-02-18 14:11:19.937535|2017-02-18 14:11:19.937535
NCT00708422|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2012-03-30|2012-03-30||July 2008||2008-07-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Travatan Z and Xalatan on Ocular Surface Health|Examination of Ocular Surface Effects With Administration of TRAVATAN Z® and Xalatan®|Completed||Phase 4|231|Actual|Alcon Research|The subjective nature of the OSDI may not be sensitive enough to detect the effects of preservatives on the corneal surface. The measurement and quantification of OSD remains a considerable clinical challenge (Pflugfelder and Baudoin, 2011).|2|||f||||f||||||||||2017-02-18 14:11:21.000439|2017-02-18 14:11:21.000439
NCT00708409|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2009-02-12|||January 2001||2001-01-01|January 2009|2009-01-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Long-Term Follow-up After the Autograft Aortic Valve Procedure (Ross Operation)|Long-Term Follow-up After the Autograft Aortic Valve Procedure (Ross Operation)-the German-Dutch- Ross Registry|Unknown status|Enrolling by invitation|N/A|1800|Anticipated|University of Luebeck|||2||f||||f||||||||||2017-02-18 14:11:21.364989|2017-02-18 14:11:21.364989
NCT00708396|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2009-01-26|||July 2008||2008-07-01|January 2009|2009-01-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study||Unknown status|Recruiting|Phase 4|20|Anticipated|BeerYaakov Mental Health Center||1|||f||||t||||||||||2017-02-18 14:11:21.682552|2017-02-18 14:11:21.682552
NCT00708383|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-29|2008-07-01|||September 2001||2001-09-01|June 2008|2008-06-01|November 2003|Actual|2003-11-01|November 2002|Actual|2002-11-01||Interventional|SSS||in Vitro Fertilization (IVF) Media Protein and Live Birth Rates|A Randomized Controlled Study of Human Serum Albumin and Serum Substitute Supplement as Protein Supplements for IVF Culture and the Effect on Live Birth Rates|Completed||N/A|538|Actual|Texas Health Resources||2|||f||||t||||||||||2017-02-18 14:11:21.795555|2017-02-18 14:11:21.795555
NCT00708370|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2011-04-12|||August 2008||2008-08-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|DISSEMINATE||A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.|An Outcome Research on the Impact of a Disease Management Program (COACH) on the Attainment of Better Cardiovascular Risk Control in Dyslipidemic Patients at Primary Care Centers (DISSEMINATE).|Completed||Phase 4|297|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:11:21.898346|2017-02-18 14:11:21.898346
NCT00708357|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-11-14|||May 2005||2005-05-01|November 2014|2014-11-01|January 2013|Actual|2013-01-01|December 2009|Actual|2009-12-01||Interventional|||Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?|Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?|Terminated||Early Phase 1|12|Actual|Medical University of Vienna||2|||f||||||||||||||2017-02-18 14:11:22.036993|2017-02-18 14:11:22.036993
NCT00708344|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2010-07-15|||June 2008||2008-06-01|July 2010|2010-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|ACTUAL||ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination|Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination: A Comparison of Active and Usual Titration Regimen in the Treatment of Hypertensive Patients Insufficiently Controlled by Monotherapy|Completed||Phase 4|832|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:11:22.141105|2017-02-18 14:11:22.141105
NCT00708331|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2008-07-01|||August 2002||2002-08-01|July 2008|2008-07-01||||May 2007|Actual|2007-05-01||Interventional|||Hydrophilic Acrylic Intraocular Lens|SC25-FOLD Hydrophilic Acrylic Intraocular Lens|Unknown status|Active, not recruiting|N/A|354|Actual|EyeKon Medical, Inc.||1|||f||||t||||||||||2017-02-18 14:11:22.255734|2017-02-18 14:11:22.255734
NCT00708318|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2008-07-01|||October 2001||2001-10-01|July 2008|2008-07-01|June 2002|Actual|2002-06-01|November 2001|Actual|2001-11-01||Interventional|||Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects|A Pilot, Phase I, 2-Period, Fasting, Bioavailability, Safety and PK Study Evaluating A Single Dose Intravenous Fentanyl 200 µg) and Single Doses of 2 or 3 mL AeroLEF (Liposome-Encapsulated Fentanyl 500 µg/mL) in Normal Healthy Non Subjects|Completed||Phase 1|6|Actual|YM BioSciences||1|||f||||f||||||||||2017-02-18 14:11:22.361706|2017-02-18 14:11:22.361706
NCT00708305|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-12-11|2010-09-14||June 2008||2008-06-01|December 2014|2014-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes|Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes|Completed||Phase 3|65|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 14:11:22.471569|2017-02-18 14:11:22.471569
NCT00333996|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2011-05-27|||May 2006||2006-05-01|May 2011|2011-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis||Terminated||Phase 2/Phase 3|5|Actual|Allergan|||||f||||||||||||||2017-02-18 16:29:40.00155|2017-02-18 16:29:40.00155
NCT00708292|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-06-30||2012-05-01|July 2008||2008-07-01|June 2015|2015-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.|An Open-label, Multi-center, Phase I-Ib/II Study of AUY922 Administered as Single Agent and in Combination With Bortezomib With or Without Dexamethasone in Adult Patients in Relapse or Refractory Multiple Myeloma.|Completed||Phase 1/Phase 2|29|Actual|Novartis||3|||f||||||||||||||2017-02-18 14:11:23.298144|2017-02-18 14:11:23.298144
NCT00708279|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2011-04-13|||August 2007||2007-08-01|June 2010|2010-06-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|SOMMA||Study of Osteopathic Manipulation in the Management of Angina|Study of Osteopathic Manipulation in the Management of Angina|Completed||N/A|1|Actual|University of New England||1|||f||||f||||||||||2017-02-18 14:11:23.416586|2017-02-18 14:11:23.416586
NCT00708266|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2008-06-27|||February 2007||2007-02-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|TNF4||The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines|A Mono-Centre Randomized Study to Investigate the Effect of Elevated Plasma Fatty Acid Concentrations on Cytokines in Interstitial Fluid of Subcutaneous Adipose Tissue|Completed||N/A|10|Actual|Medical University of Graz||2|||f||||f||||||||||2017-02-18 14:11:23.519292|2017-02-18 14:11:23.519292
NCT00708253|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2010-04-09|||June 2008||2008-06-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|SBE_vs_DBE||Single- Versus Double-balloon Enteroscopy in Small Bowel Diagnostics|Single- vs. Double-balloon Enteroscopy in Small Bowel Diagnostics: A Randomized Controlled Single-blind Multicenter Trial|Completed||N/A|150|Anticipated|University Hospital Muenster||2|||f||||t||||||||||2017-02-18 14:11:23.636942|2017-02-18 14:11:23.636942
NCT00708240|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-06-30|||January 2007||2007-01-01|June 2008|2008-06-01|December 2010|Anticipated|2010-12-01|August 2010|Anticipated|2010-08-01||Interventional|||Treatment Youth With Obsessive-Compulsive Disorder|Treatment With Escitalopram (Cipralex®) for Adolescents With Obsessive-Compulsive Disorder: Efficacy, Safety, and Changes in Executive Functions, Metacognition, and Regional Brain Activations.|Unknown status|Recruiting|Phase 4|40|Anticipated|University of Ottawa||1|||f||||t||||||||||2017-02-18 14:11:23.7538|2017-02-18 14:11:23.7538
NCT00708227|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-04-13|||September 2007||2007-09-01|April 2015|2015-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Pharmacogenetics of b2-Agonists in Asthma.|Pharmacogenetics of b2-Agonists in Asthma.|Completed||Phase 4|78|Actual|Nemours Children's Clinic||3|||f||||f||||||||||2017-02-18 14:11:23.861865|2017-02-18 14:11:23.861865
NCT00708214|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2013-12-05|2013-08-08||January 2007||2007-01-01|October 2013|2013-10-01||||February 2010|Actual|2010-02-01||Interventional||Treated set (TS). TS consisted of all patients who were dispensed study medication and have taken at least 1 dose of Afatinib.|BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer|A Phase II Study of BIBW 2992 Administration in Patients With Hormone Refractory Metastatic Breast Cancer|Completed||Phase 2|28|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:11:23.984482|2017-02-18 14:11:23.984482
NCT00708201|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2016-01-06|2013-09-10||March 2009||2009-03-01|January 2016|2016-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||All study participants|A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy|A Phase 4, Multicenter, Double-Blind, Placebo-Controlled, Parallel Study of Alvimopan for the Management of Postoperative Ileus in Subjects Undergoing Radical Cystectomy.|Completed||Phase 4|280|Actual|Cubist Pharmaceuticals LLC||2|||f||||t||||||||||2017-02-18 14:11:24.973452|2017-02-18 14:11:24.973452
NCT00708188|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2013-07-25|||March 2008||2008-03-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|COCASE||Multidetector Raw CT as a Single Tool in the Setting of Ischemic Stroke|"Evaluation of Multidetector Raw Computerized Tomography in the Etiological Analysis of Acute Ischemic Stroke: the COCASE Protocol."|Completed||N/A|49|Actual|Hospices Civils de Lyon||1|||f||||f||||||||||2017-02-18 14:11:26.162957|2017-02-18 14:11:26.162957
NCT00708175|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2012-01-03|2012-01-03||May 2008||2008-05-01|January 2012|2012-01-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.|A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Pioglitazone Compared to Placebo on Bone Metabolism in Impaired Fasting Glucose, Postmenopausal Women for One Year of Treatment|Completed||Phase 4|156|Actual|Takeda||2|||f||||f||||||||||2017-02-18 14:11:26.279552|2017-02-18 14:11:26.279552
NCT00708162|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-04-21|2014-10-23||July 2008||2008-07-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|December 2010|Actual|2010-12-01||Interventional||Safety Analysis Set: participants who were randomized and received at least one dose of study drug|Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir|A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL) Each Administered With a Background Regimen in HIV-1 Infected, Antiretroviral Treatment-Experienced Adults|Completed||Phase 3|724|Actual|Gilead Sciences|10 participants from a single study site were excluded from Intent-to-Treat (ITT) Analysis Set due to critical and multiple protocol violations (elvitegravir arm: n = 3; raltegravir arm: n = 7).|2|||f||||t||||||||||2017-02-18 14:11:27.220254|2017-02-18 14:11:27.220254
NCT00708149|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-01-06|||June 2009||2009-06-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Comparison of the Efficacy for Stress Ulcer Prophylaxis Between the Patients Received Lansoprazole OD and Control Group Weaning From Mechanical Ventilator in Respiratory Care Center: a Randomized Control Trial|Phase IV Study of Comparison of the Efficacy for Stress Ulcer Prophylaxis Between the Patients Received Lansoprazole OD and Control Group Weaning From Mechanical Ventilator in Respiratory Care Center: a Randomized Control Trial|Completed||Phase 4|120|Actual|Far Eastern Memorial Hospital||2|||f||||f||||||||||2017-02-18 14:11:30.435156|2017-02-18 14:11:30.435156
NCT00708136|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-29|2008-07-01|||January 2006||2006-01-01|November 2005|2005-11-01|June 2007|Actual|2007-06-01|January 2007|Actual|2007-01-01||Interventional|EWEB||Effect of Water-Exercise on Balance Function of Healthy Elderly Individuals|Effect of Water-Exercise on Balance Function of Healthy Elderly Individuals - A Randomized Control Study|Completed||N/A|37|Actual|Soroka University Medical Center|||||f||||t||||||||||2017-02-18 14:11:30.555164|2017-02-18 14:11:30.555164
NCT00583479|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-09-11|||June 2002||2002-06-01|September 2012|2012-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Prospective Study of Celiac Block Injection: 1 vs. 2|A Prospective Study of Celiac Block Technique: One Injection or Two?|Completed||Phase 4|100|Anticipated|Indiana University||2|||f||||f||||||||||2017-02-18 14:55:55.370806|2017-02-18 14:55:55.370806
NCT00708110|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2013-11-07|2013-08-22||June 2008||2008-06-01|August 2013|2013-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults|A Phase 2a, Multicenter, Randomized, Parallel, Double-Blind, Dose Ranging, Placebo-Controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK1349572 Monotherapy Versus Placebo Over 10 Days in HIV-1 Infected Adults (ING111521)|Completed||Phase 2|35|Actual|ViiV Healthcare||3|||f||||||||||||||2017-02-18 14:11:31.151114|2017-02-18 14:11:31.151114
NCT00708097|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2014-12-11|2011-09-15||April 2008||2008-04-01|December 2014|2014-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||In Situ Caries Efficacy of Fluoride Toothpastes|Clinical Efficacy of Fluoride Toothpastes Using an in Situ Caries Model|Completed||Phase 3|57|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-02-18 14:11:32.823004|2017-02-18 14:11:32.823004
NCT00708084|ClinicalTrials.gov processed this data on February 17, 2017|2008-07-01|2012-03-19||2009-07-31|May 2008||2008-05-01|March 2012|2012-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents|A Single-blind, Randomized, Monocentric Phase II Trial to Explore the Safety and Rabies-neutralizing Activity of Combined Administration of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin Plus Rabies Vaccine in Simulated Rabies Post-exposure Prophylaxis in Children and Adolescents|Completed||Phase 2|48|Actual|Crucell Holland BV||2|||f||||t||||||||||2017-02-18 14:11:33.654117|2017-02-18 14:11:33.654117
NCT00708071|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2012-10-19|2011-10-06||June 2008||2008-06-01|October 2012|2012-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures|An Exploratory Phase 2 Clinical Study to Evaluate Efficacy and Safety of the Adjuvant Use of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated Containing Synthetic Aprotinin (FS VH S/D 4) in Subjects Undergoing Rhytidectomy|Completed||Phase 2|45|Actual|Baxter Healthcare Corporation||1|||f||||f||||||||||2017-02-18 14:11:33.775762|2017-02-18 14:11:33.775762
NCT00708058|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2012-03-19|||August 2007||2007-08-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|September 2008|Actual|2008-09-01||Observational|||Use of Defibrillator Information in the Emergency Department|Can Pacemakers, Defibrillators, and Internal Heart Failure Devices Be Used to Evaluate and Guide Management in the Emergency Department?|Completed||N/A|50|Actual|Ohio State University|||1||f||||f||||||||||2017-02-18 14:11:34.806989|2017-02-18 14:11:34.806989
NCT00708045|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2016-08-30|||May 2007||2007-05-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|February 2015|Actual|2015-02-01||Interventional|Chemobrain||A Multi-modality Imaging Assessment of Chemobrain|A Multi-modality Imaging Assessment of Chemobrain|Active, not recruiting||N/A|34|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:11:34.903731|2017-02-18 14:11:34.903731
NCT00708032|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-05-05|2011-11-03||June 2008||2008-06-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||There were 74 subjects enrolled with 48 completing the study.|Clinical Performance of a New Daily Disposable Contact Lens Worn in a Neophyte Population.|Clinical Performance of a New Daily Disposable Contact Lens Worn in a Neophyte Population.|Completed||N/A|74|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:11:35.018125|2017-02-18 14:11:35.018125
NCT00708019|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-04-01|2015-01-22||December 2007||2007-12-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Improving Cancer Pain Management Through Self-Care|Improving Cancer Pain Management Through Self-Care|Completed||N/A|185|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:11:35.421446|2017-02-18 14:11:35.421446
NCT00708006|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2013-11-05|||May 2008||2008-05-01|November 2013|2013-11-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors|A Phase 1 Dose-Escalation Study to Evaluate the Safety and Tolerability of HGS1029 (AEG40826-2HCl) in Patients With Advanced Solid Tumors|Completed||Phase 1|66|Actual|Human Genome Sciences Inc.||1|||f||||f||||||||||2017-02-18 14:11:35.75333|2017-02-18 14:11:35.75333
NCT00707993|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-05-22|2013-02-17||June 2008||2008-06-01|May 2013|2013-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Subjects With Type 2 Diabetes|Completed||Phase 3|441|Actual|Takeda||2|||f||||f||||||||||2017-02-18 14:11:35.856073|2017-02-18 14:11:35.856073
NCT00707980|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-10-24|2013-10-24||June 2008||2008-06-01|October 2013|2013-10-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder|A Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder|Completed||Phase 3|836|Actual|Takeda||1|||f||||f||||||||||2017-02-18 14:11:37.509191|2017-02-18 14:11:37.509191
NCT00707967|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2016-11-07|2016-11-07||June 2008||2008-06-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.|Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine (692342) in HIV-positive Adults.|Completed||Phase 2|37|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 14:11:38.460902|2017-02-18 14:11:38.460902
NCT00707954|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2014-03-26|2014-03-26||June 2008||2008-06-01|March 2014|2014-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients|A Clinical Pharmacology Study of Multiple Doses of TA-7284 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|61|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 14:11:40.189606|2017-02-18 14:11:40.189606
NCT00707941|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-29|2011-07-11|||May 2008||2008-05-01|June 2008|2008-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Oseltamivir Randomised Controlled Efficacy Trial|Efficacy of Oseltamivir in Reducing the Duration of Clinical Illness, Viral Shedding, and Transmissibility Reduction Within Households Among Participants in an Influenza Disease Burden Surveillance Cohort in Urban Dhaka, Bangladesh|Completed||Phase 3|700|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||t||||||||||2017-02-18 14:11:40.719181|2017-02-18 14:11:40.719181
NCT00707928|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-28|2011-03-06|||February 2008||2008-02-01|June 2008|2008-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study|Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study|Completed||Phase 4|100|Anticipated|Mahidol University||2|||f||||f||||||||||2017-02-18 14:11:40.838582|2017-02-18 14:11:40.838582
NCT00707915|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2012-03-24|2011-07-20||January 2008||2008-01-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Discontinuation of Benzodiazepine-derivative Hypnotics on Cognitive and Motor Functions in Elderly Persons|Effects of Discontinuation of Benzodiazepine-derivative Hypnotics on Cognitive and Motor Functions in Elderly Persons: a Pilot Study|Completed||Phase 4|30|Actual|Minamihanno Hospital||1|||f||||f||||||||||2017-02-18 14:11:40.949023|2017-02-18 14:11:40.949023
NCT00707902|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2008-06-30|||February 2006||2006-02-01|June 2008|2008-06-01|August 2006||2006-08-01|||||Interventional|||Clinical Trial for Assessment of Safety and Efficacy of a Echinacea/Sage Spray Compared to a Chlorhexidine/Lidocaine Spray in the Treatment of Acute Sore Throats|Multicentric Randomized Double Blind Double Dummy Placebo Controlled Clinical Trial for Assessment of Safety and Efficacy of a Echinacea/Sage Spray in Comparison to a Chlorhexidine/Lidocaine Spray in the Treatment of Acute Sore Throats|Completed||Phase 3|154|Actual|Bioforce AG||2|||f||||t||||||||||2017-02-18 14:11:43.542833|2017-02-18 14:11:43.542833
NCT00707889|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-05-07||2013-05-07|October 2008||2008-10-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer|An Open-Label, Randomized Phase 2 Study of ABT-869 in Combination With mFOLFOX6 (Oxaliplatin, 5-Fluorouracil, and Folinic Acid) Versus Bevacizumab in Combination With mFOLFOX6 as Second-line Treatment of Subjects With Advanced Colorectal Cancer|Completed||Phase 2|159|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 14:11:43.650689|2017-02-18 14:11:43.650689
NCT00707876|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2016-09-19|||September 2008||2008-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|July 2010|Actual|2010-07-01||Interventional|||Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)|A Phase II, Open Label, Randomized, Multicenter Trial Comparing Noncontrast MRA Versus Ferumoxytol Vascular Enhanced MRI (VE-MRI) for the Detection of Clinically Significant Stenosis or Occlusion of the Aortoiliac and Superficial Femoral Arteries in Subjects With Peripheral Arterial Disease Scheduled for Digital Subtraction Angiography (DSA)|Active, not recruiting||Phase 2|108|Anticipated|AMAG Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 14:11:43.803252|2017-02-18 14:11:43.803252
NCT00707863|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-08-23|2016-07-12||May 2008||2008-05-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on Escitalopram|fMRI and Genotype Markers of Antidepressant Side Effects and Response in Young Adults Compare to Older Adults|Completed||Phase 4|17|Actual|Indiana University|Small number of subjects were studied|2|||f||||f||||||||No||2017-02-18 14:11:43.904973|2017-02-18 14:11:43.904973
NCT00707850|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2010-08-30|||May 2007||2007-05-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus Infection|A Study on PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin) in Iranian Thalassemic Patients With Chronic Hepatitis C Infection|Completed||Phase 4|300|Anticipated|Baqiyatallah Medical Sciences University||1|||f||||t||||||||||2017-02-18 14:11:46.568489|2017-02-18 14:11:46.568489
NCT00707837|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2009-04-24|||May 2005||2005-05-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Nutritional Study in Preterm Infants|Effect of Supplemental Infant Formula on Blood Levels in Preterm Infants|Completed||Phase 3|206|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-02-18 14:11:46.683294|2017-02-18 14:11:46.683294
NCT00707824|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-29|2008-07-07|||June 2000||2000-06-01|February 2006|2006-02-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Epidural Nalbuphine for Postcesarean Epidural Morphine Induced Pruritus|Study of Epidural Nalbuphine for Prevention of Epidural Morphine Induced Pruritus|Completed||Phase 4|165|Actual|Mahidol University||3|||f||||f||||||||||2017-02-18 14:11:46.782019|2017-02-18 14:11:46.782019
NCT00707811|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2008-06-27|||April 2008||2008-04-01|June 2008|2008-06-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Observational|||Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing|Evaluation of ST2 and IL-33 for Risk Stratification and Diagnosis in Patients Presenting to the Emergency Department With Dyspnea|Unknown status|Recruiting|N/A|200|Anticipated|The Cleveland Clinic|||1||f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 14:11:46.888948|2017-02-18 14:11:46.888948
NCT00707798|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2017-01-09|||June 2008||2008-06-01|January 2017|2017-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Pneumococcal Vaccine Formulations in Young Adults|A Study to Evaluate GSK Biologicals' Candidate Formulations of Pneumococcal Vaccines (GSK2189242A) in Young Adults.|Completed||Phase 1|157|Actual|GlaxoSmithKline||7|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:11:46.976576|2017-02-18 14:11:46.976576
NCT00707785|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-09-24|||December 2006||2006-12-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|April 2011|Actual|2011-04-01||Interventional|||Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis|Effect of Vitamin A in the Treatment of Sepsis and Necrotizing Enterocolitis in Hospitalized Neonates|Completed||Phase 3|424|Actual|Johns Hopkins University||4|||f||||t||||||||||2017-02-18 14:11:47.090234|2017-02-18 14:11:47.090234
NCT00707772|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2009-09-16|||March 2007||2007-03-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection|A Study on PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin) in Iranian Hemophilic Patients With Chronic Hepatitis C Infection|Completed||Phase 4|400|Anticipated|Baqiyatallah Medical Sciences University||2|||f||||t||||||||||2017-02-18 14:11:47.201632|2017-02-18 14:11:47.201632
NCT00707759|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-10-13|2015-10-13||June 2008||2008-06-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Interventional|||Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection|Multicenter, Open-Label, Randomized Study on Steroid-Free Immunosuppression, in Comparison With Daily Steroid Therapy, in Pediatric Renal Transplant : Impact on Growth, Bone Metabolism and Acute Rejection|Completed||Phase 3|28|Actual|Fondo Nacional de Desarrollo Científico y Tecnológico, Chile||2|||f||||t||||||||||2017-02-18 14:11:47.326154|2017-02-18 14:11:47.326154
NCT00707746|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2016-08-01|2013-02-25||October 2008||2008-10-01|August 2016|2016-08-01|January 2011|Actual|2011-01-01|August 2010|Actual|2010-08-01||Interventional|ASSIST||Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects|A Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of ISIS 301012 Administration in High Risk Statin Intolerant Subjects|Completed||Phase 2|34|Actual|Kastle Therapeutics, LLC||2|||f||||f||||||||||2017-02-18 14:11:47.878704|2017-02-18 14:11:47.878704
NCT00707720|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-04-09|||June 2008||2008-06-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||Multi-Center Feasibility Study of Trans-oral Endoscopic Restrictive Implant System (TERIS) for Treatment of Obesity|Multi-center Feasibility Study to Evaluate the Safety of the Trans-oral Endoscopic Restrictive Implant System (TERIS) for the Treatment of Obesity|Completed||Phase 1|40|Actual|BaroSense Inc.||1|||f||||f||||||||||2017-02-18 14:11:49.113437|2017-02-18 14:11:49.113437
NCT00707707|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2016-12-30|||September 2008||2008-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|November 2009|Actual|2009-11-01||Interventional|||Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer|Phase I/II Randomised, Double- Blind, Multi-centre Study to Assess the Efficacy of AZD2281 When Given in Combination With Paclitaxel in the 1st or 2nd Line Treatment of Patients With Metastatic Triple Negative Breast Cancer.|Active, not recruiting||Phase 1|24|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:11:49.212372|2017-02-18 14:11:49.212372
NCT00707694|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2009-01-29|||July 1998||1998-07-01|January 2009|2009-01-01||||||||Observational|||The Longevity Genes in Founder Populations Project|Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population|Unknown status|Recruiting|N/A|1500|Anticipated|Albert Einstein College of Medicine, Inc.|||3||f||||t||||||||||2017-02-18 14:11:49.318799|2017-02-18 14:11:49.318799
NCT00707681|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2010-02-24|||March 2008||2008-03-01|February 2010|2010-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)|A Phase II Randomized, Controlled Study to Evaluate the Quality of Life, Survival and Therapeutic Benefits of MS-20 in Patient With Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|60|Anticipated|Microbio Co Ltd||2|||f||||t||||||||||2017-02-18 14:11:49.598536|2017-02-18 14:11:49.598536
NCT00707668|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2014-07-25|||May 2007||2007-05-01|July 2014|2014-07-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|||Chung-ju Metabolic Disease Cohort (CMC) Study|Chung-ju Metabolic Disease Cohort (CMC) Study|Unknown status|Recruiting|N/A|10000|Anticipated|The Catholic University of Korea|||1||f||||f||||||Samples With DNA|"~     Plasma Serum Whole blood Urine~   "|||2017-02-18 14:11:49.695224|2017-02-18 14:11:49.695224
NCT00707655|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2011-11-21|2011-10-07||September 2008||2008-09-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy|An Open-label, International, Multi-Center, Phase I/II, Dose-escalation Trial Investigating the Safety of Zalutumumab, a Human Monoclonal Epidermal Growth Factor Receptor Antibody in Combination With Radiotherapy, in Patients With Stage III, IVa or IVb Locally Advanced Squamous Cell Carcinoma of the Head and Neck Ineligible for Platinum Based Chemotherapy|Terminated||Phase 1/Phase 2|8|Actual|Genmab|All adverse events were collected during the 8 week treatment period and for 4 additional weeks. Serious adverse events were collected for the extended follow-up period of 2 years.|2||The decision is based on company re-evaluation of indications to be pursued within SCCHN|f||||t||||||||||2017-02-18 14:11:49.793251|2017-02-18 14:11:49.793251
NCT00707642|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-29|2009-06-13|||May 2008||2008-05-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety Study of HBV-002 West Nile Vaccine in Healthy Adults|Phase 1, Open-Label, Safety Study of HBV-002 (West Nile Recombinant Subunit Vaccine) in Healthy Adults|Completed||Phase 1|25|Actual|Hawaii Biotech, Inc.||4|||f||||t||||||||||2017-02-18 14:11:50.316744|2017-02-18 14:11:50.316744
NCT00707629|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2016-02-29|||August 2005||2005-08-01|February 2016|2016-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Long Term Effects of Diabetes of Very Young Children|Long Term Effects of Diabetes of Very Young Children|Completed||N/A|25|Actual|Indiana University|||1||f||||f||||||||||2017-02-18 14:11:50.431121|2017-02-18 14:11:50.431121
NCT00707616|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-01-18|||March 2006||2006-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Common Genetic Variation and Type 2 Diabetes|The Effect of Diabetes-associated Gene Variation on Glucose Metabolism in Humans|Completed||N/A|190|Actual|Mayo Clinic|||1||f||||f||||||Samples With DNA|"~     Samples for hormone measurement and DNA extraction~   "|||2017-02-18 14:11:50.520401|2017-02-18 14:11:50.520401
NCT00707603|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-29|2015-07-13|||May 2006||2006-05-01|July 2015|2015-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Chronic Hepatitis C and Insulin Resistance|Understanding the Relationship Between Insulin Resistance and Chronic Hepatitis C Infection|Completed||N/A|50|Actual|Garvan Institute of Medical Research|||2||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:11:50.828931|2017-02-18 14:11:50.828931
NCT00707590|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2009-02-09|||August 2008||2008-08-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)|Randomized, Double-Blind, Placebo-Controlled Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 1|120|Anticipated|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 14:11:50.927803|2017-02-18 14:11:50.927803
NCT00707577|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-10-02|||February 2008||2008-02-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||A Maintenance Program for the Be Fit Employee Wellness Program|A Randomized Controlled Trial of a Maintenance Program for the Be Fit Employee Wellness Program at Massachusetts General Hospital|Completed||N/A|330|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:11:51.034574|2017-02-18 14:11:51.034574
NCT00707564|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2012-09-20|||July 2008||2008-07-01|September 2012|2012-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of Hemostatic Efficacy of the HemCon Dental Dressing in a Population Treated With Anticoagulant Medications|A Randomized, Self-Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing in a Population Treated With Anticoagulant Medications|Withdrawn||N/A|0|Actual|HemCon Medical Technologies, Inc||2||unable to enroll patient population|f||||f||||||||||2017-02-18 14:11:51.145087|2017-02-18 14:11:51.145087
NCT00707551|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2010-12-02|||July 2008||2008-07-01|December 2010|2010-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||An Interaction Study of Ketoconazole/Verapamil Versus AZD1305|A Phase I, Single-centre, Randomised, Open, Three-way Crossover Study to Evaluate the Effect of Ketoconazole and Verapamil, Respectively, on the Pharmacokinetics of AZD1305 After Repeated Oral Adm of Ketoconazole and Verapamil and Single Oral Dosing of AZD1305 to Young Healthy Male Volunteers|Completed||Phase 1|27|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:11:51.254852|2017-02-18 14:11:51.254852
NCT00707538|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2011-08-17|||June 2008||2008-06-01|August 2011|2011-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress|A Phase I Dosimetry, Biodistribution and Safety Study of BMS747158 in Healthy Subjects Undergoing 2-Day Rest/Stress Positron Emission Tomography|Completed||Phase 1|12|Actual|Lantheus Medical Imaging||1|||f||||t||||||||||2017-02-18 14:11:51.364807|2017-02-18 14:11:51.364807
NCT00707525|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-30|2010-03-25|||February 2008||2008-02-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Embryo Aneuploidies and Ovarian Stimulation|Incidence of EmbyoO Aneuploidies in Natural Versus Stimulated Cycles in the Same Women.|Completed||Phase 4|||Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 14:11:51.456668|2017-02-18 14:11:51.456668
NCT00707512|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-07-16|||June 2008||2008-06-01|June 2015|2015-06-01|August 2050|Anticipated|2050-08-01|August 2050|Anticipated|2050-08-01||Observational|INFORM||CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring|INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring|Terminated||N/A|87|Actual|Biogen|||1|Sponsor's decision.|f||||f||||||||||2017-02-18 14:11:51.555181|2017-02-18 14:11:51.555181
NCT00707499|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2011-10-14|||September 2007||2007-09-01|October 2011|2011-10-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158|A Single-Dose, Phase I, Dosimetry, Biodistribution, and Safety Trial of BMS 747158 in Healthy Subjects|Completed||Phase 1|13|Actual|Lantheus Medical Imaging||1|||f||||t||||||||||2017-02-18 14:11:51.686315|2017-02-18 14:11:51.686315
NCT00707486|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2012-12-06|2010-04-02||June 2008||2008-06-01|December 2012|2012-12-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|||A Randomized, Self Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing|A Randomized, Self Controlled Clinical Study of Hemostatic Efficacy of the HemCon Dental Dressing|Completed||Phase 3|72|Actual|HemCon Medical Technologies, Inc||2|||f||||f||||||||||2017-02-18 14:11:51.78948|2017-02-18 14:11:51.78948
NCT00707473|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-08-22|||June 2008||2008-06-01|August 2016|2016-08-01||||June 2018|Anticipated|2018-06-01||Interventional|||Trial of Induction Therapy With Docetaxel, Cisplatin and Fluorouracil in Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma and/or Poorly Differentiated Carcinoma of the Nasal Cavity and/or Paranasal Sinuses|Phase II Trial of Induction Therapy With Docetaxel, Cisplatin and Fluorouracil in Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma and/or Poorly Differentiated Carcinoma of the Nasal Cavity and/or Paranasal Sinuses|Recruiting||Phase 2|45|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:11:52.112185|2017-02-18 14:11:52.112185
NCT00707460|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2010-01-18|||May 2008||2008-05-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|SLHDP||The Effect of a Traditional Dietary Intervention on Diabetes Mellitus and Cardiovascular Disease Risk Factors in a First Nation Community: A Pilot Study|Objective 3: Pilot Dietary Trial; The Sandy Lake Health & Diabetes Project (SLHDP): Understanding and Addressing Metabolic Syndrome, Diabetes and Associated Complications in Aboriginal Canadians|Completed||Phase 1|60|Anticipated|University of Toronto||3|||f||||f||||||||||2017-02-18 14:11:52.229812|2017-02-18 14:11:52.229812
NCT00707447|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-08-08|2012-09-03||April 2004||2004-04-01|August 2014|2014-08-01|May 2008|Actual|2008-05-01|December 2005|Actual|2005-12-01||Interventional|PREDIAS||Evaluation of a Primary Type 2 Diabetes Prevention Programme|Evaluation of a Teaching and Treatment Programme for Primary Prevention of Type 2 Diabetes|Completed||Phase 4|182|Actual|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||f||||||||||2017-02-18 14:11:52.352909|2017-02-18 14:11:52.352909
NCT00707434|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-09-28|||June 2008||2008-06-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Continuous Glucose Monitoring in Critically Ill|Continuous Glucose Monitoring Device Compared With Point-of-Care Glucose Testing in the ICU|Terminated||N/A|6|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:11:53.135633|2017-02-18 14:11:53.135633
NCT00707421|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2009-05-28|||July 2005||2005-07-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes|A Randomized Clinical Trial Comparing Preoperative Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Compared to Placebo With Regard to Clinical Outcomes Following Trabeculectomy.|Completed||Phase 3|62|Actual|Universitaire Ziekenhuizen Leuven||3|||f||||||||||||||2017-02-18 14:11:53.246575|2017-02-18 14:11:53.246575
NCT00707408|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2009-01-30|||February 2004||2004-02-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|||||Interventional|||High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)|A Phase II Trial Evaluating the Safety and the Efficacy of High-Dose Imatinib in Relapsed/Refractory c-Kit Positive and BCR-Abl Negative AML Patients|Completed||Phase 2|15|Actual|Nantes University Hospital|||||f||||f||||||||||2017-02-18 14:11:53.356553|2017-02-18 14:11:53.356553
NCT00707382|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2012-02-09|||February 2008||2008-02-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment|A Three-armed Randomised Controled Trial on the Effect of Genotyping for CYP450 Polymorphisms and Intense Clinical Monitoring on Antipsychotic Drug Treatment.|Completed||N/A|311|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-02-18 14:11:53.44346|2017-02-18 14:11:53.44346
NCT00707369|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-03-02|||October 2008||2008-10-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|ABPARO-Studie||Adjunctive Antimicrobial Therapy of Periodontitis: Long-Term Effects on Disease Progression and Oral Microbiological Colonization|Adjunctive Antimicrobial Therapy of Periodontitis: Long-Term Effects on Disease Progression and Oral Microbiological Colonization|Completed||Phase 4|540|Actual|University Hospital Muenster||2|||f||||t||||||||||2017-02-18 14:11:53.565498|2017-02-18 14:11:53.565498
NCT00707356|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-04-17|||September 2008||2008-09-01|April 2016|2016-04-01|July 2012|Actual|2012-07-01|January 2011|Actual|2011-01-01||Interventional|||Study of WST11 in Patients With Localized Prostate Cancer|Vascular-Targeted Photodynamic Therapy Using WST 11 in Patients With Localized Prostate Cancer|Completed||Phase 2|42|Actual|Steba Biotech S.A.||1|||f||||t||||||||Yes|The data are available in case report form for each patient|2017-02-18 14:11:53.689401|2017-02-18 14:11:53.689401
NCT00707174|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2013-07-23|2012-06-04||March 2005||2005-03-01|July 2013|2013-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna|Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna|Completed||N/A|90|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 14:11:56.895769|2017-02-18 14:11:56.895769
NCT00707343|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-01-04|2015-10-14||May 2007||2007-05-01|January 2016|2016-01-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors|Preliminary Evaluation of the Efficacy of [F-18] Fluorothymidine (FLT) to Differentiate Radiation Necrosis From Tumor Recurrence and as a Marker of Proliferation in Patients With Primary Brain Tumors|Completed||Phase 1|15|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:11:53.809379|2017-02-18 14:11:53.809379
NCT00707330|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-08-08|||May 2008||2008-05-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|CLAROX||Study of the Ability of Clarithromycin to Induce Oxidative Stress|A Randomized, Single Blinded, Open-Label Crossover-Study of the Possible Induction of Oxidative Stress by Clarithromycin in Healthy Subjects|Completed||Phase 1|26|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 14:11:54.021324|2017-02-18 14:11:54.021324
NCT00707317|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2015-12-15|||June 2008||2008-06-01|December 2015|2015-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|TBNET-TIPS||T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals|Prospective Head-to-head Comparison of the Two Commercially Available Approved TIGRA (QuantiFERON-TB Gold In-Tube and T.SPOT.TB) With the Established Mendel-Mantoux Skin-test in Immunocompromized Patients|Completed||N/A|1843|Actual|Tuberculosis Network European Trialsgroup|||7||f||||f||||||Samples Without DNA|"~     Plasma supernatants of stimulated samples for cytokine analysis.~   "|||2017-02-18 14:11:54.141553|2017-02-18 14:11:54.141553
NCT00707304|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2012-08-13||2012-08-13|November 2008||2008-11-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|March 2011|Actual|2011-03-01||Interventional|FORTIS-M||Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer|FORTIS-M: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Oral Talactoferrin in Addition to Best Supportive Care in Patients With Non-small Cell Lung Cancer Who Have Failed Two or More Prior Treatment Regimens|Completed||Phase 3|742|Actual|Agennix||2|||f||||t||||||||||2017-02-18 14:11:54.287855|2017-02-18 14:11:54.287855
NCT00707291|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-07-04|||July 2008||2008-07-01|July 2014|2014-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Characterization of the Edge of Soft Contact Lens and Its Interaction With Ocular Surface|Characterization of the Edge of Soft Contact Lens and Its Interaction With Ocular Surface|Completed||N/A|61|Actual|University of Miami|||1||f||||f||||||||||2017-02-18 14:11:54.59356|2017-02-18 14:11:54.59356
NCT00707278|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-10-29|||September 2005||2005-09-01|October 2014|2014-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma|A Prospective Phase I Study of Radiation Therapy and Concurrent Capecitabine and Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma|Completed||Phase 1|13|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:11:54.687966|2017-02-18 14:11:54.687966
NCT00707265|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2013-08-01|||March 2002||2002-03-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|May 2005|Actual|2005-05-01||Interventional|CRM||rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study|A Prospective, Randomized Clinical Investigation of rhBMP-2 and Compression Resistant Matrix With the CD HORIZON® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic Degenerative Disc Disease|Completed||Phase 3|463|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-02-18 14:11:54.810506|2017-02-18 14:11:54.810506
NCT00707252|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-04-20|||January 2008||2008-01-01|April 2015|2015-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer|Phase I/II Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer|Terminated||Phase 1|11|Actual|Louisiana State University Health Sciences Center Shreveport||1||Phase II not initiated due to cancellation of supply of Poly E by collaborator.|f||||t||||||||||2017-02-18 14:11:54.958432|2017-02-18 14:11:54.958432
NCT00707239|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2012-06-05|2012-06-05||December 2008||2008-12-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia|A Phase 2, Multicenter, Randomized, Double-Blind, Comparative Study Of The Safety And Efficacy of 2 Doses Of Tigecycline Versus Imipenem/Cilastatin For The Treatment Of Subjects With Hospital-Acquired Pneumonia|Terminated||Phase 2|108|Actual|Pfizer|Formal statistical conclusions could not be made due to premature termination of study, because of enrollment difficulties, and small number of enrolled participants.|3||See termination reason in detailed description.|f||||t||||||||||2017-02-18 14:11:55.093301|2017-02-18 14:11:55.093301
NCT00707226|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-06-27|||November 2000||2000-11-01|June 2008|2008-06-01|December 2001|Actual|2001-12-01|||||Observational|||Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes|Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes|Completed||N/A|30|Actual|Medical University of Vienna|||2||f||||||||||||||2017-02-18 14:11:56.459921|2017-02-18 14:11:56.459921
NCT00707213|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-06-07|||August 2007||2007-08-01|June 2016|2016-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||FDG-PET/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients|FDG-PET/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients|Terminated||N/A|19|Actual|University of Utah||1||Funding from the NIH ended and not all patients had been accrued|f||||t||||||||||2017-02-18 14:11:56.570831|2017-02-18 14:11:56.570831
NCT00707200|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2010-01-22|||October 2007||2007-10-01|July 2009|2009-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|CPM||The Cytoadherence in Pediatric Malaria (CPM) Study|Clinical Outcomes in Pediatric Plasmodium Falciparum Malaria According to Host Cytoadherence Factors|Completed||N/A|2000|Anticipated|University Health Network, Toronto|||2||f||||f||||||Samples With DNA|"~     Freshly frozen citrated plasma aliquots, frozen spun red cell pellets, and whole blood blots~     onto nucleic acid storage cards (Whatman FTA).~   "|||2017-02-18 14:11:56.681157|2017-02-18 14:11:56.681157
NCT00707187|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2008-06-27|||July 2001||2001-07-01|June 2008|2008-06-01|July 2002||2002-07-01|July 2002||2002-07-01||Interventional|||Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction|Randomized, Placebo-Controlled, Double-Blind, Cross-Over Trial of the Efficacy and Safety of IC351 in Female Patients With Raynaud Phenomenon and Female Sexual Dysfunction Secondary to Systemic Sclerosis|Completed||Phase 2|120|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 14:11:56.791225|2017-02-18 14:11:56.791225
NCT00701896|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2017-02-10|||June 2008||2008-06-01|February 2017|2017-02-01|June 20, 2013|Actual|2013-06-20|April 20, 2013|Actual|2013-04-20||Interventional|||Smoking Cessation Using Motivational Therapy and Varenicline|Smoking Cessation and the Natural History of HIV-Associated Emphysema|Completed||N/A|368|Actual|Ohio State University||4|||f||||t||||||||||2017-02-18 14:14:14.884279|2017-02-18 14:14:14.884279
NCT00707161|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-10-28|2011-04-20||September 2005||2005-09-01|October 2014|2014-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma|A Prospective Phase II Study of Radiation Therapy and Concurrent Cisplatin Chemotherapy in the Treatment of Locally Advanced or Metastatic Malignant Melanoma|Terminated||Phase 2|1|Actual|University of Utah|Early termination due to low enrollment.|1||discontinued due to low enrollment|f||||t||||||||||2017-02-18 14:11:57.261098|2017-02-18 14:11:57.261098
NCT00707148|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-07-24|||January 2009||2009-01-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pertussis Vaccine in Healthy Pregnant Women|Safety and Immunogenicity of Tdap Vaccine in Healthy Pregnant Women, Safety in Their Neonates, and Effect of Maternal Immunization on Infant Immune Responses to DTaP Vaccine|Completed||Phase 1|80|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 14:11:57.502793|2017-02-18 14:11:57.502793
NCT00707135|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-01-16|||June 2005||2005-06-01|January 2014|2014-01-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Rapamycin in Advanced Cancers|A Phase Ib Study of Rapamycin (Sirolimus) in Patients With Advanced Malignancies|Completed||Phase 1|40|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 14:11:57.618262|2017-02-18 14:11:57.618262
NCT00707122|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-11-07|||July 2008||2008-07-01|November 2015|2015-11-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional|ALBIOS||Volume Replacement With Albumin in Severe Sepsis|Efficacy of Albumin Administration for Volume Replacement in Patients With Severe Sepsis or Septic Shock - the ALBumin Italian Outcome Sepsis (ALBIOS) Study|Completed||Phase 3|1818|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||t||||||||||2017-02-18 14:11:57.713549|2017-02-18 14:11:57.713549
NCT00707083|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-05-31|||May 2008||2008-05-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia|A Multicenter Study of Treatment Protocol for Childhood Acute Lymphoblastic Leukemia in China, 2008.|Active, not recruiting||Phase 3|2500|Anticipated|Prince of Wales Hospital, Shatin, Hong Kong||2|||f||||f||||||||||2017-02-18 14:11:57.820795|2017-02-18 14:11:57.820795
NCT00707070|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-06-27|||September 2008||2008-09-01|June 2008|2008-06-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|CobAcE||Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis|Phase IV Study on Efficacy and Safety of the Combination Treatment Acitretin and Efalizumab in Moderate to Severe Chronic Plaque Psoriasis|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Universita di Verona||2|||f||||f||||||||||2017-02-18 14:11:57.928342|2017-02-18 14:11:57.928342
NCT00707057|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2011-03-22|2009-05-21||June 2008||2008-06-01|March 2011|2011-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Ibuprofen Extended-Release Dental Pain Study|Ibuprofen 600 mg Extended-Release (ER) Multiple-Dose Dental Pain Study|Completed||Phase 3|256|Actual|SCOLR Pharma, Inc.|Of the 12 subjects who prematurely discontinued all 4 doses of the study drug, 6 subjects received 1 dose of study drug, 2 subjects received 2 doses, and 4 subjects received 3 doses.|2|||f||||f||||||||||2017-02-18 14:11:58.034611|2017-02-18 14:11:58.034611
NCT00707044|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-06-27|||January 2001||2001-01-01|June 2008|2008-06-01|May 2004|Actual|2004-05-01|October 2003|Actual|2003-10-01||Interventional|||Short-Stay Intensive Care for Coronary Artery Bypass Patients|Short-Stay Intensive Care for Coronary Artery Bypass Patients,Development of a Guideline for Giving Adequate Care on the Cardiosurgical Intensive Care|Completed||Phase 3|597|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 14:11:58.927327|2017-02-18 14:11:58.927327
NCT00707031|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-10-20|2016-08-18||June 2008||2008-06-01|October 2016|2016-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|GETGOAL-X|Safety population included all randomized patients who received at least 1 dose of study drug, regardless of the amount of treatment administered. In addition, 5 patients from one site with serious noncompliance issues were excluded from all analysis populations.|GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin|A Randomized, Open-label, Active-controlled, 2-arm Parallel-group, Multicenter 24-week Study Followed by an Extension Assessing the Efficacy and Safety of AVE0010 Versus Exenatide on Top of Metformin in Patients With Type 2 Diabetes Not Adequately Controlled With Metformin|Completed||Phase 3|639|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:11:59.034956|2017-02-18 14:11:59.034956
NCT00707018|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-05-20|||September 2004||2004-09-01|May 2016|2016-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Immobilization in External Rotation After First Time Anterior Shoulder Dislocation|Immobilization in External Rotation After First Time Anterior Shoulder Dislocation: A Prospective Randomized Study|Completed||Phase 3|50|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 14:11:59.892296|2017-02-18 14:11:59.892296
NCT00707005|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-10-30|||June 2008||2008-06-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Antibiotic Susceptibility of Conjunctival Bacterial Isolates From Refractive Surgery Patients|Antibiotic Susceptibility of Conjunctival Bacterial Isolates From Refractive Surgery Patients|Completed||N/A|105|Actual|Yonsei University|||1||f||||f||||||Samples Without DNA|"~     Conjunctival swab samples~   "|||2017-02-18 14:12:00.002568|2017-02-18 14:12:00.002568
NCT00706992|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2015-10-06|2012-12-18||June 2008||2008-06-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients|Transfer of Autologous T Cells Transduced With the Anti-MART-1 F5 T Cell Receptor in High Risk Melanoma|Terminated||Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)||7||<11 subjects were enrolled to each Arm|f||||t||||||||||2017-02-18 14:12:00.121706|2017-02-18 14:12:00.121706
NCT00706979|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2011-11-07|2011-11-07||September 2008||2008-09-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Novel Treatment to Boost Quit Attempts and Cessation Among Unmotivated Smokers|A Novel Treatment to Boost Quit Attempts and Cessation Among Unmotivated Smokers|Completed||N/A|849|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 14:12:01.629815|2017-02-18 14:12:01.629815
NCT00706446|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2014-07-16||2012-05-17|June 2008||2008-06-01|July 2014|2014-07-01|September 2011|Actual|2011-09-01|June 2010|Actual|2010-06-01||Interventional|GABLE||Study of the Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations|Genotype Stratified Treatment With Anticholinergic vs. Beta-agonist (Long Acting) and Exacerbations (GABLE)|Terminated||N/A|355|Actual|Brigham and Women's Hospital||6|||f||||f||||||||||2017-02-18 14:12:17.507424|2017-02-18 14:12:17.507424
NCT00706966|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-27|2013-12-02|2013-12-02||June 2005||2005-06-01|December 2013|2013-12-01|August 2011|Actual|2011-08-01|December 2008|Actual|2008-12-01||Interventional|||MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer|A Pilot Study of MRI and Spectroscopy Imaging Changes With 6-months of Dutasteride in Patients With Symptomatic Benign Prostatic Hypertrophy and Low-risk Prostate Cancer on Watchful Waiting or Requiring Neoadjuvant Androgen Suppression Prior to Prostate Brachytherapy|Completed||N/A|10|Actual|University of California, San Francisco|The inclusion of only men with low volume disease may have limited our ability to accurately assess response rates after dutasteride due to the background effects on normal prostate metabolism.|1|||f||||t||||||||||2017-02-18 14:12:02.097811|2017-02-18 14:12:02.097811
NCT00706953|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-04-02|||July 2008||2008-07-01|April 2015|2015-04-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib|A Phase II Single Arm Study of VELCADE and DOXIL (PLD) in Patients With Relapsed Multiple Myeloma Previously Treated With VELCADE|Withdrawn||Phase 2|0|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 14:12:02.597262|2017-02-18 14:12:02.597262
NCT00706940|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-03-08|||August 2011||2011-08-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Tear Dynamics After Restasis Treatment in Dry Eye Patients|Tear Dynamics After Restasis Treatment in Dry Eye Patients Phase II Clinical Trial and Phase IIb 6-month Follow-up After Discontinuation of Study Treatment|Active, not recruiting||N/A|60|Actual|University of Miami|||1||f||||f||||||||||2017-02-18 14:12:02.702087|2017-02-18 14:12:02.702087
NCT00706927|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-11-13|||January 2006||2006-01-01|November 2014|2014-11-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension|A Double-masked Randomized Cross-over Study Comparing of the Effect of Xalacom® (Latanoprost/Timolol)and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension|Completed||N/A|16|Actual|Medical University of Vienna||1|||f||||||||||||||2017-02-18 14:12:02.792015|2017-02-18 14:12:02.792015
NCT00706914|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-05-31||2011-09-30|June 2008||2008-06-01|May 2016|2016-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter, 4-Week Pilot Study to Assess Symptoms in Stable, Moderate to Severe COPD Patients Taking Aclidinium Bromide 200 mcg Once Daily in Combination With Formoterol Fumarate Once or Twice Daily Versus Formoterol Fumarate Twice Daily|Completed||Phase 2|156|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:12:02.895442|2017-02-18 14:12:02.895442
NCT00706901|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-09-30|2014-10-30||May 2010||2010-05-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|June 2013|Actual|2013-06-01||Interventional|GMI-IHMDs||Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans|Impact of Group Motivational Interviewing for Dually Diagnosed Veterans|Active, not recruiting||Early Phase 1|180|Actual|VA Office of Research and Development||3|||f||||f||||||||Undecided||2017-02-18 14:12:03.039707|2017-02-18 14:12:03.039707
NCT00706888|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2009-07-03||||||July 2009|2009-07-01||||||||Interventional|||Study on Effects of a Dairy Product Based on Polyphenols and Enriched With Vitamins B6, B9 and B12 on Some Cardiovascular Factor of Risk||Completed||N/A|64|Anticipated|Elvir SAS||4|||f||||||||||||||2017-02-18 14:12:04.015469|2017-02-18 14:12:04.015469
NCT00706875|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-04-28|||June 2008||2008-06-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors|A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors|Active, not recruiting||N/A|60|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:12:04.103338|2017-02-18 14:12:04.103338
NCT00706862|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2012-03-13|||February 2009||2009-02-01|March 2012|2012-03-01|March 2016|Anticipated|2016-03-01|June 2015|Anticipated|2015-06-01||Interventional|FORTIS-C||Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer|FORTIS-C: A Phase 3, Randomized, Placebo-controlled Study of Oral Talactoferrin in Combination With Carboplatin and Paclitaxel as First-line Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 3|1100|Anticipated|Agennix||2|||f||||t||||||||||2017-02-18 14:12:04.213696|2017-02-18 14:12:04.213696
NCT00706849|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-08-01|2013-02-15||July 2008||2008-07-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|RADICHOL II||Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease|A Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of ISIS 301012 as Add-on Therapy in Heterozygous Familial Hypercholesterolemia Subjects With Coronary Artery Disease|Completed||Phase 3|124|Actual|Kastle Therapeutics, LLC||2|||f||||t||||||||||2017-02-18 14:12:04.335855|2017-02-18 14:12:04.335855
NCT00706836|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-12-19|2014-12-03||June 2008||2008-06-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||16 healthy subjects (10 male; mean age=23.2±2.6)|PharmacofMRI of Anxiolytic Medications (Pregabalin)|PharmacofMRI of Anxiolytic Medications (Pregabalin)|Completed||Phase 4|16|Actual|University of California, San Diego||3|||f||||f||||||||||2017-02-18 14:12:05.801403|2017-02-18 14:12:05.801403
NCT00706823|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2016-11-07|2011-03-08||February 2008||2008-02-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|I-gel||Comparison of I-gel to the Laryngeal Mask Airway|A Randomized Clinical Comparison of the Intersurgical I-gel and the Laryngeal Mask Airway Unique in Non-Obese Adult Patients During General Surgery|Completed||N/A|50|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||Undecided||2017-02-18 14:12:06.064823|2017-02-18 14:12:06.064823
NCT00706810|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-10-02|||December 2007||2007-12-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Combination of Hydroxyurea and Verapamil for Refractory Meningiomas|Combination of Hydroxyurea and Verapamil for Refractory Meningiomas|Completed||Phase 2|8|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:12:06.5502|2017-02-18 14:12:06.5502
NCT00706797|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2011-06-16|2010-12-22||September 2008||2008-09-01|June 2011|2011-06-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects|An Open-Label, Randomized Study to Evaluate the Radiographic Efficacy and Safety of Enbrel™ (Etanercept) Added to Methotrexate in Comparison With Usual Treatment in Subjects With Moderate Rheumatoid Arthritis Disease Activity|Terminated||Phase 4|141|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|Following early termination of the study, only disposition of randomized participants, description of demographic data on safety population, and safety analyses were performed.|2|||f||||f||||||||||2017-02-18 14:12:06.660225|2017-02-18 14:12:06.660225
NCT00706784|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2014-06-12|2014-04-16||June 2008||2008-06-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|VaginalRing||Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study|Inducing a Medical Castration With a GnRH Agonist While Simultaneously Replacing Physiologic Levels and Patterns of Human Sex Steroid Hormones Using an Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System|Terminated||Phase 1/Phase 2|6|Actual|Massachusetts General Hospital|Early termination leading to small numbers of subjects analyzed.|1||Sponsor making changes to manufacturing of vaginal ring.|f||||t||||||||||2017-02-18 14:12:07.426769|2017-02-18 14:12:07.426769
NCT00706771|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-06-26|||February 2010||2010-02-01|June 2014|2014-06-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|BLISS||Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study|A Randomized Double-blind Controlled Pilot Feasibility and Safety Trial of NGAL-directed Sodium Bicarbonate to Protect Renal Function in Patients With the Systemic Inflammatory Response Syndrome, Oliguria and Elevated Lipocalin Levels|Completed||Phase 2|70|Anticipated|Austin Health||2|||f||||f||||||||||2017-02-18 14:12:07.734902|2017-02-18 14:12:07.734902
NCT00706758|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2011-07-19|||August 2004||2004-08-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Structured Patient Education Versus Written Information for Patients With Irritable Bowel Syndrome|Structured Patient Education Versus Written Information for Patients With Irritable Bowel Syndrome|Completed||N/A|143|Actual|Sahlgrenska University Hospital, Sweden||2|||f||||f||||||||||2017-02-18 14:12:07.846073|2017-02-18 14:12:07.846073
NCT00706745|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-06-11|||June 2007||2007-06-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Conjugated Linoleic Acid and Atherosclerosis|Possible Effects of Supplementation With Cis-9, Trans-11 Conjugated Linoleic Acid on Markers of Atherosclerosis|Completed||Phase 3|401|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 14:12:08.147926|2017-02-18 14:12:08.147926
NCT00706732|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2012-07-11|||June 2008||2008-06-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|AVX502-003||A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza|A Single-Site, Phase I/II, Double Blinded, Safety and Immunogenicity Trial of an Alphavirus Replicon Vaccine Expressing Influenza A/Wyoming/03/2003 Hemagglutinin (AVX502) in Adult Volunteers 65 Years of Age or Older|Completed||Phase 1/Phase 2|28|Actual|AlphaVax, Inc.||4|||f||||f||||||||||2017-02-18 14:12:08.263035|2017-02-18 14:12:08.263035
NCT00706719|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2015-07-22|2010-08-25||June 2008||2008-06-01|July 2015|2015-07-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone|A Randomized, Open-Label, Fixed Dose, Active-Control, Multi-Center Phase IIB Study to Evaluate Fertility in Men With Secondary Hypogonadism, Comparing Androxal® to a Topical Testosterone in Men Previously Treated With Topical Testosterone.|Completed||Phase 2|17|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-02-18 14:12:08.379542|2017-02-18 14:12:08.379542
NCT00706706|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2013-01-14|2012-08-24||July 2008||2008-07-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|MRCC RCC||Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma|A Single-Arm, Open-Label, Multi-Center, Phase Iv, Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma (Post Approval Commitment Study)|Completed||Phase 4|105|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:12:09.046447|2017-02-18 14:12:09.046447
NCT00706693|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2008-07-07|||August 2003||2003-08-01|July 2008|2008-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Skittles(TM) Effective for Treating Hypoglycemia in Children With Type 1 Diabetes|The Effectiveness of Glucose, Sucrose and Fructose in Treating Hypoglycemia in Children With Type 1 Diabetes|Completed||N/A|33|Actual|University of Calgary||3|||f||||f||||||||||2017-02-18 14:12:09.380452|2017-02-18 14:12:09.380452
NCT00706680|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2008-06-25|||February 2008||2008-02-01|February 2008|2008-02-01|June 2009|Anticipated|2009-06-01|February 2009|Anticipated|2009-02-01||Interventional|||Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol|The Use of Thymoglobulin in a Calcineurin Inhibitor and Steroid Minimization Protocol|Unknown status|Recruiting|Phase 4|30|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 14:12:09.502146|2017-02-18 14:12:09.502146
NCT00706667|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2013-06-19|||May 2008||2008-05-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery|Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin for the Correction of Preoperative Anaemia in Patients Undergoing Orthopaedic Surgery|Terminated||Phase 4|75|Actual|University of Zurich||3||Not being able to recuit sufficient patients due to a lack of complience|f||||f||||||||||2017-02-18 14:12:09.611573|2017-02-18 14:12:09.611573
NCT00706654|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2013-07-12|2013-03-29||September 2008||2008-09-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|ASPIRE|Baseline measures are based on the participants from the Depot Maintenance Phase.|Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia|A 38-week, Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Schizophrenia|Completed||Phase 3|937|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||t||||||||||2017-02-18 14:12:09.727296|2017-02-18 14:12:09.727296
NCT00706251|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-06-26|||January 2000||2000-01-01|June 2008|2008-06-01||||December 2007|Actual|2007-12-01||Observational|||Follow up of Nasolacrimal Intubation in Adults|Long Term Follow up of Nasolacrimal Intubation in Adults With Mild Epiphora|Completed||N/A|180|Actual|Shaare Zedek Medical Center|||1||f||||f||||||||||2017-02-18 14:12:26.943333|2017-02-18 14:12:26.943333
NCT00706641|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2015-12-10|2015-12-10||June 2008||2008-06-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||All subjects who started treatment on dastanib were included for age, gender, and ECOG PS characteristics. One patient was removed from the study because they were found to be ineligible based on histology after they started treatment and thus were not included in the T-Stage characteristics.|Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder|A Pilot Study of Neoadjuvant Dasatinib Followed by Radical Cystectomy for Transitional Cell Carcinoma of the Bladder|Completed||N/A|25|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-02-18 14:12:10.645111|2017-02-18 14:12:10.645111
NCT00706628|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-01-14|2014-11-14||March 2006||2006-03-01|January 2015|2015-01-01||||December 2008|Actual|2008-12-01||Interventional||Treated Set: The Treated Set consisted of all patients who received at least 1 dose of study medication.|A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer|A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer|Completed||Phase 2|87|Actual|Boehringer Ingelheim|Data from the ComBI 70 group were not included in analyses of efficacy, data was available for one patient for this group for the primary outcome however is not reported to avoid reporting patient level data.||||f||||||||||||||2017-02-18 14:12:11.120164|2017-02-18 14:12:11.120164
NCT00706615|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-10-28|||July 2008||2008-07-01|July 2012|2012-07-01||||April 2009|Actual|2009-04-01||Interventional|||Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer|A Single Arm Open-Label Phase I Study of An Injectable Replication-Incompetent Adenoviral Vector Vaccine Used to Produce An Immune Response to MUC-1 Positive Epithelial Cancer Cells in Metastatic Breast Cancer|Withdrawn||Phase 1|0|Actual|Jonsson Comprehensive Cancer Center||1||no accrual|f||||t||||||||||2017-02-18 14:12:14.831279|2017-02-18 14:12:14.831279
NCT00706602|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2010-06-24|||May 2008||2008-05-01|June 2010|2010-06-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|ICECOLDERIC||Predicting the Course of Chronic Obstructive Pulmonary Disease (COPD) in Primary Care|International Collaborative Effort on Chronic Obstructive Lung Disease: Exacerbation Risk Index Cohorts|Unknown status|Active, not recruiting|N/A|450|Anticipated|University of Zurich|||2||f||||f||||||||||2017-02-18 14:12:14.928139|2017-02-18 14:12:14.928139
NCT00706589|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2013-06-19|2011-01-27||October 2008||2008-10-01|June 2013|2013-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder|A Randomized, Double-blind, Dose-adjustment, Placebo-controlled Study to Evaluate the Efficacy and Safety of Aripiprazole in Children and Adolescents With Chronic Tic Disorders or Tourette's Disorder|Completed||Phase 3|61|Actual|Korea Otsuka Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-02-18 14:12:15.034022|2017-02-18 14:12:15.034022
NCT00706576|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2010-07-13|||June 2008||2008-06-01|June 2008|2008-06-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor|Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor: a Phase I Study|Unknown status|Recruiting|Phase 1|42|Anticipated|Penn State University||1|||f||||t||||||||||2017-02-18 14:12:15.441076|2017-02-18 14:12:15.441076
NCT00706563|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-10-26|2009-07-16||July 2008||2008-07-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults|A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in People Aged 18 Years or Above|Completed||Phase 3|120|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:12:15.556927|2017-02-18 14:12:15.556927
NCT00706550|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2014-03-27|2013-09-26||October 2008||2008-10-01|March 2014|2014-03-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects|Immune Responses to Pneumococcal Vaccination Among HIV-Infected Subjects|Completed||N/A|107|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:12:16.273121|2017-02-18 14:12:16.273121
NCT00706537|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2009-08-11||2009-08-11|July 2008||2008-07-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH|A Multiple Dose, Randomized, Double-Blind (3rd Party Open), Placebo-Controlled Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of CP-945598 In Subjects With Nonalcoholic Steatohepatitis (NASH)|Completed||Phase 1|9|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:12:16.802186|2017-02-18 14:12:16.802186
NCT00706511|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-09-29|||December 2007||2007-12-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Metabolic Study of Sleep Apnea in Men and Women|Sleep and Metabolism in Obesity: Impact of Gender|Active, not recruiting||N/A|60|Anticipated|University of Chicago||2|||f||||t||||||||||2017-02-18 14:12:16.906429|2017-02-18 14:12:16.906429
NCT00706498|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2014-04-30||2014-04-30|September 2006||2006-09-01|April 2014|2014-04-01||||February 2008|Actual|2008-02-01||Interventional|||Phase II Study of BI 2536 in Prostate Cancer|A Single Arm Phase II Study to Investigate the Efficacy, Safety and Pharmacokinetics of a Single Dose of 200 mg of i.v. BI 2536, Administered Once Every 3 Weeks in Patients With Advanced Metastatic Hormone-refractory Prostate Cancer.|Completed||Phase 2|20|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:12:17.022528|2017-02-18 14:12:17.022528
NCT00706485|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-10-18|2016-10-18||July 2007||2007-07-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Intra-Operative Dural Brachytherapy With Yttrium-90 Plaque Applicators|Intra-Operative Dural Brachytherapy With Yttrium-90 Plaque Applicators|Terminated||N/A|5|Actual|Massachusetts General Hospital||1||New device for dural plaque irradiation was approved by FDA.|f||||t||||||||||2017-02-18 14:12:17.127108|2017-02-18 14:12:17.127108
NCT00706459|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2012-11-13|||March 2005||2005-03-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Advanced MR Imaging in Patients With Painful, Degenerative Disc Disease: A Pilot Study|Advanced MR Imaging in Patients With Painful, Degenerative Disc Disease: A Pilot Study|Terminated||N/A|53|Actual|University of California, San Francisco|||5|Due to funding issue, study has been terminated.|f||||f||||||Samples Without DNA|"~     Disc specimens are taken out during back surgery and will be studied using techniques for~     tissue analysis to explain the properties and characteristics of disc tissue from patients~     with back pain.~   "|||2017-02-18 14:12:17.396792|2017-02-18 14:12:17.396792
NCT00706433|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2011-10-20|2009-07-09||March 2007||2007-03-01|October 2011|2011-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne|A Randomized, Evaluator-blinded, Parallel Group Light Dose Ranging Study of Photodynamic Therapy With Levulan Topical Solution + Blue Light Versus Levulan Topical Solution Vehicle + Blue Light on Moderate to Severe Facial Acne Vulgaris|Completed||Phase 2|266|Actual|DUSA Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 14:12:17.675497|2017-02-18 14:12:17.675497
NCT00706420|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-04-05|||January 2002||2002-01-01|April 2016|2016-04-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen|Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen|Active, not recruiting||Phase 1|20|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:12:23.897944|2017-02-18 14:12:23.897944
NCT00706407|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-10-12|||April 2008||2008-04-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|Uro-NIRS||Uro-NIRS Clinical Study|Uro-NIRS Clinical Study|Completed||Phase 4|50|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 14:12:24.018241|2017-02-18 14:12:24.018241
NCT00706394|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2011-09-12|||September 2005||2005-09-01|September 2011|2011-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms|Prospective, Multicenter, Single Arm Phase II Study of the Powerlink 34mm Cuff for the Endovascular Repair of Abdominal Aortic Aneurysms|Unknown status|Active, not recruiting|Phase 2/Phase 3|60|Actual|Endologix||1|||t||||t||||||||||2017-02-18 14:12:24.308169|2017-02-18 14:12:24.308169
NCT00706381|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2017-01-24|||June 19, 2008||2008-06-19|August 4, 2016|2016-08-04|August 21, 2012|Actual|2012-08-21|August 21, 2012|Actual|2012-08-21||Interventional|||Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)|Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)|Completed||N/A|39|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:12:24.434382|2017-02-18 14:12:24.434382
NCT00706368|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2008-06-25|||April 2006||2006-04-01|May 2008|2008-05-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females|Taking Charge of my Health: A Trial to Investigate the Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females|Unknown status|Recruiting|N/A|300|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||f||||||||||2017-02-18 14:12:24.544272|2017-02-18 14:12:24.544272
NCT00706355|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2012-06-15|2012-04-26||August 2008||2008-08-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Study of PF-04217903 in Patients With Advanced Cancer|Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of PF-4217903 in Patients With Advanced Cancer|Terminated||Phase 1|16|Actual|Pfizer|Insufficient number of participants had been enrolled in the study due to a strategic development decision; therefore some of the objectives for this study were either not investigated or not fully investigated.|1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:12:24.664326|2017-02-18 14:12:24.664326
NCT00706342|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-05-03|2014-07-23||January 2007||2007-01-01|May 2016|2016-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)|A Phase II, Open-Label, Efficacy and Safety, Ascending Dose, Pilot Study of be Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura|Completed||Phase 2|18|Actual|Rigel Pharmaceuticals||1|||f||||t||||||||No||2017-02-18 14:12:25.809906|2017-02-18 14:12:25.809906
NCT00706329|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2013-06-05|2013-06-05||April 2008||2008-04-01|June 2013|2013-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|MIC|The study was terminated prematurely by the IRB due to data integrity and compliance concerns.|Minimally Invasive Closure of Umbilical Hernias|Study of Minimally Invasive Closure of Umbilical Hernias|Terminated||N/A|25|Actual|South Shore Hospital|The study was terminated prematurely by the IRB due to data integrity and compliance concerns. Results are not shared due to data integrity concerns. These concerns are outlined in an FDA warning letter.|1||"The study was terminated prematurely by the IRB due to data integrity and protocol compliance~   issues"|f||||f||||||||||2017-02-18 14:12:26.2236|2017-02-18 14:12:26.2236
NCT00706316|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2015-07-08|||December 2007||2007-12-01|July 2015|2015-07-01|November 2012|Actual|2012-11-01|August 2009|Actual|2009-08-01||Interventional|NPC-CTL||Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer|A Phase I Trial Evaluating the Administration of Epstein Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes (CTLs) to Patients With Recurrent or Metastatic EBV-Positive Nasopharygneal Cancer (NPC)|Completed||Phase 1|5|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 14:12:26.394756|2017-02-18 14:12:26.394756
NCT00706303|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2008-06-26|||June 2007||2007-06-01|June 2008|2008-06-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|GSuST||Glasgow Supported Self Management Trial (GSuST)|Glasgow Supported Self-Management Randomised Controlled Trial for Patients With Moderate/ Severe COPD - GSuST|Unknown status|Recruiting|N/A|500|Anticipated|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-02-18 14:12:26.50043|2017-02-18 14:12:26.50043
NCT00706290|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2014-06-05|||April 2007||2007-04-01|June 2014|2014-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Brief CBT for Anxiety and Advanced Cancer|Brief CBT for Anxiety and Advanced Cancer|Completed||Phase 2|49|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:12:26.607722|2017-02-18 14:12:26.607722
NCT00706277|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2009-02-09|||June 2008||2008-06-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|||||Interventional|||Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function|Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function|Completed||Phase 4|60|Anticipated|Medical University Innsbruck||2|||f||||||||||||||2017-02-18 14:12:26.723342|2017-02-18 14:12:26.723342
NCT00706264|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2014-07-25|||June 2007||2007-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|PECEP||Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix|Randomized Controlled Trial: Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix (PECEP)|Completed||Phase 4|2780|Actual|Maternal-Infantil Vall d´Hebron Hospital||2|||f||||t||||||||||2017-02-18 14:12:26.832256|2017-02-18 14:12:26.832256
NCT00706238|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2014-06-19||2011-12-20|September 2008||2008-09-01|June 2014|2014-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma|Study of GSK1203486A Antigen-Specific Cancer Immunotherapeutic in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma|Terminated||Phase 2|6|Actual|GlaxoSmithKline||1||"The study was terminated early due to difficulties in recruiting subjects, not following~   concerns for the safety or absence of clinical activity in patients."|f||||||||||||||2017-02-18 14:12:27.054933|2017-02-18 14:12:27.054933
NCT00706225|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2010-09-21|||June 2008||2008-06-01|September 2010|2010-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women|An Open-Label, Single/Multiple Dose, Non-Randomized, 3-Period, Crossover Study To Determine The Potential Drug Interaction Of Bazedoxifene On Conjugated Estrogens (CE) In Healthy Postmenopausal Women|Completed||Phase 1|30|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:12:27.165517|2017-02-18 14:12:27.165517
NCT00706212|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-06-26|||June 2008||2008-06-01|May 2008|2008-05-01||||||||Observational|GS-PET-2008||The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies|A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis|Unknown status|Recruiting|N/A|60|Anticipated|Rabin Medical Center|||1||f||||||||||||||2017-02-18 14:12:27.336507|2017-02-18 14:12:27.336507
NCT00706199|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2009-10-01|||July 2008||2008-07-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Expression of Antigens in Bone Marrow Samples From Volunteering Donors.|Analysis of Expression of Antigens in Bone Marrow Samples From Volunteering Donors.|Completed||Phase 2|48|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 14:12:27.405281|2017-02-18 14:12:27.405281
NCT00706186|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2010-07-06||||||July 2010|2010-07-01||||||||Interventional|ALD||Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients|Phase IV Study Safety & Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients.|Terminated||Phase 4|4|Actual|Clayton Sleep Insititute||1||Withdrawn by Investigator, protocol in revision|f||||t||||||||||2017-02-18 14:12:27.502194|2017-02-18 14:12:27.502194
NCT00706173|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2015-06-02|||August 2009||2009-08-01|August 2011|2011-08-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Trial of Hydrocortisone for Post-Traumatic Stress Disorder (PTSD)|A Randomized Double-blind Placebo-controlled Cross-over Trial of Hydrocortisone for Post-traumatic Stress Disorder|Withdrawn||Phase 4|0|Actual|University of California, San Diego||2||Unable to recruit eligible subjects for the trial.|f||||f||||||||||2017-02-18 14:12:27.599637|2017-02-18 14:12:27.599637
NCT00706160|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2017-01-24|||June 13, 2008||2008-06-13|April 4, 2013|2013-04-04|April 4, 2013||2013-04-04|||||Observational|||Language Mapping in Patients With Epilepsy|Noninvasive Language Mapping in Patients With Localization-Related Epilepsy|Completed||N/A|153|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:12:27.724982|2017-02-18 14:12:27.724982
NCT00706147|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-02-18|||January 2009||2009-01-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis|Phase II/III Randomized, Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis (ALS)|Unknown status|Active, not recruiting|Phase 2/Phase 3|39|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 14:12:27.822916|2017-02-18 14:12:27.822916
NCT00706134|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2011-06-24|2011-01-10||May 2008||2008-05-01|June 2011|2011-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study|An Eight-week Double-blind, Multi-center, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal|Completed||Phase 3|756|Actual|Novartis||4|||f||||f||||||||||2017-02-18 14:12:27.93277|2017-02-18 14:12:27.93277
NCT00706121|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2015-11-16|||June 2008||2008-06-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|ACP||S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000|S0000D: A Study of the Effect of Vitamin E and/or Selenium on Adenomatous Colorectal Polyps (ACP) in Participants Enrolled in SELECT|Completed||Phase 3|8097|Actual|Southwest Oncology Group||4|||f||||t||||||||||2017-02-18 14:12:28.730371|2017-02-18 14:12:28.730371
NCT00706108|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2011-01-10|||January 2005||2005-01-01|January 2011|2011-01-01|March 2010|Actual|2010-03-01|||||Observational|RACoP||Adaptive Coordination in Anaesthesia Teams and Its Relationship to Clinical Performance.|Adaptive Coordination in Anaesthesia Teams and Its Relationship to Clinical Performance. (Cooperative Project ETHZ, OAT, Prof. G. Grote, and IfA/USZ; Founding by Swiss National Science Foundation to Both Institutions)|Completed||N/A|161|Actual|University of Zurich|||3||f||||f||||||||||2017-02-18 14:12:28.856588|2017-02-18 14:12:28.856588
NCT00706095|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-03-21|2011-12-22||February 2008||2008-02-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|September 2009|Actual|2009-09-01||Interventional|||Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System|An Open-label, Parallel Group Study to Explore the Pharmacokinetics of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors and Normal or Reduced Hepatic Function According to the Child-Pugh System|Completed||Phase 1|18|Actual|Eisai Inc.||3|||f||||f||||||||||2017-02-18 14:12:28.97297|2017-02-18 14:12:28.97297
NCT00706082|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2012-06-21|||October 2008||2008-10-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Observational|DETECT||Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)|A Two-stage Prospective Observational Cohort Study in Scleroderma Patients to Evaluate Screening Tests and the Incidence of Pulmonary Arterial Hypertension and Pulmonary Hypertension|Terminated||N/A|490|Actual|Actelion|||1||f||||f||||||Samples Without DNA|"~     Serum and plasma samples will be stored at a central laboratory for at least two additional~     years after official study termination.~   "|||2017-02-18 14:12:29.526972|2017-02-18 14:12:29.526972
NCT00706069|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2009-12-14|||June 2008||2008-06-01|December 2009|2009-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer|A Phase I Study Of Vinorelbine Oral Plus Capecitabine Combination In Patients With Metastatic Breast Cancer|Completed||Phase 1|40|Anticipated|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 14:12:29.690106|2017-02-18 14:12:29.690106
NCT00706056|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2011-01-03|||September 2008||2008-09-01|January 2011|2011-01-01|January 2011|Anticipated|2011-01-01|||||Observational|||A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure|A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure|Unknown status|Recruiting|N/A|85|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 14:12:29.796797|2017-02-18 14:12:29.796797
NCT00706043|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2008-06-26|||June 2008||2008-06-01|May 2008|2008-05-01||||||||Observational|||French Validation Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) Questionnaire|Validation of a French Translation of the Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ): A Prospective One-Year Follow-up Study|Unknown status|Not yet recruiting|N/A|120|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-02-18 14:12:29.884701|2017-02-18 14:12:29.884701
NCT00706030|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-06-22||2013-01-29|April 2008||2008-04-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|October 2009|Actual|2009-10-01||Interventional|||Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer|A Phase 1/2 Study Of HKI-272 In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer|Active, not recruiting||Phase 1/Phase 2|92|Actual|Puma Biotechnology, Inc.||1|||f||||f||||||||||2017-02-18 14:12:29.965865|2017-02-18 14:12:29.965865
NCT00706017|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2016-10-27|||September 2007||2007-09-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|PREDICTIVE™||Observational Study to Evaluate the Safety of Levemir® in Diabetes|Observational, Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus|Completed||N/A|2282|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:12:30.124766|2017-02-18 14:12:30.124766
NCT00706004|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2011-03-14|2011-02-16||July 2008||2008-07-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis|Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis|Completed||N/A|9|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:12:30.242711|2017-02-18 14:12:30.242711
NCT00705991|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-01-22|||January 2008||2008-01-01|November 2012|2012-11-01|October 2008||2008-10-01|||||Observational|||Validation of Thrombelastometry (ROTEM®)||Completed||Phase 4|||University of Zurich|||1||f||||f||||||||||2017-02-18 14:12:30.713054|2017-02-18 14:12:30.713054
NCT00705978|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-26|2011-08-16|||June 2008||2008-06-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis|A One Week Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study With Creon 40,000 MMS in Subjects With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis, Followed by an Open-Label Long-Term Extension|Completed||Phase 3|62|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:12:30.792547|2017-02-18 14:12:30.792547
NCT00705965|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-08-26|||November 2008||2008-11-01|August 2016|2016-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|SPIRR-CAD||Effects of a Psychotherapy Intervention in Depressed Patients With Coronary Artery Disease|A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease - a Randomised Controlled Trial (SPIRR-CAD)|Completed||N/A|570|Actual|University of Göttingen||2|||f||||t||||||||||2017-02-18 14:12:30.906544|2017-02-18 14:12:30.906544
NCT00705952|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2010-11-29|||January 2008||2008-01-01|November 2010|2010-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|GLP4Health||Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.|Effect of Intensive Lifestyle Intervention on Hormonal Factors Regulating Food Intake and Blood Glucose Control in Patients With New Onset Type 2 Diabetes.|Completed||N/A|22|Actual|The Royal Bournemouth Hospital||1|||f||||f||||||||||2017-02-18 14:12:31.025643|2017-02-18 14:12:31.025643
NCT00705939|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2014-07-14|2014-04-30||June 2008||2008-06-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|May 2012|Actual|2012-05-01||Interventional||All treated patients are included in the analysis|Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial|A Multicenter, Double-Blind, Extension Trial of Two Parallel Dose Groups of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients With Gaucher Disease|Completed||Phase 3|45|Actual|Protalix||3|||t||||t||||||||||2017-02-18 14:12:31.12954|2017-02-18 14:12:31.12954
NCT00705926|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2013-04-02|||October 2008||2008-10-01|April 2013|2013-04-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Effectiveness of Antiretroviral Therapy During Acute HIV Infection|A Phase 1 Clinical Trial to Evaluate the Initiation of Treatment Versus no Treatment During Acute HIV-1 Infection|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|Massachusetts General Hospital||3|||f||||||||||||||2017-02-18 14:12:32.27919|2017-02-18 14:12:32.27919
NCT00705913|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2012-01-06|||June 2008||2008-06-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna|A Randomized Study to Compare Sizing, Implant Techniques and Hemodynamic Performance Between the Mitroflow and the Carpentier-Edwards Magna Pericardial Tissue Valves in the Aortic Position|Terminated||N/A|368|Actual|Sorin Group USA, Inc.||2|||f||||f||||||||||2017-02-18 14:12:32.391196|2017-02-18 14:12:32.391196
NCT00705900|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2008-11-17|||January 2007||2007-01-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis|A Randomized, Single-Blind, Active Control, 18-Week Study to Evaluate the Safety and Efficacy of A New Twice-Daily, Topically Applied LCD Solution vs. Calcipotriol Cream for the Treatment of Adult Subjects With Moderate Plaque Psoriasis|Completed||N/A|60|Anticipated|NeoStrata Company, Inc.||2|||f||||t||||||||||2017-02-18 14:12:32.653972|2017-02-18 14:12:32.653972
NCT00705887|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2008-06-25|||September 2006||2006-09-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Motivational Enhancement Approach to Skin Cancer Prevention|The Feasibility of a Motivational Enhancement Approach to Skin Cancer Prevention in a Sample of Young Adult Patients|Completed||N/A|82|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:12:32.758748|2017-02-18 14:12:32.758748
NCT00705692|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2013-07-24|||March 2008||2008-03-01|July 2013|2013-07-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients|Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients: A Randomized Double-Blind Placebo-Controlled Trial|Completed||Phase 2|40|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:12:40.634419|2017-02-18 14:12:40.634419
NCT00705874|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2016-06-21|2011-11-17||May 2006||2006-05-01|June 2016|2016-06-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma|A Phase I Open Label, Multicenter, Dose-Escalation Study to Determine the Maximum Tolerated Dose, Dose Limiting Toxicity, Safety and Pharmacokinetics of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|172|Actual|Progen Pharmaceuticals||7|||f||||f||||||||||2017-02-18 14:12:32.87863|2017-02-18 14:12:32.87863
NCT00705861|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2013-04-16|||November 2007||2007-11-01|April 2013|2013-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus|A 12 Week, Multi-center, Randomized, Double Blinded, Placebo-controlled, Parallel Group, Fixed Dose Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes Mellitus|Completed||Phase 3|112|Actual|SK Chemicals Co.,Ltd.||2|||f||||t||||||||||2017-02-18 14:12:34.492372|2017-02-18 14:12:34.492372
NCT00705848|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2011-06-13|||July 2008||2008-07-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Matrix Biology of Tracheobronchomalacia and Tracheal Stenosis|Matrix Biology of Tracheobronchomalacia and Tracheal Stenosis|Completed||N/A|30|Anticipated|Beth Israel Deaconess Medical Center|||3||f||||t||||||Samples With DNA|"~     Airway biopsies and brushings are to be used for staining and culture, respectively~   "|||2017-02-18 14:12:34.598319|2017-02-18 14:12:34.598319
NCT00705835|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2012-01-06|||January 2003||2003-01-01|January 2012|2012-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel|Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel: A Trial Studying RsPMSA Doses|Completed||Phase 1|14|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:12:34.682142|2017-02-18 14:12:34.682142
NCT00705822|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2010-11-29|||August 2006||2006-08-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|PROSTATA||Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer|Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer Who Have Relapse in Biochemistry Whilst Androgenic Blockage|Terminated||Phase 3|54|Actual|Sanofi||2||low recruitment rate|f||||||||||||||2017-02-18 14:12:34.784127|2017-02-18 14:12:34.784127
NCT00705809|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2017-01-24|||June 18, 2008||2008-06-18|July 20, 2011|2011-07-20|July 20, 2011||2011-07-20|||||Observational|||T-Cell Project: Epidemiologic Component|T-Cell Project: Epidemiologic Component|Completed||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:12:34.893254|2017-02-18 14:12:34.893254
NCT00705796|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2012-05-03||||||May 2012|2012-05-01||||||||Interventional|||Influence of Administration Route of Testosterone on Male Fertility|Influence on Human Male Fertility of Testosterone After Intranasal (MPP10) or Transdermal (AndroGel™) Application|Withdrawn||Phase 1|0|Actual|M et P Pharma||2||financial constraints|f||||f||||||||||2017-02-18 14:12:34.985932|2017-02-18 14:12:34.985932
NCT00705783|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2013-06-16|2013-03-29||July 2008||2008-07-01|June 2013|2013-06-01|February 2011|Actual|2011-02-01|August 2010|Actual|2010-08-01||Interventional|ASPIRE|Baseline measures are based on the participants from the Depot Maintenance Phase.|Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia|A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia|Completed||Phase 3|843|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-02-18 14:12:35.109033|2017-02-18 14:12:35.109033
NCT00705770|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2012-05-29|||May 2008||2008-05-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Multi-Dose Study With a Treatment for Open-Angle Glaucoma||Withdrawn||Phase 2/Phase 3|0|Actual|Alcon Research||4||Change in study design|f||||f||||||||||2017-02-18 14:12:36.073086|2017-02-18 14:12:36.073086
NCT00705757|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-12-14|2014-12-25||March 2008||2008-03-01|December 2015|2015-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye|The Effects of Latanoprost, Bimatoprost and Travoprost on Periocular Skin Pigmentation|Completed||Phase 4|89|Actual|Summa Health System||3|||f||||f||||||||||2017-02-18 14:12:36.163246|2017-02-18 14:12:36.163246
NCT00705744|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2009-04-14|||April 2008||2008-04-01|April 2009|2009-04-01||||May 2008|Actual|2008-05-01||Interventional|||Dermacyd Femina (Lactic Acid) - Photo Dermatological Evaluation of the Irritation and Sensitivity Potential.|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Femina.|Completed||Phase 3|26|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:12:39.126667|2017-02-18 14:12:39.126667
NCT00705731|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2012-06-11|||March 2007||2007-03-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Adherence and the Economics of Colon Cancer Screening|Adherence and the Economics of Colon Cancer Screening|Completed||N/A|1000|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 14:12:39.218664|2017-02-18 14:12:39.218664
NCT00705718|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2016-07-26|2014-01-31||June 2008||2008-06-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|September 2012|Actual|2012-09-01||Interventional|||Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System|Endurant Stent Graft System US Clinical Study|Active, not recruiting||Phase 3|194|Actual|Medtronic Endovascular|Adverse Events and Serious Adverse Events listed in ClinicalTrials.gov were re-coded, using MeDRA codes. To do so, events were reclassified. As a result, data in listings may not match those in Clinical Update reports, SSEDs, or Instructions for Use.|2|||f||||t||||||||No||2017-02-18 14:12:39.338625|2017-02-18 14:12:39.338625
NCT00705705|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2011-11-10|||July 2004||2004-07-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks|Targeted Social Network HIV Prevention Intervention|Completed||Phase 2|852|Actual|Medical College of Wisconsin||2|||f||||f||||||||||2017-02-18 14:12:40.532212|2017-02-18 14:12:40.532212
NCT00705679|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2016-02-15|2016-01-12||August 2009||2009-08-01|February 2016|2016-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Includes all participants enrolled and randomized to a study arm|Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women|Phase 2B Safety and Effectiveness Study of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate Tablet and Emtricitabine/Tenofovir Disoproxil Fumarate Tablet for the Prevention of HIV Infection in Women|Completed||Phase 2|5029|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|In September 2011, the oral TDF arm was discontinued for futility; in November 2011, the TFV gel and gel placebo arms were discontinued for futility. The TDF-FTC and oral placebo arms continued follow-up until the end of study in August 2012.|5|||f||||||||||||||2017-02-18 14:12:40.764648|2017-02-18 14:12:40.764648
NCT00705666|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-10-01|2010-03-30||February 2006||2006-02-01|October 2015|2015-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|ADEQUATION||Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)|Real Situation Observational Study of VIRAFERONPEG® in Patients With Chronic Hepatitis C|Completed||N/A|789|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:12:44.701539|2017-02-18 14:12:44.701539
NCT00705653|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2012-03-21|2011-11-06||March 2005||2005-03-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of CGC-11047 (PG-11047) in Subjects With Advanced Refractory Solid Tumors|A Phase I Study of CGC-11047 in Subjects With Advanced Refractory Solid Tumors|Completed||Phase 1|46|Actual|Progen Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:12:44.999413|2017-02-18 14:12:44.999413
NCT00705640|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2016-12-15|||May 2008||2008-05-01|December 2016|2016-12-01||||June 2009|Actual|2009-06-01||Interventional|Mel48||Vaccine Therapy in Treating Patients With Advanced Melanoma|A Multipeptide Vaccine in Melanoma Patients With Evaluation of the Injection Site Microenvironment|Completed||Phase 1|45|Actual|University of Virginia||10|||f||||t||||||||||2017-02-18 14:12:45.292981|2017-02-18 14:12:45.292981
NCT00705627|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2014-05-26|||June 2008||2008-06-01|May 2014|2014-05-01|June 2017|Anticipated|2017-06-01|February 2015|Anticipated|2015-02-01||Interventional|||A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma|A Multicenter Trial Comparing Neoadjuvant Chemotherapy Followed by CCRT v.s. CCRT Alone in Locoregionally Advanced Nasopharyngeal Carcinoma|Recruiting||Phase 3|400|Anticipated|Sun Yat-sen University||1|||f||||t||||||||||2017-02-18 14:12:45.413774|2017-02-18 14:12:45.413774
NCT00705614|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-02-09|2014-02-25||July 2003||2003-07-01|February 2015|2015-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|ENCORE|298 of the 1121 participants enrolled in the Standard Therapy Group switched to Remicade during follow-up. They are included in both the Standard Therapy and Switched to Remicade treatment groups, but baseline measures (obtained at the time of their switch to Remicade) are shown as separate rows in the Baseline Measures table.|Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)|Crohn's Disease European Registry. A Prospective, Observational, Postmarketing Safety Surveillance Registry of Patients Treated With Remicade® or Standard Therapy|Completed||N/A|2662|Actual|Merck Sharp & Dohme Corp.|||3||f||||t||||||||||2017-02-18 14:12:45.784106|2017-02-18 14:12:45.784106
NCT00705601|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2011-02-01|||August 2008||2008-08-01|February 2011|2011-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Nonrestorative Sleep RSQ (Restorative Sleep Questionnaire) Development-- Methodology Study|Refinement Of Patient Reported Outcomes Instruments In Subjects With Insomnia Characterized By Nonrestorative Sleep|Terminated||Phase 1|64|Actual|Pfizer||1||See Detailed Description|f||||f||||||||||2017-02-18 14:12:49.127235|2017-02-18 14:12:49.127235
NCT00705588|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2008-06-25|||August 2008||2008-08-01|May 2008|2008-05-01||||January 2010|Anticipated|2010-01-01||Interventional|||Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.||Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 14:12:49.238336|2017-02-18 14:12:49.238336
NCT00705575|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2011-05-24|2010-12-22||June 2008||2008-06-01|May 2011|2011-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ACQUIRE||Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension|A 12 Week, Double-blind, Randomized, Parallel Group, Multi-center Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg Compared to Aliskiren 300 mg in Patients With Stage II Hypertension|Completed||Phase 3|688|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:12:49.337884|2017-02-18 14:12:49.337884
NCT00705562|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2009-01-02|||June 2008||2008-06-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Tolerance of Healthy Term Infants Fed Infant Formulas|Tolerance of Healthy Term Infants Fed Infant Formulas|Completed||Phase 2|190|Actual|Abbott Nutrition||5|||f||||t||||||||||2017-02-18 14:12:49.708143|2017-02-18 14:12:49.708143
NCT00705549|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2013-02-12|||February 2008||2008-02-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer|Feasibility and Efficacy of Molecular Analysis-Directed Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer|Terminated||Phase 2|88|Actual|Hellenic Oncology Research Group||11||Due to poor accrual|f||||f||||||||||2017-02-18 14:12:49.81774|2017-02-18 14:12:49.81774
NCT00705536|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2014-07-11|2011-06-07||December 2007||2007-12-01|July 2014|2014-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||All participants who received at least 1 dose of Humalog or Humulin-R with or without rHuPH20.|Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20|A Phase I, Randomized, Double-Blind Crossover Pharmacokinetic, Pharmacodynamic, and Safety Study of Subcutaneously Administered Humalog® (Insulin Lispro Injection; Rapid-Acting Insulin) With and Without Recombinant Human Hyaluronidase (rHuPH20) Versus Subcutaneously Administered Humulin R® (Regular Insulin Injection) With and Without rHuPH20|Completed||Phase 1|26|Actual|Halozyme Therapeutics||4|||f||||f||||||||||2017-02-18 14:12:49.971029|2017-02-18 14:12:49.971029
NCT00705523|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-06-01|2013-07-17||June 2008||2008-06-01|June 2015|2015-06-01|December 2011|Actual|2011-12-01|March 2010|Actual|2010-03-01||Interventional|ChA||Varenicline (Chantix™) for the Treatment of Alcohol Dependence|A Phase II, Randomized, Double-Blind Pilot Trial of Varenicline (Chantix™) for the Treatment of Alcohol Dependence|Completed||Phase 2|40|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:12:51.233889|2017-02-18 14:12:51.233889
NCT00705510|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2010-11-08|||May 2008||2008-05-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction|Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction|Completed||Phase 4|70|Actual|Mahidol University||2|||f||||t||||||||||2017-02-18 14:12:51.716542|2017-02-18 14:12:51.716542
NCT00705497|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2011-06-01|||January 2003||2003-01-01|June 2011|2011-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Radiofrequency Ablation of Tumors|Radiofrequency Ablation of Tumors (RFA) A Phase I Study|Completed||Phase 1|31|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 14:12:51.8312|2017-02-18 14:12:51.8312
NCT00705484|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2017-01-03|||June 2007||2007-06-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Observational|||European Safety Registry in Ulcerative Colitis (Study P04808AM3)|Ulcerative Colitis European Registry: A Prospective, Observational, Non-interventional, Post-Marketing Safety Surveillance Program|Completed||Phase 4|2237|Actual|Merck Sharp & Dohme Corp.|||3||f||||t||||||||||2017-02-18 14:12:51.938544|2017-02-18 14:12:51.938544
NCT00705471|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-04-07|||April 2005||2005-04-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)|Infliximab Use in Fistulizing Crohn's Disease: Impact on Health Care Resources|Terminated||N/A|42|Actual|Merck Sharp & Dohme Corp.|||1|Study stopped prematurely due to enrolment challenges.|f||||f||||||||||2017-02-18 14:12:52.253735|2017-02-18 14:12:52.253735
NCT00705458|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-08-21|||July 2008||2008-07-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|PROSPECT||Study Comparing CT Scan and Stress Test in Diagnosing Coronary Artery Disease in Patients Hospitalized for Chest Pain|A Randomized Trial Comparing Multi-Detector Coronary CT Angiography and Stress Myocardial Perfusion Imaging as the Initial Test for the Diagnosis of Coronary Artery Disease in Intermediate Risk Patients Admitted for Chest Pain|Completed||N/A|400|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-02-18 14:12:52.346994|2017-02-18 14:12:52.346994
NCT00705445|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2012-08-27|||November 2008||2008-11-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|June 2011|Actual|2011-06-01||Interventional|||Evaluation of Zinc and / or Micronutrient Supplementation on Intestinal Flora, Diarrheal Disease Burden, Intestinal Mucosal Integrity and Growth Among Children of Pakistan|Prospective Cluster Randomized Controlled Evaluation of the Impact of Zinc and / or Micronutrient Supplementation on Intestinal Flora, Diarrheal Disease Burden, Intestinal Mucosal Integrity and Growth Among Cohorts of Children in Pakistan|Completed||Phase 2/Phase 3|2745|Actual|Aga Khan University||3|||f||||t||||||||||2017-02-18 14:12:52.45941|2017-02-18 14:12:52.45941
NCT00705432|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-10-16|2011-05-13||August 2008||2008-08-01|October 2015|2015-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|SPRINT-2||Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED)|A Phase 3, Safety and Efficacy Study of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1|Completed||Phase 3|1472|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 14:12:52.581389|2017-02-18 14:12:52.581389
NCT00705419|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-02-04|||July 2007||2007-07-01|February 2015|2015-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|COVER||Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)|COVER - Continuing Observation After Vicriviroc (VCV) Exposure Registry|Completed||N/A|180|Actual|Merck Sharp & Dohme Corp.|||3||f||||t||||||||||2017-02-18 14:12:54.140299|2017-02-18 14:12:54.140299
NCT00705406|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-02-12|2015-01-16||July 2008||2008-07-01|February 2015|2015-02-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional||Intent-to-Treat (ITT)|A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza|A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza|Completed||Phase 2|405|Actual|BioCryst Pharmaceuticals|The majority of the subjects enrolled in this study with a laboratory confirmed influenza infection were infected with an influenza A/H1N1 virus containing an H275Y mutation associated with reduced susecptibility to peramivir and oseltamivir.|2|||f||||t||||||||||2017-02-18 14:12:54.254936|2017-02-18 14:12:54.254936
NCT00705380|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-03-04|||July 1998||1998-07-01|March 2015|2015-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder|Cognitive-Behavioral Treatment of Panic in Adolescence|Completed||Phase 2|25|Actual|Boston University||2|||f||||t||||||||||2017-02-18 14:12:55.41897|2017-02-18 14:12:55.41897
NCT00705367|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2013-07-23|2010-05-04||August 2008||2008-08-01|July 2013|2013-07-01|July 2011|Actual|2011-07-01|January 2009|Actual|2009-01-01||Interventional|||Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg|A Single Center, Randomized, Placebo-Controlled, Double Blind, Parallel Group Study to Evaluate the Tolerability of a Single Dose of Abatacept 30 mg/kg Via Intravenous Infusion in Chinese SLE Subjects With Lupus Nephritis|Completed||Phase 1|13|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 14:12:55.528241|2017-02-18 14:12:55.528241
NCT00705354|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2012-04-12|||January 2009||2009-01-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus Surgery|Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following|Withdrawn||N/A|0|Actual|Lahey Clinic||2||Principal Investigator left the institution requested termination.|f||||f||||||||||2017-02-18 14:12:56.220895|2017-02-18 14:12:56.220895
NCT00705341|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2013-02-11|2012-08-01||January 2009||2009-01-01|February 2013|2013-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|MeCIS||MethaCholine Bronchoprovocation Study (MeCIS)|MethaCholine Bronchoprovocation - Influence of High Potency Inhaled corticoSteroids in Asthma (MeCIS) Study|Completed||Phase 4|219|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||t||||||||||2017-02-18 14:12:56.34668|2017-02-18 14:12:56.34668
NCT00705328|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2016-04-20|||December 2005||2005-12-01|April 2016|2016-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|FFE||Families First Edmonton (FFE)|Families First Edmonton: The Comparative Effects and Expense of Four Models of Augmenting Services for Low-income Families|Completed||Phase 2|2400|Actual|University of Alberta||3|||f||||f||||||||||2017-02-18 14:12:56.832444|2017-02-18 14:12:56.832444
NCT00705315|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2010-08-18|||May 2008||2008-05-01|August 2010|2010-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer|Docetaxel-epirubicin Plus Bevacizumab as First Line Therapy for Patients With Metastatic and HER2 Negative Breast Cancer. A Multicenter Phase I-II Study|Completed||Phase 1/Phase 2|46|Anticipated|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 14:12:56.943814|2017-02-18 14:12:56.943814
NCT00705302|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2017-02-10|||September 2007|Actual|2007-09-01|February 2017|2017-02-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs|A Randomised Controlled Trial of the Effect of a Patient Education Program for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|88|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-02-18 14:12:57.082686|2017-02-18 14:12:57.082686
NCT00705289|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-07-29|2009-09-03||December 2005||2005-12-01|July 2015|2015-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|REMARK||A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)|Epidemiology, Correlation and Predictive Value of Disease Activity and Biomarkers in RA Patients Initiated on Infliximab in Clinical Practice|Completed||N/A|728|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||Samples Without DNA|"~     Blood and Urine samples~   "|||2017-02-18 14:12:57.205638|2017-02-18 14:12:57.205638
NCT00705276|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-25|2009-04-14|||April 2008||2008-04-01|April 2009|2009-04-01||||May 2008|Actual|2008-05-01||Interventional|||Dermacyd Femina Delicata (Lactic Acid)- Photo Dermatological Evaluation of the Irritation and Sensitivity Potential|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Femina Delicata|Completed||Phase 3|26|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:12:57.795015|2017-02-18 14:12:57.795015
NCT00705263|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2009-08-20|2009-05-28||October 2005||2005-10-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)|Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Slovenia|Completed||N/A|113|Actual|Schering-Plough|||1||f||||f||||||||||2017-02-18 14:12:57.902101|2017-02-18 14:12:57.902101
NCT00705250|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2016-11-21|2016-11-21||June 2008||2008-06-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma|A Phase II Study of Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma.|Completed||Phase 2|36|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:12:58.119707|2017-02-18 14:12:58.119707
NCT00705237|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2009-02-17|||March 2008||2008-03-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|May 2008|Actual|2008-05-01||Interventional|||Study of the Use of LUMA Lightwire|LUMA Lightwire Study|Terminated||Phase 4|50|Actual|Lahey Clinic||1||Insufficient findings for data analysis|f||||f||||||||||2017-02-18 14:12:58.338426|2017-02-18 14:12:58.338426
NCT00705224|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-06-04|2011-08-09||May 2008||2008-05-01|June 2015|2015-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)|Observational Multicenter Study to Evaluate Influence of Insulin Resistance on the Safety and Efficacy (as Measured by Sustained Virological Response) of Treatment With Any Pegylated Interferon and Ribavirin (Standard of Care) in Different Populations of HCV Patients in Russia.|Completed||N/A|250|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:12:58.439378|2017-02-18 14:12:58.439378
NCT00705211|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-02-24|||June 2007||2007-06-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)|Designated Drug Use Investigation (Long-Term Administration) of Zetia 10-mg Tablets - A 52-Week Long-Term Designated Drug Use Investigation of Zetia Monotherapy and Combination Therapy|Completed||N/A|1794|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:12:58.930434|2017-02-18 14:12:58.930434
NCT00705198|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2016-11-11|||September 2006||2006-09-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)|Temodal Capsule All-Case-Registered Surveillance (Designated Drug Use Investigation) - Evaluation of The Safety and Efficacy of Temodal in Patients With Newly Diagnosed Malignant Glioma (Concomitant With Radiotherapy and Then as Monotherapy) and Relapsed Malignant Glioma (as Monotherapy)|Completed||N/A|1804|Actual|Merck Sharp & Dohme Corp.|||3||f||||f||||||||||2017-02-18 14:12:59.03549|2017-02-18 14:12:59.03549
NCT00705185|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2010-06-07|||April 2008||2008-04-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|Bio-TestMDD||Exploring a Potential Blood Test to Diagnose Major Depressive Disorder|"Exploring Potential Serum/Plasma-Based Biomarkers as a Test for Major Depressive Disorder Diagnostics (Bio-Test MDD)"|Completed||N/A|120|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples Without DNA|"~     serum, plasma~   "|||2017-02-18 14:12:59.144482|2017-02-18 14:12:59.144482
NCT00705172|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2014-12-19|||November 2008||2008-11-01|December 2014|2014-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome|Efficacy and Safety of Norditropin® (Somatropin) in Children With Prader-Willi Syndrome (PWS)|Completed||N/A|41|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:12:59.266259|2017-02-18 14:12:59.266259
NCT00705159|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-03-04|2011-06-14||June 2008||2008-06-01|March 2015|2015-03-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis|Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis|Completed||Phase 4|137|Actual|Bausch & Lomb Incorporated||4|||f||||f||||||||||2017-02-18 14:12:59.376433|2017-02-18 14:12:59.376433
NCT00705146|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2014-12-09|2012-05-01||April 2008||2008-04-01|December 2014|2014-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||CMC (Carpometacarpal) OA (Osteoarthritis) Thumb Splint Study|Comparison of Two Carpometacarpal Stabilizing Splints for People With Thumb Osteoarthritis|Completed||Phase 2|56|Actual|University of British Columbia|The main limitation of this cross-over trial was that the therapists who collected the data were not blinded to the splinting intervention, as they were required to fabricate and fit each splint.|2|||f||||f||||||||||2017-02-18 14:12:59.907046|2017-02-18 14:12:59.907046
NCT00705133|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-24|||January 2008||2008-01-01|June 2008|2008-06-01|February 2009|Anticipated|2009-02-01|October 2008|Anticipated|2008-10-01||Interventional|||Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension|Using Either Intravenous (IV) or Subcutaneous (SQ) Treprostinil to Treat Pulmonary Hypertension Related to Underlying Interstitial Lung Disease|Unknown status|Recruiting|Phase 3|20|Anticipated|University of California, Los Angeles||1|||f||||f||||||||||2017-02-18 14:13:00.352031|2017-02-18 14:13:00.352031
NCT00705120|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-23|||November 1995||1995-11-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|July 2000|Actual|2000-07-01||Interventional|||Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation|Treatment of Severe (Types II and III) Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation|Completed||Phase 1|9|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-02-18 14:13:00.46273|2017-02-18 14:13:00.46273
NCT00705107|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-06-03|2009-02-11||November 2004||2004-11-01|June 2015|2015-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)|Evaluation of Adherence Rate in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C|Terminated||N/A|267|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:13:00.583117|2017-02-18 14:13:00.583117
NCT00705094|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2014-09-29|||September 2008||2008-09-01|September 2014|2014-09-01|July 2012|Actual|2012-07-01|May 2011|Actual|2011-05-01||Observational|||Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients|Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients|Completed||N/A|30|Anticipated|AHS Cancer Control Alberta|||2||f||||f||||||||||2017-02-18 14:13:00.803284|2017-02-18 14:13:00.803284
NCT00705081|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-06-08|2009-03-26||January 2006||2006-01-01|June 2015|2015-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED)|Observational Study Evaluating the LDL-C Lowering Effects of Ezetimibe With a Statin as Prescribed in Daily Routine Practice in an Indonesian Population|Completed||N/A|453|Actual|Merck Sharp & Dohme Corp.|Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data.||2||f||||f||||||||||2017-02-18 14:13:00.912967|2017-02-18 14:13:00.912967
NCT00705055|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-11-19|||November 2007||2007-11-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|DW 6/2007||Face Anthropometric Pattern Recognition Technology for Computer Aided Diagnosis of Human Genetic Disorders.|Face Anthropometric Pattern Recognition Technology, Based on 3D Reconstruction Technology, for Computer Aided Diagnosis of Human Genetic Disorders. Multicenter Collaborative Study.|Unknown status|Recruiting|N/A|800|Anticipated|Carmel Medical Center|||4||f||||t||||||||||2017-02-18 14:13:01.562999|2017-02-18 14:13:01.562999
NCT00705042|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2009-07-27|||July 2008||2008-07-01|July 2009|2009-07-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects|A Randomized, Open-Label, Single-Dose Administration, Parallel-Group, Multisite Study of the Pharmacokinetics of Etanercept, 25 or 50 mg, Administered Subcutaneously to Healthy Chinese Male Subjects|Completed||Phase 1|60|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:13:01.665206|2017-02-18 14:13:01.665206
NCT00705016|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2014-03-28|2014-03-28||October 2008||2008-10-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|September 2011|Actual|2011-09-01||Interventional|ADVANTAGE|Intention-to-treat (ITT) population included all participants who were randomized to trial treatment.|Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Open-label, Randomized, Controlled Phase I/II Study of Cilengitide to Evaluate the Safety and Efficacy of the Combination of Different Regimens of Cilengitide Added to Cisplatin, 5-FU, and Cetuximab in Subjects With Recurrent/Metastatic Squamous Cell Cancer of the Head and Neck|Completed||Phase 1/Phase 2|184|Actual|Merck KGaA||3|||f||||t||||||||||2017-02-18 14:13:01.89058|2017-02-18 14:13:01.89058
NCT00705003|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2014-06-17|2013-03-12||May 2008||2008-05-01|June 2014|2014-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)|A Double-Blind, Placebo-Controlled Study of a Combination Product (BCI-024 and BCI-049) in Patients With Major Depressive Disorder (MDD)|Completed||Phase 2|142|Actual|Massachusetts General Hospital||3|||f||||f||||||||||2017-02-18 14:13:03.441296|2017-02-18 14:13:03.441296
NCT00704990|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-10-15|||September 2008||2008-09-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD)|The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder: A Pilot Study|Completed||Phase 2/Phase 3|28|Actual|The Canadian College of Naturopathic Medicine||1|||f||||t||||||||||2017-02-18 14:13:06.566996|2017-02-18 14:13:06.566996
NCT00704977|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2008-06-24|||June 2008||2008-06-01|June 2008|2008-06-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Alcohol 20% for Separation of Pterygium and Comparison of Different Wound Closure Methods|Evaluation of Alcohol 20% for Separation of Pterygium Tissue During Pterygium Surgery and Comparison of Three Different Methods of Wound Closure in Pterygium Surgery: Bare Sclera, Sliding Flap, Amniotic Membrane With Biological Glue|Unknown status|Recruiting|N/A|150|Anticipated|Soroka University Medical Center||3|||f||||f||||||||||2017-02-18 14:13:06.693258|2017-02-18 14:13:06.693258
NCT00704964|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-10-05|2011-03-24||May 2005||2005-05-01|October 2015|2015-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|@dhere||Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)|Impact of Patient Support From Medical Staff on the Adherence to Therapy With PegIntron Plus Rebetol|Completed||N/A|746|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:13:06.798707|2017-02-18 14:13:06.798707
NCT00704951|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-08-24|||July 2008||2008-07-01|August 2015|2015-08-01|June 2011|Anticipated|2011-06-01|May 2011|Anticipated|2011-05-01||Observational|||Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)|P05532 Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections (IFIs) in Immuncompromised Patients in Austria. Version 1, 08-Nov-2007.|Withdrawn||N/A|0|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:13:07.04983|2017-02-18 14:13:07.04983
NCT00704938|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2015-10-06|2012-07-10||June 2008||2008-06-01|September 2015|2015-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer|Phase II Study of Metastatic Cancer That Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes and Dendritic Cell Vaccination|Terminated||Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)|This study was terminated prior to completing accrual due to the withdrawal of support from our collaborator.|2||Terminated due to withdrawal of support from our collaborator.|f||||t||||||||||2017-02-18 14:13:07.133058|2017-02-18 14:13:07.133058
NCT00704925|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-11-30|||January 2000||2000-01-01|November 2015|2015-11-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Expanded Access|||Treatment of Lambert-Eaton Syndrome With 3,4 DAP|Treatment of Lambert-Eaton Syndrome With 3, 4-Diaminopyridine|Available||N/A|||University of California, Davis|||||||||t||||||||||2017-02-18 14:13:07.964078|2017-02-18 14:13:07.964078
NCT00704912|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2016-11-03|2015-11-13||September 2008||2008-09-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|OWL-PCOS||Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women|Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women|Completed||Phase 2|217|Actual|Milton S. Hershey Medical Center||3|||f||||t||||||||||2017-02-18 14:13:08.086605|2017-02-18 14:13:08.086605
NCT00704899|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-25|||March 2006||2006-03-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Anti-Depressants vs Physiotherapy in Management of Fibromyalgia|Effect of Anti-Depressants vs Physiotherapy in Management of Fibromyalgia Syndrome: What Predicts a Clinical Benefit?|Completed||Phase 3|175|Actual|Mahatma Gandhi Institute of Medical Sciences||2|||f||||f||||||||||2017-02-18 14:13:09.197653|2017-02-18 14:13:09.197653
NCT00704886|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2009-06-22|||September 2007||2007-09-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Randomized Controlled Trial of Using Video Images in Dementia|A Randomized Controlled Trial of Using Video Images in Dementia|Completed||N/A|200|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:13:09.300445|2017-02-18 14:13:09.300445
NCT00704860|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2011-01-18|||February 2005||2005-02-01|February 2009|2009-02-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|||Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism|Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism|Completed||Phase 4|27|Actual|University of Ottawa||1|||f||||f||||||||||2017-02-18 14:13:09.412393|2017-02-18 14:13:09.412393
NCT00704847|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2012-10-22|2012-08-13||June 2008||2008-06-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)|A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis|Terminated||Phase 3|1030|Actual|Nordic Bioscience A/S|The study showed an underexposure to calcitonin compared to what was expected from phase I trials.|2||Male subjects were terminated due to an imbalance in prostate cancer events|f||||t||||||||||2017-02-18 14:13:09.531874|2017-02-18 14:13:09.531874
NCT00704834|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2012-11-29|||March 2006||2006-03-01|November 2012|2012-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Gene Expression Profiles in Multiple Sclerosis (MS)|Gene Expression Profiles in Patients With Multiple Sclerosis|Unknown status|Active, not recruiting|N/A|120|Anticipated|University of California, Davis|||4||f||||f||||||Samples With DNA|"~     35cc of peripheral blood will be obtained from each subject via venipuncture.~   "|||2017-02-18 14:13:10.656331|2017-02-18 14:13:10.656331
NCT00704821|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2012-04-06|||June 2008||2008-06-01|April 2012|2012-04-01|June 2014|Anticipated|2014-06-01|December 2012|Anticipated|2012-12-01||Interventional|||PTC299 for Treatment of Advanced Cancer|A Phase 1b Study to Assess the Safety Profile, Pharmacokinetics, and Anti-VEGF Activity of PTC299 in Patients With Advanced Cancer|Suspended||Phase 1|76|Anticipated|PTC Therapeutics||1|||f||||f||||||||||2017-02-18 14:13:10.768942|2017-02-18 14:13:10.768942
NCT00704808|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-09-08|2010-03-17||May 2006||2006-05-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)|Post Marketing Surveillance of Radiotherapy With Concomitant and Adjuvant Chemotherapy With Temozolomide for Patients With Newly Diagnosed and Operated Glioblastoma Multiforme|Completed||N/A|180|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:13:10.88445|2017-02-18 14:13:10.88445
NCT00704795|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2008-06-25|||June 2008||2008-06-01|June 2008|2008-06-01|October 2009|Anticipated|2009-10-01|March 2009|Anticipated|2009-03-01||Observational|||Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes|Glucagon Responses Following Oral Glucose and Isoglycemic iv Glucose in Patients With Type 1 Diabetes - a Role for the Gastrointestinal Tract in Diabetic Hyperglucagonemia?|Unknown status|Active, not recruiting|N/A|20|Actual|University Hospital, Gentofte, Copenhagen|||2||f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 14:13:11.137105|2017-02-18 14:13:11.137105
NCT00704782|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-11-13||2015-11-13|April 2008||2008-04-01|November 2015|2015-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease|An Open-Label Extension Study of Combination Therapy With Dimebon and Donepezil in Patients With Alzheimer's Disease|Terminated||Phase 2|50|Actual|Medivation, Inc.||1||The study was halted after a Phase 3 study of dimebon failed to show efficacy.|f||||||||||||||2017-02-18 14:13:11.24336|2017-02-18 14:13:11.24336
NCT00704769|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-05-27|2009-03-12||May 2005||2005-05-01|May 2015|2015-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)|Observational Study Evaluating the Safety and Efficacy of Desloratadine Syrup for Perennial Allergic Rhinitis in Indonesian Pediatric Patients|Completed||N/A|591|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:13:11.338931|2017-02-18 14:13:11.338931
NCT00704587|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2016-04-05|||November 2006||2006-11-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|ProFaCo||Prognostic Factors for All Types of Cancer Combined|Flow Cytometrical Analysis of the Human Immune System to Assess Tumor-related Material Piling up in Activated Macrophages in All Relevant Cancer Types.|Completed||N/A|520|Actual|Atrium Medical Center|||1||f||||f||||||Samples With DNA|"~     white cells~      tissue~      plasma~      serum~   "|||2017-02-18 14:13:14.608202|2017-02-18 14:13:14.608202
NCT00704756|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2014-08-08|||January 2009||2009-01-01|August 2014|2014-08-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Observational|PEGIMPACT||An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)|An Observational Multi-Center Study Exploring the Association of Safety, Patient Characteristics, Virological, and Histological Parameters With Patient Outcome (Relapse Rate, Achievement of Sustained Viral Response in Daily Clinical Practice in Belgium- PEGIMPACT|Withdrawn||N/A|0|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:13:11.569692|2017-02-18 14:13:11.569692
NCT00704743|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-24|||November 1998||1998-11-01|June 2008|2008-06-01|January 2004|Actual|2004-01-01|||||Interventional|||A Trial Comparing Circumferential Casting Versus Splinting in Displaced Colles' Fractures|A Prospective Randomized Controlled Trial Comparing Circumferential Casting Versus Splinting in Displaced Colles' Fractures|Completed||Phase 3|120|Actual|University of British Columbia||3|||f||||f||||||||||2017-02-18 14:13:11.677611|2017-02-18 14:13:11.677611
NCT00704730|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-08-19|2014-04-08||June 2008||2008-06-01|August 2015|2015-08-01|December 2015|Anticipated|2015-12-01|October 2011|Actual|2011-10-01||Interventional|EXAM||Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer|An International, Randomized, Double-Blinded, Phase 3 Efficacy Study of XL184 Versus Placebo in Subjects With Unresectable, Locally Advanced, or Metastatic Medullary Thyroid Cancer|Active, not recruiting||Phase 3|330|Actual|Exelixis||2|||f||||t||||||||||2017-02-18 14:13:11.809434|2017-02-18 14:13:11.809434
NCT00704717|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-04-08|2009-02-11||September 2005||2005-09-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)|Evaluation of Satisfaction in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C|Completed||N/A|185|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:13:13.481742|2017-02-18 14:13:13.481742
NCT00704704|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-24|||September 2008||2008-09-01|June 2008|2008-06-01|April 2011|Anticipated|2011-04-01|September 2010|Anticipated|2010-09-01||Interventional|IMDS001||Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)|A Phase 2, Single Arm Study to Determine the Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk Myelodysplastic Syndrome|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 14:13:13.683335|2017-02-18 14:13:13.683335
NCT00704691|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-21|2012-04-18|||June 2008||2008-06-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas|Open-Label, One Arm Pilot Investigation of Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas|Terminated||Early Phase 1|1|Actual|University of Alabama at Birmingham||1||Closed due to futility with only 1 patient accrued|f||||t||||||||||2017-02-18 14:13:13.777269|2017-02-18 14:13:13.777269
NCT00704678|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2016-09-22|||August 2008||2008-08-01|September 2016|2016-09-01||||June 2010|Actual|2010-06-01||Interventional|SBR759||Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis|A 12-week, Open Label, Multicenter, Titration Study, With a 12 Month Extension, to Determine the Optimal Titration Regimen for SBR759, Compared to Sevelamer HCl, in Lowering Serum Phosphate Levels in Asian Patients With Chronic Kidney Disease on Hemodialysis|Completed||Phase 2|203|Actual|Novartis||4|||f||||||||||||||2017-02-18 14:13:13.888866|2017-02-18 14:13:13.888866
NCT00704665|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-24|||December 1998||1998-12-01|June 2008|2008-06-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma|A Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Relaxin in the Treatment of Systemic Sclerosis With Diffuse Scleroderma|Completed||Phase 3|231|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 14:13:14.00509|2017-02-18 14:13:14.00509
NCT00704652|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-04-06|||May 2008||2008-05-01|April 2015|2015-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|EPOinDR||Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus|Evaluation of Functional and Morphological Retinal Changes in the Course of Systemic Aranesp Treatment in Patients With Diabetes Mellitus|Terminated||N/A|5|Actual|Medical University of Vienna|||2|Patient recruitment was not sufficient to achieve the needed patient numbers.|f||||f||||||||||2017-02-18 14:13:14.099759|2017-02-18 14:13:14.099759
NCT00704639|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-22|2017-02-15|||April 2008||2008-04-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Chemoradiation Treatment for Head and Neck Cancer|A Phase II Study of Cetuximab, Carboplatin and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma|Completed||Phase 1/Phase 2|60|Actual|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||f||||||||||2017-02-18 14:13:14.185167|2017-02-18 14:13:14.185167
NCT00704626|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2012-11-20|||January 2002||2002-01-01|November 2012|2012-11-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|SAA||Serum Auto-Antibodies|CCRC: Serum Auto-Antibodies in Neurological Disease|Unknown status|Active, not recruiting|N/A|120|Anticipated|University of California, Davis|||1||f||||f||||||Samples With DNA|"~     5cc of serum will be obtained from patients with multiple sclerosis and other autoimmune and~     inflammatory diseases of the nervous system. Samples may be processed immediately or at a~     later time. Samples will be stored frozen in the freezer located in the Neuroscience~     building at Research Park in Davis, CA. Samples are identified with initials only.~   "|||2017-02-18 14:13:14.300693|2017-02-18 14:13:14.300693
NCT00704613|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2011-11-29|||March 2008||2008-03-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Planning Margin Requirements for Pediatric Radiation Oncology|Planning Margin Requirements for Pediatric Radiation Oncology|Completed||N/A|375|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 14:13:14.412224|2017-02-18 14:13:14.412224
NCT00704600|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2014-12-05|||September 2008||2008-09-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|September 2010|Actual|2010-09-01||Interventional|Nelfinavir||Nelfinavir, a Phase I/Phase II Rectal Cancer Study|A Phase I/II Trial Testing Nelfinavir, an Inhibitor of Akt Signaling, in Combination With Preoperative Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer|Completed||Phase 1/Phase 2|15|Actual|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-02-18 14:13:14.501372|2017-02-18 14:13:14.501372
NCT00697138|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-02-29|||June 2006||2006-06-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Agonist Replacement Therapy for Cocaine Dependence|Agonist Replacement Therapy for Cocaine Dependence: Identifying Novel Medications|Completed||Phase 1|46|Actual|University of Kentucky||1|||f||||t||||||||||2017-02-18 14:16:13.672419|2017-02-18 14:16:13.672419
NCT00704574|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2017-01-30|||January 2008||2008-01-01|January 2017|2017-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|PREDICTIVE™||Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes|Safety of Levemir® (Insulin Detemir) Treatment in Children and Adolescents With Type 1 Diabetes (PREDICTIVE™ - Youth)|Completed||N/A|159|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:13:14.693198|2017-02-18 14:13:14.693198
NCT00704561|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2010-02-09|||April 2008||2008-04-01|March 2009|2009-03-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|OCTAMI||Six-month Coverage and Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography|Prospective, Randomized, Controlled Arm Study Comparing the Coverage of the Zotarolimus-eluting Stent vs Bare Metal Stent Implanted in ST- Elevation Myocardial Infarction (STEMI).|Completed||Phase 3|44|Actual|A.O. Ospedale Papa Giovanni XXIII||2|||f||||t||||||||||2017-02-18 14:13:14.800331|2017-02-18 14:13:14.800331
NCT00704548|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2009-06-25|||June 2008||2008-06-01|June 2009|2009-06-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Antihypertensive Effect of Simvastatin in Hypertensive Patients|Antihypertensive Effect of Simvastatin in Hypertensive Patients: a Randomized Clinical Trial With Ambulatory Blood Pressure Monitoring|Unknown status|Recruiting|Phase 4|92|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||||||||||||2017-02-18 14:13:14.913795|2017-02-18 14:13:14.913795
NCT00704535|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-04-09|2009-05-21||March 2006||2006-03-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED)|Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Ezetimibe Among Filipino Patients|Completed||N/A|4105|Actual|Merck Sharp & Dohme Corp.|Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data.||1||f||||f||||||||||2017-02-18 14:13:15.011042|2017-02-18 14:13:15.011042
NCT00704522|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-10-05|2010-04-21||March 2005||2005-03-01|October 2015|2015-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)|Evaluation of Adherence Rate in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program.|Completed||N/A|601|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:13:15.292949|2017-02-18 14:13:15.292949
NCT00704509|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2010-09-24|||June 2008||2008-06-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy of Bifeprunox in Patients With Schizophrenia|A Multinational, Randomised, Double-Blind, Fixed-Dose, Bifeprunox Study Combining a 12-Week Placebo-Controlled, Quetiapine-Referenced Phase With a 12-Month Quetiapine-Controlled Phase in Patients With Schizophrenia|Terminated||Phase 3|346|Actual|H. Lundbeck A/S||3||Interim analysis showed inadequate efficacy of bifeprunox|f||||f||||||||||2017-02-18 14:13:15.848762|2017-02-18 14:13:15.848762
NCT00704496|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2008-06-24|||June 2007||2007-06-01|June 2008|2008-06-01||||September 2009|Anticipated|2009-09-01||Interventional|||The Effect of Pseudoephedrine on Rhinitis and Sleep||Unknown status|Recruiting|N/A|32|Anticipated|Penn State University||2|||f||||f||||||||||2017-02-18 14:13:15.999267|2017-02-18 14:13:15.999267
NCT00704483|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2016-11-16|||July 2008||2008-07-01|November 2016|2016-11-01||||August 2010|Actual|2010-08-01||Interventional|SBR759||Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis|A 12-week, Open Label, Multicenter, Titration Study, With a 9-month Maintenance Treatment Extension, to Demonstrate Efficacy of SBR759 Compared to Sevelamer HCl in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis|Completed||Phase 2|321|Actual|Novartis||4|||f||||||||||||||2017-02-18 14:13:16.112986|2017-02-18 14:13:16.112986
NCT00704470|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2008-06-25|||April 2005||2005-04-01|June 2008|2008-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Performance and Stress During Full Scale Simulator Training|Excellence in Performance and Stress Reduction During Two Different Full Scale Simulator Training Courses: A Pilot Study|Completed||N/A|32|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-02-18 14:13:16.304163|2017-02-18 14:13:16.304163
NCT00704457|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-24|2013-08-01|||February 2004||2004-02-01|August 2013|2013-08-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Observational|||Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)|Impact Of Sacral Neuromodulation On Urine Markers For IC|Completed||N/A|11|Actual|William Beaumont Hospitals|||1||f||||f||||||Samples Without DNA|"~     Urines were collected and sent for urine marker analysis.~   "|||2017-02-18 14:13:16.414752|2017-02-18 14:13:16.414752
NCT00704444|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-02-24|||June 2007||2007-06-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)|Designated Drug Use Investigation (12 Weeks) of Zetia 10mg Tablets - A 12-Week Designated Drug Use Investigation of Zetia Monotherapy and Combination Therapy|Completed||N/A|11332|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:13:16.509921|2017-02-18 14:13:16.509921
NCT00704431|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-11-03|||May 2008||2008-05-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study With Darapladib to Collect Tolerability Information|An Open Label, Single Session Study to Collect Tolerability Information Following Repeat Dosing of Darapladib in Healthy Adult Subjects|Completed||Phase 1|2|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:13:16.610198|2017-02-18 14:13:16.610198
NCT00704418|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2013-01-11|2010-11-15||June 2008||2008-06-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery||Completed||Phase 3|156|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:13:16.721999|2017-02-18 14:13:16.721999
NCT00704223|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2014-06-23|||May 2008||2008-05-01|June 2014|2014-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|INTENSIV||Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes|Observational Study on Safety and Efficacy in Subjects Using NovoMix® 70 (Biphasic Insulin Aspart) for Treatment of Type 2 Diabetes Mellitus|Completed||N/A|619|Actual|Novo Nordisk A/S|||1||f||||f||||||Samples With DNA|"~     Blood sample~   "|||2017-02-18 14:13:20.811458|2017-02-18 14:13:20.811458
NCT00704405|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-09-01|2014-09-26||March 2009||2009-03-01|September 2015|2015-09-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional||The Baseline Population consists of all randomized C and NC participants.|Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)|A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of 4 Different Regimens of MK-7009 When Administered Concomitantly With Pegylated Interferon and Ribavirin in Treatment-Experienced Patients With Chronic Genotype 1 Hepatitis C Virus Infection|Completed||Phase 2|285|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 14:13:17.042907|2017-02-18 14:13:17.042907
NCT00704392|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-08-19|||June 2008||2008-06-01|August 2015|2015-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL647 and XL147 Administered in Combination Daily to Subjects With Solid Tumors|Withdrawn||Phase 1|0|Actual|Exelixis||1||Study not initiated|f||||||||||||||2017-02-18 14:13:18.179409|2017-02-18 14:13:18.179409
NCT00704379|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-08-10|2015-04-24||June 2008||2008-06-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury|Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury|Completed||Phase 2/Phase 3|94|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 14:13:18.279844|2017-02-18 14:13:18.279844
NCT00704366|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2011-05-13|||June 2008||2008-06-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|||AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours|A Phase I, Open-label, Dose-escalation Study to Assess the Safety and Tolerability of AZD0530 in Patients With Advanced Solid Malignancies|Completed||Phase 1|18|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 14:13:18.70998|2017-02-18 14:13:18.70998
NCT00704353|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2013-09-16|2013-09-16||June 2008||2008-06-01|September 2013|2013-09-01|March 2011|Actual|2011-03-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Tolerability of a Single Dose of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia|A Multi-Center, Randomized, Controlled Study to Investigate the Safety and Tolerability of a Single Dose of Intravenous Ferric Carboxymaltose (FCM) vs. Standard Medical Care in Treating Iron Deficiency Anemia in Subjects Who Are Not Dialysis Dependent|Completed||Phase 3|735|Actual|Luitpold Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:13:18.811896|2017-02-18 14:13:18.811896
NCT00704340|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2014-09-04|2010-04-26||September 2005||2005-09-01|September 2014|2014-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||DuraSeal Sealant Post Market Study|DuraSeal Sealant Post Market Study|Completed||N/A|237|Actual|Integra LifeSciences Corporation||2|||f||||f||||||||||2017-02-18 14:13:19.201897|2017-02-18 14:13:19.201897
NCT00704327|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-03-15|||February 2008||2008-02-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Observational|||Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition|Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition|Recruiting||N/A|100|Anticipated|Lahey Clinic|||1||f||||f||||||||||2017-02-18 14:13:19.881298|2017-02-18 14:13:19.881298
NCT00704314|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-23|||October 2002||2002-10-01|June 2008|2008-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients?|Effects of High Dose Simvastatin Therapy on Glucose Metabolism and Ectopic Lipid Deposition in Non-Obese Type 2 Diabetic Patients|Completed||N/A|20|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 14:13:19.995612|2017-02-18 14:13:19.995612
NCT00704301|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2010-08-12|||November 2008||2008-11-01|October 2009|2009-10-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Rivastigmine for Intensive Care Unit (ICU) Delirium|Rivastigmine for Delirium in Intensive Care Patients, a Double-blind, Randomized Placebo-controlled add-on Trial|Terminated||Phase 4|104|Actual|UMC Utrecht||2||The study is prematurely terminated due to a safety issue|f||||t||||||||||2017-02-18 14:13:20.11428|2017-02-18 14:13:20.11428
NCT00704288|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2014-07-15|||May 2008||2008-05-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme|A Phase 2 Study of XL184 in Subjects With Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse|Completed||Phase 2|222|Actual|Exelixis||1|||f||||||||||||||2017-02-18 14:13:20.251173|2017-02-18 14:13:20.251173
NCT00704275|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2008-06-23|||June 2007||2007-06-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|July 2008|Anticipated|2008-07-01||Interventional|||Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes|Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes|Unknown status|Recruiting|Phase 4|60|Anticipated|Chulalongkorn University||2|||f||||f||||||||||2017-02-18 14:13:20.362489|2017-02-18 14:13:20.362489
NCT00704262|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2013-10-30|||May 2008||2008-05-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds|Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and on the Intertriginous Areas|Completed||Phase 2|33|Actual|LEO Pharma||1|||f||||f||||||||||2017-02-18 14:13:20.47453|2017-02-18 14:13:20.47453
NCT00704249|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-22|2009-02-10|||July 2006||2006-07-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|VENICE||VENICE Study Nevirapine Full Dose/Dose Escalation|Randomized Multicenter Study to Compare Starting Nevirapine at the Full Dose With Dose Escalation in Patients Who Require Efavirenz to be Withdrawn Due to Adverse Reactions|Completed||Phase 4|80|Anticipated|Clinical Trial Agency of HIV Study Group||2|||f||||||||||||||2017-02-18 14:13:20.586179|2017-02-18 14:13:20.586179
NCT00704236|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2008-12-10|||September 2006||2006-09-01|December 2008|2008-12-01|February 2008|Actual|2008-02-01|||||Interventional|||Improvement of Insulin Resistance With Traditional Chinese Treatment in Patients With Type 2 Diabetes|Phase 4 Study on the Effect of Insulin Resistance With Traditional Chinese Treatment in Type 2 Diabetes|Completed||Phase 4|43|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-02-18 14:13:20.71831|2017-02-18 14:13:20.71831
NCT00704210|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-10-14|||August 2006||2006-08-01|October 2016|2016-10-01|July 2009|Anticipated|2009-07-01|December 2008|Anticipated|2008-12-01||Interventional|SpiDERS||Effectiveness of Mechanical Decompression for Low Back Pain Relief|Effectiveness of Mechanical Decompression for Low Back Pain Relief|Withdrawn||N/A|0|Actual|State University of New York - Upstate Medical University||2||Study withdrawn by sponsor|f||||f||||||||||2017-02-18 14:13:20.923131|2017-02-18 14:13:20.923131
NCT00704197|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-01-22|||August 2007||2007-08-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|December 2013|Actual|2013-12-01||Observational|ISIS||"ISIS Study of Sex Differences in Characteristics of Adiposity and Metabolism"|Study of Sex Differences in Characteristics of Adiposity and Metabolism|Active, not recruiting||N/A|23|Actual|Pennington Biomedical Research Center|||1||f||||t||||||Samples With DNA|"~     whole blood, urine, adipose tissue~   "|||2017-02-18 14:13:21.035253|2017-02-18 14:13:21.035253
NCT00704184|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-12-23|2014-09-26||July 2008||2008-07-01|December 2015|2015-12-01|April 2010|Actual|2010-04-01|December 2008|Actual|2008-12-01||Interventional||The baseline population consists of all participants treated with study medication. One participant was randomized to the placebo group but withdrew from the study prior to taking any study medication.|Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)|A Phase II, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK7009 Administered Concomitantly With Pegylated-Interferon and Ribavirin for 28 Days in Treatment-Naive Patients With Chronic Hepatitis C Infection|Completed||Phase 2|95|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 14:13:21.147487|2017-02-18 14:13:21.147487
NCT00704171|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2016-09-22|2009-12-21||January 2008||2008-01-01|September 2016|2016-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||PleuraSeal Post Market Study (Europe)|Prospective Multi-Center Randomized Post Market Study to Evaluate the PleuraSeal Sealant System as Adjunct to Standard Closure Techniques for Control of Visceral Pleural Air Leaks Following Elective Pulmonary Resection Via Open Thoracotomy|Completed||Phase 4|121|Actual|Integra LifeSciences Corporation||2|||f||||f||||||||||2017-02-18 14:13:22.581022|2017-02-18 14:13:22.581022
NCT00704158|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-02-02||2015-02-02|June 2008||2008-06-01|February 2015|2015-02-01|June 2011|Actual|2011-06-01|November 2010|Actual|2010-11-01||Interventional|||Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer|A Phase I/II Study of CR011-vcMMAE in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|42|Actual|Celldex Therapeutics||1|||f||||f||||||||||2017-02-18 14:13:23.392988|2017-02-18 14:13:23.392988
NCT00704145|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2010-02-05|||November 2007||2007-11-01|February 2010|2010-02-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|OCTAXUS||Optical Coherence Tomography Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease|A Prospective Optical Coherence Tomography Study on Completeness of Strut Coverage and Vessel Wall Response at 3-6 and 9 Months Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease|Completed||Phase 4|30|Anticipated|A.O. Ospedale Papa Giovanni XXIII||1|||f||||t||||||||||2017-02-18 14:13:23.490172|2017-02-18 14:13:23.490172
NCT00704132|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-08-13|2011-04-21||February 2007||2007-02-01|August 2015|2015-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)|A Randomized, Placebo-Controlled Study to Evaluate the Safety, Efficacy and Mechanism of Action of MK0431/Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 1|57|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:13:23.617494|2017-02-18 14:13:23.617494
NCT00704119|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2010-03-23|||May 2008||2008-05-01|March 2010|2010-03-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating the Pharmacokinetic Profile of RhuDex® in a Tablet Formulation|CT 5002 An Open-label, Non-randomized, Monocentric Phase I Study Evaluating the Pharmacokinetic Profile of RhuDex® Using a Tablet Formulation|Terminated||Phase 1|12|Actual|MediGene||1||"Following an SAE, study was put on hold. After performing preclinical follow-up studies,~   volunteers were no longer available for continuation."|f||||t||||||||||2017-02-18 14:13:23.913187|2017-02-18 14:13:23.913187
NCT00704106|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2012-05-08|||May 2008||2008-05-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|||||Observational|ADVPR||Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders|HBV Viral Suppression by Entecavir in Adefovir Partial Responders|Unknown status|Active, not recruiting|N/A|120|Anticipated|Pacific Health Foundation|||4||f||||f||||||||||2017-02-18 14:13:24.000223|2017-02-18 14:13:24.000223
NCT00704093|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-07-03|||January 2008||2008-01-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Effect of Right Ventricular Pacing on Myocardial Oxidative Metabolism and Efficiency|The Effect of Right Ventricular Pacing on Myocardial Oxidative Metabolism and Efficiency|Completed||N/A|10|Actual|University of Turku||1|||f||||f||||||||||2017-02-18 14:13:24.119208|2017-02-18 14:13:24.119208
NCT00704080|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2013-04-09|||August 2008||2008-08-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas|A Phase 1 Dose-Escalation Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Subjects With Malignant Gliomas|Completed||Phase 1|54|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:13:24.20622|2017-02-18 14:13:24.20622
NCT00704067|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-02-11|||September 2008||2008-09-01|February 2015|2015-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Improving Work Outcomes for Veterans With Traumatic Brain Injury|Improving Work Outcomes for Veterans With Traumatic Brain Injury|Completed||N/A|50|Actual|United States Department of Defense||2|||f||||f||||||||||2017-02-18 14:13:24.312139|2017-02-18 14:13:24.312139
NCT00704054|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2015-02-12|||January 2008||2008-01-01|February 2015|2015-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)|A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors|Completed||Phase 1|15|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:13:26.867454|2017-02-18 14:13:26.867454
NCT00704041|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2009-07-08|||July 2009||2009-07-01|July 2009|2009-07-01|June 2012|Anticipated|2012-06-01|June 2010|Anticipated|2010-06-01||Interventional|MAGE||Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck|A Phase 1 Open Label, Dose Escalation Study to Evaluate the Effect of Four Doses of MAGE-A3/HPV 16 Trojan Peptides 0001 and 0002 Administered Subcutaneously|Unknown status|Recruiting|Phase 1|48|Anticipated|University of Maryland||2|||f||||t||||||||||2017-02-18 14:13:26.974959|2017-02-18 14:13:26.974959
NCT00704028|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-11-21|2013-09-16||June 2008||2008-06-01|November 2016|2016-11-01|March 2011|Actual|2011-03-01|January 2010|Actual|2010-01-01||Interventional||Safety population|Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia|A Multi-Center, Randomized, Controlled Study to Investigate the Safety and Tolerability of Intravenous Ferric Carboxymaltose (FCM) vs. Iron Dextran in Treating Iron Deficiency Anemia|Completed||Phase 3|161|Actual|Luitpold Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:13:27.088819|2017-02-18 14:13:27.088819
NCT00704015|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-23|||February 2004||2004-02-01|June 2008|2008-06-01|June 2008|Anticipated|2008-06-01|December 2006|Actual|2006-12-01||Interventional|||Smoking Cessation Intervention in Acute Orthopedic Surgery|Smoking Cessation Intervention in Acute Orthopedic Surgery - A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|105|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 14:13:27.478811|2017-02-18 14:13:27.478811
NCT00704002|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2013-03-27|||December 2006||2006-12-01|March 2013|2013-03-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|CONFraM||Conservative Versus Operative Treatment of Displaced Neck Fractures of the Fifth Metacarpal|Conservative Versus Operative Treatment of Displaced Neck Fractures of the Fifth Metacarpal|Terminated||N/A|9|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-02-18 14:13:27.575108|2017-02-18 14:13:27.575108
NCT00703989|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2008-06-23|||February 2005||2005-02-01|June 2008|2008-06-01|February 2008|Actual|2008-02-01|October 2006|Actual|2006-10-01||Interventional|||Reactive Oxygen Species in the Pathogenesis of Diabetic Complications|The Role of the Glucosamine Pathway and Reactive Oxygen Species in the Pathogenesis of Diabetic Complications|Completed||N/A|21|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-02-18 14:13:27.697592|2017-02-18 14:13:27.697592
NCT00703976|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-02-17|||October 2008||2008-10-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer|Phase II Randomized Trial of Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer|Completed||Phase 2|80|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:13:27.818616|2017-02-18 14:13:27.818616
NCT00703963|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2014-08-18|2014-08-18||March 2007||2007-03-01|August 2014|2014-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care|Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care: A Randomized Controlled Trial|Completed||N/A|200|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:13:27.938824|2017-02-18 14:13:27.938824
NCT00703950|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2015-08-10|||January 2008||2008-01-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Sucking Pattern of Preterm Infants Using Cup or Bottle Before Breastfeeding|Effects of the Use of a Bottle and a Cup on Breast Sucking Patterns of Premature Infants: Safety and Efficacy|Terminated||Phase 4|56|Actual|Instituto Fernandes Figueira||2||Sample size was re- calculated considering sucking pattern parameters|f||||f||||||||||2017-02-18 14:13:28.534594|2017-02-18 14:13:28.534594
NCT00703937|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2013-09-16|2013-09-16||July 2008||2008-07-01|September 2013|2013-09-01|March 2011|Actual|2011-03-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia|A Multi-center, Randomized, Controlled Study to Investigate the Safety and Tolerability of Intravenous Ferric Carboxymaltose (FCM) vs. Standard Medical Care in Treating Iron Deficiency Anemia|Completed||Phase 3|708|Actual|Luitpold Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:13:28.644465|2017-02-18 14:13:28.644465
NCT00703924|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-12-21|2016-12-21||March 2003||2003-03-01|December 2016|2016-12-01|November 2005|Actual|2005-11-01|November 2004|Actual|2004-11-01||Interventional|||Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World|Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: a Phase 2 Study in the Old World|Completed||Phase 2|92|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||f||||||||Yes|Data will be shared with WRAIR|2017-02-18 14:13:29.087133|2017-02-18 14:13:29.087133
NCT00703911|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2016-11-22|2011-07-29||March 2008||2008-03-01|November 2016|2016-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|ONE||Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors|A Prospective Observational Registry on the Use of NovoSeven® (Activated Recombinant Human Factor VIIa) for on Demand Treatment of Mild to Moderate Bleeds in Haemophilia A and B Patients With Inhibitors|Completed||N/A|102|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:13:29.628081|2017-02-18 14:13:29.628081
NCT00703898|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2008-07-07|||November 2004||2004-11-01|June 2008|2008-06-01|April 2010||2010-04-01|December 2009||2009-12-01||Interventional|||Durability of Nevirapine-Based Antiretroviral Regimen|Durability of Stavudine, Lamivudine and Nevirapine Among Advanced HIV-1 Infected Patients With/Without Prior Co-Administration of Rifampicin: A 144-Week Prospective Study|Completed||Phase 4|140|Actual|Bamrasnaradura Infectious Diseases Institute||1|||f||||t||||||||||2017-02-18 14:13:30.704396|2017-02-18 14:13:30.704396
NCT00703885|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2014-12-19|2013-06-19||January 2008||2008-01-01|December 2014|2014-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)|PharmacofMRI of Anxiolytic Medications (Alprazolam)|Completed||Phase 4|16|Actual|University of California, San Diego|"This is a single dose cross-over study in 16 healthy subjects.~BOLD fMRI analyses for this study were not completed by the investigators."|3|||f||||f||||||||||2017-02-18 14:13:30.797149|2017-02-18 14:13:30.797149
NCT00703872|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2009-01-08|||May 2008||2008-05-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||HDV-Interferon in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients|An Evaluation of Two Dose Routes of HDV-Interferon Administered With Ribavarin in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Hepasome Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:13:31.037496|2017-02-18 14:13:31.037496
NCT00703859|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2016-02-18|||July 2008||2008-07-01|September 2011|2011-09-01||||January 2010|Anticipated|2010-01-01||Interventional|||Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma|A Phase I Single Arm Trial Combining Radiotherapy and Temozolomide With Dichloroacetate (DCA) in Patients With Newly Diagnosed Glioblastoma Multiform Tumours|Withdrawn||Phase 1|0|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 14:13:31.151379|2017-02-18 14:13:31.151379
NCT00703846|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-12-01|2012-01-19||June 2008||2008-06-01|December 2016|2016-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%|A PHASE 4, OPEN-LABEL STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% IN THE TREATMENT OF SEBORRHEIC DERMATITIS|Completed||Phase 4|498|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:13:31.243343|2017-02-18 14:13:31.243343
NCT00703833|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-22|2015-10-30|||September 2002||2002-09-01|October 2015|2015-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)|A Double-Blind, Multicenter, Placebo-Controlled Study of MK0777 Gel Extrusion Module (GEM) 1.5 mg b.i.d. in the Treatment of Outpatients With Generalized Anxiety Disorder|Completed||Phase 2|51|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:13:31.633447|2017-02-18 14:13:31.633447
NCT00703820|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-11-02|||August 2008||2008-08-01|November 2016|2016-11-01|August 2019|Anticipated|2019-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia|AML08: A Phase II Randomized Trial of Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Phase II Study Of Natural Killer Cell Transplantation In Patients With Newly Diagnosed Acute Myeloid Leukemia|Recruiting||Phase 3|270|Anticipated|St. Jude Children's Research Hospital||2|||f||||t||||||||||2017-02-18 14:13:31.72267|2017-02-18 14:13:31.72267
NCT00703807|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2014-01-13|||December 2008||2008-12-01|January 2014|2014-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers|A Phase I Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers|Completed||Phase 1|10|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:13:31.875316|2017-02-18 14:13:31.875316
NCT00703794|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-23|2012-03-08|||June 2008||2008-06-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|RACER||Researching AXIUM Coiling Experience and Recanalization (RACER)|ev3 Researching AXIUM Coiling Experience and Recanalization (RACER)|Completed||Phase 4|119|Actual|ev3||1|||f||||t||||||||||2017-02-18 14:13:31.982545|2017-02-18 14:13:31.982545
NCT00703781|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-03-04|2011-11-07||June 2008||2008-06-01|March 2015|2015-03-01||||November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery||Completed||Phase 3|126|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:13:32.104323|2017-02-18 14:13:32.104323
NCT00703768|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2009-02-13|||June 2006||2006-06-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|June 2010|Anticipated|2010-06-01||Observational|||Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year|An Open-Label, Phase ll Trial Comparing FACT-P Scores For Subjects Who Are Indicated To Receive Androgen Deprivation Therapy And Have A Doubling In PSA Post Curative Therapy Of Either Less Than Or Greater Than One Year|Unknown status|Recruiting|N/A|300|Anticipated|Urology South Shore Research Inc.|||2||f||||f||||||||||2017-02-18 14:13:32.409233|2017-02-18 14:13:32.409233
NCT00703755|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2008-06-24|||March 2003||2003-03-01|June 2008|2008-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.|A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.|Completed||Phase 2|2288|Actual|Solvay Pharmaceuticals||7|||f||||f||||||||||2017-02-18 14:13:32.494145|2017-02-18 14:13:32.494145
NCT00703742|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2011-06-24|||June 2008||2008-06-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression|A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression|Completed||N/A|50|Anticipated|Kunming Medical University||1|||f||||t||||||||||2017-02-18 14:13:32.904906|2017-02-18 14:13:32.904906
NCT00703729|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2015-08-10|2015-07-15||June 2008||2008-06-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Compression and Cold Therapy on the Post-Operative Shoulder|The Effectiveness of Simultaneous Intermittent Compression and Continuous Cold Therapy on the Post-Operative Shoulder: A Randomized Controlled Trial|Completed||N/A|58|Actual|University of Colorado, Denver|"Some patients were removed from the trial due to non-compliance, most commonly for failing to complete the pain diaries.~There is also some inherent recall bias in asking a patient to fill out a diary."|2|||f||||f||||||||||2017-02-18 14:13:33.00883|2017-02-18 14:13:33.00883
NCT00703716|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2014-09-10|||May 2008||2008-05-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|TRAUMAX||Stabilization of Trochanteric Fracture Using a Screw-plate TRAUMAX|Stabilization of Trochanteric Fracture Using a Screw-plate TRAUMAX|Completed||N/A|190|Actual|Integra LifeSciences Services|||1||f||||f||||||||||2017-02-18 14:13:33.557106|2017-02-18 14:13:33.557106
NCT00703703|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-08-01|||May 2008||2008-05-01|August 2012|2012-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects|A 3-way Cross-over, Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess Pharmacologic Effects of a 7-day Exposure to Darifenacin 15 mg o.d. and Tolterodine ER 4 mg o.d. on Cardiovascular Parameters in Healthy Subjects 50 Years of Age and Older|Completed||Phase 1|117|Actual|Novartis||3|||f||||||||||||||2017-02-18 14:13:33.672444|2017-02-18 14:13:33.672444
NCT00703690|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-06-11|||January 2002||2002-01-01|June 2015|2015-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)|A Multicenter, Double-Blind, Randomized, Placebo and Active-Controlled, Parallel Study to Evaluate the Lipid Altering Efficacy and Safety of MK0767 in Patients With Metabolic Syndrome and Dyslipidemia|Terminated||Phase 2|436|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 14:13:33.795943|2017-02-18 14:13:33.795943
NCT00703677|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-06-09|2010-04-30||September 2008||2008-09-01|June 2015|2015-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration|A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration|Completed||Phase 1/Phase 2|17|Actual|Westat|The majority of subjects did not tolerate study drug, therefore, evaluations of subjects on study drug are limited in number.|1|||f||||f||||||||||2017-02-18 14:13:33.893949|2017-02-18 14:13:33.893949
NCT00703664|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2017-01-31|||July 2008||2008-07-01|December 2016|2016-12-01||||June 2017|Anticipated|2017-06-01||Interventional|||Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma|Phase II Trial of Bortezomib and Vorinostat in Mantle Cell and Diffuse Large B-Cell Lymphomas|Active, not recruiting||Phase 2|116|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:13:34.297343|2017-02-18 14:13:34.297343
NCT00703651|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2014-01-09|||September 2003||2003-09-01|January 2014|2014-01-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults|Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route in Comparison With Intramuscular Vaccination With Vaxigrip® in Adults|Completed||Phase 2|1150|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 14:13:34.424177|2017-02-18 14:13:34.424177
NCT00703638|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2012-11-06|||May 2008||2008-05-01|November 2012|2012-11-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors|Phase I Study of Sorafenib, Pemetrexed, and Cisplatin for the Treatment of Advanced Solid Tumors.|Completed||Phase 1|16|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:13:34.550746|2017-02-18 14:13:34.550746
NCT00703625|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-06-13|||March 2008||2008-03-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|May 2011|Actual|2011-05-01||Interventional|||Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies|Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies|Active, not recruiting||Phase 1|26|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 14:13:34.666872|2017-02-18 14:13:34.666872
NCT00703612|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-06-28|||November 2007||2007-11-01|June 2008|2008-06-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Interventional|||Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Type 2 Diabetics|Phase I/II Study of Intravenous Administration of Activated Autologous Adipose-Derived Stromal Vascular Fraction in Patients With Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 1/Phase 2|34|Actual|Adistem Ltd||1|||f||||f||||||||||2017-02-18 14:13:34.798586|2017-02-18 14:13:34.798586
NCT00703599|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-06-28|||November 2007||2007-11-01|June 2008|2008-06-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|||Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes|Phase I/II Study of Intravenous Administration of Activated Autologous Adipose-Derived Stromal Vascular Fraction in Patients With Type 1 Diabetes|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Adistem Ltd||1|||f||||f||||||||||2017-02-18 14:13:34.905969|2017-02-18 14:13:34.905969
NCT00703586|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-10-22|||September 2007||2007-09-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc|A Two-Arm, Single Site, Proof of Concept Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc, a CCR5 Antagonist (ADARC 2007-02)|Completed||Phase 1|8|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 14:13:35.02015|2017-02-18 14:13:35.02015
NCT00703573|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2011-09-13|||May 2008||2008-05-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of 2 Doses of S-777469 (400 mg BID and 800 mg BID) in Patients With Atopic Dermatitis|Completed||Phase 2|209|Actual|Shionogi Inc.||3|||f||||f||||||||||2017-02-18 14:13:35.133826|2017-02-18 14:13:35.133826
NCT00703560|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-01-18|||September 2005||2005-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|September 2011|Actual|2011-09-01||Observational|VK||Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients|Molecular Basis of Interferon Response in HCV|Completed||N/A|72|Anticipated|University of Texas Southwestern Medical Center|||2||f||||f||||||Samples With DNA|"~     serum, peripheral blood mononuclear cells~   "|||2017-02-18 14:13:35.26553|2017-02-18 14:13:35.26553
NCT00703547|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2010-10-14||2010-10-14|January 2008||2008-01-01|October 2010|2010-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A First Time in Human Study of GSK586529 in Healthy Volunteers|A Single Blind, Randomized, Placebo Controlled, Crossover Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Oral Escalating Doses of GSK586529 in Healthy Volunteers|Completed||Phase 1|24|Anticipated|GlaxoSmithKline|||||f||||||||||||||2017-02-18 14:13:35.35227|2017-02-18 14:13:35.35227
NCT00703534|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2011-05-20|2011-02-04||May 2008||2008-05-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|C27||Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms|Validation of Patient-reported Outcomes Measures for the Assessment of GERD Symptoms and Their Subsequent Impact on Patients With Partial Response to Proton Pump Inhibitor (PPI) Treatment in a Two Part Multi-center Phase IIa Study Including a Four Week Randomised, Double-blind, Placebo-controlled, Parallel-group Treatment Period|Completed||Phase 2|478|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:13:35.443348|2017-02-18 14:13:35.443348
NCT00703521|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2008-10-23|||August 2002||2002-08-01|June 2008|2008-06-01|September 2005|Actual|2005-09-01|October 2002|Actual|2002-10-01||Interventional|||Rabies Immunization Concomitant With JEV in Children|A Three-Year Clinical Study on Immunogenicity, Safety and Booster Response of Purified Chick Embryo Cell Rabies Vaccine (Pcecv) Administered Intramuscularly or Intradermally to 12- to 18-Month-Old Thai Children Concomitantly With Japanese Encephalitis Vaccine|Completed||Phase 2|200|Anticipated|Mahidol University||1|||f||||f||||||||||2017-02-18 14:13:36.027938|2017-02-18 14:13:36.027938
NCT00703508|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-06-06|||July 2008||2008-07-01|June 2016|2016-06-01|March 2014|Actual|2014-03-01|September 2013|Actual|2013-09-01||Interventional|||Pharmacogenetics of Metformin Action in PCOS|Pharmacogenetics of Metformin Action in PCOS|Completed||N/A|55|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-02-18 14:13:36.114277|2017-02-18 14:13:36.114277
NCT00703495|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2009-04-03|||July 2008||2008-07-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Invasive and Non-Invasive Assessment of Cerebral Oxygenation in Patients With Severe Traumatic Brain Injury (TBI)|Validation of Non- Invasive Regional Transcranial Oxygen Saturation (rSO2) by Comparison With Invasive Brain Tissue Oxygenation (PbtO 2) Measurement in Patients With Severe Traumatic Brain Injury|Completed||N/A|20|Anticipated|Hospitales Universitarios Virgen del Rocío|||1||f||||t||||||||||2017-02-18 14:13:36.22474|2017-02-18 14:13:36.22474
NCT00703482|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2008-06-24|||May 2003||2003-05-01|June 2008|2008-06-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes|A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes|Completed||Phase 2|278|Actual|Solvay Pharmaceuticals||7|||f||||f||||||||||2017-02-18 14:13:36.334285|2017-02-18 14:13:36.334285
NCT00703469|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2010-04-22|||October 2008||2008-10-01|April 2010|2010-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|MDX1106-02||A Study of MDX-1106 to Treat Patients With Hepatitis C Infection|A Phase I, Double-blind,Multicenter,Randomized,Placebo-controlled,Safety and Pharmacokinetic Dose-escalation Study of a Single Intravenous Administration of MDX-1106, a Fully Human Monoclonal Antibody to PD-1, in Subjects With Active Hepatitis C Genotype 1 Infection|Completed||Phase 1|54|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:13:36.44976|2017-02-18 14:13:36.44976
NCT00703456|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-04-15|||June 2008||2008-06-01|April 2016|2016-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Effect of Balance Training on Unloading Reaction in Individuals With Functional Ankle Instability|The Effect of Balance Training on Unloading Reaction in Individuals With Functional Ankle Instability|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:13:36.55552|2017-02-18 14:13:36.55552
NCT00703443|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2010-02-01|||April 2007||2007-04-01|April 2009|2009-04-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Observational|||The Genetics of Cardiomyopathy and Heart Failure|The Genetics of Cardiomyopathy and Heart Failure|Unknown status|Active, not recruiting|N/A|200|Anticipated|University of California, Irvine|||1||f||||f||||||Samples With DNA|"~     Whole blood, Saliva, Buccal cells~   "|||2017-02-18 14:13:36.667252|2017-02-18 14:13:36.667252
NCT00703430|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2013-01-24|||March 2008||2008-03-01|January 2013|2013-01-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Memantine on Aggression and Agitation of Alzheimer's Disease (AD)|The Effect of Memantine on Aggression and Agitation and Its Impact on Caregiver Burden of Patients With Alzheimer's Disease: A 12-week Open-label Study|Unknown status|Recruiting|N/A|50|Anticipated|Peking University||1|||f||||t||||||||||2017-02-18 14:13:36.76106|2017-02-18 14:13:36.76106
NCT00703417|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2011-06-06|||May 2006||2006-05-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot Study|Does Bone Structure Explain the Increased Fracture Risk in Type II Diabetes Patients? A Pilot Study|Completed||N/A|40|Anticipated|University of California, San Francisco|||3||f||||f||||||||||2017-02-18 14:13:36.862004|2017-02-18 14:13:36.862004
NCT00703404|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2017-01-24|||June 18, 2008||2008-06-18|February 24, 2016|2016-02-24|February 24, 2016||2016-02-24|||||Observational|||Response to Standard HIV Treatment in Bamako, Mali|A Cohort Observational Study to Assess the Virologic Response to Standard HIV Treatment in Bamako, Mali|Completed||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:13:36.956411|2017-02-18 14:13:36.956411
NCT00703391|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-01-24|2010-11-30||June 2008||2008-06-01|January 2012|2012-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients|A 2-week, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Tolerability and Pharmacokinetics of Orally Administered AZD9668 in Patients With COPD|Completed||Phase 2|18|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:13:37.053556|2017-02-18 14:13:37.053556
NCT00703378|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2012-03-27|||May 2006||2006-05-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Interventional|||Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle|Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle|Completed||Phase 1/Phase 2|33|Actual|National University Hospital, Singapore||3|||f||||||||||||||2017-02-18 14:13:37.702033|2017-02-18 14:13:37.702033
NCT00703365|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-08-25|||February 2008||2008-02-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)|A Multicenter, Open Label, Single Arm, Phase II Study to Investigate the Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Patients With Advanced Hepatocellular Carcinoma (HCC)|Completed||Phase 2|45|Actual|Mahidol University||1|||f||||f||||||||||2017-02-18 14:13:37.821313|2017-02-18 14:13:37.821313
NCT00703352|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2011-11-30|||July 2008||2008-07-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|EVEDES||Eplerenone in Systemic Right Ventricle|Aldosterone Antagonists in Systemic Right Ventricle: a Randomized Clinical Trial.|Completed||Phase 4|26|Actual|Hospital Universitari Vall d'Hebron Research Institute||2|||f||||t||||||||||2017-02-18 14:13:37.937825|2017-02-18 14:13:37.937825
NCT00703339|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-05-10|2011-02-25||June 2008||2008-06-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis|A Single-Dose, Dose-Escalating Study Exploring the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Inhaled Treprostinil Sodium Using the Nebu-Tec OPTINEB Inhalation Device in Patients With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis|Terminated||Phase 2|1|Actual|Lung Biotechnology PBC|Study was closed on December 31, 2009 and enrolled a total of 1 patient with complete assessment and 4 screened failures. The reason for the closure was lack of enrollment. No data will be analyzed.|1||Lack of enrollment to the trial. Very difficult population to recruit.|f||||t||||||||||2017-02-18 14:13:38.040768|2017-02-18 14:13:38.040768
NCT00703326|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-10-18|2014-05-16||August 2008||2008-08-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|March 2013|Actual|2013-03-01||Interventional||Intent-to-Treat (ITT) Population: All randomized participants.|Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer|A Multicenter, Multinational, Randomized, Double-Blind, Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally-Recurrent or Metastatic Breast Cancer|Active, not recruiting||Phase 3|1144|Actual|Eli Lilly and Company|One participant assigned to placebo + docetaxel (doc) treatment and was given ramucirumab (ram) in Cycle 1. Considered ram + doc treatment arm for safety population, for ITT population the participant was analyzed according to assigned treatment.|2|||f||||t||||||||||2017-02-18 14:13:38.27759|2017-02-18 14:13:38.27759
NCT00703287|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-02-01|||January 2008||2008-01-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Specialized Physiotherapy Program for Cervical Dystonia|Randomized Trial of a Specialized Physiotherapy Program Versus Standard Physiotherapy Advice in Patients With Cervical Dystonia (Spasmodic Torticollis).|Completed||N/A|110|Actual|South Glasgow University Hospitals NHS Trust||2|||f||||f||||||||||2017-02-18 14:13:40.767348|2017-02-18 14:13:40.767348
NCT00703274|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2013-02-20|||April 2008||2008-04-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|PROTECT DC||Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia|Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia|Completed||Phase 2|230|Actual|Georgetown University||2|||f||||f||||||||||2017-02-18 14:13:40.854371|2017-02-18 14:13:40.854371
NCT00703261|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2015-10-08|2011-10-25||August 2008||2008-08-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)|A Randomized, Double-Blind, Parallel Group Study to Evaluate the Effects of High Dose Statin Therapy on 18Fluorine Fluorodeoxyglucose (18FDG) Uptake in Arteries of Patients With Atherosclerotic Vascular Disease|Completed||Phase 1|83|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:13:40.976178|2017-02-18 14:13:40.976178
NCT00703248|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-07-07|||October 2007||2007-10-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|HOME||The Human Immunodeficiency Virus and Osteopathic Manipulation Evaluation Study||Completed||N/A|||Nova Southeastern University||2|||f||||||||||||||2017-02-18 14:13:41.327416|2017-02-18 14:13:41.327416
NCT00703235|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2008-06-20||||||June 2008|2008-06-01||||||||Interventional|||Intravitreal Bevacizumab for Diabetic Macular Edema||Unknown status|Enrolling by invitation|Phase 2/Phase 3|||Isfahan Ophthalmology Research Center|||||f||||||||||||||2017-02-18 14:13:41.425194|2017-02-18 14:13:41.425194
NCT00703222|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-10-13||2013-07-25|June 2008||2008-06-01|October 2016|2016-10-01|May 2024|Anticipated|2024-05-01|May 2011|Actual|2011-05-01||Interventional|CHESAT||A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells|A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells After High-Dose Chemotherapy And Autologous Stem Cell Rescue In Patients With High Risk Neuroblastoma|Active, not recruiting||Phase 1/Phase 2|7|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:13:41.497206|2017-02-18 14:13:41.497206
NCT00703209|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2015-05-27|||January 2008||2008-01-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|DNND||Study on the Role of Decompression of Lower Extremity Nerves for the Treatment of Patients With Symptomatic Diabetic Neuropathy With Chronic Nerve Compression|Controlled, Randomized, Double-Blinded, Prospective Study On the Role of Decompression of Lower Extremity Nerves for the Treatment of Patients With Symptomatic Diabetic Neuropathy With Chronic Nerve Compression|Completed||N/A|138|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 14:13:41.606234|2017-02-18 14:13:41.606234
NCT00703196|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-10-06|||March 2007||2007-03-01|January 2014|2014-01-01||||May 2014|Actual|2014-05-01||Interventional|||Folic Acid Clinical Trial for the Prevention of Cervical Cancer|HPV Clearance by Folic Acid Supplementation (FACT for HPV)|Completed||Phase 2|368|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 14:13:41.717599|2017-02-18 14:13:41.717599
NCT00703183|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-06-25|||May 2008||2008-05-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Tolerability of ACU-4429|A Single Center, Randomized, Double-Masked, Dose-Escalating, Placebo-Controlled Study of the Safety and Tolerability ACU-4429 in Healthy Volunteers|Completed||Phase 1|46|Actual|Acucela Inc.||2|||f||||t||||||||||2017-02-18 14:13:41.826946|2017-02-18 14:13:41.826946
NCT00703170|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2013-05-22|||March 2008||2008-03-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies|Phase I Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Resistant Solid Malignancies|Completed||Phase 1|28|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 14:13:41.913979|2017-02-18 14:13:41.913979
NCT00703157|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2016-10-26|||November 2007||2007-11-01|October 2016|2016-10-01|November 2016|Anticipated|2016-11-01|August 2015|Actual|2015-08-01||Interventional|SCALAF||Surgical or Catheter Ablation of Lone Atrial Fibrillation (AF) Patients|Surgical or Catheter Ablations in Patients With Lone Atrial Fibrillation: Determination of Acute and Long Term Success Rate (SCALAF Success Trial)|Active, not recruiting||N/A|80|Actual|Medtronic Cardiovascular||2|||f||||f||||||||No|There is no plan or intention to share individual participant data (IPD)|2017-02-18 14:13:42.024633|2017-02-18 14:13:42.024633
NCT00703144|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2013-01-23|||June 2008||2008-06-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PTCRRT||Pharmacokinetics of Piperacillin/Tazobactam in Patients Treated by Continuous Renal Replacement Therapy|Pharmacokinetics of Piperacillin and Tazobactam in Anuric Septic Patients Treated by Continuous Veno Venous Hemodiafiltration|Completed||Phase 4|10|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-02-18 14:13:42.123849|2017-02-18 14:13:42.123849
NCT00703131|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2015-02-10|||April 2009||2009-04-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|SurgiSIS AFP||Surgisis Anal Fistula Plug Study: An Experience in Saudi Arabia|A Single-center Single Arm Prospective Study Evaluating the Surgisis Biodesign Anal Fistula Plug|Completed||N/A|35|Actual|Cook|||1||f||||||||||||||2017-02-18 14:13:42.228733|2017-02-18 14:13:42.228733
NCT00703118|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-12-05|2011-07-18||October 2008||2008-10-01|December 2013|2013-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment|A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of 2 Regimens of Telaprevir (With and Without Delayed Start) Combined With Pegylated Interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Subjects With Chronic, Genotype 1, Hepatitis C Infection Who Failed Prior Standard Treatment|Completed||Phase 3|663|Actual|Tibotec BVBA||3|||f||||t||||||||||2017-02-18 14:13:44.695831|2017-02-18 14:13:44.695831
NCT00703105|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2014-06-05|||October 2008||2008-10-01|June 2014|2014-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Ovarian Dendritic Cell Vaccine Trial|Defining the Role of CD4+CD25+ Immunoregulatory T-cells in the Treatment of Patients With Advanced Ovarian Cancer Who Receive Dendritic Cell Based Vaccine Therapies|Unknown status|Recruiting|Phase 2|36|Anticipated|Loyola University||3|||f||||f||||||||||2017-02-18 14:13:46.394074|2017-02-18 14:13:46.394074
NCT00703092|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2014-06-27|2014-05-27||February 2008||2008-02-01|June 2014|2014-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Pilot Study:Role of Dietary Fiber in PCOS Anovulation|Pilot Study: Role of Dietary Fiber in PCOS Anovulation|Terminated||Phase 4|2|Actual|Virginia Commonwealth University||1||P.I. left University. Study terminated|f||||t||||||||||2017-02-18 14:13:46.505697|2017-02-18 14:13:46.505697
NCT00703079|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2008-06-20|||January 1997||1997-01-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|GLUSSA||Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly|Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly: Results of a 5 Years Observational, Open, Prospective Study|Completed||N/A|100|Actual|Federico II University|||4||f||||f||||||Samples Without DNA|"~     Sera from most patients on a yearly bases are stored in our freezed at minus 80° for~     eventual further studies. No experimental parameters are included in the current study.~   "|||2017-02-18 14:13:46.706882|2017-02-18 14:13:46.706882
NCT00703066|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2008-11-23|||June 2008||2008-06-01|November 2008|2008-11-01|August 2009|Anticipated|2009-08-01|July 2009|Anticipated|2009-07-01||Interventional|||Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years|A Phase I, Randomized, Controlled, Double-Blind, Single Centre Trial to Evaluate the Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|African Malaria Network Trust||3|||f||||t||||||||||2017-02-18 14:13:46.823194|2017-02-18 14:13:46.823194
NCT00703053|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-08-15|2010-06-17||September 2008||2008-09-01|September 2009|2009-09-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||H5N1 Priming and Boosting Strategies|A Phase II Randomized Study of the Safety and Immunogenicity of Vaccination Strategies Using One or Two Clades and Different Schedules of H5N1 Unadjuvanted, Inactivated Subvirion Influenza Vaccines in H5 Naïve Healthy Adults|Completed||Phase 2|505|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||9|||f||||||||||||||2017-02-18 14:13:46.946067|2017-02-18 14:13:46.946067
NCT00703040|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-20|2016-02-29|||March 2008||2008-03-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Linkage to Care - Part I|HIV-Related Care Engagement: Linkage to Care and Care-Seeking for HIV-Infected Adolescents, Phase I|Completed||N/A|35|Actual|Westat|||3||f||||t||||||||||2017-02-18 14:13:49.703193|2017-02-18 14:13:49.703193
NCT00703027|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2012-03-26|||October 2002||2002-10-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|||||Observational|||Diabetes Mellitus Care Decision Making Model Through Data Mining|Diabetes Mellitus Care Decision Making Model Through Data Mining|Completed||N/A|2000|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-02-18 14:13:49.790952|2017-02-18 14:13:49.790952
NCT00703014|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-10-12|2014-11-18||July 2006||2006-07-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|April 2008|Actual|2008-04-01||Observational||Eligible mothers from the Base Trial P05787 (NCT00696800) who enrolled in Follow Up Trial P05712|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38819 for Org 36286 (Corifollitropin Alfa)|Completed||N/A|541|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:13:49.876177|2017-02-18 14:13:49.876177
NCT00703001|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2010-09-03|||April 2008||2008-04-01|September 2010|2010-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Waukesha Smiles: Dental Outreach to Low-income Waukesha Children|Waukesha Smiles: Dental Outreach to Low-income Waukesha Children|Completed||N/A|400|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-02-18 14:13:51.693015|2017-02-18 14:13:51.693015
NCT00702988|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-08-28|||October 2003||2003-10-01|August 2015|2015-08-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Pregnancy & Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 (Study 38827)(P06056)(COMPLETED)|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Clinical Trial 38826 for the Development of Org 36286 (Corifollitropin Alfa).|Completed||N/A|44|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:13:51.803296|2017-02-18 14:13:51.803296
NCT00702975|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-07-12|||September 2008||2008-09-01|April 2012|2012-04-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Interventional|||Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy|A Phase II Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy|Completed||Phase 2|35|Actual|Radboud University||1|||f||||f||||||||||2017-02-18 14:13:51.893731|2017-02-18 14:13:51.893731
NCT00702962|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2017-01-26|||September 2008|Actual|2008-09-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer|Phase I/II Study of Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|5|Actual|Milton S. Hershey Medical Center||2|||f||||t||||||||Undecided|To determine if data is valuable|2017-02-18 14:13:51.992552|2017-02-18 14:13:51.992552
NCT00702949|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2016-07-01|2015-01-21||June 2008||2008-06-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|February 2010|Actual|2010-02-01||Interventional|||Pregabalin in Treating Women With Hot Flashes|A Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes|Completed||Phase 3|207|Actual|Alliance for Clinical Trials in Oncology||3|||f||||||||||||||2017-02-18 14:13:52.120027|2017-02-18 14:13:52.120027
NCT00702936|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-06-19|||November 2007||2007-11-01|June 2008|2008-06-01|November 2008|Anticipated|2008-11-01|August 2008|Anticipated|2008-08-01||Interventional|TERACS||Telmisartan Versus Ramipril After Acute Coronary Syndrome|Telmisartan vs Ramipril for Reduction of Inflammation and Recruitment of Endothelial Progenitor Cells After Acute Coronary Syndrome|Unknown status|Recruiting|Phase 4|50|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-02-18 14:13:53.155736|2017-02-18 14:13:53.155736
NCT00702923|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-04-07|2014-02-24||July 2008||2008-07-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|September 2011|Actual|2011-09-01||Interventional|||CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer|Phase I Dose Escalation Trial of CP-675,206 (Tremelimumab, Anti-CTLA-4 Monoclonal Antibody) in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer|Terminated||Phase 1|12|Actual|University of Wisconsin, Madison||1||Enrollment was halted prematurely due to slow accrual.|f||||t||||||||||2017-02-18 14:13:53.270856|2017-02-18 14:13:53.270856
NCT00702910|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-11-15|||April 2008||2008-04-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients|A Randomised, Single-dose, Dose-ascending, Double-blind, Placebo-controlled, 5-way Crossover Study to Investigate the Efficacy, Pharmacokinetics and Pharmacodynamics of Inhaled Doses of GW642444M in Asthmatic Patients|Completed||Phase 1|24|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:13:53.616222|2017-02-18 14:13:53.616222
NCT00702897|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2008-06-19|||January 2008||2008-01-01|June 2008|2008-06-01||||||||Observational|||Ambulatory Surgery of Lower Extremity Varicose Vein||Unknown status|Recruiting|N/A|300|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||||||2017-02-18 14:13:53.731741|2017-02-18 14:13:53.731741
NCT00702884|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2015-04-20|||June 2008||2008-06-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer|A Mechanistic Radiographic and Biologic Phase 2 Single Agent Study of Sunitinib Malate in Relapsed/Refractory Esophageal and Gastroesophageal Cancers|Completed||Phase 2|26|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:13:53.799847|2017-02-18 14:13:53.799847
NCT00702871|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-06-19|||March 2005||2005-03-01|June 2008|2008-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia|A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia: a Randomized Prospective Study|Completed||Phase 4|50|Actual|Maulana Azad Medical College||2|||f||||f||||||||||2017-02-18 14:13:53.913797|2017-02-18 14:13:53.913797
NCT00702858|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-08-27|||April 2008||2008-04-01|August 2013|2013-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer|Pilot, Single Center Randomized Controlled, Double-Blind, Cross Over, Intent to Treat Trial of Blue Citrus to Placebo in Those Breast Cancer Patients Receiving Aromatase Inhibitor Therapy|Completed||N/A|30|Actual|Legacy Health System||2|||f||||t||||||||||2017-02-18 14:13:54.021384|2017-02-18 14:13:54.021384
NCT00702845|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-04-10|2015-04-10||January 2007||2007-01-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|Ensure|Intent-to-Treat group, which consisted of all randomized participants who received corifollitropin alfa or recFSH.|To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)|A Phase III, Randomized, Double-blind, Active-controlled, Equivalence Clinical Trial to Investigate the Efficacy and Safety of a Single Injection of 100 µg Org 36286 (Corifollitropin Alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation (COS) Using Daily Recombinant FSH (recFSH) as a Reference|Completed||Phase 3|397|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:13:54.130693|2017-02-18 14:13:54.130693
NCT00702832|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2017-02-10|||January 2008|Actual|2008-01-01|February 2017|2017-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Vestibular Rehabilitation - a Randomized Controlled Trial|Effects of Vestibular Rehabilitation in the Treatment of Patients With Acute Vestibular Loss. - A Randomized Controlled Trial|Completed||N/A|54|Actual|Norwegian University of Science and Technology||2|||f||||t|f|f||||||Undecided||2017-02-18 14:13:55.088409|2017-02-18 14:13:55.088409
NCT00702819|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2010-01-26|||June 2008||2008-06-01|June 2008|2008-06-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|BLOCK-ROP||Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity|Phase 1 Trial of Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity|Terminated||Phase 1|2|Actual|Vision Research Foundation||1||Low enrollment due to the stringent enrollment criteria. Unable to answer study questions|f||||t||||||||||2017-02-18 14:13:55.190314|2017-02-18 14:13:55.190314
NCT00702806|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-06-26|||July 2001||2001-07-01|June 2015|2015-06-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)|A Phase II, Open Label, Prospective, Randomized, Comparative Clinical Trial to Investigate the Appropriate Dose of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI.|Completed||Phase 2|99|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-02-18 14:13:55.298709|2017-02-18 14:13:55.298709
NCT00702793|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2012-05-07|||April 2008||2008-04-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)|Safety and Tolerability of Varenicline When Used for Smoking Cessation/Reduction in Individuals With Severe and Persistent Mental Illness: An Open Label Pilot Trial|Withdrawn||Phase 4|0|Actual|University of British Columbia||1||No participants enrolled|f||||f||||||||||2017-02-18 14:13:55.575305|2017-02-18 14:13:55.575305
NCT00702780|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-15|2014-05-13|2014-04-10||November 2008||2008-11-01|May 2014|2014-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ESAD||Progression Delaying Effect of Escitalopram in Alzheimer's Disease|Multi-center, Randomized, Placebo-controlled, Double-blind Clinical Trial of Escitalopram on the Progression Delaying Effect in Alzheimer's Disease|Completed||N/A|74|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:13:55.692396|2017-02-18 14:13:55.692396
NCT00702767|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-06-23|||July 2005||2005-07-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|October 2006|Actual|2006-10-01||Interventional|||Tolerance of Increased Infusion Rates of Intravenous Fat Emulsions in Very Low Birth Weight Infants|Tolerance of Increased Infusion Rates of Intravenous Fat Emulsions in Very Low Birth Weight Infants During the First Week of Life|Completed||N/A|110|Actual|OSF Healthcare System|||||f||||f||||||||||2017-02-18 14:13:56.046829|2017-02-18 14:13:56.046829
NCT00702754|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2009-09-22|2009-05-12||June 2001||2001-06-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia|An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia|Completed||Phase 4|502|Actual|Solstice Neurosciences||1|||f||||f||||||||||2017-02-18 14:13:56.135739|2017-02-18 14:13:56.135739
NCT00702741|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2014-12-02|||June 2008||2008-06-01|December 2014|2014-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy|A Long-Term Follow-up Study of Chondrogen - Adult Human Stem Cells Delivered by Intra-articular Injection Following Meniscectomy in Subjects 18-60 Years|Completed||Phase 1/Phase 2|55|Actual|Mesoblast, Ltd.||3|||f||||f||||||||||2017-02-18 14:13:56.710153|2017-02-18 14:13:56.710153
NCT00702728|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2009-10-09|||June 2008||2008-06-01|June 2008|2008-06-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|MYTHOS||Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) Prevention|A Study to Evaluate the Effectiveness of Induced Diuresis With Matched Hydration Therapy Compared to Standard Overnight Hydration in the Prevention of Contrast Induced Nephropathy -MYTHOS Study|Unknown status|Recruiting|Phase 3|120|Anticipated|Centro Cardiologico Monzino||2|||f||||f||||||||||2017-02-18 14:13:56.822743|2017-02-18 14:13:56.822743
NCT00702715|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2015-05-11|2011-03-15||September 2008||2008-09-01|May 2015|2015-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)|A Multi-center, Parallel-group, Comparative Trial Evaluating the Efficacy, Pharmacokinetics and Safety of 4.0 mg/kg Sugammadex Administered at 1-2 PTC in Subjects With Normal or Severely Impaired Renal Function|Completed||Phase 3|69|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:13:56.943077|2017-02-18 14:13:56.943077
NCT00702702|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-08-05|2014-06-23||June 2008||2008-06-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Study prematurely terminated for safety reasons|Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids|A Multi-Center, Placebo Controlled, Safety and Efficacy Study of the Selective Progesterone Receptor Modulator Proellex® (CDB-4124) in Anemic, Pre-Menopausal Women With Symptomatic Uterine Fibroids Requiring Hysterectomy|Terminated||Phase 3|56|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with any study data.|3||Repros stopped study for safety and FDA put study on hold because of safety.|f||||t||||||||||2017-02-18 14:13:57.363173|2017-02-18 14:13:57.363173
NCT00702689|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2015-09-29|2012-09-05||May 2008||2008-05-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|August 2011|Actual|2011-08-01||Interventional|||Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease|A Pilot Study of Imatinib Mesylate in Children and Adults With Sclerotic Skin Changes of Chronic Graft-Versus-Host Disease|Completed||Phase 2|20|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 14:13:57.633935|2017-02-18 14:13:57.633935
NCT00702676|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2009-07-15|||July 2008||2008-07-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison|A Double-blind, Double-dummy, Randomized, Crossover Study to Compare the Tolerability of Quetiapine Fumarate Immediate Release (SEROQUEL®) With Quetiapine Fumarate Extended Release (SEROQUEL XR®) During Initial Dose Escalation in Healthy Volunteers|Completed||Phase 1|63|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:13:58.139827|2017-02-18 14:13:58.139827
NCT00702663|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2008-06-19|||October 2007||2007-10-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|||||Observational|||Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults|Seroprevalence of Hepatitis B Infection, Effect of Booster Response, and Significance of Anti-HBc Positivity Amongst Taiwanese Young Adults|Unknown status|Recruiting|N/A|1800|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||Samples With DNA|"~     Hepatitis B DNA~   "|||2017-02-18 14:13:58.268702|2017-02-18 14:13:58.268702
NCT00702650|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2011-07-21|2010-12-15||June 2008||2008-06-01|July 2011|2011-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations|A Phase III Open-label Titration Trial to Evaluate the Effectiveness and Safety of Different Doses of a Dermal Application of Testosterone MD-Lotion® (Cutaneous Solution) in Hypogonadal Men|Completed||Phase 3|155|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:13:58.370822|2017-02-18 14:13:58.370822
NCT00702637|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-06-10|||October 2002||2002-10-01|June 2010|2010-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study of Modafinil to Treat Fatigue in Persons With Traumatic Brain Injury|Modafinil for the Treatment of Fatigue and Excessive Daytime Sleepiness in Individuals With Traumatic Brain Injury|Completed||Phase 1|60||Craig Hospital|||||f||||||||||||||2017-02-18 14:13:59.125605|2017-02-18 14:13:59.125605
NCT00702624|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-12-11|2015-04-13||April 2007||2007-04-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Observational|Care|Individuals who participated in base study P05690 (NCT00702845) and received at least one dose of either corifollitropin alfa or recFSH, who had an ongoing pregnancy confirmed by ultrasound at least 10 weeks after ET in base study P05690 and were able and willing to give written informed consent.|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 107012 for the Development of Org 36286 (Corifollitropin Alfa)|Completed||N/A|113|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:13:59.229249|2017-02-18 14:13:59.229249
NCT00702611|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2015-09-04|||June 2008||2008-06-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|ATICCA||Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis|An Open Randomized Multicenter Clinical Investigation to Compare the Efficacy and Safety of Prednisone Plus Adacolumn® GMA Apheresis vs Prednisone Alone in the Treatment of Patients With Mild or Moderately Active Steroid Dependent Ulcerative Colitis|Terminated||Phase 4|133|Actual|Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa||2||Lack of enrollment|f||||t||||||||||2017-02-18 14:14:00.1641|2017-02-18 14:14:00.1641
NCT00702598|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2012-05-07|||June 2008||2008-06-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|||The WORKER Study: Escitalopram and Telephone-based Cognitive Behaviour Therapy (CBT) for Depressed Working People|The WORKER Study: A Randomized Controlled Trial of Escitalopram and Telephone-based Cognitive Behaviour Therapy in Working Patients With Major Depressive Disorder|Completed||N/A|105|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 14:14:00.342615|2017-02-18 14:14:00.342615
NCT00702585|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-06-26|||August 2001||2001-08-01|June 2015|2015-06-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)|A Phase II, Randomized, Double-blind, Placebo-controlled, Comparative Trial to Investigate the Optimal Dose of a Single Administration of Org 36286 (Corifollitropin Alfa) to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility|Completed||Phase 2|55|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 14:14:00.461915|2017-02-18 14:14:00.461915
NCT00702572|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2016-09-21|||April 2008||2008-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|May 2016|Actual|2016-05-01||Interventional|||Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer|Phase I Study of Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|25|Actual|Milton S. Hershey Medical Center||2||Low Enrollment|f||||t||||||||||2017-02-18 14:14:00.570862|2017-02-18 14:14:00.570862
NCT00702559|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2008-06-19|||January 2008||2008-01-01|June 2008|2008-06-01||||||||Observational|||Design the Home Care Platform for the Monitoring of A Hemodialysis Arteriovenous Graft by Intelligent Physiological Signal||Unknown status|Recruiting|N/A|50|Anticipated|Far Eastern Memorial Hospital|||1||f||||||||||||||2017-02-18 14:14:00.706152|2017-02-18 14:14:00.706152
NCT00702546|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-05-04|2015-02-09||December 2006||2006-12-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational||Eligible participants from base study P05690 (NCT00702845) who enrolled in follow up study P05711|Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)|Follow-up Protocol to Collect the Outcome of Frozen-thawed Embryo Transfer Cycles After Cryopreservation of Embryos in Clinical Trial 107012|Completed||N/A|102|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:14:00.788061|2017-02-18 14:14:00.788061
NCT00702533|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2017-01-24|||June 16, 2008||2008-06-16|September 19, 2016|2016-09-19||||||||Observational|||A New Method for Determining Gastric Acid Output Using a Wireless Capsule|A New Method for Determining Gastric Acid Output Using a Wireless Capsule|Recruiting||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:14:01.363136|2017-02-18 14:14:01.363136
NCT00702520|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-12-03|2014-05-20||April 2006||2006-04-01|December 2014|2014-12-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Observational|Care|The overall number of baseline participants reflects the number of participants that started the P05783 follow-up study and not the number of participants in the P05788 base study.|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38833 for Org 36286 (Corifollitropin Alfa)|Completed||N/A|15|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:14:01.495596|2017-02-18 14:14:01.495596
NCT00702507|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2012-03-22|2011-09-01||May 2007||2007-05-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants|Prospective 2-Year Longitudinal Study to Assess for Miconazole Resistance in Candida Spp. With Repeated Treatment Courses of 0.25% Miconazole Nitrate Ointment in Neonates and Infants up to 1 Year of Age With Recurrent Moderate-Severe Diaper Dermatitis Complicated by Cutaneous Candidiasis|Completed||Phase 4|200|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:14:02.233327|2017-02-18 14:14:02.233327
NCT00702494|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2009-12-03|||June 2008||2008-06-01|December 2009|2009-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours|An Open, Phase I, Dose Escalation Study of the Monoclonal Antibody TB-403 Directed Against PlGF, Given as Multiple IV-doses to Patients With Solid Tumors.|Completed||Phase 1|21|Anticipated|BioInvent International AB||1|||f||||t||||||||||2017-02-18 14:14:02.669596|2017-02-18 14:14:02.669596
NCT00702481|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2016-03-21|||April 2008||2008-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer|Phase II Study of Nimotuzumab (TheraCim-hR3) Concurrent With Cisplatin/Radiotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)|Active, not recruiting||Phase 2|37|Actual|National Cancer Centre, Singapore||1|||f||||f||||||||||2017-02-18 14:14:02.765213|2017-02-18 14:14:02.765213
NCT00702468|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-06-13|2011-03-14||November 2007||2007-11-01|June 2013|2013-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis|A Placebo Controlled, Parallel Group, Randomised Withdrawal Study of Subjects With Symptoms of Spasticity Due to Multiple Sclerosis Who Are Receiving Long-term Sativex®.|Completed||Phase 3|36|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:14:02.872643|2017-02-18 14:14:02.872643
NCT00702455|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2012-11-19|||September 2006||2006-09-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|February 2010|Actual|2010-02-01||Interventional|KIO||Keep It Off: A Weight Loss Maintenance Study|Novel Approaches to Weight Loss Maintenance|Completed||N/A|419|Actual|HealthPartners Institute||2|||f||||t||||||||||2017-02-18 14:14:05.934446|2017-02-18 14:14:05.934446
NCT00702442|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2011-07-25|||June 2008||2008-06-01|September 2009|2009-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Role of Droperidol in Postoperative Vomiting|Role of Droperidol in Postoperative Vomiting: Phase IV Study|Completed||Phase 4|100|Actual|Aristotle University Of Thessaloniki||2|||f||||t||||||||||2017-02-18 14:14:06.049523|2017-02-18 14:14:06.049523
NCT00702429|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-08-27|||August 2008||2008-08-01|August 2014|2014-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Immunoregulation of Periodontal Disease|Immunoregulation of Periodontal Disease|Completed||N/A|23|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 14:14:06.159141|2017-02-18 14:14:06.159141
NCT00702416|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2009-11-13|||May 2008||2008-05-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Ultrasound Guidance for Interscalene Brachial Plexus Block|Ultrasound Guidance or Electrical Nerve Stimulation for Interscalene Brachial Plexus Block: a Randomized, Controlled Trial|Completed||Phase 4|50|Anticipated|University of Parma||2|||f||||f||||||||||2017-02-18 14:14:06.255205|2017-02-18 14:14:06.255205
NCT00695604|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2013-05-09|||May 2008||2008-05-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ReHICS||Repeated High-dose Inhaled Corticosteroids for Asthma|Repeated High-dose Inhaled Corticosteroids for Asthma|Completed||Phase 2|20|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:16:53.542335|2017-02-18 14:16:53.542335
NCT00702403|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2014-12-09|||April 2008||2008-04-01|December 2014|2014-12-01||||December 2013|Actual|2013-12-01||Interventional|||Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia|A Multicenter Phase I/II Study of the Prophylactic Inhibition of BCR-ABL Tyrosine Kinase by Tasigna ® (Nilotinib) After Hematopoietic Cell Transplantation for Philadelphia Chromosome-Positive Leukemias.|Completed||Phase 1/Phase 2|40|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 14:14:06.379011|2017-02-18 14:14:06.379011
NCT00702377|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-01-31|2009-09-23||June 2008||2008-06-01|January 2012|2012-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of SYSTANE Ultra Lubricant Eye Drops||Completed||N/A|109|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:14:06.707137|2017-02-18 14:14:06.707137
NCT00702364|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-08-28|2013-09-03||January 2008||2008-01-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||Baseline analysis was completed on the 55 randomized participants.|Efficacy Study of Strattera for Treating Attention Disorders in Traumatic Brain Injury (TBI)|Strattera(Atomoxetine) for the Treatment of Attention Disorders in Individuals With Traumatic Brain Injury|Completed||N/A|60|Actual|Craig Hospital||2|||f||||t||||||||||2017-02-18 14:14:07.075194|2017-02-18 14:14:07.075194
NCT00702351|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-05-21|||December 2005||2005-12-01|May 2014|2014-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|Realize||A Trial of Single Dose Corifollitropin Alfa's Ability to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI (38833)(P05788)|A Phase II, Uncontrolled Pilot Trial to Evaluate That a Single Dose of 100 μg or 150 μg Org 36286 (Corifollitropin Alfa) is Able to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI Using a Long Protocol of GnRH Agonist (Study 38833)|Completed||Phase 2|50|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:14:07.47339|2017-02-18 14:14:07.47339
NCT00702338|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-03-26|2014-03-31||May 2008||2008-05-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Observational|Care|The Baseline Analysis Population consisted of one mother with confirmed pregnancy who was treated with corifollitropin alfa + hCG in base study P05693 (NCT00697255) and enrolled in the current follow-up study. Baseline characteristics were not summarized for the infants born on study.|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Ovulation Induction in Clinical Trial 107010 for the Development of Org 36286 (Corifollitropin Alfa)|Completed||N/A|1|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:14:07.572763|2017-02-18 14:14:07.572763
NCT00702325|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-10-10|2010-09-20||June 2008||2008-06-01|October 2012|2012-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|Titan||Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans|A 12-wk, Rand., Double-blind, Double Dummy, Multi-ctr., Phase IV Study Comparing Efficacy and Safety of SYMBICORT® pMDI 160/4.5 ug x 2 Actuations Twice Daily Versus Pulmicort® (Budesonide Inhalation Powder DPI) 180 ug x 2 Inhalations Twice Daily, in Adult and Adolescent African American Subjects With Asthma|Completed||Phase 4|311|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:14:07.917228|2017-02-18 14:14:07.917228
NCT00702312|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2009-07-28|||June 2008||2008-06-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||A Bengali Dietary Salt Study to Control Blood Pressure|A Multi-method Study of a Low-salt Dietary Approach to Control Blood Pressure in the Bangladeshi Chronic Kidney Disease Population.|Completed||Phase 3|56|Actual|Barts & The London NHS Trust||2|||f||||f||||||||||2017-02-18 14:14:08.91434|2017-02-18 14:14:08.91434
NCT00702299|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2015-12-02|2012-10-01||September 2007||2007-09-01|December 2015|2015-12-01|October 2012|Actual|2012-10-01|January 2012|Actual|2012-01-01||Interventional|||Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer|Phase I Open Label Trial of Alimta® Plus Cisplatin and Paclitaxel Given Intraperitoneally (IP) as First Line Treatment for Women With Stage III Ovarian Cancer|Completed||Phase 1|15|Actual|University of Arizona|A limitation of this study is that max treatment dose was not definitively determined, in that the trial did not proceed at accrue patients at a dose level less than 1,000 mg/m2.|1|||f||||t||||||||||2017-02-18 14:14:09.021647|2017-02-18 14:14:09.021647
NCT00702286|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2008-06-19|||August 2008||2008-08-01|May 2008|2008-05-01||||||||Observational|NV-US-04-001||Evaluation of Surface Acoustics Ultrasound Device for the Treatment of Patients With Percutaneous Nephrostomy Catheters|Phase II Prospective Comparison Randomized Placebo Controlled Double Blind Study to Evaluate the Efficacy of the UroShieldTM Surface Acoustics Ultrasound Device for the Treatment of Patients With Percutaneous Nephrostomy|Unknown status|Not yet recruiting|N/A|24|Anticipated|Assaf-Harofeh Medical Center|||2||f||||f||||||None Retained|"~     urine culture~   "|||2017-02-18 14:14:09.354628|2017-02-18 14:14:09.354628
NCT00702273|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-10-12|2014-05-14||April 2006||2006-04-01|September 2016|2016-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational||Eligible participants from base study P05787 (NCT00696800) who enrolled in follow up study P05716|Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)|Follow-up Protocol to Collect the Outcome of Frozen-thawed Embryo Transfer Cycles After Cryopreservation of Embryos in Clinical Trial 38819|Completed||N/A|344|Actual|Merck Sharp & Dohme Corp.|||2||f||||f||||||||||2017-02-18 14:14:09.458605|2017-02-18 14:14:09.458605
NCT00702260|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-06-19|||January 2005||2005-01-01|June 2008|2008-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions|Completed||N/A|39|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:14:09.862223|2017-02-18 14:14:09.862223
NCT00702247|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-06-19|||July 1999||1999-07-01|June 2008|2008-06-01||||||||Interventional|||Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)|Allogeneic Stem Cell Transplantation for Multiple Myeloma: a Two Step Approach to Reduce Toxicity Involving High-Dose Melphalan and Autologous Stem Cell Transplant Followed by PBSC Allografting After Low-Dose TBI|Unknown status|Recruiting|Phase 2|||Azienda Ospedaliera San Giovanni Battista||1|||f||||||||||||||2017-02-18 14:14:09.940462|2017-02-18 14:14:09.940462
NCT00700804|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2011-05-31|2008-12-30||June 2003||2003-06-01|May 2011|2011-05-01|January 2005|Actual|2005-01-01|July 2004|Actual|2004-07-01||Interventional|||Meat Protein and Calcium: Do They Interact Synergistically or Antagonistically?|Meat Protein and Calcium: Do They Interact Synergistically or Antagonistically?|Completed||N/A|34|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-02-18 14:14:43.55011|2017-02-18 14:14:43.55011
NCT00702234|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-04-09|2015-04-09||February 2007||2007-02-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Observational|Care|Individuals who participated in base study P05714 (NCT00696878) and received at least one dose of corifollitropin alfa, who had an ongoing pregnancy confirmed by ultrasound at least 10 weeks after fresh ET in base study P05714 and were able and willing to give written informed consent to be enrolled in the follow-up study.|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38825 for Org 36286 (Corifollitropin Alfa)|Completed||N/A|268|Actual|Merck Sharp & Dohme Corp.|||1||f||||f||||||||||2017-02-18 14:14:10.038509|2017-02-18 14:14:10.038509
NCT00702221|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2016-06-20|2014-09-10||June 2008||2008-06-01|April 2016|2016-04-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional||All analyzed subjects|Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension|A Randomised, Double Blind, Placebo Controlled Study of the Efficacy and Safety of Angiotensin Therapeutic Vaccine (ATV) in Subjects With Mild to Moderate Hypertension|Terminated||Phase 2|20|Actual|BTG International Inc.|Study prematurely terminated|2||Dose limiting adverse effects|f||||t||||||||Yes|Investigators provide information to participants|2017-02-18 14:14:10.644266|2017-02-18 14:14:10.644266
NCT00702208|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-12-12|2013-07-29||September 2008||2008-09-01|July 2013|2013-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Feasibility of Delphi Screener for Cervical Cytology|The Feasibility and Acceptability of Using the Delphi Screener for Cervical Cytology Testing Among Low Income Women in New York City|Completed||Phase 2|198|Actual|Columbia University||1|||f||||f||||||||||2017-02-18 14:14:11.092929|2017-02-18 14:14:11.092929
NCT00702195|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-08-28|||January 2002||2002-01-01|August 2015|2015-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Observational|||Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)|Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials for the Development of Org 36286 (Corifollitropin Alfa).|Completed||N/A|29|Actual|Merck Sharp & Dohme Corp.|||4||f||||f||||||||||2017-02-18 14:14:11.535438|2017-02-18 14:14:11.535438
NCT00702182|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-10-17|||April 2008||2008-04-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Interventional|||Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer|Phase 1 Study of Oral Vinorelbine in Combination With Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules|Completed||Phase 1|30|Actual|National Cancer Centre, Singapore||2|||f||||f||||||||||2017-02-18 14:14:11.630675|2017-02-18 14:14:11.630675
NCT00702169|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2009-03-29|||December 2007||2007-12-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Continuous Monitoring of the Lungs Ventilation Dynamics During Mechanical Ventilation|Continuous Monitoring of the Lungs Ventilation Dynamics During Mechanical Ventilation by Small Surface Patches That Include Safe Motion Sensors|Completed||N/A|15|Actual|Carmel Medical Center|||1||f||||t||||||||||2017-02-18 14:14:11.758055|2017-02-18 14:14:11.758055
NCT00702156|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-09-02|||March 2005||2005-03-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|||Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease|Cardioselective Beta-Blockade Using Bisoprolol in Patients With Chronic Heart Failure (CHF) and Coexistent Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) With or Without Significant Reversibility.|Terminated||Phase 2|27|Actual|NHS Greater Glasgow and Clyde||2||Inadequate patient recruitment|f||||t||||||||||2017-02-18 14:14:11.84991|2017-02-18 14:14:11.84991
NCT00702143|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2012-05-08|2012-04-06||June 2008||2008-06-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)|An Open Label, Parallel Group, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-45 in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)|Completed||Phase 2|184|Actual|Avid Radiopharmaceuticals||3|||f||||f||||||||||2017-02-18 14:14:11.957349|2017-02-18 14:14:11.957349
NCT00702130|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2011-11-29|||June 2008||2008-06-01|November 2011|2011-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|EPRAVAP||Pravastatin and Ventilatory Associated Pneumonia|The Effect of Pravastatin on the Incidence and in the Natural Course of Ventilatory Associated Pneumonia in the Intensive Care Unit Patients|Completed||Early Phase 1|152|Actual|University of Thessaly||2|||f||||t||||||||||2017-02-18 14:14:12.4093|2017-02-18 14:14:12.4093
NCT00702117|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2010-12-14|||June 2008||2008-06-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|AJUAR||Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias|Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias|Completed||Phase 4|123|Actual|Hospital Clinic of Barcelona||6|||f||||f||||||||||2017-02-18 14:14:12.517331|2017-02-18 14:14:12.517331
NCT00702104|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-05-13|||January 2003||2003-01-01|May 2013|2013-05-01||||January 2008|Actual|2008-01-01||Observational|||Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area|PSA Screening of African-American Men in The San Francisco Area|Completed||N/A|||University of California, San Francisco|||1||f||||f||||||||||2017-02-18 14:14:12.624823|2017-02-18 14:14:12.624823
NCT00702091|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2008-06-19|||January 2005||2005-01-01|June 2008|2008-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions|Completed||N/A|39|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:14:12.721531|2017-02-18 14:14:12.721531
NCT00702078|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2017-01-09|||April 2008||2008-04-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|COPD-HOME||Home-based Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD)|Randomised Clinical Study on the Effect of Home-based Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.|Completed||N/A|172|Actual|St. Olavs Hospital||2|||f||||t||||||||||2017-02-18 14:14:12.822533|2017-02-18 14:14:12.822533
NCT00700791|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2017-01-20|||July 2008||2008-07-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars|Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars|Active, not recruiting||Early Phase 1|168|Anticipated|Ohio State University||9|||f||||f||||||||||2017-02-18 14:14:43.946144|2017-02-18 14:14:43.946144
NCT00702065|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2014-06-16|||November 2007||2007-11-01|June 2014|2014-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|MusiQoL||A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment|A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment|Completed||N/A|599|Actual|EMD Serono|||2||f||||||||||||||2017-02-18 14:14:12.956966|2017-02-18 14:14:12.956966
NCT00702052|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-19|2013-05-10|||August 2008||2008-08-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|PILLAR-1||Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy.|An Open-label, Single-arm Phase II Study of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® (Bortezomib).|Completed||Phase 2|58|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:14:13.120942|2017-02-18 14:14:13.120942
NCT00702039|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-06-16|||February 2007||2007-02-01|June 2008|2008-06-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Observational|||Effect of Music Therapy on Patients Undergoing Intravitreal Injections|Effect of Music Therapy on Patients Undergoing Intravitreal Injections|Unknown status|Recruiting|N/A|50|Anticipated|Yale University|||2||f||||t||||||||||2017-02-18 14:14:13.25491|2017-02-18 14:14:13.25491
NCT00702026|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2013-01-28|||August 2008||2008-08-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) Patients|The Effect of a Multispecies Probiotic on Hypersensitivity in IBS Patients|Completed||N/A|40|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 14:14:13.344055|2017-02-18 14:14:13.344055
NCT00702013|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-11-10|||March 2007||2007-03-01|October 2010|2010-10-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Observational|Onto-Pgp||Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics|Ontogenesis of the P-glycoprotein in Human Lymphocytes: Influence of the Human Immunodeficiency Virus (HIV) and Antiretroviral Therapeutics|Completed||N/A|310|Actual|Assistance Publique - Hôpitaux de Paris|||8||f||||f||||||Samples With DNA|"~     blood sample for DNA extraction and genetic polymorphism of Mdr1~   "|||2017-02-18 14:14:13.452424|2017-02-18 14:14:13.452424
NCT00702000|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-01-15|||May 2008||2008-05-01|January 2016|2016-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Study of Intensive Care Unit (ICU)-Acquired Weakness (Handgrip Strength Study)|Clinical Determinants of Handgrip Strength in Critically Ill Adults: Pilot Study|Completed||N/A|49|Actual|Ohio State University|||1||f||||t||||||||||2017-02-18 14:14:13.553317|2017-02-18 14:14:13.553317
NCT00701987|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-02-02|||June 2008||2008-06-01|February 2010|2010-02-01||||June 2009|Anticipated|2009-06-01||Interventional|||Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma|Dose-escalating, Pilot Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ALS-357 Topically Administered to Patients With Cutaneous Metastatic Melanoma|Unknown status|Recruiting|Phase 1|12|Anticipated|Advanced Life Sciences, Inc.||4|||f||||t||||||||||2017-02-18 14:14:13.654843|2017-02-18 14:14:13.654843
NCT00701974|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-10-22|||February 2008||2008-02-01|February 2008|2008-02-01||||February 2008|Actual|2008-02-01||Interventional|||Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers|Study of Non Inferiority of Product Kollagenase ®, Manufactured by Laboratory Cristália When Compared With Iruxol ®, Manufactured by Abbott Laboratory, in the Treatment of Cutaneous Ulcers|Suspended||Phase 2/Phase 3|66|Anticipated|Azidus Brasil||2|||f||||f||||||||||2017-02-18 14:14:13.765554|2017-02-18 14:14:13.765554
NCT00701961|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-09-12|||October 2008||2008-10-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy|The Pharmacokinetic of the Fixed-dose Combination of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnant Women|Completed||Phase 2/Phase 3|48|Actual|Institute of Tropical Medicine, Belgium||2|||f||||t||||||||||2017-02-18 14:14:13.860066|2017-02-18 14:14:13.860066
NCT00701948|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-04-27|||July 2008||2008-07-01|April 2010|2010-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|NOSODIAG||New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn|Interest of New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn|Unknown status|Recruiting|N/A|240|Anticipated|University Hospital, Strasbourg, France|||4||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:14:13.989911|2017-02-18 14:14:13.989911
NCT00701935|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-03-23|2013-01-11||August 2008||2008-08-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin|Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin|Terminated||Phase 2|80|Actual|AstraZeneca|The dropout rate in the study was higher than anticipated (of 80 patients randomized, only 53 completed Study Period II), and enrollment was much slower than anticipated, leading to a decision to terminate the study early for enrollment futility.|2||"Enrollment was much slower than anticipated, leading to a decision to terminate the study~   early for enrollment futility."|f||||f||||||||||2017-02-18 14:14:14.087583|2017-02-18 14:14:14.087583
NCT00701922|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-10-27|||October 2005||2005-10-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Surveillance Study of Viral Infections Following Lung Transplantation|Season Surveillance Study of Viral Infections in Lung Transplant Recipients|Completed||N/A|388|Actual|Hannover Medical School|||1||f||||f||||||Samples Without DNA|"~     Nasopharyngeal and oropharyngeal swabs~      bronchoalveolar lavage~      blood samples~   "|||2017-02-18 14:14:14.687431|2017-02-18 14:14:14.687431
NCT00701909|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-01-14|||June 2008||2008-06-01|January 2014|2014-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pain Medicine for Wound Care Procedures|The Effectiveness of Small Doses of Ketamine With Morphine on Decreasing Pain Responses During Open Wound Care|Completed||Phase 3|12|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:14:14.777682|2017-02-18 14:14:14.777682
NCT00695591|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-08-12|||July 2008||2008-07-01|August 2014|2014-08-01|July 2009|Actual|2009-07-01|September 2008|Actual|2008-09-01||Observational|HSTNMD||Home Sleep Testing in Neuromuscular Disease Patients|Home Sleep Testing in Neuromuscular Disease Patients|Completed||N/A|9|Actual|Landon Pediatric Foundation|||4||f||||f||||||||||2017-02-18 14:16:53.640623|2017-02-18 14:16:53.640623
NCT00701883|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-05-19||2015-02-16|August 2007||2007-08-01|May 2015|2015-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|MBX-8025||Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol|"Multicenter Randomized Double-Blind Placebo and Active Comparator Controlled Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of MBX-8025 in Moderately Obese Hyperlipidemic Patients With/Out Concomitant Atorvastatin"|Completed||Phase 2|183|Actual|CymaBay Therapeutics, Inc.||6|||f||||t||||||||||2017-02-18 14:14:15.04629|2017-02-18 14:14:15.04629
NCT00701870|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2013-11-25|||October 2008||2008-10-01|November 2013|2013-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer|Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintra™, TLK199 Tablets) for Treatment of Chemotherapy Induced Neutropenia in Patients With Locally Advanced or Metastatic Non‑Small Cell Lung Cancer Receiving First-Line Chemotherapy|Terminated||Phase 2|1|Actual|Telik||2||Study TLK199.2102 was terminated for lack of enrollment.|f||||f||||||||||2017-02-18 14:14:15.34123|2017-02-18 14:14:15.34123
NCT00701857|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-04-19|||February 2008||2008-02-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|April 2014|Actual|2014-04-01||Interventional|||Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer|Phase I Study of Concomitant Pemetrexed and CDDP Plus Radiation Therapy in Patients With Locally Advanced or Metastatic Esophageal or Gastroesophageal (GEJ) Carcinomas|Completed||Phase 1|10|Actual|University of Arizona||1|||f||||t||||||||||2017-02-18 14:14:15.470683|2017-02-18 14:14:15.470683
NCT00701844|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-05-28|||July 2007||2007-07-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors|Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors|Completed||N/A|315|Actual|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-02-18 14:14:15.588314|2017-02-18 14:14:15.588314
NCT00701831|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-11-03|||May 2008||2008-05-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|LANTIT||Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control|Assessment of Forced Titration to Reach the Effective Dose for Good Glycemic Control in Lantus Treated Type 2 Patients|Completed||Phase 4|241|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:14:15.699398|2017-02-18 14:14:15.699398
NCT00701818|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-06-02|||May 2008||2008-05-01|June 2015|2015-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|CORAIS||Coronary Arteriosclerosis in Patients With Acute Ischemic Stroke|Coronary Arteriosclerosis in Patients With Acute Ischemic Stroke Prevalence and Characteristics as Measured by CT Angiography, Echocardiography and Biomarkers|Completed||N/A|25|Actual|Vejle Hospital|||1||f||||f||||||||||2017-02-18 14:14:15.798811|2017-02-18 14:14:15.798811
NCT00701805|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-03-18|2010-12-28||July 2008||2008-07-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)|Phase II Study of Paricalcitol Injection Extension Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism|Completed||Phase 2|107|Actual|Abbott|The dose titration scheme was revised because of the incidence of hypercalcemia in the early weeks of the study.|4|||f||||f||||||||||2017-02-18 14:14:15.912811|2017-02-18 14:14:15.912811
NCT00701792|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-18|||March 1994||1994-03-01|June 2008|2008-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|TRANSCIAL||Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis|Randomized Trial Comparing Liver Transplantation to Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis|Completed||N/A|120|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||f||||||||||2017-02-18 14:14:17.404024|2017-02-18 14:14:17.404024
NCT00701779|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-12-18|2014-07-28||September 2005||2005-09-01|December 2014|2014-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||"Enrollment of ~ 60 subjects will allow the proportion of subjects able to discontinue Tamsulosin, (assuming 50% able to discontinue), usage within 13% using a 95% confidence interval.~Assuming 75% of the subjects are able to discontinue Tamsulosin, the proportion of subjects can be estimated to within 11% using a 95% confidence interval."|Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia|Dutasteride (0.5mg) Once Daily for One Year and Tamsulosin (0.4mg) Once Daily for 3 Months, Followed by Counseling on Flex Dose Tamsulosin as Needed on Improvement of Symptoms and Outcome in Men With Moderate to Severe Symptomatic BPH|Completed||Phase 4|63|Actual|Siami, Paul F., M.D.||1|||f||||t||||||||||2017-02-18 14:14:17.527383|2017-02-18 14:14:17.527383
NCT00701766|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-04-30||2014-04-30|October 2006||2006-10-01|October 2013|2013-10-01||||October 2009|Actual|2009-10-01||Interventional|||BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia|An Open, Randomised Clinical Phase I/IIa Trial to Investigate the Maximum Tolerated Dose, Efficacy, Safety and Pharmacokinetics of Repeated Three-week Courses of a Single Dose i.v. BI 2536 on Day 1 in Comparison to Single Doses i.v. BI 2536 on Days 1, 2 and 3 in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia|Completed||Phase 2|71|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:14:17.84489|2017-02-18 14:14:17.84489
NCT00701753|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2009-03-11|||May 2008||2008-05-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses|A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses|Terminated||N/A|24|Actual|TheraGenetics Limited|||3|Insufficient subject recruitment.|f||||f||||||Samples With DNA|"~     Whole blood DNA RNA~   "|||2017-02-18 14:14:17.931743|2017-02-18 14:14:17.931743
NCT00701740|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2008-06-18|||July 2007||2007-07-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial|Phase II Randomized Controlled Trial to Evaluate the Clinical and Histological Effects of Oral Isotretinoin for the Treatment of Photoaging on Face and Forearms|Completed||Phase 2|32|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:14:18.016809|2017-02-18 14:14:18.016809
NCT00701727|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-03-14|2011-01-10||June 2008||2008-06-01|March 2011|2011-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study|Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study|Completed||Phase 4|31|Actual|Radiant Research||2|||f||||f||||||||||2017-02-18 14:14:18.12566|2017-02-18 14:14:18.12566
NCT00701714|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-06-01|||September 2007||2007-09-01|June 2015|2015-06-01|January 2010|Actual|2010-01-01|July 2009|Actual|2009-07-01||Interventional|||Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients|Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients|Terminated||Phase 3|337|Actual|Sandoz||2||investigation of adverse events|f||||f||||||||||2017-02-18 14:14:18.735489|2017-02-18 14:14:18.735489
NCT00701701|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-10-20|||December 2008||2008-12-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Immune Tolerance Induction Study|An Exploratory Study of the Safety and Efficacy of Immune Tolerance Induction (ITI) in Patients With Pompe Disease Who Have Previously Received Myozyme|Recruiting||Phase 4|9|Anticipated|Sanofi||2|||f||||t||||||||||2017-02-18 14:14:18.973565|2017-02-18 14:14:18.973565
NCT00701688|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2012-03-22|||September 2007||2007-09-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|September 2011|Actual|2011-09-01||Interventional|||Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation|Phase I Study Of The Use Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 1|19|Actual|St. Jude Children's Research Hospital||3|||f||||f||||||||||2017-02-18 14:14:19.089205|2017-02-18 14:14:19.089205
NCT00701675|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-11-02|2014-01-16||October 2005||2005-10-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|Sert-GAD||Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly|Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly|Completed||Phase 4|42|Actual|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 14:14:19.202555|2017-02-18 14:14:19.202555
NCT00701662|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2013-06-02|2013-06-02||November 2007||2007-11-01|June 2013|2013-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)|A Multicentre Study of Subcutaneous Immunoglobulin (SCIG) in Patients With Multifocal Motor Neuropathy (MMN)|Completed||Phase 2|8|Actual|CSL Behring||1|||f||||f||||||||||2017-02-18 14:14:19.646246|2017-02-18 14:14:19.646246
NCT00701649|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2009-12-01|||March 2008||2008-03-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|||Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension|A Double Blind, Randomized, Placebo Controlled, Parallel Group Phase IIa Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of an Anti-Angiotensin II Vaccine (CYT006-AngQb) in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 2|60|Anticipated|Cytos Biotechnology AG||2|||f||||f||||||||||2017-02-18 14:14:20.055088|2017-02-18 14:14:20.055088
NCT00701636|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-07-19|2012-03-28||July 2008||2008-07-01|July 2016|2016-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||Our protocol says we will enroll 32 subjects, with the assumption that 2 may not finish the study, have protocol violations, or have data that is corrupt and unusable. Our target was 30 analyzable subjects. Since we had no subjects withdraw from the trial, and no protocol violations or data problems, we halted enrollment at 30 subjects.|Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery|Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery|Completed||Phase 3|30|Actual|Los Angeles Biomedical Research Institute||2|||f||||t||||||||Yes|Data may be shared upon written request to the principal investigator.|2017-02-18 14:14:20.166853|2017-02-18 14:14:20.166853
NCT00701623|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-10-26|||June 2008||2008-06-01|February 2008|2008-02-01||||June 2008|Anticipated|2008-06-01||Interventional|SODIC HEPARIN||Sodic Heparin Effectiveness of the Treatment of Burns|Clinical Efficacy of Product Alimax ® (Sodic Heparin) in Treatment of Burns: Comparative Study of Raw Materials Between Two Suppliers|Withdrawn||Phase 2/Phase 3|84|Anticipated|Azidus Brasil||3|||f||||f||||||||||2017-02-18 14:14:20.537725|2017-02-18 14:14:20.537725
NCT00701610|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2008-06-18|||August 2007||2007-08-01|July 2007|2007-07-01|August 2009|Anticipated|2009-08-01|August 2008|Anticipated|2008-08-01||Observational|||Levels of Von Willebrand Factor Multimers and VWF-Cleaving Protease (ADAMTS-13) in Preterm and Neonate|Levels of Von Willebrand Factor Multimers and VWF-Cleaving Protease (ADAMTS-13) in Preterm and Neonate|Unknown status|Recruiting|N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples Without DNA|"~     blood will be taken from cord blood at birth from fullterm and preterm infantsinfants~   "|||2017-02-18 14:14:20.643325|2017-02-18 14:14:20.643325
NCT00701597|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2008-06-18|||April 2007||2007-04-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma|Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma.|Completed||Phase 1|28|Actual|Medical University of Vienna|||||f||||t||||||||||2017-02-18 14:14:20.722419|2017-02-18 14:14:20.722419
NCT00701584|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2014-05-19|||January 2005||2005-01-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|August 2010|Actual|2010-08-01||Observational|DietCompLyf||The Role of Diet and Lifestyle in Breast Cancer Survival|The Role of Diet, Complementary Treatment and Lifestyle in Breast Cancer Progression and Survival|Unknown status|Active, not recruiting|N/A|3390|Actual|University College London Hospitals|||1||f||||t||||||Samples With DNA|"~     Serum, plasma, buffy coat, urine~   "|||2017-02-18 14:14:20.808053|2017-02-18 14:14:20.808053
NCT00701571|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-09-12|||September 2005||2005-09-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Video/Audio Distraction Analgesia for Simulated Oncology Procedure Pain|Video/Audio Distraction Analgesia for Simulated Oncology Procedure Pain|Completed||N/A|180|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 14:14:20.902897|2017-02-18 14:14:20.902897
NCT00701558|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-05-24|2016-04-14||August 2008||2008-08-01|May 2016|2016-05-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer|An Open Label Study to Evaluate the Effect of First Line Treatment With Tarceva in Combination With Gemcitabine on Disease Progression in Patients With Unresectable Advanced and/or Metastatic Non-small Cell Lung Cancer|Completed||Phase 2|20|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:14:21.003705|2017-02-18 14:14:21.003705
NCT00333632|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2014-07-11|||June 2006||2006-06-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|||||Interventional|||Effect of Dexmedetomidine Upon Sleep Postoperatively|Restorative Sleep: Effect of Dexmedetomidine|Withdrawn||Phase 4|0|Actual|Duke University|||||f||||||||||||||2017-02-18 16:29:57.542795|2017-02-18 16:29:57.542795
NCT00701545|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2011-02-10|||February 2008||2008-02-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|||||Observational|||A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)|A Canadian, Multi-center, Prospective, Open-label, Observational, Pharmacovigilance Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced) in Patients Transitioning From Treatment With Currently Available Humate-P®|Completed||N/A|21|Actual|CSL Behring|||1||f||||f||||||||||2017-02-18 14:14:21.257112|2017-02-18 14:14:21.257112
NCT00701532|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2013-04-10|||April 2009||2009-04-01|April 2013|2013-04-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|CAIMAN||Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction|Dopamine Transporter (DAT) in Pharmacological Treatments of Cocaine Dependence. CAIMAN (Cocaine Addiction Imaging Medications and Neurotransmitters) Study|Completed||Phase 3|29|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:14:21.463044|2017-02-18 14:14:21.463044
NCT00701519|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2017-01-13|||June 2007||2007-06-01|January 2017|2017-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||The Prevalence of Sleep Disordered Breathing in Hospitalized Patients With Acutely Decompensated Heart Failure Syndrome|The Prevalence of Sleep Disordered Breathing in Hospitalized Patients With Acutely Decompensated Heart Failure Syndrome|Completed||N/A|1600|Actual|Ohio State University|||1||f||||f||||||||No||2017-02-18 14:14:21.574428|2017-02-18 14:14:21.574428
NCT00701506|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-12-07|||May 2008||2008-05-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Patterned Electrical Neuromuscular Stimulation and Therapeutic Exercise for Osteoarthritis of the Knee: Pilot Study|Patterned Electrical Neuromuscular Stimulation and Therapeutic Exercise for Osteoarthritis of the Knee: Pilot Study|Completed||Phase 4|13|Actual|RS Medical||2|||f||||f||||||||||2017-02-18 14:14:21.673485|2017-02-18 14:14:21.673485
NCT00701493|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-06-06|||November 2004||2004-11-01|March 2010|2010-03-01|December 2004|Actual|2004-12-01|||||Interventional|||A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults|An Open-Label, Randomized, 2-Way Crossover Study of the Bioavailability of an Oral Liquid Formulation Relative to the Marketed Sprinkle Capsule Formulation of Topiramate RWJ-17021-000 in Healthy Subjects|Completed||Phase 1|40|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:14:21.798438|2017-02-18 14:14:21.798438
NCT00701480|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2008-06-17|||April 2008||2008-04-01|June 2008|2008-06-01|September 2008|Anticipated|2008-09-01|July 2008|Anticipated|2008-07-01||Interventional|||Safety and Efficacy of Skin Cleanser Contained Roselle Extract in Acne|Randomized Double-Blind Case Control Study of Safety and Efficacy of Skin Cleanser Contained Hibiscus Sabdariffa Extract in Acne Treatment.|Unknown status|Recruiting|Phase 2|50|Anticipated|Thammasat University||2|||f||||t||||||||||2017-02-18 14:14:21.884202|2017-02-18 14:14:21.884202
NCT00701467|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2013-11-17|||March 2008||2008-03-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2010|Actual|2010-03-01||Observational|HRV||Change in Heart Rate Variability Prior to Tachyarrhythmia in ICD Implanted Patients|HRV Registry to Investigate Changes During the Time Before a Spontaneous Episode of Ventricular Tachyarrhythmia|Completed||N/A|50|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 14:14:21.990235|2017-02-18 14:14:21.990235
NCT00701454|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2008-06-17|||September 2005||2005-09-01|September 2005|2005-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Survey of Thai-Muslim Health Status|Survey of Thai-Muslim Health Status|Completed||N/A|1488|Actual|Mahidol University|||1||f||||f||||||Samples Without DNA|"~     Blood serum~   "|||2017-02-18 14:14:22.072809|2017-02-18 14:14:22.072809
NCT00701441|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-10-29|2011-08-12||February 2007||2007-02-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea|The Role of Oxidative Stress in the Cardiovascular Consequences of Sleep Apnea|Completed||N/A|25|Actual|Ohio State University|Small Feasibility trial only.||2||f||||f||||||Samples With DNA|"~     Blood and tissue biopsy~   "|||2017-02-18 14:14:22.17381|2017-02-18 14:14:22.17381
NCT00701428|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2014-11-17|||June 2008||2008-06-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|December 2013|Actual|2013-12-01||Interventional|LosartanPAP||Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment|Phase 4 Study of Losartan in Hypertensive Men and Women With Obstructive Sleep Apnea Before and After Continuous Positive Airway Pressure (CPAP) Treatment|Completed||Phase 4|90|Actual|Skaraborg Hospital||3|||f||||t||||||||||2017-02-18 14:14:22.59365|2017-02-18 14:14:22.59365
NCT00701415|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-05-20|2016-05-20||September 2008||2008-09-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|FIELD||A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms|A Randomized, Multicenter, Multinational, Phase 3B, Open-Label, Parallel-Group Study of Fabrazyme (Agalsidase Beta) in Treatment-Naïve Male Pediatric Patients With Fabry Disease Without Severe Symptoms|Completed||Phase 3|31|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:14:22.870354|2017-02-18 14:14:22.870354
NCT00701402|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2009-08-04|||June 2008||2008-06-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|||||Observational|PRYSME||National Survey on Dyslipidemic Patients|Survey on Time to Lipid-lowering Drug Implementation on Dyslipidemic Patients in General Practice.|Completed||N/A|3655|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:14:23.813076|2017-02-18 14:14:23.813076
NCT00701389|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-08-13|2014-08-27||November 2007||2007-11-01|August 2015|2015-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)|A Double-Blind, Randomized, Placebo-Controlled, 3-Period, Single Dose Crossover Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK0974 in Migraine Patients|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 14:14:27.981352|2017-02-18 14:14:27.981352
NCT00701376|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-12-12|||June 2008||2008-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Hepatic Effects of Gastric Bypass Surgery|Long Term Hepatic Effects of Gastric Bypass Surgery|Active, not recruiting||N/A|100|Anticipated|The Cleveland Clinic||1|||f||||f||||||||||2017-02-18 14:14:28.783548|2017-02-18 14:14:28.783548
NCT00700778|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-12-20|||July 2008||2008-07-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations|Genomic Markers of Breast Cancer Prevention Induced by HCG in Women at High Risk|Terminated||N/A|2|Actual|Fox Chase Cancer Center||1||Unable to recruit volunteers|f||||f||||||||||2017-02-18 14:14:44.068156|2017-02-18 14:14:44.068156
NCT00701363|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-11-10|2015-09-11||October 2008||2008-10-01|November 2015|2015-11-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|LEAD|Phase 1: 15 subjects participated only in phase 1 and did not enter in phase 2.|Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects|A Prospective, International, Multi-centric, Open-label Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel 120 mg in Acromegalic Subjects Who Are Biochemically Controlled on the Long Term Treatment With Octreotide LAR 10 or 20 mg|Completed||Phase 4|124|Actual|Ipsen||1|||f||||||||||||||2017-02-18 14:14:28.934126|2017-02-18 14:14:28.934126
NCT00701350|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2010-07-19|||June 2008||2008-06-01|July 2010|2010-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|PPROM||Biomarkers of Intra-amniotic Infection in Women With Preterm Premature Ruptured Amniotic Membranes|Identification of Proteomic Markers of Intra-amniotic Infection (IAI) in Patients With Preterm Premature Rupture of Amniotic Membranes (PPROM)|Completed||N/A|79|Actual|ProteoGenix, Inc.|||1||f||||f||||||Samples Without DNA|"~     Cervical-vaginal Fluid, Amniotic Fluid, Maternal Serum, Neonatal Cord Blood, Placental and~     Umbilical Cord Tissues~   "|||2017-02-18 14:14:31.046433|2017-02-18 14:14:31.046433
NCT00701337|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2010-06-29|||September 2006||2006-09-01|June 2010|2010-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route|Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route: Pilot Study|Completed||Phase 4|40|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 14:14:31.139109|2017-02-18 14:14:31.139109
NCT00701324|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-07-21|||June 2007||2007-06-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||BI 811283 in Various Solid Tumours|An Open Phase I Single Dose Escalation Study of Two Dosing Schedules of BI 811283 Administered Intravenously Over 24 h Continuous Infusion in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit|Completed||Phase 1|124|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:14:31.254699|2017-02-18 14:14:31.254699
NCT00701311|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-09-25|2013-12-19||June 2008||2008-06-01|September 2014|2014-09-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome|An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome|Completed||Phase 2|21|Actual|William Beaumont Hospitals|The limitation of this study is that only 9 of 17 participants completed full 12 weeks of treatment and there was no placebo arm.|1|||f||||t||||||||||2017-02-18 14:14:31.541969|2017-02-18 14:14:31.541969
NCT00701298|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-02-21|||April 2009||2009-04-01|October 2011|2011-10-01||||October 2010|Actual|2010-10-01||Interventional|||Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors|Inhibition of DNA Methylation by 1-Hr Infusion of 5-aza-2'-Deoxycitidine (Decitabine) x 10 Days (M-F) With Escalating Doses of Sub-Q Pegylated (PEG) Interferon-alpha 2B (PEG-Intron): A Phase I Study With Molecular Correlates|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:14:31.785051|2017-02-18 14:14:31.785051
NCT00701285|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-05-12|||July 2008||2008-07-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|SAPHIRE||South Korean Pitavastatin Heart Failure Study|A Prospective, Randomized, Two Group Comparison Study to Evaluate the Effect of Statin on Heart Function in Patients With Chronic Ischemic Heart Failure.|Completed||Phase 4|70|Anticipated|JW Pharmaceutical||2|||f||||||||||||||2017-02-18 14:14:31.90856|2017-02-18 14:14:31.90856
NCT00701272|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2013-07-24|||June 2008||2008-06-01|July 2013|2013-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation|FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of HCV Recurrence and Progression Post Liver Transplantation|Unknown status|Enrolling by invitation|N/A|70|Anticipated|University Health Network, Toronto|||2||f||||f||||||Samples With DNA|"~     Blood samples; liver biopsy tissue~   "|||2017-02-18 14:14:32.02103|2017-02-18 14:14:32.02103
NCT00701259|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-01-13|||January 2007||2007-01-01|January 2010|2010-01-01|August 2007|Actual|2007-08-01|||||Interventional|||Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn|A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial of Fourteen Day Treatment With Lansoprazole 15 mg or 30 mg Once a Day in Frequent Nighttime Heartburn|Completed||Phase 3|852|Actual|Novartis||3|||f||||f||||||||||2017-02-18 14:14:32.113759|2017-02-18 14:14:32.113759
NCT00701246|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-03-12|||April 2005||2005-04-01|March 2014|2014-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil|Nutritional Anemia: Prevention and Treatment in Early Childhood|Completed||N/A|196|Actual|Universidade Federal de Goias||4|||f||||f||||||||||2017-02-18 14:14:32.215186|2017-02-18 14:14:32.215186
NCT00701233|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-10-26|||June 2012||2012-06-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Botulinum Toxin for Carpal Tunnel Syndrome|Evaluation of Intercarpal Botox Versus Steroid Injections for Carpal Tunnel Syndrome|Active, not recruiting||Phase 2|20|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 14:14:32.335731|2017-02-18 14:14:32.335731
NCT00701220|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-04-12|||April 2007||2007-04-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Statin Therapy for Ischemic and Nonischemic Cardiomyopathy|Statin Induced Augmentation of Circulating Endothelial Progenitor Cells and Myocardial Viability in Patients With Ischemic and Nonischemic Cardiomyopathy|Completed||Phase 4|30|Anticipated|Ohio State University||3|||f||||f||||||||||2017-02-18 14:14:32.437247|2017-02-18 14:14:32.437247
NCT00701207|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2013-05-02|||July 2008||2008-07-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Study of Nicotine Patches in Patients With Sarcoidosis|Modulation of Pulmonary Sarcoidosis by Nicotinic Acetylcholine Receptors|Suspended||Phase 4|64|Anticipated|Ohio State University||3||Interim Analysis|f||||t||||||||||2017-02-18 14:14:32.552272|2017-02-18 14:14:32.552272
NCT00701194|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2008-06-18|||December 1999||1999-12-01|June 2008|2008-06-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|EIFC||Early Intervention Foster Care: A Prevention Trial|Early Intervention Foster Care: A Prevention Trial|Unknown status|Active, not recruiting|N/A|177|Actual|Oregon Social Learning Center||3|||f||||f||||||||||2017-02-18 14:14:32.657366|2017-02-18 14:14:32.657366
NCT00701181|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2012-10-09||2012-10-09|June 2008||2008-06-01|October 2012|2012-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|DEGAS||Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema|A Phase II Prospective, Randomized, Multi-Center, Diabetic Macular Edema Dose Ranging, Comparator Study Evaluating The Efficacy And Safety Of PF-04523655 Versus Laser Therapy (DEGAS)|Terminated||Phase 2|184|Actual|Quark Pharmaceuticals||4||See termination reason in detailed description.|f||||t||||||||||2017-02-18 14:14:32.777456|2017-02-18 14:14:32.777456
NCT00701168|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-10-04||||||October 2010|2010-10-01||||||||Expanded Access|||Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer|A Humanitarian Device Exemption Use Protocol of Therasphere® for Treatment of Unresectable Hepatocellular and Metastatic Liver Tumors - HDE #980006|No longer available||N/A|||Leo W. Jenkins Cancer Center|||||f||||||||||||||2017-02-18 14:14:32.939422|2017-02-18 14:14:32.939422
NCT00701155|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-02-18|||July 2007||2007-07-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Observational Study to Evaluate the Safety While Using Levemir®|Observational, Safety Study in Subjects Using Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus|Completed||N/A|3593|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:14:33.044523|2017-02-18 14:14:33.044523
NCT00701142|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2013-09-18|||June 2008||2008-06-01|February 2011|2011-02-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Haemocomplettan® P During Aortic Replacement|Haemocomplettan® P in Patients Experiencing Acute Bleeding While Undergoing Aortic Replacement Surgery|Completed||Phase 2|80|Actual|CSL Behring||2|||f||||f||||||||||2017-02-18 14:14:33.149067|2017-02-18 14:14:33.149067
NCT00701129|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-04-09|2014-02-24||October 2009||2009-10-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Safety population included all patients who received at least one dose of alglucosidase alfa.|An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease|An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme®-Naive, CRIM(-) Patients With Infantile-onset Pompe Disease|Completed||Phase 4|4|Actual|Sanofi|Due to the small number of patients assessed in this study the results must be interpreted with caution.|1|||f||||t||||||||||2017-02-18 14:14:33.262947|2017-02-18 14:14:33.262947
NCT00701103|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-08-27|||January 2006||2006-01-01|August 2015|2015-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase I Dose Escalation Trial of MK-0646 in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001)(COMPLETED)|An Open-Label, Dose Escalation Phase I Trial of MK-0646 Given as a Weekly, Every Other Week, or Every Three Week Infusion in Patients With Advanced Solid Tumors and Multiple Myeloma|Completed||Phase 1|98|Anticipated|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-02-18 14:14:33.922646|2017-02-18 14:14:33.922646
NCT00701090|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-03-23|2010-09-13||May 2008||2008-05-01|March 2015|2015-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)|A Phase III, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin Compared With the Addition of Glimepiride in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin|Completed||Phase 3|1035|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:14:34.029375|2017-02-18 14:14:34.029375
NCT00701077|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2008-07-01|||July 2008||2008-07-01|June 2008|2008-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|DAPREB||DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome|DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome|Unknown status|Not yet recruiting|Phase 3|42|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:14:34.757975|2017-02-18 14:14:34.757975
NCT00701064|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-04-05|2015-03-26||January 2009||2009-01-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2012|Actual|2012-11-01||Interventional||Veterans with PTSD|Bright Light: An Adjunct Treatment for Combat Posttraumatic Stress Disorder (PTSD)|Bright Light: An Adjunct Treatment for Combat PTSD|Active, not recruiting||Phase 1|71|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:14:34.864572|2017-02-18 14:14:34.864572
NCT00701051|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-03-23|2015-01-26||October 2006||2006-10-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Exercise Training and Glucose Metabolism in Aging|Aging, Angiogenesis and Metabolic Responses to Aerobic Exercise|Completed||N/A|90|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:14:35.53225|2017-02-18 14:14:35.53225
NCT00701038|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2013-01-29|2011-08-12||August 2006||2006-08-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Diagnosis and Treatment of Sleep Apnea in the Acute Exacerbation of Heart Failure|The Role of Diagnosis and Treatment of Sleep Apnea in the Acute Exacerbation of Heart Failure|Completed||N/A|54|Actual|Ohio State University||2|||f||||f||||||||||2017-02-18 14:14:35.950969|2017-02-18 14:14:35.950969
NCT00701025|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-02-08|||April 2008||2008-04-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Mechanisms of Exercise-induced Bronchospasm|Mechanisms of Exercise-induced Bronchospasm|Completed||N/A|70|Anticipated|Ohio State University|||2||f||||t||||||Samples Without DNA|"~     blood, sputum, urine for pregnancy testing~   "|||2017-02-18 14:14:36.345684|2017-02-18 14:14:36.345684
NCT00701012|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2013-12-17|||January 2008||2008-01-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Low and High Ligation in the Rectal Cancer|Comparison of Functional Results of High Ligation and Low Ligation After Anterior Resection for Rectal Cancer - Randomized Controlled Trial-|Completed||N/A|100|Actual|Wakayama Medical University||2|||f||||t||||||||||2017-02-18 14:14:36.450152|2017-02-18 14:14:36.450152
NCT00700999|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-05-28|2013-09-09||October 2008||2008-10-01|May 2014|2014-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||The Baseline Participants have been determined by the number of participants that completed the first MRI scan.|Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)|Neurofunctional Markers of SSRI Treatment Response in PTSD|Completed||Phase 4|65|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:14:36.574392|2017-02-18 14:14:36.574392
NCT00694733|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2012-06-04|||May 2005||2005-05-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||Regulation of Cortisol Metabolism and Fat Patterning|Regulation of Cortisol Metabolism and Fat Patterning|Completed||N/A|140|Actual|Oregon Health and Science University||5|||f||||f||||||||||2017-02-18 14:17:06.799857|2017-02-18 14:17:06.799857
NCT00700986|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-11-30|||June 2008||2008-06-01|November 2010|2010-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056|A Randomised, Double-Blind, Placebo-Controlled, 2-Period Cross-Over Study in Healthy Male Volunteers, to Investigate Retinal Function Following a Single 800mg Oral Dose of AZD9056|Completed||Phase 1|12|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:14:36.986837|2017-02-18 14:14:36.986837
NCT00700973|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-04-06|2014-05-16||February 2009||2009-02-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|January 2012|Actual|2012-01-01||Interventional|||Treating Violence-Prone Substance Use Disorder Patients|Treating Violence-Prone Substance Use Disorder Patients|Completed||Phase 2/Phase 3|141|Actual|VA Office of Research and Development|A limitation of the trial (not a result or conclusion) is that high proportions of patients reported abstinence at baseline.|2|||f||||f||||||||||2017-02-18 14:14:37.092393|2017-02-18 14:14:37.092393
NCT00700960|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2017-01-30|||June 2007||2007-06-01|January 2017|2017-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|LIGHT||Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control|Observational Study on Efficacy on Glycaemic Control of Slow-acting Insulin Analogue in Type 2 Diabetes|Completed||N/A|2745|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:14:37.445664|2017-02-18 14:14:37.445664
NCT00700947|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2009-10-15|||October 2007||2007-10-01|October 2009|2009-10-01|July 2010|Anticipated|2010-07-01|December 2009|Anticipated|2009-12-01||Interventional|REGURG||Using Beta Blockers to Treat Mitral Regurgitation|Beta-Blockade in Chronic Mitral Regurgitation: Moving From the Laboratory Experiment to Clinical Investigation|Unknown status|Active, not recruiting|N/A|66|Anticipated|Ohio State University||3|||f||||f||||||||||2017-02-18 14:14:37.558062|2017-02-18 14:14:37.558062
NCT00700934|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-12-06|||February 2005||2005-02-01|June 2008|2008-06-01|February 2012|Anticipated|2012-02-01|February 2011|Anticipated|2011-02-01||Observational|||Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema|Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema. A National Registry.|Unknown status|Recruiting|N/A|300|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 14:14:37.668691|2017-02-18 14:14:37.668691
NCT00700921|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2012-11-26|||April 2008||2008-04-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)|Lovastatin as a Potential Modulator of Apoptosis in COPD|Completed||Phase 2|30|Actual|National Jewish Health||2|||f||||t||||||||||2017-02-18 14:14:37.76608|2017-02-18 14:14:37.76608
NCT00700908|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2013-02-20|||June 2007||2007-06-01|February 2013|2013-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes|The Impact of an Automated Telephone Intervention on HbA1c in Type 2 Diabetes: A Randomized Controlled Trial|Completed||N/A|120|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 14:14:37.867939|2017-02-18 14:14:37.867939
NCT00700895|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-06-06|||August 2006||2006-08-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose|A Randomized Controlled Trial to Assess the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regimen for Calculating Warfarin Maintenance Dose|Recruiting||Phase 3|320|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-02-18 14:14:37.96484|2017-02-18 14:14:37.96484
NCT00700882|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-09-16|||May 2009||2009-05-01|September 2014|2014-09-01||||March 2017|Anticipated|2017-03-01||Interventional|||Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery|A Phase II Trial of Dasatinib in Patients With Unresectable Locally Advanced or Stage IV Mucosal, Acral and Vulvovaginal Melanomas|Recruiting||Phase 2|87|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 14:14:38.099744|2017-02-18 14:14:38.099744
NCT00700869|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2011-10-04|||April 2008||2008-04-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|ORGAR||Evaluation of a New Mechanical Ventilation Weaning Strategy for Patients With Altered Level of Consciousness|Phase 2 Study of a New Mechanical Ventilation Weaning Strategy Governs by a Respiratory Behaviour Status Assessment for Patients With Altered Level of Consciousness|Completed||Phase 2/Phase 3|34|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 14:14:38.689872|2017-02-18 14:14:38.689872
NCT00700856|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-08-26|||September 2008||2008-09-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|TOSCA IT||Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial|Effects on Incidence of Cardiovascular Events of the Addition of Pioglitazone as Compared With a Sulphonylurea in Type 2 Diabetic Patients Inadequately Controlled With Metformin.|Active, not recruiting||Phase 4|3371|Anticipated|Italian Society of Diabetology||2|||f||||t||||||||||2017-02-18 14:14:38.79144|2017-02-18 14:14:38.79144
NCT00700843|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-05-13|||April 2008||2008-04-01|May 2015|2015-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Long-Term Follow-up of Ohio State University Medical Center (OSUMC) Bariatric Patients|Long-Term Follow-up of Ohio State University Medical Center (OSUMC) Bariatric Patients|Terminated||N/A|23|Actual|Ohio State University|||1|Difficulty recruiting|f||||f||||||||||2017-02-18 14:14:38.966509|2017-02-18 14:14:38.966509
NCT00700830|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-08-13|||January 2008||2008-01-01|December 2013|2013-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|IDEALS||Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes|Assessment of Safety and Efficacy of Levemir® (Insulin Detemir) Treatment for Insulin Naive Patients With Type 2 Diabetes Mellitus|Completed||N/A|1976|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:14:39.051959|2017-02-18 14:14:39.051959
NCT00700817|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2014-08-08|2010-06-11||June 2008||2008-06-01|August 2014|2014-08-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus|The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Subjects With Type 2 Diabetes. A 26-week, Randomised, Open-label, Active Comparator, Three-armed, Parallel-group, Multi-centre, Multinational Trial With a 52-week Extension|Completed||Phase 3|665|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-02-18 14:14:39.187579|2017-02-18 14:14:39.187579
NCT00700765|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2016-10-27|||January 2008||2008-01-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes|Observational, Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus|Completed||N/A|1531|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:14:44.185302|2017-02-18 14:14:44.185302
NCT00700752|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-05-05|2010-08-25||May 2008||2008-05-01|May 2015|2015-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Comparison of Two Contact Lenses||Completed||N/A|40|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:14:44.305173|2017-02-18 14:14:44.305173
NCT00700739|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2015-09-02|2015-07-13||May 2008||2008-05-01|September 2015|2015-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study to Investigate the Performance of Cervical Arthroplasty for the Treatment of Cervical Degenerative Disc Disease|A Multi-Centre, Prospective, Randomized, Post Marketing Surveillance Study Comparing Cervical Arthroplasty to Anterior Cervical Discectomy and Fusion (ACDF) for the Treatment of Cervical Degenerative Disc Disease|Terminated||Phase 4|60|Actual|DePuy International|Study was terminated early therefore the latest clinical data available is at the 12 month post-operative timepoint and the latest radiographic data available is at the 6 month post-operative timepoint.|2||study progress and recruitment rate too low|f||||t||||||||||2017-02-18 14:14:44.549142|2017-02-18 14:14:44.549142
NCT00700726|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-02-11|||June 2008||2008-06-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma|Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma|Completed||N/A|26|Actual|Ohio State University|||1||f||||t||||||Samples Without DNA|"~     blood, nasal lavage (optional)~   "|||2017-02-18 14:14:45.230171|2017-02-18 14:14:45.230171
NCT00700713|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-01-16|2016-01-16||June 2008||2008-06-01|January 2016|2016-01-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26|Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® (Meningococcal [Groups A, C, Y, and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) Three Years Earlier in Study MTA26|Completed||Phase 2|181|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 14:14:45.329286|2017-02-18 14:14:45.329286
NCT00700700|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2011-07-04|||October 2008||2008-10-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Cardiac Resynchronization Therapy, Dyspnea and Exercise Tolerance in Patients With Congestive Heart Failure (CHF)|Effects of Cardiac Resynchronization Therapy on Dyspnea and Exercise Tolerance in Patients With Congestive Heart Failure|Terminated||Phase 4|2|Actual|Queen's University||2||Stopped due to an inability to recruit eligible subjects.|f||||f||||||||||2017-02-18 14:14:45.99611|2017-02-18 14:14:45.99611
NCT00700687|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2009-01-09|||June 2008||2008-06-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|PA32540-109||Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib|Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib|Completed||Phase 1|90|Anticipated|POZEN||3|||f||||f||||||||||2017-02-18 14:14:46.094697|2017-02-18 14:14:46.094697
NCT00700674|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2010-02-24|||January 2008||2008-01-01|February 2010|2010-02-01||||||||Observational|||Effect of Usage of Electroencephalogram (EEG) Entropy on the Incidence of Postoperative Cognitive Dysfunction in Geriatric Patients|Is the Ese of EEG Entropy as Intra-operative Monitor Improves Postoperative Cognitive Dysfunction|Unknown status|Recruiting|N/A|60|Anticipated|King Khaled Eye Specialist Hospital|||2||f||||t||||||||||2017-02-18 14:14:46.186661|2017-02-18 14:14:46.186661
NCT00700661|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-06-22|||January 2001||2001-01-01|June 2015|2015-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)|A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Study to Determine the Efficacy of Montelukast in the Treatment of Exacerbations in Asthmatic Patients Aged 2-to-5 Years|Completed||Phase 3|500|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:14:46.340022|2017-02-18 14:14:46.340022
NCT00700648|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-18|2017-01-02|||March 2008||2008-03-01|January 2017|2017-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects|A Multicenter, Open Label, Nonrandomized, Non Interventional, Observational, Safety and Efficacy Study in Hospitalized Subjects Using Intravenous NovoRapid® (Insulin Aspart)|Completed||N/A|3024|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:14:46.459843|2017-02-18 14:14:46.459843
NCT00700635|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-04-12|2010-12-11||June 2008||2008-06-01|April 2016|2016-04-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Interventional|||Dose Comparison Study of Menactra® in US Children|Exploratory Evaluation of a Two-dose Schedule Versus a One-dose Schedule of Menactra® (Meningococcal [Groups A, C, Y and W 135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) in Children in the US|Completed||Phase 2|333|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 14:14:46.579826|2017-02-18 14:14:46.579826
NCT00700622|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2014-10-09|2014-07-22||May 2008||2008-05-01|October 2014|2014-10-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|||Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks|A Phase3, Multi-Center, Open-Label, Randomized, Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Insulin Inhalation Powder in Combination With Lantus® Versus Humalog® in Combination With Lantus® in Subjects With Type 1 Diabetes Mellitus Over a 16-Week Treatment Period|Terminated||Phase 3|130|Actual|Mannkind Corporation|- Early termination of trial leading to small numbers of subjects analyzed.|2||"Sponsor stopped development of the MedTone inhaler in favor of an improved device (Gen2~   inhaler)"|f||||f||||||||||2017-02-18 14:14:47.382099|2017-02-18 14:14:47.382099
NCT00700609|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2015-07-30|||June 2008||2008-06-01|July 2015|2015-07-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|BudFam||Family Based Treatment of Depressed Adolescents|Family-Based Treatment of Depressed Adolescents: An Empirical Study With Norwegian Adolescents in Specialty Mental Health Care|Terminated||Phase 2|20|Actual|Helse Stavanger HF||2||The PI moved to another city and position|f||||t||||||||||2017-02-18 14:14:47.895421|2017-02-18 14:14:47.895421
NCT00700596|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-08-17|||January 2009||2009-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Effects of Salvinorin A in Healthy Controls|Psychotomimetic Effects of Kappa Opioid Receptor Agonist Salvinorin A in Healthy Controls|Active, not recruiting||Phase 1|41|Anticipated|Yale University||2|||f||||||||||||||2017-02-18 14:14:50.428648|2017-02-18 14:14:50.428648
NCT00700583|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2011-05-09|||May 2008||2008-05-01|May 2011|2011-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men|Alpha-blocker Plus Diuretic Combination Therapy as Second-line Treatment for Nocturia in Men With LUTS: a Pilot Study|Completed||N/A|72|Actual|Seoul National University Hospital||1|||f||||||||||||||2017-02-18 14:14:50.530887|2017-02-18 14:14:50.530887
NCT00700570|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-11-01|2015-08-19||August 2008||2008-08-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||Intent-to-Treat (ITT) Population: All enrolled participants who received at least one dose of study drug.|A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer|An Open Label Study to Assess the Resection Rate of Liver Metastases Following Neoadjuvant Therapy With Avastin in Combination With Oxaliplatin and Capecitabine (XELOX) in Patients With Metastatic Colorectal Cancer With Unresectable Liver Metastasis|Completed||Phase 2|45|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:14:50.645019|2017-02-18 14:14:50.645019
NCT00700557|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2009-08-24|||October 2006||2006-10-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Probiotics at the Treatment of Antibiotic Associated Diarrhea|Lactobacillus Casei e Bifidobacterium Breve as Probiotics at the Treatment of Antibiotic Associated Diarrhea: a Randomized Double Blind Study|Completed||Phase 4|70|Actual|Federal University of Uberlandia||2|||f||||t||||||||||2017-02-18 14:14:51.032582|2017-02-18 14:14:51.032582
NCT00700544|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-13|||June 2002||2002-06-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|April 2005|Actual|2005-04-01||Interventional|||Treatment Outcome in Elderly Patients|Adjonction of Androgenotheapy for Post-Remission Treatment of Elderly Patients With Acute Myeloid Leukemia - Results of the Multicenter Goelams SA-2002 Trial.|Completed||Phase 3|330|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-02-18 14:14:51.14457|2017-02-18 14:14:51.14457
NCT00700531|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-10-04|||June 2008||2008-06-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|January 2014|Actual|2014-01-01||Interventional|EuLITE||European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy|European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy|Completed||N/A|90|Actual|University Hospital Birmingham||2|||f||||t||||||||Undecided|Under consideration|2017-02-18 14:14:51.256764|2017-02-18 14:14:51.256764
NCT00700518|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-12-29|||June 2008||2008-06-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon|A Phase I Trial of the Pharmacodynamic Dose Response to Topical Trinitrate in Patients With Raynaud's Phenomenon|Completed||Phase 1|10|Anticipated|Procris Pharmaceuticals||5|||f||||f||||||||||2017-02-18 14:14:51.57843|2017-02-18 14:14:51.57843
NCT00700505|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-08-13|||April 2008||2008-04-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy|A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy|Completed||N/A|20|Actual|ThermaRx, Inc.||1|||f||||t||||||||||2017-02-18 14:14:51.684462|2017-02-18 14:14:51.684462
NCT00700492|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-06-24|||May 2004||2004-05-01|June 2015|2015-06-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Does Hormonal Luteal Support After Intra-uterine Insemination (IUI) Increase the Pregnancy Rate?|Luteal Support With Vaginal Progesterone Capsules Following Ovulation Induction With Human Menopausal Gonadotropins (hMG) for Intra Uterine Insemination: A Comparative Study|Terminated||N/A|82|Actual|University Hospital, Gasthuisberg||2||Change in Belgian law on the use of hMG in IUI|f||||f||||||||||2017-02-18 14:14:51.794636|2017-02-18 14:14:51.794636
NCT00700479|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2008-06-17|||January 2006||2006-01-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Studies on Aldosterone and Vascular Function|Studies on Aldosterone and Vascular Function|Completed||Phase 1|20|Anticipated|Yale University||4|||f||||f||||||||||2017-02-18 14:14:51.900035|2017-02-18 14:14:51.900035
NCT00700466|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2010-01-15|||March 2008||2008-03-01|February 2009|2009-02-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Observational|||Intravenous Beta-blockade for Improvement of Autonomic Activity|Beta-adrenoceptor Blockade Prior to Induction of Anesthesia for Improvement of Depressed Autonomic Regulation|Completed||N/A|100|Anticipated|University of Schleswig-Holstein|||2||f||||t||||||||||2017-02-18 14:14:52.013759|2017-02-18 14:14:52.013759
NCT00700453|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-05-02|||July 2008||2008-07-01|April 2012|2012-04-01|December 2018|Anticipated|2018-12-01|March 2011|Actual|2011-03-01||Interventional|||Video Game-Brain Functioning Reversibility Study|Video Game-Brain Functioning Reversibility Study|Active, not recruiting||N/A|60|Anticipated|Indiana University||4|||f||||t||||||||||2017-02-18 14:14:52.131543|2017-02-18 14:14:52.131543
NCT00700440|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-03-09|2010-01-11||July 2008||2008-07-01|February 2009|2009-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ENCORE||Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy|Phase II Study of Cetuximab Combined With Intensity Modulated Radiotherapy (IMRT) and Concurrent Chemotherapy of Cisplatin in Nasopharyngeal Carcinoma|Completed||Phase 2|100|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-02-18 14:14:52.244512|2017-02-18 14:14:52.244512
NCT00700427|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2014-06-12|2012-08-23||June 2008||2008-06-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|August 2011|Actual|2011-08-01||Interventional||All enrolled participants.|A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|Maintenance of Response After Open-Label Treatment With Atomoxetine Hydrochloride in Adult Outpatients With Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdrawal Study|Completed||Phase 3|2017|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:14:52.513434|2017-02-18 14:14:52.513434
NCT00700414|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-11-10|||May 2001||2001-05-01|November 2016|2016-11-01|December 2040|Anticipated|2040-12-01|December 2040|Anticipated|2040-12-01||Observational|||International Pediatric Adrenocortical Tumor Registry|International Pediatric Adrenocortical Tumor Registry|Recruiting||N/A|9999|Anticipated|St. Jude Children's Research Hospital|||1||f||||f||||||Samples With DNA|"~     Peripheral blood sample with DNA and RNA; Tumor Tissue (of any histology); Adrenocortical~     tumors;~   "|||2017-02-18 14:14:53.940318|2017-02-18 14:14:53.940318
NCT00700232|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2010-06-16|||July 2006||2006-07-01|June 2010|2010-06-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Observational|||ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls|Mutations and Polymorphisms of Gene ABCB4 Among Women Suffering From Intrahepatic Cholestasis of Pregnancy. A Study With a Control Group.|Completed||N/A|120|Actual|University Hospital, Tours|||1||f||||f||||||Samples With DNA|"~     blood samples~   "|||2017-02-18 14:14:57.790624|2017-02-18 14:14:57.790624
NCT00700401|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-05-12|2016-03-28||November 2008||2008-11-01|May 2016|2016-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational||Intention-to-treat (ITT) population included all participants who received at least one dose of study drug.|POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).|A Prospective, Observational Study to Assess the Virological Response at Week 4 to the Therapy With PEGASYS® (Peginterferon Alfa 2a) Plus COPEGUS® (Ribavirin) in a Population of Treatment Naïve Patients With Chronic Hepatitis C, Genotype 2 or 3.|Completed||N/A|262|Actual|Hoffmann-La Roche|||1||f||||f||||||||||2017-02-18 14:14:54.071146|2017-02-18 14:14:54.071146
NCT00700388|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-08-02|||July 2008||2008-07-01|January 2010|2010-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|UNIKO||Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic Hypersecretion|Multicenter Controlled Trial on Efficacy of TPEP Device in Adult Patients With Chronic Hypersecretion|Completed||Phase 4|100|Actual|Villa Pineta Hospital||2|||f||||t||||||||||2017-02-18 14:14:54.46454|2017-02-18 14:14:54.46454
NCT00700375|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2010-07-12|2010-03-23||July 2008||2008-07-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection|Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection in Patients Undergoing an Emergent Coronary Procedure|Completed||Phase 4|59|Actual|Osaka General Medical Center|Single center trial|2|||f||||t||||||||||2017-02-18 14:14:54.567827|2017-02-18 14:14:54.567827
NCT00700362|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2015-04-08|||December 2011||2011-12-01|December 2011|2011-12-01|December 2016|Anticipated|2016-12-01|October 2016|Anticipated|2016-10-01||Observational|||Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)|The Effect of Insulin-Glucose Infusion on Metabolic Control (Primary) and Inflammation (Secondary) in Diabetic Patients Treated for Acute Foot Ulcer Infection or Surgical Wound Infection|Withdrawn||Phase 4|0|Actual|Karolinska Institutet||||This study is a part of the IINDU study|f||||t||||||||||2017-02-18 14:14:54.926204|2017-02-18 14:14:54.926204
NCT00700349|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2008-06-17|||September 2004||2004-09-01|June 2008|2008-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa|Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa|Completed||N/A|3000|Actual|Innovations for Poverty Action||2|||f||||||||||||||2017-02-18 14:14:55.033831|2017-02-18 14:14:55.033831
NCT00700336|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2012-12-19|||May 2008||2008-05-01|October 2011|2011-10-01|November 2012|Actual|2012-11-01|July 2012|Actual|2012-07-01||Interventional|||Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)|Phase I/II Study of a Triplet Combination of CBP501, Pemetrexed and Cisplatin in Patients With Advanced Solid Tumors and in Chemotherapy-naïve Patients With Malignant Pleural Mesothelioma|Completed||Phase 1/Phase 2|71|Actual|CanBas Co. Ltd.||2|||f||||f||||||||||2017-02-18 14:14:55.338514|2017-02-18 14:14:55.338514
NCT00700323|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2008-06-17|||July 2008||2008-07-01|June 2008|2008-06-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|ADHD-3||PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children|Phase 2b Study of PS-Omega3 Conjugate Supplementation to ADHD Diagnosed Children|Unknown status|Not yet recruiting|Phase 2|45|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-02-18 14:14:55.461504|2017-02-18 14:14:55.461504
NCT00700310|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-12-17|2012-10-23||August 2008||2008-08-01|November 2015|2015-11-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures|A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures|Completed||Phase 3|712|Actual|Eisai Inc.||4|||f||||||||||||||2017-02-18 14:14:55.575364|2017-02-18 14:14:55.575364
NCT00700297|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2008-06-17|||August 2002||2002-08-01|May 2008|2008-05-01|May 2006|Actual|2006-05-01|October 2005|Actual|2005-10-01||Interventional|||Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease|A Double Blind Cross Over Clinical Trial to Determine Colchicine Efficacy in Behcet`s Disease|Completed||Phase 2|169|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:14:56.572096|2017-02-18 14:14:56.572096
NCT00700284|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-08-31|||October 2004||2004-10-01|August 2009|2009-08-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)|Phase I Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine) as a Vaginal Microbicide|Completed||Phase 1|12|Actual|International Partnership for Microbicides, Inc.||2|||f||||f||||||||||2017-02-18 14:14:56.689618|2017-02-18 14:14:56.689618
NCT00700271|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-05-16|2010-12-15||October 2007||2007-10-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day|Efficacy of a Combination of Amlodipine / Valsartan on Blood Pressure Control, With One Nocturnal or Diurnal Intake a Day, in Ambulatory Blood Pressure Monitoring Setting, in Essential Uncontrolled Hypertensive Patients With Amlodipine 5mg ; The ExPERT Study|Completed||Phase 4|478|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:14:56.791305|2017-02-18 14:14:56.791305
NCT00700258|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2017-01-30|||January 2013||2013-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2017|Anticipated|2017-09-01||Observational|STAR-TOR||Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]|Star-tor - Registry For The Evaluation Of The Safety, Tolerability And Efficacy Of Temsirolimus (Torisel®), Sunitinib (Sutent®), And Axitnib (Inlyta®) For The Treatment Of Subjects With Advanced Renal Cell Carcinoma (Mrcc), Mantle Cell Lymphoma (Mcl), And Gastro-intestinal Stroma Tumor (Gist).|Recruiting||N/A|1600|Anticipated|Pfizer|||5||f||||f||||||||||2017-02-18 14:14:57.312775|2017-02-18 14:14:57.312775
NCT00700245|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2008-06-17|||September 2006||2006-09-01|June 2008|2008-06-01|March 2009|Anticipated|2009-03-01|June 2008|Anticipated|2008-06-01||Interventional|||The Effect of Acute and Chronic Exercise at the Metabolic Syndrome and Markers of Inflammation in Obese Subjects|The Effect of Acute and Chronic Exercise at the Metabolic Syndrome and Markers of Inflammation in Obese Subjects|Unknown status|Recruiting|N/A|100|Anticipated|Aarhus University Hospital||3|||f||||f||||||||||2017-02-18 14:14:57.691636|2017-02-18 14:14:57.691636
NCT00580671|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-07-30|2013-03-25||November 2007||2007-11-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|July 2012|Actual|2012-07-01||Interventional|||Treatment for Adolescent Marijuana Abuse|Behavioral Treatment of Adolescent Marijuana Use|Completed||N/A|153|Actual|Dartmouth-Hitchcock Medical Center||3|||f||||f||||||||||2017-02-18 14:56:43.450404|2017-02-18 14:56:43.450404
NCT00700219|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2010-07-19|||June 2008||2008-06-01|July 2010|2010-07-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Observational|IAI||Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes|Development of a Non-invasive Test to Detect Intra-amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and and Intact Amniotic Membranes|Unknown status|Recruiting|N/A|900|Anticipated|ProteoGenix, Inc.|||1||f||||f||||||Samples Without DNA|"~     Cervical-vaginal Fluid, Amniotic Fluid, Maternal Serum, Neonatal Cord Blood, Maternal Urine,~     Placental and Umbilical Cord Tissues~   "|||2017-02-18 14:14:57.888975|2017-02-18 14:14:57.888975
NCT00700206|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2011-10-10|||May 2008||2008-05-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)|Phase 2 Randomized Study Comparing Two Dose Schedules of Ezatiostat Hydrochloride (Telintra™, TLK199 Tablets) in Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)|Completed||Phase 2|86|Anticipated|Telik||2|||f||||f||||||||||2017-02-18 14:14:58.000759|2017-02-18 14:14:58.000759
NCT00700193|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-07-17|||March 2005||2005-03-01|November 2008|2008-11-01||||June 2006|Actual|2006-06-01||Interventional|||A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population|An Open-Label, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of CSL's Influenza Vaccine in a Paediatric Population (= or >6 Months to < 9 Years of Age).|Completed||Phase 3|298|Actual|Seqirus||2|||f||||f||||||||||2017-02-18 14:14:58.136087|2017-02-18 14:14:58.136087
NCT00700180|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-09-23|2014-09-16||September 2008||2008-09-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||Intent-to-treat (ITT) population. The ITT population included all participants randomized into the study.|A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.|A Randomized, Open-label Study to Explore the Correlation of Biomarkers With Response Rate in Chemo-naive Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer Who Receive Treatment With Avastin in Addition to Carboplatin-based Chemotherapy|Completed||Phase 2|303|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:14:58.242115|2017-02-18 14:14:58.242115
NCT00700167|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-04-19|||September 2001||2001-09-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy|Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy - A Phase I Trial in Melanoma|Completed||Phase 1|43|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:14:59.042826|2017-02-18 14:14:59.042826
NCT00700154|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2015-04-08|||November 2011||2011-11-01|December 2011|2011-12-01|November 2017|Anticipated|2017-11-01|December 2016|Anticipated|2016-12-01||Interventional|IINDU||Insulin Infusion Diabetes Ulcer|The Effect of Insulin Infusion on Metabolic Control and Inflammation in Diabetic Patients During Cardio-vascular Intervention and/or Treatment for Acute Foot Ulcer Infection.|Enrolling by invitation||Phase 4|40|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 14:14:59.154261|2017-02-18 14:14:59.154261
NCT00700141|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2012-05-04|2010-03-11||September 2008||2008-09-01|April 2010|2010-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil®|Non-Interventional Study on the Use of TachoSil® During Thyroid Surgery|Completed||N/A|482|Actual|Nycomed|||1||f||||f||||||||||2017-02-18 14:14:59.287353|2017-02-18 14:14:59.287353
NCT00700128|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-07-22|||June 2008||2008-06-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|MAM||Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals|Prevention of Menstrual Migraines: Effects of Continuous Oral Contraceptives to Combination With Prophylactic Frovatriptan Use During Hormone Free Intervals|Completed||N/A|30|Actual|Scott and White Hospital & Clinic||2|||f||||f||||||||||2017-02-18 14:14:59.68765|2017-02-18 14:14:59.68765
NCT00700115|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2014-11-25|2012-06-07||June 2008||2008-06-01|November 2014|2014-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|KITE||Kaletra-isentress Treatment Evaluation|A Pilot Study to Assess the Safety, Efficacy, and PK Profile of a Switch in Antiretroviral Therapy to a RTI Sparing Combination of LPV/r and RAL in Virologically Suppressed HIV-infected Patients|Completed||Phase 4|60|Actual|Emory University|The findings of the KITE study should be interpreted in the context of a pilot study with a small sample size. Furthermore, adverse effects were self-reported, and the lack of blinding may have introduced biases in the collection of the data.|2|||f||||f||||||||||2017-02-18 14:14:59.817468|2017-02-18 14:14:59.817468
NCT00700102|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-07-02|2015-07-02||February 2006||2006-02-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.|A Randomized, Open-label Phase III Intergroup Study: Effect of Adding Bevacizumab to Cross Over Fluoropyrimidine Based Chemotherapy (CTx) in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line Standard CTx/Bevacizumab Combination|Completed||Phase 3|820|Actual|Hoffmann-La Roche|Patients in the study who were randomized to receive bevacizumab could continue to receive bevacizumab following discontinuation of chemotherapy, thereby minimizing any potential bias introduced by differential follow-up time in the treatment arms.|2|||f||||||||||||||2017-02-18 14:15:00.476714|2017-02-18 14:15:00.476714
NCT00700089|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2016-10-24|||November 2007||2007-11-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|AID||AID-trial Assertive Intervention After Deliberate Self-harm|AID-trial:A Randomized Clinical Trial Comparing the Effect on Repeated Self-harm of Assertive Intervention and Standard Treatment After Deliberate Self-harm|Completed||Phase 4|243|Actual|University of Copenhagen||2|||f||||t||||||||||2017-02-18 14:15:01.675611|2017-02-18 14:15:01.675611
NCT00700076|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-12-01|||December 2006||2006-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects|Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects|Active, not recruiting||Phase 1|18|Anticipated|Yale University||2|||f||||t||||||||||2017-02-18 14:15:01.799481|2017-02-18 14:15:01.799481
NCT00699881|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2009-12-21|||May 2008||2008-05-01|June 2008|2008-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|STAGE||Study of Cetuximab to Treat Gastric Cancer|Phase II Study of Cetuximab (Erbitux®) in Combination With Modified FOLFIRI in Patients With Advanced Gastric Cancer Who Failed to First-line Chemotherapy|Completed||Phase 2|61|Actual|Fudan University||1|||f||||f||||||||||2017-02-18 14:15:16.270966|2017-02-18 14:15:16.270966
NCT00700063|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-15|2015-03-24|2012-06-13||June 2008||2008-06-01|March 2015|2015-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)|A Multicenter, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)|Completed||Phase 2|265|Actual|Peplin||8|||f||||f||||||||||2017-02-18 14:15:01.914439|2017-02-18 14:15:01.914439
NCT00700050|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2008-06-17|||April 2008||2008-04-01|June 2008|2008-06-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways|Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways - A Pilot Study|Unknown status|Recruiting|Phase 3|32|Anticipated|The Hospital for Sick Children||4|||f||||f||||||||||2017-02-18 14:15:03.702189|2017-02-18 14:15:03.702189
NCT00700037|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2014-10-28|||August 2009||2009-08-01|October 2014|2014-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|EASY-FIT||Change in Plaque Characteristics With Atorvastatin|Effect of Atorvastatin Therapy on Fibrous Cap Thickness in Coronary Atherosclerotic Plaque as Assessed by Optical Coherence Tomography|Completed||Phase 4|70|Actual|Wakayama Medical University||2|||f||||f||||||||||2017-02-18 14:15:03.818087|2017-02-18 14:15:03.818087
NCT00700024|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-09-18|||April 2008||2008-04-01|September 2009|2009-09-01|February 2010|Anticipated|2010-02-01|January 2010|Anticipated|2010-01-01||Interventional|||Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men|The Effect of Testim and Training in a Population Based, Randomized, Placebo-controlled, Double-blinded Study of Hypogonadal Men|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Odense University Hospital||3|||f||||t||||||||||2017-02-18 14:15:03.930332|2017-02-18 14:15:03.930332
NCT00700011|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2013-03-12|2012-12-06||March 2008||2008-03-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)|A Pilot Study of IV Clofarabine for Patients With Myelodysplastic Syndrome Who Have Failed 5-azacytidine|Terminated||Phase 2|10|Actual|Texas Oncology Cancer Center||2||poor accrual|f||||t||||||||||2017-02-18 14:15:04.261404|2017-02-18 14:15:04.261404
NCT00699998|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2013-03-21|2013-03-21||June 2008||2008-06-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|TRILOGY ACS||A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects|A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects With Unstable Angina/Non-ST-Elevation Myocardial Infarction Who Are Medically Managed|Completed||Phase 3|9326|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 14:15:04.885664|2017-02-18 14:15:04.885664
NCT00699985|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-08-13|||September 2006||2006-09-01|August 2010|2010-08-01|December 2007|Actual|2007-12-01|||||Observational|SCL90-R||Psychological Symptoms in Patients With Behcet's Disease by SCL90-R|Comparison of Psychological Symptoms in Patients With Behcet's Disease and Control Patients by Symptom Check List 90-Revised (SCL-90-R)|Completed||N/A|400|Actual|Tehran University of Medical Sciences|||2||f||||t||||||||||2017-02-18 14:15:13.821455|2017-02-18 14:15:13.821455
NCT00699972|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-10-30|2012-10-23||June 2008||2008-06-01|October 2015|2015-10-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures|A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures|Completed||Phase 3|390|Actual|Eisai Inc.||3|||f||||f||||||||||2017-02-18 14:15:13.952671|2017-02-18 14:15:13.952671
NCT00699959|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-08-04|||June 2008||2008-06-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|||||Observational|COMPAR||National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups|Comparison and Description of Coronary Patients Management With or Without Heart Failure in Cardiology Consulting|Completed||N/A|1650|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 14:15:14.967571|2017-02-18 14:15:14.967571
NCT00699946|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-01-19|||January 2005||2005-01-01|January 2009|2009-01-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery|A Double-Blind, Randomized, Placebo-Controlled Study of Perioperative Administration of Olanzapine to Prevent Postoperative Delirium in Joint Replacement Patients|Completed||N/A|495|Actual|The New England Baptist Hospital||2|||f||||f||||||||||2017-02-18 14:15:15.559795|2017-02-18 14:15:15.559795
NCT00699933|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2011-08-08|||May 2008||2008-05-01|June 2010|2010-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Diagnostic and Interventional Therapy in Acute Pancreatitis|Diagnostic and Interventional Therapy in Acute Pancreatitis|Unknown status|Recruiting|N/A|50|Anticipated|University of Regensburg|||1||f||||f||||||Samples With DNA|"~     Bacterial DNA~   "|||2017-02-18 14:15:15.668658|2017-02-18 14:15:15.668658
NCT00699920|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2010-06-28|||June 2008||2008-06-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|SMART-CURE||Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks|A Randomised Study to Compare a Fixed Dose Combination of Artesunate Plus Amiodaquine (Coarsucam) Versus a Fixed Dose Combination of Artemether Plus Lumefantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks Occurring During the 2 Years of Follow-up, in Children in Uganda.|Completed||Phase 4|413|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:15:15.772343|2017-02-18 14:15:15.772343
NCT00699907|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-12-11|||January 2005||2005-01-01|April 2014|2014-04-01|November 2014|Actual|2014-11-01|November 2012|Actual|2012-11-01||Interventional|||Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer|A Prospective, Phase IIA Study of the Effect of Flutamide (125 MG/DAY) Taken for 6 Weeks on Expression of Potential Biomarkers of Flutamide Action in the Ovaries of Women at Increased Risk for Ovarian Cancer|Completed||Phase 2|127|Actual|University of Arizona||1|||f||||t||||||||||2017-02-18 14:15:16.046347|2017-02-18 14:15:16.046347
NCT00699894|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2013-08-08|||June 2008||2008-06-01|August 2013|2013-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting|Comparison of Aprepitant PO and Ondansetron IV for Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Orthognathic Surgery and General Anesthesia.|Withdrawn||N/A|0|Actual|Northwell Health||2||Logistical difficulties running the study|f||||t||||||||||2017-02-18 14:15:16.157882|2017-02-18 14:15:16.157882
NCT00699868|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-06-01|||March 2008||2008-03-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|2006/25||Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients|Cellular Immunity, Cytomegalovirus Infection and Septic Shock in ICU Patients|Completed||N/A|29|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 14:15:16.384975|2017-02-18 14:15:16.384975
NCT00699855|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2014-02-17|||September 2008||2008-09-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|PREDICT LT FUP||Long Term Follow up Study of Predictive Markers in GHD and TS Children|Observational Long-term Follow-up of the Phase IV Open-label Trial of Predictive Markers in GHD and TS Pre-pubertal Children Treated With Saizen|Completed||N/A|182|Actual|Merck KGaA|||1||f||||||||||||||2017-02-18 14:15:16.509308|2017-02-18 14:15:16.509308
NCT00699842|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-10-19|2014-02-27||July 2008||2008-07-01|October 2016|2016-10-01|May 2012|Actual|2012-05-01|January 2011|Actual|2011-01-01||Interventional|||A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients|A Phase I/II Optimal Dose Study of Lenalidomide in the Non-5q- LOW and INT-1 Risk MDS Patients|Terminated||Phase 1/Phase 2|8|Actual|Thomas Jefferson University|Study was terminated as the objectives of this study have already been addressed in a larger study, and therefore the study is unlikely to yield any new information. The study closed before any data for the outcome measures was able to be collected.|1||Administratively terminated per FDA recommendation|f||||t||||||||||2017-02-18 14:15:16.612774|2017-02-18 14:15:16.612774
NCT00699829|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-02-12|||June 2008||2008-06-01|February 2009|2009-02-01||||||||Observational|BACHIMO||Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)|Comparative Medico-Economic Evaluation of Micrographic Mohs Surgery (MMS) and Traditional Surgical Excision With Immediate or Differed Reconstruction to Treat High Recurrence Risk Basal-Cell Carcinomas (BCC)|Unknown status|Recruiting|N/A|450|Anticipated|Hospital Ambroise Paré Paris|||2||f||||t||||||||||2017-02-18 14:15:17.43629|2017-02-18 14:15:17.43629
NCT00699816|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-08-23|2015-06-18||July 2008||2008-07-01|August 2015|2015-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||A total of 230 eligible participants were assigned randomly to either the immunotherapy group(n=115) or the control group(n=115). Among these randomized patients, 226(114 in the immunotherapy group and 112 in the control group) were included in the efficacy analysis. 4 patients were excluded due to violation of the inclusion and exclusion criteria.|Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients|Randomized, Open-label, Multi-center and Phase 3 Clinical Trial to Compare the Efficacy and Safety of 'Green Cross CELL Immuncell-LC Group' and 'Non-treatment Group' in Patient Undergone Curative Resection(PEIT, RFA or Operation) for Hepatocellular Carcinoma in Korea|Completed||Phase 3|230|Actual|Green Cross Cell Corporation||2|||f||||f||||||||||2017-02-18 14:15:17.522666|2017-02-18 14:15:17.522666
NCT00699803|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2014-04-04||2011-09-02|May 2008||2008-05-01|April 2014|2014-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of T-PRED(TM) Compared to Pred Forte(R)||Completed||Phase 2|56|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:15:18.633575|2017-02-18 14:15:18.633575
NCT00699790|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2015-09-23||2015-09-23|February 2009||2009-02-01|September 2015|2015-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance|A 12-Week Randomized, Double-Blinded Study to Evaluate the Effects of Daily Oral Doses of BMS-741672 in Drug-Naive Type 2 Diabetic Patients|Completed||Phase 2|58|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:15:18.735267|2017-02-18 14:15:18.735267
NCT00699777|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2013-04-15|||January 2008||2008-01-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects|A Randomized, Open-label, 2-period, Crossover Study to Assess the Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets Administered as a Single Oral Dose in Healthy Male and Female Subjects|Completed||Phase 1|96|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 14:15:18.849242|2017-02-18 14:15:18.849242
NCT00699764|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-09-06|||March 1996||1996-03-01|September 2016|2016-09-01|October 1999|Actual|1999-10-01|October 1999|Actual|1999-10-01||Interventional|||Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease|Safety of SmithKline Beecham Biologicals' Herpes Simplex Candidate Vaccine (gD2t) With MPL & Its Efficacy to Prevent Genital Herpes Disease in HSV Positive or Negative Consorts of Subjects With Genital Herpes Disease|Completed||Phase 3|2491|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:15:18.959613|2017-02-18 14:15:18.959613
NCT00699751|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-04-27|2013-06-29||June 2008||2008-06-01|April 2016|2016-04-01|February 2014|Actual|2014-02-01|July 2011|Actual|2011-07-01||Interventional|ALSYMPCA||A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases|A Double-blind, Randomised, Multiple Dose, Phase III, Multicentre Study of Alpharadin in the Treatment of Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases|Completed||Phase 3|921|Actual|Bayer||2|||f||||t||||||||||2017-02-18 14:15:19.106712|2017-02-18 14:15:19.106712
NCT00699738|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-05-23|||July 2008||2008-07-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Influence of Pregnancy and Post-partum Feeding Method (Breastfeeding Versus Bottlefeeding) on Maternal Hemodynamics (Central and Peripheral) and Vascular Function|Influence of Pregnancy and Post-partum Feeding Method (Breastfeeding Versus Bottlefeeding) on Maternal Hemodynamics (Central and Peripheral) and Vascular Function|Completed||N/A|150|Actual|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 14:15:21.809582|2017-02-18 14:15:21.809582
NCT00699725|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-12-06|||May 2008||2008-05-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|GADES||Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients|Compliance of Gastroprotection Treatment in the Prevention of Gastrointestinal Risk in Non-Steroidal Anti-inflammatory Drug (NSAID) Using Patients|Completed||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:15:21.911265|2017-02-18 14:15:21.911265
NCT00698802|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2015-04-13|||June 2008||2008-06-01|April 2015|2015-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes|Assessment of Safety and Efficacy of Biphasic Human Insulin IU 100 to EX1000 on Glycaemic Control in Subjects With Type 2 Diabetes|Completed||Phase 2|397|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 14:15:48.845948|2017-02-18 14:15:48.845948
NCT00699712|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2009-03-23|||June 2008||2008-06-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PreCONDITION||Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)|Multi-Center, Open Label, Dose Escalating, Sequential Group Study to Assess the Hemodynamic Effects, Safety and Tolerability of CD-NP in Patients With Stabilized Acute Heart Failure (AHF)|Completed||Phase 2|30|Anticipated|Nile Therapeutics||3|||f||||t||||||||||2017-02-18 14:15:22.299878|2017-02-18 14:15:22.299878
NCT00699699|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-03-12|2010-01-13||June 2008||2008-06-01|March 2014|2014-03-01||||January 2009|Actual|2009-01-01||Observational|||Observational Non-Interventional Study With Spiriva Respimat in COPD Patients|Assessment of Physical Activity (PF10 Sub Domain of SF-36 Activity Score) and Tolerability in COPD Patients During Treatment With Spiriva® Respimat®|Completed||N/A|1280|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:15:22.416951|2017-02-18 14:15:22.416951
NCT00699686|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2010-08-16|||May 2008||2008-05-01|August 2010|2010-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Endothelial Effects of Basal Insulin: Detemir Versus Glargine|Effects of Optimized Glycemic Control Achieved With add-on Basal Insulin Therapy on Indexes of Endothelial Damage and Regeneration in Type 2 Diabetic Patients With Macroangiopathy. A Randomized Cross-over Trial Comparing Detemir vs Glargine|Completed||Phase 4|50|Anticipated|University of Padova||2|||f||||f||||||||||2017-02-18 14:15:22.856909|2017-02-18 14:15:22.856909
NCT00699673|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2015-08-06|||June 2008||2008-06-01|August 2015|2015-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Evaluation of the Brain Natriuretic Peptide as a Predictor of Morbidity and Mortality in Cardiac Surgery|Evaluation of the Brain Natriuretic Peptide as a Predictor of Morbidity and Mortality in Cardiac Surgery|Active, not recruiting||N/A|500|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||||||2017-02-18 14:15:22.979887|2017-02-18 14:15:22.979887
NCT00699660|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2015-04-06|2014-09-23||May 2009||2009-05-01|September 2014|2014-09-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|E-3PTSD|Veterans undergoing compensation and pension examination for PTSD|Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment|Enhancing Equitable and Effective PTSD Disability Assessment|Completed||N/A|406|Actual|VA Office of Research and Development|Information external to interview such as psychological testing or charts were not available to the expert reviewers. Another limitation is that Veterans in our study did not undergo a concurrent, independent evaluation for assessment of PTSD.|2|||f||||t||||||||||2017-02-18 14:15:23.083536|2017-02-18 14:15:23.083536
NCT00699634|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2011-04-28|||January 2009||2009-01-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||Nabilone for the Treatment of Phantom Limb Pain|A Randomized Double-blind Placebo Controlled Trial Assessing the Effect of the Oral Cannabinoid Nabilone on Pain and Quality of Life in Patients With Phantom Limb Pain|Completed||Phase 2|50|Anticipated|University of Manitoba||1|||f||||t||||||||||2017-02-18 14:15:23.709349|2017-02-18 14:15:23.709349
NCT00699621|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2010-07-01|||January 2009||2009-01-01|July 2010|2010-07-01|December 2014|Anticipated|2014-12-01|July 2014|Anticipated|2014-07-01||Interventional|||Platelet Transfusion in Acute Intracerebral Hemorrhage|Platelet Transfusion in Acute Primary Intracerebral Hemorrhage for Patients on Platelet Inhibitors|Unknown status|Recruiting|N/A|100|Anticipated|University of Oulu||2|||f||||t||||||||||2017-02-18 14:15:23.809206|2017-02-18 14:15:23.809206
NCT00699608|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2012-05-31|2009-10-06||July 2008||2008-07-01|March 2011|2011-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.|A Randomised, Double-blind, Double-dummy, Placebo-controlled, 3-way Crossover Study to Evaluate Potential Next-day Residual Effects of a Single Evening Dose of 3mg Eszopiclone and 7.5mg Zopiclone in Healthy Adult Subjects.|Completed||Phase 3|91|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 14:15:23.927312|2017-02-18 14:15:23.927312
NCT00699595|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2014-11-08|||September 2008||2008-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|HEPP||Hormonal Effects on Pain Perception|Hormonal Effects on Pain Perception|Completed||N/A|50|Actual|University of Alabama at Birmingham|||1||f||||f||||||None Retained|"~     Plasma for progesterone levels~   "|||2017-02-18 14:15:25.19711|2017-02-18 14:15:25.19711
NCT00699582|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2014-06-26|2012-10-23||May 2008||2008-05-01|October 2012|2012-10-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures|A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures|Completed||Phase 3|389|Actual|Eisai Inc.||3|||f||||||||||||||2017-02-18 14:15:25.440125|2017-02-18 14:15:25.440125
NCT00699569|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2008-07-22|||July 2008||2008-07-01|June 2008|2008-06-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|Mucositis||Hyperimmune Colostrum and Oral Mucositis|The Effect of Hyperimmune Colostrum on Radiation-Induce Oral Mucositis of Patients With Head and Neck Cancer|Unknown status|Not yet recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-02-18 14:15:26.353278|2017-02-18 14:15:26.353278
NCT00699556|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2016-11-22|||January 2006||2006-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy|Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy|Completed||Phase 2|22|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:15:26.449245|2017-02-18 14:15:26.449245
NCT00699543|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2013-12-15|||July 2008||2008-07-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||The Efficacies of The New Paclitaxel-Eluting CoroflexTM Please Stent in Percutaneous Coronary Intervention|The Efficacies of The New Paclitaxel-Eluting CoroflexTM Please Stent in Percutaneous Coronary Intervention: Comparison or Efficacy Between COroflex PLEASe ANd TaxusTM Stent|Unknown status|Active, not recruiting|Phase 3|915|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:15:26.562866|2017-02-18 14:15:26.562866
NCT00699530|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2014-12-02|||May 2008||2008-05-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|June 2015|Anticipated|2015-06-01||Observational|||Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment|Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment|Unknown status|Recruiting|N/A|10|Anticipated|University of Aarhus|||1||f||||f||||||Samples Without DNA|"~     Whole blood, serum, muscle samples, fat samples~   "|||2017-02-18 14:15:26.662039|2017-02-18 14:15:26.662039
NCT00699517|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-11-18||2015-11-18|June 2008||2008-06-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies|A Multinational, Randomized, Double-blind Placebo Controlled Study of AVE8062 (25 mg/m2) Administered Every 3 Weeks in Patients With Advanced-stage Soft Tissue Sarcoma, Treated With Cisplatin (75 mg) After Failure of Anthracycline and Ifosfamide Chemotherapies.|Completed||Phase 3|355|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:15:26.763251|2017-02-18 14:15:26.763251
NCT00699504|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-01-13|||June 2008||2008-06-01|January 2012|2012-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers|A Double Blind, Placebo Controlled, Positive Controlled, Randomized, Crossover Study to Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers|Completed||Phase 1|67|Actual|The Medicines Company||5|||f||||f||||||||||2017-02-18 14:15:26.898755|2017-02-18 14:15:26.898755
NCT00699491|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-12-28|2015-05-05||October 2008||2008-10-01|December 2016|2016-12-01||||September 2013|Actual|2013-09-01||Interventional|||Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer|Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer|Active, not recruiting||Phase 1/Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:15:27.013147|2017-02-18 14:15:27.013147
NCT00699478|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-07-18|||April 2008||2008-04-01|July 2012|2012-07-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy|Effect of Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy|Completed||Phase 2|30|Actual|Yonsei University||1|||f||||f||||||||||2017-02-18 14:15:28.398072|2017-02-18 14:15:28.398072
NCT00699465|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2010-07-01|||August 2008||2008-08-01|July 2010|2010-07-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage|A Double-blind Randomized Trial to Compare the Efficacy of Intermittent Pneumatic Compression (IPC) With and Without Early Anticoagulant Treatment for Prevention of Venous Thromboembolism (VTE) in Patients With Acute Primary Intracerebral Hemorrhage (ICH)|Unknown status|Recruiting|Phase 4|320|Anticipated|University of Oulu||2|||f||||t||||||||||2017-02-18 14:15:30.987802|2017-02-18 14:15:30.987802
NCT00699452|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-05-18|||May 2009||2009-05-01|May 2009|2009-05-01|December 2014|Anticipated|2014-12-01|December 2012|Anticipated|2012-12-01||Interventional|ROCK-AS||The Potential of Candesartan to Retard the Progression of Aortic Stenosis|The Potential of Candesartan to Retard the Progression of Aortic Stenosis Influences of Medical Therapy to the Atheroinflammatory Process in Stenotic Aortic Valves|Unknown status|Recruiting|Phase 3|120|Anticipated|Helsinki University||2|||f||||t||||||||||2017-02-18 14:15:31.117653|2017-02-18 14:15:31.117653
NCT00699439|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2009-08-19|||July 2009||2009-07-01|August 2009|2009-08-01|January 2011|Anticipated|2011-01-01|May 2010|Anticipated|2010-05-01||Interventional|||A Reminder System for Paper-Based Asthma Guidelines in the Pediatric Emergency Department|A Reminder System for Paper-Based Asthma Guidelines in the Pediatric Emergency Department|Unknown status|Enrolling by invitation|N/A|400|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:15:31.237707|2017-02-18 14:15:31.237707
NCT00699426|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2012-08-31|||June 2008||2008-06-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Nexium||The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes|The Effect of Nexium and Cardi-04 Yoghurt on Insulin Secretion and Effect and Cardi Vascular Risk Factors Associated With the Insulin Syndrome in Patients With Type 2 Diabetes - a Randomized Double-blind, Prospective, Placebo Controlled 2 x 2 Factorial Design 3 Month's Study.|Completed||Phase 3|41|Actual|Steno Diabetes Center||4|||f||||t||||||||||2017-02-18 14:15:31.349199|2017-02-18 14:15:31.349199
NCT00699413|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-03-24|||February 2008||2008-02-01|June 2008|2008-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|SCORE||Supplements for Controlling Resistance to Insulin|Supplements for Controlling Resistance to Insulin|Terminated||Phase 4|10|Actual|University of Southern California||2||Sponsor decided to withdraw from study.|f||||f||||||||||2017-02-18 14:15:31.458313|2017-02-18 14:15:31.458313
NCT00699400|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2013-12-09|2013-05-16||June 2008||2008-06-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|May 2012|Actual|2012-05-01||Observational||"Subjects were analyzed based on the freeze cycle(s) that were used, therefore, the 4 subjects that used both types of cryopreservation techniques are summarized in both the slow freeze and vitrification arms. These 4 subjects will be double-counted in the Total (calculated) column."|Oocyte Cryopreservation Registry (HOPE Registry)|A Phase IV, Prospective, Multicenter, Observational Oocyte Cryopreservation Registry|Completed||N/A|204|Actual|EMD Serono|||1||f||||||||||||||2017-02-18 14:15:31.568875|2017-02-18 14:15:31.568875
NCT00699387|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2011-07-29|||April 2007||2007-04-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Population Pharmacokinetics of Benznidazole in Children With Chagas Disease|Population Pharmacokinetics Study of Benznidazole in Children With Chagas Disease|Completed||N/A|37|Actual|Hospital de Niños R. Gutierrez de Buenos Aires||1|||f||||t||||||||||2017-02-18 14:15:32.555396|2017-02-18 14:15:32.555396
NCT00699374|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2012-12-07|2012-12-07||July 2008||2008-07-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer|A Multinational, Randomized, Open-Label, Phase 3 Study Of Sunitinib Malate Versus Sorafenib In Patients With Advanced Hepatocellular Carcinoma|Terminated||Phase 3|1075|Actual|Pfizer|Study terminated early due to futility. Subsequently, EQ-5D data were not collected or analyzed.|2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 14:15:32.703897|2017-02-18 14:15:32.703897
NCT00699361|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2014-02-10|||August 2008||2008-08-01|June 2008|2008-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure|Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure|Withdrawn||Phase 3|0|Actual|Johann Wolfgang Goethe University Hospital||2||Study withdrawn for financial issues|f||||t||||||||||2017-02-18 14:15:34.169113|2017-02-18 14:15:34.169113
NCT00697190|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2015-05-06|2010-09-09||May 2008||2008-05-01|May 2015|2015-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Clinical Performance of Atypical Contact Lens Powers on Subjects With Astigmatism||Completed||N/A|39|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:16:12.624395|2017-02-18 14:16:12.624395
NCT00699348|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2016-03-08|2016-03-08||July 2008||2008-07-01|March 2016|2016-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|CARISMA|The safety population included all participants who were treated with at least 1 dose of C.E.R.A. and had a safety follow-up, whether withdrawn prematurely or not.|A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia|A Single Arm, Open Label Study to Assess the Efficacy, Safety and Tolerability of Once-monthly Administration of Intravenous C.E.R.A. for the Maintenance of Haemoglobin Levels in Hemodialysis Patients With Chronic Renal Anaemia|Completed||Phase 3|351|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:15:34.289924|2017-02-18 14:15:34.289924
NCT00699335|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-17|2012-05-04|2010-07-15||June 2008||2008-06-01|May 2012|2012-05-01||||July 2009|Actual|2009-07-01||Observational|Matrix LQ||Matrifen® for Therapy of Severe Chronic Pain®|Efficacy of Matrifen® in Patients Older Than 18 Years With Severe, Chronic Pain Including Quality of Life Questionnaire|Completed||N/A|5308|Actual|Nycomed|||1||f||||||||||||||2017-02-18 14:15:34.958023|2017-02-18 14:15:34.958023
NCT00699322|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-10-28|||June 2008||2008-06-01|October 2009|2009-10-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress|The Comparative Study of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on the Effect of Improving Glucose Variability and Oxidative Stress in Type 2 Diabetic Patients With Inadequate Glycemic Control on Metformin|Unknown status|Recruiting|Phase 4|36|Anticipated|The Catholic University of Korea||2|||f||||t||||||||||2017-02-18 14:15:37.285928|2017-02-18 14:15:37.285928
NCT00699309|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2013-03-19|||August 2005||2005-08-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||A Clinical Investigation of the Taperloc® Microplasty™ Hip System|A Prospective, Non-controlled, Clinical Investigation of the Taperloc® Microplasty™ Hip System|Completed||N/A|98|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 14:15:37.392403|2017-02-18 14:15:37.392403
NCT00699296|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-11-26|||May 2008||2008-05-01|November 2012|2012-11-01||||December 2008|Actual|2008-12-01||Interventional|||Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma|A Phase II Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma|Terminated||Phase 2|4|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:15:37.479069|2017-02-18 14:15:37.479069
NCT00699283|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2016-11-21|2016-03-14||August 2008||2008-08-01|November 2016|2016-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||Baseline Characteristics refer to the Intent-to-Treat Set (ITT), consisting of all randomized subjects with at least 1 intake of study medication.|A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures|An International, Double-blind, Randomized, Multi-center, Parallel Group, Historical-control Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures With or Without Secondary Generalization.|Terminated||Phase 3|62|Actual|UCB Pharma||2||"An interim analysis revealed the study was unlikely to attain a positive outcome for the~   efficacy analysis. No safety concerns were detected"|f||||f||||||||||2017-02-18 14:15:37.688556|2017-02-18 14:15:37.688556
NCT00699270|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-01-25|||August 2007||2007-08-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Observational|||A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems|A Prospective, Non-Controlled, Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems|Withdrawn||N/A|0|Actual|Zimmer Biomet|||1|Business need changed.|f||||f||||||||||2017-02-18 14:15:38.14839|2017-02-18 14:15:38.14839
NCT00699257|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-06-27|||July 2004||2004-07-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Observational|||A Clinical Investigation of the Oxford® Partial Knee System|A Prospective, Non-controlled, Clinical Investigation of the Oxford® Partial Knee System|Terminated||N/A|85|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 14:15:38.38382|2017-02-18 14:15:38.38382
NCT00699244|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-02-04|||December 2006||2006-12-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Comparison of Central Versus Peripheral Placement of Local Anesthetic|Selective Local Anesthetic Placement Using Ultrasound-guidance and Neurostimulation for the Infraclavicularbrachial Plexus Block|Completed||N/A|218|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:15:38.475014|2017-02-18 14:15:38.475014
NCT00699231|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||February 1992||1992-02-01|June 2008|2008-06-01|December 1992|Actual|1992-12-01|December 1992|Actual|1992-12-01||Interventional|||Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients|Study to Evaluate the Immunogenicity, Reactogenicity and Safety of GSK Biologicals' (Previously SmithKline Beecham Biologicals') MPL-Adjuvanted Recombinant Hepatitis B Vaccine Versus Engerix™-B, in Haemodialysis Patients|Completed||Phase 1|30|Actual|GlaxoSmithKline||8|||f||||||||||||||2017-02-18 14:15:38.596794|2017-02-18 14:15:38.596794
NCT00699218|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-10-10|||May 2008||2008-05-01|October 2012|2012-10-01|April 2010|Actual|2010-04-01|July 2009|Actual|2009-07-01||Interventional|TMS-BD||A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression|A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Bipolar Depression|Completed||Phase 1/Phase 2|15|Actual|University of California, Davis||1|||f||||f||||||||||2017-02-18 14:15:38.723949|2017-02-18 14:15:38.723949
NCT00699192|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-05-04|2011-01-11||May 2008||2008-05-01|May 2011|2011-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension|A Multicenter, Double-blind, Randomized, Parallel-group Study to Evaluate the Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 mg as Compared to Amlodipine/Valsartan 5/40 mg or to Amlodipine 5 mg Once Daily in Elderly Patients With Essential Hypertension Not Adequately Controlled After Four Weeks on Amlodipine 5 mg Once Daily|Completed||Phase 3|965|Actual|Novartis||3|||f||||f||||||||||2017-02-18 14:15:38.852256|2017-02-18 14:15:38.852256
NCT00699179|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-10-27|||June 2008||2008-06-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|EFFECTIVE||Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes|EFFicacious glycaEmia Control, Treatment Goal achIevement Very simplE With NovoMix 30: A Single-country, Multicentre, Prospective, Open Label, Non-controlled, Observational, 26-week Study in Serbian Patients Using NovoMix® 30 (Biphasic Insulin Aspart 30) for Treatment of Diabetes Mellitus in Everyday Clinical Practice|Completed||N/A|2308|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:15:39.377192|2017-02-18 14:15:39.377192
NCT00699166|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-12|||April 2004||2004-04-01|June 2008|2008-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|CDNK333B2201||Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter 2-Week Pilot Study to Evaluate the Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) Given Orally in Female Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|Completed||Phase 2|135|Actual|Novartis||3|||f||||||||||||||2017-02-18 14:15:39.4909|2017-02-18 14:15:39.4909
NCT00699153|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2015-03-04|2010-07-09||June 2008||2008-06-01|March 2015|2015-03-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery|Safety and Efficacy of Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery|Completed||Phase 3|400|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:15:39.638568|2017-02-18 14:15:39.638568
NCT00699140|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2016-01-09|2015-06-16||February 2008||2008-02-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|ITP||Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura|Clinical Trial to Evaluate the Efficacy and the Safety of IGIV3I Grifols 10% (Human Intravenous Immunoglobulin) in Patients Diagnosed With Immune Thrombocytopenic Purpura|Completed||Phase 3|18|Actual|Grifols Biologicals Inc.|The patient number was based on European Medicines Agency guidance to evaluate IVIG products in ITP patients (EMEA/CPMP/BPWG/388/95 rev.1, June 2000, in force when the study was designed): at least 15 subjects were sufficient for the analysis.|1|||f||||f||||||||||2017-02-18 14:15:40.146018|2017-02-18 14:15:40.146018
NCT00699127|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-14|2008-07-03|||July 2008||2008-07-01|July 2008|2008-07-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||Organizing the Information Given to Parents of NICU Infants in Order to Reduce Their Anxiety|Dose Organizing the Information Given to Parents of NICU Infants Reduce Their Anxiety?|Withdrawn||N/A|0|Actual|Hillel Yaffe Medical Center||2||After a discussion, we decided to withdraw the study.|f||||f||||||||||2017-02-18 14:15:40.57957|2017-02-18 14:15:40.57957
NCT00699114|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2011-07-03|||June 2007||2007-06-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Analgesic Effect of Ibuprofen, Paracetamol (Acetaminophen), and Paracetamol (Acetaminophen) Plus Codeine on Acute Pain|Analgesic Effect of Ibuprofen 400, 600 and 800 mg, Paracetamol 500 and 1000 mg, and Paracetamol 1000 mg Plus 60 mg Codeine: Single-dose, Randomized, Placebo-controlled and Double-blind Study on Acute Pain After Third Molar Surgery|Completed||Phase 4|350|Anticipated|Oslo University Hospital||7|||f||||f||||||||||2017-02-18 14:15:40.689961|2017-02-18 14:15:40.689961
NCT00699101|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-06-14|||June 2008||2008-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|March 2011|Actual|2011-03-01||Interventional|||Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy|A Multi-site Prospective, Non Randomized Study Utilizing the Conture® Multi-Lumen Balloon (MLB) Breast Brachytherapy Applicator to Deliver Accelerated Partial Breast Irradiation: Analysis of Dosimetric Success, Local Tumor Control, Cosmetic Outcome, Acute and Chronic Toxicity, and Clinical Scenarios for Optimal Use|Terminated||Phase 4|342|Actual|SenoRx, Inc.||1|||f||||t||||||||||2017-02-18 14:15:40.902067|2017-02-18 14:15:40.902067
NCT00699088|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2013-03-19|||January 2005||2005-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||A Clinical Investigation of the Balance® Microplasty™ Hip System|A Prospective, Non-controlled, Clinical Investigation of the Balance® Microplasty™ Hip System|Completed||N/A|70|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 14:15:41.006046|2017-02-18 14:15:41.006046
NCT00699062|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-01-03|||January 2010||2010-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Montelukast on the Airway Remodeling|Effect of Montelukast on the Airway Remodeling in Asthma Patients: Physiological-radiological Correlation|Completed||Phase 4|40|Actual|Chinese Academy of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:15:41.100701|2017-02-18 14:15:41.100701
NCT00699049|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2016-01-06|||June 2008||2008-06-01|January 2016|2016-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder|A Randomized, Double Blind, Placebo-Controlled, Parallel Group Comparison of the Efficacy and Safety of Any Alpha Blocker Monotherapy and Any Alpha Blocker Plus Solifenacin in Men With Residual Overactive Bladder Symptoms of Urinary Frequency and Urgency With/Without Urgency Incontinence After Previous Monotherapy With Any Alpha Blocker|Completed||Phase 4|94|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 14:15:41.221528|2017-02-18 14:15:41.221528
NCT00699036|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-06-18|||April 2007||2007-04-01|June 2009|2009-06-01|August 2009|Anticipated|2009-08-01|July 2009|Anticipated|2009-07-01||Interventional|||Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)|Rosiglitazone Versus Rosiglitazone and Metformin (Avandamet) Versus Combination Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis (NASH). A Prospective, Open-Label, Randomized Trial|Unknown status|Recruiting|Phase 2|165|Anticipated|Brooke Army Medical Center||3|||f||||t||||||||||2017-02-18 14:15:41.326491|2017-02-18 14:15:41.326491
NCT00699023|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2009-11-03|||June 2008||2008-06-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|EZE||Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes|Effects of Ezetimibe in Association With Statins on Postprandial Lipemia in Type 2 Diabetic Patients|Completed||Phase 4|13|Anticipated|Federico II University||2|||f||||f||||||||||2017-02-18 14:15:41.428842|2017-02-18 14:15:41.428842
NCT00699010|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-10-22|||March 2008||2008-03-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse|A Phase II, Single-Center, Randomized, Double-Blind Assessment of the Abuse Liability of Acurox (Oxycodone HCl and Niacin) Tablets in Subjects With a History of Opioid Abuse|Completed||Phase 2|30|Anticipated|Acura Pharmaceuticals Inc.||5|||f||||f||||||||||2017-02-18 14:15:41.535194|2017-02-18 14:15:41.535194
NCT00698997|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-12|||April 2008||2008-04-01|June 2008|2008-06-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Interventional|||Intensive Intervention for Toddlers With Autism (EARLY STEPS)|Intensive Intervention for Toddlers With Autism|Unknown status|Recruiting|N/A|108|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-02-18 14:15:41.638082|2017-02-18 14:15:41.638082
NCT00698984|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2009-01-15|||January 2007||2007-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Investigation of the Effect of BONISTEIN(R) Bone Blend on Bone Mineral Density/Content and Biomarkers of Bone Health|Pilot Study To Investigate The Effect Of Bonistein(R) Bone Blend Containing Genistein, Polyunsaturated Fatty Acids (N-3 PUFAS) And Vitamins K1 And D3 On Bone Mineral Density (BMD), Bone Mineral Content (BMC) And Biomarkers Of Bone Health In Early Postmenopausal Women|Completed||N/A|70|Actual|DSM Nutritional Products, Inc.||2|||f||||t||||||||||2017-02-18 14:15:41.760264|2017-02-18 14:15:41.760264
NCT00698958|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||June 2003||2003-06-01|June 2008|2008-06-01||||||||Interventional|||Ambulatory Adaptation to Non-Invasive Mechanical Ventilation|A Randomized Trial to Compare the Effectiveness of Hospital or Ambulatory Approach for Adaptation to Non-Invasive Mechanical Ventilation in Patients With Chronic Respiratory Failure Secondary to Neuromuscular Diseases or Thoracic Cage Alterations|Completed||Phase 4|52|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 14:15:41.864177|2017-02-18 14:15:41.864177
NCT00698945|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-12-02|||June 2008||2008-06-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)|Randomized, Investigator Masked Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)|Completed||Phase 4|40|Anticipated|Bp Consulting, Inc||2|||f||||||||||||||2017-02-18 14:15:41.9592|2017-02-18 14:15:41.9592
NCT00698932|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2011-08-17|2010-09-20||June 2008||2008-06-01|August 2011|2011-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control|A 24-Week International, Multi-centre, Randomized, Parallel-group, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise.|Completed||Phase 3|568|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:15:42.063951|2017-02-18 14:15:42.063951
NCT00698919|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||September 2008||2008-09-01|June 2008|2008-06-01|November 2010|Anticipated|2010-11-01|September 2010|Anticipated|2010-09-01||Observational|||Bacterial Infection Diagnosis Using Blood DNA|Bacterial DNA Detection as a Diagnostic Tool of Infection in Critical Ill Patients With SIRS|Unknown status|Not yet recruiting|N/A|400|Anticipated|Delafontaine Hospital|||2||f||||f||||||Samples With DNA|"~     Sample with bacterial DNA (and no human DNA will be studied)~      We will have also some blood and plasma for cytokines,peptidoglycan and endotoxin~     measurement.~   "|||2017-02-18 14:15:42.585107|2017-02-18 14:15:42.585107
NCT00698906|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||June 1997||1997-06-01|June 2008|2008-06-01||||February 1998|Actual|1998-02-01||Interventional|||Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y|Study Comparing the Immunogenicity and Reactogenicity of Different Formulations of GSK Bio's HBV-MPL Vaccine Injected as a 0, 6 Months Schedule With That of Engerix™-B Injected as a 0, 1, 6 Months Schedule in Healthy Adults Aged 19-40 Years|Completed||Phase 2|160|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-02-18 14:15:42.905233|2017-02-18 14:15:42.905233
NCT00698893|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||May 1992||1992-05-01|June 2008|2008-06-01|July 1992|Actual|1992-07-01|July 1992|Actual|1992-07-01||Interventional|||Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-Positive Adults|An Open Study in Healthy Herpes Simplex Virus (HSV)-Positive Adults to Evaluate the Safety of GSK Biologicals' Candidate gD Vaccine, With or Without MPL|Completed||Phase 1|16|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:15:45.425976|2017-02-18 14:15:45.425976
NCT00698880|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2008-06-16|||March 2007||2007-03-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization|Sequential Preoperative Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization to Induce Further Liver Regeneration in Patients With Hepatobiliary Malignancy|Completed||Phase 2/Phase 3|13|Actual|Asan Medical Center||2|||f||||t||||||||||2017-02-18 14:15:45.563488|2017-02-18 14:15:45.563488
NCT00698867|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-07-14|||June 2002||2002-06-01|July 2015|2015-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||A Clinical Investigation of the Discovery™ Elbow System|A Prospective, Non-controlled, Clinical Investigation of the Discovery™ Elbow System|Completed||N/A|98|Actual|Zimmer Biomet|||1||f||||f||||||||Undecided||2017-02-18 14:15:45.660059|2017-02-18 14:15:45.660059
NCT00698854|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-07-08|||March 2004||2004-03-01|July 2016|2016-07-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01||Observational|||A Clinical Investigation of the Vanguard™ Complete Knee System|A Prospective, Non-controlled, Clinical Investigation of the Vanguard™ Complete Knee System|Enrolling by invitation||N/A|600|Anticipated|Zimmer Biomet|||2||f||||f||||||||Undecided||2017-02-18 14:15:45.763602|2017-02-18 14:15:45.763602
NCT00698841|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2015-11-24|2011-04-14||February 2009||2009-02-01|November 2015|2015-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors|A Study to Evaluate the Relationship Between Cetuximab Therapy and Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors|Completed||Phase 2|79|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:15:45.888591|2017-02-18 14:15:45.888591
NCT00698828|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2015-10-19||2011-04-04|March 2008||2008-03-01|October 2015|2015-10-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)|A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|225|Actual|Daiichi Sankyo Inc.||3|||f||||f||||||||||2017-02-18 14:15:46.678554|2017-02-18 14:15:46.678554
NCT00698815|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-14|2016-11-29|2015-02-17||April 2008||2008-04-01|November 2016|2016-11-01||||December 2013|Actual|2013-12-01||Interventional|||Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib (NSC # 736511) or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non-small Cell Lung Cancer|Active, not recruiting||Phase 2|130|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 14:15:46.852542|2017-02-18 14:15:46.852542
NCT00698789|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-10-25||2012-10-11|May 2008||2008-05-01|October 2012|2012-10-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes|A Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety and Tolerability of INCB019602 Plus Metformin Compared to Metformin Alone in Type 2 Diabetic Subjects|Terminated||Phase 2|48|Actual|Incyte Corporation||6||Study ended after diabetes development plan review. .|f||||f||||||||||2017-02-18 14:15:48.952145|2017-02-18 14:15:48.952145
NCT00698776|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2016-06-20|||April 2009||2009-04-01|June 2016|2016-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma|Phase I/II Trial of Combination of Lenalidomide (Revlimid, LEN) and Autologous Mature Dendritic Cells Pulsed With α-galactosyl Ceramide (α-GalCer; KRN7000) in Myeloma|Completed||Phase 1|6|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:15:49.075997|2017-02-18 14:15:49.075997
NCT00698763|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2009-11-23|||August 2008||2008-08-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|Electro||Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables|Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables and Cerebrovascular Reactivity in Patients With Recent Stroke or TIA.|Completed||Phase 2|32|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-02-18 14:15:49.177166|2017-02-18 14:15:49.177166
NCT00698750|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-08-14|||April 2004||2004-04-01|August 2012|2012-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||A Clinical Investigation of the Copeland™ Humeral Resurfacing Head|A Prospective, Non-controlled, Clinical Investigation of the Copeland™ Humeral Resurfacing Head|Terminated||N/A|34|Actual|Zimmer Biomet|||1|Sponsor terminated study early due to limited enrollment and follow-up.|f||||f||||||||||2017-02-18 14:15:49.285548|2017-02-18 14:15:49.285548
NCT00698737|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-11-20|||April 2008||2008-04-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|ARC||Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)|Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)|Completed||N/A|22|Actual|Wayne State University|||1||f||||t||||||||||2017-02-18 14:15:49.576551|2017-02-18 14:15:49.576551
NCT00698724|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2009-06-08|||June 2008||2008-06-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care|A Prospective, Randomized Single-Masked Clinical Trial Comparing OCT and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care|Completed||Phase 4|200|Anticipated|Bp Consulting, Inc||2|||f||||||||||||||2017-02-18 14:15:49.667389|2017-02-18 14:15:49.667389
NCT00698711|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-01-27|||November 1997||1997-11-01|January 2012|2012-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21|Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21: A Trial Comparing MUC-2-KLH Doses|Completed||Phase 1|15|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:15:49.760555|2017-02-18 14:15:49.760555
NCT00698698|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2009-01-30|||January 2009||2009-01-01|January 2009|2009-01-01|June 2011|Anticipated|2011-06-01|December 2010|Anticipated|2010-12-01||Observational|||Study on Tear Proteins in Diabetic Retinopathy of Type 2 Diabetics|Tear Proteins and Diabetic Retinopathy|Unknown status|Active, not recruiting|N/A|350|Anticipated|Dow University of Health Sciences|||5||f||||t||||||||||2017-02-18 14:15:49.880555|2017-02-18 14:15:49.880555
NCT00698685|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-14|2015-12-02|2010-12-28||November 2005||2005-11-01|December 2015|2015-12-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Interventional|||Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation|Phase II Related or Unrelated Allogeneic Hematopoietic Cell Transplantation for High-Risk Malignancies, Using a Preparative Regimen of Pentostatin (Nipent®) and Alemtuzumab (Campath®)|Terminated||Phase 2|14|Actual|University of Arizona|We did not meet criteria to stop the study because of nonrelapse mortality (safety endpoint). However, we stopped accrual to the study because of failure to meet minimal criteria for engraftment (efficacy endpoint).|1||Pentostatin/alemtuzumab regimen had greater risk of graft failure.|f||||t||||||||||2017-02-18 14:15:49.970217|2017-02-18 14:15:49.970217
NCT00698672|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2015-07-29|||November 2004||2004-11-01|July 2015|2015-07-01|June 2017|Anticipated|2017-06-01|June 2007|Actual|2007-06-01||Interventional|||RSA-Study of Cemented Hip Prostheses With Five Different Articulations|A Prospective Randomized RSA-Study of Cemented Hip Prostheses With Five Different Articulations|Active, not recruiting||N/A|150|Actual|Haukeland University Hospital||5|||f||||f||||||||||2017-02-18 14:15:50.318113|2017-02-18 14:15:50.318113
NCT00698659|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-15|2013-12-10|||August 2007||2007-08-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies|A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth|Terminated||N/A|||National University Hospital, Singapore|||1||f||||f||||||||||2017-02-18 14:15:50.412629|2017-02-18 14:15:50.412629
NCT00698646|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2011-04-15|2010-11-16||April 2008||2008-04-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.|A 16 Week Multi-center, Randomized, Double-blind Study to Evaluate Efficacy and Safety of Valsartan/Hydrochlorothiazide (HCTZ) Combination Therapy Compared to Patients Initiated With Valsartan Monotherapy or Hydrochlorothiazide (HCTZ) Monotherapy in Very Elderly Patients With Essential Hypertension|Completed||Phase 4|384|Actual|Novartis||3|||f||||f||||||||||2017-02-18 14:15:50.52482|2017-02-18 14:15:50.52482
NCT00698633|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-10-31|||December 2001||2001-12-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||A Clinical Investigation of the M2a- Taper™ Hip System|M2a- Taper™ Hip System Prospective Data Collection|Terminated||N/A|43|Actual|Zimmer Biomet|||1|due to low follow up|f||||||||||||||2017-02-18 14:15:51.224785|2017-02-18 14:15:51.224785
NCT00682357|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-10-05|2016-10-05||May 2008||2008-05-01|October 2016|2016-10-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional|||Effect of Intraarticular Steroids on Bone Turnover in Osteoarthritis|Effect of Intraarticular Steroids on Bone Turnover in Osteoarthritis|Completed||N/A|25|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-02-18 14:21:21.795874|2017-02-18 14:21:21.795874
NCT00698607|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-15|2010-06-28|||June 2008||2008-06-01|June 2010|2010-06-01|April 2014|Anticipated|2014-04-01|April 2010|Anticipated|2010-04-01||Interventional|EXCELLENT||Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing|Comparison of the Efficacy of Everolimus-Eluting Versus Sirolimus-Eluting Stent for Coronary Lesions|Unknown status|Active, not recruiting|Phase 4|1466|Anticipated|Seoul National University Hospital||4|||f||||t||||||||||2017-02-18 14:15:51.313647|2017-02-18 14:15:51.313647
NCT00698594|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2011-08-19|||September 2008||2008-09-01|August 2011|2011-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis|Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis Allergic to Grass Pollen|Completed||Phase 4|60|Actual|Medical Universtity of Lodz||3|||f||||t||||||||||2017-02-18 14:15:51.433182|2017-02-18 14:15:51.433182
NCT00698581|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2016-03-14|2016-03-14||August 2008||2008-08-01|March 2016|2016-03-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional||Demographics refer to the Randomized Set (RS).|A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures|An International, Double-blind, Randomized, Multi-center, Parallel Group, Historical-control Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures With or Without Secondary Generalization|Terminated||Phase 3|88|Actual|UCB Pharma||2||"An interim analysis revealed the study was unlikely to attain a positive outcome for the~   efficacy analysis. No safety concerns were detected."|f||||t||||||||||2017-02-18 14:15:51.53746|2017-02-18 14:15:51.53746
NCT00698568|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2008-06-16|||October 1996||1996-10-01|June 2008|2008-06-01|April 1999|Actual|1999-04-01|April 1999|Actual|1999-04-01||Interventional|||Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects|Study to Evaluate the Safety of GSK Biologicals' Herpes Simplex Candidate Vaccine (gD2t) With MPL in HSV Seropositive or Seronegative Subjects Without Genital Herpes Disease|Completed||Phase 3|7460|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:15:52.092736|2017-02-18 14:15:52.092736
NCT00698555|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||March 1997||1997-03-01|June 2008|2008-06-01||||May 1998|Actual|1998-05-01||Interventional|||Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y|Study Comparing the Immunogenicity and Reactogenicity of Different Formulations of GSK Bio's HBV-MPL Vaccine Injected as a 0, 6 Months Schedule With That of Engerix™-B Injected as a 0, 1, 6 Months Schedule in Healthy Adults Aged 18-40 Years|Completed||Phase 2|163|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-02-18 14:15:52.400701|2017-02-18 14:15:52.400701
NCT00698542|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-12-12|||May 2008||2008-05-01|December 2008|2008-12-01|July 2009|Anticipated|2009-07-01|May 2009|Anticipated|2009-05-01||Observational|||Evaluation of the Patient Safety Screening Tool (PSST) for Sepsis|A Validation of a Patient Safety Screening Tool for Sepsis|Unknown status|Enrolling by invitation|N/A|200|Anticipated|Vanderbilt University|||1||f||||t||||||||||2017-02-18 14:15:52.529922|2017-02-18 14:15:52.529922
NCT00698529|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-04-21|||November 2008||2008-11-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|February 2013|Actual|2013-02-01||Interventional|||Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations|Communication Technology to Disseminate Evidence-Based HIV Interventions to NGOs|Active, not recruiting||Phase 2|99|Anticipated|Medical College of Wisconsin||3|||f||||f||||||||||2017-02-18 14:15:52.641259|2017-02-18 14:15:52.641259
NCT00698516|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2012-03-22|2011-01-13||July 2008||2008-07-01|March 2011|2011-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer|An Open-label, Multicenter, Non-comparative, Phase II Study of Oral Topotecan in Combination With Bevacizumab for Second-line Treatment in Subjects With Relapsed Small-cell Lung Cancer (SCLC)|Completed||Phase 2|50|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:15:52.772502|2017-02-18 14:15:52.772502
NCT00698503|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2014-03-19|||January 2002||2002-01-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||A Clinical Investigation of the M2a- 38™ Hip System|M2a- 38™ Hip System Prospective Data Collection|Terminated||N/A|190|Actual|Zimmer Biomet|||1|due to low follow up|f||||||||||||||2017-02-18 14:15:53.260489|2017-02-18 14:15:53.260489
NCT00698490|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||August 1995||1995-08-01|June 2008|2008-06-01|January 1997|Actual|1997-01-01|January 1997|Actual|1997-01-01||Interventional|||Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines|Study to Compare, in Healthy HSV Seronegative and HSV Seropositive Subjects, the Humoral and Cellular Immune Response of Herpes Simplex Candidate Vaccines Containing gD From Two Different Cell Lines and Using gD-Alum as Control|Completed||Phase 1/Phase 2|130|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-02-18 14:15:53.343447|2017-02-18 14:15:53.343447
NCT00698477|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-15|2008-06-15|||October 2007||2007-10-01|June 2008|2008-06-01||||||||Observational|||Chemotherapy on Methylation Patterns in Breast Tumor Tissue Correlating With Clinical Response and Outcomes|Study of the Effect of Chemotherapy on Methylation Patterns in Breast Tumor Tissue and Paired Plasma Samples and Correlation With Clinical Response and Outcomes|Unknown status|Recruiting|N/A|||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 14:15:53.454139|2017-02-18 14:15:53.454139
NCT00698464|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-11-03|||July 2008||2008-07-01|November 2016|2016-11-01||||April 2009|Actual|2009-04-01||Interventional|||Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function|A Phase I, Open-label, Multi-center, Single Dose Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function|Completed||Phase 1|34|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:15:53.537695|2017-02-18 14:15:53.537695
NCT00698451|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-08-20|2011-12-10||August 2008||2008-08-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers|A Phase II Single Arm Study of Carboplatin and DOXIL (PLD) Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers|Completed||Phase 2|54|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 14:15:53.652836|2017-02-18 14:15:53.652836
NCT00697164|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-12|||October 2007||2007-10-01|June 2008|2008-06-01|March 2009|Anticipated|2009-03-01|December 2008|Anticipated|2008-12-01||Interventional|EPOMAL||Randomized Trial of Erythropoietin During Cerebral Malaria|Randomized Trial of Erythropoietin to Prevent Death From Cerebral Impairment During Severe Malaria|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|Claude Bernard University||2|||f||||t||||||||||2017-02-18 14:16:13.438866|2017-02-18 14:16:13.438866
NCT00698438|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-06-12|||March 2005||2005-03-01|June 2008|2008-06-01||||August 2007||2007-08-01||Interventional|XVT-USF||Comparison Of Trabeculectomy Versus The Ex-PRESS Miniature Glaucoma Device In The Same Patient: A Prospective Randomized Study|Prospective, Randomized Clinical Trial,to Compare Standard Trabeculectomy to the Ex-PRESS Mini Glaucoma Shunt Implantation Under a Scleral Flap in Eyes With Open-Angle Glaucoma|Completed||Phase 4|30||University of Witwatersrand, South Africa||2|||f||||t||||||||||2017-02-18 14:15:54.007528|2017-02-18 14:15:54.007528
NCT00698425|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2010-08-20|||March 2008||2008-03-01|August 2010|2010-08-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Tolerability Study of Transscleral Iontophoresis by the EyeGate® II Drug Delivery Device System|Single Center, Single-masked, Randomized, Dose Escalation Study to Evaluate Safety and Tolerability of Transscleral Iontophoresis Using Citrate Buffer Delivered by the EyeGate® II Drug Delivery Device System in Healthy Adult Volunteers|Completed||Phase 1|105|Actual|Eyegate Pharmaceuticals, Inc.||19|||f||||f||||||||||2017-02-18 14:15:54.120088|2017-02-18 14:15:54.120088
NCT00698412|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-13|||January 2005||2005-01-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effectiveness of Cane in Osteoarthritis (OA) Patients|The Impact of Daily Cane Use on Pain, Function, Quality of Life and Energy Consumption During the Gait in Patients With Knee Osteoarthritis|Completed||Phase 4|64|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:15:54.253556|2017-02-18 14:15:54.253556
NCT00698399|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-12|||March 2008||2008-03-01|June 2008|2008-06-01|April 2009|Anticipated|2009-04-01|March 2009|Anticipated|2009-03-01||Observational|||Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients|Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients, Phase II|Unknown status|Enrolling by invitation|N/A|40|Actual|Vanderbilt University|||2||f||||f||||||Samples Without DNA|"~     serum of patients who are undergoing liver transplantation surgery~   "|||2017-02-18 14:15:54.363248|2017-02-18 14:15:54.363248
NCT00698386|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2009-09-14|||February 2008||2008-02-01|June 2008|2008-06-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients|Efficacy of Oral Zinc Administration as an Adjunct Therapy in Category I Pulmonary Tuberculosis Along With Assessment of Immunological Parameters (Double-blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial|Unknown status|Recruiting|Phase 3|150|Anticipated|Ministry of Science and Technology, India|||||f||||t||||||||||2017-02-18 14:15:54.459669|2017-02-18 14:15:54.459669
NCT00698373|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-16||||||June 2008|2008-06-01||||||||Observational|||Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study|Evaluation of Thoracic Tumors With 18F-FMT and 8F-FDG PET-CT: A Clinicopathological Study|Completed||N/A|||Gunma University|||1||f||||f||||||||||2017-02-18 14:15:54.564979|2017-02-18 14:15:54.564979
NCT00698360|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||July 2007||2007-07-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|CREAM 1||Circadian Rhythm of Erythropoietin And Melatonin in Renal Disease|Circadian Rhythm of Erythropoietin and Melatonin in Patients With Various Degrees of Renal Insufficiency|Completed||N/A|34|Actual|Meander Medical Center|||4||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:15:54.629734|2017-02-18 14:15:54.629734
NCT00698347|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2015-04-15|||November 2004||2004-11-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||A Clinical Investigation of the M2a-Magnum™ Hip System|A Prospective, Non-controlled, Clinical Investigation of the M2a-Magnum™ Hip System|Terminated||N/A|249|Actual|Zimmer Biomet|||1|Centers would not continue follow-up; two centers transitioned patients to a new study.|f||||f||||||||||2017-02-18 14:15:54.740151|2017-02-18 14:15:54.740151
NCT00698334|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-11-05|||April 2006||2006-04-01|November 2011|2011-11-01|April 2011|Actual|2011-04-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis|Efficacy of Thrice Weekly Intermittent Short Course Antituberculosis Chemotherapy in Tuberculosis Patients With and Without HIV Infection|Completed||Phase 3|150|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 14:15:54.83308|2017-02-18 14:15:54.83308
NCT00698321|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2013-05-17|||November 2008||2008-11-01|May 2013|2013-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A School-Based HIV/STD Prevention Program to Reduce Risky Sexual Behaviors Among Adolescents in Liberia|Liberia School-Based HIV/STD Prevention Program|Completed||N/A|866|Actual|Pacific Institute for Research and Evaluation||2|||f||||f||||||||||2017-02-18 14:15:54.959738|2017-02-18 14:15:54.959738
NCT00698295|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-15|2009-09-15|||September 2004||2004-09-01|September 2009|2009-09-01|September 2010|Anticipated|2010-09-01|||||Observational|||Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication|Study of the Relationship Between EEG and Clinical Changes in Drug-Naive or Drug-Free Patients With Schizophrenia After Atypical Antipsychotic Treatment Based on Linear and Non-Linear EEG Analysis|Unknown status|Active, not recruiting|N/A|60|Anticipated|Seoul National University Hospital|||1||f||||t||||||Samples Without DNA|"~     routine lab for changes in medical condition~   "|||2017-02-18 14:15:55.069708|2017-02-18 14:15:55.069708
NCT00698282|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2010-11-30|||August 2008||2008-08-01|November 2010|2010-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|JSAD/JMAD||Single and Multiple Ascending Doses of AZD1981 in Japan|A Randomised, Placebo-Controlled, Double-Blind, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Doses of AZD1981 in Healthy Male Japanese and Caucasian Subjects|Completed||Phase 1|47|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:15:55.166874|2017-02-18 14:15:55.166874
NCT00698269|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-10-26|||February 2008||2008-02-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment|Efficacy and Safety Study in Subjects Using Levemir® (Insulin Detemir), NovoMix®30 (Biphasic Insulin Aspart 30) and/or NovoRapid® (Insulin Aspart) for the Treatment of Type 1 or Type 2 Diabetes Mellitus|Completed||N/A|5926|Actual|Novo Nordisk A/S|||3||f||||f||||||||||2017-02-18 14:15:55.255412|2017-02-18 14:15:55.255412
NCT00698256|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2012-04-16|||February 2008||2008-02-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|maxsta||Effect of High Stanol Ester Dose on Serum Lipids, Carotenoids and Fat-soluble Vitamins|Effect of High Stanol Ester Dose on Serum Lipids, Carotenoids and Fat-soluble Vitamins|Completed||N/A|50|Actual|University of Eastern Finland||2|||f||||f||||||||||2017-02-18 14:15:55.45665|2017-02-18 14:15:55.45665
NCT00698243|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2013-04-11|||June 2008||2008-06-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma|A Phase 1 Dose-escalation Study of Intermittent, Once Weekly, and Continuous Daily Oral OSI-027 Dosing in Patients With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|128|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 14:15:55.553169|2017-02-18 14:15:55.553169
NCT00698230|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2012-03-13||2010-06-17|May 2008||2008-05-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics|Randomized Study to Evaluate the Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetic Subjects|Completed||Phase 2|302|Actual|Incyte Corporation||6|||f||||f||||||||||2017-02-18 14:15:55.663116|2017-02-18 14:15:55.663116
NCT00698204|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2014-05-07|2014-05-07||July 2003||2003-07-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|September 2012|Actual|2012-09-01||Interventional||Intent-to-treat analysis performed for 40 participants. Per-protocol analysis performed for the period in which individual participants were taking study medication (celecoxib or placebo).|Cox-2 Inhibition in Radiation-induced Oral Mucositis|Cyclooxygenase-2 Inhibition in Radiation-Induced Oral Mucositis|Completed||Phase 2|43|Actual|UConn Health||2|||f||||t||||||||||2017-02-18 14:15:55.985135|2017-02-18 14:15:55.985135
NCT00698191|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2008-06-16|||March 2007||2007-03-01|June 2008|2008-06-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)|Phase I/IIa: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells Transplantation For Refractory Systemic Lupus Erythematosus|Unknown status|Recruiting|Phase 1/Phase 2|20|Anticipated|Nanjing Medical University||1|||f||||t||||||||||2017-02-18 14:15:56.538898|2017-02-18 14:15:56.538898
NCT00698178|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2010-10-18|||June 2008||2008-06-01|October 2010|2010-10-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|||Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux Disease|Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux Disease|Completed||N/A|500|Anticipated|Lotung Poh-Ai Hospital|||3||f||||t||||||||||2017-02-18 14:15:56.648288|2017-02-18 14:15:56.648288
NCT00698165|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-16|2009-02-19|||June 2007||2007-06-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|||||Observational|||Observational Study on Costs and Caregiver Burden in Alzheimer's Disease|Observational Study on Costs and Caregiver Burden in Alzheimer's Disease|Completed||N/A|2400|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 14:15:56.752452|2017-02-18 14:15:56.752452
NCT00698152|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2015-06-17|||January 2006||2006-01-01|June 2015|2015-06-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement|A Prospective, Non-controlled, Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement|Active, not recruiting||N/A|149|Actual|Zimmer Biomet|||1||f||||f||||||||||2017-02-18 14:15:56.953546|2017-02-18 14:15:56.953546
NCT00698139|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2014-07-11|2014-01-28||April 2011||2011-04-01|July 2014|2014-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate|Cardiovascular and Neurohormonal Effects of Faster Atrial Pacing Rate for Six Hours in Patients With Congestive Heart Failure, Heart Rate <70 Beats Per Minute and Fluid Overload.|Terminated||N/A|3|Actual|Columbia University|Early termination leading to small numbers of subjects analyzed|3||Closed by Sponsor|f||||f||||||||||2017-02-18 14:15:57.0466|2017-02-18 14:15:57.0466
NCT00698126|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-13|2016-10-26|||October 2007||2007-10-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|UPGRADE||Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes|A Multicentre, Open Label, Nonrandomised, Non-interventional, Observational, Safety Study in Subjects Using Insulin Aspart (NovoRapid® ) or Soluble Human Insulin for the Treatment of Diabetes Mellitus the UPGRADE Study|Completed||N/A|4099|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 14:15:57.549951|2017-02-18 14:15:57.549951
NCT00698113|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2009-06-17|||April 2007||2007-04-01|June 2008|2008-06-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Interventional|||Parent-Delivered Massage in Paediatric Cancer|Parent-Delivered Massage in Paediatric Cancer|Unknown status|Recruiting|N/A|24|Anticipated|Centennial College||2|||f||||t||||||||||2017-02-18 14:15:57.6607|2017-02-18 14:15:57.6607
NCT00698100|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2011-09-15|||June 2002||2002-06-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines|Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines: A Phase I Trial to Assess Safety and Immune Response|Completed||Phase 1|18|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:15:57.800269|2017-02-18 14:15:57.800269
NCT00698087|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||January 1995||1995-01-01|June 2008|2008-06-01|February 1996|Actual|1996-02-01|February 1996|Actual|1996-02-01||Interventional|||Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B|Study to Compare the Safety, Immunogenicity and Reactogenicity of Different Formulations of GSK Biologicals' (Previously SmithKline Beecham Biologicals') MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B|Completed||Phase 3|60|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 14:15:57.911773|2017-02-18 14:15:57.911773
NCT00698074|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-13||||||June 2008|2008-06-01||||||||Interventional|||Diastolic Ventricular Interaction and the Effects of Biventricular Pacing in Hypertrophic Cardiomyopathy|Diastolic Ventricular Interaction and the Effects of Biventricular Pacing in Hypertrophic Cardiomyopathy|Unknown status|Recruiting|Phase 3|32|Anticipated|University Hospital Birmingham||1|||f||||||||||||||2017-02-18 14:15:58.023296|2017-02-18 14:15:58.023296
NCT00698061|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2011-11-17|||November 1999||1999-11-01|November 2011|2011-11-01|May 2001|Actual|2001-05-01|September 2000|Actual|2000-09-01||Interventional|||Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y|A Study to Compare the Immunogenicity and Safety of GSK Biologicals Adjuvanted HBV Vaccine to Engerix™-B, in a Non-responder Population ≥ 15 Years of Age, When Administered Intramuscularly, According to a 0, 1, 2, 12 Month Schedule|Completed||Phase 3|145|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:15:58.102847|2017-02-18 14:15:58.102847
NCT00697151|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2011-09-14|||June 1993||1993-06-01|September 2011|2011-09-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|PICSS||Patent Foramen Ovale in Cryptogenic Stroke Study|Patent Foramen Ovale in Cryptogenic Stroke Study|Completed||Phase 4|630|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 14:16:13.550837|2017-02-18 14:16:13.550837
NCT00698048|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2015-09-07|||August 2008||2008-08-01|September 2015|2015-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|VaCoSS||Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic Shock|Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic Shock|Completed||N/A|136|Actual|KK Women's and Children's Hospital|||3||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 14:15:58.204344|2017-02-18 14:15:58.204344
NCT00698035|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2014-05-27|2014-04-29||March 2007||2007-03-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|E-String|Baseline Characteristics for 75 participants who initiated treatment. One participant consented and was assigned to ESTRING, but did not insert ESTRING prior to withdrawing from the study.|Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients|A Phase II Study of Vaginal Testosterone Cream vs. the ESTRING for Vaginal Dryness or Decreased Libido in Early Breast Cancer Patients Treated With Aromatase Inhibitors|Completed||Phase 2|76|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:15:58.304542|2017-02-18 14:15:58.304542
NCT00698022|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2012-05-01|2010-11-04||November 2008||2008-11-01|May 2012|2012-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers|A 4-week, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers|Completed||Phase 2|76|Actual|Corcept Therapeutics||3|||f||||f||||||||||2017-02-18 14:15:58.84841|2017-02-18 14:15:58.84841
NCT00698009|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2012-10-23|2012-10-23||June 2008||2008-06-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma|Study to Infuse Haploidentical Natural Killer Cells in Patients With Relapsed or Refractory Neuroblastoma|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 14:15:59.319719|2017-02-18 14:15:59.319719
NCT00697996|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-12-19|||June 2005||2005-06-01|December 2008|2008-12-01|August 2007||2007-08-01|||||Interventional|||Rituximab for Pediatric Renal Transplant Rejection|A Prospective Open-Labeled Randomized Study of Rituximab Versus Standard of Care, for Treatment of Acute Allograft Rejection in Pediatric Renal Transplantation|Completed||Phase 2/Phase 3|20||Stanford University|||||||||||||||||||2017-02-18 14:15:59.55383|2017-02-18 14:15:59.55383
NCT00697983|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2011-04-19|||August 2008||2008-08-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|ATPBone||Cohort Study on Associations Between Purinergic Receptor SNPs and Osteoporosis Risk|Purinergic Signalling in Human Osteoporosis: Evaluation of Variability in Purinergic Receptor Genes and Receptor Function|Completed||N/A|1000|Anticipated|Maastricht University Medical Center|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, plasma~   "|||2017-02-18 14:15:59.639468|2017-02-18 14:15:59.639468
NCT00697970|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||November 1993||1993-11-01|June 2008|2008-06-01|April 1995|Actual|1995-04-01|April 1995|Actual|1995-04-01||Interventional|||Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine|Study to Evaluate the Immunogenicity and Reactogenicity of Various Formulations of GSK Biologicals' (Previously SmithKline Beecham Biologicals') Recombinant Hepatitis B Vaccine in Healthy Adult Volunteers|Completed||Phase 3|321|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-02-18 14:15:59.739293|2017-02-18 14:15:59.739293
NCT00697957|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-13|||May 2002||2002-05-01|June 2008|2008-06-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Bone Adaptation to Impact Loading|Bone Adaptation to Impact Loading - Significance of Loading Intensity|Completed||N/A|120|Actual|University of Oulu||2|||f||||f||||||||||2017-02-18 14:15:59.860184|2017-02-18 14:15:59.860184
NCT00697944|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||March 2008||2008-03-01|March 2009|2009-03-01|March 2009|Anticipated|2009-03-01|February 2009|Anticipated|2009-02-01||Interventional|AMBIDEX||Ambisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients|Ambisome® Preemptive Treatment of Multiple Colonizations by Candida in Intensive Care Patients With a Sepsis|Unknown status|Recruiting|Phase 4|30|Anticipated|Fovea||1|||f||||t||||||||||2017-02-18 14:15:59.948948|2017-02-18 14:15:59.948948
NCT00697931|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||May 1997||1997-05-01|June 2008|2008-06-01|June 1998|Actual|1998-06-01|June 1998|Actual|1998-06-01||Interventional|||Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders|Study to Compare the Immunogenicity and Reactogenicity of GSK Biologicals; (Previously SmithKline Beecham Biologicals') MPL-Adjuvanted Recombinant Hepatitis B Vaccine With That of Engerix™-B in an Adult Non-Responder Population|Completed||Phase 3|116|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:16:00.049131|2017-02-18 14:16:00.049131
NCT00697918|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-01-15||2013-01-15|March 2008||2008-03-01|January 2013|2013-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures|An Extension Study to Evaluate the Safety and Effectiveness of RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures|Completed||Phase 3|11|Actual|SK Life Science||1|||f||||||||||||||2017-02-18 14:16:00.163618|2017-02-18 14:16:00.163618
NCT00697905|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2014-11-20|||January 2008||2008-01-01|April 2010|2010-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma|An Open Labeled, Multicentre, Randomized Phase II Trial of Combination Gemcitabine and Carboplatin Chemotherapy in Patients With Metastatic or Recurrent Nasopharyngeal Carcinoma|Completed||Phase 2|18|Actual|Ministry of Health, Malaysia||2|||f||||f||||||||||2017-02-18 14:16:00.271917|2017-02-18 14:16:00.271917
NCT00697892|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2013-06-04|||July 2005||2005-07-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations|Pharmacokinetic Interactions Between Antiretroviral Agents, Lopinavir/Ritonavir and Efavirenz and Antimalarial Drug Combinations, Artesunate/Amodiaquine and Artemether/Lumefantrine.|Completed||Phase 1|38|Actual|University of California, San Francisco||2|||f||||||||||||||2017-02-18 14:16:00.392444|2017-02-18 14:16:00.392444
NCT00697879|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-11-25|||February 2008||2008-02-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|||Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours|A Phase I Study to Evaluate the Safety and Tolerability of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours|Completed||Phase 1|40|Actual|Chroma Therapeutics||1|||f||||f||||||||||2017-02-18 14:16:02.948425|2017-02-18 14:16:02.948425
NCT00697866|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2016-09-15|||August 2000||2000-08-01|September 2016|2016-09-01||||February 2001|Actual|2001-02-01||Interventional|||Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control|Evaluating the Consistency of 3 Consecutive Lots of GSK Biologicals' Novel Adjuvanted HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as a Control, Administered According to a 0, 1, 2-month Schedule in Healthy Volunteers (15-50y).|Completed||Phase 3|951|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:16:03.07237|2017-02-18 14:16:03.07237
NCT00697853|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||November 1998||1998-11-01|June 2008|2008-06-01||||July 1999|Actual|1999-07-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults|Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' Novel Adjuvanted Hepatitis B Vaccine Administered According to a 0, 6 Month Schedule and of Engerix™-B Administered According to a 0, 1, 6 Month Schedule in Healthy Adults|Completed||Phase 2|200|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-02-18 14:16:03.187441|2017-02-18 14:16:03.187441
NCT00697840|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||June 1995||1995-06-01|June 2008|2008-06-01|January 1996|Actual|1996-01-01|January 1996|Actual|1996-01-01||Interventional|||Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B|Study to Assess the Safety, Immunogenicity and Reactogenicity of GSK Biologicals' (Previously SmithKline Beecham Biologicals') Adjuvanted Recombinant Hepatitis B Vaccine, Recombinant Hepatitis B Vaccine New Formulation and Engerix™-B|Completed||Phase 3|150|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 14:16:03.299311|2017-02-18 14:16:03.299311
NCT00697827|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-06-05|2012-05-03||June 2008||2008-06-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|In-Space||A Study of the In-Space Device for Treatment of Moderate Spinal Stenosis|A Multi-Center Randomized Controlled Trial of the In-Space Compared to X STOP® for Treatment of Moderate Degenerative Lumbar Spinal Stenosis|Terminated||Phase 3|44|Actual|Synthes USA HQ, Inc.|Study terminated early secondary to low enrollment leading to small number of subjects available for analyses.|2||Study terminated due to low enrollment.|f||||f||||||||||2017-02-18 14:16:03.410335|2017-02-18 14:16:03.410335
NCT00697814|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||June 2004||2004-06-01|June 2008|2008-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clomiphene in Males With Prolactinomas and Persistent Hypogonadism|Recovery of Gonadal Function by Clomiphene in Males With Prolactinomas and Persistent Hypogonadism|Completed||Phase 2|15|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-02-18 14:16:03.86356|2017-02-18 14:16:03.86356
NCT00697801|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-12-09|2013-08-19||July 2006||2006-07-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional||The baseline characteristics are summarized on the Intent-to-treat population (those patients with at least 1 on treatment efficacy evaluation including 1 electronic diary entry).|Study of MAP0010 in Asthmatic Children and Adolescents|A Randomized, Double Blind, Placebo Controlled, 3 Arm, Parallel Group, Phase 2 Study Investigating the Efficacy, Tolerability and Pharmacokinetics of MAP0010 in Asthmatic Children and Adolescents Over 6 Weeks|Completed||Phase 2|208|Actual|Allergan||3|||f||||f||||||||||2017-02-18 14:16:03.96947|2017-02-18 14:16:03.96947
NCT00697788|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2011-12-11|||January 2006||2006-01-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|||Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients|Cardiovascular Safety of Dexmedetomidine in Pediatric Burn Patients.|Completed||Phase 2|9|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 14:16:04.61152|2017-02-18 14:16:04.61152
NCT00697775|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||March 1998||1998-03-01|June 2008|2008-06-01||||May 1999|Actual|1999-05-01||Interventional|||Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents|Study to Assess the Feasibility of GSK Bio's Candidate HBV / MPL Vaccines Following Different Schedules and Formulations and to Compare Their Safety and Immunogenicity to That of Engerix™-B in Healthy Adolescents Aged 11 to 15|Completed||Phase 2|200|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 14:16:04.7228|2017-02-18 14:16:04.7228
NCT00697762|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-01-14||2013-01-07|October 2007||2007-10-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures|A Double-Blind Study to Evaluate the Effectiveness and Safety of RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures|Terminated||Phase 3|56|Actual|SK Life Science||3||The trial was stopped based on information from the global phase 3 studies.|f||||f||||||||||2017-02-18 14:16:04.84006|2017-02-18 14:16:04.84006
NCT00697749|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-09-15|||April 1999||1999-04-01|September 2016|2016-09-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype|Phase III Study to Compare Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Novel Adjuvanted Hepatitis B Vaccine Adminstered Intramuscularly, According to a 0, 6 Month Schedule, to Engerix™-B 20 mcg Administered According to a 0,1,6 Month Schedule in Healthy Volunteers Positive for the HLA-DQ2 Genotype|Completed||Phase 3|230|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:16:04.950981|2017-02-18 14:16:04.950981
NCT00697736|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2015-11-12|||March 2007||2007-03-01|November 2015|2015-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|HTAP-SCLERO||Cardiac Repercussion of Systemic Sclerodermias|Cardiac Repercussion of Systemic Sclerodermias : Detection of Infra-clinical Abnormalities by Analysis of the Myocardic Regional Function Using Myocardial Tissular Doppler Mode.|Completed||N/A|148|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-02-18 14:16:05.061509|2017-02-18 14:16:05.061509
NCT00697723|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-13|||January 2005||2005-01-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Arterial Versus Venous Graft Recruitment by Intra-Aortic Balloon Pump||Completed||Phase 4|138|Actual|University Magna Graecia||1|||f||||||||||||||2017-02-18 14:16:05.155839|2017-02-18 14:16:05.155839
NCT00697177|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-02-12|||July 2005||2005-07-01|September 2005|2005-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||The Prevalence of Gastro-oesophageal Reflux in Chronic Lung Disease|The Prevalence of Gastro-oesophageal Reflux in Chronic Obstructive Pulmonary Disease and Bronchiectasis and the Effects of Medications, Physiotherapy Airway Clearance Techniques and Exercise on Gastro-oesophageal Function.|Completed||Phase 1/Phase 2|75|Actual|Bayside Health|||1||f||||||||||||||2017-02-18 14:16:13.336472|2017-02-18 14:16:13.336472
NCT00697710|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2011-09-13|||July 2007||2007-07-01|July 2011|2011-07-01|September 2008|Actual|2008-09-01|February 2008|Actual|2008-02-01||Interventional|||A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis|A Phase Ib/IIa, Multiple-Dose, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Mild to Moderate Atopic Dermatitis|Completed||Phase 1/Phase 2|37|Actual|Shionogi Inc.||3|||f||||f||||||||||2017-02-18 14:16:05.246954|2017-02-18 14:16:05.246954
NCT00697697|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-12-09|2013-08-19||April 2008||2008-04-01|December 2013|2013-12-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional||Subjects were randomly assigned to treatment.|A Study of 2 Doses of MAP0010 in Asthmatic Children|A Randomized, Double-blind, Active-controlled, Phase 3 Extension Study Investigating the Safety and Efficacy Over 40 Weeks of 2 Doses of MAP0010 in Asthmatic Children (12 Months to 8 Years Old at the Time of Enrollment Into the MAP0010-CL-P301 Study)|Terminated||Phase 3|192|Actual|Allergan|The study was terminated due to a corporate decision before all subjects had completed the study.|2||Corporate decision|f||||f||||||||||2017-02-18 14:16:05.349908|2017-02-18 14:16:05.349908
NCT00697684|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2016-01-21|||June 2008||2008-06-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Interventional|||Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant|A Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin and Total Lymphoid Irradiation Followed by Allogeneic Hematopoietic Stem Cell Transplantation|Active, not recruiting||Phase 1|30|Anticipated|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-02-18 14:16:05.684694|2017-02-18 14:16:05.684694
NCT00697671|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2013-07-15|||March 2007||2007-03-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|||Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies|Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies|Completed||Phase 1|48|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-02-18 14:16:05.798133|2017-02-18 14:16:05.798133
NCT00697658|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2014-04-24|||March 2008||2008-03-01|April 2014|2014-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia|INVega Is Studied In an Observational Design in the Netherlands|Completed||Phase 4|27|Actual|Janssen-Cilag B.V.|||1||f||||f||||||||||2017-02-18 14:16:05.915319|2017-02-18 14:16:05.915319
NCT00697645|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2009-02-08|||March 2009||2009-03-01|June 2008|2008-06-01||||December 2010|Anticipated|2010-12-01||Interventional|tmstroke||Use of Deep Transcranial Magnetic Stimulation After Stroke|Phase 2 Double Blind Randomized Clinical Trial of Deep Transcranial Magnetic Stimulation After Stroke|Unknown status|Not yet recruiting|Phase 1/Phase 2|40|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 14:16:06.039467|2017-02-18 14:16:06.039467
NCT00697632|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2017-01-17|||June 2008||2008-06-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies|Open-Label Dose-Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Daily Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies|Recruiting||Phase 1|150|Anticipated|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 14:16:06.151473|2017-02-18 14:16:06.151473
NCT00697619|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-03-04|2011-12-19||September 2005||2005-09-01|December 2011|2011-12-01|September 2009|Actual|2009-09-01|January 2009|Actual|2009-01-01||Interventional|||To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer|A Prospective, Open-label, Randomized Phase III Study to Evaluate the Efficacy of ZOMETA® (Zoledronic Acid) in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer|Completed||Phase 2|60|Actual|Sun Yat-sen University||2|||f||||f||||||||||2017-02-18 14:16:06.27114|2017-02-18 14:16:06.27114
NCT00697606|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2015-12-29|||July 2008||2008-07-01|December 2015|2015-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|SPARC||Seprafilm® for Prevention of Adhesions at Repeat Cesarean|Randomized Double-Blind Controlled Study to Determine if Seprafilm® Reduces Adhesions After Primary Cesarean Section|Terminated||Phase 3|450|Actual|Abington Memorial Hospital||2||lack of funding|f||||t||||||||||2017-02-18 14:16:06.870152|2017-02-18 14:16:06.870152
NCT00697593|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2014-01-20|2010-06-29||January 2008||2008-01-01|January 2014|2014-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|EASY||ChangE From Any Systemic psoriasiS therapY to Raptiva|A Phase IV Open Label Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Transitioning From Previous Systemic Antipsoriasis Therapies (Methotrexate, Cyclosporine, Retinoids or Psoralen-Ultraviolet Light A (PUVA), Narrow-Band Ultraviolet Light B (NBUVB) to Raptiva 1mg/kg/ Week Therapy.|Terminated||Phase 4|70|Actual|Merck KGaA||1||"The study was terminated after the European Medicines Agency recommended to suspend the~   marketing authorisation of Raptiva in the European Union"|f||||||||||||||2017-02-18 14:16:06.994101|2017-02-18 14:16:06.994101
NCT00697580|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2011-07-20|||May 2005||2005-05-01|July 2011|2011-07-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|SANO LA||Strength and Nutrition Outcomes for Latino Adolescents|Intra-Abdominal Fat and Risk of Disease in Adolescents|Completed||N/A|104|Anticipated|University of Southern California||4|||f||||t||||||||||2017-02-18 14:16:07.881303|2017-02-18 14:16:07.881303
NCT00697567|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2008-06-13|||September 1992||1992-09-01|June 2008|2008-06-01|December 1997|Actual|1997-12-01|December 1997|Actual|1997-12-01||Interventional|||Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant|Study in Healthy HSV Positive and HSV Negative Adults to Evaluate the Immunogenicity, Reactogenicity and Safety of GSK Biologicals' Herpes Simplex (gD) Candidate Vaccine With or Without Adjuvant|Completed||Phase 2|80|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 14:16:07.991663|2017-02-18 14:16:07.991663
NCT00697554|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2016-09-08|||January 2000||2000-01-01|September 2016|2016-09-01||||May 2002|Actual|2002-05-01||Interventional|||Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age|Study to Compare the Immunogenicity and Safety of GSK Biologicals' Novel Adjuvanted HBV Vaccine (0, 21-day Schedule) to a Double Dose of Engerix™ -B (0, 7, 21-day Schedule), in Pre-liver Transplant Patients ≥ 18 y, Boosted at Month 6-12|Completed||Phase 3|93|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:16:08.104326|2017-02-18 14:16:08.104326
NCT00697541|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2014-08-06|2013-09-19||May 2008||2008-05-01|August 2014|2014-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%|A Phase II, Single-Center, Two-Way Crossover Relative Systemic Bioavailability Study of Col-118 Administered Topically as a 0.18 % Facial Gel and Brimonidine Ophthalmic Solution 0.2% Administered to the Eye in Subjects With Moderate to Severe Erythematous Rosacea|Completed||Phase 2|20|Actual|Galderma||2|||f||||f||||||||||2017-02-18 14:16:08.225333|2017-02-18 14:16:08.225333
NCT00697528|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2013-12-18|||January 2007||2007-01-01|June 2008|2008-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy|Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy|Completed||N/A|66|Actual|University of Sao Paulo|||3||f||||t||||||||||2017-02-18 14:16:08.644759|2017-02-18 14:16:08.644759
NCT00697515|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2011-12-06|2009-11-20||July 2008||2008-07-01|December 2011|2011-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|A Phase IIIb Randomized, Double-Blind, Multicenter, Placebo-Controlled, Dose Optimization, Crossover, Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|142|Actual|Shire||2|||f||||f||||||||||2017-02-18 14:16:08.757155|2017-02-18 14:16:08.757155
NCT00697502|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-10-31|||May 2007||2007-05-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study of Capecitabine In Patients With Solid Tumors|A Phase I Study of Capecitabine In Patients With Solid Tumors|Completed||Phase 1|23|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-02-18 14:16:09.588121|2017-02-18 14:16:09.588121
NCT00697489|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-04-05|||June 2008||2008-06-01|April 2013|2013-04-01||||August 2010|Actual|2010-08-01||Interventional|||Treatment of Urinary Stress Incontinence During or Following Correction of Pelvic Organ Prolapse|Pelvic Organ Prolapse Correction Plus Preventive Treatment of Urinary Stress Incontinence vs. Correction of Pelvic Organ Prolapse Followed by Treatment of Urinary Stress Incontinence|Withdrawn||Phase 4|0|Actual|University Magna Graecia||2|||f||||t||||||||||2017-02-18 14:16:09.698664|2017-02-18 14:16:09.698664
NCT00697476|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2013-05-27|||January 2009||2009-01-01|May 2013|2013-05-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC|Phase I-II Study of Oral Suberoylanilide Hydroxamic Acid (Vorinostat) in Combination With Topotecan in Patients With Chemosensitive Recurrent Small Cell Lung Cancer (SCLC)|Terminated||Phase 1/Phase 2|2|Actual|Istituto Clinico Humanitas||1||insufficient enrollment|f||||f||||||||||2017-02-18 14:16:09.80967|2017-02-18 14:16:09.80967
NCT00697463|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-04-13|||August 2008||2008-08-01|April 2016|2016-04-01|September 2016|Anticipated|2016-09-01|July 2016|Anticipated|2016-07-01||Interventional|IOPForteo||Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women|Teriparatide for the Treatment of Idiopathic Osteoporosis in Premenopausal Women|Active, not recruiting||Phase 2/Phase 3|27|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 14:16:09.919703|2017-02-18 14:16:09.919703
NCT00697450|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-11-22|||July 2008||2008-07-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics|Observational Study Evaluating the Body Weight Progress During the Treatment With Insulin Detemir (Levemir®) in Type 2 Patients, Previously Treated With Other Basal Insulins|Completed||N/A|206|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:16:10.03553|2017-02-18 14:16:10.03553
NCT00697437|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2013-12-08|||October 2006||2006-10-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel|Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel|Completed||Phase 2|10|Actual|National University Hospital, Singapore||2|||f||||t||||||||||2017-02-18 14:16:10.143507|2017-02-18 14:16:10.143507
NCT00697424|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-12-07|||May 2008||2008-05-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Comparison of Breathing Events Detected by the SleepStyle 200 Auto Continuous Positive Airway Pressure (CPAP) Device to Attended Polysomnography|Investigation of Methods to Detect Respiratory Irregularities in Obstructive Sleep Apnea (OSA)|Completed||N/A|20|Anticipated|Fisher and Paykel Healthcare||1|||f||||t||||||||||2017-02-18 14:16:10.264817|2017-02-18 14:16:10.264817
NCT00697411|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-12-15|||October 2002||2002-10-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Study of Selected X-Linked Disorders: Aicardi Syndrome|Pathogenesis of Selected X-Linked Dominant Disorders and New Strategies to Identify the Gene Mutated in Aicardi Syndrome|Recruiting||N/A|300|Anticipated|Baylor College of Medicine|||1||f||||f||||||Samples With DNA|"~     lymphoblast DNA; tissue~   "|Yes|patient data with all identification removed will be published following peer review in journals and/or presented at scientific meetings.|2017-02-18 14:16:10.364244|2017-02-18 14:16:10.364244
NCT00697398|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2014-08-27|||October 2008||2008-10-01|January 2010|2010-01-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||Repetitive Trans-cranial Magnetic Stimulation of the Motor Cortex in Fibromyalgia: A Study Evaluating the Clinical Efficiency and the Metabolic Correlate in 18FDG-PET|Repetitive Trans-cranial Magnetic Stimulation of the Motor Cortex in Fibromyalgia: A Prospective Randomized Blinded Placebo-controlled Study Evaluating the Clinical Efficiency and the Metabolic Correlate in 18FDG-PET|Completed||N/A|38|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 14:16:10.49624|2017-02-18 14:16:10.49624
NCT00697385|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-09-18|||April 2003||2003-04-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders|Open Label Continuation Study for the Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders|Completed||N/A|13|Actual|Mary M. Gooley Hemophilia Center||1|||f||||f||||||||||2017-02-18 14:16:10.597443|2017-02-18 14:16:10.597443
NCT00697372|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2010-06-14|||September 2007||2007-09-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|October 2008|Actual|2008-10-01||Interventional|SEA-SIDE||SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis|SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis|Completed||Phase 4|150|Actual|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-02-18 14:16:10.706365|2017-02-18 14:16:10.706365
NCT00697359|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-09-27|||June 2008||2008-06-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Interventional|||Implantable Loop Recorder Versus Conventional Ambulatory Monitoring in Detecting Atrial Fibrillation After Pulmonary Vein Isolation|An Observational Study to Assess the Efficacy of Continuous Subcutaneous Arrhythmia Monitoring Versus Conventional Ambulatory ECG-monitoring in Detecting Atrial Fibrillation in Patients After Pulmonary Vein Isolation|Completed||N/A|57|Actual|Odense University Hospital||1|||f||||f||||||||No||2017-02-18 14:16:10.831263|2017-02-18 14:16:10.831263
NCT00697346|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-09-22|||July 2008||2008-07-01|September 2016|2016-09-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Study of MLN8237 in Patients With Advanced Hematological Malignancies|An Open-label, Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients With Advanced Hematological Malignancies|Active, not recruiting||Phase 1|58|Actual|Takeda||1|||f||||f||||||||||2017-02-18 14:16:10.942065|2017-02-18 14:16:10.942065
NCT00697333|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-07-13|||May 2009||2009-05-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|November 2016|Anticipated|2016-11-01||Interventional|PET-Plan||Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC|Optimisation of Radiotherapy-Planning in Patients With Inoperable Locally Advanced Non-Small-Cell Lung Cancer by FDG-PET|Recruiting||Phase 2|200|Anticipated|Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN||2|||f||||t||||||||Yes||2017-02-18 14:16:11.052094|2017-02-18 14:16:11.052094
NCT00697320|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-12-06|||June 2008||2008-06-01|December 2016|2016-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|WIRK||"Observational Study on the Efficacy and Safety of NovoSeven® During Real-life Usage in Germany"|Efficacy of NovoSeven® (Activated Recombinant Human Factor VII): Non-interventional Study in Patients With Congenital Haemophilia With Inhibitors, Acquired Haemophilia, Factor FVII Deficiency, and Glanzmann's Thrombasthenia|Completed||N/A|64|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:16:11.186616|2017-02-18 14:16:11.186616
NCT00697307|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2011-06-06|||March 2003||2003-03-01|March 2010|2010-03-01|July 2003|Actual|2003-07-01|||||Observational|||Bioequivalence Study of Patches With Different Release Profiles|A Bioequivalence Study Of A Low Cumulative Release Lot Of Norelgestromin (NGMN)/Ethinyl Estradiol (EE) Transdermal Contraceptive Systems Compared With Currently Marketed Ortho-Evra In Healthy Female Volunteers|Completed||N/A|43|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:16:11.293763|2017-02-18 14:16:11.293763
NCT00697294|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2011-12-02|||July 2008||2008-07-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|||Impact of Vitamin D Status on Bones in Breastfed Infants|Vitamin D Status and Impact on Bone Mineralization in Human Milk Fed Hispanic and Caucasian Infants|Completed||N/A|80|Actual|Baylor College of Medicine||1|||f||||f||||||||||2017-02-18 14:16:11.372916|2017-02-18 14:16:11.372916
NCT00697281|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2009-02-23|||May 2008||2008-05-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||OC000459 Dose Finding Study in Hay Fever Sufferers.|A Dose Finding Study Of The Effects Of OC000459 On Responses To Allergen Challenge In The Vienna Chamber In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis.|Completed||Phase 2|120|Anticipated|Oxagen Ltd||5|||f||||f||||||||||2017-02-18 14:16:11.497942|2017-02-18 14:16:11.497942
NCT00697268|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2017-01-24|||June 3, 2008||2008-06-03|July 28, 2016|2016-07-28|July 28, 2016||2016-07-28|||||Observational|||p11 Protein Levels in Patients With Major Depressive Disorder Treated With Citalopram|An Investigation to Determine Whether Levels of P11 Protein in Peripheral Blood Cells Correlate With Treatment Response to Citalopram in Patients With Major Depressive Disorder|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:16:11.613026|2017-02-18 14:16:11.613026
NCT00697255|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2015-05-29|2014-03-28||May 2007||2007-05-01|May 2015|2015-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)|A Phase II, Randomized, Controlled, Open-label, Feasibility Trial to Evaluate if a Single or Repeated Dose of Org 36286 (Corifollitropin Alfa) Followed by a Low Daily Dose of Either hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility|Terminated||Phase 2|8|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:16:11.738726|2017-02-18 14:16:11.738726
NCT00697242|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-11|||January 1994||1994-01-01|June 2008|2008-06-01|November 1995|Actual|1995-11-01|November 1995|Actual|1995-11-01||Interventional|||Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults|Study to Compare the Immunogenicity, Safety and Reactogenicity of GSK Biologicals' (Previously SmithKline Beecham Biologicals') Recombinant Hepatitis B Vaccines With and Without Adjuvant in Healthy Older Adult Volunteers|Completed||Phase 3|362|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-02-18 14:16:12.155274|2017-02-18 14:16:12.155274
NCT00697229|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-11|||September 1992||1992-09-01|June 2008|2008-06-01|December 1998|Actual|1998-12-01|May 1996|Actual|1996-05-01||Interventional|||Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules|Study to Evaluate the Immunogenicity and Reactogenicity of GSK Biologicals' MPL-Adjuvanted Recombinant Hepatitis B Vaccine in Comparison With Those of Engerix™-B in Healthy Adult Volunteers Following 2 Different Schedules|Completed||Phase 2|99|Actual|GlaxoSmithKline||8|||f||||||||||||||2017-02-18 14:16:12.267079|2017-02-18 14:16:12.267079
NCT00697216|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-11|||March 1997||1997-03-01|June 2008|2008-06-01||||March 1999|Actual|1999-03-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).|Study Comparing the Immunogenicity and Reactogenicity of GSK Biologicals' HBV-MPL Vaccine Injected According to a 0, 6 Months Schedule With That of Engerix™-B Injected as a 0, 1, 6 Months Schedule in a Healthy Adult Population (15-40 Years)|Completed||Phase 3|340|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:16:12.382373|2017-02-18 14:16:12.382373
NCT00697203|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-11-01|||July 2005||2005-07-01|November 2016|2016-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)|A Randomized, Double-blind Study of the Effect of RO4607381 in Combination With Pravastatin on HDL-cholesterol (HDL-C) Levels in Patients With Low or Average HDL-C Levels|Completed||Phase 2|292|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 14:16:12.494165|2017-02-18 14:16:12.494165
NCT00697125|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-11|||June 1993||1993-06-01|June 2008|2008-06-01|July 1994|Actual|1994-07-01|July 1994|Actual|1994-07-01||Interventional|||Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants|Study to Evaluate the Immunogenicity and Reactogenicity of Various Formulations of GSK Biologicals' (Previously SmithKline Beecham Biologicals') Recombinant Hepatitis B Vaccine With Different Adjuvants in Healthy Adult Volunteers|Completed||Phase 2|60|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 14:16:13.776244|2017-02-18 14:16:13.776244
NCT00697112|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2013-12-03|2013-12-03||May 2008||2008-05-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational||Safety population included all participants who had received at least 1 dose of Rapamune and were subsequently interrogated.|Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)|Surveillance Registry Of Sirolimus Use In Recipients Of Kidney Allograft From Expanded Criteria Donors (ECD)|Completed||N/A|53|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:16:13.893229|2017-02-18 14:16:13.893229
NCT00697099|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2013-01-14||2010-12-20|June 2008||2008-06-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|SAVE-HIP1||Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery|A Multinational, Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery|Completed||Phase 3|2326|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:16:14.53684|2017-02-18 14:16:14.53684
NCT00697086|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2009-07-28|||August 2002||2002-08-01|July 2009|2009-07-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|ERATO||European Study of Dronedarone in Atrial Fibrillation|Efficacy and Safety of Dronedarone for the Control of Ventricular Rate During Atrial Fibrillation (ERATO)|Completed||Phase 3|174|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:16:14.685108|2017-02-18 14:16:14.685108
NCT00697073|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2013-05-24|2011-06-07||July 2008||2008-07-01|May 2013|2013-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|IONIA-E||Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients|A Phase III Open-Label, Single Group Extension Study of the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients|Completed||Phase 3|68|Actual|Santhera Pharmaceuticals||1|||f||||t||||||||||2017-02-18 14:16:14.806383|2017-02-18 14:16:14.806383
NCT00697060|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2015-06-22|||August 2010||2010-08-01|June 2015|2015-06-01|August 2012|Anticipated|2012-08-01|August 2011|Anticipated|2011-08-01||Interventional|||A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer|A Multicenter, Phase II Trial of the Safety and Efficacy of Amplimexon® (Imexon for Injection) in Combination With Taxotere® (Docetaxel) for Previously Treated Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 2|0|Actual|AmpliMed Corporation||1||Study cancelled prior to start due to change in company priorities.|f||||||||||||||2017-02-18 14:16:15.069574|2017-02-18 14:16:15.069574
NCT00697047|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-05-25|||July 2008||2008-07-01|May 2016|2016-05-01|June 2018|Anticipated|2018-06-01|November 2017|Anticipated|2017-11-01||Interventional|SOS||Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up|Systems of Support to Increase Colon Cancer Screening and Follow-up|Active, not recruiting||N/A|4653|Actual|Group Health Cooperative||4|||f||||f||||||||Yes|Yes, a de-identified data set will be available and shared upon request.|2017-02-18 14:16:15.381269|2017-02-18 14:16:15.381269
NCT00697034|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2017-02-15|||June 2006||2006-06-01|February 2017|2017-02-01|December 2008|Actual|2008-12-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin|Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin|Terminated||Phase 4|12|Actual|Wake Forest University Health Sciences||1||Lack of qualified and willing volunteers.|f||||f||||||||||2017-02-18 14:16:15.503806|2017-02-18 14:16:15.503806
NCT00697021|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-12|||June 2008||2008-06-01|April 2008|2008-04-01|October 2009|Anticipated|2009-10-01|June 2009|Anticipated|2009-06-01||Interventional|TEG||Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance|Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance in The Patients Treated With Primary PCI for STEMI|Unknown status|Recruiting|Phase 3|50|Anticipated|Assaf-Harofeh Medical Center||2|||f||||t||||||||||2017-02-18 14:16:15.598477|2017-02-18 14:16:15.598477
NCT00697008|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2009-02-09|||December 2007||2007-12-01|February 2009|2009-02-01||||January 2009|Actual|2009-01-01||Observational|Prospect||Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study|Symptomatic Assessment and Therapeutic Outcomes in Typical GERD Patients Following a New CP Guideline in the Clinical Practice|Completed||N/A|300|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:16:15.714263|2017-02-18 14:16:15.714263
NCT00696995|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2017-01-06|||January 2007||2007-01-01|January 2017|2017-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|Start||An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment|An Observational, Prospective Safety Study in Subjects With Type 2 Diabetes Mellitus Starting NovoMix® 30 (Biphasic Insulin Aspart) Treatment|Completed||N/A|509|Actual|Novo Nordisk A/S|||1||f||||f||||||None Retained|"~     Venous blood samples drawn as part of routine clinical evaluation~   "|||2017-02-18 14:16:15.831875|2017-02-18 14:16:15.831875
NCT00696982|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-12|||June 2008||2008-06-01|June 2008|2008-06-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation|The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation|Unknown status|Recruiting|N/A|60|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 14:16:15.944944|2017-02-18 14:16:15.944944
NCT00696969|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2010-02-10|||June 2008||2008-06-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis|Randomized, Open-label, Parallel-group, Safety & Efficacy Study to Evaluate Different Combination Treatment Regimens, of Either AmBisome and Paromomycin, AmBisome and Miltefosine, or Paromomycin and Miltefosine Compared With Amphotericin B Deoxycholate (the Standard) Therapy for the Treatment of Acute, Symptomatic Visceral Leishmaniasis (VL).|Completed||Phase 3|634|Actual|Drugs for Neglected Diseases||4|||f||||t||||||||||2017-02-18 14:16:16.058193|2017-02-18 14:16:16.058193
NCT00006321|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-02|2008-07-23|||September 1999||1999-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Neurocognitive Function in Snoring Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:57.78075|2017-02-18 18:12:57.78075
NCT00696956|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-12|||April 2008||2008-04-01|May 2008|2008-05-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|Piccolo||Drug Coated Balloons for Prevention of Restenosis|Paclitaxel Coated Balloons for Prevention of Restenosis in Small Arteries Below the Knee Compared to Angioplasty Using Uncoated Balloons|Unknown status|Recruiting|Phase 2/Phase 3|114|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-02-18 14:16:16.177212|2017-02-18 14:16:16.177212
NCT00696943|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2013-02-13|||July 2008||2008-07-01|November 2008|2008-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||18F ML-10 for Early Detection of Response of Brain Metastases to SRS|An Open-label, Multi-center Study to Evaluate [18F]-ML-10 as a PET Imaging Radiotracer for Early Detection of Response of Brain Metastases to Stereotactic Radio Surgery (SRS)|Terminated||Phase 2|1|Actual|Aposense Ltd.||1||Replaced by a global study protocol NST-CA004|f||||t||||||||||2017-02-18 14:16:16.287522|2017-02-18 14:16:16.287522
NCT00696930|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2015-11-24|||June 2008||2008-06-01|November 2015|2015-11-01||||June 2008|Actual|2008-06-01||Interventional|||Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid Tumors|A Phase II Open-label Multi-center Study to Evaluate the Efficacy and Safety of 90Y-SMT487 in Subjects With Symptomatic Malignant Carcinoid Tumors|Withdrawn||Phase 2|0|Actual|Molecular Insight Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 14:16:16.383729|2017-02-18 14:16:16.383729
NCT00696917|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-11|||April 1999||1999-04-01|June 2008|2008-06-01||||February 2000|Actual|2000-02-01||Interventional|||Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y|Safety and Immunogenicity of 3 Lots of GSK Biologicals' Novel Adjuvanted Hepatitis B Vaccine, Administered According to a 2 Dose Schedule, and Engerix™-B Administered According to a 3 Dose Schedule to Healthy Volunteers ≥ 15 Years of Age|Completed||Phase 3|1303|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 14:16:16.456525|2017-02-18 14:16:16.456525
NCT00696904|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2010-10-19|||June 2008||2008-06-01|September 2010|2010-09-01||||February 2009|Actual|2009-02-01||Interventional|||Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects||Completed||Phase 1|133|Actual|Abbott||3|||f||||||||||||||2017-02-18 14:16:16.564453|2017-02-18 14:16:16.564453
NCT00696891|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-11|||June 1997||1997-06-01|June 2008|2008-06-01||||May 1999|Actual|1999-05-01||Interventional|||Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults|Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine With That of Engerix™-B When Both Are Injected According to 3 Dose Schedule (0, 1, 6 Months) in an Adult Population Aged Between 50 and 70 Years|Completed||Phase 3|380|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:16:16.659995|2017-02-18 14:16:16.659995
NCT00696878|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2015-05-20|2015-04-06||September 2006||2006-09-01|May 2015|2015-05-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional|Trust||Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)|A Phase III, Uncontrolled Trial to Assess the Non-immunogenicity and Safety of Org 36286 in Patients Undergoing Repeated Controlled Ovarian Stimulation Cycles Using a Multiple Dose GnRH Antagonist Protocol|Completed||Phase 3|682|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:16:16.986765|2017-02-18 14:16:16.986765
NCT00696865|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2009-07-15|||May 2008||2008-05-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|||||Interventional|JMAD||AZD2624 Multiple Ascending Dose Study in Japan|A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2624 When Given in Multiple Ascending Oral Doses in Young Healthy Male Japanese Subjects|Completed||Phase 1|30|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:16:18.327016|2017-02-18 14:16:18.327016
NCT00696852|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2012-09-20|||June 2008||2008-06-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Mindfulness, Yoga, and Cardiovascular Disease|Effects of Mindfulness and Yoga on Heart Rate Variability and Immune Markers|Completed||N/A|64|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-02-18 14:16:18.417385|2017-02-18 14:16:18.417385
NCT00696839|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2010-03-01|||September 2008||2008-09-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects|Clinical Trial Of Cognitive-behavioral Therapy To Reduce Antiretroviral Side Effects In HIV Patients|Completed||N/A|29|Actual|Duquesne University||2|||f||||t||||||||||2017-02-18 14:16:18.516083|2017-02-18 14:16:18.516083
NCT00696826|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2015-08-18|||April 2004||2004-04-01|August 2015|2015-08-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)|An Open-Label, Single Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK0431|Completed||Phase 1|20|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:16:18.623785|2017-02-18 14:16:18.623785
NCT00696813|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2013-02-04|||June 2008||2008-06-01|February 2013|2013-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|PILAR||Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics|PILAR: Pharmacoepidemiologic International Longitudinal Antipsychotic Registry|Completed||Phase 4|3064|Actual|Janssen-Cilag International NV|||2||f||||f||||||||||2017-02-18 14:16:18.716031|2017-02-18 14:16:18.716031
NCT00696800|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2015-07-13|2014-08-06||June 2006||2006-06-01|July 2015|2015-07-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional||The ITT group consisting of randomized participants treated with Corifollitropin Alfa or recFSH|A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)|A Phase III, Randomized, Double-Blind, Active-Controlled, Non-Inferiority Clinical Trial to Investigate the Efficacy and Safety of a Single Injection of Org 36286 (Corifollitropin Alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation Using Daily Recombinant FSH as Reference|Completed||Phase 3|1509|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 14:16:18.964053|2017-02-18 14:16:18.964053
NCT00696787|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2013-02-20|2010-01-29||June 2008||2008-06-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pregabalin-Referenced, Parallel-Group, Adaptive Design Study of DVS SR in Adult Female Outpatients With Fibromyalgia Syndrome|Terminated||Phase 2|125|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 14:16:22.241611|2017-02-18 14:16:22.241611
NCT00696774|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2010-09-02|2010-07-15||June 2008||2008-06-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|ARDENT||Switching to Duloxetine in Patients With Depression|Attributes of Response in Depressed Patients Switched to Treatment With Duloxetine (ARDENT Study)|Completed||Phase 4|242|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:16:22.900824|2017-02-18 14:16:22.900824
NCT00696761|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2014-01-15|2013-07-22||May 2006||2006-05-01|January 2014|2014-01-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients|The Long Term Effects of Alfuzosin(Xatral XL) in LUTS/BPH Patients: Evaluation of Voiding and Storage Function According to Bladder Outlet Obstruction Grade and Bladder Contractility|Completed||Phase 4|232|Actual|Asan Medical Center|Patients were not divided into three groups according to the ICS nomogram (obstructed [BOOI <40], equivocally obstructed (20 <BOOI <40), and unobstructed [BOOI <20]).|4|||f||||f||||||||||2017-02-18 14:16:24.583689|2017-02-18 14:16:24.583689
NCT00696748|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-11|||October 2005||2005-10-01|June 2008|2008-06-01|December 2010|Anticipated|2010-12-01|January 2009|Anticipated|2009-01-01||Interventional|NePlaM3||The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men|A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study With Open-Label Follow-up to Investigate the Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men|Unknown status|Recruiting|Phase 3|250|Anticipated|Russian Academy of Medical Sciences||2|||f||||f||||||||||2017-02-18 14:16:25.179014|2017-02-18 14:16:25.179014
NCT00696735|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-10-23|||June 1994||1994-06-01|September 2006|2006-09-01|May 2006|Actual|2006-05-01|May 2003|Actual|2003-05-01||Interventional|||High-Dose Therapy Treatment in Patients With Follicular Lymphoma|Randomized Phase III Study Comparison Between Conventional Chemotherapy and High-Dose Therapy Followed by Autologous Purged Stem-Cell Transplantation in Patients With Follicular Lymphoma Stage III,IV First-Line Treatment for Patients Younger Than 60 Years Old With a High Tumor Burden|Completed||Phase 3|172|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||||2017-02-18 14:16:25.281452|2017-02-18 14:16:25.281452
NCT00696722|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2010-01-24|||June 2008||2008-06-01|January 2009|2009-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|DM2ATV||Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction|Influence of Atazanavir Treatment on Endothelial Dysfunction, Vascular Inflammation and Heme Oxygenase Activity in Type 2 Diabetes Mellitus|Completed||Phase 2|16|Anticipated|Radboud University||2|||f||||||||||||||2017-02-18 14:16:25.392967|2017-02-18 14:16:25.392967
NCT00696709|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2015-10-05|||December 2008||2008-12-01|October 2015|2015-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)|A Phase I, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of V212 in Healthy Adults|Completed||Phase 1|160|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 14:16:25.69313|2017-02-18 14:16:25.69313
NCT00696696|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-05-31|2011-11-18||September 2007||2007-09-01|May 2016|2016-05-01|June 2013|Actual|2013-06-01|November 2010|Actual|2010-11-01||Interventional|||Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer|A Phase II Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer|Completed||Phase 2|45|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 14:16:25.79879|2017-02-18 14:16:25.79879
NCT00696683|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2008-06-11|||August 2004||2004-08-01|June 2008|2008-06-01|July 2005|Actual|2005-07-01|August 2004|Actual|2004-08-01||Observational|||Establishment of Natural History of Scorpion Envenomation|Establishment of Natural History of Scorpion Envenomation in the Absence of Antivenom Treatment in Pediatric Patients|Completed||N/A|97|Actual|Instituto Bioclon S.A. de C.V.|||1||f||||f||||||||||2017-02-18 14:16:26.13325|2017-02-18 14:16:26.13325
NCT00696657|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2013-10-30||2010-11-09|June 2008||2008-06-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide|Investigation of Safety and Efficacy of Five Doses of Semaglutide Versus Placebo and Open-label Liraglutide, as Add on Therapy, in Subjects Diagnosed With Type 2 Diabetes Currently Treated With Metformin or Controlled With Diet and Exercise A 12 Week Multi-centre, Multi National, Double-blind, Placebo-controlled, Randomised, Nine Armed Parallel Group, Dose Finding Trial|Completed||Phase 2|415|Actual|Novo Nordisk A/S||14|||f||||f||||||||||2017-02-18 14:16:26.234157|2017-02-18 14:16:26.234157
NCT00696644|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2011-05-05|||June 2008||2008-06-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|ISSO||A Study for Teriparatide in Severe Osteoporosis|An Italian Observational Study to Evaluate Fracture Outcomes, Compliance to Treatment, Back Pain, Health-related Quality of Life in Patients With Severe Osteoporosis Treated According to Common Clinical Practice|Completed||N/A|794|Actual|Eli Lilly and Company|||1||f||||f||||||||||2017-02-18 14:16:26.380233|2017-02-18 14:16:26.380233
NCT00696631|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-12|2010-02-12|||June 2002||2002-06-01|February 2010|2010-02-01|August 2003|Actual|2003-08-01|January 2003|Actual|2003-01-01||Interventional|ANDROMEDA||European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure|Antiarrhythmic Trial With Dronedarone in Moderate to Severe CHF Evaluating Morbidity Decrease|Terminated||Phase 3|653|Actual|Sanofi||2||Terminated as the active treatment was associated with an increased hazard|f||||t||||||||||2017-02-18 14:16:26.49886|2017-02-18 14:16:26.49886
NCT00696618|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-03-30|||July 2007||2007-07-01|August 2009|2009-08-01|March 2012|Actual|2012-03-01|July 2009|Actual|2009-07-01||Interventional|||Enema Use and Acceptability in HIV Negative Men Who Have Sex With Men|A Randomized, Blinded, Comparative Study of the Mucosal Toxicity, Colorectal Distribution, and Participant Acceptability of Three Different Preparatory Enemas (Hypo-, Iso-, and Hyper-osmolar)|Completed||N/A|9|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 14:16:26.625855|2017-02-18 14:16:26.625855
NCT00696605|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-06-22|||July 2008||2008-07-01|June 2011|2011-06-01||||||||Observational|||Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion|Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion|Unknown status|Recruiting|N/A|35|Anticipated|Hospital Centre Biel/Bienne|||1||f||||f||||||||||2017-02-18 14:16:26.737362|2017-02-18 14:16:26.737362
NCT00681590|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-12-02|2016-02-05||April 2008||2008-04-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety of Vitamin D Supplementation in Older Persons|Safety of Vitamin D Supplementation in the Elderly|Completed||Phase 3|105|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 14:21:34.481578|2017-02-18 14:21:34.481578
NCT00696592|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-10|||January 2007||2007-01-01|April 2007|2007-04-01||||||||Interventional|ARMAST||Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-Related Macular Degeneration|A Randomized, Controlled, Open Label, Phase II Study of Visudyne® Photodynamic Therapy (PDT) Combined With Bevacizumab (Avastin) vs Avastin Alone in Patients With Neovascular Age-Related Macular Degeneration (AMD)|Unknown status|Recruiting|Phase 2|80|Anticipated|University of Padova||3|||f||||t||||||||||2017-02-18 14:16:26.817504|2017-02-18 14:16:26.817504
NCT00696579|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-10|||January 2004||2004-01-01|June 2008|2008-06-01||||March 2008||2008-03-01||Interventional|||Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer|BCG vs. Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer: A Randomized Prospective Study|Completed||Phase 1/Phase 2|64|Actual|University Of Perugia||2|||f||||f||||||||||2017-02-18 14:16:26.906083|2017-02-18 14:16:26.906083
NCT00696566|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-11|||November 2007||2007-11-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Healthy Volunteer Study of Clopidogrel and Rifampicin|Study of the Potentiation of the Effects of Clopidogrel by Rifampicin in Healthy Volunteers|Completed||Phase 1|12|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 14:16:27.011485|2017-02-18 14:16:27.011485
NCT00696553|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2011-07-25|||March 2006||2006-03-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|ELAF||Nutrition and Resistance Training in Head and Neck Cancer|Randomized Trial of Specialized Nutrition Therapy (SNT) Versus SNT Plus Resistance Training (RT) in Head and Neck Cancer Patients Undergoing Concurrent Chemo-Radiation Therapy (CCR)|Completed||Phase 3|60|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:16:27.12652|2017-02-18 14:16:27.12652
NCT00696540|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-09|||June 2008||2008-06-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|September 2008|Anticipated|2008-09-01||Interventional|Hypertonic||Hypertonic Saline for Outpatient Bronchiolitis|Safety and Efficacy of Hypertonic Vrs. Normal Saline as Diluent of Salbutamol to Reduce Respiratory Distress in Outpatients With the Clinical Diagnosis of Bronchiolitis During the RSV Epidemic.|Unknown status|Recruiting|Phase 2|74|Anticipated|University Diego Portales||2|||f||||t||||||||||2017-02-18 14:16:27.220217|2017-02-18 14:16:27.220217
NCT00696527|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2010-12-09|||June 2007||2007-06-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|CSI||National Survey on Infiltrative Breast Cancer|National Prospective Survey on Women With a Diagnosis of Infiltrative Breast Cancer|Completed||N/A|1500|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:16:27.34138|2017-02-18 14:16:27.34138
NCT00696514|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-08-24|||September 2008||2008-09-01|August 2011|2011-08-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|B-PROOF||Vitamin B12 and Folic Acid Supplementation for Preventing Fractures in Elderly People|Vitamin B12 and Folic Acid Supplementation for Preventing Fractures in Elderly People|Unknown status|Active, not recruiting|Phase 1|3000|Anticipated|Wageningen University||2|||f||||t||||||||||2017-02-18 14:16:27.787525|2017-02-18 14:16:27.787525
NCT00696501|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-03-15|||May 2006||2006-05-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Direct Stimulation Of Spinal Nerve Roots To Determine Sensory And Motor Innervation Patterns|Direct Stimulation Of Spinal Nerve Roots To Determine Sensory And Motor Innervation Patterns|Recruiting||N/A|1000|Anticipated|Lahey Clinic|||1||f||||f||||||||||2017-02-18 14:16:27.900649|2017-02-18 14:16:27.900649
NCT00696488|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-02-12|||April 2007||2007-04-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|August 2007|Actual|2007-08-01||Interventional|||Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population|Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population|Completed||Phase 4|20|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 14:16:28.005983|2017-02-18 14:16:28.005983
NCT00696475|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2010-11-04|||June 2008||2008-06-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Diazoxide Choline in Hypertriglyceridemia|A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Diazoxide Choline in Non-Diabetic Hypertriglyceridemic Subjects|Completed||Phase 2|80|Anticipated|Essentialis, Inc.||4|||f||||f||||||||||2017-02-18 14:16:28.104298|2017-02-18 14:16:28.104298
NCT00696462|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-09-11|||March 2007||2007-03-01|September 2012|2012-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||The Effect of Forced Air Warming During Cesarean Section on Postoperative Infectious Morbidity|The Effect of Forced Air Warming During Cesarean Section on Postoperative Infectious Morbidity|Withdrawn||N/A|0|Actual|Vanderbilt University||2||Study terminated for lack of funds to initiate study|f||||t||||||||||2017-02-18 14:16:28.219923|2017-02-18 14:16:28.219923
NCT00696449|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-10|||June 2006||2006-06-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|May 2007|Actual|2007-05-01||Interventional|||Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris|An Analysis of Adherence and Associated Factors in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Wake Forest University Health Sciences||4|||f||||f||||||||||2017-02-18 14:16:28.330985|2017-02-18 14:16:28.330985
NCT00696436|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-03-24|2011-03-24||April 2008||2008-04-01|March 2011|2011-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.|A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared With Valsartan and Olmesartan in Subjects With Essential Hypertension|Completed||Phase 3|1291|Actual|Takeda||5|||f||||f||||||||||2017-02-18 14:16:28.467464|2017-02-18 14:16:28.467464
NCT00696423|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2016-10-26|2009-07-17||June 2008||2008-06-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children|Immunogenicity and Reactogenicity Study of GlaxoSmithKline Biologicals' Infanrix™/Hib Vaccine Administered as a Booster Dose to 18-24 Months Old Children|Completed||Phase 3|467|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:16:30.190191|2017-02-18 14:16:30.190191
NCT00696410|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2012-12-17|||June 2008||2008-06-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy|Pilot Study to Assess the Impact of Zinc Supplementation on Left Ventricular Remodeling, Function, and Oxidative Stress in Nonischemic Cardiomyopathy|Completed||Phase 1|49|Actual|University of Michigan||1|||f||||t||||||||||2017-02-18 14:16:30.915732|2017-02-18 14:16:30.915732
NCT00696397|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2012-08-08|||March 2006||2006-03-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology|Sleep Disturbance in Atopic Dermatitis: A Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology|Completed||N/A|31|Actual|Wake Forest University Health Sciences|||1||f||||f||||||Samples With DNA|"~     Blood, dermal microdialysate~   "|||2017-02-18 14:16:31.036164|2017-02-18 14:16:31.036164
NCT00696384|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-11-29|2011-03-24||June 2007||2007-06-01|November 2011|2011-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension|An 8-Month Phase 3, Open-Label Study With a Blinded Reversal Phase to Evaluate the Safety and Tolerability of TAK-491 in Subjects With Essential Hypertension|Completed||Phase 3|418|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:16:31.126446|2017-02-18 14:16:31.126446
NCT00696371|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2017-01-24|||June 6, 2008||2008-06-06|August 19, 2014|2014-08-19|August 19, 2014||2014-08-19|||||Observational|||PET Imaging of Peripheral Benzodiazepine Receptors|PET Imaging of Peripheral Benzodiazepine Receptors Using [11C](R)-PK 11195 and [11C]PBR28|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:16:31.611084|2017-02-18 14:16:31.611084
NCT00696358|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-10-30||||||October 2008|2008-10-01||||||||Interventional|||Excimer Lamp Versus Excimer Laser in Vitiligo Treatment|Comparative Study of 308nm Excimer Lamp and 308nm Excimer Laser in the Treatment of Vitiligo|Completed||Phase 3|||Centre Hospitalier Universitaire de Nice||2|||f||||||||||||||2017-02-18 14:16:31.709301|2017-02-18 14:16:31.709301
NCT00696345|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-13|||January 2005||2005-01-01|June 2008|2008-06-01|February 2007|Actual|2007-02-01|October 2006|Actual|2006-10-01||Observational|||Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay|Feasibility Study for Performance of Septin 9 in Plasma From Cases With Colorectal Cancer and Controls With Non-Diseased, Non-Colorectal Disease and Non-Colorectal Cancers|Completed||N/A|700|Actual|Epigenomics, Inc|||2||f||||f||||||Samples With DNA|"~     Residual plasma samples retained according to protocol.~   "|||2017-02-18 14:16:31.804354|2017-02-18 14:16:31.804354
NCT00696332|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-10-20||2011-08-16|September 2008||2008-09-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|ALS||Talampanel for Amyotrophic Lateral Sclerosis (ALS)|A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of Talampanel in Subjects With Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|559|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-02-18 14:16:31.90239|2017-02-18 14:16:31.90239
NCT00696319|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-06-30|||January 2007||2007-01-01|June 2011|2011-06-01|June 2013|Anticipated|2013-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Dynamic Stability of the Anterior Cruciate Ligament (ACL) Deficient Knee|Dynamic Stability of the ACL Deficient Knee - a Prospective Cohort Study|Suspended||N/A|150|Anticipated|Oslo University Hospital||2||Study was suspended due to lack of resources.|f||||f||||||||||2017-02-18 14:16:32.031841|2017-02-18 14:16:32.031841
NCT00696306|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-04-11|||February 2008||2008-02-01|April 2011|2011-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||MRI-SWI as a Predictor of Functional Outcome in Acute Ischemic Stroke|Diffusion Tensor Imaging (DTI) and Susceptibility Weighted Imaging (SWI) as a Predictor of Functional Outcome in Acute Ischemic Stroke|Completed||N/A|30|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||||||2017-02-18 14:16:32.145234|2017-02-18 14:16:32.145234
NCT00696293|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2017-01-30|2016-01-05||May 2007||2007-05-01|January 2017|2017-01-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|ACHIEVE2||Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults|Optimizing Outcomes in Older Adults With Low Back Pain and Depression|Completed||Phase 4|30|Actual|University of Pittsburgh||1|||f||||f||||||||No||2017-02-18 14:16:32.241599|2017-02-18 14:16:32.241599
NCT00696280|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2013-06-11|||November 2006||2006-11-01|June 2013|2013-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|DelayedNaus||Observational Study of Delayed Nausea and Vomiting|Observational Study of Delayed Nausea and Vomiting Following Administration of Carboplatin Containing Regimens for Treatment of Cancer|Completed||N/A|106|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 14:16:32.458105|2017-02-18 14:16:32.458105
NCT00696254|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2009-06-02|||March 2008||2008-03-01|June 2009|2009-06-01|December 2008||2008-12-01|||||Observational|||Impact of General Anaesthetics on Excitability of the Peripheral Sensory Nerve||Completed||Phase 1|||University of Zurich|||2||f||||||||||||||2017-02-18 14:16:32.576552|2017-02-18 14:16:32.576552
NCT00696241|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-07-27|2011-03-24||June 2007||2007-06-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension|A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension|Completed||Phase 3|1275|Actual|Takeda||5|||f||||f||||||||||2017-02-18 14:16:32.672554|2017-02-18 14:16:32.672554
NCT00696228|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2015-06-01|||August 2008||2008-08-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|AFN||High Fat Diet: Oxidative and Cardiovascular Effects|High Fat Diet: Oxidative Effects and Cardiovascular Risk|Completed||Phase 3|144|Actual|Vanderbilt University||4|||f||||f||||||||||2017-02-18 14:16:34.510465|2017-02-18 14:16:34.510465
NCT00696215|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-11|||June 2007||2007-06-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|June 2008|Anticipated|2008-06-01||Interventional|||The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease|The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Over 3 Months|Unknown status|Recruiting|Phase 4|40|Anticipated|Istanbul University||2|||f||||t||||||||||2017-02-18 14:16:34.61716|2017-02-18 14:16:34.61716
NCT00696202|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2014-12-30|||September 2003||2003-09-01|December 2014|2014-12-01|March 2005|Actual|2005-03-01|||||Interventional|||Mirena Efficiency and Tolerability During the First Year of Use|A Multicentre, Open Label, Uncontrolled Study of the Tolerance, Acceptability and Contraceptive Efficacy of Mirena 52 mg®, an Intra-uterine Levonorgestrel Device, During the First Year After Insertion Post-partum|Completed||Phase 4|199|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:16:34.734343|2017-02-18 14:16:34.734343
NCT00696189|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2015-04-23|||September 2006||2006-09-01|April 2015|2015-04-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Observational|||Effects of Nitrous Oxide on Intraocular Pressure|The Effects of Nitrous Oxide on Intraocular Pressure and Ocular Perfusion|Terminated||N/A|30|Actual|Rutgers, The State University of New Jersey|||1|PI is no longer at this institution|f||||f||||||||||2017-02-18 14:16:34.838869|2017-02-18 14:16:34.838869
NCT00696176|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2015-07-22|||August 2008||2008-08-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||STAT3 DECOY in Head and Neck Cancer|Preliminary Assessment of the Safety and Biological Activity of Intratumoral STAT3 DECOY in Surgically Resectable Head and Neck Squamous Cell Carcinoma|Completed||Early Phase 1|32|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:16:34.923295|2017-02-18 14:16:34.923295
NCT00696163|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-10-27|||April 2008||2008-04-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|IMPROVE Life||Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes|A Multicentre, Open Label, Nonrandomised, Non- Interventional, A Multicentre, Open Label, Nonrandomised, Non- Interventional, Observational Study to Evaluate the Quality of Life and Clinical Outcomes in Subjects Using Biphasic Insulin Aspart 30 (NovoMix® 30) for the Treatment of Diabetes Mellitus|Completed||N/A|24975|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:16:35.027982|2017-02-18 14:16:35.027982
NCT00696150|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-11|||July 2008||2008-07-01|June 2008|2008-06-01|August 2010|Anticipated|2010-08-01|July 2010|Anticipated|2010-07-01||Interventional|||Can the Femoral Nerve Block be Improved by Ultrasound Guidance?|Can the Use of Ultrasound to Guide the Insertion of a Needle for an Anterior Psoas Compartment Nerve Block Increase Its Efficacy in Comparison to Traditional Techniques Utilising Loss of Resistance and Nerve Stimulation?|Unknown status|Not yet recruiting|Phase 4|269|Anticipated|NHS Greater Glasgow and Clyde||3|||f||||f||||||||||2017-02-18 14:16:35.132319|2017-02-18 14:16:35.132319
NCT00696137|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2012-04-16|||June 2008||2008-06-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Long-term Extension Study of BEMA™ Fentanyl|Open-label, Long-term Extension Study for Treatment of Breakthrough Cancer Pain With BEMA™ Fentanyl|Completed||Phase 3|5|Actual|BioDelivery Sciences International||1|||f||||f||||||||||2017-02-18 14:16:35.234439|2017-02-18 14:16:35.234439
NCT00696124|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2010-07-21|||March 2007||2007-03-01|July 2010|2010-07-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Safety Study of Gene Therapy in Treating Lower Leg Ischemia|Phase 1, Dose-Escalation Study to Assess the Safety and Tolerability of VM202 in Subjects With Critical Limb Ischemia|Completed||Phase 1|15|Anticipated|ViroMed Co., Ltd. dba VM BioPharma||4|||f||||t||||||||||2017-02-18 14:16:35.316107|2017-02-18 14:16:35.316107
NCT00696111|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2016-08-23|||December 2007||2007-12-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea|PCOS, Sleep Apnea and Metabolic Risk in Women|Active, not recruiting||N/A|80|Anticipated|University of Chicago||3|||f||||t||||||||||2017-02-18 14:16:35.422519|2017-02-18 14:16:35.422519
NCT00696098|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-10-06|||May 2007||2007-05-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Effects of Butyrate on Colonic Health of Patients With Diarrhoea Predominant IBS and UC in Remission|Effects of Butyrate on Colonic Health of Patients With Diarrhoea Predominant|Completed||N/A|80|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 14:16:35.540863|2017-02-18 14:16:35.540863
NCT00696085|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2008-06-11|||March 2004||2004-03-01|June 2008|2008-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Fetal Alcohol Damage Prevention Study|Prevention of Fetal Alcohol Damage Using Maternal Blood Markers|Completed||N/A|612|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 14:16:35.63366|2017-02-18 14:16:35.63366
NCT00696072|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-05-10|2016-03-09||August 2008||2008-08-01|May 2016|2016-05-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||Intent to treat (ITT) population|Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic|Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic|Completed||Phase 2|120|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 14:16:35.746575|2017-02-18 14:16:35.746575
NCT00696059|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-11|||August 2004||2004-08-01|June 2008|2008-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|HURRAH||Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?|Can Bone Erosions Heal in Adalimumab (Humira) Treated Rheumatoid Arthritis Patients. An Imaging Study Using Computed Tomography and Magnetic Resonance Imaging.|Completed||Phase 4|52|Actual|Hvidovre University Hospital||1|||f||||f||||||||||2017-02-18 14:16:36.513677|2017-02-18 14:16:36.513677
NCT00696046|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-09|||March 2006||2006-03-01|June 2008|2008-06-01|June 2009|Anticipated|2009-06-01|December 2008|Anticipated|2008-12-01||Interventional|CB01||Intra Bone Marrow Injection Of Unrelated Cord Blood Cells|Direct Intra Bone Marrow Injection Of Unrelated Cord Blood Cells To Improve Engraftment And Reduce Acute Graft-Versus-Host Disease|Unknown status|Recruiting|Phase 1/Phase 2|47|Anticipated|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy||1|||f||||f||||||||||2017-02-18 14:16:36.628855|2017-02-18 14:16:36.628855
NCT00696033|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-09-16|||July 2007||2007-07-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ibid||Exploring the Effects of Diazepam and Lorazepam|Exploring the Effects of Diazepam and Lorazepam on the Neural Correlates of Perceptual Priming and Explicit Memory in Healthy Volunteers|Completed||N/A|22|Actual|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-02-18 14:16:36.728571|2017-02-18 14:16:36.728571
NCT00696020|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2015-07-20|2015-06-19||June 2008||2008-06-01|July 2015|2015-07-01||||February 2009|Actual|2009-02-01||Interventional||Treated Set (TS). The TS included all randomized patients who received at least 1 dose of study medication.|Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD)|Randomised, Double-Blind, Parallel Group Study to Assess the Efficacy and Safety of 4 Weeks of Once Daily Treatment of 3 Doses of Orally Inhaled BI 1744 CL, Each in Fixed Dose Combination With 5 Microgram Tiotropium Bromide (Delivered by the Respimat Inhaler) Compared With 5 Microgram Tiotropium Bromide Monoproduct (Delivered by the Respimat Inhaler) in Patients With COPD|Completed||Phase 2|360|Actual|Boehringer Ingelheim|"Additional secondary endpoints were listed in the original protocol. Those endpoints are of exploratory nature only and were not considered relevant for trial conclusions. For more information see tab “Full Text Review”, section “More Information."|4|||f||||||||||||||2017-02-18 14:16:36.850933|2017-02-18 14:16:36.850933
NCT00580658|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-05-11|||May 2006||2006-05-01|May 2016|2016-05-01|May 2020|Anticipated|2020-05-01|||||Expanded Access|Dystonia IRB||Humanitarian Device Exemption|Humanitarian Device Exemption for Medtronic Activa Dystonia Therapy|Approved for marketing||N/A|||Vanderbilt University|||||||||||||||||||2017-02-18 14:56:43.987852|2017-02-18 14:56:43.987852
NCT00696007|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2012-02-16|||April 2008||2008-04-01|February 2012|2012-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer|Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer|Withdrawn||Phase 2|0|Actual|Lahey Clinic||2||Study was unable to recruit subjects meeting the study requirements.|f||||f||||||||||2017-02-18 14:16:41.052367|2017-02-18 14:16:41.052367
NCT00695994|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2012-10-31|||October 2006||2006-10-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients|The Effect of Pharmacogenetics on Treatment Toxicities and Outcomes in East Asian and Caucasian Patients Undergoing Docetaxel or Gemcitabine-based Chemotherapy|Completed||Phase 2|300|Actual|National University Hospital, Singapore||2|||f||||||||||||||2017-02-18 14:16:41.173102|2017-02-18 14:16:41.173102
NCT00695981|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2017-01-31|||June 2008|Actual|2008-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Operative Versus Non-operative Management of Rotator Cuff Tear|The Effectiveness and Cost-Effectiveness of Operative and Non-operative Management of Rotator Cuff Tear|Active, not recruiting||N/A|100|Anticipated|Central Finland Hospital District||2|||f||||t||||||||Undecided||2017-02-18 14:16:41.284703|2017-02-18 14:16:41.284703
NCT00695968|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2012-07-10|||April 2008||2008-04-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI|A Prospective Study Evaluating Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography, and Magnetic Resonance Imaging in the Detection of Breast Cancer|Terminated||N/A|9|Actual|Stanford University|||1|low accrual|f||||||||||||||2017-02-18 14:16:41.399389|2017-02-18 14:16:41.399389
NCT00695955|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-03-24|2011-03-24||June 2007||2007-06-01|March 2011|2011-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension|A One-Year Phase 3, Open-Label Study to Evaluate the Safety and Tolerability of TAK-491 in Subjects With Essential Hypertension|Completed||Phase 3|669|Actual|Takeda||1|||f||||f||||||||||2017-02-18 14:16:41.49278|2017-02-18 14:16:41.49278
NCT00695942|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2012-05-16|||June 2008||2008-06-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|AngioPred||Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease|Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease: Role of Angiogenic Factors, Hemostasis and Uterine Artery Doppler|Completed||N/A|200|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||t||||||Samples Without DNA|"~     plasma and serum samples~   "|||2017-02-18 14:16:42.265732|2017-02-18 14:16:42.265732
NCT00695929|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2010-01-25|||July 2008||2008-07-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Levosimendan in Congenital Cardiac Surgery||Completed||N/A|50|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||||||||||||2017-02-18 14:16:42.36398|2017-02-18 14:16:42.36398
NCT00695916|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2017-01-30||||||January 2017|2017-01-01||||||||Interventional|||MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery|Randomized Trial of Breast MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery|Withdrawn||Phase 3|0|Actual|Stanford University||||PI|f||||||||||||||2017-02-18 14:16:42.450131|2017-02-18 14:16:42.450131
NCT00695903|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-01-05|2011-08-23||September 2008||2008-09-01|January 2016|2016-01-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|HDSAB||Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia|A Phase 2 Multicenter, Randomized, Double-blinded, Study to Describe the Safety, Efficacy, and Pharmacokinetics of Daptomycin 10 mg/kg/Day and Vancomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia|Terminated||Phase 2|38|Actual|Cubist Pharmaceuticals LLC|Because the study was terminated early due to lack of enrollment, there were not sufficient patients to provide meaningful analysis for the following secondary outcomes: persistent/recurrent bacteremia and time to defervescence/clearance.|2||terminated due to lack of enrollment|f||||t||||||||||2017-02-18 14:16:42.540418|2017-02-18 14:16:42.540418
NCT00695890|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2014-12-17|||September 2007||2007-09-01|December 2014|2014-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Effects of Sevoflurane and Propofol on Light Flash Evoked Pupillometry|Effects of Sevoflurane and Propofol on Light Flash Evoked Pupillometry.|Completed||N/A|30|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-02-18 14:16:43.025096|2017-02-18 14:16:43.025096
NCT00695877|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-03-15|||February 2009||2009-02-01|March 2016|2016-03-01||||December 2012|Actual|2012-12-01||Interventional|||Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults|A Phase I Randomized, Double-blind, Placebo Controlled Dose Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Adenovirus Serotype 5 HVR48 HIV-1 Vaccine (Ad5HVR48.ENVA.01) in Healthy, HIV-1 Uninfected Adults (Ad5HVR48.ENVA.01 (rAd5HVR48) HIV-1/IPCAVD-002 Vaccine Study)|Active, not recruiting||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 14:16:43.115686|2017-02-18 14:16:43.115686
NCT00695864|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-01-04|||May 2008||2008-05-01|January 2011|2011-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Ondansetron for Withdrawal Symptoms|Effect of Ondansetron for Withdrawal Symptoms|Completed||N/A|31|Actual|Stanford University||2|||f||||||||||||||2017-02-18 14:16:43.227252|2017-02-18 14:16:43.227252
NCT00695851|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2009-03-27|||March 2005||2005-03-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.|A Phase I Randomized Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.|Completed||Phase 1|36|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:16:43.322384|2017-02-18 14:16:43.322384
NCT00695838|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2009-08-04|||January 2008||2008-01-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|||||Observational|LINEA||National Survey on Gastroesophageal Reflux Disease (GERD) Patients|Evaluation of the Impact of Abdominal Fat on GERD Severity and GERD Frequency in General Practice|Completed||N/A|5084|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:16:43.474537|2017-02-18 14:16:43.474537
NCT00694356|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-02-04|||August 2008||2008-08-01|February 2015|2015-02-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Study of MK0646 in Patients With Solid Tumors (0646-009)(COMPLETED)|A Phase I Study of MK0646 in Patients With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:17:15.707505|2017-02-18 14:17:15.707505
NCT00695825|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-12-11|||February 2008||2008-02-01|December 2008|2008-12-01|December 2008|Anticipated|2008-12-01|November 2008|Anticipated|2008-11-01||Interventional|||Effects the Glycemic Index on Metabolic Risk Markers|Postprandial Effects of a Low vs. a High Glycemic Index Food Product on Metabolic Risk Markers in Lean and Obese Subjects|Unknown status|Active, not recruiting|N/A|30|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 14:16:45.971453|2017-02-18 14:16:45.971453
NCT00695812|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-11|||September 2008||2008-09-01|June 2008|2008-06-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|||The Development of Younger Siblings of Children With Autism Now at 10 Years of Age|The Development of Younger Siblings of Children With Autism Now at 10 Years of Age|Unknown status|Not yet recruiting|N/A|104|Anticipated|Shaare Zedek Medical Center|||2||f||||f||||||||||2017-02-18 14:16:46.06532|2017-02-18 14:16:46.06532
NCT00695799|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2013-12-10|||June 2008||2008-06-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Observational|||Propofol Concentration In The Ambient Air Of The Operating Room And In The Blood Of Anesthesia Care Providers|Measurement Of Propofol Concentration In The Ambient Air Of The Operating Room And In The Blood Of Anesthesia Care Providers During Propofol -Based General Anesthesia|Completed||N/A|20|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||Samples Without DNA|"~     Standard blood draw~   "|||2017-02-18 14:16:46.137467|2017-02-18 14:16:46.137467
NCT00695786|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-07-13|||June 2008||2008-06-01|July 2016|2016-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||Lenalidomide Plus Rituximab for Indolent Non-Hodgkin's Lymphoma|A Phase II Study of Revlimid in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Hodgkin's Lymphoma (NHL)|Active, not recruiting||Phase 2|155|Anticipated|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-02-18 14:16:46.234564|2017-02-18 14:16:46.234564
NCT00695773|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-11-28|||February 2006||2006-02-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Laparoscopic Vs. Open Prostatectomy Outcomes|Laparoscopic Vs. Open Prostatectomy Outcomes|Terminated||N/A|158|Actual|Lahey Clinic|||1|Insufficient findings for data analysis|f||||f||||||||||2017-02-18 14:16:46.349609|2017-02-18 14:16:46.349609
NCT00695747|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2009-01-21|||January 1998||1998-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy|Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy|Completed||N/A|95|Actual|Lahey Clinic||2|||f||||f||||||||||2017-02-18 14:16:46.449191|2017-02-18 14:16:46.449191
NCT00695734|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-10|||January 2007||2007-01-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Detection of Latent Tuberculosis in Hemodialysis Patients|Interferon-Gamma Release Assays (IGRA) Versus Tuberculin Skin Testing for Detection of Latent Tuberculosis Infection (TB) in Chronic Hemodialysis Patients|Completed||N/A|62|Actual|University Hospital, Geneva|||1||f||||f||||||||||2017-02-18 14:16:46.561927|2017-02-18 14:16:46.561927
NCT00695708|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2010-04-12|||January 2008||2008-01-01|June 2008|2008-06-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||Training-induced Cerebral Reorganization in Schizophrenia|Training-induced Cerebral Reorganization in Schizophrenia|Completed||N/A|60|Anticipated|University of Konstanz||3|||f||||t||||||||||2017-02-18 14:16:46.836076|2017-02-18 14:16:46.836076
NCT00695695|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2017-01-24|||May 14, 2008||2008-05-14|February 3, 2014|2014-02-03|February 3, 2014||2014-02-03|||||Observational|||The Experience of Caregivers of Children With Down Syndrome|The Role of Hope in Adaptation to Uncertainty: The Experience of Caregivers of Children With Down Syndrome|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:16:46.961904|2017-02-18 14:16:46.961904
NCT00695682|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2008-06-11|||June 2008||2008-06-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|ITVR||Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)|The Safety and Tolerability of Intravitreal Infliximab (Remicade) in Patients With Refractory Diabetic Macular Edema or Choroidal Neovascularization Secondary to Age Related Macular Degeneration- A Pilot Study|Unknown status|Recruiting|Phase 1|4|Anticipated|Retina Research Foundation||1|||f||||f||||||||||2017-02-18 14:16:47.075024|2017-02-18 14:16:47.075024
NCT00695669|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-10-18|2013-12-19||June 2008||2008-06-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64|A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64|Completed||Phase 2|312|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:16:47.203851|2017-02-18 14:16:47.203851
NCT00695656|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2009-08-04|||April 2008||2008-04-01|August 2009|2009-08-01|November 2008|Actual|2008-11-01|||||Observational|Prophyl GP||National Survey on Hypertension in General Practitioner (GP) Consultation|Profile of Hypertensive Patients Seen in General Practitioner Consultation|Completed||N/A|2853|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:16:48.67888|2017-02-18 14:16:48.67888
NCT00695643|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2014-05-16|||January 2008||2008-01-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis|Double-blind, Randomized, Placebo-controlled, Parallel Group, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis|Terminated||Phase 3|345|Actual|Dr. Falk Pharma GmbH||2|||f||||t||||||||||2017-02-18 14:16:53.227319|2017-02-18 14:16:53.227319
NCT00695630|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-11|||September 2006||2006-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Flumazenil Reversal of Oral Triazolam|Flumazenil Rescue Strategy|Completed||Phase 1/Phase 2|14|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:16:53.324849|2017-02-18 14:16:53.324849
NCT00695617|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2009-03-04|||July 2008||2008-07-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Citrate Anticoagulation During MARS Treatment|Citrate Anticoagulation During MARS Treatment|Unknown status|Recruiting|Phase 2/Phase 3|10|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-02-18 14:16:53.431345|2017-02-18 14:16:53.431345
NCT00695578|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-02-12|||October 2006||2006-10-01|February 2009|2009-02-01|February 2008|Actual|2008-02-01|June 2007|Actual|2007-06-01||Interventional|||Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy|A Randomized Right/Left Clinical Trial to Evaluate the Use of Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy|Completed||Phase 4|20|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 14:16:53.741363|2017-02-18 14:16:53.741363
NCT00695565|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-09-21|2013-07-11||May 2008||2008-05-01|September 2016|2016-09-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional||ITT (Intent-to-Treat)|Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy|A Multicenter, Randomized, Double-Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Topical Gel, 0.1% With Placebo in the Management of Pain Associated With Painful Diabetic Neuropathy|Completed||Phase 2|180|Actual|Arcion Therapeutics Inc||2|||f||||t||||||||Undecided||2017-02-18 14:16:53.8264|2017-02-18 14:16:53.8264
NCT00695552|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2010-03-17|||September 2008||2008-09-01|June 2008|2008-06-01|April 2011|Anticipated|2011-04-01|January 2011|Anticipated|2011-01-01||Interventional|DEMOII||The Effect of Exercise on Depressive Symptoms in Unmedicated Patients|DEMO II: A Randomized, Parallel-group, Observer-blinded Clinical Trial of Aerobic Exercise Versus Stretching Exercise for Patients With Light to Moderate Depression|Unknown status|Recruiting|N/A|200|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-02-18 14:16:54.722653|2017-02-18 14:16:54.722653
NCT00695539|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2009-10-02|||December 2007||2007-12-01|October 2009|2009-10-01|December 2008|Actual|2008-12-01|||||Observational|RESEARCH||Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients|A Multi-centre, Open Label, Non-randomised, Non Interventional, 24 Weeks Study for the Efficacy and Safety of Rosuvastatin Following Its Administration in Real Life Clinical Practice in Greek Hypercholesterolaemic Patients|Completed||N/A|810|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:16:54.82546|2017-02-18 14:16:54.82546
NCT00695526|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2008-06-14|||May 2006||2006-05-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Effects of Cranberry Extractive on the Lipid Profiles in Subjects With Type 2 Diabetes|Phase 3 Study of Cranberry on Lipid Profiles in Type 2 Diabetes|Completed||Phase 3|30|Actual|Taichung Veterans General Hospital||1|||f||||f||||||||||2017-02-18 14:16:54.910904|2017-02-18 14:16:54.910904
NCT00695513|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2011-09-14|||March 2006||2006-03-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Inulin and Protein Fermentation in Hemodialysis Patients|A Phase 1/2 Study on the Effects of BENEO synergy1 on the Generation Rate and Serum Concentration of P-cresol and Related Protein-fermentation Endproducts in Haemodialysis Patients|Completed||Phase 1/Phase 2|22|Anticipated|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-02-18 14:16:55.021352|2017-02-18 14:16:55.021352
NCT00695500|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-11|2016-07-05|2016-04-05||June 2008||2008-06-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|July 2014|Actual|2014-07-01||Interventional|||Varenicline to Reduce Alcohol Consumption in Heavy Drinkers|A Randomized, Double-blind, Placebo Controlled Trial (RCT) of Varenicline to Reduce Alcohol Consumption in Heavy Drinkers|Completed||Phase 1/Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)|The IV alcohol self-administration method may have shown ceiling effects limiting the interpretation of results.|2|||f||||f||||||||No||2017-02-18 14:16:55.144516|2017-02-18 14:16:55.144516
NCT00695487|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2014-03-11|||July 2008||2008-07-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|THC||Does Intravenous Cannabis Reduce Postoperative Nausea and Vomiting (PONV)?|Does Intravenous Cannabis Reduce Postoperative Nausea and Vomiting (PONV)?|Terminated||N/A|320|Actual|University Hospital Inselspital, Berne||2||In the intermediate analysis, no effect could be shown, not even a tendency.|f||||f||||||||||2017-02-18 14:16:55.747097|2017-02-18 14:16:55.747097
NCT00695474|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-07-10|||June 2008||2008-06-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Vitamin D and Type 2 Diabetes - a Cross Sectional Study|Vitamin D and Type 2 Diabetes - a Cross Sectional Study|Completed||N/A|150|Actual|University of Aarhus|||1||f||||f||||||Samples With DNA|"~     Blood samples, urine.~   "|||2017-02-18 14:16:55.842954|2017-02-18 14:16:55.842954
NCT00695461|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-10|||January 2001||2001-01-01|June 2008|2008-06-01|August 2006|Actual|2006-08-01|June 2004|Actual|2004-06-01||Interventional|Lp 299v||Lactobacillus Plantarum 299v in Colon Surgery|L Plantarum 299v to Patients Undergoing Colon Resection - a Randomized Placebo-Controlled Study|Completed||N/A|72|Actual|Skane University Hospital||2|||f||||f||||||||||2017-02-18 14:16:55.937233|2017-02-18 14:16:55.937233
NCT00695448|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2016-10-26|||June 2008||2008-06-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or Lymphoma|A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK1059615 in Patients With Solid Tumors or Lymphoma|Terminated||Phase 1|11|Actual|GlaxoSmithKline||1||"This study was terminated prematurely due to lack of sufficient exposure following single- and~   repeat-dosing."|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:16:56.036127|2017-02-18 14:16:56.036127
NCT00695435|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2010-02-23|2009-04-27||June 2008||2008-06-01|February 2010|2010-02-01||||June 2008|Actual|2008-06-01||Interventional|||Tobramycin Tear Concentrations|Evaluation of Tobramycin Tear Concentrations of TOBRADEX® Ophthalmic Suspension, Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension Versus TOBREX® Ophthalmic Solution in Normal Volunteers|Completed||Phase 1|21|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 14:16:56.134214|2017-02-18 14:16:56.134214
NCT00695422|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-07|2017-01-17|||May 2008||2008-05-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Observational|||Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials|A Companion Protocol to Evaluate Anogenital Human Papillomavirus (HPV) Infection and Anogenital Squamous Intraepithelial Lesions (ASIL) in Subjects Participating in AMC Clinical Trials|Active, not recruiting||N/A|15|Anticipated|AIDS Malignancy Consortium|||1||f||||f||||||Samples With DNA|"~     Blood specimens, anal cytology and biopsy of any lesions observed, cervical cytology and~     biopsy of any lesions observed.~   "|||2017-02-18 14:16:56.410515|2017-02-18 14:16:56.410515
NCT00693433|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2015-12-03|||December 2008||2008-12-01|June 2013|2013-06-01||||August 2010|Actual|2010-08-01||Interventional|||Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma|A Phase 1 Study of CCI-779 in Combination With Dexamethasone in Multiple Myeloma|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:17:30.611408|2017-02-18 14:17:30.611408
NCT00695409|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2016-09-09|||March 2008||2008-03-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, and High-Dose Combination Chemotherapy Followed By Peripheral Blood Stem Cell Transplant in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma|A Phase II Study of Yttrium-90-Labeled Anti-CD20 Monoclonal Antibody in Combination With High-Dose Beam (BCNU, Etoposide, Cytarabine and Melphalan) Followed by Autologous Stem Cell Transplantation for Patients With Poor Risk/Relapsed B-Cell Lymphoma|Active, not recruiting||Phase 2|118|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:16:56.543081|2017-02-18 14:16:56.543081
NCT00695396|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2012-10-02|2011-02-08||June 2008||2008-06-01|October 2012|2012-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion|A Randomized, Double Blind, Placebo Controlled, Multicenter Study Evaluating Epoetin Alfa Initiated at 40,000 IU Every Week or 80,000 IU Every Week Versus Placebo in Subjects With IPSS Low- or Intermediate-1 Risk Myelodysplastic Syndromes at Risk For Transfusion|Terminated||Phase 3|25|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Because this study was terminated prematurely due to slow enrollment, only limited data were collected. No formal statistical testing was performed. Only descriptive statistics were provided.|4||"The study was stopped due to low subject enrollment. No safety issue or other concern factored~   into this decision."|f||||t||||||||||2017-02-18 14:16:56.691564|2017-02-18 14:16:56.691564
NCT00695383|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-10|||December 2005||2005-12-01|June 2008|2008-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Early Exercise Training in Critically Ill Patients|Early Exercise in Critically Ill Patients Enhances Short-Term Functional Recovery|Completed||N/A|90|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-02-18 14:16:57.372173|2017-02-18 14:16:57.372173
NCT00695370|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-12|||January 2006||2006-01-01|June 2008|2008-06-01|January 2008|Anticipated|2008-01-01|December 2007|Anticipated|2007-12-01||Interventional|||Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children|Hematopoietic Progenitor Cell Mobilization in Children With Malignancies: Evaluation of Pegfilgrastim at 300µg/kg in Hematological Steady State|Terminated||Phase 2|30|Anticipated|University Hospital, Clermont-Ferrand||||Recruiting or enrolling participants has halted and will not resume|f||||||||||||||2017-02-18 14:16:57.481031|2017-02-18 14:16:57.481031
NCT00695357|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-04-29|||April 2008||2008-04-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|||||Observational|EPAGGELIA||Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006|Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006|Completed||N/A|832|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:16:57.780397|2017-02-18 14:16:57.780397
NCT00695344|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-01-29|||January 2006||2006-01-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|EVEROSTAT||Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant|Prospective and Randomized Study to Evaluate the Effect of Everolimus in the Clinical and Intra-Cardiac Ecography Progression of Heart Graft Vascular Illness.|Unknown status|Active, not recruiting|Phase 4|52|Actual|Fundacion Investigacion y Desarrollo||2|||f||||t||||||||||2017-02-18 14:16:57.891194|2017-02-18 14:16:57.891194
NCT00695331|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-08|2008-07-08|||February 2008||2008-02-01|July 2008|2008-07-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Interventional|||Efficacy and Safety Study of Titrated Oral Misoprostol Solution for Labor Augmentation|A Comparison of Titrated Oral Misoprostol Solution to Intravenous Oxytocin for Labor Augmentation: A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|143|Anticipated|China Medical University Hospital||2|||f||||t||||||||||2017-02-18 14:16:58.01631|2017-02-18 14:16:58.01631
NCT00695318|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2015-05-11|2015-04-17||December 2008||2008-12-01|May 2015|2015-05-01||||October 2013|Actual|2013-10-01||Interventional||Patients received either the 0.2µ/day or 0.5µ /day dose as well as a sham injection in the fellow eye. The total number of subjects enrolled/analyzed was 17.|Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy|A Randomized, Double-Masked, Fellow-Eye Comparison Of The Safety And Efficacy Of 0.2 And 0.5 µg/Day Fluocinolone Acetonide Intravitreal Insert To Sham Injection In Subjects With Bilateral Geographic Atrophy Due To AMD|Terminated||Phase 2|17|Actual|Alimera Sciences||2|||f||||f||||||||||2017-02-18 14:16:58.142654|2017-02-18 14:16:58.142654
NCT00695305|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2016-11-30||2011-03-17|November 2008||2008-11-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks|A Multicenter, Randomized, 12 Week, Double-blind, Placebo-controlled, Parallel-group, Phase IIa Study Using 18F Fluorodeoxyglucose (FDG)-PET to Measure the Effects of Rilapladib on Macrophage Activity in Subjects With Atherosclerosis|Completed||Phase 2|83|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:16:58.848767|2017-02-18 14:16:58.848767
NCT00695292|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2013-02-22|2013-01-14||June 2008||2008-06-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|June 2011|Actual|2011-06-01||Interventional|||Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer|Phase II Study of Irinotecan, Carboplatin, and Sunitinib in the First Line Treatment of Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|37|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 14:16:58.99289|2017-02-18 14:16:58.99289
NCT00695279|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2016-07-19|||December 2006||2006-12-01|July 2016|2016-07-01|December 2036|Anticipated|2036-12-01|December 2036|Anticipated|2036-12-01||Observational|||Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products|Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products at St. Jude Children's Research Hospital|Recruiting||N/A|100|Anticipated|St. Jude Children's Research Hospital|||1||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 14:16:59.343907|2017-02-18 14:16:59.343907
NCT00695266|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-08-04|||December 2007||2007-12-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|||||Observational|PROPHYL HO||National Survey on Hypertension at Hospital|Profile of Hypertensive Patients Seen in Hospital Outpatient's Department|Completed||N/A|655|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:16:59.471825|2017-02-18 14:16:59.471825
NCT00693420|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2013-09-26|2009-01-14||April 2007||2007-04-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence||Completed||Phase 3|278|Actual|Allergan||2|||f||||||||||||||2017-02-18 14:17:30.87775|2017-02-18 14:17:30.87775
NCT00695253|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-03-01|||January 2002||2002-01-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Physician-Sponsored IDE for Talent Endoluminal Spring Graft System in Patients With Abdominal Aortic Aneurysms (AAA)|Physician-Sponsored IDE for Talent Endoluminal Spring Graft System in Patients With AAA|Completed||N/A|49|Actual|Los Angeles Biomedical Research Institute||1|||f||||t||||||||Undecided||2017-02-18 14:16:59.665319|2017-02-18 14:16:59.665319
NCT00695240|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-10|||April 2007||2007-04-01|June 2008|2008-06-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Post-Operative Pain Control Using Direct Continuous Bupivacaine Infusion After Pelvic Organ Prolapse Repair|Post-Operative Pain Control Using Direct Continuous Bupivacaine Infusion After Pelvic Organ Prolapse Repair|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|St. Luke's Hospital, Kansas City, Missouri||1|||f||||f||||||||||2017-02-18 14:16:59.769308|2017-02-18 14:16:59.769308
NCT00695227|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2011-05-02|||May 2004||2004-05-01|May 2011|2011-05-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|SCE||Screening for Barrett's Esophagus in Otolaryngology Patients|Screening for Barrett's Esophagus in Otolaryngology Patients|Unknown status|Active, not recruiting|Phase 2|500|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 14:16:59.875461|2017-02-18 14:16:59.875461
NCT00695214|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2017-02-15|||February 2004||2004-02-01|February 2017|2017-02-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea|Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea|Recruiting||Phase 2|800|Anticipated|University of Southern California||1|||f||||f||||||||||2017-02-18 14:16:59.972478|2017-02-18 14:16:59.972478
NCT00695201|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2016-09-22|||August 2000||2000-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer|A Phase I Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer.|Active, not recruiting||Phase 1|72|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:17:00.104263|2017-02-18 14:17:00.104263
NCT00695188|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-02-15|2010-12-20||May 2008||2008-05-01|August 2009|2009-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis|Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis A Multicenter, Randomized, Double-blind, Controlled Phase IV Trial|Completed||Phase 4|19|Actual|Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation||2|||f||||t||||||||||2017-02-18 14:17:00.248236|2017-02-18 14:17:00.248236
NCT00695175|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2009-08-04|||February 2008||2008-02-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|||||Observational|Prophyl C||National Survey on Hypertension in Cardiologic Private Practice|Profile of Hypertensive Patients Seen in Private Cardiology Consultation|Completed||N/A|1800|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:17:00.632629|2017-02-18 14:17:00.632629
NCT00695162|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-02-15|||January 2010||2010-01-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Speech Intelligibility and Cognition: Are Inpatients Impaired by Noise?|Speech Intelligibility and Cognition: Are Inpatients Impaired by Noise?|Completed||N/A|84|Actual|Portland VA Medical Center||2|||f||||f||||||||||2017-02-18 14:17:01.527297|2017-02-18 14:17:01.527297
NCT00695149|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-06-01|||July 2005||2005-07-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|December 2008|Actual|2008-12-01||Interventional|||Treatment for Acute Spinal Cord Injury|Clinical Study of Treatment for Acute Spinal Cord Injury Using Cultured Bone Marrow Stromal Cells|Terminated||Phase 1/Phase 2|5|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||||||||||||2017-02-18 14:17:01.628873|2017-02-18 14:17:01.628873
NCT00695136|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-10|2013-04-22|2013-04-22||June 2008||2008-06-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||16 subjects completed screening and had baseline data. However, only 8 of them were eligible for further study participation and only 5 completed the drug and provided data for analysis.|The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism|An Investigation of the Relationship Between Donepezil Enhanced REM Sleep, Sleep Architecture and Behavior in the Prepubertal Child With Autism|Completed||Phase 1/Phase 2|17|Actual|National Institutes of Health Clinical Center (CC)|No controls and small number of patients.|1|||f||||f||||||||||2017-02-18 14:17:01.874572|2017-02-18 14:17:01.874572
NCT00695123|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-07|2017-02-14|||June 3, 2008||2008-06-03|January 26, 2017|2017-01-26||||||||Observational|||Screening for Subjects to Participate in Studies of Blood Disorders|Screening of Subjects to Determine Eligibility to Safely Participate in Blood Disorders Studies|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:17:02.138908|2017-02-18 14:17:02.138908
NCT00695110|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2010-08-23||2010-08-17|June 2008||2008-06-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men|Phase II, Repeat Dose, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men|Completed||Phase 2|29|Actual|Clarus Therapeutics, Inc.||4|||f||||f||||||||||2017-02-18 14:17:02.252053|2017-02-18 14:17:02.252053
NCT00695097|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2014-02-07|2013-11-13||August 2004||2004-08-01|February 2014|2014-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||Per protocol|The Effect of Rituximab on the Development of Anti-Donor Antibodies|The Effect of Rituximab on the Development of Anti-Donor Antibodies and Resolution of B Cell Infiltration in the Renal Allograft of Patients Undergoing Rejection|Completed||N/A|18|Actual|University of California, San Francisco|The limitations were small number of participants and short follow up time of only 12 months.|2|||f||||f||||||||||2017-02-18 14:17:02.37035|2017-02-18 14:17:02.37035
NCT00695084|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-10|||March 2007||2007-03-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)|Constraint-Induced Movement Therapy Trial for Progressive Multiple Sclerosis|Completed||Phase 1|7|Actual|National Multiple Sclerosis Society||1|||f||||f||||||||||2017-02-18 14:17:02.783389|2017-02-18 14:17:02.783389
NCT00678925|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2010-06-16|||December 2004||2004-12-01|June 2010|2010-06-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Interventional|||Supplemental Choline and Brain Development in Humans|Supplemental Choline and Neurodevelopment in Humans|Completed||N/A|150|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 14:22:29.325887|2017-02-18 14:22:29.325887
NCT00695071|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2011-09-23|||June 2008||2008-06-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Assess Blood Levels of Itraconazole During a Two-Week Period|Assessment of the Steady State Pharmacokinetics of Itraconazole and Hydroxy-Itraconazole in Healthy Subjects After Administration of a New Itraconazole 200 mg Film Coated Tablet Once Daily for Fourteen Days in Fed Condition|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:17:02.895428|2017-02-18 14:17:02.895428
NCT00695058|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2012-02-23|||August 2008||2008-08-01|February 2012|2012-02-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|TMNS||Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Treatment of Incontinence|Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Treatment of Incontinence|Withdrawn||Phase 3|0|Actual|Copenhagen University Hospital at Herlev||6||Failure to include|f||||t||||||||||2017-02-18 14:17:03.005436|2017-02-18 14:17:03.005436
NCT00695045|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-09|||July 2003||2003-07-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||Intrathecal Morphine in Knee Arthroplasty|Determination of the Efficacy and Side-Effect Profile of Lower Doses of Intrathecal Morphine in Patients Undergoing Total Knee Arthroplasty|Completed||N/A|60|Actual|University College Hospital Galway||3|||f||||f||||||||||2017-02-18 14:17:03.125071|2017-02-18 14:17:03.125071
NCT00695032|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-07|2014-11-04|||October 2007||2007-10-01|November 2014|2014-11-01||||September 2012|Actual|2012-09-01||Interventional|||Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors|Biologic Evaluation of Renal Toxicity of Cisplatin and Ifosfamide (TOXIPLAT)|Suspended||N/A|80|Anticipated|Institut Claudius Regaud||1|||f||||f||||||||||2017-02-18 14:17:03.233344|2017-02-18 14:17:03.233344
NCT00695019|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2013-08-27|2013-02-05||June 2009||2009-06-01|August 2013|2013-08-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Low-Dose Human Interferon-alpha by the Oral Mucosal Route During the 6-Month Follow-up Period of Standard Combination Therapy for Hepatitis C Virus Infection|Completed||Phase 2|169|Actual|Amarillo Biosciences, Inc.||3|||f||||f||||||||||2017-02-18 14:17:03.342779|2017-02-18 14:17:03.342779
NCT00695006|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-24|||September 2006||2006-09-01|June 2008|2008-06-01|July 2008|Anticipated|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Manual Therapy, Exercise and Traction for Patients With Cervical Radiculopathy: A RCT|Manual Therapy, Exercise and Traction for Patients With Cervical Radiculopathy: A RCT|Unknown status|Active, not recruiting|N/A|81|Actual|Rocky Mountain University of Health Professions||2|||f||||||||||||||2017-02-18 14:17:04.150329|2017-02-18 14:17:04.150329
NCT00694993|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2017-02-01|||December 2007||2007-12-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects|A Double-blind, Placebo-controlled, Randomized Single Dose Escalation Study and a Double-blind, Placebo-controlled, Randomised Parallel Group 14-days Once Daily Repeat Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of an Intranasal H1/H3 Dual Antagonist Compound in Healthy Male Subjects|Completed||Phase 1|8|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:17:04.348596|2017-02-18 14:17:04.348596
NCT00694980|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-07|2016-11-01|||September 2008||2008-09-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis|A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis|Completed||Phase 1|48|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 14:17:04.458084|2017-02-18 14:17:04.458084
NCT00694967|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-07|2008-06-07|||November 2003||2003-11-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix|Histologic Evaluation of the Cervix at Risk for Preterm Birth Trial:Medical Versus Surgical Therapy|Terminated||N/A|92|Actual|Lehigh Valley Hospital||2||Interim analysis showed no difference in outcome between treatment groups.|f||||f||||||||||2017-02-18 14:17:04.600437|2017-02-18 14:17:04.600437
NCT00694954|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2011-12-16|||February 2007||2007-02-01|December 2011|2011-12-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Capsule Endoscopy vs Standard of Care for Obscure Intestinal Bleeding|A Randomized Controlled Trial of Capsule Endoscopy vs Standard Care in Patients With Iron Deficiency Anemia With Suspected Obscure / Occult Gastrointestinal Bleeding|Unknown status|Recruiting|Phase 4|160|Anticipated|University of Calgary||2|||f||||f||||||||||2017-02-18 14:17:04.695702|2017-02-18 14:17:04.695702
NCT00694941|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2012-06-12|||June 2008||2008-06-01|June 2012|2012-06-01||||December 2008|Actual|2008-12-01||Interventional|||A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)|A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|15|Actual|Ono Pharmaceutical Co. Ltd||1|||f||||f||||||||||2017-02-18 14:17:04.821217|2017-02-18 14:17:04.821217
NCT00694928|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2012-02-29||2010-11-02|May 2008||2008-05-01|February 2012|2012-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Vaginal Infection Study 2||Completed||Phase 3|843|Actual|Lumara Health, Inc.||2|||f||||||||||||||2017-02-18 14:17:04.947278|2017-02-18 14:17:04.947278
NCT00694915|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2012-05-03|||August 2008||2008-08-01|May 2012|2012-05-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|STCC||Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder|Open Label, Randomized, Multicentric, Comparative and Controlled Clinical Trial to Compare the Efficacy and Toxicity of Mycobacterium w Intra-dermal to Intravesical BCG in Patients With Newly Diagnosed Superficial Transitional Cell Carcinoma With High Probability of Recurrence|Unknown status|Active, not recruiting|Phase 2|122|Actual|Cadila Pharnmaceuticals||2|||f||||t||||||||||2017-02-18 14:17:05.27444|2017-02-18 14:17:05.27444
NCT00692978|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-04-05|||August 2008||2008-08-01|September 2012|2012-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pharmacokinetics of Inhaled Monodisperse Fluticasone Propionate|The Pharmacokinetics of Inhaled Fluticasone Propionate Delivered as Monodisperse Aerosols|Completed||Phase 4|23|Actual|Imperial College London||4|||f||||f||||||||||2017-02-18 14:17:36.206765|2017-02-18 14:17:36.206765
NCT00694902|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2012-03-15|||May 2008||2008-05-01|January 2011|2011-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677|A Single-centre, Randomized, Double-blind , Placebo Controlled, Dose Escalating Cross-over Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Inhaled Doses of GSK610677 and Placebo in Healthy Male Subjects|Completed||Phase 1|24|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 14:17:05.406012|2017-02-18 14:17:05.406012
NCT00694889|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2016-05-12|||August 2007||2007-08-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia|Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia|Completed||Phase 1/Phase 2|144|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-02-18 14:17:05.493705|2017-02-18 14:17:05.493705
NCT00694876|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-07|2012-11-29|||June 2008||2008-06-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Impact of Health Literacy and Other Factors on Glaucoma Patient Adherence in South India|Impact of Health Literacy and Other Factors on Glaucoma Patient Adherence in South India|Completed||N/A|250|Actual|Robin, Alan L., M.D.|||2||f||||f||||||||||2017-02-18 14:17:05.605647|2017-02-18 14:17:05.605647
NCT00694863|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2013-01-04|||July 2008||2008-07-01|December 2010|2010-12-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|ACTHiMeN||Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy|Treatment With Synthetic Adrenocorticotropic Hormone (ACTH) in Patients With Membranous Nephropathy and High Risk for Renal Failure. A Pilot Study|Completed||Phase 2|20|Actual|Radboud University||1|||f||||f||||||||||2017-02-18 14:17:05.704318|2017-02-18 14:17:05.704318
NCT00694850|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2017-02-13|||August 2008||2008-08-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)|A Multi-center, Non-randomized, Non Blinded, Non-controlled Study to Investigate the Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease Associated Pulmonary Hypertension.|Active, not recruiting||Phase 2|22|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:17:05.806406|2017-02-18 14:17:05.806406
NCT00694837|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2015-04-09|||March 2009||2009-03-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma|Phase I/II Study for Patients With Newly Diagnosed Glioblastoma Testing Nelfinavir in Combination With Concomitant Temozolomide and Radiotherapy.|Completed||Phase 1|6|Actual|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-02-18 14:17:05.915141|2017-02-18 14:17:05.915141
NCT00694824|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-10|||November 2004||2004-11-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Vascular Calcification's Risk Factors in Haemodialysis Patients|Traditional and Not Traditional Risk Factors in Appearance and Progression of Vascular Calcification in Haemodialysis Patients.|Completed||N/A|253|Actual|St. Orsola Hospital|||1||f||||f||||||Samples Without DNA|"~     For each patient a blood sample was drawn to check the basal values of hemoglobin,~     hematocrit, folates, vitamin B12, C reactive protein, PTH, calcium, phosphorus, albumin,~     alkaline phosphatase, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides,~     uric acid, fibrinogen, homocysteine. To better understand the mineral methabolism TGFb1,~     fetuin A, OPG, FGF 23, OPN and MGP will be checked. The values for each patient will be the~     median of 4 determinations, each sample was drawn before the midweek dialysis session.~   "|||2017-02-18 14:17:06.022108|2017-02-18 14:17:06.022108
NCT00694811|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-09|2008-06-10|||August 2004||2004-08-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Re-Feeding Duration on Weight Maintenance After Weight Loss With Very-Low-Energy Diets (VLEDs)|Liquid Very-Low-Energy Diets (VLEDs) in Obesity Treatment. Effects of Re-Feeding Duration On Weight Maintenance, Eating Behaviour and Health-Related Quality of Life|Completed||Phase 4|169|Actual|Göteborg University||2|||f||||f||||||||||2017-02-18 14:17:06.126709|2017-02-18 14:17:06.126709
NCT00694798|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-05-02|||October 2008||2008-10-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|STCC||Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder|Open Label, Single Arm, Exploratory Phase I Clinical Trial to Evaluate Efficacy and Safety of Mycobacterium w (Mw) in BCG Refractory Superficial Transitional Cell Carcinoma|Completed||Phase 1|22|Actual|Cadila Pharnmaceuticals||1|||f||||t||||||||||2017-02-18 14:17:06.24911|2017-02-18 14:17:06.24911
NCT00694785|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2009-08-20|||October 2008||2008-10-01|August 2009|2009-08-01||||June 2009|Anticipated|2009-06-01||Interventional|||A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B|A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B|Withdrawn||Phase 2|2|Anticipated|Archemix Corp.||4||Sponsor decided not to go forward with the study.|f||||||||||||||2017-02-18 14:17:06.37164|2017-02-18 14:17:06.37164
NCT00694772|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2008-06-09|||June 2008||2008-06-01|June 2008|2008-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Coblation-Tonsillotomy vs Electrocautery-Tonsillectomy for the Treatment of Obstructive Sleep Apnea (OSA) in Children|Coblation-Tonsillotomy Versus Electrocautery-Tonsillectomy for Treatment of Moderate and Severe Obstructive Sleep Apnea in Children: A Randomized, Prospective, Single-Blinded Study|Unknown status|Recruiting|N/A|100|Anticipated|University of Calgary||2|||f||||f||||||||||2017-02-18 14:17:06.468614|2017-02-18 14:17:06.468614
NCT00694759|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2010-08-03|||October 2006||2006-10-01|August 2010|2010-08-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Interventional|||Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)|Cortisol Regulation in Polycystic Ovary Syndrome|Unknown status|Recruiting|N/A|107|Anticipated|Oregon Health and Science University||3|||f||||f||||||||||2017-02-18 14:17:06.574904|2017-02-18 14:17:06.574904
NCT00694746|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2016-01-28|||June 2008||2008-06-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of Fish Oil to Reduce ALT Levels in Adolescents|Randomized Trial of Fish Oil Versus Placebo to Reduce ALT Levels in Overweight Adolescents|Terminated||Phase 1|3|Actual|Boston University||2||Study closed for slow recruitment|f||||f||||||||No|Design with difficult enrollement|2017-02-18 14:17:06.688362|2017-02-18 14:17:06.688362
NCT00694720|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2009-04-30|||June 2008||2008-06-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients|A Double-Blind, Randomized, Placebo-Controlled, Study Evaluating the Safety and Activity of Four Escalating Single Doses of AVE0657 in Congestive Heart Failure Patients Presenting as Cheyne-Stokes Breathing Syndrome|Terminated||Phase 2|8|Actual|Sanofi||5||Termination following reassessment of the potential benefit-risk of AVE0657|f||||t||||||||||2017-02-18 14:17:06.920966|2017-02-18 14:17:06.920966
NCT00694707|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2012-03-02||2012-03-02|June 2008||2008-06-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia|Evaluation of the Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia|Completed||Phase 2|732|Actual|Forest Laboratories||5|||f||||f||||||||||2017-02-18 14:17:07.039086|2017-02-18 14:17:07.039086
NCT00694694|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2016-10-19|||June 2008||2008-06-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|CAZAMS||Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria.|A Randomized Trial of Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria in Tanzanian Children.|Completed||Phase 3|261|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 14:17:07.217365|2017-02-18 14:17:07.217365
NCT00694681|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2012-03-23|||October 2004||2004-10-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|WtW||Working Toward Wellness|Enhanced Services for the Hard to Employ Demonstration: Telephonic Care Management for Depressed Medicaid Recipients|Completed||N/A|499|Actual|MDRC||1|||f||||f||||||||||2017-02-18 14:17:07.457321|2017-02-18 14:17:07.457321
NCT00694668|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-11-05|||May 2008||2008-05-01|November 2009|2009-11-01|October 2012|Anticipated|2012-10-01|November 2010|Anticipated|2010-11-01||Interventional|DSH||The (Cost-) Effectiveness of Mindfulness-training and Cognitive Behavioural Therapy in Adolescents and Young Adults With Deliberate Self Harm|The (Cost-) Effectiveness of Mindfulness-training and Cognitive Behavioural Therapy in Adolescents and Young Adults With Deliberate Self Harm|Unknown status|Recruiting|Phase 2/Phase 3|84|Anticipated|Leiden University Medical Center||2|||f||||f||||||||||2017-02-18 14:17:07.552962|2017-02-18 14:17:07.552962
NCT00694655|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2016-08-16|||May 2008||2008-05-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Human Immune Responses to The Yellow Fever Virus Vaccine|Human Immune Responses to Yellow Fever Vaccination|Recruiting||N/A|200|Anticipated|Emory University||1|||f||||f||||||||||2017-02-18 14:17:07.664204|2017-02-18 14:17:07.664204
NCT00694642|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2013-08-04|||May 2008||2008-05-01|May 2008|2008-05-01|February 2012|Actual|2012-02-01|May 2009|Actual|2009-05-01||Interventional|PROGENITOR||Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis|Safety and Efficacy of Transendocardial Injection of Autologous Endothelial Progenitor Cell CD 133 for Therapeutics Angiogenesis|Completed||Phase 1/Phase 2|28|Actual|Hospital San Carlos, Madrid||2|||f||||t||||||||||2017-02-18 14:17:07.786801|2017-02-18 14:17:07.786801
NCT00694629|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2014-05-07|||December 2008||2008-12-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment|TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis|Completed||Phase 2|865|Actual|Centers for Disease Control and Prevention||4|||f||||t||||||||||2017-02-18 14:17:07.896854|2017-02-18 14:17:07.896854
NCT00694616|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2013-06-22|||July 2008||2008-07-01|June 2013|2013-06-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Prevalence of Metabolic Syndrome in Obstructive Sleep Apnea (OSA) and Effect of Treatment With Continuous Positive Airway Pressure (Auto-CPAP) on Metabolic Syndrome|Prevalence of Metabolic Syndrome in Obstructive Sleep Apnea and the Effect of Treatment With Auto-titrating Continuous Positive Airway Pressure (Auto-CPAP) on Metabolic Syndrome|Completed||N/A|90|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 14:17:08.046492|2017-02-18 14:17:08.046492
NCT00694603|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-08-02|2012-04-28||September 2006||2006-09-01|August 2012|2012-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy|A Phase II Trial of Cetuximab (c225) as Therapy for Recurrent Non-Small Cell Lung Cancer in Patients Who Have Received Prior Therapy With Tyrosine Kinase Inhibitor Directed Against the EGFR Pathway|Terminated||Phase 2|56|Actual|Massachusetts General Hospital||1||Slow accrual|f||||t||||||||||2017-02-18 14:17:08.160099|2017-02-18 14:17:08.160099
NCT00694590|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2015-03-19|||June 2008||2008-06-01|March 2015|2015-03-01|September 2011|Actual|2011-09-01|November 2010|Actual|2010-11-01||Interventional|||Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase I Study of AMD3100 and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Completed||Phase 1|24|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:17:08.585269|2017-02-18 14:17:08.585269
NCT00694577|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2016-03-14|||September 2003||2003-09-01|March 2016|2016-03-01|September 2019|Anticipated|2019-09-01|October 2010|Actual|2010-10-01||Interventional|||Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer|Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer: A Phase I Feasibility/Pilot Study|Active, not recruiting||Phase 1|330|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-02-18 14:17:08.712278|2017-02-18 14:17:08.712278
NCT00694564|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2016-01-27|2013-03-20||June 2007||2007-06-01|January 2016|2016-01-01|July 2012|Actual|2012-07-01|March 2011|Actual|2011-03-01||Interventional|||Evaluation of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children|A Pilot Open-labeled Trial of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children|Completed||N/A|8|Actual|Huang, Jeannie, M.D.||1|||f||||t||||||||||2017-02-18 14:17:08.854153|2017-02-18 14:17:08.854153
NCT00694551|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-11-15|2014-01-06||October 2008||2008-10-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|February 2013|Actual|2013-02-01||Interventional||All patients who received any amount of study treatment were considered evaluable for toxicity.|PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment|Pilot Immunotherapy Study of Combination PSMA and TARP Peptide With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment|Active, not recruiting||N/A|29|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f||||||||||2017-02-18 14:17:09.108791|2017-02-18 14:17:09.108791
NCT00694538|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2009-11-12|||January 2008||2008-01-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|December 2008|Actual|2008-12-01||Interventional|PI070046||Efficacy of Interferential Laser Therapy in Shoulder Pain|Efficacy of Interferential Laser Therapy in Pain Reduction in Shoulder Musculoskeletal Pathologies.|Completed||Phase 2|200|Anticipated|Hospital Universitario Ramon y Cajal||2|||f||||t||||||||||2017-02-18 14:17:09.701791|2017-02-18 14:17:09.701791
NCT00694525|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2009-06-01|||April 2008||2008-04-01|June 2009|2009-06-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Observational|||Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia|Potential Modulatory Role of Osteoprotegerin in Bone Metabolism of Patients With 21-Hydroxylase Deficiency|Unknown status|Recruiting|N/A|40|Anticipated|Office of Rare Diseases (ORD)|||2||f||||f||||||Samples With DNA|"~     With participant's permission, 5 mL of blood will be stored for potential new blood markers~     in the future.~   "|||2017-02-18 14:17:09.807112|2017-02-18 14:17:09.807112
NCT00694512|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2012-05-14|||February 2008||2008-02-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin|Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin|Completed||N/A|51|Actual|Oregon Health and Science University||3|||f||||f||||||||||2017-02-18 14:17:09.900274|2017-02-18 14:17:09.900274
NCT00694499|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2008-06-09|||January 2000||2000-01-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|||||Observational|NOMLI||Non-Operative Management of High Grade Blunt Hepatic Injury: Clinical Complications and the Role of Collateral Damage|Retrospective Single Centre Study Which Investigates the Safety of the Non-Operative Management of Patients With High Grade Blunt Liver Injuries (NOMLI) and the Impact of to the LI Collateral Intra- and Extra-Abdominal Damage on Interventions and Outcome|Completed||N/A|183|Actual|University of Bern|||1||f||||f||||||||||2017-02-18 14:17:10.005993|2017-02-18 14:17:10.005993
NCT00694486|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2010-09-08|||January 2008||2008-01-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Eustachian Tube Testing in a Pressure Chamber -- Validation Study|Eustachian Tube Testing in a Pressure Chamber -- Validation|Completed||N/A|30|Anticipated|Children's Hospital of Pittsburgh|||1||f||||f||||||||||2017-02-18 14:17:10.10721|2017-02-18 14:17:10.10721
NCT00694473|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2016-09-20|||June 2008||2008-06-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2010|Actual|2010-12-01||Interventional|||Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery|Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illness and Surgery|Active, not recruiting||N/A|65|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 14:17:10.19623|2017-02-18 14:17:10.19623
NCT00694460|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-06-09|||August 2002||2002-08-01|June 2008|2008-06-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers|A Phase II, Pilot, Randomized, Open-Label, Single-Center Study to Evaluate Immunogenicity, Safety and Booster Response of 3 Full Intramuscular Doses Versus 3 Half Intramuscular Doses Versus 3 Intradermal Doses Versus 2 Intradermal Doses of PCEC Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine as a Pre-Exposure Regimen in 12 to 18 Months Old Toddlers in Thailand.|Completed||Phase 2|200|Actual|Novartis||5|||f||||||||||||||2017-02-18 14:17:10.296649|2017-02-18 14:17:10.296649
NCT00694447|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2013-11-19|||February 2007||2007-02-01|November 2013|2013-11-01||||April 2008|Actual|2008-04-01||Interventional|||Acupuncture for Pain and Sleep Disturbance in Knee Osteoarthritis|Exploring Outcomes and Mechanisms of Acupuncture in Treating Pain and Sleep Disturbance in Knee Osteoarthritis|Completed||N/A|||Emory University||2|||f||||f||||||||||2017-02-18 14:17:10.408376|2017-02-18 14:17:10.408376
NCT00694434|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2008-06-09|||January 2002||2002-01-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|GES/FET||Graduated Embryo Score (GES) in the Fresh Cycle Predicts Outcome From Frozen Embryo Transfer|Graduated Embryo Score (GES) Int he Fresh Cycle Predicts Outcome From Frozen Embryo Transfer|Completed||N/A|183|Actual|Sher Institute for Reproductive Medicine, Las Vegas|||2||f||||f||||||||||2017-02-18 14:17:10.519248|2017-02-18 14:17:10.519248
NCT00694421|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2016-11-02|||January 2008||2008-01-01|November 2016|2016-11-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Observational|||Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2|Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2|Completed||N/A|139|Actual|University of Pittsburgh|||2||f||||f||||||||No||2017-02-18 14:17:10.610875|2017-02-18 14:17:10.610875
NCT00694408|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2017-01-19|||June 2008||2008-06-01|January 2017|2017-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Pilot Trial of Pediatric Liver Transplantation Without Steroids|A Randomized Pilot Trial of a Steroid-free Immunosuppressant Regimen in Pediatric Liver Transplantation|Terminated||Phase 3|15|Actual|Birmingham Children's Hospital NHS Foundation Trust||2||Study terminated due to withdrawal from market of Daclizumab|f||||t||||||||||2017-02-18 14:17:10.703261|2017-02-18 14:17:10.703261
NCT00694395|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-09|||August 2006||2006-08-01|July 2006|2006-07-01|July 2007|Actual|2007-07-01|May 2007|Actual|2007-05-01||Observational|||A Qualitative Study of Delays in Hospital Admission in Patient With Acute Stroke|Decision Making Process in Patients With Symptoms of Acute Ischemic Stroke Why do They Delay in Seeking Medical Help? A Qualitative Study|Completed||N/A|20|Anticipated|Far Eastern Memorial Hospital|||||f||||f||||||||||2017-02-18 14:17:10.921974|2017-02-18 14:17:10.921974
NCT00694382|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-01-14||2011-12-14|June 2008||2008-06-01|January 2013|2013-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|SAVE-ONCO||Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy|A Multinational, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AVE5026 in the Prevention of Venous Thromboembolism (VTE) in Cancer Patients at High Risk for VTE and Who Are Undergoing Chemotherapy|Completed||Phase 3|3212|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:17:11.009779|2017-02-18 14:17:11.009779
NCT00694369|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2016-02-19|2009-11-13||June 2008||2008-06-01|February 2016|2016-02-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)|A Phase III Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Multiple-Dose Clinical Trial to Study the Efficacy and Safety of MK0663/Etoricoxib 90 and 120 mg, Ibuprofen 600 mg, and Acetaminophen 600 mg/Codeine 60 mg in the Treatment of Patients With Postoperative Dental Pain|Completed||Phase 3|588|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 14:17:14.15168|2017-02-18 14:17:14.15168
NCT00694343|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2012-05-30|||June 2008||2008-06-01|May 2012|2012-05-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|CAESAR||Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section|Evaluation of the Efficacy of 6% Hydroxyethyl Starch (HES, 130/0.4) in Normal Saline Compared to Ringer's Lactate Solution for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section|Completed||Phase 4|167|Actual|Fresenius Kabi||2|||f||||f||||||||||2017-02-18 14:17:15.786768|2017-02-18 14:17:15.786768
NCT00694330|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2010-05-03|||June 2008||2008-06-01|May 2010|2010-05-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|||Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor|A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor|Unknown status|Recruiting|Phase 1|25|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:17:15.911851|2017-02-18 14:17:15.911851
NCT00694317|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2008-06-09|||February 2004||2004-02-01|June 2008|2008-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions.|Completed||N/A|40|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:17:16.012694|2017-02-18 14:17:16.012694
NCT00694304|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2014-02-17|2013-10-28||May 2008||2008-05-01|February 2014|2014-02-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional||Age and Sex: all-patients-treated set (APTS) – all patients who took at least one dose of Vortioxetine after Baseline; MADRS, HAM-D-24, HAM-A, CGI-S and SDS: full-analysis set (FAS) – all patients in the APTS who had at least one valid post-Baseline assessment of the MADRS total score.|Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults|A Long-term, Open-label, Flexible-dose, Extension Study Evaluating the Safety and Tolerability of [Vortioxetine] Lu AA21004 in Patients With Major Depressive Disorder|Completed||Phase 3|535|Actual|H. Lundbeck A/S||1|||f||||f||||||||||2017-02-18 14:17:16.33318|2017-02-18 14:17:16.33318
NCT00694291|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2015-03-04|||June 2008||2008-06-01|March 2015|2015-03-01||||June 2010|Anticipated|2010-06-01||Interventional|||Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer|Phase II Double Blind Randomized Placebo Controlled Study of Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer|Withdrawn||Phase 2|0|Actual|Fox Chase Cancer Center||2|||f||||t||||||||||2017-02-18 14:17:16.708851|2017-02-18 14:17:16.708851
NCT00694278|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-05|||June 2008||2008-06-01|June 2008|2008-06-01||||||||Observational|||Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes|Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes in Adults|Unknown status|Recruiting|Early Phase 1|15|Anticipated|Ferzli, George S., M.D. F.A.C.S.|||1||f||||||||||||||2017-02-18 14:17:16.821645|2017-02-18 14:17:16.821645
NCT00694265|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2008-08-25|||January 2002||2002-01-01|August 2008|2008-08-01|December 2003|Actual|2003-12-01|June 2003|Actual|2003-06-01||Observational|CTS||Sonographic Follow-up of Patients With Carpal Tunnel Syndrome Undergoing Surgical or Conservative Treatment|Sonographic Follow-up of Patients With Carpal Tunnel Syndrome Undergoing Surgical or Conservative Treatment: Prospective Cohort Study.|Completed||N/A|55|Actual|University of Bern|||2||f||||f||||||||||2017-02-18 14:17:16.893485|2017-02-18 14:17:16.893485
NCT00694252|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2015-09-25|||July 2008||2008-07-01|September 2015|2015-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Lapatinib and Circulating Tumor Cells in Breast Cancer|A Pilot Feasibility Study to Evaluate the Efficacy of Lapatinib in Eliminating Cytokeratin-positive Tumour Cells Circulating in the Blood of Women With Breast Cancer|Completed||Phase 2|20|Actual|University Hospital of Crete||1|||f||||f||||||||||2017-02-18 14:17:17.000876|2017-02-18 14:17:17.000876
NCT00694239|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2011-06-29|||May 2007||2007-05-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|RATCHET||Risk Assessment and Treat Compliance in Hypertension Education Trial|Evaluation of the Effect of Cardiovascular Risk Assessment in Treatment Compliance in Hypertension|Completed||N/A|100|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-02-18 14:17:17.119381|2017-02-18 14:17:17.119381
NCT00694226|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-06-09|||March 2004||2004-03-01|June 2008|2008-06-01||||September 2005|Actual|2005-09-01||Interventional|||Brief Intervention in Substance Use in Adolescent Psychiatric Patients|Brief Intervention in Substance Use Among Adolescent Psychiatric Patients: A Randomized Controlled Trial|Completed||N/A|143|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 14:17:17.226329|2017-02-18 14:17:17.226329
NCT00694213|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2009-02-11|||August 2007||2007-08-01|February 2009|2009-02-01||||September 2008|Actual|2008-09-01||Interventional|||Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)|A Phase 1, Double-Blinded Study to Evaluate the Safety, Tolerability, and Immunogenicity of Pandemic Influenza Plasmid DNA Vaccines Administered With the Biojector® 2000 Needle-Free System|Completed||Phase 1|47|Actual|Vical||4|||f||||t||||||||||2017-02-18 14:17:17.337119|2017-02-18 14:17:17.337119
NCT00694200|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2015-05-27|||April 2008||2008-04-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer|Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Patients With Metastatic Breast Cancer. A Multicenter Phase II Study|Terminated||Phase 2|13|Actual|Hellenic Oncology Research Group||1||Not reached the statistical hypothesis at the interim analysis|f||||f||||||||||2017-02-18 14:17:17.454168|2017-02-18 14:17:17.454168
NCT00694187|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2008-06-09|||January 2004||2004-01-01|June 2008|2008-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting Conditions.|Completed||N/A|39|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:17:17.5826|2017-02-18 14:17:17.5826
NCT00694174|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-09|||September 2005||2005-09-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Skin Blood Flow Changes Using Laser Doppler Imager for Assessment of Pain and Analgesia in Newborn Infants|Skin Blood Flow Changes Using Laser Doppler Imager for Assessment of Pain and Analgesia in Newborn Infants|Completed||Phase 4|56|Actual|Children's Hospital of Michigan||2|||f||||t||||||||||2017-02-18 14:17:17.671751|2017-02-18 14:17:17.671751
NCT00678145|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-07-24|||March 2008||2008-03-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|HAAF||Mechanisms Responsible for Hypoglycemia Associated Autonomic Failure|Mechanisms of Hypoglycemia Associated Autonomic Failure|Completed||N/A|116|Actual|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-02-18 14:22:48.062555|2017-02-18 14:22:48.062555
NCT00694161|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2013-01-04|2012-11-16||August 2008||2008-08-01|January 2013|2013-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy|The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy|Completed||Phase 2|35|Actual|Pfizer|Results for Holter monitoring parameters, increased interstitial markings, pleural effusions, PtGA and cardiothoracic ratio are presented as absolute values at specified time points and not as change from baseline as planned.|1|||f||||f||||||||||2017-02-18 14:17:17.812141|2017-02-18 14:17:17.812141
NCT00694148|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-10-29|||May 2008||2008-05-01|October 2012|2012-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines|NT 201 is a Botulinum Toxin Type A Preparation Free of Complexing Proteins. Injected Into the Muscle, NT 201 Causes a Reversible Local Relaxation of the Injected Muscle. Botulinum Toxin Type A is Widely Used for Aesthetic Treatment of Mimic Wrinkles. This Study Will Investigate the Safety and Efficacy of NT 201 in the Treatment of Glabellar Frown Lines.|Completed||Phase 3|108|Actual|Merz Pharmaceuticals GmbH||1|||f||||f||||||||||2017-02-18 14:17:19.142403|2017-02-18 14:17:19.142403
NCT00694135|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2010-08-27||2010-08-20|June 2008||2008-06-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis|A Prospective, Multi-Center, Randomized, Double-Masked, Safety, Tolerability and Efficacy Study of Four Iontophoretic Doses of Dexamethasone Phosphate Ophthalmic Solution in Patients With Non-Infectious Anterior Segment Uveitis|Completed||Phase 2|40|Actual|Eyegate Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 14:17:19.239477|2017-02-18 14:17:19.239477
NCT00694122|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2014-10-14|2013-11-04||June 2005||2005-06-01|October 2014|2014-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|DAWN||Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon|Comparison of Lantus and NPH Insulin in the Dawn Phenomenon|Completed||Phase 3|27|Actual|Massachusetts General Hospital|Limitation: delayed and slow participant recruitment due to expansive use of insulin pumps and participants unwilling to cross over to alternate insulin.|2|||f||||t||||||||||2017-02-18 14:17:19.377727|2017-02-18 14:17:19.377727
NCT00694109|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2016-08-01|2015-09-11||April 2008||2008-04-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Safety set: All enrolled participants who received at least 1 injection of study drug.|An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia|An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia|Completed||Phase 3|144|Actual|Kastle Therapeutics, LLC||1|||f||||f||||||||||2017-02-18 14:17:19.817093|2017-02-18 14:17:19.817093
NCT00694096|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2015-10-28|2015-10-28||September 2007||2007-09-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response|Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response|Completed||Phase 1|25|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:17:21.154183|2017-02-18 14:17:21.154183
NCT00694083|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-02-12|||June 2008||2008-06-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED)|A Phase I Study of MK-8669 in Patients With Metastatic or Locally Advanced Solid Tumors|Completed||Phase 1|13|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:17:21.407959|2017-02-18 14:17:21.407959
NCT00694070|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2016-01-29|2009-07-01||July 2008||2008-07-01|January 2016|2016-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Evaluation of a Diabetes Data Management System|Evaluation of a Diabetes Data Management System In a Clinical Setting|Completed||N/A|51|Actual|Ascensia Diabetes Care|||1||f||||f||||||||||2017-02-18 14:17:21.507366|2017-02-18 14:17:21.507366
NCT00694057|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2011-06-11|||June 2008||2008-06-01|June 2011|2011-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus|A Phase II, Double Blind, Randomized, Placebo-Controlled Study of the Safety, Tolerance and Activity of HE3286 When Administered Orally for 12 Weeks to Adult Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|164|Actual|Harbor Therapeutics||2|||f||||f||||||||||2017-02-18 14:17:21.731336|2017-02-18 14:17:21.731336
NCT00694044|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-06-01|||April 2008||2008-04-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects|A Randomized, Investigator and Subject Blind, Sponsor Open Parallel Group Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pro-Cognitive Effects of Varenicline, Under Various Titration Schemes, in Healthy Elderly Non-Smoking Subjects|Completed||Phase 1|50|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:17:21.861853|2017-02-18 14:17:21.861853
NCT00694031|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2014-02-27|||May 2007||2007-05-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|ESHOL||Survival Study in Patients Undergoing On-line Hemodiafiltration|A Randomized Study to Evaluate Survival in Patients Undergoing Hemodialysis or On-line Hemodiafiltration|Completed||Phase 4|906|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 14:17:21.969519|2017-02-18 14:17:21.969519
NCT00694018|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-04-06|2014-10-06||May 2009||2009-05-01|September 2014|2014-09-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Veterans Walk to Beat Back Pain|Veterans Walk to Beat Back Pain|Completed||N/A|229|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:17:22.063819|2017-02-18 14:17:22.063819
NCT00694005|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2015-11-17|||January 2008||2008-01-01|November 2015|2015-11-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|CROSS||Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch|Phase IV Study of the Choice of Optimal Strategy for Bifurcation Lesions With Normal Side Branch|Completed||Phase 4|504|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 14:17:22.463872|2017-02-18 14:17:22.463872
NCT00692991|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-02-22|||October 1999||1999-10-01|February 2013|2013-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures|Microvascular Obstruction by Contrast-enhanced MRI Following Percutaneous Coronary Interventions|Completed||N/A|144|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 14:17:36.086281|2017-02-18 14:17:36.086281
NCT00693992|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2016-12-08|2016-12-08||June 2008||2008-06-01|December 2016|2016-12-01|May 2015|Actual|2015-05-01|November 2013|Actual|2013-11-01||Interventional|||Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy|Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511) as Maintenance Therapy in Non-progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB / IV Non-small Cell Lung Cancer|Completed||Phase 3|210|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 14:17:22.695768|2017-02-18 14:17:22.695768
NCT00693979|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-06-05||||||June 2008|2008-06-01||||||||Interventional|||A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions|A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions|Unknown status|Not yet recruiting|Phase 1|||National University Hospital, Singapore|||||f||||f||||||||||2017-02-18 14:17:24.576289|2017-02-18 14:17:24.576289
NCT00693966|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2016-09-15|||October 1999||1999-10-01|September 2016|2016-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females|A Phase II Double-Blind, Randomized, Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517, a Virus-Like Particle Vaccine Against Human Papillomavirus Types 16 and 18, in Healthy Adult Female Volunteers|Completed||Phase 2|210|Actual|GlaxoSmithKline||4|||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:17:24.64969|2017-02-18 14:17:24.64969
NCT00693953|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-10-01|||January 2010||2010-01-01|October 2009|2009-10-01|December 2012|Anticipated|2012-12-01|January 2011|Anticipated|2011-01-01||Observational|||Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism|Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism|Withdrawn||N/A|200|Anticipated|Yellen & Associates, Inc.|||2|grant was not approved.|f||||f||||||||||2017-02-18 14:17:24.766845|2017-02-18 14:17:24.766845
NCT00693940|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2015-10-27|||June 2008||2008-06-01|October 2015|2015-10-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])|Increasing Activity in Peripheral Arterial Disease|Completed||Phase 3|194|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 14:17:24.85341|2017-02-18 14:17:24.85341
NCT00693927|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2011-09-01|||March 2002||2002-03-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|May 2005|Actual|2005-05-01||Interventional|||Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)|Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Phase II Trial|Completed||Phase 2|54|Actual|University Hospital of Liege||2|||f||||f||||||||||2017-02-18 14:17:24.966242|2017-02-18 14:17:24.966242
NCT00693914|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2011-10-03|||April 2007||2007-04-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Working Memory Performance Among Childhood Brain Tumor Survivors|Working Memory Performance Among Childhood Brain Tumor Survivors Treated With Conformal Radiation Therapy: A Pilot Study|Completed||N/A|130|Anticipated|St. Jude Children's Research Hospital|||3||f||||f||||||||||2017-02-18 14:17:25.064716|2017-02-18 14:17:25.064716
NCT00693901|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2012-12-13|||October 2007||2007-10-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Influence of Public Parks on Physical Activity Levels of Diverse Communities|Parks and Physical Activity in Diverse Communities|Completed||N/A|50|Actual|RAND||3|||f||||t||||||||||2017-02-18 14:17:25.170783|2017-02-18 14:17:25.170783
NCT00693888|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2010-08-16|||June 2008||2008-06-01|March 2009|2009-03-01|September 2010|Anticipated|2010-09-01|February 2010|Anticipated|2010-02-01||Interventional|ULTDEM||Lighthouse Project on Dementia, Ulm, Germany|Lighthouse Project on Dementia, Ulm, Germany - Improvement of Advice and Diagnostics for People Suffering From Dementia After the Classification of Their Level of Care (ULTDEM Study).|Unknown status|Recruiting|N/A|200|Anticipated|University of Ulm||2|||f||||t||||||||||2017-02-18 14:17:25.272474|2017-02-18 14:17:25.272474
NCT00693875|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-01-27|||April 2007||2007-04-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Observational|||The Incidence of Intra-Operative Awareness in China and Analysis of Relevant Factors: a Multicentre Study|The Incidence of Intra-Operative Awareness in China and Analysis of Relevant Factors: a Multicentre Study|Completed||N/A|11197|Actual|Capital Medical University|||1||f||||t||||||||||2017-02-18 14:17:25.37693|2017-02-18 14:17:25.37693
NCT00693862|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-06|||December 2006||2006-12-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Pharmacokinetic Study With Repeated Doses of Stalevo|Levodopa Concentration Profile After Repeated Doses of Stalevo|Completed||Phase 1|19|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-02-18 14:17:25.607811|2017-02-18 14:17:25.607811
NCT00693849|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2017-01-19|||September 2008||2008-09-01|May 2016|2016-05-01|April 2018|Anticipated|2018-04-01|December 2017|Anticipated|2017-12-01||Interventional|iSPOT-D||International Study to Predict Optimised Treatment - in Depression|International Study to Predict Optimised Treatment - in Depression|Recruiting||Phase 4|2688|Anticipated|BRC Operations Pty. Ltd.||4|||f||||f||||||||||2017-02-18 14:17:25.710051|2017-02-18 14:17:25.710051
NCT00693836|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2013-08-09|||January 2006||2006-01-01|December 2008|2008-12-01||||October 2010|Anticipated|2010-10-01||Observational|||Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region|Resource for the Study of Lung Cancer Epidemiology in North Trent|Unknown status|Recruiting|N/A|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:17:25.869402|2017-02-18 14:17:25.869402
NCT00693823|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-06|||September 2003||2003-09-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of Prosthetic Femoropopliteal Bypass Versus Viabahn Endoprosthesis for Treatment of Symptomatic Femoral Artery Occlusive Disease|A Prospective Randomized Comparison of Prosthetic Femoropopliteal Bypass Versus Viabahn Endoprosthesis for Treatment of Symptomatic Superficial Femoral Artery Occlusion|Completed||N/A|86|Actual|Texas Vascular Associates||2|||f||||t||||||||||2017-02-18 14:17:25.974642|2017-02-18 14:17:25.974642
NCT00561938|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2009-02-24|||June 2007||2007-06-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Confocal Laser Endomicroscopy|Confocal Laser Endomicroscopy in the Digestive Tract: A Multicentre French Pilot Study.|Completed||N/A|61|Actual|Nantes University Hospital||1|||f||||||||||||||2017-02-18 15:03:18.957471|2017-02-18 15:03:18.957471
NCT00693797|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-04-27|||January 2006||2006-01-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|||Clinical Significance of Collagen Metabolism Changes in Left Cardiac Ventricle|Clinical Significance of Collagen Metabolism Changes in Patients With Failing and Pressure Overloaded Left Cardiac Ventricle.|Completed||N/A|50|Anticipated|Charles University, Czech Republic|||2||f||||f||||||Samples Without DNA|"~     frozen serum for collagen metabolism detection~   "|||2017-02-18 14:17:26.074483|2017-02-18 14:17:26.074483
NCT00693784|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-05-26|2010-03-08||June 2008||2008-06-01|May 2015|2015-05-01|January 2011|Actual|2011-01-01|February 2009|Actual|2009-02-01||Interventional|||Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® Disc Augmentation System: A Pilot Study|A Multicenter Pilot Study of Resorbable Biologic Disc Augmentation for Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® Disc Augmentation System|Completed||N/A|15|Actual|Spinal Restoration, Inc.||1|||f||||t||||||||||2017-02-18 14:17:26.168344|2017-02-18 14:17:26.168344
NCT00693771|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2011-01-24|||April 2008||2008-04-01|January 2011|2011-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|OPTIMIZATION||Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin|A Prospective Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin|Completed||Phase 4|313|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:17:26.593161|2017-02-18 14:17:26.593161
NCT00693758|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-10-02|||January 2006||2006-01-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Assessment of Oxygen Changes in the Heart With Cardio-vascular Magnetic Resonance Imaging|Magnetic Resonance Imaging for the Detection of Oxygen Changes in the Heart|Completed||Early Phase 1|100|Actual|University of Calgary||7|||f||||t||||||||||2017-02-18 14:17:26.682898|2017-02-18 14:17:26.682898
NCT00693745|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2010-10-21|||September 2008||2008-09-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Observational|GALLANT||Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF|NGAL Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF|Completed||N/A|231|Actual|Biosite|||1||f||||f||||||||||2017-02-18 14:17:26.794882|2017-02-18 14:17:26.794882
NCT00693732|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2014-01-06|||February 2009||2009-02-01|January 2014|2014-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS)|Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS)|Completed||Phase 4|30|Actual|National University Hospital, Singapore||2|||f||||||||||||||2017-02-18 14:17:26.881195|2017-02-18 14:17:26.881195
NCT00693719|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2015-10-15|2013-06-12||August 2007||2007-08-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer|A Phase II Study: Irinotecan and Etoposide as Treatment for Refractory, Metastatic Breast Cancer|Completed||Phase 2|31|Actual|University of Arizona||1|||f||||t||||||||||2017-02-18 14:17:26.982454|2017-02-18 14:17:26.982454
NCT00693706|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2016-10-11|2012-12-19||June 2008||2008-06-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix|Safety and Immunogenicity Study of GSK Biologicals' Cell Culture-based Influenza Virus Vaccine 1388442A Compared With US Licensed TIV in Healthy Adults|Completed||Phase 1|200|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:17:27.287898|2017-02-18 14:17:27.287898
NCT00693693|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-11|||November 2006||2006-11-01|June 2008|2008-06-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis|Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Wake Forest University Health Sciences||3|||f||||f||||||||||2017-02-18 14:17:27.773708|2017-02-18 14:17:27.773708
NCT00693680|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-09|||January 2005||2005-01-01|June 2008|2008-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Zinc Supplementation of Imipramine Therapy|The Role of Zinc in Therapy of Unipolar Depression|Completed||N/A|60|Actual|Polish Academy of Sciences||2|||f||||t||||||||||2017-02-18 14:17:27.877553|2017-02-18 14:17:27.877553
NCT00693667|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2011-11-03|||February 2008||2008-02-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|PH3||Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women|A Phase II, Double-Blind, Randomized, Placebo-controlled, Clinical Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women|Completed||Phase 2|92|Actual|PhytoHealth Corporation||4|||f||||f||||||||||2017-02-18 14:17:27.996108|2017-02-18 14:17:27.996108
NCT00693654|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-11|||November 2006||2006-11-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|November 2006|Actual|2006-11-01||Interventional|||Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients|A Controlled Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Pruritus in Adult Hemodialysis Patients|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 14:17:28.094835|2017-02-18 14:17:28.094835
NCT00693641|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2011-06-03|||July 2008||2008-07-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional|||Efficiency of a Jellyfish Sting Inhibitor Sun Lotion and Protocols for Jellyfish Sting Pain Relief|Efficiency of a Jellyfish Sting Inhibitor Sun Lotion and Protocols for Jellyfish Sting Pain Relief|Completed||Phase 4|39|Actual|University of Oslo||2|||f||||f||||||||||2017-02-18 14:17:28.201893|2017-02-18 14:17:28.201893
NCT00693628|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-11-30|||March 2007||2007-03-01|November 2015|2015-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Shrinker Use on Healing and Volume|Effects of Shrinker Use on Healing and Volume for Transtibial Amputees|Completed||N/A|4|Actual|University of Oklahoma||2|||f||||f||||||||||2017-02-18 14:17:28.311609|2017-02-18 14:17:28.311609
NCT00693407|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2014-01-06|||September 2008||2008-09-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||Study of Endogenous Inhibitory Modulation During Gastric and Somatic Stimulation|Activation of Endogenous Inhibitory Modulation During Gastric and Somatic Stimulation in Functional Dyspepsia Patients and Healthy Controls|Completed||N/A|80|Actual|National University Hospital, Singapore||2|||f||||t||||||||||2017-02-18 14:17:31.449133|2017-02-18 14:17:31.449133
NCT00693615|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2016-09-15|||October 2000||2000-10-01|September 2016|2016-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females|Study to Evaluate the Safety and Immunogenicity of MEDI-517, a Virus-Like Particle Vaccine Against Human Papillomavirus Types 16 and 18, When Formulated With Aluminum Hydroxide, AS04, or Without Adjuvant, in Healthy Adult Female Volunteers|Completed||Phase 2|60|Actual|GlaxoSmithKline||3|||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:17:28.424909|2017-02-18 14:17:28.424909
NCT00693602|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-01-03|||June 2006||2006-06-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma|Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma|Completed||Phase 1|87|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 14:17:28.550767|2017-02-18 14:17:28.550767
NCT00693589|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-06|||January 2005||2005-01-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|February 2007|Actual|2007-02-01||Interventional|||Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-Dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease|Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Endothelium-Dependent Vasodilatation of Forearm Resistance Vessels in Patients With Coronary Heart Disease|Completed||Phase 2|36|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 14:17:28.654836|2017-02-18 14:17:28.654836
NCT00693576|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-05|||April 2007||2007-04-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates|The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates|Completed||Phase 2/Phase 3|82|Actual|Shiraz University of Medical Sciences||1|||f||||t||||||||||2017-02-18 14:17:28.757687|2017-02-18 14:17:28.757687
NCT00693563|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2013-01-10|||August 2007||2007-08-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|SCILink||Scheduled Telephone Intervention for Individuals With Spinal Cord Injury and Their Families|Scheduled Telephone Intervention for Individuals With Spinal Cord Injury and Their Families: A Randomized Controlled Trial|Completed||N/A|168|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:17:28.85435|2017-02-18 14:17:28.85435
NCT00693550|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2011-06-06|||August 2000||2000-08-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer|Oral Metal Contact Allergy: A Cause of Oral Squamous Cell Carcinoma?|Completed||N/A|115|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 14:17:28.959942|2017-02-18 14:17:28.959942
NCT00693537|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-06||||||June 2008|2008-06-01||||||||Interventional|||Exercise Training Improves Coronary Endothelial Dysfunction in Diabetes Mellitus Type 2 and Coronary Artery Disease|Long- But Not Short-Term Exercise Training Improves Coronary Endothelial Dysfunction in Diabetes Mellitus Type 2 and Coronary Artery Disease|Completed||Phase 4|||Paracelsus Medical University||2|||f||||||||||||||2017-02-18 14:17:29.050089|2017-02-18 14:17:29.050089
NCT00693524|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2014-08-25|||November 2002||2002-11-01|August 2014|2014-08-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|TAST||Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX|An Open, Randomized, Multicentre Clinical Study to Compare the Safety and Efficacy of a Combination of Sequential Therapy of Tacrolimus (FK506) With Monoclonal Anti-IL2R Antibodies and Mycophenolate Mofetil Versus Tacrolimus (FK506) With Steroids in Liver Allograft Transplantation|Completed||Phase 2|94|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:17:29.13022|2017-02-18 14:17:29.13022
NCT00693511|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2011-03-15|||October 2007||2007-10-01|March 2011|2011-03-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Circuit Training and Motivational Interviewing to Reduce Type 2 Diabetes in Youth|Circuit Training and Motivational Interviewing to Reduce Type 2 Diabetes in Youth|Unknown status|Recruiting|N/A|45|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 14:17:29.239575|2017-02-18 14:17:29.239575
NCT00693498|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2012-11-28|2011-11-30||July 2008||2008-07-01|November 2012|2012-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Washed Versus Standard Blood Cell Transfusions in Pediatric Open Heart Surgery|Standard vs. Washed Blood Cell Transfusions in Pediatric Cardiac Surgery: Impact on Post-operative Inflammation as Evidenced by the IL-6 to IL-10 Ratio.|Completed||N/A|162|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 14:17:29.459432|2017-02-18 14:17:29.459432
NCT00693485|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2013-03-13|2013-03-13||September 2008||2008-09-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy||Completed||Phase 2|70|Actual|Allergan||3|||f||||t||||||||||2017-02-18 14:17:29.800283|2017-02-18 14:17:29.800283
NCT00693472|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-11-02||2009-04-17|August 2007||2007-08-01|November 2015|2015-11-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145AM1)(COMPLETE)|Efficacy of SCH 420814 to Reduce the Frequency or Severity of Neuroleptic Induced Akathisia|Completed||Phase 2|46|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 14:17:30.304729|2017-02-18 14:17:30.304729
NCT00693459|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-01-16|||May 2008||2008-05-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of a New Circular Anal Dilator|Feasibility Study of a New Circular Anal Dilator for Transanal Hemorrhoidectomy|Completed||Phase 1/Phase 2|20|Actual|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-02-18 14:17:30.415636|2017-02-18 14:17:30.415636
NCT00693446|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2015-05-11|||April 2004||2004-04-01|May 2015|2015-05-01|April 2017|Anticipated|2017-04-01|April 2013|Actual|2013-04-01||Interventional|||A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids|An Open-Label, Comparative, Randomized, Prospective Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids|Active, not recruiting||Phase 4|118|Anticipated|Nantes University Hospital||2|||f||||f||||||||||2017-02-18 14:17:30.507875|2017-02-18 14:17:30.507875
NCT00693381|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-09-17|||February 2003||2003-02-01|September 2014|2014-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|DISTAMP||Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation|An Open, Multicentre, Randomised, Parallel Group Pilot-Study to Compare Safety and Efficacy of Discontinuation of Mycophenolate Mofetil From a Tacrolimus/MMF/Steroid Triple Regimen Following Kidney Transplantation|Completed||Phase 3|152|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:17:31.539518|2017-02-18 14:17:31.539518
NCT00693355|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-06|||December 2005||2005-12-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Butyrate Enemas on Colonic Health|Effects of Butyrate Enemas on Colonic Health|Completed||N/A|16|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 14:17:31.666815|2017-02-18 14:17:31.666815
NCT00693342|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-06|2013-04-08|||August 2008||2008-08-01|July 2008|2008-07-01||||January 2012|Anticipated|2012-01-01||Interventional|||Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission|A Randomized Phase III Trial in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer With a Polyvalent Vaccine-KLH Conjugate + OPT-821 Versus OPT-821|Withdrawn||Phase 3|0|Actual|Gynecologic Oncology Group||2||Never opened to accrual, a GOG working number, not developed into a clinical trial.|f||||||||||||||2017-02-18 14:17:31.75698|2017-02-18 14:17:31.75698
NCT00693329|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-12-17|||March 2008||2008-03-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|ENCINO||Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy|Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy|Completed||N/A|260|Anticipated|Biosite|||1||f||||t||||||Samples Without DNA|"~     Blood sample taken at 8 timepoints over 2 days.~   "|||2017-02-18 14:17:31.852505|2017-02-18 14:17:31.852505
NCT00693316|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2010-02-10|||July 2008||2008-07-01|February 2010|2010-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Tolerability Study With Single Ascending Doses of ORM-12741|Phase I Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study With Single Ascending Doses of ORM-12741|Completed||Phase 1|120|Actual|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-02-18 14:17:31.930255|2017-02-18 14:17:31.930255
NCT00693303|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2016-10-13|2009-07-10||June 2008||2008-06-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Examining the Effectiveness of My Scrivener on Handwriting Legibility|Examining the Effectiveness of My Scrivener on Handwriting Legibility|Completed||N/A|21|Actual|Shenandoah University||1|||f||||f||||||||||2017-02-18 14:17:32.028849|2017-02-18 14:17:32.028849
NCT00693290|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-06|||June 2008||2008-06-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy|Improving Outcomes for Patients Requiring Oral Bowel Preparation for Colonoscopy|Unknown status|Not yet recruiting|N/A|100|Anticipated|University of Ulster||2|||f||||t||||||||||2017-02-18 14:17:32.265451|2017-02-18 14:17:32.265451
NCT00693277|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-10-06|||September 2006||2006-09-01|October 2015|2015-10-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Assessing Novel Methods of Improving Patient Education of Nutrition|Assessing Novel Methods of Improving Patient Education of Nutrition: eHealth, Health Literacy and Chronic Kidney Disease|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 14:17:32.36434|2017-02-18 14:17:32.36434
NCT00693264|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-03-27|||May 2008||2008-05-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effects of Hoodia on Blood Pressure and Heart Function|The Hemodynamic and Electrocardiographic Effects of Hoodia Gordonii in Healthy Volunteers|Completed||N/A|15|Actual|University of Mississippi Medical Center||2|||f||||f||||||||||2017-02-18 14:17:32.437362|2017-02-18 14:17:32.437362
NCT00693251|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2015-11-16|||January 2008||2008-01-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|PERFECT||Optimal Stenting Strategy For True Bifurcation Lesions|Phase IV Study of Optimal Stenting Strategy For True Bifurcation Lesions|Completed||Phase 4|420|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 14:17:32.541241|2017-02-18 14:17:32.541241
NCT00693238|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-09-15|2013-03-14||April 2008||2008-04-01|September 2016|2016-09-01|December 2033|Anticipated|2033-12-01|June 2012|Actual|2012-06-01||Interventional|PR04||Proton Therapy for Low and Intermediate Risk Prostate Cancer|A Phase II Study of Hypofractionated Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate|Active, not recruiting||Phase 2|228|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 14:17:32.669778|2017-02-18 14:17:32.669778
NCT00693225|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-08-21|2012-08-21||January 2008||2008-01-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study|Impact of Timing on the Efficacy of Omeprazole/Sodium Bicarbonate Zegerid 40 mg in Healing Reflux Esophagitis|Completed||Phase 4|91|Actual|Mayo Clinic|Our methods relied upon pill counting as a proxy for adherence to medical therapy. Now that PPIs are available over the counter, few patients present de novo with LA C and LA D esophagitis. We didn't control for other factors that can affect GERD.|2|||f||||f||||||||||2017-02-18 14:17:33.055612|2017-02-18 14:17:33.055612
NCT00693212|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-05|||February 1986||1986-02-01|June 2008|2008-06-01|November 1994|Actual|1994-11-01|November 1994|Actual|1994-11-01||Interventional|||Further Studies of Attention Deficit Disorder - Residual Type (RT)|Further Studies of Attention Deficit Disorder - Residual Type|Completed||Phase 3|116|Actual|University of Utah||3|||t||||f||||||||||2017-02-18 14:17:33.483591|2017-02-18 14:17:33.483591
NCT00693199|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-08-07|||July 2006||2006-07-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension||Completed||N/A|360|Actual|Anhui Medical University||3|||f||||t||||||||||2017-02-18 14:17:33.592607|2017-02-18 14:17:33.592607
NCT00693186|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2010-11-17|||October 2008||2008-10-01|November 2010|2010-11-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA|An Open-label, Randomised, Controlled, Multi-centre Study of the Immunogenicity and Safety of a Booster Dose of Two Different Hepatitis B Vaccines to Explore the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children Previously Vaccinated at About 3, 5 and 11 to 13 Months of Age With Either HEXAVAC® or INFANRIX®-HEXA|Completed||Phase 3|410|Actual|MCM Vaccines B.V.||2|||f||||f||||||||||2017-02-18 14:17:33.688879|2017-02-18 14:17:33.688879
NCT00693173|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-02-11|||July 2007||2007-07-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients|Genital Drop Technique With Intensity-Modulated Radiation Therapy (IMRT) in Male Anal and Distal Rectal Cancer Patients: A Dosimetric Comparison|Completed||N/A|14|Actual|The University of Texas Medical Branch, Galveston|||1||f||||f||||||||||2017-02-18 14:17:33.774419|2017-02-18 14:17:33.774419
NCT00693160|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2014-03-07|2013-05-15||December 2007||2007-12-01|March 2014|2014-03-01|January 2011|Actual|2011-01-01|October 2010|Actual|2010-10-01||Interventional|||Effect of Spinal Ketorolac After Acute Opioid Exposure|Effect of Intrathecal Ketorolac on Mechanical Hypersensitivity Following Acute Opioid Exposure|Terminated||Phase 2|30|Actual|Wake Forest University Health Sciences||2||the manufacturing of preservative free ketorolac (Acular-PF) was discontinued|f||||t||||||||||2017-02-18 14:17:33.858879|2017-02-18 14:17:33.858879
NCT00693147|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2012-09-29|||May 2008||2008-05-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|December 2009|Actual|2009-12-01||Interventional|||Late Postoperative Course of Patients With Mini Video Assisted Thyroidectomy (miVAT) Versus Classic Thyroidectomy (T)|Late Postoperative Course of Patients With Mini Video Assisted Thyroidectomy (miVAT) Versus Classic Thyroidectomy (T)|Completed||N/A|100|Actual|Aristotle University Of Thessaloniki||2|||f||||t||||||||||2017-02-18 14:17:34.218473|2017-02-18 14:17:34.218473
NCT00693134|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05|||March 2004||2004-03-01|February 2008|2008-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Role of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs) in Children With Myocarditis|The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Children With Acute Inflammatory Cardiomyopathy|Completed||N/A|36|Actual|University of Texas Southwestern Medical Center|||2||f||||f||||||Samples Without DNA|"~     Biopsy tissue, if available.~   "|||2017-02-18 14:17:34.327728|2017-02-18 14:17:34.327728
NCT00693121|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05|||April 2003||2003-04-01|June 2008|2008-06-01|June 2008|Anticipated|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Amantadine for Treatment of Symptoms of the Post-Traumatic Confusional State|Amantadine Hydrochloride for Treatment of Symptoms of the Post-Traumatic Confusional State Among Neurorehabilitation Admissions With TBI: A Randomized, Double-Blind, Placebo-Controlled Trial|Unknown status|Active, not recruiting|Phase 4|79|Actual|Methodist Rehabilitation Center||2|||f||||f||||||||||2017-02-18 14:17:34.420197|2017-02-18 14:17:34.420197
NCT00693108|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05|||September 2006||2006-09-01|June 2008|2008-06-01||||||||Interventional|||Androgens for Poor Responders in In Vitro Fertilization|Transdermal Testosterone to Improve Ovarian Response to Gonadotropins in Poor Responder IVF Patients With Normal Basal Concentrations of FSH|Completed||Phase 3|||Hospital Clinic of Barcelona||2|||f||||||||||||||2017-02-18 14:17:34.634695|2017-02-18 14:17:34.634695
NCT00693095|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-01-20|||September 2008||2008-09-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|December 2013|Actual|2013-12-01||Interventional|ERaDICATe||Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer|Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer|Completed||Phase 1|23|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:17:34.731796|2017-02-18 14:17:34.731796
NCT00693082|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-11-19|||August 2007||2007-08-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation|Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation|Terminated||Phase 2|4|Actual|Duke University||1||recruitment and pilot funding issues|f||||t||||||||||2017-02-18 14:17:34.838902|2017-02-18 14:17:34.838902
NCT00693069|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-08-20|||September 2004||2004-09-01|June 2008|2008-06-01|April 2006|Actual|2006-04-01|||||Interventional|||Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function|Effect of Different Dosing Regimens of Clopidogrel Given Before Elective Percutaneous Coronary Intervention on Platelet Function|Completed||Phase 3|120|Actual|Hopital du Sacre-Coeur de Montreal||4|||f||||f||||||||||2017-02-18 14:17:34.933744|2017-02-18 14:17:34.933744
NCT00693056|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2009-05-04|||June 2008||2008-06-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy Study of RX-10100 to Treat Erectile Dysfunction (ED)|A Double-Blinded, Randomized, Placebo-Controlled, Dose-Exploring Study of RX-10100 for Eight Weeks of On-Demand Administration in Subjects With Erectile Dysfunction (ED)|Completed||Phase 2|40|Anticipated|Rexahn Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 14:17:35.040171|2017-02-18 14:17:35.040171
NCT00693043|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2014-03-26|||February 2008||2008-02-01|March 2014|2014-03-01||||March 2010|Actual|2010-03-01||Interventional|||Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy|A Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy|Withdrawn||N/A|0|Actual|Lahey Clinic||2||Principal Investigator left the institution requested termination|f||||f||||||||||2017-02-18 14:17:35.148661|2017-02-18 14:17:35.148661
NCT00693030|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05|||August 2006||2006-08-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|June 2008|Anticipated|2008-06-01||Interventional|ODESSA||Optical Coherence Tomography for Drug Eluting Stent Safety|In-Vivo Vascular Response of Sirolimus-,Paclitaxel- and Zotarolimus-Eluting Stents in Long Lesions Requiring Overlapping. A Prospective, Randomized, Controlled Study Using Optical Coherence Tomography|Unknown status|Recruiting|Phase 4|77|Anticipated|A.O. Ospedale Papa Giovanni XXIII||4|||f||||t||||||||||2017-02-18 14:17:35.259818|2017-02-18 14:17:35.259818
NCT00693017|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-12-21|2012-08-13||June 2008||2008-06-01|November 2015|2015-11-01||||November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy|A Double-blind, Randomised, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy|Terminated||Phase 3|10|Actual|Eisai Inc.|Due to early termination of the study by the Sponsor. No formal analyses were conducted.|2||Sponsor's decision|f||||||||||||||2017-02-18 14:17:35.397424|2017-02-18 14:17:35.397424
NCT00693004|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2009-07-28|||May 2008||2008-05-01|July 2009|2009-07-01||||January 2010|Anticipated|2010-01-01||Interventional|||Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of PRX-03140 as Monotherapy in Subjects With Alzheimer's Disease|Terminated||Phase 2|236|Anticipated|Epix Pharmaceuticals, Inc.||3|||f||||||||||||||2017-02-18 14:17:35.952227|2017-02-18 14:17:35.952227
NCT00006296|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-25|2016-02-17|||September 2000||2000-09-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||CV Risk Factors at Age 25-64 & Long-Term Medicare Costs||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:13:03.607609|2017-02-18 18:13:03.607609
NCT00692965|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-08-23|||June 2008||2008-06-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Sleep Quality and Presence of Sleep Disordered Breathing|Sleep Quality and Presence of Sleep Disordered Breathing In An Inner City African American HIV Infected Population Aged 50 Years and Older|Completed||N/A|74|Actual|University of Florida|||1||f||||f||||||||||2017-02-18 14:17:36.329604|2017-02-18 14:17:36.329604
NCT00692952|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2009-07-09|||March 2004||2004-03-01|June 2008|2008-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|BZK||Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial|Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial|Completed||Phase 2|240|Actual|Shanghai Institute of Planned Parenthood Research||2|||f||||t||||||||||2017-02-18 14:17:36.422518|2017-02-18 14:17:36.422518
NCT00692939|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-02-12|||October 2011||2011-10-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Autologous Stem Cell Transplantation for Crohn's Disease|Autologous Stem Cell Transplantation With CD34 Selected Peripheral Blood Stem Cells (PBSC) in Pediatric and Young Adult Patients With Severe Crohn's Disease|Recruiting||Phase 1/Phase 2|10|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-02-18 14:17:36.536221|2017-02-18 14:17:36.536221
NCT00692926|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-12-21|||October 2005||2005-10-01|December 2016|2016-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells|A Pilot Trial of Unrelated Umbilical Cord Blood Transplantation Augmented With Ex Vivo CytokinePrimed ALDHbr Umbilical Cord Blood Cells|Completed||Phase 1|37|Actual|Duke University||4|||f||||t||||||||||2017-02-18 14:17:36.660606|2017-02-18 14:17:36.660606
NCT00692913|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-07-21|2011-07-20||June 2008||2008-06-01|July 2015|2015-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)|A Phase III (Phase V Program), Open-Label, Randomized, Referred-Care-Controlled, Clinical Trial to Evaluate the Efficacy and Safety of MK -0217A/Alendronate Sodium-70 mg/Vitamin D3 5600 I.U. Combination Tablet on Vitamin D Inadequacy in the Treatment of Osteoporosis in Postmenopausal Women|Completed||Phase 3|515|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:17:36.778306|2017-02-18 14:17:36.778306
NCT00692900|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-01-31|||December 2008||2008-12-01|January 2016|2016-01-01|October 2013|Actual|2013-10-01|June 2013|Actual|2013-06-01||Interventional|||Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer|Phase I Dose-Escalation Parallel Studies of Intraperitoneal Oxaliplatin With Intravenous Docetaxel and Intravenous Oxaliplatin With Intraperitoneal Docetaxel in Platinum-Sensitive or Platinum-Resistant Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|Completed||Phase 1|25|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:17:37.407915|2017-02-18 14:17:37.407915
NCT00692887|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2009-01-27|||June 2008||2008-06-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|PHP||Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)|Correlation Between Visual Field Defects on Foresee PHP and OCT in Patients With CNV Before and After Treatment|Completed||N/A|15|Actual|Notal Vision Ltd|||1||f||||t||||||||||2017-02-18 14:17:37.513839|2017-02-18 14:17:37.513839
NCT00692874|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2010-12-09|||June 2008||2008-06-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Observational|AZTEK EXT||Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy|Quality of Life Analysis of Prostate Cancer Patient's Therapy|Completed||N/A|1646|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:17:37.635326|2017-02-18 14:17:37.635326
NCT00692861|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2017-01-24|||June 2, 2008||2008-06-02|January 3, 2014|2014-01-03|January 3, 2014||2014-01-03|||||Observational|||Autoimmunity in Neurologic Complications of Celiac Disease|The Role of Autoimmunity in Neurologic Complications of Celiac Disease|Completed||N/A|14|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:17:37.732008|2017-02-18 14:17:37.732008
NCT00692848|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05|||November 2006||2006-11-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source|The Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source|Completed||N/A|384|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-02-18 14:17:37.821443|2017-02-18 14:17:37.821443
NCT00692835|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2012-09-29|||May 2008||2008-05-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|December 2009|Actual|2009-12-01||Interventional|||Immediate Postoperative Course of Patients With Mini Video Assisted Total Thyroidectomy (miVAT) Versus Classic Total Thyroidectomy (cTT)|Immediate Postoperative Course of Patients With Mini Video Assisted Total Thyroidectomy (miVAT) Versus Classic Total Thyroidectomy (cTT)|Completed||N/A|100|Actual|Aristotle University Of Thessaloniki||2|||f||||t||||||||||2017-02-18 14:17:37.926076|2017-02-18 14:17:37.926076
NCT00692822|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-03-06|||June 2008||2008-06-01|February 2009|2009-02-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Observational|||Antimicrobial Susceptibility Patterns of N. Gonorrhea Isolates in an Era of Quinolone Resistance|Antimicrobial Susceptibility Patterns of Neisseria Gonorrhea Isolates in an Era of Quinolone Resistance|Completed||N/A|60|Actual|University of Florida|||1||f||||f||||||Samples Without DNA|"~     Urethral discharge for Neisseria gonorrheae culture~   "|||2017-02-18 14:17:38.026488|2017-02-18 14:17:38.026488
NCT00692809|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-09-14|||July 2008||2008-07-01|June 2008|2008-06-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Observational|HIV-TB||Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection|Impact of HIV Infection on Latent TB Among Patients With HIV-TB Co-infection|Unknown status|Recruiting|N/A|180|Anticipated|Ministry of Science and Technology, India|||4||f||||f||||||||||2017-02-18 14:17:38.130135|2017-02-18 14:17:38.130135
NCT00692796|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2010-04-16|||April 2008||2008-04-01|July 2008|2008-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis|Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis|Completed||N/A|60|Anticipated|National Jewish Health||1|||f||||f||||||||||2017-02-18 14:17:38.338159|2017-02-18 14:17:38.338159
NCT00692588|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2011-04-05|||June 2008||2008-06-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|DARAD-MRI||MRI to Measure Treatment With Antibiotics in Alzheimer's Disease|Magnetic Resonance Imaging to Measure Treatment Effects of Doxycycline and Rifampicin in Alzheimer's Disease|Completed||N/A|58|Actual|St. Joseph's Healthcare Hamilton|||5||f||||f||||||||||2017-02-18 14:17:46.157728|2017-02-18 14:17:46.157728
NCT00692783|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-05-07|||May 2008||2008-05-01|May 2015|2015-05-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Observational|ICONIC||Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility|Incidence of Oral Candidiasis, Prevalence of Candida Dubliniensis in HIV Patients and In-vitro Azole Susceptibility. (I.C.O.N.I.C.)|Terminated||N/A|10|Actual|University of Florida|||1|Dr. Vindas completed his fellowship + low enrollment|f||||f||||||||||2017-02-18 14:17:38.448834|2017-02-18 14:17:38.448834
NCT00692770|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2016-03-21|2014-11-24||August 2008||2008-08-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2013|Actual|2013-11-01||Interventional|STORM||Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)|A Phase III Randomized, Double-blind, Placebo-controlled Study of Sorafenib as Adjuvant Treatment for Hepatocellular Carcinoma After Surgical Resection or Local Ablation.|Completed||Phase 3|1114|Actual|Bayer||2|||f||||t||||||||||2017-02-18 14:17:38.584111|2017-02-18 14:17:38.584111
NCT00692757|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-10-20|||July 2008||2008-07-01|October 2008|2008-10-01|March 2009|Anticipated|2009-03-01|January 2009|Anticipated|2009-01-01||Interventional|WASH||Wound Antiseptic Study With Hypochlorous Acid & Iodopovidone|Comparative Study of Two Antiseptics Solutions for the Prevention of Surgical Site Infection|Unknown status|Recruiting|Phase 2|432|Anticipated|Universidad Tecnológica de Pereira||2|||f||||t||||||||||2017-02-18 14:17:44.589534|2017-02-18 14:17:44.589534
NCT00692744|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-09-01|||October 2008||2008-10-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|FASHE||Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH)|Study of Quality of Life After Aneurysmal Subarachnoid Hemorrhage in Patients Aged 70 Years or Older.|Completed||N/A|353|Actual|University Hospital, Rouen|||5||f||||t||||||None Retained|"~     2 randomized arms (clipping and coiling) and 3 prospective observational arms (clipping,~     coiling, conservative) For the randomized arms, we anticipated 20 patients in each arm.~   "|||2017-02-18 14:17:44.701061|2017-02-18 14:17:44.701061
NCT00692731|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-04|||June 2006||2006-06-01|June 2008|2008-06-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Observational|||Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss|A Randomized, Double-Blind, Controlled Study to Assess the Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss|Completed||N/A|132|Actual|Provident Clinical Research|||2||f||||f||||||||||2017-02-18 14:17:44.804903|2017-02-18 14:17:44.804903
NCT00692718|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-06-18|||July 2008||2008-07-01|June 2008|2008-06-01||||June 2010|Anticipated|2010-06-01||Interventional|||N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure|N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure|Unknown status|Not yet recruiting|Phase 4|160|Anticipated|Osaka General Medical Center||1|||f||||||||||||||2017-02-18 14:17:44.909417|2017-02-18 14:17:44.909417
NCT00692705|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2009-01-22|||January 2008||2008-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PET||Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid|Open Label Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid, to Determine and Compare in Vivo Brain Uptake and Distribution in Healthy Volunteers and Patients With Alzheimer's Disease|Completed||Phase 1|13|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:17:44.987559|2017-02-18 14:17:44.987559
NCT00692692|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-08-03|2013-08-03||June 2007||2007-06-01|July 2013|2013-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||36 total with 20 in the experimental group and 16 in the control group|Use of Dermal Matrix in Breast Reconstruction|The Use of An Acellular Dermal Matrix Sling in a Two-stage Breast REconstruciton After Mastectomy: A Double-blinded Randomized Trial|Terminated||N/A|36|Actual|Vanderbilt University|Study was terminated early due to more infections recorded in the dermal matrix group; I currently do not have the exact number|2||higher rate of post-operative infectin in the Dermal Matrix arm of the study|f||||f||||||||||2017-02-18 14:17:45.094693|2017-02-18 14:17:45.094693
NCT00692666|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-05|||May 2006||2006-05-01|June 2008|2008-06-01|August 2007|Actual|2007-08-01|May 2006|Actual|2006-05-01||Observational|||Letigen® and Cardiovascular Morbidity|Letigen® and Cardiovascular Morbidity. A Register-Based Epidemiological Study|Completed||Phase 4|300000||University of Southern Denmark|||||f||||f||||||||||2017-02-18 14:17:45.544631|2017-02-18 14:17:45.544631
NCT00692653|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-04-30|||February 2007||2007-02-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|P4||Personal Patient Profile Prostate (P4) Randomized, Multisite Trial|Personal Patient Profile Prostate (P4) Randomized, Multisite Trial|Completed||N/A|498|Actual|Dana-Farber Cancer Institute||2|||f||||f||||||||||2017-02-18 14:17:45.622074|2017-02-18 14:17:45.622074
NCT00692640|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-03-22|||May 2008||2008-05-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors|A Phase 1 Dose-Escalation Study of XL147 (SAR245408) in Combination With Erlotinib in Subjects With Solid Tumors|Completed||Phase 1|35|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:17:45.734152|2017-02-18 14:17:45.734152
NCT00692627|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-01-21|||July 2008||2008-07-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|PRiSM||Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum Malaria|Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum Malaria|Completed||N/A|80|Anticipated|University of Oxford|||1||f||||f||||||||||2017-02-18 14:17:45.844742|2017-02-18 14:17:45.844742
NCT00692614|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-10-30|||June 2008||2008-06-01|October 2015|2015-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)|A Phase IIb, Randomized, Masked, Sham-Controlled, Clinical Trial to Study the Efficacy and Safety of the Helical Triamcinolone Acetonide Implant (MK0140) in Diabetic Patients With Clinically Significant Macular Edema|Terminated||Phase 2|2|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 14:17:45.943882|2017-02-18 14:17:45.943882
NCT00692601|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-09-15|||April 2008||2008-04-01|June 2008|2008-06-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||The Acute Effects of Capsiate During Exercise|Effect of Differing Doses of A Sweet Pepper Extract - Capsiate (A Capsaicin Analogue) - On Energy Expenditure and Blood Parameters in Humans During Exercise|Completed||Phase 1|12|Actual|McMaster University||3|||f||||f||||||||||2017-02-18 14:17:46.043543|2017-02-18 14:17:46.043543
NCT00692575|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-04-10|||June 2008||2008-06-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|September 2012|Actual|2012-09-01||Interventional|||Telephone Intervention for Caregivers of Persons With Traumatic Brain Injury|Modular Scheduled Telephone Intervention for Caregivers of Persons With Traumatic Brain Injury: A Randomized Controlled Trial|Completed||Phase 2|153|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:17:46.250588|2017-02-18 14:17:46.250588
NCT00692562|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2011-09-15|||June 2005||2005-06-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease|Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease|Completed||Phase 1/Phase 2|7|Actual|Fuzhou General Hospital||1|||f||||t||||||||||2017-02-18 14:17:46.35926|2017-02-18 14:17:46.35926
NCT00692549|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05|||June 2005||2005-06-01|June 2008|2008-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Ultrasound Guidance for Intravenous Cannulation in Emergency Department Patients.|Ultrasound-Guided Peripheral Intravenous Cannulation in Emergency Department Patients With Difficult IV Access: a Randomized Trial.|Completed||N/A|60|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:17:46.460808|2017-02-18 14:17:46.460808
NCT00692536|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-09-01|||September 2007||2007-09-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|KNOTA||Diet Composition - Metabolic Regulation and Long-term Compliance|Diet Composition - Metabolic Regulation and Long-term Compliance|Completed||N/A|70|Actual|Umeå University||2|||f||||f||||||||||2017-02-18 14:17:46.554595|2017-02-18 14:17:46.554595
NCT00692523|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2009-10-01|||November 2008||2008-11-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|EVREST||Effectiveness of Virtual Reality Exercises in STroke Rehabilitation (EVREST)|A Pilot Randomised, Two Parallel Group Study Comparing Wii Gaming Versus Recreational Activity in Patients Receiving Standard Rehabilitation After Stroke|Completed||N/A|30|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 14:17:46.65171|2017-02-18 14:17:46.65171
NCT00692510|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-11-25|||November 2007||2007-11-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|Cocktail||Drug Interaction Study Between AZD3480 and Cytochrome P450|A Phase I, Double Blind, Randomized, Two-Way Cross Over, Single- Centre Study in Healthy CYP2D6 Extensive Metabolizers and Poor Metabolizers to Investigate the Potential of AZD3480 to Inhibit Cytochrome P450 1A2, 2C19, 3A4, 2C8, 2B6 and UGT1A1 Activity|Completed||Phase 1|18|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:17:46.753041|2017-02-18 14:17:46.753041
NCT00692497|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-01-26|||October 2010||2010-10-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|one-stop||Electronic Referral and Booking of Outpatient Day Case Surgery Compared With Traditional Referral Routines.|Costs-effectiveness and Waiting Time for Direct Electronic Referral and Booking of Outpatient Day Case Surgery Compared With Traditional Referral Routines. A Randomised Controlled Trial|Completed||N/A|120|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-02-18 14:17:46.862525|2017-02-18 14:17:46.862525
NCT00692484|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-03-21||2013-02-19|October 2007||2007-10-01|March 2013|2013-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Pilot Evaluation of the Application Procedure on the Antimicrobial Effects of 2 Antiseptics|Pilot Evaluation of the Effect of Application Procedure on the Antimicrobial Effects of an Aqueous CHG and a Traditional Iodophor Scrub Paint|Completed||Phase 3|25|Actual|CareFusion||2|||f||||f||||||||||2017-02-18 14:17:46.973161|2017-02-18 14:17:46.973161
NCT00692471|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2016-08-15|||June 2008||2008-06-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)|Assessment of Objective Sleep Disturbances in Orthostatic Intolerance Using Actigraphy|Active, not recruiting||N/A|100|Anticipated|Vanderbilt University|||2||f||||f||||||||||2017-02-18 14:17:47.082177|2017-02-18 14:17:47.082177
NCT00692458|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-08-11|||September 2008||2008-09-01|November 2015|2015-11-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)|A Phase III Study to Assess the Safety, Tolerability, and Efficacy of MK0822 (Odanacatib) in Reducing the Risk of Bone Metastasis in Women With Breast Cancer|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2||Withdrawn for administrative reasons|f||||||||||||||2017-02-18 14:17:47.19261|2017-02-18 14:17:47.19261
NCT00692445|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-06-13||2011-01-04|June 2008||2008-06-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||TC-5214 as add-on the Treatment of Major Depressive Disorder|A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group, Flexible Dose Titration, Add-On Study of TC-5214 in the Treatment of MDD With Subjects Who Are Partial Responders or Non-Responders to Citalopram Therapy|Completed||Phase 2|574|Actual|Targacept Inc.||2|||f||||f||||||||||2017-02-18 14:17:47.28037|2017-02-18 14:17:47.28037
NCT00692432|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05|||September 2001||2001-09-01|August 2007|2007-08-01|December 2008|Anticipated|2008-12-01|September 2003|Actual|2003-09-01||Observational|||Macrophage Inhibitory Factor (MIF) and High-Mobility Group-1 Protein (HMG-1) in Children Undergoing Cardiopulmonary Bypass|Macrophage Inhibitory Factor (MIF) and High-Mobility Group-1 Protein (HMG-1) in Children Undergoing Cardiopulmonary Bypass|Unknown status|Active, not recruiting|N/A|30|Actual|University of Texas Southwestern Medical Center|||1||f||||f||||||Samples Without DNA|"~     cardiac tissue serum~   "|||2017-02-18 14:17:47.486147|2017-02-18 14:17:47.486147
NCT00692419|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-04-06|2014-10-30||November 2008||2008-11-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional|SMILE||Pain, Sexual Dysfunction, and Depression in Hemodialysis Patients|Pain, Sexual Dysfunction and Depression in Hemodialysis Patients|Completed||N/A|315|Actual|VA Office of Research and Development|Individual providers were overseeing the care of patients from both study arms. The sample size was relatively small. Single geographic area. No control arm. Symptoms assessed during dialysis. No formal assessment of treatment compliance.|2|||f||||t||||||||||2017-02-18 14:17:47.728157|2017-02-18 14:17:47.728157
NCT00692406|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2013-02-21|2009-02-22||June 2005||2005-06-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|SmokeAtt01||Neuroimaging Attentional Impairment During Abstinence|Neuroimaging Attentional Impairment During Abstinence|Completed||N/A|80|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:17:48.060763|2017-02-18 14:17:48.060763
NCT00323921|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2012-08-02|||August 2005||2005-08-01|August 2012|2012-08-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Determination of Safety and Efficacy of a Laser With Cooling for Treatment of Skin||Completed||N/A|36|Actual|Candela Corporation||1|||f||||f||||||||||2017-02-18 16:33:37.526758|2017-02-18 16:33:37.526758
NCT00692393|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-06-18|||June 2008||2008-06-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|December 2012|Actual|2012-12-01||Interventional|DIVERTI||Primary vs. Secondary Anastomosis for Hinchey Stage III-IV Diverticulitis a Prospective Randomized Trial|Primary vs. Secondary Anastomosis After Sigmoid Colon Resection for Perforated Diverticulitis (Hinchey Stage III and IV): a Prospective Multicentric Randomized Trial|Completed||N/A|102|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-02-18 14:17:48.396379|2017-02-18 14:17:48.396379
NCT00692380|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-04-28|||June 2006||2006-06-01|April 2016|2016-04-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC|A Phase I Dose Intensification Study Using Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable, Non-Small Cell Lung Cancer|Terminated||Phase 1|28|Actual|Virginia Commonwealth University||1||insufficient accrual|f||||t||||||||||2017-02-18 14:17:48.495358|2017-02-18 14:17:48.495358
NCT00692367|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2014-11-02|||December 2007||2007-12-01|November 2014|2014-11-01|November 2012|Actual|2012-11-01|November 2011|Actual|2011-11-01||Interventional|||Physical Activity Following Surgery Induced Weight Loss|Physical Activity Following Surgery Induced Weight Loss|Completed||N/A|128|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:17:48.596013|2017-02-18 14:17:48.596013
NCT00692354|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2010-08-05|||October 2004||2004-10-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Interventional|||Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours|A Phase I Study to Evaluate the Safety and Tolerability, of the Aminopeptidase Inhibitor, CHR-2797, in Patients With Advanced Tumours|Completed||Phase 1|41|Actual|Chroma Therapeutics||1|||f||||t||||||||||2017-02-18 14:17:48.710459|2017-02-18 14:17:48.710459
NCT00692341|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-04-05|2012-02-25||May 2008||2008-05-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics|A Phase 1 Study To Evaluate The Pharmacokinetics Of AG-013736 In Subjects With Impaired Hepatic Function|Completed||Phase 1|24|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:17:48.803564|2017-02-18 14:17:48.803564
NCT00692328|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-05-04|||August 2005||2005-08-01|May 2015|2015-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Expectation and Response to Levodopa and Acupuncture in Parkinson's Disease|Expectation and Response to Levodopa & Acupuncture in Parkinson's Disease|Completed||N/A|63|Actual|Oregon Health and Science University||3|||f||||t||||||||||2017-02-18 14:17:49.541557|2017-02-18 14:17:49.541557
NCT00692315|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-04-13|||September 2006||2006-09-01|April 2016|2016-04-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Treating Oxidative Stress in Children With Autism|Efficacy of Methylcobalamin and Folinic Acid Treatment on Glutathione Redox Status and Core Behavior in Children With Autism|Completed||N/A|40|Actual|Arkansas Children's Hospital Research Institute||2|||f||||t||||||||||2017-02-18 14:17:49.649614|2017-02-18 14:17:49.649614
NCT00692302|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-06-05|||March 2006||2006-03-01|June 2013|2013-06-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)|Family Based Intervention for Adolescent Suicide Attempters|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|University of California, Los Angeles||3|||f||||f||||||||||2017-02-18 14:17:49.757069|2017-02-18 14:17:49.757069
NCT00692289|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2012-06-05|||June 2008||2008-06-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|RADAR II E||Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer|Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer|Completed||N/A|1510|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:17:49.864164|2017-02-18 14:17:49.864164
NCT00692276|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-10-31|||June 2008||2008-06-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Investigating Superion™ In Spinal Stenosis|A Prospective, Multi-Center, Randomized Study Comparing the VertiFlex® Superion™ Interspinous Spacer (ISS) to the X-STOP® Interspinous Process Decompression (IPD®) System in Patients With Moderate Lumbar Spinal Stenosis|Active, not recruiting||N/A|400|Anticipated|VertiFlex, Incorporated||2|||f||||t||||||||||2017-02-18 14:17:49.96027|2017-02-18 14:17:49.96027
NCT00692263|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-09-09|||February 2008||2008-02-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy Subjects|The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy Subjects|Completed||Phase 4|15|Actual|University of Southern Denmark||3|||f||||t||||||||||2017-02-18 14:17:50.089021|2017-02-18 14:17:50.089021
NCT00692250|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-05-04|||September 2007||2007-09-01|May 2015|2015-05-01|December 2007|Actual|2007-12-01|||||Interventional|||A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers|A Phase I Open Label, Randomised, Single Dose, 2-way Crossover, 2-Sequence Pharmacokinetic Study on the Interaction of Colesevelam and Ciclosporin in Healthy Volunteers|Completed||Phase 1|14|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:17:50.186929|2017-02-18 14:17:50.186929
NCT00692237|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-05-05|2011-08-23||January 2008||2008-01-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|CECSID||Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes|Cardiovascular Effects of Chronic Sildenafil (Viagra) Treatment in Diabetic Subjects With Endothelial Dysfunction.|Completed||Phase 4|59|Actual|University of Roma La Sapienza||2|||f||||t||||||||||2017-02-18 14:17:50.269548|2017-02-18 14:17:50.269548
NCT00692224|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-05|||October 2005||2005-10-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial|Effect of Oral Zinc Given Daily Between Days 2 and 7 of Life to Term or Near Term Neonates With Serum Bilirubin Levels of More Than 6 mg/dL at 24 ± 6 Hours of Life on Hyperbilirubinemia and Phototherapy|Completed||Phase 1/Phase 2|294|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 14:17:50.899101|2017-02-18 14:17:50.899101
NCT00692211|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-04-28|2014-08-11||June 2008||2008-06-01|April 2015|2015-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Interventions to Improve Colorectal Cancer Screening|Interventions to Improve Colorectal Cancer Screening Rates and Adherence|Completed||N/A|404|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:17:51.014354|2017-02-18 14:17:51.014354
NCT00285740|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2007-12-14|||August 2005||2005-08-01|December 2007|2007-12-01|January 2007||2007-01-01|||||Interventional|||Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting||Unknown status|Active, not recruiting|N/A|60||Stanford University|||||f||||||||||||||2017-02-18 16:47:33.059437|2017-02-18 16:47:33.059437
NCT00692198|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-10-28|||January 2009||2009-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|LOTT||Long-term Oxygen Treatment Trial|Effectiveness of Long-term Oxygen Therapy in Treating People With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|738|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||Yes|Datasets and associated documentation will be deposited with the National Heart, Lung, and Blood Institute Biologic Specimen and Data Repository Information Coordinating Center (NHLBI BioLINCC) repository once the contract ends, currently scheduled for May 2017. Data will be deidentified per BioLINCC requirements; datasets will include baseline and follow-up data collected during the trial. The BioLINCC Repository website includes instructions regarding accessing data on deposit in their repository.|2017-02-18 14:17:51.4056|2017-02-18 14:17:51.4056
NCT00692185|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-09-20|2009-05-28||October 2005||2005-10-01|September 2013|2013-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa|Atypical Antipsychotic Medication in Anorexia Nervosa|Completed||Phase 2|18|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 14:17:51.561783|2017-02-18 14:17:51.561783
NCT00692172|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2014-09-17|||December 2001||2001-12-01|September 2014|2014-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis|An Open-Label, Multi-center Study to Evaluate the Safety and Tolerability of Intramuscular Administration of Alefacept (LFA-3/IgG1 Fusion Protein) in Subjects With Chronic Plaque Psoriasis Who Have Completed Studies C99-717 or C99-712|Completed||Phase 3|175|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 14:17:51.989193|2017-02-18 14:17:51.989193
NCT00692159|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2010-09-08|||June 2008||2008-06-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Study of TRC102 in Combination With Pemetrexed in Cancer Patients|Open Label Phase 1 Dose Finding Study of TRC102 in Combination With Pemetrexed in Patients With Advanced or Metastatic Solid Cancer for Whom Curative Therapy is Unavailable|Completed||Phase 1|28|Actual|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||||2017-02-18 14:17:52.152677|2017-02-18 14:17:52.152677
NCT00692146|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-05|||January 2008||2008-01-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)|A Double-Blind, Randomized, Single-Centre, Placebo-Controlled, Crossover Study to Investigate the Effects of a Single Oral Dose of AZD1386 on Intradermal Capsaicin Evoked Pain Symptoms and Heat Sensitivity in Healthy Volunteers|Completed||Phase 1|36|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:17:52.26763|2017-02-18 14:17:52.26763
NCT00692133|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2010-12-08|||March 2008||2008-03-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|TOOL||Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment|Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment|Completed||N/A|250|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:17:52.364313|2017-02-18 14:17:52.364313
NCT00692120|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-10-01|||February 2007||2007-02-01|April 2010|2010-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|D2/D3||Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy|Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy|Completed||N/A|64|Actual|University of Wisconsin, Madison||4|||f||||f||||||||||2017-02-18 14:17:52.478283|2017-02-18 14:17:52.478283
NCT00692107|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2008-06-05|||June 1997||1997-06-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|May 2005|Actual|2005-05-01||Interventional|||Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose|Phase III Study for Prostate Cancer, Randomizing Between Two Radiation Dose Levels (68 Gy vs. 78 Gy) and Utilizing Three Dimensional Conformal Radiotherapy|Completed||Phase 3|669|Actual|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-02-18 14:17:52.57734|2017-02-18 14:17:52.57734
NCT00692094|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2014-04-08|||August 2004||2004-08-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Blind Elderly Melatonin Treatment Study|Melatonin Entrainment of Elderly Blind Free-runners|Completed||N/A|12|Actual|Oregon Health and Science University||4|||f||||t||||||||||2017-02-18 14:17:52.69423|2017-02-18 14:17:52.69423
NCT00692081|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05||||||June 2008|2008-06-01||||||||Interventional|SCT-ABI||Social Competence Training for Adolescents With Borderline Intellectual Functioning|A Randomized Controlled Trial of a Social Competence Group Training for Adolescents With Borderline Intellectual Functioning|Completed||Phase 2/Phase 3|77|Actual|University of Ulm||2|||f||||f||||||||||2017-02-18 14:17:52.815177|2017-02-18 14:17:52.815177
NCT00692068|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-06-05||||||June 2008|2008-06-01||||||||Observational|||Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients|Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients|Completed||N/A|||Iwata City Hospital|||2||f||||||||||||||2017-02-18 14:17:52.897649|2017-02-18 14:17:52.897649
NCT00692055|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-09-04|||June 2008||2008-06-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations|Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations|Completed||Phase 1|30|Actual|POZEN||2|||f||||f||||||||||2017-02-18 14:17:52.979078|2017-02-18 14:17:52.979078
NCT00692042|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2008-06-23|||March 2008||2008-03-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Investigate Safety, Tolerability and Pharmacokinetics of a Single Ascending Dose of AZD1704|A Phase I, First Time in Man, Single-Centre, Randomised, Double-Blind (Within Panels), Placebo-Controller Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1704 After Administration of Oral Single Ascending Doses in Healthy Volunteers|Completed||Phase 1|80|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:17:53.067818|2017-02-18 14:17:53.067818
NCT00692029|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2011-02-18|||June 2008||2008-06-01|February 2011|2011-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|ATV||Kinematics of Youth (Age 12-15) on Stationary All Terrain Vehicles|Kinematics of Youth (Age 12-15) on Stationary All Terrain Vehicles|Completed||N/A|40|Anticipated|University of Kentucky|||1||f||||f||||||||||2017-02-18 14:17:53.157044|2017-02-18 14:17:53.157044
NCT00692016|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2013-05-01|||January 2008||2008-01-01|May 2013|2013-05-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|Keifer||Fast & Fed Pharmacokinetic (PK) Study|An Open Label, Randomized, Two-Way Crossover Study to Determine the Bioavailability of a Single, Oral Dose of an Extended Release Naproxen Sodium Tablet Under Fasting and Fed Conditions|Completed||Phase 1|32|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:17:53.238372|2017-02-18 14:17:53.238372
NCT00692003|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-09-11|2012-08-13||August 2008||2008-08-01|September 2012|2012-09-01||||November 2008|Actual|2008-11-01||Interventional|||Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures|A Double-blind, Randomised, Placebo-controlled Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures|Terminated||Phase 3|21|Actual|Eisai Inc.|This study was terminated early at the Sponsor’s discretion. When this study was discontinued, only 6 subjects had been treated. Data from the 5 subjects treated with zonisamide were insufficient to draw firm conclusions regarding efficacy.|2||Sponsor's decision|f||||||||||||||2017-02-18 14:17:53.34194|2017-02-18 14:17:53.34194
NCT00691990|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-05|2011-08-03|||May 2008||2008-05-01|July 2009|2009-07-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|||Classic Total Thyroidectomy With or Without Drains|Classic Total Thyroidectomy With or Without Drains|Completed||N/A|100|Anticipated|Aristotle University Of Thessaloniki||2|||f||||t||||||||||2017-02-18 14:17:53.921999|2017-02-18 14:17:53.921999
NCT00691977|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2013-04-23|||September 2007||2007-09-01|April 2013|2013-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate|A Phase I Dose-Escalation Study of Preoperative Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk, Localized Carcinoma of the Prostate|Withdrawn||Phase 1|0|Actual|Virginia Commonwealth University||1||poor accrual|f||||f||||||||||2017-02-18 14:17:54.020621|2017-02-18 14:17:54.020621
NCT00691964|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-01-11||2011-09-09|May 2008||2008-05-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|347|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 14:17:54.175207|2017-02-18 14:17:54.175207
NCT00691951|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2008-10-17||||||June 2008|2008-06-01||||||||Interventional|D5890L00013||Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic Subjects|Comparative Effects of Budesonide and Budesonide/Formoterol (Symbicort) on Asthma Control in Smoking Asthmatic Subjects: A Pilot Study|Completed||Phase 3|||Laval University|||||f||||||||||||||2017-02-18 14:17:54.473828|2017-02-18 14:17:54.473828
NCT00691938|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-08-18|2016-08-18||June 2008||2008-06-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|July 2013|Actual|2013-07-01||Interventional|||LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)|A Phase I/II Study of LBH589 Plus Decitabine for Patients Age ≥ 60 Years With High Risk MDS or AML|Completed||Phase 1/Phase 2|52|Actual|Washington University School of Medicine||7|||f||||t||||||||||2017-02-18 14:17:54.579138|2017-02-18 14:17:54.579138
NCT00691925|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2009-06-02|||June 2008||2008-06-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Observational|||Mitigating Pain Following Refractive Surgery|Contact Lens for Mitigating Pain Following Refractive Procedure|Completed||N/A|4|Actual|FORSIGHT Vision3|||1||f||||t||||||||||2017-02-18 14:17:56.38385|2017-02-18 14:17:56.38385
NCT00691912|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2014-09-01|||December 2006||2006-12-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|MyoPac||Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin|Extended Dose Frequency 1st-line Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin (Myocet®)|Terminated||Phase 2|26|Actual|University of Magdeburg||1||Study was stopped due because recrutation.was much slower as anticipated.|f||||f||||||||||2017-02-18 14:17:56.469883|2017-02-18 14:17:56.469883
NCT00691899|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-08-11|||September 2008||2008-09-01|November 2015|2015-11-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)|A Phase III Study to Assess the Safety, Tolerability, and Efficacy of MK0822 (Odanacatib) in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2||Withdrawn for administrative reasons|f||||||||||||||2017-02-18 14:17:56.581782|2017-02-18 14:17:56.581782
NCT00691886|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-05-09|||April 2008||2008-04-01|May 2012|2012-05-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Safety and Efficacy of Intravenous (IV) Dexmedetomidine During Flexible Bronchoscopy and Endobronchial Ultrasound|Safety and Efficacy of Intravenous Dexmedetomidine Infusion During Flexible Bronchoscoy and Endobronchical Ultrasound|Withdrawn||Phase 4|0|Actual|Lahey Clinic||2||PI left institution prior to enrollment|f||||f||||||||||2017-02-18 14:17:56.700339|2017-02-18 14:17:56.700339
NCT00691873|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-05|||May 2006||2006-05-01|January 2007|2007-01-01|October 2007|Actual|2007-10-01|May 2007|Actual|2007-05-01||Interventional|||Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids|A26-wk,Randomized,Dble-Blinded,Parallel-Grp,Placebo-Controlled,Multi-Centered Study to Eval.the Effect of Xolair(Omalizumab) on Improving the Tolerability of Spec.Immunotherapy in Patients With at Least Mod. Persistent Allergic Asthma Inadequately Controlled w/Inhaled Corticosteroids|Completed||Phase 4|14|Actual|University of Mississippi Medical Center||2|||f||||t||||||||||2017-02-18 14:17:56.806295|2017-02-18 14:17:56.806295
NCT00691860|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-09-14|||April 2006||2006-04-01|June 2008|2008-06-01|February 2008|Actual|2008-02-01|January 2007|Actual|2007-01-01||Interventional|||Use of a Mesh to Prevent Parastomal Hernia|Randomized, Controlled, Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia|Completed||N/A|54|Actual|Corporacion Parc Tauli||2|||f||||f||||||||||2017-02-18 14:17:56.9153|2017-02-18 14:17:56.9153
NCT00691847|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2009-06-02|||June 2008||2008-06-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Observational|||Reducing Edema Following Refractive Surgery|Reducing Edema Following Refractive Surgery|Completed||N/A|3|Actual|FORSIGHT Vision3|||1||f||||t||||||||||2017-02-18 14:17:57.025193|2017-02-18 14:17:57.025193
NCT00691834|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2013-08-12|||August 2009||2009-08-01|November 2012|2012-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|ReNeW||Safety and Efficacy on Cell-based Therapy in Patients With Recent Large Acute Myocardial Infarction|ReNEW: A Phase 2, Randomized, Placebo-Controlled, Double-Blinded Study of the Efficacy and Safety of Autologous Bone Marrow Mononuclear Cell Transfer for Myocardial Salvage in Acute Myocardial Infarction|Withdrawn||Phase 2|0|Actual|Duke University||2||Study never received IRB approval. Study was never pursued.|f||||t||||||||||2017-02-18 14:17:57.115181|2017-02-18 14:17:57.115181
NCT00691821|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2011-07-25|||April 2009||2009-04-01|July 2011|2011-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|NPWT||Negative Pressure Wound Therapy for the Treatment of Chronic Pressure Wounds|A 12-week, Prospective, Open-label, Randomized, Controlled Clinical Trial Comparing Negative Pressure Wound Therapy (NPWT) to Standard Wound Care for the Treatment of Chronic Pressure Wounds of the Pelvic Region|Terminated||Phase 4|184|Anticipated|St. Joseph's Healthcare Hamilton||2||"Patients not meeting inclusion criteria, therefore recruitment rate low, terminated due to the~   lack of feasibility to complete the study in a timely manner."|f||||f||||||||||2017-02-18 14:17:57.204101|2017-02-18 14:17:57.204101
NCT00691808|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-02-17|2009-11-17||February 2008||2008-02-01|February 2010|2010-02-01||||October 2008|Actual|2008-10-01||Interventional|||Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment|A Randomized, Double-Blind, Placebo-Controlled Study to Determine Safety and Tolerability of LX6171 Oral Suspension Dosed for 28 Days in Subjects Exhibiting Age Associated Memory Impairment (AAMI)|Completed||Phase 2|103|Actual|Lexicon Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:17:57.326695|2017-02-18 14:17:57.326695
NCT00691795|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-02-13||||||February 2012|2012-02-01|December 2011|Actual|2011-12-01|||||Interventional|||Epidural Fentanyl-bupivacaine Versus Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor|Comparison of Fentanyl-bupivacaine and Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor in Patients With Continuous Epidural Analgesia|Withdrawn||Phase 4|0|Actual|Columbia University||2||Study was recently terminated due to poor enrollment - never enrolled.|f||||f||||||||||2017-02-18 14:17:58.284141|2017-02-18 14:17:58.284141
NCT00691782|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2017-01-24|||September 19, 2007|Actual|2007-09-19|January 2017|2017-01-01|January 30, 2013|Actual|2013-01-30|January 30, 2013|Actual|2013-01-30||Observational|||The Impact of African American Women's Hair Care Practices and Hair Attitudes on Exercise Habits|The Impact of African American Women's Hair Care Practices and Hair Attitudes on Exercise Habits|Completed||N/A|100|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||No||2017-02-18 14:17:58.394942|2017-02-18 14:17:58.394942
NCT00691769|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2017-01-24|||April 26, 2006|Actual|2006-04-26|January 2017|2017-01-01|November 26, 2012|Actual|2012-11-26|November 26, 2012|Actual|2012-11-26||Observational|||Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia|Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia|Completed||N/A|8|Actual|Wake Forest University Health Sciences|||3||f||||f||||||Samples With DNA|"~     Two, 4mm punch biopsies will be obtained of skin tissue.~   "|No||2017-02-18 14:17:58.480816|2017-02-18 14:17:58.480816
NCT00691756|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-04|||January 2002||2002-01-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Comparison of Renal Perfusion in Thoracoabdominal Aortic Aneurysm (TAAA) Repair|A Comparison of Cold Blood Versus Cold Crystalloid Renal Perfusion for Prevention of Acute Renal Failure Following Thoracoabdominal Aortic Aneurysm Repair: A Randomized Study|Completed||N/A|172|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 14:17:58.576265|2017-02-18 14:17:58.576265
NCT00691743|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2009-01-09|||March 2008||2008-03-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|||||Observational|NSAIDS II||Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2|Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2|Completed||N/A|850|Anticipated|AstraZeneca|||1||f||||||||||||||2017-02-18 14:17:58.678759|2017-02-18 14:17:58.678759
NCT00691730|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-07-22|||February 2008||2008-02-01|July 2015|2015-07-01||||June 2012|Actual|2012-06-01||Interventional|||Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for Cancer|The Role of VEGF-A Signaling in Maintenance of the Glomerular Filtration Barrier and Blood Pressure|Active, not recruiting||N/A|60|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 14:17:58.791339|2017-02-18 14:17:58.791339
NCT00691717|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-11-27||2012-11-27|June 2008||2008-06-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension|A Study of the Safety and IOP-Lowering Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2/Phase 3|201|Actual|Alcon Research||4|||f||||f||||||||||2017-02-18 14:17:58.894755|2017-02-18 14:17:58.894755
NCT00691704|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-08-14|2014-03-04||August 2008||2008-08-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|December 2012|Actual|2012-12-01||Interventional||Subjects enrolled and able to initiate induction therapy.|Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy|Lenalidomide and Low Dose Dexamethasone Induction Therapy Followed by Low Dose Melphalan, Prednisone, Lenalidomide and Bortezomib Sequential Maintenance Therapy for Newly Diagnosed High-risk Multiple Myeloma|Completed||Phase 2|18|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:17:59.000878|2017-02-18 14:17:59.000878
NCT00691691|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-01-18|||November 2007||2007-11-01|August 2011|2011-08-01||||||||Interventional|||Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors|A Phase II Study of Fractionated Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors|Unknown status|Recruiting|Phase 2|71|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 14:17:59.465566|2017-02-18 14:17:59.465566
NCT00691678|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2013-02-19|||May 2008||2008-05-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer|Pase II Study of Glucosamine With Chondroitin on Joint Symptoms Induced By Aromatase Inhibitors in Breast Cancer Patients|Completed||Phase 2|53|Actual|Columbia University||1|||f||||t||||||||||2017-02-18 14:17:59.560558|2017-02-18 14:17:59.560558
NCT00691665|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-03-23|2010-01-26||May 2008||2008-05-01|March 2010|2010-03-01||||January 2009|Actual|2009-01-01||Interventional|||Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial|A Double-masked, Randomized, Parallel Group, Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial|Completed||Phase 4|130|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:17:59.660776|2017-02-18 14:17:59.660776
NCT00691652|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2011-09-22|2011-08-11||May 2008||2008-05-01|September 2011|2011-09-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma|Phase I/II Study of Oral Clofarabine + Rituximab in Relapsed B Cell NHL|Terminated||Phase 1/Phase 2|2|Actual|OHSU Knight Cancer Institute||1|||f||||||||||||||2017-02-18 14:18:00.185739|2017-02-18 14:18:00.185739
NCT00691444|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-11-04|||September 2002||2002-09-01|November 2014|2014-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Blind Child Melatonin Treatment Study|Melatonin Studies of Blind Children|Unknown status|Recruiting|N/A|26|Anticipated|Oregon Health and Science University||3|||f||||t||||||||||2017-02-18 14:18:02.661932|2017-02-18 14:18:02.661932
NCT00691639|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2009-09-30|||March 2008||2008-03-01|September 2009|2009-09-01||||August 2009|Actual|2009-08-01||Observational|||Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)|Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)|Completed||N/A|1000|Anticipated|Alcon Research|||1||f||||f||||||||||2017-02-18 14:18:00.430958|2017-02-18 14:18:00.430958
NCT00691626|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2016-12-05|||April 2009||2009-04-01|December 2016|2016-12-01|September 2017|Anticipated|2017-09-01|January 2015|Actual|2015-01-01||Interventional|||Cognitive Behavioral Therapy (CBT) for Nightmares in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans|CBT for Nightmares in OEF/OIF Veterans|Active, not recruiting||N/A|108|Actual|VA Office of Research and Development||2|||f||||t||||||||No||2017-02-18 14:18:00.521002|2017-02-18 14:18:00.521002
NCT00691613|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-03-11|||July 2010||2010-07-01|March 2010|2010-03-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|IPIIR||Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model|Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model - A Randomised Cross-over Study to Evaluate if Infusion of a Single Dose of EPO Protects Against Ischemia-reperfusion Injury in Man|Unknown status|Not yet recruiting|N/A|12|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-02-18 14:18:00.627835|2017-02-18 14:18:00.627835
NCT00691600|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2010-12-02|||December 2007||2007-12-01|December 2010|2010-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage|Phase 3 Study Comparing Bactrim to Placebo in the Management of Abscesses < 5cm and 23 hr Observation Unit to Inpatient Treatment in the Management of Abscesses 5-10cm in the Pediatric Population.|Completed||Phase 3|472|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 14:18:00.744695|2017-02-18 14:18:00.744695
NCT00691587|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2009-07-29|||April 2008||2008-04-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa|A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa|Completed||Phase 1/Phase 2|36|Anticipated|KaloBios Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:18:00.851273|2017-02-18 14:18:00.851273
NCT00691574|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-11-09|||September 1998||1998-09-01|November 2013|2013-11-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Melatonin Levels in Smith Magenis Syndrome (SMS)|Melatonin Levels in Sleep-disordered Smith-Magenis Syndrome: a Pilot Study|Completed||N/A|5|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:18:00.963701|2017-02-18 14:18:00.963701
NCT00691561|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-03-10|||June 2008||2008-06-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|Project ABLE||Culturally-Tailored HIV Risk Reduction for African-American MSM|Culturally-Tailored HIV Risk Reduction for African-American MSM (Project ABLE: African-Americans Building Life Empowerment|Completed||N/A|220|Anticipated|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 14:18:01.096402|2017-02-18 14:18:01.096402
NCT00691548|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2015-04-09|||June 2009||2009-06-01|April 2015|2015-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|Cetuximab Zr89||Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients|Non Invasive Imaging of Cetuximab-Zirconium-89 Uptake With PET: a Phase I Trial in Stage IV Cancer|Completed||Phase 1|9|Actual|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-02-18 14:18:01.357664|2017-02-18 14:18:01.357664
NCT00691535|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-04|||October 2003||2003-10-01|June 2008|2008-06-01||||||||Observational|||Genetics of Symptomatology and Treatment Response in Psychotic Major Depression|Association of BDNF, COMT, MDRI, CRH, CRF, and GC Receptor Genetic Polymorphisms With Symptomatology and Treatment Response in Psychotic Major Depression|Unknown status|Recruiting|N/A|500||Stanford University|||||f||||||||||||||2017-02-18 14:18:01.461799|2017-02-18 14:18:01.461799
NCT00691522|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2009-01-08|||November 2008||2008-11-01|January 2009|2009-01-01|October 2009|Anticipated|2009-10-01|August 2009|Anticipated|2009-08-01||Interventional|||Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)|Open-Label, Imaging Study of Human Corticotropin-Releasing Factor (hCRF) for The Reduction of Peritumoral Brain Edema (PBE) in Patients With Primary Malignant or Metastatic Brain Tumors|Terminated||Phase 2|60|Anticipated|PharmaNet||1|||t||||f||||||||||2017-02-18 14:18:01.545759|2017-02-18 14:18:01.545759
NCT00691509|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2013-08-23|||January 2005||2005-01-01|June 2008|2008-06-01||||December 2010|Anticipated|2010-12-01||Observational|||Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer|The Role of Diet, Complementary Treatment and Lifestyle in Breast Cancer Survival|Unknown status|Recruiting|N/A|2300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:18:01.639219|2017-02-18 14:18:01.639219
NCT00691496|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-06-12|||May 2008||2008-05-01|June 2012|2012-06-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With Men|A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With Men|Completed||N/A|326|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 14:18:01.745012|2017-02-18 14:18:01.745012
NCT00691483|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-10-16|2010-09-09||September 2008||2008-09-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date|A Phase 4, Prospective, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate Smoking Cessation With Varenicline Tartrate Compared With Placebo In The Setting Of Patient Self-Selected (Flexible) Quit Date|Completed||Phase 4|659|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:18:01.854734|2017-02-18 14:18:01.854734
NCT00691470|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-02-01|||May 2008||2008-05-01|October 2008|2008-10-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|EmbraceAC||Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation|A Randomized, Double Blind Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation|Unknown status|Active, not recruiting|Phase 2/Phase 3|600|Anticipated|ARYx Therapeutics||2|||f||||t||||||||||2017-02-18 14:18:02.412805|2017-02-18 14:18:02.412805
NCT00691457|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-09-28|||April 2008||2008-04-01|June 2009|2009-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Comparison of 3 Novel Contact Lens Solutions on the Basal Lamina|Comparison of 3 Novel Contact Lens Solutions on the Basal Lamina|Completed||N/A|15|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 14:18:02.563103|2017-02-18 14:18:02.563103
NCT00691418|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-03-04|||July 2008||2008-07-01|March 2015|2015-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Docosahexaenoic Acid (DHA) Administration and Length of Gestation: a Feasibility Study|DHA Administration and Length of Gestation: a Feasibility Study|Withdrawn||N/A|0|Actual|Kaiser Permanente||2||decision made not to proceed -- no subjects were ever enrolled|f||||f||||||||||2017-02-18 14:18:02.863435|2017-02-18 14:18:02.863435
NCT00691405|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-02-21|||October 2003||2003-10-01|February 2012|2012-02-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Double-blind, Randomized, Multicenter, Two-part Parallel-group, Dose-ranging Study of Twice-daily and Once-daily (R,R) Formoterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|215|Actual|Sunovion||8|||f||||f||||||||||2017-02-18 14:18:02.966971|2017-02-18 14:18:02.966971
NCT00691392|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-08-15|||April 2009||2009-04-01|August 2012|2012-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|S30PK||Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)|Linezolid Pharmacokinetics and Pharmacodynamics in the Treatment of Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis|Completed||Phase 1/Phase 2|26|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 14:18:03.124085|2017-02-18 14:18:03.124085
NCT00691379|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-09-21|||April 2008||2008-04-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer|Weekly Paclitaxel-carboplatin Plus Bevacizumab as First Line Therapy for Patients With Triple Negative (ER-,PR-,HER2-) Metastatic Breast Cancer. A Multicenter Phase I-II Study|Completed||Phase 1/Phase 2|46|Actual|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 14:18:03.241504|2017-02-18 14:18:03.241504
NCT00691366|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-08-08|||March 2007||2007-03-01|June 2008|2008-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis|Autonomic Nervous System Physiology and Chronic Pruritus: A Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis|Completed||N/A|45|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 14:18:03.361201|2017-02-18 14:18:03.361201
NCT00691353|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-12-02|||April 2008||2008-04-01|December 2008|2008-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|DIDAXI||Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers|Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers|Completed||N/A|540|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:18:03.444445|2017-02-18 14:18:03.444445
NCT00691340|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-03-09|||June 2008||2008-06-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease|Systematic Characterization of the Cellular Proteome From Human Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease|Withdrawn||N/A|0|Actual|University Hospital, Basel, Switzerland|||4|was replaced by another study. Problems with recruitment.|f||||f||||||None Retained|"~     plasma~   "|||2017-02-18 14:18:03.543558|2017-02-18 14:18:03.543558
NCT00691327|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-10-06|2013-12-30||December 1997||1997-12-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants|Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants|Completed||N/A|84329|Actual|Allergan||3|||f||||f||||||||||2017-02-18 14:18:03.623883|2017-02-18 14:18:03.623883
NCT00691314|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-12|2011-02-23|||June 2008||2008-06-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|ESSCAS||Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis|Safety and Efficacy of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis|Completed||N/A|300|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-02-18 14:18:04.086929|2017-02-18 14:18:04.086929
NCT00691301|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2015-05-27|||September 2008||2008-09-01|May 2015|2015-05-01||||July 2014|Actual|2014-07-01||Interventional|||Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer|A Limited Access Phase II Trial of Pemetrexed (Alimta, LY231514) (NSC #698037) in Combination With Cisplatin (NSC #119875) in the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix|Completed||Phase 2|55|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 14:18:04.198588|2017-02-18 14:18:04.198588
NCT00691288|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-06-10|||June 2008||2008-06-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|October 2011|Actual|2011-10-01||Interventional|||Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children|Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children Taking Highly Active Antiretroviral Therapy (HAART): a Randomized Cross-over Study|Terminated||Phase 2|13|Actual|The Hospital for Sick Children||2||Unable to enroll sufficient patients|f||||f||||||||||2017-02-18 14:18:04.31823|2017-02-18 14:18:04.31823
NCT00691275|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-07-13|||September 2008||2008-09-01|July 2015|2015-07-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration|Ondansetron vs. Placebo in the Management of Children With Dehydration Due to Acute Gastroenteritis|Withdrawn||N/A|0|Actual|Children's Hospitals and Clinics of Minnesota||2|||f||||f||||||||||2017-02-18 14:18:04.432284|2017-02-18 14:18:04.432284
NCT00691262|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-08-29|||October 2003||2003-10-01|August 2014|2014-08-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis|A Long Term, Non-comparative, Multi-centre Study to Further Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis.|Completed||Phase 3|166|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 14:18:04.533678|2017-02-18 14:18:04.533678
NCT00691249|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2009-06-30|||May 2008||2008-05-01|May 2008|2008-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Resistant Starch on Glucose and Insulin Sensitivity in Individuals With Type 2 Diabetes|Resistant Starch on Glucose and Insulin Sensitivity in Individuals With Type 2 Diabetes|Completed||N/A|10|Actual|Kansas State University||5|||f||||f||||||||||2017-02-18 14:18:04.654833|2017-02-18 14:18:04.654833
NCT00691236|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2011-06-22|||May 2008||2008-05-01|June 2011|2011-06-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|ZOL||Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma|Evaluation of Zoledronic Acid as a Single Agent and as an Adjuvant to Chemotherapy in the Management of High Grade Osteosarcoma|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|Tata Memorial Hospital||3|||f||||t||||||||||2017-02-18 14:18:04.781401|2017-02-18 14:18:04.781401
NCT00691223|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-11-21|||June 2007||2007-06-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Study of Selected X-linked Disorders: Goltz Syndrome|Pathogenesis of Focal Dermal Hypoplasia or Goltz Syndrome and Related Disorders|Recruiting||N/A|300|Anticipated|Baylor College of Medicine|||1||f||||f||||||Samples With DNA|"~     lymphoblast DNA; tissue~   "|Yes|Deidentified patient data will be published following peer review in journals and/or presented at scientific meetings.|2017-02-18 14:18:04.887275|2017-02-18 14:18:04.887275
NCT00691210|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-08-09|2014-03-07||June 2008||2008-06-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|February 2014|Actual|2014-02-01||Interventional|SAHA||Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies|Phase I Study of Vorinostat in Combination With Niacinamide, and Etoposide for the Treatment of Patients With Relapsed and Refractory Lymphoid Malignancies|Completed||Phase 1|38|Actual|Columbia University||8|||f||||t||||||||No||2017-02-18 14:18:05.18129|2017-02-18 14:18:05.18129
NCT00691197|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2015-06-26|2009-11-06||March 2008||2008-03-01|June 2015|2015-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear|Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear|Completed||Phase 2/Phase 3|246|Actual|Allergan||2|||f||||f||||||||||2017-02-18 14:18:07.799919|2017-02-18 14:18:07.799919
NCT00691184|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-03|||February 2005||2005-02-01|June 2008|2008-06-01|December 2005|Actual|2005-12-01|June 2005|Actual|2005-06-01||Interventional|||Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis|A Double-Blind, Randomized, Parallel Design Study To Assess the Safety and Pharmacokinetics of Terbinafine Hydrogen Cloride (HCl) Nail Lacquer Applied for 28 Days in Patients With Onychomycosis|Completed||Phase 1|56|Actual|NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)||4|||f||||||||||||||2017-02-18 14:18:08.179092|2017-02-18 14:18:08.179092
NCT00691171|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2015-04-14|||January 2007||2007-01-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use|Using an Electronic Health Record-based Intervention and Broad Education Reach Strategies to Improve Quality of Care for GERD and Gastroprotection for Patients on NSAIDs: a Randomized Controlled Trial|Completed||N/A|5234|Actual|AstraZeneca|||3||f||||f||||||||||2017-02-18 14:18:08.291321|2017-02-18 14:18:08.291321
NCT00691158|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-06-04|||January 2006||2006-01-01|June 2012|2012-06-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide|A Pilot Study of the fMRI Response to Leptin and Pramlintide|Unknown status|Active, not recruiting|N/A|10|Anticipated|Oregon Health and Science University||4|||f||||t||||||||||2017-02-18 14:18:08.385717|2017-02-18 14:18:08.385717
NCT00691145|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-08-28|||October 2002||2002-10-01|August 2014|2014-08-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis|A Long-term, Non-comparative, Multi-centre Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus (FK506) Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis FG-506-06-IT-01|Completed||Phase 3|350|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 14:18:08.504512|2017-02-18 14:18:08.504512
NCT00691132|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-08-29|||February 2009||2009-02-01|August 2012|2012-08-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers|Randomized Trial of PEITC as a Modifier of NNK Metabolism in Smokers|Unknown status|Recruiting|Phase 2|120|Anticipated|Masonic Cancer Center, University of Minnesota||4|||f||||t||||||||||2017-02-18 14:18:08.65496|2017-02-18 14:18:08.65496
NCT00691119|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2013-05-08|||December 2008||2008-12-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Relaxation and Visualization Therapy for Breast Cancer Patients|A Feasibility Study of Relaxation and Visualization Therapy for Breast Cancer Patients|Terminated||N/A|9|Anticipated|National College of Natural Medicine||3||Inadequate recruitment|f||||f||||||||||2017-02-18 14:18:08.771014|2017-02-18 14:18:08.771014
NCT00691093|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2011-02-16|2010-03-15||July 2008||2008-07-01|February 2011|2011-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy|Observational Study In Patients With Overactive Bladder (OAB) Treated With Toviaz® After Failure Of Previous Antimuscarinic Therapy Due To Ineffectivity Or Intolerance.|Completed||Phase 4|823|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:18:08.888009|2017-02-18 14:18:08.888009
NCT00691080|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-01-12|||September 2007||2007-09-01|January 2016|2016-01-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Observational|REST||Understanding Sleep Problems in Children With Autism Spectrum Disorder|Characterization of Endogenous Melatonin Profiles in Children With Autism Spectrum Disorder.|Completed||Phase 2/Phase 3|58|Actual|Baylor College of Medicine|||2||f||||t||||||None Retained|"~     SAMPLE: Saliva What is the purpose of the sample collection? Determination of dim light~     melatonin onset (DMLO), as measured by salivary melatonin secretion.~      SAMPLE: Urine What is the purpose of the sample collection? Measurement of secreted~     6-suplhatoxymaltonin, a metabolite of melatonin.~   "|||2017-02-18 14:18:12.066862|2017-02-18 14:18:12.066862
NCT00691067|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2017-01-30|||May 2008||2008-05-01|January 2017|2017-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness|A Randomized, Double-blind Placebo-controlled Crossover Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness|Completed||Phase 4|65|Actual|Bronx Veterans Medical Research Foundation, Inc||2|||f||||t||||||||||2017-02-18 14:18:12.183636|2017-02-18 14:18:12.183636
NCT00690703|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-04|||July 2001||2001-07-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|RAPTURE||Radiofrequency Ablation of Pulmonary Tumors Response Evaluation|Radiofrequency Ablation of Pulmonary Tumors Response Evaluation: a Prospective, Intention-to-Treat, Multicenter Clinical Trial|Completed||Phase 2|106|Actual|Angiodynamics, Inc.||1|||f||||f||||||||||2017-02-18 14:18:18.617365|2017-02-18 14:18:18.617365
NCT00691054|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-12-14|2013-09-03||June 2008||2008-06-01|December 2016|2016-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Did Not Respond to First-Line Therapy With Gemcitabine|Phase II Trial of Abraxane® in the Treatment of Patients With Pancreatic Cancer Who Have Failed First-Line Treatment With Gemcitabine-Based Therapy|Completed||Phase 2|20|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 14:18:12.274192|2017-02-18 14:18:12.274192
NCT00691041|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-06-12|||August 2008||2008-08-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|UDP||A Network Intervention for Reducing Sexual Risk for HIV With African American Men Who Have Sex With Men (AA MSM)|A Network Intervention for Reducing Sexual Risk for HIV With African American Men Who Have Sex With Men (AA MSM)|Completed||N/A|233|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 14:18:12.796809|2017-02-18 14:18:12.796809
NCT00691028|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-01-30|2013-01-29||September 2005||2005-09-01|January 2014|2014-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis|Clinical Study to Assess the Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis|Completed||Phase 3|327|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-02-18 14:18:12.927845|2017-02-18 14:18:12.927845
NCT00691015|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2012-08-06|||May 2008||2008-05-01|August 2012|2012-08-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant|A Phase II Study of Sirolimus, Tacrolimus and Thymoglobulin®, as Graft-versus-Host- Disease Prophylaxis in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplantation|Unknown status|Active, not recruiting|Phase 2|48|Actual|Barbara Ann Karmanos Cancer Institute||6|||f||||t||||||||||2017-02-18 14:18:13.957369|2017-02-18 14:18:13.957369
NCT00691002|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2013-11-08|||May 2008||2008-05-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds|Calcipotriol Plus Hydrocortisone in Psoriasis Vulgaris on the Face and on the Intertriginous Areas|Completed||Phase 3|1245|Actual|LEO Pharma||4|||f||||f||||||||||2017-02-18 14:18:14.100742|2017-02-18 14:18:14.100742
NCT00690989|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-03-31|||July 2005||2005-07-01|March 2015|2015-03-01|June 2009|Actual|2009-06-01|June 2007|Actual|2007-06-01||Observational|||Retrospective Evaluation of Patient Failure to Follow-up at a Community Based Headache Clinic|If You Build it, They Will Come; But Will They Return for Follow-up? A Retrospective Assessment of Potential Risk Factors for Patient Failure to Follow-up at a Community Based Headache Clinic|Completed||N/A|200|Actual|Kilgo Headache Clinic|||1||f||||f||||||||||2017-02-18 14:18:14.206524|2017-02-18 14:18:14.206524
NCT00690976|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-03-10|||July 2008||2008-07-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Proyecto SOL: A Risk Reduction Intervention for Hispanic Men Who Have Sex With Men (MSM)|Proyecto SOL: A Risk Reduction Intervention for Hispanic MSM|Completed||N/A|220|Anticipated|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 14:18:14.27556|2017-02-18 14:18:14.27556
NCT00690963|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-04-05|||September 2008||2008-09-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|September 2016|Anticipated|2016-09-01||Interventional|||Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating|A Phase I/II Dose Escalation Trial Using Hypofractionation With Individualized Differential Boosting With Respiratory Gated Intensity-modulated Radiation Therapy (IMRT) in the Treatment of Non-small Cell Lung Cancer.|Active, not recruiting||Phase 1/Phase 2|12|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 14:18:14.366701|2017-02-18 14:18:14.366701
NCT00690950|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-04|||May 2008||2008-05-01|June 2008|2008-06-01||||July 2009|Anticipated|2009-07-01||Interventional|||A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart|Switch Study: Are There Any Measurable Differences When Switching Patients on Finasteride Therapy to Dutasteride?|Unknown status|Enrolling by invitation|Phase 4|50|Anticipated|Urologic Consultants of Southeastern PA||1|||f||||t||||||||||2017-02-18 14:18:14.458293|2017-02-18 14:18:14.458293
NCT00690937|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-03-17|||February 2008||2008-02-01|March 2014|2014-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|Sevelamer ECS||A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia|A Multicenter, Single-blind, Active and Placebo-controlled, Parallel-group, Randomized Study of Two Dosing Regimens of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesterolemia|Completed||Phase 2|120|Actual|Sanofi||5|||f||||f||||||||||2017-02-18 14:18:14.547927|2017-02-18 14:18:14.547927
NCT00690924|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2016-12-09|||July 2008||2008-07-01|December 2016|2016-12-01||||December 2017|Anticipated|2017-12-01||Interventional|||Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer|A Pilot Study of Oral Calcitriol in Patients at High Risk for Lung Cancer|Recruiting||N/A|40|Anticipated|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 14:18:14.884847|2017-02-18 14:18:14.884847
NCT00690911|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2017-01-24||||||January 2017|2017-01-01||||||||Interventional|||Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis|A Phase II, Multi-Center, Open Label Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis (HUM 04-36)|Withdrawn||Phase 2|0|Actual|Wake Forest University Health Sciences||1||"Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the~   study started."|f||||f||||||||||2017-02-18 14:18:14.999125|2017-02-18 14:18:14.999125
NCT00690898|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2014-02-27|2013-11-04||May 2008||2008-05-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|PRIMARYS||Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma|Phase IIIb, Multicentre, Open-label, Single-arm, Study to Assess the Efficacy and Safety of Lanreotide Autogel 120 mg Administered Every 28 Days as Primary Medical Treatment in Acromegalic Patients With Macroadenoma|Completed||Phase 3|108|Actual|Ipsen||1|||f||||t||||||||||2017-02-18 14:18:15.117546|2017-02-18 14:18:15.117546
NCT00690690|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-03-08|||June 2008||2008-06-01|March 2010|2010-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks|No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks|Completed||Phase 2/Phase 3|370|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 14:18:18.740494|2017-02-18 14:18:18.740494
NCT00690885|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-04-20|||June 2008||2008-06-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis|Evaluation of Natural Human Interferon Alpha Lozenges in the Treatment of Chronic Cough in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Idiopathic Pulmonary Fibrosis (IPF)|Terminated||Phase 2|1|Actual|Amarillo Biosciences, Inc.||2||Insufficient patient accrual|f||||f||||||||||2017-02-18 14:18:15.695271|2017-02-18 14:18:15.695271
NCT00690872|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-04|2009-06-26|||July 2008||2008-07-01|June 2009|2009-06-01||||December 2014|Anticipated|2014-12-01||Interventional|||Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer|Phase II Trial Evaluating Efficacy of a Strategy Employing Combination Gemcitabine and Carboplatin Chemotherapy Followed by EBV-Specific Cytotoxic T-Lymphocytes in Patients With Metastatic or Locally Recurrent EBV-Positive Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:18:15.821094|2017-02-18 14:18:15.821094
NCT00690859|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2009-05-28|||June 2007||2007-06-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|PREBIS||Predictors of Recurrence in Bipolar Disorder in Spain|Evaluation of Predictor Factors of Recurrence in Bipolar Disorder in Spain|Completed||N/A|595|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:18:15.920664|2017-02-18 14:18:15.920664
NCT00690846|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2015-12-14||||||December 2015|2015-12-01||||||||Interventional|||Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum|A Multi-Center, Open Label Pilot Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum (HUM 04-37)|Withdrawn||Phase 2|0|Actual|Wake Forest University Health Sciences||1||"Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the~   study started."|f||||f||||||||||2017-02-18 14:18:16.053639|2017-02-18 14:18:16.053639
NCT00690833|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-03-24|||August 2007||2007-08-01|June 2008|2008-06-01|November 2009|Actual|2009-11-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis|Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis|Completed||Phase 4|41|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 14:18:16.173808|2017-02-18 14:18:16.173808
NCT00690820|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-05-26|2009-11-30||June 2008||2008-06-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)|A Double-blind, Randomized, Multi-center, Placebo-controlled, Cross-over Study to Assess the Efficacy and Safety of Pancrelipase Delayed Release 12,000 Unit Capsules in Subjects Aged 7 - 11 With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|Completed||Phase 3|17|Actual|Solvay Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:18:16.382674|2017-02-18 14:18:16.382674
NCT00690807|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2009-09-24|||June 2008||2008-06-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis|A Phase 2 Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Atopic Dermatitis|Completed||Phase 2|30|Anticipated|Provectus Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:18:16.883095|2017-02-18 14:18:16.883095
NCT00690794|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-07-20|2012-03-30||July 2008||2008-07-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension|An Evaluation of the Ocular Surface Health in Subjects Using TRAVATAN Z® Ophthalmic Solution Versus XALATAN® Ophthalmic Solution|Completed||Phase 3|726|Actual|Alcon Research|The subjective nature of the OSDI may not be sensitive enough to detect the effects of preservatives on the corneal surface. The measurement and quantification of OSD remains a considerable clinical challenge. (Pflugfelder and Baudoin, 2011)|2|||f||||f||||||||||2017-02-18 14:18:16.984365|2017-02-18 14:18:16.984365
NCT00690781|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2011-01-26|||May 2008||2008-05-01|January 2011|2011-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SURPROL-CF-H||Protein Nutrition During Weight Loss|Effect of Milk Proteins and Protein Feeding Pattern on Body Composition and Protein Metabolism in Energy Restricted Obese Subjects|Completed||N/A|48|Anticipated|Institut National de la Recherche Agronomique||4|||f||||f||||||||||2017-02-18 14:18:17.478308|2017-02-18 14:18:17.478308
NCT00690768|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-06-03|||March 2008||2008-03-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|IBETRA||Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)|Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV for Diabetic Tractional Retinal Detachment (IBETRA Study)|Completed||Phase 2|20|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 14:18:17.607148|2017-02-18 14:18:17.607148
NCT00690755|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2016-04-12|2015-05-22||May 2000||2000-05-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome|Defective Atypical PKC Activation in Diabetes and Metabolic Syndrome|Completed||N/A|157|Actual|VA Office of Research and Development|As the study progressed, it was determined that there was not scientific merit to the Groups 2, 5 or 7. These groups were, therefore, not pursued.||7||f||||t||||||None Retained|"~     Muscle biopsies taken before and after insulin stimulation in euglycemic clamp studies~   "|No|Individual participant data will not be shared, as data is presented in the published paper as a mean plus or minus SEM.|2017-02-18 14:18:17.723604|2017-02-18 14:18:17.723604
NCT00690742|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-04|||May 2008||2008-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:18:18.311803|2017-02-18 14:18:18.311803
NCT00690729|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2010-08-26|||July 2005||2005-07-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|March 2010|Actual|2010-03-01||Interventional|||Cognitive-Behavioral Bibliotherapy for the Treatment of Obsessive Compulsive Disorder in Children and Adolescents|Cognitive-Behavioral Treatment of Obsessive Compulsive Disorder in Children and Adolescents|Completed||N/A|22|Actual|UConn Health||2|||f||||f||||||||||2017-02-18 14:18:18.36461|2017-02-18 14:18:18.36461
NCT00690716|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2012-08-06||2010-08-17|August 2008||2008-08-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Nasal Carbon Dioxide in the Treatment of Mild Headache in Migraineurs|Completed||Phase 2|292|Actual|Capnia, Inc.||2|||f||||f||||||||||2017-02-18 14:18:18.480241|2017-02-18 14:18:18.480241
NCT00690664|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2017-01-24|||April 24, 2007|Actual|2007-04-24|January 2017|2017-01-01|July 14, 2014|Actual|2014-07-14|July 14, 2014|Actual|2014-07-14||Observational|||Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair|Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair|Completed||N/A|60|Actual|Wake Forest University Health Sciences|||2||f||||f||||||Samples With DNA|"~     Hair, both broken strands and those that release from the scalp with bulb intact.~   "|No||2017-02-18 14:18:18.952659|2017-02-18 14:18:18.952659
NCT00690651|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-06-08|||July 2008||2008-07-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Rest Easy: Is Bed Rest Really Necessary After Surgical Repair of an Ankle Fracture?|Randomized Controlled Study Into Early Mobilization Following Internal Fixation of Isolated Ankle Fractures.|Completed||N/A|104|Actual|The Alfred||2|||f||||t||||||||||2017-02-18 14:18:19.034772|2017-02-18 14:18:19.034772
NCT00690638|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-04-12|||July 2008||2008-07-01|January 2010|2010-01-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|480|Anticipated|Phenomix||3|||f||||f||||||||||2017-02-18 14:18:19.141978|2017-02-18 14:18:19.141978
NCT00690625|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2008-12-08|||April 2008||2008-04-01|December 2008|2008-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Topical Application of MyoRx (Omega 3 Fatty Acids Containing) Cream|Topical Application of MyoRx (Omega 3 Fatty Acids Containing) Cream; Randomized Double Blind Clinical Trial|Completed||Phase 1|40|Anticipated|University of Washington||2|||f||||f||||||||||2017-02-18 14:18:19.286203|2017-02-18 14:18:19.286203
NCT00690612|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2011-07-07|2010-08-31||September 2007||2007-09-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|HIP||Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)|An Open-label Extension Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects Ages 1 to <11 Years: a Long Term Study|Completed||Phase 3|35|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 14:18:19.399224|2017-02-18 14:18:19.399224
NCT00690599|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-06-03|||April 2006||2006-04-01|May 2008|2008-05-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Observational|Satisfaction||Socioeconomic Profile and Patient Satisfaction Assessment|Socioeconomic Profile and Patient Satisfaction Assessment in an Academic Dental General Clinic|Completed||N/A|80|Anticipated|Fortaleza University|||1||f||||t||||||||||2017-02-18 14:18:19.74198|2017-02-18 14:18:19.74198
NCT00690586|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-06-07|||December 2007||2007-12-01|June 2008|2008-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Fluid Balance, Hormones and Urine Proteomics in Nephrotic Syndrome in Childhood|Fluid Balance, Hormones and Urine Proteomics in Nephrotic Syndrome in Childhood|Completed||N/A|21|Actual|Aarhus University Hospital|||1||f||||f||||||Samples With DNA|"~     Whole blood samples for hormone analyzes Urine samples for urine protomis, AQP II and ENaC~   "|||2017-02-18 14:18:19.820727|2017-02-18 14:18:19.820727
NCT00690573|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-09-05|2011-03-04||May 2008||2008-05-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|March 2010|Actual|2010-03-01||Interventional|||Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis|A Multicenter, Open-label Study of the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis|Completed||Phase 3|25|Actual|Abbott||1|||f||||f||||||||||2017-02-18 14:18:19.925185|2017-02-18 14:18:19.925185
NCT00690560|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2015-02-08|||May 2007||2007-05-01|February 2015|2015-02-01|October 2010|Actual|2010-10-01|March 2010|Actual|2010-03-01||Interventional|||Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma|International Phase II Study Evaluating the Association of CHOP-rituximab With Consolidation by Early Ibritumomab Tiuxetan-Y90 in Patients Aged 65 to 80 Years With CD20+ Large Cell Malignant Lymphoma and no Prior Therapy|Completed||Phase 2|30|Actual|Centre Antoine Lacassagne||1|||f||||||||||||||2017-02-18 14:18:20.484039|2017-02-18 14:18:20.484039
NCT00690547|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2009-11-27|||October 2008||2008-10-01|November 2009|2009-11-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Observational|||Force Enhancement of Musculus Quadriceps Femoris During and After Excentric Muscle Activity in Vivo|Force Enhancement of m. Quadriceps Femoris During and After Excentric Muscle Activity in Vivo by Maximal and Sub-maximal Deliberately Activation.|Unknown status|Active, not recruiting|N/A|60|Anticipated|German Research Foundation|||1||f||||f||||||||||2017-02-18 14:18:20.599387|2017-02-18 14:18:20.599387
NCT00690534|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-12-08|||September 2005||2005-09-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Insulin and Sarcopenia in the Elderly|Insulin and Sarcopenia in the Elderly|Completed||Phase 1|88|Actual|The University of Texas Medical Branch, Galveston||11|||f||||f||||||||No|No sharing. Drug was used off label for collection of measures for research project.|2017-02-18 14:18:20.706665|2017-02-18 14:18:20.706665
NCT00690521|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2008-06-03|||January 2003||2003-01-01|June 2008|2008-06-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients|A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients|Unknown status|Recruiting|Phase 4|13|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-02-18 14:18:20.850804|2017-02-18 14:18:20.850804
NCT00690508|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-06-02|||June 2008||2008-06-01|June 2008|2008-06-01|January 2010|Anticipated|2010-01-01|December 2009|Anticipated|2009-12-01||Interventional|SSTTP||Validation of Supra-Sternal Tube-Tip Palpation|Validation of Supra-Sternal Tube-Tip Palpation (SSTTP): A Method to Identify Correct Depth of Intubation in Infants and Children|Unknown status|Recruiting|N/A|150|Anticipated|University of Ottawa||1|||f||||f||||||||||2017-02-18 14:18:20.961797|2017-02-18 14:18:20.961797
NCT00690495|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-01-02|2011-08-17||May 2008||2008-05-01|January 2012|2012-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Use of a Modified Propofol Emulsion in Adults|Prospective, Monocentric Controlled, Randomized, Double-blind Study to Compare the Two Different Propofol Emulsions Regarding Tolerability and Injection Pain During the Induction of Anesthesia in Adults|Completed||Phase 3|100|Actual|B. Braun Melsungen AG||2|||f||||f||||||||||2017-02-18 14:18:21.052626|2017-02-18 14:18:21.052626
NCT00269347|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2005-12-22|||January 2001||2001-01-01|December 2005|2005-12-01|April 2005||2005-04-01|||||Interventional|||Manipulation, Exercise, and Self-Care for Low Back Pain|Manipulation, Exercise, and Self-Care for Low Back Pain|Completed||Phase 2|300||Northwestern Health Sciences University|||||f||||||||||||||2017-02-18 16:52:28.073801|2017-02-18 16:52:28.073801
NCT00690482|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-12-13|2013-07-01||May 2008||2008-05-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|Columbus|One patient randomised to placebo withdrew consent immediately after the first dose of investigational product on the day of randomisation. No clinical measurements were performed and no reports of AEs were received for this patient. Since the patient is non-informative both in terms of efficacy and safety, he has been excluded from the analyses.|Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A 4 Week Double-blind, Placebo-controlled, Randomized, Parallel Group Phase IIa Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|118|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:21.43448|2017-02-18 14:18:21.43448
NCT00690469|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2016-04-07|||June 2008||2008-06-01|April 2016|2016-04-01||||January 2100|Anticipated|2100-01-01||Observational|||Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers|Carcinogen Metabolism, DNA Repair, Parental Exposures and Retinoblastoma|Active, not recruiting||N/A|245|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"~     saliva samples, blood and tumor samples if enrolled on ARET0332~   "|||2017-02-18 14:18:22.035721|2017-02-18 14:18:22.035721
NCT00690456|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-04-18||2016-04-18|May 2008||2008-05-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|TOCCATA||Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes|A Randomized, Double Blind, Placebo Controlled Study Evaluating the Glycemic Effect of Rimonabant Added to Metformin in Patients With Type 2 Diabetes Insufficiently Controlled With Metformin Monotherapy|Terminated||Phase 3|403|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 14:18:22.191329|2017-02-18 14:18:22.191329
NCT00690443|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2013-04-04|2013-01-18||May 2008||2008-05-01|April 2013|2013-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia|A Randomized, Double Blind Comparator-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of the Combination of AEGR-733 and Atorvastatin 20 mg vs Atorvastatin Monotherapy in Subjects With Moderate Hypercholesterolemia|Completed||Phase 2|44|Actual|Aegerion Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 14:18:22.323105|2017-02-18 14:18:22.323105
NCT00690430|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-06-25|2013-04-05||April 2008||2008-04-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease|A Multicenter, Randomized, Blinded Efficacy and Safety Study of Pasireotide LAR vs Octreotide LAR in Patients With Metastatic Carcinoid Tumors Whose Disease-related Symptoms Are Inadequately Controlled by Somatostatin Analogues.|Completed||Phase 3|186|Actual|Novartis||2|||f||||t||||||||||2017-02-18 14:18:22.940014|2017-02-18 14:18:22.940014
NCT00690417|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2011-11-23|||August 2007||2007-08-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Vitamin D Inadequacy in Rural Populations, Evaluation of Correction by Food Supplementation|Vitamin D Inadequacy: Documentation in Rural Populations and Evaluation of Correction by Food Supplementation (Phase III; Manitowoc Prevalence Study)|Completed||N/A|108|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 14:18:24.945693|2017-02-18 14:18:24.945693
NCT00690404|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-12-08|||April 2008||2008-04-01|December 2010|2010-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||AZD 2066 Single Dose Formulation and Food Effect Study in Healthy Volunteers|A Phase 1, Single-center, Randomized, Open-label, Two-way Crossover, Formulation and Food Effect Study in Healthy Volunteers, to Assess the Pharmacokinetics of AZD 2066 After Single Doses of a New Oral Solid Formulation and an Oral Solution|Completed||Phase 1|20|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:18:25.042731|2017-02-18 14:18:25.042731
NCT00690391|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-05-30|||May 2008||2008-05-01|May 2008|2008-05-01|May 2013|Anticipated|2013-05-01|May 2009|Anticipated|2009-05-01||Observational|||Analysis of Palliative Surgery in View of Quality of Life and Prognosis|Analysis of Palliative Surgery in View of Quality of Life and Prognosis|Unknown status|Recruiting|N/A|250|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-02-18 14:18:25.121121|2017-02-18 14:18:25.121121
NCT00690378|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2011-08-18|||November 2008||2008-11-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections|Prospective, Multicenter, Investigator-blinded, Randomized, Comparative Study Estimate Safety, Tolerability, Efficacy of NXL104/Ceftazidime vs. Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults|Completed||Phase 2|150|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:25.211326|2017-02-18 14:18:25.211326
NCT00690365|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-12-08|||June 2007||2007-06-01|December 2010|2010-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|Q-chase||Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia|A Non-interventional, Open Label, Phase IV Observational Study for the Safety and Efficacy of Switching to Quetiapine (Seroquel) in Outpatients With Schizophrenia Who Have Been Unsuccessfully Treated With Other Antipsychotics|Completed||N/A|576|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:18:25.356461|2017-02-18 14:18:25.356461
NCT00690352|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-05-30|||March 2008||2008-03-01|May 2014|2014-05-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Observational|SSAS||Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders|Comparing Recidivism Rates of Felony Drug Offenders in Nebraska Who Were Sentenced to, and/or Participated in, Specialized Substance Abuse Supervision (SSAS) to Those Without SSAS|Completed||N/A|344|Actual|University of Nebraska|||1||f||||f||||||||||2017-02-18 14:18:25.431802|2017-02-18 14:18:25.431802
NCT00690339|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2014-10-06|2013-12-17||February 2001||2001-02-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Effectiveness of Style 410 Silicone-Filled Breast Implant Study||Completed||N/A|941|Actual|Allergan||4|||f||||||||||||||2017-02-18 14:18:25.547908|2017-02-18 14:18:25.547908
NCT00690326|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2008-06-03|||May 2006||2006-05-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|July 2006|Actual|2006-07-01||Interventional|BCC||Behavioral Change Communication (BCC) to Promote Physical Activity Among Females With Type 2 Diabetes Mellitus Attending Diabetic Clinic|Behavioral Change Communication to Promote Physical Activity Among Females With Type 2 Diabetes Mellitus Attending Diabetic Clinic.|Completed||N/A|86|Actual|Thiruvananthapuram Medical College||2|||f||||t||||||||||2017-02-18 14:18:26.147049|2017-02-18 14:18:26.147049
NCT00690313|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-06-03|||July 2008||2008-07-01|May 2008|2008-05-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|||Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections|To Compare the Efficacy of Topical Vigamox Eye Drops at Tid 3 Days Prior to Intravitreal Injection Versus Tid 1 Day Prior to Intravitreal Injection|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Illinois Retina Associates||2|||f||||||||||||||2017-02-18 14:18:26.257997|2017-02-18 14:18:26.257997
NCT00690300|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-03-02|||January 2008||2008-01-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer|Phase II Study: Docetaxel Plus Oxaliplatin as Second-line Therapy in Patients With Advanced Metastatic Pancreatic Cancer|Unknown status|Recruiting|Phase 2|44|Anticipated|University of Ulm||1|||f||||t||||||||||2017-02-18 14:18:26.353737|2017-02-18 14:18:26.353737
NCT00690287|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-01-10|||February 2008||2008-02-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients|A Dose-Ranging Study to Evaluate Fasting and Postprandial P-Glucose, Safety and Tolerability After Oral Single, B.I.D and Q.I.D Dosing of AZD6370 in Patients With Diabetes Mellitus: a Randomized, Single-Blind, Placebo-Controlled, Phase I Study|Completed||Phase 1|24|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:18:26.462064|2017-02-18 14:18:26.462064
NCT00690274|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-08-15|||June 2008||2008-06-01|June 2010|2010-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study to Demonstrate Cognitive Enhancing Effects of BF2.649|A Randomized, Double Blind, Placebo Controlled, Study to Demonstrate the Cognitive Enhancing Effects of BF2.649 in People With Schizophrenia and Schizoaffective Disorder|Completed||Phase 2|52|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 14:18:26.568109|2017-02-18 14:18:26.568109
NCT00690261|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-01|2008-06-03|||September 2007||2007-09-01|May 2008|2008-05-01|August 2010|Anticipated|2010-08-01|||||Observational|||The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction|The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples Without DNA|"~     Pleural effusions and lung cancer tissue~   "|||2017-02-18 14:18:26.670792|2017-02-18 14:18:26.670792
NCT00690248|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-12-07|||November 2007||2007-11-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Observational|MM1||Depressive Symptoms in Acute Manic Episode|Prevalence of Depressive Symptoms in Manic Episodes of Bipolar Patients: an Observational Study|Completed||N/A|250|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:18:26.76147|2017-02-18 14:18:26.76147
NCT00690235|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-27|2012-06-21|||November 2007||2007-11-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Effects of Pramlintide on Weight Reduction in Clozapine- and Olanzapine-Induced Weight Gain in Obese People Diagnosed With Schizophrenia|Completed||Phase 4|33|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 14:18:26.889997|2017-02-18 14:18:26.889997
NCT00690222|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2015-03-24|||March 2008||2008-03-01|May 2008|2008-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery|A Comparison of Intracameral Phenylephrine 2% and Tropicamide 0.2% With Topical Phenylephrine 2.5% and Tropicamide 1% for Pupillary Dilation During Cataract Surgery on Patients With and Without Pseudoexfoliation Syndrome.|Terminated||N/A|80|Actual|Nova Scotia Health Authority||4||Funding|f||||f||||||||||2017-02-18 14:18:26.999519|2017-02-18 14:18:26.999519
NCT00690209|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2014-07-04|||May 2008||2008-05-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||By Pass Surgery With Stem Cell Therapy in Chronic Ischemic Cardiopathy|Efficacy of Surgical Coronary Revascularization Associated With Stem Cells Injection in Patients With Severe Chronic Ischemic Heart Disease With Residual Viability. A Prospective, Controlled Pilot Trial.|Completed||Phase 2|12|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 14:18:27.09691|2017-02-18 14:18:27.09691
NCT00690196|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2016-07-05|||March 2008||2008-03-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms|Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanism|Completed||N/A|90|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 14:18:27.188558|2017-02-18 14:18:27.188558
NCT00690183|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2013-01-16|||June 2008||2008-06-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Observational|||Relationship Between Physical Activity and Stem Cells in Older Adults|Relationship Between Physical Activity and Stem Cells in Older Adults|Completed||N/A|39|Actual|University of Nebraska|||1||f||||f||||||Samples Without DNA|"~     Plasma will be retained for cytokine analysis.~   "|||2017-02-18 14:18:27.308775|2017-02-18 14:18:27.308775
NCT00690170|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-05-08|||December 2002||2002-12-01|May 2012|2012-05-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects|Nicotinic Modulation of (NMDA) Receptor Antagonist Schizophrenia-like Information Processing Deficits in Humans|Completed||Phase 1|30|Actual|Yale University||4|||f||||t||||||||||2017-02-18 14:18:29.842773|2017-02-18 14:18:29.842773
NCT00690157|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2009-09-14|||October 2003||2003-10-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|POLKARD HF||Registry of Patients Referred for Heart Transplantation|National Polish Registry of Patients Referred for Heart Transplantation. POLKARD HF|Completed||N/A|999|Actual|Institute of Cardiology, Warsaw, Poland|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 14:18:29.951514|2017-02-18 14:18:29.951514
NCT00690144|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-06-28|||July 2007||2007-07-01|June 2010|2010-06-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|||High-fidelity Simulation in Health Care Education|Prospective Study Focusing on Impact of High-fidelity Simulation in Health Care Education|Unknown status|Recruiting|N/A|500|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 14:18:30.052705|2017-02-18 14:18:30.052705
NCT00690131|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2008-06-03|||April 2008||2008-04-01|June 2008|2008-06-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|||An Integrated Approach to Smoking Cessation in Severe Mental Illness (SMI)|An Integrated Approach to Smoking Cessation in SMI|Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Anticipated|University of Maryland||2|||f||||t||||||||||2017-02-18 14:18:30.159902|2017-02-18 14:18:30.159902
NCT00690118|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2015-05-28|||May 2008||2008-05-01|May 2015|2015-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis|Efficacy, Safety and Tolerability Study of 45 mg Pioglitazone in Patients With Amyotrophic Lateral Sclerosis (ALS) Receiving Standard Therapy (Riluzole)|Terminated||Phase 2|219|Actual|University of Ulm||2||"The interim analysis showed no tendency in favour of the verum group. Therefore it was decided~   to stop the study prematurely."|f||||t||||||||||2017-02-18 14:18:30.262357|2017-02-18 14:18:30.262357
NCT00690105|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2014-08-28|||February 2004||2004-02-01|August 2014|2014-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Protopic Ointment in Adult Atopic Eczema of the Face|Comparative, Multicentre, Randomized, Double-blind Study to Assess the Efficacy of Tacrolimus 0.1% Ointment Versus Fluticasone 0.005% Ointment in Adult Patients Suffering From Moderate to Severe Atopic Dermatitis and Presenting With So-called 'Red Face' Lesions of the Head and Neck.|Completed||Phase 4|577|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:18:30.410976|2017-02-18 14:18:30.410976
NCT00690092|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2013-10-28|||May 2005||2005-05-01|October 2013|2013-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Multi-center Study of Spherule-Derived Coccidioidin|Safety, Sensitivity and Specificity of Spherule-derived Coccidioidin in Naive Adults, in Adults With a History of Pulmonary Coccidioidomycosis and in Adults With a History of Pulmonary Histoplasmosis|Completed||Phase 3|113|Actual|Nielsen BioSciences, Inc.||3|||f||||f||||||||||2017-02-18 14:18:30.656776|2017-02-18 14:18:30.656776
NCT00690079|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-12-08|||February 2008||2008-02-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|MAD||Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386|A Phase I, Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1386 in Healthy Caucasian Young and Elderly Subjects After Oral Multiple Doses.|Completed||Phase 1|69|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:30.763707|2017-02-18 14:18:30.763707
NCT00690066|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2014-12-02|||June 2008||2008-06-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL® (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) for Recently Diagnosed Type 1 Diabetes Mellitus|Completed||Phase 2|63|Actual|Mesoblast, Ltd.||2|||f||||t||||||||||2017-02-18 14:18:31.080656|2017-02-18 14:18:31.080656
NCT00690053|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2009-06-29|||August 2008||2008-08-01|February 2009|2009-02-01||||February 2009|Actual|2009-02-01||Interventional|HX-4||Non-Invasive Imaging of [18F]HX4 With Positron-Emission-Tomography (PET)|Non-Invasive Imaging of [18F]HX4 With Positron-Emission-Tomography (PAT): A Phase I Study|Completed||Phase 1|12|Anticipated|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-02-18 14:18:31.225582|2017-02-18 14:18:31.225582
NCT00690040|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-31|2016-09-01|2013-03-19||June 2008||2008-06-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Single Balloon Catheter Compared With Double Balloon Catheter for Ripening of the Unfavorable Cervix|Single Balloon Catheter Compared With Double Balloon Catheter for Ripening of the Unfavorable Cervix|Completed||N/A|293|Actual|HaEmek Medical Center, Israel|Blinding was not performed among patients and providers. However, other than the catheter type, management was standardized. Accordingly,such unblinding is not expected to affect the objectively measured outcomeS.|2|||f||||f||||||||||2017-02-18 14:18:31.333458|2017-02-18 14:18:31.333458
NCT00690027|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2008-06-03|||April 1988||1988-04-01|June 2008|2008-06-01|December 2005|Actual|2005-12-01|August 1996|Actual|1996-08-01||Interventional|||San Diego Bleeding Esophageal Varices Study|San Diego Bleeding Esophageal Varices Study|Completed||N/A|211|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 14:18:31.706929|2017-02-18 14:18:31.706929
NCT00690014|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2008-06-03|||August 2007||2007-08-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of Renal Drug Transport in Healthy Volunteers|Evaluation of Renal Drug Transport in Healthy Volunteers|Completed||N/A|10|Anticipated|University of Maryland||1|||f||||t||||||||||2017-02-18 14:18:31.81765|2017-02-18 14:18:31.81765
NCT00690001|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-01|2008-07-07|||April 2008||2008-04-01|April 2008|2008-04-01||||||||Observational|||The Detection of Drug-Resistant HIV-1 in Taiwan|The Detection of Drug-Resistant HIV-1 in Taiwan|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 14:18:31.936078|2017-02-18 14:18:31.936078
NCT00689988|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2008-06-03|||July 2005||2005-07-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|October 2007|Actual|2007-10-01||Interventional|||Augmentative and Alternative Communication (AAC) and Lexical Gain in Children With Down Syndrome|Augmentative and Alternative Communication and Lexical Gain in Children With Down Syndrome: Pilot Study|Completed||N/A|5|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-02-18 14:18:32.041282|2017-02-18 14:18:32.041282
NCT00689975|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2013-08-23|||February 2006||2006-02-01|December 2009|2009-12-01||||October 2008|Actual|2008-10-01||Interventional|||Diet and Exercise or Normal Care in Overweight or Obese Women Who Have Undergone Treatment for Stage I, Stage II, or Stage III Breast Cancer|The Effects of a Combined Diet and Exercise Intervention on Biomarkers Associated With Disease Recurrence After Breast Cancer Treatment: The Sheffield DEBRA Trial|Completed||N/A|100|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:18:32.157516|2017-02-18 14:18:32.157516
NCT00689962|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-31|2017-01-13|||July 2008||2008-07-01|January 2017|2017-01-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|Lisfranc||A Comparison of Steel and Bioabsorbable Screw Fixation of Lisfranc Foot Injuries|A Randomized, Prospective Comparison of Stainless Steel and Bioabsorbable Screw Fixation of Lisfranc Foot Injuries|Completed||Phase 4|50|Actual|Rothman Institute Orthopaedics||2|||f||||t||||||||||2017-02-18 14:18:32.267193|2017-02-18 14:18:32.267193
NCT00689949|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-12-21|||June 2008||2008-06-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|October 2008|Actual|2008-10-01||Interventional|||Validation of Urinary Biomarkers of Folate Status|Determination of the Suitability of Urinary Total P-aminobenzoylglutamate (p-ABG)and Formiminoglutamate (FIGLU) as a Markers for Folate Status|Completed||N/A|53|Actual|Ludwig-Maximilians - University of Munich||1|||f||||f||||||||||2017-02-18 14:18:32.596598|2017-02-18 14:18:32.596598
NCT00689598|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-06-04|||March 2008||2008-03-01|June 2008|2008-06-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|||Spironolactone for Paroxysmal Atrial Fibrillation|Use of Spironolactone to Treat Patients With Paroxysmal Atrial Fibrillation- A Multi-Center, Prospective, Randomized, Placebo-Controlled, Double Blind Study|Unknown status|Recruiting|N/A|30|Anticipated|Taichung Veterans General Hospital||2|||f||||t||||||||||2017-02-18 14:18:38.049028|2017-02-18 14:18:38.049028
NCT00689936|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2016-10-28|||August 2008||2008-08-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|FIRST||Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma|A Phase III, Randomized, Open-label, 3-arm Study to Determine the Efficacy and Safety of Lenalidomide(REVLIMID) Plus Low-dose Dexamethasone When Given Until Progressive Disease or for 18 Four-week Cycles Versus the Combination of Melphalan, Prednisone, and Thalidomide Given for 12 Six-week Cycles in Patients With Previously Untreated Multiple Myeloma Who Are Either 65 Years of Age or Older or Not Candidates for Stem Cell Transplantation.|Completed||Phase 3|1623|Actual|Celgene Corporation||3|||f||||t||||||||||2017-02-18 14:18:32.721445|2017-02-18 14:18:32.721445
NCT00689923|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-01|2008-06-03|||November 2007||2007-11-01|May 2008|2008-05-01||||October 2008|Anticipated|2008-10-01||Observational|||Vertebroplasty Using Real-Time, Fluoroscopy-Controlled, Catheter-Assisted, Low-Viscosity Cement Injection|Vertebroplasty Using Real-Time, Fluoroscopy-Controlled, Catheter-Assisted, Low-Viscosity Cement Injection|Unknown status|Active, not recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 14:18:33.377672|2017-02-18 14:18:33.377672
NCT00689910|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2012-03-28|||February 2008||2008-02-01|March 2012|2012-03-01||||||||Observational|||Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum|Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum|Withdrawn||N/A|0|Actual|University of California, San Francisco|||1||f||||||||||Samples Without DNA|"~     Plasma Cervicovaginal lavage fluid Endocervical canal fluid~   "|||2017-02-18 14:18:33.449166|2017-02-18 14:18:33.449166
NCT00689897|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2011-06-22|||June 2008||2008-06-01|April 2009|2009-04-01|July 2011|Anticipated|2011-07-01|September 2010|Actual|2010-09-01||Interventional|||Psychological Outcomes From a Study of Acupuncture Treatment on Experimentally Primary Dysmenorrhea|Psychological Outcomes From a Study of Acupuncture Treatment on Experimentally Primary Dysmenorrhea|Unknown status|Recruiting|Phase 3|60|Anticipated|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-02-18 14:18:33.532735|2017-02-18 14:18:33.532735
NCT00689884|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-07-31|2012-01-16||January 2007||2007-01-01|October 2011|2011-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies|A Prospective Feasibility and Cost Analysis of Peripheral Blood Stem Cell Mobilization Using Pegfilgrastim in Patients With Hematologic Malignancies|Terminated||N/A|7|Actual|Dartmouth-Hitchcock Medical Center|Outcome was not reported. The study was terminated for lack of enrollment. Data collection was terminated. No data analysis was performed.|1||Lack of enrollment.|f||||t||||||||||2017-02-18 14:18:33.648316|2017-02-18 14:18:33.648316
NCT00689871|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2014-10-06|2011-12-19||January 1999||1999-01-01|January 2014|2014-01-01|August 2011|Actual|2011-08-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants||Completed||N/A|715|Actual|Allergan|The Revision-reconstruction arm only had 15 patients enrolled, which makes the data for that arm difficult to interpret.|4|||f||||||||||||||2017-02-18 14:18:33.896249|2017-02-18 14:18:33.896249
NCT00689858|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2009-01-12|||May 2007||2007-05-01|June 2008|2008-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo|Clinical Trial to Assessment the PK/PD Characteristics and Safety After co-Administration of Cilostazol With Ginkgo Biloba or Placebo in Healthy Subject.|Completed||Phase 1|40|Actual|SK Chemicals Co.,Ltd.||2|||f||||||||||||||2017-02-18 14:18:34.454422|2017-02-18 14:18:34.454422
NCT00689845|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-03|2009-07-07|||June 2007||2007-06-01|July 2009|2009-07-01||||||||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma|A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma (IELSG 26)|Unknown status|Recruiting|N/A|120|Anticipated|National Cancer Institute (NCI)||5|||f||||||||||||||2017-02-18 14:18:34.553734|2017-02-18 14:18:34.553734
NCT00689832|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2014-08-28|||February 2004||2004-02-01|August 2014|2014-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Protopic Ointment in Children Atopic Eczema|Comparative, Multicentre, Randomised, Double-blind Study to Assess the Efficacy of Tacrolimus 0.03% Ointment Versus Fluticasone 0.005% Ointment in Children Aged 2 Years or Over Suffering From Moderate to Severe Atopic Dermatitis.|Completed||Phase 4|487|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:18:34.686036|2017-02-18 14:18:34.686036
NCT00689819|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2013-11-07|2013-06-14||October 2008||2008-10-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients|Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients in an Urban Emergency Department: Is a Program Focused on Early Detection and Blood Pressure Control Clinically and Cost Effective?|Completed||N/A|123|Actual|Wayne State University|Despite our best efforts, study retention was hindered by a higher than expected drop-out rate (26.0% overall; 27.7% control and 24.1% intervention).|2|||f||||t||||||||||2017-02-18 14:18:34.808912|2017-02-18 14:18:34.808912
NCT00689806|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2013-06-20||||||June 2013|2013-06-01||||||||Interventional|||Evaluation of Lovastatin in Severe Persistent Asthma|Evaluation of Lovastatin in Severe Persistent Asthma|Withdrawn||Phase 1/Phase 2|0|Actual|University of Chicago||2||Study never opened|f||||t||||||||||2017-02-18 14:18:35.402611|2017-02-18 14:18:35.402611
NCT00689793|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2013-01-15|2012-05-18||November 2008||2008-11-01|January 2013|2013-01-01|April 2011|Actual|2011-04-01|October 2010|Actual|2010-10-01||Interventional|ferdon||Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors|Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors : a Randomized Controlled Trial|Completed||Phase 4|154|Actual|University of Lausanne||2|||f||||t||||||||||2017-02-18 14:18:35.505384|2017-02-18 14:18:35.505384
NCT00689780|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2010-12-08|||March 2008||2008-03-01|December 2010|2010-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940|A Phase I, Multi-Centre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940, Including an Interaction Study, After Administration of Oral Multiple Ascending Doses in Adult Subjects With Chronic Low Back Pain|Completed||Phase 1|60|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:36.031504|2017-02-18 14:18:36.031504
NCT00561158|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2010-01-14|||June 1994||1994-06-01|January 2010|2010-01-01|May 1998|Actual|1998-05-01|||||Interventional|EWLW||Eat Well Live Well Nutrition Program|Dietary Changes in African American Women By Activation|Completed||Phase 2|398|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 15:03:44.950189|2017-02-18 15:03:44.950189
NCT00689767|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2013-04-16|||June 2008||2008-06-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|June 2009|Actual|2009-06-01||Interventional|CONFIRM 1||COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1)|COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms|Terminated||N/A|103|Actual|Atrium Medical Corporation||2||"Terminated ahead of schedule after completion of the 3-year follow-up time point due to~   Sponsor decision."|f||||t||||||||||2017-02-18 14:18:36.135318|2017-02-18 14:18:36.135318
NCT00689754|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2011-11-16|||January 2008||2008-01-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|NG||Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed|The Role of Routine Placement of Nasogastric Tube in Patients With Suspected Upper Gastrointestinal Hemorrhage|Completed||N/A|282|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 14:18:36.237379|2017-02-18 14:18:36.237379
NCT00689741|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2016-09-09|||January 2001||2001-01-01|September 2016|2016-09-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women|A Double-blind, Placebo-controlled, Randomised Study of the Efficacy of an HPV-16/18 VLP Vaccine in the Prevention of HPV-16 and/or HPV-18 Cervical Infection in Healthy Adolescent and Young Adult Women in North America and Brazil.|Completed||Phase 2|1113|Actual|GlaxoSmithKline||2|||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:18:36.347222|2017-02-18 14:18:36.347222
NCT00689728|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2010-12-09||2010-12-09|June 2008||2008-06-01|December 2010|2010-12-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy|A Phase 2 Study of Multiple Intravenous Doses of LY2127399 in Patients With Rheumatoid Arthritis on Concomitant Methotrexate and an Inadequate Response to TNFα Inhibitor Therapy|Completed||Phase 2|100|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 14:18:36.464272|2017-02-18 14:18:36.464272
NCT00689715|ClinicalTrials.gov processed this data on February 17, 2017|2008-06-02|2016-07-24|||June 2006||2006-06-01|July 2016|2016-07-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|EUS-EP||Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas|Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas|Active, not recruiting||Phase 2/Phase 3|50|Anticipated|Asan Medical Center||1|||f||||t||||||||||2017-02-18 14:18:36.615151|2017-02-18 14:18:36.615151
NCT00689702|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-03-23|||February 2007||2007-02-01|March 2012|2012-03-01|May 2013|Anticipated|2013-05-01|April 2009|Actual|2009-04-01||Interventional|XERT||Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer|Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Locally Advanced Resectable Rectal Cancer: A Phase II Pilot Study|Unknown status|Active, not recruiting|Phase 2|43|Actual|Institute of Oncology Ljubljana||1|||f||||t||||||||||2017-02-18 14:18:36.723749|2017-02-18 14:18:36.723749
NCT00689689|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-02-15|||July 1998||1998-07-01|May 2008|2008-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Randomized Clinical Study Comparing a Fully-Coated Cementless Stem Versus a Cemented Stem for Total Hip Replacements|A Randomized Clinical Study Comparing a Fully-Coated Cementless Stem Versus a Cemented Stem for Total Hip Replacements|Completed||Phase 4|48|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-02-18 14:18:36.835466|2017-02-18 14:18:36.835466
NCT00689676|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2009-02-13|||January 2006||2006-01-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Expressive Language and Cognitive Early Development in Very Low Birth-Weight Preterm Toddlers|Expressive Language and Cognitive Early Development in Very Low Birth-Weight Preterm Toddlers|Completed||N/A|32|Actual|University of Sao Paulo|||2||f||||t||||||||||2017-02-18 14:18:36.938059|2017-02-18 14:18:36.938059
NCT00689663|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2008-05-29|||May 2006||2006-05-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Laparoscopic Cholecystectomy - Fundus First and Harmonic Ace Compared With Conventional Technique|Randomized Multicentre Trial: Comparison of Harmonic Ace and Eletrocautery; Comparison of Fundus First and Conventional Dissection|Completed||N/A|233|Actual|Sundsvall Hospital||3|||f||||f||||||||||2017-02-18 14:18:37.026535|2017-02-18 14:18:37.026535
NCT00689650|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-05-30|||November 2007||2007-11-01|May 2008|2008-05-01||||||||Interventional|||Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial|Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|||Bispebjerg Hospital||2|||f||||||||||||||2017-02-18 14:18:37.130761|2017-02-18 14:18:37.130761
NCT00689637|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2009-06-30|||September 2007||2007-09-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|||||Interventional|DDI||Drug Interaction Study Between AZD3480 and Warfarin|A Single-Centre, Double Blind, Randomized, Two-Way Cross-Over Study of Repeated Doses of AZD3480 and Single Dose of Warfarin to Evaluate the Pharmacokinetic Interaction of AZD3480 and Warfarin and the Effect of AZD3480 Pharmacodynamic in Healthy Male Subjects (Phase I|Completed||Phase 1|26|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:37.213638|2017-02-18 14:18:37.213638
NCT00689624|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-09-25|||July 2007||2007-07-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer|A Triplet Combination With Irinotecan Plus Oxaliplatin,Continuous Infusion 5-Fluorouracil And Leucovorin Plus Cetuximab As First Line Treatment In Metastatic Colorectal Cancer. A Pilot Phase II Trial|Completed||Phase 2|30|Actual|University Hospital of Crete||1|||f||||f||||||||||2017-02-18 14:18:37.317051|2017-02-18 14:18:37.317051
NCT00689611|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2015-04-10|2013-12-11||December 2005||2005-12-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|ZESCA|All enrolled participants were included in the baseline analyses.|Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial|Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial|Completed||Phase 3|392|Actual|McGill University|Relatively high number who withdrew or were lost to follow-up (22.2%), but within expectations for smoking cessation trials; Relatively small numbers of serious adverse events occurred, limiting power to examine secondary safety end points.|2|||f||||t||||||||||2017-02-18 14:18:37.442382|2017-02-18 14:18:37.442382
NCT00268060|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2007-05-03|||September 2004||2004-09-01|May 2007|2007-05-01||||||||Observational|||Infant Medical Records: Case Report Proposal|Baby R. Case Report Proposal|Terminated||N/A|1||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:52:50.105612|2017-02-18 16:52:50.105612
NCT00689585|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2011-05-11|||September 2008||2008-09-01|May 2011|2011-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)|A Single Centre. Parallel-Group, Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial on Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)|Terminated||Phase 2|4|Actual|McGill University Health Center||2||Recruitment difficult and enrolment low: decision was made to stop the study.|f||||f||||||||||2017-02-18 14:18:38.161036|2017-02-18 14:18:38.161036
NCT00689572|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2014-06-02|||July 2008||2008-07-01|June 2014|2014-06-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||New Medication Treatment for Stimulant Dependence|New Medication Treatment for Stimulant Dependence|Unknown status|Active, not recruiting|Phase 2|200|Anticipated|University of Virginia||2|||f||||t||||||||||2017-02-18 14:18:38.272772|2017-02-18 14:18:38.272772
NCT00689559|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2009-06-30|||March 2008||2008-03-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|||||Interventional|||Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects|A Single-Centre, Double-Blind, Randomised, Parallel Group Study of Repeated Oral Doses of AZD3480/Placebo and a Single Dose of Aripiprazole to Evaluate the Pharmacokinetic Interaction Between AZD3480 and Aripiprazole in Healthy Subjects (Phase I)|Completed||Phase 1|52|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:38.608031|2017-02-18 14:18:38.608031
NCT00689546|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-05-30|||February 2007||2007-02-01|January 2007|2007-01-01||||||||Observational|||Acute Viral Hepatitis and Diabetes Mellitus|Natural Course of Acute Icteric Viral Hepatitis in Type II Diabetes Mellitus Patients and Non-Diabetic Patients:A Pilot Cohort Study|Unknown status|Recruiting|N/A|250|Anticipated|All India Institute of Medical Sciences, New Delhi|||4||f||||f||||||||||2017-02-18 14:18:38.71937|2017-02-18 14:18:38.71937
NCT00689533|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-05-29|||January 2008||2008-01-01|May 2008|2008-05-01|January 2016|Anticipated|2016-01-01|January 2012|Anticipated|2012-01-01||Observational|||VEPTR Implantation to Treat Children With Early Onset Scoliosis Without Rib Abnormalities|VEPTR Implantation to Treat Children With Early Onset Scoliosis Without Rib Abnormalities: a Prospective Multicenter Study|Unknown status|Recruiting|N/A|250|Anticipated|Shriners Hospitals for Children|||1||f||||f||||||||||2017-02-18 14:18:38.829514|2017-02-18 14:18:38.829514
NCT00689520|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-06-02|||January 2002||2002-01-01|May 2008|2008-05-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis|Phase IV, Randomized, Open-Label Trial Comparing Long-Term Subcutaneous Low-Molecular Weight Heparin With Oral Anticoagulant Therapy in the Treatment of Deep Venous Thrombosis|Completed||Phase 4|241|Actual|Hospital Universitari de Bellvitge||2|||f||||f||||||||||2017-02-18 14:18:38.923981|2017-02-18 14:18:38.923981
NCT00689507|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-06-25|||March 2008||2008-03-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|January 2013|Actual|2013-01-01||Interventional|||A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib|A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|48|Actual|Applied Molecular Evolution||3|||f||||f||||||||||2017-02-18 14:18:39.040373|2017-02-18 14:18:39.040373
NCT00689494|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-06-02|||June 2008||2008-06-01|June 2008|2008-06-01|May 2010|Anticipated|2010-05-01|December 2008|Anticipated|2008-12-01||Interventional|NANOPAZ||Cervical Device Contraception-2 (Nanopaz)|Cervical Device Contraception|Unknown status|Not yet recruiting|Phase 1/Phase 2|10|Anticipated|Bnai Zion Medical Center||1|||f||||t||||||||||2017-02-18 14:18:39.162437|2017-02-18 14:18:39.162437
NCT00689481|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-08-25|2010-11-05||March 2008||2008-03-01|August 2016|2016-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies|A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267 , Versus Vehicle Foam in Subjects With Plaque-type Psoriasis|Completed||Phase 3|323|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:18:39.258156|2017-02-18 14:18:39.258156
NCT00689468|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-05-30|||July 1999||1999-07-01|May 2008|2008-05-01|October 2002|Actual|2002-10-01|September 2002|Actual|2002-09-01||Interventional|||Echinacea Purpurea and Osteopathy in Children With Recurrent Otitis Media|Echinacea Purpurea and Cranial Osteopathic Manipulative Treatment in Children With Recurrent Otitis Media: a Randomized Controlled Trial.|Completed||N/A|90|Actual|University of Arizona||4|||f||||t||||||||||2017-02-18 14:18:40.381019|2017-02-18 14:18:40.381019
NCT00689455|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2010-12-02|||October 2007||2007-10-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|ORSA||Regional Observatory on Metabolic Syndrome- LAZIO|Regional Observatory on Metabolic Syndrome in Italy- LAZIO|Completed||N/A|1574|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:18:40.494765|2017-02-18 14:18:40.494765
NCT00689442|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-06-02|||January 2004||2004-01-01|May 2008|2008-05-01|March 2006|Actual|2006-03-01|November 2004|Actual|2004-11-01||Interventional|||Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels|A 4-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study Evaluating the Safety and Efficacy of JTT-705 600 mg Versus Placebo Administered Once Daily in Combination With Atorvastatin 20 mg in Patients With Low HDL Levels|Completed||Phase 2|105|Actual|Akros Pharma Inc.||2|||f||||f||||||||||2017-02-18 14:18:40.590878|2017-02-18 14:18:40.590878
NCT00689429|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-05-30|||May 2008||2008-05-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Operatively Treated Open Pilon Fractures|Natural History and Functional Outcome of Operatively Treated Open Pilon Fractures|Unknown status|Enrolling by invitation|N/A|150|Anticipated|Penn State University|||1||f||||f||||||||||2017-02-18 14:18:40.689271|2017-02-18 14:18:40.689271
NCT00689416|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2009-06-29|||December 2007||2007-12-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|||||Interventional|||Effects of Crestor on Inflammation of Atherosclerotic Plaques|Exploratory Study of New Imaging Biomarkers for Measurement of Carotid Plaque Inflammation|Completed||Early Phase 1|74|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:40.77591|2017-02-18 14:18:40.77591
NCT00689403|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2010-12-01|||February 2008||2008-02-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|2007-005765-38||Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305|A Phase I, Two-part, Randomised, Open, Single-centre, Crossover Study to Evaluate Different Extended-release Formulations of AZD1305 When Given as Single Oral Doses to Healthy Male Volunteers|Completed||Phase 1|50|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:40.899253|2017-02-18 14:18:40.899253
NCT00689390|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-11-30|2015-09-01||February 2007||2007-02-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||All Enrolled Participants|Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C (P05063)|Long-Term Follow-Up of Subjects in a Phase 1, 2, or 3 Clinical Trial in Which Boceprevir or Narlaprevir Was Administered for the Treatment of Chronic Hepatitis C|Terminated||Phase 2/Phase 3|1954|Actual|Merck Sharp & Dohme Corp.||2||The study was terminated due to satisfaction of post-marketing commitments|f||||t||||||||||2017-02-18 14:18:41.005523|2017-02-18 14:18:41.005523
NCT00689377|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2012-03-19|||May 2007||2007-05-01|March 2012|2012-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|PANDORA||Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention|Prevalence of Peripheral Arterial Disease in Subjects With a Moderate CVD Risk, With No Overt Vascular Diseases nOR diAbetes Mellitus|Completed||N/A|9000|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:18:41.801452|2017-02-18 14:18:41.801452
NCT00689364|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2011-07-20|||April 2007||2007-04-01|June 2011|2011-06-01|March 2014|Anticipated|2014-03-01|March 2012|Anticipated|2012-03-01||Observational|||Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer|Retrospective-Prospective Cohort Study Effectiveness of Comprehensive Therapy of TCM to Relieving the Risk of Recurrence and Metastasis for Stage II & III Colorectal Cancer Based on Conventional Western Medicine Therapy|Unknown status|Active, not recruiting|N/A|480|Anticipated|Ministry of Science and Technology of the People´s Republic of China|||2||f||||t||||||||||2017-02-18 14:18:42.402869|2017-02-18 14:18:42.402869
NCT00689351|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2011-06-24|2010-12-10||June 2008||2008-06-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered To Infants In Korea|Phase 2, Randomized, Active-Controlled, Double-Blind Trial Evaluating The Safety, Tolerability, And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine In Healthy Infants Given With Routine Pediatric Vaccinations In Korea|Completed||Phase 2|180|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:18:42.511909|2017-02-18 14:18:42.511909
NCT00689338|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2011-05-25|2011-04-21||July 2008||2008-07-01|May 2011|2011-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|ICE||Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study|Open-Label, Non-Comparative, Study Of Intravenous Anidulafungin, Followed Optionally By Oral Voriconazole Or Fluconazole Therapy, For Treatment Of Documented Candidemia/Invasive Candidiasis In Intensive Care Unit Patient Populations|Completed||Phase 3|216|Actual|Pfizer|In a change to the protocol, time to first negative blood/tissue culture will only concern time to first negative blood culture. Lack of regular tissue sampling meant that analysis of time to first tissue culture could not be meaningfully performed.|1|||f||||f||||||||||2017-02-18 14:18:44.493494|2017-02-18 14:18:44.493494
NCT00689325|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2010-10-26|||April 2008||2008-04-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|Xperience||Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics|A Non-interventional Study Evaluating Well-being/Quality of Life in Schizophrenic Patients Treated With Seroquel XR® (Quetiapine) and Other Atypical Antipsychotics.A 9-month, Observational, Multicentric Prospective Study.|Completed||N/A|158|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 14:18:45.098699|2017-02-18 14:18:45.098699
NCT00689312|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2013-12-10|||May 2008||2008-05-01|December 2013|2013-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Palatability of Oral Rehydration Solutions|Palatability of Oral Rehydration Solutions|Completed||Phase 3|66|Actual|The Hospital for Sick Children||3|||f||||f||||||||||2017-02-18 14:18:45.218436|2017-02-18 14:18:45.218436
NCT00689299|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2014-04-14|2011-05-24||October 2008||2008-10-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Phase 2 Study in Adults Sensitized to Cat|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging Study of Sublingual Immunotherapy (SLIT) in Adults Sensitized to the Standardized Allergenic Extract, Cat Hair (Felis Domesticus)|Completed||Phase 2|167|Actual|Antigen Laboratories, Inc.|Adverse events: 41%, 58%, and 45% > 5% in Group A, B, and C, respectively.|3|||f||||f||||||||||2017-02-18 14:18:45.321985|2017-02-18 14:18:45.321985
NCT00689286|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-06-01|||April 2008||2008-04-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||BION Treatment of Knee Osteoarthritis|BION Implantable Microstimulator System|Withdrawn||Phase 1|0|Actual|University of Southern California||3|||f||||f||||||||||2017-02-18 14:18:45.816715|2017-02-18 14:18:45.816715
NCT00689273|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-09-25||2009-04-06|August 2008||2008-08-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee|A 2-Week, Randomized, Double Blind, Placebo Controlled, Parallel-Group, Phase 2, Multicenter Study Of Pf-04136309 In Subjects With Osteoarthritic Pain Of The Knee|Completed||Phase 2|157|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:18:46.078993|2017-02-18 14:18:46.078993
NCT00689260|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-04-27|2010-06-17||March 2008||2008-03-01|April 2015|2015-04-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Interventional|||Easypod United States User Trial|A Randomized, Multicenter, 3 Month Phase IV Study to Evaluate the Effect on Subject Adherence With Injection Schedule by Using the Easypod™ rhGH Delivery Device|Completed||Phase 4|42|Actual|EMD Serono|Enrollment ended early due to slow enrollment. Only 44 enrolled of the 100 subjects needed. Of the 44 enrolled, only 35 subjects had valid device data for analysis.|2|||f||||f||||||||||2017-02-18 14:18:46.19609|2017-02-18 14:18:46.19609
NCT00689247|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2010-12-02|||April 2008||2008-04-01|December 2010|2010-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305|A Phase I, Open, Randomised, Single-Centre, Crossover Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) After Oral and Intravenous Administration of 14C-labelled and Non-labelled AZD1305 to Healthy Male Volunteers|Completed||Phase 1|10|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:46.702815|2017-02-18 14:18:46.702815
NCT00689234|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-08-05|||April 2008||2008-04-01|August 2013|2013-08-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||Diaphragm Plication in Adults With Phrenic Nerve Paralysis|Diaphragm Plication in Adults With Phrenic Nerve Paralysis: a Randomised Controlled Study|Unknown status|Recruiting|N/A|12|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-02-18 14:18:46.798678|2017-02-18 14:18:46.798678
NCT00006295|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-25|2016-08-19|||August 2000||2000-08-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Molecular & Clinical Evaluation of Low HDL Syndromes||Completed||N/A|370|Anticipated|University of Maryland|||12||f||||||||||||||2017-02-18 18:13:03.686319|2017-02-18 18:13:03.686319
NCT00689221|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2014-10-28|2014-08-28||September 2008||2008-09-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|November 2012|Actual|2012-11-01||Interventional|CENTRIC|Intent-to-treat (ITT) population included all the participants who were randomized to study treatment.|Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status|Cilengitide for Subjects With Newly Diagnosed Glioblastoma and Methylated MGMT Gene Promoter - A Multicenter, Open-label, Controlled Phase III Study, Testing Cilengitide in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy) Versus Standard Treatment Alone (CENTRIC)|Completed||Phase 3|545|Actual|EMD Serono||2|||f||||t||||||||||2017-02-18 14:18:46.906245|2017-02-18 14:18:46.906245
NCT00689208|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2009-03-12|||May 2007||2007-05-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity|Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity - a Concept Study in Mani|Completed||Early Phase 1|12|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:18:48.138292|2017-02-18 14:18:48.138292
NCT00689195|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2011-06-22|||May 2008||2008-05-01|June 2011|2011-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|OSCAT||Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma|"Evaluation of Curcumin Formulation, and Ashwagandha Root Powder Extract in the Management of Advanced High Grade Osteosarcoma"|Unknown status|Recruiting|Phase 1/Phase 2|24|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||||2017-02-18 14:18:48.226415|2017-02-18 14:18:48.226415
NCT00689182|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2017-01-30|||May 2007||2007-05-01|January 2017|2017-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Efficacy of Iron Reduction by Phlebotomy|A Phase II Trial of the Safety and Efficacy of Iron Reduction by Phlebotomy in Recipients of Hematopoietic Stem Cell Transplants|Completed||Phase 2|23|Actual|Nova Scotia Health Authority||1|||f||||f||||||||Undecided||2017-02-18 14:18:48.492036|2017-02-18 14:18:48.492036
NCT00689169|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-03-24|||August 2007||2007-08-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2011|Actual|2011-01-01||Interventional|ZBEAM2||Targeted Intensification Utilizing ZBEAM Followed by Autologous Stem Cell Transplantation (ASCT) in Patients With High-grade B-Cell Lymphoma|Targeted Intensification by a Preparative Regimen for Patients With High-grade B-Cell Lymphoma Utilizing Standard-dose Yttrium-90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy (RIT) Combined With High-dose BEAM Followed by Autologous Stem Cell Transplantation (ASCT)|Completed||Phase 2|75|Actual|Lymphoma Study Association||1|||f||||t||||||||||2017-02-18 14:18:48.593277|2017-02-18 14:18:48.593277
NCT00689156|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2013-01-03|||June 2008||2008-06-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|READ||Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer|Randomized Trial of Epirubicin and Cyclophosphamide Followed by Docetaxel Against Docetaxel and Cyclophosphamide in Patients With TOP2A Normal Early Breast Cancer|Completed||Phase 3|2015|Actual|Danish Breast Cancer Cooperative Group||2|||f||||f||||||||||2017-02-18 14:18:48.705456|2017-02-18 14:18:48.705456
NCT00689143|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-10-28|||August 2008||2008-08-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Safety/Tolerability and Pharmakokinetic Study of Sargramostim Administrated in the Gingiva|A Phase I, Open-Label, Single Center, Safety/Tolerability and Pharmacokinetic Study of Leukine® Administrated in the Gingiva as Three Single Doses on Separate Days|Completed||Phase 1|10|Actual|Innoventus Project AB||1|||f||||f||||||||||2017-02-18 14:18:48.847016|2017-02-18 14:18:48.847016
NCT00689130|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-03-06|||May 2008||2008-05-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|CVI||ADVANCE: Assessment for Defining Variability in Anesthesia Through Novel Clinical EEG|"Advance: Assessment for Defining Variability in Anesthesia"|Completed||N/A|120|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-02-18 14:18:48.953804|2017-02-18 14:18:48.953804
NCT00689117|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2011-09-22|2010-11-02||April 2008||2008-04-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel|A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of CT Gel in Subjects With Acne Vulgaris|Completed||Phase 3|1649|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 14:18:49.053088|2017-02-18 14:18:49.053088
NCT00689104|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-06-05|2012-07-17||April 2008||2008-04-01|June 2015|2015-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|SCORPIO||Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder|A Randomized, Double-Blind, Parallel Group, Placebo and Active Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder|Completed||Phase 3|2336|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-02-18 14:18:50.025174|2017-02-18 14:18:50.025174
NCT00689091|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2014-11-14|2013-12-12||May 2008||2008-05-01|November 2014|2014-11-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|MACS||Bispectral Index (BIS) Versus Electronic Alerts in the Prevention of Anesthesia Awareness: the Michigan Awareness Control Study|A Prospective, Randomized, Controlled Trial Comparing Bispectral Index Monitoring to Electronic Alerts for Prevention of Awareness During Anesthesia in the General Population|Completed||Phase 4|22185|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 14:18:53.127781|2017-02-18 14:18:53.127781
NCT00689078|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2009-05-13|||May 2008||2008-05-01|May 2009|2009-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge Model|A Single-Center, Randomized, Double-Masked Evaluation of the Efficacy of Prednisolone Acetate 1% Ophthalmic Suspension Compared to Prednisolone Acetate 0.12% Ophthalmic Suspension, Loteprednol Etabonate 0.2% Ophthalmic Suspension, and Placebo in a Modified Conjunctival Allergen Challenge (CAC) Model|Completed||Phase 4|36|Actual|ORA, Inc.||4|||f||||f||||||||||2017-02-18 14:18:53.423644|2017-02-18 14:18:53.423644
NCT00689065|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2013-10-30|||May 2008||2008-05-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Safety Study of CALAA-01 to Treat Solid Tumor Cancers|A Phase I, Dose-Escalating Study of the Safety of Intravenous CALAA-01 in Adults With Solid Tumors Refractory to Standard-of-Care Therapies|Terminated||Phase 1|24|Actual|Calando Pharmaceuticals||1|||f||||t||||||||||2017-02-18 14:18:53.537687|2017-02-18 14:18:53.537687
NCT00263302|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2008-07-02|||March 2006||2006-03-01|January 2005|2005-01-01|December 2006||2006-12-01|||||Interventional|||Diuretic Efficacy of Dexamethasone in Heart Failure|Diuretic Efficacy of Dexamethasone in Congestive Heart Failure Patients|Suspended||Phase 1|60||Hebei Medical University|||||f||||||||||||||2017-02-18 16:54:42.479781|2017-02-18 16:54:42.479781
NCT00689052|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2014-06-03|2009-10-23||July 2008||2008-07-01|May 2014|2014-05-01||||November 2008|Actual|2008-11-01||Interventional||Treated Set, All patients randomized and received treatment|Pramipexole ER vs. Placebo in Fibromyalgia|A Randomized, Double-blind, Placebo-controlled, Dose Titration Efficacy and Safety Study of Pramipexole ER (0.75 to 4.5 mg) Administered Orally Once Daily Versus Placebo Over a 16-week Maintenance Phase in Patients Diagnosed With Fibromyalgia, as Assessed by the American College of Rheumatology (ACR) Criteria Followed by a 24-week Open-label Extension Phase|Terminated||Phase 2|61|Actual|Boehringer Ingelheim|Early termination leading to no number of subjects analysed for any outcome measure|2|||f||||||||||||||2017-02-18 14:18:53.75572|2017-02-18 14:18:53.75572
NCT00689039|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2010-12-01|||April 2007||2007-04-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of an Extended Release (ER) Tablet, Single and Repeated Dosing|A Two-part, Single-centre, Open (Part A) Single Blind (Part B), Randomised, Placebo-controlled Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Doses With and Without Food and Multiple Ascending Oral Doses of AZD1305 Extended-release Tablet in Healthy & Elderly Subj|Completed||Phase 1|94|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:54.296237|2017-02-18 14:18:54.296237
NCT00689026|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2014-10-17|2014-09-30||May 2008||2008-05-01|October 2014|2014-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy of Lubiprostone in Combination With Standard PEG Preparation|Efficacy of Lubiprostone Used With Polyethylene Glycol to Enhance Colonoscopy Preparation Quality in Diabetic Patients: A Randomized Single-Blind Controlled Trial|Terminated||N/A|60|Actual|Augusta University||2|||f||||f||||||||||2017-02-18 14:18:54.39981|2017-02-18 14:18:54.39981
NCT00689013|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-04-22|||February 2008||2008-02-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting|The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting|Completed||N/A|205|Actual|University of Tennessee||2|||f||||f||||||||||2017-02-18 14:18:54.931931|2017-02-18 14:18:54.931931
NCT00689000|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2010-10-21|||May 2006||2006-05-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)|A Phase I-II Study to Evaluate the Safety, Tolerability and Anti-Disease Activity of the Aminopeptidase Inhibitor, CHR-2797, in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia or Multiple Myeloma|Completed||Phase 1/Phase 2|57|Actual|Chroma Therapeutics||1|||f||||t||||||||||2017-02-18 14:18:55.070016|2017-02-18 14:18:55.070016
NCT00688987|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-06-04|||August 2000||2000-08-01|June 2008|2008-06-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation|Cortisol, Central Obesity, and Insulin Resistance: Long Term Studies in Addison's Patients|Completed||N/A|24|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:18:55.204518|2017-02-18 14:18:55.204518
NCT00688974|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-08-17|||May 2004||2004-05-01|August 2016|2016-08-01|September 2012|Actual|2012-09-01|November 2006|Actual|2006-11-01||Observational|OBEDIAB||Longitudinal Cohort Study Comparing 2 Surgical Techniques in Patients With Class 3 Obesity and Type 2 Diabetes|Longitudinal Cohort Study Comparing 2 Surgical Techniques (Roux-en-Y Gastric Bypass and Adjustable Gastric Banding) in Patients With Class 3 Obesity and Type 2 Diabetes|Completed||Phase 2/Phase 3|56|Actual|University Hospital, Lille|||3||f||||t||||||Samples Without DNA|"~     serum and plasma during meal test (0, 30, 60, 90, 120, 180 min)~   "|||2017-02-18 14:18:55.315292|2017-02-18 14:18:55.315292
NCT00688961|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-06-02|||June 2007||2007-06-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Omacor and Aspirin on Platelet Function|A Pilot Study of the Effects of Omacor (Alone and With Aspirin) on Platelet Function in Healthy Subjects|Completed||Early Phase 1|10|Actual|Sanford Research||4|||f||||t||||||||||2017-02-18 14:18:55.428502|2017-02-18 14:18:55.428502
NCT00688948|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2011-06-23|||November 2007||2007-11-01|February 2009|2009-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)|A Pilot Study Looking At The Use Of Alfuzosin In The Treatment Of Bladder Dysfunction In Patients With Multiple Sclerosis|Terminated||Phase 2/Phase 3|20|Anticipated|Nova Scotia Health Authority||1||Lack of funding|f||||f||||||||||2017-02-18 14:18:55.551929|2017-02-18 14:18:55.551929
NCT00688935|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-11-09|||January 2005||2005-01-01|November 2013|2013-11-01|May 2014|Anticipated|2014-05-01|May 2014|Anticipated|2014-05-01||Interventional|||Young Blind Child Melatonin Treatment Study|Identification of Free-Running Rhythms in Blind Children|Unknown status|Active, not recruiting|N/A|25|Anticipated|Oregon Health and Science University||1|||f||||t||||||||||2017-02-18 14:18:55.657206|2017-02-18 14:18:55.657206
NCT00688922|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-11-28|||July 2008||2008-07-01|November 2008|2008-11-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Interventional|PRACTIC||Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study|Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study That Evaluates the Effects of Pravastatin for Acute Myocardial Infarction With LDL-Cholesterol Levels of 70-129 mg/dl|Unknown status|Recruiting|Phase 4|400|Anticipated|Osaka Acute Coronary Insufficiency Study Group||1|||f||||t||||||||||2017-02-18 14:18:55.775805|2017-02-18 14:18:55.775805
NCT00688909|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2012-11-15|||March 2008||2008-03-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|REAL||Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer|Open-label, Single-arm, Multicenter Study to Evaluate the Rheumatological Tolerability of Letrozole as an Adjuvant Breast Cancer Treatment in Postmenopausal Women Who Are Intolerant and Discontinue Anastrozole Due to Grade 2-3 Arthralgia-myalgia|Completed||Phase 4|261|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:18:55.879838|2017-02-18 14:18:55.879838
NCT00688896|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-06-02|||June 2002||2002-06-01|May 2008|2008-05-01|March 2004|Actual|2004-03-01|April 2003|Actual|2003-04-01||Interventional|||Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia|A 4-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study Evaluating the Efficacy and Safety of JTT-705 (300 mg or 600 mg) Versus Placebo in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia|Completed||Phase 2|155|Actual|Akros Pharma Inc.||3|||f||||f||||||||||2017-02-18 14:18:56.050242|2017-02-18 14:18:56.050242
NCT00688883|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-12-02|||February 2003||2003-02-01|December 2013|2013-12-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Fludara (Oral) Phase II Study for Indolent Lymphoma|A Multicenter, Open Study to Assess the Antitumor Effect and Safety of Oral Fludarabine Phosphate (Fludara (SH T 586): 40 mg/m2/Day) Administered in 3 - 6 Treatment Cycles (1 Treatment Cycle: 5-consecutive Day Dosing, Followed by a Observation Period of 23 Days) in Patients With Indolent Lymphoma|Completed||Phase 2|52|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:18:56.149831|2017-02-18 14:18:56.149831
NCT00688870|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2011-10-31|2011-01-13||June 2008||2008-06-01|October 2011|2011-10-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|||Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan|A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine In Healthy Infants Given With Routine Pediatric Vaccinations In Taiwan|Completed||Phase 3|168|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|Geometric Mean Concentration Outcome Measures were identified as secondary analysis in the study protocol, but are included to maintain consistency with other postings for this program.|2|||f||||f||||||||||2017-02-18 14:18:56.314402|2017-02-18 14:18:56.314402
NCT00688857|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-11-04|||May 2008||2008-05-01|November 2010|2010-11-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations|A Randomized, Open-label, Multi-dose Crossover Study Assessing the Pharmacokinetic Profiles of Diazoxide Choline Coated Versus Uncoated Formulations in Healthy Volunteers|Completed||Phase 1|12|Anticipated|Essentialis, Inc.||2|||f||||f||||||||||2017-02-18 14:18:58.464774|2017-02-18 14:18:58.464774
NCT00688844|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-05-13|2013-08-05||October 2008||2008-10-01|May 2015|2015-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|BH4&PKU||Nutritional and Neurotransmitter Changes in PKU Subjects on BH4|Baseline Evaluation and Long-term Follow-up of Nutritional Status and Neurotransmitter Concentrations in Phenylketonuria Patients Initiating Treatment With Sapropterin Dihydrochloride (KuvanTM), a Tetrahydrobiopterin Analog.|Completed||N/A|58|Actual|Emory University|||1||f||||f||||||Samples With DNA|"~     Blood plasma Blood platelets Whole blood Urine~   "|||2017-02-18 14:18:58.559895|2017-02-18 14:18:58.559895
NCT00688831|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2010-12-01|||January 2008||2008-01-01|December 2010|2010-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|2006-006253-27||Single Ascending Dose Study (SAD) iv Formulation|A Single-centre, Single-blind, Randomised, Placebo-controlled, Single-dose Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Ascending Intravenous Doses of AZD1305 in Helahty Male Volunteers|Completed||Phase 1|36|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:58.995704|2017-02-18 14:18:58.995704
NCT00688818|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2014-08-20|||June 2008||2008-06-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Quetiapine in Co-Morbid Depressive and Anxiety Disorders|Randomized, Placebo-Controlled Effectiveness Study of Quetiapine XR in Co-Morbid Depressive and Anxiety Disorders|Completed||N/A|108|Actual|Centre for Addiction and Mental Health||2|||f||||t||||||||||2017-02-18 14:18:59.114254|2017-02-18 14:18:59.114254
NCT00688805|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2017-01-24|||December 12, 2007||2007-12-12|December 16, 2013|2013-12-16|December 16, 2013|Actual|2013-12-16|December 16, 2013|Actual|2013-12-16||Interventional|||Effects of Propranolol on Responses to Drug-Related Imagery Scripts|Effects of Propranolol on Responses to Drug-Related Imagery Scripts|Terminated||Phase 1|200|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 14:18:59.282225|2017-02-18 14:18:59.282225
NCT00688792|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-06-02|||July 2008||2008-07-01|May 2008|2008-05-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Observational|asthma||Maternal Variables Associated With Adherence in Children With Asthma|Reasons for Poor Adherence for Long-Term Preventing Therapy in Children With Asthma|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 14:18:59.391729|2017-02-18 14:18:59.391729
NCT00688779|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-08-13|||January 2008||2008-01-01|August 2015|2015-08-01|April 2009|Actual|2009-04-01|May 2008|Actual|2008-05-01||Interventional|SAD||Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season|A Double Blind, Placebo Controlled, Randomised, First Time In Man. Study to Investigate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of AZD8848 Administered Intranasally to Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out Of Season|Completed||Phase 1|130|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:18:59.479347|2017-02-18 14:18:59.479347
NCT00688766|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2012-12-07||2012-12-06|August 2008||2008-08-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib|A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Evaluating the Efficacy and Safety of IPI-504 in Patients With Metastatic and/or Unresectable GIST Following Failure of at Least Imatinib and Sunitinib|Terminated||Phase 3|47|Actual|Infinity Pharmaceuticals, Inc.||2||Based on Independent Data Monitoring Committee (IDMC) recommendation.|f||||t||||||||||2017-02-18 14:18:59.581546|2017-02-18 14:18:59.581546
NCT00688753|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2016-07-26|2015-10-21||July 2009||2009-07-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|MACS0460||RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe|A Single Arm, Multicenter Phase II Trial of RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Cancer|Completed||Phase 2|92|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:18:59.689501|2017-02-18 14:18:59.689501
NCT00688740|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2011-02-14|2011-01-25||June 1997||1997-06-01|February 2011|2011-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|TAX316||Docetaxel in Node Positive Adjuvant Breast Cancer|A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination With Doxorubicin and Cyclophosphamide (TAC) Versus 5-fluorouracil in Combination With Doxorubicin and Cyclophosphamide (FAC) as Adjuvant Treatment of Operable Breast Cancer Patients With Positive Axillary Lymph Nodes.|Completed||Phase 3|1491|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:19:00.316862|2017-02-18 14:19:00.316862
NCT00688727|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2009-01-21|||March 2001||2001-03-01|January 2009|2009-01-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Cognitive Behavioural Therapy in Dissociative Seizures|Cognitive Behavioural Therapy in Dissociative Seizures: A Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|70|Anticipated|South London and Maudsley NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 14:19:01.135834|2017-02-18 14:19:01.135834
NCT00688714|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2008-05-30|||January 2008||2008-01-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study to Investigate Safety and Tolerability of a Single Dose of AZD6482|A Randomised, Double-Blind, Placebo-Controlled Phase I Study to Assess the Tolerability, Safety, Pharmacokinetic, and Pharmacodynamic Properties of AZD6482, Alone and co-Administered With ASA, After Single Ascending Intravenous Doses to Healthy Male Subjects|Completed||Phase 1|49|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:19:01.270834|2017-02-18 14:19:01.270834
NCT00688701|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-10-18|2016-08-16||May 2008||2008-05-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|GETGOAL-MONO|Safety population included all randomized patients who were exposed to at least 1 dose of study drug, regardless of the amount of treatment administered.|GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter 12-week Study Assessing the Efficacy and Safety of AVE0010 in Patients With Type 2 Diabetes Not Treated With Antidiabetic Agents|Completed||Phase 3|361|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 14:19:01.378386|2017-02-18 14:19:01.378386
NCT00688688|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-06-05|2012-07-23||April 2008||2008-04-01|June 2015|2015-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|TAURUS||Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder|A Randomized, Double-Blind, Parallel Group, Active Controlled, Multi-center Long-term Study to Assess the Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) 50 mg qd and 100 mg qd in Subjects With Symptoms of Overactive Bladder|Completed||Phase 3|2792|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|3|||f||||t||||||||||2017-02-18 14:19:02.65243|2017-02-18 14:19:02.65243
NCT00688675|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2010-12-06|||February 2008||2008-02-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments|GERD Segmentation: Document How Swiss GPs Allocate Their GERD Patients to the Three GERD Patient Segments|Completed||N/A|2912|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:19:05.815485|2017-02-18 14:19:05.815485
NCT00688662|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2016-06-17|2015-04-13||July 2008||2008-07-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|EPISOD||Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction|A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients|Active, not recruiting||Phase 3|214|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 14:19:05.917155|2017-02-18 14:19:05.917155
NCT00688649|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2009-02-03|||May 2008||2008-05-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|NSCS||Nutritional Supplement Compliance Study|An Investigation of the Effects of Different Modes of Delivery of Oral Nutritional Supplements in Participants at Risk of Malnutrition - A Pilot Study|Completed||Phase 3|80|Actual|Nutricia UK Ltd||2|||f||||f||||||||||2017-02-18 14:19:06.323017|2017-02-18 14:19:06.323017
NCT00688636|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-09-09|2016-04-01||January 2005||2005-01-01|September 2016|2016-09-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery|Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery|Completed||Phase 4|24|Actual|University of Pittsburgh|Limitations to our study included a small sample size, a disproportionate number of smokers in the infliximab group, more patients on immunomodulators in the placebo group, and inclusion of patients who had previously received infliximab.|2|||f||||t||||||||||2017-02-18 14:19:06.419736|2017-02-18 14:19:06.419736
NCT00688623|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2016-05-13|||June 2009||2009-06-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|RAMSETE/CDE16||RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe|A Single Arm, Multicenter Single Stage Phase II Trial of RAD001 as Monotherapy in the Treatment of Metastatic Non Syndromic Neuro-endocrine Tumors|Terminated||Phase 2|73|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:19:06.883924|2017-02-18 14:19:06.883924
NCT00688610|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2009-01-27|||November 2007||2007-11-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter|Antibiotics in Patients With Acute Respiratory Tract Infections in Primary Care in Consideration of Procalcitonin as Additive Parameter|Completed||Phase 2|571|Actual|Hannover Medical School||1|||f||||f||||||||||2017-02-18 14:19:07.009104|2017-02-18 14:19:07.009104
NCT00688597|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2011-05-16||2011-05-16|November 2008||2008-11-01|May 2011|2011-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study to Evaluate the Safety of AT2220 in Pompe Disease|An Open-Label, Multicenter, Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Three Dosing Regimens of Oral AT2220 in Patients With Pompe Disease|Terminated||Phase 2|3|Actual|Amicus Therapeutics||3|||f||||f||||||||||2017-02-18 14:19:07.106393|2017-02-18 14:19:07.106393
NCT00688584|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-04-08|||December 2008||2008-12-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Ultra-brief Intervention for Problem Drinkers|Ultra-brief Intervention for Problem Drinkers|Completed||N/A|1767|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-02-18 14:19:07.251178|2017-02-18 14:19:07.251178
NCT00688571|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2015-10-28|||October 2007||2007-10-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Melody Transcatheter Pulmonary Valve (TPV) Post-Market Surveillance Study|Melody TPV Post-Market Surveillance Study|Completed||N/A|63|Actual|Medtronic Cardiovascular||1|||f||||f||||||||||2017-02-18 14:19:07.369529|2017-02-18 14:19:07.369529
NCT00688558|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-06-02|||February 2004||2004-02-01|May 2008|2008-05-01|March 2006|Actual|2006-03-01|December 2004|Actual|2004-12-01||Interventional|||Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels|A 4-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study Evaluating the Safety and Efficacy of JTT-705 600 mg Versus Placebo Administered Once Daily in Combination With Simvastatin 40 mg in Patients With Low HDL Levels|Completed||Phase 2|92|Actual|Akros Pharma Inc.||2|||f||||f||||||||||2017-02-18 14:19:07.496609|2017-02-18 14:19:07.496609
NCT00237705|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2006-12-04|||May 2004||2004-05-01|December 2006|2006-12-01||||||||Interventional|||Intravenous Metoclopramide for the Treatment of Post Concussive Headache: a Randomized Placebo Controlled Trial||Unknown status|Recruiting|N/A|40||Vancouver General Hospital|||||f||||||||||||||2017-02-18 17:03:06.163344|2017-02-18 17:03:06.163344
NCT00688545|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2013-07-22|2013-05-07||April 2009||2009-04-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|SINCERE||Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis|SINCERE™: Safety in Idiopathic Arthritis: NSAIDs and Celebrex Evaluation Registry A Prospective Observational Registry Of Patients With Juvenile Idiopathic Arthritis (JIA) Treated With NSAIDs|Terminated||N/A|275|Actual|Pfizer|Study terminated prematurely: Sponsor released by FDA from post-marketing commitment. As a result, only a small number of participants/analyses could be performed, data must be interpreted with caution. Endpoints arbitrarily assigned as primary.||2|See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:19:07.60232|2017-02-18 14:19:07.60232
NCT00688532|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-01-30|||December 2007||2007-12-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not|A Pharmacoepidemiological Study on the Association Between Bicalutamide Treated Prostate Cancer and Risk of Coronary Heart Disease (CHD) and Heart Failure (HF) in the General Practice Research Database (GPRD)|Completed||N/A|5103|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 14:19:09.209255|2017-02-18 14:19:09.209255
NCT00688519|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-11-15|2010-11-05||March 2008||2008-03-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies|A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267, Versus Vehicle in Subjects With Plaque-type Psoriasis|Completed||Phase 3|336|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:19:09.30224|2017-02-18 14:19:09.30224
NCT00688506|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2012-07-02|||November 2009||2009-11-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain Syndrome|Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain Syndrome: A Prospective, Randomized, Double-blind, Placebo-controlled Trial|Completed||N/A|60|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 14:19:10.329898|2017-02-18 14:19:10.329898
NCT00688493|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-03-20|||July 2007||2007-07-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|||||Interventional|||Effects of Single Oral Dose Dapagliflozin QT Study|A Double-blind, Randomized, Four-period Crossover Study to Assess the Effects of Single Oral Dose Dapagliflozin Administration on QTc Interval Compared to Placebo, Using AVELOX™ (Moxifloxacin) as a Positive Control, in Healthy Male Volunteers Age 18 to 45 Years|Completed||Phase 1|36|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:19:10.426865|2017-02-18 14:19:10.426865
NCT00688480|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-11-02|||January 2008||2008-01-01|November 2016|2016-11-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?|Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?|Completed||Phase 4|67|Actual|University of Dundee||2|||f||||t||||||||||2017-02-18 14:19:10.532778|2017-02-18 14:19:10.532778
NCT00688467|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2015-09-21|2014-09-26||June 2008||2008-06-01|September 2015|2015-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Navarixin (SCH 527123) in Participants With Allergen-Induced Asthma (P05363)|A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of SCH 527123 in Subjects With Allergen-Induced Asthma|Completed||Phase 2|19|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:19:10.641042|2017-02-18 14:19:10.641042
NCT00688454|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2009-04-08|||February 2007||2007-02-01|April 2009|2009-04-01|January 2008|Actual|2008-01-01|||||Observational|||C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients|C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients|Completed||N/A|3392|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:19:13.657019|2017-02-18 14:19:13.657019
NCT00688441|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2010-08-18||2010-08-17|July 2008||2008-07-01|August 2010|2010-08-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Nasal Carbon Dioxide in the Treatment of Seasonal Allergic Rhinitis|Completed||Phase 2|453|Actual|Capnia, Inc.||2|||f||||f||||||||||2017-02-18 14:19:13.742848|2017-02-18 14:19:13.742848
NCT00688428|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2009-03-11|||April 2008||2008-04-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination|A Phase I, Open-Label, Randomized, Single-Center, 2-Stage Group Sequential Design, 2-Way Crossover Bioequivalence Study Comparing a Fixed-Dose Combination Capsule of Esomeprazole 40mg and Low-Dose Acetylsalicylic Acid (ASA) 325mg With a Free Combination of Esomeprazole Capsule 40mg and Low-Dose ASA|Completed||Phase 1|84|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:19:13.85389|2017-02-18 14:19:13.85389
NCT00688415|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2010-12-21|||November 2008||2008-11-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|August 2010|Actual|2010-08-01||Interventional|||Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer|A Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacology of VTX-2337 When Administered to Adult Subjects With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|33|Actual|VentiRx Pharmaceuticals Inc.||1|||f||||||||||||||2017-02-18 14:19:13.945949|2017-02-18 14:19:13.945949
NCT00688402|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2010-12-02|||April 2008||2008-04-01|December 2010|2010-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Compare Different Formulations of AZD3355|A Double-blind, Randomized, Cross-over Design, Phase 1 Pharmacodynamic Study to Investigate the Effect of Different Formulations of AZD3355 for the Development of Paresthesiae After Dosing in Healthy Subjects|Completed||Phase 1|48|Anticipated|AstraZeneca||5|||f||||f||||||||||2017-02-18 14:19:14.023745|2017-02-18 14:19:14.023745
NCT00688389|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-06-22|||July 2007||2007-07-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection|Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection|Recruiting||N/A|700|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||3||f||||f||||||Samples With DNA|"~     blood samples~   "|||2017-02-18 14:19:14.126533|2017-02-18 14:19:14.126533
NCT00688376|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2009-09-22|||August 2008||2008-08-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment|Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment|Completed||Phase 3|300|Actual|Eisai Inc.||2|||f||||f||||||||||2017-02-18 14:19:14.231123|2017-02-18 14:19:14.231123
NCT00688363|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2011-07-29|||February 2003||2003-02-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control|The Benefit of the Blood Glucose Self Monitoring and a Regular Three-monthly Hemoglobin A1c Profile in Patients With Type 2-diabetes and Conventional Insulin Therapy|Completed||Phase 4|300|Actual|Deutsche Diabetes Gesellschaft||4|||f||||f||||||||||2017-02-18 14:19:14.581369|2017-02-18 14:19:14.581369
NCT00688350|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-10-03|||July 2008||2008-07-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Medication Adherence in Hypertension Study|Interventions to Improve Medication-Taking Behavior in Older Adults With Hypertension: An Exploratory Study|Completed||N/A|15|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-02-18 14:19:14.737612|2017-02-18 14:19:14.737612
NCT00688337|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-30|||June 2008||2008-06-01|May 2008|2008-05-01|June 2010|Anticipated|2010-06-01|June 2009|Anticipated|2009-06-01||Observational|||Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer||Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||None Retained|"~     not relevant~   "|||2017-02-18 14:19:14.865102|2017-02-18 14:19:14.865102
NCT00688324|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2012-09-10|||June 2008||2008-06-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Biomarker Study of Acamprosate in Schizophrenia|Biomarker Study of Acamprosate in Schizophrenia|Completed||Phase 4|39|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 14:19:14.957701|2017-02-18 14:19:14.957701
NCT00688311|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2009-11-19|||May 2008||2008-05-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Pilot Trial of a Synbiotic in HIV+ Patients|Pilot Trial of a Synbiotic in HIV+ Patients|Completed||N/A|34|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 14:19:15.089154|2017-02-18 14:19:15.089154
NCT00688298|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-30|||May 2004||2004-05-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Post Market Clinical Study to Evaluate a Mid-Urethral Vaginal Tape Procedure With a Pre-Pubic Delivery Approach, for the Treatment of Stress Urinary Incontinence|A Prospective, Single-Arm, Post Market Clinical Study to Evaluate a Mid-Urethral Vaginal Tape Procedure With a Pre-Pubic Delivery Approach, for the Treatment of Stress Urinary Incontinence|Completed||Phase 4|100|Actual|Boston Scientific Corporation||1|||f||||||||||||||2017-02-18 14:19:15.210662|2017-02-18 14:19:15.210662
NCT00688285|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2011-03-24|||December 2008||2008-12-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ACRinCKD||Automated Clinical Reminders in the Care of Chronic Kidney Disease Patients|Automated Clinical Reminders in the Care of Chronic Kidney Disease Patients|Completed||N/A|248|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 14:19:15.31201|2017-02-18 14:19:15.31201
NCT00688272|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2012-03-15|||June 2008||2008-06-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag|A Phase I, Double-blind, Placebo and Observer-blind Positive Controlled, Randomized, Parallel Group Study in Healthy Subjects to Investigate the Photoirritant Potential of Eltrombopag|Completed||Phase 1|36|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 14:19:15.423952|2017-02-18 14:19:15.423952
NCT00688259|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-05-05|||April 2009||2009-04-01|May 2015|2015-05-01|June 2015|Anticipated|2015-06-01|September 2014|Actual|2014-09-01||Interventional|||Cognitive-Behavioral Therapy in Veterans With Schizophrenia|Cognitive-Behavioral Therapy in Veterans With Schizophrenia|Active, not recruiting||Phase 3|122|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:19:15.534713|2017-02-18 14:19:15.534713
NCT00688246|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-11-11|||January 2008||2008-01-01|July 2012|2012-07-01|January 2013|Actual|2013-01-01|October 2011|Actual|2011-10-01||Observational|||Bone Mineral Density in Postmenopausal Women at Increased Risk of Developing Breast Cancer And Who Are Receiving Exemestane on Clinical Trial CAN-NCIC-MAP3|The Influence of Five Years of Exemestane on Bone Mineral Density in Postmenopausal Women at Increased Risk of Developing Breast Cancer|Completed||N/A|238|Actual|Canadian Cancer Trials Group|||1||f||||t||||||Samples With DNA|"~     Serum~   "|||2017-02-18 14:19:15.647202|2017-02-18 14:19:15.647202
NCT00688233|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-05-28|||December 2007||2007-12-01|May 2008|2008-05-01|May 2009|Anticipated|2009-05-01|October 2008|Anticipated|2008-10-01||Interventional|Seifi-Fx||Effect of the Innovated Seifi's Functional Appliance on Skeletal and Dentoalveolar Changes of Class II/ 1, Deep Bite|Phase 1 Effect of the Innovated Seifi's Functional Appliance on the Skeletal and Dentoalveolar Changes of Class II/Division 1, Deep Bite Cases|Unknown status|Recruiting|Phase 1|20|Anticipated|Shahid Beheshti University of Medical Sciences||1|||f||||||||||||||2017-02-18 14:19:15.757663|2017-02-18 14:19:15.757663
NCT00688220|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-06-02|||July 2008||2008-07-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Effect of Celliant Materials on Pain and Blood Oxygenation in Subjects With Chronic Elbow and Wrist Pain|Effect of Celliant Materials on Pain and Blood Oxygenation in Subjects With Chronic Elbow and Wrist Pain|Terminated||N/A|0|Actual|Southern California Institute for Research and Education|||2|PI closed study due to lack of enrollment|f||||f||||||||||2017-02-18 14:19:15.869059|2017-02-18 14:19:15.869059
NCT00688207|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-11-04|||April 2008||2008-04-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)|An Open Label Single Oral Dose Study in Patients With Mild Alzheimer's Disease to Assess the Pharmacokinetics of Extended Release Formulation of Rosiglitazone (RSG XR) in This Population|Completed||Phase 1|14|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:19:15.959655|2017-02-18 14:19:15.959655
NCT00672880|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2015-03-24|||October 2003||2003-10-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|Low Back Pain||Self System Therapy and Chronic Low Back Pain Trial|The Use of Self-System Therapy to Alter Self-Discrepancies in Chronic Low Back Pain Patients|Completed||Phase 4|137|Actual|Duke University||3|||f||||t||||||||||2017-02-18 14:24:38.761035|2017-02-18 14:24:38.761035
NCT00688194|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2013-08-23|||May 2008||2008-05-01|May 2008|2008-05-01||||May 2013|Anticipated|2013-05-01||Interventional|||Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy|Overcoming Endocrine Resistance in Metastatic Breast Cancer: A Randomized Trial With Factorial Design Comparing Fulvestrant ± Lapatinib ± Aromatase Inhibitor in Metastatic Breast Cancer Progressing After Aromatase Inhibitor Therapy|Unknown status|Recruiting|Phase 3|396|Anticipated|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 14:19:16.069287|2017-02-18 14:19:16.069287
NCT00688181|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2009-03-30|||December 2006||2006-12-01|March 2009|2009-03-01|April 2009|Anticipated|2009-04-01|November 2008|Actual|2008-11-01||Observational|||The Prefyx PPS™ System eRegistry|The Prefyx PPS™ System eRegistry|Unknown status|Active, not recruiting|N/A|44|Actual|Boston Scientific Corporation|||1||f||||||||||||||2017-02-18 14:19:16.180392|2017-02-18 14:19:16.180392
NCT00688168|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-02-18|||May 2008||2008-05-01|February 2016|2016-02-01||||May 2018|Anticipated|2018-05-01||Observational|||Inflammatory Cytokines in Symptom Production in Multiple Myeloma|Identifying the Role of Inflammatory Cytokines in Symptom Production in Multiple Myeloma|Active, not recruiting||N/A|625|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Tissue sample by inserting a swab into mouth and rubbing firmly against the inside of cheeck~     or underneath lower or upper lip for about a minute during a regularly schedule clinic~     visit.~   "|||2017-02-18 14:19:16.514268|2017-02-18 14:19:16.514268
NCT00688155|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2008-11-13|||May 2008||2008-05-01|November 2008|2008-11-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|SHARP-P||Seniors Health and Activity Research Program-Pilot|Seniors Health and Activity Research Program-Pilot|Unknown status|Recruiting|N/A|100|Anticipated|National Institute on Aging (NIA)||4|||f||||t||||||||||2017-02-18 14:19:16.637638|2017-02-18 14:19:16.637638
NCT00688142|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-03-30|||February 2008||2008-02-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder|Magnetoencephalographic Imaging of Sleepiness: The Effect of Armodafinil in Shift Work Sleep Disorder|Completed||N/A|24|Actual|Henry Ford Health System|||2||f||||f||||||||||2017-02-18 14:19:16.738271|2017-02-18 14:19:16.738271
NCT00688129|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-03-28|||September 2005||2005-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|KITS||KITS: School Readiness in Foster Care Efficacy Trial|KITS: School Readiness in Foster Care Efficacy Trial|Active, not recruiting||N/A|200|Anticipated|Oregon Social Learning Center||2|||f||||f||||||||||2017-02-18 14:19:16.825626|2017-02-18 14:19:16.825626
NCT00688116|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2014-09-17|||October 2007||2007-10-01|September 2014|2014-09-01|November 2014|Anticipated|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors|A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|45|Anticipated|Synta Pharmaceuticals Corp.||1|||f||||f||||||||||2017-02-18 14:19:16.957331|2017-02-18 14:19:16.957331
NCT00688103|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-25|2015-09-01|2012-03-29||June 2005||2005-06-01|September 2015|2015-09-01|October 2010|Actual|2010-10-01|October 2008|Actual|2008-10-01||Interventional|JESMR||Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan|Efficacy and Safety of Etanercept in Active Rheumatoid Arthritis Despite Methotrexate Therapy in Japan|Completed||Phase 4|151|Actual|Japan Biological Agent Study Integrated Consortium||2|||f||||t||||||||||2017-02-18 14:19:17.059226|2017-02-18 14:19:17.059226
NCT00688090|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-08-02|||June 2008||2008-06-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.|A Phase 1/2, Open Label, Non-Randomized Dose Escalation Study to Evaluate the Safety, Tolerability, Immune Response and Clinical Response of Multiple Doses of MKC1106-MT in Subjects With Advanced Melanoma|Completed||Phase 1|19|Actual|Mannkind Corporation||2|||f||||f||||||||||2017-02-18 14:19:17.536354|2017-02-18 14:19:17.536354
NCT00688077|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-06-27|||May 2008||2008-05-01|June 2016|2016-06-01||||December 2012|Actual|2012-12-01||Interventional|||FGF-23 Suppressibility by Calcitonin|Evaluation of FGF-23 Suppressibility by Calcitonin in Healthy Men - Pilot Study|Completed||N/A|49|Actual|Rijnstate Hospital||2|||f||||||||||||||2017-02-18 14:19:17.644976|2017-02-18 14:19:17.644976
NCT00688064|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-03-31|2010-02-23||August 2008||2008-08-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|ACCESS I||Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris|Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Associated With Doxycycline Hyclate 100 mg Tablets Versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Vehicle Gel Associated With Doxycycline Hyclate 100 mg Tablets in the Treatment of Severe Acne Vulgaris.|Completed||Phase 3|459|Actual|Galderma||2|||f||||f||||||||||2017-02-18 14:19:17.754211|2017-02-18 14:19:17.754211
NCT00688051|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2014-09-03|||May 2008||2008-05-01|September 2014|2014-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||"Changes in Adherence After Playing My Life With CF Game"|Changes in Adherence to Diet, Treatment and Medication in the Cystic Fibrosis Patient as a Result of Participation in a Simulation Game.|Completed||N/A|30|Actual|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-02-18 14:19:18.314561|2017-02-18 14:19:18.314561
NCT00688038|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-07-12|||May 2008||2008-05-01|July 2016|2016-07-01||||May 2018|Anticipated|2018-05-01||Interventional|||Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy|A Study to Determine Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Therapy of Metastases to Bone|Active, not recruiting||Phase 4|24|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:19:18.422595|2017-02-18 14:19:18.422595
NCT00688025|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-03-30|||May 2008||2008-05-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia|Magnetoencephalographic Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia|Completed||N/A|24|Actual|Henry Ford Health System|||2||f||||f||||||||||2017-02-18 14:19:18.529052|2017-02-18 14:19:18.529052
NCT00688012|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2009-09-17|||May 2008||2008-05-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety Study of SPC3649 in Healthy Men|A Placebo-controlled, Double-blind, Randomized, Single Dose, Dose Escalating Trial in Healthy Men to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPC3649|Completed||Phase 1|64||Santaris Pharma A/S|||||f||||f||||||||||2017-02-18 14:19:18.617595|2017-02-18 14:19:18.617595
NCT00687999|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2009-08-03|||December 2005||2005-12-01|May 2008|2008-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||NIDDM and IR in Combination Therapy for CHC|Non-insulin-dependent Diabetes Mellitus and Insulin Resistance in Chronic Hepatitis C Patients Treated With Combination Therapy With Pegylated Interferon and Ribavirin in Taiwan|Completed||N/A|400|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||t||||||||||2017-02-18 14:19:18.697394|2017-02-18 14:19:18.697394
NCT00687986|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-06-02|||October 2008||2008-10-01|January 2011|2011-01-01|December 2015|Anticipated|2015-12-01|December 2013|Actual|2013-12-01||Interventional|ROSEL||Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer|A Randomized Clinical Trial of Surgery Versus Radiosurgery (Stereotactic Radiotherapy) in Patients With Stage IA NSCLC Who Are Fit to Undergo Primary Resection|Terminated||Phase 3|960|Anticipated|VU University Medical Center||2||Poor recruitment|f||||t||||||||||2017-02-18 14:19:18.81063|2017-02-18 14:19:18.81063
NCT00687973|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-03-08|2010-12-22||January 2008||2008-01-01|March 2011|2011-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|EXPLOR||Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg|Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg|Completed||Phase 4|393|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:19:18.921093|2017-02-18 14:19:18.921093
NCT00687960|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2008-05-28|||November 2006||2006-11-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|May 2007|Actual|2007-05-01||Interventional|||Effect of Resistant Starch Type 4 on Glycemia and Insulin Sensitivity in Young Adults|Effect of Resistant Starch Type 4 on Glycemia and Insulin Sensitivity in Young Adults|Completed||N/A|13|Actual|Kansas State University||4|||f||||f||||||||||2017-02-18 14:19:19.652059|2017-02-18 14:19:19.652059
NCT00687947|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2009-07-31|||May 2008||2008-05-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|CGRP-2008||Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)|CGRP-induced Headache in Patients With Familial Hemiplegic Migraine, Migraine With Aura and Healthy Controls|Completed||N/A|30|Anticipated|Danish Headache Center||3|||f||||f||||||||||2017-02-18 14:19:19.77009|2017-02-18 14:19:19.77009
NCT00687934|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2014-09-17|||October 2007||2007-10-01|September 2014|2014-09-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors|A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Once-Weekly in Patients With Solid Tumors|Completed||Phase 1|53|Actual|Synta Pharmaceuticals Corp.||1|||f||||f||||||||||2017-02-18 14:19:19.8865|2017-02-18 14:19:19.8865
NCT00687921|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-30|||June 2008||2008-06-01|May 2008|2008-05-01|June 2009|Anticipated|2009-06-01|March 2009|Anticipated|2009-03-01||Observational|||F18-Flouride PET/CT in Acute Knee Injury|F18-Flouride PET/CT in Acute Knee Injury. A Prospective Study|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||None Retained|"~     not relevant~   "|||2017-02-18 14:19:19.977887|2017-02-18 14:19:19.977887
NCT00687908|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-09-30|2010-07-16||November 2008||2008-11-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|ACCESS II||Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance|Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Vehicle Gel as a 6-month Acne Maintenance Treatment|Completed||Phase 3|243|Actual|Galderma||2|||f||||f||||||||||2017-02-18 14:19:20.06664|2017-02-18 14:19:20.06664
NCT00687895|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-28|||July 2003||2003-07-01|May 2008|2008-05-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Improved Clinical and Microscopy Diagnosis at Primary Health Care in Tanzania|Quality Malaria Case Management In Under- Fives In Primary Health Care (Phc) Institutions In Bagamoyo And Kibaha Districts Of Coastal Tanzania:a Multicomponent Controlled Intervention Study|Completed||Phase 4|3131|Actual|Muhimbili University of Health and Allied Sciences||3|||f||||t||||||||||2017-02-18 14:19:20.593195|2017-02-18 14:19:20.593195
NCT00687882|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2017-01-25|||March 2008||2008-03-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2019|Anticipated|2019-12-01||Interventional|Kids-DOTT||Evaluation of the Duration of Therapy for Thrombosis in Children|Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children|Recruiting||Phase 3|750|Anticipated|Johns Hopkins All Children's Hospital||4|||f||||t||||||||No||2017-02-18 14:19:20.707796|2017-02-18 14:19:20.707796
NCT00687869|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2013-09-18|||June 2008||2008-06-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|PaReSiS||Participative Rehabilitation in Stroke Patients|"Participative Rehabilitation Process Management Stroke in Saxony-Anhalt"|Completed||Phase 3|322|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-02-18 14:19:20.959634|2017-02-18 14:19:20.959634
NCT00687856|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-01-13|2016-01-13||April 2008||2008-04-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|RECOVER||Identifying and Facilitating Ventricular Recovery on Mechanical Support|Identifying and Facilitating Ventricular Recovery on Mechanical Support|Completed||N/A|211|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 14:19:21.074362|2017-02-18 14:19:21.074362
NCT00687843|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2012-03-20|||June 2008||2008-06-01|March 2012|2012-03-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|TMOG-GC01||Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients|Phase III Randomized Controlled Study of Postoperative Adjuvant Therapy Using TS-1 or TS-1+PSK for Stage II or III Gastric Cancer Patients|Unknown status|Active, not recruiting|Phase 3|480|Anticipated|Tokyo Metropolitan Oncology Group||2|||f||||t||||||||||2017-02-18 14:19:21.300225|2017-02-18 14:19:21.300225
NCT00687830|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-03-11|2015-02-19||February 2008||2008-02-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|CCF||Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy.|A Randomized Endoscopist-blinded Clinical Trial Comparing the Bowel Cleansing Effect and Patient Tolerability of Same Day Polyethylene Glycol Bowel Preparation Regimen v Regimen Given on the Day Before Colonoscopy|Completed||Phase 3|136|Actual|Cleveland Clinic Florida||2|||f||||f||||||||||2017-02-18 14:19:21.420028|2017-02-18 14:19:21.420028
NCT00687817|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2011-03-23|||June 2008||2008-06-01|March 2011|2011-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer|A Phase II Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|49|Actual|Peregrine Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:19:21.737939|2017-02-18 14:19:21.737939
NCT00687804|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2013-03-26|2011-01-19||May 2008||2008-05-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2010|Actual|2010-01-01||Interventional|RESTORE||A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study|A Randomized, Double-masked, Multicenter, Laser-controlled Phase III Study Assessing the Efficacy and Safety of Ranibizumab (Intravitreal Injections) as Adjunctive and Mono-therapy in Patients With Visual Impairment Due to Diabetic Macular Edema|Completed||Phase 3|345|Actual|Novartis||3|||f||||||||||||||2017-02-18 14:19:21.849281|2017-02-18 14:19:21.849281
NCT00687791|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-06-17|||December 2007||2007-12-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study|Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study|Unknown status|Recruiting|Phase 3|20|Anticipated|Pro Top & Mediking Company Limited||1|||f||||t||||||||||2017-02-18 14:19:23.834709|2017-02-18 14:19:23.834709
NCT00687778|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-30|||May 2008||2008-05-01|May 2008|2008-05-01|June 2010|Anticipated|2010-06-01|June 2009|Anticipated|2009-06-01||Observational|||11C-Acetate PET/CT Non-FDG-Avid Tumors||Unknown status|Recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||t||||||||||2017-02-18 14:19:23.945623|2017-02-18 14:19:23.945623
NCT00687765|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-07-10|||July 2008||2008-07-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma|Phase I/II Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma|Completed||Phase 1/Phase 2|126|Actual|Sanofi||1|||t||||f||||||||||2017-02-18 14:19:24.051132|2017-02-18 14:19:24.051132
NCT00687752|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-30|||May 2007||2007-05-01|May 2008|2008-05-01|May 2009|Anticipated|2009-05-01|April 2008|Anticipated|2008-04-01||Observational|FD||Sonographic Assessment of Fetal Deglutition Associated With Hydramnion:Its Absence is Indicative of Central Nervous System (CNS) Pathology|Sonographic Assessment of Fetal Deglutition Associated With Hydramnion:Its Absence is Indicative of CNS Pathology? a Report on Two Cases.|Unknown status|Enrolling by invitation|N/A|310|Actual|Hippocration General Hospital|||2||f||||t||||||||||2017-02-18 14:19:24.161864|2017-02-18 14:19:24.161864
NCT00687739|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-03-08|||May 2008||2008-05-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|POWER||Prevention of Obesity in Women Via Estradiol Regulation|Estrogen Deficiency and Mechanisms of Fat Accumulation|Completed||Phase 3|150|Actual|University of Colorado, Denver||4|||f||||t||||||||||2017-02-18 14:19:24.257256|2017-02-18 14:19:24.257256
NCT00687726|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-28|||May 2006||2006-05-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|August 2007|Actual|2007-08-01||Interventional|||Simple Home-Based Exercise for Knee Osteoarthritis|The Relationship of Knee Joint Osteoarthritis to Balance and Walking Ability.|Completed||N/A|48|Actual|Srinakharinwirot University||2|||f||||f||||||||||2017-02-18 14:19:24.385382|2017-02-18 14:19:24.385382
NCT00687713|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-12-22|2016-12-22||May 2008||2008-05-01|December 2016|2016-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence|Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence|Completed||Phase 2|200|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||No||2017-02-18 14:19:24.483163|2017-02-18 14:19:24.483163
NCT00687700|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-11-03|||March 2008||2008-03-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers|A Study to Investigate the Relative Pharmacological Activity of Aninhaled B2-agonist/Anticholinergic Dual Pharmacophore Inhealthy Volunteers|Completed||Phase 1|23|Anticipated|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:19:24.85174|2017-02-18 14:19:24.85174
NCT00687687|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2012-08-01||2012-06-15|May 2008||2008-05-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|March 2010|Actual|2010-03-01||Interventional|||Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma|A Phase II Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma|Completed||Phase 2|22|Actual|Sanofi||1|||t||||f||||||||||2017-02-18 14:19:24.964576|2017-02-18 14:19:24.964576
NCT00687674|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2012-03-07|2011-11-23||August 2008||2008-08-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|Phase I/II Study of Sorafenib, Lenalidomide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma|Terminated||Phase 1/Phase 2|13|Actual|Mayo Clinic||1||"Due to study design (and toxicity), this trial closed to accrual prior to opening the phase II~   portion."|f||||t||||||||||2017-02-18 14:19:25.110627|2017-02-18 14:19:25.110627
NCT00687661|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-09-25|||October 2008||2008-10-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|QUICK||Queen's University Investigation of Calcification in Chronic Kidney Disease|The Use of Bisphosphonates to Prevent or Delay the Progression of Vascular Calcification in End-Stage Renal Disease: A Randomized Controlled Trial|Completed||Phase 3|25|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 14:19:25.399229|2017-02-18 14:19:25.399229
NCT00687648|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-30|2009-06-16|||May 2008||2008-05-01|June 2009|2009-06-01||||April 2010|Anticipated|2010-04-01||Interventional|||Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer|Randomised Phase II Study of Metronomic Chemotherapy Plus the Same Aromatase Inhibitor Compared to Metronomic Chemotherapy Alone in Women With Hormone Receptor Positive, Her-2 Non-Overexpressing Advanced Breast Cancer Whose Disease Has Progressed While Receiving an Aromatase Inhibitor, Correlating Response With Circulating Endothelial Progenitor Cells, VEGF and VEGFR|Unknown status|Recruiting|Phase 2|70|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:19:25.515872|2017-02-18 14:19:25.515872
NCT00687453|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-02-07|2010-09-15||February 2003||2003-02-01|February 2014|2014-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Insulin Glargine Versus Twice-Daily NPH|The Utility of Insulin Glargine (Lantus) Compared to NPH in Ethnic Minority Type 2 Diabetic Subjects on Combination Insulin-Oral Agent Therapy|Completed||Phase 4|27|Actual|Charles Drew University of Medicine and Science|Early termination leading to smaller than anticipated enrollment.|2|||f||||t||||||||||2017-02-18 14:19:28.052179|2017-02-18 14:19:28.052179
NCT00687622|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-06-08|||July 2008||2008-07-01|June 2015|2015-06-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma|An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor GSK1120212 in Subjects With Solid Tumors or Lymphoma|Completed||Phase 1|94|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 14:19:25.630436|2017-02-18 14:19:25.630436
NCT00687609|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-08-18|2010-07-22||September 2008||2008-09-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|PEACE||Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE|An Open Label Pilot Study of Atomoxetine Hydrochloride in Adolescents With Attention Deficit/Hyperactivity Disorder and Comorbid Cannabis Abuse.|Terminated||Phase 4|7|Actual|Eli Lilly and Company|The study was discontinued early, owing to difficulties in recruiting the target sample after seven patients had been recruited. Therefore, only disposition, demographic, and safety data are reported.|1||"The study was discontinued early, owing to difficulties in recruiting the target sample after~   seven patients had been recruited."|f||||f||||||||||2017-02-18 14:19:25.955729|2017-02-18 14:19:25.955729
NCT00687596|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2013-06-04||2013-06-04|June 2008||2008-06-01|June 2013|2013-06-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|||Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy|A Phase 2, Double-blind, Placebo-controlled, Randomized, International, Multicenter Study of Oral TAC 101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy|Terminated||Phase 2|52|Actual|Taiho Oncology, Inc.||2||Terminated due to safety concerns|f||||f||||||||||2017-02-18 14:19:26.340066|2017-02-18 14:19:26.340066
NCT00687583|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-05-03|||April 2007||2007-04-01|May 2016|2016-05-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Observational|||Head Movement Effect on Different Tracheal Tubes|Effect of Head Movement on the Position of Different Tracheal Tubes Determined Radiologically|Withdrawn||Phase 4|0|Actual|The Hospital for Sick Children|||1|Research question deemed not of enough clinical importance to proceed.|f||||f||||||||||2017-02-18 14:19:26.459757|2017-02-18 14:19:26.459757
NCT00687570|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2015-02-19|||July 2008||2008-07-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Bowel Preparation Before Rectal Cancer Surgery|Bowel Preparation With Nutritional Drinks Instead of Traditional Bowel Preparation Before Rectal Cancer Surgery|Completed||N/A|32|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 14:19:26.541398|2017-02-18 14:19:26.541398
NCT00687544|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-09-11|2011-09-22||December 2005||2005-12-01|September 2015|2015-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)|Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon|Terminated||Phase 4|11|Actual|Merck Sharp & Dohme Corp.|The study was terminated early due to low enrollment. The primary and secondary outcomes were not evaluated. A formal safety analysis was not performed for the 11 participants enrolled in the study.|1|||f||||f||||||||||2017-02-18 14:19:26.64615|2017-02-18 14:19:26.64615
NCT00687531|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-10-19|2011-06-17||November 2006||2006-11-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|APEGO||Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate in Asthmatic Patients (Study P04879)(TERMINATED)|Open Label, 12-week Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate Dry Powder 400 mcg Once-daily in Persistent Mild-moderate Asthmatic Patients at Least 12 Years Old|Terminated||Phase 4|385|Actual|Merck Sharp & Dohme Corp.|Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data.|1|||f||||f||||||||||2017-02-18 14:19:26.926063|2017-02-18 14:19:26.926063
NCT00687518|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-05-29|||March 2008||2008-03-01|May 2008|2008-05-01|February 2009|Anticipated|2009-02-01|November 2008|Anticipated|2008-11-01||Interventional|HEPEPO||Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers|Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers|Unknown status|Recruiting|N/A|14|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-02-18 14:19:27.292985|2017-02-18 14:19:27.292985
NCT00687505|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2013-03-05|||July 2008||2008-07-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Safety Study of FP-1039 To Treat Cancer|A Phase 1, Open-Label, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of FP-1039 in Subjects With Metastatic or Locally Advanced Unresectable Solid Tumors|Completed||Phase 1|39|Actual|Five Prime Therapeutics, Inc.||1|||f||||f||||||||||2017-02-18 14:19:27.41221|2017-02-18 14:19:27.41221
NCT00687492|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-12-01|||May 2008||2008-05-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|CEPHEUS||Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia|Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia|Completed||N/A|8000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:19:27.498217|2017-02-18 14:19:27.498217
NCT00687479|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2014-12-17|||January 2006||2006-01-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Observational|DRM||Insulin Action During Pregnancy in Woman at High Risk for Gestational Diabetes|Clinically Useful Methods for Assessment of Insulin Sensitivity and Beta Cell Function in Women at High Risk for Gestational Diabetes: Does Race Matter?|Completed||N/A|175|Actual|Woman's|||3||f||||f||||||Samples Without DNA|"~     Blood samples for insulin measurements~   "|||2017-02-18 14:19:27.805617|2017-02-18 14:19:27.805617
NCT00687466|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2009-08-03|||August 2005||2005-08-01|August 2009|2009-08-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay|Phase 3 Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay|Unknown status|Active, not recruiting|Phase 3|70|Anticipated|Fondazione per la ricerca sulla Fibrosi Cistica||2|||f||||t||||||||||2017-02-18 14:19:27.912847|2017-02-18 14:19:27.912847
NCT00686907|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2012-10-23|||March 2007||2007-03-01|October 2012|2012-10-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Blind Adult Melatonin Treatment Study|Melatonin for Circadian Sleep Disorders in the Blind|Unknown status|Active, not recruiting|N/A|200|Anticipated|National Eye Institute (NEI)||1|||f||||t||||||||||2017-02-18 14:19:40.576966|2017-02-18 14:19:40.576966
NCT00687440|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-10-29|2010-01-21||May 2005||2005-05-01|October 2014|2014-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)|Pegylated Liposomal Doxorubicin (Caelyx) in Combination With Herceptin and Taxotere as First-line Chemotherapy in Metastatic Breast Cancer Patients: A 2 Stage Phase II, Open Label, Multicenter Study.|Completed||Phase 2|27|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:28.566487|2017-02-18 14:19:28.566487
NCT00687427|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-05-29|||June 2008||2008-06-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|||||Observational|||Return to Work After Hand Injury: the Role of Medical, Demographic and Psycho-Social Factors|Return to Work After Hand Injury: The Role of Medical, Demographic and Psychosocial Factors|Unknown status|Not yet recruiting|N/A|75|Anticipated|Soroka University Medical Center|||3||f||||||||||||||2017-02-18 14:19:28.961842|2017-02-18 14:19:28.961842
NCT00687414|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2010-01-08|||April 2008||2008-04-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Observational|||Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders|Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders|Completed||N/A|60|Anticipated|Spectrum Health Hospitals|||2||f||||f||||||Samples With DNA|"~     peripheral blood~   "|||2017-02-18 14:19:29.072288|2017-02-18 14:19:29.072288
NCT00687401|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-10-19|2010-12-02||June 2006||2006-06-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|ESAQUALITY||A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)|A Multi-center, Open Label Trial Evaluating the Efficacy , SAfety and the Impact on QUAlity of Life of Infliximab TherapY in Patients With Moderate-to-severe Psoriasis Not Responding to Standard or Biologic Therapy|Completed||Phase 3|215|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 14:19:29.174833|2017-02-18 14:19:29.174833
NCT00687388|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2013-06-07|||May 2008||2008-05-01|June 2013|2013-06-01||||March 2012|Anticipated|2012-03-01||Interventional|||The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia|The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia: A Prospective Randomized Multicenter Trial|Withdrawn||Phase 4|0|Actual|Samsung Medical Center||3||in order to prepare a new clinical trial to evaluate with pathological change|f||||t||||||||||2017-02-18 14:19:29.384949|2017-02-18 14:19:29.384949
NCT00687375|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-29|||April 2007||2007-04-01|May 2008|2008-05-01|March 2009|Anticipated|2009-03-01|May 2008|Anticipated|2008-05-01||Interventional|||Laparoscopic Inguinal Hernia Repair- Transabdominal Preperitoneal (TAPP) Versus Totally Extra Peritoneal (TEP)|A Randomized Controlled Trial of Laparoscopic Inguinal Hernia Repair- Transabdominal Preperitoneal (TAPP) Versus Totally Extra Peritoneal (TEP) Approach|Unknown status|Recruiting|N/A|90|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 14:19:29.511244|2017-02-18 14:19:29.511244
NCT00687362|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-02-12|2010-02-17||May 2006||2006-05-01|February 2015|2015-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)|A Multicenter, Multinational, Open Label Study on the Efficacy and Safety of Infliximab Monotherapy in Moderate-to-severe Chronic Plaque Psoriasis in Middle Eastern Population|Completed||Phase 2|22|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:29.62546|2017-02-18 14:19:29.62546
NCT00687349|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2014-09-13|||April 2007||2007-04-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|ICCS||Improving Clinician Communication Skills (ICCS)|Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses|Completed||Phase 3|6086|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 14:19:29.83816|2017-02-18 14:19:29.83816
NCT00687336|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2009-07-07|||March 2008||2008-03-01|July 2009|2009-07-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|HETUB||Helicobacter Pylori Empiric Treatment in Ulcer Bleeding|Phase IV Study Comparing Helicobacter Pylori Empiric Eradication With Test-Guided Treatment in Patients With Peptic Ulcer Bleeding|Unknown status|Recruiting|Phase 4|178|Anticipated|Hospital de Sabadell||2|||f||||f||||||||||2017-02-18 14:19:29.952444|2017-02-18 14:19:29.952444
NCT00687323|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-02-12|2012-05-04||July 2007||2007-07-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|May 2011|Actual|2011-05-01||Interventional|TALL||Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)|Phase II Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) Subjects Unsuitable for Standard Induction Therapy Exhibiting Low MGMT Expression|Completed||Phase 2|47|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 14:19:30.073655|2017-02-18 14:19:30.073655
NCT00687310|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2011-01-21|||December 2005||2005-12-01|January 2011|2011-01-01|January 2007|Actual|2007-01-01|||||Interventional|||Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) Trial|Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) Trial|Completed||Phase 4|160|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:19:30.480524|2017-02-18 14:19:30.480524
NCT00687297|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2012-11-28|2012-06-06||April 2008||2008-04-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer|A Randomized Phase II Study Evaluating Vandetanib (ZD6474) in Combination With Docetaxel and Carboplatin Followed by Placebo or Maintenance Therapy With Vandetanib in Patients With IIIb, IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|162|Actual|PrECOG, LLC.||2|||f||||t||||||||||2017-02-18 14:19:30.576595|2017-02-18 14:19:30.576595
NCT00687284|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-10-27|||February 2008||2008-02-01|October 2016|2016-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|START||Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus|Observational Study on Evaluation of Glycaemic Control in Patients Using Levemir® (Insulin Detemir) as Initiation Insulin Therapy by Levemir® (Insulin Detemir) Administered Once Daily as the Treatment for Type 2 Diabetes Mellitus.|Completed||N/A|2188|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:19:31.416805|2017-02-18 14:19:31.416805
NCT00237094|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2010-01-14|||June 2005||2005-06-01|January 2010|2010-01-01||||||||Interventional|||Use of Midlevel Providers in Diabetes Management|Use of Midlevel Providers in Diabetes Management|Completed||N/A|600|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:03:13.988222|2017-02-18 17:03:13.988222
NCT00687271|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-09-25|||June 2008||2008-06-01|September 2015|2015-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study of MK6213 Co-Administered With Atorvastatin in Patients With Hypercholesterolemia (MK-6213-006)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Efficacy, and Tolerability of MK6213 Co-Administered With Atorvastatin in Patients With Primary Hypercholesterolemia|Completed||Phase 2|330|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 14:19:31.519962|2017-02-18 14:19:31.519962
NCT00687258|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2012-04-10|||July 2006||2006-07-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|March 2007|Actual|2007-03-01||Interventional|Vi-E||Evaluation Of A New Vitamin E-Bonded Membrane On Anemia And Oxidative Stress In End-Stage Renal Disease Patients|Evaluation Of The Impact Of A New Synthetic Vitamin E-Bonded Membrane On The Anemia And Oxidative Stress In End-Stage Renal Disease (ESRD) Patients|Completed||Phase 2|20|Actual|A. Manzoni Hospital||2|||f||||t||||||||||2017-02-18 14:19:31.627004|2017-02-18 14:19:31.627004
NCT00687245|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-06-10|||August 2006||2006-08-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)|A Randomized, Open-Label Study to Evaluate the Pharmacokinetics of Single Oral Doses of Esomeprazole Magnesium in Pediatric Patients 1 to 11 Years-Old Inclusive With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)|Completed||Phase 1|40|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:19:31.738475|2017-02-18 14:19:31.738475
NCT00687232|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-11-30|||January 2008||2008-01-01|November 2010|2010-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers|A Randomised, Placebo-controlled Single-blind, Single-centre Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers|Completed||Phase 1|30|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:19:31.834992|2017-02-18 14:19:31.834992
NCT00687219|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-09-18|2011-10-27||June 2007||2007-06-01|September 2015|2015-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)|Treatment of Patients With Compensated Liver Cirrhosis With SCH 54031 + Ribavirin|Completed||Phase 3|102|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:31.938753|2017-02-18 14:19:31.938753
NCT00687206|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-01-28|||March 2008||2008-03-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage|Efficacy and Safety of Valsartan 160 mg Plus Hydrochlorothiazide 25 mg Once a Day in Patients With Slight Hypertension and Target Organ Damage|Completed||Phase 4|20|Anticipated|Federico II University||1|||f||||t||||||||||2017-02-18 14:19:32.408868|2017-02-18 14:19:32.408868
NCT00687193|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2013-03-19|2012-11-26||March 2009||2009-03-01|March 2013|2013-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Confirm Dose Responsiveness Following 12 Weeks Of The Administration Of CP-690,550 (5 Doses) Or Placebo In Subjects With Active Rheumatoid Arthritis Inadequately Responding To At Least 1 DMARD|Completed||Phase 2|318|Actual|Pfizer||6|||f||||t||||||||||2017-02-18 14:19:32.534362|2017-02-18 14:19:32.534362
NCT00687180|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2008-05-29||||||May 2008|2008-05-01||||||||Interventional|||Mycophenolate vs Azathioprin in Autoimmune Hepatitis||Completed||Phase 4|||Rigshospitalet, Denmark||2|||f||||||||||||||2017-02-18 14:19:34.819924|2017-02-18 14:19:34.819924
NCT00687167|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2010-01-11|2009-11-24||January 2005||2005-01-01|January 2010|2010-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Fed Bioavailability Study of Zonisamide Capsules|A Relative Bioavailability Study of 100 mg Zonisamide Capsules Under Non-Fasting Conditions|Completed||Phase 1|34|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:19:34.907991|2017-02-18 14:19:34.907991
NCT00687154|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-08-25|||September 2005||2005-09-01|August 2016|2016-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|PRP||Observational Study of DME Following Scatter Laser Photocoagulation|An Observational Study of the Development of Diabetic Macular Edema Following Scatter Laser Photocoagulation|Completed||N/A|155|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-02-18 14:19:35.232236|2017-02-18 14:19:35.232236
NCT00687141|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2010-12-08|||November 2007||2007-11-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects|A Phase I, Randomized, Double-blind (with-in Panel), Placebo-controlled, Parallel Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Healthy Elderly Volunteers After Oral Multiple Ascending Doses of AZD0328|Completed||Phase 1|112|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:19:35.334971|2017-02-18 14:19:35.334971
NCT00687128|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2012-02-24|||October 2004||2004-10-01|February 2012|2012-02-01|April 2010|Actual|2010-04-01|September 2009|Actual|2009-09-01||Interventional|||Exercise Dose-Response on Features of the Metabolic Syndrome|Dose-Response Effects of Aerobic Exercise on Insulin Sensitivity and the Metabolic Syndrome|Completed||N/A|93|Actual|Charles Drew University of Medicine and Science||3|||f||||t||||||||||2017-02-18 14:19:35.435976|2017-02-18 14:19:35.435976
NCT00687115|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2017-01-24|||May 15, 2008||2008-05-15|October 6, 2016|2016-10-06|March 31, 2020|Anticipated|2020-03-31|January 1, 2020|Anticipated|2020-01-01||Interventional|||Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting|Predicting Adaptive Thermogenesis|Recruiting||Phase 2|140|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:19:35.65527|2017-02-18 14:19:35.65527
NCT00687102|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2011-08-03|||October 2001||2001-10-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Co-STAR||Cognition in the Study of Tamoxifen and Raloxifene|Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene|Completed||Phase 3|1498|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 14:19:35.77016|2017-02-18 14:19:35.77016
NCT00687089|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2009-01-25|||June 2008||2008-06-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Examination of Cognitive Function in Patients Treated With Subutex|Examination of Cognitive Function, Weight, Sexual Function in Patients Receiving Treatment With Subutex at 3 Months Without Using Opiates|Completed||N/A|60|Anticipated|BeerYaakov Mental Health Center|||1||f||||t||||||||||2017-02-18 14:19:36.187841|2017-02-18 14:19:36.187841
NCT00687076|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2014-08-07|2014-07-16||April 2004||2004-04-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||Baseline characteristics were compared using analysis of variance, chi-square tests. Multilevel statistical models were used to analyze the primary outcome. Complete baseline characteristics were availabe for 95 patients. Between randomization and baseline visit, 1 patient withdrew from study, and 6 patients declined blood collection.|Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)|"Effect of Lipid Modification on Peripheral Arterial Disease After Endovascular Intervention (The ELIMIT Trial)"|Completed||Phase 4|102|Actual|Baylor College of Medicine|MRI was performed in the distal SFA. Ethnicity which was not part of the randomization protocol differed significantly between mono- and triple-therapy groups. The attrition rate was high in ELIMIT. ELIMIT was not powered to assess clinical outcomes.|2|||f||||t||||||||||2017-02-18 14:19:36.28927|2017-02-18 14:19:36.28927
NCT00687063|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-08-13|||April 2008||2008-04-01|November 2012|2012-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|DIABESITY||Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes|An Observational, Safety and Efficacy Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus.|Completed||N/A|10008|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:19:36.79954|2017-02-18 14:19:36.79954
NCT00687050|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2010-05-25|||May 2008||2008-05-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|September 2009|Actual|2009-09-01||Interventional|||Peroral Supplemental Nutrition in End-stage Renal Disease With and Without HIV Comorbidity|MRT-based Pilot Study to Evaluate Peroral Supplemental Nutrition for Prevention of Cachexia in End-stage Renal Disease With and Without HIV Comorbidity|Completed||N/A|30|Anticipated|Johann Wolfgang Goethe University Hospital||3|||f||||f||||||||||2017-02-18 14:19:36.921444|2017-02-18 14:19:36.921444
NCT00687037|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2009-02-12|||January 2008||2008-01-01|February 2009|2009-02-01||||February 2008|Actual|2008-02-01||Interventional|||Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power|Uni Centric Study, Phase III, for Safety Oral Mucosa Evaluation: Basic Acceptability With Odontological Follow up - Cepacol Canela Power|Completed||Phase 3|30|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:19:37.043505|2017-02-18 14:19:37.043505
NCT00687024|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2013-09-04|||May 2007||2007-05-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|FCP||Determining the Extent of Diffusion Tensor Abnormalities in Focal Cortical Dysplasia|Determining the Extent of Diffusion Tensor Abnormalities in Focal Cortical Dysplasia|Completed||N/A|12|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-02-18 14:19:37.141982|2017-02-18 14:19:37.141982
NCT00687011|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-08-24|||October 2006||2006-10-01|August 2015|2015-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)|Open-label Clinical Trial to Assess the Efficacy, Tolerability and Safety of a Single IV Dose of Palonosetron 0.25 mg + Dexamethasone IV in the Prevention of Moderately Emetogenic Chemotherapy-induced Nausea and Vomit (CINV).|Completed||Phase 4|118|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:37.239004|2017-02-18 14:19:37.239004
NCT00686998|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2013-03-20|2010-04-28||May 2008||2008-05-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Phase IIA Study in Patients With Schizophrenia|A Phase IIa, Double-blind, Double-Dummy, Placebo-controlled, Randomized, Parallel-Group Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of AZD2624 in Adult Schizophrenia Patients|Completed||Phase 2|106|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:19:37.338|2017-02-18 14:19:37.338
NCT00686985|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-05-29|||September 2007||2007-09-01|May 2008|2008-05-01|July 2010|Anticipated|2010-07-01|||||Interventional|DOCAR||Docetaxel - Carboplatin as Second Line Treatment in Patients With Small Cell Lung Cancer|A Phase II Study of Docetaxel - Carboplatin as Second Line Treatment in Patients With Refractory or Relapsed Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|55|Anticipated|Jeroen Bosch Ziekenhuis||1|||f||||f||||||||||2017-02-18 14:19:37.739322|2017-02-18 14:19:37.739322
NCT00686972|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2010-03-25|||May 2007||2007-05-01|March 2010|2010-03-01|May 2012|Anticipated|2012-05-01|October 2010|Anticipated|2010-10-01||Interventional|||The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition|The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition|Unknown status|Active, not recruiting|Phase 2|70|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 14:19:37.846665|2017-02-18 14:19:37.846665
NCT00686959|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-05-20|2015-10-22||September 2008||2008-09-01|May 2016|2016-05-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|PROCLAIM|All randomized participants|Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer|Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other Than Predominantly Squamous Cell Histology|Completed||Phase 3|598|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 14:19:37.96528|2017-02-18 14:19:37.96528
NCT00686946|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2017-01-29|||January 2005||2005-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|NRAMP||The National Register of Antipsychotic Medication in Pregnancy (NRAMP)|The National Register of Antipsychotic Medication in Pregnancy (NRAMP)|Recruiting||N/A|500|Anticipated|The Alfred|||1||f||||f||||||||Yes|Individual participant data will be shared, for example, in Case Studies, where personal identification is not compromised, which also allows for an aggregate view of data.|2017-02-18 14:19:40.201369|2017-02-18 14:19:40.201369
NCT00686933|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2013-01-11||2011-08-19|May 2008||2008-05-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|The Long-Term Safety and Tolerability of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD): An Open-Label Extension Study for Subjects Completing Study M10-346|Completed||Phase 2|117|Actual|AbbVie||1|||f||||f||||||||||2017-02-18 14:19:40.334303|2017-02-18 14:19:40.334303
NCT00686920|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2011-02-02|||March 2007||2007-03-01|February 2011|2011-02-01||||December 2010|Actual|2010-12-01||Interventional|||Safety Study for Patients With a History of Hepatic Encephalopathy||Completed||Phase 3|500|Anticipated|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-02-18 14:19:40.445455|2017-02-18 14:19:40.445455
NCT00686894|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-10-19|2009-11-24||January 2008||2008-01-01|October 2015|2015-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|EUSpA||Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)|Study of Peripheral Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab|Terminated||Phase 4|7|Actual|Merck Sharp & Dohme Corp.||1||Poor Enrollment|f||||f||||||||||2017-02-18 14:19:40.694231|2017-02-18 14:19:40.694231
NCT00686881|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-09-04|2012-02-03||December 2006||2006-12-01|September 2015|2015-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)|A Clinical Study of SCH 54031 as Monotherapy in IFN-treated Patients With Chronic Hepatitis C|Terminated||Phase 3|261|Actual|Merck Sharp & Dohme Corp.|This study was prematurely discontinued because of low enrollment.|2||This study was terminated due to low enrollment|f||||t||||||||||2017-02-18 14:19:40.924111|2017-02-18 14:19:40.924111
NCT00686868|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2013-11-07|||June 2008||2008-06-01|November 2013|2013-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients|Clinical Phase I/IIA Study of Subcutaneously Administration of Ofatumumab in Rheumatoid Arthritis Patients on Stable Dose Methotrexate|Completed||Phase 1|35|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-02-18 14:19:41.520062|2017-02-18 14:19:41.520062
NCT00686855|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-02-24|2013-11-20||August 2008||2008-08-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease|An Open Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease|Completed||Phase 2|46|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 14:19:41.63616|2017-02-18 14:19:41.63616
NCT00686842|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2014-08-27|2012-01-30||September 2008||2008-09-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma|A Phase I/II Trial of PTC299 in Patients With HIV-Related Kaposi's Sarcoma|Terminated||Phase 1/Phase 2|17|Actual|AIDS Malignancy Consortium||1||Drug supply unavailable.|f||||f||||||||||2017-02-18 14:19:42.059131|2017-02-18 14:19:42.059131
NCT00686829|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-02-20|||June 2005||2005-06-01|February 2015|2015-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Study P04100AM4)(COMPLETED)|Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Protocol No. P04100)|Completed||Phase 2|79|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:42.329018|2017-02-18 14:19:42.329018
NCT00686816|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2009-10-15|||July 2008||2008-07-01|October 2009|2009-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Weight Loss in Pre-diabetic, Obese Women|A Study Among Pre-diabetic, Obese Women to Evaluate the Weight Loss Effects of a Non-Digestible Fat Substitute|Completed||Phase 2|80|Actual|Procter and Gamble||2|||f||||f||||||||||2017-02-18 14:19:42.424236|2017-02-18 14:19:42.424236
NCT00686803|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2013-07-08|2011-08-24||April 2008||2008-04-01|July 2013|2013-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension|A Single-Center, Single-Dose, Placebo-Controlled, Randomized, Double-Blind, Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension|Completed||Phase 2|21|Actual|Palatin Technologies||6|||f||||f||||||||||2017-02-18 14:19:42.531841|2017-02-18 14:19:42.531841
NCT00686790|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-09-24|2010-12-21||December 2005||2005-12-01|September 2015|2015-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)|An Open Label, Uncontrolled, Study to Assess the Response of Peg-Intron in naïve Patients With Chronic Hepatitis B and D Co-infection|Completed||Phase 3|68|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:43.018466|2017-02-18 14:19:43.018466
NCT00686777|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-09-24|2011-12-12||January 2008||2008-01-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)|Low Dose Treatment of Ribavirin in Combination With PEG-IFN Alfa-2b in CHC Patients With genotype1 High Viral Load and Low Body Weight|Completed||Phase 4|75|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:43.40445|2017-02-18 14:19:43.40445
NCT00686764|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-12-10|||May 2008||2008-05-01|December 2015|2015-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Evaluation of Ultrasonic Neuroma Size With Residual Limb Pain in Above-Knee Amputees|Evaluation of Ultrasonic Neuroma Size With Residual Limb Pain in Above Knee Amputees|Completed||N/A|7|Actual|Oregon Health and Science University|||1||f||||f||||||||||2017-02-18 14:19:43.731352|2017-02-18 14:19:43.731352
NCT00686751|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2009-05-12|||December 2004||2004-12-01|May 2009|2009-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Immune Effects of Vitamin D in Hemodialysis Patients|Immunomodulatory Effects of Vitamin D in Chronic Hemodialysis Patients|Completed||Phase 2|20|Actual|Renal Research Institute||1|||f||||t||||||||||2017-02-18 14:19:43.828091|2017-02-18 14:19:43.828091
NCT00686738|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-03-22|||February 2007||2007-02-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|November 2012|Actual|2012-11-01||Observational|||Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients|Validity Verification of Indices Utilizing TGF-b1, NF-kB, PET/CT, and MRS Predicting Response to Neoadjuvant Chemotherapy in Osteosarcoma Patients|Completed||N/A|20|Actual|National Cancer Center, Korea|||1||f||||t||||||Samples Without DNA|"~     NF-kB expression status will be determined on initial biopsy and surgically removed tumor~     specimen.~   "|||2017-02-18 14:19:44.08506|2017-02-18 14:19:44.08506
NCT00686725|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-12-11|2013-02-25||June 2008||2008-06-01|December 2015|2015-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)|A Clinical Study of Standard TEMODAL® Regimen Versus Standard Regimen Plus Early Post-Surgery TEMODAL® Chemotherapy in Treatment on Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)|Completed||Phase 4|99|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:19:44.183961|2017-02-18 14:19:44.183961
NCT00686712|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-03-02|2010-09-15||February 2003||2003-02-01|March 2016|2016-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Insulin Glargine at Bedtime or in AM Versus NPH|The Utility of Insulin Glargine (Lantus) Compared to NPH in Ethnic Minority Type 2 Diabetic Subjects Starting Insulin Therapy|Completed||Phase 4|108|Actual|Charles Drew University of Medicine and Science|Early termination leading to smaller than anticipated enrollment.|3|||f||||t||||||||||2017-02-18 14:19:44.756003|2017-02-18 14:19:44.756003
NCT00686699|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-10-13|2016-03-10||July 2006||2006-07-01|October 2016|2016-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)|A Phase 2a, Multiple Dose, Placebo Controlled, Randomized, Two Way Crossover Study to Assess the Efficacy of SCH 420814 in Reducing Anti Psychotic-Induced Extra Pyramidal Symptoms Among Subjects With Schizophrenia and Schizoaffective Disorders|Terminated||Phase 2|11|Actual|Merck Sharp & Dohme Corp.|This study was terminated due to low enrollment.|2||"The study was terminated after 9 participants completed due to lack of enrollment for 6~   months."|f||||f||||||||||2017-02-18 14:19:45.303118|2017-02-18 14:19:45.303118
NCT00686686|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-09-02|2011-01-27||December 2007||2007-12-01|September 2015|2015-09-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|TIPS||Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)|A Multi Center, Open Label, Single-Arm Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP), Including the Pustular Form (PsPPP)|Completed||Phase 3|23|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:45.899325|2017-02-18 14:19:45.899325
NCT00686673|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2011-02-14|||June 2008||2008-06-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|June 2008|Actual|2008-06-01||Interventional|||Effect of a Decision Aid on Decision Making for Family Member's Disclosure of Terminal Illness|Effect of a Decision Aid on Decision Making for Family Member's Disclosure of Terminal Illness to Patient With Terminal Cancer|Completed||N/A|440|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-02-18 14:19:46.13978|2017-02-18 14:19:46.13978
NCT00686660|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-06-13|||September 2007||2007-09-01|May 2008|2008-05-01|September 2010|Anticipated|2010-09-01|June 2010|Anticipated|2010-06-01||Interventional|||A Multi-Center Study of Rehabilitation to Stable Chronic Obstructive Pulmonary Disease (COPD) Patients||Unknown status|Recruiting|N/A|300|Anticipated|Beijing Chao Yang Hospital||4|||f||||t||||||||||2017-02-18 14:19:46.250072|2017-02-18 14:19:46.250072
NCT00686647|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2011-07-14|2011-06-17||April 2008||2008-04-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|April 2010|Actual|2010-04-01||Interventional|AGILITY||AngioSculpt® Coronary Bifurcation Study|AngioSculpt® Scoring Balloon Catheter Multi-Center Coronary Bifurcation Study|Completed||N/A|93|Actual|AngioScore, Inc.||1|||f||||f||||||||||2017-02-18 14:19:46.36732|2017-02-18 14:19:46.36732
NCT00686634|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-11-25|2012-02-24||January 2008||2008-01-01|November 2014|2014-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Sitagliptin in Combination With Metformin and Sulfonylurea|Sitagliptin in Combination Oral Agent Therapy for Type 2 Diabetes|Completed||Phase 4|108|Actual|Charles Drew University of Medicine and Science||1|||f||||t||||||||||2017-02-18 14:19:46.611549|2017-02-18 14:19:46.611549
NCT00686621|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-09-07|||January 2007||2007-01-01|September 2015|2015-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)(COMPLETED)|Single Patient Emergency Treatment Use of Posaconazole in Invasive Fungal Infections|Completed||Phase 3|1|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:19:46.973851|2017-02-18 14:19:46.973851
NCT00686608|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2012-06-04|||October 2006||2006-10-01|June 2012|2012-06-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Hypothalamic Functional Magnetic Resonance Imaging (fMRI) Response to Nutrients|Hypothalamic fMRI Response to Nutrients|Unknown status|Recruiting|N/A|50|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 14:19:47.065374|2017-02-18 14:19:47.065374
NCT00686595|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-02-19|2011-01-27||October 2007||2007-10-01|February 2016|2016-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|TANGO||A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)|swiTching From etAnercept to iNfliximab in the Treatment of Moderate to Severe Psoriasis; a Multi-center, Open Label Trial evaluatinG the Efficacy, tOlerance and Safety (TANGO)|Completed||Phase 4|48|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 14:19:47.169922|2017-02-18 14:19:47.169922
NCT00686582|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2010-05-21|||August 2008||2008-08-01|May 2010|2010-05-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees|An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees|Completed||Phase 2|304|Actual|Bavarian Nordic||3|||f||||t||||||||||2017-02-18 14:19:47.591339|2017-02-18 14:19:47.591339
NCT00686569|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-08-03|||April 2007||2007-04-01|August 2014|2014-08-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Observational|||Mediastinal Microdialysis in Patients With Oesophageal or Cardia Cancer Treated by Resection|Mediastinal Microdialysis in Early Diagnosis of Anastomotic Leakage After Resection for Esophageal Cancer: Preliminary Results|Completed||N/A|40|Actual|Odense University Hospital|||1||f||||f||||||||||2017-02-18 14:19:47.691205|2017-02-18 14:19:47.691205
NCT00686556|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-29|2016-12-07|||August 2012||2012-08-01|December 2016|2016-12-01|April 2017|Anticipated|2017-04-01|February 2016|Actual|2016-02-01||Interventional|||Total Marrow Irradiation for Refractory Acute Leukemia|Total Marrow Irradiation and Myeloablative Chemotherapy Followed By Double Umbilical Cord BloodTransplantation In Patients With Refractory Acute Leukemia|Active, not recruiting||Phase 1|12|Actual|Masonic Cancer Center, University of Minnesota||5|||f||||t||||||||||2017-02-18 14:19:47.773239|2017-02-18 14:19:47.773239
NCT00686543|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-10-08|2010-04-15||December 2007||2007-12-01|October 2015|2015-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)|A Phase 4 Study of the Pharmacokinetics of Oral Posaconazole (SCH 56592) Among Patients With Compromised Gastrointestinal Function and at High Risk for Invasive Fungal Infection|Completed||Phase 4|75|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:19:47.919773|2017-02-18 14:19:47.919773
NCT00237081|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2010-03-02|||June 2004||2004-06-01|March 2010|2010-03-01|November 2008|Actual|2008-11-01|||||Observational|magic||Genetics of Interstitial Cystitis|Maryland Genetics of Interstitial Cystitis (MaGIC)|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:03:14.066439|2017-02-18 17:03:14.066439
NCT00686530|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2013-12-02|||August 2007||2007-08-01|May 2008|2008-05-01|February 2010|Anticipated|2010-02-01|August 2009|Anticipated|2009-08-01||Observational|||Comparison of Abnormal Cortical Development in Brain Malformations on Postmortem Imaging With Autopsy|Comparison of Abnormal Cortical Development in Brain Malformations on Postmortem Imaging With Autopsy|Withdrawn||N/A|0|Actual|The Hospital for Sick Children|||1||f||||f||||||Samples With DNA|"~     Macroscopic examination of the fetus will be performed initially follwed by organ removal~     for tissue fixation for a period of two weeks.~   "|||2017-02-18 14:19:51.233536|2017-02-18 14:19:51.233536
NCT00686517|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2015-07-06|2011-12-22||December 2003||2003-12-01|July 2015|2015-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137)|An Open, Randomized, Multicentre Trial to Evaluate Efficacy and Safety of a 24-week Course of PEG-Interferon Alpha-2b Versus a 12-week Course of PEG-Interferon Alpha-2b Alone or Plus Ribavirin in Patients With Acute Hepatitis C|Completed||Phase 3|130|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:19:51.334831|2017-02-18 14:19:51.334831
NCT00686504|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2010-12-08|||April 2008||2008-04-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|PET||Positron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066|An Open Label, Non-randomized Positron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066 After Oral Administration to Healthy Subjects|Completed||Phase 1|6|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:19:51.926416|2017-02-18 14:19:51.926416
NCT00686491|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2011-02-21|||June 2007||2007-06-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|cold air||Respiratory Health of Elite Athletes|Center of Excellence in CardioRespiratory Health of High-level Athletes: Evaluation of Long-term Effects of Training.|Completed||N/A|133|Actual|Laval University|||5||f||||f||||||Samples With DNA|"~     Serum - plasma - sputum~   "|||2017-02-18 14:19:52.006995|2017-02-18 14:19:52.006995
NCT00686478|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2014-01-28||||||January 2014|2014-01-01||||||||Interventional|||Intron A for the Treatment of Hypertrophic Scar|A Double-blind Placebo Controlled Trial Using Subcutaneous Injections of Intron A for the Treatment of Hypertrophic Scar|Withdrawn||Phase 3|0|Actual|University of Alberta||2||The trial is not being done at this time|f||||f||||||||||2017-02-18 14:19:52.085043|2017-02-18 14:19:52.085043
NCT00686465|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2013-02-15|||March 2009||2009-03-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|November 2011|Actual|2011-11-01||Interventional|PETREC||Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study|Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study. PET in Recurrent Cancer(PETREC)|Completed||N/A|101|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-02-18 14:19:52.201038|2017-02-18 14:19:52.201038
NCT00686452|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2008-12-18|||March 2007||2007-03-01|May 2008|2008-05-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Observational|proto nage||Airway Dysfunction and Remodelling in Athletes Following Swimming Training in Chlorinated Pools|Airway Dysfunction and Remodelling in Athletes Following Swimming Training in Chlorinated Pools|Unknown status|Recruiting|N/A|100|Anticipated|Laval University|||7||f||||f||||||Samples With DNA|"~     Serum, plasma, bronchial biopsies~   "|||2017-02-18 14:19:52.509131|2017-02-18 14:19:52.509131
NCT00686439|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2012-06-12|||June 2008||2008-06-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Adalimumab for Inflammatory Osteoarthritis|HUM 06-087: Proof of Concept Study : Adalimumab for the Treatment of Osteoarthritis|Completed||Phase 1/Phase 2|20|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 14:19:52.590716|2017-02-18 14:19:52.590716
NCT00686426|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-05-28|||November 2003||2003-11-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|February 2007|Actual|2007-02-01||Interventional|||Role of Dairy Products in Weight Maintenance|Role of Dairy Products in Weight Maintenance: Prevention of Weight Regain Following Weight Loss|Completed||N/A|338|Actual|University of Tennessee||2|||f||||f||||||||||2017-02-18 14:19:52.695664|2017-02-18 14:19:52.695664
NCT00686413|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2010-12-08|||January 2008||2008-01-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|PET||Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects|An Open Label Positron Emission Tomography (PET) Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects (Non Nicotine Users)|Completed||Phase 1|9|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:19:52.80159|2017-02-18 14:19:52.80159
NCT00686400|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2010-01-22|||May 2008||2008-05-01|May 2008|2008-05-01|May 2011|Anticipated|2011-05-01|December 2010|Anticipated|2010-12-01||Observational|||A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia|A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia|Unknown status|Recruiting|N/A|360|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||2||f||||f||||||Samples With DNA|"~     serum, CSF if patients agree to lumbar puncture all frozen and stored at -80 degree Celsius~     until analysis~   "|||2017-02-18 14:19:52.897581|2017-02-18 14:19:52.897581
NCT00686387|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2011-04-11|||May 2008||2008-05-01|April 2011|2011-04-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Establishment of a Brain and Spinal Tumor Tissue Bank|Establishment of a Brain and Spinal Tumor Tissue Bank and Clinical Data Repository for Identifying Molecular Markers of Clinical Outcome|Unknown status|Recruiting|N/A|70|Anticipated|Taipei Medical University WanFang Hospital|||1||f||||f||||||Samples With DNA|"~     Whole blood, Fresh tissue~   "|||2017-02-18 14:19:53.017487|2017-02-18 14:19:53.017487
NCT00686374|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2017-01-04|||May 2008||2008-05-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806|A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study|Active, not recruiting||Phase 3|100|Anticipated|AbbVie||2|||f||||t||||||||||2017-02-18 14:19:53.116463|2017-02-18 14:19:53.116463
NCT00685997|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2013-07-02|||June 2008||2008-06-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Observational|||Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas|Whole-body MR Imaging for Staging Malignant Lymphomas|Completed||N/A|135|Actual|UMC Utrecht|||1||f||||f||||||||||2017-02-18 14:20:03.832089|2017-02-18 14:20:03.832089
NCT00686361|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2011-06-06|||October 2007||2007-10-01|June 2011|2011-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Choline Nutrition in Children With Cystic Fibrosis (CF)|To Investigate Whether Choline Supplementation in Children With CF Will Correct Biochemical Markers of Choline Deficiency and Improve Plasma Indices of Methylation Capacity and Redox Status and Result in Decreased Pro-inflammatory Cytokines|Completed||N/A|34|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 14:19:53.256552|2017-02-18 14:19:53.256552
NCT00686348|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-05-27|||May 2008||2008-05-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|SODA||Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study|Somatuline® Depot (Lanreotide) Injection for Acromegaly (SODA): A Post-marketing Observational Study|Completed||N/A|260|Actual|Ipsen|||1||f||||f||||||Samples Without DNA|"~     Routine clinical laboratory assessments will be performed: GH and IGF-1~   "|||2017-02-18 14:19:53.351351|2017-02-18 14:19:53.351351
NCT00686335|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2012-11-27|2012-10-26||June 2008||2008-06-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|MONA||A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma|A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma|Completed||Phase 2|12|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland|This was an explorative study to collect data for a subsequent controlled trial and therefore no hypothesis testing was performed. The size of the efficacy population (N=7) is too small to detect any statistically significant changes.|2|||f||||f||||||||||2017-02-18 14:19:53.451704|2017-02-18 14:19:53.451704
NCT00686322|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2011-09-13|||April 2008||2008-04-01|June 2010|2010-06-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)|Phase IV Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin in Previously Untreated, Inoperable (Stage IIIa or IIIb) Non-small-cell Lung Cancer|Completed||Phase 4|6|Actual|Taipei Veterans General Hospital, Taiwan||1|||f||||t||||||||||2017-02-18 14:19:53.75955|2017-02-18 14:19:53.75955
NCT00686309|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2009-08-15|||July 2010||2010-07-01|August 2009|2009-08-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Observational|||Comparison of On-line and Off-line Measurements of Exhaled Nitric Oxide (NO)|Comparison of On-line and Off-line Measurements of Exhaled NO|Unknown status|Not yet recruiting|N/A|200|Anticipated|Ziv Hospital|||1||f||||f||||||||||2017-02-18 14:19:53.884118|2017-02-18 14:19:53.884118
NCT00686296|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2015-03-16|||December 2008||2008-12-01|March 2015|2015-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Pilot Study Comparing Taliderm™ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds|Pilot Study Comparing Taliderm™ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds|Completed||N/A|56|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||t||||||||||2017-02-18 14:19:53.967165|2017-02-18 14:19:53.967165
NCT00686283|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2014-05-19|||August 2007||2007-08-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Personalized Exercise for Adolescents With Diabetes|Personalized Exercise for Adolescents With Diabetes|Completed||Phase 1|39|Actual|University of Arizona||1|||f||||f||||||||||2017-02-18 14:19:54.076475|2017-02-18 14:19:54.076475
NCT00686270|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2011-06-22|||May 2008||2008-05-01|June 2011|2011-06-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||A Long Term Safety Study of Apricitabine in HIV-infected Patients|A Phase 3, Open Label 96-week Extension Study of the Safety of Apricitabine in Treatment-experienced HIV-1 Infected Patients Who Have Completed Protocol AVX-301 or AVX-302 or Who Have Met the Criteria for Open-label Access to ATC Because of Virological Failure/Lack of Response|Withdrawn||Phase 3|0|Actual|Avexa||1||Study was withdrawn owing to Sponsor decision|f||||f||||||||||2017-02-18 14:19:54.184835|2017-02-18 14:19:54.184835
NCT00686257|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2012-07-24|2012-05-30||January 2003||2003-01-01|July 2012|2012-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure|Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure|Completed||Phase 4|60|Actual|Tufts Medical Center|Could not blind subjects or investigators|2|||f||||f||||||||||2017-02-18 14:19:54.285749|2017-02-18 14:19:54.285749
NCT00686244|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-03-11|||April 2008||2008-04-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|SPRINT||IT-Based Training in Metabolic Syndrome|Effect of Personal and IT Based Training to Performance, Metabolic Profil and Quality of Life by Patients With Metabolic Syndrome|Completed||N/A|125|Anticipated|Technische Universität München||2|||f||||f||||||||||2017-02-18 14:19:54.812081|2017-02-18 14:19:54.812081
NCT00686231|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2013-07-17|2009-11-12||May 2008||2008-05-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter|The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter|Completed||Phase 1|19|Actual|University of California, San Francisco|a|3|||f||||f||||||||||2017-02-18 14:19:54.929159|2017-02-18 14:19:54.929159
NCT00686218|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2014-08-14|||May 2008||2008-05-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|March 2013|Actual|2013-03-01||Interventional|||Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia|A Phase I Dose Escalation Study of LBH589 in Combination With Imatinib Mesylate for Patients With Chronic Myeloid Leukemia in Cytogenetic Remission With Residual Disease Detectable by Q-PCR|Completed||Phase 1|9|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:19:55.392007|2017-02-18 14:19:55.392007
NCT00686205|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-12-16|2010-01-13||August 2007||2007-08-01|December 2011|2011-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay||Completed||Phase 3|24111|Actual|Abbott Diagnostics Division||2|||f||||f||||||||||2017-02-18 14:19:55.520118|2017-02-18 14:19:55.520118
NCT00686192|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-07-21|||September 2001||2001-09-01|May 2008|2008-05-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Calcium and Lipid Metabolism|The Effects of Calcium Supplementation on Adipocyte Metabolism in Overweight Women|Completed||N/A|15|Actual|USDA, Western Human Nutrition Research Center||1|||f||||f||||||||||2017-02-18 14:19:55.924048|2017-02-18 14:19:55.924048
NCT00685789|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2011-09-28|||October 2008||2008-10-01|June 2008|2008-06-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|ADAPT||Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy|Study of Effects of Deqi and Neuropsychological Factors on Acupuncture Effects in Treatment of Bell's Palsy|Completed||N/A|355|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-02-18 14:20:06.64207|2017-02-18 14:20:06.64207
NCT00686179|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-09-24|||January 2008||2008-01-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|TQT||Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days|A Double-Blind, Randomised, Multicentre, Placebo-Controlled, 4-Ways Crossover Study to Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days, Using Moxifloxacin as a Positive Control, in Healthy Male Volunteers, CYP2D6 Extensive and Poor Metabolisers.|Completed||Phase 1|75|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:19:56.019018|2017-02-18 14:19:56.019018
NCT00686166|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-28|2016-01-26|2016-01-26||February 2009||2009-02-01|January 2016|2016-01-01|July 2017|Anticipated|2017-07-01|July 2014|Actual|2014-07-01||Interventional||Eligible patients who began protocol therapy.|S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer|A Phase II Study of Oxaliplatin, Capecitabine, Cetuximab and Radiation in Pre-Operative Therapy of Rectal Cancer|Active, not recruiting||Phase 2|83|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 14:19:56.136738|2017-02-18 14:19:56.136738
NCT00686140|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-10|2016-07-10|||June 2006||2006-06-01|July 2016|2016-07-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia|Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in First-Episode and Drug-naive Patients With Schizophrenia|Completed||N/A|200|Actual|Beijing HuiLongGuan Hospital||2|||f||||t||||||||||2017-02-18 14:19:57.501101|2017-02-18 14:19:57.501101
NCT00686127|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-04-02|2014-02-14||September 2003||2003-09-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2009|Actual|2009-12-01||Interventional|||Symptom Management After Breast Cancer Surgery|A Randomized, Double-Blind, Placebo-Controlled Trial (RDBPCT) of the Effectiveness of the Lidocaine Patch in the Management of Neuropathic Pain After Breast Cancer Surgery|Completed||Phase 4|21|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:19:57.629576|2017-02-18 14:19:57.629576
NCT00686114|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-04-28|||May 2008||2008-05-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer|Concurrent Chemoradiotherapy Containing Paclitaxel and Cisplatin With/Without Tarceva in Locally Advanced Esophageal Carcinoma: a Randomized Phase III Multi-center Trial.|Unknown status|Recruiting|Phase 3|344|Anticipated|Wenzhou Medical University||4|||f||||t||||||||||2017-02-18 14:19:58.063995|2017-02-18 14:19:58.063995
NCT00686101|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2009-10-08|||December 2007||2007-12-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|SmokCess||Knowledge and Perception of Smoking Risks/Consequences|Knowledge and Perception of Smoking Risks/Consequences, Smoking Habits and Motivators for Smoking Cessation Among People With Schizophrenia|Completed||N/A|200|Actual|University of Maryland|||2||f||||f||||||||||2017-02-18 14:19:58.18179|2017-02-18 14:19:58.18179
NCT00686088|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2009-10-27|||February 2008||2008-02-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy|An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy|Completed||Phase 2|30|Anticipated|Sophiris Bio Corp||1|||f||||f||||||||||2017-02-18 14:19:58.286473|2017-02-18 14:19:58.286473
NCT00686075|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2014-09-22|2014-09-22||June 2008||2008-06-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Intent-to-treat (ITT) population included all randomized participants.|A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants|A Phase 1/2a, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, a Live, Attenuated Intranasal Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to < 24 Month-old Children and in 2 Month-old Infants|Completed||Phase 1/Phase 2|1338|Actual|MedImmune LLC||10|||f||||f||||||||||2017-02-18 14:19:58.42221|2017-02-18 14:19:58.42221
NCT00686062|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-05-28|||April 2001||2001-04-01|May 2008|2008-05-01|April 2004|Actual|2004-04-01|April 2003|Actual|2003-04-01||Interventional|||Evaluation of a Decision Assisting Tool for Prenatal Testing|Adaptation and Implementation of a Prenatal Genetic Testing Decision-Assisting Tool for Clinical Use|Completed||N/A|494||University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:20:02.950466|2017-02-18 14:20:02.950466
NCT00686049|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-02-29|||May 2008||2008-05-01|February 2016|2016-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||HIV Treatment-Readiness Measure (HTRM) Validation|Validation of the HIV Treatment Readiness Measure (HTRM)|Completed||N/A|200|Actual|Westat|||1||f||||t||||||||||2017-02-18 14:20:03.054782|2017-02-18 14:20:03.054782
NCT00686036|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-10-27|2011-04-27||May 2008||2008-05-01|October 2016|2016-10-01|October 2010|Actual|2010-10-01|April 2010|Actual|2010-04-01||Interventional|ZENITH||Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy|A Randomized, Double-blind, Multicentre, Phase II Controlled Trial Assessing ZACTIMATM (Vandetanib) Against Placebo in Prolonging the Off-treatment Interval in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy|Terminated||Phase 2|17|Actual|Sanofi|It was planned that approx 100 patients would be recruited over a period of approx 2 years, due to slow recruitment the study was terminated early. No statistical analyses was done and no conclusion can be drawn about the outcomes in this study.|2||Slow recruitment|f||||f||||||||||2017-02-18 14:20:03.168663|2017-02-18 14:20:03.168663
NCT00686023|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2008-05-28|||June 2008||2008-06-01|May 2008|2008-05-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Comparing Surgical Techniques for CRIF of Pertrochanteric Fractures|Comparing Surgical Techniques for CRIF of Pertrochanteric Fractures|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-02-18 14:20:03.626592|2017-02-18 14:20:03.626592
NCT00686010|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2008-05-28|||May 2000||2000-05-01|May 2008|2008-05-01|June 2001|Actual|2001-06-01|January 2001|Actual|2001-01-01||Interventional|||Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia|A 4-Weeks Treatment, Randomised, Double-Blind, Parallel-Group Study Evaluating The Efficacy and Safety of JTT-705 300 to 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia|Completed||Phase 2|198|Actual|Japan Tobacco Inc.||4|||f||||f||||||||||2017-02-18 14:20:03.736697|2017-02-18 14:20:03.736697
NCT00685984|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2011-10-27|||January 2008||2008-01-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Observational|PEFDIA||Peripheral Endothelial Function and Coronary Status in Asymptomatic Diabetic Patients|Peripheral Endothelial Function and Coronary Status in Asymptomatic Type 2 Diabetic Patients: Relations With Coronary Microcirculation Assessed With Trans-thoracic Echo-doppler|Completed||N/A|173|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||t||||||Samples Without DNA|"~     whole blood, serum~   "|||2017-02-18 14:20:03.934166|2017-02-18 14:20:03.934166
NCT00685971|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2014-11-20|||December 2008||2008-12-01|July 2011|2011-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Cholecalciferol for Vitamin D in Adult Cystic Fibrosis (CF) Patients|Randomized Placebo-Controlled Trial of Cholecalciferol for Vitamin D Deficiency in Adults With Cystic Fibrosis|Completed||N/A|200|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 14:20:04.032985|2017-02-18 14:20:04.032985
NCT00685958|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2009-10-01|||July 2006||2006-07-01|October 2009|2009-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery|Multicenter, Non-comparative, Open-label Study to Evaluate the Safety and Efficacy of Enoxaparin Sodium (RP54563) 20 mg Bid for 14 Days in Patients With Hip Fracture Surgery|Completed||Phase 3|54|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:20:04.154984|2017-02-18 14:20:04.154984
NCT00685945|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2013-01-21|2011-08-25||December 2007||2007-12-01|January 2013|2013-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3|Renin-Angiotensin Aldosterone System and Fibrinolysis(RAAS) Interaction in Humans- Specific Aim 3|Completed||N/A|24|Actual|Vanderbilt University||4|||f||||t||||||||||2017-02-18 14:20:04.242127|2017-02-18 14:20:04.242127
NCT00685932|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2011-10-19|||July 2008||2008-07-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Mobius® Post-cesarean Pain Randomized Control Trial|Mobius Pain Study: A Randomized Controlled Trial of Standard Versus Mobius® Retraction at Cesarean Delivery|Completed||Phase 4|125|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 14:20:04.643029|2017-02-18 14:20:04.643029
NCT00685919|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-10-14|||May 2008||2008-05-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Peripheral Dopamine in Postural Tachycardia Syndrome|Kidney Dopamine Effects on Urinary Sodium Excretion in Postural Tachycardia Syndrome|Active, not recruiting||Phase 2/Phase 3|70|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:20:04.761456|2017-02-18 14:20:04.761456
NCT00685906|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2010-12-01|||April 2008||2008-04-01|December 2010|2010-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||AZD6140 Oral Contraceptive Interaction Study|A Randomised, Double-blind, Two-way Crossover Study to Determine the Effects of Co-administration of AZD6140 and Nordette® (Combination of Levonorgestrel and Ethinyl Estradiol) After Multiple Oral Doses in Healthy Female Volunteers|Completed||Phase 1|24|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:20:04.988015|2017-02-18 14:20:04.988015
NCT00685893|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2013-06-25|||June 2003||2003-06-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|March 2008|Actual|2008-03-01||Interventional|IPACC||Integrating Palliative and Critical Care (IPACC) Study|An ICU Intervention to Improve End-of-Life Care|Completed||Phase 3|3498|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 14:20:05.088189|2017-02-18 14:20:05.088189
NCT00685880|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-26|2012-07-27|2012-07-27||May 2008||2008-05-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Prolotherapy Versus Steroids for Thumb Carpo-metacarpal Joint Arthritis|Randomized, Double Blind Comparison Trial of Prolotherapy (Dextrose) Compared to Corticosteroid Injection for the Treatment of Symptomatic Thumb Carpo-metacarpal Joint Arthritis|Terminated||N/A|2|Actual|Mayo Clinic|Early termination due to low enrollment; no subject data was analyzed.|2||Unable to recruit adequate numbers of patients|f||||f||||||||||2017-02-18 14:20:05.214792|2017-02-18 14:20:05.214792
NCT00685867|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2012-08-20|||May 2008||2008-05-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|MOSAR-04||Two Strategies for Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Prevention in Surgical Patients|An Interventional Study to Evaluate the Impact of Two Innovative Strategies in Preventing Nosocomial MRSA Infection in Surgical Patients|Completed||N/A|126750|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 14:20:05.528936|2017-02-18 14:20:05.528936
NCT00685854|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2017-01-24|||May 21, 2008||2008-05-21|March 24, 2011|2011-03-24|March 24, 2011|Actual|2011-03-24|March 24, 2011|Actual|2011-03-24||Interventional|||Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth|Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia Without Neovascularization (MACTEL 2)|Completed||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:20:05.626015|2017-02-18 14:20:05.626015
NCT00685841|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-11-01|||February 2002||2002-02-01|November 2012|2012-11-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Double-Blind, Double-Dummy, Randomized, Placebo- and Active-Controlled, Multicenter, Parallel-Group Study of (R,R)-Formoterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|717|Actual|Sunovion||5|||f||||t||||||||||2017-02-18 14:20:05.724543|2017-02-18 14:20:05.724543
NCT00685828|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2014-07-03|||January 2001||2001-01-01|July 2014|2014-07-01||||February 2002|Actual|2002-02-01||Interventional|||Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor|Phase III Randomized, Intergroup, International Trial Assessing the Clinical Activity of STI-571 at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST) Expressing the KIT Receptor Tyrosine Kinase (CD117)|Unknown status|Active, not recruiting|Phase 3|946|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 14:20:06.055537|2017-02-18 14:20:06.055537
NCT00685815|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2015-07-23|||November 2006||2006-11-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|||Intravenous Iron Metabolism in Restless Legs Syndrome|Intravenous Iron Metabolism in Restless Legs Syndrome|Completed||Phase 2|36|Actual|Luitpold Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:20:06.16947|2017-02-18 14:20:06.16947
NCT00685802|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2009-11-18|2009-11-18||June 2004||2004-06-01|November 2009|2009-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Fasted Bioavailability Study of Cilostazol Tablets, 50mg|A Comparative Bioavailability Study of Cilostazol Tablets, 50mg, Under Fasting Conditions|Completed||Phase 1|32|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:20:06.284178|2017-02-18 14:20:06.284178
NCT00685776|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2016-11-29|||March 2008||2008-03-01|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|July 2009|Actual|2009-07-01||Interventional|DEFINE||Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)|A 76-Week, Worldwide, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Tolerability and Efficacy of Anacetrapib When Added to Ongoing Therapy With a Statin in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease|Active, not recruiting||Phase 3|1500|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 14:20:06.759192|2017-02-18 14:20:06.759192
NCT00685763|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-10-03|2014-05-23||March 2008||2008-03-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|October 2013|Actual|2013-10-01||Interventional|PC01|Unresectable Carcinoma of the Pancreas|Proton Therapy for Unresectable Cancer (CA) of Pancreas|A Study Using Photon/Proton Beam Radiation Therapy and Chemotherapy for Unresectable Carcinoma of the Pancreas|Active, not recruiting||Phase 2|13|Actual|University of Florida||1|||f||||t||||||||||2017-02-18 14:20:06.887372|2017-02-18 14:20:06.887372
NCT00685750|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2015-06-15|||April 2008||2008-04-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|October 2014|Actual|2014-10-01||Interventional|||Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma|Analysis of the Expression of a Specific Set of Genes and Tumor Antigens in Patients With Non-small Cell Lung Cancer or Melanoma|Terminated||N/A|219|Actual|GlaxoSmithKline||7||"Slow enrolment over the last 2 years with none in the past 1 year. No increase in the number~   of completed subjects for 1 year and no more ongoing study subjects"|f||||||||||||||2017-02-18 14:20:07.150719|2017-02-18 14:20:07.150719
NCT00685737|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-06-25|||December 2007||2007-12-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|PNAI-002||Safety of a Hypolipidemic Agent in Healthy Normal Volunteers|A Randomized Placebo Controlled Double Blind Two Period Cross-Over Study to Assess the Safety and Pharmacokinetics and Pharmacodynamics of Oral Dosages of 1-MNA, (A Hypolipidemic Agent) in Healthy Volunteers|Completed||Phase 1|20|Actual|Pharmena North America||3|||f||||f||||||||||2017-02-18 14:20:07.324571|2017-02-18 14:20:07.324571
NCT00685724|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2011-11-17|||January 2008||2008-01-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|SMART||A Pilot SMART Design for Pathological Gamblers|A Pilot SMART Design for Pathological Gamblers|Completed||Phase 2|66|Actual|UConn Health||3|||f||||f||||||||||2017-02-18 14:20:07.435028|2017-02-18 14:20:07.435028
NCT00685711|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-08-05|||January 2008||2008-01-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety of Cat-PAD in Cat Allergic Subjects|An Escalating Single Intradermal or Subcutaneous Dose Study in Cat Allergic Subjects to Assess the Safety of Cat-PAD.|Completed||Phase 1/Phase 2|88|Actual|Circassia Limited||4|||f||||t||||||||||2017-02-18 14:20:07.535458|2017-02-18 14:20:07.535458
NCT00685698|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2014-12-25|2014-12-16||June 2008||2008-06-01|December 2014|2014-12-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional||The ITT population consists of all patients from the Enrolled population who took at least one whole dose of study medication (three capsules) and who exhibited at least one Gram-positive pathogen at Baseline (Visit 1) as confirmed by culture of wound tissue by the central (or local) laboratory.|Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections|An Open-Label, Single-Arm, Multi-Center Study of TG-873870 for Treating Patients With Diabetic Foot Infections of Mild to Moderate Severity Associated With Gram-Positive Pathogens|Completed||Phase 2|40|Actual|TaiGen Biotechnology Co., Ltd.||1|||f||||f||||||||||2017-02-18 14:20:07.647616|2017-02-18 14:20:07.647616
NCT00685685|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2010-01-11|2009-11-24||September 2004||2004-09-01|January 2010|2010-01-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Fasting Bioavailability Study of Lovastatin Tablets and Mevacor Tablets|A Single Dose Crossover Comparative Bioavailability Study of Lovastatin 40mg Tablets in Healthy Male Volunteers/Fasting State|Completed||Phase 1|54|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:20:08.728487|2017-02-18 14:20:08.728487
NCT00685672|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-03-29|||August 2008||2008-08-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Safety of Epidural Fentanyl and Adrenalin During Childbirth|Pharmacokinetic Interaction Effects of Combined Fentanyl and Adrenalin in Epidural Analgesia During Child Birth|Completed||Phase 4|40|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 14:20:09.105736|2017-02-18 14:20:09.105736
NCT00685659|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2016-10-20|2016-02-15||May 2007||2007-05-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ETDD||Effectiveness of Extended Treatments for Drug Dependence|Effectiveness of Extended Treatments for Drug Dependence|Completed||Phase 2|332|Actual|University of Pennsylvania||3|||f||||f||||||||No||2017-02-18 14:20:09.213199|2017-02-18 14:20:09.213199
NCT00685646|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-10-15|||May 2008||2008-05-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|ZAPCA||Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases|A Phase III, Multicenter, Randomized, Controlled Study of Maximum Androgen Blockade With vs. Without Zoledronic Acid in Prostatic Cancer Patients With Metastatic Bone Disease|Completed||Phase 3|227|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t||||||||||2017-02-18 14:20:10.084313|2017-02-18 14:20:10.084313
NCT00685633|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2013-08-16|||December 2008||2008-12-01|November 2008|2008-11-01||||June 2010|Anticipated|2010-06-01||Interventional|||Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer|Phase II, Randomized Study of Patients With Rising PSA at High-Risk of Progression After Primary Therapy to Assess the Clinical and Molecular Efficacy of the Enzastaurin - Bicalutamide Combination to Suppress the Androgen Receptor Without Testosterone Ablation|Withdrawn||Phase 2|0|Actual|Eastern Cooperative Oncology Group||2|||f||||||||||||||2017-02-18 14:20:10.197293|2017-02-18 14:20:10.197293
NCT00685620|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2017-01-10|||August 2002||2002-08-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|CASA||Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers|Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers|Completed||Phase 4|463|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||f||||||||||2017-02-18 14:20:10.46322|2017-02-18 14:20:10.46322
NCT00685607|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2011-10-04|||October 2008||2008-10-01|October 2011|2011-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study to Determine the Best Way to Measure How Quickly the Drug Can Give Relief From Sudden Diarrhea|A Placebo-Controlled, Double-Blind, Randomized Pilot Study to Evaluate the Appropriateness of Multiple Endpoints in Measuring the Onset of Clinical Efficacy of Loperamide-Simethicone Caplets in the Treatment of Acute Non-specific Diarrhea|Completed||Phase 4|45|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-02-18 14:20:10.583018|2017-02-18 14:20:10.583018
NCT00685594|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2015-09-18|||March 2008||2008-03-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|March 2015|Actual|2015-03-01||Interventional|||Vitamin D for the Prevention of Diabetes Type 2|Prevention of Type 2 Diabetes With Vitamin D Supplementation in Subjects With Reduced Glucose Tolerance Detected in the Tromso Study 2007/2008|Completed||Phase 2/Phase 3|511|Actual|University of Tromso||2|||f||||t||||||||||2017-02-18 14:20:10.716923|2017-02-18 14:20:10.716923
NCT00685581|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2009-03-13|||April 2007||2007-04-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|||||Interventional|TRANSQUAL WPC||Impact of Vaccenic Acid Consumption on the Metabolism of Saturated Fatty Acids: Relationship With Cardiovascular Risk Factors|Rationale, Study Design and Baseline Data of the TRANSQUAL Clinical Trial: A Study to Evaluate the Impact of Different Milk Fatty Acid Profiles on Cardiovascular Risk Factors in Healthy Volunteers; Focus on Trans Fatty Acids|Completed||N/A|107|Actual|Institut National de la Recherche Agronomique||3|||f||||t||||||||||2017-02-18 14:20:10.8376|2017-02-18 14:20:10.8376
NCT00685568|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-11-16|||December 2002||2002-12-01|November 2012|2012-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis|Phase I Pilot Toxicity/Methods Validation Study of Celecoxib in Genotype-Positive Children With Familial Adenomatous Polyposis|Completed||Phase 1|22|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:20:11.160599|2017-02-18 14:20:11.160599
NCT00685555|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2011-06-22|||October 2005||2005-10-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|SWITCH||Healthy Futures Project: A Community Based Obesity Prevention Program|SWITCH: Rationale, Design, and Implementation of a Community, School, and Family-based Intervention to Modify Behaviors Related to Childhood Obesity|Completed||Early Phase 1|1300|Actual|National Institute on Media and the Family||1|||f||||f||||||||||2017-02-18 14:20:11.289838|2017-02-18 14:20:11.289838
NCT00685542|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2010-12-02|||June 2008||2008-06-01|December 2010|2010-12-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Effect of Diacerein on Hand Osteoarthritis|Phase IV Study of Diacerein in Human Hand Osteoarthritis|Completed||Phase 4|86|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:20:11.409202|2017-02-18 14:20:11.409202
NCT00685529|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-02-21|||April 2005||2005-04-01|February 2012|2012-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)|An Open-Label, Randomized, Multiple Dose, 3-Way Crossover Study of Arformoterol Tartrate Inhalation Solution and Foradil® (Racemic Formoterol) in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|24|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 14:20:11.526376|2017-02-18 14:20:11.526376
NCT00685516|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-09-26|2016-02-18||September 2007||2007-09-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2012|Actual|2012-08-01||Interventional||93 subjects completed the intervention (Arm I, GT: 34, Arm II, control: 33, Arm III, BT: 26).|Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery|Effects of Brewed Green and Black Tea on Inflammation, Apoptosis and Oxidation in Men With Prostate Cancer|Active, not recruiting||Phase 2|113|Actual|Jonsson Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 14:20:11.662026|2017-02-18 14:20:11.662026
NCT00685503|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2017-01-24|||May 21, 2008||2008-05-21|April 12, 2011|2011-04-12|April 12, 2011|Actual|2011-04-12|April 12, 2011|Actual|2011-04-12||Interventional|||Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth|Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia With Neovascularization (MACTEL 1)|Completed||Phase 1|1|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:20:12.585414|2017-02-18 14:20:12.585414
NCT00685490|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2008-05-23|||July 1995||1995-07-01|May 2008|2008-05-01|November 2006|Actual|2006-11-01|||||Observational|||Vitrectomy for Branch Retinal Vein Occlusion|Vitrectomy for Persistent Macular Edema in Branch Retinal Vein Occlusion|Completed||N/A|70|Actual|Shinjo Ophthalmologic Institute|||1||f||||t||||||||||2017-02-18 14:20:12.684857|2017-02-18 14:20:12.684857
NCT00685477|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-12-28|2016-12-28||May 2008||2008-05-01|December 2016|2016-12-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional||Each of the 60 subjects had 3 infusion studies at least 2 days apart.|Dose Response of Intravenous Sincalide(CCK-8) for Gallbladder Emptying|Dose Response of Intravenous Sincalide (CCK-8) for Gallbladder Emptying|Completed||N/A|60|Actual|Temple University||6|||f||||f||||||||||2017-02-18 14:20:12.7933|2017-02-18 14:20:12.7933
NCT00685464|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2011-08-09|||January 2006||2006-01-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Intravenous Versus Intracoronary Use of Abciximab|Intravenous vs. Intracoronary Use of Abciximab|Completed||N/A|355|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-02-18 14:20:13.10949|2017-02-18 14:20:13.10949
NCT00685451|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2011-09-28|||November 2004||2004-11-01|September 2011|2011-09-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional|||Cognitive Therapy for PTSD in Addiction Treatment|Cognitive Therapy for PTSD in Addiction Treatment|Completed||Phase 1/Phase 2|49|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-02-18 14:20:13.222097|2017-02-18 14:20:13.222097
NCT00685438|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2008-05-27|||April 2007||2007-04-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|||||Observational|||Ultraviolet Exposure, Antioxidant Use and Skin Erythema at Extreme High Altitude|Observational Study of Skin Erythema by Spectrophotometer, and UV Exposure With Viospore Ultraviolet Monitors at Extreme Altitude (Mt. Everest, North Side)|Completed||N/A|25|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 14:20:13.334853|2017-02-18 14:20:13.334853
NCT00685425|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-02-21|||October 2002||2002-10-01|February 2012|2012-02-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol|A Dose Response and PharmacoDynamic Study of Levalbuterol and Racemic Albuterol HFA MDI in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 3|62|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 14:20:13.429395|2017-02-18 14:20:13.429395
NCT00685412|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2011-12-08|||May 2008||2008-05-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3|Phase I Open Label, Dose Escalation Study to Evaluate the Safety, Tolerability and Immunogenicity of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation (EP) in Adult Females Post Surgical or Ablative Treatment of Grade 2 or 3 Cervical Intraepithelial Neoplasia (CIN)|Completed||Phase 1|18|Actual|Inovio Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:20:13.635388|2017-02-18 14:20:13.635388
NCT00685399|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2013-11-18|||June 2008||2008-06-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Efficacy of AIN457 in Noninfectious Uveitis|An Open-label Proof-of-concept Study With a Double-masked, Dose-ranging Component to Assess the Effects of AIN457 in Patients With Noninfectious Uveitis|Completed||Phase 2|79|Actual|Novartis||3|||f||||f||||||||||2017-02-18 14:20:13.74366|2017-02-18 14:20:13.74366
NCT00685386|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2013-01-22|||June 2008||2008-06-01|April 2011|2011-04-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP)|A Randomized, Controlled, Double-blind Trial of CO2 Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography|Completed||N/A|74|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 14:20:13.87335|2017-02-18 14:20:13.87335
NCT00685373|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-27|2016-11-03|2011-04-25||May 2008||2008-05-01|September 2016|2016-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease|An Open-label, Long-term Safety and Efficacy Study of ACZ885 (Anti-interleukin-1β Monoclonal Antibody) Administered for at Least 6 Months in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease|Completed||Phase 3|166|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:20:13.980165|2017-02-18 14:20:13.980165
NCT00685360|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2015-08-13||2011-05-06|April 2008||2008-04-01|August 2015|2015-08-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|||A Placebo-controlled, Phase 2 Trial to Evaluate OPC 67683 in Patients With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)|A Multi Center, Randomized, Double-blind, Placebo-controlled Phase 2 Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Multiple Doses of OPC 67683 in Patients With Pulmonary Sputum Culture-Positive, Multidrug-resistant Tuberculosis|Completed||Phase 2|481|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||t||||||||||2017-02-18 14:20:14.5624|2017-02-18 14:20:14.5624
NCT00685347|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-02-21|||January 2003||2003-01-01|February 2012|2012-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects|A Dose Response Study of Levalbuterol and Racemic Albuterol HFA MDI in Pediatric Subjects With Asthma|Completed||Phase 2|33|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 14:20:14.690224|2017-02-18 14:20:14.690224
NCT00685334|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2013-09-25|2009-08-03||November 2003||2003-11-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa|Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa|Completed||Phase 4|22|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 14:20:14.800727|2017-02-18 14:20:14.800727
NCT00685321|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-25|2012-01-04|||June 2008||2008-06-01|January 2012|2012-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia|A Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia|Unknown status|Recruiting|N/A|45|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-02-18 14:20:15.220615|2017-02-18 14:20:15.220615
NCT00685308|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-05-27|||December 2007||2007-12-01|May 2008|2008-05-01|October 2010|Anticipated|2010-10-01|October 2009|Anticipated|2009-10-01||Observational|WingspanSSIR||Wingspan Stenting for Symptomatic Severe Stenosis of Intracranial Atherosclerosis Registry in China|Wingspan Stenting for Symptomatic Severe Stenosis of Intracranial Atherosclerosis Registry in China|Unknown status|Recruiting|N/A|200|Anticipated|Ministry of Health, China|||1||f||||t||||||||||2017-02-18 14:20:15.329376|2017-02-18 14:20:15.329376
NCT00685295|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2016-12-17|2009-02-25||August 2008||2008-08-01|December 2016|2016-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|FAIRTOP||Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain|Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain in the ED|Completed||Phase 1/Phase 2|60|Actual|Massachusetts General Hospital||2|||f||||t||||||||No|There is no plan to make individual participant data available to other researchers.|2017-02-18 14:20:15.425978|2017-02-18 14:20:15.425978
NCT00685282|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-25|2013-02-11|||November 2008||2008-11-01|February 2013|2013-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||The Effect of Stress on DNA Integrity and the Effect of Cognitive Behavioral Therapy on Stress and Infertility in Women|The Effect of Stress on DNA Integrity and the Effect of Cognitive Behavioral Therapy on Stress and Infertility in Women Undergoing IVF Treatment.|Completed||N/A|70|Actual|Soroka University Medical Center||1|||f||||t||||||||||2017-02-18 14:20:18.265047|2017-02-18 14:20:18.265047
NCT00685269|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-02-21|||August 2003||2003-08-01|February 2012|2012-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)|The Safety and Efficacy of Eszopiclone in Subjects With Mild to Moderate Obstructive Sleep Apnea Syndrome|Completed||Phase 2|20|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 14:20:18.366347|2017-02-18 14:20:18.366347
NCT00685256|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2016-10-13|||March 2008||2008-03-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children|Parent Communication Study II - Randomized Controlled Trial of Decision Support vs. Education for Parent Communication of BRCA 1/2 Cancer Genetic Test Results to Children|Recruiting||Phase 3|400|Anticipated|Georgetown University||1|||f||||f||||||||||2017-02-18 14:20:18.478534|2017-02-18 14:20:18.478534
NCT00685243|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-05-27|||January 2008||2008-01-01|May 2008|2008-05-01|July 2008|Anticipated|2008-07-01|June 2008|Anticipated|2008-06-01||Interventional|||Treatment of Surgical Scars With Fractional Photothemolysis Versus Pulse Dye Laser|Treatment of Surgical Scars With Fractional Photothemolysis Versus Pulse Dye Laser|Unknown status|Active, not recruiting|N/A|12|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-02-18 14:20:18.58711|2017-02-18 14:20:18.58711
NCT00005218|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1988||1988-04-01|April 2002|2002-04-01|March 1990|Actual|1990-03-01|||||Observational|||Epidemiological Tool To Detect Angina Pectoris in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:20.288623|2017-02-18 18:15:20.288623
NCT00685230|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2011-06-01|||May 2004||2004-05-01|June 2011|2011-06-01|October 2005|Actual|2005-10-01|August 2005|Actual|2005-08-01||Interventional|||Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients|Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation|Completed||Phase 2/Phase 3|15|Actual|Instituto Bioclon S.A. de C.V.||2|||f||||f||||||||||2017-02-18 14:20:18.699681|2017-02-18 14:20:18.699681
NCT00685217|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-08-29|||May 2008||2008-05-01|August 2016|2016-08-01|April 2012|Actual|2012-04-01|March 2011|Actual|2011-03-01||Interventional|||Transvaginal Tape (TVT) Secur Versus TVT Randomised Controlled Trial (RCT)|Tension-free Vaginal Tape Management of Stress Incontinence in Women: Randomized Trial of TVT Secur Versus TVT|Terminated||Phase 3|74|Actual|University of Calgary||2||poor recruitment|f||||f||||||||Undecided|The decision to share would depend on the protocol of an IPD analysis protocol|2017-02-18 14:20:18.820892|2017-02-18 14:20:18.820892
NCT00685204|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2008-05-22|||March 2008||2008-03-01|May 2008|2008-05-01||||||||Interventional|TL139||An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma|A Phase II Study of Milataxel (TL139) Administered Orally in Patients With Malignant Mesothelioma|Unknown status|Recruiting|Phase 2|90|Anticipated|Taxolog Inc.||1|||f||||t||||||||||2017-02-18 14:20:18.923226|2017-02-18 14:20:18.923226
NCT00685191|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2009-11-06|||June 2008||2008-06-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain|HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain|Completed||Phase 4|15|Actual|Germans Trias i Pujol Hospital||1|||f||||f||||||||||2017-02-18 14:20:19.033531|2017-02-18 14:20:19.033531
NCT00685178|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2014-06-13|||February 2007||2007-02-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Clinical Trial of Topiramate for Cocaine Addiction|Clinical Trial of Topiramate for Cocaine Addiction|Completed||Phase 2|250|Actual|Johns Hopkins University||4|||f||||t||||||||||2017-02-18 14:20:19.343975|2017-02-18 14:20:19.343975
NCT00685165|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2009-12-16|2009-11-18||May 2004||2004-05-01|November 2009|2009-11-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets|A Randomized, Two-Way, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Primidone 50 mg, Compared to an Equivalent Dose of Primidone (Mysoline®) in Healthy Adult Subjects|Completed||Phase 1|22|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:20:19.462184|2017-02-18 14:20:19.462184
NCT00685152|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2015-12-14|||January 2008||2008-01-01|December 2015|2015-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Post-traumatic Stress Disorder (PTSD)|High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Post-traumatic Stress Disorder (PTSD)|Completed||N/A|15|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 14:20:19.835056|2017-02-18 14:20:19.835056
NCT00685139|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2010-01-11|2009-11-24||January 2005||2005-01-01|January 2010|2010-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Fasting Bioavailability Study of Zonisamide Capsules|A Relative Bioavailability Study of 100 mg Zonisamide Capsules Under Fasting Conditions|Completed||Phase 1|34|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:20:19.939576|2017-02-18 14:20:19.939576
NCT00685126|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-02-21|||February 2001||2001-02-01|February 2012|2012-02-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)|A Safety, Tolerability and Efficacy Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects Birth to 48 Months Old With Reactive Airways Disease in an Acute Setting|Completed||Phase 3|117|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 14:20:20.281609|2017-02-18 14:20:20.281609
NCT00685113|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2016-07-18||2011-06-08|May 2008||2008-05-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder|A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Doses of DR-3001 Versus Placebo in Women With Overactive Bladder|Completed||Phase 3|1104|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-02-18 14:20:20.425058|2017-02-18 14:20:20.425058
NCT00685100|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2015-04-14|||January 2004||2004-01-01|May 2008|2008-05-01|January 2007|Actual|2007-01-01|January 2006|Actual|2006-01-01||Interventional|||Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone||Completed||Phase 3|40||Medical University of Vienna|||||f||||||||||||||2017-02-18 14:20:20.594909|2017-02-18 14:20:20.594909
NCT00685087|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2013-05-17|||September 2004||2004-09-01|May 2008|2008-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||A Prospective Study of Natural History of Pancreatitis|A Prospective Study of Natural History of Pancreatitis|Completed||N/A|300|Actual|Virginia Commonwealth University|||1||f||||f||||||||||2017-02-18 14:20:20.873929|2017-02-18 14:20:20.873929
NCT00685074|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2011-10-12|||September 2007||2007-09-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Computer-based Brief Intervention for Perinatal Substance Abuse|Computer-based Brief Intervention for Perinatal Drug, Alcohol, and Tobacco Abuse|Completed||Phase 1/Phase 2|143|Actual|Wayne State University||2|||f||||t||||||||||2017-02-18 14:20:20.949318|2017-02-18 14:20:20.949318
NCT00685061|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-05-27|||November 2002||2002-11-01|May 2008|2008-05-01|September 2005|Actual|2005-09-01|September 2004|Actual|2004-09-01||Interventional|||Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation|Head-to-Head Comparison of Thymoglobulin vs. Campath-1H vs. Our Standard Center Treatment Protocol in Cadaver Donor Renal Transplantation: A Study to Evaluate the Avoidance of Long-Term Nephrotoxic Calcineurin Inhibitor Therapy|Completed||Phase 4|90|Actual|University of Miami||3|||f||||t||||||||||2017-02-18 14:20:21.069729|2017-02-18 14:20:21.069729
NCT00685048|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2014-02-24|||July 2007||2007-07-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Brief Therapies for Problem Gambling Substance Abusers|Brief Therapies for Problem Gambling Substance Abusers|Completed||Phase 2|220|Actual|UConn Health||3|||f||||f||||||||||2017-02-18 14:20:21.171787|2017-02-18 14:20:21.171787
NCT00684853|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-05-27|||November 2007||2007-11-01|May 2008|2008-05-01||||May 2008|Actual|2008-05-01||Interventional|||Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD|Intravitreal Bevacizumab Combined With PDT (Full Fluence) Versus Bevacizumab to Treat Exudative Age-Related Macular Degeneration|Unknown status|Recruiting|Phase 2|50|Anticipated|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:20:24.811175|2017-02-18 14:20:24.811175
NCT00685035|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-06-24|2012-12-18||May 2008||2008-05-01|June 2016|2016-06-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings|Comparison of Sine Waveform High Frequency Chest Wall Oscillation Using Different Settings in Cystic Fibrosis|Completed||Phase 4|17|Actual|University of Minnesota - Clinical and Translational Science Institute|"Sputum weights varied more than anticipated and the study was underpowered to detect differences in the primary outcomes.~Study not generalizable to patients that do not produce sputum or have an FEV1 < 40% predicted."|2|||f||||t||||||||||2017-02-18 14:20:21.281007|2017-02-18 14:20:21.281007
NCT00685022|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-02-21|||June 2003||2003-06-01|February 2012|2012-02-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma|A Cumulative Dose Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 2|49|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 14:20:21.736777|2017-02-18 14:20:21.736777
NCT00685009|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2015-10-16|||January 1996||1996-01-01|October 2015|2015-10-01|March 2008|Actual|2008-03-01|September 1997|Actual|1997-09-01||Observational|||The Women's Health Initiative Memory Study (The WHIMS Study)|Women's Health Initiative Memory Study|Completed||N/A|7525|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||3||f||||t||||||||||2017-02-18 14:20:21.84401|2017-02-18 14:20:21.84401
NCT00684996|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2014-04-28|2013-11-25||June 2008||2008-06-01|April 2013|2013-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer|A Phase I and a Randomized Phase II Study of Maximal Angiogenic Blockade in Advanced Renal Carcinoma: Bevacizumab (NSC-704865) With or Without MEDI-522 (NSC-719850)|Terminated||Phase 1/Phase 2|5|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:20:21.983441|2017-02-18 14:20:21.983441
NCT00684983|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-11-22|2014-10-01||July 2008||2008-07-01|November 2016|2016-11-01||||January 2014|Actual|2014-01-01||Interventional||Total of 68 patient were accrued. Three are cancels and one is ineligible. Sixty four (64) started the study treatment.|Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer|Randomized Phase II Trial of Capecitabine and Lapatinib With or Without IMC-A12 in Patients With HER2 Positive Breast Cancer Previously Treated With Trastuzumab and an Anthracycline and/or a Taxane|Active, not recruiting||Phase 2|64|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 14:20:22.638866|2017-02-18 14:20:22.638866
NCT00684970|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2013-12-04|||March 2009||2009-03-01|December 2013|2013-12-01||||February 2014|Anticipated|2014-02-01||Interventional|TLH-202||Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)|A Phase IIB Clinical Trial of the Anti-Angiogenic Drug Combination Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)|Unknown status|Recruiting|Phase 2|100|Anticipated|Tiltan Pharma Ltd.||1|||f||||t||||||||||2017-02-18 14:20:23.871885|2017-02-18 14:20:23.871885
NCT00684957|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-11-02|||January 2008||2008-01-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors|Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors in Adult Patients With Growth Hormone Deficiency|Terminated||N/A|5|Actual|Columbia University||2||Poor enrollment|f||||f||||||||||2017-02-18 14:20:23.975049|2017-02-18 14:20:23.975049
NCT00684944|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2012-02-01|||July 2007||2007-07-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Open Label Study of TRx0014 in Alzheimer's Disease|An Open Label Continuation Study of the Effects of TRx0014 30 mg TID and 60 mg TID in Patients With Alzheimer's Disease|Completed||Phase 2|111|Actual|TauRx Therapeutics Ltd||2|||f||||f||||||||||2017-02-18 14:20:24.090029|2017-02-18 14:20:24.090029
NCT00684931|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2009-06-22|||February 2008||2008-02-01|June 2009|2009-06-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|TDA/H||Cerebellar Loops and Attention Deficit Hyperactivity Disorder (ADHD)|Alterations of Fronto-Cerebello-Frontal Loops in Attention Deficit Hyperactivity Disorder (ADHD) : A Study Using Magnetic Resonance Imaging (MRI)|Terminated||N/A|19|Actual|University Hospital, Bordeaux||2||Difficulties in the organisation|f||||f||||||||||2017-02-18 14:20:24.185114|2017-02-18 14:20:24.185114
NCT00684918|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2013-08-16||2013-08-16|April 2008||2008-04-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)|A Multicenter, Open-Label, 2-Stage, Phase II Study of Single-Agent Obatoclax Mesylate Administered For Three Consecutive Days Every 2 Weeks to Older Patients With Previously Untreated Acute Myeloid Leukemia (AML)|Completed||Phase 2|18|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 14:20:24.296355|2017-02-18 14:20:24.296355
NCT00684905|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2012-11-09|||April 2000||2000-04-01|November 2012|2012-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy|Phase II Interstitial Brachytherapy Combined With Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Prior External Beam Irradiation|Completed||Phase 2|50|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:20:24.411292|2017-02-18 14:20:24.411292
NCT00684892|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2009-01-20|||May 2008||2008-05-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)|A Safety and Feasibility Study of the Chartis System in Subjects With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)|Completed||Phase 1/Phase 2|25|Actual|Pulmonx, Inc.||1|||f||||f||||||||||2017-02-18 14:20:24.516295|2017-02-18 14:20:24.516295
NCT00684879|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2017-01-24|||May 21, 2008||2008-05-21|January 7, 2016|2016-01-07|January 7, 2016||2016-01-07|||||Observational|||Screening Behavior in Adults With Hereditary Hemorrhagic Telangiectasia|Illness Perceptions and the Health Belief Model: Screening Behavior in Adults With Hereditary Hemorrhagic Telangiectasia|Completed||N/A|320|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:20:24.60916|2017-02-18 14:20:24.60916
NCT00684866|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-02-21|||January 2003||2003-01-01|February 2012|2012-02-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma|A Cumulative Dose Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatric Subjects With Asthma|Completed||Phase 2|31|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 14:20:24.697039|2017-02-18 14:20:24.697039
NCT00684840|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-06-01|||March 2008||2008-03-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|DSS||Effects of Stress and Other Factors on Opiate Drug Choice.|Biobehavioral Study of Opioid Drug Seeking Behavior: Study 4|Completed||N/A|16|Anticipated|Wayne State University|||1||f||||t||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 14:20:24.918488|2017-02-18 14:20:24.918488
NCT00684827|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2012-02-21|||October 2002||2002-10-01|February 2012|2012-02-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma|A Cumulative Dose Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 2|32|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 14:20:25.204727|2017-02-18 14:20:25.204727
NCT00684814|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2012-04-18|2009-12-04||May 2004||2004-05-01|April 2012|2012-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions|A Randomized, Two-way Crossover, Single-Dose, Open-Label Study to Evaluate the Relative Bioequivalence of a Test Tablet Formulation of Zolpidem Tartrate 10 mg, Compared to an Equivalent Dose of Ambien® in Healthy Adult Subjects.|Completed||Phase 1|38|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:20:25.313538|2017-02-18 14:20:25.313538
NCT00684801|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2015-10-08|||August 2007||2007-08-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers|Improving the Quality of Advanced Cancer Care With Disease Management|Completed||N/A|605|Actual|Case Comprehensive Cancer Center|||2||f||||t||||||||||2017-02-18 14:20:25.683758|2017-02-18 14:20:25.683758
NCT00684788|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-05-23|||May 2006||2006-05-01|May 2008|2008-05-01||||||||Interventional|||Employment-Based Depot Naltrexone Clinical Trial|Employment-Based Depot Naltrexone Clinical Trial|Unknown status|Recruiting|Phase 2|80|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 14:20:25.796345|2017-02-18 14:20:25.796345
NCT00684775|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2008-05-23|||May 2008||2008-05-01|May 2008|2008-05-01||||May 2010|Anticipated|2010-05-01||Interventional|||Employment-Based Depot Naltrexone Clinical Trial II||Unknown status|Not yet recruiting|Phase 2|40|Anticipated|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 14:20:25.898145|2017-02-18 14:20:25.898145
NCT00684762|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2009-11-18|2009-11-18||March 2004||2004-03-01|November 2009|2009-11-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Fasted Bioavailability Study of Cilostazol Tablets, 100 mg|A Comparative Bioavailability Study of Cilostazol Tablets, 100mg Under Fasting Conditions|Completed||Phase 1|32|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:20:26.001677|2017-02-18 14:20:26.001677
NCT00684749|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-02-19|2013-02-20||May 2008||2008-05-01|February 2015|2015-02-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Observational|||A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation Mammaplasty|Pilot Study to Investigate The BodyLogic TM System (Mentor) in Breast Augmentation.|Completed||N/A|142|Actual|University of Minnesota - Clinical and Translational Science Institute|snap shot view, responder bias||1||f||||f||||||||||2017-02-18 14:20:26.354155|2017-02-18 14:20:26.354155
NCT00684736|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2008-08-07|||June 2004||2004-06-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2007|Actual|2007-04-01||Observational|TSK||Tryptophan, Serotonin and Kynurenine in Septic Shock|Tryptophan, Serotonin and Kynurenine in Septic Shock|Completed||N/A|30|Actual|Versailles Hospital|||1||f||||f||||||||||2017-02-18 14:20:26.557811|2017-02-18 14:20:26.557811
NCT00684723|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-24|2010-01-11|2009-11-24||July 2004||2004-07-01|January 2010|2010-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Fed Bioavailability Study of Lovastatin Tablets and Mevacor Tablets|A Single Dose Crossover Comparative Bioavailability Study of Lovastatin 40mg Tablets in Healthy Male Volunteers/Fed State|Completed||Phase 1|54|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:20:26.653025|2017-02-18 14:20:26.653025
NCT00684710|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2009-01-28|||April 2008||2008-04-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects|Ascending Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of PAZ 417 Administered Orally to Healthy Young Japanese Male and Healthy Elderly Japanese Male Subjects|Completed||Phase 1|56|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:20:27.033345|2017-02-18 14:20:27.033345
NCT00684697|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-07-07|||May 2008||2008-05-01|July 2016|2016-07-01|May 2020|Anticipated|2020-05-01|April 2017|Anticipated|2017-04-01||Interventional|Piron||Iron Status and Myelination in Premature Infants|Double Blind Randomized Placebo Controlled Trial of Iron Supplementation in Premature Infants|Recruiting||Phase 2/Phase 3|100|Anticipated|University of Rochester||3|||f||||t||||||||||2017-02-18 14:20:27.130004|2017-02-18 14:20:27.130004
NCT00684684|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2009-01-20|||May 2008||2008-05-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Feasibility Study of the Chartis System|A Safety and Feasibility Study of the Chartis System During Diagnostic Bronchoscopy|Completed||Phase 1|18|Actual|Pulmonx, Inc.||1|||f||||f||||||||||2017-02-18 14:20:27.245722|2017-02-18 14:20:27.245722
NCT00684671|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-23|2016-10-18|2009-10-29||May 2008||2008-05-01|October 2016|2016-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination|Challenge Dose Administration of Twinrix™ or Comparator 4 Years After Primary Vaccination.|Completed||Phase 4|506|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:20:27.337138|2017-02-18 14:20:27.337138
NCT00684658|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2012-10-16|||May 2008||2008-05-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||TEENCOPE: An Internet Coping Skills Training Program for Teens With Type 1 Diabetes|An Internet Coping Skills Training Program for Teens With Type 1 Diabetes|Completed||Phase 3|320|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:20:27.930772|2017-02-18 14:20:27.930772
NCT00684645|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2012-07-17|2012-04-18||June 2008||2008-06-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®|Non-Interventional Study In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®|Completed||N/A|186|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:20:28.06448|2017-02-18 14:20:28.06448
NCT00684632|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2017-01-03|||March 2008||2008-03-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients|A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients|Completed||Phase 3|51|Actual|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||No||2017-02-18 14:20:29.120074|2017-02-18 14:20:29.120074
NCT00684619|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2010-08-20|||June 2003||2003-06-01|May 2008|2008-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)|Phase II-Study With Nelarabine in Patients With Refractory Oder Relapsed T- ALL or T-lymphoblastic Lymphoma (Amend.7)|Completed||Phase 2|160|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||||2017-02-18 14:20:29.217011|2017-02-18 14:20:29.217011
NCT00684606|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2008-06-18|||May 2008||2008-05-01|June 2008|2008-06-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Transcervical Foley Catheter With or Without Oxytocin for Induction of Labor|Transcervical Foley Catheter With or Without IV Oxytocin Infusion for Induction of Labor: a Randomized Controlled Trial|Unknown status|Recruiting|N/A|120|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 14:20:29.328237|2017-02-18 14:20:29.328237
NCT00684593|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-09-21|2014-09-26||June 2007||2007-06-01|September 2015|2015-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)|A Study to Assess the Clinical Effects of SCH 527123 in Psoriasis|Completed||Phase 2|31|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:20:29.442181|2017-02-18 14:20:29.442181
NCT00684580|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-12-19|||May 2000||2000-05-01|December 2016|2016-12-01|May 2025|Anticipated|2025-05-01|May 2025|Anticipated|2025-05-01||Observational|||Protocol For Collecting Data On Patients With Childhood Cancer|Protocol For Collecting Data On Patients With Childhood Cancer|Recruiting||N/A|12000|Anticipated|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 14:20:29.79851|2017-02-18 14:20:29.79851
NCT00684567|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-01-19|2008-10-31||September 2005||2005-09-01|January 2015|2015-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)|SCH 52365 Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|30|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 14:20:29.915389|2017-02-18 14:20:29.915389
NCT00684554|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-04-06|2015-05-19||December 2007||2007-12-01|April 2016|2016-04-01|April 2010|Actual|2010-04-01|August 2008|Actual|2008-08-01||Interventional||Adult Opioid Dependent treatment seekers|Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial|Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial of At-Home Versus In-Office Buprenorphine Induction|Completed||Phase 2/Phase 3|20|Actual|New York State Psychiatric Institute|The primary pilot study limitations are sample size and treatment setting, which restricts statistical comparison of outcomes and generalizability.|2|||f||||f||||||||||2017-02-18 14:20:30.34209|2017-02-18 14:20:30.34209
NCT00684541|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2014-04-02|2013-12-13||September 2007||2007-09-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|SP Interp||Interpretation Modification Program for Social Phobia|Interpretation Modification Program for Social Phobia|Completed||N/A|49|Actual|San Diego State University||2|||f||||t||||||||||2017-02-18 14:20:30.724406|2017-02-18 14:20:30.724406
NCT00684528|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2012-03-16|||June 2008||2008-06-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin||Unknown status|Recruiting|Phase 3|1000|Anticipated|Meir Medical Center||2|||f||||t||||||||||2017-02-18 14:20:31.082072|2017-02-18 14:20:31.082072
NCT00684515|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-10-15|2014-05-09||September 2006||2006-09-01|October 2015|2015-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)|Phase II Study of SCH 530348 in Subjects With Cerebral Infarction|Completed||Phase 2|90|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 14:20:31.201716|2017-02-18 14:20:31.201716
NCT00684502|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2010-12-08|||January 2008||2008-01-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects|A Phase I, Single-centre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects After Oral Multiple Ascending Doses|Completed||Phase 1|110|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:20:31.816211|2017-02-18 14:20:31.816211
NCT00684489|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-05-22|||September 2003||2003-09-01|May 2008|2008-05-01|September 2005|Actual|2005-09-01|March 2005|Actual|2005-03-01||Interventional|Renin||Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension|Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled or Complicated Hypertension|Completed||N/A|52|Actual|Medical University of South Carolina||4|||f||||f||||||||||2017-02-18 14:20:31.91902|2017-02-18 14:20:31.91902
NCT00684476|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2008-05-23|||June 2004||2004-06-01|March 2004|2004-03-01|May 2006||2006-05-01|||||Interventional|||Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-Stings||Completed||Phase 4|60||Meir Medical Center|||||f||||||||||||||2017-02-18 14:20:32.014475|2017-02-18 14:20:32.014475
NCT00684463|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-04-07|||April 2007||2007-04-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)|Study to Evaluate the Efficacy and Safety of Single IV Doses of Onicit® (Palonosetron) 0.25 mg in the Prevention of Acute and Delayed Nausea and Vomiting Associated With Moderate and Highly Emetogenic Chemotherapy in Colombia|Completed||Phase 4|59|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:20:32.097629|2017-02-18 14:20:32.097629
NCT00684450|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-08-24|||June 2008||2008-06-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Protamine||Cardiac Surgery: In Vivo Titration of Protamine|Cardiac Surgery : In Vivo Titration of Protamine|Completed||N/A|138|Actual|Montreal Heart Institute||2|||f||||t||||||||||2017-02-18 14:20:32.185764|2017-02-18 14:20:32.185764
NCT00684437|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-10-03|||May 2008||2008-05-01|October 2016|2016-10-01||||May 2018|Anticipated|2018-05-01||Interventional|||Literacy and Smoking Risk Communications|Literacy and Smoking Risk Communications|Active, not recruiting||N/A|495|Anticipated|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 14:20:32.302032|2017-02-18 14:20:32.302032
NCT00684424|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2010-05-27|2010-03-09||July 2008||2008-07-01|May 2010|2010-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency|Non-Interventional Study (NIS) With Lyrica In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency|Completed||Phase 4|199|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:20:32.419352|2017-02-18 14:20:32.419352
NCT00684411|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-11-08|2016-09-11||June 2008||2008-06-01|November 2016|2016-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma|A Pilot Study of Gleevec (Imatinib Mesylate) in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|12|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 14:20:33.323172|2017-02-18 14:20:33.323172
NCT00684398|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2017-01-24|||May 15, 2008||2008-05-15|November 27, 2015|2015-11-27|November 27, 2015||2015-11-27|||||Observational|||Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I|Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I|Completed||N/A|645|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:20:33.654865|2017-02-18 14:20:33.654865
NCT00684385|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2017-01-24|||August 2001||2001-08-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2014|Actual|2014-09-01||Interventional|||An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck|An International Expanded Access Clinical Programme With ZD1839 (IRESSA) for Patients With Advanced Non-small Cell Lung Cancer(NSCLC) and Patients With Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck (H&NC)|Active, not recruiting||Phase 4|269|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 14:20:33.75345|2017-02-18 14:20:33.75345
NCT00684372|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-02-05|||May 2007||2007-05-01|February 2009|2009-02-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||BK Viremia After Renal Transplantation|BK Viremia After Renal Transplantation: Screening, Early Diagnosis, Early Reduction in Immunosuppression and Treatment With Leflunomide (Arava)|Unknown status|Active, not recruiting|N/A|100|Anticipated|Karolinska University Hospital||1|||f||||t||||||||||2017-02-18 14:20:34.087341|2017-02-18 14:20:34.087341
NCT00684359|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2010-05-28|||June 2007||2007-06-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|||||Observational|PRACTICE I||Platelet Reactivity After Cessation of Clopid in the Setting of Coronary Stent Implantation I: PRACTICE I|Platelet Reactivity After Cessation of Clopid in the Setting of Coronary Stent Implantation I: PRACTICE I|Completed||N/A|30|Anticipated|Medstar Health Research Institute|||1||f||||t||||||||||2017-02-18 14:20:34.175193|2017-02-18 14:20:34.175193
NCT00684346|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-08-30|||April 2008||2008-04-01|August 2013|2013-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients|A Pilot Study of 18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients After Treatment for a Pulmonary Exacerbation|Completed||Phase 3|20|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-02-18 14:20:34.257412|2017-02-18 14:20:34.257412
NCT00684333|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-01-10|||June 2009||2009-06-01|January 2009|2009-01-01|February 2010|Anticipated|2010-02-01|December 2009|Anticipated|2009-12-01||Interventional|||Safety and Efficacy of EZ-Ject Injector a Pain-Free Subcutaneous Automatic Injection in Healthy Volunteers|Assessment of Safety and Efficacy of EZ-Ject Injector a Novel Device for Pain-Free Subcutaneous Automatic Injection in Healthy Volunteers|Suspended||N/A|42|Anticipated|Sindolor||1|||f||||f||||||||||2017-02-18 14:20:34.364897|2017-02-18 14:20:34.364897
NCT00684320|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2014-04-02|2013-12-18||September 2006||2006-09-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|SPAttn||Attention Disengagement Training for Social Phobia|Attention Disengagement Training for Social Phobia|Completed||N/A|48|Actual|San Diego State University||2|||f||||t||||||||||2017-02-18 14:20:34.470781|2017-02-18 14:20:34.470781
NCT00684307|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2012-03-20|2011-08-17||February 2007||2007-02-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation|A Controlled, Randomized, Parallel, Multicentre Study to Assess Safety and Tolerability of the Oral Direct Thrombin Inhibitor AZD0837, Given as an Extended-release Formulation, in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation|Completed||Phase 2|1084|Actual|AstraZeneca||5|||f||||t||||||||||2017-02-18 14:20:34.894852|2017-02-18 14:20:34.894852
NCT00684294|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-09-30|||May 2008||2008-05-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Interventional|Auto TAG||Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer|Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer|Active, not recruiting||Phase 1|50|Anticipated|Mary Crowley Medical Research Center||2|||f||||t||||||||||2017-02-18 14:20:36.333941|2017-02-18 14:20:36.333941
NCT00684281|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-08-27|||July 2008||2008-07-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|||Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment|Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment|Completed||N/A|60|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||f||||||||||2017-02-18 14:20:36.435172|2017-02-18 14:20:36.435172
NCT00684268|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-10-24|||October 2007||2007-10-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|NRSily||Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders|Multicenter Study To Evaluate The Efficacy Of Silymarin In Addition To Combination-Therapy With Pegylated Interferon Alfa 2a (Peg-Ifn Alfa 2a) And Ribavirin In Patients With Chronic Hepatitis C|Completed||Phase 2|100|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:20:36.537609|2017-02-18 14:20:36.537609
NCT00684255|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2014-02-06|2008-12-22||August 2007||2007-08-01|February 2014|2014-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)|Reduced Intensity Conditioning And Allogeneic Stem Cell Transplantation in Patients With Medically Refractory Systemic Lupus Erythematosus and Medically Refractory Systemic Sclerosis (SSc)|Terminated||Phase 1|1|Actual|New York Medical College|Study closed due to low accrual. Did not meet enrollment goals.|2||inactive|f||||t||||||||||2017-02-18 14:20:36.649293|2017-02-18 14:20:36.649293
NCT00684242|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2012-12-20|2012-12-20||May 2008||2008-05-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain|A Pilot Clinical Trial of Lenalidomide (Revlimid®) for the Treatment of Refractory Cancer Pain|Terminated||Phase 2|4|Actual|M.D. Anderson Cancer Center||1||Low accrual.|f||||f||||||||||2017-02-18 14:20:36.897308|2017-02-18 14:20:36.897308
NCT00684229|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-09-13|||December 2007||2007-12-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Regional Anesthesia in Colon Rectal Surgery|Regional Anesthesia in Patients Undergoing Colon-Rectal Surgery|Withdrawn||N/A|0|Actual|The Cleveland Clinic||2||investigator could not identify any patients|f||||t||||||||||2017-02-18 14:20:37.121278|2017-02-18 14:20:37.121278
NCT00684216|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2012-05-10|||April 2008||2008-04-01|May 2012|2012-05-01|May 2013|Anticipated|2013-05-01|May 2012|Actual|2012-05-01||Interventional|||Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer|Randomized Phase II/III Study of Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic Estrogen Receptor Positive Breast Cancer|Terminated||Phase 2/Phase 3|10|Actual|The Netherlands Cancer Institute||2||acrual too slow|f||||f||||||||||2017-02-18 14:20:37.229262|2017-02-18 14:20:37.229262
NCT00684203|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-07-20|2014-05-09||December 2006||2006-12-01|July 2015|2015-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)|Phase II Study of SCH 530348 in Subjects With Acute Coronary Syndrome|Completed||Phase 2|120|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 14:20:39.748119|2017-02-18 14:20:39.748119
NCT00684190|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2010-12-02|||March 2008||2008-03-01|December 2010|2010-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Drug Interaction Study Between AZD3355 and Nexium|An Open, Randomised, Three Period Cross, Single Centre, Phase 1 Pharmacokinetic Interaction Study of the Reflux Inhibitor AZD3355 150 mg Bid and Esomeprazole 40 mg od After 7 Days of Treatment in Healthy Volunteers|Completed||Phase 1|30|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:20:41.315632|2017-02-18 14:20:41.315632
NCT00684177|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-10-11|2010-06-03||May 2008||2008-05-01|October 2016|2016-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)|A Randomized, Double-Blind, Multicenter, Placebo-controlled, Phase III Superiority Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adult and Pediatric Subjects With SITL|Completed||Phase 3|508|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:20:41.433936|2017-02-18 14:20:41.433936
NCT00684164|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-03-05|||May 2008||2008-05-01|March 2015|2015-03-01|June 2010|Anticipated|2010-06-01|November 2009|Anticipated|2009-11-01||Interventional|||Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients|Safety and Efficacy of Conivaptan for the Correction of Euvolemic and Hypervolemic Hyponatremia in Critically Ill Neurological Patients|Withdrawn||Phase 3|0|Actual|Columbia University||2||Unable to complete a contract with the Sponsor|f||||t||||||||||2017-02-18 14:20:42.155678|2017-02-18 14:20:42.155678
NCT00684151|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2011-12-09|||April 2008||2008-04-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|||||Observational|||Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand|Lipid-lowering Therapy in Patients With High Cardiovascular Risk and Their 3-year Mortality Rate in General Practice in Thailand|Completed||N/A|1240|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:20:42.268722|2017-02-18 14:20:42.268722
NCT00684138|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2010-07-06|2009-01-30||June 2007||2007-06-01|July 2010|2010-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (IOL)|ACRYSOF® ReSTOR® Aspheric +3.0 D Add Power Intraocular Lens (IOL)|Completed||Phase 4|300|Actual|Alcon Research|Data from one investigator, who implanted 20 subjects, were excluded from analysis due to non compliance with data collection and documentation. This resulted in 280 implanted subjects that were considered evaluable.|2|||f||||f||||||||||2017-02-18 14:20:42.397258|2017-02-18 14:20:42.397258
NCT00684125|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-07-21|||June 2008||2008-06-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|May 2010|Actual|2010-05-01||Interventional|Blake||Evaluation of Different Strategies of Pericardial Drainage After Aortic Valvular Surgery|Evaluation of Different Strategies of Pericardial Drainage After Aortic Valvular Surgery: A Prospective Randomized Trial|Completed||N/A|150|Anticipated|Montreal Heart Institute||2|||f||||f||||||||||2017-02-18 14:20:43.029128|2017-02-18 14:20:43.029128
NCT00684112|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2013-08-15|||May 2008||2008-05-01|August 2013|2013-08-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Analgesic Effects of Gabapentin After Scoliosis Surgery in Children|Analgesic Effects of Gabapentin After Scoliosis Surgery in Children|Completed||Phase 3|35|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 14:20:43.135719|2017-02-18 14:20:43.135719
NCT00684099|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2009-12-14|||May 2006||2006-05-01|December 2009|2009-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)|A Phase I/II Study Of The Docetaxel/Pemetrexed Combination As First Line Treatment In Patients With Advanced/Metastatic NSCLC|Completed||Phase 1/Phase 2|70|Anticipated|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 14:20:43.242356|2017-02-18 14:20:43.242356
NCT00684086|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2008-05-23|||April 2007||2007-04-01|May 2008|2008-05-01||||||||Interventional|||English Diabetes Self-Management Program|English Diabetes Self-Management Program|Completed||N/A|350||Stanford University|||||f||||||||||||||2017-02-18 14:20:43.357535|2017-02-18 14:20:43.357535
NCT00684073|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2011-04-14|2008-12-17||July 2007||2007-07-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)|Evaluation of Preference for a Buprenorphine-based Maintenance Therapy, After a Switch From Buprenorphine Alone (Subutex®) to the Buprenorphine/Naloxone Combination (Suboxone®), in Opioid-dependent Patients With Buprenorphine Maintenance Therapy|Completed||Phase 4|60|Actual|Indivior Inc.||1|||f||||f||||||||||2017-02-18 14:20:43.453805|2017-02-18 14:20:43.453805
NCT00222924|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2007-12-14|||December 2003||2003-12-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Mitochondrial Impairment in Muscle Insulin Resistance|Mitochondrial Impairment in Muscle Insulin Resistance|Completed||N/A|49||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:06.580638|2017-02-18 17:07:06.580638
NCT00684060|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-07-07|2012-04-09||July 2008||2008-07-01|July 2015|2015-07-01|February 2012|Actual|2012-02-01|August 2011|Actual|2011-08-01||Interventional|||Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study)|A Phase II, Randomized, Controlled, Double-Blind Pilot Trial Evaluating the Safety and Effect of Administration of Bone Marrow Mononuclear Cells Two to Three Weeks Following Acute Myocardial Infarction|Completed||Phase 2|87|Actual|The University of Texas Health Science Center, Houston|Lack of in-vivo testing of cell product. While there are several different approaches to measure myocardial strain (myocardial tagging, DENSE, etc.), these were not employed in this study due to the need for specialized expertise at each site.|2|||f||||t||||||||||2017-02-18 14:20:43.701889|2017-02-18 14:20:43.701889
NCT00684047|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2015-12-17|2015-09-25||February 2008||2008-02-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional||Demographic information is summarized for the subjects in the Intent to treat population.|Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis|A Prospective, Single-blind, Randomized, Phase II/III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Peripheral Vascular Surgery|Completed||Phase 2/Phase 3|239|Actual|Grifols Biologicals Inc.||3|||f||||f||||||||||2017-02-18 14:20:44.232923|2017-02-18 14:20:44.232923
NCT00684034|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-08-27|||June 2008||2008-06-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Redox State in the Course of Chronic Renal Insufficiency and Hemodialysis: Implications in Morbimortality|Redox State in the Course of Chronic Renal Insufficiency and Hemodialysis: Implications in Morbimortality|Completed||N/A|131|Actual|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-02-18 14:20:44.774118|2017-02-18 14:20:44.774118
NCT00684021|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-06-02|2013-01-18||July 2008||2008-07-01|June 2015|2015-06-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|||Use of Adult Autologous Stem Cells in Treating People Who Have Had a Heart Attack (The TIME Study)|Transplantation in Myocardial Infarction Evaluation (TIME) Protocol: A Phase II, Randomized, Controlled, Double-Blind Trial Evaluating the Effect of Timing on the Administration of Bone Marrow Mononuclear Cells (BMMNCs) Versus Placebo in Patients With Acute Myocardial Infarction|Completed||Phase 2|120|Actual|The University of Texas Health Science Center, Houston|The choice of Day 3 or Day 7 as randomization points while based on the literature were nevertheless somewhat arbitrary. cMR-baseed ejection fractions tended to be high.|4|||f||||t||||||||||2017-02-18 14:20:44.885295|2017-02-18 14:20:44.885295
NCT00684008|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2012-07-25|||March 2008||2008-03-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|||||Interventional|||Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant|A Phase I Study of CYT107 (Recombinant Glycosylated Human IL-7) in Recipients of HLA Matched Ex Vivo T Cell Depleted Bone Marrow or Peripheral Blood Stem Cell Transplant|Completed||Phase 1|12|Actual|Cytheris, Inc.||1|||f||||t||||||||||2017-02-18 14:20:45.709863|2017-02-18 14:20:45.709863
NCT00683995|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2017-01-03|||March 2008||2008-03-01|December 2016|2016-12-01||||July 2009|Actual|2009-07-01||Interventional|||A Phase III Clinical Study of KW-2246|A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients|Completed||Phase 3|43|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-02-18 14:20:46.014941|2017-02-18 14:20:46.014941
NCT00683982|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2008-05-23|||August 2007||2007-08-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus|Nitazoxanide vs Probiotics in the Treatment of Acute Rotavirus Diarrhea in Children: A Randomized Single Blind Controlled Trial in Bolivian Children|Completed||N/A|75|Actual|Centro Pediatrico Albina de Patino||3|||f||||f||||||||||2017-02-18 14:20:46.105331|2017-02-18 14:20:46.105331
NCT00683969|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-05-23|||August 2004||2004-08-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, 36-Week Trial to Assess the Efficacy and Safety of Adjunct Mycophenolate Mofetil (MMF) to Maintain or Improve Symptom Control With Reduced Corticosteroid in Subjects With Myasthenia Gravis|Completed||Phase 3|136|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:20:46.2256|2017-02-18 14:20:46.2256
NCT00683956|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2011-11-22|||May 2008||2008-05-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of a Closed-Loop Control System for Administering Patient-Specific Anesthesia|Evaluation of a Closed-Loop Control System for Patient-Specific Induction and Maintenance of Propofol Hypnosis|Completed||Phase 1|35|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 14:20:46.37687|2017-02-18 14:20:46.37687
NCT00683943|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2017-01-24|||May 18, 2008||2008-05-18|February 27, 2014|2014-02-27|February 25, 2010|Actual|2010-02-25|February 25, 2010|Actual|2010-02-25||Interventional|||Lithium Treatment for Patients With Spinocerebellar Ataxia Type I|Pilot Study of Tolerability of Lithium Therapy in Patients With Spinocerebellar Ataxia Type I (SCA1)|Completed||Phase 1|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:20:46.471499|2017-02-18 14:20:46.471499
NCT00683930|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2011-05-25|2009-11-18||May 2004||2004-05-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)|A Prospective, Randomised, Double-blind, Placebo-controlled, Parallel Group, Mult-center, 52-week Trial to Assess the Efficacy and Safety of Adjunct Mycophenolate Mofetil (MMF) to Achieve Remission With Reduced Corticosteroid in Subjects With Pemphigus Vulgaris|Completed||Phase 3|96|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 14:20:46.580153|2017-02-18 14:20:46.580153
NCT00683917|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2014-08-05|2014-06-25||May 2008||2008-05-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Study prematurely terminated|Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids|A Multi-center, Active Controlled, Pharmacokinetic, Safety and Efficacy Study of Proellex in Pre-Menopausal Women With Symptomatic Uterine Fibroids to Assess Persistence of Response|Terminated||Phase 2|10|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with any study data.|3||Repros stopped the study for safety and FDA put the study on hold for safety.|f||||t||||||||||2017-02-18 14:20:47.495896|2017-02-18 14:20:47.495896
NCT00005217|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-27|||April 1988||1988-04-01|January 2016|2016-01-01|March 1991||1991-03-01|||||Observational|||Intermittent ST Depression and Prognosis After Myocardial Infarction||Completed||N/A|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:15:20.355523|2017-02-18 18:15:20.355523
NCT00683904|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2016-02-09|2011-02-08||June 2008||2008-06-01|February 2016|2016-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer|A Phase I Study of Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer as First-line Treatment|Completed||Phase 1|12|Actual|R-Pharm||2|||f||||t||||||||||2017-02-18 14:20:47.766259|2017-02-18 14:20:47.766259
NCT00683891|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2008-06-18||||||June 2008|2008-06-01||||||||Observational|FOCUS||FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey|FazaClo Outcomes in the Control of Schizophrenia (FOCUS)|Completed||N/A|||Azur Pharma, Inc|||1||f||||||||||||||2017-02-18 14:20:48.661376|2017-02-18 14:20:48.661376
NCT00683878|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2015-03-24||2011-06-21|July 2008||2008-07-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Add-on to Thiazolidinedione (TZD) Failures|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Thiazolidinedione Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Thiazolidinedione Therapy Alone|Completed||Phase 3|420|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:20:48.754707|2017-02-18 14:20:48.754707
NCT00683865|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-10-12|||April 2003||2003-04-01|October 2014|2014-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|MAIDEN||Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.|Prospective, Randomized, Double-blind, Multicenter, Multinational Study Comparing Efficacy and Safety of Moxifloxacin 400 mg po od for 14 Days With Ofloxacin 400 mg po Bid Plus Metronidazole 500 mg po Bid for 14 Days in Patients With Uncomplicated Pelvic Inflammatory Disease (PID)|Completed||Phase 3|749|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:20:49.148829|2017-02-18 14:20:49.148829
NCT00683852|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2010-08-11|||July 2008||2008-07-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy|A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy (ADT) Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior ADT|Completed||Phase 3|224|Anticipated|Massachusetts General Hospital||3|||f||||f||||||||||2017-02-18 14:20:49.34465|2017-02-18 14:20:49.34465
NCT00683839|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2011-10-24|||January 2006||2006-01-01|October 2011|2011-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|PHD2||Tobacco Cessation Via Public Health Dental Clinics|Tobacco Cessation Via Public Health Dental Clinics (PHD2)|Completed||Phase 2|2637|Actual|Oregon Research Institute||2|||f||||t||||||||||2017-02-18 14:20:49.461949|2017-02-18 14:20:49.461949
NCT00683826|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-22|2013-03-04|2011-03-01||May 2007||2007-05-01|March 2013|2013-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Effects of Leucine on Body Weight|Effects of Leucine Supplement on Body Weight and Cardiometabolic Changes|Completed||N/A|8|Actual|Columbia University||3|||f||||t||||||||||2017-02-18 14:20:49.581274|2017-02-18 14:20:49.581274
NCT00683813|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2015-05-18|||November 2008||2008-11-01|May 2015|2015-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|vCRP||Trial of a Cardiac Rehabilitation Program Delivered Remotely Through the Internet|Randomized Trial of a Cardiac Rehabilitation Program Delivered Remotely Through the Internet|Completed||N/A|79|Actual|Simon Fraser University||2|||f||||f||||||||||2017-02-18 14:20:50.01684|2017-02-18 14:20:50.01684
NCT00683800|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-07-21|2011-04-21||June 2008||2008-06-01|July 2011|2011-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women|A Double-Blind, Randomized, Placebo-Controlled Study Assessing The Safety And Efficacy Of DVS SR For The Treatment Of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|2186|Actual|Pfizer|GCS scales were analyzed only for main study efficacy population.|2|||f||||t||||||||||2017-02-18 14:20:50.163274|2017-02-18 14:20:50.163274
NCT00683787|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-12-29|2014-05-12||May 2008||2008-05-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|April 2009|Actual|2009-04-01||Interventional||All treated and eligible patients.|Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer|Multicenter Randomized Phase II Trial of Docetaxel With/Without VANDETANIB for Advanced Gastroesophageal Cancer|Terminated||Phase 2|8|Actual|Roswell Park Cancer Institute|Due to the study's early termination and inadequate number of patients no statistical inference of the primary and secondary aims were carried forth.|3||low accrual|f||||t||||||||||2017-02-18 14:20:53.321515|2017-02-18 14:20:53.321515
NCT00683774|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-08-19|2014-05-30||November 2005||2005-11-01|August 2014|2014-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||Obese women with and without PCOS between the ages of 18-40 years selected after examination and eligibility screening|Insulin and Polycystic Ovary Syndrome|Determination if Direct Inhibition of Insulin Release With Diazoxide Decreases Renal Clearance of D-Chiroinositol (DCI) and Increases Circulating DCI in Obese Women With Polycystic Ovary Syndrome (PCOS)|Completed||N/A|21|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 14:20:54.080348|2017-02-18 14:20:54.080348
NCT00683761|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-07-16|||August 2008||2008-08-01|July 2009|2009-07-01|April 2010|Anticipated|2010-04-01|February 2010|Anticipated|2010-02-01||Interventional|||A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma|A Phase 1/2 Multi-Center, Safety and Efficacy Study Evaluating Intravenously Administered 131I-TM601 in Patients With Progressive and/or Recurrent Malignant Glioma|Unknown status|Active, not recruiting|Phase 1/Phase 2|64|Anticipated|TransMolecular||1|||f||||f||||||||||2017-02-18 14:20:54.77933|2017-02-18 14:20:54.77933
NCT00683748|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-02-04|||March 2007||2007-03-01|February 2009|2009-02-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Observational|||Monitoring Cellular Immunity After Kidney and Liver Transplantation|Monitoring Cellular Immunity After Kidney and Liver Transplantation|Unknown status|Active, not recruiting|N/A|100|Anticipated|Karolinska University Hospital|||2||f||||f||||||Samples Without DNA|"~     Serum, whole blood~   "|||2017-02-18 14:20:54.904973|2017-02-18 14:20:54.904973
NCT00683735|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2015-12-17|||February 2009||2009-02-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis|Quantification of the DPP-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis|Completed||Phase 2/Phase 3|20|Actual|Diabeteszentrum Bad Lauterberg im Harz||4|||f||||t||||||||||2017-02-18 14:20:54.987565|2017-02-18 14:20:54.987565
NCT00222196|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-03|||November 2000||2000-11-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Oslo Balloon Angioplasty Versus Conservative Treatment|Oslo Balloon Angioplasty Versus Conservative Treatment|Completed||N/A|200||Oslo University Hospital|||||f||||||||||||||2017-02-18 17:07:12.775346|2017-02-18 17:07:12.775346
NCT00683722|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-12-03|||April 2008||2008-04-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL™ (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Treatment of Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|62|Actual|Mesoblast, Ltd.||2|||f||||||||||||||2017-02-18 14:20:55.098774|2017-02-18 14:20:55.098774
NCT00683709|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-08-02|||January 2007||2007-01-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder|Metabolic Side Effects, Diet and Exercise Counseling and Brain Function in a Naturalistic Clinical Trial of Clozapine for Treatment Resistant Bipolar and Schizoaffective Disorder|Completed||Phase 4|48|Anticipated|St. Joseph's Healthcare Hamilton|||2||f||||f||||||||||2017-02-18 14:20:55.222021|2017-02-18 14:20:55.222021
NCT00683696|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2014-04-17|2014-03-12||August 2008||2008-08-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|EchoCRT|Baseline characterisics were analzed for the randomized population.|Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)|Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)|Terminated||Phase 2/Phase 3|1680|Actual|Biotronik, Inc.|Endpoint results should be interpreted with caution and take into consideration the early study closure and subsequent reduction in sample size (809 vs. 1258) and events (218 vs. 381). These changes impact the statistical power of the findings.|2|||f||||t||||||||||2017-02-18 14:20:55.355057|2017-02-18 14:20:55.355057
NCT00683683|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-05-25|||April 2008||2008-04-01|May 2014|2014-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|SPARC||The Strategies for Post Arrest Resuscitation and Care Network|The Strategies for Post Arrest Resuscitation and Care Network|Completed||N/A|32|Actual|St. Michael's Hospital, Toronto||1|||f||||t||||||||||2017-02-18 14:20:56.205647|2017-02-18 14:20:56.205647
NCT00683670|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2017-02-13|||August 2008||2008-08-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|February 2017|Anticipated|2017-02-01||Interventional|||Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma|Mature Dendritic Cell Vaccination Against gp100 in Patients With Advanced Melanoma|Active, not recruiting||Phase 1|17|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 14:20:56.312633|2017-02-18 14:20:56.312633
NCT00683657|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2015-05-08|2010-02-19||July 2008||2008-07-01|May 2015|2015-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone|A 4-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial To Evaluate The Efficacy And Safety Of Saxagliptin In Comparison To Placebo As Add On Treatment To Metformin XR In Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet And Exercise And A Stable Dose Of Metformin ≥1500 mg/Day|Completed||Phase 3|93|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:20:56.46601|2017-02-18 14:20:56.46601
NCT00683644|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-02-13|||January 2008||2008-01-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Zinc to Treat Tinnitus|Zinc to Treat Tinnitus in the Elderly|Unknown status|Recruiting|Phase 2|200|Anticipated|University of Iowa||2|||f||||||||||||||2017-02-18 14:20:57.146638|2017-02-18 14:20:57.146638
NCT00683631|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-10-18|||January 2004||2004-01-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|TheraSphere||TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)|TheraSphere HUD For Treatment of Unresectable HCC|Completed||N/A|150|Actual|University of Louisville||1|||f||||t||||||||||2017-02-18 14:20:57.236792|2017-02-18 14:20:57.236792
NCT00683618|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2012-03-19|2010-07-09||May 2008||2008-05-01|March 2012|2012-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia|A Randomised, Double-blind Trial to Compare the Efficacy of Rosuvastatin 5 and 10 mg to Atorvastatin 10 mg in the Treatment of High Risk Patients With Hypercholesterolemia Followed by an Open Label Treatment Period With Rosuvastatin Up-titrated to the Maximum Dose of 20 mg for Those Patients Who do Not Achieve Goal|Completed||Phase 3|934|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:20:57.345532|2017-02-18 14:20:57.345532
NCT00683592|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2010-10-05|2010-07-19||March 2008||2008-03-01|October 2010|2010-10-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)|A Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Safety of Vilazodone 40 mg qd and Evaluating Genetic Biomarkers Associated With Treatment Response in Patients With Major Depressive Disorder (MDD)|Completed||Phase 3|481|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 14:20:58.485869|2017-02-18 14:20:58.485869
NCT00683579|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-02-29|||December 2007||2007-12-01|February 2016|2016-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Neurocognitive Assessment in Youth Initiating HAART|Neurocognitive Assessment in Youth Initiating HAART|Completed||N/A|220|Actual|Westat|||4||f||||t||||||||||2017-02-18 14:20:58.984633|2017-02-18 14:20:58.984633
NCT00683566|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2014-08-27|||February 2008||2008-02-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||State Dependent Resonance in the BG-cortical Loops|State Dependent Resonance in the BG-cortical Loops|Completed||N/A|10|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 14:20:59.115843|2017-02-18 14:20:59.115843
NCT00683553|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2010-11-12|||May 2008||2008-05-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)|A Phase I, Randomized, Double-Blind, Dose Escalation Trial of the Safety and Pharmacokinetics of a Single Intravenous Injection of I5NP in Patients at High Risk of Acute Kidney Injury Undergoing Major Cardiovascular Surgery|Terminated||Phase 1|3|Actual|Quark Pharmaceuticals||2||Lack of an available patient population|f||||t||||||||||2017-02-18 14:20:59.219076|2017-02-18 14:20:59.219076
NCT00683540|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2015-04-06|||January 2009||2009-01-01|August 2014|2014-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Formative Evaluation in Implementation Research: Guideline Development|Formative Evaluation in Implementation Research: Guideline Development|Completed||N/A|9|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 14:20:59.353407|2017-02-18 14:20:59.353407
NCT00683527|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2008-05-21|||May 2006||2006-05-01|May 2008|2008-05-01|January 2007|Actual|2007-01-01|November 2006|Actual|2006-11-01||Interventional|||Timing of Iron Supplementation in Very Low Birth Weight Infants|New Versus Standard Enteral Iron Supplementation Regime in Very Low Birth Weight Infants - A Randomized Controlled Trial|Completed||N/A|46|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 14:20:59.44989|2017-02-18 14:20:59.44989
NCT00683514|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-10-03|||April 2005||2005-04-01|October 2016|2016-10-01||||September 2011|Actual|2011-09-01||Interventional|||Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer|Oral Vinorelbine And Cisplatin With Concomitant Radiotherapy Followed By Either Consolidation Therapy With Oral Vinorelbine And Cisplatin Plus Best Supportive Care Or Best Supportive Care Alone In Stage III Non Small Cell Lung Cancer (NSCLC), A Randomized Phase III Study|Completed||Phase 3|201|Actual|Pierre Fabre Medicament||2|||f||||f||||||||||2017-02-18 14:20:59.577427|2017-02-18 14:20:59.577427
NCT00683501|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-06-02|||October 2007||2007-10-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|DNB-001||Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure|A Phase II Study to Investigate the Safety, Efficacy, and Pharmacokinetic Profile of Twice-Daily DNB-001 in Previously Untreated Patients With Elevated Intraocular Hypertension|Completed||Phase 1/Phase 2|54|Actual|Danube Pharmaceuticals, Inc.||5|||f||||t||||||||||2017-02-18 14:20:59.682668|2017-02-18 14:20:59.682668
NCT00683488|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-02-29|||April 2008||2008-04-01|February 2016|2016-02-01|April 2011|Actual|2011-04-01|August 2010|Actual|2010-08-01||Interventional|||Integrated Treatment of Marijuana Abuse for HIV+ Youth|Integrated Treatment of Alcohol and/or Marijuana Abuse for HIV-Infected Youth - Phase I|Completed||Phase 1|46|Actual|Westat||3|||f||||t||||||||||2017-02-18 14:20:59.793537|2017-02-18 14:20:59.793537
NCT00683475|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2014-10-07|2014-05-16||August 2008||2008-08-01|October 2014|2014-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||Modified intent to treat population (mITT): All participants who received any quantity of study drug.|A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer|A Phase 2, Multicenter, Randomized Study of IMC-A12 or IMC-1121B Plus Mitoxantrone and Prednisone in Metastatic Androgen-Independent Prostate Cancer (AIPC) Following Disease Progression on Docetaxel-Based Chemotherapy|Completed||Phase 2|138|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 14:20:59.919683|2017-02-18 14:20:59.919683
NCT00683462|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-10-29|||May 2008||2008-05-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|||||Interventional|||An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)|An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|24|Anticipated|AstraZeneca||3|||f||||||||||||||2017-02-18 14:21:01.101628|2017-02-18 14:21:01.101628
NCT00683449|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-10-05|2011-02-16||June 2008||2008-06-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma|A Phase II, Randomized, Modified Single-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma|Terminated||Phase 2|29|Actual|MediciNova||2||"Data from Dose Groups 1,2 and other MN-221 studies resulted in the determination of a more~   appropriate dosing scheme for MN-221 in subjects with asthma."|f||||f||||||||||2017-02-18 14:21:01.213869|2017-02-18 14:21:01.213869
NCT00683436|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2008-07-21|||May 2008||2008-05-01|July 2008|2008-07-01|November 2008|Anticipated|2008-11-01|October 2008|Anticipated|2008-10-01||Interventional|||Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs|A Multi-Center, Randomized, Blinded, Active and Placebo-Controlled, Crossover Study of the Efficacy and Safety of Two Doses of Adipiplon Bilayer Tablets in Primary Insomniacs|Terminated||Phase 2|84|Anticipated|Neurogen Corporation||4|||f||||f||||||||||2017-02-18 14:21:02.041694|2017-02-18 14:21:02.041694
NCT00683423|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2015-09-23||2010-09-10|July 2008||2008-07-01|September 2015|2015-09-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||BMS-741672 for Diabetic Neuropathic Pain|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial to Evaluate the Efficacy and Safety of BMS-741672 in Patients With Diabetic Neuropathic Pain|Completed||Phase 2|50|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:21:02.163159|2017-02-18 14:21:02.163159
NCT00683410|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2010-10-15|2010-10-15||April 2007||2007-04-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)|A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Pneumococcal Conjugate Vaccine, 7-valent (Prevenar) 0.5 mL by Intramuscular Injection|Completed||N/A|3366|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 14:21:02.279403|2017-02-18 14:21:02.279403
NCT00683397|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-11-10|||May 2008||2008-05-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Frankfurt Thrombophilia Registry|Frankfurt Thrombophilia Registry - Evaluation of Patients With Venous Thromboembolism|Completed||N/A|2000|Actual|Cardioangiologisches Centrum Bethanien|||1||f||||||||||Samples With DNA|"~     whole blood, serum~   "|||2017-02-18 14:21:02.497193|2017-02-18 14:21:02.497193
NCT00683384|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2010-10-15|2010-10-15||January 2007||2007-01-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Study Evaluating the Safety of Enbrel (Etanercept)|A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Etanercept (Enbrel) 25 mg by Subcutaneous Injection|Completed||N/A|93|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 14:21:02.594152|2017-02-18 14:21:02.594152
NCT00683371|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-06-10|||October 2007||2007-10-01|June 2014|2014-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis|Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis|Unknown status|Recruiting|N/A|20|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:21:02.799593|2017-02-18 14:21:02.799593
NCT00683163|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2013-08-29|2013-04-01||May 2008||2008-05-01|August 2013|2013-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|PICS||PTH & Ibandronate Combination Study (PICS)|PTH & Ibandronate Combination Study (PICS): Optimizing the Use of PTH With Boniva (Pilot Randomized Controlled Trial)|Completed||Phase 2/Phase 3|44|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:21:07.642692|2017-02-18 14:21:07.642692
NCT00683358|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2009-05-06|||May 2008||2008-05-01|January 2009|2009-01-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer|Phase Ⅰ/Ⅱ Trial of Human Leukocyte Antigen (HLA)-A*2402-Restricted Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)-Derived Peptide Vaccination Combined With Gemcitabine for Advanced Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|14|Anticipated|Tokyo University||1|||f||||t||||||||||2017-02-18 14:21:02.907236|2017-02-18 14:21:02.907236
NCT00683345|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2015-08-18|||January 2008||2008-01-01|August 2015|2015-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome|Fatigue and IL-1 Blockade in Primary Sjøgrens Syndrome|Completed||Phase 2|28|Actual|Helse Stavanger HF||2|||f||||f||||||||||2017-02-18 14:21:03.047764|2017-02-18 14:21:03.047764
NCT00683332|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-06-09|2011-05-02||April 2007||2007-04-01|June 2011|2011-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)|A Prospective, Observational Study To Monitor Safety In Patients Who Were Administered With Tigecycline (Tygacil) 50 mg By Intravenous Injection (An Observational Study for Safety - Monitored Release)|Completed||N/A|621|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:21:03.157983|2017-02-18 14:21:03.157983
NCT00683319|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2013-09-19|||April 2008||2008-04-01|June 2009|2009-06-01||||March 2034|Anticipated|2034-03-01||Observational|||Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy|CCLG Observational Study of the Outcome of Ependymoma in Infants Diagnosed Before Their Third Birthday|Active, not recruiting||Phase 3|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:21:05.868995|2017-02-18 14:21:05.868995
NCT00683306|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2017-01-24|||January 2005||2005-01-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment|Multicentre, Open Label, Extension Study of Treatment With Gefitinib(IRESSA™) for Patients Completing Other Gefitinib Clinical Studies Who May Benefit From Gefitinib Treatment|Active, not recruiting||Phase 3|95|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 14:21:05.978462|2017-02-18 14:21:05.978462
NCT00683293|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-03-11|2013-11-12||November 2008||2008-11-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Clinical Trial Comparing Conventional and Robot-assisted(Da Vinci®)Laparoscopic Interventions for Hysterectomy|Laparoscopic Hysterectomy: a Clinical Randomized Trial Comparing Conventional and Robot-assisted(Da Vinci®)Techniques|Completed||N/A|100|Actual|Kantonsspital Aarau||2|||f||||f||||||||||2017-02-18 14:21:06.130478|2017-02-18 14:21:06.130478
NCT00683280|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2016-12-08|||May 2008||2008-05-01|November 2011|2011-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|Donaghue||Contingency Management and Pharmacotherapy for Smoking Cessation|Contingency Management and Pharmacotherapy for Smoking Cessation|Completed||Phase 2|59|Actual|UConn Health||2|||f||||f||||||||||2017-02-18 14:21:06.529125|2017-02-18 14:21:06.529125
NCT00683267|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2009-05-01|||September 2007||2007-09-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of a Single Intraoperative Localized Instillation of 4975 in Patients Undergoing Primary Unilateral Total Hip Arthroplasty|Terminated||Phase 2|118|Actual|Anesiva, Inc.||2||"Enrollment of patients has halted prematurely and will not resume. No future patients will be~   enrolled or treated."|f||||f||||||||||2017-02-18 14:21:06.620288|2017-02-18 14:21:06.620288
NCT00683254|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2008-05-22|||May 2008||2008-05-01|May 2008|2008-05-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Observational|||Analysis of Impact on Nasal Obstruction by Commercially Available Internal Nasal Stents|Analysis of Impact on Nasal Obstruction by Commercially Available Internal Nasal Stents|Unknown status|Not yet recruiting|N/A|35|Anticipated|University of Iowa|||1||f||||f||||||||||2017-02-18 14:21:06.943312|2017-02-18 14:21:06.943312
NCT00683241|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2013-02-25|||November 2007||2007-11-01|February 2013|2013-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer|A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine Leaded With Autologous Tumor Cell Lysate for Recurrent Ovarian or Primary Peritoneal Cancer|Completed||Phase 1|36|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||f||||||||||2017-02-18 14:21:07.040394|2017-02-18 14:21:07.040394
NCT00683228|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2014-11-26|||October 2007||2007-10-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Using a Structured Tobacco Cessation Education Program|Effect of Using a Structured Tobacco Cessation Education Program in Resident Training on Reducing Secondhand Smoke Exposure in Children|Completed||N/A|31|Actual|State University of New York - Upstate Medical University||1|||f||||f||||||||||2017-02-18 14:21:07.187266|2017-02-18 14:21:07.187266
NCT00683202|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2008-05-22|||March 2001||2001-03-01|March 2001|2001-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Low-Dose Aspirin in in Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Treatments|The Significance of Low-Dose Aspirin on Ovarian Responsiveness, Uterine Hemodynamics and Pregnancy Outcome in in Vitro Fertilization and in Intracytoplasmic Sperm Injection: A Randomized, Placebo-Controlled Double-Blind Study|Completed||N/A|374|Actual|University of Oulu||2|||f||||t||||||||||2017-02-18 14:21:07.294164|2017-02-18 14:21:07.294164
NCT00683189|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-03-18|||June 2007||2007-06-01|March 2011|2011-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy|Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy|Completed||N/A|10|Anticipated|The Cooper Health System||1|||f||||f||||||||||2017-02-18 14:21:07.414117|2017-02-18 14:21:07.414117
NCT00683176|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2011-08-24|||September 2008||2008-09-01|August 2011|2011-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effect of Choline Fenofibrate (SLV348) on Macular Edema|Effect of Choline Fenofibrate (SLV348) on Macular Edema Measured by Optical Coherence Tomography in Subjects With Diabetic Macular Edema - a One-year, Placebo-Controlled, Randomized Study|Completed||Phase 2|110|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:21:07.518626|2017-02-18 14:21:07.518626
NCT00682968|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2015-04-06|||July 2008||2008-07-01|July 2014|2014-07-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Observational|||Evidence Synthesis: Hypertension Medication Adherence & Intensification|Evidence Synthesis: Hypertension Medication Adherence & Intensification|Completed||N/A|20|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 14:21:11.65546|2017-02-18 14:21:11.65546
NCT00683150|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2012-07-27|||May 2008||2008-05-01|July 2012|2012-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Perioperative Kinetics of Reactive Hyperemia Using Noninvasive Digital Thermal Monitoring|Characterizing the Perioperative Kinetics of Reactive Hyperemia Using Noninvasive Digital Thermal Monitoring: an Observational Study of a Surrogate Marker of Endothelial Function|Completed||N/A|59|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:21:08.065316|2017-02-18 14:21:08.065316
NCT00683137|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-05-22|||October 2002||2002-10-01|May 2008|2008-05-01|February 2003|Actual|2003-02-01|||||Interventional|||Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery|Clinical Protocol for a Multiple Dose Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Placebo in Patients for Treatment of Post-Surgical Pain From Bunionectomy Surgery|Completed||Phase 3|450|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:21:08.173212|2017-02-18 14:21:08.173212
NCT00683124|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-07-20|||July 2008||2008-07-01|July 2011|2011-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|MaNeLo||Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients|Effects of Losartan vs. Nebivolol vs. the Association of Both on the Progression of Aortic Root Dilation in Marfan Syndrome (MFS) With FBN1 Gene Mutations.|Unknown status|Recruiting|Phase 3|291|Anticipated|IRCCS Policlinico S. Matteo||3|||f||||t||||||||||2017-02-18 14:21:08.577577|2017-02-18 14:21:08.577577
NCT00683111|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2012-06-05|||July 2008||2008-07-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease|Famotidine Compared With Esomeprazole in the Prevention of Ulcer Complications in Patients With Acute Coronary Syndrome or Myocardial Infarction|Completed||Phase 4|500|Anticipated|Ruttonjee Hospital||2|||f||||t||||||||||2017-02-18 14:21:08.708841|2017-02-18 14:21:08.708841
NCT00683098|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-04-15|||June 2008||2008-06-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Observational|||Long-term Results After Endoscopic Total Extraperitoneal Repair of Recurrent Inguinal Hernia|Long-term Results After Endoscopic Total Extraperitoneal Repair of Recurrent Inguinal Hernia|Completed||N/A|300|Actual|St. Claraspital AG|||1||f||||f||||||||||2017-02-18 14:21:08.812825|2017-02-18 14:21:08.812825
NCT00683085|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2011-07-20|2009-06-09||May 2008||2008-05-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer|Phase I/II Trial of Human Leukocyte Antigen (HLA)-A*02:01-restricted Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)-Derived Peptide Vaccination Combined With Conventional Dose of Gemcitabine for Advanced Pancreatic Cancer|Terminated||Phase 1/Phase 2|2|Actual|Tokyo University|Early termination leading to small numbers of subjects analyzed|1||Lack of eligible patient|f||||t||||||||||2017-02-18 14:21:08.926949|2017-02-18 14:21:08.926949
NCT00683072|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2008-05-22|||March 2008||2008-03-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Patient-Ventilator Dyssynchrony: How is the Effect of Management?|Patient-Ventilator Dyssynchrony: How is the Effect of Management?|Unknown status|Recruiting|N/A|40|Anticipated|National Cheng-Kung University Hospital|||1||f||||||||||||||2017-02-18 14:21:09.196692|2017-02-18 14:21:09.196692
NCT00683059|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-10-14|||March 2008||2008-03-01|October 2016|2016-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Single Agent Abraxane as Second Line Therapy in Bladder Cancer|A Multi-Institutional Phase II Study of Single Agent Abraxane as Second Line Therapy in Patients With Advanced Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|48|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-02-18 14:21:09.274641|2017-02-18 14:21:09.274641
NCT00683046|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2016-10-07|2014-02-14||November 2001||2001-11-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies|T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies|Completed||Phase 2|204|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 14:21:09.385907|2017-02-18 14:21:09.385907
NCT00683033|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2011-11-17|||May 2008||2008-05-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|R21||Contingency Management for Smoking in Substance Abusers|Contingency Management for Smoking in Substance Abusers|Completed||Phase 2|51|Actual|UConn Health||2|||f||||f||||||||||2017-02-18 14:21:09.650313|2017-02-18 14:21:09.650313
NCT00683020|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2013-05-14|2012-12-10||April 2009||2009-04-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|November 2011|Actual|2011-11-01||Interventional|SMARTSteps|Data is based on the 252 participants with both baseline and 6-month follow-up measures.|Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health Plan|Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health Plan|Completed||N/A|362|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:21:09.758946|2017-02-18 14:21:09.758946
NCT00683007|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2012-08-01|||May 2011||2011-05-01|August 2012|2012-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Esophageal Echo Assessment of LV Function During Acute Normovolemic Hemodilution Using Crystalloid or Hypertonic Saline|Use of Transesophageal Echocardiography to Assess Left Ventricular Performance During Acute Normovolemic Hemodilution and Randomized Replacement With Intravenous Crystalloid or Hypertonic Saline|Completed||Phase 4|9|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 14:21:11.032849|2017-02-18 14:21:11.032849
NCT00682994|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-02-17|||March 2008||2008-03-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Patient and Family Decision Making in the Palliative Care Setting|Patient and Family Decision Making and Information Disclosure Preferences in the Palliative Care Setting: a Multi-Center Survey in Chile, Guatemala, and U.S.|Completed||N/A|780|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:21:11.140444|2017-02-18 14:21:11.140444
NCT00682981|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-07-19||2013-08-27|May 2008||2008-05-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)|A Phase I Followed by a Randomized, Phase II Study of Carboplatin and Etoposide With or Without Obatoclax Administered Every 3 Weeks to Patients With Extensive- Stage Small Cell Lung Cancer (ES-SCLC)|Completed||Phase 1/Phase 2|218|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-02-18 14:21:11.259654|2017-02-18 14:21:11.259654
NCT00682955|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-05-21|||August 2007||2007-08-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|Zinc||Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea|Comparing the Efficacy of Different Zinc Formulations in the Treatment of Acute Diarrhea Among Young Children at Hospital Based Setting in Pakistan|Completed||N/A|300|Actual|Aga Khan University||2|||f||||f||||||||||2017-02-18 14:21:11.74961|2017-02-18 14:21:11.74961
NCT00682942|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2011-11-30|||May 2008||2008-05-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||How to Predict Lung Recruitment at the Bedside in Patients Affected by Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS)|How to Predict Lung Recruitment at the Bedside in Patients Affected by Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS)|Completed||N/A|50|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-02-18 14:21:11.857629|2017-02-18 14:21:11.857629
NCT00682929|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2016-11-14|||March 2003||2003-03-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Cannabis for Spasticity in Multiple Sclerosis|Cannabis for Spasticity in Multiple Sclerosis: A Placebo-Controlled Study|Terminated||Phase 1/Phase 2|42|Actual|University of California, Davis||3||Unable to complete subject recruitment|f||||t||||||||No||2017-02-18 14:21:11.950614|2017-02-18 14:21:11.950614
NCT00682916|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2012-10-25|||April 2007||2007-04-01|May 2008|2008-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Compare Effects of a Soluble Fiber on Weight and Blood Cholesterol|CCRC: FBCx® And Body Weight Regulation in Overweight Humans|Completed||N/A|42|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 14:21:12.067255|2017-02-18 14:21:12.067255
NCT00682903|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2014-08-27|||January 2008||2008-01-01|August 2014|2014-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Use of a Bearable Continuous Interstitial Glucose Monitoring Device (GuardianR) During Teaching Sessions to Functional Insulin Therapy Concept in Patients Suffering From Type 1 Diabetes: Evaluation at 6 and 12 Months|Use of a Bearable Continuous Interstitial Glucose Monitoring Device (GuardianR) During Teaching Sessions to Functional Insulin Therapy Concept in Patients Suffering From Type 1 Diabetes: Evaluation at 6 and 12 Months|Completed||N/A|64|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 14:21:12.173958|2017-02-18 14:21:12.173958
NCT00682890|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-21|2014-08-01|2014-01-21||November 2005||2005-11-01|August 2014|2014-08-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)|Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)|Terminated||Phase 4|28|Actual|Virginia Commonwealth University|study duration was relatively brief,earlier serum markers of the inflammatory process,e.g.,IL-6, were not evaluated,sample size planned was not achieved despite intensive recruitment efforts.|2||Lack of recruitment|f||||t||||||||||2017-02-18 14:21:12.287576|2017-02-18 14:21:12.287576
NCT00682877|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-05-22|||July 2007||2007-07-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Observational|GETOver65||A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old|A Comparison Trial of SmartPill Corporation GI Monitoring System With Scintigraphic Gastric Emptying Procedure for Determining Gastric Residence Time - In Subjects Over 65 Years of Age|Completed||N/A|23|Actual|The SmartPill Corporation|||2||f||||f||||||||||2017-02-18 14:21:12.644238|2017-02-18 14:21:12.644238
NCT00682851|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2016-08-15|2011-07-08||July 2008||2008-07-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test|A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test|Completed||N/A|519|Actual|University of Pittsburgh|A major limitation of this study was that in the first 122 women, 24% of the cohort, the vaginal swabs used for the diagnostic tests were collected in random order, which resulted in decreased sensitivity of the OSOM Rapid and BVBLue tests.||1||f||||f||||||||No||2017-02-18 14:21:12.744243|2017-02-18 14:21:12.744243
NCT00682838|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2016-07-20|2015-07-08||July 2009||2009-07-01|July 2016|2016-07-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional||The target population for this study is all Veterans with OSA. It was expected that most participants would be middle-aged and older men and women, from a variety of ethnic backgrounds and with a full range of medical co-morbidities.|Improving Obstructive Sleep Apnea Management Via Wireless Telemonitoring|Improving Obstructive Sleep Apnea Management Via Wireless Telemonitoring|Completed||Phase 2/Phase 3|280|Actual|VA Office of Research and Development||4|||f||||f||||||||No||2017-02-18 14:21:13.162207|2017-02-18 14:21:13.162207
NCT00682825|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2011-01-03|||March 2008||2008-03-01|January 2011|2011-01-01||||December 2010|Actual|2010-12-01||Interventional|BAG-RECALL||Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia|BAG-RECALL Study: BIS or Anesthesia Gas to Reduce Explicit Recall|Completed||Phase 4|6000|Anticipated|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 14:21:13.668716|2017-02-18 14:21:13.668716
NCT00682812|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2014-08-27|||June 2008||2008-06-01|January 2010|2010-01-01|December 2014|Anticipated|2014-12-01|April 2014|Actual|2014-04-01||Interventional|||Significance of the High-risk Hpv Viral Load|Significance of the High-risk Hpv Viral Load|Unknown status|Active, not recruiting|N/A|149|Actual|Assistance Publique Hopitaux De Marseille||3|||f||||f||||||||||2017-02-18 14:21:13.794241|2017-02-18 14:21:13.794241
NCT00682799|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-01-14|||April 2007||2007-04-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)|Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC) EWOG MDS SCT RC RIC-06|Completed||N/A|112|Actual|University Hospital Freiburg|||1||f||||f||||||Samples With DNA|"~     Hematopoietic chimerism will be investigated from PB samples. Prior to transplant 5 ml EDTA~     PB from patient and donor are required and will be sent to the laboratory of the~     Coordinating Investigator (P.B.). Post transplant PB samples (5 -10 ml EDTA blood) from day~     +30 (4 days), +60(4 days), +100 (7 days) and +180 (7 days) will also being sent to the~     laboratory of the Coordinating Investigator (P.B.) From EDTA PB cell subpopulations will be~     isolated and DNA will be extracted and stored for further investigations.~   "|||2017-02-18 14:21:13.902143|2017-02-18 14:21:13.902143
NCT00682786|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2014-09-05|2014-07-14||October 2002||2002-10-01|September 2014|2014-09-01|August 2010|Actual|2010-08-01|December 2008|Actual|2008-12-01||Interventional|||Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma|Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma|Completed||Phase 2|135|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 14:21:14.009382|2017-02-18 14:21:14.009382
NCT00682760|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-05-21|||October 2005||2005-10-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|February 2006|Actual|2006-02-01||Interventional|||Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm|Double-Blind, Randomized, Phase 3, Comparative Study of a New Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm|Completed||Phase 3|60|Actual|Pacific Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:21:15.562213|2017-02-18 14:21:15.562213
NCT00682747|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2016-10-26|||May 2008||2008-05-01|October 2016|2016-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Hyperbaric Oxygen for the Treatment of a Dry Mouth Which Occurred After Radiotherapy|Randomized Phase II Trial of Hyperbaric Oxygen for the Treatment of Radiation-induced Xerostomia|Terminated||Phase 2|13|Actual|Martin-Luther-Universität Halle-Wittenberg||2||poor recruitment|f||||f||||||||||2017-02-18 14:21:15.885126|2017-02-18 14:21:15.885126
NCT00682734|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-11-28|2011-07-24||April 2008||2008-04-01|November 2012|2012-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|MDFS||Metoclopramide for Migraine: A Dose Finding Study|Metoclopramide for Acute Migraine: A Dose Finding Study|Completed||Phase 3|349|Actual|Montefiore Medical Center||3|||f||||t||||||||||2017-02-18 14:21:15.993389|2017-02-18 14:21:15.993389
NCT00682721|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2012-02-29|||February 2009||2009-02-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women|Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women|Withdrawn||N/A|0|Actual|University of Pittsburgh||2||Sponsor has withdrawn support for this study and it will not be performed|f||||f||||||||||2017-02-18 14:21:16.371642|2017-02-18 14:21:16.371642
NCT00682708|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-05-21|||August 2006||2006-08-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Sentinel Surveillance of Malnutrition, Niger|Sentinel Surveillance of Acute Malnutrition in the Region of Maradi, Niger, Children Under 5: Impact of a Preventive Intervention|Completed||N/A|||Epicentre|||||f||||f||||||||||2017-02-18 14:21:16.480948|2017-02-18 14:21:16.480948
NCT00682695|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2017-01-19|||September 1997||1997-09-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|GERFHS||Genetic and Environmental Risk Factors for Hemorrhagic Stroke|Genetic and Environmental Risk Factors for Hemorrhagic Stroke|Completed||N/A|3187|Actual|University of Cincinnati|||1||f||||f||||||Samples With DNA|"~     whole blood or buccal DNA~   "|||2017-02-18 14:21:16.565908|2017-02-18 14:21:16.565908
NCT00682682|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-09-12|||December 2007||2007-12-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|4DO||Reducing Brief Thermal and Electrical Pain (Four Study Days)|Reducing Brief Thermal and Electrical Pain (Four Study Days)|Completed||N/A|20|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:21:16.672915|2017-02-18 14:21:16.672915
NCT00682669|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-08-18|||September 2006||2006-09-01|August 2011|2011-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Asthma and Mindfulness-Based Stress Reduction (MBSR)|Asthma and Mindfulness-Based Stress Reduction (MBSR)|Completed||Phase 1/Phase 2|83|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 14:21:16.768726|2017-02-18 14:21:16.768726
NCT00682656|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2014-10-16|||June 2008||2008-06-01|July 2011|2011-07-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|PCL01||Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis|Open Label Randomized Study to Assess Safety and Efficacy of Azithromycin Versus Meglumine Antimoniate to Treat Cutaneous Leishmaniasis|Terminated||Phase 2/Phase 3|48|Actual|Oswaldo Cruz Foundation||2||Efficacy issues on test arm|f||||f||||||||||2017-02-18 14:21:16.87557|2017-02-18 14:21:16.87557
NCT00682643|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-11-29|2011-12-08||June 2008||2008-06-01|November 2016|2016-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Two-Year Study to Evaluate the Ocular Safety of Once-Daily, Fluticasone Furoate Nasal Spray 110mcg in Adults and Adolescents 12 Years of Age and Older With Perennial Allergic Rhinitis|Completed||Phase 4|550|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:21:17.003608|2017-02-18 14:21:17.003608
NCT00682630|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-01-21|||September 2007||2007-09-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|SP-C-009-07||Bioequivalence of Pyronaridine Artesunate to-be-Marketed Tablet to the Clinical Trial Reference Tablet|Bioequivalence Trial of Pyronaridine:Artesunate to-be-Marketed Tablet to the Clinical Trial Reference Tablet|Completed||Phase 1|42|Anticipated|Medicines for Malaria Venture||2|||f||||t||||||||||2017-02-18 14:21:18.246028|2017-02-18 14:21:18.246028
NCT00682617|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2013-05-06|||August 2006||2006-08-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Hip Osteoarthritis: Effects of Exercise Programs on Pain and Disability|Hip Osteoarthritis: Effects of Structured Exercise Programs on Pain and Long-term Disability|Unknown status|Recruiting|N/A|30|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:21:18.343952|2017-02-18 14:21:18.343952
NCT00682604|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-05-20|||September 2006||2006-09-01|May 2008|2008-05-01|October 2006|Actual|2006-10-01|||||Observational|||The Nutritional Status and Food Intake of Community Health Agents|Community Health Agents From East Zone of Sao Paulo City, Brazil: A Look at Their Nutritional Status and Food Intake|Completed||N/A|88|Actual|Unidade Itaquera|||1||f||||f||||||||||2017-02-18 14:21:18.445778|2017-02-18 14:21:18.445778
NCT00682591|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2009-02-03|||July 2008||2008-07-01|February 2009|2009-02-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Evaluation of Neurocognitive Performance in Drug Substituted Patients Under Hepatitis C Therapy|Evaluation of Neurocognitive Performance, Quality of Life, and Emotional State in Drug Substituted Patients (Methadone, Buprenorphine, Suboxone) Under Hepatitis C Therapy (Peginterferon Alfa and Ribavirin)|Withdrawn||N/A|190|Anticipated|University of Wuerzburg|||1|Study had to be withdrawn because financial support was cancelled.|f||||t||||||||||2017-02-18 14:21:18.526|2017-02-18 14:21:18.526
NCT00682578|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2010-01-21|||July 2007||2007-07-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|||A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan|Randomized Clinical Trial of the Efficacy and Safety of Dihydroartimisinine+Papiraquine (Artekin) Compared With First Line Drugs for Treatment of Vivax and Uncomplicated Falciparum Malaria in Afghanistan|Unknown status|Recruiting|Phase 3|1100|Anticipated|University of Oxford||2|||f||||t||||||||||2017-02-18 14:21:18.619168|2017-02-18 14:21:18.619168
NCT00682565|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2010-02-03|2009-11-30||April 2008||2008-04-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||Pharmacokinetics (PK) and Tolerability of Intravenous (IV) and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina|Tolerability and CK-1827452 Plasma Concentrations During Intravenous and Immediate-Release Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina|Completed||Phase 2|94|Actual|Cytokinetics||2|||f||||||||||||||2017-02-18 14:21:18.745429|2017-02-18 14:21:18.745429
NCT00682552|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2014-08-27|||May 2008||2008-05-01|August 2014|2014-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence|Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence|Terminated||N/A|14|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 14:21:19.346988|2017-02-18 14:21:19.346988
NCT00682539|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-03-03|2015-11-06||October 2007||2007-10-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|TRIASTIN|The sample size will be calculated so that a true group difference in changes of macular edema of 50 μm can be detected with a probability of 90 %. Repeated-measures-ANOVA will be used to reveal differences between macular edema measurements before and after treatment and between groups|Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema|A Randomized, Double-masked Study With Intraocular Anti-VEGF (Avastin®/Lucentis®) Compared With Intraocular Triamcinolone (Volon A®) in Patients With Clinical Significant Diabetic Macular Edema|Completed||Phase 4|71|Actual|Medical University of Vienna||3|||f||||t||||||||No||2017-02-18 14:21:19.451137|2017-02-18 14:21:19.451137
NCT00682526|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-02-21|||June 2003||2003-06-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|September 2008|Actual|2008-09-01||Observational|||Pre-Hospital Wireless Transmission of Electrocardiograms to a Cardiologist Via a Hand-Held Device|Pre-hospital Wireless Transmission of Electrocardiograms to a Cardiologist Via a Hand-held Device: The TIME Multicenter Study|Completed||N/A|527|Actual|Welch Allyn|||3||f||||f||||||||||2017-02-18 14:21:19.896835|2017-02-18 14:21:19.896835
NCT00682513|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-10-31|||April 2008||2008-04-01|October 2016|2016-10-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|||Studies of the Variable Phenotypic Presentations of Rapid-Onset Dystonia Parkinsonism and Other Movement Disorders|Clinical, Genetic, and Cellular Consequences of Mutations in the NA,K-ATPase ATP1A3|Recruiting||N/A|130|Anticipated|Wake Forest University Health Sciences|||1||f||||f||||||Samples With DNA|"~     whole blood, tissue (saliva samples)~   "|No||2017-02-18 14:21:20.009801|2017-02-18 14:21:20.009801
NCT00682500|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2012-07-23|||May 2008||2008-05-01|July 2012|2012-07-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|CARDS||Calfactant for Direct Acute Respiratory Distress Syndrome|Calfactant Therapy for Direct Acute Respiratory Distress Syndrome & Direct Acute Lung Injury in Adults and Children|Terminated||Phase 3|332|Actual|Pneuma Pharmaceuticals Incorporated||2||Expected mortality rates in placebo and treatment groups lower than predicted|f||||t||||||||||2017-02-18 14:21:20.346615|2017-02-18 14:21:20.346615
NCT00682487|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2009-06-18|||June 2008||2008-06-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Hair Cortisol and the Risk of Acute Myocardial Infarction|Hair Cortisol and the Risk of Acute Myocardial Infarction|Completed||N/A|120|Actual|Meir Medical Center|||2||f||||t||||||||||2017-02-18 14:21:20.511403|2017-02-18 14:21:20.511403
NCT00682474|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-08-18|||September 2006||2006-09-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|June 2009|Actual|2009-06-01||Interventional|||School Nurse-Delivered Smoking Cessation Intervention|School Nurse-Delivered Smoking Cessation Intervention|Completed||Phase 2/Phase 3|1058|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 14:21:20.623632|2017-02-18 14:21:20.623632
NCT00682461|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2013-01-24|2013-01-24||September 2007||2007-09-01|January 2013|2013-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Oral Tolerability Of Two Nicotine Dosage Forms|A Randomized, Open Label Study to Evaluate the Oral Tolerability of a Nicotine Prototype|Completed||Phase 1|200|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:21:20.749969|2017-02-18 14:21:20.749969
NCT00682448|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2012-12-10||2012-11-29|August 2007||2007-08-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Metformin for the Prevention of the Metabolic Side-effects of Zyprexa|Metformin to Prevent the Metabolic Complications of Olanzapine|Completed||Phase 4|27|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 14:21:21.17354|2017-02-18 14:21:21.17354
NCT00682435|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-05-21|||June 2007||2007-06-01|May 2008|2008-05-01||||November 2007|Actual|2007-11-01||Interventional|||Safety Study of Intravenous Hydromorphone Using Incremental 1mg Doses up to 2mg for Adult ED Patients|Safety and Speed of Onsent of Intravenous Hydromorphone Using Incremental 1mg Doses up to 2mg in the Treatment of Adult ED Patients With Moderate to Severe Pain|Unknown status|Active, not recruiting|Phase 4|350|Anticipated|Montefiore Medical Center||1|||f||||f||||||||||2017-02-18 14:21:21.290363|2017-02-18 14:21:21.290363
NCT00682422|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-10-01|||February 2008||2008-02-01|June 2010|2010-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Kid STRIDE: Exploring Participation in a Family-based Intervention|Kid STRIDE: Exploring Participation in a Family-based Intervention|Completed||N/A|10|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 14:21:21.384076|2017-02-18 14:21:21.384076
NCT00682409|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-08-27|||January 2008||2008-01-01|August 2014|2014-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Magnetic Resonance (MR) Imaging in the Post Operative Follow-up of Cholesteatoma in Children||Completed||N/A|37|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 14:21:21.492265|2017-02-18 14:21:21.492265
NCT00682383|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2012-10-29|||September 2003||2003-09-01|October 2012|2012-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)|Phase II Trial of Combined Modality Therapy With Growth Factor Support in Locally Advanced NSCLC|Completed||Phase 2|26|Actual|Mt. Sinai Medical Center, Miami||1|||f||||t||||||||||2017-02-18 14:21:21.589725|2017-02-18 14:21:21.589725
NCT00682370|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-01-13|||October 2007||2007-10-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|HEMAHS||Effects of Heme Arginate in Healthy Male Subjects|Dose Escalation, Randomized, Placebo Controlled Study to Investigate the Effects of Intravenous Heme Arginate on Heme Oxygenase-1 (HO-1) and Heme Metabolism in Association With HO-1 Gene GTn Promoter Polymorphism in Healthy Male Subjects|Completed||Phase 1|15|Actual|Medical University of Vienna||4|||f||||f||||||||||2017-02-18 14:21:21.691288|2017-02-18 14:21:21.691288
NCT00682344|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-08-27|||January 2008||2008-01-01|August 2014|2014-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Pharmacokinetic of levobupivacaïne After Sciatic Nerve Block in Children|Pharmacokinetic of levobupivacaïne After Sciatic Nerve Block in Children|Terminated||Phase 3|7|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 14:21:22.296211|2017-02-18 14:21:22.296211
NCT00682318|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2016-08-15|||May 2008||2008-05-01|August 2016|2016-08-01||||November 2017|Anticipated|2017-11-01||Interventional|||Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers|Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers: a Randomized Double-blinded Trial on the Modulation of the Eicosanoid and Isoprostane Pathways in Healthy Subjects by Omega-3 Polyunsaturated Fatty Acids and Red Wine.|Recruiting||N/A|40|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 14:21:22.382907|2017-02-18 14:21:22.382907
NCT00682305|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-05-12|||March 2007||2007-03-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|January 2013|Actual|2013-01-01||Interventional|||Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)|Allogeneic Stem Cell Transplantation With Treosulfan, VP-16 and Cyclophosphamide for Patients With Acute Lymphoblastic Leukemia (ALL) Not Eligible for TBI-containing Conditioning Regimen: A Phase II-study|Completed||Phase 2|50|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-02-18 14:21:22.511513|2017-02-18 14:21:22.511513
NCT00682292|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-05-21|||May 2001||2001-05-01|February 2004|2004-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|TAXI||Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk|Multicenter Randomized Study to Compare Induction Therapy With Polyclonal Antithymocytes Globulins (ATG) Versus Monoclonal Anti-IL2R Antibody (Daclizumab) in a Triple Drug Regimen in Renal Transplant Recipients With High Immunological Risk.|Completed||Phase 3|227|Actual|University Hospital, Lille||2|||f||||t||||||||||2017-02-18 14:21:22.611302|2017-02-18 14:21:22.611302
NCT00682279|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2015-04-15|||September 2008||2008-09-01|April 2015|2015-04-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|||A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors|A Phase I, Open-label Study of the Safety, Tolerability, and Pharmacokinetics of Oral Topotecan in Combination With Lapatinib in Subjects With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||1||Cancelled before enrollment|f||||||||||||||2017-02-18 14:21:22.734295|2017-02-18 14:21:22.734295
NCT00682266|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2012-01-05|||February 2004||2004-02-01|January 2012|2012-01-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||High-intensity Exercise Training or Multidisciplinary Treatment in Extremely Obese Adolescents|Reducing Cardiovascular Risk Factors In Overweight Adolescents: Multidisciplinary Treatment and Intensity Controlled Interval Training|Completed||N/A|54|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 14:21:22.831854|2017-02-18 14:21:22.831854
NCT00682253|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2009-09-08|||May 2008||2008-05-01|September 2009|2009-09-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Observational|||Use of Bone Scintigraphy, CT and MRI in Breast Cancer|Use og Bone Scintigraphy, CT and MRI for Detection of Metastases in Patients With Breast Cancer|Unknown status|Recruiting|N/A|180|Anticipated|University of Aarhus|||1||f||||||||||||||2017-02-18 14:21:22.934927|2017-02-18 14:21:22.934927
NCT00682240|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2015-02-13|||October 2007||2007-10-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|pascal||Morphological and Functional Retinal Changes Following Retinal Photocoagulation|Morphological and Functional Retinal Changes Following Retinal Photocoagulation Using a Semiautomated Patterned Scanning Laser System in Proliferative Retinopathy or Macular Edema Secondary to Diabetes Mellitus or Retinal Vein Occlusion|Completed||Phase 4|64|Actual|Medical University of Vienna||4|||f||||||||||||||2017-02-18 14:21:23.00435|2017-02-18 14:21:23.00435
NCT00682227|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-05-23|||August 2006||2006-08-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Peptide Vaccination in Treating Patients With Esophageal Cancer|Phase I Study of Peptide Vaccination Therapy Using Novel Cancer Testis Antigens for Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma|Unknown status|Recruiting|Phase 1|10|Anticipated|University of Yamanashi||1|||f||||t||||||||||2017-02-18 14:21:23.113303|2017-02-18 14:21:23.113303
NCT00682214|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-06-14|||May 2008||2008-05-01|May 2008|2008-05-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|MRVD||Cholecalciferol Supplementation, Muscle Strength|Skeletal Muscle Strength Including Its Energy Metabolism, Bone Mineral Homeostasis and Th1/Th2 Cytokines Expression in Asian Indians With Chronic Hypovitaminosis D Before and After Oral Cholecalciferol Supplementation|Completed||Phase 1|40|Actual|Indian Council of Medical Research||2|||f||||f||||||||||2017-02-18 14:21:23.215098|2017-02-18 14:21:23.215098
NCT00682201|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-07-03|||August 2007||2007-08-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Hemodynamic Changes During Normal Pregnancy|Hemodynamic Changes During Normal Pregnancy: A Prospective Cohort Study of 100 Healthy Pregnant Women|Completed||N/A|120|Anticipated|Oslo University Hospital|||1||f||||t||||||||||2017-02-18 14:21:23.319957|2017-02-18 14:21:23.319957
NCT00682188|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2014-03-12|||September 2008||2008-09-01|March 2014|2014-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A School Nurse-Delivered Intervention for Overweight and At Risk Adolescents|A School Nurse-Delivered Intervention for Overweight and At Risk Adolescents|Completed||Phase 1|84|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 14:21:23.408293|2017-02-18 14:21:23.408293
NCT00682175|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2009-03-25|||May 2008||2008-05-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Metabolic Derangements in Acute Heart Failure Syndrome|Metabolic Derangements in Acute Heart Failure Syndrome|Terminated||N/A|100|Anticipated|The Cleveland Clinic|||1|Project not initiated|f||||f||||||Samples Without DNA|"~     serum, plasma~   "|||2017-02-18 14:21:23.506222|2017-02-18 14:21:23.506222
NCT00682162|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2015-01-12|||January 1998||1998-01-01|May 2008|2008-05-01|June 1999|Actual|1999-06-01|January 1999|Actual|1999-01-01||Interventional|||Impact of Acupuncture on Vasomotor Rhinitis|Impact of Acupuncture on Vasomotor Rhinitis: a Randomised Placebo Controlled Pilot Study|Completed||Phase 3|24|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-02-18 14:21:23.593759|2017-02-18 14:21:23.593759
NCT00682149|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-05-20|||May 2008||2008-05-01|May 2008|2008-05-01|October 2008|Anticipated|2008-10-01|July 2008|Anticipated|2008-07-01||Interventional|||Effects of Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients|Effects Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients|Unknown status|Recruiting|N/A|120|Anticipated|Yeditepe University Hospital||2|||f||||f||||||||||2017-02-18 14:21:23.696517|2017-02-18 14:21:23.696517
NCT00682136|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2010-06-02|||April 2008||2008-04-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Analgesic Efficacy of Local Anesthetic Transversus Abdominis Plane (TAP) Blocks in Abdominal Surgery|Efficacy of Local Anesthetic TAP Blocks in Providing Pain Relief Following Laparoscopic and Open Abdominal Surgery|Completed||Phase 1|206|Anticipated|Hunter Colorectal Research||2|||f||||f||||||||||2017-02-18 14:21:23.806187|2017-02-18 14:21:23.806187
NCT00682123|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-05-20|||March 2006||2006-03-01|May 2008|2008-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Risk of Positive Doping Tests Following Ingestion of Supplements Contaminated With Trace Quantities of Nandrolone Metabolites|Supplement Contamination: Detection of Nandrolone Metabolites in Urine After Administration of Small Doses of a Nandrolone Precursor|Completed||Phase 1/Phase 2|20|Actual|Loughborough University||1|||f||||f||||||||||2017-02-18 14:21:23.917235|2017-02-18 14:21:23.917235
NCT00682110|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2010-03-31|||July 2007||2007-07-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|January 2009|Actual|2009-01-01||Observational|OLT||Hemodynamic Measurements During Liver Transplantation|Comparing Different Methods For Measurement of Cardiac Output During Orthotopic Liver Transplantation|Completed||N/A|30|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 14:21:24.069269|2017-02-18 14:21:24.069269
NCT00682097|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-11-01|||May 2008||2008-05-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.|A Randomized, Double-Blind, Multiple-Ascending-Dose, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO4998452 Following Oral Administrations in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|55|Actual|Hoffmann-La Roche||7|||f||||||||||||||2017-02-18 14:21:24.157178|2017-02-18 14:21:24.157178
NCT00682084|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2014-12-02|||April 2008||2008-04-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|July 2015|Anticipated|2015-07-01||Observational|||Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome|Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome Before and After Surgical Treatment|Unknown status|Recruiting|N/A|10|Anticipated|University of Aarhus|||1||f||||f||||||Samples Without DNA|"~     Whole blood, serum, muscle samples, fat samples~   "|||2017-02-18 14:21:24.261386|2017-02-18 14:21:24.261386
NCT00682071|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-10-01|||August 2003||2003-08-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Ultrasound Guided Embryo Transfer: Abdominal Versus Transvaginal, a RCT|Abdominal Versus Transvaginal Ultrasound Guided Embryo Transfer: Results of a Randomized Clinical Trial|Completed||N/A|224|Actual|University of Wisconsin, Madison|||2||f||||f||||||||||2017-02-18 14:21:24.364764|2017-02-18 14:21:24.364764
NCT00682058|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-06-01|||October 2006||2006-10-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Body Composition & REE Responses to Bariatric Surgery|Body Composition & REE Responses to Bariatric Surgery|Active, not recruiting||N/A|106|Actual|Columbia University|||1||f||||t||||||||Undecided||2017-02-18 14:21:24.4442|2017-02-18 14:21:24.4442
NCT00682045|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2010-06-01|||June 2008||2008-06-01|March 2009|2009-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Latent Tuberculosis Infection in Renal Transplant Recipients|A Prospective Observational Study of Usefulness of a T Cell-based Assay for Latent Tuberculosis Infection in Renal Transplant Recipients|Completed||N/A|240|Anticipated|Asan Medical Center|||1||f||||t||||||Samples With DNA|"~     peripheral blood mononuclear cells~   "|||2017-02-18 14:21:24.544799|2017-02-18 14:21:24.544799
NCT00682032|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2016-11-21|||April 2008||2008-04-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Effect of Beta-glucan in Non-Small Cell Lung Cancer|Beta-glucan's Immuno-modulatory Effect on Non-Small Cell Lung Cancer|Recruiting||N/A|300|Anticipated|James Graham Brown Cancer Center||2|||f||||t||||||||||2017-02-18 14:21:24.640362|2017-02-18 14:21:24.640362
NCT00682019|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-10-10|||December 2003||2003-12-01|October 2013|2013-10-01|August 2004|Actual|2004-08-01|||||Interventional|||Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Duration of Efficacy and Safety of Vardenafil Administered for 10 Weeks in a Flexible-Dose Regimen Compared to Placebo in Subjects With Erectile Dysfunction|Completed||Phase 3|383|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:21:24.764059|2017-02-18 14:21:24.764059
NCT00682006|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2011-07-07|||January 2008||2008-01-01|July 2009|2009-07-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|Chlorhexidine||Topical Application of Chlorhexidine to the Umbilical Cord for Prevention of Omphalitis and Neonatal Mortality in Rural District of Pakistan|Topical Application of Chlorhexidine to the Umbilical Cord for Prevention of Omphalitis and Neonatal Mortality in Rural District of Pakistan: A Community-based Randomized Control Trial|Completed||Phase 3|9800|Actual|Aga Khan University||4|||f||||f||||||||||2017-02-18 14:21:24.863991|2017-02-18 14:21:24.863991
NCT00681993|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-11-15|||April 2008||2008-04-01|November 2012|2012-11-01|July 2017|Anticipated|2017-07-01|June 2014|Anticipated|2014-06-01||Interventional|PBIC||Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens|"A Feasibility Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens (PBIC)"|Active, not recruiting||N/A|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center||5|||f||||t||||||||||2017-02-18 14:21:24.980383|2017-02-18 14:21:24.980383
NCT00681980|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2015-12-01|||February 2008||2008-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|September 2009|Actual|2009-09-01||Interventional|||Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)|Study Of Valproic Acid To Treat TSP/HAM Patients In Sao Paulo, Brazil|Completed||Phase 3|60|Actual|University of Sao Paulo||3|||f||||f||||||||||2017-02-18 14:21:25.098983|2017-02-18 14:21:25.098983
NCT00681967|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2010-09-21|||February 2004||2004-02-01|September 2010|2010-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|IRESSA&H&N||Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer|Conventional Postoperative Radiotherapy (Standard Fractionation) Plus Iressa or Hyperfractionated Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer: A Phase I Pilot Trial|Completed||Phase 1|30|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:21:27.687944|2017-02-18 14:21:27.687944
NCT00681954|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2015-01-14|||October 2005||2005-10-01|January 2015|2015-01-01|January 2014|Actual|2014-01-01|January 2012|Actual|2012-01-01||Observational|||Mild Pulmonary Function Changes With Transfusion|Mild Pulmonary Function Changes With Transfusion|Completed||N/A|92|Actual|University of California, San Francisco|||1||f||||f||||||Samples Without DNA|"~     Biospecimens are retained for cytokine and inflammatory marker analyses.~   "|||2017-02-18 14:21:27.797732|2017-02-18 14:21:27.797732
NCT00681941|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2015-03-19|||January 2006||2006-01-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis|An Open Label, Dose Titration of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphatemic Chronic Kidney Disease Patients Not On Dialysis|Completed||Phase 3|49|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:21:27.897271|2017-02-18 14:21:27.897271
NCT00681928|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-11-30|||October 2007||2007-10-01|November 2011|2011-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy|The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients With Breast Cancer|Completed||N/A|72|Actual|City of Hope Medical Center|||2||f||||t||||||||||2017-02-18 14:21:28.036844|2017-02-18 14:21:28.036844
NCT00681915|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2010-12-07|||March 2008||2008-03-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|MAD||AZD7325 Multiple Ascending Dose Study|A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD7325 When Given in Multiple Ascending Oral Doses in Healthy Male and Healthy Female Subjects of Non-child Bearing Potential|Completed||Phase 1|48|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:21:28.150419|2017-02-18 14:21:28.150419
NCT00681902|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-02-04|||March 2007||2007-03-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|November 2007|Actual|2007-11-01||Interventional|||Jet Lidocaine for Pain Relief During Needle Insertion in a Pediatric Emergency Department|Jet Lidocaine for Pain Relief During Needle Insertion in a Pediatric Emergency Department.|Completed||N/A|150|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-02-18 14:21:28.243861|2017-02-18 14:21:28.243861
NCT00681889|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-10-10|2012-10-10||April 2008||2008-04-01|October 2012|2012-10-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)|Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)|Completed||Phase 1|9|Actual|Massachusetts Eye and Ear Infirmary|Further and larger studies are needed to better establish the efficacy profile of this drug and optimize its dosing and formulation.|1|||f||||f||||||||||2017-02-18 14:21:28.370419|2017-02-18 14:21:28.370419
NCT00681876|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2013-02-12|||April 2008||2008-04-01|February 2013|2013-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer|Phase II Study of Avastin Plus Erbitux Plus Irinotecan as 2nd Line Treatment of Locally Advanced or Metastatic Colorectal Cancer in Patients Achieving Disease Progression as Best Response After 1st Line Treatment With FOLFIRI+Avastin or XELIRI+Avastin|Terminated||Phase 2|16|Actual|Hellenic Oncology Research Group||1||Due to poor accrual|f||||f||||||||||2017-02-18 14:21:28.848812|2017-02-18 14:21:28.848812
NCT00681863|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2014-05-07|2010-10-13||May 2008||2008-05-01|May 2014|2014-05-01||||October 2009|Actual|2009-10-01||Interventional||Treated Set (TS) included all patients who were entered, were dispensed study medication and were documented to have taken at least one dose of study medication.|Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome|Open Label Extension Study With Pramipexole (PPX) in Children With Tourette Syndrome|Terminated||Phase 3|45|Actual|Boehringer Ingelheim|The sponsor cancelled this trial prematurely. Thus, enrollment for 248.642 (NCT00681863) was significantly less than what was planned (120 planned vs. 45 entered). Therefore, the objectives of this study could not be fully assessed.|5||Terminated for slow enrollment.|f||||||||||||||2017-02-18 14:21:28.99733|2017-02-18 14:21:28.99733
NCT00681850|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2010-06-01|||March 2008||2008-03-01|June 2010|2010-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|Optimise||OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.|OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.|Completed||N/A|4027|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 14:21:29.831399|2017-02-18 14:21:29.831399
NCT00681837|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-11-17|||May 2008||2008-05-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|||||Observational|||Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France|Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France|Completed||N/A|2500|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:21:30.379222|2017-02-18 14:21:30.379222
NCT00681824|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2013-05-21|2013-03-12||May 2008||2008-05-01|May 2013|2013-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||"Primary Safety Dataset Note: This includes 13 initial run-in participants in the FS VH S/D 500 s-apr arm (one for each site permitted to familiarize the investigators with the study procedures)"|Fibrin Sealant for the Sealing of Dura Sutures|An Exploratory Phase 2 Study Evaluating the Efficacy and Safety of Fibrin Sealant, Vapor Heated, Solvent/Detergent Treated (FS VH S/D) 500 S-APR for the Sealing of Dura Defect Sutures in Posterior Fossa Surgery|Completed||Phase 2|95|Actual|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-02-18 14:21:30.497063|2017-02-18 14:21:30.497063
NCT00681811|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2015-08-04|2012-09-26||February 2008||2008-02-01|February 2014|2014-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD|A Multi-center, Open-Label Extension Study of HGT-1111 (Recombinant Human Arylsulfatase A or rhASA) Treatment in Patients With Late Infantile Metachromatic Leukodystrophy (MLD)|Terminated||Phase 2|11|Actual|Shire|Early termination due to lack of efficacy.|2||Terminated prior to planned completion date due to lack of efficacy.|f||||f||||||||||2017-02-18 14:21:31.089985|2017-02-18 14:21:31.089985
NCT00681798|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-08-26|||July 2006||2006-07-01|August 2016|2016-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma|Dose Escalation Study of the Combination of ZD6474, Gemcitabine and Capecitabine in Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 1|8|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 14:21:31.765427|2017-02-18 14:21:31.765427
NCT00681785|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-05-19|||June 2006||2006-06-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Thrombophylaxis in Transurethral Surgery With Dalteparine|Thromboseprophylaxe Mit Niedermolekularem Heparin Bei Transurethralen Eingriffen|Completed||N/A|250|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 14:21:31.881172|2017-02-18 14:21:31.881172
NCT00557726|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-10|2017-01-24|||February 17, 1978||1978-02-17|August 26, 2016|2016-08-26||||||||Observational|||Diagnosis and Management of Inflammatory and Infectious Diseases|Diagnosis and Management of Inflammatory and Infectious Diseases|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:05:13.38532|2017-02-18 15:05:13.38532
NCT00681772|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-12-10|||March 2003||2003-03-01|December 2014|2014-12-01|November 2003|Actual|2003-11-01|||||Interventional|||Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction|Open-label, Multi-centre, Study to Investigate the Safety, Tolerability and Efficacy of Flexible Doses of Vardenafil Given on Demand in Males With Erectile Dysfunction|Completed||Phase 4|333|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:21:31.983284|2017-02-18 14:21:31.983284
NCT00681759|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2008-10-30|||January 2008||2008-01-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|||||Observational|||An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients|A Prospective Descriptive, Multi-National, Multi-Centre Observational Study of Burden of Upper GI-Symptoms in Subjects With Cardiovascular Risk or Disease Receiving Treatment With Low-Dose Aspirin|Completed||N/A|1836|Actual|AstraZeneca|||3||f||||f||||||||||2017-02-18 14:21:32.089252|2017-02-18 14:21:32.089252
NCT00681746|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2010-12-08|||February 2008||2008-02-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|PET||Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280|An Open Label Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280 After Oral Administration to Healthy Volunteers|Completed||Phase 1|8|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:21:32.383907|2017-02-18 14:21:32.383907
NCT00681733|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-05-20|||January 2007||2007-01-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|NASH||Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)|A Study Of Metabolic Factors And Efficacy Of Pentoxifylline Versus Pioglitazone In Lean And Obese Nash (Non-Alcoholic Steatohepatitis) Patients.|Unknown status|Recruiting|N/A|20|Anticipated|Govind Ballabh Pant Hospital||2|||f||||t||||||||||2017-02-18 14:21:32.481689|2017-02-18 14:21:32.481689
NCT00681720|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-08-20|||February 2008||2008-02-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|PET||Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325|An Open Label Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325 After Oral Administration to Healthy Volunteers|Completed||Phase 1|4|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:21:32.597599|2017-02-18 14:21:32.597599
NCT00681707|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-07-08|||May 2008||2008-05-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|||||Observational|SAPPHIRE||Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke|A Retrospective, Multi Centre, Non-Interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Post Stroke Patients With Hypertension.|Completed||N/A|1000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:21:32.704641|2017-02-18 14:21:32.704641
NCT00681694|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2010-04-27|||March 2002||2002-03-01|April 2010|2010-04-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Observational|||Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer|Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer|Unknown status|Recruiting|N/A|414|Anticipated|Massachusetts General Hospital|||3||f||||t||||||||||2017-02-18 14:21:32.801655|2017-02-18 14:21:32.801655
NCT00681681|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2014-12-10|||February 2008||2008-02-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|SAVVY||Sex Differences in Vascular Markers of Stroke Risk|Sex Differences in Vascular Markers of Stroke Risk|Completed||N/A|117|Actual|Wake Forest University Health Sciences|||1||f||||f||||||Samples With DNA|"~     RNA and DNA samples collected~   "|||2017-02-18 14:21:32.912015|2017-02-18 14:21:32.912015
NCT00681668|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2010-12-07|2009-10-29||August 2007||2007-08-01|December 2010|2010-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Quetiapine in Postpartum Depression|The Effect of the Atypical Antipsychotic Quetiapine in the Treatment of Postpartum Depressive Disorder With Psychotic Symptoms|Terminated||Phase 2|5|Actual|AstraZeneca|Study termination (the study could not finalised in the planned,nor in an acceptable time).|1||Recruitment behind plan, no increase expected|f||||f||||||||||2017-02-18 14:21:33.01017|2017-02-18 14:21:33.01017
NCT00681655|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2016-12-07|||May 2008||2008-05-01|December 2016|2016-12-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|GPRA||GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)|GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)|Active, not recruiting||N/A|141|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 14:21:33.325093|2017-02-18 14:21:33.325093
NCT00681642|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2011-01-06|||March 2007||2007-03-01|December 2010|2010-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Corneal Epithelial Wound Healing Difference Between Human Autoserum and Cord Blood Serum|Phase 1 Study of Comparison of the Effects on Promoting Corneal Epithelial Wound Healing Between Human Autoserum and Cord Blood Serum—in Vitro Cell Culture Experiment|Completed||N/A|7|Actual|National Taiwan University Hospital|||2||f||||f||||||||||2017-02-18 14:21:33.438283|2017-02-18 14:21:33.438283
NCT00681629|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2012-06-22|2010-04-07||July 2008||2008-07-01|June 2012|2012-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|CARE II||Schizophrenic Patients in Integrated Care|CARE II - Evaluation of Treatment Outcomes in Schizophrenic Patients Taking Part in the Integrated Care Program - a Single-country, Multi-centre Phase IV Study|Terminated||Phase 4|7|Actual|AstraZeneca|The study was stopped due to poor enrollment and no data analysis was performed.|2||"Difficulty finding eligible sites/patients; current situation in health policy cause negative~   effect on existing/planned contracts for integrated care program"|f||||f||||||||||2017-02-18 14:21:33.554079|2017-02-18 14:21:33.554079
NCT00681616|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-03-03|||January 2009||2009-01-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|TS2||Study of New Catheter & Pressure Monitor System to Help Prevent Compartment Syndrome From Developing in the Injured Leg|Randomized Clinical Trial of Tissue Ultrafiltration and Pressure Monitoring for the Diagnosis and Prevention of Compartment Syndrome|Unknown status|Recruiting|N/A|90|Anticipated|Twin Star Medical, Inc.||2|||f||||t||||||||||2017-02-18 14:21:34.227656|2017-02-18 14:21:34.227656
NCT00681603|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-05-20|||August 2007||2007-08-01|August 2007|2007-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization|The Application of Subconjunctival Injection of Bevacizumab (Avastin) in the Treatment of Corneal Neovasculization|Completed||N/A|13|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 14:21:34.374789|2017-02-18 14:21:34.374789
NCT00005216|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||April 1988||1988-04-01|January 2016|2016-01-01|December 1994||1994-12-01|||||Observational|||Multicenter Study of Silent Myocardial Ischemia (MSSMI)||Completed||N/A|||University of Rochester|||||f||||||||||||||2017-02-18 18:15:20.425709|2017-02-18 18:15:20.425709
NCT00681577|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-11-18|||May 2008||2008-05-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*2402 in Treating Patients With Refractory Gastric Cancer|Completed||Phase 1/Phase 2|14|Anticipated|Tokyo University||1|||f||||t||||||||||2017-02-18 14:21:34.818612|2017-02-18 14:21:34.818612
NCT00681564|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2014-03-31|2013-11-26||May 2008||2008-05-01|March 2014|2014-03-01|January 2012|Actual|2012-01-01|March 2011|Actual|2011-03-01||Interventional|||Periodontal Infection and Endothelial Dysfunction|Impact of Periodontal Therapy on Endothelial Function|Completed||Phase 3|102|Actual|Universidad del Valle, Colombia|1. Patient recruitment take more time that previously expected, 2. Longer time than expected for the standardization for laboratory techniques, 3. Changes of the study personnel during patient recruitment and laboratory analysis of biological samples|2|||f||||t||||||||||2017-02-18 14:21:34.946059|2017-02-18 14:21:34.946059
NCT00681551|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-12-11|||February 2003||2003-02-01|December 2014|2014-12-01|March 2004|Actual|2004-03-01|||||Interventional|||Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis|Intra-individual Comparison Study of Intravenously Administered Magnevist (SH L 451A) on Lesion Detection Ability in MRI After an Initial Dose of 0.1 mmol/kg and After an Additional Dose of 0.1 mmol/kg in Patients With Metastatic Brain Tumor|Completed||Phase 3|45|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:21:35.875406|2017-02-18 14:21:35.875406
NCT00681538|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2015-03-09|2011-03-23||January 2008||2008-01-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)|A Two-phase, Phase 3 Study of the Safety and Efficacy of Sativex, in the Symptomatic Relief of Spasticity in Subjects With Spasticity Due to Multiple Sclerosis: Phase A - Single-blind Response Assessment; Phase B - Double-blind, Randomised, Placebo Controlled, Parallel Group Study.|Completed||Phase 3|572|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:21:35.994486|2017-02-18 14:21:35.994486
NCT00681525|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2010-10-18|||April 2008||2008-04-01|September 2010|2010-09-01||||June 2008|Actual|2008-06-01||Interventional|||A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe||Completed||Phase 1|18|Actual|Abbott||3|||f||||||||||||||2017-02-18 14:21:36.954505|2017-02-18 14:21:36.954505
NCT00681512|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2014-02-18|||April 2008||2008-04-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||The Effect of Berries on Lung Cancer Tumors|Berry Interventional Trial (BIT) in Resected Non-Small Cell Lung Cancer|Terminated||N/A|6|Actual|James Graham Brown Cancer Center||1||slow accrual|f||||t||||||||||2017-02-18 14:21:37.048464|2017-02-18 14:21:37.048464
NCT00681499|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2015-11-12|||February 2008||2008-02-01|November 2015|2015-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Quality of Life After Liver Resection|Long-term Evaluation of the Quality of Life After Major Hepatic Resection for Malignant and Benign Diseases.|Completed||N/A|198|Actual|University of Bern|||2||f||||f||||||||||2017-02-18 14:21:37.148928|2017-02-18 14:21:37.148928
NCT00681486|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-08-20|||October 2003||2003-10-01|August 2009|2009-08-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|Phase 3||Ghrelin - A Possible Opportunity to Improve Appetite|Ghrelin - A Possible Opportunity to Improve Appetite, Nutritional State, Metabolic Integrity and Physical Functioning in Cancer Patients With Progressive Weight Loss|Completed||Phase 3|30|Anticipated|Göteborg University||2|||f||||||||||||||2017-02-18 14:21:37.249448|2017-02-18 14:21:37.249448
NCT00681473|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2017-01-06|2017-01-06||July 2007||2007-07-01|January 2017|2017-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||All 20 baseline participants were included in analysis.|Late Effects of Proton Radiation Therapy in Patients With Low-Grade Glioma|Late Effects of Proton Radiation Therapy in Patients With Low-Grade Glioma|Completed||N/A|20|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:21:37.358906|2017-02-18 14:21:37.358906
NCT00681460|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2015-05-23|||May 2008||2008-05-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|MetGDM||Metformin in Gestational Diabetes Mellitus|Effects of Insulin and/or Metformin Treatment on Perinatal Outcome and Metabolic Parameters in Women With Gestational Diabetes Mellitus: Prospective Randomized Trial.|Completed||N/A|78|Actual|K. Marcinkowski University of Medical Sciences||2|||f||||f||||||||||2017-02-18 14:21:37.621093|2017-02-18 14:21:37.621093
NCT00681447|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2015-10-20|||February 2008||2008-02-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|February 2010|Actual|2010-02-01||Interventional|||Treatment of Chronic Low Back and Lower Extremity Pain|A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Lumbar Interlaminar Epidural Injections in Lumbar Disc Herniation, and Discogenic Pain|Completed||N/A|120|Actual|Pain Management Center of Paducah||2|||f||||f||||||||||2017-02-18 14:21:37.731534|2017-02-18 14:21:37.731534
NCT00681434|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2014-08-01|||May 2005||2005-05-01|August 2014|2014-08-01||||August 2007|Actual|2007-08-01||Interventional|||Bilateral Training Versus Unilateral Training in Stroke|Bilateral Training for Upper Extremity Hemiparesis in Stroke|Completed||Phase 2|24|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-02-18 14:21:37.841008|2017-02-18 14:21:37.841008
NCT00681421|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-11-18|||May 2008||2008-05-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*0201 in Treating Patients With Refractory Esophageal Cancer|Completed||Phase 1/Phase 2|14|Anticipated|Tokyo University||1|||f||||t||||||||||2017-02-18 14:21:37.956023|2017-02-18 14:21:37.956023
NCT00681408|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2015-05-27|||March 2007||2007-03-01|May 2015|2015-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)|Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)|Completed||Phase 2/Phase 3|41|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 14:21:38.069339|2017-02-18 14:21:38.069339
NCT00681395|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-09-27|||May 2008||2008-05-01|September 2012|2012-09-01||||August 2008|Actual|2008-08-01||Interventional|||Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium||Completed||Phase 1|64|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:21:38.174164|2017-02-18 14:21:38.174164
NCT00005215|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||April 1988||1988-04-01|May 2000|2000-05-01|March 1992|Actual|1992-03-01|||||Observational|||Lipoprotein Subfractions and Coronary Heart Disease During 25 Year Follow-up||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:20.496992|2017-02-18 18:15:20.496992
NCT00681382|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2011-01-21|||October 2006||2006-10-01|January 2011|2011-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland|INSPIRE Asthma Patient Survey to Clarify the Use of Asthma Medication and Effects of Asthma in Everyday Life in Finland|Completed||N/A|142|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:21:38.269418|2017-02-18 14:21:38.269418
NCT00681369|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2011-01-21|||May 2007||2007-05-01|January 2011|2011-01-01|June 2007|Actual|2007-06-01|||||Observational|||Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France|Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France|Completed||N/A|217|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:21:38.352943|2017-02-18 14:21:38.352943
NCT00681356|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2009-05-01|||September 2007||2007-09-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement|A Phase 3, Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Study to Evaluate the Efficacy, Tolerability, Safety, and Pharmacokinetics of 4975 in Patients Undergoing Primary Unilateral Total Knee Arthroplasty|Completed||Phase 3|214|Anticipated|Anesiva, Inc.||3|||f||||t||||||||||2017-02-18 14:21:38.430301|2017-02-18 14:21:38.430301
NCT00681343|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-05-23|||September 2002||2002-09-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation|Head-to-Head Comparison of Thymoglobulin vs. Campath-1H vs. Our Standard Center Treatment Protocol in Living Donor Renal Transplantation - A Study to Evaluate the Avoidance of Long-Term Nephrotoxic Calcineurin Inhibitor Therapy|Completed||Phase 4|38|Actual|University of Miami||3|||f||||t||||||||||2017-02-18 14:21:38.558381|2017-02-18 14:21:38.558381
NCT00681330|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-11-18|||May 2008||2008-05-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*2402 in Treating Patients With Refractory Esophageal Cancer|Completed||Phase 1/Phase 2|14|Anticipated|Tokyo University||1|||f||||t||||||||||2017-02-18 14:21:38.663815|2017-02-18 14:21:38.663815
NCT00681317|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2010-12-07|||March 2008||2008-03-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|MAD||AZD6280 Multiple Ascending Dose Study|A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6280 When Given in Multiple Ascending Oral Doses in Healthy Male and Healthy Female Subjects of Non-child Bearing Potential|Completed||Phase 1|48|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:21:38.774151|2017-02-18 14:21:38.774151
NCT00681304|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-11-15|||August 2007||2007-08-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Observational|||Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System|"Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System (J-0728)"|Completed||Early Phase 1|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 14:21:38.866539|2017-02-18 14:21:38.866539
NCT00681291|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-04-06|2013-09-18||April 2008||2008-04-01|April 2016|2016-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|RING||Strattice in Repair of Inguinal Hernias|Prospective, Randomized, Controlled, Third-Party Blinded Multicenter Evaluation of Strattice/LTM in the Repair of Inguinal Hernias|Completed||Phase 4|172|Actual|LifeCell||2|||f||||f||||||||||2017-02-18 14:21:38.963258|2017-02-18 14:21:38.963258
NCT00681278|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2010-12-01|||April 2008||2008-04-01|December 2010|2010-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|CRYSTAL||Retrospective Survey for Patients With Hypertension and Diabetes Mellitus|A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With Hypertension.|Completed||N/A|2000|Anticipated|AstraZeneca|||1||f||||||||||||||2017-02-18 14:21:39.344704|2017-02-18 14:21:39.344704
NCT00681265|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-10-24|2012-09-16||June 2008||2008-06-01|October 2012|2012-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Tear Film Break-up Time After Instillation of Artificial Tears|A Randomized, Masked Exploratory Trial Comparing the Effect of Two Different Over-the-Counter Artificial Tear Preparations on Tear Film Break-up Time|Completed||N/A|16|Actual|Eyeon Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 14:21:39.456699|2017-02-18 14:21:39.456699
NCT00681252|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-11-18|||May 2008||2008-05-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*0201 in Treating Patients With Refractory Gastric Cancer|Completed||Phase 1/Phase 2|14|Anticipated|Tokyo University||1|||f||||t||||||||||2017-02-18 14:21:39.739414|2017-02-18 14:21:39.739414
NCT00681239|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2009-12-30|||May 2008||2008-05-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Atkins Plus KetoCal for Childhood Epilepsy|An Open-label Evaluation of KetoCal in Initial Combination With the Modified Atkins Diet for the Treatment of Intractable Childhood Epilepsy|Completed||Phase 3|30|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 14:21:39.854959|2017-02-18 14:21:39.854959
NCT00681226|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2012-04-04|||January 2008||2008-01-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|August 2011|Actual|2011-08-01||Interventional|||Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease|ACE Inhibition; A Potential New Therapy for Peripheral Arterial Disease|Completed||Phase 4|200|Actual|Bayside Health||1|||f||||f||||||||||2017-02-18 14:21:39.972863|2017-02-18 14:21:39.972863
NCT00681213|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2008-05-23|||May 2000||2000-05-01|May 2008|2008-05-01|December 2002|Actual|2002-12-01|December 2001|Actual|2001-12-01||Interventional|||Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation|Tacrolimus and Mycophenolate Versus Tacrolimus and Sirolimus vs. Neoral and Sirolimus Used in Combination in Cadaver and Non-HLA Identical Living Related Kidney Transplants|Completed||Phase 4|150|Actual|University of Miami||3|||f||||t||||||||||2017-02-18 14:21:40.073622|2017-02-18 14:21:40.073622
NCT00681200|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2013-03-11|||April 2008||2008-04-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|July 2011|Actual|2011-07-01||Interventional|HMEC||Evaluating Mechanisms of Blood Pressure Reduction Using Meditation in Hypertensive African Americans|Mechanisms of Meditation in Hypertension in Blacks|Completed||N/A|152|Actual|Maharishi University of Management||2|||f||||t||||||||||2017-02-18 14:21:40.175481|2017-02-18 14:21:40.175481
NCT00681187|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-02-09|2011-09-01||June 2008||2008-06-01|February 2012|2012-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|SAPHE||Somatuline Autogel Preference and Health Economy Study|A Phase IV, International, Open-label, Randomised, Cross-over Study to Assess Patient Preference and Health Economy in Patients With Neuroendocrine Tumours, Treated With Lanreotide Autogel Given as Self Administration.|Completed||Phase 4|26|Actual|Ipsen||1|||f||||f||||||||||2017-02-18 14:21:40.283176|2017-02-18 14:21:40.283176
NCT00681174|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-01-05|||July 2008||2008-07-01|January 2012|2012-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Controlled-Release Oxycodone For Postoperative Analgesia After Video-Assisted Thoracic Surgery|Preoperative Controlled-Release Oxycodone or Intraoperative Morphine As Transition Opioid After Intravenous Anesthesia For Video-Assisted Thoracic Surgery: a Randomized, Double-blind, Controlled Trial.|Terminated||Phase 4|22|Actual|University of Parma||2||Failure to enroll sufficient patients by expected deadline.|f||||t||||||||||2017-02-18 14:21:41.215746|2017-02-18 14:21:41.215746
NCT00681161|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-07-31|||March 2006||2006-03-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Autonomic Function in Obstructive Sleep Apnea|Autonomic Function in Obstructive Sleep Apnea (OSA)|Unknown status|Active, not recruiting|N/A|90|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 14:21:41.36134|2017-02-18 14:21:41.36134
NCT00681148|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2013-11-19||||||November 2013|2013-11-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Botulinum Toxin Injection With Prostate Brachytherapy|Botulinum Toxin Injection With Prostate Brachytherapy: A Randomized, Placebo-controlled Study Monitoring Urinary Symptoms and PSA|Withdrawn||Phase 2|0|Actual|Emory University||2||No funding|f||||f||||||||||2017-02-18 14:21:41.47869|2017-02-18 14:21:41.47869
NCT00681135|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2012-02-21|||April 2008||2008-04-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||Mechanical Plaque Control and Gingivitis Reduction in Fixed Appliance Patients|Mechanical Plaque Control and Gingivitis Reduction in Fixed Appliance Patients: Comparison of Different Toothbrushing Protocols|Completed||N/A|118|Actual|University of Jena||4|||f||||f||||||||||2017-02-18 14:21:41.610682|2017-02-18 14:21:41.610682
NCT00681122|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-20|2016-01-15|||May 2008||2008-05-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|CARIATIDE||CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)|An International, Observational Study to Evaluate the Impact of Educational Material on the Compliance and Persistence Rates to Adjuvant Aromatase Inhibitor (AI) Medication for Postmenopausal Woman|Completed||N/A|2600|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 14:21:41.739208|2017-02-18 14:21:41.739208
NCT00681109|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2012-12-07|2011-12-19||January 2008||2008-01-01|December 2012|2012-12-01|October 2010|Actual|2010-10-01|May 2010|Actual|2010-05-01||Interventional|||Topical IL-1-Ra for Treatment of Posterior Blepharitis|Safety and Efficacy of Topical Interleukin-1-Receptor Antagonist in the Treatment of Signs and Symptoms of Posterior Blepharitis|Completed||Phase 1/Phase 2|75|Actual|Massachusetts Eye and Ear Infirmary||3|||f||||f||||||||||2017-02-18 14:21:42.025673|2017-02-18 14:21:42.025673
NCT00681096|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-18|2008-05-20|||June 2008||2008-06-01|May 2008|2008-05-01||||||||Observational|||Causes of Low Back Pain in Nurses in Israeli Hospitals||Unknown status|Not yet recruiting|N/A|350|Anticipated|Hillel Yaffe Medical Center|||1||f||||||||||||||2017-02-18 14:21:42.477685|2017-02-18 14:21:42.477685
NCT00681083|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2011-07-10|||April 2008||2008-04-01|July 2011|2011-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification|Titrations Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification|Completed||N/A|20|Anticipated|Fisher and Paykel Healthcare||2|||f||||f||||||||||2017-02-18 14:21:42.746751|2017-02-18 14:21:42.746751
NCT00681070|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-19|2017-02-08|||April 2008|Actual|2008-04-01|February 2017|2017-02-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Interventional|Catgut||Cosmetic Outcomes of Absorbable Versus Non-absorbable Sutures in Pediatric Facial Lacerations|Cosmetic Outcomes of Absorbable Versus Non-absorbable Sutures in Pediatric Facial Lacerations, Part 2|Completed||N/A|74|Actual|Temple University||2|||f||||f||||||||||2017-02-18 14:21:42.857703|2017-02-18 14:21:42.857703
NCT00680225|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-05-01|||September 2007||2007-09-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma|Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma|Completed||Phase 3|10|Actual|New England Retina Associates||1|||f||||f||||||||||2017-02-18 14:21:42.964353|2017-02-18 14:21:42.964353
NCT00680212|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2009-02-17|||July 2008||2008-07-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Vitamin A Equivalence of Plant Carotenoids in Children|Phase 2 Study of VITAMIN A EQUIVALENCE OF PLANT CAROTENOIDS IN CHILDREN|Completed||Phase 2|72|Anticipated|Tufts University||1|||f||||t||||||||||2017-02-18 14:21:43.058647|2017-02-18 14:21:43.058647
NCT00680199|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-10-26|||June 2008||2008-06-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|COTE||Information Processing at Sleep Onset and During Sleep in Patients With Insomnia|Information Processing at Sleep Onset and During Sleep in Patients With Insomnia|Completed||N/A|50|Anticipated|University of Rochester|||2||f||||f||||||||||2017-02-18 14:21:43.169709|2017-02-18 14:21:43.169709
NCT00681057|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2009-08-13|||January 2008||2008-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:21:43.254238|2017-02-18 14:21:43.254238
NCT00681044|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-18|2016-01-14|||October 2006||2006-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||HD Melphalan and SCT in Patients With IGDD or LCDD|High-Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT) in Light-Chain Deposition Disease (LCDD) and Immunoglobulin Deposition Disease (IGDD)|Terminated||Phase 2|5|Actual|Boston Medical Center||1||Poor accrual|f||||t||||||||||2017-02-18 14:21:43.30466|2017-02-18 14:21:43.30466
NCT00681031|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2009-04-03|||May 2008||2008-05-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||Zostavax® at Minimum Release Specification Approaching Expiry||Completed||Phase 4|98|Actual|MCM Vaccines B.V.||1|||f||||f||||||||||2017-02-18 14:21:43.439831|2017-02-18 14:21:43.439831
NCT00681018|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2010-08-30|||September 2008||2008-09-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Feeding Study in Premature Infants|Feeding Study in Premature Infants|Completed||N/A|143|Anticipated|Mead Johnson Nutrition||2|||f||||f||||||||||2017-02-18 14:21:43.527428|2017-02-18 14:21:43.527428
NCT00681005|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-12-09|||April 2006||2006-04-01|December 2013|2013-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes|A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes|Completed||N/A|178|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 14:21:43.71337|2017-02-18 14:21:43.71337
NCT00680992|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-12-16|||September 2008||2008-09-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of Denosumab in Subjects With Giant Cell Tumor of Bone|An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects With Giant Cell Tumor of Bone|Active, not recruiting||Phase 2|536|Actual|Amgen||1|||f||||||||||||||2017-02-18 14:21:43.808489|2017-02-18 14:21:43.808489
NCT00680979|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-17|2017-01-24|||May 15, 2008||2008-05-15|August 20, 2015|2015-08-20|April 16, 2015|Actual|2015-04-16|April 16, 2015|Actual|2015-04-16||Interventional|||Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity|Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity|Completed||Phase 2|166|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:21:43.954402|2017-02-18 14:21:43.954402
NCT00680966|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-03-10|||January 2008||2008-01-01|March 2014|2014-03-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Interventional|Sequencing||Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD|Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD|Completed||N/A|180|Actual|Oregon Research Institute||3|||f||||f||||||||||2017-02-18 14:21:44.063426|2017-02-18 14:21:44.063426
NCT00680953|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-02-19|2013-07-12||May 2008||2008-05-01|February 2015|2015-02-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|DIRECT|The demography information shows the number of participants included in the full analysis set (FAS) for efficacy analyses, which includes all randomized subjects except for those who did not have osteoporosis, did not receive the investigational product, or had no available efficacy data after the first dose of the investigational product.|Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis|A Randomized, Double-Blind, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of Denosumab in Japanese Osteoporotic Subjects With Prevalent Fragility Vertebral Fracture(s)|Completed||Phase 3|1262|Actual|Daiichi Sankyo Inc.||3|||f||||t||||||||||2017-02-18 14:21:44.181944|2017-02-18 14:21:44.181944
NCT00680940|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2012-08-04|||June 2008||2008-06-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|NSCLC||A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer|Open Label, Randomized Multicentric Phase II Clinical Trial of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel and Cisplatin in Advanced Non Small Cell Lung Cancer.|Completed||Phase 2|221|Actual|Cadila Pharnmaceuticals||2|||f||||t||||||||||2017-02-18 14:21:47.501296|2017-02-18 14:21:47.501296
NCT00680927|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-06-02|||September 2007||2007-09-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Reveal® XT Performance Trial (XPECT)|Reveal® XT Performance Trial|Completed||Phase 4|247|Actual|Medtronic BRC||1|||f||||f||||||||||2017-02-18 14:21:47.626542|2017-02-18 14:21:47.626542
NCT00680914|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2016-10-11|2010-05-13||June 2008||2008-06-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™|Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A or Prevenar™ Co-administered With Hiberix™|Completed||Phase 3|503|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:21:47.969228|2017-02-18 14:21:47.969228
NCT00680901|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-07-28|2013-05-16||June 2008||2008-06-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|September 2012|Actual|2012-09-01||Interventional|||LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib|A Phase III Study for ErbB2 Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Junction Adenocarcinoma Treated With Capecitabine Plus Oxaliplatin With or Without Lapatinib|Active, not recruiting||Phase 3|545|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:21:48.770029|2017-02-18 14:21:48.770029
NCT00680888|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2010-12-07|||August 2005||2005-08-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Adherence in Adolescents and Children Treated on Quetiapine|Adherence in Adolescents and Children Treated on Quetiapine|Completed||N/A|30|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:21:50.251478|2017-02-18 14:21:50.251478
NCT00680875|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2011-10-13|||March 2007||2007-03-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|Intranet||Intranet-based Tobacco Prevention Program for Children||Completed||N/A|3225|Anticipated|Oregon Research Institute||2|||f||||f||||||||||2017-02-18 14:21:50.330453|2017-02-18 14:21:50.330453
NCT00680862|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2014-09-26|2014-08-27||June 2008||2008-06-01|September 2014|2014-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational||VA employees|Qualitative Assessment of Implementing Routine Rapid HIV Testing|Qualitative Assessment of Implementing Routine Rapid HIV Testing|Completed||N/A|25|Actual|VA Office of Research and Development|||1||f||||t||||||||||2017-02-18 14:21:50.445857|2017-02-18 14:21:50.445857
NCT00680849|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2011-10-11|||December 2003||2003-12-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Enhancing Support for Women With Type 2 Diabetes: Follow-Up|Enhancing Support for Women With Type 2 Diabetes: Follow-Up|Completed||N/A|227|Actual|Oregon Research Institute|||2||f||||t||||||||||2017-02-18 14:21:50.667003|2017-02-18 14:21:50.667003
NCT00680836|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-08-19|2013-12-09||October 2007||2007-10-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|October 2008|Actual|2008-10-01||Interventional||A total of 54 patients were randomized. Of that 54 patients,10 patients were excluded from the analyses. Reasons included, patient withdrawal, physician decision, and loss to follow up.Total of 44 patients were analysed. All data presented here, includes the 44 patients only.|Gulf War Digestive Health Study|Diarrhea-Predominant Irritable Bowel Syndrome in Persian Gulf Veterans|Completed||N/A|54|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:21:50.767737|2017-02-18 14:21:50.767737
NCT00670943|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2009-03-24|||January 2008||2008-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Effect of Abrupt Plavix® Discontinuation on Platelet Function|Effect of Abrupt Plavix® Discontinuation on Platelet Function|Completed||N/A|52|Anticipated|Université de Montréal|||2||f||||t||||||||||2017-02-18 14:25:11.747271|2017-02-18 14:25:11.747271
NCT00680823|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2016-06-25|||January 2009||2009-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache|Is Paraspinal Intramuscular Ropivacaine Injection an Effective Treatment for Headache in a Pediatric Emergency Department?|Completed||N/A|150|Actual|Children's Hospital of Pittsburgh||3|||f||||t||||||||No||2017-02-18 14:21:51.210661|2017-02-18 14:21:51.210661
NCT00680797|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-10-25|2014-07-24||January 2005||2005-01-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|||Metabolic Effects of Androgenicity in Aging Men and Women|Metabolic Effects of Androgenicity in Aging Men and Women|Active, not recruiting||N/A|33|Actual|VA Office of Research and Development|Small sample size may limit generalizability of these results. Follow-up studies are being conducted to further evaluate these results.|4|||f||||t||||||||Undecided||2017-02-18 14:21:51.544066|2017-02-18 14:21:51.544066
NCT00680784|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-05-12||2015-03-17|April 2008||2008-04-01|May 2015|2015-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||HKT-500 in Adult Patients With Ankle Sprain|Protocol HKT-500-US10: A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Grade I or Grade II Ankle Sprain|Completed||Phase 3|260|Actual|Hisamitsu Pharmaceutical Co., Inc.||2|||f||||t||||||||||2017-02-18 14:21:52.123995|2017-02-18 14:21:52.123995
NCT00680771|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2012-09-14|2011-09-26||March 2008||2008-03-01|September 2012|2012-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||The Psychoneuroimmunology of Insomnia|The Psychoneuroimmunology of Insomnia: Response to a Vaccine Challenge|Completed||N/A|28|Actual|University of Rochester|Sample size limited by much higher than expected number of otherwise eligible participants having alrady been exposed to Hep B vaccine or virus.||2||f||||f||||||||||2017-02-18 14:21:52.27284|2017-02-18 14:21:52.27284
NCT00680758|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-18|2013-03-07|||May 2008||2008-05-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|August 2009|Actual|2009-08-01||Interventional|||Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer|A Phase I Study of Cisplatin, Paclitaxel, and RAD001 Patients With Metastatic Breast Cancer|Completed||Phase 1|18|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 14:21:52.590745|2017-02-18 14:21:52.590745
NCT00680745|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-08-09|2011-04-13||April 2008||2008-04-01|August 2013|2013-08-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional||Full Analysis Set defined as all randomized participants (as randomized) who received at least one dose of double-blind study medication, who have a non-missing baseline value and at least one post-baseline efficacy value for at least one efficacy variable during double-blind treatment period.|Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients|A 24-Week,Int.,Rand.,Double-blind,Parallel-group,Multi-centre, Plac.-Controlled Phase III Study With a 24-Wk Ext.Per.to Eval.the Efficacy and Safety of Dapagliflozin in Comb.With Glimepiride (a Sulphonylurea) in Subjects With Type2 Diab.Who Have Inadeq. Glycaemic Control on Glimepiride Therapy Alone|Completed||Phase 3|597|Actual|AstraZeneca|For participants who did not complete 24 weeks LOCF (last observation carried forward) was used. Only values prior to rescue medication were used.|4|||f||||f||||||||||2017-02-18 14:21:52.727547|2017-02-18 14:21:52.727547
NCT00680732|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2010-09-12|||June 2003||2003-06-01|September 2010|2010-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component|Prevention of Intrauterine Growth Retardation in Hounde District, Burkina Faso: the Malaria Component|Completed||Phase 4|1370|Actual|Institute of Tropical Medicine, Belgium||4|||f||||f||||||||||2017-02-18 14:21:53.82337|2017-02-18 14:21:53.82337
NCT00680719|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-08-04|||June 2004||2004-06-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Preventing HIV/Aids in Drug Abusing Youth|Preventing HIV/Aids in Tx-Resistant Drug-Abusing Youth|Completed||Phase 1|111|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-02-18 14:21:53.944885|2017-02-18 14:21:53.944885
NCT00680706|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-08-12|2012-07-27||January 2008||2008-01-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|February 2010|Actual|2010-02-01||Interventional|||Thiamine and Acute Decompensated Heart Failure: Pilot Study|Targeting Myocardial Energy Metabolism for the Treatment of Acute Heart Failure: The Effect of Thiamine on Biochemical, Electrocardiographic and Respiratory Parameters in Hospitalized Patients.|Completed||Phase 2|131|Actual|Baystate Medical Center||2|||f||||f||||||||||2017-02-18 14:21:54.046296|2017-02-18 14:21:54.046296
NCT00680693|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2011-11-17|||October 2006||2006-10-01|February 2010|2010-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|M-IBS||Mindfulness vs. Support Groups for Irritable Bowel Syndrome|Mindfulness for Irritable Bowel Syndrome|Completed||N/A|75|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 14:21:54.364521|2017-02-18 14:21:54.364521
NCT00680680|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2008-05-19|||May 2004||2004-05-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|AUR||Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker|Phase 4 Study of Dual Five Alpha Reductase Inhibition Combined With Alpha Blockade in Men With Refractory Urinary Retention Secondary to BPH|Completed||N/A|20|Anticipated|Franklin D. Gaylis, MD Inc.|||||f||||f||||||||||2017-02-18 14:21:54.468617|2017-02-18 14:21:54.468617
NCT00680667|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-18|2012-11-06|||April 2007||2007-04-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Clinical Trial of Trametes Versicolor in Women With Breast Cancer|Phase I Clinical Trial of Trametes Versicolor in Women With Breast Cancer|Completed||Phase 1|11|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:21:54.544354|2017-02-18 14:21:54.544354
NCT00680654|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-12-14|||October 2008||2008-10-01|December 2015|2015-12-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID|Interaction Study to Investigate Safety, Tolerability, Pharmacokinetics and the Impact on Pulmonary and Systemic Hemodynamics of Single Doses of 0.5 and 1 mg of BAY 63-2521 in Patients With PAH and Stable Treatment of Sildenafil 20 mg TID in a Non-randomized, Non-blinded Design|Completed||Phase 1|7|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:21:54.65143|2017-02-18 14:21:54.65143
NCT00680641|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2011-08-04|||April 2008||2008-04-01|August 2011|2011-08-01|February 2012|Anticipated|2012-02-01|February 2011|Actual|2011-02-01||Interventional|||Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)|The Effects of Simvastatin in Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Active, not recruiting|Phase 4|20|Anticipated|University of East Anglia||2|||f||||f||||||||||2017-02-18 14:21:54.763678|2017-02-18 14:21:54.763678
NCT00680628|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-07-22|2013-10-29||May 2008||2008-05-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional||see manuscript|Clot Dissolving Treatment for Blood Clots in the Lungs|Randomized Trial of Tenecteplase to Treat Severe Submassive Pulmonary Embolism|Terminated||Phase 3|83|Actual|Carolinas Healthcare System||2||PI changed institution and impossible to solve problem with contract's sites|f||||t||||||||||2017-02-18 14:21:54.889818|2017-02-18 14:21:54.889818
NCT00680615|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2012-09-03|||May 2008||2008-05-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||An Internet-Based Smokeless Tobacco Cessation Program for Teens|QuitSpit: An Internet-Based Smokeless Tobacco Cessation Program for Teens|Completed||Phase 2|1716|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-02-18 14:21:55.516969|2017-02-18 14:21:55.516969
NCT00680602|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2009-02-13|||January 2006||2006-01-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|GCBTVF||Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial|Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Randomized Open Trial for Any Patient.|Completed||Phase 4|158|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 14:21:55.610933|2017-02-18 14:21:55.610933
NCT00680589|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2011-03-25|||July 2006||2006-07-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response|Injection of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response|Completed||Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:21:55.732492|2017-02-18 14:21:55.732492
NCT00680576|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-10-08|||March 2008||2008-03-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|ADAPT||Adolescent Substance Abuse: Progressive Treatment||Completed||Phase 1|140|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-02-18 14:21:55.833381|2017-02-18 14:21:55.833381
NCT00680563|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-11-04|||April 2009||2009-04-01|November 2013|2013-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.|An Open Label Study of the Safety, Tolerability and Effect on Hemoglobin Levels of Once-monthly Subcutaneous Mircera in Predialysis Patients With Chronic Renal Anemia Not Currently Treated With ESA.|Terminated||Phase 3|4|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:21:55.92982|2017-02-18 14:21:55.92982
NCT00680550|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-10-15|||April 2008||2008-04-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||INSIGHT (R)XT. Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT|Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT.|Completed||N/A|1003|Actual|Medtronic BRC|||1||f||||f||||||||||2017-02-18 14:21:56.052081|2017-02-18 14:21:56.052081
NCT00680537|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2010-02-17|||April 2008||2008-04-01|April 2008|2008-04-01|April 2011|Anticipated|2011-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Physical Therapy Program for Prevention of Shoulder Pain After Device Implant|Physical Therapy Program for Prevention of Shoulder Pain After Device Implant|Unknown status|Recruiting|N/A|100|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 14:21:56.217856|2017-02-18 14:21:56.217856
NCT00680524|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-04-06|2014-06-25||September 2008||2008-09-01|June 2014|2014-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Telephone-based Care for OEF/OIF Veterans With PTSD|Telephone Based Care for OIF/OEF Veterans With PTSD|Completed||N/A|20|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 14:21:56.3299|2017-02-18 14:21:56.3299
NCT00680511|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-08-04|||September 2007||2007-09-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|AIMS||Development of a Family-Based Treatment for Adolescent Methamphetamine Use|Development of a Family-Based Treatment for Adolescent Methamphetamine Use|Completed||Phase 1|60|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-02-18 14:21:56.555669|2017-02-18 14:21:56.555669
NCT00680498|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2012-03-27|||February 2007||2007-02-01|March 2012|2012-03-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|CLOVER||Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment|Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment|Completed||Phase 4|10|Actual|Illinois Retina Associates||2|||f||||||||||||||2017-02-18 14:21:56.664957|2017-02-18 14:21:56.664957
NCT00680485|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2017-01-19|||June 2007||2007-06-01|January 2017|2017-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416|A Three Part Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeat Escalating Oral Doses of GSK580416; the Safety, Tolerability, and Pharmacokinetics of GSK580416 Following a Loading Dose Regimen; and the Effect of Ketoconazole on the Pharmacokinetics of GSK580416|Terminated||Phase 1|96||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 14:21:56.774768|2017-02-18 14:21:56.774768
NCT00680472|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-05-12||2015-03-17|April 2008||2008-04-01|May 2015|2015-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|Pain||HKT-500 in Adult Patients With Shoulder Pain|Protocol HKT-500-US08: A Randomized, Multicenter, Double-blind, Placebo-controlled, Two-week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Acute Shoulder Pain|Completed||Phase 3|368|Actual|Hisamitsu Pharmaceutical Co., Inc.||2|||f||||t||||||||||2017-02-18 14:21:56.882433|2017-02-18 14:21:56.882433
NCT00680459|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-01-29|2013-09-03||May 2008||2008-05-01|January 2014|2014-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Ethanol Locks for the Treatment of Central Venous Line Infections|Ethanol Locks for the Treatment of Central Venous Line Infections|Terminated||Phase 3|13|Actual|Baystate Medical Center||2||inability to enroll adequate number of patients|f||||f||||||||||2017-02-18 14:21:57.028623|2017-02-18 14:21:57.028623
NCT00680446|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-06-18|||April 2008||2008-04-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency|An Open-Label Study of Ig NextGen 16% Administered by Subcutaneous Infusion in Patients With Primary Immunodeficiency (PID).|Completed||Phase 3|41|Actual|CSL Limited||1|||f||||f||||||||||2017-02-18 14:21:57.440137|2017-02-18 14:21:57.440137
NCT00680433|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-03-27|||April 2008||2008-04-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT)|A Double-blind Randomised, Placebo-controlled Study of Adjunctive Ketamine Anaesthesia in ECT (Electroconvulsive Therapy)|Completed||Phase 4|83|Actual|Northside Clinic, Australia||2|||f||||f||||||||||2017-02-18 14:21:57.56401|2017-02-18 14:21:57.56401
NCT00680420|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-03-06|||June 2008||2008-06-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Observational|||DNA Microarray Study of Pancreas Cancer|DNA Microarray Analysis of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsies to Discriminate Benign From Malignant Pancreatic Lesions|Completed||N/A|27|Actual|Oregon Health and Science University|||1||f||||t||||||||||2017-02-18 14:21:57.665996|2017-02-18 14:21:57.665996
NCT00680407|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-12-23|2015-12-23||April 2008||2008-04-01|December 2015|2015-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|SyNCH||Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis|A Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Orally Administered Silymarin Preparation (Legalon®) for the Treatment of Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis|Completed||Phase 2|78|Actual|Madaus Inc||3|||f||||t||||||||||2017-02-18 14:21:57.752464|2017-02-18 14:21:57.752464
NCT00680394|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-03-11|||July 2007||2007-07-01|March 2013|2013-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol Alone|Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol Alone|Completed||N/A|440|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-02-18 14:21:58.223723|2017-02-18 14:21:58.223723
NCT00680381|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-08-04|||January 2004||2004-01-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|Transitions||Transitional Treatment of Adolescents in Family Therapy|Transitional Treatment of Adolescents in Family Therapy|Completed||Phase 1|90|Actual|Oregon Research Institute||3|||f||||f||||||||||2017-02-18 14:21:58.336975|2017-02-18 14:21:58.336975
NCT00680368|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2015-04-06|2014-08-29||March 2008||2008-03-01|August 2014|2014-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational||Physician residents who consented to participate in the study.|Resident Supervision Index: Assessing Feasibility and Validity|Resident Supervision Index: Assessing Feasibility and Validity|Completed||N/A|97|Actual|VA Office of Research and Development|Single site study limiting generalizability of findings||1||f||||f||||||None Retained|"~     The study did not involve a biospecimen. None was collected. None was retained.~   "|||2017-02-18 14:21:58.442705|2017-02-18 14:21:58.442705
NCT00680355|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2013-06-28|||August 2004||2004-08-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Bioavailability of Golden Rice Carotenoids in Humans|Bioavailability of Golden Rice Carotenoids in Humans|Completed||N/A|14|Actual|Tufts University||3|||f||||f||||||||||2017-02-18 14:21:58.682399|2017-02-18 14:21:58.682399
NCT00680342|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-03-11||2013-03-11|April 2008||2008-04-01|March 2013|2013-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|SyNCH||Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment|A Multicenter, Randomized, Double-masked, Placebo-controlled Phase II Study to Assess the Safety and Efficacy of a Standardized Orally Administered Silymarin Preparation (Legalon) for the Treatment of Patients With Chronic Hepatitis C Who Failed Conventional Antiviral Therapy|Completed||Phase 2|154|Actual|National Center for Complementary and Integrative Health (NCCIH)||3|||f||||t||||||||||2017-02-18 14:21:58.789364|2017-02-18 14:21:58.789364
NCT00680329|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2012-05-29|||May 2008||2008-05-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|GAS||Glaucoma Adherence Study, Spain|A Pilot Study of Adherence Assessment With the Travalert™ Dosing Aid in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma Who Are Treated With the Travoprost/Timolol Maleate Fixed Combination Every Evening|Completed||Phase 4|55|Actual|Alcon Research|||1||f||||f||||||||||2017-02-18 14:21:58.920247|2017-02-18 14:21:58.920247
NCT00680316|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2016-11-25|2010-08-31||June 2008||2008-06-01|November 2016|2016-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis|A Phase IV, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Pulmozyme® in 3- to 5-Year-Old Patients With Cystic Fibrosis|Terminated||Phase 4|3|Actual|Genentech, Inc.|Children were unable to perform forced oscillometry (FOT) or did not remain stable during the study. No efficacy analyses were performed because no patients had complete (pre- or post-treatment) data for pulmonary function tests, including FOT.|2||"Most patients were unable to perform the test being used to measure lung function, thus it~   became clear the study would not yield clinically meaningful data"|f||||||||||||||2017-02-18 14:21:59.026483|2017-02-18 14:21:59.026483
NCT00680303|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-15|||January 2008||2008-01-01|April 2008|2008-04-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Spacing Lidcombe Program Clinic Visits|The Effect of Spacing of Lidcombe Program Clinic Visits|Unknown status|Recruiting|Phase 2|120|Anticipated|University of Sydney||3|||f||||t||||||||||2017-02-18 14:21:59.339192|2017-02-18 14:21:59.339192
NCT00680290|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-19|||July 2007||2007-07-01|May 2008|2008-05-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||The Effect of Low Intensity Exercise on Quality of Life and Hemodynamics in Patients With Permanent Atrial Fibrillation|The Effect of Low Intensity Exercise on Quality of Life and Hemodynamics in Patients With Permanent Atrial Fibrillation|Unknown status|Recruiting|N/A|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 14:21:59.650446|2017-02-18 14:21:59.650446
NCT00680277|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2009-09-22|||April 2004||2004-04-01|September 2009|2009-09-01|May 2009|Anticipated|2009-05-01|March 2009|Anticipated|2009-03-01||Interventional|||Vitamin A Value of Spirulina Carotenoids in Humans|Vitamin A Value of Spirulina Carotenoids in Humans|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|Tufts University||2|||f||||f||||||||||2017-02-18 14:21:59.758716|2017-02-18 14:21:59.758716
NCT00680264|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2016-04-18|||June 2008||2008-06-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|PCPS||Prospective Study of Scoliosis in Children With Cerebral Palsy|Prospective Study of Scoliosis in Children With Cerebral Palsy|Recruiting||N/A|402|Anticipated|Setting Scoliosis Straight Foundation|||2||f||||f||||||||||2017-02-18 14:21:59.874471|2017-02-18 14:21:59.874471
NCT00680251|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2016-08-11|||May 2008||2008-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:22:00.024542|2017-02-18 14:22:00.024542
NCT00680238|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-19|||June 2004||2004-06-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Pregnancy/Implantation Rates Using a Day 3 Score Versus Graduated Embryo Score Plus a Biochemical Marker (sHLA-G)|Pregnancy and Implantation Rates When Embryos Are Selected Based on a Single Day 3 Score (Day 3)vs Graduated Embryo Score(GES) Plus Soluble Human Leukocyte Antigen-G Expression.|Completed||N/A|214|Actual|University of Stellenbosch||2|||f||||t||||||||||2017-02-18 14:22:00.073406|2017-02-18 14:22:00.073406
NCT00680186|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-16|2014-05-08|2012-05-04||April 2008||2008-04-01|December 2013|2013-12-01||||May 2011|Actual|2011-05-01||Interventional|RE-COVER II||Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)|A Phase III, Randomised, Double Blind, Parallel-group Study of the Efficacy and Safety of Oral Dabigatran Etexilate (150 mg Bid) Compared to Warfarin (INR 2.0-3.0) for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism, Following Initial Treatment (5-10 Days) With a Parenteral Anticoagulant Approved for This Indication|Completed||Phase 3|2589|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:22:00.211167|2017-02-18 14:22:00.211167
NCT00680173|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-03-11|||August 2006||2006-08-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|PBMC||Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients|Analysis of Gene Expression of PBMC in the Hepatitis C Virus Genotype 1b-infected Patients During Peg-interferon-α Plus Ribavirin Combination Therapy|Completed||Phase 4|30|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-02-18 14:22:01.754531|2017-02-18 14:22:01.754531
NCT00680160|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-15|||April 2006||2006-04-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)|An Open-Label, Multiple-Dose Study of the Absorption and Systemic Pharmacokinetics of AN2690 Applied as a 7.5% Solution to All Toenails of Adult Patients With Moderate to Severe Onychomycosis|Completed||Phase 1/Phase 2|15|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:22:01.882615|2017-02-18 14:22:01.882615
NCT00680147|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-05-19|||July 2008||2008-07-01|May 2015|2015-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers|HPV Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers|Completed||Phase 2|614|Actual|Syracuse University||1|||f||||f||||||||||2017-02-18 14:22:01.981313|2017-02-18 14:22:01.981313
NCT00680134|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-15|||June 2006||2006-06-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis|An Open Label, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied AN2690 1% and 5% Solutions for the Treatment of Adult Subjects With Onychomycosis of the Great Toenail|Completed||Phase 2|60|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:22:02.089122|2017-02-18 14:22:02.089122
NCT00680121|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2014-09-23|2014-04-28||July 2008||2008-07-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|August 2011|Actual|2011-08-01||Interventional|B1AS||High Dose Vitamin B1 to Reduce Abusive Alcohol Use|The Effectiveness of Benfotiamine in Reducing Abusive Drinking Among Family History Positive and Negative Alcoholics|Completed||Phase 4|120|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:22:02.202588|2017-02-18 14:22:02.202588
NCT00680108|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-08-26|||September 1999||1999-09-01|August 2015|2015-08-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution|A Double-Masked, Randomized, Placebo-Controlled, Rising-Dose Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution in Patients With Mild to Moderate Dry Eye Disease.|Completed||Phase 2|62|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 14:22:02.770999|2017-02-18 14:22:02.770999
NCT00680095|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-15|||January 2007||2007-01-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Cumulative Irritation Test|21-Day Cumulative Irritation Test|Completed||Phase 1|37|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 14:22:02.861007|2017-02-18 14:22:02.861007
NCT00680082|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2010-12-01|||February 2008||2008-02-01|December 2010|2010-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Observational Usage Study of Statins in Primary Care in France|Observational Usage Study of Statins in Primary Care in France|Completed||N/A|2100|Actual|AstraZeneca|||1||f||||t||||||||||2017-02-18 14:22:02.972689|2017-02-18 14:22:02.972689
NCT00680069|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-12-22||2011-07-20|November 2008||2008-11-01|August 2015|2015-08-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||H5N1 (Clade 2) Vaccination of Adults and Elderly|A Randomized, Double-Blinded, Phase I/II Study of the Safety, Reactogenicity, and Immunogenicity of an Inactivated Influenza Vaccine Derived From A/H5N1/Indonesia/05/05 (Clade 2) in Healthy Adults and Elderly Who Participated in a Previous A/H5N1/Vietnam/1203/2004 (Clade 1) Vaccine Study|Completed||Phase 1/Phase 2|517|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 14:22:05.52488|2017-02-18 14:22:05.52488
NCT00680056|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2010-01-12|2009-01-26||November 2007||2007-11-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients|Randomised Cross-over Study to Compare the Effect of Formoterol Plus Tiotropium Versus Formoterol Monotherapy on Breathlessness, Dynamic Hyperinflation and Exercise Tolerance in Moderate-to-severe Stable COPD Patients|Completed||Phase 4|33|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 14:22:05.637595|2017-02-18 14:22:05.637595
NCT00680043|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2012-06-22|2012-04-26||June 2008||2008-06-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA|AFX01-15: A Phase 2, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Correction of Anemia in Patients With Chronic Renal Failure (CRF) Undergoing Hemodialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment|Completed||Phase 2|114|Actual|Affymax||3|||f||||f||||||||||2017-02-18 14:22:06.038631|2017-02-18 14:22:06.038631
NCT00680030|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-15|||September 2007||2007-09-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|September 2008|Anticipated|2008-09-01||Observational|||Reversibility of Dysmotility After Gastric Banding|Reversibility of Esophageal Dysmotilities Associated With Gastric Banding After Conversion to Gastric Bypass|Unknown status|Enrolling by invitation|N/A|50|Anticipated|Cantonal Hospital of St. Gallen|||1||f||||t||||||||||2017-02-18 14:22:06.899583|2017-02-18 14:22:06.899583
NCT00680017|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2012-09-27|2012-04-25||June 2008||2008-06-01|September 2012|2012-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease|A 30-Week, Multicenter, Randomized, Double-Blind, Parallel-Group Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy in Dyslipidemic Subjects With Stage 3 Chronic Kidney Disease|Completed||Phase 3|280|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:22:06.999471|2017-02-18 14:22:06.999471
NCT00680004|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-16|||January 2007||2007-01-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|September 2008|Anticipated|2008-09-01||Observational|||Dynamic Computed Tomography Angiography (CTA) Follow-up for EndoVascular Aortic Replacement (EVAR)|The Value of Dynamic CTA During the Follow-up of EndoVascular Aortic Replacement (EVAR): a Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Radboud University|||2||f||||t||||||||||2017-02-18 14:22:07.626653|2017-02-18 14:22:07.626653
NCT00679991|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-04-08||2011-11-10|November 2008||2008-11-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients|A Phase 1-2, Multi-Center, Dose Escalation Study of a Single Dose of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease|Completed||Phase 1/Phase 2|66|Actual|Proteon Therapeutics||2|||f||||t||||||||||2017-02-18 14:22:07.721698|2017-02-18 14:22:07.721698
NCT00679978|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2009-09-17|||January 2001||2001-01-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Vertebral Fracture and Osteonecrosis Associated With High-dose Glucocorticoid|Vertebral Fracture and Osteonecrosis of the Femoral Head Associated With High-dose Glucocorticoid Therapy|Completed||Phase 4|60|Actual|Saitama Medical University|||1||f||||f||||||||||2017-02-18 14:22:07.833092|2017-02-18 14:22:07.833092
NCT00679965|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2012-07-26||2012-07-26|February 2006||2006-02-01|July 2012|2012-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Different Doses of a Novel Treatment for Onychomycosis|A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied AN2690 2.5%, 5.0%, and 7.5% Solutions vs. Vehicle for the Treatment of Adult Subjects With Onychomycosis of the Great Toenail|Completed||Phase 2|159|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:22:08.141384|2017-02-18 14:22:08.141384
NCT00679952|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2014-05-08|2011-03-13||March 2007||2007-03-01|May 2014|2014-05-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Interventional|||Closed Suction Drainage and Natural Drainage of the Pancreatic Duct in Pancreaticojejunostomy|Randomised Prospective Study of Clinical Outcomes After Closed Suction Drainage and Natural Drainage of the Pancreatic Duct in Pancreaticojejunostomy After Pancreatoduodenectomy|Completed||Phase 3|168|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:22:08.264622|2017-02-18 14:22:08.264622
NCT00679939|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-11-30|2011-01-07||April 2008||2008-04-01|November 2016|2016-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health|A 52 Week Randomized, Double-Blind, Multicenter, Mechanistic Study With a 24 Week Open-Label Follow-Up to Evaluate the Effect of AVANDIA TM on Bone in Postmenopausal Women With Type 2 Diabetes Mellitus|Completed||Phase 4|226|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:22:08.712522|2017-02-18 14:22:08.712522
NCT00679926|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2012-10-09|||May 2008||2008-05-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Kaletra and Viread in Antiretroviral Naïve Patients|A Phase IV Open Label Investigation of the Efficacy and Durability of Once Daily Antiretroviral Therapy With Kaletra and Viread in Antiretroviral Naïve Patients.|Terminated||Phase 4|6|Actual|Oklahoma State University Center for Health Sciences||1||Lack of enrollment|f||||f||||||||||2017-02-18 14:22:11.225649|2017-02-18 14:22:11.225649
NCT00679913|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2014-05-08|2014-04-07||November 2005||2005-11-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Standardization of Surgery on the Pancreatic Cancer|Randomized Controlled Study: Comparison Between Extended and Standard Pancreatoduodenectomy|Completed||Phase 3|244|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:22:11.340937|2017-02-18 14:22:11.340937
NCT00679900|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2010-11-29|||April 2008||2008-04-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|DREAMS||Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties|Comparison of the Safety and Efficacy of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties. A 4 Week, Randomized, Double-blind,Comparative, Parallel-group Study|Completed||Phase 3|283|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:22:11.681449|2017-02-18 14:22:11.681449
NCT00679887|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-16|||September 2003||2003-09-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Chronic Shoulder Pain Treated by Pressures With the Thumbs on the Trigger Points|Chronic Shoulder Pain of Myofascial Origin,a Randomised Clinical Trial Using Ischemic Compression Therapy.|Completed||Phase 1/Phase 2|59|Actual|Guy Hains Chiropractor||1|||f||||t||||||||||2017-02-18 14:22:11.795577|2017-02-18 14:22:11.795577
NCT00679874|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2011-10-02|||May 2008||2008-05-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|Cardiotox||Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR)|Characterization of the Cardiotoxic Effects of Chemotherapies With Anthracyclines and Trastuzumab for Breast Cancer by Contrast-enhanced Cardiovascular Magnetic Resonance Imaging (CMR).|Terminated||N/A|66|Anticipated|University of Calgary|||1|No subjects indentifiable|f||||t||||||||||2017-02-18 14:22:11.908228|2017-02-18 14:22:11.908228
NCT00679861|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-16|||October 2004||2004-10-01|May 2008|2008-05-01|June 2009|Anticipated|2009-06-01|August 2008|Anticipated|2008-08-01||Interventional|PRO GP||Smoking Interventions in General Medical Practices|Different Types of Proactive Smoking Interventions for General Medical Practices: An Implementation Study|Unknown status|Active, not recruiting|Phase 2|3215|Anticipated|University Medicine Greifswald||3|||f||||t||||||||||2017-02-18 14:22:12.018268|2017-02-18 14:22:12.018268
NCT00679848|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2017-01-09|||May 2008||2008-05-01|January 2017|2017-01-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|TRIM||Transoral Gastric Volume Reduction as an Intervention for Weight Management|Transoral Gastric Volume Reduction as an Intervention for Weight Management (TRIM): A Non-Randomized Multicenter Feasibility Study of Subjects With Class II or Low Grade Class III Obesity|Completed||Phase 1|18|Actual|C. R. Bard||1|||f||||f||||||||||2017-02-18 14:22:12.11155|2017-02-18 14:22:12.11155
NCT00679835|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-07-27|||May 2008||2008-05-01|July 2015|2015-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections|An Evaluation of the Pharmacokinetic Profile and Safety of a Single Dose of Daptomycin in Pediatric Subjects Aged Two to Six Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-positive Infection|Completed||Phase 1|24|Actual|Cubist Pharmaceuticals LLC||2|||f||||f||||||||||2017-02-18 14:22:12.204725|2017-02-18 14:22:12.204725
NCT00679822|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2014-02-12|||June 2007||2007-06-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||The Prevalence and Risk Factors of Sleep Disordered Breathing in a Heart Failure Program|The Prevalence and Risk Factors of Sleep Disordered Breathing in a Heart Failure Program|Completed||N/A|195|Actual|Ohio State University|||1||f||||f||||||||||2017-02-18 14:22:12.299368|2017-02-18 14:22:12.299368
NCT00679809|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-05-28|||October 2008||2008-10-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|July 2009|Actual|2009-07-01||Observational|||Safety, Fatigue, and Continuity in the Intensive Care Unit (ICU)|Safety, Fatigue, and Continuity in the ICU: a Pragmatic Mixed-methods Study|Completed||N/A|19|Actual|The Hospital for Sick Children|||1||f||||t||||||||||2017-02-18 14:22:12.399417|2017-02-18 14:22:12.399417
NCT00679796|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2012-10-25|||February 2008||2008-02-01|October 2012|2012-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||The Effectiveness of Varicella Vaccination in Children in Germany|The Effectiveness of Varicella Vaccination in Children in Germany|Completed||N/A|1012|Actual|GlaxoSmithKline|||2||f||||f||||||Samples With DNA|"~     samples from skin lesions~   "|||2017-02-18 14:22:12.50099|2017-02-18 14:22:12.50099
NCT00679783|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-10-14|2011-07-19||July 2008||2008-07-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|March 2010|Actual|2010-03-01||Interventional|||Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer|Phase II, Open Label, Non-Randomized Study of AZD2281 in the Treatment of Patients With Known BRCA or Recurrent High Grade Serous/ Undifferentiated Tubo-Ovarian Carcinoma and in Known BRCA or Triple Negative Breast Cancer to Determine Response Rate and Correlative Markers of Response|Active, not recruiting||Phase 2|112|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:22:12.647964|2017-02-18 14:22:12.647964
NCT00679770|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2012-07-26||2012-07-26|June 2006||2006-06-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of Different Doses of a Novel Treatment for Onychomycosis|A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied AN2690 2.5%, 5.0%, and 7.5% Solutions vs. Vehicle for the Treatment of Adult Subjects With Onychomycosis of the Great Toenail|Completed||Phase 2|28|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:22:14.535838|2017-02-18 14:22:14.535838
NCT00679757|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2010-06-09|||January 2008||2008-01-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||The Prevalence and Implications of Obstructive Sleep Apnea in the Population of a Wound Center|The Prevalence and Implications of Obstructive Sleep Apnea in the Population of a Wound Center|Completed||N/A|300|Actual|Ohio State University|||1||f||||f||||||||||2017-02-18 14:22:14.649373|2017-02-18 14:22:14.649373
NCT00679744|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-02-21|||May 2008||2008-05-01|February 2013|2013-02-01||||March 2010|Actual|2010-03-01||Interventional|||A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis|A Dose-Escalated, Double-Blind, Placebo-Controlled, Randomized Phase I Clinical Trial of Pyrimethamine in Patients Affected With Chronic GM2 Gangliosidosis (Tay-Sachs or Sandhoff Variants)|Withdrawn||Phase 1|0|Actual|Exsar Corporation||1||Due to lack of funding|f||||f||||||||||2017-02-18 14:22:14.745241|2017-02-18 14:22:14.745241
NCT00679731|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-01-22||2011-08-24|April 2008||2008-04-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis|A Phase 3, Multicenter, Randomized, Double-blind Study Comparing the Safety Efficacy of ABT-874 to Methotrexate in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|317|Actual|AbbVie||2|||f||||t||||||||||2017-02-18 14:22:14.868589|2017-02-18 14:22:14.868589
NCT00679718|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2015-08-26|||January 2000||2000-01-01|August 2015|2015-08-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution vs. Placebo in Patients With Moderate to Severe Dry Eye Disease|Completed||Phase 2|150|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 14:22:15.12253|2017-02-18 14:22:15.12253
NCT00679705|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2009-04-17|||May 2008||2008-05-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Influence of Tocolytical Medications on Hemodynamics (Central and Peripheral) and Vascular Function in a Pilot Study to Determine the Design of the Final Study and the Final Study Itself|Pilot Study: A Dose-Response Finding Study of Ritodrine (Pre-Par®) to Find the Highest Well Tolerated Dose in Young, Healthy, Female Volunteers. To Find the Size-Order of the Hemodynamical Effects of Ritodrine (PrePar®) and Atosiban (Tractocile®) to Determine the Relevance of a PK/PD-Modelling in the Final Study. Final Study: Investigating the Influence of Tocolytical Medications: Ritodrine (PrePar®) and Atosiban (Tractocile®) at the Clinical Dose on the Hemodynamics and Arterial Function in Healthy Female Volunteers, Compared to Placebo During Continuous Intravenous Infusion.|Completed||Phase 1|23|Actual|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 14:22:15.210162|2017-02-18 14:22:15.210162
NCT00679692|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-16|||September 2006||2006-09-01|January 2006|2006-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease|Insulin-Like Growth Factor-1,Insulin-Like Growth Factor Binding Protein-3 and Human Growth Hormone in Serum of Patients With Chronic Liver Disease and Possible Clinical Applications.|Completed||N/A|210|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||t||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:22:15.320506|2017-02-18 14:22:15.320506
NCT00679679|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-16|||January 2003||2003-01-01|May 2008|2008-05-01|December 2005|Actual|2005-12-01|September 2005|Actual|2005-09-01||Interventional|||Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome|Clinical Metabolic and Endocrine Parameters in Response to Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome: A Phase 4 Randomized, Double- Blind and Placebo Control Trial|Completed||Phase 4|30|Actual|Hospital Privado de Cordoba, Argentina||2|||f||||f||||||||||2017-02-18 14:22:15.409573|2017-02-18 14:22:15.409573
NCT00679666|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2011-07-29|||April 2008||2008-04-01|July 2011|2011-07-01|October 2010|Actual|2010-10-01|April 2010|Actual|2010-04-01||Interventional|CXL||Corneal Crosslinking in Keratoconus and Corneal Ectasia|Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia|Withdrawn||Phase 2/Phase 3|207|Anticipated|Ohio State University||2||Investigator no longer at university|f||||f||||||||||2017-02-18 14:22:15.545809|2017-02-18 14:22:15.545809
NCT00005214|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||April 1988||1988-04-01|May 2000|2000-05-01|March 1993||1993-03-01|||||Observational|||Epidemiology of Genetic Factors in Lipid Metabolism||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:20.569822|2017-02-18 18:15:20.569822
NCT00679653|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-05-16|||February 2002||2002-02-01|May 2008|2008-05-01||||December 2003|Actual|2003-12-01||Interventional|HOS||Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives|Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives|Completed||Phase 3|171|Actual|Abbott||3|||f||||f||||||||||2017-02-18 14:22:15.694602|2017-02-18 14:22:15.694602
NCT00679640|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2010-12-01|||January 2008||2008-01-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Observational|SISTOLA||Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France|Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France|Completed||N/A|450|Actual|AstraZeneca|||1||f||||t||||||||||2017-02-18 14:22:15.795518|2017-02-18 14:22:15.795518
NCT00679627|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-09-10|2013-04-23||June 2008||2008-06-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|April 2012|Actual|2012-04-01||Interventional|||A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo-controlled Trial of Long-term (2-year) Treatment of Galantamine in Mild to Moderately-Severe Alzheimer's Disease|Terminated||Phase 3|2051|Actual|Janssen Research & Development, LLC||2||"Due to a pre-specified imbalance of deaths between treatment groups, the DSMB recommended~   early termination of the trial"|f||||||||||||||2017-02-18 14:22:16.22054|2017-02-18 14:22:16.22054
NCT00679614|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2009-09-02|||September 2008||2008-09-01|September 2009|2009-09-01|November 2009|Anticipated|2009-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Effect of Combined Use of Naloxone and Tramacet on Postop Analgesia in Elderly Patients Having Joint Replacement Surgery|The Effect of the Combined Use of Naloxone and Tramacet on Postoperative Analgesia in Elderly Patients Having Joint Replacement Surgery: a Randomized Controlled Study.|Unknown status|Recruiting|Phase 3|51|Anticipated|Lawson Health Research Institute||3|||f||||f||||||||||2017-02-18 14:22:17.753307|2017-02-18 14:22:17.753307
NCT00679601|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-15|||March 2007||2007-03-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)|An Open-Label, Multiple-Dose Study of the Absorption and Systemic Pharmacokinetics of AN2690 Applied as a 7.5% Solution to All Toenails of Adult Patients With Moderate to Severe Onychomycosis|Completed||Phase 1/Phase 2|20|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:22:17.861588|2017-02-18 14:22:17.861588
NCT00679588|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-11-21||2011-07-22|April 2008||2008-04-01|November 2013|2013-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|SAVE-ABDO||Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery|A Multinational, Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery|Completed||Phase 3|4413|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:22:17.977384|2017-02-18 14:22:17.977384
NCT00679575|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2010-12-06|||March 2007||2007-03-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Statins and Risk of Myocardial Infarction in Real Life in France|Statins and Risk of Myocardial Infarction in Real Life in France|Completed||N/A|13171|Actual|AstraZeneca|||2||f||||t||||||||||2017-02-18 14:22:18.535257|2017-02-18 14:22:18.535257
NCT00679562|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2009-02-05|||March 2008||2008-03-01|February 2009|2009-02-01||||April 2008|Actual|2008-04-01||Interventional|||Lactacyd Radiance (Lactic Acid) Prophetic Patch Test|Skin Irritation : Prophetic Patch Test of Lactacyd Radiance|Completed||Phase 2|200|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:22:18.696503|2017-02-18 14:22:18.696503
NCT00679549|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2017-01-13|||March 2008||2008-03-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure|The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure|Active, not recruiting||N/A|170|Anticipated|Ohio State University||2|||f||||t||||||||||2017-02-18 14:22:18.784162|2017-02-18 14:22:18.784162
NCT00679536|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2014-01-22|||May 2008||2008-05-01|January 2014|2014-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors|Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors Using Fludarabine, Busulfan, 400 cGy Total Body Irradiation, and Thymoglobulin|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||t||||||||||2017-02-18 14:22:18.885444|2017-02-18 14:22:18.885444
NCT00679523|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2008-05-16|||November 2005||2005-11-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail|An Open-Label, Rising Multiple-Dose, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied AN2690 5.0% and 7.5% Solution for the Treatment of Adult Subjects With Onychomycosis of the Great Toenail|Completed||Phase 2|60|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:22:19.001489|2017-02-18 14:22:19.001489
NCT00679510|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2016-01-07|||February 2004||2004-02-01|January 2016|2016-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|RORA||Rosuvastatin in Rheumatoid Arthritis (RORA)|Phase 2: Effects of Rosuvastatin on Surrogate Markers for Cardiovascular Events in Patients With Rheumatoid Arthritis|Completed||Phase 2/Phase 3|50|Actual|University of Dundee||2|||f||||t||||||||Yes||2017-02-18 14:22:19.121472|2017-02-18 14:22:19.121472
NCT00679497|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2013-02-21|||June 2008||2008-06-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|RisVac02||A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection|A Phase I Study of MVA-B in Healthy Volunteers at Low Risk of HIV Infection|Completed||Phase 1|30|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 14:22:19.335259|2017-02-18 14:22:19.335259
NCT00679484|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2010-08-06|||June 2008||2008-06-01|August 2010|2010-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|OLMEBNP||Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24|A 24-Week Multicentre, Randomized, Double-Blind, Controlled, Parallel Group Non-Inferiority Study to Assess the Efficacy and Safety of Olmesartan Medoxomil Versus Candesartan Cilexetil in Patients With Symptomatic Heart Failure (NYHA II-IV)|Terminated||Phase 3|400|Anticipated|Daiichi Sankyo Inc.||2||Lack of subject recruitment|f||||f||||||||||2017-02-18 14:22:19.436894|2017-02-18 14:22:19.436894
NCT00548041|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2015-10-05|2015-04-20||April 2007||2007-04-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Rapid HIV Testing Program in the Emergency Department|Pilot Study to Evaluate a Rapid HIV Testing Program in the Emergency Department|Completed||N/A|100|Actual|Temple University||1|||f||||f||||||||||2017-02-18 15:09:37.530601|2017-02-18 15:09:37.530601
NCT00679471|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-06-03|||November 2007||2007-11-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Brain Structure and Development in Pre-Term and Full-Term Infants|The Relationship Between Early Brain Structure and Development in Full-Term and Pre-Term Infants|Completed||N/A|47|Actual|Christiana Care Health Services|||2||f||||f||||||||||2017-02-18 14:22:19.546524|2017-02-18 14:22:19.546524
NCT00679458|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2010-01-06|||September 2008||2008-09-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine|A Randomized, Double-blind, Cross-over Trial Comparing the Analgesic Potency and Side Effects of Buprenorphine and Ultra-low-dose Naloxone to Buprenorphine Alone|Completed||N/A|12|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:22:19.629128|2017-02-18 14:22:19.629128
NCT00679445|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2011-07-26|||December 2007||2007-12-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|ROSE||A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy|A Feasibility Study to Evaluate the Safety And Tolerability of the EPI-RAD90™ Ophthalmic System for the Treatment of Subfoveal Choroidal Neovascularization (CNV) in Patients With Age-Related Macular Degeneration (AMD) That Have Failed Primary Anti-VEGF Therapy|Completed||Phase 2|20|Anticipated|NeoVista||1|||f||||f||||||||||2017-02-18 14:22:19.727119|2017-02-18 14:22:19.727119
NCT00679432|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2014-07-03|2014-04-25||June 2008||2008-06-01|July 2014|2014-07-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional||Intent-to-Treat (ITT) population= primary population for efficacy/baseline characteristics analyses. ITT population= randomized patients who received study drug, and did not include patients with major entry criteria/GCP violations or normal histology at baseline (N= 509 randomized - 3[infectious colitis] - 17[normal histology at baseline] = 489).|(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis|Efficacy and Safety of New Oral Budesonide-MMX™ (CB-01-02) 6 mg and 9 mg Extended Release Tablet Formulations in Patients With Mild or Moderate, Active Ulcerative Colitis. A Multicenter, Randomized, Double-blind, Double Dummy Comparative Study Versus Placebo, With an Additional Reference Arm Evaluating Asacol® 2400 mg.|Completed||Phase 3|510|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-02-18 14:22:19.860172|2017-02-18 14:22:19.860172
NCT00679419|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2012-11-01|||December 2007||2007-12-01|October 2012|2012-10-01|May 2013|Anticipated|2013-05-01|May 2011|Actual|2011-05-01||Observational|CAD-REF||Coronary Artery Disease and Renal Failure Registry|Coronary Artery Disease and Renal Failure Registry|Unknown status|Active, not recruiting|N/A|3352|Anticipated|Institut für Klinisch-Kardiovaskuläre Forschung GmbH|||6||f|||||||||||"~     Urine, whole blood, serum~   "|||2017-02-18 14:22:20.984705|2017-02-18 14:22:20.984705
NCT00679406|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2012-06-15|||June 2008||2008-06-01|June 2012|2012-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|BBTIMV1||Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 1|Treatment of Insomnia in Military Veterans:Phase 1|Completed||N/A|12|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:22:21.115045|2017-02-18 14:22:21.115045
NCT00679393|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2015-02-10|||February 2004||2004-02-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|Sanders IV||Comparative Study of Fixation or Fusion of Calcaneal Fractures|A Prospective Randomized Multicentre Clinical Trial Comparing Open Reduction Internal Fixation With Primary Subtalar Fusion in Patients With Severely Comminuted (Sanders IV), Displaced, Intra-articular Fractures of the Calcaneus|Completed||N/A|26|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 14:22:21.223464|2017-02-18 14:22:21.223464
NCT00679380|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2014-07-03|2014-04-25||June 2008||2008-06-01|July 2014|2014-07-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional||Baseline characteristics were analyzed with the ITT population, defined as randomized patients who received study drug, had no entry criteria/GCP violation, and had abnormal mucosal histology at baseline. ITT population=410 patients: 511 - 101 patients who were not randomized, had entry criteria/GCP violation, or had normal histology at baseline.|(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis|Efficacy and Safety of Oral Budesonide-MMX™ (CB-01-02) 6 mg and 9 mg Extended Release Tablets in Patients With Mild or Moderate Active Ulcerative Colitis. A Multicentre, Randomised, Double-Blind, Double-Dummy, Comparative Study Versus Placebo With an Additional Reference Arm Evaluating Entocort®EC|Completed||Phase 3|514|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-02-18 14:22:21.340919|2017-02-18 14:22:21.340919
NCT00679367|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2016-03-16|||May 2008||2008-05-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|MRD||Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis|A Phase II Trial of MRD (Melphalan, Lenalidomide and Dexamethasone) for Patients With AL Amyloidosis|Completed||Phase 2|16|Actual|Boston Medical Center||1|||f||||t||||||||||2017-02-18 14:22:22.568752|2017-02-18 14:22:22.568752
NCT00679354|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2014-05-05|2014-01-06||June 2008||2008-06-01|October 2011|2011-10-01|July 2011|Actual|2011-07-01|October 2010|Actual|2010-10-01||Interventional|||Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy|Cilengitide (EMD 121974) (IND# 59073) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:22:22.784299|2017-02-18 14:22:22.784299
NCT00679341|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-12-09|2013-02-22||September 2008||2008-09-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|November 2010|Actual|2010-11-01||Interventional|||A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease|A Randomized, Multicenter, Phase ii Study of the Efficacy and Safety of Trastuzumab-MCC-DM1 vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease|Completed||Phase 2|137|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:22:23.134207|2017-02-18 14:22:23.134207
NCT00679328|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2011-06-09|||February 1992||1992-02-01|June 2011|2011-06-01|December 1999|Actual|1999-12-01|August 1996|Actual|1996-08-01||Interventional|||OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions|Study #91-01 - A Randomized Study of the Stryker OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions|Completed||N/A|122|Actual|Olympus Biotech Corporation||2|||f||||f||||||||||2017-02-18 14:22:23.906139|2017-02-18 14:22:23.906139
NCT00679315|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-06-07|||June 2008||2008-06-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female|Efficacy and Safety of Alfuzosin for the Treatment of Non-neurogenic Voiding Dysfunction in Female: An 8 Week Prospective, Randomized Double Blind, Placebo-Controlled, Parallel Group Study (Phase Ⅱ)|Completed||Phase 2|190|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 14:22:24.02751|2017-02-18 14:22:24.02751
NCT00679302|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2014-03-28|2013-01-29||July 2006||2006-07-01|March 2014|2014-03-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management|A Double Blinded Randomized Controlled Trial for the Management of Pediatric Community Acquired Skin Abscesses - To Treat or Not to Treat With Antibiotics|Completed||Phase 4|161|Actual|St. Louis University|Small sample size with large number of loss to follow up at the 3 month mark.|2|||f||||t||||||||||2017-02-18 14:22:24.159171|2017-02-18 14:22:24.159171
NCT00679289|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2015-08-20|||March 2008||2008-03-01|August 2015|2015-08-01|October 2015|Anticipated|2015-10-01|April 2015|Actual|2015-04-01||Interventional|||Phase II Study of KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Melanoma|Phase II Study of the Anti-Ganglioside GD3 Mouse/Human Chimeric Antibody KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Melanoma|Active, not recruiting||Phase 2|50|Anticipated|Ludwig Institute for Cancer Research||3|||f||||t||||||||||2017-02-18 14:22:24.766389|2017-02-18 14:22:24.766389
NCT00679276|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2010-06-04|||May 2008||2008-05-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Treatment Outcomes of Vaginal Prolapse Repair|Treatment Outcomes of Vaginal Prolapse Repair|Completed||N/A|291|Actual|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 14:22:24.910441|2017-02-18 14:22:24.910441
NCT00679263|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2011-12-14|2011-02-16||February 2008||2008-02-01|November 2011|2011-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma|A Randomized, Single-blind, Parallel Group, Placebo-controlled, Dose Rate Escalation Study Evaluating the Safety and Effects of MN-221 in Subjects Diagnosed With Moderate to Severe Asthma|Completed||Phase 2|17|Actual|MediciNova||2|||f||||f||||||||||2017-02-18 14:22:25.009557|2017-02-18 14:22:25.009557
NCT00679250|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2008-05-15|||November 2005||2005-11-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis|A Placebo Controlled Trial to Evaluate The Effects of Levocetirizine on Nasal Allergen Challenge And Adenosine Monophosphate Challenge In Patients With Intermittent and Persistent Allergic Rhinitis|Completed||Phase 4|25|Actual|University of Dundee||2|||f||||f||||||||||2017-02-18 14:22:25.535064|2017-02-18 14:22:25.535064
NCT00679237|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2014-04-11|||September 2007||2007-09-01|April 2014|2014-04-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Interventional|SPREK!||Risk Reduction in Coronary Heart Disease|Risk Reduction in Coronary Heart Disease - a Prospective Randomized Study|Recruiting||N/A|2000|Anticipated|Sorlandet Hospital HF||2|||f||||f||||||||||2017-02-18 14:22:25.646067|2017-02-18 14:22:25.646067
NCT00679224|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-11-07|||June 2008||2008-06-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|VOLT||An Observational Study For Ambrisentan|A Post-Marketing Observational Surveillance Programme for Ambrisentan (VOLT)|Completed||N/A|800|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 14:22:25.782866|2017-02-18 14:22:25.782866
NCT00679211|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-05-23|2013-03-12||August 2008||2008-08-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|September 2009|Actual|2009-09-01||Interventional|||A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer|A Phase II, Single-Arm, Open-Label Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer|Completed||Phase 2|110|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 14:22:26.002501|2017-02-18 14:22:26.002501
NCT00679198|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-01-14|||March 2009||2009-03-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||Improving Osteoporosis Care in High-Risk Home Health Patients|Improving Osteoporosis Care in High-Risk Home Health Patients Through a High-Intensity Intervention|Completed||N/A|667|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:22:26.366013|2017-02-18 14:22:26.366013
NCT00679185|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2012-06-20|||January 2007||2007-01-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema|Effects of Expressive Writing in Breast Cancer Survivors With Lymphedema|Completed||N/A|107|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:22:26.462218|2017-02-18 14:22:26.462218
NCT00679172|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2009-01-30|||May 2008||2008-05-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults|A Randomised, Double-Blind, Placebo-Controlled, Single Dose, Dose Escalation Study to Determine the Immunogenicity, Safety and Tolerability of S. Typhi (Ty2 aroC‾ssaV‾) ZH9 at Doses of 5.0 x 10E9 CFU, 7.5 x 10E9 CFU, 1.1 x 10E10 and 1.7 x 10E10 CFU and 1.7 x 10E10 CFU, Following Oral Administration to Healthy, Typhoid Vaccine naïve Subjects in the USA.|Completed||Phase 2|187|Actual|Emergent BioSolutions||2|||f||||f||||||||||2017-02-18 14:22:26.587694|2017-02-18 14:22:26.587694
NCT00679159|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2010-02-08|||February 2008||2008-02-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of MVA85A in Healthy Children and Infants|A Phase II Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Healthy Children and Infants After BCG Vaccination at Birth|Completed||Phase 2|168|Actual|University of Oxford||5|||f||||t||||||||||2017-02-18 14:22:26.785267|2017-02-18 14:22:26.785267
NCT00679146|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2010-06-10|||April 2008||2008-04-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TIOKET||Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain|Efficacy and Safety of a Fixed Combination (Thiocolchicoside 8 mg + Ketoprofen 100 mg ) Compared to Thiocolchicoside 8 mg Administered Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain|Completed||Phase 3|334|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:22:26.892452|2017-02-18 14:22:26.892452
NCT00678132|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2017-01-24|||April 24, 2008||2008-04-24|September 7, 2012|2012-09-07|November 23, 2010|Actual|2010-11-23|November 23, 2010|Actual|2010-11-23||Interventional|||AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers|A Phase I Combination Study of AZD2281 and Cisplatin Plus Gemcitabine in Adults With Solid Tumors|Completed||Phase 1|23|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:22:48.170124|2017-02-18 14:22:48.170124
NCT00679133|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2015-01-06|||April 2008||2008-04-01|January 2015|2015-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies|Open-Label Dose-Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies|Completed||Phase 1|47|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 14:22:26.998886|2017-02-18 14:22:26.998886
NCT00679120|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2014-10-21|||May 2009||2009-05-01|October 2014|2014-10-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types|Oxford Partial Knee Replacement: A Randomized Clinical Trial of Three Implant Types.|Active, not recruiting||N/A|75|Anticipated|University of Aarhus||3|||f||||t||||||||||2017-02-18 14:22:27.110441|2017-02-18 14:22:27.110441
NCT00679107|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2011-06-09|||June 1999||1999-06-01|June 2011|2011-06-01|July 2005|Actual|2005-07-01|December 2000|Actual|2000-12-01||Interventional|||A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions|A Prospective, Randomized, Controlled, Multicenter, Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions|Completed||N/A|48|Actual|Olympus Biotech Corporation||2|||f||||f||||||||||2017-02-18 14:22:27.225321|2017-02-18 14:22:27.225321
NCT00679094|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2016-12-28|||June 2007||2007-06-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Bowman-Birk Inhibitor Concentrate in Healthy Men|Phase I Single Dose Safety and Pharmacokinetic Study of a New Formulation of Bowman Birk Inhibitor Concentrate, Delivered as an Orange Juice Suspension to Healthy Male Volunteers Between 18 and 65 Years of Age|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:22:27.330403|2017-02-18 14:22:27.330403
NCT00679081|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2012-01-09|2011-10-10||May 2008||2008-05-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root Coverage|A Prospective, Randomized, Controlled Pilot Study of CelTx(TM) (Apligraf®) as an Alternative to Tissue From the Palate in the Treatment of Gingival Recession Requiring Root Coverage|Terminated||Phase 1/Phase 2|15|Actual|Organogenesis|This study was terminated early due to suboptimal clinical outcomes. Due to two study design changes, the data could not be combined and analyzed for effectiveness (ie, no secondary effectiveness endpoints were tested).|2|||f||||f||||||||||2017-02-18 14:22:27.441285|2017-02-18 14:22:27.441285
NCT00679068|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2015-08-19|||May 2008||2008-05-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Bosentan on Respiratory Mechanics|Effects of 12 Weeks Treatment With Bosentan on Respiratory Mechanics in Patients With Pulmonary Hypertension|Terminated||Phase 4|4|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1||lack of recruitment of patients|f||||t||||||||||2017-02-18 14:22:27.957735|2017-02-18 14:22:27.957735
NCT00679055|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2016-04-05|2015-01-30||March 2007||2007-03-01|March 2016|2016-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)|An Exploratory Double-Blind, Placebo Controlled, Randomized, 12-Week Oral Dose Study to Evaluate the Effects of MK0736 on Atherosclerotic Disease Biomarkers in Lower Extremity Plaque Excised From Patients With Peripheral Arterial Disease|Terminated||Phase 1|14|Actual|Merck Sharp & Dohme Corp.|Study terminated due to lack of recruitment.|2||Lack of recruitment|f||||f||||||||||2017-02-18 14:22:28.061367|2017-02-18 14:22:28.061367
NCT00679042|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2016-12-12|||June 2007||2007-06-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|August 2017|Anticipated|2017-08-01||Interventional|||Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol|Islet Transplantation in Type 1 Diabetic Patients Using the UIC Protocol, Phase 3|Recruiting||Phase 3|1000|Anticipated|University of Illinois at Chicago||1|||f||||t||||||||||2017-02-18 14:22:28.456136|2017-02-18 14:22:28.456136
NCT00679029|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-15|2011-08-08|||May 2008||2008-05-01|August 2011|2011-08-01||||December 2013|Anticipated|2013-12-01||Interventional|||Combination Chemotherapy and Bevacizumab in Treating Women With HER2/Neu-Negative Stage II or Stage III Breast Cancer|Adjuvant Doxorubicin, Cyclophosphamide Followed by Avastin Given With Paclitaxel and Gemcitabine for Stage II and III Breast Cancer That Does Not Over-express HER-2/Neu|Unknown status|Active, not recruiting|Phase 2|26|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:22:28.587728|2017-02-18 14:22:28.587728
NCT00679003|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2015-04-14|||September 2007||2007-09-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|Managing IBD||Managing Inflammatory Bowel Disease|Psychosocial Intervention for Children With IBD|Completed||N/A|190|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:22:28.72175|2017-02-18 14:22:28.72175
NCT00678990|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2016-01-28|||April 2016||2016-04-01|January 2016|2016-01-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Heparinized Islets in Clinical Islet Transplantation|Open Study to Evaluate Safety and Efficacy of Allogenic Islet Transplantation Using Islets Coated With Immobilised Heparin|Not yet recruiting||N/A|10|Anticipated|Corline Biomedical AB||1|||f||||t||||||||No||2017-02-18 14:22:28.832906|2017-02-18 14:22:28.832906
NCT00678977|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-04-11|||April 2008||2008-04-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors|A Phase I, Open-label, Study of the Safety, Tolerability and Pharmacokinetics of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors.|Completed||Phase 1|22|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:22:28.952405|2017-02-18 14:22:28.952405
NCT00678964|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2008-05-15|||June 2006||2006-06-01|May 2008|2008-05-01||||November 2008|Anticipated|2008-11-01||Interventional|TIE||Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Multicentre Randomised Phase II Trial of Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients (=/> 70 Years) With Advanced Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|260|Anticipated|LungenClinic Grosshansdorf||2|||f||||t||||||||||2017-02-18 14:22:29.070793|2017-02-18 14:22:29.070793
NCT00678938|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2008-05-14|||October 2004||2004-10-01|May 2008|2008-05-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Smoking Interventions in the General Population|General Population Based Interventions for Smokers Not Ready to Quit: Testing Smoking Reduction vs. Abstinence Oriented Computer Expert Systems|Unknown status|Active, not recruiting|Phase 2|1462|Actual|University Medicine Greifswald||3|||f||||t||||||||||2017-02-18 14:22:29.236315|2017-02-18 14:22:29.236315
NCT00678912|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2012-09-18|||September 2007||2007-09-01|September 2012|2012-09-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Weaning Children From Mechanical Ventilation:Computer-driven System Versus Usual Care|Single Center Randomized Clinical Trial Comparing Weaning From Mechanical Ventilation With Computer-driven System vs Usual Care in Children|Completed||Phase 3|30|Actual|St. Justine's Hospital||2|||f||||t||||||||||2017-02-18 14:22:29.424476|2017-02-18 14:22:29.424476
NCT00678899|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2015-06-19|2014-09-10||April 2008||2008-04-01|June 2015|2015-06-01|July 2014|Actual|2014-07-01|June 2012|Actual|2012-06-01||Interventional|||Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System|Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant|Completed||N/A|50|Actual|Cochlear||1|||f||||f||||||||||2017-02-18 14:22:29.536963|2017-02-18 14:22:29.536963
NCT00678886|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2016-08-25||2013-01-04|July 2008||2008-07-01|August 2016|2016-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|DEFEND-1||Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1|Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes - DEFEND|Completed||Phase 3|272|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 14:22:29.797181|2017-02-18 14:22:29.797181
NCT00678873|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2009-12-14|||March 2008||2008-03-01|August 2008|2008-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|SILC||Single Incision Laparoscopic Cholecystectomy|Single Incision Laparoscopic Cholecystectomy|Completed||Phase 1|20|Anticipated|North Texas Veterans Healthcare System||1|||f||||f||||||||||2017-02-18 14:22:30.134308|2017-02-18 14:22:30.134308
NCT00678860|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2017-01-24|||May 9, 2008||2008-05-09|October 31, 2011|2011-10-31|October 31, 2011||2011-10-31|||||Observational|||Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires|Pilot Validation Study of Computer Administration of Vision Targeted Quality of Life Instruments|Completed||N/A|147|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:22:30.236405|2017-02-18 14:22:30.236405
NCT00678847|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2008-05-15|||March 2008||2008-03-01|March 2008|2008-03-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Chronic Venous ULcer TReatment Analyzing Bio-Electrical Stimulation Therapy|Chronic Venous ULcer TReatment Analyzing Bio-Electrical Stimulation Therapy|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Kingfisher Healthcare||2|||f||||f||||||||||2017-02-18 14:22:30.322876|2017-02-18 14:22:30.322876
NCT00678834|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2014-09-08|2014-07-02||March 2006||2006-03-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||The healthy participants included: age 21–40 y, good health, nonsmoker, nonpregnant or nonbreastfeeding, and no recent (past 6 mo) or current use of supplements containing vitamin E. The surgical participants group included adipose, brain, cardiac muscle, and liver tissue of the surgical participants age 21 and older.|Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol|Human Tissue Distribution of Orally Supplemented Natural Vitamin E Tocotrienol|Completed||Early Phase 1|80|Actual|Ohio State University||3|||f||||t||||||||||2017-02-18 14:22:30.438133|2017-02-18 14:22:30.438133
NCT00678821|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2017-01-24|||May 6, 2008||2008-05-06|September 2, 2016|2016-09-02|September 23, 2015|Actual|2015-09-23|September 23, 2015|Actual|2015-09-23||Interventional|||Aerobic Exercise in Patients With Pulmonary Hypertension|The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Pulmonary Hypertension: Initial Studies for Establishing Guidelines|Completed||Phase 2|97|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:22:30.933678|2017-02-18 14:22:30.933678
NCT00678808|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2016-09-01|||April 2008||2008-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:22:31.029855|2017-02-18 14:22:31.029855
NCT00678795|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-06-13|2012-07-18||August 2002||2002-08-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis|A Double Blind, Randomised, Placebo Controlled, Parallel Group Study of Cannabis Based Medicine (CBM) Extract, in Patients Suffering Detrusor Overactivity Associated With Multiple Sclerosis.|Completed||Phase 3|135|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:22:31.085485|2017-02-18 14:22:31.085485
NCT00678782|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2008-05-15|||April 2005||2005-04-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis|Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis: a Placebo Controlled, Single-Blind, Crossover-Trial, With Randomisation of Treatment Sequence|Completed||Phase 2|31|Actual|University of Padova||1|||f||||t||||||||||2017-02-18 14:22:31.941323|2017-02-18 14:22:31.941323
NCT00678769|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2015-11-03|||May 2008||2008-05-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|June 2013|Actual|2013-06-01||Interventional|||Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer|Phase I Study of IMC-A12 (NSC# 742460) in Combination With Temsirolimus CCI-779 (NSC# 683864) in Patients With Advanced Cancers|Completed||Phase 1|72|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 14:22:32.053902|2017-02-18 14:22:32.053902
NCT00678756|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2010-06-07|||March 2008||2008-03-01|June 2010|2010-06-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|VITAKET||Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol|Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol|Unknown status|Active, not recruiting|Phase 2|12|Anticipated|Technische Universität Dresden||1|||f||||t||||||||||2017-02-18 14:22:32.177627|2017-02-18 14:22:32.177627
NCT00678743|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2008-05-14|||August 2007||2007-08-01|May 2008|2008-05-01|September 2009|Anticipated|2009-09-01|August 2009|Anticipated|2009-08-01||Interventional|||An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin|An Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate Simvastatin 20 mg Plus Omacor 4g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia|Unknown status|Active, not recruiting|Phase 4|13|Actual|Provident Clinical Research||1|||f||||f||||||||||2017-02-18 14:22:32.27084|2017-02-18 14:22:32.27084
NCT00678730|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2017-02-02|||July 2007||2007-07-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Pharmacogenetics of Cannabinoid Response|Pharmacogenetics of Cannabinoid Response|Active, not recruiting||Phase 1|162|Anticipated|Yale University||2|||f||||||||||||||2017-02-18 14:22:32.364515|2017-02-18 14:22:32.364515
NCT00678717|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2010-09-23|||February 2008||2008-02-01|September 2010|2010-09-01|February 2009|Anticipated|2009-02-01|January 2009|Anticipated|2009-01-01||Interventional|AFTSCSCVP||Autonomic Function Testing and Spinal Cord Stimulation in Chronic Visceral Pain|Autonomic Function Testing and Spinal Cord Stimulation: Implications for Successful Therapy in Chronic Visceral Pain|Terminated||Phase 4|60|Anticipated|Vanderbilt University||2||Lack of funding|f||||f||||||||||2017-02-18 14:22:32.46339|2017-02-18 14:22:32.46339
NCT00678704|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-12-18|||January 2004||2004-01-01|December 2014|2014-12-01|November 2004|Actual|2004-11-01|||||Interventional|||BAY38-9456 - Pivotal Trial for Diabetes Patient|A Randomized, Placebo-controlled, Double-blind, Multi-centre, Parallel Group Study to Investigate the Efficacy and Safety of BAY 38-9456 in Males With Diabetes Suffering From Erectile Dysfunction|Completed||Phase 3|790|Actual|Bayer||3|||f||||f||||||||||2017-02-18 14:22:35.093875|2017-02-18 14:22:35.093875
NCT00678691|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2014-12-09|2012-09-06||August 2007||2007-08-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue||Completed||Phase 4|55|Actual|State University of New York - Upstate Medical University||2|||f||||f||||||||||2017-02-18 14:22:35.214546|2017-02-18 14:22:35.214546
NCT00678678|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-05-13||||||April 2008|2008-04-01||||||||Interventional|||Chest Physiotherapy After Bariatric Aurgery - A Comparison Between Incentive Spirometry and Expiratory Positive Airway Pressure (Epap)|Chest Physiotherapy After Bariatric Surgery - a Comparison Between Incentive Spirometry and Epap|Completed||N/A|||Universidade Metodista de Piracicaba||2|||f||||||||||||||2017-02-18 14:22:35.588732|2017-02-18 14:22:35.588732
NCT00678665|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2008-05-14|||May 2008||2008-05-01|May 2008|2008-05-01||||||||Observational|||Changes in Heart Rate in Response to Heat Pressure and Neural Stimulation|Initial Study for the Definition in Heart Rate Changes in Response to Heat Pressure and Neural Stimulation|Unknown status|Not yet recruiting|N/A|20|Anticipated|Soroka University Medical Center|||1||f||||t||||||||||2017-02-18 14:22:35.672455|2017-02-18 14:22:35.672455
NCT00678652|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2010-12-01|||April 2008||2008-04-01|December 2010|2010-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|HOPS||Group B Meningococcal Vaccine|A Phase 1 Dose-Escalation Study of the Safety and Immunogenicity of Three Injections, Given at 0, 6, and 12 Weeks, of Group B Meningococcal 8570 HOPS-G NOMV Vaccine Administered Intramuscularly to Healthy Subjects at 10, 25, 50, or 75 μg With Adjuvant|Completed||Phase 1|36|Anticipated|Walter Reed Army Institute of Research (WRAIR)||1|||f||||f||||||||||2017-02-18 14:22:35.76929|2017-02-18 14:22:35.76929
NCT00678639|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2010-04-28|2010-03-19||January 2008||2008-01-01|April 2010|2010-04-01||||March 2009|Actual|2009-03-01||Interventional|||Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain|Randomized Cost Comparison of Cardiac MRI Use in ED Patients With Chest Pain|Completed||N/A|110|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 14:22:35.861124|2017-02-18 14:22:35.861124
NCT00678626|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2015-04-30|||April 2009||2009-04-01|April 2015|2015-04-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer|A Randomized Phase 2, Open-Label Study Of CP-751,871 In Combination With Docetaxel And Docetaxel Alone As A First Line Treatment Of Patients With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:22:36.546096|2017-02-18 14:22:36.546096
NCT00678613|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2008-05-14|||July 2007||2007-07-01|May 2008|2008-05-01||||||||Interventional|||Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial||Unknown status|Recruiting|Phase 2/Phase 3|250|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||||||||||||2017-02-18 14:22:36.655908|2017-02-18 14:22:36.655908
NCT00678600|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2013-11-19|||September 2007||2007-09-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care|Optimizing HIV Disease-Specific Provider Alerts: A Randomized Controlled Informatics Trial Comparing Electronic Health Record (EHR) vs. Non-EHR Provider Alerts|Completed||N/A|1011|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||f||||||||||2017-02-18 14:22:36.776262|2017-02-18 14:22:36.776262
NCT00678587|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2013-02-07|2010-10-10||June 2008||2008-06-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|ELEVATE||Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures|Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study to Evaluate the Safety and Efficacy of Eltrombopag to Reduce the Need for Platelet Transfusion in Thrombocytopenic Subjects With Chronic Liver Disease Undergoing Elective Invasive Procedures|Terminated||Phase 3|292|Actual|GlaxoSmithKline||2||GSK decision|f||||t||||||||||2017-02-18 14:22:36.906434|2017-02-18 14:22:36.906434
NCT00678574|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2017-01-03|||March 1998||1998-03-01|January 2017|2017-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder|The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder|Completed||Phase 4|20|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-02-18 14:22:38.263912|2017-02-18 14:22:38.263912
NCT00678561|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2010-11-12||2010-08-24|October 2008||2008-10-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Topical CP-690,550 For Chronic Plaque Psoriasis|Phase 2A Randomized, Double-Blind, Vehicle-Controlled, Intra-Individual Comparison Trial Assessing Safety, Toleration, Pharmacokinetics And Pilot Efficacy Of 4 Weeks Treatment With Topical CP-690,550 In Chronic Plaque Psoriasis|Completed||Phase 2|81|Actual|Pfizer||8|||f||||f||||||||||2017-02-18 14:22:38.358745|2017-02-18 14:22:38.358745
NCT00678548|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2015-04-07|||October 2008||2008-10-01|April 2015|2015-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Guided Imagery on Patients With Chronic Pain Related to Spinal Cord Injury|Effect of Positive Guided Imagery on Patients With in or Below-level Chronic Pain Related to Spinal Cord Injury|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||2||Due to other projects priority|f||||f||||||||||2017-02-18 14:22:38.493718|2017-02-18 14:22:38.493718
NCT00678535|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2014-07-11|2013-03-30||June 2008||2008-06-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|March 2012|Actual|2012-03-01||Interventional|EXPAND||Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer|Open-label, Randomized, Controlled, Multicenter Phase III Study Investigating Cetuximab in Combination With Capecitabine (Xeloda, X) and Cisplatin (P) Versus XP Alone as First-line Treatment for Subjects With Advanced Gastric Adenocarcinoma Including Adenocarcinoma of the Gastroesophageal Junction|Completed||Phase 3|904|Actual|Merck KGaA||2|||f||||t||||||||||2017-02-18 14:22:38.620298|2017-02-18 14:22:38.620298
NCT00678522|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2008-05-14|||September 2007||2007-09-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes|The Acute Effect of Atorvastatin on Renal Sodium Excretion, Glomerular Filtration Rate, Tubular Function and Vasoactive Hormones in Patients With Non-Insulin Dependent Type II Diabetes.|Completed||Phase 4|25|Anticipated|Regional Hospital Holstebro||1|||f||||t||||||||||2017-02-18 14:22:40.122108|2017-02-18 14:22:40.122108
NCT00678509|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2009-12-28|||May 2008||2008-05-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*2402 in Treating Patients With Refractory Breast Cancer|Terminated||Phase 1/Phase 2|14|Anticipated|Tokyo University||1||Lack of financial support|f||||t||||||||||2017-02-18 14:22:40.235462|2017-02-18 14:22:40.235462
NCT00678496|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2009-09-23|||October 2008||2008-10-01|September 2009|2009-09-01||||||||Interventional|CoSMoS||Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis|Computerised Cognitive Behavioural Therapy for Treatment of Depression in MS (CoSMoS): Clinical Trial Pilot Study|Completed||Phase 2|24|Anticipated|University of Sheffield||3|||f||||f||||||||||2017-02-18 14:22:40.351613|2017-02-18 14:22:40.351613
NCT00678483|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2009-06-16|||April 2008||2008-04-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|MODERATO||Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients|A Randomized, Double-Blind, Parallel-Group, Multicenter, Multinational Study to Assess the Long-Term Effect, Over 1 Year, of Rimonabant 10 mg in Comparison With Rimonabant 20 mg After an Initial Treatment Period of 6 Months With Rimonabant 20 mg in Overweight or Obese Patients|Terminated||Phase 3|331|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 14:22:40.470127|2017-02-18 14:22:40.470127
NCT00678470|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2013-02-19|2012-11-20||September 2007||2007-09-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis|A Single Arm, Open Label Study to Explore if Response to Intralesional Alefacept Injections Prior to the Standard Course of Intramuscular Treatment Can Predict Clinical Outcomes in Patients With Moderate to Severe Chronic Plaque Psoriasis|Completed||N/A|18|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 14:22:40.583709|2017-02-18 14:22:40.583709
NCT00678457|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-01-29|||January 2007||2007-01-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial|Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial|Completed||Phase 2|40|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 14:22:40.819235|2017-02-18 14:22:40.819235
NCT00678444|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-10|2016-01-27|||April 2008||2008-04-01|January 2016|2016-01-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional|||Patient Satisfaction Regarding Timing of Clean Intermittent Self-Catheterization Teaching After Prolapse or Incontinence Surgery||Completed||N/A|199|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:22:40.942924|2017-02-18 14:22:40.942924
NCT00678431|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-11-13|||January 2008||2008-01-01|November 2012|2012-11-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Randomized Trial of a Nutritional Supplement in Alzheimer's Disease|A Single Center, Multi-site, Randomized, Double-blind, Placebo-controlled Trial of Resveratrol With Glucose and Malate (RGM) to Slow the Progression of Alzheimer's Disease|Completed||Phase 3|27|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:22:41.04897|2017-02-18 14:22:41.04897
NCT00678418|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2016-12-21|2010-12-20||June 2008||2008-06-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|October 2009|Actual|2009-10-01||Interventional|||ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence|Efficacy and Safety of VIVITROL® (Naltrexone for Extended-release Injectable Suspension) in Adults With Opioid Dependence|Completed||Phase 3|250|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-02-18 14:22:41.164704|2017-02-18 14:22:41.164704
NCT00678405|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2010-06-24|||August 2008||2008-08-01|June 2010|2010-06-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Trial of a Breathlessness Intervention Service for Intractable Breathlessness|Phase III Randomized Controlled Trial of a Breathlessness Intervention Service for Intractable Breathlessness.|Unknown status|Recruiting|Phase 3|120|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 14:22:41.699482|2017-02-18 14:22:41.699482
NCT00678392|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2016-03-18|2012-02-25||September 2008||2008-09-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|August 2010|Actual|2010-08-01||Interventional|||Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer|Axitinib (AG-013736) As Second Line Therapy For Metastatic Renal Cell Cancer: Axis Trial|Completed||Phase 3|723|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:22:41.842985|2017-02-18 14:22:41.842985
NCT00678379|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-12-10|||April 2008||2008-04-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Pediatric Tonsillectomy Pain Reduction Study|Pediatric Tonsillectomy Pain Reduction Study, a Randomized, Placebo Controlled, Double-Blind Clinical Trial Using Clonidine and Local Anesthetics|Completed||Phase 3|120|Anticipated|Vanderbilt University||3|||f||||t||||||||||2017-02-18 14:22:43.116959|2017-02-18 14:22:43.116959
NCT00678366|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-10-25|||May 2008||2008-05-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Evaluation of Adding Small Amounts of Oxygen to the CO2 Pneumoperitoneum Upon Pain and Inflammation|Evaluation of Adding Small Amounts of Oxygen to the CO2 Pneumoperitoneum Upon Pain and Inflammation|Completed||Phase 3|60|Anticipated|University Hospital, Gasthuisberg||2|||f||||f||||||||||2017-02-18 14:22:43.228127|2017-02-18 14:22:43.228127
NCT00678353|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2011-06-09|||May 2007||2007-05-01|June 2011|2011-06-01|August 2007|Actual|2007-08-01|||||Observational|||Study of OP-1 Putty in Uninstrumented Posterolateral Fusions|Prospective Data Collection From the Stryker Biotech Pivotal IDE Study of OP-1 Putty in Uninstrumented Posterolateral Fusions|Completed||N/A|202|Actual|Olympus Biotech Corporation|||1||f||||f||||||||||2017-02-18 14:22:43.334506|2017-02-18 14:22:43.334506
NCT00678340|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2013-03-05|||September 2007||2007-09-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Randomized Trial of Two Ablation Catheters in Paroxysmal Atrial Fibrillation|A Single Centre, Randomized, Single Blinded Trial of Wide Area Circumferential Ablation With Pulmonary Vein Isolation Compared to a Multipolar, Circular Ablation Catheter in Patients With Paroxysmal Atrial Fibrillation|Completed||Phase 4|178|Actual|University College London Hospitals||2|||f||||t||||||||||2017-02-18 14:22:43.449489|2017-02-18 14:22:43.449489
NCT00678327|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2013-08-23|||August 2008||2008-08-01|June 2009|2009-06-01||||September 2012|Anticipated|2012-09-01||Interventional|||Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma|A Randomized Phase III Trial to Assess Response Adapted Therapy Using FDG-PET Imaging in Patients With Newly Diagnosed, Advanced Hodgkin Lymphoma|Unknown status|Recruiting|Phase 3|1200|Anticipated|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 14:22:43.550171|2017-02-18 14:22:43.550171
NCT00678314|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2008-05-13|||January 2004||2004-01-01|May 2008|2008-05-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters|Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters|Completed||Phase 4|88|Actual|Region Örebro County||3|||f||||t||||||||||2017-02-18 14:22:43.674585|2017-02-18 14:22:43.674585
NCT00678301|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2016-10-06||2009-09-25|June 2008||2008-06-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™|Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A Co-administered With Zilbrix™ Hib and Polio Sabin™|Completed||Phase 3|365|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:22:43.778097|2017-02-18 14:22:43.778097
NCT00678288|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2014-11-24|2010-09-10||April 2008||2008-04-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.|A Phase II, Randomized, Open-label, Multicenter, Study Evaluating the Efficacy of Sorafenib Alone and Sorafenib in Combination With Low Dose Interferon Alpha-2a as Second-line Treatment of Sunitinib Failure in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|16|Actual|Bayer|The study was terminated early by the Sponsor due to low accrual. No efficacy analyses were performed.|2|||f||||f||||||||||2017-02-18 14:22:43.904357|2017-02-18 14:22:43.904357
NCT00678275|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2015-05-12|||October 2006||2006-10-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|February 2014|Actual|2014-02-01||Interventional|||Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia|Prophylaxis of Chronic Graft-versus-host Disease (cGvHD) With or Without Anti-T-lymphocyte-globulin (ATG Fresenius) Prior Allogeneic Peripheral Stem Cell Transplantation From HLA-identical Siblings After Myeloablative Conditioning in Patients With Acute Leukemia: A Randomized Phase III-study|Completed||Phase 3|161|Actual|Universitätsklinikum Hamburg-Eppendorf||2|||f||||f||||||||||2017-02-18 14:22:44.617664|2017-02-18 14:22:44.617664
NCT00678262|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2010-09-19|||May 2008||2008-05-01|September 2010|2010-09-01|October 2008||2008-10-01|October 2008|Actual|2008-10-01||Observational|HRVW1||Changes in Heart Rate in Response to Cold Pressor Test|Changes in Heart Rate in Response to Cold Pressor Test|Completed||N/A|20|Anticipated|Soroka University Medical Center|||1||f||||f||||||||||2017-02-18 14:22:44.721805|2017-02-18 14:22:44.721805
NCT00678249|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2011-05-10|2009-02-20||January 2001||2001-01-01|May 2011|2011-05-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Pivotal Study for the FLAIR Endovascular Stent Graft|A Prospective, Multi-Center, Randomized Evaluation of an IMPRA/Bard ePTFE Encapsulated Carbon Lined Nitinol Endoluminal Device for AV Access Graft Stenoses|Completed||N/A|227|Actual|C. R. Bard||3|||f||||t||||||||||2017-02-18 14:22:44.816165|2017-02-18 14:22:44.816165
NCT00678236|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-08-19|||June 2008||2008-06-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Migration and Bone Density Study Comparing 2 Types of Bone Cement in the OptiPac Bone Cement Mixing System|A Migration and Bone Density Study Comparing Refobacin Bone Cement R vs. Refobacin Plus Bone Cement in the OptiPac Bone Cement Mixing System. A Prospective Randomized Study on Primary Total Knee Arthroplasty|Completed||N/A|54|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:22:45.519528|2017-02-18 14:22:45.519528
NCT00678210|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2012-11-19|2012-11-19||July 2008||2008-07-01|November 2012|2012-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase 2B, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial Evaluating The Efficacy And Safety Of Dose Regimens With Oral CP-690,550 In The Treatment Of Subjects With Moderate To Severe Chronic Plaque Psoriasis|Completed||Phase 2|197|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:22:45.657529|2017-02-18 14:22:45.657529
NCT00678197|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2015-04-30|||April 2003||2003-04-01|April 2015|2015-04-01|September 2007||2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Philippine Child Health and Policy Experiment|Philippine Child Health and Policy Experiment|Completed||N/A|||University of California, San Francisco||3|||f||||||||||||||2017-02-18 14:22:47.429918|2017-02-18 14:22:47.429918
NCT00678184|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2008-05-14|||January 2007||2007-01-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake|The Effect of Acute HMG-CoA-Reductase Inhibition (Atorvastatin) on Renal Sodium Excretion, Renal Hemodynamics, Tubular Function and Vasoactive Hormones in Healthy Subjects During Normal and High Sodium Intake|Completed||Phase 4|23|Actual|Regional Hospital Holstebro||1|||f||||t||||||||||2017-02-18 14:22:47.525125|2017-02-18 14:22:47.525125
NCT00678171|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2014-01-03||2014-01-03|February 2007||2007-02-01|January 2014|2014-01-01|March 2010|Actual|2010-03-01|March 2008|Actual|2008-03-01||Interventional|||A Pilot Study to Evaluate an Osteogenic Protein 1 (OP-1) Putty Spinal System and an Autograft Spinal System|A Pilot Study to Evaluate an OP-1 Putty Spinal System and an Autograft Spinal System in Patients Requiring Transforaminal Lumbar Interbody Fusion of the Spine|Completed||N/A|30|Actual|Olympus Biotech Corporation||2|||f||||f||||||||||2017-02-18 14:22:47.637093|2017-02-18 14:22:47.637093
NCT00678158|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2015-11-16|||August 2006||2006-08-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Study Using High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue Masses, Lymph Node, or Bone|Phase I Dose Escalation Study Using High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue Masses, Lymph Node, or Bone|Completed||Phase 1|68|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 14:22:47.752305|2017-02-18 14:22:47.752305
NCT00678119|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2013-07-11||2013-07-09|January 2008||2008-01-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment|A Phase II Study Testing the Safety and Activity of AGS-003 as an Immunotherapeutic in Subjects With Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination With Sunitinib|Completed||Phase 2|25|Actual|Argos Therapeutics||1|||f||||t||||||||||2017-02-18 14:22:48.278202|2017-02-18 14:22:48.278202
NCT00678106|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2009-10-09|||September 2008||2008-09-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections|A Phase 1, Open Label, Single Dose Study To Investigate The Pharmacokinetics, Safety And Tolerability Of Dalbavancin In Hospitalized Adolescents, Aged 12 Through 17 Years Receiving Standard Intravenous Anti-Infective Treatment For Bacterial Infections|Completed||Phase 1|10|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:22:48.413528|2017-02-18 14:22:48.413528
NCT00678093|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-05-13|||January 2005||2005-01-01|May 2008|2008-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|Mulligan||Effects of a Mulligan Mobilisation in the Lumbar Flexion Range of Asymptomatic Subjects|The Effects of the Mulligan Mobilisation Sustained Natural Apophyseal Glide (SNAG) in the Lumbar Flexion Range of Asymptomatic Subjects as Measured by the Zebris CMS20 3-D Motion Analysis System|Completed||N/A|49|Actual|University of Manchester||1|||f||||f||||||||||2017-02-18 14:22:48.525949|2017-02-18 14:22:48.525949
NCT00678080|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2014-07-23|||September 2008||2008-09-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|July 2014|Anticipated|2014-07-01||Interventional|||Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes|A Randomized, Controlled Trial of Metformin Versus Insulin in Women With Type 2 Diabetes Mellitus During Pregnancy in a Population With Severe Health Disparities|Unknown status|Recruiting|N/A|100|Anticipated|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 14:22:48.63904|2017-02-18 14:22:48.63904
NCT00678067|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-05-16|||June 2005||2005-06-01|May 2008|2008-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|DHA-RICHOIL||Effects of Docosahexaenoic and Eicosapentaenoic Acids in Hypercholesterolemic Children Plus Diet on Docosahexaenoic Acid (DHA) Status|Effects of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid(EPA)Supplementation on DHA Plasmatic Status and Blood Lipid Profile in Hypercholesterolemic Children in Addition to National Cholesterol Education Program Step I Diet|Completed||N/A|36|Actual|University of Milan||3|||f||||f||||||||||2017-02-18 14:22:48.762921|2017-02-18 14:22:48.762921
NCT00678054|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-05-22|||April 1999||1999-04-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)|A Phase II Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for the Treatment of Patients With Evidence of Serologic (PSA) Progression After Definitive Therapy for Localized Prostate Cancer|Active, not recruiting||Phase 2|30|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 14:22:48.863152|2017-02-18 14:22:48.863152
NCT00678041|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-10|2016-08-03|2016-05-10||May 2008||2008-05-01|August 2016|2016-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|APPIC|This is a randomized, double-blind, placebo-controlled clinical trial|Nitrofurantoin and Urinary Tract Infections (UTIs)|A Randomized, Double-blind, Placebo-controlled Trial Examining the Effect of Nitrofurantoin Prophylaxis in Women Performing Clean Intermittent Self-catheterization (CISC) After Surgery for Urinary Incontinence and/or Pelvic Organ Prolapse|Terminated||N/A|10|Actual|University of Pittsburgh|Study terminated prior to accumulation of any data. Participating subjects were withdrawn prior to measuring any outcome data|2||Inadequate patient recruitment|f||||f||||||||No||2017-02-18 14:22:48.967806|2017-02-18 14:22:48.967806
NCT00678028|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-17|2009-04-22|||February 2008||2008-02-01|April 2009|2009-04-01||||||||Observational|||Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection|Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection|Completed||N/A|200|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||Samples With DNA|"~     whole blood for genetic test and serum for MBL test~   "|||2017-02-18 14:22:49.308736|2017-02-18 14:22:49.308736
NCT00678015|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2014-03-11|2014-01-28||May 2008||2008-05-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer|A Phase II Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non-Metastatic Recurrent Prostate Cancer|Terminated||Phase 2|12|Actual|University of California, San Francisco|Per protocol - accrual was stopped early after a pre-planned interim analysis showed no significant PSA declines after 3 cycles of treatment among the first 12 patients enrolled.|1||"Per protocol - interim analysis showed no significant PSA declines among the first 12 patients~   after 3 cycles of treatment"|f||||t||||||||||2017-02-18 14:22:49.398367|2017-02-18 14:22:49.398367
NCT00678002|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2016-04-21|||October 2008||2008-10-01|April 2016|2016-04-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Quality of Life in Pediatric Transplant Patients|Quality of Life and Vulnerability in Pediatric Solid Organ Transplant Recipients|Enrolling by invitation||N/A|150|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 14:22:49.655932|2017-02-18 14:22:49.655932
NCT00677989|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2009-02-06|||May 2008||2008-05-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Study on Laparoscopic Operation for Perforated Appendicitis|The Role of Oxidized Proteins and Free Radicals on Laparoscopic Operation for Perforated Appendicitis|Unknown status|Recruiting|N/A|60|Anticipated|Far Eastern Memorial Hospital|||2||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:22:49.758553|2017-02-18 14:22:49.758553
NCT00677976|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2017-02-10|||June 2007||2007-06-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|June 2013|Actual|2013-06-01||Observational|fMRI||Use of Functional Magnetic Resonance Imaging (fMRI) to Study Brain Activation in Children With Irritable Bowel Syndrome|Use of Functional Magnetic Resonance Imaging (fMRI) to Study Brain Activation Following Rectal Stimulation in Children With Irritable Bowel Syndrome|Active, not recruiting||N/A|17|Actual|Medical College of Wisconsin|||2||f||||f||||||||||2017-02-18 14:22:49.876231|2017-02-18 14:22:49.876231
NCT00533234|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-03-14|||December 2009||2009-12-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|||||Observational|||ExploR® Modular Radial Head Data Collection|ExploR® Modular Radial Head Data Collection|Terminated||N/A|4|Actual|Zimmer Biomet|||1|There was a lack of business need to continue this data collection.|f||||f||||||||||2017-02-18 15:15:08.197309|2017-02-18 15:15:08.197309
NCT00677963|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-04-19|||June 2009||2009-06-01|April 2011|2011-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation|Contrast-enhanced Ultrasound and Magnetic Resonance Imaging for the Evaluation of Neovascularisation in Carotid Artery Plaques|Completed||N/A|18|Anticipated|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 14:22:49.984874|2017-02-18 14:22:49.984874
NCT00677950|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2011-06-09|||October 2001||2001-10-01|June 2011|2011-06-01|November 2005|Actual|2005-11-01|November 2003|Actual|2003-11-01||Interventional|||OP-1 Putty for Posterolateral Fusions|OP-1 Putty for Posterolateral Fusions|Completed||N/A|336|Actual|Olympus Biotech Corporation||2|||f||||f||||||||||2017-02-18 14:22:50.086746|2017-02-18 14:22:50.086746
NCT00677937|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2014-12-04|||May 2009||2009-05-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|July 2014|Actual|2014-07-01||Interventional|PREVENTION||A Diabetes Prevention Study Targeting High Risk Individuals With Education and Ongoing Support|A Randomised Controlled Trial to Investigate an Educational Programme and Continuous Monitoring to Prevent Diabetes in Individuals With Screen Detected Pre-diabetes in a Multi-ethnic Population|Completed||N/A|748|Actual|University Hospitals, Leicester||2|||f||||t||||||||||2017-02-18 14:22:50.21333|2017-02-18 14:22:50.21333
NCT00677924|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2011-11-21|2011-09-12||April 2008||2008-04-01|November 2011|2011-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|GEN206||Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer|A Dose-Escalation, Randomized Phase I/II Trial of Zalutumumab - a Human Monoclonal Anti-EGF Receptor Antibody - With or Without Irinotecan Chemotherapy in Cetuximab Refractory Colorectal Cancer Patients Who Have Failed Standard Chemotherapy and Progressed During or Within 3 Months of Stopping Cetuximab-Based Therapy|Terminated||Phase 1/Phase 2|9|Actual|Genmab|The trial was prematurely closed when 9 out of 97 patients were enrolled. The trial design was originally divided in two parts. Patient allocation was terminated before Part 2 was started.|2||Due to changes in portfolio review|f||||t||||||||||2017-02-18 14:22:50.322663|2017-02-18 14:22:50.322663
NCT00677911|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2008-05-13|||February 2007||2007-02-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Immunologic Response to Negative Cognition in Persons With Chronic Pain|Immunologic Response to Negative Cognition in Persons With Chronic Pain|Completed||Early Phase 1|47|Actual|Oregon Health and Science University||1|||f||||t||||||||||2017-02-18 14:22:50.743954|2017-02-18 14:22:50.743954
NCT00677898|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2015-04-06|2014-09-05||March 2010||2010-03-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|March 2012|Actual|2012-03-01||Interventional|||A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)|A Patient-Centered Approach to Improve Screening for Side Effects of SGAs|Completed||N/A|239|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:22:50.852555|2017-02-18 14:22:50.852555
NCT00677885|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2017-01-24|||May 9, 2008||2008-05-09|August 25, 2014|2014-08-25|August 25, 2014||2014-08-25|||||Observational|||P-glycoprotein Function in Brain Diseases|Measurement of P-Glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:22:51.305017|2017-02-18 14:22:51.305017
NCT00677872|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2009-07-28|||May 2008||2008-05-01|July 2009|2009-07-01||||December 2008|Anticipated|2008-12-01||Interventional|||An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease||Terminated||Phase 2|40|Anticipated|Epix Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 14:22:51.404753|2017-02-18 14:22:51.404753
NCT00677859|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-14|2012-01-03|||July 2008||2008-07-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia|A Phase I, Multicenter, Dose-Escalation Trial Evaluating Maximum-Tolerated Dose of Single and Repeated Administration of Allogeneic MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia|Completed||Phase 1|36|Actual|Athersys, Inc||2|||f||||t||||||||||2017-02-18 14:22:51.497783|2017-02-18 14:22:51.497783
NCT00677846|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2008-05-13|||April 2007||2007-04-01|May 2008|2008-05-01|August 2008|Anticipated|2008-08-01|July 2008|Anticipated|2008-07-01||Observational|||Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging|Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging, a Follow up Study|Unknown status|Recruiting|N/A|31|Anticipated|University Hospital Freiburg|||1||f||||f||||||||||2017-02-18 14:22:51.626689|2017-02-18 14:22:51.626689
NCT00677833|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2014-05-27|2014-05-27||June 2008||2008-06-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa|Phase 2/3, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa|Completed||Phase 2/Phase 3|361|Actual|Pfizer|Cohort 1 was a screening cohort, meant for safety evaluation, but not included in the efficacy assessments.|2|||f||||t||||||||||2017-02-18 14:22:51.833845|2017-02-18 14:22:51.833845
NCT00677820|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2010-10-12|2010-08-20||June 2008||2008-06-01|October 2010|2010-10-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|MI-MA182||A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Trivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|Completed||Phase 4|300|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 14:22:53.362753|2017-02-18 14:22:53.362753
NCT00677807|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2011-08-18|2011-07-22||May 2008||2008-05-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)|A 26-week Extension to a 26-week Treatment, Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptive, Seamless, Parallel-group Study to Assess Safety, Tolerability and Efficacy of Two Doses of Indacaterol (150 and 300 µg o.d.) in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|415|Actual|Novartis||3|||f||||f||||||||||2017-02-18 14:22:54.057953|2017-02-18 14:22:54.057953
NCT00677794|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-13|2015-09-23|||March 2008||2008-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|August 2013|Actual|2013-08-01||Interventional|||Small Bowel Cleansing Prior to Video Capsule Endoscopy Examination|Small Bowel Cleansing Prior to Video Capsule Endoscopy Examination: a Randomized, Blinded, Controlled Trial|Completed||Phase 4|198|Actual|Queen's University||3|||f||||f||||||||||2017-02-18 14:22:55.089995|2017-02-18 14:22:55.089995
NCT00677781|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-09-05|||February 2008||2008-02-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|December 2008|Actual|2008-12-01||Observational|||Impact of Microparticles on Postoperative Complications in Surgical Patients|The Impact of Microparticles on Inflammatory Responses During Visceral and Cardiac Surgery|Completed||N/A|108|Actual|University of Bern|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:22:55.200651|2017-02-18 14:22:55.200651
NCT00677768|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2016-06-02|||April 2008||2008-04-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|BIO_ALS-01||Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)|A Multicenter Study for the Validation of ALS Biomarkers|Completed||N/A|475|Actual|Massachusetts General Hospital|||4||f||||f||||||Samples With DNA|"~     650 blood samples (plasma and serum)will be collected from four groups: ALS volunteers~     diagnosed with ALS, volunteers with pure lower or pure upper motor neuron diseases,~     volunteers with other neurological diseases and healthy control volunteers.~      300 cerebrospinal fluid (CSF) samples will be collected from all four groups: ALS volunteers~     diagnosed with ALS, volunteers with pure lower or pure upper motor neuron diseases,~     volunteers with other neurological diseases and healthy control volunteers.~      Up to 600 DNA samples will also be collected from all 4 groups: ALS volunteers diagnosed~     with ALS, volunteers with pure lower or pure upper motor neuron diseases, volunteers with~     other neurological diseases and healthy control volunteers.~   "|||2017-02-18 14:22:55.299579|2017-02-18 14:22:55.299579
NCT00677755|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2008-05-15|||October 2004||2004-10-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Medical Abortion for Emergency Contraception Failure|Medical Termination of Pregnancy Due to Emergency Contraception Failure: A Randomized Trial Comparing Mifepristone Combined Misoprostol and Misoprostol Alone.|Completed||N/A|394|Actual|Taizhou Hospital||2|||f||||f||||||||||2017-02-18 14:22:57.843485|2017-02-18 14:22:57.843485
NCT00677742|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-12-11|||June 2007||2007-06-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|April 2009|Actual|2009-04-01||Interventional|SixPack||The Impact of Pack Supply on Birth Control Pill Continuation|Impact of Pack Supply on Oral Contraception Continuation|Completed||N/A|700|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 14:22:57.990358|2017-02-18 14:22:57.990358
NCT00677729|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-11-12|||November 2008||2008-11-01|November 2015|2015-11-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Hypertonic Saline to Reduce Hospital Admissions in Bronchiolitis|Inhaled Hypertonic Saline to Reduce Hospital Admissions in Infants With Viral Bronchiolitis (HS in ER Study)|Completed||Phase 2|81|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 14:22:58.086398|2017-02-18 14:22:58.086398
NCT00677716|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2014-04-23|||July 2007||2007-07-01|April 2014|2014-04-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse|Open-label, Dose Confirmation Study of Interstitial 131I-chTNT-1/B MAb (Cotara®) for the Treatment of Glioblastoma Multiforme (GBM) at First Relapse|Completed||Phase 2|41|Actual|Peregrine Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:22:58.193041|2017-02-18 14:22:58.193041
NCT00677703|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-11-16|||January 2008||2008-01-01|November 2012|2012-11-01|July 2012|Actual|2012-07-01|April 2010|Actual|2010-04-01||Interventional|||Txt Now 2 Decrease Pregnancies L8r: A Study to Evaluate the Effect of Daily Text Message Reminders on Pill Continuation|The Effect of Text Message Reminders on Contraceptive Continuation, a Randomized Controlled Trial|Completed||N/A|968|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 14:22:58.301914|2017-02-18 14:22:58.301914
NCT00677690|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-11-04|2009-01-05||January 2007||2007-01-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|March 2008|Actual|2008-03-01||Interventional|||Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)|Combination of Pulmonary Rehabilitation and Neuromuscular Electrical Stimulation and in COPD Patients: a Randomized Clinical Trial of Efficacy|Completed||Phase 3|83|Actual|Fondazione Salvatore Maugeri||2|||f||||f||||||||||2017-02-18 14:22:58.414799|2017-02-18 14:22:58.414799
NCT00677677|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2014-12-30|||May 2008||2008-05-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|April 2011|Actual|2011-04-01||Interventional|||Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients|Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients.|Completed||Phase 3|50|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 14:22:58.858328|2017-02-18 14:22:58.858328
NCT00677664|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2008-05-13|||July 2006||2006-07-01|May 2008|2008-05-01|September 2008|Anticipated|2008-09-01|July 2008|Anticipated|2008-07-01||Interventional|||Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation|Effects of Glatiramer Acetate (Copaxone) in the Nerve Fiber Layer Thickness and Retinal Function in Diabetic Patients After Pan- Retinal Photocoagulation (PRP), a Double- Masked Randomized Clinical Trial.|Unknown status|Active, not recruiting|Phase 4|30|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 14:22:58.952573|2017-02-18 14:22:58.952573
NCT00677651|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2009-08-17|||April 2008||2008-04-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Sex Differences in Gene Expression in Human Adipose Tissue|Sex Differences in Gene Expression in Human Adipose Tissue|Completed||N/A|10|Anticipated|University of California, San Diego|||2||f||||t||||||Samples With DNA|"~     Blood, Fat tissue from abdomen and buttock~   "|||2017-02-18 14:22:59.269873|2017-02-18 14:22:59.269873
NCT00677638|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2009-12-02|||June 2008||2008-06-01|December 2009|2009-12-01|December 2014|Anticipated|2014-12-01|January 2010|Anticipated|2010-01-01||Interventional|||Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease|Catheter-Based Transapical Implantation of the Ventor Embracer™ Heart Valve Prosthesis in Patients With Severe Aortic Valve Disease|Unknown status|Active, not recruiting|N/A|30|Anticipated|Ventor Technologies||1|||f||||f||||||||||2017-02-18 14:22:59.379166|2017-02-18 14:22:59.379166
NCT00677625|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2016-06-20|||June 2003||2003-06-01|June 2016|2016-06-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Pediatric Liver Database|Pediatric Liver Disease and Liver Transplant Database|Recruiting||N/A|500|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 14:22:59.474274|2017-02-18 14:22:59.474274
NCT00677612|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2009-12-28|||May 2008||2008-05-01|January 2009|2009-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*0201 in Combination With Tegafur/Uracil/Folinate in Treating Patients With Refractory Colorectal Cancer|Terminated||Phase 1/Phase 2|14|Anticipated|Tokyo University||1||Lack of financial support|f||||t||||||||||2017-02-18 14:22:59.579253|2017-02-18 14:22:59.579253
NCT00677599|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2011-05-12|||May 2008||2008-05-01|May 2011|2011-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|FLAVO||The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 Diabetes|Reducing Cardiovascular Risk With Dietary Flavonoids in Post Menopausal Women With Type 2 Diabetes|Completed||N/A|152|Anticipated|University of East Anglia||2|||f||||f||||||||||2017-02-18 14:22:59.698885|2017-02-18 14:22:59.698885
NCT00677586|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2009-03-24|||January 2000||2000-01-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||I Phase Surgery Versus Staged Surgery for Synchronous Liver Metastasis of Colorectal Cancer||Completed||Phase 4|120|Actual|Fudan University||2|||f||||t||||||||||2017-02-18 14:22:59.8005|2017-02-18 14:22:59.8005
NCT00677573|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2008-05-09|||May 2008||2008-05-01|May 2008|2008-05-01|November 2008|Anticipated|2008-11-01|October 2008|Anticipated|2008-10-01||Interventional|||Efficacy of Urinary Follicle-Stimulating Hormone (FSH) Among Poor Responders|Comparison of Urinary Purified Follicle-Stimulating Hormone (FSH) and Rec-FSH Among Poor Responders Undergoing Ovarian Stimulation With GnRH Antagonist|Unknown status|Not yet recruiting|N/A|||German Hospital, Istanbul||1|||f||||f||||||||||2017-02-18 14:22:59.899116|2017-02-18 14:22:59.899116
NCT00677560|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2008-05-13|||August 2008||2008-08-01|May 2008|2008-05-01||||||||Observational|||Impulse Oscillometry and Airway Inflammation in Chronic Obstructive Pulmonary Disease|Impulse Oscillometry and Airway Inflammation in Chronic Obstructive Pulmonary Disease|Unknown status|Not yet recruiting|N/A|105|Anticipated|Imperial College London|||3||f||||t||||||||||2017-02-18 14:23:00.005559|2017-02-18 14:23:00.005559
NCT00677547|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2011-09-13|||November 2007||2007-11-01|September 2011|2011-09-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Observational|||Cell-mediated Immune Response to Influenza Vaccine|Humoral and Cell-mediated Immune Response to Influenza Vaccine in Kidney Tranpslant Recipients.|Completed||Phase 1|100|Anticipated|University of Alberta|||2||f||||f||||||||||2017-02-18 14:23:00.153827|2017-02-18 14:23:00.153827
NCT00677534|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2014-04-10|2012-06-11||May 2008||2008-05-01|April 2014|2014-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||A total of 11 subjects were consented to the study. 1 subject was hospitalized before starting any procedures and did not complete any study procedures. 1 subject did not qualify for the study after consenting. Two subjects withdrew after consenting.|Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease|Exploring the Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease|Completed||N/A|7|Actual|University of Kansas Medical Center|This was a pilot study using a small number of patients. Further studies are needed to validate these findings in larger groups of patients.|1|||f||||f||||||||||2017-02-18 14:23:00.276004|2017-02-18 14:23:00.276004
NCT00677521|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2013-08-16|||January 2007||2007-01-01|August 2013|2013-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)|A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)|Terminated||Phase 2|1|Actual|The Hospital for Sick Children||1||poor recruitment and no student currently interested in working on this project.|f||||f||||||||||2017-02-18 14:23:00.5296|2017-02-18 14:23:00.5296
NCT00677508|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2017-02-10|||September 2005|Actual|2005-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|March 2012|Actual|2012-03-01||Observational|||Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling|Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling|Active, not recruiting||N/A|800|Anticipated|Medical College of Wisconsin|||3||f||||f||||||||||2017-02-18 14:23:00.632953|2017-02-18 14:23:00.632953
NCT00677495|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2014-04-24|||May 2007||2007-05-01|April 2014|2014-04-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Gluten-free Diet in Gluten-genetically Predisposed Subjects|Usefulness of Gluten-free Diet in Gluten-genetically Predisposed Subjects Positive to Intestinal-mucosa Anti-transglutaminase Antibodies|Unknown status|Active, not recruiting|N/A|30|Anticipated|IRCCS Burlo Garofolo||1|||f||||f||||||||||2017-02-18 14:23:00.745727|2017-02-18 14:23:00.745727
NCT00677482|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2015-05-26|||April 2008||2008-04-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Observational|||Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates|Cytomegalovirus (CMV) microRNA Expression in Vivo and Immune Evasion Correlates|Active, not recruiting||N/A|30|Anticipated|University of Alberta|||1||f||||f||||||||||2017-02-18 14:23:00.856801|2017-02-18 14:23:00.856801
NCT00677469|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2008-05-13|||July 2007||2007-07-01|May 2008|2008-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Low Doses of Cholestyramine in the Treatment of Hyperthyroidism|Low Doses of Cholestyramine in the Treatment of Hyperthyroidism|Completed||N/A|45|Actual|Shiraz University of Medical Sciences||3|||f||||f||||||||||2017-02-18 14:23:00.947703|2017-02-18 14:23:00.947703
NCT00677456|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2008-05-12|||January 2008||2008-01-01|January 2008|2008-01-01|January 2013|Anticipated|2013-01-01|February 2010|Anticipated|2010-02-01||Interventional|||Evaluation of Four Reconstructions After Total Gastrectomy|Postoperative Life Quality Evaluation of Four Reconstructions After Total Gastrectomy|Unknown status|Recruiting|Phase 1|80|Anticipated|Tang-Du Hospital||4|||f||||t||||||||||2017-02-18 14:23:01.062322|2017-02-18 14:23:01.062322
NCT00677443|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2013-06-12|||June 2008||2008-06-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|September 2009|Actual|2009-09-01||Interventional|||Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer|A Randomized Phase III Study of SOX vs. COX in Patients With Advanced Colorectal Cancer|Completed||Phase 3|344|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 14:23:01.178486|2017-02-18 14:23:01.178486
NCT00677430|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2017-02-16|||May 2008|Actual|2008-05-01|February 2017|2017-02-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|||Quantitative Analysis of Outcomes in Breast Reconstruction|Multimodality Anthropometric Analysis for Quantitative Assessment of Outcomes in Breast Reconstructive Surgery|Active, not recruiting||N/A|300|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:23:01.310765|2017-02-18 14:23:01.310765
NCT00677417|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-10-15|||May 2008||2008-05-01|October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Diagnostic Value of Hyperbilirubinaemia as a Predictive Factor for Appendiceal Perforation in Acute Appendicitis|A Retrospective Study Investigating the Diagnostic Value of Hyperbilirubinaemia as a Predictive Factor for Appendiceal Perforation in Acute Appendicitis|Completed||N/A|538|Actual|Ruhr University of Bochum|||1||f||||f||||||||||2017-02-18 14:23:01.636925|2017-02-18 14:23:01.636925
NCT00677404|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2011-07-27|||January 2008||2008-01-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Autologous Transplantation of Bone Marrow Mononuclear Cell (BM-MNC) With and Without Granulocyte-Colony Stimulation Factor (G-CSF) for Treatment of Chronic Lower Limb Ischemic Patients|Evaluation of Clinical Outcome in Advanced Chronic Lower Limb Ischemia by Stem Cell Transplantation With or Without (Granulocyte-colony Stimulation Factor) G-CSF Injection|Completed||Phase 1/Phase 2|20|Actual|Royan Institute||1|||f||||t||||||||||2017-02-18 14:23:01.730077|2017-02-18 14:23:01.730077
NCT00677391|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2008-05-13|||December 2002||2002-12-01|May 2008|2008-05-01||||November 2004|Actual|2004-11-01||Interventional|||Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population|Randomized Trial of Obese Non-Diabetic Malaysians Using Sibutramine: A Randomized Double-Blind Placebo-Controlled Study of Sibutramine in the Management of Obese Subjects in Malaysia|Completed||Phase 3|103|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:23:01.852695|2017-02-18 14:23:01.852695
NCT00677378|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2015-10-21|||December 2006||2006-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Observational|TRPV1||Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain|Capsaicin-sensitive Transient Receptor Potential Vanilloid One (TRPV1) and Tyrosine Kinase (TrkA) Receptor Expression in Children With Retrosternal Pain|Completed||N/A|77|Actual|Medical College of Wisconsin|||2||f||||f||||||Samples Without DNA|"~     We are collecting a single mucosal biopsy during an endoscopy procedure.~   "|||2017-02-18 14:23:01.967074|2017-02-18 14:23:01.967074
NCT00677365|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-05-08|2011-09-04||June 2008||2008-06-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients|Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Efficacy of Three Dosage Regimens of MP-376 Solution for Inhalation Given for 28 Days to Stable CF Patients|Completed||Phase 2|151|Actual|Forest Laboratories||4|||f||||t||||||||||2017-02-18 14:23:02.105996|2017-02-18 14:23:02.105996
NCT00677352|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2011-05-17|2011-01-19||May 2008||2008-05-01|May 2011|2011-05-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder|A Randomized, Double-Blind, Multicenter Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder|Completed||Phase 4|321|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:23:02.933888|2017-02-18 14:23:02.933888
NCT00677339|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-01-17|||June 2008||2008-06-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|AVDAPT||L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)|Phase 3 Trial of Oral L-arginine and / or Vitamin D as Adjunctive Therapies in Pulmonary Tuberculosis in Papua Province, Indonesia.|Completed||Phase 3|200|Actual|Menzies School of Health Research||4|||f||||t||||||||||2017-02-18 14:23:03.525389|2017-02-18 14:23:03.525389
NCT00677326|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2009-12-28|||May 2008||2008-05-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|April 2009|Anticipated|2009-04-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*0201 in Treating Patients With Refractory Breast Cancer|Terminated||Phase 1/Phase 2|1|Actual|Tokyo University||1||Difficulty in recruiting|f||||t||||||||||2017-02-18 14:23:03.653527|2017-02-18 14:23:03.653527
NCT00677313|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2015-04-08||2013-10-15|March 2009||2009-03-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy|An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy|Completed||N/A|41|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 14:23:03.765479|2017-02-18 14:23:03.765479
NCT00677300|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2014-09-05|||January 2009||2009-01-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|RADAR||Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients|Evaluation of Safety and Efficacy of Raltegravir/Darunavir Combination in Antiretroviral-Naive Patients|Completed||Phase 4|85|Actual|Dallas VA Medical Center||2|||f||||t||||||||||2017-02-18 14:23:03.8645|2017-02-18 14:23:03.8645
NCT00677287|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2009-12-28|||May 2008||2008-05-01|May 2008|2008-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*2402 in Combination With Tegafur/Uracil/Folinate in Treating Patients With Refractory Colorectal Cancer|Terminated||Phase 1/Phase 2|14|Anticipated|Tokyo University||1||Lack of financial support|f||||t||||||||||2017-02-18 14:23:03.977068|2017-02-18 14:23:03.977068
NCT00677274|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2009-02-11|||May 2008||2008-05-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|EACDRCD||Epidural Analgesia in Different Cervix Diameter and the Rate of Cesarean Delivery|Epidural Labor Analgesia in Different Cervical Dilation Diameter and the Risk of Cesarean Delivery|Completed||N/A|780|Actual|Nanjing Medical University||8|||f||||t||||||||||2017-02-18 14:23:04.105549|2017-02-18 14:23:04.105549
NCT00677261|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2014-11-19|||June 2008||2008-06-01|July 2011|2011-07-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Comparing Postoperative Functional Recovery and Analgesic Efficacy of a Single Shot Sciatic Nerve Block Versus Posterior Capsule/Fat Pad Infiltration of Local Anesthetic for Total Knee Arthroplasty|A Prospective, Unicenter, Randomized, Placebo Controlled, Clinical Interventional Trial, Comparing the Postoperative Functional Recovery as Well as Analgesic Efficacy of a Single Shot Sciatic Nerve Block Versus Posterior Capsule/Fat Pad Infiltration of Local Anesthetic for Total Knee Arthroplasty.|Completed||N/A|104|Actual|Sunnybrook Health Sciences Centre||3|||f||||t||||||||||2017-02-18 14:23:04.434312|2017-02-18 14:23:04.434312
NCT00677248|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2008-11-27|||April 2008||2008-04-01|May 2008|2008-05-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe|A Phase II, Placebo-Controlled, Double-Blind, Randomised, 10-Week, Parallel-Group Study to Assess the Efficacy of Different Doses of KB2115 as Add on to Ezetimibe Treatment in Patients With Primary Hypercholesterolemia|Completed||Phase 2|120|Anticipated|Karo Bio AB||4|||f||||t||||||||||2017-02-18 14:23:04.537328|2017-02-18 14:23:04.537328
NCT00519870|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2007-08-22|||January 2005||2005-01-01|August 2007|2007-08-01|July 2005||2005-07-01|||||Interventional|||Losartan Therapy in Pulmonary Hypertension|Losartan Decreases Pulmonary Artery Pressure and Improves Exercise Capacity in Patients With Pulmonary Hypertension|Completed||Phase 3|||Baskent University||1|||f||||||||||||||2017-02-18 15:20:34.03983|2017-02-18 15:20:34.03983
NCT00677235|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2016-12-01|2014-01-20||December 2008||2008-12-01|December 2016|2016-12-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|RENOVA|Subjects with hemodynamically significant stenosis fifty percent, clinical evidence of graft dysfunction (without thrombotic occlusion) at the synthetic AV access graft anastomosis, and who were selected from the Investigator’s general subject population were eligible for participation in this study.|Post-Approval Study for the FLAIR Endovascular Stent Graft|A Prospective, Randomized, Concurrently-Controlled Post-Approval Study of the FLAIR Endovascular Stent Graft|Completed||Phase 4|270|Actual|C. R. Bard||2|||f||||f||||||||||2017-02-18 14:23:04.645545|2017-02-18 14:23:04.645545
NCT00677222|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-05-10|||May 2008||2008-05-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|March 2010|Actual|2010-03-01||Interventional|||Safety Study of AMI MultiStem® to Treat Heart Attacks|A Phase I, Multicenter, Dose-Escalation Trial Evaluating the Safety of Allogeneic AMI MultiStem® in Patients With Acute Myocardial Infarction|Completed||Phase 1|25|Actual|Athersys, Inc||2|||f||||t||||||||||2017-02-18 14:23:05.365531|2017-02-18 14:23:05.365531
NCT00677209|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2010-12-28|||July 2006||2006-07-01|May 2008|2008-05-01|December 2010|Actual|2010-12-01|August 2008|Actual|2008-08-01||Interventional|FIAVS||The Effect of Autologous Autovaccine in Patients With Allergy on House-dust-mite|Frankfurt Investigator-initiated Autovaccine-study|Completed||Phase 1|8|Actual|Johann Wolfgang Goethe University Hospital||1|||f||||t||||||||||2017-02-18 14:23:05.477028|2017-02-18 14:23:05.477028
NCT00677196|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2010-09-23|||February 2008||2008-02-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The StoneBreakerTM Trial|The Canadian StoneBreakerTM Trial: A Randomized, Multicentre Trial Comparing The LMA StoneBreakerTM and the Swiss LithoClastR During Percutaneous Nephrolithotripsy.|Completed||Phase 3|40|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 14:23:05.589573|2017-02-18 14:23:05.589573
NCT00677183|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2015-08-21|||May 2008||2008-05-01|August 2015|2015-08-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Observational|NASH||Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children|Development of a Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children|Withdrawn||N/A|0|Actual|Medical College of Wisconsin|||2|PI did not receive funding for this PI-initiated study. PI subsequently left the institution.|f||||f||||||Samples With DNA|"~     10mL of blood will be retained from each participant and their parents. 5mL of this blood~     will undergo DNA extraction and genotyping for several known NASH related genes. The other~     5mL of blood will be saved as serum for future analysis.~   "|||2017-02-18 14:23:05.700845|2017-02-18 14:23:05.700845
NCT00677170|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2013-07-15|||April 2008||2008-04-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|February 2012|Actual|2012-02-01||Interventional|||Study of MLN4924 in Adult Patients With Nonhematologic Malignancies|An Open-Label, Dose Escalation, Phase I Study of MLN4924, a Novel Inhibitor of Nedd8-Activating Enzyme, in Adult Patients With Nonhematologic Malignancies|Completed||Phase 1|62|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 14:23:05.797532|2017-02-18 14:23:05.797532
NCT00677157|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2017-01-24|||May 6, 2008||2008-05-06|November 15, 2016|2016-11-15||||||||Observational|||Evaluation and Diagnosis of People With Pain and Fatigue Syndromes|Evaluation and Diagnosis of Potential Research Subjects With Pain and Fatigue Syndromes|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:23:05.884975|2017-02-18 14:23:05.884975
NCT00677144|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2012-10-04|||April 2008||2008-04-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer|A Randomized Phase II Study of Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) in Patients With Advanced or Recurrent Colorectal Cancer|Completed||Phase 2|88|Actual|Hallym University Medical Center||2|||f||||f||||||||||2017-02-18 14:23:05.990631|2017-02-18 14:23:05.990631
NCT00677131|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-12-02|||April 2008||2008-04-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of the Evaluation of Patient Education Efficacy in Pharmacy of National Taiwan University Hospital|Study of the Evaluation of Patient Education Efficacy: Reconstitution, Storage, and Administration of Oral Antibiotic Suspension From Powder Dosage Form at Pharmacy of National Taiwan University Hospital|Completed||N/A|500|Anticipated|National Taiwan University Hospital||3|||f||||t||||||||||2017-02-18 14:23:06.105116|2017-02-18 14:23:06.105116
NCT00677118|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2013-07-11|||June 2006||2006-06-01|March 2010|2010-03-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|A Multicenter Prospective Randomized Trial Comparing Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy With Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma|Unknown status|Active, not recruiting|Phase 3|506|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 14:23:06.205074|2017-02-18 14:23:06.205074
NCT00677105|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2012-09-14|||August 2007||2007-08-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.|An Open-Label Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of JNJ-26481585 in Subjects With Advanced Stage and/or Refractory Solid Malignancies and Lymphomas|Completed||Phase 1|92|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||t||||||||||2017-02-18 14:23:06.327138|2017-02-18 14:23:06.327138
NCT00677092|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-03-25|||May 2008||2008-05-01|March 2009|2009-03-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|GENESYF||Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis|An Open Label Phase 2 Pilot Study to Determine the Safety, Efficacy and Tolerability of Gleevec (Imatinib Mesylate) in the Treatment of Nephrogenic Systemic Fibrosis|Unknown status|Active, not recruiting|Phase 2|12|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 14:23:06.423416|2017-02-18 14:23:06.423416
NCT00677079|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2013-09-23||2012-12-21|June 2008||2008-06-01|September 2013|2013-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase 2, Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Completed||Phase 2|12|Actual|Sanofi||1|||t||||f||||||||||2017-02-18 14:23:06.538721|2017-02-18 14:23:06.538721
NCT00220948|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2004||2004-08-01|July 2005|2005-07-01|March 2006||2006-03-01|||||Interventional|||Large Array EMG Discriminability in Discogenic Low Back Pain|Large Array EMG Discriminability in Discogenic Low Back Pain|Unknown status|Recruiting|N/A|60||Texas Back Institute|||||f||||||||||||||2017-02-18 17:07:26.918789|2017-02-18 17:07:26.918789
NCT00677066|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-05-12|||August 2007||2007-08-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety Study of Home Oxygen Therapy for Children With Acute Bronchiolitis|A Randomised Controlled Trial: Home Oxygen Therapy Versus Hospital Oxygen Therapy for Children With Acute Bronchiolitis|Completed||Phase 3|44|Actual|Princess Margaret Hospital for Children||2|||f||||t||||||||||2017-02-18 14:23:06.646786|2017-02-18 14:23:06.646786
NCT00677053|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2016-03-13||2016-03-13|March 2008||2008-03-01|March 2016|2016-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes|A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes|Completed||Phase 2|2753|Actual|Takeda||9|||f||||t||||||||||2017-02-18 14:23:06.755968|2017-02-18 14:23:06.755968
NCT00677040|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2011-09-19|||April 2008||2008-04-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Observational|||Normal Tissue Oxygenation Following Radiotherapy|Normal Tissue Oxygenation Following Radiotherapy|Completed||N/A|20|Actual|Essentia Health|||1||f||||f||||||||||2017-02-18 14:23:06.988758|2017-02-18 14:23:06.988758
NCT00677027|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2008-05-12|||February 2008||2008-02-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Dose Escalation Safety Study of MM-10-001 in Healthy Subjects|Dose Escalation Safety Study of MM-10-001|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|GlycaNova Norge AS||2|||f||||t||||||||||2017-02-18 14:23:07.075789|2017-02-18 14:23:07.075789
NCT00677014|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2013-04-17|2012-07-27||May 2008||2008-05-01|April 2013|2013-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SMART-AV||Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy (CRT)|SMARTDELAY Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy|Completed||Phase 4|1060|Actual|Boston Scientific Corporation||3|||f||||f||||||||||2017-02-18 14:23:07.176514|2017-02-18 14:23:07.176514
NCT00677001|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2010-04-26|||September 2005||2005-09-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|||||Interventional|||A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.|A Phase I Study to Evaluate the Safety and Pharmacokinetics of R306465 in Subjects With Advanced Solid Malignancies|Completed||Phase 1|15|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 14:23:07.902048|2017-02-18 14:23:07.902048
NCT00676988|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2012-06-13|||May 2008||2008-05-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|X-Sectional||Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients|A Cross Sectional Study To Determine The Relationship Between Serum Infliximab Concentration And Efficacy In Patients With Luminal Crohn's Disease|Completed||N/A|327|Actual|University of Western Ontario, Canada|||1||f||||t||||||Samples Without DNA|"~     Serum infliximab concentrations and CRP levels.~   "|||2017-02-18 14:23:07.986198|2017-02-18 14:23:07.986198
NCT00676975|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2014-11-26|||May 2008||2008-05-01|November 2014|2014-11-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01||Interventional|TCM-IBS||The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome|Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome(TCM- IBS)|Unknown status|Active, not recruiting|Phase 2|104|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 14:23:08.082543|2017-02-18 14:23:08.082543
NCT00676962|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2015-09-21|||May 2008||2008-05-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Facilitating Implementation of Cognitive Behavioral Therapy in Primary Care and Community Clinics|Facilitating Implementation of Cognitive Behavioral Therapy in Primary Care and Community Clinics|Completed||N/A|23|Actual|South Central VA Mental Illness Research, Education & Clinical Center||1|||f||||f||||||||||2017-02-18 14:23:08.187789|2017-02-18 14:23:08.187789
NCT00676949|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2011-06-22|||November 2007||2007-11-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|peptidevac||Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors|Phase I Study of Tumor Specific Potentiated Vaccine Therapy Using Cyclophosphamide Combined Epitope Peptide Cocktail for Progressive/Relapsed Solid Tumors(GI/Lung/Cervical Cancer)|Completed||Phase 1|18|Actual|Kyushu University||1|||f||||t||||||||||2017-02-18 14:23:08.290169|2017-02-18 14:23:08.290169
NCT00676936|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-07-27|||April 2008||2008-04-01|July 2016|2016-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Corticosteroids for Cancer Pain|Corticosteroids for Cancer Pain|Completed||Phase 3|50|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 14:23:08.406324|2017-02-18 14:23:08.406324
NCT00676923|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2012-11-12|||March 2008||2008-03-01|November 2012|2012-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|LABS-3||Improving Diabetes After Bariatric Surgery|LABS-3 Diabetes: Mechanisms for Improvement of Type 2 Diabetes Following Bariatric Surgery|Completed||N/A|63|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     serum, plasma~   "|||2017-02-18 14:23:08.529387|2017-02-18 14:23:08.529387
NCT00676910|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2010-03-24|||November 2006||2006-11-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|||||Interventional|||A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.|A Phase I Study to Determine the Safety, Pharmacology, and Pharmacodynamics of JNJ26854165 in Subjects With Advanced Stage and/or Refractory Solid Tumors|Completed||Phase 1|71|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 14:23:08.611968|2017-02-18 14:23:08.611968
NCT00676897|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2015-09-03|||February 2008||2008-02-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Statin Therapy in the Treatment of Sepsis|Study of Statin Therapy in the Treatment of Sepsis|Completed||Phase 2/Phase 3|13|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 14:23:08.691895|2017-02-18 14:23:08.691895
NCT00676884|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2008-05-09|||February 2006||2006-02-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema|A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema|Completed||Phase 2|25|Actual|Aerovance, Inc.||2|||f||||f||||||||||2017-02-18 14:23:08.80679|2017-02-18 14:23:08.80679
NCT00669084|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-26|2017-01-24|||April 21, 2008||2008-04-21|November 19, 2013|2013-11-19|November 19, 2013||2013-11-19|||||Observational|||Innate and Acquired Resistance to Plasmodium Falciparum Malaria in Mali|Studies of Innate and Acquired Resistance to P. Falciparum Malaria in Mali|Completed||N/A|2100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:25:50.332107|2017-02-18 14:25:50.332107
NCT00676871|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-09-04|||June 2008||2008-06-01|September 2008|2008-09-01|June 2011|Anticipated|2011-06-01|March 2010|Anticipated|2010-03-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)|A Phase 1/2, Open-Label, Single-Arm, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of the Bispecific T-Cell Engager MEDI-538 In Adults With B-Cell Chronic Lymphocytic Leukemia(CLL)Who Have Residual Disease Following Previous Therapy for CLL|Withdrawn||Phase 1/Phase 2|30|Anticipated|MedImmune LLC||7||Replacing this trial with a new trial.|f||||f||||||||||2017-02-18 14:23:08.921495|2017-02-18 14:23:08.921495
NCT00676858|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2010-04-21|||July 2008||2008-07-01|April 2010|2010-04-01||||June 2011|Anticipated|2011-06-01||Observational|||Gas Embolism With Use of Argon Plasma Coagulation|Gas Embolism With Use of Argon Plasma Coagulation|Unknown status|Recruiting|N/A|75|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||t||||||||||2017-02-18 14:23:09.02437|2017-02-18 14:23:09.02437
NCT00676845|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2012-04-26|||August 2008||2008-08-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|ArtStiff||Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection|Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects With Metabolic Syndrome|Completed||Phase 3|133|Actual|Daiichi Sankyo Inc.||4|||f||||f||||||||||2017-02-18 14:23:09.114694|2017-02-18 14:23:09.114694
NCT00676832|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2010-09-27||2010-09-16|May 2008||2008-05-01|September 2010|2010-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis|Completed||Phase 2|190|Actual|Prometheus Laboratories||5|||f||||f||||||||||2017-02-18 14:23:09.225726|2017-02-18 14:23:09.225726
NCT00676819|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2012-06-05|||January 2002||2002-01-01|September 2011|2011-09-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes|Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Soluble Insulin in Geriatric Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|19|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:23:09.4424|2017-02-18 14:23:09.4424
NCT00676806|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2016-11-30|2016-05-02||July 2005||2005-07-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2013|Actual|2013-07-01||Interventional|||A Phase II Study of Umbilical Cord Blood Transplantation|A Phase II Study of Umbilical Cord Blood Transplantation Following Myeloablative or Reduced-Intensity Conditioning|Terminated||Phase 2|7|Actual|Tufts Medical Center|Early termination leading to small numbers of subjects analyzed.|2||Slow accrual|f||||t||||||||No||2017-02-18 14:23:09.556456|2017-02-18 14:23:09.556456
NCT00676793|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2012-09-25|2011-09-02||May 2004||2004-05-01|September 2012|2012-09-01|July 2013|Anticipated|2013-07-01|December 2009|Actual|2009-12-01||Interventional|||A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression|Phase II Clinical Trial to Determine if Polyphenon E Inhibits c-Met Signaling and Activation of Pathways Contributing to Breast Cancer Progression|Unknown status|Active, not recruiting|Phase 2|32|Actual|Louisiana State University Health Sciences Center Shreveport||1|||f||||t||||||||||2017-02-18 14:23:10.078066|2017-02-18 14:23:10.078066
NCT00676780|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2012-06-29|2011-08-29||May 2004||2004-05-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Green Tea Extract and Prostate Cancer|Green Tea Extract and Prostate Cancer|Completed||Phase 2|33|Actual|Louisiana State University Health Sciences Center Shreveport|Patient compliance was an issue.|1|||f||||t||||||||||2017-02-18 14:23:10.368524|2017-02-18 14:23:10.368524
NCT00676767|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-05-22|||August 2006||2006-08-01|May 2008|2008-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Resistant Starch on Glycemic Response in Older Adults|Resistant Starch Type 4 on the Glycemic Response in Older Adults|Completed||N/A|9|Actual|Kansas State University||3|||f||||f||||||||||2017-02-18 14:23:10.646062|2017-02-18 14:23:10.646062
NCT00676754|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-03-27|||September 2009||2009-09-01|March 2013|2013-03-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|Estudio Epi||Epidemiology of MDR-TB in Peru|Epidemiology of Multidrug-Resistant Tuberculosis in Peru|Unknown status|Active, not recruiting|Phase 4|18544|Actual|Harvard University Faculty of Medicine|||1||f||||f||||||Samples With DNA|"~     whole blood, sputum~   "|||2017-02-18 14:23:10.75212|2017-02-18 14:23:10.75212
NCT00676741|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2016-10-27|||February 2008||2008-02-01|October 2016|2016-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|COMMIT||Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin|Observational Study on Evaluation of Glycaemic Control in Patients Using a Modern Insulin - NovoRapid® (Insulin Aspart), NovoMix® 30 (Biphasic Insulin Aspart) or Levemir® (Insulin Detemir) - for Treatment of Diabetes Mellitus|Completed||N/A|3809|Actual|Novo Nordisk A/S|||3||f||||f||||||||||2017-02-18 14:23:10.85292|2017-02-18 14:23:10.85292
NCT00676728|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2012-09-13|||December 2008||2008-12-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome|A Phase 1 Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Subjects With Advanced or Refractory Leukemia or Myelodysplastic Syndrome|Terminated||Phase 1|10|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1||Sponsor Decision|f||||f||||||||||2017-02-18 14:23:10.960045|2017-02-18 14:23:10.960045
NCT00676715|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2016-10-03||2013-03-25|July 2008||2008-07-01|October 2016|2016-10-01||||September 2009|Actual|2009-09-01||Interventional|||A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis|Phase II, Multicenter, Randomized, Parallel-Group, Partially Blinded, Placebo and Avonex Controlled Dose Finding Study to Evaluate the Efficacy As Measured by Brain MRI Lesions, and Safety of 2 Dose Regimens of Ocrelizumab in Patients With RRMS|Active, not recruiting||Phase 2|221|Actual|Genentech, Inc.||4|||f||||||||||||||2017-02-18 14:23:11.076608|2017-02-18 14:23:11.076608
NCT00676702|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-05-18|||July 2008||2008-07-01|February 2010|2010-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)|A Single-Dose, Open-Label, Randomized, Crossover Study to Evaluate Intraduodenal Enzyme Delivery of PANCREASE MT in Subjects With Severe Exocrine Pancreatic Insufficiency|Completed||Phase 1|13|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-02-18 14:23:11.26916|2017-02-18 14:23:11.26916
NCT00676689|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2016-07-21|2016-05-04||April 2008||2008-04-01|July 2016|2016-07-01|November 2019|Anticipated|2019-11-01|November 2015|Actual|2015-11-01||Interventional||Safety Population (SP): All enrolled subjects for whom the procedure has begun, regardless of whether the valve was successfully implanted. The definition of “procedure has begun” is “the time of the creation of vascular access - incision or puncture.”|COMPASSION: COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV|Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position|Active, not recruiting||N/A|81|Actual|Edwards Lifesciences||1|||f||||t||||||||||2017-02-18 14:23:11.594715|2017-02-18 14:23:11.594715
NCT00676676|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2012-11-01|2012-05-10||March 2007||2007-03-01|November 2012|2012-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effects of Testosterone in Women With Depression|Effects of Testosterone in Women With Depression: A Pilot Study|Completed||N/A|9|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:23:11.980546|2017-02-18 14:23:11.980546
NCT00676663|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2014-03-19|||May 2008||2008-05-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|December 2010|Actual|2010-12-01||Interventional|ENCORE301||Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer|A Ph 2, Randomized, Double-Blind, Multicenter Study of Exemestane +/- Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer, Progressing on Treatment With a Non-Steroidal AI|Completed||Phase 2|130|Actual|Syndax Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:23:12.227842|2017-02-18 14:23:12.227842
NCT00676650|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-02-05|2012-12-20||July 2008||2008-07-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SUN 1120||Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy|A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Castration-Resistant Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen|Terminated||Phase 3|873|Actual|Pfizer|A complete analysis was not performed due to the sponsors early termination of the clinical trial.|2||"Study A6181120 was prematurely discontinued due to futility on 27 September 2010. No new or~   unexpected safety issues were identified."|f||||t||||||||||2017-02-18 14:23:12.42684|2017-02-18 14:23:12.42684
NCT00676637|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-05-29|||May 2008||2008-05-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|GAS||Glaucoma Adherence Study|A Pilot Study of Adherence Assessment With the Travalert™ Dosing Aid in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma Who Are Treated With the Travoprost/Timolol Maleate Fixed Combination Every Evening|Completed||Phase 4|55|Actual|Alcon Research|||1||f||||f||||||||||2017-02-18 14:23:13.797721|2017-02-18 14:23:13.797721
NCT00676624|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2014-05-14|||April 2008||2008-04-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Infectious Causes of Uveitis|Infectious Causes of Uveitis, With Special Focus on Infection With Leptospira|Completed||N/A|100|Anticipated|Statens Serum Institut|||2||f||||t||||||Samples With DNA|"~     Corpus vitreum (vitreus body) Aqua from the anterior champer Whole blood in dry container~     Whole blood in container containing EDTA Whole blood in QuantiFERON test KIT for~     tuberculosis Urine~   "|||2017-02-18 14:23:13.912399|2017-02-18 14:23:13.912399
NCT00676611|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-05-12|||May 2008||2008-05-01|May 2008|2008-05-01|September 2008|Anticipated|2008-09-01|||||Observational|||Acetabular Fractures of Both Columns|Both Column Acetabular Fractures With Associated Posterior Deformity Patterns: Implications for Surgical Treatment and Prognosis|Unknown status|Enrolling by invitation|N/A|10|Anticipated|Penn State University|||1||f||||f||||||||||2017-02-18 14:23:14.012602|2017-02-18 14:23:14.012602
NCT00676598|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2012-01-04|||January 2007||2007-01-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Observational|||A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest|A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest|Completed||N/A|70|Actual|Advocate Hospital System|||1||f||||f||||||||||2017-02-18 14:23:14.095803|2017-02-18 14:23:14.095803
NCT00676585|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2014-09-16|||October 2007||2007-10-01|August 2014|2014-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest|Corticosteroids Therapy in Refractory Shock Following Cardiac Arrest|Completed||Phase 1/Phase 2|50|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 14:23:14.190942|2017-02-18 14:23:14.190942
NCT00676572|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-02-23|||May 2008||2008-05-01|February 2016|2016-02-01|April 2016|Anticipated|2016-04-01|January 2013|Actual|2013-01-01||Observational|||p38 Mitogen−Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma|p38 MAPK Activation as the Basis for Corticosteroid Insensitivity in Severe Asthma|Active, not recruiting||N/A|120|Anticipated|Imperial College London|||2||f||||f||||||Samples With DNA|"~     sputum cell pellets and supernatant; BAL supernatant; endobronchial biopsies; smooth muscle~     cell culture from biopsies~   "|||2017-02-18 14:23:14.288951|2017-02-18 14:23:14.288951
NCT00676559|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-08-25|||April 2008||2008-04-01|August 2016|2016-08-01|April 2010|Anticipated|2010-04-01|April 2009|Anticipated|2009-04-01||Interventional|CAPTURE||Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study|Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study|Withdrawn||Phase 1|0|Actual|Johns Hopkins University||3||Unrelated serious adverse events involving one of the proposed medications|f||||t||||||||||2017-02-18 14:23:14.389336|2017-02-18 14:23:14.389336
NCT00676546|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2008-05-09|||March 2008||2008-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:23:16.998798|2017-02-18 14:23:16.998798
NCT00676533|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2013-10-10|||June 2003||2003-06-01|October 2013|2013-10-01|January 2004|Actual|2004-01-01|||||Interventional|||Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections|Cipro® XR Excellence in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections|Completed||Phase 4|276|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:23:17.054786|2017-02-18 14:23:17.054786
NCT00676520|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-10-10|2012-06-07||July 2008||2008-07-01|October 2012|2012-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|XVU-Phase 1||XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)|XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study|Completed||Phase 4|8053|Actual|Abbott Vascular|||1||f||||t||||||||||2017-02-18 14:23:17.217002|2017-02-18 14:23:17.217002
NCT00676507|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2015-05-06|||July 2008||2008-07-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|STOP||Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy|Phase III Study of Lucanix™ (Belagenpumatucel-L) in Advanced Non-small Cell Lung Cancer: An International Multicenter, Randomized, Double-blinded, Placebo-controlled Study of Lucanix™ Maintenance Therapy for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Disease Following One Regimen of Front-line, Platinum-based Combination Chemotherapy|Completed||Phase 3|532|Actual|NovaRx Corporation||2|||f||||t||||||||||2017-02-18 14:23:18.54519|2017-02-18 14:23:18.54519
NCT00676494|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-05-18|2009-02-23||February 2006||2006-02-01|May 2009|2009-05-01|February 2008|Actual|2008-02-01|July 2007|Actual|2007-07-01||Interventional|||The Pathway PVD Study for Percutaneous Peripheral Vascular Interventions|A Prospective, Single Arm, Multi-Center Study to Assess Performance of the Pathway PV Atherectomy System During Percutaneous Peripheral Vascular (PV) Interventions|Completed||N/A|172|Actual|Pathway Medical Technologies Inc.||1|||f||||t||||||||||2017-02-18 14:23:18.95889|2017-02-18 14:23:18.95889
NCT00676481|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2015-03-05|||July 2004||2004-07-01|May 2008|2008-05-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Rapid HIV Testing for Emergency Department Patients|Rapid HIV Testing for Emergency Department Patients|Completed||N/A|570|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||f||||||||||2017-02-18 14:23:19.179085|2017-02-18 14:23:19.179085
NCT00676468|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2009-10-08|||September 2008||2008-09-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Comparative Effects of Fish Oil Supplementation and a Montelukast on EIB and Airway Inflammation in Asthma|Comparative Effects of Fish Oil Supplementation and a Leukotriene Receptor Antagonist on EIB and Airway Inflammation in Asthma|Completed||Phase 1|20|Actual|Indiana University||3|||f||||f||||||||||2017-02-18 14:23:19.288458|2017-02-18 14:23:19.288458
NCT00676455|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-05-09|2009-08-26||February 2007||2007-02-01|May 2013|2013-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Computer Assisted Volumetric Analysis of CT-Identified Metastatic Pulmonary Or Hepatic Lesions|Computer Assisted Volumetric Analysis of CT-Identified Metastatic Pulmonary Or Hepatic Lesions|Terminated||N/A|14|Actual|Lahey Clinic|||1|Low participant enrollment, Insufficient findings for data analysis|f||||f||||||||||2017-02-18 14:23:19.41753|2017-02-18 14:23:19.41753
NCT00676442|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-09-04|||May 2008||2008-05-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Evaluating the Effect of Food on the Bioavailability of PN400 Components|An Open-Label, Randomized, Four-Way Crossover Study to Evaluate the Effect of Food on the Bioavailability of Naproxen and Esomeprazole From a PN 400 Tablet in Healthy Subjects|Completed||Phase 1|24|Actual|POZEN||4|||f||||f||||||||||2017-02-18 14:23:19.635686|2017-02-18 14:23:19.635686
NCT00676429|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2008-11-17|||July 2006||2006-07-01|November 2008|2008-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders|Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders in Children and Adolescents - a Placebo Controlled, Randomized, Double Blind Clinical Trial|Completed||Phase 2|51|Actual|University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 14:23:19.731091|2017-02-18 14:23:19.731091
NCT00676416|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-03-30|||April 2008||2008-04-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|PAMAP||Influence of Propofol on Alveolar Macrophage in Asthmatic Patients|Influence of Propofol on Alveolar Macrophage Immunity in Asthmatic Patients Undergoing General Anesthesia|Completed||Phase 4|80|Anticipated|Nanjing Medical University|||2||f||||t||||||||||2017-02-18 14:23:19.857756|2017-02-18 14:23:19.857756
NCT00676403|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2010-06-28|2010-01-08||April 2008||2008-04-01|June 2010|2010-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients|Randomized, Double-Blind, 6-Week Study Of Pregabalin In Subjects With Restless Legs Syndrome|Completed||Phase 2|137|Actual|Pfizer||6|||f||||f||||||||||2017-02-18 14:23:20.023846|2017-02-18 14:23:20.023846
NCT00676390|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2013-10-25|||March 2008||2008-03-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|H2OBis||Estimated Physical Activity of Congestive Heart Failure Patients by a Physical Activity Questionnaire|Estimated Physical Activity of Congestive Heart Failure Patients by a Physical Activity Questionnaire : Concordance Study.|Completed||N/A|25|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-02-18 14:23:24.300781|2017-02-18 14:23:24.300781
NCT00676377|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2008-05-12|||August 2007||2007-08-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||A New Approach of Neostigmine in Unavoidable Post Operative Ileus|A New Approach of Neostigmine in Unavoidable Post Operative Ileus After Surgery|Completed||Phase 4|3|Actual|Baqiyatallah Medical Sciences University||2|||f||||t||||||||||2017-02-18 14:23:24.39857|2017-02-18 14:23:24.39857
NCT00676364|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2012-08-24|2012-05-01||March 2003||2003-03-01|August 2012|2012-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Randomized Control Trial of a Topical Anesthetic to Evaluate Pain and Anxiety During Venipuncture|A Randomized, Placebo-Controlled Trial to Evaluate Pain and Anxiety During Venipuncture in Pediatric Patients With or Without Pre-treatment by a Topical Anesthetic|Completed||Phase 4|114|Actual|Lehigh Valley Hospital|Convenience sample at one hospital site during dayshift hours Monday through Friday. Variable ages may increase the variance among pain measurements. Analyzed IV cannulation and lab draw together. We did not conduct interrater reliability testing.|2|||f||||t||||||||||2017-02-18 14:23:24.730075|2017-02-18 14:23:24.730075
NCT00676351|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2008-05-12|||January 2004||2004-01-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Follow up of Ventilatory Function in Infant After Bronchiolitis During the First Year of Life|Follow up of Ventilatory Function in Infant After One (or More) Bronchiolitis During the First Year of Life. Course Towards Asthma|Completed||N/A|29|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 14:23:25.137355|2017-02-18 14:23:25.137355
NCT00676338|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2015-03-20|2012-02-14||November 2008||2008-11-01|March 2015|2015-03-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)|Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes|Completed||Phase 3|820|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:23:25.257495|2017-02-18 14:23:25.257495
NCT00676325|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2008-05-12|||January 2007||2007-01-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|Nazcatc™||Surgical Treatment To Greater Anterior Vaginal Prolapse|A Randomized Controlled Trial Study, To Compare Colporrhaphy Versus NAZCA TC™ ,Macroporous Polypropylene Mesh, In Surgical Treatment To Greater Anterior Vaginal Prolapse .|Unknown status|Enrolling by invitation|Phase 4|70|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:23:26.670714|2017-02-18 14:23:26.670714
NCT00676312|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-12-10|||May 2008||2008-05-01|December 2008|2008-12-01||||August 2008|Actual|2008-08-01||Interventional|||Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects|A Partially-Blinded, Randomized, Placebo and Active Controlled, Ascending Single-Dose Crossover Phase I Study to Explore the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of PTH134 Formulated With Different Concentrations of 5-CNAC in Healthy Postmenopausal Women|Completed||Phase 1|32|Anticipated|Novartis||1|||f||||||||||||||2017-02-18 14:23:26.797047|2017-02-18 14:23:26.797047
NCT00676299|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2010-04-22|||August 2006||2006-08-01|April 2010|2010-04-01|July 2008|Actual|2008-07-01|||||Interventional|||A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.|An Open-label, Phase I Study to Determine the Safety and Pharmacokinetics of JNJ-26483327, a Multi-targeted Kinase Inhibitor, Administered to Subjects With Advanced Stage and/or Refractory Solid Malignancies|Completed||Phase 1|19|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 14:23:26.909932|2017-02-18 14:23:26.909932
NCT00676286|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-12|2016-07-04|||November 2008||2008-11-01|July 2016|2016-07-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers|Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19|Completed||Phase 1|26|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 14:23:26.99483|2017-02-18 14:23:26.99483
NCT00676273|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2008-05-12|||March 2007||2007-03-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|March 2009|Anticipated|2009-03-01||Interventional|||TVT-Secur Versus TVT-Obturator: A Randomized Trial of Suburethral Sling Operative Procedures|TVT-Secur Versus TVT-Obturator: A Randomized Trial of Suburethral Sling Operative Procedures|Unknown status|Recruiting|Phase 4|140|Anticipated|Boston Urogynecology Associates||2|||f||||f||||||||||2017-02-18 14:23:27.090466|2017-02-18 14:23:27.090466
NCT00676260|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-09|2012-02-27|||December 2002||2002-12-01|February 2012|2012-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin|Effect of Pioglitazone 15 mg or 30 mg on Microcirculation in Type 2 Diabetes Patients Treated With Insulin|Completed||Phase 2|29|Actual|Takeda||2|||f||||f||||||||||2017-02-18 14:23:27.187434|2017-02-18 14:23:27.187434
NCT00676247|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2009-01-19|||April 2008||2008-04-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Cerebral Blood Flow Parameters and Neurobehavioral Development in Infants at Term Age|Cerebral Blood Flow Parameters and Neurobehavioral Development in Full-Term Infants and Very Low Birth Weight Preterm Infants at Term Age|Completed||N/A|1|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-02-18 14:23:27.301722|2017-02-18 14:23:27.301722
NCT00676234|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2009-06-26|||May 2008||2008-05-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Recombinant Human Erythropoietin Use in Intensive Care Unit (ICU) Patients: Does it Prevent Acute Renal Failure|Recombinant Human Erythropoietin Use in ICU Patients: Does it Prevent Acute Renal Failure?|Completed||Phase 2|80|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 14:23:27.389181|2017-02-18 14:23:27.389181
NCT00676221|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2008-05-14|||July 2006||2006-07-01|May 2008|2008-05-01|September 2008|Anticipated|2008-09-01|August 2008|Anticipated|2008-08-01||Interventional|||Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS)|Patient Reported Outcomes in Renal Transplant Patients Tolerating GI Symptoms Converted to Myfortic (EC-MPS).|Unknown status|Active, not recruiting|Phase 4|110|Anticipated|Foothills Medical Centre||1|||f||||f||||||||||2017-02-18 14:23:27.495726|2017-02-18 14:23:27.495726
NCT00676208|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-04-06|2014-09-29||April 2008||2008-04-01|August 2014|2014-08-01|February 2012|Actual|2012-02-01|September 2008|Actual|2008-09-01||Interventional|||Improving Medical Training for the Care of Chronic Conditions|Improving Medical Training for the Care of Chronic Conditions|Completed||N/A|33|Actual|VA Office of Research and Development|The small sample sizes and the reliance on one site for the data. This was a pilot study, both limitations were recognized from the outset and indeed seen as an advantage given the focus on trying to identify measures to include in a larger study.|2|||f||||f||||||||||2017-02-18 14:23:27.75843|2017-02-18 14:23:27.75843
NCT00676195|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-12-02|||June 2008||2008-06-01|December 2015|2015-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||An Open-Label Study of N-Acetyl Cysteine in Children With Autism|An Open-Label Study of N-Acetyl Cysteine in Autism|Completed||Phase 2|24|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 14:23:28.122841|2017-02-18 14:23:28.122841
NCT00676182|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-03-24|2016-03-24||July 2008||2008-07-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|April 2015|Actual|2015-04-01||Observational|||Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury|Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury|Completed||N/A|81|Actual|VA Office of Research and Development|||1||f||||f||||||||No||2017-02-18 14:23:28.238901|2017-02-18 14:23:28.238901
NCT00676169|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2015-02-23|||October 2004||2004-10-01|February 2015|2015-02-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Observational|EPIC OBS||The EPIC Observational Study|Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children With CF|Active, not recruiting||N/A|1700|Anticipated|CF Therapeutics Development Network Coordinating Center|||1||f||||f||||||Samples With DNA|"~     For study purposes, OP swabs or expectorated sputum for bacterial culture will be obtained~     annually beginning in the calendar year of first isolation of Pa from a respiratory culture~     at the local site laboratory. A serum sample for serology assessment and banking will be~     obtained annually in conjunction with a scheduled clinical blood draw whenever possible.~     Under a separate consent, additional blood (6 ml) will be collected for DNA use and banking~     for studies of genetic factors that may be associated with CF pathogenesis, disease~     progression, and clinical outcomes. These studies will test for association between gene~     variants and various CF-related phenotypes using either a targeted (i.e., candidate gene)~     approach or by performing a whole-genome scan.~   "|||2017-02-18 14:23:29.079577|2017-02-18 14:23:29.079577
NCT00676156|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2012-11-02|||December 2005||2005-12-01|November 2012|2012-11-01|November 2008|Actual|2008-11-01|February 2008|Actual|2008-02-01||Interventional|||A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis|A Pilot Trial to Study the Pharmacokinetics of Oral Lipoic Acid (LA) and Immunological Effects of LA in Multiple Sclerosis|Completed||Phase 1|40|Actual|Oregon Health and Science University||3|||f||||f||||||||||2017-02-18 14:23:29.231013|2017-02-18 14:23:29.231013
NCT00676143|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2016-05-03|2013-10-14||January 2008||2008-01-01|May 2016|2016-05-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional||Safety population included all randomized participants who received at least one infusion or portion of an infusion of study drug.|Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients|A Phase Iii, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Efficacy And Safety Trial Of Bapineuzumab (Aab 001, Eln115727) In Subjects With Mild To Moderate Alzheimer Disease Who Are Apolipoprotein E 4 Carriers|Terminated||Phase 3|1100|Actual|Pfizer||2||"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical~   benefit. This decision was not based on any new safety concerns."|f||||t||||||||||2017-02-18 14:23:29.358275|2017-02-18 14:23:29.358275
NCT00676130|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-08-12|2012-07-03||May 2007||2007-05-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients|Randomized Trial of Trimethoprim-Sulfamethoxazole Versus Placebo Added to Standard Treatment of Uncomplicated Cellulitis in Emergency Department Patients|Completed||N/A|153|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 14:23:31.082359|2017-02-18 14:23:31.082359
NCT00676117|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-03-11|||April 2008||2008-04-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males|A Single-Centre, Open, Randomised, Three-Way Cross-Over Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Healthy Male Subjects|Completed||Phase 1|30|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:23:31.508992|2017-02-18 14:23:31.508992
NCT00676104|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-12-19|||July 2006||2006-07-01|December 2013|2013-12-01|October 2008|Actual|2008-10-01|August 2007|Actual|2007-08-01||Interventional|||Discrete Hypothermia in the Management of Traumatic Brain Injury|Discrete Hypothermia in the Management of Traumatic Brain Injury|Completed||Phase 3|25|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:23:31.614535|2017-02-18 14:23:31.614535
NCT00676091|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2011-08-04|2010-09-22||April 2008||2008-04-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil|A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Brazil|Completed||Phase 3|354|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:23:31.725567|2017-02-18 14:23:31.725567
NCT00676078|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-09-29|||May 2005||2005-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:23:33.681521|2017-02-18 14:23:33.681521
NCT00676065|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2014-11-13|2014-11-13||February 2001||2001-02-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Observational|||Long-term Active Surveillance Study for Oral Contraceptives (LASS)|Long-term Active Surveillance Study for Oral Contraceptives (LASS)|Completed||N/A|58303|Actual|Center for Epidemiology and Health Research, Germany|In non-experimental studies the possibility of bias and residual confounding can never be entirely eliminated. The findings may exclude large, but not small relative risks.||3||f||||t||||||||||2017-02-18 14:23:33.741484|2017-02-18 14:23:33.741484
NCT00676052|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-11-15||2012-03-29|May 2008||2008-05-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Dose-Ranging Study for GSK233705B Delivered Once Daily in Subjects With COPD|Completed||Phase 2|576|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:23:34.238795|2017-02-18 14:23:34.238795
NCT00676039|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2009-02-10|||November 2007||2007-11-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations|Examination of the Pharmacokinetic Properties of Two Generic Antidepressants and Their Respective Brand Preparations in Healthy Male Volunteers|Completed||Phase 1|18|Actual|University of Ottawa||2|||f||||f||||||||||2017-02-18 14:23:34.44143|2017-02-18 14:23:34.44143
NCT00676026|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2016-12-01|||May 2005||2005-05-01|December 2016|2016-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women|The Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women|Completed||N/A|8|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-02-18 14:23:34.539881|2017-02-18 14:23:34.539881
NCT00676013|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-09-06|||December 1997||1997-12-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|Quad||Skin Substitutes in Burn Care|The Use of Alloderm and Other Skin Substitutes in Acute Burn Treatment and Burn Scar Reconstruction|Terminated||Phase 2/Phase 3|158|Actual|The University of Texas Medical Branch, Galveston||4|||f||||t||||||||||2017-02-18 14:23:34.648255|2017-02-18 14:23:34.648255
NCT00676000|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-03-17|||April 2008||2008-04-01|March 2009|2009-03-01||||December 2009|Anticipated|2009-12-01||Interventional|||Randomized Trial of Interrupted Versus Continuous Vaginal Closure of Anterior Repair With Mesh|Randomized Trial of Interrupted Versus Continuous Vaginal Closure of Anterior Repair With Mesh|Withdrawn||N/A|350|Anticipated|Brigham and Women's Hospital||2||Due to decrease in Avaulta mesh kit usage & inability to recruit study subjects.|f||||t||||||||||2017-02-18 14:23:34.764134|2017-02-18 14:23:34.764134
NCT00675987|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-02-04|2011-07-19||May 2007||2007-05-01|February 2013|2013-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients|Protocol Merck 318-00: A Double-Blind, Placebo-Controlled, Randomized, Parallel, Clinical Trial To Study The Effect Of Losartan Potassium On Endothelial Dysfunction And Insulin Resistance In Obese Patients With Impaired Fasting Glucose|Completed||Phase 4|53|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 14:23:34.862328|2017-02-18 14:23:34.862328
NCT00675974|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-11-13|||August 2005||2005-08-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|December 2012|Anticipated|2012-12-01||Interventional|Jobst||Use of Pressure Garments for Burn Scars|Prospective Randomized Study of the Effectiveness of Prospective Randomized Study on the Effectiveness of Pressure Garment Therapy for the Prevention of Hypertrophic Scarring in Burned Children|Withdrawn||Phase 2/Phase 3|0|Actual|The University of Texas Medical Branch, Galveston||2|||f||||t||||||||||2017-02-18 14:23:35.247766|2017-02-18 14:23:35.247766
NCT00675961|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-07-14|||January 2007||2007-01-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|IMPACT||Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, Russia|Effectiveness of Alcohol Interventions Among TB Patients in Tomsk Oblast, Russia|Completed||N/A|400|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-02-18 14:23:35.450187|2017-02-18 14:23:35.450187
NCT00675948|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2013-06-13|2012-07-05||April 2002||2002-04-01|June 2013|2013-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain|An Open-label, Extension Study, to Investigate the Long-term Safety and Tolerability of Cannabis Based Medicine Extracts in Patients With Cancer-related Pain.|Completed||Phase 3|43|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 14:23:35.570657|2017-02-18 14:23:35.570657
NCT00675935|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2010-07-22|||September 2007||2007-09-01|July 2010|2010-07-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|Falls TIPS||Falls - Tailoring Interventions for Patient Safety|Translating Fall Risk Status Into Interventions to Prevent Patient Falls: Falls TIPS (Tailoring Interventions for Patient Safety)|Completed||Phase 1/Phase 2|2000|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 14:23:36.178107|2017-02-18 14:23:36.178107
NCT00675922|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-12-10|2012-08-06||July 1995||1995-07-01|December 2012|2012-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|Soaks||Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks|Comparing the Use of Sulfamylon 5%, Dakins 0.025%, Cerium, Silver Nitrate 5% and/or Other Topical Antimicrobial Products for the Treatment of Excised and/or Grafted Burn Wounds|Terminated||Phase 2/Phase 3|98|Actual|The University of Texas Medical Branch, Galveston||1||Data inconclusive.|f||||t||||||||||2017-02-18 14:23:36.292415|2017-02-18 14:23:36.292415
NCT00675909|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2012-06-11|2011-07-29||November 2006||2006-11-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Improving Sedation of Children Undergoing Procedures in the Emergency Department|Improving Sedation of Children Undergoing Procedures in the Emergency Department: Evaluation of Different Dosages and Routes of Administration of the Sedative Midazolam|Completed||N/A|180|Actual|Seattle Children's Hospital||3|||f||||t||||||||||2017-02-18 14:23:36.70167|2017-02-18 14:23:36.70167
NCT00675896|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-07-03|||April 2007||2007-04-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome|A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and Tolerability of Quetiapine Fumarate Sustained Release(Seroquel SRTM) in the Treatment of Major Depression With Comorbid Fibromyalgia Syndrome.|Completed||Phase 4|120|Anticipated|Dr Alexander McIntyre Inc.||2|||f||||f||||||||||2017-02-18 14:23:37.155037|2017-02-18 14:23:37.155037
NCT00675883|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2012-01-26|||May 2008||2008-05-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|COMPASS||COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS|COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS|Completed||N/A|1000|Actual|Biogen|||2||f||||f||||||||||2017-02-18 14:23:37.264928|2017-02-18 14:23:37.264928
NCT00675870|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2008-05-09|||April 2008||2008-04-01|May 2008|2008-05-01||||April 2010|Anticipated|2010-04-01||Interventional|||Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia|Phase II Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia|Unknown status|Recruiting|Phase 2|65|Anticipated|NuRx Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:23:37.350047|2017-02-18 14:23:37.350047
NCT00675857|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2010-08-23|||April 2008||2008-04-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes|A Phase IIa Study of the Safety and Clinical Proof-of-concept of NC-503 (Eprodisate Disodium) in Patients With Type II Diabetes and Features of Metabolic Syndrome|Completed||Phase 2|200|Anticipated|Bellus Health Inc||2|||f||||||||||||||2017-02-18 14:23:37.451199|2017-02-18 14:23:37.451199
NCT00675844|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2014-01-20||2014-01-20|May 2008||2008-05-01|January 2014|2014-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment|An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment for 48-Weeks in Subjects Who Have Completed 96 -Weeks of Elvucitabine Therapy in Protocol ACH443-015 or 48 Weeks of Therapy in Protocol ACH443-018|Completed||Phase 2|7|Actual|Achillion Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:23:37.569361|2017-02-18 14:23:37.569361
NCT00675831|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-09-28|||December 2007||2007-12-01|September 2016|2016-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies|Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies After Matched Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 1|24|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 14:23:37.69441|2017-02-18 14:23:37.69441
NCT00675818|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2012-03-09|||May 2008||2008-05-01|March 2012|2012-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|OMAKI||The Optimal Mode of Renal Replacement Therapy in Acute Kidney Injury (OMAKI) Study|The Optimal Mode of Renal Replacement Therapy in Acute Kidney Injury (OMAKI) Study: A Pilot Randomized Controlled Trial of Convective Versus Diffusive Clearance|Completed||Phase 4|78|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-02-18 14:23:37.812443|2017-02-18 14:23:37.812443
NCT00675805|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2014-09-19|||May 2008||2008-05-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Preventing Intravenous Immunoglobulin-associated Adverse Reactions|Prospective Assessment of 0.2 um Pore-sized Filters in Preventing Intravenous Immunoglobulin-associated Adverse Reactions|Completed||N/A|42|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 14:23:37.918238|2017-02-18 14:23:37.918238
NCT00517023|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2008-05-06|||August 2007||2007-08-01|May 2008|2008-05-01|August 2009|Anticipated|2009-08-01|July 2008|Anticipated|2008-07-01||Interventional|EaSyAS II||Eastbourne Syncope Assessment Study II|Eastbourne Syncope Assessment Study II|Unknown status|Recruiting|N/A|240|Anticipated|Eastbourne General Hospital||4|||f||||f||||||||||2017-02-18 15:21:41.452194|2017-02-18 15:21:41.452194
NCT00675792|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-02-24|2013-05-21||May 2008||2008-05-01|February 2015|2015-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Sugammadex Administered at 1-2 Post Tetanic Counts (PTCs) or Better With Neostigmine Administered as Per Standard of Care to Reverse Rocuronium-Induced Neuromuscular Blockade in Adults Undergoing Elective Open Abdominal Procedure (19.4.334) (P05774)|A Multi-center, Randomized, Parallel Group, Comparative, Active Controlled, Safety-assessor Blinded, Anesthesiologist-TOF-Watch® SX Blinded Trial Comparing T4/T1 Ratio at Time of Tracheal Extubation Using 4 mg/kg Sugammadex Administered at 1-2 PTCs or Better After the Last Dose of Rocuronium Bromide to 50 µg/kg Neostigmine Administered as Per Standard of Care in Adult Subjects Undergoing Elective Open Abdominal Procedures Requiring Neuromuscular Blockade Reversal|Completed||Phase 3|100|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:23:38.034293|2017-02-18 14:23:38.034293
NCT00675779|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-09|||April 2008||2008-04-01|May 2008|2008-05-01|March 2011|Anticipated|2011-03-01|November 2010|Anticipated|2010-11-01||Interventional|EndoStatin||Efficacy Study of Atorvastatin in Pelvic Pain Relief in Women With Endometriosis|Comparison of Pain Relief and Inflammatory Status in Women With Surgically Confirmed Endometriosis Treated With Atorvastatin, Oral Contraceptive or Combined Oral Contraceptives and Atorvastatin: Open Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|44|Anticipated|Poznan University of Medical Sciences||2|||f||||f||||||||||2017-02-18 14:23:38.667412|2017-02-18 14:23:38.667412
NCT00675766|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-04-29|2015-02-13||September 2005||2005-09-01|April 2015|2015-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences|Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences|Completed||N/A|223|Actual|VA Office of Research and Development|Large number of subjects who were lost to follow up (i.e moved from community, did not answer follow up calls to schedule visits) resulted in a reduced sample size of subjects who completed the study.||4||f||||t||||||||||2017-02-18 14:23:38.779709|2017-02-18 14:23:38.779709
NCT00675753|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-12-16|||September 2008||2008-09-01|December 2015|2015-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families|Genetic Variations in Three Interacting Single Nucleotide Polymorphisms and the Risk of Preterm Birth in Black Families|Terminated||N/A|258|Actual|University of Miami|||2|Study site did not have sufficient subjects for the case group|f||||t||||||Samples With DNA|"~     Blood spot specimens were collected from the mother and her infant.~   "|||2017-02-18 14:23:39.549948|2017-02-18 14:23:39.549948
NCT00675740|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2010-02-01|||January 2004||2004-01-01|January 2010|2010-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Physical Exercise Versus Rosiglitazone in CAD and Prediabetes|Effects of Physical Exercise Versus Rosiglitazone on Endothelial Function in Coronary Artery Disease Patients With Prediabetes|Completed||Phase 4|45|Actual|University of Leipzig||3|||f||||f||||||||||2017-02-18 14:23:39.826099|2017-02-18 14:23:39.826099
NCT00675727|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2009-06-10|||December 2006||2006-12-01|June 2009|2009-06-01||||December 2010|Anticipated|2010-12-01||Interventional|||Safety Study of CADI-05 in Patients With Advanced Stage Melanoma|Open Label, Single Arm, Phase I/II Study of CADI-05 in Patients With Advanced Stage III or Stage IV Melanoma|Terminated||Phase 1/Phase 2|20|Anticipated|Cadila Pharnmaceuticals||1||"DSMB reviewed data of 1st 10 subjects; determined no safety concerns. Efficacy as a single~   agent in this patient population was unlikely. Voluntary Termination"|f||||t||||||||||2017-02-18 14:23:39.927944|2017-02-18 14:23:39.927944
NCT00675714|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-06-16|||January 2004||2004-01-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation|Assessment of the Treatment of the Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation|Recruiting||Phase 2/Phase 3|1100|Anticipated|The University of Texas Medical Branch, Galveston||9|||f||||t||||||||||2017-02-18 14:23:40.039405|2017-02-18 14:23:40.039405
NCT00675701|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-06-20|||May 2008||2008-05-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study|A Double Blind, Randomized, Repeat-Dose, Parallel Group Study to Define the ECG Effects of Lixivaptan Using a Clinical and a Supratherapeutic Dose, Compared to Placebo and Moxifloxacin (a Positive Control), in Healthy Adult Men and Women: A Thorough ECG Study|Completed||Phase 1|298|Actual|CardioKine Inc.||3|||f||||t||||||||||2017-02-18 14:23:40.211537|2017-02-18 14:23:40.211537
NCT00675688|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2008-05-09|||April 2002||2002-04-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women|A Double-Blind, Randomized, Placebo- and Active-Controlled Safety and Efficacy Study of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women|Completed||Phase 3|3544|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 14:23:40.313947|2017-02-18 14:23:40.313947
NCT00675675|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-08-19|||July 2007||2007-07-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders|TRECC: Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders|Completed||N/A|53|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 14:23:40.406459|2017-02-18 14:23:40.406459
NCT00675662|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-01-12|||April 2008||2008-04-01|September 2015|2015-09-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|TrimTots||Trim Tots Pre-school Obesity Prevention Programme|TrimTots Pre-school Obesity Prevention Programme|Completed||N/A|173|Actual|Institute of Child Health||2|||f||||f||||||||||2017-02-18 14:23:40.510233|2017-02-18 14:23:40.510233
NCT00675649|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2015-04-09|||May 2008||2008-05-01|April 2015|2015-04-01||||||||Interventional|||A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent Asthma|A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Parallel-group Study Evaluating the Efficacy and Safety of Golimumab Administered Subcutaneously in Symptomatic Subjects With Severe, Persistent Asthma|Withdrawn||Phase 2|0|Actual|Centocor, Inc.||2|||f||||t||||||||||2017-02-18 14:23:40.621403|2017-02-18 14:23:40.621403
NCT00675636|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2011-04-01|||January 2007||2007-01-01|April 2011|2011-04-01||||April 2012|Anticipated|2012-04-01||Observational|||Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer|Vanderbilt Hereditary Colorectal Cancer Registry|Unknown status|Recruiting|N/A|500|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-02-18 14:23:40.725814|2017-02-18 14:23:40.725814
NCT00675623|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-09-24||2016-09-24|May 2008||2008-05-01|September 2016|2016-09-01||||December 2009|Actual|2009-12-01||Interventional|CONNECTION||A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease|A Global Phase 3, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Oral Dimebon in Patients With Mild-to-Moderate Alzheimer's Disease (CONNECTION)|Completed||Phase 3|598|Actual|Medivation, Inc.||3|||f||||t||||||||||2017-02-18 14:23:40.825326|2017-02-18 14:23:40.825326
NCT00675610|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-03-31|||May 2008||2008-05-01|March 2015|2015-03-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|ECHO||Enhancing Communication and HIV Outcomes|Enhancing Communication and HIV Outcomes|Completed||Phase 3|186|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:23:40.961414|2017-02-18 14:23:40.961414
NCT00675597|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-10-20|2015-10-20||May 2008||2008-05-01|October 2015|2015-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer|A Pilot Study of Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer|Completed||N/A|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:23:41.075116|2017-02-18 14:23:41.075116
NCT00675584|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-02-24|2012-04-30||August 2008||2008-08-01|February 2013|2013-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|MIST||Childhood Asthma Research and Education (CARE) Network Trial - Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)|Childhood Asthma Research and Education (CARE) Network Trial - Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)|Completed||Phase 3|278|Actual|Milton S. Hershey Medical Center|May not be applicable to young children whose asthma is more severe than that of the children in the study. Daily or intermittent use of inhaled glucocorticoids may not be efficacious in preschool-age children with transient or infrequent wheezing.|2|||f||||t||||||||||2017-02-18 14:23:41.33396|2017-02-18 14:23:41.33396
NCT00675558|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-07-14|2012-12-06||November 2006||2006-11-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|April 2011|Actual|2011-04-01||Observational|||Bariatric Surgery for Morbid Obesity|Bariatric Surgery for Morbid Obesity: Clinical and Pathophysiologic Consequences|Completed||N/A|50|Actual|Columbia University|||3||f||||f||||||Samples With DNA|"~     Blood samples and biopsies of omental and subcutaneous fat.~   "|||2017-02-18 14:23:41.713182|2017-02-18 14:23:41.713182
NCT00675545|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2012-03-30|||May 2007||2007-05-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients|A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients|Completed||Phase 2|2|Actual|National University Hospital, Singapore||1|||f||||f||||||||||2017-02-18 14:23:42.151496|2017-02-18 14:23:42.151496
NCT00675532|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-07-19|||May 2011||2011-05-01|July 2013|2013-07-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|||Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol).|Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol).|Withdrawn||N/A|0|Actual|Yale University||2||Resources|f||||t||||||||||2017-02-18 14:23:42.258777|2017-02-18 14:23:42.258777
NCT00675519|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2015-04-06|||January 2004||2004-01-01|April 2015|2015-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|BI||An Evaluation of the Brief Interventional for Problem Drinkers Among Medical Inpatients|Effects of Brief Intervention for General Hospital Inpatients With Unhealthy Alcohol Use in Taiwan: A Randomized, Controlled Trial|Completed||N/A|300|Actual|Mackay Memorial Hospital||1|||f||||t||||||||||2017-02-18 14:23:42.477829|2017-02-18 14:23:42.477829
NCT00675506|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2012-12-03|2012-10-23||July 2008||2008-07-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese|Physiologic Effects of Long-Term GHRH1-44 in Abdominal Obesity|Completed||Phase 2|60|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:23:42.570771|2017-02-18 14:23:42.570771
NCT00675493|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-02-18|||May 2008||2008-05-01|February 2016|2016-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30|A Prospective, Multicentre, Open Label, Non-controlled, Observational, 24-week Study in Patients Using NovoMix® 30 (Biphasic Insulin Aspart 30) for Treatment of Type 1 and Type 2 Diabetes Mellitus in Romania|Completed||N/A|942|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:23:43.055112|2017-02-18 14:23:43.055112
NCT00675480|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2009-01-28|||November 2004||2004-11-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|TAMI||Thrombectomy in Acute Myocardial Infarction|Aspiration Thrombectomy as an Adjunctive Therapy to Primary Angioplasty in Patients With ST Segment Elevation Myocardial Infarction|Completed||Phase 3|140|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||f||||||||||2017-02-18 14:23:43.158496|2017-02-18 14:23:43.158496
NCT00675467|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-04-07|||April 2008||2008-04-01|April 2016|2016-04-01||||April 2016|Actual|2016-04-01||Observational|||Palliative Care and Symptom Management for the Pediatric Oncology Patient|Palliative Care and Symptom Management for the Pediatric Oncology Patient|Completed||N/A|13|Actual|M.D. Anderson Cancer Center|||7||f||||f||||||||||2017-02-18 14:23:43.262714|2017-02-18 14:23:43.262714
NCT00675454|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-08-19|||January 2000||2000-01-01|August 2013|2013-08-01||||November 2004|Actual|2004-11-01||Observational|||Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema|Emphysema: Outcomes and Technology Assessment|Unknown status|Enrolling by invitation|N/A|300|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 14:23:43.366981|2017-02-18 14:23:43.366981
NCT00675441|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-10-21|2013-10-21||April 2008||2008-04-01|October 2013|2013-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)|A Phase II Study of Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Versus-Host Disease (GVHD)|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center|The study did not meet all primary and secondary objectives due to slow patient accrual.|1||Terminated due to slow accrual.|f||||f||||||||||2017-02-18 14:23:43.451444|2017-02-18 14:23:43.451444
NCT00668889|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-01-28|||November 2007||2007-11-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Dermacyd Tina Gel Tangerina Mix - Photo Evaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Tina Gel Tangerina Mix.|Completed||Phase 3|25|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:25:53.025066|2017-02-18 14:25:53.025066
NCT00675428|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-09-15|2014-09-15||September 2008||2008-09-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of Natalizumab in Relapsed/Refractory Multiple Myeloma|A Phase 1/2, Two-Arm, Dose-Finding Study of Natalizumab for the Treatment of Subjects With Relapsed or Refractory Multiple Myeloma|Terminated||Phase 1/Phase 2|6|Actual|Biogen||2||Sponsor decision due to low enrollment and not safety concerns.|f||||t||||||||||2017-02-18 14:23:43.822444|2017-02-18 14:23:43.822444
NCT00675415|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2014-02-22|||September 2006||2006-09-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?|Does Capnography Prevent Hypoxemia During ERCP and EUS? A Randomized, Controlled Trial|Completed||N/A|263|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 14:23:44.254421|2017-02-18 14:23:44.254421
NCT00675402|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-03-21|||January 2009||2009-01-01|March 2011|2011-03-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Observational|VAPAV||Micro- and Macrovascular Adaptations in Patients With Peripheral Arterial Disease During Supervised Exercise Therapy|Micro- and Macrovascular Adaptations in Patients With Peripheral Arterial Disease During Supervised Exercise Therapy: a MRI Study|Unknown status|Recruiting|N/A|117|Anticipated|Maastricht University Medical Center|||1||f||||f||||||||||2017-02-18 14:23:44.361394|2017-02-18 14:23:44.361394
NCT00675389|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2012-03-28|||March 2006||2006-03-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|April 2008|Actual|2008-04-01||Interventional|||Impact of Peer Health Workers and Mobile Phones on HIV Care|Impact of Peer Health Workers and Mobile Phones on HIV Care|Completed||N/A|1200|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-02-18 14:23:44.448658|2017-02-18 14:23:44.448658
NCT00675376|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-08-19|||January 2006||2006-01-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Evaluating Quality of Life for Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation|Lung Transplant for COPD: Outcomes/Technology|Unknown status|Enrolling by invitation|N/A|350|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 14:23:44.540059|2017-02-18 14:23:44.540059
NCT00675363|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2011-09-23|||January 2008||2008-01-01|September 2011|2011-09-01|November 2011|Anticipated|2011-11-01|August 2011|Actual|2011-08-01||Interventional|SLEAP||Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol|A Randomized Trial of Daily Sedative Interruption in Critically Ill, Mechanically Ventilated Patients Being Managed With a Sedation Protocol|Unknown status|Active, not recruiting|N/A|410|Anticipated|Mount Sinai Hospital, Canada||2|||f||||t||||||||||2017-02-18 14:23:44.634872|2017-02-18 14:23:44.634872
NCT00675350|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2014-05-09|||April 2008||2008-04-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors|A Pharmacokinetic Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors|Completed||Phase 1|12|Actual|Teva Pharmaceutical Industries||1|||f||||t||||||||||2017-02-18 14:23:44.757555|2017-02-18 14:23:44.757555
NCT00675337|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2008-12-30|||June 2008||2008-06-01|December 2008|2008-12-01|April 2009|Anticipated|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Infant Placement on Iron Stores in Infancy: A Pilot Study|The Effect of Infant Placement at Delivery on Iron Stores in Early Infancy: A Pilot Study|Unknown status|Active, not recruiting|N/A|30|Anticipated|Davison, James, D.O.||2|||f||||t||||||||||2017-02-18 14:23:44.867621|2017-02-18 14:23:44.867621
NCT00675324|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2012-09-17|||April 2008||2008-04-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Bowel Preparation Before Colonoscopy|Bowel Preparation With Nutritional Drinks Instead of Traditional Bowel Preparation|Terminated||N/A|47|Actual|Karolinska Institutet||2||The bowel was not clean when the colonoscopy was performed|f||||f||||||||||2017-02-18 14:23:44.971815|2017-02-18 14:23:44.971815
NCT00675311|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2009-12-17|||March 2008||2008-03-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Remote Monitoring in Diabetes Disease Management|A Randomized Study of the Clinical and Economic Impact of Remote Monitoring Program With Disease Management Compared to Conventional Diabetes Disease Management Interventions|Completed||N/A|300|Anticipated|LifeScan||2|||f||||f||||||||||2017-02-18 14:23:45.075688|2017-02-18 14:23:45.075688
NCT00675298|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2017-02-02|||January 2006||2006-01-01|February 2014|2014-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|IC||Linkage Analysis in Interstitial Cystitis|Genetic Studies of Urologic Chronic Pelvic Pain Syndrome|Completed||N/A|300|Anticipated|Beth Israel Deaconess Medical Center|||5||f||||f||||||Samples With DNA|"~     Saliva and urine~   "|||2017-02-18 14:23:45.187408|2017-02-18 14:23:45.187408
NCT00675285|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2008-05-08|||September 2005||2005-09-01|May 2008|2008-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effects of Montelukast in Children With Asthma|Effects of Oral Montelukast on Airway Inflammation in Children With Mild Asthma|Completed||Phase 3|26|Actual|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-02-18 14:23:45.277023|2017-02-18 14:23:45.277023
NCT00675272|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-04-03|||May 2008||2008-05-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|HYDRO||Organ Donation and Hydrocortisone Treatment|Organ Donation and Vasopressor Use: Effects of Hydrocortisone Treatment|Terminated||N/A|38|Actual|Kuopio University Hospital||2||Routine use of corticoids became standard therapy|f||||f||||||||||2017-02-18 14:23:45.380097|2017-02-18 14:23:45.380097
NCT00675259|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-11-22|2015-11-10||July 2008||2008-07-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|May 2011|Actual|2011-05-01||Interventional|||Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer|Phase II Trial of Neoadjuvant Chemotherapy [NCT] With Weekly Nanoparticle Albumin-bound Paclitaxel [Nab-paclitaxel; Abraxane®] in Combination With Carboplatin and Bevacizumab in Women With Clinical Stages I-III Breast Cancer|Completed||Phase 2|33|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:23:45.488399|2017-02-18 14:23:45.488399
NCT00675246|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2010-06-08|||May 2008||2008-05-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|ACTLPT||Antenatal Corticoid Therapy for Late Preterm Babies|Antenatal Corticoid Therapy for Fetal Lung Maturation in Late Preterm Pregnancies: a Randomized Controlled Trial|Completed||N/A|320|Anticipated|Instituto Materno Infantil Prof. Fernando Figueira||1|||f||||t||||||||||2017-02-18 14:23:45.899205|2017-02-18 14:23:45.899205
NCT00675233|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-08|2016-10-26|||January 2008||2008-01-01|October 2016|2016-10-01||||June 2013|Actual|2013-06-01||Interventional|||Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx|Phase I Trial of Photodynamic Therapy With HPPH (2-1[Hexyloxyethyl]-2-devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Larynx|Active, not recruiting||Phase 1|29|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 14:23:46.009026|2017-02-18 14:23:46.009026
NCT00675220|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-10-26|||June 2007||2007-06-01|October 2016|2016-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™|A Prospective, Open-Labelled, Non-Controlled, Observational Study to Assess the Efficacy and Safety of NovoRapid™ FlexPen™ in the Treatment of Acute Hyperglycemia: A Post-Marketing Surveillance Study|Completed||N/A|373|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:23:46.119324|2017-02-18 14:23:46.119324
NCT00675207|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2008-05-06|||January 2006||2006-01-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs|Comparison of Brimonidine 0.15% Purite, Dorzolamide 2%, and Brinzolamide 1% as Adjunctive Therapy to Prostaglandin Analogs|Completed||Phase 4|120|Actual|Northwestern Ophthalmic Institute S.C.||3|||f||||t||||||||||2017-02-18 14:23:46.231313|2017-02-18 14:23:46.231313
NCT00675194|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2008-05-16|||October 2003||2003-10-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer|A Prospective, Open, Comparative Multicentre Phase II Study for the Evaluation of Irinotecan and Capecitabine Versus Cisplatin and Capecitabine in Advanced Gastric Adenocarcinoma or Gastric-Oesophagal Junction|Completed||Phase 2|120|Anticipated|Johannes Gutenberg University Mainz|||||f||||t||||||||||2017-02-18 14:23:46.342416|2017-02-18 14:23:46.342416
NCT00675181|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2012-09-10|||May 2008||2008-05-01|September 2012|2012-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|MelO2||Effects of Melatonin and Oxygen Consumption and Choroidal Blood Flow|Effects of Melatonin on Oxygen Consumption and Choroidal Blood Flow in Women With Vasospastic Syndrome in Comparison to Controls|Completed||N/A|16|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 14:23:46.435978|2017-02-18 14:23:46.435978
NCT00675168|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-02-18|||May 2008||2008-05-01|February 2009|2009-02-01|June 2012|Anticipated|2012-06-01|June 2010|Anticipated|2010-06-01||Interventional|PROLOG||Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice|PET/CT and Roentgen in Lung Cancer. Evaluation of Patients in General Practice|Unknown status|Recruiting|Phase 4|1700|Anticipated|Odense University Hospital||1|||f||||t||||||||||2017-02-18 14:23:46.546995|2017-02-18 14:23:46.546995
NCT00675155|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-01-02|||May 2008||2008-05-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|May 2010|Anticipated|2010-05-01||Interventional|||Far Infrared Irradiation for Stroke Rehabilitation|Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Stroke Rehabilitation|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:23:46.64138|2017-02-18 14:23:46.64138
NCT00675142|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2015-06-21|||May 2008||2008-05-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Optimal Timing of Intrauterine Insemination (IUI) When Utilizing Superovulation Combined With GnRH Antagonists|A Randomized Open Three Arm Prospective Trial To Determine The Optimal Timing for Intrauterine Insemination After Superovulation With Recombinant Gonadotropins Utilizing GnRH Antagonists|Completed||N/A|107|Actual|HaEmek Medical Center, Israel||3|||f||||||||||||||2017-02-18 14:23:46.737388|2017-02-18 14:23:46.737388
NCT00675129|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-10-22|||May 2008||2008-05-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|||Treatment for Adolescents With Deliberate Self Harm|A Randomized Controlled Trial for Repetitive Deliberate Self-harm and Suicidal Behaviours Among Norwegian Adolescents: a Comparison Between Dialectical Behaviour Therapy Adapted for Adolescents (DBT-A) and Enhanced Usual Care (EUC)|Completed||Phase 2|77|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 14:23:46.837399|2017-02-18 14:23:46.837399
NCT00675116|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2010-10-14||2010-10-14|April 2008||2008-04-01|October 2010|2010-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||GW823296 Repeat Dose Study In Healthy Male And Female Subjects|A Single-Blind, Randomised, Placebo Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GW823296 After Once-Daily Repeated Oral Doses in Healthy Male and Female Subjects|Completed||Phase 1|30|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 14:23:46.948624|2017-02-18 14:23:46.948624
NCT00675103|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-06-07|2011-06-07||May 2008||2008-05-01|June 2011|2011-06-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients|Multicenter, Open-Label, 24 Week Regimen of 8 mg Pegloticase i.v. in Symptomatic Gout Subjects Who Participated in Previous Studies of Pegloticase i.v.|Completed||Phase 3|7|Actual|Savient Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:23:47.028343|2017-02-18 14:23:47.028343
NCT00675090|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-10-11|||February 2008||2008-02-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease|A Single Blind, Placebo-controlled, Randomised Study in Mild to Moderate Alzheimer's Disease Patients to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK239512, a Selective Histamine H3 Receptor Antagonist|Completed||Phase 1|28|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:23:47.392736|2017-02-18 14:23:47.392736
NCT00675077|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-01-02|||May 2008||2008-05-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|May 2010|Anticipated|2010-05-01||Interventional|||Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)|Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Control, Management and Treatment of HD|Unknown status|Active, not recruiting|Phase 1|5|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:23:47.513942|2017-02-18 14:23:47.513942
NCT00675064|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-03-15|||May 2008||2008-05-01|October 2011|2011-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects|Single-blind, Placebo-controlled, Randomized Study Testing Single Ascending Doses of GSK369796 in Healthy Subjects|Completed||Phase 1|41|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:23:47.622683|2017-02-18 14:23:47.622683
NCT00675051|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-10-25|||March 2008||2008-03-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension|Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension|Completed||N/A|20|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 14:23:47.732309|2017-02-18 14:23:47.732309
NCT00675038|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-09-14|||October 2005||2005-10-01|September 2011|2011-09-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Observational|||Pilot Study of Non-Invasive Assessment of Hepatic And Myocardial Iron Through T2* Magnet Resonance Imaging (MRI) In Patients With Iron Overload|Pilot Study of Non-Invasive Assessment of Hepatic And Myocardial Iron Through T2* MRI In Patients With Iron Overload|Completed||N/A|52|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 14:23:47.80481|2017-02-18 14:23:47.80481
NCT00675025|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2008-12-10|||April 2008||2008-04-01|December 2008|2008-12-01||||February 2009|Anticipated|2009-02-01||Interventional|||Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial|An Open-Label Study To Evaluate The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial|Terminated||Phase 2|128|Anticipated|Eisai Inc.||1||Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns.|f||||||||||||||2017-02-18 14:23:47.907443|2017-02-18 14:23:47.907443
NCT00675012|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2014-05-29|||December 2007||2007-12-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|December 2010|Actual|2010-12-01||Interventional|||NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer|NGR005: Pilot Study of NGR-hTNF Administered at Low and High Doses in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|24|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 14:23:48.039968|2017-02-18 14:23:48.039968
NCT00674999|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-11-13|||June 2005||2005-06-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|Amnion||Use of Amnion on Partial Thickness Burns|Project Title The Treatment of Partial Thickness Burns: Treated Amnion Versus Currently in Use Topical Medications|Withdrawn||Phase 2/Phase 3|0|Actual|The University of Texas Medical Branch, Galveston||3||Hurricane- terminated study due to skin bank being destroyed|f||||f||||||||||2017-02-18 14:23:48.327214|2017-02-18 14:23:48.327214
NCT00674986|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-08-19|2013-05-03||March 2008||2008-03-01|August 2013|2013-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||Intent to treat population included all enrolled participants who completed the baseline training visit.|A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 Diabetes|A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 Diabetes|Completed||N/A|522|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:23:48.441456|2017-02-18 14:23:48.441456
NCT00674973|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-05-13|2016-03-24||June 2008||2008-06-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|December 2010|Actual|2010-12-01||Interventional|||A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer|A Phase II Biomarker Identification Trial for Erlotinib (Tarceva®) in Patients With Advanced Pancreatic Carcinoma|Completed||Phase 2|207|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:23:49.090455|2017-02-18 14:23:49.090455
NCT00674960|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-08-14|||May 2008||2008-05-01|August 2009|2009-08-01|October 2009|Anticipated|2009-10-01|May 2009|Anticipated|2009-05-01||Interventional|||Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia|Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Management, Control and Treatment of Frontotemporal Dementia (Pick's Disease)|Unknown status|Active, not recruiting|Phase 1|0|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:23:49.703446|2017-02-18 14:23:49.703446
NCT00674947|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2013-09-12|||June 2008||2008-06-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors|A Phase I Study of BIIB015, a Humanized, IgG1, DM4-Conjugated, Anti-Cripto, Monoclonal Antibody, for the Treatment of Subjects With Relapsed or Refractory Solid Tumors|Completed||Phase 1|55|Actual|Biogen||1|||f||||||||||||||2017-02-18 14:23:49.816927|2017-02-18 14:23:49.816927
NCT00674934|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-01-02|||May 2008||2008-05-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|May 2010|Anticipated|2010-05-01||Interventional|||Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)|Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Multiple Sclerosis.|Unknown status|Active, not recruiting|Phase 1|5|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:23:49.907728|2017-02-18 14:23:49.907728
NCT00674921|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2008-06-04|||June 2008||2008-06-01|May 2008|2008-05-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|CCS||Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda|Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda|Unknown status|Not yet recruiting|Phase 4|1650|Anticipated|MRC/UVRI Uganda Research Unit on Aids||4|||f||||f||||||||||2017-02-18 14:23:50.01637|2017-02-18 14:23:50.01637
NCT00674908|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-06-24|||March 2008||2008-03-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine|A Single Blind, Multicentric, Comparative, Vaccine Interchangeability Trial of Shan 5 (Liquid) and Easy Five (Liquid) [Diphtheria-Tetanus- Pertussis, Hepatitis B and Hib Pentavalent Combination Vaccines] in Indian Infants.|Completed||Phase 4|144|Actual|Shantha Biotechnics Limited||2|||f||||f||||||||||2017-02-18 14:23:50.147034|2017-02-18 14:23:50.147034
NCT00674895|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-01-02|||May 2008||2008-05-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|May 2010|Anticipated|2010-05-01||Interventional|||Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)|Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Control and Treatment of Parkinson's Disease.|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:23:50.257222|2017-02-18 14:23:50.257222
NCT00668486|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-02-09|||January 2008||2008-01-01|February 2009|2009-02-01||||February 2008|Actual|2008-02-01||Interventional|||Dermacyd Delicata Breeze - Photo Evaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Breeze.|Completed||Phase 3|28|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:25:59.197847|2017-02-18 14:25:59.197847
NCT00674882|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-09-21|||January 2002||2002-01-01|September 2016|2016-09-01|December 2045|Anticipated|2045-12-01|December 2040|Anticipated|2040-12-01||Observational|||Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant|Protocol For Collecting Long-Term Follow-Up Data On Recipients of Hematopoietic Stem Cell Transplant|Recruiting||N/A|600|Anticipated|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 14:23:50.370703|2017-02-18 14:23:50.370703
NCT00674869|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-02-20|||December 2004||2004-12-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effectiveness of Pit and Fissure Sealants in the Prevention of Dental Caries|Effectiveness of Pit and Fissure Sealants in the Prevention of Dental Caries|Completed||N/A|400|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 14:23:50.594153|2017-02-18 14:23:50.594153
NCT00674856|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-01-27|||May 2008||2008-05-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|HCT3012-X-106||A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function|A Phase 1 Repeated Dose Open Label Study to Investigate the Pharmacokinetics and Safety of Naproxcinod 750mg Bid Administered to Patients With Impaired Renal Function Compared to Matching Healthy Subjects|Completed||Phase 1|32|Anticipated|NicOx||1|||f||||t||||||||||2017-02-18 14:23:50.705334|2017-02-18 14:23:50.705334
NCT00674843|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-08-14|||May 2008||2008-05-01|August 2009|2009-08-01|June 2010|Anticipated|2010-06-01|May 2010|Anticipated|2010-05-01||Interventional|||The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies|Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation to Manage or Treat Muscular Dystrophies.|Unknown status|Active, not recruiting|Phase 1|4|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:23:50.817101|2017-02-18 14:23:50.817101
NCT00674830|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-08-14|||April 2008||2008-04-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Self-help Treatment for Insomnia in Breast Cancer Patients|Self-help Treatment for Insomnia in Breast Cancer Patients|Completed||N/A|240|Actual|Centre Hospitalier Universitaire de Québec, CHU de Québec||3|||f||||f||||||||||2017-02-18 14:23:50.914905|2017-02-18 14:23:50.914905
NCT00674817|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-11-04|||April 2008||2008-04-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.|A Randomized, Double-blind, Crossover Study to Investigate the Bronchodilatation Post-inhalation of GSK961081 Alone and With the Addition of Cumulative Doses of Short Acting Bronchodilators (Salbutamol and Ipratropium Bromide) in Patients With COPD|Completed||Phase 2|45|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:23:51.012485|2017-02-18 14:23:51.012485
NCT00674804|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2017-01-24|||April 24, 2008||2008-04-24|July 16, 2009|2009-07-16|July 16, 2009|Actual|2009-07-16|July 16, 2009|Actual|2009-07-16||Observational|||Communicating a Cancer Diagnosis-Current Methods and Their Effects|Communicating a Cancer Diagnosis: Current Methods and Their Effects|Completed||N/A|1100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:23:51.153623|2017-02-18 14:23:51.153623
NCT00674791|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-06-18|||June 2007||2007-06-01|March 2011|2011-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease|A Phase I Study of Cancer Peptides Plus GM-CSF and Adjuvant (Montanide ISA 51) Following Completion of Prescribed Chemotherapy or Trastuzumab for TXN2-3M0 or Metastatic Breast Cancer With No Evidence of Disease|Completed||Phase 1|13|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:23:51.234019|2017-02-18 14:23:51.234019
NCT00674778|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-07|||June 2006||2006-06-01|May 2008|2008-05-01|June 2006||2006-06-01|||||Interventional|PREVAIL||Prospective Registry on Vascular Access in Interventions in Lazio Region|Prospective Registry on Vascular Access in Interventions in Lazio Region|Completed||Phase 4|1052|Actual|San Filippo Neri General Hospital||2|||f||||f||||||||||2017-02-18 14:23:51.335072|2017-02-18 14:23:51.335072
NCT00674765|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-09-16|2014-05-01||January 2008||2008-01-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|||Seroquel for Frequent, Heavy Drinkers|A Phase II Double-blind, Placebo-controlled Trial of Quetiapine for Frequent, Heavy Drinkers (Seroquel2)|Completed||Phase 2|156|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:23:51.427639|2017-02-18 14:23:51.427639
NCT00674752|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-04-22|||March 2006||2006-03-01|April 2011|2011-04-01|August 2006|Actual|2006-08-01|||||Interventional|||A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia|A Randomized, Double-Blind, Single-Dose, Placebo-Controlled, Multicenter, Polysomnographic Study Of Gabapentin 250 mg And 500 mg In Transient Insomnia Induced By A Sleep Phase Advance|Completed||Phase 3|377|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:23:51.824778|2017-02-18 14:23:51.824778
NCT00674739|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2011-05-19|2011-04-24||May 2008||2008-05-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts|A Phase 3, Randomized, Double-blind, Placebo-controlled, Multi-center, Efficacy and Safety Study of Imiquimod Creams in the Treatment of External Genital Warts|Completed||Phase 3|470|Actual|Graceway Pharmaceuticals, LLC||3|||f||||f||||||||||2017-02-18 14:23:51.95484|2017-02-18 14:23:51.95484
NCT00674726|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2012-10-29|||May 2008||2008-05-01|October 2012|2012-10-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Observational|||Study on the Difference of Axilo-rectal Temperature in Appendicitis|Prospective Study on the Difference of Axilar-rectal Temperature in Acute Appendicitis|Withdrawn||N/A|0|Actual|Cirujanos la Serena|||2||f||||f||||||||||2017-02-18 14:23:52.499952|2017-02-18 14:23:52.499952
NCT00674713|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-07|||January 2006||2006-01-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effect of Acupuncture on Postoperative Nausea and Vomiting||Completed||Phase 4|140|Actual|Catholic University of the Sacred Heart||4|||f||||||||||||||2017-02-18 14:23:52.606907|2017-02-18 14:23:52.606907
NCT00674700|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-04-12|2016-01-25||October 2007||2007-10-01|April 2016|2016-04-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional||The Full Analysis Set included all participants who received at least one dose of the investigational product and had at least one Adjusted Symptom Score evaluation in the year.|Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis|A Randomized, DBPC, Multi-national Phase II/III Study of the Safety and Efficacy of Two Doses of Sublingual Immunotherapy (SLIT) Administered as Allergen-based Tablets Once Daily to Adult Patients Suffering From HDM Allergic Rhinitis|Completed||Phase 2/Phase 3|509|Actual|Stallergenes||3|||f||||f||||||||||2017-02-18 14:23:52.733634|2017-02-18 14:23:52.733634
NCT00674687|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2008-05-08|||July 2004||2004-07-01|May 2008|2008-05-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing|A Randomized Double-Blind, Placebo-Controlled, Crossover Study To Assess The Reproducibility And The Effect Of Gabapentin On Quantitative Sensory Testing In Neuropathic Pain Patients|Completed||N/A|23|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:23:55.742223|2017-02-18 14:23:55.742223
NCT00674674|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-05-11|||October 2005||2005-10-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|PBTC-019||Phase 1 Intrathecal Topotecan for Neoplastic Meningitis|A Phase I Pharmacokinetic Optimal Dosing Study of Intrathecal Topotecan for Children With Neoplastic Meningitis|Completed||Phase 1|22|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:23:55.850366|2017-02-18 14:23:55.850366
NCT00674661|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-12-02|2016-08-17||December 2007||2007-12-01|December 2016|2016-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|CXL||Corneal Collagen Cross-Linking for Ectasia (CXL)|Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery|Completed||Phase 3|130|Actual|Avedro, Inc.||2|||f||||f||||||||||2017-02-18 14:23:55.966635|2017-02-18 14:23:55.966635
NCT00674648|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-05-26|||August 2007||2007-08-01|May 2016|2016-05-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants|A Phase I Dose Escalation Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of CMV Infections Following Allogeneic Hematopoietic Stem Cell Transplants|Active, not recruiting||Phase 1|30|Actual|Atara Biotherapeutics||1|||f||||||||||||||2017-02-18 14:23:56.570057|2017-02-18 14:23:56.570057
NCT00674635|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-11-30||2012-03-15|April 2008||2008-04-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis|A Randomized, Double-blind, Placebo-controlled, Bayesian Adaptive Dose Finding Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Intravenous Infusions GSK315234A in Patients With Active Rheumatoid Arthritis (RA)|Completed||Phase 2|135|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:23:56.886952|2017-02-18 14:23:56.886952
NCT00674622|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-05-13|2016-01-08||September 2007||2007-09-01|May 2016|2016-05-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||Prolotherapy for the Treatment of Chronic Lateral Epicondylitis|Prolotherapy for the Treatment of Chronic Lateral Epicondylitis|Completed||Phase 2/Phase 3|67|Actual|University of Pittsburgh||3|||f||||t||||||||Yes|Presented at conference.|2017-02-18 14:23:57.015283|2017-02-18 14:23:57.015283
NCT00674609|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2013-06-13|2012-07-05||February 2002||2002-02-01|June 2013|2013-06-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Interventional|SPRAY||A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy|A Double Blind, Randomized, Parallel Group, Placebo Controlled, Comparative Study of the Efficacy, Safety and Tolerability of Cannabis Based Medicine (CBM) Extracts in Patients With Cancer-related Pain.|Completed||Phase 3|177|Actual|GW Pharmaceuticals Ltd.||3|||f||||f||||||||||2017-02-18 14:23:57.628044|2017-02-18 14:23:57.628044
NCT00674596|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2008-05-07|||January 2006||2006-01-01|May 2008|2008-05-01|March 2008||2008-03-01|March 2008||2008-03-01||Interventional|||The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria||Completed||Phase 4|60|Anticipated|Gulhane School of Medicine|||||||||||||||||||2017-02-18 14:23:58.576281|2017-02-18 14:23:58.576281
NCT00674583|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2016-10-18||2009-09-03|May 2008||2008-05-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of GSK Biologicals' Meningococcal Vaccine (GSK134612) and Licensed MenC-CRM197 Vaccine in Healthy Children|Non-inferiority of GSK Biologicals' Meningococcal Vaccine (GSK134612) Compared to Licensed MenC-CRM197 Conjugate Vaccine in Healthy Children|Completed||Phase 3|414|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:23:58.666558|2017-02-18 14:23:58.666558
NCT00674570|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-10-11|||July 2008||2008-07-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|VSL||Veteran Stress and Learning Study|Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder|Active, not recruiting||N/A|140|Anticipated|VA Office of Research and Development||3|||f||||f||||||||No||2017-02-18 14:23:58.817149|2017-02-18 14:23:58.817149
NCT00674557|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2013-07-09|||June 2008||2008-06-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|||||Interventional|||Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer|A Cancer Research UK Randomised Phase II Trial of ATN-224 (Copper Binding Agent) in Combination With Exemestane Versus Exemestane Alone in Post-menopausal Women With Recurrent or Advanced, Oestrogen and/or Progesterone Receptor Positive Breast Cancer|Terminated||Phase 2|111|Anticipated|National Cancer Institute (NCI)||||"Withdrawn as the clinical development of ATN-224 was terminated by the drug company who was~   providing ATN-224 for the study"|f||||||||||||||2017-02-18 14:23:59.141406|2017-02-18 14:23:59.141406
NCT00674544|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-01-27|||May 2008||2008-05-01|April 2009|2009-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Ballabeina||Influence of a Lifestyle Intervention in Preschool Children on Physiological and Psychological Parameters|Influence of a Lifestyle Intervention in Preschool Children on Physiological and Psychological Parameters (Ballabeina)|Completed||N/A|650|Anticipated|University of Lausanne Hospitals||2|||f||||f||||||||||2017-02-18 14:23:59.246904|2017-02-18 14:23:59.246904
NCT00674531|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-07|2014-10-08|||January 2008||2008-01-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ATH-ENTE||Detection of Enterovirus RNA in Atheromatous Lesions|Detection of Enterovirus RNA by RT-PCR in Atheromatous Lesions|Completed||N/A|100|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-02-18 14:23:59.34438|2017-02-18 14:23:59.34438
NCT00674518|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2008-05-06|||January 2005||2005-01-01|May 2008|2008-05-01|March 2009|Anticipated|2009-03-01|June 2008|Anticipated|2008-06-01||Interventional|CHOICE||Changing Healthy Outcomes In Clinic Environments|Health Promotion Intervention: Sedentary Primary Care Patients|Unknown status|Active, not recruiting|N/A|100|Anticipated|Oregon Health and Science University||3|||f||||t||||||||||2017-02-18 14:23:59.453642|2017-02-18 14:23:59.453642
NCT00674505|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2010-02-16|||January 2008||2008-01-01|February 2010|2010-02-01||||June 2009|Anticipated|2009-06-01||Interventional|FORTRESS||Safety & Performance Study of Lumen Biomedical's FiberNet Distal Protection System for the Treatment of Renal Artery Stenosis|FiberNet Renal Artery Embolic Protection Study: A Prospective, Single-arm Feasibility Trial of Renal Artery Distal Protection Using the Lumen Biomedical FiberNet Embolic Protection System|Unknown status|Active, not recruiting|N/A|20|Actual|VIVA Physicians||1|||f||||t||||||||||2017-02-18 14:23:59.559544|2017-02-18 14:23:59.559544
NCT00674492|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2015-04-27|2015-02-05||May 2008||2008-05-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational||patients who initiated antiviral treatment|Hepatitis C Virus (HCV) Treatment Completion or Withdrawal|Patients' View of Hepatitis C Treatment Completion or Withdrawal|Completed||N/A|21|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 14:23:59.648282|2017-02-18 14:23:59.648282
NCT00674479|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2016-12-08|||May 2008||2008-05-01|December 2016|2016-12-01||||May 2018|Anticipated|2018-05-01||Interventional|||INCB018424 in Patients With Advanced Hematologic Malignancies|Phase II Study of INCB018424 in Patients With Advanced Hematologic Malignancies|Active, not recruiting||Phase 2|120|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:23:59.874001|2017-02-18 14:23:59.874001
NCT00674466|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-11-18|||March 2008||2008-03-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase II Study to Evaluate the Efficacy and Safety of 3 Months of Twice-a-Week Injections of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus on Metformin Monotherapy|Completed||Phase 2|90|Anticipated|ConjuChem||3|||f||||t||||||||||2017-02-18 14:23:59.993258|2017-02-18 14:23:59.993258
NCT00674453|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2011-08-08|||September 2004||2004-09-01|August 2011|2011-08-01|September 2007|Actual|2007-09-01|||||Interventional|LACE||The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation|The Effect Of Lasofoxifene On Local Mediators Of Bone Resorption In The Prevention Of Postmenopausal Osteoporosis|Completed||Phase 2|51|Actual|Ligand Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:24:00.09698|2017-02-18 14:24:00.09698
NCT00674440|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2017-01-31||2013-01-25|December 2004||2004-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2008|Actual|2008-12-01||Interventional|||Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism|Localization of Focal Forms of Hyperinsulinism of Infancy With 18F-labeled L-fluoro-DOPA PET Scan|Active, not recruiting||Phase 2|105|Actual|Children's Hospital of Philadelphia||3|||f||||t||||||||||2017-02-18 14:24:00.20804|2017-02-18 14:24:00.20804
NCT00674427|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2016-12-01||2016-11-14|January 2008||2008-01-01|December 2016|2016-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant|A Phase I/II Trial Of DLI And Activated DLI (ADLI) Followed By Either Repetitive Dosing Of ADLI Or Dose Escalated ADLI For Patients With Relapse After Allogeneic Stem Cell Transplantation|Terminated||Phase 1/Phase 2|13|Actual|University of Pennsylvania||2||Insufficient funds|f||||f||||||||||2017-02-18 14:24:00.345837|2017-02-18 14:24:00.345837
NCT00674414|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2013-01-17|||April 2008||2008-04-01|January 2013|2013-01-01||||January 2013|Actual|2013-01-01||Interventional|||Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery|A Phase II, Randomized, Multi-center Study, Assessing Value of Adding Everolimus (RAD001) to Trastuzumab as Preoperative Therapy of HER-2 Positive Primary Breast Cancer Amenable to Surgery.|Terminated||Phase 2|82|Actual|UNICANCER||2||IDMC decision due to accrual issue (82 pts accrued / 120 expected)|f||||||||||||||2017-02-18 14:24:00.466279|2017-02-18 14:24:00.466279
NCT00674401|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2013-09-21|||January 2009||2009-01-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|RADAR-AF||Radiofrequency Ablation of Drivers of Atrial Fibrillation|RADAR-AF: Radiofrequency Ablation of Drivers of Atrial Fibrillation|Completed||N/A|232|Actual|Hospital General Universitario Gregorio Marañon||2|||f||||t||||||||||2017-02-18 14:24:00.591254|2017-02-18 14:24:00.591254
NCT00674388|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2016-04-13|||February 2008||2008-02-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|2 Weeks|Observational [Patient Registry]|WUS||The Pediatric Anesthesia Quality Improvement Project|The Pediatric Anesthesia Quality Improvement Project|Recruiting||N/A|3000000|Anticipated|The Society for Pediatric Anesthesia|||1||f||||f||||||||||2017-02-18 14:24:00.707815|2017-02-18 14:24:00.707815
NCT00674375|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2015-03-17|||November 2008||2008-11-01|March 2015|2015-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Risk Score Alerts for Chest Pain Care|Can Risk Score Alerts Improve Office Care for Chest Pain?|Completed||Phase 3|8000|Actual|Harvard Vanguard Medical Associates||2|||f||||t||||||||||2017-02-18 14:24:00.883705|2017-02-18 14:24:00.883705
NCT00674362|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2011-12-09|2011-12-09||June 2008||2008-06-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|CERTAIN||Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study|A Phase IIIB, Multi-center, Double-blind, Placebo-controlled, Parallel Group, 52-week Study to Evaluate the Safety and Efficacy of Certolizumab Pegol, Administered With DMARDs, in Patients With Low to Moderate Disease Activity Rheumatoid Arthritis|Completed||Phase 3|194|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 14:24:01.008953|2017-02-18 14:24:01.008953
NCT00674349|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2008-07-21|||January 2006||2006-01-01|January 2006|2006-01-01|December 2011|Anticipated|2011-12-01|January 2007|Anticipated|2007-01-01||Interventional|||Screening of Biomarkers on Endometrial Cancers|Screening and Identification of Novel Diagnostic and Prognostic Biomarkers on Endometrial Cancers|Unknown status|Recruiting|N/A|250|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 14:24:02.369253|2017-02-18 14:24:02.369253
NCT00674336|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2013-11-18|||September 2007||2007-09-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Interventional|Shellfish||Infectivity of Norovirus in Shellfish Treated With High Hydrostatic Pressure Processing-Human Challenge Study|Norwalk Virus Inactivation by High Hydrostatic Pressure Processing: A Comprehensive and Integrated Program for Research and Outreach|Completed||N/A|51|Actual|Emory University||1|||f||||t||||||||||2017-02-18 14:24:02.455934|2017-02-18 14:24:02.455934
NCT00674128|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2010-12-01|2010-10-05||May 2008||2008-05-01|December 2010|2010-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of Cyanoacrylate Tissue Adhesive and Suture for Closure of Cardiac Device Pockets|Prospective Comparison of Cyanoacrylate Tissue Adhesive (Dermabond) and Suture (Vicryl) for Closure of Cardiac Device Pockets|Terminated||N/A|103|Actual|Mayo Clinic||2||Slow accrual.|f||||f||||||||||2017-02-18 14:24:05.033654|2017-02-18 14:24:05.033654
NCT00674323|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2011-04-15|2010-12-21||April 2008||2008-04-01|April 2011|2011-04-01||||May 2009|Actual|2009-05-01||Interventional|PCV||Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy|A Multicentre, Randomized, Double Masked, Exploratory, Indocyanine Green Angiography (ICGA) Guided Study of 6 Months Duration to Compare the Safety and Effect on Polyp Regression of Verteporfin Photodynamic Therapy (PDT) Alone or Added to Ranibizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy|Completed||Phase 4|61|Actual|Novartis||3|||f||||f||||||||||2017-02-18 14:24:02.560665|2017-02-18 14:24:02.560665
NCT00674310|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-20|||February 2004||2004-02-01|May 2008|2008-05-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions|A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions|Completed||N/A|29|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:24:03.056506|2017-02-18 14:24:03.056506
NCT00674297|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-02-03|||May 2008||2008-05-01|February 2013|2013-02-01||||July 2011|Actual|2011-07-01||Interventional|||Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients|Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Hospital for Special Surgery, New York||1|||f||||t||||||||||2017-02-18 14:24:03.156913|2017-02-18 14:24:03.156913
NCT00674284|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2009-11-23|||February 2008||2008-02-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Adrenal Exhaustion Syndrome in Critically Ill Patients Without Improvement|Change of Serum Cortisol Levels in Patients Without Improvement in Intensive Care Unit|Completed||N/A|80|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 14:24:03.267534|2017-02-18 14:24:03.267534
NCT00674271|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2011-11-03|||May 2008||2008-05-01|November 2011|2011-11-01|May 2018|Anticipated|2018-05-01|March 2011|Actual|2011-03-01||Observational|IMPACT||Immune Profile and Complication Risk in Type 2 Diabetes|Immune Profile and Complications Risk in Type 2 Diabetes|Active, not recruiting||N/A|200|Anticipated|University of Aarhus|||2||f||||f||||||Samples With DNA|"~     Whole blood, urine~   "|||2017-02-18 14:24:03.346214|2017-02-18 14:24:03.346214
NCT00674258|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-12|||May 2008||2008-05-01|May 2008|2008-05-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*0201 in Treating Patients With Refractory Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 1/Phase 2|14|Anticipated|Tokyo University||1|||f||||t||||||||||2017-02-18 14:24:03.448837|2017-02-18 14:24:03.448837
NCT00674245|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2010-08-18|||April 2008||2008-04-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.|The Effect Of Pantoprazole 40 mg Once Daily Versus Placebo On The Power Spectral Analysis Of The Sleep Electroencephalogram (EEG) Of Patients With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 2/Phase 3|40|Actual|Southern Arizona VA Health Care System||2|||f||||f||||||||||2017-02-18 14:24:03.562874|2017-02-18 14:24:03.562874
NCT00674232|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-05-05|||May 2006||2006-05-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical Treatment|Misoprostol for Treatment of Incomplete Abortion|Completed||N/A|311|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-02-18 14:24:03.689039|2017-02-18 14:24:03.689039
NCT00674219|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2014-05-19|||May 2005||2005-05-01|May 2014|2014-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder|Differential Efficacy of Memantine for Obsessive-compulsive Disorder vs. Generalized Anxiety Disorder: an Open-label Trial|Completed||Phase 3|17|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-02-18 14:24:03.80813|2017-02-18 14:24:03.80813
NCT00674206|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2013-11-18|2012-03-30||October 2008||2008-10-01|November 2013|2013-11-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer|A Phase II Trial of Gemcitabine and Oxaliplatin for ER-, PR-, HER2NEU- (Triple Negative) Metastatic Breast Cancer|Terminated||Phase 2|6|Actual|Emory University|Early termination of the study due to slow accrual|1||Sponsor funding stopped|f||||t||||||||||2017-02-18 14:24:03.924096|2017-02-18 14:24:03.924096
NCT00674193|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-09-23|||February 2008||2008-02-01|September 2016|2016-09-01||||January 2100|Anticipated|2100-01-01||Observational|||Evaluating Dactinomycin and Vincristine in Young Patients With Cancer|A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer|Active, not recruiting||N/A|158|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"~     blood and urine~   "|||2017-02-18 14:24:04.165346|2017-02-18 14:24:04.165346
NCT00674180|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-06|||April 2008||2008-04-01|May 2008|2008-05-01||||April 2008|Actual|2008-04-01||Observational|||Data Analysis of a Managed Care Weight Reduction Trial|Data Analysis of a Managed Care Weight Reduction Trial|Unknown status|Active, not recruiting|N/A|588|Actual|Albert Einstein College of Medicine, Inc.|||3||f||||f||||||||||2017-02-18 14:24:04.31764|2017-02-18 14:24:04.31764
NCT00674167|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2015-06-11|||May 2007||2007-05-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Interventional|||The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma|The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma.|Active, not recruiting||Phase 2|21|Actual|National University Hospital, Singapore||3|||f||||t||||||||||2017-02-18 14:24:04.428035|2017-02-18 14:24:04.428035
NCT00674154|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-10-23|2013-08-06||May 2008||2008-05-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Effect of Vitamin D Treatment in Primary Hyperparathyroidism|Effect of Vitamin D Treatment in Primary Hyperparathyroidism|Completed||Phase 2/Phase 3|46|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:24:04.539141|2017-02-18 14:24:04.539141
NCT00674141|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2010-06-02|||July 2008||2008-07-01|May 2008|2008-05-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Interventional|||Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment|Nasal Administration of Dexamethasone for MS Treatment|Withdrawn||Phase 1|10|Anticipated|Hadassah Medical Organization||1||was not approved by the ministry of health|f||||f||||||||||2017-02-18 14:24:04.936593|2017-02-18 14:24:04.936593
NCT00674115|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-02-20|2009-09-17||April 2008||2008-04-01|February 2015|2015-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)|Randomized, Crossover Pharmacodynamic Study Comparing the Effects of Zegerid® (20 mg Omeprazole/Sodium Bicarbonate) and Prilosec OTC® (20 Mg-equivalent Omeprazole)|Completed||Phase 3|60|Actual|Bayer||3|||f||||f||||||||||2017-02-18 14:24:05.339727|2017-02-18 14:24:05.339727
NCT00674102|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2016-04-15|||April 2008||2008-04-01|April 2016|2016-04-01||||March 2009|Actual|2009-03-01||Interventional|||An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)|An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With NSCLC|Completed||Phase 1|15|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:24:05.818599|2017-02-18 14:24:05.818599
NCT00674089|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-08-09|||January 2007||2007-01-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|VA||Newborn Vitamin A (VA) Supplementation Pilot Project, Pakistan|Evaluation of the Effectiveness of Vitamin A Supplementation (VAS) as Part of a Neonatal Post Partum Care Package in Rural Pakistan|Completed||N/A|7400|Actual|Aga Khan University||2|||f||||t||||||||||2017-02-18 14:24:05.923742|2017-02-18 14:24:05.923742
NCT00674076|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2012-07-08|||March 2008||2008-03-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Clinical Application of Ultrasound in Obstructive Sleep Apnea|Clinical Application of Ultrasound in Obstructive Sleep Apnea|Completed||N/A|105|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-02-18 14:24:06.026523|2017-02-18 14:24:06.026523
NCT00674063|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-08-25|||July 2003||2003-07-01|August 2014|2014-08-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis|A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Weekly Intravenous Administration of 7.5mg and 0.075mg/kg Alefacept in Subjects Weighing Between 100kg and 150kg, With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|78|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:24:06.120671|2017-02-18 14:24:06.120671
NCT00674050|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2012-06-12|||May 2008||2008-05-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers|A Phase 1, Open-Label Study to Investigate the Effect of Albuterol (Salbutamol) and Fluticasone on the Pharmacokinetics of Inhaled Technosphere® Insulin Inhalation Powder in Healthy Subjects|Completed||Phase 1|13|Actual|Mannkind Corporation||1|||f||||||||||||||2017-02-18 14:24:06.245945|2017-02-18 14:24:06.245945
NCT00674037|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2014-10-31|||September 2006||2006-09-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|COFRASAanc||Efficacy of Monetary Incentives for Primary Care Physicians on Patients|Efficacy of Monetary Incentives for Primary Care Physicians on Patients' Recruitment|Terminated||N/A|170|Actual|Assistance Publique - Hôpitaux de Paris||2||default inclusion|f||||f||||||||||2017-02-18 14:24:06.354032|2017-02-18 14:24:06.354032
NCT00674024|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2017-01-24|||October 7, 2008||2008-10-07|January 22, 2013|2013-01-22|January 22, 2013|Actual|2013-01-22|January 22, 2013|Actual|2013-01-22||Interventional|||Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function|A Phase I and Pharmacokinetic Single Agent Study of Pazopanib in Adults With Advanced Malignancies and Varying Degrees of Liver Dysfunction|Completed||Phase 1|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:24:06.45762|2017-02-18 14:24:06.45762
NCT00674011|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-05-05|||January 2008||2008-01-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Hypertension in Breast Cancer Patients Receiving Bevacizumab|A Pilot Study of Hypertension in Breast Cancer Patients Receiving Bevacizumab|Terminated||N/A|10|Actual|Dana-Farber Cancer Institute|||1|Slow accrual|f||||f||||||||||2017-02-18 14:24:06.550754|2017-02-18 14:24:06.550754
NCT00673998|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2008-05-06|||February 2005||2005-02-01|May 2008|2008-05-01|November 2006|Actual|2006-11-01|March 2006|Actual|2006-03-01||Interventional|||Isokinetic Testing Protocol in Elderly and Young Men|The Effects of Rest Interval on Quadriceps Torque During an Isokinetic Testing Protocol in Elderly and Young Men|Completed||N/A|38|Actual|University of Brasilia|||||f||||f||||||||||2017-02-18 14:24:06.651276|2017-02-18 14:24:06.651276
NCT00673985|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2010-10-21|||July 2004||2004-07-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|August 2006|Actual|2006-08-01||Interventional|RESILIENT||Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study|A Randomized Study Comparing the Edwards Self-ExpandIng LifeStent Versus Angioplasty-alone In LEsions INvolving The SFA and/or Proximal Popliteal Arter|Completed||N/A|246|Actual|C. R. Bard||2|||f||||t||||||||||2017-02-18 14:24:06.754936|2017-02-18 14:24:06.754936
NCT00673972|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2010-03-08|||April 2008||2008-04-01|March 2010|2010-03-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|||Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome|A Comparative Study of Epigastric Pain Syndrome and Postprandial Distress Syndrome in Personality, Helicobacter Pylori Infection, Gastric Emptying and Response to Lansoprazole Treatment|Withdrawn||Phase 4|80|Anticipated|National Taiwan University Hospital||2||difficulty in recruiting patients|f||||t||||||||||2017-02-18 14:24:06.849975|2017-02-18 14:24:06.849975
NCT00673959|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-01-31|2009-09-10||December 2007||2007-12-01|January 2012|2012-01-01||||February 2008|Actual|2008-02-01||Interventional|||Acute Comfort of Lubricant Eye Drop FID 111421||Completed||N/A|20|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:24:06.967228|2017-02-18 14:24:06.967228
NCT00673946|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-12-06|||March 2008||2008-03-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Impact of Oximetry on Hospitalization in Acute Bronchiolitis|Impact of Oximetry on Hospitalization|Completed||Phase 4|213|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 14:24:07.198416|2017-02-18 14:24:07.198416
NCT00673933|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-07-11|2013-02-14||May 2008||2008-05-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris|A Blinded, Randomized, Intra-individual, Vehicle-controlled and Multi-centre Study of Photodynamic Therapy With MAL Cream in Patients With Skin Type V or VI With Acne Vulgaris|Completed||Phase 2|20|Actual|Photocure||2|||f||||f||||||||||2017-02-18 14:24:07.300493|2017-02-18 14:24:07.300493
NCT00673920|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-06-28||2013-06-28|April 2008||2008-04-01|June 2013|2013-06-01||||July 2011|Actual|2011-07-01||Interventional|FEATURE||A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy|A Randomized, Double-Blind, Parallel-Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Given As a Single Infusion or Dual Infusion Compared With Placebo in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy|Terminated||Phase 3|314|Actual|Genentech, Inc.||3||"Based on analysis of results and consideration of available treatments, the overall benefit to~   risk profile of ocrelizumab was not favorable in RA."|f||||||||||||||2017-02-18 14:24:07.69039|2017-02-18 14:24:07.69039
NCT00673907|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2012-02-01|||January 2007||2007-01-01|February 2012|2012-02-01|November 2009|Actual|2009-11-01|June 2008|Actual|2008-06-01||Interventional|HIPWOODS||HIPWOODS - Health Effects Related to Exposure to Particle Pollution From Woodburning Stoves|Health Effects Related to Exposure to Particle Pollution From Woodburning|Completed||N/A|20|Actual|University of Aarhus||3|||f||||f||||||||||2017-02-18 14:24:07.802122|2017-02-18 14:24:07.802122
NCT00673894|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2008-06-19|||April 2008||2008-04-01|June 2008|2008-06-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Effects of Glutamine on GLP-1 and Insulin Secretion in Man|Study of the Effects of Glutamine on GLP-1, Insulin Secretion and Glycaemia in Man|Unknown status|Recruiting|Phase 1|20|Anticipated|Garvan Institute of Medical Research||1|||f||||f||||||||||2017-02-18 14:24:07.912094|2017-02-18 14:24:07.912094
NCT00673881|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2011-03-25|2011-01-24||March 2008||2008-03-01|March 2011|2011-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study|ABT-335 (Choline Fenofibrate)Reverse Cholesterol Transport (RCT) Study|Completed||Phase 1/Phase 2|25|Actual|Radiant Research||1|||f||||f||||||||||2017-02-18 14:24:08.00152|2017-02-18 14:24:08.00152
NCT00673868|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2009-01-22|||October 2007||2007-10-01|April 2008|2008-04-01||||||||Interventional|||Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants|A Phase I-II Randomized Trial to Examine the Clinical, Immunologic and Virologic Effects of CMV Specific CTL When Used for Prophylaxis Against CMV Disease in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants|Completed||Phase 1/Phase 2|47|Anticipated|Penn State University||2|||f||||t||||||||||2017-02-18 14:24:08.329505|2017-02-18 14:24:08.329505
NCT00673855|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-01-31|2009-09-10||May 2008||2008-05-01|January 2012|2012-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Acute Comfort of Lubricant Eye Drops FID 112903||Completed||N/A|20|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:24:08.43935|2017-02-18 14:24:08.43935
NCT00673842|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-07-07|||March 2011||2011-03-01|July 2016|2016-07-01|December 2021|Anticipated|2021-12-01|January 2019|Anticipated|2019-01-01||Interventional|REFINE-ICD||Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction|Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy|Recruiting||Phase 3|1000|Anticipated|University of Calgary||2|||f||||t||||||||Undecided|uncertain|2017-02-18 14:24:08.676081|2017-02-18 14:24:08.676081
NCT00673829|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2016-06-16|||May 2008||2008-05-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer|Phase Ia/Ib Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer|Suspended||Phase 1|26|Anticipated|Roger Williams Medical Center||2||Funding|f||||t||||||||||2017-02-18 14:24:08.944783|2017-02-18 14:24:08.944783
NCT00673816|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-11-14|2011-09-27||May 2008||2008-05-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|VHL3||Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome|Pilot Study of Sunitinib Malate for Advanced Ocular Disease of Von Hippel-Lindau Syndrome|Terminated||Phase 1/Phase 2|2|Actual|National Institutes of Health Clinical Center (CC)|Early termination of the trial resulted in a small number of participants being analyzed, and Microperimetry (MP-1) results were not accurate for either participant due to fixation issues.|1||Inability to recruit and adequate number of participants|f||||t||||||||||2017-02-18 14:24:09.060489|2017-02-18 14:24:09.060489
NCT00673803|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2010-08-16|||December 2008||2008-12-01|December 2008|2008-12-01|June 2010|Actual|2010-06-01|July 2009|Actual|2009-07-01||Interventional|||Influence of Two Different Preloaded Intraocular Lens (IOLs) on Posterior Capsule Opacification|Influence of Two Sharp-edged Hydrophobic Acrylic Micro-incision-IOLs on Posterior Capsule Opacification. A Randomized, Double-masked Study With Intraindividual Comparison.|Completed||Phase 4|40|Actual|Hospital Hietzing||2|||f||||f||||||||||2017-02-18 14:24:09.473076|2017-02-18 14:24:09.473076
NCT00673790|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2010-09-22|||May 2008||2008-05-01|September 2010|2010-09-01||||July 2010|Actual|2010-07-01||Interventional|||The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose|Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose|Completed||Phase 4|543|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 14:24:09.59395|2017-02-18 14:24:09.59395
NCT00673777|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-12|||May 2008||2008-05-01|May 2008|2008-05-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer|Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*0201 in Treating Patients With Refractory Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 1/Phase 2|14|Anticipated|Tokyo University||1|||f||||t||||||||||2017-02-18 14:24:10.016905|2017-02-18 14:24:10.016905
NCT00673764|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-01-31|2009-09-18||May 2008||2008-05-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance||Completed||N/A|48|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:24:10.142769|2017-02-18 14:24:10.142769
NCT00673751|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-06||||||May 2008|2008-05-01||||||||Interventional|||Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome|GLP-2 Mediated Increased SMA Blood Flow in Patients With Short Bowel Syndrome|Unknown status|Enrolling by invitation|N/A|8|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-02-18 14:24:10.412243|2017-02-18 14:24:10.412243
NCT00673413|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-05|||September 2006||2006-09-01|May 2008|2008-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||The Perception of the Estomy-Individual Regarding of Its Situation|The Perception of the Estomy-Individual Regarding of Its Situation|Completed||N/A|||Universidade da Regiao da Campanha|||1||f||||f||||||||||2017-02-18 14:24:19.861916|2017-02-18 14:24:19.861916
NCT00673738|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2015-09-23|2013-09-18||April 2008||2008-04-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|December 2013|Actual|2013-12-01||Interventional|||Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)|Safety and Efficacy (Phase II) Study of Concurrent Cetuximab Plus Conformal Thoracic Radiotherapy in (Poor Prognosis) Patients With Inoperable or Unresectable, Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)|Completed||Phase 2|27|Actual|H. Lee Moffitt Cancer Center and Research Institute|Accrual, and therefore treatment ended earlier than planned due to pulmonary toxicity. Three participants remain on follow-up.|1|||f||||t||||||||||2017-02-18 14:24:10.523534|2017-02-18 14:24:10.523534
NCT00673725|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-08-22|||March 2008||2008-03-01|August 2014|2014-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis|A Phase IV,Open Label Study of the Treatment of Children With Moderate to Severe Atopic Dermatitis (AD) Using Locobase® REPAIR as an Adjunctive to Standard Treatment|Completed||Phase 4|49|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 14:24:10.926079|2017-02-18 14:24:10.926079
NCT00673712|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2015-04-16|2015-04-03||April 2008||2008-04-01|April 2015|2015-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Multicenter Infection Surveillance Study Following Open Heart Surgery|Phase 4 Multicenter Infection Surveillance Study Following Cardiac Surgical Procedures|Completed||Phase 4|646|Actual|Halyard Health||2|||f||||f||||||||||2017-02-18 14:24:11.041658|2017-02-18 14:24:11.041658
NCT00673699|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-05|||May 2008||2008-05-01|May 2008|2008-05-01|February 2009|Anticipated|2009-02-01|January 2009|Anticipated|2009-01-01||Observational|||The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal Metaplasia|Observational: Studies in Human Beings Health Outcomes|Unknown status|Not yet recruiting|N/A|70|Anticipated|Hillel Yaffe Medical Center|||1||f||||t||||||Samples Without DNA|"~     Gastric mucosal biopsy during upper gastrointestinal endoscopy~   "|||2017-02-18 14:24:11.546237|2017-02-18 14:24:11.546237
NCT00673686|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-10-10|||May 2004||2004-05-01|October 2014|2014-10-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D|Single Center, Double-blind, Randomized Study to Compare the Effect of SH T 00186 D on Follicular Development in a 24-day Regimen Versus a 21-day Regimen in Healthy Female Volunteers|Completed||Phase 2|105|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:24:11.656186|2017-02-18 14:24:11.656186
NCT00673673|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2015-01-21|2014-05-13||May 2008||2008-05-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|May 2013|Actual|2013-05-01||Interventional|||FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer|Phase II Study of FOLFOX With Bevacizumab (Avastin(TM)) in Metastatic or Unresectable Gastroesophageal and Gastric Cancer|Completed||Phase 2|39|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:24:11.766199|2017-02-18 14:24:11.766199
NCT00673660|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2010-11-05|2010-10-06||October 2007||2007-10-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels|Assessment Of Statin Treatment Compliance In Dyslipidemia Patients: An Observational Study|Completed||N/A|375|Actual|Pfizer|The registered endpoint - observing reasons of compliance or non-compliance to statin treatment - was separated into outcome measure 6 and 7 because observing reasons for compliance with statin treatment were not collected or analyzed.||1||f||||f||||||None Retained|"~     No biospecimen is retained~   "|||2017-02-18 14:24:12.012842|2017-02-18 14:24:12.012842
NCT00673647|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2009-08-25|||May 2008||2008-05-01|August 2009|2009-08-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|CANDIS-II||CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS|Evaluation of the Cognitive-behavioral Treatment Programme CANDIS in the German Outpatient Treatment Service System (CANDIS-II)|Unknown status|Active, not recruiting|Phase 3|450|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-02-18 14:24:12.3779|2017-02-18 14:24:12.3779
NCT00673634|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-06-10|||March 2008||2008-03-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficiency of Preoxygenation in Obese Patients: Pressure Assisted Versus Traditional Method|Efficiency of Preoxygenation in Obese Patients: Evaluation of Traditional Method Versus Pressure Assisted Preoxygenation.|Completed||N/A|30|Actual|Maisonneuve-Rosemont Hospital||2|||f||||f||||||||||2017-02-18 14:24:12.543375|2017-02-18 14:24:12.543375
NCT00673621|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2012-06-12|||May 2008||2008-05-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics|A Phase 1, Open-Label, Controlled Clinical Trial to Evaluate Pharmacokinetics After Administration of Technosphere® Insulin Inhalation Powder Alone and With Salbutamol (Albuterol) and/or After Methacholine Challenge Testing in Subjects With Asthma Versus Matched Healthy Subjects Without Asthma|Completed||Phase 1|30|Actual|Mannkind Corporation||1|||f||||||||||||||2017-02-18 14:24:12.658511|2017-02-18 14:24:12.658511
NCT00673608|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2016-11-16|||November 2007||2007-11-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload|A Study of Magnetic Resonance Imaging Assessment of Cardiac and Liver Iron Load in Patients With Haemoglobinopathies, Myelodysplastic Syndromes (MDS) or Other Anaemias Treated With Exjade® (Deferasirox) (The MILE Study)|Completed||Phase 4|118|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:24:12.77032|2017-02-18 14:24:12.77032
NCT00673595|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2012-02-21|2012-02-21||March 2007||2007-03-01|February 2012|2012-02-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|||Endothelial Function and Autonomic Regulation After Short-term Smoking Cessation: Varenicline Versus Placebo|Endothelial Function and Autonomic Regulation After Short-term Smoking Cessation: Varenicline Versus Placebo|Terminated||N/A|19|Actual|Mayo Clinic|This study was terminated early due to difficulty with recruiting subjects and with subjects complying with the protocol.|2||Difficulty with recruiting sujects and subjects complying with the protocol|f||||t||||||||||2017-02-18 14:24:12.879982|2017-02-18 14:24:12.879982
NCT00673400|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2012-10-01|2012-07-16||January 2008||2008-01-01|October 2012|2012-10-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|STARR||Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM|Morbidity and Functional Outcome of Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM in Obstructed Defecation|Completed||N/A|52|Actual|Cantonal Hospital of St. Gallen||1|||f||||f||||||||||2017-02-18 14:24:19.946786|2017-02-18 14:24:19.946786
NCT00673582|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2009-08-24|||April 2008||2008-04-01|August 2009|2009-08-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|||Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients|Randomized, Multicentre, Double- Blind, Placebo Controlled Trial of Rosuvastatin 10 mg for Inhibition of Atherosclerosis Progression Assessed by Carotid Artery Ultrasound in HIV-positive Patients Treated With Antiretrovirals|Terminated||Phase 4|250|Anticipated|University of British Columbia||2||Sponsor has withdrawn the funding|f||||t||||||||||2017-02-18 14:24:13.238532|2017-02-18 14:24:13.238532
NCT00673569|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2010-08-05|||September 2006||2006-09-01|August 2010|2010-08-01||||July 2007|Actual|2007-07-01||Interventional|||Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment|A Phase II Single-Arm Trial Assessing the Use of an Ex Vivo Sensitivity Assay to Predict Response of Relapsed Metastatic Non-Small Cell Lung Cancer Patients to Erlotinib|Completed||Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 14:24:13.352492|2017-02-18 14:24:13.352492
NCT00673556|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-08-25|||October 2003||2003-10-01|August 2014|2014-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate|A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study Examining the Efficacy and Safety of Weekly Intramuscular Administration of 15mg Alefacept Over 12 Weeks in a Population of Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate|Completed||Phase 3|195|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 14:24:13.458908|2017-02-18 14:24:13.458908
NCT00673543|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2011-01-03|||May 2008||2008-05-01|January 2011|2011-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Corticosteroid Therapy on Glucose Control in Pregnant Women With Diabetes|The Effects of Corticosteroid Therapy on Glucose Control in Pregnant Women With Insulin Requiring Diabetes Mellitus|Completed||N/A|16|Actual|The University of Texas Health Science Center, Houston|||2||f||||f||||||||||2017-02-18 14:24:16.064411|2017-02-18 14:24:16.064411
NCT00673530|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-03-07|||July 2006||2006-07-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|NUTRICORE||Clinical Nutrition Concept for Hospitalized Patients With Malnutrition|Effect of an Evidence Based Clinical Nutrition Concept on Clinical Outcomes in Hospitalized Patients With Malnutrition When Severity of Disease is Taken Into Consideration|Completed||N/A|10242|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 14:24:16.162785|2017-02-18 14:24:16.162785
NCT00673517|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-11-14|||November 2007||2007-11-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||The Effect of High Frequency Oscillation on Biological Markers of Lung Injury|The Effect of High Frequency Oscillation on Biological Markers of Ventilator Induced Lung Injury (VILI): Nested Translational Biology Sub-Study of the OSCILLATE Pilot Study|Completed||N/A|20|Anticipated|St. Michael's Hospital, Toronto|||2||f||||f||||||Samples With DNA|"~     Known biomarkers: IL6, IL8, IL10, IL-1Beta, ICAM-1, TGFBeta, Chemokine ligand 10, FGFBeta,~     VEGF, and INFGamma Novel biomarkers: ACE, surfactant protein D, clara cell protetin, von~     Willerbrand Facotr, Ang1, Ang2, and TF, PCIII, neuropeptide Y, PBEF, APCRc, and PAI-1~   "|||2017-02-18 14:24:16.272545|2017-02-18 14:24:16.272545
NCT00673504|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-11-30|||April 2008||2008-04-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer|Prospective Randomized Phase II Trial With Gemcitabine Plus Sunitinib Versus Gemcitabine Alone in First-line Therapy of Metastatic or Locally Advanced Pancreatic Cancer|Completed||Phase 2|105|Actual|Central European Society for Anticancer Drug Research||2|||f||||f||||||||||2017-02-18 14:24:16.604565|2017-02-18 14:24:16.604565
NCT00673491|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-06|||July 2005||2005-07-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Clinical Pathways for Effective and Appropriate Care|Diffusion of Clinical Pathways for the Implementation of Effective and Appropriate Care|Completed||N/A|448|Actual|Agenzia Regionale Sanitaria delle Marche||2|||f||||t||||||||||2017-02-18 14:24:16.713895|2017-02-18 14:24:16.713895
NCT00673478|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-04-30||2014-04-30|May 2008||2008-05-01|April 2014|2014-04-01||||June 2009|Actual|2009-06-01||Interventional|||Tiotropium and Salmeterol PK Study in COPD Patients|A Randomised, Open-label, 4-way Crossover Study to Characterize the Pharmacokinetics, Safety and Efficacy of FDC Tiotropium/Salmeterol, Tiotropium, Salmeterol and a Free Combination of Tiotropium Plus Salmeterol Following 4-week Treatment Periods in Patients With COPD.|Completed||Phase 3|50|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:24:16.799661|2017-02-18 14:24:16.799661
NCT00673465|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2016-12-22|2016-10-13||May 2008||2008-05-01|December 2016|2016-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||All treated participants.|Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)|A Randomized, Placebo-controlled, Three-Way Crossover Study to Evaluate the Effect of SCH 497079 on Metabolic Parameters and to Determine the Influence of Race/Ethnic Origin on Therapeutic Response|Completed||Phase 1|17|Actual|Merck Sharp & Dohme Corp.|Part 2 of the study was not conducted. Part 2 of the study was to be conducted if the analysis of Part 1 indicated a clinically significant decrease in blood glucose in participants type 2 diabetes mellitus compared to placebo.|6|||f||||f||||||||||2017-02-18 14:24:16.929338|2017-02-18 14:24:16.929338
NCT00673452|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2010-05-28|2010-04-14||June 2008||2008-06-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia|Flexible Dosed Duloxetine Versus Placebo in the Treatment of Fibromyalgia|Completed||Phase 4|530|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:24:17.925106|2017-02-18 14:24:17.925106
NCT00673439|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-05-03|2013-05-03||November 2007||2007-11-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)|A Phase II Trial Using Fondaparinux in Patients With Confirmed or Suspected Heparin-Induced Thrombocytopenia (HIT)|Terminated||Phase 2|3|Actual|James Graham Brown Cancer Center|Study terminated, results data not available|1||study terminated due to low accrual|f||||t||||||||||2017-02-18 14:24:19.569952|2017-02-18 14:24:19.569952
NCT00673426|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-06|||January 2008||2008-01-01|January 2008|2008-01-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|Enoxaparin||Safety Evaluation of Use Sodic Enoxaparin|Safety Evaluation of Use Sodic Enoxaparin Produced by the Laboratory Blausiegel When Compared With Product Clexane of Sanofi-Aventis Ltda in Chronic Renal Desease Patients.|Completed||Phase 3|60|Actual|Azidus Brasil||1|||f||||f||||||||||2017-02-18 14:24:19.766785|2017-02-18 14:24:19.766785
NCT00673387|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2015-03-26|2013-08-12||April 2008||2008-04-01|March 2015|2015-03-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional||Intent to treat population. All participants randomized to a treatment and received at least 1 dose. Drug Randomization stratified:sex,3 categories baseline BMI (12 arms); 3 treatment arms combined for summaries as single placebo treatment group; 3 combined for summaries as single pramlintide monotherapy treatment group (total:8 treatment groups).|Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Examine the Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects.|Completed||Phase 2|636|Actual|AstraZeneca|Drug Randomization stratified:sex,3 categories baseline BMI (12 arms); 3 treatment arms combined for summaries as single placebo treatment group; 3 combined for summaries as single pramlintide monotherapy treatment group (total:8 treatment groups).|8|||f||||f||||||||||2017-02-18 14:24:20.366452|2017-02-18 14:24:20.366452
NCT00673374|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2014-02-23|||May 2008||2008-05-01|February 2014|2014-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Correlation of Location of Abdominal Tenderness With Acute CT Abnormalities in Emergency Department Patients|Correlation of Location of Abdominal Tenderness With Acute CT Abnormalities in Emergency Department Patients|Completed||N/A|102|Actual|Duke University|||1||f||||f||||||||||2017-02-18 14:24:23.713681|2017-02-18 14:24:23.713681
NCT00673361|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2016-01-11|2013-03-20||March 2007||2007-03-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||"Pilot Trial of Chemo-Switch Regimen to Treat Advanced Melanoma"|"Phase II Pilot Trial of Chemo-Switch Regimen of Biochemotherapy Followed by Daily Low-Dose Temozolomide Plus Sorafenib in Advanced Melanoma"|Terminated||Phase 2|9|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:24:23.809164|2017-02-18 14:24:23.809164
NCT00673348|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-07-22|||May 2008||2008-05-01|June 2008|2008-06-01|April 2010|Anticipated|2010-04-01|April 2009|Anticipated|2009-04-01||Observational|||Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations|A Prospective Observational Study of Plasma Voriconazole Concentration Measurement and Its Correlation With CYP2C19 Genotype in Korean Patients|Unknown status|Recruiting|N/A|40|Anticipated|The Catholic University of Korea|||1||f||||f||||||Samples With DNA|"~     -  Two times of venous blood sampling will be carried out at steady state. Three ml of~          venous blood is sampled right before the morning dose (trough sampling). The second~          sampling is carried out at any time point within 2-4 hours after the morning dose (peak~          sampling). To obtain the exact dose and sampling history, at least three dosing times~          around the trough and peak sampling will be recorded to the minute. Sampling time will~          also be recorded as clock time.~        -  Genotyping of CYP2C19 will also be performed using 3 ml of peripheral blood sampled~          into EDTA tubes.~   "|||2017-02-18 14:24:24.052167|2017-02-18 14:24:24.052167
NCT00673335|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-06-22|||May 2008||2008-05-01|June 2016|2016-06-01|February 2022|Anticipated|2022-02-01|February 2017|Anticipated|2017-02-01||Interventional|LIBER||Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation|Prevention of Breast Cancer by Letrozole in Post-menopausal Women Carrying a BRCA1/BRCA2 Mutation|Active, not recruiting||Phase 3|386|Anticipated|UNICANCER||2|||f||||f||||||||||2017-02-18 14:24:24.162684|2017-02-18 14:24:24.162684
NCT00673322|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2016-06-16|||May 2008||2008-05-01|June 2016|2016-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Trial of Second Generation Designer T Cells in Colorectal Carcinoma|Phase II/Pilot Trial of Second Generation Designer T Cells in Colorectal Cancer|Terminated||Phase 1|1|Actual|Roger Williams Medical Center||1||This study will be incorporated into another study.|f||||t||||||||||2017-02-18 14:24:24.305664|2017-02-18 14:24:24.305664
NCT00673309|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-05-04|||July 2002||2002-07-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Assessment of Mechanisms of Improved Wound Healing|Assessment of Mechanisms of Improved Wound Healing of Anabolic Agents and Diet in Severely Burned Patients|Completed||Phase 2/Phase 3|644|Actual|The University of Texas Medical Branch, Galveston||13|||f||||t||||||||||2017-02-18 14:24:24.620119|2017-02-18 14:24:24.620119
NCT00673296|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-05|||January 2007||2007-01-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation|Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation|Unknown status|Active, not recruiting|N/A|6|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 14:24:24.776563|2017-02-18 14:24:24.776563
NCT00673283|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2014-07-31|||April 2007||2007-04-01|January 2013|2013-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging|Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging|Completed||Early Phase 1|86|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:24:24.882728|2017-02-18 14:24:24.882728
NCT00673270|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2012-03-01|||May 2008||2008-05-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|AFLUCO2||Effects of Fludrocortisone and Hydrocortisone in Healthy Volunteers With Aldosterone Induced Suppression|Hemodynamic and Biological Effects of Fludrocortisone and Hydrocortisone, in Healthy Volunteers With Aldosterone Induced Suppression|Terminated||Phase 1/Phase 2|13|Actual|Rennes University Hospital||4|||f||||f||||||||||2017-02-18 14:24:24.997682|2017-02-18 14:24:24.997682
NCT00673257|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-09-06|2013-10-08||January 2007||2007-01-01|September 2016|2016-09-01||||July 2011|Actual|2011-07-01||Interventional|||Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer|Pharmacokinetics of Daunomycin in Children|Active, not recruiting||N/A|107|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 14:24:25.105602|2017-02-18 14:24:25.105602
NCT00673244|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-02-18|||April 2008||2008-04-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|AKI||Protocol to Assess the Severity of Acute Kidney Injury|Protocol to Assess the Severity of Acute Kidney Injury|Completed||N/A|44|Actual|George Washington University||1|||f||||f||||||||||2017-02-18 14:24:25.498693|2017-02-18 14:24:25.498693
NCT00673075|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2010-09-02|2010-09-02||May 2008||2008-05-01|September 2010|2010-09-01||||September 2009|Actual|2009-09-01||Interventional|||The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease|Efficacy and Tolerability of Nebivolol Compared With Carvedilol in Patients With Coronary Artery Disease and Stage I or II Hypertension|Completed||Phase 4|39|Actual|Forest Laboratories|The study was terminated early because of difficulties with enrollment. Only 39 out of 160 planned patients were randomized.|2|||f||||f||||||||||2017-02-18 14:24:29.023826|2017-02-18 14:24:29.023826
NCT00673231|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2013-09-25|2013-01-21||April 2008||2008-04-01|September 2013|2013-09-01|January 2011|Actual|2011-01-01|May 2009|Actual|2009-05-01||Interventional||Full Analysis Set defined as all randomized participants (as randomized) who received at least one dose of double-blind study medication, who have a non-missing baseline value and at least one post-baseline efficacy value for at least one efficacy variable during double-blind treatment period.|Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin|A 24-week International, Randomized, Parallel-group, Double-blind, Placebo-controlled Phase III Study With a 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Patients With Type 2 Diabetes With Inadequate Glycaemic Control on Insulin|Completed||Phase 3|1240|Actual|AstraZeneca|For participants who did not complete 24 weeks LOCF (last observation carried forward) was used. Only values prior to insulin up-titration were used for outcome measures except for mean daily insulin dose which was evaluated regardless of.|4|||f||||f||||||||||2017-02-18 14:24:25.621634|2017-02-18 14:24:25.621634
NCT00673218|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2012-07-03|||June 2007||2007-06-01|July 2012|2012-07-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils|The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils|Unknown status|Active, not recruiting|Phase 4|25|Anticipated|Creighton University||2|||f||||f||||||||||2017-02-18 14:24:26.940691|2017-02-18 14:24:26.940691
NCT00673205|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2010-12-09|||September 1995||1995-09-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|Capri||(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer|A Randomized, Double-Blind, Parallel-Group Trial Comparing Bicalutamide (Casodex) 150mg Once Daily With Placebo in Patients With Non-metastatic Prostate Cancer|Completed||Phase 3|3588|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:24:27.060638|2017-02-18 14:24:27.060638
NCT00673192|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-06|||January 2008||2008-01-01|January 2008|2008-01-01|December 2008|Anticipated|2008-12-01|January 2008|Anticipated|2008-01-01||Interventional|||Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population|Evaluation of ELISA Assay on HPV Infection Population|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 14:24:27.459734|2017-02-18 14:24:27.459734
NCT00673179|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2014-09-03|2013-06-12||May 2008||2008-05-01|September 2014|2014-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy|Outpatient Chemotherapy in Pediatric Osteosarcoma: Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy|Terminated||N/A|7|Actual|M.D. Anderson Cancer Center|Study could not meet accrual goal due to logistical considerations, terminated early.|2||Low accrual.|f||||f||||||||||2017-02-18 14:24:27.538169|2017-02-18 14:24:27.538169
NCT00673166|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2017-01-25|||January 2008||2008-01-01|January 2017|2017-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of Local Mechanisms for Staff Motivation to Reduce Hospital Mortality|Evaluation of Local Mechanisms for Staff Motivation to Improve Treatment and Reduce Mortality Due to Malaria at the Paediatric Ward|Completed||N/A|900|Actual|London School of Hygiene and Tropical Medicine||1|||f||||f||||||||||2017-02-18 14:24:27.849719|2017-02-18 14:24:27.849719
NCT00673153|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2011-11-03|||March 2008||2008-03-01|November 2011|2011-11-01||||August 2010|Actual|2010-08-01||Interventional|||Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid or SAHA; Zolinza™) in Combination With Gemtuzumab Ozogamicin (Mylotarg™) as Induction and Post-Remission Therapy in Older Patients With Previously Untreated Non-M3 Acute Myeloid Leukemia|Terminated||Phase 2|107|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 14:24:27.949954|2017-02-18 14:24:27.949954
NCT00673140|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2009-08-14|||May 2008||2008-05-01|August 2009|2009-08-01|June 2010|Anticipated|2010-06-01|May 2010|Anticipated|2010-05-01||Interventional|||Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)|Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig's Disease|Unknown status|Active, not recruiting|Phase 1|7|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:24:28.076392|2017-02-18 14:24:28.076392
NCT00673127|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2015-04-20|2013-07-09||February 2005||2005-02-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|February 2012|Actual|2012-02-01||Interventional|KHAD||Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer|A Phase II Trial of Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer|Completed||Phase 2|57|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 14:24:28.186882|2017-02-18 14:24:28.186882
NCT00673114|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2015-03-16|2013-05-08||August 2007||2007-08-01|March 2015|2015-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies|A Prospective, Phase I/II Trial Determining the Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Banked Unrelated Umbilical Cord Blood Supplemented With Related, Haplo-Identical T-Cell Depleted Stem Cells in Subjects With High Risk Malignancies|Completed||Phase 1/Phase 2|3|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:24:28.517107|2017-02-18 14:24:28.517107
NCT00673101|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2017-01-23|||January 2006||2006-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|Methoscan||Prospective Evaluation of FibroScan in Patients Treated With Methotrexate|Evaluation of Liver Fibrosis Using FibroScan and Non-invasive Biochemical Markers in Patients Treated With Methotrexate|Recruiting||N/A|500|Anticipated|Association HGE CHU Bordeaux Sud|||1||f||||f||||||||||2017-02-18 14:24:28.829229|2017-02-18 14:24:28.829229
NCT00673088|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2008-05-21|||February 2004||2004-02-01|May 2008|2008-05-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:24:28.928193|2017-02-18 14:24:28.928193
NCT00667238|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2008-04-25|||November 2006||2006-11-01|April 2008|2008-04-01||||||||Observational|||Chronic Pediatric Pain|Functional Impact of Chronic Pediatric Pain|Unknown status|Recruiting|N/A|300||Stanford University|||||f||||||||||||||2017-02-18 14:26:31.417199|2017-02-18 14:26:31.417199
NCT00673062|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2015-10-08||2009-04-14|May 2008||2008-05-01|October 2015|2015-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED)|Study of the Decongestant Effect of SCH 900538 Compared With Placebo and Pseudoephedrine as Active Control in Subjects With Seasonal Allergic Rhinitis (SAR) Exposed to Pollen in an Environmental Exposure Unit|Completed||Phase 2|265|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:24:29.580794|2017-02-18 14:24:29.580794
NCT00673049|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-07-22|2013-04-26||May 2008||2008-05-01|July 2013|2013-07-01|April 2012|Actual|2012-04-01|March 2011|Actual|2011-03-01||Interventional|NSCLC||Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer|Randomized, Open Label, Phase 3 Trial Of Erlotinib Alone Or In Combination With CP-751,871 In Patients With Advanced Non Small Cell Lung Cancer Of Non Adenocarcinoma Histology|Terminated||Phase 3|583|Actual|Pfizer||2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 14:24:30.001532|2017-02-18 14:24:30.001532
NCT00673036|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2017-01-24|||October 2005||2005-10-01|October 2016|2016-10-01|June 2019|Anticipated|2019-06-01|December 2017|Anticipated|2017-12-01||Observational|Fast-MI||French Registry of Acute Coronary Syndrome|French Registry of Acute Coronary Syndrome With or Without ST Elevation|Active, not recruiting||N/A|3750|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum and DNA~   "|||2017-02-18 14:24:32.561293|2017-02-18 14:24:32.561293
NCT00673023|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2008-05-04|||October 2007||2007-10-01|May 2008|2008-05-01||||December 2007|Actual|2007-12-01||Interventional|||Study the Role of Genetic Variation in the Determining Lipid Profile Response to Dietary Change|Study the Role of Polymorphism at the CETP Gene Locuse in the Determining Lipid Profile Response to Dietary Change|Completed||N/A|102|Actual|Tabriz University||3|||f||||t||||||||||2017-02-18 14:24:32.696583|2017-02-18 14:24:32.696583
NCT00673010|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-06|2016-03-07|||March 2005||2005-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma|Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma|Active, not recruiting||Phase 1|20|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:24:32.781081|2017-02-18 14:24:32.781081
NCT00672997|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2014-07-14||2014-07-10|May 2008||2008-05-01|July 2014|2014-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension|A Six-Week, Multi-Center, Double-Masked, Safety and Efficacy Study of Travoprost 0.004%/Timolol 0.5% BAC-free Compared to Travoprost 0.004%/Timolol 0.5% in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|301|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:24:32.877923|2017-02-18 14:24:32.877923
NCT00672984|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2009-12-22|2009-09-23||April 2008||2008-04-01|December 2009|2009-12-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Guanfacine Immediate-release Electrocardiogram Results (QTc) Study|A Phase I, Randomized, Gender Stratified, Double-Blind, Placebo- and Positive-Controlled, Three Period Crossover Trial to Assess the Effect of Guanfacine Hydrochloride on QT/QTc Interval in Healthy Men and Women|Completed||Phase 1|83|Actual|Shire||3|||f||||||||||||||2017-02-18 14:24:32.977371|2017-02-18 14:24:32.977371
NCT00672971|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2008-05-05|||September 2007||2007-09-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice|An Open Label Randomized Study to Compare the Safety and Efficacy of Silcap Plus (Approximately 4% Dimeticone) Against Nix Cream Rinse.|Completed||N/A|31|Actual|Oystershell NV||2|||f||||f||||||||||2017-02-18 14:24:36.357303|2017-02-18 14:24:36.357303
NCT00672958|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2013-10-24|2013-04-19||April 2008||2008-04-01|October 2013|2013-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder|A Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study Comparing the Efficacy and Safety of Lu AA21004 Versus Placebo in Acute Treatment of Adults With Major Depressive Disorder|Completed||Phase 3|600|Actual|Takeda||2|||f||||f||||||||||2017-02-18 14:24:36.47163|2017-02-18 14:24:36.47163
NCT00672945|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2009-07-28|||April 2008||2008-04-01|July 2009|2009-07-01||||January 2010|Anticipated|2010-01-01||Interventional|||A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil|Phase 2 Double-Blind Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil|Terminated||Phase 2|420|Anticipated|Epix Pharmaceuticals, Inc.||2|||f||||||||||||||2017-02-18 14:24:37.879963|2017-02-18 14:24:37.879963
NCT00672932|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2013-05-29|2012-06-18||April 2008||2008-04-01|May 2013|2013-05-01|February 2011|Actual|2011-02-01|October 2010|Actual|2010-10-01||Interventional|||Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients|Pilot Study of Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients|Completed||N/A|18|Actual|University of California, San Francisco|The underlying hypothesis might not have actually been addressed because of the particular makeup of the subject group with minimal CNS infection and immunoactivation that left little room to discern a therapeutic effect.|2|||f||||f||||||||||2017-02-18 14:24:38.017621|2017-02-18 14:24:38.017621
NCT00672919|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-02-27|||November 2003||2003-11-01|February 2012|2012-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|COMPLEMENT||Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.|A Single-Arm, Open-Label, Multicenter Study Evaluating the Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia Following Treatment Conversion From Rosiglitazone to Pioglitazone HCl in Combination With Stable Statin Therapy|Completed||Phase 4|305|Actual|Takeda||1|||f||||f||||||||||2017-02-18 14:24:38.412706|2017-02-18 14:24:38.412706
NCT00672906|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2014-09-12|||July 2005||2005-07-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|GPT-AN||Group Parent Training for Adolescent Eating Disorders|Group Parent Training for Adolescent Eating Disorders|Completed||N/A|124|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:24:38.572232|2017-02-18 14:24:38.572232
NCT00672893|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2009-06-15|||February 2006||2006-02-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Vibration Response Imaging (VRI) in Patients That Are Undergoing Pulmonary Interventional Procedure|Vibration Response Imaging (VRI) in Patients That Are Undergoing Pulmonary Interventional Procedure|Completed||N/A|200|Anticipated|Deep Breeze|||1||f||||f||||||||||2017-02-18 14:24:38.664027|2017-02-18 14:24:38.664027
NCT00672867|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2014-12-17|||December 2007||2007-12-01|July 2012|2012-07-01|September 2014|Actual|2014-09-01|November 2012|Actual|2012-11-01||Interventional|||A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B|A Open Randomized Clinical Trial Comparing the Efficacy and Safety of Clevudine 30mg Versus Adefovir 10mg in Patients With LC-B|Completed||Phase 3|102|Anticipated|Bukwang Pharmaceutical||2|||f||||||||||||||2017-02-18 14:24:38.868274|2017-02-18 14:24:38.868274
NCT00672854|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-07-02|2014-07-02||November 2008||2008-11-01|July 2014|2014-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|TPN 2||Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in Intensive Care Unit Patients|StudyComparing a Soybean Oil-Based vs Olive Oil-Based Lipid Emulsion: Effects on Endothelial Function, Inflammatory Markers, Oxidative Stress, Immune Function,Insulin Sensitivity and Carb Metabolism Intensive Care Unit Patients|Completed||Phase 2/Phase 3|100|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:24:39.179651|2017-02-18 14:24:39.179651
NCT00672841|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2015-01-20|2012-02-21||June 2008||2008-06-01|November 2012|2012-11-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients|Randomized Comparison of β-D-Glucan Surveillance With Preemptive Anidulafungin Versus Standard Care for the Management of Invasive Candidiasis in Surgical Intensive Care Unit Patients|Completed||N/A|64|Actual|Duke University|This study represents a 1st attempt at preemptive antifungal therapy based on the fungal biomarker 1,3-Beta-D-Glucan in the intensive care unit. Main limitation: the small number of subjects with proven/probable invasive candidiasis.|2|||f||||t||||||||||2017-02-18 14:24:39.533968|2017-02-18 14:24:39.533968
NCT00672828|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-03|2013-08-16|||January 2008||2008-01-01|August 2013|2013-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|PACT||Interactive Computer Program or Brochure in Increasing Colorectal Cancer Screening Among African Americans|Promoting Colon Cancer Screening Among African Americans|Completed||N/A|693|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 14:24:39.997175|2017-02-18 14:24:39.997175
NCT00672815|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2010-01-20|||April 2006||2006-04-01|January 2010|2010-01-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Observational|TXSB42||The Impact of Texas Senate Bill 42 on Middle School Children's Level of Physical Activity|The Impact of Texas Senate Bill 42 on Middle School Children's Level of Physical Activity|Completed||N/A|141|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-02-18 14:24:40.110094|2017-02-18 14:24:40.110094
NCT00672802|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-02-27|||August 2003||2003-08-01|February 2012|2012-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease|A Phase II Safety Study of TAK-375 in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease|Completed||Phase 2|26|Actual|Takeda||1|||f||||f||||||||||2017-02-18 14:24:40.204894|2017-02-18 14:24:40.204894
NCT00672789|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2013-05-24|||April 2008||2008-04-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Adherence to Hydroxyurea in Children With Sickle Cell Anemia|Adherence to Hydroxyurea in Children With Sickle Cell Anemia|Completed||N/A|31|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:24:40.333119|2017-02-18 14:24:40.333119
NCT00672776|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2015-01-16|||May 2003||2003-05-01|January 2015|2015-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)|Effects of Paxil CR on Neural Circuits in PTSD|Completed||Phase 4|40|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:24:40.44649|2017-02-18 14:24:40.44649
NCT00672763|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-06-03|||May 2008||2008-05-01|June 2011|2011-06-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|IBDVit1||Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease|The Immunomodulatory Role of Vitamin D in Inflammatory Bowel Disease (The IBDVit Study): Double-Blind, Placebo-Controlled Trial of Adjuvant Vitamin D (Colecalciferol) With Corticosteroids in Active Crohn's Disease|Withdrawn||Phase 4|0|Actual|Imperial College London||2||Unable to recruit adequate trial participants|f||||t||||||||||2017-02-18 14:24:40.537769|2017-02-18 14:24:40.537769
NCT00672750|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2017-01-24|||February 2008||2008-02-01|January 2017|2017-01-01|September 16, 2016|Actual|2016-09-16|September 16, 2016|Actual|2016-09-16||Observational|retromyo||A Retrospective Review Of Outcomes Following Laparoscopic Myomectomy|A Retrospective Review Of Outcomes Following Laparoscopic Myomectomy|Terminated||N/A|70|Actual|The Advanced Gynecologic Surgery Institute|||1|did not have resources to continue this study|f||||f||||||||||2017-02-18 14:24:40.658015|2017-02-18 14:24:40.658015
NCT00672737|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2010-05-07|||February 2008||2008-02-01|May 2010|2010-05-01|December 2010|Anticipated|2010-12-01|August 2010|Anticipated|2010-08-01||Interventional|||Study of Pain Processing in Subjects Suffering From Obstructive Sleep Apnea|Experimental Pain Processing and Autonomic Function in Subjects Suffering From Obstructive Sleep Apnea|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 14:24:40.747948|2017-02-18 14:24:40.747948
NCT00672724|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-02-27|||February 2005||2005-02-01|February 2012|2012-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy of Ramelteon in Adults With Chronic Insomnia|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Subjective Response to Treatment With Ramelteon in Adult Subjects With Chronic Insomnia by Utilizing an Interactive Voice Response System (IVRS) for Collecting Diary Data|Terminated||Phase 3|1081|Actual|Takeda||2||Issues with data collection tool|f||||f||||||||||2017-02-18 14:24:40.846271|2017-02-18 14:24:40.846271
NCT00672711|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2017-01-23|||April 2008||2008-04-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Susceptibility to Chronic Post-Traumatic Extremity Pain|Susceptibility to Chronic Post-Traumatic Extremity Pain|Completed||N/A|250|Actual|William Beaumont Hospitals|||3||f||||f||||||Samples With DNA|"~     Whole blood serum~   "|||2017-02-18 14:24:41.001099|2017-02-18 14:24:41.001099
NCT00672698|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-10-29|||November 2008||2008-11-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Evaluation of Surgical Risk in Elderly Patients Submitted to Elective Surgery|Evaluation of Surgical Risk in Elderly Patients Submitted to Elective Surgery: Comparative Study of Elective Vascular, Digestive and Biliary Surgery|Withdrawn||N/A|0|Actual|Cirujanos la Serena|||3|NOT ENOUGH DATA AVAILABLE|f||||f||||||||||2017-02-18 14:24:41.096352|2017-02-18 14:24:41.096352
NCT00665535|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-03-20|||March 2008||2008-03-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|TURN||Pressure Ulcer Prevention: Turning for Ulcer Reduction|Preventing Pressure Ulcers: A Multi-site RCT in Nursing Facilities|Completed||Phase 3|967|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-02-18 14:27:21.520355|2017-02-18 14:27:21.520355
NCT00672685|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-04-16|||May 2008||2008-05-01|April 2015|2015-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|MAPT||Omega-3 Fatty Acids and/or Multi-domain Intervention in the Prevention of Age-related Cognitive Decline|Assessment of the Efficacy of Omega-3 Fatty Acids Supplementation, Multi-domain Intervention or Their Combination on the Change of Cognitive Functions in Frail Elderly Subjects|Completed||N/A|1680|Actual|University Hospital, Toulouse||4|||f||||f||||||||||2017-02-18 14:24:41.192283|2017-02-18 14:24:41.192283
NCT00672672|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2011-08-02|||February 2009||2009-02-01|August 2011|2011-08-01||||July 2012|Anticipated|2012-07-01||Interventional|||Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients|Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients|Terminated||Phase 3|250|Anticipated|University of Nebraska||1||Study closed with no subjects accrued. PI decided to stop study.|f||||t||||||||||2017-02-18 14:24:41.306386|2017-02-18 14:24:41.306386
NCT00672659|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2011-04-29|||February 2008||2008-02-01|April 2011|2011-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)|Phase IIa Proof of Concept Study of Pipamperone/Citalopram (PipCit) Versus Citalopram in the Treatment of Major Depressive Disorder (MDD)|Completed||Phase 2|165|Actual|PharmaNeuroBoost N.V.||2|||f||||t||||||||||2017-02-18 14:24:41.392191|2017-02-18 14:24:41.392191
NCT00672646|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-05-07|2011-08-31||April 2008||2008-04-01|May 2012|2012-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386|A Double-blind, Randomized, Placebo and Naproxen Controlled Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386, in Patients Undergoing Impacted Mandibular Third Molar Extraction|Completed||Phase 2|103|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 14:24:41.503377|2017-02-18 14:24:41.503377
NCT00672633|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2013-05-24|2013-03-08||April 2008||2008-04-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides|A Double Blind Randomized Controlled Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides.|Terminated||Phase 2|25|Actual|Boston Children’s Hospital|Early termination leading to small numbers of subjects analyzed|2||Very slow recruitment.|f||||t||||||||||2017-02-18 14:24:42.242807|2017-02-18 14:24:42.242807
NCT00672620|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2013-10-25|2013-10-25||April 2008||2008-04-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder|Completed||Phase 3|611|Actual|Takeda||4|||f||||f||||||||||2017-02-18 14:24:42.918444|2017-02-18 14:24:42.918444
NCT00672607|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2009-09-30|||February 2005||2005-02-01|September 2009|2009-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|ACT-RCT-C 01||a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)||Completed||Phase 2|217|Actual|Schwabe-Wenex International Ltd||2|||f||||t||||||||||2017-02-18 14:24:45.095525|2017-02-18 14:24:45.095525
NCT00672594|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2014-07-31|2013-10-25||July 2006||2006-07-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|||Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy|Investigator-Initiated Pilot Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy|Completed||Phase 2|30|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:24:45.20254|2017-02-18 14:24:45.20254
NCT00672581|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2010-09-27|||April 2008||2008-04-01|September 2010|2010-09-01|March 2009|Actual|2009-03-01|||||Interventional|||Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic Impairment|An Open-label Comparative Study of the Pharmacokinetics, Safety and Tolerability of ZD4054 (Zibotentan) Following a 10 mg Single Oral Dose of ZD4054(Zibotentan) to Healthy Subjects and to Subjects With Mild, Moderate and Severe Hepatic Impairment|Completed||Phase 1|32|Anticipated|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:24:45.786838|2017-02-18 14:24:45.786838
NCT00672568|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2009-05-01|||July 2008||2008-07-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Stage Exploratory Study to Evaluate Safety, Tolerability, Efficacy, and Pharmacokinetics of Intraoperative Subacromial Injection With 4975 in Patients Undergoing Arthroscopic Rotator Cuff Repair of the Shoulder|Terminated||Phase 2|24|Actual|Anesiva, Inc.||4||"Study has been halted after completing Stage 1, for corporate reasons. No future patients will~   be enrolled or treated."|f||||f||||||||||2017-02-18 14:24:45.891085|2017-02-18 14:24:45.891085
NCT00672555|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2011-06-03|2010-04-28||August 2006||2006-08-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|January 2009|Actual|2009-01-01||Interventional|||Limberg-flap: Prospective Data Collection|Prospective Evaluation of Feasibility and Results of the Treatment of Pilonidal Sinus by Excision and Covering of the Defect With a Limberg-flap.|Completed||N/A|70|Actual|Cantonal Hospital of St. Gallen|Study was conducted as planned. A long time was needed to get the follow-up information.|1|||f||||t||||||||||2017-02-18 14:24:46.019155|2017-02-18 14:24:46.019155
NCT00672542|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-03|2014-01-21|||January 2008||2008-01-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|March 2013|Actual|2013-03-01||Interventional|||Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells|Phase I Study of Active Immunotherapy of Metastatic Melanoma With Mature Autologous Dendritic Cells Transfected With Tumor Antigen RNA and Small Inhibitory RNAs to Alter Proteasomal Antigen Processing|Completed||Phase 1|12|Actual|Duke University||3|||f||||f||||||||||2017-02-18 14:24:46.310464|2017-02-18 14:24:46.310464
NCT00672529|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2011-02-02|||February 2011||2011-02-01|February 2011|2011-02-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Orthomolecular Therapy and Asthma in Children|Orthomolecular Treatment as add-on Therapy for Childhood Asthma|Unknown status|Recruiting|Phase 2|90|Anticipated|Canadian Institute of Natural and Integrative Medicine||2|||f||||f||||||||||2017-02-18 14:24:46.412935|2017-02-18 14:24:46.412935
NCT00672516|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-05-26|||April 2008||2008-04-01|May 2015|2015-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Management of Bleeding Following Cardiopulmonary Bypass|Management of Excessive Bleeding Following Cardiopulmonary Bypass: A Pilot Feasibility Study|Completed||N/A|43|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-02-18 14:24:46.531081|2017-02-18 14:24:46.531081
NCT00672503|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2011-10-07|||May 2008||2008-05-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Decreasing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit|"Decreasing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit"|Completed||N/A|321|Actual|Children's Mercy Hospital Kansas City|||4||f||||f||||||||||2017-02-18 14:24:46.626864|2017-02-18 14:24:46.626864
NCT00672490|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-06-11|2010-06-24||April 2008||2008-04-01|June 2012|2012-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|MANIA||Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder|An Open Label, 4-Week, Randomised, Multi-Centre, Phase IV Study to Compare the Efficacy and Safety of Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder|Completed||Phase 4|376|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:24:46.72002|2017-02-18 14:24:46.72002
NCT00672477|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2013-11-07|||June 2008||2008-06-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness|A Randomized, Double-Blind, Placebo-Controlled Study Of A Fixed Dose Of Subcutaneous Methylnaltrexone In Adults With Advanced Illness And Opioid-Induced Constipation: Efficacy, Safety, And Additional Health Outcomes|Completed||Phase 4|254|Anticipated|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 14:24:47.198248|2017-02-18 14:24:47.198248
NCT00672464|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2014-07-29|||April 2008||2008-04-01|July 2014|2014-07-01|February 2010|Anticipated|2010-02-01|December 2009|Anticipated|2009-12-01||Interventional|CRASOD||Cardio Risk of Acute Schizophrenia Olanzapine Duke|Combined Treatment of Cardiovascular Risk Factors In Newly Admitted Patients With Schizophrenia or Schizoaffective Disorder Who Are Receiving Olanzapine And Matched Controls|Withdrawn||Phase 4|0|Actual|Duke University||5||lack of funding|f||||f||||||||||2017-02-18 14:24:47.38073|2017-02-18 14:24:47.38073
NCT00672451|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2011-08-18|||January 2008||2008-01-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|RACE II||Rhubarb and Angiotensin Converting Enzyme Inhibitor|Rhubarb and Angiotensin Converting Enzyme Inhibitor|Terminated||N/A|8|Actual|Wake Forest University Health Sciences||2||unable to meet recruitment goal|f||||t||||||||||2017-02-18 14:24:47.489374|2017-02-18 14:24:47.489374
NCT00672438|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2017-01-04|2013-05-28||May 2008||2008-05-01|January 2017|2017-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||Baseline data collected for all enrolled participants.|Heritability of Opioid Effects: A Twin Study|Heritability of Opioid Effects: A Twin Study|Completed||N/A|242|Actual|Stanford University|The study was completed as intended, enrolling 121 twin pairs for a total of 114 evaluable pairs. There are no unexpected adverse events to report.|2|||f||||f||||||||||2017-02-18 14:24:47.600769|2017-02-18 14:24:47.600769
NCT00672412|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-09-11||2010-12-20|October 2008||2008-10-01|September 2012|2012-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand|A Phase I/II Comparative Pharmacokinetic Study of the Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC), and Nevirapine (NVP) as GPO-Vir Z30 Pediatric Tablets Versus the Individual Liquid Formulations in HIV-Infected Children Greater Than or Equal to Five Months and Less Than 13 Years of Age in Thailand|Completed||Phase 1/Phase 2|42|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 14:24:48.257916|2017-02-18 14:24:48.257916
NCT00672399|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2015-02-23|||April 2008||2008-04-01|January 2015|2015-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects|A Placebo- and Positive-Controlled Study of the Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects|Completed||Phase 1|70|Actual|AstraZeneca||6|||f||||f||||||||||2017-02-18 14:24:48.384387|2017-02-18 14:24:48.384387
NCT00672386|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2014-07-10||2011-06-03|December 2007||2007-12-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes|A 12-Week, Double-Blind, Randomized, Placebo-Controlled Study in Type 2 Diabetes Mellitus Subjects to Evaluate the Efficacy, Safety and Tolerability of MTP Inhibitor JNJ-16269110 (R256918)|Completed||Phase 2|352|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||t||||||||||2017-02-18 14:24:48.49562|2017-02-18 14:24:48.49562
NCT00672373|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2008-05-05|||December 2006||2006-12-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|EGBTD||Extract of Ginkgo Biloba and Tardive Dyskinesia|A Double-Blind, Randomised, Parallel-Group Comparison of Extract of Ginkgo Biloba(EGB-761) Versus Placebo as Add-on Medication in Patients With Established Tardive Dyskinesia|Completed||Phase 3|157|Actual|Beijing HuiLongGuan Hospital||2|||f||||t||||||||||2017-02-18 14:24:48.672447|2017-02-18 14:24:48.672447
NCT00672360|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2015-09-10|||May 2007||2007-05-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Folate Rechallenge|Folate Rechallenge: A Pilot Study|Completed||Phase 2|13|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 14:24:48.783037|2017-02-18 14:24:48.783037
NCT00672347|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2010-03-18|||July 2008||2008-07-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Clonidine and Morphine in Caudal Anesthesia|Comparison of Clonidine and Morphine Plus Bupivacaine in Caudal Peridural Anesthesia for Postoperative Analgesia After Pediatric Urogenital Surgery|Completed||Phase 1/Phase 2|80|Actual|Federal University of Minas Gerais||4|||f||||t||||||||||2017-02-18 14:24:49.046745|2017-02-18 14:24:49.046745
NCT00672334|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-07-31|||May 2008||2008-05-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|June 2011|Actual|2011-06-01||Interventional|Bic-MC||Sodium Bicarbonate in Cardiac Surgery Study|A Multicenter, Randomized, Double Blind, Placebo Controlled Study of the Effect of Sodium Bicarbonate on Postoperative Renal Function in Patients Undergoing Elective Cardiopulmonary Bypass|Terminated||Phase 2/Phase 3|350|Actual|Austin Health||2|||f||||t||||||||||2017-02-18 14:24:49.158264|2017-02-18 14:24:49.158264
NCT00672321|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-03|2013-08-09|||December 2007||2007-12-01|July 2009|2009-07-01||||September 2010|Anticipated|2010-09-01||Observational|||Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma|Melanoma Lifestyle Study|Unknown status|Recruiting|N/A|2774|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:24:49.2686|2017-02-18 14:24:49.2686
NCT00672308|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-03|2008-05-05|||May 2003||2003-05-01|December 2004|2004-12-01|August 2006|Actual|2006-08-01|February 2005|Actual|2005-02-01||Interventional|ORS||Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in Adults|Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in Adults|Completed||Phase 2|195|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||3|||f||||f||||||||||2017-02-18 14:24:49.357039|2017-02-18 14:24:49.357039
NCT00672295|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2012-12-27|||August 2007||2007-08-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|September 2011|Actual|2011-09-01||Interventional|||PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer|A Phase I Trial of A SRC Kinase Inhibitor, Dasatinib,in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Recurrent Ovarian, Peritoneal, and Tubal Cancer|Completed||Phase 1|11|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:24:49.468175|2017-02-18 14:24:49.468175
NCT00672282|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2009-05-26|||October 1995||1995-10-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|||||Interventional|SPCG6||Casodex vs Placebo in Non-Metastatic Early Prostate Cancer|A Randomized, Double-Blind, Parallel-Group Trial Comparing Casodex 150mg Once Daily With Placebo in Patients With Non-Metastatic Prostate Cancer.|Completed||Phase 3|1218|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:24:49.590097|2017-02-18 14:24:49.590097
NCT00672269|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2009-02-03|||April 2008||2008-04-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|April 2009|Anticipated|2009-04-01||Observational|||Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors|A Pilot Study to Investigate Germ-Line MEN1 and SDHD Gene Mutation in Familial Cases of Carcinoid Cancer|Unknown status|Recruiting|N/A|25|Anticipated|Rutgers University|||1||f||||f||||||Samples With DNA|"~     Blood: a small sample of 2 tubes (2 - 4 teaspoons, or 20 ml). One tube will be used to~     prepare the DNA (your genetic material) for the test. The other would be used for further~     gene evaluation. The DNA will be stored with Rutgers University Cell and DNA Repository~     (RUCDR).~   "|||2017-02-18 14:24:49.752449|2017-02-18 14:24:49.752449
NCT00672256|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2014-07-14|2009-03-30||January 2007||2007-01-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|SmokeAtt02||Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence|Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence|Completed||N/A|62|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:24:49.854196|2017-02-18 14:24:49.854196
NCT00672243|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-08-02|2011-03-30||April 2007||2007-04-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme|Phase II Trial of Erlotinib Plus Sirolimus for Patients With Recurrent Malignant Glioma Multiforme|Completed||Phase 2|32|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:24:50.157321|2017-02-18 14:24:50.157321
NCT00672230|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2008-05-05|||August 2005||2005-08-01|May 2008|2008-05-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Dietary Lutein and the Retinopathy of Prematurity|The Placental and Mammary Transfer of Lutein and Zeaxanthin Into the Fetus and the Breast-Fed Infant|Unknown status|Recruiting|N/A|80|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 14:24:50.586805|2017-02-18 14:24:50.586805
NCT00672217|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-05-26|||July 2008||2008-07-01|January 2013|2013-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|REST||Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment|Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment|Completed||N/A|64|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 14:24:50.697064|2017-02-18 14:24:50.697064
NCT00672204|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2013-02-20|2013-02-20||November 2007||2007-11-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|December 2010|Actual|2010-12-01||Interventional|RAPTIVA||Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes|Efalizumab (Raptiva) Combined With Sirolimus in Type 1 Diabetic Islet Allograft Recipients|Completed||Phase 1/Phase 2|3|Actual|University of Minnesota - Clinical and Translational Science Institute|Early termination due to Raptiva being withdrawn from market|1|||f||||t||||||||||2017-02-18 14:24:50.810572|2017-02-18 14:24:50.810572
NCT00672191|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-05|2013-01-22||2013-01-22|February 2008||2008-02-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|August 2010|Actual|2010-08-01||Interventional|||Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV|A Phase II Study Testing the Activity and Safety of AGS-004 as an Immunotherapeutic in Successfully ART-Treated Subjects Infected With HIV-1 in Combination With ART Followed by ART Interruption|Completed||Phase 2|59|Actual|Argos Therapeutics||1|||f||||t||||||||||2017-02-18 14:24:51.077487|2017-02-18 14:24:51.077487
NCT00672178|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2016-11-23|2010-09-21||March 2008||2008-03-01|January 2011|2011-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)|Phase I/II Trial Evaluating Toxicity and Efficacy of Adding Stereotactic Body Radiotherapy to Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer|Terminated||Phase 1/Phase 2|1|Actual|Duke University|Early termination due to low accrual, only one subject enrolled.|1||Slow accrual|f||||f||||||||||2017-02-18 14:24:51.198765|2017-02-18 14:24:51.198765
NCT00672165|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-02-24|||July 2005||2005-07-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies|Phase I Trial of Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies|Completed||Phase 1|23|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:24:51.405941|2017-02-18 14:24:51.405941
NCT00672152|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2013-12-07|||June 2007||2007-06-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|April 2013|Actual|2013-04-01||Interventional|WT-1||A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation|A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CmML, ALL, MDS, and B Cell Malignancies|Terminated||Phase 1|8|Actual|Duke University||1||low accrual|f||||f||||||||||2017-02-18 14:24:51.514023|2017-02-18 14:24:51.514023
NCT00672139|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-06-27|||July 2008||2008-07-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation|Open-Label Extension Study To Assess The Safety Of A Fixed Dose Of Subcutaneous Methylnaltrexone In Subjects With Advanced Illness And Opioid-Induced Constipation|Unknown status|Recruiting|Phase 4|168|Anticipated|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-02-18 14:24:51.622075|2017-02-18 14:24:51.622075
NCT00672113|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2014-12-18|||December 2003||2003-12-01|December 2014|2014-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension|Effects of Adalat LA 30 mg and Coracten 30 mg on Nifedipine Plasma Concentration , Plasma Catecholamines, Blood Pressure Response and Heart Rate in Fed Mild to Moderate Hypertensive Patients.|Completed||Phase 4|43|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:24:51.773871|2017-02-18 14:24:51.773871
NCT00672100|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2013-05-22|2011-07-12||January 2009||2009-01-01|May 2013|2013-05-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Interventional|||Initial Local Anesthetic Dose With Continuous Interscalene Analgesia|The Effect Of Initial Local Anesthetic Dose With Continuous Interscalene Analgesia On Postoperative Pain And Diaphragmatic Function In Arthroscopic Shoulder Surgery Patients: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study|Completed||N/A|36|Actual|William Beaumont Hospitals||3|||f||||f||||||||||2017-02-18 14:24:51.87163|2017-02-18 14:24:51.87163
NCT00672087|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2017-02-02|||September 2003||2003-09-01|February 2014|2014-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Diagnostic Challenges in IC (and Male CPPS)|Diagnostic Challenges in IC (and Male CPPS)|Completed||N/A|1000|Anticipated|Beth Israel Deaconess Medical Center|||3||f||||f||||||Samples With DNA|"~     saliva, whole blood, serum, white cells, urine, prostatic fluid, prostate/bladder tissue~   "|||2017-02-18 14:24:52.484812|2017-02-18 14:24:52.484812
NCT00672074|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2011-06-08||2011-06-08|April 2008||2008-04-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus|A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in Patients|Completed||Phase 2|117|Actual|Helsinn Therapeutics (U.S.), Inc||2|||f||||f||||||||||2017-02-18 14:24:52.598501|2017-02-18 14:24:52.598501
NCT00672061|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-02-27|||July 2003||2003-07-01|February 2012|2012-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea|A Phase II Safety Study of TAK-375 in Subjects With Mild to Moderate Obstructive Sleep Apnea|Completed||Phase 2|26|Actual|Takeda||1|||f||||f||||||||||2017-02-18 14:24:52.723529|2017-02-18 14:24:52.723529
NCT00672048|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2014-01-03|||October 2007||2007-10-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Partnership for Glaucoma|Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership|Completed||N/A|721|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:24:52.85552|2017-02-18 14:24:52.85552
NCT00672035|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2012-03-13|||October 2006||2006-10-01|March 2012|2012-03-01|July 2008|Actual|2008-07-01|December 2006|Actual|2006-12-01||Interventional|||Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study|Randomized, Double-Blinded, Placebo-Controlled, Dose Ranging Study to Assess the Immunogenicity and Safety of LT Application in Healthy Adults|Completed||Phase 2|406|Actual|Intercell USA, Inc.||10|||f||||f||||||||||2017-02-18 14:24:52.968574|2017-02-18 14:24:52.968574
NCT00672022|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2008-05-05|||July 2004||2004-07-01|July 2005|2005-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses|Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset GM2 Gangliosidosis: Single and Steady State Oral Doses|Completed||Phase 3|10|Anticipated|Children's Research Institute|||||f||||||||||||||2017-02-18 14:24:53.085313|2017-02-18 14:24:53.085313
NCT00672009|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2014-09-03|||April 2008||2008-04-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|April 2011|Actual|2011-04-01||Interventional|||A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer|A Phase II Study of Ixabepilone Prior to Surgery for High-risk Localized Prostate Cancer|Terminated||Phase 2|11|Actual|Cedars-Sinai Medical Center||1||The sponsor terminated funding for the study.|f||||f||||||||||2017-02-18 14:24:53.172142|2017-02-18 14:24:53.172142
NCT00671996|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-04|2010-05-03|||June 2008||2008-06-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|MANFOL||Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C|A Local Feasibility Study on Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Patients Operated Upon Colon Cancer Stage Dukes' C|Completed||Phase 2|14|Actual|PledPharma AB||2|||f||||f||||||||||2017-02-18 14:24:53.28426|2017-02-18 14:24:53.28426
NCT00671983|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2016-10-17|||March 2010||2010-03-01|October 2016|2016-10-01|July 2014|Anticipated|2014-07-01|June 2014|Anticipated|2014-06-01||Interventional|||The Effect of Obstructive Sleep Apnea on Medical Outcomes After Gastric Bypass Surgery|The Effect of Obstructive Sleep Apnea on Medical and Neurobehavioral Outcomes After Gastric Bypass Surgery - An Exploratory Investigation|Withdrawn||Phase 1/Phase 2|0|Actual|Stanford University||1||not adequate resources|f||||||||||||||2017-02-18 14:24:53.545529|2017-02-18 14:24:53.545529
NCT00671970|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-03-29|2012-12-28||February 2007||2007-02-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|November 2008|Actual|2008-11-01||Interventional|||Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)|Phase II Trial of Bevacizumab Plus Erlotinib for Patients With Recurrent Malignant Glioma|Completed||Phase 2|57|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:24:53.641317|2017-02-18 14:24:53.641317
NCT00671957|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2016-12-01|||February 2006||2006-02-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|July 2007|Actual|2007-07-01||Observational|Energy||Energy Expenditure and Gastric Bypass Surgery Study|Energy Expenditure and Gastric Bypass Surgery Study|Suspended||N/A|40|Anticipated|Oregon Health and Science University|||1|Funding hiatus|f||||t||||||||||2017-02-18 14:24:54.276395|2017-02-18 14:24:54.276395
NCT00671944|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2010-06-30|||May 2003||2003-05-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||Long-term Nutritional Intervention Study to Determine How Protein Affects Calcium Metabolism|Long-term Impact of Protein on Calcium Kinetics|Completed||Phase 1|11|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:24:54.38726|2017-02-18 14:24:54.38726
NCT00671931|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2013-08-22|2011-06-24||April 2007||2007-04-01|August 2013|2013-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine|Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine|Completed||Phase 1|44|Actual|Children's Hospital Medical Center, Cincinnati||5|||f||||t||||||||||2017-02-18 14:24:54.501662|2017-02-18 14:24:54.501662
NCT00220350|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||October 2001||2001-10-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Lupron Sex Offender Therapy|Leuprolide Acetate Suppresses Pedophilic Urges and Arousability|Unknown status|Active, not recruiting|Phase 2/Phase 3|10||Schober, Justine, M.D.|||||f||||||||||||||2017-02-18 17:07:34.859902|2017-02-18 17:07:34.859902
NCT00671918|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2013-06-06|2013-04-13||April 2008||2008-04-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional||Of the 186 participants who enrolled in the trial, 179 were administered the study agent, Lymphoseek, and therefore this participant number is used for the baseline analysis.|Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma|A Phase 3, Prospective, Open-Label, Multicenter Comparison Study of Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Melanoma or Breast Cancer Who Are Undergoing Lymph Node Mapping|Completed||Phase 3|186|Actual|Navidea Biopharmaceuticals||1|||f||||f||||||||||2017-02-18 14:24:55.174874|2017-02-18 14:24:55.174874
NCT00671905|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2013-04-10|||May 2008||2008-05-01|April 2013|2013-04-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Circumferential Versus Ganglionated Plexi Ablation for Atrial Fibrillation (AF)|Circumferential vs Ganglionated Plexi Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Study|Completed||N/A|150|Anticipated|Cardiovascular Research Society, Greece||3|||f||||t||||||||||2017-02-18 14:24:55.469404|2017-02-18 14:24:55.469404
NCT00671892|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2013-07-15|||September 2001||2001-09-01|July 2013|2013-07-01|April 2008|Actual|2008-04-01|August 2006|Actual|2006-08-01||Interventional|||Role of TLR4 in Environmental Asthma|Role of TLR4 in Environmental Asthma|Completed||Phase 1|855|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:24:55.580191|2017-02-18 14:24:55.580191
NCT00671879|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-10-22|2011-07-13||April 2008||2008-04-01|October 2012|2012-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back|Randomized, Double-Blind, Double-Dummy Trial of Two Sustained Release Formulations of Carisoprodol Compared to Placebo in Subjects With Acute, Painful, Musculoskeletal Spasm of the Lower Back|Completed||Phase 3|830|Actual|Meda Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:24:55.694084|2017-02-18 14:24:55.694084
NCT00671866|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2008-05-04||||||April 2008|2008-04-01||||||||Observational|||Neurotoxic Health Hazards of Long-Term Low-Level Exposure to Organophosphate (OP) Compounds in in Hula Valley||Unknown status|Not yet recruiting|N/A|||Shaare Zedek Medical Center|||3||f||||||||||||||2017-02-18 14:24:56.38745|2017-02-18 14:24:56.38745
NCT00671853|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-11-09|2012-04-16||April 2008||2008-04-01|November 2016|2016-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)|Quetiapine XR in the Treatment of Comorbid Generalized Anxiety Disorder in Bipolar Depression With or Without Substance Use Disorder|Completed||Phase 3|120|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-02-18 14:24:56.469306|2017-02-18 14:24:56.469306
NCT00671827|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-11-07|||April 2008||2008-04-01|November 2016|2016-11-01||||April 2018|Anticipated|2018-04-01||Observational|||Evaluation of Robot-Assisted Surgery in Gynecologic Oncology|Prospective Evaluation of Robot-Assisted Surgery in Gynecologic Oncology|Recruiting||N/A|1000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:24:56.936304|2017-02-18 14:24:56.936304
NCT00671814|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-05-18|||January 2008||2008-01-01|May 2016|2016-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|SAD/MAD||Single and Multiple Ascending Dose Pharmacokinetic Study of TR701 in Healthy Adults|A Double-Blind, Placebo and Active Controlled, Single and Multiple Rising Dose, Safety, Tolerance, and Pharmacokinetic Study of TR-701 in Normal Healthy Adults|Completed||Phase 1|90|Actual|Trius Therapeutics LLC||3|||f||||f||||||||||2017-02-18 14:24:57.053871|2017-02-18 14:24:57.053871
NCT00671801|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2015-02-16|||April 2008||2008-04-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I|Phase I Trial of Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme|Terminated||Phase 1|24|Actual|M.D. Anderson Cancer Center||1||Poor accrual.|f||||f||||||||||2017-02-18 14:24:57.168213|2017-02-18 14:24:57.168213
NCT00671788|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2016-03-17|2014-01-31||June 2008||2008-06-01|March 2016|2016-03-01||||December 2010|Actual|2010-12-01||Interventional||Eligible and treated participants|A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|35|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 14:24:57.298681|2017-02-18 14:24:57.298681
NCT00671775|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2011-03-15|||September 2005||2005-09-01|March 2011|2011-03-01||||March 2010|Anticipated|2010-03-01||Observational|||Cognitive Effects of Bariatric Surgery|Cognitive Effects of Bariatric Surgery|Unknown status|Active, not recruiting|N/A|250|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||f||||||||||2017-02-18 14:24:57.648844|2017-02-18 14:24:57.648844
NCT00671749|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-02-16|2014-08-12||December 2007||2007-12-01|February 2016|2016-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris|A Clinical Assessment of Combination Therapy With Differin® Gel, 0.3% With Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris|Completed||Phase 4|100|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||No||2017-02-18 14:24:57.751839|2017-02-18 14:24:57.751839
NCT00671736|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2009-08-26|||October 2007||2007-10-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Lancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic Fibrosis|A Randomized, Double-Blind, Placebo-Controlled, Dose-finding Study to Evaluate the Efficacy and Safety of Aerosolized Moli1901 in Adolescents (12 Years of Age or Older) and Adults With Cystic Fibrosis|Completed||Phase 2|160|Anticipated|AOP Orphan Pharmaceuticals AG||4|||f||||t||||||||||2017-02-18 14:25:00.601746|2017-02-18 14:25:00.601746
NCT00671723|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2014-01-06|||October 2006||2006-10-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Dornase Alpha Versus Hypertonic Saline for Lung Atelectasis in Non-Cystic Fibrosis Patients|Dornase Alpha Versus Hypertonic Saline for Lung Atelectasis|Completed||N/A|33|Actual|University of Oklahoma||3|||f||||t||||||||||2017-02-18 14:25:00.721897|2017-02-18 14:25:00.721897
NCT00671710|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2011-01-13|||April 2008||2008-04-01|June 2010|2010-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain|A Phase 1 and 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain|Completed||Phase 1|26|Anticipated|Advocate Hospital System||1|||f||||f||||||||||2017-02-18 14:25:00.82517|2017-02-18 14:25:00.82517
NCT00671697|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2013-05-31|||May 2008||2008-05-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|January 2010|Actual|2010-01-01||Interventional|||Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia|A Phase I Study of Intravenous Decitabine in Combination With Arsenic Trioxide and Ascorbic Acid in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia|Completed||Phase 1|13|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 14:25:00.923561|2017-02-18 14:25:00.923561
NCT00671684|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2008-05-02|||October 2007||2007-10-01|May 2008|2008-05-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|EDGE||Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease|Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial|Unknown status|Enrolling by invitation|Phase 1/Phase 2|50|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 14:25:01.059894|2017-02-18 14:25:01.059894
NCT00671671|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2013-11-25|2013-11-25||April 2008||2008-04-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.|A Phase 1, Non- Randomized, Open Label, Sequential Group, Multicenter Study To Evaluate The Antiviral Activity Of Multiple Doses Of A Small Molecule Direct Antiviral Agent In Chronically Infected Hepatitis C Subjects.|Completed||Phase 1|20|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:25:01.164634|2017-02-18 14:25:01.164634
NCT00671658|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2013-08-23|||November 2002||2002-11-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia|Phase II Study of The Modified Hyper-CVAD Program for Acute Lymphoblastic Leukemia|Completed||Phase 2|220|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:25:02.013913|2017-02-18 14:25:02.013913
NCT00671645|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2009-03-12|||July 2008||2008-07-01|March 2009|2009-03-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy|Preoperative Combined RadioChemo-MolecularTargetTherapy of the Locally Advanced Rectum Carcinoma (cT3NxM0) - a Phase II Pilot Study With Preoperative Application of Capecitabine, Bevacizumab and Radiotherapy (RTx)|Terminated||Phase 2|8|Actual|Austrian Breast & Colorectal Cancer Study Group||1||"reaching of step 1 (recruitment of 8 patients) per protocol -> risk assessment -> termination~   because of occurance of toxicity Grade 3 and 4"|f||||f||||||||||2017-02-18 14:25:02.178049|2017-02-18 14:25:02.178049
NCT00671632|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-02-27|||June 2003||2003-06-01|February 2012|2012-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse|A Randomized, Single Center, Double-Blind, Multiple-Dose, Placebo-Controlled, Crossover, Double-Dummy Study of The Acute Behavioral and Subjective Effects of Ramelteon in Subjects With a History of Polydrug Abuse.|Completed||Phase 2|14|Actual|Takeda||1|||f||||f||||||||||2017-02-18 14:25:02.319719|2017-02-18 14:25:02.319719
NCT00671619|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-08-22|||April 2008||2008-04-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study of ESBA105 Eye Drops in Healthy Subjects|A Phase I, Randomized, Vehicle-Controlled, Double-Blind, Mono-Centric, Single and Repeated Dose, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ESBA105 Eye Drops in Healthy Subjects|Completed||Phase 1|27|Actual|ESBATech AG||1|||f||||f||||||||||2017-02-18 14:25:02.449608|2017-02-18 14:25:02.449608
NCT00671606|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-04-29|2011-06-30||April 2008||2008-04-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Hysteroscopic Lymphatic Mapping for Endometrial Cancer|Hysteroscopic Injection of Tracers for Sentinel Node Identification in Women With Endometrial Cancer|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center|Early termination due to low detection rate of sentinel lymph nodes in the five participants.|1||Slow accrual.|f||||f||||||||||2017-02-18 14:25:02.549|2017-02-18 14:25:02.549
NCT00671593|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2013-07-15|||October 2006||2006-10-01|July 2013|2013-07-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge|Genetics of Environmental Asthma: Differential Gene Expression in the Lung and Peripheral Blood After Inhaled Allergen Challenge|Terminated||Phase 1|40|Actual|Duke University||1||funding terminated|f||||t||||||||||2017-02-18 14:25:02.760416|2017-02-18 14:25:02.760416
NCT00671580|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2009-06-02|||May 2008||2008-05-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection|A Phase II Randomized, Observer-Blind, Multi-Center Study to Evaluate the Safety, Potential Efficacy, and Pharmacokinetics of Two Dosing Regimens of Intravenous PZ-601 and Standard of Care in the Treatment of Complicated Skin and Skin Structure Infections|Completed||Phase 2|99|Anticipated|Protez Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 14:25:02.87254|2017-02-18 14:25:02.87254
NCT00671567|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-11-16|||December 2002||2002-12-01|November 2012|2012-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Ramelteon in Adults With Chronic Insomnia|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Outpatient, Safety and Efficacy Study of TAK-375 in Adults With Chronic Insomnia|Completed||Phase 3|848|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:25:02.989008|2017-02-18 14:25:02.989008
NCT00671554|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2014-05-16|2012-04-03||April 2008||2008-04-01|May 2014|2014-05-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma|Phase II, Open-Label Trial in Patients With Stage IV Malignant Melanoma Using Melaxin as a Cancer Vaccine in Conjunction With BCG|Terminated||Phase 1/Phase 2|3|Actual|Greenville Health System||1||Due to business considerations; not due to toxicities or adverse events.|f||||f||||||||||2017-02-18 14:25:03.380991|2017-02-18 14:25:03.380991
NCT00671541|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-02-16|||March 2006||2006-03-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Nasospore Stent For Use in Enodscopic Sinus Surgery|Nasospore Stent For The Use in Endoscopic Sinus Surgery|Withdrawn||Phase 4|0|Actual|Lahey Clinic||2||Principal Investigator left the institution requested study terminated.|f||||f||||||||||2017-02-18 14:25:03.630479|2017-02-18 14:25:03.630479
NCT00671346|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2015-11-04|||December 1998||1998-12-01|November 2015|2015-11-01|January 2021|Anticipated|2021-01-01|December 2020|Anticipated|2020-12-01||Observational|NORVITWENBIT||NORVIT and WENBIT - Long-term Follow-up|Combined Analyses and Long-term Follow-up in the Two Norwegian Homocysteine-Lowering B-Vitamin Trials NORVIT and WENBIT|Active, not recruiting||N/A|6839|Anticipated|Haukeland University Hospital|||4||f||||f||||||||||2017-02-18 14:25:06.933088|2017-02-18 14:25:06.933088
NCT00671528|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2014-12-29|2011-05-19||July 2009||2009-07-01|December 2014|2014-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)|Double-blind Evaluation of the Safety and Efficacy of Quadriderme® (Betamethasone Diproprionate, Clotrimazole and Gentamicin) Compared With Betamethasone Diproprionate Combined With Gentamicin Sulfate and With Betamethasone Diproprionate in the Treatment of Impetiginous Eczema|Terminated||Phase 4|3|Actual|Merck Sharp & Dohme Corp.|This study was terminated early due to lack of recruitment (only 3 of 201 participants were enrolled). Statistical analyses were not performed.|3||terminated early due to lack of recruitment [only 3 of 207 subjects were enrolled]|f||||f||||||||||2017-02-18 14:25:03.732425|2017-02-18 14:25:03.732425
NCT00671515|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-11-30|2013-10-31||April 2008||2008-04-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome|Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome|Completed||Phase 2|23|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-02-18 14:25:04.116381|2017-02-18 14:25:04.116381
NCT00671502|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2011-10-04|2011-06-28||April 2008||2008-04-01|October 2011|2011-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back|Randomized, Double-Blind, Double-Dummy Trial of Two Sustained Release Formulations of Carisoprodol Compared to Placebo in Subjects With Acute, Painful, Musculoskeletal Spasm of the Lower Back|Completed||Phase 3|840|Actual|Meda Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:25:04.374819|2017-02-18 14:25:04.374819
NCT00671489|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-07-02|||May 2008||2008-05-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-01 Study|Phase 2 Study of Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-01 Study|Completed||Phase 1/Phase 2|15|Actual|Japan Science and Technology Agency||1|||f||||t||||||||||2017-02-18 14:25:04.922716|2017-02-18 14:25:04.922716
NCT00671476|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2014-01-09|||February 2008||2008-02-01|June 2009|2009-06-01||||February 2011|Anticipated|2011-02-01||Interventional|||Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery|Intraductal Therapy of DCIS: A Presurgery Study|Unknown status|Recruiting|N/A|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:25:05.030826|2017-02-18 14:25:05.030826
NCT00671463|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2013-06-10|||April 2008||2008-04-01|June 2013|2013-06-01||||April 2010|Anticipated|2010-04-01||Interventional|LEAPS||Pancreatic Stent to Prevent Leak After Distal Pancreatectomy|Leak Elimination After Pancreatic Stenting, a Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Massachusetts General Hospital||2||Anticipated high risk of pancreatitis|f||||t||||||||||2017-02-18 14:25:05.137968|2017-02-18 14:25:05.137968
NCT00671450|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2013-01-24|||October 2008||2008-10-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|VDMTBI||Visual Dysfunction in Mild Traumatic Brain Injury (MTBI): A Comparison Group Study|Visual Dysfunction in MTBI: A Comparison Group Study|Completed||N/A|75|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 14:25:05.24992|2017-02-18 14:25:05.24992
NCT00671437|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2015-08-28|2015-07-02||June 2008||2008-06-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|December 2011|Actual|2011-12-01||Interventional|SCCHN|Baseline participants are based on the number of evaluable patients. 15 out of the 42 enrolled patients were not considered evaluable for analyses.|Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer|Determination of Tumor SUV by FDG-PET/CT Before and After Cetuximab in Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|42|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:25:05.350557|2017-02-18 14:25:05.350557
NCT00671424|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2012-03-15|||March 2008||2008-03-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide|An Evaluation of the Safety, Tolerability, and Pharmacodynamic Effects of GSK189075 When Administered With Furosemide or Hydrochlorothiazide|Completed||Phase 1|48|Anticipated|GlaxoSmithKline|||||||||f||||||||||2017-02-18 14:25:06.256681|2017-02-18 14:25:06.256681
NCT00671411|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2015-12-23|||March 2008||2008-03-01|December 2015|2015-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast|Evaluation of Renal Masses Using Ultrasound Intravenous Microbubble Contrast|Completed||Phase 1|42|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:25:06.354174|2017-02-18 14:25:06.354174
NCT00671398|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-02-27|||December 2002||2002-12-01|February 2012|2012-02-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Efficacy of Ramelteon on Transient Insomnia in Healthy Adults|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Single-Dose Study of TAK-375 in Healthy Adult Volunteers in a Sleep Lab Model of Transient Insomnia|Completed||Phase 3|289|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:25:06.468395|2017-02-18 14:25:06.468395
NCT00671385|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2011-01-30|||April 2008||2008-04-01|January 2011|2011-01-01|April 2011|Anticipated|2011-04-01|April 2009|Anticipated|2009-04-01||Observational|||Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning|Early Screening of Breast Cancer Using Radiation-Free Pressure-Free Optical Scanning|Unknown status|Recruiting|N/A|2000|Anticipated|Spectros Corporation|||1||f||||t||||||||||2017-02-18 14:25:06.611212|2017-02-18 14:25:06.611212
NCT00671372|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2016-11-01|||July 2006||2006-07-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer|A Phase Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Multiple Doses of Dulanermin Administered Intravenously in Combination With Camptosar®/Erbitux® Chemotherapy or the Folfiri Regimen With or Without Bevacizumab in Subjects With Previously Treated Metastatic Colorectal Cancer|Completed||Phase 1|42|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 14:25:06.705395|2017-02-18 14:25:06.705395
NCT00671359|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-04-27|||April 2008||2008-04-01|April 2016|2016-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Food Effects of Single Oral Dose of 600mg TR-701|An Open-Label, Single-Dose, Two-Treatment, Randomized, Two-Way Crossover, Safety, Tolerance, and Pharmacokinetic Study of TR-701 in Normal Healthy Adults in the Fed and Fasted State|Completed||Phase 1|12|Actual|Trius Therapeutics LLC||2|||f||||f||||||||||2017-02-18 14:25:06.825844|2017-02-18 14:25:06.825844
NCT00671333|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-04-18|||April 2008||2008-04-01|April 2016|2016-04-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|TMC/PyroDisk||PRCT: Ligament Reconstruction & Tendon Interposition With a Joint Spacer for Trapeziometacarpal OA|A Randomized Prospective Study Comparing Ligament Reconstruction and Tendon Interposition (LRTI) With a Joint Spacer (Ascension PyroDisk) for Trapeziometacarpal Osteoarthritis.|Recruiting||N/A|130|Anticipated|Simon Fraser Orthopaedic Fund||2|||f||||f||||||||||2017-02-18 14:25:07.05288|2017-02-18 14:25:07.05288
NCT00671320|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-04-30|||December 2002||2002-12-01|April 2008|2008-04-01|October 2003|Actual|2003-10-01|||||Interventional|||A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib And Diclofenac In Patients With A Sprained Ankle|A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib Vs. Diclofenac In Ankle Sprain|Completed||Phase 4|202|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:25:07.18049|2017-02-18 14:25:07.18049
NCT00671307|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2010-09-27|||March 2008||2008-03-01|April 2010|2010-04-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels|Phase 1b Randomized, Double-blind, Placebo-controlled, Ascending Single Dose Infusion Trial of the Pharmacokinetics of Rhu-pGelsolin in Patients With Decreased Natural Gelsolin Levels|Completed||Phase 1/Phase 2|40|Anticipated|Critical Biologics Corporation||4|||f||||t||||||||||2017-02-18 14:25:07.299621|2017-02-18 14:25:07.299621
NCT00671294|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-02-27|||October 2002||2002-10-01|February 2012|2012-02-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Safety and Efficacy of TAK-375 in Elderly Subjects With Chronic Insomnia.|Completed||Phase 3|100|Actual|Takeda||1|||f||||f||||||||||2017-02-18 14:25:07.416423|2017-02-18 14:25:07.416423
NCT00671281|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2010-09-02|||October 2008||2008-10-01|September 2010|2010-09-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus Surgery|The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus Surgery: A Randomized, Prospective, Double-Blinded Study|Withdrawn||N/A|74|Anticipated|University of Calgary||2||Study was cancelled|f||||f||||||||||2017-02-18 14:25:07.555535|2017-02-18 14:25:07.555535
NCT00671268|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2013-11-07|||March 2008||2008-03-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|AMETHYST||Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma|Multicentre, Multinational Randomised DBPC Clinical Trial for Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma|Completed||Phase 3|256|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 14:25:07.662656|2017-02-18 14:25:07.662656
NCT00671255|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-02-27|||December 2002||2002-12-01|February 2012|2012-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Outpatient, Safety and Efficacy Study of TAK-375 in Elderly Subjects With Chronic Insomnia|Completed||Phase 3|829|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:25:07.784199|2017-02-18 14:25:07.784199
NCT00671242|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2008-05-02||||||January 2008|2008-01-01||||||||Observational|angiogenesis||Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake|Correlation of Angiogenesis With 18F-FMT and 18F-FDG Uptake in Non-Small Cell Lung Cancer|Completed||N/A|||Gunma University|||2||f||||t||||||||||2017-02-18 14:25:08.019535|2017-02-18 14:25:08.019535
NCT00671229|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-04-13|||May 2003||2003-05-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1|Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1|Completed||N/A|420|Actual|National Institute of Environmental Health Sciences (NIEHS)|||2||f||||f||||||Samples With DNA|"~     Serum samples, DNA, Exhaled Breah Condensate~   "|||2017-02-18 14:25:08.091814|2017-02-18 14:25:08.091814
NCT00671216|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-11-02|||May 2008||2008-05-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.|A Single Centre, Randomised, Placebo-controlled, Four-way Cross Over Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of GSK233705 and GW642444 as Monotherapies and in Combination in Healthy Subjects.|Completed||Phase 1|16|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:25:08.186742|2017-02-18 14:25:08.186742
NCT00671203|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2011-01-30|||June 2007||2007-06-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|||Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair|Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair|Completed||Phase 3|500|Anticipated|Spectros Corporation||1|||f||||t||||||||||2017-02-18 14:25:08.282372|2017-02-18 14:25:08.282372
NCT00671190|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-02-27|||March 2005||2005-03-01|February 2012|2012-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Safety and Efficacy of Ramelteon in Healthy Subjects|A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Phase-Shifting Effects of Repeated Daily Dosing of Ramelteon in Healthy Subjects|Completed||Phase 2|75|Actual|Takeda||5|||f||||f||||||||||2017-02-18 14:25:08.588341|2017-02-18 14:25:08.588341
NCT00671177|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2009-01-28|||September 2007||2007-09-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique|Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique|Completed||N/A|229|Actual|VA Palo Alto Health Care System||2|||f||||t||||||||||2017-02-18 14:25:08.723646|2017-02-18 14:25:08.723646
NCT00671151|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2008-05-02|||June 2005||2005-06-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Low-Dose Theophylline During Chronic Obstructive Pulmonary Disease (COPD) Exacerbations|Molecular Mechanisms of COPD Exacerbations. Effect of Low-Dose Theophylline|Completed||N/A|35|Actual|Hospital Universitari Son Dureta||2|||f||||f||||||||||2017-02-18 14:25:08.82961|2017-02-18 14:25:08.82961
NCT00671138|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-01-31|||October 2007||2007-10-01|January 2016|2016-01-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Interventional|||Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity|A Phase 2a, Randomized, Double Blinded, Placebo Controlled, Study Evaluating Immunity and Gluten-sensitivity by Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus.|Completed||Phase 2|20|Actual|Princess Alexandra Hospital, Brisbane, Australia||2|||f||||t||||||||||2017-02-18 14:25:08.941581|2017-02-18 14:25:08.941581
NCT00671125|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-11-08|||January 2003||2003-01-01|November 2012|2012-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Study of Efficacy of Ramelteon in Adults With Chronic Insomnia|A Phase III, Randomized, Double-Blind Placebo-Controlled, PSG Plus Outpatient Study to Determine the Safety and Efficacy of TAK-375 in Adults With Chronic Insomnia|Completed||Phase 3|405|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:25:09.066458|2017-02-18 14:25:09.066458
NCT00671112|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-02|2015-10-27|||June 2008||2008-06-01|October 2015|2015-10-01||||October 2015|Actual|2015-10-01||Interventional|||Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma|A Phase 1 Trial of the Combination of Everolimus (RAD001) and Bortezomib (VELCADE) for Relapsed or Refractory Lymphoma|Terminated||Phase 1|30|Actual|Case Comprehensive Cancer Center||1||Treatment ineffective|f||||t||||||||||2017-02-18 14:25:09.212871|2017-02-18 14:25:09.212871
NCT00671099|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2014-01-20|||December 2008||2008-12-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-02 Study|Tachikawa Project for Prevention of Posttraumatic Stress Disorder With Polyunsaturated Fatty Acid (TPOP): TPOP-02 Study|Completed||Phase 3|110|Actual|Japan Science and Technology Agency||2|||f||||t||||||||||2017-02-18 14:25:09.334298|2017-02-18 14:25:09.334298
NCT00671086|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2012-02-27|||February 2003||2003-02-01|February 2012|2012-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Efficacy of Ramelteon in Subjects With Chronic Insomnia|A Phase 3, Open-label, Fixed-dose Study to Determine the Safety of Long-term Administration of TAK-375 in Subjects With Chronic Insomnia|Completed||Phase 3|1213|Actual|Takeda||2|||f||||f||||||||||2017-02-18 14:25:09.450981|2017-02-18 14:25:09.450981
NCT00671073|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2012-03-01||2012-03-01|April 2008||2008-04-01|March 2012|2012-03-01||||May 2009|Actual|2009-05-01||Interventional|||Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Phase II Dose-Ranging Study of the Efficacy and Safety of Oglemilast in Patients With COPD|Completed||Phase 2|427|Actual|Forest Laboratories||4|||f||||f||||||||||2017-02-18 14:25:09.700079|2017-02-18 14:25:09.700079
NCT00671060|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2013-05-06|2013-02-13||October 2008||2008-10-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy|Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy, Inclusive, Not Accompanied by Complete Expulsion of the Contents of the Uterus|Completed||Phase 3|153|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-02-18 14:25:09.862617|2017-02-18 14:25:09.862617
NCT00671047|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2008-12-29|||December 2007||2007-12-01|December 2008|2008-12-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Observational|SAGE||The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study|The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study|Unknown status|Active, not recruiting|N/A|1000|Anticipated|XDx|||1||f||||f||||||Samples With DNA|"~     Whole blood, plasma, serum~   "|||2017-02-18 14:25:10.286782|2017-02-18 14:25:10.286782
NCT00671034|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-12-14|||July 2008||2008-07-01|December 2016|2016-12-01||||February 2011|Actual|2011-02-01||Interventional|||Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia|A Pilot Study of Intravenous EZN-2285 (SC-PEG E. Coli L-asparaginase, IND# 100594) or Intravenous Oncaspar® in the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia (ALL)|Active, not recruiting||N/A|166|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 14:25:10.40755|2017-02-18 14:25:10.40755
NCT00671021|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2012-08-20|||July 2008||2008-07-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Duration of Platelet Inhibition by Aspirin|Evaluation of Duration of Platelet Inhibition by Aspirin in a Standard 24-hour Interval Dosing Regimen|Completed||N/A|10|Actual|Hopital du Sacre-Coeur de Montreal|||1||f||||t||||||||||2017-02-18 14:25:10.602993|2017-02-18 14:25:10.602993
NCT00671008|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-03-02|||December 2007||2007-12-01|March 2016|2016-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes|Efficacy of Glycaemic Control of Biphasic Insulin Aspart (NovoMix® 30) or Insulin Detemir (Levemir®) in Patients With Type 1 or 2 Diabetes Mellitus|Completed||N/A|400|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 14:25:10.692813|2017-02-18 14:25:10.692813
NCT00670995|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2012-02-16|||November 2009||2009-11-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Tobacco Zero: Interactive Tobacco Education for Teens|Tobacco World: Interactive Tobacco Education for Teens|Completed||Phase 2|1864|Actual|Deschutes Research, Inc.||1|||f||||f||||||||||2017-02-18 14:25:10.798951|2017-02-18 14:25:10.798951
NCT00670982|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2013-03-29|2013-02-15||May 2008||2008-05-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer|Phase 2 Study of Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer|Completed||Phase 2|29|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 14:25:10.89725|2017-02-18 14:25:10.89725
NCT00670969|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2008-05-01|||May 2008||2008-05-01|April 2008|2008-04-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Observational|||Validation of Hand Held Indirect Calorimeter in Overweight and Obese Patients|Validation of Handheld Indirect Calorimeter in Overweight and Obese Patients|Unknown status|Not yet recruiting|N/A|60|Anticipated|Penn State University|||2||f||||f||||||||||2017-02-18 14:25:11.369682|2017-02-18 14:25:11.369682
NCT00670956|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2015-03-18|2015-03-18||April 2008||2008-04-01|March 2015|2015-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|CCAM Steroids|Only one participant was enrolled to the study before it was terminated; no participants were enrolled to the control arm|Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)|Investigation of Prenatal Steroids for Treatment of Prenatally Diagnosed CCAMs|Terminated||Phase 1/Phase 2|1|Actual|University of California, San Francisco||2||"Recruitment has been poor. Study drug is being offered as part of standard care of women~   carrying a pregnancy diagnosed with CCAM"|f||||t||||||||||2017-02-18 14:25:11.463319|2017-02-18 14:25:11.463319
NCT00670930|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2012-12-12|2012-11-16||April 2008||2008-04-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|eXplore||Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists|A Randomized, Multi-center, Double-blind, Placebo-controlled, Parallel-group Trial to Explore the Effects of 78 Weeks Omalizumab Treatment Given as Add on Therapy on Markers of Airway Inflammation and Remodeling in Patients With Moderate to Severe Persistent Allergic Asthma Receiving Inhaled Corticosteroids and Long Acting Beta-agonists|Completed||Phase 4|36|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:25:12.060806|2017-02-18 14:25:12.060806
NCT00670917|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2010-04-09|||April 2008||2008-04-01|July 2009|2009-07-01||||April 2009|Anticipated|2009-04-01||Interventional|||Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy|A Randomized Controlled Trial Assessing the Effect of Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy|Unknown status|Recruiting|N/A|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:25:12.588799|2017-02-18 14:25:12.588799
NCT00670904|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2010-01-11|||October 2005||2005-10-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation|Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation|Completed||N/A|101|Actual|University of Montana||2|||f||||f||||||||||2017-02-18 14:25:12.722132|2017-02-18 14:25:12.722132
NCT00670891|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-05-26|||July 2007||2007-07-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|VPH||A Clinical Trial of the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children|A Prospective, Non-Randomized, Open-Label Study on the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children|Completed||Phase 1|7|Actual|Vachira Phuket Hospital||1|||f||||t||||||||||2017-02-18 14:25:12.816463|2017-02-18 14:25:12.816463
NCT00670878|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2012-03-31|||June 2008||2008-06-01|March 2012|2012-03-01||||October 2011|Actual|2011-10-01||Interventional|||Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer|Prospectively Randomized Phase III Trial, Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer|Completed||Phase 3|799|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-02-18 14:25:12.920347|2017-02-18 14:25:12.920347
NCT00670865|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2010-04-15|||May 2008||2008-05-01|April 2010|2010-04-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Automated Versus Conventional Hospital Discharge Summaries and Prescriptions|Automated Versus Conventional Hospital Discharge Summaries and Prescriptions: A Randomized Controlled Trial|Completed||N/A|209|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 14:25:13.023458|2017-02-18 14:25:13.023458
NCT00670852|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2011-04-25|||April 2008||2008-04-01|April 2011|2011-04-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Observational|Glenoid||Followup of Glenoid Fix Utilizing Auto Bone Graft in Shoulder Replacement|Computed Tomographic and Functional Follow-up of Glenoid Anchor Peg Component Fixation Utilizing Autologous Bone Graft in Total Shoulder Arthroplasty|Unknown status|Recruiting|N/A|70|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-02-18 14:25:13.132336|2017-02-18 14:25:13.132336
NCT00670839|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2013-08-08|||May 2008||2008-05-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|December 2011|Actual|2011-12-01||Interventional|B-BOOST||Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)|Open-label, Randomized, and Multicenter Phase III Clinical Trial Comparing Immunogenicity of Double-dose (40 µg at S0, S4 and S24), Versus Standard Dose Vaccination (20 µg at S0, S4 and S24), Against Hepatitis B Virus in HIV-1-infected Patients Without Any Previous Immune Response After Primary Immunization Plus One Single Boost|Completed||Phase 3|178|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 14:25:13.23864|2017-02-18 14:25:13.23864
NCT00670826|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-05-01|||July 2008||2008-07-01|April 2008|2008-04-01|November 2008|Anticipated|2008-11-01|September 2008|Anticipated|2008-09-01||Interventional|||Comparison Study of Intraoperative Patient Warming Systems|Intraoperative Warming: Comparison of Performance of the Dynatherm Medical vitalHEAT Temperature Management System(vH2)With the Arizant Bair Hugger System|Unknown status|Not yet recruiting|N/A|100|Anticipated|Dynatherm Medical Inc.||2|||f||||f||||||||||2017-02-18 14:25:13.361126|2017-02-18 14:25:13.361126
NCT00670813|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2011-07-19|||May 2008||2008-05-01|April 2008|2008-04-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Enhancing the Therapeutic Efficacy of Sleep Deprivation by Modafinil|Verstärkung Der Therapeutischen Wirkung Von Schlafentzug Durch Modafinil - Eine Doppelblinde, Randomisierte, Placebokontrollierte Monozentrische Studie Der Phase II (Enhancing the Therapeutic Efficacy of Sleep Deprivation by Modafinil - a Double Blind, Placebo-controlled Monocentric Phase II Study)|Withdrawn||Phase 2|30|Anticipated|Technische Universität München||2|||f||||t||||||||||2017-02-18 14:25:13.462146|2017-02-18 14:25:13.462146
NCT00670800|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2014-05-15|2013-01-02||January 2008||2008-01-01|May 2014|2014-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Two controls were excluded from data analysis as they were later found to be insulin resistant.|Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome|Influence of Insulin Resistance on Cognitive, Emotional and Opioid System Functioning in Women With Polycystic Ovary Syndrome|Completed||N/A|14|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 14:25:13.592018|2017-02-18 14:25:13.592018
NCT00670787|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2011-03-04|||June 2008||2008-06-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|COMFORT||Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial|A Randomized Trial to Establish the Effects of Combination Pill of Losartan Potassium and Hydrochlorothiazide on Medication Compliance Among Patients With High Blood Pressure.|Completed||Phase 3|207|Actual|Kyushu University||2|||f||||t||||||||||2017-02-18 14:25:14.350779|2017-02-18 14:25:14.350779
NCT00670397|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-03-14|||June 2010||2010-06-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|November 2011|Actual|2011-11-01||Interventional|||Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer|Phase I Trial of Photodynamic Therapy With HPPH (2-1[Hexyloxyethyl]-2-devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and Stage I Carcinoma of the Oral Cavity|Terminated||Phase 1|11|Actual|Roswell Park Cancer Institute||1||safety issues|f||||t||||||||||2017-02-18 14:25:24.013265|2017-02-18 14:25:24.013265
NCT00670774|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2015-06-03|||March 2008||2008-03-01|June 2015|2015-06-01|August 2017|Anticipated|2017-08-01|May 2017|Anticipated|2017-05-01||Interventional|||Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant|A Single Center, Open-label Study to Determine the Safety and Efficacy of a Dosing Regimen of Eculizumab Added to Conventional Treatment in the Prevention of Antibody-mediated Rejection (AMR) in Positive Crossmatch Living Donor Kidney Transplantation|Active, not recruiting||N/A|20|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:25:14.458952|2017-02-18 14:25:14.458952
NCT00670761|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-07-26|||July 2004||2004-07-01|July 2016|2016-07-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Misoprostol for the Treatment of Incomplete Abortion|Misoprostol for the Treatment of Incomplete Abortion: Comparison of Treatment Options|Completed||N/A|720|Actual|Gynuity Health Projects||3|||f||||f||||||||||2017-02-18 14:25:14.565739|2017-02-18 14:25:14.565739
NCT00670748|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2016-10-26|2016-05-19||April 2008||2008-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|May 2013|Actual|2013-05-01||Interventional|||Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer|Phase II Study of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 TCR-Gene Engineered Lymphocytes|Terminated||Phase 2|45|Actual|National Institutes of Health Clinical Center (CC)||4||A more highly selected protocol with ESO TCR opened for pts with melanoma|f||||f||||||||No||2017-02-18 14:25:14.686091|2017-02-18 14:25:14.686091
NCT00670735|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-11-18|||April 2008||2008-04-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)|HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)|Recruiting||N/A|1400|Anticipated|University of Utah|||1||f||||f||||||||||2017-02-18 14:25:15.815811|2017-02-18 14:25:15.815811
NCT00670722|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-10-27|||January 2008||2008-01-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin|Observational Study on Evaluation of Glycaemic Control in Patients Using a Modern Insulin - NovoRapid® (Insulin Aspart), NovoMix® 30 (Biphasic Insulin Aspart 30) or Levemir® (Insulin Detemir) for Treatment of Type 2 Diabetes Mellitus|Completed||N/A|6500|Actual|Novo Nordisk A/S|||4||f||||f||||||||||2017-02-18 14:25:15.942838|2017-02-18 14:25:15.942838
NCT00670709|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2013-02-04|2009-06-16||September 2006||2006-09-01|February 2013|2013-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|HD||Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease|Examination of Quantitative Electroencephalographic Biomarkers in Huntington's Disease: A Pilot Project|Completed||N/A|42|Actual|University of California, Los Angeles|||2||f||||f||||||||||2017-02-18 14:25:16.05417|2017-02-18 14:25:16.05417
NCT00670696|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2012-04-24|||April 2008||2008-04-01|April 2012|2012-04-01||||December 2008|Anticipated|2008-12-01||Interventional|||A Study to Compare the Efficacy of Rapydan Versus Tetracaine Gel|A Randomised, Controlled, Single-blinded, Cross Over Comparison Study to Compare the Efficacy of the Rapydan Medicated Plaster Versus Tetracaine Gel|Withdrawn||Phase 4|0|Actual|Jazz Pharmaceuticals||2||No longer sponsor of trial|f||||f||||||||||2017-02-18 14:25:16.448471|2017-02-18 14:25:16.448471
NCT00670683|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-03-02|||July 2007||2007-07-01|March 2016|2016-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Observational Study of Patients With Diabetes Using Levemir® FlexPen®|Safety and Efficacy of Insulin Detemir (Levemir® FlexPen®) in Patients With Diabetes Mellitus|Completed||N/A|797|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:25:16.557446|2017-02-18 14:25:16.557446
NCT00670670|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2014-12-04|||July 2008||2008-07-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 1|A Prospective, Randomized Clinical Study on the Effects of CPP-ACP Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 1|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 14:25:19.066747|2017-02-18 14:25:19.066747
NCT00670657|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2009-03-26|||May 2007||2007-05-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|CRITIC||CRITIC - Treatment of Candidemia and Invasive Candidiasis|CRITIC: Phase II Pilot Multicenter Study on Efficacy and Safety of Liposomal Amphotericin B (AmBisome®) at 2 mg/kg/Day in the Treatment of Candidemia and Invasive Candidiasis in Non-Neutropenic Patients|Completed||Phase 4|39|Anticipated|Gilead Sciences||1|||f||||f||||||||||2017-02-18 14:25:19.158652|2017-02-18 14:25:19.158652
NCT00670644|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2015-12-07|||May 2006||2006-05-01|December 2015|2015-12-01|March 2011|Actual|2011-03-01|May 2007|Actual|2007-05-01||Observational|||Self-Care for Lymphedema in Patients With Breast Cancer|Breast Cancer Treatment Related Lymphedema Self Care Practices|Completed||N/A|51|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 14:25:19.257412|2017-02-18 14:25:19.257412
NCT00670631|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-11-26|||February 2008||2008-02-01|November 2013|2013-11-01|April 2014|Anticipated|2014-04-01|May 2012|Actual|2012-05-01||Interventional|||Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment|Tandem Autotransplantation for Multiple Myeloma Patients With Less Than 12 Months of Preceding Therapy, Incorporating Bortezomib With the Transplant Chemotherapy and During Maintenance|Unknown status|Active, not recruiting|Phase 2|204|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:25:19.382506|2017-02-18 14:25:19.382506
NCT00670618|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2014-12-04|||June 2008||2008-06-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 2|A Prospective, Randomized Clinical Study on the Effects of CPP-ACP Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 2|Unknown status|Recruiting|N/A|400|Anticipated|University Hospital, Ghent||4|||f||||f||||||||||2017-02-18 14:25:19.470746|2017-02-18 14:25:19.470746
NCT00670605|ClinicalTrials.gov processed this data on February 17, 2017|2008-05-01|2011-03-23|||June 2007||2007-06-01|March 2011|2011-03-01||||December 2009|Actual|2009-12-01||Observational|||Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center|VICC Adolescent and Young Adult Oncology Review|Terminated||N/A|||Vanderbilt University|||1||f||||||||||||||2017-02-18 14:25:19.576682|2017-02-18 14:25:19.576682
NCT00670592|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2014-01-21|||March 2008||2008-03-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies|A Phase IA/II, Multi-center, Open-label Study of HCD122 Administered Intravenously Once Weekly for Four Weeks in Adult Patients With Advanced Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies (CHIR-12.12-LYM-01)|Completed||Phase 1/Phase 2|111|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:25:19.878886|2017-02-18 14:25:19.878886
NCT00670579|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2011-08-22|||May 2008||2008-05-01|August 2011|2011-08-01|September 2010|Actual|2010-09-01|October 2009|Actual|2009-10-01||Observational|||Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF)|A Prospective Study About Complications of Totally Implantable Central Venous Access Ports in People With CF|Completed||N/A|80|Actual|University of Florence|||1||f||||||||||||||2017-02-18 14:25:19.995991|2017-02-18 14:25:19.995991
NCT00670566|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2009-09-14|||April 2008||2008-04-01|September 2009|2009-09-01||||March 2009|Actual|2009-03-01||Interventional|||Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients|Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients|Completed||Phase 4|503|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:25:20.132975|2017-02-18 14:25:20.132975
NCT00670553|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-08-31|||September 2008||2008-09-01|August 2016|2016-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer|A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer|Completed||Phase 1|7|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:25:20.379343|2017-02-18 14:25:20.379343
NCT00670540|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2012-05-04|2012-02-09||November 2004||2004-11-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|January 2009|Actual|2009-01-01||Observational|OPTIMEV||Epidemiology of Thromboembolism Disease: A Cohort Study|A Prospective Epidemiological Multicenter Cohort Study on Patients Clinically Suspected of Deep Vein Thrombosis or Pulmonary Embolism|Completed||N/A|8256|Actual|University Hospital, Grenoble|||1||f||||f||||||||||2017-02-18 14:25:20.49156|2017-02-18 14:25:20.49156
NCT00670527|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2012-10-05|||January 2008||2008-01-01|October 2012|2012-10-01|April 2013|Anticipated|2013-04-01|February 2013|Anticipated|2013-02-01||Interventional|PROPET||[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases|Evaluation of [18F] Fluorocholine PET/CT for Detection of Regional Lymph Node Metastases From Prostate Cancer|Unknown status|Recruiting|N/A|205|Anticipated|Odense University Hospital||1|||f||||t||||||||||2017-02-18 14:25:21.258028|2017-02-18 14:25:21.258028
NCT00670514|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-04-30|||April 2003||2003-04-01|April 2008|2008-04-01||||||||Interventional|||Smoking Cessation in a Dentistry Setting|A Comparing Study of the Smoking Cessation Program NIX Individual and the Self-Help Program Fimpa Dig Fri|Completed||N/A|300||Uppsala University||2|||f||||f||||||||||2017-02-18 14:25:21.367399|2017-02-18 14:25:21.367399
NCT00670501|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-29|||August 1996||1996-08-01|April 2008|2008-04-01|April 1999|Actual|1999-04-01|April 1999|Actual|1999-04-01||Interventional|||Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis|Effects of LY333334 in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 3|1637|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-02-18 14:25:21.450175|2017-02-18 14:25:21.450175
NCT00670488|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2015-02-02|||April 2008||2008-04-01|February 2015|2015-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Dose Escalation Study With MK2206 in Patients With Locally Advanced or Metastatic Solid Tumors (2206-002)|A Phase I Dose Escalation Study of Oral MK2206 in Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|104|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:25:21.594983|2017-02-18 14:25:21.594983
NCT00670475|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2010-04-28|||April 2008||2008-04-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|May 2009|Actual|2009-05-01||Interventional|||Comparative Study of Olive Oil With Piroxicam Gel in Osteoarthritis of the Knee|Comparative Study of Olive Oil With Piroxicam Gel in Osteoarthritis of the Knee|Completed||Phase 2|60|Actual|Ardabil University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:25:21.691418|2017-02-18 14:25:21.691418
NCT00670462|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2014-11-12|2014-11-12||October 2004||2004-10-01|November 2014|2014-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|LIFE||Maintenance-Tailored Obesity Treatment|Maintenance-Tailored Obesity Treatment|Completed||Phase 3|213|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 14:25:21.821258|2017-02-18 14:25:21.821258
NCT00670449|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2013-06-26|2013-03-08||April 2008||2008-04-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis|An Extension of the 6-month, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study Comparing Efficacy and Safety of FTY720 0.5 mg and 1.25 mg Administered Orally Once Daily in Patients With Relapsing Multiple Sclerosis|Completed||Phase 2|143|Actual|Novartis||3|||f||||||||||||||2017-02-18 14:25:22.631349|2017-02-18 14:25:22.631349
NCT00670436|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-06-07|||February 2008||2008-02-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|September 2009|Actual|2009-09-01||Interventional|PEPCAD-CTO||The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions|The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions|Completed||Phase 2|48|Actual|University of Ulm||2|||f||||f||||||||||2017-02-18 14:25:23.677849|2017-02-18 14:25:23.677849
NCT00670423|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-02-24|||May 2008||2008-05-01|February 2016|2016-02-01|October 2013|Actual|2013-10-01|July 2012|Actual|2012-07-01||Interventional|||A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation|A Phase I Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation|Completed||Phase 1|27|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 14:25:23.793245|2017-02-18 14:25:23.793245
NCT00670410|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-06-22|||November 2003||2003-11-01|June 2016|2016-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma|A Pilot Study of Sequential Autologous Stem Cell Transplantation and Immunotherapy With Reduced Intensity Allogeneic Stem Cell Transplant for High Risk Neuroblastoma|Terminated||Phase 1|15|Actual|Columbia University||2||Poor accrual|f||||t||||||||Undecided|Unknown.|2017-02-18 14:25:23.895332|2017-02-18 14:25:23.895332
NCT00670384|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-01-08||||||January 2014|2014-01-01||||||||Interventional|||Phase 2 Study in Adults Sensitized to Short Ragweed|A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging Study of Sublingual Immunotherapy in Adults Sensitized to the Standardized Allergenic Extract, Short Ragweed (Ambrosia Artemisiifolia)|Withdrawn||Phase 2|0|Actual|Antigen Laboratories, Inc.||3||No funding.|f||||f||||||||||2017-02-18 14:25:24.111643|2017-02-18 14:25:24.111643
NCT00670371|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2009-11-24|||March 2008||2008-03-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|||||Observational|||Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study|Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study|Completed||N/A|100|Anticipated|AstraZeneca|||2||f||||f||||||||||2017-02-18 14:25:24.200426|2017-02-18 14:25:24.200426
NCT00670358|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2016-10-10|||August 2008||2008-08-01|October 2016|2016-10-01||||May 2017|Anticipated|2017-05-01||Interventional|||Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma|Phase I/II Study of Lenalidomide (Revlimid), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R2CHOP) Chemoimmunotherapy in Patients With Newly Diagnosed Diffuse Large Cell and Follicular Grade IIIA/B B Cell Lymphoma|Recruiting||Phase 1/Phase 2|47|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:25:24.301198|2017-02-18 14:25:24.301198
NCT00670345|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-04-04|||April 2008||2008-04-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|TRANEX-URO||Tranexamic Acid in Urologic Surgery|Efficacy of Tranexamic Acid in Reducing Perioperative Bleeding in Patients Undergoing Radical Prostatectomy. A Randomized Controlled Double-blind Study.|Completed||Phase 4|||Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-02-18 14:25:24.426394|2017-02-18 14:25:24.426394
NCT00670332|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-29|||July 2007||2007-07-01|April 2008|2008-04-01||||||||Observational|PACE||Prognostic Assessment of Contrast Echocardiography (PACE Study)|Prognostic Assessment of Contrast Echocardiography (PACE Study): An Observational Follow-up Study of Patients With Chest Pain Evaluated With AI-700 Contrast Echocardiography|Terminated||N/A|773|Anticipated|Acusphere|||1||t||||||||||||||2017-02-18 14:25:24.552493|2017-02-18 14:25:24.552493
NCT00670319|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-30|||November 1994||1994-11-01|April 2008|2008-04-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|MORE||Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis|Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 3|7705|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-02-18 14:25:24.639993|2017-02-18 14:25:24.639993
NCT00670306|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2011-04-01|2010-10-18||March 2008||2008-03-01|April 2011|2011-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|AEZS-102-Z041||Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)|Cetrorelix Pamoate (AEZS-102) in Patients With Symptomatic BPH: an Open-Labeled Safety and Efficacy Assessment Study|Completed||Phase 3|528|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 14:25:24.788622|2017-02-18 14:25:24.788622
NCT00670293|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-04-06|||July 2008||2008-07-01|August 2015|2015-08-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Observational|||Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa|Imaging of Dopamine Systems in Anorexia Nervosa|Completed||N/A|50|Actual|New York State Psychiatric Institute|||2||f||||f||||||||||2017-02-18 14:25:25.127109|2017-02-18 14:25:25.127109
NCT00670280|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-01-05|||May 2008||2008-05-01|January 2016|2016-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Reducing Environmental Tobacco Smoke in Neonatal Intensive Care Unit (NICU) Infants' Homes|Reducing Environmental Tobacco Smoke in NICU Infants' Homes|Completed||N/A|144|Actual|The University of Texas Health Science Center, Houston||3|||f||||t||||||||||2017-02-18 14:25:25.240578|2017-02-18 14:25:25.240578
NCT00670267|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-04-06|2015-06-16||January 2007||2007-01-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Oral Nadolol for the Treatment of Adults With Mild Asthma|An Open-Label, Dose-Escalating, Study to Evaluate the Safety, Efficacy and Tolerability of Oral Nadolol for the Treatment of Adults With Mild Asthma|Completed||Phase 1/Phase 2|10|Actual|Invion, Inc.||1|||f||||f||||||||||2017-02-18 14:25:25.347697|2017-02-18 14:25:25.347697
NCT00670254|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2013-09-26|||January 2009||2009-01-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|HYPRESS||Hydrocortisone for Prevention of Septic Shock|Placebo-controlled, Randomised, Double-blind Study to Investigate the Efficacy and Safety of Low Dose Hydrocortisone to Prevent the Development of Septic Shock in Patients With Severe Sepsis|Completed||Phase 3|380|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 14:25:25.630763|2017-02-18 14:25:25.630763
NCT00670241|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2015-03-25|2010-11-23||April 2008||2008-04-01|March 2015|2015-03-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris|A Phase 3 Study Comparing a Gel Containing Calcipotriol 50 mcg/g Plus Betamethasone 0.5 mg/g (as Dipropionate) With Tacalcitol Ointment (4 mcg/g) and Gel Vehicle, Used Once Daily in the Treatment of Psoriasis Vulgaris|Completed||Phase 3|458|Actual|LEO Pharma||3|||f||||f||||||||||2017-02-18 14:25:25.979394|2017-02-18 14:25:25.979394
NCT00670228|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2011-01-14|2010-11-16||April 2008||2008-04-01|January 2011|2011-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|INTENSIVE||Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction|A Multi-center, Phase 3b, Stratified, Randomized, Open-label Clinical Trial to Evaluate the Efficacy of Intensive Apidra®/Lantus® Therapy vs Sliding Scale Insulin on Infarct Size in Hyperglycemic Subjects With Anterior STEMI (ST Elevation Myocardial Infarction) Undergoing PCI (Percutaneous Coronary Intervention)|Terminated||Phase 3|34|Actual|Sanofi|Early termination leading to small numbers of subjects analyzed. Only descriptive statistics were presented for primary and key secondary efficacy endpoints. The analysis focused on a review of safety Adverse Events (AEs) data.|2||"Due to Negative feasibility assessment of recruiting the planned number of subjects within the~   study timelines"|f||||t||||||||||2017-02-18 14:25:26.569921|2017-02-18 14:25:26.569921
NCT00669461|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2016-11-09|2011-10-25||June 2009||2009-06-01|November 2016|2016-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Lubiprostone as a Treatment for Constipation in Parkinson's Disease|Lubiprostone as a Treatment for Constipation in Parkinson's Disease|Terminated||N/A|1|Actual|University of Arkansas|Early termination leading to small numbers of subjects analyzed|1||Lack of recruitment|f||||f||||||||||2017-02-18 14:25:39.504198|2017-02-18 14:25:39.504198
NCT00670215|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-12-18|||April 2004||2004-04-01|December 2014|2014-12-01|October 2004|Actual|2004-10-01|||||Interventional|||BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis|Prospective, Randomized, Double-blind, Comparison of Ciprofloxacin Extended-release 1000 mg Tablets Given as Two Different Prophylactic Dosing Regimens (Regimen I - Single-dose Ciprofloxacin MR 1000 mg or Regimen II - Multiple-dose Ciprofloxacin MR 1000 mg Once Daily for 3 Days) for the Prevention of Post-operative Infectious Complications in Patients Undergoing Transrectal Needle Biopsy of the Prostate|Completed||Phase 3|497|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:25:27.170947|2017-02-18 14:25:27.170947
NCT00670202|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2010-05-03|||April 2008||2008-04-01|May 2010|2010-05-01|April 2011|Anticipated|2011-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis|The Effect of Fasudil on Rho Kinase Activity in Patients Scheduled for Elective Carotid Endarterectomy|Unknown status|Recruiting|Phase 2|60|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-02-18 14:25:27.331475|2017-02-18 14:25:27.331475
NCT00670189|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-08-13|||July 2008||2008-07-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|April 2014|Actual|2014-04-01||Interventional|||A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer|A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|53|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:25:27.428355|2017-02-18 14:25:27.428355
NCT00670176|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-30||||||April 2008|2008-04-01|June 2005|Actual|2005-06-01|||||Interventional|||Pre- and Postoperative Cardiopulmonary Rehabilitation Reduces Complications After Coronary Artery Bypass Surgery: A Randomized Trial|Pre- and Postoperative Cardiopulmonary Rehabilitation Reduces Complications After Coronary Artery Bypass Surgery: A Randomized Trial|Completed||N/A|56||Universidade do Sul de Santa Catarina||1|||f||||t||||||||||2017-02-18 14:25:27.532211|2017-02-18 14:25:27.532211
NCT00670163|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2013-12-11|||April 2008||2008-04-01|December 2013|2013-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru|Comunidades Positivas and Enhanced Partner Therapy in Peru|Completed||N/A|718|Actual|University of California, Los Angeles||4|||f||||t||||||||||2017-02-18 14:25:27.60533|2017-02-18 14:25:27.60533
NCT00670150|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2015-10-24|||May 2010||2010-05-01|October 2015|2015-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia|Phase II Study of NRX 195183 Induction and NRX 195183 Combined With Arsenic Trioxide (As2o3) as Initial Consolidation Therapy Followed by Continuous NRX 195183 Maintenance Therapy for Patients With Untreated Acute Promyelocytic Leukemia|Withdrawn||Phase 2|0|Actual|University of Southern California||1||sponsor withdrew support|f||||f||||||||||2017-02-18 14:25:27.709455|2017-02-18 14:25:27.709455
NCT00670137|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-30|||January 2008||2008-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:25:27.797652|2017-02-18 14:25:27.797652
NCT00670124|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-11-04|||January 2005||2005-01-01|November 2014|2014-11-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Hypothermia to Prevent High Intracranial Pressure in Patients With Acute Liver Failure|Pilot Trial on the Effect of Mild Hypothermia on Intracranial Pressure in Patients With Hyperacute Liver Failure|Completed||N/A|50|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 14:25:27.846551|2017-02-18 14:25:27.846551
NCT00670111|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2011-08-08|||July 2008||2008-07-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|RESET||Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction|Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction|Terminated||N/A|400|Anticipated|Boston Scientific Corporation||1||Difficulty in enrollment|f||||t||||||||||2017-02-18 14:25:27.972273|2017-02-18 14:25:27.972273
NCT00670098|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2015-10-20|||August 2005||2005-08-01|November 2011|2011-11-01|September 2013|Actual|2013-09-01|October 2007|Actual|2007-10-01||Interventional|||Changes in Sexual Function Following Bariatric Surgery|Psychosocial Changes Associated With Weight Loss|Completed||N/A|207|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 14:25:28.087753|2017-02-18 14:25:28.087753
NCT00670059|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-30|||October 2004||2004-10-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|June 2007|Actual|2007-06-01||Interventional|||Pre-Implantation Genetic Screening in Women Under the Age of 36 Years With Single Embryo Transfer|Pre-Implantation Genetic Screening in Women Under the Age of 36 With Single-Embryo Transfer|Terminated||N/A|240|Actual|Vrije Universiteit Brussel||2||At the first prespecified interim analysis|f||||f||||||||||2017-02-18 14:25:28.179293|2017-02-18 14:25:28.179293
NCT00670046|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2011-02-18|||May 2008||2008-05-01|July 2009|2009-07-01||||April 2009|Anticipated|2009-04-01||Interventional|||Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer|Randomized, Controlled Phase II Study of Valproic Acid in Patients With Non-metastatic Biochemical Progression of Prostate Cancer|Unknown status|Recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:25:28.287931|2017-02-18 14:25:28.287931
NCT00670033|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-07-09||2014-07-09|April 2008||2008-04-01|June 2014|2014-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension|Comparison of Safety and IOP-Lowering Efficacy of Three Alternative Travoprost Formulations to Vehicle and TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|158|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 14:25:28.398796|2017-02-18 14:25:28.398796
NCT00670020|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-30|||January 2001||2001-01-01|April 2008|2008-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection|Supplemental Perioperative Oxygen to Reduce the Incidence of Post-Cesarean Endometritis and Wound Infection|Completed||N/A|143|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:25:28.509937|2017-02-18 14:25:28.509937
NCT00670007|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-07-13|2016-06-02||April 2008||2008-04-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.|An Open-label, Non-controlled, Multicenter, Multinational Study to Evaluate the Efficacy and Safety of Zemaira® Administration in Chronic Augmentation and Maintenance Therapy in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency Who Completed Clinical Study CE1226_4001|Completed||Phase 4|140|Actual|CSL Behring||1|||f||||||||||||||2017-02-18 14:25:28.629695|2017-02-18 14:25:28.629695
NCT00669994|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-12-18|||July 2003||2003-07-01|December 2014|2014-12-01|October 2003|Actual|2003-10-01|||||Interventional|||Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections|Prospective, Open Label Non-comparative, Multi-center Trial to Evaluate the Efficacy and Safety of Cipro® XR 500 mg Once Daily for 3 Days in Treating Female Patients With Acute, Uncomplicated, Symptomatic Lower Urinary Tract Infections|Completed||Phase 4|180|Actual|Bayer||1|||f||||||||||||||2017-02-18 14:25:29.479791|2017-02-18 14:25:29.479791
NCT00669981|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2013-11-22|||August 2008||2008-08-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effectiveness of Cognitive Behavioral Couples Therapy for Post-traumatic Stress Disorder|Cognitive-Behavioral Couples Therapy for Posttraumatic Stress Disorder|Completed||Phase 2/Phase 3|80|Actual|Ryerson University||2|||f||||f||||||||||2017-02-18 14:25:29.620673|2017-02-18 14:25:29.620673
NCT00669968|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2012-05-30|||February 2008||2008-02-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Study of Value of Cardiac PET Scans With or Without CT Angiography and/or Measurement of Coronary Flow Reserve|PET Myocardial Perfusion Imaging With CT Angiography and Measurement of Coronary Flow Reserve: A Prospective Study of Effectiveness, Impact on Patient Management, Prognostic Value, and Downstream Costs|Completed||N/A|17|Actual|Kettering Health Network|||1||f||||f||||||||||2017-02-18 14:25:29.730823|2017-02-18 14:25:29.730823
NCT00669955|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2010-08-03|2010-06-21||June 2008||2008-06-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy|Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given X 10 Days With Omeprazole in Eradication of Helicobacter Pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given X 7 Days|Completed||Phase 3|440|Actual|Axcan Pharma||2|||f||||f||||||||||2017-02-18 14:25:29.815405|2017-02-18 14:25:29.815405
NCT00669942|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2015-03-27|2015-01-28||December 2005||2005-12-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients|A Randomized, Double Blind, Placebo-controlled, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients With Pharmacodynamics Assessed in an Expanded Cohort at the Maximum Tolerated Dose|Completed||Phase 1/Phase 2|104|Actual|Novartis||12|||f||||f||||||||||2017-02-18 14:25:30.489537|2017-02-18 14:25:30.489537
NCT00669929|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2009-02-18|||May 2008||2008-05-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Observational|||Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea|Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea|Unknown status|Recruiting|N/A|200|Anticipated|Yonsei University|||3||f||||f||||||||||2017-02-18 14:25:32.204579|2017-02-18 14:25:32.204579
NCT00669916|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2015-04-09|2015-01-28||February 2007||2007-02-01|April 2015|2015-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis|Phase 2a Single-Dose, Randomized, Double Blind, Multi-Center, Parallel-Group, Placebo-Controlled Proof of Concept Study to Assess the Efficacy, Safety, Tolerability, and Population Pharmacokinetics of AIN457 in Patients With Stable Plaque-type Psoriasis|Completed||Phase 1/Phase 2|36|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:25:32.313955|2017-02-18 14:25:32.313955
NCT00669903|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2010-07-09|2010-02-04||April 2008||2008-04-01|July 2010|2010-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia|A Phase IIa, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Oral Multiple Ascending Doses of AZD0328 in Patients With Schizophrenia|Terminated||Phase 2|100|Actual|AstraZeneca||4||"Since AZD0328 is unlikely to meet the current Target Product Profile, Astrazeneca decided to~   stop further development of AZD0328"|f||||||||||||||2017-02-18 14:25:32.724451|2017-02-18 14:25:32.724451
NCT00669890|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2015-04-20|||May 2004||2004-05-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|High Risk||Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML|Gemtuzumab Ozogamicin in Combination With Busulfan and Cyclophosphamid and Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ Acute Myelogenous Leukemia/Myelodysplastic Syndrome/Juvenile Myelomonocytic Leukemia|Terminated||Phase 1|12|Actual|New York Medical College||1||PI left institution|f||||t||||||||||2017-02-18 14:25:33.665168|2017-02-18 14:25:33.665168
NCT00669877|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2015-10-08|||August 2002||2002-08-01|October 2015|2015-10-01||||October 2015|Actual|2015-10-01||Interventional|||Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma|Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma|Completed||Phase 2|56|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:25:33.791055|2017-02-18 14:25:33.791055
NCT00669864|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-03-03|2010-04-29||November 2007||2007-11-01|March 2016|2016-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin|Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin|Completed||Phase 4|293|Actual|Novo Nordisk A/S|This single-armed trial does not permit a comprehensive comparison between BIAsp30 and basal insulin. Otherwise, this could have proffered greater clarity on the putative benefits that BIAsp30 brings to subjects with type 2 diabetes.|1|||f||||f||||||||||2017-02-18 14:25:33.922783|2017-02-18 14:25:33.922783
NCT00669851|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-29|||November 2006||2006-11-01|April 2008|2008-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study|A Phase 3, International, Exploratory, Open-Label, Multicenter, Dual-Injection, Echocardiographic Imaging Settings and Safety Study of AI-700 in Normal Volunteers and Stable Cardiac Patients|Completed||Phase 3|39|Actual|Acusphere|||||||||||||||||||2017-02-18 14:25:34.351262|2017-02-18 14:25:34.351262
NCT00669838|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-30|||January 2003||2003-01-01|April 2008|2008-04-01|July 2005|Actual|2005-07-01|||||Observational|||Anesthesia for Dental Treatment in Cardiac Patients: Lidocaine Comparative Study|Loco Regional Anesthesia for Dental Treatment in Cardiac Patients: Comparative Study Between Plain Lidocaine 2% and Lidocaine 2% With Epinephrine 1:100.000|Completed||N/A|59|Actual|University of Sao Paulo|||2||f||||f||||||||||2017-02-18 14:25:34.448622|2017-02-18 14:25:34.448622
NCT00669825|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2010-02-17|||March 2008||2008-03-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|FED||Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal|A Phase 1, Two Stage, Single-Blind, Single Dose, Placebo Controlled, Dose Escalation, Crossover Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal|Completed||Phase 1|36|Anticipated|Alvine Pharmaceuticals Inc.||2|||f||||f||||||||||2017-02-18 14:25:34.546313|2017-02-18 14:25:34.546313
NCT00669812|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-30|2013-08-23|||February 2008||2008-02-01|November 2008|2008-11-01||||||||Interventional|||High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma|A Phase II Evaluation of High Dose Chemotherapy and Autologous Stem Cell Transplantation for Intestinal T-cell Lymphomas|Unknown status|Recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:25:34.654501|2017-02-18 14:25:34.654501
NCT00669799|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2015-05-27|||March 2008||2008-03-01|May 2015|2015-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study|Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study|Withdrawn||N/A|0|Actual|University of South Florida||2||UNABLE TO PROCEED WITH STUDY DUE TO STAFFING OF COLLABORATIVE INVESTIGATORS|f||||f||||||||||2017-02-18 14:25:34.755891|2017-02-18 14:25:34.755891
NCT00669786|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2008-04-30||||||April 2008|2008-04-01||||||||Interventional|||Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles|Highly Purified Human Menopausal Gonadotropin Versus Recombinant Follicle Stimulating Hormone in Ovarian Hyperstimulation With Gonadotropin Releasing Hormone Antagonists. A Randomized Study.|Completed||Phase 3|||Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 14:25:34.852352|2017-02-18 14:25:34.852352
NCT00669773|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-27|2013-12-08|||February 2007||2007-02-01|December 2013|2013-12-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient|Phase 2 Randomized Study of Adriamycin & Docetaxel in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor to Validate Gene Expression & Proteomic Signatures Predictive of Treatment Response|Unknown status|Active, not recruiting|Phase 2|49|Actual|National University Hospital, Singapore||2|||f||||||||||||||2017-02-18 14:25:34.950661|2017-02-18 14:25:34.950661
NCT00669760|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2015-01-06|||July 2008||2008-07-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|July 2011|Actual|2011-07-01||Observational|StaphCI||Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients|Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients, a Non-interventional, Prospective, Longitudinal Multicenter Study.|Completed||N/A|195|Actual|University Hospital Muenster|||1||f||||f||||||None Retained|"~     Sera~   "|||2017-02-18 14:25:35.061863|2017-02-18 14:25:35.061863
NCT00669747|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-10-01|||May 2008||2008-05-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)|A Phase II Randomized Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ|Unknown status|Recruiting|Phase 2|45|Anticipated|Windy Hill Medical, Inc.||3|||f||||f||||||||||2017-02-18 14:25:35.199595|2017-02-18 14:25:35.199595
NCT00669734|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2017-01-31|||February 2010||2010-02-01|December 2016|2016-12-01||||November 2013|Actual|2013-11-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery|Immunotherapy for Unresectable Pancreas Cancer: A Phase 1 Study of Intratumoral Recombinant Fowlpox PANVAC (PANVAC-F) Plus Subcutaneous Recombinant Vaccinia PANVAC (PANVAC-V), PANVAC-F and Recombinant Granulocyte-Macrophage Colony Stimulating Factor (rH-GM-CSF)|Active, not recruiting||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:25:35.321643|2017-02-18 14:25:35.321643
NCT00669721|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2008-04-28|||March 2008||2008-03-01|April 2008|2008-04-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis|Effects of UFH and LMWH on Osteoprotegerin and RANKL Plasma Levels in Hemodialysis Patients|Unknown status|Recruiting|N/A|40|Anticipated|St. Orsola Hospital||2|||f||||t||||||||||2017-02-18 14:25:35.440691|2017-02-18 14:25:35.440691
NCT00669708|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2010-02-01|||April 2008||2008-04-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Topical Therapy With Cooling Effect in Dry Itchy Skin|kühlender Effekt Der Eucerin pH5 Lotion Und Der Eucerin pH5 Lotion Mit Cooling Compound Bei Trockener, Juckender Haut|Completed||N/A|70|Anticipated|University Hospital Muenster||2|||f||||f||||||||||2017-02-18 14:25:35.561056|2017-02-18 14:25:35.561056
NCT00669695|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2013-09-23|||May 2008||2008-05-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|StatinflaSAS||Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin|Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin|Terminated||Phase 2|54|Actual|University Hospital, Grenoble||4||Interim analysis performed without efficient results|f||||t||||||||||2017-02-18 14:25:35.72812|2017-02-18 14:25:35.72812
NCT00669682|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2013-04-11|2013-02-15||August 2008||2008-08-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||T-wave Alternans and Intrathoracic Impedance Measurements|T-wave Alternans and Intrathoracic Impedance Measurements|Completed||N/A|9|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 14:25:35.854074|2017-02-18 14:25:35.854074
NCT00669669|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2016-08-10|||February 2009||2009-02-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Interventional|||O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas|Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cells for Patients With Malignant Gliomas|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 14:25:36.07073|2017-02-18 14:25:36.07073
NCT00669656|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2015-10-24|||November 2008||2008-11-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|||Herbal Therapy for Treatment of Recurrent Prostate Cancer|A Phase II Trial of a Combination Herbal Therapy for Men With Biochemical Recurrence of Prostate Cancer After Initial Local Therapy|Completed||Phase 2|43|Actual|University of Southern California||1|||f||||t||||||||||2017-02-18 14:25:36.211386|2017-02-18 14:25:36.211386
NCT00669643|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-07-15|||February 2007||2007-02-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|September 2012|Actual|2012-09-01||Interventional|U-MDT||Uniform Multidrug Therapy Regimen for Leprosy Patients|Independent Study to Establish the Efficacy of the Six Doses Uniform MDT Regimen (U-MDT) for Leprosy Patients|Active, not recruiting||Phase 4|859|Actual|University of Brasilia||4|||f||||t||||||||No|Data sharing was not previously requested to the Ethical Committee. Therefore, if there will be a request for it, new ethical approval must be obtained.|2017-02-18 14:25:36.323288|2017-02-18 14:25:36.323288
NCT00669630|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2010-01-11|||September 2008||2008-09-01|January 2010|2010-01-01|June 2012|Anticipated|2012-06-01|September 2011|Anticipated|2011-09-01||Interventional|GoodNEWS||The GoodNEWS Lifestyle Enhancement Program|The GoodNEWS (Genes, Nutrition, Exercise, Wellness, and Spiritual Growth) Trial|Unknown status|Recruiting|N/A|400|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 14:25:36.450477|2017-02-18 14:25:36.450477
NCT00669617|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2011-09-07|2011-07-22||April 2008||2008-04-01|September 2011|2011-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Phase III, Randomized, Double-blind, Triple-dummy, Placebo Controlled, Multicenter, 5-period, Single-dose Complete Block Crossover Study to Determine the Onset of Action of Indacaterol (150 and 300 μg) in Patients With Moderate to Severe COPD Using Salbutamol (200 μg) and Salmeterol/Fluticasone (50/500 μg) as Active Controls|Completed||Phase 3|89|Actual|Novartis||5|||f||||f||||||||||2017-02-18 14:25:36.547078|2017-02-18 14:25:36.547078
NCT00669604|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-04-29|||March 2004||2004-03-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||HIV Vertical Transmission in Vietnam|Counseling on Formula Feeding and Antiretroviral Prophylaxis Successfully Reduced Transmission of HIV-1 From Mother to Child in Northern Vietnam|Completed||N/A|135|Actual|National Institute of Hygiene and Epidemiology, Vietnam|||1||f||||f||||||Samples With DNA|"~     Peripheral EDTA blood samples were collected from the child at birth (1-2 days), at 1, 3, 6,~     12, and 18 months of age and processed at the Molecular Laboratory in the Hanoi Obstetric~     and Gynaecology hospital. The maternal blood samples were taken at the same day as the first~     sample of their child. Three ml EDTA blood was taken from the mother and 2 ml from the~     child. The blood was processed within 8 hours. Cells and plasma were stored separately at -~     20 Celcius degree.~   "|||2017-02-18 14:25:36.981203|2017-02-18 14:25:36.981203
NCT00669591|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2010-08-26|||January 2008||2008-01-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer|A Phase II Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|46|Actual|Peregrine Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:25:37.071805|2017-02-18 14:25:37.071805
NCT00669578|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2015-10-29|2012-11-07||May 2008||2008-05-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|July 2010|Actual|2010-07-01||Interventional|||CC-4047 in Treating Patients With Myelofibrosis|A Phase I/II, Prospective, Open-Label Study to Determine the Safety and Efficacy of CC-4047 in Patients With Primary, Post Polycythemia Vera, or Post Essential Thrombocythemia Myelofibrosis®|Completed||Phase 1/Phase 2|77|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:25:37.179332|2017-02-18 14:25:37.179332
NCT00669565|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2011-03-23|||July 2008||2008-07-01|March 2011|2011-03-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer|A Phase II Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|46|Actual|Peregrine Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:25:37.598511|2017-02-18 14:25:37.598511
NCT00669552|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2013-04-11|2013-02-15||August 2008||2008-08-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Intracardiac T-wave Alternans and Ischemia|Intracardiac T-wave Alternans and Ischemia During Percutaneous Coronary Interventions|Completed||N/A|11|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 14:25:37.844548|2017-02-18 14:25:37.844548
NCT00669539|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2016-07-07|2012-04-16||May 2008||2008-05-01|July 2016|2016-07-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Observational|ATS13||Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old|An Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old|Completed||N/A|156|Actual|Jaeb Center for Health Research|||2||f||||f||||||||||2017-02-18 14:25:38.062607|2017-02-18 14:25:38.062607
NCT00669526|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-04-29|||October 2004||2004-10-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Clinical and Cost Effectiveness of Brief Cognitive-Behavioral Therapy (CBT) for Pediatric Internalizing Disorders|Clinical and Cost Effectiveness of Brief CBT for Pediatric Internalizing Disorders|Completed||Phase 2|60|Actual|Robert Wood Johnson Foundation||2|||f||||f||||||||||2017-02-18 14:25:38.9491|2017-02-18 14:25:38.9491
NCT00669513|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-04-29|||January 2006||2006-01-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Cardiovascular Effects of Partial Sleep Deprivation|Cardiovascular Effects of Partial Sleep Deprivation in Healthy Volunteers|Completed||Phase 3|15|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 14:25:39.073309|2017-02-18 14:25:39.073309
NCT00669500|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2011-09-27|||July 2007||2007-07-01|September 2011|2011-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Body Worlds 3 Nutrition Display|Body Worlds 3 - Nutrition and College of Pharmacy Weeks Exhibit and Lifestyle Intervention|Completed||N/A|3188|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 14:25:39.189661|2017-02-18 14:25:39.189661
NCT00669487|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-05-27|||April 2008||2008-04-01|May 2015|2015-05-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP||Completed||Phase 3|150|Actual|South East Asia Research Collaboration with Hawaii||3|||f||||t||||||||||2017-02-18 14:25:39.280303|2017-02-18 14:25:39.280303
NCT00669474|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2015-06-03|||June 2009||2009-06-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Unicentric Comparing Study of Suction Curettage With Standard BOTOX Injection in the Treatment of Patients With Essential Axillar Hyperhidrosis: Comparing of Efficacy, Duration of Effectiveness, and Adverse Events.|Unicentric Comparing Study of Suction Curettage With Standard BOTOX Injection in the Treatment of Patients With Essential Axillar Hyperhidrosis: Comparing of Efficacy, Duration of Effectiveness, and Adverse Events.|Terminated||Phase 4|25|Anticipated|University Hospital, Ghent||2||Study never started|f||||f||||||||||2017-02-18 14:25:39.399836|2017-02-18 14:25:39.399836
NCT00669448|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2011-08-18|||April 2008||2008-04-01|April 2008|2008-04-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||A Pilot Trial on Effect of Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivities (MCS)|"A Pilot Trial on the Effect of Mindfulness-based Cognitive Therapy Versus Treatment as Usual for Individuals With Multiple Chemical Sensitivities"|Completed||N/A|39|Actual|University Hospital, Gentofte, Copenhagen||1|||f||||f||||||||||2017-02-18 14:25:39.733958|2017-02-18 14:25:39.733958
NCT00669435|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2008-04-28|||April 2008||2008-04-01|April 2008|2008-04-01|April 2009|Anticipated|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis|Ultrasonographic Modification of Liver Steatosis and Visceral Fat Induced by Treatment With Losartan and Simvastatin in Hypertensive Normocholesterolemic Obese Patients|Unknown status|Recruiting|Phase 4|75|Anticipated|University of Pavia||2|||f||||f||||||||||2017-02-18 14:25:39.840218|2017-02-18 14:25:39.840218
NCT00669422|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2012-10-04|||October 2006||2006-10-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|||||Observational|||ChemoFx® PRO - A Post-Market Data Collection Study|ChemoFx® PRO - A Post-Market Data Collection Study Utilizing Physician Reported Outcomes|Terminated||N/A|2756|Actual|Precision Therapeutics|||1||f||||f||||||Samples With DNA|"~     Leftover tumor cells from the test and pathology slides will be collected and stored to look~     for potential genetic variations related to drug pathway genes to identify patterns~     associated with clinical outcome.~   "|||2017-02-18 14:25:39.952374|2017-02-18 14:25:39.952374
NCT00669409|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2011-01-10||2011-01-03|June 2008||2008-06-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee|A Phase 1/2A, Randomized, Placebo-Controlled, Double Blind, Dose-Escalation, Multicenter Study Of The Safety, Tolerability, Efficacy And Pharmacokinetics, Of A Single Intravenous Dose Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee|Completed||Phase 1/Phase 2|83|Actual|Pfizer||6|||f||||t||||||||||2017-02-18 14:25:40.105232|2017-02-18 14:25:40.105232
NCT00669396|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2014-12-04|2009-06-18||April 2008||2008-04-01|December 2014|2014-12-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception|A Pilot Study of Copper T380A IUDs Versus Oral Levonorgestrel for Emergency Contraception|Completed||N/A|57|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 14:25:40.221339|2017-02-18 14:25:40.221339
NCT00669383|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2012-01-17|||June 2001||2001-06-01|January 2012|2012-01-01||||July 2007|Actual|2007-07-01||Interventional|||Rescue Antenatal Steroids and Pulmonary Function Tests in Preterm Infants|Rescue Antenatal Steroids and Lung Volumes in Preterm Infants|Unknown status|Active, not recruiting|N/A|80|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:25:40.734019|2017-02-18 14:25:40.734019
NCT00669370|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-04-29|||June 2006||2006-06-01|April 2008|2008-04-01||||March 2009|Anticipated|2009-03-01||Interventional|GAST-TaxXel||Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer|Biweekly Docetaxel (Taxotere®)in Combination With Capecitabine (Xeloda®)as First-Line Treatment in Patients With Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|50|Anticipated|University of Turku||1|||f||||f||||||||||2017-02-18 14:25:40.847485|2017-02-18 14:25:40.847485
NCT00669357|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2013-05-01||||||May 2013|2013-05-01||||||||Expanded Access|||AbioCor Implantable Replacement Heart|AbioCor Implantable Replacement Heart|No longer available||N/A|||Abiomed Inc.|||||f||||||||||||||2017-02-18 14:25:40.957882|2017-02-18 14:25:40.957882
NCT00669344|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2017-02-09|||February 2006||2006-02-01|February 2017|2017-02-01|February 2008|Actual|2008-02-01|April 2007|Actual|2007-04-01||Interventional|RIVIVE||RIVastigmine In Vascular cognitivE Impairment|A 24-week Prospective, Double Blind, Randomized, Placebo-controlled Pilot Study of 9 mg/Day Rivastigmine in Patients With Vascular Cognitive Impairment Not Dementia to Evaluate Efficacy, Safety and Tolerability in Asian Patients|Completed||Phase 4|50|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-02-18 14:25:41.039732|2017-02-18 14:25:41.039732
NCT00669331|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2016-03-29|2015-11-22||November 2009||2009-11-01|March 2016|2016-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||Patients randomised and treated with at least one dose of study medication|Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis|: A Phase III Multicenter, Randomized, Parallel Group, Controlled, Double Blind Study to Investigate the Safety and Efficacy of Inhaled Mannitol Over 12 Months in the Treatment of Bronchiectasis.|Completed||Phase 3|485|Actual|Pharmaxis|Relatively few studies in this area -ideal choice of endpoints not well-defined. No widely accepted exacerbation definition. Relies on patients’ accurate & timely symptom reporting.Unclear event end-dates may impact on counting of subsequent events.|2|||f||||t||||||||||2017-02-18 14:25:41.162205|2017-02-18 14:25:41.162205
NCT00669318|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2014-06-20|2014-05-20||July 2008||2008-07-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|May 2013|Actual|2013-05-01||Interventional|||Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) With Pentostatin, Alemtuzumab, and Low Dose Rituximab: A Phase II Clinical Trial|Completed||Phase 2|41|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:25:44.613818|2017-02-18 14:25:44.613818
NCT00669305|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2016-08-04|||July 2007||2007-07-01|August 2016|2016-08-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||Bone Marrow for Hemoglobinopathy Research|Bone Marrow for Hemoglobinopathy Research|Recruiting||N/A|25|Anticipated|St. Jude Children's Research Hospital|||1||f||||f||||||Samples With DNA|"~     Stem Cells through Bone Marrow Aspiration~   "|||2017-02-18 14:25:44.914461|2017-02-18 14:25:44.914461
NCT00669292|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2010-09-08|||November 2006||2006-11-01|September 2010|2010-09-01||||November 2009|Anticipated|2009-11-01||Interventional|||PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer|Phase I/II Study of URLC10-177 and TTK-567, Novel Tumor Specific Epitope Peptides Restricted to HLA-A*2402 Derived From Tumor Associated Antigens, Combined With CpG7909, a TLR9 Agonist, in Patients With Advanced or Recurrent Esophageal Cancer.|Unknown status|Recruiting|Phase 1/Phase 2|29|Anticipated|Wakayama Medical University||1|||f||||t||||||||||2017-02-18 14:25:45.05477|2017-02-18 14:25:45.05477
NCT00669279|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2012-02-17|2011-12-05||April 2008||2008-04-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure|Non-Invasive Determination of Central Aortic Blood Pressure in Hypertensive Patients Treated With Controlled-Release Carvedilol or Atenolol|Completed||Phase 4|41|Actual|University of Florida|Small sample size, short duration.|2|||f||||f||||||||||2017-02-18 14:25:45.158981|2017-02-18 14:25:45.158981
NCT00669266|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2016-10-28|||September 2002||2002-09-01|October 2016|2016-10-01|December 2024|Anticipated|2024-12-01|December 2022|Anticipated|2022-12-01||Observational|||Adrenal Tumors - Pathogenesis and Therapy|Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen|Recruiting||N/A|500|Anticipated|University of Wuerzburg|||2||f||||f||||||Samples With DNA|"~     Germline DNA Tumor samples Serum Plasma Urine~   "|||2017-02-18 14:25:45.547601|2017-02-18 14:25:45.547601
NCT00669253|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2014-12-04|||June 2008||2008-06-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Periodontitis Using Er:YAG Laser vs. Conventional Treatment Modalities|Randomized Controlled Trial to Evaluate the Efficacy of Er:YAG Laser and Surgical Therapy in Treatment of Chronic Periodontitis|Completed||N/A|60|Actual|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 14:25:45.655522|2017-02-18 14:25:45.655522
NCT00669240|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2015-06-30|2010-06-07||November 2007||2007-11-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Observational|CHOICES||Varenicline Observational Investigation In The Cessation of Smoking|Champix Observational Investigation In The Cessation of Smoking|Completed||N/A|567|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:25:45.996808|2017-02-18 14:25:45.996808
NCT00669227|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2014-06-07|||October 2005||2005-10-01|June 2014|2014-06-01||||January 2009|Actual|2009-01-01||Interventional|SCAMI||Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction (SCAMI)|Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction - A Randomized, Double-blind, Placebo Controlled Trial (SCAMI)|Completed||Phase 2|42|Actual|University of Ulm||2|||f||||f||||||||||2017-02-18 14:25:46.643312|2017-02-18 14:25:46.643312
NCT00669214|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2016-11-25|2010-08-24||February 2008||2008-02-01|November 2016|2016-11-01||||January 2009|Actual|2009-01-01||Interventional|SCALP||A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp|A Phase IV Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of 1.0 mg/kg Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp|Completed||Phase 4|89|Actual|Genentech, Inc.|Since the completion of this study, efalizumab has been voluntarily withdrawn from the U.S. market because of a safety issue.|2|||f||||||||||||||2017-02-18 14:25:46.77256|2017-02-18 14:25:46.77256
NCT00669201|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-04-29|||December 2007||2007-12-01|April 2008|2008-04-01||||||||Observational|||Wrist Cartilage - High Resolution in Vivo MR T2 Mapping- a Feasibility Study|Wrist Cartilage - High Resolution in Vivo MR T2 Mapping- a Feasibility Study|Unknown status|Recruiting|N/A|70|Anticipated|Sheba Medical Center|||3||f||||f||||||||||2017-02-18 14:25:47.942264|2017-02-18 14:25:47.942264
NCT00669188|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-29|2017-01-24|||April 21, 2008||2008-04-21|December 22, 2016|2016-12-22|December 26, 2013|Actual|2013-12-26|April 21, 2008|Actual|2008-04-21||Interventional|||Patient Provider Communication and Interaction in a Virtual Clinical Setting|Patient-Provider Communication and Interaction in a Virtual Clinical Setting|Completed||N/A|208|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:25:48.042582|2017-02-18 14:25:48.042582
NCT00669175|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2011-07-19|||February 2008||2008-02-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|||||Observational|||Safety and Efficacy of a Low Dose Naloxone Infusion in NICU Patients|Safety and Efficacy of a Low Dose Naloxone Infusion in NICU Patients|Completed||N/A|25|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-02-18 14:25:48.125558|2017-02-18 14:25:48.125558
NCT00669162|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2017-01-24|||August 2012||2012-08-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|August 2016|Actual|2016-08-01||Interventional|||Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0 Prostate Cancer|A Phase I/II Trial of Post-Prostatectomy Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3NO Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|27|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-02-18 14:25:48.213667|2017-02-18 14:25:48.213667
NCT00669149|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2011-07-01|||June 2008||2008-06-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|August 2012|Anticipated|2012-08-01||Interventional|TACA||Anticoagulant Treatments and Percutaneous Coronary Angioplasty|Anticoagulant Treatments Evaluation During Percutaneous Coronary Angioplasty in Stable Patients|Unknown status|Recruiting|Phase 4|480|Anticipated|Centre Hospitalier de PAU||4|||f||||t||||||||||2017-02-18 14:25:48.321201|2017-02-18 14:25:48.321201
NCT00669136|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2015-12-01|||June 2009||2009-06-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma|A Phase I/II Trial Testing Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma|Terminated||Phase 1|2|Actual|University of Pittsburgh||1||"Poor accrual and limited target patient population for future accrual. Did not complete the~   Phase 1 portion of the trial."|f||||t||||||||||2017-02-18 14:25:48.434849|2017-02-18 14:25:48.434849
NCT00669123|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2008-04-28||||||April 2008|2008-04-01||||||||Interventional|||Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis|Fase IV Clinical Trial to Evaluate Chondroitin Sulphate Efficacy and Safety in Patients With Knee Osteoarthritis and Psoriasis|Completed||Phase 4|126|Actual|Bioiberica||2|||f||||f||||||||||2017-02-18 14:25:48.543223|2017-02-18 14:25:48.543223
NCT00669110|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2011-04-21|2011-04-21||May 2008||2008-05-01|April 2011|2011-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder|6-Month, Multicenter, Open-Label, Flexible-Dose Study To Evaluate Safety, Efficacy, And Tolerability Of Desvenlafaxine Succinate Sustained-Release Tablets In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder|Completed||Phase 2|40|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:25:48.669535|2017-02-18 14:25:48.669535
NCT00669097|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2011-08-31|||April 2008||2008-04-01|August 2011|2011-08-01||||January 2010|Actual|2010-01-01||Interventional|||Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies|An Open-Label, Non-Randomized, Single-Center, Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion (ADME) of TKI258 After a Single Oral Administration of TKI258 500mg and to Assess the Preliminary Safety of TK258 400mg Once Daily in Patients With Advanced Solid Malignancies|Completed||Phase 1|13|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:25:50.033504|2017-02-18 14:25:50.033504
NCT00669071|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-09-21|2009-09-25||January 2008||2008-01-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma|Split-Face, Randomized, Open-Label Study of Sequential Treatment With Tri-Luma® Cream With Intense Pulsed Light (IPL) vs. a Mild Inactive Control Cream With Intense Pulsed Light (IPL) in Subjects With Melasma|Terminated||Phase 4|56|Actual|Galderma Laboratories, L.P.||2||Enrollment closed|f||||f||||||||||2017-02-18 14:25:50.417524|2017-02-18 14:25:50.417524
NCT00669058|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-01-27|||December 2007||2007-12-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Tangerina Mix|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd Tina Gel Tangerina Mix.|Completed||Phase 3|52|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:25:50.809483|2017-02-18 14:25:50.809483
NCT00669045|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-27|2017-02-13|||September 1, 2000|Actual|2000-09-01|February 2017|2017-02-01|March 31, 2006|Actual|2006-03-31|March 31, 2006|Actual|2006-03-31||Observational|||An Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and 5 (POST)|A Phase IV, Prospective, Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and 5 (POST)|Completed||N/A|253668|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 14:25:50.915101|2017-02-18 14:25:50.915101
NCT00669032|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2016-01-19|2015-11-19||October 2003||2003-10-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional||Considering a statistical power of 80% and assuming up to a 40% dropout rate, the sample size was planned to include a total of 300 patients (150 per treatment arm). Analysis was performed based on the modified intention-to-treat population. The imputation method for handling missing data was the last observation carried forward.|Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid in Patients With OA of the Knee|Random, Phase IV, Multicentre, Double Blind, Placebo Controlled, Parallel Study to Assess Long-term Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid (ADANT®) in Patients With Knee OA of the Knee|Completed||Phase 4|446|Actual|Tedec-Meiji Farma, S.A.|Control of rescue medication: patients were asked at every assessment visit about the frequency and doses of consumption, but it was not delivered in hand.|2|||f||||f||||||||||2017-02-18 14:25:50.990453|2017-02-18 14:25:50.990453
NCT00669019|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-26|2014-05-06|2013-12-10||July 2006||2006-07-01|January 2014|2014-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery|A Phase 2 Study of AZD0530 in Metastatic Melanoma|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)|Trial was designed with a maximum target accrual of 37 patients. Per protocol, the trial was stopped after the first stage based on an interim analysis of the response rate among the first 23 patients.|1|||f||||t||||||||||2017-02-18 14:25:51.589229|2017-02-18 14:25:51.589229
NCT00669006|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2016-03-19|||April 2008||2008-04-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|December 2012|Actual|2012-12-01||Observational|NePDatabase||Neuropathic Pain Database|National Neuropathic Pain Database Study|Active, not recruiting||N/A|900|Anticipated|Lawson Health Research Institute|||1||f||||t||||||||||2017-02-18 14:25:51.829398|2017-02-18 14:25:51.829398
NCT00668993|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-27|2009-09-19|||April 2008||2008-04-01|September 2009|2009-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Randomized Clinical Trial Investigating Efficacy of EFT (Emotional Freedom Technique) for Food Cravings|The Emotional Freedom Technique (EFT) Versus a Waitlist for Food Cravings: A Randomized Clinical Trial|Completed||N/A|60|Anticipated|Soul Medicine Institute||1|||f||||f||||||||||2017-02-18 14:25:51.92292|2017-02-18 14:25:51.92292
NCT00668980|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2010-01-13|||July 2006||2006-07-01|January 2010|2010-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Symbolic Representation in Young Children With Down Syndrome|The Constitution of Symbolic Representation in Young Children With Down Syndrome|Completed||N/A|25|Actual|University of Sao Paulo|||2||f||||t||||||||||2017-02-18 14:25:52.027841|2017-02-18 14:25:52.027841
NCT00668967|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2009-07-07|||February 2008||2008-02-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Bioequivalence Study Of Verapamil|Bioequivalence Study Of Verapamil (Covera HS) 240 Mg Extended Release Tablets Produced By Alza Corporation, Vacaville And Pfizer Inc, Puerto Rico: A Two Sequence, Four-Way Crossover Design, Single Dose, Open-Label, Randomized Study In Healthy Volunteers|Completed||Phase 1|79|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:25:52.121772|2017-02-18 14:25:52.121772
NCT00668954|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2015-07-29|||April 2008||2008-04-01|July 2015|2015-07-01|November 2010|Actual|2010-11-01|April 2009|Actual|2009-04-01||Interventional|||Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus|Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus Following a Glucose Load|Completed||N/A|26|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 14:25:52.233804|2017-02-18 14:25:52.233804
NCT00668941|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-27|2016-02-26|||September 2005||2005-09-01|February 2016|2016-02-01|November 2016|Anticipated|2016-11-01|February 2016|Actual|2016-02-01||Interventional|||Cyclic Versus Daily Teriparatide on Bone Mass|Cyclic Versus Daily Teriparatide on Bone Mass|Active, not recruiting||Phase 2|140|Anticipated|Helen Hayes Hospital||6|||f||||f||||||||||2017-02-18 14:25:52.340205|2017-02-18 14:25:52.340205
NCT00668928|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-28|||January 2006||2006-01-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Dietary Polyphenols on Insulin Sensitivity|Effect of Dietary Polyphenols on Insulin Sensitivity|Completed||Phase 1|20|Actual|USDA Beltsville Human Nutrition Research Center||1|||f||||t||||||||||2017-02-18 14:25:52.470468|2017-02-18 14:25:52.470468
NCT00668915|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-04-28||||||April 2008|2008-04-01||||||||Observational|||Arthroplasty Rehabilitation Score - Can we Predict the Short Term Postoperative Outcome?|Arthroplasty Rehabilitation Score - Can we Predict the Short Term Postoperative Outcome?|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 14:25:52.547195|2017-02-18 14:25:52.547195
NCT00668902|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2014-12-15|2014-12-08||March 2007||2007-03-01|December 2014|2014-12-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole|Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole|Completed||N/A|25|Actual|Indiana University||3|||f||||t||||||||||2017-02-18 14:25:52.628945|2017-02-18 14:25:52.628945
NCT00668876|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2008-12-02|||May 2006||2006-05-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Immunonutrition in Patients Undergoing Pancreaticoduodenectomy|Effects of Immunonutrition on Surgical Site Infection and Th1/Th2/Th17 Differentiation in Patients Undergoing Pancreaticoduodenectomy|Completed||Phase 4|30|Actual|Chiba University||3|||f||||f||||||||||2017-02-18 14:25:53.107719|2017-02-18 14:25:53.107719
NCT00668863|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2011-10-11|2011-09-02||May 2008||2008-05-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study Of Sunitinib With FOLFIRI In Colorectal Cancer|A Phase II Study Of Sunitinib In Combination With Irinotecan, L-leucovorin, And 5-Fluorouracil In Patients With Unresectable Or Metastatic Colorectal Cancer|Completed||Phase 2|71|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:25:53.217244|2017-02-18 14:25:53.217244
NCT00668850|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2011-06-06|||April 2008||2008-04-01|June 2011|2011-06-01|September 2011|Anticipated|2011-09-01|August 2011|Anticipated|2011-08-01||Interventional|||Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin|A 26-Week, Open-Label, Randomized, Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin In Subjects With Type-1 Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 3|500|Anticipated|Generex Biotechnology Corp.||2|||f||||f||||||||||2017-02-18 14:25:53.924319|2017-02-18 14:25:53.924319
NCT00668837|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2011-06-06|||February 2004||2004-02-01|March 2010|2010-03-01|June 2006|Actual|2006-06-01|||||Interventional|||A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.|Open Label Extension to R076477-SCH-305 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.|Completed||Phase 3|407|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:25:54.108838|2017-02-18 14:25:54.108838
NCT00668824|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2009-07-31|||March 2007||2007-03-01|July 2009|2009-07-01|December 2009|Anticipated|2009-12-01|July 2008|Anticipated|2008-07-01||Interventional|CHD Vasovist||Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist|Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist|Unknown status|Recruiting|Phase 4|||Guy's Hospital|||||f||||f||||||||||2017-02-18 14:25:54.19079|2017-02-18 14:25:54.19079
NCT00668811|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2016-03-24|||April 2008||2008-04-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|September 2015|Actual|2015-09-01||Interventional|IIT Sutent||Sutent Adjunctive Treatment of Differentiated Thyroid Cancer|Sutent Adjunctive Treatment of Differentiated Thyroid Cancer|Completed||Phase 2|23|Actual|Washington Hospital Center||1|||f||||t||||||||||2017-02-18 14:25:54.284516|2017-02-18 14:25:54.284516
NCT00668798|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2008-04-28|||January 2005||2005-01-01|April 2008|2008-04-01|March 2008|Anticipated|2008-03-01|January 2008|Anticipated|2008-01-01||Observational|||Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms|Incidence and Clinical Outcome of Human Cytomegalovirus Transmission Via Thawed Frozen Breast Milk in Preterm Infants <31 Weeks. A Prospective Trial.|Suspended||N/A|58|Actual|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples With DNA|"~     thawed frozen breast milk of lactating mothers~   "|||2017-02-18 14:25:54.407388|2017-02-18 14:25:54.407388
NCT00668785|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2015-04-07|2013-09-06||March 2007||2007-03-01|April 2015|2015-04-01|March 2012|Actual|2012-03-01|June 2010|Actual|2010-06-01||Interventional|||Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)|Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)|Terminated||Phase 2|6|Actual|Jumper, J. Michael, M.D.|Study was terminated by Sponsor and Investigator due to low enrollment. Data not analyzed. Technical problems with measurement leading to unreliable or uninterpretable data.|1||Study was terminated due to low enrollment|f||||f||||||||||2017-02-18 14:25:54.509634|2017-02-18 14:25:54.509634
NCT00668772|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-04-30||2014-04-30|April 2008||2008-04-01|April 2014|2014-04-01||||October 2008|Actual|2008-10-01||Interventional|||Tiotropium/Salmeterol Inhalation Powder in COPD|1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)|Terminated||Phase 3|207|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-02-18 14:25:54.736718|2017-02-18 14:25:54.736718
NCT00668759|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2009-12-12|||April 2008||2008-04-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|AVRO||A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation|A Phase III Prospective, Randomized, Double-Blind, Active-Controlled, Multi-Center, Superiority Study of Vernakalant Injection Versus Amiodarone in Subjects With Recent Onset Atrial Fibrillation|Completed||Phase 3|254|Actual|Cardiome Pharma||2|||f||||f||||||||||2017-02-18 14:25:54.92378|2017-02-18 14:25:54.92378
NCT00668746|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2011-12-06|2010-02-26||December 2007||2007-12-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Long-term Safety of Minocycline in Patients With Gum Disease|Long-term Safety Evaluation of Minocycline Resistance After Treatment With Minocycline HCl Microspheres, 1 mg in Subjects With Chronic Periodontitis|Completed||Phase 4|35|Actual|OraPharma||2|||f||||f||||||||||2017-02-18 14:25:55.152037|2017-02-18 14:25:55.152037
NCT00668733|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2010-07-13|2010-06-15||April 2008||2008-04-01|July 2010|2010-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year|Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year After Completion of Studies GW01-0702, GW01-0703, GW01-0704, and GW01-0705|Completed||N/A|179|Actual|Graceway Pharmaceuticals, LLC|||1||f||||f||||||||||2017-02-18 14:25:56.016411|2017-02-18 14:25:56.016411
NCT00668720|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2011-06-29|||April 2008||2008-04-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) for Tinnitus|Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Patients With Chronic Tinnitus|Completed||N/A|52|Actual|UMC Utrecht||2|||f||||f||||||||||2017-02-18 14:25:56.369534|2017-02-18 14:25:56.369534
NCT00668707|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2016-08-02|||September 2007||2007-09-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|AMPLCaRe||Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality|Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality: A Randomized Placebo Controlled Clinical Trial|Active, not recruiting||Phase 3|711|Actual|The Canadian College of Naturopathic Medicine||2|||f||||t||||||||||2017-02-18 14:25:56.474629|2017-02-18 14:25:56.474629
NCT00668694|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-27|2011-07-11|||October 2007||2007-10-01|April 2008|2008-04-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Interventional|IDA||Iron Deficiency Anemia and Psychosocial Stimulation|Effect of Psychosocial Stimulation on Development of Iron-deficient Anemic Infants: A Randomized Controlled Trial|Completed||N/A|424|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh||4|||f||||f||||||||||2017-02-18 14:25:56.661084|2017-02-18 14:25:56.661084
NCT00668681|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2012-10-15|||April 2008||2008-04-01|October 2012|2012-10-01|February 2009|Anticipated|2009-02-01|December 2008|Actual|2008-12-01||Interventional|EndoRefix||Evaluation of EndoRefix Endovascular Delivery System and Staple|Safety Data Collection for Delivery System and Use of Staple in Endovascular Procedures|Withdrawn||N/A|0|Actual|Lombard Medical||1||Company business decision, IDE closed, no commercialization planned|f||||f||||||||||2017-02-18 14:25:56.768344|2017-02-18 14:25:56.768344
NCT00668668|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-01-27|||December 2007||2007-12-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Sweet Flower|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd Tina Gel Sweet Flower.|Completed||Phase 3|52|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:25:57.024737|2017-02-18 14:25:57.024737
NCT00668655|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2012-09-11|||February 2008||2008-02-01|September 2012|2012-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%|An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%|Completed||N/A|30|Actual|Galderma Laboratories, L.P.|||1||f||||f||||||||||2017-02-18 14:25:57.121189|2017-02-18 14:25:57.121189
NCT00668642|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2014-02-13|||March 2007||2007-03-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer|Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer|Completed||Phase 2|21|Actual|NorthShore University HealthSystem Research Institute||2|||f||||t||||||||||2017-02-18 14:25:57.247107|2017-02-18 14:25:57.247107
NCT00668629|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-01-27|||November 2007||2007-11-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Dermacyd Tina Gel Sweet Flower - Photo Evaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Tina Gel Sweet Flower.|Completed||Phase 3|25|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:25:57.359615|2017-02-18 14:25:57.359615
NCT00668616|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2010-07-28|||March 2000||2000-03-01|July 2010|2010-07-01|July 2009|Actual|2009-07-01|July 2005|Actual|2005-07-01||Interventional|||Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes|Cyclophosphamid + Farmorubicin® With Subsequent Administration of Taxol® (q3w) Versus Intensified Administration of Farmorubicin® Followed by Taxol® (q2w) in the Adjuvant Treatment of Breast Cancer in Patients With 1-3 Afflicted Lymph Nodes (1-3 LK+)|Completed||Phase 3|1034|Actual|North Eastern Germany Society of Gynaecologic Oncology||2|||f||||||||||||||2017-02-18 14:25:57.454192|2017-02-18 14:25:57.454192
NCT00668603|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-02-18|||August 2005||2005-08-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|SYMPTOM||Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)|Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy: A Randomized, Placebo-controlled Prospective Study|Completed||N/A|160|Actual|Helsinki University||2|||f||||t||||||||||2017-02-18 14:25:57.554324|2017-02-18 14:25:57.554324
NCT00668590|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2011-04-08|||August 2008||2008-08-01|April 2011|2011-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Improving Diabetes Care With Patient Decision Aids - A Trial in Community-based Primary Care|Improving Diabetes Care With Patient Decision Aids - A Randomized Controlled Trial in Community-based Primary Care|Completed||N/A|201|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:25:57.68976|2017-02-18 14:25:57.68976
NCT00668577|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-02-09|||December 2007||2007-12-01|February 2009|2009-02-01||||February 2008|Actual|2008-02-01||Interventional|||Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd Breeze.|Completed||Phase 3|52|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:25:57.800075|2017-02-18 14:25:57.800075
NCT00668564|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2012-11-06|2011-06-14||March 2008||2008-03-01|November 2012|2012-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism|Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Hematopoietic Cell Transplantation|Terminated||Phase 2|18|Actual|Masonic Cancer Center, University of Minnesota|Other secondary objectives outlined in study protocol were not analyzed; number of patients were too few to be relevant.|1||Replaced by another study|f||||t||||||||||2017-02-18 14:25:57.898336|2017-02-18 14:25:57.898336
NCT00668551|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2009-04-10|||April 2008||2008-04-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|Tele-PD||Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population|Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population|Completed||N/A|14|Actual|University of Rochester|||2||f||||f||||||||||2017-02-18 14:25:58.190555|2017-02-18 14:25:58.190555
NCT00668538|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2008-10-16|||April 2008||2008-04-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Uptake of the Antifungal Miconazole and Effect on Estrogen Metabolizing Enzymes in Humans|Uptake of the Antifungal Miconazole and Effect on Estrogen Metabolizing Enzymes in Humans|Completed||N/A|20|Actual|University of Southern Denmark||1|||f||||t||||||||||2017-02-18 14:25:58.302079|2017-02-18 14:25:58.302079
NCT00668525|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2010-05-07|2010-03-22||April 2008||2008-04-01|May 2010|2010-05-01||||February 2009|Actual|2009-02-01||Interventional|||Escitalopram in Adult Patients With Major Depressive Disorder|A Double-blind, Fixed-dose Study of Escitalopram in Adult Patients With Major Depressive Disorder|Completed||Phase 3|877|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 14:25:58.39621|2017-02-18 14:25:58.39621
NCT00668512|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2015-03-17|||March 2007||2007-03-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Intratumoral Injection Of Alpha-Gal Glycosphingolipids|Phase I Study To Evaluate The Toxicity And Feasibility Of Intratumoral Injection Of Alpha-Gal (Beta-galactosidase ) Glycosphingolipids In Patients With Advanced Melanoma|Completed||Phase 1|12|Actual|University of Massachusetts, Worcester||1|||f||||t||||||||||2017-02-18 14:25:58.979402|2017-02-18 14:25:58.979402
NCT00668499|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2014-05-19|||April 2008||2008-04-01|May 2014|2014-05-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|||A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma|A Phase I/II Study of VEGF-Antisense Oligonucleotide (VEGF-AS, Veglin) in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma|Withdrawn||Phase 1/Phase 2|0|Actual|University of Southern California||1||Sponsor withdrew support|f||||f||||||||||2017-02-18 14:25:59.090502|2017-02-18 14:25:59.090502
NCT00668473|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2016-10-24|||May 2007||2007-05-01|October 2016|2016-10-01|January 2012|Actual|2012-01-01|May 2008|Actual|2008-05-01||Observational|||Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis|Endostatin and Other Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis|Completed||N/A|30|Actual|University of Michigan|||2||f||||f||||||Samples Without DNA|"~     skin serum~   "|||2017-02-18 14:25:59.28626|2017-02-18 14:25:59.28626
NCT00668460|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-01-28|||November 2007||2007-11-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR|Study for Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability, Dermical Sensitivity) of Dermacyd Delicata Pocket BR.|Completed||Phase 3|52|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:25:59.373572|2017-02-18 14:25:59.373572
NCT00668447|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2008-04-25|||November 2001||2001-11-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Soy and Isoflavones Effect on Bone|Soy Proteins and Isoflavones Impact Bone Mineral Density in Older Women|Completed||Phase 4|97|Actual|National Institute on Aging (NIA)||4|||f||||f||||||||||2017-02-18 14:25:59.45601|2017-02-18 14:25:59.45601
NCT00668434|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2015-04-09|2014-10-20||November 2008||2008-11-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|ACT FAST||Effectiveness of Oral Prednisone in Improving Physical Functioning and Decreasing Pain in People With Sciatica|A Corticosteroid Taper for Acute Sciatica Treatment (The ACT FAST Study)|Completed||Phase 2|269|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 14:25:59.568926|2017-02-18 14:25:59.568926
NCT00668421|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2014-11-24|||April 2008||2008-04-01|November 2014|2014-11-01|January 2015|Anticipated|2015-01-01|September 2013|Actual|2013-09-01||Interventional|||CEP-701 (Lestaurtinib) in Myelofibrosis|A Multicenter, Open Label Phase I/II Study of CEP-701 (Lestaurtinib) in Adults With Myelofibrosis|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-02-18 14:26:00.150061|2017-02-18 14:26:00.150061
NCT00668408|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2009-08-27|||May 2008||2008-05-01|August 2009|2009-08-01|October 2012|Anticipated|2012-10-01|March 2012|Anticipated|2012-03-01||Interventional|||LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure|Long-Term Oxygen Therapy (LTOT) in Chronic Obstructive Pulmonary Disease (COPD) Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure (CHF)|Unknown status|Recruiting|Phase 4|1000|Anticipated|Azienda Ospedaliero-Universitaria Careggi||2|||f||||t||||||||||2017-02-18 14:26:00.27268|2017-02-18 14:26:00.27268
NCT00668395|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2014-09-18|2013-04-10||May 2007||2007-05-01|September 2014|2014-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics|Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics, Autoinduction and Drug Interactions in Healthy Volunteers.|Completed||N/A|73|Actual|Indiana University||3|||f||||t||||||||||2017-02-18 14:26:00.513642|2017-02-18 14:26:00.513642
NCT00668382|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2013-05-10|2012-10-25||July 2007||2007-07-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection|Phase I Study To Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection Of Alpha-Gal Glycosphingolipids In Patients With Advanced Or Refractory Solid Tumors|Completed||Phase 1|11|Actual|University of Massachusetts, Worcester|No allergic/immune toxicity. The single toxicity/AE was bacterial infection with UGI flora at injection site following EUS (endoscopic ultra-sound) guided injection of pancreatic cancer. Added injections covered with antibiotic prophylaxis.|1|||f||||t||||||||||2017-02-18 14:26:01.131889|2017-02-18 14:26:01.131889
NCT00668369|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2013-12-19|||April 2008||2008-04-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation|Effect of Immunosuppression Drug Weaning on Hepatitis C Virus Induced Liver Damage After Liver Transplantation.|Completed||Phase 2|34|Actual|Hospital Clinic of Barcelona||1|||f||||f||||||||||2017-02-18 14:26:01.349557|2017-02-18 14:26:01.349557
NCT00668356|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2009-02-06|||September 2009||2009-09-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|September 2010|Anticipated|2010-09-01||Interventional|ddI||Bioequivalence Study of Didanosine in Children Treated for HIV|PKPOP Study of Didanosine in HIV Treated Children, at Fasting Period and During the Meal|Suspended||Phase 2|26|Anticipated|Assistance Publique - Hôpitaux de Paris||2||questions of the benefit efficacy/risks of ddI during the meal not resolved|f||||f||||||||||2017-02-18 14:26:01.454493|2017-02-18 14:26:01.454493
NCT00668343|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-27|2010-07-29|||April 2005||2005-04-01|July 2010|2010-07-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|irmsrct||Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo||Completed||Phase 3|80|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:26:01.559749|2017-02-18 14:26:01.559749
NCT00668330|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2012-02-10|||April 2007||2007-04-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus|Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus-Prevalence,Risk Factors and Treatment|Completed||Phase 4|40|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 14:26:01.659169|2017-02-18 14:26:01.659169
NCT00668317|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-10-16|2012-03-16||September 2006||2006-09-01|October 2012|2012-10-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Bronchial Hyper-responsiveness in Reflux Cough|An 8 Week Non-selected Cohort Study to Investigate Whether the Treatment of Reflux Induced Cough Alters Associated Bronchial Hyper-responsiveness|Terminated||Phase 3|5|Actual|Hull and East Yorkshire Hospitals NHS Trust||1||Primary care physicians began prescribing antacid therapy for chronic cough|f||||t||||||||||2017-02-18 14:26:01.771902|2017-02-18 14:26:01.771902
NCT00668304|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2014-12-18|||June 2004||2004-06-01|December 2014|2014-12-01|January 2005|Actual|2005-01-01|||||Interventional|SPEED||Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox|Prospective, Multicenter, Open, Uncontrolled Trial to Evaluate the Time to Bacterial Eradication and Key Symptom Relief in the Treatment of Acute Bacterial Maxillary Sinusitis With Moxifloxacin 400 mg QD|Completed||Phase 4|192|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:26:04.436966|2017-02-18 14:26:04.436966
NCT00668291|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2016-07-05|||January 2008||2008-01-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|May 2015|Actual|2015-05-01||Observational|EVACARNEY||Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC)|Assessment of the Clinical Symptoms of the Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC).|Completed||N/A|133|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"~     2 tubes EDTA 5 mL each (DNA) and 2 tubes heparine 5 mL each (cellular biology)~   "|||2017-02-18 14:26:04.572654|2017-02-18 14:26:04.572654
NCT00668278|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2009-01-27|||February 2008||2008-02-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|IGE(L)MA||I-Gel Versus Disposable Laryngeal Mask (LMA) for General Anesthesia (GA) With Controlled Ventilation|I-Gel Versus Disposable Laryngeal Mask Airway for General Anesthesia With Controlled Ventilation|Completed||N/A|200|Anticipated|Northern Health and Social Care Trust||2|||f||||f||||||||||2017-02-18 14:26:04.661396|2017-02-18 14:26:04.661396
NCT00668265|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-28|2013-02-15|2012-10-19||January 2008||2008-01-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Anxiety in Recovering Opiate Dependence|A Prospective, Sixteen-Week, Double-Blind, Placebo-Controlled, Trial of Seroquel in Combination With Treatment as Usual in Patients With GAD and Remitted Comorbid Opiate Dependence|Terminated||Phase 4|14|Actual|Beth Israel Medical Center||1||The study was not completed, the funding sponsor lost interest.|f||||f||||||||||2017-02-18 14:26:04.75696|2017-02-18 14:26:04.75696
NCT00668252|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2008-04-28|||April 2006||2006-04-01|March 2006|2006-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|Oestropec||Circulating Endothelium Progenitor Cells and Endogenous Oestrogen in Healthy Subjects|Impact of Endogenous Sexual Hormones (Oestrogens and Testosterone) on the Endothelium Circulatory on Rolling at the Young and Old Healthy Volunteer.|Completed||N/A|48|Actual|Assistance Publique - Hôpitaux de Paris|||4||f||||f||||||None Retained|"~     whole peripheral blood (150 ml)~   "|||2017-02-18 14:26:05.110776|2017-02-18 14:26:05.110776
NCT00668239|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2008-04-28|||September 2004||2004-09-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|April 2006|Actual|2006-04-01||Interventional|||Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser|Treatment of Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone and Laser Photocoagulation: Randomized Clinical Trial With Morphological and Functional Evaluation|Completed||N/A|14|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 14:26:05.413802|2017-02-18 14:26:05.413802
NCT00668226|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-01-28|||December 2007||2007-12-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Dermacyd Delicata Pocket BR - Photo Evaluation|Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Delicata Pocket BR.|Completed||Phase 3|25|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:26:05.534236|2017-02-18 14:26:05.534236
NCT00668213|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-01-08|||June 2006||2006-06-01|January 2014|2014-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Antioxidant Systems and Age-Related Macular Degeneration|Antioxidant Systems and Age-Related Macular Degeneration|Completed||N/A|143|Actual|Vanderbilt University|||1||f||||f||||||Samples Without DNA|"~     Blood serum~   "|||2017-02-18 14:26:05.620822|2017-02-18 14:26:05.620822
NCT00668200|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-02-17|2013-11-04||May 2008||2008-05-01|February 2015|2015-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||The ITT population includes 80 enrolled patients and the Safety population includes 81enrolled patients. During monitoring it was discovered that one patient signed the consent form from another Paget’s study; therefore, this patient was excluded from the ITT population but included in the safety population.Baseline used ITT data set|Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®|Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation|Completed||Phase 4|81|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:26:05.714848|2017-02-18 14:26:05.714848
NCT00668187|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2017-01-31|||December 2010|Actual|2010-12-01|January 2017|2017-01-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2019|Anticipated|2019-08-31||Observational|||A Natural History Study of the Gangliosidoses|A Natural History Study of the Gangliosidoses|Recruiting||N/A|52|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t|f|f||||||Yes|"De-identified individual data is input to the NIH-funded Rare Diseases Clinical Research Network's Data Management & Coordinating Center (DMCC). Eventually this data will become part of the database of Genotypes and Phenotypes (dbGaP), which is part of the National Center for Biotechnology Information, U.S. National Library of Medicine."|2017-02-18 14:26:05.99311|2017-02-18 14:26:05.99311
NCT00668174|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2012-11-26|||January 1997||1997-01-01|November 2012|2012-11-01|December 2004|Actual|2004-12-01|December 2003|Actual|2003-12-01||Interventional|||Effect of Exercise on Sex Hormones in Postmenopausal Women|Physical Activity and Total Health Trial|Completed||Phase 2/Phase 3|173|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 14:26:06.122213|2017-02-18 14:26:06.122213
NCT00668161|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-11-26|||January 2001||2001-01-01|November 2012|2012-11-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|APPEAL||Effect of Exercise on Biomarkers of Colon Cancer Risk|Exercise Intervention Trial for Colorectal Polyp Patients|Completed||Phase 2/Phase 3|202|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 14:26:06.22565|2017-02-18 14:26:06.22565
NCT00668148|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2012-05-08||2010-09-01|July 2008||2008-07-01|September 2011|2011-09-01|February 2012|Actual|2012-02-01|October 2010|Actual|2010-10-01||Interventional|||A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma|A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously-Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET|Completed||Phase 2|111|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 14:26:06.33789|2017-02-18 14:26:06.33789
NCT00668135|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2014-12-15|||March 2003||2003-03-01|December 2014|2014-12-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia|Randomised, Double Blind, Placebo Controlled, Parallel Group, Multi-centre, Multinational Study to Evaluate the Efficacy and Tolerability of Vardenafil (BAY 38-9456) in Treatment of Male Erectile Dysfunction in Asia|Completed||Phase 4|348|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:06.491345|2017-02-18 14:26:06.491345
NCT00668122|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2009-06-29|||March 2004||2004-03-01|June 2009|2009-06-01|January 2006|Actual|2006-01-01|||||Interventional|EMERON||Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections|Efficacy and Safety of Ciprofloxacin Extended-Release 1000 mg Once-Daily Versus Ciprofloxacin Immediate-Release 500 mg Twice-Daily Given 7-14 Days in Patients With Complicated Urinary Tract Infections: Prospective, Randomized, Double-Blind Trial.|Completed||Phase 3|212|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:06.611503|2017-02-18 14:26:06.611503
NCT00664209|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-04-21|||January 2008||2008-01-01|April 2008|2008-04-01||||||||Interventional|||Treating H. Pylori in Parkinson's Patients With Motor Fluctuations|Helicobacter Pylori Eradication and Motor Fluctuations in Parkinson's Disease|Unknown status|Recruiting|Phase 3|100|Anticipated|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:27:44.362886|2017-02-18 14:27:44.362886
NCT00668109|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-12-18|||December 2003||2003-12-01|December 2014|2014-12-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|LUTECIA||Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia|A Randomized, Open-label, Multi-center, Parallel Group Study to Investigate the Efficacy and Safety of Vardenafil in Comparison to Tadalafil in Males With Erectile Dysfunction and a Diagnosis of Diabetes, Hypertension or Hyperlipidemia|Completed||Phase 3|614|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:06.755566|2017-02-18 14:26:06.755566
NCT00668096|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-12-23|||May 2004||2004-05-01|December 2014|2014-12-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|FINDER||A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.|A Randomized, Double Blind, Placebo Controlled, Flexible Dose, Multicentre Study of Levitra in a Broad Population of Men With Erectile Dysfunction and Previously Untreated With PDE5 Inhibitors.|Completed||Phase 4|260|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:07.159031|2017-02-18 14:26:07.159031
NCT00668083|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2010-12-09|||September 2007||2007-09-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|October 2007|Actual|2007-10-01||Observational|Sorse||Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer|Observational Retrospective Trial on Sequential Hormonal Therapy in Patients|Completed||N/A|214|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:26:07.306263|2017-02-18 14:26:07.306263
NCT00668070|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2013-03-19|||April 2008||2008-04-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|ASTER||A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831|Protocol for a Phase II, Randomized, Double-blind, Parallel-group, Placebo-controlled, 12-week Treatment, Adaptive Proof-of-principle Study of Twice Daily Oral Dosing of a Novel PDE4 Inhibitor (ASP9831) in Subjects With Non-alcoholic Steatohepatitis (NASH)|Completed||Phase 2|114|Actual|Astellas Pharma Inc||3|||f||||t||||||||||2017-02-18 14:26:07.403194|2017-02-18 14:26:07.403194
NCT00668057|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-03-05|||December 2002||2002-12-01|March 2015|2015-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.|Randomized, Double-blind, Multi-centre, Parallel-goup Study to Investigate the Efficacy and Safety of Three Doses of BAY38-9456 (5 mg, 10 mg and 20 mg) Versus Placebo in the Treatment of Patients With Erectile Dysfunction|Completed||Phase 3|624|Actual|Bayer||6|||f||||f||||||||||2017-02-18 14:26:07.546997|2017-02-18 14:26:07.546997
NCT00668044|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2009-10-26|||November 2002||2002-11-01|October 2009|2009-10-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Ciprofloxacin on Burned Patients|A Population Pharmacokinetics Study of Plasma Levels of Ciprofloxacin Following a Regimen of Repeated Dose I.V. Administration (400 mg TID) on Burn Patients|Completed||Phase 3|18|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:07.673213|2017-02-18 14:26:07.673213
NCT00668031|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2014-12-26|||February 2005||2005-02-01|December 2014|2014-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement Surgery|Completed||Phase 3|359|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:07.788668|2017-02-18 14:26:07.788668
NCT00668018|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-12-18|||January 2003||2003-01-01|December 2014|2014-12-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 Hours|An Open-label, Multicenter Study to Assess Safety, Tolerability, Efficacy and Impact on Quality of Life of Vardenafil 10mg in Patients With Erectile Dysfunction Within a Time Window of up to 6 Hours After Intake of Study Drug|Completed||Phase 3|887|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:26:07.945494|2017-02-18 14:26:07.945494
NCT00668005|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-12-15|||February 2003||2003-02-01|December 2014|2014-12-01|September 2003|Actual|2003-09-01|||||Interventional|||Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension|A Randomized, Double-blind, Parallel-group, Plac-controlled Study Evaluating the Efficacy and Safety of Vardenafil Administration for 12 Weeks in a Flexible-dose Regimen Compared to Placebo in Men With Arterial Hypertension and Erectile Dysfunction|Completed||Phase 3|388|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:08.042188|2017-02-18 14:26:08.042188
NCT00667992|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-10-09|2010-05-12||April 2008||2008-04-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma|A Phase 3, Randomised, Open-label, Crossover Study to Compare HFA vs CFC pMDI Formulations of Budesonide on Methacholine Hyper-reactivity in Patients With Stable, Persistent, Mild to Moderate Asthma|Completed||Phase 3|99|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:26:08.143396|2017-02-18 14:26:08.143396
NCT00667979|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2009-06-29|||September 2004||2004-09-01|June 2009|2009-06-01|December 2004|Actual|2004-12-01|||||Interventional|||Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse|A Pilot, Randomized, Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy and Safety of Vardenafil Versus Placebo Administered 12, 18 and 24 Hours Prior to Initiation of Sexual Intercourse in Subjects With ED|Completed||Phase 4|264|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:08.845561|2017-02-18 14:26:08.845561
NCT00667966|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-05-05|||July 2005||2005-07-01|May 2015|2015-05-01|February 2007|Actual|2007-02-01|||||Interventional|LEMDE||Assess Efficacy in Subjects With Traumatic Spinal Cord Injury|Double-blind, Cross-over, Placebo Controlled Pilot Study to Characterize the Profile of Those Patients With Spinal Cord Injury Diagnosed by Electrophysiological, Urodynamic and Clinical (ASIA Group) Assessment Who May Respond to Vardenafil Treatment. (LEMDE)|Completed||Phase 4|45|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:08.936603|2017-02-18 14:26:08.936603
NCT00667953|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-09-23|||January 2003||2003-01-01|September 2016|2016-09-01||||March 2011|Actual|2011-03-01||Interventional|||Study of Temzolomide and Gleevec in Advanced Melanoma|Phase I/II Study of Temozolomide and Gleevec (Imatinib Mesylate, Formerly Known as STI571) in Advanced Melanoma|Active, not recruiting||Phase 1/Phase 2|56|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||f||||||||||2017-02-18 14:26:09.047568|2017-02-18 14:26:09.047568
NCT00667940|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-25|||March 2006||2006-03-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|June 2006|Actual|2006-06-01||Interventional|||Faculty Development to Improve Mini-CEX Ratings|Effect of Faculty Development on Mini-CEX Score Reliability and Accuracy: A Randomized, Controlled Trial|Completed||N/A|52|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:26:09.347598|2017-02-18 14:26:09.347598
NCT00667927|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2008-04-25|||March 1991||1991-03-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|January 1995|Actual|1995-01-01||Interventional|||Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission|Autologous Bone Marrow Transplant for Children With AML in First Complete Remission: Use of Marker Genes to Investigate the Biology of Marrow Reconstitution and the Mechanism of Relapse|Completed||Phase 1|17|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 14:26:09.457611|2017-02-18 14:26:09.457611
NCT00667914|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2016-08-19|||April 2008||2008-04-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|January 2013|Actual|2013-01-01||Interventional|||A New Clinical Pathway for Patients With Fractured Neck of Femur|A New Clinical Pathway for Patients With Fractured Neck of Femur - The Orthopedics Operate, the Geriatricians Manage the Medical Work-up|Completed||Phase 2|397|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-02-18 14:26:09.576139|2017-02-18 14:26:09.576139
NCT00667901|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2009-12-10|||February 2007||2007-02-01|December 2009|2009-12-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery|A Phase 0 Trial of Riluzole in Patients With Resectable Stage III and IV Melanoma|Terminated||Phase 1|15|Anticipated|Rutgers, The State University of New Jersey||||All enrollment, treatment, follow-up & data analysis completed|f||||t||||||||||2017-02-18 14:26:09.69649|2017-02-18 14:26:09.69649
NCT00667888|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2017-01-03|||January 2001||2001-01-01|January 2017|2017-01-01||||January 2019|Anticipated|2019-01-01||Interventional|||A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation|A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation|Active, not recruiting||Phase 3|225|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:26:09.802627|2017-02-18 14:26:09.802627
NCT00667875|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-03-17|2016-03-17||April 2008||2008-04-01|March 2016|2016-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|NALAPZ||An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence|An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence|Completed||Phase 2|60|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-02-18 14:26:09.92057|2017-02-18 14:26:09.92057
NCT00667862|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2016-11-15|||April 2008||2008-04-01|November 2016|2016-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Efficacy and Safety Study of Panobinostat in Patients With Metastatic Hormone Refractory Prostate Cancer|A Phase II, Open Label, Single Arm Study of i.v. Panobinostat (LBH589) in Patients With Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|35|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:26:10.299599|2017-02-18 14:26:10.299599
NCT00667849|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-11-04|2015-09-24||September 2008||2008-09-01|November 2015|2015-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|TRUST||Trial to Evaluate UltraSound in the Treatment of Tibial Fractures|Trial to Evaluate UltraSound in the Treatment of Tibial Fractures|Terminated||N/A|501|Actual|Bioventus LLC|Poor Compliance: Protocol defined compliance as ≥18 minutes use per day. Devices have a treatment monitor that showed average compliance of 42.3% (sham) and 44.6% (active) in 80% of treatment days. Poor treatment adherence confounds results.|2||Study was terminated due to futility|f||||t||||||||||2017-02-18 14:26:10.421976|2017-02-18 14:26:10.421976
NCT00667836|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2008-04-24|||March 2006||2006-03-01|April 2008|2008-04-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Observational|||Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients|Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients|Unknown status|Recruiting|N/A|300|Anticipated|Shriners Hospitals for Children|||1||f||||f||||||||||2017-02-18 14:26:10.928881|2017-02-18 14:26:10.928881
NCT00667823|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-11-18|||October 2008||2008-10-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|SERAPHIN OL||Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension|Long-term Single-arm Open-label Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension|Active, not recruiting||Phase 3|550|Actual|Actelion||1|||f||||t||||||||||2017-02-18 14:26:11.01901|2017-02-18 14:26:11.01901
NCT00667810|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-12-04|2013-10-22||June 2008||2008-06-01|December 2015|2015-12-01|August 2013|Actual|2013-08-01|October 2012|Actual|2012-10-01||Interventional||Safety population included all randomized participants who received at least one infusion or portion of an infusion of study drug.|Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy And Safety Trial Of Bapineuzumab (Aab-001, Eln115727) In Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E 4 Non-carriers|Terminated||Phase 3|901|Actual|Pfizer|The impact of study termination, the shorter observational periods and the resulting small sample size coupled with not having enough participants with post baseline assessments for various reasons were limiting factors for data interpretation.|3||"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical~   benefit. This decision was not based on any new safety concerns."|f||||t||||||||||2017-02-18 14:26:11.282168|2017-02-18 14:26:11.282168
NCT00667797|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-02-21|||March 2003||2003-03-01|February 2012|2012-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|POLARIS||Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects|Pharmacoeconomic Outcomes of Levalbuterol and Racemic Albuterol in Inpatients Requiring Nebulization (POLARIS)|Completed||Phase 4|486|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 14:26:13.531924|2017-02-18 14:26:13.531924
NCT00667784|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-03-29|||April 2008||2008-04-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Long Term Minor Sibling Donor Well-Being|Long Term Minor Sibling Donor Well-Being|Terminated||N/A|2|Actual|M.D. Anderson Cancer Center|||1|Slow accrual.|f||||f||||||||||2017-02-18 14:26:13.653766|2017-02-18 14:26:13.653766
NCT00667771|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2017-01-24|||April 22, 2008||2008-04-22|April 4, 2011|2011-04-04|April 4, 2011|Actual|2011-04-04|December 27, 2010|Actual|2010-12-27||Interventional|||The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion|Effect of Naltrexone on Craving and Ethanol-Induced Brain Activity|Completed||Early Phase 1|70|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:26:13.759955|2017-02-18 14:26:13.759955
NCT00662155|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2015-10-09|||July 2006||2006-07-01|February 2011|2011-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|ADER||The Role of Partial Reinforcement in the Long Term Management of Insomnia|The Role of Partial Reinforcement in the Long Term Management of Insomnia|Completed||N/A|318|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 14:28:28.325215|2017-02-18 14:28:28.325215
NCT00667758|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-08-03|||May 2008||2008-05-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|AGRA||Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis|Antagonist to Gonadotropin-Releasing Hormone in Rheumatoid Arthritis (AGRA): A Double-blind, Randomized, Placebo Controlled Trial|Completed||Phase 2|104|Actual|Betanien Hospital||2|||f||||t||||||||||2017-02-18 14:26:14.069312|2017-02-18 14:26:14.069312
NCT00667745|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2013-04-30|2012-10-25||April 2008||2008-04-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|LiTMUS||Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder|Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial|Completed||Phase 4|283|Actual|National Institute of Mental Health (NIMH)||2|||f||||t||||||||||2017-02-18 14:26:14.172756|2017-02-18 14:26:14.172756
NCT00667732|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2013-02-04|2012-12-11||March 2007||2007-03-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|MEXELIN||How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics|Metformin, Exenatide, and Glargine Insulin in Combination for Treatment of Patients With Type 2 Diabetes|Completed||Phase 4|41|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:26:14.65297|2017-02-18 14:26:14.65297
NCT00667719|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-11-15|||June 2008||2008-06-01|November 2012|2012-11-01||||October 2009|Actual|2009-10-01||Interventional|||A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Patients With Essential Hypertension|A 28 to 54-week, Open-label, Multicenter Study to Assess the Long-term Safety and Tolerability of the Combination of Aliskiren / Amlodipine / Hydrochlorothiazide in Patients With Essential Hypertension|Completed||Phase 3|564|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:26:15.290094|2017-02-18 14:26:15.290094
NCT00667706|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-04-25|||April 2008||2008-04-01|April 2008|2008-04-01||||April 2013|Anticipated|2013-04-01||Interventional|||Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy|Prospective Randomized Study of Effects of Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 14:26:15.402473|2017-02-18 14:26:15.402473
NCT00667693|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-09-13|2016-07-18||February 2008||2008-02-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pentax Airway Scope (AWS) Intubation|Pentax AWS Intubation Study|Completed||N/A|101|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 14:26:15.492503|2017-02-18 14:26:15.492503
NCT00667680|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2009-11-13|||March 2007||2007-03-01|November 2009|2009-11-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant Depression|Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant Depression - Effect on Clinical and Neurophysiological Parameters|Completed||Phase 2|20|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-02-18 14:26:15.941673|2017-02-18 14:26:15.941673
NCT00667667|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-05-27|||April 2008||2008-04-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Whole Body Vibration on Postmenopausal Risk-factors in Elderly Women|Effect of Whole Body Vibration Training on Two Different Devices on Osteoporotic Risk Factors in Postmenopausal Women. A Randomized Controlled Trial.|Terminated||Phase 3|108|Actual|University of Erlangen-Nürnberg Medical School||3|||f||||f||||||||||2017-02-18 14:26:16.043602|2017-02-18 14:26:16.043602
NCT00667654|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2016-12-05||2016-10-11|August 2007||2007-08-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Tolerability of 4975 in the Treatment of Moderate to Severe Knee Pain Due to Osteoarthritis (OA)|A Phase 2, Open-label Study to Evaluate Safety and Tolerability, and to Explore the Efficacy, of Dosing Regimens of Intraarticular 4975 in Patients With Chronic Moderate to Severe Pain of the Knee Associated With Osteoarthritis|Completed||Phase 2|54|Actual|Centrexion Therapeutics||5|||f||||f||||||||||2017-02-18 14:26:16.154357|2017-02-18 14:26:16.154357
NCT00667641|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2011-05-09|||March 2007||2007-03-01|May 2011|2011-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors|Phase I Study of Paclitaxel (Taxol) and Bortezomib (Velcade) in Patients With Refractory Solid Tumor Malignancies Involving an Activated MAPK Pathway|Completed||Phase 1|16|Actual|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-02-18 14:26:16.268579|2017-02-18 14:26:16.268579
NCT00667628|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2013-06-04||2013-06-04|April 2008||2008-04-01|June 2013|2013-06-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of TAC-101 in Combination With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma|Terminated||Phase 2|52|Actual|Taiho Oncology, Inc.||2||Terminated due to safety concerns.|f||||f||||||||||2017-02-18 14:26:16.392101|2017-02-18 14:26:16.392101
NCT00667615|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-03-07|||April 2008||2008-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)|A Multi-Center Phase I/II Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)|Active, not recruiting||Phase 1/Phase 2|59|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:26:16.524922|2017-02-18 14:26:16.524922
NCT00667602|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2013-09-03|2013-02-18||March 2008||2008-03-01|September 2013|2013-09-01|October 2010|Actual|2010-10-01|July 2009|Actual|2009-07-01||Interventional||As one site has been excluded, the number of subjects included in the analysis are MenACWY-CRM197 (2dose) + Concomitant Vaccines N= 196, MenACWY-CRM197 (1dose) + Concomitant Vaccines N= 205 and MenC (1dose) + Concomitant Vaccines N= 193|Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers|A Phase 3, Open-Label, Randomized, Multi-Center Study to Evaluate the Safety and Immunogenicity After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infants and Toddlers|Completed||Phase 3|662|Actual|Novartis|GCP compliance issues were identified at one site, data collected for this site were not used in this data posting.|3|||f||||||||||||||2017-02-18 14:26:16.656891|2017-02-18 14:26:16.656891
NCT00667589|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2013-05-28|2013-02-26||June 2008||2008-06-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Sorafenib-induced Hand- Foot Skin Reaction Treatment|Four-arm Study to Evaluate Urea 40% Cream, Fluocinonide 0.05% Cream, Tazarotene 0.1% Cream, and an Emollient Cream for the Treatment of Hand-foot Skin Reaction Related to the Use of Multi-targeted Tyrosine Kinase Inhibitor Sorafenib.|Terminated||Phase 2|6|Actual|Northwestern University||4||Study was halted due to poor subject accrual.|f||||f||||||||||2017-02-18 14:26:18.185931|2017-02-18 14:26:18.185931
NCT00667576|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-01-18|2010-03-18||April 2008||2008-04-01|January 2012|2012-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis|Late Phase 2 Study of Paricalcitol Injection: Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism (Examination of Initial Dose and Incremental Dose)|Completed||Phase 2|153|Actual|Abbott|Different PTH thresholds were applied for suspending study drug: paricalcitol groups <60 pg/mL, maxacalcitol group ≤150 pg/mL. This study was not statistically powered to compare treatments.|5|||f||||f||||||||||2017-02-18 14:26:18.709707|2017-02-18 14:26:18.709707
NCT00667563|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2016-02-01|2014-01-23||August 2009||2009-08-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||Enrolled in study|Vaccine Therapy in Preventing HPV in HIV-Positive Women in India|A Single-Arm, Open-Label Pilot Study of the Safety and Immunogenicity of the Merck Quadrivalent Human Papillomavirus Vaccine Among HIV-Positive Women in India|Completed||Phase 1|150|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-02-18 14:26:19.819108|2017-02-18 14:26:19.819108
NCT00667550|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2010-07-13|||March 2008||2008-03-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Lower Urinary Tract and Sexual Function in Women Following Surgery for Colorectal Disorders|Lower Urinary Tract and Sexual Function in Women Following Surgery for Colorectal Disorders|Completed||N/A|34|Actual|University of California, Irvine|||1||f||||t||||||||||2017-02-18 14:26:20.120894|2017-02-18 14:26:20.120894
NCT00667537|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-12-11|||July 2007||2007-07-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||PK in Pts With HRPC & Skeletal Metastes|A Phase I, Open-label, Dosimetry, Biodistribution and Pharmacokinetic Study of Alpharadin™ in Patients With Hormone Refractory Prostate Cancer and Skeletal Metastases|Completed||Phase 1|6|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:26:20.207006|2017-02-18 14:26:20.207006
NCT00667524|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2009-12-24|||February 2008||2008-02-01|December 2009|2009-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation|Eosinophilic Esophagitis: Influence of Esophageal Dilation on the Underlying Inflammation and Efficacy/Safety of the Procedure|Completed||N/A|207|Actual|University of Bern|||1||f||||f||||||Samples Without DNA|"~     formalin-fixed esophageal biopsies (blinded review of histology slides)~   "|||2017-02-18 14:26:20.306496|2017-02-18 14:26:20.306496
NCT00667511|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-01-12|2014-12-22||April 2008||2008-04-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional||58 patients were enrolled in the cross-over study. Patients were required to complete the home short daily hemodialysis phase before transitioning to the home nocturnal hemodialysis phase.|Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™|Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™|Completed||N/A|58|Actual|NxStage Medical||2|||f||||t||||||||||2017-02-18 14:26:20.415734|2017-02-18 14:26:20.415734
NCT00667498|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2009-02-16|||March 2004||2004-03-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance|Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance|Completed||Phase 4|28|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:26:20.679406|2017-02-18 14:26:20.679406
NCT00667485|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-01-16|||April 2008||2008-04-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Rapamycin Plus Bevacizumab in Advanced Cancers|A Phase I Study of Rapamycin (Sirolimus) With Bevacizumab in Patients With Advanced Malignancies|Completed||Phase 1|28|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 14:26:20.877765|2017-02-18 14:26:20.877765
NCT00667472|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2017-02-08|||March 2008||2008-03-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks|Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks|Withdrawn||Phase 1|0|Actual|University of California, Irvine||2||No participants enrolled|f||||t||||||||||2017-02-18 14:26:20.981547|2017-02-18 14:26:20.981547
NCT00667459|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-01-22|2014-08-22||January 2005||2005-01-01|January 2015|2015-01-01|June 2014|Actual|2014-06-01|January 2008|Actual|2008-01-01||Interventional|||Study of Safety & Effectiveness of PRESTIGE® LP Cervical Disc vs. Anterior Cervical Fusion in Cervical DDD|A Prospective, Multicenter, Controlled Clinical Trial of an Artificial Cervical Disc LP at a Single Level for Symptomatic Cervical Disc Disease|Completed||Phase 3|280|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-02-18 14:26:21.096068|2017-02-18 14:26:21.096068
NCT00667446|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-01-08|2013-10-16||December 2008||2008-12-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional||Participants who received at least 1 dose of study drug in this extension study.|Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty|A 36 Month, Multi-Center, Open-Label Extension Study to Evaluate the Safety of Leuprolide Acetate 11.25 mg and 30 mg Formulations in Children With Central Precocious Puberty|Completed||Phase 3|72|Actual|AbbVie||2|||f||||f||||||||||2017-02-18 14:26:22.845971|2017-02-18 14:26:22.845971
NCT00667433|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2013-09-03|||June 2008||2008-06-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|REAL||Raltegravir as Early Therapy in African-Americans Living With HIV Study|CID 0706 - Safety, Tolerability, Pharmacokinetic, and Metabolic Features of Raltegravir Among African-American Men and Women With HIV Infection|Completed||Phase 4|43|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 14:26:23.499091|2017-02-18 14:26:23.499091
NCT00667043|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-04-25|||April 2008||2008-04-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|Cool Sedation||Remifentanil and Propofol Versus Fentanyl and Midazolam for Sedation During Therapeutic Hypothermia. A Randomised, Controlled Trial|Remifentanil and Propofol Versus Fentanyl and Midazolam for Sedation During Therapeutic Hypothermia. A Randomised, Controlled Trial|Completed||Phase 4|60|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 14:26:34.448488|2017-02-18 14:26:34.448488
NCT00667420|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-07-03|2014-06-27||April 2008||2008-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|June 2011|Actual|2011-06-01||Interventional|EOXP|17 patients with adenocarcinoma of the stomach were enrolled on this study of perioperative EOX-P.|Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma|A Pilot Study of Perioperative Panitumumab in Combination With Epirubicin, Oxaliplatin and Xeloda in Patients With Resectable Gastroesophageal Adenocarcinoma|Terminated||Phase 1/Phase 2|17|Actual|Massachusetts General Hospital|This study was stopped early due to poor tolerability. We will not further study this regimen in this patient population.|1||Closed due to slow accrual|f||||f||||||||||2017-02-18 14:26:23.612016|2017-02-18 14:26:23.612016
NCT00667407|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-02-21|||November 2000||2000-11-01|February 2012|2012-02-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma|A Randomized, Double-Blind Study to Determine the Efficacy of Levalbuterol Versus Racemic Albuterol in the Treatment of Acute Asthma|Completed||Phase 3|627|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 14:26:23.909171|2017-02-18 14:26:23.909171
NCT00667394|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2015-10-13|2012-07-30||April 2008||2008-04-01|October 2015|2015-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors|A Phase 2 Trial of Tandutinib in Combination With Bevacizumab for Patients With Recurrent High-Grade Gliomas|Completed||Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 14:26:24.36444|2017-02-18 14:26:24.36444
NCT00667381|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2010-10-19|2010-09-27||April 2008||2008-04-01|October 2010|2010-10-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|FAUST||Femoral Arterial Access With Ultrasound Trial|Femoral Arterial Access With Ultrasound Trial|Completed||N/A|1014|Actual|University of California, Irvine||2|||f||||f||||||||||2017-02-18 14:26:25.107144|2017-02-18 14:26:25.107144
NCT00667368|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-11-05|2015-09-24||July 2008||2008-07-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All randomized participants|Bacterial Vaginosis Home Screening to Prevent STDs|Home Screening for Bacterial Vaginosis to Prevent STDs|Completed||Phase 3|1370|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 14:26:25.705211|2017-02-18 14:26:25.705211
NCT00667355|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-01-24|2010-05-28||February 2008||2008-02-01|January 2012|2012-01-01|January 2011|Actual|2011-01-01|May 2009|Actual|2009-05-01||Interventional|||A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis|A Multi-Center, Open-Label Efficacy, Safety, and Pharmacokinetic Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis|Completed||Phase 3|41|Actual|Abbott||1|||f||||f||||||||||2017-02-18 14:26:26.283756|2017-02-18 14:26:26.283756
NCT00667342|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-10-17|2014-06-09||May 2008||2008-05-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|May 2014|Actual|2014-05-01||Interventional||Participants were eligible if they were ≤30 years of age on date of diagnostic biopsy confirmation of high-grade osteosarcoma or malignant fibrous histiocytoma (MFH) of bone. Participants had no previous chemotherapy or radiation therapy.|A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma|A Study of Bevacizumab, a Humanized Monoclonal Antibody Against Vascular Endothelial Growth Factor (VEGF), in Combination With Chemotherapy for Treatment of Osteosarcoma|Active, not recruiting||Phase 2|43|Actual|St. Jude Children's Research Hospital|Accrual to this study was stopped early after 4.5 years due to slow accrual of participants. No eligible participants were enrolled on Stratum B. All enrolled participants continue on study and results will be reported when available.|3|||f||||t||||||||||2017-02-18 14:26:26.920753|2017-02-18 14:26:26.920753
NCT00667329|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-09-12|||July 1999||1999-07-01|September 2016|2016-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab|Primary Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab|Active, not recruiting||N/A|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:26:27.791156|2017-02-18 14:26:27.791156
NCT00667316|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-03-11|||February 2008||2008-02-01|March 2014|2014-03-01|September 2014|Anticipated|2014-09-01|May 2014|Anticipated|2014-05-01||Observational|||The Influence of Different Factors on Workers' Disability Due to Low Back Pain|Study to Identify the Influence of Different Factors on Workers' Disability Due to Low Back Pain|Unknown status|Recruiting|N/A|7200|Anticipated|Kovacs Foundation|||1||f||||t||||||||||2017-02-18 14:26:27.912393|2017-02-18 14:26:27.912393
NCT00667303|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-09-06|||December 2007||2007-12-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Observational|||Prospective Surveillance For Respiratory Virus Infections In Children Undergoing Hematopoietic Stem Cell Transplantation|Prospective Surveillance For Respiratory Virus Infections In Children Undergoing Hematopoietic Stem Cell Transplantation|Completed||N/A|51|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||Samples Without DNA|"~     Nasopharyngeal washes Fluorescent antibody detection Respiratory viral culture~   "|||2017-02-18 14:26:28.016145|2017-02-18 14:26:28.016145
NCT00667290|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2008-04-24|||July 2000||2000-07-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Exercise for Elderly Peripheral Revascularized Patients|Exercise for Elderly Peripheral Revascularized Patients|Completed||N/A|80|Actual|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 14:26:28.136882|2017-02-18 14:26:28.136882
NCT00667277|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-08-08|2014-04-11||March 2008||2008-03-01|August 2014|2014-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis|Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis|Terminated||Phase 2|13|Actual|Icahn School of Medicine at Mount Sinai|The study was terminated due to lack of response activity in the setting of an unacceptable toxicity profile at the completion of the first stage.|1||lack of response activity in the setting of an unacceptable toxicity profile|f||||t||||||||||2017-02-18 14:26:28.25446|2017-02-18 14:26:28.25446
NCT00667264|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-06-26|||October 2008||2008-10-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Interventional|||Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain|Ambulatory Continuous Peripheral Nerve Blocks for Treatment of Post-Amputation Phantom Limb and Stump Pain|Completed||N/A|7|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 14:26:28.525861|2017-02-18 14:26:28.525861
NCT00667251|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-25|2016-03-22|2013-09-24||October 2008||2008-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|August 2012|Actual|2012-08-01||Interventional|||Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer|A Randomized, Open-Label, Phase III Study of Taxane Based Chemotherapy With Lapatinib or Trastuzumab as First-Line Therapy for Women With HER2/Neu Positive Metastatic Breast Cancer|Active, not recruiting||Phase 3|652|Actual|Novartis||2|||f||||t||||||||||2017-02-18 14:26:28.647959|2017-02-18 14:26:28.647959
NCT00667225|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2011-06-16|2011-04-28||January 2008||2008-01-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of Cantharidin in Molluscum Contagiosum|Efficacy of Cantharidin in Molluscum Contagiosum: A Randomized, Blinded, Placebo-Controlled Prospective Study|Completed||N/A|29|Actual|University of North Carolina, Chapel Hill|Small sample size and random disproportionate assignment to the vehicle group. Other limitations include short duration of follow up and interval between treatments. Finally, matching subjects in each group with comparable lesion counts.|2|||f||||f||||||||||2017-02-18 14:26:31.505793|2017-02-18 14:26:31.505793
NCT00667212|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2013-06-11|||August 2006||2006-08-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Psychotherapy for Intermittent Explosive Disorder|Individual Cognitive Behavioral Psychotherapy for Intermittent Explosive Disorder|Completed||Phase 2|60|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 14:26:31.922374|2017-02-18 14:26:31.922374
NCT00667199|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-06-24|||May 2005||2005-05-01|June 2014|2014-06-01|October 2009|Actual|2009-10-01|April 2008|Actual|2008-04-01||Interventional|||BAY88-8223, Does Response Study in HRPC Patients|A Double Blind, Dose Response Phase II, Multicentre Study of Radium 223 (Alpharadin®) for the Palliation of Painful Bone Metastases in Hormone Refractory Prostate Cancer Patients|Completed||Phase 2|100|Actual|Bayer||4|||f||||f||||||||||2017-02-18 14:26:32.046259|2017-02-18 14:26:32.046259
NCT00667186|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-01-30|2012-10-29||January 2008||2008-01-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||HIV Screening in the Emergency Department Setting|HIV Screening in the Emergency Department Setting|Completed||N/A|9572|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 14:26:32.176598|2017-02-18 14:26:32.176598
NCT00667173|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-02-16||2010-09-02|November 2007||2007-11-01|February 2012|2012-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea|A Phase 2, Multi-Center, Evaluator-Blind, Randomized, Vehicle-Controlled Clinical Study to Assess the Safety and Efficacy of IDP-115 in the Treatment of Rosacea|Completed||Phase 2|140|Actual|Dow Pharmaceutical Sciences||3|||f||||f||||||||||2017-02-18 14:26:32.508705|2017-02-18 14:26:32.508705
NCT00667160|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-09-17|||December 2002||2002-12-01|September 2014|2014-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis|A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Pediatric Patients With Mild Atopic Dermatitis|Completed||Phase 4|426|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:26:32.609608|2017-02-18 14:26:32.609608
NCT00667147|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-11-18|||March 2008||2008-03-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|May 2012|Actual|2012-05-01||Interventional|||Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib|Phase I Trial of Abraxane Administered on a Weekly and Three Weekly Schedule in Combination With Vandetanib|Completed||Phase 1|65|Actual|University of Southern California||2|||f||||f||||||||||2017-02-18 14:26:32.755974|2017-02-18 14:26:32.755974
NCT00667134|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2016-10-24|||March 2008||2008-03-01|October 2016|2016-10-01|February 2012|Actual|2012-02-01|August 2008|Actual|2008-08-01||Observational|||Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis|Stimulatory Autoantibodies to the PDGFR and Phosphorylation of the PDGFR in Patients With Systemic Sclerosis|Completed||N/A|26|Actual|University of Michigan|||3||f||||f||||||Samples Without DNA|"~     skin serum~   "|||2017-02-18 14:26:32.850449|2017-02-18 14:26:32.850449
NCT00667121|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-10-10|||March 2008||2008-03-01|January 2016|2016-01-01||||May 2017|Anticipated|2017-05-01||Observational|||Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline|The Effect of Antidepressants and Gabapentin on Tamoxifen Pharmacokinetics: A Prospective Study|Active, not recruiting||N/A|85|Anticipated|Mayo Clinic|||1||f||||t||||||||||2017-02-18 14:26:32.954484|2017-02-18 14:26:32.954484
NCT00667108|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||October 2004||2004-10-01|April 2008|2008-04-01|January 2005|Actual|2005-01-01|||||Interventional|||A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance|A Randomized, Double-Blind, Single-Dose, Placebo-Controlled, Multicenter Study of Gabapentin 250 mg and 500 mg in Transient Insomnia Induced by a Sleep Phase Advance|Completed||Phase 3|784|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:26:33.061784|2017-02-18 14:26:33.061784
NCT00667095|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-07-10|2014-05-09||April 2008||2008-04-01|July 2014|2014-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Over Active Bladder Instillation Study - Botox|Evaluation of the Efficacy of Botulinum-A Toxin/DMSO Instillation in the Treatment of Women With Over Active Bladder (OAB) Syndrome and/or Urinary Urge Incontinence|Terminated||Phase 3|25|Actual|Mayo Clinic||2||Study terminated early due to PI's extended medical leave.|f||||t||||||||||2017-02-18 14:26:33.27346|2017-02-18 14:26:33.27346
NCT00667082|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-09-29|||March 2008||2008-03-01|September 2016|2016-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma|NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma|Completed||Phase 1|22|Actual|Triphase Research and Development I Corporation||1|||f||||f||||||||Undecided||2017-02-18 14:26:34.073662|2017-02-18 14:26:34.073662
NCT00667069|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2009-02-06|||December 2007||2007-12-01|April 2008|2008-04-01||||December 2022|Anticipated|2022-12-01||Interventional|||Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer|Randomized, Multicenter Study Comparing the Immediate Adjuvant Radiotherapy Associate With Hormonal Therapy of LH-RH Analogue (Decapeptyl® LP) vs Delayed Radiotherapy Until Biochemical Relapse Associated With Hormonal Therapy of LH-RH Analogue (Decapeptyl® LP) in Patients With Operable Prostate Cancer pT3 R1 pN0 or pNx at Intermediate Risk.|Recruiting||Phase 3|718|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:26:34.182832|2017-02-18 14:26:34.182832
NCT00667056|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-09-17|||July 2004||2004-07-01|September 2014|2014-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis|A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Trial to Assess the Safety and Efficacy of 0.1% Tacrolimus Ointment in the Treatment of Chronic Allergic Contact Dermatitis|Completed||Phase 4|98|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:26:34.329705|2017-02-18 14:26:34.329705
NCT00667030|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2013-01-15|||July 2005||2005-07-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|ALIVE||Aging, Lifestyle and Inflammation in Veterans Exercising|Aging, Lifestyle and Inflammation in Veterans Exercising|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of Maryland||1|||f||||t||||||||||2017-02-18 14:26:34.555825|2017-02-18 14:26:34.555825
NCT00667017|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2010-02-04|||July 2008||2008-07-01|February 2010|2010-02-01||||February 2010|Actual|2010-02-01||Interventional|||RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma|Phase II Study of IMTOX25 in Relapsed/Refractory Cutaneous T-Cell Lymphoma|Completed||Phase 2|29|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 14:26:34.661149|2017-02-18 14:26:34.661149
NCT00667004|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2013-01-03||2011-09-02|April 2008||2008-04-01|January 2013|2013-01-01||||December 2008|Actual|2008-12-01||Interventional|||Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease||Completed||Phase 2|183|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:26:34.771879|2017-02-18 14:26:34.771879
NCT00666991|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-02-26|||July 2008||2008-07-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers|A Phase 1 Study of Intraperitoneal Nanoparticle Paclitaxel in Patients With Peritoneal Malignancies|Completed||Phase 1|22|Actual|CritiTech, Inc.||6|||f||||t||||||||||2017-02-18 14:26:34.883233|2017-02-18 14:26:34.883233
NCT00666978|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2012-10-08|||December 2007||2007-12-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking|Enhancing Tobacco Use Treatment for African American Light Smokers|Completed||N/A|540|Actual|University of Kansas Medical Center|||3||f||||f||||||||||2017-02-18 14:26:34.998181|2017-02-18 14:26:34.998181
NCT00666965|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-03-26|2014-02-03||June 2008||2008-06-01|March 2014|2014-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||3 subjects (1 for each placebo, 4.5 mg/day and 6.75 mg/day arm) were excluded by criteria|A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients|A Placebo-Controlled Study for SPM 962 in RLS Patients|Completed||Phase 2|230|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-02-18 14:26:35.124612|2017-02-18 14:26:35.124612
NCT00666952|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-09-10|||May 2008||2008-05-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|POINT of View||Study Testing Patient Decision Tools Related to the Risks and Benefits of Weight Loss Surgery|Randomized Trial of a Patient Decision Aid for Bariatric Surgery|Completed||N/A|150|Anticipated|Group Health Cooperative||2|||f||||f||||||||||2017-02-18 14:26:38.350984|2017-02-18 14:26:38.350984
NCT00666939|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||October 2004||2004-10-01|April 2008|2008-04-01|January 2005|Actual|2005-01-01|||||Interventional|||A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance|A Randomized, Double-Blind, Single-Dose, Placebo-Controlled, Multicenter Study Of Gabapentin 100 mg and 250 mg in Transient Insomnia Induced By A Sleep Phase Advance|Completed||Phase 3|773|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:26:38.4586|2017-02-18 14:26:38.4586
NCT00666926|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2013-03-14|2012-05-11||December 2005||2005-12-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms|A Phase 1, Open-Label, Dose Escalation Study To Evaluate Safety, Pharmacokinetics And Pharmacodynamics Of PF-00562271 In Patients With Advanced Non-Hematologic Malignancies|Completed||Phase 1|99|Actual|Verastem, Inc.|PET and RECIST Response Analysis Sets as defined in Protocol Amendment 3 dated 20Mar2007 are reported in Basic Results per the revised definitions in Statistical Analysis Plan version 2 dated 11Apr2008.|4|||f||||f||||||||||2017-02-18 14:26:40.927732|2017-02-18 14:26:40.927732
NCT00666913|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2015-09-28|||October 2007||2007-10-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Menopausal Symptoms in Women With Breast Cancer or At High Risk of Breast Cancer Treated on Another Clinical Trial|Menopausal Symptoms in Women With Breast Cancer|Completed||N/A|183|Actual|Case Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 14:26:46.365543|2017-02-18 14:26:46.365543
NCT00666900|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-02-16||2010-09-15|January 2008||2008-01-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris|A Phase 2, Multicenter, Randomized, Double-Blind, Dose-Ranging Study to Evaluate IDP-107 Versus Placebo in the Treatment of Severe Acne Vulgaris With Nodules|Completed||Phase 2|366|Actual|Dow Pharmaceutical Sciences||3|||f||||f||||||||||2017-02-18 14:26:46.461036|2017-02-18 14:26:46.461036
NCT00666887|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2015-07-13|||January 2009||2009-01-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|December 2014|Actual|2014-12-01||Interventional|MinoCIS||Minocycline in Clinically Isolated Syndromes (CIS)|A Phase III Double-blind, Randomized, Placebo-controlled Trial of Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)|Completed||Phase 3|142|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 14:26:46.57417|2017-02-18 14:26:46.57417
NCT00666874|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||February 1999||1999-02-01|April 2008|2008-04-01|February 2002|Actual|2002-02-01|December 2001|Actual|2001-12-01||Interventional|||Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women|Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women|Completed||N/A|120|Actual|Second University of Naples||2|||f||||f||||||||||2017-02-18 14:26:46.688101|2017-02-18 14:26:46.688101
NCT00666861|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-07-28|||April 2008||2008-04-01|July 2009|2009-07-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Observational|||Type 2 Diabetes and Exercise - A Pilot Study|Understanding the Acute Effects of Prolonged Sedentary Behaviour (Sitting) on Post-meal Glucose and Lipids - A Pilot Study|Terminated||N/A|2|Actual|Bayside Health|||1|Pilot study superseded by a larger NHMRC funded trial|f||||f||||||Samples Without DNA|"~     Plasma samples~   "|||2017-02-18 14:26:46.792829|2017-02-18 14:26:46.792829
NCT00666848|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-04-12|2011-09-04||March 2008||2008-03-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome|Effect of Sitagliptin on the Blood Pressure Response to ACE Inhibition in the Metabolic Syndrome|Completed||Phase 4|24|Actual|Vanderbilt University||3|||f||||f||||||||||2017-02-18 14:26:46.873925|2017-02-18 14:26:46.873925
NCT00665548|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2009-04-16|||March 2008||2008-03-01|March 2008|2008-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Weight-Bearing Magnetic Resonance Imaging (MRI) for Analysis of Knee Osteoarthritis (OA)|Weight-Bearing MRI for Analysis of Knee OA|Completed||N/A|33|Anticipated|University of California, San Francisco|||2||f||||||||||||||2017-02-18 14:27:21.413098|2017-02-18 14:27:21.413098
NCT00666835|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2016-10-21|||April 2004||2004-04-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study to Evaluate the Efficacy and Safety of HX 575 vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients|Randomized, Double-blind, Multicenter, Parallel-group, Equivalence Study to Evaluate the Efficacy and Safety of HX 575 vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients|Completed||Phase 3|462|Actual|Sandoz||2|||f||||f||||||||No||2017-02-18 14:26:47.551173|2017-02-18 14:26:47.551173
NCT00666822|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-02-04|||December 2007||2007-12-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|September 2009|Actual|2009-09-01||Observational|||Compliance to a Hormone Therapy Regimen in Breast Cancer|Adherence to Endocrine Therapy in Women With Breast Cancer in Clinical Practice Settings|Completed||N/A|178|Actual|Case Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 14:26:47.71971|2017-02-18 14:26:47.71971
NCT00666809|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-12-08|||October 2006||2006-10-01|December 2014|2014-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Vardenafil in Tinnitus|Evaluation of Vardenafil for the Treatment of Subjective Tinnitus: A Controlled Pilot Study|Completed||Phase 2|43|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:26:47.810675|2017-02-18 14:26:47.810675
NCT00666796|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||April 2005||2005-04-01|April 2008|2008-04-01|May 2005|Actual|2005-05-01|||||Interventional|||A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy Subjects|A Randomized, Double-Blind, 4-Way Crossover, Placebo-Controlled, Single Center Trial to Evaluate the Potential Pharmacodynamic Interaction Between Gabapentin 500 mg and Ethanol in Healthy Volunteers|Completed||Phase 4|20|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:26:47.91825|2017-02-18 14:26:47.91825
NCT00666783|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-24||||||August 2006|2006-08-01||||||||Interventional|||An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients|A Phase II, Multicenter,Double-Blind, Randomized Trial of Palonosetron Compared With Granisetron in Preventing Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in the Chinese Cancer Patients|Completed||Phase 2|208|Actual|Xijing Hospital||2|||f||||||||||||||2017-02-18 14:26:48.025286|2017-02-18 14:26:48.025286
NCT00666770|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||October 2004||2004-10-01|April 2008|2008-04-01|November 2004|Actual|2004-11-01|||||Interventional|||A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance|A Randomized, Double-Blind, Single-Dose, Placebo-Controlled, Multicenter, Polysomnographic Study of Gabapentin 250 mg and 500 mg in Transient Insomnia Induced by a Sleep Phase Advance|Completed||Phase 3|309|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:26:48.111857|2017-02-18 14:26:48.111857
NCT00666757|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2010-05-12|2010-02-16||May 2008||2008-05-01|May 2010|2010-05-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|TRY FIRST||A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression|TRY FIRST: A 12-Week, Randomized, Open-Label Trial of Duloxetine Versus Generic SSRIs in the Treatment of a Severe Depressive Episode|Completed||Phase 4|750|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-02-18 14:26:48.242724|2017-02-18 14:26:48.242724
NCT00666744|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-10-28|||April 2008||2008-04-01|April 2008|2008-04-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|FAME||A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke|A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke|Unknown status|Recruiting|Phase 3|40|Anticipated|University of Dublin, Trinity College||2|||f||||f||||||||||2017-02-18 14:26:50.109088|2017-02-18 14:26:50.109088
NCT00666731|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-11-02|||October 2006||2006-10-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|BCCR||Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer|Development and Implementation of The Breast Cancer Collaborative Registry (BCCR)|Recruiting||N/A|999999|Anticipated|University of Nebraska|||1||f||||f||||||Samples With DNA|"~     Tissue, blood~   "|Yes|Collaborating centers may ask other centers to participate in future studies. Only shared among centers belonging to the BCCR|2017-02-18 14:26:50.238003|2017-02-18 14:26:50.238003
NCT00666718|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2011-05-11|2011-02-18||April 2008||2008-04-01|May 2011|2011-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients|A Prospective Randomized Trial to Compare Basal Bolus Therapies That Use Either Insulin Lispro Protamine Suspension or Insulin Glargine Together With Lispro Insulin in Patients With Type 2 Diabetes|Completed||Phase 3|374|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:26:50.528343|2017-02-18 14:26:50.528343
NCT00666705|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2013-01-16|2009-03-05||February 2008||2008-02-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects|An Open Label Phase 4 Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects|Completed||Phase 4|18|Actual|ViiV Healthcare||3|||f||||f||||||||||2017-02-18 14:26:51.865021|2017-02-18 14:26:51.865021
NCT00666692|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-04-25|||April 2008||2008-04-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)|Phase 1b Trial Evaluating the Safety of Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in Subjects With Previously Untreated Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|7|Actual|Abbott||1|||f||||t||||||||||2017-02-18 14:26:52.381489|2017-02-18 14:26:52.381489
NCT00666679|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2015-04-23|2010-01-07||May 2008||2008-05-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)|Randomized, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma|Completed||Phase 2|134|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:26:52.500304|2017-02-18 14:26:52.500304
NCT00666666|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-12-17|2013-10-08||July 2009||2009-07-01|August 2014|2014-08-01|June 2012|Actual|2012-06-01|May 2011|Actual|2011-05-01||Interventional|||R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer|A Phase II Study of AT101, to Abrogate BCL-2 Mediated Resistance to Androgen Ablation Therapy in Patients With Newly Diagnosed Stage D2 Prostate Cancer|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 14:26:53.125634|2017-02-18 14:26:53.125634
NCT00666653|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-24|||July 2003||2003-07-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|DALI||Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease|Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease: a Double-Blind Placebo Controlled Crossover Study|Completed||Phase 1|13|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:26:53.564659|2017-02-18 14:26:53.564659
NCT00666640|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-09-18|||May 2008||2008-05-01|September 2014|2014-09-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|3DScans||3D Imaging of the Hip Using DXA|Parameters Derived From DXA-based Structural Engineering Models of the Proximal Femur as a Biomarker for Hip Fracture Prediction.|Completed||N/A|100|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||2||f||||f||||||||||2017-02-18 14:26:53.668146|2017-02-18 14:26:53.668146
NCT00666627|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-06-14|||April 2007||2007-04-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|September 2012|Anticipated|2012-09-01||Interventional|||Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects|A 2-year Randomised Parallel Group Trial of Alendronate, Ibandronate and Risedronate for Postmenopausal Osteoporosis in Secondary Care.|Unknown status|Active, not recruiting|Phase 2|410|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||4|||f||||t||||||||||2017-02-18 14:26:53.76783|2017-02-18 14:26:53.76783
NCT00666614|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-01-03|||April 2008||2008-04-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Pilot Study to Examine Sleep and Fatigue in Pediatric Brain Tumor Patients Hospitalized for High Dose Chemotherapy|A Pilot Study to Examine Sleep and Fatigue in Pediatric Brain Tumor Patients Hospitalized for High Dose Chemotherapy|Completed||N/A|43|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-02-18 14:26:53.893158|2017-02-18 14:26:53.893158
NCT00666601|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2016-04-27|||April 2008||2008-04-01|April 2016|2016-04-01|March 2009|Actual|2009-03-01|June 2008|Actual|2008-06-01||Interventional|||Microdialysis and Pharmacokinetic Study of TR-701|An Open Label, Single Dose, Microdialysis and Pharmacokinetic Study of TR-701 in Normal Healthy Adults|Completed||Phase 1|15|Actual|Trius Therapeutics LLC||2|||f||||f||||||||||2017-02-18 14:26:54.005114|2017-02-18 14:26:54.005114
NCT00666588|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-05-13|2013-12-18||April 2008||2008-04-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia|A Phase II Pilot Study of Bortezomib (PS-341, Velcade) Combined With Reinduction Chemotherapy in Children and Young Adults With Recurrent, Refractory or Secondary Acute Myeloid Leukemia|Completed||Phase 2|52|Actual|National Cancer Institute (NCI)||4|||f||||t||||||||||2017-02-18 14:26:54.113539|2017-02-18 14:26:54.113539
NCT00666575|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||December 2004||2004-12-01|April 2008|2008-04-01|May 2005|Actual|2005-05-01|||||Interventional|||A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Actual Use Study of the Safety and Tolerability of Gabapentin 500 mg in a Potential OTC Population|Completed||Phase 3|2105|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 14:26:55.570283|2017-02-18 14:26:55.570283
NCT00666562|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2016-11-22|2016-01-20||July 2008||2008-07-01|November 2016|2016-11-01||||April 2012|Actual|2012-04-01||Interventional|||Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer|A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG|Active, not recruiting||Phase 2|31|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 14:26:55.692677|2017-02-18 14:26:55.692677
NCT00666549|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2016-08-03|||September 2007||2007-09-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Research Tissue Bank|Research Tissue Bank|Recruiting||N/A|400|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||Samples With DNA|"~     Blood, bone marrow, bone marrow biopsy, toenail clippings, phlebotomized blood, spleen cells~   "|||2017-02-18 14:26:57.037308|2017-02-18 14:26:57.037308
NCT00666536|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2016-09-20|2010-11-16||March 2008||2008-03-01|April 2011|2011-04-01||||January 2009|Actual|2009-01-01||Interventional|EXTRA||The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy|A Multicenter, Randomized, Double Blind, Parallel Design Trial to Evaluate the Blood Pressure Lowering Efficacy Comparing Moderate Versus Aggressive Treatment Regimen of Valsartan + Amlodipine in Patients Uncontrolled on ARB Monotherapy|Completed||Phase 4|728|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:26:57.146527|2017-02-18 14:26:57.146527
NCT00666523|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||January 2007||2007-01-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Phytalgic in Osteoarthritis (OA)|Randomized Double-Blind Study of Food Supplement Phytalgic on Symptoms of Osteoarthritis|Completed||N/A|81|Actual|Université Victor Segalen Bordeaux 2||2|||f||||f||||||||||2017-02-18 14:26:57.663769|2017-02-18 14:26:57.663769
NCT00666510|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||January 1999||1999-01-01|April 2008|2008-04-01|December 2004|Actual|2004-12-01|||||Observational|||Bronchospasm Associated With High Nitric Oxide|Higher Exhaled Nitric Oxide (NO) is Associated With Intraoperative Bronchospasm|Completed||N/A|31|Actual|University of Sao Paulo|||3||f||||f||||||Samples Without DNA|"~     Sputum~   "|||2017-02-18 14:26:57.957092|2017-02-18 14:26:57.957092
NCT00666497|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2015-04-22||2015-04-06|June 2008||2008-06-01|April 2015|2015-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)|A Phase 2, Randomized, Open-Label Study of Azacitidine (Vidaza) vs MGCD0103 vs Azacitidine in Combination With MGCD0103 for the Treatment of Elderly Subjects With Newly Diagnosed AML or Intermediate-2 or High-Risk MDS|Terminated||Phase 2|6|Actual|Mirati Therapeutics Inc.||3||"Celgene terminated its collaboration agreement with MethylGene for the development of~   MGCD0103. All Celgene-sponsored trials with MGCD0103 with be closed."|f||||t||||||||||2017-02-18 14:26:58.050174|2017-02-18 14:26:58.050174
NCT00666484|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-24|2014-12-03|||March 2008||2008-03-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma|Phase II Study Evaluating the Toxicity and Efficacy of a Modified German Paediatric Hodgkin's Lymphoma Protocol (HD95) in Young Adults (Aged 18-30 Years) With Hodgkin's Lymphoma|Completed||Phase 2|47|Actual|University College, London||3|||f||||t||||||||||2017-02-18 14:26:58.167267|2017-02-18 14:26:58.167267
NCT00509613|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2009-09-17|||June 2007||2007-06-01|September 2009|2009-09-01||||May 2009|Actual|2009-05-01||Interventional|||Phase 1 Study With Sorafenib and Sirolimus|Phase 1 Dose Escalation Study With Sorafenib in Combination With Sirolimus in Patients With Solid Tumor|Completed||Phase 1|||Radboud University|||||f||||f||||||||||2017-02-18 15:24:15.563412|2017-02-18 15:24:15.563412
NCT00666471|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-06-10|||June 2008||2008-06-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|MICE||Minimally Invasive Control of Epistaxis (MICE)|Minimally Invasive Control of Epistaxis: Efficacy and Economic Analysis|Terminated||Phase 2/Phase 3|3|Actual|University of Calgary||2||"one PI (BM) no longer felt he had clinical equipoise regarding the intervention. No adverse~   events."|f||||f||||||||||2017-02-18 14:26:58.285094|2017-02-18 14:26:58.285094
NCT00666458|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2010-03-05|2010-03-05||April 2008||2008-04-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)|18-wk, International, Multi-centre, Randomized, Parallel-group, Double-Blind, Active-Controlled Phase IIIb Study to Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin in Comparison With Sitagliptin in Combination With Metformin in Adult Patients With T2D Who Have Inadequate Glycaemic Control on Metformin Alone|Completed||Phase 3|822|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:26:58.387001|2017-02-18 14:26:58.387001
NCT00666445|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2010-08-12|||April 2008||2008-04-01|August 2010|2010-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test|Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test: AD Template Development Study|Completed||N/A|150|Anticipated|Orasi Medical, Inc.|||2||f||||f||||||||||2017-02-18 14:26:58.974958|2017-02-18 14:26:58.974958
NCT00666432|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-11-30|||May 2008||2008-05-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2012|Actual|2012-09-01||Observational|||Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes|Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes|Active, not recruiting||N/A|3500|Anticipated|University of Maryland|||3||f||||t||||||Samples With DNA|"~     Blood or saliva will be stored for future genetic analysis.~   "|||2017-02-18 14:26:59.077037|2017-02-18 14:26:59.077037
NCT00666419|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2011-06-26|||September 2006||2006-09-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Prevalence of Back Pain and Associated Risk Factors in 10-12 Year Old Schoolchildren|Prevalence of Back Pain and Associated Risk Factors in 10-12 Year Old Schoolchildren|Withdrawn||N/A|8000|Anticipated|Kovacs Foundation|||1|Recruiting at schools was slower than planned. Missing data higher than acceptable.|f||||t||||||||||2017-02-18 14:26:59.186568|2017-02-18 14:26:59.186568
NCT00666406|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-06-26|2013-02-13||March 2008||2008-03-01|February 2013|2013-02-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A|Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A: a Phase IV, Prospective, Randomized, Controlled, Cross-over, Single Center Study|Completed||Phase 4|9|Actual|Baxalta US Inc.||2|||f||||f||||||||||2017-02-18 14:26:59.287845|2017-02-18 14:26:59.287845
NCT00666393|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2014-02-28|||October 2008||2008-10-01|February 2014|2014-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients|An Open-Label Evaluation of Safety of the IONSYS System [Fentanyl Iontophoretic Transdermal System (40ug) for Management of Acute Post-Operative Pain in Pediatric Patients|Withdrawn||Phase 3|0|Actual|Alza Corporation, DE, USA||1||Program Cancelled.|f||||f||||||||||2017-02-18 14:27:02.787141|2017-02-18 14:27:02.787141
NCT00666380|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-05-27|||April 2008||2008-04-01|May 2015|2015-05-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya|Phase 1a Open-label Dose Escalation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Candidate Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered Intramuscularly With GSK Biologicals' Adjuvant AS01B in Healthy Malaria-Naïve Adults|Completed||Phase 1|26|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-02-18 14:27:02.90852|2017-02-18 14:27:02.90852
NCT00666367|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2010-12-23|||January 2008||2008-01-01|October 2009|2009-10-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Vitamin D as Treatment for Chronic Obstructive Pulmonary Disease (COPD)|High Dosis of Vitamin D as Treatment for COPD.|Completed||Phase 4|182|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-02-18 14:27:03.036596|2017-02-18 14:27:03.036596
NCT00666354|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2009-02-09|||October 2007||2007-10-01|February 2009|2009-02-01|January 2009|Anticipated|2009-01-01|September 2008|Anticipated|2008-09-01||Interventional|||Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis|Phase IIB Dose Response and Safety Study of Topical Formulations of Methotrexate (MQX-5902, MQX-5904 and MQX-5906) in the Treatment of Fingernail Psoriasis|Unknown status|Active, not recruiting|Phase 2|83|Anticipated|MediQuest Therapeutics||3|||f||||t||||||||||2017-02-18 14:27:03.169623|2017-02-18 14:27:03.169623
NCT00666341|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2013-11-07|||September 2007||2007-09-01|November 2013|2013-11-01|May 2010|Actual|2010-05-01|January 2009|Actual|2009-01-01||Interventional|||Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens|A Double-blind Placebo-controlled Dose-response Study for Evaluation of Safety and Efficacy of Immunotherapy With a Cocktail of Recombinant Major Allergens of Timothy Grass Pollen (Phleum Pratense) Adsorbed to Aluminium Hydroxide in Patients With IgE-mediated Allergic Rhinitis/Rhinoconjunctivitis With or Without Bronchial Asthma|Completed||Phase 2|50|Actual|Allergopharma GmbH & Co. KG||5|||f||||t||||||||||2017-02-18 14:27:03.288934|2017-02-18 14:27:03.288934
NCT00666328|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2014-08-21|2012-07-25||June 2008||2008-06-01|August 2014|2014-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|ACCELERATE||Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)|The Evaluation of Patients With Acute Hypertension and Intracerebral Hemorrhage With Intravenous Clevidipine Treatment (ACCELERATE)|Completed||Phase 3|37|Actual|The Medicines Company||1|||f||||f||||||||||2017-02-18 14:27:03.626684|2017-02-18 14:27:03.626684
NCT00666315|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2008-05-21|||December 2007||2007-12-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid Disease|Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid Disease -A Prospective, Comparative, Multicenter, Observational Study|Completed||N/A|80|Actual|Ethicon Endo-Surgery (Europe) GmbH|||2||f||||f||||||||||2017-02-18 14:27:04.092134|2017-02-18 14:27:04.092134
NCT00005213|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||March 1988||1988-03-01|June 2000|2000-06-01|February 1990|Actual|1990-02-01|||||Observational|||Lithium Countertransport and Blood Pressure In CARDIA and TOMHS||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:20.753318|2017-02-18 18:15:20.753318
NCT00666302|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-09-17|||October 2002||2002-10-01|September 2014|2014-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis|A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Patients With Atopic Dermatitis|Completed||Phase 4|413|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:27:04.191042|2017-02-18 14:27:04.191042
NCT00666289|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-07-26|||March 2008||2008-03-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Familial Myeloproliferative Disorders|Molecular Biology of Familial Myeloproliferative Disorders|Recruiting||N/A|200|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||Samples With DNA|"~     Blood samples from subjects and family members with myeloproliferative disease.~   "|||2017-02-18 14:27:04.32778|2017-02-18 14:27:04.32778
NCT00666276|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-05-29|2012-03-28||February 2007||2007-02-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)|Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)|Completed||N/A|1004|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:27:04.468177|2017-02-18 14:27:04.468177
NCT00666263|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2015-06-26|2012-10-19||August 2008||2008-08-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy|A Randomized, Double-Blind, Placebo Controlled, Cross-over Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Multifocal Motor Neuropathy|Completed||Phase 3|50|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-02-18 14:27:05.233741|2017-02-18 14:27:05.233741
NCT00666250|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-02-04|||January 2006||2006-01-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors|Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors|Completed||N/A|10|Actual|University of Utah||3|||f||||f||||||||||2017-02-18 14:27:06.808435|2017-02-18 14:27:06.808435
NCT00666237|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2017-01-10|||April 2008||2008-04-01|January 2017|2017-01-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Primary Tube Versus Trabeculectomy Study|Primary Tube Versus Trabeculectomy Study|Active, not recruiting||N/A|242|Actual|Bascom Palmer Eye Institute||2|||f||||t||||||||||2017-02-18 14:27:06.926066|2017-02-18 14:27:06.926066
NCT00666224|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-06-19|2012-05-03||January 2004||2004-01-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|October 2007|Actual|2007-10-01||Interventional|PreCISe||Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome|A Multinational, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Effect of Early Glatiramer Acetate Treatment in Delaying the Conversion to Clinically Definite Multiple Sclerosis (CDMS) of Subjects Presenting With Clinically Isolated Syndrome (CIS)|Completed||Phase 3|481|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-02-18 14:27:07.053326|2017-02-18 14:27:07.053326
NCT00666211|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2012-08-04|2011-10-21||May 2005||2005-05-01|August 2012|2012-08-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain|Phase III Randomized Trial of an Opioid Titration Order Sheet Compared to Standard of Care in Patients With Cancer Related Pain.|Completed||Phase 3|98|Actual|Vanderbilt-Ingram Cancer Center||2|||f||||f||||||||||2017-02-18 14:27:08.518285|2017-02-18 14:27:08.518285
NCT00666198|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-08-03|||May 2008||2008-05-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)|Special Investigation For Long-term Use Of Revatio (Regulatory Post Marketing Commitment Plan)|Completed||N/A|3337|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:27:09.163182|2017-02-18 14:27:09.163182
NCT00666185|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2014-09-17|||August 2003||2003-08-01|September 2014|2014-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis|A Phase 3, Randomized, Double-Blind, Comparative Trial of Micafungin Versus Fluconazole for the Treatment of Esophageal Candidiasis|Completed||Phase 3|523|Actual|Astellas Pharma Inc||2|||f||||||||||||||2017-02-18 14:27:09.264656|2017-02-18 14:27:09.264656
NCT00666172|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2017-01-24|||April 8, 2008||2008-04-08|August 18, 2015|2015-08-18|November 1, 2012|Actual|2012-11-01|November 1, 2012|Actual|2012-11-01||Interventional|||Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women|Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women|Completed||Phase 2|270|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:27:09.410196|2017-02-18 14:27:09.410196
NCT00666159|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-09-17|||December 2002||2002-12-01|September 2014|2014-09-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis|A Randomized, Investigator Blinded Study of Protopic (Tacrolimus) Ointment Vs. Elidel (Pimecrolimus) Cream in Pediatric Patients With Moderate to Severe Atopic Dermatitis|Completed||Phase 4|226|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:27:09.512074|2017-02-18 14:27:09.512074
NCT00666146|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2017-01-03|||July 2004||2004-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|July 2010|Actual|2010-07-01||Observational|||Familial Schizophrenia and Spectrum Personality Disorders|Familial Schizophrenia and Spectrum Personality Disorders|Active, not recruiting||N/A|539|Actual|University of Maryland|||3||f||||t||||||Samples With DNA|"~     Blood sample for DNA extraction~   "|No||2017-02-18 14:27:09.638882|2017-02-18 14:27:09.638882
NCT00666133|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2009-12-08|||April 2008||2008-04-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Treatment Approaches for Preeclampsia in Low-Resource Settings|Treatment Approaches for Preeclampsia in Low-Resource Settings|Completed||N/A|304|Anticipated|Gynuity Health Projects||2|||f||||f||||||||||2017-02-18 14:27:09.730455|2017-02-18 14:27:09.730455
NCT00666120|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2008-04-23|||June 2005||2005-06-01|April 2008|2008-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Assessment of Feeding Tolerance in Infants Fed Cow Milk Formula|Assessment of Feeding Tolerance in Infants Fed Cow Milk Formula|Completed||N/A|333|Actual|Mead Johnson Nutrition||2|||f||||f||||||||||2017-02-18 14:27:09.834463|2017-02-18 14:27:09.834463
NCT00666107|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-03-12|||June 2008||2008-06-01|November 2010|2010-11-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|MIRB #862||Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men|Pilot Study to Evaluate the Immunogenicity and Safety of the HPV Quadrivalent Vaccine (Gardasil) in HIV-infected Men|Unknown status|Active, not recruiting|N/A|150|Anticipated|Southern California Institute for Research and Education||1|||f||||f||||||||||2017-02-18 14:27:09.938204|2017-02-18 14:27:09.938204
NCT00666094|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2017-02-07|||August 2008|Actual|2008-08-01|February 2017|2017-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Randomized Controlled Trial of Exercise Training Among Men With Type 2-diabetes|A Randomized Controlled Trial of Strength Versus Aerobic Exercise Training to Improve Glycemic Control in Men With Type 2-diabetes|Completed||N/A|26|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 14:27:10.045566|2017-02-18 14:27:10.045566
NCT00666081|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-04-15|||April 2008||2008-04-01|April 2015|2015-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies|A Phase I Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Potential Anti-cancer Activity of the AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||1||Study Cancelled before enrollment|f||||||||||||||2017-02-18 14:27:10.17381|2017-02-18 14:27:10.17381
NCT00666068|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2011-05-11|||February 2008||2008-02-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism|Effects of CRH on the Sleep in Patients With Hypopituitarism|Completed||N/A|30|Anticipated|Max-Planck-Institute of Psychiatry||2|||f||||f||||||||||2017-02-18 14:27:10.264344|2017-02-18 14:27:10.264344
NCT00666055|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-09-18|||March 2008||2008-03-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Sex, Aging and Antiretroviral Pharmacokinetics|CID 0708 - Sex, Aging and Antiretroviral Pharmacokinetics|Completed||N/A|11|Actual|University of North Carolina, Chapel Hill|||2||f||||f||||||Samples With DNA|"~     blood; genital secretions; genital tissue~   "|||2017-02-18 14:27:10.57126|2017-02-18 14:27:10.57126
NCT00666042|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-01-18|||February 2009||2009-02-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Bioequivalence of Eye Drops and Spray Administration of Vigamox|Laboratory-masked, Randomized Parallel, Comparative, Pilot Study on the Bioavailability of Vigamox in the Aqueous Humor When Administered Either as Commercially Available Eye Drops or in a Spray Form|Completed||N/A|16|Anticipated|Advanced Ophthalmic Pharma||2|||f||||f||||||||||2017-02-18 14:27:10.772444|2017-02-18 14:27:10.772444
NCT00666029|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-06-08|2016-04-21||February 2006||2006-02-01|June 2016|2016-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||"Age 18-75 years, body mass index (BMI) 20-35 kg/m2, with > 3 criteria for the metabolic syndrome.~(One person in the placebo arm did not have complete baseline data)."|Implications for Treatment of the Metabolic Syndrome|Implications for Treatment of the Metabolic Syndrome|Completed||Phase 2|40|Actual|University Hospital Southampton NHS Foundation Trust||2|||f||||f||||||||No||2017-02-18 14:27:11.023319|2017-02-18 14:27:11.023319
NCT00666016|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-11-21|||April 2008||2008-04-01|November 2016|2016-11-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)|Double-Blind vs Placebo, Randomized, Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 500 mg QD for One Month in Patients With Non-Alcoholic Steatohepatitis (NASH)|Completed||Phase 2|35|Actual|Hoffmann-La Roche||1|||f||||f||||||||||2017-02-18 14:27:11.402907|2017-02-18 14:27:11.402907
NCT00666003|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2011-02-07|||April 2008||2008-04-01|February 2011|2011-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|APCOvC-Line||Hemodynamic Assessment APCO Monitor vs Crit Line for Renal Replacement Rx|Hemodynamic Assessment Comparison Between Arterial Pressure Cardiac Output Monitor and Crit Line Utilized During Renal Replacement Therapy|Completed||N/A|26|Actual|Baystate Medical Center|||1||f||||f||||||||||2017-02-18 14:27:11.500493|2017-02-18 14:27:11.500493
NCT00665990|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-01-08|||November 2007||2007-11-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia|Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia|Completed||Phase 1|49|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 14:27:11.587424|2017-02-18 14:27:11.587424
NCT00665977|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-07-06|||September 2007||2007-09-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|Thermosmart||Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure|Effect of Heated Humidity With Thermosmart™ Compared to an Intranasal Steroid in Improving Compliance and Nasal Symptoms in Patients Using Continuous Positive Airway Pressure|Completed||Phase 3|44|Anticipated|Clayton Sleep Insititute||3|||f||||f||||||||||2017-02-18 14:27:11.70447|2017-02-18 14:27:11.70447
NCT00665964|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2009-08-10|||May 2008||2008-05-01|August 2009|2009-08-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Comparing X-3 To N2vac Polyethylene With the Triathlon Total Knee System|A Prospective, Randomized, Multi-center Study Comparing the Ten-Year Survival for X-3 Polyethylene to N2vac Polyethylene When Used With the Triathlon Posterior Stabilized (PS) Total Knee System|Withdrawn||Phase 4|384|Anticipated|Dalhousie University||2||Not funded at this time.|f||||f||||||||||2017-02-18 14:27:11.832788|2017-02-18 14:27:11.832788
NCT00665951|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-02-24|||September 2008||2008-09-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|SURF||Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)|The Pharmacokinetics of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children: a Pilot Study of Lopimune vs. the Branded Product (SURF Study).|Completed||Phase 1|12|Actual|Radboud University||3|||f||||f||||||||||2017-02-18 14:27:11.929084|2017-02-18 14:27:11.929084
NCT00665938|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2012-01-27|||October 2006||2006-10-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Followup of Infants Fed Non-routine Infant Formula||Completed||N/A|183|Anticipated|Mead Johnson Nutrition||3|||f||||f||||||||||2017-02-18 14:27:12.040105|2017-02-18 14:27:12.040105
NCT00665925|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-08-05|2016-05-03||May 2008||2008-05-01|August 2016|2016-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Taski-2||Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of Two Doses of R935788 in Rheumatoid Arthritis Patients Failing to Respond to Methotrexate|Completed||Phase 2|457|Actual|Rigel Pharmaceuticals|The 2 placebo groups (bid and qd) were pooled for all efficacy data summaries and analysis since the observed ACR20 response rate difference between the placebo groups was <15 percentage points (prospectively defined in protocol).|3|||f||||t||||||||No||2017-02-18 14:27:12.158931|2017-02-18 14:27:12.158931
NCT00665912|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-12-05|||January 2008||2008-01-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Interventional|||Platelet-Rich and Concentrated Platelet-Poor Plasma to Reduce Air Leak Post-Lobectomy: A Randomized Controlled Trial|Platelet-Rich and Concentrated Platelet Poor Plasma to Reduce Air Leak Post Lobectomy: A Randomized Controlled Trial|Completed||N/A|204|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 14:27:16.366645|2017-02-18 14:27:16.366645
NCT00665899|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-10-25|||July 2004||2004-07-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|CanThrive||A Couples Approach to Enhance Breast Cancer Survivorship|A Couples Approach to Enhance Breast Cancer Survivorship|Completed||N/A|163|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-02-18 14:27:16.460441|2017-02-18 14:27:16.460441
NCT00665886|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2009-04-10|||March 2008||2008-03-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|June 2008|Actual|2008-06-01||Interventional|COSMOS||Compact Closed System Versus Mounted Open System (COSMOS)|Randomized Study of Closed Peripheral Intravenous Systems Versus Mounted Open Systems|Completed||Phase 4|1200|Actual|Hospital San Carlos, Madrid||2|||f||||t||||||||||2017-02-18 14:27:16.5735|2017-02-18 14:27:16.5735
NCT00665873|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-05-07|||January 2004||2004-01-01|May 2008|2008-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|TIVAD||Antibiotic Therapy is Not Necessary to Implant Totally Implantable Venous Access Devices: Randomized Prospective Study|Antibiotic Therapy is Not Necessary to Implant Totally Implantable Venous Access Devices: Randomized Prospective Study|Completed||Phase 4|100|Actual|Universita degli Studi di Catania||2|||f||||t||||||||||2017-02-18 14:27:16.686501|2017-02-18 14:27:16.686501
NCT00665860|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2008-04-22|||April 2001||2001-04-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|OPUS||Safety and Effectiveness of Soy Phytoestrogens to Prevent Bone Loss|Safety, Efficacy, and Optimal Dosage of Soy Isoflavones to Prevent Osteoporosis|Completed||N/A|403|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-02-18 14:27:16.783059|2017-02-18 14:27:16.783059
NCT00665847|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-04-02|2012-06-14||November 2008||2008-11-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents|A Phase II, Open-label Trial, to Evaluate the Safety, Tolerability and Antiviral Activity of TMC125 in Antiretroviral Experienced HIV-1 Infected Children and Adolescents|Completed||Phase 2|103|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||t||||||||||2017-02-18 14:27:16.931419|2017-02-18 14:27:16.931419
NCT00665834|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-03-28|||April 2006||2006-04-01|March 2016|2016-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome|Comparison of the Effect Noted in The Apo/Apo-1 Ratio Using Rosuvastatin and Atorvastatin in Patients With acUte Coronary Syndrome CENTAURUS Study|Completed||Phase 4|18|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 14:27:17.396239|2017-02-18 14:27:17.396239
NCT00665821|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2009-05-14|||September 2008||2008-09-01|May 2009|2009-05-01|February 2011|Anticipated|2011-02-01|November 2010|Anticipated|2010-11-01||Interventional|||The Effect of Two Short Education Programs for Nonspecific Low Back Pain in a Workers' Health Care Organization|Study of the Effect of Two Short Education Programs for the Treatment of Nonspecific Low Back Pain in Patients Seen at a Workers' Health Care Organization|Terminated||N/A|657|Anticipated|Kovacs Foundation||1||"From Sept./08 to April/09 only 30 subjects were recruited. It has proved extremely difficult~   to recruit subjects."|f||||t||||||||||2017-02-18 14:27:17.51263|2017-02-18 14:27:17.51263
NCT00665808|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-10-27|||October 2007||2007-10-01|October 2016|2016-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||"Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During Real-life Usage in Germany"|Insulin Detemir (Levemir®) Versus Isophane (NPH) Insulin (Protaphane®) in Combination With Oral Antidiabetic Agents (OAD) in Patients With Diabetes Mellitus Type 2 Comparing Treatment Satisfaction, Diabetes-related and General Health-related Quality of Life, as Well as Diabetes-control|Completed||N/A|8125|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 14:27:17.611106|2017-02-18 14:27:17.611106
NCT00665795|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2013-11-17|||July 2005||2005-07-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy|Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy Using Multidetector Computed Tomography Scan and Color Doppler Imaging.|Completed||N/A|80|Actual|University of Sao Paulo|||2||f||||f||||||||||2017-02-18 14:27:17.728706|2017-02-18 14:27:17.728706
NCT00665782|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2015-10-22|||March 2008||2008-03-01|October 2015|2015-10-01||||July 2010|Actual|2010-07-01||Observational|||Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast|Stress Measures in Women With Newly Diagnosed Breast Cancer|Completed||N/A|24|Actual|Wake Forest University Health Sciences|||1||f||||t||||||||||2017-02-18 14:27:17.832043|2017-02-18 14:27:17.832043
NCT00665769|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2017-02-03|||June 2008||2008-06-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|November 2015|Actual|2015-11-01||Interventional|PhysDis||Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage|Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage|Terminated||N/A|103|Actual|Baylor University||2||Recruitment was proceeding too slowly|f||||t||||||||||2017-02-18 14:27:17.944151|2017-02-18 14:27:17.944151
NCT00665756|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||January 2006||2006-01-01|April 2008|2008-04-01|July 2008|Anticipated|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients|Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients|Unknown status|Active, not recruiting|N/A|40|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 14:27:18.061064|2017-02-18 14:27:18.061064
NCT00005212|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||March 1988||1988-03-01|May 2000|2000-05-01|February 1993|Actual|1993-02-01|||||Observational|||Work Organization and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:20.818857|2017-02-18 18:15:20.818857
NCT00665743|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-06-09|||March 2008||2008-03-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations|An Open-Label, Randomized, 3-Way Crossover Study to Evaluate the Relative Bioavailability of a Single Oral Dose of Naproxen 500 mg Administered as PN 400 (Naproxen / Esomeprazole), as the [Active Comparator 1], or as [Active Comparator 2] in Healthy Volunteers|Completed||Phase 1|30|Anticipated|POZEN||3|||f||||f||||||||||2017-02-18 14:27:18.176894|2017-02-18 14:27:18.176894
NCT00665730|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2015-05-07|||July 2007||2007-07-01|May 2015|2015-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions|Evaluation of the Safety and Effectiveness of Sepraspray™ in Limiting the Formation of Postoperative Adhesions to Serosal Tissue (Abdominal Surgery)|Terminated||N/A|5|Actual|Sanofi||2||Study terminated due to low enrollment.|f||||t||||||||||2017-02-18 14:27:18.278107|2017-02-18 14:27:18.278107
NCT00665717|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2011-06-06|||May 2008||2008-05-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|GRAPPA||The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)|The Influence of Raltegravir on Pravastatin Pharmacokinetics in Healthy Volunteers (GRAPPA)|Completed||Phase 1|24|Actual|Radboud University||3|||f||||f||||||||||2017-02-18 14:27:18.389563|2017-02-18 14:27:18.389563
NCT00665704|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-04-06|2014-06-25||March 2009||2009-03-01|June 2014|2014-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Tobacco Tactics Website for Veteran Smokers|Tobacco Tactics Website for Veteran Smokers|Completed||Phase 1|9|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 14:27:18.514644|2017-02-18 14:27:18.514644
NCT00665691|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2011-06-01|||September 2003||2003-09-01|June 2011|2011-06-01||||July 2010|Actual|2010-07-01||Observational|||Pilot Test for a Newly Developed Nutrition Screening Method: Pediatric Subjective Global Assessment|Pilot Test for a Newly Developed Nutrition Screening Method: Pediatric Subjective Global Assessment|Completed||N/A|132|Anticipated|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 14:27:18.764434|2017-02-18 14:27:18.764434
NCT00665678|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-07-10|||April 2008||2008-04-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Neural Correlates of Early Intervention for Posttraumatic Stress Disorder (PTSD)|Neural Correlates of Early Intervention for PTSD|Terminated||Phase 4|160|Anticipated|Atlanta Research and Education Foundation||2|||f||||t||||||||||2017-02-18 14:27:18.863382|2017-02-18 14:27:18.863382
NCT00665665|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2016-12-22|||November 2007||2007-11-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers|Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Healthy Male and Female Volunteers|Terminated||Phase 1|101|Actual|Novo Nordisk A/S||4||The trial is terminated due to re-evaluation of the compound|f||||f||||||||||2017-02-18 14:27:18.96545|2017-02-18 14:27:18.96545
NCT00665652|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2011-06-22|||April 2008||2008-04-01|June 2011|2011-06-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|MGUS||Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance|A Phase II Trial of Lenalidomide as a Treatment for Neuropathy Associated With Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)|Suspended||Phase 2|30|Anticipated|Dartmouth-Hitchcock Medical Center||1||The study has been suspended for slower than anticipated enrollment to date.|f||||t||||||||||2017-02-18 14:27:19.071282|2017-02-18 14:27:19.071282
NCT00665639|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2014-08-19|||June 2004||2004-06-01|August 2014|2014-08-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis|A Phase 3, Randomized, Double-Blind, Comparative Trial of Two Dosing Regimens of Micafungin (FK463) Versus Caspofungin for the Treatment of Esophageal Candidiasis|Completed||Phase 3|454|Actual|Astellas Pharma Inc||3|||f||||||||||||||2017-02-18 14:27:19.171752|2017-02-18 14:27:19.171752
NCT00665626|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-08-05|2016-06-06||May 2008||2008-05-01|August 2016|2016-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Taski-3||Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3)|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of R935788 in Patients With Rheumatoid Arthritis Who Have Failed at Least One Biologic|Completed||Phase 2|219|Actual|Rigel Pharmaceuticals||2|||f||||t||||||||No||2017-02-18 14:27:19.324073|2017-02-18 14:27:19.324073
NCT00665613|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-10-13|||October 2004||2004-10-01|October 2015|2015-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin|The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin|Completed||N/A|300|Actual|Northwell Health|||1||f||||t||||||||||2017-02-18 14:27:20.489346|2017-02-18 14:27:20.489346
NCT00665600|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-02-21|||February 2002||2002-02-01|February 2012|2012-02-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)|A Double-Blind, Randomized, Multicenter, Parallel-Group Study of Levalbuterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|257|Actual|Sunovion||4|||f||||f||||||||||2017-02-18 14:27:20.590169|2017-02-18 14:27:20.590169
NCT00665587|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2008-04-23|||June 2007||2007-06-01|April 2008|2008-04-01|June 2012|Anticipated|2012-06-01|June 2009|Anticipated|2009-06-01||Observational|AmP||AMAZING PRAGUE (PRAGUE-12)|Surgical Treatment of Atrial Fibrillation - Prospective Randomized Study|Unknown status|Enrolling by invitation|N/A|220|Anticipated|Charles University, Czech Republic|||2||f||||t||||||||||2017-02-18 14:27:20.741967|2017-02-18 14:27:20.741967
NCT00665574|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2009-07-13|||March 2008||2008-03-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||ActaVisc and ActaVisc Mx Intra-articular Injection for Pain Associated With Osteoarthritis in the Knee|A Prospective, Multi-center, Randomized, Double-blind Feasibility Study to Evaluate the Safety and Performance of ActaVisc and ActaVisc Mx Intra-articular Injection for Management of Pain Associated With Osteoarthritis in the Knee.|Terminated||N/A|23|Actual|Carbylan Therapeutics, Inc.||4||Business decision|f||||f||||||||||2017-02-18 14:27:20.849409|2017-02-18 14:27:20.849409
NCT00665561|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2016-12-05|||March 2008||2008-03-01|December 2016|2016-12-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|POEM||Prospective Observational Epidemiologic Study of Maraviroc's Safety|An International, Multicenter, Prospective Observational Study Of The Safety Of Maraviroc Used With Optimized Background Therapy In Treatment-experienced Hiv-1 Infected Patients|Active, not recruiting||N/A|3000|Anticipated|ViiV Healthcare|||2||f||||f||||||||||2017-02-18 14:27:20.956563|2017-02-18 14:27:20.956563
NCT00665522|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-04-09|||December 2007||2007-12-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)|A Prospective Safety Surveillance Study of IONSYS (Fentanyl HCl)|Terminated||Phase 4|218|Actual|Alza Corporation, DE, USA|||2|"Study was terminated at the request of the company due to the recall of marketed product in~   Europe."|f||||f||||||||||2017-02-18 14:27:21.657199|2017-02-18 14:27:21.657199
NCT00665509|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2008-08-12|||June 2008||2008-06-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.|Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2008/2009. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subjects and Elderly Subjects|Completed||Phase 3|120|Actual|Solvay Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:27:21.798814|2017-02-18 14:27:21.798814
NCT00665496|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2014-12-15|||June 2003||2003-06-01|December 2014|2014-12-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction|A Randomized, Double Blind, Double Dummy, Parallel Group, Multi-center Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction.|Completed||Phase 3|732|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:27:21.909001|2017-02-18 14:27:21.909001
NCT00665483|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2013-11-07|||March 2007||2007-03-01|November 2013|2013-11-01|November 2010|Actual|2010-11-01|September 2007|Actual|2007-09-01||Interventional|||Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.|Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a 6-grass Pollen Mixture, House Dust Mite (Dermatophagoides Pteronyssinus), Birch Pollen, and Mugwort Pollen|Completed||Phase 4|||Allergopharma GmbH & Co. KG||1|||f||||f||||||||||2017-02-18 14:27:22.182744|2017-02-18 14:27:22.182744
NCT00665470|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-23|2015-09-28|2012-12-12||April 2008||2008-04-01|September 2015|2015-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma|Phase II Study in Patients With Metastatic Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of gp100 Reactive Peripheral Blood Lymphocytes (PBL) and High or Low Dose Aldesleukin|Completed||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 14:27:22.282471|2017-02-18 14:27:22.282471
NCT00665457|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2013-06-17|||April 2004||2004-04-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Biomarkers in Women Receiving Chemotherapy and Celecoxib for Stage II or Stage III Breast Cancer That Can Be Removed by Surgery|Neoadjuvant Therapy and Biomarker Analysis of Stage II and III Breast Cancer With Docetaxel/Capecitabine and Celecoxib Followed by Doxorubicin/Cyclophosphamide and Celecoxib|Completed||Phase 2|3|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:27:22.812156|2017-02-18 14:27:22.812156
NCT00665444|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2016-01-14|2016-01-14||April 2008||2008-04-01|January 2016|2016-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder|Reducing Medical Risks in Individuals With Bipolar Disorder: Enhancing Outcomes With Aripiprazole|Terminated||N/A|3|Actual|University of Pittsburgh||1||The study was terminated by the sponser due to low study enrollment.|f||||f||||||||||2017-02-18 14:27:22.936155|2017-02-18 14:27:22.936155
NCT00665431|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-11-01|2010-05-27||April 2008||2008-04-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis|Randomized, Double-Blind, Parallel Group, Placebo-Controlled Multi-Center Study Evaluating the Efficacy of PN400 (VIMOVO) Twice Daily (Bid) and Celecoxib Once Daily (qd) in Patients With Osteoarthritis of the Knee|Completed||Phase 3|610|Actual|POZEN||3|||f||||f||||||||||2017-02-18 14:27:23.170956|2017-02-18 14:27:23.170956
NCT00665418|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2009-03-11|||February 2008||2008-02-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Sevoflurane and Laryngeal Reflex Responses in Pediatric Patients|Impact of High Concentrations of Sevoflurane on Laryngeal Reflex Responses in Pediatric Patients|Terminated||Phase 4|40|Actual|University Hospital, Basel, Switzerland||1||Recruitment finished earlier, because all 40 patients enrolled|f||||f||||||||||2017-02-18 14:27:23.858093|2017-02-18 14:27:23.858093
NCT00665405|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-04-21|||July 2006||2006-07-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|||||Observational|||Atelectasis During Delivery - Comparing Cesarian (c) -Section and Labor|CT Study of Atelectasis After Delivery - Comparison Between Cesarian Section and Labor|Completed||N/A|20|Actual|University of Sao Paulo|||2||f||||f||||||||||2017-02-18 14:27:26.271488|2017-02-18 14:27:26.271488
NCT00665392|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-08-21|||February 2008||2008-02-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Cetuximab and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Oropharynx Cancer That Can Be Removed by Surgery|Induction Chemotherapy With Cetuximab, Docetaxel, Cisplatin, and Fluorouracil (ETPF)for Squamous Cell Carcinoma of the Oropharynx That is Operable Stage III-IV|Completed||Phase 2|42|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||f||||||||||2017-02-18 14:27:26.394622|2017-02-18 14:27:26.394622
NCT00665379|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-05-19|||April 2008||2008-04-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Comparative Trial in Compression Therapy in Leg Lymphedema|Prospective, Randomized Controlled Trial Comparing the Effect of 3M Coban 2 Layer Compression System Versus Trico Bandages in the Treatment of Leg Lymphedema.|Completed||N/A|30|Actual|Nij Smellinghe Hosptial||2|||f||||f||||||||||2017-02-18 14:27:26.525373|2017-02-18 14:27:26.525373
NCT00665366|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-11-07|2012-09-28||June 2008||2008-06-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder|A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Adjunctive Aripiprazole Therapy in the Treatment of Mania in Bipolar I Disorder Patients Treated on Valproate or Lithium and in Need of Further Clinical Improvement|Completed||Phase 3|493|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-02-18 14:27:26.649137|2017-02-18 14:27:26.649137
NCT00477841|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2008-04-17|||April 2004||2004-04-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer||Completed||Phase 2|60|Actual|Southeast University, China||2|||f||||f||||||||||2017-02-18 15:35:53.298503|2017-02-18 15:35:53.298503
NCT00665353|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2013-05-14|2012-06-07||March 2009||2009-03-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance|A Pilot Study of Therapy With Pioglitazone Prior to HCV Treatment in HIV-1 and HCV Genotype 1-Infected Subjects With Insulin Resistance Who Are Prior Nonresponders to Peginterferon and Ribavirin Therapy|Completed||Phase 2|19|Actual|AIDS Clinical Trials Group|The study did not fully enroll and the small sample size precluded subgroup analysis.|1|||f||||t||||||||||2017-02-18 14:27:30.135845|2017-02-18 14:27:30.135845
NCT00665340|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-10-10|||July 2004||2004-07-01|October 2013|2013-10-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)|A Randomized, Double Blind, Placebo-controlled, Parallel Group, Multi-center Study to Investigate the Responsiveness of the Erectile Quality Scale (EQS) to Vardenafil HCl Flexible Dose Versus Placebo in Males With Erectile Dysfunction.|Completed||Phase 4|219|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:27:30.73031|2017-02-18 14:27:30.73031
NCT00665327|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-11-17|||November 2002||2002-11-01|November 2014|2014-11-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia|A Study of Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia|Completed||Phase 4|401|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:27:30.85536|2017-02-18 14:27:30.85536
NCT00665314|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2014-02-10|||November 2007||2007-11-01|February 2014|2014-02-01|June 2009|Actual|2009-06-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).|A Multicenter, Randomized, Comparative, Patient-blinded Study to Evaluate the Safety and Efficacy of G-CSF Alone Versus AMD3100 (240 µg/kg) Added to a G-CSF Mobilization Regimen in Adult Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkins Disease (HD) or Multiple Myeloma (MM) Who Have Previously Failed Stem Cell Collections or Collection Attempts|Completed||Phase 2|5|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:27:31.246266|2017-02-18 14:27:31.246266
NCT00665301|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-07-07|||March 2008||2008-03-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Cardiac Output Pulmonary Arterial Catheter Compared to FloWave™ 1000|Validation Study Comparing the Cardiac Output Pulmonary Arterial Catheter (Swan Ganz) to the FloWave™ 1000 Device|Completed||N/A|54|Actual|Woolsthorpe Technologies, LLC|||1||f||||f||||||||||2017-02-18 14:27:31.364302|2017-02-18 14:27:31.364302
NCT00665288|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2012-03-26|||January 2008||2008-01-01|March 2012|2012-03-01|August 2010|Actual|2010-08-01|March 2009|Actual|2009-03-01||Observational|||Survey of Attitudes and Factors Associated With CPR in an Older Population|A Survey of Attitudes and Factors Associated With Successful Cardiopulmonary Resuscitation (CPR) Knowledge Transfer in an Older Population Most Likely to Witness Cardiac Arrest|Completed||N/A|413|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:27:31.449878|2017-02-18 14:27:31.449878
NCT00665275|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-18|||March 2007||2007-03-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Complementary and Alternative Medicine Among Outpatients With Inflammatory Rheumatic Diseases in Western Sweden|The Use of Complementary and Alternative Medicine Among Outpatients With Inflammatory Rheumatic Diseases in Western Sweden.|Completed||N/A|200|Actual|Göteborg University|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:27:31.543712|2017-02-18 14:27:31.543712
NCT00665262|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-18|||March 2006||2006-03-01|April 2008|2008-04-01|December 2008||2008-12-01|September 2007|Actual|2007-09-01||Interventional|||The Effect of the Combined Use of Naloxone and Tramacet on Postoperative Analgesia in the Elderly|The Effect of the Combined Use of Naloxone and Tramacet on Postoperative Analgesia in Elderly Patients Having Joint Replacement Surgery: a Prospective Feasibility Study|Completed||Phase 4|10|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 14:27:31.645442|2017-02-18 14:27:31.645442
NCT00665249|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-04-27|||April 2008||2008-04-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking|Component Analysis of Motivational Interviewing|Completed||N/A|89|Actual|Northwell Health||3|||f||||t||||||||||2017-02-18 14:27:31.739612|2017-02-18 14:27:31.739612
NCT00665236|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2012-11-30|||September 2006||2006-09-01|November 2012|2012-11-01|September 2010|Actual|2010-09-01|May 2009|Actual|2009-05-01||Interventional|||Craniosacral Therapy in Migraine: A Feasibility Study|Craniosacral Therapy in Migraine: A Feasibility Study|Completed||N/A|66|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 14:27:31.861805|2017-02-18 14:27:31.861805
NCT00665223|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-07-19||2013-02-19|April 2008||2008-04-01|July 2016|2016-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|MermaiHD||A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease|A Multicentre, Multinational, Randomized, Double-blind, Parallel-group Study Comparing ACR16 Versus Placebo for the Symptomatic Treatment of Huntington's Disease|Completed||Phase 3|437|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-02-18 14:27:31.965248|2017-02-18 14:27:31.965248
NCT00665210|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-10-24|||October 2007||2007-10-01|October 2011|2011-10-01||||||||Observational|||Digital Sizing for Orthopaedic Hip Implants|Photo-manipulation of Digital Radiographs and Digitized Templates as a Method for Preoperative Sizing of Total Hip Arthroplasties|Unknown status|Recruiting|N/A|100|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:27:32.111669|2017-02-18 14:27:32.111669
NCT00665197|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-10-12|||February 2007||2007-02-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia|Improving Outcomes in Radiotherapy Using New Strategies of Treatment Delivery With Focus on Oesophageal Cancer.|Completed||Phase 3|200|Actual|International Atomic Energy Agency||2|||f||||f||||||||||2017-02-18 14:27:32.196944|2017-02-18 14:27:32.196944
NCT00665184|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-09-20|||August 2007||2007-08-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Strength Training and Medication Effects in Parkinson Disease Effects on Hypokinesia in Parkinson Disease|High Force Resistance Training and Dopamine Replacement Effects on Hypokinesia in Parkinson Disease|Completed||N/A|41|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 14:27:32.322207|2017-02-18 14:27:32.322207
NCT00637936|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2009-01-09|||March 2008||2008-03-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Respiratory Effects of Perioperative Oxygen During General Anaesthesia|Perioperative Oxygen Fraction - Effects on the PaO2/FiO2-Index During Laparotomy|Completed||Phase 4|35|Actual|University of Copenhagen||2|||f||||f||||||||||2017-02-18 14:36:29.806664|2017-02-18 14:36:29.806664
NCT00665171|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-22|||June 2008||2008-06-01|April 2008|2008-04-01||||||||Observational|||Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome|Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome - a Study on Multigenerational Families|Unknown status|Not yet recruiting|N/A|1500|Anticipated|Maaynei Hayesha Medical Center|||1||f||||f||||||Samples With DNA|"~     The study aims to perform a whole genome analysis for the detection of genes, associated~     with the polycystic ovary syndrome. Therefore, the main clinical effort is the diagnosis of~     index cases and recruitment of family members to give DNA samples.~   "|||2017-02-18 14:27:32.431373|2017-02-18 14:27:32.431373
NCT00665158|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-10-27|||September 2003||2003-09-01|October 2008|2008-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|PROACTIVE||Prevention and Reduction of Obesity Through Active Living|Prevention and Reduction of Obesity Through Active Living|Completed||N/A|500|Anticipated|Queen's University||2|||f||||t||||||||||2017-02-18 14:27:32.519805|2017-02-18 14:27:32.519805
NCT00665145|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2012-10-30||2012-10-30|January 2008||2008-01-01|October 2012|2012-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509|A Phase 2 Study of Stem-Cell-Mobilization in Subjects With Diabetic Neuropathy Receiving SB-509|Completed||Phase 2|23|Actual|Sangamo Therapeutics||4|||f||||f||||||||||2017-02-18 14:27:32.61963|2017-02-18 14:27:32.61963
NCT00665132|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2016-05-01|2016-02-02||April 2008||2008-04-01|May 2016|2016-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|StimRouter|">/=18 years of age~Carpal Tunnel chronic peripheral pain >/=3 mo with mean pain >/=5/10~Failed prior carpal tunnel release surgery >/=3 mo~Tolerates transcutaneous electrical nerve stimulation (TENS)~6. Pain relief by local anesthetic block of target nerve 7. Give informed consent 8. Quantify pain using 0 to 10 NRS"|Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves|Acute Human Study: StimRouter for Peripheral Nerve Stimulation of Discrete Peripheral Nerves|Completed||Phase 1/Phase 2|10|Actual|Bioness Inc||1|||f||||f||||||||||2017-02-18 14:27:32.732428|2017-02-18 14:27:32.732428
NCT00665119|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-12-17|||April 2008||2008-04-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effects of Remifentanil on Respiratory Function in Mechanically Ventilated Patients|Effects of Remifentanil on Breathing Pattern, Respiratory Effort and Gas Exchange in Mechanically Ventilated Patients.|Completed||Phase 4|14|Actual|Fondazione Poliambulanza Istituto Ospedaliero||1|||f||||f||||||||||2017-02-18 14:27:33.031687|2017-02-18 14:27:33.031687
NCT00665106|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-05-26|||April 2008||2008-04-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||"Safety and Tolerability of NOVA63035 Corticosteroid in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy"|A Phase I, Open-Label, Dose-Escalation Clinical Study to Assess the Safety and Tolerability of NOVA63035 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy|Completed||Phase 1|20|Actual|Santen SAS||4|||f||||||||||||||2017-02-18 14:27:33.143221|2017-02-18 14:27:33.143221
NCT00665093|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2017-01-06|||May 2007||2007-05-01|January 2017|2017-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes|A Prospective, Multicentre, Open Label, Non-controlled, Observational, 24-week Study in Patients Using NovoMix® 30 (Biphasic Insulin Aspart 30) or Levemir® (Insulin Detemir) for Treatment of Type 1 or Type 2 Diabetes Mellitus in Macedonia|Completed||Phase 4|1569|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 14:27:33.234992|2017-02-18 14:27:33.234992
NCT00665067|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2016-08-03|||April 2007||2007-04-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||Correlative Biomarker Study in Patients With Myeloproliferative Disorders|Correlative Biomarker Study for MPD-RC Treatment Studies in the Philadelphia Chromosome Negative MPD|Recruiting||N/A|860|Anticipated|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||Samples With DNA|"~     Leftover tissue will be asked for to be stored in the MPD-RC Tissue Bank~   "|||2017-02-18 14:27:33.343513|2017-02-18 14:27:33.343513
NCT00665054|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-12-23|||August 2004||2004-08-01|December 2014|2014-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction|Multi-centre, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Assess the Efficacy and Tolerability of Vardenafil and Its Influence on Self-esteem and Self Confidence in Subjects With Erectile Dysfunction.|Completed||Phase 4|160|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:27:33.703587|2017-02-18 14:27:33.703587
NCT00665041|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-09-16|||May 2008||2008-05-01|September 2009|2009-09-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome|A Randomised, Double-blind, Parallel Groups, Placebo-controlled, Single-centre Pilot Study Assessing the Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome|Completed||Phase 2|30|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 14:27:33.820077|2017-02-18 14:27:33.820077
NCT00665028|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-01-06|||November 2007||2007-11-01|January 2015|2015-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Perioperative Ischemia Reduction Study (PROSE) Pilot|Perioperative Ischemia Reduction Study (PROSE) Pilot|Completed||N/A|30|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:27:33.910393|2017-02-18 14:27:33.910393
NCT00665015|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-04-21|||January 2004||2004-01-01|April 2008|2008-04-01|October 2006|Actual|2006-10-01|December 2005|Actual|2005-12-01||Observational|||Pleural Effusion Following Cardiac Surgery: Prevalence, Risk Factors and Clinical Features|Pleural Effusions Following Cardiac Surgery: Prevalence, Risk Factors and Clinical Features.|Completed||N/A|2892|Actual|Laval University|||1||f||||f||||||||||2017-02-18 14:27:34.003876|2017-02-18 14:27:34.003876
NCT00665002|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-02-11|2014-06-25||June 2008||2008-06-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|July 2013|Actual|2013-07-01||Interventional||All participants|Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms|Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms|Completed||N/A|16|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 14:27:34.102877|2017-02-18 14:27:34.102877
NCT00664989|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-10-21|||August 2007||2007-08-01|August 2010|2010-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Resurfacing Hemiarthoplasty Versus Conventional Stemmed Arthroplasty|Resurfacing Hemiarthroplasty Versus Conventional Stemmed Hemiarthroplasty|Completed||N/A|10|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:27:34.413807|2017-02-18 14:27:34.413807
NCT00664976|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2017-01-15|||April 2008||2008-04-01|January 2017|2017-01-01|September 2013|Actual|2013-09-01|May 2011|Actual|2011-05-01||Interventional|||Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy|Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy|Completed||N/A|73|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 14:27:34.506538|2017-02-18 14:27:34.506538
NCT00664963|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-12-16|||April 2006||2006-04-01|December 2014|2014-12-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|YUKON-BTK||YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study|YUKON-drug-eluting Stent Below The Knee - Prospective Randomized Double-blind Multicenter Study|Completed||Phase 4|130|Actual|Herz-Zentrums Bad Krozingen||2|||f||||f||||||||||2017-02-18 14:27:34.618599|2017-02-18 14:27:34.618599
NCT00664950|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-09-01|||November 2007||2007-11-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||InterTAN IM Nail Versus Sliding Hip Screw in Geriatric Fractures|A Multi-centre Randomized Control Trail Comparing a Novel Intramedullary Device (InterTAN) Versus Conventional Treatment (Sliding Hip Screw) of Geriatric Fractures.|Completed||N/A|240|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-02-18 14:27:34.729254|2017-02-18 14:27:34.729254
NCT00664937|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2015-06-24|||May 2007||2007-05-01|June 2015|2015-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Exercise Induced Bronchoconstriction (0476-359)|A 3 Period, Double-Blind, Randomized Crossover Study to Evaluate the Effects of a Single Dose of Montelukast Compared With Placebo on Exercise-Induced Bronchoconstriction as Assessed by Hyperpolarized Gas Magnetic Resonance Imaging.|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 14:27:34.848402|2017-02-18 14:27:34.848402
NCT00664924|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2017-01-20|||October 2007||2007-10-01|January 2017|2017-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Comparative in Patient, Non-intervention Study of the Remote Physiological Monitoring System (RPM™) vs Standard Physiological Monitoring Devices|Comparative In-patient, Non-intervention Study of the Remote Physiological Monitoring System (RPM™), a Non-invasive, Remote, Ambulatory Vital Signs Monitoring Device, Versus Standard Physiological Monitoring Devices by Simultaneous Monitoring of Heart Rate, ECG, SpO2, Blood Pressure, Body Temperature, and Respiration Rate in a 24 hr Monitoring Period (BRYTECH #BRY-C-01-06-RPM)|Completed||N/A|40|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:27:34.952371|2017-02-18 14:27:34.952371
NCT00664911|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2013-10-15|||March 2008||2008-03-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|April 2012|Actual|2012-04-01||Interventional|OLD||Combination Chemotherapy in Treating Older Patients With Solid Tumour,|Study of a Scale Predicting the Feasibility of Chemotherapy in Patients Aged 75 Years or Older With Solid Tumour|Completed||Phase 4|516|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||1|||f||||f||||||||||2017-02-18 14:27:35.048302|2017-02-18 14:27:35.048302
NCT00664898|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-11-11|||May 2008||2008-05-01|November 2011|2011-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma|An Open-Label, Phase Ib, Dose-Escalation Study of the Safety and Pharmacology of the Anti-CD40 Monoclonal Antibody SGN-40 Administered in Combination With Bortezomib (Velcade®, PS-341) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|18|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 14:27:35.17366|2017-02-18 14:27:35.17366
NCT00664885|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-01-08|||January 2008||2008-01-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Interventional|||Effectiveness of Cultural Sensitive Collaborative Treatment of Depressed Chinese|Effectiveness of Cultural Sensitive Collaborative Treatment of Depressed Chinese in Primary Care|Completed||N/A|280|Actual|Mackay Memorial Hospital||1|||f||||||||||||||2017-02-18 14:27:35.27513|2017-02-18 14:27:35.27513
NCT00664872|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-01-08|||August 2007||2007-08-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Psychosocial Treatment by the Case Manager in Patients After a Suicide Attempt|Effect of Proactive Psychosocial Treatment by the Case Manager in Patients After a Suicide Attempt: a Randomised Controlled Trial|Completed||N/A|147|Actual|Mackay Memorial Hospital||1|||f||||t||||||||||2017-02-18 14:27:35.369588|2017-02-18 14:27:35.369588
NCT00664859|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2014-12-18|||October 2007||2007-10-01|October 2009|2009-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia|A 12-Month, Open-Label, Extension Study of the Safety and Efficacy of LCP-AtorFen in Subjects With Dyslipidemia|Completed||Phase 2/Phase 3|220|Actual|Veloxis Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:27:35.498578|2017-02-18 14:27:35.498578
NCT00664846|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-12|2011-04-08|||April 2008||2008-04-01|February 2011|2011-02-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|SMART||Standard Medical Management in Secondary Prevention of Ischemic Stroke in China|Standard Medical Management in Secondary Prevention of Ischemic Stroke in China.|Completed||N/A|4000|Anticipated|Peking Union Medical College Hospital||2|||f||||f||||||||||2017-02-18 14:27:35.62398|2017-02-18 14:27:35.62398
NCT00664833|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-12-08|||May 2004||2004-05-01|December 2014|2014-12-01|October 2005|Actual|2005-10-01|||||Interventional|||Evaluation of LEVITRA to Advance the Treatment of Erectile Dysfunction|An Open-label, Multi-center, Factorial Design, Cluster-randomized Clinical Study of Vardenafil in Canadian Males With Erectile Dysfunction: Impact of Education of the Primary Care Physician and Patient on Patient Outcomes.|Completed||Phase 4|1029|Actual|Bayer||4|||f||||f||||||||||2017-02-18 14:27:35.785289|2017-02-18 14:27:35.785289
NCT00664820|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-09-02|||March 2008||2008-03-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effects of Probiotics on Rheumatoid Arthritis Patients|Effects of Probiotics on Rheumatoid Arthritis Patients|Completed||N/A|50|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 14:27:35.884216|2017-02-18 14:27:35.884216
NCT00664807|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2009-08-24|||April 2008||2008-04-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Observational|GAME||Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study)|Medtronic Genetic Arrhythmia Markers for Early Detection|Completed||Phase 4|1023|Actual|Medtronic Corporate Technologies and New Ventures|||1||f||||f||||||||||2017-02-18 14:27:35.992867|2017-02-18 14:27:35.992867
NCT00664599|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-20|2008-04-27|||April 2006||2006-04-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease|Effect of Rituximab in the Treatment of Resistant Ocular Inflammatory Lesions of Behcet's Disease (Pilot Study)|Completed||Phase 2|20|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:27:38.023661|2017-02-18 14:27:38.023661
NCT00664794|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2011-07-19|||October 2006||2006-10-01|July 2011|2011-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Rotator Cuff Repair With Arthroscopic Acromioplasty (Shaving the Acromion Bone) Versus Repair Without Acromioplasty|Arthroscopic Rotator Cuff Repair With and Without Arthroscopic Acromioplasty in the Treatment of Full Thickness Rotator Cuff Tears|Completed||N/A|48|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 14:27:36.079203|2017-02-18 14:27:36.079203
NCT00664781|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-05-23|||December 2007||2007-12-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer|A Cancer Research UK Phase II Proof of Principle Trial of the Activity of the PARP-1 Inhibitor, AG-014699, in Known Carriers of a BRCA 1 or BRCA 2 Mutation With Locally Advanced or Metastatic Breast or Advanced Ovarian Cancer|Completed||Phase 2|78|Actual|Cancer Research UK|||||f||||||||||||||2017-02-18 14:27:36.169205|2017-02-18 14:27:36.169205
NCT00664768|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-03-05|||March 2008||2008-03-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|CMA||A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy|A Prospective, Randomized, Double-Blind Controlled Study to Evaluate the Nutritional Safety (Growth) of an Amino Acid Based Formula With Prebiotics and Probiotics in Infants Diagnosed With Cow Milk Allergy, With or Without Other Food Allergies.|Completed||N/A|126|Actual|Nutricia North America||2|||f||||f||||||||||2017-02-18 14:27:36.288222|2017-02-18 14:27:36.288222
NCT00664755|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-08-04|||July 2007||2007-07-01|July 2010|2010-07-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity|Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity|Unknown status|Recruiting|Phase 4|214|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 14:27:36.409504|2017-02-18 14:27:36.409504
NCT00664742|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-04-19|2011-01-05||September 2006||2006-09-01|April 2011|2011-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome|The Effect Of Fluvastatin XL® Treatment On The Lipid Profile In Patients With Metabolic Syndrome|Completed||Phase 4|614|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:27:36.72862|2017-02-18 14:27:36.72862
NCT00664729|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2010-01-12|||November 2002||2002-11-01|April 2008|2008-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|DEMO||Diet, Exercise, Metabolism, and Obesity in Older Women|Diet, Exercise, Metabolism, and Obesity in Older Women:DEMO|Completed||N/A|112|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||||2017-02-18 14:27:36.967221|2017-02-18 14:27:36.967221
NCT00664716|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-12-17||2015-12-17|July 2007||2007-07-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|RESPOND||Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants|Assessment Of Safety, Efficacy, PK&PD Of BG9924 in RA Patients Who Have Had An Inadequate Response To Conventional DMARD Therapy.|Completed||Phase 2|391|Actual|Biogen||6|||f||||t||||||||||2017-02-18 14:27:37.084442|2017-02-18 14:27:37.084442
NCT00664703|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2013-06-19|||July 2008||2008-07-01|June 2013|2013-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients|A Double-Blind, Double-Dummy, Placebo-Controlled, Dose Ranging Study of 7.5, 15, and 30 mg of Sublingual Lobeline in Adult ADHD Patients|Completed||Phase 2|13|Actual|Yaupon Therapeutics||7|||f||||t||||||||||2017-02-18 14:27:37.205887|2017-02-18 14:27:37.205887
NCT00664690|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-22|||July 2004||2004-07-01|April 2008|2008-04-01||||December 2008|Anticipated|2008-12-01||Interventional|||Effect of Celecoxib on Transitional Pain After Outpatient Surgery|Effect of Celecoxib on Transitional Pain After Outpatient Surgery|Unknown status|Recruiting|Phase 4|60|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 14:27:37.324739|2017-02-18 14:27:37.324739
NCT00664677|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2016-02-20|||August 2007||2007-08-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia|Phase 1 Study of Terameprocol (EM-1421) a Survivin and Cyclin-Dependent Kinase-1 (Cdc2) Inhibitor, in Patients With Leukemia|Terminated||Phase 1|16|Actual|Erimos Pharmaceuticals||1||Funding constraints|f||||f||||||||No||2017-02-18 14:27:37.418971|2017-02-18 14:27:37.418971
NCT00664664|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-12-29|||April 2008||2008-04-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia|A Randomized, Double-Blind, Placebo-Controlled Subjective Study to Assess the Efficacy of APD125 in Patients With Primary Insomnia Characterized by Difficulty Maintaining Sleep|Completed||Phase 2|675|Anticipated|Arena Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:27:37.537387|2017-02-18 14:27:37.537387
NCT00664651|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-04-22|||December 2006||2006-12-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Joint Stiffness Following Knee Replacement Surgery|Capsular Changes in Joint Contractures Post-Knee Arthroplasty:A Case-Control Study|Withdrawn||N/A|0|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:27:37.629913|2017-02-18 14:27:37.629913
NCT00664638|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2013-11-01|||April 2008||2008-04-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|HTN-1||Renal Denervation in Patients With Refractory Hypertension|Renal Denervation in Patients With Refractory Hypertension|Completed||N/A|45|Actual|Medtronic Vascular||1|||f||||f||||||||||2017-02-18 14:27:37.717163|2017-02-18 14:27:37.717163
NCT00664625|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-09-23||2010-09-10|May 2008||2008-05-01|September 2015|2015-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects|Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BMS-791325 in Subjects Chronically Infected With Hepatitis C Virus Genotype 1|Completed||Phase 1/Phase 2|24|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 14:27:37.810486|2017-02-18 14:27:37.810486
NCT00664612|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-10-15|||January 2008||2008-01-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Comparison of AirTraq Laryngoscope to Macintosh Laryngoscope for Intubation of Patients With Potential Cervical Spine Injury|Comparison of AirTraq Laryngoscope to Macintosh Laryngoscope for Intubation of Patients With Potential Cervical Spine Injury|Completed||N/A|24|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 14:27:37.923987|2017-02-18 14:27:37.923987
NCT00220142|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-05-30|||November 2003||2003-11-01|May 2013|2013-05-01||||||||Observational|||Molecular Markers of Prognosis in Colorectal Cancer Patients|Molecular Markers of Prognosis in Colorectal Cancer Patients|Completed||N/A|103|Actual|Royal Marsden NHS Foundation Trust|||1||f||||f||||||||||2017-02-18 17:07:36.549998|2017-02-18 17:07:36.549998
NCT00664586|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2016-02-20|||May 2007||2007-05-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors|A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors.|Terminated||Phase 1|21|Actual|Erimos Pharmaceuticals||1||Funding constraints|f||||f||||||||No||2017-02-18 14:27:38.145069|2017-02-18 14:27:38.145069
NCT00664573|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-12-17||2015-12-17|November 2007||2007-11-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|RESPOND-EXT||104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants|Assessment of Safety and Efficacy of BG9924 in Subjects With RA Who Have Participated in Study 104RA202.|Terminated||Phase 2|339|Actual|Biogen||4||Analysis of data from 104RA202 failed to meet primary endpoint|f||||t||||||||||2017-02-18 14:27:38.270811|2017-02-18 14:27:38.270811
NCT00664560|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-01-20|2010-05-27||April 2008||2008-04-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis|Randomized, Double-Blind, Parallel Group, Placebo-Controlled Multi-Center Study Evaluating the Efficacy of PN400 (VIMOVO) Twice Daily (Bid) and Celecoxib Once Daily (qd) in Patients With Osteoarthritis of the Knee|Completed||Phase 3|614|Actual|POZEN||3|||f||||f||||||||||2017-02-18 14:27:38.389641|2017-02-18 14:27:38.389641
NCT00664547|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-04-22|||September 1997||1997-09-01|April 2008|2008-04-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Reduction in Cardiovascular Risk Factors and Visceral Adipose Tissue in Men: Separate Effects of Diet- and Exercise-Induced Weight Loss|Reduction in Cardiovascular Risk Factors and Visceral Adipose Tissue in Men: Separate Effects of Diet- and Exercise-Induced Weight Loss|Completed||N/A|||Queen's University||4|||f||||f||||||||||2017-02-18 14:27:39.112771|2017-02-18 14:27:39.112771
NCT00664534|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-11-09|2011-11-09||April 2008||2008-04-01|November 2011|2011-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast|Comparison of Premixed Insulin Lispro Low-Mixture and Mid-Mixture Regimens With Separate Basal and Bolus Insulin Injections in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Oral Therapy Who Consume Light Breakfast|Completed||Phase 4|344|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:27:39.21915|2017-02-18 14:27:39.21915
NCT00664521|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2016-11-04|2016-09-16||March 2008||2008-03-01|November 2016|2016-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|August III|Intent-to-treat (ITT) population included all randomized participants.|Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)|A Randomized, Double-blind, Placebo Controlled, Multi-centre, Exploratory, Pilot, Phase II Trial of 150mg Atacicept Given Subcutaneously in Combination With Rituximab in Subjects With Rheumatoid Arthritis.|Completed||Phase 2|27|Actual|Merck KGaA||2|||f||||||||||||||2017-02-18 14:27:40.413293|2017-02-18 14:27:40.413293
NCT00664508|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-05-21|||November 2007||2007-11-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|||Mobility Assessment of Patients With Total Hip Arthroplasty|Mobility Assessment of Patients With Total Hip Arthroplasty: Joint Mechanics and Rehabilitation|Active, not recruiting||N/A|30|Anticipated|Ottawa Hospital Research Institute||3|||f||||f||||||||||2017-02-18 14:27:41.122124|2017-02-18 14:27:41.122124
NCT00664495|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-04-22|||April 1999||1999-04-01|April 2008|2008-04-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Reduction of Abdominal Obesity and Insulin Resistance in Women|Reduction of Abdominal Obesity and Insulin Resistance in Women|Completed||N/A|||Queen's University||4|||f||||f||||||||||2017-02-18 14:27:41.226972|2017-02-18 14:27:41.226972
NCT00664482|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2013-01-22||2013-01-22|May 2007||2007-05-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Single-Patient Study Using AGS 006|A Single-Patient Study Using AGS 006 as an Immunotherapeutic in a Subject With Newly Diagnosed Resectable Pancreatic Cancer|Completed||N/A|1|Actual|Argos Therapeutics||1|||f||||f||||||||||2017-02-18 14:27:41.337277|2017-02-18 14:27:41.337277
NCT00664469|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-07-27|||August 2007||2007-08-01|July 2011|2011-07-01|November 2010|Actual|2010-11-01|March 2010|Actual|2010-03-01||Interventional|INFINITY||INdians Followed for INtensive Lipid Lowering Treatment and Its safetY|INdians Followed for INtensive Lipid Lowering Treatment and Its safetY: To Assess The Safety And Effectiveness Of Ezetimibe Co-Administered With Any Statin Compared To Doubling Of Current Statin Daily Dose In South Asian Canadians|Terminated||Phase 3|64|Actual|Sunnybrook Health Sciences Centre||2||Poor enrollment|f||||f||||||||||2017-02-18 14:27:41.442172|2017-02-18 14:27:41.442172
NCT00664456|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2016-09-27|||April 2008||2008-04-01|September 2016|2016-09-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Interventional|SHIP0804||Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer|A Phase III, Multicenter, Randomized, Controlled Study of Neoadjuvant LHRH-agonist Therapy and Permanent I-125 Implantation With vs. Without Adjuvant LHRH-agonist Therapy in Patients With Untreated Intermediate-risk Prostate Cancer.|Active, not recruiting||Phase 3|421|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t||||||||||2017-02-18 14:27:41.546639|2017-02-18 14:27:41.546639
NCT00664443|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-10-21|||July 2007||2007-07-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Observational|||Effectiveness of Dispatch-Assisted Cardiopulmonary Resuscitation (CPR) Instructions|Effectiveness of Dispatch-Assisted Cardiopulmonary Resuscitation (CPR) Instructions: An Evaluation of 9-1-1 Calls.|Completed||Phase 1|8357|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:27:41.667829|2017-02-18 14:27:41.667829
NCT00664430|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2012-01-18|2010-06-03||January 2009||2009-01-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects|Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects|Terminated||Phase 4|13|Actual|Abbott|Early termination leading to no efficacy evaluation. All adverse events occurred during calcitriol challenge phase.|1||Low enrollment rate|f||||f||||||||||2017-02-18 14:27:41.774467|2017-02-18 14:27:41.774467
NCT00664417|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-22|2012-04-16|||April 2008||2008-04-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|September 2009|Actual|2009-09-01||Interventional|||Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine|Safety and Immunogenicity of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine in Healthy Adults|Completed||Phase 1|375|Actual|Sanofi||9|||f||||t||||||||||2017-02-18 14:27:42.043311|2017-02-18 14:27:42.043311
NCT00664404|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2012-10-23|||April 2008||2008-04-01|October 2012|2012-10-01||||October 2012|Actual|2012-10-01||Interventional|||Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal|Pharmacogenetics, Emotional Reactivity and Smoking Cessation: Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal|Completed||Phase 3|64|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 14:27:42.173968|2017-02-18 14:27:42.173968
NCT00664391|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-02-09|||January 2008||2008-01-01|February 2009|2009-02-01||||February 2008|Actual|2008-02-01||Interventional|||Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze|Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze|Completed||Phase 3|32|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:27:42.280087|2017-02-18 14:27:42.280087
NCT00664378|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-04-25||2013-04-25|January 2008||2008-01-01|April 2013|2013-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy Study of CYT997 in Multiple Myeloma|A Prospective, Single-arm, Two-stage, Open-label Phase II Trial of CYT997 in Relapsed and Refractory Multiple Myeloma|Terminated||Phase 2|5|Actual|Gilead Sciences||1||Difficulty enrolling patients|f||||t||||||||||2017-02-18 14:27:42.375577|2017-02-18 14:27:42.375577
NCT00664365|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-03-15|||April 2008||2008-04-01|February 2011|2011-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||FTIH Study With GSK958108|A Single Blind, Randomised, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK958108 in Healthy Male Subjects|Completed||Phase 1|20|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 14:27:42.47185|2017-02-18 14:27:42.47185
NCT00664352|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2009-01-05|||February 2008||2008-02-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites|A Double Blind, Placebo Controlled Trial to Investigate the Efficacy and Safety of Two Concentrations of Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites Using Different Dosing Regimes|Completed||Phase 1/Phase 2|195|Anticipated|Renovo||5|||f||||f||||||||||2017-02-18 14:27:42.563393|2017-02-18 14:27:42.563393
NCT00664339|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-04-17|||May 2007||2007-05-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|FLUVACS-IC||Flu Vaccination in Congestive Heart Failure|Influenza Vaccine Pilot Study in Severe Congestive Heart Failure Patients. The Flu Vaccination Heart Failure (FLUVACS II) Study|Completed||Phase 4|117|Actual|La Fundacion Favaloro para la Investigacion y la Docencia Medica||2|||f||||t||||||||||2017-02-18 14:27:42.678045|2017-02-18 14:27:42.678045
NCT00664326|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2016-12-19|2012-10-28||April 2008||2008-04-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|May 2009|Actual|2009-05-01||Interventional|||A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC|A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable Renal Cell Cancer (RCC)|Active, not recruiting||Phase 2|49|Actual|Bayer||1|||f||||t||||||||||2017-02-18 14:27:42.785415|2017-02-18 14:27:42.785415
NCT00664313|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-10-01|||April 2009||2009-04-01|October 2012|2012-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|LiMiT||TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB|TBTC Study 30: A Phase I/II Pilot Study for Evaluation of Low Dose, Once Daily, Linezolid Plus Optimized Background Therapy (OBT) Versus Placebo Plus OBT for the Treatment of Multi-drug Resistant Tuberculosis|Completed||Phase 1/Phase 2|36|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 14:27:43.30425|2017-02-18 14:27:43.30425
NCT00664300|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-01-18|||August 2007||2007-08-01|January 2011|2011-01-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Observational|||Facial Expression Recognition of Emotion and Categorization of Emotional Words in Gilles de la Tourette's Syndrome|Facial Expression Recognition of Emotion and Categorization of Emotional Words in Gilles de la Tourette's Syndrome|Completed||N/A|60|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-02-18 14:27:43.415927|2017-02-18 14:27:43.415927
NCT00664287|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-04-08|||September 2008||2008-09-01|April 2015|2015-04-01||||November 2009|Anticipated|2009-11-01||Interventional|||Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study to Evaluate the Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Dyslipidemic Patients Deemed Appropriate for Further Lipid Modification.|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:27:43.513715|2017-02-18 14:27:43.513715
NCT00664274|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2015-04-16|||April 2007||2007-04-01|April 2015|2015-04-01|October 2016|Anticipated|2016-10-01|January 2015|Actual|2015-01-01||Interventional|COMT||Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia|COMT Genotype and Response to Cognitive Remediation in Schizophrenia|Active, not recruiting||N/A|142|Anticipated|Manhattan Psychiatric Center||1|||f||||t||||||||||2017-02-18 14:27:43.609829|2017-02-18 14:27:43.609829
NCT00664261|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-19|2013-12-17|||September 2007||2007-09-01|June 2011|2011-06-01|July 2013|Actual|2013-07-01|September 2011|Actual|2011-09-01||Interventional|||Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking|Addressing Parental Smoking by Changing Pediatric Office Systems|Completed||N/A|3000|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:27:43.731828|2017-02-18 14:27:43.731828
NCT00664248|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-18|||October 2006||2006-10-01|April 2008|2008-04-01||||August 2007|Actual|2007-08-01||Interventional|||A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris||Completed||Phase 3|1414|Actual|Dow Pharmaceutical Sciences||4|||f||||||||||||||2017-02-18 14:27:43.829088|2017-02-18 14:27:43.829088
NCT00664235|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-04-21|||February 2008||2008-02-01|April 2008|2008-04-01|June 2008|Anticipated|2008-06-01|April 2008|Anticipated|2008-04-01||Observational|||The Analysis of Skin Temperature by Long Wave Infrared Imaging to Determine Its Effectiveness as a Predictor of Tissue Injury|Study of Thermal Imaging as an Objective RISK Indicator; The Evaluation of Skin Blood Flow and Temperature by Long Wave Infra-Red Imaging to Determine Effectiveness as a Predictor of Pressure Ulcer or Non-Visible Deep Tissue Damage|Unknown status|Recruiting|N/A|100|Anticipated|Trillennium Medical Imaging, Inc.|||1||f||||f||||||||||2017-02-18 14:27:44.168328|2017-02-18 14:27:44.168328
NCT00664222|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-21|||January 2004||2004-01-01|April 2008|2008-04-01|December 2005||2005-12-01|||||Interventional|||Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)|Effects of Spironolactone on Insulin Resistance in Patients With Chronic Heart Failure|Completed||Phase 4|16|Actual|Tottori University Hospital|||||f||||||||||||||2017-02-18 14:27:44.264299|2017-02-18 14:27:44.264299
NCT00664196|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2016-06-16|||April 2008||2008-04-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning|Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning|Suspended||Phase 1|18|Anticipated|Roger Williams Medical Center||1||Funding|f||||t||||||||||2017-02-18 14:27:44.488684|2017-02-18 14:27:44.488684
NCT00664183|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-10-19|||March 2008||2008-03-01|October 2009|2009-10-01||||December 2009|Anticipated|2009-12-01||Interventional|||A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects|A Phase 3 Safety and Efficacy Study of Vitreosolve® for Ophthalmic Intravitreal Injection in Retinopathy Subjects|Terminated||Phase 2/Phase 3|400|Anticipated|Vitreoretinal Technologies, Inc.||2||slow enrollment , interim analysis conducted.|f||||f||||||||||2017-02-18 14:27:44.600107|2017-02-18 14:27:44.600107
NCT00664170|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-05-27|||April 2008||2008-04-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer|A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer|Completed||Phase 1|39|Actual|Mast Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 14:27:44.713228|2017-02-18 14:27:44.713228
NCT00664157|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-01-18|||September 2007||2007-09-01|January 2011|2011-01-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic Nucleus|Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic Nucleus .|Completed||N/A|80|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 14:27:44.83566|2017-02-18 14:27:44.83566
NCT00664144|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-03-06|||July 2002||2002-07-01|March 2012|2012-03-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|GRAAL2||Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma|Study of Efficacy and Safety of Rasburicase for the Treatment/Prevention of Hyperuricemia Related to Tumor Lysis Syndrome in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma, Previously Treated or Not With Urate Oxidase Presenting With Hyperuricemia and/or Bulky Disease|Terminated||Phase 2|33|Actual|Sanofi||||due to poor enrollment|f||||||||||||||2017-02-18 14:27:44.942701|2017-02-18 14:27:44.942701
NCT00664131|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-09-22|||August 2005||2005-08-01|September 2011|2011-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors|Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors|Completed||N/A|165|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 14:27:45.06121|2017-02-18 14:27:45.06121
NCT00664118|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-05-26|||April 2008||2008-04-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|DCLEAP||Doula Combined Latent Phrase Epidural Analgesia in Primiparous Women|In Combination of Doula and Epidural Analgesia in the Latent Phrase of Labor in Primiparous Women|Completed||N/A|500|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 14:27:45.175053|2017-02-18 14:27:45.175053
NCT00664105|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-19|2012-08-30|2010-09-30||February 2004||2004-02-01|August 2012|2012-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)|PhII Study of Concurrent Chemoradiotherapy With Weekly Docetaxel, Carboplatin and Radiation Therapy Followed by Consolidation Chemotherapy With Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|63|Actual|Vanderbilt-Ingram Cancer Center|"Outcome measure #4, Number of participants with AEs by grade, will not match the total number of participants in this study. Some participants have multiple events in one or more grade designations or some participants have no events at all."|1||Treatment became standard.|f||||t||||||||||2017-02-18 14:27:45.289957|2017-02-18 14:27:45.289957
NCT00664092|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-02-10|||October 2007||2007-10-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Evaluating Alternative Aftercare Models for Ex-Offenders|Evaluating Alternative Aftercare Models for Ex-Offenders|Completed||Phase 2|300|Actual|DePaul University||3|||f||||t||||||||||2017-02-18 14:27:45.668267|2017-02-18 14:27:45.668267
NCT00664079|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-03-11|||October 2005||2005-10-01|July 2008|2008-07-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Observational|Thyroid||Thyroid Hormones in Critically Ill Children|Thyroid Hormone Deficiency in Critically Ill Children|Terminated||N/A|22|Actual|Children's Hospital of Philadelphia|||1|Sluggish enrollment.|f||||f||||||Samples Without DNA|"~     Whole blood and serum~   "|||2017-02-18 14:27:45.775961|2017-02-18 14:27:45.775961
NCT00664066|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2009-09-28|2009-08-18||April 2008||2008-04-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|DELFT||DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)|A Non-Interventional, Post-Authorisation Study to Assess Adverse Events and Drug Utilisation Among Chronic Kidney Disease Patients Treated With DYNEPO|Terminated||N/A|3|Actual|Shire|This study terminated early due to a decision by Shire Pharmaceuticals to permanently cease marketing Dynepo due to commercial reasons, it was not the result of any safety signal. Not enough subjects completed the study to do any efficacy analyses.||1|"The termination of the study is not linked to a product recall or result of any safety signal.~   Rather it was sponsor's commercial decision to withdraw the MA"|f||||||||||||||2017-02-18 14:27:45.910751|2017-02-18 14:27:45.910751
NCT00664053|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-25|||October 2004||2004-10-01|April 2008|2008-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Effects of DHEA/Exercise on Bone, Muscle and Balance|Effects of DHEA/Exercise on Bone, Muscle and Balance|Completed||Phase 4|99|Actual|National Institute on Aging (NIA)||4|||f||||f||||||||||2017-02-18 14:27:46.384933|2017-02-18 14:27:46.384933
NCT00664040|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2016-08-23|||May 2003||2003-05-01|August 2016|2016-08-01|August 2006|Actual|2006-08-01|||||Interventional|HAPI||Heredity and Phenotype Intervention (HAPI) Heart Study|Heredity and Phenotype Intervention (HAPI) Heart Study|Completed||N/A|868|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 14:27:46.503712|2017-02-18 14:27:46.503712
NCT00664027|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-11-29||2012-11-29|April 2008||2008-04-01|November 2012|2012-11-01||||May 2009|Actual|2009-05-01||Interventional|||Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy|An Open-Label, Randomized, Dose-ranging Phase IIa Trial to Determine the Effects of RTA 402 (Bardoxolone Methyl) on Renal Function in Patients With Diabetic Nephropathy|Completed||Phase 2|80|Actual|Reata Pharmaceuticals, Inc.||4|||f||||||||||||||2017-02-18 14:27:46.589341|2017-02-18 14:27:46.589341
NCT00664014|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2010-03-05|||May 2008||2008-05-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia|Randomized, Double-blind, Multicenter, Placebo-controlled (Standard Therapy + Placebo), Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia|Completed||Phase 2|240|Anticipated|Otsuka Beijing Research Institute||2|||f||||f||||||||||2017-02-18 14:27:46.688959|2017-02-18 14:27:46.688959
NCT00664001|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-21|||March 2003||2003-03-01|April 2008|2008-04-01|December 2003|Actual|2003-12-01|August 2003|Actual|2003-08-01||Interventional|||Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness|Randomized Double-Blind Placebo-Controlled Trial of Oral Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness.|Completed||Phase 3|83|Actual|Altitude Physiology Expeditions||2|||f||||f||||||||||2017-02-18 14:27:46.80122|2017-02-18 14:27:46.80122
NCT00663988|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-20|2008-04-20|||April 2006||2006-04-01|February 2006|2006-02-01||||April 2006|Actual|2006-04-01||Interventional|||Human Partial Facial Allotransplantation|Human Partial Facial Allotransplantation|Completed||Phase 3|1|Actual|Xijing Hospital||1|||f||||t||||||||||2017-02-18 14:27:46.921087|2017-02-18 14:27:46.921087
NCT00663975|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2010-05-12|||February 2009||2009-02-01|May 2010|2010-05-01|November 2009|Anticipated|2009-11-01|August 2009|Anticipated|2009-08-01||Interventional|||Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients|An Open-Label, Multi-Center Safety and Efficacy Study of DCI-1020 in Pediatric Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency|Withdrawn||N/A|24|Anticipated|Digestive Care, Inc.||1||Study not being conducted|f||||t||||||||||2017-02-18 14:27:47.026552|2017-02-18 14:27:47.026552
NCT00663962|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2016-01-29|2013-01-31||April 2008||2008-04-01|January 2016|2016-01-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional||Of the 7 participants randomized to the pregabalin group, 3 receieved 150mg of pregabalin while 4 recieved 300mg pregabalin.|Pregabalin and Post-thoracotomy Pain|A Prospective, Randomized, Double Blinded, Placebo Controlled Pilot Study Assessing the Effect of Perioperative Pregabalin on the Incidence of Chronic Post Thoracotomy Pain Syndrome|Completed||Phase 4|15|Actual|Queen's University||2|||f||||t||||||||No||2017-02-18 14:27:47.138803|2017-02-18 14:27:47.138803
NCT00663949|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-04-21|||February 2006||2006-02-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy|Phase 2 Trial of Effect of Combine Pentoxifylline and Captopril on Proteinuria in Diabetic Nephropathy|Completed||Phase 2/Phase 3|70|Actual|Shiraz University of Medical Sciences||2|||f||||f||||||||||2017-02-18 14:27:47.501445|2017-02-18 14:27:47.501445
NCT00663936|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-10-09||2012-12-09|April 2008||2008-04-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease|A Phase 2a Multi-center, Randomized, Double Blind, Placebo-controlled Study to Investigate the Efficacy and Safety of T-817MAa in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|373|Actual|Toyama Chemical Co., Ltd.||2|||f||||t||||||||||2017-02-18 14:27:47.661897|2017-02-18 14:27:47.661897
NCT00663923|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-03-10|2009-12-30||November 2007||2007-11-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|PRK||Comparison of Cross-cylinder and Conventional Photorefractive Keratectomy(PRK) in Correcting Medium-high Astigmatism|Comparison of Cross-cylinder and Conventional PRK for Laser Correction of Astigmatism: A Randomized Clinical Trial.|Completed||Phase 3|50|Actual|Tabriz University||2|||f||||t||||||||||2017-02-18 14:27:47.792427|2017-02-18 14:27:47.792427
NCT00663910|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-19|2016-12-30|||March 2008||2008-03-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer|Evaluation of Protoporphyrin Formation in Non-Melanoma Skin Cancers After Topical Application of 5-Aminolevulinic Acid: A Pilot Study|Terminated||Early Phase 1|18|Actual|The Cleveland Clinic||1||Of the 8 histologically proven tumors, detection of PpIX proved to be ambiguous.|f||||t||||||||No|IPD will not be shared.|2017-02-18 14:27:48.157602|2017-02-18 14:27:48.157602
NCT00663897|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2009-10-08|||May 2008||2008-05-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Lansoprazole Versus Mosapride for Functional Dyspepsia|A Comparative Study of Lansoprazole and Mosapride for Functional Dyspepsia: Focus on Difference Between Epigastric Pain Syndrome and Postprandial Distress Syndrome|Completed||Phase 4|329|Actual|Lotung Poh-Ai Hospital||2|||f||||t||||||||||2017-02-18 14:27:48.255672|2017-02-18 14:27:48.255672
NCT00663884|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-03-28|||February 2008||2008-02-01|March 2012|2012-03-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|GLORIA||Glufast On Insulin Glargine Trial in Type 2 DM|A Prospective, Randomized and Multi-center Clinical Study to Evaluate Efficacy and Safety of Combination Therapy of Mitiglinide or Voglibose With Long-acting Insulin in Type 2 Diabetic Patients|Completed||Phase 4|167|Actual|JW Pharmaceutical||2|||f||||t||||||||||2017-02-18 14:27:48.373012|2017-02-18 14:27:48.373012
NCT00663871|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-07-05|||June 2008||2008-06-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior|BioBehavioral Studies of Cardiovascular Disease|Completed||Phase 2/Phase 3|275|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 14:27:48.479512|2017-02-18 14:27:48.479512
NCT00663858|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2010-12-15|2010-11-11||March 2008||2008-03-01|December 2010|2010-12-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)|Cetrorelix Pamoate (AEZS-102) in Patients With Symptomatic BPH: a Double-blind Placebo-controlled Efficacy Study|Completed||Phase 3|420|Actual|AEterna Zentaris||3|||f||||t||||||||||2017-02-18 14:27:51.030417|2017-02-18 14:27:51.030417
NCT00663845|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2013-10-10|||May 2006||2006-05-01|October 2013|2013-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and Hyperlipidemia|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia.|Completed||Phase 4|395|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:27:52.0486|2017-02-18 14:27:52.0486
NCT00662142|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2013-05-15|||January 2006||2006-01-01|May 2013|2013-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function|Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function|Completed||Phase 3|30|Actual|University of Cincinnati||1|||f||||||||||||||2017-02-18 14:28:28.44624|2017-02-18 14:28:28.44624
NCT00663832|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-05-15|||February 2008||2008-02-01|May 2012|2012-05-01||||December 2011|Actual|2011-12-01||Interventional|||A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer|An Open Label, Single Arm, Phase Ib Dose Finding Study of i.v. Panobinostat (LBH589) With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 1|44|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:27:52.140306|2017-02-18 14:27:52.140306
NCT00663819|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-09-02|2014-08-21||April 2008||2008-04-01|September 2014|2014-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Patients were considered for the study if they were at least 18 years of age and scheduled to undergo one the following (with the anastomosis < 10 cm from the anal verge): low anterior resection, proctectomy, proctocolectomy or a restorative anastomosis by means of Hartmann’s reversal, coloanal anastomosis, or ileo-pouch-anal anastomosis.|Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses|Efficacy of Bioabsorbable Staple Line Reinforcement in Colorectal, Coloanal and Ileoanal Anastomoses: A Prospective Randomized Study|Terminated||N/A|258|Actual|W.L.Gore & Associates||2||Per SAP|f||||f||||||||||2017-02-18 14:27:52.474145|2017-02-18 14:27:52.474145
NCT00663806|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-12-01|||February 2003||2003-02-01|December 2014|2014-12-01|July 2003|Actual|2003-07-01|||||Interventional|EXPRESS||A Phase IV Study of Cipro XR in Uncomplicated UTI|EXPRESS: Evaluating Cipro XR Patient Response, Education, Safety, and Satisfaction|Completed||Phase 4|7614|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:27:52.819952|2017-02-18 14:27:52.819952
NCT00663793|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2010-12-27|2010-06-25||October 2008||2008-10-01|December 2010|2010-12-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|ORAL-T-6||ORAL T-6: Oral Androgens in Man-6|Oral Androgens in Man-6: Pharmacokinetics of Slow and Fast Release, External Matrix Oral Testosterone Formulations in Normal Men With Experimental Hypogonadism|Completed||Phase 1|16|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:27:52.92396|2017-02-18 14:27:52.92396
NCT00663780|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2009-01-05|||February 2008||2008-02-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082|Pharmacogenomic Analysis of Blood Samples to Identify Polymorphisms That Segregate Responders From Non-Responders Following Treatment With Juvidex of Split Skin Donor Sites in Renovo's Clinical Study RN1004-0082|Completed||N/A|195|Anticipated|Renovo|||1||f||||f||||||Samples With DNA|"~     Plasma retained until samples analysed then destroyed~   "|||2017-02-18 14:27:53.504166|2017-02-18 14:27:53.504166
NCT00663767|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-11-29||2009-12-09|April 2008||2008-04-01|November 2011|2011-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction||Completed||Phase 2|250|Actual|Array BioPharma||6|||f||||||||||||||2017-02-18 14:27:53.588154|2017-02-18 14:27:53.588154
NCT00663754|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2014-03-03|||March 2005||2005-03-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effectiveness of a Dissonance-Based Eating Disorder Prevention Program (The Body Project II)|Eating Disorder Prevention Program Effectiveness Trial|Completed||N/A|306|Actual|Oregon Research Institute||3|||f||||t||||||||||2017-02-18 14:27:53.69093|2017-02-18 14:27:53.69093
NCT00663741|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2013-06-09|||May 2008||2008-05-01|June 2013|2013-06-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Sorafenib Gastric Cancer Asian Phase I Study|Phase I Study to Investigate Safety, Pharmacokinetics and Preliminary Efficacy Profile of Sorafenib (BAY 43-9006) in Combination With S-1 Plus CDDP in Asian Patients With Unresectable / Recurrent Gastric Cancer|Completed||Phase 1|13|Actual|Bayer||3|||f||||t||||||||||2017-02-18 14:27:53.790036|2017-02-18 14:27:53.790036
NCT00663728|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-12-26|||September 2004||2004-09-01|December 2014|2014-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Assessment of Duration of Erection With Vardenafil 10 mg|A Randomized, Double-blind, Crossover Study to Evaluate the Duration of Erection Following Vardenafil (10mg) Administration for Four Weeks in a Fixed Dose Regimen Compared to Placebo in Males With ED|Completed||Phase 4|201|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:27:53.894156|2017-02-18 14:27:53.894156
NCT00663715|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-03-11|||April 2009||2009-04-01|April 2010|2010-04-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Observational|||Ultrasound Description of the Sciatic Nerve|Anatomical Description of the Sciatic Nerve Via a Lateral Mid-Thigh Approach Using Ultrasound|Withdrawn||N/A|0|Actual|Children's Hospital of Philadelphia|||1|No subjects were enrolled. Sciatic blocks infrequently used for pain control.|f||||f||||||||||2017-02-18 14:27:53.981513|2017-02-18 14:27:53.981513
NCT00663702|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-02-17|2012-01-19||May 2008||2008-05-01|February 2015|2015-02-01|January 2012|Actual|2012-01-01|December 2009|Actual|2009-12-01||Interventional|||Phase IIIB Switching From Intravenous to Subcutaneous Study|A Phase 3B Multi-center Open-Label Study to Evaluate the Safety of Abatacept in Subjects Who Switch From Intravenous to Subcutaneous Abatacept Therapy|Completed||Phase 3|123|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:27:54.096308|2017-02-18 14:27:54.096308
NCT00663689|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-04-21|||March 2008||2008-03-01|April 2008|2008-04-01|January 2012|Anticipated|2012-01-01|March 2011|Anticipated|2011-03-01||Interventional|||Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer|A Phase II Study of Erlotinib in Benefitted Patients With Asymptomatic Brain Metastases Advanced Non-Small Cell Lung Cancer By Chemotherapy.|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|Guangdong Provincial People's Hospital||1|||f||||t||||||||||2017-02-18 14:27:55.426128|2017-02-18 14:27:55.426128
NCT00663663|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-08-29|||September 2009||2009-09-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|TIPS||Telephone Intervention for Pain Study (TIPS)|Efficacy of Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain|Completed||N/A|207|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:27:55.531207|2017-02-18 14:27:55.531207
NCT00663650|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-07-11|||August 2008||2008-08-01|July 2011|2011-07-01|June 2013|Anticipated|2013-06-01|December 2012|Anticipated|2012-12-01||Interventional|||Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control|A Randomized Clinical Trial in the Surgical Treatment of Basal Cell Carcinoma of the Eyelid: Surgical Excision With Frozen Section vs. Permanent Section Control|Unknown status|Recruiting|Phase 3|290|Anticipated|Queen's University||2|||f||||f||||||||||2017-02-18 14:27:55.627816|2017-02-18 14:27:55.627816
NCT00663637|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-05-28|||April 2008||2008-04-01|April 2008|2008-04-01||||||||Interventional|RESCUE||Removal of Endotracheal Tube Secretions Comprehensively Until Extubation|Evaluation of the Safety and Efficacy of CAM (Complete Airway Management) Catheters: Phase II Study|Unknown status|Recruiting|Phase 2|30|Anticipated|O. M. Neotech, Inc.||1|||f||||f||||||||||2017-02-18 14:27:55.728368|2017-02-18 14:27:55.728368
NCT00663624|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-11-20||||||November 2013|2013-11-01||||||||Interventional|NOVO ER||Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care|Management of Hyperglycemia in the Emergency Room: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care|Withdrawn||Phase 4|0|Actual|Emory University||2||Lack of funding for the study at the Emory site|f||||t||||||||||2017-02-18 14:27:55.827512|2017-02-18 14:27:55.827512
NCT00663611|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2017-01-24|||October 19, 2006||2006-10-19|December 8, 2016|2016-12-08|October 6, 2014|Actual|2014-10-06|October 6, 2014|Actual|2014-10-06||Interventional|||Growth Hormone Administration and the Human Immune System|Growth Hormone Administration and the Human Immune System|Completed||Phase 1|150|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 14:27:55.918794|2017-02-18 14:27:55.918794
NCT00663598|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-12-18|||October 2003||2003-10-01|December 2014|2014-12-01|September 2004|Actual|2004-09-01|||||Interventional|REALISE||Levitra® - Real Life Safety and Efficacy of Levitra|REALISE Levitra® - Real Life Safety and Efficacy of Levitra|Completed||Phase 4|30825|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:27:56.023006|2017-02-18 14:27:56.023006
NCT00663585|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2016-07-28|||April 2008||2008-04-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|||Intensive Meditation and Migraines: Effects on Health and Well Being|Intensive Meditation and Migraines: Effects on Health and Well Being|Completed||N/A|36|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:27:56.118616|2017-02-18 14:27:56.118616
NCT00663572|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-09-02|||March 2008||2008-03-01|September 2013|2013-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|Polynuca||Food Habit Programming: Influence of Genetics and Early Nutrition in a Population of Preterm Infants|Food Habit Programming: Influence of Genetics and Early Nutrition in a Population of Preterm Infants|Terminated||N/A|234|Actual|Nantes University Hospital|||1||f||||||||||||||2017-02-18 14:27:56.209742|2017-02-18 14:27:56.209742
NCT00663559|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2014-12-17|||February 2008||2008-02-01|November 2007|2007-11-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|SOGUG/0107||Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy|Study Phase II to Determinate the Efficacy of Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy|Completed||Phase 2|59|Actual|Spanish Oncology Genito-Urinary Group||1|||f||||t||||||||||2017-02-18 14:27:56.288271|2017-02-18 14:27:56.288271
NCT00663546|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-19|2017-01-24|||March 24, 2008||2008-03-24|December 5, 2013|2013-12-05|December 5, 2013||2013-12-05|||||Observational|||Malaria Studies in Cambodia|Studies of P. Vivax and P. Falciparum Malaria in Cambodia|Completed||N/A|2765|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:27:56.404827|2017-02-18 14:27:56.404827
NCT00663533|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2014-12-02|||April 2008||2008-04-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|July 2008|Actual|2008-07-01||Interventional|VAS-2||VAS-2 Vasectomy With the Vax-X|Vasectomy With the Vas-X, a Simple, Minimally Invasive Device for Male Sterilization: A Pilot Study|Completed||Phase 1|10|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:27:56.496634|2017-02-18 14:27:56.496634
NCT00663520|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-07-22|||January 2008||2008-01-01|April 2008|2008-04-01||||June 2012|Anticipated|2012-06-01||Observational|MVD||Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women|Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women|Unknown status|Recruiting|N/A|100|Anticipated|Oregon Health and Science University|||2||f||||t||||||||||2017-02-18 14:27:56.600204|2017-02-18 14:27:56.600204
NCT00663507|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-02-25|||March 2008||2008-03-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Kidney Transplantation in Patients With Sickle Cell Disease|Kidney Transplantation in Patients With Sickle Cell Disease|Terminated||N/A|2|Actual|Emory University|||1|"Only 1 patient was enrolled. No funding, small number of eligible patients so would not~   achieve statistical power."|f||||t||||||Samples With DNA|"~     100 mLs of whole blood will be collected at designated time points. Baseline, and at~     1,3,6,9,12,18 and 24 months post-transplant~   "|||2017-02-18 14:27:56.689097|2017-02-18 14:27:56.689097
NCT00663494|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-07-20|||February 2003||2003-02-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|||||Observational|||Matrix Metalloproteinase (MMP) in Heart Failure|MMP is Produced in Failing Hearts|Completed||N/A|22|Anticipated|Tottori University Hospital|||1||f||||||||||||||2017-02-18 14:27:56.773578|2017-02-18 14:27:56.773578
NCT00663481|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-05-27|||April 2008||2008-04-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.|A Single Dose, Within Subject, 3 Period, Pharmacokinetic Bridging Study of CoFactor Formulations and of Leucovorin Administered Intravenously in Healthy, Adult Subjects.|Completed||Phase 1|15|Anticipated|Mast Therapeutics, Inc.||3|||f||||f||||||||||2017-02-18 14:27:56.843504|2017-02-18 14:27:56.843504
NCT00663468|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-09-21|||April 2008||2008-04-01|September 2012|2012-09-01||||||||Observational|||Treatment of Sub-capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer||Unknown status|Active, not recruiting|N/A|11|Actual|Active Implants|||1||f||||||||||||||2017-02-18 14:27:57.142413|2017-02-18 14:27:57.142413
NCT00663455|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-06-03|||December 2008||2008-12-01|June 2015|2015-06-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|Recaltox||Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients|A Multicenter, Randomized, Parallel-group, Trial to Reduce Toxicity of Calcineurininhibitor-therapy in Steroid-free Longterm Immunosuppression in Pediatric and Adolescent Kidney Transplant Recipients|Terminated||Phase 4|50|Actual|University of Erlangen-Nürnberg Medical School||2||"Recruitment goals were not achieved. Extension of the trial concept had to be abjected due to~   methodological reasons."|f||||t||||||||||2017-02-18 14:27:57.221013|2017-02-18 14:27:57.221013
NCT00663442|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-21|||December 1999||1999-12-01|April 2008|2008-04-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)|Dose Response Pharmacogenetic Study of ADHD|Completed||Phase 4|48|Actual|University of Illinois at Chicago||1|||f||||f||||||||||2017-02-18 14:27:57.335605|2017-02-18 14:27:57.335605
NCT00661271|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-07-18|||September 2007||2007-09-01|March 2011|2011-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Mindfulness-based Stress Reduction for Urban Youth|Mindfulness-based Stress Reduction for Urban Youth|Completed||Phase 1/Phase 2|60|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:28:56.592263|2017-02-18 14:28:56.592263
NCT00663429|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-08-30|||November 2007||2007-11-01|January 2009|2009-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma|A Phase II Open-Label Extension Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma|Completed||Phase 2|10|Actual|Callisto Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:27:57.465331|2017-02-18 14:27:57.465331
NCT00663416|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-08-10|||March 2008||2008-03-01|August 2009|2009-08-01|January 2009|Anticipated|2009-01-01|October 2008|Anticipated|2008-10-01||Interventional|REGENESIS||REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients|A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)|Terminated||Phase 2|134|Anticipated|Stem Cell Therapeutics Corp.||2|||f||||t||||||||||2017-02-18 14:27:57.563482|2017-02-18 14:27:57.563482
NCT00663403|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-12-01|2010-04-29||February 2007||2007-02-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)|Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)|Completed||Phase 4|8|Actual|University of Michigan|Transmembrane and total body clearance results limited to continuous venovenous hemodialysis run at ~2 L/h dialysate flow. Clinical outcomes (such as infection cure rate, length of hospital stay, mortality rate) of subjects was not assessed.|1|||f||||f||||||||||2017-02-18 14:27:57.698305|2017-02-18 14:27:57.698305
NCT00663390|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-01-28|||December 2007||2007-12-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR|Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR|Completed||Phase 3|30|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:27:57.980031|2017-02-18 14:27:57.980031
NCT00663377|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-18|||April 2006||2006-04-01|April 2008|2008-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Effects of Losartan on Insulin Resistance in Patients With Heart Failure|Losartan Improved Insulin Resistance and Decreased Inflammatory Cytokines in Patients With Chronic Heart Failure Treated With Angiotensin Converting Enzyme Inhibitors|Completed||Phase 4|16|Anticipated|Tottori University Hospital|||||f||||f||||||||||2017-02-18 14:27:58.073433|2017-02-18 14:27:58.073433
NCT00663364|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2010-07-06|||April 2008||2008-04-01|February 2009|2009-02-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Care of the Dry Skin With Physiogel AI Lotion® (W0156)|Klinische Untersuchung Zur Pflege Trockener Haut Mit Physiogel AI Lotion Und Physiogel Lotion|Completed||N/A|100|Actual|University Hospital Muenster||2|||f||||t||||||||||2017-02-18 14:27:58.167822|2017-02-18 14:27:58.167822
NCT00663351|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2015-03-18|||December 2004||2004-12-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|RCH||Safety and Effectiveness Study of the Reflection Ceramic Acetabular System|Post Approval Study: Reflection Ceramic Acetabular System|Completed||N/A|456|Actual|Smith & Nephew, Inc.||2|||f||||||||||||||2017-02-18 14:27:58.269314|2017-02-18 14:27:58.269314
NCT00663338|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2011-02-18|||January 2010||2010-01-01|January 2010|2010-01-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke|A Multi-centre Exploratory Study to Evaluate the Efficacy of the Dopamine Receptor Agonist Rotigotine in the Treatment of Hemispatial Neglect and Motor Deficits Following Stroke|Completed||Phase 2|20|Anticipated|University College, London||1|||f||||t||||||||||2017-02-18 14:27:58.385641|2017-02-18 14:27:58.385641
NCT00663325|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-01-07|||December 2007||2007-12-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower|Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Tangerina Mix|Completed||Phase 3|30|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:27:58.496796|2017-02-18 14:27:58.496796
NCT00663312|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-10-07|||April 2008||2008-04-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease|Impact of Deep Brain Stimulation of Subthalamic Nucleus on the Hepatic Glucose Production in Parkinson's Disease|Terminated||N/A|8|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 14:27:58.602606|2017-02-18 14:27:58.602606
NCT00663299|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-05-15|||June 2004||2004-06-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|COMPLEX||COMPLEX Post Market Surveillance Electronic Registry|COMPLEX Post Market Surveillance Electronic Registry|Completed||N/A|299|Actual|Codman & Shurtleff||1|||f||||f||||||||||2017-02-18 14:27:58.708701|2017-02-18 14:27:58.708701
NCT00663286|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-18|||October 2006||2006-10-01|April 2008|2008-04-01||||August 2007|Actual|2007-08-01||Interventional|||A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris||Completed||Phase 3|1399|Actual|Dow Pharmaceutical Sciences||4|||f||||||||||||||2017-02-18 14:27:58.823411|2017-02-18 14:27:58.823411
NCT00663273|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2009-01-07|||December 2007||2007-12-01|January 2009|2009-01-01||||January 2008|Actual|2008-01-01||Interventional|||Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower|Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower|Completed||Phase 3|30|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 14:27:58.967349|2017-02-18 14:27:58.967349
NCT00663260|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2016-12-20|2016-09-28||June 2008||2008-06-01|December 2016|2016-12-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional||All randomized participants who received at least 1 dose of study medication|Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment|A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase 2/3 Trial to Evaluate the Glycemic Efficacy, Renal Safety, Pharmacokinetics, and Pharmacodynamics of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control|Completed||Phase 2/Phase 3|631|Actual|AstraZeneca||3|||f||||t||||||||||2017-02-18 14:27:59.072001|2017-02-18 14:27:59.072001
NCT00663247|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-06-13|||April 2008||2008-04-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease|Mechanistic Randomized Controlled Trial of Mesalazine in Symptomatic Diverticular Disease|Completed||N/A|40|Actual|University of Nottingham||2|||f||||t||||||||||2017-02-18 14:28:00.032381|2017-02-18 14:28:00.032381
NCT00663234|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2016-03-08|2015-12-03||August 2009||2009-08-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All participants who initiated Atorvastatin were included in the baseline characteristics.|IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia|Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of PI-Associated Increased LDL Cholesterol in HIV-Infected Children and Adolescents|Terminated||Phase 1/Phase 2|28|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|Target enrollment was 40 participants (20 in each age cohort). However, the study was prematurely discontinued due to administrative reasons, having enrolled only 28 participants (21 participants aged 10 to 14 and 7 participants aged 15 to 23).|2||The study was prematurely discontinued due to administrative reasons.|f||||t||||||||||2017-02-18 14:28:00.158272|2017-02-18 14:28:00.158272
NCT00663221|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2009-07-03|||March 2008||2008-03-01|July 2009|2009-07-01||||||||Interventional|||Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin D||Completed||Phase 2|56|Anticipated|Elvir SAS||2|||f||||||||||||||2017-02-18 14:28:01.057309|2017-02-18 14:28:01.057309
NCT00663208|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-09-16|2015-08-14||May 2008||2008-05-01|September 2015|2015-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||The analysis was performed on all treated participants.|A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects|Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Antiviral Activity and Safety, Tolerability, and Pharmacokinetics of Daclatasvir in Subjects Infected With Hepatitis C Virus Genotype 1|Completed||Phase 2|167|Actual|Bristol-Myers Squibb||6|||f||||f||||||||||2017-02-18 14:28:01.162208|2017-02-18 14:28:01.162208
NCT00663195|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2008-04-18|||January 2004||2004-01-01|April 2008|2008-04-01|December 2005|Actual|2005-12-01|||||Interventional|||Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure|Effects of Spironolactone on Circulating MMPs in Patients With Chronic Heart Failure|Completed||Phase 4|16|Actual|Tottori University Hospital|||||f||||||||||||||2017-02-18 14:28:03.268773|2017-02-18 14:28:03.268773
NCT00663182|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2008-04-22|||January 2008||2008-01-01|April 2008|2008-04-01|December 2012|Anticipated|2012-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis|Entecavir for Patients With Decompensated HBV-Related Cirrhosis:a Prospective Randomized Controlled Trial|Unknown status|Enrolling by invitation|Phase 4|200|Anticipated|Shanghai Changzheng Hospital||2|||f||||t||||||||||2017-02-18 14:28:03.360131|2017-02-18 14:28:03.360131
NCT00663169|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2012-12-04|2012-08-30||April 2008||2008-04-01|December 2012|2012-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout|A Randomized, Double-blind, Double-dummy, Active-controlled, Parallel Group Study of a Single Dose of ACZ885 in Hospitalized Patients With Acute Gout|Completed||Phase 2|6|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:28:03.480801|2017-02-18 14:28:03.480801
NCT00663156|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2013-02-14|||March 2008||2008-03-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Prospective Study of Autologous Fat Grafting for Breast Augmentation||Completed||N/A|13|Actual|Georgetown University||2|||f||||||||||||||2017-02-18 14:28:03.932381|2017-02-18 14:28:03.932381
NCT00663143|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-03-30|||July 2009||2009-07-01|March 2015|2015-03-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Observational|TZDBONE||Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation|Thiazolidinedione-Induced Bone Loss: Effects on Bone Marrow Stromal Cell Differentiation Capacity and Osteoblast Formation|Completed||N/A|9|Actual|Emory University|||1||f||||t||||||Samples Without DNA|"~     Bone Marrow~   "|||2017-02-18 14:28:04.036595|2017-02-18 14:28:04.036595
NCT00663130|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2013-10-09|||April 2004||2004-04-01|October 2013|2013-10-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)|A Randomised, Double-blind, Double-dummy, Parallel-group, Active-controlled Study Evaluating the Efficacy of Vardenafil Versus Tadalafil When Intercourse is Attempted Within 45 Minutes of Administration in Subjects With Erectile Dysfunction|Completed||Phase 4|759|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:28:04.346774|2017-02-18 14:28:04.346774
NCT00663117|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-05-16|2012-11-30||September 2006||2006-09-01|May 2013|2013-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|LDN||The Effects of Naltrexone on Active Crohn's Disease|The Effects of Naltrexone in Active Crohn's Disease|Completed||Phase 2|40|Actual|Penn State University||2|||f||||t||||||||||2017-02-18 14:28:04.445099|2017-02-18 14:28:04.445099
NCT00663104|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-21|2015-05-27|||April 2008||2008-04-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause|Effect of Exercise and Exercise + Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause|Terminated||Phase 3|126|Actual|University of Erlangen-Nürnberg Medical School||3|||f||||f||||||||||2017-02-18 14:28:04.944672|2017-02-18 14:28:04.944672
NCT00663091|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-09-06|||September 2006||2006-09-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|WPP-201||A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers|A Prospective, Randomized Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers|Completed||Phase 1|64|Actual|Southwest Regional Wound Care Center||1|||f||||t||||||||||2017-02-18 14:28:05.052314|2017-02-18 14:28:05.052314
NCT00663078|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2010-01-13|||August 2007||2007-08-01|February 2009|2009-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|BackonTrack||Group Cognitive Behavioral Therapy (CBT) Intervention for Women With Mild to Moderate Depression|A Pilot Study to Develop a Brief Group Intervention for Women With Mild and Moderate Depression|Completed||Early Phase 1|75|Actual|University of Bristol||2|||f||||f||||||||||2017-02-18 14:28:05.158444|2017-02-18 14:28:05.158444
NCT00663065|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2009-08-03|||April 2008||2008-04-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of the Safety of PAZ-417 in Healthy Elderly Adults|An Ascending Multiple-Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of PAZ-417 Administered Orally to Elderly Subjects|Terminated||Phase 1|40|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:28:05.248385|2017-02-18 14:28:05.248385
NCT00005187|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||April 1986||1986-04-01|April 2000|2000-04-01|March 1991||1991-03-01|||||Observational|||Cardiovascular Risk Profile Among Mexican-Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:23.062432|2017-02-18 18:15:23.062432
NCT00663052|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-03-29|2011-01-18||June 2008||2008-06-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|PRISTINE||Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis|A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe Psoriasis|Completed||Phase 4|273|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:28:05.365069|2017-02-18 14:28:05.365069
NCT00663039|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2016-09-23|||October 2009||2009-10-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2015|Actual|2015-07-01||Interventional|||Effects of Oxytocin Nasal Spray on Social Affiliation|Effects of Oxytocin Nasal Spray on Social Affiliation|Active, not recruiting||Phase 2|29|Actual|University of Maryland||2|||f||||t||||||||No||2017-02-18 14:28:08.640503|2017-02-18 14:28:08.640503
NCT00663026|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2013-09-11|2013-09-11||November 2008||2008-11-01|September 2013|2013-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Study Evaluating Bapineuzumab In Alzheimer Disease Subjects|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Safety, Tolerability, Reactogenicity, And Pharmacokinetic Study Of Bapineuzumab (AAB 001) Administered Subcutaneously In Subjects With Mild To Moderate AD|Completed||Phase 2|79|Actual|Pfizer|Designation of outcomes as primary, secondary was based on study team’s input as study did not specify them as primary or secondary.|3|||f||||t||||||||||2017-02-18 14:28:08.755463|2017-02-18 14:28:08.755463
NCT00663013|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2011-01-03|||October 2007||2007-10-01|January 2011|2011-01-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Virtual Reality for Burn Wound Care Pain Control|Virtual Reality for Burn Wound Care Pain Control|Unknown status|Recruiting|N/A|12|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:28:09.423719|2017-02-18 14:28:09.423719
NCT00663000|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-09-13|||April 2008||2008-04-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|April 2011|Actual|2011-04-01||Observational|||Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance|Observational, Cross-sectional, Longitudinal, Multi-center, Diagnostic Study to Evaluate the Influence of Acromegaly on Glucose Tolerance and to Evaluate the Changes of Impaired Glucose Tolerance During Standard Treatment of Acromegaly.|Completed||N/A|138|Actual|University Hospital Tuebingen|||1||f||||t||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:28:09.536922|2017-02-18 14:28:09.536922
NCT00662987|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-04-17|||September 2005||2005-09-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy|Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy|Completed||N/A|50|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:28:09.644285|2017-02-18 14:28:09.644285
NCT00662974|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-04-18|||May 2008||2008-05-01|March 2008|2008-03-01|March 2009|Anticipated|2009-03-01|December 2008|Anticipated|2008-12-01||Interventional|||Searching for the Perfect Oil to Protect the Perineum: A Randomized-Controlled, Double-Blind Trial|A Randomised Double Blind Clinical Trial to Verify if Perineal Massage Increases the Chances of Delivering With an Intact Perineum Comparing the Two Oils. As Secondary Objective, we Will Evaluate the Effects of Perineal Massage on Specific Tear Location, the Severity of Perineal Tears and the Amount of Suture Material Required for Repair|Unknown status|Not yet recruiting|N/A|300|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-02-18 14:28:09.745886|2017-02-18 14:28:09.745886
NCT00662961|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-17|||January 2007||2007-01-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|Forehead||Forehead Lift Fixation|Periosteum Versus Bone for the Fixation of Forehead Lift: A Prospective, Randomized, Controlled, Split-Face Trial.|Completed||N/A|12|Actual|Federal University of Uberlandia||2|||f||||f||||||||||2017-02-18 14:28:09.832138|2017-02-18 14:28:09.832138
NCT00662948|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2016-05-16|||December 2008||2008-12-01|May 2016|2016-05-01|October 2016|Anticipated|2016-10-01|October 2014|Actual|2014-10-01||Interventional|||ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)|Open Study in Phase II to Evaluate Efficacy of Initial R-CHOP Combination in Folicular Lymphoma no Treated Previously. Consolidation w Ith One Dose of 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)|Suspended||Phase 2|140|Anticipated|PETHEMA Foundation||2||No inclusion|f||||t||||||||||2017-02-18 14:28:09.925889|2017-02-18 14:28:09.925889
NCT00662935|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-04-17|||May 2005||2005-05-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH)|Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH)|Completed||N/A|12|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 14:28:10.076103|2017-02-18 14:28:10.076103
NCT00662922|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2010-01-08|||April 2008||2008-04-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Consequences of Hypoglycemia on Intensive Care Unit (ICU) Patients|Does Hypoglycemia Under Intensive Insulin Therapy During Critical Illness Lead to Neurocognitive Dysfunction|Completed||N/A|74|Actual|University Hospital Muenster|||2||f||||f||||||||||2017-02-18 14:28:10.164593|2017-02-18 14:28:10.164593
NCT00662909|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2015-06-05|2012-07-11||April 2008||2008-04-01|June 2015|2015-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ARIES||Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder|A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder|Completed||Phase 3|2149|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|3|||f||||f||||||||||2017-02-18 14:28:10.264307|2017-02-18 14:28:10.264307
NCT00662896|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2011-06-16|||March 2008||2008-03-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|HCT3012-X-112||To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension|A 16-week, Phase 1, Multicenter, Double-Blind, Randomized, Naproxen and Ibuprofen-controlled, Parallel-Group Pharmacological Study, to Assess the Effect of Naproxcinod (375mg and750mg, Bid) Compared to Doses of Naproxen (250mg and 500mg, Bid) and to Ibuprofen (600mg, Tid) on Arterial Blood Pressure as Measured by Ambulatory Blood Pressure Monitoring in Osteoarthritis Patients With Controlled Essential Hypertension.|Completed||Phase 1|300|Anticipated|NicOx||5|||f||||t||||||||||2017-02-18 14:28:15.040274|2017-02-18 14:28:15.040274
NCT00662883|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-04-21|||November 2007||2007-11-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)|A Randomized, Open Label Study to Assess the Effects of a Nasal Corticosteroid on the Pharmacokinetics, Safety, and Tolerability of PMI-150 (Intranasal Ketamine Hydrochloride) 30 mg|Completed||Phase 1|18|Actual|Javelin Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:28:15.397378|2017-02-18 14:28:15.397378
NCT00662870|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-01-26|||May 2001||2001-05-01|January 2012|2012-01-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine|Safety, Immunogenicity and Lot Comparability of DAPTACEL™ (Aventis Pasteur Classic Five-component Pertussis Vaccine in Combination With Tetanus and Diphtheria Toxoids Adsorbed) When Administered With Other Recommended Vaccines at 2, 4, 6, and 15 to 16 Months of Age.|Completed||Phase 3|1941|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 14:28:15.499901|2017-02-18 14:28:15.499901
NCT00662857|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2014-10-09|2014-07-22||April 2008||2008-04-01|October 2014|2014-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro|"A Phase 2, Open-Label, Randomized, 2-Way Crossover, Clinical Trial to Compare the Pharmacokinetics of 2 Formulations of Intended Commercial Product Technosphere® Insulin Inhalation Powder and to Determine the Bioavailability of a 30 Unit Cartridge of Intended Commercial Product Technosphere® Insulin Inhalation Powder Versus a 10 Unit Subcutaneous Injection of Insulin Lispro in Subjects With Type 1 Diabetes Mellitus"|Completed||Phase 2|29|Actual|Mannkind Corporation||3|||f||||||||||||||2017-02-18 14:28:15.647614|2017-02-18 14:28:15.647614
NCT00662844|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2016-03-24|||April 2008||2008-04-01|March 2016|2016-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|VITADAS||Vitamin D Supplementation in Younger Women|Optimum Vitamin D Nutrition in Young Women|Completed||N/A|198|Actual|Creighton University||5|||f||||t||||||||No||2017-02-18 14:28:16.195613|2017-02-18 14:28:16.195613
NCT00662831|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2011-12-01|2011-08-11||April 2008||2008-04-01|December 2011|2011-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|FEENICS||Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients|A 6 Month, Prospective, Randomized, Double Blind, Placebo-Controlled, Parallel Group, Multiple Center Trial To Evaluate The Efficacy And Safety Of Fragmin In The Treatment Of Chronic Neuroischaemic Foot Ulcers In Diabetic Patients|Completed||Phase 2/Phase 3|276|Actual|Pfizer|Study enrollment was terminated before planned number of participants was obtained. Although randomized participants were allowed to complete entire course of therapy according to protocol and study status was therefore designated as completed.|2|||f||||t||||||||||2017-02-18 14:28:16.341222|2017-02-18 14:28:16.341222
NCT00662818|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2015-09-03|2014-09-05||March 2008||2008-03-01|September 2015|2015-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||All treated participants|Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)|A Multicenter, Randomized, Double-Blind, Placebo- and Active Controlled, Crossover Study to Evaluate the Safety and Efficacy of MK-0974 in the Treatment of Acute Migraine in Patients With Stable Vascular Disease|Completed||Phase 3|165|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 14:28:17.333045|2017-02-18 14:28:17.333045
NCT00662805|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2014-01-16|||June 2004||2004-06-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)|A 2-year Observational Study to Evaluate Safety of Seretide 50/500μg Twice Daily Administered by DISKUS, in Patients With COPD|Completed||N/A|762|Actual|GlaxoSmithKline|||1||f||||f||||||Samples Without DNA|"~     Participants will undergo physical examination and blood pressure measurement. A complete~     medical history will be taken, as well as blood and urine samples.~   "|||2017-02-18 14:28:17.981132|2017-02-18 14:28:17.981132
NCT00662792|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-04-30||2014-04-30|April 2008||2008-04-01|April 2014|2014-04-01||||August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD|A Randomised, Double-blind Clinical Efficacy and Safety Comparison of Tiotropium/Salmeterol 7.5/25 Inhalation Powder in the Morning Via Tiotropium/Salmeterol HandiHaler, Tiotropium 18 Mcg Inhalation Powder in the Morning Via Spiriva HandiHaler, Salmeterol 50 Mcg MDPI in the Morning and Evening and the Free Combination Tiotropium 18 Mcg Inhalation Powder in the Morning Via Spiriva HandiHaler Plus Salmeterol 50 Mcg MDPI in the Morning and Evening Following Chronic Administration (6-week Treatment Periods) in Patients With COPD|Completed||Phase 3|147|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:28:18.079629|2017-02-18 14:28:18.079629
NCT00662779|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2015-12-09|||April 2008||2008-04-01|December 2015|2015-12-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|EIB||Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)|Evaluation of the Bronchoprotective Effect of Arformoterol in Children With Exercise Induced Bronchospasm|Withdrawn||Phase 3|0|Actual|University of New Mexico||3||High number of screen failures-couldn't find qualified subjects in timely manner|f||||t||||||||||2017-02-18 14:28:18.190352|2017-02-18 14:28:18.190352
NCT00662766|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2008-04-16|||September 2005||2005-09-01|April 2008|2008-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Intervention With Black Currant Seed Press Residues in Healthy Subjects|Intervention Study on the Health Beneficial Effects of Bread Enriched With Black Currant Seed Press Residues in Healthy Subjects|Completed||N/A|36|Actual|University of Jena||1|||f||||t||||||||||2017-02-18 14:28:18.30404|2017-02-18 14:28:18.30404
NCT00662753|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2016-02-23|||April 2008||2008-04-01|April 2008|2008-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure|A Structured Program for Hypertension Control in Community Clinics: A Randomized Trial|Completed||Phase 1|111|Actual|George Washington University||2|||f||||f||||||||||2017-02-18 14:28:18.388716|2017-02-18 14:28:18.388716
NCT00662740|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-04-30||2014-04-30|April 2008||2008-04-01|April 2014|2014-04-01||||November 2008|Actual|2008-11-01||Interventional|||Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol PE Capsule) in COPD|1-yr Study Comparing TioSal Combo Regimens Versus Single Agent Therapies (Spiriva HandiHaler and Salmeterol PE Capsule)|Terminated||Phase 3|220|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-02-18 14:28:18.498496|2017-02-18 14:28:18.498496
NCT00662727|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2013-02-17|||January 2007||2007-01-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|June 2012|Actual|2012-06-01||Interventional|||Extracorporeal Shockwave Therapy for the Treatment of Refractory Angina Pectoris|Randomized, Placebo Controlled, Double Blind Clinical Trial Evaluating the Treatment of Patients With Refractory Angina Pectoris With Low Intensity Extracorporeal Shockwave Therapy Device|Completed||Phase 2|28|Actual|Medispec||2|||f||||f||||||||||2017-02-18 14:28:18.701602|2017-02-18 14:28:18.701602
NCT00662714|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-07-06|||September 2001||2001-09-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis|Open Randomised Prospective Comparative Multi-centre Intervention Study of Patients With Cystic Fibrosis and Early Diagnosed Diabetes Mellitus|Completed||Phase 3|73|Actual|Mukoviszidose Institut gGmbH||2|||f||||f||||||||||2017-02-18 14:28:18.810727|2017-02-18 14:28:18.810727
NCT00662701|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2015-11-18|||May 2007||2007-05-01|November 2015|2015-11-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|FAST||Ablation or Surgery for Atrial Fibrillation (AF) Treatment|Atrial Fibrillation: Ablation or Surgical Treatment; A Randomized Study Comparing Non-pharmacologic Therapy in Patients With Drug-refractory Atrial Fibrillation|Completed||N/A|120|Actual|St. Antonius Hospital||2|||f||||t||||||||||2017-02-18 14:28:18.94909|2017-02-18 14:28:18.94909
NCT00662688|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-03-12|||October 2007||2007-10-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PAM07||Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer|Chemotherapy With or Without Preventive Anticoagulation for Metastatic Cancer of the Pancreas|Terminated||Phase 3|42|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2||recruitment prematurely stopped due to a lack of eligible patients.|f||||f||||||||||2017-02-18 14:28:19.056449|2017-02-18 14:28:19.056449
NCT00662675|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-04-24|2010-02-05||August 2008||2008-08-01|April 2014|2014-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency|A Randomized Double-blind (Withdrawal) Phase 3 Study to Evaluate the Efficacy and Tolerability of Pancrelipase MT Capsules Compared With Placebo in the Treatment of Subjects With Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency|Completed||Phase 3|40|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-02-18 14:28:19.173534|2017-02-18 14:28:19.173534
NCT00662662|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2016-02-18|||April 2008||2008-04-01|February 2016|2016-02-01||||April 2018|Anticipated|2018-04-01||Observational|||Sexual Behavior in Head and Neck Cancer Patients|Sexual Behavior in Head and Neck Cancer Patients|Active, not recruiting||N/A|1500|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 14:28:19.700786|2017-02-18 14:28:19.700786
NCT00662649|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-06-09|2012-06-09||February 2008||2008-02-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis|An Extension of the 24-month, Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing Efficacy and Safety of Fingolimod (FTY720) 1.25 mg and 0.5 mg Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis|Completed||Phase 3|920|Actual|Novartis||5|||f||||||||||||||2017-02-18 14:28:19.829163|2017-02-18 14:28:19.829163
NCT00662636|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2016-04-18|||August 2008||2008-08-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery|Phase I Trial of the Combination of Dasatinib and Lapatinib|Active, not recruiting||Phase 1|38|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:28:21.354413|2017-02-18 14:28:21.354413
NCT00662623|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-05-12|||April 2008||2008-04-01|May 2016|2016-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Enabling Sleep Apnea Patient-Centered Care Via an Internet Intervention|Enabling Sleep Apnea Patient-Centered Care Via an Internet Intervention|Completed||Phase 2/Phase 3|200|Anticipated|Veterans Medical Research Foundation||2|||f||||f||||||||||2017-02-18 14:28:21.470571|2017-02-18 14:28:21.470571
NCT00662610|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2011-06-16|||March 2008||2008-03-01|June 2011|2011-06-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|HCT3012-X-111||A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure|A 12-Week, Phase 1, Multicenter, Double-Blind, Randomized, Dose Ranging, Forced Titration, Naproxen-Controlled, Parallel-Group, Pharmacodynamic Study, to Assess the Effects Different Doses of Naproxcinod and Naproxen on Arterial Blood Pressure as Measured by Ambulatory Blood Pressure Monitoring in Osteoarthritis Patients With Controlled Essential Hypertension|Completed||Phase 1|120|Anticipated|NicOx||2|||f||||t||||||||||2017-02-18 14:28:21.573865|2017-02-18 14:28:21.573865
NCT00662597|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-05-03||2012-05-01|April 2008||2008-04-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|ATRACT-1||ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer|A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of ASA404 in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 3|1285|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:28:21.727565|2017-02-18 14:28:21.727565
NCT00662584|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-08-17|||August 2006||2006-08-01|August 2016|2016-08-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Repetitive Magnetic Transcranial Stimulation (rTMS) in the Treatment of Generalized Anxiety Disorder (GAD)|The Efficacy of Functional Magnetic Resonance Imaging (fMRI) Guided Low Frequency Repetitive Magnetic Transcranial Stimulation (rTMS) Therapy on Symptoms of Generalized Anxiety Disorder (GAD)|Completed||Phase 3|10|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-02-18 14:28:22.291414|2017-02-18 14:28:22.291414
NCT00662571|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2013-03-20|||May 2008||2008-05-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|ACAM||Acamprosate: Genes Associated With Response|A Probe Study of Acamprosate: Genes Associated With Response|Completed||Phase 4|485|Actual|Mayo Clinic|||1||f||||t||||||Samples With DNA|"~     Samples obtained from study Developing a DNA Repository for Genomic Studies of Addiction: A~     Pilot Study~   "|||2017-02-18 14:28:22.395864|2017-02-18 14:28:22.395864
NCT00661258|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2008-05-08|||June 2006||2006-06-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|AFL||China Adherence for Life|Adherence for Life Pilot Study: Phases II and III|Completed||N/A|80|Actual|Boston University||2|||f||||f||||||||||2017-02-18 14:28:56.702162|2017-02-18 14:28:56.702162
NCT00662558|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-10-21|2009-09-10||January 2008||2008-01-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain|A Six Week Double-Blind, Randomized, Multicenter Comparison Study Of The Analgesic Effectiveness Of Celecoxib 200 Mg BID Compared To Tramadol Hydrochloride 50 Mg QID In Subjects With Chronic Low Back Pain|Completed||Phase 3|802|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:28:22.516982|2017-02-18 14:28:22.516982
NCT00662545|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2013-05-17|2013-05-14||April 2008||2008-04-01|May 2013|2013-05-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection|Entecavir Intensification for Persistent Hepatitis B Virus (HBV) Viremia in HIV-HBV Infection|Completed||Phase 4|10|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:28:23.401764|2017-02-18 14:28:23.401764
NCT00662532|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2011-12-06|2010-04-27||April 2008||2008-04-01|December 2011|2011-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Antibiotic Study for Dental Implants|Multi-Center Phase 3 Trial of Minocycline HCl 1mg Microspheres for the Use in Subjects With Peri-Implantitis|Completed||Phase 3|44|Actual|OraPharma||2|||f||||f||||||||||2017-02-18 14:28:24.070656|2017-02-18 14:28:24.070656
NCT00662519|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2015-04-08|||April 2008||2008-04-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Neulasta in Type 1 Diabetes|Short Course of Pegylated GCSF (Neulasta®) as Immunomodulatory Therapy for Type 1 Diabetes|Completed||Phase 1|21|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 14:28:24.482294|2017-02-18 14:28:24.482294
NCT00662506|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2017-01-31|||April 2008||2008-04-01|November 2016|2016-11-01||||March 2017|Anticipated|2017-03-01||Interventional|||Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma|A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:28:24.605366|2017-02-18 14:28:24.605366
NCT00662493|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-18|||March 2003||2003-03-01|April 2008|2008-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Comparison of Two Exercise Programs on Knee Motor Control|The Effect of Specific Versus Generalised Quadriceps Exercise on Neural Control of the Vasti|Completed||Phase 2|60|Actual|University of Melbourne||1|||f||||f||||||||||2017-02-18 14:28:24.747685|2017-02-18 14:28:24.747685
NCT00662480|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2016-02-24|||September 2008||2008-09-01|February 2009|2009-02-01|December 2023|Anticipated|2023-12-01|September 2018|Anticipated|2018-09-01||Interventional|||Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark|Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark|Recruiting||Phase 4|40000|Anticipated|Central Jutland Regional Hospital||2|||f||||t||||||||||2017-02-18 14:28:24.851038|2017-02-18 14:28:24.851038
NCT00662467|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-04-18|||November 2006||2006-11-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Warfarin After Anterior ST-Elevation Myocardial Infarction|Warfarin After Anterior ST-Elevation Myocardial Infarction|Completed||N/A|20|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 14:28:24.963095|2017-02-18 14:28:24.963095
NCT00662454|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2011-08-03|||January 2006||2006-01-01|August 2011|2011-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Oral Contraceptive Efficacy and Body Weight|Oral Contraceptive Efficacy and Body Weight: Does Obesity Affect the Risk of Contraceptive Failure?|Completed||Phase 4|120|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:28:25.079165|2017-02-18 14:28:25.079165
NCT00662441|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2009-06-19|||September 2003||2003-09-01|June 2009|2009-06-01|June 2004|Actual|2004-06-01|||||Interventional|||Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction|Open-Label, Multi-Centre, Study of Levitra 10 mg Once a Day in Males With Erectile Dysfunction Was Carried Out in Four Centres Namely Lagos, Port Harcourt, Enuge and Maiduguri at Their University Teaching Hospitals|Completed||Phase 4|102|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:28:25.187936|2017-02-18 14:28:25.187936
NCT00662428|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-06-20|||May 2008||2008-05-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|September 2010|Actual|2010-09-01||Interventional|INCA||Increasing Cost-effectiveness of Inpatient Treatment of Affective Disorders|Evaluation of a Guideline-based Net Care Intervention to Reduce the Duration of Inpatient Depression Treatment|Completed||N/A|202|Actual|University Hospital Freiburg||2|||f||||||||||||||2017-02-18 14:28:25.276252|2017-02-18 14:28:25.276252
NCT00662415|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2008-04-14|||February 2008||2008-02-01|April 2008|2008-04-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Examining Brain Changes Using Functional Magnetic Resonance Imaging (fMRI) in Amputees With Phantom Limb Pain Following Mirror Therapy|Study Using Functional MRI to Examine Changes in the Brain in Unilateral Lower Limb Amputees Treated With Mirror Therapy for Phantom Limb Pain.|Unknown status|Recruiting|N/A|42|Anticipated|Walter Reed Army Medical Center||2|||f||||f||||||||||2017-02-18 14:28:25.380517|2017-02-18 14:28:25.380517
NCT00662402|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2015-10-20|||April 2008||2008-04-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Impact of Extensive Consultation on Career Development Grant Outcomes|Impact of Extensive Consultation on Career Development Grant Outcomes|Active, not recruiting||N/A|132|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:28:25.480616|2017-02-18 14:28:25.480616
NCT00662389|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2009-07-22|2009-07-22||April 2008||2008-04-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Application of the Apsara Thermal Wand System|TP-1013 Pilot 1: Application of the Apsara Thermal Wand System|Completed||Early Phase 1|4|Actual|Apsara Medical Corporation||1|||f||||||||||||||2017-02-18 14:28:25.584041|2017-02-18 14:28:25.584041
NCT00662376|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-12-05|||April 2008||2008-04-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study on Safety, Tolerance and Metabolic Effects of a Nutritional Supplement, Given as a Drink Before Gallbladder Surgery|Safety, Tolerance and Metabolic Effects of Using a Preoperative Oral Nutritional Supplement (PreOP Booster) in Gastrointestinal Surgery|Completed||N/A|40|Actual|Fresenius Kabi||2|||f||||||||||||||2017-02-18 14:28:25.777868|2017-02-18 14:28:25.777868
NCT00662168|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-04-17|||January 2008||2008-01-01|April 2008|2008-04-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Observational|||An Investigation of Small Intestinal Carcinoid Carcinoma in Families|An Investigation of Eight Reported Cases of Small Intestinal Carcinoid Carcinoma in Multiple Family Members|Unknown status|Recruiting|N/A|8|Anticipated|Rutgers University|||1||f||||f||||||||||2017-02-18 14:28:28.215845|2017-02-18 14:28:28.215845
NCT00662363|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2013-02-27|2012-10-23||April 2008||2008-04-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation|Lubiprostone (Amitiza®) Compared to Standard Care in the Treatment of Postoperative Opioid-induced Constipation in Inpatient Rehabilitation Patients Following Orthopedic Procedures|Completed||N/A|64|Actual|Rehabilitation Institute of Chicago|Additional laxatives were frequently required for symptom control|2|||f||||f||||||||||2017-02-18 14:28:25.870767|2017-02-18 14:28:25.870767
NCT00662350|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2010-02-03|||June 2008||2008-06-01|February 2010|2010-02-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|WT-DK-TMW08||Temperature Mapping of the Prostate With the Wallterm™ System|Temperature Mapping of the Prostate With the Wallterm™ System|Completed||N/A|6|Actual|Pnn Medical A/S|||1||f||||f||||||||||2017-02-18 14:28:26.273166|2017-02-18 14:28:26.273166
NCT00662337|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-09-07|||October 2006||2006-10-01|September 2011|2011-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride|A Randomized, Two-Way Crossover Evaluation of the Bioequivalence Between Two Oral Formulations of Diphenhydramine: ULTRATAB Tablet Versus KAPSEALS Capsule|Completed||Phase 1|36|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||f||||||||||2017-02-18 14:28:26.581606|2017-02-18 14:28:26.581606
NCT00662324|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2013-05-29|||April 2008||2008-04-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Development of a Clinical Trial Specific Question Prompt List|Development of a Clinical Trial Specific Question Prompt List|Completed||N/A|67|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 14:28:26.678769|2017-02-18 14:28:26.678769
NCT00662311|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2013-05-07|||March 2008||2008-03-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|January 2010|Actual|2010-01-01||Interventional|||Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery|Phase I/II Clinical Trial Evaluating the Use of Vorinostat Combined With Paclitaxel and Radiotherapy in Patients With Inoperable Stage III Non-Small Cell Lung Cancer Unable to Tolerate Cisplatin|Terminated||Phase 1/Phase 2|5|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:28:26.776373|2017-02-18 14:28:26.776373
NCT00662298|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2015-03-25|||June 2011||2011-06-01|June 2011|2011-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Prednisolone Pharmacokinetics in Severe Asthma|The Pharmacokinetics and Anti-inflammatory Effects of Prednisolone in Severe Asthma|Completed||Phase 4|5|Actual|Imperial College London||1|||f||||f||||||||||2017-02-18 14:28:26.894702|2017-02-18 14:28:26.894702
NCT00662285|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-04-18|||April 2008||2008-04-01|April 2008|2008-04-01|April 2009|Anticipated|2009-04-01|April 2008|Anticipated|2008-04-01||Interventional|||Description of Iron Status in Blood Donors|Description of Iron Status in Blood Donors|Unknown status|Enrolling by invitation|N/A|400|Anticipated|Haukeland University Hospital||1|||f||||t||||||||||2017-02-18 14:28:27.02161|2017-02-18 14:28:27.02161
NCT00662272|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2010-03-15|||June 2008||2008-06-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|H-100-001||Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant|Randomized, Double Blind, Controlled Phase I Trial of the Safety, Tolerability and Immunogenicity of Fluzone® Inactivated Trivalent Influenza Virus Vaccine Administered With Ascending Doses of JVRS-100 Adjuvant|Completed||Phase 1|128|Actual|Colby Pharmaceutical Company||3|||f||||t||||||||||2017-02-18 14:28:27.136436|2017-02-18 14:28:27.136436
NCT00662259|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2009-05-21|||April 2008||2008-04-01|May 2009|2009-05-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder|Randomized, Double-Blind, Placebo-Controlled Study of a Benzodiazepine vs Placebo on Functional Magnetic Resonance Imaging (fMRI) of the Brain, and on Behavioral/Clinical Measures in Patients With Generalized Anxiety Disorder|Unknown status|Recruiting|Phase 4|36|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-02-18 14:28:27.27303|2017-02-18 14:28:27.27303
NCT00662246|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-04-02|||January 2007||2007-01-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma|A Phase I Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma|Completed||Phase 1|24|Actual|National Cancer Center, Korea||1|||f||||||||||||||2017-02-18 14:28:27.402441|2017-02-18 14:28:27.402441
NCT00662233|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-03-31|||October 1991||1991-10-01|March 2015|2015-03-01||||September 2015|Anticipated|2015-09-01||Interventional|||Combination Chemotherapy in Treating Patients With Sarcoma|A Pilot Study for Soft Tissue Sarcoma|Active, not recruiting||N/A|120|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:28:27.488972|2017-02-18 14:28:27.488972
NCT00662220|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-07-11|||April 2008||2008-04-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|VIRID||High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4|High-dose Versus Standard-dose Weight-based Ribavirin in Combination With Peginterferon Alfa-2a for Patients Infected With Hepatitis C Virus Genotype 1 or 4|Terminated||Phase 3|110|Actual|Foundation for Liver Research||2||"Due to the arrival of DAAs replacing standard of care for genotype 1 patients the VIRID study~   had to be terminated."|f||||t||||||||||2017-02-18 14:28:27.599581|2017-02-18 14:28:27.599581
NCT00662207|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-11-04|2014-11-04||October 2008||2008-10-01|November 2014|2014-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||baseline anal pressure|Two Devices for Reflex Voiding Following Spinal Cord Injury|Two Devices for Reflex Voiding Following SCI: Urodynamic Evaluation|Completed||Phase 1|3|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 14:28:27.7657|2017-02-18 14:28:27.7657
NCT00662194|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-03-06|||April 2008||2008-04-01|March 2014|2014-03-01|October 2014|Anticipated|2014-10-01|April 2014|Anticipated|2014-04-01||Observational|||Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)|A Study of Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C or Hepatitis B|Unknown status|Recruiting|N/A|40|Anticipated|Bayside Health|||8||f||||f||||||Samples Without DNA|"~     Serum samples~   "|||2017-02-18 14:28:28.008206|2017-02-18 14:28:28.008206
NCT00662181|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-04-18|||May 2008||2008-05-01|April 2008|2008-04-01|January 2009|Anticipated|2009-01-01|October 2008|Anticipated|2008-10-01||Observational|||Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone|Follow-up on the HIGH: Low Study - the Longterm Effect of Growth Hormone|Unknown status|Not yet recruiting|N/A|46|Anticipated|Hvidovre University Hospital|||1||f||||t||||||||||2017-02-18 14:28:28.110811|2017-02-18 14:28:28.110811
NCT00662129|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2016-08-12|||November 2008||2008-11-01|August 2016|2016-08-01||||August 2010|Actual|2010-08-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer|Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer|Active, not recruiting||Phase 2|51|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 14:28:28.554676|2017-02-18 14:28:28.554676
NCT00662116|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2009-01-29|||March 2008||2008-03-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|BREAK-DHF-I||Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure|Terminated||Phase 2|160|Anticipated|Synvista Therapeutics, Inc||2||Study has been terminated early due to financial constraints.|f||||t||||||||||2017-02-18 14:28:28.771856|2017-02-18 14:28:28.771856
NCT00662103|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2015-10-13|||March 2008||2008-03-01|October 2015|2015-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors|Comparison of Aerobic and Resistance Exercise in Older Breast Cancer Survivors|Completed||N/A|115|Actual|OHSU Knight Cancer Institute||3|||f||||||||||||||2017-02-18 14:28:28.893036|2017-02-18 14:28:28.893036
NCT00662090|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2015-12-02|||January 2006||2006-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|EWOG MDS 2006||Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood|Prospective Non-randomized Multi-center Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood|Recruiting||N/A|260|Anticipated|University Hospital Freiburg|||1||f||||f||||||Samples With DNA|"~     At diagnosis, prior to HSCT and at relapse material form peripheral blood and bone marrow~     will be retrieved and stored for research purposes. If there are other diagnostic bone~     marrow examinations at other time points (prior to HSCT), the material will be handled the~     same way.~      The following material will be retrieved:~        -  8 smears from PB~        -  8 smears from BM~        -  at least 5 ml of heparinized PB~        -  at least 5 ml of heparinized BM~   "|||2017-02-18 14:28:29.012293|2017-02-18 14:28:29.012293
NCT00662077|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-07-31||||||July 2008|2008-07-01||||||||Interventional|||Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort|Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort|Suspended||Phase 4|65|Anticipated|Germans Trias i Pujol Hospital||2||Financial difficulties|f||||f||||||||||2017-02-18 14:28:29.109151|2017-02-18 14:28:29.109151
NCT00662064|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-06-19|||February 2002||2002-02-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Pharmacology and Physiology of the Lower Urinary Tract|Pharmacology and Physiology of the Lower Urinary Tract|Unknown status|Recruiting|N/A|200|Anticipated|University College London Hospitals|||2||f||||f||||||Samples Without DNA|"~     bladder biopsies from patients with lower urinary tract dysfunction and from healthy~     controls~   "|||2017-02-18 14:28:29.222494|2017-02-18 14:28:29.222494
NCT00662051|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2013-08-07|||April 2008||2008-04-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Oral Contraceptives and Asthma Control|Oral Contraceptives and Asthma Control|Withdrawn||N/A|0|Actual|University of Kentucky|||2||f||||f||||||||||2017-02-18 14:28:29.307755|2017-02-18 14:28:29.307755
NCT00662038|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2016-07-13|||August 2008||2008-08-01|July 2016|2016-07-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|PIPF-012||Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)|An Open-Label Extension Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 3|1058|Actual|Genentech, Inc.||1|||f||||f||||||||||2017-02-18 14:28:29.392422|2017-02-18 14:28:29.392422
NCT00662025|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2013-05-22|2010-09-20||April 2008||2008-04-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|December 2009|Actual|2009-12-01||Interventional|||Study Of Sunitinib With Capecitabine In Breast Cancer|A Phase II Study Of Sunitinib Malate In Combination With Capecitabine In Patients With Advanced Or Metastatic Breast Cancer|Completed||Phase 2|63|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 14:28:29.570936|2017-02-18 14:28:29.570936
NCT00662012|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2016-08-25|||June 2002||2002-06-01|August 2016|2016-08-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Sodium Stibogluconate Treatment of Leishmaniasis|Sodium Stibogluconate Treatment of Leishmaniasis|Completed||Phase 2|418|Actual|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 14:28:32.58921|2017-02-18 14:28:32.58921
NCT00661999|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-05-13|2011-02-14||January 2006||2006-01-01|May 2011|2011-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer|A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Cancer Patients With Chemotherapy-Associated Anemia|Completed||Phase 3|502|Actual|Mayo Clinic||3|||f||||t||||||||||2017-02-18 14:28:32.714961|2017-02-18 14:28:32.714961
NCT00661986|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2010-02-01|||February 2008||2008-02-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Different Dosages of Dark Chocolate on Arterial Blood Pressure in Cardiovascular High-risk Patients|Effect of Different Dosages of Dark Chocolate on Arterial Blood Pressure in Cardiovascular High-risk Patients|Completed||Phase 4|102|Actual|University of Leipzig||2|||f||||f||||||||||2017-02-18 14:28:34.611427|2017-02-18 14:28:34.611427
NCT00661973|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2015-06-03|||April 2008||2008-04-01|June 2011|2011-06-01|March 2011|Anticipated|2011-03-01|December 2010|Anticipated|2010-12-01||Interventional|||Inhaled Corticosteroids on Airway Smooth Muscle in Asthma|The Effect of Inhaled Corticosteroids (ICS) on Airway Smooth Muscle in Asthma|Withdrawn||Phase 4|0|Actual|Imperial College London||1||The study was withdrawn for administrative reasons|f||||f||||||||||2017-02-18 14:28:34.691243|2017-02-18 14:28:34.691243
NCT00661960|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2017-01-11|2013-01-18||March 2008||2008-03-01|January 2017|2017-01-01|July 2011|Actual|2011-07-01|September 2010|Actual|2010-09-01||Interventional|||Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy|A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy|Completed||N/A|25|Actual|University of California, Davis|Limitations of the study include small numbers of subjects over all - Several subjects dropped out due to moving out of the region and lost to follow up.|3|||f||||f||||||||||2017-02-18 14:28:34.788989|2017-02-18 14:28:34.788989
NCT00661947|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2012-02-14|||March 2008||2008-03-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Pharmacokinetics and Pharmacodynamics of Fructose|Pharmacokinetics and Pharmacodynamics of Fructose Following Soft Drink Consumption: Sucrose vs High Fructose Corn Syrup|Completed||N/A|40|Actual|University of Florida|||1||f||||t||||||Samples With DNA|"~     DNA, whole blood, serum, plasma, and urine~   "|||2017-02-18 14:28:35.232419|2017-02-18 14:28:35.232419
NCT00661934|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-07-30|||May 2008||2008-05-01|July 2008|2008-07-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Observational|||Recording of Heart Signals From the Chest Wall|Recording of Heart Signals From the Chest Wall|Unknown status|Recruiting|N/A|200|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-02-18 14:28:35.334472|2017-02-18 14:28:35.334472
NCT00661921|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2009-02-05|||June 2008||2008-06-01|February 2009|2009-02-01|October 2009|Anticipated|2009-10-01|June 2009|Anticipated|2009-06-01||Interventional|||A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus|A Mutiple Dose, Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous AMG 108 in Patients With Type 2 Diabetes Mellitus|Withdrawn||Phase 2|200|Anticipated|Amgen||4||Program Development discontinued|f||||||||||||||2017-02-18 14:28:35.420768|2017-02-18 14:28:35.420768
NCT00661908|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-04-16|||March 2004||2004-03-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Diabetes-Related Discrimination at Workplace and by Insurances|Discrimination of Insulin-Treated Diabetic Subjects at the Workplace and by Insurances|Completed||N/A|509|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 14:28:35.517597|2017-02-18 14:28:35.517597
NCT00661895|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-11-06|2011-08-04||August 2005||2005-08-01|November 2012|2012-11-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|BEAT||Black Education and Treatment of Hypertension (BEAT HTN)|Black Education and Treatment of Hypertension (BEAT HTN)|Completed||Phase 4|99|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 14:28:35.589269|2017-02-18 14:28:35.589269
NCT00661882|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-18|2011-06-30|||February 2003||2003-02-01|June 2011|2011-06-01||||December 2014|Anticipated|2014-12-01||Observational|||Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder|1) Development of the Pancreatic Cancer Collaborative Registry and Risk Assessment Models; 2) Pancreatic Cancer Pre-Validation Reference Set for Serum/Plasma Biomarkers; 3) Effects of Tobacco and Alcohol on Pancreatic Cancer; 4) Enhancing the Biomedical Computing Platform for Pancreatic Cancer Research|Unknown status|Recruiting|N/A|240|Anticipated|University of Nebraska|||1||f||||f||||||||||2017-02-18 14:28:36.185002|2017-02-18 14:28:36.185002
NCT00661869|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2010-08-06|||September 2006||2006-09-01|August 2010|2010-08-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Interventional|Wellness||Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness|Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness|Completed||N/A|295|Actual|Manhattan Psychiatric Center||1|||f||||t||||||||||2017-02-18 14:28:36.29535|2017-02-18 14:28:36.29535
NCT00661856|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2008-04-17|||January 2001||2001-01-01|April 2008|2008-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|SoyPTI||Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance Indices|The Effect of Increased Soy Protein Intake on Bone Metabolism|Completed||N/A|203|Actual|Creighton University||3|||f||||t||||||||||2017-02-18 14:28:36.429677|2017-02-18 14:28:36.429677
NCT00661843|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2010-10-04|||May 2008||2008-05-01|August 2010|2010-08-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||A Study of Yoga for Treating Geriatric Insomnia|A Mixed Design, With Wait List Control Crossover to Intervention, Clinical Trial of Integrated Yoga Style Practice Intervention for Improving Sleep and Quality of Life in the Elderly Population|Completed||N/A|74|Actual|Shaare Zedek Medical Center||2|||f||||t||||||||||2017-02-18 14:28:36.537562|2017-02-18 14:28:36.537562
NCT00661830|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2013-09-18|2012-08-27||May 2008||2008-05-01|September 2013|2013-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)|A Randomized, Double-blind, Multicenter Phase II Trial With Gemcitabine Plus Sorafenib Versus Gemcitabine Plus Placebo in Patients With Chemo-naive Advanced or Metastatic Adenocarcinoma of the Biliary Tract|Completed||Phase 2|103|Actual|Johannes Gutenberg University Mainz||2|||f||||f||||||||||2017-02-18 14:28:36.6592|2017-02-18 14:28:36.6592
NCT00661817|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2012-03-03|||November 2006||2006-11-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|BFBW||Evaluating a Blood Pressure Reduction and Weight Loss Program in a Low Income, Ethnically Diverse Population (The Be Fit, Be Well [BFBW] Study)|Integrated Weight Loss Technologies for Weight and Blood Pressure Control in Urban Clinics|Completed||N/A|365|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 14:28:37.988113|2017-02-18 14:28:37.988113
NCT00661804|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2011-11-09|||May 2007||2007-05-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Observational|||Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study|A Longitudinal Cohort Study of Patients With Thalassemia in the Thalassemia Clinical Research Network|Completed||N/A|416|Actual|New England Research Institutes|||2||f||||t||||||Samples With DNA|"~     DNA and frozen plasma genetic biorepository~   "|||2017-02-18 14:28:38.101533|2017-02-18 14:28:38.101533
NCT00661791|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-17|||February 2003||2003-02-01|April 2008|2008-04-01|October 2007|Actual|2007-10-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Massage Therapy and Kinesthetic Stimulation on Pre-Term Infants|Effects of Massage Therapy and Kinesthetic Stimulation on Pre-Term Infants|Completed||N/A|60|Actual|George Washington University||3|||f||||f||||||||||2017-02-18 14:28:38.202372|2017-02-18 14:28:38.202372
NCT00661778|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2014-07-09|2014-05-27||July 2007||2007-07-01|July 2014|2014-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Intent-to-treat population: All enrolled participants who received at least 1 treatment.|A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer|An Open Label Study to Assess the Effect of First-line Treatment With Avastin in Combination With Docetaxel and Cisplatin on Progression-free Survival in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer|Completed||Phase 2|50|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:28:38.309034|2017-02-18 14:28:38.309034
NCT00661245|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2009-05-04|||July 2008||2008-07-01|May 2009|2009-05-01||||October 2010|Anticipated|2010-10-01||Interventional|TOGA®||Transoral Gastroplasty for the Treatment of Morbid Obesity||Unknown status|Active, not recruiting|Phase 3|275|Anticipated|Satiety, Inc.||2|||f||||t||||||||||2017-02-18 14:28:56.810677|2017-02-18 14:28:56.810677
NCT00661765|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2009-04-22|||April 2008||2008-04-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.|A Phase I, Open-Label, Randomized, Single Dose, Cross Over Study to Estimate the Relative Bioavailability of a Varenicline (CP-526,555) Transdermal Delivery System to the Chantix Immediate Release Tablet Formulation in Adult Smokers|Completed||Phase 1|18|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:28:38.71207|2017-02-18 14:28:38.71207
NCT00661752|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-08-25|||May 2007||2007-05-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Observational|||Protocol for Evaluation of Quarter-Time Cardiac Imaging: 5-Minutes Rest and 3-Minutes Stress Wide Beam Reconstruction (WBR) Versus Full-Time Filtered Back Projection (FBP)|Quarter-Time Myocardial Perfusion SPECT|Completed||N/A|134|Actual|St. Luke's-Roosevelt Hospital Center|||4||f||||t||||||||||2017-02-18 14:28:38.822935|2017-02-18 14:28:38.822935
NCT00661739|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2011-08-31|||July 2005||2005-07-01|September 2010|2010-09-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|RiTa||A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer|A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer|Completed||Phase 1|38|Actual|German Breast Group||1|||f||||t||||||||||2017-02-18 14:28:38.934708|2017-02-18 14:28:38.934708
NCT00661726|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2014-04-09|2012-05-01||January 2008||2008-01-01|February 2014|2014-02-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia|A Phase IIA Study of Subcutaneous 5-aza-2'- Deoxycytidine (Decitabine) in Patients With Thalassemia Intermedia|Completed||Phase 2|6|Actual|New England Research Institutes||1|||f||||t||||||||||2017-02-18 14:28:39.242864|2017-02-18 14:28:39.242864
NCT00661713|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2015-10-07|2015-02-03||June 2008||2008-06-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules|A Phase 2b/3, Multi-Center, Observer-Blind, Controlled Study of the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents Aged 11-17 Years According to Different Vaccination Schedules|Completed||Phase 2/Phase 3|1631|Actual|Novartis||8|||f||||||||||||||2017-02-18 14:28:39.735334|2017-02-18 14:28:39.735334
NCT00661700|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-11-17|||April 2003||2003-04-01|November 2014|2014-11-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||"A Double-blind Preferred Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction"|"A Double-blind Preferred Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction"|Completed||Phase 3|611|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:28:42.001024|2017-02-18 14:28:42.001024
NCT00661687|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2011-12-07|2009-02-20||December 2007||2007-12-01|December 2011|2011-12-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Comparative Performance of PureVision Lens Designs|A Study to Evaluate the Product Performance of the Redesigned Bausch & Lomb PureVision® Contact Lens (Test) Compared to the Currently Marketed Bausch & Lomb PureVision® Contact Lens (Control) When Worn on an Extended Wear Basis.|Completed||Phase 3|206|Actual|Bausch & Lomb Incorporated|2 participants discontinued due to adverse events, not classified as serious. One subject in the test group developed corneal ulcer, one subject in the control group developed a central epithelial defect, both conditions resolved following treatment.|2|||f||||f||||||||||2017-02-18 14:28:42.133593|2017-02-18 14:28:42.133593
NCT00661674|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-06-05|||April 2008||2008-04-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||POWS: Palonosetron/Ondansetron Opioid Withdrawal Study|POWS: Palonosetron/Ondansetron Opioid Withdrawal Study|Completed||N/A|10|Actual|Stanford University||1|||f||||||||||||||2017-02-18 14:28:42.593101|2017-02-18 14:28:42.593101
NCT00661661|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2015-04-23|2015-02-17||April 2008||2008-04-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan|A Long-term, Open-label Study Of Cp-690,550 to Confirm The Safety Following Long Term Administration Of Cp-690,550 In The Treatment Of Rheumatoid Arthritis|Completed||Phase 3|487|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:28:42.704806|2017-02-18 14:28:42.704806
NCT00661648|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2009-01-28|||April 2007||2007-04-01|January 2009|2009-01-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Interventional|||Effect of an Artificial Pancreas in Patients Undergoing Pancreatic Resection|Prevention for Surgical Site Infection After Pancreatic Resection|Unknown status|Recruiting|Phase 4|50|Anticipated|Kochi University||2|||f||||t||||||||||2017-02-18 14:28:45.621139|2017-02-18 14:28:45.621139
NCT00661635|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-04-21|||November 2002||2002-11-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|||||Interventional|||A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain|A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Placebo in Patients for Treatment of Post-Surgical Pain From Laparoscopic Cholecystectomy Surgery|Completed||Phase 3|490|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:28:45.744993|2017-02-18 14:28:45.744993
NCT00661622|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-10-19|2015-03-24||October 2004||2004-10-01|October 2016|2016-10-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF|Immuno-embolization of Hepatic Artery With Granulocyte-macrophage Colony Stimulating Factor (GM-CSF)|Completed||Phase 2|53|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 14:28:45.945169|2017-02-18 14:28:45.945169
NCT00661609|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2010-12-13|2010-07-19||May 2008||2008-05-01|December 2010|2010-12-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer|A Phase II, Single Arm, Single Agent, Multicentre, Adaptive 2-Stage Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD4877 Administered Weekly in Patients With Recurrent Advanced Urothelial Cancer|Completed||Phase 2|54|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 14:28:46.704846|2017-02-18 14:28:46.704846
NCT00661232|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-04-16|||August 2003||2003-08-01|February 2006|2006-02-01||||October 2008|Anticipated|2008-10-01||Observational|||Multicenter Myocardial Viability Trial|An International, Multicenter Trial Assessing Myocardial Viability With Contrast - Enhanced Magnetic Resonance Imaging|Unknown status|Active, not recruiting|N/A|235|Actual|CHI St. Luke's Health, Texas|||1||f||||f||||||||||2017-02-18 14:28:56.923257|2017-02-18 14:28:56.923257
NCT00661596|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-12-28|||May 2003||2003-05-01|December 2014|2014-12-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile Dysfunction|Multi-centre, Randomised, Double-blind, Parallel, Placebo-controlled Clinical Study to Assess the Efficacy of Vardenafil and Its Influence on Self-esteem and Self-confidence in Patients With Erectile Dysfunction|Completed||Phase 3|129|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:28:47.045176|2017-02-18 14:28:47.045176
NCT00661583|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2016-08-19|2016-07-01||April 2008||2008-04-01|August 2016|2016-08-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|OCTOPUS||Use of Ranibizumab With Mitomycin C During Trabeculectomy|Occlusion Prevention for Trabeculectomy Procedures Using Combination Ranibizumab and Mitomycin C (MMC) During Surgery (OCTOPUS Study)|Completed||Phase 1/Phase 2|30|Actual|University of Colorado, Denver||3|||f||||f||||||||No|"Subject medical information obtained by this study is confidential, and disclosure to third parties other than those noted below is prohibited.~Upon the subject's permission, medical information may be given to his/her personal physician or other appropriate medical personnel responsible for his/her welfare.~Data generated by this study will be available for inspection upon request by representatives of the U.S. FDA, national and local health authorities, the drug manufacturer and the IRB/EC, if appropriate."|2017-02-18 14:28:47.270654|2017-02-18 14:28:47.270654
NCT00661570|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2010-10-13|2010-08-02||March 2008||2008-03-01|October 2010|2010-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis|Amendment on Phase I Trial NO7VEG 'Assessment of a Next Generation Indwelling Provox Voice Rehabilitation System (Vega)|Terminated||Phase 2|26|Actual|Atos Medical AB||1||Primary endpoint reached, slow accrual, leakage around|f||||f||||||||||2017-02-18 14:28:47.765639|2017-02-18 14:28:47.765639
NCT00661557|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-09-09||2009-09-03|May 2008||2008-05-01|September 2016|2016-09-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects|Immunogenicity & Safety Study of GSK Biologicals' Meningococcal Vaccine GSK134612 Administered in Healthy Subjects Either Previously Primed With Mencevax™ ACWY or naïve to Meningococcal Vaccination.|Completed||Phase 2|272|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:28:48.005181|2017-02-18 14:28:48.005181
NCT00661544|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2013-02-26|2009-03-13||March 2004||2004-03-01|February 2013|2013-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients|Phase I/II Study of the Combination of Arsenic Trioxide With Ascorbic Acid and High-Dose Melphalan for Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|48|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:28:48.118902|2017-02-18 14:28:48.118902
NCT00661531|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2015-11-28|||April 2008||2008-04-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy|A Single Arm Phase II Study of Pharmacologic Dose Estrogen in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapies|Terminated||Phase 2|11|Actual|Georgetown University||1||Poor accrual|f||||t||||||||||2017-02-18 14:28:48.340062|2017-02-18 14:28:48.340062
NCT00661518|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-14|||October 2007||2007-10-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|October 2008|Anticipated|2008-10-01||Observational|ASAP||PET/CT Imaging of Aneurysm Wall Inflammation|Imaging of Aneurysm Wall Inflammation Using Positron Emission Tomography.|Unknown status|Recruiting|N/A|35|Anticipated|Radboud University|||2||f||||f||||||||||2017-02-18 14:28:48.448375|2017-02-18 14:28:48.448375
NCT00661505|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-06-08|2016-06-08||May 2008||2008-05-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||Baseline characteristics are presented for the safety population which included all participants who received at least one dose C.E.R.A. and underwent a safety follow-up, whether withdrawn prematurely or not.|A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia|A Single Arm Open Label Study to Assess the Efficacy, Safety and Tolerability of Once-monthly Administration of Intravenous C.E.R.A. for the Maintenance of Haemoglobin Levels in Haemodialysis Patients With Chronic Renal Anaemia.|Completed||Phase 3|132|Actual|Hoffmann-La Roche|Low number of participants completed the study as per the protocol. Administration of iron (oral/IV) was as per discretion of individual centers; therefore, C.E.R.A. responses have been limited by iron levels too low for efficient erythropoiesis.|1|||f||||||||||||||2017-02-18 14:28:48.531012|2017-02-18 14:28:48.531012
NCT00661492|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-10-13|2013-07-31||May 2008||2008-05-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)|A Randomized Phase II Study of Mitoxantrone vs. Mitoxantrone With Cetuximab in Metastatic Androgen Independent Prostate Cancer (AIPC) Previously Treated With Docetaxel-based Chemotherapy|Completed||Phase 2|115|Actual|US Oncology Research||2|||f||||f||||||||||2017-02-18 14:28:51.466446|2017-02-18 14:28:51.466446
NCT00661479|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2013-03-13|2013-03-13||July 2008||2008-07-01|March 2013|2013-03-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa||Completed||Phase 1/Phase 2|21|Actual|Allergan||4|||f||||t||||||||||2017-02-18 14:28:52.562103|2017-02-18 14:28:52.562103
NCT00661466|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-09-12|||April 2008||2008-04-01|February 2011|2011-02-01|February 2010|Actual|2010-02-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery|A Phase II, Randomized, Single-dose, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Pharmacokinetic Profile of the CollaRx Bupivacaine Implant in Patients After Gastrointestinal Surgery|Terminated||Phase 2|7|Actual|Innocoll||2||Business decision|f||||f||||||||||2017-02-18 14:28:53.104037|2017-02-18 14:28:53.104037
NCT00661453|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2015-06-01|2015-06-01||April 2008||2008-04-01|June 2015|2015-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I|Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I)|Completed||Phase 1/Phase 2|40|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:28:53.212671|2017-02-18 14:28:53.212671
NCT00661440|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2009-11-25|||May 2008||2008-05-01|November 2009|2009-11-01||||||||Interventional|||Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus|Efficacy and Safety of Neramexane Mesylate in Congenital Idiopathic Nystagmus and Acquired Nystagmus: a Randomized, Double-blind, Placebo-controlled, Single Center, Proof of Concept Study Using a Two-period Cross-over Design|Completed||Phase 2|48|Anticipated|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-02-18 14:28:53.532304|2017-02-18 14:28:53.532304
NCT00661427|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-10-19|2015-10-19||November 2007||2007-11-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer|A Phase II Randomized Study of Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer.|Completed||Phase 2|61|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||t||||||||||2017-02-18 14:28:53.834798|2017-02-18 14:28:53.834798
NCT00661414|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-01-27|||April 2008||2008-04-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ASONEP||Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors|A Multi-Center, Open-Label, Single-Arm, Phase 1, Dose Escalation Study of ASONEP (Sonepcizumab/LT1009) Administered as a Single Agent Weekly to Subjects With Refractory Advanced Solid Tumors|Completed||Phase 1|37|Actual|Lpath, Inc.||1|||f||||f||||||||||2017-02-18 14:28:54.326023|2017-02-18 14:28:54.326023
NCT00661401|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-15|||January 2002||2002-01-01|April 2008|2008-04-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin|Serum IgG Antibody to Streptococcus Pneumoniae, Haemophilus Influenzae Type b and Tetanus Toxoid in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin Infusions|Completed||N/A|5|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 14:28:54.428831|2017-02-18 14:28:54.428831
NCT00661388|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-07-28|2016-06-09||August 2008||2008-08-01|July 2016|2016-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||Safety population included all participants who received at least one dose of the trial medication and underwent a safety follow-up, whether withdrawn prematurely or not.|A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.|A Single Arm, Open Label Study to Assess the Efficacy, Safety and Tolerability of Once-monthly Administration of Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anaemia in Pre-dialysis Patients Not Currently Treated With ESA.|Completed||Phase 3|75|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:28:54.550525|2017-02-18 14:28:54.550525
NCT00661375|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-12-23|||November 2004||2004-11-01|December 2014|2014-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||BAY43-9006 Phase II Study for Renal Cell Carcinoma|Phase II Study of BAY 43-9006 in Japanese Patients With Renal Cell Carcinoma|Completed||Phase 2|131|Actual|Bayer||1|||f||||t||||||||||2017-02-18 14:28:55.077547|2017-02-18 14:28:55.077547
NCT00661362|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2012-02-06|2010-09-20||June 2008||2008-06-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes|A 24-Week International, Multi-centre, Randomized, Parallel-group, Double-blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Therapy|Completed||Phase 3|570|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:28:55.250115|2017-02-18 14:28:55.250115
NCT00661349|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2009-04-22|||February 2008||2008-02-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients|Prospective, Open Label and Randomized Clinical Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients|Terminated||Phase 4|9|Actual|Germans Trias i Pujol Hospital||2||It has been impossible to achieve the number of patients defined by protocol|f||||f||||||||||2017-02-18 14:28:55.948522|2017-02-18 14:28:55.948522
NCT00661336|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2015-03-12|||April 2008||2008-04-01|April 2010|2010-04-01||||December 2009|Actual|2009-12-01||Interventional|||A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma|An Open-Label, Multicenter, Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability and Anti-tumor Activity of Systemic Buthionine Sulfoximine (BSO) in Combination With Normothermic Isolated Limb Infusion of Melphalan in Subjects With Locally Advanced In-Transit Malignant Melanoma|Withdrawn||Phase 1|0|Actual|Duke University||||The study was withdrawn due to lack of patients.|||||||||||||||2017-02-18 14:28:56.067024|2017-02-18 14:28:56.067024
NCT00661323|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-06-22|||July 2010||2010-07-01|June 2016|2016-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Evaluating a New Echocardiography Imaging Procedure for Evaluating Heart Function|Left Ventricular Strain Quantification From 4D Echocardiography|Completed||N/A|1|Actual|Yale University|||2||f||||f||||||||||2017-02-18 14:28:56.174727|2017-02-18 14:28:56.174727
NCT00661310|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-12-04|||September 2005||2005-09-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|June 2006|Actual|2006-06-01||Interventional|||Optimizing Drug-Therapy in Patients 80 Years and Older|Optimizing Drug-Therapy in Patients, 80 Years and Older, in Order to Reduce Drug-Related Morbidity and Usage of Secondary Care - a Randomized Controlled Trial|Completed||N/A|400|Actual|Uppsala University Hospital||2|||f||||f||||||||||2017-02-18 14:28:56.28044|2017-02-18 14:28:56.28044
NCT00661297|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-12-01|||June 2003||2003-06-01|December 2014|2014-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil|A Randomised, Double-blind, Parallel-group, Placebo-controlled Study Evaluating the Efficacy, Safety, and Reliability of 10mg Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction|Completed||Phase 3|523|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:28:56.385328|2017-02-18 14:28:56.385328
NCT00661284|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-07-31|||April 2008||2008-04-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|March 2009|Actual|2009-03-01||Observational|||A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)|A Study to Investigate the Duration of Maintained Efficacy in Patients With Rheumatoid Arthritis Who Had Treated With MRA|Completed||N/A|189|Actual|Chugai Pharmaceutical|||1||f||||||||||||||2017-02-18 14:28:56.489874|2017-02-18 14:28:56.489874
NCT00661219|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-12-18|||December 2002||2002-12-01|December 2014|2014-12-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|DRIVER||Depression Related Improvement With Vardenafil for Erectile Response|A Randomized Double-blind Multi-center Parallel Group Three Month Study to Compare the Tolerability and Efficacy of Flexible Dose Vardenafil Versus Placebo in Men With Depression and Erectile Dysfunction.|Completed||Phase 3|280|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:28:57.019014|2017-02-18 14:28:57.019014
NCT00661206|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-10-08|||September 2008||2008-09-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|ISAR-SAFE||Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting|Randomized, Double-Blind, Placebo-controlled Trial of 6 vs. 12 Months Clopidogrel Therapy After Implantation of a Drug-Eluting Stent|Unknown status|Active, not recruiting|Phase 4|4005|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 14:28:57.195999|2017-02-18 14:28:57.195999
NCT00661193|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-17|2016-11-04|2016-11-04||December 2008||2008-12-01|November 2016|2016-11-01||||December 2015|Actual|2015-12-01||Interventional|||S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Selection Design of Pharmacodynamic Separation of Carboplatin/Paclitaxel/OSI-774 (Erlotinib; NSC-718781) or OSI-774 Alone in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Performance Status 2 (PS-2)|Active, not recruiting||Phase 2|59|Actual|Southwest Oncology Group||2|||f||||f||||||||||2017-02-18 14:28:57.381758|2017-02-18 14:28:57.381758
NCT00661180|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-12-18|||January 2004||2004-01-01|December 2014|2014-12-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|ORACLE||Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec|Open Label Multi-Centric Phase II Study of the Raf Kinase Inhibitor BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec (Imatinib)|Completed||Phase 2|10|Actual|Bayer||1|||t||||||||||||||2017-02-18 14:28:58.582218|2017-02-18 14:28:58.582218
NCT00661167|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2012-01-16|||April 2008||2008-04-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||Phase II Study of ABI-007 for Gastric Cancer|Phase II Study of ABI-007 by Tri-weekly Schedule for Patients With Unresectable or Recurrent Gastric Cancer Refractory to 5-FU Containing Regimen.|Completed||Phase 2|56|Actual|Taiho Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-02-18 14:28:58.694324|2017-02-18 14:28:58.694324
NCT00661154|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2012-08-08|||February 2008||2008-02-01|August 2012|2012-08-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Observational|||Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project|Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project|Completed||N/A|7|Actual|Stanford University|||1||f||||t||||||||||2017-02-18 14:28:58.804463|2017-02-18 14:28:58.804463
NCT00661141|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2012-09-25|||April 2008||2008-04-01|November 2009|2009-11-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism|Phase IIa, Prospective, Randomized, Blinded, Intra-Subject Controlled, Dose Escalation Study of Fomepizole for Mitigation of Acetaldehyde Related Toxicity in Human Subjects With Altered Ethanol Metabolism With Concomitant Ethanol Exposure|Completed||Phase 1/Phase 2|32|Actual|Raptor Pharmaceuticals Inc.||1|||f||||f||||||||||2017-02-18 14:28:58.895817|2017-02-18 14:28:58.895817
NCT00661128|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2012-12-18|||September 2007||2007-09-01|December 2012|2012-12-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|GenSCA||Evaluating the Genetic Factors That May Lead to Sudden Cardiac Arrest (The GenSCA Study)|Genomics of Sudden Cardiac Arrest|Unknown status|Enrolling by invitation|N/A|8750|Anticipated|University of Washington|||4||f||||t||||||Samples With DNA|"~     De-identified white blood cells, red blood cells, plasma, and DNA~   "|||2017-02-18 14:28:59.002338|2017-02-18 14:28:59.002338
NCT00661115|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-12-15|||May 2003||2003-05-01|December 2014|2014-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.|A Randomised, Double Blind, Placebo Controlled, Multi-center, Fixed Dose, Parallel Group Study to Investigate the Efficacy and Safety of Vardenafil (BAY 38-9456) in Men With Erectile Dysfunction .|Completed||Phase 3|173|Actual|Bayer||2|||f||||t||||||||||2017-02-18 14:28:59.096516|2017-02-18 14:28:59.096516
NCT00661102|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-11-01|||December 2008||2008-12-01|November 2016|2016-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).|A Randomized, Open Label Study Comparing the Efficacy of Topical Corticosteroids or Bepantol in the Prophylaxis of Hand-foot Syndrome in Patients Receiving Oral Xeloda for Treatment of Metastatic Breast Cancer or Colorectal Cancer.|Completed||Phase 3|598|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 14:28:59.221359|2017-02-18 14:28:59.221359
NCT00661089|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2012-11-29|2011-10-01||September 2003||2003-09-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|March 2009|Actual|2009-03-01||Interventional|||Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity|"A Randomized Double-Blind Placebo-Controlled Trial of Botulinum Toxin Type A (BOTOX ) in the Treatment of Hemiplegic Shoulder Pain and Spasticity"|Completed||N/A|21|Actual|Rehabilitation Institute of Chicago|Best and Worst pain collected, which may have limited the ability to detect overall pain. At the time of enrollment, subjects were on average very impaired by the Fugl-Meyer Scale measure, and pain on average had been present for several years.|2|||f||||f||||||||||2017-02-18 14:28:59.370254|2017-02-18 14:28:59.370254
NCT00661076|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-11-01|||August 2008||2008-08-01|November 2016|2016-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B|A Randomized, Open Label Study to Compare the Effect of Combination Treatment With PEGASYS + Adefovir Dipivoxil Versus PEGASYS Monotherapy on HBV-DNA and ALT Levels in Patients With HBeAg-negative, Chronic Hepatitis B.'|Completed||Phase 3|10|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 14:28:59.785586|2017-02-18 14:28:59.785586
NCT00661063|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-17|||April 2008||2008-04-01|April 2008|2008-04-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Interventional|||Diabetic Neuropathy Topical Treatment|Diabetic Neuropathic Pain Topical Treatment- Comparative Study|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Irmandade da Santa Casa de Misericordia de Sao Paulo||4|||f||||t||||||||||2017-02-18 14:28:59.896916|2017-02-18 14:28:59.896916
NCT00660712|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2009-05-22|||March 2008||2008-03-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|||||Observational|||Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey|Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey|Completed||N/A|1018|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:29:08.243012|2017-02-18 14:29:08.243012
NCT00661050|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2011-03-18|||April 2008||2008-04-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Treatment of Interstitial Cystitis/Painful Bladder Syndrome Using Alternative Techniques: Exercise, Meditation, Tai Chi|Exercise and Meditation: A Pilot Study of Alternative Techniques in the Treatment of Chronic Pelvic Pain Related to Painful Bladder Syndrome (PBS)/Interstitial Cystitis (IC) PI: Dr. Christopher Payne|Terminated||N/A|0|Actual|Stanford University|||1|Terminated due to low enrollment.|f||||f||||||||||2017-02-18 14:29:00.030542|2017-02-18 14:29:00.030542
NCT00661037|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2012-08-31|||March 2008||2008-03-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|May 2011|Actual|2011-05-01||Observational|SAFE-ICD||SAFEty of Two Strategies of ICD Management at Implantation|SAFEty of Two Strategies of ICD Management at Implantation|Completed||N/A|2130|Actual|Guidant Corporation|||2||f||||t||||||||||2017-02-18 14:29:00.117901|2017-02-18 14:29:00.117901
NCT00661024|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-17|||January 2006||2006-01-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|June 2007|Actual|2007-06-01||Interventional|||Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves in Thyroid Surgery|Randomized Clinical Trial Evaluating Visualization Versus Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerves in Thyroid Surgery|Completed||N/A|1000|Actual|Jagiellonian University||2|||f||||t||||||||||2017-02-18 14:29:00.24676|2017-02-18 14:29:00.24676
NCT00661011|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2015-02-11|||January 2007||2007-01-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy|A Phase II Study Assessing the Curative Effect of the Combination of Lobectomy Followed by Mediastinal Concomitant Radiochemotherapy in Patients With Locally Advanced Unresectable Stage III Non-small Cell Lung Cancer Responding to Induction Chemotherapy|Terminated||Phase 2|75|Actual|European Lung Cancer Working Party||1||The study was terminated due to too slow recruitment|f||||t||||||||||2017-02-18 14:29:00.371597|2017-02-18 14:29:00.371597
NCT00660998|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-12-10|||February 2003||2003-02-01|December 2014|2014-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 Diabetes|A Rand, db, Parallel-group, Plac-controlled Study Evaluating the Efficacy and Safety of Vardenafil Administered for 12 Weeks in a Flexible-dose Regimen Compared to Plac in Men With Diabetes Mellitus Type 1 and Erectile Dysfunction|Completed||Phase 4|318|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:29:00.487033|2017-02-18 14:29:00.487033
NCT00660985|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2011-01-19|2009-10-15||May 2008||2008-05-01|January 2011|2011-01-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%|A Pharmacokinetic Study to Compare the Systemic Exposure to Adapalene During Dermal Application of Either Differin® Gel, 0.3% (Adapalene 0.3%) or Differin® Gel, 0.1% (Adapalene 0.1%) for 30 Days in Subjects With Acne Vulgaris|Completed||Phase 4|51|Actual|Galderma||2|||f||||||||||||||2017-02-18 14:29:00.596869|2017-02-18 14:29:00.596869
NCT00660972|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2015-06-08|||May 2008||2008-05-01|June 2015|2015-06-01|April 2010|Actual|2010-04-01|January 2009|Actual|2009-01-01||Interventional|||Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)|First-Phase Viral Decay Rates in Treatment-Naive Subjects Initiating Treatment With Raltegravir (RAL) and Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF): A Pilot Study|Completed||Phase 1|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 14:29:01.134152|2017-02-18 14:29:01.134152
NCT00660959|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2011-06-20||2011-06-20|April 2008||2008-04-01|November 2010|2010-11-01||||June 2010|Actual|2010-06-01||Interventional|||Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia|Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia|Completed||Phase 3|106|Actual|CardioKine Inc.||2|||f||||t||||||||||2017-02-18 14:29:01.277249|2017-02-18 14:29:01.277249
NCT00660946|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2008-04-16|||June 2005||2005-06-01|April 2008|2008-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin|Correlation of Point of Care INR to Laboratory INR in Hemodialysis Patients Taking Warfarin|Completed||N/A|37|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 14:29:01.442411|2017-02-18 14:29:01.442411
NCT00660933|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-03-07|||September 2005||2005-09-01|September 2005|2005-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Intravenous Iron Versus Oral Iron for Severe Postpartum Anemia|Intravenous Iron Versus Oral Iron for Severe Postpartum Anemia Randomized Trial|Completed||Phase 4|70|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 14:29:01.529826|2017-02-18 14:29:01.529826
NCT00660920|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2016-02-12|||May 2008||2008-05-01|February 2016|2016-02-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies|A Phase 1 Dose Escalation Trial to Determine the Safety, Tolerability and Maximum Tolerated Dose of Oral AP24534 in Patients With Refractory or Advanced Chronic Myelogenous Leukemia and Other Hematologic Malignancies|Active, not recruiting||Phase 1|81|Actual|Ariad Pharmaceuticals||1|||t||||f||||||||||2017-02-18 14:29:01.646519|2017-02-18 14:29:01.646519
NCT00660907|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2015-03-10|2013-01-21||March 2008||2008-03-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|December 2009|Actual|2009-12-01||Interventional||Full Analysis Set defined as all randomized participants (as randomized) who received at least one dose of double-blind study medication, who have a non-missing baseline value and at least one post-baseline efficacy value for at least one efficacy variable during double-blind treatment period.|Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients|A 52-Week International, Multi-centre, Randomised, Parallel-group, Double-blind, Active-controlled, Phase III Study With a 156-Week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin in Combination With Metformin Compared With Sulphonylurea in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Therapy Alone.|Completed||Phase 3|1217|Actual|AstraZeneca|For participants who did not complete 52 weeks LOCF (last observation carried forward) was used.|2|||f||||f||||||||||2017-02-18 14:29:01.76562|2017-02-18 14:29:01.76562
NCT00659854|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-05-05|||April 2008||2008-04-01|April 2008|2008-04-01||||April 2010|Anticipated|2010-04-01||Interventional|||Cow's Milk Allergy in Infants With Obstructive Sleep Apnea (OSA)|Cow's Milk Allergy in Infants With Obstructive Sleep Apnea|Unknown status|Not yet recruiting|N/A|50|Anticipated|Soroka University Medical Center||2|||f||||t||||||||||2017-02-18 14:29:32.392894|2017-02-18 14:29:32.392894
NCT00660894|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-08-02|||April 2008||2008-04-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|June 2012|Actual|2012-06-01||Interventional|||Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery|Randomized Phase III Study of UFT+Leucovorin vs. TS-1 as Adjuvant Treatment for Stage III Colon Cancer , and Investigate Predictive Factors Based on Gene Expression|Completed||Phase 3|1535|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||f||||||||||2017-02-18 14:29:02.907143|2017-02-18 14:29:02.907143
NCT00660881|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-07-03||2012-07-03|May 2008||2008-05-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease|A Phase IIb Multi-Center, Open-label, Follow-up Study to Assess Safety and Efficacy of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease Who Participated in Study SL0007|Completed||Phase 2|210|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:29:03.02969|2017-02-18 14:29:03.02969
NCT00660868|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-02-04|||November 2009||2009-11-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Is Pentoxifylline Able to Improve Olfactory Sensitivity?|Agapurin Retard Used in Patients With Smell Disorder- A Post-marketing Observational Study|Completed||N/A|7|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-02-18 14:29:03.191295|2017-02-18 14:29:03.191295
NCT00660855|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-21|||June 2004||2004-06-01|April 2008|2008-04-01|July 2004|Actual|2004-07-01|||||Interventional|||A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain|A Multicenter, Open Label Trial To Evaluate Analgesic Effect Of Intravenous And Subsequent Oral Therapy With Parecoxib/Valdecoxib (Bextra® IM/IV And Bextra®) 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain|Terminated||Phase 4|4|Actual|Pfizer||1||See Detailed Description.|f||||f||||||||||2017-02-18 14:29:03.307795|2017-02-18 14:29:03.307795
NCT00660842|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2016-01-13|||November 2008||2008-11-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|MITO-7||Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer|Weekly Versus Every 3 Week Carboplatin and Paclitaxel in Patients With Ovarian Cancer: a Phase III Randomized Multicenter Study|Active, not recruiting||Phase 3|800|Anticipated|National Cancer Institute, Naples||2|||f||||f||||||||||2017-02-18 14:29:03.427809|2017-02-18 14:29:03.427809
NCT00660829|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2015-04-09|2009-09-30||December 2007||2007-12-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies|Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 in Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|536|Actual|Meda Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:29:03.612374|2017-02-18 14:29:03.612374
NCT00660816|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2015-10-08|2014-07-10||January 2008||2008-01-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|April 2013|Actual|2013-04-01||Interventional|||Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Randomized Phase II Trial, Comparing Standard of Care Chemotherapy (Pemetrexed or Docetaxel) Plus Erlotinib to Standard of Care Chemotherapy (Pemetrexed or Docetaxel) Alone in EGFR TKI-Responsive Non-Small Cell Lung Cancer|Completed||Phase 2|46|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 14:29:04.207931|2017-02-18 14:29:04.207931
NCT00660803|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2010-01-20|||May 2008||2008-05-01|January 2010|2010-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer|Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer|Completed||N/A|200|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:29:05.056158|2017-02-18 14:29:05.056158
NCT00660790|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2012-10-30|||April 2008||2008-04-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|CARDIONOR||Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders|Multifactorial Treatment of Cardiovascular Risk in Patients With Diabetes Mellitus Type-2: Identification of Treatment Non-Responders (The CARDIONOR Study)|Completed||N/A|97|Actual|Medical University of Graz|||1||f||||f||||||Samples Without DNA|"~     plasma, serum~   "|||2017-02-18 14:29:05.167219|2017-02-18 14:29:05.167219
NCT00660777|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-15|||February 2004||2004-02-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01||Interventional|||Effects of OroPharyngeal Exercises on Patients With Moderate Obstructive Sleep Apnea|Effects of OroPharyngeal Exercises on Patients With Moderate Obstructive Sleep Apnea: A Randomized, Controlled Study|Completed||Phase 3|30|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 14:29:05.258804|2017-02-18 14:29:05.258804
NCT00660764|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2009-03-13|||May 2003||2003-05-01|March 2009|2009-03-01|April 2005|Actual|2005-04-01|||||Observational|HEROS||Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)|Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)|Completed||N/A|||AstraZeneca|||1||f||||||||||||||2017-02-18 14:29:05.360127|2017-02-18 14:29:05.360127
NCT00660751|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-16|||August 2007||2007-08-01|February 2008|2008-02-01||||August 2009|Anticipated|2009-08-01||Interventional|||The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control|The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control|Unknown status|Active, not recruiting|N/A|100|Anticipated|Rambam Health Care Campus||2|||f||||||||||||||2017-02-18 14:29:05.459622|2017-02-18 14:29:05.459622
NCT00660738|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-01-22|||January 2007||2007-01-01|January 2012|2012-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Functional Tests in Individuals With Chronic Obstructive Pulmonary Disease (COPD)|Comparison of Different Functional Tests and Relation With Functional State and Quality of Life in Individuals With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|11|Actual|Universidade Federal de Sao Carlos|||1||f||||t||||||||||2017-02-18 14:29:07.993058|2017-02-18 14:29:07.993058
NCT00660725|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-01-21|||February 2009||2009-02-01|January 2014|2014-01-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Study of GemOx and Vandetanib in Advanced Solid Malignancy|An Open Label Phase I Study of Gemcitabine/Oxaliplatin (GEMOX) and Vandetanib (ZACTIMA; ZD6474) Combination in Patients With Advanced Solid Malignancy (IRUSZACT0070) (UPCI 07-025)|Completed||Phase 1|22|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:29:08.131988|2017-02-18 14:29:08.131988
NCT00660699|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2015-05-07|2015-03-30||September 2002||2002-09-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|September 2010|Actual|2010-09-01||Interventional|||A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers|A Feasibility Phase II Study of Gemcitabine With Docetaxel With Concurrent 3-D Conformal Radiation Plus Continuous Infusion 5-Fluorouracil in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers|Completed||Phase 2|50|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 14:29:08.352826|2017-02-18 14:29:08.352826
NCT00660686|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2015-10-20|||January 2006||2006-01-01|October 2015|2015-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Exercise for Physical Health in Men With Prostate Cancer|Exercise for Physical Health in Men With Prostate Cancer|Completed||N/A|56|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-02-18 14:29:09.190781|2017-02-18 14:29:09.190781
NCT00660673|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2017-01-20|||November 2009||2009-11-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced PD|Open-Label Continuation Treatment Study With Levodopa - Carbidopa Intestinal Gel In Subjects With Advanced Parkinson's Disease And Severe Motor-Fluctuations Who Have Exhibited A Persistent And Positive Effect To Treatment In Previous Studies|Active, not recruiting||Phase 3|261|Anticipated|AbbVie||1|||f||||f||||||||||2017-02-18 14:29:09.310343|2017-02-18 14:29:09.310343
NCT00660660|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2015-02-19|2009-06-12||April 2008||2008-04-01|February 2015|2015-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 4|276|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:29:09.494566|2017-02-18 14:29:09.494566
NCT00660647|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2015-11-23|||September 2007||2007-09-01|November 2015|2015-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|OPERA||Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)|Optimized Treatment Algorithm in Early Rheumatoid Arthritis: Methotrexate and Intra-articular Glucocorticosteroid Plus Adalimumab or Placebo in the Treatment of Early Rheumatoid Arthritis|Completed||Phase 3|180|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:29:10.857279|2017-02-18 14:29:10.857279
NCT00660634|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2008-04-25|||December 2004||2004-12-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|PTA-PAD-FMD||Angioplasty in Peripheral Arterial Disease and Endothelial Function|The Effect of Angioplasty in Peripheral Arterial Disease on Endothelial Function|Completed||Phase 4|33|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-02-18 14:29:10.970868|2017-02-18 14:29:10.970868
NCT00660621|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2010-01-18|||April 2008||2008-04-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|KARE004||A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma|A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma|Unknown status|Recruiting|Phase 2|40|Anticipated|Kentuckiana Cancer Institute||1|||f||||t||||||||||2017-02-18 14:29:11.063962|2017-02-18 14:29:11.063962
NCT00660608|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2010-07-02|||April 2008||2008-04-01|July 2010|2010-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Conservation of Red Cell Mass , Oxygen Supply and Demand in Cardiac Surgery|Conservation of Red Cell Mass, Oxygen Supply and Demand in Cardiac Surgery|Completed||N/A|50|Anticipated|Virginia Commonwealth University|||1||f||||t||||||||||2017-02-18 14:29:11.153369|2017-02-18 14:29:11.153369
NCT00660595|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2010-08-24|2009-12-04||September 2008||2008-09-01|August 2010|2010-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose|A Pilot Study of Three-Week, Randomised, Open Comparison in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose|Terminated||Phase 3|29|Actual|AstraZeneca||2||To difficult to recruit patients in the acute setting|f||||f||||||||||2017-02-18 14:29:11.248614|2017-02-18 14:29:11.248614
NCT00660582|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2015-01-20|||April 2008||2008-04-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|May 2011|Actual|2011-05-01||Interventional|||FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor|FLOX + Cetuximab (Erbitux®): First Line Treatment for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor, A Phase II Study|Completed||Phase 2|152|Actual|Odense University Hospital||1|||f||||t||||||||||2017-02-18 14:29:11.596083|2017-02-18 14:29:11.596083
NCT00660569|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2010-11-30|||January 2008||2008-01-01|November 2010|2010-11-01|February 2009|Actual|2009-02-01|||||Observational|||Utilization Patterns of Pulmicort in Real Life Practice|Utilization Patterns of Pulmicort HFA in Real Life Practice|Completed||N/A|260|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:29:11.688096|2017-02-18 14:29:11.688096
NCT00659516|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-15|||May 2008||2008-05-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|August 2008|Anticipated|2008-08-01||Observational|||Smart Capnography Respiratory Index in Post Anesthesia Patients|Smart Capnography Respiratory Index: Clinical Evaluation|Unknown status|Not yet recruiting|N/A|40|Anticipated|Shaare Zedek Medical Center|||2||f||||f||||||||||2017-02-18 14:29:11.7854|2017-02-18 14:29:11.7854
NCT00659503|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-12-01|||February 2005||2005-02-01|October 2016|2016-10-01|November 2005|Actual|2005-11-01|April 2005|Actual|2005-04-01||Interventional|||Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray (200 mg, Once Daily), in the Treatment of Seasonal Allergic Rhinitis (SAR) in Patients 18 Years and Older|Completed||Phase 3|420|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:29:11.863877|2017-02-18 14:29:11.863877
NCT00659490|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-06-05|2010-05-04||February 2008||2008-02-01|May 2010|2010-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940|A Randomised, Double Blind, Placebo-Controlled Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940, in Patients Undergoing Impacted Mandibular Third Molar Extraction|Completed||Phase 2|151|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:29:11.978282|2017-02-18 14:29:11.978282
NCT00659477|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2010-07-29|||March 2008||2008-03-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|COBIN 2||Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)|Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With OADs in Patients With DMT2, Assessed by Continuous Glucose Monitoring System (CGMS). Multicentre, Prospective, Open- Label, Single Arm, Comparative Study in Patients Switched From NPH Insulin to Insulin Lantus®.|Completed||Phase 4|117|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:29:12.804931|2017-02-18 14:29:12.804931
NCT00659464|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-02-09|||January 2008||2008-01-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|NIRS & Tilt||Multi-Site Near Infrared Spectroscopy (NIRS) Monitoring of Children During Tilt Table Testing|Use of Multi-site Near Infrared Spectroscopy (NIRS) Monitoring for Hemodynamic Assessment During Tilt Table Testing in Children|Completed||N/A|22|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 14:29:12.901947|2017-02-18 14:29:12.901947
NCT00659451|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-14|||April 2008||2008-04-01|April 2008|2008-04-01|April 2009|Anticipated|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular|Effects Of Losartan On Myocardial Structure And Function And On Epicardial Fat Deposition In Diabetic Hypertensive Patients With Left Ventricular: Qualitative And Quantitative Alteration|Unknown status|Recruiting|Phase 3|100|Anticipated|University of Pavia||2|||f||||f||||||||||2017-02-18 14:29:13.201186|2017-02-18 14:29:13.201186
NCT00659438|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-10-11|2011-11-14||February 2008||2008-02-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|November 2010|Actual|2010-11-01||Interventional|||Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer|A Randomized, Double-blind Phase II Trial to Assess the Efficacy and Safety of Bicalutamide (Casodex® ) Associated to ZD6474 (Zactima™ ) or to Placebo in Patients With Castration-refractory Metastatic Prostate Cancer Without Any Clinical Symptom Related to Disease Progression|Completed||Phase 2|95|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:29:13.303739|2017-02-18 14:29:13.303739
NCT00659425|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2015-05-19|||September 2008||2008-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma|A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Children, Adolescents and Young Adults With Refractory CD22+ Acute Lymphoblastic Leukemia (ALL) or Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 1|58|Actual|MedImmune LLC||1|||f||||f||||||||||2017-02-18 14:29:13.875513|2017-02-18 14:29:13.875513
NCT00659412|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2014-09-17|||September 2003||2003-09-01|September 2014|2014-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis|A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Alefacept When Given in Combination With Methotrexate in Subjects With Psoriatic Arthritis With an Open-label Retreatment Course|Completed||Phase 2|185|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 14:29:13.9838|2017-02-18 14:29:13.9838
NCT00659399|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2015-03-16|||January 2008||2008-01-01|March 2015|2015-03-01|November 2010|Anticipated|2010-11-01|September 2010|Anticipated|2010-09-01||Interventional|||Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression|07-742 Phase I/ Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression|Withdrawn||Phase 1|0|Actual|New York University School of Medicine||1||Low accrual|f||||t||||||||||2017-02-18 14:29:14.131537|2017-02-18 14:29:14.131537
NCT00659386|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2009-02-03|||February 2009||2009-02-01|February 2009|2009-02-01|August 2010|Anticipated|2010-08-01|February 2010|Anticipated|2010-02-01||Interventional|||IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load|Intravenous Immunoglobulin Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load|Unknown status|Recruiting|Phase 1|40|Anticipated|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 14:29:14.231838|2017-02-18 14:29:14.231838
NCT00659373|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2016-07-11|2015-07-14||December 2007||2007-12-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Interventional|Co-SOFT||Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02|Investigating Cognitive Function for Patients Participating in the SOFT Trial in Selected Centers|Completed||Phase 3|86|Actual|International Breast Cancer Study Group||3|||f||||t||||||||||2017-02-18 14:29:14.340494|2017-02-18 14:29:14.340494
NCT00659360|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2015-07-02|2014-06-19||February 2008||2008-02-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|January 2009|Actual|2009-01-01||Interventional|||AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma|A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:29:14.688214|2017-02-18 14:29:14.688214
NCT00659347|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2008-12-04|||March 2008||2008-03-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DOV 21,947 in Patients With Major Depressive Disorder|Terminated||Phase 2|200|Anticipated|DOV Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:29:14.9918|2017-02-18 14:29:14.9918
NCT00659334|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-10-10|2012-05-15||August 2000||2000-08-01|October 2012|2012-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation|Multi-disciplinary Study: MR, Histologic and EM Imaging of Intravenous Superparamagnetic Crystalline Particles (Combidex) to Brain, Intra-cerebral Tumors and in CNS Inflammation|Terminated||Phase 2|116|Actual|OHSU Knight Cancer Institute|Early trial termination due to study drug Combidex no longer manufactured.|7||AMAG not continuing with Combidex, the study drug|f||||t||||||||||2017-02-18 14:29:15.12255|2017-02-18 14:29:15.12255
NCT00660556|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-02-08|||February 2003||2003-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:29:15.857623|2017-02-18 14:29:15.857623
NCT00215579|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-09-19|||April 2004||2004-04-01|March 2012|2012-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence||Completed||Phase 4|64|Actual|Duke University|||||f||||f||||||||||2017-02-18 17:08:49.611162|2017-02-18 17:08:49.611162
NCT00660543|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-04-08|2016-02-12||December 2006||2006-12-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy|Early Assessment of Tumor Response to Therapy Using Ferumoxytol (Code 7228) as an MR Contrast Agent in Patients With Glioblastoma Multiforme (MedDRA Code 10018337)|Completed||N/A|14|Actual|OHSU Knight Cancer Institute||3|||f||||t||||||||||2017-02-18 14:29:15.903362|2017-02-18 14:29:15.903362
NCT00660530|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2013-12-16|||January 2008||2008-01-01|December 2013|2013-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients|An Evaluation of Chewed vs. Crushed Lanthanum Carbonate in the Efficacy of Phosphate Binding in Hemodialysis Patients|Completed||Phase 2|14|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-02-18 14:29:16.200907|2017-02-18 14:29:16.200907
NCT00660517|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2012-07-23|2012-05-17||December 2007||2007-12-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies|Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Astelin Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis|Completed||Phase 3|607|Actual|Meda Pharmaceuticals||4|||f||||f||||||||||2017-02-18 14:29:16.303862|2017-02-18 14:29:16.303862
NCT00660504|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2014-07-09|2013-11-21||April 2008||2008-04-01|July 2014|2014-07-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer|Randomized, Open-label, phase3 Trial Comparing Amrubicin Combined With Cisplatin Versus Etoposide-Cisplatin as First-line Treatment in Patients With Extensive Disease SCLC|Completed||Phase 3|300|Actual|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.||2|||f||||f||||||||||2017-02-18 14:29:17.150146|2017-02-18 14:29:17.150146
NCT00660491|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-01-05|||January 2008||2008-01-01|January 2012|2012-01-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Endothelial Dysfunction Induced by Postprandial Lipemia|Endothelial Dysfunction Induced by Postprandial Lipemia: Complete Protection Afforded by High Intensity Aerobic Interval Exercise|Completed||Phase 2|8|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-02-18 14:29:17.62255|2017-02-18 14:29:17.62255
NCT00660478|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2013-08-28|||January 2006||2006-01-01|September 2008|2008-09-01|October 2009|Actual|2009-10-01|December 2007|Actual|2007-12-01||Interventional|SORT-OUTIII||Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients|Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients|Completed||Phase 3|2342|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-02-18 14:29:17.716029|2017-02-18 14:29:17.716029
NCT00660465|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2014-11-09|||May 2008||2008-05-01|February 2008|2008-02-01||||||||Observational|||Exploring the Relationship Between Varying CO2 Levels and the Regional BOLD Signal, by Using Breathing Exercises|Exploring the Relationship Between Varying CO2 Levels and the Regional BOLD Signal, by Using Breathing Exercises .|Unknown status|Not yet recruiting|N/A|6|Anticipated|Soroka University Medical Center|||1||f||||f||||||||||2017-02-18 14:29:17.812019|2017-02-18 14:29:17.812019
NCT00660452|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2011-10-10|||October 2007||2007-10-01|October 2011|2011-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites|A Randomised, Double-blind, Placebo-controlled, Multi-centre, Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Chinese Asthmatic Patients Allergic to House-dust Mites|Completed||Phase 3|484|Actual|Stallergenes||2|||f||||f||||||||||2017-02-18 14:29:17.897739|2017-02-18 14:29:17.897739
NCT00660439|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2008-04-15|||May 2007||2007-05-01|April 2008|2008-04-01|November 2010|Anticipated|2010-11-01|December 2009|Anticipated|2009-12-01||Interventional|||Treatment Effects of Narrative Exposure Therapy|Treatment Effects of Narrative Exposure Therapy on Psychiatric Symptoms and Cortisol Levels in Patients With Posttraumatic Stress Disorder|Unknown status|Recruiting|Phase 2|40|Anticipated|University of Bergen||2|||f||||f||||||||||2017-02-18 14:29:17.993529|2017-02-18 14:29:17.993529
NCT00660426|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2013-04-22|||March 2005||2005-03-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|October 2006|Actual|2006-10-01||Interventional|||Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors|Phase I Study Of Oxaliplatin, Gemcitabine And Capecitabine In Advanced Gastrointestinal Malignancies And Other Solid Tumors|Completed||Phase 1|30|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-02-18 14:29:18.10558|2017-02-18 14:29:18.10558
NCT00660413|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-15|||December 2007||2007-12-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agents|Comparison of Acceleromyography and Mechanomyography for Establishing Potency of Neuromuscular Blocking Agents, A Randomized Controlled Study|Completed||Phase 4|40|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 14:29:18.233867|2017-02-18 14:29:18.233867
NCT00660400|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2014-09-11|2014-05-27||March 2008||2008-03-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional||21 of 25 participants proceeded to allogeneic HCT and were evaluated for most measures.|Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant|A Pilot Study Of Pre-Transplant 5-Azacitidine (Vidaza) In Patients With High-Risk Myelodysplastic Syndrome (MDS) Who Are Candidates For Allogeneic Hematopoietic Cell Transplantation|Completed||N/A|25|Actual|H. Lee Moffitt Cancer Center and Research Institute|Limitation: Small single center pilot study to show the use of pre-treatment 5-Azacitidine and successfully proceeding to transplant.|1|||f||||f||||||||||2017-02-18 14:29:18.339688|2017-02-18 14:29:18.339688
NCT00660387|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2015-01-12|2015-01-12||December 2009||2009-12-01|January 2015|2015-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects|A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations|Completed||Phase 3|35|Actual|AbbVie||2|||f||||t||||||||||2017-02-18 14:29:18.650391|2017-02-18 14:29:18.650391
NCT00215085|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-03-14|||May 2005||2005-05-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Observational|||Cardiac Tumors in Children|Cardiac Tumors in Children|Terminated||N/A|70|Anticipated|Children's Healthcare of Atlanta|||1|insufficient data|f||||f||||||||||2017-02-18 17:08:59.718072|2017-02-18 17:08:59.718072
NCT00660374|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2015-05-04|||February 2008||2008-02-01|May 2015|2015-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes|Assessment of Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation on Glycaemic Control in Subjects With Type 2 Diabetes|Completed||Phase 2|402|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 14:29:19.658475|2017-02-18 14:29:19.658475
NCT00660361|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-04-16|||April 2008||2008-04-01|April 2008|2008-04-01|September 2010|Anticipated|2010-09-01|April 2010|Anticipated|2010-04-01||Observational|||A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients|A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir (TDF) in HIV-HBV co-Infected Patients|Unknown status|Recruiting|N/A|92|Anticipated|Bayside Health|||1||f||||f||||||Samples Without DNA|"~     Stored serum samples~   "|||2017-02-18 14:29:19.764586|2017-02-18 14:29:19.764586
NCT00660348|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2014-10-07|2014-05-21||March 2008||2008-03-01|October 2014|2014-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer|A Randomized Study of Optimal Pain Management: Standard Pain Control Versus Early Intervention With Intrathecal Therapy in Patients With Advanced Pancreatic Cancer|Terminated||N/A|1|Actual|Sidney Kimmel Comprehensive Cancer Center|Subject started study 7/14/2010, but withdrew her consent on 7/24/2010 due to increased upper quadrant pain. One subject enrolled. She withdrew consent before study team could collect any follow-up data. We do not have any participants to analyze.|2||Low enrollment|f||||||||||||||2017-02-18 14:29:19.855059|2017-02-18 14:29:19.855059
NCT00660335|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2009-12-02|||March 2008||2008-03-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas|Phase III Study to Demonstrate the Efficacy and Safety of RG1068 (Synthetic Human Secretin)- Enhanced Magnetic Resonance Cholangiopancreatography (MRCP) in the Evaluation of Subjects With a History of Acute or Acute Recurrent Pancreatitis|Completed||Phase 3|258|Actual|Repligen Corporation||1|||f||||f||||||||||2017-02-18 14:29:20.288488|2017-02-18 14:29:20.288488
NCT00660322|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-15|||January 2004||2004-01-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|January 2006|Actual|2006-01-01||Interventional|||Using the Telephone to Improve Care in Childhood Asthma|Using the Telephone to Improve Care in Childhood Asthma|Completed||N/A|362|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-02-18 14:29:20.379842|2017-02-18 14:29:20.379842
NCT00660309|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2012-08-27|2012-07-20||April 2008||2008-04-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus|An Open-label, Randomized, Parallel-group Study to Evaluate the Acute and Steady-state Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|45|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:29:20.491308|2017-02-18 14:29:20.491308
NCT00660296|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-16|||February 2008||2008-02-01|April 2008|2008-04-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Randomized Controlled Trial Comparing Co2 vs. Air in Colonoscopy in Sedated Patients|Randomized Controlled Trial Comparing Co2 vs. Air in Colonoscopy in Sedated Patients|Unknown status|Recruiting|N/A|300|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:29:21.387999|2017-02-18 14:29:21.387999
NCT00660283|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2010-01-18|||January 2009||2009-01-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|KARE003||A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma|A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Kentuckiana Cancer Institute||1|||f||||t||||||||||2017-02-18 14:29:21.511969|2017-02-18 14:29:21.511969
NCT00660270|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2013-04-22|||May 2002||2002-05-01|April 2013|2013-04-01|February 2009|Actual|2009-02-01|November 2006|Actual|2006-11-01||Interventional|||Chemotherapy and Radiation Following Pancreatic Surgery|A Phase II Trial Of Adjuvant Chemoradiation Following Pancreatic Resection For Adenocarcinomas Of The Pancreas Using 3-D Conformal Radiation With Cisplatin, 5FU, And Alpha-Interferon As Radiosensitizing Agents Followed By Gemcitabine|Completed||Phase 2|53|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:29:21.605346|2017-02-18 14:29:21.605346
NCT00660257|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2008-04-16|||January 2007||2007-01-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine|Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza (H5N1)Vaccine in Two-Dose Primed Healthy Adults: A Single Center, Non-Randomized Clinical Trial|Completed||Phase 1|57|Actual|Sinovac Biotech Co., Ltd||4|||f||||t||||||||||2017-02-18 14:29:21.736335|2017-02-18 14:29:21.736335
NCT00660244|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-06-05|||February 2008||2008-02-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|||||Observational|||Breast Cancer Tumor Care Observational Programme|Breast Cancer Tumor Care Patient Observation Programme|Completed||N/A|150|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:29:21.832891|2017-02-18 14:29:21.832891
NCT00660231|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2014-12-02|||March 2008||2008-03-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|September 2011|Actual|2011-09-01||Interventional|GemBex||Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|A Phase II Study of Gemcitabine and Bexarotene (Gembex) in the Treatment of Cutaneous T-cell Lymphoma|Completed||Phase 2|36|Actual|University College, London||1|||f||||t||||||||||2017-02-18 14:29:21.94225|2017-02-18 14:29:21.94225
NCT00660218|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2015-03-19|||March 2008||2008-03-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer|A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer|Recruiting||Phase 1/Phase 2|60|Anticipated|State University of New York - Upstate Medical University||1|||f||||t||||||||||2017-02-18 14:29:22.070014|2017-02-18 14:29:22.070014
NCT00632437|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2012-07-27|||February 2008||2008-02-01|July 2012|2012-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Intraoperative Optical Imaging of Brain Function|Intraoperative Optical Imaging of Brain Function|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||1|Terminated due to poor enrollment.|f||||f||||||||||2017-02-18 14:38:46.683207|2017-02-18 14:38:46.683207
NCT00660205|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-03-23|||February 2008||2008-02-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|GIVTE||Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer|Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer|Completed||N/A|285|Actual|University of Aarhus|||3||f||||f||||||Samples Without DNA|"~     Blood samples with seperation in plasma and serum. Urin samples. tumour tissue samples.~   "|||2017-02-18 14:29:22.204916|2017-02-18 14:29:22.204916
NCT00660192|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-02-15|2014-08-18||January 2008||2008-01-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2012|Actual|2012-07-01||Interventional|||Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches|Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches|Completed||Phase 2/Phase 3|25|Actual|Yale University|Small study- results could have been different if numbers were larger Technique of injection different from PREEMPT study. Larger doses were injected into temporal and posterior neck muscles. No trapezius injection.|2|||f||||t||||||||||2017-02-18 14:29:22.317302|2017-02-18 14:29:22.317302
NCT00660179|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2015-09-10|2013-11-05||May 2008||2008-05-01|August 2015|2015-08-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|SERAPHIN|For the baseline measures of age, gender, and World Health Organization (WHO) functional class, data were missing for 1 patient in the placebo group and for 2 patients in the 3 mg macitentan group.|Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Phase III Study to Assess the Effects of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension|Completed||Phase 3|742|Actual|Actelion||3|||f||||t||||||||||2017-02-18 14:29:22.708394|2017-02-18 14:29:22.708394
NCT00660166|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2012-06-25|||April 2006||2006-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions|HLA Class I Haplotype Mismatched Natural Killer Cell Infusions After Autologous Stem Cell Transplant for Hematological Malignancies|Completed||Phase 1|13|Actual|Tufts Medical Center||1|||f||||t||||||||||2017-02-18 14:29:28.047487|2017-02-18 14:29:28.047487
NCT00660153|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2012-08-24|||June 2008||2008-06-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers|A Phase 1b, Open-Label, Dose-Escalation Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers|Completed||Phase 1|30|Actual|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:29:28.148855|2017-02-18 14:29:28.148855
NCT00660140|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2013-08-09|||March 2002||2002-03-01|August 2013|2013-08-01|April 2009|Actual|2009-04-01|January 2007|Actual|2007-01-01||Interventional|||Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer|A Phase II Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer|Completed||Phase 2|49|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 14:29:28.252549|2017-02-18 14:29:28.252549
NCT00660127|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-08-08|||October 2007||2007-10-01|April 2008|2008-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients|The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients|Completed||N/A|25|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 14:29:28.572718|2017-02-18 14:29:28.572718
NCT00660114|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2009-05-27|||April 2008||2008-04-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|PUL NIS||Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients|A Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Patient Aged 5-Year Old or Younger in Outpatient Department|Completed||N/A|914|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:29:28.652794|2017-02-18 14:29:28.652794
NCT00660101|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2015-12-02|||June 2008||2008-06-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer|OVax®: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse:|Active, not recruiting||Phase 1/Phase 2|34|Actual|AVAX Technologies||3|||f||||f||||||||||2017-02-18 14:29:28.768121|2017-02-18 14:29:28.768121
NCT00660088|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2008-10-07|||April 2008||2008-04-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Observational|||Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly|Tolerability, Safety, And Pharmacokinetics Of Three Formulations Of Oral Ketasyn™ (Ac-1202) Administered For Fourteen Days, With Or Without Titration, In Healthy Elderly Volunteers|Completed||Phase 1|60|Anticipated|Accera, Inc.|||6||f||||f||||||Samples Without DNA|"~     plasma beta-hydroxybutyrate~   "|||2017-02-18 14:29:28.886219|2017-02-18 14:29:28.886219
NCT00660075|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2012-11-13|2011-05-18||February 2008||2008-02-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Evaluate The Effects of Sitagliptin on Postprandial Plasma Lipoprotein Concentrations in Men With Type 2 Diabetes|Completed||Phase 3|36|Actual|Laval University||2|||f||||t||||||||||2017-02-18 14:29:28.990975|2017-02-18 14:29:28.990975
NCT00660062|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2014-12-07|||August 2009||2009-08-01|April 2011|2011-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|DUAG-7||Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)|Relapse Prevention in Patients With a Major Depressive Episode Treated With Electroconvulsive Treatment Using a Fixed Dose Range of Escitalopram Compared to a Fixed Dose of Nortriptyline (DUAG-7) A Randomised Controlled 6 Month Double-blind Study|Terminated||Phase 4|47|Actual|Hillerod Hospital, Denmark||4||Slow inclusion|f||||f||||||||||2017-02-18 14:29:29.345857|2017-02-18 14:29:29.345857
NCT00660049|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-11-23|2016-05-26||March 2008||2008-03-01|November 2016|2016-11-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional||12|Feasibility Study of a Novel Device for Chronic Wounds|Feasibility Study of a Novel Device for Chronic Wounds|Completed||N/A|12|Actual|Stanford University|Open label design without comparator arm|1|||f||||t||||||||No|No sharing|2017-02-18 14:29:29.465155|2017-02-18 14:29:29.465155
NCT00660036|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2016-01-14|||September 2008||2008-09-01|January 2016|2016-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia|Phase I/II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy (UPCI 07-154)|Terminated||Phase 1|5|Actual|University of Pittsburgh||1||due to new safety information|f||||t||||||||||2017-02-18 14:29:29.703591|2017-02-18 14:29:29.703591
NCT00660023|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2016-02-16|2016-02-16||August 2008||2008-08-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||Intent-to-Treat (ITT) Population: All participants who received at least one dose of Mircera/CERA and for whom data from at least one follow-up assessment were available.|A Study of Intravenous Mircera in Participants With Chronic Renal Anemia Who Are on Dialysis|A Single Arm, Open Label Study to Assess the Efficacy, Safety, and Tolerability of Once-Monthly Administration of Intravenous C.E.R.A. for the Maintenance of Haemoglobin Levels in Dialysis Patients With Chronic Renal Anaemia|Completed||Phase 3|124|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:29:29.820292|2017-02-18 14:29:29.820292
NCT00660010|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2011-04-08|2010-04-22||January 1991||1991-01-01|April 2011|2011-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study of Lupron Depot In The Treatment of Central Precocious Puberty|Study of Lupron Depot In The Treatment of Central Precocious Puberty|Completed||Phase 3|55|Actual|Abbott|Study drug was discontinued usually at the initiation of puberty (12 years for males and 11 years for females) with the concurrence of the investigator, or at the discretion of the investigator. Adverse events are coded with the COSTART dictionary.|1|||f||||f||||||||||2017-02-18 14:29:30.241144|2017-02-18 14:29:30.241144
NCT00659997|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2008-04-15|||June 2006||2006-06-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|ALBvLEV||Efficacy Albendazole and Levamisole Against STH on Unguja|Longitudinal Study of Efficacy of Standard Albendazole Treatment Versus Levamisole/Pyrantel Pamoate on Soil Transmitted Helminth Infections|Completed||Phase 4|20|Actual|Natural History Museum, United Kingdom||2|||f||||f||||||||||2017-02-18 14:29:30.882503|2017-02-18 14:29:30.882503
NCT00659984|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2012-08-01|||March 2008||2008-03-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|August 2010|Actual|2010-08-01||Interventional|||N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma|A Phase 2a Study of Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma|Completed||Phase 2|16|Actual|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-02-18 14:29:30.990806|2017-02-18 14:29:30.990806
NCT00659971|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-06-25|||January 2008||2008-01-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis|A Phase 2B Dose-Ranging Study of PAC113 Mouthrinse for Clinical and Microbial Evaluation in HIV Seropositive Individuals With Oral Candidiasis to Establish the Optimal Dose of PAC113|Completed||Phase 2|223|Actual|Pacgen Biopharmaceuticals Corporation||4|||f||||t||||||||||2017-02-18 14:29:31.108295|2017-02-18 14:29:31.108295
NCT00659958|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2013-05-09|||April 2008||2008-04-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs|Post-authorization, Observational and Prospective Follow up Study to Evaluate Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs|Completed||Phase 4|32|Actual|Eisai Inc.||1|||f||||f||||||||||2017-02-18 14:29:31.216207|2017-02-18 14:29:31.216207
NCT00659945|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2013-02-01|2011-08-10||June 2008||2008-06-01|February 2013|2013-02-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery|Efficacy of Pre-operative Aprepitant Plus Ondansetron vs Ondansetron Plus Placebo in Patients at Moderate-to-High Risk Post-operative Nausea (PONV) Undergoing Ambulatory Plastic Surgery|Completed||Phase 4|150|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:29:31.342474|2017-02-18 14:29:31.342474
NCT00659932|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-14|||May 2002||2002-05-01|December 2007|2007-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes|Dealing With Anxiety: A Pilot Cognitive Behavioural Program for Diabetic Clinic Outpatient Attendees|Completed||N/A|64|Actual|Hunter and New England Health||2|||f||||f||||||||||2017-02-18 14:29:31.766518|2017-02-18 14:29:31.766518
NCT00659919|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-16|2008-06-15|||November 2000||2000-11-01|June 2008|2008-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Treatment of Neuroleptic Induced Acute Akathisia With Trazodone||Completed||Phase 4|13|Actual|BeerYaakov Mental Health Center||2|||f||||||||||||||2017-02-18 14:29:31.872948|2017-02-18 14:29:31.872948
NCT00659906|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2015-05-26|||January 2006||2006-01-01|May 2015|2015-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Optimizing Body Composition & Health After Breast Cancer|Optimizing Body Composition & Health After Breast Cancer|Completed||N/A|71|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-02-18 14:29:31.96132|2017-02-18 14:29:31.96132
NCT00659893|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2015-09-11|||April 2008||2008-04-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2|A Multi-center, Open Label, Dose-area Escalation, Cohort Study to Evaluate the Safety and Tolerability of 0.05% PEP005 Topical Gel Applied for Two Consecutive Days to Treatment Area(s) of up to a Total of 100 cm2 in Patients With Actinic Keratoses on the Extensor (Dorsal Aspect) Forearm(s)|Completed||Phase 1|64|Actual|Peplin||8|||f||||f||||||||||2017-02-18 14:29:32.069457|2017-02-18 14:29:32.069457
NCT00659880|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2015-07-17|||April 2008||2008-04-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|Meniscus||Clinical Application of BioCleanse Meniscus|Clinical Application of BioCleanse Meniscus Registry|Completed||Phase 4|10|Actual|RTI Surgical|||1||f||||f||||||||||2017-02-18 14:29:32.190519|2017-02-18 14:29:32.190519
NCT00659867|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-09-26|||December 2008||2008-12-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2015|Actual|2015-07-01||Interventional|||Endomicroscopy in Ulcerative Colitis|Chromoscopy-guided Endomicroscopy With the PENTAX EC-3870CIFK / EC-3870CILK Confocal Colonoscopes for the Detection of Intraepithelial Neoplasias in Subjects With Long Standing Ulcerative Colitis|Terminated||N/A|182|Actual|PENTAX Europe GmbH||2||Recruitment problems|f||||f||||||||||2017-02-18 14:29:32.281431|2017-02-18 14:29:32.281431
NCT00659841|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-12-01|||December 2003||2003-12-01|October 2016|2016-10-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray (200µg Once Daily) in the Treatment of Seasonal Allergic Rhinitis (SAR) in Patients 12 Years and Older|Completed||Phase 3|302|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:29:32.488448|2017-02-18 14:29:32.488448
NCT00659828|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2008-04-14|||June 2005||2005-06-01|April 2008|2008-04-01|December 2010|Anticipated|2010-12-01|January 2010|Anticipated|2010-01-01||Interventional|||Effects of Leptin Replacement in Children|Effects of Leptin Replacement in Children|Unknown status|Active, not recruiting|Phase 2|1|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 14:29:32.599883|2017-02-18 14:29:32.599883
NCT00659815|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-12|2011-12-07|2010-09-07||March 2008||2008-03-01|December 2011|2011-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a New Packaging Configuration|Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a Clear Polyethylene Terephthalate (PET) Bottle.|Completed||N/A|312|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:29:32.713664|2017-02-18 14:29:32.713664
NCT00659802|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-09-04|||March 2008||2008-03-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase II Study of HMPL-004 in Patients With Ulcerative Colitis|A Phase II, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis With or Without Mesalamine|Completed||Phase 2|224|Actual|Hutchison Medipharma Limited||3|||f||||f||||||||||2017-02-18 14:29:33.21218|2017-02-18 14:29:33.21218
NCT00659789|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-11-08|2015-07-22||August 2008||2008-08-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional||ITT population|Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV|A Phase II, Randomized, Double-blind, Multicenter, Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV-1 Who Have Maintained an Adequate Response to ART|Completed||Phase 2|137|Actual|Bionor Immuno AS||2|||f||||t||||||||No|Participants have not provided informed consent for their anonymized individual data to be made available beyond that described in the patient information sheet.|2017-02-18 14:29:33.302877|2017-02-18 14:29:33.302877
NCT00659776|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-11-28|||July 2004||2004-07-01|November 2012|2012-11-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation|Multi-Disciplinary Study: MR, Histologic And EM Imaging Of Intravenous Superparamagnetic Crystalline Particles (Ferumoxytol) In CNS Inflammation|Unknown status|Recruiting|Phase 2|120|Anticipated|Oregon Health and Science University||4|||f||||t||||||||||2017-02-18 14:29:34.283566|2017-02-18 14:29:34.283566
NCT00659763|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-02-17|||February 2008||2008-02-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome|Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome and the Prevalence of Intestinal Parasites in Patients Suspected of Irritable Bowel Syndrome|Completed||N/A|149|Actual|University Hospital Koge|||2||f||||f||||||Samples With DNA|"~     Blood and fecal sample~   "|||2017-02-18 14:29:34.402127|2017-02-18 14:29:34.402127
NCT00659750|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-12-01|||December 2003||2003-12-01|October 2016|2016-10-01|April 2005|Actual|2005-04-01|May 2004|Actual|2004-05-01||Interventional|||To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial to Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray (200 mg Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 12 Years and Older|Completed||Phase 3|418|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:29:34.509717|2017-02-18 14:29:34.509717
NCT00659737|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-05-01|2014-03-27||April 2008||2008-04-01|September 2013|2013-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting|A Randomized, Double-blind Comparison of Oral Aprepitant Alone Versus Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting|Completed||N/A|115|Actual|Drexel University||2|||f||||f||||||||||2017-02-18 14:29:34.650288|2017-02-18 14:29:34.650288
NCT00659724|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2011-05-27|2011-03-07||March 2008||2008-03-01|May 2011|2011-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer|The Gambro Polyflux HD-C4 Big Ease Of Use And Thrombogenicity Study|Completed||N/A|33|Actual|Gambro Renal Products, Inc.|||1||f||||f||||||||||2017-02-18 14:29:34.929359|2017-02-18 14:29:34.929359
NCT00659711|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-12-17|||March 2008||2008-03-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|1928||The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects|The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects|Unknown status|Active, not recruiting|N/A|40|Anticipated|Kaleida Health||2|||f||||f||||||||||2017-02-18 14:29:35.276984|2017-02-18 14:29:35.276984
NCT00659698|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2008-04-15|||April 2007||2007-04-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of an Artificial Pancreas in Patients Undergoing Hepatic Resection|Prevention for Surgical Site Infection After Hepatic Resection|Completed||Phase 4|70|Actual|Kochi University||2|||f||||t||||||||||2017-02-18 14:29:35.366024|2017-02-18 14:29:35.366024
NCT00659685|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2008-04-15|||November 2003||2003-11-01|March 2008|2008-03-01||||||||Interventional|||Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, Cross Over Bioavailability of Kali's Ondansetron 16 mg ODT With That of GlaxoSmithKine's Zofran 16 mg ODT in Healthy, Male and Female Subjects Under Fasting Conditions|Completed||Phase 1|24|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:29:35.469026|2017-02-18 14:29:35.469026
NCT00659672|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2011-02-08|||September 2008||2008-09-01|February 2011|2011-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Whey Protein on Blood Pressure|Effect of Whey Protein on Blood Pressure|Completed||N/A|35|Actual|USDA Beltsville Human Nutrition Research Center||1|||f||||t||||||||||2017-02-18 14:29:35.574642|2017-02-18 14:29:35.574642
NCT00214006|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-06|||November 2001||2001-11-01|March 2013|2013-03-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Observational|||Carotid Atherosclerotic Plaque Study|Carotid Atherosclerotic Plaque Study|Completed||N/A|162|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 17:09:16.260434|2017-02-18 17:09:16.260434
NCT00659659|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2012-10-09|||January 2008||2008-01-01|October 2012|2012-10-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma|A Phase 1, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Effects of MEDI-563, A Humanized Anti-Interleukin-5 Receptor Alpha Monoclonal Antibody, on Airway Eosinophils in Adults With Atopic Asthma|Completed||Phase 1|27|Actual|MedImmune LLC||4|||f||||f||||||||||2017-02-18 14:29:35.668888|2017-02-18 14:29:35.668888
NCT00659646|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2013-04-29|||April 2008||2008-04-01|April 2013|2013-04-01|February 2010|Actual|2010-02-01|May 2009|Actual|2009-05-01||Interventional|||The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers|A Randomized, Controlled, Open Label Study of the Safety and Efficacy of a Topical Gentamicin Collagen Sponge Combined With An Antibiotic Compared to Antibiotic Therapy Alone in Diabetic Patients With Moderately Infected Foot Ulcers|Completed||Phase 2|56|Actual|Innocoll||2|||f||||f||||||||||2017-02-18 14:29:35.781675|2017-02-18 14:29:35.781675
NCT00659633|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-09-14|||December 2008||2008-12-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|June 2016|Actual|2016-06-01||Interventional|||The Effect of Intravenous Lidocaine on Allodynia|The Effect of Intravenous Lidocaine on Allodynia (Carl Koller Grant)|Completed||N/A|10|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-02-18 14:29:35.893903|2017-02-18 14:29:35.893903
NCT00659620|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-14|||May 2008||2008-05-01|April 2008|2008-04-01|May 2010|Anticipated|2010-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy|Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Organ Transplant Institute, China||1|||f||||t||||||||||2017-02-18 14:29:35.996857|2017-02-18 14:29:35.996857
NCT00659607|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2014-05-08|2009-07-29||September 2003||2003-09-01|May 2014|2014-05-01||||July 2008|Actual|2008-07-01||Observational|||Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension|PMS Study of MicardisPlus Tablet|Completed||N/A|6901|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:29:36.111544|2017-02-18 14:29:36.111544
NCT00659594|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-12-01|||November 2004||2004-11-01|October 2016|2016-10-01|September 2005|Actual|2005-09-01|February 2005|Actual|2005-02-01||Interventional|||Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray (200 mg, Once Daily), in the Treatment of Seasonal Allergic Rhinitis (SAR) in Patients 18 Years and Older|Completed||Phase 3|500|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:29:37.05643|2017-02-18 14:29:37.05643
NCT00659581|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2016-07-25|2011-12-16||April 2006||2006-04-01|July 2016|2016-07-01||||June 2010|Actual|2010-06-01||Observational|||J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation|Special Survey (Survey on Cerebrovascular and Cardiovascular Events Under Long-term Use) of Micardis Tablets (Telmisartan)|Completed||N/A|21471|Actual|Boehringer Ingelheim|This study is prospective observational study with no limitation of other antihypertensive treatment in compliance with Japanese Pharmaceutical Affairs Law (JPAL) and Good Post-marketing Study Practice (GPSP).||1||f||||||||||||||2017-02-18 14:29:37.176338|2017-02-18 14:29:37.176338
NCT00659568|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2013-05-29|||March 2008||2008-03-01|August 2010|2010-08-01|August 2010||2010-08-01|February 2010|Actual|2010-02-01||Interventional|||Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma|A Phase I Study of Temsirolimus in Combination With Metformin in Advanced Solid Tumours|Completed||Phase 1|28|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:29:37.861796|2017-02-18 14:29:37.861796
NCT00659555|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-03-15|||April 2008||2008-04-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops|An Open-label, Two-period, Fixed-sequence Study in Healthy Volunteers to Evaluate the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Dose of Pazopanib (GW786034) Administered as Eye Drops|Completed||Phase 1|22|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 14:29:37.96776|2017-02-18 14:29:37.96776
NCT00659542|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2010-03-10|||October 2007||2007-10-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|Cyanoacr||Glubran Mesh Fixation in Lichtenstein Hernioplasty|Randomized Study of Mesh Fixation With Absorbable Sutures or Glubran Tissue Sealant in Lichtenstein Hernioplasty|Completed||Phase 2|300|Anticipated|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 14:29:38.063945|2017-02-18 14:29:38.063945
NCT00659529|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2014-04-01|2014-04-01||August 2008||2008-08-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional||All patiens who received at least one dose of study drug.|Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease|The Role of Phosphodiesterase Inhibitors in CF Lung Disease|Completed||Phase 1/Phase 2|36|Actual|National Jewish Health||1|||f||||t||||||||||2017-02-18 14:29:38.175396|2017-02-18 14:29:38.175396
NCT00659321|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-01-10|||January 2007||2007-01-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome|Placebokontrollierte Untersuchung Zur Wirkung Von Nikotinsäure Auf Die Dyslipidämie Bei Metabolischem Syndrom Und Das Arterioskleroserisiko (Placebo Controlled Investigation of Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome and the Risk of Atherosclerosis)|Completed||Phase 3|68|Actual|GWT-TUD GmbH||2|||f||||||||||||||2017-02-18 14:29:38.397179|2017-02-18 14:29:38.397179
NCT00659308|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-14|||June 2005||2005-06-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|July 2005|Actual|2005-07-01||Interventional|||Amniotic Membrane and Anterior Stromal Puncture to the Treatment of Symptomatic Bullous Keratopathy|Amniotic Membrane and Anterior Stromal Puncture: a Comparative Study in the Treatment of Symptomatic Bullous Keratopathy|Completed||N/A|38|Actual|Federal University of São Paulo||1|||f||||f||||||||||2017-02-18 14:29:38.490259|2017-02-18 14:29:38.490259
NCT00659295|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2014-08-15|2011-06-16||June 2004||2004-06-01|August 2014|2014-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|PREDICTIVE™||Observational Study to Evaluate the Safety of Levemir® in Diabetes|A Multicentre, Open Label, Nonrandomised, Non-interventional, Observational, Safety Study in Subjects Using Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus: The PREDICTIVE™ Study: Predictable Results and Experience in Diabetes Through Intensification and Control to Target: an International Variability Evaluation|Completed||N/A|51170|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 14:29:38.590757|2017-02-18 14:29:38.590757
NCT00659282|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2017-01-05|||September 2006||2006-09-01|January 2017|2017-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|IMPROVE™||Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes|Observational Study of Safety and Effectiveness of NovoMix® 30 (Biphasic Insulin Aspart) for the Treatment of Diabetes Mellitus|Completed||N/A|57610|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:29:40.224362|2017-02-18 14:29:40.224362
NCT00659269|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-01-27|2015-06-18||July 2006||2006-07-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2013|Actual|2013-06-01||Interventional|||A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients|A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients.|Completed||Phase 3|319|Actual|New Mexico Cancer Care Alliance|The number of completed surveys decreased as time went on for each group of patients. This resulted in small numbers of patients to analyze, especially in Group 3 (Vinca Alkaloids), since there weren't many patients in this group to begin with.|2|||f||||t||||||||||2017-02-18 14:29:40.363955|2017-02-18 14:29:40.363955
NCT00659256|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2017-01-24|||April 8, 2008||2008-04-08|March 24, 2015|2015-03-24|March 24, 2015||2015-03-24|||||Observational|||Hepatitis C Treatment and Atherosclerosis|Hepatitis C Eradication and Progression of Atherosclerosis|Completed||N/A|70|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:29:40.895392|2017-02-18 14:29:40.895392
NCT00659243|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2014-10-31|||March 2008||2008-03-01|October 2014|2014-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Pasteurized Breast Milk for Preterm Infants|A Prospective, Randomized, Double-blind Crossover Study Comparing 0.15 g/L rhBSSL Added to Pasteurized Breast Milk Versus Placebo During One Week of Treatment in Preterm Infants Born Before Week 32 of Gestational Age|Completed||Phase 2|32|Actual|Swedish Orphan Biovitrum||2|||f||||t||||||||||2017-02-18 14:29:40.999483|2017-02-18 14:29:40.999483
NCT00659230|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2014-07-02|||April 2009||2009-04-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|March 2014|Actual|2014-03-01||Interventional|Nepicastat||Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans|A Randomized, Placebo-Controlled Trial of the Dopamine-B-Hydroxylase (DBH) Inhibitor, Nepicastat, for the Treatment of PTSD in OIF/OEF Veterans|Completed||Phase 2|100|Actual|Tuscaloosa Research & Education Advancement Corporation||2|||f||||t||||||||||2017-02-18 14:29:41.126193|2017-02-18 14:29:41.126193
NCT00659217|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-14|||May 2008||2008-05-01|April 2008|2008-04-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis|Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Organ Transplant Institute, China||1|||f||||t||||||||||2017-02-18 14:29:41.243513|2017-02-18 14:29:41.243513
NCT00659204|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2008-04-15|||April 2008||2008-04-01|April 2008|2008-04-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||Efficacy of Silver Nanoparticle Gel Versus a Common Antibacterial Hand Gel|A Randomized Controlled Trial of the Efficacy of a Novel Silver Nanoparticle Gel Versus a Common Antibacterial Hand Gel Against Bacterial Hand Flora|Unknown status|Recruiting|Phase 3|40|Anticipated|Madigan Army Medical Center||2|||f||||f||||||||||2017-02-18 14:29:41.346786|2017-02-18 14:29:41.346786
NCT00659191|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2010-10-14||2010-10-14|February 2008||2008-02-01|October 2010|2010-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744|A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single and Repeat Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1265744 in Healthy Male and Female Subjects and Subjects Infected With HIV|Completed||Phase 1|58|Anticipated|GlaxoSmithKline||1|||||||||||||||||2017-02-18 14:29:41.458797|2017-02-18 14:29:41.458797
NCT00659178|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-11-30|||June 2008||2008-06-01|November 2016|2016-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer|A Phase I, Dose Escalation Study to Assess the Safety & Biological Activity of Interleukin 18 (SB-485232) Administered by IV Infusion in Combination With Pegylated Liposomal Doxorubicin (Doxil) in Advanced Stage Epithelial Ovarian Cancer|Completed||Phase 1|15|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:29:41.565511|2017-02-18 14:29:41.565511
NCT00659165|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2011-09-06|2011-01-19||April 2008||2008-04-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes|Exploration of the Weight Neutral Effects of Insulin Detemir Compared to Insulin Glargine: A Measure of Satiety and Calories Consumed in Type 1 Diabetes|Completed||N/A|10|Actual|University of New Mexico||2|||f||||f||||||||||2017-02-18 14:29:41.697351|2017-02-18 14:29:41.697351
NCT00659152|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2015-04-27|||February 2008||2008-02-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Morphofunctional Lung Analysis by Positron Emission Tomography|Morphofunctional Lung Analysis by Positron Emission Tomography in ALI-ARDS Patients|Completed||N/A|30|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-02-18 14:29:42.091681|2017-02-18 14:29:42.091681
NCT00659139|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2008-04-10|||June 2008||2008-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:29:42.175587|2017-02-18 14:29:42.175587
NCT00659126|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-12-05|||November 2006||2006-11-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors|A Phase II Study of Ferumoxytol and Gadolinium Magnetic Resonance Imaging at 3T and 7T in Subjects With Primary or Metastatic Brain Tumors Either Before or After Therapy|Recruiting||Phase 2|150|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 14:29:42.224229|2017-02-18 14:29:42.224229
NCT00659113|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-15|2011-12-03|||March 2008||2008-03-01|December 2008|2008-12-01||||||||Interventional|||S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery|A Phase II Trial of a TS-1/Cisplatin Based Definitive Chemoradiotherapy for Resectable Esophageal Cancer|Unknown status|Recruiting|Phase 2|32|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:29:42.347057|2017-02-18 14:29:42.347057
NCT00659100|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-04-22|||August 2006||2006-08-01|April 2011|2011-04-01|January 2007|Actual|2007-01-01|||||Interventional|||A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment|A 3-Month, Open-Label, Pharmacy-Based, Actual-Use Trial in a Simulated Over-The-Counter (OTC) Environment to Assess Self-Selection and Consumer Use Patterns of Gabapentin 250 mg for Occasional Sleeplessness|Completed||Phase 3|1254|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:29:42.450025|2017-02-18 14:29:42.450025
NCT00659087|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-08-02|||April 2008||2008-04-01|August 2016|2016-08-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Effectiveness of a Femoral Block Following Total Knee Arthroplasty (TKA)|A Pilot Study of the Feasibility of Early Discharge After Total Knee Arthroplasty Using a Femoral Nerve Block|Completed||Phase 4|20|Actual|Edmonton Civic Employees Research Fund||2|||f||||f||||||||||2017-02-18 14:29:42.594812|2017-02-18 14:29:42.594812
NCT00659074|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2008-04-15|||October 2003||2003-10-01|March 2008|2008-03-01|February 2004|Actual|2004-02-01|January 2004|Actual|2004-01-01||Interventional|||Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, Cross Over Bioavailability of Kali's Ondansetron 24 mg ODT With That of GlaxoSmithKine's Zofran 24 mg ODT in Healthy, Male and Female Subjects Under Fasting Conditions|Completed||Phase 1|24|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:29:42.686476|2017-02-18 14:29:42.686476
NCT00659061|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2009-05-28|2008-12-15||August 2007||2007-08-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|Sprinkles||Monitoring and Evaluation of Micronutrients (Sprinkles) Project|Monitoring and Evaluation of Micronutrients (Sprinkles) Project|Completed||N/A|610|Actual|Aga Khan University|The attrition rate was high (6.8% in intervention group and 5.0% in the control group) due to unforeseen migration because of political unrest in the region.|2|||f||||f||||||||||2017-02-18 14:29:42.862703|2017-02-18 14:29:42.862703
NCT00659048|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-11-30|||December 2004||2004-12-01|October 2016|2016-10-01|December 2005|Actual|2005-12-01|April 2005|Actual|2005-04-01||Interventional|||Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)|Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients (18-60 Years) With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|106|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:29:43.322507|2017-02-18 14:29:43.322507
NCT00659035|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2016-11-08|||April 2008||2008-04-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|OpDrive||Use of Driving Tests to Evaluate Patient Performance on Oral Opioids|Use of Driving Tests to Evaluate Patient Performance on Oral Opioids|Active, not recruiting||Phase 3|450|Anticipated|Rush University Medical Center|||5||f||||f||||||||||2017-02-18 14:29:43.426823|2017-02-18 14:29:43.426823
NCT00659022|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-09-09|||July 2008||2008-07-01|February 2009|2009-02-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|||Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth|Accelerated Growth of Synchronous Colorectal Liver Metastases: Effects of Neo-adjuvant Therapy|Unknown status|Recruiting|Phase 2|60|Anticipated|Radboud University||4|||f||||t||||||||||2017-02-18 14:29:43.53323|2017-02-18 14:29:43.53323
NCT00659009|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2012-08-14|||May 2008||2008-05-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effects of Mild Hypobaric Hypoxia on Oxygen Saturation During Sleep|The Effects of Mild Hypobaric Hypoxia on Oxygen Saturation During Sleep: An Investigation of the Physiologic Mechanisms and Significance|Completed||N/A|16|Actual|The Boeing Company||3|||f||||f||||||||||2017-02-18 14:29:43.656784|2017-02-18 14:29:43.656784
NCT00658996|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-12|2011-12-07|2010-12-14||April 2008||2008-04-01|December 2011|2011-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Product Performance of a Toric Contact Lens|A Study to Evaluate the Product Performance of a Prism-Ballasted Toric Contact Lens When Worn by Currently Adapted Soft Contact Lens Wearers.|Completed||N/A|220|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:29:43.761506|2017-02-18 14:29:43.761506
NCT00658983|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2014-12-04|||April 2008||2008-04-01|February 2014|2014-02-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Autologous Platelet Enriched Gel Versus Metalloproteinase Inhibitor in the Healing of Chronic Lower Leg Ulcers|Autologous Platelet Enriched Gel Versus Metalloproteinase Inhibitor in the Healing of Chronic Lower Leg Ulcers|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 14:29:44.067634|2017-02-18 14:29:44.067634
NCT00658970|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-06-07|||November 2007||2007-11-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|March 2010|Actual|2010-03-01||Interventional|||Evaluation of KX2-391 in Patients With Advanced Malignancies|A Combined Rising Single-dose (RSD) and Rising Multiple-dose (RMD)Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of KX2-391 in Patients With Advanced Malignancies That Are Refractory to Conventional Therapies|Completed||Phase 1|50|Anticipated|Kinex Pharmaceuticals Inc||1|||f||||f||||||||||2017-02-18 14:29:44.16195|2017-02-18 14:29:44.16195
NCT00658957|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-03-22|||April 2008||2008-04-01|March 2012|2012-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer|A Phase II, Randomized, Parallel, Double-blind, Placebo-controlled Study to Assess Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With Uninfected Lower Extremity Skin Ulcers|Terminated||Phase 2|49|Actual|Innocoll||2||Business Decision|f||||f||||||||||2017-02-18 14:29:46.687454|2017-02-18 14:29:46.687454
NCT00658944|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2008-04-15|||May 2002||2002-05-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Observational|||Predictive Objective Parameters for Outcome of the Treatment of Stress Urinary Incontinence|Preoperative MUCP and VLPP Failed to Predict Long Term (4-Years) Outcome in Patients Who Underwent Transobturator Mid-Urethral Slings. a Prospective Observational Descriptive Study|Completed||N/A|65|Actual|University Of Perugia|||1||f||||f||||||||||2017-02-18 14:29:46.816174|2017-02-18 14:29:46.816174
NCT00658931|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2010-02-10|||April 2008||2008-04-01|February 2010|2010-02-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Cymbalta for Depression as a Complication of Bereavement|Cymbalta for Depression as a Complication of Bereavement|Unknown status|Active, not recruiting|Phase 4|20|Anticipated|Jefferson Clinic, P.C.||1|||f||||f||||||||||2017-02-18 14:29:46.908505|2017-02-18 14:29:46.908505
NCT00658918|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2016-12-01|||September 2004||2004-09-01|October 2016|2016-10-01|November 2005|Actual|2005-11-01|April 2005|Actual|2005-04-01||Interventional|||To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Clinical Trial Designed to Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, 200µg, 100µg or 25µg Once Daily for Six Weeks, in the Treatment of Perennial Allergic Rhinitis (PAR) in Pediatric Patients 2-5 Years of Age.|Completed||Phase 3|120|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 14:29:47.018807|2017-02-18 14:29:47.018807
NCT00658905|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-14|2014-10-31|||April 2008||2008-04-01|October 2014|2014-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm Infants|A Prospective, Randomized, Double-blind Crossover Study Comparing 0.15 g/L rhBSSL Added to Infant Formula Versus Placebo During One Week of Treatment in Preterm Infants Born Before Week 32 of Gestational Age|Completed||Phase 2|33|Actual|Swedish Orphan Biovitrum||2|||f||||t||||||||||2017-02-18 14:29:47.125843|2017-02-18 14:29:47.125843
NCT00658892|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-12|2016-04-19|||April 2008||2008-04-01|April 2016|2016-04-01||||February 2010|Actual|2010-02-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma|B7-DC Xab Plasma Therapy for the Treatment of Metastatic Melanoma. A Feasibility/Pilot Study|Active, not recruiting||Phase 1|18|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 14:29:47.232977|2017-02-18 14:29:47.232977
NCT00658879|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2016-12-19|||August 2007||2007-08-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|November 2016|Actual|2016-11-01||Observational|||Long Term Use of Pegvisomant For A Regulatory Post Marketing Commitment Plan|Special Investigation Of Somavert -Long Term Use-|Active, not recruiting||N/A|200|Anticipated|Pfizer|||1||f||||f||||||||||2017-02-18 14:29:47.332953|2017-02-18 14:29:47.332953
NCT00658866|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2011-08-08|||February 2008||2008-02-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|2007-005020-33||Target Site Pharmacokinetics of Ertapenem After Multiple Doses in Diabetes Patients With Soft Tissue Infection|Target Site Pharmacokinetics of Ertapenem After Multiple Doses in Diabetes Patients With Soft Tissue Infection|Completed||Phase 4|10|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-02-18 14:29:47.421094|2017-02-18 14:29:47.421094
NCT00658853|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-07-15|||January 2004||2004-01-01|July 2016|2016-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Effective High Aerobic Intensity Endurance Training Regimes in Chronic Obstructive Pulmonary Disease (COPD) Patients|Effective High Aerobic Intensity Interval Training to Improve Maximal Oxygen Uptake in COPD Patients|Completed||N/A|26|Actual|Norwegian University of Science and Technology||3|||f||||t||||||||||2017-02-18 14:29:47.507028|2017-02-18 14:29:47.507028
NCT00658840|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2012-04-02|||June 2006||2006-06-01|April 2012|2012-04-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma|A Phase II Study of Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma|Unknown status|Recruiting|Phase 2|55|Anticipated|National Cancer Center, Korea||1|||f||||||||||||||2017-02-18 14:29:47.607676|2017-02-18 14:29:47.607676
NCT00658827|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2016-12-30|||January 2007||2007-01-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis|Exposure to Remicade (Infliximab) During Pregnancy in Patients With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Psoriasis: a Review and Analysis of Birth Outcomes From the Swedish, Danish and Finnish Medical Birth Registers|Active, not recruiting||Phase 4|370|Anticipated|Janssen Biotech, Inc.|||8||f||||f||||||||||2017-02-18 14:29:47.907584|2017-02-18 14:29:47.907584
NCT00658814|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-12|2016-12-08|2013-07-22||December 2008||2008-12-01|November 2016|2016-11-01||||June 2013|Actual|2013-06-01||Interventional||Eligible patients who began protocol therapy|Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|A Phase II Trial of Azacitidine (NSC-102816) Plus Gemtuzumab Ozogamicin (NSC-720568) as Induction and Post-Remission Therapy in Patients of Age 60 and Older With Previously Untreated Non-M3 Acute Myeloid Leukemia|Active, not recruiting||Phase 2|133|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:29:48.032995|2017-02-18 14:29:48.032995
NCT00658801|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2011-07-07|||January 2007||2007-01-01|July 2011|2011-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma|A Phase II Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma|Terminated||Phase 1|4|Actual|National Cancer Center, Korea||1||difficult to register|f||||||||||||||2017-02-18 14:29:49.570082|2017-02-18 14:29:49.570082
NCT00658788|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2014-08-12|2014-08-12||March 2008||2008-03-01|September 2012|2012-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis|A Multi-Center, Open-Label Study to Evaluate the Safety and Efficacy of a Consecutive Treatment Regimen of Clobetasol Propionate 0.05% Spray, Followed by Calcitriol Ointment 3µg/g, in the Management of Moderate to Severe Plaque Psoriasis|Completed||Phase 3|305|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-02-18 14:29:49.653943|2017-02-18 14:29:49.653943
NCT00658775|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2015-11-19|2015-06-08||February 2008||2008-02-01|November 2015|2015-11-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)|A Randomized, Double-Blind, Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|1069|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 14:29:50.467416|2017-02-18 14:29:50.467416
NCT00658762|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2012-11-09||2010-08-25|May 2008||2008-05-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)|A Phase 3, Randomized, Double-Blind, Parallel Group, 10-Week Placebo Controlled Fixed Dose Study of PD 0332334 and Paroxetine Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder|Terminated||Phase 3|286|Actual|Pfizer||4||Please see Detailed Description for termination reason.|f||||f||||||||||2017-02-18 14:29:51.134722|2017-02-18 14:29:51.134722
NCT00658749|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2009-06-24|||April 2008||2008-04-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|AIR645-CS1||A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma|A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma|Completed||Phase 1|80|Actual|Altair Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 14:29:51.277906|2017-02-18 14:29:51.277906
NCT00658736|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2013-07-29|||March 2008||2008-03-01|July 2013|2013-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis|A RANDOMIZED, TRIPLE-BLINDED STUDY OF ENDOSCOPIC ULTRASOUND GUIDED CELIAC PLEXUS BLOCKADE (EUS-CPB) WITH BUPIVICAINE AND TRIAMCINOLONE VS. BUPIVICAINE ALONE FOR TREATMENT OF PAIN IN CHRONIC PANCREATITIS|Completed||Phase 3|41|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 14:29:51.377818|2017-02-18 14:29:51.377818
NCT00658723|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2014-09-09|2014-03-29||March 2008||2008-03-01|September 2014|2014-09-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||The Fibrin Patch Soft Tissue Study|A Prospective, Randomized, Controlled, Superiority Evaluation of Fibrin Patch as an Adjunct to Control Soft Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic Surgery|Completed||Phase 2|141|Actual|Ethicon, Inc.||2|||f||||t||||||||||2017-02-18 14:29:51.483367|2017-02-18 14:29:51.483367
NCT00658710|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2013-11-06|||June 2008||2008-06-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|HEMIMARCHE||Impact of Prolonged Physical Therapy on Gait Performance of Chronic Phase Stroke Patients|Impact of Prolonged Physical Therapy on Gait Performance of Chronic Phase Stroke Patients|Terminated||N/A|70|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t||||||||||2017-02-18 14:29:52.382093|2017-02-18 14:29:52.382093
NCT00658697|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2016-06-22|2015-07-29||June 2008||2008-06-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|September 2014|Actual|2014-09-01||Interventional||41 (One patient never started any study treatment, and was excluded from analysis).|Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer|A Phase II Trial of Avastin, Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising Prostate Specific Antigen (PSA) After Local Therapy|Completed||Phase 2|42|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 14:29:52.505829|2017-02-18 14:29:52.505829
NCT00658684|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2010-10-05|2010-07-14||February 2008||2008-02-01|October 2010|2010-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.|An Open-Label, Multicenter, Long Term Study to Evaluate the Safety, Tolerability and Efficacy of Fesoterodine in Patients With Overactive Bladder.|Completed||Phase 3|153|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:29:52.951158|2017-02-18 14:29:52.951158
NCT00658671|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2016-01-26|||April 2008||2008-04-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Interventional|||A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer|An Open-Label, Dose-Escalation, Safety, and Pharmacokinetic Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer|Completed||Phase 1|67|Actual|CASI Pharmaceuticals, Inc.||4|||f||||f||||||||Undecided||2017-02-18 14:29:54.338084|2017-02-18 14:29:54.338084
NCT00658658|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-04-12|2016-01-20||March 2008||2008-03-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Panitumumab in Children With Solid Tumors|A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children With Solid Tumors|Completed||Phase 1|31|Actual|Amgen||1|||f||||f||||||||||2017-02-18 14:29:54.459123|2017-02-18 14:29:54.459123
NCT00658645|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2010-09-24|||March 2008||2008-03-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy of Bifeprunox in Patients With Schizophrenia|A Multinational, Randomised, Double-blind, Fixed-dose, Bifeprunox Study Combining a 12-Week Placebo-controlled, Quetiapine-referenced Phase With a 12-month Quetiapine-controlled Phase in Patients With Schizophrenia|Terminated||Phase 3|227|Actual|H. Lundbeck A/S||3||Interim analysis showed inadequate efficacy of bifeprunox|f||||f||||||||||2017-02-18 14:29:56.49697|2017-02-18 14:29:56.49697
NCT00658632|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2016-03-28|2015-06-08||February 2008||2008-02-01|March 2016|2016-03-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional||The analysis was performed using the Intent-to-Treat (ITT) population, defined as all randomized subjects who received at least 1 dose of study drug, minus two participants from one site who were excluded from the ITT Population per an agreement with the FDA due to concerns of possible misconduct.|Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)|A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|1397|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 14:29:56.853373|2017-02-18 14:29:56.853373
NCT00658619|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2013-03-13|2013-03-13||May 2008||2008-05-01|March 2013|2013-03-01|April 2011|Actual|2011-04-01|June 2010|Actual|2010-06-01||Interventional|||Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)|Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to AMD|Completed||Phase 2|119|Actual|Allergan||5|||f||||f||||||||||2017-02-18 14:29:57.330482|2017-02-18 14:29:57.330482
NCT00658606|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2013-01-03|2011-02-17||October 2007||2007-10-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects|Efficacy and Safety of Alefacept in Combination With Narrow-band UVB (nbUVB) Compared to Alefacept Alone in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 4|98|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||t||||||||||2017-02-18 14:29:58.184977|2017-02-18 14:29:58.184977
NCT00658593|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-12|2012-12-17|||March 2008||2008-03-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|||||Interventional|||Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Biliary Cancer|A Phase III Study of Gemcitabine Plus Capecitabine (GEMCAP) Versus Gemcitabine Alone in Advanced Biliary Cancer|Terminated||Phase 3|19|Actual|Canadian Cancer Trials Group||||due to poor accrual|f||||||||||||||2017-02-18 14:29:58.923171|2017-02-18 14:29:58.923171
NCT00658580|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2015-02-11|||April 2000||2000-04-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|December 2013|Actual|2013-12-01||Interventional|||Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer|A Phase III Randomized Study Comparing A Chemotherapy With Cisplatin And Etoposide To A Etoposide Regimen Without Cisplatin For Patients With Extensive Small-Cell Lung Cancer|Completed||Phase 3|361|Actual|European Lung Cancer Working Party||2|||f||||t||||||||||2017-02-18 14:29:59.034369|2017-02-18 14:29:59.034369
NCT00658567|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2014-08-29|2014-02-06||March 2008||2008-03-01|August 2014|2014-08-01||||December 2009|Actual|2009-12-01||Interventional|||A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis||Completed||Phase 3|123|Actual|ACADIA Pharmaceuticals Inc.||3|||f||||||||||||||2017-02-18 14:29:59.143788|2017-02-18 14:29:59.143788
NCT00658554|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2008-06-18|||April 2008||2008-04-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Bioequivalence Study of ARQ 197 Amorphous and Crystalline Polymorphs A and B in Normal Healthy Volunteers|Bioequivalence Study of ARQ 197 Amorphous and Crystalline Polymorphs A and B in Normal Healthy Volunteers|Completed||Phase 1|24|Actual|ArQule||1|||t||||f||||||||||2017-02-18 14:29:59.818836|2017-02-18 14:29:59.818836
NCT00658541|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2011-04-29|2009-12-16||May 2004||2004-05-01|April 2011|2011-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Fed Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Tablets|A Randomized, Two-way Crossover, Single-dose, Open-label Study to Evaluate the Relative Bioequivalence of a Test Tablet Formulation of Zolpidem Tartrate 10mg, Compared to an Equivalent Dose of Ambien® in Fed, Healthy, Adult Subjects|Completed||Phase 1|38|Actual|Mutual Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:29:59.905747|2017-02-18 14:29:59.905747
NCT00658528|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2015-11-19|2015-06-08||February 2008||2008-02-01|November 2015|2015-11-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)|A Randomized Double-Blind Parallel Study of Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|1061|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 14:30:00.259406|2017-02-18 14:30:00.259406
NCT00658515|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-11-01||2016-08-09|April 2008||2008-04-01|November 2016|2016-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome|A Randomized, Double-blind, Placebo-controlled Study Assessing the Effect of RO4607381 on Cardiovascular Mortality and Morbidity in Clinically Stable Patients With a Recent Acute Coronary Syndrome|Completed||Phase 3|15865|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:30:00.954173|2017-02-18 14:30:00.954173
NCT00658502|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2008-04-14|||March 2008||2008-03-01|March 2008|2008-03-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Observational|||Ocular Response Analyzer Assessment of Intraocular Pressure and Corneal Biomechanical Properties in Myopic and Anisometropic Patients Under Atropine Treatment|Ocular Response Analyzer Assessment of Intraocular Pressure and Corneal Biomechanical Properties in Myopic and Anisometropic Patients Under Atropine Treatment|Unknown status|Recruiting|N/A|100|Anticipated|Far Eastern Memorial Hospital|||2||f||||||||||||||2017-02-18 14:30:07.149651|2017-02-18 14:30:07.149651
NCT00658489|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2011-11-09|||January 2008||2008-01-01|November 2011|2011-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Implementation and Evaluation of Bright Futures Curriculum Within CORNET Continuity Practice|Implementation and Evaluation of Bright Futures Curriculum Within CORNET Continuity Practice|Completed||N/A|10|Actual|Christiana Care Health Services||2|||f||||f||||||||||2017-02-18 14:30:07.22685|2017-02-18 14:30:07.22685
NCT00658476|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-03-26|||November 2006||2006-11-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|PUFA||Omega-3 Fatty Acids for Treatment of Depression in Adolescents|Treating Adolescent Depression With Fish Oils|Completed||Phase 3|4|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-02-18 14:30:07.324901|2017-02-18 14:30:07.324901
NCT00658463|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-14|||January 2006||2006-01-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Interventional|||Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients|Effects of Rosuvastatin on the, in Vivo, Kinetic of VLDL apoB, IDL apoB, LDL apoB and HDL apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients|Completed||Phase 4|8|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||t||||||||||2017-02-18 14:30:07.420802|2017-02-18 14:30:07.420802
NCT00658450|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2012-12-05|||February 2008||2008-02-01|December 2012|2012-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Rehabilitation Program for Cognitive Deficits in Ugandan Children After Cerebral Malaria|A Randomised Trial to Investigate the Effect of a Rehabilitation Program for Cognitive Deficits in Ugandan Children After Cerebral Malaria.|Completed||N/A|123|Actual|Makerere University||2|||f||||t||||||||||2017-02-18 14:30:07.526208|2017-02-18 14:30:07.526208
NCT00658437|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2011-06-07|||April 2008||2008-04-01|August 2009|2009-08-01|May 2010|Actual|2010-05-01|August 2009|Actual|2009-08-01||Interventional|||CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy|A Phase II Multicenter Study to Test Progression-free and Overall Survival of CY-503 in the Treatment of Patients With Unresectable Stage IV Metastatic Melanoma After Antineoplastic Treatment Failure|Completed||Phase 2|31|Actual|Cytavis Biopharma GmbH||1|||f||||f||||||||||2017-02-18 14:30:07.636565|2017-02-18 14:30:07.636565
NCT00658411|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-04-05|2012-12-04||August 2008||2008-08-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation|A Pilot Study of Deferoxamine Before and During Myeloablative Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndromes or Acute Leukemia and Iron Overload|Terminated||N/A|5|Actual|Dana-Farber Cancer Institute|The number of patients enrolled on this study is far too small to draw reliable conclusions.|1||Closed due to slow patient accrual|f||||t||||||||||2017-02-18 14:30:07.733188|2017-02-18 14:30:07.733188
NCT00658398|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2015-05-19|||May 2008||2008-05-01|August 2013|2013-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|BREVALCO||The BREVALCO Study, Effect of an Interactive Computer Program to Prevent Alcohol Misuse|Effect of an Interactive Computer Program to Prevent Alcohol Misuse. A Multicentre Randomized Controlled Trial. The BREVALCO Study.|Completed||Phase 3|601|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:30:08.212939|2017-02-18 14:30:08.212939
NCT00658385|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-10-04|2015-04-07||April 2008||2008-04-01|October 2016|2016-10-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major|A Pilot Trial to Assess the Feasibility and Safety of GCSF Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major|Completed||N/A|5|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:30:08.330204|2017-02-18 14:30:08.330204
NCT00658372|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2012-11-09||2010-08-25|May 2008||2008-05-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)|A Phase 3, Randomized, Double-Blind, Parallel Group, 10-Week Placebo Controlled Fixed Dose Study Of PD 0332334 And Paroxetine Evaluating The Efficacy And Safety Of PD 0332334 For The Treatment Of Generalized Anxiety Disorder|Terminated||Phase 3|360|Actual|Pfizer||4||Please see Detailed Description for termination reason.|f||||f||||||||||2017-02-18 14:30:08.560256|2017-02-18 14:30:08.560256
NCT00658359|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2015-08-18|||August 2008||2008-08-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|March 2015|Actual|2015-03-01||Interventional|||Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients|A Phase 2, Multicenter, Open-label, Active Comparator-controlled, Extension Trial To Evaluate The Long-term Safety And Efficacy Of Cp-690,550 In Renal Allograft Recipients|Completed||Phase 2|178|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 14:30:08.724654|2017-02-18 14:30:08.724654
NCT00658346|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2017-01-11|||June 2010||2010-06-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|August 2015|Actual|2015-08-01||Observational|||Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon|Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon|Completed||N/A|141|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)|||2||f||||t||||||Samples With DNA|"~     plasma and mononucleus cells~   "|||2017-02-18 14:30:08.903636|2017-02-18 14:30:08.903636
NCT00658333|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-07-31|2010-12-02||March 2008||2008-03-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms|A Multicenter, Randomized, Double Blind, Double Dummy Controlled Study to Assess the Tolerability of an Increased Dose of Enteric Coated MPA After Conversion From MMF in Renal Transplant Recipients Who Required MMF Dose Reductions Due to Gastrointestinal Symptoms|Terminated||Phase 4|30|Actual|Novartis|Due to the insufficient number of patients enrolled in the study, no conclusions can be made from the data.|2|||f||||||||||||||2017-02-18 14:30:09.014523|2017-02-18 14:30:09.014523
NCT00658320|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2013-05-13|2011-08-10||February 2008||2008-02-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|August 2010|Actual|2010-08-01||Interventional||Baseline Measures are based on the data obtained in the Core Study.|Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids|A 12-month, Multicenter, Randomized, Open-label Study to Investigate Efficacy and Safety of Concentration Controlled Everolimus With Reduced Dose Cyclosporine A Versus Mycophenolate Mofetil With Standard Dose Cyclosporine A in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids|Completed||Phase 3|122|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:30:09.568202|2017-02-18 14:30:09.568202
NCT00658307|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2014-05-01|||April 2008||2008-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Effects of Repetitive Transcranial Magnetic Stimulation in Healthy Human Subjects|The Effects of Repetitive Transcranial Magnetic Stimulation in Healthy Human Subjects|Completed||N/A|56|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-02-18 14:30:10.55169|2017-02-18 14:30:10.55169
NCT00658294|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-04-11|||January 2008||2008-01-01|April 2008|2008-04-01|January 2009|Anticipated|2009-01-01|||||Observational|||Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles|Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology|Unknown status|Recruiting|Phase 4|30|Anticipated|University of Zurich|||1||f||||f||||||||||2017-02-18 14:30:10.674834|2017-02-18 14:30:10.674834
NCT00658281|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2015-10-05|||March 2008||2008-03-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients|A Pilot Study of Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients Using On-Board Imaging System With Linear Accelerator|Completed||N/A|28|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:30:10.756207|2017-02-18 14:30:10.756207
NCT00658268|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2012-01-26|||March 2008||2008-03-01|January 2012|2012-01-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Bisphosphonates and Impaction Grafting in Hip Revision|Bisphosphonates and Impaction Grafting in Hip Revision Evaluated With Radiostereophotogrametri. A Randomized, Double-blind Study in Patients Operated for Aseptic Loosening and Osteolysis.|Unknown status|Recruiting|Phase 2|32|Anticipated|Region Skane||2|||f||||f||||||||||2017-02-18 14:30:10.859632|2017-02-18 14:30:10.859632
NCT00658255|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-01-21|||October 2002||2002-10-01|January 2011|2011-01-01|May 2003|Actual|2003-05-01|||||Interventional|||Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler|A Randomized, Multicenter, Open-label, Active-controlled, Single-dose, 5-period, Incomplete Block, Cross-over Study to Evaluate the Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort pMDI or Oxis Turbuhaler to Adults With Stable Asthma|Completed||Phase 2|175|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:30:10.959627|2017-02-18 14:30:10.959627
NCT00658242|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-08-07|||March 2008||2008-03-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Craniofacial Surgery Perioperative Registry|Craniofacial Surgery Perioperative Registry|Completed||N/A|249|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 14:30:11.054393|2017-02-18 14:30:11.054393
NCT00658229|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-10-12|||November 2008||2008-11-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PEPC||The Physical Exercise and Prostate Cancer Study|Physical Exercise for Patients With Prostate Cancer During Androgen Deprivation Therapy - A Randomized Trial|Completed||Phase 3|60|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 14:30:11.143549|2017-02-18 14:30:11.143549
NCT00658216|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-08-02|||June 2007||2007-06-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|August 2011|Actual|2011-08-01||Observational|BED||Brain Natriuretic Peptide (BNP) Usefulness In Elderly Dyspneic Patients (BED)|Usefulness of Measuring Plasma Brain Natriuretic Peptide for Diagnosis and Prognosis in Very Elderly Patients.|Completed||N/A|390|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples Without DNA|"~     Blood sample for brain natriuretic peptide measurement~   "|||2017-02-18 14:30:11.244175|2017-02-18 14:30:11.244175
NCT00658203|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-07|||November 2005||2005-11-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Clinical Evaluation on Advanced Resynchronization|Clinical Evaluation on Advanced Resynchronization|Completed||Phase 4|310|Anticipated|LivaNova||2|||f||||t||||||||||2017-02-18 14:30:11.357071|2017-02-18 14:30:11.357071
NCT00658190|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2015-04-06|||October 2003||2003-10-01|April 2012|2012-04-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|IBCCSP||Internet-Based Cervical Cytology Screening Program|Internet-Based Cervical Cytology Screening Program|Completed||N/A|175|Actual|Massachusetts General Hospital|||1||f||||f||||||||||2017-02-18 14:30:11.494568|2017-02-18 14:30:11.494568
NCT00658177|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2014-12-01|||June 2003||2003-06-01|December 2014|2014-12-01|February 2004|Actual|2004-02-01|||||Interventional|||Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile Dysfunction|A Randomized, Double-blind, Parallel-group, Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil Administered for 12 Weeks in a Flexible-dose Regimen Compared to Placebo in Male Erectile Dysfunction Subjects|Completed||Phase 3|463|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:30:11.683168|2017-02-18 14:30:11.683168
NCT00658164|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2008-04-11|||October 2007||2007-10-01|July 2007|2007-07-01||||March 2009|Anticipated|2009-03-01||Interventional|||Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores||Unknown status|Recruiting|Phase 3|150|Anticipated|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||1|||f||||||||||||||2017-02-18 14:30:11.789981|2017-02-18 14:30:11.789981
NCT00658151|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-04-11|||April 2008||2008-04-01|April 2008|2008-04-01||||January 2009|Anticipated|2009-01-01||Observational|||Ultrasound Diagnosis of Antibiotic Associated Diarrhea||Unknown status|Not yet recruiting|N/A|100|Anticipated|Shaare Zedek Medical Center|||1||f||||||||||||||2017-02-18 14:30:11.881544|2017-02-18 14:30:11.881544
NCT00658138|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-02-23|2011-12-29||December 2008||2008-12-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|November 2010|Actual|2010-11-01||Interventional|||Clinical Evaluation of 3M™ ESPE™ Adper™ Scotchbond™ SE Self-Etch Adhesive in Class I and Class II Restorations in Adults|Clinical Evaluation of 3M™ ESPE™ Adper™ Scotchbond™ SE Self-Etch Adhesive in Class I and Class II Restorations in Adults|Completed||N/A|61|Actual|3M|Main limitation of study was small sample size and short duratrion. Study was a pilot of one year's duration.|2|||f||||f||||||||||2017-02-18 14:30:11.957959|2017-02-18 14:30:11.957959
NCT00658125|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2010-04-07|||March 2007||2007-03-01|January 2010|2010-01-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Deep Brain Stimulation (DBS) for Alzheimer's Disease|Modulation of Cognitive Function Using Electrical Brain Stimulation in Patients With Early Alzheimer Disease|Unknown status|Active, not recruiting|Phase 1|6|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 14:30:12.183628|2017-02-18 14:30:12.183628
NCT00658112|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2013-06-19|||July 2006||2006-07-01|June 2013|2013-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne|Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne|Completed||Phase 4|20|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 14:30:12.264212|2017-02-18 14:30:12.264212
NCT00658099|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2017-01-30|||November 2007||2007-11-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|EVIDENCE||Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®|Change in Weight on Insulin Detemir (Levemir®) or Isophane (NPH) Insulin (Insulatard®) in Patients With Type 2 Diabetes Mellitus|Completed||N/A|699|Actual|Novo Nordisk A/S|||2||f||||f||||||||||2017-02-18 14:30:12.360736|2017-02-18 14:30:12.360736
NCT00658086|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2009-06-15|||April 2008||2008-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)|Completed||Phase 2|24|Actual|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:30:12.462847|2017-02-18 14:30:12.462847
NCT00658073|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2011-03-07|||March 2008||2008-03-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts|Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Recipients of Living Kidney Allografts|Completed||N/A|165|Actual|Fuzhou General Hospital||3|||f||||t||||||||||2017-02-18 14:30:12.72757|2017-02-18 14:30:12.72757
NCT00658060|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-04-11|||September 2007||2007-09-01|April 2008|2008-04-01||||||||Observational|||Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients|Exertional Muscle Fatigue In FMF Patients Evaluated By MRI And MR Spectroscopy Of The Thigh|Unknown status|Recruiting|N/A|20|Anticipated|Sheba Medical Center|||2||f||||f||||||||||2017-02-18 14:30:12.840041|2017-02-18 14:30:12.840041
NCT00658047|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-04-09||2013-03-27|April 2008||2008-04-01|April 2013|2013-04-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|CH-1504-201||A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis|A Phase II, Multi-center, Randomized, Double-blind, Methotrexate Controlled Study to Assess the Clinical Efficacy, Safety, and Tolerability of CH-1504 in Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|201|Actual|Chelsea Therapeutics||4|||f||||t||||||||||2017-02-18 14:30:12.933623|2017-02-18 14:30:12.933623
NCT00658034|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2011-10-25|||April 2008||2008-04-01|October 2011|2011-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue|Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: a Randomized Phase III Trial|Unknown status|Recruiting|Phase 3|20|Anticipated|Alta Bates Summit Medical Center||2|||f||||f||||||||||2017-02-18 14:30:13.04571|2017-02-18 14:30:13.04571
NCT00005186|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1986||1986-04-01|March 2005|2005-03-01|June 1992|Actual|1992-06-01|||||Observational|||Epidemiology of Cardiovascular Diseases in The Elderly||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:23.138153|2017-02-18 18:15:23.138153
NCT00658021|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2017-02-10|||May 2008||2008-05-01|February 2017|2017-02-01|May 2020|Anticipated|2020-05-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes|Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes.|Recruiting||Phase 3|195|Anticipated|AstraZeneca||3|||f||||t||||||||||2017-02-18 14:30:13.150961|2017-02-18 14:30:13.150961
NCT00658008|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-11-09||2010-08-25|April 2008||2008-04-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)|A Phase 3, Randomized, Double-Blind, Parallel Group, 10-Week Placebo Controlled Fixed Dose Study Of PD 0332334 And Paroxetine Evaluating The Efficacy And Safety Of PD 0332334 For The Treatment Of Generalized Anxiety Disorder|Terminated||Phase 3|501|Actual|Pfizer||5||Please see Detailed Description for termination reason.|f||||f||||||||||2017-02-18 14:30:13.324749|2017-02-18 14:30:13.324749
NCT00657995|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-08|||April 2007||2007-04-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Tight Glycemic Control by Artificial Pancreas|Continuous Postoperative Blood Glucose Monitoring and Control by an Artificial Pancreas in Patients Undergoing Pancreatic Resection: A Prospective Randomized Clinical Trial|Completed||N/A|32|Actual|Kochi University||1|||f||||t||||||||||2017-02-18 14:30:13.496617|2017-02-18 14:30:13.496617
NCT00657982|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2009-01-19|||April 2008||2008-04-01|January 2009|2009-01-01||||March 2010|Anticipated|2010-03-01||Interventional|||Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer|Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer|Unknown status|Recruiting|Phase 2|15|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 14:30:13.609394|2017-02-18 14:30:13.609394
NCT00657969|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2009-10-20|||July 2005||2005-07-01|October 2009|2009-10-01|September 2009|Anticipated|2009-09-01|January 2009|Actual|2009-01-01||Observational|CADISP||Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections|Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections|Unknown status|Active, not recruiting|N/A|4169|Actual|Cervical Artery Dissections and Ischemic Stroke Patients - Consortium|||3||f||||||||||Samples With DNA|"~     DNA, plasma, serum~   "|||2017-02-18 14:30:13.711288|2017-02-18 14:30:13.711288
NCT00657956|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-03-28|||April 2008||2008-04-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Roentgen Stereophotogrammetric Analysis (RSA) to Evaluate Fixation of Biofoam Advance Total Knee Arthroplasty Components|Prospective RCT Using Roentgen Stereophotogrammetric Analysis (RSA) to Evaluate Fixation of the Biofoam Advance Total Knee Arthroplasty Components With and Without Screw Augmentation|Completed||N/A|50|Actual|Dalhousie University||1|||f||||f||||||||||2017-02-18 14:30:13.837237|2017-02-18 14:30:13.837237
NCT00657943|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-02-02|||April 2008||2008-04-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CIMT||The Copenhagen Insulin and Metformin Therapy Trial|The Effect of Metformin Versus Placebo, Including Three Insulin-Analogue Regimens With Variating Postprandial Glucose Regulation, on CIMT in T2DM Patients - A Randomized, Multicenter Trial|Completed||Phase 4|415|Actual|Steno Diabetes Center||6|||f||||t||||||||||2017-02-18 14:30:13.931641|2017-02-18 14:30:13.931641
NCT00657930|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2016-03-02|||March 2008||2008-03-01|March 2016|2016-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|LEONCET2||Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)|Evaluation on Glycaemic Control and Weight Change of Once Daily Levemir® (Insulin Detemir) in Type 2 Diabetes Mellitus Treated by an Intensive Insulin Treatment (ICT)|Completed||N/A|2289|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:30:14.057247|2017-02-18 14:30:14.057247
NCT00657917|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2011-11-29|||November 2004||2004-11-01|November 2011|2011-11-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396|Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396|Completed||Phase 2|1|Actual|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 14:30:14.161984|2017-02-18 14:30:14.161984
NCT00657904|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2012-06-05|||August 1995||1995-08-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer|A Randomized Double-Blind Comparative Trial of Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer.|Completed||Phase 3|3618|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:30:14.480824|2017-02-18 14:30:14.480824
NCT00657891|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-09-30|||March 2007||2007-03-01|September 2013|2013-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Effect of Xolair (Omalizumab) on Allergy Blood Cells|The Effect of Xolair (Omalizumab) on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils|Completed||Phase 4|49|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 14:30:14.76144|2017-02-18 14:30:14.76144
NCT00657878|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2015-10-28|||November 2008||2008-11-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|July 2016|Anticipated|2016-07-01||Interventional|MITO-8||Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval|Liposomal Doxorubicin Versus Carboplatin/Paclitaxel in Patients With Ovarian Cancer Recurrence Between 6 and 12 Months After Previous Platinum Based Therapy: Phase III Randomized Multicenter Study Amendment Title Protocol Version 2.0: Phase III International Multicenter Randomized Study Testing the Effect on Survival of Prolonging Platinum-free Interval in Patients With Ovarian Cancer Recurring Between 6 and 12 Months After Previous Platinum Based Chemotherapy.|Active, not recruiting||Phase 3|215|Actual|National Cancer Institute, Naples||2|||f||||f||||||||||2017-02-18 14:30:14.872814|2017-02-18 14:30:14.872814
NCT00657865|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2011-08-19|||March 2008||2008-03-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|March 2010|Actual|2010-03-01||Interventional|||Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril|Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril|Completed||Phase 4|18|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:30:15.035565|2017-02-18 14:30:15.035565
NCT00657852|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-04-08|||December 2000||2000-12-01|April 2008|2008-04-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant|Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Disodium Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant|Completed||Phase 4|79|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 14:30:15.281431|2017-02-18 14:30:15.281431
NCT00657839|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2014-10-27|||October 2005||2005-10-01|October 2014|2014-10-01|June 2006|Actual|2006-06-01|||||Interventional|||Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia|A Randomized, Double-blind, Placebo-controlled, Multi-center, Parallel Group Study to Assess the Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia|Completed||Phase 2|222|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:30:15.397829|2017-02-18 14:30:15.397829
NCT00657826|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-06-20||2016-06-20|October 2001||2001-10-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||ATS 3f(r) Aortic Bioprosthesis Model 1000, 19mm|ATS 3f(r) Aortic Bioprosthesis Model 1000|Terminated||N/A|22|Actual|Medtronic Cardiovascular||1||Business decision to end study due to limited enrollment and study population|f||||t||||||||No||2017-02-18 14:30:15.519252|2017-02-18 14:30:15.519252
NCT00657813|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2010-10-07|||March 2008||2008-03-01|October 2010|2010-10-01|July 2008|Actual|2008-07-01|June 2008|Anticipated|2008-06-01||Interventional|||Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition|Evaluation of [123I] MNI-330 and Single Photon Emission Computed Tomography (SPECT) as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Terminated||Phase 1|3|Actual|Institute for Neurodegenerative Disorders||1||Data did not evidence [123I]MNI-330 as a useful tool in the detection of AD.|f||||f||||||||||2017-02-18 14:30:15.628432|2017-02-18 14:30:15.628432
NCT00657800|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2010-09-21|||December 2007||2007-12-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|October 2009|Actual|2009-10-01||Interventional|||The Effect of a Coordinated Inpatient Diabetes Education Program in the Outpatient Setting|The Effect of a Coordinated Inpatient Diabetes Education Program on Glycemic Control, Diabetes Self-Management, Patient Satisfaction, and Quality of Life in the Outpatient Setting|Completed||N/A|60|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:30:15.733505|2017-02-18 14:30:15.733505
NCT00657787|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2016-01-20|||September 2008||2008-09-01|January 2016|2016-01-01|September 2017|Anticipated|2017-09-01|||||Observational|||Development of a Post-Traumatic Stress Disorder (PTSD) Population Registry for Veterans|Development of a Post-Traumatic Stress Disorder (PTSD) Population Registry for Veterans|Active, not recruiting||N/A|1600|Anticipated|Boston VA Research Institute, Inc.|||3||f||||f||||||||||2017-02-18 14:30:15.838972|2017-02-18 14:30:15.838972
NCT00657774|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-11-28|||April 2008||2008-04-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands|A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group, 6-Week Study to Evaluate the Effect of Multiple Doses of FlutiForm™ 250/10 Microgram HFA pMDI Twice Daily, FlutiForm™ 100/10 Microgram HFA pMDI Twice Daily, Prednisone and Placebo on the Hypothalmic-Pituitary-Adrenal Axis in Adult Subjects With Mild to Moderate Asthma.|Completed||Phase 1|160|Anticipated|SkyePharma AG||4|||f||||f||||||||||2017-02-18 14:30:15.942975|2017-02-18 14:30:15.942975
NCT00657761|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-04-08|||September 2005||2005-09-01|April 2008|2008-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Metabolic Effects of Enfuvirtide in Healthy Volunteers|Effect of Enfuvirtide on Lipid and Glucose Metabolism and Mitochondrial Function in Healthy Volunteers|Completed||Phase 4|15|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 14:30:16.108101|2017-02-18 14:30:16.108101
NCT00657748|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2015-04-20|||September 2009||2009-09-01|April 2015|2015-04-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|||Lithium and Acetate for Canavan Disease|Evaluation of the Tolerance and Efficiency of a Combined Oral Therapy With Lithium and GTA in Patients With Canavan Disease|Withdrawn||Phase 2|0|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 14:30:16.267833|2017-02-18 14:30:16.267833
NCT00657735|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-01-04|||January 2009||2009-01-01|January 2012|2012-01-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Double Blind Randomized Controlled, H1 Coil In Subjects With Bipolar Depression|A Prospective Double Blind Randomized Controlled Trial To Explore The Tolerability, Safety And Efficacy Of The H1-Coil Deep Transcranial Magnetic Stimulation (TMS) In Subjects With Bipolar Depression|Unknown status|Recruiting|N/A|50|Anticipated|Shalvata Mental Health Center||2|||f||||t||||||||||2017-02-18 14:30:16.4073|2017-02-18 14:30:16.4073
NCT00657722|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2013-04-10|||January 2008||2008-01-01|April 2013|2013-04-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|ETHAPE||Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic Hypertension|Identification Of The Predictive Angiographic And Computed Tomographic (CT) Criteria Of The Success Of The Thromboendarterectomy In Chronic Pulmonary Hypertension|Completed||N/A|249|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 14:30:16.508886|2017-02-18 14:30:16.508886
NCT00657709|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2015-04-13|2015-02-13||March 2008||2008-03-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants|A Phase 3, Partially Blinded, Randomized, Multi-Center, Controlled Study to Evaluate Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants|Completed||Phase 3|3630|Actual|Novartis||5|||f||||t||||||||||2017-02-18 14:30:16.638087|2017-02-18 14:30:16.638087
NCT00657696|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2016-09-02|||January 2009||2009-01-01|September 2016|2016-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|Learn & Relate||Learning and Relationships in Primary Care|Learning and Relationships in Primary Care Clinical Microsystems|Completed||N/A|7905|Actual|VA Office of Research and Development|||2||f||||f||||||||||2017-02-18 14:30:18.495421|2017-02-18 14:30:18.495421
NCT00657683|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-12-07|||December 2007||2007-12-01|December 2011|2011-12-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age|A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age|Completed||Phase 1|65|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:30:18.586696|2017-02-18 14:30:18.586696
NCT00631631|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2014-05-13|||January 2008||2008-01-01|May 2014|2014-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma|Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine (L-MTP-PE) for High-risk Osteosarcoma|Completed||N/A|205|Actual|Millennium Pharmaceuticals, Inc.|||1||f||||f||||||||||2017-02-18 14:39:01.442094|2017-02-18 14:39:01.442094
NCT00657670|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2009-10-08|||April 2008||2008-04-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|November 2008|Actual|2008-11-01||Interventional|RECS||Evaluation of Effectiveness of Correcting Refractive Error With Ready-made Spectacles|Evaluation of the Feasibility of Correcting Refractive Error From a Limited Inventory of Ready-made Spectacles: Wearer Retention, Vision Function, Quality of Life and Cost|Completed||N/A|800|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:30:18.68773|2017-02-18 14:30:18.68773
NCT00657657|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2016-10-26|2009-08-06||April 2008||2008-04-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine|Immune Response to a Hepatitis B Vaccine Challenge Dose in Healthy Subjects Who Received Primary Vaccination of GlaxoSmithKline Biologicals' Hepatitis B Vaccine, Approximately 20 Years Ago.|Completed||Phase 4|29|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:30:18.975219|2017-02-18 14:30:18.975219
NCT00657644|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-12-23|||August 2003||2003-08-01|December 2014|2014-12-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction|Open-label Multi-centre Non Randomised Study of Efficacy and Safety of Vardenafil (BAY 38-9456; SB-782528) Administered in Flexible-dose Regimen in Males With Erectile Dysfunction of Broad Aetiology.|Completed||Phase 3|130|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:30:19.238162|2017-02-18 14:30:19.238162
NCT00657631|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2009-10-09|||April 2008||2008-04-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|ACT||Acceptance and Commitment Therapy for Delusions|Acceptance and Commitment Therapy for Delusions|Completed||N/A|4|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 14:30:19.362831|2017-02-18 14:30:19.362831
NCT00657618|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2016-10-24|||October 2004||2004-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Use of Sodium Stibogluconate as a Treatment for Leishmaniasis|Department of Defense Protocol for the Use of Sodium Stibogluconate (Pentostam) as a Treatment for Leishmaniasis|Enrolling by invitation||Phase 1/Phase 2|1000|Anticipated|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 14:30:19.477312|2017-02-18 14:30:19.477312
NCT00657605|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2008-04-14|||June 2001||2001-06-01|April 2008|2008-04-01|December 2010|Anticipated|2010-12-01|January 2010|Anticipated|2010-01-01||Interventional|||Effects of Human Leptin Replacement|Effects of Human Leptin Replacement|Unknown status|Active, not recruiting|Phase 2|3|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 14:30:19.594115|2017-02-18 14:30:19.594115
NCT00657592|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-03-26|||March 2008||2008-03-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Interventional|||Treatment of Major Depressive Disorder (MDD) With Ziprasidone|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Sequential Trial of Ziprasidone as Monotherapy for Major Depressive Disorder|Completed||Phase 3|61|Actual|Cedars-Sinai Medical Center||3|||f||||f||||||||||2017-02-18 14:30:19.72985|2017-02-18 14:30:19.72985
NCT00657579|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2009-03-12||||||March 2009|2009-03-01||||||||Interventional|||Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension|A Randomized, Double-Masked, Parallel-Group, Dose-Response Trial of DE-104 Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|||Santen Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-02-18 14:30:19.843093|2017-02-18 14:30:19.843093
NCT00657566|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2015-10-05|||September 2008||2008-09-01|December 2013|2013-12-01|August 2014|Actual|2014-08-01|August 2013|Actual|2013-08-01||Interventional|||SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection|SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection|Completed||Phase 3|518|Actual|National Institute of General Medical Sciences (NIGMS)||2|||f||||t||||||||||2017-02-18 14:30:19.938618|2017-02-18 14:30:19.938618
NCT00657553|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2011-06-13|2011-04-14||February 2008||2008-02-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|2007-77||Preemptive Strike With Bortezomib in Multiple Myeloma Patients|Preemptive Strike With Bortezomib (VELCADE) in Participants With Multiple Myeloma Still Event-free on Total Therapy 2 (UARK 98-026)|Terminated||Phase 3|10|Actual|University of Arkansas|Early termination leading to small numbers of subjects analyzed|2||Due to poor accrual|f||||t||||||||||2017-02-18 14:30:20.099169|2017-02-18 14:30:20.099169
NCT00657540|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2015-12-15|||August 2009||2009-08-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|BWSP3||Black Widow Spider Antivenin for Patients With Systemic Latrodectism|A Phase III Multicenter Clinical Trial of Analatro® [Antivenin Latrodectus (Black Widow) Equine Immune F(ab)2] in Patients With Systemic Latrodectism|Completed||Phase 3|60|Actual|Instituto Bioclon S.A. de C.V.||2|||f||||t||||||||||2017-02-18 14:30:20.450395|2017-02-18 14:30:20.450395
NCT00657527|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2009-03-13|||December 2001||2001-12-01|March 2009|2009-03-01|December 2002|Actual|2002-12-01|||||Interventional|||Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease|An 8-Week Randomized Double Blind Placebo Controlled Multicenter Trial to Evaluate the Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease.|Completed||Phase 3|280|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:30:20.572432|2017-02-18 14:30:20.572432
NCT00657514|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-08-13|||May 2008||2008-05-01|August 2014|2014-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease|Evaluation of Ranolazine on Skeletal Muscle Endpoints During Exercise In Subjects With Chronic Angina and Peripheral Arterial Disease|Withdrawn||Phase 4|0|Actual|Colorado Prevention Center||2||Insufficient enrollment|f||||t||||||||||2017-02-18 14:30:20.672165|2017-02-18 14:30:20.672165
NCT00657501|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-01-04||2013-01-04|March 2008||2008-03-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|BLOOM||Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women|Completed||Phase 3|575|Actual|BioSante Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:30:20.796796|2017-02-18 14:30:20.796796
NCT00656760|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2016-05-17|||July 2007||2007-07-01|May 2016|2016-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer|The Clinical Utility of PET-CT in the Management of Squamous Cell Carcinoma of Neck Nodes With an Unknown Primary Malignancy.|Completed||N/A|20|Actual|University of Calgary||1|||f||||f||||||||||2017-02-18 14:30:34.808402|2017-02-18 14:30:34.808402
NCT00657488|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2016-11-29|||December 2001||2001-12-01|November 2016|2016-11-01|April 2006|Actual|2006-04-01|October 2005|Actual|2005-10-01||Interventional|||Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma|Multicenter, Randomized Study Comparing the Efficacy and Safety of Two Doses of Thalidomide (100 mg/Day Versus 400 mg/Day) in the Treatment of Subjects With Refractory or Relapsed Multiple Myeloma.|Completed||Phase 2/Phase 3|400|Actual|Celgene Corporation||2|||f||||f||||||||||2017-02-18 14:30:20.963562|2017-02-18 14:30:20.963562
NCT00657475|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-05-06|||June 2008||2008-06-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|APPACHES||Coronary Bypass and Artotic Leaflet Surgery : Heparin Low Dose vs Full Dose|A Prospective Study of Coronary Artery Bypass Graft and/or Aortic Valve Replacement With Conventional Versus Half Heparin Dose Under Closed and Coated Extra Corporeal Circulation System (MECC) - APPACHES Study.|Completed||Phase 4|238|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 14:30:21.206525|2017-02-18 14:30:21.206525
NCT00657462|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2017-01-30|||April 2008||2008-04-01|January 2017|2017-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|PAMLTIPS||Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts|Effect of Reminder Prompts on Utilization of the PAML Builder Application Features|Completed||N/A|14122|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 14:30:21.315952|2017-02-18 14:30:21.315952
NCT00657449|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-04-08|||June 2003||2003-06-01|March 2008|2008-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Double-Blind, Double-Dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain|A Double-Blind, Double-Dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg vs. Rofecoxib 50 mg in the Symptomatic Treatment of Patients With Ankle Sprain|Terminated||Phase 4|256|Actual|Pfizer||2||See Detailed Description|f||||f||||||||||2017-02-18 14:30:21.420366|2017-02-18 14:30:21.420366
NCT00657436|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-05-30|||March 2008||2008-03-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|MyRiAD||Myeloid-Related Protein in Evaluation of Acute Chest Pain in the Emergency Departement|Study of Myeloid-related Protein 8/14 and Additional Biomarkers (Multi Marker Approach) for Early Diagnosis and Risk Stratification in Patients Presenting With Acute Chest Pain at the Emergency Department|Completed||N/A|403|Actual|University of Zurich|||1||f||||f||||||||||2017-02-18 14:30:21.540407|2017-02-18 14:30:21.540407
NCT00657423|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2010-09-15|||April 2008||2008-04-01|August 2008|2008-08-01|April 2009|Anticipated|2009-04-01|December 2008|Anticipated|2008-12-01||Interventional|||Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)|Study of Endostar Combined With Docetaxel and Cisplatin on the Angiogenesis of Advanced Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 3|80|Anticipated|Xijing Hospital||2|||f||||t||||||||||2017-02-18 14:30:21.629711|2017-02-18 14:30:21.629711
NCT00657410|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2016-07-14|||April 2008||2008-04-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|February 2016|Actual|2016-02-01||Interventional|ITP0207||Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura|Randomized Study of the Treatment of Primary Immune Thrombocytopenic Purpura (ITP) in Newly Diagnosed Untreated Adult Patients. Comparison of Standard Dose Prednisone Versus High-dose Dexamethasone.|Active, not recruiting||Phase 3|150|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||2|||f||||f||||||||||2017-02-18 14:30:21.741552|2017-02-18 14:30:21.741552
NCT00657397|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-07-23|||January 2009||2009-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|Methaville||Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices|Initialization of Methadone in Primary Care; a Randomized Intervention Research for Preventing HCV Transmission Practices. ANRS Methaville|Completed||Phase 3|197|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 14:30:21.910454|2017-02-18 14:30:21.910454
NCT00657384|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-09-06|||October 2008||2008-10-01|September 2013|2013-09-01|November 2013|Anticipated|2013-11-01|October 2013|Anticipated|2013-10-01||Interventional|||Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy|Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy : a Prospective Randomized Double-blinding Study|Unknown status|Recruiting|Phase 3|130|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 14:30:22.016958|2017-02-18 14:30:22.016958
NCT00657371|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-10-11|2013-10-11||March 2008||2008-03-01|October 2013|2013-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||Of the 288 registered, only 249 had a screening colonoscopy to meet inclusion in the study.|Efficacy of the Third Eye Retroscope Auxiliary Imaging System|A Prospective Efficacy Evaluation of the Third Eye Retroscope Auxiliary Imaging System|Completed||N/A|288|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:30:22.124653|2017-02-18 14:30:22.124653
NCT00657358|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2013-11-24|2012-05-24||April 2008||2008-04-01|November 2013|2013-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers|The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers (Carl Koller Grant) (The Effect of Intravenous Lidocaine on Allodynia)|Completed||N/A|22|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-02-18 14:30:22.357977|2017-02-18 14:30:22.357977
NCT00657345|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-11-04|||March 2008||2008-03-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||IRS Proteins and Trastuzumab Resistance|IRS Proteins and Trastuzumab Resistance|Completed||N/A|9|Actual|University of Massachusetts, Worcester|||1||f||||f||||||||||2017-02-18 14:30:22.646737|2017-02-18 14:30:22.646737
NCT00657332|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2010-02-26|||July 2007||2007-07-01|February 2010|2010-02-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Observational|||Clinical and Pathologic Studies in Neuroendocrine Tumors|Clinical and Pathologic Studies in Neuroendocrine Tumors|Terminated||N/A|200|Anticipated|Stanford University|||1|not known|f||||||||||Samples Without DNA|"~     biopsy of tumor, blood sample and/or urine samples.~   "|||2017-02-18 14:30:25.241849|2017-02-18 14:30:25.241849
NCT00657319|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2017-01-06|||October 2007||2007-10-01|January 2017|2017-01-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Observational|||Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins|Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins|Completed||N/A|3495|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:30:25.325233|2017-02-18 14:30:25.325233
NCT00657306|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2008-04-11|||May 2008||2008-05-01|April 2008|2008-04-01|May 2009|Anticipated|2009-05-01|December 2008|Anticipated|2008-12-01||Interventional|AILD||Adrenal Insufficiency in Cirrhotics With Ascites. Effects of Hydrocortisone on Renal and Haemodynamic Function|Adrenal Insufficiency in Cirrhotics With Ascites. Effects of Stress Doses of Hydrocortisone on Renal Function and on Liver and Systemic Haemodynamics|Unknown status|Not yet recruiting|Phase 2|50|Anticipated|University of Turin, Italy||2|||f||||t||||||||||2017-02-18 14:30:25.42969|2017-02-18 14:30:25.42969
NCT00657293|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2010-02-19|||July 2008||2008-07-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Arm Training in Patients With Chronic Obstructive Pulmonary Disease|Arm Training in COPD: Short and Medium Term Effects on Dyspnoea, Health-related Quality of Life, Arm Function and Arm Exercise Capacity.|Completed||N/A|34|Actual|West Park Healthcare Centre||2|||f||||f||||||||||2017-02-18 14:30:25.525316|2017-02-18 14:30:25.525316
NCT00657280|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2014-12-04|2014-05-13||April 2008||2008-04-01|December 2014|2014-12-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Interventional|S-001|Adult patients diagnosis of nonischemic dilated cardiomyopathy with Class I-III symptoms. all patients were required to have been on a stable comprehensive heart failure regimen for at least three months, including therapy with beta-blockers and angiotensin-converting-enzyme inhibitors or angiotensin-receptor-blockers unless they were intolerant.|Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure|Effect of Sitagliptin on Insulin Resistance and Myocardial Metabolism in Heart Failure|Completed||Early Phase 1|16|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 14:30:25.63889|2017-02-18 14:30:25.63889
NCT00657267|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-02-13|2013-06-16||May 2008||2008-05-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|November 2011|Actual|2011-11-01||Interventional||Of the 58 participants who registered and started study treatment, 3 were ineligible for analysis and 1 withdrew before response assessment.|Dose-Intense Temozolomide in Recurrent Glioblastoma|Phase 2 Study of Dose-Intense Temozolomide in Recurrent Glioblastoma|Completed||Phase 2|58|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 14:30:25.872027|2017-02-18 14:30:25.872027
NCT00657254|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-12-18|||December 2002||2002-12-01|December 2014|2014-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Extension Program for Bay 43-9006|Extension Program for Bay 43-9006|Completed||Phase 2|9|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:30:26.531752|2017-02-18 14:30:26.531752
NCT00657241|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2010-06-30|||April 2008||2008-04-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril|Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril|Completed||Phase 3|30|Actual|State University of New York at Buffalo||2|||f||||t||||||||||2017-02-18 14:30:26.643824|2017-02-18 14:30:26.643824
NCT00657228|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2017-01-05|||December 2009||2009-12-01|January 2017|2017-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department|Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic/Anaphylactoid Reactions in the Emergency Department|Withdrawn||N/A|0|Actual|University of Missouri, Kansas City||2||Study did not start.|f||||t||||||||||2017-02-18 14:30:26.755235|2017-02-18 14:30:26.755235
NCT00657202|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-07-06|||March 2008||2008-03-01|July 2016|2016-07-01|December 2013|Actual|2013-12-01|October 2009|Actual|2009-10-01||Interventional|||Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1|Pilot Study of Ranibizumab (Lucentis) for Neurofibromas Associated With Neurofibromatosis 1|Completed||Early Phase 1|11|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:30:26.877525|2017-02-18 14:30:26.877525
NCT00657189|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2016-08-05||2016-08-05|July 2008||2008-07-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus|A Phase 2A , Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Study to Evaluate the Safety and Tolerability of Multiple Subcutaneous Doses of MEDI-545, A Fully Human Anti-Interferon-Alpha Monoclonal Antibody, In Subjects With Systemic Lupus Erythematosus|Completed||Phase 2|87|Actual|MedImmune LLC||5|||f||||f||||||||||2017-02-18 14:30:26.992188|2017-02-18 14:30:26.992188
NCT00657176|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2008-04-17|||March 2008||2008-03-01|April 2008|2008-04-01|June 2009|Anticipated|2009-06-01|March 2009|Anticipated|2009-03-01||Interventional|||An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors|A Phase 1, Open-Label, Non-Randomized Study of OPB-31121 in Patients With Advanced Solid Tumors|Unknown status|Recruiting|Phase 1|36|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 14:30:27.144829|2017-02-18 14:30:27.144829
NCT00657163|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2011-09-15|||March 2005||2005-03-01|July 2009|2009-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|FLAME||Fluoxetine on Motor Rehabilitation After Ischemic Stroke|Effects of 3 Months Daily Treatment With Selective Serotonin Reuptake Inhibitor (SSRI, Fluoxetine) on Motor Rehabilitation After Ischemic Stroke. FLAME Trial|Completed||Phase 2|100|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 14:30:27.223264|2017-02-18 14:30:27.223264
NCT00657150|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2014-06-23|2010-11-18||March 2008||2008-03-01|December 2013|2013-12-01||||September 2009|Actual|2009-09-01||Interventional||Treated set|Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty|A Phase III Randomised, Parallel Group, Double-blind, Active Controlled Study to Investigate the Efficacy and Safety of Orally Administered 220 mg Dabigatran Etexilate Capsules (110 mg Administered on the Day of Surgery Followed by 220 mg Once Daily) Compared to Subcutaneous 40 mg Enoxaparin Once Daily for 28-35 Days, in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip Arthroplasty Surgery. (RE-NOVATE II)|Completed||Phase 3|2055|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:30:27.354835|2017-02-18 14:30:27.354835
NCT00657137|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2012-03-13|||April 2008||2008-04-01|March 2012|2012-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|APRiCOT-B||APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)|A Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of Patients With HER2/Neu+ Breast Cancer Who Have Failed Trastuzumab and Chemotherapy Including a Taxane|Terminated||Phase 2|12|Actual|Tragara Pharmaceuticals, Inc.||2||Slow accrual|f||||t||||||||||2017-02-18 14:30:28.509247|2017-02-18 14:30:28.509247
NCT00656565|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-08-05|||June 2008||2008-06-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Inspiratory Flow and Volumes in Bronchiectatics|Inspiratory Flow Rates and Volumes in Subjects With Bronchiectasis Using Low and High Resistance Dry Powder Inhaler Devices|Completed||N/A|15|Anticipated|Pharmaxis|||1||f||||f||||||||||2017-02-18 14:30:37.747728|2017-02-18 14:30:37.747728
NCT00657124|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-11|||April 2007||2007-04-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Preoperative Supplementation in Insulin Resistance|Preoperative Oral Supplementation of Carbohydrate and Branched-Chain Amino Acids-Enriched Nutrient Improves Insulin Resistance in Patients With Hepatectomy; Prospective Randomized Clinical Trial by Using Artificial Pancreas|Completed||Phase 4|26|Actual|Kochi University||2|||f||||t||||||||||2017-02-18 14:30:28.655145|2017-02-18 14:30:28.655145
NCT00657111|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2016-05-20|||April 2008||2008-04-01|May 2016|2016-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||CS-8958 Single Inhaled Dose in Elderly|CS-8958 - A Phase I, Double-Blind, Placebo Controlled, Ascending Single Inhaled Dose, Safety, Tolerability and Pharmacokinetic Study in Elderly Subjects|Completed||Phase 1|38|Actual|Aviragen Therapeutics||8|||f||||t||||||||||2017-02-18 14:30:28.766845|2017-02-18 14:30:28.766845
NCT00657098|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2015-10-05|||March 2008||2008-03-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|Mabtornib||Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed Therapy|Mabtornib Protocol.Vascular, Metabolic and Hormonal Effects of Angiogenesis Inhibitors and Epidermal Growth Factor Receptor Inhibitors|Terminated||N/A|73|Actual|University Medical Center Groningen|||1|slow inclusion rate|f||||f||||||Samples With DNA|"~     Serum Plasma Urine DNA~   "|||2017-02-18 14:30:28.878022|2017-02-18 14:30:28.878022
NCT00657085|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2008-12-10|||March 2008||2008-03-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Evaluation of the LightSheer HS Hand Piece as Compared to the LightSheer ET Hand Piece for the Intended Use of Hair Removal and Permanent Hair Reduction|Evaluation of the LightSheer HS Hand Piece as Compared to the LightSheer ET Hand Piece for the Intended Use of Hair Removal and Permanent Hair Reduction|Completed||N/A|5|Anticipated|Lumenis Ltd.|||1||f||||f||||||Samples With DNA|"~     Biopsied hair follicles retained and analzed through horizontal sectioning and viability~     staining~   "|||2017-02-18 14:30:28.968126|2017-02-18 14:30:28.968126
NCT00657072|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2015-11-20|||May 2003||2003-05-01|November 2015|2015-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Biomechanical Evaluation of Wrist Ligament Injuries: Diagnostic Tool to Detect Wrist Instability|Biomechanical Evaluation of Wrist Ligament Injuries: Diagnostic Tool to Detect Wrist Instability|Completed||N/A|50|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:30:29.042287|2017-02-18 14:30:29.042287
NCT00657059|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2016-10-16|||September 2007||2007-09-01|October 2016|2016-10-01|April 2019|Anticipated|2019-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)|A Prospective, Multicenter, Randomized Controlled Trial of Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)|Active, not recruiting||Phase 3|151|Actual|Sun Yat-sen University||3|||f||||t||||||||||2017-02-18 14:30:29.11672|2017-02-18 14:30:29.11672
NCT00657046|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2014-05-27|2014-04-24||December 2007||2007-12-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|IDH201||Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension|A Phase II, Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Assess the Clinical Benefit and Safety of Droxidopa in Patients With Intradialytic Hypotension|Completed||Phase 2|85|Actual|Chelsea Therapeutics||3|||f||||f||||||||||2017-02-18 14:30:29.236041|2017-02-18 14:30:29.236041
NCT00657033|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2013-10-10|||October 2003||2003-10-01|October 2013|2013-10-01|August 2004|Actual|2004-08-01|||||Interventional|||Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction|A Randomized, Double Blind, Parallel Group, Multi-center Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction, and Their Female Partners' Sexual Quality of Life.|Completed||Phase 3|229|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:30:30.37384|2017-02-18 14:30:30.37384
NCT00657020|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2015-02-12|2009-10-12||September 2007||2007-09-01|June 2013|2013-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms|Simultaneous fMRI/EEG of the 4 mg Nicotine Lozenge in Relief of Cognitive Impairment Associated With Nicotine Withdrawal|Completed||Phase 4|23|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:30:30.520165|2017-02-18 14:30:30.520165
NCT00657007|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2013-08-01|||February 2002||2002-02-01|August 2013|2013-08-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)|A Phase 1, Multi-Center, Double-Blind, Single and Double Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Systemic Lupus Erythematosus|Completed||Phase 1|70|Actual|Human Genome Sciences Inc.||5|||f||||f||||||||||2017-02-18 14:30:31.198276|2017-02-18 14:30:31.198276
NCT00656994|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-02-27|||January 2003||2003-01-01|February 2012|2012-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia|A Phase III Safety Study to Evaluate the Long-term Effects of TAK-375 on Endocrine Function in Adult Subjects With Chronic Insomnia|Completed||Phase 3|122|Actual|Takeda||2|||f||||f||||||||||2017-02-18 14:30:31.331052|2017-02-18 14:30:31.331052
NCT00656981|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2014-12-29|||January 2003||2003-01-01|December 2014|2014-12-01|June 2004|Actual|2004-06-01|||||Interventional|||Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety & Efficacy of Oral Contraceptive Prep., Containing Drospirenone 3 mg/Ethinyl Estradiol 20 Mcg for 6 Treatment Cycles in Women With Moderate Acne Vulgaris|Completed||Phase 3|541|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:30:31.471789|2017-02-18 14:30:31.471789
NCT00656968|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-09-14|2010-08-17||May 2007||2007-05-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|960025||Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection|Sequential Versus Concomitant Therapy for Helicobacter Pylori Infection|Completed||Phase 4|232|Actual|Kaohsiung Veterans General Hospital.|The trial was performed in a single country|2|||f||||f||||||||||2017-02-18 14:30:31.592857|2017-02-18 14:30:31.592857
NCT00656955|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-11|2017-01-24|||April 10, 2008||2008-04-10|August 16, 2016|2016-08-16||||||||Observational|||Follow-Up Study of Kidney Cancer Patients|Follow-up of Kidney Cancer Patients From the Central European Multicenter Case-Control Study|Completed||N/A|1002|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:30:32.187222|2017-02-18 14:30:32.187222
NCT00656942|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2014-09-03|||July 2006||2006-07-01|September 2014|2014-09-01|December 2014|Anticipated|2014-12-01|December 2013|Actual|2013-12-01||Observational|||Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain|Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain|Unknown status|Active, not recruiting|N/A|164|Anticipated|Massachusetts General Hospital|||1||f||||t||||||||||2017-02-18 14:30:32.283559|2017-02-18 14:30:32.283559
NCT00656929|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-10|||December 2006||2006-12-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Randomized Controlled Trial of Vitamin D3 Supplementation for Viral Upper Respiratory Tract Infections (URI) Prevention|A Randomized Controlled Trial of Vitamin D3 Supplementation for the Prevention of Viral Upper Respiratory Tract Infections|Completed||N/A|167|Actual|Winthrop University Hospital||2|||f||||f||||||||||2017-02-18 14:30:32.370649|2017-02-18 14:30:32.370649
NCT00656916|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2012-03-29|2012-02-07||March 2008||2008-03-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Inhaled Corticosteroids Versus Observation for Patients With Decreased Lung Function Status|Randomized Study of Early Treatment With Inhaled Corticosteroids Versus Observation for Patients Who Have Decreased Lung Function Status Post Allogeneic Stem Cell Transplantation|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||2||Terminated due to slow accrual.|f||||f||||||||||2017-02-18 14:30:32.4686|2017-02-18 14:30:32.4686
NCT00656903|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2017-01-24|||April 7, 2008||2008-04-07|August 19, 2014|2014-08-19|August 19, 2014||2014-08-19|||||Observational|||High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration|High Speed Indocyanine Green Angiography Findings in Induction/PRN Regimen of Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration|Completed||N/A|75|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:30:32.745301|2017-02-18 14:30:32.745301
NCT00656890|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2015-09-23||2015-09-23|April 2008||2008-04-01|September 2015|2015-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|MDX1100-06||A Study of MDX-1100 in Subjects With Active Ulcerative Colitis|A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis|Completed||Phase 2|110|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 14:30:32.842065|2017-02-18 14:30:32.842065
NCT00656877|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2008-04-04|||January 2006||2006-01-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|Fat Embolism||Incidence of Fat Embolism With Computer Assisted Total Knee Arthroplasty|Incidence of Fat Embolism With Computer Assisted Total Knee Arthroplasty|Completed||N/A|50|Anticipated|Marshall University|||1||f||||f||||||||||2017-02-18 14:30:33.006561|2017-02-18 14:30:33.006561
NCT00656864|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2011-02-01|||May 2008||2008-05-01|January 2010|2010-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Pioglitazone Incretin Study|Effects of Pioglitazone on the Regulation of Insulin Secretion in Patients With Type 2 Diabetes|Completed||Phase 4|24|Actual|University of Vermont||2|||f||||f||||||||||2017-02-18 14:30:33.102415|2017-02-18 14:30:33.102415
NCT00656851|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2013-08-19|2013-04-30||September 2005||2005-09-01|August 2013|2013-08-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|WU197||Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome|Myocardial Function, Free Fatty Acid and Glucose Metabolism in HIV Metabolic Syndrome|Completed||N/A|24|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|We did not perform the myocardial metabolic measurements under insulin-stimulated conditions (i.e. hyperinsulinemic clamps). Small number of participants and high measurement variability, efficacy was not found. Study ended to minimize risk/benefit.|2|||f||||f||||||||||2017-02-18 14:30:33.217188|2017-02-18 14:30:33.217188
NCT00656838|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-02-19|||April 2008||2008-04-01|October 2011|2011-10-01|February 2013|Actual|2013-02-01|April 2011|Actual|2011-04-01||Interventional|FIBER||Focusing Implementation to Bring Effective Reminders (FIBER)|Focusing Implementation to Bring Effective Reminders (FIBER)|Completed||N/A|85289|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-02-18 14:30:33.792218|2017-02-18 14:30:33.792218
NCT00656825|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-11-04|||March 2007||2007-03-01|November 2008|2008-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers|Multicentre, Placebo-Controlled, Multi-Dosis, Phase I Clinical Trial to Evaluate the Tolerability and Bioavailability of TGF β1 Inhibitor Peptide 144 After Topical Administration in Healthy Volunteers.|Completed||Phase 1|36|Actual|ISDIN||4|||f||||f||||||||||2017-02-18 14:30:33.903868|2017-02-18 14:30:33.903868
NCT00656812|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2013-12-23|||May 2008||2008-05-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma|Phase II Trial of Rituximab Plus 2CdA in Patients With Advanced or Relapsed Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)|Completed||Phase 2|40|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||f||||||||||2017-02-18 14:30:34.018291|2017-02-18 14:30:34.018291
NCT00656799|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2015-02-20|2013-05-21||April 2008||2008-04-01|February 2015|2015-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Dialysis of Sugammadex in Participants With Severe Renal Impairment (Study 19.4.333) (P05773)|A Single Center, Open-Label Trial in Subjects With Severe Renal Impairment Evaluating the Dialysability of the Sugammadex-Rocuronium Complex|Completed||Phase 3|6|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:30:34.145457|2017-02-18 14:30:34.145457
NCT00656786|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2015-06-02|||April 2008||2008-04-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash|A Phase 1, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Safety, Tolerability, and Systemic Absorption of Menadione Topical Lotion as an Emergent and Pre-emergent Treatment for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash|Active, not recruiting||Phase 1|24|Anticipated|Spectrum Pharmaceuticals, Inc||2|||f||||t||||||||||2017-02-18 14:30:34.59215|2017-02-18 14:30:34.59215
NCT00656773|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2016-05-06|||January 2008||2008-01-01|May 2016|2016-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Randomized, Double-blind Comparison of Morphine and Sufentanil for Prehospital Traumatic Severe Acute Pain|A Randomized, Double-blind Comparison of Morphine and Sufentanil for Treatment of Prehospital Traumatic Severe Acute Pain.|Completed||Phase 3|108|Actual|University Hospital, Toulouse||2|||f||||t||||||||No||2017-02-18 14:30:34.698788|2017-02-18 14:30:34.698788
NCT00656747|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-11-27|||March 2008||2008-03-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis|MAESTRAL - A Prospective, Multinational, Multicenter, Randomized, Double Blind, Double Dummy, Controlled Study Comparing the Efficacy and Safety of Moxifloxacin to That of Amoxicillin Clavulanic Acid for the Treatment of Subjects With Acute Exacerbations of Chronic Bronchitis.|Completed||Phase 4|1372|Actual|Bayer||2|||f||||t||||||||||2017-02-18 14:30:34.915354|2017-02-18 14:30:34.915354
NCT00656734|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-05-13|||April 2008||2008-04-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|MDX1411-01||Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.|A Phase 1, Open-Label, Multicenter Dose-escalation, Multidose Study of MDX1411 Administered Every 14 Days in Subjects With Advanced or Recurrent Clear Cell Renal Cell Carcinoma|Completed||Phase 1|27|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:30:35.475872|2017-02-18 14:30:35.475872
NCT00656721|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2015-06-18|||September 2004||2004-09-01|June 2015|2015-06-01|June 2006|Actual|2006-06-01|November 2005|Actual|2005-11-01||Interventional|||Respiratory Mechanics Effects of Flutter Valve in Bronchiectasis Patients|Flutter Valve Improves Respiratory Mechanics and Sputum Production in Bronchiectasis Patients|Completed||N/A|8|Actual|Universidade Federal do Rio de Janeiro||1|||f||||f||||||||||2017-02-18 14:30:35.603306|2017-02-18 14:30:35.603306
NCT00656708|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2009-08-18|||August 2008||2008-08-01|August 2009|2009-08-01|January 2011|Anticipated|2011-01-01|June 2009|Actual|2009-06-01||Interventional|||Kerlix Gauze Study in a Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients|Kerlix AMD Gauze Study In A Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients|Unknown status|Active, not recruiting|Phase 2|432|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:30:35.726832|2017-02-18 14:30:35.726832
NCT00656695|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2012-06-21|||April 2008||2008-04-01|June 2012|2012-06-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation|The Comparison Between Clinical and Paraclinical Effect of Iminoral Vs Neoral in Prevention of Acute Rejection in the First Year Afer Transplantation in De Novo Renal Transplant Patients|Completed||Phase 4|208|Actual|Imam Khomeini Hospital||2|||f||||t||||||||||2017-02-18 14:30:35.853568|2017-02-18 14:30:35.853568
NCT00656682|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2014-08-05|||April 2008||2008-04-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|RAPID||Primary Care Community Partnerships to Prevent Diabetes|Primary Care Community Partnerships to Prevent Diabetes|Completed||N/A|509|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 14:30:35.96166|2017-02-18 14:30:35.96166
NCT00656669|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2014-07-21|2014-06-18||April 2008||2008-04-01|July 2014|2014-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer|An Exploratory Study of the Biological and Clinical Activity of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer|Completed||N/A|23|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 14:30:36.082109|2017-02-18 14:30:36.082109
NCT00656656|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2016-10-28|2016-10-28||January 2008||2008-01-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus|Combined Treatment of Autoimmune Bullous Diseases With Protein A Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab|Completed||Phase 2|23|Actual|University of Luebeck||1|||f||||t||||||||No||2017-02-18 14:30:36.638798|2017-02-18 14:30:36.638798
NCT00656643|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-01-08|||June 2008||2008-06-01|July 2010|2010-07-01|May 2012|Actual|2012-05-01|November 2009|Actual|2009-11-01||Interventional|||Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema|A Phase 2, Randomized, Double-Masked, Placebo-Controlled, Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injections of Sirolimus in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy|Completed||Phase 2|131|Actual|Santen Inc.||4|||f||||f||||||||||2017-02-18 14:30:36.864407|2017-02-18 14:30:36.864407
NCT00656630|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-12-07|||December 2007||2007-12-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Medication Development in Alcoholism: Acamprosate Versus Naltrexone|Medication Development in Protracted Abstinence in Alcoholism: Acamprosate Versus Naltrexone|Completed||Phase 2|62|Actual|The Scripps Research Institute||3|||f||||f||||||||||2017-02-18 14:30:36.969196|2017-02-18 14:30:36.969196
NCT00656617|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2015-02-26|2015-02-26||April 2008||2008-04-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Three participants completed the first run-in portion of the study while 99 of remaining 103 additional participants were evaluable for the second phase of the study.|Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)|Phase II Study of Idarubicin, Cytarabine, and Vorinostat in Patients With High-Risk MDS and AML|Completed||Phase 2|106|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:30:37.083474|2017-02-18 14:30:37.083474
NCT00656604|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2013-03-04|||November 2003||2003-11-01|March 2013|2013-03-01|January 2008|Actual|2008-01-01|October 2005|Actual|2005-10-01||Interventional|||Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics|Evaluation of Patients With Breast Cancer Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, and Proteomics|Completed||N/A|30|Actual|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-02-18 14:30:37.405839|2017-02-18 14:30:37.405839
NCT00656591|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2008-04-07|||March 2005||2005-03-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Community-Based Interventions for Infant Health in Nepal|An Evaluation of the Cost-Effectiveness of Community-Based Participatory Interventions for Pregnant Women in Nepal to Reduce Fetal and Infant Mortality, and to Improve Fetal Growth and Cognitive Development in Infancy.|Unknown status|Recruiting|Phase 1|192000|Anticipated|Institute of Child Health|||1||f||||||||||||||2017-02-18 14:30:37.506174|2017-02-18 14:30:37.506174
NCT00656578|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2009-05-01|||March 2008||2008-03-01|May 2009|2009-05-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety Study of 4975 to Manage Pain of Bunionectomy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Efficacy and Safety of a Single Intraoperative Administration of 4975 in Patients Undergoing Unilateral Transpositional First Metatarsal Osteotomy for the Correction of Hallux Valgus Deformity|Completed||Phase 3|300|Anticipated|Anesiva, Inc.||2|||f||||f||||||||||2017-02-18 14:30:37.644617|2017-02-18 14:30:37.644617
NCT00656552|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-10|||May 2008||2008-05-01|April 2008|2008-04-01||||December 2008|Anticipated|2008-12-01||Interventional|||Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation|Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation A Double-Blind, Placebo-Controlled, Fixed-Dose,Randomized Controlled Study|Unknown status|Not yet recruiting|Early Phase 1|100|Anticipated|Cairo University||1|||f||||t||||||||||2017-02-18 14:30:37.832063|2017-02-18 14:30:37.832063
NCT00656539|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2011-09-20||2009-03-24|April 2008||2008-04-01|September 2011|2011-09-01||||November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis|A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite® Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Four Weeks in Subjects With Posterior Blepharitis|Completed||Phase 4|20|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:30:37.925071|2017-02-18 14:30:37.925071
NCT00656526|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-10|||September 2007||2007-09-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Preemptive Analgesia for Postlaminectomy|Intraoperative Perineural Injection of Lidocaine for Postlaminectomy Pain|Completed||Phase 4|40|Actual|Harran University||2|||f||||f||||||||||2017-02-18 14:30:38.013047|2017-02-18 14:30:38.013047
NCT00656513|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-10|2015-03-26|||September 2008||2008-09-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer|A Phase II/III Study Comparing Acupuncture-like Transcutaneous Electrical Nerve Stimulation (ALTENS) Versus Pilocarpine in Treating Early Radiation-Induced Xerostomia|Completed||Phase 2/Phase 3|196|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 14:30:38.117575|2017-02-18 14:30:38.117575
NCT00656500|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-02-02|||July 2007||2007-07-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|February 2010|Actual|2010-02-01||Interventional|||Quitline Use in Surgical Patients|Increasing QUITPLAN Helpline Utilization in Surgical Patients|Completed||N/A|300|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:30:38.244994|2017-02-18 14:30:38.244994
NCT00656487|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2012-07-19|||April 2008||2008-04-01|July 2012|2012-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|SCCAN||Neurobiology of Cannabis Dependence|Neurobiology of Cannabis Dependence|Completed||N/A|60|Actual|The Scripps Research Institute||3|||f||||f||||||||||2017-02-18 14:30:38.344222|2017-02-18 14:30:38.344222
NCT00656474|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2011-07-22|2011-06-23||March 2008||2008-03-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation|Double-blind, Randomized, Placebo-controlled Phase 2 Pilot Study to Investigate the Safety and Clinical Outcomes of 1.0 % Topically Applied GLYC-101, Compared to Placebo, in Healthy Subjects Undergoing Retro-auricular Carbon Dioxide Laser Skin Resurfacing.|Completed||Phase 1/Phase 2|12|Actual|Glycotex, Inc.||2|||f||||||||||||||2017-02-18 14:30:38.463621|2017-02-18 14:30:38.463621
NCT00656461|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2009-11-23|||March 2008||2008-03-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Phase 1 Study of MKC-1 in Patients With Advanced Cancer|Phase 1 Study of MKC-1 in Patients With Advanced or Metastatic Solid Malignancies|Completed||Phase 1|24|Anticipated|CASI Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:30:41.164758|2017-02-18 14:30:41.164758
NCT00656448|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2013-11-04|2013-11-04||March 2008||2008-03-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS|Randomized Study of Procrit vs no Procrit in Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) Undergoing Frontline Myelosuppressive Induction/Consolidation Chemotherapy|Completed||Phase 3|51|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:30:41.2599|2017-02-18 14:30:41.2599
NCT00656435|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-04-07|||December 2006||2006-12-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|August 2007|Actual|2007-08-01||Interventional|||Bevacizumab and Long Acting Gas in Diabetic Vitrectomy|Bevacizumab Pretreatment and Long Acting Gas Infusion on the Vitreous Clear-up After Diabetic Vitrectomy|Completed||Phase 3|16|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 14:30:41.616304|2017-02-18 14:30:41.616304
NCT00656422|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-10-31|||November 2007||2007-11-01|October 2012|2012-10-01||||||||Interventional|||Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine|Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine|Terminated||Phase 3|66|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-02-18 14:30:41.728136|2017-02-18 14:30:41.728136
NCT00656409|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-10|||June 2006||2006-06-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|||||Interventional|||Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)|Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)|Completed||Phase 3|30|Actual|Institute of Child Health|||||f||||f||||||||||2017-02-18 14:30:41.838669|2017-02-18 14:30:41.838669
NCT00656396|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2015-09-07|||May 2008||2008-05-01|September 2015|2015-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|POC-OP||Point of Care Coagulation Testing in Patients Undergoing Major Surgery|Does Point of Care Coagulation Testing Reduce the Transfusion of Non-erythrocyte Blood Products in Patients Undergoing Major Surgery? A Randomized-Controlled Trial|Completed||Phase 3|228|Actual|University of Bern||2|||f||||f||||||||||2017-02-18 14:30:41.938665|2017-02-18 14:30:41.938665
NCT00656383|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2015-11-18|||October 2000||2000-10-01|November 2015|2015-11-01|March 2005|Actual|2005-03-01|March 2004|Actual|2004-03-01||Interventional|||Effectiveness and Efficiency of Two Models of Delivering Care to a Chronic Wound Population|Effectiveness and Efficiency of Two Models of Delivering Care to a Chronic Wound Population|Completed||N/A|401|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 14:30:42.051245|2017-02-18 14:30:42.051245
NCT00656370|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2010-04-27|2010-02-18||December 2007||2007-12-01|April 2010|2010-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|INFUSE-NSLR||Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)|The INcreased Flow Utilizing Subcutaneously-Enabled Normal Saline and Lactated Ringer's (INFUSE-NSLR) Study: A Phase IV, Double-Blind, Randomized Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex) in Volunteer Subjects|Completed||Phase 4|15|Actual|Halozyme Therapeutics||2|||f||||f||||||||||2017-02-18 14:30:42.386548|2017-02-18 14:30:42.386548
NCT00656357|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-03-09||2009-12-03|June 2008||2008-06-01|February 2014|2014-02-01||||May 2009|Actual|2009-05-01||Interventional|||Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers|A Human Laboratory Assessment of the Safety and Potential Efficacy of SYN117 (Nepicastat) in Cocaine-dependent Volunteers Receiving Cocaine|Completed||Phase 1/Phase 2|20|Actual|Biotie Therapies Inc.||2|||f||||t||||||||||2017-02-18 14:30:42.662067|2017-02-18 14:30:42.662067
NCT00656344|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2013-12-06|||October 2006||2006-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse|Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse|Completed||N/A|3|Actual|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-02-18 14:30:42.771057|2017-02-18 14:30:42.771057
NCT00656331|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2012-04-11|||August 2005||2005-08-01|April 2012|2012-04-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.|The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications: A Comparison of Amlodipine and Hydrochlorothiazide|Terminated||N/A|20|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-02-18 14:30:42.866452|2017-02-18 14:30:42.866452
NCT00656318|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2009-08-24|||August 2008||2008-08-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Impact of Oral Contraceptives on GABA and Neurosteroids|Impact of Oral Contraceptives on GABA and Neurosteroids|Terminated||N/A|6|Actual|Yale University|||2|Funding withdrawn from study sponsor.|f||||f||||||||||2017-02-18 14:30:42.964856|2017-02-18 14:30:42.964856
NCT00656305|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2014-08-07|||March 2008||2008-03-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Metastatic Bone Tumors for the Palliation of Pain|A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Metastatic and Multiple Myeloma Bone Tumors for the Palliation of Pain in Patients Who Are Not Candidates for Radiation Therapy|Completed||Phase 3|147|Actual|InSightec||2|||f||||||||||||||2017-02-18 14:30:43.080446|2017-02-18 14:30:43.080446
NCT00656292|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-06-03|||April 2008||2008-04-01|June 2014|2014-06-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||"Assessing the Role of Statin Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery"|"Perioperative HMG-CoA-Reductase-Inhibitors: A Pilot Study Assessing the Role of Statin Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery"|Unknown status|Recruiting|Phase 4|70|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:30:43.20843|2017-02-18 14:30:43.20843
NCT00656279|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2013-05-07|||April 2008||2008-04-01|May 2013|2013-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Intensive Dietary Education to Lower Serum Phosphorus in Patients With Chronic Kidney Disease|Intensive Patient Education Using the Phosphorus Point System© Tool to Improve Serum Phosphorus Levels in Patients With Chronic Kidney Disease|Completed||N/A|24|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 14:30:43.316964|2017-02-18 14:30:43.316964
NCT00656266|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-22|||November 2004||2004-11-01|April 2008|2008-04-01|July 2008|Anticipated|2008-07-01|April 2008|Anticipated|2008-04-01||Interventional|||Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation|A Prospective Randomized Trial of Prednisone and Tacrolimus Versus Prednisone, Tacrolimus and Mycophenolate Mofetil in Pediatric Liver Transplantation|Terminated||Phase 4|13|Actual|Baylor College of Medicine||2||insufficient funding|f||||f||||||||||2017-02-18 14:30:43.424135|2017-02-18 14:30:43.424135
NCT00656253|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2011-03-21|||August 2008||2008-08-01|September 2009|2009-09-01|February 2011|Actual|2011-02-01|September 2010|Actual|2010-09-01||Interventional|||Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease||Completed||Phase 2/Phase 3|158|Actual|Fudan University||2|||f||||t||||||||||2017-02-18 14:30:43.521848|2017-02-18 14:30:43.521848
NCT00656240|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2009-03-12||||||March 2009|2009-03-01||||||||Interventional|||To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension|A Randomized, Double-Masked, Parallel-Group Trial of DE-104 Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|||Santen Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 14:30:43.62616|2017-02-18 14:30:43.62616
NCT00656227|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-10|||April 2004||2004-04-01|April 2008|2008-04-01|July 2012|Anticipated|2012-07-01|July 2007|Actual|2007-07-01||Interventional|||A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision|A Double Blind, Placebo Controlled Randomised Trial to Investigate the Scar Improvement Efficacy of a Single Intradermal Application of RN1001 (Avotermin) in Subjects Undergoing Excision of Benign Head and Neck Naevi.|Unknown status|Active, not recruiting|Phase 2|239|Actual|Renovo|||||f||||f||||||||||2017-02-18 14:30:43.714503|2017-02-18 14:30:43.714503
NCT00656214|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-09|||December 2004||2004-12-01|November 2004|2004-11-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Treatmant of Oral Lichen Planus With Lycopene|Efficacy of Oral Lycopene in the Management of Oral Lichen Planus|Completed||Phase 2|30|Actual|College of Dental Sciences, India||2|||f||||||||||||||2017-02-18 14:30:43.801216|2017-02-18 14:30:43.801216
NCT00656201|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2011-09-20|2011-06-27||July 2003||2003-07-01|September 2011|2011-09-01|July 2009|Actual|2009-07-01|November 2008|Actual|2008-11-01||Interventional|||Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)|Comparison of Crinone 8% Intravaginal Gel or Intramuscular Progesterone Supplementation for In Vitro Fertilization (IVF) and Embryo Transfer (ET) Cycles in Women Under Age 40 Years Old|Completed||Phase 4|468|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 14:30:43.915793|2017-02-18 14:30:43.915793
NCT00656188|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-10-09|||October 2002||2002-10-01|October 2013|2013-10-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction|A Randomized, Double-blind, Parallel-group, Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil Administered for 12 Weeks in a Flexible-dose Regimen Compared to Placebo in Male Erectile Dysfunction Subjects|Completed||Phase 2/Phase 3|463|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:30:44.29733|2017-02-18 14:30:44.29733
NCT00655447|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-04-08|||January 1980||1980-01-01|April 2008|2008-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Observational|||Examining the Long-Term Risks of Oophorectomy|Ovarian Conservation: Long-Term Health Outcomes From the Nurse's Health Study.|Completed||N/A|32175|Actual|Parker, William H., M.D.|||2||f||||f||||||||||2017-02-18 14:31:02.622362|2017-02-18 14:31:02.622362
NCT00656175|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2012-12-17|2012-06-12||September 2008||2008-09-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Raltegravir Therapy for Women With HIV and Fat Accumulation|Phase II Study of Raltegravir as Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Based Antiretroviral Therapy in Women With Fat Accumulation|Completed||Phase 2|39|Actual|University of California, Los Angeles|High prevalence of generalized obesity; small sample size; short follow-up; not designed to assess the potential contribution of NRTIs to lipohypertrophy, nor could we exclude the NRTI backbone as a confounding factor.|2|||f||||f||||||||||2017-02-18 14:30:44.411427|2017-02-18 14:30:44.411427
NCT00656162|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-06|2010-11-04|||January 2009||2009-01-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Ultrasound Detection of Radiographically Negative Fractures of Elbow in Children||Completed||N/A|||Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 14:30:45.09599|2017-02-18 14:30:45.09599
NCT00656149|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2017-01-10|||May 2007||2007-05-01|January 2017|2017-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|SCI-IHT||In-home Telerehabilitation for Quadriplegic Hand Function|Outcome Evaluation of Exercise and Electrical Therapy for Quadriplegic Hand Function|Completed||Phase 2/Phase 3|13|Actual|University of Alberta||2|||f||||f||||||||||2017-02-18 14:30:45.193159|2017-02-18 14:30:45.193159
NCT00656136|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-06-24|2013-08-08||April 2008||2008-04-01|June 2016|2016-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||Randomized Set (RS) included all patients randomised to receive treatment|BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)|Phase IIb/III Randomized, Double-blind Trial of BIBW 2992 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-Lung 1)|Completed||Phase 3|585|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:30:45.332042|2017-02-18 14:30:45.332042
NCT00656123|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2013-12-17|||March 2008||2008-03-01|July 2009|2009-07-01||||February 2009|Anticipated|2009-02-01||Interventional|||Vaccine Therapy and Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Liver Metastases Due to Colorectal Cancer|A Phase I Clinical Trial of an Allogeneic Colon Cancer Cell Vaccine Administered With a GM-CSF Producing Bystander Cell Line in Patients With Metastatic Colorectal Cancer|Unknown status|Recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 14:30:46.326725|2017-02-18 14:30:46.326725
NCT00656110|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-06|2009-03-09|||April 2008||2008-04-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|||Neuroma Injections to Treat Restless Legs Syndrome - RCT|Randomized, Placebo-Controlled Trial of Bilateral 3rd/4th Common Digital Foot Nerve Injections to Treat Restless Legs Syndrome|Unknown status|Recruiting|N/A|60|Anticipated|Lowcountry Infectious Diseases||2|||f||||f||||||||||2017-02-18 14:30:46.431253|2017-02-18 14:30:46.431253
NCT00656097|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2011-09-15||2009-06-24|March 2008||2008-03-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects|A Randomized, Single-blind, Controlled, Monocentric Phase II Trial to Compare the Safety and Neutralizing Activity of Simulated Rabies Post-exposure Prophylaxis With CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects|Completed||Phase 2|140|Actual|Crucell Holland BV||3|||f||||f||||||||||2017-02-18 14:30:46.547847|2017-02-18 14:30:46.547847
NCT00656084|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-09-15|2016-02-02||December 2004||2004-12-01|September 2016|2016-09-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional||ITT population|Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell|A Phase II Study of Gemzar, Novantrone and Rituxan in Relapsed or Refractory Mantle Cell Lymphoma (MCL) (B9E-US-X436)|Completed||Phase 2|16|Actual|US Oncology Research||1|||f||||f||||||||||2017-02-18 14:30:46.663175|2017-02-18 14:30:46.663175
NCT00656071|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-09-05|||October 2007||2007-10-01|September 2012|2012-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Retrospective Postoperative ARDS Study at Vanderbilt University|Intraoperative Anesthetic Characteristics and the Development of ARDS|Completed||N/A|89|Actual|Vanderbilt University|||2||f||||f||||||||||2017-02-18 14:30:46.966128|2017-02-18 14:30:46.966128
NCT00656058|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2016-08-29|2016-08-29||March 2008||2008-03-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|November 2015|Actual|2015-11-01||Interventional|||Montelukast to Treat Bronchiolitis Obliterans|Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults|Active, not recruiting||Phase 2|25|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||No||2017-02-18 14:30:47.281775|2017-02-18 14:30:47.281775
NCT00656045|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-09-26|||March 2008||2008-03-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|LEAN||Leisure Time Activity and Nutrition Program|The Effects of Two Different Leisure-Time Activity Prescriptions on Eating and Activity Behaviors During Behavioral Weight Loss Treatment|Completed||N/A|24|Actual|University of Tennessee||2|||f||||t||||||||||2017-02-18 14:30:47.766005|2017-02-18 14:30:47.766005
NCT00656032|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-01-09|||April 2008||2008-04-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Vitamin D, Insulin Resistance and Inflammation in ESRD|Vitamin D, Insulin Resistance and Inflammation in ESRD|Completed||Phase 2|12|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:30:47.878246|2017-02-18 14:30:47.878246
NCT00656019|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-07-24|||April 2008||2008-04-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Development of Vitamin D as a Therapy for Breast Cancer - Phase II|Development of Vitamin D as a Therapy for Breast Cancer - Phase II|Completed||Phase 2|56|Actual|Stanford University||3|||f||||t||||||||||2017-02-18 14:30:47.995256|2017-02-18 14:30:47.995256
NCT00656006|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2013-08-01|||November 2005||2005-11-01|August 2013|2013-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3|A Randomized, Multi-Center, Open-Label Study To Evaluate The Efficacy And Safety Of Albuferon (HGS 1008, Recombinant Human Albumin-Interferon Alfa Fusion Protein) In Combination With Ribavirin In Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 OR 3|Completed||Phase 2|43|Actual|Human Genome Sciences Inc.|||||f||||t||||||||||2017-02-18 14:30:48.112319|2017-02-18 14:30:48.112319
NCT00213369|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-14|||January 2007||2007-01-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|||||Observational|||Neuromodulation of Aspiration Secondary to Stroke|Neuromodulation of Aspiration Secondary to Stroke|Completed||N/A|20|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-02-18 17:09:23.790648|2017-02-18 17:09:23.790648
NCT00655993|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-09|||April 2008||2008-04-01|April 2008|2008-04-01|December 2009|Anticipated|2009-12-01|March 2009|Anticipated|2009-03-01||Interventional|||Effect of Statin Therapy on C-Reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)|Effect of Statin Therapy on C-Reactive Protein Levels in Patients With COPD|Unknown status|Recruiting|Phase 1|40|Anticipated|VA Loma Linda Health Care System||2|||f||||f||||||||||2017-02-18 14:30:48.228634|2017-02-18 14:30:48.228634
NCT00655980|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-04-11|||February 2008||2008-02-01|April 2012|2012-04-01|July 2012|Anticipated|2012-07-01|December 2011|Actual|2011-12-01||Interventional|VINO||Vitamins in Nitrous Oxide Study|Pharmacogenetics of Adverse Outcomes After Nitrous Oxide Anesthesia|Unknown status|Active, not recruiting|N/A|625|Anticipated|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 14:30:48.341124|2017-02-18 14:30:48.341124
NCT00655967|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2009-07-24|||December 2006||2006-12-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|SAFADIE||Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE)|Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study|Unknown status|Recruiting|Phase 4|25|Anticipated|University of New Mexico||1|||f||||f||||||||||2017-02-18 14:30:48.455131|2017-02-18 14:30:48.455131
NCT00655954|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-09||||||April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Osteoprotegerin (OPG) in Induced Chronic Obstructive Pulmonary Disease (COPD) Sputum|Osteoprotegerin (OPG) in Induced Sputum as a Novel Biomarker for COPD|Completed||N/A|||Imperial College London|||||f||||||||||||||2017-02-18 14:30:48.56924|2017-02-18 14:30:48.56924
NCT00655941|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-01-05|||April 2008||2008-04-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|CAROT||Influence of Weight Loss or Exercise on Cartilage in Obese Knee Osteoarthritis Patients|Influence of Weight Loss or Exercise on CARtilage in Obese Knee Osteoarthritis Patients: a Randomized Controlled Trial (CAROT).|Completed||N/A|192|Actual|Frederiksberg University Hospital||3|||f||||f||||||||||2017-02-18 14:30:48.660485|2017-02-18 14:30:48.660485
NCT00655928|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2011-12-22|||August 2007||2007-08-01|December 2011|2011-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Modulation of Lung Injury Complicating Lung Resection|Modulation of Lung Injury Complicating Lung Resection|Completed||Phase 2|47|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 14:30:48.782238|2017-02-18 14:30:48.782238
NCT00655915|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2011-03-08|||December 2007||2007-12-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Corticosteroid Injection as a Predictor of Outcome in Carpal Tunnel Release|Corticosteroid Injection as a Predictor of Outcome in Carpal Tunnel Release|Terminated||N/A|200|Anticipated|Vanderbilt University|||1|Study was terminated by principal investigator|f||||f||||||||||2017-02-18 14:30:48.890687|2017-02-18 14:30:48.890687
NCT00655902|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2011-04-28|||April 2008||2008-04-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|COBRA||Copenhagen Obesity Risk Assessment Study|Copenhagen Obesity Risk Assessment Study - A Double Blind Randomized Dietary Intervention Study Examining the Effect of a High Intake of Trans Fatty Acids on Abdominal Obesity and Risk Markers of Type 2 Diabetes and Cardiovascular Disease.|Completed||N/A|52|Actual|University of Copenhagen||2|||f||||f||||||||||2017-02-18 14:30:48.994374|2017-02-18 14:30:48.994374
NCT00655889|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-06-04|2013-06-04||January 2006||2006-01-01|June 2013|2013-06-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Interdental Papillary Insufficiency||Completed||Phase 2|13|Actual|Fibrocell Technologies, Inc.|This was a small, open-label study without a placebo control, and was not powered to provide statistically significant demonstrations of product efficacy.|1|||f||||f||||||||||2017-02-18 14:30:49.106716|2017-02-18 14:30:49.106716
NCT00655876|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2016-09-28|||June 2008||2008-06-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer|A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery|Active, not recruiting||Phase 3|420|Anticipated|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 14:30:49.386111|2017-02-18 14:30:49.386111
NCT00655863|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-05-23|2013-02-17||July 2007||2007-07-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.|Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing SYR-322 Alone and Combination SYR-322 With Pioglitazone Versus Placebo on Postprandial Lipids in Subjects With Type 2 Diabetes|Completed||Phase 3|71|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:30:49.759149|2017-02-18 14:30:49.759149
NCT00655850|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-02-22|||March 2008||2008-03-01|February 2016|2016-02-01|September 2016|Anticipated|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer|Pilot Phase II Study of Metronomic Chemotherapy in Combination With Avastin in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|35|Actual|University of Alabama at Birmingham||1|||f||||t||||||||No||2017-02-18 14:30:51.390158|2017-02-18 14:30:51.390158
NCT00655837|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-12-17|||April 2008||2008-04-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL|A Phase Ib Study of SGN-40 in Combination With Rituximab and Gemcitabine for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Completed||Phase 1|33|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-02-18 14:30:51.515742|2017-02-18 14:30:51.515742
NCT00655824|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-09-19|2012-03-26||January 2008||2008-01-01|September 2013|2013-09-01|March 2013|Actual|2013-03-01|May 2011|Actual|2011-05-01||Interventional|||Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403|An Open-label, International, Multi-center, Phase II, Extension Trial Investigating Long-term Efficacy and Safety of Repeated Treatment Courses of Ofatumumab, a Fully Human Monoclonal Anti-CD20 Antibody, in Adult Patients With Active Rheumatoid Arthritis Who Previously Received Ofatumumab or Placebo|Terminated||Phase 2|124|Actual|GlaxoSmithKline|Development of the IV route of ofatumumab (OFA) administration in RA will no longer be pursued. This study was prematurely terminated; OFA treatment was discontinued. Participants could complete only <=7 treatment courses and a follow-up evaluation.|1||"The clinical development of intravenously administered ofatumumab in RA will no longer be~   pursued, so this study was prematurely terminated by the Sponsor."|f||||f||||||||||2017-02-18 14:30:51.682763|2017-02-18 14:30:51.682763
NCT00655811|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-12-18|||February 2008||2008-02-01|December 2012|2012-12-01|October 2009|Actual|2009-10-01|August 2008|Actual|2008-08-01||Interventional|||Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects|Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects|Completed||Phase 4|40|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 14:30:53.757722|2017-02-18 14:30:53.757722
NCT00655798|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-04|||December 2006||2006-12-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Effect of Nutritional Interventions on Inflammatory Status in Healthy Overweight Men|Effect of Nutritional Interventions on Inflammatory Status in Healthy Overweight Men|Completed||N/A|42|Actual|TNO||4|||f||||||||||||||2017-02-18 14:30:53.860361|2017-02-18 14:30:53.860361
NCT00655785|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-03-13|||September 2007||2007-09-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)|Phase Ｉ/Ⅱ Sturdy on Antiangiogenic Vaccine Therapy Using Epitope Peptide Derived From VEGFR1 and VEGFR2 With Gemcitabine in Treating Patients With Unresectable, Recurrent, or Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|17|Actual|Fukushima Medical University||1|||f||||f||||||||||2017-02-18 14:30:53.963724|2017-02-18 14:30:53.963724
NCT00655772|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-04|||February 2007||2007-02-01|March 2008|2008-03-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||A Clinical Trial to Assess the Effects of a Mouthwash Containing Chlorine Dioxide on Oral Malodor|A Randomized, Double Blind, Crossover, Placebo-Controlled Clinical Trial to Assess the Effects of a Mouthwash Containing Chlorine Dioxide on Oral Malodor|Completed||Phase 1|15|Actual|Tokyo Medical and Dental University||1|||f||||f||||||||||2017-02-18 14:30:54.072991|2017-02-18 14:30:54.072991
NCT00655746|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-12-08|2009-06-11||April 2008||2008-04-01|December 2009|2009-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects|The Effect of Omeprazole on the Pharmacokinetics of Dasatinib (BMS-354825) in Healthy Subjects|Completed||Phase 1|14|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:30:54.175339|2017-02-18 14:30:54.175339
NCT00655733|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-06|2012-11-04|2011-04-18||April 2006||2006-04-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Phase II Study of HMPL-004 in Subjects With Crohn's Disease||Completed||Phase 2|101|Actual|Hutchison Medipharma Limited||2|||f||||f||||||||||2017-02-18 14:30:54.516887|2017-02-18 14:30:54.516887
NCT00655720|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-10|||March 2006||2006-03-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Effects on Growth of a Non-Routine Infant Formula|The Effects on Growth and Tolerance of Hydrolyzed Formulas Fed to Term Infants|Completed||N/A|293|Actual|Mead Johnson Nutrition||3|||f||||f||||||||||2017-02-18 14:30:54.98258|2017-02-18 14:30:54.98258
NCT00655707|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2015-06-04|||January 2006||2006-01-01|June 2015|2015-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency|A Phase I/II Safety and Tolerability Dose Escalation Study Following the Autologous Infusion of Expanded Adult Haematopoietic Stem Cells to Patients With Liver Insufficiency|Completed||Phase 1/Phase 2|5|Actual|Imperial College London||1|||f||||t||||||||||2017-02-18 14:30:55.06835|2017-02-18 14:30:55.06835
NCT00655694|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2015-06-03||||||April 2008|2008-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)|A Non Interventional Study to Asses the Utility of Genomic/ Proteomic/ Metabonomic Profiling Approaches to the Classification and Pathological Basis of Inflammatory Lung Disease in Smokers, and Ex-smokers vs. Non-smokers and Asthmatics|Completed||N/A|||Imperial College London|||||f||||||||||||||2017-02-18 14:30:55.181308|2017-02-18 14:30:55.181308
NCT00655681|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-02-29|||September 2007||2007-09-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Prevention of Post Operative Bone Loss in Children|Prevention of Post Operative Bone Loss in Children|Completed||N/A|24|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 14:30:55.261588|2017-02-18 14:30:55.261588
NCT00655668|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-11-22|2011-11-30||March 2008||2008-03-01|November 2016|2016-11-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|EXPECT||A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma|A Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid®) in Subjects With Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma|Terminated||Phase 2|54|Actual|Celgene Corporation||1||Decision not to pursue as single agent in the study population.|f||||t||||||||||2017-02-18 14:30:55.378871|2017-02-18 14:30:55.378871
NCT00655655|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2016-04-18|||December 2004||2004-12-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors|A Phase I Trial of the mTOR Inhibitor RAD001 in Combination With VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|96|Anticipated|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:30:56.300463|2017-02-18 14:30:56.300463
NCT00655642|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-09-30|2011-03-21||March 2007||2007-03-01|September 2013|2013-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED|A Randomized, Double Blind, and Placebo-Controlled Trial Comparing Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult Emergency Department.|Terminated||N/A|171|Actual|Vanderbilt University|Early termination resulted in failure to meet our predetermined sample size.|4||"Conditional analysis showed observed differences were significantly less than power~   calculations"|f||||f||||||||||2017-02-18 14:30:56.42833|2017-02-18 14:30:56.42833
NCT00655629|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-07-29|2010-10-07||April 2008||2008-04-01|July 2014|2014-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.|Pivotal Phase III Trial to Investigate the Efficacy and Safety of an Orodispersible Tablet Vardenafil Versus Placebo in the Treatment of Men With Erectile Dysfunction (ED) - a Fixed-dose, Double-blind, Randomized Multi-center Trial|Completed||Phase 3|339|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:30:56.977171|2017-02-18 14:30:56.977171
NCT00655070|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-04-02|||April 2008||2008-04-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium|Evaluation of the Effect of T3US on Myocardial Blow Flow in the Hibernating|Terminated||Early Phase 1|9|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 14:31:07.333817|2017-02-18 14:31:07.333817
NCT00655616|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2011-03-23|||August 2007||2007-08-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics|A Proof-of-concept Study to Evaluate the Benefit From add-on Therapy With Montelukast Versus Salmeterol in Children With Asthma Carrying the Arg/Arg-16 beta2-receptor Genotype|Completed||N/A|64|Actual|University of Dundee||2|||f||||t||||||||||2017-02-18 14:30:57.885992|2017-02-18 14:30:57.885992
NCT00655603|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2009-04-03|||March 2008||2008-03-01|April 2009|2009-04-01|September 2009|Anticipated|2009-09-01|May 2009|Anticipated|2009-05-01||Interventional|||Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus|Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of GLP-1 in Patients With Type 2 Diabetes Mellitus.|Unknown status|Enrolling by invitation|N/A|20|Anticipated|University Hospital, Gentofte, Copenhagen||2|||f||||f||||||||||2017-02-18 14:30:57.992305|2017-02-18 14:30:57.992305
NCT00655590|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-12-26|||January 2005||2005-01-01|December 2014|2014-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm Function|A Randomized, Double-blind, Placebo Controlled, Parallel Arm, Multicenter Trial Assessing the Effect of Daily Treatment of Vardenafil 20 mg or Sildenafil 100 mg Compared to Placebo on Spermatogenesis|Completed||Phase 4|200|Actual|Bayer||3|||f||||||||||||||2017-02-18 14:30:58.082133|2017-02-18 14:30:58.082133
NCT00655577|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-04|||August 1998||1998-08-01|April 2008|2008-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Exercise and Prevention of Hip Fractures|Role of Exercise in Prevention of Osteoporotic Fractures in Elderly Women|Completed||N/A|160|Actual|University of Oulu||2|||f||||f||||||||||2017-02-18 14:30:58.203277|2017-02-18 14:30:58.203277
NCT00655564|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-12-19|2012-06-27||May 2008||2008-05-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis|Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis|Completed||Phase 4|15|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 14:30:58.296697|2017-02-18 14:30:58.296697
NCT00655551|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2015-03-10|2010-09-23||April 2008||2008-04-01|March 2015|2015-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures|A Multicenter, Open-label Trial to Assess the Safety and Tolerability of a Single Intravenous Loading Dose of Lacosamide Followed by Oral Lacosamide Maintenance as Adjunctive Therapy in Subjects With Partial-onset Seizures|Completed||Phase 3|100|Actual|UCB Pharma||3|||f||||t||||||||||2017-02-18 14:30:58.610363|2017-02-18 14:30:58.610363
NCT00655538|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-11-01|||February 2008||2008-02-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients|A Randomized, Placebo-controlled Study of the Safety, Tolerability and Effect on Endothelial Function, as Measured by Flow Mediated Dilatation, of RO4607381 in Patients With Coronary Heart Disease (CHD) or CHD Risk Equivalents.|Completed||Phase 2|476|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:30:59.169578|2017-02-18 14:30:59.169578
NCT00655525|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-04-22|||April 2008||2008-04-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Omega-3 Fatty Acid Administration in Dialysis Patients|Omega-3 Fatty Acid Administration in Dialysis Patients|Completed||Phase 2|38|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:30:59.290584|2017-02-18 14:30:59.290584
NCT00655512|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-06-10|||January 2008||2008-01-01|June 2014|2014-06-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|OCT||Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound|Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream (Elidel® 1% Cream), Hydrocortisonacetat 1% Cream (Hydrogalen® Cream), Betamethasonvalerat 0,1% Cream (Betagalen® Cream) and Clobetasol-17-propionat 0,05% Cream (Clobegalen® Cream) Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound - a Single Blind, Placebo-controlled, Randomized, Monocenter Clinical Trial|Completed||Phase 1|40|Actual|Technische Universität Dresden||5|||f||||f||||||||||2017-02-18 14:30:59.384609|2017-02-18 14:30:59.384609
NCT00655499|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-09|2012-08-22|||June 2008||2008-06-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer|An Open-label Phase II Clinical Trial of Panitumumab in Combination With Irinotecan for Patients With Advanced Metastatic Colorectal Cancer Without KRAS Mutation (Wild Type) in Third Line Chemotherapy (Patients Pretreated With FOLFOX or XELOX ± Bevacizumab and Irinotecan Alone or FOLFIRI or CAPIRI ± Bevacizumab) [PIMABI]|Completed||Phase 2|68|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)|||||f||||f||||||||||2017-02-18 14:30:59.491155|2017-02-18 14:30:59.491155
NCT00655486|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2015-03-10|2011-06-15||April 2008||2008-04-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures|A Multicenter, Open-label Extension Trial to Assess the Long-term Safety and Tolerability of Lacosamide as Adjunctive Therapy in Subjects With Partial-onset Seizures|Completed||Phase 3|97|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:30:59.602047|2017-02-18 14:30:59.602047
NCT00655473|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-11-01||2016-07-08|March 2008||2008-03-01|November 2016|2016-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease|A Randomized, Placebo-controlled Study of the Effect of RO4607381 on Progression or Regression of Atherosclerotic Plaque in Patients With Coronary Heart Disease (CHD) Including Patients With Other CHD Risk Factors|Completed||Phase 2|130|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:30:59.886783|2017-02-18 14:30:59.886783
NCT00655460|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2015-02-24|||February 2006||2006-02-01|January 2008|2008-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1|Clinical Process Improvement With A Bedside Computerized Insulin Therapy Protocol For Blood Glucose Control (eProtocol-insulin) in Adult And Pediatric ICU Patients:Further Refinement and Validation of eProtocol-insulin|Recruiting||Phase 2|200|Anticipated|Intermountain Health Care, Inc.||1|||f||||t||||||||||2017-02-18 14:31:02.460809|2017-02-18 14:31:02.460809
NCT00655434|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-01-08|||March 2008||2008-03-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population|HerpeSelect® Express Rapid Test Study Protocol Sexually Active Adult Population|Completed||N/A|400|Anticipated|Focus Diagnostics, Inc.|||1||f||||f||||||Samples With DNA|"~     Serum~   "|||2017-02-18 14:31:02.732386|2017-02-18 14:31:02.732386
NCT00655421|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-07-02|||April 2008||2008-04-01|July 2009|2009-07-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Oral Cancer Screening in Mumbai, India by Primary Health Care Workers|Comparing the Test Characteristics of Three Oral Cancer Screening Techniques:1)Unaided Visual Examination 2)VelScope Examination and 3)Toluidine Blue Application, by Trained Primary Health Care Workers in Mumbai, India.|Unknown status|Active, not recruiting|Phase 3|329|Actual|Tata Memorial Hospital||3|||f||||t||||||||||2017-02-18 14:31:02.820887|2017-02-18 14:31:02.820887
NCT00655408|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-04-03|||April 2003||2003-04-01|April 2008|2008-04-01|January 2004|Actual|2004-01-01|September 2003|Actual|2003-09-01||Interventional|IDA||Iron-Deficiency Anemia in Infants in Two Weekly Programs|Iron-Deficiency Anemia in Infants: Comparative Study of Two Weekly Supplement Programs|Completed||N/A|130|Actual|Sao Jose do Rio Preto University||1|||f||||f||||||||||2017-02-18 14:31:02.932181|2017-02-18 14:31:02.932181
NCT00655395|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2010-03-08|||March 2008||2008-03-01|March 2010|2010-03-01|October 2010|Anticipated|2010-10-01|April 2010|Anticipated|2010-04-01||Interventional|||Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine|A Phase I/Phase II Evaluation of Laromustine (VNP40101M), A Sulfonylhydrazine Alkylating Agent, Combined With Infusional Cytarabine in Elderly Patients With Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome|Unknown status|Active, not recruiting|Phase 1/Phase 2|52|Anticipated|Weill Medical College of Cornell University||5|||f||||||||||||||2017-02-18 14:31:03.030559|2017-02-18 14:31:03.030559
NCT00655382|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2010-05-20|||October 2007||2007-10-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Dynamic MRI Evaluation Post Operative Stapled Trans Anal Rectal Resection (STARR) Procedure|Dynamic MRI Evaluation Post op STARR Procedure|Completed||N/A|10|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 14:31:03.137884|2017-02-18 14:31:03.137884
NCT00655369|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-07-17||2009-12-10|April 2008||2008-04-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep|PD 0200390 Dose-Ranging Trial: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Outpatient Trial of PD 0200390 in Adults With Nonrestorative Sleep|Completed||Phase 2|306|Actual|Pfizer||6|||f||||f||||||||||2017-02-18 14:31:03.232827|2017-02-18 14:31:03.232827
NCT00655356|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2012-02-09|2012-02-09||November 2006||2006-11-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles||Completed||Phase 3|218|Actual|Fibrocell Technologies, Inc.||2|||f||||f||||||||||2017-02-18 14:31:03.614287|2017-02-18 14:31:03.614287
NCT00655343|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-12-09|||February 2003||2003-02-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|March 2007|Actual|2007-03-01||Interventional|||Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)|GvHD Prophylaxis With ATG-Fresenius S in Allogeneic Stem Cell Transplantation From Matched Unrelated Donors: A Randomized Phase III Multicenter Trial Comparing a Standard GvHD Prophylaxis With Cyclosporine A and Methotrexate With Additional Pretransplant ATG-Fresenius S|Completed||Phase 3|202|Actual|Neovii Biotech||2|||f||||t||||||||||2017-02-18 14:31:04.257733|2017-02-18 14:31:04.257733
NCT00655330|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2016-08-23|||May 2008||2008-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy|A Prospective Randomized, Controlled, Open-labeled Trial of Probucol Combined With Valsartan in Patients With Diabetes Nephropathy|Active, not recruiting||N/A|170|Anticipated|Guangdong General Hospital||2|||f||||t||||||||||2017-02-18 14:31:04.381304|2017-02-18 14:31:04.381304
NCT00655317|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-03-10|||August 2007||2007-08-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Acupuncture and Post-Operative Ileus|Acupuncture and Post-Operative Ileus: A Prospective Randomized Study to Evaluate the Effects of Electrostimulated Acupuncture on Recovery From Ileus Following Standard Elective Colon Surgery|Completed||N/A|107|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:31:04.489017|2017-02-18 14:31:04.489017
NCT00655304|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-07-26|||March 2007||2007-03-01|July 2010|2010-07-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure|The Effect of Prometheus (R) Liver Support Dialysis on Intracranial Pressure, Cerebral Oxidative Metabolism and Hemodynamics in Patients With Acute Liver Failure|Completed||N/A|8|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 14:31:04.61971|2017-02-18 14:31:04.61971
NCT00655291|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-10-07|||April 2008||2008-04-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy of XP20B Following Bunionectomy Surgery|Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of the Analgesic Efficacy of XP20B in Subjects With Pain Following Bunionectomy Surgery|Completed||Phase 3|190|Anticipated|Xanodyne Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:31:04.727088|2017-02-18 14:31:04.727088
NCT00655278|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-12-19|||August 2007||2007-08-01|November 2013|2013-11-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||T2000 in Essential Tremor - Open Label Continuation|Phase II Efficacy and Safety of Taro Pharmaceuticals' Pro-Drug T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric Acid) in Patients With Essential Tremor: An Open-Label Dose Continuation Study|Terminated||Phase 2|5|Actual|Taro Pharmaceuticals USA||1|||f||||t||||||||||2017-02-18 14:31:04.829978|2017-02-18 14:31:04.829978
NCT00655265|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2014-02-10|||August 2007||2007-08-01|February 2014|2014-02-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing Medication|A Phase 4 Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, MultiCentre Study of Colesevelam as Add-on Therapy in Patients With Familial Hypercholesterolaemia|Completed||Phase 4|86|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:31:04.934219|2017-02-18 14:31:04.934219
NCT00477828|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2007-05-22|||April 2000||2000-04-01|May 2007|2007-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Effect of Treating Sleep Apnea on Cognition in Patients With Dementia|Cognitive Benefits of Treating Apnea in Dementia|Completed||N/A|61|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 15:35:53.396306|2017-02-18 15:35:53.396306
NCT00655252|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2011-08-18||||||August 2011|2011-08-01||||||||Expanded Access|||Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy|An Open-Label, Multi-Center, Expanded Access Study of RAD001 in Patients With Metastatic Carcinoma of the Kidney Who Are Intolerant of or Have Progressed Despite Any AvailableVascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy|No longer available||N/A|||Novartis|||||||||||||||||||2017-02-18 14:31:05.04826|2017-02-18 14:31:05.04826
NCT00655239|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2016-05-12|||June 2008||2008-06-01|May 2016|2016-05-01|May 2016|Anticipated|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis|Neuroscience-Guided Cognitive Remediation in Adolescents at Risk for Psychosis|Active, not recruiting||Phase 1/Phase 2|100|Anticipated|University of California, San Francisco||3|||f||||f||||||||||2017-02-18 14:31:05.43956|2017-02-18 14:31:05.43956
NCT00655226|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-08-05|||March 2008||2008-03-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients|Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients|Terminated||N/A|26|Actual|Icahn School of Medicine at Mount Sinai||2||low enrollment|f||||t||||||||||2017-02-18 14:31:05.550978|2017-02-18 14:31:05.550978
NCT00655213|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||November 2003||2003-11-01|April 2008|2008-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|SAVER||Spontaneous Atrio Ventricular Conduction Preservation|Spontaneous Atrio Ventricular Conduction Preservation|Completed||Phase 4|622|Actual|LivaNova||4|||f||||t||||||||||2017-02-18 14:31:05.692395|2017-02-18 14:31:05.692395
NCT00655200|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-08-13|||February 2008||2008-02-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus|Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus|Completed||N/A|2286|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:31:05.866439|2017-02-18 14:31:05.866439
NCT00655187|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-11-25|||April 2008||2008-04-01|November 2011|2011-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants|Case-control Study to Evaluate the Vaccine Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children < 5 Years of Age in KK Hospital, Singapore|Completed||N/A|1270|Actual|GlaxoSmithKline|||2||f||||||||||Samples With DNA|"~     Stool samples~   "|||2017-02-18 14:31:05.973039|2017-02-18 14:31:05.973039
NCT00655174|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-04|||June 1999||1999-06-01|April 2008|2008-04-01|January 2007|Actual|2007-01-01|September 2006|Actual|2006-09-01||Interventional|||Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?|A Double-Blind Placebo-Controlled Randomized Clinical Trial of Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?|Completed||Phase 3|108|Actual|The Hospital for Sick Children||3|||f||||t||||||||||2017-02-18 14:31:06.086649|2017-02-18 14:31:06.086649
NCT00655161|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2014-01-28|||April 2008||2008-04-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation|A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation|Completed||Phase 2|24|Actual|GlobeImmune||1|||f||||t||||||||||2017-02-18 14:31:06.209616|2017-02-18 14:31:06.209616
NCT00655148|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-01-18|||September 2003||2003-09-01|January 2013|2013-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine|Clinical Trial Comparing the Safety and Immunogenicity of Two Combined Diphtheria, Tetanus, Acellular Pertussis, and Inactivated Poliovirus (DTaP-IPV) Vaccines Administered to Healthy Children at 2, 3½, and 16 Months of Age|Completed||Phase 3|817|Actual|Statens Serum Institut||2|||f||||f||||||||||2017-02-18 14:31:06.31228|2017-02-18 14:31:06.31228
NCT00655135|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-04-08|||February 2000||2000-02-01|April 2008|2008-04-01||||June 2002|Actual|2002-06-01||Interventional|||Phase 2 Study of the Safety and Efficacy of LDP-02 in Mildly to Moderately Active Crohn's Patients|Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study to Determine the Safety, Pharmacokinetics, and Effectiveness of LDP-02 in Patients With Mildly to Moderately Active Crohn's Disease|Completed||Phase 2|185|Actual|Millennium Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 14:31:06.42442|2017-02-18 14:31:06.42442
NCT00655122|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-09-25|||April 2003||2003-04-01|September 2008|2008-09-01|December 2003|Actual|2003-12-01|||||Interventional|||Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study|Double-Blind, Placebo-Controlled, Pilot Study, In Medical Patients With Prophylaxis Of Venous Thromboembolism in Primary Care|Terminated||Phase 4|8|Actual|Pfizer||2||See Detailed Description.|f||||f||||||||||2017-02-18 14:31:06.535877|2017-02-18 14:31:06.535877
NCT00655109|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-02|||February 2008||2008-02-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis|A Comparison of Olopatadine Versus Fluticasone Nasal Spray in the Prevention of the Signs and Symptoms of Allergic Conjunctivitis|Completed||Phase 4|60|Actual|Greiner, Jack V., OD DO PhD||4|||f||||f||||||||||2017-02-18 14:31:06.659451|2017-02-18 14:31:06.659451
NCT00655096|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2017-01-24|||April 3, 2008||2008-04-03|December 5, 2016|2016-12-05||||||||Observational|||Screening for Research Participants|Screening Study for the Evaluation and Diagnosis of Potential Research Participants|Recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:31:06.778093|2017-02-18 14:31:06.778093
NCT00655083|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-10-11|2010-05-27||March 2008||2008-03-01|October 2011|2011-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants|Pilot Study to Evaluate the Oral Absorption, Safety, and Tolerability of Nepadutant Administered as Single Oral Doses to Infants With Colic and Other Functional Gastrointestinal Disorders|Completed||Phase 1|21|Actual|Menarini Group|No infants aged 18-24 weeks were dosed at 0.5 mg/kg dose when the trial was stopped because of slow recruitment and drug expiration.|2|||f||||f||||||||||2017-02-18 14:31:06.881824|2017-02-18 14:31:06.881824
NCT00655057|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2012-07-26|||October 2005||2005-10-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression|SPECT Brain Imaging as a Bio-Marker of Major Depression|Completed||Phase 2/Phase 3|66|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 14:31:07.426259|2017-02-18 14:31:07.426259
NCT00655044|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-10-27|||May 2007||2007-05-01|October 2016|2016-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|PREDICTIVE™||Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes|Observational, Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 1 or Type 2 Diabetes Mellitus|Completed||N/A|3637|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 14:31:07.542947|2017-02-18 14:31:07.542947
NCT00655031|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-08-14|||April 2008||2008-04-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection|A Placebo Controlled, Randomized, Double Blind Pilot Study to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection in Human Subjects|Completed||Phase 2|150|Anticipated|POM Wonderful LLC||2|||f||||f||||||||||2017-02-18 14:31:07.856597|2017-02-18 14:31:07.856597
NCT00655018|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-04-08|||January 2003||2003-01-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|VITENAFLD||Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)|Lifestyle Intervention and Antioxidants in Children With Nonalcoholic Fatty Liver Disease: A Randomized, Controlled Trial|Completed||Phase 2/Phase 3|90|Actual|Bambino Gesù Hospital and Research Institute||2|||f||||t||||||||||2017-02-18 14:31:07.986851|2017-02-18 14:31:07.986851
NCT00655005|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2012-09-07|||May 2007||2007-05-01|September 2012|2012-09-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Observational|||Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer|Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer|Completed||N/A|100|Actual|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-02-18 14:31:08.128222|2017-02-18 14:31:08.128222
NCT00654992|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2009-04-28|2009-03-17||September 2006||2006-09-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|EPO-CABG||Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery|Prevention of Acute Kidney Injury (AKI) by Erythropoietin (EPO) in Patients Undergoing Coronary Artery Bypass Grafting (CABG) Surgery - A Prospective Placebo-Controlled Randomized Trial|Completed||Phase 2/Phase 3|71|Actual|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-02-18 14:31:08.240155|2017-02-18 14:31:08.240155
NCT00654979|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2013-05-30|||July 2003||2003-07-01|May 2013|2013-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Pivotal Study to Evaluate the Safety and Effectiveness of RMT Medical Technology's SafeFlo® Vena Cava Filter|A Pivotal Study to Evaluate the Safety and Effectiveness of RMT Medical Technology's SafeFlo® Vena Cava Filter|Completed||N/A|117|Actual|RMT Medical Technologies, Ltd.||1|||f||||f||||||||||2017-02-18 14:31:08.620025|2017-02-18 14:31:08.620025
NCT00654966|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-07-19|||June 2009||2009-06-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers|Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers.|Completed||Phase 2|16|Actual|Monash University||2|||f||||f||||||||||2017-02-18 14:31:08.737725|2017-02-18 14:31:08.737725
NCT00654953|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2011-03-28|2011-03-28||January 2006||2006-01-01|March 2011|2011-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent Humans|Sertraline Augmented With GABA Agents for Cocaine Dependence|Completed||Phase 2|102|Actual|University of Arkansas||3|||f||||t||||||||||2017-02-18 14:31:08.852079|2017-02-18 14:31:08.852079
NCT00654940|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2010-02-08|2010-01-05||May 2008||2008-05-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients|Methodology Study To Assess The Ability Of A Randomized, Double-Blind, Placebo-Controlled, Two Period Crossover Study To Detect The Effect Of Pregabalin In Post-Traumatic Neuropathic Pain Patients|Completed||Phase 1|25|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:31:09.366648|2017-02-18 14:31:09.366648
NCT00654927|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-03-01|2012-01-31||November 2003||2003-11-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis|Phase 3 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis|Completed||Phase 3|177|Actual|Acorda Therapeutics||1|||f||||t||||||||||2017-02-18 14:31:09.866267|2017-02-18 14:31:09.866267
NCT00654914|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2014-12-18|||May 2003||2003-05-01|December 2014|2014-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|VIS||A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile Dysfunction|A National, Multicentre, Open Label, Flexible Dose, Twelve Week Treatment to Assess the Efficacy and Safety of 5mg, 10mg and 20mg Bay 38-9456, a Phosphodiesterase Type V Inhibitor, in the Treatment of Male Patients With Erectile Dysfunction|Completed||Phase 3|527|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:31:10.420738|2017-02-18 14:31:10.420738
NCT00654901|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2016-04-08|2013-05-06||March 2008||2008-03-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™|Immunogenicity Study of the Antibody Persistence and Booster Effect of the DTaP-IPV-Hep B-PRP~T Combined Vaccine at 15 to 18 Months of Age Following a Primary Series of DTaP-IPV-Hep B-PRP~T or Infanrix Hexa™ Administered at 2, 4, and 6 Months of Age in Healthy Mexican Infants|Completed||Phase 3|881|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 14:31:10.522193|2017-02-18 14:31:10.522193
NCT00654888|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-04-10|||March 2005||2005-03-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|March 2006|Actual|2006-03-01||Interventional|ALKSBK||Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy|Study of Automated Lamellar Keratectomy With a New Option in Treatment in Symptomatic Patients With Bullous Keratopathy.|Completed||N/A|28|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:31:11.646206|2017-02-18 14:31:11.646206
NCT00654875|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-06-24|2010-12-13||March 2008||2008-03-01|June 2011|2011-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.|A 10 Week, Randomized, Double-blind, Parallel Group, Multi-center Study to Evaluate the Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg qd) to Twice Daily Dosing of Aliskiren (150 mg Bid) in Patients With Essential Hypertension.|Completed||Phase 4|328|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:31:11.751218|2017-02-18 14:31:11.751218
NCT00654862|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-02-17|||October 2007||2007-10-01|February 2009|2009-02-01||||September 2008|Actual|2008-09-01||Interventional|||Acute Hemodynamic Effects of Cocoa Polyphenols in Subjects With Hypertension and Optimal Blood Pressure|Randomized Controlled, Double-Blind, Sample Size-Calculated, Three-Period Crossover, Phase 1 Study to Investigate the Efficacy of a Single Oral Dose of Cocoa Phenols on Blood, Pressure, Heart Rate and Plasma Levels of Phenols, Bioactive Nitric Oxide and Oxidation Markers in Subjects With Stage 1 Essential Hypertension and Optimal Blood Pressure|Completed||Phase 1|48|Actual|University of Cologne||2|||f||||f||||||||||2017-02-18 14:31:12.190151|2017-02-18 14:31:12.190151
NCT00654849|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-21|||February 2007||2007-02-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|PKAHRCT||Electrosurgical Bipolar Plasmakinetic Vessel Sealing During Abdominal Hysterectomy: A Randomized Controlled Trial|Electrosurgical Bipolar Plasmakinetic Vessel Sealing During Abdominal Hysterectomy: A Randomized Controlled Trial|Completed||N/A|94|Actual|Hospital de Concentracion Norte de Petroleos||2|||f||||f||||||||||2017-02-18 14:31:12.286341|2017-02-18 14:31:12.286341
NCT00654836|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-08|2016-06-30|||October 2007||2007-10-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|February 2012|Actual|2012-02-01||Interventional|||Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer|A Phase II Study of Carboplatin, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Avastin as the First Line Therapy in Metastatic Breast Cancer.|Completed||Phase 2|32|Actual|Loyola University||1|||f||||f||||||||||2017-02-18 14:31:12.402962|2017-02-18 14:31:12.402962
NCT00654823|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-04|||June 2008||2008-06-01|April 2008|2008-04-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Observational|PGxWarfarin||Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial|Prospective Study Comparing Between the Commonly-Used and Pharmacogenetically-Guided Warfarin Administration Protocols|Unknown status|Not yet recruiting|N/A|500|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 14:31:12.515964|2017-02-18 14:31:12.515964
NCT00654810|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2008-04-07|||February 1994||1994-02-01|April 2008|2008-04-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Exercise Rehabilitation of Younger and Older People With Claudication|Exercise Rehabilitation of Younger and Older People With Claudication|Completed||N/A|64|Actual|National Institute on Aging (NIA)||2|||f||||f||||||||||2017-02-18 14:31:12.599307|2017-02-18 14:31:12.599307
NCT00654797|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-07|2015-02-24|||September 2007||2007-09-01|February 2015|2015-02-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2|Clinical Process Improvement With A Bedside Computerized Insulin Therapy Protocol For Blood Glucose Control (eProtocol-insulin) in Adult And Pediatric Intensive Care Unit Patients-Second Phase (Phase-2): Distribution and Implementation of Validated eProtocol-insulin in Naïve ICUs|Recruiting||Phase 2|200|Anticipated|Intermountain Health Care, Inc.||1|||f||||t||||||||||2017-02-18 14:31:12.708122|2017-02-18 14:31:12.708122
NCT00654784|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-07-29|2011-06-07||October 2005||2005-10-01|July 2011|2011-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|DELPHI||Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy|A Phase IIa Double Blind, Randomised, Placebo Controlled, Single Centre Study at the University of Leuven to Assess the Efficacy and Tolerability of Idebenone in 8 - 16 Year Old Males With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy|Completed||Phase 2|21|Actual|Santhera Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:31:12.845569|2017-02-18 14:31:12.845569
NCT00654771|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-08-14|||July 2005||2005-07-01|August 2012|2012-08-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Observational|UPREE||Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia Evaluation|Prospective Comparison of Catheterized and Clean Catch Urine Specimens for Determination of Protein/Creatinine Ratio in Evaluation of Preeclampsia|Completed||N/A|76|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 14:31:13.253956|2017-02-18 14:31:13.253956
NCT00654758|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-04-25|||December 2007||2007-12-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase 1b Trial to Evaluate the Safety and Pharmacokinetics of Volociximab (M200) in Combination With Carboplatin and Paclitaxel in Subjects With Previously Untreated Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1|33|Actual|Abbott||1|||f||||t||||||||||2017-02-18 14:31:13.357929|2017-02-18 14:31:13.357929
NCT00654745|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2010-07-09|2010-04-21||May 2008||2008-05-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics|A Prospective, Open-label, Ambulatory Blood Pressure Monitoring (ABPM) Dose Titration Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil and Amlodipine Based Treatment Regimen in Hypertensive, Type 2 Diabetic Subjects|Completed||Phase 4|207|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 14:31:13.4925|2017-02-18 14:31:13.4925
NCT00654732|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2016-10-03|||March 2008||2008-03-01|October 2016|2016-10-01||||March 2018|Anticipated|2018-03-01||Interventional|||Phase II R-ABVD Versus ABVD for Advanced Stage Classical Hodgkin Lymphoma|A Randomized Phase II Study of Rituximab With ABVD Versus Standard ABVD for Patients With Advanced-Stage Classical Hodgkin Lymphoma With Poor Risk Features (IPS Score > 2)|Active, not recruiting||Phase 2|120|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:31:14.869243|2017-02-18 14:31:14.869243
NCT00654719|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-04-03|||April 2001||2001-04-01|April 2008|2008-04-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Enteral Nutrition in Congestive Heart Failure and Cardiac Cachexia|The Influence of Enteral Nutrition on Functional Status and Inflammatory Activation in Patients With Congestive Heart Failure and Cardiac Cachexia.|Completed||Phase 2|29|Actual|National Heart and Lung Institute||2|||f||||t||||||||||2017-02-18 14:31:15.003289|2017-02-18 14:31:15.003289
NCT00654706|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2014-05-14||2014-05-14|March 2008||2008-03-01|May 2014|2014-05-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia|A Randomised, Double-Blind, Parallel-Group, Flexible-Dose Study Exploring the Neurocognitive Effect of Sertindole Versus Comparator in Patients With Schizophrenia Using the MATRICS Consensus Cognitive Battery (MCCB)|Completed||Phase 3|264|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 14:31:15.134509|2017-02-18 14:31:15.134509
NCT00654693|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-09-06|||March 2008||2008-03-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Observational|||NTX Wireless Patient Monitoring System|A Pilot Study to Evaluate the Performance of Nihon Kohden's NTX Wireless Patient Monitoring System|Completed||N/A|26|Actual|Vanderbilt University|||1||f||||t||||||||||2017-02-18 14:31:15.286133|2017-02-18 14:31:15.286133
NCT00654680|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-09-26|||October 2002||2002-10-01|September 2013|2013-09-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury|A Rand, db, Parallel-group, Plac-controlled Study Evaluating the Efficacy and Safety of Vardenafil Administered for 12 Weeks in a Flexible-dose Regimen Compared to Plac in Subjects With ED Solely Secondary to Traumatic Spinal Cord Injury|Completed||Phase 3|418|Actual|Bayer||2|||f||||||||||||||2017-02-18 14:31:15.403282|2017-02-18 14:31:15.403282
NCT00654667|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2015-03-03|||May 2007||2007-05-01|March 2015|2015-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|RSV||Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome|Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome.|Withdrawn||Phase 2|0|Actual|University of California, San Francisco||2||no participant enrollment|f||||f||||||||||2017-02-18 14:31:15.504592|2017-02-18 14:31:15.504592
NCT00654654|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-02-09|2012-02-09||March 2007||2007-03-01|February 2012|2012-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Facial Wrinkles and Creases||Completed||Phase 2|50|Actual|Fibrocell Technologies, Inc.||1|||f||||f||||||||||2017-02-18 14:31:15.612377|2017-02-18 14:31:15.612377
NCT00654641|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2012-12-18|2010-02-03||September 2007||2007-09-01|December 2012|2012-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy|Prevention of Abdominal Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy|Terminated||N/A|54|Actual|West Virginia University|Slow enrollment caused the closure of the trial prior to meeting enrollment target.|2||Poor enrollment. No apparent treatment effect.|f||||f||||||||||2017-02-18 14:31:15.846879|2017-02-18 14:31:15.846879
NCT00654628|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2015-08-11|2010-07-30||August 2007||2007-08-01|August 2015|2015-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|BRAVO||Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)|Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients|Completed||Phase 4|173|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:31:16.193455|2017-02-18 14:31:16.193455
NCT00654615|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2015-06-08|||May 2008||2008-05-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Fixation of Unstable Distal Radius Fractures|The Fixation of Unstable Metaphyseal Distal Radius Fractures: A Randomized, Controlled Trial|Completed||N/A|59|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 14:31:16.656653|2017-02-18 14:31:16.656653
NCT00654602|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-05-27|||February 2002||2002-02-01|May 2009|2009-05-01|November 2004|Actual|2004-11-01|||||Interventional|||48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety|A 48 Week, Open Label, Non-Comparative, Multicentre, Phase IIIb Study to Evaluate the Efficacy and Safety of the Lipid-Regulating Agent Rosuvastatin in the Treatment of Subjects With Fredrickson Type IIa and Type IIb Dyslipidaemia, Including Heterozygous Familial Hypercholesterolaemia.|Completed||Phase 3|1500|Anticipated|AstraZeneca||1|||||||||||||||||2017-02-18 14:31:16.766941|2017-02-18 14:31:16.766941
NCT00654589|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2016-11-16|||February 2008||2008-02-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload|A One-year, Open-label, Single Arm, Multi-center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20 mg/kg/d) in Patients Three to Six Months After Allogeneic Hematopoietic Cell Transplantation in Whom Iron Overload is Present|Completed||Phase 4|75|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:31:16.854612|2017-02-18 14:31:16.854612
NCT00654576|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-04-07|||February 2005||2005-02-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ACPIOS||Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia|Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia:One-Year Follow up.|Completed||Phase 4|1400|Anticipated|Central South University||2|||f||||t||||||||||2017-02-18 14:31:16.970677|2017-02-18 14:31:16.970677
NCT00654563|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-03-26|||August 2007||2007-08-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Memory Disorders Registry|Memory Disorders Registry|Completed||N/A|12|Actual|Cedars-Sinai Medical Center|||1||f||||f||||||Samples Without DNA|"~     The main Memory Disorders Registry only involves records-keeping to follow subjects' care,~     and does not involve any biospecimen collection. The optional postmortem exam (brain-only~     autopsy) obtains brain tissue, and it would be performed after death, so that no risks will~     impact the subject involved in the postmortem examination. With regard to cosmetic concerns,~     the incision is made from ear to ear through the neck region, leaving no disfiguration. The~     postmortem exam is not a genetic screen, but in rare instances it might find brain atrophy,~     although no specific inclusions. If found, the subject's family would be informed of this~     finding.~   "|||2017-02-18 14:31:17.087557|2017-02-18 14:31:17.087557
NCT00654550|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-01-06|||April 2008||2008-04-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surgery for Nearsightedness|A Phase 1 Randomized, Prospective, Double-Masked, Vehicle-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability and Clinical Effect of Nexagon™ in Subjects Following Bilateral Photorefractive Keratectomy (PRK) for the Correction of Mild to Moderate Myopia.|Completed||Phase 1|24|Anticipated|CoDa Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 14:31:17.180759|2017-02-18 14:31:17.180759
NCT00654537|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-03-13|||April 2001||2001-04-01|March 2009|2009-03-01|October 2004|Actual|2004-10-01|||||Interventional|STELLAR||STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges|A 6 Week Open Label, Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Subjects With Hypercholesterolemia.|Completed||Phase 3|5625|Anticipated|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:31:17.276045|2017-02-18 14:31:17.276045
NCT00654524|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2011-03-14|||March 2008||2008-03-01|September 2008|2008-09-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis|A Randomized Study Comparing Goserelin or Expectant Management Following Laparoscopic Surgery for Advanced Endometriosis|Unknown status|Recruiting|Phase 4|60|Anticipated|Zhejiang University||2|||f||||t||||||||||2017-02-18 14:31:17.380383|2017-02-18 14:31:17.380383
NCT00654511|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-03-28|2011-02-23||January 2005||2005-01-01|March 2011|2011-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|DexT&A||Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy|Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy.|Completed||Phase 4|101|Actual|Children's Research Institute||4|||f||||t||||||||||2017-02-18 14:31:17.496434|2017-02-18 14:31:17.496434
NCT00654498|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2014-06-03|2009-12-18||April 2008||2008-04-01|March 2014|2014-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||Safety Set, all randomized patients that received treatment|Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)|A Randomized, Double-blind, Placebo Controlled Dose Titration Trial With 0.125-0.75 mg Pramipexole (Sifrol®) Orally q.n. to Investigate the Safety and Efficacy in Out-patients With Idiopathic Restless Legs Syndrome for 6 Weeks|Completed||Phase 3|306|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:31:18.061629|2017-02-18 14:31:18.061629
NCT00654485|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-03-13|||May 2002||2002-05-01|March 2009|2009-03-01|February 2005|Actual|2005-02-01|||||Interventional|||COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects|A 12 Week Randomized, Double-Blind, Force-Titration, Parallel Group, Multi Centre, Phase IIIb Study to Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects With Raised LDL-C and a 10 Year Risk of CHD >10%|Completed||Phase 3|940|Anticipated|AstraZeneca||2|||||||||||||||||2017-02-18 14:31:18.582007|2017-02-18 14:31:18.582007
NCT00654472|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-07|||April 2008||2008-04-01|April 2008|2008-04-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Observational|||Mitral Valve Area Assessment: Comparison With Transthoracic Echocardiography and Magnetic Resonance Imaging|Quantification of Rheumatic Mitral Stenosis With Cardiac Magnetic Resonance Imaging and Comparison With Transthoracic Echocardiography|Unknown status|Recruiting|N/A|30|Anticipated|Florence Nightingale Hospital, Istanbul|||2||f||||t||||||||||2017-02-18 14:31:18.670622|2017-02-18 14:31:18.670622
NCT00654459|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-14|||July 2007||2007-07-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Observational|||Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function|Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function|Completed||Phase 4|50|Actual|Federico II University|||2||f||||t||||||||||2017-02-18 14:31:18.977887|2017-02-18 14:31:18.977887
NCT00654446|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-03-13|||September 2002||2002-09-01|March 2009|2009-03-01|April 2004|Actual|2004-04-01|||||Interventional|||IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin|A 6-wk Open-Label, Randomised, Multicentre, Phase IIIb, Parallel-Group Study, Which Describes the Renal Effects of the Lipid-Regulating Agents Rosuvastatin and Simvastatin in the Treatment of Sub's With Fredrickson Type IIa & Type IIb Dyslipidaemia, Inc. Heterozygous Familial Hypercholesterolaemia|Completed||Phase 3|442||AstraZeneca||2|||f||||||||||||||2017-02-18 14:31:19.100358|2017-02-18 14:31:19.100358
NCT00654433|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2014-07-07|||March 2008||2008-03-01|July 2014|2014-07-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|UCBT-002||ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases|A Phase III Trial of ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transplantation (UCBT) in Patients With Inborn Errors of Metabolism|Terminated||Phase 3|40|Anticipated|Aldagen||1||Terminated - Sponsor Decision|f||||t||||||||||2017-02-18 14:31:19.211656|2017-02-18 14:31:19.211656
NCT00654420|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2016-10-28|2016-10-28||March 2008||2008-03-01|October 2016|2016-10-01|February 2012|Actual|2012-02-01|November 2009|Actual|2009-11-01||Interventional|||A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007)|An Open Label, Randomized Phase I/IIa Trial Evaluating MK-0646 in Combination With Erlotinib (TARCEVA™) for Patients With Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|95|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 14:31:19.341786|2017-02-18 14:31:19.341786
NCT00654407|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-03-13|||November 2001||2001-11-01|March 2009|2009-03-01|September 2004|Actual|2004-09-01|||||Interventional|||Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia|An Open Label, Randomized, Multi-Center, Phase IIIB, Parallel Group Switching Study to Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia.|Completed||Phase 3|4875|Anticipated|AstraZeneca||3|||||||f||||||||||2017-02-18 14:31:20.551321|2017-02-18 14:31:20.551321
NCT00654394|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-03-13|||January 2000||2000-01-01|March 2009|2009-03-01|August 2004|Actual|2004-08-01|||||Interventional|||Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects|Randomized, Double-Blind, Multicenter, Trial to Assess the Effect of High & Low Doses of ZD4522 on Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects With Asymptomatic Carotid Stenosis After 24 Months of Dosing.|Completed||Phase 3|200|Anticipated|AstraZeneca||1|||||||f||||||||||2017-02-18 14:31:20.652804|2017-02-18 14:31:20.652804
NCT00654381|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-12-11|2011-05-18||April 2008||2008-04-01|December 2013|2013-12-01||||January 2010|Actual|2010-01-01||Interventional|||Japanese P III vs Voglibose and Placebo|A Double-blind Phase III Study to Evaluate the Efficacy of BI 1356 5 mg and 10 mg vs. Placebo for 12 Weeks and vs. Voglibose 0.6 mg for 26 Weeks in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control, Followed by an Extension Study to 52 Weeks to Evaluate Long-term Safety|Completed||Phase 3|561|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 14:31:20.757364|2017-02-18 14:31:20.757364
NCT00654368|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2014-07-14|2014-02-10||June 2008||2008-06-01|July 2014|2014-07-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Interventional|||CAMEO: Canadian Methotrexate and Etanercept Outcome Study|Canadian Methotrexate and Etanercept Outcome Study: An Open Label Randomized Trial of Etanercept and Methotrexate Versus Etanercept Alone in the Treatment of Rheumatoid Arthritis (CAMEO)|Completed||Phase 4|258|Actual|Amgen||2|||f||||f||||||||||2017-02-18 14:31:21.990081|2017-02-18 14:31:21.990081
NCT00654355|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-01-09|||April 2008||2008-04-01|January 2009|2009-01-01||||September 2009|Anticipated|2009-09-01||Interventional|||Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit|Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit|Unknown status|Recruiting|Phase 4|30|Anticipated|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 14:31:25.74436|2017-02-18 14:31:25.74436
NCT00654342|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-02|||October 2007||2007-10-01|April 2008|2008-04-01||||February 2009|Anticipated|2009-02-01||Interventional|||Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer|Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer|Unknown status|Recruiting|N/A|100|Anticipated|Chung-Ang University||2|||f||||f||||||||||2017-02-18 14:31:26.060158|2017-02-18 14:31:26.060158
NCT00654329|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-03-28|2011-02-23||August 2005||2005-08-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|DexBMT||Dexmedetomidine vs Fentanyl for BMT|Dexmedetomidine for Peri-operative Sedation and Analgesia in Children Undergoing Bilateral Myringotomy With Tube Placement (BMT)|Completed||Phase 4|101|Actual|Children's Research Institute||4|||f||||t||||||||||2017-02-18 14:31:26.158917|2017-02-18 14:31:26.158917
NCT00654316|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-04|||February 2004||2004-02-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine|A Phase I Study of the Safety and Immunogenicity of BCG (Bacille Calmette-Guerin) Vaccine Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG.|Completed||Phase 1|11|Actual|University of Oxford||1|||f||||t||||||||||2017-02-18 14:31:26.750668|2017-02-18 14:31:26.750668
NCT00654303|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-03-13|||August 1999||1999-08-01|March 2009|2009-03-01|February 2005|Actual|2005-02-01|||||Interventional|||OLE Study to Evaluate Safety / Efficacy of ZD4522|ZD4522 Long Term Extension Trial|Completed||Phase 3|3500|Anticipated|AstraZeneca||1|||f||||||||||||||2017-02-18 14:31:26.863383|2017-02-18 14:31:26.863383
NCT00654290|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-04|||March 2007||2007-03-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft|Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft, A Prospective Double-Blind Randomized Study|Completed||N/A|240|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-02-18 14:31:26.957105|2017-02-18 14:31:26.957105
NCT00654277|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2008-04-10|||August 2002||2002-08-01|April 2008|2008-04-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, Cross Over Bioavailability of Kali's Ondansetron 8 mg ODT With That of GlaxoSmithKine's Zofran 8 mg ODT in Healthy, Male and Female Subjects Under Fasting Conditions|Completed||Phase 1|32|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:27.078927|2017-02-18 14:31:27.078927
NCT00654264|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-10-27|||December 2007||2007-12-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Water Immersion in Right-Sided Heart Failure: A Pilot Study|Water Immersion in Right-Sided Heart Failure: A Pilot Study|Completed||Phase 4|13|Anticipated|University of Maryland||2|||f||||t||||||||||2017-02-18 14:31:27.174865|2017-02-18 14:31:27.174865
NCT00654251|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2009-04-28|||February 2008||2008-02-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias|Utility Of Home Based Gait Monitoring, Performance Scores And Functional Visual Assessment In Spinocerebellar Ataxias (SCA)|Completed||N/A|20|Actual|University of Mississippi Medical Center|||1||f||||f||||||||||2017-02-18 14:31:27.271115|2017-02-18 14:31:27.271115
NCT00654238|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-06-20|||February 2006||2006-02-01|June 2014|2014-06-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer|Phase II Study of BAY 43-9006 in Patients With Metastatic Thyroid Cancer|Completed||Phase 2|61|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 14:31:27.367061|2017-02-18 14:31:27.367061
NCT00654225|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-03-13|||October 2002||2002-10-01|March 2009|2009-03-01|March 2005|Actual|2005-03-01|||||Interventional|IRIS||Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)|A 6-Week, Randomized,Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolaemia in South Asian Subjects.|Completed||Phase 3|2340|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:31:27.473613|2017-02-18 14:31:27.473613
NCT00654212|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2015-05-03|||January 2002||2002-01-01|May 2015|2015-05-01|December 2007|Actual|2007-12-01|May 2005|Actual|2005-05-01||Interventional|||Endo-Laparoscopic Approach Versus Conventional Open Surgery in Obstructing Left-sided Colon Cancer: RCT|Endo-Laparoscopic Approach Versus Conventional Open Surgery in the Management of Obstructing Left-sided Colon Cancer: A Randomized Trial|Completed||Phase 4|50|Actual|Pamela Youde Nethersole Eastern Hospital||2|||f||||t||||||||||2017-02-18 14:31:27.571539|2017-02-18 14:31:27.571539
NCT00654199|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2012-03-07|||May 2006||2006-05-01|March 2012|2012-03-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Observational|||Ventricular Asynchrony in Cardiac Surgery Patients|Ventricular Asynchrony in Cardiac Surgery Patients|Completed||N/A|20|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 14:31:27.678596|2017-02-18 14:31:27.678596
NCT00654186|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2014-02-28|2014-01-15||February 2008||2008-02-01|February 2014|2014-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||32 patients started the study. 27 patients had two or mor cycles of study medication. 5 patients withdrew from the study before completing one cycle, making them not evaluable for response|Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients|A Phase II Study Evaluating the Toxicity and Efficacy of Single Agent Lenalidomide (Revlimid®) in Chemotherapy-Naïve Androgen-Independent Prostate Cancer Patients|Completed||Phase 2|32|Actual|Oncology Specialists, S.C.||1|||f||||f||||||||||2017-02-18 14:31:27.758568|2017-02-18 14:31:27.758568
NCT00654173|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-03-13|||June 2002||2002-06-01|March 2009|2009-03-01|September 2004|Actual|2004-09-01|||||Interventional|SOLAR||Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)|A 12-Week, Randomized, Open-Label, 3 Arm Parallel Group, Multicenter, Phase IIIb Study Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin Achieving NCEP ATP III LDL-C Goals in High Risk Subjects With Hypercholesterolaemia in the Managed Care Setting.|Completed||Phase 3|4444|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:31:28.075971|2017-02-18 14:31:28.075971
NCT00654160|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2016-04-19|||June 2008||2008-06-01|April 2016|2016-04-01||||June 2016|Anticipated|2016-06-01||Interventional|||Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer|A Pharmacogenetic-Based Phase I Trial of Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in Patients With Advanced Gastrointestinal Cancer|Active, not recruiting||Phase 1|70|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:31:28.394341|2017-02-18 14:31:28.394341
NCT00654147|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2015-07-11|2015-01-20||April 2008||2008-04-01|July 2015|2015-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|HIV||Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects|A Pilot Study to Assess Virologic Suppression and Immune Recovery With Raltegravir and Lopinavir/Ritonavir and Raltegravir and Emtricitabine/Tenofovir in HIV-1 Infected Treatment-naïve Subjects|Completed||Phase 2|44|Actual|University of Miami|Pilot study with 44 subjects and generalization f results is limited by the small sample size.|2|||f||||t||||||||||2017-02-18 14:31:28.51117|2017-02-18 14:31:28.51117
NCT00654134|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2013-08-06|||October 2005||2005-10-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|Entox||Inhalation of 20,000 Endotoxin Units(EU) of Clinical Center Reference Endotoxin in Healthy Volunteers|Inhalation of 20,000 EU of Clinical Center Reference Endotoxin in Healthy Volunteers|Completed||Phase 1|20|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 14:31:29.163357|2017-02-18 14:31:29.163357
NCT00654121|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-04|||February 2000||2000-02-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|April 2004|Actual|2004-04-01||Interventional|||Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives|Prevention of Clinical Onset of Type 1 Diabetes by Daily Administration of Metabolically Active Insulin in High Risk First Degree Relatives.|Completed||Phase 2|112|Actual|AZ-VUB||2|||f||||f||||||||||2017-02-18 14:31:29.249335|2017-02-18 14:31:29.249335
NCT00654108|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-02-03|||June 2008||2008-06-01|February 2010|2010-02-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects|A Randomized, Double-Blind, Placebo-Controlled Dose Escalation, Inpatient Phase I Study to Determine the Safety and Immunogenicity of a Single Oral Dose of a Combined Live, Attenuated, Enterotoxigenic Escherichia Coli (ETEC)-Cholera Vaccine (Peru-15 pCTB) in Healthy Adult Subjects|Completed||Phase 1|62|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 14:31:29.363313|2017-02-18 14:31:29.363313
NCT00654095|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-06-09|2010-05-27||December 2007||2007-12-01|June 2015|2015-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)|Open-label, Long-term Study of Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia Who Have Not Reached LDL-cholesterol Target With HMG-CoA Reductase Inhibitors|Completed||Phase 3|146|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:31:29.478747|2017-02-18 14:31:29.478747
NCT00654082|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-04-02|||September 2002||2002-09-01|April 2008|2008-04-01|August 2003|Actual|2003-08-01|||||Interventional|||A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction|A Placebo-Controlled, Randomized, Two-Way Cross-Over, Double-Blind, Flexible Dose, Multicenter Study to Evaluate the Efficacy and Safety of Viagra in Male Patients With Traumatic Spinal Cord Injury and Erectile Dysfunction|Completed||Phase 4|88|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:31:29.741849|2017-02-18 14:31:29.741849
NCT00654069|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-02|||September 2007||2007-09-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Repeat-Dose Study of the Safety and Efficacy of OxyADF (Oxycodone HCl and Niacin) Tablets for the Treatment of Acute, Moderate to Severe Postoperative Pain Following Bunionectomy Surgery in Adult Patients|Completed||Phase 3|405|Actual|Acura Pharmaceuticals Inc.||3|||f||||f||||||||||2017-02-18 14:31:29.862875|2017-02-18 14:31:29.862875
NCT00654056|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2013-03-08|||March 2008||2008-03-01|March 2013|2013-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Severe Insulin Resistance in Patients With Type 2 Diabetes|Severe Insulin Resistance in Patients With Type 2 Diabetes: Mechanisms Behind Insulin Resistance.|Completed||N/A|8|Actual|University of Aarhus||4|||f||||f||||||||||2017-02-18 14:31:29.963173|2017-02-18 14:31:29.963173
NCT00654043|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-10|||April 2001||2001-04-01|April 2008|2008-04-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Bioavailability Study of Torsemide Tablets Under Fed Conditions|Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Torsemide Tablets 20mg With That of Roche Demadex 1*20 mg in Healthy Subjects Under Fed Conditions.|Completed||Phase 1|24|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:30.080171|2017-02-18 14:31:30.080171
NCT00654030|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2013-04-08|2011-08-17||October 2006||2006-10-01|April 2013|2013-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer|Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|12|Actual|University of Kentucky||1|||f||||t||||||||||2017-02-18 14:31:30.194503|2017-02-18 14:31:30.194503
NCT00654017|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-04-02|||October 2002||2002-10-01|April 2008|2008-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis|Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Flexible, Titration Dose Administered on an As Needed Basis (PRN) to Evaluate the Efficacy and the Safety of Sildenafil for the Treatment of Erectile Dysfunction in Male Patients on Hemodialysis|Completed||Phase 4|100|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 14:31:30.515767|2017-02-18 14:31:30.515767
NCT00653653|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-04-07|||August 2008||2008-08-01|April 2009|2009-04-01|October 2009|Anticipated|2009-10-01|June 2009|Anticipated|2009-06-01||Observational|MORE||Medication Optimisation for Reducing Events in a Private Practice Setting|Observational Study of the Pharmaco-Economic and Medical Effects of Optimising Medication Using Pharmacokinetic Pharmacogenomics and Medication Interaction Analysis in Private Practice.|Unknown status|Active, not recruiting|N/A|500|Anticipated|Awenydd GmbH|||1||f||||t||||||||||2017-02-18 14:31:35.505566|2017-02-18 14:31:35.505566
NCT00654004|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-04-18|2012-12-11||April 2006||2006-04-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Observational|||Fatty Acid Oxidation Disorders & Body Weight Regulation Grant|Fatty Acid Oxidation Disorders & Body Weight Regulation|Completed||N/A|26|Actual|Oregon Health and Science University|Trial included small number of subjects with a rare disorder of long-chain fatty acid oxidation. Subjects were predominately children and adolescents. There were some technical difficulties with recruitment and collection of all the outcomes.||2||f||||f||||||Samples Without DNA|"~     Blood and urine samples. Body composition and energy expenditure data. MRI/MRS images.~   "|||2017-02-18 14:31:30.627137|2017-02-18 14:31:30.627137
NCT00653991|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2009-03-10|||October 2010||2010-10-01|March 2009|2009-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|SOLVE-IT||Effectiveness of Interactive Virtual Environment Games in Reducing Risky Sexual Behavior Among Men Who Have Sex With Men (The SOLVE-IT Study)|SOLVE IT: Real Risk Reduction for MSM|Unknown status|Not yet recruiting|N/A|4000|Anticipated|National Institute of Mental Health (NIMH)||2|||f||||f||||||||||2017-02-18 14:31:31.121865|2017-02-18 14:31:31.121865
NCT00653978|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2011-06-21|||May 2008||2008-05-01|July 2009|2009-07-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|||Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures|Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures: A Prospective, Multi-center Randomized Controlled Trial|Unknown status|Recruiting|Phase 3|150|Anticipated|Changhai Hospital||2|||f||||t||||||||||2017-02-18 14:31:31.22873|2017-02-18 14:31:31.22873
NCT00653965|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-03-13|||May 2003||2003-05-01|March 2009|2009-03-01|February 2005|Actual|2005-02-01|||||Interventional|STARSHIP||Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)|A 6-Week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolaemia in Hispanic Subjects.|Completed||Phase 3|3000|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:31:31.343075|2017-02-18 14:31:31.343075
NCT00653952|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2010-04-23|||May 1997||1997-05-01|April 2010|2010-04-01|April 2000|Actual|2000-04-01|||||Interventional|||CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy|A Phase 3, Randomized, Open-Label, Comparative Study of CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy|Terminated||Phase 3|220|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2||Poor accrual|f||||t||||||||||2017-02-18 14:31:31.444278|2017-02-18 14:31:31.444278
NCT00653939|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2015-01-22|2015-01-14||March 2008||2008-03-01|January 2015|2015-01-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|FALCON||A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer|A Phase II Study to Assess the Safety and Efficacy of the Combination of Carboplatin, Paclitaxel, and Bevacizumab ± Combretastatin A4 Phosphate (CA4P) Followed by Bevacizumab ± CA4P in Subjects With Chemotherapy Naïve Stage IIIB/IV Non-Squamous Cell Histology Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|63|Actual|Mateon Therapeutics||2|||f||||t||||||||||2017-02-18 14:31:31.774889|2017-02-18 14:31:31.774889
NCT00653926|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-04|||September 2005||2005-09-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|March 2007|Actual|2007-03-01||Interventional|||Local Infiltration Analgesia Following Unicompartmental Knee Arthroplasty|Local Infiltration Analgesia (LIA) With Ropivacaine, Ketorolac and Epinephrine Intra- and Postoperatively in Unicompartmental Knee Arthroplasty|Completed||N/A|40|Actual|Region Örebro County||2|||f||||t||||||||||2017-02-18 14:31:33.032384|2017-02-18 14:31:33.032384
NCT00653913|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-07|||March 2004||2004-03-01|April 2015|2015-04-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)|Evaluation of Potential for Pharmacokinetic Drug Interaction Between SCH 58235 and Pitavastatin|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 14:31:33.136856|2017-02-18 14:31:33.136856
NCT00653900|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-02|||April 2008||2008-04-01|April 2008|2008-04-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Observational|||Platelet Function Testing Help and Intraoperative Bleeding Risk for Patients Who Are on Plavix Prior to Surgery|Does Platelet Function Testing Help us Assess Intraoperative Bleeding Risk in Cardiac and Vascular Surgery for Patients Who Are on Plavix Prior to Admission?|Unknown status|Recruiting|N/A|20|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||Samples Without DNA|"~     1 drop of blood for the verify now test, which is done before the procedure.~   "|||2017-02-18 14:31:33.232427|2017-02-18 14:31:33.232427
NCT00653887|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2012-02-14|||January 2008||2008-01-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|Biofeedback||Biofeedback and Cortical Excitability|Modifications of the Anal Muscle Cortical Excitability Area After Biofeedback Training|Terminated||N/A|24|Anticipated|University Hospital, Rouen||2||Procedure needs to be changed|f||||t||||||||||2017-02-18 14:31:33.320237|2017-02-18 14:31:33.320237
NCT00653874|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-04-04|||November 2006||2006-11-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates|Routine Use of Transcutaneous Bilirubinometry Reduces the Need for Blood Sampling in Neonates With Jaundice|Completed||Phase 3|617|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 14:31:33.423705|2017-02-18 14:31:33.423705
NCT00653861|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2014-10-06|2009-07-22||April 2008||2008-04-01|December 2013|2013-12-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Effectiveness of JUVÉDERM™ Injectable Gel With Lidocaine||Completed||N/A|72|Actual|Allergan||2|||f||||t||||||||||2017-02-18 14:31:33.540275|2017-02-18 14:31:33.540275
NCT00653848|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2016-10-27|||May 2007||2007-05-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|AdRad||Treatment of Prostate Cancer With Docetaxel + Hormonal Treatment Versus Hormonal Treatment in Patients Treated With Radical Radiotherapy|Randomized Adjuvant Phase III Trial of Six Cycles of Docetaxel+Hormonal Treatment Versus Hormonal Treatment in Patients With Intermediate or High-risk Prostate Cancer Treated With Radical Radiotherapy|Active, not recruiting||Phase 3|378|Actual|Scandinavian Prostate Cancer Group||2|||f||||t||||||||||2017-02-18 14:31:33.831248|2017-02-18 14:31:33.831248
NCT00653640|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2012-06-19|||May 2006||2006-05-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Physical Work Capacity After Traumatic Brain Injury|Physical Work Capacity After Traumatic Brain Injury|Completed||N/A|88|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-02-18 14:31:35.596361|2017-02-18 14:31:35.596361
NCT00653835|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-04-15|||September 2003||2003-09-01|April 2015|2015-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)|SCH 58235: A Multicenter, Randomised, Parallel Groups, Placebo-Controlled Study Comparing The Efficacy, Safety, and Tolerability Of The Daily Co-Administration of Ezetimibe 10 mg With Simvastatin 20 mg vs Ezetimibe Placebo With Simvastatin 20 mg in Untreated Subjects With Primary Hypercholesterolaemia And Coronary Heart Disease (Protocol P03435)|Completed||Phase 4|153|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:31:33.959501|2017-02-18 14:31:33.959501
NCT00653822|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2013-02-26|||March 2008||2008-03-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single Dose Study to Assess the Tolerability, Safety, and Pharmacokinetics of Alefacept in Caucasian and Japanese Healthy Volunteers|Completed||Phase 1|75|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-02-18 14:31:34.056219|2017-02-18 14:31:34.056219
NCT00653809|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2012-04-05|||June 2007||2007-06-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Observational|||Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE)|Elucidating the Role of Nitric Oxide and Endothelin-1 Activation in Endothelial Cells Co-cultured With Placental Explants From African-american and Caucasian High Risk Pregnancies|Completed||N/A|52|Actual|University of Mississippi Medical Center|||8||f||||f||||||Samples With DNA|"~     Placental Tissue~   "|||2017-02-18 14:31:34.168932|2017-02-18 14:31:34.168932
NCT00653796|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-04-15|||September 2003||2003-09-01|April 2015|2015-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)|SCH 58235: A Multicentre, Randomised, Parallel Group, Placebo-Controlled Study Comparing the Efficacy, Safety, And Tolerability of the Daily Co-Administration of Ezetimibe 10 mg With Atorvastatin 10 mg vs. Ezetimibe Placebo With Atorvastatin 10 mg in Untreated Subjects With Primary Hypercholesterolaemia and Coronary Heart Disease|Completed||Phase 4|148|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:31:34.255447|2017-02-18 14:31:34.255447
NCT00653783|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2008-12-30|||August 2007||2007-08-01|December 2008|2008-12-01||||July 2008|Anticipated|2008-07-01||Observational|PROBE||Diagnostic and Prognostic Biomarkers in Parkinson Disease|Blood Alpha-Synuclein, Gene Expression, and Smell Testing as Diagnostic and Prognostic Biomarkers in Parkinson's Disease|Unknown status|Active, not recruiting|N/A|200|Anticipated|The Parkinson Study Group|||3||f||||f||||||Samples With DNA|"~     Whole Blood, serum~   "|||2017-02-18 14:31:34.355461|2017-02-18 14:31:34.355461
NCT00653770|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2010-02-08|||September 2007||2007-09-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A|A Phase I Study to Assess the Safety and Immunogenicity of New TB Vaccine Candidates FP85A and MVA85A, in Healthy Adults Who Have Previously Been Immunized With BCG, Using a Prime-boost Delivery Schedule|Completed||Phase 1|31|Actual|University of Oxford||3|||f||||t||||||||||2017-02-18 14:31:34.44526|2017-02-18 14:31:34.44526
NCT00653757|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2012-03-15|||March 2002||2002-03-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer|Phase I/II Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer|Completed||Phase 1/Phase 2|100|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:31:34.542917|2017-02-18 14:31:34.542917
NCT00653744|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-03-13|||March 2002||2002-03-01|March 2009|2009-03-01|March 2004|Actual|2004-03-01|||||Interventional|ARIES||Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)|A 6-Week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects. (ARIES)|Completed||Phase 3|1700|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:31:34.642742|2017-02-18 14:31:34.642742
NCT00653731|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2011-08-30|||February 2008||2008-02-01|August 2011|2011-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|WISDE||Effective Strategies for Dementia Care|Testing Three Interventions for Clinical Effectiveness in Long Term Care Residents With Dementia: Snoezelen, Structured Reminiscence Therapy, 10-minutes Activation. A Cluster-randomized Controlled Trial.|Completed||N/A|327|Actual|Martin-Luther-Universität Halle-Wittenberg||4|||f||||f||||||||||2017-02-18 14:31:34.741998|2017-02-18 14:31:34.741998
NCT00653718|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-07-30|||May 2008||2008-05-01|September 2008|2008-09-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Observational|AIMS||Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot Study|Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot Study|Completed||N/A|30|Actual|Centre hospitalier de l'Université de Montréal (CHUM)|||1||f||||f||||||||||2017-02-18 14:31:34.851668|2017-02-18 14:31:34.851668
NCT00653705|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2013-05-30|||January 2007||2007-01-01|May 2013|2013-05-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||The Effect of Yogurt Containing BB12 on Children's Health and Child Care Absenteeism|The Effect of Daily Consumption of Yogurt Containing Bifidobacterium Lactis (BB12) on Children's' Health and Child Care Absenteeism|Completed||N/A|181|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 14:31:34.935093|2017-02-18 14:31:34.935093
NCT00653692|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-02-20|||May 2007||2007-05-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Observational|||Fetal Neurobehavior in Poly-drug Dependent Women|Methadone, Buprenorphine and Fetal Neurobehavior|Completed||N/A|29|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 14:31:35.228486|2017-02-18 14:31:35.228486
NCT00653679|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-04-13|||September 2008||2008-09-01|April 2015|2015-04-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Exercise and Muscle Protein Signalling|The Impact of Resistance Versus Endurance Exercise on the Muscle Protein Signalling Response|Withdrawn||N/A|0|Actual|Maastricht University Medical Center||1||A paper on the same topic came out just before we wanted to start our study.|f||||f||||||||||2017-02-18 14:31:35.320967|2017-02-18 14:31:35.320967
NCT00653666|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2010-02-24|||October 2007||2007-10-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Metabolic Consequences of CPT-1 Deficiency|Metabolic Consequences of CPT1A Deficiency in Alaska Native Children|Completed||N/A|12|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||f||||||||||2017-02-18 14:31:35.41039|2017-02-18 14:31:35.41039
NCT00653627|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2010-06-30|||August 2007||2007-08-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination|A Human Pilot Study to Quantify BCG From the BCG Vaccination Site, and to More Fully Characterise the Immune Response to BCG|Completed||Phase 1|40|Actual|University of Oxford||2|||f||||t||||||||||2017-02-18 14:31:35.704542|2017-02-18 14:31:35.704542
NCT00653614|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2015-04-21|||March 2008||2008-03-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Cycle Control and Safety of E2-DRSP|A Multi-center, Double-blind, Randomized, Parallel-group Study to Evaluate Cycle Control and Safety of 6 Different Regimens of an Oral Contraceptive Containing Estradiol and Drospirenone in Healthy Female Volunteers Aged Between 18 and 35 Years Over 7 Cycles|Completed||Phase 2|635|Actual|Bayer||6|||f||||f||||||||||2017-02-18 14:31:35.809397|2017-02-18 14:31:35.809397
NCT00653601|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-09-03|||April 2008||2008-04-01|September 2009|2009-09-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Observational|||Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery|Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery|Unknown status|Recruiting|N/A|20|Anticipated|Cedars-Sinai Medical Center|||2||f||||f||||||Samples Without DNA|"~     2 mL of blood for testing X 5 per patient~   "|||2017-02-18 14:31:35.953519|2017-02-18 14:31:35.953519
NCT00653588|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-03-13|||April 2003||2003-04-01|March 2009|2009-03-01|September 2004|Actual|2004-09-01|||||Interventional|POLARIS||Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks|A 26-Week, Double Blind, Randomised, Multi-Centre, Phase IIIb, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin (40 mg) With Atorvastatin (80 mg) in Subjects With Hypercholesterolaemia and Coronary Heart Disease or CHD Risk Equivalents|Completed||Phase 3|||AstraZeneca||2|||f||||f||||||||||2017-02-18 14:31:36.051426|2017-02-18 14:31:36.051426
NCT00653575|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-04-12|||August 2008||2008-08-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Adult Sexual Risk Behavior Among Women With a History of Childhood Sexual Abuse|HIV Risk Among Women With a History of Childhood Sexual Abuse|Completed||N/A|481|Actual|Syracuse University|||2||f||||f||||||||||2017-02-18 14:31:36.150815|2017-02-18 14:31:36.150815
NCT00653562|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2017-02-15|||November 2006||2006-11-01|February 2017|2017-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography|Single Blind, Multi-center, Post Marketing Clinical Study of Zolpidem (Myslee) in Adolescent Patients With Insomnia - Evaluation With Polysomnography|Completed||Phase 4|11|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 14:31:36.257482|2017-02-18 14:31:36.257482
NCT00653549|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-06-16|||April 2001||2001-04-01|June 2011|2011-06-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Bioavailability Study of Torsemide Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Torsemide Tablets 20mg With That of Roche Demadex 1*20 mg in Healthy Subjects Under Fasting Conditions.|Completed||Phase 1|26|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:36.379959|2017-02-18 14:31:36.379959
NCT00653536|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2017-01-11|||March 2008||2008-03-01|January 2017|2017-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|PAO||A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke|Feasibility and Safety of NeuroFlo™ in Patients With Persistent Arterial Occlusion (PAO) After Failed Mechanical Revascularization|Withdrawn||Phase 1|0|Actual|University of California, Los Angeles||1||No Patients enrolled; sponsor not providing devices anymore|f||||t||||||||||2017-02-18 14:31:36.482206|2017-02-18 14:31:36.482206
NCT00653523|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-06-09|2010-05-27||December 2007||2007-12-01|June 2015|2015-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)|Open-label, Long-term Study of Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia Who Have Not Reached LDL-cholesterol Target With HMG-CoA Reductase Inhibitors|Completed||Phase 3|151|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:31:36.584014|2017-02-18 14:31:36.584014
NCT00653510|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2012-09-17|||March 2008||2008-03-01|September 2012|2012-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 Diabetes|The Effect of Acute Hyperglycemia on Cardiac Output, Amino Acid, Lipid and Glucose Metabolism in Patients With Type 2 Diabetes|Completed||N/A|18|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 14:31:36.835286|2017-02-18 14:31:36.835286
NCT00653497|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||March 1997||1997-03-01|April 2008|2008-04-01|June 1998|Actual|1998-06-01|June 1998|Actual|1998-06-01||Interventional|||Effectiveness and Cost-Efficiency of Aquatic Exercise for Management of Osteoarthritis|Effectiveness and Cost-Efficiency of Aquatic Exercise for Management of Osteoarthritis|Completed||N/A|249|Actual|University of Washington||2|||f||||||||||||||2017-02-18 14:31:36.941128|2017-02-18 14:31:36.941128
NCT00653484|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2013-12-16|||March 2008||2008-03-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|May 2009|Actual|2009-05-01||Interventional|||Energy Balance Interventions for Colorectal Cancer Prevention|Energy Balance Interventions for Colorectal Cancer Prevention|Completed||N/A|40|Actual|Vanderbilt University||3|||f||||t||||||||||2017-02-18 14:31:37.03802|2017-02-18 14:31:37.03802
NCT00653471|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-07-18|||June 2006||2006-06-01|July 2016|2016-07-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Micro-stream Capnography in Non-intubated Lean and Obese Patients With and Without Obstructive Sleep Apnea|The Accuracy of End-tidal PCO2 Measurements With Main-stream and Micro-stream Capnography in Non-intubated Lean and Obese Patients With and Without Obstructive Sleep Apnea|Completed||Early Phase 1|60|Actual|The Cleveland Clinic||3|||f||||f||||||||||2017-02-18 14:31:37.149301|2017-02-18 14:31:37.149301
NCT00653458|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-04|2008-04-10|||August 2002||2002-08-01|April 2008|2008-04-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions|Comparative, Randomized, Single-Dose, Cross Over Bioavailability Study of Kali's Ondansetron ODT 8 mg With That of GlaxoSmithKine's Zofran ODT 8 mg in Healthy Adult Subjects Under Fed Conditions|Completed||Phase 1|18|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:37.258909|2017-02-18 14:31:37.258909
NCT00653250|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2013-05-20|||December 2000||2000-12-01|May 2013|2013-05-01|January 2008|Actual|2008-01-01|March 2006|Actual|2006-03-01||Interventional|||Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer|COX-2 Activity in Early and Advanced NSCLC and The Effect of Short-Term Administration of Specific COX-2 Inhibitors (Celecoxib)|Completed||N/A|22|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 14:31:39.47876|2017-02-18 14:31:39.47876
NCT00653445|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2009-03-25|||June 2004||2004-06-01|March 2009|2009-03-01|June 2005|Actual|2005-06-01|||||Interventional|EXPLORER||Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg|A 6wk Open-Label, Randomised, Multicentre, Phase IIIb, Parallel Group Study to Compare the Safety & Efficacy of Rosuvastatin 40mg in Comb.With Ezetimibe 10mg in Subjects With Hypercholesterolaemia & CHD or Atherosclerosis or a CHD Risk Equiv. (10 yr Risk Score >20%).|Completed||Phase 3|||AstraZeneca||2|||f||||f||||||||||2017-02-18 14:31:37.359785|2017-02-18 14:31:37.359785
NCT00653432|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2010-06-21|||January 2008||2008-01-01|June 2010|2010-06-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Effectiveness Study of Hyaluronic Acid for Osteoarthritis of the Knee||Completed||N/A|350|Anticipated|Anika Therapeutics, Inc.||1|||f||||f||||||||||2017-02-18 14:31:37.470348|2017-02-18 14:31:37.470348
NCT00653419|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||June 1998||1998-06-01|April 2008|2008-04-01|September 1998|Actual|1998-09-01|September 1998|Actual|1998-09-01||Interventional|||Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of Par and Bristol-Myers Squibb (Buspar) 15 mg Buspirone HCl Tablets in Healthy Adult Males Under Fasting Conditions Following Administration of a 30 mg Dose|Completed||Phase 1|48|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:37.582307|2017-02-18 14:31:37.582307
NCT00653406|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-05-16|||November 2002||2002-11-01|March 2010|2010-03-01|October 2003|Actual|2003-10-01|||||Interventional|||A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients|Multiple-dosing Study of Long Acting Injectable of Risperidone in Schizophrenic Patients|Completed||Phase 1/Phase 2|29|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 14:31:37.69433|2017-02-18 14:31:37.69433
NCT00653393|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||October 2004||2004-10-01|April 2008|2008-04-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions|To Compare Bioavailability of Kali Tranylcypromine 10mg Tablets to That of Parnate 10 mg Tablets Under Fasting Conditions.|Completed||Phase 1|39|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:37.783194|2017-02-18 14:31:37.783194
NCT00653380|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||September 1999||1999-09-01|April 2008|2008-04-01|October 1999|Actual|1999-10-01|October 1999|Actual|1999-10-01||Interventional|||Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions|Randomized, Open-Label, 2-Way Crossover, Comparative Bioavailability Study of Par's and Oclassen's (Monodox) Doxycycline Monohydrate Capsules Administered as 1 x 100 mg Capsule in Healthy Adult Males Under Fasting Conditions|Completed||Phase 1|24|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:37.891102|2017-02-18 14:31:37.891102
NCT00653367|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2012-02-23|||December 2011||2011-12-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|April 2012|Anticipated|2012-04-01||Interventional|||Evaluation of Chronic Pain After Nerve Section During Thoracotomy|Post Thoracotomy Pain After Nerve Section|Withdrawn||N/A|0|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 14:31:38.000566|2017-02-18 14:31:38.000566
NCT00653354|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-07|||December 2002||2002-12-01|April 2008|2008-04-01|March 2003|Actual|2003-03-01|||||Interventional|||Analgesic Efficacy Of Valdecoxib In Patients Following Bunion Surgery|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Assessment Of The Analgesic Efficacy Of The Dosing Regimen Of Valdecoxib Compared To Placebo Patients In Pain Following Bunionectomy|Completed||Phase 3|360|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:31:38.095008|2017-02-18 14:31:38.095008
NCT00653341|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2009-04-17|||January 2000||2000-01-01|April 2009|2009-04-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)|Target Glycemic Control and the Incidence of Symptomatic Nocturnal Hypoglycemia in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s) and Treated With Insulin Glargine or NPH Human Insulin.|Completed||Phase 3|764|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:31:38.31954|2017-02-18 14:31:38.31954
NCT00653328|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-05-16|2010-09-30||May 2003||2003-05-01|May 2012|2012-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma|A Phase II Study of Atrasentan (ABT-627) Plus DOXIL in Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Serous Papillary Adenocarcinoma Following Platinum + Taxane Therapy|Terminated||Phase 2|15|Actual|Vanderbilt-Ingram Cancer Center||1||Abbott (drug manufacturer) discontinued manufacture of ABT-627|f||||t||||||||||2017-02-18 14:31:38.418377|2017-02-18 14:31:38.418377
NCT00653315|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-09|||May 2002||2002-05-01|April 2008|2008-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions|To Compare the Relative Bioavailability of the Kali's Tramadol APAP Tablets With Ortho-McNeil's Ultracet Tablets Under Fasting Conditions.|Completed||Phase 1|28|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:38.76004|2017-02-18 14:31:38.76004
NCT00653302|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-12-02|||April 2003||2003-04-01|December 2008|2008-12-01|October 2005|Actual|2005-10-01|September 2004|Actual|2004-09-01||Interventional|GALATEE||Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)|Assessment of the Phenotype of the Type 2 Diabetic Responders to the First Insulinisation Using Lantus (Insulin Glargine) Plus Glucophage (Metformin) Combination After Failure in OADs Treatment|Completed||Phase 4|280|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:31:38.85548|2017-02-18 14:31:38.85548
NCT00653276|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-07-29|||November 2003||2003-11-01|July 2015|2015-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||MD Ezetimibe Cyclosporine Interaction (0653-057)|An Open-Label, 2-Period, Crossover Study to Determine the Effect of Multiple Oral Doses of Ezetimibe 20 mg on the Pharmacokinetics of a Single Oral Dose of Cyclosporine in Young, Healthy, Normal, Male and Female Subjects|Completed||Phase 1|13|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:31:38.945646|2017-02-18 14:31:38.945646
NCT00653263|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2010-02-22|2009-10-22||August 2006||2006-08-01|February 2010|2010-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study|Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study|Completed||N/A|8|Actual|University of Arkansas|The small sample size (N=6) is a significant limitation of the current study.||1||f||||t||||||||||2017-02-18 14:31:39.197563|2017-02-18 14:31:39.197563
NCT00652574|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-09-23|||March 2008||2008-03-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Interventional|||Dasatinib in Resectable Malignant Pleural Mesothelioma|Phase I Trial of Induction Dasatinib Therapy in Patients With Resectable Malignant Pleural Mesothelioma|Active, not recruiting||Phase 1|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:31:58.265234|2017-02-18 14:31:58.265234
NCT00653237|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-03-11|||March 2008||2008-03-01|March 2014|2014-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Laryngeal Mask Supreme™ Versus the I-gel™|A Comparison of The Laryngeal Mask Supreme™ and the I-gel™ in a Simulated Difficult Airway Scenario in Anesthetized and Ventilated Patients|Completed||N/A|60|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 14:31:39.591227|2017-02-18 14:31:39.591227
NCT00653224|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-08-29|2009-07-28||April 2008||2008-04-01|December 2009|2009-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine 5 mg Once Daily Given for 2 Weeks in Subjects 18 yr of Age and Older With Seasonal Allergic Rhinitis|Completed||Phase 4|580|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 14:31:39.723152|2017-02-18 14:31:39.723152
NCT00652158|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-09-20|||April 2006||2006-04-01|September 2013|2013-09-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies|A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies|Terminated||Phase 1|44|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:31:42.076495|2017-02-18 14:31:42.076495
NCT00652145|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-05-04|2014-12-01||September 2008||2008-09-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|DEAR||Dose Escalation and Remission (DEAR)|Test Treat Strategy to Prevent Ulcerative Colitis Relapse|Completed||Phase 4|119|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 14:31:42.167396|2017-02-18 14:31:42.167396
NCT00653211|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2015-04-14|||February 2008||2008-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:31:43.160247|2017-02-18 14:31:43.160247
NCT00653198|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-03-17|||March 2008||2008-03-01|March 2011|2011-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama|Hospital-based, Case-control Study to Assess the Vaccine Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children Born After 1 March 2006 and at Least 12 Weeks of Age, in Panama|Completed||N/A|885|Actual|GlaxoSmithKline|||2||f||||||||||Samples With DNA|"~     Stool samples~   "|||2017-02-18 14:31:43.207579|2017-02-18 14:31:43.207579
NCT00653185|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2016-06-20||2016-06-20|May 2007||2007-05-01|June 2016|2016-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate Weekly Treatment With SYR-472 in Subjects With Type 2 Diabetes|Completed||Phase 2|369|Actual|Takeda||5|||f||||f||||||||||2017-02-18 14:31:43.297208|2017-02-18 14:31:43.297208
NCT00653172|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2009-01-08|||October 2007||2007-10-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|||Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia|A Double-Blind, Multicenter, Randomized, Double Dummy, Three-Arm Parallel-Group Comparative Study of the Efficacy, Safety and Tolerance of Oral NXL 103 Versus Oral Comparator in the Treatment of Community-Acquired Pneumonia in Adults|Completed||Phase 2|302|Actual|Novexel Inc||3|||f||||f||||||||||2017-02-18 14:31:43.679181|2017-02-18 14:31:43.679181
NCT00653159|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2012-10-17|2012-09-18||July 2007||2007-07-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|MINT||Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial|Intrauterine Contraception for Adolescents Aged 14 to 18: A Multi-center Randomized Controlled Feasibility Trial of Levonorgestrel-releasing Intrauterine System Compared to the Copper T 380A|Completed||Phase 4|23|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 14:31:43.856392|2017-02-18 14:31:43.856392
NCT00653146|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2016-12-01|||September 2007||2007-09-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia|Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV|Completed||N/A|186|Actual|Fox Chase Cancer Center||2|||f||||f||||||||||2017-02-18 14:31:44.70476|2017-02-18 14:31:44.70476
NCT00653133|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2014-12-10|2011-05-19||May 2007||2007-05-01|December 2014|2014-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|cpnb||Multicenter Continuous Peripheral Nerve Block Surveillance Study|Multicenter Continuous Peripheral Nerve Block Surveillance Study Comparing Ultrasound Guided Catheter Placement to Non Ultrasound Guided Catheter Placement Techniques|Completed||Phase 4|1821|Actual|Halyard Health||2|||f||||f||||||||||2017-02-18 14:31:44.816075|2017-02-18 14:31:44.816075
NCT00653120|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||May 2005||2005-05-01|April 2008|2008-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Bioavailability Study of Propranolol Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Propranolol 160 mg With That of Inderal-LA Propranolol 160 mg in Healthy Subjects Under Fasting Conditions.|Completed||Phase 2|48|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:45.253258|2017-02-18 14:31:45.253258
NCT00653107|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2012-04-12|||June 2008||2008-06-01|April 2012|2012-04-01|May 2020|Anticipated|2020-05-01|April 2012|Actual|2012-04-01||Interventional|PACO||Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only|Palliation of Dysphagia in Patients With Advanced Cancer of the Oesophagus by Comparing Stent Followed by 3 Courses of Brachytherapy With 3 Courses of Brachytherapy Only. A Randomised Phase III Study (PACO)|Terminated||Phase 3|41|Actual|Oslo University Hospital||2||The study was closed prematurely due to slow recruitment|f||||f||||||||||2017-02-18 14:31:45.362234|2017-02-18 14:31:45.362234
NCT00653094|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||June 2008||2008-06-01|April 2008|2008-04-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Interventional|||An Open Label, Prospective, One Arm, Feasibility, Study for The Use of Halevy Kit for the Treatment of Perianal Fistulas in Patients With Crohn's Disease|An Open Label, Prospective, One Arm, Feasibility, Study for The Use of Halevy Kit for the Treatment of Perianal Fistulas in Patients With Crohn's Disease|Unknown status|Not yet recruiting|N/A|10|Anticipated|ResQ Medical Ltd||1|||f||||t||||||||||2017-02-18 14:31:45.463289|2017-02-18 14:31:45.463289
NCT00652353|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-03-18|||May 2008||2008-05-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Mnemonic for the Ottawa Ankle Rule|Efficacy of a Mnemonic to Improve Knowledge of the Ottawa Ankle and Foot Rules Among Medical Students and Residents; a Randomized Controlled Trial.|Completed||N/A|191|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-02-18 14:32:01.920857|2017-02-18 14:32:01.920857
NCT00653081|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-04-03|||July 2006||2006-07-01|January 2007|2007-01-01|December 2008|Anticipated|2008-12-01|September 2007|Actual|2007-09-01||Interventional|||Supervised Exercises Compared With Radial Extracorporal Shock Wave Therapy (rESWT) in Patients With SIS|Supervised Exercises Compared With Radial Extracorporal Shock Wave Therapy (rESWT) in Patients With Subacromial Impingement Syndrome: A Single Blind Clinical Randomized Study|Unknown status|Active, not recruiting|Phase 3|104|Actual|Ullevaal University Hospital||2|||f||||t||||||||||2017-02-18 14:31:45.554044|2017-02-18 14:31:45.554044
NCT00653068|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2016-12-20|2016-12-20||December 2008||2008-12-01|November 2016|2016-11-01||||April 2015|Actual|2015-04-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System|Treatment of Atypical Teratoid/Rhabdoid Tumors (AT/RT) of the Central Nervous System With Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation|Active, not recruiting||Phase 3|70|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 14:31:45.662865|2017-02-18 14:31:45.662865
NCT00653055|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||August 2001||2001-08-01|April 2008|2008-04-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions|Randomized, 4-Way Replicate Crossover, Bioequivalence Study of Cabergoline 0.5 mg Tablets and Dostinex 0.5 mg Tablets Administered as 2 x 0.5 mg Tablets in Healthy Adult Females and Males Under Fasting Conditions|Completed||Phase 1|40|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:46.709839|2017-02-18 14:31:46.709839
NCT00653042|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-05-18|||March 2004||2004-03-01|March 2010|2010-03-01|June 2005|Actual|2005-06-01|||||Interventional|||Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA|A Pilot, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Nesiritide Infusion, Initiated Post-Induction of Anesthesia, in the Management of Coronary Artery Bypass Graft (CABG) Patients Requiring CardioPulmonary Bypass (CPB)|Completed||Phase 2|305|Actual|Scios, Inc.|||||||||||||||||||2017-02-18 14:31:46.836151|2017-02-18 14:31:46.836151
NCT00653029|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2016-05-01|||October 2006||2006-10-01|May 2016|2016-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||An fMRI Study of Attention and Effort After Concussion|An fMRI Study of Selective Attention, Working Memory, and Effort After Mild Traumatic Brain Injury|Terminated||N/A|12|Actual|State University of New York - Upstate Medical University|||1|Difficulties with recruitment and MRI scanner became unavailable.|f||||f||||||None Retained|"~     No biospecimens~   "|||2017-02-18 14:31:47.011271|2017-02-18 14:31:47.011271
NCT00653016|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2010-03-25|||October 2002||2002-10-01|March 2010|2010-03-01|August 2003|Actual|2003-08-01|||||Interventional|||An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method|An Open Label Multicentre Study to Evaluate Patient Satisfaction and Preference for the EVRA Transdermal Contraceptive System Compared to Previously Used Contraceptive Method.|Completed||Phase 4|405|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 14:31:47.102783|2017-02-18 14:31:47.102783
NCT00653003|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||December 2003||2003-12-01|April 2008|2008-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Bioavailability Study of Leflunomide Tablets Under Fed Conditions|To Compare the Relative Bioavailability of Leflunomide 20mg Tablets (Kali) With That of ARAVA 20mg Tablets(Aventis) Under Fed Conditions|Completed||Phase 1|62|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:47.185044|2017-02-18 14:31:47.185044
NCT00652977|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-04|||December 1999||1999-12-01|April 2008|2008-04-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Ritgens Maneuver for the Prevention of Anal Sphincter Tears at Delivery: A Randomized Controlled Trial|Modified Ritgens Maneuver for Perineal Protection at Delivery|Completed||N/A|1623|Actual|Lund University Hospital||2|||f||||f||||||||||2017-02-18 14:31:47.283012|2017-02-18 14:31:47.283012
NCT00652964|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2012-11-06|||September 2009||2009-09-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood|PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood|Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 14:31:47.389748|2017-02-18 14:31:47.389748
NCT00652951|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-10-11||2011-11-17|April 2008||2008-04-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib|Non-inferiority of Co-administration of GSK Biologicals'Pneumococcal Conjugate Vaccine GSK1024850A With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib.|Completed||Phase 3|780|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:31:47.486048|2017-02-18 14:31:47.486048
NCT00652938|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-10-06|2010-08-04||April 2008||2008-04-01|October 2016|2016-10-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects|Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV Vaccine (580299) Co-administrated With a Commercially Available Vaccine in Healthy Female Adolescents|Completed||Phase 3|744|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:31:47.605511|2017-02-18 14:31:47.605511
NCT00652925|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-05-29|||October 2002||2002-10-01|April 2008|2008-04-01|April 2005|Actual|2005-04-01|April 2004|Actual|2004-04-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA|Randomized, Double-Blind, Multicenter, Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA|Completed||Phase 3|225|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 14:31:51.039402|2017-02-18 14:31:51.039402
NCT00652912|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||March 2004||2004-03-01|April 2008|2008-04-01|May 2004|Actual|2004-05-01|April 2004|Actual|2004-04-01||Interventional|||Bioavailability Study of Clonazepam ODT Under Fasting Conditions|Comparative, Randomized, Single-Dose, Bioavailability Study of Kali's Clonazepam ODT 1 mg With That of Klonopin Wafers 1 mg ODT in Healthy Adult Subjects Under Fasting Conditions.|Completed||Phase 1|32|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:51.202596|2017-02-18 14:31:51.202596
NCT00652899|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2012-11-06|2010-08-20||March 2008||2008-03-01|November 2012|2012-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer|MT2007-19R: WCC #53 Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer|Terminated||Phase 2|14|Actual|Masonic Cancer Center, University of Minnesota|"Endpoint for association of clinical benefit response with donor/recipient KIR ligand matching status is not evaluable due to 0 complete responders.~Correlative laboratory objectives are irrelevant due to ineffectiveness of study regimen."|2||Withdrawn due to toxicity|f||||t||||||||||2017-02-18 14:31:51.527768|2017-02-18 14:31:51.527768
NCT00652886|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||March 2005||2005-03-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|March 2005|Actual|2005-03-01||Interventional|||Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions|Compare the Relative Bioavailability of Oxandrolone 10mg Tablets With That of OXANDRIN 10 mg Tablets Following a Single Oral Dose(1*10 mg Tablet) in Healthy, Adult Subjects Under Fasting Conditions.|Completed||Phase 1|26|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:51.872072|2017-02-18 14:31:51.872072
NCT00652873|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||July 2001||2001-07-01|April 2008|2008-04-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Cabergoline 0.5 mg Tablets and Dostinex 0.5 mg Tablets Administered as 2 x 0.5 mg Tablets in Healthy Adult Females and Males Under Fed Conditions|Completed||Phase 1|24|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:52.072695|2017-02-18 14:31:52.072695
NCT00652860|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2011-05-13|||August 2001||2001-08-01|May 2011|2011-05-01||||November 2006|Actual|2006-11-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery|Chemotherapy, Irradiation, and Surgery for Function-Preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and GM-CSF; Aerosol GM-CSF During Preoperative Irradiation and Postoperatively|Completed||Phase 2|39|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:31:52.179574|2017-02-18 14:31:52.179574
NCT00652847|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-10-29|||May 2005||2005-05-01|October 2015|2015-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)|Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia|Completed||Phase 4|1140|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:31:52.27452|2017-02-18 14:31:52.27452
NCT00652834|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2016-02-05|2014-12-02||April 2009||2009-04-01|December 2014|2014-12-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional||of 23 participants, 18 participants completed the study.|Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®|Gastrointestinal Mucosal Findings in Patients Receiving Mycophenolic Acid (MPA) as Demonstrated by Small Bowel Capsule Endoscopy (SBCE)|Completed||Phase 4|23|Actual|University of California, Los Angeles|We did not enroll asymptomatic patients and in the extension of the trial the number of patients re-examined were few and the data obtained from them are not enough to provide definitive information.|1|||f||||f||||||||||2017-02-18 14:31:52.371766|2017-02-18 14:31:52.371766
NCT00652821|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-09|||May 2002||2002-05-01|April 2008|2008-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions|To Compare the Relative Bioavailability of the Kali's Tramadol APAP Tablets With Ortho-McNeil's Ultracet Tablets Under Fed Conditions.|Completed||Phase 1|22|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:52.653011|2017-02-18 14:31:52.653011
NCT00652808|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-07|||May 2004||2004-05-01|April 2008|2008-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis of the Knee|Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg QD and Naproxen 500 mg BID in Treating the Signs and Symptoms of Osteoarthritis of the Knee|Completed||Phase 3|265|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:31:52.764652|2017-02-18 14:31:52.764652
NCT00652795|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||July 2004||2004-07-01|April 2008|2008-04-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions|Randomized, 2-Way Crossover, Bioequivalence Study of Doxycycline 150 mg Tablet and Monodox 50 mg Capsule Administered as 1 x 150 mg Tablet or 3 x 50 mg Capsules in Healthy Subjects Under Fasting Conditions|Completed||Phase 1|36|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:52.876628|2017-02-18 14:31:52.876628
NCT00652782|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||December 2004||2004-12-01|April 2008|2008-04-01||||August 2005|Actual|2005-08-01||Interventional|||Effects of MK7418 on Diuresis and Renal Function in Congestive Heart Failure Patients|A Randomized, Double-Blind, Placebo Controlled Dose-Ranging Study of The Effects of MK7418, Both as Monotherapy and in Combination With Furosemide, On Diuresis and Renal Function in Patients With Congestive Heart Failure (CHF) And Renal Impairment Treated With Oral Loop Diuretics Who Require Hospitalization For Fluid Overload|Completed||Phase 2|160|Actual|NovaCardia, Inc.||5|||f||||||||||||||2017-02-18 14:31:52.987515|2017-02-18 14:31:52.987515
NCT00652769|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-10-17|||March 2008||2008-03-01|October 2011|2011-10-01|July 2012|Anticipated|2012-07-01|September 2011|Actual|2011-09-01||Interventional|BOOST||A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)|A Randomized Controlled Trial of Endobronchial or Endoscopic Ultrasound as a First Test in the Diagnosis and Staging of Lung Cancer|Unknown status|Active, not recruiting|Phase 3|168|Anticipated|University College London Hospitals||2|||f||||t||||||||||2017-02-18 14:31:53.08526|2017-02-18 14:31:53.08526
NCT00652756|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2017-02-13|||August 2007||2007-08-01|February 2017|2017-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|iVent||Evaluation of the Versamed iVent in the Transport of Patients Receiving Mechanical Ventilation|Evaluation of the Versamed iVent in the Transport of Patients Receiving Mechanical Ventilation|Terminated||N/A|16|Actual|Tufts Medical Center||2||Unable to recruit adequately|f||||f||||||||||2017-02-18 14:31:53.195933|2017-02-18 14:31:53.195933
NCT00211367|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-20|||April 2004||2004-04-01|June 2007|2007-06-01|March 2007|Actual|2007-03-01|||||Interventional|||Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)||Terminated||Phase 2|2|Actual|Manhattan Eye, Ear & Throat Hospital||||poor enrollment|t||||f||||||||||2017-02-18 17:09:28.094234|2017-02-18 17:09:28.094234
NCT00652743|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-10-18||2012-07-23|March 2008||2008-03-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules|Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules|Completed||Phase 3|516|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:31:53.30145|2017-02-18 14:31:53.30145
NCT00652730|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||July 1998||1998-07-01|April 2008|2008-04-01|September 1998|Actual|1998-09-01|September 1998|Actual|1998-09-01||Interventional|||Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions|Comparative, Randomized, 3-Way Crossover Bioavailability Study of Par and Bristol-Myers Squibb (Buspar)15 mg Buspirone HCl Tablets Following Administration of a 30 mg Dose in Healthy Adult Males Under Fed and Fasting Conditions|Completed||Phase 1|21|Actual|Par Pharmaceutical, Inc.||3|||f||||f||||||||||2017-02-18 14:31:53.412875|2017-02-18 14:31:53.412875
NCT00652717|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2016-01-21|||February 2005||2005-02-01|January 2016|2016-01-01|August 2005|Actual|2005-08-01|February 2005|Actual|2005-02-01||Interventional|||Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)|A Multicenter, Open Study To Evaluate The Efficacy Of Ezetimibe 10 Mg Added On Statin Therapy, In Reducing LDL Cholesterol To Target Levels In Patients After Acute Coronary Syndrome|Completed||Phase 4|280|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:31:53.528903|2017-02-18 14:31:53.528903
NCT00652704|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||July 1999||1999-07-01|April 2008|2008-04-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions|Randomized, Open-Label, 3-Way Crossover, Comparative Bioavailability Study of Par's and Oclassen's (Monodox) Doxycycline Monohydrate Capsules Administered as 1 x 100 mg Capsule in Healthy Adult Males Under Fasting and Fed Conditions|Completed||Phase 1|24|Actual|Par Pharmaceutical, Inc.||3|||f||||f||||||||||2017-02-18 14:31:53.835527|2017-02-18 14:31:53.835527
NCT00652691|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-03|2016-04-18|||August 1998||1998-08-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer|A Dose Seeking Trial of Topotecan Combined With High-Dose Cyclophosphamide and Carboplatin With Peripheral Blood Stem Cell Transplant for the Treatment of Relapsed Ovarian Cancer and Primary Peritoneal Cancer|Active, not recruiting||Phase 1|48|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:31:53.952934|2017-02-18 14:31:53.952934
NCT00652678|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-07-08|||August 2006||2006-08-01|July 2011|2011-07-01|August 2012|Anticipated|2012-08-01|||||Observational|||Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients|Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients|Unknown status|Recruiting|N/A|45|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||Samples With DNA|"~     peripheral blood mononuclear cells~   "|||2017-02-18 14:31:54.05315|2017-02-18 14:31:54.05315
NCT00652665|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||June 2003||2003-06-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Bioavailability Study of Leflunomide Tablets Under Fasting Conditions|To Compare the Relative Bioavailability of Leflunomide 20mg Tablets (Kali) With That of ARAVA 20mg Tablets(Aventis) Under Fasting Conditions|Completed||Phase 1|52|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:54.147|2017-02-18 14:31:54.147
NCT00652652|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-05-18|||March 2003||2003-03-01|March 2010|2010-03-01|January 2004|Actual|2004-01-01|||||Interventional|||Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS|Evaluation of Synergy Between Natrecor and Furosemide on Renal and Neurohormone Responses in Chronic Heart Failure: A Phase-IV Study|Completed||Phase 4|||Scios, Inc.|||||||||||||||||||2017-02-18 14:31:54.244178|2017-02-18 14:31:54.244178
NCT00652639|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||February 2004||2004-02-01|April 2008|2008-04-01|April 2004|Actual|2004-04-01|March 2004|Actual|2004-03-01||Interventional|||Bioavailability Study of Clonazepam Tablets Under Fasting Conditions|Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Kali's Clonazepam Tablets 1 mg With That of Klonopin Tablets 1 mg in Healthy Adult Subjects Under Fasting Conditions.|Completed||Phase 1|32|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:54.335271|2017-02-18 14:31:54.335271
NCT00652626|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2016-03-24|2013-08-02||November 2008||2008-11-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|RENAL|Safety population. The total number of participants in the study was 27; 18 continued treatment in the extension phase.|Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function|A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function|Completed||Phase 1|31|Actual|Celgene Corporation||5|||f||||f||||||||||2017-02-18 14:31:54.46813|2017-02-18 14:31:54.46813
NCT00652613|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-04-09|||August 2005||2005-08-01|April 2008|2008-04-01|August 2009|Anticipated|2009-08-01|March 2008|Anticipated|2008-03-01||Interventional|||Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)|Phase II Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) vs Intensity Modulated Radiotherapy (IMRT) for Squamous Cell Carcinoma of the Head and Neck (HNSCC)|Unknown status|Active, not recruiting|Phase 2|60|Actual|Tata Memorial Hospital||2|||f||||t||||||||||2017-02-18 14:31:57.933304|2017-02-18 14:31:57.933304
NCT00652600|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||September 2005||2005-09-01|April 2008|2008-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Bioavailability Study of Propranolol Under Fed Conditions|Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Propranolol 160 mg With That of Inderal-LA Propranolol 160 mg in Healthy Subjects Under Fed Conditions.|Completed||Phase 1|46|Actual|Par Pharmaceutical, Inc.||2|||f||||f||||||||||2017-02-18 14:31:58.043231|2017-02-18 14:31:58.043231
NCT00652587|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-03-31|||January 2002||2002-01-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma|A Randomized Controlled Trial of Hepatectomy With Adjuvant Transcatheter Arterial Chemoembolization Versus Hepatectomy Alone for Stage IIIA Hepatocellular Carcinoma|Completed||Phase 3|115|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 14:31:58.15442|2017-02-18 14:31:58.15442
NCT00652561|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-03-17|||February 2005||2005-02-01|March 2011|2011-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer|An Open-Label, Non-Randomized, Multicenter, Three Stage, Phase 2 Study of S-1 as 2nd Line Therapy for Patients With Advanced Non-Small Cell Lung Cancer (Stage IIIB/Stage IV)|Completed||Phase 2|57|Actual|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-02-18 14:31:58.377277|2017-02-18 14:31:58.377277
NCT00652548|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2010-01-12|||March 2008||2008-03-01|March 2008|2008-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Use of Ultrasound to Evaluate Clavicle Fractures in Pediatric Patients|Utility of Bedside Ultrasound to Diagnose Clavicle Fractures in the Pediatric Emergency Department|Completed||N/A|100|Anticipated|University of Louisville|||1||f||||f||||||||||2017-02-18 14:31:58.468|2017-02-18 14:31:58.468
NCT00652522|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-11-30|||January 2008||2008-01-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|AMICA||Atrial Fibrillation Management in Congestive Heart Failure With Ablation|Atrial Fibrillation Management in Congestive Heart Failure With Ablation|Active, not recruiting||N/A|202|Actual|St. Jude Medical||2|||f||||t||||||||||2017-02-18 14:31:58.561379|2017-02-18 14:31:58.561379
NCT00652509|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-05-13|||May 2008||2008-05-01|May 2016|2016-05-01|July 2011|Actual|2011-07-01|March 2010|Actual|2010-03-01||Interventional|||Journey for Control of Diabetes Study (0431-111)|Journey for Control of Diabetes Study|Completed||N/A|621|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 14:31:58.696267|2017-02-18 14:31:58.696267
NCT00652496|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||January 2005||2005-01-01|April 2008|2008-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 2|249|Actual|Allergan||5|||f||||||||||||||2017-02-18 14:31:58.782698|2017-02-18 14:31:58.782698
NCT00652483|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||May 2003||2003-05-01|April 2008|2008-04-01|September 2004|Actual|2004-09-01|December 2003|Actual|2003-12-01||Interventional|||Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|433|Actual|Allergan||2|||f||||||||||||||2017-02-18 14:31:58.893806|2017-02-18 14:31:58.893806
NCT00652470|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-12-15|||September 2005||2005-09-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Study Comparing Two Treatments for Infants With Hydrocephalus|International Infant Hydrocephalus Study: A Multicentre, Prospective Study|Active, not recruiting||Phase 2|182|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 14:31:59.00729|2017-02-18 14:31:59.00729
NCT00652457|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-03-31||||||March 2008|2008-03-01||||||||Interventional|||Study of Memantine to Treat Huntington's Disease|"A Pilot Study of Memantine for Cognitive and Behavioral Dysfunction in Huntington's Disease"|Unknown status|Recruiting|Phase 4|60||University of California, San Diego||1|||f||||t||||||||||2017-02-18 14:31:59.153209|2017-02-18 14:31:59.153209
NCT00652444|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-01-21|||September 2003||2003-09-01|January 2016|2016-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)|Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 4|120|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:31:59.262391|2017-02-18 14:31:59.262391
NCT00652431|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-11-14|||May 2007||2007-05-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)|SCH 465981: Assessment of Bi-Directional Interaction Between Components of Vytorin® (Ezetimibe and Simvastatin) and Niaspan® (Niacin Extended-Release Tablets) in Healthy Subjects|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:31:59.374155|2017-02-18 14:31:59.374155
NCT00652418|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2013-10-10|||July 2004||2004-07-01|October 2013|2013-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography|Evaluation of a Single Intravenous Injection of Magnevist (SH L 451 A) at 0.1 mmol/kg and 0.2 mmol/kg in Contrast-enhanced 3D-Magnetic Resonance Angiography in Patients With Arterial Disease in the Abdominal to Leg Regions in the Ability of Detecting of Vessel Abnormalities|Completed||Phase 2|12|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:31:59.484514|2017-02-18 14:31:59.484514
NCT00652405|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2010-08-10|||May 2008||2008-05-01|May 2008|2008-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|AR22||Effect of Alcohol on Cephalic Phase Reflex and Gene Expression|Effect of Moderate Alcohol Consumption on Cephalic Phase Reflex and Gene Expression of Adipose Tissue in Postmenopausal Women|Completed||N/A|24|Actual|TNO||2|||f||||t||||||||||2017-02-18 14:31:59.597918|2017-02-18 14:31:59.597918
NCT00652392|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-01-21|||April 2003||2003-04-01|January 2011|2011-01-01|June 2004|Actual|2004-06-01|||||Interventional|||Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM|A 12 Week, Randomized, Double-Blind, Double-Dummy, Placebo and Active-controlled Study of Symbicort pMDI Administered Once Daily in Adults and Adolescents With Asthma - STEM|Completed||Phase 3|750|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:31:59.707933|2017-02-18 14:31:59.707933
NCT00652379|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2012-01-25|||June 2008||2008-06-01|January 2012|2012-01-01|May 2011|Actual|2011-05-01|November 2009|Actual|2009-11-01||Interventional|||Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients|Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients: Impact on Insulin Sensitivity, Glucose Tolerance, and Pharmacoeconomics|Completed||N/A|18|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:31:59.863079|2017-02-18 14:31:59.863079
NCT00652366|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-01-27|2014-12-08||May 2008||2008-05-01|January 2015|2015-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Safety analysis population (SAP): all participants who received at least 1 dose of the trial medication and had at least 1 safety follow-up, whether withdrawn prematurely or not.|A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer|A Randomized, Open-label, Dose-escalation to Rash Study to Assess the Effect of Tarceva in Combination With Gemcitabine on Overall Survival in Patients With Metastatic Pancreatic Cancer.|Completed||Phase 2|467|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:32:00.138953|2017-02-18 14:32:00.138953
NCT00005185|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1986||1986-04-01|May 2000|2000-05-01|March 1990|Actual|1990-03-01|||||Observational|||Myocardial Infarction and Non-contraceptive Estrogen Use||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:23.217423|2017-02-18 18:15:23.217423
NCT00652340|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2012-03-13|2012-03-13||April 2008||2008-04-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|June 2010|Actual|2010-06-01||Interventional|TP2001-201||APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer|APRiCOT-L (Apricoxib in Combination Oncology Treatment - Lung) A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Erlotinib in Non-Small Cell Lung Cancer Patients|Completed||Phase 2|120|Actual|Tragara Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 14:32:02.036367|2017-02-18 14:32:02.036367
NCT00652327|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-06-23|2010-05-12||December 2005||2005-12-01|June 2015|2015-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)|A Multicenter, Randomized, Open-labeled, Parallel Group Comparison Study to Evaluate the Efficacy, Safety and Tolerability of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Ongoing Statin in the Treatment of Hypercholesterolemia.|Completed||Phase 4|83|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:32:02.556706|2017-02-18 14:32:02.556706
NCT00652314|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-02-05|2015-12-04||March 2008||2008-03-01|February 2016|2016-02-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|Control||Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-Thrombin|Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-Thrombin|Completed||Phase 4|97|Actual|Vascular Solutions, Inc||2|||f||||f||||||||No||2017-02-18 14:32:03.126688|2017-02-18 14:32:03.126688
NCT00652301|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-02-16|||July 2003||2003-07-01|February 2015|2015-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled,4-Period, Crossover Study to Evaluate the Effects of Ezetimibe and Simvastatin, Coadministered and Alone, on Intestinal Absorption of Cholesterol|Completed||Phase 3|40|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 14:32:03.596859|2017-02-18 14:32:03.596859
NCT00652288|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-08-30|||April 2007||2007-04-01|August 2016|2016-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|PK/PD||Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs|Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs Given as a Bolus by Continuous Subcutaneous Insulin Infusion (CSII) and in MDI Basal-Bolus Therapy in Pediatric Subjects With Type 1 Diabetes (TID)|Completed||Phase 1|36|Actual|Yale University||4|||f||||f||||||||||2017-02-18 14:32:03.713768|2017-02-18 14:32:03.713768
NCT00652275|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-05-06|||May 2008||2008-05-01|April 2008|2008-04-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Interventional|||Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine|Phase IIb Immunogenicity, Efficacy and Safety Study of P. Falciparum Vaccine Candidate, MSP3-LSP Adjuvanted in Aluminium Hydroxide Versus Verorab Control in Healthy Children Aged 12-48 Months in Mali.|Unknown status|Recruiting|Phase 2|378|Anticipated|African Malaria Network Trust||2|||f||||t||||||||||2017-02-18 14:32:03.831625|2017-02-18 14:32:03.831625
NCT00652262|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-12-18|||March 2004||2004-03-01|December 2014|2014-12-01|November 2004|Actual|2004-11-01|||||Interventional|||BAY38-9456 - Supportive Trial for Spinal Injury|An Open, Multi-centre, Flexible Dose Uptitration Study to Investigate the Efficacy and Safety of Vardenafil 10 mg and 20 mg in Males With Spinal Cord Injury Suffering From Erectile Dysfunction|Completed||Phase 3|32|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:32:03.943259|2017-02-18 14:32:03.943259
NCT00652249|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2012-06-04|||March 2009||2009-03-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Diagnosing Malfunctioning Hydrocephalic Shunt Valves With a Flow Sensor|A Flow Monitor for Pediatric Hydrocephalic Shunts - Study of Flow Sensor With the Shunt Valve|Withdrawn||N/A|0|Actual|Transonic Systems Inc.|||1|Due to lack of enrollment.|f||||f||||||||||2017-02-18 14:32:04.052063|2017-02-18 14:32:04.052063
NCT00652236|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-03-31|||January 2006||2006-01-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Observational|||Cost of Long Term Disability in Patients With Chronic Non-Specific Low Back Pain|Cost of Long Term Disability in Patients With Chronic Non-Specific Low Back Pain. Three-Year Follow up of a Randomized Trial|Terminated||N/A|174|Actual|Klinik Valens|||2|Study was terminated according the study protocol end of 2007|f||||f||||||||||2017-02-18 14:32:04.146079|2017-02-18 14:32:04.146079
NCT00652223|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-04|||March 2005||2005-03-01|April 2008|2008-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy|Safety, Immunogenicity and Clinical Efficacy of an Allergen Vaccine (AllQbG10) in Subjects With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy|Completed||Phase 1/Phase 2|21|Actual|Cytos Biotechnology AG||1|||f||||f||||||||||2017-02-18 14:32:04.254284|2017-02-18 14:32:04.254284
NCT00652210|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-12-08|||June 2005||2005-06-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|MPM||Use of Multiphoton Microscopy in the Diagnosis of Cancer|Use of Multiphoton Microscopy in the Diagnosis of Cancer|Completed||Phase 1|344|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 14:32:04.345862|2017-02-18 14:32:04.345862
NCT00652197|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-05-25|||March 2009||2009-03-01|May 2016|2016-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor|A Flow Monitor for Pediatric Hydrocephalic Shunts - Flow Sensor Study|Completed||N/A|16|Actual|Transonic Systems Inc.|||1||f||||f||||||||||2017-02-18 14:32:04.452015|2017-02-18 14:32:04.452015
NCT00652184|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-10-03|||March 2008||2008-03-01|October 2008|2008-10-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|||Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)|Phase 2/3 Multi-Center, Double-Blind, Controlled Trial Comparing Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir, and Combination Topical ARYS-01 Cream /Oral Valaciclovir for Treatment of Herpes Zoster in Immunocompetent Patients 18 Years of Age or Older|Unknown status|Active, not recruiting|Phase 2|300|Anticipated|aRigen Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 14:32:04.546592|2017-02-18 14:32:04.546592
NCT00652171|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-03|||January 2004||2004-01-01|April 2008|2008-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Antidepressant Augmentation With Lamotrigine|Efficacy and Safety of Antidepressant Augmentation With Lamotrigine in Patients With Treatment-Resistant Depression|Completed||Phase 3|34|Actual|Institute of Social Security of the Civil Servants of Minas Gerais||2|||f||||t||||||||||2017-02-18 14:32:04.670879|2017-02-18 14:32:04.670879
NCT00652132|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2013-08-09|||December 2007||2007-12-01|June 2009|2009-06-01||||||||Interventional|||Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, Stage II, or Stage III Childhood Liver Cancer|A Multi-centre Open-label Randomised Phase III Trial of the Efficacy of Sodium Thiosulphate in Reducing Ototoxicity in Patients Receiving Cisplatin Chemotherapy for Standard Risk Hepatoblastoma|Unknown status|Recruiting|Phase 3|115|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:32:04.773957|2017-02-18 14:32:04.773957
NCT00652119|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-08-24|||February 2008||2008-02-01|August 2016|2016-08-01||||February 2018|Anticipated|2018-02-01||Interventional|||Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin|Pilot Trial of Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Treatment of Women With Newly Diagnosed, Optimally Cytoreduced Carcinoma of Mullerian Origin|Active, not recruiting||N/A|46|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:32:04.89221|2017-02-18 14:32:04.89221
NCT00652106|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||June 2003||2003-06-01|April 2008|2008-04-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|432|Actual|Allergan||3|||f||||||||||||||2017-02-18 14:32:05.024751|2017-02-18 14:32:05.024751
NCT00652093|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-02-24|2012-07-10||March 2008||2008-03-01|February 2016|2016-02-01|August 2011|Actual|2011-08-01|November 2010|Actual|2010-11-01||Interventional|LUSTORII||Lumbar Stenosis Outcomes Research II|Lumbar Stenosis Outcomes Research II: Opana IR Versus Placebo and Active Control (Darvocet) for the Treatment of Walking Impairment in Lumbar Spinal Stenosis: A Double-Blind Randomized, Cross-Over Trial|Terminated||Phase 4|24|Actual|University of Rochester|This study terminated early (leading to small number of subjects analyzed) due to US Food and Drug Administration (FDA) removing active control (Darvocet) from the U.S. market.|6||Removal of Darvocet from US market|f||||t||||||||||2017-02-18 14:32:05.140792|2017-02-18 14:32:05.140792
NCT00652080|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2012-07-24|||June 2008||2008-06-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)||Completed||Phase 1/Phase 2|35|Actual|Berg, LLC||1|||f||||t||||||||||2017-02-18 14:32:06.490855|2017-02-18 14:32:06.490855
NCT00652067|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-04-02|||May 2006||2006-05-01|March 2008|2008-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI)|IND for One Patient to Receive Clofazamine for Treatment of MAI|Completed||N/A|1|Actual|Yale University|||1||f||||f||||||||||2017-02-18 14:32:06.58038|2017-02-18 14:32:06.58038
NCT00652054|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-03-17|||June 2005||2005-06-01|March 2011|2011-03-01|October 2007|Actual|2007-10-01|June 2007|Actual|2007-06-01||Interventional|||Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer|An Open-Label, Non-Randomized, Multicenter, Two-Stage, Phase 2 Study of S-1 as 2nd Line Therapy for Patients With Metastatic Pancreatic Cancer Who Have Previously Received 1st Line Treatment With a Gemcitabine Regimen|Completed||Phase 2|39|Actual|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-02-18 14:32:06.659529|2017-02-18 14:32:06.659529
NCT00652041|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-09-16|||January 2007||2007-01-01|September 2011|2011-09-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|TaCyDexVMP7||Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma|Thalidomide-Cyclophosphamide-Dexamethasone in Patients < 75 Years or Velcade-Melfalan-Prednisone (V-MP)/Thalidomide-Cyclophosphamide-Dexamethasone in Patients >75 Years, in Refractary or Relapsed Multiple Myeloma|Completed||Phase 4|40|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 14:32:06.752887|2017-02-18 14:32:06.752887
NCT00652028|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2015-08-07|2015-03-11||November 2008||2008-11-01|August 2015|2015-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||Safety Population: Participants who received any amount of study drug were included in the Safety Population|Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects|A Phase II, Open-Label, Multicenter, Escalating Dose, Study to Determine Pharmacokinetic and Pharmacodynamic Profile of Dexmedetomidine in Pediatric Subjects Ages ≥ 2 Through < 17 Years Old|Completed||Phase 2|69|Actual|Hospira, Inc.||4|||f||||t||||||||||2017-02-18 14:32:06.869678|2017-02-18 14:32:06.869678
NCT00652015|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-09-22|||May 2008||2008-05-01|September 2015|2015-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Molecular and Cellular Mechanisms of the In-stent-thrombosis|Molecular and Cellular Mechanisms of the In-stent-thrombosis. Is it Possible to Predict a In-stent-thrombosis Using Biomarkers?|Withdrawn||N/A|0|Actual|RWTH Aachen University|||2|Recruitment numbers could not at all been achieved in an acceptable period of time|f||||f||||||Samples Without DNA|"~     1 sample of approximately 30 mL blood will be taken from each patient of both study group.~      CD39 and CD73 activity as well as EPC-number and function will be analyzed.~   "|||2017-02-18 14:32:08.131441|2017-02-18 14:32:08.131441
NCT00652002|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-01-21|||July 2002||2002-07-01|January 2011|2011-01-01|January 2004|Actual|2004-01-01|||||Interventional|||Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5|A 12 Week, Randomized, Double-blind, Double-dummy, Placebo-controlled Trial of Symbicort TM (160/4.5mcg) Versus Its Mono-products (Budesonide and Formoterol) in Adolescents (at Least 12 Years of Age) and Adults With Asthma - SPRUCE 160/4.5|Completed||Phase 3|450|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:32:08.23346|2017-02-18 14:32:08.23346
NCT00651989|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-02|||April 2008||2008-04-01|March 2008|2008-03-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Observational|||Agreement Between Spectral Domain and Time Domain Optical Coherence Tomography (OCT)|Agreement in Foveal Thickness Measurements Between Spectralis® and Stratus® Optical Coherence Tomography|Unknown status|Not yet recruiting|N/A|40|Anticipated|G. d'Annunzio University|||1||f||||t||||||||||2017-02-18 14:32:08.332275|2017-02-18 14:32:08.332275
NCT00651976|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2016-07-13|||March 2008||2008-03-01|July 2016|2016-07-01|September 2019|Anticipated|2019-09-01|March 2019|Anticipated|2019-03-01||Interventional|||Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery|Pre-Surgical Trial of Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer (Spore)|Recruiting||N/A|200|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 14:32:08.438038|2017-02-18 14:32:08.438038
NCT00651586|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-07-25|||October 2003||2003-10-01|July 2008|2008-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers||Completed||Phase 2|129|Actual|Allergan||2|||f||||||||||||||2017-02-18 14:32:12.771088|2017-02-18 14:32:12.771088
NCT00651963|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-05-04|||September 2004||2004-09-01|May 2015|2015-05-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)|Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia|Completed||Phase 4|80|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:32:08.584894|2017-02-18 14:32:08.584894
NCT00651950|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2012-06-04|||March 2009||2009-03-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Bench Study of Transcutaneous Hydrocephalic Shunt Flow Sensor Alignment Accuracy and Repeatability|A Flow Monitor for Pediatric Hydrocephalic Shunts - Bench Study of Sensor Alignment Accuracy and Repeatability|Withdrawn||N/A|0|Actual|Transonic Systems Inc.|||1|Withdrawn due to lack of enrollment.|f||||f||||||||||2017-02-18 14:32:08.674917|2017-02-18 14:32:08.674917
NCT00651937|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-01-21|||March 2008||2008-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden|Randomized Phase II Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden in High Risk Patients With Multiple Myeloma or Amyloidosis|Completed||Phase 2|80|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:32:08.786611|2017-02-18 14:32:08.786611
NCT00651924|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-06|2014-09-17||December 2008||2008-12-01|June 2014|2014-06-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional||Phase 2: two individuals completed all 10 sessions of treatment, however, we have baseline measures on 6 individuals (1 dropped after 5 sessions, 2 dropped after 1 session, 1 dropped after 2 sessions and 1 dropped after 4 sessions).|Piloting IVR (Interactive Voice Response) for Chronic Pain Treatment|Piloting Interactive Voice Response Modules for Chronic Pain Treatment|Completed||N/A|27|Actual|VA Office of Research and Development|Difficulty recruiting for phase 2 lead to a small number of subjects analyzed.|2|||f||||f||||||||||2017-02-18 14:32:08.917142|2017-02-18 14:32:08.917142
NCT00651911|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-03-31|||July 2003||2003-07-01|March 2008|2008-03-01|July 2004|Actual|2004-07-01|||||Interventional|||Fasturtec TLS Treatment / Prophylysis|A Multicenter Open Label Study of the Efficacy and Safety of Rasburicase in the Treatment of Prophylysis for Tumor Lysis Syndrome|Completed||Phase 4|45|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:32:09.297841|2017-02-18 14:32:09.297841
NCT00651898|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-02-27|||August 2006||2006-08-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Circulating-water Garment With Forced-air Warming and Circulating-water Mattress During Abdominal Surgery|Comparison of a Circulating-water Garment With a Combination of Forced-air Warming and Circulating-water Mattress Warming During Major Abdominal Surgery|Completed||N/A|50|Actual|The Cleveland Clinic|||2||f||||f||||||||No||2017-02-18 14:32:09.38973|2017-02-18 14:32:09.38973
NCT00651885|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-05-13|||March 2008||2008-03-01|March 2008|2008-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure|A Randomized, Single-Center, Placebo Controlled Study To Assess the Safety of UT-15C (Treprostinil Diethanolamine) Sustained Release (SR) in Patients Undergoing an Infra-Popliteal Endovascular Intervention for the Treatment of Critical Limb Ischemia|Completed||Phase 2|20|Anticipated|Ochsner Health System||2|||f||||f||||||||||2017-02-18 14:32:09.481022|2017-02-18 14:32:09.481022
NCT00651872|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-03-05|||June 2008||2008-06-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Development and Validation of a PTSD-Related Functional Impairment Scale|Development and Validation of a PTSD-Related Functional Impairment Scale|Completed||N/A|740|Actual|Boston VA Research Institute, Inc.|||1||f||||f||||||||||2017-02-18 14:32:09.59135|2017-02-18 14:32:09.59135
NCT00651859|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||November 2002||2002-11-01|April 2008|2008-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 2|111|Actual|Allergan||3|||f||||||||||||||2017-02-18 14:32:09.682788|2017-02-18 14:32:09.682788
NCT00651846|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-12-29|||June 2003||2003-06-01|December 2014|2014-12-01|February 2005|Actual|2005-02-01|||||Interventional|||Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women|Single Center, Double Blind, Randomized, Crossover Study to Investigate the Impact of the Oral Contraceptive Yasmin (30 µg EE / 3 mg DRSP) Compared to Microgynon (30 µg / 150 LNG) on Hemostasis Parameters in 40 Female Volunteers|Completed||Phase 4|43|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:32:09.788668|2017-02-18 14:32:09.788668
NCT00651833|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-03-17|||February 2005||2005-02-01|March 2011|2011-03-01|July 2007|Actual|2007-07-01|October 2006|Actual|2006-10-01||Interventional|||Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer|An Open-Label, Non-Randomized, Multicenter, Three-Stage, Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy for Patients With Advanced Non-Small Cell Lung Cancer (Stage IIIB/Stage IV)|Completed||Phase 2|60|Actual|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-02-18 14:32:09.896945|2017-02-18 14:32:09.896945
NCT00651820|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-06-07|2010-06-04||April 2008||2008-04-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|||Effect of Collagenase on Healing and Scarring|A Randomized, Double-blind, Paired-Comparison of the Effect of Collagenase Santyl® Ointment on Healing and Scarring Characteristics of 600μm Dermatome Wounds|Completed||Phase 4|28|Actual|Healthpoint||2|||f||||f||||||||||2017-02-18 14:32:09.992496|2017-02-18 14:32:09.992496
NCT00651807|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-02-03|||March 2008||2008-03-01|February 2015|2015-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)|Phase II, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Efficacy and Safety of Org 3236 Tablets in Men With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia (BPH)|Terminated||Phase 2|16|Actual|Merck Sharp & Dohme Corp.||2||Business Reasons|f||||f||||||||||2017-02-18 14:32:10.280471|2017-02-18 14:32:10.280471
NCT00651794|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-01-07|||June 2007||2007-06-01|January 2011|2011-01-01|January 2010|Anticipated|2010-01-01|May 2009|Actual|2009-05-01||Interventional|||Improving Teamwork for Neonatal Resuscitation|Improving Teamwork for Neonatal Resuscitation|Unknown status|Active, not recruiting|N/A|104|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||f||||||||||2017-02-18 14:32:10.391253|2017-02-18 14:32:10.391253
NCT00005184|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||December 1985||1985-12-01|May 2000|2000-05-01|November 1989|Actual|1989-11-01|||||Observational|||Immunogenetic Factors of Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:23.28649|2017-02-18 18:15:23.28649
NCT00651781|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-02-27|||April 2008||2008-04-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia|A Phase I/II National, Open-label, Multicenter Study of Bortezomib (Velcade) in Combination With FLAG-IDA (VFLAG- IDA) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML).|Completed||Phase 1/Phase 2|40|Actual|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 14:32:10.491016|2017-02-18 14:32:10.491016
NCT00651768|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-01-21|||August 2003||2003-08-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|||||Interventional|||Titratable Dosing in Moderate to Severe Asthmatics|A 52 wk Randomized, Doubleblind, Single Dummy, Parallel Group Multicenter Phase 3 Study Comparing the Long Term Safety of Symbicort pMDI 4x160/4.5mcg Bid to SymbicortpMDI 2x160/4.5mcg Bid & Budesonide HFA pMDI 4x160mcg Bid in Adult and Adolescent Subjects With Asthma|Completed||Phase 3|570|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:32:10.613165|2017-02-18 14:32:10.613165
NCT00651755|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-06-28|2013-02-08||March 2008||2008-03-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients|Evaluation of Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Patients With Non-Hodgkin's Lymphoma|Completed||N/A|23|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:32:10.713285|2017-02-18 14:32:10.713285
NCT00651742|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-06-04||2013-06-04|February 2006||2006-02-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer|An Open-Label, Non-Randomized, Multicenter, Two-Stage, Phase 2 Study of S-1 in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|28|Actual|Taiho Oncology, Inc.||1|||f||||f||||||||||2017-02-18 14:32:11.114169|2017-02-18 14:32:11.114169
NCT00651729|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-05-23|||April 2003||2003-04-01|May 2008|2008-05-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity||Completed||Phase 2|279|Actual|Allergan||1|||f||||||||||||||2017-02-18 14:32:11.208068|2017-02-18 14:32:11.208068
NCT00651716|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-02|2016-06-22|||December 2006||2006-12-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|October 2018|Anticipated|2018-10-01||Observational|||T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant|Regulatory T Cells at Engraftment as Predictors of Acute Graft-Versus-Host Disease Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation|Suspended||N/A|200|Anticipated|Vanderbilt-Ingram Cancer Center|||1|Funding unavailable|f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 14:32:11.32343|2017-02-18 14:32:11.32343
NCT00651703|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2010-11-11|||April 2008||2008-04-01|November 2010|2010-11-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients|Safety, Tolerability, and Immunogenicity of CYT004-MelQbG10 Vaccine With or Without Immunostimulating Adjuvant in HLA-A2 Positive Patients With Stage III/IV Malignant Melanoma|Completed||Phase 2|21|Actual|Cytos Biotechnology AG||4|||f||||f||||||||||2017-02-18 14:32:11.44709|2017-02-18 14:32:11.44709
NCT00651690|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-05-23|||March 2004||2004-03-01|May 2008|2008-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment||Completed||Phase 2|62|Actual|Allergan||2|||f||||||||||||||2017-02-18 14:32:11.538007|2017-02-18 14:32:11.538007
NCT00651677|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-04-18|||April 2011||2011-04-01|April 2011|2011-04-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||"Hand Assisted Versus Pure Laparoscopic Assisted Proctectomy for Rectal Cancer"|"A Multicenter Prospective Randomized Study Comparing Hand Assisted Versus Pure Laparoscopic Assisted Proctectomy for Rectal Cancer"|Unknown status|Recruiting|N/A|128|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:32:11.639763|2017-02-18 14:32:11.639763
NCT00651664|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-11-15|||October 2007||2007-10-01|November 2013|2013-11-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|||A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Patients With Advanced Malignancies|A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Patients With Advanced Malignancies|Completed||Phase 1|59|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:32:11.744408|2017-02-18 14:32:11.744408
NCT00651651|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2011-01-21|||August 2002||2002-08-01|January 2011|2011-01-01|September 2003|Actual|2003-09-01|||||Interventional|||Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5|A 12 Week Randomized, Double-blind, Double-Dummy, Placebo-controlled Trial of Symbicort TM (160/4.5mcg) Versus Its Mono-Products (Budesonide and Formoterol) in Children (at Least 6years of Age) and Adults With Asthma-SPRUCE 80/4.5|Completed||Phase 3|450|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:32:11.931421|2017-02-18 14:32:11.931421
NCT00651638|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-06-18|||March 2008||2008-03-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||A Study of ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) Genotype|A Study of ARQ 197 in Healthy Volunteers to Assess the Pharmacokinetic (PK) Profile in Extensive and Poor Metabolizers as Defined by Cytochrome P450 2C19 (CYP 2C19) Genotype|Completed||Phase 1|17|Actual|ArQule||1|||f||||f||||||||||2017-02-18 14:32:12.025468|2017-02-18 14:32:12.025468
NCT00651625|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-02-02|2013-06-05||November 2004||2004-11-01|February 2016|2016-02-01|August 2010|Actual|2010-08-01|January 2010|Actual|2010-01-01||Interventional|RPD||Reciprocating Medical Devices - a Study of a New Safety Device|Randomized Controlled Trial of the Reciprocating Procedure Device Versus the Conventional Syringe in Syringe-and-Needle Procedures|Completed||N/A|437|Actual|University of New Mexico|no adverse events|2|||f||||t||||||||No||2017-02-18 14:32:12.120898|2017-02-18 14:32:12.120898
NCT00651612|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2008-04-01|||November 2005||2005-11-01|April 2008|2008-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients||Completed||Phase 3|604|Actual|Allergan||2|||f||||||||||||||2017-02-18 14:32:12.550478|2017-02-18 14:32:12.550478
NCT00651599|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-12-30|||July 2004||2004-07-01|December 2014|2014-12-01|May 2005|Actual|2005-05-01|||||Interventional|||Treatment of Vasomotor Symptoms in Korean Post Menopausal Women|A Double-blind, Randomized, Placebo-controlled, Multicenter Study Investigating the Efficacy and Tolerability of Angeliq(drospirenon2mg and Estradiol 1mg) in Postmenopausal Korean Women With Vasomotor Symptoms Over 3, 28 Day Treatment Cycle|Completed||Phase 3|90|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:32:12.660896|2017-02-18 14:32:12.660896
NCT00651573|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-12-04|||March 2007||2007-03-01|December 2013|2013-12-01|July 2014|Anticipated|2014-07-01|March 2014|Anticipated|2014-03-01||Interventional|||Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery|Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery|Unknown status|Recruiting|N/A|1300|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 14:32:12.88186|2017-02-18 14:32:12.88186
NCT00651560|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-05-13|||November 2005||2005-11-01|May 2016|2016-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)|Vytorin As Strategy To Reduce Dislipidemia In Adults|Completed||Phase 3|167|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:32:13.132072|2017-02-18 14:32:13.132072
NCT00651547|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2009-03-27|||July 2002||2002-07-01|March 2009|2009-03-01|October 2003|Actual|2003-10-01|||||Interventional|||Symbicort in Asthmatic Children - SEEDLING|A 12 Week Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial of Symbicort TM (40/4.5 Mcg) Versus Its Mono-Products (Budesonide and Formoterol) in Asthmatic Children Aged Six to Eleven Years - SEEDLING 40/4.5|Completed||Phase 3|405|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:32:13.219592|2017-02-18 14:32:13.219592
NCT00651534|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-04-28|||February 2008||2008-02-01|April 2016|2016-04-01||||||||Interventional|||To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females|An Open-label, Randomized, Five Period Crossover Study to Estimate the Relative Bioavailability of Five Formulations of 400 mg Ronacaleret (a Calcium-sensing Receptor Antagonist) Administered as a Single Oral Dose to Healthy Postmenopausal Females.|Completed||Phase 1|32||GlaxoSmithKline|||||||||f||||||||||2017-02-18 14:32:13.30724|2017-02-18 14:32:13.30724
NCT00651521|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2013-12-24|||April 2009||2009-04-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|||||Observational|||Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease Patients|Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease Patients|Unknown status|Recruiting|N/A|1000|Anticipated|Chang Gung Memorial Hospital|||6||f||||t||||||||||2017-02-18 14:32:13.397616|2017-02-18 14:32:13.397616
NCT00651508|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2016-04-19||2010-09-10|April 2008||2008-04-01|April 2016|2016-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|Open Label, Multi-center, Phase 2 Study of KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Previously Treated With First-Line Chemotherapy|Completed||Phase 2|1|Actual|Bristol-Myers Squibb||1|||t||||||||||||||2017-02-18 14:32:13.507939|2017-02-18 14:32:13.507939
NCT00651495|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-11-23|||April 2008||2008-04-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Activating Seniors to Improve Chronic Disease Care|Activating Seniors to Improve Chronic Disease Care|Completed||N/A|116|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:32:13.627017|2017-02-18 14:32:13.627017
NCT00651482|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2014-06-30|2014-06-30||August 2008||2008-08-01|June 2014|2014-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)|Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)|Terminated||Phase 2|10|Actual|Stanford University||1||slow accrual|f||||t||||||||||2017-02-18 14:32:13.74215|2017-02-18 14:32:13.74215
NCT00651469|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2014-12-29|||January 2003||2003-01-01|December 2014|2014-12-01|July 2004|Actual|2004-07-01|||||Interventional|||Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety & Efficacy of Oral Contraceptive Prep., Containing Drospirenone 3 mg/Ethinyl Estradiol 20 Mcg for 6 Treatment Cycles in Women With Moderate Acne Vulgaris.|Completed||Phase 3|534|Actual|Bayer||2|||t||||||||||||||2017-02-18 14:32:14.217615|2017-02-18 14:32:14.217615
NCT00651456|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-29|2016-09-01|||February 2008||2008-02-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|January 2015|Actual|2015-01-01||Interventional|MAPS||Mesothelioma Avastin Plus Pemetrexed-cisplatin Study|A Phase II-III Randomized Trial Pemetrexed-Cisplatin Chemotherapy With or Without Bevacizumab (Avastin), 15 mg/kg, for Malignant Pleural Mesothelioma (MPM)|Completed||Phase 2/Phase 3|448|Actual|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||t||||||||Undecided||2017-02-18 14:32:14.363323|2017-02-18 14:32:14.363323
NCT00651443|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-01-06|||August 2008||2008-08-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma|A Phase I, Open Label Study to Evaluate the Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma|Terminated||Phase 1|20|Anticipated|Biogen||1||"A company's strategic decision to focus on areas whereit believes it can be competitive and~   decided to exit Oncology"|f||||f||||||||||2017-02-18 14:32:14.567688|2017-02-18 14:32:14.567688
NCT00651430|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2010-06-10|||March 2008||2008-03-01|December 2007|2007-12-01|May 2010|Actual|2010-05-01|May 2008|Actual|2008-05-01||Observational|||Physical Functioning Following Total Hip Arthroplasty|Step Execution, Stability, Quality of Life, Fear of Falling and Their Association Following Total Hip Arthroplasty|Completed||N/A|30|Anticipated|Soroka University Medical Center|||1||f||||f||||||None Retained|"~     no biospecimens are to be retained~   "|||2017-02-18 14:32:14.660663|2017-02-18 14:32:14.660663
NCT00651417|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-06-21|||April 2005||2005-04-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue|A Phase II, Pilot, Randomized, Double-blind Study Comparing the Effectiveness Organic Germanium to Placebo in Decreasing the Severity of Fatigue in Patients Undergoing Radiation Therapy for Prostae and Bbreast Cancers|Unknown status|Recruiting|Phase 2|101|Anticipated|Arizona Oncology Services||2|||f||||t||||||||||2017-02-18 14:32:14.760548|2017-02-18 14:32:14.760548
NCT00651404|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-07|||January 2004||2004-01-01|April 2015|2015-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)|A Multicenter, Randomized, Parallel Groups, Placebo-Controlled Study Comparing The Efficacy, Safety, And Tolerability Of The Daily Co-administration Of Ezetimibe 10 mg Or Ezetimibe Placebo To Ongoing Treatment With Atorvastatin 10 mg In Subjects With Primary Hypercholesterolemia And Coronary Heart Disease.|Completed||Phase 3|137|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:32:14.870561|2017-02-18 14:32:14.870561
NCT00651391|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-15|||October 2003||2003-10-01|April 2015|2015-04-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Ezetimibe Plus Simvastatin Compared With Simvastatin Alone on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (The EFFECTS Trial)|Terminated||Phase 3|28|Actual|Merck Sharp & Dohme Corp.||3||Slow enrollment|f||||f||||||||||2017-02-18 14:32:14.958745|2017-02-18 14:32:14.958745
NCT00651378|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-28|||September 2004||2004-09-01|April 2015|2015-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)|"An Open-Label, Randomized, Parallel-Group, Multicenter Study to Compare the Efficacy and Safety of Switching to Rosuvastatin 10 mg Daily Versus Atorvastatin 10 mg Daily With Ezetimibe 10 mg Daily Versus Doubling the Dose of Atorvastatin to 20 mg Daily in Subjects With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease or Diabetes Mellitus Who Have Not Achieved Study Target LDL-C Goal While Dosing With Atorvastatin 10 mg Daily"|Terminated||Phase 4|87|Actual|Merck Sharp & Dohme Corp.||3||Slow enrollment [HIGH SCREEN FAILURE RATE]|f||||f||||||||||2017-02-18 14:32:15.044597|2017-02-18 14:32:15.044597
NCT00651365|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-03-07|||February 2008||2008-02-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Safety and Dose-finding Study of JNJ-38877605 in Patients With Advanced or Refractory Solid Tumors.|A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of the Selective Met Inhibitor JNJ-38877605 in Subjects With Advanced or Refractory Solid Tumors|Terminated||Phase 1|14|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1||Early termination due to increase in serum creatinine levels and minimal PD activity.|f||||t||||||||||2017-02-18 14:32:15.12968|2017-02-18 14:32:15.12968
NCT00651352|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2014-11-20|||February 2008||2008-02-01|June 2014|2014-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges|A Single Dose Bioequivalence Study of 2mg and 4mg Nicotine Lozenges|Completed||Phase 1|32|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 14:32:15.226507|2017-02-18 14:32:15.226507
NCT00651339|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2010-04-12|||February 2008||2008-02-01|February 2008|2008-02-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Observational|||The Effect of Botox Injection on Postural Stability of Cerebral Palsy (CP) Children||Terminated||N/A|20|Anticipated|Soroka University Medical Center|||1|recruiting or enrolling participants has halted prematurely and will not resume|f||||t||||||||||2017-02-18 14:32:15.323228|2017-02-18 14:32:15.323228
NCT00651326|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2012-12-17|||March 2008||2008-03-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|||||Interventional|||Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer|A Phase III Study of Neoadjuvant Docetaxel and Androgen Suppression Plus Radiation Therapy Versus Androgen Suppression Alone Plus Radiation Therapy for High-Risk Localized Adenocarcinoma of the Prostate (DART)|Terminated||Phase 3|48|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 14:32:15.425203|2017-02-18 14:32:15.425203
NCT00651313|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2012-02-16|2011-06-07||August 2007||2007-08-01|February 2012|2012-02-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|Lidocaine 04||Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods)|A Phase II, Double-Blind, Crossover Study to Assess the Efficacy and Safety of 10% (150mg) Lidocaine Vaginal Gel Administered to Women With Recurrent Dysmenorrhea|Completed||Phase 2|81|Actual|Juniper Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 14:32:15.648893|2017-02-18 14:32:15.648893
NCT00651300|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2009-06-08|||April 2003||2003-04-01|June 2009|2009-06-01|March 2004|Actual|2004-03-01|||||Interventional|||A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery|A Multicentre, Double-Blind, Placebo-Controlled Study of the Recovery Benefits Following Treatment With a Cox-2 Regimen in Patients Undergoing Elective Laparoscopic Intra-Peritoneal Abdominal Surgery|Terminated||Phase 3|91|Actual|Pfizer||2||See Detailed Description field.|f||||f||||||||||2017-02-18 14:32:16.025735|2017-02-18 14:32:16.025735
NCT00651287|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-04-07|||December 2002||2002-12-01|March 2008|2008-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension|A 12-Week Open-Label, Uncontrolled Multicenter Study to Assess the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Subjects With Mild to Moderate Hypertension|Completed||Phase 4|200|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:32:16.137045|2017-02-18 14:32:16.137045
NCT00651274|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-15|||April 2003||2003-04-01|April 2015|2015-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)|A Multicenter, Randomized, Parallel Groups, Placebo-Controlled Study Comparing The Efficacy, Safety, And Tolerability Of The Daily Co-administration Of Ezetimibe 10 Mg Or Ezetimibe Placebo To Ongoing Treatment With Simvastatin 20 Mg In Subjects With Primary Hypercholesterolemia And Coronary Heart Disease|Completed||Phase 4|144|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:32:16.242253|2017-02-18 14:32:16.242253
NCT00651261|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2016-12-12|2016-12-12||April 2008||2008-04-01|December 2016|2016-12-01||||July 2016|Actual|2016-07-01||Interventional|||Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 3|717|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 14:32:16.385517|2017-02-18 14:32:16.385517
NCT00651248|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-03-31|||September 2006||2006-09-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|||||Observational|||Evaluation of Salivary Flow and Buffer Capacity Associated to Aged People's Oral Health|Evaluation of Salivary Flow and Buffer Capacity Associated to Aged People's Oral Health|Completed||N/A|68|Actual|Academia Cearense de Odontologia|||1||f||||t||||||||||2017-02-18 14:32:23.906021|2017-02-18 14:32:23.906021
NCT00647764|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2012-05-15|||March 2008||2008-03-01|May 2012|2012-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas|Phase 1 Study Of SNX-5422 Mesylate In Adults With Refractory Solid Tumor Malignancies And Lymphomas|Completed||Phase 1|32|Actual|Esanex Inc.||1|||f||||f||||||||||2017-02-18 14:33:15.773045|2017-02-18 14:33:15.773045
NCT00651235|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2010-06-08|||February 2007||2007-02-01|June 2010|2010-06-01|June 2011|Anticipated|2011-06-01|February 2011|Anticipated|2011-02-01||Interventional|MFS||A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome|A Randomized, Open-label, Active Control Trial to Evaluate the Effect of LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome|Unknown status|Recruiting|Phase 2|44|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 14:32:23.984729|2017-02-18 14:32:23.984729
NCT00651222|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-03-31||||||March 2008|2008-03-01||||||||Observational|||Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy|Influence of Androgen Suppression Therapy for Prostate Cancer on the Timing and Onset of Fatal Myocardial Infarctions in Men Undergoing Prostate Brachytherapy|Completed||N/A|||Prostate Cancer Foundation of Chicago|||1||f||||f||||||||||2017-02-18 14:32:24.088233|2017-02-18 14:32:24.088233
NCT00651209|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-03-06|||February 2008||2008-02-01|March 2014|2014-03-01||||December 2011|Actual|2011-12-01||Interventional|||A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)|A Single-arm, Multinational, Two Year Study Evaluating the Efficacy and Safety of lead-in Telbivudine for 24 Weeks With or Without Tenofovir Treatment Intensification in Adult Patients With HBeAg-positive Chronic Hepatitis B.|Completed||Phase 4|105|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:32:24.178384|2017-02-18 14:32:24.178384
NCT00651196|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2013-03-14|||January 2008||2008-01-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|DMB||Bone Health in Type 1 Diabetes|Pilot Study - Type 1 Diabetes and Bone Health|Completed||N/A|60|Anticipated|Creighton University|||2||f||||f||||||Samples Without DNA|"~     Transilial bone specimens are retained for measurements~   "|||2017-02-18 14:32:24.289766|2017-02-18 14:32:24.289766
NCT00651183|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2014-05-09|2009-12-14|||||May 2014|2014-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational||Safety set (SAF)|Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment|Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment|Completed||Phase 4|286|Actual|Boehringer Ingelheim|||1||||||||||||||||2017-02-18 14:32:24.406149|2017-02-18 14:32:24.406149
NCT00651170|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-09-23|||March 2008||2008-03-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|Echoalr||Diffusion of Local Anesthetic After Median Nerve Block|Can Ultrasound Predict Success of Median Nerve Block? Relationship Between Diffusion of Local Anesthetic and Effectiveness of a Nerve Block|Completed||N/A|103|Actual|Hopital Foch|||1||f||||f||||||||No||2017-02-18 14:32:25.03505|2017-02-18 14:32:25.03505
NCT00651157|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-03-21|2013-08-05||April 2008||2008-04-01|February 2014|2014-02-01|October 2012|Actual|2012-10-01|December 2011|Actual|2011-12-01||Interventional|||Viral Therapy in Treating Patients With Metastatic Melanoma|A Phase II Trial of Intravenous Administration of Reovirus Serotype 3 - Dearing Strain (Reolysin®) in Patients With Metastatic Melanoma|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:32:25.131676|2017-02-18 14:32:25.131676
NCT00651144|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-15|||March 2003||2003-03-01|April 2015|2015-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)|SCH 058235: Assessment of a Multiple-Dose Drug Interaction Between Ezetimibe and Rosuvastatin in Healthy Hypercholesterolemic Subjects|Completed||Phase 1|40|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 14:32:25.429996|2017-02-18 14:32:25.429996
NCT00651131|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2009-06-24|||June 2004||2004-06-01|June 2009|2009-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|PSW||Cubicin(R) for Complicated Post-Surgical Wound Infections|Cubicin(R) for Complicated Post-Surgical Wound Infections|Terminated||Phase 4|69|Actual|Cubist Pharmaceuticals LLC||1||terminated due to slow enrollment|f||||f||||||||||2017-02-18 14:32:25.528261|2017-02-18 14:32:25.528261
NCT00651118|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2012-08-27|2012-05-10||March 2008||2008-03-01|August 2012|2012-08-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies|Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Azelastine Hydrochloride Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis|Completed||Phase 3|832|Actual|Meda Pharmaceuticals||4|||f||||f||||||||||2017-02-18 14:32:25.631536|2017-02-18 14:32:25.631536
NCT00651105|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-11-16|||February 2008||2008-02-01|November 2016|2016-11-01||||May 2009|Actual|2009-05-01||Interventional|||Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects|A Double-blind, Placebo-controlled, Randomized, Cross-over Study to Evaluate the GLP-1-mediated and Non-GLP-1-mediated Effects of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects|Completed||Phase 3|63|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:32:26.291997|2017-02-18 14:32:26.291997
NCT00651092|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-04-01|||March 2008||2008-03-01|March 2008|2008-03-01|January 2010|Anticipated|2010-01-01|May 2008|Anticipated|2008-05-01||Interventional|||Inferior Submucosal Turbinectomy Versus Blunt Turbinectomy for Inferior Turbinate Hypertrophy|to Compare Two Well Popularized Methods of Inferior Nasal Turbinectomy|Unknown status|Not yet recruiting|N/A|50|Anticipated|Soroka University Medical Center||2|||f||||f||||||||||2017-02-18 14:32:26.404946|2017-02-18 14:32:26.404946
NCT00651079|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2010-10-14||2010-10-14|February 2008||2008-02-01|October 2010|2010-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||GSK1247303 First Time in Human Study|A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single and Repeat Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1247303 in Healthy Male and Female Subjects|Terminated||Phase 1|58|Anticipated|GlaxoSmithKline||1|||||||||||||||||2017-02-18 14:32:26.620121|2017-02-18 14:32:26.620121
NCT00651066|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2013-07-16|||June 2010||2010-06-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam|Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in the Treatment of Tuberculosis Patient With HIV Infection in Vietnam : A Phase II Trial|Completed||Phase 2|47|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 14:32:26.722774|2017-02-18 14:32:26.722774
NCT00475267|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-03-09|||May 2007||2007-05-01|November 2009|2009-11-01|January 2012|Actual|2012-01-01|July 2010|Actual|2010-07-01||Interventional|||Aortic Valve Replacement With Trifecta(TM)|An Observational, Prospective Evaluation of the Trifecta Valve|Completed||N/A|203|Actual|St. Jude Medical||1|||f||||t||||||||||2017-02-18 15:36:37.705639|2017-02-18 15:36:37.705639
NCT00651053|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2016-02-02|||May 2005||2005-05-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|||||Interventional|||Endoscopic Ultrasound Compared With Pancreatic Function Testing for Diagnosis of Chronic Pancreatitis|Validation of Endoscopic Ultrasound Criteria for Diagnosis of Chronic Pancreatitis Using Dual Secretin and Cholecystokinin Pancreatic Function Testing as Reference Standard|Completed||N/A|70|Actual|The Cleveland Clinic||1|||||||f||||||||||2017-02-18 14:32:26.841197|2017-02-18 14:32:26.841197
NCT00651040|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-04-06|2015-10-29||May 2008||2008-05-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|Prometheus||Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM|A Prospective, Randomised, Assessor-blind, Multicenter Study of Efficacy and Safety of Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With Polymyositis and Dermatomyositis.|Completed||Phase 3|31|Actual|Institute of Rheumatology, Prague||2|||f||||f||||||||||2017-02-18 14:32:26.935442|2017-02-18 14:32:26.935442
NCT00651027|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2014-01-02|||February 2008||2008-02-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554|An Open Label Study, To Evaluate The Pharmacokinetics, Safety And Toleration Of A Single Oral Dose Of Pf-00868554 In Subjects With Hepatic Impairment To Subjects With Normal Hepatic Function|Completed||Phase 1|24|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:32:27.348176|2017-02-18 14:32:27.348176
NCT00651014|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-15|||January 2004||2004-01-01|April 2015|2015-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Co-administered With Existing Simvastatin 10mg or 20mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease and/or Type II Diabetes|Terminated||Phase 4|82|Actual|Merck Sharp & Dohme Corp.||2||"slow subject recruitment and lack of medical and scientific merit due to change in new~   standard of therapy during that same period."|f||||t||||||||||2017-02-18 14:32:27.45979|2017-02-18 14:32:27.45979
NCT00651001|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2009-08-03|||June 2008||2008-06-01|August 2009|2009-08-01|June 2009||2009-06-01|January 2009|Actual|2009-01-01||Observational|||Metabolic Syndrome and Leptin Level Associated With Fructose Consumption in Spain|Prevalence of Cardiovascular Risk Factors in Minorca - Spain|Completed||N/A|800|Anticipated|Hospital Mateo Orfila|||1||f||||f||||||Samples Without DNA|"~     Serum and urine collections.~   "|||2017-02-18 14:32:27.554295|2017-02-18 14:32:27.554295
NCT00650988|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2012-12-21|||September 2005||2005-09-01|December 2012|2012-12-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers|A Pilot Study of Cryotherapy for Barrett's Esophagus With High-Grade Dysplasia and Early Esophageal Cancers|Completed||Early Phase 1|37|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 14:32:27.64005|2017-02-18 14:32:27.64005
NCT00650975|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-01-19|||March 2008||2008-03-01|January 2011|2011-01-01|January 2010|Actual|2010-01-01|||||Interventional|TAAMI||ThromboAblation in Acute Myocardial Infarction|ThromboAblation in Acute Myocardial Infarction|Terminated||Phase 2/Phase 3|78|Actual|KCRI||2||Slow enrollment rate.|f||||t||||||||||2017-02-18 14:32:27.748761|2017-02-18 14:32:27.748761
NCT00650962|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2012-01-02|||February 2008||2008-02-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|CPR||Pre-shock Cardiopulmonary Resuscitation to Patients With Out-of-hospital Resuscitation, A Randomised Clinical Trial|Does Longer Pre-shock Cardiopulmonary Resuscitation Improve the Outcome of Patients With Out-of-hospital Cardiac Arrest? A Randomized Control Trial.|Completed||N/A|1666|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 14:32:28.018607|2017-02-18 14:32:28.018607
NCT00650949|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2013-04-25||2013-04-25|November 2009||2009-11-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma|A Phase Ib/II Study of CYT997 in Combination With Carboplatin in Relapsed Glioblastoma Multiforme|Terminated||Phase 1/Phase 2|20|Actual|Gilead Sciences||1||Strategic|f||||t||||||||||2017-02-18 14:32:28.137711|2017-02-18 14:32:28.137711
NCT00650936|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-01-30|||August 2007||2007-08-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study||Unknown status|Active, not recruiting|N/A|1000|Anticipated|St. Jude Medical||1|||f||||f||||||||||2017-02-18 14:32:28.256644|2017-02-18 14:32:28.256644
NCT00650923|ClinicalTrials.gov processed this data on February 17, 2017|2008-04-01|2014-05-29|||July 2008||2008-07-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma|Phase I Trial of Aflibercept (VEGF Trap) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Glioma|Completed||Phase 1|61|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:32:28.404907|2017-02-18 14:32:28.404907
NCT00650910|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2012-05-31|||April 2008||2008-04-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer|An Open-Label, Two-Part, Single Sequence Study to Examine the Effects of Lapatinib on the Pharmacokinetics of Orally Administered Digoxin in Subjects With Metastatic ErbB2 Positive Breast Cancer|Completed||Phase 1|17|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:32:28.546157|2017-02-18 14:32:28.546157
NCT00650897|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-30|||April 2008||2008-04-01|March 2008|2008-03-01|October 2009|Anticipated|2009-10-01|June 2009|Anticipated|2009-06-01||Interventional|EFDID||Efficacy Study of Escitalopram for Depression in Patients With Diabetes|Escitalopram Treatment of Major Depression in Diabetes Mellitus: An Open Label|Unknown status|Not yet recruiting|Phase 4|30|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 14:32:28.660961|2017-02-18 14:32:28.660961
NCT00650884|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2012-04-27|||February 2008||2008-02-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Plantar Fasciitis Treated With Dynamic Splinting|Plantar Fasciopathy Treated With Dynamic Splinting: A Randomized, Controlled, Cross-Over Study|Completed||N/A|66|Anticipated|Dynasplint Systems, Inc.||3|||f||||t||||||||||2017-02-18 14:32:28.772971|2017-02-18 14:32:28.772971
NCT00201552|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-19||||||September 2005|2005-09-01||||||||Interventional|||Statin and PAF in Patients With Pacemaker|Atorvastatin Decreases Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation|Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:12:18.968906|2017-02-18 17:12:18.968906
NCT00650871|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2009-05-15|||July 2004||2004-07-01|May 2009|2009-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia|Completed||Phase 2|48|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 14:32:28.910943|2017-02-18 14:32:28.910943
NCT00650858|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-06-13|2009-03-12||February 2004||2004-02-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|CLEAR IVH||Clinical Trial on Treatment of Intraventricular Hemorrhage|Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (IVH)|Completed||Phase 2|52|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 14:32:29.02878|2017-02-18 14:32:29.02878
NCT00650845|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2015-05-21|2015-03-11||January 2008||2008-01-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|RESCUE||Renal Safety Evaluation After Dotarem®-Enhanced MRI|Renal Safety Evaluation After Dotarem®-Enhanced MRI Compared With Non-enhanced MRI in Patients at High Risk of Developing Contrast Medium Induced Nephropathy|Completed||Phase 4|135|Actual|Guerbet||2|||f||||t||||||||||2017-02-18 14:32:29.817864|2017-02-18 14:32:29.817864
NCT00650832|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2011-06-02||2011-06-02|October 2003||2003-10-01|June 2011|2011-06-01|July 2007|Actual|2007-07-01|February 2005|Actual|2005-02-01||Interventional|||TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.|A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Subjects, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.|Completed||Phase 2|334|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-02-18 14:32:30.388416|2017-02-18 14:32:30.388416
NCT00650819|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-08|||June 2004||2004-06-01|April 2015|2015-04-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)|A Multicenter, Double-blind, Randomized, Active-controlled Parallel Groups Study Comparing The Efficacy and Safety of The Daily Co-Administration of Ezetimibe 10 mg With Simvastatin 20 mg Vs Simvastatin Or Ezetimibe Alone in Subjects With Primary Hypercholesterolemia|Completed||Phase 3|240|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:32:30.577518|2017-02-18 14:32:30.577518
NCT00650806|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-04-01|2013-04-01||May 2008||2008-05-01|April 2013|2013-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Investigate the Safety and Efficacy of JNJ-28431754 in Nondiabetic Overweight and Obese Subjects|Completed||Phase 2|376|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||f||||||||||2017-02-18 14:32:30.682265|2017-02-18 14:32:30.682265
NCT00650793|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-06-06|||March 2004||2004-03-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia|A Randomized, DB, PC and AC, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of 3 Fixed Dosages of Extended Release OROS� Paliperidone (6, 9, 12 mg/Day) and Olanzapine (10 mg/Day), With Open-Label Extension, in the Treatment of Subjects With Schizophrenia - Open Label Phase|Completed||Phase 3|473|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:32:31.761343|2017-02-18 14:32:31.761343
NCT00650780|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-04-01|||October 2007||2007-10-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|Gc||Vitamin D Binding Protein (Gc) Allele Variation Effects Response to Vitamin D Treatment|Vitamin D Binding Protein (Gc) Allele Variation Effects Response to Vitamin D Treatment|Completed||N/A|29|Actual|Creighton University|||1||f||||f||||||||||2017-02-18 14:32:31.854202|2017-02-18 14:32:31.854202
NCT00650767|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2016-09-20|2016-07-21||March 2008||2008-03-01|September 2016|2016-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||Baseline Demographics represent the Intent-to-Treat (ITT) population, which is all patients who were randomized to a treatment group.|A Study of ARRY-438162 in Patients With Rheumatoid Arthritis||Completed||Phase 2|201|Actual|Array BioPharma||4|||f||||t||||||||||2017-02-18 14:32:31.997818|2017-02-18 14:32:31.997818
NCT00650754|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-09-28|||March 2008||2008-03-01|September 2015|2015-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|DHEAFert||Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility|A Randomized Double Blinded Trail of DHEA Supplementation for Treatment of Couples With Normal Hysterosalpingogram and Normal Semen Analysis and Evidence of Premature Ovarian Aging (POA).|Terminated||Phase 2/Phase 3|35|Actual|Center for Human Reproduction||2||Failure to recruit designed nuimebrt of subjects|f||||f||||||||||2017-02-18 14:32:37.658084|2017-02-18 14:32:37.658084
NCT00650741|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-30|||February 2008||2008-02-01|March 2008|2008-03-01||||||||Observational|||Evaluation of a New Non-Invasive Device for Detection of Endothelial Dysfunction|Evaluation of a New Non-Invasive Device for Detection of Endothelial Dysfunction|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Lavi Cardiatec|||3||f||||f||||||||||2017-02-18 14:32:37.775011|2017-02-18 14:32:37.775011
NCT00650728|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2011-06-22|||March 2008||2008-03-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Esophagus Imaging for Radiofrequency Ablation of Atrial Fibrillation|Esophagus Imaging for Radiofrequency Ablation of Atrial Fibrillation: Comparison of Two Methods|Completed||N/A|||Luzerner Kantonsspital||1|||f||||t||||||||||2017-02-18 14:32:37.858192|2017-02-18 14:32:37.858192
NCT00650715|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-03-31|||December 2004||2004-12-01|March 2008|2008-03-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Effects of Whole-Body Vibration Exercise on Serum IGF-1 in Fibromyalgia|Effect of Acute and Chronic Whole-Body Vibration Exercise on Serum Insulin-Like Growth Factor-1 Levels in Women With Fibromyalgia|Completed||N/A|24|Actual|Institut Nacional d'Educacio Fisica de Catalunya||2|||f||||||||||||||2017-02-18 14:32:37.957296|2017-02-18 14:32:37.957296
NCT00650156|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2010-11-11|||June 2007||2007-06-01|September 2010|2010-09-01||||October 2007|Actual|2007-10-01||Interventional|||Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis|A Randomized, Parallel-group, Open-Label, Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis.|Completed||Phase 1|24|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:32:46.159479|2017-02-18 14:32:46.159479
NCT00650702|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2013-09-16||2011-02-23|March 2008||2008-03-01|March 2011|2011-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|CORE||Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension|A Phase II, Randomized, Masked, Parallel-Group Study of Safety and Preliminary Efficacy of the Punctum Plug Delivery System in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|36|Actual|Mati Therapeutics Inc.||3|||f||||f||||||||||2017-02-18 14:32:38.053284|2017-02-18 14:32:38.053284
NCT00650689|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-07-03|||May 2003||2003-05-01|July 2015|2015-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)|A Multicenter, Randomized, Parallel Groups, Placebo-controlled Study Comparing the Efficacy, Safety, and Tolerability of the Daily Coadministration of Ezetimibe 10 mg With Atorvastatin 10 mg in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease for Whom Diet and Exercise Have Failed.|Completed||Phase 3|122|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:32:38.19397|2017-02-18 14:32:38.19397
NCT00650676|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2010-09-19|||January 2008||2008-01-01|September 2010|2010-09-01|June 2010|Actual|2010-06-01|March 2009|Actual|2009-03-01||Observational|||The Effect of Somatosensory Cue on Postural Stability in Blinded Persons|The Effect of Somatosensory Cue on Postural Stability in Blinded Persons|Completed||N/A|60|Anticipated|Soroka University Medical Center|||1||f||||t||||||||||2017-02-18 14:32:38.290007|2017-02-18 14:32:38.290007
NCT00650663|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2015-04-07|||October 2003||2003-10-01|April 2015|2015-04-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)|A Multicenter, Double-Blind, Randomized Study to Evaluate the Lipid-Altering Efficacy, Safety, and Tolerability of Ezetimibe Coadministered With Simvastatin Versus Simvastatin Monotherapy in African-American Subjects With Primary Hypercholesterolemia|Completed||Phase 4|247|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:32:38.376972|2017-02-18 14:32:38.376972
NCT00650650|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2009-04-20|||March 2008||2008-03-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Comparison of Ultrasound Versus Radiography for Diagnosis of Nasal Fractures|Comparison of Ultrasound Versus Radiography for Diagnosis of Nasal Fractures|Completed||N/A|80|Anticipated|Klinikum der Universitaet Muenchen, Grosshadern|||1||f||||f||||||||||2017-02-18 14:32:38.488938|2017-02-18 14:32:38.488938
NCT00650637|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2011-06-03|||January 2003||2003-01-01|June 2011|2011-06-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea|A Randomized, Open-Label, Third-Party Blinded Study for the Prophylaxis and Treatment of Nelfinavir-associated Diarrhea|Terminated||Phase 3|17|Actual|Pfizer||2||"The study was prematurely discontinued due to administrative reasons on August 18, 2003. There~   were no safety concerns that led to the decision to terminate."|f||||t||||||||||2017-02-18 14:32:38.566194|2017-02-18 14:32:38.566194
NCT00650624|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-04-07|||June 2003||2003-06-01|March 2008|2008-03-01|January 2004|Actual|2004-01-01|||||Interventional|||A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)|A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg QD Versus Placebo In Patients With OA Of The Knee|Completed||Phase 2|416|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:32:38.695772|2017-02-18 14:32:38.695772
NCT00650611|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-07|||December 2003||2003-12-01|April 2008|2008-04-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders|A 27-Week Open-Label Trial To Characterize The Safety And Tolerability Of Orally Administered Ziprasidone In Children And Adolescent Subjects With Bipolar I Disorder (Manic Or Mixed), Schizophrenia Or Schizoaffective Disorder|Completed||Phase 2|63|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:32:38.842727|2017-02-18 14:32:38.842727
NCT00650598|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-10-06|||March 2004||2004-03-01|October 2008|2008-10-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||A Multicentre, Double-Blind, Double-Dummy, Randomised Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy for Anterior Cruciate Ligament (ACL) Reconstruction|A Multicentre, Double-Blind, Double-Dummy, Randomised Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Diclofenac Sodium in Patients Undergoing Knee Arthroscopy Procedure for Anterior Cruciate Ligament Reconstruction|Completed||Phase 4|328|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:32:38.962453|2017-02-18 14:32:38.962453
NCT00650585|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-06-05|2009-07-27||May 2004||2004-05-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||An Effectiveness Trial of Project ALERT|Promising Programs for Substance Abuse Prevention: Replication and Evaluation Initiative|Completed||N/A|8338|Actual|Pacific Institute for Research and Evaluation||2|||f||||f||||||||||2017-02-18 14:32:39.09331|2017-02-18 14:32:39.09331
NCT00650572|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2013-03-06|||May 2008||2008-05-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of ARRY-380 in Patients With Advanced HER2+ Cancer||Completed||Phase 1|50|Actual|Array BioPharma||1|||f||||f||||||||||2017-02-18 14:32:39.654558|2017-02-18 14:32:39.654558
NCT00650559|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-03-28|||June 2004||2004-06-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|TE||Thorax Enlarging Surgery: a Novel Surgical Approach to Emphysema|Chest Wall Enlargement by Widening Sternotomy in Patients With Severe Emphysema: a Feasibility Trial.|Terminated||N/A|4|Actual|Katholieke Universiteit Leuven||1||post-surgical complications in the last 2 patients|f||||f||||||||||2017-02-18 14:32:39.744279|2017-02-18 14:32:39.744279
NCT00650546|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-06-07|2015-08-31||August 2006||2006-08-01|June 2016|2016-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|NAFLD|eight adult patients with known type 2 DM and biopsy -proven NAFLD were treated with 5-10 subcutaneous exenatide for 28 weeks|Role of Exenatide in NASH-a Pilot Study|Role of Exenatide in Treatment of NASH-a Pilot Study|Completed||Phase 2/Phase 3|8|Actual|Indiana University|As a case series our findings are limited by a control group and a small number of subjects enrolled. These limitations are tempered by the single expert hepatologist and the stringent definitions for histological improvement, ((primary end point)..|1|||f||||f||||||||||2017-02-18 14:32:39.850167|2017-02-18 14:32:39.850167
NCT00650533|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2004||2004-11-01|March 2008|2008-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg|Single-Dose Food In Vivo Bioequivalence Study of Glimepiride Tablets (1 mg; Mylan) to Amaryl® Tablets (1 mg; Aventis) in Healthy Volunteers|Completed||Phase 1|40|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:40.123661|2017-02-18 14:32:40.123661
NCT00650520|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||May 2007||2007-05-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets|Study of Mylan Pharmaceuticals Inc. and Novartis Pharmaceuticals Corporation (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets Following a 10 mg Dose in Healthy Adult Volunteers Under Fed Conditions|Completed||Phase 1|119|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:40.222432|2017-02-18 14:32:40.222432
NCT00650507|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2013-08-25|||March 2008||2008-03-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Clinical and Genomic Responses to Open Heart Surgery|Clinical and Genomic Responses to Open Heart Surgery: A Randomized Controlled Trial of the Effects of Remote Ischemic Preconditioning|Completed||Phase 3|300|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 14:32:40.31852|2017-02-18 14:32:40.31852
NCT00650494|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-11|||August 2005||2005-08-01|November 2009|2009-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg|Single-Dose Food in Vivo Bioequivalence Study of Valacyclovir Hydrochloride Tablets (1000 mg; Mylan) to Valtrex® Tablets (1000 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|66|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:40.431053|2017-02-18 14:32:40.431053
NCT00650481|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Fasting Study of Oxybutynin Chloride Extended-Release Tablets 5 mg and Ditropan XL® Tablets 5 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Oxybutynin Chloride Extended-Release Tablets (5 mg; Mylan) and Ditropan XL® Tablets (5 mg; ALZA) in Healthy Volunteers|Completed||Phase 1|60|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:40.541691|2017-02-18 14:32:40.541691
NCT00650468|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2011-11-15|||November 1999||1999-11-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients|A Prospective, Randomized, Multi-Center Double-Blind Study of Early Corticosteroid Cessation vs. Long Term Corticosteroid Therapy With Prograf and CellCept in Primary Renal Transplant Patients|Completed||Phase 4|397|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 14:32:40.653972|2017-02-18 14:32:40.653972
NCT00650455|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-07-18|||February 2003||2003-02-01|July 2008|2008-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients|Clinical Protocol for a Multicenter, Double-Blind, Randomized, Placebo Controlled, Comparison of the Efficacy and Safety of Bextra® (Valdecoxib) 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe RA Population|Completed||Phase 4|489|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:32:40.789391|2017-02-18 14:32:40.789391
NCT00650442|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2003||2003-01-01|March 2008|2008-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System|Evaluation of the Adhesion Quality and Primary Dermal Irritation Potential of an Alternate Second Generation Estradiol Transdermal Systems in Normal Healthy Female Volunteers|Completed||Phase 1|39|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:40.950494|2017-02-18 14:32:40.950494
NCT00650429|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-07|||October 2003||2003-10-01|April 2008|2008-04-01|May 2005|Actual|2005-05-01|||||Interventional|||A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder|Ziprasidone Intramuscular/Oral In The Treatment Of Acute Exacerbation Of Schizophrenia Or Schizoaffective Disorder: A Six-Week Open Administration Study|Completed||Phase 4|28|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:32:41.051806|2017-02-18 14:32:41.051806
NCT00650416|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||March 2004||2004-03-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Carvedilol Tablets (12.5 mg; Mylan) to Coreg® Tablets (12.5 mg; GSK) in Healthy Volunteers|Completed||Phase 1|50|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:43.622199|2017-02-18 14:32:43.622199
NCT00650403|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2006||2006-12-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg|Single-Dose Fed Bioequivalence Study of Paroxetine Hydrochloride Tablets (40 mg; Mylan) and Paxil® Tablets (40 mg; GSK) in Healthy Adult Volunteers|Completed||Phase 1|66|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:43.716966|2017-02-18 14:32:43.716966
NCT00650390|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-03-28||||||March 2008|2008-03-01||||||||Expanded Access|PROWD||Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab|Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab|Approved for marketing||N/A|||Abbott|||||f||||||||||||||2017-02-18 14:32:43.810234|2017-02-18 14:32:43.810234
NCT00650377|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2004||2004-10-01|March 2008|2008-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg|Single-Dose Food In Vivo Bioequivalence Study of Finasteride Tablets (5 mg; Mylan) to Proscar® Tablets (5 mg; Merck) in Healthy Male Volunteers|Completed||Phase 1|30|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:43.88877|2017-02-18 14:32:43.88877
NCT00650364|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2002||2002-08-01|March 2008|2008-03-01|September 2002|Actual|2002-09-01|August 2002|Actual|2002-08-01||Interventional|||Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Midodrine HCl Tablets (5 mg; Mylan) and ProAmatine® Tablets (5 mg; Roberts) in Healthy Volunteers|Completed||Phase 1|38|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:43.97827|2017-02-18 14:32:43.97827
NCT00650351|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2005||2005-10-01|March 2008|2008-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg|Single-Dose Food In Vivo Bioequivalence Study of Ciprofloxacin Extended-Release Tablets (1000 mg; Mylan) and Cipro® XR Tablets (1000 mg; Bayer) in Healthy Volunteers|Completed||Phase 1|35|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:44.066837|2017-02-18 14:32:44.066837
NCT00200226|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-20|||February 2003||2003-02-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Oral Misoprostol Before Endometrial Biopsy|Oral Misoprostol Before Endometrial Biopsy|Completed||Phase 3|72|Actual|Memorial University of Newfoundland||2|||f||||f||||||||||2017-02-18 17:12:33.669616|2017-02-18 17:12:33.669616
NCT00650338|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-11-01|||March 2008||2008-03-01|November 2011|2011-11-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension|A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension|Completed||Phase 2|165|Anticipated|Santen Inc.||5|||f||||||||||||||2017-02-18 14:32:44.160339|2017-02-18 14:32:44.160339
NCT00650325|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2002||2002-11-01|March 2008|2008-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Sertraline Hydrochloride Tablets (100 mg; Mylan) and Zoloft® Tablets (100 mg; Pfizer) in Healthy Volunteers|Completed||Phase 1|49|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:44.26469|2017-02-18 14:32:44.26469
NCT00650312|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2002||2002-10-01|March 2008|2008-03-01|November 2002|Actual|2002-11-01|October 2002|Actual|2002-10-01||Interventional|||Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Metformin Hydrochloride ER Tablets (500 mg; Mylan) and Glucophage® XR Tablets (500 mg; Bristol-Myers Squibb) in Healthy Volunteers|Completed||Phase 1|50|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:44.364556|2017-02-18 14:32:44.364556
NCT00650299|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2004||2004-08-01|March 2008|2008-03-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Fed Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg|Single-Dose Food In Vivo Bioequivalence Study of Alprazolam Extended-Release Tablets (3 mg; Mylan) to Xanax XR® Tablets (3 mg; Pharmacia & Upjohn) in Healthy Volunteers|Completed||Phase 1|21|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:44.66258|2017-02-18 14:32:44.66258
NCT00650286|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||September 2002||2002-09-01|March 2008|2008-03-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg|Single-Dose Food In Vivo Bioequivalence Study of Modafinil Tablets (200 mg; Mylan) to Provigil® Tablets (200 mg; Cephalon) in Healthy Volunteers|Completed||Phase 1|20|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:44.762233|2017-02-18 14:32:44.762233
NCT00650273|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||April 2005||2005-04-01|March 2008|2008-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Azithromycin Tablets (600 mg; Mylan) to Zithromax® Tablets (600 mg; Pfizer) in Healthy Volunteers|Completed||Phase 1|54|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:44.86433|2017-02-18 14:32:44.86433
NCT00650260|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2012-09-25|2010-08-05||February 2009||2009-02-01|September 2012|2012-09-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Intraoperative Warming Comparison of Devices|Intraoperative Warming : Comparison of Performance of the Dynatherm Medical vitalHEAT™ Temperature Management System (vH2) and the Arizant Bair Hugger System|Completed||N/A|42|Actual|University of South Florida||2|||f||||f||||||||||2017-02-18 14:32:44.967825|2017-02-18 14:32:44.967825
NCT00650247|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-30|||November 2004||2004-11-01|November 2009|2009-11-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg|Single-Dose Food In Vivo Bioequivalence Study of Sumatriptan Succinate Tablets (100 mg; Mylan) to Imitrex® Tablets (100 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|57|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:45.478284|2017-02-18 14:32:45.478284
NCT00650234|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||February 2004||2004-02-01|March 2008|2008-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Metformin Hydrochloride ER Tablets (500 mg; Mylan) and Glucophage® XR Tablets (500 mg; Bristol-Myers Squibb) in Healthy Volunteers|Completed||Phase 1|47|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:45.575336|2017-02-18 14:32:45.575336
NCT00650221|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||June 2003||2003-06-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects|A Two-Way Crossover, Open-Label, Single-Dose, Fasting, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|43|Actual|Mylan Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:32:45.679214|2017-02-18 14:32:45.679214
NCT00650208|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2004||2004-07-01|March 2008|2008-03-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Lamotrigine Tablets (25 mg; Mylan) to Lamictal® Tablets (25 mg; GSK) in Healthy Volunteers|Completed||Phase 1|27|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:45.791472|2017-02-18 14:32:45.791472
NCT00650195|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||February 2004||2004-02-01|March 2008|2008-03-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Interventional|||Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Metolazone Tablets (10 mg; Mylan) and Zaroloxyn® Tablets (10 mg; Celltech) in Healthy Volunteers|Completed||Phase 1|56|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:45.886873|2017-02-18 14:32:45.886873
NCT00650182|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2011-05-18|||January 2003||2003-01-01|April 2010|2010-04-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid Tolerant|Safety Evaluation of D-TRANS Fentanyl With Naltrexone HCL in Opioid Tolerant Patients (ALZA C-2002-022)|Completed||Phase 2|406|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 14:32:45.976104|2017-02-18 14:32:45.976104
NCT00650169|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2004||2004-12-01|March 2008|2008-03-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg|Single-Dose Food In Vivo Bioequivalence Study of Clopidogrel Bisulfate Tablets (75 mg; Mylan) to Plavix® Tablets (75 mg; Bristol-Myers Squibb/Sanofi) in Healthy Volunteers|Completed||Phase 1|47|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:46.063138|2017-02-18 14:32:46.063138
NCT00475254|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2011-04-05|||August 2007||2007-08-01|August 2008|2008-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Stress and Vision Fluctuations in Retinitis Pigmentosa|Stress and Vision Fluctuations in Retinitis Pigmentosa|Completed||Early Phase 1|50|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 15:36:37.795322|2017-02-18 15:36:37.795322
NCT00650143|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-07-07|||March 2008||2008-03-01|July 2011|2011-07-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|SITAGRAMI||Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction|Safety and Efficacy of Sitagliptin Plus Granulocyte-colony Stimulating Factor in Patients Suffering From Acute Myocardial Infarction|Unknown status|Recruiting|Phase 2/Phase 3|174|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-02-18 14:32:46.260319|2017-02-18 14:32:46.260319
NCT00650130|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2013-11-01|||May 2008||2008-05-01|November 2013|2013-11-01|October 2011|Actual|2011-10-01|December 2008|Actual|2008-12-01||Observational|||Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines|DRUID Sub-study: Substance Concentration Ratio/Impairment|Completed||N/A|300|Actual|National Institute for Health and Welfare, Finland|||1||f||||f||||||Samples With DNA|"~     Blood samples and oral fluid are collected for the study. However no DNA detection is done~     at any stage. The laboratory where samples are analysed do not analyse DNA. DNA is not~     relevant to this study.~   "|||2017-02-18 14:32:46.371657|2017-02-18 14:32:46.371657
NCT00650117|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2006||2006-10-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System|Single-Dose In Vivo Bioequivalence and Wear Study of Fentanyl Transdermal System (25 µg/h; Mylan) and Fentanyl Transdermal System With Overlay (25 µg/h; Mylan) in Healthy Volunteers|Completed||Phase 1|12|Actual|Mylan Pharmaceuticals||6|||f||||||||||||||2017-02-18 14:32:46.472357|2017-02-18 14:32:46.472357
NCT00650104|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2013-05-02|2010-02-24||May 2002||2002-05-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164|101648/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients With Parkinson's Disease Who Completed the Previous Ropinirole CR Studies 167 or 164|Completed||Phase 3|76|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:32:46.583873|2017-02-18 14:32:46.583873
NCT00650091|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2015-05-27|2014-07-31||October 2009||2009-10-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|October 2013|Actual|2013-10-01||Interventional|PANTHER-IPF||Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF|Prednisone, Azathioprine, and N-acetylcysteine: A Study That Evaluates Response in IPF|Completed||Phase 3|264|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:32:47.408458|2017-02-18 14:32:47.408458
NCT00650078|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2013-04-23|2012-11-01||March 2008||2008-03-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|CAPRA-2||Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis|A Randomized Multi-Center, Double-Blind, Placebo-Controlled Study of a New Modified-Release Tablet Formulation of Prednisone (Lodotra®) in Patients With Rheumatoid Arthritis|Completed||Phase 3|350|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||2|||f||||f||||||||||2017-02-18 14:32:48.144829|2017-02-18 14:32:48.144829
NCT00650065|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2002||2002-11-01|March 2008|2008-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Cetirizine HCl Tablets (10 mg; Mylan) and Zyrtec® Tablets (10 mg; Pfizer) in Healthy Volunteers|Completed||Phase 1|26|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:48.92907|2017-02-18 14:32:48.92907
NCT00650052|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2003||2003-11-01|March 2008|2008-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Zonisamide Capsules (100 mg; Mylan) to Zonegran® Capsules (100 mg; Elan) in Healthy Volunteers|Completed||Phase 1|107|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:49.034481|2017-02-18 14:32:49.034481
NCT00650039|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-06-03|||March 2004||2004-03-01|March 2008|2008-03-01|February 2005|Actual|2005-02-01|||||Interventional|||Double-Blind, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg Daily And Valdecoxib 20 Mg Twice Daily Compared To Placebo For Management Of Acute Postsurgical Pain In Anterior Cruciate Ligament (ACL) Reconstruction|A Multicenter, Double-Blind, Placebo-Controlled, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg QD And Valdecoxib 20 Mg BID Compared To Placebo Over Multiple Days For Management Of Acute Postsurgical Pain In Patients Undergoing Anterior Cruciate Ligament Reconstruction|Completed||Phase 3|488|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:32:49.135777|2017-02-18 14:32:49.135777
NCT00650026|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-04-10||||||April 2008|2008-04-01||||||||Expanded Access|ReAct||Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis|Multicenter Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis|Approved for marketing||N/A|||Abbott|||||f||||||||||||||2017-02-18 14:32:49.327463|2017-02-18 14:32:49.327463
NCT00650013|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2002||2002-07-01|March 2008|2008-03-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg|Single-Dose Food In Vivo Bioequivalence Study of Midodrine HCl Tablets (5 mg; Mylan) and ProAmatine® Tablets (5 mg; Roberts) in Healthy Volunteers|Completed||Phase 1|23|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:49.402073|2017-02-18 14:32:49.402073
NCT00650000|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2002||2002-10-01|March 2008|2008-03-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Modafinil Tablets (200 mg; Mylan) and Provigil® Tablets (200 mg; Cephalon) in Healthy Volunteers|Completed||Phase 1|32|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:49.508901|2017-02-18 14:32:49.508901
NCT00649987|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||September 2005||2005-09-01|March 2008|2008-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg|Single-Dose Fed Bioequivalence Study of Albuterol Sulfate Extended-Release Tablets (8 mg; Mylan) and VoSpire® ER Tablets (8 mg; Pliva) in Healthy Volunteers|Completed||Phase 1|21|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:49.616514|2017-02-18 14:32:49.616514
NCT00647777|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||June 2003||2003-06-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg|Single-Dose Food In Vivo Bioequivalence Study of Olanzapine Tablets (5 mg; Mylan) and Zyprexa® Tablets (5 mg; Eli Lilly) in Healthy Volunteers|Completed||Phase 1|32|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:15.676271|2017-02-18 14:33:15.676271
NCT00649974|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-23|||May 2005||2005-05-01|November 2009|2009-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Valacyclovir Hydrochloride Tablets (1000 mg; Mylan) to Valtrex® Tablets (1000 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:49.721668|2017-02-18 14:32:49.721668
NCT00649961|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2014-01-13|2014-01-13||May 2010||2010-05-01|January 2011|2011-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|MIND|less than 31 weeks gestation|Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study|Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study|Completed||Phase 2|18|Actual|Imperial College London||1|||f||||f||||||||||2017-02-18 14:32:49.821481|2017-02-18 14:32:49.821481
NCT00649948|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||February 2004||2004-02-01|March 2008|2008-03-01|June 2004|Actual|2004-06-01|May 2004|Actual|2004-05-01||Interventional|||Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg|Single-Dose Food In Vivo Bioequivalence Study Metformin Hydrochloride ER Tablets (500 mg; Mylan) and Glucophage® XR (500 mg; Bristol-Myers Squibb) in Healthy Volunteers|Completed||Phase 1|27|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:50.038449|2017-02-18 14:32:50.038449
NCT00649935|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||May 2005||2005-05-01|March 2008|2008-03-01|June 2005|Actual|2005-06-01|May 2005|Actual|2005-05-01||Interventional|||Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mg|Single-Dose Fed In Vivo Bioequivalence Study of Azithromycin Tablets (600 mg; Mylan) to Zithromax® Tablets (600 mg; Pfizer) in Healthy Volunteers|Completed||Phase 1|54|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:50.149544|2017-02-18 14:32:50.149544
NCT00649922|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-03-31|||October 2003||2003-10-01|March 2008|2008-03-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis|Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis|Completed||Phase 4|226|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:32:50.26177|2017-02-18 14:32:50.26177
NCT00649909|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2009-02-08|||November 2008||2008-11-01|February 2009|2009-02-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Observational|||Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients|Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients|Unknown status|Recruiting|N/A|30|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 14:32:50.356311|2017-02-18 14:32:50.356311
NCT00649896|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2003||2003-08-01|March 2008|2008-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day|Comparative Evaluation of the Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System (0.025 mg/Day; Mylan) and Climara® Transdermal System (0.025 mg/Day; Berlex) in Healthy Postmenopausal Female Volunteers|Completed||Phase 1|76|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:50.460368|2017-02-18 14:32:50.460368
NCT00649883|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2011-12-07|||January 2008||2008-01-01|December 2011|2011-12-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months|A Phase II, Observer-Blind, Randomized, Multi-center Study to Evaluate the Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Investigational Vaccine and Active Influenza Vaccine in Healthy Children Aged 6 to <60 Months|Completed||Phase 2|360|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:32:50.556328|2017-02-18 14:32:50.556328
NCT00649870|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-23|||May 2005||2005-05-01|November 2009|2009-11-01|June 2005|Actual|2005-06-01|May 2005|Actual|2005-05-01||Interventional|||Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg|Single-Dose Food In Vivo Bioequivalence Study of Valacyclovir Hydrochloride Tablets (1000 mg; Mylan) to Valtrex® Tablets (1000 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|26|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:50.659084|2017-02-18 14:32:50.659084
NCT00649857|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2002||2002-11-01|March 2008|2008-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg|Single-Dose Food In Vivo Bioequivalence Study of Cetirizine HCl Tablets (10 mg; Mylan) and Zyrtec® (10 mg; Pfizer) in Healthy Volunteers|Completed||Phase 1|18|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:50.755064|2017-02-18 14:32:50.755064
NCT00649844|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2009-09-24|||January 2003||2003-01-01|September 2009|2009-09-01|September 2004|Actual|2004-09-01|||||Interventional|MOZART||A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs|Double Blind, Double-Dummy Multicenter, Parallel Group Comparison Of The Efficacy And The Tolerability Of Ziprasidone Vs. Clozapine In Schizophrenic Patients Who Are Refractory And/Or Intolerant To Antipsychotic Therapy|Completed||Phase 3|147|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:32:50.85121|2017-02-18 14:32:50.85121
NCT00649831|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-10-20|||October 2002||2002-10-01|October 2008|2008-10-01|June 2003|Actual|2003-06-01|||||Interventional|||A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis|Azithromycin (Zithromax®) 5 Days Versus Amoxicillin-Clavulanic Acid (Augmentin®): Multicentre, Randomised, Open-Label Study To Compare The Clinical Efficacy And Safety Of Azithromycin With Those Of Amoxicillin-Clavulanic Acid In Patients Presenting With An Exacerbation Of Chronic Bronchitis|Completed||Phase 3|250|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 14:32:50.975429|2017-02-18 14:32:50.975429
NCT00649818|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2004||2004-12-01|March 2008|2008-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Lorazepam Tablets (2 mg; Mylan) and Ativan Tablets (2 mg; Wyeth) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:51.099016|2017-02-18 14:32:51.099016
NCT00649623|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-23|||December 2005||2005-12-01|November 2009|2009-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Olmesartan Medoxomil Tablets (40 mg; Mylan) to Benicar® Tablets (40 mg; Sankyo) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:53.250976|2017-02-18 14:32:53.250976
NCT00649805|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2006||2006-01-01|March 2008|2008-03-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg|Single-Dose Fasting Bioequivalence Study of Verapamil HCl Extended-Release Capsules (300 mg;Mylan) and Verelan® PM Extended-Release Capsules (300 mg; Schwarz) Sprinkled on Applesauce in Healthy Volunteers|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:51.277762|2017-02-18 14:32:51.277762
NCT00649792|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2012-02-24|2012-01-25||August 2007||2007-08-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial|Phase 3 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial|Completed||Phase 3|214|Actual|Acorda Therapeutics||1|||f||||t||||||||||2017-02-18 14:32:51.375711|2017-02-18 14:32:51.375711
NCT00649779|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||September 2005||2005-09-01|March 2008|2008-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg|Single-Dose Fasting Bioequivalence Study of Albuterol Sulfate Extended-Release Tablets (8 mg; Mylan) and VoSpire® ER Tablets (8 mg; Pliva) in Healthy Volunteers|Completed||Phase 1|21|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:52.020966|2017-02-18 14:32:52.020966
NCT00649766|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-03-28|||June 2006||2006-06-01|March 2008|2008-03-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Tailored Messages to Increase Eye Examination Behavior|Tailored Messages to Increase Eye Examination Behavior|Unknown status|Active, not recruiting|N/A|330|Actual|National Eye Institute (NEI)||2|||f||||f||||||||||2017-02-18 14:32:52.130931|2017-02-18 14:32:52.130931
NCT00649753|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2009-07-22|||March 2008||2008-03-01|March 2008|2008-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|Algometer||Algometer and Category II Pelvic Blocking and Cranial Protocol|An Investigation of Algometer Readings for DeJarnette Category II Indicators After Category II Blocking and Cranial Protocol|Completed||N/A|40|Anticipated|Logan College of Chiropractic||4|||f||||||||||||||2017-02-18 14:32:52.244097|2017-02-18 14:32:52.244097
NCT00649740|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-23|||November 2005||2005-11-01|November 2009|2009-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg|Single-Dose Fasting Bioequivalence Study of Topiramate Sprinkle Capsules (25 mg; Mylan) and Topamax® Sprinkle Capsules (25 mg; Ortho-McNeil Neurologics) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:52.339352|2017-02-18 14:32:52.339352
NCT00649727|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2002||2002-07-01|March 2008|2008-03-01|August 2002|Actual|2002-08-01|July 2002|Actual|2002-07-01||Interventional|||Fed Study of Oxybutynin Chloride Extended-Release Tablets 10 mg and Ditropan XL® Tablets 10 mg|Single-Dose Food In Vivo Bioequivalence Study of Oxybutynin Chloride Extended-Release Tablets (10 mg; Mylan) and Ditropan XL® Tablets(10 mg; ALZA) in Healthy Volunteers|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:52.445104|2017-02-18 14:32:52.445104
NCT00649714|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2003||2003-12-01|March 2008|2008-03-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg|Single-Dose Food In Vivo Bioequivalence Study of Zonisamide Capsules (100 mg; Mylan) to Zonegran® Capsules (100 mg; Elan) in Healthy Volunteers|Completed||Phase 1|110|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:52.547163|2017-02-18 14:32:52.547163
NCT00649701|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-06-19|||April 2008||2008-04-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|5Part||Novel Internet-Based Interventions to Reduce Sexual Risk Among Men Who Have Sex With Men|Phase 1 Online Intervention to Reduce Sexual Risk Among Men Who Have Sex With Men|Unknown status|Active, not recruiting|Phase 1|3097|Actual|Public Health Solutions||5|||f||||t||||||||||2017-02-18 14:32:52.652337|2017-02-18 14:32:52.652337
NCT00649688|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2003||2003-01-01|March 2008|2008-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets (100/50 mg; Mylan) and Lopressor HCT® Tablets (100/50 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|32|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:52.766991|2017-02-18 14:32:52.766991
NCT00649675|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2004||2004-08-01|March 2008|2008-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg|Single-Dose Food In Vivo Bioequivalence Study of Meloxicam Tablets (15 mg; Mylan) and Mobic® Tablets (15 mg; Boehringer Ingelheim) in Healthy Volunteers|Completed||Phase 1|27|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:52.86717|2017-02-18 14:32:52.86717
NCT00649662|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2005||2005-10-01|March 2008|2008-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Ciprofloxacin Extended-Release Tablets (1000 mg; Mylan) and Cipro® XR Tablets (1000 mg; Bayer) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:52.96293|2017-02-18 14:32:52.96293
NCT00649649|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Food Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg|Single-Dose Food In Vivo Bioequivalence Study of Quinapril Hydrochloride Tablets (40 mg; Mylan) and Accupril® Tablets (40 mg; Parke-Davis) in Healthy Volunteers|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:53.061076|2017-02-18 14:32:53.061076
NCT00649636|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||February 2006||2006-02-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mg|Single-Dose Fasting Bioequivalence Study of Fluoxetine Capsules (40 mg; Mylan) and Prozac Pulvules (40 mg; Dista) in Healthy Adult Volunteers|Completed||Phase 1|32|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:53.151164|2017-02-18 14:32:53.151164
NCT00649428|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2012-02-09|2012-02-09||October 2006||2006-10-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles||Completed||Phase 3|203|Actual|Fibrocell Technologies, Inc.||2|||f||||f||||||||||2017-02-18 14:32:54.767149|2017-02-18 14:32:54.767149
NCT00649610|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-07|||November 2002||2002-11-01|March 2008|2008-03-01|May 2003|Actual|2003-05-01|||||Interventional|||Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain|Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily vs. Diclofenac 75 mg Twice Daily in Subjects With Acute Low Back Pain|Completed||Phase 4|340|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:32:53.350666|2017-02-18 14:32:53.350666
NCT00649597|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2002||2002-11-01|March 2008|2008-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Benazepril HCl and Hydrochlorothiazide Tablets (20 mg/25 mg; Mylan) to Lotensin HCT® Tablets (20 mg/25 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|56|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:53.50835|2017-02-18 14:32:53.50835
NCT00649584|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2014-12-17|||March 2008||2008-03-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies|A Phase I Dose Escalation Study of Weekly SGN-35 Monotherapy and in Combination With Gemcitabine in Patients With Relapsed/Refractory CD30-positive Hematologic Malignancies|Terminated||Phase 1|44|Actual|Seattle Genetics, Inc.||1||Sponsor decision not to enroll cohorts of combined SGN-35 and gemcitabine therapy.|f||||f||||||||||2017-02-18 14:32:53.620806|2017-02-18 14:32:53.620806
NCT00649571|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2005||2005-07-01|March 2008|2008-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Fasting Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Doxycycline Monohydrate Tablets (100 mg; Mylan) and Adoxa Tablets (100 mg; Par) in Healthy Volunteers|Completed||Phase 1|35|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:53.734832|2017-02-18 14:32:53.734832
NCT00649558|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||February 2003||2003-02-01|March 2008|2008-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Pioglitazone HCl Tablets (45 mg; Mylan) and Actos® Tablets (45 mg; Takeda) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:53.841685|2017-02-18 14:32:53.841685
NCT00649545|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-03-31||||||March 2008|2008-03-01||||||||Expanded Access|CanAct||Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis|A Multi-Center Study of the Safety and Efficacy of Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients With Active Rheumatoid Arthritis|Approved for marketing||N/A|||Abbott|||||f||||||||||||||2017-02-18 14:32:53.941639|2017-02-18 14:32:53.941639
NCT00649532|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2003||2003-07-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Ondansetron Tablets (24 mg; Mylan) and Zofran® Tablets (24 mg; GSK) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:54.011696|2017-02-18 14:32:54.011696
NCT00649519|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||May 2004||2004-05-01|March 2008|2008-03-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Amlodipine and Benazepril HCl Capsules (10 mg/20 mg; Mylan) to Lotrel® Capsules (10 mg/20 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|54|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:54.102547|2017-02-18 14:32:54.102547
NCT00649506|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||September 2003||2003-09-01|March 2008|2008-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg|Single-Dose Food In Relative Bioavailability Study of Mylan Nitrofurantoin Macrocrystals 100 mg Capsules and Procter & Gamble Macrodantin® 100 mg Capsules in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:54.198679|2017-02-18 14:32:54.198679
NCT00649493|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-23|||May 2003||2003-05-01|November 2009|2009-11-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg|Single-Dose Food In Vivo Bioequivalence Study of Rabeprazole Sodium Tablets (20 mg; Mylan) and Aciphex® Tablets (20 mg; Eisai) in Healthy Volunteers|Completed||Phase 1|72|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:54.291273|2017-02-18 14:32:54.291273
NCT00649480|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2007||2007-01-01|December 2006|2006-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg|Single-Dose Fed Bioequivalence Study of Balsalazide Disodium Capsules (750 mg; Mylan) and Colazal® Capsules (750 mg; Salix) in Healthy Volunteers|Completed||Phase 1|60|Actual|Mylan Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:32:54.383804|2017-02-18 14:32:54.383804
NCT00649467|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-23|||November 2005||2005-11-01|November 2009|2009-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg|Single-Dose Fasting Bioequivalence Study of Topiramate Sprinkle Capsules (25 mg; Mylan) and Topamax® Sprinkle Capsules (25 mg; Ortho-McNeil Neurologics) in Healthy Volunteers Dosed With Applesauce|Completed||Phase 1|35|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:54.483673|2017-02-18 14:32:54.483673
NCT00649454|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||June 2005||2005-06-01|March 2008|2008-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Glipizide and Metformin HCl Tablets (5 mg/500 mg; Mylan) to Metaglip® Tablets (5 mg/500 mg; Bristol-Myers Squibb) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:54.575276|2017-02-18 14:32:54.575276
NCT00649441|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2003||2003-08-01|March 2008|2008-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Quinapril HCl and Hydrochlorothiazide Tablets (20 mg/25 mg; Mylan) to Accuretic™ Tablets (20 mg/25 mg; Parke-Davis) in Healthy Volunteers|Completed||Phase 1|60|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:54.675344|2017-02-18 14:32:54.675344
NCT00649415|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-07|||January 2003||2003-01-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|||||Interventional|||A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea|A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg BID, PRN In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea|Completed||Phase 4|154|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:32:55.424322|2017-02-18 14:32:55.424322
NCT00649402|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||May 2004||2004-05-01|March 2008|2008-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg|Single-Dose Food in Vivo Bioequivalence Study of Amlodipine and Benazepril HCl Capsules (10 mg/20 mg; Mylan) to Lotrel® Capsules (10 mg/20 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|64|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:55.534042|2017-02-18 14:32:55.534042
NCT00649389|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2010-08-31|2010-08-09||May 2008||2008-05-01|August 2010|2010-08-01|December 2009|Actual|2009-12-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension|A Randomized, Double-Blind, Parallel Group Study Evaluating the Efficacy and Safety of Co-Administration of a Triple Combination Therapy of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Subjects With Hypertension|Completed||Phase 3|2500|Actual|Daiichi Sankyo Inc.||4|||f||||f||||||||||2017-02-18 14:32:55.646171|2017-02-18 14:32:55.646171
NCT00649376|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2003||2003-10-01|March 2008|2008-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Fexofenadine Tablets (180 mg; Mylan) and Allegra® Tablets (180 mg; Aventis) in Healthy Adult Volunteers|Completed||Phase 1|68|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:57.363595|2017-02-18 14:32:57.363595
NCT00649363|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2005||2005-07-01|March 2008|2008-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Ondansetron Orally Disintegrating Tablets (8 mg; Mylan) to Zofran ODT® Tablets (8 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:57.458679|2017-02-18 14:32:57.458679
NCT00649350|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2003||2003-12-01|March 2008|2008-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg|Single-Dose Food In Vivo Bioequivalence Study Metformin Hydrochloride ER Tablets (750 mg; Mylan) and Glucophage XR (750 mg; Bristol-Myers Squibb) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:57.556034|2017-02-18 14:32:57.556034
NCT00649337|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-27|||January 2003||2003-01-01|March 2008|2008-03-01|January 2010|Anticipated|2010-01-01|July 2008|Anticipated|2008-07-01||Interventional|||Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons|Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Screening Mammography, Including Cost Comparisons|Unknown status|Recruiting|N/A|4650|Anticipated|SonoCine, Inc.||1|||f||||t||||||||||2017-02-18 14:32:57.670141|2017-02-18 14:32:57.670141
NCT00649324|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2005||2005-10-01|March 2008|2008-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg|Single-Dose Fasting In-Vivo Bioequivalence Study of Hydrochlorothiazide Tablets (50 mg; Mylan) to Hydrochlorothiazide Tablets (50 mg; Ivax) in Healthy Volunteers|Completed||Early Phase 1|40|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:57.774856|2017-02-18 14:32:57.774856
NCT00649311|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2009-11-30|||April 2003||2003-04-01|November 2009|2009-11-01|September 2003|Actual|2003-09-01|||||Interventional|||A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension|Clinical Protocol For A Double-Blind, Randomized, Active- Controlled Comparison Study Of The Antihypertensive Effect Of Eplerenone Versus Losartan In Patients With Mild To Moderate Hypertension|Terminated||Phase 2|248|Actual|Pfizer||2||Poor enrollment; termination not due to safety reasons.|f||||f||||||||||2017-02-18 14:32:57.871645|2017-02-18 14:32:57.871645
NCT00649298|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2015-06-23|||May 2008||2008-05-01|June 2013|2013-06-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|ACTIVE||A Clinical Trial of IntensiVE Dialysis|ACTIVE Dialysis - A Multicentre, Unblinded, Randomised, Controlled Trial to Assess Quality of Life, Clinical Outcomes and Cost Utility for Extended vs Standard Duration of Dialysis in Patients With End Stage Kidney Disease.|Completed||Phase 4|200|Actual|The George Institute||2|||f||||t||||||||||2017-02-18 14:32:57.984245|2017-02-18 14:32:57.984245
NCT00649285|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2002||2002-10-01|March 2008|2008-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg|Single-Dose Food In Vivo Bioequivalence Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules (100 mg; Mylan) and Macrobid® Capsules (100 mg; Procter & Gamble) in Healthy Volunteers|Completed||Phase 1|71|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:58.216762|2017-02-18 14:32:58.216762
NCT00649272|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2006||2006-01-01|February 2008|2008-02-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg|Single-Dose Fasting Bioequivalence Study of Oxybutynin Chloride Extended-Release Tablets (15 mg; Mylan)and Ditropan XL® Tablets (15 mg; ALZA) in Healthy Volunteers|Completed||Phase 1|80|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:58.305423|2017-02-18 14:32:58.305423
NCT00649259|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2002||2002-10-01|March 2008|2008-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg|Single-Dose Food In Vivo Bioequivalence Study of Oxybutynin Chloride ER Tablets (10 mg; Mylan) and Ditropan XL® Tablets (10 mg; ALZA) in Healthy Volunteers|Completed||Phase 1|39|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:58.401945|2017-02-18 14:32:58.401945
NCT00469716|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-08-23|||April 2007||2007-04-01|August 2016|2016-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|HH||Hypertonic Saline-hetastarch in Cardiac Surgery|Infusion of Hypertonic Saline-hetastarch in Cardiac Surgery|Completed||Phase 4|50|Actual|Haukeland University Hospital||1|||f||||t||||||||||2017-02-18 15:38:47.865352|2017-02-18 15:38:47.865352
NCT00649246|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2011-05-12|||July 1997||1997-07-01|May 2011|2011-05-01||||||||Observational|PANDA||Prospective Assessment in Newborns for Diabetes Autoimmunity|1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D|Unknown status|Recruiting|N/A|50000|Anticipated|Augusta University|||3||f||||t||||||Samples With DNA|"~     whole blood, DNA, serum, RNA, urine~   "|||2017-02-18 14:32:58.502633|2017-02-18 14:32:58.502633
NCT00649233|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2003||2003-01-01|March 2008|2008-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg|Single-Dose Food In Vivo Bioequivalence Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets (100/50 mg; Mylan) to Lopressor HCT® Tablets (100/50 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|32|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:58.601952|2017-02-18 14:32:58.601952
NCT00649220|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-09-22|2011-08-09||July 2008||2008-07-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|MemAP||Memantine and Antipsychotics Use|Prospective, Single-arm, Multi-centre, Open-label Study to Investigate the Potential to Reduce Concomitant Antipsychotics Use in Patients With Moderate to Severe Dementia of Alzheimer's Type (DAT) Treated With Memantine|Terminated||Phase 4|19|Actual|Merz Pharmaceuticals GmbH|Early termination due to too slow enrollment lead to a small sample size, limiting the ability for confirmatory analysis. All analysis of the primary efficacy endpoint were treated as exploratory.|1||Study terminated due to too slow enrollment|f||||f||||||||||2017-02-18 14:32:58.705645|2017-02-18 14:32:58.705645
NCT00649207|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2013-05-10|||March 2008||2008-03-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases|A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases|Completed||Phase 1|80|Actual|AbbVie||1|||f||||f||||||||||2017-02-18 14:32:59.045398|2017-02-18 14:32:59.045398
NCT00649194|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2003||2003-08-01|March 2008|2008-03-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg|Single-Dose Food In Vivo Bioequivalence Study of Rabeprazole Sodium Delayed-Release Tablets (20 mg; Mylan) to Aciphex® Tablets (20 mg; Eisai) in Healthy Volunteers|Completed||Phase 1|72|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:59.167597|2017-02-18 14:32:59.167597
NCT00649181|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2003||2003-10-01|March 2008|2008-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Metolazone Tablets (5 mg; Mylan) and Zaroloxyn® Tablets (5 mg; Celltech) in Healthy Volunteers|Completed||Phase 1|52|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:59.260605|2017-02-18 14:32:59.260605
NCT00649168|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||April 2007||2007-04-01|March 2008|2008-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg|Study of Mylan Pharmaceuticals Inc. and Novartis Pharmaceuticals Corporation (Parlodel®) 5 mg Bromocriptine Mesylate Capsules Following a 10 mg Dose in Healthy Adult Volunteers Under Fed Conditions|Completed||Phase 1|120|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:59.352092|2017-02-18 14:32:59.352092
NCT00649155|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2005||2005-11-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Ciprofloxacin Extended-Release Tablets (500 mg; Mylan) and Cipro® XR Tablets (500 mg; Bayer) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:32:59.45855|2017-02-18 14:32:59.45855
NCT00649142|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2009-01-20|||January 2007||2007-01-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Predisposing Factors for Chronic Postherniotomy Pain|Prospective Study of Predisposing Factors for Chronic Postherniotomy Pain|Completed||N/A|455|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 14:32:59.555157|2017-02-18 14:32:59.555157
NCT00649129|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2002||2002-07-01|March 2008|2008-03-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Oxybutynin Chloride ER Tablets (10 mg; Mylan) and Ditropan XL® Tablets (10 mg; ALZA) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:02.108265|2017-02-18 14:33:02.108265
NCT00649116|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg|Single-Dose Food In Vivo Bioequivalence Study of Metoprolol Tartrate Tablets (100 mg; Mylan) and Lopressor® (100 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|20|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:02.232471|2017-02-18 14:33:02.232471
NCT00649103|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Fasting Study of Quinapril Hydrochloride Tablets 40 mg and Accupril® Tablets 40 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Quinapril Hydrochloride Tablets (40 mg; Mylan) and Accupril® Tablets (40 mg; Parke-Davis) in Healthy Volunteers|Completed||Phase 1|60|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:02.34535|2017-02-18 14:33:02.34535
NCT00649090|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-09-25|||March 2005||2005-03-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer|A Phase 4, Open-Label Exemestane Adjuvant Safety Surveillance Program: Adjuvant Exemestane (Aromasin) Treatment Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer (IES Inclusion Criteria)|Completed||Phase 4|1549|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:33:02.444579|2017-02-18 14:33:02.444579
NCT00649077|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2004||2004-08-01|March 2008|2008-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Meloxicam Tablets (15 mg; Mylan) and Mobic® Tablets (15 mg; Boehringer Ingelheim) in Healthy Volunteers|Completed||Phase 1|30|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:02.608995|2017-02-18 14:33:02.608995
NCT00649064|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-07|||December 2003||2003-12-01|April 2008|2008-04-01|September 2004|Actual|2004-09-01|||||Interventional|||A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs|A Multi-Center Study To Examine The Clinical Effects Of Cross Titration Of Antipsychotics With Ziprasidone In Subjects With Schizophrenia Or Schizoaffective Disorder|Completed||Phase 4|46|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:33:02.705249|2017-02-18 14:33:02.705249
NCT00649051|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Metolazone Tablets (2.5 mg; Mylan) and Zaroloxyn® Tablets (2.5 mg; Celltech) in Healthy Volunteers|Completed||Phase 1|52|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:03.02365|2017-02-18 14:33:03.02365
NCT00649038|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg|Single-Dose Food in Vivo Bioequivalence Study of Benazepril HCl and Hydrochlorothiazide Tablets (20 mg/25 mg; Mylan) to Lotensin HCT® Tablets (20 mg/25 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:03.130482|2017-02-18 14:33:03.130482
NCT00649025|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2010-08-24||2010-08-24|March 2008||2008-03-01|August 2010|2010-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults|A Randomized, Double-blind, Active-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™ 250/10ug Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Fluticasone (250ug Twice Daily) Alone in SkyePharma HFA pMDI and Flovent® HFA pMDI in Adolescent and Adult Patients With Moderate to Severe Asthma|Completed||Phase 3|438|Actual|SkyePharma AG||3|||f||||t||||||||||2017-02-18 14:33:03.247907|2017-02-18 14:33:03.247907
NCT00649012|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||March 2003||2003-03-01|March 2008|2008-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg|Single-Dose Food In Vivo Bioequivalence Study of Pioglitazone HCl Tablets (45 mg; Mylan) to Actos® Tablets (45 mg; Takeda) in Healthy Volunteers|Completed||Phase 1|40|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:03.478286|2017-02-18 14:33:03.478286
NCT00648999|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2013-03-14|||November 2003||2003-11-01|January 2013|2013-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients|Phase IV, Non Randomized Study in ARV Experienced Patients Under Switch Therapy With Kaletra|Completed||Phase 4|207|Actual|AbbVie||2|||f||||f||||||||||2017-02-18 14:33:03.582879|2017-02-18 14:33:03.582879
NCT00648986|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2014-06-30|||August 2005||2005-08-01|June 2014|2014-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails|Single Center, Open-Label, Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails|Completed||Phase 4|20|Actual|Columbia University||1|||f||||f||||||||||2017-02-18 14:33:03.708249|2017-02-18 14:33:03.708249
NCT00648973|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-08-19|||November 2006||2006-11-01|August 2011|2011-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses|Evaluation of Nasal Congestion Clinical Efficacy for Diphenhydramine 25 mg and Diphenhydramine 50 mg in Seasonal Allergic Rhinitis: a Randomized, Double-blind, Placebo and Pseudoephedrine Controlled Study|Completed||Phase 4|1021|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-02-18 14:33:03.81769|2017-02-18 14:33:03.81769
NCT00648960|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-03-31|||July 2003||2003-07-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State|Single Dose Crossover Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Healthy Male and Female Volunteers / Fasting State|Completed||Phase 1|64|Actual|Mylan Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:33:03.949298|2017-02-18 14:33:03.949298
NCT00648947|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2004||2004-12-01|March 2008|2008-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Clopidogrel Bisulfate Tablets (75 mg; Mylan) to Plavix® Tablets (75 mg; Bristol-Myers Squibb/Sanofi) in Healthy Volunteers|Completed||Phase 1|46|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:04.058761|2017-02-18 14:33:04.058761
NCT00648934|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-23|||November 2005||2005-11-01|November 2009|2009-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg|Single-Dose Fed Bioequivalence Study of Topiramate Sprinkle Capsules (25 mg; Mylan) and Topamax® Sprinkle Capsules (25 mg; Ortho-McNeil Neurologics) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:04.153916|2017-02-18 14:33:04.153916
NCT00648921|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||June 2003||2003-06-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Olanzapine Tablets (5 mg; Mylan) and Zyprexa® Tablets (5 mg; Eli Lilly) in Healthy Volunteers|Completed||Phase 1|30|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:04.246672|2017-02-18 14:33:04.246672
NCT00648908|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2012-02-24|2012-01-25||June 2006||2006-06-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial|Phase 3 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Subjects With Multiple Sclerosis Who Participated in the MS-F203 Trial|Completed||Phase 3|269|Actual|Acorda Therapeutics||1|||f||||t||||||||||2017-02-18 14:33:04.409101|2017-02-18 14:33:04.409101
NCT00648895|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2010-08-30|2010-07-21||November 2007||2007-11-01|August 2010|2010-08-01||||July 2009|Actual|2009-07-01||Interventional|||A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients|Effect of Nebivolol on Forearm Vasodilation, Nitric Oxide Bioavailability, and Oxidative Stress in Patients With Stage 1/2 Hypertension|Completed||Phase 3|12|Actual|Forest Laboratories|The study was terminated early because of difficulties with enrollment. Only 12 of 30 planned patients were enrolled.|2|||f||||f||||||||||2017-02-18 14:33:05.155338|2017-02-18 14:33:05.155338
NCT00648882|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||March 2007||2007-03-01|March 2008|2008-03-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Fasting Study of Levothyroxine Sodium Tablets 300 Mcg to Synthroid® Tablets 300 Mcg|Single-Dose Fasting Bioequivalence Study of Levothyroxine Sodium Tablets (300 Mcg; Mylan) to Synthroid® Tablets (300 Mcg; Abbott)|Completed||Phase 1|33|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:05.555812|2017-02-18 14:33:05.555812
NCT00648869|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2009-10-25|||June 2008||2008-06-01|March 2008|2008-03-01|November 2008|Anticipated|2008-11-01|October 2008|Anticipated|2008-10-01||Interventional|||Open-label Crossover Metformin Gum Versus Tablet in Healthy Volunteers|Open-label,Randomized, Crossover Study Comparing Metformin Gum and Immediate Release Tablet in Healthy Volunteers|Withdrawn||N/A|12|Anticipated|Hadassah Medical Organization||1||Drug was not sent|f||||t||||||||||2017-02-18 14:33:05.648158|2017-02-18 14:33:05.648158
NCT00648856|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg|Single-Dose Food In Vivo Bioequivalence Study of Sertraline Hydrochloride Tablets (100 mg; Mylan) and Zoloft® Tablets (100 mg; Pfizer) in Healthy Volunteers|Completed||Phase 1|21|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:05.730941|2017-02-18 14:33:05.730941
NCT00648843|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Food Study of Oxybutynin Chloride Extended-Release Tablets 5 mg and Ditropan XL® Tablets 5 mg|Single-Dose Food In Vivo Bioequivalence Study of Oxybutynin Chloride Extended-Release Tablets (5 mg; Mylan) and Ditropan XL® Tablets (5 mg; ALZA) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:05.827282|2017-02-18 14:33:05.827282
NCT00648830|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-03-31|||May 2004||2004-05-01|March 2008|2008-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Comparative Bioavailability Study of Clarithromycin 250 mg Tablets|Randomized Single Dose Crossover Replicate Comparative Bioavailability Study of Clarithromycin 250 mg Tablets in Healthy Male and Female Volunteers Under Fasted Conditions|Completed||Phase 1|32|Actual|Mylan Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:33:05.929335|2017-02-18 14:33:05.929335
NCT00648817|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-03-31|||July 2006||2006-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male Volunteers|A Phase IV, Randomized, Double-Blind, Placebo-Controlled, Two-Phase Crossover Study of the Metabolic Impact of Tenofovir Disoproxil Fumarate on HIV-1 Seronegative Healthy Adult Males|Completed||Phase 4|8|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 14:33:06.034837|2017-02-18 14:33:06.034837
NCT00648804|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2005||2005-07-01|March 2008|2008-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mg|Single-Dose Food In Vivo Bioequivalence Study of Ondansetron Orally Disintegrating Tablets (8 mg; Mylan) to Zofran ODT® Tablets (8 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:06.146844|2017-02-18 14:33:06.146844
NCT00648791|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||September 2004||2004-09-01|March 2008|2008-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Finasteride Tablets (5 mg; Mylan) and Proscar Tablets (5 mg; Merck) in Healthy Male Volunteers|Completed||Phase 1|29|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:06.242021|2017-02-18 14:33:06.242021
NCT00648778|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2003||2003-01-01|March 2008|2008-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Loxapine Succinate Capsules (25 mg; Mylan) and Loxitane® Capsules (25 mg; Watson) in Healthy Volunteers|Completed||Phase 1|53|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:06.33977|2017-02-18 14:33:06.33977
NCT00648765|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2003||2003-01-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg|Single-Dose Food In Vivo Bioequivalence Study of Anagrelide Hydrochloride Capsules (1 mg; Mylan) to Agrylin® Capsules (1 mg; Shire US) in Healthy Volunteers|Completed||Phase 1|22|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:06.439482|2017-02-18 14:33:06.439482
NCT00648739|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2017-01-27||2017-01-27|June 2008||2008-06-01|January 2017|2017-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Safety and Dose Ranging Study of ALXN6000 to Treat Relapsing or Refractory CLL or MM|A Phase I/II Open Label Study To Evaluate The Safety, Pharmacokinetics And Pharmacodynamics Of ALXN6000 In Patients With Relapsing Or Refractory B-Cell Chronic Lymphocytic Leukemia Or Multiple Myeloma|Completed||Phase 1/Phase 2|26|Actual|Alexion Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:33:06.538018|2017-02-18 14:33:06.538018
NCT00648726|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-03-27|||January 2003||2003-01-01|March 2008|2008-03-01|August 2003|Actual|2003-08-01|||||Interventional|||An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia|An Open, Prospective, Randomized, Multi-Center Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin vs. Cefuroxime Monotherapy or Plus Oral Erythromycin for the Treatment of Chinese Hospitalized Patients With Community- Acquired Pneumonia|Completed||Phase 3|139|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:33:06.646036|2017-02-18 14:33:06.646036
NCT00648713|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||February 2004||2004-02-01|March 2008|2008-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg|Single-Dose Food In Vivo Bioequivalence Study of Terbinafine Hydrochloride Tablets (250 mg; Mylan) and Lamisil® (250 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:06.962384|2017-02-18 14:33:06.962384
NCT00648700|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2005||2005-08-01|March 2008|2008-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg|Single-Dose Fasting In Vivo Bioequivalence Study of Levothyroxine Sodium Tablets (300 μg; Mylan) to Levothroid® Tablets (300 μg; Llyod) in Healthy Volunteers.|Completed||Phase 1|32|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:07.065026|2017-02-18 14:33:07.065026
NCT00648687|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2010-07-21|||March 2008||2008-03-01|September 2009|2009-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|ROP||Pain Response During Examination for Retinopathy of Prematurity|Evaluation of the Pain Response During Examination for Retinopathy of Prematurity in Very Low Birth Weight Infants|Completed||N/A|100|Anticipated|National Bioethics Commission of Brazil||2|||f||||f||||||||||2017-02-18 14:33:07.162361|2017-02-18 14:33:07.162361
NCT00648674|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2015-08-18|||July 2008||2008-07-01|August 2015|2015-08-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers|A Prospective, Single-Site Study to Identify and Characterize the Molecular Mechanisms of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers|Withdrawn||Phase 4|0|Actual|Organogenesis||1|||f||||f||||||||||2017-02-18 14:33:07.262991|2017-02-18 14:33:07.262991
NCT00648661|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||September 2004||2004-09-01|March 2008|2008-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg|Single-Dose Food In Vivo Bioequivalence Study of Escitalopram Oxalate Tablets (20 mg; Mylan) to Lexapro® Tablets (20 mg; Forest) in Healthy Volunteers|Completed||Phase 1|35|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:07.359739|2017-02-18 14:33:07.359739
NCT00648648|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2015-02-03|||February 2008||2008-02-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)|A Phase I Dose Escalation Study Evaluating MK1775 in Both Monotherapy and in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adult Subjects With Advanced Solid Tumors|Completed||Phase 1|203|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-02-18 14:33:07.459843|2017-02-18 14:33:07.459843
NCT00648635|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-09-26|||March 2008||2008-03-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Observational|||Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations|A Pilot Study for Prospective Discovery of Possible Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations in Patients Undergoing Treatment for Locally Recurrent Rectal Adenocarcinoma|Recruiting||N/A|164|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:33:07.573514|2017-02-18 14:33:07.573514
NCT00648622|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||April 2004||2004-04-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg|Single-Dose Food In Vivo Bioequivalence Study of Carvedilol Tablets (12.5 mg; Mylan) to Coreg® Tablets (12.5 mg; GSK) in Healthy Volunteers|Completed||Phase 1|50|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:07.695592|2017-02-18 14:33:07.695592
NCT00648609|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-06-16|||March 2008||2008-03-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Community Based Self Management of COPD Facilitated by a Palliative Care Team:Impact on Health Care Utilization and QOL|Community Based Self Management of COPD Facilitated by a Palliative Care Team:Impact on Health Care Utilization and QOL|Completed||N/A|23|Actual|Essentia Health|||2||f||||f||||||||||2017-02-18 14:33:07.798486|2017-02-18 14:33:07.798486
NCT00648596|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2015-04-21|||May 2003||2003-05-01|April 2015|2015-04-01|May 2004|Actual|2004-05-01|||||Interventional|||A Study to Evaluate Self-esteem and Relationships in Males With Erectile Dysfuntion|An International, Multicentre, Randomized, Parallel Group, Double Blind, Placebo Controlled, Flexible Dose Study to Evaluate Self-esteem and Relationships in Males With Erectile Dysfunction Treated With Sildenafil Citrate|Completed||Phase 4|780|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:33:07.905598|2017-02-18 14:33:07.905598
NCT00648583|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2003||2003-07-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg|Single-Dose Food In Vivo Bioequivalence Study of Ondansetron Tablets (24 mg; Mylan) and Zofran® Tablets (24 mg; GSK) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:08.086548|2017-02-18 14:33:08.086548
NCT00648570|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2004||2004-08-01|March 2008|2008-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg|The Objective of This Study Was to Investigate the Bioequivalence of Mylan's Escitalopram Oxalate 20 mg Tablets to Forest's Lexapro® 20 mg Tablets Following a Single, Oral 20 mg (1 x 20 mg) Dose Administered Under Fasting Conditions.|Completed||Phase 1|37|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:08.178807|2017-02-18 14:33:08.178807
NCT00648557|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2003||2003-01-01|March 2008|2008-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Levothyroxine Sodium Tablets (200 mg; Mylan) to Synthroid Tablets (200 mg; Abbott) in Healthy Volunteers|Completed||Phase 1|32|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:08.279993|2017-02-18 14:33:08.279993
NCT00648544|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2003||2003-07-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects|A Two-Way Crossover, Open-Label, Single-Dose, Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Non-Smoking Male and Female Subjects|Completed||Phase 1|44|Actual|Mylan Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:33:08.379423|2017-02-18 14:33:08.379423
NCT00648531|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||May 2004||2004-05-01|March 2008|2008-03-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Balsalazide Disodium Capsules (750 mg; Mylan) and Colazal® Capsules (750 mg; Salix) in Healthy Volunteers|Completed||Phase 1|80|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:08.490483|2017-02-18 14:33:08.490483
NCT00200213|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||February 2004||2004-02-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Liking of Snack Foods - Sub-Study 1|The Effect of Portion Size and Quantity of Food Provided on Intake|Completed||N/A|32||The Miriam Hospital|||||f||||||||||||||2017-02-18 17:12:33.767725|2017-02-18 17:12:33.767725
NCT00648518|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2003||2003-12-01|March 2008|2008-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Metformin Hydrochloride ER Tablets (750 mg; Mylan) and Glucophage® XR Tablets (750 mg; Bristol-Myers Squibb) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:08.586873|2017-02-18 14:33:08.586873
NCT00648505|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||June 2005||2005-06-01|March 2008|2008-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg|Single-Dose Food In Vivo Bioequivalence Study of Glipizide and Metformin HCl Tablets (5 mg/500 mg; Mylan) to Metaglip® Tablets (5 mg/500 mg; Bristol-Myers Squibb) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:08.701635|2017-02-18 14:33:08.701635
NCT00648492|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2002||2002-10-01|March 2008|2008-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg|Single-Dose Food In Vivo Bioequivalence Study Metformin Hydrochloride ER Tablets (500 mg; Mylan) and Glucophage® XR (500 mg; Bristol-Myers Squibb) in Healthy Volunteers|Completed||Phase 1|18|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:08.799186|2017-02-18 14:33:08.799186
NCT00648479|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2011-12-25||||||December 2011|2011-12-01||||||||Interventional|||New Method for Distal Interlocking of Cannulated Intramedullary Nails|New Method for Distal Interlocking of Cannulated Intramedullary Nails|Terminated||Phase 1/Phase 2|10|Anticipated|Hadassah Medical Organization||2||the company does not want to proceed yet with the study|f||||||||||||||2017-02-18 14:33:08.899696|2017-02-18 14:33:08.899696
NCT00648466|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-30|||November 2004||2004-11-01|November 2009|2009-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Sumatriptan Succinate Tablets (100 mg; Mylan) to Imitrex® Tablets (100 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|55|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:08.98278|2017-02-18 14:33:08.98278
NCT00648453|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-01|||December 2002||2002-12-01|April 2008|2008-04-01|April 2004|Actual|2004-04-01|||||Interventional|||Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function|Effect of Plavix Treatment on NO Production Measured by Laser Doppler Method Referring to Endothelial Function in Patients With Severe Coronary Heart Disease|Completed||Phase 4|39|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:33:09.089968|2017-02-18 14:33:09.089968
NCT00648440|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2002||2002-10-01|March 2008|2008-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Food Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg|Single-Dose Food In Vivo Bioequivalence Study of Midodrine HCl Tablets (5 mg; Mylan) and ProAmatine® Tablets (5 mg; Roberts) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:09.182502|2017-02-18 14:33:09.182502
NCT00648427|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||April 2005||2005-04-01|March 2008|2008-03-01|May 2005|Actual|2005-05-01|April 2005|Actual|2005-04-01||Interventional|||Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Paroxetine Hydrochloride Controlled-Release Tablets (25 mg; Mylan) to Paxil CR™ Tablets (25 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|75|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:09.288484|2017-02-18 14:33:09.288484
NCT00648414|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2006||2006-10-01|March 2008|2008-03-01||||October 2006|Actual|2006-10-01||Interventional|||Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr|Investigational Study of the Effect of Clinical Procedures on Drug Delivery of the Fentanyl Transdermal System (25 µg/hr; Mylan) and Duragesic® (25 µg/hr; Janssen) in Healthy Volunteers|Terminated||Phase 1|12|Actual|Mylan Pharmaceuticals||6||due to multiple subjects reporting pain and burning at the phlebotomy sites after 38hr|f||||||||||||||2017-02-18 14:33:09.390731|2017-02-18 14:33:09.390731
NCT00648401|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2006||2006-01-01|March 2008|2008-03-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg|Single-Dose Fed Bioequivalence Study of Verapamil HCl Extended-Release Capsules (300 mg; Mylan) and Verelan® PM Extended-Release Capsules (300 mg; Schwarz) in Healthy Volunteers|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:09.499643|2017-02-18 14:33:09.499643
NCT00648388|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||March 2004||2004-03-01|March 2008|2008-03-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Cilostazol Tablets (100 mg; Mylan) and Pletal® Tablets(100 mg; Otsuka) in Healthy Volunteers|Completed||Phase 1|44|Actual|Mylan Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:33:09.608145|2017-02-18 14:33:09.608145
NCT00648375|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2012-06-27|||December 2003||2003-12-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Effectiveness of Propranolol For Treating People With Post-Traumatic Stress Disorder|Efficacy of Propanolol for Treatment of Posttraumatic Stress Disorder|Terminated||Phase 4|12|Actual|Weill Medical College of Cornell University||2||inadequate recruitment|f||||f||||||||||2017-02-18 14:33:09.72035|2017-02-18 14:33:09.72035
NCT00648362|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2004||2004-11-01|March 2008|2008-03-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Glimepiride Tablets (1 mg; Mylan) to Amaryl® Tablets (1 mg; Aventis) in Healthy Volunteers|Completed||Phase 1|40|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:09.839133|2017-02-18 14:33:09.839133
NCT00648349|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||May 2003||2003-05-01|March 2008|2008-03-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Rabeprazole Sodium Delayed-Release Tablets (20 mg; Mylan) to Aciphex® Delayed-Release Tablets (20 mg; Eisia) in Healthy Volunteers|Completed||Phase 1|72|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:09.943717|2017-02-18 14:33:09.943717
NCT00192764|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-09-21|||December 1996||1996-12-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|||||Interventional|||High Dose CHOP in Lymphoma|Phase II Study of Short High-dose CHOP Chemotherapy for Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|45||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:14:39.694098|2017-02-18 17:14:39.694098
NCT00648336|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2003||2003-11-01|March 2008|2008-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Mercaptopurine (50 mg; Mylan) and Purinethol® Tablets (50 mg; Gate) in Healthy Male Volunteers|Completed||Phase 1|60|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:10.041957|2017-02-18 14:33:10.041957
NCT00648323|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-04-02|||November 2003||2003-11-01|March 2008|2008-03-01|January 2005|Actual|2005-01-01|||||Interventional|||Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement|A Prospective, Open-Labeled Trial of the Safety and Efficacy of Doxazosin GITS in Patients With Benign Prostate Hyperplasia|Completed||Phase 4|80|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:33:10.363668|2017-02-18 14:33:10.363668
NCT00648310|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-03-27|||January 2004||2004-01-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|||||Interventional|||Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity|Is There A Synergic Effect Of Topical Oestrogens When Associated To Antimuscarinics In The Treatment Of Symptomatic Detrusor Overactivity|Completed||Phase 2/Phase 3|||Università degli Studi dell'Insubria||2|||f||||f||||||||||2017-02-18 14:33:10.476082|2017-02-18 14:33:10.476082
NCT00648297|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2006||2006-08-01|March 2008|2008-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg|Single-Dose Fed Bioequivalence Study of Nadolol/Bendroflumethiazide Tablets (80 mg/5 mg; Mylan) and Corzide® Tablets (80 mg/5 mg; King) in Healthy Volunteers|Completed||Phase 1|42|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:10.586067|2017-02-18 14:33:10.586067
NCT00648284|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-10-13|||March 2004||2004-03-01|October 2008|2008-10-01||||||||Observational|||Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects|An Observational Study to Assess the Impact of Pharmacological Intervention and Life Style Changes in the Reduction of Cardiovascular Disease in Patients With Diabetes Type 2 in Greece|Completed||N/A|1100||GlaxoSmithKline|||||f||||||||||||||2017-02-18 14:33:10.685652|2017-02-18 14:33:10.685652
NCT00648271|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2002||2002-12-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg|Single-Dose Food In Vivo Bioequivalence Study of Metoprolol Tartrate Tablets (25 mg; Mylan) and Lopressor® (50 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|19|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:10.765336|2017-02-18 14:33:10.765336
NCT00648258|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-07|||July 2003||2003-07-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|||||Interventional|||A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan|A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg QD And Naproxen 500mg BID In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan|Completed||Phase 3|130|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:33:10.877458|2017-02-18 14:33:10.877458
NCT00648245|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2011-02-09|||June 2008||2008-06-01|February 2011|2011-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|BREATH-1||Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD|A Phase 2a, Double Blind, Placebo Controlled, Multicenter, Dose Escalation Study to Evaluate the Safety and Efficacy of BIO 11006 Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|172|Anticipated|BioMarck Pharmaceuticals, Ltd.||5|||f||||t||||||||||2017-02-18 14:33:10.996772|2017-02-18 14:33:10.996772
NCT00648232|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2013-12-11|||May 2008||2008-05-01|December 2013|2013-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||HIV Counseling and Testing and Linkage to Care in Uganda|HIV Counseling and Testing and Linkage to Care in Uganda|Completed||N/A|3415|Actual|University of California, Los Angeles||6|||f||||t||||||||||2017-02-18 14:33:11.143536|2017-02-18 14:33:11.143536
NCT00648219|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-23|||December 2005||2005-12-01|November 2009|2009-11-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg|Single-Dose Fed In Vivo Bioequivalence Study of Olmesartan Medoxomil Tablets (40 mg; Mylan) to Benicar® Tablets (40 mg; Sankyo) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:11.259581|2017-02-18 14:33:11.259581
NCT00648206|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2013-11-01|||September 2008||2008-09-01|November 2013|2013-11-01|October 2011|Actual|2011-10-01|September 2008|Actual|2008-09-01||Observational|||Testing Alcohol Only Samples for Drugs and Drugs Only Samples for Alcohol|Retrospective Study of Unrequested Analytical Data in DUID-cases From a 2 Week Period|Completed||N/A|250|Actual|National Institute for Health and Welfare, Finland|||2||f||||f||||||Samples With DNA|"~     Whole blood samples are collected for the study. However no DNA detection is done at any~     point in the study. The laboratory where the samples are analysed does not analyse DNA. DNA~     is not relevant for this study~   "|||2017-02-18 14:33:11.354011|2017-02-18 14:33:11.354011
NCT00648193|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||December 2006||2006-12-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg|Single-Dose Fasting Bioequivalence Study of Paroxetine Hydrochloride Tablets (40 mg; Mylan) and Paxil® Tablets (40 mg; GSK) in Healthy Adult Volunteers|Completed||Early Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:11.454553|2017-02-18 14:33:11.454553
NCT00648180|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2005||2005-07-01|March 2008|2008-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mg|Single-Dose Food In Vivo Bioequivalence Study of Doxycycline Monohydrate Tablets (100 mg; Mylan) and Adoxa Tablets (100 mg; Par) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:11.551384|2017-02-18 14:33:11.551384
NCT00648167|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2014-10-10|2014-10-04||March 2008||2008-03-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||Intent-to-Treat|A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)|A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)|Completed||Phase 2|55|Actual|Keryx Biopharmaceuticals||1|||f||||t||||||||||2017-02-18 14:33:11.64779|2017-02-18 14:33:11.64779
NCT00005183|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||December 1985||1985-12-01|April 2000|2000-04-01|November 1988||1988-11-01|||||Observational|||Apolipoprotein A-I Gene Polymorphism and Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:23.359547|2017-02-18 18:15:23.359547
NCT00648154|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-30|||November 2005||2005-11-01|November 2009|2009-11-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg|Single-Dose Fed Bioequivalence Study of Letrozole Tablets (2.5 mg; Mylan) and Femara® Tablets (2.5 mg; Novartis) in Healthy Postmenopausal Female Volunteers|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:11.889544|2017-02-18 14:33:11.889544
NCT00648141|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-04-07|||January 2003||2003-01-01|March 2008|2008-03-01|January 2005|Actual|2005-01-01|||||Interventional|||Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis|A 12-Week Symptomatic Effect Evaluation to Compare Celecoxib 200 mg QD, Celecoxib 200 mg BID and Diclofenac 75 mg SR BID in Patients With Ankylosing Spondylitis|Completed||Phase 3|458|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:33:11.983861|2017-02-18 14:33:11.983861
NCT00648128|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-31|2008-03-31|||March 2003||2003-03-01|February 2003|2003-02-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State|Single Dose Crossover Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Healthy Male and Female Volunteers / Fed State|Completed||Phase 1|44|Actual|Mylan Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:33:12.135256|2017-02-18 14:33:12.135256
NCT00648115|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-08-09|2015-02-09||June 2009||2009-06-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|October 2014|Actual|2014-10-01||Interventional|||Evaluating Vocational Materials for Incarcerated Veterans With Mental Illness or Substance Abuse|Evaluating Vocational Materials for Incarcerated Veterans With Mental Illness|Active, not recruiting||N/A|111|Actual|VA Office of Research and Development||3|||f||||f||||||||No||2017-02-18 14:33:12.237184|2017-02-18 14:33:12.237184
NCT00648102|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2010-07-23|||January 2006||2006-01-01|July 2010|2010-07-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|CDX1307-02||Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer|A Phase I, Open-Label, Dose-Escalation, Multidose Study of CDX-1307, a Mannose Receptor-Targeted hCG-β Vaccine, in Patients With Incurable Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder and Ovarian Cancer|Completed||Phase 1|36|Anticipated|Celldex Therapeutics||1|||f||||f||||||||||2017-02-18 14:33:12.681353|2017-02-18 14:33:12.681353
NCT00648089|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-01-28|||April 2008||2008-04-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|EPOMI||EPOMI Study: ErythroPOietin in Myocardial Infarction|ErythroPOietin in Myocardial Infarction|Completed||Phase 2|110|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-02-18 14:33:12.776676|2017-02-18 14:33:12.776676
NCT00648076|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-09-24|||December 2004||2004-12-01|September 2009|2009-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg|Single-Dose Food In Vivo Bioequivalence Study of Divalproex Sodium Extended-Release Tablets (500 mg; Mylan) to Depakote ER® Tablets (500 mg; Abbott) in Healthy, Adult Male Volunteers|Completed||Phase 1|40|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:12.877166|2017-02-18 14:33:12.877166
NCT00648063|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-30|||November 2005||2005-11-01|November 2009|2009-11-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg|Single-Dose Fasting Bioequivalence Study of Letrozole Tablets (2.5 mg; Mylan) and Femara® Tablets (2.5 mg; Novartis) in Healthy Postmenopausal Female Volunteers|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:12.975316|2017-02-18 14:33:12.975316
NCT00648050|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||March 2006||2006-03-01|March 2008|2008-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg|Single-Dose Fasting Bioequivalence Study of Verapamil HCl Extended-Release Capsules (300 mg; Mylan) to Verelan® PM Extended-Release Capsules (300 mg; Schwarz) in Healthy Volunteers Dosed in the Evening|Completed||Phase 1|72|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:13.082647|2017-02-18 14:33:13.082647
NCT00648037|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2015-12-29|2015-10-20||March 2008||2008-03-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT|Pilot Trial of Rituximab (Rituxan) for the Prevention of EBV-LPD Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT|Completed||N/A|26|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:33:13.190473|2017-02-18 14:33:13.190473
NCT00648024|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2003||2003-01-01|March 2008|2008-03-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Anagrelide Hydrochloride Capsules (1 mg; Mylan) to Agrylin® Capsules (1 mg; Shire US) in Healthy Volunteers|Completed||Phase 1|47|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:13.419299|2017-02-18 14:33:13.419299
NCT00648011|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2003||2003-08-01|March 2008|2008-03-01|September 2003|Actual|2003-09-01|August 2003|Actual|2003-08-01||Interventional|||Food Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg|Single-Dose Food In Vivo Bioequivalence Study of Quinapril HCl and Hydrochlorothiazide Tablets (20 mg/25 mg; Mylan) to Accuretic™ Tablets (20 mg/25 mg; Parke-Davis) in Healthy Volunteers|Completed||Phase 1|44|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:13.523993|2017-02-18 14:33:13.523993
NCT00647998|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-11-03|2016-11-03||January 2008||2008-01-01|November 2016|2016-11-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|DISC||The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial|Phase 2 Dose Finding Trial of Prophylactic Darbepoetin Alfa to Improve Outcomes From Ischemic Complications of Surgery|Completed||Phase 2|18|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 14:33:13.621736|2017-02-18 14:33:13.621736
NCT00647985|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2003||2003-11-01|March 2008|2008-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg|Single-Dose Food In Vivo Bioequivalence Study of Fexofenadine Tablets (180 mg; Mylan) and Allegra® Tablets (180 mg; Aventis) in Healthy Adult Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:13.946864|2017-02-18 14:33:13.946864
NCT00192556|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-02-08|||March 2005||2005-03-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||Food Incentives for TB Treatment Compliance in East Timor (FITTCET)|Food Incentives for TB Treatment Compliance in East Timor|Completed||N/A|270||Menzies School of Health Research|||||f||||||||||||||2017-02-18 17:14:42.38452|2017-02-18 17:14:42.38452
NCT00647972|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-11-19|||May 2003||2003-05-01|November 2009|2009-11-01||||May 2003|Actual|2003-05-01||Interventional|||Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Olanzapine Tablets (20 mg; Mylan) and Zyprexa® Tablets (20 mg; Eli Lilly) in Healthy Volunteers|Terminated||Phase 1|32|Actual|Mylan Pharmaceuticals||2||"during Period 1 due to numerous orthostatic AEs that occurred. Subsequently, RLD was reduced~   to 5 mg due to safety concerns."|f||||||||||||||2017-02-18 14:33:14.038958|2017-02-18 14:33:14.038958
NCT00647959|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||March 2006||2006-03-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Fasting Study of Doxycycline Monohydrate Tablets 150 mg and Adoxa Tablets 150 mg|Single-Dose Fasting Bioequivalence Study of Doxycycline Monohydrate Tablets (150 mg; Mylan) and Adoxa Tablets (150 mg; Par) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:14.131045|2017-02-18 14:33:14.131045
NCT00647946|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-06-27|||February 2003||2003-02-01|June 2008|2008-06-01|February 2006|Actual|2006-02-01|October 2004|Actual|2004-10-01||Interventional|RAVE||Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue|A Phase II, Open-Label, Multicentre, Randomised, Comparator Study of Substitution With Tenofovir or Abacavir in HIV-1 Infected Individuals, With a Viral Load < 50 Copies/mL, Receiving a Thymidine Analogue (Zidovudine or Stavudine) as Part of Their Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 2|100|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 14:33:14.224997|2017-02-18 14:33:14.224997
NCT00647933|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2015-06-26|||June 2000||2000-06-01|June 2015|2015-06-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)|An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 After a Single Subcutaneous Dose in Healthy Female Volunteers Whose Pituitary Function is Suppressed by Lyndiol®.|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 14:33:14.326949|2017-02-18 14:33:14.326949
NCT00647920|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-03-28|||July 2003||2003-07-01|March 2008|2008-03-01||||April 2005|Actual|2005-04-01||Interventional|||Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate|Study of the Human Anti-TNF-Antibody Adalimumab|Completed||Phase 3|47|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:33:14.424074|2017-02-18 14:33:14.424074
NCT00647907|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-05-12|||April 2003||2003-04-01|May 2011|2011-05-01|May 2004|Actual|2004-05-01|||||Interventional|||A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections|An Open Label, Non-comparative, Multicenter Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infection|Completed||Phase 4|7|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:33:14.732754|2017-02-18 14:33:14.732754
NCT00647894|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2008-03-31|||January 2005||2005-01-01|March 2008|2008-03-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Alprazolam Extended-Release Tablets (1 mg; Mylan) to Xanax XR Tablets (1 mg; Pharmacia & Upjohn) in Healthy Volunteers|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:14.839911|2017-02-18 14:33:14.839911
NCT00647881|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||April 2005||2005-04-01|March 2008|2008-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg|Single-Dose Food In Vivo Bioequivalence Study of Paroxetine Hydrochloride Controlled-Release Tablets (25 mg; Mylan) to Paxil CR™ Tablets (25 mg; GlaxoSmithKline) in Healthy Volunteers|Completed||Phase 1|75|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:14.942049|2017-02-18 14:33:14.942049
NCT00647868|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2012-05-02|||May 2008||2008-05-01|May 2012|2012-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers|A Multiple Dose, Pharmacokinetic Study Comparing Different Regimens of Testosterone Given as Intranasal NASOBOL® in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers|Completed||Phase 2|32|Actual|M et P Pharma||3|||f||||f||||||||||2017-02-18 14:33:15.044328|2017-02-18 14:33:15.044328
NCT00647855|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||May 2003||2003-05-01|March 2008|2008-03-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg|Single-Dose Fasting In Vivo Bioequivalence Study of Levothyroxine Sodium Tablets (300 μg; Mylan) to Synthroid® Tablets (300 μg; Abbott) in Healthy Volunteers.|Completed||Phase 1|30|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:15.166229|2017-02-18 14:33:15.166229
NCT00647842|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||November 2005||2005-11-01|March 2008|2008-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System|Single-Dose In Vivo Bioequivalence and Wear Study of Fentanyl Transdermal System (25 µg/h; Mylan) and Fentanyl Transdermal System With Overlay (25 µg/h; Mylan) in Healthy Volunteers|Completed||Phase 1|120|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:15.261907|2017-02-18 14:33:15.261907
NCT00647829|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-04-23|||February 2003||2003-02-01|April 2008|2008-04-01|December 2003|Actual|2003-12-01|||||Interventional|||A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat|Clinical Protocol For A Double-Blind, Randomized, Placebo-Controlled Comparison Of The Efficacy, Safety, And Tolerability Of Bextra® (Valdecoxib) 20 Mg Twice Daily, Bextra® 40 Mg Once Daily, And Placebo In The Symptomatic Treatment Of Subjects With Pharyngitis|Completed||Phase 3|197|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:33:15.361948|2017-02-18 14:33:15.361948
NCT00647816|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||September 2005||2005-09-01|March 2008|2008-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg|Single-Dose Fasting Bioequivalence Study of Propranolol Hydrochloride Extended-Release Capsules (160 mg; Mylan) and Inderal® LA Capsules (160 mg; Wyeth) in Healthy Volunteers|Completed||Phase 1|100|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:15.475496|2017-02-18 14:33:15.475496
NCT00647790|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2015-08-12|||November 2006||2006-11-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer|PET Using Hormone Receptor Ligands in Breast Cancer|Completed||N/A|79|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"~     Serum blood sample postimaging, Serum Estradiol (female only)~   "|||2017-02-18 14:33:15.575328|2017-02-18 14:33:15.575328
NCT00647751|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2004||2004-08-01|March 2008|2008-03-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg|Single-Dose Food In Vivo Bioequivalence Study of Lamotrigine Tablets (25 mg; Mylan) to Lamictal® Tablets (25 mg; GSK) in Healthy Volunteers|Completed||Phase 1|28|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:15.874412|2017-02-18 14:33:15.874412
NCT00647738|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2003||2003-10-01|March 2008|2008-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State|Single Dose Crossover Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State|Completed||Phase 1|27|Actual|Mylan Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:33:15.984321|2017-02-18 14:33:15.984321
NCT00647725|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2009-09-30|||January 2003||2003-01-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|LALP||Labor Analgesia in the Latent Phrase|Labor Analgesia in the Latent Phrase of the First-stage of Spontaneous Delivery|Completed||N/A|15000|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 14:33:16.096581|2017-02-18 14:33:16.096581
NCT00647712|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2009-09-24|||December 2004||2004-12-01|September 2009|2009-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Divalproex Sodium Extended-Release Tablets (500 mg; Mylan) to Depakote ER® Tablets (500 mg; Abbott) in Healthy, Adult Male Volunteers|Completed||Phase 1|38|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:16.208696|2017-02-18 14:33:16.208696
NCT00647699|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-12-02|2016-05-02||December 2007||2007-12-01|December 2016|2016-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|CXL||Corneal Collagen Cross-linking for Progressive Keratoconus|Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus|Completed||Phase 3|147|Actual|Avedro, Inc.||2|||f||||f||||||||||2017-02-18 14:33:16.324159|2017-02-18 14:33:16.324159
NCT00647686|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||June 2006||2006-06-01|March 2008|2008-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay|Single-Dose In Vivo Bioequivalence and Wear Study of Fentanyl Transdermal System (25 µg/h; Mylan) and Fentanyl Transdermal System With Overlay (25 µg/h; Mylan) in Healthy Volunteers|Completed||Phase 1|80|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:16.940078|2017-02-18 14:33:16.940078
NCT00647673|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||January 2006||2006-01-01|March 2008|2008-03-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg|Single-Dose Fasting Bioequivalence Study of Verapamil HCl Extended-Release Capsules (300 mg; Mylan) to Verelan® PM Extended-Release Capsules (300 mg; Schwarz) in Healthy Volunteers Dosed in the Evening|Completed||Phase 1|24|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:17.033394|2017-02-18 14:33:17.033394
NCT00647660|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||July 2006||2006-07-01|March 2008|2008-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg|Single-Dose Fasting Bioequivalence Study of Nadolol/Bendroflumethiazide Tablets (80 mg/5 mg; Mylan) to Corzide® Tablets (80 mg/5 mg; King) in Healthy Volunteers|Completed||Phase 1|66|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:17.138661|2017-02-18 14:33:17.138661
NCT00647647|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||February 2004||2004-02-01|March 2008|2008-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Terbinafine Hydrochloride Tablets (250 mg; Mylan) to Lamisil® Tablets (250 mg; Novartis) in Healthy Volunteers|Completed||Phase 1|36|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:17.23709|2017-02-18 14:33:17.23709
NCT00647634|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||August 2004||2004-08-01|March 2008|2008-03-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg|Single-Dose Fasting In Vivo Bioequivalence Study of Alprazolam Extended-Release Tablets (3 mg; Mylan) to Xanax XR® Tablets (3 mg; Pharmacia & Upjohn) in Healthy Volunteers|Completed||Phase 1|21|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:17.333957|2017-02-18 14:33:17.333957
NCT00647621|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||October 2005||2005-10-01|February 2008|2008-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg|Steady-State Bioequivalence Study of Extended Phenytoin Sodium Capsules (100 mg; Mylan) and Dilantin® Kapseals® (100 mg; Pfizer) in Healthy Adult Volunteers|Completed||Phase 1|72|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:17.436058|2017-02-18 14:33:17.436058
NCT00647608|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-30|2008-03-31|||September 2005||2005-09-01|March 2008|2008-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg|Single-Dose Fed Bioequivalence Study of Propranolol Hydrochloride Extended-Release Capsules (160 mg; Mylan) and Inderal® LA Capsules (160 mg; Wyeth) in Healthy Volunteers|Completed||Phase 1|98|Actual|Mylan Pharmaceuticals||2|||f||||||||||||||2017-02-18 14:33:17.5301|2017-02-18 14:33:17.5301
NCT00647595|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2015-04-21|||October 2007||2007-10-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Physical Activity on Metabolic Syndrome in Pregnancy & Fetal Outcome|Effect of Physical Activity on Metabolic Syndrome in Pregnancy & Fetal Outcome|Completed||Phase 3|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 14:33:17.628962|2017-02-18 14:33:17.628962
NCT00647582|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2016-04-19|||October 2002||2002-10-01|April 2016|2016-04-01||||June 2005|Actual|2005-06-01||Interventional|||Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast Cancer|Phase II Study of Intra-operative Electron Irradiation and External Beam Irradiation After Lumpectomy in Patients With Stage T1N0M0 or T2N0M0 Breast Cancer|Active, not recruiting||Phase 2|80|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:33:17.739092|2017-02-18 14:33:17.739092
NCT00647036|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-28|||July 2008||2008-07-01|March 2008|2008-03-01||||July 2010|Anticipated|2010-07-01||Interventional|||Microbial Invasion During Parenteral Nutrition in Surgical Infants Receiving Glutamine|Microbial Invasion During Parenteral Nutrition in Surgical Infants Receiving Glutamine.|Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Institute of Child Health||2|||f||||f||||||||||2017-02-18 14:33:27.992886|2017-02-18 14:33:27.992886
NCT00647569|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2013-09-06|||April 2008||2008-04-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|VRAM||Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer|Randomized Controlled Trial of Collagen Mesh for Prevention of Ventral Hernia in Patients With Vertical Rectus Abdominis Musculocutaneus Flap for Advanced Pelvic Malignancy|Completed||Phase 3|59|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 14:33:17.827403|2017-02-18 14:33:17.827403
NCT00647556|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2012-09-21|2011-01-28||April 2008||2008-04-01|September 2012|2012-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage|A Comparative Study of Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream, for the Treatment of Photodamage|Completed||Phase 3|30|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||||2017-02-18 14:33:17.9922|2017-02-18 14:33:17.9922
NCT00647543|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-04-28|||August 2003||2003-08-01|April 2008|2008-04-01|April 2004|Actual|2004-04-01|||||Interventional|||Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand|A Multicenter, Eight-Week Treatment, Single-Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic Patients Achieving LDL Cholesterol Target With Atorvastatin Starting Doses Of 10 Mg, 20 Mg, And 40 Mg|Completed||Phase 4|242|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:33:21.195214|2017-02-18 14:33:21.195214
NCT00647530|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2013-08-06|||January 2008||2008-01-01|November 2008|2008-11-01|November 2012|Actual|2012-11-01|January 2012|Actual|2012-01-01||Interventional|||Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery|FOxTROT - Fluoropyrimidine, Oxaliplatin and Targeted Receptor Pre-Operative Therapy: a Controlled Trial in High-Risk Operable Colon Cancer|Completed||Phase 3|1050|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:33:21.297636|2017-02-18 14:33:21.297636
NCT00647517|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-03-31|||March 2008||2008-03-01|January 2008|2008-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|CS07102||Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis|Chung Shan Medical University Hospital, Taiwan|Completed||Phase 4|60|Actual|Chung Shan Medical University||2|||f||||f||||||||||2017-02-18 14:33:21.414656|2017-02-18 14:33:21.414656
NCT00647504|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-09-09|||October 2007||2007-10-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Observational|NIVUS||Prospective Clinical Observational Registry Including Consecutive Patients With In-stent Restenosis or Stent Thrombosis|Nordic IVUS Study: Prospective Clinical Observational Registry Study Including Consecutive Patients With Clinical Signs or Symptoms Due to In-stent Restenosis (ISR) or Definite (ARC Criteria) Stent Thrombosis (ST)|Completed||N/A|450|Anticipated|University of Tampere|||4||f||||t||||||||||2017-02-18 14:33:21.520615|2017-02-18 14:33:21.520615
NCT00647491|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2008-03-27|||February 2004||2004-02-01|March 2008|2008-03-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis||Completed||Phase 2/Phase 3|352|Actual|Abbott||4|||f||||f||||||||||2017-02-18 14:33:21.626149|2017-02-18 14:33:21.626149
NCT00647478|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2013-06-05|||October 2007||2007-10-01|June 2013|2013-06-01|July 2012|Actual|2012-07-01|October 2010|Actual|2010-10-01||Observational|SIGAL||System-IGF-1 Pathway and Alzheimer's Disease|A Multicenter Study to Assess Differences Between Circulating Levels of IGF-I and IGFBP-3 in Patients With Sporadic Late-onset Alzheimer's Disease and Control Elderly Subjects.|Completed||N/A|693|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||Samples With DNA|"~     Blood for plasma levels and polymorphisms in IGF1 system components~   "|||2017-02-18 14:33:21.754994|2017-02-18 14:33:21.754994
NCT00647465|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-28|||October 2005||2005-10-01|November 2005|2005-11-01|March 2008|Actual|2008-03-01|May 2006|Actual|2006-05-01||Interventional|GP-INFA||Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer|Randomized Double-Blind Placebo Controlled Study Evaluating the Effect of Sublingual Administration of IFNa on the Immune Response to Influenza Vaccination in Subjects Aged 75 or More.|Terminated||Phase 3|140|Actual|Assistance Publique - Hôpitaux de Paris||2||End of the study|f||||t||||||||||2017-02-18 14:33:22.07126|2017-02-18 14:33:22.07126
NCT00647452|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-11-07|||April 2008||2008-04-01|November 2011|2011-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Very Low Density Lipoprotein (VLDL) Triglyceride Metabolism in Exercise|Very Low Density Lipoprotein (VLDL) Triglyceride Metabolism in Exercise|Completed||N/A|16|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:33:22.179037|2017-02-18 14:33:22.179037
NCT00647439|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2017-01-24|||March 24, 2008||2008-03-24|November 30, 2016|2016-11-30||||||||Observational|||Genetics and Markers of Degenerative and Inflammatory Eye Diseases|Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:33:22.283697|2017-02-18 14:33:22.283697
NCT00647426|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2016-09-23|||November 2007||2007-11-01|December 2011|2011-12-01|December 2012|Actual|2012-12-01|August 2011|Actual|2011-08-01||Interventional|||Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|A Phase II Study of Sorafenib in Combination With Carboplatin and Docetaxel in the First Line Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|7|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||f||||||||||2017-02-18 14:33:22.395371|2017-02-18 14:33:22.395371
NCT00647413|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-28|||May 2008||2008-05-01|March 2008|2008-03-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|GESA||Prevent Exposure to Tobacco Smoke at Home [Gesunde Atemluft zu Hause]|Cancer Prevention by Reducing Exposure to Environmental Tobacco Smoke at Home|Unknown status|Not yet recruiting|N/A|6000|Anticipated|University Medicine Greifswald||2|||f||||f||||||||||2017-02-18 14:33:22.493846|2017-02-18 14:33:22.493846
NCT00647400|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-04-01|2009-12-04||April 2006||2006-04-01|April 2011|2011-04-01|April 2010|Actual|2010-04-01|September 2007|Actual|2007-09-01||Interventional|||Adalimumab in Adult Japanese Subjects With Psoriasis|A Multicenter Open-Label Continuation Study of the Long-term Safety and Efficacy of Adalimumab (D2E7) in Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2/Phase 3|147|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:33:22.601082|2017-02-18 14:33:22.601082
NCT00647387|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-12-14|||March 2008||2008-03-01|December 2016|2016-12-01|September 2023|Anticipated|2023-09-01|December 2018|Anticipated|2018-12-01||Interventional|VPA||Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study||Recruiting||N/A|100|Anticipated|St. Jude Medical||1|||f||||t||||||||||2017-02-18 14:33:23.360387|2017-02-18 14:33:23.360387
NCT00646347|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2009-02-04|||March 2008||2008-03-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|January 2009|Anticipated|2009-01-01||Interventional|NHOP||A Pilot Study of Neuro Hand Orthosis Program In Stroke Upper Limb Rehabilitation|A Pilot Study of Neuro Hand Orthosis Program: A Promising Restorative Therapy Treatment for the Severe Paralytic Arm in Subacute Stroke Rehabilitation|Unknown status|Recruiting|N/A|30|Anticipated|St Luke's Hospital, Singapore||2|||f||||t||||||||||2017-02-18 14:33:23.77247|2017-02-18 14:33:23.77247
NCT00646334|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2015-05-27|||June 2006||2006-06-01|May 2015|2015-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|Optilene||Comparative Study of AESCULAP Optilene® Mesh Elastic Versus Ethicon Ultrapro® Mesh in Incisional Hernia Repair|A Randomised, Multi-center, Prospective, Observer and Patient Blind Study to Evaluate AESCULAP Optilene® Mesh Elastic Versus Ethicon Ultrapro® Mesh in Incisional Hernia Repair|Completed||N/A|80|Actual|Aesculap AG||2|||f||||f||||||||||2017-02-18 14:33:23.875493|2017-02-18 14:33:23.875493
NCT00647374|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-03-01|||May 2008||2008-05-01|February 2010|2010-02-01||||||||Observational|||Assessment of Cortical Plasticity Following Short Term Limb Immobility|Assessment of Cortical Plasticity Following Short Term Limb Immobility|Suspended||N/A|||Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 14:33:23.996599|2017-02-18 14:33:23.996599
NCT00647361|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-07-18|||March 2008||2008-03-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Mechanical Ventilation Controlled by the Electrical Activity of the Patient's Diaphragm - Effects on Cardiac Performance|Short Term Effects of Neurally Adjusted Ventilatory Assist and Pressure Support Ventilation on Cardiac Performance|Completed||Phase 1|15|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 14:33:24.069806|2017-02-18 14:33:24.069806
NCT00647348|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2012-11-26|||January 2008||2008-01-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|MS-STAT||Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis|A Phase II Randomised, Placebo-controlled Clinical Trial of Simvastatin in Patients With Secondary Progressive Multiple Sclerosis.|Completed||Phase 2|140|Actual|Imperial College London||2|||f||||t||||||||||2017-02-18 14:33:24.169273|2017-02-18 14:33:24.169273
NCT00647335|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2013-05-08|||February 2008||2008-02-01|November 2011|2011-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Genetics of Polycystic Ovary Syndrome|Population Genetics of Polycystic Ovary Syndrome|Completed||N/A|189|Actual|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"~     Saliva~   "|||2017-02-18 14:33:24.280892|2017-02-18 14:33:24.280892
NCT00647322|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||September 2008||2008-09-01|March 2008|2008-03-01||||September 2010|Anticipated|2010-09-01||Interventional|||The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy|The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy|Unknown status|Not yet recruiting|Phase 4|64|Anticipated|Institute of Child Health||2|||f||||||||||||||2017-02-18 14:33:24.372675|2017-02-18 14:33:24.372675
NCT00647309|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2012-06-11|||April 2008||2008-04-01|June 2012|2012-06-01|June 2013|Anticipated|2013-06-01|February 2013|Anticipated|2013-02-01||Observational|||Troponin Elevation in the Elderly Patient With Hip Fracture|Correlation Between Troponin Level and Rehabilitation Outcome in Elderly Patient With Hip Fracture|Unknown status|Recruiting|N/A|100|Anticipated|Sheba Medical Center|||2||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 14:33:24.475787|2017-02-18 14:33:24.475787
NCT00647296|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2013-08-08||2011-01-25|March 2008||2008-03-01|August 2013|2013-08-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|CL201||Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)|A 2-Part, Randomized, Double-Blind, Safety and Tolerability Study Evaluating KNS-760704 in Patients With Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|102|Actual|Knopp Biosciences||4|||f||||f||||||||||2017-02-18 14:33:24.560305|2017-02-18 14:33:24.560305
NCT00647283|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-04-19|||November 2005||2005-11-01|April 2011|2011-04-01|December 2012|Anticipated|2012-12-01|September 2010|Actual|2010-09-01||Interventional|||Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance|ASSESSMENT OF THE SAFETY AND BENEFIT OF PROSPECTIVE IMMUNOSUPPRESSIVE DRUG WITHDRAWAL IN LIVER TRANSPLANTATION AND PREDICTION OF OPERATIONAL TOLERANCE|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|Hospital Clinic of Barcelona||1|||f||||t||||||||||2017-02-18 14:33:24.698626|2017-02-18 14:33:24.698626
NCT00647270|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-04-07|2010-04-14||December 2007||2007-12-01|April 2011|2011-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing|A Multi-center, Randomized, Double-blind,Placebo-controlled Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing|Completed||Phase 3|420|Actual|Abbott|Abbott identified Investigator non-compliance with the protocol requirements at one site and made the decision to exclude the data from this site from all efficacy analyses. Sample size was too small to demonstrate superiority and non-inferiority.|3|||f||||f||||||||||2017-02-18 14:33:24.821581|2017-02-18 14:33:24.821581
NCT00647257|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-03-31|||April 2008||2008-04-01|March 2010|2010-03-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome|The Effect of Losartan on Atrial Fibrillation and Pacemaker Dependence in Sick Sinus Syndrome (SSS) Patients Receiving Physiological Pacemaker - A Prospective, Randomized, Multicenter Study in Taiwan|Unknown status|Recruiting|N/A|220|Anticipated|Chung Shan Medical University||2|||f||||t||||||||||2017-02-18 14:33:25.77201|2017-02-18 14:33:25.77201
NCT00647244|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-12-17|||June 2008||2008-06-01|December 2010|2010-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|SWAP||Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients|Efficacy and Safety of Switching From AZT to Tenofovir|Completed||Phase 4|40|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:33:26.083578|2017-02-18 14:33:26.083578
NCT00647231|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2015-05-12||2015-03-17|March 2008||2008-03-01|May 2015|2015-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||HKT-500-US12 In Adult Patients With OA Knee Pain|Protocol HKT-500-US12: A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee|Completed||Phase 2|300|Actual|Hisamitsu Pharmaceutical Co., Inc.||2|||f||||t||||||||||2017-02-18 14:33:26.19768|2017-02-18 14:33:26.19768
NCT00647218|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2012-10-03|||February 2000||2000-02-01|October 2012|2012-10-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer|A Pilot Study of Neoadjuvant Paclitaxel and Concurrent Radiation With Correlative Molecular Studies in Stage II/III Breast Cancer|Completed||N/A|38|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 14:33:26.340077|2017-02-18 14:33:26.340077
NCT00647205|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-08-08|||January 2008||2008-01-01|August 2011|2011-08-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT|Evaluation of 2 Interferon γ Assays (QuantiFERON TB Gold In-Tube® and T-SPOT.TB®) in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT|Completed||Phase 4|240|Anticipated|French National Agency for Research on AIDS and Viral Hepatitis||6|||f||||f||||||||||2017-02-18 14:33:26.460191|2017-02-18 14:33:26.460191
NCT00647192|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2012-02-09|||March 2008||2008-03-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|EPLERAF||EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion|EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion|Terminated||Phase 2|38|Actual|University Hospital, Saarland||2||Inclusion rate too low. Recruitment of further study centers too costly.|f||||t||||||||||2017-02-18 14:33:26.592254|2017-02-18 14:33:26.592254
NCT00647179|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2016-08-11|||February 2008||2008-02-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|January 2017|Anticipated|2017-01-01||Observational|||Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment|Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment|Recruiting||N/A|20|Anticipated|University of Aarhus|||1||f||||f||||||Samples Without DNA|"~     Whole blood, serum, muscle samples, fat samples~   "|||2017-02-18 14:33:26.702401|2017-02-18 14:33:26.702401
NCT00647166|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2015-10-06|||May 2008||2008-05-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|March 2015|Actual|2015-03-01||Interventional|CHUSPAN2||Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)|Evaluation of a New Treatment Strategy for Patients With Microscopic Polyangiitis, Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) Without Poor Prognosis Factors|Completed||Phase 3|114|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:33:26.828784|2017-02-18 14:33:26.828784
NCT00647153|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-28|2015-06-03|||May 2006||2006-05-01|June 2015|2015-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer|Pre-Surgical Detection of Colorectal Carcinomas Using 123Iodine-Labeled cT84.66 Diabody Antibody Fragments to Carcinoembryonic Antigen (CEA)|Completed||N/A|1|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:33:26.94554|2017-02-18 14:33:26.94554
NCT00647140|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-07-06|||August 2007||2007-08-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|DOPMET||Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer|Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer.|Terminated||Phase 2|29|Actual|Assistance Publique - Hôpitaux de Paris||1||Insuffisent recruitment|f||||f||||||||||2017-02-18 14:33:27.061622|2017-02-18 14:33:27.061622
NCT00647127|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2012-09-13|||February 2008||2008-02-01|September 2012|2012-09-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain|Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain|Completed||Phase 3|22|Actual|University of Aarhus||3|||f||||t||||||||||2017-02-18 14:33:27.178709|2017-02-18 14:33:27.178709
NCT00647114|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2015-03-12|||August 2007||2007-08-01|March 2015|2015-03-01|April 2009|Actual|2009-04-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED)|A Phase I Study to Evaluate the Safety/Tolerability and Immunogenicity of V930/V932 in Patients With Cancer Expressing HER-2 and/or CEA|Completed||Phase 1|41|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:33:27.285466|2017-02-18 14:33:27.285466
NCT00647101|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-28|||December 2003||2003-12-01|March 2008|2008-03-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma|Open Multicenter Study on the Efficacy of Xalatan at 3 Months as First-Line Therapy in Naive Patients With Ocular Hypertension (OH) or Open Angle Glaucoma (OAG), Based on Initial Intraocular Pressure (IOP): 20 mmHg Less Than or Equal to IOP Less Than 24 mmHg, IOP Greater Than or Equal to 24 mmHg|Completed||Phase 4|600|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:33:27.395888|2017-02-18 14:33:27.395888
NCT00647088|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2016-02-24|||March 2008||2008-03-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|GENERAC||Genetic of Aortic Valve Stenosis - Clinical and Therapeutic Implications|Genetic of Aortic Valve Stenosis - Clinical and Therapeutic Implications|Recruiting||N/A|2200|Anticipated|Assistance Publique - Hôpitaux de Paris|||2||f||||t||||||Samples With DNA|"~     blood samples DNA Tissue valve~   "|No||2017-02-18 14:33:27.675099|2017-02-18 14:33:27.675099
NCT00647075|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-12-14|||November 2007||2007-11-01|March 2010|2010-03-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|YUNZHI-BC||Yunzhi as Dietary Supplement in Breast Cancer|A Randomized, Parallel, Double-blind, Placebo-controlled, Pilot Clinical Study on the Effects of Yunzhi as Dietary Supplement in 60 Adult Patients Undergoing Adjuvant/Neoadjuvant Chemotherapy for Breast Cancer.|Unknown status|Recruiting|Phase 4|60|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 14:33:27.78558|2017-02-18 14:33:27.78558
NCT00647049|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-11-16|||January 2007||2007-01-01|November 2009|2009-11-01|August 2013|Anticipated|2013-08-01|May 2013|Anticipated|2013-05-01||Interventional|||Freiburg ZNS-NHL Study|Freiburg ZNS-NHL Study: Therapy for Patients With Primary Non-Hodgkin Lymphoma of the CNS - Sequential High Dosage Chemotherapy With Autologous Peripheral Blood Stem Cell Plantation|Unknown status|Recruiting|Phase 2|78|Anticipated|University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 14:33:27.881288|2017-02-18 14:33:27.881288
NCT00647023|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||February 2004||2004-02-01|March 2008|2008-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)||Terminated||N/A|66|Actual|Hvidovre University Hospital||1|||f||||f||||||||||2017-02-18 14:33:28.082394|2017-02-18 14:33:28.082394
NCT00646997|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-06-27|||March 2008||2008-03-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Impact of Left Atrial Function on Postoperative Atrial Fibrillation|Impact Of Velocity Vector Imaging, Tissue Doppler Imaging, Conventional Echocardiography And P Wave Dispertion In Evaluating Post-Operative Atrial Fibrillation After Coronary Bypass Graft Surgery|Completed||N/A|80|Anticipated|Florence Nightingale Hospital, Istanbul|||2||f||||t||||||||||2017-02-18 14:33:28.169918|2017-02-18 14:33:28.169918
NCT00646984|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-28|||January 2002||2002-01-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|April 2005|Actual|2005-04-01||Interventional|||Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy|Comparison of Strategies of Interruption/Reinitiation of Antiretroviral Therapy in Response to Immunologic/Virologic Changes in HIV-Infected Patients With Lipodystrophy.|Completed||Phase 4|147|Actual|Hospital Clinic of Barcelona||3|||f||||t||||||||||2017-02-18 14:33:28.270369|2017-02-18 14:33:28.270369
NCT00646971|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2010-07-09|||January 2008||2008-01-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|SOREVAS||Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea|Exhaled Markers of Oxidative Stress and Endothelium-dependent Vascular Relaxation in Obstructive Sleep Apnea. Effect of Continuous Positive Airway Pressure Therapy.|Terminated||N/A|11|Actual|Assistance Publique - Hôpitaux de Paris||2||Insuffisent recrutment|f||||f||||||||||2017-02-18 14:33:28.381918|2017-02-18 14:33:28.381918
NCT00646958|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2014-02-26|2009-03-24||December 2007||2007-12-01|February 2014|2014-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||The intent-to-treat (ITT) population included those patients who were randomized and took at least one (1) dose of study medication.|Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections|A Phase 2, Multicenter, Randomized, Open-Label, Comparative Study to Evaluate the Safety and Efficacy of RX-1741 Versus Linezolid in the Outpatient Treatment of Adult Patients With Uncomplicated Skin and Skin Structure Infection|Completed||Phase 2|150|Actual|Melinta Therapeutics, Inc.|This was an unblinded study, which raises the possibility of bias.|3|||f||||f||||||||||2017-02-18 14:33:28.495696|2017-02-18 14:33:28.495696
NCT00646945|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2009-01-09|||September 2007||2007-09-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology|International, Randomized, Controled, Double-Blind Study Assessing Efficacy of Kalinox® 170 Bar During the Realization of Invasive Gestures in Adult Oncology|Completed||Phase 4|286|Anticipated|Air Liquide Santé International||2|||f||||f||||||||||2017-02-18 14:33:29.117965|2017-02-18 14:33:29.117965
NCT00646932|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||November 2005||2005-11-01|March 2008|2008-03-01||||February 2007|Actual|2007-02-01||Interventional|||Paricalcitol Injection Phase II Trial|A Phase 2, Open-Label, Multicenter, Multi-Dose Study to Evaluate the Pharmacokinetics and Tolerability of Paricalcitol Injection in Chronic Kidney Disease Stage 5 Subjects With Secondary Hyperparathyroidism Undergoing Hemodialysis|Completed||Phase 2|25|Actual|Abbott||4|||f||||f||||||||||2017-02-18 14:33:29.213945|2017-02-18 14:33:29.213945
NCT00646919|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26||||||March 2008|2008-03-01||||||||Observational|||Preoperative Nasal Swabs From Pediatric Patients|Double-Blind Prospective Study Concerning the Connection Between Positive Nasal Culture for Staphyloccoci in Pediatric Patients Undergoing Any Elective Surgery in the Out-Patient Clinic in the Hillel Yaffe Medical Center, Over a Period of One Year|Unknown status|Not yet recruiting|N/A|||Hillel Yaffe Medical Center|||1||f||||t||||||||||2017-02-18 14:33:29.338854|2017-02-18 14:33:29.338854
NCT00646906|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2013-05-14|||May 2004||2004-05-01|December 2011|2011-12-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Mechanisms of Action of Acetaminophen|A Randomized, Double-Blind, Crossover Study to Evaluate the Mechanism of Action of Acetaminophen|Completed||Phase 4|12|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-02-18 14:33:29.417414|2017-02-18 14:33:29.417414
NCT00646893|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-02-21|||June 2008||2008-06-01|February 2010|2010-02-01|April 2011|Anticipated|2011-04-01|January 2011|Anticipated|2011-01-01||Interventional|||Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age|Comparison of Embryo Transfer With and Without PGS for the Indication of Advanced Reproductive Age (37-42) in Patients Undergoing ART|Suspended||Phase 4|1200|Anticipated|Reprogenetics||2||lack of appropriate funding|f||||t||||||||||2017-02-18 14:33:29.557594|2017-02-18 14:33:29.557594
NCT00646880|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-28|||March 2003||2003-03-01|March 2008|2008-03-01|August 2003|Actual|2003-08-01|||||Interventional|||A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring|Double-Blind Crossover Comparative Ambulatory Urodynamic Monitoring (AUM) Study of Tolterodine PR and Propiverine in Korean Patients With Overactive Bladder (OAB)|Completed||Phase 3|41|Actual|Pfizer||2|||f||||||||||||||2017-02-18 14:33:29.674815|2017-02-18 14:33:29.674815
NCT00646867|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-05-19|||February 2008||2008-02-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis|An Open Label Study of the Therapeutic Effects of Tetrix Cream in Allergic Contact and Irritant Contact Dermatitis|Completed||N/A|44|Actual|Coria Laboratories, Ltd.||2|||f||||f||||||||||2017-02-18 14:33:29.782849|2017-02-18 14:33:29.782849
NCT00646854|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-01-08|||June 2008||2008-06-01|November 2012|2012-11-01|December 2016|Anticipated|2016-12-01|April 2015|Anticipated|2015-04-01||Interventional|ACT-1||Alemtuzumab and CHOP in T-cell Lymphoma|A Randomized Phase III Study to Evaluate the Efficacy of Chemoimmunotherapy With the Monoclonal Antibody Campath-1H (Alemtuzumab) Given in Combination With 2-weekly CHOP Versus 2-weekly CHOP Alone and Consolidated by Autologous Stem Cell Transplant, in Young Patients With Previously Untreated Systemic Peripheral T-cell Lymphomas|Unknown status|Active, not recruiting|Phase 3|308|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:33:29.878582|2017-02-18 14:33:29.878582
NCT00646841|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-08-07|||February 2003||2003-02-01|August 2008|2008-08-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients|The Effects of Doxazosin Gastrointestinal Therapeutic System (GITS) on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensives on Drug Therapy|Completed||Phase 4|89|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:33:30.058616|2017-02-18 14:33:30.058616
NCT00646828|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-01-18|||May 2008||2008-05-01|July 2010|2010-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|PHACARV||Cardiovascular Evaluation of Adult PHA 1 Patients|Cardiovascular Evaluation of a Rare Condition With Hyperaldosteronism Without Hypertension: PHA 1|Completed||N/A|98|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-02-18 14:33:30.182182|2017-02-18 14:33:30.182182
NCT00646815|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2009-10-21|||March 2008||2008-03-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency|Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency|Completed||N/A|24|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 14:33:30.294145|2017-02-18 14:33:30.294145
NCT00646802|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2016-08-18|||June 2008||2008-06-01|August 2016|2016-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PROMISE||Vaginal PROgesterone as Maintenance Treatment After an epISode of prEterm Labor (PROMISE Study)|Vaginal Progesterone as a Maintenance Treatment in Women With Previous Preterm Labor. Randomized, Double Blinded, Placebo-controlled Trial|Completed||Phase 4|265|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 14:33:30.406327|2017-02-18 14:33:30.406327
NCT00646789|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2015-05-29|||May 2008||2008-05-01|May 2015|2015-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019)|A Multicenter, Open-Label, Single Dose Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:33:30.519513|2017-02-18 14:33:30.519513
NCT00646776|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2013-01-23|2010-09-03||April 2008||2008-04-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Drug Interaction Study|Study to Evaluate the Exposure of Rifabutin Administered in an Alternate Regimen in Combination With Atazanavir and Ritonavir Healthy Subjects|Completed||Phase 1|85|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:33:30.620413|2017-02-18 14:33:30.620413
NCT00646763|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2013-11-26|2012-03-14||April 2008||2008-04-01|November 2013|2013-11-01|February 2011|Actual|2011-02-01|September 2009|Actual|2009-09-01||Interventional|||A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation|A Phase II Single Institution Randomized Study Comparing Cytokine Administration Sites for Mobilization of Peripheral Hematopoietic Progenitor Cells for Patients Undergoing Autologous Hematopoietic Progenitor Cell Transplant|Terminated||Phase 2|35|Actual|Emory University||2||Accrual goal met|f||||t||||||||||2017-02-18 14:33:31.747652|2017-02-18 14:33:31.747652
NCT00646750|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-02-12|||January 2008||2008-01-01|February 2016|2016-02-01|June 2012|Actual|2012-06-01|February 2010|Actual|2010-02-01||Interventional|Z-BEAM LDGGB||Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom|Autologous Transplantation of Haematopoietic Stem Cells With Conditioning Including Zevalin + BEAM to Patients Suffering From Refractory Large B-cell Diffuse Lymphom|Completed||Phase 2|31|Actual|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||f||||||||||2017-02-18 14:33:32.152187|2017-02-18 14:33:32.152187
NCT00646737|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2012-05-07|||May 2008||2008-05-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant|Phase IV Study of Enteric-coated Mycophenolate Sodium in Combination With Tacrolimus in Renal Transplant Patient|Completed||Phase 4|18|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:33:32.265811|2017-02-18 14:33:32.265811
NCT00646724|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2011-06-15|||January 2008||2008-01-01|June 2011|2011-06-01|January 2014|Anticipated|2014-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients|Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Fuzhou General Hospital||1|||f||||t||||||||||2017-02-18 14:33:32.369945|2017-02-18 14:33:32.369945
NCT00646711|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||February 2003||2003-02-01|March 2008|2008-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Pediatric Switch Study for Children and Adolescent Patients With Epilepsy|A 14 Day Randomized, Open-Label, Cross-Over, Single Center, Outpatient Study of Depakote Delayed-Release or Depakote Sprinkle vs. Divalproex Sodium Extended-Release in Child and Adolescent Patients With Epilepsy|Completed||Phase 2|16|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:33:32.461748|2017-02-18 14:33:32.461748
NCT00646698|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-03-27|||April 2006||2006-04-01|March 2008|2008-03-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Observational|||Body Composition and Very-Low-Density-Lipoprotein-Triglycerides (VLDL-TG) Kinetics|Impact of Body Composition on Very-Low-Density-Lipoprotein-Triglycerides Kinetics|Completed||N/A|30|Actual|University of Aarhus|||3||f||||f||||||||||2017-02-18 14:33:32.557988|2017-02-18 14:33:32.557988
NCT00646685|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2014-07-24|||February 2008||2008-02-01|June 2012|2012-06-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Duct-to-duct vs Roux-en-y Hepaticojejunostomy for Biliary Reconstruction in Adult Living Donor Liver Transplantation|Prospective Randomized Trial for Comparison of Duct-to-duct and Roux-en-y Hepaticojejunostomy for Biliary Reconstruction in Adult Living Donor Liver Transplantation|Unknown status|Enrolling by invitation|Phase 4|80|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 14:33:32.647135|2017-02-18 14:33:32.647135
NCT00646672|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2017-01-24|||March 17, 2008||2008-03-17|April 16, 2010|2010-04-16|April 16, 2010||2010-04-16|||||Observational|||Aneurysms and Carotid Artery Block in Newborns|Assessment of Cerebral Circulation and Perfusion in Adults After Neonatal Carotid Occlusion|Completed||N/A|6|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:33:32.749647|2017-02-18 14:33:32.749647
NCT00646659|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2013-01-07|||February 2008||2008-02-01|January 2013|2013-01-01|April 2011|Actual|2011-04-01|May 2010|Actual|2010-05-01||Interventional|||Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery|Randomized Phase II Feasibility Study of Cetuximab Combined With 4 Cycles of TPF Followed by Platinum Based Chemo-radiation Strategies|Terminated||Phase 2|47|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||Recruitment was suspended prematurely for safety concerns and closed after IDMC review|f||||||||||||||2017-02-18 14:33:32.885395|2017-02-18 14:33:32.885395
NCT00646646|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2014-04-08|2013-06-27||April 2007||2007-04-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|Eye Movement||The Effect of Sedation on Eye Movements|The Effect of Sedation on Eye Movements|Completed||N/A|65|Actual|University of Alabama at Birmingham||4|||f||||f||||||||||2017-02-18 14:33:33.150462|2017-02-18 14:33:33.150462
NCT00646061|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2009-09-20|||November 2007||2007-11-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pain Control in Renal Colic||Completed||Phase 1|||Seoul National University Hospital||2|||f||||||||||||||2017-02-18 14:33:41.915367|2017-02-18 14:33:41.915367
NCT00646633|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2016-07-05|||March 2008||2008-03-01|March 2008|2008-03-01|October 2009|Actual|2009-10-01|January 2009|Actual|2009-01-01||Interventional|||Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors|Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors|Completed||N/A|12|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 14:33:33.702858|2017-02-18 14:33:33.702858
NCT00646620|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-04-03|||April 2003||2003-04-01|April 2009|2009-04-01|September 2003|Actual|2003-09-01|||||Interventional|||Symbicort Onset of Action 1|A Randomized, Multicenter, Placebo and Active-Controlled, Single-Dose, 4-Period, Crossover Study to Evaluate the Bronchodilating Effect of SYMBICORT pMDI Versus Advair Diskus and Ventolin HFA.|Completed||Phase 3|48|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:33:33.814723|2017-02-18 14:33:33.814723
NCT00646607|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2014-11-25|||June 2007||2007-06-01|December 2009|2009-12-01|November 2014|Actual|2014-11-01|April 2013|Actual|2013-04-01||Interventional|TOSCA||FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer|A Randomized Trial Investigating the Role of FOLFOX-4 Regimen Duration (3 Versus 6 Months) and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer|Completed||Phase 3|3756|Actual|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente||2|||f||||t||||||||||2017-02-18 14:33:33.928702|2017-02-18 14:33:33.928702
NCT00646594|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-03-26|||November 2003||2003-11-01|March 2009|2009-03-01|January 2005|Actual|2005-01-01|||||Interventional|||Atlantis Symbicort|A Two Stage Randomized, Open-Label, Parallel Group, Phase III, Multicenter, 7 Month Study to Assess the Efficacy & Safety of SYMBICORT pMDI Adminstered Either as Fixed or as an Adjustable Regimen Versus a Fixed Regimen of Advair in Subjects 12 Yrs of Age and Older With Asthma.|Completed||Phase 3|1200|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:33:34.182532|2017-02-18 14:33:34.182532
NCT00646581|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-02-12|2012-08-17||October 2006||2006-10-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of Single Dose Intranasal Insulin On Cognitive Function|Effect of Single Dose Intranasal Insulin on Cognitive Function in Patients With Schizophrenia|Completed||Phase 4|30|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 14:33:34.279838|2017-02-18 14:33:34.279838
NCT00646568|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2011-06-22|||June 2008||2008-06-01|June 2011|2011-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Human Chorionic Gonadotropin (hCG) Test: A Novel Method to Evaluate the Ovarian Reserve|hCG Stimulating Test of the Thecal Cells to Evaluate the Ovarian Reserve|Completed||N/A|60|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-02-18 14:33:34.731454|2017-02-18 14:33:34.731454
NCT00646555|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2017-01-24|||November 20, 2003||2003-11-20|April 10, 2012|2012-04-10|April 10, 2012||2012-04-10|||||Observational|||Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis|Evaluation of Angiogenesis Parameters and Tumor Markers in Inflammatory Breast Cancer Specimens|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:33:34.830339|2017-02-18 14:33:34.830339
NCT00646542|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-01-03||2013-01-02|March 2005||2005-03-01|January 2013|2013-01-01||||October 2010|Actual|2010-10-01||Interventional|||Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency|A Multi-center, Randomized, Double-blind Clinical Trial to Evaluate the Safety and Tolerability of 24 Weeks Treatment With (50 mg qd) Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency|Completed||Phase 3|525|Actual|Novartis||2|||f||||t||||||||||2017-02-18 14:33:34.921804|2017-02-18 14:33:34.921804
NCT00646529|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-03-27|||July 2002||2002-07-01|March 2009|2009-03-01|October 2003|Actual|2003-10-01|||||Interventional|||Long-Term Safety of Symbicort in Asthmatic Children - SAPLING|A Six Month, Randomized, Open-Label, Safety Study of Symbicort (160/4.5mcg) Compared to Pulmicort Turbuhaler in Asthmatic Children Aged Six to Eleven Years - SAPLING|Completed||Phase 3|175|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:33:35.036734|2017-02-18 14:33:35.036734
NCT00646516|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-01-21|||October 2003||2003-10-01|January 2011|2011-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Gemini Symbicort pMDI|A Rand, Doubleblind, Activecontrolled, Parallel-grp,Singledummy, Multicenter,12 wk Study to Assess the Effic.&Safety of Symbicort pMDI 2x160/4.5mcg QD Compared to Symb. pMDI 2x80/4.5mcg QD, Symb. pMDI 2x80/4.5mcg Bid and to Budesonide pMDI 2x160 Mcg QD in Asthmatic Sub's12yrs and Over|Completed||Phase 3|615|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:33:35.130122|2017-02-18 14:33:35.130122
NCT00646503|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2016-11-16|||March 2008||2008-03-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B|A Single Arm, Multicenter, Open-label, 52-week, the Omnibus Extension Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B and Are HBV DNA PCR Negative at the End of Year 4 Treatment|Completed||Phase 4|150|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:33:35.217447|2017-02-18 14:33:35.217447
NCT00646490|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2013-02-27|||July 2005||2005-07-01|March 2008|2008-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Pleural Fluid and Serum Procalcitonin in Patients With Parapneumonic Pleural Effusion|Diagnostic and Prognostic Values of Pleural Fluid Procalcitonin in Parapneumonic Pleural Effusion|Completed||N/A|150|Actual|Chang Gung Memorial Hospital|||2||f||||f||||||Samples Without DNA|"~     serum,pleural fluid~   "|||2017-02-18 14:33:35.327133|2017-02-18 14:33:35.327133
NCT00646477|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||October 2007||2007-10-01|March 2008|2008-03-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|||ISIS 1 Therapeutic Effectiveness|Therapeutic Efficacy Evaluation of the CPAP/autoCPAP Sandman in the Treatment of New Patients With Obstructive Sleep Apnoea Syndrome|Unknown status|Recruiting|Phase 3|24|Anticipated|Tyco Healthcare Group||4|||f||||f||||||||||2017-02-18 14:33:35.41419|2017-02-18 14:33:35.41419
NCT00646464|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2009-08-10|||February 2008||2008-02-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|May 2010|Anticipated|2010-05-01||Observational|CPT||New Continuous Performance Tests (CPT) for the Diagnosis of Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)|New Computerized Continuous Performance Test (CPT) for Diagnosing Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)|Unknown status|Recruiting|N/A|500|Anticipated|Hadassah Medical Organization|||2||f||||f||||||||||2017-02-18 14:33:35.509685|2017-02-18 14:33:35.509685
NCT00645645|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2017-01-24|||October 2, 1998||1998-10-02|September 26, 2016|2016-09-26||||||||Observational|||A Study of the Genetic Analysis of Brain Disorders|Genetic Analysis of Brain Disorders|Recruiting||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:33:49.194025|2017-02-18 14:33:49.194025
NCT00646451|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-11-04|||June 2006||2006-06-01|November 2015|2015-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pregabalin in the Treatment of Essential Tremor|A 17 Week, Investigator-initiated, Single-center, Double-blind, Randomized, Placebo-controlled, Cross-over Trial of Pregabalin in Essential Tremor|Completed||Phase 4|20|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 14:33:35.606975|2017-02-18 14:33:35.606975
NCT00646438|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2009-02-03|||March 2009||2009-03-01|March 2008|2008-03-01|December 2012|Anticipated|2012-12-01|February 2012|Anticipated|2012-02-01||Interventional|USCDP||United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study|United States CABG Diabetes Project (USCDP) Pilot Study|Unknown status|Not yet recruiting|N/A|120|Anticipated|Providence Heart & Vascular Institute||2|||f||||f||||||||||2017-02-18 14:33:35.712789|2017-02-18 14:33:35.712789
NCT00646425|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-08-17|||May 2008||2008-05-01|August 2010|2010-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|BSX-003||The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis|Randomized, Double-Masked, Placebo-controlled Evaluation of the Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis Who Undergo Tapering of Concomitant Immunosuppressive Medications|Terminated||Phase 2|5|Actual|Cerimon Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:33:35.827118|2017-02-18 14:33:35.827118
NCT00646412|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2015-09-08|||July 2008||2008-07-01|September 2015|2015-09-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|A-PART||A-Part® Gel as Adhesion Prophylaxis After Major Abdominal Surgery Versus a Non-treated Group|A Prospective, Randomised, Controlled, Single-blind Phase I-II Clinical Trial on the Safety of A-Part® Gel as Adhesion Prophylaxis After Major Abdominal Surgery Versus a Non-treated Group|Completed||Phase 1/Phase 2|60|Actual|Aesculap AG||2|||f||||f||||||||||2017-02-18 14:33:35.929891|2017-02-18 14:33:35.929891
NCT00646399|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-10-20|2011-08-22||March 2009||2009-03-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis|A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight (VLBW) Neonates for the Prevention of Staphylococcal Sepsis|Completed||Phase 2/Phase 3|1579|Actual|Biosynexus Incorporated||2|||f||||t||||||||||2017-02-18 14:33:36.10037|2017-02-18 14:33:36.10037
NCT00646386|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||March 2003||2003-03-01|March 2008|2008-03-01||||April 2004|Actual|2004-04-01||Interventional|||Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis|Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis|Completed||Phase 2|315|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:33:36.641931|2017-02-18 14:33:36.641931
NCT00646373|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2011-04-19|||December 2006||2006-12-01|December 2006|2006-12-01||||December 2006|Actual|2006-12-01||Interventional|||Effect of Decreased Pump Prime Volume on Blood Transfusions and Postoperative Complications of Patients Undergoing High Risk Cardiac Surgical Procedures|Effect of Decreased Pump Prime Volume on Blood Transfusions and Postoperative Complications of Patients Undergoing High Risk Cardiac Surgical Procedures: A Pilot Study|Terminated||N/A|50|Actual|University Health Network, Toronto||1||"Protocol was comparing to standard of practice, which has changed over the course of slow~   recruitment and no longer can be used as a comparator."|f||||||||||||||2017-02-18 14:33:36.729052|2017-02-18 14:33:36.729052
NCT00646360|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2016-02-17|||February 2005||2005-02-01|February 2016|2016-02-01|December 2018|Anticipated|2018-12-01|July 2007|Actual|2007-07-01||Interventional|||Effects of Prenatal DHA Supplements on Infant Development|Effects of Prenatal DHA Supplements on Infant Development|Active, not recruiting||Phase 3|1094|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:33:36.804336|2017-02-18 14:33:36.804336
NCT00646321|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-01-21|||April 2003||2003-04-01|January 2011|2011-01-01|August 2004|Actual|2004-08-01|||||Interventional|||Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT|A 12 Week, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study of SYMBICORT pMDI Administered Once Daily in Children and Adolescents 6 to 15 Years of Age With Asthma - SPROUT|Completed||Phase 3|540|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:33:36.895549|2017-02-18 14:33:36.895549
NCT00646308|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2011-04-22|||March 2008||2008-03-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Observational|||Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas|Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas|Terminated||N/A|60|Anticipated|Columbia University|||2|Poor enrollment|f||||f||||||None Retained|"~     Serum samples~   "|||2017-02-18 14:33:36.98983|2017-02-18 14:33:36.98983
NCT00646295|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-06-18|||June 2008||2008-06-01|June 2008|2008-06-01|September 2010|Anticipated|2010-09-01|June 2010|Anticipated|2010-06-01||Interventional|||Pascal Pascal Dynamic Contour Tonometer (DCT) Intraocular Pressure and Ocular Pulse Amplitude in Patients With Thyroid Related Orbitopathy: A Comparison to Goldmann Tonometer and to Muscles Characteristics on CT Scan|Pascal Dynamic Contour Tonometer Intraocular Pressure and Ocular Pulse Amplitude in Patients With Thyroid Related Orbitopathy: A Comparison to Goldmann Tonometer and to Muscles Characteristics on Orbital CT Scan|Unknown status|Recruiting|N/A|30|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 14:33:37.101286|2017-02-18 14:33:37.101286
NCT00646282|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2015-01-14|2015-01-14||April 2008||2008-04-01|January 2015|2015-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|PAD||Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients|Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney|Terminated||Phase 4|12|Actual|Emory University|Due to slow enrollment and primary investigator leaving institution, the study was terminated. Subjects were notified and those on active drug returned to their physicians to be treated according to standard of care.|2||slow enrollment and discontinued once original principal investigator left Emory|f||||f||||||||||2017-02-18 14:33:37.193554|2017-02-18 14:33:37.193554
NCT00646269|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2013-07-31|||March 2008||2008-03-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|ETNA3||Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease|Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease|Completed||Phase 3|640|Actual|University Hospital, Bordeaux||4|||f||||t||||||||||2017-02-18 14:33:39.967899|2017-02-18 14:33:39.967899
NCT00005159|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-08-05|||July 1983||1983-07-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|||||Observational|||National Longitudinal Mortality Study (NLMS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:25.601317|2017-02-18 18:15:25.601317
NCT00646256|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||February 2006||2006-02-01|March 2008|2008-03-01||||December 2008|Anticipated|2008-12-01||Interventional|COGPIP||Cognitive Determinants of Psychoeducation and Information in Psychoses|Psychoeducation in Patients With Schizophrenia: Neuropsychological Performance and Cognitive Training as Determinants of Outcome|Unknown status|Recruiting|N/A|120|Anticipated|German Research Foundation||2|||f||||f||||||||||2017-02-18 14:33:40.127509|2017-02-18 14:33:40.127509
NCT00646243|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-27|||March 2008||2008-03-01|March 2008|2008-03-01|March 2009|Anticipated|2009-03-01|||||Observational|IMPROVE||Echo Assessment of Intraventricular Dyssynchrony|Italian Multicenter PROject on Echo Assessment of Left VEntricular (IMPROVE) Dyssynchrony Study|Unknown status|Not yet recruiting|N/A|336|Anticipated|Italian Society of Cardiology|||2||f||||f||||||||||2017-02-18 14:33:40.23759|2017-02-18 14:33:40.23759
NCT00646230|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-12-20|||December 2006||2006-12-01|December 2016|2016-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|IV Fenretinide||N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma|A Phase I Study of Intravenous (Emulsion) Fenretinide in Children With Recurrent or Resistant Neuroblastoma|Completed||Phase 1|17|Actual|Children's Hospital Los Angeles||1|||f||||t||||||||||2017-02-18 14:33:40.351015|2017-02-18 14:33:40.351015
NCT00646217|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2016-11-23|||July 2005||2005-07-01|November 2016|2016-11-01|February 2010|Actual|2010-02-01|March 2008|Actual|2008-03-01||Interventional|||Self Care TALK Study - Promoting Stroke Caregiver Health|Promoting Stroke Caregiver Health Vis Self Care TALK: Education and Support Telephone Partnerships With Nurses|Completed||N/A|39|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:33:40.465642|2017-02-18 14:33:40.465642
NCT00646204|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2009-04-30|||April 2006||2006-04-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease|A 16 WEEK, INVESTIGATOR-INITIATED, SINGLE-CENTER, DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF NAMENDA® (MEMANTINE HCL) FOR NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE|Completed||Phase 4|40|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 14:33:40.569456|2017-02-18 14:33:40.569456
NCT00646191|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||March 2003||2003-03-01|March 2008|2008-03-01||||June 2004|Actual|2004-06-01||Interventional|||Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Multicenter Extension Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|137|Actual|Abbott||3|||f||||f||||||||||2017-02-18 14:33:40.679626|2017-02-18 14:33:40.679626
NCT00646178|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||June 2003||2003-06-01|March 2008|2008-03-01||||March 2004|Actual|2004-03-01||Interventional|||Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy|Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy|Completed||Phase 3|102|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:33:40.98924|2017-02-18 14:33:40.98924
NCT00646165|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-03-30|||July 2008||2008-07-01|March 2010|2010-03-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|||Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia|Phase 1, Multicentre, Open-label, Dose Finding Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia|Terminated||Phase 1|1|Actual|Mundipharma Research Limited||||Poor recruitment and change in development strategy|f||||||||||||||2017-02-18 14:33:41.088982|2017-02-18 14:33:41.088982
NCT00646152|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2017-01-24|||March 24, 2008||2008-03-24|July 1, 2014|2014-07-01|December 16, 2009|Actual|2009-12-16|December 16, 2009|Actual|2009-12-16||Interventional|||Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study|A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC|Completed||Phase 1|57|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:33:41.17715|2017-02-18 14:33:41.17715
NCT00646139|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-03-01|||October 2007||2007-10-01|March 2011|2011-03-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Interventional|||KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment|A Combined Rising Single-Dose (RSD) and Rising Multiple-Dose (RMD) Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of KX2-391 in Patients With Advanced Malignancies That Are Refractory to Conventional Therapies|Completed||Phase 1|7|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 14:33:41.27885|2017-02-18 14:33:41.27885
NCT00646126|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-27|||August 2005||2005-08-01|August 2005|2005-08-01||||||||Interventional|||Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission|Validation of the Use of Istope-Based Molecular Techniques for Malaria Control|Completed||Phase 3|||Tropical Medicine Research Institute||2|||f||||t||||||||||2017-02-18 14:33:41.388233|2017-02-18 14:33:41.388233
NCT00646113|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2016-03-21|||March 2008||2008-03-01|March 2016|2016-03-01||||August 2014|Actual|2014-08-01||Interventional|||Study Evaluating OsseoSpeed™ Narrow Implant in the Upper and Lower Anterior Jaw|An Open, Prospective, Single Arm, Multi-centre Study Evaluating Osseospeed™ Implant 3 mm Diameter Replacing a Central or Lateral Mandibular Incisor or Lateral Maxillary Incisor. A 5-year Follow-up Study.|Completed||N/A|72|Actual|Dentsply Sirona Implants||1|||f||||f||||||||||2017-02-18 14:33:41.487673|2017-02-18 14:33:41.487673
NCT00646100|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2012-06-05|||July 2007||2007-07-01|June 2012|2012-06-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|TACEHCC||Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis|Transarterial Chemoembolization Versus Best Support for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis|Completed||Phase 4|164|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 14:33:41.595753|2017-02-18 14:33:41.595753
NCT00646087|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2011-06-03|||March 2008||2008-03-01|June 2011|2011-06-01||||||||Interventional|||Ketamine Frequency Treatment for Major Depressive Disorder|Ketamine Frequency Treatment for Major Depressive Disorder|Withdrawn||Phase 4|0|Actual|Essentia Health||2||Pilot study determined that this study would not be feasible.|f||||f||||||||||2017-02-18 14:33:41.712892|2017-02-18 14:33:41.712892
NCT00646074|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2012-03-05|||July 2006||2006-07-01|March 2012|2012-03-01|August 2008|Actual|2008-08-01|March 2008|Actual|2008-03-01||Interventional|||Self- Care TALK Study - Promoting Alzheimer's Disease (AD) Spousal Caregiver Health|Self Care TALK to Promote AD Spousal Caregiver Health|Completed||N/A|46|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:33:41.823875|2017-02-18 14:33:41.823875
NCT00646048|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-01-26|2010-06-29||February 2003||2003-02-01|January 2011|2011-01-01|March 2010|Actual|2010-03-01|November 2004|Actual|2004-11-01||Interventional|AAA IDE||A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms|A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms|Completed||Phase 1|43|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 14:33:42.020291|2017-02-18 14:33:42.020291
NCT00646035|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||January 2002||2002-01-01|March 2008|2008-03-01||||November 2002|Actual|2002-11-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis|A Phase III, Prospective, Placebo-Controlled, Double-Blind, Randomized, Multi-Center Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis|Completed||Phase 3|75|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:33:42.375774|2017-02-18 14:33:42.375774
NCT00646022|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2017-01-24|||March 24, 2008||2008-03-24|September 14, 2016|2016-09-14||||||||Observational|||Natural History of Familial Carcinoid Tumor|Natural History of Familial Carcinoid Tumor|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:33:42.708169|2017-02-18 14:33:42.708169
NCT00646009|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-01-21|||March 2003||2003-03-01|January 2011|2011-01-01|August 2003|Actual|2003-08-01|||||Interventional|||Symbicort Onset of Action 2|A Randomized, Multicenter, Placebo and Active-controlled, Single-dose, 4-period, Crossover Study to Evaluate the Bronchodilating Effect of SYMBICORT pMDI Versus Advair Diskus and Ventolin HFA.|Completed||Phase 3|48|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:33:42.806341|2017-02-18 14:33:42.806341
NCT00645996|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-26|||March 2008||2008-03-01|March 2008|2008-03-01|October 2009|Anticipated|2009-10-01|July 2009|Anticipated|2009-07-01||Interventional|||The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants||Unknown status|Recruiting|N/A|100|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 14:33:42.909809|2017-02-18 14:33:42.909809
NCT00645983|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2009-12-01|||October 2005||2005-10-01|December 2009|2009-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Chamomile Therapy for Generalized Anxiety|Chamomile Therapy for Generalized Anxiety Disorder|Completed||Phase 4|61|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:33:43.010065|2017-02-18 14:33:43.010065
NCT00645970|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2015-05-14|2014-12-08||July 2008||2008-07-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Pain, Psychiatric Disorders, and Disability Among Veterans With and Without Polytrauma|Pain, Psychiatric Disorders, and Disability Among Veterans With and Without Polytrauma|Completed||N/A|359|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 14:33:43.121266|2017-02-18 14:33:43.121266
NCT00645957|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-11-19|||February 2008||2008-02-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|redrubber||A Comparison of Redrubber Versus Penrose Drains|A Comparison of Redrubber Versus Penrose Drains in the Management of Odontogenic (Dental) Infections|Completed||N/A|50|Actual|Emory University||2|||f||||f||||||||||2017-02-18 14:33:43.522697|2017-02-18 14:33:43.522697
NCT00645944|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2015-06-22|2015-05-05||April 2008||2008-04-01|June 2015|2015-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional||Of the remaining 39 randomized, 19 were randomized to placebo and 20 to eszopiclone 3mg. Two participants in the placebo arm and 1 participant in the eszopiclone arm withdrew before receiving study medication|Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia|Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia|Completed||N/A|39|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:33:43.631664|2017-02-18 14:33:43.631664
NCT00645931|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2009-12-29|||June 2004||2004-06-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Observational|||Psychological Effects of Bone Marrow Transplants in Children|Proposal for a Bone Marrow Transplant Pre, Post, and Long Term Psychological Evaluation Study.|Completed||N/A|40|Anticipated|Spectrum Health Hospitals|||1||f||||f||||||||||2017-02-18 14:33:44.011292|2017-02-18 14:33:44.011292
NCT00645918|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2011-06-15|||June 2008||2008-06-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|GRAVITAS||GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety|GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety|Completed||N/A|2800|Actual|Accumetrics, Inc.||3|||f||||t||||||||||2017-02-18 14:33:44.125994|2017-02-18 14:33:44.125994
NCT00645905|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||June 2003||2003-06-01|March 2008|2008-03-01||||March 2005|Actual|2005-03-01||Interventional|||Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|148|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:33:44.310239|2017-02-18 14:33:44.310239
NCT00645892|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||November 2003||2003-11-01|March 2008|2008-03-01||||September 2004|Actual|2004-09-01||Interventional|||Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|32|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:33:44.393358|2017-02-18 14:33:44.393358
NCT00645879|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2015-01-17|||July 2008||2008-07-01|January 2015|2015-01-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Anaplerotic Therapy in Propionic Acidemia|Safety & Efficacy of Investigational Products: Ornithine Alpha-ketoglutarate, Glutamine, or Disodium Citrate on Hyperammonemia in Propionic Acidemia.|Completed||Phase 1|3|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:33:44.484891|2017-02-18 14:33:44.484891
NCT00645866|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2011-05-13|||April 2003||2003-04-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer|A Neo-Adjuvant Study of Sequential Epirubicin and Docetaxel in Combination With Capecitabine in Patients With Locally Advanced Breast Cancer|Completed||Phase 2|47|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:33:44.607221|2017-02-18 14:33:44.607221
NCT00645853|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2012-03-20|2011-06-30||October 2007||2007-10-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Long-term Safety in Atrial Fibrillation Patients|Long-term Treatment With the Oral Direct Thrombin Inhibitor AZD0837, Compared to Vitamin-K Antagonists, as Stroke Prevention in Patients With Non-valvular Atrial Fibrillation and One or More Risk Factors for Stroke and Systemic Embolic Events. A 5-year Follow-up Study|Completed||Phase 2|523|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:33:44.710748|2017-02-18 14:33:44.710748
NCT00645840|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2012-06-12|||March 2008||2008-03-01|June 2010|2010-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes|An Exploratory, Open Label Study of Anti-inflammatory Therapy With Anakinra in Children With Newly Diagnosed Type 1 Diabetes Mellitus|Completed||Phase 1/Phase 2|15|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 14:33:45.627796|2017-02-18 14:33:45.627796
NCT00645827|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2014-09-12|2014-09-03||January 2008||2008-01-01|September 2014|2014-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|IICE||Use of an Insulin Infusion Conversion Equation (IICE) to Control Blood Glucose in Hospitalized Patients|Use of an Insulin Infusion Conversion Equation (IICE) to Improve Inpatient Glycemic Control: A Randomized Controlled Trial|Completed||N/A|78|Actual|Emory University||2|||f||||f||||||||||2017-02-18 14:33:45.737644|2017-02-18 14:33:45.737644
NCT00645814|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2008-03-26|||March 2003||2003-03-01|March 2008|2008-03-01||||September 2003|Actual|2003-09-01||Interventional|||Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|148|Actual|Abbott||3|||f||||f||||||||||2017-02-18 14:33:46.193203|2017-02-18 14:33:46.193203
NCT00645801|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2012-09-04|||March 2008||2008-03-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Amitiza® Plus GoLYTELY® Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation|Amitiza® (Lubiprostone) Plus GoLYTELY® (Polyethylene Glycol-electrolyte Solution) vs. Placebo Plus GoLYTELY® (Polyethylene Glycol-electrolyte Solution) for Outpatient Colonoscopy Preparation: A Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 4|158|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-02-18 14:33:46.29791|2017-02-18 14:33:46.29791
NCT00645788|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2014-05-30|2012-01-21||May 2008||2008-05-01|May 2014|2014-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis|Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Inhaled Ciprofloxacin Compared to Placebo in Subjects With Cystic Fibrosis|Completed||Phase 2|288|Actual|Bayer||4|||f||||t||||||||||2017-02-18 14:33:46.419076|2017-02-18 14:33:46.419076
NCT00645775|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||November 2006||2006-11-01|August 2006|2006-08-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome|The Efficacy of Irvingia Gabonensis (Bush Mango) in the Management of Overweight, Obesity and Metabolic Syndrome in Cameroon.|Completed||N/A|102|Actual|Gateway Health Alliance||1|||f||||t||||||||||2017-02-18 14:33:47.489849|2017-02-18 14:33:47.489849
NCT00645762|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2013-06-20|2013-03-15||September 2007||2007-09-01|June 2013|2013-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|BREATHE I||Balloon REmodeling Antrostomy THErapy Study|Balloon REmodeling Antrostomy THErapy Study (BREATHE I)|Completed||Phase 2|71|Actual|Entellus Medical, Inc.||1|||f||||f||||||||||2017-02-18 14:33:47.583494|2017-02-18 14:33:47.583494
NCT00645749|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2015-10-09|||July 2008||2008-07-01|October 2015|2015-10-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|HINT||Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis|Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis|Active, not recruiting||N/A|18|Anticipated|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:33:47.792763|2017-02-18 14:33:47.792763
NCT00645736|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2011-11-21|||February 2008||2008-02-01|November 2011|2011-11-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Observational|CHARM||CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study|Study of Acquired Viral Mutations in Chronic Hepatitis B Patients on Antihepadnaviral Therapy|Completed||N/A|788|Actual|Gilead Sciences|||1||f||||f||||||||||2017-02-18 14:33:47.884508|2017-02-18 14:33:47.884508
NCT00645723|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2009-08-03|||April 2008||2008-04-01|August 2009|2009-08-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|||Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii|Phase 3b Randomized Double Blind Controled Placebo Comparative Trial of Intravenous Colistin vs Intravenous Colistin Plus Nebulized Colistin in Patients With Ventilator-associated Pneumonia (VAP) Due Multiresistant Acinetobacter Baumanii|Unknown status|Recruiting|Phase 3|67|Anticipated|Hospitales Universitarios Virgen del Rocío||2|||f||||t||||||||||2017-02-18 14:33:47.98925|2017-02-18 14:33:47.98925
NCT00645710|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-27|2016-11-04|||February 2005||2005-02-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Interventional|||Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery|A Phase I/II Trial of Radioimmunotherapy (Y-90 cT84.66), Gemcitabine and Hepatic Arterial Infusion of Fudr for Metastatic Colorectal Carcinoma to the Liver|Active, not recruiting||Phase 1/Phase 2|28|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:33:48.301659|2017-02-18 14:33:48.301659
NCT00645697|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||January 2007||2007-01-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|AVA-ION||Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization|Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization: Multicenter Collaborative Study|Completed||Phase 4|100|Actual|Rafic Hariri University Hospital|||1||f||||f||||||||||2017-02-18 14:33:48.414869|2017-02-18 14:33:48.414869
NCT00645684|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||April 1998||1998-04-01|March 2008|2008-03-01|May 2002|Actual|2002-05-01|September 2001|Actual|2001-09-01||Interventional|||Clinical Use of an Absorbable Coated Suture Material in Surgery (Safil)|Clinical Use of an Absorbable Coated Suture Material in Surgery (Safil) One Layer Running(A) vs. Two-Layer Suture Technique (B)|Completed||Phase 4|210|Actual|Aesculap AG||2|||f||||f||||||||||2017-02-18 14:33:48.508989|2017-02-18 14:33:48.508989
NCT00645671|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2015-03-04|2010-06-28||March 2008||2008-03-01|March 2015|2015-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery|A Randomized Multicenter, Double-Masked, Parallel-Group Clinical Safety and Efficacy Evaluation of Loteprednol Etabonate Ophthalmic Ointment, 0.5% Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery|Completed||Phase 3|400|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:33:48.621934|2017-02-18 14:33:48.621934
NCT00645658|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2012-05-03|||August 2007||2007-08-01|May 2012|2012-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Testosterone Replacement Therapy in Advanced Chronic Kidney Disease|Testosterone Replacement Therapy in Advanced Chronic Kidney Disease|Completed||N/A|17|Actual|Stanford University||1|||f||||||||||||||2017-02-18 14:33:49.097611|2017-02-18 14:33:49.097611
NCT00645632|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2011-05-13|||November 1990||1990-11-01|May 2011|2011-05-01|January 2008|Actual|2008-01-01|January 1995|Actual|1995-01-01||Interventional|||Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma|Treatment of Newly Diagnosed Untreated Osteosarcoma: A Pilot Study of a New Chemotherapeutic Regimen Including Ifosfamide|Completed||N/A|60|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 14:33:49.298689|2017-02-18 14:33:49.298689
NCT00645619|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-26|||November 2007||2007-11-01|March 2008|2008-03-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Observational|||Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children|Use of a Novel Protein (sTREM-1) to Differentiate Pure Viral Lung Infection From Viral With co-Existing Bacterial Lung Infection|Unknown status|Recruiting|N/A|60|Anticipated|University of Texas Southwestern Medical Center|||4||f||||f||||||Samples Without DNA|"~     Bronchoalveolar lavage fluid and Serum.~   "|||2017-02-18 14:33:49.392391|2017-02-18 14:33:49.392391
NCT00645606|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2015-10-16|||December 2007||2007-12-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|February 2014|Actual|2014-02-01||Interventional|LLC2007SA||Fludarabine, Cyclophosphamide, and Rituximab Followed by Rituximab or Observation in Older Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia|Single-agent Rituximab as Maintenance Treatment Versus Observation After Combined Induction Immunochemotherapy With Fludarabine, Cyclophosphamide and Rituximab (FCR) in Patients Older Than 65 Years With Previously Untreated B-cell Chronic Lymphocytic Leukemia (B-CLL): a Phase III Intergroup Trial of the GOELAMS and the FCGCLL/WM Groups|Completed||Phase 3|542|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-02-18 14:33:49.482112|2017-02-18 14:33:49.482112
NCT00645593|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2016-04-14|2014-07-16||March 2008||2008-03-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|April 2014|Actual|2014-04-01||Interventional||Although 89 patients were enrolled, only 88 patients were analyzed. 1 patient was randomized to arm A, was treated, and developed grade 4 neutropenia but was found to be ineligible upon histology review and was removed from the study.|Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer|Phase II Randomized Trial of Gemcitabine and Cisplatin With or Without Cetuximab in Patients With Urothelial Carcinoma|Completed||Phase 2|89|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-02-18 14:33:49.613291|2017-02-18 14:33:49.613291
NCT00645580|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-23|2009-02-18|||April 2008||2008-04-01|March 2008|2008-03-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function|Alterations in mRNA and Protein Expression in Human Peripheral Mononuclear Blood Cells (PMC) of Schizophrenia Patients Treated With Fluvoxamine Augmentation of Antipsychotics: Relationship to Clinical Symptoms and Cognitive Function|Unknown status|Active, not recruiting|N/A|15|Anticipated|Sha’ar Menashe Mental Health Center||1|||f||||f||||||||||2017-02-18 14:33:50.411871|2017-02-18 14:33:50.411871
NCT00645567|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2014-12-17|||January 2010||2010-01-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|March 2011|Actual|2011-03-01||Observational|||Biomechanics of Wheelchair Transfers|Evaluation of Transfer Technologies to Preserve Shoulder Function in SCI|Completed||N/A|5|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 14:33:50.538844|2017-02-18 14:33:50.538844
NCT00645554|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2011-05-18||||||March 2010|2010-03-01|September 2004|Actual|2004-09-01|||||Interventional|||A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers|A Bioequivalent Study to Compare Galantamine Oral Solution With Marketed Galantamine Capsule After Single Oral Administration of 10 mg.|Completed||Phase 1|2|Actual|Xian-Janssen Pharmaceutical Ltd.|||||f||||||||||||||2017-02-18 14:33:50.625789|2017-02-18 14:33:50.625789
NCT00645541|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2012-08-01|||March 2008||2008-03-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Axillary Reverse Mapping for Invasive Carcinoma of the Breast|Axillary Reverse Mapping for Invasive Carcinoma of the Breast|Completed||Phase 1|35|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:33:50.727766|2017-02-18 14:33:50.727766
NCT00645528|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2015-05-06|2014-12-10||April 2008||2008-04-01|May 2015|2015-05-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional||Subjects were eligible to participate if they (a) were referred to the group by their primary care provider; (b) had uncontrolled diabetes (hemoglobin A1c (A1c) >= 8.0%) not treated with insulin; (c) brought a glucose log to the first visit and (d) signed a consent form.|Do Group Insulin Education Visits Reduce Barriers to Insulin Initiation?|Do Group Insulin Education Visits Reduce Barriers to Insulin Initiation?|Completed||N/A|39|Actual|VA Office of Research and Development|This was a pilot study. Limitations include the small sample size and lack of a control group.|1|||f||||f||||||||||2017-02-18 14:33:50.842422|2017-02-18 14:33:50.842422
NCT00645515|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-04-25|||June 2003||2003-06-01|April 2008|2008-04-01|December 2003|Actual|2003-12-01|||||Interventional|||A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia|Ziprasidone Versus Risperidone In The Treatment Of Chronic Schizophrenia: A Six Months, Double Blind Randomized, Parallel Group Study|Terminated||Phase 3|240|Anticipated|Pfizer||2||"This study was terminated on November 20, 2003 because of poor recruitment. This study was not~   terminated due to safety/efficacy."|f||||f||||||||||2017-02-18 14:33:51.106693|2017-02-18 14:33:51.106693
NCT00645502|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2010-04-22|||June 2003||2003-06-01|April 2010|2010-04-01|July 2003|Actual|2003-07-01|||||Interventional|||Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.|A Bioequivalence Study Comparing a Single Oral Intake of a 4mg Orally-disintegrating Tablet With a 4mg Conventional Risperdal Tablet in Patients With Schizophrenia|Completed||Phase 1|40|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:33:51.219652|2017-02-18 14:33:51.219652
NCT00645489|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2010-01-04|||March 2008||2008-03-01|December 2008|2008-12-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|||A Family Intervention for Improving Self-Care of Patients With Heart Failure|A Family Intervention for Improving Self-Care of Patients With Heart Failure|Completed||Early Phase 1|40|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:33:51.305468|2017-02-18 14:33:51.305468
NCT00645476|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2012-03-26|||February 2006||2006-02-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|Memantine||Memantine and Cognitive Dysfunction in Bipolar Disorder|This is a Placebo-controlled Study. It Will Compare the Effects of Memantine With Placebo on Cognitive Dysfunction|Completed||N/A|47|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-02-18 14:33:51.433835|2017-02-18 14:33:51.433835
NCT00005158|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1982||1982-07-01|June 2000|2000-06-01|June 1991|Actual|1991-06-01|||||Observational|||Segregation/Linkage Analysis for Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:25.686096|2017-02-18 18:15:25.686096
NCT00645463|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2009-09-16|||March 2007||2007-03-01|March 2008|2008-03-01|June 2007|Actual|2007-06-01|||||Interventional|||Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics|A Phase 1, Randomized, Fixed Sequence Study To Evaluate The Effect Of Multiple Dose Administration Of Modified Release Diltiazem On The Multiple Dose Pharmacokinetics Of CP-945,598 In Healthy Overweight And Obese Subjects|Completed||Phase 1|28|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:33:51.548575|2017-02-18 14:33:51.548575
NCT00645450|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2013-11-19|||April 2008||2008-04-01|November 2013|2013-11-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||PTSD Symptom Reduction by Propranolol Given After Trauma Memory Activation|PTSD Symptom Reduction by Propranolol Given After Memory Activation|Terminated||Phase 4|9|Actual|VA Office of Research and Development||2||Difficulty recruiting subjects and unable to replace study physician who changed jobs|f||||t||||||||||2017-02-18 14:33:51.650698|2017-02-18 14:33:51.650698
NCT00645437|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2011-06-06|||October 2004||2004-10-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|||||Interventional|||A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.|An Open-Label Randomized Multiple-Dose Study to Evaluate Levofloxacin Steady-State Pharmacokinetics and Safety in Subjects With Varying Degrees of Renal Function|Completed||Phase 1|59|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:33:51.757826|2017-02-18 14:33:51.757826
NCT00645424|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-04-28|||December 2003||2003-12-01|April 2008|2008-04-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol|A Randomized, 12-Week, Open Labeled Study To Evaluate The Efficacy And Safety Of Once Daily Atorvastatin In Diabetes Mellitus Type 2 With Hyperlipidemia|Completed||Phase 4|155|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:33:51.845868|2017-02-18 14:33:51.845868
NCT00645411|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2015-10-20|2012-11-21||October 2007||2007-10-01|October 2015|2015-10-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|||Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents|A Combined Phase II/III, Observer-Blind, Randomized, Multi-center Study to Evaluate Safety, Tolerability and Immunogenicity of Trivalent Subunit Influenza Vaccines, Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs, in Healthy Children and Adolescents|Completed||Phase 2/Phase 3|3604|Actual|Novartis||4|||f||||t||||||||||2017-02-18 14:33:51.955105|2017-02-18 14:33:51.955105
NCT00645398|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-04-23|||September 2004||2004-09-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|||||Interventional|||A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia|A 13-Week, Randomized, Double-Blind, Placebo-Controlled, Monotherapy Trial of Pregabalin (BID) in Patients With Fibromyalgia|Completed||Phase 3|751|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 14:33:53.438234|2017-02-18 14:33:53.438234
NCT00645385|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2009-08-26|||June 2007||2007-06-01|August 2009|2009-08-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|Gliadel-MRS||Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.|Treatment Of Newly Diagnosed, High-Grade, Malignant Glioma With Polifeprosan 20 Containing Carmustine Implant (Gliadel® Wafer) Using MR Spectroscopy Data As A Primary Indicator Of Therapeutic Response.|Terminated||N/A|15|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 14:33:53.644493|2017-02-18 14:33:53.644493
NCT00645372|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2015-04-21|||July 2004||2004-07-01|April 2015|2015-04-01|May 2005|Actual|2005-05-01|||||Interventional|||A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients|A Six Week, Multicenter, Double Blind, Double-Dummy, Parallel, Comparative Study To Compare The Efficacy, Safety And Tolerability Of Ziprasidone With Risperidone In The Treatment Of Chinese Subjects With Acute Exacerbation Of Schizophrenia|Completed||Phase 3|242|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:33:53.743967|2017-02-18 14:33:53.743967
NCT00645359|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-10-03|2014-10-03||November 2006||2006-11-01|October 2014|2014-10-01||||July 2011|Actual|2011-07-01||Observational|dMRI||Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma|Pilot Study of Diffusion MRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B Cell Lymphoma|Terminated||N/A|9|Actual|University of Michigan Cancer Center|This study was not completed due to insufficient resources to evaluate the pilot phase of the study, secondary to shifting research priorities.||1|Insufficient resources to evaluate pilot, second to shift in research priorities|f||||t||||||||||2017-02-18 14:33:53.903367|2017-02-18 14:33:53.903367
NCT00645346|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2011-12-07|||February 2008||2008-02-01|December 2011|2011-12-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age|A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age|Completed||Phase 1|130|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:33:54.087945|2017-02-18 14:33:54.087945
NCT00645333|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-02-24|2013-08-09||March 2008||2008-03-01|February 2014|2014-02-01|October 2012|Actual|2012-10-01|January 2010|Actual|2010-01-01||Interventional|||Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer|Phase I/II Trial of MK-0752 Followed by Docetaxel in Locally Advanced or Metastatic Breast Cancer: A Study by the Stem Cell Clinical Consortium|Completed||Phase 1/Phase 2|30|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 14:33:54.194414|2017-02-18 14:33:54.194414
NCT00645320|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-04-07|||August 2003||2003-08-01|April 2008|2008-04-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study|An Open Label, Extension Study To Assess The Efficacy And Tolerability Of Oral Ziprasidone In Patients Successfully Completing A Previous Study With Ziprasidone|Completed||Phase 4|75|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:33:54.655977|2017-02-18 14:33:54.655977
NCT00645138|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-08-04|||April 2008||2008-04-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery|A Comparison of Ultrasound-assisted Paravertebral Block and General Anesthesia for Outpatient Breast Cancer Surgery, a Prospective Randomized Trial|Completed||Phase 3|40|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:33:59.304518|2017-02-18 14:33:59.304518
NCT00645307|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2011-06-06|||May 2004||2004-05-01|April 2010|2010-04-01|August 2006|Actual|2006-08-01|||||Interventional|||A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study With an Open-Label Extension Evaluating Extended Release OROS® Paliperidone in the Prevention of Recurrence in Subjects With Schizophrenia - Open Label Phase|Completed||Phase 3|235|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 14:33:57.166798|2017-02-18 14:33:57.166798
NCT00645294|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-03-21|||February 2003||2003-02-01|March 2008|2008-03-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV|A Phase 1-2 Open-Label Study of the Pharmacokinetics and Safety of a Single Dose of Adefovir Dipivoxil in Children and Adolescents (Aged 2-17) With Chronic Hepatitis B|Completed||Phase 1/Phase 2|47|Actual|Gilead Sciences||3|||f||||f||||||||||2017-02-18 14:33:57.280436|2017-02-18 14:33:57.280436
NCT00645281|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||March 2004||2004-03-01|March 2008|2008-03-01|January 2005|Actual|2005-01-01|||||Interventional|||A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.|Symptom Specific Effectiveness of Tolterodine ER 4 mg in Patients With Symptoms of Overactive Bladder (OAB) in a Primary Care Setting. A Phase IV, Open-Label, Single-Arm, Non-Randomized, Trial in Adult Patients With OAB.|Completed||Phase 4|896|Actual|Pfizer||1|||f||||||||||||||2017-02-18 14:33:57.393688|2017-02-18 14:33:57.393688
NCT00645268|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-03-20|||December 2002||2002-12-01|March 2008|2008-03-01|January 2004|Actual|2004-01-01|||||Interventional|||A Multicenter, Double-Blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes|A Multicenter, Double-Blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Viagra® (Sildenafil Citrate) on the PRN Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes|Completed||Phase 4|300|Anticipated|Pfizer||3|||f||||f||||||||||2017-02-18 14:33:57.797546|2017-02-18 14:33:57.797546
NCT00645255|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-24|||September 1998||1998-09-01|March 2008|2008-03-01||||January 2003|Actual|2003-01-01||Interventional|||Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects|A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Examine the Longer-Term Efficacy and Safety of Meridia (Sibutramine Hydrochloride) in Obese Subjects|Terminated||Phase 3|466|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:33:57.928858|2017-02-18 14:33:57.928858
NCT00645242|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-25|||November 2002||2002-11-01|March 2008|2008-03-01|March 2003|Actual|2003-03-01|||||Interventional|||A Study Of Diflucan In Children With Ringworm Of The Scalp|An Open Label, Multicenter Trial Of Diflucan (Fluconazole) For 6 Weeks Given Once Daily To Pediatric Patients With Tinea Capitis|Completed||Phase 3|185|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 14:33:58.025884|2017-02-18 14:33:58.025884
NCT00645229|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-04-07|||September 2004||2004-09-01|April 2008|2008-04-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder|Efficacy And Safety Of Ziprasidone In Acute Exacerbation Of Schizophrenia Or Schizoaffective Disorder, Including Patients With A Diagnosis Of Recent Onset|Terminated||Phase 3|1|Actual|Pfizer||1||Please see Detailed Description for termination reason.|f||||f||||||||||2017-02-18 14:33:58.173231|2017-02-18 14:33:58.173231
NCT00645216|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2009-08-06|||June 2007||2007-06-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And Safety|A Phase 1, Open Label, Randomized, Fixed Sequence Study To Evaluate The Effect Of Multiple Dose Administration Of Grapefruit Juice On The Multiple Dose Pharmacokinetics Of CP-945,598 In Healthy Overweight And Obese Subjects|Completed||Phase 1|28|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 14:33:58.301659|2017-02-18 14:33:58.301659
NCT00645203|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-03-20|||July 2002||2002-07-01|March 2008|2008-03-01||||April 2003|Actual|2003-04-01||Interventional|||Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media|An Open-Label, Safety and Efficacy Study of Cefdinir Oral Suspension, 25 mg/kg Once Daily, in Pediatric Subjects With Acute Otitis Media|Completed||Phase 2/Phase 3|447|Actual|Abbott||1|||f||||||||||||||2017-02-18 14:33:58.396616|2017-02-18 14:33:58.396616
NCT00645190|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2011-05-18|||March 2004||2004-03-01|March 2010|2010-03-01|February 2005|Actual|2005-02-01|||||Interventional|||A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease|A Randomized, Double Blind, Active Control, Flexible Dose, Multicenter Study to Evaluate Galantamine HBr in the Treatment of Alzheimer's Disease:Safety and Effectiveness of an Immediate-release Table Formulation.|Completed||Phase 3|215|Actual|Xian-Janssen Pharmaceutical Ltd.|||||f||||||||||||||2017-02-18 14:33:58.522266|2017-02-18 14:33:58.522266
NCT00645177|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-01-23||2011-08-23|July 2008||2008-07-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer|A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone as First-line Treatment in Subjects With Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 2|10|Actual|AbbVie||2|||f||||||||||||||2017-02-18 14:33:58.611579|2017-02-18 14:33:58.611579
NCT00645164|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2010-06-01|2008-10-08||March 2008||2008-03-01|June 2010|2010-06-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment|Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment|Completed||Phase 1|59|Actual|Healthpoint|Interpretation of frequency distribution of skin irritation scores was based on long term experience with this type of testing.|1|||f||||f||||||||||2017-02-18 14:33:58.724624|2017-02-18 14:33:58.724624
NCT00645151|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-04-08|||April 2004||2004-04-01|April 2008|2008-04-01|February 2005|Actual|2005-02-01|||||Interventional|LA ATGOAL||A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol|A Multicenter, Eight-Week Treatment, Single Step Titration, Open-Label Study Assessing The Percentage Of Subjects Achieving Low Density Lipoprotein Cholesterol Target With Atorvastatin Starting Doses Of 10 Mg, 20 Mg, 40 Mg, And 80 Mg (Latin American Atorvastatin ATGOAL Study)|Completed||Phase 4|512|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:33:58.958358|2017-02-18 14:33:58.958358
NCT00005157|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1982||1982-07-01|May 2000|2000-05-01|November 1989|Actual|1989-11-01|||||Observational|||Speech Characteristics in Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:25.766177|2017-02-18 18:15:25.766177
NCT00645125|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2008-03-26|||January 2003||2003-01-01|March 2008|2008-03-01||||February 2003|Actual|2003-02-01||Interventional|||A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications|A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications|Completed||Phase 4|154|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:33:59.438587|2017-02-18 14:33:59.438587
NCT00645112|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2008-03-22|||November 2003||2003-11-01|March 2008|2008-03-01||||January 2004|Actual|2004-01-01||Interventional|||A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media|A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media|Completed||Phase 4|357|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:33:59.553308|2017-02-18 14:33:59.553308
NCT00645099|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-04-24|2010-04-07||October 2007||2007-10-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia|A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects With Schizophrenia|Completed||Phase 3|462|Actual|Janssen-Cilag International NV|Open-label design|2|||f||||f||||||||||2017-02-18 14:33:59.691965|2017-02-18 14:33:59.691965
NCT00645086|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-26|||December 2002||2002-12-01|March 2008|2008-03-01||||April 2004|Actual|2004-04-01||Interventional|||Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis|A Phase III Comparative Efficacy Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Subjects With Acute Bacterial Exacerbation of Chronic Bronchitis.|Completed||Phase 3|465|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:34:00.669291|2017-02-18 14:34:00.669291
NCT00645073|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2008-03-22|||November 2003||2003-11-01|March 2008|2008-03-01||||March 2004|Actual|2004-03-01||Interventional|||Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis|A Phase IV Comparative Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis|Completed||Phase 4|271|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:34:01.125188|2017-02-18 14:34:01.125188
NCT00645060|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2016-12-09|||October 2006||2006-10-01|December 2016|2016-12-01||||September 2017|Anticipated|2017-09-01||Interventional|||Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors|A Phase I Study of Yttrium-90 Labeled Humanized Anti-CEA M5A Antibody in Patients With CEA Producing Advanced Malignancies|Active, not recruiting||Phase 1|18|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:34:01.269435|2017-02-18 14:34:01.269435
NCT00645047|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2014-08-11|||February 2009||2009-02-01|August 2014|2014-08-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|VTOPS||Veterans Telemedicine Outreach for PTSD Services|Veterans Telemedicine Outreach for PTSD Services|Completed||N/A|207|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:34:01.414971|2017-02-18 14:34:01.414971
NCT00645034|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-03-26|||November 2002||2002-11-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin|A Double-Blind, Placebo-Controlled, Randomized, 2-Way Crossover Study to Investigate the Hemodynamic Effects of a Single Dose of Sildenafil (100mg) in Subjects With Benign Prostatic Hyperplasia Being Treated With Doxazosin|Completed||Phase 2|20|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:01.522782|2017-02-18 14:34:01.522782
NCT00645021|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2009-08-26||2009-08-26|April 2008||2008-04-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug|A Phase 1, Open-Label, Parallel Group, Multiple-Dose Study To Evaluate The Pharmacokinetics, Safety And Toleration Of CP-945,598 Administered To Subjects With Impaired And Normal Hepatic Function|Completed||Phase 1|24|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:34:01.631386|2017-02-18 14:34:01.631386
NCT00645008|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2017-02-02|||April 2008|Actual|2008-04-01|February 2017|2017-02-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Observational|||Identification of Dominate Stressors in the Intensive Care Unit (ICU)|Stressors Associated With Cardiac Surgery Intensive Care Treatment|Completed||N/A|160|Actual|Weill Medical College of Cornell University|||1||f||||f|f|f||||||No|Will not be shared|2017-02-18 14:34:01.728636|2017-02-18 14:34:01.728636
NCT00644995|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2014-07-23|2013-07-01||November 2008||2008-11-01|July 2014|2014-07-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|||Effectiveness of The Step Up Wellness Program for People With Depression|Step Up Wellness Program for Depression, Physical Inactivity, and Smoking|Completed||N/A|52|Actual|Group Health Cooperative|"This was a pilot feasibility trial and was not powered to detect statistically significant outcomes.~Point prevalent abstinence outcomes imputed missing values as smokers."|2|||f||||f||||||||||2017-02-18 14:34:01.829144|2017-02-18 14:34:01.829144
NCT00644982|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-04-07|||October 2002||2002-10-01|April 2008|2008-04-01|September 2003|Actual|2003-09-01|||||Interventional|||A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression|A Multicenter Randomized, Double-Blind, Parallel-Group Study of Sertraline Versus Venlafaxine XR in the Acute Treatment of Outpatients With Major Depressive Disorder|Completed||Phase 4|163|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:02.31757|2017-02-18 14:34:02.31757
NCT00644969|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2011-03-23|2011-03-23||May 2008||2008-05-01|March 2011|2011-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder|A Phase 3B 12-Week, Double -Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Varenicline Tartrate (CP-526,555) 1 mg BID for Smoking Cessation in Subjects With Schizophrenia and Schizoaffective Disorder.|Completed||Phase 3|128|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:34:02.458197|2017-02-18 14:34:02.458197
NCT00644956|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-26|||June 2003||2003-06-01|March 2008|2008-03-01|November 2003|Actual|2003-11-01|||||Interventional|||A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And Tadalafil|A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Viagra (Sildenafil Citrate) And Cialis (Tadalafil)|Completed||Phase 4|56|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:03.368225|2017-02-18 14:34:03.368225
NCT00644943|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-03-21|||February 2003||2003-02-01|March 2008|2008-03-01||||April 2003|Actual|2003-04-01||Interventional|||A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media|A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media|Completed||Phase 4|425|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:34:03.465868|2017-02-18 14:34:03.465868
NCT00644930|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2008-03-26|||August 2003||2003-08-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|September 2005|Actual|2005-09-01||Interventional|NPPV||Non-Invasive Positive Pressure Ventilation and Adult Respiratory Distress Syndrome (ARDS)|The Efficacy of Non-Invasive Positive Pressure Ventilation in ARDS: A Controlled Cohort Study|Completed||N/A|20|Actual|Eskisehir Osmangazi University||2|||f||||t||||||||||2017-02-18 14:34:03.586245|2017-02-18 14:34:03.586245
NCT00644917|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-12-11|2013-10-09||February 2008||2008-02-01|December 2013|2013-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment|Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment|Completed||Phase 1|38|Actual|Healthpoint||3|||f||||f||||||||||2017-02-18 14:34:03.697461|2017-02-18 14:34:03.697461
NCT00644904|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-27|||July 2006||2006-07-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|VitD4MS||Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis|A Phase I/II Dose-Escalation Trial of Vitamin D3 With Calcium Supplementation in Patients With Multiple Sclerosis|Completed||Phase 1/Phase 2|49|Actual|University of Toronto||2|||f||||f||||||||||2017-02-18 14:34:04.179159|2017-02-18 14:34:04.179159
NCT00644891|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2008-03-26|||January 2003||2003-01-01|March 2008|2008-03-01||||January 2003|Actual|2003-01-01||Interventional|||Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications|A Comparative, Multi-Center, Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications|Completed||Phase 4|158|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:34:04.298251|2017-02-18 14:34:04.298251
NCT00644878|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-11-16|||October 2008||2008-10-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|MACS0254||Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib|A Multi-center, Open-label, Exploratory Study of Bcr-Abl Kinetics in Adult Patients on Nilotinib With Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) and a Suboptimal Molecular Response to Imatinib|Completed||Phase 4|18|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:34:04.413028|2017-02-18 14:34:04.413028
NCT00644852|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-05-22|||January 2007||2007-01-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone|Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone|Completed||Phase 4|342|Actual|Johnson & Johnson Taiwan Ltd|||1||f||||||||||||||2017-02-18 14:34:04.552608|2017-02-18 14:34:04.552608
NCT00644839|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2009-08-11||2009-08-11|April 2008||2008-04-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug|A Phase 1, Open-Label, Fixed Sequence Study To Evaluate The Effect Of Multiple Dose Administration Of Omeprazole On The Single Dose Pharmacokinetics Of CP-945,598 In Healthy Overweight And Obese Subjects|Completed||Phase 1|28|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:34:04.652899|2017-02-18 14:34:04.652899
NCT00644826|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-26|2010-06-01|||September 2007||2007-09-01|January 2010|2010-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Growing Old at Home|Growing Old at Home - Effectiveness and Cost-effectiveness of Preventive Home Visits to Reduce Nursing Home Admissions in the Elderly|Completed||N/A|336|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-02-18 14:34:04.752828|2017-02-18 14:34:04.752828
NCT00644813|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2016-12-15|||March 2008||2008-03-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Clinical Outcomes Following Glenoid Neck Fracture as Correlated With Quantitative Assessment of Osseous Injury|Clinical Outcomes Following Glenoid Neck Fracture as Correlated With Quantitative Assessment of Osseous Injury|Recruiting||N/A|50|Anticipated|Boston Medical Center|||1||f||||t||||||||||2017-02-18 14:34:04.858561|2017-02-18 14:34:04.858561
NCT00644800|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-04-07|||July 2003||2003-07-01|April 2008|2008-04-01|May 2004|Actual|2004-05-01|||||Interventional|||A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis|An Open, Multicenter, Non-Comparative Study To Assess The Efficacy And Tolerability Of Intramuscular Ziprasidone Followed By Oral Ziprasidone In Patients With Acute Psychosis|Completed||Phase 4|89|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:34:04.990944|2017-02-18 14:34:04.990944
NCT00644787|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-06-06|2013-04-01||December 2007||2007-12-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Out of a total of 156 participants, Baseline characteristics were available for only 155 participants who were included in Full Analysis Set (FAS) population. FAS population included all participants who applied at least 1 study drug patch and had 1 VAS assessment performed after application of the study drug.|A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain|A Phase II/III Study of JNS020QD in Cancer Pain Patients - A Dose-Finding, Double-Blind Study of JNS020QD Compared With JNS005 in Patients Previously Untreated With Opioid Analgesics|Completed||Phase 2/Phase 3|156|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-02-18 14:34:05.128713|2017-02-18 14:34:05.128713
NCT00644774|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2008-03-26|||January 2003||2003-01-01|March 2008|2008-03-01||||January 2003|Actual|2003-01-01||Interventional|||A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications|A Comparative, Multi-Center, Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications|Completed||Phase 4|157|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:34:06.375455|2017-02-18 14:34:06.375455
NCT00644761|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-04-07|||February 2004||2004-02-01|April 2008|2008-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients|A Multi-Center Phase 2, Open-Label Study to Evaluate the Pharmacokinetics of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil 10 mg to Patients Post-Liver Transplantation|Completed||Phase 2|16|Actual|Gilead Sciences||1|||f||||f||||||||||2017-02-18 14:34:06.686758|2017-02-18 14:34:06.686758
NCT00644748|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-10-09|||May 2003||2003-05-01|October 2008|2008-10-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy|An Open, Multicenter Study on the Efficacy, Safety and Tolerability of Gabapentin, Titrated for Reaching an Effect for the Treatment of the Painful Diabetic Neuropathy|Completed||Phase 4|95|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:34:06.805937|2017-02-18 14:34:06.805937
NCT00644735|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-03-25|||December 2002||2002-12-01|March 2009|2009-03-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed|Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed.|Completed||Phase 4|750|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:34:06.90952|2017-02-18 14:34:06.90952
NCT00644722|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2009-01-27|||April 2008||2008-04-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|LAMETA||Out-of-Hospital Intubation With Metal Single Use Laryngoscope Blades|Out-of-Hospital Intubation in Emergency Conditions With Either Metal Single Use or Reusable Laryngoscope Blades : Impact on Intubation Difficulties|Completed||Phase 4|800|Anticipated|Henri Mondor University Hospital||2|||f||||t||||||||||2017-02-18 14:34:06.998384|2017-02-18 14:34:06.998384
NCT00644709|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-27|||September 2003||2003-09-01|March 2008|2008-03-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)|A Multicenter, Open-Label Extension Study Of High-Risk Hyperlipidemic Patients Treated With An Atorvastatin Starting Dose Adapted To Their Baseline LDL-C Level|Completed||Phase 4|196|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:34:07.31102|2017-02-18 14:34:07.31102
NCT00644696|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2016-06-02|||April 2008||2008-04-01|June 2016|2016-06-01||||July 2012|Actual|2012-07-01||Interventional|||Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma|A Phase One Study of Intravenous Irinotecan and Bortezomib in Children With Recurrent/Refractory High-Risk Neuroblastoma|Active, not recruiting||Phase 1|18|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 14:34:07.433793|2017-02-18 14:34:07.433793
NCT00644683|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2014-06-05|||September 2007||2007-09-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|March 2012|Actual|2012-03-01||Observational|||A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy|A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy|Completed||N/A|28|Actual|University of Michigan Cancer Center|||1||f||||t||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:34:07.552804|2017-02-18 14:34:07.552804
NCT00644670|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-26|||June 2003||2003-06-01|March 2008|2008-03-01|March 2004|Actual|2004-03-01|||||Interventional|||A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol|A Multicenter, Twelve-Week Treatment, Single-Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic High-Risk Patients Achieving LDL Cholesterol Targets With Atorvastatin Starting Doses Of 10 Mg, 20 Mg And 40 Mg.|Completed||Phase 4|232|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:07.635474|2017-02-18 14:34:07.635474
NCT00644657|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2011-09-07|2011-01-06||March 2007||2007-03-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization|The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization|Completed||N/A|27|Actual|University of Oklahoma|Limited to primarily Male VA population.|1|||f||||f||||||||||2017-02-18 14:34:07.780498|2017-02-18 14:34:07.780498
NCT00644644|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-25|||March 2008||2008-03-01|March 2008|2008-03-01|June 2009|Anticipated|2009-06-01|February 2009|Anticipated|2009-02-01||Observational|TATRC||Validation of the NTX Wireless Patient Monitoring System|A Validation of the NTX Wireless Patient Monitoring System in Combination With Novel Computer Interface to Generate Proactive Medical Responses to Patient Specific Events|Unknown status|Enrolling by invitation|N/A|1200|Anticipated|Vanderbilt University|||2||f||||t||||||||||2017-02-18 14:34:08.00239|2017-02-18 14:34:08.00239
NCT00644631|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-26|||June 2003||2003-06-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|||||Interventional|||A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study To Evaluate Sexual And Relationship Satisfaction In The Female Partner Of Men With Erectile Dysfunction Treated With Sildenafil Citrate|A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study To Evaluate Sexual And Relationship Satisfaction In The Female Partner Of Men With Erectile Dysfunction Treated With Viagra (Sildenafil Citrate) In The United States|Completed||Phase 4|300|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:08.123669|2017-02-18 14:34:08.123669
NCT00644618|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-24|||January 2003||2003-01-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy|Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy Versus Gemcitabine Alone in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 3|120|Actual|Huazhong University of Science and Technology||2|||f||||t||||||||||2017-02-18 14:34:08.281216|2017-02-18 14:34:08.281216
NCT00644605|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2015-04-21|||October 2002||2002-10-01|April 2015|2015-04-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension|A Multinational, Multi-centre, Randomised, Double-blind, Double-dummy, Placebo-controlled Study to Assess the Efficacy and Safety of 20, 40, and 80mg TID Sildenafil in the Treatment of Pulmonary Arterial Hypertension in Subjects Aged 18 Years and Over|Completed||Phase 3|275|Anticipated|Pfizer||4|||f||||f||||||||||2017-02-18 14:34:08.376404|2017-02-18 14:34:08.376404
NCT00644592|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2012-05-24|2012-03-12||March 2008||2008-03-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||LXRA Gene Polymorphisms and Response to Fenofibrate|LXRA Gene Polymorphisms and Response to Fenofibrate|Terminated||N/A|11|Actual|University of Florida||2||supply issues with the formulation of fenofibrate that was used.|f||||f||||||||||2017-02-18 14:34:08.568156|2017-02-18 14:34:08.568156
NCT00644397|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2016-03-15|||May 2006||2006-05-01|March 2016|2016-03-01||||May 2026|Anticipated|2026-05-01||Observational|||Plate Fixation of Distal Femur Fractures: A Protocol for a Study of Two Plate Options|Plate Fixation of Distal Femur Fractures: a Protocol for a Randomized, Prospective Study of Two Plate Options|Recruiting||N/A|100|Anticipated|MetroHealth Medical Center|||2||f||||f||||||||||2017-02-18 14:34:10.607897|2017-02-18 14:34:10.607897
NCT00644579|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2008-03-26|||March 2008||2008-03-01|March 2008|2008-03-01|February 2009|Anticipated|2009-02-01|December 2008|Anticipated|2008-12-01||Interventional|||bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients|bLAC - A Phase II Double-Blind, Placebo Controlled, Clinical Proof of Concept Trial of the Efficacy of 8 Weeks Treatment of Cutaneous Warts With bLAC in Immune Suppressed, Kidney Transplanted Patients|Unknown status|Recruiting|Phase 2|120|Anticipated|NatImmune A/S||3|||f||||f||||||||||2017-02-18 14:34:08.954589|2017-02-18 14:34:08.954589
NCT00644566|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2010-11-04|||August 2006||2006-08-01|November 2010|2010-11-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|shared care||Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager|Pilot Study of Shared Care of ADHD in a Pediatric Clinic:Colocation of a Psychologist as an ADHD Care Manager|Unknown status|Recruiting|N/A|140|Anticipated|Weill Medical College of Cornell University||2|||f||||||||||||||2017-02-18 14:34:09.059837|2017-02-18 14:34:09.059837
NCT00644553|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2008-03-26|||May 2003||2003-05-01|March 2008|2008-03-01||||March 2004|Actual|2004-03-01||Interventional|||Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis|A Phase IIIB/IV Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets vs. Amoxicillin-Clavulanate for the Treatment of Subjects With Acute Bacterial Sinusitis|Completed||Phase 3|437|Actual|Abbott||2|||f||||||||||||||2017-02-18 14:34:09.168915|2017-02-18 14:34:09.168915
NCT00644540|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-11-30|||November 2007||2007-11-01|January 2014|2014-01-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study|A Phase II, Observer-Blind, Parallel Groups, Single Center, Extension Study to Evaluate the Immunogenicity and Safety Following a Single Intramuscular Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine in the Previous V70P2 Study.|Completed||Phase 2|89|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:34:09.317003|2017-02-18 14:34:09.317003
NCT00644527|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-11-17|||March 2008||2008-03-01|November 2008|2008-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Receptive Music Therapy for the Treatment of Depression|"Rezeptive Musiktherapie Bei Depression - Eine Randomisierte, Placebokontrollierte Studie / Receptive Music Therapy in Depression: A Randomized Placebo-Controlled Trial"|Completed||N/A|203|Actual|Heidelberg University||4|||f||||t||||||||||2017-02-18 14:34:09.421916|2017-02-18 14:34:09.421916
NCT00644514|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-07-15|||September 2007||2007-09-01|July 2013|2013-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Genetics of Asthma - Bronchoscopy Studies|The Genetics of Environmental Asthma: LPS Inhalation and Bronchoscopy in Normal Subjects and Subjects With Mild Atopic Asthma|Terminated||Phase 1|17|Actual|Duke University||1||grant funding no longer available|f||||f||||||||||2017-02-18 14:34:09.543312|2017-02-18 14:34:09.543312
NCT00644501|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2013-07-10|||September 2008||2008-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes|Open Label Study to Evaluate Long Term Treatment Effect of DiaPep277® in Patients Who Have Completed Studies 461* (Phase II) or 901** (Pase III)|Completed||Phase 3|43|Actual|Andromeda Biotech Ltd.||1|||f||||t||||||||||2017-02-18 14:34:09.649357|2017-02-18 14:34:09.649357
NCT00644488|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-01-24|||July 2008||2008-07-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer|A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer|Completed||Phase 1|7|Actual|Bristol-Myers Squibb||1|||f||||t||||||||||2017-02-18 14:34:09.74098|2017-02-18 14:34:09.74098
NCT00644475|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-25|||March 2008||2008-03-01|March 2008|2008-03-01|March 2009|Anticipated|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension|Randomized, Controlled, Parallel Arm, PROBE Study to Evaluate Different Effects of Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension|Unknown status|Recruiting|Phase 3|60|Anticipated|University of Pavia||2|||f||||f||||||||||2017-02-18 14:34:09.836318|2017-02-18 14:34:09.836318
NCT00644462|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2009-01-10|||June 2009||2009-06-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording|Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording|Unknown status|Not yet recruiting|N/A|50|Anticipated|KarmelSonix Ltd.|||2||f||||f||||||||||2017-02-18 14:34:09.942409|2017-02-18 14:34:09.942409
NCT00644449|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-05-12|||January 2003||2003-01-01|May 2011|2011-05-01|March 2004|Actual|2004-03-01|||||Interventional|||A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis|A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB)|Completed||Phase 3|551|Actual|Pfizer||2|||f||||||||||||||2017-02-18 14:34:10.04696|2017-02-18 14:34:10.04696
NCT00644436|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-03-26|||November 2007||2007-11-01|March 2008|2008-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study to Determine if Tetrix Cream is Removed From the Hands by Gentle Washing With Soap and Water|A Study of the Substantivity of Tetrix Cream|Completed||N/A|10|Actual|Coria Laboratories, Ltd.||2|||f||||f||||||||||2017-02-18 14:34:10.275578|2017-02-18 14:34:10.275578
NCT00644423|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-03-15|||September 2008||2008-09-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)|Omega-3 Fatty Acids and PTSD|Active, not recruiting||N/A|18|Actual|Durham VA Medical Center||2|||f||||f||||||||||2017-02-18 14:34:10.37971|2017-02-18 14:34:10.37971
NCT00644410|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2015-03-16|||September 2008||2008-09-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Autologous Mesenchymal Stromal Cell Therapy in Heart Failure|A Single Centre, Randomised Controlled Study of the Effect of NOGA-guided Direct Intramyocardial Injection of Mesenchymal Stromal Cells on the Development of New Myocardium and Blood Vessels in Patients With Heart Failure|Completed||Phase 1/Phase 2|59|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 14:34:10.497308|2017-02-18 14:34:10.497308
NCT00644384|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2011-05-13|||February 2003||2003-02-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer|Chemoprevention Trial of Acitretin Versus Placebo in Patients at High Risk for Basal Cell Carcinoma or Squamous Cell Carcinoma|Completed||N/A|130|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:34:10.712781|2017-02-18 14:34:10.712781
NCT00644371|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-03-27|||November 2007||2007-11-01|March 2008|2008-03-01||||September 2009|Anticipated|2009-09-01||Interventional|Z-RIC-Allo||Allogenic Stem Cell Transplantation (SCT) With Non-Myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)|Allogeneic Transplantation of Haematopoietic Stem Cells Following Non-Myeloablative Conditioning With Melphalan, Fludarabine, Thiotepa, Rituximab and Ibritumomab Tiuxetan (Zevalin) in Patients With Aggressive Non-Hodgkin's B-Cell Lymphoma|Unknown status|Recruiting|Phase 2|30|Anticipated|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea||1|||f||||f||||||||||2017-02-18 14:34:13.1798|2017-02-18 14:34:13.1798
NCT00644358|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-09-15|||December 2007||2007-12-01|September 2011|2011-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)|A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder|Completed||Phase 3|616|Actual|Forest Laboratories||1|||f||||f||||||||||2017-02-18 14:34:13.332442|2017-02-18 14:34:13.332442
NCT00644345|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-23|2008-03-25|||May 2008||2008-05-01|March 2008|2008-03-01|May 2009|Anticipated|2009-05-01|January 2009|Anticipated|2009-01-01||Observational|||T-Wave Alternans (TWA) Reproducibility in CAD Patients|Reproducibility of T Wave Alternans Testing in Patients With Ischemic Heart Disease.|Unknown status|Not yet recruiting|N/A|100|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-02-18 14:34:13.471562|2017-02-18 14:34:13.471562
NCT00644332|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2012-05-29|2012-05-29||November 2007||2007-11-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)|An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Women's Ischemia Symptom Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)|Completed||Phase 4|172|Actual|Gilead Sciences|The study was terminated early at 86% of targeted enrollment (172 of approximately 200 subjects).|1|||f||||f||||||||||2017-02-18 14:34:13.563155|2017-02-18 14:34:13.563155
NCT00644319|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2009-07-07|||March 2007||2007-03-01|July 2009|2009-07-01||||September 2009|Anticipated|2009-09-01||Interventional|||Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion|A 2 x 2 Factorial Trial to Assess Whether Non-Steroidal Anti-Inflammatory Analgesics and Small Bore Chest Tubes Are Less Painful Than Opiate Analgesics and a Large Bore Chest Tubes in Pleurodesis for Malignant Pleural Effusion [TIME1]|Unknown status|Recruiting|Phase 2|320|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:34:14.183945|2017-02-18 14:34:14.183945
NCT00644306|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-03-20|||April 2002||2002-04-01|March 2008|2008-03-01|May 2007|Actual|2007-05-01|||||Interventional|IFM 01/01||Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma|Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma|Terminated||Phase 3|232|Actual|Central Hospital, Nancy, France||2||survival advantage demonstrated|f||||t||||||||||2017-02-18 14:34:14.285856|2017-02-18 14:34:14.285856
NCT00644293|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-06-03|||January 2003||2003-01-01|June 2011|2011-06-01|April 2004|Actual|2004-04-01|||||Interventional|||A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults|A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Three-Day Azithromycin for the Treatment of Group A β-Hemolytic Streptococcal Pharyngitis/Tonsillitis in Adolescents and Adults|Completed||Phase 3|598|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:14.39946|2017-02-18 14:34:14.39946
NCT00644280|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-07-25|2013-05-29||April 2008||2008-04-01|July 2013|2013-07-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery|"Evaluation of Safety and Efficacy of Ranibizumab in Glaucoma Patients Treated With Filtration Tubes"|Terminated||N/A|11|Actual|University of California, San Francisco|IOP reduction may be attributable to cataract surgery instead of or in addition to ranibizumab use. Further studies, with larger sample size and longer follow-up, are needed to evaluate safety and potential efficacy of intravitreal ranibizumab.|2||low recruitment|f||||t||||||||||2017-02-18 14:34:14.566021|2017-02-18 14:34:14.566021
NCT00644267|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2010-09-30|||April 2008||2008-04-01|September 2010|2010-09-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|AHRQ||Using a Telemedicine System to Promote Patient Care Among Underserved Individuals|Using a Telemedicine System to Promote Patient Care Among Underserved Individuals|Unknown status|Active, not recruiting|N/A|242|Actual|Temple University||2|||f||||t||||||||||2017-02-18 14:34:14.922402|2017-02-18 14:34:14.922402
NCT00644254|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2009-07-06|||October 2007||2007-10-01|July 2009|2009-07-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Observational|ECLNI DPAC||The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma|The Prognostic Impact of Extracapsular Lymph Node Involvement (ECLNI) in Ductal Pancreatic Adenocarcinoma (DPAC).|Completed||N/A|145|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-02-18 14:34:15.038294|2017-02-18 14:34:15.038294
NCT00644241|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2015-10-19|||January 2008||2008-01-01|October 2015|2015-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|SCT||Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus|Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|10|Actual|Postgraduate Institute of Medical Education and Research||1|||f||||f||||||||||2017-02-18 14:34:15.141049|2017-02-18 14:34:15.141049
NCT00644228|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2016-10-07|||April 2008||2008-04-01|October 2016|2016-10-01||||July 2016|Actual|2016-07-01||Interventional|||Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma|A Randomized Phase III Trial of CC-5013 (Lenalidomide, NSC-703813) and Low Dose Dexamethasone (LLD) Versus Bortezomib (PS-341, NSC-681239), Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients With Previously Untreated Multiple Myeloma Without an Intent for Immediate Autologous Stem Cell Transplant|Active, not recruiting||Phase 3|525|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 14:34:15.26081|2017-02-18 14:34:15.26081
NCT00644215|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-06-16|||June 2007||2007-06-01|June 2008|2008-06-01||||February 2009|Anticipated|2009-02-01||Interventional|||Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb Failure|Comparison of Subconjunctival 5-FU Injection and Mitomycin C for Treatment of Early Bleb Failure, a Randomized Clinical Trial|Unknown status|Recruiting|N/A|40|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:34:16.36642|2017-02-18 14:34:16.36642
NCT00644202|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-03-20|||May 2006||2006-05-01|March 2008|2008-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Pilot Weight Control Intervention at HPHC|A Pilot Weight Control Intervention at Harvard Pilgrim Health Care (HPHC)|Completed||N/A|101|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 14:34:16.477755|2017-02-18 14:34:16.477755
NCT00644189|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2016-12-17|||June 2008||2008-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2013|Actual|2013-12-01||Interventional|||Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma|A Phase II Study of Oral Clofarabine in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma|Completed||Phase 1/Phase 2|25|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:34:16.584301|2017-02-18 14:34:16.584301
NCT00644176|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-06-03|||November 2004||2004-11-01|June 2011|2011-06-01|April 2005|Actual|2005-04-01|||||Interventional|||A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery|A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin in Serum, Bronchial Washings and Lung Tissue Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Resection|Completed||Phase 2|66|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:16.695665|2017-02-18 14:34:16.695665
NCT00644163|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-01-23|||November 2003||2003-11-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples|NIMH Multisite HIV/STD Prevention Trial for African American Couples|Completed||N/A|1070|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:34:16.805767|2017-02-18 14:34:16.805767
NCT00644150|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-12-11|||April 2007||2007-04-01|December 2013|2013-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China|Project Ai Shi Zi: Integrating HIV/STI Prevention and Treatment in China|Completed||N/A|1373|Actual|University of California, Los Angeles||6|||f||||t||||||||||2017-02-18 14:34:16.92132|2017-02-18 14:34:16.92132
NCT00644137|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2015-07-07|||August 2007||2007-08-01|July 2015|2015-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||GABA (Gamma Amino Butyric Acid) Medication for Tobacco|Pregabalin Given to Tobacco Users to Study Addiction|Completed||Early Phase 1|24|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:34:17.027926|2017-02-18 14:34:17.027926
NCT00644124|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-05-05|||March 2008||2008-03-01|May 2016|2016-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma|A Phase I Open-label Dose-escalation Study of Intravenous Aflibercept (AVE0005, VEGF Trap) in Combination With R-CHOP Administered Every 2 Weeks or Every 3 Weeks in Patients With Non Hodgkin's B-cell Lymphoma|Completed||Phase 1|25|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:34:17.139307|2017-02-18 14:34:17.139307
NCT00644111|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2013-02-11|||February 2008||2008-02-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Post-operative Epidural Analgesia After Minimally Invasive Lumbar Decompression and Fusion|Post-operative Epidural Analgesia After Minimally Invasive Lumbar Decompression and Fusion|Completed||N/A|32|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 14:34:17.238079|2017-02-18 14:34:17.238079
NCT00644098|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2015-09-30|||September 2008||2008-09-01|September 2015|2015-09-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors|The Effect and Dose-response of Soluble Fibre Blend and Medium Chain Triglycerides (MCT) on Body Composition and Cardiometabolic Risk Factors in Overweight and Obese Adults: a Double-blind, Placebo-controlled Study.|Completed||Phase 2|138|Actual|Canadian Center for Functional Medicine||2|||f||||||||||||||2017-02-18 14:34:17.344242|2017-02-18 14:34:17.344242
NCT00644085|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-03-26|||April 2000||2000-04-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|||||Interventional|||Does Low-Dose Aspirin Improve Outcome in In Vitro Fertilisation/Intra Cytoplasmatic Sperm Injection (IVF/ICSI)?|Does Low-Dose Aspirin Improve Outcome in IVF/ICSI? A Prospective, Randomized, Double Blind Placebo Controlled Trial|Completed||Phase 3|201|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 14:34:17.440346|2017-02-18 14:34:17.440346
NCT00644072|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2017-01-24|||March 7, 2008||2008-03-07|June 16, 2011|2011-06-16|June 16, 2011|Actual|2011-06-16|June 30, 2009|Actual|2009-06-30||Interventional|||SNX-5422 to Treat Solid Tumor Cancers and Lymphomas|Phase I Study of SNX-5422 Mesylate in Adults With Refractory Solid Tumor Malignancies and Lymphomas|Completed||Phase 1|33|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:34:17.544088|2017-02-18 14:34:17.544088
NCT00644059|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2015-08-31|2011-10-06||November 2007||2007-11-01|August 2015|2015-08-01|August 2010|Actual|2010-08-01|April 2010|Actual|2010-04-01||Interventional|||Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines|A Phase III, Randomized, Observer-blind, Controlled, Multi-center Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of One and Two Intramuscular Doses of Influenza Vaccine Versus Control Vaccines in Healthy Subject Aged 6 to <72 Months|Completed||Phase 3|4902|Actual|Novartis||3|||f||||t||||||||||2017-02-18 14:34:17.665458|2017-02-18 14:34:17.665458
NCT00644046|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2012-09-05|||July 2007||2007-07-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Chronic Kidney Disease Prevention of An-Lo District, Keelung|Chronic Kidney Disease Prevention of An-Lo District, Keelung.|Completed||Phase 4|1500|Actual|Chang Gung Memorial Hospital||2|||f||||t||||||||||2017-02-18 14:34:21.097396|2017-02-18 14:34:21.097396
NCT00644033|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2011-06-13|||June 2001||2001-06-01|June 2011|2011-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine||Completed||Phase 3|579|Actual|Endo Pharmaceuticals||3|||f||||||||||||||2017-02-18 14:34:21.20847|2017-02-18 14:34:21.20847
NCT00644020|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-23|2008-03-25|||December 2007||2007-12-01|December 2007|2007-12-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Observational|||Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients|A Randomized, Double Blind, Placebo Controled, Multicenter Phase ⅡStudy to Evaluate the Safety and Efficacy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients|Unknown status|Recruiting|N/A|100|Anticipated|Shenzhen Kangzhe Pharmaceutical Co., Ltd.|||4||f||||t||||||Samples With DNA|"~     collection of blood sample before the operation and ahead of the third and the sixth period.~      collection of the tumor tissue during the operation~   "|||2017-02-18 14:34:21.311751|2017-02-18 14:34:21.311751
NCT00644007|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-23|2013-04-16|||December 2007||2007-12-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension|A Double Blind, Randomized, Placebo-controlled, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction Taking Antihypertensive Medication|Completed||Phase 3|109|Actual|SK Chemicals Co.,Ltd.||2|||f||||t||||||||||2017-02-18 14:34:21.423198|2017-02-18 14:34:21.423198
NCT00643994|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-07-14|||December 2007||2007-12-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution|Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Homogenous Dose Distribution|Active, not recruiting||Phase 2|298|Anticipated|Accuray Incorporated||1|||f||||t||||||||||2017-02-18 14:34:21.542494|2017-02-18 14:34:21.542494
NCT00643981|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-04-27|||February 2008||2008-02-01|December 2008|2008-12-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|CI||Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia|Phase I Study to See if a of A Combination Stem Cell Therapy is Safe and Feasible for the Treatment of Severe Coronary Ischemia|Completed||Phase 1|10|Anticipated|TCA Cellular Therapy||1|||f||||||||||||||2017-02-18 14:34:21.674907|2017-02-18 14:34:21.674907
NCT00643968|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-06-27|||March 2003||2003-03-01|June 2008|2008-06-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|COOL||Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial|Randomized Multicenter Open-Label, Pilot Trial to Evaluate the Efficacy and Safety of Switching HIV-1 Stable Infected Patients Under HAART to a New Once Daily Triple Therapy Combination Including EFV+3TC+TDF Versus a Dual QD Therapy Containing EFV+TDF|Completed||Phase 4|140|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 14:34:21.761188|2017-02-18 14:34:21.761188
NCT00643955|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-25|||March 2008||2008-03-01|March 2008|2008-03-01||||||||Observational|||Neuromuscular Characteristics of Individuals With Down Syndrome (DS)|Neuromuscular Characteristics of Individuals With Down Syndrome|Unknown status|Recruiting|N/A|15|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:34:21.867145|2017-02-18 14:34:21.867145
NCT00643227|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-19|||January 2003||2003-01-01|March 2008|2008-03-01|March 2004|Actual|2004-03-01|||||Interventional|||A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients|A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Clarithromycin Extended Release for the Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults|Completed||Phase 3|504|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:21.964617|2017-02-18 14:34:21.964617
NCT00643214|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-05-19|||October 2007||2007-10-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis|A Study to Determine if Tetrix Cream Impedes the Resolution of Experimentally Induced Allergic Contact Dermatitis|Completed||N/A|12|Actual|Coria Laboratories, Ltd.||2|||f||||f||||||||||2017-02-18 14:34:22.152708|2017-02-18 14:34:22.152708
NCT00643201|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2014-04-17|2014-03-04||July 2008||2008-07-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Randomized Participants|Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism|A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism|Completed||Phase 3|5614|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 14:34:22.405829|2017-02-18 14:34:22.405829
NCT00643188|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2016-09-01|||January 2008||2008-01-01|September 2016|2016-09-01|September 2019|Anticipated|2019-09-01|April 2019|Anticipated|2019-04-01||Interventional|CASTLE-AF||Catheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AF|Catheter Ablation Versus Standard Conventional Treatment in Patients With Left Ventricular Dysfunction and Atrial Fibrillation|Active, not recruiting||Phase 4|398|Actual|Biotronik SE & Co. KG||2|||f||||t||||||||Undecided|It is planned to publish results of this investigation in peer-reviewed journals (online: open-access), but it is not yet decided to annex individual participant data (IPD).|2017-02-18 14:34:26.394258|2017-02-18 14:34:26.394258
NCT00643175|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2009-12-29|||June 2007||2007-06-01|December 2009|2009-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture||Terminated||N/A|20|Anticipated|State University of New York - Upstate Medical University|||1|Dr. Grose has left this practice, this study is terminated|f||||||||||||||2017-02-18 14:34:26.730924|2017-02-18 14:34:26.730924
NCT00643162|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2012-03-26|||June 2006||2006-06-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Depression in Older Adults|Combination Lexapro and Massage for Treatment in Depression in Older Subjects|Completed||N/A|17|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-02-18 14:34:26.829743|2017-02-18 14:34:26.829743
NCT00643149|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-05-16|||May 2003||2003-05-01|May 2011|2011-05-01|March 2004|Actual|2004-03-01|||||Interventional|||A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children|A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial Of Azithromycin SR Versus Amoxicillin For The Treatment Of Group A Β-Hemolytic Streptococcal Pharyngitis/Tonsillitis In Children|Completed||Phase 3|693|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:26.948422|2017-02-18 14:34:26.948422
NCT00643812|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-03-25|||November 2004||2004-11-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Improving Firearm Storage in Alaska Native Villages|Improving Firearm Storage in Alaska Native Villages|Completed||N/A|266|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:34:30.92268|2017-02-18 14:34:30.92268
NCT00643136|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-04-23|||November 2002||2002-11-01|April 2008|2008-04-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures|Pregabalin BID Add-on Trial: a Randomized, Double-Blind, Placebo-Controlled Parallel-Group Single-Center Sleep EEG Study in Patients With Partial Seizures and Sleep Disturbance Part B: a Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of Pregabalin Add-on Treatment|Completed||Phase 3|17|Actual|Pfizer||2|||f||||||||||||||2017-02-18 14:34:27.118701|2017-02-18 14:34:27.118701
NCT00643123|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2012-03-26|||September 2007||2007-09-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Allopurinol Add-on Treatment for Refractory Mania|A Double-Blind, Placebo Controlled Augmentation Study With Allopurinol for Treatment Resistant Mania|Completed||Phase 4|40|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-02-18 14:34:27.238342|2017-02-18 14:34:27.238342
NCT00643110|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2015-03-24|||April 2008||2008-04-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Milk as Treatment for Hypoglycemia|Milk as Treatment for Hypoglycemia|Withdrawn||N/A|0|Actual|Creighton University||1||Not funded|f||||f||||||||||2017-02-18 14:34:27.35665|2017-02-18 14:34:27.35665
NCT00643097|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2016-12-02|2014-01-06||September 2007||2007-09-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|January 2012|Actual|2012-01-01||Interventional|ACTIVATe||Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Complementary Trial of an Immunotherapy Vaccine Against Tumor-Specific EGFRvIII|Completed||Phase 2|40|Actual|Duke University||3|||f||||t||||||||||2017-02-18 14:34:27.458346|2017-02-18 14:34:27.458346
NCT00643084|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-24|||May 2008||2008-05-01|March 2008|2008-03-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Bowel Prep vs Non-Bowel Prep for Laparoscopic Colorectal Surgery|A Randomized Controlled Trial of Bowel-Prepped vs Non-Bowel-Prepped Laparoscopic Colorectal Surgery|Unknown status|Not yet recruiting|N/A|120|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 14:34:28.176251|2017-02-18 14:34:28.176251
NCT00643942|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2015-05-08|||June 2007||2007-06-01|March 2008|2008-03-01||||January 2008|Actual|2008-01-01||Observational|||Staining in a Healthy, Non-Dry Eye Population||Completed||N/A|120||Alcon Research|||1||f||||f||||||||||2017-02-18 14:34:28.286312|2017-02-18 14:34:28.286312
NCT00643929|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2015-04-16|||February 2007||2007-02-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|LENS||LENS - Long-term Eltrombopag Observational Study|LENS - Long-term Eltrombopag Observational Study - A Long Term Observational Ocular Safety Follow-up Study in Adults Who Have Received Study Medication (SB-497115-GR / Eltrombopag Olamine or Placebo) in a Phase II or III Clinical Study Evaluating Eltrombopag|Completed||N/A|164|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 14:34:28.369043|2017-02-18 14:34:28.369043
NCT00643916|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-01-21|2009-09-24||December 2004||2004-12-01|January 2014|2014-01-01|October 2007|Actual|2007-10-01|March 2006|Actual|2006-03-01||Interventional|||Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age|Safety and Immunogenicity of a Tetravalent (A, C, Y, and W-135) Meningococcal Diphtheria Toxoid Conjugate Vaccine (TetraMenD) In Toddlers 9 to 18 Months of Age|Completed||Phase 2|378|Actual|Sanofi||6|||f||||t||||||||||2017-02-18 14:34:28.655502|2017-02-18 14:34:28.655502
NCT00643903|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2012-01-18|||April 2004||2004-04-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||Effectiveness of Coping Training for People With HIV Experiencing Treatment Side Effects (The Balance Project)|The Balance Project - RCT of an HIV Treatment Side Effects Coping Intervention|Completed||N/A|250|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:34:30.058518|2017-02-18 14:34:30.058518
NCT00643890|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2012-02-20|||August 2008||2008-08-01|February 2012|2012-02-01||||December 2010|Actual|2010-12-01||Interventional|||Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease|Phase 2 Safety and Efficacy Study Evaluating Glutamic Acid Decarboxylase Gene Transfer to Subthalamic Nuclei in Subjects With Advanced Parkinson's Disease|Terminated||Phase 2|44|Anticipated|Neurologix, Inc.||||Due to financial reasons|f||||t||||||||||2017-02-18 14:34:30.16821|2017-02-18 14:34:30.16821
NCT00643877|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2009-03-24|||December 2008||2008-12-01|March 2009|2009-03-01|December 2014|Anticipated|2014-12-01|December 2009|Anticipated|2009-12-01||Interventional|PHRAC||Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer|A Prospective,Multi-Center,Randomized Control Trial of Preoperative Hepatic and Regional Arterial Chemotherapy(PHRAC) Using Oxaliplatin, Fluorodeoxyuridine(FUDR) and Mitomycin C(MMC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer|Unknown status|Recruiting|Phase 3|600|Anticipated|Fudan University||2|||f||||t||||||||||2017-02-18 14:34:30.266133|2017-02-18 14:34:30.266133
NCT00643864|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2012-02-09|||February 2006||2006-02-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Mirror-Box Training in Adults With Chronic Hemiparesis Secondary to Stroke|Mirror-Box Training in Adults With Chronic Hemiparesis Secondary to Stroke: A Descriptive Case Series and Pilot Study|Terminated||N/A|3|Actual|Carolinas Healthcare System||1||lack of enrollment|f||||t||||||||||2017-02-18 14:34:30.3777|2017-02-18 14:34:30.3777
NCT00643851|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2015-03-20|||June 2008||2008-06-01|March 2015|2015-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets|A Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin as Initial Therapy as Compared With Dapagliflozin Monotherapy and Metformin Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|Completed||Phase 3|600|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:34:30.480319|2017-02-18 14:34:30.480319
NCT00643838|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2009-01-09|||December 2007||2007-12-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Use of 50% Nitrous Oxide / 50% Oxygen Premix in Primary Care Dental Centers|Sedation Faisability by Inhalation of Kalinox 170 Bar During Therapeutic Cares in Primary Care Dental Centers|Completed||Phase 3|480|Anticipated|Air Liquide Santé International||1|||f||||f||||||||||2017-02-18 14:34:30.711196|2017-02-18 14:34:30.711196
NCT00643825|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2010-07-22|||January 2008||2008-01-01|July 2010|2010-07-01|January 2012|Anticipated|2012-01-01|January 2011|Anticipated|2011-01-01||Interventional|PATSGO||"Prolonged Adjuvant Temozolomide vs Stop & Go in Glioblastoma Patients"|"Randomized Multicentric Phase II Study of Prolonged Adjuvant Temozolomide or Stop and Go in Glioblastoma Patients: The PATSGO Study"|Unknown status|Recruiting|Phase 2|64|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-02-18 14:34:30.808141|2017-02-18 14:34:30.808141
NCT00643799|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-04-22|||March 2004||2004-03-01|April 2008|2008-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|CLOAK||Safety and Efficacy of Celecoxib Versus Naproxen in the 6-Month Treatment of Knee Osteoarthritis|A Randomized, Multicenter, Double-Blind, Double-Dummy Study Comparing the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) and Naproxen 500 mg Twice Daily in the 6-Month Treatment of Subjects With Osteoarthritis of the Knee|Completed||Phase 4|586|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:34:31.045292|2017-02-18 14:34:31.045292
NCT00643786|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2014-06-23|||February 2004||2004-02-01|June 2014|2014-06-01|June 2008|Actual|2008-06-01|May 2007|Actual|2007-05-01||Interventional|||Interest of Re-oxygenation After Inhalation of 50% Nitrous Oxide / 50% Oxygen Premix in Dental Cares|Validation of a Kalinox's Administration Protocol for Dental Cares : Interest of Re-oxygenation and Pollution Control|Terminated||Phase 3|128|Actual|Air Liquide Santé International||2|||f||||f||||||||||2017-02-18 14:34:31.228438|2017-02-18 14:34:31.228438
NCT00643773|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-08-25|||May 2008||2008-05-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients|The Influence of Leucine Supplementation on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients.|Completed||Phase 2/Phase 3|60|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 14:34:31.320313|2017-02-18 14:34:31.320313
NCT00643760|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2013-07-15|2011-04-21||March 2008||2008-03-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)|Study PXN110448: A Dose-response Study of XP13512, Compared With Concurrent Placebo Control and LYRICA(Pregabalin), in Subjects With Neuropathic Pain Associated Withdiabetic Peripheral Neuropathy (DPN)|Completed||Phase 2|421|Actual|XenoPort, Inc.||5|||f||||f||||||||||2017-02-18 14:34:31.428484|2017-02-18 14:34:31.428484
NCT00643747|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2015-12-04|||January 2007||2007-01-01|December 2013|2013-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis|An Open-label Dose Escalation Study of an Adeno-associated Virus Vector (AAV2/2-hRPE65p-hRPE65) for Gene Therapy of Severe Early-onset Retinal Degeneration|Completed||Phase 1/Phase 2|12|Actual|University College, London||1|||f||||t||||||||||2017-02-18 14:34:33.576913|2017-02-18 14:34:33.576913
NCT00643734|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-19|||April 2003||2003-04-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|||||Interventional|||A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients|A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults|Completed||Phase 3|468|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:33.719603|2017-02-18 14:34:33.719603
NCT00643721|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-25|||September 2007||2007-09-01|March 2008|2008-03-01|April 2008|Anticipated|2008-04-01|April 2008|Anticipated|2008-04-01||Observational|||Body Water Content Sensor|Body Water Content Sensor|Unknown status|Active, not recruiting|N/A|12|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:34:34.066767|2017-02-18 14:34:34.066767
NCT00643708|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-25|||January 2005||2005-01-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Ovarian Laser Treatment in Women With Polycystic Ovarian Syndrome: A Randomized Study on the Laser Dose|Transvaginal Ultrasound-Guided Ovarian Interstitial Laser Treatment in Anovulatory Women With Polycystic Ovarian Syndrome: A Randomized Prospective Study on the Effect of Laser Dose Used on the Outcome|Completed||Phase 3|56|Actual|Shen-Zhen City Maternity and Child Healthcare Hospital|||4||f||||t||||||||||2017-02-18 14:34:34.167017|2017-02-18 14:34:34.167017
NCT00643695|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-03-28|||March 2008||2008-03-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C|Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C|Completed||N/A|14|Actual|Portland VA Medical Center||2|||f||||f||||||||||2017-02-18 14:34:34.274872|2017-02-18 14:34:34.274872
NCT00643682|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2012-08-29|2012-07-09||February 2006||2006-02-01|August 2012|2012-08-01|October 2009|Actual|2009-10-01|June 2008|Actual|2008-06-01||Interventional|||Improving Bowel Preparation for Colonoscopy With a Simple Educational Card|Improving Bowel Preparation for Colonoscopy With a Simple Educational Card|Completed||N/A|2000|Actual|Boston Medical Center||2|||f||||f||||||||||2017-02-18 14:34:34.377155|2017-02-18 14:34:34.377155
NCT00643669|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2012-11-27||2012-11-27|February 2008||2008-02-01|November 2012|2012-11-01||||April 2008|Actual|2008-04-01||Interventional|||24 Hour IOP Lowering Efficacy of AL-3789||Completed||Phase 2|25|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:34:34.755883|2017-02-18 14:34:34.755883
NCT00643656|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2009-01-09|||October 2007||2007-10-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion|Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion|Completed||Phase 4|94|Anticipated|Air Liquide Santé International||2|||f||||f||||||||||2017-02-18 14:34:34.841562|2017-02-18 14:34:34.841562
NCT00643643|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2010-11-09|||October 2002||2002-10-01|November 2010|2010-11-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus|A Randomised, Double Blind, Placebo-Controlled, Multicentre Study Of UK-427,857 25mg O.D. , 50mg B.I.D., 100mg B.I.D And 300mg B.I.D. In Asymptomatic HIV Infected Patients To Investigate Pharmacodynamics, Pharmacokinetics, Safety And Toleration.|Completed||Phase 2|41|Actual|ViiV Healthcare||5|||f||||f||||||||||2017-02-18 14:34:34.939696|2017-02-18 14:34:34.939696
NCT00643630|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2008-05-19|||October 2007||2007-10-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials|A Study to Determine the Skin Barrier Effect of Tetrix Cream|Completed||N/A|36|Actual|Coria Laboratories, Ltd.||2|||f||||f||||||||||2017-02-18 14:34:35.079071|2017-02-18 14:34:35.079071
NCT00643617|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-07-14|||November 2007||2007-11-01|July 2016|2016-07-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry|Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry|Active, not recruiting||Phase 2|253|Anticipated|Accuray Incorporated||1|||f||||t||||||||||2017-02-18 14:34:35.173649|2017-02-18 14:34:35.173649
NCT00643604|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2013-06-19|2013-03-28||March 2008||2008-03-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|January 2010|Actual|2010-01-01||Interventional|||Rapid Switch From Flolan to Remodulin in the Outpatient Clinic|Rapid Switch From Intravenous Epoprostenol to Intravenous Remodulin® (Treprostinil Sodium) in Patients With Stable Pulmonary Arterial Hypertension in the Outpatient Clinic: Safety, Efficacy and Treatment Satisfaction|Terminated||Phase 4|7|Actual|United Therapeutics|The main limitations of this study are the small sample size, open-label design and relatively short duration of follow-up.|1||"Due to availability of eligible subjects at center and enrollment competition with other~   studies."|f||||f||||||||||2017-02-18 14:34:35.322187|2017-02-18 14:34:35.322187
NCT00643591|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2015-04-09|||June 2008||2008-06-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Observational|||Positron Emission Tomography-Computed Tomography (PET-CT) High-grade Glioma|Pilot Study on the Determination of Therapy Resistant Areas Within the Tumor in Patients With High-grade Glioma by Repeated 18F-FDG-PET-CT Scans|Terminated||N/A|10|Actual|Maastricht Radiation Oncology|||1|Patient compliance was low.|f||||t||||||Samples Without DNA|"~     EDTA blood, serum~   "|||2017-02-18 14:34:35.846962|2017-02-18 14:34:35.846962
NCT00643578|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-11-29|2011-08-05||March 2008||2008-03-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay|A Pilot Study to Evaluate the Dose-response of Inhaled Formoterol to Inhibit Airway Responsiveness to Methacholine in Patients With Mild Asthma|Completed||N/A|37|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 14:34:35.947073|2017-02-18 14:34:35.947073
NCT00643565|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-01-15|2015-12-07||July 2008||2008-07-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|May 2015|Actual|2015-05-01||Interventional||Intent-to-treat (ITT) population included all participants randomized to the treatment group in the study.|A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.|An Open-label, Multi-center, Randomized Study of the Safety and Effect on Event-free Survival of Bevacizumab in Combination With Standard Chemotherapy in Childhood and Adolescent Patients With Metastatic Rhabdomyosarcoma and Non-rhabdomyosarcoma Soft Tissue Sarcoma|Active, not recruiting||Phase 2|154|Actual|Hoffmann-La Roche|Reported results represent the interim results up to approximately 6.75 years (data cut-off date 31 May 2015).|2|||f||||||||||||||2017-02-18 14:34:36.358084|2017-02-18 14:34:36.358084
NCT00643552|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-25||||||March 2008|2008-03-01||||||||Observational|||Muscle Strength, Physical Work Capacity and Functional Performance in Individuals With Down Syndrome|Muscle Strength, Physical Work Capacity and Functional Performance in Individuals With Down Syndrome|Completed||N/A|18|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:34:37.263909|2017-02-18 14:34:37.263909
NCT00643539|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-19|||December 2002||2002-12-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|||||Interventional|||Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat|Multicenter, Open, Randomized Comparative Trial To Compare Bacteriological And Clinical Efficacy Of Azithromycin Versus Amoxicillin In Children With Streptococcus Tonsillitis|Completed||Phase 4|360|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:37.33511|2017-02-18 14:34:37.33511
NCT00643526|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2015-04-09|||December 2007||2007-12-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector|An Open-Label, Randomized, Validation Study to Establish That the Design, Functionality, and Ergonomic Features of the Autoinjector Conform to Defined User Needs and Intended Use for Self-Administration by Subjects With Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Psoriasis|Completed||Early Phase 1|68|Actual|Centocor, Inc.||2|||f||||f||||||||||2017-02-18 14:34:39.947529|2017-02-18 14:34:39.947529
NCT00643513|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2009-04-21|||June 2007||2007-06-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|||||Observational|||Quality Of Life While Receiving Faslodex|Quality Of Life And Symptoms In Postmenopausal Women With Hormone Receptor Positive Disseminated Breast Cancer While Receiving Faslodex.|Completed||N/A|120|Anticipated|AstraZeneca|||1||f||||||||||||||2017-02-18 14:34:40.053839|2017-02-18 14:34:40.053839
NCT00643500|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2013-11-14|||January 2002||2002-01-01|September 2009|2009-09-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy|Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy|Completed||Phase 4|342|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:34:40.152166|2017-02-18 14:34:40.152166
NCT00643487|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-05-03|2016-05-03||February 2006||2006-02-01|May 2016|2016-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||In Vivo Arthroscopic Behavior of the Infrapatellar Plica of the Knee|In Vivo Arthroscopic Behavior of the Infrapatellar Plica of the Knee|Completed||N/A|8|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:34:40.236497|2017-02-18 14:34:40.236497
NCT00643474|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-03-01|||March 2008||2008-03-01|May 2010|2010-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||PRISMA Study (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients)|PRISMA Study (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients)|Completed||N/A|1000|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:34:40.45957|2017-02-18 14:34:40.45957
NCT00643461|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2013-04-16|||April 2008||2008-04-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Observational|||Clinical Evaluation of Three Dental Adhesive Systems in Class V Restorations|Clinical Evaluation of Three Dental Adhesive Systems in Class V Restorations|Completed||N/A|46|Actual|3M|||3||f||||f||||||||||2017-02-18 14:34:40.805628|2017-02-18 14:34:40.805628
NCT00643448|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2011-12-21|2011-01-24||March 2008||2008-03-01|December 2011|2011-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Explorative Study of AZD1305 in Atrial Fibrillation Patients|A Randomised, Placebo-controlled, Double-blind, Parallel-group, Multicentre, Phase IIa Study to Explore the Relationship Between QTcF Interval at First Dose (Loading Dose) and at Steady State After Treatment With AZD1305 Extended-release Tablets or Placebo When Given to Patients With Documented AF|Completed||Phase 2|65|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:34:40.907321|2017-02-18 14:34:40.907321
NCT00643435|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2008-03-25|||February 2006||2006-02-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|June 2007|Actual|2007-06-01||Interventional|SEE-IT||Self-Efficacy Enhancing Interviewing Techniques Study|Self-Efficacy Enhancing Interviewing Techniques Study|Completed||N/A|64|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 14:34:41.369558|2017-02-18 14:34:41.369558
NCT00643422|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-22|2008-07-21||||||July 2008|2008-07-01||||||||Observational|||Reproducibility of Cirrus Optical Coherence Tomography Measurements|Reproducibility of Retinal Thickness and Volume Measurements Determined With the Cirrus Spectral Domain OCT|Completed||N/A|16|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|||1||f||||||||||||||2017-02-18 14:34:41.460546|2017-02-18 14:34:41.460546
NCT00643409|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-05-10|||January 2003||2003-01-01|May 2011|2011-05-01|February 2004|Actual|2004-02-01|||||Interventional|||A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults|A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Acute Bacterial Maxillary Sinusitis in Adults Undergoing Diagnostic Sinus Aspiration|Completed||Phase 3|541|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:41.554136|2017-02-18 14:34:41.554136
NCT00643396|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2016-02-24|||February 2008||2008-02-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer|Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|30|Actual|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 14:34:41.734635|2017-02-18 14:34:41.734635
NCT00643383|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2012-04-30||2010-01-12|March 2008||2008-03-01|April 2012|2012-04-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||A Two-Arm Study Comparing the Analgesic Efficacy and Safety of Acetaminophen and Tramadol Combination BID Versus Placebo for the Treatment of Acute Low Back Pain||Completed||Phase 3|277|Actual|Labopharm Inc.||2|||f||||||||||||||2017-02-18 14:34:41.828797|2017-02-18 14:34:41.828797
NCT00643370|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2016-02-12|||April 2008||2008-04-01|August 2011|2011-08-01||||January 2011|Actual|2011-01-01||Observational|||Quantifying Lung Tumor Movement Under Deep Inspiration Breath Holds|Quantifying Lung Tumor Movement Under Dep Inspiration Breath Holds|Completed||N/A|8|Actual|AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 14:34:42.168957|2017-02-18 14:34:42.168957
NCT00643357|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2012-01-18|||March 2008||2008-03-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|Burns||Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns|Study of the Efficacy and Safety of KALINOX® 170 Bar for the Performance of Care Procedures in Children With Burns|Withdrawn||Phase 3|0|Actual|Air Liquide Santé International||2||No patient recruited due to current guidelines for the pain related to burn|f||||f||||||||||2017-02-18 14:34:42.273974|2017-02-18 14:34:42.273974
NCT00643344|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-10-25|||January 2008||2008-01-01|October 2014|2014-10-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|CALMM||Craving and Lifestyle Management Through Mindfulness Pilot Study|Craving and Lifestyle Management Through Mindfulness Pilot Study|Completed||N/A|15|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:34:42.372743|2017-02-18 14:34:42.372743
NCT00643331|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2015-06-02|||February 2001||2001-02-01|March 2008|2008-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||The Effect of Exercise in Postmenopausal Women With Low Bone Density|The Effect of Exercise in Postmenopausal Women With Low Bone Density|Completed||Phase 2|38|Actual|University of Melbourne||2|||f||||f||||||||||2017-02-18 14:34:42.496502|2017-02-18 14:34:42.496502
NCT00643318|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-07-14|||April 2006||2006-04-01|July 2016|2016-07-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer|A Prospective Evaluation of Outcomes of Radiosurgical Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|40|Actual|Accuray Incorporated||1|||f||||f||||||||||2017-02-18 14:34:42.594896|2017-02-18 14:34:42.594896
NCT00643305|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2013-05-02|||February 2006||2006-02-01|March 2008|2008-03-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||HIV Prevention With the Mentally Ill|HIV Prevention With the Mentally Ill: Motivation-Skills|Completed||Phase 2|53|Actual|Boston Medical Center||2|||f||||t||||||||||2017-02-18 14:34:42.727936|2017-02-18 14:34:42.727936
NCT00643292|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-05-16|||January 2003||2003-01-01|May 2011|2011-05-01|May 2004|Actual|2004-05-01|||||Interventional|||A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections|A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Amoxicillin/Clavulanate Potassium (Augmentin ES-600 Trademark) for the Treatment of Acute Otitis Media in Children Undergoing Diagnostic Tympanocentesis|Completed||Phase 3|902|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:34:42.836637|2017-02-18 14:34:42.836637
NCT00643279|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2013-01-31|||March 2003||2003-03-01|January 2013|2013-01-01||||June 2005|Actual|2005-06-01||Interventional|||Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)|Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF)|Unknown status|Active, not recruiting|Phase 2|274|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||t||||||||||2017-02-18 14:34:42.998993|2017-02-18 14:34:42.998993
NCT00643266|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2016-12-21|||February 2008||2008-02-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Recollection Training in Healthy Older Adults and Older Adults With Amnestic Mild Cognitive Impairment|Memory Interventions for Older Adults|Completed||N/A|91|Actual|Baycrest||2|||f||||f||||||||||2017-02-18 14:34:43.116947|2017-02-18 14:34:43.116947
NCT00643253|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-07-09|||March 2008||2008-03-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|September 2012|Actual|2012-09-01||Interventional|PAIRINGS||Provider Approaches to Improved Rates of Infant Nutrition and Growth Study|Provider Approaches to Improved Rates of Infant Nutrition and Growth Study|Completed||Phase 3|299|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-02-18 14:34:43.223182|2017-02-18 14:34:43.223182
NCT00643240|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-25|2012-11-06|||January 2008||2008-01-01|November 2012|2012-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia|Phase I Open Label, Single Arm Escalation Trial to Evaluate the Biodistribution and Safety of BU-12 in Patients With Advanced Leukemia|Terminated||Phase 1|1|Actual|Masonic Cancer Center, University of Minnesota||1||Due to slow accrual|f||||t||||||||||2017-02-18 14:34:43.324478|2017-02-18 14:34:43.324478
NCT00642408|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2010-09-12|||June 2003||2003-06-01|September 2010|2010-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Prevention of Intrauterine Growth Retardation in Hounde District, Burkina Faso|Prevention of Intrauterine Growth Retardation in Hounde District, Burkina Faso|Completed||Phase 4|1370|Actual|Institute of Tropical Medicine, Belgium||2|||f||||t||||||||||2017-02-18 14:34:57.649789|2017-02-18 14:34:57.649789
NCT00643071|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2014-08-25|||September 2006||2006-09-01|August 2014|2014-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients|Tacrolimus (FK506) P-III, Open-label Study in Severe Refractory Ulcerative Colitis Patients or Patients Who Attended and Received Placebo in F506-CL-1107 Study|Completed||Phase 3|32|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-02-18 14:34:43.436183|2017-02-18 14:34:43.436183
NCT00643058|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2013-07-15|||April 2003||2003-04-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Nitric Oxide, LPS and the Pathogenesis of Asthma Phase II|Nitric Oxide, LPS and the Pathogenesis of Asthma - Phase II|Terminated||Phase 1|70|Actual|Duke University||1||Funding period completed.|f||||f||||||||||2017-02-18 14:34:43.556878|2017-02-18 14:34:43.556878
NCT00643045|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-03-24|||December 2004||2004-12-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|January 2006|Actual|2006-01-01||Interventional|||Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist|A Phase III, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of a Low (50 100 mg/Day) and High (150 200 mg/Day) Dose Range of Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist|Completed||Phase 3|269|Actual|Newron||3|||f||||t||||||||||2017-02-18 14:34:43.657933|2017-02-18 14:34:43.657933
NCT00643032|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-19|||March 2008||2008-03-01|March 2008|2008-03-01||||January 2010|Anticipated|2010-01-01||Interventional|||Preoperative Anxiety and Postoperative Pain in Children|Comparison of 2 Methods to Reduce Postoperative Pain in Children and a Comparison of 3 Methods of Preoperative Education Intervention to Reduce Anxiety in Children and Their Family|Unknown status|Not yet recruiting|Phase 4|250|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-02-18 14:34:43.769651|2017-02-18 14:34:43.769651
NCT00643019|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2015-04-14|||January 1993||1993-01-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|January 1994|Actual|1994-01-01||Interventional|SAFE||Project Sexual Awareness for Everyone (SAFE)|Preventing Recurrent Sexually Transmitted Infections in Minority Women|Completed||Phase 3|800|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-02-18 14:34:43.847218|2017-02-18 14:34:43.847218
NCT00643006|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2012-09-28|2012-05-03||January 2008||2008-01-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Physical Exercise and Its Impact on Signs of Inflammation in Fibromyalgia|Physical Exercise and Its Impact on Signs of Inflammation in Women With Fibromyalgia|Completed||N/A|67|Actual|Göteborg University||2|||f||||f||||||||||2017-02-18 14:34:43.948176|2017-02-18 14:34:43.948176
NCT00642993|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-09-06|2016-09-06||June 2008||2008-06-01|August 2016|2016-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)|A Multicenter, Randomized, Parallel-Group, Placebo-Controlled, Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Subjects|Completed||Phase 2|401|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:34:44.516424|2017-02-18 14:34:44.516424
NCT00642980|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2014-01-22|||April 2006||2006-04-01|January 2008|2008-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|PREMEVA||Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis|Randomized Multicenter Trial for the Prevention of Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis in the First Trimester of Pregnancy|Completed||Phase 4|3105|Actual|University Hospital, Lille||3|||f||||t||||||||||2017-02-18 14:34:44.91029|2017-02-18 14:34:44.91029
NCT00642967|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-02-01|||May 2008||2008-05-01|February 2016|2016-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Study of Subcutaneous Mircera For The Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis|A Single Arm, Open Label, French Multi-centre Study to Assess the Maintenance of Hemoglobin Levels With Once Monthly Subcutaneous Administration of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in Patients With Chronic Kidney Disease Not on Dialysis|Completed||Phase 3|127|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:34:45.027415|2017-02-18 14:34:45.027415
NCT00642954|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-02-25|||February 2008||2008-02-01|February 2016|2016-02-01|August 2013|Actual|2013-08-01|September 2012|Actual|2012-09-01||Interventional|||Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)|A Phase I Study of Vorinostat in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|31|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:34:45.214812|2017-02-18 14:34:45.214812
NCT00642941|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-11-02||2016-11-02|November 2007||2007-11-01|November 2016|2016-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.|A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor for the Treatment of Patients With Recurrent or Refractory Ewing's Sarcoma, Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas.|Completed||Phase 2|228|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:34:45.323837|2017-02-18 14:34:45.323837
NCT00642928|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2012-06-08|||October 2007||2007-10-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients|Randomized, Dose-finding Study of BF 2.649 5, 10 20 and 40 mg/d in Comparison to Placebo in Excessive Daytime Sleepiness in Parkinson's Disease Patients (PD)|Completed||Phase 2|108|Actual|Bioprojet||5|||f||||t||||||||||2017-02-18 14:34:45.455481|2017-02-18 14:34:45.455481
NCT00642915|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-08-22|||June 2003||2003-06-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|||||Interventional|||Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)|A 24 Week, Open-Label, Single Arm, Multi-Center Clinical Study to Document the Benefits of the Combination of Lantus and Amaryl in Ethnic Japanese Type 2 Diabetic Patients Living Outside of Japan (in US or Brazil), Who Failed Good Metabolic Control With Oral Antidiabetic Drugs (OADs)|Completed||Phase 4|100|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:34:45.567102|2017-02-18 14:34:45.567102
NCT00642434|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2011-08-24|||January 2004||2004-01-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Blood Pressure Medications on Metabolism|Carvedilol vs.Metoprolol: A Comparison of Effects on Endothelial Function and Oxidative Stress in Response to Acute Hyperglycemia in Patients With Type 2 Diabetes and Hypertension|Completed||Phase 4|21|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 14:34:57.442713|2017-02-18 14:34:57.442713
NCT00642902|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-04-15|2016-04-15||April 2008||2008-04-01|April 2016|2016-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|ATAMS|Intent-to-treat (ITT) population included all randomized participants.|A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)|A Four-Arm Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study to Evaluate the Safety, Tolerability and Efficacy as Assessed by Frequent MRI Measures of 3 Doses of Atacicept Monotherapy in Subjects With Relapsing Multiple Sclerosis (RMS) Over a 36 Week Treatment Course|Terminated||Phase 2|255|Actual|EMD Serono|Sponsor voluntarily decided to prematurely terminate this trial due to an increase in multiple sclerosis (MS) disease activity observed in atacicept arms as compared to placebo during a routine independent data monitoring committee (IDMC) review.|4||"Sponsor voluntarily decided to terminate trial due to increased MS disease activity in~   atacicept arms as compared to placebo during a routine IDMC review."|f||||t||||||||||2017-02-18 14:34:45.6651|2017-02-18 14:34:45.6651
NCT00642889|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-03-21|||June 2005||2005-06-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|January 2007|Actual|2007-01-01||Interventional|||Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)|A PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12-MONTH EXTENSION STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF A DOSE RANGE OF SAFINAMIDE OF 50-200 MG/DAY, AS ADD-ON THERAPY IN PATIENTS WITH EARLY IDIOPATHIC PARKINSON'S DISEASE TREATED WITH A STABLE DOSE OF A SINGLE DOPAMINE AGONIST.|Completed||Phase 3|227|Actual|Newron||3|||f||||t||||||||||2017-02-18 14:34:46.346154|2017-02-18 14:34:46.346154
NCT00642876|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2013-07-31|||October 2002||2002-10-01|February 2013|2013-02-01|May 2013|Actual|2013-05-01|July 2006|Actual|2006-07-01||Interventional|||PRESTIGE® Cervical Disc Study|Investigation of the PRESTIGE® Cervical Disc Device at a Single Level for Symptomatic Cervical Disc Disease|Completed||N/A|541|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-02-18 14:34:46.440794|2017-02-18 14:34:46.440794
NCT00642863|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2014-10-28|||April 2008||2008-04-01|March 2014|2014-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Brain and Behavior Depending on Timing of Iron Deficiency in Human Infants|Brain and Behavior Depending on Timing of Iron Deficiency in Human Infants|Completed||N/A|1614|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||7|||f||||t||||||||||2017-02-18 14:34:46.558777|2017-02-18 14:34:46.558777
NCT00642850|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-05-17|2016-05-17||November 2007||2007-11-01|May 2016|2016-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||The safety population was defined as all participants enrolled into the study.|STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients|A Single Arm, Open Label Study to Assess the Efficacy, Safety and Tolerability of Once-monthly Administration of Intravenous C.E.R.A. for the Maintenance of Haemoglobin Levels in Dialysis Patients With Chronic Renal Anaemia|Completed||Phase 3|188|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:34:46.675259|2017-02-18 14:34:46.675259
NCT00642837|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2014-04-24|||September 2007||2007-09-01|April 2014|2014-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets|Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets ; Multicenter, Open-label, Prospective, Observational Study|Completed||Phase 4|982|Actual|Janssen Korea, Ltd., Korea|||9||f||||||||||||||2017-02-18 14:34:47.222851|2017-02-18 14:34:47.222851
NCT00642824|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-11-01|||May 2007||2007-05-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.|Local Substudy Associated to the International Study MO19390 to Determine the BRCA1 Gene mRNA Expression as a Predictive Marker of Response to Chemotherapy|Terminated||Phase 2|3|Actual|Hoffmann-La Roche||1||Terminated due to low enrollment. No statistical analyses were performed.|f||||||||||||||2017-02-18 14:34:47.336096|2017-02-18 14:34:47.336096
NCT00642811|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-08-30|2011-01-27||May 2008||2008-05-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|RESPOND||A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders|A Randomised, Double-Blind, Outpatient, Crossover Study of the Anti-platelet Effects of Ticagrelor Compared With Clopidogrel in Patients With Stable Coronary Artery Disease Previously Identified as Clopidogrel Non-responders or Responders [RESPOND]|Completed||Phase 2|98|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:34:47.458891|2017-02-18 14:34:47.458891
NCT00642798|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2015-02-02|||March 2008||2008-03-01|February 2015|2015-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)|An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:34:48.412406|2017-02-18 14:34:48.412406
NCT00642785|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-05-30|||January 2008||2008-01-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections|A Research Study Examining the Effectiveness of Distant Activation of ACE Pigments Associated With Recurrent Human Herpes Simplex Virus-Induced Skin Lesions.|Completed||N/A|500|Anticipated|Institute of Progressive Medicine|||4||f||||t||||||||||2017-02-18 14:34:48.495922|2017-02-18 14:34:48.495922
NCT00642772|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2015-04-06|2014-06-05||March 2008||2008-03-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||Group Physical Therapy for Knee Osteoarthritis|Pilot Study of Group Physical Therapy for Knee Osteoarthritis|Completed||N/A|24|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 14:34:48.583065|2017-02-18 14:34:48.583065
NCT00642759|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-10-18|2016-10-18||April 2008||2008-04-01|October 2016|2016-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer|A Phase II Trial of Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|36|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-02-18 14:34:48.784693|2017-02-18 14:34:48.784693
NCT00622778|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2012-04-10|||October 2007||2007-10-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Observational|MHI||Immunemodulation in Patients With Minor Head Injury|Diagnostic Algorithm in Minor Head Injury|Completed||N/A|130|Actual|Medical University of Vienna|||1||f||||f||||||Samples Without DNA|"~     Serum from peripheral blood~   "|||2017-02-18 14:41:58.275657|2017-02-18 14:41:58.275657
NCT00642746|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2014-09-24|2014-02-12||March 2008||2008-03-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||11 patients included for all baseline measures except for age, categorical because the age is missing for the 1 patient who eventually was ineligible.|Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)|Phase II Study of Erlotinib (Tarceva) Alternating With Chemotherapy for Second-line Treatment of Metastatic Colorectal Cancer With Molecular Correlates for p53 Pathway|Terminated||Phase 2|16|Actual|OHSU Knight Cancer Institute|Study terminated before target enrollment was reached due to excessive toxicities and limited enrollment.|2||Terminated due to poor enrollment and grade 3 toxicities noted during an interim analysis.|f||||t||||||||||2017-02-18 14:34:49.016644|2017-02-18 14:34:49.016644
NCT00642733|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-08-22|||August 2007||2007-08-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer|An Open Label Study to Evaluate the Effect of First Line Treatment With Tarceva in Combination With Gemcitabine on Overall Survival and Disease Progression in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer|Terminated||Phase 4|6|Actual|Hoffmann-La Roche||1||poor recruitment|f||||||||||||||2017-02-18 14:34:49.432484|2017-02-18 14:34:49.432484
NCT00642720|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-03-24|||October 2006||2006-10-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|mec-2005-290||Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients|The Effects of Weekly Administration of 40 mg Pegvisomant or Placebo on Quality of Life and Insulin Sensitivity in Acromegalic Patients With Normal IGF-I Concentrations During Long-Term Treatment With Long-Acting Somatostatin Analogs|Completed||Phase 4|20|Actual|Erasmus Medical Center||2|||f||||f||||||||||2017-02-18 14:34:49.524349|2017-02-18 14:34:49.524349
NCT00642707|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2015-12-14|2013-04-12||March 2008||2008-03-01|December 2015|2015-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection|A Phase 2a, Randomized, Double-blind, Placebo Controlled Study of PRO 140 by Subcutaneous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection|Completed||Phase 2|44|Actual|CytoDyn, Inc.||4|||f||||f||||||||||2017-02-18 14:34:49.631067|2017-02-18 14:34:49.631067
NCT00642694|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2012-10-24|2012-03-29||May 2007||2007-05-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|TAKEDA||Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon|Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon|Terminated||Phase 3|29|Actual|University of Texas Southwestern Medical Center||2||Enrollment discontinued based on mutually agreed upon decision by PI and funding sponsor|f||||f||||||||||2017-02-18 14:34:50.436432|2017-02-18 14:34:50.436432
NCT00642681|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2014-12-01|||December 2007||2007-12-01|December 2014|2014-12-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Observational|||Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge|Evaluation of the Effect of Symptomatic Upper Respiratory Infections on Pharmacological Characteristics of Technosphere®/Insulin in Subjects With Diabetes Mellitus After a Meal Challenge|Completed||Phase 2|20|Actual|Mannkind Corporation|||1||f||||||||||||||2017-02-18 14:34:50.860491|2017-02-18 14:34:50.860491
NCT00642668|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-06-09|2016-06-09||June 2008||2008-06-01|June 2016|2016-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||The safety population included all participants who received at least one dose of active drug.|A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia|Subcutaneous Treatment of Anemia in Patients With a GFR Below 45 ml/Min/1.73m2 Through Injections With Mircera as Low Frequent as Once Monthly (STABILO)|Completed||Phase 4|35|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:34:50.96356|2017-02-18 14:34:50.96356
NCT00642655|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-24|||September 2005||2005-09-01|March 2008|2008-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation|A Phase I/II Trial to Investigate the Safety and Efficacy of Rituximab and IVIG as Agents to Desensitize Highly-HLA Sensitized Dialysis Patients Awaiting Kidney Transplantation|Completed||Phase 1/Phase 2|20|Actual|Cedars-Sinai Medical Center|||||f||||f||||||||||2017-02-18 14:34:51.675892|2017-02-18 14:34:51.675892
NCT00642642|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2013-07-19|2012-02-09||November 2007||2007-11-01|July 2013|2013-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring|A Phase II/III Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of Isolagen Therapy in the Treatment of Moderate to Sever Facial Acne Scarring|Completed||Phase 2/Phase 3|122|Actual|Fibrocell Technologies, Inc.||2|||f||||f||||||||||2017-02-18 14:34:51.769262|2017-02-18 14:34:51.769262
NCT00642629|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2014-02-03|||December 2005||2005-12-01|February 2014|2014-02-01||||||||Interventional|||A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes||Completed||Phase 2|35|Anticipated|Synta Pharmaceuticals Corp.||2|||f||||f||||||||||2017-02-18 14:34:52.155632|2017-02-18 14:34:52.155632
NCT00642616|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-02-12|2015-11-23||March 2009||2009-03-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional||Subjects who received at least one dose of study medication|Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease|A Phase 3, Open-label, Randomized Clinical Trial to Evaluate the Safety of Technosphere® Insulin Inhalation Powder in Type 1 or Type 2 Diabetic Subjects With Obstructive Pulmonary Disease (Asthma or Chronic Obstructive Pulmonary Disease) Over a 12 Months Treatment Period With a 2 Month Follow-up|Terminated||Phase 3|34|Actual|Sanofi|- Early termination of trial leading to small numbers of subjects analyzed|4||Terminated upon recommendation of the Data Safety Monitoring Board (DSMB)|f||||t||||||||||2017-02-18 14:34:52.241234|2017-02-18 14:34:52.241234
NCT00642421|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2010-02-07|||February 2008||2008-02-01|February 2010|2010-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients|Safety and Biological Activity of a New Prolonged Release Formulation of Octreotide Acetate, C2l-OCT-01 PR, Administered Intra Muscularly Every 4, 5 or 6 Weeks in Acromegalic Patients|Terminated||Phase 3|40|Anticipated|Ambrilia Biopharma, Inc.||2||Commercial reasons|f||||f||||||||||2017-02-18 14:34:57.537233|2017-02-18 14:34:57.537233
NCT00642603|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-05-31|2010-06-10||May 2008||2008-05-01|May 2011|2011-05-01|September 2012|Anticipated|2012-09-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer|A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|41|Actual|Hoffmann-La Roche|This study was terminated early because interim data from a predecessor study invalidated the scientific rationale that provided justification for the conduct of this study. Efficacy analyses were not performed.|2|||f||||||||||||||2017-02-18 14:34:52.900427|2017-02-18 14:34:52.900427
NCT00642590|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2016-03-30|||March 2008||2008-03-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|December 2016|Anticipated|2016-12-01||Observational|||Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy|Antioxidant Status, Diet and Early Pregnancy|Active, not recruiting||N/A|266|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||Samples With DNA|"~     Whole blood, plasma, serum, urine~   "|||2017-02-18 14:34:53.434164|2017-02-18 14:34:53.434164
NCT00642577|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2013-10-07|||July 2007||2007-07-01|October 2013|2013-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.|A Randomized, Open Label Study to Compare the Effect of First-line Treatment With Avastin in Combination With Irinotecan + 5-fluorouracil/Folinic Acid, and Irinotecan + 5-fluorouracil/Folinic Acid Alone, on Progression-free Survival in Chinese Patients With Metastatic Colorectal Cancer.|Completed||Phase 3|214|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:34:53.545376|2017-02-18 14:34:53.545376
NCT00642564|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2014-05-22|||February 2008||2008-02-01|May 2014|2014-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Study on Migraine and Headache in Epileptic Patients|MIGRAINE AND HEADACHE IN EPILEPTIC PATIENTS|Completed||Phase 4|955|Actual|Johnson & Johnson Taiwan Ltd|||1||f||||||||||||||2017-02-18 14:34:53.655251|2017-02-18 14:34:53.655251
NCT00642551|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2012-06-11|||March 2008||2008-03-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Beneficial Effects of Long Term Menaquinone-7|Clinical Trial on Beneficial Effects of Long Term Menaquinone-7 (Vitamin K2) Intake by Postmenopausal Women|Completed||N/A|240|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 14:34:53.745897|2017-02-18 14:34:53.745897
NCT00642538|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2012-06-12|||February 2008||2008-02-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus|A Phase 1, Repeated Single-Dose, Double Blind, Randomized, Five Treatment Controlled Safety and Pharmacological Response Evaluation Trial of MKC253 Inhalation Powder in Adult Male and Postmenopausal Female Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|20|Actual|Mannkind Corporation||5|||f||||||||||||||2017-02-18 14:34:53.838859|2017-02-18 14:34:53.838859
NCT00642525|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-19|||January 2006||2006-01-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Detection of Anastomotic Leakage After Esophageal Surgery|Radiologic vs. Endoscopic Evaluation of the Conduit After Esophageal Resection: a Prospective, Blinded, Intraindividual Controlled Diagnostic Study.|Completed||N/A|55|Actual|Heidelberg University||1|||f||||f||||||||||2017-02-18 14:34:53.939249|2017-02-18 14:34:53.939249
NCT00642512|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-03-31|||July 2003||2003-07-01|March 2008|2008-03-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Efficacy Study of Oral Dronabinol Alone and in Combination With Ondansetron Versus Ondansetron Alone in Subjects With Delayed Chemotherapy-Induced Nausea and Vomiting|Completed||Phase 3|64|Actual|Solvay Pharmaceuticals||4|||f||||f||||||||||2017-02-18 14:34:54.037316|2017-02-18 14:34:54.037316
NCT00642499|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-04-01|||August 2003||2003-08-01|March 2008|2008-03-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting|A Double-Blind, Randomized, Parallel-Group, Pilot Study of Oral Dronabinol Versus Placebo in the Treatment or Prevention of Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting|Completed||Phase 2|103|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:34:54.189321|2017-02-18 14:34:54.189321
NCT00642486|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-24|2010-05-25|||February 2008||2008-02-01|March 2008|2008-03-01|March 2010|Actual|2010-03-01|July 2009|Actual|2009-07-01||Interventional|HomePAP||Portable Monitoring for Diagnosis and Management of Sleep Apnea|Portable Monitoring in the Diagnosis and Management of Obstructive Sleep Apnea|Completed||N/A|373|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-02-18 14:34:54.409993|2017-02-18 14:34:54.409993
NCT00642473|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-04-14|2016-03-09||February 2008||2008-02-01|April 2016|2016-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|MATER|All enrolled participants|A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash|A Phase II Trial Assessing Metronidazol Actavis 1% Topical Cream in the Prevention and Treatment of Erlotinib Associated Rash|Completed||Phase 2|34|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:34:54.510967|2017-02-18 14:34:54.510967
NCT00642460|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-06-24|2011-09-16||May 2008||2008-05-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|September 2009|Actual|2009-09-01||Interventional|||A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)|A Randomized, Placebo-controlled Study to Evaluate the Effect of Tocilizumab on Disease Response in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA), With an Open-label Extension to Examine the Long Term Use of Tocilizumab|Completed||Phase 3|112|Actual|Hoffmann-La Roche|"This study consists of 3 parts:~Part I: a 12 week double-blind placebo controlled study is complete. Part II: a 92 week single arm open-label extension study- CSR completed Dec. 2011.~Part III: a 3 year open label continuation study is ongoing."|2|||f||||||||||||||2017-02-18 14:34:55.114349|2017-02-18 14:34:55.114349
NCT00642447|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-24|||April 2007||2007-04-01|March 2008|2008-03-01||||||||Interventional|||Helium:Oxygen Noninvasive Positive Pressure Ventilation in Patients Exposed to Sulfur Mustard|Helium:Oxygen Versus Air:Oxygen Nonivasive Positive Pressure Ventilation in Patients Exposed to Sulfur Mustard|Completed||Phase 2/Phase 3|23||Baqiyatallah Medical Sciences University||1|||f||||||||||||||2017-02-18 14:34:57.356738|2017-02-18 14:34:57.356738
NCT00642395|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2011-10-10|||July 2007||2007-07-01|October 2011|2011-10-01|July 2011|Actual|2011-07-01|October 2008|Actual|2008-10-01||Interventional|||Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)|Velcade®-Melphalan Association as Conditioning Regimen Before Autologous Stem-cell Transplantation in Multiple Myeloma Patients Under 65 Years|Completed||Phase 2|61|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-02-18 14:34:57.759273|2017-02-18 14:34:57.759273
NCT00642382|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-11-15|||April 2008||2008-04-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Effectiveness of Agilus (Hyaluronic Acid) for Ankle Osteoarthritis|Randomized, Double Blind,Saline-Controlled, Multi-Center, Prospective Study to Evaluate the Safety and Effectiveness of Carticept's Agilus Device for the Treatment of Ankle Osteoarthritis|Terminated||Phase 3|17|Actual|Cartiva, Inc.||2||For safety concerns|f||||f||||||||No||2017-02-18 14:35:00.359751|2017-02-18 14:35:00.359751
NCT00642369|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-03-21|2009-12-14||March 2008||2008-03-01|March 2014|2014-03-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia|Study of Evaluating Quetiapine in Improving Sleep Quality of Schizophrenia|Completed||N/A|60|Actual|Guang Dong Provincial Mental Health Institute|the present study lasted for only 4 weeks. it might be too short to investigate the effect of quetiapine fumarate and haloperidol on sleep and clinical parameters.|2|||f||||f||||||||||2017-02-18 14:35:00.49519|2017-02-18 14:35:00.49519
NCT00642356|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-02-16|2010-12-14||March 2008||2008-03-01|February 2011|2011-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off|An 8-week, Prospective, Randomized, Double-blind, Double-dummy, Active-controlled, Multi-center Comparison Study of the Effects of Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off|Terminated||Phase 4|14|Actual|Novartis||2||slow enrollment|f||||||||||||||2017-02-18 14:35:00.947447|2017-02-18 14:35:00.947447
NCT00642343|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2010-06-14|||March 2008||2008-03-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Balance in Children With Cochlear Implants|Balance in Children With Cochlear Implants|Completed||Early Phase 1|66|Actual|University of Oklahoma||4|||f||||f||||||||||2017-02-18 14:35:01.620734|2017-02-18 14:35:01.620734
NCT00642330|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-03-24|||January 2007||2007-01-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|||Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants|Randomized Pilot Study Comparing Oral Ibuprofen With Intravenous Ibuprofen in Very Low Birth Weight Infants With Patent Ductus Arteriosus|Completed||Phase 4|62|Actual|Hopital La Rabta||2|||f||||t||||||||||2017-02-18 14:35:01.760679|2017-02-18 14:35:01.760679
NCT00642317|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2012-07-31|||March 2008||2008-03-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Asian Youth and Tobacco Control Survey|Asian Youth and Tobacco Control Survey|Completed||N/A|617|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:35:01.878139|2017-02-18 14:35:01.878139
NCT00642304|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-09-16|2016-09-16||July 2008||2008-07-01|September 2016|2016-09-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional||Safety population included all participants who received at least one dose trial medication and underwent a safety follow-up, whether withdrawn prematurely or not.|A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.|A Single Arm Open Label Study to Assess Efficacy, Safety and Tolerability of Once-monthly Administration of Subcutaneously C.E.R.A. for the Maintenance of Hemoglobin Levels in Patients With Chronic Renal Anemia Not on Dialysis|Completed||Phase 3|20|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:35:01.995937|2017-02-18 14:35:01.995937
NCT00642291|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-04-07|||November 2002||2002-11-01|April 2008|2008-04-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects|An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects|Completed||Phase 2|16|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 14:35:02.319305|2017-02-18 14:35:02.319305
NCT00642278|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2013-07-15|2013-04-01||April 2008||2008-04-01|July 2013|2013-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Double-Dummy, Parallel Group, Multicenter, Dose-Ranging Study in Subjects With Type 2 Diabetes Mellitus to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered SGLT2 Inhibitor JNJ-28431754 With Sitagliptin as a Reference Arm|Completed||Phase 2|451|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||7|||f||||f||||||||||2017-02-18 14:35:02.44337|2017-02-18 14:35:02.44337
NCT00642265|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2014-12-04|||April 2008||2008-04-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||The Treatment of Clavicular Fractures|The Treatment of Displaced, Midshaft Clavicular Fractures: Operative vs Conservative. A Prospected, Randomized Study|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 14:35:04.637074|2017-02-18 14:35:04.637074
NCT00642252|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-03-23|||January 2012||2012-01-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Development and Validation of a Multi-Mineral Fluoride Mouthrinse|Development and Validation of a Multi-Mineral Fluoride Mouthrinse|Completed||Phase 1|30|Actual|Indiana Nanotech, LLC||2|||f||||f||||||||||2017-02-18 14:35:04.748657|2017-02-18 14:35:04.748657
NCT00642239|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2008-05-13|||April 2008||2008-04-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma|A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Sodium Glycididazole in Concurrent Radiochemotherapy for the Treatment of Thoracic Esophageal Squamous Carcinoma|Unknown status|Recruiting|Phase 4|48|Anticipated|Shandong Luye Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 14:35:04.855947|2017-02-18 14:35:04.855947
NCT00642057|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-09-26|||June 1989||1989-06-01|September 2016|2016-09-01|February 2013|Actual|2013-02-01|December 2009|Actual|2009-12-01||Expanded Access|TBZ||Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements|Compassionate Use of Tetrabenazine in the Treatment of Hyperkinesias|Available||N/A|||Baylor College of Medicine||||Commercial availability of Xenazine|||||||||||||||2017-02-18 14:35:07.069641|2017-02-18 14:35:07.069641
NCT00642226|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2014-01-03|||November 2006||2006-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)|A Randomized Study Comparing Combined Vitrectomy and Triamcinolone to Laser Grid in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)|Terminated||Phase 3|34|Actual|Helse Stavanger HF||2||"Due to recruiting problems and the introduction of new treatment strategies (ranibizumab and~   dexamethasone implant)."|f||||f||||||||||2017-02-18 14:35:04.965535|2017-02-18 14:35:04.965535
NCT00642213|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-05-19|||July 1993||1993-07-01|May 2016|2016-05-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Observational|GCNKSS||A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites|A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites: A Population-Based Study in Cincinnati, Ohio|Active, not recruiting||N/A|1200|Actual|University of Cincinnati|||2||f||||f||||||Samples With DNA|"~     We have collected blood and/or buccal samples from an interviewed cohort during years~     1999,2005, and 2010.~   "|Yes|we have a website: www.gcnkss.com where de-identified data can be requested via an approval process|2017-02-18 14:35:05.076799|2017-02-18 14:35:05.076799
NCT00642200|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-05-20|||January 1997||1997-01-01|May 2008|2008-05-01|April 2007|Actual|2007-04-01|February 2002|Actual|2002-02-01||Interventional|||Recurrent Inguinal Hernia Treatment - Lichtenstein Versus Laparoscopic Totally Extraperitoneal Preperitoneal Hernioplasty|Lichtenstein Hernioplasty Versus Totally Extraperitoneal Laparoscopic Hernioplasty in Treatment of Recurrent Inguinal Hernia - A Prospective Randomized Trial|Completed||N/A|100|Actual|North Karelia Central Hospital||2|||f||||f||||||||||2017-02-18 14:35:05.174098|2017-02-18 14:35:05.174098
NCT00642187|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-01-21|||July 2002||2002-07-01|January 2011|2011-01-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||New Version Pulmicort Turbuhaler USA Adults|A Placebo-controlled Comparison of the Efficacy and Safety of the Current US Version of Pulmicort (Budesonide) Turbuhaler and the New Version of Pulmicort Turbuhaler in Asthmatic Adults Currently Treated With Inhaled Steroids.|Completed||Phase 3|525|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:35:05.260323|2017-02-18 14:35:05.260323
NCT00642174|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2010-02-19|2010-01-18||April 2008||2008-04-01|February 2010|2010-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|OPTIMUS-3||Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)|A Pharmacodynamic Comparison of Prasugrel (LY640315) Versus High Dose Clopidogrel in Subjects With Type 2 Diabetes Mellitus and Coronary Artery Disease.|Completed||Phase 2|35|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:35:05.36555|2017-02-18 14:35:05.36555
NCT00642161|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-01-21|||November 2002||2002-11-01|January 2011|2011-01-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||New Version Pulmicort Turbuhaler USA Children|A Placebo-controlled Comparison of the Efficacy, Safety and Pharmacokinetics of the Current US Version of Pulmicort (Budesonide) Turbuhaler and the New Version of Pulmicort Turbuhaler in Asthmatic Children and Adolescents.|Completed||Phase 3|430|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 14:35:06.05182|2017-02-18 14:35:06.05182
NCT00642148|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2011-03-10||2010-02-05|February 2008||2008-02-01|March 2011|2011-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A 12-week, Randomised, Double-blind, Placebo-controlled Study to Assess the Anti-inflammatory Activity, Efficacy and Safety of GW856553 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|306|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 14:35:06.132046|2017-02-18 14:35:06.132046
NCT00642135|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-04-09|||January 2006||2006-01-01|January 2006|2006-01-01|June 2008|Anticipated|2008-06-01|February 2008|Anticipated|2008-02-01||Interventional|||CLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference Treatment|Efficacy and Tolerance of Ophthalmic Insert Mydriasert® Versus Reference Treatment (Phenylephrine and Tropicamide Eyedrops) in Premature Newborns, Neonates and Infants Justifying a Mydriasis for a Bilateral Diagnosis Fundus|Terminated||Phase 3|80|Actual|Assistance Publique - Hôpitaux de Paris||2||The total number of patients has been reached.|f||||t||||||||||2017-02-18 14:35:06.260711|2017-02-18 14:35:06.260711
NCT00642122|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-01-21|||April 2003||2003-04-01|January 2011|2011-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Adults With Moderate to Severe Asthma|A Randomized, Blinded, Multicenter, Parallel Study Comparing the Efficacy and Safety of Pulmicort Respules at 0.5mg QD, 1.0mg QD, 1.0mg Bid, 2.0mg Bid and Pulmicort Turbuhaler at 4.00mcg Bid on Adolescents (12 Yrs of Age and Older) With Adults With Moderate to Severe Asthma.|Completed||Phase 3|900|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:35:06.36461|2017-02-18 14:35:06.36461
NCT00642109|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-07-25|||January 2006||2006-01-01|July 2015|2015-07-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||A Comparison of the Retropubic (TVT) With the Transobturator Sling Operation in the Treatment of Female Stress Urinary Incontinence or Stress Dominated Mixed Urinary Incontinence|A Prospective Randomized Clinical Trial: Comparison of the Retropubic (TVT) With the Transobturator (outside-in T.O.T. Monarc or Inside-out TVT-O) Sling Operation in the Treatment of Female Stress Urinary Incontinence or Stress Dominated Mixed Urinary Incontinence|Terminated||N/A|160|Actual|University of Zurich||3||higher incidence of pain related sexual dysfunction in the TO arm|f||||f||||||||||2017-02-18 14:35:06.524765|2017-02-18 14:35:06.524765
NCT00642096|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-03-24|||June 2003||2003-06-01|March 2009|2009-03-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Factorial Study of Metoprolol Succinate TOPROL-XL (324A)|A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Factorial Study of Metoprolol Succinate Extended Release Tablets (TOPROL-XL) Hydrochlorothiazide and Their Combination in Patients With Essential Hypertension.|Completed||Phase 3|1900|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:35:06.629515|2017-02-18 14:35:06.629515
NCT00642083|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-12-14||||||December 2011|2011-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|SHARE||Stenting of Haemodialysis Acces Trial|Stenting of Haemodialysis Acces Re-stenosis Trial (SHARE Trial)|Terminated||Phase 2|20|Anticipated|Rijnstate Hospital||1||slow inclusion|f||||||||||||||2017-02-18 14:35:06.8868|2017-02-18 14:35:06.8868
NCT00642070|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-06-03|||February 2008||2008-02-01|June 2014|2014-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Host Response to Urinary Tract Infection in Women|Host Response to Urinary Tract Infection in Women|Completed||N/A|326|Actual|University of Washington|||1||f||||f||||||Samples With DNA|"~     whole blood,serum, urine~   "|||2017-02-18 14:35:06.96726|2017-02-18 14:35:06.96726
NCT00642044|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-04-22|||February 2007||2007-02-01|March 2008|2008-03-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study|Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study|Unknown status|Recruiting|N/A|100|Anticipated|Universidade Federal do Rio de Janeiro||2|||f||||f||||||||||2017-02-18 14:35:07.161577|2017-02-18 14:35:07.161577
NCT00642031|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2016-08-06|||August 2006||2006-08-01|August 2016|2016-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies|A Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies|Completed||Phase 1|20|Actual|Prescient Therapeutics, Ltd.||1|||f||||f||||||||||2017-02-18 14:35:07.27265|2017-02-18 14:35:07.27265
NCT00642018|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-05-24||2012-05-24|March 2008||2008-03-01|May 2012|2012-05-01|April 2012|Actual|2012-04-01|August 2011|Actual|2011-08-01||Interventional|||A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer|A Randomized Phase 2 Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Hormone Refractory Prostate Cancer|Completed||Phase 2|150|Anticipated|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:35:07.386464|2017-02-18 14:35:07.386464
NCT00642005|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2014-03-10|||April 2008||2008-04-01|March 2014|2014-03-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Humidification in Laparoscopic Colonic Surgery|Humidification in Laparoscopic Colonic Surgery - A Double Blinded, Randomised Controlled Trial.|Completed||N/A|82|Actual|University of Auckland, New Zealand||2|||f||||f||||||||||2017-02-18 14:35:07.512992|2017-02-18 14:35:07.512992
NCT00641992|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-17|||May 1999||1999-05-01|March 2008|2008-03-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Observational|||Prognosis of Failure Treatment of Amebic Liver Abscess|Prognosis Factors of the Response After Medical Treatment of Amebic Liver Abscess|Completed||N/A|40|Actual|Universidad Autonoma de San Luis Potosí|||2||f||||f||||||||||2017-02-18 14:35:07.62672|2017-02-18 14:35:07.62672
NCT00641979|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-01-21|||April 2002||2002-04-01|January 2011|2011-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||New Nasal Applicator / New Formulation - User Study|A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Functionality of a New Nasal Device With Reformulated Rhinocort Aqua (Budesonide) Versus the Current Product and Versus Placebo in Subjects With Seasonal Allergic Rhinitis (SAR).|Completed||Phase 2|200|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:35:07.735033|2017-02-18 14:35:07.735033
NCT00641953|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-06-13|||August 2007||2007-08-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||IMX-150 Cream for Diabetic Neuropathy|A Randomized, Phase II, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Response Study of an Aqueous Topical Formulation of Nitroglycerin, IMX-150, in the Treatment of Pain in Diabetic Peripheral Neuropathy of the Feet|Completed||Phase 2|155|Actual|Procris Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:35:07.830897|2017-02-18 14:35:07.830897
NCT00641940|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-03-17|||October 2005||2005-10-01|March 2008|2008-03-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|GT||Girls in Transition Study: Helping Girls Enter the Teenage Years|Girls in Transition Study: Helping Girls Enter the Teenage Years|Unknown status|Active, not recruiting|Phase 1|32|Actual|Swarthmore College||2|||f||||||||||||||2017-02-18 14:35:07.936256|2017-02-18 14:35:07.936256
NCT00641927|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-03-18|||April 2002||2002-04-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Antidepressant Therapy for Bipolar II Major Depression|Acute Antidepressant Therapy in Bipolar II Major Depression|Completed||Phase 4|90|Actual|Stanley Medical Research Institute||2|||f||||t||||||||||2017-02-18 14:35:08.041363|2017-02-18 14:35:08.041363
NCT00641914|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-03-24|||October 1996||1996-10-01|March 2009|2009-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|START||Inhaled Steroid Treatment as Regular Therapy in Early Asthma|Inhaled Steroid Treatment As Regular Therapy in Early Asthma. A Study on the Effect of Early Intervention With Long-Term Inhaled Budesonide (Pulmicort Turbuhaler ® ) in Newly Diagnosed Asthma.|Completed||Phase 4|6800|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:35:08.150591|2017-02-18 14:35:08.150591
NCT00641901|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2013-02-27|||January 2007||2007-01-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|TRIUMPH||A Study to Evaluate Associations Between Gingivitis and Pregnancy Outcomes|A Study of Oral Health Care Education and Therapy to Reduce Gingivitis During Pregnancy|Completed||N/A|120|Actual|University of Alabama at Birmingham|||1||f||||f||||||Samples Without DNA|"~     Samples of venous blood and gingivial crevicular fluid (GCF)will be collected at baseline~     and at week-8.~      GCF samples will be harvested from two non-adjacent oral sites, flash-frozen in liquid~     nitrogen and stored at -70 degrees F. until batched testing. GCF samples will be analyzed~     for TNFalpha, IL1beta and IL 6 by Lumidex methodology.~      Blood samples will be analyzed for Serum Inflammatory markers, C-Reative Protein and~     inflammatory cytokines.~   "|||2017-02-18 14:35:08.244131|2017-02-18 14:35:08.244131
NCT00641888|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2010-01-19|||March 2008||2008-03-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|January 2010|Anticipated|2010-01-01||Observational|||Impact of Antiretroviral Therapy on Cardiac Biomarkers|Impact of Antiretroviral Therapy on Biomarkers of Inflammation Associated With Cardiovascular Risk|Unknown status|Recruiting|N/A|20|Anticipated|University of California, Davis|||2||f||||f||||||||||2017-02-18 14:35:08.361968|2017-02-18 14:35:08.361968
NCT00641875|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-04-23|||December 2005||2005-12-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||The Effect of Nocturnal Haemodialysis on Arterial Stiffness|The Effect of Nocturnal Haemodialysis on Arterial Stiffness|Completed||N/A|30|Actual|Melbourne Health|||1||f||||f||||||||||2017-02-18 14:35:08.449326|2017-02-18 14:35:08.449326
NCT00641862|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-08-22|2016-08-22||December 2008||2008-12-01|August 2016|2016-08-01|April 2019|Anticipated|2019-04-01|January 2011|Actual|2011-01-01||Interventional|B12||Randomized Trial of Vitamin B12 in Pregnant Indian Women|Randomized Trial of Vitamin B12 in Pregnant Indian Women|Active, not recruiting||Phase 3|366|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-02-18 14:35:08.529882|2017-02-18 14:35:08.529882
NCT00641849|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2016-10-03|||July 2008||2008-07-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|Compliance||Physical Activity and Dietary Behaviors of Adults 18 to 80 Years of Age|Physical Activity and Dietary Behaviors of Adults 18 to 80 Years of Age|Terminated||N/A|54|Actual|University of Missouri-Columbia||2||Terminated by PI r/t lack of funding and retirement of study personel.|f||||f||||||||No||2017-02-18 14:35:08.852729|2017-02-18 14:35:08.852729
NCT00641836|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-03-18|||July 2005||2005-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|||||Interventional|||Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension|One-Year Follow-Up of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension|Completed||N/A|98|Actual|Zhejiang University|||||f||||||||||||||2017-02-18 14:35:08.995167|2017-02-18 14:35:08.995167
NCT00640848|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2016-02-11|||May 2006||2006-05-01|February 2016|2016-02-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|Insomnia||Almorexant in Primary Insomnia|Multi-center, Multiple-stage, Double-blind, Randomized, Placebo-controlled, Two-way Crossover, Single-dose Study to Investigate the Effects of ACT-078573 on Sleep Measured by Polysomnography in Patients With Primary Insomnia|Completed||Phase 1|161|Actual|Midnight Pharma, LLC||5|||f||||t||||||||||2017-02-18 14:35:09.077523|2017-02-18 14:35:09.077523
NCT00640835|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2012-11-06|2010-09-30||February 2008||2008-02-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Tolerability of Buprenorphine/Naloxone Film Strips|A Phase 2 Multi-Center Open-label Study to Assess the Safety and Tolerability of a Buprenorphine/Naloxone Film Strip Administered by the Sublingual and Buccal Routes|Completed||Phase 2|382|Actual|Indivior Inc.||2|||f||||f||||||||||2017-02-18 14:35:09.207407|2017-02-18 14:35:09.207407
NCT00641823|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2013-03-21|||March 2008||2008-03-01|March 2013|2013-03-01||||March 2015|Anticipated|2015-03-01||Observational|||Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies|Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies|Unknown status|Recruiting|N/A|60|Anticipated|Hadassah Medical Organization|||3||f||||||||||||||2017-02-18 14:35:09.925927|2017-02-18 14:35:09.925927
NCT00641810|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2013-12-29|||March 2008||2008-03-01|December 2013|2013-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Effect of Caffeine Reduction on Snoring and Quality of Life|The Effect of Caffeine Reduction on Snoring and Quality of Life|Completed||N/A|30|Anticipated|University of Vermont||1|||f||||f||||||||||2017-02-18 14:35:09.996446|2017-02-18 14:35:09.996446
NCT00641797|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-09-07|||November 2006||2006-11-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|December 2010|Actual|2010-12-01||Interventional|||Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients|A Randomized Trial to Evaluate Resolution of Symptoms Using Vestibular Rehab Versus Conventional Therapy in Patients Presenting to the Emergency Department (ED) With Diagnosis of Benign Paroxysmal Positional Vertigo (BPPV)|Completed||N/A|26|Actual|Lehigh Valley Hospital||2|||f||||t||||||||No|No plan to share IPD, just publish the study's results.|2017-02-18 14:35:10.092489|2017-02-18 14:35:10.092489
NCT00641784|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2009-09-17|||March 2008||2008-03-01|September 2009|2009-09-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population|A Randomized Trial of Oral Nifedipine Versus Intravenous Magnesium Sulfate in the Acute Management of Preterm Labor in Women With Singleton Gestations, Intact Fetal Membranes, and Positive Vaginal Fetal Fibronectin|Terminated||Phase 3|200|Anticipated|MemorialCare||2|||f||||f||||||||||2017-02-18 14:35:10.218808|2017-02-18 14:35:10.218808
NCT00641771|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-12-24|||May 2004||2004-05-01|December 2014|2014-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter 4-Week Study to Assess the Effect of Alendronate 70 mg and Vitamin D3 2800 IU Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women|Completed||Phase 1|56|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:35:10.308335|2017-02-18 14:35:10.308335
NCT00641758|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2010-02-09|||March 2008||2008-03-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Pycnogenol and Endothelial Function in Coronary Artery Disease|A Double-blind, Randomized, Placebo-controlled, Cross - Over Design, Single Center Study to Evaluate the Effects of Treatment With Pycnogenol® on Endothelial Function in Subjects With Stable Coronary Artery Disease (Pycno2007-003)|Completed||N/A|25|Anticipated|University of Zurich||2|||f||||f||||||||||2017-02-18 14:35:10.41723|2017-02-18 14:35:10.41723
NCT00641745|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2015-06-16|2011-09-01||March 2008||2008-03-01|June 2015|2015-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia|Long-Term Safety, Tolerability, and Effectiveness of Lurasidone in Subjects With Schizophrenia or Schizoaffective Disorder: A Randomized, Active Comparator-Controlled Trial|Completed||Phase 3|629|Actual|Sunovion||2|||f||||t||||||||||2017-02-18 14:35:10.61816|2017-02-18 14:35:10.61816
NCT00641732|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2016-03-13||2016-03-13|October 2007||2007-10-01|March 2016|2016-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement|A Phase 2, Randomized, Active Comparator-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement|Completed||Phase 2|1045|Actual|Takeda||7|||f||||t||||||||||2017-02-18 14:35:11.444322|2017-02-18 14:35:11.444322
NCT00641719|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2011-03-03|2011-03-03||March 2008||2008-03-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Long-term Study for the Treatment of Painful Diabetic Neuropathy|A Superiority Study of LY248686 Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain - Extension Phase|Completed||Phase 3|258|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 14:35:11.64481|2017-02-18 14:35:11.64481
NCT00641706|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2014-04-28|2013-03-06||July 2008||2008-07-01|October 2011|2011-10-01|November 2010|Actual|2010-11-01|July 2010|Actual|2010-07-01||Interventional|||Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme|Phase II Study of Vorinostat (SAHA) in Combination With Bortezomib (PS-341) in Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 14:35:12.816385|2017-02-18 14:35:12.816385
NCT00641693|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-01-21|||April 2004||2004-04-01|January 2011|2011-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Assess the Efficacy and Safety of Rhinocort Aqua|A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel Group, Phase II Study to Assess the Efficacy and Safety of RHINOCORT AQUA (Budesonide) Nasal Spray 16mg, 32mg and 64mg Per Day Versus Placebo in Paediatric Subjects Ages 2-5 Years Old With Allergic Rhinitis.|Completed||Phase 2|650|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:35:13.777725|2017-02-18 14:35:13.777725
NCT00641680|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-01-21|||April 2003||2003-04-01|January 2011|2011-01-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Rhinocort Aqua Versus Placebo and Fluticasone Propionate|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-group, Phase IIIb Study to Assess the Efficacy, Safety & Product Attributes of Rhinocort Aqua(Budesonide) Versus Placebo and FluticasonePropionate as an Active Comparator in Patients 12yrs Age &Older With SeasonalAllergicRhinitis|Completed||Phase 3|750|Anticipated|AstraZeneca||3|||f||||||||||||||2017-02-18 14:35:13.888558|2017-02-18 14:35:13.888558
NCT00641667|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2013-05-31|2013-03-21||January 2008||2008-01-01|May 2013|2013-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain|A Phase III Study of JNS020QD in Cancer Pain Patients - Evaluation of the Efficacy and Safety of JNS020QD Switched From Opioid Analgesics|Completed||Phase 3|66|Actual|Janssen Pharmaceutical K.K.||1|||f||||f||||||||||2017-02-18 14:35:14.007948|2017-02-18 14:35:14.007948
NCT00641654|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2012-08-29|||January 2007||2007-01-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|RelapC||Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin|An Open-label Multicenter Study Evaluating the Efficacy and Safety of 24 or 48 Weeks Pegylated Interferon Alfa-2a 40 kD (PEGASYS) Combination Therapy With Ribavirin (Copegus) in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After a Minimum of 12 Weeks and a Maximum of 24 Weeks of Therapy With Pegylated Interferon and Ribavirin|Terminated||Phase 4|75|Actual|Göteborg University||3||Recruitment problems in Denmark and Norway|f||||f||||||||||2017-02-18 14:35:14.512884|2017-02-18 14:35:14.512884
NCT00641641|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-05-23|2012-04-11||March 2008||2008-03-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|PINT||The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection|An Open Label Study to Examine the Characteristics of HIV Decay Following Introduction of Combination Antiretroviral Therapy Including Raltegravir During Primary and Chronic HIV Infection|Completed||N/A|16|Actual|Kirby Institute|Limited cohort (n=16) of exclusively male participants treated with a licensed regimen of combination antiretroviral therapy with the primary focus being a detailed examination of virus decay characteristics|1|||f||||t||||||||||2017-02-18 14:35:14.632955|2017-02-18 14:35:14.632955
NCT00641628|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-03-19|||July 2003||2003-07-01|March 2008|2008-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Nipple Areola Complex Conservation|Subcutaneous Mastectomy With Conservation of the Nipple Areola Complex: Broadening the Indications|Completed||N/A|||Technische Universität München|||1||f||||f||||||Samples Without DNA|"~     Breast Carcinoma Tissue~   "|||2017-02-18 14:35:14.87067|2017-02-18 14:35:14.87067
NCT00641615|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-05-11|||May 2007||2007-05-01|May 2015|2015-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer|Phase I Study of Peptide Vaccine and S-1 Plus CPT-11 Chemotherapy in Patients With Unresectable Recurrent or Metastatic Colorectal Cancer|Completed||Phase 1|18|Actual|Tokyo Women's Medical University||1|||f||||t||||||||||2017-02-18 14:35:14.965007|2017-02-18 14:35:14.965007
NCT00641602|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-03-25|||December 2002||2002-12-01|March 2009|2009-03-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis|A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis.|Completed||Phase 4|1000|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:35:15.073384|2017-02-18 14:35:15.073384
NCT00641589|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2011-05-17|||January 2006||2006-01-01|April 2010|2010-04-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease|An Open-Label, Randomized Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Subjects With Chronic Kidney Disease|Completed||Phase 1|40|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:35:15.169127|2017-02-18 14:35:15.169127
NCT00641576|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2013-07-18|||April 2005||2005-04-01|July 2013|2013-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|ACE-2005||Evaluation of the ACE Dental Implant|A Study to Evaluate the Morse Taper Lock and Connection of the ACE Implant Internal-Connection and Its Effect of the Biological Gap|Completed||N/A|23|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 14:35:15.253681|2017-02-18 14:35:15.253681
NCT00641563|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2011-10-13|2009-04-27||March 2004||2004-03-01|October 2011|2011-10-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Electroencephalogram (EEG)|The Effects of Dexmedetomidine/Remifentanil and Midazolam/Remifentanil on Auditory-evoked Potentials and Electroencephalogram at Light-to-moderate Sedation Levels in Healthy Subjects|Completed||N/A|10|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 14:35:15.352906|2017-02-18 14:35:15.352906
NCT00641550|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2011-12-12|||April 2008||2008-04-01|December 2011|2011-12-01|December 2011|Anticipated|2011-12-01|April 2009|Actual|2009-04-01||Interventional|||Exercise and Pregnancy: Randomized Clinical Trial|Effects of Physical Exercise During Pregnancy on the Maternal and Perinatal Outcomes: A Randomized Clinical Trial|Unknown status|Recruiting|N/A|188|Anticipated|Universidade Estadual da Paraiba||3|||f||||f||||||||||2017-02-18 14:35:15.628003|2017-02-18 14:35:15.628003
NCT00641537|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2014-01-10|2013-09-30||February 2008||2008-02-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Intention-to-treat (ITT) population included all participants who were randomized in the study.|CLARITY Extension Study|A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects With Relapsing-Remitting Multiple Sclerosis Who Have Completed Trial 25643 (CLARITY)|Completed||Phase 3|867|Actual|EMD Serono||5|||f||||||||||||||2017-02-18 14:35:15.827991|2017-02-18 14:35:15.827991
NCT00641524|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-05-12|||January 2009||2009-01-01|May 2016|2016-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease|Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease|Completed||N/A|45|Actual|University of Western Ontario, Canada||1|||f||||f||||||||||2017-02-18 14:35:22.01245|2017-02-18 14:35:22.01245
NCT00641511|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-06-08|||June 2008||2008-06-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)|Pharmacogenetic Clinical Trial of Nepicastat for PTSD|Completed||Phase 2|30|Anticipated|Michael Debakey Veterans Affairs Medical Center||2|||f||||t||||||||||2017-02-18 14:35:22.119352|2017-02-18 14:35:22.119352
NCT00641498|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-03-27|||March 2007||2007-03-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|December 2009|Actual|2009-12-01||Interventional|||Effectiveness of Standard Emergency Department Psychiatric Treatment Associated With Treatment Delivery by a Suicide Prevention Center|Effectiveness of Standard Emergency Department Psychiatric Treatment Compared With Effectiveness of Standard Emergency Department Psychiatric Treatment Associated With Treatment Delivery by a Suicide Prevention Center.|Completed||N/A|607|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 14:35:22.226456|2017-02-18 14:35:22.226456
NCT00641472|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-03-24|||October 2002||2002-10-01|March 2009|2009-03-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children|An Evaluation of the Effectiveness of Pulmicort Respules (Budesonide Inhalation Suspension) Versus SINGULAIR (Montelukast Sodium) in Children 2-8 Years Old With Asthma Requiring Controller Therapy.|Completed||Phase 4|380|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:35:22.540128|2017-02-18 14:35:22.540128
NCT00641459|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2014-05-22|||September 2007||2007-09-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||A Study on Behavioral and Psychological Symptoms of Dementia|Behavioral and Psychological Symptoms of Dementia (BPSD) in Taiwan - An Observational Study|Completed||Phase 4|359|Actual|Johnson & Johnson Taiwan Ltd|||1||f||||||||||||||2017-02-18 14:35:22.634016|2017-02-18 14:35:22.634016
NCT00641446|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-03-24|||October 2001||2001-10-01|March 2009|2009-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Varicella Vaccination With Pulmicort|Rates of Seroconversion Following Varicella Vaccination of Asthmatic Children Between the Ages of One and Eight Years Treated With Pulmicort Respules® Versus Non-Steroidal Conventional Asthma Therapy|Completed||Phase 4|250|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:35:22.72264|2017-02-18 14:35:22.72264
NCT00641433|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-03-18|||November 2005||2005-11-01|March 2008|2008-03-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails|Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|80|Anticipated|Rosalind Franklin University of Medicine and Science||2|||f||||f||||||||||2017-02-18 14:35:22.818893|2017-02-18 14:35:22.818893
NCT00641420|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-03-21|||September 2007||2007-09-01|March 2008|2008-03-01|September 2008|Anticipated|2008-09-01|August 2008|Anticipated|2008-08-01||Interventional|||Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin|Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin|Unknown status|Active, not recruiting|N/A|15|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-02-18 14:35:22.92846|2017-02-18 14:35:22.92846
NCT00641407|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-03-28|||January 2007||2007-01-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes|Bedtime Insulin Glargine or Bedtime Neutral Protamine Lispro Combined With Sulfonylurea and Metformin in Type 2 Diabetes. A Randomized, Controlled Trial|Completed||Phase 4|100|Actual|Second University of Naples||2|||f||||f||||||||||2017-02-18 14:35:23.034358|2017-02-18 14:35:23.034358
NCT00641394|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2012-04-09|||April 2008||2008-04-01|April 2012|2012-04-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||The Effect of Psychotherapy on Stress Biochemistry: An RCT of Psychotherapy and Emotional Freedom Techniques (EFT)|The Effect of Psychotherapy on Stress Biochemistry: A Randomized Blind Controlled Trial of Psychotherapy and Emotional Freedom Techniques (EFT)|Completed||N/A|83|Actual|Soul Medicine Institute||3|||f||||t||||||||||2017-02-18 14:35:23.1523|2017-02-18 14:35:23.1523
NCT00641381|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2017-01-27|||May 2000||2000-05-01|January 2017|2017-01-01|October 2017||2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma|High Dose Chemotherapy and Combination Anti-HIV Therapy for HIV-Associated Hodgkin's and Non-Hodgkin's Lymphoma|Active, not recruiting||N/A|25|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:35:23.264345|2017-02-18 14:35:23.264345
NCT00641368|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-03-17|||October 2007||2007-10-01|March 2008|2008-03-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|R4Power||R4Power: An Online Resilience Program for Adolescents|R4Power: An Online Resilience Program for Adolescents|Unknown status|Recruiting|Phase 1|200|Anticipated|Swarthmore College||2|||f||||||||||||||2017-02-18 14:35:23.377657|2017-02-18 14:35:23.377657
NCT00641355|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-03-21|||April 2008||2008-04-01|March 2008|2008-03-01|September 2012|Anticipated|2012-09-01|||||Observational|||Acute Phase Proteins as Early Markers in Sepsis|Acute Phase Proteins as Early Markers in Sepsis|Unknown status|Not yet recruiting|N/A|15|Anticipated|University of Zurich|||1||f||||f||||||||||2017-02-18 14:35:23.48825|2017-02-18 14:35:23.48825
NCT00641342|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-02-06|||March 2007||2007-03-01|March 2008|2008-03-01|February 2015|Anticipated|2015-02-01|February 2015|Anticipated|2015-02-01||Interventional|||Prevention of Parastomal Hernia by Primary Mesh Insertion|Prevention of Parastomal Hernia by Primary Mesh Insertion: a Randomized Double-blinded Controlled Multi-centre Study.|Terminated||Phase 2/Phase 3|198|Anticipated|University Hospital, Gentofte, Copenhagen||3||"Lack of recruitment from different study sites and due to structural changes in the included~   centers"|f||||f||||||||||2017-02-18 14:35:23.563387|2017-02-18 14:35:23.563387
NCT00641329|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2010-04-08|||February 2008||2008-02-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD|Phase III Evaluation of the Safety and Efficacy of CLONICEL (Clonidine HCl Sustained Release) as Add-on to Psychostimulant Medication vs. Psychostimulant Medication Alone in Children and Adolescents With ADHD|Completed||Phase 3|198|Actual|Addrenex Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 14:35:23.670197|2017-02-18 14:35:23.670197
NCT00641316|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2013-02-27|||April 2008||2008-04-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|April 2010|Actual|2010-04-01||Interventional|FMD-007||An Assessment of Bone Augmentation in Post-Extraction Sockets|A Prospective Study of Bone Augmentation Techniques in Extraction Sockets and Implant Surface Textures|Completed||N/A|102|Actual|University of Alabama at Birmingham||4|||f||||t||||||||||2017-02-18 14:35:23.792985|2017-02-18 14:35:23.792985
NCT00641303|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-21|2012-01-26|||May 2008||2008-05-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer|A Multi-Center Randomized Controlled Double Blind Trial Assessing the Effect of Acupuncture in Reducing Musculoskeletal Symptoms in Breast Cancer Patients Taking Aromatase Inhibitors|Completed||Phase 2|51|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 14:35:23.903655|2017-02-18 14:35:23.903655
NCT00641290|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-04-04|||April 2008||2008-04-01|April 2008|2008-04-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Observational|||Vigileo FloTrac vs Pulmonary Artery Catheter|Cardiac Output and Central Venous Oxygen Saturation Monitoring Using the Vigileo FloTrac Sensor Versus Conventional Thermodilution Method Using the Pulmonary Artery Catheter: A Prospective Study|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hospital Sultanah Aminah Johor Bahru|||||f||||t||||||||||2017-02-18 14:35:24.144981|2017-02-18 14:35:24.144981
NCT00641277|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2013-02-27|||March 2004||2004-03-01|February 2013|2013-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|Maximus||Longitudinal Efficacy of Dental Implants in Anterior Areas|A Study to Evaluate the Efficacy of the 3mm Maximus Dental Implant in Areas of Limited Tooth-to-tooth Spacing|Completed||N/A|15|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 14:35:24.242243|2017-02-18 14:35:24.242243
NCT00641264|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-06-10|||May 2001||2001-05-01|June 2009|2009-06-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Quality of Life Validation in Laryngitis|Laryngopharyngeal Reflux Health Related Quality of Life (LPR-HRQL) Questionnaire Development and Psychometric Testing in Patients Receiving Omeprazole 20 mg Bid as Treatment for Laryngopharyngeal Reflux.|Completed||Phase 4|90|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:35:24.340563|2017-02-18 14:35:24.340563
NCT00641251|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-08-04|||February 2008||2008-02-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|January 2014|Actual|2014-01-01||Interventional|DSS||DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery|Global Randomized Prospective Study of Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery|Active, not recruiting||Phase 4|120|Actual|Medtronic - MITG||2|||f||||t||||||||||2017-02-18 14:35:24.426191|2017-02-18 14:35:24.426191
NCT00641238|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-05-12|||March 2004||2004-03-01|May 2015|2015-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)|Clinical Follow-up of Patients Treated With Radiofrequency Ablation of Lung Masses.|Completed||N/A|20|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:35:24.522192|2017-02-18 14:35:24.522192
NCT00641225|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2013-02-21|||March 2008||2008-03-01|February 2013|2013-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis|An Ascending Single Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of SBI-087 Administered To Subjects With Rheumatoid Arthritis|Completed||Phase 1|62|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:35:24.627008|2017-02-18 14:35:24.627008
NCT00641212|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-03-24|||January 2000||2000-01-01|March 2009|2009-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Children, Perennial Allergic Rhinitis (PAR), l-t Growth|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Long-Term Treatment With Rhinocort Aqua (Budesonide) Nasal Spray in Children With Perennial Allergic Rhinitis.|Completed||Phase 4|209|Anticipated|AstraZeneca||2|||||||||||||||||2017-02-18 14:35:24.735921|2017-02-18 14:35:24.735921
NCT00641199|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2010-01-14|||March 2008||2008-03-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Probiotics for Prevention of Antibiotic-associated Diarrhea|The Effect of Jarro-Dophilus EPS Probiotics on the Prevention of Diarrhea, Quality of Life and Symptoms in Adults Receiving Antibiotic Therapy.|Completed||N/A|204|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-02-18 14:35:24.828627|2017-02-18 14:35:24.828627
NCT00641186|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-04-30|||September 2004||2004-09-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|Xyrem||Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)|A Phase II, Eight Week, Multi-Center, Open Label Trial of Xyrem(R) (Sodium Oxybate) for Excessive Daytime Sleepiness and Nocturnal Sleep Disturbance in Patients With Mild to Moderate Parkinson's Disease|Completed||N/A|30|Anticipated|Baylor College of Medicine||1|||f||||f||||||||||2017-02-18 14:35:24.940964|2017-02-18 14:35:24.940964
NCT00641173|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-06-25|||September 2008||2008-09-01|June 2015|2015-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Early Intervention for Post Traumatic Stress Disorder (PTSD)|Early Intervention for PTSD in Iraqi Veterans|Withdrawn||N/A|0|Actual|VA Office of Research and Development||2||Withdrawn by funding source|f||||t||||||||||2017-02-18 14:35:25.037225|2017-02-18 14:35:25.037225
NCT00641160|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-09-24|||March 2008||2008-03-01|September 2008|2008-09-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies|A Phase 1 Study of the Safety, Pharmacokinetics, and Biological Activity of Metronomic Dosing With Orally Administered Vinorelbine Tablets in Subjects With Non-Hematologic Malignancies For Which There Are No Currently Accepted Therapies|Unknown status|Active, not recruiting|Phase 1|12|Anticipated|Metronome Therapeutics||3|||f||||f||||||||||2017-02-18 14:35:25.16252|2017-02-18 14:35:25.16252
NCT00641147|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-12-13|||October 2010||2010-10-01|December 2016|2016-12-01||||November 2016|Actual|2016-11-01||Interventional|||Curcumin in Treating Patients With Familial Adenomatous Polyposis|Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 14:35:25.430398|2017-02-18 14:35:25.430398
NCT00641134|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-02-05|||April 2008||2008-04-01|February 2009|2009-02-01|November 2010|Anticipated|2010-11-01|November 2009|Anticipated|2009-11-01||Interventional|CR-AGE-EXTRA||Cardiac Rehabilitation in Advanced aGE: EXercise TRaining and Active Follow-up CR-AGE-EXTRA Trial|Cardiac Rehabilitation in Advanced aGE: EXercise TRaining and Active Follow-up, a Randomised Controlled Trial. CR-AGE EXTRA Trial|Unknown status|Recruiting|N/A|80|Anticipated|University of Florence||2|||f||||f||||||||||2017-02-18 14:35:25.553094|2017-02-18 14:35:25.553094
NCT00641121|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-03-20|||November 2005||2005-11-01|March 2008|2008-03-01||||||||Observational|||Bethaherpesviruses in Children Who Are Immune Suppressed|Bethaherpesviruses in Children Who Are Immune Suppressed|Unknown status|Recruiting|N/A|60|Anticipated|The Cleveland Clinic|||1||f||||f||||||||||2017-02-18 14:35:25.66578|2017-02-18 14:35:25.66578
NCT00641108|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2012-07-26|||January 2008||2008-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression|Effect of Psychotherapy on Brain Serotonin Activity|Completed||Phase 2/Phase 3|30|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:35:25.737901|2017-02-18 14:35:25.737901
NCT00641095|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2013-08-09|||December 2006||2006-12-01|November 2008|2008-11-01||||September 2010|Anticipated|2010-09-01||Interventional|||Fludarabine and Cyclophosphamide With or Without Rituximab in Treating Patients With Previously Untreated Mantle Cell Lymphoma|Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma|Unknown status|Recruiting|Phase 3|550|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:35:25.852932|2017-02-18 14:35:25.852932
NCT00641082|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2012-04-24|||February 2008||2008-02-01|April 2012|2012-04-01||||March 2012|Actual|2012-03-01||Interventional|||A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function|A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function|Completed||Phase 4|43|Actual|Bukwang Pharmaceutical||2|||f||||||||||||||2017-02-18 14:35:26.029707|2017-02-18 14:35:26.029707
NCT00641069|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-07-14|||February 2008||2008-02-01|July 2009|2009-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Automated Chest Compression in Cardiac Arrest|Effect on Hemodynamics of Automated Band Chest Compression Device in Cardiac Arrest Resuscitation|Completed||N/A|30|Anticipated|Beaujon Hospital|||1||f||||f||||||||||2017-02-18 14:35:26.140947|2017-02-18 14:35:26.140947
NCT00641056|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-05-21|2012-02-14||April 2008||2008-04-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)|Efficacy of Once-Weekly Exenatide Long-Acting Release and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea|Completed||Phase 3|467|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:35:26.260757|2017-02-18 14:35:26.260757
NCT00641043|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2014-01-22|2011-05-13||March 2008||2008-03-01|January 2014|2014-01-01||||June 2009|Actual|2009-06-01||Interventional|||Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone|A Randomised, Double-blind, Placebo Controlled, Parallel Group 24 Week Study to Assess the Efficacy and Safety of BI 1356 (5 mg) in Combination With 30 mg Pioglitazone (Both Administered Orally Once Daily), Compared to 30 mg Pioglitazone Plus Placebo in Drug Naive or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control.|Completed||Phase 3|389|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:35:27.045369|2017-02-18 14:35:27.045369
NCT00641030|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2012-07-16|||July 2007||2007-07-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes|A Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation|Completed||Phase 1|20|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:35:27.819014|2017-02-18 14:35:27.819014
NCT00641017|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-02-22|||March 2008||2008-03-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine|A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Human Parainfluenza Type 1 Virus Vaccine, rHPIV1 84/del170/942A, Lot PIV1 #104A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV1-Seropositive Children 15 to 59 Months of Age, and HPIV1-Seronegative Infants and Children 6 to 59 Months of Age|Completed||Phase 1|87|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||t||||||||||2017-02-18 14:35:27.924854|2017-02-18 14:35:27.924854
NCT00641004|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-08-23|||April 2008||2008-04-01|December 2009|2009-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy|Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy|Completed||Phase 4|30|Anticipated|Otsuka Pharmaceutical, Inc., Philippines||2|||f||||f||||||||||2017-02-18 14:35:28.03551|2017-02-18 14:35:28.03551
NCT00640991|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2010-06-15|||April 2008||2008-04-01|June 2009|2009-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|RECREATE Pilot||REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)|An International Multicentre Randomized Controlled Trial of Intensive Insulin Therapy Targeting Normoglycemia In Acute Myocardial Infarction: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Pilot Study|Completed||Phase 3|500|Anticipated|Population Health Research Institute||2|||f||||t||||||||||2017-02-18 14:35:28.291027|2017-02-18 14:35:28.291027
NCT00640978|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2012-06-18|2011-07-22||March 2008||2008-03-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer|Phase II Study of Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer|Terminated||Phase 2|16|Actual|M.D. Anderson Cancer Center||1||Significant Adverse Effects - Futility|f||||f||||||||||2017-02-18 14:35:28.413554|2017-02-18 14:35:28.413554
NCT00640965|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2009-05-04|||July 2008||2008-07-01|May 2009|2009-05-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Interventional|||DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study|Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Two-Arm, Multi-Center Phase II Trial to Assess the Safety, Tolerability, and Efficacy of DP-VPA (up to 900 mg) Once Daily for 10 Weeks in Adult Subjects With Migraine|Withdrawn||Phase 2|40|Anticipated|D-Pharm Ltd.||2||STUDY WAS NOT STARTED|f||||f||||||||||2017-02-18 14:35:28.688518|2017-02-18 14:35:28.688518
NCT00640952|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-11-10|||August 2006||2006-08-01|November 2015|2015-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease|Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease|Withdrawn||N/A|0|Actual|Baylor College of Medicine||1||PI left site|f||||f||||||||||2017-02-18 14:35:28.803276|2017-02-18 14:35:28.803276
NCT00468702|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2016-11-01|||September 2007||2007-09-01|November 2016|2016-11-01||||||||Interventional|||Postoperative Canadian Oral Anticoagulation Self-management (Post-COAGS) Trial|Postoperative Canadian Oral Anticoagulation Self-Management (Post-COAGS) Trial|Withdrawn||N/A|0|Actual|Hoffmann-La Roche|||||f||||||||||||||2017-02-18 15:39:11.732836|2017-02-18 15:39:11.732836
NCT00640939|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-08-05|||December 2007||2007-12-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Diclofenac Sodium Patch for the Topical Treatment of Pain Due to Mild to Moderate Tendonitis or Bursitis|Completed||Phase 2/Phase 3|308|Actual|Cerimon Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:35:28.908731|2017-02-18 14:35:28.908731
NCT00640926|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2016-04-07|2010-01-08||October 2007||2007-10-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia|A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of RX-1741 in the Treatment of Adult Patients With Mild to Moderate Severity of Community-Acquired Pneumonia (CAP)|Completed||Phase 2|158|Actual|Melinta Therapeutics, Inc.|The yield of typical bacterial pathogens, most importantly S. pneumoniae, was quite low. The presence of atypical pathogens was assessed only by paired serologies, not by culture or polymerase chain reaction (PCR).|3|||f||||f||||||||||2017-02-18 14:35:29.030842|2017-02-18 14:35:29.030842
NCT00640913|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2008-03-19|||February 2008||2008-02-01|March 2008|2008-03-01|November 2009|Anticipated|2009-11-01|April 2009|Anticipated|2009-04-01||Observational|ELSOR||Early Reversal of Defunctioning Stoma Trial|Early Reversal of Defunctioning Stoma Trial|Unknown status|Recruiting|N/A|20|Anticipated|Rectal Cancer Trial on Defunctioning Stoma Study Group|||1||f||||t||||||Samples Without DNA|"~     Analysis of serum C-Reactive Protein (CRP) and Procalcitonin (PCT).~   "|||2017-02-18 14:35:29.588273|2017-02-18 14:35:29.588273
NCT00640900|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-03-31|||July 2007||2007-07-01|March 2008|2008-03-01|July 2010|Anticipated|2010-07-01|July 2009|Anticipated|2009-07-01||Interventional|FAB||Food, Activity and Behavior Trial|A Multi-Site Randomized Trial of a Commercial Weight Loss Program|Unknown status|Active, not recruiting|N/A|440|Anticipated|Jenny Craig, Inc.||3|||f||||t||||||||||2017-02-18 14:35:29.693448|2017-02-18 14:35:29.693448
NCT00640887|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2011-06-17|||February 2009||2009-02-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa|Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in the Treatment of Tuberculosis Patient With HIV Infection in South Africa: A Phase II Trial|Completed||Phase 2|48|Anticipated|French National Agency for Research on AIDS and Viral Hepatitis||3|||f||||t||||||||||2017-02-18 14:35:29.797541|2017-02-18 14:35:29.797541
NCT00640874|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2012-04-22||||||April 2012|2012-04-01||||||||Observational|PIPET C||A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza|A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza.|Withdrawn||N/A|0|Actual|Kirby Institute|||1||f||||f||||||||||2017-02-18 14:35:29.909734|2017-02-18 14:35:29.909734
NCT00640861|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2016-09-12|||August 2008||2008-08-01|August 2016|2016-08-01||||May 2017|Anticipated|2017-05-01||Interventional|||Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer|MUC1/HER-2/Neu Peptide Based Immunotherapeutic Vaccines for Breast Adenocarcinomas|Active, not recruiting||N/A|45|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:35:30.019145|2017-02-18 14:35:30.019145
NCT00640822|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2015-04-07|2010-11-23||February 2008||2008-02-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds|A Phase 3 Study Comparing an Ointment Containing Calcipotriol 25 mcg/g Plus Hydrocortisone 10 mg g With Tacalcitol 4 mcg/g Ointment and the Ointment Vehicle Alone, All Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and on the Intertriginous Areas|Completed||Phase 3|782|Actual|LEO Pharma||3|||f||||f||||||||||2017-02-18 14:35:30.130898|2017-02-18 14:35:30.130898
NCT00640809|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-04-02|||October 2003||2003-10-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|||||Interventional|||Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole|Double-Blind, Placebo-Controlled, Randomized Two-Week Study, Comparing Small Bowel Lesions Associated With Celecoxib (200 mg BID) vs. Ibuprofen (800 mg TID) Plus Omeprazole (20 mg QD)|Completed||Phase 4|408|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:35:30.602517|2017-02-18 14:35:30.602517
NCT00640796|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2014-04-23|||September 2008||2008-09-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors|Pilot Study of Expanded, Activated Haploidentical Natural Killer Cell Infusions for Non-B Lineage Hematologic Malignancies and Solid Tumors|Completed||Phase 1|22|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 14:35:30.719171|2017-02-18 14:35:30.719171
NCT00640783|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-03-19|||June 2001||2001-06-01|March 2008|2008-03-01|January 2004|Actual|2004-01-01|October 2003|Actual|2003-10-01||Interventional|||Mediterranean Diet and the Metabolic Syndrome|Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome|Completed||N/A|180|Actual|Second University of Naples||2|||f||||f||||||||||2017-02-18 14:35:30.836316|2017-02-18 14:35:30.836316
NCT00640770|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2011-03-14|||March 2008||2008-03-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|ACHILLES||Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease|A Prospective, Randomized, Multicenter Comparison of Balloon Angioplasty and the Cypher Selecttm + Coronary and Infrapopliteal Stent in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease|Completed||Phase 4|200|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 14:35:30.939317|2017-02-18 14:35:30.939317
NCT00640757|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2015-12-17|||July 2006||2006-07-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Methionine-Restriction Diet (MRD) in Obese Adults With Metabolic Syndrome|Methionine-Restriction Diet (MRD) in Obese Adults With Metabolic Syndrome|Completed||Phase 2|56|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-02-18 14:35:31.048429|2017-02-18 14:35:31.048429
NCT00640744|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2010-12-02|||February 2006||2006-02-01|December 2010|2010-12-01|February 2010|Anticipated|2010-02-01|November 2009|Anticipated|2009-11-01||Interventional|DCAT||Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions|Phase 3 Study of Atorvastatin Effects on Carotid Atherosclerosis|Unknown status|Recruiting|Phase 4|12|Anticipated|Baylor College of Medicine||1|||f||||f||||||||||2017-02-18 14:35:31.151437|2017-02-18 14:35:31.151437
NCT00640731|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-03-20|||March 2008||2008-03-01|March 2008|2008-03-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|SONIC I||Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis|Study of the OmniWave Endovascular System in Subjects With Lower and Upper Extremity Deep Vein Thrombosis - SONIC I Study|Unknown status|Enrolling by invitation|Phase 4|50|Anticipated|OmniSonics Medical Technologies, Inc.||1|||f||||t||||||||||2017-02-18 14:35:31.266077|2017-02-18 14:35:31.266077
NCT00640718|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-07-17|||March 2008||2008-03-01|March 2008|2008-03-01|May 2010|Anticipated|2010-05-01|March 2009|Anticipated|2009-03-01||Observational|||Evaluation of EverOn™ System in Medical / Surgical Ward|Evaluation of EarlySense EverOn™ System in Medical / Surgical Ward|Withdrawn||N/A|0|Actual|EarlySense Ltd.|||1||f||||t||||||||||2017-02-18 14:35:31.45191|2017-02-18 14:35:31.45191
NCT00640705|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-09-03|||January 2008||2008-01-01|September 2008|2008-09-01|October 2008|Anticipated|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Diclofenac Sodium Patch for the Topical Treatment of Pain Due to Mild to Moderate Ankle Sprain.|Terminated||Phase 2/Phase 3|170|Actual|Cerimon Pharmaceuticals||2||Sponsor decision|f||||f||||||||||2017-02-18 14:35:31.523062|2017-02-18 14:35:31.523062
NCT00640692|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-09-18|||December 2007||2007-12-01|September 2009|2009-09-01|April 2011|Anticipated|2011-04-01|September 2009|Anticipated|2009-09-01||Observational|||Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial|Kinase Genotyping of Gastrointestinal Stromal Tumors (GIST) From Patients Enrolled in the A6181112 Phase IIIb Trial at Participating U.S. and Ex-U.S. Medical Centers|Terminated||N/A|120|Anticipated|Oregon Health and Science University|||2|Insufficient enrollment|f||||f||||||Samples With DNA|"~     Genomic DNA from tumor samples~   "|||2017-02-18 14:35:31.635989|2017-02-18 14:35:31.635989
NCT00640679|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-07-26|||April 2008||2008-04-01|June 2012|2012-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|ISAR-CAUTION||Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation|Prospective, Randomized, Double-Blind Trial of Abrupt and Tapered Interruption of Long-term Clopidogrel Therapy After Implantation of a Drug-Eluting Stent|Terminated||Phase 4|782|Actual|Deutsches Herzzentrum Muenchen||2||Due to slow enrollment the study was stopped prematurely.|f||||t||||||||||2017-02-18 14:35:31.718132|2017-02-18 14:35:31.718132
NCT00640666|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2015-05-09|||March 2008||2008-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2013|Actual|2013-03-01||Interventional|CICK||Changes in Cancer-related Cytokines After Participation in a Physical Activity Behavior Change Intervention (CICK Study)|Changes in Cancer-related Cytokines After Participation in a Physical Activity Behavior Change Intervention (CICK Study)|Completed||N/A|30|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:35:31.830089|2017-02-18 14:35:31.830089
NCT00640653|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2008-04-07|||September 2001||2001-09-01|April 2008|2008-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Effectiveness of an Abstinence-Only HIV/Sexually Transmitted Disease Risk-Reduction Intervention for Young African-American Adolescents|HIV/STD Prevention Interventions for Black Adolescents|Completed||Phase 2/Phase 3|662|Actual|National Institute of Mental Health (NIMH)||5|||f||||f||||||||||2017-02-18 14:35:31.940693|2017-02-18 14:35:31.940693
NCT00640640|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2008-03-20|||August 2007||2007-08-01|March 2008|2008-03-01|February 2009|Anticipated|2009-02-01|December 2008|Anticipated|2008-12-01||Interventional|AMD||The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)|The Effect of Intravitreal Bevacizumab & Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration|Unknown status|Recruiting|N/A|60|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 14:35:32.061481|2017-02-18 14:35:32.061481
NCT00640627|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-04-02|||December 2003||2003-12-01|March 2008|2008-03-01|September 2004|Actual|2004-09-01|||||Interventional|||Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen|A Double-Blind, Placebo-Controlled Study of the Efficacy and Tolerability of Once Daily Celebrex® (Celecoxib) vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee Non-Responsive to Naproxen and Ibuprofen|Completed||Phase 4|380|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:35:32.164504|2017-02-18 14:35:32.164504
NCT00640614|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-11-18|2013-02-21||April 2008||2008-04-01|November 2015|2015-11-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy|Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol|Completed||Phase 3|235|Actual|Allerderm||2|||f||||f||||||||||2017-02-18 14:35:32.461648|2017-02-18 14:35:32.461648
NCT00640601|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2012-06-22|2011-06-21||March 2008||2008-03-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SPECTRUM||Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia|A Multicentre, Open-label, Prospective Long-term Study Evaluating the Clinical Benefit and Effectiveness of SEROQUEL XR® (Quetiapine Fumarate Extended-Release Tablets) in Subjects With Schizophrenia|Completed||Phase 3|331|Actual|AstraZeneca|The open-label design and lack of a placebo group constitute potential limitations. In addition, the small sample size of some of the subgroups may limit conclusions drawn from subgroup analyses.|1|||f||||f||||||||||2017-02-18 14:35:33.247611|2017-02-18 14:35:33.247611
NCT00640588|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2012-05-07|||March 2008||2008-03-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|EBEREST||Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine|Prospective Exploratory Study to Describe in CHB naïve and Non-naïve Patients, Hepatitis B Virus (HBV) Kinetics During the First 24 Weeks of Treatment With Telbivudine|Completed||Phase 3|30|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:35:33.647139|2017-02-18 14:35:33.647139
NCT00640575|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2011-07-03|||March 2005||2005-03-01|March 2005|2005-03-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Subacromial Ultrasound-guided or Systemic Steroid Injection for Rotator Cuff Disease, a Randomized Double Blinded Study|Subacromial Ultrasound-guided or Systemic Steroid Injection for Rotator Cuff Disease, a Randomized Double Blinded Study|Completed||N/A|106|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 14:35:33.757615|2017-02-18 14:35:33.757615
NCT00640393|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-09-01|2010-08-27||April 2008||2008-04-01|September 2011|2011-09-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Efficacy of Combining nbUVB to Etanercept in Patients|A Randomized Study Combining Etanercept and Short Courses of Narrow-Band UVB in Patients With Psoriasis Vulgaris|Completed||Phase 4|99|Actual|Innovaderm Research Inc.||3|||f||||f||||||||||2017-02-18 14:35:38.885079|2017-02-18 14:35:38.885079
NCT00640562|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2012-05-17|2011-03-29||February 2008||2008-02-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|ExAttitude||Quetiapine Extended Release Depression Symptoms|Comparison of Quetiapine Extended-Release (Seroquel XR™) and Risperidone in the Treatment of Depressive Symptoms, in Schizophrenic or Schizoaffective Patients: A Randomized, Open Label, Flexible-dose, Parallel Group, Non Inferiority, 12-week Study|Completed||Phase 3|216|Actual|AstraZeneca|Multicentre, randomized, open-label, flexible dose, parallel group, non inferiority|2|||f||||f||||||||||2017-02-18 14:35:33.849398|2017-02-18 14:35:33.849398
NCT00640549|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2008-03-28|||March 2003||2003-03-01|March 2008|2008-03-01|October 2004|Actual|2004-10-01|||||Interventional|ALPIN||Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus|Impact of Atorvastatin on the Distribution, Composition, and Metabolism of LDL and HDL Subfractions: A Double-Blind Placebo-Controlled Phase IV Study With Patients Suffering From Combined Hyperlipidemia and Diabetes. Atorvastatin and LDL Profile in NIDDM (ALPIN Study)|Terminated||Phase 4|41|Actual|Pfizer||2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:35:34.372774|2017-02-18 14:35:34.372774
NCT00640536|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-11-28|||June 2006||2006-06-01|November 2008|2008-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Right Ventricular Function in Obstructive Sleep Apnea|The Evaluation of Subclinical Right Ventricular Dysfunction in Obstructive Sleep Apnea Patients Without Systemic and Pulmonary Arterial Hypertension Using Velocity Vector Imaging|Completed||N/A|53|Actual|Florence Nightingale Hospital, Istanbul|||2||f||||t||||||||||2017-02-18 14:35:34.499488|2017-02-18 14:35:34.499488
NCT00640523|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2012-01-18||2012-01-18|March 2008||2008-03-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|||Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)|Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|23|Actual|BioCryst Pharmaceuticals||1|||f||||t||||||||||2017-02-18 14:35:34.6886|2017-02-18 14:35:34.6886
NCT00640510|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-08-26|2009-07-16||March 2008||2008-03-01|August 2009|2009-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia|A Placebo-Controlled, Double-Blind Confirmatory Study of Rapid-Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia|Completed||Phase 3|34|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:35:34.795007|2017-02-18 14:35:34.795007
NCT00640497|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-04-28|||January 2010||2010-01-01|April 2009|2009-04-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease|A Phase I/II Multicentric Study to Determine the Safety and Efficacy of a Combination of Anti-CD3 & Anti-CD7 Ricin A Immunotoxins for the Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease|Withdrawn||Phase 1/Phase 2|12|Anticipated|Henogen||1||Unavailability of investigational product|f||||t||||||||||2017-02-18 14:35:35.508339|2017-02-18 14:35:35.508339
NCT00640484|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2010-08-24||2010-08-18|April 2008||2008-04-01|August 2010|2010-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD|Evaluation of the Effect of 2 Weeks Treatment With CHF 4226 pMDI 2µg and 4µg, Given Once Daily in the Morning, on 24-Hour FEV1 in Patients With COPD|Completed||Phase 2|57|Actual|Chiesi Farmaceutici S.p.A.||4|||f||||f||||||||||2017-02-18 14:35:35.623887|2017-02-18 14:35:35.623887
NCT00640471|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-20|2013-07-16|||May 2008||2008-05-01|November 2012|2012-11-01|January 2013|Actual|2013-01-01|March 2011|Actual|2011-03-01||Interventional|||Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer|A Phase III Randomized Study of Brivanib Alaninate (BMS-582664) in Combination With Cetuximab (Erbitux®) Versus Placebo in Combination With Cetuximab (Erbitux®) in Patients With K-RAS Wild Type Tumors Previously Treated With Combination Chemotherapy for Metastatic Colorectal Carcinoma|Completed||Phase 3|750|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 14:35:35.754179|2017-02-18 14:35:35.754179
NCT00640458|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-04-04|||April 2004||2004-04-01|April 2008|2008-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-Menopausal Women With Female Sexual Arousal Disorder|A Double Blind, Placebo Controlled 2-Way Cross-Over Study to Assess the Clitoral Engorgement Response as Measured by Non-Contrast Magnetic Resonance Imaging (MRI) in Women With Female Sexual Arousal Disorder (FSAD) When Administered a Single Dose of Sildenafil (100mg) Followed by Audio/Visual Sexual Stimulation|Completed||Phase 2|20|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:35:35.904958|2017-02-18 14:35:35.904958
NCT00640445|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2015-09-21|||June 2011||2011-06-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|April 2013|Actual|2013-04-01||Interventional|M2C||Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration|Military to Civilian: RCT of an Intervention to Promote Postdeployment Reintegration|Completed||Phase 2/Phase 3|1292|Actual|Minneapolis Veterans Affairs Medical Center||3|||f||||f||||||||||2017-02-18 14:35:36.008382|2017-02-18 14:35:36.008382
NCT00640432|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-04-02|||October 2003||2003-10-01|March 2008|2008-03-01|October 2004|Actual|2004-10-01|||||Interventional|||Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain|A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of The Safety, Tolerability And Efficacy Of Celecoxib 200 Mg Twice A Day (With A 400 Mg Attack Dose) Versus Sodium Diclofenac 75 Mg Twice A Day In Subjects With Acute Low Back Pain|Completed||Phase 4|244|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:35:36.113548|2017-02-18 14:35:36.113548
NCT00640419|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2013-01-10||2011-08-18|March 2008||2008-03-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of 0.7 mg/kg/Day and 1.4 mg/kg/Day of ABT-089 in the Treatment of Children With Attention Deficit-Hyperactivity Disorder (ADHD)|Completed||Phase 2|121|Actual|AbbVie||3|||f||||t||||||||||2017-02-18 14:35:36.224196|2017-02-18 14:35:36.224196
NCT00640406|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-07-20|||April 2008||2008-04-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|December 2011|Actual|2011-12-01||Interventional|RADAR||Comparison of Best Medical Treatment Versus Best Medical Treatment Plus Renal Artery Stenting|A Randomized, Multi-centre, Prospective Study Comparing Best Medical Treatment Versus Best Medical Treatment Plus Renal Artery Stenting in Patients With Hemodynamically Relevant Atherosclerotic Renal Artery Stenosis|Completed||Phase 3|86|Actual|Biotronik AG||2|||f||||t||||||||||2017-02-18 14:35:38.765524|2017-02-18 14:35:38.765524
NCT00640380|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-04-07|||May 2008||2008-05-01|April 2008|2008-04-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||A Comparison Between Neurostimulation and Loss of Resistance for Cervical Paravertebral Blocks|A Comparison Between Neurostimulation and Loss of Resistance for Cervical Paravertebral Blocks|Unknown status|Not yet recruiting|N/A|90|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-02-18 14:35:39.963337|2017-02-18 14:35:39.963337
NCT00640367|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-04-24|||February 2008||2008-02-01|April 2014|2014-04-01|July 2012|Actual|2012-07-01|February 2009|Actual|2009-02-01||Interventional|SYNTHESIS EXP||Intra-arterial Versus Systemic Thrombolysis for Acute Ischemic Stroke|Synthesis Expansion: A Randomized Controlled Trial on Intra-Arterial Versus Intravenous Thrombolysis in Acute Ischemic Stroke|Completed||Phase 3|350|Actual|Niguarda Hospital||2|||f||||t||||||||||2017-02-18 14:35:40.064767|2017-02-18 14:35:40.064767
NCT00640354|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-03-18|||December 2006||2006-12-01|March 2008|2008-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Time to Defibrillation Using Automated External Defibrillators by Pediatric Residents in Simulated Cardiac Arrests|Defibrillation by Automated External Defibrillators Versus Manual Defibrillators in Simulated Pediatric In-Hospital Cardiac Arrests: A Prospective Randomized Controlled Trial of Pediatric Residents|Completed||N/A|60|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 14:35:40.173131|2017-02-18 14:35:40.173131
NCT00640341|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-12-07|2011-02-03||February 2008||2008-02-01|December 2011|2011-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparative Performance of PureVision, Acuvue Oasys and O2Optix|Product Performance of Bausch & Lomb PureVision® Contact Lens When Compared to Johnson & Johnson Acuvue Oasys Contact Lens and the Ciba Vision O2Optix Contact Lens Worn Daily.|Completed||Phase 4|510|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-02-18 14:35:40.288815|2017-02-18 14:35:40.288815
NCT00640328|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-06-19|2012-11-01||May 2008||2008-05-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|May 2010|Actual|2010-05-01||Interventional|OMS115102||Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients|A Double-blind, Randomized, Placebo Controlled, Multicenter, Dose-finding Trial of Ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) Patients|Completed||Phase 2|38|Actual|GlaxoSmithKline||6|||f||||t||||||||||2017-02-18 14:35:40.766429|2017-02-18 14:35:40.766429
NCT00640315|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2016-11-04|2013-11-07||August 2008||2008-08-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.|Proof of Concept Study to Investigate Safety, Tolerability, Pharmacokinetics and the Impact on Pulmonary and Systemic Hemodynamics, Gas Exchange and Lung Function Parameters of a Single-dose of BAY63-2521 IR-tablet in Patients With COPD Associated Pulmonary Hypertension in an Non-randomized, Non-blinded Design|Completed||Phase 1|23|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:35:43.820794|2017-02-18 14:35:43.820794
NCT00640302|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-16|2012-04-22||||||April 2012|2012-04-01||||||||Observational|PIPET A||A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza|A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza Infection|Withdrawn||N/A|0|Actual|Kirby Institute|||1||f||||f||||||Samples With DNA|"~     Patients will be asked to provide a blood sample and an appropriate respiratory tract~     sample. As a minimum, we will collect a combined nose and throat sample.~      A further respiratory tract swab will be collected on day 5 (range 5-10) and stored for~     future use. Index case follow-up will include an assessment and respiratory tract specimen~     and blood sample 14 days after informed consent. A final assessment for outcomes (including~     a blood sample) will occur approximately one month after enrolment.~   "|||2017-02-18 14:35:45.446043|2017-02-18 14:35:45.446043
NCT00640289|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-02-09|||January 2000||2000-01-01|March 2008|2008-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Clinical Trial of Factor XIII (FXIII) Concentrate|Clinical Research Study of Factor XIII Concentrate From Human Plasma Fibrogammin P in Patients With Factor XIII Deficiency|Completed||N/A|73|Actual|Children’s Hospital of Orange County||1|||f||||f||||||||||2017-02-18 14:35:45.543753|2017-02-18 14:35:45.543753
NCT00640276|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2012-03-28|||April 2008||2008-04-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|ProPit||Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome|A Prospective Comparative Clinical Study to Identify Efficacy and Safety of Pitavastatin in Patients With a Metabolic Syndrome|Completed||Phase 4|187|Actual|JW Pharmaceutical||2|||f||||t||||||||||2017-02-18 14:35:45.651774|2017-02-18 14:35:45.651774
NCT00640263|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-04-11|||December 2009||2009-12-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding|A Randomised Controlled Trial Comparing the Efficacy of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir (LPV/r) Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding|Completed||Phase 3|1500|Anticipated|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 14:35:45.76276|2017-02-18 14:35:45.76276
NCT00640250|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-02-19|||April 2008||2008-04-01|May 2010|2010-05-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response|Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Bronopol and Disperse Blue 106 Dose Response Study|Completed||Phase 2|48|Actual|Allerderm||1|||f||||f||||||||||2017-02-18 14:35:45.878804|2017-02-18 14:35:45.878804
NCT00640237|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-16|2008-03-20|||March 2008||2008-03-01|March 2008|2008-03-01|August 2008|Anticipated|2008-08-01|July 2008|Anticipated|2008-07-01||Interventional|||Interventional Trial of Vitamin D Deficiency in the Patients of General Departments|Vitamin D Deficiency in the Elder Patients of General Departments and Its Treatment During the Hospitalization|Unknown status|Recruiting|Phase 3|300|Anticipated|Rambam Health Care Campus||2|||f||||f||||||||||2017-02-18 14:35:45.988306|2017-02-18 14:35:45.988306
NCT00640224|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2016-01-27|||March 2005||2005-03-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study|Obesity, Insulin Resistance, and Bone Metabolism in Adolescents With PCOS: Effects of Insulin Sensitizers Versus Oral Contraceptives|Completed||Phase 4|65|Actual|Children's Hospital of Pittsburgh||4|||f||||f||||||||||2017-02-18 14:35:46.100062|2017-02-18 14:35:46.100062
NCT00640211|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2012-04-22||||||April 2012|2012-04-01||||||||Observational|PIPET B||A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B|A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B|Withdrawn||N/A|0|Actual|Kirby Institute|||1||f||||f||||||||||2017-02-18 14:35:46.209273|2017-02-18 14:35:46.209273
NCT00640198|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2008-03-20|||March 2005||2005-03-01|March 2008|2008-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Memantine and Intensive Speech-Language Therapy in Aphasia|A 24-Week Pilot, Double-Blind, Randomized, Parallel, Placebo-Controlled Study of Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:Correlation With Cognitive Evoked Potentials During Recovery.|Completed||Phase 4|28|Actual|Gabinete Berthier y Martínez||2|||f||||f||||||||||2017-02-18 14:35:46.408016|2017-02-18 14:35:46.408016
NCT00640185|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2013-01-10||2011-08-18|March 2008||2008-03-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Pilot, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety, Tolerability and Efficacy of 40 mg QD and 80 mg QD ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)|Completed||Phase 2|160|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 14:35:46.525139|2017-02-18 14:35:46.525139
NCT00640172|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2016-03-23|||August 2009||2009-08-01|March 2016|2016-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Anemia in the Elderly|Anemia in the Elderly|Completed||N/A|343|Actual|Stanford University|||5||f||||f||||||Samples With DNA|"~     blood, urine and bone marrow~   "|No||2017-02-18 14:35:46.626771|2017-02-18 14:35:46.626771
NCT00640159|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2009-03-12|||January 2007||2007-01-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease|Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease.|Completed||Phase 4|55|Anticipated|Baylor College of Medicine||1|||f||||f||||||||||2017-02-18 14:35:46.715426|2017-02-18 14:35:46.715426
NCT00640146|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2011-07-17|||October 2007||2007-10-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Phase 2 Study of Once-Daily Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures|Completed||Phase 2|33|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 14:35:46.820823|2017-02-18 14:35:46.820823
NCT00640133|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-07-01|||March 2008||2008-03-01|July 2016|2016-07-01|May 2017|Anticipated|2017-05-01|May 2016|Actual|2016-05-01||Interventional|||Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder|Controlled Trial of Deep Brain Stimulation for Obsessive-Compulsive Disorder|Active, not recruiting||Phase 2|30|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-02-18 14:35:46.933125|2017-02-18 14:35:46.933125
NCT00640120|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-15|2011-06-08|||July 2008||2008-07-01|March 2008|2008-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording|Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording|Completed||N/A|40|Anticipated|KarmelSonix Ltd.|||2||f||||f||||||||||2017-02-18 14:35:47.05438|2017-02-18 14:35:47.05438
NCT00640107|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-05-12|||October 2006||2006-10-01|May 2015|2015-05-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||The Purpose of This Study is to Evaluate New Commercially Available MRI Sequence and/or Hardware|Evaluation and Optimization of New MRI Hardware and Software in Existing SUNY MRI Units and Newly Installed Commercially Available Units.|Active, not recruiting||N/A|30|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:35:47.155762|2017-02-18 14:35:47.155762
NCT00640094|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-07-22|||May 2013||2013-05-01|July 2016|2016-07-01|November 2016|Anticipated|2016-11-01|March 2016|Actual|2016-03-01||Interventional|MARIA||The Melatonin Adjunct in the Acute myocaRdial Infarction Treated With Angioplasty|Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Melatonin as an Adjunct in Patients With Acute myocaRdial Infarction Undergoing Primary Angioplasty|Terminated||Phase 2|272|Actual|Fundación Canaria Rafael Clavijo para la Investigación Biomédica||2|||f||||t||||||||||2017-02-18 14:35:47.386944|2017-02-18 14:35:47.386944
NCT00640081|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-03-22|||July 2007||2007-07-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|June 2010|Actual|2010-06-01||Interventional|||Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer|A Two-arm Phase II Randomised Trial of Intermittent Chemotherapy Plus Continuous Cetuximab and of Intermittent Chemotherapy Plus Intermittent Cetuximab in First Line Treatment of Patients With K-ras-normal (Wild-type) Metastatic Colorectal Cancer|Completed||Phase 2|169|Actual|Medical Research Council||2|||f||||t||||||||Yes|Publication|2017-02-18 14:35:47.500526|2017-02-18 14:35:47.500526
NCT00640068|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2014-04-02|||July 2007||2007-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|ACIC||Advanced Cardiovascular Imaging Consortium|Advanced Cardiovascular Imaging Consortium: A Collaborative Quality Improvement Project|Completed||N/A|42926|Actual|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 14:35:47.646466|2017-02-18 14:35:47.646466
NCT00640055|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-07-29|||July 2007||2007-07-01|July 2014|2014-07-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|VA||Verbal Autopsy to Assess Early Neonatal Death and Stillbirth|Using Verbal Autopsy to Determine Cause of Stillbirths and Early Neonatal Deaths Within the NICHD Global Network|Completed||Phase 4|200|Anticipated|NICHD Global Network for Women's and Children's Health||2|||f||||t||||||||||2017-02-18 14:35:47.788658|2017-02-18 14:35:47.788658
NCT00640042|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2012-06-06|2009-11-30||March 2008||2008-03-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|ACCESS 2008||Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza|AVINZA Control of Chronic Pain, Effectiveness and Safety Study (ACCESS 2008) A Multi-Center Study to Evaluate the Effectiveness and Tolerability of AVINZA for Chronic Moderate-Severe Pain: A Focus on Risk Minimization Assessment, Intervention and Outcomes|Completed||Phase 4|1570|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:35:47.903075|2017-02-18 14:35:47.903075
NCT00640029|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2015-03-06|||February 2008||2008-02-01|March 2015|2015-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|EVA||Evaluation of the Prosthetic Disc Replacement|Medico-economic Evaluation of the Prosthetic Replacement of the Lumbar and Cervical Intervertebral Disc|Terminated||N/A|301|Actual|Assistance Publique - Hôpitaux de Paris||5||Insuffisent recruitment|f||||t||||||||||2017-02-18 14:35:49.027572|2017-02-18 14:35:49.027572
NCT00640016|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2016-12-07|2016-06-03||January 2008||2008-01-01|December 2016|2016-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||Analysis population included all participants who were enrolled.|A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With Asthma|A Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of CAT-354|Terminated||Phase 2|14|Actual|MedImmune LLC|Study was prematurely terminated due to low recruitment rate, delay due to temporary halt and potential for expiry date of study drug. It was not considered possible to draw meaningful conclusions from the small dataset.|4||The study was terminated prematurely by the sponsor due to slow recruitment.|f||||f||||||||||2017-02-18 14:35:49.151719|2017-02-18 14:35:49.151719
NCT00640003|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2011-03-03|||April 2007||2007-04-01|December 2010|2010-12-01|February 2011|Anticipated|2011-02-01|February 2011|Anticipated|2011-02-01||Interventional|||Baclofen Treatment of Ataxia Telangiectasia||Unknown status|Active, not recruiting|Early Phase 1|12|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:35:50.124378|2017-02-18 14:35:50.124378
NCT00639990|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-12|||June 2007||2007-06-01|March 2008|2008-03-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Respiratory Mechanics in Brain Injured Patients|Effects of PEEP in Brain Injury Patients|Unknown status|Recruiting|N/A|40|Anticipated|Università degli Studi dell'Insubria||4|||f||||f||||||||||2017-02-18 14:35:50.243545|2017-02-18 14:35:50.243545
NCT00639977|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2008-03-19|||September 2007||2007-09-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Acupuncture on Intraocular Pressure|Effect of Acupuncture on Intraocular Pressure|Completed||Phase 1/Phase 2|50|Actual|Federal University of São Paulo||3|||f||||t||||||||||2017-02-18 14:35:50.350989|2017-02-18 14:35:50.350989
NCT00639964|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2016-05-31|||January 2008||2008-01-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|January 2012|Actual|2012-01-01||Interventional|DIAMANT||Exploration of the Lipid Metabolism During the Diabetic Pregnancies|Exploration of the Lipid Metabolism During the Diabetic Pregnancies and Research for New Biological Predictors to Nutritional Interventions|Completed||N/A|186|Actual|University Hospital, Lille||3|||f||||t||||||||||2017-02-18 14:35:50.441297|2017-02-18 14:35:50.441297
NCT00639951|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2016-07-18|||January 2008||2008-01-01|July 2016|2016-07-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite Envenomation|Multicentric, Randomized,Controlled and Comparative Study to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite Envenomation|Terminated||Phase 4|10|Actual|Instituto Bioclon S.A. de C.V.||2||Administrative reasons|f||||f||||||||Undecided|Not yet decided|2017-02-18 14:35:50.556923|2017-02-18 14:35:50.556923
NCT00639938|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2008-04-01|||July 2004||2004-07-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda|A Phase III Randomized Clinical Trial of the Standard Two Dose Nevirapine (NVP) Regimen With the Addition of HIV Immune Globulin(HIVIGLOB) or Extended Infant NVP Dosing Compared With the Standard NVP Regimen Alone for the Prevention of Maternal-Infant HIV Transmission in Uganda|Completed||Phase 3|722|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 14:35:50.681005|2017-02-18 14:35:50.681005
NCT00639925|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-03-13|||March 2007||2007-03-01|March 2013|2013-03-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer|Phase I Sturdy on Antiangiogenic Vaccine Therapy Using Epitope Peptide Derived From VEGFR1 and VEGFR2 With Gemcitabine in Treating Patients With Unresectable, Recurrent, or Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1|5|Actual|Fukushima Medical University||1|||f||||t||||||||||2017-02-18 14:35:50.789425|2017-02-18 14:35:50.789425
NCT00639912|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2010-11-29|||June 2007||2007-06-01|March 2008|2008-03-01|October 2010|Actual|2010-10-01|May 2010|Actual|2010-05-01||Interventional|CINIMA||Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.|Randomized Trial on the Effects of Hydration With Sodium Chloride Versus Sodium Bicarbonate to Prevent Contrast Induced Nephropathy, in Patients Undergoing Primary Coronary Interventions for Acute ST Elevation Myocardial Infarction.|Completed||Phase 4|599|Actual|Arcispedale Santa Maria Nuova-IRCCS||4|||f||||f||||||||||2017-02-18 14:35:50.894668|2017-02-18 14:35:50.894668
NCT00639899|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2008-03-19|||September 2007||2007-09-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Effect of Spermatic Vein Embolization on Prostatic Hypertrophy|Selective Retrograde Venography and Sclerotherapy of Internal Spermatic Veins and Associated Venous Bypasses and Retro-Peritoneal Collateral in Patients With Varicocele and Hypertrophy of Prostate|Completed||N/A|35|Actual|Maaynei Hayesha Medical Center||1|||f||||f||||||||||2017-02-18 14:35:51.171221|2017-02-18 14:35:51.171221
NCT00639873|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2013-08-22|||June 2008||2008-06-01|August 2013|2013-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Artemisinin Resistance in Bangladesh|Artemisinin Resistance in Bangladesh|Completed||N/A|126|Actual|Medical University of Vienna||3|||f||||f||||||||||2017-02-18 14:35:51.264917|2017-02-18 14:35:51.264917
NCT00639860|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2016-03-01|2015-12-11||March 2008||2008-03-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|OSSIX||Evaluation of OSSIX-Plus Resorbable Collagen Membranes for Alveolar Ridge Preservation Following Exodontia|Clinical and Histological Evaluation of OSSIX-Plus Resorbable Collagen Membranes for Alveolar Ridge Preservation Following Exodontia|Completed||Phase 1/Phase 2|10|Actual|University of Michigan||1|||f||||f||||||||No||2017-02-18 14:35:51.380417|2017-02-18 14:35:51.380417
NCT00639847|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2008-03-21|||October 1998||1998-10-01|March 2008|2008-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||This Study Compared an in Home Asthma Management Program Provided by Nurses or Respiratory Therapist|A Randomized Controlled Study to Evaluate the Role of an In Home Asthma Disease Management Program Provided by Respiratory Therapists in Improving Outcomes and Reducing the Cost of the Care|Completed||N/A|159|Actual|The University of Texas Health Science Center at San Antonio||3|||f||||f||||||||||2017-02-18 14:35:51.660438|2017-02-18 14:35:51.660438
NCT00639834|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2013-05-21|||February 2008||2008-02-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|MDX1342-01||Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis|A Phase 1, Multicenter, Single-dose, Dose-escalation, Safety and Tolerability Study of MDX-1342 (Anti-CD19 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis|Completed||Phase 1|26|Actual|Bristol-Myers Squibb||1|||f||||t||||||||||2017-02-18 14:35:51.764982|2017-02-18 14:35:51.764982
NCT00639821|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2012-10-19|||July 2004||2004-07-01|October 2012|2012-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Mucosal Gene Expression Defects in IBD|Mucosal Gene Expression Defects in Patients With Inflammatory Bowel Disease Before and After First Infliximab Therapy|Completed||N/A|73|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||Samples Without DNA|"~     Ileal/colonic mucosal biopsies from patiens with inflammatory bowel disease refractory to~     corticosteroids and/or immunosuppression and from 12 control individuals~   "|||2017-02-18 14:35:51.894046|2017-02-18 14:35:51.894046
NCT00639808|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2008-03-19|||August 2006||2006-08-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis|Multicenter, Randomized, Double-Blind, Placebo Controlled, Crossover Single Dose Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Effect on Gastric Emptying of TZP-101 IV Infusion in Diabetic Gastroparesis Patients|Completed||Phase 1|10|Actual|Tranzyme, Inc.||2|||f||||f||||||||||2017-02-18 14:35:51.995097|2017-02-18 14:35:51.995097
NCT00639795|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2013-07-02|||March 2008||2008-03-01|July 2013|2013-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|VATS_IM||Study of the Effect of Regional Nerve Blocks on Pain and Inflammation After Video Assisted Thorascopic Lung Surgery|Prospective Randomized Trial Evaluating the Effects of Paravertebral Nerve Blocks on Postoperative Pain and the Perioperative Inflammatory Response Following Video Assisted Thorascopic Surgery|Terminated||N/A|60|Anticipated|Memorial Medical Center||2||inadequate sample population|f||||t||||||||||2017-02-18 14:35:52.094319|2017-02-18 14:35:52.094319
NCT00639782|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-16|2015-09-04|||July 2003||2003-07-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|July 2017|Anticipated|2017-07-01||Interventional|PROSE||Prospective Randomized On-X Versus SJM Evaluation Trial|Thromboembolic Related Complications in a Randomized Trial of Previous and Current Generation Mechanical Valve Prostheses|Recruiting||N/A|1000|Anticipated|On-X Life Technologies, Inc.||2|||f||||t||||||||||2017-02-18 14:35:52.201355|2017-02-18 14:35:52.201355
NCT00639769|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2012-09-07|2010-10-11||February 2002||2002-02-01|September 2012|2012-09-01|July 2008|Actual|2008-07-01|May 2007|Actual|2007-05-01||Interventional|||Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|Phase II Trial of Irinotecan Plus Cisplatin in Patients With Recurrent or Metastatic Squamous Carcinoma of the Head and Neck|Completed||Phase 2|41|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 14:35:52.337157|2017-02-18 14:35:52.337157
NCT00639756|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2008-10-10|||June 2008||2008-06-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||The Effect of Allopurinol on Insulin Resistance and Blood Pressure|Phase 2 Study to Determine if Allopurinol Blocks Features of Metabolic Syndrome Induced by Fructose Ingestion|Completed||Phase 2|60|Anticipated|Hospital Mateo Orfila||2|||f||||f||||||||||2017-02-18 14:35:52.663926|2017-02-18 14:35:52.663926
NCT00639743|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2015-03-26|||November 2007||2007-11-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|July 2012|Actual|2012-07-01||Interventional|PEITHO||PEITHO Pulmonary Embolism Thrombolysis Study|Comparison Trial Evaluating Efficacy and Safety of Single i.v. Bolus Tenecteplase Plus Standard Anticoagulation as Compared With Standard Anticoagulation in Normotensive Patients|Active, not recruiting||Phase 3|1005|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:35:52.763436|2017-02-18 14:35:52.763436
NCT00639730|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2010-05-26|||May 2006||2006-05-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Use of the Atkins Diet for Children With Sturge Weber Syndrome|Use of the Atkins Diet for Children With Sturge Weber Syndrome|Completed||Phase 1|5|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 14:35:52.895684|2017-02-18 14:35:52.895684
NCT00639717|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-06-23|2014-09-19||March 2009||2009-03-01|June 2016|2016-06-01||||January 2012|Actual|2012-01-01||Interventional|||Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant|Addition of Etanercept and Extracorporeal Photopheresis to Standard GVHD Prophylaxis in Patients Undergoing Reduced Intensity Unrelated Donor Hematopoietic Stem Cell Transplant|Active, not recruiting||Phase 2|48|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 14:35:53.000117|2017-02-18 14:35:53.000117
NCT00639704|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-05-13|||January 1996||1996-01-01|May 2015|2015-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Improve Nuclear Medicine Heart Imaging, Compare MRI Results With Single Photon Emission Computed Tomography Imaging|Evaluation of EM-IntraSPECT Reconstruction Algorithm by Comparison of Transmission Images Reconstructed From SPECT Projections Alone With MRI Studies|Completed||N/A|6|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:35:53.29924|2017-02-18 14:35:53.29924
NCT00639691|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2016-09-28|||January 2005||2005-01-01|September 2016|2016-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy|A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab)in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy|Completed||Phase 4|48|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:35:53.377795|2017-02-18 14:35:53.377795
NCT00639678|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2014-02-13|2013-09-05||March 2008||2008-03-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects|A Randomized, Single-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Raxibacumab (Human Monoclonal Antibody to B. Anthracis Protective Antigen) in Healthy Subjects|Completed||Phase 3|322|Actual|GlaxoSmithKline||4|||f||||t||||||||||2017-02-18 14:35:53.481321|2017-02-18 14:35:53.481321
NCT00639483|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2009-03-12|||March 2003||2003-03-01|March 2009|2009-03-01|January 2004|Actual|2004-01-01|||||Interventional|||Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia|A Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia|Completed||Phase 2|270|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:35:57.432928|2017-02-18 14:35:57.432928
NCT00639665|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2015-03-30|||January 2008||2008-01-01|March 2015|2015-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Cocoa, Polyphenols, and the Kidney in Healthy Subjects and in Subjects With Hypertension and Diabetes Mellitus|Cocoa, Polyphenols, and the Kidney in Healthy Subjects and in Subjects With Hypertension and Diabetes Mellitus|Completed||N/A|228|Actual|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"~     Whole red blood cells will be retained for DNA analysis. Subjects may opt-out of genetic~     testing.~   "|||2017-02-18 14:35:55.735546|2017-02-18 14:35:55.735546
NCT00639652|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2008-03-14|||December 2007||2007-12-01|March 2008|2008-03-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970|Observational Study: Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970|Unknown status|Enrolling by invitation|N/A|800|Anticipated|University Hospital Tuebingen|||2||f||||f||||||Samples Without DNA|"~     Paraffinized histology blocks and sections.~   "|||2017-02-18 14:35:55.826115|2017-02-18 14:35:55.826115
NCT00639639|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2016-07-26|||January 2006||2006-01-01|July 2016|2016-07-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|ATTAC||Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced Lymphopenia|Active, not recruiting||Phase 1|16|Anticipated|Duke University||4|||f||||t||||||||||2017-02-18 14:35:55.936422|2017-02-18 14:35:55.936422
NCT00639626|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2015-05-14|||August 2008||2008-08-01|May 2015|2015-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)|Use of Levemir® Improves Metabolic and Clinical Status in CFRD|Terminated||Phase 2/Phase 3|5|Actual|Nationwide Children's Hospital||1||PI left the institution|f||||f||||||||||2017-02-18 14:35:56.063524|2017-02-18 14:35:56.063524
NCT00639613|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-06-25|||March 2008||2008-03-01|June 2015|2015-06-01||||June 2015|Actual|2015-06-01||Observational|T2DM-PC1-2||The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia|Exspression of Prohormone Convertase 1 and 2 in Small Intestinal Endocrine Mucosa Cells in Patients With Type 2 Diabetes|Completed||N/A|20|Actual|University Hospital, Gentofte, Copenhagen|||2||f||||t||||||Samples With DNA|"~     Buffy coat~   "|||2017-02-18 14:35:56.182574|2017-02-18 14:35:56.182574
NCT00639600|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2010-05-28|||June 2008||2008-06-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|GRAGIL1||Transplantation of Pancreatic Islets in Patients With Type 1 Diabetes Mellitus and Functional Kidney Graft|Transplantation d'îlots pancréatiques allogéniques Adultes Pour le Traitement du diabète insulinodépendant. Etude GRAGIL 1|Terminated||Phase 1/Phase 2|21|Anticipated|University Hospital, Grenoble||1||a new study has began recently|f||||t||||||||||2017-02-18 14:35:56.286303|2017-02-18 14:35:56.286303
NCT00639587|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2009-09-03|||August 2002||2002-08-01|September 2009|2009-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis|A Double-blind, Parallel, Active Comparator Controlled, Randomized Trial; Comparison of the Efficacy and Safety in Children With Perennial Allergic Rhinitis of Cetirizine Tablets Versus Ketotifen Dry Syrup|Completed||Phase 3|149|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 14:35:56.381294|2017-02-18 14:35:56.381294
NCT00639574|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2010-03-26|||March 2008||2008-03-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|November 2008|Actual|2008-11-01||Interventional|||Nefopam and Morphine Consumption in the Treatment of Ureteral Calculi|Interest of Néfopam in the Treatment of Pain During the Intense Ureteral Calculi Uncomplicated in Adults in Emergencies Unit.|Completed||Phase 4|52|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 14:35:56.465407|2017-02-18 14:35:56.465407
NCT00639561|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2009-02-16|||February 2008||2008-02-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|AlimIntest||Calibrated Diets and Human Intestinal Microflora|Effect of Controlled Diets on Structural and Functional Dynamic of the Human Intestinal Microflora|Completed||N/A|20|Actual|University Hospital, Grenoble||2|||f||||f||||||||||2017-02-18 14:35:56.648578|2017-02-18 14:35:56.648578
NCT00639548|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-12|||November 2004||2004-11-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|July 2006|Actual|2006-07-01||Observational|||ERPS, BIS and Entropy for Neuromonitoring in ICU Patients|Auditory Event-Related Potentials, BIS-Index and Entropy for the Discrimination of Different Levels of Sedation in the ICU Patients|Completed||N/A|20|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-02-18 14:35:56.753156|2017-02-18 14:35:56.753156
NCT00639535|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-05-20|||January 2002||2002-01-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Study Comparing the PET Scan and MRI in Identifying Breast Malignancies in Women With Breast Abnormalities|Comparative Study of the Diagnostic Accuracy of Scintimammography (Fluorine 18-FDG PET Scintigraphic Imaging) and Magnetic Resonance Imaging in Identifying Malignant Breast Lesions, In Subjects With Breast Abnormalities|Completed||N/A|56|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:35:56.84007|2017-02-18 14:35:56.84007
NCT00639522|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2009-04-14|||May 2008||2008-05-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma|A Phase I Clinical Trial to Investigate the Maximum Tolerated Dose and Pharmacokinetics of Liposomal Paclitaxel With/Without Capecitabine in Chinese Cancer Patients With Advanced Gastric Carcinoma.|Unknown status|Recruiting|Phase 1|18|Anticipated|Nanjing Sike Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 14:35:56.91582|2017-02-18 14:35:56.91582
NCT00639509|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2014-05-07|2013-09-25||March 2008||2008-03-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||IMC-A12 in Treating Patients With Advanced Liver Cancer|A Phase 2 Study of IMC-A12 (NSC742460) in Hepatocellular Carcinoma|Completed||Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:35:57.019793|2017-02-18 14:35:57.019793
NCT00639496|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2015-03-04|||March 2000||2000-03-01|March 2008|2008-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|IFIGENIA||Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)|Idiopathic Pulmonary Fibrosis International Group Exploring NAC I Annual Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 3|184|Actual|Zambon SpA||2|||f||||t||||||||||2017-02-18 14:35:57.315587|2017-02-18 14:35:57.315587
NCT00639470|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-08-12|||August 2005||2005-08-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|March 2007|Actual|2007-03-01||Interventional|||Parents Reading Comprehension of Their Child's Post-Operative Medicine Fact Sheets|Parents Reading Comprehension of Their Child's Post-Operative Medicine Fact|Completed||N/A|23|Actual|State University of New York - Upstate Medical University||1|||f||||f||||||||||2017-02-18 14:35:57.545758|2017-02-18 14:35:57.545758
NCT00639457|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2013-09-16|2013-05-02||January 2005||2005-01-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Exercise and Pioglitazone for HIV-Metabolic Syndromes|Exercise and Pioglitazone for HIV-Metabolic Syndromes|Completed||N/A|44|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|No intervention and exercise training only control groups were not included. Intracellular mechanisms were not explored. Relatively small number of participants taking a variety of anti-HIV medication regimens.|2|||f||||f||||||||||2017-02-18 14:35:57.652203|2017-02-18 14:35:57.652203
NCT00639444|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2013-12-09|||September 2004||2004-09-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|December 2007|Actual|2007-12-01||Interventional|CELIPREV||Risk of Celiac Disease and Age at Gluten Introduction|Infant Nutrition and Development of Celiac Disease in Genetically At-risk Babies: a Dietary Intervention Study at Weaning|Completed||N/A|703|Actual|Università Politecnica delle Marche||2|||f||||f||||||||||2017-02-18 14:35:58.299761|2017-02-18 14:35:58.299761
NCT00639431|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2014-08-11|||December 2007||2007-12-01|August 2014|2014-08-01|August 2014|Anticipated|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study to Assess the Efficacy of Direct Observation and Mental Visualization of Foot Movements to Treat Bilateral Lower Limb Phantom Limb Pain|Study to Assess the Efficacy of Direct Observation and Mental Visualization of Foot Movements to Treat Bilateral Lower Limb Phantom Limb Pain|Unknown status|Recruiting|N/A|42|Anticipated|Walter Reed Army Medical Center||6|||f||||f||||||||||2017-02-18 14:36:00.838841|2017-02-18 14:36:00.838841
NCT00639418|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2014-09-12|2014-01-10||August 2007||2007-08-01|September 2014|2014-09-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Observational|||A Study to Describe Pediatric Influenza Vaccine Coverage|An Observational Study to Describe Pediatric Influenza Vaccine Coverage Among Pediatricians in the United States|Completed||Phase 4|147494|Actual|MedImmune LLC|||4||f||||f||||||||||2017-02-18 14:36:00.966704|2017-02-18 14:36:00.966704
NCT00639405|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2011-04-26|||September 2005||2005-09-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas|Localization of Parathyroid Adenomas Using MRI and SPECT Fusion Software in Patients With Persistent or Recurrent Hyperparathyroidism|Terminated||N/A|12|Actual|State University of New York - Upstate Medical University|||1|Subject population not available.|f||||f||||||||||2017-02-18 14:36:01.857083|2017-02-18 14:36:01.857083
NCT00639392|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2011-11-10|||June 2007||2007-06-01|November 2011|2011-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Phase 1 Study of Zoledronic Acid in Sickle Cell Disease|Phase 1 Study of Zoledronic Acid in Sickle Cell Disease|Withdrawn||Phase 1/Phase 2|0|Actual|Virginia Commonwealth University||2||Ended early due to inability to identify eligible subjects|f||||t||||||||||2017-02-18 14:36:01.937673|2017-02-18 14:36:01.937673
NCT00639379|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2015-05-05|2010-06-18||February 2008||2008-02-01|May 2015|2015-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Two Toric Contact Lenses on Current Toric Wearers|A Multi-Center, Subject Masked, Randomized, Two Week Crossover Design, Investigation of the Acuvue Cypress Toric Silicone Hydrogel Lens Compared to the Bausch & Lomb SofLens66® Toric Hydrophilic Lens|Completed||N/A|89|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:36:02.039462|2017-02-18 14:36:02.039462
NCT00639366|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-19|2013-08-06|||February 2007||2007-02-01|December 2008|2008-12-01|October 2010|Actual|2010-10-01|February 2010|Actual|2010-02-01||Interventional|||Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer|Prospective Randomised Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated With Trastuzumab (Herceptin®) for Metastatic Breast Cancer|Completed||Phase 3|390|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:36:02.364233|2017-02-18 14:36:02.364233
NCT00639353|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2014-10-28|||February 2008||2008-02-01|October 2014|2014-10-01||||June 2008|Actual|2008-06-01||Interventional|||Silicone Hydrogel Contact Lenses on Low Astigmatism in Japan|The Clinical Performance of the Silicone Hydrogel Contact Lens on Low to Moderate Astigmatism in Japan|Terminated||N/A|102|Actual|Johnson & Johnson Vision Care, Inc.||2||"English to Japanese translation issues caused enrollment of incorrect and unqualified~   subjects; error applied to all subjects enrolled prior to termination."|f||||f||||||||||2017-02-18 14:36:02.471466|2017-02-18 14:36:02.471466
NCT00639340|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2010-02-22|||October 2001||2001-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:36:02.572099|2017-02-18 14:36:02.572099
NCT00639327|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2011-06-27|||March 2008||2008-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer|Randomized Phase II/III Trial of Second Line Chemotherapy Comparing CPT-11 Monotherapy Versus S-1/CPT-11 Combination for S-1 Refractory Gastric Cancer|Completed||Phase 2/Phase 3|300|Anticipated|Japan Clinical Cancer Research Organization||2|||f||||t||||||||||2017-02-18 14:36:02.832748|2017-02-18 14:36:02.832748
NCT00639314|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2011-06-23|||October 2005||2005-10-01|January 2010|2010-01-01|March 2011|Actual|2011-03-01|May 2009|Actual|2009-05-01||Interventional|||Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy|Randomized Controlled Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy|Completed||N/A|130|Anticipated|Wakayama Medical University||2|||f||||t||||||||||2017-02-18 14:36:03.045111|2017-02-18 14:36:03.045111
NCT00639301|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2016-11-14|||March 2008||2008-03-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life|Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life|Active, not recruiting||N/A|473|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:36:03.158151|2017-02-18 14:36:03.158151
NCT00639288|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2016-03-18|||March 2008||2008-03-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional|||Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence|Modification of Cognitive Processing Therapy (CPT-C) for Posttraumatic Stress Disorder (PTSD) and Alcohol Dependence (AD)|Completed||Phase 2/Phase 3|9|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:36:03.265993|2017-02-18 14:36:03.265993
NCT00639275|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2013-01-08|||June 2008||2008-06-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|SCPDig||Deep Brain Stimulation and Digestive Symptomatology|Effects of Subthalamic Nucleus Deep Brain Stimulation on Gastrointestinal Symptoms and Motility in Parkinson's Disease.|Completed||N/A|14|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-02-18 14:36:03.376262|2017-02-18 14:36:03.376262
NCT00639262|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2016-10-19|||March 2008||2008-03-01|October 2016|2016-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors|Phase I Study of the Combination of Sorafenib and Radiation Therapy -/+ Temozolomide for the Treatment of Patients With Brain Metastases and Primary Brain Tumors|Completed||Phase 1|35|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 14:36:03.451069|2017-02-18 14:36:03.451069
NCT00639249|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2009-07-28|||February 2008||2008-02-01|July 2009|2009-07-01||||June 2009|Actual|2009-06-01||Interventional|||Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke|A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Phase IIa Study of Safety and Motor Function Restoration in Subjects Treated With SA4503 Following Acute Ischemic Stroke|Completed||Phase 2|60|Actual|M's Science Corporation||3|||f||||t||||||||||2017-02-18 14:36:03.573612|2017-02-18 14:36:03.573612
NCT00639236|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2008-03-19|||May 2004||2004-05-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|September 2004|Actual|2004-09-01||Interventional|||Effectiveness and Safety of Inhaling Hypertonic Saline in Patients With Chronic Obstructive Pulmonary Disease|Effectiveness and Safety of Inhaling Hypertonic Saline in the Functional Exercise Capacity of Patients With Chronic Obstructive Pulmonary Disease: a Randomized Trial|Completed||Phase 4|68|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 14:36:03.677128|2017-02-18 14:36:03.677128
NCT00639223|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2009-12-09|2009-12-09||January 2008||2008-01-01|December 2009|2009-12-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance|Red Yeast Rice vs. Pravastatin: A Double-Blind Randomized Comparative Study of Myopathic Symptoms|Completed||Phase 2|43|Actual|University of Pennsylvania|Small sample size precluded definitive conclusions.|2|||f||||t||||||||||2017-02-18 14:36:03.766135|2017-02-18 14:36:03.766135
NCT00639210|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2008-03-19|||September 2005||2005-09-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|BREX||BREAST CANCER AND EXERCISE|BREAST CANCER AND EXERCISE BREX: A Multicenter Phase III Open Randomised Trial of the Efficacy of Exercise in the Prevention of Long-Term Adverse Effects of Adjuvant Treatments and Breast Cancer Recurrences in Women With Primary Breast Cancer.|Completed||Phase 3|573|Actual|Finnish Breast Cancer Group||2|||f||||t||||||||||2017-02-18 14:36:04.195049|2017-02-18 14:36:04.195049
NCT00639197|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-04-10|||March 2008||2008-03-01|March 2008|2008-03-01||||June 2008|Anticipated|2008-06-01||Interventional|UGIST||UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling|UGIST Pilot Trial: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling. Does it Reduce the Technical Difficulty and Mechanical Complications?|Unknown status|Recruiting|N/A|20|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 14:36:04.308303|2017-02-18 14:36:04.308303
NCT00639184|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2014-07-29|||June 2007||2007-06-01|July 2014|2014-07-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|BRAIN-HIT||BRAIN - Home Intervention Trial|Brain Research to Ameliorate Impaired Neurodevelopment (BRAIN): Home-based Intervention A Multicenter Trial of the Global Network for Women's and Children's Health Research|Completed||Phase 4|240|Anticipated|NICHD Global Network for Women's and Children's Health||2|||f||||t||||||||||2017-02-18 14:36:04.414301|2017-02-18 14:36:04.414301
NCT00639171|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-12-02|||November 2005||2005-11-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant|Clinical Implementation and Evaluation of MR Spectroscopy for Breast Cancer Detection|Completed||N/A|13|Actual|State University of New York - Upstate Medical University|||2||f||||f||||||||||2017-02-18 14:36:04.517461|2017-02-18 14:36:04.517461
NCT00639158|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2011-06-09|2009-10-02||February 2008||2008-02-01|June 2011|2011-06-01||||October 2008|Actual|2008-10-01||Interventional|||Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood|A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Combined (Atherogenic) Dyslipidemia|Completed||Phase 3|543|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:36:04.612904|2017-02-18 14:36:04.612904
NCT00639145|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2013-08-13|||September 2010||2010-09-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|MEP Project||Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol|Maternal Events and Pregnancy Outcomes in a Cohort of Human Immunodeficiency Virus‐Infected Women Receiving Antiretroviral Therapy in Sub‐ Saharan Africa|Completed||N/A|600|Actual|Elizabeth Glaser Pediatric AIDS Foundation|||1||f||||f||||||||||2017-02-18 14:36:05.495685|2017-02-18 14:36:05.495685
NCT00639132|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2017-02-14|||January 2012||2012-01-01|February 2017|2017-02-01|January 2026|Anticipated|2026-01-01|January 2021|Anticipated|2021-01-01||Observational|NH-US||The Natural History of Metachromatic Leukodystrophy|The Natural History of Metachromatic Leukodystrophy|Active, not recruiting||N/A|10|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"~     blood, CSF and urine~   "|||2017-02-18 14:36:05.592933|2017-02-18 14:36:05.592933
NCT00639119|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-03-18|||August 2007||2007-08-01|February 2008|2008-02-01||||August 2008|Anticipated|2008-08-01||Interventional|||Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type|Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type|Unknown status|Enrolling by invitation|Phase 2|16|Anticipated|University of Turku||1|||f||||f||||||||||2017-02-18 14:36:05.689519|2017-02-18 14:36:05.689519
NCT00639106|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-04-28|||March 2008||2008-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial|The Use of Alloderm in Two-Stage, Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial|Active, not recruiting||Phase 3|98|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:36:05.774397|2017-02-18 14:36:05.774397
NCT00639054|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-01-06|||March 2008||2008-03-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|MM-FISH/DNA||The Molecular Characterization of Multiple Myeloma at Relapse|The Molecular Characterization of Multiple Myeloma at Relapse|Completed||N/A|134|Actual|Rigshospitalet, Denmark|||3||f||||f||||||Samples With DNA|"~     Peripheral whole blood Bone marrow~   "|||2017-02-18 14:36:06.461648|2017-02-18 14:36:06.461648
NCT00639041|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2011-09-21|||April 2006||2006-04-01|February 2008|2008-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Changes in Blood Lipids After Long-term Consumption of n-3 LC-PUFA-Enriched Dairy Products|Changes in Blood Lipids After Long Time Consumption of n-3 LC-PUFA-enriched Dairy Products in Hypertriglyceridemic Patients: a Randomized, Double-blind, Cross-over Study|Completed||N/A|51|Actual|University of Jena||2|||f||||t||||||||||2017-02-18 14:36:06.587633|2017-02-18 14:36:06.587633
NCT00639028|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2014-01-22|||November 2007||2007-11-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|TALOS||Comparative Study of Two Radiological Modalities, Ultrasonography Versus Stress Radiography, in the Urgent Care and Prognosis of Lateral Ankle Sprain (TALOS)|Comparative Study of Two Radiological Modalities, Ultrasonography Versus Stress Radiography, in the Urgent Care and Prognosis of Lateral Ankle Sprains.|Completed||N/A|390|Anticipated|University Hospital, Grenoble||3|||f||||t||||||||||2017-02-18 14:36:06.698773|2017-02-18 14:36:06.698773
NCT00639015|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-08-15|||November 2007||2007-11-01|March 2008|2008-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Phenylephrine in Septic Shock|Phenylephrine Versus Norepinephrine in Septic Shock: Effects on Systemic and Regional Hemodynamics. A Randomized, Controlled, Trial|Completed||Phase 2|32|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-02-18 14:36:06.810495|2017-02-18 14:36:06.810495
NCT00639002|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-06-05|2011-12-16||March 2008||2008-03-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma|A Phase 2, Two Stage, Open-label, Clinical Trial to Determine the Therapeutic Effect and Safety of an Oral JAK2-inhibitor (INCB018424) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|13|Actual|Incyte Corporation||1|||f||||f||||||||||2017-02-18 14:36:06.923488|2017-02-18 14:36:06.923488
NCT00638989|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2009-03-05|||March 2008||2008-03-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Assess Bioavailability and Pharmacokinetics of CAT 354|An Open-Label, Parallel-Group, Bioavailability Study to Assess the Pharmacokinetics of CAT-354 Following Subcutaneous and Intravenous Administration|Completed||Phase 1|30|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 14:36:07.394935|2017-02-18 14:36:07.394935
NCT00638976|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2010-05-27|||November 2007||2007-11-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|INSTANT||INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial|INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial|Completed||Phase 3|91|Actual|Fondazione Mediolanum per Attività e Ricerche Cardiovascolari Onlus||2|||f||||t||||||||||2017-02-18 14:36:07.489693|2017-02-18 14:36:07.489693
NCT00638963|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2015-01-19|2011-06-23||October 2008||2008-10-01|January 2015|2015-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|STOP||Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)|Temozolomide in Metastatic Breast Cancer Patients at High Risk of Brain Recurrence: Impact on the Incidence of Brain Metastases (STOP)|Terminated||Phase 2|6|Actual|Merck Sharp & Dohme Corp.|The primary outcome measure and the survival analyses could not be analyzed due to the low enrollment.|2||Terminated due to poor accrual|f||||f||||||||||2017-02-18 14:36:07.587048|2017-02-18 14:36:07.587048
NCT00638950|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2011-09-21|||September 2004||2004-09-01|February 2008|2008-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products in Patients With Rheumatoid Arthritis|Long-term Moderate Intervention With n-3 LC-PUFA-supplemented Dairy Products: Effects on Pathophysiological Biomarkers in Rheumatoid Arthritis|Completed||N/A|45|Actual|University of Jena||2|||f||||t||||||||||2017-02-18 14:36:08.027554|2017-02-18 14:36:08.027554
NCT00638937|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2015-06-22|2014-08-28||February 2008||2008-02-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy|A Phase 2 Study of AZD0530 in Patients With Advanced, Recurrent Non-Small Cell Lung Cancer Who Have Previously Received Platinum-Based Combination Chemotherapy|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:36:08.349668|2017-02-18 14:36:08.349668
NCT00638924|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-06-13|2012-05-06||December 2007||2007-12-01|June 2012|2012-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Physiologic Variables in Healthy Women in Shuttle Walk Test|Analysis of Physiologic Variables in Healthy Women in Shuttle Walk Test|Completed||N/A|40|Actual|University of Campinas, Brazil|Small number of subjects, only females were analyzed making generalization impossible.||1||f||||f||||||||||2017-02-18 14:36:08.679638|2017-02-18 14:36:08.679638
NCT00638911|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2012-05-18|||September 2004||2004-09-01|May 2012|2012-05-01||||October 2009|Actual|2009-10-01||Observational|||Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension|PMS Assessing the Safety and Efficacy of Telmisartan in Patients With Mild-to-moderate Essential Hypertension|Completed||N/A|33247|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:36:08.922078|2017-02-18 14:36:08.922078
NCT00638898|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-18|2016-11-04|||December 2006||2006-12-01|November 2016|2016-11-01||||April 2019|Anticipated|2019-04-01||Interventional|||Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor|Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors|Active, not recruiting||N/A|25|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:36:09.007208|2017-02-18 14:36:09.007208
NCT00638885|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-01-08|2015-01-08||April 2010||2010-04-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Observational||Vietnam veteran twins with and without PTSD.|Memory and the Hippocampus in Twins|Memory and the Hippocampus in Vietnam Twins With PTSD|Completed||N/A|142|Actual|VA Office of Research and Development|||1||f||||t||||||Samples With DNA|"~     blood for genetic testing, blood samples and urine and saliva collections~   "|||2017-02-18 14:36:09.148743|2017-02-18 14:36:09.148743
NCT00638872|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-09-10|||October 2007||2007-10-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers|Diabetic Foot Ulcers and Use of PDRN (Polydeoxyribonucleotide -Placentex Mastelli) as a Treatment for Wound Healing.|Completed||Phase 4|215|Actual|University of Messina||2|||f||||t||||||||||2017-02-18 14:36:09.369764|2017-02-18 14:36:09.369764
NCT00638859|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2009-10-01|||March 2004||2004-03-01|October 2009|2009-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia|Evaluation of the Safety, Pharmacokinetics, Efficacy, and Acceptability of HMR3647 20 mg/kg qd for 5-7 Days With Community-Acquired Pneumonia (CAP) in Children (Multicenter, Open Label, Noncomparative Study)|Completed||Phase 3|56|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:36:09.481844|2017-02-18 14:36:09.481844
NCT00638846|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2015-05-05|2010-06-18||February 2008||2008-02-01|May 2015|2015-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Performance of Two Silicone Hydrogel Toric Contact Lenses|Multi-Center Evaluation Of Two Silicone Hydrogel Toric Contact Lenses|Completed||N/A|276|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:36:09.583152|2017-02-18 14:36:09.583152
NCT00638833|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-06-07|||September 2007||2007-09-01|June 2012|2012-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Memantine-MS||Memantine Therapy for Multiple Sclerosis|Pilot Clinical Trial With Memantine for Cognitive Deficits in Patients With Multiple Sclerosis|Terminated||Phase 2|20|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2||Unexpected side-effects: reversible and mild to moderate neurological impairment|f||||f||||||||||2017-02-18 14:36:09.999326|2017-02-18 14:36:09.999326
NCT00638820|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-02-22|2009-08-26||September 2007||2007-09-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Reduced Intensity AlloTransplant For Osteopetrosis|Reduced Intensity Allogeneic Transplantation For Severe Osteopetrosis Incorporating A Second Cd34 Selected Graft|Terminated||Phase 2|3|Actual|Masonic Cancer Center, University of Minnesota|Only 3 participants were treated in this study; all died by Day 100. Data for both treatment arms were combined due to low number. (Arm 1 utilized mobilized peripheral blood or marrow (related or unrelated). Arm 2 received cord blood transplants).|1||Excess toxicity|f||||t||||||||||2017-02-18 14:36:10.120185|2017-02-18 14:36:10.120185
NCT00638807|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2009-03-12|||December 2003||2003-12-01|March 2009|2009-03-01|July 2004|Actual|2004-07-01|||||Interventional|||Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen|A Double-Blind, Placebo Controlled Study of the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee Non-Responsive to Naproxen and Ibuprofen|Completed||Phase 4|388|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:36:10.404592|2017-02-18 14:36:10.404592
NCT00638794|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-01-22|||January 2008||2008-01-01|August 2012|2012-08-01|January 2013|Actual|2013-01-01|December 2011|Actual|2011-12-01||Observational|ADAPT-DES||Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents|Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents|Completed||N/A|8575|Actual|Cardiovascular Research Foundation, New York|||2||f||||f||||||||||2017-02-18 14:36:10.541281|2017-02-18 14:36:10.541281
NCT00638781|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-12|||March 2001||2001-03-01|March 2008|2008-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Desmoteplase in Acute Ischemic Stroke (DIAS)|Multicentre, Multinational, Double-Blind, Placebo-Controlled, Randomised Phase II Trial of Desmoteplase (INN) in the Indication of Acute Ischaemic Stroke|Completed||Phase 2|104|Actual|PAION Deutschland GmbH||4|||f||||t||||||||||2017-02-18 14:36:10.656204|2017-02-18 14:36:10.656204
NCT00638768|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-12|||February 2006||2006-02-01|March 2008|2008-03-01||||||||Interventional|||Effectiveness of Physiotherapy for Osteoporotic Spinal Fracture|Effectiveness of Physiotherapy for Vertebral Osteoporotic Fracture: a Randomised Controlled Pilot Trial|Completed||Phase 2|20|Actual|University of Melbourne||2|||f||||f||||||||||2017-02-18 14:36:10.770431|2017-02-18 14:36:10.770431
NCT00638755|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2010-08-17||2010-08-17|February 2008||2008-02-01|August 2010|2010-08-01|July 2008||2008-07-01|May 2008|Actual|2008-05-01||Interventional|||The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis|A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Evaluate the Effect of Nasal Carbon Dioxide on Nasal Congestion Via Acoustic Rhinometry in Subjects With Perennial Allergic Rhinitis|Completed||Phase 2|20|Actual|Capnia, Inc.||4|||f||||f||||||||||2017-02-18 14:36:10.862983|2017-02-18 14:36:10.862983
NCT00638742|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-12-29|||May 2008||2008-05-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.|A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost 0.005%.|Completed||Phase 1|47|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:36:10.968084|2017-02-18 14:36:10.968084
NCT00638729|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-18|||August 2005||2005-08-01|February 2008|2008-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Clonidine Versus Midazolam for Premedication|Effects of Clonidine and Midazolam Premedication on Bispectral Index and Recovery After Elective Surgery|Completed||N/A|60|Actual|University of Schleswig-Holstein||3|||f||||f||||||||||2017-02-18 14:36:11.08592|2017-02-18 14:36:11.08592
NCT00638716|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2008-11-18|||February 2008||2008-02-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|DM200-101||A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase II Study to Evaluate the Efficacy and Safety of 3 Months of Weekly Injections of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus on Metformin Monotherapy|Completed||Phase 2|90|Anticipated|ConjuChem||3|||f||||t||||||||||2017-02-18 14:36:11.197783|2017-02-18 14:36:11.197783
NCT00638703|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2013-05-07||2013-05-07|October 2007||2007-10-01|June 2011|2011-06-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|PHOENIX||Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients|A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multi-center, International Study to Evaluate the Efficacy and Safety of OxabactTM to Reduce Urinary Oxalate in Subjects With Primary Hyperoxaluria|Completed||Phase 2/Phase 3|43|Actual|OxThera||2|||f||||f||||||||||2017-02-18 14:36:11.296338|2017-02-18 14:36:11.296338
NCT00638690|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2014-04-10|2011-08-23||May 2008||2008-05-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|August 2010|Actual|2010-08-01||Interventional|||Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy|Completed||Phase 3|1195|Actual|Cougar Biotechnology, Inc.||2|||f||||t||||||||||2017-02-18 14:36:11.417933|2017-02-18 14:36:11.417933
NCT00638677|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2013-01-07|||June 2004||2004-06-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier|Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier|Completed||Phase 4|106|Actual|University of Turku||3|||f||||t||||||||||2017-02-18 14:36:13.659546|2017-02-18 14:36:13.659546
NCT00638664|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2015-05-20|||May 1995||1995-05-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Evaluation of the MRI in Measuring the Cardiac Chambers and Thoracic Great Vessels|Optimized MRI Evaluation of Maximal Temporal and Spatial Measurability of the Cardiac Chambers and Thoracic Great Vessels. A Comparison of MR Acquisition Pulse Sequences.|Completed||N/A|31|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:36:13.791035|2017-02-18 14:36:13.791035
NCT00638651|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2014-08-20|2014-08-20||February 2008||2008-02-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal|Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal|Completed||Phase 1|12|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 14:36:13.875968|2017-02-18 14:36:13.875968
NCT00638638|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-09-16|||January 2005||2005-01-01|September 2009|2009-09-01|January 2010|Anticipated|2010-01-01|August 2009|Anticipated|2009-08-01||Interventional|MISTRAL||Myocardial Infarction With ST-Elevation|Myocardial Infarction With ST-elevation Treated by Primary Percutaneous Intervention Facilitated by Early Reopro Administration in Alsace.|Unknown status|Active, not recruiting|Phase 3|292|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 14:36:14.20547|2017-02-18 14:36:14.20547
NCT00638625|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-05-12|||January 2010||2010-01-01|May 2015|2015-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Correlation of X-ray and Pathology With Needle Biopsy of Lung Tumors|Pilot Study of Radiologic-Pathologic Correlation in Lung Tumors Based on Core Needle Biopsy|Withdrawn||N/A|0|Actual|State University of New York - Upstate Medical University|||1|Due to specimen collection difficulties; this study has been terminated|f||||f||||||||||2017-02-18 14:36:14.310594|2017-02-18 14:36:14.310594
NCT00638612|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2015-10-28|||August 2008||2008-08-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|May 2013|Actual|2013-05-01||Interventional|PaTK01||AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)|AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas Cancer|Completed||Phase 1|27|Actual|Advantagene, Inc.||2|||f||||t||||||||||2017-02-18 14:36:14.394263|2017-02-18 14:36:14.394263
NCT00638599|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-07-14|||January 2008||2008-01-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|LMATBBC||Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer|Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube for Airway Management in Modified Radical Mastectomy on Breast Cancer|Completed||Phase 4|200|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 14:36:14.5087|2017-02-18 14:36:14.5087
NCT00638586|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-12|||April 2008||2008-04-01|March 2008|2008-03-01||||||||Observational|||Comparison of Patients Undergoing Radial or Femoral Arterial Access for Percutaneous Catheterization-Nursing Aspects||Unknown status|Not yet recruiting|N/A|160|Anticipated|Hillel Yaffe Medical Center|||2||f||||||||||||||2017-02-18 14:36:14.613938|2017-02-18 14:36:14.613938
NCT00638573|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-01-12|||January 2006||2006-01-01|March 2008|2008-03-01|July 2006||2006-07-01|||||Observational|||The Incretin Effect in Patients With Chronic Pancreatitis|The Incretin Effect in Patients With Chronic Pancreatitis With and Without Secondary Diabetes Mellitus|Completed||N/A|32|Actual|University Hospital, Gentofte, Copenhagen|||4||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 14:36:14.680815|2017-02-18 14:36:14.680815
NCT00638560|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-01-19|||March 2008||2008-03-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Changes of Biomarkers in Response to Training and Antioxidant Treatment|Effects of Training and Antioxidant Treatment on Circulating Markers of Oxidative Stress and Skeletal Muscle mRNA Expression|Completed||Phase 1|40|Actual|University of Leipzig||2|||f||||f||||||||||2017-02-18 14:36:14.76062|2017-02-18 14:36:14.76062
NCT00638547|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-01-22|||January 2008||2008-01-01|January 2016|2016-01-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Intrathecal Enzyme Replacement for Hurler Syndrome|Intrathecal Enzyme Replacement Therapy For Patients With Mucopolysaccharidosis Type I (Hurler Syndrome)|Active, not recruiting||Phase 1|25|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:36:17.264196|2017-02-18 14:36:17.264196
NCT00638534|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2009-10-01|||February 2004||2004-02-01|October 2009|2009-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media|Evaluation of the Safety, Efficacy, Pharmacokinetics, and Acceptability of HMR3647 20 mg/kg qd for 5 Days With Acute Otitis Media (AOM) in Children (Multicenter, Open Label, Non Comparative Study)|Completed||Phase 3|56|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:36:17.386315|2017-02-18 14:36:17.386315
NCT00638521|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2013-12-10|||June 2008||2008-06-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|August 2012|Actual|2012-08-01||Observational|||Immune-cell Membrane Trafficking|Trauma and Sepsis Induced Changes in Immune-cell Membrane Receptor Trafficking|Completed||N/A|213|Actual|University of Washington|||1||f||||f||||||Samples Without DNA|"~     whole blood~   "|||2017-02-18 14:36:17.471002|2017-02-18 14:36:17.471002
NCT00638508|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-18|||June 2007||2007-06-01|March 2008|2008-03-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||ON-Q Pump Infusion of Ketorolac and Ropivacaine at the Wound Site for Postoperative Pain Management|The Analgesic Efficacy of Continuous Infusion of Ketorolac and Ropivacaine at the Wound Site Using ON-Q Pump for Postoperative Pain Management|Unknown status|Recruiting|N/A|70|Anticipated|Maimonides Medical Center||2|||f||||t||||||||||2017-02-18 14:36:17.545366|2017-02-18 14:36:17.545366
NCT00468156|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2012-12-19|||September 2006||2006-09-01|November 2008|2008-11-01|June 2008|Actual|2008-06-01|September 2007|Actual|2007-09-01||Interventional|||The Fruit and Vegetable Study|Implementation Intentions for Improving Fruit and Vegetable Intakes|Completed||N/A|97|Actual|University of Michigan||3|||f||||t||||||||||2017-02-18 15:39:22.877891|2017-02-18 15:39:22.877891
NCT00638495|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-01-28|||March 2008||2008-03-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase II Study of TRK-820 Soft Capsules — Intractable Pruritus in Patients With Chronic Liver Disease —|Phase II Study of TRK-820 Soft Capsules — Intractable Pruritus in Patients With Chronic Liver Disease —|Completed||Phase 2|120|Anticipated|Toray Industries, Inc||2|||f||||f||||||||||2017-02-18 14:36:17.647432|2017-02-18 14:36:17.647432
NCT00638482|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-17|||July 2003||2003-07-01|July 2003|2003-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|DESY||Dose-Dependent Effect of Thiazide in Dent's Disease Hypercalciuria|Pharmacodynamic Evaluation of the ANTICALCIURIC Effect of Hydrochlorothiazide in Dent's Disease|Terminated||Phase 2/Phase 3|10|Actual|Assistance Publique - Hôpitaux de Paris||1||terminated|f||||f||||||||||2017-02-18 14:36:17.737969|2017-02-18 14:36:17.737969
NCT00638469|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2013-10-31|||March 2008||2008-03-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis|Prospective, Randomized Half-side Study on the Efficacy of UVB-311nm Phototherapy in Patients With Psoriasis After Partial Remission to Treatment With Adalimumab|Unknown status|Recruiting|N/A|10|Anticipated|Medical University of Graz||1|||f||||f||||||||||2017-02-18 14:36:17.849101|2017-02-18 14:36:17.849101
NCT00638456|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2009-09-09|||February 2008||2008-02-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis|Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis, a Randomized Clinical Trial|Completed||Phase 2|33|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 14:36:17.960843|2017-02-18 14:36:17.960843
NCT00638443|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-05-11|2012-07-09||March 2008||2008-03-01|May 2016|2016-05-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|LUSTOR||Lumbar Stenosis Outcomes Research (LUSTOR)|Lumbar Stenosis Outcomes Research (LUSTOR)- A Randomized, Double-blind, Cross-over Trial of Pregabalin vs. Diphenhydramine in Patients With Lumbar Spinal Stenosis and Neuropathic Low Back Pain|Completed||Phase 4|29|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 14:36:18.077704|2017-02-18 14:36:18.077704
NCT00638430|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-12|||March 2007||2007-03-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Observational|||The Effect of Myopic Optical Defocus on the Humphrey Matrix 30-2 Test|The Effect of Myopic Optical Defocus on the Humphrey Matrix 30-2 Test|Completed||N/A|40|Actual|Samsung Medical Center|||2||f||||f||||||||||2017-02-18 14:36:18.786618|2017-02-18 14:36:18.786618
NCT00638417|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-07-15|||January 2006||2006-01-01|July 2016|2016-07-01|November 2007|Actual|2007-11-01|March 2006|Actual|2006-03-01||Interventional|||Treatment and Rehabilitation of Patients With Hip Arthroplasty to Regain Walk and Work Efficiency and Quality of Life|Treatment and Rehabilitation of Patients With Hip Arthroplasty to Regain Walk and Work Efficiency and Quality of Life|Completed||Phase 2|24|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 14:36:18.897116|2017-02-18 14:36:18.897116
NCT00638404|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-02-01|||August 2007||2007-08-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Severity Postoperative Pain Prediction|Predicting Severity of Postoperative Pain After Surgery|Terminated||N/A|300|Actual|Wake Forest University Health Sciences|||2|"Further evaluation determined it was not feasible to enroll the post-partum tubal ligation~   group at our facility"|f||||t||||||||||2017-02-18 14:36:18.983525|2017-02-18 14:36:18.983525
NCT00638391|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-13|2008-03-19|||May 2005||2005-05-01|March 2008|2008-03-01|March 2007|Actual|2007-03-01|||||Observational|Ax-003||Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer|Postmenopausal Women With Early Hormone-Receptor Positive Breast Cancer/no Metastasis|Completed||N/A|1600|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:36:19.080655|2017-02-18 14:36:19.080655
NCT00638378|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-01-20|2011-12-15||February 2008||2008-02-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer|A Phase 2, Open-Label Study of INCB018424 Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer|Terminated||Phase 2|22|Actual|Incyte Corporation||1||"According to the protocol, the sponsor terminated the study after it was determined that less~   than 2 of the first 22 patients showed a PSA50 response."|f||||f||||||||||2017-02-18 14:36:19.194013|2017-02-18 14:36:19.194013
NCT00638365|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2014-06-04|2011-07-12||March 2008||2008-03-01|June 2014|2014-06-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa|A Phase I/II Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa|Completed||Phase 1/Phase 2|27|Actual|KaloBios Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:36:19.492649|2017-02-18 14:36:19.492649
NCT00638352|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-07-15|||June 2006||2006-06-01|July 2016|2016-07-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Observational|||False/Negative Rate of Lung Percutaneous Needle Biopsy|Determination of the False Negative Rate of Percutaneous Needle Biopsies That Include Core Tissue Samples|Completed||N/A|5|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||No||2017-02-18 14:36:20.018036|2017-02-18 14:36:20.018036
NCT00638339|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2017-01-19|||November 2006|Actual|2006-11-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2013|Actual|2013-12-01||Observational|||Effects Of Invasive And Noninvasive Mechanical Ventilation On Sleep In The Intensive Care Unit (ICU)|Effects Of Invasive And Noninvasive Mechanical Ventilation On Sleep In The Icu|Active, not recruiting||N/A|20|Anticipated|Tufts Medical Center|||2||f||||f||||||||No||2017-02-18 14:36:20.105396|2017-02-18 14:36:20.105396
NCT00638326|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2010-03-20|||March 2008||2008-03-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|DOSER||Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity|150 mg Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity After Elective Percutaneous Coronary Intervention|Terminated||Phase 3|500|Anticipated|University of Pecs||3||Greater differences between randomized patients than previously anticipated|f||||t||||||||||2017-02-18 14:36:20.196094|2017-02-18 14:36:20.196094
NCT00638313|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2009-07-30|||August 2007||2007-08-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|||||Interventional|||Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects|A Phase 1, Placebo-Controlled, Randomized Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Following Single, Escalating Subcutaneous Doses Of PF-04603629 In Type 2 Diabetic Adult Subjects|Completed||Phase 1|71|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:36:20.304271|2017-02-18 14:36:20.304271
NCT00638300|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-07-11|||March 2008||2008-03-01|March 2008|2008-03-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|||Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD)|Removal of Ligand-bound Iron During Intravenous Iron Administration in Hemodialysis by Large Pore Dialyzers|Completed||N/A|25|Actual|Soroka University Medical Center||6|||f||||f||||||||||2017-02-18 14:36:20.62897|2017-02-18 14:36:20.62897
NCT00638287|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-10-03|||November 2007||2007-11-01|September 2008|2008-09-01|January 2011|Anticipated|2011-01-01|||||Observational|||Inter-Assay Growth Hormone and IGF-I Variability|Inter-Assay Growth Hormone and IGF-I Variability|Withdrawn||N/A|171|Anticipated|Cedars-Sinai Medical Center|||3||f||||f||||||Samples With DNA|"~     1. Group I Growth Hormone Deficiency (GHD): subjects with pituitary disease undergoing~          testing for GH deficiency: GHRH-ARG Test, collect total of 84 cc whole blood.~        2. Group II Acromegaly: subjects with suspicion for (or diagnosis of) acromegaly~          undergoing OGTT Test, collect total of 48 cc whole blood.~        3. Group III Normal Controls: subjects without evidence of pituitary dysfunction~          undergoing OGTT Test, collect total of 136 cc whole blood.~   "|||2017-02-18 14:36:20.750935|2017-02-18 14:36:20.750935
NCT00638274|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2017-02-07|||July 2005||2005-07-01|February 2017|2017-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Comparison of Loss of Resistance Techniques|Comparison of Loss of Resistance Technique With Air Versus Saline to Identify Epidural Space for Combined Spinal Epidural Labor Analgesia|Completed||N/A|350|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 14:36:20.834965|2017-02-18 14:36:20.834965
NCT00638261|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-03-15|||March 2008||2008-03-01|March 2012|2012-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Primary UVB-311nm and Adalimumab in Psoriasis Patients|Adalimumab in Primary Combination With UVB-311nm Half-side Phototherapy in Patients With Psoriasis|Completed||N/A|4|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 14:36:20.933458|2017-02-18 14:36:20.933458
NCT00638248|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-12|||March 2003||2003-03-01|March 2008|2008-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|DEDAS||Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)|International, Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase I/II Trial of Desmoteplase in the Indication of Acute Ischemic Stroke|Completed||Phase 1/Phase 2|38|Actual|PAION Deutschland GmbH||3|||f||||t||||||||||2017-02-18 14:36:21.048278|2017-02-18 14:36:21.048278
NCT00638235|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-09-06|2016-09-06||May 2006||2006-05-01|September 2016|2016-09-01|September 2012|Actual|2012-09-01|February 2011|Actual|2011-02-01||Observational|PROPEL||Pelvic Floor Repair Systems for Prolapse Repair|A Prospective, Multi-Center Study to Assess the AMS Pelvic Floor Repair System Devices for Prolapse Repair|Completed||N/A|725|Actual|ASTORA Women's Health|"Ph- II ended before all subjects reached 24M visit b/c the next generation of Perigee was already under trial, Ph-III/IV~Ph-VI ended after 12M visit because the next generation of study device was already under clinical evaluation in Phase VII"||9||f||||f||||||||No||2017-02-18 14:36:21.183036|2017-02-18 14:36:21.183036
NCT00638222|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2014-11-05|2014-07-08||May 2008||2008-05-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease|Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease|Terminated||N/A|6|Actual|University of Toledo Health Science Campus|Early termination due to poor enrollment leading to small number of subjects to be analyzed.|1||Poor enrollment|f||||t||||||||||2017-02-18 14:36:25.739578|2017-02-18 14:36:25.739578
NCT00638209|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2008-03-18|||February 2008||2008-02-01|March 2008|2008-03-01||||May 2010|Anticipated|2010-05-01||Interventional|||Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2|Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Typ 2|Unknown status|Recruiting|N/A|42|Anticipated|University Hospital Tuebingen||2|||f||||f||||||||||2017-02-18 14:36:26.137176|2017-02-18 14:36:26.137176
NCT00638196|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2015-08-07|||March 2008||2008-03-01|August 2015|2015-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PLACATE-MS||Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS|Phase II Study of Linoleic Acid in Relapsing Multiple Sclerosis|Terminated||Phase 1|9|Actual|University of Rochester||1||funding stopped due to slow enrollment.|f||||t||||||||||2017-02-18 14:36:26.230625|2017-02-18 14:36:26.230625
NCT00638183|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2014-06-18|2010-01-19||April 2005||2005-04-01|June 2014|2014-06-01||||January 2009|Actual|2009-01-01||Observational||"Number of participants in this summary is Number of patients eligible for efficacy analysis~Throughout this report, the discrepancy between the total number of participants and the numbers analyzed for a certain parameter is due to missing data."|Special Survey Long-term Treatment With Tiotropium on COPD|Special Survey Long-term Treatment|Completed||N/A|385|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:36:26.346081|2017-02-18 14:36:26.346081
NCT00638170|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2009-02-13|||May 2001||2001-05-01|January 2008|2008-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Cranberry Juice in the Prevention of Urinary Tract Infections in Children|The Efficacy of Cranberry Juice in the Prevention of Urinary Tract Infections in Children - Randomized, Placebo Controlled Multi-Center Study|Completed||N/A|262|Anticipated|University of Oulu||2|||f||||f||||||||||2017-02-18 14:36:26.705867|2017-02-18 14:36:26.705867
NCT00638157|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-01-05|2013-03-04||March 2008||2008-03-01|January 2016|2016-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||Intent-to-Treat (ITT) Population used. Includes all randomized subjects.|Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)|A Phase 4 Multicenter, Randomized, Double Blind Study to Describe the Efficacy and Safety of Cubicin® (Daptomycin for Injection) With and Without Initial Gentamicin Combination Therapy in the Treatment of S. Aureus Infective Endocarditis|Terminated||Phase 4|24|Actual|Cubist Pharmaceuticals LLC|As the study was terminated prematurely, conclusions that can be drawn from the efficacy results are limited.|2||commitment completed|f||||f||||||||||2017-02-18 14:36:26.81488|2017-02-18 14:36:26.81488
NCT00638144|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-09-29|||February 2008||2008-02-01|September 2015|2015-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C|Prevention of Graft Reinfection After Liver Transplantation for HCV Related End-stage Liver Disease . Study of Humoral Anti-HCV Response|Recruiting||N/A|300|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||Samples Without DNA|"~     blood~   "|||2017-02-18 14:36:27.491752|2017-02-18 14:36:27.491752
NCT00638131|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-06-14|||January 2009||2009-01-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|March 2010|Anticipated|2010-03-01||Interventional|||Bosentan Use in Patients With Diabetic Nephropathy|Effect of Bosentan on Systemic and Renal Inflammatory Markers in Patients With Diabetic Nephropathy on Angiotensin II Receptor Blockers|Terminated||Phase 3|1|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2||problem of recruitment|f||||f||||||||||2017-02-18 14:36:27.606151|2017-02-18 14:36:27.606151
NCT00638118|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2011-01-10|||February 2003||2003-02-01|January 2011|2011-01-01|May 2003|Actual|2003-05-01|||||Interventional|||Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen|A Comparison of Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen|Completed||Phase 4|48|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:36:27.704208|2017-02-18 14:36:27.704208
NCT00638092|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2015-05-15|||March 2010||2010-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Interventional|I2S2||A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years|A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants With Follow-up at 2 Years|Completed||Phase 4|1275|Actual|University of Oxford||2|||f||||t||||||||||2017-02-18 14:36:27.789955|2017-02-18 14:36:27.789955
NCT00638079|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-04-18|||June 2006||2006-06-01|August 2015|2015-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Evaluating the Effect of Food on Absorption of Megace ES|Single-center, Randomized, Open-label, 2-way Crossover Bioavailability Study, Evaluating the Effect of Food on Megace ES (Megestrol Acetate 625 mg/5 mL Oral Suspension) Following a 625 mg Dose in Healthy Subjects|Completed||Phase 1|24|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:36:27.916706|2017-02-18 14:36:27.916706
NCT00638066|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2008-03-17|||October 2007||2007-10-01|March 2008|2008-03-01|April 2008|Anticipated|2008-04-01|April 2008|Anticipated|2008-04-01||Interventional|||Botulinum Toxin Injection for Treatment of Vaginismus|Comparison of Efficacy of 250 Units Versus 500 Units of Botulinum Toxin in the Treatment of Refractory Vaginismus|Unknown status|Active, not recruiting|Phase 3|40|Anticipated|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-02-18 14:36:28.02224|2017-02-18 14:36:28.02224
NCT00638053|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-27|||November 2002||2002-11-01|March 2008|2008-03-01|November 2003|Actual|2003-11-01|||||Interventional|GHD||A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury|Head Trauma With Traumatic Brain Injury (TBI): A Multicenter, Phase IV Study to Evaluate the Effects of Genotropin in Adult Patients With Growth Hormone Deficiency (GHD) Caused by Trauma and/or Head Injury|Terminated||Phase 4|100|Anticipated|Pfizer||1||See reason for termination in detailed description.|f||||f||||||||||2017-02-18 14:36:28.128838|2017-02-18 14:36:28.128838
NCT00638040|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2014-07-09|||September 2009||2009-09-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression|The Gene Expression Studies of Tumor Microenvironments and Their Roles in Tumor Progression|Withdrawn||N/A|0|Actual|Duke University|||1|the study has stopped due to no recruitment|f||||t||||||||||2017-02-18 14:36:28.2412|2017-02-18 14:36:28.2412
NCT00638027|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2015-11-06|2013-01-31||July 2006||2006-07-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Memantine for Spasticity in MS Patients|Memantine for Spasticity in MS Patients|Completed||Phase 4|21|Actual|University of Rochester|Small exploratory study that may have been hindered due to lack of adequate power.|2|||f||||f||||||||||2017-02-18 14:36:28.340795|2017-02-18 14:36:28.340795
NCT00638014|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2011-04-05|2011-02-23||March 2008||2008-03-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|TALON||Rapid Sternal Closure System (TALON)|A Randomized, Controlled, Phase 4 Study of Sternal Plating (Rapid Sternal Closure System, KLS Martin L.P.) in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Complications.|Completed||Phase 4|51|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:36:28.912282|2017-02-18 14:36:28.912282
NCT00638001|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2014-07-10|||March 2008||2008-03-01|July 2014|2014-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy||Completed||Phase 4|70|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||t||||||||||2017-02-18 14:36:29.298553|2017-02-18 14:36:29.298553
NCT00637988|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-01-20|||April 2002||2002-04-01|January 2011|2011-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Barrett's Esophagus - 315 - 3 Way Cross Over|A Multicenter, Open-label, Four-way Crossover Study of the Effects of Esomeprazole, Aspirin and Rofecoxib on Prostaglandin (PGE2) Production, Cyclooxygenase-2 Enzyme Activity and PCNA Expression in Patients With Barrett's Esophagus|Completed||Phase 4|32|Anticipated|AstraZeneca||4|||f||||||||||||||2017-02-18 14:36:29.374996|2017-02-18 14:36:29.374996
NCT00637975|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2011-02-01|||September 2007||2007-09-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain|Randomized Phase II Trial Evaluating Activity and Tolerability of Fixed Dose of Oxycodone and Increasing Dose of Pregabalin Versus Increasing Dose of Oxycodone and Fixed Dose of Pregabalin for the Treatment of Oncological Neuropathic Pain|Completed||Phase 2|80|Anticipated|Associazione Progetto Oncologia UMAN.A||2|||f||||t||||||||||2017-02-18 14:36:29.471669|2017-02-18 14:36:29.471669
NCT00637962|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-02-10|||September 2007||2007-09-01|February 2011|2011-02-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|SG06RS02||Reactogenicity and Immunogenicity of Vaginal CNgp140|Phase I Clinical Trial in Healthy Female Volunteers of Reactogenicity and Immunogenicity of Nine Vaginal Immunisations With HIV CN54gp140 Glycoprotein|Terminated||Phase 1|23|Actual|St George's, University of London||2||IMP expired prior to completion of recruitment|f||||f||||||||||2017-02-18 14:36:29.598335|2017-02-18 14:36:29.598335
NCT00637949|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-17|||December 2000||2000-12-01|March 2008|2008-03-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Safety of Lumiracoxib in Patients With Osteoarthritis|A 6-Week Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Parallel Group Clinical Saftey Study to Evaluate Incidence of Predefined Gastrointestinal Adverse Events and Peripheral Edema in Subjects With Primary Osteoarthritis Treated With COX189 400 mg o-do Using Rofecoxib 25 mg o.d. as a Comparator|Completed||Phase 3|309|Actual|Novartis||2|||||||||||||||||2017-02-18 14:36:29.718854|2017-02-18 14:36:29.718854
NCT00466219|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-04-25|||May 2002||2002-05-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant||Completed||Phase 3|25||University Hospital, Geneva|||||f||||f||||||||||2017-02-18 15:40:07.890398|2017-02-18 15:40:07.890398
NCT00637923|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2014-01-09|2013-11-18||March 2008||2008-03-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|STEALTHC-3||Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients|Phase II, Randomized, Double-blind, Placebo-controlled Study of Nitazoxanide in Combination With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Hepatitis C|Completed||Phase 2|112|Actual|Romark Laboratories L.C.||2|||f||||t||||||||||2017-02-18 14:36:30.051896|2017-02-18 14:36:30.051896
NCT00637910|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2012-02-23|||November 2007||2007-11-01|February 2012|2012-02-01|February 2013|Anticipated|2013-02-01|February 2012|Anticipated|2012-02-01||Interventional|TAILOR||Tarceva Italian Lung Optimization tRial|Optimization of Erlotinib for the Treatment of Patients With Advanced Non Small Cell Lung Cancer: an Italian Randomized Trial|Unknown status|Recruiting|Phase 3|850|Anticipated|Fatebenefratelli and Ophthalmic Hospital||2|||f||||t||||||||||2017-02-18 14:36:30.73655|2017-02-18 14:36:30.73655
NCT00637897|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2015-10-22|||March 2008||2008-03-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|November 2011|Actual|2011-11-01||Interventional|||Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer|Feasibility of Dose Titrating Paricalcitol (Zemplar) in Women Receiving Taxanes or Ixabepilone for Metastatic Breast Cancer|Completed||Phase 1|24|Actual|Wake Forest University Health Sciences||1|||f||||t||||||||||2017-02-18 14:36:30.962772|2017-02-18 14:36:30.962772
NCT00637884|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2011-01-10|||November 2003||2003-11-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|||||Interventional|||A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms|A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms|Completed||Phase 4|70|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:36:31.060584|2017-02-18 14:36:31.060584
NCT00637871|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2011-01-21|||November 2002||2002-11-01|January 2011|2011-01-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Casodex - Nolvadex Combination|Randomised, Double-blind, Placebo Controlled, Parallel-group, Multicentre Phase II Study to Assess Dose Response Relationship of Nolvadex (Oral Tablet) in Prophylactic Treatment of Gynaecomastia and Breast Pain Associated With CASODEX 150 mg (Oral Tablet), and to Assess the Tumour Control…..|Completed||Phase 2|||AstraZeneca||2|||||||||||||||||2017-02-18 14:36:31.139093|2017-02-18 14:36:31.139093
NCT00637858|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2013-01-06|||October 2008||2008-10-01|July 2009|2009-07-01|January 2011|Actual|2011-01-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Different Doses of Tomato Lycopene on Blood Pressure in Pre-hypertensive Otherwise Healthy Subjects|Effect of Different Doses of Tomato Lycopene on the Blood Pressure in Prehypertensives and Grade I Never Treated Otherwise Healthy Subjects|Terminated||N/A|130|Actual|Soroka University Medical Center||5||difficulty to enroll more subjects|f||||f||||||||||2017-02-18 14:36:31.229922|2017-02-18 14:36:31.229922
NCT00637845|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-01-20|||June 2002||2002-06-01|January 2011|2011-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)|A Multi-centred, Phase IV, Post-Marketing, Prospective, Randomized, Double-Blind Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease While on 30mg Once Daily Lansoprazole Therapy|Completed||Phase 4|248|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:36:31.326669|2017-02-18 14:36:31.326669
NCT00637832|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2009-10-06|||April 2008||2008-04-01|July 2009|2009-07-01||||March 2010|Anticipated|2010-03-01||Interventional|||Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma|Short Chemo Radiotherapy in Follicular Lymphoma Trial of 90Y Ibritumomab Tiuxetan (ZevalinTM) as Therapy for First and Second Relapse in Follicular Lymphoma|Unknown status|Recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:36:31.434367|2017-02-18 14:36:31.434367
NCT00637819|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-27|||January 2003||2003-01-01|March 2008|2008-03-01|July 2004|Actual|2004-07-01|||||Interventional|||Leflunomide in Systemic Lupus Erythematosus|A Randomized, Double-Blind, Placebo Controlled Clinical Trial of Leflunomide in Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|27|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:36:31.54245|2017-02-18 14:36:31.54245
NCT00637806|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-03-31|2016-01-29||June 2006||2006-06-01|March 2016|2016-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional||All subjects who received at least 1 dose of study medication and who had at least 1 on-therapy safety assessment|Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension|A Randomized, Double-blind, Placebo-controlled Study of Megestrol Acetate Concentrated Suspension for the Treatment of Cancer-associated Anorexia in Subjects With Cancer of Multiple Types|Terminated||Phase 3|4|Actual|Par Pharmaceutical, Inc.||3||Difficulty finding the required patient population|f||||f||||||||||2017-02-18 14:36:31.626483|2017-02-18 14:36:31.626483
NCT00637793|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2009-01-28|||February 2008||2008-02-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|||||Interventional|||Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome|A Double-Blind, Placebo-Controlled, Cross Over Study Using a Latin Square Design to Evaluate the Safety, Tolerability, and Efficacy of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjogren's Syndrome|Completed||Phase 2|24|Anticipated|TorreyPines Therapeutics||4|||f||||f||||||||||2017-02-18 14:36:32.413615|2017-02-18 14:36:32.413615
NCT00637780|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-07-18|||June 2010||2010-06-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis|An Open Label Non-randomized Study To Characterize The Steady State Pharmacokinetics Of Sulfasalazine Delayed Release Tablets In Children With Juvenile Idiopathic Arthritis|Terminated||Phase 4|2|Actual|Pfizer||1||"Study terminated on 13 April 2016 for business reasons. No safety and/or efficacy concerns~   contributed to the termination of the study"|f||||f||||||||||2017-02-18 14:36:32.513257|2017-02-18 14:36:32.513257
NCT00637767|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2009-07-07|||December 2007||2007-12-01|July 2009|2009-07-01||||December 2010|Anticipated|2010-12-01||Interventional|||High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant|A Randomised Phase II Clinical Trial Using Targeted Radiotherapy Delivered by an Yttrium-90 Radio-Labelled Anti-CD66 Monoclonal Antibody With High Dose Melphalan Compared to Melphalan Alone, Prior to Autologous Stem Cell Transplantation for Multiple Myeloma|Unknown status|Recruiting|Phase 2|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:36:32.618957|2017-02-18 14:36:32.618957
NCT00637754|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2015-06-10|||September 2006||2006-09-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|||Safety of Sports for Patients With Implantable Cardioverter-Defibrillators|Safety of Sports for Patients With Implantable Cardioverter-Defibrillators: A Multi-Center Registry|Completed||N/A|400|Actual|Yale University|||1||f||||t||||||||||2017-02-18 14:36:32.723038|2017-02-18 14:36:32.723038
NCT00637741|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-11-30|||March 2008||2008-03-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|September 2009|Actual|2009-09-01||Interventional|||DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions|Physician Initiated Trial Investigating the Efficacy of the Implant of EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions|Completed||Phase 4|100|Actual|Flanders Medical Research Program||1|||f||||f||||||||||2017-02-18 14:36:33.030027|2017-02-18 14:36:33.030027
NCT00637728|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-05-18|2016-01-29||June 2006||2006-06-01|May 2016|2016-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional||All subjects who received at least 1 dose of study medication and who had at least 1 on-therapy safety assessment|Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients|A Randomized, Double-blind, Placebo-controlled Study of Megestrol Acetate Concentrated Suspension for the Treatment of Cancer-associated Anorexia in Subjects With Lung or Pancreatic Cancer|Terminated||Phase 3|5|Actual|Par Pharmaceutical, Inc.||2||Difficulty finding the required patient population|f||||f||||||||||2017-02-18 14:36:33.145317|2017-02-18 14:36:33.145317
NCT00637715|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-04-01|||October 2003||2003-10-01|April 2008|2008-04-01|December 2004|Actual|2004-12-01|||||Interventional|||Once Daily Given Alfuzosin in the Treatment of BPH|Evaluation of the Effect of 10 mg Alfuzosin (Alfetim Uno®) o. d. in Patients Presenting Low-Urinary Tract Symptoms|Completed||Phase 4|60|Actual|Sanofi|||||f||||f||||||||||2017-02-18 14:36:33.787276|2017-02-18 14:36:33.787276
NCT00637702|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2013-02-15|||February 2008||2008-02-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Study of ARRY-334543 in Patients With Advanced Cancer||Completed||Phase 1|31|Actual|Array BioPharma||1|||f||||||||||||||2017-02-18 14:36:33.88037|2017-02-18 14:36:33.88037
NCT00637689|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-08-23|||September 2007||2007-09-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|May 2014|Actual|2014-05-01||Observational|||Improving Outcomes Assessment in Chronic GVHD|Improving Outcomes Assessment in Chronic GVHD|Active, not recruiting||N/A|601|Actual|Fred Hutchinson Cancer Research Center|||1||f||||f||||||Samples With DNA|"~     Some centers are collecting serum, plasma, cells and urine.~   "|||2017-02-18 14:36:33.97001|2017-02-18 14:36:33.97001
NCT00637676|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-09-22|||July 2008||2008-07-01|March 2008|2008-03-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Tunneled Pleural Catheter in Partially Entrapped Lung|Randomized Trial of Tunneled Pleural Catheter Versus Standard Chest Tube in Management of Malignant Pleural Effusion in Patients With Partial Entrapment of the Lung|Completed||Phase 2|50|Anticipated|Heidelberg University||2|||f||||t||||||||||2017-02-18 14:36:34.078462|2017-02-18 14:36:34.078462
NCT00637663|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2015-03-04|||February 2008||2008-02-01|March 2015|2015-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA|Randomized, Open-Labeled Study Evaluating the Antiviral Efficacy, Safety, and Tolerability of Continuing Lamivudine Therapy or Switching to Entecavir in Subjects With Chronic Hepatitis B Who Achieved Undetectable HBV DNA|Completed||Phase 4|72|Actual|Pusan National University Hospital||2|||f||||t||||||||||2017-02-18 14:36:34.194229|2017-02-18 14:36:34.194229
NCT00637650|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2009-02-09|||June 2007||2007-06-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Management of Fragments During Ureteroscopy|"Should we Strive for Absolute Stone Freedom While Performing Holmium Laser Lithotripsy for Ureteral Stones? A Randomized Controlled Trial."|Completed||N/A|||The Chaim Sheba Medical Center||2|||f||||||||||||||2017-02-18 14:36:34.309235|2017-02-18 14:36:34.309235
NCT00637637|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-14|2013-08-09|||September 2007||2007-09-01|December 2008|2008-12-01||||June 2009|Anticipated|2009-06-01||Interventional|||External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases|Radiation Therapy in Combination With Indinavir / Ritonavir (Crixivan / Norvir) for the Treatment of Brain Metastases: a Randomized Phase II Study|Unknown status|Recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:36:34.392801|2017-02-18 14:36:34.392801
NCT00637624|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-08-08|||March 2008||2008-03-01|August 2011|2011-08-01|February 2012|Anticipated|2012-02-01|December 2011|Anticipated|2011-12-01||Interventional|NAC-PNP||N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy|A Randomized Double-blind Study of N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy in Patients Treated for (Non)Small Cell Lung Cancer and Malignant Mesothelioma|Unknown status|Recruiting|N/A|50|Anticipated|Rijnstate Hospital||2|||f||||||||||||||2017-02-18 14:36:34.498582|2017-02-18 14:36:34.498582
NCT00637611|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2011-01-11|||February 2003||2003-02-01|January 2011|2011-01-01|April 2003|Actual|2003-04-01|||||Interventional|||Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit|Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit (Study I)|Completed||Phase 4|1010|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:36:34.611382|2017-02-18 14:36:34.611382
NCT00637598|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2014-07-31|||November 2004||2004-11-01|July 2014|2014-07-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Early Detection of Breast Cancer Using Tomosynthesis Imaging|Early Detection of Breast Cancer Using Tomosynthesis Imaging|Completed||N/A|385|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:36:34.695382|2017-02-18 14:36:34.695382
NCT00637585|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2011-01-10|||December 2002||2002-12-01|January 2011|2011-01-01|July 2003|Actual|2003-07-01|||||Interventional|||Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine|A Comparison of Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine|Completed||Phase 4|42|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:36:34.801112|2017-02-18 14:36:34.801112
NCT00636688|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-04-17|||October 2000||2000-10-01|March 2008|2008-03-01|October 2003|Actual|2003-10-01|April 2003|Actual|2003-04-01||Interventional|||Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men: a Randomized Controlled Trial|Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men: a Randomized Controlled Trial.|Completed||N/A|110|Actual|Second University of Naples||2|||f||||f||||||||||2017-02-18 14:36:57.308512|2017-02-18 14:36:57.308512
NCT00637572|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-09-14|2016-01-29||December 2004||2004-12-01|August 2016|2016-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional||Analysis based on Intend to Treat (ITT) population; all randomized subjects who were dispensed medication and had at least one post-randomization visit.|Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss|A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)|Completed||Phase 2|63|Actual|Endo Pharmaceuticals||2|||f||||f||||||||No||2017-02-18 14:36:34.891791|2017-02-18 14:36:34.891791
NCT00637559|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-01-24|||March 2002||2002-03-01|January 2011|2011-01-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Barrett's Esophagus - 315 - 3 Way Cross-Over|A Multicenter, Double-blind, Three-way Crossover Intraesophageal and Intragastric pH Study of Three Esomeprazole Treatment Regimens in Documented Barrett's Esophagus Patients|Completed||Phase 4|50|Anticipated|AstraZeneca||3|||f||||||||||||||2017-02-18 14:36:35.538494|2017-02-18 14:36:35.538494
NCT00637546|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2010-01-13|||September 2007||2007-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|||Gait and Balance of Diabetes Type 2 Patients|Efficacy of a Specific Physiotherapy Group Treatment on Gait and Balance in Patients With Diabetic Neuropathy|Completed||Phase 2/Phase 3|71|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-02-18 14:36:35.625925|2017-02-18 14:36:35.625925
NCT00637533|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-01-18|||May 2004||2004-05-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.|A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.|Completed||N/A|10|Actual|Stanford University||2|||f||||||||||||||2017-02-18 14:36:35.729706|2017-02-18 14:36:35.729706
NCT00637520|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-09-14|||July 2007||2007-07-01|September 2016|2016-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study|Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study|Recruiting||N/A|80|Anticipated|Duke University|||3||f||||f||||||Samples With DNA|"~     Frozen tissue, serum, whole blood, urine~   "|||2017-02-18 14:36:35.833588|2017-02-18 14:36:35.833588
NCT00637507|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-11-18|||March 2008||2008-03-01|November 2016|2016-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|HFO-TGI-2||Study of a Novel Technique of Mechanical Ventilation in Patients With Severe Acute Respiratory Failure|Phase II/Phase III Study of the Effect of Combined High-frequency Oscillation and Tracheal Gas Insufflation on the Survival to Hospital Discharge of Patients With Severe Acute Respiratory Distress Syndrome|Completed||Phase 2/Phase 3|124|Actual|University of Athens||2|||f||||t||||||||||2017-02-18 14:36:35.942844|2017-02-18 14:36:35.942844
NCT00637494|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-12-23|2016-12-23||March 2008||2008-03-01|December 2016|2016-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features|A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features|Terminated||Phase 3|292|Actual|Corcept Therapeutics||2||DRC recommended stopping study as it had missed its primary endpoint|f||||t||||||||No||2017-02-18 14:36:36.068727|2017-02-18 14:36:36.068727
NCT00637481|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-17|2016-12-28|||March 2008||2008-03-01|December 2016|2016-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer|A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer|Completed||Phase 1|66|Actual|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 14:36:36.635853|2017-02-18 14:36:36.635853
NCT00637468|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-17|||September 2002||2002-09-01|March 2008|2008-03-01||||||||Interventional|EAGLE||EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye|Multizenterstudie Der European Assessment Group for Lysis in the Eye (EAGLE) Zur Behandlung Des Zentralarterienverschlusses (ZAV): Lysetherapie Versus Konservative Therapie|Terminated||Phase 3|84|Actual|University Hospital Freiburg||2||"Due to results of conditional power analysis performed at the first interim analysis and due~   to observed spectrum of adverse events."|f||||t||||||||||2017-02-18 14:36:36.752992|2017-02-18 14:36:36.752992
NCT00637455|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2011-01-10|||September 2003||2003-09-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|||||Interventional|||Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel|Single Center, Randomized,Double-Blind,Crossover Study Comparing the Effects of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel|Completed||Phase 4|72|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:36:36.884511|2017-02-18 14:36:36.884511
NCT00637442|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2010-11-08|||February 2008||2008-02-01|July 2010|2010-07-01||||December 2010|Anticipated|2010-12-01||Interventional|CASL-AD-01||Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)|Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)|Unknown status|Active, not recruiting|N/A|30|Anticipated|University Hospital, Bonn||1|||f||||f||||||||||2017-02-18 14:36:36.973386|2017-02-18 14:36:36.973386
NCT00637429|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-04-01|||November 2007||2007-11-01|March 2008|2008-03-01||||||||Observational|||HIV-HBV Co-Infection and Liver Disease|Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) co-Infection and Liver Disease|Unknown status|Recruiting|N/A|70|Anticipated|Bayside Health|||1||f||||f||||||Samples Without DNA|"~     serum samples~   "|||2017-02-18 14:36:37.223629|2017-02-18 14:36:37.223629
NCT00637416|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2016-11-29|2016-10-05||March 2008||2008-03-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness|The Effect of Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness|Terminated||Phase 4|9|Actual|University of Kansas Medical Center||2||Enrollment challenges|f||||f||||||||||2017-02-18 14:36:37.314227|2017-02-18 14:36:37.314227
NCT00636675|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2016-10-24|||September 2009||2009-09-01|October 2016|2016-10-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|CONNECT||CONNECT for Quality: A Study to Reduce Falls in Nursing Homes|Outcomes of Nursing Management Practice in Nursing Homes|Completed||N/A|1350|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:36:57.402831|2017-02-18 14:36:57.402831
NCT00637403|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-10-13|||May 2006||2006-05-01|October 2016|2016-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension|An Open-Label, Single-Dose Study to Assess the Effect of Renal Impairment on the Pharmacokinetic Characteristics, Safety, and Tolerability of Megestrol Acetate|Terminated||Phase 1|7|Actual|Par Pharmaceutical, Inc.||5||Difficulty finding the required subject population|f||||f||||||||||2017-02-18 14:36:37.672896|2017-02-18 14:36:37.672896
NCT00637390|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2016-12-01|||March 2008||2008-03-01|December 2016|2016-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.|A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.|Terminated||Phase 1|3|Actual|University of Michigan Cancer Center||1||"Genzyme will no longer supply the study drug for this trial as it does not believe the study~   will not fully enroll within an appropriate time frame."|f||||t||||||||||2017-02-18 14:36:37.793211|2017-02-18 14:36:37.793211
NCT00637377|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2014-11-28|2011-12-16||April 2008||2008-04-01|November 2014|2014-11-01|August 2011|Actual|2011-08-01|September 2010|Actual|2010-09-01||Interventional|VIEW 2||Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)|A Randomized, Double Masked, Active Controlled, Phase 3 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects With Neovascular Age-related Macular Degeneration (AMD)|Completed||Phase 3|1240|Actual|Bayer|The conditional sequence of hypothesis testing had to stop after testing the first superiority hypothesis. Therefore, all further statistical tests are exploratory tests.|4|||f||||t||||||||||2017-02-18 14:36:37.92092|2017-02-18 14:36:37.92092
NCT00637364|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2009-01-12|||March 2008||2008-03-01|January 2009|2009-01-01||||July 2010|Anticipated|2010-07-01||Interventional|HIFU Pancreas||High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain|An Open Label, Non-Randomized, Single-Center, Therapeutic Trial Examining the Feasibility, Safety, and Efficacy of FEP-BY02, a High Intensity Focused Ultrasound Tumor Treatment Device, in Patients With Pancreatic Cancer Pain|Suspended||Phase 1/Phase 2|5|Anticipated|CMED HIFU Development Corporation||1||Sponsor is not proceeding with USA human trial at this time|f||||t||||||||||2017-02-18 14:36:40.56658|2017-02-18 14:36:40.56658
NCT00637351|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2014-01-09|||March 2008||2008-03-01|January 2014|2014-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays|A Study to Collect Blood and Urine Samples in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays|Completed||N/A|21|Actual|GlaxoSmithKline|||2||f||||||||||Samples With DNA|"~     whole blood, urine samples~   "|||2017-02-18 14:36:40.662927|2017-02-18 14:36:40.662927
NCT00637338|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2009-07-30|||April 2008||2008-04-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus|A Phase 1, Randomized, Placebo-Controlled, Sequential Parallel Group, Multiple Dose Escalation Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of 4, Once-Weekly Subcutaneous Doses Of PF-04603629 To Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 1|42|Actual|Pfizer||2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:36:40.760773|2017-02-18 14:36:40.760773
NCT00637325|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-03-10|||November 2007||2007-11-01|March 2008|2008-03-01|April 2011|Anticipated|2011-04-01|May 2009|Anticipated|2009-05-01||Interventional|TOP||Trastuzumab Optimization Trial in Breast Cancer|TOP Trial. A Randomised Phase III Clinical Trial of Trastuzumab (Herceptin) Optimization in Patients With Locally Advanced and/or Metastatic Breast Cancer Overexpressing HER2 After a First Line Chemotherapy Plus Trastuzumab.|Unknown status|Recruiting|Phase 3|500|Anticipated|Regione Lombardia||2|||f||||||||||||||2017-02-18 14:36:40.867252|2017-02-18 14:36:40.867252
NCT00637312|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2014-02-12|2014-02-12||March 2008||2008-03-01|February 2014|2014-02-01|February 2013|Actual|2013-02-01|July 2011|Actual|2011-07-01||Interventional|||Advent™ Cervical Disc Versus ACDF for Treatment of One Level Degenerative Disc Disease (IDE Study)|Clinical Trial Comparing the Blackstone Advent™ Cervical Disc to Anterior Cervical Discectomy and Fusion (ACDF) for the Treatment of One Level Degenerative Disc Disease|Terminated||N/A|108|Actual|Orthofix Inc.|The study was suspended for a high rate of adverse events in the treatment group. Enrollment was stopped and patients were followed for 36 months in the Advent group. Approval is not being pursued and thus no analysis has been completed.|2||Greater-than-anticipated rate of revisions|f||||t||||||||||2017-02-18 14:36:40.997508|2017-02-18 14:36:40.997508
NCT00637299|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2011-10-16|2009-01-05||January 2008||2008-01-01|October 2011|2011-10-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|||Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation Trial|Osteopathic Treatment May Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease|Completed||Early Phase 1|20|Actual|Fondazione Salvatore Maugeri||2|||f||||f||||||||||2017-02-18 14:36:43.872133|2017-02-18 14:36:43.872133
NCT00637286|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2009-04-03|||July 2004||2004-07-01|April 2009|2009-04-01|May 2005|Actual|2005-05-01|||||Interventional|||ZAP, US. Zomig for Appropriate for Primary Care|A Multicenter, Open-Label Study Using the MIDAS Questionnaire to Assess the Effect of Using the HCPC Guidelines for Migraine Management in Primary Care, Including the Use of Zomig-ZMT (Zolmitriptan) Orally Disintegrating Tablets 5.0mg and Zomig Nasal Spray 5.0mg as Indicated.|Completed||Phase 4|120|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:36:44.262721|2017-02-18 14:36:44.262721
NCT00637273|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2015-03-19|2012-02-14||January 2008||2008-01-01|March 2015|2015-03-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)|A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Long-Acting Release(Once Weekly) to Those of Sitagliptin and a Thiazolidinedione in Subjects With Type 2 Diabetes Mellitus Treated With Metformin|Completed||Phase 3|514|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:36:44.350591|2017-02-18 14:36:44.350591
NCT00637260|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2015-09-01|||December 2007||2007-12-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Motor Cortex Stimulation for Parkinson's Disease|Motor Cortex Stimulation for Parkinson's Disease. A Prospective Double Blind Randomized Study With Cross-over|Completed||N/A|13|Actual|Catholic University, Italy||2|||f||||t||||||||||2017-02-18 14:36:45.588207|2017-02-18 14:36:45.588207
NCT00637247|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2010-11-30|2010-09-17||April 2008||2008-04-01|November 2010|2010-11-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer|A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)|Completed||Phase 2|142|Actual|AmpliMed Corporation||2|||f||||t||||||||||2017-02-18 14:36:45.716879|2017-02-18 14:36:45.716879
NCT00637234|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2008-07-23|||July 2004||2004-07-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|OXC-SCZ||Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia|Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia|Completed||Phase 2/Phase 3|54|Actual|University of Cologne||2|||f||||t||||||||||2017-02-18 14:36:46.36073|2017-02-18 14:36:46.36073
NCT00637221|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2012-04-26|||March 2008||2008-03-01|April 2012|2012-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome|An Open Label Exploratory Study to Investigate the Safety and Effects of NPL-2009 ( 50 mg - 150 mg Single Dose) on Prepulse Inhibition Tests and Continuous Performance Tasks, in Adults With Fragile X Syndrome|Completed||Phase 1/Phase 2|12|Actual|Neuropharm||1|||f||||t||||||||||2017-02-18 14:36:46.549405|2017-02-18 14:36:46.549405
NCT00637208|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2008-03-14|||November 2007||2007-11-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate Cancer|Selective Retrograde Venography and Sclerotherapy of Internal Spermatic Veins and Associated Venous Bypasses and Retro-Peritoneal Collateral in Patients With Bilateral Varicocele and Localized Prostate Cancer|Completed||N/A|10|Actual|Maaynei Hayesha Medical Center||2|||f||||f||||||||||2017-02-18 14:36:46.789961|2017-02-18 14:36:46.789961
NCT00637195|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-10-11|2009-11-12||March 2008||2008-03-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)|Evaluation of the Immunogenicity and Safety of a Commercially Available Vaccine When Co-administered With GlaxoSmithKline Biologicals' HPV Vaccine (580299) in Healthy Female Subjects.|Completed||Phase 3|152|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:36:46.896877|2017-02-18 14:36:46.896877
NCT00637182|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-03-10|||January 2001||2001-01-01|March 2008|2008-03-01|October 2002|Actual|2002-10-01|June 2002|Actual|2002-06-01||Interventional|||Gynecomastia Extension Study|An OptioExtension of Trial 1033US/0006 to Assess Safety, Tolerability, Efficacy of Anastrozole (ZD1033, Arimidex™) in Treatment of Gynecomastia in Pubertal Boys Given Placebo and to Conduct a Long-Term Safety Follow-Up of Non-Responding Subjects Given Anastrozole in the Previous Trial|Completed||Phase 3|||AstraZeneca|||||||||f||||||||||2017-02-18 14:36:47.555189|2017-02-18 14:36:47.555189
NCT00637169|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2014-12-04|||December 2006||2006-12-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|COT||Canadian Oxygen Trial (COT)|Efficacy and Safety of Targeting Lower Arterial Oxygen Saturations to Reduce Oxygen Toxicity and Oxidative Stress in Very Preterm Infants: The Canadian Oxygen Trial (COT)|Completed||Phase 3|1201|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 14:36:47.656407|2017-02-18 14:36:47.656407
NCT00637156|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2016-09-27|2016-08-02||June 2006||2006-06-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|January 2011|Actual|2011-01-01||Interventional|||Study of the Safety and Effectiveness of the Artificial Cervical Disc - Low Profile Device at Two Adjacent Levels|A Prospective, Randomized, Controlled, Multicenter Pivotal Clinical Trial of the Artificial Cervical Disc-LP at Two Levels for Symptomatic Cervical Disc Disease|Active, not recruiting||Phase 3|397|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-02-18 14:36:47.83194|2017-02-18 14:36:47.83194
NCT00637143|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2017-02-15|||April 1999||1999-04-01|February 2017|2017-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)|Prograf® (Tacrolimus) as Secondary Intervention vs. Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure|Completed||Phase 4|107|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:36:50.691247|2017-02-18 14:36:50.691247
NCT00637130|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2012-12-04||2012-12-03|October 2007||2007-10-01|December 2012|2012-12-01||||January 2008|Actual|2008-01-01||Interventional|||Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost|Safety and IOP Lowering Efficacy of Low Dose Travoprost Ophthalmic Solutions Dosed BID Compared to TRAVATAN® in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|138|Actual|Alcon Research||5|||f||||f||||||||||2017-02-18 14:36:50.823976|2017-02-18 14:36:50.823976
NCT00637117|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2013-08-22|||July 2008||2008-07-01|August 2013|2013-08-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.|A Phase I/II Study of Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.|Withdrawn||Phase 1/Phase 2|0|Actual|Baylor Research Institute||1||The study never opened and not sure if it ever will.|f||||t||||||||||2017-02-18 14:36:50.928742|2017-02-18 14:36:50.928742
NCT00637104|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2010-02-08|||July 2008||2008-07-01|February 2010|2010-02-01|June 2011|Anticipated|2011-06-01|December 2010|Anticipated|2010-12-01||Interventional|MARTIN||European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent|A European Multicenter, Randomized, Single Blind Study of the MAR-Tyn Cobalt Chromium TiN-Coated Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions|Unknown status|Recruiting|Phase 2/Phase 3|160|Anticipated|International Biomedical Systems S.p.A.||2|||f||||t||||||||||2017-02-18 14:36:51.033311|2017-02-18 14:36:51.033311
NCT00637091|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2014-07-17|||March 2008||2008-03-01|July 2014|2014-07-01|September 2011|Actual|2011-09-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions|A Phase II Trial of Cetuximab Plus Irinotecan as a 2nd-line Treatment in Patients With Metastatic Colorectal Cancer After Failure to Irinotecan That Express Wild-type KRAS With and Without Detectable EGFR Expression|Completed||Phase 2|40|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 14:36:51.163996|2017-02-18 14:36:51.163996
NCT00637078|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2012-06-13|||February 2008||2008-02-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|STITCH2||STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)|Evaluation of a Primary Treatment Algorithm Using Combination Therapy for the Management of Patients With Hypertension and Hypercholesterolemia|Completed||Phase 4|1000|Actual|University of Western Ontario, Canada||2|||f||||f||||||||||2017-02-18 14:36:51.273941|2017-02-18 14:36:51.273941
NCT00637065|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2008-03-10|||April 2008||2008-04-01|March 2008|2008-03-01|August 2010|Anticipated|2010-08-01|April 2010|Anticipated|2010-04-01||Interventional|B-PHIT||Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study|Use of the Endothelin-1 Antagonist Bosentan in Patients With Established Pulmonary Hypertension and Fibrotic Lung Disease. - A Randomised, Placebo-Controlled, Double-Blinded Study.|Unknown status|Not yet recruiting|Phase 4|48|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 14:36:51.392921|2017-02-18 14:36:51.392921
NCT00637052|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2012-09-19||2012-01-13|February 2008||2008-02-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia||Completed||Phase 1/Phase 2|36|Actual|Array BioPharma||1|||f||||||||||||||2017-02-18 14:36:51.519886|2017-02-18 14:36:51.519886
NCT00637039|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2013-03-11|||February 2008||2008-02-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|June 2009|Actual|2009-06-01||Interventional|||Study of AZD8931 in Patients With Advanced Solid Malignancies|A Phase 1, Open-label, Multiple-dose, Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD8931 in Patients With Advanced Solid Malignancies|Completed||Phase 1|41|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:36:51.677756|2017-02-18 14:36:51.677756
NCT00637026|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2009-04-22|||July 2003||2003-07-01|April 2009|2009-04-01|February 2005|Actual|2005-02-01|||||Interventional|||Ph II Early BC Pre-Surgical Biologic Study|A PreSurgical Study to Evaluate Molecular Alterations That Occur in Human Breast Cancer Tissue and Normal Skin After Short Term Exposure to ZD1839 (IRESSA) and to Correlate These Alterations With Pharmacokinetic Parameters.|Completed||Phase 2|65|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 14:36:51.928397|2017-02-18 14:36:51.928397
NCT00637013|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2017-01-31|||June 2008|Actual|2008-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Operative Versus Non-operative Management of Subacromial Impingement|The Effectiveness and Cost-effectiveness of Operative Versus Non-operative Management of Subacromial Impingement|Active, not recruiting||N/A|100|Anticipated|Central Finland Hospital District||2|||f||||t||||||||Undecided||2017-02-18 14:36:52.004643|2017-02-18 14:36:52.004643
NCT00637000|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2014-04-09|2010-09-30||March 2008||2008-03-01|February 2014|2014-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone|Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone|Completed||Phase 2|38|Actual|Indivior Inc.||2|||f||||f||||||||||2017-02-18 14:36:52.144478|2017-02-18 14:36:52.144478
NCT00636987|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2016-03-09|||April 2007||2007-04-01|September 2015|2015-09-01|March 2016|Actual|2016-03-01|October 2015|Actual|2015-10-01||Interventional|||Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra|Post-Approval Study Protocol of the St. Jude Medical Biocor and Biocor Supra Valves|Completed||N/A|300|Actual|St. Jude Medical||1|||f||||f||||||||||2017-02-18 14:36:53.207139|2017-02-18 14:36:53.207139
NCT00636974|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-10-22|||January 2006||2006-01-01|October 2013|2013-10-01|July 2008|Actual|2008-07-01|||||Interventional|||A Randomised Comparison on the Dose Requirement Between, Levobupivacaine, Ropivacaine and Bupivacaine in Intrathecal Anaesthesia|Minimum Local Anaesthetic Dose for Intrathecal Anaesthesia: a Randomised Comparison Between Levobupivacaine, Ropivacaine and Bupivacaine|Completed||N/A|75|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 14:36:53.338951|2017-02-18 14:36:53.338951
NCT00636961|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2011-07-29|2011-07-29||February 2008||2008-02-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)|An Exploratory, Double Blind, Randomized, Placebo-controlled, 2-way Cross-over Study to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With COPD|Completed||Phase 2|27|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:36:53.432563|2017-02-18 14:36:53.432563
NCT00636948|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-03-10|||December 1999||1999-12-01|March 2008|2008-03-01||||June 2005|Actual|2005-06-01||Observational|RECTODES||Rectal Cancer Trial On Defunctioning Stoma|Rectal Cancer Trial On Defunctioning Stoma|Completed||N/A|234|Actual|Rectal Cancer Trial on Defunctioning Stoma Study Group|||1||f||||t||||||||||2017-02-18 14:36:53.844986|2017-02-18 14:36:53.844986
NCT00636935|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-08-20|||February 2008||2008-02-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)|Oral Corticosteroids Therapy and Interstitial Fibrosis in Patients With Pneumocystis Jirovecii Pneumonia (PCP) and pO2 of >70 at Presentation.|Withdrawn||Phase 4|0|Actual|George Washington University||3||No patient completed protocol|f||||f||||||||||2017-02-18 14:36:53.933651|2017-02-18 14:36:53.933651
NCT00636922|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2013-02-12|||February 2010||2010-02-01|February 2013|2013-02-01|January 2014|Anticipated|2014-01-01|July 2013|Anticipated|2013-07-01||Interventional|||Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia|A Phase I Dose Finding Study of Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia (AML) Unfit for Intensive Induction Chemotherapy|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|Bayside Health||1|||f||||f||||||||||2017-02-18 14:36:54.058838|2017-02-18 14:36:54.058838
NCT00636909|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2016-02-05|||July 1999||1999-07-01|February 2016|2016-02-01||||March 2006|Actual|2006-03-01||Interventional|MINI HEME||Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders|Nonmyeloablative Allogeneic Stem Cell Transplant for the Treatment of Hematologic Disorders|Completed||Phase 2|25|Actual|Beth Israel Deaconess Medical Center||1|||f||||t||||||||||2017-02-18 14:36:54.179247|2017-02-18 14:36:54.179247
NCT00636896|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2008-03-10|||July 2006||2006-07-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Modafinil on Olanzapine Weight Gain|A Comparison of the Effects of Modafinil on Olanzapine Associated Eating Behaviors in Normal Human Subjects|Completed||N/A|50|Actual|Neuropsychiatric Research Institute, Fargo, North Dakota||2|||f||||f||||||||||2017-02-18 14:36:54.277452|2017-02-18 14:36:54.277452
NCT00636883|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-08|2014-01-19|||January 2008||2008-01-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|GEMOX-T||Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer|Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer|Terminated||Phase 2|9|Actual|National Guard Health Affairs||1||slow accrual rate|f||||t||||||||||2017-02-18 14:36:54.396574|2017-02-18 14:36:54.396574
NCT00636870|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2011-01-10|||February 2003||2003-02-01|January 2011|2011-01-01|January 2004|Actual|2004-01-01|||||Interventional|||Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine|A Randomized, Double-blind, Repeat-dose, Crossover Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Desloratadine (Clarinex®) Compared to Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine.|Completed||Phase 4|220|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:36:54.497065|2017-02-18 14:36:54.497065
NCT00636857|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2013-06-11|||March 2008||2008-03-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Postoperative Hyponatremia - Are There Gender Differences?|Postoperative Hyponatremia - Are There Gender Differences?|Unknown status|Recruiting|N/A|60|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-02-18 14:36:54.591903|2017-02-18 14:36:54.591903
NCT00636844|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2013-03-11|||January 2008||2008-01-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Observational|||Detection of Chemotherapy Induced Cardiotoxicity|Detection of Chemotherapy Induced Cardiotoxicity|Completed||N/A|36|Actual|George Washington University|||1||f||||f||||||Samples With DNA|"~     Blood sample for analysis of mRNA and oxidative stress markers~   "|||2017-02-18 14:36:54.704241|2017-02-18 14:36:54.704241
NCT00636831|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2012-02-06|||July 2007||2007-07-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|RCT-herniation||Prophylactic Antibiotic Use in Hernioplasty|Prophylactic Antibiotic Use in Inguinal Hernioplasty: A Placebo-controlled, Double-blind Trial|Completed||Phase 3|400|Actual|Nihon University||2|||f||||||||||||||2017-02-18 14:36:54.900078|2017-02-18 14:36:54.900078
NCT00636818|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2010-10-20|2009-09-18||March 2008||2008-03-01|October 2010|2010-10-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)|An Open Study of Atomoxetine (LY139603) in Adult Subjects With Attention-deficit/Hyperactivity Disorder|Completed||Phase 2|45|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:36:54.997649|2017-02-18 14:36:54.997649
NCT00636805|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2014-03-04|2014-01-09||May 2008||2008-05-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab|A Phase II Single Arm Trial of Palonosetron (PALO) for the Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Malignant Glioma (MG) Patients Receiving Irinotecan in Combination With Bevacizumab|Terminated||Phase 2|63|Actual|Duke University||1||Study was halted early after 63 subjects were enrolled due to slow accrual.|f||||f||||||||||2017-02-18 14:36:55.688422|2017-02-18 14:36:55.688422
NCT00636792|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2012-01-11|2011-05-31||February 2008||2008-02-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|VERTICAL||A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma|A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma|Completed||Phase 2|73|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 14:36:56.010272|2017-02-18 14:36:56.010272
NCT00636779|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2011-06-12|||March 2008||2008-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|BraveNet||BraveNet Integrative Medicine Descriptive Study|BraveNet Multi-Center Integrative Medicine Survey|Completed||N/A|4340|Actual|Duke University|||1||f||||f||||||||||2017-02-18 14:36:56.339409|2017-02-18 14:36:56.339409
NCT00636766|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2012-11-01|||September 2005||2005-09-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque|Atherosclerotic Plaque Texture-Experimental and Clinical Study on the Diagnostic and Therapeutic Strategies of Atherosclerotic Plaque Vulnerability|Completed||N/A|300|Actual|Aristotle University Of Thessaloniki||1|||f||||||||||||||2017-02-18 14:36:56.439534|2017-02-18 14:36:56.439534
NCT00636753|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2010-07-29|||September 2008||2008-09-01|July 2010|2010-07-01||||July 2009|Anticipated|2009-07-01||Observational|||Antipsychotics and Metabolic Syndrome||Suspended||N/A|60|Anticipated|Glostrup University Hospital, Copenhagen|||2|this study has not finding place|f||||t||||||None Retained|"~     whole blood, serum/plasma~   "|||2017-02-18 14:36:56.545965|2017-02-18 14:36:56.545965
NCT00636740|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2009-02-19|||February 2008||2008-02-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients|A Multi-Center Phase II Study to Compare MER-101 (20mg) Tablets To Intravenous Zometa 4mg in Male Bisphosphonate-Naive Hormone Refractory Prostate Cancer Patients|Completed||Phase 2|30|Actual|Merrion Pharmaceuticals, LLC||3|||f||||f||||||||||2017-02-18 14:36:56.632898|2017-02-18 14:36:56.632898
NCT00636727|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2013-11-19|||January 2007||2007-01-01|November 2013|2013-11-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|TMJ||A Comparison of Arthrocentesis, Arthroscopy and Arthroplasty in the Treatment of Temporomandibular Joint Dysfunction|A Comparison of Arthrocentesis, Arthroscopy and Arthroplasty in the Treatment of Temporomandibular Joint Dysfunction|Completed||N/A|100|Actual|Emory University||3|||f||||f||||||||||2017-02-18 14:36:56.746446|2017-02-18 14:36:56.746446
NCT00636714|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2017-01-03|||January 2008||2008-01-01|January 2017|2017-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Comparison of 2 Methods to Achieve Tight Glucose Control in Cardiovascular ICU Patients|Randomized Controlled Trial of Nurse-directed vs Nomogram-directed Intensive Glucose Control in the CVICU|Completed||Phase 4|40|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 14:36:56.848307|2017-02-18 14:36:56.848307
NCT00636701|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2015-04-15|2014-11-20||September 2007||2007-09-01|April 2015|2015-04-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Improving Rehabilitation by Magnetic Brain Stimulation|Improving Rehabilitation by Magnetic Brain Stimulation: Improving Motor Recovery After Stroke|Completed||Phase 1|4|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:36:56.960497|2017-02-18 14:36:56.960497
NCT00636662|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2009-01-08|||February 2008||2008-02-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|FLUA+B||FLU A+B Nasal Swab Clinical Study|Evaluation of the RAMP FLU A+B Test Versus Viral Culture Using Clinical Nasal Swab Samples From Patients With Suspected Influenza Infections|Completed||N/A|800|Actual|Response Biomedical Corp.|||1||f||||f||||||Samples With DNA|"~     mucous~   "|||2017-02-18 14:36:57.51858|2017-02-18 14:36:57.51858
NCT00636649|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-03|2016-05-23|2012-12-07||October 2008||2008-10-01|May 2016|2016-05-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|||Escitalopram Treatment of Night Eating Syndrome|Escitalopram Treatment of Night Eating Syndrome: a Randomized Controlled Trial|Completed||N/A|40|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:36:57.61606|2017-02-18 14:36:57.61606
NCT00636636|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2012-02-21|2011-10-13||March 2008||2008-03-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Efficacy of Gabapentin in Postherpetic Neuralgia|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Patients With Postherpetic Neuralgia|Completed||Phase 3|452|Actual|Depomed||2|||f||||f||||||||||2017-02-18 14:36:58.238237|2017-02-18 14:36:58.238237
NCT00636623|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-03-07|||November 2006||2006-11-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|FM||Comparison of Exercise and Massage in Fibromyalgia|Comparison of Pilates Exercises and Connective Tissue Massage in Females With Fibromyalgia|Completed||N/A|36|Actual|Pamukkale University||2|||f||||f||||||||||2017-02-18 14:36:58.841558|2017-02-18 14:36:58.841558
NCT00636610|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2012-06-01|2012-02-14||May 2008||2008-05-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer|A Randomized, Placebo-Controlled Phase II Study of Vismodegib (GDC-0449, Systemic Hedgehog Antagonist) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer|Completed||Phase 2|199|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 14:36:58.95737|2017-02-18 14:36:58.95737
NCT00636597|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2011-10-19|||April 2007||2007-04-01|October 2011|2011-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||A Prospective Evaluation of Same Day Bidirectional Endoscopy for Occult Bleeding|Prospective Evaluation of Same Day Bidirectional Endoscopy for Occult Bleeding|Terminated||N/A|200|Anticipated|VA Office of Research and Development|||1|Not able to find enough eligible patients (200) in last 4 years.|f||||f||||||||||2017-02-18 14:36:59.923777|2017-02-18 14:36:59.923777
NCT00636584|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-03-07|||February 2008||2008-02-01|March 2008|2008-03-01|March 2008|Anticipated|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Clinical Study Investigating the Effect of Sodium Nitroprusside Infusion on Thyroidal Function|Does Sodium Nitroprusside Infusion Affect Thyroidal Function in Patients Undergoing Coronary Artery Bypass Grafting, a Prospective Randomized Clinical Trial.|Unknown status|Recruiting|Phase 4|106|Anticipated|Kavaklıdere Umut Hospital||2|||f||||f||||||||||2017-02-18 14:37:00.006244|2017-02-18 14:37:00.006244
NCT00636571|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-10-25|||March 2006||2006-03-01|October 2013|2013-10-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|||Feasibility of Exercise With Post-Op Lung Cancer Patients|Determining the Feasibility of Post-Operative Training for Patients Diagnosed With Non-Small Cell Lung Cancer|Completed||N/A|21|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:37:00.281919|2017-02-18 14:37:00.281919
NCT00636558|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2012-06-07|||March 2008||2008-03-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers|A Phase I, Open-Label, Cohort Study of Multiple Doses of Cavatak™ (Coxsackie Virus A21) Given Intravenously to Stage IV Solid Tumour Cancer Patients Bearing ICAM-1 With or Without DAF Expressing Tumours|Completed||Phase 1|8|Actual|Viralytics||1|||f||||t||||||||||2017-02-18 14:37:00.380727|2017-02-18 14:37:00.380727
NCT00636545|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2012-04-04|||May 2007||2007-05-01|January 2009|2009-01-01|March 2010|Actual|2010-03-01|March 2008|Actual|2008-03-01||Interventional|||Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors|A Safety, Pharmacokinetic, and Pharmacodynamic Assessment of Genasense Administered as a 2-hour Intravenous Infusion to Subjects With Solid Tumors|Completed||Phase 1|25|Actual|Genta Incorporated||3|||f||||f||||||||||2017-02-18 14:37:00.503572|2017-02-18 14:37:00.503572
NCT00636519|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2011-02-22|||February 2008||2008-02-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle|Botulism Antitoxin Effects on Paralysis Induced by Type A and Type B Botulinum Neurotoxins in the Extensor Digitorum Brevis Muscle|Completed||Phase 1|36|Actual|Cangene Corporation||2|||f||||f||||||||||2017-02-18 14:37:00.614179|2017-02-18 14:37:00.614179
NCT00636506|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-11|||August 2005||2005-08-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|February 2006|Actual|2006-02-01||Interventional|||Evaluate Improvement of Erectile Dysfunction After Placement of the AMS IPP 2005 Inflatable Penile Prosthesis|A Multi-Center Study to Assess the AMS IPP 2005 Inflatable Penile Prosthesis Cylinders, Pump and Reservoir.|Completed||Phase 2|70|Actual|American Medical Systems||1|||f||||||||||||||2017-02-18 14:37:00.73968|2017-02-18 14:37:00.73968
NCT00636493|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2012-12-11|||October 2002||2002-10-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)|A Pilot Study of a Sustained-Release Fluocinolone Implant for Treatment of Retinal Vein Occlusion|Completed||Early Phase 1|30|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:37:00.853466|2017-02-18 14:37:00.853466
NCT00636480|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2016-01-07||2013-02-19|October 2007||2007-10-01|January 2016|2016-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Preoperative Skin Preparation Evaluation|Preoperative Skin Preparation Evaluation of One Test Product With a Positive and a Negative Control|Completed||Phase 3|60|Actual|CareFusion||3|||f||||f||||||||||2017-02-18 14:37:00.983044|2017-02-18 14:37:00.983044
NCT00636467|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-09-25|||March 2008||2008-03-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|GAS2PLUS||Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm|Evaluation of the Technique of Axillary Sentinel Lymph Node (SLN) Detection in Breast Cancers > 2 cm|Completed||Phase 2|249|Actual|Centre Leon Berard||1|||f||||f||||||||||2017-02-18 14:37:01.111581|2017-02-18 14:37:01.111581
NCT00636454|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2013-09-25|||May 2008||2008-05-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effectiveness of a Training Program in Improving Coping Skills in People With Arthritis Pain|Coping Skills Training for Arthritis: An Effectiveness Trial|Completed||Phase 2/Phase 3|257|Actual|Stony Brook University||2|||f||||f||||||||||2017-02-18 14:37:01.498378|2017-02-18 14:37:01.498378
NCT00636441|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2015-11-16|2014-05-07||April 2008||2008-04-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||All patients who signed a consent form are included in the baseline analysis.|Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer|A Randomized Phase II Trial Evaluating the Performance of Genomic Expression Profiles to Direct the Use of Preoperative Chemotherapy for Early Stage Breast Cancer|Terminated||Phase 2|56|Actual|Duke University||2||Study terminated due to reproducibility issues with genomics prediction model|f||||f||||||||||2017-02-18 14:37:01.646281|2017-02-18 14:37:01.646281
NCT00636428|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-04-08|||March 2007||2007-03-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Clinical Trial of Oral Midazolam in Pediatric Endoscopy|Clinical Trial of Oral Midazolam in Pediatric Endoscopy|Completed||Phase 4|50|Actual|Tabriz University||2|||f||||t||||||||||2017-02-18 14:37:03.061789|2017-02-18 14:37:03.061789
NCT00636415|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-11|||June 2004||2004-06-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|July 2005|Actual|2005-07-01||Interventional|||Intra-Articular Morphine Versus Bupivacaine on Knee Motion in Patients With Osteoarthritis|Intra-Articular Morphine Versus Bupivacaine on Knee Motion in Patients With Osteoarthritis: Randomized and Double-Blind Clinical Trial|Completed||N/A|30|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 14:37:03.16363|2017-02-18 14:37:03.16363
NCT00636402|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-12-10|||March 2008||2008-03-01|December 2008|2008-12-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Study of Efficacy and Adverse Effects: Vessel Sealing System Tonsillectomy Versus Cold Knife Tonsillectomy|Vessel Sealing System Tonsillectomy vs Cold Knife Tonsillectomy: A Randomized, Paired Control Study of Efficacy and Adverse Effects|Unknown status|Enrolling by invitation|N/A|20|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-02-18 14:37:03.267968|2017-02-18 14:37:03.267968
NCT00636389|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2011-07-18|2011-03-07||February 2008||2008-02-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers|Urea, Phosphate and b2-Microglobulin Removal and Ease of Use: Comparing the Polyflux HD-C4 With the Polyflux 210H|Completed||N/A|12|Actual|Gambro Renal Products, Inc.||2|||f||||f||||||||||2017-02-18 14:37:03.382265|2017-02-18 14:37:03.382265
NCT00636376|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-10-20|||January 2002||2002-01-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effects of Head Elevation on Intracranial Pressure in Children|Effect of Head Elevation on Intracranial Pressure and Cerebral Venous Outflow in Children|Completed||N/A|18|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 14:37:03.784447|2017-02-18 14:37:03.784447
NCT00636363|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2015-03-04|2011-02-03||March 2008||2008-03-01|March 2015|2015-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution||Completed||N/A|541|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-02-18 14:37:03.892002|2017-02-18 14:37:03.892002
NCT00636350|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2009-09-22|||September 2007||2007-09-01|September 2009|2009-09-01|May 2009|Anticipated|2009-05-01|September 2008|Anticipated|2008-09-01||Interventional|||Bioavailability of Pepper Carotenoids in Humans||Unknown status|Active, not recruiting|Phase 1|5|Anticipated|Tufts University||1|||f||||f||||||||||2017-02-18 14:37:04.41981|2017-02-18 14:37:04.41981
NCT00636337|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-02-15|||December 2007||2007-12-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|June 2010|Actual|2010-06-01||Interventional|TRICCS||Inattention in Childhood Cancer Survivors|TRICCS: Targeting Inattention in Childhood Cancer Survivors|Completed||N/A|23|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:37:04.530796|2017-02-18 14:37:04.530796
NCT00636324|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2009-02-09|||July 2007||2007-07-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|March 2008|Actual|2008-03-01||Interventional|L-CPAP||Level of Continuous Positive Airway Pressure (CPAP) in Preterm Infants After Extubation (L-CPAP Study)|Nasal Continuous Positive Airway Pressure in Preterm Infants After Extubation: Comparison of Different Levels of Pressure|Terminated||Phase 2|23|Actual|McMaster University||2||Difficulties in recruitment - will require longer time to achieve sample size|f||||t||||||||||2017-02-18 14:37:04.642284|2017-02-18 14:37:04.642284
NCT00636311|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2010-09-01|||February 2008||2008-02-01|September 2010|2010-09-01|February 2010|Actual|2010-02-01|April 2008|Actual|2008-04-01||Interventional|||A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma|IGEV +/- Bortezomib (Velcade) as Induction Before High Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma After First Line Treatment: a Randomized Phase II Trial. On Behalf of Intergruppo Italiano Linfomi|Completed||Phase 2|13|Actual|Istituto Clinico Humanitas||2|||f||||f||||||||||2017-02-18 14:37:04.755268|2017-02-18 14:37:04.755268
NCT00636298|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2013-11-18|||October 2008||2008-10-01|November 2013|2013-11-01|March 2012|Anticipated|2012-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy|Phase II Study of Cetuximab and Bevacizumab in Esophageal Carcinoma That Failed First Line Therapy|Withdrawn||Phase 2|0|Actual|Emory University||1||lack of funding|f||||t||||||||||2017-02-18 14:37:04.867574|2017-02-18 14:37:04.867574
NCT00636285|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-10-08|||April 2001||2001-04-01|October 2008|2008-10-01|November 2001|Actual|2001-11-01|September 2001|Actual|2001-09-01||Interventional|||Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants|Phase 1, Open-Label, Dose-Ranging, Safety and Pharmacokinetics Study in Adults of BSYX-A110, a Human Chimeric Anti-Staphylococcal Monoclonal Antibody for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants|Completed||Phase 1|8|Actual|Biosynexus Incorporated||3|||f||||f||||||||||2017-02-18 14:37:04.982289|2017-02-18 14:37:04.982289
NCT00636272|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-08-14|||March 2008||2008-03-01|August 2008|2008-08-01||||||||Observational|LSR||Longitudinal Surveillance Registry|Longitudinal Surveillance Registry|Terminated||N/A|2500|Anticipated|Boston Scientific Corporation|||1||f||||t||||||||||2017-02-18 14:37:05.097871|2017-02-18 14:37:05.097871
NCT00635284|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2016-10-25|||December 2007||2007-12-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies|A Phase I Trial of ABI-009 (Nab-rapamycin) Administered Weekly in Patients With Advanced Non-hematologic Malignancies|Completed||Phase 1|27|Actual|Celgene Corporation||1|||f||||f||||||||||2017-02-18 14:37:05.180071|2017-02-18 14:37:05.180071
NCT00635271|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-08|2017-01-24|||February 29, 2008||2008-02-29|November 28, 2012|2012-11-28|November 28, 2012||2012-11-28|||||Observational|||Biomarkers in Exhaled Breath From Asthmatic Patients|Identification of Biomarkers in Exhaled Breath Condensates From Asthmatic Patients|Terminated||N/A|19|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:37:05.28413|2017-02-18 14:37:05.28413
NCT00635258|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-03-06|||January 2004||2004-01-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|GnRH-Ovodon||Administration of GnRH Antagonist to Oocyte Donation Recipients|Administration of GnRH Antagonist to Oocyte Donation Recipients During Endometrial Preparation.|Completed||N/A|100|Actual|Centro Ginecologia y Obstetricia.|||2||f||||t||||||||||2017-02-18 14:37:05.370483|2017-02-18 14:37:05.370483
NCT00635245|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-03-10||||||March 2015|2015-03-01||||||||Interventional|||CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery|A Phase 1 Pharmacodynamic Study Of CP-751,871 As Neoadjuvant Treatment For Early Breast Cancer|Withdrawn||Phase 1|0|Actual|Pfizer|||||f||||||||||||||2017-02-18 14:37:05.4822|2017-02-18 14:37:05.4822
NCT00635232|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2011-09-12|2011-08-09||March 2008||2008-03-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension|A Randomized, Double-Blind, Placebo And Active-Controlled, Parallel Group Study To Evaluate The Dose-Related Efficacy And Safety Of PS433540 In Subjects With Hypertension|Completed||Phase 2|261|Actual|Ligand Pharmaceuticals|The 800mg dose level was discontinued from further enrollment per protocol amendment due to findings from another PS433540 trial that suggested clinical benefit beyond 500mg was expected to be limited.|5|||f||||f||||||||||2017-02-18 14:37:05.579742|2017-02-18 14:37:05.579742
NCT00635219|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-12-23|2013-10-28||February 2008||2008-02-01|December 2013|2013-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional||Full-analysis set (FAS) - all patients in the all-patients-treated set (APTS) who had at least one valid postbaseline assessment of the primary efficacy variable|Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder|A Randomised, Double-blind, Parallel-group, Placebo-controlled, Duloxetine-referenced, Fixed-dose Study Evaluating the Efficacy and Safety of Three Dosages of [Vortioxetine] Lu AA21004, in Acute Treatment of Major Depressive Disorder|Completed||Phase 3|766|Actual|H. Lundbeck A/S||5|||f||||f||||||||||2017-02-18 14:37:08.927452|2017-02-18 14:37:08.927452
NCT00635206|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2009-07-13|||September 2007||2007-09-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|BIPAP||Investigation of a Novel Positive Pressure Therapy to Rescue Patients Failing to Tolerate CPAP During an Initial Encounter|Investigation of a Novel Positive Pressure Therapy to Rescue Patients Failing to Tolerate CPAP During an Initial Encounter|Completed||Phase 3|51|Actual|Clayton Sleep Insititute||2|||f||||t||||||||||2017-02-18 14:37:10.388607|2017-02-18 14:37:10.388607
NCT00635193|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-01-10||2012-05-04|July 2007||2007-07-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)|A Phase 1/2, Open-Label, Adaptive, Randomized Study of Liposomal Doxorubicin With or Without M200 (Volociximab) for the Treatment of Subjects With Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer That Have Relapsed After Prior Therapy With a Platinum/Taxane-Based Chemotherapy|Completed||Phase 1/Phase 2|138|Actual|AbbVie||5|||f||||f||||||||||2017-02-18 14:37:10.493576|2017-02-18 14:37:10.493576
NCT00633529|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-10-21|||November 2007||2007-11-01|October 2013|2013-10-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|||Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC|Open-Label Phase 1b Study of Erlotinib Plus Bevacizumab and IMO-2055 in Patients With Non-Small Cell Lung Cancer Who Have Progressed Following Initial Chemotherapy for Advanced or Metastatic Disease|Completed||Phase 1|36|Actual|EMD Serono||1|||f||||f||||||||||2017-02-18 14:37:10.650286|2017-02-18 14:37:10.650286
NCT00633516|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2017-02-08|||July 2008||2008-07-01|February 2017|2017-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions|A Pilot Study to Evaluate the Correlation Between Modified Two Layer Diffuse Optical Spectroscopy With the Clinical and Histological Examinations of Pigmented Skin Lesions Based on Physiological Parameters|Completed||N/A|37|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:37:10.777432|2017-02-18 14:37:10.777432
NCT00633503|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2012-11-11|||January 2011||2011-01-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||Monitoring of Tissue Transfer Flaps by Modulated Imaging (MI) Spectroscopy|Monitoring of Tissue Transfer Flaps by Modulated Imaging (MI) Spectroscopy|Unknown status|Recruiting|N/A|200|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:37:10.889265|2017-02-18 14:37:10.889265
NCT00633490|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2008-07-21|||July 2007||2007-07-01|March 2008|2008-03-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Study of Apatinib as an Inhibitor of Tumor Angiogenesis|Phase 1 Study of Apatinib as an Inhibitor of Angiogenesis|Unknown status|Recruiting|Phase 1|18|Anticipated|Fudan University||1|||f||||f||||||||||2017-02-18 14:37:10.99856|2017-02-18 14:37:10.99856
NCT00633477|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2013-01-10|2012-12-05||February 2008||2008-02-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of TAK-242 Versus Placebo in Subjects With Sepsis-Induced Cardiovascular and Respiratory Failure|Terminated||Phase 3|18|Actual|Takeda||2||Business Decision; No Safety Or Efficacy Concerns.|f||||t||||||||||2017-02-18 14:37:11.113778|2017-02-18 14:37:11.113778
NCT00633464|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-02-09|2012-03-30||June 2008||2008-06-01|February 2016|2016-02-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|||Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer|Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative (ER, PR, Her2 Negative) Locally Advanced Non-resectable and/or Metastatic Breast Cancer|Completed||Phase 2|79|Actual|R-Pharm||2|||f||||f||||||||||2017-02-18 14:37:11.926696|2017-02-18 14:37:11.926696
NCT00633451|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2013-03-26|||February 2008||2008-02-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Randomized Clinical Trial of Rehabilitation for Subacromial Impingement Syndrome|Randomized Clinical Trial of Rehabilitation for Subacromial Impingement Syndrome: A Comparison of Manual Therapy + Exercise to Exercise Only|Completed||N/A|109|Actual|Proaxis Therapy||2|||f||||f||||||||||2017-02-18 14:37:13.050499|2017-02-18 14:37:13.050499
NCT00191399|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||May 2004||2004-05-01|January 2007|2007-01-01|March 2006||2006-03-01|||||Interventional|||Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response|Bipolar Depression Assessment Study on Tx Response|Completed||Phase 4|150||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:05.483507|2017-02-18 17:15:05.483507
NCT00633438|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-03-12|||January 2004||2004-01-01|March 2009|2009-03-01|June 2004|Actual|2004-06-01|||||Interventional|||Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery|A Double-Blind, Placebo-Controlled, Randomized Comparison Study of the Efficacy of Celebrex 400 mg Single Dose Pre and Celebrex 200 mg Post Ambulatory Arthroscopic Knee Surgery for Total Analgesic Use After Surgery|Completed||Phase 4|204|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:37:13.166016|2017-02-18 14:37:13.166016
NCT00633425|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-03-26|||October 2002||2002-10-01|March 2008|2008-03-01|October 2003|Actual|2003-10-01|||||Interventional|||Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride||Completed||Phase 4|43|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:37:13.307748|2017-02-18 14:37:13.307748
NCT00633412|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2009-06-09|||February 2001||2001-02-01|June 2009|2009-06-01|March 2003|Actual|2003-03-01|||||Interventional|||A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only||Completed||Phase 3|400|Anticipated|AstraZeneca||3|||f||||||||||||||2017-02-18 14:37:13.391765|2017-02-18 14:37:13.391765
NCT00633399|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2014-06-24|2014-06-24||July 2008||2008-07-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs|A Three-phase Study Designed to Test the Efficacy, Tolerability and Safety of the Combination of Ziprasidone With Selective Serotonin Reuptake Inhibitors (SSRI) for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs.|Completed||Phase 2|458|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:37:13.484239|2017-02-18 14:37:13.484239
NCT00633386|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-03-12|||February 2003||2003-02-01|March 2009|2009-03-01|August 2003|Actual|2003-08-01|||||Interventional|||Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery|A Double-Blind, Placebo-Controlled, Randomized, Comparison Study of the Efficacy of Celebrex 400 mg Single Dose Pre and Celebrex 200 mg Post Ambulatory Arthroscopic Knee Surgery for Total Analgesic Use After Surgery|Completed||Phase 4|200|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:37:13.848209|2017-02-18 14:37:13.848209
NCT00633373|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2012-09-13||||||September 2012|2012-09-01||||||||Expanded Access|||Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients|An Open-label Treatment Use Protocol of Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients|No longer available||N/A|||APT Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 14:37:13.966528|2017-02-18 14:37:13.966528
NCT00633360|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2014-07-09|||February 2008||2008-02-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||The Oral Contraceptive Pill for Premenstrual Worsening of Depression|The Oral Contraceptive Pill for Premenstrual Worsening of Depression.|Completed||N/A|99|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:37:14.057204|2017-02-18 14:37:14.057204
NCT00636259|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-06-10||||||June 2008|2008-06-01||||||||Expanded Access|||Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer|A Compassionate Use Trial With Bicalutamide (Casodex) 150-mg for Subjects With Prostate Cancer|No longer available||N/A|||AstraZeneca|||||||||||||||||||2017-02-18 14:37:14.164039|2017-02-18 14:37:14.164039
NCT00636246|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-04-03|||June 2004||2004-06-01|April 2008|2008-04-01|August 2005|Actual|2005-08-01|||||Interventional|||A Comparison of Sertraline-Reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.|Sertraline/[S,S]-Reboxetine Combination Versus Sertraline And [S,S]-Reboxetine Monotherapy In Major Depressive Disorder (MDD) In A Double-Blind, Placebo-Controlled, Eight Week Study.|Completed||Phase 2|510|Actual|Pfizer||8|||f||||f||||||||||2017-02-18 14:37:14.242177|2017-02-18 14:37:14.242177
NCT00636233|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2016-06-22|||May 1993||1993-05-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Genetics of Spina Bifida and Anencephaly|The Hereditary Basis of Neural Tube Defects|Recruiting||N/A|10000|Anticipated|Duke University|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, saliva, cord blood, fetal tissue, cultured fetal cells~   "|No||2017-02-18 14:37:14.363892|2017-02-18 14:37:14.363892
NCT00636220|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2015-07-27|2009-01-08||March 2008||2008-03-01|July 2015|2015-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|HIVOF||Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid|Evaluation of the DPP HIV Test With Reader and the HIV 1/2 Stat-Pak Test Using Oral Fluids|Completed||N/A|101|Actual|Chembio Diagnostic Systems, Inc.|||1||f||||t||||||Samples Without DNA|"~     oral fluid samples and venous blood~   "|||2017-02-18 14:37:14.470765|2017-02-18 14:37:14.470765
NCT00636207|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2016-04-07|2012-12-20||August 2007||2007-08-01|April 2016|2016-04-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)|A Sequential, 3-Part, Double-Blind, Randomized, Placebo-Controlled, Single-Rising-Dose and Rising-Multiple-Dose Study in Healthy Subjects and Mild or Moderate Asthmatic Patients to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled MK-0476|Completed||Phase 1|46|Actual|Merck Sharp & Dohme Corp.||6|||f||||||||||||||2017-02-18 14:37:14.913507|2017-02-18 14:37:14.913507
NCT00636194|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2011-12-07|2010-12-14||February 2008||2008-02-01|December 2011|2011-12-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Comparative Performance of a Bausch & Lomb Multipurpose Solution and Alcon OptiFree Replenish Multipurpose Solution|Product Performance of Bausch & Lomb Multi-Purpose Solution Compared to Alcon Opti-Free Replenish Multi-Purpose Solution When Used With Silicone Hydrogel Contact Lenses Worn on a Daily Wear Basis|Completed||N/A|361|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:37:15.957145|2017-02-18 14:37:15.957145
NCT00636181|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-06-09|||January 2008||2008-01-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Positive Pressure Treatment of Obstructive Sleep Apnea|Positive Airway Pressure Initiation: Impact of Therapy Mode and Titration Process on Adherence and Outcomes|Completed||N/A|150|Anticipated|Philips Respironics||3|||f||||f||||||||||2017-02-18 14:37:16.410157|2017-02-18 14:37:16.410157
NCT00635986|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-03-11|||May 2004||2004-05-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|June 2005|Actual|2005-06-01||Interventional|FTN||Analgesic Effect and Plasma Concentration of Epidural Versus Intravenous Fentanyl|Analgesic Effect and Plasma Concentration of Epidural Versus Intravenous Fentanyl|Completed||N/A|30|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 14:37:21.307888|2017-02-18 14:37:21.307888
NCT00636168|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2016-06-20|2014-07-25||June 2008||2008-06-01|October 2015|2015-10-01|July 2016|Anticipated|2016-07-01|July 2013|Actual|2013-07-01||Interventional||All participants randomized to a study arm (Intent to treat population) were analyzed in the arm to which they were allocated by randomization.|Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma|Adjuvant Immunotherapy With Anti-CTLA-4 Monoclonal Antibody (Ipilimumab) Versus Placebo After Complete Resection of High Risk Stage III Melanoma: A Randomized, Double-blind Phase 3 Trial of the EORTC Melanoma Group|Active, not recruiting||Phase 3|1211|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 14:37:16.538332|2017-02-18 14:37:16.538332
NCT00636155|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-11-26|2012-05-29||February 2008||2008-02-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|August 2011|Actual|2011-08-01||Interventional|||EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase II Study of EL625 in Patients in Persistent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Terminated||Phase 2|20|Actual|Duke University||1||funding|f||||f||||||||||2017-02-18 14:37:18.833431|2017-02-18 14:37:18.833431
NCT00636142|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-13|||September 2005||2005-09-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Interventional|||Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity|A Prospective Trial of Anti-TNF-Alpha Chimeric Monoclonal Antibody (Infliximab, Remicade®) on Insulin Sensitivity, Beta Cell Function and Cardiovascular Risk Profile in Insulin Resistant Human Obesity|Completed||Phase 4|9|Actual|Medical University of Graz||2|||f||||t||||||||||2017-02-18 14:37:19.238687|2017-02-18 14:37:19.238687
NCT00636129|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2011-09-16|||December 2006||2006-12-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Biochemical and Physiological Changes Associated With Differing Durations of Relaxation Response Training|Biochemical and Physiological Changes Associated With Differing Durations of Relaxation Response Training|Completed||N/A|30|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"~     Whole blood Serum Plasma~   "|||2017-02-18 14:37:19.345833|2017-02-18 14:37:19.345833
NCT00636116|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2012-01-09|||May 2008||2008-05-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.|A Comparison of Anavip® and CroFab® in the Treatment of Patients With Crotalinae Envenomation: A Randomized, Prospective, Blinded, Controlled, Comparative, Multicenter Study|Completed||Phase 3|121|Actual|Instituto Bioclon S.A. de C.V.||3|||f||||f||||||||||2017-02-18 14:37:19.439521|2017-02-18 14:37:19.439521
NCT00636103|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-11|||July 2002||2002-07-01|March 2008|2008-03-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma|A Randomized Double-Blind Placebo-Controlled Study of the Effect of Traditional Chinese Medicines in the Treatment of Childhood Asthma|Completed||Phase 1/Phase 2|90|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 14:37:19.572328|2017-02-18 14:37:19.572328
NCT00636090|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2013-12-03|||January 2007||2007-01-01|December 2013|2013-12-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Observational|||Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001|Molecular, Genetic, and Genomic Assessments of MTOR Inhibition in Metastatic Hormone-Refractory Prostate Cancer Tissue From Patients Treated With RAD001|Completed||N/A|35|Actual|Duke University|||1||f||||f||||||Samples With DNA|"~     This study involves the retention of tissue sample from tumor biopsies as well as blood~     samples.~   "|||2017-02-18 14:37:19.684711|2017-02-18 14:37:19.684711
NCT00636077|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-06-06|2011-03-07||February 2008||2008-02-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For Hemodialysis|Effect Of Dialysate Flow Rate On Mass Transfer Coefficient - Area (KoA) In Dialyzers With Different Membrane Packing Densities|Completed||N/A|12|Actual|Gambro Renal Products, Inc.||4|||f||||f||||||||||2017-02-18 14:37:19.78757|2017-02-18 14:37:19.78757
NCT00636064|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-10-09|||January 2003||2003-01-01|March 2008|2008-03-01|January 2004|Actual|2004-01-01|||||Interventional|||A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery|A Double-Blind Multicenter Study of the Safety and Efficacy of Parecoxib Sodium/Valdecoxib and Placebo/Valdecoxib Compared to Placebo for Treatment of Post-Surgical Pain in Patients Who Have Coronary Bypass Graft Via Median Sternotomy|Completed||Phase 3|1671|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 14:37:20.314058|2017-02-18 14:37:20.314058
NCT00636051|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2009-06-08|||February 2005||2005-02-01|June 2009|2009-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Evidence-Based Practice (EBP) Awareness Project: Peer-to-Peer Dissemination|Evidence-Based Practice (EBP) Awareness Project: Peer-to-Peer Dissemination|Completed||N/A|91|Actual|State University of New York - Upstate Medical University|||2||f||||f||||||||||2017-02-18 14:37:20.828309|2017-02-18 14:37:20.828309
NCT00636038|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-03-13|||January 2008||2008-01-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Bioavailability of Yellow Maize Carotenoids in Humans||Completed||Phase 1|8|Actual|Tufts University|||||f||||f||||||||||2017-02-18 14:37:20.908411|2017-02-18 14:37:20.908411
NCT00636025|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2015-02-24|||July 2008||2008-07-01|February 2015|2015-02-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Observational|||Cellulite and Magnetic Resonance Imaging|Anatomy of Subcutaneous Structures in Areas With and Without Cellulite Depressions by Magnetic Resonance Imaging|Completed||N/A|30|Actual|Brazilan Center for Studies in Dermatology|||1||f||||f||||||None Retained|"~     None retained~   "|||2017-02-18 14:37:21.020431|2017-02-18 14:37:21.020431
NCT00636012|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2012-07-09|||March 2008||2008-03-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|GSW||Stimulation of Gastric Slow Waves With Acupuncture at St36 and Pe6 - a Randomized Single-blind Controlled Trial|Stimulation of Gastric Slow Waves by Acupuncture of St36 and Pe6 - a Randomized Single-blind Controlled Trial|Completed||N/A|65|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 14:37:21.100215|2017-02-18 14:37:21.100215
NCT00635999|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-10-22|||October 1991||1991-10-01|August 2009|2009-08-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||A Comparison Between Cognitive, Behavioral, and Cognitive-Behavioral Therapy for Generalized Anxiety Disorder|Desensitization and Cognitive Therapy in General Anxiety|Completed||Phase 1|76|Actual|National Institute of Mental Health (NIMH)||3|||f||||f||||||||||2017-02-18 14:37:21.201929|2017-02-18 14:37:21.201929
NCT00005156|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-29|||April 1982||1982-04-01|February 2016|2016-02-01|July 1996||1996-07-01|||||Observational|||Mortality Surveillance of MRFIT Screenees||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:15:25.834821|2017-02-18 18:15:25.834821
NCT00635973|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2009-04-21|||February 2000||2000-02-01|April 2009|2009-04-01|October 2003|Actual|2003-10-01|||||Interventional|||Open-Label Extension of Other SZ1839 (Iressa) Trials|Multi-Centre, Open-Label Extension Trial of Treatment With ZD1839 (Iressa) in Patients Who Have Been Treated in Other ZD1839 Clinical Trials and May Benefit From Continued Monotherapy ZD 1839.|Completed||Phase 3|100|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:37:21.391989|2017-02-18 14:37:21.391989
NCT00635960|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2010-05-25|||March 2007||2007-03-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|July 2009|Actual|2009-07-01||Interventional|||Growth Hormone in Amyotrophic Lateral Sclerosis|Efficacy, Safety and Tolerability of Growth Hormone in Patients With Amyotrophic Lateral Sclerosis as add-on Therapy to Riluzole|Completed||Phase 2|40|Anticipated|Federico II University||2|||f||||t||||||||||2017-02-18 14:37:21.467005|2017-02-18 14:37:21.467005
NCT00635947|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-03-13|||July 1998||1998-07-01|March 2008|2008-03-01|January 2005|Actual|2005-01-01|July 1999|Actual|1999-07-01||Interventional|||Study of Maternal Hydration on the Increase of Amniotic Fluid Index|Randomized Trial of Maternal Hydration on the Increase of Amniotic Fluid Index|Completed||Phase 4|99|Actual|UPECLIN HC FM Botucatu Unesp||3|||f||||t||||||||||2017-02-18 14:37:21.585793|2017-02-18 14:37:21.585793
NCT00635934|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2012-04-24|||December 2005||2005-12-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|October 2009|Actual|2009-10-01||Interventional|||A-MAV™ Anterior Motion Segment Replacement|A Prospective, Non-Randomized Pilot Clinical Investigation of the A-MAV™ Anterior Motion Segment Replacement in Patients With Lumbar Degenerative Disc Disease|Completed||Phase 1|53|Actual|Medtronic Spinal and Biologics||1|||f||||t||||||||||2017-02-18 14:37:21.715886|2017-02-18 14:37:21.715886
NCT00635921|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2008-03-11|||March 2004||2004-03-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Ziprasidone in the Treatment of Borderline Personality Disorder|Ziprasidone in the Treatment of Borderline Personality Disorder: A Double-Blind, Placebo-Controlled, Randomized Study|Completed||Phase 2|60|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-02-18 14:37:21.814146|2017-02-18 14:37:21.814146
NCT00635895|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2008-03-07|||June 2006||2006-06-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|FM||Comparison of Lymph Drainage and Connective Tissue Massage in Fibromyalgia Patients|Comparison of Manual Lymph Drainage Therapy and Connective Tissue Massage in Females With Fibromyalgia: A Randomized Controlled Trial|Completed||N/A|50|Actual|Pamukkale University||2|||f||||f||||||||||2017-02-18 14:37:21.911669|2017-02-18 14:37:21.911669
NCT00635882|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2015-09-18|2010-10-22||February 2008||2008-02-01|September 2015|2015-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)|A 2-Week Double-Blind, Placebo-Controlled, Parallel Group Study Comparing the Anti-Inflammatory Effects of Low, Medium, and High Dose Mometasone Furoate/Formoterol Fumarate MDI Formulation and Medium Dose Mometasone Furoate DPI and MDI Formulations in Adults and Adolescents With Persistent Allergic Asthma|Completed||Phase 2|93|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 14:37:22.027552|2017-02-18 14:37:22.027552
NCT00635869|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2008-03-13|||September 2005||2005-09-01|March 2008|2008-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Advancing Research and Clinical Practice Through Close Collaboration (ARCC): A Pilot Test of an Intervention to Improve Evidence-Based Care and Patient Outcomes|Advancing Research and Clinical Practice Through Close Collaboration (ARCC): A Pilot Test of an Intervention to Improve Evidence-Based Care and Patient Outcomes|Completed||N/A|29|Actual|State University of New York - Upstate Medical University|||3||f||||f||||||||||2017-02-18 14:37:23.145652|2017-02-18 14:37:23.145652
NCT00635856|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2009-04-22|||May 2001||2001-05-01|April 2009|2009-04-01|February 2003|Actual|2003-02-01|||||Interventional|||Open Label Trial to Assess Iressa in Prostate Cancer Patients|Phase II, Open-Label Trial to Assess the Activity of ZD1839 (IRESSA TM) in Patients With Recurrent Prostate Cancer Who Have Rising Serum PSA Levels Despite Serum Testosterone < 50mg/dl|Completed||Phase 2|100|Anticipated|AstraZeneca||1|||t||||f||||||||||2017-02-18 14:37:23.245911|2017-02-18 14:37:23.245911
NCT00635843|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-08-01|||April 2003||2003-04-01|October 2011|2011-10-01|November 2010|Actual|2010-11-01|October 2006|Actual|2006-10-01||Interventional|||MAVERICK™ Total Disc Replacement- Pivotal Study|"A Prospective, Randomized Controlled Clinical Investigation of MAVERICK™ Total Disc Replacement in Patients With Degenerative Disc Disease"|Completed||Phase 3|577|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-02-18 14:37:23.330084|2017-02-18 14:37:23.330084
NCT00635830|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-10-08|2009-03-17||March 2008||2008-03-01|October 2015|2015-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)|An Open-Label, Single-Dose, Safety and Tolerability Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Chinese Female Subjects Aged 9 to 26 Years|Completed||Phase 1|40|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:37:23.469565|2017-02-18 14:37:23.469565
NCT00635817|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2011-10-25|2011-01-20||June 2008||2008-06-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty|A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30 mg Formulations in Children With Central Precocious Puberty|Completed||Phase 3|84|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:37:23.819157|2017-02-18 14:37:23.819157
NCT00635804|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-12-15|2016-02-18||February 2008||2008-02-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)|A 2-Part, Randomized, Double-Blind, Placebo-Controlled, Multiple-Rising Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy Male Subjects and Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-3281 in Hepatitis C Infected Male Patients|Completed||Phase 1|60|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-02-18 14:37:24.819973|2017-02-18 14:37:24.819973
NCT00635791|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-06-18|||March 2008||2008-03-01|June 2013|2013-06-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||Phase I Study of Vorinostat and Sorafenib in Advanced Cancer|A Phase I Safety and Tolerability Study of Vorinostat in Combination With Sorafenib in Patients With Advanced Solid Tumors, With Exploration of Two Tumor-type Specific Expanded Cohorts at the Recommended Phase 2 Dose|Completed||Phase 1|36|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-02-18 14:37:26.702781|2017-02-18 14:37:26.702781
NCT00635778|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2016-04-07|||August 2006||2006-08-01|April 2016|2016-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Infusion of MK-0646 in Subjects With Advanced Solid Tumors (MK-0646-002)(COMPLETED)|An Open-Label, Dose Escalation Phase I Trial of MK-0646 Given as a One to Two Hour Every Other Week Infusion in Patients With Relapsed or Refractory Locally Advanced or Metastatic Cancers|Completed||Phase 1|50|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 14:37:26.822841|2017-02-18 14:37:26.822841
NCT00635765|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2009-06-03|||October 2007||2007-10-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients|Open Label Extension Study Evaluating the Safety and Biological Activity of a New Prolonged Release Formulation of Octreotide Acetate, C2L-OCT-01 PR, Administered Intra Muscularly Every 6, 5 or 4 Weeks in Acromegalic Patients|Completed||Phase 3|63|Anticipated|Ambrilia Biopharma, Inc.||1|||f||||f||||||||||2017-02-18 14:37:26.926192|2017-02-18 14:37:26.926192
NCT00635752|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2015-04-22|||April 2008||2008-04-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|February 2011|Actual|2011-02-01||Interventional|||Trauma-focused Cognitive-behavioural Therapy(TF-CBT) for Children: A Study of Process and Outcome.|Trauma-focused Cognitive-behavioural Therapy for Children: A Study of Process and Outcome.|Completed||N/A|156|Actual|Norwegian Center for Violence and Traumatic Stress Studies||2|||f||||f||||||||||2017-02-18 14:37:27.024281|2017-02-18 14:37:27.024281
NCT00635739|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2012-05-30|||April 2008||2008-04-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effect of Whey Protein Supplementation and Resistance Exercise on Muscle Parameters in Older Adults|Efficacy of Whey Protein Supplementation on Resistance Exercise-Induced Changes in Muscle Strength, Fat Free Mass, and Function in Mobility-Limited Older Adults|Completed||N/A|80|Anticipated|Tufts University||2|||f||||f||||||||||2017-02-18 14:37:27.147386|2017-02-18 14:37:27.147386
NCT00635726|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2015-10-07|||February 2008||2008-02-01|October 2015|2015-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer|Sequential High Dose MVAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin), Followed by Gemcitabine Plus Cisplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer|Terminated||Phase 2|41|Actual|Hellenic Oncology Research Group||1||Due to poor accrual|f||||f||||||||||2017-02-18 14:37:27.259068|2017-02-18 14:37:27.259068
NCT00635713|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2009-04-09|||May 1997||1997-05-01|April 2009|2009-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Second Line Breast Cancer Trial|A Double-Blind, Randomized, Multi-Center Trial Comparing the Efficacy and Tolerability of 125 and 250mg of Faslodex (Long Acting ICI 182,780) With 1mg Arimidex (Anastrazole) in Postmenopausal Women With Advanced Breast Cancer.|Completed||Phase 3|588|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:37:27.389697|2017-02-18 14:37:27.389697
NCT00635700|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2016-09-06|2016-09-06||March 2008||2008-03-01|September 2016|2016-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|ZIP|Of 51 patients randomized, 27 were assigned to placebo and 24 to ziprasidone. One case allocated to ziprasidone was never dispensed study medication and was removed from analysis per protocol, leaving 23.|Ziprasidone in the Psychosis Prodrome|Ziprasidone vs Placebo in the Prevention of Psychosis Among Symptomatic Adolescents and Young Adults at Prodromal Risk|Completed||Phase 2|66|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:37:27.494677|2017-02-18 14:37:27.494677
NCT00635687|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-03-04|||March 2008||2008-03-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|March 2012|Actual|2012-03-01||Interventional|PROME||Transient Elastography and Variceal Bleeding|Can Liver Stiffness Values Predict Early Rebleeding in Variceal Rupture|Terminated||N/A|29|Actual|University Hospital, Rouen||1||lack of recruitment|f||||f||||||||||2017-02-18 14:37:27.818223|2017-02-18 14:37:27.818223
NCT00635674|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-13|||February 2007||2007-02-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effects of CPAP on Cardiovascular Risk in Obstructive Sleep Apnea (OSA) and Metabolic Syndrome|Effects of CPAP on Cardiovascular Risk Profile in Patients With Severe Obstructive Sleep Apnea and Metabolic Syndrome|Completed||N/A|32|Actual|Pavol Jozef Safarik University||2|||f||||f||||||||||2017-02-18 14:37:27.925283|2017-02-18 14:37:27.925283
NCT00635661|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2012-01-31|2011-08-09||January 2008||2008-01-01|January 2012|2012-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Assessment of the Stroke Rehabilitation Assessment of Movement as a Clinical Tool|A Comparison of the Stroke Rehabilitation Assessment of Movement, the Functional Independence Measure and the Stroke Impact Scale|Completed||N/A|34|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:37:28.037305|2017-02-18 14:37:28.037305
NCT00635648|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-09-07|2012-04-26||January 2008||2008-01-01|September 2015|2015-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)|A Non-comparative, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Acetate (MK-0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults|Completed||Phase 3|63|Actual|Merck Sharp & Dohme Corp.|This was an open-label non-comparative study with a relatively small sample size.|1|||f||||||||||||||2017-02-18 14:37:28.232238|2017-02-18 14:37:28.232238
NCT00635635|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-09|2010-05-25|||October 2007||2007-10-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Guided Imagery for Military Sexual Trauma-Related Posttraumatic Stress Disorder (PTSD)|Guided Imagery for Military Sexual Trauma-Related PTSD|Completed||N/A|40|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:37:28.485579|2017-02-18 14:37:28.485579
NCT00635622|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2009-07-09|||April 2008||2008-04-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy Study of Lactobacillus Administered Vaginally in Women With Bacterial Vaginosis|A Phase IIa Study of the Colonization Efficiency, Safety and Acceptability of LACTIN-V Administered Vaginally to Women With Bacterial Vaginosis|Completed||Phase 2|40|Anticipated|Osel, Inc.||2|||f||||t||||||||||2017-02-18 14:37:28.593562|2017-02-18 14:37:28.593562
NCT00635609|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2012-04-18|2009-09-23||March 2008||2008-03-01|April 2012|2012-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate|Randomized, Open-label Study to Evaluate the Efficacy and Safety of Doryx Tablets Compared to Doxycycline Hyclate in the Treatment of Acne Vulgaris.|Completed||Phase 4|93|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 14:37:28.713955|2017-02-18 14:37:28.713955
NCT00635596|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2015-01-12|||March 2008||2008-03-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2014|Actual|2014-01-01||Interventional|MT110-101||Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer|An Open-label, Multi-center Dose Escalation Phase I Study to Investigate the Safety and Tolerability of a Continuous Infusion of the Bispecific T-cell Engager (BiTE) MT110 in Locally Advanced, Recurrent or Metastatic Solid Tumors Which Commonly Express EpCAM and Are Not Amenable to Curative Treatment|Completed||Phase 1|65|Actual|Amgen Research (Munich) GmbH||1|||f||||t||||||||||2017-02-18 14:37:29.305026|2017-02-18 14:37:29.305026
NCT00635583|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2012-04-18|||March 2008||2008-03-01|April 2012|2012-04-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|B3||The Effect of Dairy on Bone Mass and Body Composition in 4th-8th Grade Boys and Girls|Influence of Dairy on Bone Accrual and Bone Size and Fat and Lean Mass in Early Pubertal Overweight vs. Healthy-weight Boys and Girls|Unknown status|Active, not recruiting|N/A|240|Anticipated|Purdue University||2|||f||||f||||||||||2017-02-18 14:37:29.417003|2017-02-18 14:37:29.417003
NCT00635570|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-06-24|2012-10-05||July 2008||2008-07-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|ACCEPT||Acceptability of the NuvaRing Among Students|Acceptability of the NuvaRing Among College and Graduate Students|Completed||Phase 4|273|Actual|University of Chicago|This study is an randomized controlled trial offering internal but not necessarily external validity. Thus, we do not know whether these findings would be replicable in other populations.|2|||f||||f||||||||||2017-02-18 14:37:29.516813|2017-02-18 14:37:29.516813
NCT00635557|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2011-03-24|||March 2008||2008-03-01|March 2011|2011-03-01|August 2011|Anticipated|2011-08-01|October 2010|Actual|2010-10-01||Interventional|||Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme|Dose Finding Phase 1 Study of the Treatment of Recurrent/Relapsed Glioblastoma Multiforme With MPC-6827 in Combination With Carboplatin|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|Myrexis Inc.||1|||f||||f||||||||||2017-02-18 14:37:33.042956|2017-02-18 14:37:33.042956
NCT00635544|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2009-01-27|||January 2007||2007-01-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|HELENA-COMS||Cross-Over Multicentre Study in Adolescents|Healthy Life Style in Europe by Nutrition in Adolescence: Cross-Over Multicentre Study|Completed||N/A|80|Anticipated|Federico II University||2|||f||||t||||||||||2017-02-18 14:37:33.152699|2017-02-18 14:37:33.152699
NCT00635531|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-04-07|||April 2004||2004-04-01|April 2008|2008-04-01|September 2004|Actual|2004-09-01|||||Interventional|||A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder|A Randomized, Double-Blind, Placebo-Controlled Study of Xanax XR in the Treatment of Adolescents With a Primary Diagnosis of Panic Disorder|Terminated||Phase 4|16|Actual|Pfizer||2||Please see Detailed Description for termination reason.|f||||t||||||||||2017-02-18 14:37:33.251964|2017-02-18 14:37:33.251964
NCT00635518|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2011-06-22|||March 2008||2008-03-01|May 2011|2011-05-01||||||||Interventional|||Randomized Controlled Trial of Dietary Advice in Primary Care to Promote Healthy Feeding of Infants|Randomized Controlled Trial of Dietary Advice in Primary Care to Promote Healthy Feeding of Infants|Withdrawn||N/A|329|Anticipated|Federal University of Health Science of Porto Alegre||1||Funding was canceled and no resources are available.|f||||f||||||||||2017-02-18 14:37:33.374664|2017-02-18 14:37:33.374664
NCT00635505|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-07-11||2013-07-10|September 2007||2007-09-01|July 2012|2012-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients|Randomized, Placebo-Controlled, Parallel, Multi-Center, 12-Week Study to Evaluate the Efficacy and Safety of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Adult and Adolescent Asthmatic Patients|Terminated||Phase 3|300|Actual|Amphastar Pharmaceuticals, Inc.||3||IND voluntarily withdrawn, without prejudice|f||||f||||||||||2017-02-18 14:37:33.468366|2017-02-18 14:37:33.468366
NCT00635492|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2015-03-20|2013-07-31||January 2008||2008-01-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational||Analysis population description: all patients who provided consent to release information and who fulfill the study entry criteria were included in the analyses. Patients were assigned to the exenatide BID or insulin cohort based on their initial injectable treatment started at baseline.|CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy|CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy - A European Observational Study of Patients With Type 2 Diabetes Initiating Injectable Therapy to Determine Time to Treatment Change, Factors Associated With Treatment Changes and Outcomes Over 24 Months|Completed||N/A|2515|Actual|AstraZeneca|"Serious adverse events (SAEs) and adverse events (AEs) were not collected as part of this observational study~Factors associated with treatment choice : this analysis was done on baseline lock( april 2009) where all others are from final lock."||2||f||||f||||||||||2017-02-18 14:37:33.844918|2017-02-18 14:37:33.844918
NCT00635479|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2014-02-28|2014-01-01||March 2008||2008-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures|Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures|Completed||N/A|115|Actual|University of Missouri-Columbia||2|||f||||f||||||||||2017-02-18 14:37:34.937004|2017-02-18 14:37:34.937004
NCT00635466|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2011-06-15|||February 2008||2008-02-01|June 2011|2011-06-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|Lap RC||Phase II Trial to Evaluate Laparoscopic Surgery for Stage 0/I Rectal Carcinoma|Phase II Trial to Evaluate Laparoscopic Surgery for Stage 0/I Rectal Carcinoma|Unknown status|Active, not recruiting|Phase 2|495|Actual|Japan Society of Laparoscopic Colorectal Surgery||1|||f||||t||||||||||2017-02-18 14:37:35.466848|2017-02-18 14:37:35.466848
NCT00635453|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2012-07-17|||March 2008||2008-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|February 2010|Actual|2010-02-01||Interventional|||"Impact of the Ten Steps for Healthy Feeding of Children Younger Than Two Years in Health Centers"|"Impact of the Ten Steps for Healthy Feeding of Children Younger Than Two Years in Health Centers"|Completed||N/A|474|Actual|Federal University of Health Science of Porto Alegre||1|||f||||f||||||||||2017-02-18 14:37:35.576407|2017-02-18 14:37:35.576407
NCT00635440|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-12|||December 2005||2005-12-01|March 2008|2008-03-01||||||||Interventional|||Randomized, Controlled Study to Investigate the Effect of Neuromuscular Electrical Stimulation (NMES) on Muscle Metabolism of Abdominal Surgical Patients|The Effect of Neuromuscular Electrical Stimulation on Muscle Metabolism of Major Abdominal Surgical Patients|Completed||N/A|26|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:37:35.681216|2017-02-18 14:37:35.681216
NCT00635427|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2015-05-15|2013-12-11||May 2008||2008-05-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Two participants who did not have type 1 Gaucher disease were withdrawn from the ITT study as per SAP definition and removed from the long-term efficacy analyses in this study, needed to support the interpretation of the long-term efficacy results. Therefore, 93 of 95 (97.9%) participants were included in the HGT-GCB-044 ITT population.|An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease|An Open-Label Extension Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease|Completed||Phase 3|95|Actual|Shire||3|||f||||f||||||||||2017-02-18 14:37:35.799999|2017-02-18 14:37:35.799999
NCT00635414|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2011-01-24|||August 2002||2002-08-01|January 2011|2011-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously|An Open, Randomized, Two-way Crossover Study Comparing the Effect of 40mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD).|Completed||Phase 4|60|Anticipated|AstraZeneca||2|||||||||||||||||2017-02-18 14:37:37.047297|2017-02-18 14:37:37.047297
NCT00635401|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-04-07|||May 2004||2004-05-01|April 2008|2008-04-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking|A Multicenter, Open-Label Study Exploring the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking|Completed||Phase 2|30|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:37:37.14342|2017-02-18 14:37:37.14342
NCT00635388|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2009-10-15|||February 2008||2008-02-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study of the Effects of Probiotics in Children Grades 1-3|A Double-blind, Randomized, Placebo-controlled Study of the Effects of Probiotics in Children Grades 1-3|Completed||N/A|360|Actual|Procter and Gamble||3|||f||||f||||||||||2017-02-18 14:37:37.246144|2017-02-18 14:37:37.246144
NCT00635375|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2009-01-09|||March 2008||2008-03-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparative Study of Phototherapy for Hyperbilirubinemia|A Comparative Study Between BiliSoft Blue LED Fiberoptic Blanket Phototherapy, Giraffe Spot PT Phototherapy, Natus Blue LED Bank Light Phototherapy, and BiliSoft + Giraffe Spot PT Combination Therapy|Completed||N/A|82|Anticipated|GE Healthcare||4|||f||||f||||||||||2017-02-18 14:37:37.329687|2017-02-18 14:37:37.329687
NCT00635362|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-04-01|2013-02-22||May 2007||2007-05-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|January 2011|Actual|2011-01-01||Interventional|||Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion|Immediate Post-placental Insertion of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean Delivery vs. 4-8 Week Post-delivery Interval Insertion: A Randomized Controlled Trial|Terminated||N/A|42|Actual|University of Chicago||2||Low recruitment|f||||f||||||||||2017-02-18 14:37:37.426326|2017-02-18 14:37:37.426326
NCT00635349|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2013-07-16|2013-05-02||May 2007||2007-05-01|July 2013|2013-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee Osteoarthritis|A Comparison of Tramadol/Acetaminophen Tablets Maintenance Versus NSAID Maintenance After Tramadol/Acetaminophen and NSAID Combination Therapy in Knee Osteoarthritis Patients: Multicenter, Randomized, Open Comparative Study|Completed||Phase 4|143|Actual|Janssen Korea, Ltd., Korea|There was no wash-out period after Day 28 to show drug efficacy in participants whose pain was already relieved and results were not meet the objective by setting inappropriate non-inferiority limit by applying WOMAC total score in hypothesis.|2|||f||||f||||||||||2017-02-18 14:37:38.547907|2017-02-18 14:37:38.547907
NCT00635336|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2010-10-20|||February 2007||2007-02-01|January 2009|2009-01-01|February 2010|Actual|2010-02-01|February 2007|Actual|2007-02-01||Interventional|||Novel Peptide Vaccination for Patients With Advanced Bladder Cancer|Phase I Study of Vaccination With MPHOSHP1 and DEPDC1 Derived Epitope Peptides for HLA-A-24-positive Patients With Advanced Bladder Cancer|Completed||Phase 1|20|Anticipated|Iwate Medical University||1|||f||||t||||||||||2017-02-18 14:37:39.030874|2017-02-18 14:37:39.030874
NCT00635323|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-04-02|||November 2002||2002-11-01|April 2008|2008-04-01|May 2005|Actual|2005-05-01|||||Interventional|||Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma|A Phase 2 Study of the Efficacy and Safety of Irinotecan (Campto®) in Combination With Capecitabine (Xeloda®) as First-Line Chemotherapy in Asian Subjects With Inoperable Hepatocellular Carcinoma|Completed||Phase 2|73|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 14:37:39.137612|2017-02-18 14:37:39.137612
NCT00635310|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2012-12-19|||January 2005||2005-01-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin|Safety Profiles of Percutaneous Liver Biopsy in Hemodialysis Patients With Chronic Hepatitis C Pre-treated With 1-Deamino-8- D-Arginine Vasopressin|Unknown status|Recruiting|N/A|3520|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 14:37:39.242056|2017-02-18 14:37:39.242056
NCT00635297|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2010-03-02|||April 2008||2008-04-01|January 2008|2008-01-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Percutaneous Vertebroplasty: Prophylactic Treatment of Adjacent Vertebra|Percutaneous Vertebroplasty.Study of Refracture Rates After Prophylactic Vertebroplasty of Adjacent Vertebrae|Suspended||N/A|100|Anticipated|Ullevaal University Hospital||2||Problems with patient recruitement|f||||t||||||||||2017-02-18 14:37:39.360471|2017-02-18 14:37:39.360471
NCT00635180|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2011-07-03|||January 2007||2007-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|March 2007|Actual|2007-03-01||Interventional|||Intraocular Pressure (IOP) and Isometric Exercise|Changes in Intraocular Pressure and Pulsatile Ocular Blood Flow Measured Continuously During Isometric Exercise|Completed||N/A|9|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-02-18 14:37:39.465274|2017-02-18 14:37:39.465274
NCT00635167|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-04-09|||January 2008||2008-01-01|April 2008|2008-04-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)|Contrast Enhanced Transrectal Ultrasound (TRUS) to Assess Prostatic Vascularity as a Measure of Treatment Response and Early Prediction of Treatment Failure After XRT|Unknown status|Recruiting|N/A|14|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 14:37:39.55142|2017-02-18 14:37:39.55142
NCT00635154|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2010-12-17|2010-11-09||December 2002||2002-12-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|December 2009|Actual|2009-12-01||Interventional|||Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma|A Phase II Study of Anakinra (IL-1 Receptor Antagonist) in Patients With Smoldering/Indolent Multiple Myeloma|Completed||Phase 2|55|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 14:37:39.644797|2017-02-18 14:37:39.644797
NCT00635141|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2013-08-30|||March 2008||2008-03-01|August 2013|2013-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic Fibrosis|The Effect of Inhaled Hypertonic Saline (7%) Versus Normal Saline (0.9%) on the Lung Clearance Index in Patients With Cystic Fibrosis|Completed||Phase 3|20|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 14:37:39.988257|2017-02-18 14:37:39.988257
NCT00635128|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2016-10-27||2009-05-20|February 2008||2008-02-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine|Evaluation of GSK Biological's dTpa-IPV Booster Vaccine in Children and Adolescents, 5 Years After Previous dTpa-IPV Boosting.|Completed||Phase 4|415|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:37:40.096304|2017-02-18 14:37:40.096304
NCT00635115|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2008-03-12|||February 2006||2006-02-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|VEPRO||The VEPRO Trial: A Cross-Over Randomised Controlled Trial Comparing 2 Corrective Lenses for Patients With Presbyopia|The VEPRO Trial: A Cross-Over Randomised Controlled Trial Comparing 2 Corrective Lenses for Patients With Presbyopia|Completed||N/A|127|Actual|Santéclair||2|||f||||f||||||||||2017-02-18 14:37:40.234147|2017-02-18 14:37:40.234147
NCT00635102|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2016-12-14|2016-01-06||October 1997||1997-10-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||57 individuals signed consent forms, of the 57 individuals 27 were alcohol dependent and 30 were healthy subjects. Of the alcohol dependent subjects 20 completed, 3 completed part of the study and 4 withdrew from the study. Of the healthy subjects, 22 completed, 4 completed part of the study and 4 withdrew from the study.|Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy Subjects|Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy Subjects|Completed||N/A|57|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:37:40.425187|2017-02-18 14:37:40.425187
NCT00635089|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2013-08-16||2013-08-16|May 2008||2008-05-01|August 2013|2013-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis|An Open-Label Safety and Efficacy Study of Reslizumab (CTx55700) for the Treatment of Pediatric Subjects With Eosinophilic Esophagitis Who Completed Study Res-5-0002|Completed||Phase 3|190|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 14:37:42.064339|2017-02-18 14:37:42.064339
NCT00635076|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-04-07|||July 2004||2004-07-01|April 2008|2008-04-01|September 2004|Actual|2004-09-01|||||Interventional|||A Study to Assess the Long-Term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder|A Randomized, Double-Blind, Placebo-Controlled Study of Continuation Treatment With Xanax XR in the Treatment of Adolescents With a Primary Diagnosis of Panic Disorder|Terminated||Phase 4|3|Actual|Pfizer||2||Please see Detailed Description for the termination reason.|f||||t||||||||||2017-02-18 14:37:42.202222|2017-02-18 14:37:42.202222
NCT00635063|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-06-05|||February 2008||2008-02-01|June 2008|2008-06-01||||||||Interventional|||A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects|A Multicentre, Randomised, Double-Blind, Double-Dummy, Crossover Study to Evaluate the Safety and Efficacy of AD 923 (Fentanyl Sublingual) in Comparison to Morphine Sulphate Immediate Release (MSIR) for the Treatment of Breakthrough Pain in Subjects With Malignancies|Terminated||Phase 3|150|Anticipated|Sosei||2||"Termination is due to a combination of a device defect potentially impacting the quality of~   the AD 923 IMP and a major change in corporate strategy."|f||||f||||||||||2017-02-18 14:37:42.323789|2017-02-18 14:37:42.323789
NCT00635050|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2016-06-15|2016-03-31||March 2008||2008-03-01|June 2016|2016-06-01|June 2015|Actual|2015-06-01|December 2014|Actual|2014-12-01||Interventional||women with locally advanced invasive breast cancer|Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin|Phase II Trial of Primary Systemic Therapy for Locally Advanced Breast Cancer Using Sequential Doxil, Paclitaxel, and Cyclophosphamide With Concurrent Avastin|Completed||Phase 2|32|Actual|University of Alabama at Birmingham|pilot study|1|||f||||t||||||||No||2017-02-18 14:37:42.421404|2017-02-18 14:37:42.421404
NCT00635037|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-03-12|||June 2004||2004-06-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|February 2005|Actual|2005-02-01||Interventional|ACP||Myofascial Pain:Acupuncture Versus Trigger Point Injection Combined With Dipyrone and Cyclobenzaprine|Acupuncture Versus Trigger Point Injection Combined With Dipyrone and Cyclobenzaprine on Pain Relief of Patients With Myofascial Pain: Randomized Clinical Study|Completed||N/A|30|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 14:37:42.684493|2017-02-18 14:37:42.684493
NCT00635024|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-12-20|2010-08-27||May 2008||2008-05-01|August 2011|2011-08-01|November 2010|Actual|2010-11-01|July 2008|Actual|2008-07-01||Interventional|||Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma|A Phase II Trial of Thymoglobulin and Melphalan in Patients With Relapsed Multiple Myeloma|Terminated||Phase 2|1|Actual|Mayo Clinic|After 1 patient was recruited, this trial temporarily closed to allow the first dose of Anti-thymocyte Globulin to be split over two days. Before the modification was written, it was decided to permanently close this study due to competing trials.|1||Due to competing trials, this study is permanenlty closed to patient acrrual.|f||||||||||||||2017-02-18 14:37:42.788709|2017-02-18 14:37:42.788709
NCT00635011|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2015-03-18|||February 2008||2008-02-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2011|Actual|2011-12-01||Interventional|||Pre- and Postoperative Cognitive Behavior Therapy for Patients Accepted for Bariatric Surgery|Pre- and Postoperative Cognitive Behavior Therapy for Patients Accepted for Bariatric Surgery|Active, not recruiting||N/A|100|Anticipated|Helse Fonna||1|||f||||t||||||||||2017-02-18 14:37:43.109884|2017-02-18 14:37:43.109884
NCT00634998|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2012-09-06|||November 2007||2007-11-01|July 2008|2008-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy|Vitamin C Supplementation as a Preventive Treatment of Diabetic Peripheral Neuropathy|Completed||Phase 1|10|Actual|Washington State University||2|||f||||f||||||||||2017-02-18 14:37:43.198499|2017-02-18 14:37:43.198499
NCT00634985|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2011-04-22|||November 2002||2002-11-01|April 2011|2011-04-01|December 2003|Actual|2003-12-01|||||Interventional|||Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs|A Multicentre, Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of Eletriptan 40 Mg for the Treatment of Migraine (With or Without Aura) in Subjects Unsuccessfully Treated With NSAIDS|Completed||Phase 4|120|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:37:43.301073|2017-02-18 14:37:43.301073
NCT00634972|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-03-12|||November 2005||2005-11-01|March 2008|2008-03-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|ROP||Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity|Topical Application of ACULAR a Randomized, Vehicle Controlled Clinical Trial: Efficiency in Inhibiting Proliferative Retinopathy of Prematurity|Unknown status|Enrolling by invitation|Phase 4|200|Anticipated|University of South Alabama||2|||f||||f||||||||||2017-02-18 14:37:43.406404|2017-02-18 14:37:43.406404
NCT00634959|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2010-11-09|||July 2003||2003-07-01|November 2010|2010-11-01|December 2003|Actual|2003-12-01|||||Interventional|||Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus|An Investigation Into The Effects Of Food And Dose Regimen On Viral Load Response In HIV Infected Patients On Short-Term Monotherapy With UK-427,857 (Maraviroc)|Completed||Phase 2|37|Actual|ViiV Healthcare||5|||f||||f||||||||||2017-02-18 14:37:43.518257|2017-02-18 14:37:43.518257
NCT00634946|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-03-29|||January 2008||2008-01-01|March 2011|2011-03-01|August 2010|Actual|2010-08-01|November 2009|Actual|2009-11-01||Interventional|||SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation|A Multicenter, Randomized, Double-blind Recommended Dose-finding Study of SI-6603 in Patients With Lumbar Disc Herniation (Phase II/III Study)|Completed||Phase 2/Phase 3|195|Actual|Seikagaku Corporation||4|||f||||||||||||||2017-02-18 14:37:43.639158|2017-02-18 14:37:43.639158
NCT00634933|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-02-06|2012-12-27||March 2008||2008-03-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|February 2010|Actual|2010-02-01||Interventional|||Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis|A Randomized, Parallel, Double-Blind, Placebo-Controlled Dose Regimen Finding Study To Evaluate The Safety And Efficacy Of TRU-015 In Subjects With Active Seropositive Rheumatoid Arthritis On A Stable Background Of Methotrexate|Terminated||Phase 2|222|Actual|Pfizer|As the results of the primary analysis did not meet the predefined efficacy criteria, the development of TRU-015 was discontinued.|3||"The study was terminated on 21 June 2010 due to results not meeting the primary endpoint. No~   safety reasons contributed to the termination of the study."|f||||f||||||||||2017-02-18 14:37:43.828418|2017-02-18 14:37:43.828418
NCT00634920|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2014-08-12|2014-05-06||March 2008||2008-03-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients|A Controlled Randomized Open-label Multicenter Study Evaluating if Early Conversion to Everolimus (Certican) From Cyclosporine (Neoral) in de Novo Renal Transplant Recipients Can Improve Long-term Renal Function and Slow Down the Progression of Chronic Allograft Nephropathy|Completed||Phase 4|204|Actual|Novartis||2|||f||||t||||||||||2017-02-18 14:37:45.610684|2017-02-18 14:37:45.610684
NCT00634907|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2008-09-25|||October 2006||2006-10-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)|Prospective CYP2C9 And VKORC1 Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)For Anticoagulation|Completed||N/A|263|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 14:37:46.903708|2017-02-18 14:37:46.903708
NCT00634894|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2016-04-19|||March 2008||2008-03-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II, Double-Blinded, Randomized Evaluation of Femara (Letrozole) Versus Placebo for Adjuvant Treatment After Completion of First-Line Chemotherapy for Patients With Optimally Debulked and Chemoresponsive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||2||Study halted with no registration, the drug company sponsor withdrew support.|f||||t||||||||||2017-02-18 14:37:46.996858|2017-02-18 14:37:46.996858
NCT00634881|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2016-11-22|||November 2003||2003-11-01|September 2016|2016-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia|Consolidation Therapy With Alemtuzumab (MabCampath®) in Patients With Chronic Lymphocytic Leukemia Who Are in Complete or Partial 2nd Remission After Cytoreduction With Fludarabine or Fludarabine Plus Cyclophosphamide or Fludarabine Plus Cyclophosphamide Plus Rituximab or Bendamustine or Bendamustine Plus Rituximab - a Phase I/II Study|Completed||Phase 1/Phase 2|13|Actual|German CLL Study Group||2|||f||||f||||||||No||2017-02-18 14:37:47.108826|2017-02-18 14:37:47.108826
NCT00634868|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2011-06-09|||August 2008||2008-08-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Wounds Utilizing Light||Terminated||N/A|30|Anticipated|QRay Ltd.||2||Slow patients recruitment|f||||t||||||||||2017-02-18 14:37:47.380077|2017-02-18 14:37:47.380077
NCT00634855|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-03-12|||March 2008||2008-03-01|March 2008|2008-03-01||||||||Observational|||Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR|Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR|Unknown status|Not yet recruiting|N/A|30|Anticipated|Medical University of South Carolina|||2||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 14:37:47.473915|2017-02-18 14:37:47.473915
NCT00634842|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2012-06-26|2009-10-23||February 2008||2008-02-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|TITRATE™||Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily|Effect of Two Different Fasting Blood Glucose Titration Targets in Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily in Combination With 1-3 Oral Agents|Completed||Phase 4|244|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 14:37:47.572008|2017-02-18 14:37:47.572008
NCT00634829|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-07-11||2013-07-10|February 2008||2008-02-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction|Randomized, Double-Blind, Controlled, Single-Dose, Three-Treatment, Cross-Over Study of The Protective Effects Of Albuterol-HFA In Preventing Exercise-Induced Bronchoconstriction In Adolescent And Adult Asthmatic Patients|Terminated||Phase 3|24|Actual|Amphastar Pharmaceuticals, Inc.||3||IND voluntarily withdrawn, without prejudice|f||||f||||||||||2017-02-18 14:37:48.108052|2017-02-18 14:37:48.108052
NCT00634816|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2013-05-29|||April 2003||2003-04-01|May 2013|2013-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers|Cross-sectional Study of Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers|Completed||N/A|38|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:37:48.221283|2017-02-18 14:37:48.221283
NCT00634803|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-09-29|||September 2009||2009-09-01|September 2014|2014-09-01|August 2015|Anticipated|2015-08-01|May 2015|Anticipated|2015-05-01||Interventional|POD||Clinical Trial of Integrated Treatment for Pain and Opioid Dependence|Clinical Trial of Integrated Treatment for Pain and Opioid Dependence|Unknown status|Recruiting|Phase 1/Phase 2|91|Anticipated|Yale University||3|||f||||f||||||||||2017-02-18 14:37:48.322808|2017-02-18 14:37:48.322808
NCT00634790|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-04-07|||May 2004||2004-05-01|April 2008|2008-04-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks|An Open-Label Study to Assess the Safety and Tolerability of Xanax XR in the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks|Terminated||Phase 4|49|Actual|Pfizer||1||Please see Detailed Description for termination reason.|f||||t||||||||||2017-02-18 14:37:48.431926|2017-02-18 14:37:48.431926
NCT00634777|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2011-07-19|||January 2007||2007-01-01|July 2011|2011-07-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|pet||Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma|Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma|Unknown status|Recruiting|N/A|239|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-02-18 14:37:48.585115|2017-02-18 14:37:48.585115
NCT00634764|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-07-18|||November 2006||2006-11-01|July 2008|2008-07-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Observational|||Predictors of Maternal Weight Gain and Neonatal Body Composition|Resting Metabolic Rate, Insulin Resistance, and Attitude Towards Weight Gain During Pregnancy to Predict Maternal Weight Gain and Neonatal Body Composition.|Unknown status|Recruiting|N/A|50|Anticipated|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 14:37:48.67372|2017-02-18 14:37:48.67372
NCT00634751|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2012-01-19|||February 2008||2008-02-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma|"A Phase I/II STudy of Oxaliplatin, Oral Capecitabine and Sorafenib in Patients With Advanced Pancreatic and Biliary Carcinoma"|Completed||Phase 1/Phase 2|48|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:37:48.767197|2017-02-18 14:37:48.767197
NCT00634738|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2011-06-25|||January 2007||2007-01-01|June 2010|2010-06-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||The Treatment of the Median Nerve for the Elimination of the Symptoms Associated With the Carpal Tunnel Syndrome|Neuropathy Along the Median Nerve: Etiology of Symptoms Associated With the Carpal Tunnel Syndrome, a Preliminary Study|Completed||Phase 1/Phase 2|60|Anticipated|Guy Hains Chiropractor||1|||f||||f||||||||||2017-02-18 14:37:48.872806|2017-02-18 14:37:48.872806
NCT00634725|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-12-10|||February 2008||2008-02-01|November 2012|2012-11-01|September 2014|Actual|2014-09-01|February 2013|Actual|2013-02-01||Interventional|||Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery|Randomized Multicenter Phase III Study in Patients With Locally Advanced Adenocarcinoma of the Pancreas: Gemcitabine With or Without Chemoradiotherapy and With or Without Erlotinib. Intergroup Study|Completed||Phase 3|820|Anticipated|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||4|||f||||t||||||||||2017-02-18 14:37:48.979071|2017-02-18 14:37:48.979071
NCT00634712|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2011-01-24|||June 1999||1999-06-01|January 2011|2011-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)|Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity. Clinical Study of Candesartan in Patients With Heart Failure and Preserved Left Ventricular Systolic Function|Completed||Phase 3|734|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:37:49.332285|2017-02-18 14:37:49.332285
NCT00634699|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2011-06-25|||September 2006||2006-09-01|June 2011|2011-06-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||The Treatment of Carpal Tunnel Syndrome Using Thumb Pressure Along the Median Nerve|Neuropathy Along the Median Nerve: Etiology of Symptoms Associated With the Carpal Tunnel Syndrome: a Preliminary Study.|Completed||Phase 1/Phase 2|60|Anticipated|Guy Hains Chiropractor||1|||f||||t||||||||||2017-02-18 14:37:49.416057|2017-02-18 14:37:49.416057
NCT00634686|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2009-01-29|||January 2007||2007-01-01|January 2009|2009-01-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Effects of Omega-3 Fatty Acids on Bone and Frailty|Effects of Omega-3 Fatty Acids on Bone and Frailty|Unknown status|Active, not recruiting|Phase 4|150|Anticipated|National Institute on Aging (NIA)||2|||f||||f||||||||||2017-02-18 14:37:49.510307|2017-02-18 14:37:49.510307
NCT00634673|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2008-03-12|||June 2006||2006-06-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM)|FABP2 Ala54Thr Genotype Influences the Postprandial Serum Fatty Acids Profile in Type 2 Diabetic Patients|Completed||N/A|26|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 14:37:49.621984|2017-02-18 14:37:49.621984
NCT00634660|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2017-01-30|||May 2008||2008-05-01|January 2017|2017-01-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria|A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria|Completed||Phase 1|25|Actual|BioMarin Pharmaceutical||7|||f||||t|t|f||||||No||2017-02-18 14:37:49.724317|2017-02-18 14:37:49.724317
NCT00634647|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-09-30|2013-02-27||February 2008||2008-02-01|September 2015|2015-09-01|April 2013|Actual|2013-04-01|August 2011|Actual|2011-08-01||Interventional|||Satraplatin and Prednisone to Treat Prostate Cancer|A Phase II Study of Satraplatin and Prednisone in Metastatic Androgen Independent Prostate Cancer (AIPC)|Completed||Phase 2|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 14:37:49.834844|2017-02-18 14:37:49.834844
NCT00633178|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2015-08-31|||January 2005||2005-01-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effectiveness of Group Interpersonal Psychotherapy in Treating Women With Prenatal Depression|Therapy for Prenatal Depression: Maternal & Fetal Effects|Completed||N/A|116|Actual|New York State Psychiatric Institute||3|||f||||t||||||||||2017-02-18 14:38:20.443304|2017-02-18 14:38:20.443304
NCT00634634|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2017-01-20|||August 2008||2008-08-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer|Phase I/II Trial of Letrozole (Femara) and Sorafenib (Nexavar) in Postmenopausal Women With Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 1/Phase 2|54|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 14:37:50.357357|2017-02-18 14:37:50.357357
NCT00634621|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2014-08-12|2014-07-09||February 2008||2008-02-01|August 2014|2014-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer|A Post-authorization, Observational Study to Assess the Impact of Blue Light Cystoscopy After Administration of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer.|Completed||N/A|283|Actual|GE Healthcare|||1||f||||f||||||||||2017-02-18 14:37:50.469353|2017-02-18 14:37:50.469353
NCT00634608|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2016-09-29|||February 2008||2008-02-01|September 2016|2016-09-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow|Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow|Completed||N/A|224|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-02-18 14:37:50.735915|2017-02-18 14:37:50.735915
NCT00634595|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2010-07-26|||March 2008||2008-03-01|July 2010|2010-07-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Trial of E10A in Head and Neck Cancer|A Randomized Phase II Clinical Trial of an Adenovirus-mediated Endostatin Gene (E10A) Combined With Cisplatin and Paclitaxel in Patients With Head and Neck Cancer|Unknown status|Recruiting|Phase 2|116|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 14:37:50.84421|2017-02-18 14:37:50.84421
NCT00634582|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-12|2015-09-22|2013-11-22||January 2009||2009-01-01|November 2013|2013-11-01|June 2015|Actual|2015-06-01|January 2013|Actual|2013-01-01||Interventional|||Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases|Phase II Trial of Zemplar (19-nor-1 a,25-Dihydroxyvitamin D2, Paricalcitol Capsule) on Bony Remodeling in Advanced Androgen-Insensitive Prostate Cancer|Terminated||Phase 2|2|Actual|Wake Forest University Health Sciences||1||slow accrual|f||||t||||||||||2017-02-18 14:37:50.951485|2017-02-18 14:37:50.951485
NCT00634569|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-12-07|2015-05-20||May 2008||2008-05-01|December 2016|2016-12-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects|Evaluation of the Efficacy and Safety of Flebogamma 5% DIF [Immune Globulin Intravenous (Human)] for Replacement Therapy in Pediatric Subjects With Primary Immunodeficiency Diseases.|Completed||Phase 4|24|Actual|Grifols Biologicals Inc.||1|||f||||f||||||||||2017-02-18 14:37:51.200558|2017-02-18 14:37:51.200558
NCT00634556|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-06-11|||February 2006||2006-02-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|TSfMRI||Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)|Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)|Completed||N/A|49|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 14:37:51.780845|2017-02-18 14:37:51.780845
NCT00634543|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2013-07-26|2013-04-30||December 2006||2006-12-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Full analysis set (FAS) included all randomly assigned participants who met the eligibility criteria and had at least 1 post-baseline efficacy assessment data.|A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic Neuropathy|Comparison of the Effectiveness and Safety Between Tramadol 37.5 Mg/Acetaminophen 325mg And Gabapentin for The Treatment of Painful Diabetic Neuropathy: Multicenter, Randomized, Open Comparative Study|Completed||Phase 4|162|Actual|Janssen Korea, Ltd., Korea|The study was a non-inferiority study to demonstrate that tramadol/acetaminophen did not have poorer ffectiveness as compared to gabapentin. However this could not be demonstrated because of error in the minimum significant difference set-up.|2|||f||||f||||||||||2017-02-18 14:37:51.91174|2017-02-18 14:37:51.91174
NCT00634530|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-10|2009-02-03|||September 2007||2007-09-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Impact of a Nutritional Intervention Program for Weight Control During Pregnancy|Impact of a Nutritional Intervention Program for Weight Control During Pregnancy|Completed||N/A|318|Actual|Federal University of Health Science of Porto Alegre||1|||f||||f||||||||||2017-02-18 14:37:52.434326|2017-02-18 14:37:52.434326
NCT00634517|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-07-11||2013-07-10|March 2008||2008-03-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma|A Multi-Center, Randomized, Double-Blind, Active-Controlled, Parallel Group, 4-Week Study to Evaluate the Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Patients With Asthma in Pediatric Patients With Asthma|Terminated||Phase 3|48|Actual|Amphastar Pharmaceuticals, Inc.||2||IND voluntarily withdrawn, without prejudice|f||||f||||||||||2017-02-18 14:37:52.531792|2017-02-18 14:37:52.531792
NCT00634504|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2014-06-04|2014-06-04||May 2008||2008-05-01|June 2014|2014-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|LVPK|Safety population|Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze|An Open-Label Study to Assess the Pharmacokinetics of Leucovorin in Patients Receiving High Dose Methotrexate, With or Without Voraxaze Treatment|Completed||Phase 1|20|Actual|BTG International Inc.||2|||f||||f||||||||||2017-02-18 14:37:52.645333|2017-02-18 14:37:52.645333
NCT00634491|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-03-04|||September 2007||2007-09-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy|Effect of Acetazolamide in Prevention of Contrast Nephropathy|Completed||Phase 2|240|Actual|Shiraz University of Medical Sciences||3|||f||||t||||||||||2017-02-18 14:37:53.154753|2017-02-18 14:37:53.154753
NCT00634478|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-08-21|||October 2008||2008-10-01|August 2015|2015-08-01|September 2021|Anticipated|2021-09-01|March 2021|Anticipated|2021-03-01||Interventional|||Pre-lemniscal Radiation Deep Brain Stimulation for ET|Pre-lemniscal Radiation Deep Brain Stimulation for ET|Terminated||Phase 2/Phase 3|10|Actual|Medical College of Wisconsin||2||Difficulty in recruitment. Funding issues.|f||||f||||||||||2017-02-18 14:37:53.362308|2017-02-18 14:37:53.362308
NCT00631618|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2014-02-22|||September 2007||2007-09-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Clinical Trial of Sutent to Treat Metastatic Melanoma|A Phase II Trial of Sutent in Metastatic Melanoma Patients With KIT Aberrations.|Completed||Phase 2|12|Actual|California Pacific Medical Center Research Institute||1|||f||||||||||||||2017-02-18 14:39:01.559127|2017-02-18 14:39:01.559127
NCT00634465|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2015-05-22|||October 2006||2006-10-01|May 2015|2015-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||A Biomechanical Assessment of the AST Stabilimax BAR Using Radiostereometric Analysis (RSA)|A Biomechanical Assessment of the AST Stabilimax BAR Using Radiostereometric Analysis (RSA)|Withdrawn||N/A|0|Actual|State University of New York - Upstate Medical University|||1|low enrollment|f||||f||||||||||2017-02-18 14:37:53.466438|2017-02-18 14:37:53.466438
NCT00634452|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2012-12-05|||February 2008||2008-02-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|MDX1401-01||Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma|A Phase 1, Open-label, Dose-escalation, Multidose Study of MDX-1401 Administered Weekly for 4 Weeks in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma|Completed||Phase 1|22|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:37:53.549929|2017-02-18 14:37:53.549929
NCT00634439|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-09-14|||January 2008||2008-01-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Safety Study of Atomoxetine and Cerebrovascular Outcomes|Atomoxetine and Cerebrovascular Outcomes in Adults|Completed||N/A|72000|Anticipated|Eli Lilly and Company|||3||f||||f||||||||||2017-02-18 14:37:53.650165|2017-02-18 14:37:53.650165
NCT00634426|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-05-19|||March 2008||2008-03-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|MESCC||Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression|Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression. Quality of Life and Cost-effectiveness Outcomes|Completed||Phase 4|163|Actual|AOSpine North America Research Network|||3||f||||f||||||||||2017-02-18 14:37:53.757724|2017-02-18 14:37:53.757724
NCT00634413|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2009-02-27|||February 2008||2008-02-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD|A Phase II, Randomised, Double-Blind, Placebo-Controlled Pilot Efficacy Study of ADC4022 on Markers of Pulmonary Inflammation in Subjects With Moderate to Severe COPD|Completed||Phase 2|91|Actual|Pulmagen Therapeutics||2|||f||||f||||||||||2017-02-18 14:37:53.874884|2017-02-18 14:37:53.874884
NCT00634400|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2011-01-24|||March 1999||1999-03-01|January 2011|2011-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)|Candesartan in Heart Fail. Assess. of Reduction in Mortality & Morbidity. Candesartan in Patients With Heart Failure Who Are ACE Inhibitor Intolerant and Have Depressed Left Ventricular Systolic Function|Completed||Phase 3|6268|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:37:53.986186|2017-02-18 14:37:53.986186
NCT00633698|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2009-08-03|||January 2008||2008-01-01|August 2009|2009-08-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|NICOLa||Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)|Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 14:37:54.075953|2017-02-18 14:37:54.075953
NCT00633685|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2010-05-24|||March 2010||2010-03-01|February 2010|2010-02-01|August 2012|Anticipated|2012-08-01|June 2012|Anticipated|2012-06-01||Interventional|||Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure|Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure|Unknown status|Recruiting|Phase 4|300|Anticipated|TEMPVA Research Group, Inc.||2|||f||||f||||||||||2017-02-18 14:37:54.178174|2017-02-18 14:37:54.178174
NCT00633672|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-01-24|||February 2001||2001-02-01|January 2011|2011-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued|A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued|Completed||Phase 3|400|Anticipated|AstraZeneca||3|||||||||||||||||2017-02-18 14:37:54.458278|2017-02-18 14:37:54.458278
NCT00633659|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2013-08-15|||September 2007||2007-09-01|August 2013|2013-08-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia|A Phase II Study of Hemospan® Versus Voluven® to Evaluate Vascular Resistance and Forearm Blood Flow, and to Assess Local Skin Blood Flow and Tissue Oxygenation in the Ischemic Foot of Patients With Chronic Critical Limb Ischemia|Completed||Phase 2|6|Actual|Sangart||2|||f||||f||||||||||2017-02-18 14:37:54.571668|2017-02-18 14:37:54.571668
NCT00633646|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-04-24|||January 2006||2006-01-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Protein-Restricted Diet on Nitrogen Balance and Residual Renal Function in Peritoneal Dialysis (PD) Patients|Effect of Protein-Restricted Diet on Nitrogen Balance and Residual Renal Function in PD Patients|Completed||N/A|94|Actual|Shanghai Jiao Tong University School of Medicine||3|||f||||f||||||||||2017-02-18 14:37:54.69672|2017-02-18 14:37:54.69672
NCT00633633|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-02-29|||February 2008||2008-02-01|February 2016|2016-02-01||||February 2018|Anticipated|2018-02-01||Interventional|||Lifestyle Intervention for Heart Failure|Take Heart: Exercise & Diet Intervention for Heart Failure in Cancer Survivors|Active, not recruiting||N/A|85|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 14:37:54.795467|2017-02-18 14:37:54.795467
NCT00633620|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-03-11|||March 2007||2007-03-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|BECOP-2||Narrow Band Versus Conventional Endoscopic Imaging for Screening Colonoscopy|Narrow Band Versus Conventional Endoscopic Imaging for Screening Colonoscopy in a Private Practice Setting - A Large Prospective Randomized Trial|Completed||N/A|1250|Actual|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-02-18 14:37:54.911649|2017-02-18 14:37:54.911649
NCT00633607|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2016-01-14|||April 2012||2012-04-01|January 2016|2016-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Hereditary Colorectal and Associated Tumor Registry Study|Hereditary Colorectal and Associated Tumor Registry Study|Recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     Serum, plasma, and extracted DNA are stored for potential future studies.~   "|||2017-02-18 14:37:55.017896|2017-02-18 14:37:55.017896
NCT00181090|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2009-03-26|||February 2005||2005-02-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Use of the Atkins Diet for Children With Intractable Epilepsy: A Comparison of Daily Carbohydrate Limits||Completed||Phase 1|30||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:43.555039|2017-02-18 17:17:43.555039
NCT00633594|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-12-06|2016-08-19||June 2008||2008-06-01|December 2016|2016-12-01|November 2016|Actual|2016-11-01|April 2015|Actual|2015-04-01||Interventional||Based on efficacy evaluable population, all participants that received any study therapy. Participants were stratified based on phase of study (Phase I vs Phase II) and previous treatment status prior to study start (Previously Untreated vs Previously Treated (relapsed or refractory))|Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma|Phase I/II Study Evaluating Rituximab, Lenalidomide, and Bortezomib in the First-Line or Second-Line Treatment of Patients With Mantle Cell Lymphoma|Completed||Phase 1/Phase 2|39|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||No||2017-02-18 14:37:55.124444|2017-02-18 14:37:55.124444
NCT00633581|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2009-04-08|||March 2008||2008-03-01|April 2009|2009-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy of Vitamin C Injection on Fatigue in Workers After Work|Efficacy of High Dose Vitamin C Parenteral Supplement on Amelioration of Fatigue in Company Workers After Work: A Double-Blind, Randomized Controlled Trial|Completed||Phase 2/Phase 3|150|Actual|DongGuk University||2|||f||||f||||||||||2017-02-18 14:37:56.454241|2017-02-18 14:37:56.454241
NCT00633568|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2015-02-11|||January 2007||2007-01-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|December 2014|Actual|2014-12-01||Interventional|||Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer|A Phase III Randomised Study Comparing Concomitant Radiochemotherapy With Cisplatin and Docetaxel as Induction Versus Consolidation Treatment in Patients With Locally Advanced Unresectable Non-small Cell Lung Cancer.|Terminated||Phase 3|125|Actual|European Lung Cancer Working Party||2||Slow recruitment|f||||t||||||||||2017-02-18 14:37:56.57082|2017-02-18 14:37:56.57082
NCT00633555|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2011-02-09|||July 2006||2006-07-01|February 2011|2011-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|LR||A Comparison of the Microdose Leuprolide Protocol vs. Luteal Phase Ganirelix Protocol in Women Who Are or Who Are Predicted to be Low Responders|A Randomized Controlled Trial of Microdose Leuprolide Protocol vs. Luteal Phase Ganirelix Protocol in Predicted Low Responders|Completed||N/A|54|Actual|UConn Health|||1||f||||f||||||||||2017-02-18 14:37:56.68423|2017-02-18 14:37:56.68423
NCT00633542|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-03-04|||June 2003||2003-06-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)|Thalidomide-Dexamethasone vs Alpha-Interferon-Dexamethasone as Maintenance Therapy After Thalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin Combination for|Completed||Phase 3|103|Actual|Università Politecnica delle Marche||2|||f||||f||||||||||2017-02-18 14:37:56.788416|2017-02-18 14:37:56.788416
NCT00634387|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2011-07-03|||March 2008||2008-03-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Anthocyans on Cardiovascular and Sympathetic Function|Effects of Anthocyans on Cardiovascular and Sympathetic Function|Completed||N/A|27|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 14:37:56.99333|2017-02-18 14:37:56.99333
NCT00634374|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-04-11|||January 2005||2005-01-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Administration of a Bitter-Tasting Medication: Comparison Between the Rx Medibottle and the Oral Syringe|Efficacy of the Rx Medibottle Compared to the Oral Syringe in Delivering Infant-Acceptable Liquid Medication Completely and Accurately: a Controlled Clinical Trial|Completed||N/A|81|Actual|Bronx-Lebanon Hospital Center Health Care System||2|||f||||f||||||||||2017-02-18 14:37:57.087123|2017-02-18 14:37:57.087123
NCT00634361|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2014-05-21|||September 2001||2001-09-01|May 2014|2014-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Ethyl-EPA Treatment of Prodromal Patients|Ethyl-EPA Treatment of Prodromal Patients|Completed||Phase 2/Phase 3|7|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:37:57.182556|2017-02-18 14:37:57.182556
NCT00634348|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-06-17|||April 2004||2004-04-01|June 2008|2008-06-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients|A Four-Week Double Blind Multicenter Study Comparing The Efficacy And Safety Of Ziprasidone To Aripiprazole In Subjects With Schizophrenia Or Schizoaffective Disorder Needing Inpatient Care|Completed||Phase 4|256|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:37:57.273043|2017-02-18 14:37:57.273043
NCT00634335|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-12-29|||March 2008||2008-03-01|February 2008|2008-02-01|June 2009|Anticipated|2009-06-01|March 2009|Anticipated|2009-03-01||Observational|||Echocardiographic Characteristics of High Endurance Israeli Athletes|Echocardiographic Characteristics of High Endurance Israeli Athletes|Unknown status|Recruiting|N/A|81|Anticipated|Soroka University Medical Center|||1||f||||t||||||||||2017-02-18 14:37:57.420813|2017-02-18 14:37:57.420813
NCT00634322|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2014-09-09|2012-11-30||October 2008||2008-10-01|September 2014|2014-09-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma|Randomized, Blinded, Placebo-Controlled Trial of High Dose Methotrexate With Leucovorin Rescue (HDMTX-LV) With or Without Glucarpidase in Osteosarcoma|Terminated||Phase 2|7|Actual|BTG International Inc.|No efficacy endpoints were reported due to early termination (insufficient enrollment).|3||Lack of enrollment|f||||f||||||||||2017-02-18 14:37:57.497924|2017-02-18 14:37:57.497924
NCT00634309|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2011-01-24|||June 1999||1999-06-01|January 2011|2011-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)|Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity. Clinical Study of Candesartan in Patients With Heart Failure and Depressed Left Ventricular Systolic Function|Completed||Phase 3|597|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:37:57.866903|2017-02-18 14:37:57.866903
NCT00634296|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2008-03-06|||March 2005||2005-03-01|March 2008|2008-03-01|March 2010|Anticipated|2010-03-01|March 2008|Anticipated|2008-03-01||Interventional|||The Effects of the Inspiratory Muscle Plus Aerobic Training Compare to Aerobic Training Alone in Heart Failure Patients.|The Effects of the Inspiratory Muscle Training Plus Aerobic Training Compare to Aerobic Training Alone in Heart Failure Patients With Inspiratory Muscle Weakness.|Unknown status|Recruiting|N/A|30|Anticipated|Hospital de Clinicas de Porto Alegre||1|||f||||f||||||||||2017-02-18 14:37:57.957998|2017-02-18 14:37:57.957998
NCT00634283|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2009-08-06|||February 2008||2008-02-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects|Physiologic Monitoring of Antidepressant Medication Effects in Normal Healthy Subjects II|Completed||Phase 4|7|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-02-18 14:37:58.058543|2017-02-18 14:37:58.058543
NCT00634270|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-12-21|2015-07-03||April 2008||2008-04-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|November 2014|Actual|2014-11-01||Interventional|Protocol 102|Of the 49 patients enrolled in Stratum 1; 46 were evaluable. Of the 13 enrolled in Stratum 2; 12 were evaluable. This information is also listed in the Analysis Population Descriptions and Additional Description.|A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas|A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas|Completed||Phase 2|58|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 14:37:58.156408|2017-02-18 14:37:58.156408
NCT00634257|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2017-01-23|||February 22, 2008|Actual|2008-02-22|January 2017|2017-01-01|February 1, 2019|Anticipated|2019-02-01|February 1, 2019|Anticipated|2019-02-01||Observational|||Spirituality/Religiosity in Patients and Caregivers|A Preliminary Study of Spirituality/Religiosity, Symptom Distress and Quality of Life Among Palliative Care Patients and Their Primary Caregivers|Active, not recruiting||N/A|193|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 14:38:01.314029|2017-02-18 14:38:01.314029
NCT00634244|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2015-07-02|2015-06-10||October 2008||2008-10-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional||Eligible and treated patients|Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)|Completed||Phase 2|92|Actual|National Cancer Institute (NCI)||3|||f||||f||||||||||2017-02-18 14:38:01.450181|2017-02-18 14:38:01.450181
NCT00634231|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-12-30|||April 2010||2010-04-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2015|Actual|2015-12-01||Interventional|||A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors|A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors|Active, not recruiting||Phase 1|12|Anticipated|Advantagene, Inc.||1|||f||||t||||||||||2017-02-18 14:38:02.804487|2017-02-18 14:38:02.804487
NCT00634218|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2012-06-25|||February 2008||2008-02-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Reaching and Treating Lesbian, Gay, Bisexual, and Transgender (LGBT) Cigarette Smokers|REaching and Treating LGBT Smokers: The Internet|Completed||Phase 2/Phase 3|363|Actual|University of California, San Francisco||4|||f||||t||||||||||2017-02-18 14:38:02.922858|2017-02-18 14:38:02.922858
NCT00634205|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2015-02-11|||July 2006||2006-07-01|February 2015|2015-02-01|June 2010|Actual|2010-06-01|March 2009|Actual|2009-03-01||Interventional|||Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma|A Phase II Study Assessing the Activity of Valproate Acid Plus Doxorubicin in Refractory or Recurrent Malignant Mesothelioma|Completed||Phase 2|45|Actual|European Lung Cancer Working Party||1|||f||||t||||||||||2017-02-18 14:38:03.037585|2017-02-18 14:38:03.037585
NCT00634192|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2010-08-31|||February 2008||2008-02-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|||Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin|A Multicenter, Open Label, 2 Period Cross-over Study to Evaluate the PK of a 8 Week Continuous Treatment With 1x300mg/d and 2x300mg/d Tobramycin Inhaled With a 'Soft Mist' Nebulizer in Cystic Fibrosis (CF) Subjects|Completed||Phase 3|50|Anticipated|Novartis||2|||f||||||||||||||2017-02-18 14:38:03.148776|2017-02-18 14:38:03.148776
NCT00634179|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2016-09-21|2016-02-17||February 2008||2008-02-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional||A total of 37 patients were enrolled on this study. However, not all patients participated in both phases of this study. For phase I, 19 patients were enrolled, and for phase II, 30 patients were enrolled.|A Phase I/II Trial of VR-CHOP in Lymphoma Patients|A Phase I/II Trial of VR-CHOP for Patients With Untreated Follicular Lymphoma and Other Low Grade B-Cell Lymphomas|Completed||Phase 1/Phase 2|37|Actual|Emory University||1|||f||||t||||||||||2017-02-18 14:38:03.259531|2017-02-18 14:38:03.259531
NCT00634166|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2016-03-15|2014-09-22||September 2007||2007-09-01|April 2013|2013-04-01|April 2014|Actual|2014-04-01|December 2013|Actual|2013-12-01||Interventional||The full analysis set (FAS) consisted of all subjects in the safety analysis set who had at least 1 graft assessment after Day 1. Subjects who had no graft assessments after Day 1 were excluded from the FAS population.|Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group|Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group|Terminated||Phase 4|220|Actual|Mylan Bertek Pharmaceuticals|The study was terminated on 17 June 2013 due to the recommendation and request by the FDA to design a superiority clinical study to satisfy the sponsor’s post marketing study commitment for SS5%.|2||"FDA request as study could not serve as the confirmatory trial as required under Subpart H~   approval."|f||||f||||||||||2017-02-18 14:38:03.634519|2017-02-18 14:38:03.634519
NCT00634153|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2016-01-14|||January 2004||2004-01-01|January 2016|2016-01-01||||December 2020|Anticipated|2020-12-01||Observational|||The Surgical Gastrointestinal Diseases Registry Protocol|The Surgical Gastrointestinal Diseases Registry Protocol|Active, not recruiting||N/A|10000|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 14:38:04.081078|2017-02-18 14:38:04.081078
NCT00634140|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-03-27|||August 2009||2009-08-01|March 2015|2015-03-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||The Influence of Ezetimibe on Gallbladder Function|Te Influence of Ezetimibe on Gallbladder Function|Withdrawn||N/A|0|Actual|Indiana University||2||Study was never initiated due to lack of funding support.|f||||t||||||||||2017-02-18 14:38:04.392787|2017-02-18 14:38:04.392787
NCT00634114|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2010-05-18|2010-05-18||January 2008||2008-01-01|May 2010|2010-05-01|May 2009|Actual|2009-05-01|||||Interventional|||Reflux Esophagitis Phase III Study (Maintenance Treatment)|A Multicentre, Randomised, Double-blind, Parallel-group, Comparative Study to Compare the Efficacy and Safety of Esomeprazole 20 mg Once Daily Oral Administration With Omeprazole 10 mg and Esomeprazole 10 mg Once Daily Oral Administration in Maintenance Treatment in Patients With Healed Reflux Esophagitis|Completed||Phase 3|540|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:38:04.512839|2017-02-18 14:38:04.512839
NCT00634101|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-08-30|||January 2008||2008-01-01|August 2011|2011-08-01||||March 2008|Actual|2008-03-01||Interventional|||A Comparison of Two Daily Disposable Contact Lenses|The Comparative Clinical Performance of Narafilcon A and the FOCUS DAILIES AquaComfort Plus Lens|Terminated||N/A|280|Anticipated|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:38:05.125298|2017-02-18 14:38:05.125298
NCT00634088|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-02-09|2011-04-01||June 2008||2008-06-01|February 2016|2016-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer|Parallel Phase I Study of Ixabepilone Plus Lapatinib and Ixabepilone Plus Lapatinib Plus Capecitabine in Subjects With HER2 Positive Locally Advanced or Metastatic Breast Cancer|Terminated||Phase 1|13|Actual|R-Pharm||4||Slow Accrual|f||||f||||||||||2017-02-18 14:38:05.25378|2017-02-18 14:38:05.25378
NCT00634075|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-08-12|||March 2008||2008-03-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe Sepsis|Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe Sepsis|Completed||Phase 4|100|Anticipated|Li Shin Hospital||2|||f||||t||||||||||2017-02-18 14:38:06.569014|2017-02-18 14:38:06.569014
NCT00634062|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-03-11|||December 2004||2004-12-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder|Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder|Completed||Phase 4|28|Actual|Mclean Hospital||2|||f||||t||||||||||2017-02-18 14:38:06.67304|2017-02-18 14:38:06.67304
NCT00634049|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-06-09|2015-12-02||April 2008||2008-04-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|January 2014|Actual|2014-01-01||Interventional|VITAL|Intent to Treat Population (ITT)|Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi|Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi|Completed||Phase 3|149|Actual|Astellas Pharma Inc|Enrollment in the clinical study was suspended in January 2009 pending further characterization of newly identified impurities. After successful study completion resumption of enrollment started in April 2011 for the 9766-CL-0103/WSA-CS-003 study.|1|||f||||t||||||||||2017-02-18 14:38:06.828798|2017-02-18 14:38:06.828798
NCT00634036|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-01-08|||October 2009||2009-10-01|January 2016|2016-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|GLITZ Asthma||Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics|A Randomized, Placebo-Controlled Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics|Completed||Phase 2|19|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:38:08.689868|2017-02-18 14:38:08.689868
NCT00634023|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2009-03-10|||January 2008||2008-01-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|RANGE||Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD|A Cross-Sectional, Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With Gastroesophageal Reflux Disease (GERD) RANGE: Retrospective ANalysis of GErd|Completed||N/A|500|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 14:38:08.812357|2017-02-18 14:38:08.812357
NCT00634010|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-04-05|2016-01-28||February 2008||2008-02-01|April 2016|2016-04-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain|Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain|Terminated||Phase 3|36|Actual|M.D. Anderson Cancer Center||2||Slow Accrual|f||||t||||||||||2017-02-18 14:38:08.898129|2017-02-18 14:38:08.898129
NCT00633997|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-04-25||2016-04-25|February 2008||2008-02-01|April 2016|2016-04-01||||December 2008|Actual|2008-12-01||Interventional|||Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes|An Open-label, Multiple Dose Study to Assess the Steady-state Skin Concentrations and Pharmacokinetics of Vildagliptin 50 mg BID for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes|Terminated||Phase 1/Phase 2|22|Actual|Novartis||2||"After analysis of the existing data, it was determined that additional skin biopsy samples~   would not be required to determine study outcome."|f||||f||||||||||2017-02-18 14:38:09.496167|2017-02-18 14:38:09.496167
NCT00633984|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2014-04-14|2014-01-02||March 2007||2007-03-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||D-Cycloserine Enhancement of Exposure in Social Phobia|D-Cycloserine Enhancement of Exposure in Social Phobia|Completed||Phase 4|169|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:38:09.605433|2017-02-18 14:38:09.605433
NCT00633971|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2011-04-21|||March 2008||2008-03-01|April 2011|2011-04-01|September 2011|Anticipated|2011-09-01|June 2010|Actual|2010-06-01||Interventional|||Treatment Trial for Post-Thrombotic Syndrome|A Randomized Trial to Determine the Impact of Lymphedema Therapy on Quality of Life and Disease Severity in Patients With Post-Thrombotic Syndrome|Unknown status|Active, not recruiting|Phase 3|44|Anticipated|University of Vermont||2|||f||||f||||||||||2017-02-18 14:38:09.939205|2017-02-18 14:38:09.939205
NCT00633958|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2011-07-06|||March 2008||2008-03-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|FLT||A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors|A Pilot, Non-Therapeutic NeuroImaging Study of 18F-FLT in Pediatric Patients With Newly Diagnosed Central Nervous System Tumors|Terminated||N/A|5|Anticipated|Dana-Farber Cancer Institute||1||Large phase II opened to accue same patients|f||||f||||||||||2017-02-18 14:38:10.050807|2017-02-18 14:38:10.050807
NCT00633945|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2011-02-18|||November 2007||2007-11-01|March 2009|2009-03-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)|Evaluation of Lenalidomide (REVLIMID®) in Cutaneous LE: A Prospective, Non Controlled, Open Label Pilot Study to Evaluate the Off-Label Use of the FDA-approved Drug Lenalidomide (REVLIMID®) in Patients With Cutaneous Lupus Erythematosus|Completed||N/A|6|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 14:38:10.148655|2017-02-18 14:38:10.148655
NCT00633932|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2010-12-02|2009-12-10||December 2007||2007-12-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|||||Interventional|||Reflux Esophagitis Phase III Study (Initial Treatment)|A Multicentre, Randomised, Double-blind, Parallel-group, Comparative Study to Compare the Efficacy and Safety of Esomeprazole 20 mg and 40 mg Once Daily Oral Administration With Omeprazole 20 mg Once Daily Oral Administration in Patients With Reflux Esophagitis|Completed||Phase 3|602|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:38:10.243367|2017-02-18 14:38:10.243367
NCT00633191|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-08-31|||November 2003||2003-11-01|August 2016|2016-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PseudIgY||Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis|Post Marketing Study of Anti-pseudomonas IgY in Prevention of Recurrence of Pseudomonas Aeruginosa Infections Infections in Cystic Fibrosis (CF) Patients|Completed||Phase 1/Phase 2|14|Actual|Immunsystem AB||1|||f||||t||||||||No||2017-02-18 14:38:20.323767|2017-02-18 14:38:20.323767
NCT00633919|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2011-06-07|2010-11-11||July 2006||2006-07-01|June 2011|2011-06-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy of SLITone in House Dust Mite Allergic Patients|A Randomised, Double-blind, Placebo-controlled Trial Assessing the Efficacy of SLITone in House Dust Mite Allergic Patients|Completed||Phase 2/Phase 3|124|Actual|ALK-Abelló A/S|Retrospectively, trial design (medication use did not reflect the asthma status of subjects), and subject number (low power) and characteristics (mild, well-controlled asthma; low medication use needed) were not optimal for this trial purpose.|2|||f||||f||||||||||2017-02-18 14:38:10.965969|2017-02-18 14:38:10.965969
NCT00633906|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-11-18|||April 2002||2002-04-01|June 2008|2008-06-01|October 2005|Actual|2005-10-01|August 2004|Actual|2004-08-01||Interventional|HORIZONS||HORIZONS HIV Intervention|Reducing HIV Risk in Female Teens: A Tailored Approach|Completed||N/A|715|Actual|Emory University||2|||f||||f||||||||||2017-02-18 14:38:11.460823|2017-02-18 14:38:11.460823
NCT00633893|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-10-30|2013-08-19||May 2008||2008-05-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||All randomized participants regardless of whether treatment was actually received were included; intent to treat (ITT) principle.|Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism|A Safety and Efficacy Trial Evaluating the Use of Apixaban for the Extended Treatment of Deep Vein Thrombosis and Pulmonary Embolism|Completed||Phase 3|2711|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-02-18 14:38:11.595628|2017-02-18 14:38:11.595628
NCT00633880|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2014-04-22|2014-03-18||January 2008||2008-01-01|April 2014|2014-04-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|NOH302||Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)|Phase III, Multi-Center, Study to Assess the Clinical Effect of Droxidopa in Subjects With Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency or Non-Diabetic Neuropathy and Symptomatic NOH|Completed||Phase 3|181|Actual|Chelsea Therapeutics||2|||f||||t||||||||||2017-02-18 14:38:15.032486|2017-02-18 14:38:15.032486
NCT00633867|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2011-07-29|2010-02-25||February 2008||2008-02-01|March 2008|2008-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Randomised Controlled Trial of Intubation With the McGrath Series 5 Video Laryngoscope vs the Macintosh Laryngoscope|Randomised Controlled Trial of Intubation With the McGrath Series 5 Video Laryngoscope vs the Macintosh Laryngoscope|Completed||N/A|120|Actual|NHS Grampian||2|||f||||t||||||||||2017-02-18 14:38:16.315511|2017-02-18 14:38:16.315511
NCT00633854|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-03-04|||February 2008||2008-02-01|February 2008|2008-02-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Observational|||High-Frequency-Ultrasound Annular Arrays for Ophthalmic Imaging|High-Frequency-Ultrasound Annular Arrays for Small Animal and Ophthalmic Imaging|Unknown status|Enrolling by invitation|N/A|30|Anticipated|Weill Medical College of Cornell University|||1||f||||t||||||||||2017-02-18 14:38:16.657175|2017-02-18 14:38:16.657175
NCT00633841|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2010-10-18|||February 2008||2008-02-01|October 2010|2010-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease|Randomized, Controlled, Parallel Group, Patient-Blinded, Single-Center Phase I Pilot Study to Assess Tolerability and Safety of Repeated s.c. Administration of a Single-Dose of AFFITOPE AD02 Applied With or Without Adjuvant to Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|24|Actual|Affiris AG||2|||f||||t||||||||||2017-02-18 14:38:16.760984|2017-02-18 14:38:16.760984
NCT00633828|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-04-14|||August 1999||1999-08-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Influence of External Factors on Skeletal Growth in Youth|Determinants for Peak Bone Mass, Skeletal Architecture, Fractures, Adipositas and Cardiovascular Risk Factors During Growth and Adulthood|Active, not recruiting||N/A|500|Actual|Region Skane||2|||f||||f||||||||||2017-02-18 14:38:16.875495|2017-02-18 14:38:16.875495
NCT00633815|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-09-09|||January 2008||2008-01-01|September 2009|2009-09-01|November 2008||2008-11-01|November 2008|Actual|2008-11-01||Observational|||Upright Versus Supine Exercise Testing in Fontan-palliated Patients|Study of Upright Versus Supine Exercise Testing in Fontan-palliated Patients, Compared With Healthy Controls, to Evaluate for Postural Effects on Exercise Parameters|Completed||N/A|45|Actual|University of Michigan|||2||f||||f||||||||||2017-02-18 14:38:16.980049|2017-02-18 14:38:16.980049
NCT00633802|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-03-11|||April 2004||2004-04-01|March 2008|2008-03-01||||April 2009|Anticipated|2009-04-01||Interventional|||Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder||Unknown status|Recruiting|N/A|30|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||||||||||||2017-02-18 14:38:17.07032|2017-02-18 14:38:17.07032
NCT00633789|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2015-09-23||2015-09-23|June 2008||2008-06-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|February 2012|Actual|2012-02-01||Interventional|||Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types|A Randomized Discontinuation Study of Brivanib Alaninate (BMS-582664) Versus Placebo in Subjects With Advanced Tumors|Completed||Phase 2|597|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:38:17.17023|2017-02-18 14:38:17.17023
NCT00633776|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-08-02|||March 2008||2008-03-01|August 2016|2016-08-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)|Perforomist Versus Foradil Evaluated by Inspiratory Capacity and HRCT|Withdrawn||Phase 4|0|Actual|University of California, Los Angeles||2||Sponsor withdrew funding prior to study initiation|f||||f||||||||||2017-02-18 14:38:17.31476|2017-02-18 14:38:17.31476
NCT00633763|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-05-27|||February 2008||2008-02-01|May 2009|2009-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus|PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus|Completed||N/A|30|Anticipated|University of California, Irvine|||2||f||||f||||||||||2017-02-18 14:38:17.430598|2017-02-18 14:38:17.430598
NCT00633750|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-11|2012-08-02|2012-05-01||August 2002||2002-08-01|July 2012|2012-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery|Phase II Trial of OSI-774 (Tarceva), a Human Epidermal Growth Factor (HER) (erbB, Also Known as Epidermal Growth Factor Receptor, EGFR) Tyrosine Kinase Inhibitor, in Treatment-Naïve Operable Breast Cancer|Completed||Phase 2|50|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 14:38:17.539524|2017-02-18 14:38:17.539524
NCT00633737|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2013-12-19|||March 2008||2008-03-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||The Effects of Stress Reduction on Surgical Wound Healing|The Effects of Stress Reduction on Surgical Wound Healing: A Randomised Controlled Trial|Completed||N/A|70|Actual|University of Auckland, New Zealand||2|||f||||f||||||||||2017-02-18 14:38:17.84808|2017-02-18 14:38:17.84808
NCT00633724|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-08-13|||May 2007||2007-05-01|August 2013|2013-08-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer|Phase I Study of Multiple-vaccine Therapy Including Antiangiogenic Vaccine Using Epitope Peptide Restricted to HLA-A*2402 in Treating Patients With Unresectable or Recurrent Non-small Cell Lung Cancer|Completed||Phase 1|9|Anticipated|Fukushima Medical University||1|||f||||t||||||||||2017-02-18 14:38:17.954616|2017-02-18 14:38:17.954616
NCT00633711|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2011-06-15|||March 2007||2007-03-01|April 2010|2010-04-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Obstructive Sleep Apnea Treatment by Fixed CPAP and by Auto-CPAP (Somnosmart2)|Differential Effects of Chronic Treatment of OSAS by CPAP and SOMNOsmart2 on Norepinephrine and Blood Pressure|Completed||Phase 4|17|Actual|"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"||2|||f||||f||||||||||2017-02-18 14:38:18.057272|2017-02-18 14:38:18.057272
NCT00633347|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2013-02-14|||January 2007||2007-01-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation||Completed||Phase 4|570|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 14:38:18.167039|2017-02-18 14:38:18.167039
NCT00633334|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-12-01|||September 2003||2003-09-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Observational|||Development of Early Detection Signs for Gastrointestinal Cancer|Investigation of the Immune Response to Gastrointestinal Tumors and Development of Novel Biomarkers for the Presence of Gastrointestinal Cancer|Recruiting||N/A|1500|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     peripheral blood portions of tumor tumor draining lymph nodes~   "|||2017-02-18 14:38:18.268244|2017-02-18 14:38:18.268244
NCT00633321|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2011-06-07|||May 2007||2007-05-01|June 2011|2011-06-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose-Ranging Study of 100 or 250 μg of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation|Completed||Phase 2|522|Anticipated|Celtic Pharma Development Services||3|||f||||f||||||||||2017-02-18 14:38:18.380786|2017-02-18 14:38:18.380786
NCT00633308|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-02-29|||March 2008||2008-03-01|February 2016|2016-02-01|February 2011|Anticipated|2011-02-01|January 2010|Anticipated|2010-01-01||Interventional|hemodialysis||Phosphorus and Calcium Removal During Long Hemodialysis Treatment Sessions|Phosphorus and Calcium Removal During Long Hemodialysis Treatment Sessions|Withdrawn||Phase 2|0|Actual|Indiana University||1||No coordinator available to work on study.|f||||f||||||||||2017-02-18 14:38:18.514345|2017-02-18 14:38:18.514345
NCT00633295|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2011-01-18|||June 2008||2008-06-01|January 2011|2011-01-01||||May 2010|Actual|2010-05-01||Interventional|||Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor|An Open-label, Multi-center Study to Evaluate the Efficacy and Safety of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor|Completed||Phase 2|9|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:38:18.609261|2017-02-18 14:38:18.609261
NCT00633282|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2012-06-03|||March 2008||2008-03-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease|Role of Pioglitazone and Berberine in Treatment of Non-alcoholic Fatty Liver Disease(NAFLD) Patients With Impaired Glucose Regulation or Type 2 Diabetes Mellitus|Completed||Phase 2|184|Actual|Fudan University||3|||f||||t||||||||||2017-02-18 14:38:18.70981|2017-02-18 14:38:18.70981
NCT00633269|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2009-01-13|||April 2008||2008-04-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours|Open, Non-Randomized, Single Centre Phase I Study to Assess the Metabolism, Excretion and Pharmacokinetics of a Single Oral 100 mg Dose of [14C]-AZD2281 (KU-0059436) in Patients With Advanced or Metastatic Solid Tumours Refractory to Standard Treatments|Completed||Phase 1|6|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:38:18.830501|2017-02-18 14:38:18.830501
NCT00633256|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2012-03-14|2012-03-14||December 2006||2006-12-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers|The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers.|Completed||N/A|20|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:38:18.931974|2017-02-18 14:38:18.931974
NCT00633243|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2013-01-01|2012-10-19||April 2007||2007-04-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effective Treatment of Hepatitis C in Substance Users|Effective Treatment of Hepatitis C in Substance Users|Completed||N/A|21|Actual|Yale University|This trial contains a small sample size of patients with considerable comorbidity and is drawn from one specialized treatment setting. Our conclusions will need empiric testing within carefully conducted RCTs.|2|||f||||f||||||||||2017-02-18 14:38:19.300705|2017-02-18 14:38:19.300705
NCT00633230|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-06-24||||||June 2015|2015-06-01||||||||Interventional|||Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C|Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C|Withdrawn||Phase 1|0|Actual|University of Virginia||2||No funding secured|f||||f||||||||||2017-02-18 14:38:19.679084|2017-02-18 14:38:19.679084
NCT00633217|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-10-26|2009-10-22||March 2008||2008-03-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)|A Randomized, Double-Blind, Double-Dummy, Parallel Group 12-Week Comparison of the Efficacy and Safety of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler 230/42mcg Twice-daily With Fluticasone Propionate/Salmeterol DISKUS 250/50mcg Twice-daily in Subjects With COPD|Completed||Phase 4|247|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:38:19.775218|2017-02-18 14:38:19.775218
NCT00633204|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2011-06-22|||February 2008||2008-02-01|January 2009|2009-01-01|November 2011|Anticipated|2011-11-01|November 2011|Anticipated|2011-11-01||Interventional|||Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer|Phase II Study of Bladder Cancer Using Novel Tumor Antigens for Prevention of the Recurrence for Bladder Cancer After TUR-Bt|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|Iwate Medical University||1|||f||||t||||||||||2017-02-18 14:38:20.219731|2017-02-18 14:38:20.219731
NCT00633165|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2010-02-24|||August 2007||2007-08-01|February 2010|2010-02-01|June 2010|Anticipated|2010-06-01|October 2008|Actual|2008-10-01||Interventional|SMI-BRS-202||Brostallicin Clinical Trial for Myxoid Liposarcoma|A Phase II, Multicenter Study to Explore the Efficacy and Safety of Brostallicin in Patients With Myxoid Liposarcoma With (12:16) Translocation|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|Systems Medicine LLC||1|||f||||f||||||||||2017-02-18 14:38:20.547149|2017-02-18 14:38:20.547149
NCT00633152|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2012-10-09|2012-07-25||February 2008||2008-02-01|October 2012|2012-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections|A Phase 2, Multicenter, Randomized, Open-label, Comparative Study to Evaluate the Efficacy and Safety of Intramuscular Ceftaroline Versus Intravenous Linezolid in Adult Subjects With Complicated Skin and Skin Structure Infections|Completed||Phase 2|150|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 14:38:20.639372|2017-02-18 14:38:20.639372
NCT00633139|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-07-14|2010-10-06||August 2007||2007-08-01|February 2014|2014-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)|A Single Center, Open-Label, Non-Randomized, Uncontrolled, Multiple-Dose, Dose Escalation Study of the Safety, Pharmacokinetics, Efficacy and Long Term Safety of HGT-1111 (Recombinant Human Arylsulfatase A [rhASA, Metazym]) for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)|Completed||Phase 1/Phase 2|13|Actual|Shire||3|||f||||t||||||||||2017-02-18 14:38:21.007901|2017-02-18 14:38:21.007901
NCT00633126|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-02-11|2012-03-28||March 2008||2008-03-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age|Pharmacokinetics of a Single Dose of Ceftaroline in Subjects 12 to 17 Years of Age Receiving Antibiotic Therapy|Completed||Phase 1|9|Actual|Forest Laboratories||1|||f||||f||||||||||2017-02-18 14:38:21.638318|2017-02-18 14:38:21.638318
NCT00633113|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2013-04-25|||November 2007||2007-11-01|April 2013|2013-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|MIKRO||Minimally Invasive Knee Replacement Outcomes (MIKRO) Study|A Randomized, Prospective, Blinded Clinical Trial Comparing Two Total Knee Replacement Techniques|Completed||N/A|131|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 14:38:24.265182|2017-02-18 14:38:24.265182
NCT00633087|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-11-15|2013-11-15||November 2006||2006-11-01|November 2013|2013-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|2-Deoxyglucose||A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer|A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer|Terminated||Phase 1/Phase 2|12|Actual|Rutgers, The State University of New Jersey||1||Slow accrual|f||||f||||||||||2017-02-18 14:38:24.370944|2017-02-18 14:38:24.370944
NCT00633074|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2016-11-03|2012-04-26||March 2008||2008-03-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations|Non-inferiority Study of GlaxoSmithKline Biologicals' Influenza Vaccine GSK576389A Using Different Formulations.|Completed||Phase 2|720|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:38:24.633142|2017-02-18 14:38:24.633142
NCT00633061|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2013-02-06|||March 2008||2008-03-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|DVT||Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer|Phase II Study on the Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer|Completed||Phase 2|136|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 14:38:27.561967|2017-02-18 14:38:27.561967
NCT00633048|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2009-02-16|||March 2008||2008-03-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study Evaluating the Safety and Tolerability of NSA-789|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NSA-789 Administered Orally to Healthy Subjects|Completed||Phase 1|64|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:38:27.67171|2017-02-18 14:38:27.67171
NCT00633035|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-10-12|||September 2007||2007-09-01|October 2013|2013-10-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit|Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit|Completed||Phase 4|60|Actual|Far Eastern Memorial Hospital||2|||f||||t||||||||||2017-02-18 14:38:27.766413|2017-02-18 14:38:27.766413
NCT00633022|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2017-01-31||2012-03-22|June 2008||2008-06-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging|A Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Effects of Two Regimens of GW856553, Over a Period of 3 Month, on In-vivo Macrophage Activity, as Assessed by FDG-PET/CT Imaging, in the Carotid Arteries and Aorta of Subjects With Established Atherosclerosis|Completed||Phase 2|102|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:38:27.878225|2017-02-18 14:38:27.878225
NCT00633009|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-10-28|2012-07-19||August 2008||2008-08-01|October 2013|2013-10-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen|A Blinded, Placebo Controlled Study Evaluating Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen (LtSTA)|Completed||Phase 2|50|Actual|Nielsen BioSciences, Inc.||3|||f||||f||||||||||2017-02-18 14:38:27.989748|2017-02-18 14:38:27.989748
NCT00632996|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-12-18|||January 2008||2008-01-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Exercise and Manual Therapy for Shoulder Subacromial Impingement Syndrome|Effectiveness of Rehabilitation for Subacromial Impingement Syndrome|Completed||Phase 2|162|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 14:38:28.681115|2017-02-18 14:38:28.681115
NCT00632632|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-07-29|2015-06-10||January 2005||2005-01-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|VR-DCS||Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)|Combined Exposure Therapy and D-Cycloserine vs. Placebo for Posttraumatic Stress Disorder|Completed||N/A|25|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 14:38:42.445013|2017-02-18 14:38:42.445013
NCT00632983|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-08|2012-04-13|||June 2001||2001-06-01|October 2011|2011-10-01||||December 2013|Anticipated|2013-12-01||Interventional|||Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer|Acitve Monitoring, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 3|2050|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:38:28.800891|2017-02-18 14:38:28.800891
NCT00632970|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2011-07-07|||February 2008||2008-02-01|February 2009|2009-02-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals|A Multi-Center Comparison of Raltegravir to Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV-Infected Individuals Naive to Antiretroviral Therapy|Completed||Phase 4|80|Anticipated|George Washington University||2|||f||||t||||||||||2017-02-18 14:38:28.925173|2017-02-18 14:38:28.925173
NCT00632957|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2011-04-11|||September 2004||2004-09-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses|Center for the Biologic Basis of Oral/Systemic Diseases Project 5: Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses.|Completed||N/A|126|Actual|University of Kentucky||2|||f||||f||||||||||2017-02-18 14:38:29.027718|2017-02-18 14:38:29.027718
NCT00632944|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-06-04|||January 2007||2007-01-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Effects of Nursing Rounds on Patients Fall Rates|Effects of Nursing Rounds on Patients Fall Rates, Satisfaction, and Call Light Use in an In-patient Medical Surgical Unit|Completed||N/A|300|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:38:29.131665|2017-02-18 14:38:29.131665
NCT00632931|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-07-08|2010-01-18||July 2007||2007-07-01|July 2015|2015-07-01|April 2009|Actual|2009-04-01|May 2008|Actual|2008-05-01||Interventional|||A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED)|A Randomized, Partially-Blind, Placebo-Controlled, 2-Period Crossover Study to Assess the Effects of a Single Dose of Vorinostat on the QTc Interval in Patients With Advanced Cancer|Completed||Phase 1|25|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:38:29.214076|2017-02-18 14:38:29.214076
NCT00632918|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2008-12-25|||October 2007||2007-10-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Observational|DSCT||Effects of Heart Rates and Variability of Heart Rates on Image Quality of Dual-Source CT Coronary Angiography|A Retrospective Study of Effects of Heart Rates and Variability of Heart Rates on Image Quality of Dual-Source CT Coronary Angiography With Regard to Motion Artifact.|Completed||N/A|149|Actual|Far Eastern Memorial Hospital|||1||f||||t||||||None Retained|"~     No biospecimens~   "|||2017-02-18 14:38:29.934784|2017-02-18 14:38:29.934784
NCT00632905|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-12-21|||September 2007||2007-09-01|December 2016|2016-12-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|BHOS||Bone Health Observational Study|A Prospective Study to Evaluate the Incidence of Skeletal Related Events In Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT).|Completed||N/A|599|Actual|CMX Research|||3||f||||f||||||||Undecided||2017-02-18 14:38:30.037124|2017-02-18 14:38:30.037124
NCT00632892|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2008-03-10|||December 2007||2007-12-01|February 2008|2008-02-01||||January 2008|Actual|2008-01-01||Observational|||The Correlation Between Oxidative Stress and Indinated Contrast-Media Nephrotoxicity|The Correlation Between Oxidative Stress and Indinated Contrast-Media Nephrotoxicity|Completed||N/A|80||Far Eastern Memorial Hospital|||1||f||||t||||||Samples Without DNA|"~     The urine samples are collected just before and 30 minutes after IVP.The samples are~     immediately frozen at -80'C until analyzed.~   "|||2017-02-18 14:38:30.366462|2017-02-18 14:38:30.366462
NCT00632879|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2008-07-07|||March 2007||2007-03-01|July 2008|2008-07-01|March 2008|Anticipated|2008-03-01|||||Observational|||The Study of Metabolic Syndrome in Hemodialysis Patients|The Study of Metabolic Syndrome in Hemodialysis Patients|Unknown status|Recruiting|N/A|300|Anticipated|Far Eastern Memorial Hospital|||1||f||||||||||Samples With DNA|"~     Blood samples are collected for analysis~   "|||2017-02-18 14:38:30.437666|2017-02-18 14:38:30.437666
NCT00632866|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2012-07-01|||March 2008||2008-03-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2011|Actual|2011-05-01||Interventional|JOQUER||Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome|Randomized, Double-blind, Placebo-controlled Trial of Hydroxychloroquine in Primary Sjögren's Syndrome|Completed||Phase 3|120|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:38:30.509873|2017-02-18 14:38:30.509873
NCT00632853|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-08|2017-01-24|||March 2008||2008-03-01|January 2017|2017-01-01||||June 2023|Anticipated|2023-06-01||Interventional|||Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide|Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide|Recruiting||Phase 3|729|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 14:38:30.63674|2017-02-18 14:38:30.63674
NCT00632840|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-02-29|||June 2001||2001-06-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2002|Actual|2002-12-01||Interventional|||Pharmacological Regulation of Fat Transport in Metabolic Syndrome|Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate With the Metabolic Syndrome|Completed||Phase 4|11|Actual|The University of Western Australia||3|||f||||f||||||||||2017-02-18 14:38:31.156623|2017-02-18 14:38:31.156623
NCT00632827|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2014-10-03|||June 2008||2008-06-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)|Treatment of Peripheral T-cell Lymphoma With Aggressive Induction Chemotherapy Followed by Autologous Stem Cell Transplant Using Denileukin Diftitox (Ontak) for In-vivo Purging and Post-Transplant Therapy: A Multicenter Phase II Clinical Trial|Unknown status|Active, not recruiting|Phase 2|21|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:38:31.259765|2017-02-18 14:38:31.259765
NCT00632814|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2015-06-04|2011-01-14||June 2007||2007-06-01|June 2015|2015-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Russian Kogenate Pediatric Study|A Prospective Study to Evaluate the Effect of rFVIII-FS in Different Prophylactic Regimens on Bleeding Events Frequency and Development of Arthropathy in Previously Treated and Minimally Treated Hemophilia A Pediatric Population.|Completed||Phase 4|32|Actual|Bayer|Protocol deviations were not excluded: e.g. a previously untreated patient developed the transitory inhibitor; change to a higher group did not always occur according protocol; there was temporary lack of smaller vial sizes at the centers.|3|||f||||f||||||||||2017-02-18 14:38:31.367353|2017-02-18 14:38:31.367353
NCT00632801|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2014-12-07|||December 2007||2007-12-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Does Chewing Gum After Elective Laparoscopic Colectomy Surgery Decrease Ileus?|Does Chewing Gum After Elective Laparoscopic Colectomy Surgery Decrease Ileus?|Terminated||N/A|3|Actual|State University of New York - Upstate Medical University||1||Change in procedure nd medication used instead of gum|f||||f||||||||||2017-02-18 14:38:32.595388|2017-02-18 14:38:32.595388
NCT00632788|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2008-03-03|||April 2006||2006-04-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Observational|||The Influence of Acute Myocardial Infarction Checklist on the Door-to-Balloon Time|The Influence of Acute Myocardial Infarction Checklist on the Door-to-Balloon Time in Patients Suffering From Acute ST-Elevation Myocardial Infarction|Completed||N/A|213|Actual|Far Eastern Memorial Hospital|||2||f||||f||||||||||2017-02-18 14:38:32.70384|2017-02-18 14:38:32.70384
NCT00632775|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-08-23|||December 2007||2007-12-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized Children|Randomized, Double Blind, Controlled Trial of 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized Children|Completed||Phase 3|110|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 14:38:32.800236|2017-02-18 14:38:32.800236
NCT00632762|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-04-07|||November 2007||2007-11-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|AMANDYSK||Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)|Evaluation of the Long-term Effects of Amantadine in Parkinsonian's Suffering From Dyskinesia Induced by Levodopa: Study Randomised Double-blind, Placebo - Cessation of a Chronic Prescription. STUDY AMANDYSK.|Completed||Phase 4|80|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 14:38:32.912285|2017-02-18 14:38:32.912285
NCT00632749|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2015-08-31|2015-03-27||May 2008||2008-05-01|August 2015|2015-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||68 participants were randomised, and 64 were treated with the study treatment hence the number of participants differs from the number of participants that started in the participant flow.|BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment|An Open Phase I/IIa Trial to Investigate the Maximum Tolerated Dose, Safety, Efficacy and Pharmacokinetics of BI 811283 in Combination With Cytarabine in Patients With Previously Untreated Acute Myeloid Leukaemia Ineligible for Intensive Treatment|Completed||Phase 2|68|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:38:33.098828|2017-02-18 14:38:33.098828
NCT00632736|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-12-01|2010-12-02||February 2004||2004-02-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease|An Open-Label Extension Study With REQUIP (Ropinirole) CR for Subjects From Studies 101468/165, 101468/168 and 101468/169|Completed||Phase 3|419|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:38:40.871062|2017-02-18 14:38:40.871062
NCT00632723|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2009-04-21|||April 2001||2001-04-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|||||Interventional|||IRESSA™ (Gefitinib) in Breast Cancer Patients|A Phase II Trial to Assess the Efficacy of IRESSA™ (Gefitinib) 500 mg/Day in Patients With Breast Cancer Who Have Failed Tamoxifen or Have an Oestrogen Receptor Negative Tumour and Would be Considered for Systemic Therapy|Completed||Phase 2|54|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 14:38:41.59218|2017-02-18 14:38:41.59218
NCT00632710|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2008-03-04|||July 2004||2004-07-01|March 2008|2008-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Assessment of the Effectiveness of Low-Level Laser Therapy on the Hands of Patients With Rheumatoid Arthritis|Assessment of the Effectiveness of Low-Level Laser Therapy on the Hands of Patients With Rheumatoid Arthritis: a Randomized Double-Blind Controlled Trial|Completed||N/A|82|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 14:38:41.81677|2017-02-18 14:38:41.81677
NCT00632697|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2008-03-10|||October 2001||2001-10-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|LETS1||Pentoxifylline and Endometriosis|Combined Laparoscopic Surgery and Pentoxifylline Therapy for Treatment of Endometriosis-Associated Infertility: A Preliminary Study|Completed||Phase 3|104|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 14:38:41.923995|2017-02-18 14:38:41.923995
NCT00632684|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2011-11-22|||July 2006||2006-07-01|April 2009|2009-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effectiveness of an Adaptive Treatment Model for At-risk Family Caregivers|Adaptive Intervention for At-risk Family Caregivers|Completed||N/A|65|Actual|Penn State University||2|||f||||f||||||||||2017-02-18 14:38:42.011791|2017-02-18 14:38:42.011791
NCT00632671|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2013-12-31|||March 2005||2005-03-01|December 2013|2013-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|COLOMBES||COLOMBES Project:Constitution of a Population-based Cohort of Obese Subjects With Longitudinal Long-term Follow-up|Constitution of a Population-based Cohort of Obese Subjects With Longitudinal Long-term Follow-up.|Active, not recruiting||N/A|311|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"~     plasma, serum, DNA, RNA, cell blood, for persons undergoing bariatric surgery (specific~     consentment): samples of liver and adipocytes~   "|||2017-02-18 14:38:42.12197|2017-02-18 14:38:42.12197
NCT00632658|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2009-01-27|||January 2008||2008-01-01|January 2009|2009-01-01|July 2010|Anticipated|2010-07-01|July 2009|Anticipated|2009-07-01||Observational|cGVHD||Development and Validation of a Symptom Scale for Children With Chronic Graft-Versus-Host Disease|Development and Validation of a Symptoms Scale for Children With Chronic Graft-Versus-Host Disease|Unknown status|Recruiting|N/A|24|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||||||2017-02-18 14:38:42.219058|2017-02-18 14:38:42.219058
NCT00632645|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-07-30|||April 2009||2009-04-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|NEUROHD||Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride|Neuroleptic and Huntington Disease. Comparison of : Olanzapine, la Tetrabenazine and Tiapride. A Multicentric, Randomised, Controlled Study.|Recruiting||Phase 3|180|Anticipated|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-02-18 14:38:42.313839|2017-02-18 14:38:42.313839
NCT00460759|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2009-07-17|||June 2007||2007-06-01|October 2007|2007-10-01|December 2007||2007-12-01|||||Interventional|||Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine|Pharmacokinetic Issues in the Use of Moxifloxacin Plus Rifapentine|Unknown status|Active, not recruiting|Phase 1|16||Johns Hopkins University|||||||||||||||||||2017-02-18 15:42:07.35306|2017-02-18 15:42:07.35306
NCT00632619|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-04-12|2012-08-29||March 2009||2009-03-01|April 2013|2013-04-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|||Group-Based Behavioral Therapy Combined With Stimulant Medication for Treating Children With Attention Deficit Hyperactivity Disorder and Impaired Mood|A Novel Multimodal Intervention for Children With ADHD and Impaired Mood|Completed||N/A|68|Actual|Florida International University|relatively small sample size, the lack of a gold standard measurement for mood dysregulation in children, run at a specialty mental health research center and therapy subjects had more contact with study staff which may have impacted results.|2|||f||||t||||||||||2017-02-18 14:38:42.836485|2017-02-18 14:38:42.836485
NCT00632606|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2012-12-21|||August 2008||2008-08-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|MagHead||MgSO4 vs Metoclopramide for Headache in Pregnant Women|Magnesium Sulfate vs Metoclopramide for Headache in Pregnant Women|Withdrawn||Phase 2/Phase 3|0|Actual|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||||2017-02-18 14:38:43.465873|2017-02-18 14:38:43.465873
NCT00632593|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-03-07|||March 2005||2005-03-01|February 2008|2008-02-01|May 2007|Actual|2007-05-01|January 2007|Actual|2007-01-01||Interventional|||Trial Comparing Early Complications of Two Techniques in the Laparoscopic Gastric Bypass|Prospective Randomized Trial Comparing Early Complications of Hand-Sewn Versus Circular Stapled Gastro-Jejunal Anastomosis in Laparoscopic Gastric Bypass|Completed||N/A|102|Actual|Hospital Universitari de Bellvitge||2|||f||||f||||||||||2017-02-18 14:38:43.574584|2017-02-18 14:38:43.574584
NCT00632580|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-03-17|||January 2008||2008-01-01|March 2009|2009-03-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||Intra- Versus Extraarticular Injection of Ropivacaine in Total Knee Arthroplasty|Intraartikulær Versus ekstraartikulær Bolus Injektion Med Ropivacain Ved Total knæalloplastik: et Prospektivt, Randomiseret, Dobbeltblindet, Kontrolleret Studie|Unknown status|Recruiting|Phase 4|60|Anticipated|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 14:38:43.663587|2017-02-18 14:38:43.663587
NCT00632567|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-12-14|||March 2008||2008-03-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|EPIC||EPIC :Anal Incontinence After Delivery. Secondary Prevention With Caesarean Section.|Anal Incontinence After Delivery. Secondary Prevention With Caesarean Section.|Completed||N/A|554|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||Undecided||2017-02-18 14:38:43.769038|2017-02-18 14:38:43.769038
NCT00632554|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2014-09-18|||June 2008||2008-06-01|September 2014|2014-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia|Phase 4, Randomized Study of Three Months-prednisolone Therapy in the Treatment of Chronic Eosinophilic Pneumonia|Completed||Phase 4|50|Anticipated|Hamamatsu University||2|||f||||f||||||||||2017-02-18 14:38:43.867798|2017-02-18 14:38:43.867798
NCT00632541|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2015-12-02|2015-12-02||October 2007||2007-10-01|December 2015|2015-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||From October 2008 to March 2009, 18 patients were enrolled. Nearly half of the patients have triple negative (ER-, PR-, HER2-) disease, and most had received 1 or 2 prior chemotherapy regimens.|A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer|A Phase II Study of Combined VEGF Inhibitor (Bevacizumab + Sorafenib) in Patients With Metastatic Breast Cancer: Hoosier Oncology Group BRE06-109|Terminated||Phase 2|18|Actual|Hoosier Cancer Research Network|The study was terminated early due to a poor safety profile as well as the lack of significant efficacy of this combination over bevacizumab alone in the short followup period where it was evaluated. Therefore, secondary objectives were not analyzed.|1||Significant Toxicities Experienced|f||||t||||||||||2017-02-18 14:38:43.969997|2017-02-18 14:38:43.969997
NCT00632528|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-01-09|||March 2008||2008-03-01|February 2008|2008-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|KINOPA||MEOPA to Improve Physical Therapy Results After Multilevel Surgery|"Evaluation of the Efficacy of MEOPA Used to Obtain Better ROM Immediately After Multilevel Surgery in Children With Spastic Diplegia, Quadriplegia or Hemiplegia."|Completed||Phase 3|64|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:38:44.390172|2017-02-18 14:38:44.390172
NCT00632515|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2017-02-06|||January 2008|Actual|2008-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Observational|||Screening for Familial Colorectal Cancer (CRC) Patients|Screening and Risk Communication for First Degree Relatives of Colorectal Cancer Patients|Active, not recruiting||N/A|325|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:38:44.495186|2017-02-18 14:38:44.495186
NCT00632502|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-10-28|2014-10-14||May 2008||2008-05-01|October 2015|2015-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional||All randomized participants who received study drug|Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)|Safety of SCH 527123 in Subjects With Neutrophilic Asthma|Completed||Phase 2|37|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 14:38:44.608218|2017-02-18 14:38:44.608218
NCT00632489|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-06-04|2015-05-18||May 2008||2008-05-01|June 2015|2015-06-01|July 2011|Actual|2011-07-01|January 2009|Actual|2009-01-01||Interventional|||LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients|A Phase I Study of LBH589 in Combination With Capecitabine ± Lapatinib|Completed||Phase 1|20|Actual|SCRI Development Innovations, LLC||3|||f||||f||||||||||2017-02-18 14:38:45.136802|2017-02-18 14:38:45.136802
NCT00632476|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-08-31|||March 2007||2007-03-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|July 2011|Actual|2011-07-01||Interventional|||Evaluating the Effects of Supplemental Vitamin C on Infant Lung Function in Pregnant Smoking Women|In-Utero Smoke, Vitamin C, and Newborn Lung Function|Completed||N/A|282|Actual|Oregon Health and Science University||3|||f||||t||||||||||2017-02-18 14:38:45.604291|2017-02-18 14:38:45.604291
NCT00632463|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-03-12|2013-02-22||February 2008||2008-02-01|March 2013|2013-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness|RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness|Completed||Phase 2|21|Actual|ADMA Biologics, Inc.|Unfortunately enrollment in this study was suspended early due to slow accrual rates.|3|||f||||t||||||||||2017-02-18 14:38:45.719262|2017-02-18 14:38:45.719262
NCT00632450|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2010-03-25|||December 2007||2007-12-01|March 2010|2010-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|EnSite RT CPM||EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study|EnSite Real-Time Cardiac Performance Measurements Study, a Non-significant Risk Study|Completed||N/A|21|Actual|St. Jude Medical|||1||f||||f||||||||||2017-02-18 14:38:46.454731|2017-02-18 14:38:46.454731
NCT00632424|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2016-02-09|2010-09-15||May 2008||2008-05-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase 1 Trial of Oral Ixabepilone|A Phase 1 Study of Ixabepilone Administered as 3 Oral Doses Each Separated by 6 Hours Every 21 Days in Subjects With Advanced Cancer|Terminated||Phase 1|23|Actual|R-Pharm|The MTD of oral ixabepilone at the scheduled doses used in this study was not determined due to early study discontinuation.|1||Business Objectives Changed|f||||f||||||||||2017-02-18 14:38:46.793432|2017-02-18 14:38:46.793432
NCT00632411|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2014-07-18|||April 2008||2008-04-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|AFIII||Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study)|Efficacy of a Smoking Quit Line in the Military|Completed||N/A|1298|Actual|University of Tennessee||2|||f||||t||||||||||2017-02-18 14:38:47.816827|2017-02-18 14:38:47.816827
NCT00632398|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2015-12-12|||March 2008||2008-03-01|December 2015|2015-12-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Multimedia Training for Family Caregivers in Use of Touch and Massage in Supportive Cancer Care|Couples and Cancer: Building Partner Efficacy in Caring|Completed||Phase 2|228|Actual|Collinge and Associates, Inc.||2|||f||||f||||||||||2017-02-18 14:38:47.934932|2017-02-18 14:38:47.934932
NCT00632385|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2011-04-22|||January 2003||2003-01-01|April 2011|2011-04-01|August 2003|Actual|2003-08-01|||||Interventional|||Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy|An Open-label Study of Eletriptan for the Acute Treatment of Migraine in Migraine Sufferers Who Are Dissatisfied With Rizatriptan Therapy|Completed||Phase 4|127|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:38:48.259136|2017-02-18 14:38:48.259136
NCT00632372|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2016-06-09||2016-05-18|January 2008||2008-01-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|September 2011|Actual|2011-09-01||Interventional|zLAP||Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study|CRT-D Based Heart Failure Monitoring Study|Completed||Phase 2|8|Actual|St. Jude Medical||1|||f||||t||||||||No||2017-02-18 14:38:48.405148|2017-02-18 14:38:48.405148
NCT00632359|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-10-13|||February 2008||2008-02-01|October 2015|2015-10-01||||October 2015|Actual|2015-10-01||Interventional|||Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease|A Study of Lenalidomide in Patients With Chronic Lymphocytic Leukemia and Residual Disease After Chemotherapy - RV-CLL-PI-0270|Completed||Phase 2|36|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 14:38:48.531202|2017-02-18 14:38:48.531202
NCT00632346|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2008-03-07|||September 2007||2007-09-01|February 2008|2008-02-01|February 2008|Anticipated|2008-02-01|February 2008|Anticipated|2008-02-01||Observational|||Relationship of Adverse Childhood Experiences to Overweight and Obesity|Relationship of Adverse Childhood Experiences (Childhood Abuse, Neglect, and Household Dysfunction) to the Severity of Overweight and Obesity in Young Adults in a Military Dependent Population.|Unknown status|Active, not recruiting|N/A|200|Actual|Brooke Army Medical Center|||1||f||||t||||||||||2017-02-18 14:38:48.649459|2017-02-18 14:38:48.649459
NCT00632333|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2011-07-20|||February 2008||2008-02-01|September 2009|2009-09-01|March 2012|Anticipated|2012-03-01|December 2011|Anticipated|2011-12-01||Interventional|||Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer|Phase I Study of Chemoradiation Therapy With Epitope Peptide Vaccine Therapy in Treating Patients With Unresectable, Advanced or Recurrent Esophageal Cancer|Unknown status|Recruiting|Phase 1|9|Anticipated|Teikyo University||1|||f||||t||||||||||2017-02-18 14:38:48.753164|2017-02-18 14:38:48.753164
NCT00632320|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-02|2008-03-07|||October 2004||2004-10-01|March 2008|2008-03-01|August 2005|Actual|2005-08-01|December 2004|Actual|2004-12-01||Observational|||Continuous Positive Airway Pressure and Oxygen Concentration on Measurement of Rapid Shallow Breathing Index|Effect of Continuous Positive Airway Pressure and Oxygen Concentration on Measurement of Rapid Shallow Breathing Index|Completed||N/A|98|Actual|Taipei Veterans General Hospital, Taiwan|||1||f||||f||||||||||2017-02-18 14:38:48.883628|2017-02-18 14:38:48.883628
NCT00632307|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2016-09-06|||July 2006||2006-07-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Observational|||Breath Analysis by Ion Mobility Spectrometry|Detection of Clusters of Volatile Organic Compounds (VOC)in Patients With Different Lung Disorders by Ion Mobility Spectrometry. Different Clusters of VOC in the Diagnosis of Different Lung Disorders Using Ion Mobility Spectrometry|Recruiting||N/A|1000|Anticipated|Lung Clinic Hemer|||8||f||||f||||||Samples Without DNA|"~     breath, pleural fluid (only in patients with therapeutic pleurocentesis)~   "|||2017-02-18 14:38:48.989675|2017-02-18 14:38:48.989675
NCT00632294|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-07-31|||December 2007||2007-12-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Retrospective Study of the Biomechanical Properties of Large Allografts|Retrieved Allograft Study: Retrospective Study of the Biomechanical Properties of Large Allografts|Terminated||N/A|2|Actual|M.D. Anderson Cancer Center|||1|Low accrual.|f||||f||||||Samples With DNA|"~     A leftover sample of the removed allograft bone will be collected and used to learn about~     the properties (such as bone strength, bone density, and new bone formation) of the removed~     transplant tissue.~   "|||2017-02-18 14:38:49.117633|2017-02-18 14:38:49.117633
NCT00632281|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2012-01-17|2011-12-01||January 2006||2006-01-01|June 2010|2010-06-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors|Stereotactic Body Radiation Therapy for Tumors in the Thorax|Completed||N/A|38|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 14:38:49.227905|2017-02-18 14:38:49.227905
NCT00632268|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2013-08-19|||February 2008||2008-02-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer|Phase II Study of Low-dose RAD001(Everolimus) Plus Cisplatin and HDFL (Weekly 24-Hour Infusion of High-dose 5-Fluorouracil and Leucovorin) Chemotherapy for First-line Treatment of Unresectable, Recurrent or Metastatic Gastric Cancer|Completed||Phase 2|40|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 14:38:49.487436|2017-02-18 14:38:49.487436
NCT00632255|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-06-02|||January 2008||2008-01-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment|Compliance to Long Term Imatinib Therapy in Newly Diagnosed Patients With Chronic Myeloid Leukaemia.|Completed||N/A|88|Actual|Imperial College London|||1||f||||f||||||||||2017-02-18 14:38:49.599528|2017-02-18 14:38:49.599528
NCT00456443|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04|||January 2006||2006-01-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Observational|||Invasive Infections in Children With Hemoglobinopathies|Invasive Infections in Children With Hemoglobinopathies. A Clinical Descriptive Retrospective Study.|Completed||N/A|200||HaEmek Medical Center, Israel|||||f||||f||||||||||2017-02-18 15:43:25.02136|2017-02-18 15:43:25.02136
NCT00632242|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2009-01-08|||January 2008||2008-01-01|March 2008|2008-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders|A Phase 2 Pilot Study of the Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders|Completed||Phase 2|28|Anticipated|Archemix Corp.||5|||f||||f||||||||||2017-02-18 14:38:49.698217|2017-02-18 14:38:49.698217
NCT00632229|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2013-12-19|2013-10-23||October 2007||2007-10-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder|Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder|Completed||Phase 2|34|Actual|University of South Florida|"Modest sample and analyses were potentially underpowered to detect between-group differences on OCD measures.~It was not possible to determine response from participants' current medication.~Little racial/ethnic and socioeconomic variability"|2|||f||||f||||||||||2017-02-18 14:38:49.806223|2017-02-18 14:38:49.806223
NCT00632216|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2008-03-10|||May 2004||2004-05-01|March 2008|2008-03-01|May 2006|Actual|2006-05-01|||||Interventional|ROSPA-CTx||A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis|Multicenter and Prospective Study to Determine the Satisfaction With Actonel (Risedronate Sodium) 35mg Once a Week Using Biochemical Markers of Bone as a Control, in Postmenopausal Women With Osteoporosis|Completed||Phase 4|464|Actual|Sanofi|||||f||||f||||||||||2017-02-18 14:38:50.235915|2017-02-18 14:38:50.235915
NCT00632203|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-08-26|2011-12-22||March 2008||2008-03-01|August 2015|2015-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)|A Randomized Phase 2 Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients|Terminated||Phase 2|53|Actual|Merck Sharp & Dohme Corp.|The interpretation of the study results should be taken with caution because of the small sample size due to early termination.|2|||f||||f||||||||||2017-02-18 14:38:50.321725|2017-02-18 14:38:50.321725
NCT00632190|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2010-01-27|||January 2000||2000-01-01|January 2009|2009-01-01||||March 2003|Actual|2003-03-01||Interventional|||Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy|Measurement of Fluorescence EEM of Cervical Intraepithelial Neoplasia|Completed||N/A|1800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:38:50.942116|2017-02-18 14:38:50.942116
NCT00632164|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2008-02-29|||January 2005||2005-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Sympathetic and Parasympathetic Responses to Specific Chiropractic Adjustments|Sympathetic and Parasympathetic Responses to Specific Chiropractic Adjustments of Subluxation of the Cervical and Thoracic Spine|Completed||N/A|40|Actual|Sherman College of Straight Chiropractic|||2||f||||f||||||||||2017-02-18 14:38:51.030264|2017-02-18 14:38:51.030264
NCT00632138|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-08-06|||January 2005||2005-01-01|December 2008|2008-12-01|July 2011|Actual|2011-07-01|December 2008|Actual|2008-12-01||Interventional|||Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate|MAPS (Men After Prostate Surgery) : Conservative Treatment for Men With Urinary Incontinence After Prostate Surgery; Multicentre Randomised Controlled Trial of Pelvic Floor Muscle Training and Biofeedback [MAPS]|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:38:51.103537|2017-02-18 14:38:51.103537
NCT00632125|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-06-01|||July 2008||2008-07-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|EPO-PASS||Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.|Post-authorization Safety Study to Prospectively Monitor the Incidence of Relevant Drug-related Adverse Events and EPO-related Lack of Efficacy Among CKD Subjects Receiving HX575 Recombinant Human Erythropoietin Alfa i.v.|Completed||Phase 4|1706|Actual|Sandoz||1|||f||||t||||||||||2017-02-18 14:38:51.243189|2017-02-18 14:38:51.243189
NCT00632112|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2009-06-03|||March 2008||2008-03-01|June 2009|2009-06-01||||July 2009|Anticipated|2009-07-01||Observational|||A Real Life Evaluation of the Performance of a Large Volume Nebulizer|A Real Life Evaluation of the Performance of a Large Volume Nebulizer|Unknown status|Recruiting|N/A|50|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:38:51.452945|2017-02-18 14:38:51.452945
NCT00632099|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2014-04-09|2014-04-09||February 2008||2008-02-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PROG||Progesterone Treatment for Cocaine-dependent Women: A Pilot Study|Progesterone Treatment for Cocaine-dependent Women: A Pilot Study|Completed||Phase 2/Phase 3|21|Actual|New York State Psychiatric Institute|Given the limited sample size, it was not possible to adequately determine whether OM-PROG may be an effective treatment for cocaine-dependence in women, but it was well tolerated.|2|||f||||t||||||||||2017-02-18 14:38:51.53291|2017-02-18 14:38:51.53291
NCT00632086|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2008-03-07|||February 2008||2008-02-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers|A Phase 1, Open-Label, Randomized, 3-Way Crossover Study to Evaluate the Relative Bioavailability of a Single Oral Dose of Aspirin Administered as PA32540 (Aspirin/Omeprazole) or as the Aspirin Component of PA32540 or as Ecotrin® 325 mg in Healthy Volunteers|Completed||Phase 1|36|Anticipated|POZEN||3|||f||||f||||||||||2017-02-18 14:38:51.932579|2017-02-18 14:38:51.932579
NCT00632073|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-02-20|||March 2008||2008-03-01|February 2015|2015-02-01|March 2010|Actual|2010-03-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)|Effect of Vicriviroc on HIV RNA Levels in Cerebrospinal Fluid|Completed||Phase 1|13|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:38:54.468688|2017-02-18 14:38:54.468688
NCT00632060|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2008-03-07|||February 2008||2008-02-01|February 2008|2008-02-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Manual and Manipulative Therapy for Low Back Pain|The Efficacy of Manual and Manipulative Therapy for Low Back Pain in Military Active Duty Personnel: A Feasibility Study|Unknown status|Recruiting|N/A|100|Anticipated|Samueli Institute for Information Biology||2|||f||||||||||||||2017-02-18 14:38:54.592223|2017-02-18 14:38:54.592223
NCT00632047|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2013-08-23|||May 1998||1998-05-01|July 2009|2009-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Early Detection of Breast Cancer and Cervical Cancer in Women in India|Early Detection of Common Cancers in Women in India|Unknown status|Recruiting|Phase 2|151538|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:38:54.693669|2017-02-18 14:38:54.693669
NCT00632034|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2016-02-19|||May 2010||2010-05-01|May 2010|2010-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|STIF||Stem Cells and Tibial Fractures|A Phase I Safety Study Following the Infusion of Expanded Autologous Progeny of an Adult CD34+ Stem Cell Subset to Patients With Recent Tibial Fractures|Completed||Phase 1|9|Actual|Imperial College London||1|||f||||t||||||||||2017-02-18 14:38:54.788015|2017-02-18 14:38:54.788015
NCT00632021|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2013-12-11|||May 2008||2008-05-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|September 2009|Actual|2009-09-01||Interventional|PILL-CVD||Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)|Pharmacist Intervention for Low-Literacy in Cardiovascular Disease|Completed||N/A|862|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:38:54.895982|2017-02-18 14:38:54.895982
NCT00632008|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2010-01-25|||March 2007||2007-03-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers|A Randomised, Double-blind, Placebo-controlled Study to Determine the Efficacy of Soluble Beta-1,3/1,6-glucan in Chronic Foot Ulcers in Diabetes|Completed||Phase 3|122|Actual|Biotec Pharmacon ASA||2|||f||||f||||||||||2017-02-18 14:38:55.007464|2017-02-18 14:38:55.007464
NCT00631995|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2016-03-22|||April 2008||2008-04-01|March 2016|2016-03-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers|Safety and Immunogenicity of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine (TetraMen-T) in Toddlers|Completed||Phase 1|373|Actual|Sanofi||6|||f||||t||||||||||2017-02-18 14:38:55.105405|2017-02-18 14:38:55.105405
NCT00631982|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2008-03-07|||April 2008||2008-04-01|March 2008|2008-03-01||||October 2009|Anticipated|2009-10-01||Interventional|||Invitro Maturation of Oocytes for Patients With Polycystic Ovaries|In Vitro Maturation of Oocytes for Patients With Polycystic Ovaries|Unknown status|Not yet recruiting|N/A|30|Anticipated|Assaf-Harofeh Medical Center||1|||f||||||||||||||2017-02-18 14:38:55.22264|2017-02-18 14:38:55.22264
NCT00631969|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2014-12-08|2010-10-05||April 2008||2008-04-01|December 2014|2014-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction|Pivotal Phase III Trial to Investigate the Efficacy and Safety of an Orodispersible Tablet Vardenafil Versus Placebo in the Treatment of Men With Erectile Dysfunction (ED) - a Fixed-dose, Double-blind, Randomized Multi-center Trial - POTENT I|Completed||Phase 3|362|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:38:55.323929|2017-02-18 14:38:55.323929
NCT00631956|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2016-04-05|||October 2006||2006-10-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||SAPPHIRe III in Taiwan－Progression Evaluation and Cardiovascular Outcomes of Hypertensive Families|Progression Evaluation and Cardiovascular Outcomes of Hypertensive Families－A Follow-up Genetic Study of Taiwan SAPPHIRe Cohort|Active, not recruiting||N/A|1038|Actual|National Health Research Institutes, Taiwan|||1||f||||f||||||Samples With DNA|"~     Plasma, serum, urine, and buffy coat~   "|Undecided||2017-02-18 14:38:56.584493|2017-02-18 14:38:56.584493
NCT00631943|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2011-04-22|||November 2004||2004-11-01|April 2011|2011-04-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain|An Open Label, Non-comparative, Multicentre Study to Evaluate the Efficacy and Tolerability of Pregabalin in Peripheral Neuropathic Pain|Completed||Phase 3|112|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:38:56.657852|2017-02-18 14:38:56.657852
NCT00631917|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2011-06-30|2011-01-05||February 2008||2008-02-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension|A 54 Week, Randomized, Double-blind, Parallel-group, Multicenter Study Evaluating the Long-term Gastrointestinal (GI) Safety and Tolerability of Aliskiren (300 mg) Compared to Ramipril (10 mg) in Patients With Essential Hypertension|Completed||Phase 4|774|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:38:56.76487|2017-02-18 14:38:56.76487
NCT00631904|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2011-08-31|||January 2005||2005-01-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Observational|||St. Mary's Duluth Clinic (SMDC) Pacemaker Magnetic Resonance Imaging (MRI) Study|SMDC Pacemaker-MRI Cohort Study|Completed||N/A|150|Actual|Essentia Health|||1||f||||f||||||||||2017-02-18 14:38:57.622895|2017-02-18 14:38:57.622895
NCT00631878|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2008-02-29|||November 2001||2001-11-01|February 2008|2008-02-01|August 2003|Actual|2003-08-01|May 2003|Actual|2003-05-01||Interventional|N002||Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110|Phase I/II Randomized, Double Blind, Placebo Controlled, Dose Escalation, Safety and Pharmacokinetics Study in VLBW Neonates, a Human Chimeric Anti-Staphylococcal Monoclonal Antibody for the Prevention of S. Epidermidis Infection|Completed||Phase 1/Phase 2|53|Actual|Biosynexus Incorporated||5|||f||||t||||||||||2017-02-18 14:38:57.719624|2017-02-18 14:38:57.719624
NCT00631865|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2016-07-18|||February 2009||2009-02-01|February 2009|2009-02-01|May 2015|Actual|2015-05-01|February 2015|Actual|2015-02-01||Interventional|||Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin|Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin|Completed||Phase 3|300|Actual|Royan Institute||1|||f||||t||||||||||2017-02-18 14:38:57.828332|2017-02-18 14:38:57.828332
NCT00631852|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2016-11-02|||February 2008||2008-02-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer|A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer|Active, not recruiting||Phase 2|20|Anticipated|Southern Illinois University||1|||f||||t||||||||||2017-02-18 14:38:57.935994|2017-02-18 14:38:57.935994
NCT00631839|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-02|2008-10-06|||January 2002||2002-01-01|October 2008|2008-10-01|October 2008|Anticipated|2008-10-01|January 2006|Actual|2006-01-01||Observational|||Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury|Prospect Study to Evaluate Clinical, Dosimetrical, Functional, Biological and Genetic Factors in Predicting Chemo-Radiotherapy Induced Lung and Esophagus Injury|Unknown status|Active, not recruiting|N/A|140|Actual|Shanghai Cancer Hospital, China|||1||f||||t||||||Samples With DNA|"~     Patients' blood samples will be retained for the purpose of cytokine and MnSOD assay and DNA~     detection. The samples will be left till the study ends. Paitents will have their vein blood~     drawn from left arm 6am every Monday during RT. All above is stated in informed consent~     form.~   "|||2017-02-18 14:38:58.045475|2017-02-18 14:38:58.045475
NCT00005155|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||February 1982||1982-02-01|May 2000|2000-05-01|January 1989|Actual|1989-01-01|||||Observational|||Physiological and Psychosocial Correlates of Type A Behavior||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:25.921124|2017-02-18 18:15:25.921124
NCT00631826|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2012-04-04|||October 2007||2007-10-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Shoulder Rotational Flexibility and Throwing Arm Injuries of Baseball Pitchers|Shoulder Internal/External Rotational Flexibility is Related to Throwing Arm Injuries in Professional Baseball Players|Completed||N/A|40|Actual|University of Florida|||1||f||||f||||||||||2017-02-18 14:38:58.1564|2017-02-18 14:38:58.1564
NCT00631813|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2008-05-28|||November 1995||1995-11-01|February 2008|2008-02-01|April 1997|Actual|1997-04-01|April 1997|Actual|1997-04-01||Interventional|||Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation|A Double-Blind Placebo-Controlled Dose-Finding Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation|Completed||Phase 2|253|Actual|Movetis||4|||f||||f||||||||||2017-02-18 14:38:58.232884|2017-02-18 14:38:58.232884
NCT00631800|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2008-02-29|||May 2003||2003-05-01|February 2008|2008-02-01|November 2004|Actual|2004-11-01|March 2004|Actual|2004-03-01||Interventional|N003||Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110|Phase II Randomized, Double Blind, Placebo Controlled, Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110, for the Prevention of Staphylococcal Infection|Completed||Phase 2|88|Actual|Biosynexus Incorporated||3|||f||||t||||||||||2017-02-18 14:38:58.331671|2017-02-18 14:38:58.331671
NCT00631787|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2017-01-24|||February 29, 2008||2008-02-29|December 7, 2015|2015-12-07|December 7, 2015||2015-12-07|||||Observational|||Evaluation of Toxicity From Stem Cell Transplant|Evaluation of Systemic Toxicity Associated With Allogeneic Peripheral Blood Stem Cell Infusion|Completed||N/A|61|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:38:58.43803|2017-02-18 14:38:58.43803
NCT00631774|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-02|2011-12-05|||November 2007||2007-11-01|December 2011|2011-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna SR in Obese Type 2 Diabetes|An Open Label, Randomized, and Parallel Study to Evaluate the Postprandial Metabolic Response After 24-Week Use of Glucerna SR in Obese Asian Subjects With Type 2 Diabetes|Completed||N/A|60|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-02-18 14:38:58.530911|2017-02-18 14:38:58.530911
NCT00631761|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-08-18|||May 2008||2008-05-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Standardized Criteria to Judge Diagnostic Urethrocystoscopy Skills|Standardized Criteria to Judge Diagnostic Urethrocystoscopy Skills|Completed||N/A|36|Anticipated|University of Cincinnati||2|||f||||f||||||||||2017-02-18 14:38:58.642171|2017-02-18 14:38:58.642171
NCT00631748|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2014-03-03|2011-12-16||February 2008||2008-02-01|March 2014|2014-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|AZC||Quetiapine for the Reduction of Cocaine Use|A Double-Blind, Placebo-Controlled Trial of the Efficacy of Quetiapine for the Reduction of Cocaine Use|Completed||N/A|60|Actual|Seattle Institute for Biomedical and Clinical Research|1) High number of drop-outs (68%) means that analyses are limited by a lack of power. 2) More males than females included-may reflect differences in cocaine drug usage between the sexes.|2|||f||||t||||||||||2017-02-18 14:38:58.752014|2017-02-18 14:38:58.752014
NCT00631735|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2009-06-16|||February 2007||2007-02-01|June 2009|2009-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Perceptions of Touch in People With Cancer|Perceptions of Touch in People With Cancer|Completed||N/A|12|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:38:59.186055|2017-02-18 14:38:59.186055
NCT00631722|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2012-08-21|||May 2007||2007-05-01|February 2008|2008-02-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia||Completed||N/A|80|Actual|Peking University||2|||f||||f||||||||||2017-02-18 14:38:59.269829|2017-02-18 14:38:59.269829
NCT00631709|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-04-07|||March 2008||2008-03-01|April 2015|2015-04-01|February 2010|Actual|2010-02-01|November 2009|Actual|2009-11-01||Interventional|REMOTE-IPG||REmote MOnitoring Transmission Evaluation of IPGs|REmote MOnitoring Transmission Evaluation of IPGs|Completed||Phase 4|120|Actual|Medtronic||1|||f||||f||||||||||2017-02-18 14:38:59.364688|2017-02-18 14:38:59.364688
NCT00631696|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2012-09-24|2012-09-24||February 2008||2008-02-01|September 2012|2012-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo|Prospective Randomized Double-Blind Study Of Sperm Production In Healthy Volunteers Receiving Pregabalin Or Placebo|Completed||Phase 4|222|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:38:59.446066|2017-02-18 14:38:59.446066
NCT00631683|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2009-05-14|||February 2008||2008-02-01|May 2009|2009-05-01|February 2008|Anticipated|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Assessment of Hemodynamic Changes During Weaning From Mechanical Ventilation With Flo-Trac Vigileo (TM) Monitor.|Use of Flo-Trac/Vigileo (TM) for Hemodynamic Monitoring During Discontinuation From Mechanical Ventilation|Withdrawn||N/A|80|Anticipated|The University of Texas Health Science Center, Houston|||1|Terms for legal agreements between institution and Sponsor could not be made.|f||||f||||||||||2017-02-18 14:39:00.211915|2017-02-18 14:39:00.211915
NCT00631670|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2012-02-01|2011-11-28||October 2005||2005-10-01|June 2010|2010-06-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord|Stereotactic Body Radiation Therapy for Tumors Near the Spinal Cord|Completed||N/A|21|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 14:39:00.307141|2017-02-18 14:39:00.307141
NCT00631657|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-07-21|2014-05-15||March 2008||2008-03-01|July 2015|2015-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||The Baseline Analysis Population consists of all participants who received study drug. Two participants in the esmertazapine 4.5 mg group and one participant in the placebo group did not receive study drug.|A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)|A 6-Month, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Outpatient Trial, Investigating the Efficacy and Safety of Org 50081 in Adult Patients With Chronic Primary Insomnia|Completed||Phase 3|460|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:39:00.733525|2017-02-18 14:39:00.733525
NCT00631644|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-07|2017-01-24|||March 5, 2008||2008-03-05|September 8, 2015|2015-09-08|September 8, 2015||2015-09-08|||||Observational|||Eating Behavior in Adolescents|Eating Behavior in Adolescents|Completed||N/A|301|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:39:01.34776|2017-02-18 14:39:01.34776
NCT00631605|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2009-03-01|||May 2007||2007-05-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Studies of Neuroendocrine and Energy Metabolism in Patients With Eating Disorders|Studies of Neuroendocrine and Energy Metabolism in Patients With Eating Disorders|Completed||N/A|112|Actual|National Taiwan University Hospital|||2||f||||t||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:39:01.663772|2017-02-18 14:39:01.663772
NCT00631592|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2017-02-01|||February 2008||2008-02-01|October 2010|2010-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study|GSK1349572 Repeat Dose Escalation Study|Completed||Phase 1|44|Actual|ViiV Healthcare||1|||f||||f||||||||No||2017-02-18 14:39:01.760616|2017-02-18 14:39:01.760616
NCT00631579|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-10-01|||April 2003||2003-04-01|October 2009|2009-10-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma|Open-label, Multicenter Study of Repeated Doses of SR29142 (Rasburicase) as a Uricolytic Therapy for Hyperuricemia in Adult Patients With Leukemia or Lymphoma.|Completed||Phase 2|50|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:39:01.871726|2017-02-18 14:39:01.871726
NCT00631566|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2016-05-10|||May 2007||2007-05-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|December 2016|Anticipated|2016-12-01||Interventional|MRSA||Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons|Prospective Study on the Incidence, Predictors, and Characteristics of Methicillin-Resistant Staphylococcus Aureus Infections and a Randomized, Double-Blind Study on Decolonization Procedures for Prevention of MRSA Infections Among HIV-Infected Persons|Active, not recruiting||N/A|550|Anticipated|Uniformed Services University of the Health Sciences||2|||f||||t||||||||||2017-02-18 14:39:01.959604|2017-02-18 14:39:01.959604
NCT00631553|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-08-06|||June 2006||2006-06-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound|Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound|Unknown status|Recruiting|N/A|20|Anticipated|University of Virginia||1|||f||||f||||||||||2017-02-18 14:39:02.07675|2017-02-18 14:39:02.07675
NCT00631540|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-11-21|2011-02-11||February 2008||2008-02-01|November 2013|2013-11-01|May 2012|Actual|2012-05-01|May 2010|Actual|2010-05-01||Interventional|||REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent||Completed||N/A|100|Actual|Cook||1|||f||||t||||||||||2017-02-18 14:39:02.163187|2017-02-18 14:39:02.163187
NCT00631527|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2015-01-28|||February 2008||2008-02-01|January 2015|2015-01-01||||January 2015|Actual|2015-01-01||Interventional|||Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer|Sunitinib, Hormonal Ablation and External Beam Radiation Therapy for High-Risk and Locally Advanced Prostate Cancer|Completed||Phase 1|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:39:02.550898|2017-02-18 14:39:02.550898
NCT00631514|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-03-07|||January 2005||2005-01-01|February 2008|2008-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)|Relevance of the Interaction Between Antihypertensive and Antirheumatic Drugs in a Family Practice|Completed||Phase 4|88|Actual|University of Split||3|||f||||f||||||||||2017-02-18 14:39:02.671575|2017-02-18 14:39:02.671575
NCT00631501|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-02-27||||||February 2008|2008-02-01||||||||Interventional|||Doxycycline for Lateral Epicondylalgia - RCT||Unknown status|Recruiting|N/A|34|Anticipated|Kaunas University of Medicine||2|||f||||||||||||||2017-02-18 14:39:02.777455|2017-02-18 14:39:02.777455
NCT00631488|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-12-30|2011-10-07||February 2008||2008-02-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)|A Phase IIa, Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of MK0893 in Combination With Sitagliptin or in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 2|146|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 14:39:02.880009|2017-02-18 14:39:02.880009
NCT00631475|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-09-09|2012-06-19||April 2008||2008-04-01|March 2015|2015-03-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|BUILD OL||Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443|Open-Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321 (NCT00391443)|Completed||Phase 3|128|Actual|Actelion||1|||f||||f||||||||||2017-02-18 14:39:03.350992|2017-02-18 14:39:03.350992
NCT00631462|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2009-10-22|||January 2008||2008-01-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis|A Phase 1, Open-label, Dose-escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered TG101348 in Patients With Primary, Post-polycythemia Vera, or Post-essential Thrombocythemia Myelofibrosis|Completed||Phase 1|59|Actual|TargeGen||1|||f||||f||||||||||2017-02-18 14:39:04.054494|2017-02-18 14:39:04.054494
NCT00631449|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2015-10-30|2013-11-12||February 2008||2008-02-01|October 2015|2015-10-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|||Raltegravir Intensification in HIV-infected Patients|Raltegravir Intensification in Antiretroviral-treated Patients Exhibiting a Suboptimal CD4+ T Cell Response|Completed||Phase 4|30|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:39:04.169896|2017-02-18 14:39:04.169896
NCT00631436|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-07-20|||April 2008||2008-04-01|February 2008|2008-02-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Observational|||The Effects of Explosive Blast as Compared to Post-Traumatic Stress Disorder on Brain Function and Structure|The Effects of Explosive Blast as Compared to Post-Traumatic Stress Disorder on Brain Function and Structure|Unknown status|Recruiting|N/A|180|Anticipated|Minnesota Veterans Medical Research and Education Foundation|||4||f||||t||||||Samples With DNA|"~     Whole blood samples and isolated DNA and serum~   "|||2017-02-18 14:39:04.541191|2017-02-18 14:39:04.541191
NCT00631423|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2015-04-14|||July 2007||2007-07-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Observational|||Evaluation of Patients With Vena Cava Inferior Thrombosis|Clinical Course and Prognosis of Patients With Vena Cava Inferior Thrombosis|Completed||N/A|120|Anticipated|Johann Wolfgang Goethe University Hospital|||2||f||||f||||||Samples With DNA|"~     Whole blood, serum~   "|||2017-02-18 14:39:04.62903|2017-02-18 14:39:04.62903
NCT00631410|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2011-03-11|2010-07-21||January 2008||2008-01-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|July 2009|Actual|2009-07-01||Interventional|||Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer|Phase I Study Of Sunitinib In Combination With Oxaliplatin, L-Leucovorin, And 5-Fluorouracil In Patients With Metastatic Colorectal Cancer|Completed||Phase 1|12|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:39:04.721919|2017-02-18 14:39:04.721919
NCT00631397|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2012-06-14|||March 2007||2007-03-01|March 2007|2007-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||A Preliminary Study of Bone Density in Neonates|A Preliminary Study of Bone Density Measurements in Neonates Using the Sunlight Omnisense 7000P Ultrasound Bone Sonometer|Completed||N/A|40|Actual|University of South Florida|||1||f||||t||||||Samples Without DNA|"~     Measuring proteins in the blood plasma~   "|||2017-02-18 14:39:05.470606|2017-02-18 14:39:05.470606
NCT00631384|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-03-06|||March 2003||2003-03-01|February 2008|2008-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|CVCT||Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania|Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania|Completed||N/A|1521|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-02-18 14:39:05.580388|2017-02-18 14:39:05.580388
NCT00631371|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-03-25|2013-04-18||April 2008||2008-04-01|March 2016|2016-03-01|April 2015|Actual|2015-04-01|April 2012|Actual|2012-04-01||Interventional|INTORACT||Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects|Phase 3b, Randomized, Open-Label Study Of Bevacizumab + Temsirolimus Vs. Bevacizumab + Interferon-Alfa As First-Line Treatment In Subjects With Advanced Renal Cell Carcinoma|Completed||Phase 3|791|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:39:05.694354|2017-02-18 14:39:05.694354
NCT00631358|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2010-03-29|2010-02-17||February 2008||2008-02-01|March 2010|2010-03-01||||February 2009|Actual|2009-02-01||Interventional|||Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention||Completed||Phase 4|97|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:39:07.211391|2017-02-18 14:39:07.211391
NCT00631345|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-04-26|||August 2007||2007-08-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|HELPPD||Healthy Living Partnership to Prevent Diabetes|Translating Research Into the Prevention of Diabetes Mellitus (TRIP DM)|Completed||Phase 3|301|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-02-18 14:39:07.635349|2017-02-18 14:39:07.635349
NCT00631332|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-02-28|||July 1999||1999-07-01|February 2008|2008-02-01|June 2008|Anticipated|2008-06-01|September 2007|Actual|2007-09-01||Observational|WHISCA||Women's Health Initiative Study of Cognitive Aging|Effects of Hormone Replacement Therapy on Cognitive Aging: Women's Health Initiative Study of Cognitive Aging (WHISCA)|Unknown status|Active, not recruiting|N/A|2303|Actual|Wake Forest University Health Sciences|||||f||||t||||||||||2017-02-18 14:39:07.762696|2017-02-18 14:39:07.762696
NCT00631319|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-03-20|||February 2008||2008-02-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|OA Pain||A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic OA Pain|A Phase III, Flexible Dose Titration Followed by a Randomized Double-Blind Study of Controlled Release OROS Hydromorphone HCL Compared to Placebo in Patients With Chronic OA Pain|Completed||Phase 3|200|Actual|Mallinckrodt||1|||f||||f||||||||||2017-02-18 14:39:07.839011|2017-02-18 14:39:07.839011
NCT00631306|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-08-10|||February 2008||2008-02-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Observational|||Effects of Cranberry Juice on Risk Factors for Cardiovascular Disease|Effects of Cranberry Juice on Risk Factors for Cardiovascular Disease|Completed||N/A|60|Anticipated|Mayo Clinic|||2||f||||f||||||Samples Without DNA|"~     blood~   "|||2017-02-18 14:39:07.930344|2017-02-18 14:39:07.930344
NCT00631293|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-04-06|||March 2008||2008-03-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of the Effect of Lactisole on the Intestinal Glucose Uptake|Study on the Effect of Lactisole on the Intestinal Glucose Uptake|Completed||Phase 1/Phase 2|10|Anticipated|University Ghent||2|||f||||f||||||||||2017-02-18 14:39:08.029402|2017-02-18 14:39:08.029402
NCT00631280|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2015-03-03|||September 2007||2007-09-01|March 2015|2015-03-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|||Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD|Response Variability in Children With ADHD|Completed||N/A|70|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-02-18 14:39:08.131965|2017-02-18 14:39:08.131965
NCT00631267|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2014-11-05|||July 2008||2008-07-01|November 2014|2014-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|CoNCReTe||CoNCReTe-trial: Colles Fractures, Determining the Norm in Closed Reduction Techniques|Colles Fractures, Determining the Norm in Closed Reduction Techniques|Terminated||N/A|98|Actual|Rijnstate Hospital||2||Due to poor patient accrual|f||||f||||||||||2017-02-18 14:39:08.23048|2017-02-18 14:39:08.23048
NCT00631254|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-05-07|||October 2003||2003-10-01|November 2007|2007-11-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic Rhinitis|Modulation of the CysLT1-r Expression Following Allergen Exposure in Non Asthmatic Subjects With Allergic Rhinitis and Mild Allergic Asthmatic Subjects Using the Induced Sputum Technique.|Unknown status|Recruiting|N/A|30|Anticipated|Laval University||2|||f||||f||||||||||2017-02-18 14:39:08.33073|2017-02-18 14:39:08.33073
NCT00631241|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2016-04-28|||February 2008||2008-02-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer|Histopathologic Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer Undergoing Radical Hysterectomy or Radical Trachelectomy and Pelvic Lymph Node Dissection: A Feasibility Study|Completed||N/A|20|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:39:08.426689|2017-02-18 14:39:08.426689
NCT00631228|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-08-13|||June 2008||2008-06-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|April 2010|Actual|2010-04-01||Observational|XIENCE V India||XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study|XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-Arm Study|Completed||Phase 4|1000|Actual|Abbott Vascular|||1||f||||t||||||||||2017-02-18 14:39:08.538191|2017-02-18 14:39:08.538191
NCT00631033|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2014-11-05|||July 2008||2008-07-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||DZX Mediated Insulin Suppression in Obese Men|Diazoxide-mediated Insulin Suppression in Hyperinsulinemic Obese Men, Part III|Completed||Phase 2|51|Actual|Rijnstate Hospital||3|||f||||||||||||||2017-02-18 14:39:13.64944|2017-02-18 14:39:13.64944
NCT00631215|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-03-06|||January 2008||2008-01-01|January 2008|2008-01-01|October 2009|Anticipated|2009-10-01|June 2009|Anticipated|2009-06-01||Interventional|||Effects of Hyperbaric Oxygen Therapy on Cognitive Function on Autistic Spectrum Disordered Children|Effects of Hyperbaric Oxygen Therapy on Cognitive Function on Autistic Spectrum Disordered Children|Unknown status|Recruiting|N/A|40|Anticipated|Pediatric Partners of Ponte Vedra||1|||f||||f||||||||||2017-02-18 14:39:08.667255|2017-02-18 14:39:08.667255
NCT00631202|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2010-05-26|||February 2008||2008-02-01|May 2010|2010-05-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia|Single-Center, Open-Label, Sequential Trial to Test the Efficacy, Safety and Tolerability of Epoetin Alfa in Patients With Friedreich's Ataxia|Completed||Phase 2|10|Anticipated|Federico II University||1|||f||||f||||||||||2017-02-18 14:39:08.76726|2017-02-18 14:39:08.76726
NCT00631189|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-11-25|2010-03-11||October 2007||2007-10-01|June 2011|2011-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|CAP-Chol||Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients|Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Subjects With Type IIa and IIb Hypercholesterolaemia|Completed||Phase 4|668|Actual|AstraZeneca|As the recruitment target was not reached at the date initially planned, and in view of the recruitment difficulties, AstraZeneca decided not to extend the patient recruitment period and to perform only a descriptive analysis of the data.|2|||f||||f||||||||||2017-02-18 14:39:08.890073|2017-02-18 14:39:08.890073
NCT00631176|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2010-01-07|||June 2007||2007-06-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|JIT||"Just-In-Time Training in Pediatric Airway Management"|"Effectiveness of Just-In-Time Training With/Without a High Fidelity Simulation on Patient Safety in Airway Management in Pediatric Intensive Care Unit"|Completed||N/A|13|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 14:39:12.304635|2017-02-18 14:39:12.304635
NCT00631163|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2016-11-15|||October 2007||2007-10-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis|A Multi-Center, Open-label, Non Comparative, Phase II Trial on Efficacy and Safety of ICL670 Given for 1 Year With Dose Adjustments Based on Serum Ferritin in Patients With Chronic Anemia and Transfusional Hemosiderosis Including an Additional 1 Year Extension.|Completed||Phase 2|114|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:39:12.408779|2017-02-18 14:39:12.408779
NCT00631150|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-11-14|||March 2003||2003-03-01|September 2009|2009-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy|A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy|Completed||Phase 4|35|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:39:12.753682|2017-02-18 14:39:12.753682
NCT00631137|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2008-09-29|||January 2008||2008-01-01|March 2008|2008-03-01||||September 2008|Anticipated|2008-09-01||Interventional|||Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men Receiving Glucocorticoids for Newly Diagnosed High-Grade Glioma|A Randomized, Controlled Comparative Trial to Determine if Testosterone Gel Prevents Steroid Related Weakness in Brain Cancer Patients|Terminated||N/A|60|Anticipated|National Cancer Institute (NCI)||||Study terminated due to low accrual.|f||||||||||||||2017-02-18 14:39:12.837744|2017-02-18 14:39:12.837744
NCT00631124|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2014-11-28|||February 2008||2008-02-01|November 2014|2014-11-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles|A Double-blind, Randomized, Uncontrolled Study to Evaluate Inhibition of Ovulation of Two Oral Estradiol / Drospirenone Regimens in Healthy Young Female Volunteers Over a Period of 3 Treatment Cycles|Completed||Phase 2|103|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:39:12.939593|2017-02-18 14:39:12.939593
NCT00631111|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-07-10||2009-07-10|November 2007||2007-11-01|July 2009|2009-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental Pain|Ibuprofen 400 mg Effervescent Tablet Dental Pain Study II|Completed||Phase 3|270|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-02-18 14:39:13.050987|2017-02-18 14:39:13.050987
NCT00631098|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2009-01-20|||March 2004||2004-03-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CARE||Cannulation for Resuscitation|The Feasibility of Cannulating External Jugular Vein Compared With Cubital Vein (by Paramedics and Emergency Department Interns)|Completed||Phase 4|60|Anticipated|Kuopio University Hospital||1|||f||||f||||||||||2017-02-18 14:39:13.162736|2017-02-18 14:39:13.162736
NCT00631085|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-04-14|||May 2008||2008-05-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|GammaTox||Effect of Gamma Tocopherol Supplementation on Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Normal Adults|Effect of Gamma Tocopherol Supplementation on Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Normal Adults|Completed||Phase 1|18|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 14:39:13.261024|2017-02-18 14:39:13.261024
NCT00631072|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-10-16|||February 2008||2008-02-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|August 2014|Actual|2014-08-01||Interventional|||In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer|A Phase I Trial of in Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer|Completed||Phase 1|24|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 14:39:13.354739|2017-02-18 14:39:13.354739
NCT00631059|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2010-10-11|||March 2008||2008-03-01|October 2010|2010-10-01|June 2010|Actual|2010-06-01|||||Interventional|||Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients|Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients|Terminated||N/A|40|Anticipated|University of California, Irvine||1||Haluted due to slow accrual|f||||t||||||||||2017-02-18 14:39:13.456455|2017-02-18 14:39:13.456455
NCT00631046|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-07-14|||February 2008||2008-02-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|EFiON||Essential Fatty Acids During Complementary Feeding|The Importance of Increasing Intake of Essential Fatty Acids During Complementary Feeding on Infant Growth and Body Composition, Intestinal Health, Immune Function and Risk Markers for Later Metabolic Complications.|Completed||N/A|150|Anticipated|University of Copenhagen||2|||f||||||||||||||2017-02-18 14:39:13.545472|2017-02-18 14:39:13.545472
NCT00631020|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2015-04-18|2014-12-02||December 2007||2007-12-01|April 2015|2015-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||"Youth Smoking Cessation: Therapy +/- The Patch"|Determining the Efficacy of Cognitive-behavioral Motivational Enhancement +/- Nicotine Replacement Therapy for Adolescents|Completed||N/A|34|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-02-18 14:39:13.738033|2017-02-18 14:39:13.738033
NCT00631007|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2010-08-18|2010-08-18||February 2008||2008-02-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator|A Randomized, Double-Blind, Placebo-Controlled, 24-Week Study to Evaluate the Efficacy and Safety of INT131 Besylate Compared to Pioglitazone in Subjects With Type 2 Diabetes|Completed||Phase 2|367|Actual|InteKrin Therapeutics, Inc.||6|||f||||f||||||||||2017-02-18 14:39:14.032286|2017-02-18 14:39:14.032286
NCT00630994|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2015-11-25|2012-01-09||March 2008||2008-03-01|November 2012|2012-11-01|April 2012|Actual|2012-04-01|August 2009|Actual|2009-08-01||Interventional|||Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis|Phase II Trial of Low Dose Decitabine (Dacogen) in Patients With Primary Myelofibrosis and Post ET/PV Myelofibrosis|Terminated||Phase 2|4|Actual|Mayo Clinic|Study terminated early. Most analyses were not performed.|1||Stopped due to slow accrual|f||||t||||||||||2017-02-18 14:39:15.460797|2017-02-18 14:39:15.460797
NCT00630981|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-04-16|||February 2008||2008-02-01|April 2009|2009-04-01|July 2009|Anticipated|2009-07-01|April 2009|Actual|2009-04-01||Observational|||Psychotherapy and Pharmacotherapy in Dissociative Disorders|The Interest of a Specific Combined Treatment (Psychotherapy and Pharmacotherapy) in Patients With Dissociative Disorders|Unknown status|Active, not recruiting|N/A|30|Actual|Espace Hogan|||1||f||||t||||||||||2017-02-18 14:39:15.787995|2017-02-18 14:39:15.787995
NCT00630968|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-11-14|||August 2000||2000-08-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy|Trial Studying the Safety and Efficacy of Keppra® as Adjunctive Therapy in Adult Patients With Uncontrolled Partial Epilepsy|Completed||Phase 4|1541|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 14:39:15.903268|2017-02-18 14:39:15.903268
NCT00630955|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2016-11-03|2013-08-19||June 2006||2006-06-01|November 2016|2016-11-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Family History Study of Alcohol Consumption Using Memantine|NMDA Antagonist Efficacy in Reducing Human Alcohol Consumption: Impact of Family History|Completed||Phase 2|111|Actual|Yale University||3|||f||||t||||||||||2017-02-18 14:39:15.992907|2017-02-18 14:39:15.992907
NCT00630942|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2010-12-03|||February 2003||2003-02-01|December 2010|2010-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Minocycline in Primary Sclerosing Cholangitis (PSC)|Open Label Pilot Study Evaluating Minocycline in Patients With Primary Sclerosing Cholangitis (PSC)|Completed||Phase 1|16|Actual|Mayo Clinic||1|||||||f||||||||||2017-02-18 14:39:16.496365|2017-02-18 14:39:16.496365
NCT00630929|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-09-10|||January 2003||2003-01-01|September 2008|2008-09-01|February 2004|Actual|2004-02-01|||||Interventional|||Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)|A Study of the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) and Three Times Daily Ibuprofen vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee|Completed||Phase 4|388|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:39:16.627857|2017-02-18 14:39:16.627857
NCT00630916|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-09-20|2011-07-08||November 2003||2003-11-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|December 2005|Actual|2005-12-01||Interventional|||Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve|Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve|Completed||N/A|756|Actual|Sorin Group USA, Inc.||1|||f||||t||||||||||2017-02-18 14:39:16.772482|2017-02-18 14:39:16.772482
NCT00630903|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-03-06|||January 2000||2000-01-01|February 2008|2008-02-01||||January 2003|Anticipated|2003-01-01||Interventional|MF99||PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides|Prospective, Randomized Multicentic to Compare PUVA+IFN Alpha 2a vs PUVA Alone in Mycosis Fungoides Stages Ia, Ib or IIa.|Terminated||Phase 4|54|Actual|Madrilenian Group of Cutaneous Lymphomas||2||Insufficient accrual|f||||f||||||||||2017-02-18 14:39:17.125498|2017-02-18 14:39:17.125498
NCT00630890|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2015-09-09|||October 2007||2007-10-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)|Phase I Dose Escalation Trial of External Beam Radiation and Cyberknife Radiosurgery Boost With Concurrent Capecitabine for Hilar Cholangiocarcinoma (Klatskin Tumor)|Terminated||Phase 1|11|Actual|University of California, San Francisco||1||investigator left UCSF and study was closed prematurely in 2008. No results to report.|f||||f||||||||||2017-02-18 14:39:17.440467|2017-02-18 14:39:17.440467
NCT00630877|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2009-09-09|2009-06-11||February 2008||2008-02-01|September 2009|2009-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin|A Randomized, Double-blind, Parallel, Multicenter, Placebo-controlled, Prospective Study to Evaluate the Functionality of the Flushing ASsessment Tool (FAST) in Subjects Administered Niaspan® Plus Acetylsalicylic Acid (ASA), Niaspan® Plus ASA Placebo or Niaspan® Placebo Plus ASA Placebo Daily for Six Weeks|Completed||Phase 3|276|Actual|Abbott||3|||f||||f||||||||||2017-02-18 14:39:17.558225|2017-02-18 14:39:17.558225
NCT00630864|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-01-09|2012-11-16||June 2008||2008-06-01|January 2013|2013-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis|The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis|Completed||Phase 2|21|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:39:18.203431|2017-02-18 14:39:18.203431
NCT00630851|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2015-03-04|||October 2002||2002-10-01|March 2015|2015-03-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes|A Six-month, Multicenter, Double-blind, Parallel, Placebo-controlled Study of the Effect on Global/Behavioural/ADL Functions and Tolerability of Aricept in Patients Wtih Severe Alzheimer's Disease Living in an Assisted Care Facility|Completed||Phase 3|249|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:39:18.990938|2017-02-18 14:39:18.990938
NCT00630656|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-08-18||2011-08-11|April 2008||2008-04-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis|A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis|Completed||Phase 2|190|Actual|Agennix||2|||f||||t||||||||||2017-02-18 14:39:24.668277|2017-02-18 14:39:24.668277
NCT00630838|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-06-07|2015-04-01||September 2006||2006-09-01|April 2015|2015-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)|Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)|Completed||Phase 2|62|Actual|University of Michigan|The secondary outcome measure was defined before beginning the study as the measure of the expression of MUC-2 and MUC-3 expressed proteins in the stools of study patients. However, stool samples were not collected and this analysis was not done.|2|||f||||t||||||||||2017-02-18 14:39:19.151154|2017-02-18 14:39:19.151154
NCT00630825|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2014-12-08|2014-10-03||April 2008||2008-04-01|December 2014|2014-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|EGO|Participants who received at least one dose of LY2189265 or Placebo.|A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus|The Effect of Dose Titration of LY2189265 in Overweight and Obese Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|262|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 14:39:19.562753|2017-02-18 14:39:19.562753
NCT00630812|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2012-08-06||2012-08-06|September 2008||2008-09-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|April 2010|Actual|2010-04-01||Interventional|||Long Term Administration of Inhaled Mannitol in Cystic Fibrosis|Long Term Administration of Inhaled Mannitol in Cystic Fibrosis- A Safety and Efficacy Study|Completed||Phase 3|318|Actual|Pharmaxis||2|||f||||t||||||||||2017-02-18 14:39:21.491511|2017-02-18 14:39:21.491511
NCT00630799|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2010-09-07||2010-08-30|May 2008||2008-05-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients|Efficacy and Safety of a New Leuprolide Acetate 17 mg Depot Formulation, GP-Pharm S.A., When Given as Palliative Treatment to Prostate Cancer Patients|Terminated||Phase 3|20|Actual|GP-Pharm||1|||f||||f||||||||||2017-02-18 14:39:21.684951|2017-02-18 14:39:21.684951
NCT00630786|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2014-02-05|2010-08-06||January 2008||2008-01-01|February 2014|2014-02-01|November 2010|Actual|2010-11-01|May 2009|Actual|2009-05-01||Interventional|||Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study|A Phase 1b/2 Trial of AMG 655 in Combination With Panitumumab in Subjects With Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|53|Actual|Amgen||1|||f||||f||||||||||2017-02-18 14:39:21.801557|2017-02-18 14:39:21.801557
NCT00630773|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-12-02|||March 2007||2007-03-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|PUCK||Q-CPR Compression Sensor Size Qualification in Children|Feasibility of CPR Adjuncts in Children: Q-CPR Compression Sensor Size Qualification|Completed||N/A|150|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 14:39:22.426458|2017-02-18 14:39:22.426458
NCT00630760|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2014-05-19|||February 2008||2008-02-01|May 2014|2014-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Oral NRX 194204 in Patients With Refractory Malignancies|A Multiple-Center, Open-Label, Dose Escalation Study of the Safety and Pharmacokinetics of Oral NRX 194204 Capsule Administered Daily for a Minimum of 4 Weeks in Patients With Refractory Malignancies|Terminated||Phase 1|24|Actual|University of Southern California||1||Sponsor withdrew study. Accrual not completed|f||||f||||||||||2017-02-18 14:39:22.511087|2017-02-18 14:39:22.511087
NCT00630747|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2015-07-16|2012-02-27||September 2004||2004-09-01|May 2014|2014-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase|An Open-Label Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Iduronate-2-Sulfatase Enzyme Replacement Therapy|Completed||Phase 2/Phase 3|94|Actual|Shire|This study design was open-label, and the lack of a concurrently followed placebo group limits the strength of the observations, because the progression of the disease is variable and has not been well described.|1|||f||||t||||||||||2017-02-18 14:39:22.598334|2017-02-18 14:39:22.598334
NCT00630734|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2014-05-20|2011-09-12||February 2008||2008-02-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|October 2009|Actual|2009-10-01||Interventional|||Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin|Genetic Predictors of Pharmacokinetic Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin: the Role of SLCO1B1 Polymorphisms.|Completed||Phase 4|32|Actual|University of Colorado, Denver|The study included only heterozygous carriers of the SLCO1B1 *15 and *17 haplotypes. Pravastatin urine concentrations were not measured; therefore the impact of darunavir/ritonavir on pravastatin renal clearance was not assessed in this population.|3|||f||||t||||||||||2017-02-18 14:39:23.444355|2017-02-18 14:39:23.444355
NCT00630721|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-04-02|||September 2007||2007-09-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|May 2010|Actual|2010-05-01||Interventional|||Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells|Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells|Completed||Phase 1|56|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 14:39:24.173269|2017-02-18 14:39:24.173269
NCT00630708|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-04-02|||February 2008||2008-02-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|SDBRAS||Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency|Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency|Terminated||N/A|309|Anticipated|Nanfang Hospital of Southern Medical University||3||Significant differences observed between groups.|f||||t||||||||||2017-02-18 14:39:24.264269|2017-02-18 14:39:24.264269
NCT00630695|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2012-01-13|||March 2008||2008-03-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer|Evaluation of the Efficacity of Lanreotide LP 90 mg to Minimized the Lymphorrhea Post Axillary Lymphadenectomy in Breast Cancer|Completed||Phase 3|148|Actual|University Hospital, Limoges||2|||f||||f||||||||||2017-02-18 14:39:24.37508|2017-02-18 14:39:24.37508
NCT00630682|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-05-30|||September 2006||2006-09-01|May 2013|2013-05-01|August 2011|Actual|2011-08-01|March 2009|Actual|2009-03-01||Interventional|1D||A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence|A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence|Completed||Phase 2|60|Actual|California Pacific Medical Center Research Institute||2|||f||||t||||||||||2017-02-18 14:39:24.472768|2017-02-18 14:39:24.472768
NCT00630669|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-03-06|||December 1997||1997-12-01|May 2001|2001-05-01|May 2001|Actual|2001-05-01|May 2000|Actual|2000-05-01||Interventional|||Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation Probe|Randomized Study Of Endoscopic Band Ligation Versus Bipolar Probe Electrocoagulation Of Bleeding Internal Hemorrhoids|Completed||N/A|45|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:39:24.572968|2017-02-18 14:39:24.572968
NCT00630643|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-03-06|||January 2006||2006-01-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||NI-0401 in Active Crohn's Disease|A Phase I/IIa, Double-Blind, Placebo-Controlled, Dose-Escalation Study of NI-0401 in Patients With Moderate to Severe Active Crohn´s Disease|Completed||Phase 1/Phase 2|40|Actual|NovImmune SA||2|||f||||t||||||||||2017-02-18 14:39:24.816035|2017-02-18 14:39:24.816035
NCT00630630|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-11-25|||November 2002||2002-11-01|September 2009|2009-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy|A Multicenter, Double-blind, Placebo-controlled, Parallel Group Study of the Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Adult Female Subjects (18 to 40 Years of Age) With C1 Catamenial Epilepsy|Completed||Phase 4|3|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 14:39:24.90934|2017-02-18 14:39:24.90934
NCT00630617|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-02-28|||July 2004||2004-07-01|February 2008|2008-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Childhood Obesity Prevention|Project FAMILIA Giya Marianas: Childhood Obesity Prevention Program|Completed||N/A|900|Actual|Western Michigan University||1|||f||||t||||||||||2017-02-18 14:39:25.021717|2017-02-18 14:39:25.021717
NCT00630604|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-03-06||||||February 2008|2008-02-01||||||||Observational|US||Quantitative Ultrasonography (US) Evaluation on Femoral Condyle Cartilage|Quantitative Evaluation by Ultrasonography for Severity of Knee Osteoarthritis|Completed||N/A|||Kaohsiung Medical University|||||f||||||||||||||2017-02-18 14:39:25.131219|2017-02-18 14:39:25.131219
NCT00630591|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2017-02-01|||February 2008||2008-02-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||DAMES: Daughters And MothErS Against Breast Cancer|DAMES: Daughters And MothErS Against Breast Cancer|Completed||N/A|482|Actual|Duke University||3|||f||||t||||||||||2017-02-18 14:39:25.195656|2017-02-18 14:39:25.195656
NCT00630578|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-04-06|||August 2007||2007-08-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Improving Effectiveness: Treatment Outcome Research|Improving Effectiveness: Treatment Outcome Research|Completed||N/A|50|Anticipated|Center for Trauma Recovery, St Louis||2|||f||||f||||||||||2017-02-18 14:39:25.304001|2017-02-18 14:39:25.304001
NCT00630565|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-06|2016-08-15|||July 2006||2006-07-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|January 2017|Anticipated|2017-01-01||Interventional|||Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia|Autologous Peripheral Blood Stem Cell Transplant for Acute Non-Lymphocytic Leukemia (ANLL)|Recruiting||Phase 2/Phase 3|60|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-02-18 14:39:25.397162|2017-02-18 14:39:25.397162
NCT00630552|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-10-26||2015-04-06|June 2007||2007-06-01|October 2016|2016-10-01|April 2012|Actual|2012-04-01|January 2010|Actual|2010-01-01||Interventional|||QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer|A Phase 1b/2 Study to Evaluate the Safety and Efficacy of AMG 655 or AMG 479 in Combination With Gemcitabine as First-Line Therapy for Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|138|Actual|NantCell, Inc.||3|||f||||||||||||||2017-02-18 14:39:25.529277|2017-02-18 14:39:25.529277
NCT00630539|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-05-21|2013-03-19||August 2007||2007-08-01|March 2013|2013-03-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women|Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women: A Phase II Dose Ranging, 12-Week, Randomized , Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing Oral Ospemifene 5 mg, 15 mg and 30 mg Daily Doses With Placebo|Completed||Phase 2|126|Actual|Shionogi Inc.||4|||f||||||||||||||2017-02-18 14:39:25.698708|2017-02-18 14:39:25.698708
NCT00630526|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-04-29|||February 2008||2008-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:39:26.805824|2017-02-18 14:39:26.805824
NCT00630513|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-08-17|||January 2008||2008-01-01|September 2008|2008-09-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|TEA||T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam|A Prospective, Double-blind, Multi Center, Randomized Clinical Study to Compare the Efficacy and Safety of Ertapenem 3 Days Versus Ampicillin-Sulbactam 3 Days in the Treatment of Localized Community Acquired Intra-abdominal Infection (IAI). (T.E.A. Study Three Days Ertapenem vs Three Days Ampicillin- Sulbactam)|Completed||Phase 4|142|Actual|University of Bologna||2|||f||||f||||||||||2017-02-18 14:39:26.85067|2017-02-18 14:39:26.85067
NCT00630500|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2015-07-27|||February 2006||2006-02-01|February 2009|2009-02-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|MEMPDD||Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)|A Double-blind, Placebo-controlled Multicentre Trial of Memantine in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies|Completed||Phase 2|75|Actual|Helse Stavanger HF||2|||f||||t||||||||||2017-02-18 14:39:26.96647|2017-02-18 14:39:26.96647
NCT00630487|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-02-26|2010-08-03||May 2008||2008-05-01|February 2013|2013-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|IGHD||Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency|Prospective, Randomized, Double Blind Placebo-Controlled Trial On The Efficacy Of Growth Hormone Replacement Therapy In Adult Patients With Isolated Growth Hormone Deficiency (PRO ISO-GHD Study)|Terminated||Phase 3|9|Actual|Pfizer||2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:39:27.073913|2017-02-18 14:39:27.073913
NCT00630474|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2009-12-21|||January 2004||2004-01-01|December 2009|2009-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Nasal Decongestion and Obstructive Sleep Apnea|Does Nasal Decongestion Improve Obstructive Sleep Apnea ?|Completed||Phase 4|12|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 14:39:27.705843|2017-02-18 14:39:27.705843
NCT00630461|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-10-05|||May 2008||2008-05-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma|Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma|Terminated||Phase 1|4|Actual|University of North Carolina, Chapel Hill||1||Data collected under different protocol; funding exhuasted|f||||f||||||||||2017-02-18 14:39:27.819023|2017-02-18 14:39:27.819023
NCT00629161|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2010-05-26|||November 2008||2008-11-01|September 2009|2009-09-01||||August 2010|Anticipated|2010-08-01||Interventional|||Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease||Unknown status|Recruiting|Phase 2/Phase 3|144|Anticipated|Fudan University||2|||f||||||||||||||2017-02-18 14:39:46.78961|2017-02-18 14:39:46.78961
NCT00630448|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2016-10-31|||November 2008||2008-11-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)|Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University|||2|Prinicipal Investigator initiated study closure.|f||||t||||||Samples With DNA|"~     Blood~   "|No||2017-02-18 14:39:27.928079|2017-02-18 14:39:27.928079
NCT00630435|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-02-03|||February 2008||2008-02-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation|An Open-Label, Single-Dose, Randomized, 4-Period, Crossover, Bioequivalence Study of 3 New Formulations of Premarin® /MPA 0.625 mg/2.5 mg Compared With Reference Formulation of Premarin®/MPA in Healthy Postmenopausal Women|Completed||Phase 1|76|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-02-18 14:39:28.019742|2017-02-18 14:39:28.019742
NCT00630422|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-03-06|||February 2006||2006-02-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Observational|||Functional Abilities in Rett Syndrome|Functional Abilities in Rett Syndrome|Completed||N/A|64|Actual|Faculdades Metropolitanas Unidas|||1||f||||f||||||||||2017-02-18 14:39:28.121197|2017-02-18 14:39:28.121197
NCT00630409|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-01-17|||September 2004||2004-09-01|January 2013|2013-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma|Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma|Completed||Phase 2|19|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:39:28.212861|2017-02-18 14:39:28.212861
NCT00630396|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-12-09|2011-08-01||May 2008||2008-05-01|December 2011|2011-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|MINOS||Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke|Minocycline to Improve Neurologic Outcome in Stroke (MINOS)|Completed||Phase 1/Phase 2|60|Actual|Augusta University|"Some statistical tests could not be performed due to small sample size in the 4.5 and 6mg/kg dose tiers.~The modified continual reassessment method (CRM) failed to identify the maximum tolerated dose of intravenous minocycline."|1|||f||||t||||||||||2017-02-18 14:39:28.332598|2017-02-18 14:39:28.332598
NCT00630383|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2012-06-13|||February 2008||2008-02-01|June 2012|2012-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|WIRMS-1||Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.|Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.|Withdrawn||Phase 2|0|Actual|University of Nottingham||2||superceded by another similar study|f||||t||||||||||2017-02-18 14:39:28.753049|2017-02-18 14:39:28.753049
NCT00630370|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-06-16|||February 2008||2008-02-01|December 2008|2008-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome|A Phase II, Randomized, Adaptive Design, Multicenter, Parallel Group, Placebo-Controlled, 58 Day, Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome|Terminated||Phase 2|6|Actual|Procter and Gamble||4|||f||||f||||||||||2017-02-18 14:39:28.88678|2017-02-18 14:39:28.88678
NCT00630357|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-11-14|||March 2003||2003-03-01|September 2009|2009-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy|A Phase IV, Open-label, Multi-center Trial to Evaluate the Safety and Efficacy of Keppra® After Conversion to Mono-therapy in Adult Subjects With Partial Epilepsy|Completed||Phase 4|14|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:39:29.068862|2017-02-18 14:39:29.068862
NCT00630344|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-01-29|2014-01-20||February 2008||2008-02-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|December 2013|Actual|2013-12-01||Interventional|||RAD001 and Bicalutamide for Androgen Independent Prostate Cancer|A Phase II Trial of RAD001 and Bicalutamide for Androgen Independent Prostate Cancer|Terminated||Phase 2|36|Actual|Dana-Farber Cancer Institute||1||Low overall response rate|f||||t||||||||||2017-02-18 14:39:29.1599|2017-02-18 14:39:29.1599
NCT00630331|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-01-15|2012-11-21||October 2007||2007-10-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects|A Phase III, Randomized, Observer-Blind, Placebo-Controlled, Multicenter Study to Assess Clinical Efficacy of a Cell-Derived Subunit Influenza Vaccine and an Egg-Derived Subunit Influenza Vaccine in the 2007-2008 Influenza Season in Healthy Adult Subjects|Completed||Phase 3|11404|Actual|Novartis||3|||f||||||||||||||2017-02-18 14:39:29.538369|2017-02-18 14:39:29.538369
NCT00630318|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2017-01-11|||March 2008||2008-03-01|January 2017|2017-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Testing New Method of Analyzing MR Images|Imaging Protocol Design for Anti-Angiogenesis Tracking With MRI|Terminated||Phase 1|12|Actual|Indiana University||1||Unable to accrue enough subjects to analyze data.|f||||f||||||||||2017-02-18 14:39:30.979221|2017-02-18 14:39:30.979221
NCT00630305|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-08-19|||January 2008||2008-01-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Endothelial Bleb Response With Toric Lenses|Evaluation of the Short-Term Corneal Endothelial Response to Wear of Toric Soft Contact Lenses in Asian Eyes|Completed||N/A|37|Actual|Johnson & Johnson Vision Care, Inc.||3|||f||||f||||||||||2017-02-18 14:39:31.086086|2017-02-18 14:39:31.086086
NCT00630292|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2010-05-10|2010-02-03||March 2008||2008-03-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors|Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors|Terminated||N/A|6|Actual|University of North Carolina, Chapel Hill|The software used to perform breast vessel analysis failed to detect any vessels in the breast due to the limited spatial resolution possible for breast imaging with the 1.5T Magnetic Resonance Imaging System used in the study.|1||Existing vessel analysis software could not be applied to breast MRI data.|f||||f||||||||||2017-02-18 14:39:31.200754|2017-02-18 14:39:31.200754
NCT00630279|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2009-08-04|||February 2008||2008-02-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis|A Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate Oral Recombinant Microbial Lipase Efficacy in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis|Terminated||Phase 2|56|Actual|Solvay Pharmaceuticals||4||This trial discontinued March 7,2009 due to high screen failure rate.|f||||f||||||||||2017-02-18 14:39:31.436018|2017-02-18 14:39:31.436018
NCT00630266|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2009-06-16|||January 2008||2008-01-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|MVR + CorCap||Confirmation Trial of the Acorn CorCap Cardiac Support Device (CSD) at the Same Time as Mitral Valve Repair|Clinical Evaluation of Acorn CorCap Cardiac Support Device Concomitant to MVR - A Confirmatory Trial|Unknown status|Recruiting|Phase 2|50|Anticipated|Acorn Cardiovascular, Inc.||1|||f||||f||||||||||2017-02-18 14:39:34.079424|2017-02-18 14:39:34.079424
NCT00630253|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-08-15|||February 2000||2000-02-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia|A Study of Cyclophosphamide, Fludarabine, and Antithymocyte Globulin Followed by Matched Sibling Donor Hematopoietic Cell Transplantation in Patients With Fanconi Anemia|Recruiting||Phase 1/Phase 2|45|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:39:34.216963|2017-02-18 14:39:34.216963
NCT00630240|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-08-30|||February 2008||2008-02-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization|Investigation the Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation in Patients With Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization|Completed||N/A|53|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||t||||||Samples Without DNA|"~     plasma~   "|||2017-02-18 14:39:34.351945|2017-02-18 14:39:34.351945
NCT00630227|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-10-21|||February 2008||2008-02-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study|Phase 2 Study of the 20 mL Biologic Lung Volume Reduction (BLVR) System in Patients With Homogeneous or Upper Lobe Predominant Emphysema|Completed||Phase 2|33|Actual|Aeris Therapeutics||1|||f||||f||||||||||2017-02-18 14:39:34.440844|2017-02-18 14:39:34.440844
NCT00630214|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-05|||May 2004||2004-05-01|February 2008|2008-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection|Phase 2 Study of Routine Oral Calcium and Vitamine D Supplements to Prevent Hypocalcemia After Total Thyroidectomy in Papillary Thyroid Carcinoma Patients|Completed||Phase 2|200|Actual|Asan Medical Center||4|||f||||t||||||||||2017-02-18 14:39:34.553525|2017-02-18 14:39:34.553525
NCT00630201|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2014-10-06||2011-01-05|October 2007||2007-10-01|October 2012|2012-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|PRO-807||Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence|An Open-Label, Multi-Center Extension Study Of Probuphine in Patients With Opioid Dependence|Completed||Phase 3|62|Actual|Titan Pharmaceuticals||1|||f||||t||||||||||2017-02-18 14:39:34.675617|2017-02-18 14:39:34.675617
NCT00630188|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2008-03-05|||March 2005||2005-03-01|February 2008|2008-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial|Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial|Completed||N/A|128|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 14:39:34.785446|2017-02-18 14:39:34.785446
NCT00630175|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-05-15|||September 2003||2003-09-01|May 2009|2009-05-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia|Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia. A Double-Blind, Randomized, Placebo-Controlled,Three Way Cross-Over Study|Completed||Phase 3|113|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:39:34.951988|2017-02-18 14:39:34.951988
NCT00630162|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-02-02|||March 2007||2007-03-01|May 2008|2008-05-01|July 2008|Actual|2008-07-01|||||Observational|||Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts|Survey of Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts|Completed||N/A|400|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||||||||||||2017-02-18 14:39:35.205606|2017-02-18 14:39:35.205606
NCT00630149|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2012-02-14|||November 2007||2007-11-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional|||Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy|Open-Label Single-Arm Phase 2 Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Who Have Had Prior Platinum Based Chemotherapy|Completed||Phase 2|35|Actual|Sun Yat-sen University||1|||f||||||||||||||2017-02-18 14:39:35.294427|2017-02-18 14:39:35.294427
NCT00630136|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2010-03-23|||February 2008||2008-02-01|October 2008|2008-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Effectiveness of the Consent Process|Effectiveness of the Consent Process Used for Outpatient Endoscopy|Completed||N/A|20|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-02-18 14:39:35.404992|2017-02-18 14:39:35.404992
NCT00630123|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2015-12-14|||November 2006||2006-11-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Effect of Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation(TMS) on Brain Derived Neurotrophic Factor (BDNF) in Depressed Patients.|Effect of Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS) on Serum Levels of Brain Derived Neurotrophic Factor in Depressed Patients.|Completed||N/A|36|Actual|Queen's University|||2||f||||f||||||Samples Without DNA|"~     serum frozen~   "|||2017-02-18 14:39:35.518248|2017-02-18 14:39:35.518248
NCT00630110|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2011-08-15|||February 2008||2008-02-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer|Study of the Vascular Disrupting Agent NPI-2358 in Combination With Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|172|Actual|Nereus Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 14:39:35.601425|2017-02-18 14:39:35.601425
NCT00630097|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-06-21|||December 2009||2009-12-01|June 2010|2010-06-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|||A Dose Ranging Study of Modafinil for Methamphetamine Dependence|A Dose Ranging Study of Modafinil for Methamphetamine Dependence|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|California Pacific Medical Center Research Institute||1|||f||||t||||||||||2017-02-18 14:39:35.756944|2017-02-18 14:39:35.756944
NCT00630084|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2015-09-03|||August 2006||2006-08-01|September 2015|2015-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma|The Response and Outcomes of Pegylated Interferon Plus Ribavirin Combination Therapy for Chronic Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma|Completed||Phase 4|120|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-02-18 14:39:35.853854|2017-02-18 14:39:35.853854
NCT00630071|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2012-10-15|||February 2008||2008-02-01|October 2012|2012-10-01|August 2008|Actual|2008-08-01|||||Observational|||Diagnostic Value of Procalcitonin in Patients With Acute Appendicitis|A Prospective Study Investigating the Diagnostic Value of Procalcitonin in Patients With Acute Appendicitis|Completed||N/A|103|Actual|Ruhr University of Bochum|||1||f||||t||||||Samples With DNA|"~     1.5 ml whole blood~   "|||2017-02-18 14:39:35.986296|2017-02-18 14:39:35.986296
NCT00630058|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2014-04-16|2012-12-12||April 2008||2008-04-01|April 2014|2014-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C|A Phase I, Open-Label, Two-Arm Study of MP-424 in Combination With Peginterferon Alfa 2b and Ribavirin in Patients With Genotype 1b Hepatitis C|Completed||Phase 1|20|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 14:39:36.069599|2017-02-18 14:39:36.069599
NCT00630045|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-03-05|||January 2008||2008-01-01|February 2008|2008-02-01|June 2015|Anticipated|2015-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis|A Phase III Study of Surgery in Combination With Neoadjuvant Chemotherapy of Oxaliplatin Plus Capecitabine in Colorectal Cancer With Respectable Liver Metastasis|Unknown status|Recruiting|Phase 3|392|Anticipated|Peking University People's Hospital||2|||f||||t||||||||||2017-02-18 14:39:36.670106|2017-02-18 14:39:36.670106
NCT00630032|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2016-06-22|||September 2007||2007-09-01|June 2016|2016-06-01|September 2017|Anticipated|2017-09-01|June 2014|Actual|2014-06-01||Interventional|TavIx||Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer|Randomized, Open Label, Multicentric Phase III Evaluating the Benefit of a Sequential Regimen Associating FEC 100 and Ixabepilone in Adjuvant Treatment of Non Metastatic, Poor Prognosis Breast Cancer Defined as Triple-negative Tumor [HER2 Negative - ER Negative - PR Negative] or [HER2 Negative and PR Negative] Tumor; in Node Positive or Node Negative Patients.|Active, not recruiting||Phase 3|762|Actual|UNICANCER||2|||f||||t||||||||||2017-02-18 14:39:36.786711|2017-02-18 14:39:36.786711
NCT00630019|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2009-02-04|||February 2008||2008-02-01|February 2009|2009-02-01||||October 2008|Actual|2008-10-01||Interventional|||Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator||Completed||Phase 4|96|Anticipated|Santen Inc.||2|||f||||f||||||||||2017-02-18 14:39:37.206136|2017-02-18 14:39:37.206136
NCT00630006|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-03-05|||January 2007||2007-01-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Genetic Polymorphisms of Interleukin-10 and TNF-α on Outcome of HCV-Related Chronic Liver Disease||Unknown status|Recruiting|N/A|||Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||f||||||||||2017-02-18 14:39:37.309609|2017-02-18 14:39:37.309609
NCT00629993|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2011-02-28|||January 2004||2004-01-01|February 2011|2011-02-01|August 2010|Actual|2010-08-01|August 2006|Actual|2006-08-01||Interventional|||Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved Communities|Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved Communities|Terminated||Phase 4|282|Actual|Columbia University||1||Principal Investigator left the institution|f||||t||||||||||2017-02-18 14:39:37.398551|2017-02-18 14:39:37.398551
NCT00629980|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-09-20||2009-03-24|February 2008||2008-02-01|September 2011|2011-09-01||||September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis|A Multi-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite® Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone in Subjects With Blepharitis|Completed||Phase 4|60|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:39:37.506626|2017-02-18 14:39:37.506626
NCT00629967|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-02-26|||April 2005||2005-04-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients|A Randomized, Open Labeled, Active-Controlled Trial of 24-Week Versus 48-Week Courses of Peg-Interferon Alpha Plus Ribavirin for Genotype-1 Infected Chronic Hepatitis C Patients|Completed||Phase 4|200|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||2|||f||||t||||||||||2017-02-18 14:39:37.611016|2017-02-18 14:39:37.611016
NCT00629954|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2013-09-25|||November 2009||2009-11-01|August 2012|2012-08-01|November 2016|Anticipated|2016-11-01|November 2014|Anticipated|2014-11-01||Observational|AHS||Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases|Abuja Heart Study (AHS) is a Multi-site Prospective Epidemiological Investigation of Cardiovascular Disease (CVD) .|Unknown status|Recruiting|N/A|10000|Anticipated|Healthsystem Plus|||1||f||||t||||||||||2017-02-18 14:39:37.735275|2017-02-18 14:39:37.735275
NCT00629941|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-09-20||2009-03-24|March 2008||2008-03-01|September 2011|2011-09-01||||August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis|A Multi-Center, Open-Label Study Evaluating the Cytokine and Eyelid Margin Bacterial Load Levels of Subjects Diagnosed With Chronic Blepharitis Following Dosing With AzaSite® (Azithromycin Ophthalmic Solution) 1%|Completed||Phase 4|25|Anticipated|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:39:37.84211|2017-02-18 14:39:37.84211
NCT00629928|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-01-24|||February 2001||2001-02-01|January 2011|2011-01-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Ulcer Prevention II|A Comparative Efficacy and Safety of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Placebo for the Prevention of Gastric and Duodenal Ulcers Associated With Daily NSAID Use in Patients at Risk|Completed||Phase 3|800|Anticipated|AstraZeneca||3|||||||||||||||||2017-02-18 14:39:37.939012|2017-02-18 14:39:37.939012
NCT00629915|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2015-06-01|||October 2006||2006-10-01|June 2015|2015-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||The Role of Cerebral Hemodynamics in Moyamoya Disease|The Role of Cerebral Hemodynamics in Moyamoya Disease|Active, not recruiting||N/A|56|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 14:39:38.034829|2017-02-18 14:39:38.034829
NCT00629902|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2008-05-09|||February 2008||2008-02-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Heart Valve Prosthesis-Patient Mismatch|Impact of Prosthesis-Patient Mismatch on Clinical Outcomes After Mitral Valve Replacement|Completed||N/A|100|Anticipated|Florence Nightingale Hospital, Istanbul|||2||f||||t||||||||||2017-02-18 14:39:38.130617|2017-02-18 14:39:38.130617
NCT00629889|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-05-21|||February 2008||2008-02-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|||Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors|Levetiracetam and Pregabalin for Monotherapy in Patients With Brain Tumors and Seizures. A Phase II Randomized Study.|Completed||Phase 2|52|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-02-18 14:39:38.22824|2017-02-18 14:39:38.22824
NCT00629876|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2011-11-29|||January 2008||2008-01-01|November 2011|2011-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.|A Phase 1, Multicenter, Open-Label Dose Escalation Study Evaluating the Safety and Tolerability of Multiple Hematide Injections in Subjects With Refractory Non-Small Cell Lung Cancer, Breast Cancer, or Prostate Cancer Who Are Anemic and Receiving Cytotoxic Chemotherapy|Terminated||Phase 1|2|Actual|Takeda||1||"Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology~   indications."|f||||f||||||||||2017-02-18 14:39:38.342631|2017-02-18 14:39:38.342631
NCT00629863|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2013-08-06|||September 2004||2004-09-01|January 2009|2009-01-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer|Cancer of the Oesophagus or Gastricus: New Assessment of the Technology of Endosonography COGNATE|Completed||N/A|700|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:39:38.465762|2017-02-18 14:39:38.465762
NCT00629850|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2011-08-17|2011-07-19||February 2008||2008-02-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Respiratory Resistance Training on Sleep Quality in Persons With Spinal Cord Injury|Concurrent Respiratory Resistance Training and Changes in Respiratory Muscle Strength and Sleep Quality in Persons With Spinal Cord Injury|Terminated||Phase 1|1|Actual|Texas State University, San Marcos|Unable to recruit subjects for the study|2||unable to recruit participants.|f||||f||||||||||2017-02-18 14:39:38.57867|2017-02-18 14:39:38.57867
NCT00629837|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2014-11-17|||September 2005||2005-09-01|November 2014|2014-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980|A Randomized, Double-blind, Cross-over Study to Determine the Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 in Previously Treated Patients With Severe Hemophilia A|Completed||Phase 1|27|Actual|Bayer||4|||f||||f||||||||||2017-02-18 14:39:38.943273|2017-02-18 14:39:38.943273
NCT00629824|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2010-09-06|||February 2007||2007-02-01|February 2007|2007-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C|Efficacy and Safety of Pegylated Interferon Plus Ribavirin Combination Therapy in Treating Older Patients With Chronic Hepatitis C|Completed||Phase 4|250|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||3|||f||||t||||||||||2017-02-18 14:39:39.054898|2017-02-18 14:39:39.054898
NCT00629811|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-02-26|||September 2006||2006-09-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women|A Double-Blind, Placebo-Controlled, Randomised Dose Ranging Trial to Investigate the Efficacy of Two Different Dosing Regimens of Avotermin (Juvista) in the Improvement of Scar Appearance When Applied to Approximated Wound Margins in Healthy Volunteers.|Completed||Phase 2|78|Actual|Renovo|||||f||||f||||||||||2017-02-18 14:39:39.16634|2017-02-18 14:39:39.16634
NCT00629798|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-12-15|||February 2008||2008-02-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)|A Phase II Trial of Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 2|52|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:39:39.252503|2017-02-18 14:39:39.252503
NCT00629785|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-02-26||||||March 2007|2007-03-01||||||||Observational|||The Analysis of BMI, Asthma Prevalence, and Lung Functions of Schoolchildren in Southern Taiwan||Completed||N/A|||Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||||||||||||2017-02-18 14:39:39.366503|2017-02-18 14:39:39.366503
NCT00629772|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-09-01|2010-04-14||March 2007||2007-03-01|September 2011|2011-09-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy of Infliximab in Palmoplantar Psoriasis|A Double-Blind Study on the Safety and Efficacy of Infliximab in Palmoplantar Psoriasis|Completed||Phase 3|24|Actual|Innovaderm Research Inc.|The lack of validated scales to specifically assess severity of palmoplantar psoriasis. The study was powered to detect a difference of 55 percentage points.|2|||f||||f||||||||||2017-02-18 14:39:39.434086|2017-02-18 14:39:39.434086
NCT00629759|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2013-01-03|||January 2006||2006-01-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma|Phase 1 Clinical Study for Evaluating the Safety and Efficacy of a Transdermal Injection of JX-594 (Thymidine Kinase (-)/GM-CSF(+) Vaccinia Virus) Within the Tumor of Patients With Hepatic Carcinoma|Completed||Phase 1|14|Actual|Jennerex Biotherapeutics||4|||f||||t||||||||||2017-02-18 14:39:40.28208|2017-02-18 14:39:40.28208
NCT00629746|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2010-09-06|||June 2006||2006-06-01|May 2010|2010-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Intraoperative Electromyographic Monitoring of the Recurrent Laryngeal Nerve in Thyroid Surgery|Intraoperative Electromyographic Monitoring of the Recurrent Laryngeal Nerve in Thyroid Surgery|Unknown status|Recruiting|N/A|1000|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||t||||||||||2017-02-18 14:39:40.391683|2017-02-18 14:39:40.391683
NCT00629733|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2011-06-07|||December 2007||2007-12-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers||Completed||Phase 1|12|Anticipated|Rovi Pharmaceuticals Laboratories||1|||f||||f||||||||||2017-02-18 14:39:40.503795|2017-02-18 14:39:40.503795
NCT00629720|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-12-11|||July 2006||2006-07-01|December 2009|2009-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|ALFACHIP||Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology|Four-week, Open-label, Multicenter, Randomized, Parallel-group Study to Investigate the Pharmacokinetics, Safety, Tolerability and the Effects on Leak Point Pressure of Two Oral Doses of Alfuzosin (0.1 mg/kg/Day; 0.2 mg/kg/Day) in Children and Adolescents 2 to 16 Years-of-age With Elevated Detrusor Leak-point Pressure of Neuropathic Etiology|Completed||Phase 3|29|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:39:40.607159|2017-02-18 14:39:40.607159
NCT00629707|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2012-09-12|2012-06-18||June 2008||2008-06-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Cerebral Edema in Pediatric Diabetic Ketoacidosis|Cerebral Edema in Pediatric Diabetic Ketoacidosis|Completed||N/A|20|Actual|University of California, Davis|Study terminated after enrollment of 20 subjects. Review of data from these subjects showed minimal difference between groups and substantial variability suggesting that a larger sample would be very unlikely to show significant differences.|2|||f||||t||||||||||2017-02-18 14:39:40.69725|2017-02-18 14:39:40.69725
NCT00629694|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2012-01-20|||September 2007||2007-09-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Adenoidectomy, Myringotomy and Tubes' Insertion vs Adenoidectomy and Myringotomy Alone in Children With Otitis Media With Effusion and Adenoid Hypertrophy|Adenoidectomy, Myringotomy and Tubes' Insertion vs Adenoidectomy and Myringotomy Alone in Children With Otitis Media With Effusion and Adenoid Hypertrophy|Completed||Phase 2|52|Actual|Aghia Sophia Children's Hospital of Athens||2|||f||||||||||||||2017-02-18 14:39:41.075682|2017-02-18 14:39:41.075682
NCT00629681|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2011-04-22|||November 2004||2004-11-01|April 2011|2011-04-01|February 2006|Actual|2006-02-01|||||Interventional|||A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia|Efficacy and Safety of Pregabalin in an Open-label, Non-comparative, Flexible-dose Trial With Diabetic Peripheral Neuropathy or Postherpetic Neuralgia|Completed||Phase 4|217|Actual|Pfizer||1|||f||||||||||||||2017-02-18 14:39:41.176635|2017-02-18 14:39:41.176635
NCT00629668|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-03-05|||January 2007||2007-01-01|July 2007|2007-07-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease||Unknown status|Recruiting|N/A|||Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||||2017-02-18 14:39:41.35936|2017-02-18 14:39:41.35936
NCT00629655|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2009-06-04|||February 2008||2008-02-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||A Spinal Functional Magnetic Resonance Imagine (fMRI) Study of Resting-State, Motor Task and Acupoint Stimulation|A Spinal fMRI Study of Resting-State, Motor Task and Acupoint Stimulation|Completed||N/A|22|Actual|China Rehabilitation Research Center|||2||f||||t||||||||||2017-02-18 14:39:41.441898|2017-02-18 14:39:41.441898
NCT00629642|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2013-03-04|||March 2008||2008-03-01|September 2012|2012-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|SONIC||Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis|A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity|Completed||Phase 4|249|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-02-18 14:39:41.547078|2017-02-18 14:39:41.547078
NCT00629629|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2008-03-05|||October 2001||2001-10-01|March 2008|2008-03-01|June 2003|Actual|2003-06-01|October 2002|Actual|2002-10-01||Interventional|||Impacts of the 10 Steps for Healthy Feeding in Infants: a Randomized Field Trial|Impacts of the 10 Steps for Healthy Feeding in Infants: a Randomized Field Trial|Completed||N/A|500|Actual|Federal University of Health Science of Porto Alegre||1|||f||||f||||||||||2017-02-18 14:39:41.714203|2017-02-18 14:39:41.714203
NCT00629616|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2014-08-05|||August 2007||2007-08-01|August 2014|2014-08-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|NIMFEA||Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer|A Randomized Multicenter Phase II Study Identifying Hormone Sensitivity Profiles and Evaluating the Efficacy of Anastrozole and Fulvestrant in the Neo-adjuvant Treatment of Operable Breast Cancer in Postmenopausal Women.|Unknown status|Active, not recruiting|Phase 2|116|Actual|UNICANCER||2|||f||||t||||||||||2017-02-18 14:39:41.80774|2017-02-18 14:39:41.80774
NCT00629603|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2013-04-17|||January 2007||2007-01-01|April 2013|2013-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease|Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease|Completed||N/A|600|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||||2017-02-18 14:39:41.932658|2017-02-18 14:39:41.932658
NCT00629590|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2011-09-20||2009-03-24|March 2008||2008-03-01|September 2011|2011-09-01||||July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis|A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite® Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Two Weeks in Subjects With Posterior Blepharitis|Completed||Phase 4|20|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:39:42.046723|2017-02-18 14:39:42.046723
NCT00629577|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-05|2017-01-30|||September 2006||2006-09-01|November 2010|2010-11-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Interventional|SAGE||Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples|Ex Vivo Gene Expression Profiling of Cervical Cancer Progression in Biopsies And Tissue Samples From Patients With Cervical Lesions|Terminated||Phase 1|50|Anticipated|British Columbia Cancer Agency||1||no funding|f||||f||||||||||2017-02-18 14:39:42.141822|2017-02-18 14:39:42.141822
NCT00629564|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-01-24|||September 2002||2002-09-01|January 2011|2011-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)|An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)|Completed||Phase 4|60|Actual|AstraZeneca||2|||||||||||||||||2017-02-18 14:39:42.232976|2017-02-18 14:39:42.232976
NCT00629551|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2016-04-26||2016-04-26|February 2008||2008-02-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|COMPASS||An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder|An Eight-week, Double-blind Study to Evaluate the Efficacy, Safety, and Tolerability of Two Fixed Doses of Saredutant (100 mg and 30 mg) Once Daily in Combination With Paroxetine 20 mg Once Daily Compared to Saredutant Placebo in Combination With Paroxetine 20 mg Once Daily in Patients With Major Depressive Disorder|Completed||Phase 3|825|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 14:39:42.321944|2017-02-18 14:39:42.321944
NCT00629538|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2010-12-28|||March 2007||2007-03-01|December 2010|2010-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Therapeutic Thoracentesis for Patients With Congestive Heart Failure and Large Pleural Effusion|Effect of Therapeutic Thoracentesis on Cardiopulmonary Function in Patients With Congestive Heart Failure Complicated With Large to Massive Pleural Effusion|Completed||N/A|20|Anticipated|Taipei Medical University Hospital||1|||f||||t||||||||||2017-02-18 14:39:42.431505|2017-02-18 14:39:42.431505
NCT00629525|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2015-02-12|2013-01-04||August 2005||2005-08-01|February 2015|2015-02-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer|A Single Arm, Two Center, Phase II Study of RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer|Completed||Phase 2|35|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:39:42.5182|2017-02-18 14:39:42.5182
NCT00629512|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2009-03-12|||March 2001||2001-03-01|March 2009|2009-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Prevention of Gastric Ulcers|A Comparative Efficacy and Safety Study of Nexium (Esomeprazole Magnesium) Delayed-Release Capsules (40mg qd and 20mg qd) Versus Placebo for the Prevention of Gastric Ulcers Associated With Daily NSAID Use in Patients at Risk|Completed||Phase 3|504|Anticipated|AstraZeneca||3|||||||||||||||||2017-02-18 14:39:42.794998|2017-02-18 14:39:42.794998
NCT00629499|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2013-08-29|2012-08-22||April 2008||2008-04-01|August 2013|2013-08-01|September 2010|Actual|2010-09-01|October 2008|Actual|2008-10-01||Interventional|||Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer|Phase II Trial of Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer (With Trastuzumab in HER2 Positive Patients)|Completed||Phase 2|63|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 14:39:42.890592|2017-02-18 14:39:42.890592
NCT00629486|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2013-04-17|||January 2007||2007-01-01|April 2013|2013-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma|Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma|Completed||N/A|300|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||1|||f||||f||||||||||2017-02-18 14:39:43.347757|2017-02-18 14:39:43.347757
NCT00629473|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2014-08-11|||July 2007||2007-07-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Phase 1 Clinical Trial in Patients With Advanced Malignancies|A Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies|Completed||Phase 1|86|Actual|Triphase Research and Development I Corporation||2|||f||||f||||||||||2017-02-18 14:39:43.463335|2017-02-18 14:39:43.463335
NCT00629460|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2012-10-16|||February 2008||2008-02-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|August 2010|Actual|2010-08-01||Observational|||A Pilot Study of PET-CT in the Assessment of Pulmonary Nodules in Children With Malignant Solid Tumors|A Pilot Study of PET-CT in the Assessment of Pulmonary Nodules in Children With Malignant Solid Tumors|Completed||N/A|27|Actual|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 14:39:43.576062|2017-02-18 14:39:43.576062
NCT00629447|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-01-04|||February 2004||2004-02-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|March 2007|Actual|2007-03-01||Interventional|||Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients|A Pilot Trial of Innohep (Tinzaparin) Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumor Patients|Completed||N/A|40|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:39:43.670832|2017-02-18 14:39:43.670832
NCT00629434|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-04|||June 2001||2001-06-01|February 2008|2008-02-01|August 2008|Anticipated|2008-08-01|June 2008|Anticipated|2008-06-01||Interventional|||A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person|A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person|Unknown status|Active, not recruiting|N/A|68|Actual|State University of New York - Upstate Medical University||2|||f||||f||||||||||2017-02-18 14:39:43.779488|2017-02-18 14:39:43.779488
NCT00629421|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2013-04-17|||January 2001||2001-01-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study|Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study|Unknown status|Recruiting|N/A|1300|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1||f||||f||||||||||2017-02-18 14:39:43.880795|2017-02-18 14:39:43.880795
NCT00629395|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-05-31|||June 2007||2007-06-01|May 2013|2013-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Computerized Cognitive Training for Childhood Cancer Survivors|Computerized Cognitive Training for Childhood Cancer Survivors: A Pilot Study|Terminated||N/A|9|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:39:43.963839|2017-02-18 14:39:43.963839
NCT00629382|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-12-01|||December 2004||2004-12-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|EUPHAS||Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis|Dispositivo Adsorbente Con Polymyxina B Immobilizzata Nello Shock Settico - Studio Clinico Randomizzato e Prospettico, Multicentrico|Completed||Phase 4|70|Actual|St. Bortolo Hospital||2|||f||||f||||||||||2017-02-18 14:39:44.064812|2017-02-18 14:39:44.064812
NCT00629369|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-07|||October 2007||2007-10-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Duration of Second Stage of Labor Wearing a Dental Occlusion Device|Duration of Second Stage of Labor Wearing a Dental Occlusion Device: a Randomized Controlled Trial|Completed||N/A|64|Actual|Mercy Medical Center||2|||f||||t||||||||||2017-02-18 14:39:44.174186|2017-02-18 14:39:44.174186
NCT00629356|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2015-03-31|||July 2007||2007-07-01|May 2010|2010-05-01|July 2008|Anticipated|2008-07-01|||||Observational|||Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection|Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection|Withdrawn||N/A|0|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital|||1|The study had been revised and made a new application.|f||||f||||||||||2017-02-18 14:39:44.271899|2017-02-18 14:39:44.271899
NCT00629343|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2012-11-07|||October 2007||2007-10-01|November 2012|2012-11-01|August 2014|Anticipated|2014-08-01|October 2012|Actual|2012-10-01||Interventional|||Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide|A Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide In Patients With Unresectable Or Metastatic Soft Tissue Sarcoma or Malignant Mesothelioma|Unknown status|Active, not recruiting|Phase 1|28|Actual|Columbia University||1|||f||||t||||||||||2017-02-18 14:39:44.364054|2017-02-18 14:39:44.364054
NCT00629330|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2015-10-12|||January 2004||2004-01-01|February 2011|2011-02-01|November 2010|Actual|2010-11-01|March 2008|Actual|2008-03-01||Interventional|||Dissemination of Prostate Cancer Screening to PCP's in African American Communities|Dissemination of Prostate Cancer Screening to Primary Care Physicians in African American Communities|Terminated||Phase 4|86|Actual|Columbia University||1||Principal Investigator left the institution.|f||||t||||||||||2017-02-18 14:39:44.476057|2017-02-18 14:39:44.476057
NCT00629317|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2009-03-13|||February 2008||2008-02-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage|A Randomized, Double-Blind, Placebo-Controlled Trial of Methyl Aminolevulinate + Aktilite in Patients With Facial Photodamage|Completed||Phase 3|49|Actual|Universidad de Antioquia||2|||f||||f||||||||||2017-02-18 14:39:44.580818|2017-02-18 14:39:44.580818
NCT00629304|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2012-02-08|||September 2007||2007-09-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|TELEDIAB-1||Multicenter Assessment of the PDA-FIT System in Type 1 Diabetic Patients|Multicenter Assessment of the PDA-FIT System in Type 1 Diabetic Patients With Chronic Failure of Intensive Insulin Therapy and Conventional Care. The TELEDIAB-1 STUDY|Completed||Phase 3|180|Actual|Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète||3|||f||||f||||||||||2017-02-18 14:39:44.699406|2017-02-18 14:39:44.699406
NCT00629291|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2010-05-09|||January 2008||2008-01-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.|Evaluation of Iron Overload in the Heart, Liver and Pancreas: Patients With Sickle β Thalassemia and Sickle Cell Anemia.|Completed||N/A|60|Anticipated|Sheba Medical Center|||2||f||||f||||||None Retained|"~     No biosepcimens retained~   "|||2017-02-18 14:39:44.850108|2017-02-18 14:39:44.850108
NCT00629278|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2013-08-06|||December 2007||2007-12-01|July 2009|2009-07-01||||December 2010|Anticipated|2010-12-01||Interventional|||Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer|SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF 2 DIFFERENT ADJUVANT CHEMOTHERAPY REGIMENS PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN HER2 POSITIVE BREAST CANCER PATIENTS|Unknown status|Recruiting|Phase 3|2500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:39:44.955828|2017-02-18 14:39:44.955828
NCT00629265|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2014-10-29|2013-08-28||March 2008||2008-03-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|April 2012|Actual|2012-04-01||Interventional|||Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients|Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients|Completed||N/A|170|Actual|Boston Medical Center|Because of funding limitations research assistants could not be hired at most sites, and so 170 (instead of 240) subjects were enrolled. However, the results suggest additional patients would not have changed the outcome.|2|||f||||t||||||||||2017-02-18 14:39:45.077084|2017-02-18 14:39:45.077084
NCT00629252|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2012-09-14|||February 2008||2008-02-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients||Terminated||N/A|14|Actual|University of Zurich||3||Not enough subjects have been recruited in the expected period.|f||||f||||||||||2017-02-18 14:39:45.513656|2017-02-18 14:39:45.513656
NCT00629239|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2010-11-04|2010-11-04||January 2008||2008-01-01|November 2010|2010-11-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|TOP||Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A 4-week Double-blind, Placebo-controlled, Randomized, Parallel Group Phase IIa Study to Assess the Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|65|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:39:45.629932|2017-02-18 14:39:45.629932
NCT00629226|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-01|2011-09-29|||October 2007||2007-10-01|September 2011|2011-09-01||||December 2010|Actual|2010-12-01||Interventional|||Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer|Phase I Study of Bortezomib and Cetuximab Without or With Cisplatin in Combination With Radiation Therapy for Advanced Head and Neck Cancer|Completed||Phase 1|46|Anticipated|National Institutes of Health Clinical Center (CC)||2|||||||||||||||||2017-02-18 14:39:46.207683|2017-02-18 14:39:46.207683
NCT00629213|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-03-05||||||March 2008|2008-03-01||||||||Interventional|||Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial|Metabolic Syndrome and Its Single Traits as Risk Factors of Diabetes in People With Impaired Glucose Tolerance: The STOP-NIDDM Trial|Completed||Phase 3|1429||GWT-TUD GmbH||2|||f||||t||||||||||2017-02-18 14:39:46.329646|2017-02-18 14:39:46.329646
NCT00629200|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2011-11-21|||September 2006||2006-09-01|November 2011|2011-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies|A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sodium Stibogluconate in Combination With Interferon Alpha-2b for Patients With Advanced Malignancies|Completed||Phase 1|33|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:39:46.443262|2017-02-18 14:39:46.443262
NCT00629187|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2012-04-26|||April 2004||2004-04-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|CN-306||Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy|Phase I Dose Escalation Study of Temozolomide With Autologous Stem Cell Rescue for Patients With Relapsed/Refractory CNS Malignancy Including Isolated Metastatic Disease|Terminated||Phase 1|2|Actual|Tufts Medical Center||1||The study was stopped due to lack of adequate enrollment.|f||||f||||||||||2017-02-18 14:39:46.559621|2017-02-18 14:39:46.559621
NCT00629174|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-11|||June 2006||2006-06-01|March 2008|2008-03-01||||December 2008|Anticipated|2008-12-01||Interventional|BBF||Prevention of the Age-Related Cognitive Impairment by Exercise and Mental Activity - Berlin Bleibt Fit|Randomized, Controlled Study About the Effects of an Exercise Program and Mental Activity on the Age-Associated Impairment of Cognitive Function|Unknown status|Recruiting|Phase 3|252|Anticipated|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-02-18 14:39:46.680703|2017-02-18 14:39:46.680703
NCT00629148|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2011-07-06|||August 2007||2007-08-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|August 2009|Actual|2009-08-01||Interventional|||Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)|Randomized Multicenter Phase II Study of Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine as First Line Chemotherapy for Patients With Metastatic Breast Cancer|Completed||Phase 2|60|Actual|Fudan University||2|||f||||f||||||||||2017-02-18 14:39:46.90367|2017-02-18 14:39:46.90367
NCT00629135|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2011-06-21|||November 2005||2005-11-01|May 2010|2010-05-01|August 2012|Anticipated|2012-08-01|February 2012|Anticipated|2012-02-01||Interventional|MEMO||Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses|Single Centre, Prospective, Comparative, Open-label, Randomised Study to Evaluate the Efficacy and Tolerability of the Combination of Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses|Unknown status|Recruiting|Phase 3|180|Anticipated|Hannover Medical School||2|||f||||t||||||||||2017-02-18 14:39:47.016003|2017-02-18 14:39:47.016003
NCT00629122|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2010-11-04|||February 2008||2008-02-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation|Pharmacokinetic Evaluation of Sublingual Versus Oral Tacrolimus Administration in Patients Awaiting Kidney Transplantation|Completed||Phase 4|20|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:39:47.132682|2017-02-18 14:39:47.132682
NCT00629096|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2014-12-04|||February 2008||2008-02-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy|Effects of Intracoronary Infusion of Bone Marrow-derived Progenitor Cells on Myocardial Regeneration in Patients With Non-ischemic Dilated Cardiomyopathy.|Completed||Phase 2|27|Actual|Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud||1|||f||||f||||||||||2017-02-18 14:39:47.238888|2017-02-18 14:39:47.238888
NCT00629083|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2015-02-06||2015-02-06|April 2008||2008-04-01|February 2015|2015-02-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Bulking Agents for the Treatment of Stress Urinary Incontinence in Females|A Single-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Bulkamid® and Contigen® as Bulking Agents for the Treatment of Stress Urinary Incontinence in Females|Completed||N/A|345|Actual|Contura||2|||f||||t||||||||||2017-02-18 14:39:47.344865|2017-02-18 14:39:47.344865
NCT00629070|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2010-07-30|||January 2009||2009-01-01|July 2010|2010-07-01|May 2011|Anticipated|2011-05-01|January 2011|Anticipated|2011-01-01||Interventional|||Quadriceps Muscle Plasticity in Children With Cerebral Palsy|In Vivo Assessment of Quadriceps Muscle Plasticity in Children With Cerebral Palsy|Unknown status|Recruiting|Phase 2|30|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 14:39:47.478092|2017-02-18 14:39:47.478092
NCT00629057|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2013-05-06|||March 2008||2008-03-01|June 2011|2011-06-01|September 2011|Actual|2011-09-01|December 2010|Actual|2010-12-01||Interventional|BNIT-PR-001||A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer|An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer|Completed||Phase 1|24|Actual|Bavarian Nordic, Inc.||3|||f||||f||||||||||2017-02-18 14:39:47.809284|2017-02-18 14:39:47.809284
NCT00629044|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2011-03-25|||November 2007||2007-11-01|August 2009|2009-08-01|January 2011|Actual|2011-01-01|November 2009|Actual|2009-11-01||Interventional|||Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD|Etude du Polymorphysme génétique de la cholestérol 24S Hydroxylase et Des Teneurs en 24S hydroxycholestérol Chez Des Patients Atteints de Glaucome ou de dégénérescence Maculaire liée à l'âge.|Completed||N/A|320|Anticipated|Centre Hospitalier Universitaire Dijon||3|||f||||t||||||||||2017-02-18 14:39:47.938886|2017-02-18 14:39:47.938886
NCT00629031|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-09-11|||February 2008||2008-02-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|February 2008|Actual|2008-02-01||Interventional|||An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis|An Open Lable Randomised Two -Arm Study to Assess the Safety and Efficacy of Paromomycin Administered Intramuscularly at Two Different Dosing Regimens (14 Days Versus 21 Days) for the Treatment of Indian Visceral Leishmaniasis (VL)|Completed||Phase 3|329|Actual|Banaras Hindu University||2|||f||||f||||||||||2017-02-18 14:39:48.054856|2017-02-18 14:39:48.054856
NCT00629018|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2015-04-23|2013-04-09||May 2006||2006-05-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy|The Effects of Autologous Intracoronary Stem Cell Transplantation In Patients With End-Stage Dilated Cardiomyopathy|Completed||Phase 2|110|Actual|University Medical Centre Ljubljana||2|||f||||t||||||||||2017-02-18 14:39:48.171001|2017-02-18 14:39:48.171001
NCT00629005|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2013-01-28|||February 2008||2008-02-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Strength Training and Stroke|Should We Train Strength or Skill in Post-Stroke Rehabilitation?|Completed||Phase 1/Phase 2|20|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:39:48.638831|2017-02-18 14:39:48.638831
NCT00628992|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2015-03-26|||February 2008||2008-02-01|March 2015|2015-03-01|September 2011|Actual|2011-09-01|November 2008|Actual|2008-11-01||Interventional|||Early Rehabilitation of COPD Patients in ICU|Effects of Early Rehabilitation in Chronic Obstructive Pulmonary Disease Patients Under Mechanical Ventilation for Acute Respiratory Failure in Intensive Care Unit.|Terminated||N/A|5|Actual|University Hospital, Strasbourg, France||4|||f||||||||||||||2017-02-18 14:39:48.759879|2017-02-18 14:39:48.759879
NCT00628979|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2009-07-01|||March 2008||2008-03-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|March 2008|Actual|2008-03-01||Interventional|||Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder|Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder|Completed||N/A|23|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 14:39:48.876587|2017-02-18 14:39:48.876587
NCT00628953|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-03-12|||October 2002||2002-10-01|March 2009|2009-03-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Adult Asthmatics and Acid Reflux|A Randomized, Double-Blind, Parallel Group Multicenter Efficacy and Safety Phase IIB Pilot Study of Esomeprazole 40mg Bid Versus Placebo Bid in Adult Asthmatics Treated for 4 Months|Completed||Phase 2|1400|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:39:48.980408|2017-02-18 14:39:48.980408
NCT00628940|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2014-12-04|||January 2010||2010-01-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Interventional|||PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?|PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?|Unknown status|Recruiting|Phase 1|20|Anticipated|University Ghent||1|||f||||f||||||||||2017-02-18 14:39:49.08478|2017-02-18 14:39:49.08478
NCT00628927|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-03|2015-12-01|2013-05-03||February 2008||2008-02-01|December 2015|2015-12-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Observational||Stimulant dependent participants were starting treatment, and participating in the CTN0031 study. Normal controls were recruited from the community.|An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.|An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers|Completed||Phase 3|217|Actual|University of Cincinnati|||2||f||||t||||||Samples With DNA|"~     Blood sample for the oxidative stress/damage analysis~   "|||2017-02-18 14:39:49.197014|2017-02-18 14:39:49.197014
NCT00628914|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2010-08-19|||May 2008||2008-05-01|July 2010|2010-07-01|February 2010|Anticipated|2010-02-01|November 2009|Anticipated|2009-11-01||Interventional|||Brain Mechanisms and Targeting Insomnia in Major Depression|Brain Mechanisms and Targeting Insomnia in Major Depression|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|University of California, Los Angeles||3|||f||||f||||||||||2017-02-18 14:39:49.659122|2017-02-18 14:39:49.659122
NCT00628901|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2012-07-02|2011-06-13||January 2006||2006-01-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|December 2009|Actual|2009-12-01||Interventional|||A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)|A Prospective, Randomized, Single-Center Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)|Completed||Phase 4|60|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-02-18 14:39:49.802596|2017-02-18 14:39:49.802596
NCT00628888|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2014-12-18|||July 2006||2006-07-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Waitlist-Controlled Trial of the Unified Protocol for the Treatment of Emotional Disorders in Adolescents|Treatment of Emotional Disorders in Adolescence|Completed||N/A|51|Actual|University of Miami||2|||f||||f||||||||||2017-02-18 14:39:51.670285|2017-02-18 14:39:51.670285
NCT00628875|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2010-04-12|||January 2007||2007-01-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Observational|Vent Detection||Feasibility of Ventilation Detection Via Standard Defibrillator Pads in Mechanically Ventilated Pediatric Patients|"Feasibility of Ventilation Detection Using Thoracic Impedence Acquired Via Standard Defibrillator Electrode Pads in Mechanically Ventilated Pediatric Patients"|Completed||N/A|28|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 14:39:51.78239|2017-02-18 14:39:51.78239
NCT00628862|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-09-25|2010-03-19||December 2007||2007-12-01|September 2012|2012-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|OCEAN||Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU|A 12-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-national, Phase III, Efficacy and Safety Study of Inhaled Formoterol 4.5 μg and 9 μg Twice Daily in Japanese and European Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|613|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:39:51.869901|2017-02-18 14:39:51.869901
NCT00628849|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2013-11-19|||February 2007||2007-02-01|November 2013|2013-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|Mand||Champy Versus AO for Mandible Fractures|A Comparison of 2mm Plates and Screws With Larger Plates Ans Screws in the Treatment of Mandibular Fractures|Completed||N/A|126|Actual|Emory University|||3||f||||f||||||||||2017-02-18 14:39:52.641534|2017-02-18 14:39:52.641534
NCT00628836|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2015-06-01|||June 2001||2001-06-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Treatment of Shoulder Subluxation in Chronic Stroke Patients|BION Implantable Microstimulation System|Completed||Phase 1|30|Actual|University of Southern California||2|||f||||f||||||||||2017-02-18 14:39:52.732625|2017-02-18 14:39:52.732625
NCT00628823|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2016-05-14|||March 2003||2003-03-01|May 2016|2016-05-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|TMCD||Treatment of Mild Enteropathy Celiac Disease|Treatment of Mild Enteropathy Celiac Disease|Completed||N/A|73|Actual|Tampere University Hospital||2|||f||||f||||||||||2017-02-18 14:39:52.848267|2017-02-18 14:39:52.848267
NCT00628810|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-05-27|||January 2007||2007-01-01|May 2016|2016-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer|Chemotherapy With FOLFIRI Plus Bevacizumab (AvastinR) in Patients With Metastatic Colorectal Cancer Bearing Genotype UGT1A1*1/UGT1A1*1 or UGT1A1*1/UGT1A1*1/UGT1A1*28: Prospective, Phase II, Multicenter Study|Completed||Phase 2|86|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||f||||||||||2017-02-18 14:39:52.94985|2017-02-18 14:39:52.94985
NCT00628797|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2010-01-27|||February 2008||2008-02-01|January 2010|2010-01-01|November 2010|Anticipated|2010-11-01|July 2010|Anticipated|2010-07-01||Interventional|||Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis|Multizenter-Studie Zur UVA-1 Therapie für Die Hautbeteiligung Bei Systemischer Sklerodermie|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|University of Cologne||2|||f||||f||||||||||2017-02-18 14:39:55.560826|2017-02-18 14:39:55.560826
NCT00628784|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-07-22|||March 2007||2007-03-01|July 2008|2008-07-01|March 2012|Anticipated|2012-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer|Endoesophageal Cryotherapy: A New Technique For Ablating Barrett's Esophagus And Early Stage Esophageal Cancer|Unknown status|Recruiting|Phase 4|100|Anticipated|Walter Reed Army Medical Center||4|||f||||t||||||||||2017-02-18 14:39:55.660181|2017-02-18 14:39:55.660181
NCT00628771|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2016-07-25|||June 2008||2008-06-01|July 2016|2016-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women|Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study|Completed||Phase 4|1233|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:39:55.76682|2017-02-18 14:39:55.76682
NCT00005131|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-12|||July 1985||1985-07-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Atherosclerosis Risk in Communities (ARIC)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:28.258499|2017-02-18 18:15:28.258499
NCT00628758|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2012-07-06|2009-09-18||December 2005||2005-12-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|PASSION||A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma|A Comparison of Symbicort® Single Inhaler Therapy (Symbicort Turbuhaler® 160/4.5mg, 1 Inhalation Two Times a Day (b.i.d.) Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults a -26-week, Randomized, Open-label, Parallel-group, Multicentre Study|Completed||Phase 3|430|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:39:55.901241|2017-02-18 14:39:55.901241
NCT00628745|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2017-01-31|||July 2007||2007-07-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|June 2021|Anticipated|2021-06-01||Observational|THAOS||Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)|Transthyretin-associated Amyloidosis Outcomes Survey (Thaos): A Global, Multi-center, Longitudinal, Observational Survey Of Patients With Documented Transthyretin (Ttr) Mutations Or Wild-type Ttr Amyloidosis|Recruiting||N/A|1|Anticipated|Pfizer|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 14:39:56.328507|2017-02-18 14:39:56.328507
NCT00628732|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2009-01-27|||January 2005||2005-01-01|January 2009|2009-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors|A Pharmacokinetic and Phase II Study of Oral Cyclophosphamide and Oral Topotecan in Children With Recurrent and or Refractory Solid Tumors|Completed||Phase 2|36|Anticipated|Children's Medical Center Dallas||1|||f||||f||||||||||2017-02-18 14:39:56.697903|2017-02-18 14:39:56.697903
NCT00628719|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2009-04-02|||February 2008||2008-02-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Interventional|||Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis|A Phase III Randomized, Controlled, Clinical Trial to Assess the Safety and Efficacy of Single Infusion of Liposomal Amphotericin B in Patients With Visceral Leishmaniasis|Completed||Phase 3|400|Anticipated|Banaras Hindu University||2|||f||||f||||||||||2017-02-18 14:39:56.807872|2017-02-18 14:39:56.807872
NCT00628706|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2009-02-17|||April 2008||2008-04-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|FIX||Investigating the Acute Effects of THC on Functional Brain Systems|Investigating the Acute Effects of THC on Functional Brain Systems|Completed||Phase 1|12|Anticipated|UMC Utrecht||2|||f||||t||||||||||2017-02-18 14:39:56.920257|2017-02-18 14:39:56.920257
NCT00628693|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2016-01-26|||June 2006||2006-06-01|January 2016|2016-01-01|November 2015|Actual|2015-11-01|June 2015|Actual|2015-06-01||Observational|Q-CPR||Quantitative Measurement of Cardiopulmonary Resuscitation (CPR) During In Hospital Cardiac Arrest|Quantitative Measurement of Cardiopulmonary Resuscitation During In Hospital Cardiac Arrest|Completed||N/A|89|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 14:39:57.030119|2017-02-18 14:39:57.030119
NCT00628680|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-03-04|||July 2006||2006-07-01|February 2008|2008-02-01||||July 2008|Actual|2008-07-01||Interventional|||A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis|Pivotal/Phase III Multicentered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 Solution (Zuragen), and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis|Unknown status|Active, not recruiting|Phase 3|415|Actual|Ash Access Technology||2|||f||||f||||||||||2017-02-18 14:39:57.116304|2017-02-18 14:39:57.116304
NCT00628667|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2011-01-24|||February 2002||2002-02-01|January 2011|2011-01-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux|A Multicenter, Double -Blind, Placebo-controlled Study to Evaluate the Effects of Esomeprazole 40mg Bid on the Signs and Symptoms of Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux|Completed||Phase 4|120|Anticipated|AstraZeneca||2|||||||||||||||||2017-02-18 14:39:57.240056|2017-02-18 14:39:57.240056
NCT00628654|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-04|2016-12-20|||October 2005||2005-10-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants|Clinical Protocol to Evaluate Glycans Analysis As a Diagnostic Test for Ovarian Cancer|Recruiting||N/A|700|Anticipated|University of California, Davis|||2||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 14:39:57.332727|2017-02-18 14:39:57.332727
NCT00628628|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2013-05-31|2013-05-31||January 2008||2008-01-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Rasburicase in Patients at Risk for Tumor Lysis Syndrome|Phase 2 Study of Rasburicase Administered by Two Different Schedules (Fixed Dosing vs. As Needed Dosing) in Patients at High Risk or Potential Risk for Tumor Lysis Syndrome|Completed||Phase 2|82|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:39:57.434077|2017-02-18 14:39:57.434077
NCT00628615|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-12-15|||April 2008||2008-04-01|December 2008|2008-12-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Observational|||Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase|Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase|Unknown status|Active, not recruiting|N/A|50|Anticipated|Maastricht University Medical Center|||2||f||||f||||||||||2017-02-18 14:39:57.777322|2017-02-18 14:39:57.777322
NCT00628602|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2015-06-01|||November 2007||2007-11-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||BION Active Seating for Pressure Ulcer Prevention|BION Active Seating for Pressure Ulcer Prevention|Completed||Phase 1|3|Actual|University of Southern California||2|||f||||f||||||||||2017-02-18 14:39:57.879256|2017-02-18 14:39:57.879256
NCT00628589|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-06-10|||February 2008||2008-02-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Staccato® Loxapine Treatment of Schizophrenic Patients With Agitation|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Efficacy and Safety Study of Staccato® Loxapine for Inhalation in Schizophrenic Patients With Agitation|Completed||Phase 3|300|Anticipated|Alexza Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 14:39:58.02823|2017-02-18 14:39:58.02823
NCT00628576|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-02-26|||October 1993||1993-10-01|February 2008|2008-02-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities|Deep Venous Thrombosis. Long-Term Results After Treatment With Either Low-Molecular -Weight Heparin or Unfractionated Heparin. Examinations of the Venous System.|Completed||Phase 3|99|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-02-18 14:39:58.284292|2017-02-18 14:39:58.284292
NCT00628563|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-02-26|||September 2007||2007-09-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|REALL||REALL: A Retrospective Observational Study to Compare the Effectiveness and Cost-Effectiveness Between Different Step-3 Asthma Treatment Strategies|REALL STUDY: A Retrospective Observational Study to Compare the Effectiveness and Cost-effectiveness Between Different Step-3 Asthma Treatment Strategies in Real Life Patients in Primary Care|Completed||N/A|50000|Actual|University of Aberdeen|||1||f||||t||||||||||2017-02-18 14:39:58.40218|2017-02-18 14:39:58.40218
NCT00628550|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2010-06-24|||April 2008||2008-04-01|June 2010|2010-06-01|December 2011|Anticipated|2011-12-01|April 2011|Anticipated|2011-04-01||Interventional|Vasopressin||Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation|A Prospective, Randomized, Controlled Trial of Combination Vasopressin and Epinephrine to Epinephrine Only for In-Intensive Care Unit Pediatric Cardiopulmonary Resuscitation|Unknown status|Recruiting|Phase 1|130|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 14:39:58.483552|2017-02-18 14:39:58.483552
NCT00628537|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2015-06-01|||April 2004||2004-04-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Prevention of Post-Stroke Hand/Wrist Flexion Deformity|BION Implantable Microstimulator|Completed||Phase 1|30|Actual|University of Southern California||3|||f||||f||||||||||2017-02-18 14:39:58.602774|2017-02-18 14:39:58.602774
NCT00628524|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2013-12-06|||February 2008||2008-02-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|July 2013|Actual|2013-07-01||Observational|HCS||Homburg Cream & Sugar Study|Prospective Investigation of the Influence of Triglyceride Tolerance on Cardiovascular Outcomes in Patients With Coronary Artery Disease|Completed||N/A|514|Actual|University Hospital, Saarland|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:39:58.704202|2017-02-18 14:39:58.704202
NCT00628511|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2016-02-08|||January 2007||2007-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Observational|||Validation of Portable Monitoring Device for Diagnosing Sleep Apnea|A Validation Study of A New Diagnostic Device for Screening of Obstructive Sleep Apnea in High Risk Patient Population|Completed||N/A|175|Actual|Chinese University of Hong Kong|||1||f||||f||||||||||2017-02-18 14:39:58.787476|2017-02-18 14:39:58.787476
NCT00628498|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2017-01-20|||December 2007||2007-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|Treatment IND||Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study|Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study|Completed||Phase 3|1206|Actual|Jazz Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:39:58.889191|2017-02-18 14:39:58.889191
NCT00628485|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2015-06-01|||October 2007||2007-10-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||BION Treatment of Dysphagia After Radical Head-Neck Surgery|BION Stimulation to Improve Swallowing Function After Radical Head-neck Surgery and Follow-up Chemoradiation Therapy|Completed||Phase 1|4|Actual|University of Southern California||3|||f||||f||||||||||2017-02-18 14:39:59.123454|2017-02-18 14:39:59.123454
NCT00628472|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-04|||January 2007||2007-01-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort|Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort|Completed||N/A|21|Actual|Henry Ford Health System||1|||f||||f||||||||||2017-02-18 14:39:59.228427|2017-02-18 14:39:59.228427
NCT00628459|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-04|||August 2006||2006-08-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Effect of Iron Versus Multiple Micronutrient Supplementation on Anemia in Preschool Children of Malaria-Endemic Area||Completed||N/A|297|Actual|Centre National de la Recherche Scientifique et Technologique||3|||f||||f||||||||||2017-02-18 14:39:59.328076|2017-02-18 14:39:59.328076
NCT00628446|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2015-07-27|2012-02-27||September 2007||2007-09-01|July 2015|2015-07-01|December 2009|Actual|2009-12-01|November 2008|Actual|2008-11-01||Observational|||Coronary Heart Disease as Measured by Coronary Calcium Score Among Individuals With Chronic Traumatic Spinal Cord Injury|Prevalence and Risk of Coronary Heart Disease as Measured by Coronary Calcium Score Among Individuals With Chronic Traumatic Spinal Cord Injury(SCI): A Pilot Study|Completed||N/A|45|Actual|Carolinas Healthcare System|||1||f||||t||||||||||2017-02-18 14:39:59.441632|2017-02-18 14:39:59.441632
NCT00628433|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2011-06-11|||February 2008||2008-02-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis|A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis|Completed||Phase 1/Phase 2|27|Actual|Harbor Therapeutics||5|||f||||f||||||||||2017-02-18 14:39:59.666629|2017-02-18 14:39:59.666629
NCT00628420|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2011-06-27|||January 2005||2005-01-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|November 2006|Actual|2006-11-01||Interventional|ACP-104||Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics|A Randomized, Double Blind, Placebo Controlled, Single Oral Dose Study to Demonstrate the Safety, Tolerability, and Pharmacokinetics of ACP-104 (N-desmethylclozapine) in Schizophrenia, or Other Psychotic Disorders.|Completed||Phase 1|45|Actual|University of Texas Southwestern Medical Center||3|||f||||t||||||||||2017-02-18 14:39:59.786669|2017-02-18 14:39:59.786669
NCT00628407|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2011-03-09|2010-11-18||January 2007||2007-01-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Observational|SWP||Effects of Sternal Wall Pressure in Children|Effect of Gentle Sternal Chest Wall Pressure on Intrathoracic Pressure During Mechanical Ventilation in Children.|Completed||N/A|13|Actual|Children's Hospital of Philadelphia|||1||f||||f||||||||||2017-02-18 14:39:59.887212|2017-02-18 14:39:59.887212
NCT00628394|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2012-06-21|||September 2003||2003-09-01|June 2012|2012-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation|Cognitive Treatments in Schizophrenia|Completed||Phase 4|119|Actual|University of Texas Southwestern Medical Center||4|||f||||f||||||||||2017-02-18 14:40:00.088329|2017-02-18 14:40:00.088329
NCT00628381|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2010-09-02|||January 2011||2011-01-01|September 2010|2010-09-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||L-citrulline Supplementation During Sepsis|Arginine and Nitric Oxide (NO) Metabolism in Sepsis; L-citrulline Enteral Supplementation for the Normalisation of the Arginine-NO Metabolism|Unknown status|Not yet recruiting|Phase 3|48|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 14:40:00.203758|2017-02-18 14:40:00.203758
NCT00628368|ClinicalTrials.gov processed this data on February 17, 2017|2008-03-01|2009-12-13|||November 2005||2005-11-01|July 2009|2009-07-01||||September 2009|Anticipated|2009-09-01||Interventional|||Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer|Study to Analyze the Predictive Role of Factors Implicated in the Signaling Pathway of the EGFR in Response to Treatment With Neoadjuvant Chemoradiotherapy in Patients With Cancer of the Esophagus or Rectum|Unknown status|Recruiting|N/A|160|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:40:00.540225|2017-02-18 14:40:00.540225
NCT00628355|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2014-05-23|2010-09-15||February 2008||2008-02-01|May 2014|2014-05-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Interventional|||Lidocaine Injection and Ischemic Compression on Chronic Pelvic Pain Treatment|Local Injection of Lidocaine Versus Ischemic Compression in Treatment of Woman With Chronic Pelvic Pain Caused by Abdominal Myofascial Pain Syndrome: Randomized Clinical Trial.|Terminated||Phase 4|30|Actual|University of Sao Paulo|Early termination leading to small numbers of subjects analyzed.|2||Lidocaine injection group showed significant improvement in pain|f||||t||||||||||2017-02-18 14:40:00.641482|2017-02-18 14:40:00.641482
NCT00628342|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-03-11|||April 2003||2003-04-01|March 2009|2009-03-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 4|600|Anticipated|AstraZeneca||3|||f||||||||||||||2017-02-18 14:40:01.04338|2017-02-18 14:40:01.04338
NCT00628329|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2012-05-03|||May 2008||2008-05-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Vitamin A, Its Receptors and Asthma|Vitamin A, Its Receptors and Asthma: Vitamin A Levels in Serum and Expression and Responsiveness of Vitamin A Receptors in Circulating Mononuclear Cells of Asthmatics|Withdrawn||N/A|0|Actual|University of Kansas Medical Center|||2||f||||f||||||Samples With DNA|"~     Serum without DNA, cells with DNA~   "|||2017-02-18 14:40:01.150609|2017-02-18 14:40:01.150609
NCT00628316|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2011-03-21|||January 2008||2008-01-01|February 2008|2008-02-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Caffeine in Tinnitus|Effects of Caffeine Consumption on Tinnitus Perception|Completed||N/A|50|Anticipated|Faculdade de Medicina de Valenca||1|||f||||f||||||||||2017-02-18 14:40:01.255702|2017-02-18 14:40:01.255702
NCT00628303|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2012-07-30|||October 2010||2010-10-01|July 2012|2012-07-01|December 2011|Anticipated|2011-12-01|February 2011|Anticipated|2011-02-01||Interventional|||A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Motavizumab Prophylaxis on Reduction of the Incidence of Serious Early Childhood Wheezing in Preterm Infants|Withdrawn||Phase 3|0|Actual|MedImmune LLC||2||Study never officially opened for enrollment|f||||||||||||||2017-02-18 14:40:01.366951|2017-02-18 14:40:01.366951
NCT00628290|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-03-17|||October 2002||2002-10-01|January 2008|2008-01-01|March 2008|Actual|2008-03-01|November 2004|Actual|2004-11-01||Interventional|CBD-CT1||Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis|Evaluation of the Antipsychotic Efficacy of the Phytocannabinoid Cannabidiol in Treating Acute Schizophrenic Psychosis. A Double-Blind, Controlled Clinical Trial|Completed||Phase 2|42|Anticipated|University of Cologne||2|||f||||f||||||||||2017-02-18 14:40:01.472321|2017-02-18 14:40:01.472321
NCT00628277|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2008-02-26|||October 2002||2002-10-01|February 2008|2008-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Methods of Weight Loss in Overweight Coronary Patients|Methods of Weight Loss in Overweight Coronary Patients|Completed||Phase 3|74|Actual|University of Vermont||2|||f||||t||||||||||2017-02-18 14:40:01.584505|2017-02-18 14:40:01.584505
NCT00628264|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2009-05-29|||March 2008||2008-03-01|May 2009|2009-05-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery|Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery|Terminated||Phase 2|75|Anticipated|Action Pharma A/S||2||The study was terminated due to a considerably lower recruitment rate than anticipated|f||||t||||||||||2017-02-18 14:40:01.701118|2017-02-18 14:40:01.701118
NCT00628251|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2016-12-27|2015-01-14||July 2008||2008-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|September 2009|Actual|2009-09-01||Interventional|ICEBERG 3||Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer|A Phase II, Open-Label, Randomised, Comparative, International Multicentre Study to Assess the Safety and Efficacy of Different Doses of AZD2281 Given Orally Twice Daily Versus Intravenous Liposomal Doxorubicin Given Monthly in Patients With Advanced BRCA1- or BRCA2-Associated Ovarian Cancer Who Have Failed Previous Platinum-based Chemotherapy|Active, not recruiting||Phase 2|125|Actual|AstraZeneca|The AEs reported include all events up to the OS data cut-off. After the PFS data cut-off, AEs were only collected for the olaparib and cross-over groups. The safety profile of these 2 groups at OS was consistent with that at the time of PFS.|3|||f||||t||||||||||2017-02-18 14:40:01.817583|2017-02-18 14:40:01.817583
NCT00628238|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2010-09-08|||February 2008||2008-02-01|September 2010|2010-09-01|July 2011|Anticipated|2011-07-01|February 2011|Anticipated|2011-02-01||Interventional|||Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)|A Two-Arm, Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)|Unknown status|Recruiting|Phase 2|80|Anticipated|Chronic Lymphocytic Leukemia Research Consortium||2|||t||||t||||||||||2017-02-18 14:40:03.011354|2017-02-18 14:40:03.011354
NCT00628225|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-10-16|||March 2000||2000-03-01|February 2008|2008-02-01|December 2003|Actual|2003-12-01|December 2002|Actual|2002-12-01||Interventional|SMOCC||Smoking Cessation in Patients With COPD (SMOCC) in General Practice|Smoking Cessation in Patients With COPD (SMOCC) in General Practice|Completed||Phase 4|667|Actual|Radboud University||3|||f||||t||||||||||2017-02-18 14:40:03.141211|2017-02-18 14:40:03.141211
NCT00628212|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2013-04-12|2013-04-12||January 2008||2008-01-01|April 2013|2013-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes|A Phase II, Double-Blind, Placebo-Controlled, Monotherapy Study of MP-513 in Japanese Patients With Type 2 Diabetes Mellitus -Confirmative Study-|Completed||Phase 2|324|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||f||||||||||2017-02-18 14:40:03.252931|2017-02-18 14:40:03.252931
NCT00628199|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2009-02-20|||September 2007||2007-09-01|February 2009|2009-02-01||||January 2010|Anticipated|2010-01-01||Observational|||Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability|Derivation of Primary Donor Cell Lines for Human Cell Reprogramming|Unknown status|Enrolling by invitation|N/A|60|Anticipated|Stanford University|||||f||||||||||||||2017-02-18 14:40:04.342718|2017-02-18 14:40:04.342718
NCT00628186|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2010-01-15|||April 2005||2005-04-01|January 2010|2010-01-01|February 2008|Actual|2008-02-01|August 2007|Actual|2007-08-01||Interventional|||Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy|Prospective, Randomized, and Controlled Trial That Lost Stent Versus External Stent of Pancreaticojejunostomy After Pancreaticoduodenectomy|Completed||N/A|100|Actual|Wakayama Medical University||1|||f||||t||||||||||2017-02-18 14:40:04.43141|2017-02-18 14:40:04.43141
NCT00628173|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-10-16|||January 2005||2005-01-01|February 2008|2008-02-01|December 2007||2007-12-01|May 2007||2007-05-01||Interventional|||Results of Different Location of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma, Superior Versus Inferior||Completed||N/A|106|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 14:40:04.550698|2017-02-18 14:40:04.550698
NCT00628160|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2016-02-23|||October 2006||2006-10-01|February 2016|2016-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Terlipressin in Septic Shock in Cirrhosis|Effects on Survival of Terlipressin Administration in Cirrhotic Patients With Severe Sepsis or Septic Shock. A Randomized, Open Labelled Controlled Trial|Completed||Phase 2/Phase 3|72|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||Yes|We are currently writing the manuscript|2017-02-18 14:40:04.622228|2017-02-18 14:40:04.622228
NCT00628147|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-03-03|||January 2006||2006-01-01|February 2008|2008-02-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Clinical Evaluation of Narrow Band Imaging Colonoscope|Tandem Colonoscopy Study of Narrow Band Imaging Versus White Light Examination to Compare Neoplasia Miss Rates|Completed||Phase 4|284|Actual|VA Palo Alto Health Care System||1|||f||||t||||||||||2017-02-18 14:40:04.73611|2017-02-18 14:40:04.73611
NCT00628134|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2016-06-08|2013-06-19||March 2008||2008-03-01|June 2016|2016-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Cystic fibrosis subjects|Self-dispersing Liquids as Aerosol Drug Carriers|Self-dispersing Liquids as Aerosol Drug Carriers|Completed||N/A|8|Actual|University of Pittsburgh|Our aerosol delivery method resulted in more peripheral distribution than was anticipated. The more peripheral deposition pattern likely affected the location and quantity of deposited calfactant available to cause transport.|2|||f||||t||||||||Yes||2017-02-18 14:40:04.846592|2017-02-18 14:40:04.846592
NCT00628121|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2008-02-25|||April 2006||2006-04-01|February 2008|2008-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer|Clinical Pharmacological Study of NS75A for Healthy Adult Women|Completed||N/A|31|Actual|Nippon Kayaku Co.,Ltd.||3|||f||||f||||||||||2017-02-18 14:40:05.138386|2017-02-18 14:40:05.138386
NCT00628108|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2015-02-18|2009-09-09||March 2008||2008-03-01|February 2015|2015-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|BALL||Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months With Symptoms of Allergic Rhinitis or Chronic Urticaria.|Completed||Phase 3|69|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 14:40:05.250093|2017-02-18 14:40:05.250093
NCT00628095|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2009-10-07||2009-04-13|March 2008||2008-03-01|October 2009|2009-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of CE-224,535, An Antagonist Of The P2x7 Receptor, In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis In Subjects Who Are Inadequately Controlled On Methotrexate|Completed||Phase 2/Phase 3|100|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:40:05.948339|2017-02-18 14:40:05.948339
NCT00628082|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2008-02-24|||March 2006||2006-03-01|February 2008|2008-02-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Observational|||Energetic Abnormalities in Heart Failure With Preserved Ejection Fraction|Energetic Abnormalities in Heart Failure With Preserved Ejection Fraction|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital Birmingham|||2||f||||f||||||||||2017-02-18 14:40:06.071287|2017-02-18 14:40:06.071287
NCT00628069|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2012-09-04|||March 2009||2009-03-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||The Effect of Bench-model Training in Cognitive Learning in the Operating Room|The Effect of Bench-model Training in Cognitive Learning in the Operating Room|Completed||N/A|30|Actual|The Physicians' Services Incorporated Foundation|||2||f||||||||||||||2017-02-18 14:40:06.165352|2017-02-18 14:40:06.165352
NCT00628056|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2008-02-24|||October 2006||2006-10-01|February 2008|2008-02-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|DDCM||Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes|Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes|Unknown status|Recruiting|Phase 1/Phase 2|75|Anticipated|University Hospital Birmingham||2|||f||||f||||||||||2017-02-18 14:40:06.250008|2017-02-18 14:40:06.250008
NCT00628043|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2009-09-17|||May 2008||2008-05-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients|A Phase Ⅲ Randomized Double-Blind Placebo-Controlled Study of Epoetin Beta for the Treatment of Chemotherapy-Induced Anemia (CIA) in Cancer Patients|Completed||Phase 3|160|Anticipated|Chugai Pharmaceutical||2|||f||||||||||||||2017-02-18 14:40:06.357035|2017-02-18 14:40:06.357035
NCT00628030|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2015-01-09|2014-01-06||April 2008||2008-04-01|January 2015|2015-01-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|NOURISH|Families completed baseline, post, and six-month follow-up assessments. Although baseline and outcome data for parents and children were collected, only parents participated in the intervention: NOURISH (n = 92; 44 parents/caregivers, 48 children). Wellness Group (n = 92; 47 parents/caregivers, 45 children).|NOURISH: Nourishing Our Understanding of Role Modeling to Improve Support and Health|Parent Skills Training to Enhance Weight Loss in Overweight Children|Completed||N/A|184|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 14:40:06.466862|2017-02-18 14:40:06.466862
NCT00619164|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2013-05-09|||November 2007||2007-11-01|February 2010|2010-02-01||||September 2009|Actual|2009-09-01||Interventional|||A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome|A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome|Completed||Phase 2|240|Actual|Eisai Inc.||4|||f||||||||||||||2017-02-18 14:43:25.505657|2017-02-18 14:43:25.505657
NCT00628017|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2008-02-24|||January 2003||2003-01-01|February 2008|2008-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Preliminary Study of Fish Oil and Dementia|The Effects of Omega-3 Fatty Acids Monotherapy in Alzheimer's Disease and Mild Cognitive Impairment: a Preliminary Randomized Double-Blind Placebo-Controlled Study|Completed||N/A|46|Actual|Taipei City Psychiatric Center, Taiwan||2|||f||||f||||||||||2017-02-18 14:40:06.872174|2017-02-18 14:40:06.872174
NCT00628004|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2015-09-03|||May 2008||2008-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:40:06.985147|2017-02-18 14:40:06.985147
NCT00627991|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2016-04-12|||August 2007||2007-08-01|April 2016|2016-04-01||||||||Interventional|||Blood Pressure Lowering in Acute Stroke Trial (BLAST)|The Use of Valsartan for the Management of Blood Pressure in Acute Stroke: Effects on Cerebral Blood Flow.|Withdrawn||N/A|0|Actual|Stanford University|||||f||||||||||||||2017-02-18 14:40:07.028903|2017-02-18 14:40:07.028903
NCT00627978|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2010-10-27|||November 2007||2007-11-01|October 2010|2010-10-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons|Phase II Study of Ixabepilone in Patients With Metastatic Breast Cancer and a Prospective Evaluation of Its Effects on the Ultrastructure of Neurons|Unknown status|Recruiting|Phase 2|20|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 14:40:07.126311|2017-02-18 14:40:07.126311
NCT00627965|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2008-02-24|||March 2003||2003-03-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|||||Interventional|||Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness|Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness|Completed||Phase 4|62|Actual|Altitude Physiology Expeditions||2|||f||||f||||||||||2017-02-18 14:40:07.285577|2017-02-18 14:40:07.285577
NCT00627952|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2013-01-18|||November 2007||2007-11-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients|Double Blind, Randomized, Parallel Group, Multicentre Study to Evaluate the Effects of Manidipine 20 MG Vs. Amlodipine 10 MG and the Combination of Manidipine 10 MG Plus Delapril 30 MG Vs. Amlodipine 5 MG Plus Delapril 30 MG on Intraglomerular Pressure in Hypertensive Patients|Completed||Phase 3|100|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-02-18 14:40:07.546535|2017-02-18 14:40:07.546535
NCT00627926|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2014-07-16|2011-06-22||March 2008||2008-03-01|July 2014|2014-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||The full analysis (FA) set included all randomized subjects who received at least 1 dose of any study drug.|A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)|A Phase 3 Study of 2 Dose Regimens of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Treatment-Naive Subjects With Genotype 1 Chronic Hepatitis C|Completed||Phase 3|1095|Actual|Vertex Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-02-18 14:40:07.671702|2017-02-18 14:40:07.671702
NCT00627913|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2010-04-22|||February 2008||2008-02-01|January 2008|2008-01-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Retrobulbar Injection of Anesthesia Versus Healon 5 in the Management of Intraoperative Floppy Iris Syndrome|Retrobulbar Injection of Anesthesia Versus Injection of Healon 5 Viscoelastic Into the Anterior Chamber in the Management of Intraoperative Floppy Iris Syndrome|Terminated||N/A|6|Actual|Penn State University||2||Study terminated due to insufficient subject participation|f||||t||||||||||2017-02-18 14:40:09.176303|2017-02-18 14:40:09.176303
NCT00627900|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2008-02-24|||April 2003||2003-04-01|February 2008|2008-02-01||||September 2008|Anticipated|2008-09-01||Interventional|GERSHWIN||Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents|Model Project for the Reduction of Coronary Restenosis|Completed||Phase 4|958|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 14:40:09.283957|2017-02-18 14:40:09.283957
NCT00627887|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2012-06-20|||January 2008||2008-01-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression|Randomised Controlled Trial of Electroconvulsive Therapy (ECT) With Pharmacotherapy or Pharmacotherapy Alone in Relapse Prevention of Depression|Completed||Phase 4|56|Actual|Örebro County Council||2|||f||||f||||||||||2017-02-18 14:40:09.391561|2017-02-18 14:40:09.391561
NCT00627874|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2009-02-20|||April 2010||2010-04-01|February 2009|2009-02-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|PLS||Trial of Myopia Prevention Using +3D Lenses|A Randomised, Controlled Trial of Prevention of Juvenile-Onset Myopia in Chinese Children|Unknown status|Not yet recruiting|N/A|1200|Anticipated|Sun Yat-sen University||2|||f||||||||||||||2017-02-18 14:40:09.518606|2017-02-18 14:40:09.518606
NCT00627861|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2015-10-26|2011-08-19||November 2008||2008-11-01|October 2015|2015-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Combined Renin Inhibition/Beta-blockade|Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade|Terminated||N/A|1|Actual|The Rogosin Institute||1||The renin laboratory used in the study is no longer available.|f||||f||||||||||2017-02-18 14:40:09.615106|2017-02-18 14:40:09.615106
NCT00627848|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2011-10-27|||March 2007||2007-03-01|October 2011|2011-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ADFRMI||Rivastigmine in Mild Alzheimer's Disease, FMRI Study|Effect of Rivastigmine on FMRI in Mild Alzheimer's Disease|Completed||N/A|20|Actual|Kuopio University Hospital||1|||f||||f||||||||||2017-02-18 14:40:09.914611|2017-02-18 14:40:09.914611
NCT00627835|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-07-18||||||November 2010|2010-11-01||||||||Interventional|||Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)|A Phase I Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)|Withdrawn||Phase 1|0|Actual|British Columbia Cancer Agency||5||Site decided not to open this study|f||||f||||||||||2017-02-18 14:40:10.000415|2017-02-18 14:40:10.000415
NCT00627822|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-02-22|||March 2005||2005-03-01|February 2008|2008-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Medical Education in a Private Hospital|Patient and Companion Perspectives on Medical Education in a Non-Teaching Private Hospital|Completed||N/A|209|Actual|Instituto do Cerebro de Brasilia|||3||f||||f||||||||||2017-02-18 14:40:10.10904|2017-02-18 14:40:10.10904
NCT00627809|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2009-06-22|||January 2007||2007-01-01|June 2009|2009-06-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction|Phase 4 Study of Application of Intracoronary Low Dose Streptokinase Complementary to Standard Percutaneous Coronary Intervention in Patients With ST Elevation Acute Myocardial Infarction: Effect of Adjunctive Intracoronary Streptokinase on Late Term Left Ventricular Infarct Size and Volumes in Patients With Acute Myocardial Infarction|Completed||Phase 4|53|Actual|Istanbul University||2|||f||||f||||||||||2017-02-18 14:40:10.184126|2017-02-18 14:40:10.184126
NCT00627796|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-02-22|||January 2003||2003-01-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ATG1line||Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly|A Multicenter, Open, Prospective, Observational Study to Investigate the Effect of Lanreotide Autogel 120 mg on Control of GH and IGF-I Excess and Tumor Shrinkage in Newly Diagnosed Patients With Acromegaly|Completed||Phase 4|27|Actual|Federico II University||1|||f||||f||||||||||2017-02-18 14:40:10.293625|2017-02-18 14:40:10.293625
NCT00627783|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-02-29|||December 2000||2000-12-01|February 2008|2008-02-01|July 2005||2005-07-01|July 2005||2005-07-01||Interventional|DYNAMIT||Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes|Randomized Strategy Trial Comparing Detection of Silent Ischemia With no Detection of Silent Ischemia in Asymptomatic Patients With Type 2 Diabetes Mellitus. Effects on Cardiovascular Events.|Terminated||N/A|642|Actual|Hospices Civils de Lyon||2||Poor recruiting status|f||||f||||||||||2017-02-18 14:40:10.403211|2017-02-18 14:40:10.403211
NCT00627770|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-01-28|||January 2008||2008-01-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Lower Leg Edema Evaluation After Total Knee Arthroplasty Using Bioimpedance|Validation of a Procedure Using Bioimpedance to Measure the Edema of Lower Leg of Patients After Total Knee Surgery|Completed||N/A|34|Actual|Haute Ecole Cantonale Vaudoise de Santé||1|||f||||f||||||||||2017-02-18 14:40:10.485678|2017-02-18 14:40:10.485678
NCT00627757|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2010-07-29|||February 2008||2008-02-01|July 2010|2010-07-01|December 2010|Anticipated|2010-12-01|February 2010|Anticipated|2010-02-01||Observational|AMMS1||Antipsychotic Medicine and Metabolic Syndrome|Changes in Enteroendocrine and Neuroendocrine Axes in Patients With Weight Gain After Treatment With Antipsychotics|Unknown status|Recruiting|N/A|100|Anticipated|Glostrup University Hospital, Copenhagen|||2||f||||t||||||Samples Without DNA|"~     whole blood, serum, plasma~   "|||2017-02-18 14:40:10.584062|2017-02-18 14:40:10.584062
NCT00627744|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2015-12-10|||May 2008||2008-05-01|December 2015|2015-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|BEGAMI||Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction|Phase IV Study Evaluating the Effect of Sitagliptin (Januvia™) on Beta-cell Function in Patients With Acute Myocardial Infarction or Unstable Angina Pectoris and Newly Detected Impaired Glucose Tolerance or Type 2 Diabetes.|Completed||Phase 4|85|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 14:40:10.883409|2017-02-18 14:40:10.883409
NCT00627731|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2011-09-05|||June 2007||2007-06-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients|Phase 4, Randomized Study of Oral Glucocorticosteroid Administration in the Treatment of Acute Severe Asthma Exacerbation in Hospitalized Patients|Completed||Phase 4|50|Actual|Hamamatsu University||2|||f||||f||||||||||2017-02-18 14:40:10.99212|2017-02-18 14:40:10.99212
NCT00627718|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-02-29|||April 2008||2008-04-01|February 2008|2008-02-01|July 2009|Anticipated|2009-07-01|April 2009|Anticipated|2009-04-01||Interventional|||Assessment of Macular Edema Using HRT Technique|Assessment of Macular Edema Using HRT Technique|Unknown status|Not yet recruiting|N/A|50|Anticipated|McGill University Health Center||1|||f||||f||||||||||2017-02-18 14:40:11.095183|2017-02-18 14:40:11.095183
NCT00627705|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2011-07-20|||February 2008||2008-02-01|July 2011|2011-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Study of N-Acetyl Cysteine in Children With Autism|Double-blind , Randomized, Placebo Controlled Study of N-Acetyl Cysteine in Autism.|Completed||Phase 2|40|Anticipated|Stanford University||2|||f||||||||||||||2017-02-18 14:40:11.206047|2017-02-18 14:40:11.206047
NCT00627692|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2008-05-28|||February 1999||1999-02-01|January 2008|2008-01-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility|A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Tolerability of Oral Once-Daily Prucalopride (R108512) Solution in Constipated Elderly Subjects Living in a Nursing Facility|Completed||Phase 2|100|Actual|Movetis||5|||f||||f||||||||||2017-02-18 14:40:11.505455|2017-02-18 14:40:11.505455
NCT00627679|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2013-12-09|2013-08-19||December 2005||2005-12-01|December 2013|2013-12-01|May 2006|Actual|2006-05-01|December 2005|Actual|2005-12-01||Interventional|UDB P101||Safety and Blood Level Study of Unit Dose Budesonide|A Randomized, Double Blind, Active Controlled, Single Dose, 4 Arm, 4 Period Crossover, Phase 1 Study Investigating the Tolerability and Pharmacokinetics of MAP0010|Completed||Phase 1|16|Actual|Allergan||4|||f||||f||||||||||2017-02-18 14:40:11.629153|2017-02-18 14:40:11.629153
NCT00627666|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2013-03-25|||January 2003||2003-01-01|July 2009|2009-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer|Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning For Patients With Hematological Malignancies|Completed||Phase 2|52|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:40:12.086525|2017-02-18 14:40:12.086525
NCT00627653|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-02-18|||October 2005||2005-10-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|PPAR||Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function|PET (Positron Emission Tomography) Detection of the Effects of Aging on the Human Heart (Aim #2 Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function)|Unknown status|Active, not recruiting|N/A|60|Anticipated|National Institute on Aging (NIA)||1|||f||||f||||||||||2017-02-18 14:40:12.198631|2017-02-18 14:40:12.198631
NCT00627458|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-10-26||2009-05-20|February 2008||2008-02-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine|Immunogenicity and Reactogenicity of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine When Given as a Booster Dose|Completed||Phase 2|403|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:40:15.730078|2017-02-18 14:40:15.730078
NCT00627640|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2013-03-27|||February 2009||2009-02-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|SETTLE||Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa|A Phase III, Double-blind, Placebo-controlled, Randomised Trial to Determine the Efficacy and Safety of a Dose Range of 50 to 100 mg/Day of Safinamide, as add-on Therapy, in Subjects With Idiopathic Parkinson's Disease With Motor Fluctuations, Treated With a Stable Dose of Levodopa and Who May be Receiving Concomitant Treatment With Stable Doses of a Dopamine Agonist, an Anticholinergic and/or Amantadine|Completed||Phase 3|549|Actual|Newron||2|||f||||||||||||||2017-02-18 14:40:12.321658|2017-02-18 14:40:12.321658
NCT00627627|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2010-02-01|||April 2008||2008-04-01|February 2010|2010-02-01||||February 2010|Anticipated|2010-02-01||Interventional|||A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer|A Phase 2, Open-Label, Single-Arm, Multicenter, Multinational Study to Evaluate the Antitumor Activity and Safety of IPI-504, A Novel Small Molecule Inhibitor of Heat Shock Protein 90(HSP90), in Patients With Locally Advanced or Metastatic Human Epidermal Growth Factor Receptor 2-Positive(HER2+) Breast Cancer That Has Progressed Despite Prior Her2=Targeted Therapy|Withdrawn||Phase 1/Phase 2|56|Anticipated|MedImmune LLC||1||Redirect focus of the indication|f||||t||||||||||2017-02-18 14:40:12.567894|2017-02-18 14:40:12.567894
NCT00627614|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-06-01|||March 2006||2006-03-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Vibro-Acoustography Imaging in Diagnosing Breast Masses in Women With a Breast Mass or Breast Cancer|Identification and Differentiation of Breast Masses by Vibro-Acoustography|Completed||N/A|147|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:40:12.678873|2017-02-18 14:40:12.678873
NCT00627588|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-05-09|||January 2008||2008-01-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease|A Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin®, Administered Using Stereotactic Injection to the Striatum of Patients With Bilateral, Idiopathic Parkinson's Disease.|Completed||Phase 1/Phase 2|15|Actual|Oxford BioMedica||2|||f||||t||||||||||2017-02-18 14:40:12.794552|2017-02-18 14:40:12.794552
NCT00627575|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-11-15|||February 2008||2008-02-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||AED/Statin Interaction Study|An Open-label, Two-cohort Study to Assess the Effect of Lamotrigine and Phenytoin on the Pharmacokinetics of Atorvastatin in Healthy Subjects|Completed||Phase 1|119|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:40:12.899947|2017-02-18 14:40:12.899947
NCT00627562|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2016-03-15|||July 2007||2007-07-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|June 2014|Actual|2014-06-01||Interventional|||A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery|A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery|Active, not recruiting||N/A|71|Actual|Montefiore Medical Center||1|||f||||t||||||||||2017-02-18 14:40:13.012271|2017-02-18 14:40:13.012271
NCT00627549|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-02-29||||||February 2008|2008-02-01||||||||Interventional|||Avaulta Versus Anterior Repair|The Use of Avaulta Plus for Anterior Repair. A Multicenter Randomised Prospective Controlled Study|Unknown status|Not yet recruiting|N/A|||Zealand University Hospital||2|||f||||||||||||||2017-02-18 14:40:13.128459|2017-02-18 14:40:13.128459
NCT00627536|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-03-03|||July 2006||2006-07-01|March 2008|2008-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions|A Double-Blind, Placebo-Controlled, Randomised Dose-Ranging Trial to Investigate the Efficacy of Avotermin (Juvista) in the Improvement of Scar Appearance When Applied to Approximated Wound Margins in Healthy Volunteers|Completed||Phase 2|39|Actual|Renovo||8|||f||||f||||||||||2017-02-18 14:40:13.234248|2017-02-18 14:40:13.234248
NCT00627523|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2014-10-27|2014-09-10||February 2008||2008-02-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|EGN||Genotropin Treatment In Very Young Children Born Small For Gestational Age|A Two Year Multicentre, Randomized Two Arm Study Of Genotropin Treatment In Very Young Children Born Small For Gestational Age: Early Growth And Neurodevelopment(Egn)|Completed||Phase 3|43|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:40:13.35824|2017-02-18 14:40:13.35824
NCT00627510|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-02-22|||June 2005||2005-06-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|July 2005|Actual|2005-07-01||Observational|||Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission|Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission for Determination of Compliance and/or Speed of Drug Metabolism|Completed||N/A|161|Actual|Medical University Innsbruck|||1||f||||t||||||||||2017-02-18 14:40:13.981654|2017-02-18 14:40:13.981654
NCT00627497|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2012-04-24|2011-11-29||February 2008||2008-02-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||DIAM™ Spinal Stabilization System vs. Decompression, Formerly vs. Posterolateral Fusion|A Prospective, Randomized, Controlled Pivotal Clinical Investigation of DIAM™ Spinal Stabilization System in Patients With Degenerative Lumbar Spinal Stenosis.|Terminated||Phase 3|32|Actual|Medtronic Spinal and Biologics|Studies terminated before full cohort of participants were enrolled. Data and adverse events presented are through 24 months of follow-up.|4||slow patient recruitment|f||||t||||||||||2017-02-18 14:40:14.092109|2017-02-18 14:40:14.092109
NCT00627484|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-07-28|||March 2005||2005-03-01|July 2016|2016-07-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Changes in Insulin Sensitivity After Weight Loss|Changes in Insulin Sensitivity After Weight Loss Induced by Diet or Bariatric Surgery|Recruiting||N/A|110|Anticipated|Columbia University|||5||f||||t||||||Samples With DNA|"~     The researchers may want to retain your blood and/or tissue sample(s) so that additional~     research studies can be done now or in the future.~   "|Undecided||2017-02-18 14:40:15.502619|2017-02-18 14:40:15.502619
NCT00627471|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2010-06-01|||January 2008||2008-01-01|June 2010|2010-06-01||||March 2009|Actual|2009-03-01||Interventional|Malbec||Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)|A 24 Weeks, Randomized, 2 Arms, Controlled, Multi-centre, National, Open-labeled, Parallel Study in Insulin naïve Patients With Type 2 Diabetes to Compare a Lantus Titration Algorithm vs. Physician's Standard Practice|Terminated||Phase 4|9|Actual|Sanofi||2||Low recruitment in spite of strategies implemented|f||||t||||||||||2017-02-18 14:40:15.633497|2017-02-18 14:40:15.633497
NCT00627445|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2014-10-14|2010-03-11||February 2008||2008-02-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Biphasic Insulin Aspart 50 Compared to Biphasic Insulin Aspart 30 Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes|Completed||Phase 3|441|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 14:40:18.34626|2017-02-18 14:40:18.34626
NCT00627432|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2010-10-06|||July 2004||2004-07-01|July 2009|2009-07-01||||March 2009|Anticipated|2009-03-01||Interventional|||Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer|Phase 2 Randomized Study Evaluating the Efficacy of Gemcitabine With or Without Oxaliplatin in Patients With Advanced Urothelial Cancer That Cannot be Treated With Cisplatin-based Chemotherapy|Suspended||Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:40:18.991587|2017-02-18 14:40:18.991587
NCT00627419|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2012-12-06||2012-12-06|February 2008||2008-02-01|December 2012|2012-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma|A Phase 2, Open-Label, Single-Arm, Multicenter Study Evaluating the Safety and Antitumor Activity of IPI-504, A Novel Small Molecule Inhibitor of Heat Shock Protein 90 (HSP90), in Patients With Metastatic Melanoma|Terminated||Phase 2|1|Actual|Infinity Pharmaceuticals, Inc.||1||Study closed & recruitment will not recommence|f||||f||||||||||2017-02-18 14:40:19.088015|2017-02-18 14:40:19.088015
NCT00627406|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2013-09-25|2013-09-25||January 2009||2009-01-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles|A Prospective Randomised Study to Evaluate the Effect of Triggering Ovulation With GnRHa (Buserelin) and Low Dose hCG (Pregnyl) as Compared to the Use of Conventional Doses of hCG (Pregnyl)|Completed||Phase 4|384|Actual|Regionshospitalet Viborg, Skive||4|||f||||f||||||||||2017-02-18 14:40:19.412898|2017-02-18 14:40:19.412898
NCT00627393|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2015-04-16|2014-12-02||April 2008||2008-04-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|RING|All randomized subjects.|Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)|High Dose Granulocyte Transfusions for the Treatment of Infection in Neutropenia: The RING Study (Resolving Infection in Neutropenia With Granulocytes)|Completed||Phase 3|114|Actual|New England Research Institutes||3|||f||||t||||||||||2017-02-18 14:40:19.976384|2017-02-18 14:40:19.976384
NCT00627380|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2010-07-23|||November 2005||2005-11-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Yoga for the Management of HIV-Metabolic Syndromes|Yoga for the Management of HIV-Metabolic Syndromes|Completed||Phase 4|60|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 14:40:21.061169|2017-02-18 14:40:21.061169
NCT00627367|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2011-07-19|||October 2007||2007-10-01|July 2011|2011-07-01||||October 2008|Actual|2008-10-01||Interventional|||Protocolized vs Nonprotocolized Treatment of Adult ED Patients With Acute Severe Pain|A Randomized Controlled Trial Comparing Protocolized Versus Non-protocolized Treatment of Adult ED Patients With Acute Severe Pain|Completed||Phase 3|224|Anticipated|Montefiore Medical Center||2|||f||||f||||||||||2017-02-18 14:40:21.185266|2017-02-18 14:40:21.185266
NCT00627354|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2011-05-13|||September 2006||2006-09-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|Phase 2 Randomized Study Evaluating 3 Chemotherapy Regimens as Second-line Treatment in Patients With Hormone-refractory Metastatic Prostate Cancer|Completed||Phase 2|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:40:21.297962|2017-02-18 14:40:21.297962
NCT00627341|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-05-10|||December 2007||2007-12-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa|Addressing Fear of Food in Anorexia Nervosa|Completed||Phase 1/Phase 2|34|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 14:40:21.396178|2017-02-18 14:40:21.396178
NCT00627328|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-02-22|||July 2000||2000-07-01|February 2008|2008-02-01|September 2004|Actual|2004-09-01|||||Observational|||The Atrial High Rate Episodes in Pacemaker Patients|The Atrial High Rate Episodes (A-HIRATE) in Pacemaker Patients|Completed||N/A|427|Actual|Medtronic Cardiac Rhythm and Heart Failure|||2||f||||f||||||||||2017-02-18 14:40:21.500075|2017-02-18 14:40:21.500075
NCT00627315|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-07-28|||March 2015||2015-03-01|July 2016|2016-07-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Prospective Study of Hormone Levels After Bariatric Surgery|Prospective Study of Hormone Levels and Appetite After Bariatric Surgery|Recruiting||N/A|240|Anticipated|Columbia University|||1||f||||t||||||Samples With DNA|"~     blood samples~   "|Undecided||2017-02-18 14:40:21.854209|2017-02-18 14:40:21.854209
NCT00627302|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-11-20|||February 2008||2008-02-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision||Completed||Phase 4|40|Actual|Bp Consulting, Inc||2|||f||||||||||||||2017-02-18 14:40:21.980785|2017-02-18 14:40:21.980785
NCT00627289|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2014-04-04|||February 2008||2008-02-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Selective Neurectomy and Mesh Removal for Chronic Postherniotomy Pain|The Effect of Selective Neurectomy and Mesh Removal on Chronic Postherniotomy Pain|Completed||N/A|21|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-02-18 14:40:22.076854|2017-02-18 14:40:22.076854
NCT00627276|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-29|2015-07-17|||December 2007||2007-12-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|December 2012|Actual|2012-12-01||Interventional|||Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia|Omega-3 Fatty Acids and Prevention of DCIS and/or ADH: A Translational Approach|Completed||N/A|16|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-02-18 14:40:22.159693|2017-02-18 14:40:22.159693
NCT00627263|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-03-30|||January 2008||2008-01-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|RISTA||Stress Reduction Program to Reduce Abnormal Heart Rhythms Treated With Implantable Cardioverter Defibrillators (The RISTA Study)|Reducing Vulnerability to ICD Shock Treated Ventricular Arrhythmias|Unknown status|Recruiting|Phase 3|304|Anticipated|Yale University||2|||f||||t||||||||||2017-02-18 14:40:22.261103|2017-02-18 14:40:22.261103
NCT00004838|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||September 1997||1997-09-01|September 1998|1998-09-01|July 1998||1998-07-01|||||Interventional|||Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children||Completed||N/A|175||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:13.278383|2017-02-18 18:16:13.278383
NCT00627250|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2010-03-23|||March 2003||2003-03-01|February 2008|2008-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability|Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability: A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||N/A|76|Actual|Carolinas Healthcare System||2|||f||||t||||||||||2017-02-18 14:40:22.358148|2017-02-18 14:40:22.358148
NCT00627237|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-09-23|||January 2008||2008-01-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|STEP||"Improving Executive Functioning After Traumatic Brain Injury (TBI): A Trial of the Short Term Executive Plus Program"|Short-Term Executive Plus (STEP): A Randomized Controlled Trial of Short Term Intensive Cognitive Rehabilitation.|Completed||N/A|101|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 14:40:22.49269|2017-02-18 14:40:22.49269
NCT00627211|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2008-02-28|||February 2008||2008-02-01|February 2008|2008-02-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Carbon Dioxide Versus Air Insufflation in Oesophago-Gastro-Duodenoscopy (OGD)|A Double-Blinded, Randomized Trial Comparing Carbondioxide(CO2)and Air Insufflation in Oesophago-Gastro-Duodenoscopy (OGD)|Unknown status|Enrolling by invitation|N/A|120|Anticipated|Norwegian Department of Health and Social Affairs||2|||f||||f||||||||||2017-02-18 14:40:22.602942|2017-02-18 14:40:22.602942
NCT00627198|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2010-12-01|||December 2006||2006-12-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|CPTK787||The Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors|An Open Label Phase II Study Evaluating the Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors That Have Evidence of Progressive Disease or an Increase in Disease Related Syndrome Symptoms|Completed||Phase 2|20|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:40:22.683915|2017-02-18 14:40:22.683915
NCT00627185|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-03-05|||September 2003||2003-09-01|August 2010|2010-08-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|DTC||Dental Tobacco Control.Net:Improving Practice|Dental Tobacco Control.Net:Improving Practice|Completed||Early Phase 1|190|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 14:40:22.779046|2017-02-18 14:40:22.779046
NCT00627172|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-08-08|||January 2007||2007-01-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|||||Observational|PECTUS||Combined Use of Coronary MDCTA, Coronary Doppler Ultrasonography and PET Perfusion in Diagnosing Coronary Artery Disease|Combined Use of Coronary MDCTA, Coronary Doppler Ultrasonography and PET Perfusion in Diagnosis of Coronary Artery Disease|Completed||N/A|107|Actual|University of Turku|||1||f||||f||||||Samples With DNA|"~     serum~   "|||2017-02-18 14:40:22.892842|2017-02-18 14:40:22.892842
NCT00627159|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-02-20|||May 2007||2007-05-01|February 2008|2008-02-01|June 2008|Anticipated|2008-06-01|April 2008|Anticipated|2008-04-01||Interventional|ICA-CHAMP||ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program|ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program|Unknown status|Active, not recruiting|N/A|375|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 14:40:22.983746|2017-02-18 14:40:22.983746
NCT00627146|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2008-09-25|||June 2000||2000-06-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients|Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients|Completed||Phase 2|80|Actual|AZ-VUB||2|||f||||f||||||||||2017-02-18 14:40:23.105098|2017-02-18 14:40:23.105098
NCT00627133|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-10-23|||February 2008||2008-02-01|February 2008|2008-02-01||||July 2008|Anticipated|2008-07-01||Interventional|||Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study|A Pilot Study Examining the Efficacy of Keppra in Acute Alcohol Related Seizure Control in the Emergency Department Setting|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Medical University of South Carolina||1|||f||||f||||||||||2017-02-18 14:40:23.212595|2017-02-18 14:40:23.212595
NCT00627120|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2009-01-08|||February 2008||2008-02-01|January 2009|2009-01-01||||September 2008|Actual|2008-09-01||Interventional|||Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects|A Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety and Pharmacokinetics of VGX-1027 in Healthy Subjects|Completed||Phase 1|48|Anticipated|VGX Pharmaceuticals, LLC||6|||f||||f||||||||||2017-02-18 14:40:23.308041|2017-02-18 14:40:23.308041
NCT00627107|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2010-11-27|||February 2008||2008-02-01|November 2010|2010-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|RW||A Study Testing Safety and Tolerance of the ReWalk Exoskeleton Suit|Study of the ReWalk Motorized Exoskeleton Suit That Enables Individuals With Lower Limbs Impairment to Walk and to Perform Other Basic Mobility Functions.|Completed||N/A|6|Anticipated|ReWalk Robotics, Inc.||1|||f||||t||||||||||2017-02-18 14:40:23.419021|2017-02-18 14:40:23.419021
NCT00627094|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-12-14|2015-09-03||March 2008||2008-03-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Biatain Ibu vs. Biatain in Painful Chronic Venous Leg Ulcers|A Randomised, Controlled and Double-blind Clinical Investigation on the Effectiveness and Safety of a Foam Dressing Biatain Ibu Non-adhesive vs. Biatain Non-adhesive, in Painful Chronic Venous Leg Ulcers|Completed||Phase 3|120|Actual|Coloplast A/S||2|||f||||f||||||||No||2017-02-18 14:40:23.536974|2017-02-18 14:40:23.536974
NCT00627081|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-09-22|||February 2008||2008-02-01|September 2016|2016-09-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|Drone-APDT||Effect of Thoracic Epidural Analgesia on Intravenous Closed-Loop Anesthesia|Intravenous Opioid-sparing Effect of Thoracic Epidural Administration of Chirocaine (5 mg/ml) During Thoracotomy|Completed||Phase 4|40|Actual|Hopital Foch||2|||f||||f||||||||||2017-02-18 14:40:23.992335|2017-02-18 14:40:23.992335
NCT00627068|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2011-09-16|||July 2007||2007-07-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||The Role of Nitric Oxide Synthase in Circulating Progenitor Cell Function|The Role of Nitric Oxide Synthase in Circulating Progenitor Cell Function|Completed||N/A|60|Actual|University of California, San Francisco|||4||f||||t||||||Samples Without DNA|"~     whole blood~   "|||2017-02-18 14:40:24.091253|2017-02-18 14:40:24.091253
NCT00627055|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2011-02-03|||May 2008||2008-05-01|February 2011|2011-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens|The HIV Second-line Therapy AntiRetroviral Study in Patients Who Failed NNRTI-based Regimens|Completed||Phase 4|200|Anticipated|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||t||||||||||2017-02-18 14:40:24.193149|2017-02-18 14:40:24.193149
NCT00627042|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2014-09-29|2014-05-16||February 2008||2008-02-01|September 2014|2014-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||Participants who received at least 1 dose of ramucirumab.|Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy|An Open Label, Multicenter, Phase 2 Study Evaluating the Safety and Efficacy of IMC-1121B as First Line Monotherapy in Patients With Unresectable Hepatocellular Cancer|Completed||Phase 2|42|Actual|Eli Lilly and Company|The duration of response results should be interpreted with caution since the sample size for this analysis was very small (2 participants).|1|||f||||f||||||||||2017-02-18 14:40:24.318068|2017-02-18 14:40:24.318068
NCT00627029|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2015-09-29|||September 2000||2000-09-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|August 2015|Actual|2015-08-01||Interventional|Coca||Evaluation of Programs of Coordinated Care and Disease Management|Evaluation of Programs of Coordinated Care and Disease Management|Active, not recruiting||N/A|18277|Actual|Mathematica Policy Research, Inc.||2|||f||||f||||||||||2017-02-18 14:40:25.100422|2017-02-18 14:40:25.100422
NCT00627016|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2011-04-25|2010-03-18||March 2008||2008-03-01|April 2011|2011-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn|A Phase 3 Multicenter, Randomized, Double-Blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy of TAK-390MR (30 mg QD) Compared to Placebo on Relief of Nocturnal Heartburn in Subjects With Symptomatic Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|305|Actual|Takeda||2|||f||||f||||||||||2017-02-18 14:40:25.238204|2017-02-18 14:40:25.238204
NCT00627003|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2011-04-22|||November 2002||2002-11-01|April 2011|2011-04-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS|A Double-blind, Randomized, Placebo-controlled Multicenter Efficacy Study for the Treatment of Patients With Restless Legs Syndrome (RLS)|Completed||Phase 3|43|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:40:25.851679|2017-02-18 14:40:25.851679
NCT00626990|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-02-09|||December 2007||2007-12-01|February 2016|2016-02-01||||January 2020|Anticipated|2020-01-01||Interventional|CATNON||Phase III Trial of Anaplastic Glioma Without 1p/19q LOH|Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.|Active, not recruiting||Phase 3|751|Actual|European Organisation for Research and Treatment of Cancer - EORTC||4|||f||||t||||||||||2017-02-18 14:40:25.949849|2017-02-18 14:40:25.949849
NCT00626977|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2015-07-07|||May 2000||2000-05-01|February 2008|2008-02-01|December 2001|Actual|2001-12-01|May 2000|Actual|2000-05-01||Observational|LA||Labor Analgesia With Ropivacaine and Clonidine|Labor Analgesia With Ropivacaine Added to Clonidine. A Randomized Clinical Trial|Completed||N/A|32|Actual|UPECLIN HC FM Botucatu Unesp|||2||f||||t||||||||||2017-02-18 14:40:26.206897|2017-02-18 14:40:26.206897
NCT00626964|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-02-28|||February 2008||2008-02-01|February 2008|2008-02-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Observational|SphCor||Prevention of Coronary Heart Disease in Morbidly Obese Patients|Prevention of Coronary Heart Disease in Morbidly Obese Patients. Lifestyle Intervention, Low Energy Diet or Bariatric Surgery.|Unknown status|Recruiting|N/A|200|Anticipated|The Hospital of Vestfold|||1||f||||f||||||Samples With DNA|"~     Blood samples to biobank.~   "|||2017-02-18 14:40:26.309556|2017-02-18 14:40:26.309556
NCT00626951|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2008-06-25|||December 2007||2007-12-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Supreme||Crossover Study With the ProSeal and Supreme Laryngeal Mask Airway|The Supreme Laryngeal Mask Airway. A Randomized, Crossover Study With the ProSeal Laryngeal Mask Airway in Paralyzed, Anesthetized Patients|Completed||N/A|94|Actual|Medical University Innsbruck||2|||f||||f||||||||||2017-02-18 14:40:26.417501|2017-02-18 14:40:26.417501
NCT00626938|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2012-11-05|||March 2005||2005-03-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Role of Proteomics in Diagnosing Sarcoidosis|Proteomics as a Tool for Biomarker Detection in Sarcoidosis|Completed||N/A|1000|Actual|Maastricht University Medical Center|||2||f||||f||||||Samples With DNA|"~     Blood will be collected from all participants, but all samples will be stored anonymously.~   "|||2017-02-18 14:40:26.523438|2017-02-18 14:40:26.523438
NCT00626925|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-08-02|2016-04-08||February 2008||2008-02-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||In the Total topiramate and Placebo group e included all subjects enrolled who were randomized into the study based.|Topiramate Treatment of Problem Drinkers|Topiramate Treatment of Problem Drinkers|Completed||Phase 4|200|Actual|UConn Health||2|||f||||f||||||||||2017-02-18 14:40:26.631501|2017-02-18 14:40:26.631501
NCT00626912|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-08-03|||June 2007||2007-06-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|PRET||PRET: Patients Prone to Recurrence After Endovascular Treatment|PRET: Patients Prone to Recurrence After Endovascular Treatment. A Randomized Trial Comparing Platinum and Hydrogel-coated Coils|Completed||Phase 4|447|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||2|||f||||t||||||||||2017-02-18 14:40:27.624136|2017-02-18 14:40:27.624136
NCT00626899|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2010-01-13|||March 2007||2007-03-01|January 2010|2010-01-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Observational|||Comparison Performance Vigileo vs. Continuous CCO (Vigilance) in Patients With Induced Therapeutic Hypothermia|Comparison of the Performance of a New Pulse-contour Analysis Cardiac Output Measurement (Vigileo) With the Traditional Method in Patients With Induced Therapeutic Hypothermia After Cardiac Arrest|Completed||N/A|8|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-02-18 14:40:27.961194|2017-02-18 14:40:27.961194
NCT00626886|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-04-29|||January 2008||2008-01-01|April 2013|2013-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy|A Phase II, Randomized, Single Dose, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Pharmacokinetic Profile of the CollaRx® Bupivacaine Implant in Men After Open Mesh Herniorrhaphy|Completed||Phase 2|53|Actual|Innocoll||2|||f||||f||||||||||2017-02-18 14:40:28.039253|2017-02-18 14:40:28.039253
NCT00626873|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2009-08-11|||January 2007||2007-01-01|October 2008|2008-10-01||||January 2013|Anticipated|2013-01-01||Interventional|||Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary|Microvascular Perfusion Sonographic Imaging to Detect Early Stage Ovarian Cancer|Unknown status|Recruiting|N/A|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:40:28.178978|2017-02-18 14:40:28.178978
NCT00626860|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2008-02-21|||July 2000||2000-07-01|February 2008|2008-02-01|November 2008|Anticipated|2008-11-01|January 2002|Actual|2002-01-01||Interventional|||The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma|The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||t||||||||||2017-02-18 14:40:28.269918|2017-02-18 14:40:28.269918
NCT00626847|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-11-17|||March 2008||2008-03-01|November 2016|2016-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||How Does Your Genetic Make-up (Profile) Influence Your Glaucoma?|Nuclear Genetic and Mitochondrial Influences in Glaucoma|Completed||N/A|97|Actual|Wills Eye|||2||f||||f||||||Samples With DNA|"~     whole blood~   "|Yes|Two manuscripts have been written and published.|2017-02-18 14:40:28.365637|2017-02-18 14:40:28.365637
NCT00626834|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2017-01-11|||February 2008||2008-02-01|August 2016|2016-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Vigabatrin Ph 1 Cocaine Interaction Study|A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Intravenous Cocaine and Oral Gamma Vinyl-Gamma-Amino Butyric Acid (VIGABATRIN) Interaction Study|Completed||Phase 1|24|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||t||||||||No||2017-02-18 14:40:28.469236|2017-02-18 14:40:28.469236
NCT00626821|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2012-02-09|2011-10-06||February 2008||2008-02-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Coloplast DialogueStudy|An Open Label, Non-comparative, Multi-national Post-Market Study to Document Real Life Experience on SenSura With Focus on Skin Condition and Quality of Life|Completed||Phase 4|3017|Actual|Coloplast A/S||1|||f||||f||||||||||2017-02-18 14:40:28.583251|2017-02-18 14:40:28.583251
NCT00626808|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2014-07-21|2014-07-21||October 2007||2007-10-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children|A Post Marketing Evaluation of the Effectiveness of the Risk Minimization Plan For Use of FluMist Among Children Less Than 5 Years of Age|Completed||Phase 4|321697|Actual|MedImmune LLC|||4||f||||f||||||||||2017-02-18 14:40:28.824215|2017-02-18 14:40:28.824215
NCT00626795|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2013-11-22|||February 2008||2008-02-01|November 2013|2013-11-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)|Efficacy, Safety and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)|Completed||Phase 2|682|Actual|LEO Pharma||3|||f||||t||||||||||2017-02-18 14:40:29.731562|2017-02-18 14:40:29.731562
NCT00626782|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-11-08|2015-02-11||January 2008||2008-01-01|November 2016|2016-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Lucentis Versus Mitomycin C During Glaucoma Surgery|Lucentis Versus Mitomycin C as Adjunctive Agent During Trabeculectomy Surgery|Completed||Phase 2/Phase 3|24|Actual|Wills Eye||2|||f||||f||||||||Yes|We plan to submit a manuscript.|2017-02-18 14:40:29.846651|2017-02-18 14:40:29.846651
NCT00626769|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2009-05-18|||July 2005||2005-07-01|May 2009|2009-05-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Observational|||Third Year Evaluation on Genistein Efficacy and Safety|Safety Profile and Bone Efficacy of the Phytoestrogen Genistein in a Cohort of Osteopenic, Postmenopausal Women After Three Years of Treatment: a Follow-up Study|Completed||Phase 2/Phase 3|138|Actual|University of Messina|||2||f||||f||||||Samples With DNA|"~     whole blood, serum, plasma, urine.~   "|||2017-02-18 14:40:30.25891|2017-02-18 14:40:30.25891
NCT00626756|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2008-02-28|||January 2008||2008-01-01|February 2008|2008-02-01||||December 2008|Anticipated|2008-12-01||Interventional|LIGA||Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients|LIGA Trial-Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients|Unknown status|Recruiting|N/A|15|Anticipated|ASQA a.s.||2|||f||||f||||||||||2017-02-18 14:40:30.369398|2017-02-18 14:40:30.369398
NCT00626743|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2014-03-13|2014-03-13||May 2008||2008-05-01|March 2014|2014-03-01|July 2011|Actual|2011-07-01|May 2009|Actual|2009-05-01||Interventional|||Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine|Clinical Trial to Investigate the Influence of SK3530 on the Blood Pressure of Patients With Hypertension Taking Amlodipine|Completed||Phase 1|13|Actual|SK Chemicals Co.,Ltd.||2|||f||||||||||||||2017-02-18 14:40:30.471571|2017-02-18 14:40:30.471571
NCT00626730|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2014-07-16|||December 2007||2007-12-01|July 2014|2014-07-01||||February 2013|Actual|2013-02-01||Interventional|||Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma|Adjuvant Postoperative High-Dose Radiotherapy for Atypical and Malignant Meningioma: a Phase-II and Observation Study|Completed||Phase 2|78|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 14:40:30.786373|2017-02-18 14:40:30.786373
NCT00626717|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-01-16|||August 2007||2007-08-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CCL||Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus|Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus|Completed||Phase 2/Phase 3|30|Actual|University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 14:40:30.876868|2017-02-18 14:40:30.876868
NCT00626704|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-05-07||2015-03-24|November 2007||2007-11-01|April 2015|2015-04-01|March 2011|Actual|2011-03-01|August 2009|Actual|2009-08-01||Interventional|||Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma|A Phase 1b/2 Study of AMG 655 in Combination With Doxorubicin for the First-Line Treatment of Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma|Completed||Phase 1/Phase 2|134|Actual|Amgen||2|||f||||f||||||||||2017-02-18 14:40:30.972179|2017-02-18 14:40:30.972179
NCT00626691|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2009-02-18|||February 2007||2007-02-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effects of Walnuts on Antioxidant Capacity and Nutritional Status in Humans|The Effects of Walnuts on Antioxidant Capacity and Nutritional Status in Humans|Completed||N/A|24|Actual|Tufts University||1|||f||||t||||||||||2017-02-18 14:40:31.079956|2017-02-18 14:40:31.079956
NCT00626678|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2010-11-26|||January 2008||2008-01-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|September 2008|Actual|2008-09-01||Interventional|||Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone|A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Adjuvant Azathioprine Therapy in New Cases of Pemphigus Vulgaris Receiving Prednisone|Completed||Phase 2|48|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:40:31.173974|2017-02-18 14:40:31.173974
NCT00004771|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||October 1992||1992-10-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease||Completed||Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.250693|2017-02-18 18:16:17.250693
NCT00626665|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2013-03-21|||December 2007||2007-12-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma|Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma|Completed||Phase 3|25|Actual|Sanjay Gandhi Postgraduate Institute of Medical Sciences||1|||f||||f||||||||||2017-02-18 14:40:31.302393|2017-02-18 14:40:31.302393
NCT00626652|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2010-01-07|||March 2008||2008-03-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|RESTORATION||Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation|A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study of the Effects of K201 Injection, 2 mg/mL on the Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation|Completed||Phase 2|153|Actual|Sequel Pharmaceuticals, Inc||1|||f||||f||||||||||2017-02-18 14:40:31.403801|2017-02-18 14:40:31.403801
NCT00626639|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-04-12|2014-01-24||July 2005||2005-07-01|April 2016|2016-04-01|July 2015|Actual|2015-07-01|May 2007|Actual|2007-05-01||Interventional|||A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy|A Phase 1/2 Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Weekly Doses of Palifermin (rHuKGF) for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer (HNC) Receiving Postoperative Radiotherapy With Concurrent Chemotherapy|Completed||Phase 1/Phase 2|5|Actual|Swedish Orphan Biovitrum||2|||f||||t||||||||||2017-02-18 14:40:31.508986|2017-02-18 14:40:31.508986
NCT00626626|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-01-08|||May 2007||2007-05-01|January 2013|2013-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation|Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation|Terminated||Phase 1/Phase 2|10|Actual|Milton S. Hershey Medical Center||2||Investigator decision|f||||t||||||||||2017-02-18 14:40:31.964965|2017-02-18 14:40:31.964965
NCT00626613|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-29||||||February 2008|2008-02-01||||||||Interventional|||The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)|Phase IV Study of General Clinical Research Center Of the Jinan Mental Hospital(TAIWAN)|Unknown status|Active, not recruiting|Phase 4|||Jinan Mental Hospital|||||f||||||||||||||2017-02-18 14:40:32.077955|2017-02-18 14:40:32.077955
NCT00626600|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2012-10-25|||May 2008||2008-05-01|October 2012|2012-10-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion|An Open, Multi-centre, Non-comparative Observational Study to Assess the Safety and Tolerability of Oxycodone Injection 50 mg/mL as a Subcutaneous Infusion in Patients With Severe Cancer Pain.|Terminated||Phase 3|33|Actual|Mundipharma Research Limited||1||Lack of recruitment|f||||||||||||||2017-02-18 14:40:32.177505|2017-02-18 14:40:32.177505
NCT00626587|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2008-02-28|||January 2005||2005-01-01|January 2005|2005-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||EBUS-Guided TBNA Increases the Diagnostic Yield of Peripheral Pulmonary Lesions|Endobronchial Ultrasonography-Guided Transbronchial Needle Aspiration Increases the Diagnostic Yield of Peripheral Pulmonary Lesions : A Randomized Trial|Completed||N/A|182|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-02-18 14:40:32.260802|2017-02-18 14:40:32.260802
NCT00626574|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2012-09-25|2011-09-08||July 2007||2007-07-01|September 2012|2012-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|EPO||Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa|A Double Blinded, Placebo Controlled, Pilot Study to Evaluate the Safety of Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa|Terminated||Phase 4|3|Actual|University of South Florida|In late October 2008, we received a letter from the sponsor requesting that we terminate any further work on this study.|2||"This study is terminated as a result of data from a study that showed increased mortality in~   stroke patients."|f||||t||||||||||2017-02-18 14:40:32.359458|2017-02-18 14:40:32.359458
NCT00626561|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2014-06-05|2014-06-05||February 2008||2008-02-01|June 2014|2014-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||One participant not treated.|Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix|A Phase II Evaluation of Bevacizumab and Paclitaxel in Patients With Recurrent Small Cell, Large Cell, and Neuroendocrine Tumors of the Cervix and Uterus|Terminated||Phase 2|4|Actual|M.D. Anderson Cancer Center||1||Due to slow accrual.|f||||f||||||||||2017-02-18 14:40:32.910435|2017-02-18 14:40:32.910435
NCT00626548|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-08-29|2012-04-26||January 2008||2008-01-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|ENTHUSE M0||A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer|A Phase III, Randomised, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 (Zibotentan) 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Patients|Terminated||Phase 3|2577|Actual|AstraZeneca||2||"early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely~   to meet its primary efficacy endpoints"|f||||t||||||||||2017-02-18 14:40:33.145367|2017-02-18 14:40:33.145367
NCT00626535|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2009-03-11|||March 2003||2003-03-01|March 2009|2009-03-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)|A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)|Completed||Phase 3|500|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:40:34.652217|2017-02-18 14:40:34.652217
NCT00626522|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-09-27|2016-06-28||February 2008||2008-02-01|September 2016|2016-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Aclidinium/Formoterol Fixed Combination Dose Finding Study|A Randomised, 4-week, Placebo-controlled, Double-blind, 6 Arm Parallel Group, Dose-finding Clinical Trial, to Assess the Efficacy, Safety and Pharmacokinetics of Three Different Doses of Formoterol Combined With the Inhaled Anticholinergic Aclidinium Bromide, Aclidinium Bromide Monotherapy and Formoterol Monotherapy All Administrated Once Daily by Inhalation Via Almirall Inhaler in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease.|Completed||Phase 2|808|Actual|AstraZeneca||6|||f||||f||||||||||2017-02-18 14:40:34.75402|2017-02-18 14:40:34.75402
NCT00626509|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2013-08-09|||February 2008||2008-02-01|June 2009|2009-06-01||||January 2011|Anticipated|2011-01-01||Interventional|||Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer|Sunitinib Either Before or After Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma|Unknown status|Recruiting|Phase 2|110|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:40:35.551937|2017-02-18 14:40:35.551937
NCT00626496|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-09-12|||April 2004||2004-04-01|September 2016|2016-09-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Family Study of Lymphoproliferative Disorders|Genetic Epidemiology of Lymphoproliferative Disorders|Recruiting||N/A|2000|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"~     We will collect blood samples from patients and their relatives for DNA and cytogenetic~     studies. A one time blood draw of 50 cc will be done.~   "|||2017-02-18 14:40:35.63894|2017-02-18 14:40:35.63894
NCT00626483|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-07-26|||March 2007||2007-03-01|July 2016|2016-07-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|REGULATe||Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia|REGULATory T-Cell Inhibition With Basiliximab (Simulect®) During Recovery From Therapeutic Temozolomide-induced Lymphopenia During Antitumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme|Active, not recruiting||Phase 1|18|Anticipated|Duke University||1|||f||||t||||||||||2017-02-18 14:40:35.737927|2017-02-18 14:40:35.737927
NCT00626470|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2015-03-17|||December 2008||2008-12-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|TSP||Prospective Trial on Trochanteric Femur Fractures Treated With or Without a Trochanter Support Plate|A Prospective Randomised Study of Unstable Trochanteric Femur Fractures Treated With Dynamic Hip Screw With and Without a Trochanter Support Plate|Completed||N/A|100|Actual|St. Olavs Hospital||2|||f||||f||||||||||2017-02-18 14:40:35.845797|2017-02-18 14:40:35.845797
NCT00626457|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2015-06-30|||February 2008||2008-02-01|June 2015|2015-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Promoting Healthy Weight With 'Stability Skills First'|Promoting Healthy Weight With 'Stability Skills First' (Fresh Start Weight Loss Study)|Completed||N/A|267|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 14:40:35.949315|2017-02-18 14:40:35.949315
NCT00626444|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-10-19|2014-11-24||February 2008||2008-02-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)|Phase II Trial of High Dose Intravenous Vitamin C in Patients With Refractory Non-Hodgkin Lymphoma|Terminated||Phase 2|2|Actual|Thomas Jefferson University|Study was terminated due to poor accrual. No reportable data has been collected for any of the specified outcome measures.|1||Slow accrual|f||||t||||||||||2017-02-18 14:40:36.048014|2017-02-18 14:40:36.048014
NCT00626431|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-07-15|2010-08-20||February 2008||2008-02-01|July 2011|2011-07-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||A Study of Leuprolide to Treat Prostate Cancer|A Phase 3, Multi-Center, Open-Label, Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of Two 6-Month Leuprolide Formulations, in Subjects With Prostatic Adenocarcinoma|Completed||Phase 3|310|Actual|Abbott|Treatment with Formulation B was prematurely discontinued as testosterone was not adequately suppressed to <= 50 ng/dL or escapes from suppression occurred. Subjects who had not received dose 2 of Formulation B were discontinued after Week 24.|2|||f||||f||||||||||2017-02-18 14:40:36.467757|2017-02-18 14:40:36.467757
NCT00626418|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2011-09-29|||February 2008||2008-02-01|September 2011|2011-09-01||||October 2008|Actual|2008-10-01||Interventional|||The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome|A Single-blind, Placebo Controlled Sleep Laboratory Study of the Acute Effects of Aplindore in Restless Legs Syndrome|Completed||Phase 2|24|Anticipated|Ligand Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:40:37.432016|2017-02-18 14:40:37.432016
NCT00626405|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-08-12|||August 2008||2008-08-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|July 2010|Actual|2010-07-01||Interventional|||Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery|A Randomized Phase II Trial of Temozolomide (TMZ) and Bevacizumab or ABI-007 (ABX)/Carboplatin (CBDCA) and Bevacizumab in Patients With Unresectable Stage IV Malignant Melanoma|Completed||Phase 2|95|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 14:40:37.543413|2017-02-18 14:40:37.543413
NCT00626392|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2009-08-26|2009-04-16||February 2008||2008-02-01|August 2009|2009-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|ASA EFFECTS||Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia|Multicenter, Randomized, Double-Blind, Parallel, Acetylsalicylic Acid (ASA) Run-In Study to Evaluate the EFFECTS of Acetylsalicylic Acid on Niaspan®-Induced Flushing in Subjects With Dyslipidemia|Completed||Phase 3|277|Actual|Abbott||6|||f||||f||||||||||2017-02-18 14:40:38.052894|2017-02-18 14:40:38.052894
NCT00626379|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2015-02-27|||November 2007||2007-11-01|February 2015|2015-02-01|December 2016|Anticipated|2016-12-01|August 2010|Actual|2010-08-01||Observational|CHAS||Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])|Low CV Risk, Ages 25-44 & CV/Non-CV Outcomes, Ages 65+|Unknown status|Active, not recruiting|N/A|1395|Actual|Northwestern University|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, white cells, and urine~   "|||2017-02-18 14:40:38.846571|2017-02-18 14:40:38.846571
NCT00626366|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-02-20|||March 2008||2008-03-01|February 2008|2008-02-01|June 2008|Anticipated|2008-06-01|April 2008|Anticipated|2008-04-01||Interventional|||Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison|Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison|Unknown status|Not yet recruiting|N/A|8|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-02-18 14:40:38.942096|2017-02-18 14:40:38.942096
NCT00626353|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2014-03-17|||July 2007||2007-07-01|March 2014|2014-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Interdisciplinary Home Rehabilitation of Patients With Stroke. A Randomised Controlled Intervention Trial.|Interdisciplinary Home Rehabilitation of Patients With Stroke. A Randomised Controlled Intervention Trial.|Completed||N/A|71|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-02-18 14:40:39.053394|2017-02-18 14:40:39.053394
NCT00625781|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2016-05-10|||February 2008||2008-02-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|June 2012|Actual|2012-06-01||Interventional|TIP||Treatment of Impaired Glucose Tolerance in Pregnancy|Randomized Controlled, Multicenter Study Evaluating Treatment of Glucose Intolerance in Pregnancy|Completed||N/A|72|Actual|Region Örebro County||2|||f||||f||||||||||2017-02-18 14:40:54.387256|2017-02-18 14:40:54.387256
NCT00626340|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2017-02-13|||July 1999||1999-07-01|February 2017|2017-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder|Measurement of GABA and Neurosteroid Levels in Women With Menopausal Major Depression Before and After Treatment With Estrogen Alone, Fluoxetine Alone, or Estrogen and Fluoxetine and Normal Controls Before and After Treatment With Estrogen|Completed||Phase 4|18|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-02-18 14:40:39.164661|2017-02-18 14:40:39.164661
NCT00626327|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-04-12|2013-02-12||February 2008||2008-02-01|April 2013|2013-04-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers|A Phase 3, Open-Label, Randomized, Multi-Center Study to Evaluate the Safety and Immunogenicity of MMRV Vaccine When Administered Concomitantly With Novartis Meningococcal ACWY Conjugate Vaccine to Healthy Toddlers|Completed||Phase 3|1630|Actual|Novartis||3|||f||||||||||||||2017-02-18 14:40:39.288028|2017-02-18 14:40:39.288028
NCT00626314|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2008-02-28|||March 2008||2008-03-01|February 2008|2008-02-01|August 2010|Anticipated|2010-08-01|March 2010|Anticipated|2010-03-01||Interventional|CAuSMIc II||Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System|A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Trial to Assess the Efficacy, Safety and Tolerability of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Myocardium, Using an Endomyocardial Delivery System|Unknown status|Not yet recruiting|Phase 2|165|Anticipated|Mytogen, Inc.||2|||f||||||||||||||2017-02-18 14:40:40.207399|2017-02-18 14:40:40.207399
NCT00626301|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2015-03-25|||November 2007||2007-11-01|March 2015|2015-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Lopinavir/Ritonavir Monotherapy in Children|Simplifying Antiretroviral Treatment in Virally Suppressed Children by Switching From Double Boosted Protease Inhibitors to Lopinavir/Ritonavir Monotherapy|Completed||Phase 4|40|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||f||||||||||2017-02-18 14:40:40.300775|2017-02-18 14:40:40.300775
NCT00626288|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2013-07-25|||December 2007||2007-12-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|IBS-02/07||Mesalazine Therapy in Patients With Irritable Bowel Syndrome|A Randomised Controlled Multicenter Trial Assessing the Efficacy and Safety of Mesalazine Therapy in Patients With Irritable Bowel Syndrome.|Completed||Phase 3|187|Actual|SOFAR S.p.A.||2|||f||||f||||||||||2017-02-18 14:40:40.410602|2017-02-18 14:40:40.410602
NCT00626275|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2015-06-04|2015-04-27||October 2007||2007-10-01|June 2015|2015-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||All participants who received at least 1 dose of study drug|Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis|A Phase 2a Randomized, Placebo- and Active-Controlled, Single-Dose, 3-Period, Crossover Study Followed by a Randomized, Placebo-Controlled, 14-Day, Parallel-Group Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Subjects With Rheumatoid Arthritis|Completed||Phase 2|46|Actual|Cubist Pharmaceuticals LLC||5|||f||||f||||||||||2017-02-18 14:40:40.660777|2017-02-18 14:40:40.660777
NCT00626262|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2011-01-21|||July 2002||2002-07-01|January 2011|2011-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv|An Open, Randomised Two Way Crossover Study Comparing the Effects of 20mg of Esomeprazole Administered Orally and Intravenously as a 3 Minute Injection on Basal and Pentagastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)|Completed||Phase 4|60|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:40:41.732579|2017-02-18 14:40:41.732579
NCT00626249|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2013-12-13|||August 2007||2007-08-01|December 2013|2013-12-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function|A Phase 1b, Single-Dose, Open Label, Parallel Design, Controlled Pharmacology Trial of Fumaryl Diketopiperazine Administered as Technosphere Inhalation Power in Subjects With Either Mild or Moderate Chronic Kidney Disease vs. Matched Subjects Without Chronic Kidney Disease|Completed||Phase 1|36|Actual|Mannkind Corporation||2|||f||||||||||||||2017-02-18 14:40:41.839548|2017-02-18 14:40:41.839548
NCT00626236|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-01-18||2013-01-18|September 2008||2008-09-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems|A Randomized, Multicenter, Parallel Group, Dose-Ranging Study to Evaluate the Safety and Tolerability of SPN-810 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Persistent Serious Conduct Problems|Completed||Phase 2|78|Actual|Supernus Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-02-18 14:40:41.951956|2017-02-18 14:40:41.951956
NCT00626223|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-02-28|||January 1998||1998-01-01|February 2008|2008-02-01|July 2007|Actual|2007-07-01|July 2001|Actual|2001-07-01||Interventional|||5-Methyltetrahydrofolate Survival and Inflammation in ESRD Patients|5-Methyltetrahydrofolate Survival and Inflammation in ESRD Patients|Completed||N/A|341|Actual|St. Orsola Hospital||2|||f||||f||||||||||2017-02-18 14:40:42.160652|2017-02-18 14:40:42.160652
NCT00626210|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2014-10-28|2014-06-12||February 2008||2008-02-01|October 2014|2014-10-01|October 2012|Actual|2012-10-01|April 2011|Actual|2011-04-01||Interventional|||Modafinil Treatment for Sleep/Wake Disturbances in Older Adults|Modafinil Treatment for Sleep/Wake Disturbances in Older Adults|Terminated||Phase 4|2|Actual|VA Palo Alto Health Care System|Early termination leading to small numbers of subjects analyzed|1|||f||||f||||||||||2017-02-18 14:40:42.291075|2017-02-18 14:40:42.291075
NCT00626197|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-03-17||2016-03-17|February 2008||2008-02-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|October 2009|Actual|2009-10-01||Interventional|BELONG||A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)|A Randomised, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of Ocrelizumab in Patients With WHO or ISN Class III or IV Nephritis Due to Systemic Lupus Erythematosus|Active, not recruiting||Phase 3|369|Anticipated|Genentech, Inc.||2|||f||||||||||||||2017-02-18 14:40:42.52761|2017-02-18 14:40:42.52761
NCT00626184|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2009-08-17|||February 2008||2008-02-01|August 2009|2009-08-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease|A Phase 1, Two Stage, Single Dose, Single-Blind, Placebo Controlled, Dose Escalation, Crossover Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease|Completed||Phase 1|28|Actual|Alvine Pharmaceuticals Inc.||2|||f||||f||||||||||2017-02-18 14:40:42.641917|2017-02-18 14:40:42.641917
NCT00626171|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-04-23|||August 2008||2008-08-01|April 2013|2013-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Role of Cigarette Smoking in Regulating Allergen-induced Early and Late Responses in Mild Asthmatics|A Study Evaluating the Role of Cigarette Smoking in Regulating Allergen-induced Early and Late Responses in Mild Asthmatics.|Completed||Early Phase 1|25|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 14:40:42.751713|2017-02-18 14:40:42.751713
NCT00626158|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2012-04-03|||February 2008||2008-02-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers|A Phase I Study, With Expanded Cohort, of Biweekly Fixed-dose Rate Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic and Biliary Carcinomas|Completed||Phase 1|45|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 14:40:42.855238|2017-02-18 14:40:42.855238
NCT00626145|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-02-28|||March 2003||2003-03-01|February 2008|2008-02-01|March 2008|Anticipated|2008-03-01|March 2008|Anticipated|2008-03-01||Interventional|||Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI|Long Term Functional Evaluation After Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells in Patients With ST-Elevation Myocardial Infarction|Unknown status|Active, not recruiting|Phase 1/Phase 2|37|Actual|Xijing Hospital||2|||f||||t||||||||||2017-02-18 14:40:42.96944|2017-02-18 14:40:42.96944
NCT00626132|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2015-12-17|||May 2007||2007-05-01|December 2015|2015-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Standardized Eucommia Extract in the Treatment of Hypertension|Evaluation of the Safety and Efficacy of a Standardized Eucommia Extract in the Treatment of Hypertension|Completed||Phase 2|30|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-02-18 14:40:43.085867|2017-02-18 14:40:43.085867
NCT00626119|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2012-06-19|||June 2001||2001-06-01|June 2012|2012-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in Women|In Vivo Breast Imaging by Vibro-acoustography|Completed||N/A|34|Actual|Mayo Clinic|||2||f||||t||||||||||2017-02-18 14:40:43.188806|2017-02-18 14:40:43.188806
NCT00626106|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-10-26||2015-01-16|March 2008||2008-03-01|October 2016|2016-10-01|August 2011|Actual|2011-08-01|July 2010|Actual|2010-07-01||Interventional|||QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer|An International, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|156|Actual|NantCell, Inc.||3|||f||||||||||||||2017-02-18 14:40:43.29536|2017-02-18 14:40:43.29536
NCT00626093|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2013-01-18|2011-07-21||January 2008||2008-01-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||'Effect of CRT on Defibrillation Threshold Estimates' Study|Effect of Cardiac Resynchronization Therapy (CRT) on the Defibrillation Threshold (DFT) Estimates|Completed||Phase 4|77|Actual|St. Jude Medical||1|||f||||f||||||||||2017-02-18 14:40:43.484803|2017-02-18 14:40:43.484803
NCT00626080|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2011-12-29|||January 2009||2009-01-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|INcEREBRO||Insulin Detemir Action in Cerebro|Effects of INsulin dEtemiR and Neutral protaminE Hagedorn (NPH) Insulin on BRain glucOse Metabolism: a Study in Persons With Type 1 Diabetes|Completed||N/A|40|Anticipated|VU University Medical Center||1|||f||||f||||||||||2017-02-18 14:40:43.736577|2017-02-18 14:40:43.736577
NCT00626067|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-11-08|||September 2006||2006-09-01|November 2016|2016-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of Patient Use and Perception of the Travatan Dosing Aid|Pilot Study of Patient Acceptance and Impact of the New Travatan™ Compliance Monitoring Dispenser (Travatan™ Dosing Aid)|Completed||Phase 4|45|Actual|Wills Eye||3|||f||||f||||||||Yes|A Manuscript has been accepted and published in Patient Preference and Adherence.|2017-02-18 14:40:43.827154|2017-02-18 14:40:43.827154
NCT00626054|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-04-12|||March 2009||2009-03-01|April 2016|2016-04-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|PEG||Comparison of Two Methods of Administration of a PEG Solution|Comparison of Two Methods of Administration of a PEG Solution During Bowel Preparation for Colonoscopy in Hospitalized Patients|Completed||Phase 4|400|Actual|Rabin Medical Center||2|||f||||t||||||||||2017-02-18 14:40:43.924518|2017-02-18 14:40:43.924518
NCT00626041|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2010-01-25|||February 2008||2008-02-01|January 2010|2010-01-01|June 2011|Anticipated|2011-06-01|December 2010|Anticipated|2010-12-01||Interventional|U-CHAMP||U-CHAMP: Urban Cardiovascular Health Assessment and Management Program|U-CHAMP: Urban Cardiovascular Health Assessment and Management Program|Unknown status|Recruiting|N/A|110|Anticipated|University of Calgary||1|||f||||f||||||||||2017-02-18 14:40:44.036719|2017-02-18 14:40:44.036719
NCT00626028|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-09-08|2009-09-21||September 2004||2004-09-01|September 2016|2016-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Comparison of Inhaled Nitric Oxide and Oxygen in Patient Reactivity During Acute Pulmonary Vasodilator Testing|Comparison of Supplemental Oxygen and Nitric Oxide for Inhalation in the Evaluation of the Reactivity of the Pulmonary Vasculature During Acute Pulmonary Vasodilator Testing|Completed||Phase 3|136|Actual|Mallinckrodt|Although the first and last treatments were randomly assigned, the second treatment was always the iNO/O2 combination. Without randomization of all 3 treatments, we cannot exclude an interaction of time with treatment.|3|||f||||f||||||||||2017-02-18 14:40:44.157593|2017-02-18 14:40:44.157593
NCT00626015|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2016-01-20|||March 2007||2007-03-01|January 2016|2016-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|ZAP IT||Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery|Zenapax®-Activated Peptide ImmunoTherapy [ZAP IT]|Completed||Phase 1|16|Actual|Duke University||3|||f||||t||||||||||2017-02-18 14:40:44.703086|2017-02-18 14:40:44.703086
NCT00626002|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2013-01-28||2012-10-05|February 2008||2008-02-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Open Label Continuation Study in Moderate to Severe Psoriasis|A Phase 3, Multi-center, Open-label Continuation Study in Moderate to Severe Plaque Psoriasis in Subjects Who Completed a Preceding Psoriasis Study With ABT-874|Completed||Phase 3|2301|Actual|AbbVie||1|||f||||f||||||||||2017-02-18 14:40:44.83173|2017-02-18 14:40:44.83173
NCT00625989|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2015-04-30|2015-04-14||February 2008||2008-02-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics|The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics|Completed||Early Phase 1|12|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 14:40:45.191158|2017-02-18 14:40:45.191158
NCT00625976|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2014-09-18|||May 2008||2008-05-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|December 2012|Actual|2012-12-01||Interventional|||Graded Exposure (GEXP) in Vivo Versus Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I)|The Effectivity of Graded Exposure in Vivo Versus Standardized Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I) Patients With Pain Related Fear: a Randomized Clinical Trial|Completed||N/A|46|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 14:40:45.601284|2017-02-18 14:40:45.601284
NCT00625963|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-07-29|||April 2007||2007-04-01|July 2013|2013-07-01|July 2011|Actual|2011-07-01|June 2008|Actual|2008-06-01||Observational|||The Study Of CT Scans and Echo Parameters in Patients With PAH|The Study of CT Scan and Echocardiogram Parameters in Patients With Pulmonary Hypertension With Regards to Hemodynamics, Sleep Studies, and Various Laboratory Markers.|Completed||N/A|71|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 14:40:45.702461|2017-02-18 14:40:45.702461
NCT00625950|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2009-01-09|||February 2008||2008-02-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Endometriosis Patients Undergoing Quinagolide Treatment|Effect of Treatment With Agonist Dopaminergics on Endometriosic Lesions.|Completed||Phase 4|5|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA||1|||f||||f||||||||||2017-02-18 14:40:45.798262|2017-02-18 14:40:45.798262
NCT00625937|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-28|2011-02-25|||November 2006||2006-11-01|February 2011|2011-02-01||||November 2010|Anticipated|2010-11-01||Interventional|||Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer|A Phase ll Trial of Induction Docetaxel and S-1 Followed by Concomitant Radiotherapy With Low-dose Daily Cisplatin in Locally Advanced Head and Neck Cancer|Unknown status|Recruiting|Phase 2|46|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:40:45.88226|2017-02-18 14:40:45.88226
NCT00625924|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2014-01-14|||February 2008||2008-02-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Sensory Morbidity Following Breast Surgery|Sensory Morbidity Following Breast Surgery|Completed||N/A|290|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 14:40:45.981499|2017-02-18 14:40:45.981499
NCT00625911|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2008-02-28|||September 2001||2001-09-01|February 2008|2008-02-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Ketamine Improves Post-Thoracotomy Analgesia|Ketamine Improves Post-Thoracotomy Analgesia|Completed||N/A|44|Actual|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-02-18 14:40:46.086401|2017-02-18 14:40:46.086401
NCT00625898|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2014-07-07|||April 2008||2008-04-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|June 2013|Actual|2013-06-01||Interventional|BETH||BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab|A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients With HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab With Chemotherapy Plus Trastuzumab Plus Bevacizumab|Terminated||Phase 3|3509|Actual|NSABP Foundation Inc||4|||f||||t||||||||||2017-02-18 14:40:46.231089|2017-02-18 14:40:46.231089
NCT00625885|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-11-01|||February 2007||2007-02-01|November 2016|2016-11-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Observational|MARS||Multicenter ACL Revision Study (MARS)|Multicenter ACL Revision Study (MARS)|Active, not recruiting||N/A|1250|Anticipated|Vanderbilt University|||1||f||||f||||||||No||2017-02-18 14:40:47.139779|2017-02-18 14:40:47.139779
NCT00625872|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2012-01-27|2012-01-27||July 2008||2008-07-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|SGA-POWER||Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy|Neuromuscular Changes In Small For Gestational Age (SGA) Children During Somatropin Therapy - A Prospective Randomized, Controlled, Open-Label Multicenter Trial|Terminated||Phase 3|23|Actual|Pfizer|The study was prematurely discontinued, therefore not all data was powered.|2||"The study terminated on 19-Jan-2011 due to insufficient recruitment of patients. No safety~   reasons contributed to the termination of the study."|f||||f||||||||||2017-02-18 14:40:49.631199|2017-02-18 14:40:49.631199
NCT00625859|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2012-03-15|||January 2008||2008-01-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects|A Double-blind, Randomized, 6-sequence, 3-period Crossover Drug-drug Interaction Study to Evaluate the Pharmacokinetics of WELLBUTRIN SR (Bupropion) and GSK189075 When Co-administered or Administered Alone in Healthy Male Volunteers|Completed||Phase 1|30|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 14:40:53.301623|2017-02-18 14:40:53.301623
NCT00625846|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2017-01-31|||February 2008||2008-02-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer|A Phase II Study of GW 786034 (Pazopanib) in Advanced Thyroid Cancer|Active, not recruiting||Phase 2|188|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:40:53.40554|2017-02-18 14:40:53.40554
NCT00625833|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2009-02-16|||December 2007||2007-12-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.|A Randomized, Double-Blind Placebo Controlled Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.|Terminated||Phase 2|330|Anticipated|Pfizer||2||Study was terminated for futility following the planned interim analysis.|f||||f||||||||||2017-02-18 14:40:53.752713|2017-02-18 14:40:53.752713
NCT00625820|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-08-22|2015-08-04||May 2008||2008-05-01|August 2016|2016-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria|Safety and Efficacy of Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria: An Open-Label Pilot Study|Completed||Phase 2|17|Actual|University of Michigan|It was a small single center non-randomized pilot study & was not powered to detect significant changes in albuminuria.|1|||f||||f||||||||No||2017-02-18 14:40:53.930269|2017-02-18 14:40:53.930269
NCT00625807|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2009-12-03|||January 2008||2008-01-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Comparison of Two Behavioral Treatments for Stress Reduction|Exploratory Analysis of RR and MBSR for Stress Reduction|Completed||Early Phase 1|70|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:40:54.18921|2017-02-18 14:40:54.18921
NCT00625794|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-27|||September 2005||2005-09-01|May 2007|2007-05-01|July 2007|Actual|2007-07-01|May 2007|Actual|2007-05-01||Interventional|||Nicotine Replacement and Counseling In Adolescents|A Randomized Trial of the Nicotine Nasal Spray in Adolescent Smokers|Completed||Phase 4|40|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:40:54.28869|2017-02-18 14:40:54.28869
NCT00625768|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2009-08-24|||January 2008||2008-01-01|August 2009|2009-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma|A Phase I Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma|Completed||Phase 1|13|Actual|Antisoma Research||1|||f||||t||||||||||2017-02-18 14:40:54.497963|2017-02-18 14:40:54.497963
NCT00625755|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-03-10|||December 2002||2002-12-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|June 2005|Actual|2005-06-01||Interventional|||A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma|A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma|Completed||Phase 1/Phase 2|40|Actual|Beth Israel Deaconess Medical Center||1|||f||||t||||||||||2017-02-18 14:40:54.60969|2017-02-18 14:40:54.60969
NCT00625742|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-01-08|2015-12-04||February 2008||2008-02-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Multimodal Treatment Strategy for Cancer Cachexia|An Exploratory Trial of a Multimodal Treatment Strategy for Cancer Cachexia|Terminated||N/A|15|Actual|M.D. Anderson Cancer Center|The sample size of the available data is too small to detect any significant differences.|1||Low Accrual|f||||f||||||||||2017-02-18 14:40:54.723387|2017-02-18 14:40:54.723387
NCT00625729|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2012-11-06|2010-07-02||January 2008||2008-01-01|November 2012|2012-11-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia|MT2007-12 Allogeneic Natural Killer Cells With Rituximab in Patients With CD20 Positive Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia. Strategies to Increase Sensitivity of CLL Tumor Cells to Natural Killer Cell-Immune-Mediated Cytolysis|Terminated||Phase 1/Phase 2|6|Actual|Masonic Cancer Center, University of Minnesota|Study was terminated early due to lack of NK expansion and failure to meet primary outcome.|1||No patients exhibited natural killer cell expansion (primary endpoint).|f||||t||||||||||2017-02-18 14:40:54.983144|2017-02-18 14:40:54.983144
NCT00625703|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2009-01-21|||May 2008||2008-05-01|December 2008|2008-12-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Pharmacokinetics of Linezolid in Children With Cystic Fibrosis|Pharmacokinetics of Linezolid in Children With Cystic Fibrosis|Unknown status|Recruiting|Phase 2|14|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 14:40:55.29019|2017-02-18 14:40:55.29019
NCT00625690|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-02-03|||May 2005||2005-05-01|February 2011|2011-02-01||||December 2011|Anticipated|2011-12-01||Observational|||CT Scans in Screening for Lung Cancer in Current and Former Smokers|Development of a Lung Cancer-Screening Program at the University of Nebraska Medical Center: A Feasibility Study|Unknown status|Active, not recruiting|N/A|100|Actual|University of Nebraska|||1||f||||t||||||Samples Without DNA|"~     Collection of blood sample: At the time of the initial CT scan, every subject will be asked~     to donate a small blood sample, approximately 10 ml in a yellow EDTA tube (less than 1~     tablespoon) from their arm by standard blood drawing techniques, for storage for use in~     future studies. The blood sample will be number coded, and serum from the blood sample will~     be stored frozen and held at UNMC for future studies. All studies will be proposed in future~     IRB submissions.~   "|||2017-02-18 14:40:55.625543|2017-02-18 14:40:55.625543
NCT00625677|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2010-09-01|||February 2008||2008-02-01|September 2010|2010-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|Sched2||Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life|A Phase IV, Randomized Study to Evaluate the Immune Response of UK Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life|Completed||Phase 4|130|Anticipated|Public Health England||2|||f||||f||||||||||2017-02-18 14:40:55.733508|2017-02-18 14:40:55.733508
NCT00625664|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-04-06||2016-04-06|February 2008||2008-02-01|April 2016|2016-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|CILAB||Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer|Randomized Study of LAROTAXEL + Cisplatin (LC) vs. Gemcitabine + Cisplatin (GC) in the First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer|Completed||Phase 3|337|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:40:55.856285|2017-02-18 14:40:55.856285
NCT00625651|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2014-03-28||2014-01-15|October 2007||2007-10-01|March 2014|2014-03-01|September 2011|Actual|2011-09-01|August 2010|Actual|2010-08-01||Interventional|||Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer|A Phase 1b/2 Study of AMG 655 in Combination With Modified FOLFOX6 and Bevacizumab for the First-Line Treatment of Subjects With Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|202|Actual|Amgen||3|||f||||||||||||||2017-02-18 14:40:56.148952|2017-02-18 14:40:56.148952
NCT00625638|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-09-27|||January 2008||2008-01-01|September 2016|2016-09-01||||January 2018|Anticipated|2018-01-01||Interventional|||Interactive Voice Response System in Advanced Cancer Patients|Symptom Assessment in Advanced Cancer Patients Using an Interactive Voice Response (IVR) System|Active, not recruiting||N/A|136|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:40:56.366076|2017-02-18 14:40:56.366076
NCT00625625|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2013-09-16|||March 2004||2004-03-01|February 2008|2008-02-01||||November 2007|Anticipated|2007-11-01||Interventional|||Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer|Ultrastaging of Early Cancer of the Large Bowel Using Intraoperative Lymphatic Mapping, Sentinel Node Analysis and Blood Testing|Unknown status|Active, not recruiting|Phase 2|225|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:40:56.477501|2017-02-18 14:40:56.477501
NCT00625612|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-10-08||2011-03-24|February 2008||2008-02-01|October 2015|2015-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease|A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease and FEV1 Greater Than or Equal to 75% Predicted But Less Than or Equal to 110% Predicted|Completed||Phase 3|466|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 14:40:56.570751|2017-02-18 14:40:56.570751
NCT00625599|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-28|||January 2008||2008-01-01|January 2008|2008-01-01||||April 2008|Anticipated|2008-04-01||Observational|||Fractures in the Elderly Population of El Salvador at Hospital Zacamil: Exploring Knowledge, Causes, Risk Factors, and Outcomes|Fractures in the Elderly Population of El Salvador at Hospital Zacamil: Exploring Knowledge, Causes, Risk Factors, and Outcomes|Unknown status|Recruiting|N/A|400|Anticipated|Edward Via Virginia College of Osteopathic Medicine|||2||f||||t||||||||||2017-02-18 14:40:56.972706|2017-02-18 14:40:56.972706
NCT00625586|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2012-11-20|2012-08-20||March 2008||2008-03-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer|A Phase 2 Evaluation of the Monoclonal Antibody, RAV12, in Combination With Standard Gemcitabine in the Treatment of Patients With Metastatic Pancreatic Cancer Who Have Not Been Previously Treated for Metastatic Disease|Terminated||Phase 2|2|Actual|MacroGenics|Only 2 patients enrolled in the trial. Both were evaluable for safety and only one was evaluable for efficacy. No statistical analyses were performed.|1||Corporate decision|f||||f||||||||||2017-02-18 14:40:57.058281|2017-02-18 14:40:57.058281
NCT00625573|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2009-09-17|||September 2007||2007-09-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|ABX067||Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)|Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)|Completed||Phase 2|29|Anticipated|Mt. Sinai Medical Center, Miami||1|||f||||t||||||||||2017-02-18 14:40:57.598918|2017-02-18 14:40:57.598918
NCT00625560|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2012-05-07|||February 2008||2008-02-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Interventional|||Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA|Randomized, Open-Labelled Study Evaluating the Antiviral Efficacy, Safety, and Tolerability of Continuing Lamivudine Therapy or Switching to Entecavir in Subjects With Chronic Hepatitis B With Detectable HBV DNA|Completed||Phase 4|72|Actual|Yonsei University||2|||f||||t||||||||||2017-02-18 14:40:57.707017|2017-02-18 14:40:57.707017
NCT00625547|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-10-28|||January 2003||2003-01-01|October 2008|2008-10-01|December 2004|Actual|2004-12-01|||||Interventional|||A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS|A Double-Blind, Randomized, Active-Controlled Multicenter Efficacy Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)|Completed||Phase 3|361|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:40:57.834039|2017-02-18 14:40:57.834039
NCT00625534|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-04-10|||April 2008||2008-04-01|April 2008|2008-04-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|GENINGHERNIA||Functional Outcome After Groin Hernia Mesh Repair: Open Versus Laparoscopy|Chronic Significant Pain and Functional Outcome After Laparoscopic Versus Open Groin Hernia Mesh Repair: Design of a Randomized Controlled Clinical Trial|Unknown status|Recruiting|Phase 4|260|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 14:40:57.990923|2017-02-18 14:40:57.990923
NCT00625521|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-02-28|||November 2006||2006-11-01|February 2008|2008-02-01|July 2007|Actual|2007-07-01|||||Interventional|||Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions|Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Patients With Newly Developed Discoid Lupus Erythematosus (DLE) Lesions. An International Multi-Centre Clinical Phase 2, Placebo Controlled and Double Blind Proof of Concept Study|Completed||Phase 2|32|Actual|Astion Pharma A/S||2|||f||||f||||||||||2017-02-18 14:40:58.102379|2017-02-18 14:40:58.102379
NCT00625495|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-01-21|||September 2002||2002-09-01|January 2011|2011-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)|An Open, Randomised Two Way Crossover Study Comparing the Effects of 40mg of Esomeprazole Adminstered Orally and Intravenously as a 3 Minute Injection on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)|Completed||Phase 4|60|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:40:58.19517|2017-02-18 14:40:58.19517
NCT00625482|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2013-10-22|||February 2008||2008-02-01|October 2013|2013-10-01||||||||Interventional|||Sex-Differential Health Interventions In Low-Birth-Weight Infants|Sex-Differential Health Interventions In Low-Birth-Weight Infants|Unknown status|Active, not recruiting|N/A|||Bandim Health Project||4|||f||||||||||||||2017-02-18 14:40:58.305025|2017-02-18 14:40:58.305025
NCT00625469|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||October 2007||2007-10-01|February 2008|2008-02-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan|Treatment of Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Hypertension With Bosentan: A Single Center Pilot Study|Unknown status|Recruiting|Phase 4|50|Anticipated|University of California, Los Angeles||3|||f||||t||||||||||2017-02-18 14:40:58.401163|2017-02-18 14:40:58.401163
NCT00625456|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2015-11-30|||June 2008||2008-06-01|March 2012|2012-03-01|June 2014|Actual|2014-06-01|April 2010|Actual|2010-04-01||Interventional|||Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors|A Phase I Dose Escalation Study of JX-594 (Thymidine Kinase-deleted Vaccinia Virus Plus GM-CSF) Administered by Intravenous Infusion in Patients With Refractory Solid Tumors|Completed||Phase 1|23|Actual|SillaJen, Inc.||1|||f||||t||||||||||2017-02-18 14:40:58.506198|2017-02-18 14:40:58.506198
NCT00625443|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2013-10-30||2013-05-21|May 2007||2007-05-01|October 2013|2013-10-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With Chronic ITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003|A Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Who Completed 28 Days of Study Treatment in Protocol 501-CL-003|Completed||Phase 2|52|Actual|Eisai Inc.||3|||f||||f||||||||||2017-02-18 14:40:58.622648|2017-02-18 14:40:58.622648
NCT00625430|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-07-08|||March 2008||2008-03-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|FP253-GDEPT||A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer|A Phase I, Open-label, Dose Escalation Study to Assess the Safety and Tolerability of FP253 in Combination With Fludarabine Phosphate|Unknown status|Recruiting|Phase 1|18|Anticipated|Biotech Equity Partners Pty Ltd||1|||f||||t||||||||||2017-02-18 14:40:58.749072|2017-02-18 14:40:58.749072
NCT00625417|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2012-01-09|||August 2006||2006-08-01|January 2012|2012-01-01||||August 2013|Anticipated|2013-08-01||Interventional|||Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors|Breast Tumor Detection Using Optical Spectroscopy|Unknown status|Recruiting|Phase 1|||Vanderbilt University|||||f||||||||||||||2017-02-18 14:40:58.857924|2017-02-18 14:40:58.857924
NCT00625404|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2014-04-22|2013-12-09||May 2009||2009-05-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Interventional|||FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women|Phase 3, Multi-center, Double-blind, Randomized, Placebo-controlled Effectiveness and Safety Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women|Completed||Phase 3|2120|Actual|FHI 360||2|||f||||t||||||||||2017-02-18 14:40:58.967778|2017-02-18 14:40:58.967778
NCT00625391|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2014-08-01|2012-12-05||February 2008||2008-02-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|GTP-TC-Bone||Green Tea and Tai Chi for Bone Health|GTP and Tai Chi for Bone Health: a Pilot Study|Completed||Phase 1/Phase 2|171|Actual|Texas Tech University Health Sciences Center|Limitation of this study included: (1) the number of subjects in each group at the baseline was not equal. (2) The amount of dietary calcium intake for each subject was not available.|4|||f||||f||||||||||2017-02-18 14:41:00.145298|2017-02-18 14:41:00.145298
NCT00625378|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2017-02-13|||December 2007||2007-12-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|STEP||Sorafenib Long Term Extension Program (STEP)|Sorafenib Long Term Extension Program|Recruiting||Phase 3|1000|Anticipated|Bayer||1|||f||||f||||||||||2017-02-18 14:41:00.769175|2017-02-18 14:41:00.769175
NCT00625365|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2015-12-31|2010-12-17||February 2008||2008-02-01|August 2011|2011-08-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice|CARES (Contrast EchocArdiography REgistry for Safety Surveillance): A Prospective, Phase IV, Open-Label, Nonrandomized, Multicenter, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice|Completed||Phase 4|1060|Actual|Lantheus Medical Imaging||1|||f||||f||||||||||2017-02-18 14:41:00.99297|2017-02-18 14:41:00.99297
NCT00625352|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||February 2008||2008-02-01|February 2008|2008-02-01||||December 2009|Anticipated|2009-12-01||Interventional|||Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma|Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-Line Treatment in Elderly Patients With Advanced Non-Small Cell Carcinoma|Unknown status|Recruiting|Phase 2|48|Anticipated|Ulsan University Hospital||1|||f||||f||||||||||2017-02-18 14:41:01.260814|2017-02-18 14:41:01.260814
NCT00625339|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2012-05-07|||February 2008||2008-02-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA|Randomized, Open-Labeled Study Evaluating the Antiviral Efficacy, Safety, and Tolerability of Continuing Lamivudine Therapy or Switching to Entecavir in Subjects With Chronic Hepatitis B Who Achieved Undetectable HBV DNA|Completed||Phase 4|72|Actual|Yonsei University||2|||f||||t||||||||||2017-02-18 14:41:01.356903|2017-02-18 14:41:01.356903
NCT00625326|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-04-19||2010-12-01|January 2008||2008-01-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis|A Phase II Study of the Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis|Completed||Phase 2|321|Actual|Deltanoid Pharmaceuticals||5|||f||||f||||||||||2017-02-18 14:41:01.485002|2017-02-18 14:41:01.485002
NCT00625313|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2015-08-17|||March 2004||2004-03-01|August 2015|2015-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|HMY||Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens|A Prospective, Multi-center, Single-phase, Non-randomized, Open-label Study to Assess the Safety and Efficacy of the HMY Model YA-60BB Intraocular Lens (IOL) for the Correction of Aphakia Following Phacoemulsification Cataract Extraction|Completed||N/A|617|Actual|Hoya Surgical Optics, Inc.||1|||f||||f||||||||||2017-02-18 14:41:01.629394|2017-02-18 14:41:01.629394
NCT00625300|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2009-10-19|||April 2008||2008-04-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|r-TMS||Repetitive Transcranial Stimulation (r-TMS) Treatment for Patients With Parkinson's Disease|Efficacy and Safety Study:The Influence of Repetitive Transcranial Stimulation (r-TMS) Treatment on Motor and Cognitive Measurements in Patients With Parkinson's Disease|Completed||Phase 2|20|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 14:41:01.736621|2017-02-18 14:41:01.736621
NCT00625274|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-02-27|||June 2004||2004-06-01|February 2008|2008-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients||Completed||Phase 4|100|Anticipated|AstraZeneca||3|||f||||||||||||||2017-02-18 14:41:01.846324|2017-02-18 14:41:01.846324
NCT00625261|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||October 2003||2003-10-01|August 2007|2007-08-01|October 2011|Anticipated|2011-10-01|February 2008|Actual|2008-02-01||Interventional|||Effectiveness of Early Parent-Based Language Intervention|Effectiveness of a Parent-Based Language Intervention Group Program for Two-Year-Old Children With Language Delay|Unknown status|Active, not recruiting|Phase 3|150|Actual|Heidelberg University||2|||f||||t||||||||||2017-02-18 14:41:01.963689|2017-02-18 14:41:01.963689
NCT00625248|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2013-06-20|||February 2008||2008-02-01|June 2013|2013-06-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Observational|||Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy|A Prospective Evaluation of Bleeding Risk of Anticoagulant and Antiplatelet Therapy for Interventional Techniques|Completed||N/A|12000|Actual|Pain Management Center of Paducah|||3||f||||t||||||||||2017-02-18 14:41:02.077103|2017-02-18 14:41:02.077103
NCT00625235|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||July 2003||2003-07-01|June 2003|2003-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A High Protein Diet and Weight Maintenance|The Use of a High Protein Diet in Achieving Long-Term Weight Loss and Improved Cardiovascular Risk Factors|Completed||N/A|180||University of Melbourne||2|||f||||f||||||||||2017-02-18 14:41:02.187914|2017-02-18 14:41:02.187914
NCT00625222|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2010-01-27|||September 2007||2007-09-01|January 2010|2010-01-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Transcranial Direct Current Stimulation (tDCS) As A Tool For Prospective Responder Identification Before Vagus Nerve Stimulation (VNS) Implantation||Unknown status|Recruiting|N/A|70|Anticipated|University of Luebeck||1|||f||||t||||||||||2017-02-18 14:41:02.278956|2017-02-18 14:41:02.278956
NCT00625209|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-07-19|||March 2008||2008-03-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|June 2015|Actual|2015-06-01||Interventional|APROCCHS||Activated Protein C and Corticosteroids for Human Septic Shock|Phase III of Recombinant Human Activated Protein C and Low Dose of Hydrocortisone and Fludrocortisone in Adult Septic Shock|Completed||Phase 3|1241|Actual|University of Versailles||4|||f||||t||||||||||2017-02-18 14:41:02.386012|2017-02-18 14:41:02.386012
NCT00625196|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-11-03|||February 2008||2008-02-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects|A Randomised, Double-blind, Placebo-controlled, Four-way Crossover Study to Compare the Pharmacodynamics and Pharmacokinetics of GW685698X and GW642444M When Administered Separately and in Combination as a Single Dose From a Novel Dry Powder Device in Healthy Japanese Subjects|Completed||Phase 1|16|Anticipated|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:41:02.51478|2017-02-18 14:41:02.51478
NCT00625183|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-26|2016-01-19|2014-09-19||March 2008||2008-03-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional||All treated and eligible patients|Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma|A Phase II Study of Capecitabine, Oxaliplatin and Selenomethionine and Radiation Therapy in Patients With Stage II and III Rectal Adenocarcinoma|Terminated||Phase 2|5|Actual|Roswell Park Cancer Institute|Due to the study's early termination, as a result of low accrual, target accrual was not reached and no statistical inference of the primary and secondary aims were carried forth.|1||Withdrawn due to poor/low accrual|f||||||||||||||2017-02-18 14:41:02.615713|2017-02-18 14:41:02.615713
NCT00625170|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||May 2004||2004-05-01|March 2004|2004-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans|Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans|Completed||N/A|11|Actual|Leiden University Medical Center||2|||f||||f||||||||||2017-02-18 14:41:03.07057|2017-02-18 14:41:03.07057
NCT00625157|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-02-28||||||February 2008|2008-02-01||||||||Interventional|||Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)|Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Patients With Newly Developed Discoid Lupus Erythematosus (DLE) Lesions. An International Multi-Centre Clinical Phase 2, Placebo Controlled and Double Blind Proof of Concept Study (2)|Completed||Phase 2|||Astion Pharma A/S||2|||f||||f||||||||||2017-02-18 14:41:03.184003|2017-02-18 14:41:03.184003
NCT00625131|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2014-11-12|2014-10-28||May 2008||2008-05-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Nicotine Patch Pretreatment for Smoking Cessation in PTSD|Nicotine Patch Pre-treatment for Smoking Cessation in PTSD|Completed||Early Phase 1|87|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:41:03.28028|2017-02-18 14:41:03.28028
NCT00625118|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2010-11-02|||December 2007||2007-12-01|January 2009|2009-01-01||||||||Observational|DIPS||A Study to Gather Safety Data Following Administration of a Hib-containing Booster Vaccine in Children Aged Two to Five Years|A Study to Gather Safety Data Following Administration of a Hib-containing Booster Vaccine in Children Aged Two to Five Years|Completed||N/A|500|Anticipated|Public Health England|||1||f||||f||||||||||2017-02-18 14:41:03.854819|2017-02-18 14:41:03.854819
NCT00625105|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2014-11-05|||January 2011||2011-01-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|HRVB||Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans|Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans|Unknown status|Active, not recruiting|N/A|30|Anticipated|William Jennings Bryan Dorn VA Medical Center||2|||f||||t||||||||||2017-02-18 14:41:03.954973|2017-02-18 14:41:03.954973
NCT00625092|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2011-12-15|||October 2007||2007-10-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|January 2010|Actual|2010-01-01||Interventional|||Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies|Phase I Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies|Completed||Phase 1|17|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:41:04.039197|2017-02-18 14:41:04.039197
NCT00625079|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||February 2007||2007-02-01|February 2008|2008-02-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil|Randomized Placebo-Controlled Study of Sildenafil For The Treatment of Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis: A Pilot Study|Unknown status|Recruiting|Phase 4|50|Anticipated|University of California, Los Angeles||3|||f||||t||||||||||2017-02-18 14:41:04.165005|2017-02-18 14:41:04.165005
NCT00625066|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2010-01-27|||January 2003||2003-01-01|October 2008|2008-10-01||||January 2011|Anticipated|2011-01-01||Observational|||Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy|Tennessee Colorectal Polyp Study|Unknown status|Recruiting|N/A|7000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:41:04.275784|2017-02-18 14:41:04.275784
NCT00625053|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-04-10|||April 2008||2008-04-01|April 2008|2008-04-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|GINCISHERNIA||Functional Outcome After Incisional Hernia Repair: Open Versus Laparoscopic Repair|Abdominal Midline Incisional Hernia Repair and Functional Outcome: Randomized Controlled Trial to Compare Open and Laparoscopic Surgical|Unknown status|Recruiting|Phase 4|60|Anticipated|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 14:41:04.387852|2017-02-18 14:41:04.387852
NCT00625040|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2014-10-08|||January 2008||2008-01-01|October 2014|2014-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Incretin Physiology and Beta-cell Function Before and After Weight-loss|Incretin Physiology and Beta-cell Function Before and After Weight-loss - Effects of Long-term Weight Loss Following Laparoscopic Adjustable Gastric Banding|Terminated||N/A|10|Actual|Glostrup University Hospital, Copenhagen|||1|Not enough patients in the follow-up period|f||||t||||||Samples With DNA|"~     p-glucose, p-glucagon, p-GLP1, p-GIP, p-cpeptid, p-insulin, p-paracetamol, buffy coat,~     urine, whole blood sampels~   "|||2017-02-18 14:41:04.504371|2017-02-18 14:41:04.504371
NCT00625027|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2013-07-31|||March 2004||2004-03-01|July 2013|2013-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||The Effect of Telehealth Ontario on Non-urgent Emergency Department Use at The Hospital for Sick Children|The Effect of Telehealth Ontario on Non-urgent Emergency Department Use at The Hospital for Sick Children|Completed||N/A|115|Actual|The Hospital for Sick Children|||1||f||||f||||||||||2017-02-18 14:41:04.616995|2017-02-18 14:41:04.616995
NCT00457288|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-11-09|||April 2007||2007-04-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Efficacy and Safety of TF002 in Cutaneous Mastocytosis|Efficacy and Safety of TF002 in Cutaneous Mastocytosis|Completed||Phase 2|30|Anticipated|JADO Technologies GmbH|||||f||||t||||||||||2017-02-18 15:43:31.649273|2017-02-18 15:43:31.649273
NCT00625014|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||March 2005||2005-03-01|February 2008|2008-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans|Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans|Completed||N/A|8|Actual|Leiden University Medical Center||1|||f||||f||||||||||2017-02-18 14:41:04.724952|2017-02-18 14:41:04.724952
NCT00625001|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||November 1994||1994-11-01|February 2008|2008-02-01|June 2010|Anticipated|2010-06-01|October 1996|Actual|1996-10-01||Observational|||Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome|Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome|Unknown status|Active, not recruiting|N/A|54|Actual|University of Aarhus|||2||f||||f||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 14:41:04.833047|2017-02-18 14:41:04.833047
NCT00624988|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-10-16|||July 2008||2008-07-01|October 2008|2008-10-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|SCI||The Effect of Vibration Therapy on the Bone Density of the Tiba in Patients With Spinal Cord Injury|The Effect of Vibration Therapy on the Bone Density of the Tiba in Patients With Spinal Cord Injury|Unknown status|Recruiting|Phase 1/Phase 2|10|Anticipated|Logan College of Chiropractic||1|||f||||t||||||||||2017-02-18 14:41:04.910055|2017-02-18 14:41:04.910055
NCT00624975|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2012-07-30|||November 2008||2008-11-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants|A Multi-site, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of Trehalose-reformulated Peru-15 (Choleragarde)Vaccine Given Simultaneously With Measles Vaccine in Healthy Indian and Bangladeshi Infants|Terminated||Phase 2|74|Actual|International Vaccine Institute||2||one of site was not able to get an approval from the national regulatory authority.|f||||t||||||||||2017-02-18 14:41:05.009984|2017-02-18 14:41:05.009984
NCT00624962|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2014-12-10|||March 2006||2006-03-01|November 2010|2010-11-01|January 2008|Anticipated|2008-01-01|January 2008|Anticipated|2008-01-01||Interventional|||Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors|Pilot Study of Early Enteral Tube Feedings in Children Receiving Chemotherapy for Newly Diagnosed AML/MDS and High Risk Solid Tumors|Withdrawn||N/A|0|Actual|Vanderbilt University||1||no participants enrolled|f||||t||||||||||2017-02-18 14:41:05.124224|2017-02-18 14:41:05.124224
NCT00624949|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-27|||August 2003||2003-08-01|February 2008|2008-02-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Observational|||Aortic Dimensions in Turner Syndrome|Aortic Dimensions, 24hour Ambulatory Blood Pressure and Sympathovagal Tone in Turner Syndrome. In Relation to Aortic Dilatation and Dissection.|Unknown status|Active, not recruiting|N/A|102|Actual|University of Aarhus|||2||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 14:41:05.234745|2017-02-18 14:41:05.234745
NCT00624936|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-27|2010-04-09|||April 2008||2008-04-01|June 2009|2009-06-01||||March 2011|Anticipated|2011-03-01||Interventional|||Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes|Phase I Study of Vidaza and Velcade (Bortezomib) in Acute Myeloid Leukemia|Unknown status|Recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:41:05.315507|2017-02-18 14:41:05.315507
NCT00624923|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2015-03-30|||September 2008||2008-09-01|March 2015|2015-03-01||||January 2015|Actual|2015-01-01||Interventional|TINSAL-CVD||Targeting Inflammation Using Salsalate in CardioVascular Disease|Targeting Inflammation Using Salsalate in CardioVascular Disease (TINSAL-CVD)|Active, not recruiting||Phase 2/Phase 3|278|Anticipated|Joslin Diabetes Center||2|||f||||t||||||||||2017-02-18 14:41:05.420686|2017-02-18 14:41:05.420686
NCT00624910|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2012-03-22|||December 2007||2007-12-01|March 2012|2012-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety of A Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy|A Phase II, Single Dose, Blinded, Prospective Study to Investigate the Efficacy and Safety of the CollaRx® Bupivacaine Implant in Women Following Abdominal Hysterectomy or Other Nonlaparoscopic Benign Gynecological Procedure|Completed||Phase 2|54|Actual|Innocoll||3|||f||||f||||||||||2017-02-18 14:41:05.556243|2017-02-18 14:41:05.556243
NCT00624884|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-06-27|||March 2008||2008-03-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Observational|||Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation|Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation|Completed||N/A|50|Anticipated|Florence Nightingale Hospital, Istanbul|||2||f||||t||||||||||2017-02-18 14:41:05.676915|2017-02-18 14:41:05.676915
NCT00624871|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2008-02-27|||April 2004||2004-04-01|February 2008|2008-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy|Ascorbic Acid Combined With Ibuprofen in Hypoxic Ischemic Encephalopathy: A Randomized Controlled Trial.|Completed||N/A|60|Actual|Al-Azhar University||2|||f||||t||||||||||2017-02-18 14:41:05.774604|2017-02-18 14:41:05.774604
NCT00624858|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2012-10-23||2012-10-23|January 2008||2008-01-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression|An Open-Label Study Assessing the Safety and Efficacy of Naltrexone Sustained Release (SR)/Bupropion Sustained Release (SR) in Overweight or Obese Subjects With Major Depression|Completed||Phase 2|25|Anticipated|Orexigen Therapeutics, Inc||1|||f||||f||||||||||2017-02-18 14:41:05.884614|2017-02-18 14:41:05.884614
NCT00624845|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2011-06-17||2011-06-17|December 2007||2007-12-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|C07-004||Double-Blind, Multicenter, Study Comparing the Efficacy and Safety of OMS103HP With Vehicle Irrigation Solution in Subjects Undergoing Meniscectomy|Double-Blind, Multicenter, Study Comparing the Efficacy and Safety of OMS103HP|Completed||Phase 2/Phase 3|200|Anticipated|Omeros Corporation||2|||f||||f||||||||||2017-02-18 14:41:05.984501|2017-02-18 14:41:05.984501
NCT00624832|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2011-04-12|2011-01-21||February 2008||2008-02-01|April 2011|2011-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels|A Randomized, Double-blind, Placebo-controlled Study to Demonstrate the Efficacy of Xolair in an Allergen Bronchoprovocation Study in Asthmatic Populations Defined by Serum IgE Concentrations|Completed||Phase 4|60|Actual|Novartis||4|||f||||f||||||||||2017-02-18 14:41:06.101308|2017-02-18 14:41:06.101308
NCT00455988|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03|||September 2006||2006-09-01|April 2007|2007-04-01|December 2007|Anticipated|2007-12-01|||||Observational|||Developement of Questionnaire to Evaluate a Regularity of Lifestyle in Type 2 Diabetic Patients||Unknown status|Recruiting|Phase 4|360||Eulji University Hospital|||||f||||f||||||||||2017-02-18 15:43:48.782679|2017-02-18 15:43:48.782679
NCT00624819|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-10-18||2012-07-24|March 2008||2008-03-01|October 2016|2016-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine|Long-term Follow-up Study to Assess Antibody Persistence in Children Previously Vaccinated With Four Doses of Pneumococcal Conjugate Vaccine in Primary Vaccination Study (105553) and Booster Vaccination Study (107046)|Completed||Phase 3|524|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:41:06.747473|2017-02-18 14:41:06.747473
NCT00624806|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-04-06|2014-07-25||February 2008||2008-02-01|July 2014|2014-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Developing a Home Telehealth Program to Manage Pressure Ulcers in SCI/D|Developing a Home Telehealth Program to Manage Pressure Ulcers in SCI/D|Completed||N/A|18|Actual|VA Office of Research and Development|The study duration was short and the sample was small. Because we only studied subjects who received the DMP, it is unknown how many would have had skin breakdown in a comparable period without the DMP.|2|||f||||f||||||||||2017-02-18 14:41:06.877252|2017-02-18 14:41:06.877252
NCT00624793|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2012-06-21|||May 2005||2005-05-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|AcuN||Acupuncture for Nausea in HIV|Acupuncture for Chronic Nausea in HIV: A Randomized Clinical Trial|Completed||Phase 2|159|Actual|New York University School of Medicine||3|||f||||f||||||||||2017-02-18 14:41:08.849928|2017-02-18 14:41:08.849928
NCT00624780|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2013-03-05|2013-03-05||May 2009||2009-05-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder|Long Term Safety And Efficacy Study Of Pregabalin (Lyrica) In Subjects With Generalized Anxiety Disorder|Completed||Phase 4|615|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 14:41:09.183804|2017-02-18 14:41:09.183804
NCT00624767|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2008-05-16|||March 2008||2008-03-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients|A Phase 2, Randomized, Crossover Study to Evaluate the Effect of Intranasal Insulin and NovoLog on Postprandial Glycemic Control in Type 2 Diabetic Patients|Completed||Phase 2|18|Actual|Nastech Pharmaceutical Company, Inc.||2|||f||||f||||||||||2017-02-18 14:41:11.699284|2017-02-18 14:41:11.699284
NCT00624754|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2013-05-03|||March 2008||2008-03-01|January 2009|2009-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|Alloforb||Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT|recipientsProspective Evaluation of the Efficacy of Budesonide/Formoterol (Symbicort®) in Bronchiolitis Obliterans in Allogeneic Haematopoietic Stem Cell Transplantation (AHSCT) Recipients|Completed||Phase 2|32|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:41:11.804509|2017-02-18 14:41:11.804509
NCT00624741|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2012-06-20||||||June 2012|2012-06-01||||||||Expanded Access|||Compassionate Use Study of Pergolide in Patients With Parkinson's Disease|Compassionate Use of Pergolide as Adjunctive Therapy to Levodopa/Carbidopa for Treating Parkinson's Disease|No longer available||N/A|||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 14:41:11.914821|2017-02-18 14:41:11.914821
NCT00624728|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2012-05-03|||February 2008||2008-02-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|GLIO-TEP||Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)|Assessment of 18Fluoro-thymidine PET-CT for the Volume Definition of High-grade Gliomas (GLIO-TEP) : Correlation With Histopathology|Completed||Phase 1/Phase 2|21|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-02-18 14:41:12.006075|2017-02-18 14:41:12.006075
NCT00624715|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2016-12-01|||July 2007||2007-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Cannabinoid Receptor Function & Alcoholism|Cannabinoid Receptor Function & Alcoholism: Effects of Δ-9-THC|Active, not recruiting||Phase 1|36|Anticipated|Yale University||2|||f||||||||||||||2017-02-18 14:41:12.117049|2017-02-18 14:41:12.117049
NCT00624702|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2010-08-26|||February 2008||2008-02-01|August 2010|2010-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma|A Multi-center, Randomized, Single-dose, Double-blind, 4-way Cross-over Study to Evaluate Tolerability Following Treatment With Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma|Completed||Phase 1|98|Actual|Novartis||4|||f||||f||||||||||2017-02-18 14:41:12.209093|2017-02-18 14:41:12.209093
NCT00624689|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-10-28|||March 2008||2008-03-01|October 2016|2016-10-01|March 2018|Anticipated|2018-03-01|March 2013|Actual|2013-03-01||Interventional|TUMME||Effects of Milk Fat Globule Membrane (MFGM) - Enriched Formula With Reduced Energy and Protein Content on Growth and Development|Double-blinded Interventional Study on the Effects of MFGM-enriched Formula With Reduced Energy and Protein Content on Growth and Development|Active, not recruiting||N/A|240|Anticipated|Umeå University||3|||f||||f||||||||||2017-02-18 14:41:12.352071|2017-02-18 14:41:12.352071
NCT00624676|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2011-09-18|||January 2006||2006-01-01|September 2011|2011-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris|Randomized Study Comparing the Efficacy and Tolerance of a Lipophilic Hydroxy Acid Derivative of Salicylic Acid and 5% Benzoyl Peroxide in the Treatment of Facial Acne Vulgaris|Completed||N/A|80|Actual|Cosmetique Active International||2|||f||||f||||||||||2017-02-18 14:41:12.453309|2017-02-18 14:41:12.453309
NCT00624663|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2014-03-26|||January 2009||2009-01-01|February 2008|2008-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|RIVA-1||A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers|A Double-Blind, Placebo-controlled Crossover Study to Assess the Pharmacokinetic Profile and the Physiological and Behavioral Effects of Repeat Rivastigmine (Exelon®) Administration in Young Healthy Male Volunteers|Completed||N/A|15|Actual|Tel-Aviv Sourasky Medical Center||3|||f||||t||||||||||2017-02-18 14:41:12.569314|2017-02-18 14:41:12.569314
NCT00624650|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2011-05-27|||February 2008||2008-02-01|July 2010|2010-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|HEAL||Hemodynamics and Extravascular Lung Water in Acute Lung Injury|Hemodynamics and Extravascular Lung Water in Acute Lung Injury: A Prospective Randomized Controlled Multicentered Trial of Goal Directed Treatment of EVLW Versus Standard Management for the Treatment of Acute Lung Injury|Completed||Phase 2|72|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:41:12.677286|2017-02-18 14:41:12.677286
NCT00624637|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2008-02-25|||January 2008||2008-01-01|February 2008|2008-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|aromatherapy||Does Massage With or Without Aromatherapy Reduce Infant's Distress?|Does Massage With or Without Aromatherapy Reduce Infant's Distress After Craniofacial Surgery? A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|110|Anticipated|Erasmus Medical Center||3|||f||||f||||||||||2017-02-18 14:41:12.833065|2017-02-18 14:41:12.833065
NCT00624624|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2014-11-05|||September 2009||2009-09-01|November 2014|2014-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism|Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism|Completed||N/A|24|Actual|Rijnstate Hospital|||4||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:41:12.943795|2017-02-18 14:41:12.943795
NCT00624611|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2011-04-12|||February 2008||2008-02-01|April 2011|2011-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||The Effect of Washing Red Blood Cells on Post Heart Surgery Blood Loss|Post Cardiac Surgery Blood Loss: Effect of Washing Residual Cardiopulmonary Bypass Circuit Blood Red Cells Prior to Re-infusion. A Proof of Concept Study|Completed||Phase 3|9|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 14:41:13.021873|2017-02-18 14:41:13.021873
NCT00624598|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-09-15|||January 2008||2008-01-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|WCPC||The Short-Term Effect of a Technology Driven Weight Control (SMART) Program for Obese Adults|Phase I Study of Integrating RMR Technology and Email Counseling in a PCP Office.|Completed||N/A|110|Actual|Colorado Center for Chronic Care Innovations, Inc.||2|||f||||f||||||||||2017-02-18 14:41:13.122937|2017-02-18 14:41:13.122937
NCT00624585|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2013-11-21|2012-05-23||February 2008||2008-02-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts|A Pilot Study of Oral Dasatinib in Subjects With MDS and Excess Marrow Blasts|Completed||N/A|18|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 14:41:13.20671|2017-02-18 14:41:13.20671
NCT00624572|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2008-02-25|||October 2007||2007-10-01|February 2008|2008-02-01|February 2009|Anticipated|2009-02-01|November 2008|Anticipated|2008-11-01||Interventional|||Efficacy of Chlorexidine as Intracanal Medicament in Primary Teeth|Efficacy of 1% Chlorexidine Gel as Intracanal Medicament in Primary Molar Teeth - a Clinical and Microbiological Study|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Universidade Federal do Ceara||1|||f||||||||||||||2017-02-18 14:41:15.992843|2017-02-18 14:41:15.992843
NCT00624559|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2012-01-04|2011-08-17||February 2008||2008-02-01|January 2012|2012-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure|COX-2 Regulation of Renal Sodium Handling in Blood Pressure Maintenance|Completed||Phase 4|12|Actual|University of Delaware||4|||f||||t||||||||||2017-02-18 14:41:16.077843|2017-02-18 14:41:16.077843
NCT00624546|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-10-23|||January 2009||2009-01-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD|Effect of Antireflux Therapy on the Expression of Genes Known to be Important in Inflammation, Metaplasia and Neoplasia in Patients With GERD|Terminated||N/A|24|Actual|University of Rochester|||2|Expected recruitment numbers have not been achieved.|f||||t||||||Samples With DNA|"~     Esophageal mucosal biopsies~   "|||2017-02-18 14:41:16.623368|2017-02-18 14:41:16.623368
NCT00624533|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-26|||January 2006||2006-01-01|February 2008|2008-02-01|October 2006|Actual|2006-10-01|March 2006|Actual|2006-03-01||Interventional|GDS||Efficiency of GDS Method for Lumbar Stabilization for Non-Specific Low Back Pain in Primary Care|Evaluation of the Efficiency of Physiotherapeutic Treatment of Non-Specific Low Back Pain in Primary Care Centers Through GDS Techniques for Articular and Muscular Chains|Completed||Phase 2|160|Actual|Carlos III Health Institute||2|||f||||t||||||||||2017-02-18 14:41:16.729122|2017-02-18 14:41:16.729122
NCT00624520|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2014-12-15|2014-11-19||September 2008||2008-09-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|May 2012|Actual|2012-05-01||Interventional||Subjects randomized , including drop-outs before commencement of intervention.|Mental Stress Reduction in Defibrillator Patients|Effectiveness of Mental Stress Reduction in Defibrillator Patients|Terminated||Phase 3|129|Actual|VA Office of Research and Development|Early termination of study after 12 month study extension and interim data analysis, due to high drop-out rate and exhaustion of population pool, 9 subjects short of revised target enrollment.|2||"Exhaustion of subject population pool, greater than expected drop-out rates . Data analysis~   approved by DMC for study completions"|f||||t||||||||||2017-02-18 14:41:17.053009|2017-02-18 14:41:17.053009
NCT00624494|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2011-01-04|||May 2005||2005-05-01|January 2011|2011-01-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|OPCAB||Single Transpulmonary Thermodilution and Continuous Monitoring of Central Venous Oxygen Saturation During Off-pump Coronary Surgery|Single Transpulmonary Thermodilution and Continuous Monitoring of Central Venous Oxygen Saturation During Off-pump Coronary Surgery|Completed||N/A|40|Actual|Northern State Medical University||2|||f||||f||||||||||2017-02-18 14:41:17.898338|2017-02-18 14:41:17.898338
NCT00624481|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-03-11|||March 2008||2008-03-01|March 2008|2008-03-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD|A Phase 2, 24-Week, Multicenter, Randomized, Parallel-Group, Dose-Ranging Study To Evaluate The Effect Of Teriparatide Nasal Spray On Bone Mineral Density In Postmenopausal Women With Low Bone Mineral Density|Withdrawn||Phase 2|350|Anticipated|Nastech Pharmaceutical Company, Inc.||5|||f||||f||||||||||2017-02-18 14:41:18.011997|2017-02-18 14:41:18.011997
NCT00624468|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-01-19|2016-01-19||June 2008||2008-06-01|January 2016|2016-01-01|January 2011|Actual|2011-01-01|September 2009|Actual|2009-09-01||Interventional||Intent-to-treat (ITT) population included all randomized participants.|Atacicept in Subjects With Optic Neuritis|A Two-arm, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Study to Evaluate Safety and Tolerability and to Explore the Neuroprotective Effect of Atacicept as Assessed by Optical Coherence Tomography (OCT) in Subjects With Optic Neuritis (ON) as Clinically Isolated Syndrome (CIS) Over a 36-week Treatment Course|Terminated||Phase 2|34|Actual|EMD Serono|The Sponsor voluntarily terminated this trial after observing increased Multiple Sclerosis (MS) disease activity in trial 28063 (ATAMS).|2||"EMD Serono voluntarily decided to terminate this trial after observing increased MS disease~   activity in trial 28063 ATAMS [Please refer to ATAMS]"|f||||t||||||||||2017-02-18 14:41:18.142445|2017-02-18 14:41:18.142445
NCT00624455|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2009-08-17|||July 2007||2007-07-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||How Does Gabapentin Affects Post-operative Tonsillectomy Pain?|Does a Single Preoperative Dose of Gabapentin Reduce Postoperative Tonsillectomy Pain and Subsequent Morphine Requirement in Children?|Completed||Phase 3|28|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 14:41:19.256886|2017-02-18 14:41:19.256886
NCT00624442|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-06-28|2010-02-28||April 2007||2007-04-01|June 2011|2011-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study of CK-1827452 Infusion in Stable Heart Failure|A Phase II, Multi Center, Double-Blind, Randomized, Placebo Controlled, Dose-Escalation, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CK-1827452 in Patients With Stable Heart Failure|Completed||Phase 2|45|Actual|Cytokinetics|Other Adverse Event table shows treatment emergent adverse events that occurred in two or more patients. Total for Other Adverse Events is the number of patients affected by an adverse event where an adverse event occurred in two or more patients.|5|||f||||||||||||||2017-02-18 14:41:19.371841|2017-02-18 14:41:19.371841
NCT00624429|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2009-09-17|||March 2008||2008-03-01|February 2009|2009-02-01|January 2010|Anticipated|2010-01-01|December 2009|Anticipated|2009-12-01||Interventional|||A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children|A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children|Unknown status|Recruiting|Phase 4|20|Anticipated|Phoenix Children's Hospital||1|||f||||f||||||||||2017-02-18 14:41:20.419065|2017-02-18 14:41:20.419065
NCT00624416|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2015-12-17|2011-02-10||October 2007||2007-10-01|December 2015|2015-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas|A Pilot Study: Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas|Completed||Phase 1/Phase 2|10|Actual|Pennington Biomedical Research Center|The single case that did not have an increase in lipoma volume showed variability which may have been because of a small lipoma making accurate measurement difficult.|1|||f||||f||||||||||2017-02-18 14:41:20.513743|2017-02-18 14:41:20.513743
NCT00624403|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2015-03-09|||March 2008||2008-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|I-Gel||Comparison of Two Type of Laryngeal Mask : I-Gel & LMA ProSeal|LMA ProSeal & I-Gel : a Prospective Controlled Trial|Completed||N/A|700|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 14:41:20.757632|2017-02-18 14:41:20.757632
NCT00624390|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-12-13||2016-12-13|November 2007||2007-11-01|December 2016|2016-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Sepraspray™ Laparoscopic Myomectomy Study|A Randomized, Masked Patient, Independent Reviewer, Multi-Center Pilot Study to Evaluate the Feasibility of Sepraspray™ Adhesion Barrier in Laparoscopic Myomectomy|Completed||N/A|41|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:41:20.869407|2017-02-18 14:41:20.869407
NCT00624377|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2014-02-27|2012-02-23||December 2007||2007-12-01|February 2014|2014-02-01||||March 2010|Actual|2010-03-01||Observational|||Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice|Safety and Effectiveness of Spiriva® in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice|Completed||N/A|2031|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:41:20.958883|2017-02-18 14:41:20.958883
NCT00624364|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2017-01-05|||May 2004||2004-05-01|January 2017|2017-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes|Comparison of Efficacy and Safety of Biphasic Insulin Aspart Plus Metformin to Biphasic Insulin Aspart Monotherapy in Subjects With Type 2 Diabetes|Completed||Phase 4|140|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:41:21.479643|2017-02-18 14:41:21.479643
NCT00624351|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2011-09-02||2010-11-22|January 2008||2008-01-01|July 2011|2011-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease|A Phase IIb Randomized, Double-blind, Placebo-controlled, Dose and Dose Regimen-ranging Study of the Safety and Efficacy of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease|Completed||Phase 2|227|Actual|UCB Pharma||6|||f||||t||||||||||2017-02-18 14:41:21.596586|2017-02-18 14:41:21.596586
NCT00624338|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-03-11|2016-01-19||January 2008||2008-01-01|March 2016|2016-03-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Interventional|APRIL-SLE|Intent-to-treat (ITT) population included all the randomized participants, regardless of whether they received treatment.|Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)|A Randomised, Double-blind, Placebo Controlled, Multicentre Prospective Dose-finding Phase II/III Study With Atacicept Given Subcutaneously to Subjects Having Recently Experienced a Flare of Systemic Lupus Erythematosus (SLE)|Completed||Phase 2/Phase 3|461|Actual|EMD Serono|Atacicept 150 mg group was discontinued on 2 February 2011 based on the recommendation from the Independent Data Monitoring Committee.|3|||f||||||||||||||2017-02-18 14:41:21.767336|2017-02-18 14:41:21.767336
NCT00624325|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2011-03-10|||July 2007||2007-07-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|SCIN-C||Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders|Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders|Completed||Phase 2/Phase 3|30|Actual|Foundation for Liver Research||3|||f||||t||||||||||2017-02-18 14:41:22.931582|2017-02-18 14:41:22.931582
NCT00624312|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2013-09-30|||February 2008||2008-02-01|September 2013|2013-09-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations|A Prospective, Randomized, Double-Blinded Control Study of Procrit Versus Placebo to Determine Efficacy in Pre-Operative Patients Undergoing Major Surgical Oncology Operations|Withdrawn||Phase 2|0|Actual|University of Louisville||2|||f||||t||||||||||2017-02-18 14:41:23.205146|2017-02-18 14:41:23.205146
NCT00624299|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2015-03-17|||March 2008||2008-03-01|March 2015|2015-03-01|May 2010|Anticipated|2010-05-01|March 2010|Anticipated|2010-03-01||Interventional|||Botox Clinical Trial|Botulinum Toxin: an Adjunct in Limb Reconstruction - Can it Reduce Pain and Joint Complications in the Lengthening Phase?|Withdrawn||Phase 4|0|Actual|Sheffield Children's NHS Foundation Trust||2||"A similar study had already been conducted, therefore pursuing this trial would have been~   unethical"|f||||f||||||||||2017-02-18 14:41:23.314951|2017-02-18 14:41:23.314951
NCT00455780|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2011-05-24|||January 2005||2005-01-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|PrimaryCare||Weight Loss Maintenance in Primary Care|Weight Loss Maintenance in Primary Care|Completed||N/A|238|Actual|Drexel University||4|||f||||f||||||||||2017-02-18 15:43:54.071336|2017-02-18 15:43:54.071336
NCT00624286|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2011-07-22|2011-07-22||February 2008||2008-02-01|July 2011|2011-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Indacaterol (150 μg o.d.) in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|416|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:41:23.425323|2017-02-18 14:41:23.425323
NCT00624273|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2009-01-06|||February 2004||2004-02-01|July 2003|2003-07-01|February 2007|Actual|2007-02-01|November 2004|Actual|2004-11-01||Interventional|Sildenafil||Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis|Effect of Sildenafil on Digital Ulcers in Systemic Sclerosis|Completed||Phase 2|17|Actual|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-02-18 14:41:23.898943|2017-02-18 14:41:23.898943
NCT00624260|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-03-17|||June 2008||2008-06-01|March 2016|2016-03-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|ITEP||Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized Study|Impact of PET Scan on the Curative Strategy of Colo-rectal Cancers : A Randomized Study|Completed||N/A|240|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:41:24.003774|2017-02-18 14:41:24.003774
NCT00624247|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2014-10-16|||August 2007||2007-08-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|SWAB||Early Versus Delayed Routine HIV Testing in Connecticut Jails|Early Versus Delayed Routine HIV Testing in Connecticut Jails|Completed||Early Phase 1|621|Actual|Yale University||3|||f||||f||||||||||2017-02-18 14:41:24.106463|2017-02-18 14:41:24.106463
NCT00624234|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-25|2013-12-19|||February 2006||2006-02-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|March 2013|Actual|2013-03-01||Interventional|||Neurobiology and Treatment of Reading Disability in NF-1|Neurobiology and Treatment of Reading Disability in Neurofibromatosis Type 1 (NF-1)|Unknown status|Active, not recruiting|N/A|180|Anticipated|Vanderbilt University||3|||f||||f||||||||||2017-02-18 14:41:24.222018|2017-02-18 14:41:24.222018
NCT00624221|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-03-28|2010-02-02||January 2006||2006-01-01|October 2010|2010-10-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Study of Eye Bank Pre-cut Donor Grafts for Endothelial Keratoplasty|A Prospective, Randomized, Single Center Study Evaluating Use of Surgeon- and Eye Bank-prepared Donor Tissue for Descemet's Stripping and Endothelial Keratoplasty, a Type of Cornea Transplant|Completed||N/A|40|Actual|Cornea Research Foundation of America||2|||f||||f||||||||||2017-02-18 14:41:24.33314|2017-02-18 14:41:24.33314
NCT00624208|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2009-08-17|||February 2008||2008-02-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||The Effects of the Anti Nausea Drugs Droperidol and Ondansetron on the Way the Heart Recovers Between Beats|The Effects of Droperidol and Ondansetron on Dispersion of Myocardial Repolarization in Children|Completed||N/A|80|Anticipated|University of British Columbia||4|||f||||f||||||||||2017-02-18 14:41:24.630453|2017-02-18 14:41:24.630453
NCT00624195|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2014-03-21|2013-12-09||March 2007||2007-03-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Clinical Trial of CNS-targeted HAART (CIT2)|HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART|Completed||Phase 2/Phase 3|59|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 14:41:24.743321|2017-02-18 14:41:24.743321
NCT00624182|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2015-06-22|||February 2008||2008-02-01|June 2015|2015-06-01|December 2016|Anticipated|2016-12-01|April 2016|Anticipated|2016-04-01||Interventional|||Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer|Phase 1 Study of Gemcitabine With Vaccine Therapy Targeting Tumor Antigen, URLC10, For The Patients With Unresectable or Recurrent Bile Duct Cancer|Suspended||Phase 1|9|Anticipated|Akita University Hospital||1|||f||||t||||||||||2017-02-18 14:41:25.239952|2017-02-18 14:41:25.239952
NCT00624169|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2010-05-26|||November 2007||2007-11-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|PULP||Peptic Ulcer Perforation Study|Peptic Ulcer Perforation Study - an Optimized Perioperative Course for Patients Surgically Treated for Peptic Ulcer Perforation|Completed||N/A|200|Anticipated|Copenhagen University Hospital at Herlev||1|||f||||f||||||||||2017-02-18 14:41:25.358409|2017-02-18 14:41:25.358409
NCT00624156|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2015-10-28|||February 2008||2008-02-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Expressive Writing and Adjustment to Metastatic Breast Cancer|Expressive Writing and Adjustment to Metastatic Breast Cancer|Completed||N/A|98|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:41:25.451537|2017-02-18 14:41:25.451537
NCT00624143|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||February 2008||2008-02-01|January 2008|2008-01-01||||December 2009|Anticipated|2009-12-01||Interventional|||Antifungal Prophylaxis in Pediatric Acute Leukemia|Oral Voriconazole vs IV Low Dose Amphotericin B for Primary Antifungal Prophylaxis in Pediatric Acute Leukemia Induction:A Prospective, Randomized, Clinical Trial.|Unknown status|Recruiting|Phase 3|100|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 14:41:25.56653|2017-02-18 14:41:25.56653
NCT00624130|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2014-12-30|||March 2004||2004-03-01|December 2014|2014-12-01|June 2005|Actual|2005-06-01|||||Interventional|||Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers|Open, Randomized, Parallel Multi-center Comparison of Cycle Control and Safety of the Oral Contraceptive Yasmin 20 in a 24-day Regimen vs. Mercilon for 7 Cycles in 440 Healthy Female Volunteers|Completed||Phase 3|453|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:41:25.667539|2017-02-18 14:41:25.667539
NCT00624117|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2010-05-25|||May 2006||2006-05-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|||Progressive Exercise After Operation of Rotator Cuff Rupture and Anterior Labrum Rupture|Progressive Exercise After Operation of Rotator Cuff Rupture and Anterior Labrum Rupture: Randomized Controlled Trial|Completed||N/A|100|Actual|Jyväskylä Central Hospital||1|||f||||f||||||||||2017-02-18 14:41:25.782349|2017-02-18 14:41:25.782349
NCT00624104|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2011-11-04|||March 2008||2008-03-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||VLDL-triglyceride Under Acute Hyperinsulinaemia|VLDL-triglyceride Under Acute Hyperinsulinaemia|Completed||N/A|16|Actual|University of Aarhus|||2||f||||t||||||Samples With DNA|"~     specimen of muscle specimen of adipose tissue~   "|||2017-02-18 14:41:25.869971|2017-02-18 14:41:25.869971
NCT00623909|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2017-02-03|||January 2008||2008-01-01|February 2017|2017-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Laser Therapy in the Treatment of Post Thoracotomy Pain; A Pilot Study|Laser Therapy in the Treatment of Post Thoracotomy Pain; A Pilot Study.|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University||1||Principal Investigator left the institution|f||||f||||||||No|Not Applicable, study terminated prior to enrollment and closed|2017-02-18 14:41:29.416103|2017-02-18 14:41:29.416103
NCT00624091|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-02|2008-02-18|||September 2007||2007-09-01|February 2008|2008-02-01|September 2010|Anticipated|2010-09-01|November 2007|Anticipated|2007-11-01||Interventional|ENDOVAL||Rationale, Design and Methods for the Early Surgery in Infective Endocarditis Study (ENDOVAL)|Rationale, Design and Methods for the Early Surgery in Infective Endocarditis Study: a Multicenter, Prospective, Randomized Trial Comparing the State-of-the-Art Therapeutic Strategy Versus Early Surgery Strategy in Infective Endocarditis|Unknown status|Recruiting|Phase 4|216|Anticipated|Instituto de Ciencias del Corazon||2|||f||||t||||||||||2017-02-18 14:41:25.956522|2017-02-18 14:41:25.956522
NCT00624078|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-02-19|||May 2005||2005-05-01|February 2011|2011-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation|Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation|Completed||Phase 2/Phase 3|1426|Actual|Instituto Bioclon S.A. de C.V.||1|||f||||f||||||||||2017-02-18 14:41:26.218919|2017-02-18 14:41:26.218919
NCT00624065|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-11-04|2009-06-11||March 2008||2008-03-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure|COR111096, A Randomized, Double-Blind, Active-Controlled, Parallel Group, Multicenter Study Comparing the Proportion of Subjects With Stage 1 or 2 Essential Hypertension Who Achieve Target Blood Pressure While Receiving Either Carvedilol CR + Lisinopril or Lisinopril Monotherapy|Completed||Phase 3|348|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:41:26.358191|2017-02-18 14:41:26.358191
NCT00624052|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2014-05-13|2009-12-28||March 2008||2008-03-01|May 2014|2014-05-01||||June 2009|Actual|2009-06-01||Interventional|||26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension|An Open Label Trial of the Efficacy and Safety of Chronic Administration of the Fixed Dose Combination of Telmisartan 40mg + Amlodipine 10mg or Fixed Dose Combination of Telmisartan 80mg + Amlodipine 10mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension|Completed||Phase 3|838|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:41:27.022456|2017-02-18 14:41:27.022456
NCT00624039|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2008-02-18|||May 2006||2006-05-01|May 2006|2006-05-01|March 2008|Anticipated|2008-03-01|March 2008|Anticipated|2008-03-01||Interventional|||The Effect of Cataract Extraction on the Contractility of Ciliary Muscle|The Effect of Cataract Extraction on the Contractility of Ciliary Muscle|Unknown status|Enrolling by invitation|N/A|15|Actual|Samsung Medical Center||1|||f||||f||||||||||2017-02-18 14:41:27.927261|2017-02-18 14:41:27.927261
NCT00624026|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-10-31|||November 2007||2007-11-01|October 2011|2011-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Memantine - Communication Study|Prospective, Single-arm, Multicenter, Open-label Study to Investigate the Efficacy and Tolerability of the Once Daily (OD) Memantine Treatment|Completed||Phase 3|107|Actual|Merz Pharmaceuticals GmbH||1|||f||||f||||||||||2017-02-18 14:41:28.043239|2017-02-18 14:41:28.043239
NCT00624013|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2008-02-15|||September 2006||2006-09-01|February 2008|2008-02-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|DandD||Diabetes and Depression in Hispanics and African Americans: Treatment of Depression With Sertraline and Its Effect on A1c and Quality of Life|The Effects of Pharmacologic Treatment of Depression on Glycated Hemoglobin, Lipids and Quality of Life in Underserved Hispanics and African Americans With Diabetes: A Randomized, Placebo Controlled Trial|Unknown status|Active, not recruiting|Phase 4|89|Actual|Charles Drew University of Medicine and Science||2|||f||||t||||||||||2017-02-18 14:41:28.150523|2017-02-18 14:41:28.150523
NCT00624000|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-11-04|||March 2004||2004-03-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|September 2007|Actual|2007-09-01||Interventional|||IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion|IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion|Completed||N/A|7|Actual|University of North Carolina, Chapel Hill||2|||f||||||||||||||2017-02-18 14:41:28.256424|2017-02-18 14:41:28.256424
NCT00623987|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-03-24|||June 1999||1999-06-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|June 2006|Actual|2006-06-01||Interventional|Exten-DACUS||Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants|Absence of Residual Vein Thrombosis After an Episode of Unprovoked Deep Vein Thrombosis: Short-Term Anticoagulation is Safe.|Completed||Phase 4|500|Actual|Azienda Ospedaliera Universitaria Policlinico||2|||f||||t||||||||||2017-02-18 14:41:28.368144|2017-02-18 14:41:28.368144
NCT00623974|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2012-12-04|2010-08-13||May 2008||2008-05-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia|A Phase II Study of Short-Term Use of Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia|Terminated||Phase 2|7|Actual|M.D. Anderson Cancer Center||4||Terminated due to slow accrual.|f||||t||||||||||2017-02-18 14:41:28.477743|2017-02-18 14:41:28.477743
NCT00623961|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-01-12|||April 2007||2007-04-01|June 2010|2010-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Validation Study of Neuropathic Pain|Validation Study of Positive Phenomena in Neuropathic Pain|Completed||N/A|7|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 14:41:28.879276|2017-02-18 14:41:28.879276
NCT00623948|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-05-21|||September 2012||2012-09-01|May 2015|2015-05-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Implanted Gluteal Stimulation System for Pressure Sore Prevention|Implanted Gluteal Stimulation System for Pressure Sore Prevention|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||Suitable implanted technolgy was not available|f||||f||||||||||2017-02-18 14:41:28.960651|2017-02-18 14:41:28.960651
NCT00623935|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-03-10|2014-06-17||March 2007||2007-03-01|March 2016|2016-03-01|November 2015|Actual|2015-11-01|June 2013|Actual|2013-06-01||Interventional|||Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia|Hematopoietic Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia|Completed||Phase 2|56|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-02-18 14:41:29.058164|2017-02-18 14:41:29.058164
NCT00623922|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-04-07|||February 2008||2008-02-01|April 2015|2015-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effect of Patient Education in Rheumatic Diseases|The Effect of Patient Education on Coping and Well Being in Patients With Arthritis.|Completed||N/A|141|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 14:41:29.301657|2017-02-18 14:41:29.301657
NCT00623896|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-17|2008-02-25|||June 2007||2007-06-01|June 2007|2007-06-01|August 2008|Anticipated|2008-08-01|May 2008|Anticipated|2008-05-01||Observational|Nehb-STEMI||3 Nehb Precordial Leads Anterior, Dorsalis and Inferior Allow Accurate Diagnostics of Different Heart Conditions|Nehb 3-Lead Bipolar Leads for Rapid Diagnosis & Treatment of STEMI|Unknown status|Recruiting|N/A|100|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-02-18 14:41:29.520821|2017-02-18 14:41:29.520821
NCT00623883|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2008-02-15|||January 1999||1999-01-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded Trial|Colonoscopic Biomarkers for Cancer Risk Assessment and Prevention|Completed||N/A|98|Actual|National Naval Medical Center||2|||f||||t||||||||||2017-02-18 14:41:29.612565|2017-02-18 14:41:29.612565
NCT00623870|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2016-11-01|||May 2008||2008-05-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.|An Open Label Study to Investigate the Maximum Tolerated Dose of RO5045337 in Patients With Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) in Blast Phase, or Refractory Chronic Lymphocytic Leukemia/Small Cell Lymphocytic Lymphoma (CLL / SCLL)|Completed||Phase 1|116|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:41:29.877237|2017-02-18 14:41:29.877237
NCT00623857|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2014-11-14|||March 2008||2008-03-01|November 2014|2014-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|MACH||Micronutrients and Child Health Study|Effects of Supplementation With Zinc and Other Micronutrients on the Health and Development of African Children|Completed||Phase 3|612|Actual|Wageningen University||4|||f||||t||||||||||2017-02-18 14:41:29.999541|2017-02-18 14:41:29.999541
NCT00623844|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-03-30|||May 2007||2007-05-01|December 2014|2014-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|PAKT||Prevention Through Activity in Kindergarten Trial|Prevention Through Acitivity in Kindergarten Trial|Completed||Phase 2/Phase 3|718|Actual|University of Wuerzburg||2|||f||||f||||||||||2017-02-18 14:41:30.171187|2017-02-18 14:41:30.171187
NCT00623831|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-11-10|2016-09-21||May 2007||2007-05-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional||All Enrolled Subjects|A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen|A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen.|Completed||Phase 1|17|Actual|Ludwig Institute for Cancer Research||2|||f||||f||||||||Yes|Data have been published|2017-02-18 14:41:30.284774|2017-02-18 14:41:30.284774
NCT00623818|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2017-01-25|||February 11, 2008||2008-02-11|December 21, 2016|2016-12-21||||||||Observational|||Mirror Therapy for Phantom Limb Pain|fMRI Investigation of Cortical Reorganization and Phantom Limb Pain Following Amputation|Completed||N/A|45|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:41:31.308258|2017-02-18 14:41:31.308258
NCT00623805|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2014-07-16|2014-06-06||March 2008||2008-03-01|July 2014|2014-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Intent-to-treat population: All randomized participants with a least 1 post-randomization efficacy assessment.|A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer|A Randomized, Multicenter Phase III Trial to Assess the Efficacy and Safety of Bevacizumab and Capecitabine as Maintenance Treatment, After Initial Combination Treatment With Capecitabine, Oxaliplatin and Bevacizumab in Patients With Metastatic Colorectal Adenocarcinoma|Completed||Phase 3|123|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:41:31.410778|2017-02-18 14:41:31.410778
NCT00623792|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-03-15|||March 2008||2008-03-01|March 2016|2016-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PREP||Study on Impact of Lifestyle Change and Weight Loss Before Bariatric Surgery|Preoperative Lifestyle Intervention in Bariatric Surgery|Completed||N/A|300|Actual|Duquesne University||2|||f||||f||||||||||2017-02-18 14:41:31.847767|2017-02-18 14:41:31.847767
NCT00623779|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2012-03-20|2011-06-30||October 2007||2007-10-01|March 2012|2012-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)|A Controlled, Randomized, Parallel , Multi-centre Feasibility Study of the Oral Direct Thrombin Inhibitor, AZD0837, Given as ER Formulation, in the Prevention of Stroke and Systolic Embolic Events in Patients With Atrial Fibrillation, Who Are Appropriate for But Unable/Unwilling to Take VKA Therapy|Completed||Phase 2|128|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 14:41:31.95688|2017-02-18 14:41:31.95688
NCT00623766|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2014-05-27|2013-12-17||July 2008||2008-07-01|May 2014|2014-05-01|October 2012|Actual|2012-10-01|September 2009|Actual|2009-09-01||Interventional|||Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases|A Multi-Center Phase II Study to Evaluate Tumor Response to Ipilimumab (BMS-734016) Monotherapy in Subjects With Melanoma Brain Metastases|Completed||Phase 2|99|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:41:32.772158|2017-02-18 14:41:32.772158
NCT00623753|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2011-09-14|||May 2007||2007-05-01|September 2011|2011-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults|Evaluate Tolerability and Safety of Multi-Envelope, Prime-boost HIV Vaccine (DVP) in Healthy Adults|Terminated||Phase 1|3|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 14:41:33.744175|2017-02-18 14:41:33.744175
NCT00623740|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2016-08-12|||April 2008||2008-04-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|PREMILOC||PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates|Early Prevention of Broncho-pulmonary Dysplasia and Neonatal Mortality in Very Preterm Infants Using Low Dose of Hydrocortisone: a Randomized Controlled Trial|Completed||Phase 3|523|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:41:33.857786|2017-02-18 14:41:33.857786
NCT00623727|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2013-07-08|2011-06-10||June 2008||2008-06-01|July 2013|2013-07-01|October 2010|Actual|2010-10-01|April 2010|Actual|2010-04-01||Interventional|||BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A|Randomized, Active-controlled, Double-blind, Parallel Design Study to Evaluate the Efficacy and Safety of a Once-a-week Prophylaxis Treatment With BAY79-4980 Compared to Three Times-per-week Prophylaxis With rFVIII-FS in Previously Treated Patients With Severe Hemophilia A|Terminated||Phase 2|143|Actual|Bayer|The recruitment and double-blind study phase were prematurely terminated after a scheduled interim analysis confirmed overt failure regarding the primary endpoint as judged by the independent Data and Safety Monitoring Board.|2|||f||||t||||||||||2017-02-18 14:41:33.976334|2017-02-18 14:41:33.976334
NCT00623714|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-04-15|2010-05-24||January 2008||2008-01-01|April 2015|2015-04-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Induced Sputum Study (0000-065)|A Randomized, Placebo-Controlled, Crossover Study to Assess the Effects of Inhaled Fluticasone on Markers of Inflammation After Allergen Challenge in Patients With Allergic Asthma|Completed||Phase 1|13|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:41:37.373624|2017-02-18 14:41:37.373624
NCT00623701|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2013-11-07|||March 2008||2008-03-01|November 2013|2013-11-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional|ALLEGRA6||Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation|A Multicentre, Multinational, Placebo-controlled, Double-blind, Randomized Study to Evaluate Efficacy and Safety of a Perennial, Sublingual, Specific Immunotherapy in Patients With Rhinoconjunctivitis With/Without Controlled Asthma Caused by Grass Pollen|Completed||Phase 3|126|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 14:41:37.645255|2017-02-18 14:41:37.645255
NCT00623688|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2015-01-13|||February 2008||2008-02-01|January 2015|2015-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital|Effectiveness and Costs of Albuterol Delivered by MDI With Spacer Versus Nebulizer in Children Hospitalized With Moderate and Severe Asthma Exacerbations|Completed||N/A|11|Actual|Akron Children's Hospital||2|||f||||t||||||||||2017-02-18 14:41:37.744867|2017-02-18 14:41:37.744867
NCT00623675|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-17|2009-07-06|||February 2008||2008-02-01|July 2009|2009-07-01||||||||Interventional|||Heavy Metal Urine Analysis in 20 Healthy Persons Taking Mineralox|Heavy Metal Urine Analysis in 20 Healthy Persons Taking Mineralox|Suspended||Phase 4|20|Anticipated|CreoMed, Inc.||1|||f||||f||||||||||2017-02-18 14:41:37.859593|2017-02-18 14:41:37.859593
NCT00623662|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-03-25|||February 2008||2008-02-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Preoperative Glucose Infusion: a Novel Strategy to Improve Liver Function After Liver Resection|Metabolic Preconditioning Using Intravenous Dextrose: a Novel Strategy to Improve Hepatic Function After Liver Resection|Recruiting||N/A|50|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-02-18 14:41:37.952|2017-02-18 14:41:37.952
NCT00623649|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2014-04-02|||November 2007||2007-11-01|February 2014|2014-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection|A Phase 1B, Multicentre, Randomized, Double-Blinded, and PLacebo-Controlled Study of the Antiviral Activity, Safety, Tolerability, and PK of Multiple Ascending Doses of VCH-916 in the Treatment Naive or Experienced Subjects With Chronic Hep C-Infection.|Completed||Phase 1|42|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||t||||||||||2017-02-18 14:41:38.069106|2017-02-18 14:41:38.069106
NCT00623636|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2013-12-09|2013-08-19||July 2008||2008-07-01|December 2013|2013-12-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|FREEDOM301|mITT population was defined as all randomized subjects who reported a qualifying migraine and received at least one dose of study treatment, and had at least one post-treatment efficacy evaluation.|Phase 3 Study of MAP0004 in Adult Migraineurs|A Randomized, Double Blind, Placebo Controlled, Parallel Group, Phase 3 Study of MAP0004 in Adult Migraineurs for a Single Migraine Followed by Open Label Extension.|Completed||Phase 3|902|Actual|Allergan||2|||f||||t||||||||||2017-02-18 14:41:38.195197|2017-02-18 14:41:38.195197
NCT00623623|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2014-04-30||2014-04-30|March 2008||2008-03-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction|STREAM (Strategic Reperfusion Early After Myocardial Infarction). Comparison of the Efficacy and Safety of a Strategy of Early Fibrinolytic Treatment With Tenecteplase and Additional Antiplatelet and Antithrombin Therapy Followed by Catheterisation Within 6-24 Hours or Rescue Coronary Intervention Versus a Strategy of Standard Primary PCI in Patients With Acute Myocardial Infarction Within 3 Hours of Onset of Symptoms|Completed||Phase 3|1891|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:41:38.685272|2017-02-18 14:41:38.685272
NCT00623610|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-19|||September 2000||2000-09-01|February 2008|2008-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes|Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes|Completed||Phase 1/Phase 2|36|Actual|AZ-VUB||1|||f||||f||||||||||2017-02-18 14:41:39.190468|2017-02-18 14:41:39.190468
NCT00623597|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2016-02-04|2015-12-10||June 2008||2008-06-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||The Safety Analysis Population (SAP) comprised all participants who received at least one dose of study medication. The SAP was used for all efficacy and safety analyses|A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.|A Phase I/II Study of Invirase® Boosted With Ritonavir in HIV Infected Infants and Children 4 Months to Less Than 6 Years Old|Completed||Phase 2|18|Actual|Hoffmann-La Roche||1|||f||||f||||||||Yes||2017-02-18 14:41:39.2937|2017-02-18 14:41:39.2937
NCT00623584|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2010-12-07|||April 2011||2011-04-01|December 2010|2010-12-01|October 2012|Anticipated|2012-10-01|April 2012|Anticipated|2012-04-01||Interventional|SFM||Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture Media|In Vitro and Clinical Comparison of Corneal Grafts Cultured in Serum Free Medium or Standard Serum Supplemented Medium in Patients With Degeneration of the Corneal Endothelium|Unknown status|Not yet recruiting|N/A|60|Anticipated|Klinikum Chemnitz gGmbH||2|||f||||t||||||||||2017-02-18 14:41:40.57815|2017-02-18 14:41:40.57815
NCT00623571|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2008-02-25|||April 2004||2004-04-01|January 2004|2004-01-01|October 2005|Actual|2005-10-01|April 2005|Actual|2005-04-01||Interventional|||Hospitalization at Home of Elderly Patients With Heart Failure|"Acute Exacerbation of Chronic Heart Failure: Hospital at Home Versus Inpatient Care for Elderly Patients. A Randomized, Controlled Trial."|Completed||N/A|101|Actual|Azienda Ospedaliera San Giovanni Battista||2|||f||||f||||||||||2017-02-18 14:41:40.688073|2017-02-18 14:41:40.688073
NCT00623558|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-17|2013-12-03|||April 2008||2008-04-01|April 2013|2013-04-01|August 2013|Actual|2013-08-01|November 2012|Actual|2012-11-01||Interventional|||Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)|A Randomized, Multicenter, Open Phase II Study of Cetuximab With Docetaxel, Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)|Completed||Phase 2|92|Actual|Seoul National University Hospital||2|||f||||f||||||||||2017-02-18 14:41:40.787805|2017-02-18 14:41:40.787805
NCT00004770|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||October 1995||1995-10-01|December 2001|2001-12-01||||||||Interventional|||Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy||Completed||N/A|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.32953|2017-02-18 18:16:17.32953
NCT00623545|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-01-05|2013-07-22||January 2008||2008-01-01|January 2015|2015-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Bioenergetic Alterations After Exenatide Administration|Bioenergetic Alterations After Exenatide Administration|Completed||Phase 4|28|Actual|University of Wisconsin, Madison|study was limited by the number of subjects who did not complete the study as a result of nausea. The nausea was short-lived and mild in all subjects that completed the study.|1|||f||||f||||||||||2017-02-18 14:41:40.899911|2017-02-18 14:41:40.899911
NCT00623532|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2009-05-18|||May 2006||2006-05-01|May 2009|2009-05-01|February 2008|Actual|2008-02-01|||||Interventional|||Intervention Study of Mind-Body Physical Activity in Frail Institutionalized Elderly|A Randomized Interventional Study of a Cognition-Action Physical Activity and Adapted Tai-Chi in Frail Institutionalized Elderly|Completed||N/A|160|Actual|Association de Recherche Gerontologique||3|||f||||t||||||||||2017-02-18 14:41:41.168174|2017-02-18 14:41:41.168174
NCT00623519|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-03-06|||June 2004||2004-06-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|||||Observational|||Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole|Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole.|Completed||N/A|165|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 14:41:41.276663|2017-02-18 14:41:41.276663
NCT00623506|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2013-05-13|2013-03-05||January 2008||2008-01-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|August 2009|Actual|2009-08-01||Interventional|||Adjunctive Pregnenolone in Veterans With Mild TBI|Adjunctive Pregnenolone in Veterans With Mild TBI|Completed||N/A|30|Actual|Durham VA Medical Center||2|||f||||||||||||||2017-02-18 14:41:41.390197|2017-02-18 14:41:41.390197
NCT00623493|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-24|2017-01-24|||February 6, 2008||2008-02-06|December 15, 2016|2016-12-15||||||||Observational|||Detecting Risk of Suicide in a Pediatric Emergency Department|Detecting Risk of Suicide in a Pediatric Emergency Department|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:41:41.839098|2017-02-18 14:41:41.839098
NCT00623480|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-11-05|2013-05-02||March 2008||2008-03-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|September 2011|Actual|2011-09-01||Interventional|SPINART||Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment|Randomized, Controlled, Parallel, Prospective Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects, as Applicable, Compared to That of Episodic Treatment|Completed||Phase 3|84|Actual|Bayer||2|||f||||t||||||||||2017-02-18 14:41:41.94723|2017-02-18 14:41:41.94723
NCT00623467|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2014-01-16|2011-06-20||December 2007||2007-12-01|January 2014|2014-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging|A Multicenter, Open-label, Phase 3 Study to Determine the Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients Referred for Contrast-enhanced MRI of the Central Nervous System (CNS).|Completed||Phase 3|343|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:41:42.511575|2017-02-18 14:41:42.511575
NCT00623454|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-08-25|||March 2007||2007-03-01|August 2011|2011-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Non Cardiac Chest Pain and Benign Palpitations|A Randomized Controlled Trial of Cognitive Behavioural Therapy for Non-cardiac Chest Pain and Palpitations.|Completed||Phase 4|40|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 14:41:43.785114|2017-02-18 14:41:43.785114
NCT00623441|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2015-10-26|2009-09-01||September 2005||2005-09-01|October 2015|2015-10-01|February 2009|Actual|2009-02-01|November 2007|Actual|2007-11-01||Observational|eFive||E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent|E-Five Registry: To Evaluate the 'Real World' Clinical Performance of the Medtronic Endeavor ABT-578 Eluting Coronary Stent System; A Prospective, Multicenter Registry|Completed||N/A|8314|Actual|Medtronic Cardiovascular|Data collection in this large global registry was limited to MACE (major adverse cardiac events) defined as the composite endpoint of death, myocardial infarction (Q- and non-Q-wave), emergent cardiac bypass surgery and TLR.||1||f||||t||||||||||2017-02-18 14:41:43.879478|2017-02-18 14:41:43.879478
NCT00623428|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2013-07-15|2013-05-02||June 2008||2008-06-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response|A Randomized, Open-label Study of the Effects of 24 vs 48 Weeks of Combination Therapy With PEGASYS (Peginterferon Alfa-2a 40KD) Plus COPEGUS (Ribavirin) on Sustained Virological Response in Patients With Chronic Hepatitis C, Genotype 2 or 3 Who do Not Achieve a Rapid Viral Response|Completed||Phase 3|235|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:41:44.169381|2017-02-18 14:41:44.169381
NCT00623415|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-01-27|||December 2007||2007-12-01|January 2016|2016-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|FLORIMS||Flupirtine as Oral Treatment in Multiple Sclerosis|Multicentric, Prospective, Double Blind, Randomized/Stratified, Placebo-controlled Pilot-study for Evaluation of Safety and Efficacy of Flupirtine add-on to Interferon-β1b on Neurodegeneration in Patients With Relapsing Remitting Multiple Sclerosis|Terminated||Phase 2|30|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 14:41:45.079325|2017-02-18 14:41:45.079325
NCT00623402|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-01-11|||January 2008||2008-01-01|February 2008|2008-02-01||||October 2009|Actual|2009-10-01||Interventional|SoraPeg||Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma|Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma: a Prospective Non-randomized, Multicenter Phase II Study|Completed||Phase 2|55|Anticipated|University of Schleswig-Holstein||1|||f||||t||||||||||2017-02-18 14:41:45.176062|2017-02-18 14:41:45.176062
NCT00623389|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2016-03-17|||May 2005||2005-05-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|LE-IST||Evaluation of an Advanced Lower Extremity Neuroprostheses|Evaluation of Advanced Lower Extremity Neuroprostheses|Recruiting||N/A|10|Anticipated|Case Western Reserve University||1|||f||||t||||||||||2017-02-18 14:41:45.302762|2017-02-18 14:41:45.302762
NCT00623376|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-25|||July 2007||2007-07-01|June 2007|2007-06-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Randomized Double Blind Cross Over Study for Nabilone in Spasticity in Spinal Cord Injury Persons|Randomized Double Blind Cross Over Study Assessing the Effect of Cannabiniods on Spasticity in Spinal Cord Injured Persons :A Pilot Study|Completed||Phase 2|||University of Manitoba||2|||f||||||||||||||2017-02-18 14:41:45.417028|2017-02-18 14:41:45.417028
NCT00623350|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2011-05-11|||December 2007||2007-12-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Stroke DOC Arizona TIME - Stroke Team Remote Evaluation Using a Digital Observation Camera|Stroke Team Remote Evaluation Using a Digital Observation Camera Arizona - The Initial Mayo Clinic Experience|Completed||N/A|60|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:41:45.603565|2017-02-18 14:41:45.603565
NCT00623337|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2010-02-17|||January 2009||2009-01-01|February 2010|2010-02-01|April 2010|Anticipated|2010-04-01|March 2010|Anticipated|2010-03-01||Interventional|Newhints||Ghana Newborn Home Visits Neonatal Mortality Trial|Cluster Randomised Trial to Evaluate the Impact of Routine Home Visits to Provide a Package of Essential Newborn Care Interventions in the Third Trimester of Pregnancy and the 1st Week of Life on Neonatal Mortality in Rural Ghana|Unknown status|Active, not recruiting|Phase 3|15000|Anticipated|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 14:41:45.710199|2017-02-18 14:41:45.710199
NCT00623324|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-09-29|||January 2008||2008-01-01|September 2011|2011-09-01||||July 2008|Actual|2008-07-01||Interventional|||The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease|A Phase II, Dose Ranging, Randomized, Double Blind, Placebo-controlled, Multi-center, Pilot Study to Assess the Safety, Tolerability, Efficacy and Pharmacokinetics of Aplindore in Patients With Early Stage Parkinson's Disease|Completed||Phase 2|40|Anticipated|Ligand Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:41:45.821442|2017-02-18 14:41:45.821442
NCT00623298|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-25|||January 2005||2005-01-01|February 2008|2008-02-01|March 2006|Actual|2006-03-01|||||Interventional|||Narrative Exposure Therapy Versus Group Interpersonal Psychotherapy|Narrative Exposure Therapy Versus Group Interpersonal Psychotherapy -A Controlled Clinical Trial With Orphaned Survivors of the Rwandan Genocide|Terminated||Phase 2|26|Actual|University of Konstanz||3|||f||||f||||||||||2017-02-18 14:41:46.124191|2017-02-18 14:41:46.124191
NCT00623285|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-03-14|||April 2008||2008-04-01|March 2011|2011-03-01|June 2011|Anticipated|2011-06-01|March 2011|Anticipated|2011-03-01||Interventional|||The Effects of Peri-operative Pregabalin Administration on Post-operative Analgesia in Patients Undergoing Coronary Bypass Grafting|The Effects of Peri-operative Pregabalin Administration on Post-operative Analgesia in Patients Undergoing Coronary Bypass Grafting|Unknown status|Recruiting|Phase 3|40|Anticipated|University of Manitoba||2|||f||||t||||||||||2017-02-18 14:41:46.215259|2017-02-18 14:41:46.215259
NCT00623272|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-08-21|||November 2008||2008-11-01|June 2008|2008-06-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|||Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between Bi-, Three-dimensional and Cardiac Magnetic Resonance|Left Ventricular Function Assessment After Acute Myocardial Infarction: Comparison Between bi-, Three-dimensional and Cardiac Magnetic Resonance|Completed||N/A|120|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||t||||||||||2017-02-18 14:41:46.321384|2017-02-18 14:41:46.321384
NCT00623259|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2010-05-19|||May 2008||2008-05-01|May 2010|2010-05-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects|Phase I Vaccination Study Testing the Safety and Reactogenicity of a Recombinant MVA HIV Multiantigen Vaccine (MVA-mBN120B) in HIV-infected Subjects With CD4 Count > 350/µL|Completed||Phase 1|15|Anticipated|Bavarian Nordic||1|||||||t||||||||||2017-02-18 14:41:46.420669|2017-02-18 14:41:46.420669
NCT00623246|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-09-28|||December 2007||2007-12-01|December 2014|2014-12-01|November 2015|Actual|2015-11-01|November 2012|Actual|2012-11-01||Interventional|BREATHE||Evaluating Behavioral Treatments to Improve Adherence to Continuous Positive Airway Pressure (CPAP) Therapy in People With Obstructive Sleep Apnea (The BREATHE Study)|Motivating Adherence to CPAP in Obstructive Sleep Apnea|Completed||N/A|306|Actual|National Jewish Health||3|||f||||t||||||||||2017-02-18 14:41:46.513163|2017-02-18 14:41:46.513163
NCT00623233|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2011-12-02|2011-12-02||March 2008||2008-03-01|December 2011|2011-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer|A Phase 2 Study of Gemcitabine and Bevacizumab as First-Line Treatment in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer Previously Treated With Taxanes|Completed||Phase 2|52|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:41:46.629343|2017-02-18 14:41:46.629343
NCT00623220|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2013-10-28|||March 2008||2008-03-01|October 2013|2013-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Inhaled Nitrous Oxide for Pain Relief During Eye Exam in the Pre-term Infant|A Randomized Controlled Trial on the Effectiveness of Inhaled Nitrous Oxide for Pain Relief During ROP Screening Exam in the Pre-term Infant|Completed||Phase 3|40|Actual|McGill University Health Center||2|||f||||f||||||||||2017-02-18 14:41:47.049666|2017-02-18 14:41:47.049666
NCT00623207|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-07-24|||December 2007||2007-12-01|July 2015|2015-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Use of Atropine in Tredmill Stress Testing|Safety and Feasibility of Atropine Added During Treadmill Stress Testing in Patients With Chronotropic Incompetence or Poor Exercise Capacity.|Completed||Phase 3|103|Actual|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-02-18 14:41:47.154641|2017-02-18 14:41:47.154641
NCT00623194|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-10-17|2010-09-05||February 2008||2008-02-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689|A 52-Week, Multinational, Multi-Centre, Open-Labelled Extension Trial of Insulin Detemir in Children and Adolescents 3-17 Years With Type 1 Diabetes on a Basal-Bolus Regimen With Insulin Aspart as Bolus Insulin|Completed||Phase 3|146|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 14:41:47.258745|2017-02-18 14:41:47.258745
NCT00623181|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2016-04-12|2011-07-14||January 2008||2008-01-01|April 2016|2016-04-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults|Preference for Fluzone Vaccine Administered Intradermally Versus Intramuscularly in Healthy Adult Subjects 18-49 Years of Age|Completed||Phase 2|110|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:41:47.821801|2017-02-18 14:41:47.821801
NCT00623168|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-08-24|||February 2008||2008-02-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Ribavirin for Hemorrhagic Fever With Renal Syndrome|A Phase 2 Treatment Protocol of Intravenous Ribavirin in Adult Subjects With Hemorrhagic Fever With Renal Syndrome (HFRS) in the 121st Combat Support Hospital (Seoul, Korea)|Enrolling by invitation||Phase 2|50|Anticipated|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 14:41:48.325102|2017-02-18 14:41:48.325102
NCT00623155|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-22|||July 2002||2002-07-01|September 2002|2002-09-01|January 2004|Actual|2004-01-01|July 2003|Actual|2003-07-01||Interventional|||Seasonal Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine in Children in Mali|Evaluation of a Malaria Transmission Target Strategy Based on the Periodic Treatment With Sulfadoxine-Pyrimethamine vs. Early Case Management|Completed||N/A|262|Actual|University of Bamako||2|||f||||f||||||||||2017-02-18 14:41:48.434497|2017-02-18 14:41:48.434497
NCT00623142|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-22|||January 2005||2005-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||The Protective Effects Of Treatment With Hyperbaric Oxygen Prior To Bypass Heart Surgery|The Effects of Hyperbaric Oxygen Preconditioning On Cardiovascular Protection & Ischemic Reperfusion Injury|Completed||Phase 1/Phase 2|81|Actual|Hull and East Yorkshire Hospitals NHS Trust||2|||f||||t||||||||||2017-02-18 14:41:48.529342|2017-02-18 14:41:48.529342
NCT00623129|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2016-04-18|||February 2006||2006-02-01|August 2011|2011-08-01||||November 2010|Actual|2010-11-01||Interventional|||Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer|Electroacupuncture for Xerostomia in Head and Neck Patients|Terminated||N/A|30|Anticipated|Mayo Clinic||||Slow accrual; did not meet accrual goal|f||||t||||||||||2017-02-18 14:41:48.643713|2017-02-18 14:41:48.643713
NCT00623116|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-02-13|||December 2007||2007-12-01|January 2008|2008-01-01|December 2025|Anticipated|2025-12-01|December 2012|Anticipated|2012-12-01||Interventional|||A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland|Kallmann Syndrome in Finland|Enrolling by invitation||N/A|50|Anticipated|Hospital for Children and Adolescents, Finland||1|||f||||f||||||||||2017-02-18 14:41:48.739074|2017-02-18 14:41:48.739074
NCT00623103|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-10-19|2011-10-19||January 2008||2008-01-01|October 2011|2011-10-01||||November 2010|Actual|2010-11-01||Interventional|||Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)|A 76-week Prospective, Open-label, Multicenter Study to Evaluate the Long-term Effect of Rivastigmine Capsule and Transdermal Patch on Worsening of the Underlying Motor Symptoms of PD in Patients With Mild to Moderately Severe Dementia Associated With Parkinson's Disease (PDD)|Completed||Phase 3|583|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:41:48.849785|2017-02-18 14:41:48.849785
NCT00623090|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2012-12-11|||October 2007||2007-10-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Interventional|PCSEd||Internet-Based Education for Prostate Cancer Screening|Internet-Based Education for Prostate Cancer Screening|Completed||Phase 3|1893|Actual|Georgetown University||3|||f||||f||||||||||2017-02-18 14:41:50.151365|2017-02-18 14:41:50.151365
NCT00623077|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2015-04-10|||August 2005||2005-08-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|July 2012|Actual|2012-07-01||Interventional|||MT2004-30: Tomotherapy for Solid Tumors|Dose Escalation of Total Marrow Irradiation Added to an Alkylator-Intense Conditioning Regimen for Patients With High Risk or Relapsed Solid Tumors|Terminated||Phase 1|23|Actual|Masonic Cancer Center, University of Minnesota||1||Replaced by another study|f||||t||||||||||2017-02-18 14:41:50.26593|2017-02-18 14:41:50.26593
NCT00623064|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2014-06-30|||November 2007||2007-11-01|June 2014|2014-06-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional|||Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer|Phase I Study of Cisplatin, Gemcitabine and Lapatinib as First Line Treatment in Advanced/Metastatic Urothelial Cancer|Completed||Phase 1|18|Actual|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||||||||||||2017-02-18 14:41:50.414225|2017-02-18 14:41:50.414225
NCT00623051|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-07-16|||January 2008||2008-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ORANGE FARM 2||Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)|Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)|Completed||N/A|27000|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||f||||||||||2017-02-18 14:41:50.518293|2017-02-18 14:41:50.518293
NCT00623038|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-04-21|||March 2008||2008-03-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|TEST-APGAR||Trial to Evaluate a Specified Type of APGAR|Trial to Evaluate a Specified Type of APGAR|Completed||N/A|1855|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-02-18 14:41:50.623945|2017-02-18 14:41:50.623945
NCT00623025|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-07-28|||January 2009||2009-01-01|July 2011|2011-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Creon in HIV Patients With Steatorrhea|Double-blind, Cross-over, Randomized, Placebo-controlled, Multi-center Study to Investigate the Effect of Creon®25 000 on the Coefficient of Fat Absorption of HIV-infected Patients|Terminated||Phase 3|34|Actual|Abbott||2||Discontinued prematurely due to low enrollment|f||||f||||||||||2017-02-18 14:41:50.707165|2017-02-18 14:41:50.707165
NCT00623012|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-12-09|2016-10-06||February 2008||2008-02-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Rapamycin for Prevention of Chronic Graft-Versus-Host Disease|Rapamycin for Prevention of Chronic Graft-Versus-Host Disease|Terminated||Phase 1/Phase 2|2|Actual|Yale University|Only 2 patients were enrolled. Early termination of trial, so patients were not followed long enough to see improvement.|1||Low accrual|f||||f||||||||||2017-02-18 14:41:50.824319|2017-02-18 14:41:50.824319
NCT00622999|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-03-10|||January 2003||2003-01-01|March 2011|2011-03-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|||Effects of Malnutrition on Colon Cancer Patients With Abdominal Surgery|Effects of Malnutrition on Colon Cancer Patients With Abdominal Surgery|Completed||N/A|186|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-02-18 14:41:51.040808|2017-02-18 14:41:51.040808
NCT00622986|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-22|||February 2008||2008-02-01|February 2008|2008-02-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|CCCCC||China Cimicifuga Trial of Climacteric Complaint Control|A Multicentered RCT Study of the Efficacy and Safety of an Extract of Cimicifuga Foetida L. for the Treatment of Climacteric Symptoms of Chinese Women|Unknown status|Recruiting|Phase 4|288|Anticipated|Shandong Luye Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-02-18 14:41:51.13077|2017-02-18 14:41:51.13077
NCT00622973|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2011-10-07|||September 2007||2007-09-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases|Noninvasive Detection of Clinically Occult Lymph Node Metastases in Prostate and Bladder Cancer Evaluated by USPIO-Enhanced MRI and Diffusion-Weighted MRI: A Histopathological Correlation|Completed||Phase 3|130|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-02-18 14:41:51.261432|2017-02-18 14:41:51.261432
NCT00622960|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2008-02-22|||April 2004||2004-04-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes|Comparison of High Monounsaturated Fat and High Carbohydrate Diets on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes|Completed||Phase 1|124|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 14:41:51.377465|2017-02-18 14:41:51.377465
NCT00622947|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2010-06-25|||February 2008||2008-02-01|June 2010|2010-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Antidepressant Effect of Right Temporal Low Frequency rTMS Compared to Sham|The Antidepressant Effect of Right Temporal Kow Frequency rTMS Compared to Sham. A Clinical Controlled, Randomized, Blinded Study.|Terminated||Phase 2/Phase 3|10|Actual|University of Aarhus||2||to few included patients|f||||f||||||||||2017-02-18 14:41:51.487421|2017-02-18 14:41:51.487421
NCT00622934|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2010-11-17|||July 2007||2007-07-01|November 2010|2010-11-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|EPREX||Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients|Relationship Between Clinical Recovery and Oxidative Stress and Inflammation Following Usage of Erythropoietin in Admitted Traumatic Patient In Intensive Care Unit|Unknown status|Recruiting|Phase 2|20|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:41:51.60187|2017-02-18 14:41:51.60187
NCT00622921|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2012-01-26|||February 2008||2008-02-01|January 2012|2012-01-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Couples-based Behavioral Psychotherapy for Male Patients With Posttraumatic Stress Disorder and Alcohol Dependence|Couples-based Behavioral Psychotherapy for Male Patients With Posttraumatic Stress Disorder and Alcohol Dependence|Withdrawn||Phase 2/Phase 3|0|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:41:51.709379|2017-02-18 14:41:51.709379
NCT00622908|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-03-04|2009-06-29||December 2004||2004-12-01|March 2015|2015-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis|A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis|Completed||Phase 2|270|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:41:51.86072|2017-02-18 14:41:51.86072
NCT00622895|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2016-09-06|||September 2006||2006-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis|Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis|Recruiting||Phase 1/Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 14:41:52.369052|2017-02-18 14:41:52.369052
NCT00622882|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-01-06|||October 2007||2007-10-01|January 2014|2014-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia|Early Infectious Disease Consultation for Better Outcomes From Staphylococcus Aureus Bacteremia|Unknown status|Recruiting|N/A|200|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-02-18 14:41:52.513956|2017-02-18 14:41:52.513956
NCT00622869|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2013-05-17|2013-04-02||January 2008||2008-01-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|RAD||Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients|A 24 Month, Multicenter, Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients|Completed||Phase 3|719|Actual|Novartis||3|||f||||||||||||||2017-02-18 14:41:52.633156|2017-02-18 14:41:52.633156
NCT00622856|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2017-01-10|||February 2008||2008-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||The Cost-efficacy of Psychological Intervention for Strengthening Parental Authority Among Parents of Diabetic Adolescents With Poor Glycemic Control|The Cost-efficacy of Psychological Intervention for Strengthening Parental Authority Among Parents of Diabetic Adolescents With Poor Glycemic Control|Recruiting||N/A|100|Anticipated|Rabin Medical Center||3|||f||||f||||||||||2017-02-18 14:41:57.597356|2017-02-18 14:41:57.597356
NCT00622843|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-10-07|||December 2002||2002-12-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting|An Open-Label, Phase III, Randomized Study of Pneumococcal Conjugate Vaccination in HIV, in Comparison to Polysaccharide Vaccine Boosting in Previously Vaccinated Patients|Completed||Phase 3|275|Actual|Uniformed Services University of the Health Sciences||3|||f||||t||||||||||2017-02-18 14:41:57.719282|2017-02-18 14:41:57.719282
NCT00622830|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-11-02|||January 2008||2008-01-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-|Phase I Study of SB-480848 (Darapladib) -A Double Blind, Randomised, Placebo-controlled, Parallel-group, Repeat Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SB-480848 in Healthy Japanese Male Subjects-|Completed||Phase 1|18|Anticipated|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:41:57.83452|2017-02-18 14:41:57.83452
NCT00622817|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-25|||October 2004||2004-10-01|February 2002|2002-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||The Influence of Inhaled Adrenalin Versus Decongestant as a Local Nasal Treatment in Bronchiolitis|Double Blinded Controled Study:Treatment With Adrenaline Inhalation Versus Nasal Decongestant Drops for Bronchiolitis|Completed||N/A|65|Actual|Schneider Children's Medical Center, Israel||2|||f||||f||||||||||2017-02-18 14:41:57.936077|2017-02-18 14:41:57.936077
NCT00622804|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2009-07-31|||July 2007||2007-07-01|July 2009|2009-07-01||||July 2009|Anticipated|2009-07-01||Interventional|||Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy|Phase III Study on Comparison for Bile Reflux and Gastric Stasis in Patients With Gastric Cancer After Distal Gastrectomy|Withdrawn||Phase 3|90|Anticipated|The Catholic University of Korea||3||It was very difficult to enroll patients in this study.|f||||f||||||||||2017-02-18 14:41:58.044125|2017-02-18 14:41:58.044125
NCT00622791|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2008-02-13||||||February 2008|2008-02-01||||||||Observational|||Propofol Pharmacokinetics and Pharmacodynamics During Cardiopulmonary Bypass|Effects of Cardiopulmonary Bypass on Plasma Propofol Concentrations and Bis Values During Coronary Surgery|Completed||N/A|20|Actual|University of Sao Paulo|||2||f||||t||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 14:41:58.16934|2017-02-18 14:41:58.16934
NCT00622765|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-04-24||2011-06-03|November 2007||2007-11-01|April 2014|2014-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Investigate the Safety and Efficacy of JNJ-16269110 in Overweight and Obese Subjects|Completed||Phase 2|321|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||t||||||||||2017-02-18 14:41:58.36976|2017-02-18 14:41:58.36976
NCT00622752|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2008-06-16|||February 2008||2008-02-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes|A Double-Blind, Randomized, Placebo- and NRT -Controlled Phase II Study to Assess the Effects of EVT 302 Alone and in Combination With NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes|Completed||Phase 2|90|Anticipated|Evotec Neurosciences GmbH||4|||f||||f||||||||||2017-02-18 14:41:58.501616|2017-02-18 14:41:58.501616
NCT00622739|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-06-25|2014-03-12||February 2007||2007-02-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Ziprasidone in Pediatric Bipolar Disorder|Ziprasidone in Pediatric Bipolar Disorder: a 6-week, Open-label Comparison of Rapid vs. Slow Dose Titration|Completed||Phase 4|28|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 14:41:58.621615|2017-02-18 14:41:58.621615
NCT00622726|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-02-22|2013-05-08||March 2008||2008-03-01|February 2016|2016-02-01|August 2020|Anticipated|2020-08-01|August 2010|Actual|2010-08-01||Interventional|BEAT-ROP||Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity|Intravitreal Bevacizumab (AvastinTM) Injections Versus Conventional Laser Surgery for Vision-threatening Retinopathy of Prematurity: a Prospective, Randomized, Non-blinded, Controlled, Multi-center, Clinical Trial|Active, not recruiting||Phase 2|150|Actual|The University of Texas Health Science Center, Houston|"Limitations:~number of patients is too small to determine efficacy of bevacizumab in posterior zone II ROP.~number of patients is too small to determine safety of bevacizumab systemically."|2|||f||||t||||||||||2017-02-18 14:41:58.956121|2017-02-18 14:41:58.956121
NCT00622713|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-06-27|2010-12-10||January 2008||2008-01-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|EXTRA||A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)|A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (MMSE 10-26)|Completed||Phase 4|228|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:41:59.605965|2017-02-18 14:41:59.605965
NCT00622700|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-02-25|2014-11-07||February 2008||2008-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|December 2012|Actual|2012-12-01||Interventional|TOPIC|Randomized population: all randomized participants according to the treatment group to which they were assigned.|Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis|An International, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Year Treatment With Teriflunomide 7 mg Once Daily and 14 mg Once Daily Versus Placebo in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis Plus a Long Term Extension Period|Completed||Phase 3|618|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 14:41:59.922664|2017-02-18 14:41:59.922664
NCT00622687|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-22|||September 1997||1997-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2003|Actual|2003-12-01||Interventional|ILODOSE||Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis|Comparision Between Maximally Tolerated Intravenous Iloprost Doses Versus Low-Dosed Iloprost for a 21-Day Treatment Course|Terminated||Phase 2|50|Actual|Charite University, Berlin, Germany||2||sufficient number to reach the primary endpoint and as planned|f||||f||||||||||2017-02-18 14:42:01.51804|2017-02-18 14:42:01.51804
NCT00622674|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2010-04-13|||November 2005||2005-11-01|April 2010|2010-04-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors|Phase I Study of Bortezomib (Velcade) and Cetuximab (Erbitux) for Patients With Solid Tumors Expressing EGFR|Completed||Phase 1|37|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:42:01.663101|2017-02-18 14:42:01.663101
NCT00622661|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2012-01-04|||June 2006||2006-06-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|CARB||Carbohydrates and Related Biomarkers|A Feeding Study to Examine the Effect of Glycemic Load and Obesity on Cancer Biomarkers|Completed||N/A|89|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 14:42:01.796562|2017-02-18 14:42:01.796562
NCT00622648|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2010-12-27|||January 2008||2008-01-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|LIFENOX||Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin|International, Multi-center, Randomized, Double Blind Study to Compare the Overall Mortality in Acutely Ill Medical Patients Treated With Enoxaparin Versus Placebo in Addition to Graduated Elastic Stockings|Completed||Phase 4|8329|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:42:01.917621|2017-02-18 14:42:01.917621
NCT00622635|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2011-07-22|2011-07-22||January 2008||2008-01-01|July 2011|2011-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)|A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, 3-period, 14-day Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol (300 µg Once Daily [od]) in Patients With Moderate-to-severe COPD, Using Open-label Salmeterol (50 µg Twice Daily [Bis in Die, Bid]) as Active Control|Completed||Phase 3|68|Actual|Novartis||6|||f||||||||||||||2017-02-18 14:42:02.047673|2017-02-18 14:42:02.047673
NCT00622622|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2009-02-17|||November 2006||2006-11-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|December 2006|Actual|2006-12-01||Interventional|||Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer|Phase I Study of Gemcitabine With Antiangiogenic Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*2402 Derived From VEGFR2 in Patients With Unresectable, Locally Advanced, Recurrent or Metastatic Pancreatic Cancer|Completed||Phase 1|21|Actual|Wakayama Medical University||1|||f||||t||||||||||2017-02-18 14:42:02.905161|2017-02-18 14:42:02.905161
NCT00622427|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2013-04-02|2012-06-05||February 2008||2008-02-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia|Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia|Completed||Phase 4|32|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:42:05.907758|2017-02-18 14:42:05.907758
NCT00622609|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-10-26|||August 2007||2007-08-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Anti-MAG First Administration to Human|A Single-blind, Single Dose, Placebo Controlled, Parallel Group, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Ascending IV Doses of GSK249320 in Healthy Volunteers|Completed||Phase 1|46|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:42:03.015791|2017-02-18 14:42:03.015791
NCT00622596|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-08-23|||October 2003||2003-10-01|August 2016|2016-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|Project BEST||Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance|Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance|Completed||N/A|200|Actual|Yale University||1|||f||||t||||||||No||2017-02-18 14:42:03.134512|2017-02-18 14:42:03.134512
NCT00622583|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-12-20|||September 2007||2007-09-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|IHMR||International Hernia Mesh Registry|A Two-Year Follow-up, Post-Implantation, Multi-center, International Hernia Mesh Registry|Recruiting||N/A|3500|Anticipated|Ethicon, Inc.|||1||f||||f||||||||||2017-02-18 14:42:03.243832|2017-02-18 14:42:03.243832
NCT00622570|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-22|||May 2002||2002-05-01|July 2007|2007-07-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension|Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension.|Terminated||Phase 3|44|Actual|Hospital Universitari Son Dureta||2||Slowly recruitment rate. Intermediate analysis|f||||f||||||||||2017-02-18 14:42:03.52895|2017-02-18 14:42:03.52895
NCT00622557|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-12-11|||May 2007||2007-05-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|SOCRATES||General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)|General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)|Unknown status|Recruiting|N/A|200000|Anticipated|University Hospitals Cleveland Medical Center|||1||f||||f||||||||||2017-02-18 14:42:03.651765|2017-02-18 14:42:03.651765
NCT00622544|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2013-12-12|||July 2007||2007-07-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|MA||A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome|A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome|Completed||N/A|44|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||Samples Without DNA|"~     Each urine sample will be assayed for albumin, total protein and creatinine. The following~     definitions will be used:~        -  Microalbuminuria: urine albumin:creatinine ratio (ACR) > 30 mcg/mg, on 3 consecutive~          measurements spaced one month apart~        -  Overt proteinuria: urine protein:creatinine ratio (UPC) > 0.2 mg/mg, on 3 consecutive~          measurements spaced one month apart~   "|||2017-02-18 14:42:03.736199|2017-02-18 14:42:03.736199
NCT00622531|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2015-11-16|||January 2007||2007-01-01|November 2015|2015-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|USE-BNP||Serial BNP Testing for Heart Failure Management|Utilizing, Studying, Evaluating BNP for Monitoring in Patients With Heart Failure (USE-BNP)|Terminated||N/A|108|Actual|Siemens Healthcare Diagnostics Inc|||2|Study terminated due to insufficient enrollment|f||||f||||||Samples Without DNA|"~     plasma~   "|||2017-02-18 14:42:03.825036|2017-02-18 14:42:03.825036
NCT00622518|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2010-11-04|2010-09-28||February 2008||2008-02-01|November 2010|2010-11-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Ear Drops for Children With Otitis Media|Ear Drops for Children With Otitis Media|Completed||N/A|119|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 14:42:03.960029|2017-02-18 14:42:03.960029
NCT00622505|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-11-16|||November 2007||2007-11-01|November 2016|2016-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|Z-MARK||Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients|Bone Marker Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Advanced Multiple Myeloma|Completed||Phase 4|159|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:42:04.565739|2017-02-18 14:42:04.565739
NCT00622492|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-22|||January 2008||2008-01-01|February 2008|2008-02-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Observational|ECMO||Circulatory Changes During Venovenous (VV)- and Venoarterial (VA) Extracorporeal Membrane Oxygenation (ECMO)|ECMO in Newborn Infants: Circulatory Changes in Relation to Venovenous and Venoarterial Bypass. Implications for Peripheral Organ Circulation|Unknown status|Recruiting|N/A|30|Anticipated|Radboud University|||2||f||||||||||Samples Without DNA|"~     whole blood, urine~   "|||2017-02-18 14:42:04.720904|2017-02-18 14:42:04.720904
NCT00622479|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-12-17|||May 2008||2008-05-01|December 2014|2014-12-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.|Mechanistic Evaluations on Sorafenib Induced Hypophosphatemia in Patients With Advanced Renal Cell Carcinoma|Terminated||Phase 1|12|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:42:04.82178|2017-02-18 14:42:04.82178
NCT00622466|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2015-05-29|||October 2007||2007-10-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer|Phase II Trial of Sorafenib and Paclitaxel for Measurable Metastatic HER2-Negative Breast Cancer|Active, not recruiting||Phase 2|41|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-02-18 14:42:04.938129|2017-02-18 14:42:04.938129
NCT00622453|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2015-07-29|||September 1996||1996-09-01|July 2015|2015-07-01|December 2017|Anticipated|2017-12-01|January 2006|Actual|2006-01-01||Observational|DM1||Arrhythmias in Myotonic Muscular Dystrophy|A Registry of Arrhythmias in Myotonic Muscular Dystrophy|Active, not recruiting||N/A|448|Actual|Indiana University|||1||f||||t||||||||||2017-02-18 14:42:05.062164|2017-02-18 14:42:05.062164
NCT00622440|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-08-11|2014-07-17||March 2008||2008-03-01|August 2014|2014-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|AIJP||Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream|Phase II Study for Treatment of Anal HSIL Through Use of a Chinese Herbal Topical Cream|Completed||Phase 2|70|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:42:05.181184|2017-02-18 14:42:05.181184
NCT00180284|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-09-28|||November 2004||2004-11-01|September 2011|2011-09-01|February 2008|Actual|2008-02-01|May 2005|Actual|2005-05-01||Interventional|||SITELINE 2 Polyurethane|SITELINE 2 Polyurethane Clinical Investigation|Completed||Phase 3|200|Actual|Boston Scientific Corporation||1|||f||||||||||||||2017-02-18 17:17:52.648763|2017-02-18 17:17:52.648763
NCT00622414|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-22|2014-02-21|||April 2008||2008-04-01|October 2011|2011-10-01||||February 2010|Actual|2010-02-01||Interventional|||Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors|A Phase I Study of VEGF Trap (NSC# 724770, IND# 100137) in Children With Refractory Solid Tumors|Completed||Phase 1|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:42:06.265777|2017-02-18 14:42:06.265777
NCT00622401|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-02-16|2016-01-20||December 2009||2009-12-01|February 2016|2016-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Females >18yo with metastatic breast cancer|Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12|Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12|Terminated||Phase 1/Phase 2|8|Actual|Dana-Farber Cancer Institute|In the conduct of the study, it became apparent that the setting of advanced breast cancer with malignant effusions/ascites for vaccine generation was a difficult setting for evaluation of an immune based therapy.|3|||f||||t||||||||||2017-02-18 14:42:06.381817|2017-02-18 14:42:06.381817
NCT00622388|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2015-07-02|2011-08-04||December 2007||2007-12-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|May 2010|Actual|2010-05-01||Interventional|||Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant|An Open-label, Single-arm. Multi-center Phase 2 Trial With Ofatumumab in Patients With Relapsed/Progressive Diffuse Large B-Cell Lymphoma (DLBCL) Ineligible for Transplant or Relapse/Progression After Autologous Transplant|Completed||Phase 2|81|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-02-18 14:42:06.786663|2017-02-18 14:42:06.786663
NCT00622375|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2009-12-21|||February 2008||2008-02-01|December 2009|2009-12-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers|A Phase I, Single- And Multiple-Dose, Relative Bioavailability and Pharmacokinetic Study of Encapsulated Mesalamine Granules Administered Orally to Healthy Volunteers|Completed||Phase 1|24|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-02-18 14:42:07.29297|2017-02-18 14:42:07.29297
NCT00622362|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2015-07-14|||January 2008||2008-01-01|January 2009|2009-01-01||||February 2009|Actual|2009-02-01||Interventional|||Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract|Depigmented and Polymerised Allergenic Extract of Dermatophagoides Pteronyssinus as Antiasthmatic Treatment for Children With Slight Allergic Asthma to Mites|Suspended||Phase 2|90|Anticipated|Laboratorios Leti, S.L.||3||Lack of recruitment|f||||f||||||||||2017-02-18 14:42:07.506167|2017-02-18 14:42:07.506167
NCT00622349|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2013-01-29|||February 2004||2004-02-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|||Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer|A Phase III Randomised Study Comparing Three Combination Chemotherapy Regimens in Patients With Non Pre-treated Advanced Non-small Cell Lung Cancer|Completed||Phase 3|707|Actual|European Lung Cancer Working Party||3|||f||||t||||||||||2017-02-18 14:42:07.623002|2017-02-18 14:42:07.623002
NCT00622336|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2014-12-18|2014-12-18||December 2003||2003-12-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma|Open-Label, Single-Arm Study of the Safety and Efficacy of CC-5013 Monotherapy for Subjects With Multiple Myeloma: A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010|Completed||Phase 3|330|Actual|Celgene||1|||f||||f||||||||||2017-02-18 14:42:07.756023|2017-02-18 14:42:07.756023
NCT00622323|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2016-10-25|||February 2008||2008-02-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients|Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients|Completed||N/A|41|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:42:08.72275|2017-02-18 14:42:08.72275
NCT00622310|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-05-06|||September 2007||2007-09-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|March 2018|Anticipated|2018-03-01||Interventional|||Energy Expenditure & Activity During & After Exercise-Induced Weight Loss|Energy Expenditure & Activity During & After Exercise-Induced Weight Loss|Active, not recruiting||N/A|40|Anticipated|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 14:42:08.819367|2017-02-18 14:42:08.819367
NCT00622284|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2013-12-11|2011-11-30||February 2008||2008-02-01|December 2013|2013-12-01||||December 2010|Actual|2010-12-01||Interventional|||Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes|A Randomised Double-blind, Active-controlled Parallel Group Efficacy and Safety Study of BI 1356 ( 5.0 mg, Administered Orally Once Daily) Compared to Glimepiride Over Two Years in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy|Completed||Phase 3|1560|Actual|Boehringer Ingelheim|With the exception of HbA1c<6.5% and HbA1c<7.0% at Week52, all other endpoints are presented in the Week52 repeated analysis within the final clinical trial report, where discrepancies between interim and final results are also explained.|2|||f||||||||||||||2017-02-18 14:42:08.950075|2017-02-18 14:42:08.950075
NCT00622271|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-11-16|||February 2008||2008-02-01|November 2011|2011-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Intervention Groups for Adolescents With Type 1 Diabetes Mellitus|Adjustment and Self-Management Intervention Groups for Adolescents With Type 1 Diabetes Mellitus and Their Parents.|Completed||N/A|30|Actual|Children's Hospital and Health System Foundation, Wisconsin||1|||f||||f||||||||||2017-02-18 14:42:11.041695|2017-02-18 14:42:11.041695
NCT00622258|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2014-09-24|||March 2008||2008-03-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 1|13|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:42:11.140007|2017-02-18 14:42:11.140007
NCT00622245|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2010-09-24|||January 2008||2008-01-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression|Randomised, Double-blind, Parallel-group, Placebo-controlled, and Active Referenced Study of Lu AA34893 to Evaluate the Efficacy and Safety of Three Doses Lu AA34893 in the Treatment of Depression in Patients With Bipolar I or II Disorder|Terminated||Phase 2|166|Actual|H. Lundbeck A/S||5||Human metabolite not yet covered sufficiently by nonclinical data|f||||f||||||||||2017-02-18 14:42:11.252829|2017-02-18 14:42:11.252829
NCT00171665|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-13|||May 2005||2005-05-01|April 2015|2015-04-01|December 2005||2005-12-01|||||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis|Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis|Completed||Phase 3|360||Novartis|||||||||||||||||||2017-02-18 17:19:45.448999|2017-02-18 17:19:45.448999
NCT00622232|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2011-06-07|||December 2007||2007-12-01|June 2011|2011-06-01|June 2023|Anticipated|2023-06-01|January 2009|Actual|2009-01-01||Interventional|Rollover||A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial|A Rollover Study to Evaluate Safety and Therapeutic Effect of Re-infusing Subjects Who Completed Participation in the VRX496-USA-05-002 Trial With Autologous T Cells Transduced With VRX496|Active, not recruiting||Phase 2|40|Anticipated|VIRxSYS Corporation||1|||f||||t||||||||||2017-02-18 14:42:11.408905|2017-02-18 14:42:11.408905
NCT00622219|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-01-02|||March 2008||2008-03-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Mentored Clinical Career Award in Adolescent Substance Abuse|Mentored Clinical Career Award in Adolescent Substance Abuse|Unknown status|Active, not recruiting|Phase 1/Phase 2|90|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 14:42:11.502423|2017-02-18 14:42:11.502423
NCT00622206|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-04-03|||January 2008||2008-01-01|April 2012|2012-04-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Pharmacokinetics of Low Dose Ritonavir|Pharmacokinetics of Low Dose Ritonavir in Thai Patients on a Saquinavir 1500 mg Based HAART Regimen|Completed||Phase 1/Phase 2|20|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||f||||||||||2017-02-18 14:42:11.603899|2017-02-18 14:42:11.603899
NCT00622193|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2011-06-08||2011-06-08|March 2008||2008-03-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Anamorelin HCl Dose Range Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients With NSCLC|Completed||Phase 2|228|Actual|Helsinn Therapeutics (U.S.), Inc||3|||f||||t||||||||||2017-02-18 14:42:11.716575|2017-02-18 14:42:11.716575
NCT00622180|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2009-01-21|||January 2008||2008-01-01|February 2008|2008-02-01|April 2009|Anticipated|2009-04-01|January 2009|Anticipated|2009-01-01||Interventional|||The Efficacy of Hand NBUVB Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands|The Efficacy of Hand-Foot Narrow-Band UVB Versus Focal 308-nm Treatment in Inducing Repigmentation of Vitiligo After Minigrafting on the Dorsal Hands|Unknown status|Active, not recruiting|N/A|25|Anticipated|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 14:42:11.96137|2017-02-18 14:42:11.96137
NCT00622167|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-01-03|2011-07-28||January 2008||2008-01-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|April 2008|Actual|2008-04-01||Interventional|||Comparison of DSCT With IB-IVUS and Angiography in the Assessment of Coronary Artery Disease|Comparison of Dual Source Computed Tomography (DSCT) With Integrated Backscatter Intravascular Ultrasound (IB-IVUS) and Contrast Angiography in the Assessment of Coronary Artery Disease|Terminated||N/A|24|Actual|Massachusetts General Hospital|Study terminated after imaging 4 subjects due to slow enrollment. Results will not be analyzed.|1||Subject recruitment was slow, so enrollment has been closed.|f||||f||||||||||2017-02-18 14:42:12.065384|2017-02-18 14:42:12.065384
NCT00622141|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-03-24||||||March 2015|2015-03-01||||||||Interventional|||Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®|Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir® in Thai Healthy Volunteers|Withdrawn||Phase 1/Phase 2|0|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2||"The study was never started because the sponsor decided not to manufacture the investigational~   product."|f||||f||||||||||2017-02-18 14:42:12.285839|2017-02-18 14:42:12.285839
NCT00622128|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2010-10-14|||June 2009||2009-06-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|PAVeD||Preventing Aggressive Behavior in Demented Patients|Preventing Aggressive Behavior in Demented Patients|Completed||Phase 3|10|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 14:42:12.389376|2017-02-18 14:42:12.389376
NCT00622115|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2011-03-14|||July 2007||2007-07-01|March 2011|2011-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)|A Phase I, Pharmacokinetic and Tolerability Study of Intravenous Unfractionated Heparin After Subcutaneous Enoxaparin 1mg/kg Bid Repeated Administration in Healthy Subjects|Completed||Phase 1|72|Actual|Sanofi||3|||f||||||||||||||2017-02-18 14:42:12.488395|2017-02-18 14:42:12.488395
NCT00622102|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2009-12-01|||December 2007||2007-12-01|December 2009|2009-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Testing Strategies to Improving Warfarin Adherence|Testing Strategies to Improving Warfarin Adherence|Completed||N/A|101|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:42:12.588159|2017-02-18 14:42:12.588159
NCT00622089|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-05-22|||January 2008||2008-01-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients|An Open Label Follow-On Study of Safety and Pharmacodynamic Effects of 24 Weeks of Treatment With DIO-902 in Combination With Metformin and Atorvastatin in Subjects With Type 2 Diabetes Mellitus (Protocol No. DIO-503)|Terminated||Phase 2/Phase 3|150|Anticipated|DiObex||3||Program terminated|f||||f||||||||||2017-02-18 14:42:12.696161|2017-02-18 14:42:12.696161
NCT00622076|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2008-02-13|||January 2006||2006-01-01|January 2008|2008-01-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Postoperative Catheterization After Anterior Colporrhaphy|Randomised Controled Multicenter Trial Regarding the Appropriate Length of Postoperative Catheterization After Anterior Colporrhaphy for Repair of Cystocele|Unknown status|Recruiting|N/A|230|Anticipated|Atrium Medical Center||2|||f||||t||||||||||2017-02-18 14:42:12.973608|2017-02-18 14:42:12.973608
NCT00622063|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2013-02-22||2013-02-21|December 2006||2006-12-01|February 2013|2013-02-01||||September 2008|Actual|2008-09-01||Interventional|||An Extension Study for Patients Previously Treated With ARQ 501|An Extension Study for Patients Previously Treated With ARQ 501|Completed||Phase 1/Phase 2|1|Actual|ArQule||1|||f||||f||||||||||2017-02-18 14:42:13.07065|2017-02-18 14:42:13.07065
NCT00622050|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-10-15|||January 2008||2008-01-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|TView||The Relationship of TV Viewing to Energy Balance in Adults|The Effects of Limiting TV Viewing on Diet, Exercise, and Sleep in Overweight and Obese Adults|Completed||N/A|44|Anticipated|University of Vermont||2|||f||||||||||||||2017-02-18 14:42:13.162474|2017-02-18 14:42:13.162474
NCT00622037|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2010-02-02|||February 2008||2008-02-01|February 2010|2010-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality||Completed||Phase 4|70|Anticipated|Bp Consulting, Inc||2|||f||||||||||||||2017-02-18 14:42:13.254734|2017-02-18 14:42:13.254734
NCT00622024|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-02-22|||January 2009||2009-01-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery|Perioperative Depression and Postoperative Arrhythmia in Elective Coronary Bypass Graft Surgery|Completed||N/A|120|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 14:42:13.367204|2017-02-18 14:42:13.367204
NCT00622011|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-02-11|||January 2008||2008-01-01|January 2008|2008-01-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Interventional|||Risperidone and Zotepine in the Treatment of Delirium|Risperidone and Zotepine in the Treatment of Delirium|Unknown status|Recruiting|Phase 4|60|Anticipated|Changhua Christian Hospital||2|||f||||f||||||||||2017-02-18 14:42:13.454146|2017-02-18 14:42:13.454146
NCT00621998|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2008-02-13|||July 2000||2000-07-01|February 2000|2000-02-01|June 2004|Actual|2004-06-01|December 2003|Actual|2003-12-01||Interventional|||Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia|A Randomized Controlled Trial of Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia|Completed||Phase 4|60|Actual|Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan||2|||f||||t||||||||||2017-02-18 14:42:13.57188|2017-02-18 14:42:13.57188
NCT00621985|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2011-01-26|2010-09-17||April 2008||2008-04-01|January 2011|2011-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Dexamethasone Treatment of Congenital Adrenal Hyperplasia|Dexamethasone Treatment of Congenital Adrenal Hyperplasia|Completed||Phase 2|5|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-02-18 14:42:13.682624|2017-02-18 14:42:13.682624
NCT00621972|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-02-21|||January 2008||2008-01-01|January 2008|2008-01-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Observational|||AV Fistula Salvage in Advanced CKD Using Sodium Bicarbonate Prophylaxis|A Prospective Observational Study on the Use of Iodinated Contrast for AV Fistula Salvage in Stage 4/5 CKD Using Bicarbonate Prophylaxis|Unknown status|Recruiting|N/A|25|Anticipated|Maine Medical Center|||1||f||||f||||||||||2017-02-18 14:42:13.939075|2017-02-18 14:42:13.939075
NCT00621959|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-01-06|2009-06-18||March 2008||2008-03-01|January 2015|2015-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine 5 mg Once Daily Given for 2 Weeks in Subjects 18 yr of Age and Older With Seasonal Allergic Rhinitis|Completed||Phase 4|596|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 14:42:14.043485|2017-02-18 14:42:14.043485
NCT00621946|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2014-01-02|2013-05-24||March 2008||2008-03-01|January 2014|2014-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||One participant had no post-baseline data, leaving 25 evaluable participants in the intent-to-treat sample that was used in the analysis.|Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder|Escitalopram in the Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 4|26|Actual|University of Texas Southwestern Medical Center|A limitation of this proof-of-concept study was the small sample size.|2|||f||||||||||||||2017-02-18 14:42:14.413729|2017-02-18 14:42:14.413729
NCT00621933|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2012-07-16|2011-10-17||December 2007||2007-12-01|July 2012|2012-07-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Observational|||Surveillance of Ocular Surface Flora (SURFACE)||Completed||N/A|399|Actual|Allergan|||1||f||||f||||||Samples Without DNA|"~     Culture Swabs of the conjunctiva and eyelids~   "|||2017-02-18 14:42:14.954219|2017-02-18 14:42:14.954219
NCT00621920|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-02-08|||January 2008||2008-01-01|February 2012|2012-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy Study of Bowel Preparation Before Colonoscopy|Efficacy Study of Bowel Preparation Before Colonoscopy|Completed||Phase 2|72|Actual|C.B. Fleet Company, Inc.||1|||f||||f||||||||||2017-02-18 14:42:15.213578|2017-02-18 14:42:15.213578
NCT00621907|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2010-09-15|||March 2008||2008-03-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|LEVOBU||Study : LEVOBUPIVACAINE Versus Placebo|Levobupivacïne Into Post-analgesia : Randomized Monocentric Study Against Placebo|Completed||Phase 3|140|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t||||||||||2017-02-18 14:42:15.284194|2017-02-18 14:42:15.284194
NCT00621894|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-07-26||2012-07-26|March 2008||2008-03-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation|A Phase IIA Randomized, Double-Blind, Placebo-Controlled Study of LGD-4665 in Patients With Immune Thrombocytopenic Purpura (ITP) With an Open Label Extension|Completed||Phase 2|22|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:42:15.389036|2017-02-18 14:42:15.389036
NCT00621881|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2011-06-16|||January 2008||2008-01-01|June 2011|2011-06-01||||April 2008|Actual|2008-04-01||Interventional|||A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects|A Phase 1, Repeated-Dose, Open-Label Study to Investigate the Pharmacokinetics and Safety of Naproxcinod 750 mg Bid Administered to Patients With Impaired Hepatic Function Compared to Matching Healthy Subjects|Completed||Phase 1|24|Anticipated|NicOx||1|||f||||t||||||||||2017-02-18 14:42:15.50301|2017-02-18 14:42:15.50301
NCT00621868|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2016-01-18|||February 2008||2008-02-01|January 2016|2016-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Phase 2 Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus|A Phase 2, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|361|Actual|Astellas Pharma Inc||5|||f||||f||||||||Undecided||2017-02-18 14:42:15.611348|2017-02-18 14:42:15.611348
NCT00621855|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-02-10|2010-11-18||March 2008||2008-03-01|February 2014|2014-02-01||||October 2009|Actual|2009-10-01||Interventional|||RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome|RandomizEd Dabigatran Etexilate Dose Finding Study in Patients With Acute Coronary Syndromes Post Index Event With Additional Risk Factors for Cardiovascular Complications Also Receiving Aspirin and Clopidogrel: Multi-centre, Prospective, Placebo Controlled, Cohort Dose Escalation Study (RE-DEEM)|Completed||Phase 2|1878|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-02-18 14:42:15.734294|2017-02-18 14:42:15.734294
NCT00448162|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-03-30|||May 2005||2005-05-01|May 2009|2009-05-01|December 2009||2009-12-01|||||Observational|||The Chinese Mutation Hotspot of ENaC Causing Liddle's Syndrome and the Association of ENaC Variations and Hypertension||Suspended||N/A|2000|Anticipated|Peking Union Medical College|||1|no enough fund|f||||t||||||||||2017-02-18 15:46:45.356636|2017-02-18 15:46:45.356636
NCT00621842|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2014-12-08|2011-08-09||January 2008||2008-01-01|December 2014|2014-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|Geri-BD SAD||Lamotrigine for Symptoms of Geriatric Bipolar Depression|Open-label, Prospective Trial of Lamotrigine for Symptoms of Geriatric Bipolar Depression|Completed||Phase 3|57|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-02-18 14:42:17.970892|2017-02-18 14:42:17.970892
NCT00621829|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2011-10-11|||February 2008||2008-02-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms|Pilot Study of Supplemental Eicosapentanoic Acid (EPA)-Enriched Omega-3 Polyunsaturated Fatty Acids (n3-PUFA) in a Subset of Moderate to Severe Asthmatics With Polymorphisms of the Arachidonate 5-lipoxygenase (ALOX5) Gene|Completed||N/A|30|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-02-18 14:42:18.364353|2017-02-18 14:42:18.364353
NCT00621816|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-12-02|||January 2009||2009-01-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine the Pharmacodynamics of Sodium Nitroprusside During Prolonged Infusion in Pediatric Subjects|Completed||Phase 2|45|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 14:42:18.551851|2017-02-18 14:42:18.551851
NCT00621803|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-02-21|||March 2003||2003-03-01|February 2008|2008-02-01|October 2005|Anticipated|2005-10-01|October 2004|Anticipated|2004-10-01||Interventional|||Lcr35 / ICU / P. Aeruginosa|Prevention of Gastric Colonisation by Antibiotic Resistant Pseudomonas Aeruginosa Strains Using Oral Probiotic in ICU-Patients|Terminated||N/A|400|Actual|University Hospital, Clermont-Ferrand||1||Recruiting or enrolling participants has halted and will not resume|f||||||||||||||2017-02-18 14:42:18.671866|2017-02-18 14:42:18.671866
NCT00621790|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-10-13|||February 2008||2008-02-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|FENO HSR||Fenoldopam and Acute Renal Failure|Efficacy of Fenoldopam in Reducing the Need for Renal Replacement Therapy After Cardiac Surgery. A Randomized Controlled Study.|Completed||Phase 3|667|Actual|Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-02-18 14:42:18.758991|2017-02-18 14:42:18.758991
NCT00621777|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-05-19|2015-05-01||February 2008||2008-02-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SCRP||A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder|Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking|Completed||Phase 4|247|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:42:18.881496|2017-02-18 14:42:18.881496
NCT00621764|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2014-09-23|2014-09-09||March 2008||2008-03-01|September 2014|2014-09-01|May 2013|Actual|2013-05-01|December 2009|Actual|2009-12-01||Interventional|||Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children|A Controlled Study of the Safety and Immunogenicity of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children|Completed||Phase 2|300|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 14:42:19.463953|2017-02-18 14:42:19.463953
NCT00621751|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-08-11|||February 2008||2008-02-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|September 2013|Actual|2013-09-01||Interventional|||Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression|Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression: A 42-Day, Single-Site, Forced-Titration, Parallel Group, Randomized, Double-Blind, Placebo Controlled Trial|Completed||N/A|74|Actual|Carolinas Healthcare System||2|||f||||t||||||||||2017-02-18 14:42:23.086113|2017-02-18 14:42:23.086113
NCT00621738|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2010-02-09|||December 2007||2007-12-01|February 2010|2010-02-01||||December 2009|Actual|2009-12-01||Observational|||Effect of Mental Stress on Platelet Function in Healthy Subject|Effect of Mental Stress on Platelet Function in Healthy Subject|Completed||Phase 1|45|Anticipated|University of Zurich|||1||f||||||||||||||2017-02-18 14:42:23.199739|2017-02-18 14:42:23.199739
NCT00621725|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-07-14|||January 2008||2008-01-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|July 2010|Actual|2010-07-01||Interventional|||Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours|A Phase I, Open Label Study of the Pharmacokinetics and Safety of Cediranib (RECENTINTM, AZD2171) Following Single and Multiple Oral Doses in Patients With Advanced Solid Tumours With Various Degrees of Hepatic Dysfunction|Completed||Phase 1|36|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:42:23.278434|2017-02-18 14:42:23.278434
NCT00621712|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-03-07|||October 2007||2007-10-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties|Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties: Efficacy and Effect of Intensive Catheter and Exit Site Care Education|Completed||N/A|90|Actual|Gambro Dialysatoren GmbH||2|||f||||f||||||||||2017-02-18 14:42:23.392896|2017-02-18 14:42:23.392896
NCT00621699|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-02-12|||September 2007||2007-09-01|February 2008|2008-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects|Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects|Completed||Phase 1|24|Actual|University Medicine Greifswald||3|||f||||f||||||||||2017-02-18 14:42:23.497706|2017-02-18 14:42:23.497706
NCT00621686|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2016-11-07|2016-11-07||September 2008||2008-09-01|November 2016|2016-11-01||||October 2010|Actual|2010-10-01||Interventional|||Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme|Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme|Active, not recruiting||Phase 2|54|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 14:42:23.619883|2017-02-18 14:42:23.619883
NCT00621673|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2014-12-17|||May 2006||2006-05-01|December 2014|2014-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A|Assessment of the Risk of Inhibitor Formation in Subjects With Severe Hemophilia A When Switched From a Replacement Therapy With a rFVIII Produced by a Chinese Hamster Ovary (CHO) Cell Line to a rFVIII Produced by a Baby Hamster Kidney (BHK) Cell Line (Kogenate® FS).|Terminated||Phase 4|1|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:42:24.603936|2017-02-18 14:42:24.603936
NCT00621660|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-02-21|||January 2004||2004-01-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Acupuncture Versus Sham for Radiotherapy-Induced Emesis|Acupuncture Compared To Sham With a Placebo-Needle in Radiotherapy-Induced Nausea - a Randomised Controlled Study|Completed||N/A|237|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-02-18 14:42:24.705328|2017-02-18 14:42:24.705328
NCT00621647|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-03-24|||September 2002||2002-09-01|March 2009|2009-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Seroquel- Agitation Associated With Dementia|A Multicenter, Double-Blind, Randomized, Comparison of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Agitation Associated With Dementia.|Completed||Phase 3|333|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:42:24.81135|2017-02-18 14:42:24.81135
NCT00621634|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-02-21|||February 2008||2008-02-01|September 2007|2007-09-01||||June 2011|Anticipated|2011-06-01||Interventional|||Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia|Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy of Omega-3 Supplementation With Docosahexaenoic Acid (DHA) on Tardive Dyskinesia|Unknown status|Recruiting|Phase 2|40|Anticipated|Université de Montréal||2|||f||||t||||||||||2017-02-18 14:42:25.108971|2017-02-18 14:42:25.108971
NCT00621621|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2015-04-06|2014-07-22||December 2006||2006-12-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|PS-010|A total of 105 subjects gave actual consent in the study. Of the 105 consented 75 went on to have an ablation procedure performed. Data from 675 subjects were taken from published data that met inclusion criteria with publication search approved by the FDA.|CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)|CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)|Completed||Phase 4|105|Actual|Medtronic Atrial Fibrillation Solutions|Slow enrollment in the trial showed limited the amount of available data. Detailed subject data from the published literature was not available.|2|||f||||f||||||||||2017-02-18 14:42:25.226894|2017-02-18 14:42:25.226894
NCT00621608|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-05-07|||April 2008||2008-04-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|HBOT||Hyperbaric Oxygen Therapy (HBOT) for Chronic Diabetic Lower Limb Ulcers|A Prospective, Double-blind, Randomized, Controlled Clinical Trial Comparing Standard Wound Care With Adjunctive Hyperbaric Oxygen Therapy (HBOT) to Standard Wound Care Only for the Treatment of Chronic, Non-healing Ulcers of the Lower Limb in Patients With Diabetes Mellitus.|Completed||Phase 4|107|Actual|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-02-18 14:42:25.628549|2017-02-18 14:42:25.628549
NCT00621595|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-09-09|||November 2000||2000-11-01|September 2015|2015-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||The Effects of Breakfast on Brain Function|The Effects of Breakfast on Cognitive Functioning|Completed||N/A|166|Actual|Arkansas Children's Hospital Research Institute||1|||f||||f||||||||||2017-02-18 14:42:25.745823|2017-02-18 14:42:25.745823
NCT00621582|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2014-10-14|2010-02-09||May 2006||2006-05-01|October 2014|2014-10-01||||February 2008|Actual|2008-02-01||Observational|||Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities|Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities|Completed||N/A|4918|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:42:25.83737|2017-02-18 14:42:25.83737
NCT00621569|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2013-03-15|||January 2005||2005-01-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|July 2008|Actual|2008-07-01||Interventional|ADAPT||ADAPT-Altering Diet for African American Populations to Treat Hypertension|A Culturally Appropriate Intervention in Hypertensive African-Americans Based on the DASH Diet—The ADAPT Hypertension Study = Altering Diet for African American Populations to Treat Hypertension|Completed||N/A|122|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:42:26.100295|2017-02-18 14:42:26.100295
NCT00621556|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2009-01-27|||February 2008||2008-02-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas|RG1068 (Synthetic Human Secretin) Enhanced MRCP for Morphological Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas|Terminated||Phase 1|2|Actual|Massachusetts General Hospital||1||Poor patient enrollment due to logistical issues|f||||f||||||||||2017-02-18 14:42:26.210661|2017-02-18 14:42:26.210661
NCT00621543|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2011-07-12|2011-04-04||March 2006||2006-03-01|July 2011|2011-07-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||Insertion of an Intrauterine Device (IUD) After Medical Abortion|Insertion of an IUD After Medical Abortion|Completed||N/A|120|Actual|Boston University|21 women did not return for the 3 months follow-up. Some of the 21 women were contacted earlier 3 months, and none had had an expulsion. 2 women were ineligible at the first visit.|1|||f||||f||||||||||2017-02-18 14:42:26.323126|2017-02-18 14:42:26.323126
NCT00621530|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2014-05-28|||March 2008||2008-03-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Effect of Spinal Ketorolac on Mechanical Hypersensitivity After a Total Hip Replacement|Effect of Intrathecal Ketorolac on Mechanical Hypersensitivity After Total Hip Arthroplasty|Terminated||Phase 2|62|Actual|Wake Forest University Health Sciences||2||Terminated due to discontinuation of Acular PF (investigational medication)|f||||t||||||||||2017-02-18 14:42:26.585118|2017-02-18 14:42:26.585118
NCT00621517|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-04-04|2012-03-04||February 2008||2008-02-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Bupropion and Restless Legs Syndrome|Bupropion and Restless Legs Syndrome|Completed||Phase 2/Phase 3|60|Actual|East Tennessee State University|Possible Type II error as we were unable to recruit our target of 100 participants.|2|||f||||f||||||||||2017-02-18 14:42:26.701242|2017-02-18 14:42:26.701242
NCT00621504|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2011-09-20|2010-10-12||January 2008||2008-01-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|CAP||Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia|A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Ceftriaxone, With Adjunctive Clarithromycin, in the Treatment of Adult Subjects With Community-Acquired Pneumonia|Completed||Phase 3|606|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 14:42:27.117589|2017-02-18 14:42:27.117589
NCT00621491|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2012-10-25|||February 2004||2004-02-01|January 2008|2008-01-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation|Randomized Controlled Clinical Trial for Prevention of Thromboembolic Complications After Permanent Transvenous Leads Implantation in High-risk Patients|Completed||N/A|101|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-02-18 14:42:28.057345|2017-02-18 14:42:28.057345
NCT00621478|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2012-12-14|||February 2008||2008-02-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)|Use Of Lorazepam For The Treatment Of Pediatric Status Epilepticus: A Randomized, Double-Blinded Trial Of Lorazepam And Diazepam|Completed||Phase 2/Phase 3|259|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 14:42:28.185387|2017-02-18 14:42:28.185387
NCT00621465|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2011-12-28|||April 2002||2002-04-01|December 2011|2011-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental Illness|CTI in the Transition From Hospital to Community|Completed||N/A|150|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 14:42:28.32984|2017-02-18 14:42:28.32984
NCT00621452|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2014-08-04|||August 2007||2007-08-01|August 2014|2014-08-01||||January 2014|Actual|2014-01-01||Interventional|||Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma|A Pilot Study to Evaluate the Safety and Feasibility of Cellular Immunotherapy Using Genetically Modified Autologous CD20-Specific T Cells For Patients With Relapsed or Refractory Mantle Cell and Indolent B Cell Lymphomas|Completed||Phase 1|12|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 14:42:28.442611|2017-02-18 14:42:28.442611
NCT00621439|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-11-28|||March 2007||2007-03-01|November 2013|2013-11-01||||June 2008|Actual|2008-06-01||Interventional|||Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye|Exploratory Trial of Interferon Alpha-2b in Neoadjuvant Treatment of Ocular Melanoma|Withdrawn||N/A|0|Actual|Emory University||2||no funding- study never began|f||||f||||||||||2017-02-18 14:42:28.565224|2017-02-18 14:42:28.565224
NCT00621426|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-03-11|||April 2007||2007-04-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||T-Wave Alternans in Dialysis Patients|T-Wave Alternans in Dialysis Patients|Completed||N/A|40|Actual|Northwestern University|||1||f||||f||||||||||2017-02-18 14:42:28.664765|2017-02-18 14:42:28.664765
NCT00621413|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-02-21|||February 2007||2007-02-01|February 2008|2008-02-01||||||||Observational|||Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer|Dosimetric and Morbidity Outcomes of Cs-131 Brachytherapy in Combination With External Beam Radiation Therapy in Subjects With Intermediate to High Risk Adenocarcinoma of the Prostate: An Observational Study|Unknown status|Enrolling by invitation|N/A|100|Anticipated|IsoRay Medical, Inc.|||1||f||||f||||||||||2017-02-18 14:42:28.761106|2017-02-18 14:42:28.761106
NCT00621400|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2011-05-09|||January 2008||2008-01-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis|A Multicenter Phase I/II Dose Escalation Study of Lenalidomide in Combination With Melphalan and Dexamethasone in Subjects With Newly-diagnosed Light-chain (AL)-Amyloidosis|Completed||Phase 1/Phase 2|27|Actual|Nantes University Hospital||1|||f||||f||||||||||2017-02-18 14:42:28.852462|2017-02-18 14:42:28.852462
NCT00621387|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-02-11|||November 1993||1993-11-01|November 2007|2007-11-01|June 1998|Actual|1998-06-01|||||Interventional|||Study of Long-Term Antibiotic Treatment in Reactive Arthritis|Double-Blind, Placebo-Controlled Study of Three-Month Treatment With the Combination of Ofloxacin and Roxithromycin in Recent-Onset Reactive Arthritis|Completed||N/A|56|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 14:42:28.960588|2017-02-18 14:42:28.960588
NCT00621374|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2013-01-14|||February 2008||2008-02-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Management of Pain in Persons With Multiple Sclerosis|Pilot Study of CBT and Self-hypnosis Training for Pain in Persons With Multiple Sclerosis|Completed||N/A|22|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:42:29.072163|2017-02-18 14:42:29.072163
NCT00621361|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-12-13|||February 2008||2008-02-01|December 2012|2012-12-01|February 2012|Actual|2012-02-01|August 2009|Actual|2009-08-01||Interventional|||Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients|A Phase I, Multi-Centre, Open-Label, Dose Selection Study to Assess the Safety and Tolerability of Cediranib (RECENTIN™, AZD2171) in Combination With Etoposide and Cisplatin (EP) as First Line Therapy for Lung Cancer Patients With Extensive Stage or Metastatic Disease for Whom EP Would be a Standard Therapy|Completed||Phase 1|62|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:42:29.188876|2017-02-18 14:42:29.188876
NCT00621348|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2011-08-08|2011-07-12||September 2006||2006-09-01|August 2011|2011-08-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Maintenance Intravenous Fluids in Children|A RCT to Evaluate the Effect of Normal Saline in 5% Dextrose at Maintenance Rate, N/5 Saline in 5% Dextrose at 2/3 Maintenance Rate and N/5 Saline in 5% Dextrose at Maintenance Rate on Incidence of Hyponatremia in Hospitalized Children.|Completed||Phase 3|167|Actual|All India Institute of Medical Sciences, New Delhi||3|||f||||f||||||||||2017-02-18 14:42:29.305838|2017-02-18 14:42:29.305838
NCT00621335|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2013-02-22|||March 2007||2007-03-01|February 2013|2013-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|CICOM1010||A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt|A 12- Week Investigator Masked, Parallel Comparison of Tolerability of Combigan and Cosopt in the Treatment of Open Angle Glaucoma or Ocular Hypertension|Completed||N/A|64|Actual|DBYAN Medicine Professional Corporation|||1||f||||t||||||||||2017-02-18 14:42:30.030854|2017-02-18 14:42:30.030854
NCT00621322|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2016-12-08|2016-12-08||April 2008||2008-04-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults|Dose Range Study Evaluating Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis Vaccines (692342) When Administered to Healthy Adults Aged 18 to 45 Years.|Completed||Phase 2|181|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-02-18 14:42:30.149097|2017-02-18 14:42:30.149097
NCT00621309|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2009-11-12|||March 2008||2008-03-01|November 2009|2009-11-01|September 2010|Anticipated|2010-09-01|June 2010|Anticipated|2010-06-01||Interventional|||Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions|Phase I Clinical Trial to Evaluate the Efficacy of Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|University of Washington||3|||f||||f||||||||||2017-02-18 14:42:33.07855|2017-02-18 14:42:33.07855
NCT00621296|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2014-04-16|2012-09-19||January 2008||2008-01-01|April 2014|2014-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C|Phase II Study of MP-424 in Patients With (Genotype 1b) Hepatitis C|Completed||Phase 2|15|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-02-18 14:42:33.190591|2017-02-18 14:42:33.190591
NCT00620906|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2013-05-01|||January 2007||2007-01-01|May 2013|2013-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Motion Capture Analysis of Sacroiliac Joint Motion After Manipulation|Motion Capture Analysis of Sacroiliac Joint Motion After Manipulation|Completed||N/A|20|Actual|Logan College of Chiropractic||1|||f||||f||||||||||2017-02-18 14:42:39.675742|2017-02-18 14:42:39.675742
NCT00621283|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2009-01-27|||February 2008||2008-02-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population|RG1068 (Synthetic Human Secretin) Enhanced MRCP for Morphological Evaluation of the Pancreatic Duct in the Pediatric Population|Terminated||Phase 1|0|Actual|Massachusetts General Hospital||1||Poor patient enrollment due to logistical issues|f||||f||||||||||2017-02-18 14:42:33.64955|2017-02-18 14:42:33.64955
NCT00621270|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2011-10-20|||January 2008||2008-01-01|October 2011|2011-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety|A 6-Week Randomised Double-Blind, Placebo-Controlled Study of BCI-540 80 mg q.d. and 80 mg t.i.d. in the Treatment of Adults With Major Depressive Disorder and Concomitant Anxiety|Completed||Phase 2|115|Actual|BrainCells Inc.||3|||f||||f||||||||||2017-02-18 14:42:33.75229|2017-02-18 14:42:33.75229
NCT00621257|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2016-12-27|2016-12-27||January 2008||2008-01-01|December 2016|2016-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Vitamin D Levels in Children With IBD|Optimization of Vitamin D Stores and Its Impact on the Bone Health and Disease Outcomes of Children and Adolescents With IBD.|Terminated||N/A|134|Actual|Boston Children’s Hospital||5||Maintenance phase outcome unattenable|f||||t||||||||||2017-02-18 14:42:33.873297|2017-02-18 14:42:33.873297
NCT00621244|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-05-01||2012-05-01|March 2006||2006-03-01|May 2012|2012-05-01||||August 2009|Actual|2009-08-01||Interventional|||A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies|A Phase IA/II, Two-arm, Multi-center, Open-label, Dose-escalation Study of LBH589 Administered Orally Via Different Dosing Schedules in Adult Patients With Advanced Hematological Malignancies|Completed||Phase 1/Phase 2|308|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:42:34.415262|2017-02-18 14:42:34.415262
NCT00621231|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-02-21|||September 2007||2007-09-01|May 2007|2007-05-01|April 2008||2008-04-01|December 2007|Actual|2007-12-01||Interventional|ProF||The Protein (Meat) and Function Study|Effect of Normal Versus High Amounts of Protein Intake on Physiological Functions and Proteomics in Healthy Men|Completed||N/A|||University of Copenhagen||2|||f||||f||||||||||2017-02-18 14:42:34.520325|2017-02-18 14:42:34.520325
NCT00621218|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-12-17|||February 2008||2008-02-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea|A Pilot Study to Compare Tretinoin Gel, 0.05% to Tretinoin Gel Vehicle When Dosed Once or Twice Daily in Female Subjects With Classical Rosacea|Completed||Phase 2|36|Actual|Coria Laboratories, Ltd.||2|||f||||f||||||||||2017-02-18 14:42:34.620738|2017-02-18 14:42:34.620738
NCT00621205|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2012-04-16|||October 2003||2003-10-01|April 2012|2012-04-01|December 2005|Actual|2005-12-01|December 2004|Actual|2004-12-01||Interventional|Genobin||Gene Expression in Obesity and Insulin Resistance|Gene Expression in Adipose Tissue of Genes Involved in Obesity, Insulin Resistance and Lipid Metabolism Before and After Weight Loss or an Intensive Exercise Period|Completed||N/A|75|Actual|University of Eastern Finland|||||f||||f||||||||||2017-02-18 14:42:34.73116|2017-02-18 14:42:34.73116
NCT00621192|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2015-03-30|2011-10-20||June 2008||2008-06-01|March 2015|2015-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections|Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 Days) With Suspected or Complicated Intra-abdominal Infections|Completed||Phase 1/Phase 2|200|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||t||||||||||2017-02-18 14:42:34.834401|2017-02-18 14:42:34.834401
NCT00621179|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2008-02-13|||March 2003||2003-03-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|IntegrinIVF||Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF|Do Endometrial Implantation Markers Predict in Vitro Fertilization-Embryo Transfer Cycle Outcomes in Endometriosis Patients Pretreated With Leuprolide Acetate in Depot Suspension?|Completed||Phase 4|37|Actual|Colorado Center for Reproductive Medicine||4|||f||||t||||||||||2017-02-18 14:42:35.841868|2017-02-18 14:42:35.841868
NCT00621166|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-04-03|||June 2008||2008-06-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women|The Pharmacokinetics and Safety of Generic Lopinavir/Ritonavir (200/50 mg Tablets) 400/100 mg q12h in Thai HIV-infected Pregnant Women|Completed||Phase 2|20|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||f||||||||||2017-02-18 14:42:35.96162|2017-02-18 14:42:35.96162
NCT00621153|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2010-02-24|2010-02-24||February 2008||2008-02-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|CAESAR||Candesartan Effect in Second Stage Arterial Hypertension|Open-label, Randomised, 2-Arm Parallel Group, Multicentre, 8-week, Phase IV Study to Assess the Antihypertensive Efficacy and Safety of the Candesartan Cilexetil 16 mg and Hydrochlorothiazide 12.5 mg Combination Therapy in Comparison With Candesartan 16 mg Monotherapy in Hypertensive Adults|Completed||Phase 4|214|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:42:36.069152|2017-02-18 14:42:36.069152
NCT00621140|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2014-01-22|2011-05-13||February 2008||2008-02-01|January 2014|2014-01-01||||May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control|A Randomised, Double-blind, Placebo-controled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug Naive or Previously Treated (6 Weeks Washout) Type 2 Diabetic Patients With Insufficient Glycemic Control|Completed||Phase 3|503|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:42:36.382857|2017-02-18 14:42:36.382857
NCT00621114|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2010-01-26|||August 2007||2007-08-01|January 2010|2010-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|ABBA||Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application|Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysis Application|Completed||N/A|69|Actual|Gambro Dialysatoren GmbH||2|||f||||f||||||||||2017-02-18 14:42:37.199378|2017-02-18 14:42:37.199378
NCT00621101|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-02-12|||April 2007||2007-04-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects|Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects|Completed||Phase 1|24|Actual|University Medicine Greifswald||3|||f||||f||||||||||2017-02-18 14:42:37.457924|2017-02-18 14:42:37.457924
NCT00621088|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2010-09-12|||February 2008||2008-02-01|September 2010|2010-09-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Interventional|||A Prospective Randomised Multicenter Study Comparing the Sliding Hip Screw and the Intertan Nail in Trochanteric and Subtrochanteric Femoral Fractures|A Prospective Randomised Multicenter Study Comparing the Sliding Hip Screw and the Intertan Nail in Trochanteric and Subtrochanteric Femoral Fractures|Completed||N/A|500|Anticipated|Haukeland University Hospital||1|||f||||||||||||||2017-02-18 14:42:37.572701|2017-02-18 14:42:37.572701
NCT00621075|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2010-03-08|||April 2007||2007-04-01|March 2010|2010-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans|Correlation of Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans|Completed||N/A|50|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 14:42:37.662473|2017-02-18 14:42:37.662473
NCT00621062|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2014-01-31|||January 2008||2008-01-01|March 2011|2011-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|RAFPELS||Prospective Randomized Trial Comparing the New Endovenous Procedures Versus Conventional Surgery for Varicose Veins Due to Great Saphenous Vein Incompetence|Randomized Prospective Trial of Varicose Vein Surgery|Completed||N/A|540|Actual|Uppsala University||4|||f||||t||||||||||2017-02-18 14:42:37.767522|2017-02-18 14:42:37.767522
NCT00621049|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-05-13|2015-04-24||December 2007||2007-12-01|May 2015|2015-05-01|February 2014|Actual|2014-02-01|July 2013|Actual|2013-07-01||Interventional||All patients on-study|Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC|Randomized Phase II Trial of Adjuvant Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Patients With Resected Non-Small Cell Lung Cancer|Completed||Phase 2|112|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 14:42:37.874144|2017-02-18 14:42:37.874144
NCT00621036|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-21|2010-04-01|||November 2007||2007-11-01|August 2008|2008-08-01||||June 2009|Anticipated|2009-06-01||Interventional|||Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma|A Phase 2, Open-Label Study to Evaluate the Efficacy and Safety of Patient-Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH (Id-KLH) and Administered With GM-CSF, in Patients With CNS Lymphoma|Unknown status|Recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 14:42:38.404353|2017-02-18 14:42:38.404353
NCT00621023|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-01-30|2012-12-21||November 2007||2007-11-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome|A Pilot Phase II Study of Decitabine, Arsenic Trioxide and Ascorbic Acid for Patients With Myelodysplastic Syndrome|Completed||Phase 2|7|Actual|Duke University|Enrollment stopped early, which lead to a small number of subjects analyzed. The subjects who were enrolled did complete the entire protocol and their data was analyzed.|1|||f||||t||||||||||2017-02-18 14:42:38.511057|2017-02-18 14:42:38.511057
NCT00621010|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-07-07|||June 2007||2007-06-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|CTS||Safety Study of CTS21166 to Treat Alzheimer Disease|A Phase 1 Single Escalating Dose Study to Assess the Safety and Pharmacokinetics of CTS21166 Administered Intravenously to Healthy Adult Males|Completed||Phase 1|56|Actual|CoMentis||1|||f||||t||||||||||2017-02-18 14:42:38.813076|2017-02-18 14:42:38.813076
NCT00620997|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-02-21|||October 2005||2005-10-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|Dogma||Proparacaine vs Placebo for Corneal Injuries|Challenging the Dogma: Topical Proparacaine is Safe and Effective for the Emergency Department Management of Acute Traumatic Corneal Injuries|Completed||Phase 1|43|Actual|London Health Sciences Centre||2|||f||||f||||||||||2017-02-18 14:42:38.926642|2017-02-18 14:42:38.926642
NCT00620984|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2015-05-29|||August 2006||2006-08-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Observational|||Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis|Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis: A Large Prospective Study|Completed||N/A|557|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:42:39.035893|2017-02-18 14:42:39.035893
NCT00620971|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-06-24|||January 2008||2008-01-01|June 2014|2014-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC|Sequential Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus Cisplatin/Docetaxel/Bevacizumab in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer|Completed||Phase 2|77|Actual|Hellenic Oncology Research Group||2|||f||||f||||||||||2017-02-18 14:42:39.124472|2017-02-18 14:42:39.124472
NCT00620958|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2016-08-08|||August 2008||2008-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Cognitive Behavioral Therapy With Parental Involvement for Treating Children With Anxiety Disorders|Parent Mediation of Child Anxiety CBT Outcome|Active, not recruiting||Phase 1|336|Anticipated|Florida International University||3|||f||||t||||||||||2017-02-18 14:42:39.266336|2017-02-18 14:42:39.266336
NCT00620945|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-02-11|||June 2006||2006-06-01|February 2008|2008-02-01|July 2016|Anticipated|2016-07-01|June 2016|Anticipated|2016-06-01||Interventional|||Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-Pulmonary Bypass|Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-Pulmonary Bypass in Infants and Children With Congenital Heart Disease and to Assist Steady State Alfa-Blockade in the Intensive Care Phase|Unknown status|Recruiting|N/A|1000|Anticipated|The Cleveland Clinic||1|||f||||t||||||||||2017-02-18 14:42:39.377044|2017-02-18 14:42:39.377044
NCT00620932|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2013-10-25|||January 2008||2008-01-01|October 2013|2013-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Exercise Training Among Men With Prostate Cancer|Feasibility of Endurance Exercise Training on Cardiovascular Risk Factors Following Radical Prostatectomy Among Men With Localized Prostate Cancer; A Community-Based Intervention|Withdrawn||N/A|0|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:42:39.480797|2017-02-18 14:42:39.480797
NCT00620919|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2009-01-27|||February 2008||2008-02-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic Pancreatitis|RG1068 (Synthetic Human Secretin) Enhanced Multidetector CT Pancreatography: Evaluation of the Pancreatic Duct in Patients With Known or Suspected Chronic Pancreatitis|Terminated||Phase 1|0|Actual|Massachusetts General Hospital||1||Poor patient enrollment due to logistical issues.|f||||f||||||||||2017-02-18 14:42:39.579848|2017-02-18 14:42:39.579848
NCT00620893|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2009-09-17|||February 2008||2008-02-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).||Completed||Phase 4|100|Anticipated|Bp Consulting, Inc||2|||f||||||||||||||2017-02-18 14:42:39.766138|2017-02-18 14:42:39.766138
NCT00620880|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-11-19|||September 2005||2005-09-01|November 2008|2008-11-01|September 2006|Actual|2006-09-01|||||Observational|||IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy|Performance of CAST With Different Allergens in Patients With Cat Dander Allergy|Completed||N/A|||University of Zurich|||||f||||f||||||||||2017-02-18 14:42:39.870821|2017-02-18 14:42:39.870821
NCT00620867|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-11-05|||October 2002||2002-10-01|November 2008|2008-11-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)|A Study of the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) and Three Times Daily Ibuprofen vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee|Completed||Phase 4|393|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:42:39.951335|2017-02-18 14:42:39.951335
NCT00620854|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2012-01-30|2009-04-22||February 2008||2008-02-01|January 2012|2012-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women||Completed||Phase 2|24|Actual|Tarsa Therapeutics, Inc.||3|||f||||f||||||||||2017-02-18 14:42:40.087632|2017-02-18 14:42:40.087632
NCT00620841|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-13|2008-02-21|||May 2007||2007-05-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|DDI-TAC||Gene Polymorphisms in Tacrolimus Drug Interactions|Gene Polymorphisms in Tacrolimus Drug Interactions in Renal Transplant Patients|Completed||N/A|40|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||Samples With DNA|"~     DNA samples~   "|||2017-02-18 14:42:40.753858|2017-02-18 14:42:40.753858
NCT00620828|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2015-06-02|2010-06-17||May 2007||2007-05-01|March 2013|2013-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Role of Intra-Operative Intracapsular Blocks in Post-Operative Pain Management Following Total Knee Arthroplasty|The Role of Intra-Operative Intracapsular Blocks in Post-Operative Pain Management Following Total Knee Arthroplasty: A Double-Blinded Randomized Controlled Trial|Completed||Phase 4|67|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:42:40.85248|2017-02-18 14:42:40.85248
NCT00620815|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2016-03-03|2011-07-04||November 2007||2007-11-01|March 2016|2016-03-01|December 2008|Actual|2008-12-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above|A Phase II, Randomized, Placebo-controlled, Observer-blind, Multi Center Study on the Safety and Immunogenicity of Novartis Tetravalent Influenza Vaccine (Containing Both Interpandemic Strains and H5N1) in Adults Aged 18 Years and Above|Completed||Phase 2|601|Actual|Novartis||6|||f||||f||||||||||2017-02-18 14:42:41.438228|2017-02-18 14:42:41.438228
NCT00620802|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2008-08-22|||November 2007||2007-11-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Pharmacodynamics of CGT 2168 Compared With Plavix®|A Phase I, Open-Label, Randomized, Multiple-Dose, Two-Way Crossover Study of the Pharmacodynamics of CGT 2168 Compared With Plavix®|Completed||Phase 1|60|Actual|Cogentus Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:42:42.642075|2017-02-18 14:42:42.642075
NCT00620789|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2013-05-30|||March 2008||2008-03-01|May 2013|2013-05-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Behavioral Insomnia Therapy For Those With Insomnia and Depression|Behavioral Insomnia Therapy For Those With Insomnia and Depression|Unknown status|Recruiting|N/A|477|Anticipated|Ryerson University||3|||f||||f||||||||||2017-02-18 14:42:42.75009|2017-02-18 14:42:42.75009
NCT00620776|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2016-12-23|2016-10-31||October 2006||2006-10-01|December 2016|2016-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||26 out of 29 patients who consented to receive combined treatment received at least one session of CBT. 35 out of 40 patients who consented to received medication only received at least one dose of medication.|Combined Treatment for Generalized Anxiety Disorder (GAD)|Combined Treatment for Generalized Anxiety Disorder (GAD)|Completed||Phase 2|69|Actual|University of Pennsylvania|Only one-third of those approached to add on CBT were interested in this option. Strict exclusion criteria reduces the generalizability of the study results. Possible that other forms of CBT treatment may produce different results.|2|||f||||t||||||||No||2017-02-18 14:42:42.883968|2017-02-18 14:42:42.883968
NCT00620763|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2011-08-04|2008-12-31||January 2008||2008-01-01|August 2011|2011-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Calcium Retention as Influenced by Dietary Components That Induce an Acid Load|Calcium Retention in Postmenopausal Women as Influenced by Beef and Other Dietary Components That Induce an Acid Load|Completed||N/A|22|Actual|USDA Grand Forks Human Nutrition Research Center||2|||f||||f||||||||||2017-02-18 14:42:43.886678|2017-02-18 14:42:43.886678
NCT00620750|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2011-08-22|2011-06-09||July 2007||2007-07-01|August 2011|2011-08-01|February 2010|Actual|2010-02-01|November 2008|Actual|2008-11-01||Interventional|||Extended-release Naltrexone for Alcohol Dependence in Primary Care|Extended-release Naltrexone (Vivitrol) for the Treatment of Alcohol Dependence in Urban Primary Care: a Feasibility Study|Completed||Phase 4|72|Actual|New York University School of Medicine|There was no formal control arm. Drinking and satisfaction outcomes were self-reported, these outcomes and Adverse Event data were not available for those lost to follow-up. The drinking Timeline Follow-Back is subject to recall and response biases.|1|||f||||f||||||||||2017-02-18 14:42:44.122437|2017-02-18 14:42:44.122437
NCT00620737|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2012-02-08|||February 2008||2008-02-01|February 2012|2012-02-01||||December 2008|Anticipated|2008-12-01||Interventional|||Pilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars||Withdrawn||Phase 2|0|Actual|Fibrocell Technologies, Inc.||2||Company Decision|f||||f||||||||||2017-02-18 14:42:44.3795|2017-02-18 14:42:44.3795
NCT00620724|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2014-07-09|||January 2008||2008-01-01|July 2014|2014-07-01|September 2012|Actual|2012-09-01|June 2012|Actual|2012-06-01||Interventional|||Tocolytic Therapy in Conservative Management of Symptomatic Placenta Previa|Maintenance Oral Nifedipine for Management of Symptomatic Placenta Previa : A Randomized Clinical Trial|Completed||Phase 2|109|Actual|University Hospital, Rouen||2|||f||||||||||||||2017-02-18 14:42:44.467291|2017-02-18 14:42:44.467291
NCT00620711|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2014-07-30|2014-05-28||February 2008||2008-02-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||Preterm infants with HIE|Pilot Study of Head Cooling in Preterm Infants With Hypoxic Ischemic Encephalopathy|"IRB# 070984 Pilot Study of Head Cooling in Preterm Infants With Hypoxic Ischemic Encephalopathy"|Completed||Phase 1|4|Actual|Vanderbilt University||1|||f||||t||||||||||2017-02-18 14:42:44.557381|2017-02-18 14:42:44.557381
NCT00620698|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-09|2014-09-13|2014-07-18||May 2007||2007-05-01|September 2014|2014-09-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Observational|||Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials|Electrical Impedance Myography as an Outcome Measure in ALS Clinical Trials|Completed||N/A|89|Actual|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-02-18 14:42:44.790304|2017-02-18 14:42:44.790304
NCT00620685|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2011-05-16||2009-04-06|March 2008||2008-03-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate|A 4-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Safety And Pharmacokinetic Profile Of 1 And 5 Mg Ph-797804 Administered Once Daily In Subjects With Rheumatoid Arthritis Who Are Taking Oral Methotrexate|Completed||Phase 2|27|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:42:45.12015|2017-02-18 14:42:45.12015
NCT00620672|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2016-05-30|||May 2004||2004-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2011|Actual|2011-12-01||Interventional|||N-3 Fatty Acid Requirements for Human Development|To Compare Measures of Central Nervous System Maturity of Visual Acuity, Language, Mental and Motor Skill Development in Term Infants Following Maternal Supplementation Wit the n-3 Fatty Acid Docosahexaenoic Acid (DHA) During Gestation.|Completed||Phase 1|270|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 14:42:45.240048|2017-02-18 14:42:45.240048
NCT00620659|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2015-04-27|2010-10-13||February 2008||2008-02-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)|Phase IIa, Randomized, Double-blind, Placebo-controlled, 3-period Crossover, Adaptive Dose Design, Clinical Trial to Evaluate Safety & Efficacy of MK0249 in Treating Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome Appropriately Using nCPAP Therapy.|Terminated||Phase 2|125|Actual|Merck Sharp & Dohme Corp.||6|||f||||||||||||||2017-02-18 14:42:45.560081|2017-02-18 14:42:45.560081
NCT00620646|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-27|2009-02-11|||February 2008||2008-02-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|4C-DES||The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol|The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol in Clopidogrel Non-Responders After Drug-Eluting Stent Implantation|Completed||N/A|80|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 14:42:46.568744|2017-02-18 14:42:46.568744
NCT00620633|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2016-03-29|||February 2008||2008-02-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation|A Phase I Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation|Active, not recruiting||Phase 1|22|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:42:46.667553|2017-02-18 14:42:46.667553
NCT00620620|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2013-07-13|||February 2008||2008-02-01|July 2013|2013-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Staccato Zaleplon Single Dose PK|Safety, Tolerability, and Pharmacokinetics of a Single Dose of Staccato® Zaleplon for Inhalation in Healthy Volunteers|Completed||Phase 1|40|Actual|Alexza Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 14:42:46.77198|2017-02-18 14:42:46.77198
NCT00620607|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2015-08-25|||May 2007||2007-05-01|April 2009|2009-04-01|September 2010|Anticipated|2010-09-01|May 2010|Anticipated|2010-05-01||Interventional|||huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas|A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas|Withdrawn||Phase 2|0|Actual|ImmunoGen, Inc.||1||Lack of accrual|f||||||||||||||2017-02-18 14:42:46.870612|2017-02-18 14:42:46.870612
NCT00620594|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2017-02-13|||December 21, 2006|Actual|2006-12-21|February 2017|2017-02-01|January 8, 2013|Actual|2013-01-08|January 8, 2013|Actual|2013-01-08||Interventional|||A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer|A Phase I/II, Multi-center, Open-label Study of BEZ235, Administered Orally on a Continuous Daily Dosing Schedule in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer|Completed||Phase 1|183|Actual|Novartis||4|||f||||||||||||||2017-02-18 14:42:46.958064|2017-02-18 14:42:46.958064
NCT00620581|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2008-02-07||||||November 2005|2005-11-01||||||||Interventional|PMDD||Luteal Phase Administration of Paroxetine for the Treatment of PMDD|Luteal Phase Administration of Paroxetine for the Treatment of PMDD: A Randomized, Double-Blind, Placebo-Controlled Trial in Canadian Women|Completed||Phase 3|||McMaster University||1|||f||||||||||||||2017-02-18 14:42:49.58167|2017-02-18 14:42:49.58167
NCT00620568|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2009-08-03|||February 2008||2008-02-01|August 2009|2009-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating Multiple Ascending Dose in Schizophrenia Patients|An Ascending Multiple-Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SLV-313 Sustained-Release (SR) Tablets Administered Orally to Subjects With Schizophrenia and Schizoaffective Disorder|Terminated||Phase 1|32|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-02-18 14:42:49.672943|2017-02-18 14:42:49.672943
NCT00620555|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2012-01-24|2011-11-14||May 2008||2008-05-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures|A 52 Weeks, Open-Label, Multicenter Study Evaluating The Efficacy And Safety Of Gabapentin As Adjunctive Therapy In Pediatric Patients Who Have Completed The 12 Weeks Treatment In Study A9451162 (NCT00603473)|Completed||Phase 3|65|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:42:49.764611|2017-02-18 14:42:49.764611
NCT00620542|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-07-11|2012-05-22||January 2008||2008-01-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|SATURN||CRESTOR Athero Imaging Head to Head IVUS Study|Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin (SATURN)|Completed||Phase 3|2333|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 14:42:50.080648|2017-02-18 14:42:50.080648
NCT00620334|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-08-09|||February 2007||2007-02-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Predicting the Diagnosis of Asthma|Predicting the Diagnosis of Asthma Based on History|Completed||N/A|50|Anticipated|University of South Florida|||2||f||||f||||||||||2017-02-18 14:42:55.403291|2017-02-18 14:42:55.403291
NCT00620529|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2010-01-31|||February 2008||2008-02-01|January 2010|2010-01-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|fops||The Effects of Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat in the Polycystic Ovary Syndrome|A Clinical Trial to Measure the Effect of DHA-enriched Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat Content in the Polycystic Ovary Syndrome|Completed||Phase 4|40|Anticipated|Keogh Institute for Medical Research||2|||f||||t||||||||||2017-02-18 14:42:52.4022|2017-02-18 14:42:52.4022
NCT00620516|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-11-18|||March 2004||2004-03-01|November 2013|2013-11-01||||December 2007|Actual|2007-12-01||Observational|||Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients|Regulatory Requisite Post Marketing Surveillance to Assess the Safety and Efficacy of Spiriva® HandiHaler® (Tiotropium Bromide Inhalation Powder 18mcg, q.d.) in Korean COPD Patients: A 30-Day, Open Label, Non-interventional Study|Completed||N/A|3008|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:42:52.512552|2017-02-18 14:42:52.512552
NCT00620503|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2010-02-08|||February 2008||2008-02-01|February 2010|2010-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|PK||Proellex® Pharmacokinetic Bridging Study II|Proellex® Pharmacokinetic Bridging Study II|Completed||Phase 1|12|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-02-18 14:42:52.655848|2017-02-18 14:42:52.655848
NCT00620490|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-06-25|||March 2008||2008-03-01|March 2008|2008-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Paravertebral Analgesia Associated With Intravenous Morphine PCA After Thoracotomy|Postoperative Analgesia After Thoracotomy Without Thoracic Epidural Analgesia : Paravertebral Analgesia With a Catheter Associated With Intravenous Morphine Patient-controlled-analgesia (Pca)|Completed||Phase 3|60|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 14:42:52.747233|2017-02-18 14:42:52.747233
NCT00620477|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2014-12-04|||July 2008||2008-07-01|December 2014|2014-12-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Evaluation of Arthroscopic Reconstruction of the Anterior Cruciate Ligament by One Night Hospital Stay or by Day Surgery: a Randomised, Prospective Clinical Trial|Evaluation of Arthroscopic Reconstruction of the Anterior Cruciate Ligament by One Night Hospital Stay or by Day Surgery: a Randomised, Prospective Clinical Trial|Unknown status|Recruiting|Phase 4|75|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 14:42:52.847871|2017-02-18 14:42:52.847871
NCT00620464|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-08-11|2010-02-17||May 2005||2005-05-01|August 2015|2015-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Bioequivalence Study of IMPLANON and Radiopaque IMPLANON (34528)(P05720)|A Randomized, Double-Blind, Parallel Group, Bioequivalence Study of IMPLANON and Radiopaque IMPLANON|Completed||Phase 3|108|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:42:52.949808|2017-02-18 14:42:52.949808
NCT00620451|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2012-07-12|||February 2008||2008-02-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate (AT-1001) in Active Celiac Disease|A Phase IIb, Randomized, Double-Blind, Placebo Controlled Study for the Treatment of Active Celiac Disease With AT-1001|Completed||Phase 2|105|Actual|Alba Therapeutics||3|||f||||f||||||||||2017-02-18 14:42:53.682809|2017-02-18 14:42:53.682809
NCT00620438|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-12-03|||February 2008||2008-02-01|December 2010|2010-12-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients|Pharmacokinetic Interaction Between Coartem® and Either Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|Makerere University||3|||f||||f||||||||||2017-02-18 14:42:53.839933|2017-02-18 14:42:53.839933
NCT00620425|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2012-07-16|2010-11-01||December 2007||2007-12-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs|A Single-Center, Open-label, Single-Arm Study to Evaluate the Effects of Repeat Doses of Subcutaneously Delivered Sumatriptan Via the Intraject System of Local Injection Site Signs in Healthy Adult Subjects.|Completed||Phase 1|18|Actual|Zogenix, Inc.||1|||f||||t||||||||||2017-02-18 14:42:53.958926|2017-02-18 14:42:53.958926
NCT00620412|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2011-01-16|||September 2007||2007-09-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Probiotics to Enhance Immunogenicity of Influenza Vaccine in Healthy Adults|Lactobacillus GG to Enhance the Immunogenicity of Influenza Vaccine in Healthy Adults - Proof of Concept Study|Completed||Phase 1|52|Anticipated|Tufts Medical Center||2|||f||||t||||||||||2017-02-18 14:42:54.235001|2017-02-18 14:42:54.235001
NCT00620399|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-02-20|||May 1996||1996-05-01|February 2008|2008-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Study on the Use of a Brace Following Low Back Surgery|Lumbar Fusion With and Without Postoperative Bracing: A Randomized Prospective Study|Completed||Phase 3|||Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 14:42:54.344732|2017-02-18 14:42:54.344732
NCT00620386|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2008-02-08|||October 2006||2006-10-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|June 2007|Actual|2007-06-01||Interventional|||Endotracheal Intubation Using Bonfils Fibrescope Without Neuromuscular Blockade|Comparing Intubating Conditions and Hemodynamic Changes Between Macintosh Laryngoscopy and Bonfils Fibrescope During Endotracheal Intubation Without Neuromuscular Blockade|Completed||Phase 2/Phase 3|80|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-02-18 14:42:54.433786|2017-02-18 14:42:54.433786
NCT00620373|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-07-30|2013-08-15||August 2005||2005-08-01|July 2014|2014-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts|Evaluation of Low-dose Molecular Breast Imaging as a Screening Tool in Women With Mammographically Dense Breasts and Increased Risk of Breast Cancer|Completed||N/A|969|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:42:54.534034|2017-02-18 14:42:54.534034
NCT00620360|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-02-23|||January 2008||2008-01-01|February 2012|2012-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Acute Effect of Fructose on Lipid Metabolism and Gender Differences|Acute Effect of Fructose on Lipid Metabolism and Gender Differences|Completed||N/A|18|Actual|University of Lausanne||1|||f||||f||||||||||2017-02-18 14:42:55.196813|2017-02-18 14:42:55.196813
NCT00620347|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-06-17|||March 2008||2008-03-01|June 2013|2013-06-01|September 2012|Actual|2012-09-01|February 2012|Actual|2012-02-01||Interventional|||Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer|A Phase II Study of Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer.|Completed||Phase 2|25|Actual|National Cancer Center, Korea||1|||f||||t||||||||||2017-02-18 14:42:55.297669|2017-02-18 14:42:55.297669
NCT00620321|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2010-10-25||2010-10-25|March 2008||2008-03-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia|An Open-Label Phase 2 Trial of LY2181308 Sodium Administered in Combination With Idarubicin and Cytarabine to Patients With Refractory or Relapsed Acute Myeloid Leukemia|Completed||Phase 2|24|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:42:55.487639|2017-02-18 14:42:55.487639
NCT00620308|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-10|2012-09-07|||June 2008||2008-06-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|CD-NP||CD-NP in Subjects With Stable Chronic Heart Failure|A Human Physiologic Study to Evaluate the Renal and Neurohumoral Effects of a Novel Chimeric Natriuretic Peptide, CD-NP, in Subjects With Stable Chronic Heart Failure|Completed||Phase 1|19|Actual|Mayo Clinic||3|||f||||t||||||||||2017-02-18 14:42:55.587971|2017-02-18 14:42:55.587971
NCT00620295|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2012-11-06|||March 2007||2007-03-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|February 2009|Actual|2009-02-01||Interventional|||Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors|Phase I Study of Bortezomib and Gemcitabine in Elderly Patients With Solid Tumors (X05227)|Completed||Phase 1|17|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:42:55.688318|2017-02-18 14:42:55.688318
NCT00620282|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2014-10-29|2011-05-19||February 2008||2008-02-01|October 2014|2014-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus|The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus: A 12-week Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial With an Open-label Glimepiride Arm|Completed||Phase 3|49|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-02-18 14:42:55.812365|2017-02-18 14:42:55.812365
NCT00620269|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2011-11-04|||February 2008||2008-02-01|November 2011|2011-11-01|March 2015|Anticipated|2015-03-01|March 2015|Anticipated|2015-03-01||Interventional|||Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III|A Randomized Phase II Study of Induction Chemotherapy Followed by Concurrent Chemoradiation Therapy According to EGFR Mutation Status in Patients With Unresectable Stage III NSCLC|Unknown status|Recruiting|Phase 2|212|Anticipated|National Cancer Center, Korea||4|||f||||t||||||||||2017-02-18 14:42:57.402193|2017-02-18 14:42:57.402193
NCT00620256|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2012-12-03||2012-12-03|November 2007||2007-11-01|December 2012|2012-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Adjunctive Study of AL-37807 Ophthalmic Suspension|Comparison of Safety and Efficacy of Al-37807 Ophthalmic Suspension vs. Timolol Gel Forming Solution and Vehicle, All Dosed Concomitantly With Xalatan in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|129|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 14:42:57.513823|2017-02-18 14:42:57.513823
NCT00620243|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-01-06|||June 2004||2004-06-01|January 2012|2012-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.|Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.|Completed||Early Phase 1|9|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||f||||||||||2017-02-18 14:42:57.620691|2017-02-18 14:42:57.620691
NCT00620230|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-09-24|||October 2007||2007-10-01|September 2010|2010-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects|A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetic Profile and Pharmacodynamic Effect of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects|Completed||Phase 1|46|Actual|Novartis||2|||||||f||||||||||2017-02-18 14:42:57.725744|2017-02-18 14:42:57.725744
NCT00620217|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2009-11-27|||December 2004||2004-12-01|November 2009|2009-11-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|VIF-CAD||Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial|"Therapeutic Angiogenesis Using Human VEGF-A165/bFGF Plasmid Injected Percutaneously Into the Ischemic Myocardium of No-option Coronary Artery Disease Patients; Double-blind Placebo Controlled Study"|Completed||Phase 2|52|Anticipated|Institute of Cardiology, Warsaw, Poland||2|||f||||t||||||||||2017-02-18 14:42:57.823329|2017-02-18 14:42:57.823329
NCT00620204|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-10|2009-04-02|||January 2008||2008-01-01|April 2009|2009-04-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|ESAVA||Efficacy Study of Atorvastatin to Treat Variant Angina|Efficacy Study of Atorvastatin to Treat Variant Angina|Unknown status|Recruiting|Phase 4|136|Anticipated|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 14:42:57.935012|2017-02-18 14:42:57.935012
NCT00620191|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2013-03-13|||February 2008||2008-02-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|MCI||Metformin in Amnestic Mild Cognitive Impairment|Metformin in the Prevention of Alzheimer's Disease|Completed||Phase 2|80|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 14:42:58.046214|2017-02-18 14:42:58.046214
NCT00620178|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2010-12-01|||March 2008||2008-03-01|December 2010|2010-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|Real Life||Atacand (Candesartan) Real Life Study|"A REtrospective Study on the Effects of cAndesartan vs. Losartan on Blood Pressure, Health Care Consumption and cardiovascuLar Events In a Real-liFe GP sEtting in Sweden"|Completed||N/A|14000|Anticipated|AstraZeneca|||2||f||||||||||||||2017-02-18 14:42:58.16945|2017-02-18 14:42:58.16945
NCT00620165|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2009-04-16|||January 2005||2005-01-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy of Levetiracetam in Essential Tremor|Efficacy of Levetiracetam in Patients With Essential Tremor|Completed||Phase 1/Phase 2|10|Actual|Southern California Institute for Research and Education||2|||f||||f||||||||||2017-02-18 14:42:58.274964|2017-02-18 14:42:58.274964
NCT00620152|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2010-08-20|||April 2008||2008-04-01|August 2010|2010-08-01||||||||Interventional|||Nutrition Study for School Age Children|Randomized Trial of Telephone Interventions for Pediatric Obesity in School Age Children|Completed||N/A|40|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||||2017-02-18 14:42:58.384476|2017-02-18 14:42:58.384476
NCT00620139|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-10-23|||March 2005||2005-03-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma|Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma|Completed||Early Phase 1|17|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples Without DNA|"~     Urine Blood Tissue~   "|||2017-02-18 14:42:58.482463|2017-02-18 14:42:58.482463
NCT00620126|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-10-10|2011-08-13||January 2008||2008-01-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|UCHAT||The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis|The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis|Completed||Phase 3|47|Actual|University of Maryland|"Insufficient sample size to detect moderate differences in outcomes between arms~Differences between groups at baseline may have resulted in no overall difference between arms at one year~Higher rate of attrition than expected"|2|||f||||f||||||||||2017-02-18 14:42:58.581697|2017-02-18 14:42:58.581697
NCT00620113|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2016-03-15|||December 2007||2007-12-01|March 2016|2016-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||MK0822 Clinical Study in Patients With Involutional Osteoporosis (0822-022)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Dose-Finding Study of MK0822 in the Treatment of Involutional Osteoporosis|Completed||Phase 2|280|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 14:42:58.974746|2017-02-18 14:42:58.974746
NCT00620100|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2009-05-29|||September 2004||2004-09-01|May 2009|2009-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent|A Multicenter, Open Label, Phase II Trial Evaluating Docetaxel (Taxotere®) + Anthracycline (Epirubicin or Doxorubicin) x 4 Cycles Followed by Docetaxel (T) Single Agent x 4 Cycles as First-Line Therapy in Patients With Her2 Negative Locally Advanced or Metastatic Breast Cancer Who Have Relapsed > or = 12 Months From Completion of Neoadjuvant/Adjuvant Taxotere®-Based Chemotherapy|Terminated||Phase 2|2|Actual|Sanofi||1||the study was early terminated due to lack of recruitment.|f||||||||||||||2017-02-18 14:42:59.076792|2017-02-18 14:42:59.076792
NCT00620087|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-10-06|||August 2003||2003-08-01|October 2016|2016-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Molecular Breast Imaging in Women With Atypia and LCIS|Evaluation of a Small Field of View Gamma Camera for Scintimammography in Patients With Atypical Ductal Hyperplasia, Atypical Lobular Hyperplasia, and Lobular Carcinoma In Situ|Completed||N/A|66|Actual|Mayo Clinic||2|||f||||f||||||||Undecided||2017-02-18 14:42:59.16376|2017-02-18 14:42:59.16376
NCT00620074|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2010-01-21|2010-01-21||August 2008||2008-08-01|January 2010|2010-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)|Phase IV Open-Label Pilot Study to Evaluate the Combination of Voriconazole and Anidulafungin for the Treatment of Subjects With Proven or Probable Invasive Aspergillosis Who Are Intolerant of Polyene Treatment|Terminated||Phase 4|6|Actual|Pfizer|Due to low enrollment and early termination of the study, data was insufficient for descriptive or inferential analysis as planned; no significant treatment-related safety results were identified in the subjects treated with combination therapy.|2||See Detailed Description|f||||t||||||||||2017-02-18 14:42:59.275659|2017-02-18 14:42:59.275659
NCT00620061|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-02-01||2011-03-04|November 2007||2007-11-01|February 2013|2013-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone|A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction|Completed||Phase 3|440|Actual|Sucampo Pharma Americas, LLC||1|||f||||||||||||||2017-02-18 14:42:59.662189|2017-02-18 14:42:59.662189
NCT00620048|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2015-03-30|||March 2008||2008-03-01|November 2011|2011-11-01||||January 2011|Actual|2011-01-01||Interventional|||Stem Cell Study for Subjects With Congestive Heart Failure|Injection of Autologous CD34+ Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF < 40%|Terminated||Phase 1|4|Actual|Losordo, Douglas, M.D.||2||Study terminated due to lack of funding.|f||||f||||||||||2017-02-18 14:42:59.801941|2017-02-18 14:42:59.801941
NCT00620035|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-08-26|2011-09-22||March 2007||2007-03-01|August 2015|2015-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator (34530)(P05702)|An Open-Label, Non-Controlled Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator|Completed||Phase 3|301|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:42:59.903609|2017-02-18 14:42:59.903609
NCT00620022|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2011-07-22|2011-07-22||April 2008||2008-04-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Phase III Randomized, Double-blind, Placebo-controlled, 2-period Crossover, Multicenter Study to Assess the Effect of Indacaterol (300 μg o.d.) on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|90|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:43:00.398966|2017-02-18 14:43:00.398966
NCT00620009|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-02-11|||June 2002||2002-06-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|EMPATHY||The Measurement of Empathy and Its Efficacy in Psychotherapy|The Measurement of Empathy and Its Efficacy in Psychotherapy|Completed||N/A|16|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-02-18 14:43:00.684337|2017-02-18 14:43:00.684337
NCT00619996|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2009-02-25|||March 2007||2007-03-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|P1||Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer|Phase II Study of Sorafenib (Bay 43-9006) and Docetaxel in Metastatic Prostate Cancer|Completed||Phase 2|43|Anticipated|Italian Trial in Medical Oncology||1|||f||||t||||||||||2017-02-18 14:43:00.789976|2017-02-18 14:43:00.789976
NCT00619983|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-12-08|||February 2008||2008-02-01|December 2015|2015-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy|Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy|Terminated||N/A|22|Actual|Wake Forest University Health Sciences||4||Study terminated due to low enrollment|f||||f||||||||||2017-02-18 14:43:00.90128|2017-02-18 14:43:00.90128
NCT00619970|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2017-02-15|2016-09-27||February 2007||2007-02-01|February 2017|2017-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|CAP&SIBO||Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?|Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?|Completed||N/A|115|Actual|Children's Hospital Los Angeles||3|||f||||t||||||||||2017-02-18 14:43:01.025574|2017-02-18 14:43:01.025574
NCT00619957|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2011-09-20|2011-05-23||June 2002||2002-06-01|September 2011|2011-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis|Two-year Study to Determine the Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis for 2 Years Followed by a 2 Year Open Label Study|Completed||Phase 3|285|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 14:43:01.497002|2017-02-18 14:43:01.497002
NCT00619944|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-12-03|||February 2008||2008-02-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir|Lumefantrine Pharmacokinetics When Administered as a Fixed Dose Combination With Artemether in HIV Positive Patients on Lopinavir/Ritonavir|Completed||Phase 4|32|Anticipated|Makerere University||2|||f||||f||||||||||2017-02-18 14:43:03.279441|2017-02-18 14:43:03.279441
NCT00619931|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-12-29|||January 2008||2008-01-01|December 2008|2008-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers||Completed||Phase 1|50|Anticipated|Arena Pharmaceuticals|||5||f||||f||||||||||2017-02-18 14:43:03.384937|2017-02-18 14:43:03.384937
NCT00619918|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2013-07-29|2013-07-29||February 2008||2008-02-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Nebulized Hypertonic Saline for Bronchiolitis|Nebulized Hypertonic Saline for Treatment of Viral Bronchiolitis|Completed||Phase 2/Phase 3|447|Actual|Children's Hospital Los Angeles|"Albuterol administered before each study treatment~Did not reach subject accrual goals~Number of patients recruited from inpatient unit too small to analyze separately"|2|||f||||t||||||||||2017-02-18 14:43:03.488683|2017-02-18 14:43:03.488683
NCT00619905|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2008-02-08|||December 2003||2003-12-01|February 2008|2008-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate|A Randomized, Double-Blind, Placebo-Controlled, Cohort Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 (Anti-Interleukin-1Beta Monoclonal Antibody) in Patients With Active Rheumatoid Arthritis (RA) Despite Ongoing Treatment With Methotrexate (MTX) 15 mg or More Weekly for at Least 3 Months.|Completed||Phase 1/Phase 2|53|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:43:03.980746|2017-02-18 14:43:03.980746
NCT00619892|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-12-15|2015-07-27||February 2008||2008-02-01|December 2015|2015-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients|An 8-week, Randomized, Double-Blind, Placebo-Controlled Trial of Seroquel SR Co-administration for SSRI-Resistant, Comorbid Panic Disorder|Completed||Phase 4|26|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 14:43:04.096391|2017-02-18 14:43:04.096391
NCT00619879|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2011-03-29|||March 2007||2007-03-01|March 2011|2011-03-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies|Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies|Recruiting||Phase 3|200|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-02-18 14:43:04.629414|2017-02-18 14:43:04.629414
NCT00619866|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-01-02||2012-02-07|December 2007||2007-12-01|January 2013|2013-01-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Interventional|||An Efficacy and Safety Study of NBI-56418 in Endometriosis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-56418 in Subjects With Endometriosis|Completed||Phase 2|155|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 14:43:04.744273|2017-02-18 14:43:04.744273
NCT00619853|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-10|2008-02-20|||June 2007||2007-06-01|February 2008|2008-02-01|October 2007||2007-10-01|||||Interventional|CIMT||The Influence of MCIMT (Modified Constrained Induced Movement Therapy), Bilateral Intensive Treatment, and NDT Approach on the UL Function in Children With Hemiplegic Cerebral Palsy||Completed||Phase 2|||Sheba Medical Center|||||f||||f||||||||||2017-02-18 14:43:05.053926|2017-02-18 14:43:05.053926
NCT00619840|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-02-11|||November 2004||2004-11-01|February 2008|2008-02-01||||May 2006|Actual|2006-05-01||Interventional|EMMA||Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD|Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD|Completed||Phase 3|363|Actual|Medice Arzneimittel Pütter GmbH & Co KG||2|||f||||f||||||||||2017-02-18 14:43:05.141067|2017-02-18 14:43:05.141067
NCT00619827|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2016-04-18|2016-01-25||September 2007||2007-09-01|April 2016|2016-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||The Intent-to-treat (ITT) population included all randomised subjects who received at least one dose of the investigational product.|Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract|A Randomised, Double-blind, in Parallel Groups Placebo-controlled, Mono-centre, Phase I Study to Assess After Allergen Challenge in an Allergen Exposition Chamber the Effect and Its Time Course of Sublingual Immunotherapy (SLIT) Administered as 300IR Allergen-based Tablets Once Daily to Adults Suffering From Grass Pollen Rhinoconjunctivitis|Completed||Phase 1|89|Actual|Stallergenes||2|||f||||f||||||||||2017-02-18 14:43:05.255355|2017-02-18 14:43:05.255355
NCT00619814|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2008-02-20|||September 2003||2003-09-01|February 2008|2008-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|DCBE||Is Barium Enema an Adequate Diagnostic Test for Patients With Positive FOBT?|Is Barium Enema an Adequate Diagnostic Test for Patients With Positive FOBT?|Completed||N/A|50|Actual|VA Caribbean Healthcare System||1|||f||||t||||||||||2017-02-18 14:43:05.586817|2017-02-18 14:43:05.586817
NCT00619801|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-02-18|2009-07-28||March 2008||2008-03-01|February 2015|2015-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|PAL||Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin|A Multi-Center, Randomized, Double Blind, Placebo Controlled Parallel Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation b.i.d Dosing in Children Aged 1 to < 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin|Completed||Phase 3|173|Actual|UCB Pharma||2|||f||||||||||||||2017-02-18 14:43:05.675014|2017-02-18 14:43:05.675014
NCT00619788|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-07-02|||March 2008||2008-03-01|July 2010|2010-07-01|October 2009|Actual|2009-10-01|November 2008|Actual|2008-11-01||Interventional|MASCOT||FeMoropopliteal AngioSculpt™ SCoring BallOon CaTheter Study|Prospective, Multicenter, Non-randomized Clinical Trial Investigating the Safety and Efficacy of the AngioSculpt Scoring Balloon Catheter (AngioScore, Inc.) for the Treatment of Femoropopliteal Stenotic Disease.|Completed||Phase 2/Phase 3|50|Anticipated|Flanders Medical Research Program||1|||f||||f||||||||||2017-02-18 14:43:06.50365|2017-02-18 14:43:06.50365
NCT00619762|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2016-10-04|2012-12-19||October 2007||2007-10-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Observational|||Immediate Postmastectomy Breast Reconstruction (Strattice Breast)|A Multicenter, Prospective, Open-Label Study to Assess the Clinical Outcomes of LTM Use in Two-Stage Breast Reconstruction Immediately Post Mastectomy|Completed||N/A|17|Actual|LifeCell|Small number of subjects and breasts analyzed.||1||f||||f||||||Samples Without DNA|"~     Tissue sample~   "|||2017-02-18 14:43:06.723361|2017-02-18 14:43:06.723361
NCT00619749|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2016-07-07|||March 2008||2008-03-01|July 2016|2016-07-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Polyphenols and Endothelial Function|Polyphenols Rich Fruit Juice Effects on Endothelial Function and Exercise Capacity|Terminated||Phase 3|50|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 14:43:06.986446|2017-02-18 14:43:06.986446
NCT00619736|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2009-01-28|||March 2008||2008-03-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Evaluating the Safety, Tolerability and Pharmacokinetics of NSA-789 in Healthy Japanese Male Subjects|Ascending Single Dose Study of the Safety, Tolerability and Pharmacokinetics of NSA-789 Administered Orally to Healthy Japanese Male Subjects|Completed||Phase 1|56|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:43:07.083791|2017-02-18 14:43:07.083791
NCT00619723|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2013-04-29||2013-04-22|April 2008||2008-04-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Citicoline for Bipolar 1 Disorder and Cocaine Dependence|A 12-week, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial of Citicoline as an add-on Therapy Will be Conducted in 200 Outpatients With Bipolar I Disorder and Cocaine Dependence.|Completed||Phase 4|130|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 14:43:07.160946|2017-02-18 14:43:07.160946
NCT00619710|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2008-02-20|||February 2001||2001-02-01|February 2008|2008-02-01|April 2004|Actual|2004-04-01|December 2003|Actual|2003-12-01||Interventional|||Complicated Skin and Skin Structure Infections|A Multicenter, Randomized, Double Blind, Comparative Trial of Intravenous MERREM (Meropenem, ICI 194,660) vs PRIMAXIN I.V. (Imipenem-Cilastatin) in the Treatment of Hospitalised Subjects With Complicated Skin and Skin Structure Infections.|Completed||Phase 3|1000|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 14:43:07.265042|2017-02-18 14:43:07.265042
NCT00619697|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2017-01-05|||December 2003||2003-12-01|January 2017|2017-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|EUROMIX||Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes|Comparison of Efficacy and Safety of Biphasic Insulin Aspart 30 Plus Metformin With Insulin Glargine Plus Glimepiride in Type 2 Diabetes|Completed||Phase 4|260|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:43:07.355578|2017-02-18 14:43:07.355578
NCT00619684|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2015-09-28|||February 2008||2008-02-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant|A Phase II Study of Lenalidomide Following Allogeneic Stem Cell Transplant for Multiple Myeloma Patients Who Relapse or Have Disease Progression|Completed||Phase 2|18|Actual|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 14:43:07.512486|2017-02-18 14:43:07.512486
NCT00619671|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-01-15|||April 2004||2004-04-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Pilot Trial of Rituxan in Refractory Myasthenia Gravis|Phase 1-2 Pilot Study of Rituximab (Rituxan) in Refractory Myasthenia Gravis.|Completed||Phase 1/Phase 2|10|Anticipated|University of Vermont||1|||f||||t||||||||||2017-02-18 14:43:07.642395|2017-02-18 14:43:07.642395
NCT00619658|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2016-01-27|||February 2008||2008-02-01|January 2016|2016-01-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|SMART||The Feasibility of Simplified Telephone Follow-up After Medical Abortion|The Feasibility of Simplified Telephone Follow-up After Medical Abortion|Completed||N/A|139|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:43:07.864038|2017-02-18 14:43:07.864038
NCT00619645|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2014-03-20|||June 2007||2007-06-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers|Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan|Completed||Phase 2|1|Actual|University of California, Davis||3|||f||||t||||||||||2017-02-18 14:43:07.975597|2017-02-18 14:43:07.975597
NCT00619632|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2015-01-13|||February 2008||2008-02-01|January 2015|2015-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|BINGO||Boosting Breastfeeding in Low-Income, Multi-ethnic Women: A Primary Care Based RCT|Boosting Breastfeeding in Low-Income, Multi-ethnic Women: A Primary Care Based RCT|Completed||N/A|666|Actual|Albert Einstein College of Medicine, Inc.||4|||f||||t||||||||||2017-02-18 14:43:08.099302|2017-02-18 14:43:08.099302
NCT00619619|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2011-02-18|2010-11-10||February 2008||2008-02-01|February 2011|2011-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder|Final Report: Multicenter, Open-Label, Safety, Tolerability, And Pharmacokinetic Study To Evaluate Single Ascending Doses And Subsequent Short-Term Administration Of Fixed Doses Of DVS SR Tablets In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder|Completed||Phase 2|59|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:43:08.217838|2017-02-18 14:43:08.217838
NCT00619606|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-02-20|||November 2006||2006-11-01|February 2008|2008-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||To Determine the Efficacy of the TwinGuard in Oxygen Delivery During and Post Endoscopic Procedure|A Randomised, Parallel, Open Label Study to Determine the Efficacy of a New Oral-Nasal Oxygenating Device (TwinGuard) Compared to Standard Bite Block Plus Nasal Cannulae|Completed||Phase 2|150|Actual|Trawax Pty Limited|||||f||||t||||||||||2017-02-18 14:43:12.857289|2017-02-18 14:43:12.857289
NCT00619593|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-01-09|||February 2008||2008-02-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|April 2014|Actual|2014-04-01||Interventional|SPIRIT-ICD||Survival of Patients With Primary Prophylactic ICD Indication|Survival of Patients With Primary Prophylactic ICD Indication, Provided With Intensified Care After 1st ICD Therapy|Completed||Phase 4|504|Actual|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-02-18 14:43:12.936483|2017-02-18 14:43:12.936483
NCT00619580|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2014-12-05|||February 2008||2008-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Ampicillin-sulbactam Resistant E.Coli at UPMC|Ampicillin-sulbactam Resistant E.Coli at UPMC|Withdrawn||N/A|0|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 14:43:13.084674|2017-02-18 14:43:13.084674
NCT00619541|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2009-02-25|||January 2007||2007-01-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|November 2007|Actual|2007-11-01||Interventional|P2||Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)|Phase II Study of Sorafenib (Bay 43-9006) and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma.|Completed||Phase 2|46|Anticipated|Italian Trial in Medical Oncology||1|||f||||t||||||||||2017-02-18 14:43:15.696654|2017-02-18 14:43:15.696654
NCT00619528|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2016-10-07|||July 2007||2007-07-01|October 2016|2016-10-01|February 2021|Anticipated|2021-02-01|February 2018|Anticipated|2018-02-01||Interventional|||HLA-Identical Sibling Renal Transplant Tolerance|HLA-Identical Sibling Renal Transplant Tolerance With Donor Hematopoietic Stem Cells and Campath-1H|Active, not recruiting||N/A|230|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 14:43:15.795743|2017-02-18 14:43:15.795743
NCT00619515|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-20|2013-02-27|||December 2007||2007-12-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer|Prospective Evaluation of Cyberknife Stereotactic Radiosurgery for Low and Low/Intermediate Risk Prostate Cancer|Completed||N/A|73|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:43:15.894241|2017-02-18 14:43:15.894241
NCT00619502|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2016-04-08|2014-02-22||December 2007||2007-12-01|April 2016|2016-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants|Immunogenicity and Safety Study of a Booster Dose of DTaP-IPV-Hep B-PRP~T Combined Vaccine at 15 to 18 Months of Age Following a Primary Series at 2, 3 and 4 Months of Age in Healthy Turkish Infants|Completed||Phase 3|254|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:43:16.009384|2017-02-18 14:43:16.009384
NCT00619489|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2014-06-19|2014-06-19||December 2007||2007-12-01|June 2014|2014-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||"The Safety Analysis Set defined as all enrolled participants who received at least 1 dose of study drug. Patients were analyzed based on the lowest dose they received.~Baseline is the time closest to, but before, the start of study drug administration; for participants who rolled over from Study C13002 Baseline data are from the C13002 dataset."|Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease|Phase 2, Multiple Dose, Open-Label Study to Determine the Long Term Safety of MLN0002 in Patients With Ulcerative Colitis and Crohn's Disease|Completed||Phase 2|72|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 14:43:16.627244|2017-02-18 14:43:16.627244
NCT00619476|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2013-07-15|2011-04-26||February 2008||2008-02-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)|Study PXN110748: An Efficacy and Safety Study of XP13512 Compared With a Concurrent Placebo Control in Subjects With Neuropathic Pain Associated With Post-herpetic Neuralgia (PHN)|Completed||Phase 2|376|Actual|XenoPort, Inc.||4|||f||||f||||||||||2017-02-18 14:43:17.597336|2017-02-18 14:43:17.597336
NCT00619463|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-09-23|||August 2007||2007-08-01|September 2013|2013-09-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effects of Aerobic Exercise on Cognition, Mood and Fatigue Following TBI|Effects of Aerobic Exercise on Cognition, Mood and Fatigue Following TBI|Completed||N/A|154|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 14:43:19.345456|2017-02-18 14:43:19.345456
NCT00619450|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2017-01-31|||August 2007|Actual|2007-08-01|January 2017|2017-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|DynaC-Arm||Siemens 3-D C-Arm CT of the Heart Chambers|Three Dimensional C-Arm Computed Tomography of the Heart Chambers|Completed||N/A|16|Actual|The Cleveland Clinic|||1||f||||f|f|f|||t|||No||2017-02-18 14:43:19.459327|2017-02-18 14:43:19.459327
NCT00619437|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-10|2008-02-10|||April 2008||2008-04-01|February 2008|2008-02-01|December 2009|Anticipated|2009-12-01|||||Observational|||Genetics of Schizophrenia|Genetics of Schizophrenia|Unknown status|Not yet recruiting|N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples With DNA|"~     Cell Lines / DNA~   "|||2017-02-18 14:43:19.569268|2017-02-18 14:43:19.569268
NCT00619424|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-05-31|||November 2007||2007-11-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors|A Phase I Study of Pazopanib in Combination With Either Erlotinib or Pemetrexed in Patients With Advanced Solid Tumors|Completed||Phase 1|58|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:43:19.645152|2017-02-18 14:43:19.645152
NCT00619411|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2012-03-08|||November 2007||2007-11-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Interpersonal Psychotherapy for Depressed Adolescents and Parents|An Open Clinical Trial of Interpersonal Psychotherapy for Depressed Adolescence and Parents|Completed||Phase 1|10|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-02-18 14:43:19.758251|2017-02-18 14:43:19.758251
NCT00619398|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-02-23|||January 2008||2008-01-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients|A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients and a Pharmacokinetics Study|Completed||Phase 3|172|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-02-18 14:43:19.868253|2017-02-18 14:43:19.868253
NCT00619385|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2014-08-05|2014-06-27||February 2008||2008-02-01|August 2014|2014-08-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|PK||A Safety and Pharmacokinetic Study of Proellex®|A Safety and Pharmacokinetic Study of 100 mg, 150 mg and 200 mg of Proellex® Taken for Seven Days by Healthy Adult Female Subjects|Completed||Phase 1|25|Actual|Repros Therapeutics Inc.||3|||f||||f||||||||||2017-02-18 14:43:19.997567|2017-02-18 14:43:19.997567
NCT00619372|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-10|2009-02-03|||January 2008||2008-01-01|January 2008|2008-01-01|June 2008|Anticipated|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Oral OKT3 in Combination With Beta-D-Glucosylceramide|Administration of Anti-CD3 (OKT3) in Combination With Beta-D-Glucosylceramide|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|Hadassah Medical Organization||6|||f||||t||||||||||2017-02-18 14:43:20.530288|2017-02-18 14:43:20.530288
NCT00619177|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-01-30|2009-05-22||March 2007||2007-03-01|January 2015|2015-01-01||||May 2008|Actual|2008-05-01||Observational||Treated set|Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life|Assessing the Impact of MOVALIS on Health Related Quality of Life|Completed||N/A|3569|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:43:24.721309|2017-02-18 14:43:24.721309
NCT00619359|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-03-14|2010-01-19||February 2008||2008-02-01|March 2016|2016-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|EASE||Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)|A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of a Single Dose of Intravenous MK-0517 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With Cisplatin Chemotherapy|Completed||Phase 3|2322|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:43:20.656021|2017-02-18 14:43:20.656021
NCT00619346|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2013-03-06|||November 2007||2007-11-01|March 2013|2013-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects|Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects|Terminated||Phase 1|100|Actual|Immtech Pharmaceuticals, Inc||2||FDA Full Clinical Hold due to safety concerns, as of 12/21/07|f||||f||||||||||2017-02-18 14:43:21.843837|2017-02-18 14:43:21.843837
NCT00619333|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2010-01-11|||March 2007||2007-03-01|January 2010|2010-01-01||||March 2010|Anticipated|2010-03-01||Interventional|||Inactive FSH in Galactosemia|The Role of Inactive Follicle Stimulating Hormone in Ovarian Dysfunction in Galactosemia|Unknown status|Active, not recruiting|N/A|25|Anticipated|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 14:43:21.944713|2017-02-18 14:43:21.944713
NCT00619320|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2013-02-11|||December 2008||2008-12-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|||Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women|Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women|Completed||Phase 2/Phase 3|380|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 14:43:22.033032|2017-02-18 14:43:22.033032
NCT00619307|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2014-01-26|2010-05-11||July 2007||2007-07-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|TRANSFER||Transition to Rebif New Formulation|A Randomized, Multicenter, Two-arm, Open-label, Phase IIIb Study to Evaluate the Satisfaction in Relapsing Multiple Sclerosis Subjects Transitioning to Rebif® New Formulation From Rebif® (Interferon Beta-1a) With Ibuprofen When Necessary (PRN) or as Prophylaxis|Completed||Phase 3|117|Actual|Merck KGaA||2|||f||||||||||||||2017-02-18 14:43:22.141014|2017-02-18 14:43:22.141014
NCT00619294|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2013-09-25|||August 2006||2006-08-01|September 2013|2013-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Endothelial Dysfunction and Coronary Artery Spasm|Digital Tonometry for Measurement of Peripheral Artery Reactive Hyperemia as Non-invasive Test for Diagnosis of Coronary Artery Spasm|Completed||N/A|158|Actual|Kumamoto University|||1||f||||f||||||||||2017-02-18 14:43:22.610793|2017-02-18 14:43:22.610793
NCT00619281|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2009-11-23|||October 2007||2007-10-01|November 2009|2009-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||How Much Cardiac Output is Enough?|Prospective, Observational Study in Cardiac Surgery: How Much Cardiac Output is Enough?|Completed||N/A|600|Anticipated|Klinikum Ludwigshafen|||1||f||||f||||||||||2017-02-18 14:43:22.707389|2017-02-18 14:43:22.707389
NCT00619268|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2013-02-14|||February 2008||2008-02-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|TORAVA||Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma|Open Label, Randomized, Multicenter Phase II Study of a Combination of Torisel® (Temsirolimus) and Avastin® (Bevacizumab) Versus Sutent® (Sunitinib) and Versus a Combination of Avastin® (Bevacizumab) and Roféron® (Interferon Alpha-2a) in First-line Treatment of Patients With Metastatic Renal Cell Carcinoma.|Completed||Phase 2|160|Anticipated|Centre Leon Berard||3|||f||||t||||||||||2017-02-18 14:43:22.885047|2017-02-18 14:43:22.885047
NCT00619255|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2013-11-25|||March 2008||2008-03-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|December 2012|Actual|2012-12-01||Interventional|ATRSCC||Adolescent Trauma Recovery and Stress Disorders Collaborative Care (ATRSCC) Model Program Trial|Maternal Child Health Bureau Adolescent Trauma Recovery and Stress Disorders Collaborative Care (ATRSCC) Model Program Trial|Unknown status|Active, not recruiting|Phase 1/Phase 2|300|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 14:43:23.041915|2017-02-18 14:43:23.041915
NCT00619242|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2014-02-10|2009-09-23||June 2006||2006-06-01|February 2014|2014-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|Barrett's||The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer|A Pilot Study of the Effect of Sorafenib on Molecular Biomarkers in Barrett's Esophagus With High Grade Dysplasia|Terminated||N/A|3|Actual|University of Chicago||1||Low accrual|f||||t||||||||||2017-02-18 14:43:23.164186|2017-02-18 14:43:23.164186
NCT00619229|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2014-10-17|2011-01-27||July 2006||2006-07-01|November 2011|2011-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Alprostadil in Maculopathy Study (AIMS)|Confirmatory, Prospective, Randomized, Double-blind, Placebo-controlled, Parallel Groups Study to Assess the Efficacy and Safety of Prostaglandin E1 in Subjects With Dry Age-related Macular Degeneration.|Terminated||Phase 3|37|Actual|UCB Pharma||2||Interim Analysis: Optimization of study design required.|f||||t||||||||||2017-02-18 14:43:23.390399|2017-02-18 14:43:23.390399
NCT00619216|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2011-06-01|||March 2008||2008-03-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Myfortic Conversion Trial in OLT Recipients With GI Intolerance|A Three-Month, Open-Label, Two Cohort Study to Investigate the Safety and Tolerability of Myfortic in Combination With Neoral (Cyclosporin) or Prograf (Tacrolimus) in Liver Transplant Recipients With GI Intolerance|Completed||N/A|31|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 14:43:24.061651|2017-02-18 14:43:24.061651
NCT00619203|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2012-07-09|||March 2008||2008-03-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|GLYIP||Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis|Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis - A Prospective, Randomized, and Double-Blind Clinical Study Using a Two-by-Two Factorial Design|Completed||Phase 3|466|Actual|University of Malawi College of Medicine||4|||f||||f||||||||||2017-02-18 14:43:24.159748|2017-02-18 14:43:24.159748
NCT00619190|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2014-02-07|2013-09-16||January 2006||2006-01-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|PAIRS||Study of Aripiprazole to Treat Children and Adolescents With Autism|An Open Label Study of Aripiprazole in Children and Adolescents With Autism Spectrum Disorders|Completed||Phase 2|30|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 14:43:24.274074|2017-02-18 14:43:24.274074
NCT00619151|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2011-11-07|2011-06-07||December 2007||2007-12-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||CarboMedics Top Hat vs St. Jude Medical Regent Valve Comparing Sizing and Hemodynamics|A Randomized Study to Compare Sizing, Implant Techniques, & Hemodynamic Performance Between the CarboMedics Supra-annular Top Hat Valve and the St. Jude Medical Regent Valve in the Aortic Position.|Terminated||N/A|2|Actual|Sorin Group USA, Inc.|Early termination due to low enrollment resulted in only 2 patients. Insufficient data for analysis.|2||Study stopped due to lack of elegible patient enrollment|f||||f||||||||||2017-02-18 14:43:25.640463|2017-02-18 14:43:25.640463
NCT00619138|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-01-25|||March 2008||2008-03-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|May 2012|Actual|2012-05-01||Interventional|TSPPA||Treatment of Social Phobia and Panic Disorder in Adults|A Randomized, Controlled Study of a Stepped-care Model for the Treatment of Social Phobia and Panic Disorder in Adults|Completed||Phase 3|174|Actual|Haukeland University Hospital||2|||f||||f||||||||||2017-02-18 14:43:25.930805|2017-02-18 14:43:25.930805
NCT00619125|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2011-10-19|||April 2008||2008-04-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Observational|||Proposal Evaluating Time-specific Relationships Between Variables of Pain, Stress, and Bloating in IBS Diarrhea and Constipation Symptoms Using a Palm Pilot|A Proposal to Evaluate Time-specific Relationships Between Variables of Pain, Stress, and Bloating in the Onset of IBS Diarrhea and Constipation Symptoms Using Ecological Momentary Assessment (EMA)|Completed||N/A|85|Actual|University of North Carolina, Chapel Hill|||4||f||||f||||||||||2017-02-18 14:43:26.027329|2017-02-18 14:43:26.027329
NCT00619112|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2013-10-29|2013-06-17||October 2007||2007-10-01|October 2013|2013-10-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Temozolomide in Treating Patients With Recurrent High-Grade Glioma|Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients With High-Grade Glioma|Completed||Phase 2|60|Actual|University of California, San Francisco|The trial reached enrollment. There were no unexpected toxicities.|1|||f||||t||||||||||2017-02-18 14:43:26.109593|2017-02-18 14:43:26.109593
NCT00619099|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2013-09-18|2013-07-14||May 2008||2008-05-01|September 2013|2013-09-01||||March 2012|Actual|2012-03-01||Interventional||Modified Intent to Treat (mITT) Population|A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)|Randomized Open-label Phase 2 Study of Low Dose Dacogen® for Injection (Decitabine) in Patients With Low or Intermediate 1 Risk Myelodysplastic Syndromes|Completed||Phase 2|67|Actual|Eisai Inc.||2|||f||||f||||||||||2017-02-18 14:43:26.392312|2017-02-18 14:43:26.392312
NCT00619086|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2008-06-06|||November 2005||2005-11-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Steroid Before Thyroidectomy|Does a Single Dose of Steroid Before Thyroidectomy Improve Postoperative Nausea, Pain and Vocal Function?|Completed||N/A|72|Actual|University of Bern||2|||f||||f||||||||||2017-02-18 14:43:27.12761|2017-02-18 14:43:27.12761
NCT00619073|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2015-04-09|2012-01-10||April 2008||2008-04-01|April 2015|2015-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|PACT||PACT (Platelet Activity After Clopidogrel Termination)|PACT (Platelet Activity After Clopidogrel Termination)|Completed||N/A|15|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-02-18 14:43:27.222516|2017-02-18 14:43:27.222516
NCT00619060|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2016-03-09|2013-11-27||August 2007||2007-08-01|September 2014|2014-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers|A Phase I Study of Topical Myristyl Nicotinate Cream on Human Skin in Healthy Volunteers|Completed||Phase 1|22|Actual|University of Arizona||2|||f||||t||||||||||2017-02-18 14:43:27.480989|2017-02-18 14:43:27.480989
NCT00619047|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-11-18|||January 2002||2002-01-01|November 2009|2009-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||The Role of Impact Activity in Peripubertal Bone Accrual|The Role of Impact Activity in Peripubertal Bone Accrual|Completed||N/A|131|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:43:27.78947|2017-02-18 14:43:27.78947
NCT00619034|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-12-28|||September 2007||2007-09-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|XAVOT||Pharmacological Intervention in Diabetic Retinopathy|Pharmacological Intervention Against Diabetic Retinal Flow Disturbances.|Completed||N/A|87|Actual|University of Aarhus||3|||f||||t||||||||||2017-02-18 14:43:27.868167|2017-02-18 14:43:27.868167
NCT00619021|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2012-11-06|||January 2003||2003-01-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer|A Phase I Study Evaluating Bronchial Artery Infusion (BAI) of Gemcitabine in Recurrent or Progressive Non-Small Cell Lung Cancer|Terminated||Phase 1|4|Actual|Masonic Cancer Center, University of Minnesota||4||Funding and study drugs unavailable|f||||t||||||||||2017-02-18 14:43:27.983894|2017-02-18 14:43:27.983894
NCT00619008|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2008-10-02|||April 2005||2005-04-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|BALANCE||Energy Balance Weight Regulation Study|Energy and Appetite Regulation by High and Low CHO Diets|Completed||Phase 2|35|Actual|National Center for Complementary and Integrative Health (NCCIH)||3|||f||||t||||||||||2017-02-18 14:43:28.100096|2017-02-18 14:43:28.100096
NCT00618995|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-08-25|2008-12-05||August 2007||2007-08-01|August 2015|2015-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, 4-Period, Crossover Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With Type 2 Diabetes|Completed||Phase 1|26|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 14:43:28.207151|2017-02-18 14:43:28.207151
NCT00618982|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-11-23|2010-04-30||February 2008||2008-02-01|November 2015|2015-11-01|January 2011|Actual|2011-01-01|April 2009|Actual|2009-04-01||Interventional|||Sorafenib Dose Escalation in Renal Cell Carcinoma|A Phase II, Multi-centre, Open-label Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of Intrapatient Dose Escalation of Sorafenib as First Line Treatment for Metastatic Renal Cell Carcinoma.|Completed||Phase 2|83|Actual|Bayer||1|||f||||t||||||||||2017-02-18 14:43:28.944549|2017-02-18 14:43:28.944549
NCT00618969|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2016-03-01|||February 2008||2008-02-01|March 2016|2016-03-01|February 2016|Actual|2016-02-01|December 2013|Actual|2013-12-01||Interventional|||Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors|A Phase II Study of Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors for Treatment of Hematologic Malignancies and Hematopoietic Failure States|Completed||Phase 2|2|Actual|University of Arizona||1|||f||||t||||||||||2017-02-18 14:43:29.587215|2017-02-18 14:43:29.587215
NCT00618956|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-11-10|2009-07-29||October 2007||2007-10-01|November 2009|2009-11-01||||July 2008|Actual|2008-07-01||Interventional|||A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring|A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Milnacipran 100 And 200 MG Daily in Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure|Completed||Phase 3|321|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 14:43:29.715214|2017-02-18 14:43:29.715214
NCT00618943|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2011-12-07|||April 2008||2008-04-01|December 2011|2011-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Treating Tobacco Dependence in Adolescents With Co-occurring Psychiatric Disorders|Treating Tobacco Dependence in Adolescents With Co-occurring Psychiatric Disorders|Completed||Phase 3|60|Actual|University of California, San Francisco||1|||f||||||||||||||2017-02-18 14:43:30.339334|2017-02-18 14:43:30.339334
NCT00618930|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-04-14|||February 2008||2008-02-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Moviprep® Versus Fleet Phospho-Soda® (Golden Standard): A Study That Compared Two Laxatives on Patients Undergoing Colo-Rectal Cleansing Prior to an Abdominal Operation|Moviprep® Versus Fleet Phospho-Soda® (Golden Standard): A Study That Compared Two Laxatives on Patients Undergoing Colo-Rectal Cleansing Prior to an Abdominal Operation.|Completed||Phase 4|40|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 14:43:30.423679|2017-02-18 14:43:30.423679
NCT00618917|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2015-12-23|||November 2005||2005-11-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|MnSOD||MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)|Chemotherapy (Paclitaxel and Carboplatin)and Thoracic Radiotherapy With Swallowed Manganese Superoxide Dismutase (MnSOD) Plasmid Liposome Protection in Patients With Locally Advanced Stage III Non-Small Cell Lung Cancer: A Phase I-II Study|Suspended||Phase 1/Phase 2|45|Anticipated|University of Pittsburgh||1||MnSOD currently being manufactured|f||||t||||||||||2017-02-18 14:43:30.522048|2017-02-18 14:43:30.522048
NCT00618904|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2013-07-08|||December 2005||2005-12-01|July 2013|2013-07-01|September 2007|Actual|2007-09-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy of Probiotic Bacteria in Subjects With IBS or Functional Diarrhea/ Bloating|Clinical Efficacy of Probiotic Bacteria in Subjects With Irritable Bowel Syndrome (IBS), Functional Diarrhea, or Functional Bloating|Completed||N/A|56|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 14:43:30.632435|2017-02-18 14:43:30.632435
NCT00618878|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2008-10-16|||October 2008||2008-10-01|October 2008|2008-10-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Electroacupuncture and Laser Therapy on Neck Pain|The Effects of Electroacupuncture and Laser Therapy on Chronic Neck Pain, A Pilot Study|Unknown status|Recruiting|N/A|20|Anticipated|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 14:43:30.74302|2017-02-18 14:43:30.74302
NCT00618865|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2008-02-08|||June 2004||2004-06-01|February 2008|2008-02-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy|Omega-3 Polyunsaturated Fatty Acids in Women With Major Depressive Disorders During Pregnancy|Completed||N/A|36|Actual|National Science Council, Taiwan||2|||f||||f||||||||||2017-02-18 14:43:30.854263|2017-02-18 14:43:30.854263
NCT00618852|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2008-02-19|||January 2007||2007-01-01|February 2008|2008-02-01|June 2009|Anticipated|2009-06-01|December 2008|Anticipated|2008-12-01||Interventional|||Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates|A Randomized Controlled Trial of Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates|Unknown status|Recruiting|Phase 3|64|Anticipated|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 14:43:30.941065|2017-02-18 14:43:30.941065
NCT00618839|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2012-08-08|2009-05-08||July 2006||2006-07-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects|Open-Label, Controlled, Randomized, Comparative, Dose Escalation Study Of The Safety, Human Immunology, And Efficacy Of StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects In Patients Undergoing Sequential Skin Reconstruction Procedures|Completed||Phase 1/Phase 2|15|Actual|Stratatech, a Mallinckrodt Company||1|||f||||t||||||||||2017-02-18 14:43:31.055659|2017-02-18 14:43:31.055659
NCT00618826|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2010-08-27|||November 2006||2006-11-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer|A Phase II Trial of Biweekly Gemcitabine, Paclitaxel, and Avastin as Frontline Therapy for Metastatic Breast Cancer|Terminated||Phase 2|45|Anticipated|University of Cincinnati||1||PI left institution|f||||f||||||||||2017-02-18 14:43:31.480515|2017-02-18 14:43:31.480515
NCT00618813|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2014-09-11|2013-12-17||March 2008||2008-03-01|September 2014|2014-09-01||||March 2010|Actual|2010-03-01||Interventional|||Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors|A Pilot Study of Chemotherapy Intensification by Adding Vincristine, Topotecan and Cyclophosphamide to Standard Chemotherapy Agents With an Interval Compression Schedule in Newly Diagnosed Patients With Localized Ewing Sarcoma Family of Tumors|Completed||N/A|35|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 14:43:31.595589|2017-02-18 14:43:31.595589
NCT00618800|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2011-09-16|||August 2004||2004-08-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Preventing Falls Through Enhanced Pharmaceutical Care|Preventing Falls Through Enhanced Pharmaceutical Care|Completed||N/A|200|Anticipated|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 14:43:31.995918|2017-02-18 14:43:31.995918
NCT00618787|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-04-09|2009-07-29||February 2008||2008-02-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Prospective Randomized Double Blind Clinical Trial of Polyhexamethylene Biguanide Impregnated Foam Dressing|Prospective Randomized Double Blind Clinical Trial of Polyhexamethylene Biguanide Impregnated Foam Dressing|Completed||Phase 2|45|Actual|Tyco Healthcare Group||2|||f||||||||||||||2017-02-18 14:43:32.102463|2017-02-18 14:43:32.102463
NCT00618774|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2014-06-17|2009-12-28||January 2008||2008-01-01|April 2014|2014-04-01||||October 2009|Actual|2009-10-01||Interventional|||An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination|An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination|Completed||Phase 3|259|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:43:34.960065|2017-02-18 14:43:34.960065
NCT00004558|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-09|2016-02-17|||February 1999||1999-02-01|December 2005|2005-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Antiarrhythmic Effects of N-3 Fatty Acids||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:16:33.603579|2017-02-18 18:16:33.603579
NCT00618761|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-06-14|||October 2004||2004-10-01|January 2008|2008-01-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Controls|Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Non-Diabetic Kidney Recipients, Insulin Independent Recipients of Beta-cell Grafts and Healthy Controls.|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Gasthuisberg||4|||f||||t||||||||||2017-02-18 14:43:35.51297|2017-02-18 14:43:35.51297
NCT00618748|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2011-07-25|2011-05-24||February 2008||2008-02-01|July 2011|2011-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed|Safety and Efficacy of Olanzapine (LY170053) in the Long-term Treatment for Patients With Bipolar I Disorder, Depressed|Completed||Phase 3|101|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 14:43:35.618955|2017-02-18 14:43:35.618955
NCT00618735|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2016-12-27|||February 2008||2008-02-01|December 2016|2016-12-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors|A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of BIIB021 Administered Once or Twice Daily to Subjects With Advanced Solid Tumors|Completed||Phase 1|68|Actual|Biogen||2|||f||||t||||||||||2017-02-18 14:43:36.869667|2017-02-18 14:43:36.869667
NCT00618722|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-06-17|2015-05-28||August 2007||2007-08-01|June 2015|2015-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|ATX-101|Safety analysis set|Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat|Phase 1-2, Multicenter, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) for the Reduction of Subcutaneous Fat in the Submental Area|Completed||Phase 1/Phase 2|85|Actual|Kythera Biopharmaceuticals||4|||f||||f||||||||||2017-02-18 14:43:36.981073|2017-02-18 14:43:36.981073
NCT00618709|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-05-28|||January 2008||2008-01-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Dose-Escalation Safety and Pharmacokinetic Study of ATX-101|Phase 1, Open-Label, Dose-Escalation Safety and Pharmacokinetic Study of ATX-101 (Sodium Deoxycholate for Injection) Following Subcutaneous Injections in the Submental Area|Completed||Phase 1|24|Actual|Kythera Biopharmaceuticals||4|||f||||f||||||||||2017-02-18 14:43:38.328594|2017-02-18 14:43:38.328594
NCT00618696|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2011-08-23|||July 2005||2005-07-01|August 2011|2011-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia|MT2005-13R - Phase I Open Label, Single Arm, Dose Escalation Trial to Evaluate the Biodistribution and Safety of AHN-12 in Patients With Advanced Leukemia|Terminated||Phase 1|4|Actual|Masonic Cancer Center, University of Minnesota||1||Replaced with another study|f||||t||||||||||2017-02-18 14:43:38.436872|2017-02-18 14:43:38.436872
NCT00618683|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2016-11-18|||March 2004||2004-03-01|November 2016|2016-11-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|AVNRT||AV Nodal Reentrant Tachycardia Study|Localization of the Anterograde and Retrograde Components of the Reentrant Circuit of AV Nodal Reentrant Tachycardia|Recruiting||N/A|100|Anticipated|University of Oklahoma||1|||f||||f||||||||||2017-02-18 14:43:38.550752|2017-02-18 14:43:38.550752
NCT00618670|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2009-12-18|||September 2006||2006-09-01|December 2009|2009-12-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Home-based vs. Supervised Exercise for People With Claudication|Home-based vs. Supervised Exercise for Claudicants|Unknown status|Recruiting|N/A|111|Anticipated|National Institute on Aging (NIA)||3|||f||||t||||||||||2017-02-18 14:43:38.679237|2017-02-18 14:43:38.679237
NCT00618657|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2016-11-28|||February 2008||2008-02-01|November 2016|2016-11-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting|A Phase II Study of Breast Cancer Treatment Using Weekly Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting|Active, not recruiting||Phase 2|132|Actual|University of California, Irvine||2|||f||||t||||||||||2017-02-18 14:43:38.79377|2017-02-18 14:43:38.79377
NCT00618644|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2012-09-25|||January 2010||2010-01-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Ranibizumab for Neovascularization in Sickle Cell Retinopathy|A Phase I Study to Evaluate the Ocular and Non Ocular Safety of Ranibizumab in Treating Neovascularization Secondary to Sickle Cell Retinopathy|Withdrawn||N/A|0|Actual|Kresge Eye Institute||1||Withdrawn due to lack of eligible participants|f||||f||||||||||2017-02-18 14:43:38.924016|2017-02-18 14:43:38.924016
NCT00618631|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-17|2017-01-24|||January 17, 2008||2008-01-17|January 8, 2015|2015-01-08|January 8, 2015|Actual|2015-01-08|||||Interventional|||Effects of Smoking on Opioid Receptor Binding: A PET Study|Effects of Smoking on Opioid Receptor Binding Using [(11)C]Carfentanil: An Imaging PET Study|Completed||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:43:39.038409|2017-02-18 14:43:39.038409
NCT00618618|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-06-17|2015-05-28||April 2008||2008-04-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||Safety/Modified Intent-to-Treat (mITT) subset included all randomized participants who received at least 1 dose of study material and who had at least 1 post-baseline observation|Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat|Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Safety and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Given by Three Dosing Paradigms for the Reduction of Localized Subcutaneous Fat in the Submental Area|Completed||Phase 2|73|Actual|Kythera Biopharmaceuticals||6|||f||||f||||||||||2017-02-18 14:43:39.156468|2017-02-18 14:43:39.156468
NCT00618605|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-18|2016-10-31|||February 2008||2008-02-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|July 2011|Actual|2011-07-01||Interventional|||Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults|A Phase 1 Randomized, Double-Blind, Placebo Controlled Dose Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Adenovirus Serotype 26 HIV-1 Vaccine (Ad26.ENVA.01) in Healthy, HIV-1 Uninfected Adults|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 14:43:40.662838|2017-02-18 14:43:40.662838
NCT00618592|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2010-07-21|||February 2008||2008-02-01|February 2009|2009-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|Preop||Does Pre-operative Carbohydrate Loading Reduce Insulin Resistance and Improve Outcomes in Elective Surgical Patients?|Does Pre-operative Carbohydrate Loading Reduce Insulin Resistance and Improve Outcomes in Elective Surgical Patients?|Completed||N/A|60|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-02-18 14:43:40.773866|2017-02-18 14:43:40.773866
NCT00618579|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2014-04-04|||February 2008||2008-02-01|April 2014|2014-04-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin|A Randomised, Controlled Study Investigating the Safety and Anticoagulant Activity of Administration of Low-molecular-weight Heparin in Healthy Male Subjects Treated With the Monoclonal Anti-factor VIII Antibody, TB-402 and the Safety and Anticoagulant Activity of Administration of TB-402 in Healthy Male Subjects Treated With Warfarin|Completed||Phase 1|15|Actual|ThromboGenics||4|||f||||f||||||||||2017-02-18 14:43:40.887234|2017-02-18 14:43:40.887234
NCT00618566|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-10-15|||October 2007||2007-10-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|CBT-WPD||Group Therapy Program for Women With Physical Disabilities|A Peer Implemented Cognitive Behavioral Group Therapy Intervention for Use With Women With Physical Disabilities With Secondary Depression|Completed||N/A|82|Actual|Oregon Health and Science University||1|||f||||t||||||||||2017-02-18 14:43:41.037518|2017-02-18 14:43:41.037518
NCT00618553|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-11-09|||January 2008||2008-01-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Interventional|||Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting|The Efficacy of Pulmonary Rehabilitation in Improving Surgical Eligibility for Lung Resection|Active, not recruiting||Phase 2|75|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:43:41.30175|2017-02-18 14:43:41.30175
NCT00618540|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2015-10-02|2015-04-22||January 2007||2007-01-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis|Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis|Terminated||Phase 2|1|Actual|Masonic Cancer Center, University of Minnesota||1||Slow accrual|f||||t||||||||||2017-02-18 14:43:41.414514|2017-02-18 14:43:41.414514
NCT00618527|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-11-14|||August 2006||2006-08-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Combination Therapy Using Cellcept and Rebif in RRMS|Combination Therapy Using Mycophenolate Mofetil (CellCept) and Human Interferon beta1a (Rebif) in Early Treatment of Multiple Sclerosis|Completed||Early Phase 1|31|Actual|Ohio State University||2|||f||||t||||||||||2017-02-18 14:43:41.730299|2017-02-18 14:43:41.730299
NCT00618514|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2015-03-20|2010-01-26||June 2008||2008-06-01|June 2013|2013-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|BRILLIANT|Reporting per limb treated (versus per subject)|The BRILLIANT Study|Comparative Evaluation of the FDA-Cleared Bright Tip Laser Fiber Versus Commercially Available Bare Laser Fiber (the Control) in the Treatment of Reflux in the Greater Saphenous Vein (GSV) Using Endovenous Laser Therapy|Terminated||N/A|93|Actual|Vascular Solutions, Inc|Due to budgetary constraints, enrollment in the BRILLIANT trial was ended after 90 subjects (110 limbs) were enrolled in the study. This study had an insufficient sample size to perform the planned formal statistical hypothesis testing.|2||Sponsor decision|f||||f||||||||||2017-02-18 14:43:41.849556|2017-02-18 14:43:41.849556
NCT00618501|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2013-03-25|||October 2005||2005-10-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|Gleevec (Imatinib) Plus Multi-Agent Chemotherapy For Newly-Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:43:42.318002|2017-02-18 14:43:42.318002
NCT00618488|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2008-02-19|||February 2007||2007-02-01|February 2008|2008-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy of Yogurt Containing BB12 in Subjects With GI Symptoms|Clinical Efficacy of Yogurt Containing Bifidobacterium Lactis (BB12) in Subjects With Functional Gastrointestinal Symptoms|Completed||N/A|63|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 14:43:42.425973|2017-02-18 14:43:42.425973
NCT00618475|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-03-25|||August 2008||2008-08-01|March 2016|2016-03-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Observational|||Cognitive Behavioral Treatment of Depression in ESRD Patients on Dialysis||Completed||N/A|65|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||f||||||||||2017-02-18 14:43:42.521909|2017-02-18 14:43:42.521909
NCT00618462|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2011-12-23|||August 2004||2004-08-01|December 2011|2011-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Cognitive Behavioral Treatments for Pathological Gambling|Cognitive Behavioral Treatments for Pathological Gambling|Completed||Phase 2|210|Actual|UConn Health||3|||f||||t||||||||||2017-02-18 14:43:42.618437|2017-02-18 14:43:42.618437
NCT00618449|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-04-10|2011-01-27||January 2008||2008-01-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|||Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger|Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger|Completed||Phase 4|1139|Actual|University of California, San Francisco|Prevalence of infection in communities was less than predicted, as was return of infection post-treatment, thus hypothesis could not be evaluated.|2|||f||||f||||||||||2017-02-18 14:43:42.736615|2017-02-18 14:43:42.736615
NCT00618436|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2014-03-07|2013-08-29||August 2007||2007-08-01|March 2014|2014-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|Keppra|One patient was enrolled at 17 years of age. His age was unknown at the time of admission to the hospital after his trauma, and based on body size/habitus he appeared to be a young adult. It was later discovered that he was only 17, but turning 18 in 3 days. The PI decided to allow his participation in the study at the parents request.|Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention|Assessment of Seizure Prophylaxis Protocols Using Intravenous Levetiracetam in a Neuroscience Intensive Care Unit|Completed||Phase 4|52|Actual|University of Cincinnati||2|||f||||t||||||||||2017-02-18 14:43:43.134257|2017-02-18 14:43:43.134257
NCT00618423|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2013-04-12|||October 2007||2007-10-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|KetaDol||The Effect of Perioperative Ketamine on Acute and Chronic Pain After Major Back Surgery|The Effect of Perioperative Intravenous Low-dose Ketamine on Acute and Chronic Neuropathic Pain After Major Back Surgery. A Randomised, Placebo-controlled, Double-blind Study|Completed||Phase 2|160|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 14:43:43.517749|2017-02-18 14:43:43.517749
NCT00618410|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2013-12-09|2013-08-28||February 2008||2008-02-01|December 2013|2013-12-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|||Intranasal CO2 for Allergic Rhinitis|Intranasal CO2 for Allergic Rhinitis|Completed||N/A|13|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 14:43:43.635118|2017-02-18 14:43:43.635118
NCT00618397|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2016-10-24|||June 2006||2006-06-01|October 2016|2016-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Pharmacokinetics of Low Dose Ketamine Infusion|Phase I Trial to Determine Steady State Pharmacokinetics and Sedative Effects of Low Dose Ketamine Infusion|Terminated||Phase 1|5|Actual|University of Texas Southwestern Medical Center||1||Poor recruitement|f||||f||||||||||2017-02-18 14:43:43.949084|2017-02-18 14:43:43.949084
NCT00618384|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-06-06|||January 2008||2008-01-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|SOCRATES||TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)|Phase II Study Evaluating Transarterial Chemoembolization (TACE) in Combination With Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)|Terminated||Phase 2|43|Actual|Heinrich-Heine University, Duesseldorf||1|||f||||f||||||||||2017-02-18 14:43:44.063358|2017-02-18 14:43:44.063358
NCT00618371|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-29|2016-12-06|2011-09-12||October 2007||2007-10-01|December 2016|2016-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia|Investigating the Source of HIV-1 Viremia in Patients on Antiretroviral Therapy Through Intensification With MK-0518|Completed||N/A|10|Actual|University of Pittsburgh||1|||f||||t||||||||No|Data were analyzed and there is no plan to make individual participant data available|2017-02-18 14:43:44.175551|2017-02-18 14:43:44.175551
NCT00618358|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-03-26|||March 2007||2007-03-01|January 2010|2010-01-01||||||||Interventional|VSS||Vascular Sealant Study|A Prospective, Randomized, Multi-Center, Two Arm Study to Evaluate the Safety and Effectiveness of the Vascular Sealant System Compared With Gelfoam/Thrombin for Control of Anastomosis Suture Line Bleeding in Patients Undergoing Vascular Reconstructive Surgery With PTFE Grafts|Terminated||Phase 1|||Georgetown University||2||Sponsor - Confluent Surgical terminated study re: surgical techniques Letter dated 4/31/2008|f||||t||||||||||2017-02-18 14:43:44.4352|2017-02-18 14:43:44.4352
NCT00618345|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-19|2011-05-13|||March 2005||2005-03-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|October 2006|Actual|2006-10-01||Interventional|||Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma|Phase II Trial of RAD001 in Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|35|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:43:44.519493|2017-02-18 14:43:44.519493
NCT00618332|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2014-01-21|2013-11-21||April 2008||2008-04-01|January 2014|2014-01-01|July 2010|Actual|2010-07-01|July 2008|Actual|2008-07-01||Interventional|||Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?|Does the Response to a Nasal Decongestant Test Predict the Outcome to Treatment of Seasonal Allergic Rhinitis With Nasonex?|Completed||N/A|40|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 14:43:44.612629|2017-02-18 14:43:44.612629
NCT00618319|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-09-17||2015-09-17|February 2008||2008-02-01|March 2011|2011-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)|An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) Refractory to, Intolerant of, or Not a Candidate for Imatinib and Sunitinib Treatment|Completed||Phase 2|20|Actual|Biogen||1|||f||||f||||||||||2017-02-18 14:43:45.060808|2017-02-18 14:43:45.060808
NCT00618293|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-01-03|||January 2008||2008-01-01|January 2012|2012-01-01|July 2011|Actual|2011-07-01|July 2010|Anticipated|2010-07-01||Interventional|HAVAS||Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis|Phase 2 Study in Evaluation of the Efficacy and Safety of Haemate HS in This Clinical Setting (Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis)|Withdrawn||Phase 2|0|Actual|Heinrich-Heine University, Duesseldorf||2||No patient met the criteria for inclusion in the study.|f||||f||||||||||2017-02-18 14:43:45.158728|2017-02-18 14:43:45.158728
NCT00618280|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-03-01|||January 2008||2008-01-01|March 2012|2012-03-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|NIKOGEN||Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail|Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail|Completed||Phase 1/Phase 2|101|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-02-18 14:43:45.466219|2017-02-18 14:43:45.466219
NCT00618267|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2010-03-04|||March 2008||2008-03-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|Cylex||"ATP Expression in Lymphocytes of MS Patients by Means of ImmuKnow® Assay."|"Single Center, Pilot Study to Measure ATP Expression in Lymphocytes of MS Patients Undergoing Various Therapies by Means of Using the ImmuKnow® Test"|Completed||N/A|100|Actual|Biogen|||1||f||||t||||||Samples Without DNA|"~     About 1 ½ teaspoons of blood will be drawn.~   "|||2017-02-18 14:43:45.58163|2017-02-18 14:43:45.58163
NCT00618254|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-18|||March 2005||2005-03-01|February 2008|2008-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions|A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions|Completed||N/A|32|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:43:45.663398|2017-02-18 14:43:45.663398
NCT00618241|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2011-06-06|||February 2008||2008-02-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|GRANOLA||Pharmacokinetic Study on Raltegravir and Lamotrigine|The Influence of Raltegravir (MK-0518) on the Pharmacokinetics of Single-dose Lamotrigine in Healthy Male Subjects (GRANOLA)|Completed||Phase 1|24|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 14:43:45.754229|2017-02-18 14:43:45.754229
NCT00618228|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-18|||January 2004||2004-01-01|February 2008|2008-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, Randomized Crossover Bioequivalency Study of 750 mg Balsalazide Capsules Under Fasting Conditions|Completed||N/A|52|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:43:45.872511|2017-02-18 14:43:45.872511
NCT00618215|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-18|||September 2006||2006-09-01|February 2008|2008-02-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||A Cluster Randomized Controlled Trial in Primary Oral Care|Impact of Multifaceted Peer Group Education to Improve Routine Oral Examinations in Primary Care A Cluster-Randomised Controlled Trial|Completed||Early Phase 1|1161|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 14:43:45.975811|2017-02-18 14:43:45.975811
NCT00617825|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2011-08-04|||September 2007||2007-09-01|September 2007|2007-09-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|Cryo||Feasibility Study of Cryotherapy for Chronic Venous Disorders|Cryotherapy for Chronic Venous Disorders|Completed||N/A|60|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-02-18 14:43:55.81818|2017-02-18 14:43:55.81818
NCT00618202|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-18|||May 2005||2005-05-01|February 2008|2008-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions|Completed||N/A|52|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:43:46.086643|2017-02-18 14:43:46.086643
NCT00618176|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-03-21|||January 2005||2005-01-01|March 2008|2008-03-01||||September 2006|Actual|2006-09-01||Interventional|||Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort||Completed||Phase 4|198|Actual|Peking Union Medical College||3|||f||||||||||||||2017-02-18 14:43:46.1794|2017-02-18 14:43:46.1794
NCT00618163|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-15|||March 2005||2005-03-01|February 2008|2008-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 15 mg Meloxicam Tablets Under Fasting Conditions|Completed||N/A|47|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:43:46.278896|2017-02-18 14:43:46.278896
NCT00618150|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2017-01-16|||September 1996||1996-09-01|January 2017|2017-01-01||||December 1999|Actual|1999-12-01||Interventional|||Patient Education in Gastroesophageal Reflux Disease|Patient Education in Gastroesophageal Reflux Disease|Completed||N/A|211|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 14:43:46.374478|2017-02-18 14:43:46.374478
NCT00618137|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-08-23|||January 2007||2007-01-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Inert Dusts and Pathology of Chronic Obstructive Pulmonary Disease|Longitudinal Assessment of Clinical and Molecular Pathology of Chronic Obstructive Lung Disease and the Possible Influence of Inert Dusts in Working Volunteers of the Greater Vienna Area|Completed||N/A|160|Actual|Medical University of Vienna|||1||f||||t||||||Samples With DNA|"~     Transbronchial lung biopsies Blood serum~   "|||2017-02-18 14:43:46.477777|2017-02-18 14:43:46.477777
NCT00618124|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-04-29|||May 2005||2005-05-01|April 2010|2010-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together|A Phase 1 Safety And Pharmacokinetic Study Of SU011248 And Capecitabine In Patients With Advanced Solid Tumors|Completed||Phase 1|77|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:43:46.558514|2017-02-18 14:43:46.558514
NCT00618111|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-15|||March 2005||2005-03-01|February 2008|2008-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed Conditions|A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed Conditions|Completed||N/A|32|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:43:46.658433|2017-02-18 14:43:46.658433
NCT00618098|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2016-10-17||2015-07-07|May 2008||2008-05-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|March 2012|Actual|2012-03-01||Interventional|||Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures|A Randomized, Open-label, Efficacy and Safety Study of Octaplex and Fresh Frozen Plasma (FFP) in Patients Under Vitamin K Antagonist Therapy With the Need for Urgent Surgery or Invasive Procedures|Completed||Phase 3|200|Actual|Octapharma||2|||f||||t||||||||||2017-02-18 14:43:46.750403|2017-02-18 14:43:46.750403
NCT00618085|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2009-05-01|||February 2008||2008-02-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Motor Imagery Practice in Neurological Rehabilitation|An Integrated Motor Imagery Program in Rehabilitation - a RCT|Completed||Phase 2|50|Anticipated|Nuffield Orthopaedic Centre NHS Trust||2|||f||||f||||||||||2017-02-18 14:43:46.861775|2017-02-18 14:43:46.861775
NCT00618072|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2014-03-27|2014-01-30||January 2008||2008-01-01|March 2014|2014-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|EMPOWIR||EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance|EMPOWIR: Enhance the Metabolic Profile of Women With Insulin Resistance: Carbohydrate Modified Diet Alone and in Combination With Metformin or Metformin Plus Avandia in Non-diabetic Women With Midlife Weight Gain and Documented Insulin Elevations (Syndrome W)|Completed||Phase 2|46|Actual|New York Medical College|Widespread media coverage of cardiovascular risks of rosiglitazone led to an unanticipated high drop out rate of subjects just prior to their randomization; 22 of 68 eligible subjects did not undergo randomization due to concerns about the drug.|3|||f||||t||||||||||2017-02-18 14:43:46.97543|2017-02-18 14:43:46.97543
NCT00618059|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-15|||August 2004||2004-08-01|February 2008|2008-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Sequence Crossover Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fed Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:43:47.924503|2017-02-18 14:43:47.924503
NCT00618046|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-02-15|||November 2004||2004-11-01|February 2008|2008-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions|Completed||N/A|48|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:43:48.00067|2017-02-18 14:43:48.00067
NCT00618033|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2011-06-08|||February 2008||2008-02-01|June 2011|2011-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|Dextrose||Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients|Short-Term Study of Physiologic Dialysate Glucose Concentration in Chronic Hemodialysis Patients|Completed||N/A|30|Actual|Renal Research Institute||2|||f||||f||||||||||2017-02-18 14:43:48.091804|2017-02-18 14:43:48.091804
NCT00618020|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-07-17|||August 2007||2007-08-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy of the CiTop™ Guidewire for Crossing Chronic Total Occlusions in Coronary Arteries|A Feasibility Study to Evaluate the Safety and Efficacy of the CiTop™ Guidewire for Crossing Chronic Total Occlusion in Coronary Arteries|Completed||N/A|10|Actual|Ovalum||1|||f||||t||||||||||2017-02-18 14:43:48.20249|2017-02-18 14:43:48.20249
NCT00617838|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2013-08-22|||October 2007||2007-10-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|August 2014|Anticipated|2014-08-01||Interventional|||Celiac Disease Prevention|Prevention of Celiac Disease in Children at Genetic Risk - Optimized Introduction of Gluten and Follow-up of Immunization|Unknown status|Active, not recruiting|N/A|168|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 14:43:55.716854|2017-02-18 14:43:55.716854
NCT00618007|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2011-06-09||2009-03-20|February 2008||2008-02-01|June 2011|2011-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of PF-00734200 in Subjects With Type 2 Diabetes|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of 12-Week Administration Of PF-00734200 To Subjects With Type 2 Diabetes Mellitus And Insufficient Glycemic Control On Metformin Treatment|Completed||Phase 2|289|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:43:48.300915|2017-02-18 14:43:48.300915
NCT00617994|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2012-03-13||2010-06-28|August 2007||2007-08-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis|An Open Label, Safety, Tolerability, Pharmacokinetic (PK), Pharmacodynamic (PD) and Preliminary Efficacy Study of INCB018424 When Applied to Patients With Plaque Psoriasis Involving 2 - 20% Body Surface Area (BSA).|Completed||Phase 2|25|Actual|Incyte Corporation||3|||f||||f||||||||||2017-02-18 14:43:48.475104|2017-02-18 14:43:48.475104
NCT00617981|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2014-02-03|||February 2008||2008-02-01|February 2014|2014-02-01|December 2015|Anticipated|2015-12-01|January 2013|Actual|2013-01-01||Interventional|||Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)|A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 3|700|Actual|Celsion||2|||f||||t||||||||||2017-02-18 14:43:48.574281|2017-02-18 14:43:48.574281
NCT00617968|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-09-01|||October 2003||2003-10-01|September 2009|2009-09-01|June 2005|Actual|2005-06-01|||||Interventional|||GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer|A Multicenter, Randomized, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Neoadjuvant Treatment Consisting of Either a Docetaxel - Letrozole Combination or Letrozole Alone in Women Over 60 Years of Age Suffering From Grade I or II Operable Hormone Receptor-positive Breast Tumor.|Completed||Phase 2|5|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:43:48.754129|2017-02-18 14:43:48.754129
NCT00617955|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2016-04-18|||September 2007||2007-09-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates|Systemic Effects of Aprotinin During Cardiac Surgery/ Long Term Death Rates|Completed||N/A|462|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:43:48.850729|2017-02-18 14:43:48.850729
NCT00617942|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2014-07-15|||February 2008||2008-02-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|August 2012|Actual|2012-08-01||Interventional|||Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer|BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer|Unknown status|Active, not recruiting|Phase 2|60|Actual|Brown University||1|||f||||t||||||||||2017-02-18 14:43:48.959524|2017-02-18 14:43:48.959524
NCT00617929|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2016-11-22|2016-09-28||January 2008||2008-01-01|April 2015|2015-04-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|||Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant|Conditioning for Graft Failure After Hematopoietic Stem Cell Transplantation|Terminated||Phase 2|12|Actual|Masonic Cancer Center, University of Minnesota||1||Replaced by another protocol|f||||t||||||||||2017-02-18 14:43:49.076309|2017-02-18 14:43:49.076309
NCT00617916|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-06-02|||March 2006||2006-03-01|June 2009|2009-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers|Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers|Completed||N/A|256|Actual|HyperMed|||1||f||||f||||||||||2017-02-18 14:43:49.454903|2017-02-18 14:43:49.454903
NCT00617903|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-12-26|2013-05-02||January 2008||2008-01-01|December 2013|2013-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea|A 12-week Exploratory, Multicenter, Double-blind, Vehicle-controlled Study to Investigate the Efficacy and Safety of Topical Azelaic Acid 15% Foam Twice Daily in Patients With Papulopustular Rosacea|Completed||Phase 2|83|Actual|Bayer||2|||f||||f||||||||||2017-02-18 14:43:49.71122|2017-02-18 14:43:49.71122
NCT00617890|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-08-26|2015-11-09||February 2008||2008-02-01|August 2016|2016-08-01|August 2013|Actual|2013-08-01|August 2011|Actual|2011-08-01||Interventional||Three participants did not receive study treatment but are included in the baseline population.|A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)|A Study to Determine the Activity of SCH 717454 in Subjects With Osteosarcoma or Ewing's Sarcoma That Has Relapsed After Standard Systemic Therapy|Terminated||Phase 2|219|Actual|Merck Sharp & Dohme Corp.|The study was stopped prematurely for administrative reasons; not all planned endpoints were analyzed.|4||The study was prematurely terminated for strategic reasons, not for a safety concern.|f||||f||||||||||2017-02-18 14:43:50.762534|2017-02-18 14:43:50.762534
NCT00617877|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2009-07-21|||March 2005||2005-03-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Antihypertensive Response to Losartan and Genetic Polymorphisms|Pharmacogenetic of the Antihypertensive Response to the Angiotensin II Blockers in Monotherapy or Associated to Hydrochlorothiazide|Completed||N/A|800|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 14:43:52.116645|2017-02-18 14:43:52.116645
NCT00617864|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-02-20|||September 2007||2007-09-01|February 2012|2012-02-01||||||||Interventional|||The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome|The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome.|Withdrawn||N/A|0|Actual|Yale University||2||"The syndrome of hyperstimulation is so rare that after one year no patients were eligible.The~   study was withdrawn and never started."|f||||t||||||||||2017-02-18 14:43:52.207836|2017-02-18 14:43:52.207836
NCT00617851|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-05-03|2010-02-03||November 2007||2007-11-01|May 2012|2012-05-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old|A Phase III, Randomized, Controlled, Observer-Blind, Single-Center Study to Evaluate the Consistency of Three Consecutive Lots of a Trivalent Subunit Influenza Vaccine Produced in Embryonated Hen Eggs in Healthy Subjects Aged 18 to 49 Years|Completed||Phase 3|1507|Actual|Novartis||5|||f||||||||||||||2017-02-18 14:43:52.317064|2017-02-18 14:43:52.317064
NCT00172744|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-10|||April 2005||2005-04-01|March 2005|2005-03-01|July 2006||2006-07-01|||||Observational|||Effect of Cyclic Tensional Force on Osteogenic Differentiation of Human Periodontal Ligament Stem Cells||Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:48.378112|2017-02-18 17:19:48.378112
NCT00617812|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-06-24|||March 2008||2008-03-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine|An Open Label Multicentric Study to Evaluate the Immunogenicity and Safety of Indigenously Developed DTPwHB-Hib (Liquid) Pentavalent Combination Vaccine (Shan 5) in Indian Infants.|Completed||Phase 4|160|Actual|Shantha Biotechnics Limited||1|||f||||f||||||||||2017-02-18 14:43:55.911646|2017-02-18 14:43:55.911646
NCT00617799|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2009-06-16|||October 2007||2007-10-01|June 2009|2009-06-01||||December 2012|Anticipated|2012-12-01||Interventional|||Biomarkers That Predict Response to High-Dose Aldesleukin in Patients With Metastatic Kidney Cancer or Metastatic Melanoma|Pilot Study to Identify Biomarkers That May Predict Response to High Dose IL-2|Unknown status|Active, not recruiting|N/A|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:43:56.015025|2017-02-18 14:43:56.015025
NCT00617786|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2011-11-22|||October 2008||2008-10-01|November 2011|2011-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||CPT Testing for Sacral Neuromodulation Outcomes|Current Perception Threshold Testing for Sacral Neuuromodulation Outcomes|Completed||N/A|13|Actual|William Beaumont Hospitals||1|||f||||f||||||||||2017-02-18 14:43:56.109481|2017-02-18 14:43:56.109481
NCT00617773|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2013-11-01|2013-05-15||May 2008||2008-05-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||The baseline descriptive analyses were performed for the safety population. Lewis Y antigen expression and blood type were also analyzed for this population.|Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A PHASE II TRIAL OF Hu3S193 THERAPY FOR PATIENTS WITH PLATINUM REFRACTORY OR PLATINUM RESISTANT EPITHELIAL OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER|Completed||Phase 2|31|Actual|Recepta Biopharma||1|||f||||f||||||||||2017-02-18 14:43:56.208522|2017-02-18 14:43:56.208522
NCT00617760|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2015-05-20|||March 2008||2008-03-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)|Open-label, Randomized, 3-arm, Phase 3B Clinical Study to Investigate the Safety and Immunogenicity of a Concomitant Administration of Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate (MenC-TT) Vaccine and 7-valent Pneumococcal CRM197-conjugate Vaccine (PCV7) in Toddlers Previously Immunized During Infancy With PCV7|Completed||Phase 3|330|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 14:43:56.911287|2017-02-18 14:43:56.911287
NCT00617747|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-04-03|||September 2002||2002-09-01|April 2009|2009-04-01|June 2003|Actual|2003-06-01|||||Interventional|||Efficacy and Tolerability of Zolmitriptan Nasal Spray|A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group Trial to Evaluate Early Efficacy and Tolerability of Zolmitriptan (ZOMIG) Nasal Spray in the Acute Treatment of Adult Subjects With Migraine.|Completed||Phase 3|2114|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:43:57.04114|2017-02-18 14:43:57.04114
NCT00617734|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2012-08-03||2010-09-10|March 2008||2008-03-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|||Study of IMC-A12, Alone or in Combination With Cetuximab, in Patients With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck|A Randomized Phase 2 Open-Label Study of IMC-A12, as a Single Agent or in Combination With Cetuximab, in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Disease Progression on Prior Platinum-Based Chemotherapy|Completed||Phase 2|91|Actual|ImClone LLC||2|||f||||f||||||||||2017-02-18 14:43:57.132264|2017-02-18 14:43:57.132264
NCT00617721|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2016-06-16|||June 2008||2008-06-01|June 2016|2016-06-01||||||||Observational|||Markers of Defective Membrane Remodelling in Scott-like Syndromes|Defect in Cell Stimulation and Unexplained hemorrhagesMarkers Related to Membrane Remodelling in the Prognosis Scott-like Syndormes|Terminated||N/A|29|Actual|University Hospital, Strasbourg, France|||2||f||||f||||||Samples With DNA|"~     plasma, white cells, DNA (when the family is informative)~   "|||2017-02-18 14:43:57.262622|2017-02-18 14:43:57.262622
NCT00617708|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2014-07-25|2013-10-07||March 2008||2008-03-01|October 2013|2013-10-01|February 2014|Actual|2014-02-01|September 2011|Actual|2011-09-01||Interventional||Eligible patients who began protocol therapy|S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery|A Phase I and Randomized Phase II Trial of Gemcitabine + Erlotinib (NSC-718781) + IMC-A12 (NSC-742460) vs. Gemcitabine + Erlotinib as First-Line Treatment in Patients With Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|134|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 14:43:57.393808|2017-02-18 14:43:57.393808
NCT00617695|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-04-03|||September 2003||2003-09-01|April 2009|2009-04-01|October 2004|Actual|2004-10-01|||||Interventional|||Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study With Single-Blind, Placebo-Challenge Evaluating the Efficacy of Zolmitriptan (Zomig) Nasal Spray 5mg, in the Treatment of Acute Migraine Headache in Adolescents.|Completed||Phase 3|247|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:43:59.368541|2017-02-18 14:43:59.368541
NCT00617682|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2008-02-14|||October 2000||2000-10-01|February 2008|2008-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Maternal Immunization To Prevent Infant Otitis Media|Maternal Immunization To Prevent Infant Otitis Media|Completed||Phase 1/Phase 2|153|Actual|National Institute on Deafness and Other Communication Disorders (NIDCD)||2|||f||||t||||||||||2017-02-18 14:43:59.468666|2017-02-18 14:43:59.468666
NCT00617669|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-09-04|2012-04-26||January 2008||2008-01-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|ENTHUSE M1C||A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer|A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 10 mg ZD4054 (Zibotentan) in Combination With Docetaxel in Comparison With Docetaxel in Patients With Metastatic Hormone-resistant Prostate Cancer|Completed||Phase 3|1494|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:43:59.607458|2017-02-18 14:43:59.607458
NCT00617656|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2015-07-03|||February 2008||2008-02-01|July 2015|2015-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|BREC||Multicenter, Predictive, Prospective, Phase III, Open, Randomized, Pharmacogenomic Study in Patients With Advanced Lung Carcinoma|Multicenter Phase III, Randomized Study to Evaluate Treatment Customized According to RAP80 and BRCA1 Assessment in Patients With Advanced Non-small-cell Lung Cancer|Terminated||Phase 3|400|Actual|Spanish Lung Cancer Group||4||"No safety reasons. Interim analysis shows that the hypothesis superiority of the experimental~   arm over the control arm- would not be confirmed."|f||||t||||||||||2017-02-18 14:44:01.047409|2017-02-18 14:44:01.047409
NCT00617643|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2010-12-03|||May 2008||2008-05-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|June 2009|Actual|2009-06-01||Interventional|||Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis|Comparison of Nevirapine Levels With and Without Dose Escalation in HIV-infected Patients Commencing Antiretroviral Therapy Who Are Also Receiving Rifampicin Based Anti-tuberculous Therapy|Completed||Phase 4|18|Anticipated|Makerere University||2|||f||||t||||||||||2017-02-18 14:44:01.163038|2017-02-18 14:44:01.163038
NCT00617630|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2015-10-26|||November 1999||1999-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:44:01.276768|2017-02-18 14:44:01.276768
NCT00617617|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-09-21|||February 2002||2002-02-01|February 2010|2010-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Specific Role of Isoflavones in Reducing Prostate Cancer Risk|The Specific Role of Isoflavones in Reducing Prostate Cancer Risk|Completed||Phase 2|52|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-02-18 14:44:01.3253|2017-02-18 14:44:01.3253
NCT00617604|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2016-01-05|2016-01-05||December 2007||2007-12-01|January 2016|2016-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||All randomized patients who took at least 1 dose of study drug (Safety Analysis Set).|A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients|Efficacy and Safety of Alefacept in Combination With Tacrolimus, Mycophenolate Mofetil and Steroids in de Novo Kidney Transplantation - a Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study|Completed||Phase 2|218|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 14:44:01.435563|2017-02-18 14:44:01.435563
NCT00617591|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2013-12-16|2013-10-25||January 2008||2008-01-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||All participants|Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)|Phase II Study of Pegylated Liposomal Doxorubicin (Doxil®), Low Frequency Dexamethasone and Revlimid® (Dd-R) in Newly Diagnosed Multiple Myeloma|Completed||Phase 2|57|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 14:44:02.807202|2017-02-18 14:44:02.807202
NCT00617578|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2013-12-18|||November 2007||2007-11-01|May 2012|2012-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|FavoriteATP||Fast VT Episodes Are Terminated by ATP One Shot|Fast VT Episodes Are Terminated by ATP One Shot|Completed||Phase 4|194|Actual|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-02-18 14:44:03.187944|2017-02-18 14:44:03.187944
NCT00617565|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-05-24|||July 2003||2003-07-01|May 2012|2012-05-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes|A Multi-centre, Randomised, Parallel, Open Labelled Study to Compare the Efficacy and Safety Profile of Biphasic Insulin Aspart 30 (BIAsp 30) and Biphasic Human Insulin 30/70 (BHI 30/70) in Chinese Type 1 and 2 Diabetics|Completed||Phase 3|219|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:44:03.302951|2017-02-18 14:44:03.302951
NCT00617552|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-12-05||2012-12-05|July 2007||2007-07-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess Efficacy and Safety of TZP-101 When Administered as 30 Minute i.v. Infusion for POI to Subjects Undergoing Major Open Abdominal Surgery|Completed||Phase 2|267|Actual|Tranzyme, Inc.||8|||f||||t||||||||||2017-02-18 14:44:03.400127|2017-02-18 14:44:03.400127
NCT00617539|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-15|2014-10-16|||February 2005||2005-02-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|||Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases|A Phase II Study of Irinotecan and Temozolomide in Breast Cancer Patients With Brian Metastases That Have Progressed After Stereotactic Radiosurgery or Whole Brain Radiation|Completed||Phase 2|30|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 14:44:03.538888|2017-02-18 14:44:03.538888
NCT00617526|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2013-12-20||2013-10-29|January 2008||2008-01-01|December 2013|2013-12-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Naïve HIV POC Monotherapy Trial|A Multicenter Phase 2a, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial to Determine the Antiviral Activity, Pharmacokinetics, Tolerability and Safety of RDEA806 in HIV-1 Positive, Antiretroviral naïve Subjects|Completed||Phase 2|48|Actual|Ardea Biosciences, Inc.||4|||f||||f||||||||||2017-02-18 14:44:03.647558|2017-02-18 14:44:03.647558
NCT00617513|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2008-05-28|||March 1995||1995-03-01|February 2008|2008-02-01|March 1996|Actual|1996-03-01|March 1996|Actual|1996-03-01||Interventional|||Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation|A Double-Blind Placebo-Controlled Dose-Finding Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation|Completed||Phase 2|174|Actual|Movetis||4|||f||||f||||||||||2017-02-18 14:44:03.748856|2017-02-18 14:44:03.748856
NCT00617500|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2009-09-18|||July 2008||2008-07-01|September 2009|2009-09-01|November 2009|Anticipated|2009-11-01|December 2008|Anticipated|2008-12-01||Interventional|||Climacteric Clinical Trial : the Use of Complementary Therapy and Hormonal Replacement|Climacteric Clinical Trial : the Use of Complementary Therapy and Hormonal Replacement|Unknown status|Active, not recruiting|Phase 4|278|Anticipated|Sociedade Hospital Samaritano||4|||f||||t||||||||||2017-02-18 14:44:03.841632|2017-02-18 14:44:03.841632
NCT00617487|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-08-03|||December 2007||2007-12-01|August 2009|2009-08-01|January 2010|Anticipated|2010-01-01|||||Observational|||Pulmonary Arterial Hypertension in Systemic Sclerosis|Stress Echocardiography in the Early Identification of Pulmonary Arterial Hypertension in Systemic Sclerosis|Unknown status|Recruiting|N/A|200|Anticipated|IRCCS Policlinico S. Matteo|||1||f||||t||||||||||2017-02-18 14:44:03.937598|2017-02-18 14:44:03.937598
NCT00617474|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2008-03-27|||March 2008||2008-03-01|March 2008|2008-03-01|March 2009|Anticipated|2009-03-01|September 2008|Anticipated|2008-09-01||Interventional|||The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group|The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group|Unknown status|Not yet recruiting|Phase 1|50|Anticipated|Labbafinejhad Hospital||2|||f||||||||||||||2017-02-18 14:44:04.018775|2017-02-18 14:44:04.018775
NCT00617084|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-05-27|2010-11-22||April 2008||2008-04-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|May 2010|Actual|2010-05-01||Interventional|RESOLUTE-AC||Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent|RESOLUTE-III All-comers Trial: A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention|Completed||Phase 4|2292|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-02-18 14:44:15.055678|2017-02-18 14:44:15.055678
NCT00617461|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2013-07-15|2011-04-26||March 2008||2008-03-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment|Study PXN110527: The Investigation of the Efficacy and Pharmacokinetics of XP13512 in Subjects With Neuropathic Pain Associated With Post-herpetic Neuralgia (PHN) Who Have Had an Inadequate Response to Gabapentin Treatment.|Completed||Phase 2|96|Actual|XenoPort, Inc.||2|||f||||f||||||||||2017-02-18 14:44:04.109404|2017-02-18 14:44:04.109404
NCT00617448|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-15|||May 2005||2005-05-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|June 2006|Actual|2006-06-01||Interventional|LDHLA||Ligasure Versus Diathermy Haemorrhoidectomy Under Local Anesthesia|Ligasure™ Versus Diathermy Haemorrhoidectomy Under Spinal or Local Anaesthesia With Ropivacaine. A Randomized Study With One Year Follow-up|Completed||N/A|81|Actual|Hospital de Viladecans||4|||f||||t||||||||||2017-02-18 14:44:05.205512|2017-02-18 14:44:05.205512
NCT00617435|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2009-03-13|||October 2007||2007-10-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|Trans-Insulin||Impact of Trans Fatty Acids From Natural and Industrial Origin in the Induction of Insulin Resistance Development||Completed||N/A|66|Anticipated|Institut National de la Recherche Agronomique||3|||f||||||||||||||2017-02-18 14:44:05.33332|2017-02-18 14:44:05.33332
NCT00617409|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2016-12-13|2016-09-12||October 2007||2007-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|September 2015|Actual|2015-09-01||Interventional||All participants.|To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid|A Randomized Phase II Trial Using Dendritic Cells Transduced With an Adenoviral Vector Containing the p53 Gene to Immunize Patients With Extensive Stage Small Cell Lung Cancer in Combination With Chemotherapy With or Without All Trans Retinoic Acid|Active, not recruiting||Phase 2|69|Actual|H. Lee Moffitt Cancer Center and Research Institute|Protocol V.10.1, 04/11/2012: Arm A was closed due to lack of feasibility; Arm B was closed at the end of the first stage due to lack of efficacy.|3|||f||||t||||||||||2017-02-18 14:44:05.461177|2017-02-18 14:44:05.461177
NCT00617396|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2014-02-04|2013-07-12||February 2008||2008-02-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional||Subjects who received the investigational medication were analyzed. 4 subjects did not meet the study inclusion/exclusion criteria and were not analyzed.|Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder|An Open Label Study of Seroquel SR® (Quetiapine) for the Treatment of Refractory and Treatment Resistant Functional Bowel Disorders|Completed||N/A|25|Actual|University of North Carolina, Chapel Hill|"Uncontrolled open label study and is vulnerable to biases favoring a treatment response.~Sample size is small."|1|||f||||f||||||||||2017-02-18 14:44:06.360404|2017-02-18 14:44:06.360404
NCT00617383|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-02-21|||February 2008||2008-02-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|ARMS||AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS|Determine if the Presence of Characteristic MS-like Lesion(s) on Baseline MRI Predisposes to CIS/MS in Female MZ Twins Discordant for CIS/MS.|Completed||N/A|3|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples Without DNA|"~     blood for serum and peripheral mononuclear cells; optional CSF - cerebrospinal fluid at~     entry and exit from trail~   "|||2017-02-18 14:44:06.616655|2017-02-18 14:44:06.616655
NCT00617370|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2015-12-21|||November 2004||2004-11-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|July 2005|Actual|2005-07-01||Interventional|||Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility|Pilot Study of Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in High-Risk Breast Cancer: Feasibility|Completed||N/A|38|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:44:06.709143|2017-02-18 14:44:06.709143
NCT00617357|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2015-10-29|2012-08-16||September 2007||2007-09-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|RICH|83 subjects enrolled, of which 80 subjects were implanted. The ITT population is defined as subjects enrolled and implanted (n=80).|Repair of Infected or Contaminated Hernias|A Multicenter, Prospective, Observational Evaluation of Repair of Infected or Contaminated Hernias (RICH) Using LTM|Completed||N/A|83|Actual|LifeCell||1|||f||||f||||||||||2017-02-18 14:44:06.811416|2017-02-18 14:44:06.811416
NCT00617344|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2016-04-12||2011-02-15|April 2008||2008-04-01|September 2014|2014-09-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US|Immunogenicity and Safety of Three Tetravalent Formulations of Dengue Vaccine Candidates in Healthy Adults Aged 18 to 45 Years in the US|Completed||Phase 2|260|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 14:44:07.166765|2017-02-18 14:44:07.166765
NCT00617331|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-07-20||2011-07-20|February 2008||2008-02-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||H9 Priming Study in Healthy Adults|A Randomized, Double-Blind, Clinical Trial Evaluating the Immunogenicity of an Inactivated Influenza A/H9N2 Vaccine Among Healthy Adults With and Without Prior Exposure to Influenza A/H2N2|Completed||Phase 2|121|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 14:44:07.287459|2017-02-18 14:44:07.287459
NCT00617318|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2008-02-15|||January 2007||2007-01-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Pomegranate Products for Prevention of Common Cold|Pomegranate Products for Prevention of Common Cold and Influenza-Like Symptoms: A Double- Blind, Placebo-Controlled Randomized Clinical Trial|Completed||Phase 3|461|Actual|Texas Heart Institute||2|||f||||t||||||||||2017-02-18 14:44:07.390248|2017-02-18 14:44:07.390248
NCT00617305|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-06-22|2012-05-11||April 2008||2008-04-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|February 2011|Actual|2011-02-01||Interventional|ATHENA-1||Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)|An Open-label, Multicenter Study of Ambrisentan and a Phosphodiesterase Type-5 Inhibitor Combination Therapy in Subjects With Pulmonary Arterial Hypertension Who Have Demonstrated a Sub-Optimal Response to a Phosphodiesterase Type-5 Inhibitor|Completed||Phase 4|38|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 14:44:07.715136|2017-02-18 14:44:07.715136
NCT00617292|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-12-08|||January 2008||2008-01-01|December 2008|2008-12-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Observational|||Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers|Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency|Unknown status|Recruiting|N/A|233|Anticipated|Office of Rare Diseases (ORD)|||3||f||||t||||||||||2017-02-18 14:44:09.477272|2017-02-18 14:44:09.477272
NCT00617279|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-12-08|2011-02-07||December 2007||2007-12-01|December 2011|2011-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|PRODIGY||GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft|Comparison of Primary Patency Between GORE PROPATEN Vascular Graft and Disadvantaged Autologous Vein Graft For Below-Knee Arterial Bypass (PRODIGY Study)|Terminated||Phase 4|31|Actual|W.L.Gore & Associates|The study was terminated prior to completion of enrollment. The primary patency and secondary endpoints were not calculated due to the paucity of data.|2||Study terminated due to low enrollment|f||||f||||||||||2017-02-18 14:44:09.592786|2017-02-18 14:44:09.592786
NCT00617266|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-02-14|||August 2007||2007-08-01|February 2008|2008-02-01|February 2009|Anticipated|2009-02-01|April 2008|Anticipated|2008-04-01||Interventional|||Tobacco Control Among Business Process Outsourcing (BPO) Employees|Tobacco Control Among Business Process Outsourcing (BPO) Employees|Unknown status|Recruiting|Phase 3|800|Anticipated|Tata Memorial Hospital||4|||f||||t||||||||||2017-02-18 14:44:10.486315|2017-02-18 14:44:10.486315
NCT00617253|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-10-24|||July 2007||2007-07-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients|An Open Label, Dose Escalation Safety and Tolerability Trial of the Combination of s.c. Recombinant Human IL-21 (rIL-21) and Sunitinib (Phase 1) Followed by an Open Label Stratified Randomized 2-arm Trial of rIL-21 Plus Sunitinib Versus Sunitinib Alone (Phase 2a) in Subjects With Stage IV Renal Cell Carcinoma|Completed||Phase 1/Phase 2|9|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-02-18 14:44:10.588757|2017-02-18 14:44:10.588757
NCT00617240|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2014-02-07|2013-09-02||January 2007||2007-01-01|February 2014|2014-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|PREVENT||Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth|Metformin Mitigation of Atypical Antipsychotic-Induced Metabolic Dysregulation in Adolescent Youth|Completed||Phase 2|9|Actual|University of North Carolina, Chapel Hill|Small number of subjects analyzed and recruited, however, based on preliminary data, a larger, multi-site trial was developed.|2|||f||||f||||||||||2017-02-18 14:44:10.697122|2017-02-18 14:44:10.697122
NCT00617227|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2010-02-09|||October 2007||2007-10-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|May 2008|Actual|2008-05-01||Observational|||Serum Vancomycin Levels in Patients Receiving Enteral Vancomycin|Measurement of Serum Vancomycin in Patients Receiving Enteral ( Oral/Intracolonic) Vancomycin.|Completed||N/A|100|Anticipated|Maimonides Medical Center|||1||f||||t||||||||||2017-02-18 14:44:11.186585|2017-02-18 14:44:11.186585
NCT00617214|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2010-12-08|||January 2008||2008-01-01|October 2008|2008-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|CARE I||Schizophrenic Patients Taking Part in Integrated Care Program|Evaluation of Treatment Outcomes in Schizophrenic Patients Taking Part in the Integrated Care Program - a Single-country, Multi-centre Non-interventional Study|Terminated||N/A|20|Actual|AstraZeneca|||1|"Difficulty finding eligible sites/patients:current situation in health policy cause negative~   effects on existing/planned contracts for integrated care programs"|f||||f||||||||||2017-02-18 14:44:11.497189|2017-02-18 14:44:11.497189
NCT00617201|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-11-13|2012-11-13||July 2007||2007-07-01|November 2012|2012-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial|Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial|Completed||Phase 2|50|Actual|University of Kentucky||2|||f||||t||||||||||2017-02-18 14:44:11.607194|2017-02-18 14:44:11.607194
NCT00617188|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2012-11-06|2009-06-12||June 2007||2007-06-01|November 2012|2012-11-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer|Phase II Trial of Fulvestrant in Treatment of Recurrent Ovarian Carcinoma|Completed||Phase 2|26|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:44:12.041813|2017-02-18 14:44:12.041813
NCT00617175|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-03-23|2012-08-30||March 2008||2008-03-01|March 2016|2016-03-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|ADVANCEIII||Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III|ADVANCE III: Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III|Completed||Phase 4|1902|Actual|Medtronic Bakken Research Center||2|||f||||t||||||||||2017-02-18 14:44:12.440591|2017-02-18 14:44:12.440591
NCT00617162|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-08-27|||March 2008||2008-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:44:13.281828|2017-02-18 14:44:13.281828
NCT00617149|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2009-09-17|||November 2007||2007-11-01|September 2009|2009-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Effect of Regular Exercise in Prevention of Excessive Weight Gain in Pregnancy|Effect of Regular Exercise in Prevention of Excessive Weight Gain in Pregnancy. A Single Blind Randomized Controlled Trial|Completed||Phase 1|105|Actual|Norwegian School of Sport Sciences||1|||f||||f||||||||||2017-02-18 14:44:13.332371|2017-02-18 14:44:13.332371
NCT00617136|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-12-16|||April 2008||2008-04-01|December 2014|2014-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|HOT||Perioperative Temperature Management|Perioperative Temperature Management: A Big Small Problem|Completed||N/A|70|Actual|VU University Medical Center||3|||f||||f||||||||||2017-02-18 14:44:13.438088|2017-02-18 14:44:13.438088
NCT00617123|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2015-06-23|2014-05-09||July 2008||2008-07-01|June 2015|2015-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||Participants who were included in the analysis of ocular safety.|Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Ocular Safety of SCH 530348 in Subjects Participating in the Schering-Plough P04737 Study (TRA^SM-Secondary Prevention Ocular Safety Study)|Completed||Phase 3|258|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 14:44:13.559087|2017-02-18 14:44:13.559087
NCT00617110|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2015-06-01|||January 2008||2008-01-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|FLAIR||Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies|Effects of Diesel Exhaust Particles on Influenza-induced Nasal Inflammation in Allergic Rhinitics and Non-allergic Individuals|Completed||N/A|54|Actual|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-02-18 14:44:13.965495|2017-02-18 14:44:13.965495
NCT00617097|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2014-10-15|2014-06-09||January 2008||2008-01-01|October 2014|2014-10-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Paracervical Block in First Trimester Surgical Abortions|Paracervical Block With Ketorolac and Lidocaine in First Trimester Surgical Abortions|Completed||Phase 2/Phase 3|50|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:44:14.09539|2017-02-18 14:44:14.09539
NCT00617071|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2013-12-17|||January 2007||2007-01-01|July 2009|2009-07-01||||December 2010|Anticipated|2010-12-01||Interventional|||Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants|Tailored Navigation in CRC Screening|Unknown status|Recruiting|Phase 3|900|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:44:18.732328|2017-02-18 14:44:18.732328
NCT00617058|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-11-28|2012-10-29||March 2007||2007-03-01|November 2012|2012-11-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|ZAC||Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine|Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine|Terminated||Phase 2|1|Actual|University of North Carolina, Chapel Hill|In terms of study limitations, this research study was only able to enroll a single study participant before the trial was terminated prematurely due to study start-up for a larger, multisite effort examining similar outcome measures.|3||Terminated in lieu of similar,competing large, multi-site study.|f||||t||||||||||2017-02-18 14:44:18.828898|2017-02-18 14:44:18.828898
NCT00617045|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-06-15|||July 2007||2007-07-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|DuloxPPD||Duloxetine for the Treatment of Postpartum Depression|Duloxetine in the Treatment of Postpartum-onset and Non-Postpartum Onset Major Depressive Disorder|Withdrawn||N/A|0|Actual|Yale University||1||poor patient recruitment|f||||f||||||||No||2017-02-18 14:44:19.410645|2017-02-18 14:44:19.410645
NCT00617032|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-05|||February 2004||2004-02-01|February 2008|2008-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94|A Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94, a Recombinant Adeno-Associated Vector Containing the TNFR:Fc Fusion Gene, in Inflammatory Arthritis|Completed||Phase 1|15|Actual|Targeted Genetics Corporation||3|||f||||t||||||||||2017-02-18 14:44:19.52044|2017-02-18 14:44:19.52044
NCT00617019|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2013-11-11|||September 2006||2006-09-01|November 2013|2013-11-01||||January 2008|Actual|2008-01-01||Observational|||Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)|A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Disease Patients Treated With MIRAPEX® (Pramipexole) and Other Anti-parkinson Agents (DOMINION Study)|Completed||N/A|3234|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:44:19.842467|2017-02-18 14:44:19.842467
NCT00617006|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-14|||July 2007||2007-07-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Observational|||Potential Nosocomial Infection Prevention Via Modification of Anesthesia Intraoperative Aseptic Practice|Before and After Study Evaluating Deployment of the Sprixx GJ Personal Hand Hygiene Device in the Intra-Operative Environment|Completed||N/A|114|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||f||||||Samples Without DNA|"~     Environmental Bacterial Samples of Workspace~   "|||2017-02-18 14:44:19.979245|2017-02-18 14:44:19.979245
NCT00616993|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2011-06-29|||January 2008||2008-01-01|June 2011|2011-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)||Completed||Phase 3|120|Anticipated|Sirion Therapeutics, Inc.||2|||f||||||||||||||2017-02-18 14:44:20.072263|2017-02-18 14:44:20.072263
NCT00616980|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2011-07-21|||December 2007||2007-12-01|July 2011|2011-07-01|August 2010|Actual|2010-08-01|April 2010|Actual|2010-04-01||Interventional|ACT34-CLI||Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia|Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia|Completed||Phase 1/Phase 2|28|Actual|Losordo, Douglas, M.D.||3|||f||||t||||||||||2017-02-18 14:44:20.17286|2017-02-18 14:44:20.17286
NCT00616967|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2014-06-16|2014-04-08||May 2008||2008-05-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|June 2012|Actual|2012-06-01||Interventional||"The information for the primary populations for analysis are included (Placebo and Vorinostat arms). The initial run-in phase of 6 participants was conducted to confirm safety and dosing for the combination of vorinostat with chemotherapy only, and these data are not a part of our primary study analyses."|Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer|A Multi-Institutional Double-Blind Phase II Study Evaluating Response and Surrogate Biomarkers to Carboplatin and Nab-Paclitaxel (CP) With or Without Vorinostat as Preoperative Chemotherapy in HER2-negative Primary Operable Breast Cancer|Completed||Phase 2|68|Actual|Sidney Kimmel Comprehensive Cancer Center|A proportion of women received additional preoperative chemotherapy after study treatment,complicating the evaluation of primary endpoint and role of FDG-PET in predicting response. Limited matched samples for Ki67 analysis.|2|||f||||f||||||||||2017-02-18 14:44:20.288578|2017-02-18 14:44:20.288578
NCT00616954|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-04-19|||May 2008||2008-05-01|August 2009|2009-08-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT|An Investigator Initiated, Prospective, Randomized, Controlled Study in Order to Evaluate the Effect of Anti-thymocyte Globulin (Fresenius ATG) on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical Allogeneic Hematopoietic Stem-cell Transplantation|Terminated||Phase 3|50|Anticipated|Hadassah Medical Organization||2||low recruitment|f||||||||||||||2017-02-18 14:44:21.106368|2017-02-18 14:44:21.106368
NCT00616941|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-04-16|||August 2008||2008-08-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||A Phase I Study of NY-ESO-1 Overlapping Peptides (OLP4) Immunoadjuvants Montanide and Poly-ICLC Vaccination of Epithelial Ovarian Cancer (EOC), Fallopian Tube, or Primary Peritoneal Cancer Patients in Second or Third Remission|A Phase I Study of NY-ESO-1 Overlapping Peptides (OLP4) With or Without Immunoadjuvants Montanide and Poly-ICLC Vaccination of Epithelial Ovarian Cancer (EOC), Fallopian Tube, or Primary Peritoneal Cancer Patients in Second or Third Remission|Completed||Phase 1|26|Anticipated|Ludwig Institute for Cancer Research||3|||f||||t||||||||||2017-02-18 14:44:21.209357|2017-02-18 14:44:21.209357
NCT00616928|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-10-11|2013-12-19||January 2008||2008-01-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|||Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years|A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccination Regimen in Adults Aged ≥18 Years|Completed||Phase 3|4561|Actual|GlaxoSmithKline||10|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:44:21.330749|2017-02-18 14:44:21.330749
NCT00616915|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2015-12-14|||January 2007||2007-01-01|December 2015|2015-12-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Interventional|||Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?|Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?|Completed||Phase 1|20|Actual|Queen's University||1|||f||||f||||||||||2017-02-18 14:44:23.187228|2017-02-18 14:44:23.187228
NCT00616902|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-01-18|2010-05-21||January 2009||2009-01-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|PRIMO II||The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5|Clinical Study Protocol M10-221 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5|Terminated||Phase 3|12|Actual|Abbott|This study was prematurely terminated due to low enrollment. Only 12 subjects were randomized at 10 investigative sites with none of the subjects completing the study.|2||This study was prematurely terminated due to low enrollment|f||||t||||||||||2017-02-18 14:44:23.306777|2017-02-18 14:44:23.306777
NCT00616889|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-12-14|||May 2006||2006-05-01|December 2015|2015-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder|Effects of Seroquel on Sleep Architecture in Patients With Bipolar Depression or Major Depressive Disorder - An Open Label Study|Completed||Phase 1|15|Actual|Queen's University|||1||f||||f||||||||||2017-02-18 14:44:24.232776|2017-02-18 14:44:24.232776
NCT00616876|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-14|||February 2005||2005-02-01|February 2008|2008-02-01|January 2007|Actual|2007-01-01|August 2006|Actual|2006-08-01||Interventional|||Lactulose Supplementation in Premature Infants|The Effects of Lactulose Supplementation to Enteral Feedings in Premature Infants - A Pilot Study|Completed||Phase 2|28|Actual|Bnai Zion Medical Center||2|||f||||f||||||||||2017-02-18 14:44:24.334947|2017-02-18 14:44:24.334947
NCT00616863|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-02-14|||July 2004||2004-07-01|February 2008|2008-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions|A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Oxcarbazapine 600 mg Tablets Under Fed Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:44:24.458627|2017-02-18 14:44:24.458627
NCT00616850|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-05-20|||October 2007||2007-10-01|May 2014|2014-05-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|||Treatment of Postoperative Pain After Total Knee Arthroplasy Using Intravenous Lidocaine Infusion|Treatment of Postoperative Pain After Total Knee Arthroplasty Using Intravenous Lidocaine Infusion in Combination With Patient Controlled Analgesia Versus Continuous Femoral Block Catheter in Combination With Patient Controlled Analgesia: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Study.|Withdrawn||N/A|0|Actual|Loma Linda University||3||Orthopedic surgeon that does our knee surgeries moved to a different location|f||||f||||||||||2017-02-18 14:44:24.558032|2017-02-18 14:44:24.558032
NCT00616837|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-12-16|||November 2007||2007-11-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2012|Actual|2012-10-01||Interventional|||Remote Orthopedic Outpatient Consultation by Help of Telemedicine|Remote Orthopedic Outpatient Consultation by Help of Telemedicine|Completed||N/A|400|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-02-18 14:44:24.66355|2017-02-18 14:44:24.66355
NCT00616824|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2013-08-03|||September 2007||2007-09-01|February 2008|2008-02-01|September 2013|Anticipated|2013-09-01|September 2013|Anticipated|2013-09-01||Interventional|||The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction|The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction After Mastectomy: A Double-Blinded, Randomized Trial|Terminated||Phase 4|60|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:44:24.756208|2017-02-18 14:44:24.756208
NCT00616811|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-01-02||2013-01-02|January 2008||2008-01-01|January 2013|2013-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency|A Multi-center, Randomized, Double-blind, Active-controlled Clinical Trial to Evaluate the Safety and Tolerability of 24 Weeks Treatment With Vildagliptin (50 mg qd) Versus Sitagliptin (25 mg qd) in Patients With Type 2 Diabetes and Severe Renal Insufficiency|Completed||Phase 3|148|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:44:24.85617|2017-02-18 14:44:24.85617
NCT00616798|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-06-23||2013-08-20|March 2008||2008-03-01|June 2014|2014-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.|Randomized, Double-blind, Placebo-controlled add-on Trial of the Safety and Efficacy of RO4917838 in Outpatients on Select Atypical Antipsychotics With Prominent Negative or Disorganized Thought Symptoms|Completed||Phase 2|323|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 14:44:25.039033|2017-02-18 14:44:25.039033
NCT00616785|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2009-02-06|||June 2007||2007-06-01|September 2008|2008-09-01||||November 2010|Anticipated|2010-11-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|Phase II Trial Irinotecan and Cisplatin Induction Chemotherapy Followed by Radiotherapy Concurrently With Etoposide/Cisplatin in Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|41|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:44:25.350626|2017-02-18 14:44:25.350626
NCT00616772|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2013-12-03|2013-09-13||February 2008||2008-02-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|FIRST|All randomized participants who received at least 1 dose of study drug.|Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood|Evaluation of Choline Fenofibrate (ABT-335) on Carotid Intima-Media Thickness (cIMT) in Subjects With Type IIb Dyslipidemia With Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial|Completed||Phase 3|682|Actual|AbbVie||2|||f||||t||||||||||2017-02-18 14:44:25.462087|2017-02-18 14:44:25.462087
NCT00616759|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-12-30|2010-11-30||September 2006||2006-09-01|December 2012|2012-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||The Effect on Cognition of Terminating ECT Induced Seizures With Propofol|The Effect on Cognition of Terminating ECT Induced Seizures With Propofol|Completed||N/A|20|Actual|Loma Linda University||2|||f||||f||||||||||2017-02-18 14:44:26.549566|2017-02-18 14:44:26.549566
NCT00616746|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-07-07|||January 2007||2007-01-01|July 2014|2014-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans|Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans|Completed||Early Phase 1|18|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:44:26.925971|2017-02-18 14:44:26.925971
NCT00616733|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2011-03-09|||March 2008||2008-03-01|March 2011|2011-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients|An Open-label, Escalating-dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral CS-0777, Administered for 12 Weeks, in Patients With Multiple Sclerosis|Completed||Phase 1|25|Actual|Daiichi Sankyo Inc.||3|||f||||t||||||||||2017-02-18 14:44:27.026435|2017-02-18 14:44:27.026435
NCT00616720|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-05-13|||August 2001||2001-08-01|May 2011|2011-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma|Randomized Phase II Trial of Dendritic Cell-Based Idiotype Vaccination With Adjuvant Cytokines for Plateau Phase and Post-Transplant Multiple Myeloma|Completed||Phase 2|15|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 14:44:27.138048|2017-02-18 14:44:27.138048
NCT00616707|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-11-22|||August 2006||2006-08-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|IM||Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds|Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds|Completed||N/A|68|Actual|University of California, Davis|||1||f||||f||||||Samples Without DNA|"~     Aliquots from the citrate vial & Serum seperator vial are being retained~   "|||2017-02-18 14:44:27.234853|2017-02-18 14:44:27.234853
NCT00616694|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-20|||July 2002||2002-07-01|February 2008|2008-02-01|December 2004|Actual|2004-12-01|||||Interventional|ACTIVATE||Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy|A Randomized Multicenter Parallel Group Study to Determine if Knowledge of Baseline Vertebral Fracture Prevalence (as Determined by Hologic IVA) and Bone Turnover Marker Determinations Improves Persistence With Actonel 5mg Daily Therapy in Subjects Receiving Chronic Glucocorticoid Therapy|Completed||Phase 4|248|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:44:27.323618|2017-02-18 14:44:27.323618
NCT00616681|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-02-14|||June 2004||2004-06-01|February 2008|2008-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions|A Single Dose, Two-Treatment, Two-Period, Two-Sequence Crossover Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fasting Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:44:27.4151|2017-02-18 14:44:27.4151
NCT00616668|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-02-14|||January 2003||2003-01-01|February 2008|2008-02-01|December 2005|Actual|2005-12-01|||||Interventional|||Early Postoperative Fitting of the Air- Limb Prosthesis for Transtibial Amputees|Early Postoperative Fitting of the Air- Limb Prosthesis for Transtibial Amputees|Completed||Phase 2|20|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 14:44:27.498282|2017-02-18 14:44:27.498282
NCT00616655|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-03-10|2015-06-02||January 2008||2008-01-01|March 2016|2016-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||ITT Population|Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects|A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.|Completed||Phase 2|456|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 14:44:27.591587|2017-02-18 14:44:27.591587
NCT00616642|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2013-03-04|2013-03-04||October 2006||2006-10-01|March 2013|2013-03-01||||November 2010|Actual|2010-11-01||Interventional|||Rosiglitazone in Treating Patients With Pituitary Tumors|Rosiglitazone (Peroxisome Proliferating Activating Receptor-gamma {PPAR-y} Ligand) Treatment of Pituitary Tumors|Terminated||Phase 2|1|Actual|Jonsson Comprehensive Cancer Center|Recruitment was the main limitation. Patients were available but were not interested in the study due to possible side effects of the study drug.|2||low patient recruitment|f||||t||||||||||2017-02-18 14:44:28.979263|2017-02-18 14:44:28.979263
NCT00616629|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2011-08-17|2011-01-24||January 2008||2008-01-01|August 2011|2011-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Cardiac Electrophysiological Study|A Multi-centre, Double-blind, Randomised, Placebo-controlled, Singledose, Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness and Haemodynamics of an Intravenous Infusion of AZD1305 in Patients Undergoing an Invasive Electrophysiological Procedure|Completed||Phase 2|55|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:44:29.364722|2017-02-18 14:44:29.364722
NCT00616616|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-10-24|||September 2007||2007-09-01|October 2016|2016-10-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|SIL||Single Incision Laparoscopy|Single Incision Laparoscopy|Completed||N/A|24|Actual|University of California, San Diego||1|||f||||f||||||||||2017-02-18 14:44:30.077652|2017-02-18 14:44:30.077652
NCT00616603|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-06-10|2013-05-17||August 2007||2007-08-01|June 2014|2014-06-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|||The Effects of Dexamethasone on the Duration of Sciatic Nerve Blocks|The Effects of Dexamethasone on the Duration of Sciatic Nerve Blocks|Terminated||N/A|43|Actual|Loma Linda University|PI left the institution and data analysis cannot be summarized due to poor data integrity.|3||PI is no longer here.|f||||f||||||||||2017-02-18 14:44:30.178904|2017-02-18 14:44:30.178904
NCT00616590|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2014-06-15|||July 2007||2007-07-01|June 2014|2014-06-01||||July 2012|Anticipated|2012-07-01||Observational|||Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer|Assessment of Insomnia in Patients With Head and Neck Cancer During Treatment|Withdrawn||N/A|0|Actual|Vanderbilt University|||1||f||||||||||||||2017-02-18 14:44:30.638492|2017-02-18 14:44:30.638492
NCT00616577|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-12-14|2015-04-02||October 2007||2007-10-01|December 2016|2016-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||PI left institution and records cannot be located|Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine|Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study|Terminated||N/A|26|Actual|Loma Linda University||3||PI is no longer here.|f||||f||||||||||2017-02-18 14:44:30.745124|2017-02-18 14:44:30.745124
NCT00616564|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-05-02|||February 2006||2006-02-01|May 2012|2012-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma|Multicenter Phase II Trial of High-Dose Interleukin (IL-2) With Priming and Concomitant Sargramostim (GM-CSF) in Patients With Advanced Melanoma|Completed||Phase 2|36|Actual|Mt. Sinai Medical Center, Miami||1|||f||||t||||||||||2017-02-18 14:44:31.021815|2017-02-18 14:44:31.021815
NCT00616551|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-10-07|||April 2007||2007-04-01|October 2008|2008-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients|Open Label, Randomized Study Comparing the Biological Efficacy & Safety of a New Prolonged Release Formulation of Octreotide Acetate, C2L-OCT-01 PR, 30 mg Administered Every 42 Days for 84 Days With Sandostatin LAR 30 mg Administered Every 28 Days for 84 Days to Acromegalic Patients|Completed||Phase 3|65|Actual|Ambrilia Biopharma, Inc.||2|||f||||f||||||||||2017-02-18 14:44:31.127118|2017-02-18 14:44:31.127118
NCT00616538|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-05|||December 2006||2006-12-01|February 2008|2008-02-01||||April 2007|Actual|2007-04-01||Interventional|||Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis|Prospective, Randomized, Investigator-Blind, Controlled, Pilot Study Comparing Effect of Epiceram™ Device vs Standard of Care Therapy of Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) in Treatment of Atopic Dermatitis in Pediatric Subjects|Completed||Phase 4|121|Actual|Ceragenix Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:44:31.2379|2017-02-18 14:44:31.2379
NCT00616512|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2011-06-22|||April 2008||2008-04-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Randomized Controlled Trial of a Water Protocol for Clients With Thin Liquid Dysphagia|A Randomized Controlled Trial of a Water Protocol for Clients With Thin Liquid Dysphagia: a Pilot Project|Completed||Phase 1|40|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 14:44:31.328166|2017-02-18 14:44:31.328166
NCT00616499|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2009-02-06|||November 2006||2006-11-01|September 2008|2008-09-01||||November 2010|Anticipated|2010-11-01||Interventional|||Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer|A Phase II Trial of Neoadjuvant Gefitinib Therapy Based on Mutation Study in Biopsy- Proven Stage IIIA N2 Non-Squamous Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:44:31.425001|2017-02-18 14:44:31.425001
NCT00616486|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2015-12-14|||January 2008||2008-01-01|December 2015|2015-12-01|November 2012|Actual|2012-11-01|May 2010|Actual|2010-05-01||Interventional|||rTMS in Treatment of Obsessive Compulsive Disorder (OCD)|A Multicentre, Double-blind, Randomized, Placebo-controlled Study Evaluating the Efficacy, Safety, and Clinical Outcomes of Low Frequency, Repetitive Transcranial Magnetic Stimulation (Over Supplementary Motor Area (SMA) Applied Bilaterally and Simultaneously) Versus Sham (Placebo rTMS) Treatment for 6 Weeks, When Added to a Stable Pharmacotherapy in Subjects With Obsessive Compulsive Disorder (OCD).|Completed||N/A|24|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 14:44:31.520658|2017-02-18 14:44:31.520658
NCT00616473|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-12-01|||January 2007||2007-01-01|February 2008|2008-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Quality End-of-Life Care in Nursing Homes|The Impact of Quality End-of-Life Care in Nursing Homes|Completed||N/A|8500|Anticipated|University of Nebraska|||2||f||||f||||||||||2017-02-18 14:44:31.706302|2017-02-18 14:44:31.706302
NCT00616460|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2015-06-11|||February 2008||2008-02-01|June 2015|2015-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|ACRIPAB||ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding||Completed||Phase 3|100|Actual|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-02-18 14:44:31.799712|2017-02-18 14:44:31.799712
NCT00616447|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2015-12-14|||January 2008||2008-01-01|December 2015|2015-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||rTMS Treatment in Patients With General Anxiety Disorder|A 12-week, Double-blind, Randomized, Placebo-controlled Multicentered Study Evaluating Efficacy and Safety of High-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment in Patients With Generalized Anxiety Disorder (GAD)|Completed||N/A|30|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 14:44:31.896622|2017-02-18 14:44:31.896622
NCT00616434|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2014-07-23|2014-07-23||May 2008||2008-05-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Avonex® in Subjects With Moderate to Severe Ulcerative Colitis|Completed||Phase 2|123|Actual|Biogen||2|||f||||f||||||||||2017-02-18 14:44:32.014131|2017-02-18 14:44:32.014131
NCT00616421|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-01-19|2011-02-28||March 2008||2008-03-01|January 2016|2016-01-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children|A Phase 3, Randomized, Observer-blind, Multi-Center Study to Compare the Safety and Immunogenicity of One Dose of Novartis Meningococcal ACWY Conjugate Vaccine With One Dose of Licensed Meningococcal ACWY Conjugate Vaccine Administered to Healthy Children 2-10 Years of Age|Completed||Phase 3|2907|Actual|Novartis||3|||f||||t||||||||||2017-02-18 14:44:32.398477|2017-02-18 14:44:32.398477
NCT00616408|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-05|||January 1997||1997-01-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Prediction of Tumor Shrinkage in Acromegaly|Predictive Value of 3 Months Results on 12 Months Tumor Shrinkage After First-Line Octreotide-LAR Therapy in Patients With Acromegaly|Completed||N/A|61|Actual|Federico II University|||1||f||||f||||||||||2017-02-18 14:44:33.557164|2017-02-18 14:44:33.557164
NCT00616395|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2017-01-24|||September 2002||2002-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|Beginnings||Study of Early Infant Diet on Growth and Development|Effects of Diet on Metabolism, Body Composition, Brain Function in Infants/Children|Active, not recruiting||N/A|600|Anticipated|Arkansas Children's Hospital Research Institute|||1||f||||f||||||Samples Without DNA|"~     Plasma, urine, and stool may be collected from some study participants.~   "|||2017-02-18 14:44:33.668596|2017-02-18 14:44:33.668596
NCT00616382|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-13|2008-02-14|||March 2008||2008-03-01|January 2008|2008-01-01||||March 2010|Anticipated|2010-03-01||Interventional|||Treating the Resistant Patent Ductus Arteriosus (PDA)|New Therapeutic Approaches to the Resistant Patent Ductus Arteriosus (PDA) in Low Birth Weight Neonates|Unknown status|Not yet recruiting|Phase 2|68|Anticipated|Shaare Zedek Medical Center||2|||f||||t||||||||||2017-02-18 14:44:33.759798|2017-02-18 14:44:33.759798
NCT00614224|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-05-27|||January 2008||2008-01-01|January 2008|2008-01-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Structural Neuroplasticity Associated With Aerobic Treadmill Training in Geriatric Chronic Stroke Survivors|Structural Neuroplasticity Associated With Aerobic Treadmill Training in Geriatric Chronic Stroke Survivors|Completed||N/A|38|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-02-18 14:44:35.596747|2017-02-18 14:44:35.596747
NCT00172731|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||March 2005||2005-03-01|February 2005|2005-02-01|June 2005||2005-06-01|||||Observational|||Measurement of Activity Participation for Persons With Schizophrenia Living in the Community||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:48.470627|2017-02-18 17:19:48.470627
NCT00616369|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2016-01-07|||January 2008||2008-01-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Observational|Genotype||Identification of Genetic Markers for Cardiopulmonary Diseases (Genotype)|Identification of Genetic Markers for Cardiopulmonary Diseases|Completed||N/A|255|Actual|University of Alabama at Birmingham|||2||f||||f||||||Samples With DNA|"~     The following genetic tests will be performed on these specimens:~      Endothelin1, Endothelin receptors A&B, Prostaglandin, Prostaglandin receptors,~     CytochromeP450, NPR, A, B and C, Transforming Growth Factor (B), Pai-1 HindIII, Toll-like~     receptor4, Pai-1 4g5g, Xho-1, P22, Tissue Plasminogin Activators, Urokinase Plasminogen~     Activators, Fibrinogen, Nitric Oxide Synthase, BMPRs, SMADs, VEGFs, FGFs, Rho Kinase,~     Elastins, Angiopoietin, PDE5, Serotonin receptor, Angiotensin, Alk 1, and Cell Culture (DNA~     immortalization)~      There is a possibility that other genetic testing could arise as the study progresses. In~     this case, the IRB would be notified prior to testing.~   "|||2017-02-18 14:44:33.862057|2017-02-18 14:44:33.862057
NCT00616356|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2011-11-07|||December 2007||2007-12-01|November 2011|2011-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults|Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults|Completed||N/A|8|Anticipated|Rockefeller University|||1||f||||f||||||||||2017-02-18 14:44:33.94796|2017-02-18 14:44:33.94796
NCT00616343|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-07-16|2014-06-12||June 2003||2003-06-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional||•<=18 years Male/Female Hx essential tremor|Zonisamide in the Treatment of Essential Tremor|Pilot Study of Zonisamide in the Treatment of Essential Tremor|Terminated||N/A|9|Actual|Loma Linda University|PI has left the institution and we are unable to accurately assess the data from the remaining records.|1||Principal Investigator left the study site on December 28, 2012.|f||||t||||||||||2017-02-18 14:44:34.035804|2017-02-18 14:44:34.035804
NCT00616330|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-02-29||2010-11-02|January 2008||2008-01-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Vaginal Infection Study||Completed||Phase 3|1443|Actual|Lumara Health, Inc.||3|||f||||||||||||||2017-02-18 14:44:34.263261|2017-02-18 14:44:34.263261
NCT00616317|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-10-24|||September 2006||2006-09-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|APS||Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study|Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study|Recruiting||N/A|50|Anticipated|University of California, Davis|||1||f||||f||||||||||2017-02-18 14:44:34.488393|2017-02-18 14:44:34.488393
NCT00616304|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-06-24|||February 2008||2008-02-01|June 2013|2013-06-01||||March 2009|Actual|2009-03-01||Interventional|ARGISM||Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria|Safety and Preliminary Efficacy, Pharmacokinetics, Pharmacodynamics of L-arginine in Severe Falciparum Malaria|Suspended||Phase 2|8|Actual|Menzies School of Health Research||2||Local circumstances & difficulties in site access has prevented continuation|f||||t||||||||||2017-02-18 14:44:34.574915|2017-02-18 14:44:34.574915
NCT00616291|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2012-11-05|||April 2006||2006-04-01|November 2012|2012-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer|Immunotherapy of Patients With Androgen-Independent Prostate Carcinoma Using NY-ESO-1/LAGE1 Peptide Vaccine (SPORE #: 11-01-30-14)|Completed||Phase 1|14|Actual|Baylor College of Medicine||3|||f||||||||||||||2017-02-18 14:44:34.682584|2017-02-18 14:44:34.682584
NCT00616278|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-11-22|||October 2005||2005-10-01|November 2012|2012-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|NCGS||National Cooperative Growth Study in CKD|National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End-Stage Renal Disease (ESRD)|Completed||N/A|27|Actual|University of California, Davis|||1||f||||t||||||||||2017-02-18 14:44:34.787117|2017-02-18 14:44:34.787117
NCT00616265|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-02-28|||June 2008||2008-06-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Continuous Positive Airway Pressure (CPAP) Treatment in the Control of Refractory Hypertension|Effect of CPAP Treatment in the Control of Refractory Hypertension|Completed||N/A|210|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||t||||||||||2017-02-18 14:44:34.869538|2017-02-18 14:44:34.869538
NCT00616252|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2010-12-03|||February 2008||2008-02-01|December 2010|2010-12-01|September 2009|Actual|2009-09-01|November 2008|Actual|2008-11-01||Observational|||Antiretroviral Drug Levels During and After Pregnancy|Comparison of the Pharmacokinetics of Antiretroviral Agents in HIV Infected Ugandan Women During and After Pregnancy|Completed||N/A|16|Actual|Makerere University|||1||f||||f||||||Samples With DNA|"~     Human plasma Red cell pellets~   "|||2017-02-18 14:44:35.074614|2017-02-18 14:44:35.074614
NCT00616239|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-01-09|2013-08-26||January 2008||2008-01-01|January 2014|2014-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women|The Efficacy of Salicylic Acid Peels Combined With 4% Hydroquinone Cream Versus 4% Hydroquinone Cream Alone in the Treatment of Hispanic Women With Moderate to Severe Melasma|Completed||Phase 4|20|Actual|University of Texas Southwestern Medical Center|Two subjects did not complete the study were unable to come in for visits because of scheduling difficulties and had no adverse effects at the time of discontinuation.|2|||f||||f||||||||||2017-02-18 14:44:35.168139|2017-02-18 14:44:35.168139
NCT00614263|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-09-10|||March 2006||2006-03-01|September 2013|2013-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||A Study to Examine Levels of Sedation During Outpatient Colonoscopies|A Prospective, Blinded Study Examining Sedation Levels During Outpatient Colonoscopies|Completed||N/A|100|Actual|Baylor Research Institute|||2||f||||f||||||||||2017-02-18 14:44:35.405544|2017-02-18 14:44:35.405544
NCT00614250|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-07-17|||January 2008||2008-01-01|July 2009|2009-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea|A Double-blind, Randomized, Placebo-controlled, Study of the Safety and Activity of Four Escalating Single Doses of AVE0657 in Patients Suffering From Obstructive Sleep Apnea Hypopnea Syndrome|Completed||Phase 2|38|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 14:44:35.4958|2017-02-18 14:44:35.4958
NCT00611962|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-01-28|||December 2000||2000-12-01|January 2008|2008-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin|Phase II Study of Combined Oxaliplatin and Paclitaxel for Metastatic Germ Cell Tumors|Completed||Phase 2|27|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:46:04.633235|2017-02-18 14:46:04.633235
NCT00614211|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-11-23|||January 2008||2008-01-01|November 2016|2016-11-01|July 2022|Anticipated|2022-07-01|July 2018|Anticipated|2018-07-01||Interventional|LACC||Laparoscopic Approach to Cervical Cancer|A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy Versus Abdominal Radical Hysterectomy in Patients With Early Stage Cervical Cancer|Recruiting||Phase 3|740|Anticipated|Queensland Centre for Gynaecological Cancer||2|||f||||t||||||||No||2017-02-18 14:44:35.681995|2017-02-18 14:44:35.681995
NCT00614198|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2010-08-31|2010-05-17||April 2006||2006-04-01|May 2010|2010-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|ScanBrit||ScanBrit Dietary Intervention in Autism|The ScanBrit Randomised Controlled Study of Gluten- and Casein-free Dietary Intervention for Children With Autism Spectrum Disorders|Completed||Phase 2|72|Actual|Center for Autisme, Denmark|Single-blind trial, no placebo condition, analysis based on per protocol (not intention to treat), socio-economic status not recorded, independent screening for underlying somatic conditions potentially associated with results not undertaken|2|||f||||f||||||||||2017-02-18 14:44:36.120801|2017-02-18 14:44:36.120801
NCT00614172|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-04-26|||February 2004||2004-02-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Proton Therapy for Early Stage Breast Cancer|Phase II Trial of Lumpectomy and Partial Breast Proton Therapy for Early Stage Breast Cancer|Active, not recruiting||Phase 2|150|Anticipated|Loma Linda University||1|||f||||t||||||||||2017-02-18 14:44:36.604368|2017-02-18 14:44:36.604368
NCT00614159|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-06-30|||October 2007||2007-10-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Ketamine Compared to Propofol for Pediatric GI Endoscopy||Completed||N/A|34|Anticipated|State University of New York - Upstate Medical University|||1||f||||f||||||||||2017-02-18 14:44:36.722402|2017-02-18 14:44:36.722402
NCT00614146|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-06-15|||April 2003||2003-04-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|January 2008|Actual|2008-01-01||Interventional|RELIEF||Recompensation of Exacerbated Liver Insufficiency With Hyperbilirubinemia and/or Encephalopathy and/or Renal Failure|Therapeutic Impact of Albumin Dialysis With the Molecular Adsorbents Recirculating System (MARS®) in Severely Decompensated Chronic Liver Disease|Completed||N/A|172|Anticipated|Gambro Lundia AB||2|||f||||t||||||||||2017-02-18 14:44:36.833083|2017-02-18 14:44:36.833083
NCT00614133|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-01-30|||June 2004||2004-06-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Intravenous Nutrition and Epidural Analgesia on Protein Loss After Surgery|Hypocaloric Isonitrogenous Nutrition and Epidural Analgesia: a Novel Strategy to Induce Anabolism After Surgery|Completed||N/A|22|Actual|McGill University Health Center||2|||f||||f||||||||||2017-02-18 14:44:36.997468|2017-02-18 14:44:36.997468
NCT00616226|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-02-27|||August 2006||2006-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:44:37.10669|2017-02-18 14:44:37.10669
NCT00616213|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2011-05-31|||February 2008||2008-02-01|May 2011|2011-05-01|June 2009|Actual|2009-06-01|September 2008|Actual|2008-09-01||Interventional|||PR104 and G-CSF in Treating Patients With Solid Tumors|A Phase I, Multi-Center, Open-Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR104 Given With Prophylactic G-CSF in Subjects With Solid Tumors|Completed||Phase 1|5|Actual|Proacta, Incorporated||1|||f||||||||||||||2017-02-18 14:44:37.166602|2017-02-18 14:44:37.166602
NCT00616200|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2011-10-05|2010-06-29||August 2009||2009-08-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)|The Effect of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome: A Prospective Pilot Study|Completed||Early Phase 1|17|Actual|University of North Carolina, Chapel Hill|Low N, lack of standard control group and specific overweight/obese female predominant population.|1|||f||||f||||||||||2017-02-18 14:44:37.278115|2017-02-18 14:44:37.278115
NCT00616187|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-14|||October 2003||2003-10-01|February 2008|2008-02-01||||June 2007|Actual|2007-06-01||Interventional|||Atorvastatin in Relapsing-Remitting Multiple Sclerosis|Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|41|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 14:44:37.551156|2017-02-18 14:44:37.551156
NCT00616174|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2014-03-14|||February 2008||2008-02-01|March 2014|2014-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Does Warming Mothers During Cesarean Delivery Help Keep Babies Warm When Delivered?|The Effect of Maternal Warming During Cesarean Delivery on Neonatal Temperature|Completed||N/A|70|Actual|University of British Columbia||1|||f||||t||||||||||2017-02-18 14:44:37.636925|2017-02-18 14:44:37.636925
NCT00616161|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2008-02-05|||August 2006||2006-08-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|HORIZON-HF||A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function|A Phase II Study to Assess the Hemodynamic Effects of Istaroxime, a Novel Lusinotropic Agent, in Patients Hospitalized With Worsening Heart Failure and a Reduced Left Ventricular Systolic Function|Completed||Phase 2|120|Actual|sigma-tau i.f.r. S.p.A.||4|||f||||t||||||||||2017-02-18 14:44:37.731379|2017-02-18 14:44:37.731379
NCT00616148|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-12-26||2013-06-17|August 2007||2007-08-01|December 2013|2013-12-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy of YKP3089 in Patients With Photosensitive Epilepsy|Pharmacodynamic Evaluation of YKP3089 in Epilepsy Patients With a Photo-induced Paroxysmal EEG-Response: Proof of Principle|Completed||Phase 2|11|Actual|SK Life Science||2|||f||||t||||||||||2017-02-18 14:44:37.840905|2017-02-18 14:44:37.840905
NCT00616135|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2011-05-13|||June 2008||2008-06-01|May 2011|2011-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|RESTORE-2||Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy|A Clinical Evaluation Of Adipose Derived Regenerative Cells In The Treatment Of Patients With BrEast Deformities Post Segmental Breast ResecTion (Lumpectomy) With Or Without Radiation ThErapy. A Phase IV Post Market Study.|Completed||Phase 4|71|Anticipated|Cytori Therapeutics||1|||f||||f||||||||||2017-02-18 14:44:37.945629|2017-02-18 14:44:37.945629
NCT00615940|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2014-01-28||2014-01-28|July 2008||2008-07-01|January 2014|2014-01-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer|A Phase 2, Two-arm, Double-blind, Multi-center, Randomized Study of the Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer|Completed||Phase 2|132|Actual|Wilex||2|||f||||f||||||||||2017-02-18 14:44:42.857558|2017-02-18 14:44:42.857558
NCT00616122|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2013-11-01|2012-12-18||March 2006||2006-03-01|November 2013|2013-11-01|December 2012|Actual|2012-12-01|March 2011|Actual|2011-03-01||Interventional|||Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer|Phase I/II Study of SU11248 (Sutent) in Combination With Metronomic Dosing of Cyclophosphamide and Methotrexate in Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|32|Actual|University of California, San Francisco|Based on published literature indicating significant toxicity and low response rate for combination sunitinib in the treatment of advanced breast cancer, the PI and Breast Oncology Site Committee closed enrollment after accrual of 32 participants.|1|||f||||t||||||||||2017-02-18 14:44:38.031773|2017-02-18 14:44:38.031773
NCT00616109|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2014-03-13|2013-02-07||September 2007||2007-09-01|March 2014|2014-03-01|January 2011|Actual|2011-01-01|December 2009|Actual|2009-12-01||Interventional||Lung cancer patients who are greater than or equal to 18 years old, who have had a response or maintained stable disease after undergoing no more that 4 cycles with platinum with etoposide chemotherapy|Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC|Phase II Trial of Sunitinib (Sutent, SU11248) Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|16|Actual|University of Michigan Cancer Center|The trial was to be terminated at stage 1 if less than, or equal to, 8 patients were progression free at 4 months. The PFS rate did not reach the threshold required for study continuation and, therefore, the study was discontinued early.|1|||f||||t||||||||||2017-02-18 14:44:38.306984|2017-02-18 14:44:38.306984
NCT00616096|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2010-01-27|||January 2008||2008-01-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels|Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels|Completed||N/A|10|Actual|University of Luebeck||1|||f||||f||||||||||2017-02-18 14:44:38.729701|2017-02-18 14:44:38.729701
NCT00616083|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2009-08-19|||April 2006||2006-04-01|August 2009|2009-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|PeaPod||Percent Body Fat in Breast Fed Infants|Developing Normative Body Composition Data in Early Infancy|Completed||N/A|190|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:44:38.841832|2017-02-18 14:44:38.841832
NCT00616070|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2011-06-29|||December 2007||2007-12-01|June 2011|2011-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)||Completed||Phase 3|120|Anticipated|Sirion Therapeutics, Inc.||2|||f||||||||||||||2017-02-18 14:44:38.929093|2017-02-18 14:44:38.929093
NCT00616057|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-07-04|||February 2008||2008-02-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|FRUCTOB||Evaluation of Fructans Supplementation on Parameters of Metabolic Syndrome|Evaluation of Fructans Supplementation on Parameters of Metabolic Syndrome|Completed||N/A|34|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-02-18 14:44:39.029582|2017-02-18 14:44:39.029582
NCT00616044|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-02-14|||March 2008||2008-03-01|January 2008|2008-01-01|January 2009|Anticipated|2009-01-01|February 2008|Anticipated|2008-02-01||Interventional|Spinocath||Continuous Spinal Anesthesia Versus Combined Spinal Epidural Block|Continuous Spinal Anesthesia Versus Combined Spinal Epidural Block for Major Orthopedic Surgeries. Study Prospective and Randomized.|Unknown status|Not yet recruiting|N/A|240|Anticipated|Sao Jose do Rio Preto University||2|||f||||f||||||||||2017-02-18 14:44:39.150729|2017-02-18 14:44:39.150729
NCT00616031|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-14|2013-08-09|||January 2008||2008-01-01|July 2009|2009-07-01||||December 2011|Anticipated|2011-12-01||Interventional|||Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II, Multinational and Multicenter, Randomized, Controlled Study of Paclitaxel and Carboplatin With vs Without Nitroglycerin in Patients With Untreated Advanced Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:44:39.262466|2017-02-18 14:44:39.262466
NCT00616018|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-07-10|2011-03-03||August 2007||2007-08-01|July 2012|2012-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|Non-Drinker||Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days|Acetaminophen Adduct Formation in Alcohol Abstaining Subjects Administered Therapeutic Doses of Acetaminophen for Ten Consecutive Days|Completed||Phase 4|35|Actual|Denver Health and Hospital Authority|One limitation is that this study did not include a placebo group. The study was limited to healthy volunteers. The ingestion of each dose and use of other medications was self-reported.|1|||f||||t||||||||||2017-02-18 14:44:39.364734|2017-02-18 14:44:39.364734
NCT00616005|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-03|2014-08-14|||November 2005||2005-11-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|July 2007|Actual|2007-07-01||Interventional|||Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide|Phase II Treatment of Adults With Primary Malignant Glioma With Irinotecan Plus Temozolomide|Completed||Phase 2|41|Anticipated|Duke University||2|||f||||t||||||||||2017-02-18 14:44:39.625866|2017-02-18 14:44:39.625866
NCT00615992|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2016-01-13|2009-06-30||April 2007||2007-04-01|January 2016|2016-01-01||||April 2008|Actual|2008-04-01||Observational|||Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines|Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines|Completed||N/A|754|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:44:39.746522|2017-02-18 14:44:39.746522
NCT00615979|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-01-26|||October 2002|Actual|2002-10-01|January 2017|2017-01-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Observational|||Far Forward Battlefield Telemedicine: Evaluation of Handheld Ultrasound|Far Forward Battlefield Telemedicine:Ultrasound Guidance System (UGS)|Completed||N/A|120|Actual|The Cleveland Clinic|||1||f||||f|f|t|f|f|t|||No||2017-02-18 14:44:42.539346|2017-02-18 14:44:42.539346
NCT00615966|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-06-24||2011-06-07|February 2008||2008-02-01|June 2011|2011-06-01|February 2010|Actual|2010-02-01|January 2009|Actual|2009-01-01||Interventional|||Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients|A Phase 2, Two-Part Study of the Safety and Tolerability of Diannexin in Kidney Transplant Recipients|Completed||Phase 2|58|Actual|Alavita Pharmaceuticals Inc||3|||f||||t||||||||||2017-02-18 14:44:42.642675|2017-02-18 14:44:42.642675
NCT00615953|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-03|2011-06-28|||May 2007||2007-05-01|June 2011|2011-06-01|May 2017|Anticipated|2017-05-01|||||Observational|ANSWERProg||American Norditropin Studies - Registry of Growth Hormone (GH) Patients|American Norditropin Studies: Web-Enabled Research (The ANSWER Program) ID#: HGH-2149|Suspended||N/A|79|Anticipated|Duke University|||1|New Consent Forms necessary with new website|f||||t||||||||||2017-02-18 14:44:42.745922|2017-02-18 14:44:42.745922
NCT00615927|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-03|2013-03-13|2012-12-31||February 2006||2006-02-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|April 2009|Actual|2009-04-01||Interventional|||Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)|Phase II Study of Imatinib Mesylate Plus Hydroxyurea in the Treatment of Patients With Recurrent / Progressive Grade II Low-Grade Glioma|Completed||Phase 2|64|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:44:42.983143|2017-02-18 14:44:42.983143
NCT00615914|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-06-10|2010-09-08||February 2004||2004-02-01|June 2014|2014-06-01||||March 2009|Actual|2009-03-01||Observational||Data set for safety analysis - The number of patients enrolled was 1645. The number of case report forms which were collected was 1581. Moreover the number of patients analyzed as safety analysis was 1553 because 28 patients were excluded due to protocol violations.|Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole|Pramipexole Special Survey on Long-Term Use|Completed||N/A|1645|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:44:43.707774|2017-02-18 14:44:43.707774
NCT00615901|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2015-10-28|||January 2008||2008-01-01|October 2015|2015-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer|Pilot Study of Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer|Completed||N/A|85|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:44:44.564353|2017-02-18 14:44:44.564353
NCT00615888|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-01-13|||September 2005||2005-09-01|September 2005|2005-09-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Fast Track Management in Elective Open Infrarenal Aortic Aneurysm Repair|Prospective Randomized Controlled Trial to Evaluate Fast Track Recovery in Elective Open Infrarenal Aortic Aneurysm Repair|Completed||N/A|100|Actual|University of Ulm||2|||f||||t||||||||||2017-02-18 14:44:44.67681|2017-02-18 14:44:44.67681
NCT00615875|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2008-02-01|||March 2008||2008-03-01|January 2008|2008-01-01|June 2008|Anticipated|2008-06-01|May 2008|Anticipated|2008-05-01||Interventional|NAPS||Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial|Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial|Unknown status|Not yet recruiting|Phase 4|24|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 14:44:44.783344|2017-02-18 14:44:44.783344
NCT00615862|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2012-02-21|||March 2008||2008-03-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Relationship Between Alcohol Use Disorders and Cortisol Levels in Patients With Sepsis|Relationship Between Alcohol Use Disorders and Cortisol Levels in Patients With Sepsis|Completed||N/A|40|Anticipated|Virginia Commonwealth University|||1||f||||f||||||Samples Without DNA|"~     1. Diagnosis of alcohol use disorders will be made through the use of a validated~          questionnaire.~        2. Blood collected as part of routine patient care (and that is destined to be discarded)~          will be evaluated for a number of immune markers. Cortisol levels measured as part of~          routine care will be recorded.~        3. Delirium will be assessed through the use of a validated instrument.~   "|||2017-02-18 14:44:44.898933|2017-02-18 14:44:44.898933
NCT00615849|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-09-28|||November 2006||2006-11-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Interventional|||Efficacy of the Additional Mechanical Pleurodesis for Surgical Management of Primary Spontaneous Pneumothorax|Phase III Study of Evaluation of the Efficacy of Additional Mechanical Pleurodesis After Thoracoscopic Wedge Resection for the Management of Primary Spontaneous Pneumothorax|Completed||Phase 3|1440|Actual|Seoul National University Bundang Hospital||1|||f||||t||||||||||2017-02-18 14:44:44.998622|2017-02-18 14:44:44.998622
NCT00615836|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2015-11-11|2015-06-23||December 2007||2007-12-01|November 2015|2015-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||Demographic data provided for the Efficacy Analysis Dataset, which consisted of the intent-to-treat population from CS29 (all randomized patients who received at least 1 dose of study drug and provided at least 1 primary efficacy measure during Part I) who were on active treatment (i.e., placebo participants are not included).|"An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving (Melt) Formulation of Desmopressin for the Treatment of Nocturia in Adults"|"A Multi-Center Extension Study Investigating the Long Term Efficacy and Safety of a Fast-Dissolving (Melt) Formulation of Desmopressin for the Treatment of Nocturia in Adults"|Completed||Phase 3|554|Actual|Ferring Pharmaceuticals||4|||f||||t||||||||||2017-02-18 14:44:45.120995|2017-02-18 14:44:45.120995
NCT00615823|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-02-22|||February 2007||2007-02-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|APATH||Atorvastatin in Pulmonary Hypertension|Clinical Effect and Tolerability of Atorvastatin Versus Placebo in Patients With Pulmonary Hypertension: Double-blinded, Randomised, Prospective Phase II Study for 6 Months With Adjusted Doses of Atorvastatin|Completed||Phase 2|220|Actual|Chinese Academy of Medical Sciences, Fuwai Hospital||2|||f||||t||||||||||2017-02-18 14:44:47.26068|2017-02-18 14:44:47.26068
NCT00615810|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-07-30|||March 2008||2008-03-01|July 2010|2010-07-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|ROCKET I||ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial|A Phase 4, Open Label, Randomized, Controlled Study to Assess the Effect on Lipid Profile of Switching From a Stable HAART Regimen of Fixed Dose Abacavir/Lamivudine (Kivexa) Plus Efavirenz, to Once Daily Atripla in Adult HIV-1 Infected Subjects With Raised Cholesterol|Completed||Phase 4|159|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 14:44:47.365252|2017-02-18 14:44:47.365252
NCT00615797|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2014-12-03|||May 2002||2002-05-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea|Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea|Completed||N/A|20|Actual|University of Cape Town||2|||f||||f||||||||||2017-02-18 14:44:47.47094|2017-02-18 14:44:47.47094
NCT00615784|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2016-09-23|||January 2008||2008-01-01|September 2016|2016-09-01||||October 2013|Actual|2013-10-01||Interventional|UPCC 04407||Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia|A Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia|Active, not recruiting||Phase 2|25|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||f||||||||||2017-02-18 14:44:47.576549|2017-02-18 14:44:47.576549
NCT00615771|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2016-11-23|||January 2007||2007-01-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Day of Embryo Transfer for Patients Undergoing In Vitro Fertilization|Embryo Transfer on Day 2 vs. Day 3 After Oocyte Retrieval in Patients Who Plan to Replace All Embryos After an In Vitro Fertilization Cycle|Completed||N/A|242|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 14:44:47.668763|2017-02-18 14:44:47.668763
NCT00615758|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2009-12-14|||October 2006||2006-10-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV|ERLOTINIB, A TYROSINE KINASE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AS FIRST LINE TREATMENT, IN PATIENTS WITH LOCALLY ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER (NSCLC). A PHASE II STUDY|Completed||Phase 2|50|Anticipated|Hellenic Oncology Research Group||1|||f||||f||||||||||2017-02-18 14:44:47.761715|2017-02-18 14:44:47.761715
NCT00615745|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2011-11-18|||April 2008||2008-04-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|ONCE||ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla|A Phase IV, Open-label, Prospective Observational Study to Evaluate Virological Response in Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla (Efavirenz/Emtricitabine/Tenofovir DF) on an Empty Stomach|Completed||Phase 4|115|Actual|Gilead Sciences||1|||f||||f||||||||||2017-02-18 14:44:47.872329|2017-02-18 14:44:47.872329
NCT00615732|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2012-07-09|||March 2008||2008-03-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|January 2009|Actual|2009-01-01||Interventional|QENA||Qigong and Exercise for Neck Pain in Adults (QENA)|Prospective, Randomized Controlled Trial on the Effectiveness of Qigong and Exercise Therapy in Patients With Chronic Neck Pain|Completed||N/A|123|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-02-18 14:44:48.187997|2017-02-18 14:44:48.187997
NCT00615719|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2011-12-07|2011-08-15||October 2006||2006-10-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|EDCCTA||Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation|Utility of 64-slice Multidetector CT Coronary Angiography in the Evaluation of Low to Intermediate Risk ED Patients|Terminated||N/A|35|Actual|Virginia Commonwealth University|Early termination leading to small numbers of subjects analyzed||1|Enrollment rate was too slow.|f||||f||||||||||2017-02-18 14:44:48.294122|2017-02-18 14:44:48.294122
NCT00615706|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-09-22|||January 2005||2005-01-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|ABI/BALA||Study to Evaluate the Impact of Obesity on Airway Inflammation and Mechanics in Asthmatics||Completed||N/A|300|Anticipated|Emory University|||2||f||||f||||||Samples With DNA|"~     Serum, urine, DNA, exhaled breath condensate. For substudy participants, bronchoalveolar~     lavage samples.~   "|||2017-02-18 14:44:48.501794|2017-02-18 14:44:48.501794
NCT00615693|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2012-05-31|||July 2008||2008-07-01|May 2012|2012-05-01||||October 2009|Actual|2009-10-01||Interventional|||Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis|A Multicenter, Single Sequence, Open-label Study to Assess the Tolerability, Safety, and Efficacy of 2 Weeks Oral AEB071 300 mg Twice Daily, Followed by 6 Weeks AEB071 200 mg Twice Daily in the Treatment of Patients With Macular Edema Associated With Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis|Completed||Phase 2|13|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:44:48.59347|2017-02-18 14:44:48.59347
NCT00615667|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2016-04-19|||June 2006||2006-06-01|April 2016|2016-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)||Completed||Phase 3|61|Actual|Sun Yat-sen University||1|||f||||t||||||||||2017-02-18 14:44:48.706544|2017-02-18 14:44:48.706544
NCT00615654|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2008-10-17|||January 2007||2007-01-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|February 2007|Actual|2007-02-01||Interventional|||Aquatic Physical Therapy in Fibromyalgia|A Randomized Clinical Trial of Aquatic Physiotherapy Program on Functional Capacity in Patients With Fibromyalgia.|Completed||Phase 3|40|Actual|Sao Camilo University Center||1|||f||||t||||||||||2017-02-18 14:44:48.813156|2017-02-18 14:44:48.813156
NCT00615641|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-02-12|||June 2007||2007-06-01|February 2010|2010-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Diet, Exercise and Body Fat in 3-5 Year Olds|Relationship of Dietary Factors and Physical Activity to Body Fat in 3-5 Year Old Children|Completed||N/A|65|Anticipated|Arkansas Children's Hospital Research Institute|||3||f||||f||||||Samples Without DNA|"~     Urine~   "|||2017-02-18 14:44:48.921373|2017-02-18 14:44:48.921373
NCT00615628|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2013-05-29|||April 2002||2002-04-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:|Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18: Examination of Osteosarcoma Tissue Samples From Two Family Members for Loss of Heterozygosity in the Chromosome 18 Region, Genetically Linked With Paget's Disease of Bone|Terminated||N/A|8|Actual|State University of New York - Upstate Medical University|||1|low enrollment low enrollment|f||||f||||||Samples With DNA|"~     Once a specimen is obtained DNA will be isolated for paraffin-embedded tissue and peripheral~     blood. Osteosarcoma samples from paraffin embedded, formalin-fixed post-surgical tissue~     samples will be obtained for the proband and father. Matched normal spamples will be~     obtained from these individuals as adjacent normal tissue from the post-surgical specimens~   "|||2017-02-18 14:44:49.009129|2017-02-18 14:44:49.009129
NCT00615615|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-27|2013-09-16|||September 1999||1999-09-01|September 2009|2009-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures|Evaluation of the Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures: A 28-Week Double-Blind, Placebo-Controlled Multi-center Trial|Completed||Phase 3|216|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 14:44:49.101918|2017-02-18 14:44:49.101918
NCT00615602|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2015-03-03|||October 2004||2004-10-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer|A Multicenter Randomized Phase III Study Comparing 6 Versus 12 Months of Trastuzumab in Combination With Dose Dense Docetaxel Following FE75C as Adjuvant Treatment of Women With Axillary Lymph Node Positive Breast Cancer Over-expressing HER2|Completed||Phase 3|489|Actual|Hellenic Oncology Research Group||2|||f||||f||||||||||2017-02-18 14:44:49.193184|2017-02-18 14:44:49.193184
NCT00615589|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-03-03|2014-12-03||February 2008||2008-02-01|March 2016|2016-03-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen|Allogeneic Hematopoietic Stem Cell Transplantation For The Treatment Of High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen|Terminated||Phase 2|22|Actual|University of Michigan Cancer Center||1||Low accrual|f||||t||||||||||2017-02-18 14:44:49.334061|2017-02-18 14:44:49.334061
NCT00615576|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-10-14||2010-10-14|March 2008||2008-03-01|October 2010|2010-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Repeat Dose Study in Male Healthy Volunteer Smokers|A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SB-656933 Following 14 Days Repeat Dosing in Healthy Male Smokers.|Completed||Phase 1|16|Anticipated|GlaxoSmithKline|||||f||||||||||||||2017-02-18 14:44:49.650333|2017-02-18 14:44:49.650333
NCT00615563|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-11-20|||March 2007||2007-03-01|November 2013|2013-11-01|January 2008||2008-01-01|January 2008|Actual|2008-01-01||Observational|||Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)|Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)|Completed||Phase 4|246|Actual|Boehringer Ingelheim|||2||f||||||||||||||2017-02-18 14:44:49.746963|2017-02-18 14:44:49.746963
NCT00615550|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-02-27|2012-02-24||March 2008||2008-03-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||PREGNANT Short Cervix Trial|The Effect of Vaginal Progesterone Administration in the Prevention of Preterm Birth in Women With a Short Cervix [Vaginal Progesterone Bioadhesive Gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix - Trial (PREGNANT Short Cervix - Trial)]|Completed||Phase 3|465|Actual|Juniper Pharmaceuticals, Inc.|Trial not powered for subgroup analysis.|2|||f||||t||||||||||2017-02-18 14:44:49.983391|2017-02-18 14:44:49.983391
NCT00615537|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-03|2011-04-04|||February 2008||2008-02-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses|Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses|Completed||N/A|20|Anticipated|BioTex, Inc.||1|||f||||t||||||||||2017-02-18 14:44:51.047482|2017-02-18 14:44:51.047482
NCT00615524|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2013-03-01|||April 2008||2008-04-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer|A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Study to Compare the Efficacy and Tolerability of Pazopanib Administered in Combination With Exemestane Versus Exemestane Plus Placebo in Postmenopausal Subjects With Advanced or Metastatic Hormone Receptor Positive Breast Cancer|Terminated||Phase 2|150|Anticipated|GlaxoSmithKline||||Cancelled Before Enrollment|f||||||||||||||2017-02-18 14:44:51.157815|2017-02-18 14:44:51.157815
NCT00615511|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2015-12-18|||June 2007||2007-06-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Efficacy of Pregnenolone in Patients With Schizophrenia|Efficacy of Pregnenolone in Patients With Schizophrenia|Completed||Phase 2|100|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:44:51.245983|2017-02-18 14:44:51.245983
NCT00615498|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-07-30|||July 2006||2006-07-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Study to Evaluate the Effects of Weight Loss on Airway Inflammation and Mechanics in Subjects With Asthma (Asthma-Bariatric Surgery Study)|Study to Evaluate the Effects of Weight Loss on Airway Inflammation and Mechanics in Subjects With Asthma|Completed||N/A|80|Anticipated|Emory University|||2||f||||f||||||Samples With DNA|"~     Blood and exhaled breath condensate samples will obtained at all time points (baseline, 1~     month, 6 months, and 1 year.~   "|||2017-02-18 14:44:51.358011|2017-02-18 14:44:51.358011
NCT00615485|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2013-05-29|||January 2006||2006-01-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric Cancers|Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric Cancers|Completed||N/A|38|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||Samples Without DNA|"~     bone specific alkaline phosphatase n-telopeptide~   "|||2017-02-18 14:44:51.445891|2017-02-18 14:44:51.445891
NCT00615472|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-06-19|2015-06-02||October 2003||2003-10-01|June 2015|2015-06-01|April 2011|Actual|2011-04-01|April 2010|Actual|2010-04-01||Interventional||Patients had neuropsychometric analysis before and after procedure.|Intravenous Versus Inhalational Anesthesia in Parkinson's Disease|Intravenous General Anesthesia Versus Inhalational General Anesthesia in Parkinson's Disease|Terminated||N/A|58|Actual|Columbia University||2||Lack of funding|f||||f||||||||||2017-02-18 14:44:51.538294|2017-02-18 14:44:51.538294
NCT00615459|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-07-22|2011-07-22||February 2008||2008-02-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control|A Phase III, Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, 3-period Incomplete Block, Multidose Crossover Study to Determine the Effect on Lung Function of Indacaterol (150 and 300 μg o.d.) in Patients With Moderate to Severe COPD, Using Tiotropium (18 μg o.d.) as an Active Control|Completed||Phase 3|169|Actual|Novartis||4|||f||||f||||||||||2017-02-18 14:44:51.934697|2017-02-18 14:44:51.934697
NCT00615446|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-04-29|||March 2005||2005-03-01|April 2010|2010-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors|A Phase 1 Study Of SU011248 And Gemcitabine In Patients With Advanced Solid Tumors|Completed||Phase 1|44|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:44:52.327476|2017-02-18 14:44:52.327476
NCT00615433|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2015-05-19|2010-11-08||January 2008||2008-01-01|May 2015|2015-05-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia|A Phase 3 Randomized, Placebo-and Active Comparator Controlled, Clinical Trial to Study the Safety and Efficacy of Two Doses of Lurasidone HCl in Acutely Psychotic Patients With Schizophrenia.|Completed||Phase 3|478|Actual|Sunovion||4|||f||||t||||||||||2017-02-18 14:44:52.442528|2017-02-18 14:44:52.442528
NCT00615420|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-05-22|||July 2008||2008-07-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer|A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer|Completed||Phase 3|106|Actual|British Columbia Cancer Agency||2|||f||||f||||||||||2017-02-18 14:44:53.176599|2017-02-18 14:44:53.176599
NCT00615407|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-11-14|||January 2007||2007-01-01|November 2013|2013-11-01||||||||Observational|AIM Asthma||A Pilot Evaluation of the Impact of Alcohol Use on Airway Inflammation and Mechanics in Asthmatics||Withdrawn||N/A|0|Actual|Emory University|||2|Dr. Holguin is relocating.|f||||f||||||Samples With DNA|"~     Blood, urine, and exhaled breath condensate~   "|||2017-02-18 14:44:53.374824|2017-02-18 14:44:53.374824
NCT00615394|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2008-02-01|||April 2004||2004-04-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|STEMDILCARD||Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy|Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy in Dilated Cardiomyopathy - Technique and Early Results|Completed||Phase 1/Phase 2|6|Actual|Instituto de Cardiologia do Rio Grande do Sul||1|||f||||t||||||||||2017-02-18 14:44:53.449336|2017-02-18 14:44:53.449336
NCT00615381|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2015-04-21|||January 2009||2009-01-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Supraphysiologic Insulin to Improve Outcomes After Surgical Treatment of Unruptured Cerebral Aneurysms|Clinical Trial of Euglycemia Maintenance With Supraphysiologic Insulin vs Conventional Intensive Insulin Therapy to Improve Outcomes (Neurologic, Neuropsychiatric, and Biomarkers) After Surgical Treatment of Unruptured Cerebral Aneurysms|Withdrawn||N/A|0|Actual|Northwestern University||2||Study was not initiated and has been withdrawn due to lack of appropriate cases|f||||f||||||||||2017-02-18 14:44:53.533518|2017-02-18 14:44:53.533518
NCT00615368|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2015-08-20|||May 2008||2008-05-01|August 2015|2015-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Treatment With Erythropoietin and Cognition During Hypoglycaemia|The Effect of Intravenous Erythropoietin Treatment on Cognition During Hypoglycemia in Patients With Type 1 Diabetes.|Completed||N/A|11|Actual|Hillerod Hospital, Denmark||2|||f||||f||||||||||2017-02-18 14:44:53.640355|2017-02-18 14:44:53.640355
NCT00615355|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-02|2017-01-11|||February 2008||2008-02-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment|Efficacy of Narrow-band UVB Treatment After Transplantation of Harvested Epidermal Cells in Vitiligo|Completed||N/A|11|Actual|Medical University of Graz||2|||f||||f||||||||||2017-02-18 14:44:53.752515|2017-02-18 14:44:53.752515
NCT00614120|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-10-29|2010-02-23||January 2008||2008-01-01|October 2014|2014-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Liraglutide or Glimepiride Added to Metformin on Glycaemic Control in Subjects With Type 2 Diabetes|Completed||Phase 3|929|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-02-18 14:44:53.863954|2017-02-18 14:44:53.863954
NCT00614107|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-12|||January 2008||2008-01-01|January 2008|2008-01-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Observational|A-Fib||Organization in Acute Atrial Fibrillation Post Open Heart Surgery|Organization in Acute Atrial Fibrillation Post Open Heart Surgery|Unknown status|Enrolling by invitation|N/A|75|Actual|State University of New York - Upstate Medical University|||1||f||||f||||||Samples With DNA|"~     Tissue sample for the right and left sid eof the heart.~   "|||2017-02-18 14:44:55.177504|2017-02-18 14:44:55.177504
NCT00614094|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-07-08|||December 2007||2007-12-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||Maternal Hypoglycemia and Placental Pathology|Maternal Hypoglycemia During One Hour Glucose Tolerance Test as a Risk for Decreased Placental Weight and Placental Pathology|Completed||N/A|350|Anticipated|Oklahoma State University Center for Health Sciences|||1||f||||t||||||||||2017-02-18 14:44:55.251902|2017-02-18 14:44:55.251902
NCT00614081|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2013-05-21|||January 2008||2008-01-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|IREN||GFR Measurement With Contrast-enhanced Dynamic MRI|Measurement of Glomerular Filtration Rate With Contrast-enhanced Dynamic MR Imaging in Renal Transplant Recipients: Evaluation of the Agreement With the Cr51 -EDTA Method and of Reproducibility|Completed||N/A|71|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-02-18 14:44:55.35075|2017-02-18 14:44:55.35075
NCT00614068|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2015-04-03|||January 2007||2007-01-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Effectiveness of Trauma-Focused Cognitive Behavioral Therapy in Treating Children With Post-Traumatic Stress Disorder|Creating a Collaborative Field Research Organization|Completed||N/A|40|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 14:44:55.464723|2017-02-18 14:44:55.464723
NCT00614055|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-12-10|2015-10-16||January 2008||2008-01-01|December 2015|2015-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes|A 16 Week Randomised, Open Labelled, 3 Armed, Parallel Group, Treat-to-target Trial Comparing Once Daily Injection of SIAC 30 (B), SIAC 45 (B) and Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes Failing on OAD Treatment|Completed||Phase 2|178|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-02-18 14:44:55.585674|2017-02-18 14:44:55.585674
NCT00614042|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-08-22|||January 2008||2008-01-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma|A Phase 1/1b Study of TRU-016 in Patients With Previously Treated Chronic Lymphocytic Leukemia or Select Subtypes of Non-Hodgkin's Lymphoma|Completed||Phase 1|96|Actual|Aptevo Therapeutics||1|||f||||t||||||||||2017-02-18 14:44:56.376772|2017-02-18 14:44:56.376772
NCT00614029|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2009-11-23|||December 2006||2006-12-01|November 2009|2009-11-01||||December 2006|Actual|2006-12-01||Interventional|||A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System|A Randomized, Open-Label, Single-Dose, Four-way Crossover Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System Versus IMITREX STATdose at Three Injection Sites in Healthy Adults|Completed||Phase 1|54|Actual|Zogenix, Inc.||6|||f||||t||||||||||2017-02-18 14:44:56.505949|2017-02-18 14:44:56.505949
NCT00614016|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2008-08-01|||January 2008||2008-01-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers|A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers|Completed||Phase 1|40|Actual|HemaQuest Pharmaceuticals Inc.||1|||f||||f||||||||||2017-02-18 14:44:56.616996|2017-02-18 14:44:56.616996
NCT00614003|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2015-05-21|||April 2007||2007-04-01|May 2015|2015-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of an Intervention Designed to Enhance the Quality of Decision Support Provided to Patients Making Decisions About End-of-life Place of Care|Efficacy of a Training Intervention on the Quality of Case Coordinators and Nurses' Decision Support for Patients Deciding About the Place of Care at the End Of-Life: A Randomized Control Trial|Completed||Phase 2|90|Actual|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-02-18 14:44:56.729452|2017-02-18 14:44:56.729452
NCT00613977|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-09-19|||January 2008||2008-01-01|September 2011|2011-09-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Observational|||Comparison of Two Fetal Lung Maturity Tests|Pilot Study-A Cost and Time Savings Comparison of Lamellar Body Count and FLM II|Withdrawn||N/A|10|Anticipated|Oklahoma State University Center for Health Sciences|||1|Withdrawn|f||||t||||||None Retained|"~     Amniotic fluid for fetal lung maturity test~   "|||2017-02-18 14:44:56.841246|2017-02-18 14:44:56.841246
NCT00613964|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-07-20|||May 2009||2009-05-01|February 2009|2009-02-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure|The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure|Terminated||Phase 4|200|Anticipated|Nara Medical University||2|||f||||t||||||||||2017-02-18 14:44:56.937773|2017-02-18 14:44:56.937773
NCT00613951|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-11-27|2015-10-16||January 2008||2008-01-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes|A 16 Week Randomised, Open Labelled, 3-armed, Parallel Group, Treat-to-target Trial Comparing Twice Daily (BID) Injections of SIAC 30 (B), SIAC 45 (B) and NovoMix®30, All in Combination With Metformin in Subjects With Type 2 Diabetes Failing on OAD Treatment|Completed||Phase 2|182|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-02-18 14:44:57.043999|2017-02-18 14:44:57.043999
NCT00615342|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-02-17|||October 2005||2005-10-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:44:57.750295|2017-02-18 14:44:57.750295
NCT00615329|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2014-11-24|||April 2003||2003-04-01|November 2014|2014-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Huntsman Biopsy Study|The Huntsman Cancer Institute - The Use of Microarray Analysis in Characterizing Mesenchymal Tissue Tumors: Differentiation of Normal, Benign, and Malignant Conditions|Terminated||N/A|142|Actual|State University of New York - Upstate Medical University|||1|Huntmans Cancer Institute terminated study|f||||f||||||Samples With DNA|"~     cDNA microarrays facilitate the systematic and comprehensive analysis of transcriptional~     alterations occurring in diseased tissues.~   "|||2017-02-18 14:44:57.793303|2017-02-18 14:44:57.793303
NCT00615316|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-02-13|||December 2006||2006-12-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Guaraná for Radiation Related Fatigue in Breast Cancer Patients|"Guaraná (Paullinia Cupana) for Radiation Related Fatigue in Breast Cancer Patients: Results Of A Pilot Double Blind Randomized Study"|Completed||Phase 2|36|Actual|Faculdade de Medicina do ABC||2|||f||||t||||||||||2017-02-18 14:44:57.880806|2017-02-18 14:44:57.880806
NCT00615303|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2013-02-21|||December 2006||2006-12-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effectiveness of Simethicone In Improving Visibility During Colonoscopy|The Effectiveness of Simethicone In Improving Visibility During Colonoscopy: A Randomized, Placebo-controlled Study|Completed||Phase 4|194|Actual|Ramathibodi Hospital||2|||f||||f||||||||||2017-02-18 14:44:58.072174|2017-02-18 14:44:58.072174
NCT00615290|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-08-06|2010-02-03||June 2007||2007-06-01|August 2014|2014-08-01||||May 2009|Actual|2009-05-01||Observational||All enrolled patients|Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy|Pharmaco-epidemiological Description of the Patient Population Treated With Aptivus Under Market Conditions, Safety & Efficacy|Completed||N/A|42|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:44:58.184473|2017-02-18 14:44:58.184473
NCT00615277|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2008-02-13|||October 2006||2006-10-01|February 2008|2008-02-01||||January 2007|Actual|2007-01-01||Interventional|||The Effect of Long-Chain Polyunsaturated Fatty Acids on Cognitive Performance and Mood|The Effect of Long-Chain Polyunsaturated Fatty Acids on Cognitive Performance and Mood of Healthy Young Adults|Completed||N/A|82|Actual|University of Ulm||2|||f||||f||||||||||2017-02-18 14:44:58.501929|2017-02-18 14:44:58.501929
NCT00615264|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-05-25|2015-11-16||September 2005||2005-09-01|May 2016|2016-05-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|DIA-AID||Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients|A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Investigate The Clinical Efficacy And Safety of DiaPep277® in Newly Diagnosed Type 1 Diabetes Patients|Completed||Phase 3|457|Actual|Andromeda Biotech Ltd.||2|||f||||t||||||||||2017-02-18 14:44:58.596808|2017-02-18 14:44:58.596808
NCT00615251|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-08-30||2011-06-08|February 2008||2008-02-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization|A Phase 3, Single-Blind, Randomized Study to Compare DR-2011 to a Progesterone Gel for Luteal Phase Supplementation for In Vitro Fertilization|Completed||Phase 3|1297|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 14:44:59.399144|2017-02-18 14:44:59.399144
NCT00615238|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-12|2010-03-17|||April 2000||2000-04-01|March 2010|2010-03-01|May 2004|Actual|2004-05-01|March 2004|Actual|2004-03-01||Interventional|CHANGE||PHYSICAL ACTIVITY IN THE TREATMENT OF OBESITY|Physical Activity in the Treatment of Obesity: A Randomized Trial|Completed||N/A|177|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||f||||||||||2017-02-18 14:44:59.531773|2017-02-18 14:44:59.531773
NCT00615225|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-02-13|||January 2000||2000-01-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Observational|||Brain Death: Inflammatory Response, Apoptosis, and Endotoxin Tolerance|Observational Study on the Systemic Inflammatory Response During Brain Death.|Completed||N/A|||Delafontaine Hospital|||3||f||||f||||||||||2017-02-18 14:44:59.634992|2017-02-18 14:44:59.634992
NCT00615212|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-10-13||2010-10-13|January 2008||2008-01-01|October 2010|2010-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects|A Single Center, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK376501 on Hepatic Cytochrome P450 Activity in Healthy Adult Subjects|Completed||Phase 1|24|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 14:44:59.746965|2017-02-18 14:44:59.746965
NCT00615199|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-01-18|2012-11-28||January 2008||2008-01-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study To Investigate The Safety And Efficacy Of CP-690,550 In Subjects With Moderate To Severe Crohn's Disease.|Completed||Phase 2|139|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:44:59.852422|2017-02-18 14:44:59.852422
NCT00615186|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-02-08|||June 2008||2008-06-01|February 2011|2011-02-01|December 2013|Anticipated|2013-12-01|August 2013|Anticipated|2013-08-01||Interventional|Glass-Art||Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy|A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme|Terminated||Phase 3|9|Actual|Bradmer Pharmaceuticals Inc.||2||Due to delay in site initiation and funding considerations|f||||t||||||||||2017-02-18 14:45:00.962563|2017-02-18 14:45:00.962563
NCT00615173|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2008-10-27|||July 2006||2006-07-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis||Completed||Phase 3|81|Actual|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 14:45:01.087712|2017-02-18 14:45:01.087712
NCT00615160|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-01-11|||December 2006||2006-12-01|December 2007|2007-12-01||||September 2008|Actual|2008-09-01||Interventional|||PTK/ZK in Disseminated Malignant Melanoma|Phase II Randomized, Parallel-Group Trial on PTK-ZK With or Without DTIC in Patients With Non-resectable Metastatic Malignant Melanoma|Suspended||Phase 1/Phase 2|30|Anticipated|University of Schleswig-Holstein||2||Substance was withdrawn from further development.|f||||t||||||||||2017-02-18 14:45:01.276111|2017-02-18 14:45:01.276111
NCT00615147|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2012-01-06|||May 2005||2005-05-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population|Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population: A Correlation With Ct Pulmonary Angiogram in the Urgent Care Setting|Completed||N/A|213|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:45:01.391036|2017-02-18 14:45:01.391036
NCT00615134|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-01-19|||January 2008||2008-01-01|January 2015|2015-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.|A Randomized, Open-label Study Evaluating the Antiviral Activity and Safety of 3 Month Fuzeon Induction With an Optimized Background Antiretroviral Regimen Versus OB Alone, in Fuzeon-naive HIV-1 Infected Patients With Virological Failure.|Completed||Phase 2|29|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:45:01.502233|2017-02-18 14:45:01.502233
NCT00615121|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-03|2016-01-21|||June 2004||2004-06-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Genetics of Peripheral Artery Genomics|Genetics of Peripheral Artery Disease|Completed||N/A|122|Actual|Duke University|||2||f||||f||||||Samples With DNA|"~     Peripheral artery samples collected from patients are stored in -80celcius refrigerator for~     future analysis.~   "|||2017-02-18 14:45:01.647088|2017-02-18 14:45:01.647088
NCT00615108|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-02-28|2009-12-16||December 2006||2006-12-01|February 2014|2014-02-01||||December 2008|Actual|2008-12-01||Observational|||Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters|Safety and Effectiveness of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertension Patients|Completed||N/A|3148|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:45:01.762791|2017-02-18 14:45:01.762791
NCT00615095|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-04-19|||February 1997||1997-02-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Differential Risks for Melanoma: p16 and DNA Repair|Differential Risks for Melanoma: p16 and DNA Repair|Completed||N/A|323|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 14:45:02.136388|2017-02-18 14:45:02.136388
NCT00615082|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-09-06|||February 2007||2007-02-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|May 2009|Actual|2009-05-01||Interventional|Balance||The Balance Study Balancing Life and Reducing Stress For Those Providing Elder Care|Stress Reduction for Caregivers: A Randomized Controlled Pilot Study|Completed||N/A|78|Actual|HealthPartners Institute||2|||f||||t||||||||||2017-02-18 14:45:02.240591|2017-02-18 14:45:02.240591
NCT00615069|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-03-23|2009-03-26||May 2006||2006-05-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|March 2008|Actual|2008-03-01||Interventional|||Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms|A Clinical Study Evaluating the Use of the GORE EXCLUDER® AAA Endoprosthesis - 31mm In the Primary Treatment of Infrarenal Abdominal Aortic Aneurysms|Completed||Phase 2|35|Actual|W.L.Gore & Associates||1|||f||||f||||||||||2017-02-18 14:45:02.346671|2017-02-18 14:45:02.346671
NCT00615056|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2013-04-12|2012-03-28||March 2008||2008-03-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|March 2011|Actual|2011-03-01||Interventional|||A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen|A Randomized, Phase 2 Study Of FOLFOX Or FOLFIRI With AG-013736 Or Bevacizumab (Avastin) In Patients With Metastatic Colorectal Cancer After Failure Of An Irinotecan Or Oxaliplatin-Containing First-Line Regimen|Completed||Phase 2|171|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 14:45:02.623756|2017-02-18 14:45:02.623756
NCT00615043|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-12-20|||February 2008||2008-02-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Observational|||Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure|A Multi Center Study to Obtain Bladder Tissue Specimens From Subjects Undergoing Transurethral Resection of Bladder Tumor (TURBT) or Other Transurethral Biopsy Procedures|Completed||N/A|6|Actual|Tengion|||1||f||||f||||||Samples Without DNA|"~     Tissue~   "|||2017-02-18 14:45:07.671078|2017-02-18 14:45:07.671078
NCT00615030|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-07-22|2011-07-22||January 2008||2008-01-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Phase III Randomized, Double Blind, Double Dummy, Placebo Controlled, Multicenter, 4 Treatments, 3 Period Incomplete Block Crossover Study to Assess the Efficacy and Safety of Indacaterol 300 µg o.d. Dosed in the Evening in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Salmeterol 50 µg b.i.d. as Active Control|Completed||Phase 3|96|Actual|Novartis||12|||f||||f||||||||||2017-02-18 14:45:07.770771|2017-02-18 14:45:07.770771
NCT00615017|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-07-19|2012-11-30||January 2008||2008-01-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||AZD9773 Dose Escalation Study|A Placebo-controlled, Double-blind, Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of Single and Multiple Intravenous Infusions of CytoFab (AZD9773) in Patients With Severe Sepsis|Completed||Phase 2|70|Actual|AstraZeneca||6|||f||||t||||||||||2017-02-18 14:45:08.275455|2017-02-18 14:45:08.275455
NCT00615004|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2008-02-13|||January 1997||1997-01-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|CVAcro||Cardiovascular Outcome After Surgery or Somatostatin Analogues|An Observational, Retrospective, Comparative Study to Investigate Differential Outcome on Cardiomyopathy Following Control of Acromegaly After Surgery or Somatostatin Analogues Given as First-Line Therapy|Completed||N/A|215|Actual|Federico II University|||2||f||||f||||||Samples Without DNA|"~     Sera from most patients on a yearly bases are stored in our freezed at minus 80° for~     eventual further studies. No experimental parameters are included in the current study.~   "|||2017-02-18 14:45:11.271383|2017-02-18 14:45:11.271383
NCT00614991|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2016-01-27|2015-03-24||January 2008||2008-01-01|January 2016|2016-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||An Interaction Study to Assess Drug Levels in Healthy Adult Subjects|Steady-State Plasma Amprenavir (APV) and Raltegravir (RTG) Pharmacokinetics After Fosamprenavir (FPV) and Raltegravir (RTG) Are Each Administered Alone Versus in Combination With or Without Ritonavir (RTV) Boosting in Healthy Adult Subjects|Completed||N/A|44|Actual|Garden State Infectious Disease Associates, PA|Data for primary outcomes are not available per intervention . Values reported as means are uncertain measure type (data no longer available).|6|||f||||f||||||||||2017-02-18 14:45:11.386562|2017-02-18 14:45:11.386562
NCT00614978|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2012-09-18|||January 2008||2008-01-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|LAPTEM||Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer|Phase 1 Study of the Combination of Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer|Completed||Phase 1|18|Actual|Jules Bordet Institute||1|||f||||f||||||||||2017-02-18 14:45:12.216779|2017-02-18 14:45:12.216779
NCT00614965|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-05-20|||November 2006||2006-11-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV|A Multicenter Randomized Phase II Study of the Combination of Irinotecan/Cisplatin Versus Pemetrexed/Cisplatin as Second-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|124|Anticipated|Hellenic Oncology Research Group||2|||f||||f||||||||||2017-02-18 14:45:12.336968|2017-02-18 14:45:12.336968
NCT00614952|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2016-04-19|||January 2006||2006-01-01|December 2012|2012-12-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|Telesleep||Cost/Effectiveness Analysis of the Respiratory Poligraphy at Home|Diagnostic Validity Study and Cost Analysis of Domiciliary Respiratory|Completed||N/A|320|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||f||||||||||2017-02-18 14:45:12.457706|2017-02-18 14:45:12.457706
NCT00614939|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-05-16|2010-06-07||January 2008||2008-01-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|June 2009|Actual|2009-06-01||Interventional|||Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment|A Short-term 12-Week, Multi-centre, Randomized, Parallel-group, Double-blind, Placebo-controlled Study to Evaluate the Treatment Effect of Saxagliptin Compared With Placebo in Adult Patients With Type 2 Diabetes and Renal Impairment (Moderate, Severe, and End-Stage) With an Additional 40-week, Randomized, Double-blind, Placebo-controlled Long-term Observational Period.|Completed||Phase 3|572|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:45:12.564863|2017-02-18 14:45:12.564863
NCT00614926|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-02-17|2011-01-12||June 2006||2006-06-01|February 2012|2012-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Modafinil for Treatment of Fatigue in ALS Patients|Modafinil for Treatment of Fatigue in ALS Patients: Pilot Study|Completed||Phase 4|32|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 14:45:13.720925|2017-02-18 14:45:13.720925
NCT00614913|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-16|2011-06-29||May 1998||1998-05-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Proton Beam Therapy for Treatment of Hepatocellular Carcinoma|Phase I/II Study of Proton Beam Therapy for Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|76|Actual|Loma Linda University||1|||f||||t||||||||||2017-02-18 14:45:14.116486|2017-02-18 14:45:14.116486
NCT00614900|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-09-17|||March 2008||2008-03-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Prevalence of Pulmonary Hypertension in COPD Patients|Prevalence and Influence of Pulmonary Hypertension in COPD Patients|Completed||N/A|117|Actual|University of Aarhus|||1||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 14:45:14.349589|2017-02-18 14:45:14.349589
NCT00614887|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-02-12|||March 2006||2006-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|November 2006|Actual|2006-11-01||Observational|SAHENDO||Hypothalamo-, Pituitary-, Adrenal Axis Dysfunction in Subarachnoid Hemorrhage|Hypothalamo-, Pituitary-, Adrenal Axis Dysfunction in Subarachnoid Hemorrhage|Completed||N/A|46|Actual|Kuopio University Hospital|||2||f||||t||||||Samples Without DNA|"~     serum and plasma samples~   "|||2017-02-18 14:45:14.443152|2017-02-18 14:45:14.443152
NCT00614874|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-09-01|2011-06-17||December 2008||2008-12-01|September 2011|2011-09-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||The Use of Rosiglitazone to Treat Asthma|The Effects of the PPARy Agonist Rosiglitazone on Airway Hyperreactivity|Completed||Phase 2|16|Actual|Creighton University|Small sample size. Lack of placebo control arm.|1|||f||||f||||||||||2017-02-18 14:45:14.544706|2017-02-18 14:45:14.544706
NCT00614861|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-05-22|||September 2007||2007-09-01|May 2014|2014-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Pain Satisfaction Survey|A Clinical Survey on Satisfaction of Pain Management in Patients With Non-cancer Pain in Taiwan|Completed||Phase 4|2929|Actual|Johnson & Johnson Taiwan Ltd|||1||f||||||||||||||2017-02-18 14:45:14.836576|2017-02-18 14:45:14.836576
NCT00614848|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2011-04-08|||June 2003||2003-06-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|January 2005|Actual|2005-01-01||Interventional|ENDEAVOR II||The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions|Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions|Completed||N/A|1200|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-02-18 14:45:14.920832|2017-02-18 14:45:14.920832
NCT00614835|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-12-21|||August 2001||2001-08-01|December 2015|2015-12-01|January 2012|Actual|2012-01-01|February 2006|Actual|2006-02-01||Interventional|||Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus|A Pilot Study of Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus|Completed||N/A|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:45:15.021703|2017-02-18 14:45:15.021703
NCT00614822|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2017-02-03|||November 2007||2007-11-01|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|H3E-US-X072||Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer|A Phase II Trial of Carboplatin, Bevacizumab and Pemetrexed in Advanced Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|50|Anticipated|Christiana Care Health Services||1|||f||||t||||||||||2017-02-18 14:45:15.281693|2017-02-18 14:45:15.281693
NCT00614809|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-02-13|||December 2007||2007-12-01|December 2007|2007-12-01|December 2010|Anticipated|2010-12-01|March 2010|Anticipated|2010-03-01||Interventional|||Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer|A Phase II Study of Gefitinib in Benefited Patients With Asymptomatic Brain Metastasis Advanced Non-Small Cell Lung Cancer by Chemotherapy|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|Guangdong Provincial People's Hospital||1|||f||||t||||||||||2017-02-18 14:45:15.405095|2017-02-18 14:45:15.405095
NCT00614796|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-03-23|||November 2006||2006-11-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|August 2009|Actual|2009-08-01||Interventional|COACH||A Structured Lifestyle Intervention on Daily Physical Activity Level in COPD|A Study Evaluating the Effects of a Structured Lifestyle Intervention on Daily Physical Activity Level of COPD Patients in the First, Second and Third Echelon.|Completed||N/A|155|Actual|Groningen Research Institute for Asthma and COPD||2|||f||||f||||||||||2017-02-18 14:45:15.506461|2017-02-18 14:45:15.506461
NCT00614783|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2012-12-03|||May 2007||2007-05-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|SEED||Screening for Early Evidence of Diabetes|A Prospective, Multi-Center, Paired Data, Cohort Screening Trial Comparing SCOUT to the Fasting Plasma Glucose Test in Subjects at Risk for Diabetes|Completed||N/A|3478|Actual|VeraLight, Inc.|||1||f||||f||||||||||2017-02-18 14:45:15.618038|2017-02-18 14:45:15.618038
NCT00614770|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2010-06-16|||February 2008||2008-02-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Narrow Band Imaging Colon Polyp Study|A Multicenter, Prospective, Randomized Controlled Trial for the Detection of Colon Polyps and Predicting Histology|Completed||N/A|630|Actual|Kansas City Veteran Affairs Medical Center||3|||f||||f||||||||||2017-02-18 14:45:15.72854|2017-02-18 14:45:15.72854
NCT00614757|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-10-25|||May 2005||2005-05-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|IR||Insulin Resistance Study|The Prevalence of Insulin Resistance and the Potential Modulation of Insulin Resistance by N-acetylcysteine (NAC) in Patients Chronically Infected by the Hepatitis C Virus|Suspended||N/A|121|Actual|Midwest Biomedical Research Foundation||2|||f||||t||||||||||2017-02-18 14:45:15.840242|2017-02-18 14:45:15.840242
NCT00614744|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2016-12-08|||April 2008||2008-04-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Late Hypothermia for Hypoxic-Ischemic Encephalopathy|Evaluation of Systemic Hypothermia Initiated After 6 Hours of Age in Infants ≥36 Weeks Gestation With Hypoxic-Ischemic Encephalopathy: A Bayesian Evaluation. A Protocol for the NICHD Neonatal Research Network|Completed||Phase 2/Phase 3|168|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-02-18 14:45:15.936198|2017-02-18 14:45:15.936198
NCT00614731|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2017-01-10|||December 2007||2007-12-01|January 2017|2017-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route|Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route|Completed||Phase 1|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 14:45:16.082891|2017-02-18 14:45:16.082891
NCT00614718|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-12|||January 1993||1993-01-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|January 2004|Actual|2004-01-01||Observational|||Failure of Chronically Implanted Defibrillator Leads -Incidence and Management|Failure of Chronically Implanted Defibrillator Leads -Incidence and Management A Retrospective Multicenter Study|Completed||N/A|1317|Actual|University Hospital, Basel, Switzerland|||3||f||||f||||||||||2017-02-18 14:45:16.372564|2017-02-18 14:45:16.372564
NCT00614705|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-05-09||2009-04-06|April 2008||2008-04-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia|A Four Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2A Study Of PH-797804 In The Treatment Of Post-Herpetic Neuralgia|Completed||Phase 2|80|Actual|Pfizer||2|||f||||||||||||||2017-02-18 14:45:16.470196|2017-02-18 14:45:16.470196
NCT00614679|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2008-02-11|||October 2006||2006-10-01|February 2008|2008-02-01||||December 2008|Anticipated|2008-12-01||Interventional|||A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia|A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia|Unknown status|Recruiting|Phase 1|20|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-02-18 14:45:16.596738|2017-02-18 14:45:16.596738
NCT00614666|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-02-12|||September 2007||2007-09-01|August 2009|2009-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment|Phase I/II Evaluation of the Safety, Pharmacokinetics, and Preliminary Effectiveness of Nikkomycin Z in the Treatment of Patients With Uncomplicated Coccidioides Pneumonia|Terminated||Phase 1/Phase 2|6|Actual|University of Arizona||4||Recruitment challenges and lack of funding caused an early end to this study|f||||t||||||||||2017-02-18 14:45:16.708045|2017-02-18 14:45:16.708045
NCT00614653|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-07-29|||January 2008||2008-01-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer|Phase I Trial of Preoperative Radiotherapy With Concurrent Bevacizumab, Erlotinib and Capecitabine for Locally Advanced Pancreatic Cancer|Completed||Phase 1|17|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:45:16.811706|2017-02-18 14:45:16.811706
NCT00614640|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-09-04||||||September 2013|2013-09-01||||November 2013|Anticipated|2013-11-01||Interventional|||Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults|A Phase I/II Study of the Safety, Tolerability, and Immunogenicity of a Topical Therapeutic DNA Dendritic Cell Vaccine (DermaVir Patch) in Children, Adolescents, and Young Adults With HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)|Withdrawn||Phase 1/Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 14:45:16.931448|2017-02-18 14:45:16.931448
NCT00614614|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-10-06|2012-06-15||February 2008||2008-02-01|October 2016|2016-10-01|August 2010|Actual|2010-08-01|September 2009|Actual|2009-09-01||Interventional|||Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014|Immunogenicity and Safety Study of a Booster Dose of GSK Biologicals' Meningococcal Vaccine 134612 Given at 12-15 Months of Age or at 15-18 Months of Age (Co-administered With Infanrix®) in Primed Healthy Toddlers.|Completed||Phase 3|1558|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:45:17.06443|2017-02-18 14:45:17.06443
NCT00614601|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-05-29||2014-05-28|January 2008||2008-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|May 2010|Actual|2010-05-01||Interventional|||Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer|A Phase II Study of Low Dose Algenpantucel-L (HyperAcute Pancreas) Cancer Vaccine in Subjects With Surgically Resected Pancreatic Cancer|Terminated||Phase 2|9|Actual|NewLink Genetics Corporation||2||Sponsor proceeded with a phase III study for same indication.|f||||t||||||||||2017-02-18 14:45:19.238037|2017-02-18 14:45:19.238037
NCT00614588|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-07-18|||January 2008||2008-01-01|July 2016|2016-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Temperature Measurement in Post-Anesthesia Care Units|Accuracy of Temperature Measurement in Post-Anesthesia Care Units|Completed||N/A|50|Actual|The Cleveland Clinic|||1||f||||f||||||||||2017-02-18 14:45:19.345496|2017-02-18 14:45:19.345496
NCT00614575|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-08-01|2011-02-23||January 2007||2007-01-01|August 2014|2014-08-01||||August 2009|Actual|2009-08-01||Observational|||Survey on PD Patients With Depressive Symptoms|BI_Sifrol Tablets Special Drug Use Surveillance(Survey on the Safety and Efficacy in Parkinson's Disease Patients With Depressive Symptoms)|Completed||N/A|1089|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:45:19.459932|2017-02-18 14:45:19.459932
NCT00614562|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-02-02|||January 2008||2008-01-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|June 2009|Actual|2009-06-01||Interventional|||Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Critical Illness Associated Polyneuropathy / or Polymyopathy (CIP/M)|Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Critical Illness Associated Polyneuropathy / or Polymyopathy (CIP/M)|Completed||Phase 1|15|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 14:45:20.169224|2017-02-18 14:45:20.169224
NCT00614549|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2012-05-25|||March 2007||2007-03-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Efficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and Romania.|Long-term Evaluation of the Efficacy and Safety of Levetiracetam in Routine Clinical Practice in the Czech and Slovak Republics, Hungary, and Romania - Non-interventional Study|Completed||N/A|2569|Actual|UCB Pharma|||1||f||||f||||||||||2017-02-18 14:45:20.276689|2017-02-18 14:45:20.276689
NCT00614536|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2014-04-24|||September 2007||2007-09-01|April 2014|2014-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period|Observational Study: Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period|Completed||Phase 4|1142|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-02-18 14:45:20.364603|2017-02-18 14:45:20.364603
NCT00614523|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-04-05|2012-01-20||July 2008||2008-07-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|July 2012|Actual|2012-07-01||Interventional|||Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)|A Randomized, Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)|Completed||Phase 2|250|Actual|Amgen||2|||f||||t||||||||||2017-02-18 14:45:20.471094|2017-02-18 14:45:20.471094
NCT00614510|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-07-28|||August 2006||2006-08-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||SynCardia CardioWest TAH-t Postmarket Surveillance Study|The SynCardia CardioWest Temporary Total Artificial Heart (TAH-t) Postmarket Surveillance Study|Completed||N/A|196|Actual|SynCardia Systems. Inc.|||1||f||||t||||||||||2017-02-18 14:45:21.676278|2017-02-18 14:45:21.676278
NCT00614484|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-04-28|2013-07-16||August 1999||1999-08-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||28 subjects were enrolled and received the study treatment. All 28 were followed for treatment outcomes.|Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer|Phase I/II Study of Combined Chemotherapy and High Dose, Accelerated Proton Radiation for the Treatment of Locally Advanced Non-Small Cell Lung Carcinoma|Terminated||Phase 1/Phase 2|28|Actual|Loma Linda University|Slow enrollment over a long time period limits the conclusions that can be drawn.|1||Low participant enrollment rates. Significant comparative data not obtained.|f||||t||||||||||2017-02-18 14:45:21.742383|2017-02-18 14:45:21.742383
NCT00614471|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2016-11-01|||August 2007||2007-08-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.|A Randomized, Open Label Study of the Effect of Peginterferon Alfa-2a (40KD) (PEGASYS®) Plus Entecavir (Baraclude®) Combination Therapy on Quantitative Changes in HBeAg in Treatment-naive Patients With HBeAg Positive Chronic Hepatitis B|Completed||Phase 4|219|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 14:45:21.978472|2017-02-18 14:45:21.978472
NCT00614458|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-10-24|2011-04-15||April 2007||2007-04-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection|10493 - MK-0518 Intensification and HDAC Inhibition in Depletion of Resting CD4+ T Cell HIV Infection|Terminated||Phase 2|6|Actual|University of North Carolina, Chapel Hill||1||Due to insufficient funds|f||||t||||||||||2017-02-18 14:45:22.082589|2017-02-18 14:45:22.082589
NCT00614445|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2011-08-04|2011-08-01||January 2008||2008-01-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy|A Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Of The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy|Completed||Phase 3|280|Actual|Duchesnay Inc.||2|||f||||f||||||||||2017-02-18 14:45:22.416702|2017-02-18 14:45:22.416702
NCT00614432|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2010-12-16|||January 2008||2008-01-01|December 2010|2010-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women|Blood Loss at the Time of First Trimester Surgical Abortion in Anticoagulated Women|Completed||N/A|30|Anticipated|University of Hawaii|||2||f||||f||||||Samples Without DNA|"~     Whole blood~   "|||2017-02-18 14:45:22.80439|2017-02-18 14:45:22.80439
NCT00614419|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-02-12|||January 2003||2003-01-01|December 2007|2007-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Prospective Randomized Trial Comparing Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Surgisis|Prospective Randomized, Double-Blind, Controlled Trial Comparing Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Surgisis ES Soft Tissue Graft|Completed||Phase 4|70|Actual|St. Orsola Hospital||2|||f||||f||||||||||2017-02-18 14:45:22.905021|2017-02-18 14:45:22.905021
NCT00614406|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-12-11|2011-07-15||January 2008||2008-01-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle|The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle.|Completed||N/A|11|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:45:23.016872|2017-02-18 14:45:23.016872
NCT00614393|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-11-01|2016-11-01||December 2007||2007-12-01|November 2016|2016-11-01|March 2012|Actual|2012-03-01|June 2010|Actual|2010-06-01||Interventional||The Baseline Analysis Population was the All Participants As Treated (APAT) population and consisted of all participants who received at least one dose of study drug.|Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)|A Phase II/III Study of Dalotuzumab (MK-0646) Treatment in Combination With Cetuximab and Irinotecan for Patients With Metastatic Colorectal Cancer|Completed||Phase 2|558|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 14:45:23.494578|2017-02-18 14:45:23.494578
NCT00614380|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-12-16|2009-12-14||January 2008||2008-01-01|December 2013|2013-12-01||||March 2009|Actual|2009-03-01||Interventional|||Open Label Study Telmisartan and Amlodipine in Hypertension|An Open Label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Combination of Telmisartan 40mg + Amlodipine 5mg or the Combination of Telmisartan 80mg + Amlodipine 5mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension.|Completed||Phase 3|976|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:45:25.387821|2017-02-18 14:45:25.387821
NCT00614367|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-11|||October 2005||2005-10-01|January 2008|2008-01-01|June 2008|Anticipated|2008-06-01|March 2008|Anticipated|2008-03-01||Observational|||Chromosomal Analysis of Single Cells in Human Embryos|Chromosomal Analysis of Single Cells in Human Embryos|Unknown status|Active, not recruiting|N/A|30|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||Samples With DNA|"~     Single blastomeres of human embryos~   "|||2017-02-18 14:45:26.416444|2017-02-18 14:45:26.416444
NCT00614354|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2013-10-23|||October 2008||2008-10-01|October 2012|2012-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients.|Phase II Study of 99mTc-glucarate in Chest Pain Patients Suspected With ACS With no Obvious Signs of AMI and With Known Previous CAD.|Completed||Phase 2|66|Actual|Molecular Targeting Technologies, Inc.||1|||f||||f||||||||||2017-02-18 14:45:26.497533|2017-02-18 14:45:26.497533
NCT00614341|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-12|||May 2006||2006-05-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|DPN||Effect of Pulsing Electrical Fields on Lower Extremity Diabetic Neuropathy: A Pilot, Open-Label Study|A Phase IV Clinical Trial. Effect of Pulsing Electromagnetic Fields on Lower Extremity Diabetic Neuropathy: A Pilot, Open-Label Study|Completed||Phase 4|23|Actual|MedRelief||1|||f||||f||||||||||2017-02-18 14:45:26.602281|2017-02-18 14:45:26.602281
NCT00614328|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-05-05|||July 2007||2007-07-01|May 2011|2011-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.|Feasibility and Tolerability of a Combination of Naltrexone and Baclofen for Alcohol Dependence: A Pilot Study.|Completed||Phase 1|40|Actual|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-02-18 14:45:26.717531|2017-02-18 14:45:26.717531
NCT00614315|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-10-20|2009-02-20||December 2007||2007-12-01|October 2010|2010-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|FLAIR DS||FLAIR™ Delivery System Study|A Prospective Observational Study of the FLAIR™ Endovascular Stent Graft Optimized Delivery System|Completed||N/A|30|Actual|C. R. Bard||1|||f||||f||||||||||2017-02-18 14:45:26.822116|2017-02-18 14:45:26.822116
NCT00614302|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-10-01|||June 2007||2007-06-01|October 2009|2009-10-01||||October 2008|Actual|2008-10-01||Observational|||Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population|Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Patient Population|Completed||N/A|428|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:45:29.550784|2017-02-18 14:45:29.550784
NCT00614289|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2010-03-04|||August 2006||2006-08-01|October 2008|2008-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Novel Topical Treatment of Hand Dermatitis (Eczema)|Phase 1 Study to Demonstrate Efficacy of Epikeia Coatings in a Human Clinical Trial|Completed||Phase 1|30|Actual|Biomedical Development Corporation||1|||f||||f||||||||||2017-02-18 14:45:29.660138|2017-02-18 14:45:29.660138
NCT00614276|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-01-07|||October 2007||2007-10-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Female Sexual Dysfunction Intervention|TENDRILS: A Multimedia Intervention for Women's Sexual Dysfunction After Cancer|Completed||N/A|91|Actual|M.D. Anderson Cancer Center|||3||f||||t||||||||||2017-02-18 14:45:29.769706|2017-02-18 14:45:29.769706
NCT00613938|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-04-24|2009-10-02||February 2008||2008-02-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.|A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Tapentadol Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy|Completed||Phase 3|901|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||f||||||||||2017-02-18 14:45:29.888429|2017-02-18 14:45:29.888429
NCT00613925|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-04-07|2012-06-04||January 2008||2008-01-01|April 2014|2014-04-01|January 2011|Actual|2011-01-01|January 2009|Actual|2009-01-01||Interventional|||Endometrial Biopsy Instrument Comparison Study|Comparison of Pain Experienced by Patients Undergoing Endometrial Biopsy by Pipelle and Explora Curette|Completed||N/A|73|Actual|Oregon Health and Science University|Providers not blinded|2|||f||||f||||||||||2017-02-18 14:45:30.688203|2017-02-18 14:45:30.688203
NCT00613912|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-11-18|||March 2008||2008-03-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Observational|||Advanced MRI in Major Depression|Advanced MRI at 3T for the Evaluation of Ambulant Patients With Major Depression|Completed||N/A|49|Actual|University of Aarhus|||1||f||||t||||||||||2017-02-18 14:45:31.333104|2017-02-18 14:45:31.333104
NCT00613899|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-02-03|||October 2007||2007-10-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|March 2008|Actual|2008-03-01||Interventional|||Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)|Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS)|Completed||Phase 4|40|Actual|Fondazione Salvatore Maugeri||1|||f||||f||||||||||2017-02-18 14:45:31.449245|2017-02-18 14:45:31.449245
NCT00613886|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-06-26|||March 2006||2006-03-01|June 2013|2013-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|NPH||Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus|Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus|Terminated||N/A|16|Actual|University of California, Irvine||1||"Funding was withdrawn by Codman as expected number of patient subjects enrolled did not meet~   expected numbers."|f||||f||||||||||2017-02-18 14:45:31.572032|2017-02-18 14:45:31.572032
NCT00613873|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-01-14|||July 2003||2003-07-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Use of Screening Colonoscopy Among Minority Women and Men|A Model Program for Increasing Use of Screening Colonoscopy Among Minority Women and Men|Completed||N/A|611|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:45:31.676892|2017-02-18 14:45:31.676892
NCT00613860|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-04-26|||January 2008||2008-01-01|January 2008|2008-01-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Sequential Endoscopic Lung Volume Reduction|Sequential Endoscopic Lung Volume Reduction in Patients With Heterogeneous Lung Emphysema|Unknown status|Recruiting|Phase 3|30|Anticipated|Heidelberg University||1|||f||||t||||||||||2017-02-18 14:45:31.773432|2017-02-18 14:45:31.773432
NCT00613847|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2015-12-23|||October 2006||2006-10-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab|Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab|Completed||Phase 1|17|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:45:31.881348|2017-02-18 14:45:31.881348
NCT00613834|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-02-09|||May 2007||2007-05-01|February 2012|2012-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Intrauterine Lidocaine Infusion for Essure Sterilization Procedures|Intrauterine Lidocaine Infusion for Pain Management During Outpatient Essure Transcervical Tubal Sterilization Procedures|Completed||N/A|58|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:45:32.0071|2017-02-18 14:45:32.0071
NCT00613821|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-10-15|||September 2007||2007-09-01|October 2015|2015-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Lidocaine and Pain Management in First Trimester Abortions|A Comparison of Intrauterine Lidocaine Infusion and Paracervical Block for Pain Management in First Trimester Abortions|Completed||N/A|80|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:45:32.11208|2017-02-18 14:45:32.11208
NCT00613808|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2012-01-24|||February 2008||2008-02-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers|An Investigation of Topical Application of Gaseous Nitric Oxide on Safety and Efficacy in Venous Stasis Ulcers of the Lower Extremities|Terminated||Phase 2|6|Actual|Nitric BioTherapeutics, Inc||2|||f||||t||||||||||2017-02-18 14:45:32.216285|2017-02-18 14:45:32.216285
NCT00613795|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2010-03-17|||August 2004||2004-08-01|March 2010|2010-03-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia|Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia: A Prospective, Randomized, Placebo-controlled, Double-blind Study|Completed||Phase 3|125|Anticipated|Creighton University||2|||f||||f||||||||||2017-02-18 14:45:32.334004|2017-02-18 14:45:32.334004
NCT00613782|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-06-30|||January 2009||2009-01-01|June 2012|2012-06-01|April 2014|Actual|2014-04-01|January 2014|Actual|2014-01-01||Interventional|||Reandron in Diabetic Men Witn Low Testosterone Level|Testosterone Replacement Therapy in Men With Type 2 Diabetes Mellitus and Low Testosterone Levels|Completed||Phase 2/Phase 3|88|Actual|Austin Health||2|||f||||t||||||||||2017-02-18 14:45:32.440732|2017-02-18 14:45:32.440732
NCT00613769|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-09-27|||September 2007||2007-09-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Orally Administered Trimethoprim-sulfamethoxazole and Metronidazole as Prophylaxis of Infection Following Elective Colorectal Surgery|A Prospective, Randomized, Blind, Multicenter Trial Comparing Orally Administered Trimethoprim-sulfamethoxazole With Intravenously Administered Cefuroxime and Metronidazole as Prophylaxis of Infection Following Elective Colorectal Surgery|Completed||Phase 4|1073|Actual|Halmstad County Hospital||2|||f||||t||||||||||2017-02-18 14:45:32.540915|2017-02-18 14:45:32.540915
NCT00613756|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-11-12|||February 2004||2004-02-01|November 2013|2013-11-01||||September 2008|Actual|2008-09-01||Observational|||Special Survey on PD Patients With Renal Dysfunction|Post Marketing Surveillance of BI-Sifrol® (Pramipexole). Special Survey on Patients With Parkinson's Disease and Renal Dysfunction|Completed||N/A|107|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:45:32.651941|2017-02-18 14:45:32.651941
NCT00613743|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2010-01-12|||December 2007||2007-12-01|January 2008|2008-01-01|December 2008|Actual|2008-12-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Topical Morphine (Mouthwash) on Oral Pain Due to Chemo- and/or Radiotherapy Induced Mucositis|Effect of Topical Morphine (Mouthwash) on Oral Pain Due to Chemo- and/or Radiotherapy Induced Mucositis|Completed||N/A|30|Anticipated|University Hospital, Geneva||2|||f||||t||||||||||2017-02-18 14:45:33.036016|2017-02-18 14:45:33.036016
NCT00613730|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-11-15|2010-08-06||January 2007||2007-01-01|November 2013|2013-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|APPRISE 1||Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint|Phase II, Multi-center, Open-label, Single-Arm Study Using Gemcitabine and Panitumumab in the First-line Treatment of Subjects With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas|Terminated||Phase 2|3|Actual|Amgen||1||"APPRISE closure prompted by SWOG S0205 not meeting primary endpoint-improving OS. APPRISE~   enrollment closure due to similar design;no unexpected safety data"|f||||||||||||||2017-02-18 14:45:33.15148|2017-02-18 14:45:33.15148
NCT00613717|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2014-10-28|||November 2009||2009-11-01|March 2014|2014-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Healthy Infant Development Project|Timing, Duration and Severity of Infant Iron Deficiency: Developmental Impacts|Completed||N/A|2371|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||4|||f||||t||||||||||2017-02-18 14:45:33.457227|2017-02-18 14:45:33.457227
NCT00613691|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-10-17|||January 2008||2008-01-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|||A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma|A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma|Completed||Phase 1|36|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-02-18 14:45:33.571021|2017-02-18 14:45:33.571021
NCT00613678|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-08-03|||July 2006||2006-07-01|August 2015|2015-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Exercise Plus Activity Strategy Training for Osteoarthritis|Exercise Plus Activity Strategy Training for Older Adults With Osteoarthritis|Completed||N/A|54|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 14:45:33.672854|2017-02-18 14:45:33.672854
NCT00613665|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-06-10|||February 2001||2001-02-01|June 2013|2013-06-01|April 2002|Actual|2002-04-01|December 2001|Actual|2001-12-01||Interventional|||Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults|Phase I, Randomized, Controlled, Single-blind, Dose-Ranging and Schedule-Finding Study of the Safety, Tolerability, and Immunogenicity of Chiron Helicobacter Pylori Vaccine in Healthy, Helicobacter Pylori-negative Adults|Completed||Phase 1|113|Actual|Novartis||7|||f||||||||||||||2017-02-18 14:45:33.778608|2017-02-18 14:45:33.778608
NCT00613652|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-07-20|||January 2008||2008-01-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients|A Phase I, Open-Label, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 Administered Weekly in Japanese Adult Patients With Advanced Solid Malignancies|Completed||Phase 1|30|Anticipated|AstraZeneca||1|||f||||t||||||||||2017-02-18 14:45:33.893721|2017-02-18 14:45:33.893721
NCT00613626|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-10-19|2015-08-31||January 2008||2008-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Subjects 18 years of age or older at time of consent, ECOG Performance Status of 0-1 14 days prior to registration, and histological or cytological proof of chemotherapy naive extensive small cell cancers or neuroendocrine cancers that are high grade or poorly differentiated.|Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer|A Randomized Double Blind Phase II Trial of Cisplatin Plus Etoposide With/Without Concurrent ZD6474 in Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer: Hoosier Oncology Group LUN06-113|Completed||Phase 2|74|Actual|Hoosier Cancer Research Network|The primary object analysis was under powered. The sample size calculation determined 34 subjects per arm, however the actual primary objective analysis was based on 31 subjects per arm.|3|||f||||t||||||||||2017-02-18 14:45:33.98551|2017-02-18 14:45:33.98551
NCT00613613|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-12-01|||January 2008||2008-01-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|FPI||Fenofibrate and Pharmacogenetic Impact in Dyslipidemia|The Impact of Genetic Determinants of Fenofibrate's Pharmacogenetics on Lipid Response|Completed||Phase 4|56|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 14:45:35.229323|2017-02-18 14:45:35.229323
NCT00613600|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-12-01|||February 2008||2008-02-01|December 2011|2011-12-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Effectiveness Study of a Fiber Supplement for Weight Loss|Safety and Efficacy of Glucomannan for Weight Loss|Completed||Phase 2|50|Anticipated|Rush University Medical Center||2|||f||||t||||||||||2017-02-18 14:45:35.342441|2017-02-18 14:45:35.342441
NCT00613587|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2012-10-08|||August 2007||2007-08-01|September 2012|2012-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Roflumilast In-Vitro Basophil Release|Effect of Roflumilast In-Vitro on Basophil Histamine, Leukotriene, IL-4 and IL13-release.|Completed||N/A|15|Actual|Creighton University|||1||f||||f||||||Samples Without DNA|"~     Polymorphal Blood Mononuclar Cells will be stimulated to release various cytokines. The~     supernatant of the stimulations will be stored for batched analysis.~   "|||2017-02-18 14:45:35.658729|2017-02-18 14:45:35.658729
NCT00613574|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-03-12|2009-10-29|||||March 2014|2014-03-01|October 2007||2007-10-01|||||Observational|||RUSSE / Russian Spiriva® Safety & Efficacy Study|RUSSE / Russian Spiriva® Safety & Efficacy Study|Completed||Phase 4|407|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:45:35.756369|2017-02-18 14:45:35.756369
NCT00613561|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-05-26|||December 2007||2007-12-01|May 2009|2009-05-01|December 2017|Anticipated|2017-12-01|December 2012|Anticipated|2012-12-01||Interventional|SIDS||Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases|Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases|Recruiting||Phase 2|25|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-02-18 14:45:36.088422|2017-02-18 14:45:36.088422
NCT00613548|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-11-10|||February 2008||2008-02-01|November 2008|2008-11-01|June 2015|Anticipated|2015-06-01|June 2010|Anticipated|2010-06-01||Interventional|MoMIC||Moderate Mitral Regurgitation in CABG Patients|Moderate Mitral Regurgitation in CABG Patients|Unknown status|Recruiting|N/A|550|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:45:36.199079|2017-02-18 14:45:36.199079
NCT00613535|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-05-18|||April 2008||2008-04-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|MILE||Knee Articular Cartilage Debridement in Conjunction With Partial Meniscectomy|Magnetic Resonance Imaging and Clinical Outcomes After Three Different Treatments for Articular Cartilage Lesions Concomitant With Partial Meniscectomy|Terminated||Phase 4|165|Actual|Smith & Nephew, Inc.||3||"The correlation coefficient at the interim analysis with results for all three groups pooled,~   did not reach the level of statistical significance of (p<0.05)."|f||||f||||||||||2017-02-18 14:45:36.313366|2017-02-18 14:45:36.313366
NCT00613522|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-03-04|||November 2007||2007-11-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|AVSAS||Role of Obstructive Sleep Apnea in Stroke Appearance|Role of Nocturnal Respiratory Disorders on Ischemic Stroke Occurrence|Completed||N/A|289|Actual|University Hospital, Bordeaux|||2||f||||f||||||||||2017-02-18 14:45:36.443105|2017-02-18 14:45:36.443105
NCT00613509|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-04-12|2010-09-14||June 2008||2008-06-01|April 2016|2016-04-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma|Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma|Terminated||Phase 2|23|Actual|Sanofi||2||"No safety concerns, the study was terminated due to slow enrollment. All enrolled patients~   were followed per protocol."|f||||t||||||||||2017-02-18 14:45:36.562339|2017-02-18 14:45:36.562339
NCT00613496|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-05-28|||May 2009||2009-05-01|May 2009|2009-05-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|CREATIVE-AF||Irbesartan and Adhesion Molecules in AF|Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients With Persistent Atrial Fibrillation|Unknown status|Recruiting|Phase 4|60|Anticipated|University of Magdeburg||2|||f||||t||||||||||2017-02-18 14:45:37.411068|2017-02-18 14:45:37.411068
NCT00613470|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2013-12-16|||March 2005||2005-03-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|PGRN-SSRI||Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram|Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram|Completed||Phase 1|927|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:45:37.542764|2017-02-18 14:45:37.542764
NCT00613457|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2015-01-13|||September 2000||2000-09-01|January 2015|2015-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|AIEOP LLA 2000||Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia|AIEOP LLA 2000 Multicenter Study for the Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia|Completed||Phase 3|2039|Actual|Associazione Italiana Ematologia Oncologia Pediatrica||7|||f||||t||||||||||2017-02-18 14:45:37.638795|2017-02-18 14:45:37.638795
NCT00613444|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-04-30|||February 2008||2008-02-01|April 2015|2015-04-01|March 2010|Actual|2010-03-01|February 2008|Actual|2008-02-01||Interventional|||Photodynamic Therapy in the Treatment of Acne|Photodynamic Therapy in the Treatment of Acne Vulgaris Using Non-Coherent Red Light (Derm 590)|Withdrawn||N/A|0|Actual|University of Michigan||1||Study was never started due to logistical issues.|f||||f||||||||||2017-02-18 14:45:37.767138|2017-02-18 14:45:37.767138
NCT00613431|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-12-19|||January 2008||2008-01-01|December 2008|2008-12-01||||August 2008|Actual|2008-08-01||Interventional|||Effects of CS-8080 in Healthy Volunteers|A Randomized, Placebo-Controlled, Single Ascending Dose Study To Assess The Safety, Tolerability and Pharmacokinetics Of CS-8080 In Healthy Volunteers|Completed||Phase 1|72|Anticipated|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 14:45:37.860275|2017-02-18 14:45:37.860275
NCT00613418|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2012-09-27||||||September 2012|2012-09-01||||||||Interventional|I-WIN||Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac Artery|Comparative Study of Safety and Efficacy of the SUPERA® Wire Interwoven Self-expanding Nitinol Stent and Currently Approved Stents for Patients With Iliac Lesions|Withdrawn||Phase 2/Phase 3|0|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 14:45:37.946907|2017-02-18 14:45:37.946907
NCT00613405|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-11|2013-04-23|2011-06-15||January 2008||2008-01-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Stress and Marijuana Cue-elicited Craving and Reactivity|Stress and Marijuana Cue-elicited Craving and Reactivity|Completed||N/A|87|Actual|Medical University of South Carolina|A control group of non-marijuana dependent individuals was not included, which may have provided further insight into the interactions of stress and cues both in the presence and absence of addiction.|2|||f||||f||||||||||2017-02-18 14:45:38.022881|2017-02-18 14:45:38.022881
NCT00613392|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2016-01-25|||November 2007||2007-11-01|October 2010|2010-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Antioxidant Supplementation in Trauma Patients|Antioxidant Supplementation in Trauma Patients|Terminated||Phase 3|18|Actual|Boston Medical Center||2||Supplement expired and unable to obtain more from company manufacturing|f||||f||||||||||2017-02-18 14:45:38.370539|2017-02-18 14:45:38.370539
NCT00613379|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2016-06-16|2013-04-12||December 2007||2007-12-01|June 2016|2016-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||PRO 140 by IV Administration in Adults With HIV-1 Infection|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of PRO 140 by Intravenous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection|Completed||Phase 2|30|Actual|CytoDyn, Inc.||3|||f||||f||||||||||2017-02-18 14:45:38.46318|2017-02-18 14:45:38.46318
NCT00613366|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-02-04|2012-06-01||June 2007||2007-06-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Misoprostol With Intrauterine Device Insertion|Effect of Prophylactic Misoprostol Prior to Intrauterine Device Insertion|Completed||N/A|40|Actual|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:45:39.25794|2017-02-18 14:45:39.25794
NCT00613353|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2008-11-12|||January 2008||2008-01-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Sedentary Behavior in Overweight Women|Sedentary Behavior in Overweight Women|Completed||N/A|38|Anticipated|University of Mississippi Medical Center|||1||f||||t||||||||||2017-02-18 14:45:39.646293|2017-02-18 14:45:39.646293
NCT00613340|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-08-05|||January 2008||2008-01-01|August 2009|2009-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||The Specificity of Cervical Facet Medial Branch Blocks|Randomized Study Comparing the Accuracy and Specificity of Cervical Facet Medial Branch Blocks With 0.25 ml and 0.5 ml of Local Anesthetic|Completed||N/A|20|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 14:45:39.738734|2017-02-18 14:45:39.738734
NCT00613327|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-10-24|2013-07-09||September 2007||2007-09-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional||Intent-to-treat (ITT) population included all participants who received study drug at least once and had data for efficacy evaluation (goal achievement in treatment) available.|An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants|The Efficacy of Oxybutynin Chloride OROS in Patient-Reported Outcomes With Dose Escalation in Korean Overactive Bladder Patients|Completed||Phase 4|345|Actual|Janssen Korea, Ltd., Korea||1|||f||||f||||||||||2017-02-18 14:45:39.859629|2017-02-18 14:45:39.859629
NCT00613314|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-04-30|2010-02-08||June 2007||2007-06-01|April 2014|2014-04-01||||April 2008|Actual|2008-04-01||Observational||The figure was based on the ITT (intention to treat) population which was reported in the PMS report. The total ITT population is 14, 161.|Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen|Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen (CENTER)|Completed||N/A|15268|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:45:40.48875|2017-02-18 14:45:40.48875
NCT00613301|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-05-28|2010-09-08||February 2004||2004-02-01|May 2014|2014-05-01||||September 2009|Actual|2009-09-01||Observational||Data Set for Safety Analysis|Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa|Pramipexole Special Survey on Patients Without Concomitant Use of L-Dopa|Completed||N/A|416|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 14:45:40.85631|2017-02-18 14:45:40.85631
NCT00613288|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-10-21|||September 2007||2007-09-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism|Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism|Completed||N/A|12|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-02-18 14:45:41.465558|2017-02-18 14:45:41.465558
NCT00613262|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-04-06|||April 2012||2012-04-01|February 2009|2009-02-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|NBI||A Prospective, Single Blinded Study for Predicting Colon Polyp Histology With Narrow Band Imaging|A Prospective, Single Blinded Study for Predicting Colon Polyp Histology With Narrow Band Imaging|Unknown status|Recruiting|N/A|200|Anticipated|Midwest Biomedical Research Foundation||1|||f||||t||||||||||2017-02-18 14:45:41.688388|2017-02-18 14:45:41.688388
NCT00613249|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2009-03-26|||November 2007||2007-11-01|March 2009|2009-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels|A Double-Blind, Randomized, Placebo-Controlled Phase I Study to Compare the Pharmacokinetics of Intravaginal Dapivirine Gel 4750, 0.05%, 2.5g and Dapivirine Gel 4789, 0.05%, 2.5g Formulations and to Assess the Safety as Compared to the Intravaginal HEC-Based Universal Placebo Gel, 2.5g in Healthy HIV-Negative Women.|Completed||Phase 1|36|Actual|International Partnership for Microbicides, Inc.||3|||f||||f||||||||||2017-02-18 14:45:41.781348|2017-02-18 14:45:41.781348
NCT00613223|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-02-19|||February 2008||2008-02-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|October 2010|Actual|2010-10-01||Interventional|||Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas|Phase I Dose Escalation of Vandetanib (Zactima, ZD6474) in Combination With Etoposide for Malignant Gliomas|Completed||Phase 1|49|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:45:41.893776|2017-02-18 14:45:41.893776
NCT00613210|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-02-11|||January 2008||2008-01-01|January 2008|2008-01-01||||June 2008|Anticipated|2008-06-01||Observational|||Sonographic Prediction of Preterm Delivery Between 24-34 Weeks of Gestation|Sonographic Prediction of Preterm Delivery Between 24-34 Weeks of Gestation|Unknown status|Active, not recruiting|N/A|150|Anticipated|Soroka University Medical Center|||3||f||||||||||None Retained|"~     sonographic measurments~   "|||2017-02-18 14:45:42.026954|2017-02-18 14:45:42.026954
NCT00613197|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-04-03|||January 2003||2003-01-01|April 2013|2013-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|EPIC-1||EPANOVA in Crohn's Disease, Study 1|A One Year, Multi-center, Randomised, Double-blind Placebo-controlled Parallel-groups Assessment of the Tolerability, Safety and Efficacy of Epanova Soft Gelatin Capsules 4g/Day for Maintenance of Remission of Crohn's Disease.|Completed||Phase 3|384|Actual|Tillotts Pharma AG||2|||f||||t||||||||||2017-02-18 14:45:42.116754|2017-02-18 14:45:42.116754
NCT00613184|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2008-02-11|||November 2006||2006-11-01|January 2008|2008-01-01|January 2008|Anticipated|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses|Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses|Unknown status|Active, not recruiting|N/A|150|Anticipated|Kern Medical Center||4|||f||||f||||||||||2017-02-18 14:45:42.221783|2017-02-18 14:45:42.221783
NCT00613171|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2014-07-08|||January 2008||2008-01-01|July 2014|2014-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Patients With Systemic Sclerosis|A Multi-centre, Open-label, Proof of Concept (PoC) Study to Evaluate the Efficacy and Tolerability of STI571 for the Treatment of Fibrosis in Patients With Systemic Sclerosis|Completed||Phase 2|27|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:45:42.331749|2017-02-18 14:45:42.331749
NCT00613158|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2016-07-28|||March 2007||2007-03-01|April 2009|2009-04-01|February 2010|Actual|2010-02-01|August 2007|Actual|2007-08-01||Observational|||Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk|Atherosclerosis Risk Refinement - a Multi-marker Approach Using Microarrays|Completed||N/A|120|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||3||f||||t||||||||||2017-02-18 14:45:42.444078|2017-02-18 14:45:42.444078
NCT00613145|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-01-31|||February 2008||2008-02-01|January 2013|2013-01-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors|A Phase I Pharmacokinetic and Safety Study of Sorafenib + Capecitabine in Advanced Solid Tumors|Completed||Phase 1|32|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 14:45:42.542515|2017-02-18 14:45:42.542515
NCT00613132|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-02-19|||May 2005||2005-05-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|August 2008|Actual|2008-08-01||Interventional|||Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG|Phase I Dose Escalation of Gleevec in Combination With RAD001 Plus Hydroxyurea for Patients With Recurrent Malignant Glioma|Completed||Phase 1|78|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:45:42.66507|2017-02-18 14:45:42.66507
NCT00613119|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-10|2017-02-14|||January 31, 2008||2008-01-31|October 5, 2016|2016-10-05||||||||Observational|||PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia|PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Neurological Disorders|Completed||N/A|108|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:45:42.79209|2017-02-18 14:45:42.79209
NCT00613106|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-04-23|2011-05-23||September 2007||2007-09-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|HZ-CA-304||Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)|Double-Blind Follow-On Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg)in Subjects Who Have Completed Participation in Horizon Protocol HZ-CA-301 (NCT00450658)or Horizon Protocol HZ-CA-303 (NCT00450216)|Completed||Phase 3|179|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||2|||f||||t||||||||||2017-02-18 14:45:42.897207|2017-02-18 14:45:42.897207
NCT00613093|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2014-07-08|||October 2002||2002-10-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|March 2006|Actual|2006-03-01||Interventional|||Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma|Phase II Trial of Temodar Plus O6-Benzylguanine (O6-BG) (NSC 637037) in the Treatment of Patients With Temodar-Resistant Malignant Glioma|Completed||Phase 2|67|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:45:43.389953|2017-02-18 14:45:43.389953
NCT00613080|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-09|2016-12-30|2013-04-12||April 2008||2008-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|January 2010|Actual|2010-01-01||Interventional||All eligible patients.|Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer|A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer|Completed||Phase 2|79|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 14:45:43.51893|2017-02-18 14:45:43.51893
NCT00613067|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2010-06-29|||December 2007||2007-12-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|N1||ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder|The Amplitude Change of the Auditory Evoked N1 Component as a Predictor of Response to Escitalopram Treatment in Patients With Generalized Anxiety Disorder|Completed||N/A|35|Anticipated|Inje University||1|||f||||f||||||||||2017-02-18 14:45:44.135959|2017-02-18 14:45:44.135959
NCT00613054|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2012-12-04|||November 2007||2007-11-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma|Phase I Study of Zactima (ZD6474) Plus Imatinib Mesylate and Hydroxyurea for Patients With Recurrent Malignant Glioma|Completed||Phase 1|27|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:45:44.244574|2017-02-18 14:45:44.244574
NCT00613041|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2016-09-26|||April 2003||2003-04-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||3-D Reconstruction of CT Scan Images in the Evaluation of Non-Specific Pulmonary Nodules|Pilot Study: 3-D Reconstruction of CT Scan Images in the Evaluation of Non-Specific Pulmonary Nodules|Active, not recruiting||N/A|19|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:45:44.357698|2017-02-18 14:45:44.357698
NCT00613028|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-07-10|2012-12-31||April 2008||2008-04-01|July 2013|2013-07-01|January 2011|Actual|2011-01-01|October 2009|Actual|2009-10-01||Interventional|||Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan|Phase II Study of Bevacizumab Plus Either Temozolomide or Etoposide for (GBM) Patients Who Have Failed Bevacizumab Plus Irinotecan|Completed||Phase 2|23|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:45:44.448936|2017-02-18 14:45:44.448936
NCT00613015|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2016-02-08|2013-05-23||May 2008||2008-05-01|February 2016|2016-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Stress and Medication Effects on Cocaine Cue Reactivity|Interdisciplinary Medication Development for Multiple Risk Factors in Relapse.|Completed||Phase 2|109|Actual|Medical University of South Carolina||6|||f||||t||||||||||2017-02-18 14:45:47.305446|2017-02-18 14:45:47.305446
NCT00613002|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2013-01-04||2013-01-04|December 2006||2006-12-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|BLOOM||Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women|A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of the Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women|Completed||Phase 3|597|Actual|BioSante Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:45:48.019373|2017-02-18 14:45:48.019373
NCT00612989|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2014-07-15|||February 2005||2005-02-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|August 2007|Actual|2007-08-01||Interventional|||Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM|Phase I Trial of a 5-day Regimen of Temodar Plus O6-Benzylguanine (O6-BG) in the Treatment of Patients With Recurrent / Progressive Glioblastoma Multiforme|Completed||Phase 1|42|Anticipated|Duke University||3|||f||||t||||||||||2017-02-18 14:45:48.204992|2017-02-18 14:45:48.204992
NCT00612976|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2008-02-11|||February 2006||2006-02-01|January 2008|2008-01-01||||September 2006|Actual|2006-09-01||Observational|SYMBIOSE||Symbicort in Chronic Obstruktive Pulmonary Disease|Symbicort in Chronic Obstruktive Pulmonary Disease|Completed||N/A|18014|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:45:48.547866|2017-02-18 14:45:48.547866
NCT00612963|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2010-03-04|||April 2007||2007-04-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Novel Rinse to Treat in Oral Candidiasis in Cancer Patients|"Novel Rinse to Treat Oral Candidiasis in Cancer Patients Evaluate Iocide Oral Rinse in Any Patient With Thrush, Including But Not Limited to Patients Currently Receiving or Post Radiation Therapy for Head and Neck Cancer or Patients Positive for HIV/AIDS or Transplant Patients"|Completed||N/A|23|Actual|Biomedical Development Corporation|||1||f||||f||||||||||2017-02-18 14:45:48.640056|2017-02-18 14:45:48.640056
NCT00612950|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-02-11|||October 2006||2006-10-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|February 2007|Actual|2007-02-01||Interventional|||Beta-Cell Function After Near-Normalisation of Blood Glucose|Four Weeks of Near Normalisation of Blood Glucose Improves the Insulin Response to GLP-1 and GIP in Patients With Type 2 Diabetes|Completed||N/A|8|Actual|Hvidovre University Hospital||3|||f||||f||||||||||2017-02-18 14:45:48.750801|2017-02-18 14:45:48.750801
NCT00612937|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-10|2017-01-24|||February 4, 2008||2008-02-04|June 19, 2015|2015-06-19|June 19, 2015||2015-06-19|||||Observational|||Streptococcal Infection and Respiratory Distress in Newborns|Respiratory Distress of the Newborn and Its Relationship to Group B Streptococcal Colonization|Completed||N/A|16000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:45:48.862033|2017-02-18 14:45:48.862033
NCT00612924|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-02-10|2016-02-10||April 2009||2009-04-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2013|Actual|2013-07-01||Interventional|||The Vascutek AnacondaTM Stent Graft System Phase II IDE Study|The Anaconda Endovascular Graft US FDA Phase II Clinical Study|Active, not recruiting||Phase 2|195|Actual|Terumo CVS||1|||f||||t||||||||||2017-02-18 14:45:48.957482|2017-02-18 14:45:48.957482
NCT00612911|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-01-29|||February 2005||2005-02-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Observational|||Cell Therapy in Dilated Cardiomyopathy: Observational Study|Cell Therapy in Dilated Cardiomyopathy: A Safety and Feasibility Study Using Autologous Bone Marrow Mononuclear Cells|Terminated||N/A|24|Actual|Ministry of Health, Brazil|||1|finish study as protocol|f||||f||||||||||2017-02-18 14:45:49.660615|2017-02-18 14:45:49.660615
NCT00612898|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2012-01-19|||February 2008||2008-02-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection|A Phase 2b/3, Randomized, Double Blind, Dose Confirming Study of the Safety, Efficacy and Tolerability of Apricitabine Versus Lamivudine in Treatment-experienced HIV-1 Infected Patients With the M184V/I Mutation in Reverse Transcriptase|Terminated||Phase 2/Phase 3|239|Actual|Avexa||2||Sponsor decision|f||||t||||||||||2017-02-18 14:45:49.758986|2017-02-18 14:45:49.758986
NCT00612885|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2013-10-31|||March 2004||2004-03-01|October 2013|2013-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study|Post Marketing Surveillance to Assess the Safety and Efficacy of Mobic® (Meloxicam) Intramuscular Injection (7.5mg ~ 15mg, q.d.) up to 3 Days (in Case of Need for Prolonged Treatment, Switch to Mobic® Capsule Therapy Was Possible) in Korean Patients With Osteoarthritis and Rheumatoid Arthritis (KFDA Regulatory Requirement PMS)|Completed||Phase 4|425|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:45:50.183906|2017-02-18 14:45:50.183906
NCT00612872|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2010-09-20|||January 2008||2008-01-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|CLINDE||Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects|Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects|Terminated||Phase 1|46|Actual|Institute for Neurodegenerative Disorders||1||Results did not show reason to continue with study.|f||||f||||||||||2017-02-18 14:45:50.277631|2017-02-18 14:45:50.277631
NCT00612859|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-11-25|||September 2003||2003-09-01|September 2009|2009-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)|A Multicenter, Randomized, Double-Blind, PBO-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Levetiracetam Versus PBO for the Treatment of Social Anxiety Disorder (Generalized Type)|Completed||Phase 2|217|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 14:45:50.390479|2017-02-18 14:45:50.390479
NCT00612846|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2008-01-29|||March 2000||2000-03-01|January 2008|2008-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study Investigating the Best Method of Treatment of Bile Duct Stones in Higher Risk Patients|A Randomised Clinical Trial to Compare Endoscopic Sphincterotomy and Subsequent Laparoscopic Cholecystectomy With Primary Laparoscopic Bile Duct Exploration During Cholecystectomy in Higher Risk Patients With Choledocholithiasis|Terminated||N/A|91|Actual|North Bristol NHS Trust||2||Terminated early due to slow recruitment|f||||t||||||||||2017-02-18 14:45:50.47144|2017-02-18 14:45:50.47144
NCT00612833|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-09-09|||January 2009||2009-01-01|September 2013|2013-09-01||||||||Interventional|||A Randomized Controlled Trial of Three Vasectomy Techniques|A Randomized Controlled Trial of Three Vasectomy Techniques|Terminated||N/A|||FHI 360||3||FHI 360 participation in the study was terminated due to lack of funding|f||||t||||||||||2017-02-18 14:45:50.562136|2017-02-18 14:45:50.562136
NCT00612820|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2016-11-02||2010-10-13|January 2008||2008-01-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)|An 8 Day, Randomised, Double Blind, 3-way Crossover Trial of Repeat Doses of Intranasal GSK256066 and Fluticasone Propionate in the Vienna Challenge Chamber in Subjects With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 2|55|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:45:50.674988|2017-02-18 14:45:50.674988
NCT00612807|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-06-17|2011-02-16||July 2006||2006-07-01|March 2011|2011-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Treatment of Mood and Marriage Study (TOMMS)|Adapting Marital Therapy in Older Adults With Depression|Completed||Phase 1/Phase 2|42|Actual|Duke University|Small sample size limits power to detect differences. Some participants reported difficulty understanding how to complete the questions, which may introduce additional variability into the data.|2|||f||||t||||||||||2017-02-18 14:45:50.793104|2017-02-18 14:45:50.793104
NCT00612794|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-02-23|||September 2007||2007-09-01|January 2015|2015-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes|Multiple-Dose Study to Examine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY2148568 Long-Acting Release in Japanese Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|30|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 14:45:51.253533|2017-02-18 14:45:51.253533
NCT00612781|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2008-01-29|||December 2005||2005-12-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|February 2007|Actual|2007-02-01||Interventional|YeWhi||Yellow Versus White Study|Influence of Blue-Light-Filter IOLs on Color Perception and Contrast Acuity. A Randomized, Double-Masked Study With Intraindividual Comparison.|Completed||Phase 4|24|Actual|Hospital Hietzing||2|||f||||f||||||||||2017-02-18 14:45:51.356005|2017-02-18 14:45:51.356005
NCT00612768|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2013-02-19|||January 2008||2008-01-01|May 2010|2010-05-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations|Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens: Bioequivalence of PVP Formulations|Completed||Phase 2|50|Actual|Allerderm||1|||f||||f||||||||||2017-02-18 14:45:51.461395|2017-02-18 14:45:51.461395
NCT00612755|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2008-01-29|||October 2005||2005-10-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4|Open, Randomized, Multicenter Phase IV Study to Evaluate Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Patients Genotype 1 and/or 4|Completed||Phase 4|43|Actual|Hospital Clinico Universitario San Cecilio||2|||f||||f||||||||||2017-02-18 14:45:51.579915|2017-02-18 14:45:51.579915
NCT00612742|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2013-01-04|||January 2008||2008-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|BLOOM||Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Long-Term Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women|Completed||Phase 3|3656|Actual|BioSante Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:45:51.726457|2017-02-18 14:45:51.726457
NCT00612729|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2010-08-16|||May 2008||2008-05-01|December 2008|2008-12-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Light Filters in Intraocular Lenses (IOLs) and Its Influence on Colour and Contrast Vision.|Influence of Light-filters in IOLs on Color Perception and Contrast Acuity. A Randomized, Double-masked Study With Intraindividual Comparison.|Completed||Phase 4|32|Actual|Hospital Hietzing||1|||f||||f||||||||||2017-02-18 14:45:51.989322|2017-02-18 14:45:51.989322
NCT00612716|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-09|2016-08-15|||October 1999||1999-10-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia|Unrelated or Partially Matched Allogeneic Donor Stem Cells for Lymphoma, Myeloma, and Chronic Lymphocytic Leukemia|Recruiting||Phase 2|15|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:45:52.083314|2017-02-18 14:45:52.083314
NCT00612703|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2012-07-20|||February 2008||2008-02-01|July 2012|2012-07-01||||September 2010|Actual|2010-09-01||Interventional|||A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors|A Phase 1 Dose Escalation Study of ARQ 197 Administered in Combination With Erlotinib in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|32|Actual|ArQule||1|||f||||f||||||||||2017-02-18 14:45:52.447725|2017-02-18 14:45:52.447725
NCT00612690|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-05-15|2013-08-16||June 2005||2005-06-01|May 2014|2014-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||Total number of students, teachers, parents, and service providers (in the Links to Learn condition only) who were consented to participate in the study (Note: Service providers in the Services as Usual condition were not research participants).|School-Based Mental Health Services for Urban Children|Mental Health Services & Predictors of Learning in Urban Schools|Completed||N/A|482|Actual|University of Illinois at Chicago|This study was conducted in high poverty urban communities and therefore there were many impediments to recruitment and retention such as school closings and family migration.|2|||f||||f||||||||||2017-02-18 14:45:52.552864|2017-02-18 14:45:52.552864
NCT00612677|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-12-13|2011-02-21||June 2007||2007-06-01|December 2013|2013-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem|Phase II Combination of Pemetrexed and Oxaliplatin in Patients With Recurrent Non-Small Cell Lung Cancer After Failure to Platinum Based Adjuvant Chemotherapy|Terminated||Phase 2|1|Actual|H. Lee Moffitt Cancer Center and Research Institute|Terminated due to slow accrual. Study closed before treatment started.|1||slow accrual - the 1 patient accrued did not go on treatment|f||||f||||||||||2017-02-18 14:45:53.197635|2017-02-18 14:45:53.197635
NCT00612664|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-09-23||2011-06-21|March 2008||2008-03-01|September 2015|2015-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase II, 2nd Line Melanoma - RAND Monotherapy|A Randomized, Multi-Dose, Open-Label, Phase II Study of BMS-663513 as a Second-Line Monotherapy in Subjects With Previously Treated Unresectable Stage III or IV Melanoma|Completed||Phase 2|158|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 14:45:53.448952|2017-02-18 14:45:53.448952
NCT00612651|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-02-15|||October 2005||2005-10-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|January 2009|Actual|2009-01-01||Interventional|||PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas|A Phase I Trial of the Addition of the Farnesyl Transferase Inhibitor, SCH 66336, to Temodar for Patients With Grade 3 and 4 Malignant Gliomas|Completed||Phase 1|37|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:45:53.591123|2017-02-18 14:45:53.591123
NCT00612638|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-06-18|||January 2005||2005-01-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|January 2007|Actual|2007-01-01||Interventional|||Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas|Phase I Trail of Temodar Plus O6-Benzylguanine (O6-BG) (NSC 637037) Plus Irinotecan (CPT-11) (NSC 616348) in the Treatment of Patients With Recurrent / Progressive Cerebral Anaplastic Gliomas|Completed||Phase 1|96|Anticipated|Duke University||2|||f||||t||||||||||2017-02-18 14:45:53.71172|2017-02-18 14:45:53.71172
NCT00612625|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-02-11|||February 2004||2004-02-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|July 2004|Actual|2004-07-01||Interventional|||Near Normalisation of BG Improves the Potentiating Effect of GLP-1|Near Normalisation of Blood Glucose Improves the Potentiating Effect of GLP-1 on Glucose Induced Insulin Secretion in Patients With Type 2 Diabetes|Completed||N/A|9|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 14:45:53.832512|2017-02-18 14:45:53.832512
NCT00612612|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2013-09-27|||January 2008||2008-01-01|September 2013|2013-09-01||||July 2013|Actual|2013-07-01||Interventional|||Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia|A Phase 1 Study of Obatoclax Mesylate (GX15-070MS) in Combination With Fludarabine-Based Chemoimmunotherapy in Previously Treated Patients With B-Cell Chronic Lymphocytic Leukemia (B-CLL)|Terminated||Phase 1|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:45:53.932703|2017-02-18 14:45:53.932703
NCT00612599|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2017-01-05|||September 2003||2003-09-01|January 2017|2017-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes|Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Non-obese and Obese With Type 2 Diabetes Mellitus|Completed||Phase 3|75|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:45:54.049975|2017-02-18 14:45:54.049975
NCT00612586|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2012-02-17||2010-10-25|February 2008||2008-02-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|January 2010|Actual|2010-01-01||Interventional|||Phase 2 Study of Enzastaurin With 5 FU/LV Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer|A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of Enzastaurin With 5 FU/LV Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colorectal Cancer.|Completed||Phase 2|150|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 14:45:54.159234|2017-02-18 14:45:54.159234
NCT00612573|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-04-15|2011-02-14||February 2008||2008-02-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Treatment of Moderate to Severe Facial Acne Vulgaris|Phase 2 Study Randomized, Double-blind Study to Evaluate the Safety and Efficacy of 3 Doses of Doxycycline as Compared to Placebo in the Treatment of Moderate to Severe Facial Acne Vulgaris|Completed||Phase 2|257|Actual|Warner Chilcott||4|||f||||f||||||||||2017-02-18 14:45:54.309986|2017-02-18 14:45:54.309986
NCT00612560|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2014-05-07|||November 2007||2007-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|January 2011|Actual|2011-01-01||Interventional|FABrC||Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics|Flaxseed vs. Aromatase Inhibitors: Breast Tumor Characteristics and Prognosis|Completed||Early Phase 1|28|Actual|Roswell Park Cancer Institute||4|||f||||t||||||||||2017-02-18 14:45:55.014614|2017-02-18 14:45:55.014614
NCT00612547|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2009-02-25|||February 2008||2008-02-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||ACT for the Home Management in Malagasy Children|Assessment of the Use of Fixed Doses of Artesunate Plus Amodiaquine Combination for the Home Management of Presumed Malaria in Malagasy Children|Completed||N/A|1200|Actual|National Malaria Control Programme, Madagascar|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 14:45:55.128097|2017-02-18 14:45:55.128097
NCT00612534|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2014-01-22|2013-10-18||March 2008||2008-03-01|January 2014|2014-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|ARX-F01||A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement|A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement|Completed||Phase 2|94|Actual|AcelRx Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 14:45:55.237664|2017-02-18 14:45:55.237664
NCT00612521|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-08-28|||August 2007||2007-08-01|August 2012|2012-08-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis|Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis|Terminated||Phase 3|200|Actual|Ottawa Heart Institute Research Corporation||2||"At half the sample size, the results were negative with no benefit demonstrated with~   adenosine."|f||||f||||||||||2017-02-18 14:45:55.856426|2017-02-18 14:45:55.856426
NCT00612508|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2012-10-09|2010-12-16||May 2007||2007-05-01|October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Hormonal Contraception and Vaginal Health|The Effects of Oral vs. Intravaginal Hormonal Contraception on Vaginal Health|Completed||N/A|14|Actual|Oregon Health and Science University|Did not fully recruit; small number of subject|2|||f||||f||||||||||2017-02-18 14:45:55.964193|2017-02-18 14:45:55.964193
NCT00612495|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-02-08|||January 2001||2001-01-01|January 2008|2008-01-01|March 2005|Actual|2005-03-01|||||Interventional|||Endometrial Cancer - LOHP Alone and With 5FU|Parallel Randomised Open Phase II Study of Oxaliplatin (L-OHP) Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Locally Advanced or Metastatic Endometrial Cancer Previously Treated With Cisplatin or Arboplatin|Completed||Phase 2|31|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:45:56.577151|2017-02-18 14:45:56.577151
NCT00612482|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2011-03-11|||December 2006||2006-12-01|March 2011|2011-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education|Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education: A High School Pilot Study|Completed||Phase 1|225|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 14:45:56.66744|2017-02-18 14:45:56.66744
NCT00612469|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2008-01-29|||October 2005||2005-10-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|July 2006|Actual|2006-07-01||Interventional|||The Use of Antimicrobial Agents in the Inhibition of Mutans Streptococci in Children With Dental Caries|Sodium Fluoride, Chlorhexidine and Vancomycin Effect in the Inhibition of Mutans Streptococci in Children With Dental Caries: a Randomized, Double-Blind Clinical Trial|Completed||N/A|69|Actual|Universidade Federal do Ceara||4|||f||||f||||||||||2017-02-18 14:45:56.777739|2017-02-18 14:45:56.777739
NCT00612456|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-02-28||2010-02-05|March 2008||2008-03-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD|A Double-masked, Randomized, Parallel-group Study to Investigate the Pharmacodynamics, Safety, and Systemic Pharmacokinetics of Pazopanib Drops, Administered for 28 Days to Adult Subjects With Neovascular Age-related Macular Degeneration.|Completed||Phase 2|70|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 14:45:56.892259|2017-02-18 14:45:56.892259
NCT00612443|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2009-01-20|||January 2008||2008-01-01|January 2008|2008-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy|Healing Touch and Health-Related Quality of Life in Women With Breast Cancer in Women With Breast Cancer Receiving Radiation Therapy|Completed||Phase 2/Phase 3|40|Actual|University of Wisconsin, Milwaukee||2|||f||||f||||||||||2017-02-18 14:45:57.02274|2017-02-18 14:45:57.02274
NCT00612430|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-07-30|2013-05-28||March 2007||2007-03-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2008|Actual|2008-09-01||Interventional|||Ph II Bevacizumab + Etoposide for Pts w Recurrent MG|Phase II Trial of Bevacizumab Plus Etoposide for Patients With Recurrent Malignant Glioma|Completed||Phase 2|59|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:45:57.139892|2017-02-18 14:45:57.139892
NCT00612417|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2014-04-04|||January 2008||2008-01-01|April 2014|2014-04-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402|A Randomised, Double-blind and Placebo-controlled Study Investigating the Pharmacodynamic Effects of Administration of Recombinant Human Factor VIII in Healthy Male Subjects Treated With the Monoclonal Anti-factor VIII Antibody, TB-402|Completed||Phase 1|12|Actual|ThromboGenics||2|||f||||f||||||||||2017-02-18 14:45:57.768962|2017-02-18 14:45:57.768962
NCT00612404|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-02-08|||September 2005||2005-09-01|January 2008|2008-01-01||||December 2005|Actual|2005-12-01||Observational|||Symptoms and Endoscopic Results in Consideration of Pretreatment|Symptoms and Endoscopic Results in Consideration of Pretreatment|Completed||N/A|16255|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:45:57.864872|2017-02-18 14:45:57.864872
NCT00612391|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2016-11-25|||November 2007||2007-11-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|August 2017|Anticipated|2017-08-01||Interventional|HURA||Lateral Mini Approach vs Anterior Approach for Plating of Proximal Humerus Fracture|A Randomized Clinical Trail Comparing a Lateral Minimally Invasive Approach and the Traditional Anterior Approach for Plating of Proximal Humerus Fractures|Active, not recruiting||N/A|79|Actual|Université de Montréal||2|||f||||f||||||||||2017-02-18 14:45:57.942065|2017-02-18 14:45:57.942065
NCT00612378|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2014-06-23|||September 2007||2007-09-01|June 2014|2014-06-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||A Multi-center Acute Efficacy Trial of GFX For Reduction of Glabellar Furrowing|A Multi-center Acute Efficacy Trial of GFX For Reduction of Glabellar Furrowing|Completed||N/A|94|Actual|Advanced Cosmetic Intervention||1|||f||||t||||||||||2017-02-18 14:45:58.040341|2017-02-18 14:45:58.040341
NCT00612365|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2016-07-28|||September 2007||2007-09-01|February 2009|2009-02-01|June 2013|Actual|2013-06-01|August 2012|Actual|2012-08-01||Observational|MESA ABD||Association Between Abdominal Body Composition, Inflammation, and Risk for Cardiovascular Disease (The MESA ABD Study)|Abdominal Body Composition, Inflammation, and Cardiovascular Disease|Completed||N/A|1975|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||f||||||||||2017-02-18 14:45:58.151416|2017-02-18 14:45:58.151416
NCT00612352|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2015-09-08|||March 2001||2001-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism|Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism|Completed||N/A|182|Actual|Yale University||3|||f||||t||||||||||2017-02-18 14:45:58.242985|2017-02-18 14:45:58.242985
NCT00612339|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2013-05-20|2012-08-09||August 2007||2007-08-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas|Avastin in Combination With Temozolomide for Unresectable or Multifocal Glioblastoma Multiformes and Gliosarcomas|Completed||Phase 2|41|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:45:58.3746|2017-02-18 14:45:58.3746
NCT00612326|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2015-12-16|||June 2004||2004-06-01|December 2015|2015-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging|Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging|Completed||N/A|26|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:45:58.628361|2017-02-18 14:45:58.628361
NCT00612313|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2015-12-03|2014-07-03||February 2008||2008-02-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|February 2013|Actual|2013-02-01||Interventional|||Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse|Pediatric MDD: Sequential Treatment With Fluoxetine and Relapse Prevention|Completed||N/A|144|Actual|University of Texas Southwestern Medical Center|"Primary outcomes based on data through 30 weeks.~Participants were not blinded to treatment assignment."|2|||f||||t||||||||||2017-02-18 14:45:58.723995|2017-02-18 14:45:58.723995
NCT00612300|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2010-02-16|||June 2007||2007-06-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|GTS||Gait Training for Persons With Stroke|The Lokomat Gait Orthosis Compared to Categorized Gait Training by Physical Therapists in Patients Early Post Stroke|Completed||Early Phase 1|16|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-02-18 14:45:59.396829|2017-02-18 14:45:59.396829
NCT00612287|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2009-04-06|||April 2009||2009-04-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|May 2009|Anticipated|2009-05-01||Interventional|||Sublingual Buprenorphine for Chronic Pain|Sublingual Buprenorphine for Chronic Pain in Patients at Risk for Drug Abuse|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 14:45:59.491576|2017-02-18 14:45:59.491576
NCT00612274|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2016-11-29|||October 2007||2007-10-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation|Pilot Study of Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute Graft Versus Host Disease in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation|Completed||Early Phase 1|26|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:45:59.60077|2017-02-18 14:45:59.60077
NCT00612261|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2008-01-25|||October 2006||2006-10-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion|Arteriovenous Crossing Sheathotomy Versus Intravitreal Triamcinolone Acetonide Injection for Treatment of Macular Edema Associated With Branch Retinal Vein Occlusion|Completed||N/A|40|Actual|Yonsei University||2|||f||||t||||||||||2017-02-18 14:45:59.698716|2017-02-18 14:45:59.698716
NCT00612248|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2008-01-29|||July 2005||2005-07-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||Functional Splint for Osteoarthritis of the Trapeziometacarpal Joint|Assessment of the Effectiveness of a Functional Splint for Osteoarthritis of the Trapeziometacarpal Joint on the Dominant Hand: A Randomized Controlled Study|Completed||Phase 2|40|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 14:45:59.806831|2017-02-18 14:45:59.806831
NCT00612235|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2010-03-15|||November 2007||2007-11-01|March 2010|2010-03-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Observational|||Premenstrual Dysphoric Disorder and Antiepileptic Drugs|Comparison of Different Antiepileptic Drug Monotherapies for the Occurrence of Premenstrual Dysphoric Disorder Among Women With Epilepsy|Unknown status|Recruiting|N/A|100|Anticipated|Beth Israel Deaconess Medical Center|||5||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:45:59.904264|2017-02-18 14:45:59.904264
NCT00612222|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-10-06|2012-03-13||January 2008||2008-01-01|October 2015|2015-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma|Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes and ALVAC Virus Immunization|Terminated||Phase 2|4|Actual|National Institutes of Health Clinical Center (CC)|Early termination leading to small numbers of subjects analyzed.|1||The study was terminated due to low accrual.|f||||t||||||||||2017-02-18 14:46:00.004015|2017-02-18 14:46:00.004015
NCT00612209|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2012-07-20|||April 2007||2007-04-01|July 2012|2012-07-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|ARQ 197||A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors|A Phase 1 Dose Escalation Study of ARQ 197 Given Twice Daily Continuously in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|51|Actual|ArQule||1|||f||||f||||||||||2017-02-18 14:46:00.384125|2017-02-18 14:46:00.384125
NCT00612196|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2014-04-04|||March 2007||2007-03-01|April 2014|2014-04-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers|A Randomised, Phase I, Single Dose, Placebo-Controlled, Dose Escalation Study of TB-402, A Monocloncal Antibody Directed Against FACTOR VIII, Administered Intravenously in Healthy Male Volunteers.|Completed||Phase 1|56|Actual|ThromboGenics||10|||f||||f||||||||||2017-02-18 14:46:00.482314|2017-02-18 14:46:00.482314
NCT00612183|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2010-07-21|||December 2007||2007-12-01|May 2010|2010-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma|Phase II Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma (Multicenter, Open-label Study)|Completed||Phase 2|56|Anticipated|SymBio Pharmaceuticals||1|||f||||t||||||||||2017-02-18 14:46:00.803706|2017-02-18 14:46:00.803706
NCT00612170|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2011-04-06|||December 2007||2007-12-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.|A 14-week, Randomized, Double-blind, Placebo-controlled, Multi-center Study of [S,S]-Reboxetine (PNU-165442G) Administered Once Daily (O.D.) in Patients With Fibromyalgia|Completed||Phase 3|1129|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 14:46:00.918541|2017-02-18 14:46:00.918541
NCT00612157|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2009-02-25|||January 2008||2008-01-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|June 2008|Actual|2008-06-01||Interventional|CPAPASAP||Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)|Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Effect of Eszoplicone on Initial Continuous Positive Airway Pressure (CPAP) Compliance|Completed||Phase 4|154|Anticipated|Walter Reed Army Medical Center||2|||f||||t||||||||||2017-02-18 14:46:01.179246|2017-02-18 14:46:01.179246
NCT00612144|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2013-03-26|||December 2007||2007-12-01|March 2013|2013-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM|A Multicenter, Randomized, Parallel-group, Open Study to Compare the Efficacy and Safety of Early Combination Therapy With Amaryl M to Metformin Uptitration in Type 2 DM Patients Inadequately Controlled on Metformin HCL|Completed||Phase 4|192|Anticipated|Handok Pharmaceuticals Co., Ltd.||2|||f||||f||||||||||2017-02-18 14:46:01.30974|2017-02-18 14:46:01.30974
NCT00612131|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2012-10-15|||November 2007||2007-11-01|September 2007|2007-09-01||||January 2008|Actual|2008-01-01||Observational|||Medical Residents Performance: Effect of Simulation-Based Training|Medical Residents Performance in Maximum Barrier Precautions During Central Venous Catheter Placement: Effect of Simulation-Based Training|Completed||N/A|47|Anticipated|St. Luke's-Roosevelt Hospital Center|||1||f||||f||||||||||2017-02-18 14:46:01.426212|2017-02-18 14:46:01.426212
NCT00612118|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2012-05-31||2009-07-22|February 2008||2008-02-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis|A Randomised, Double Blind, 2-way Crossover Trial of 8 Days Repeat Dosing With Intranasal GSK256066 and Azelastine Hydrochloride in the Vienna Challenge Chamber in Subjects With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 2|70|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 14:46:01.509156|2017-02-18 14:46:01.509156
NCT00612105|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2011-12-09|2011-07-08||October 2007||2007-10-01|November 2011|2011-11-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN)|A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Proof-of-Concept Study to Evaluate the Efficacy of Maximally Tolerated Doses of Retigabine vs. Placebo in Reducing the Pain Associated With Post-Herpetic Neuralgia|Completed||Phase 2|187|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 14:46:01.625596|2017-02-18 14:46:01.625596
NCT00612092|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-08-26|||May 2008||2008-05-01|August 2008|2008-08-01|February 2009|Anticipated|2009-02-01|January 2009|Anticipated|2009-01-01||Interventional|PROTECTION-III||Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A Sequential Scan Protocol|Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A Sequential Scan Protocol|Unknown status|Recruiting|Phase 4|400|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 14:46:02.67109|2017-02-18 14:46:02.67109
NCT00612079|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-09-14|||September 2007||2007-09-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of Sertindole on Sensory Gating and Cognition in Healthy Volunteers||Completed||N/A|30|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 14:46:02.775425|2017-02-18 14:46:02.775425
NCT00612066|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2016-01-19|2013-01-11||April 2007||2007-04-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)|An Open Label, Multicenter Study Evaluating the Safety and Efficacy of Short Term (6 Weeks) Rosiglitazone Treatment in Patient's With Cushing's Disease|Terminated||Phase 2|2|Actual|Jonsson Comprehensive Cancer Center|Recruitment was a major limitation. Patients were available but were not interested in the study due to possible side effects of the study drug.|1||Low accrual and funding term ended|f||||t||||||||||2017-02-18 14:46:02.878571|2017-02-18 14:46:02.878571
NCT00612053|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2010-06-28|||May 2008||2008-05-01|February 2010|2010-02-01|December 2015|Anticipated|2015-12-01|December 2009|Anticipated|2009-12-01||Observational|RITMO||Italian Registry on Unprotected Left Main|Italian Registry on Treatment for Unprotected Left Main Disease (Registro Italiano Sul Trattamento Del Tronco coMune Non protettO)|Unknown status|Recruiting|N/A|1200|Anticipated|University of Turin, Italy|||1||f||||t||||||||||2017-02-18 14:46:03.142589|2017-02-18 14:46:03.142589
NCT00612040|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2015-11-27|2015-10-16||January 2008||2008-01-01|November 2015|2015-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes|A 16 Week Randomised, Open Labelled, 3-armed, Treat-to-target, Parallel Group Trial Comparing SIBA (D) Once Daily + NovoRapid®, SIBA (E) Once Daily + NovoRapid® and Insulin Glargine Once Daily + NovoRapid®, All in a Basal/Bolus Regimen in Subjects With Type 1 Diabetes|Completed||Phase 2|178|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-02-18 14:46:03.244988|2017-02-18 14:46:03.244988
NCT00612027|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2008-02-08|||January 2006||2006-01-01|January 2008|2008-01-01||||March 2006|Actual|2006-03-01||Observational|||Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions|Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions|Completed||N/A|29586|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:46:04.087172|2017-02-18 14:46:04.087172
NCT00612014|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2012-12-05||2012-12-05|October 2007||2007-10-01|December 2012|2012-12-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-ranging Study to Assess the Efficacy and Safety of TZP-101 When Administered as a 30 Minute I.V. Infusion to Subjects With Severe Gastroparesis Due to Diabetes Mellitus|Completed||Phase 2|78|Actual|Tranzyme, Inc.||6|||f||||t||||||||||2017-02-18 14:46:04.17082|2017-02-18 14:46:04.17082
NCT00612001|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2015-10-01|||May 2006||2006-05-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|January 2011|Actual|2011-01-01||Interventional|||Vaccine Therapy in Treating Patients With Malignant Glioma|Phase I Study of Glioma-Associated Antigen (GAA) Peptide-pulsed Dendritic Cell Vaccination in Malignant Glioma Patients|Completed||Phase 1|8|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:46:04.297186|2017-02-18 14:46:04.297186
NCT00611988|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-12-09|||August 2006||2006-08-01|December 2013|2013-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Self-Managed Walking Improves Function|Self-Managed Walking Improves Function in Patients With Diabetes Mellitus and Peripheral Arterial Disease|Completed||Phase 2|145|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:46:04.408433|2017-02-18 14:46:04.408433
NCT00611975|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-06-27|||October 2005||2005-10-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Antidepressants on Sex Hormone Levels and Sexual Functioning|Effect of Serotonin Reuptake Inhibitors on Gonadal Steroid Hormones|Completed||Phase 4|80|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:46:04.52148|2017-02-18 14:46:04.52148
NCT00611949|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2015-12-17|||May 2002||2002-05-01|December 2015|2015-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparison of 2 Vials of Components of a Synthetic Geranium Oil|EPT 101: New Geranium Oil Formulation for the Treatment of Neuropathy Pain|Completed||N/A|64|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-02-18 14:46:04.930486|2017-02-18 14:46:04.930486
NCT00611936|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2012-07-24|||June 2006||2006-06-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Atomoxetine Treatment in Humans|Effects of Atomoxetine Treatment in Humans|Completed||Phase 1/Phase 2|10|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:46:05.044038|2017-02-18 14:46:05.044038
NCT00611923|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-06-27|||February 2005||2005-02-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric Disorder|Androgen Hormones in PMDD|Completed||Phase 4|25|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:46:05.149878|2017-02-18 14:46:05.149878
NCT00611910|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2011-05-12|||November 2007||2007-11-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|ISAR-CABG||Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions|Prospective, Randomized Trial of Drug-eluting Stents vs. Bare Metal Stents for the Reduction of Restenosis in Bypass Grafts.|Completed||Phase 4|610|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 14:46:05.270939|2017-02-18 14:46:05.270939
NCT00611897|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2015-05-07|2013-01-10||January 2006||2006-01-01|May 2015|2015-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||N-acetylcysteine and NMDA Antagonist Interactions|N-acetylcysteine and NMDA Antagonist Interactions|Completed||Phase 1/Phase 2|16|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:46:05.407166|2017-02-18 14:46:05.407166
NCT00611884|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2015-10-16|2015-10-16||January 2008||2008-01-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes|A 16 Week Randomised, Open-labelled, Four-armed, Treat-to-target, Parallel-group Trial Comparing SIBA D Once Daily, SIBA E Once Daily, SIBA D Monday, Wednesday and Friday and Insulin Glargine Once Daily, All in Combination With Metformin in Subjects With Type 2 Diabetes Failing on OAD Treatment|Completed||Phase 2|245|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-02-18 14:46:05.886817|2017-02-18 14:46:05.886817
NCT00611871|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2016-10-31|||September 2007||2007-09-01|October 2016|2016-10-01|September 2015|Actual|2015-09-01|August 2015|Actual|2015-08-01||Interventional|||The Use of Propranolol to Block Memory Reconsolidation in PTSD|The Use of Propranolol to Block Memory Reconsolidation in Post Traumatic Stress Disorders (PTSD)|Terminated||Phase 2|12|Actual|Wayne State University||3||Low enrollment, grant term expired|f||||f||||||||No||2017-02-18 14:46:06.913298|2017-02-18 14:46:06.913298
NCT00611858|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2017-02-06|||January 2008||2008-01-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|July 2016|Actual|2016-07-01||Interventional|||Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer|Phase II Study of Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer|Terminated||Phase 2|13|Actual|Dana-Farber Cancer Institute||1||Slow accrual|f||||t||||||||||2017-02-18 14:46:07.015652|2017-02-18 14:46:07.015652
NCT00611845|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2014-06-20||||||June 2014|2014-06-01||||||||Expanded Access|||Aprotinin US Special Access Protocol|Aprotinin US Special Access Protocol: An Open Label, Non-Comparative Treatment Protocol for the Use of Aprotinin in Patients Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass Who Are at Increased Risk of Blood Loss and Transfusion|No longer available||N/A|||Bayer|||||||||f||||||||||2017-02-18 14:46:07.123062|2017-02-18 14:46:07.123062
NCT00611832|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2014-03-27|||May 2008||2008-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|December 2011|Actual|2011-12-01||Interventional|ParentMedia||Evaluation of a Video-Based Media Series to Promote Effective Parenting|Evaluation of a Video-Based Media Series to Promote Effective Parenting|Completed||N/A|318|Actual|Oregon Research Institute||3|||f||||f||||||||||2017-02-18 14:46:07.220251|2017-02-18 14:46:07.220251
NCT00611819|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2008-01-25|||November 2005||2005-11-01|January 2008|2008-01-01|December 2008|Anticipated|2008-12-01|April 2008|Anticipated|2008-04-01||Interventional|||Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV|Open, Randomized and Multicenter Phase IV Study to Compare the Efficacy and Safety of Two Different Treatments Duration 24 Versus 48 Weeks in Chronic Hepatitis C Genotypes 2 and/or 3 co-Infected HIV-HCV Patients.|Unknown status|Active, not recruiting|Phase 4|59|Actual|University of Valencia||2|||f||||f||||||||||2017-02-18 14:46:07.320312|2017-02-18 14:46:07.320312
NCT00611806|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2014-07-31|2014-07-31||December 2007||2007-12-01|July 2014|2014-07-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia|A Placebo-Controlled Trial of Folate With B12 in Schizophrenia Patients With Residual Symptoms|Completed||Phase 4|140|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:46:07.456339|2017-02-18 14:46:07.456339
NCT00611793|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2009-01-22|||October 2004||2004-10-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|||PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies|A Phase I Trial of PTK787/ZK222584 in Combination With Bevacizumab (Avastin) in Patients With Refractory and/or Advanced Malignancies|Completed||Phase 1|50|Anticipated|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 14:46:07.922773|2017-02-18 14:46:07.922773
NCT00611780|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-08-26|||January 2008||2008-01-01|August 2008|2008-08-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Interventional|PROTECTION-II||Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A 100kV Protocol|Prospective Randomized Trial On RadiaTion Dose Estimates Of CT AngIOgraphy In PatieNts Scanned With A 100kV Protocol|Unknown status|Recruiting|Phase 4|400|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 14:46:08.066117|2017-02-18 14:46:08.066117
NCT00611767|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2012-11-02|||November 2005||2005-11-01|January 2008|2008-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence|GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence|Completed||N/A|2|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:46:08.163578|2017-02-18 14:46:08.163578
NCT00610961|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2011-09-26|||October 2007||2007-10-01|September 2011|2011-09-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Observational|BK||Induction Related BK Viremia in Renal Transplant Patients|The Induction Agent Effect on BK Viremia in Renal and Pancreas Transplant Patients|Completed||Phase 4|60|Actual|University of Florida|||2||f||||f||||||||||2017-02-18 14:46:26.628978|2017-02-18 14:46:26.628978
NCT00611754|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-01-28|||May 2000||2000-05-01|January 2008|2008-01-01|February 2003|Actual|2003-02-01|||||Interventional|||Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck|Phase II Study of Oxaliplatin in Combination With 5-Fluorouracil (5-FU) in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|15|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:46:08.262903|2017-02-18 14:46:08.262903
NCT00611741|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2016-02-06|||March 2007||2007-03-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|MRS||The Effect of Plasma Osmolality on Brain Glutamate|The Role of Cortical Glutamate and GABA in Brains Osmotic Regulation: A Pilot Study in Healthy Volunteers and in Patients With Schizophrenia|Completed||Phase 1|30|Actual|Yale University||1|||f||||t||||||||||2017-02-18 14:46:08.351586|2017-02-18 14:46:08.351586
NCT00611728|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2014-07-18|||March 2008||2008-03-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Ph I SU011248 + Irinotecan in Treatment of Pts w MG|A Phase I Study of SU011248 Plus Irinotecan in the Treatment of Patients With Malignant Glioma|Completed||Phase 1|25|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:46:08.451342|2017-02-18 14:46:08.451342
NCT00611715|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-08-03|2012-03-12||November 2003||2003-11-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.|A Phase II Trial of Letrozole Plus OSI-774 (Tarceva) in Post-menopausal Women With ER and/or PR-Positive Metastatic Breast Cancer|Terminated||Phase 2|48|Actual|Vanderbilt-Ingram Cancer Center|The total number of worst-grade toxicities will not match the total number of participants, as patients can have multiple events or no events.|2||low accrual|f||||t||||||||||2017-02-18 14:46:08.566167|2017-02-18 14:46:08.566167
NCT00611702|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2015-05-13|||June 2008||2008-06-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)|Genomics of Chronic Renal Allograft Rejection|Completed||N/A|588|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"~     Blood from both kidney donor and recipient and transplant kidney biopsy samples~   "|||2017-02-18 14:46:11.584132|2017-02-18 14:46:11.584132
NCT00611689|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-01-31|||July 2004||2004-07-01|January 2013|2013-01-01|April 2011|Actual|2011-04-01|January 2008|Actual|2008-01-01||Interventional|||Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors|A Phase I Study to Determine the Safety of Imatinib in Combination With PTK787/ZK222584 in Patients With Refractory and/or Advanced Solid Tumors|Completed||Phase 1|45|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 14:46:11.688238|2017-02-18 14:46:11.688238
NCT00611676|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2008-01-25|||September 2004||2004-09-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Single-Blind Placebo Run-In Study of Venlafaxine for Activity-Limiting Osteoarthritis Pain|A Single-Blind Placebo Run-In Study of Venlafaxine for Activity-Limiting Osteoarthritis Pain|Completed||Phase 4|18|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:46:11.789303|2017-02-18 14:46:11.789303
NCT00611663|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-07-05|||May 2008||2008-05-01|December 2015|2015-12-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Interventional|VACCILUP||Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus|"VACCILUP A Multicenter, Randomized Double-blind Trial Comparing Two Pneumococcal Vaccination Strategies in Patients With Systemic Lupus Erythematosus"|Completed||Phase 2/Phase 3|47|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:46:11.884497|2017-02-18 14:46:11.884497
NCT00611650|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-08|2012-03-07|||October 2006||2006-10-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia|Phase II Trial of Polyphenon E in Current and Former Smokers With Bronchial Dysplasia|Terminated||Phase 2|23|Actual|British Columbia Cancer Agency||2||Slow recruitment|f||||t||||||||||2017-02-18 14:46:11.993759|2017-02-18 14:46:11.993759
NCT00611637|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2012-11-08|||August 2005||2005-08-01|November 2012|2012-11-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|CMV-BMT||CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease|A Pilot Clinical Trial of CMV pp65 Specific T Cell Adoptive Immunotherapy in Patients Who Have Undergone Allogeneic Stem Cell Transplantation for Malignant Disease|Terminated||Phase 1|2|Actual|Duke University||1||low accrual|f||||f||||||||||2017-02-18 14:46:12.10401|2017-02-18 14:46:12.10401
NCT00611624|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2014-04-05|||May 2006||2006-05-01|April 2014|2014-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|Mammosite||Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma|A Phase II Trial of Mammosite Breast Brachytherapy Optimization in the Treatment of Stage 0, I and II Breast Carcinoma|Completed||Phase 2|40|Actual|Yale University||1|||f||||t||||||||||2017-02-18 14:46:12.216093|2017-02-18 14:46:12.216093
NCT00611611|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2011-04-27|||October 2007||2007-10-01|April 2011|2011-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||BLYS and IFN in SLE|BLyS and IFN Responses to Antigen Challenge in Human SLE|Completed||N/A|39|Actual|University of Alabama at Birmingham|||2||f||||f||||||||||2017-02-18 14:46:12.331448|2017-02-18 14:46:12.331448
NCT00611598|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-10-03|||February 2003||2003-02-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||DNA Repair and Genetic Susceptibility to Lung Cancer|DNA Repair and Genetic Susceptibility to Lung Cancer|Active, not recruiting||N/A|218|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     -  30 ml. Blood in heparinized, green top tubes.~        -  Fresh tumor or normal tissue, when available.~        -  Tissue or cells from routine bronchoscopy, when available.~   "|||2017-02-18 14:46:12.420618|2017-02-18 14:46:12.420618
NCT00611585|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-02-23|||September 2006||2006-09-01|February 2016|2016-02-01|December 2026|Anticipated|2026-12-01|December 2026|Anticipated|2026-12-01||Interventional|BHR||A Safety and Efficacy Study of the Birmingham Hip Resurfacing System|Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System|Active, not recruiting||N/A|359|Actual|Smith & Nephew, Inc.||1|||f||||f||||||||||2017-02-18 14:46:12.518066|2017-02-18 14:46:12.518066
NCT00611572|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2016-02-08|||January 2007||2007-01-01|February 2016|2016-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||GABA-glutamate Interactions and Psychosis|Contribution of Gabaergic and Glutamatergic Mechanisms to Cognitive Dysfunction|Active, not recruiting||Phase 1|15|Anticipated|Yale University||2|||f||||f||||||||||2017-02-18 14:46:12.827703|2017-02-18 14:46:12.827703
NCT00611559|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2016-10-27|2009-06-22||February 2008||2008-02-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children|Immunogenicity and Reactogenicity Study of a New Formulation of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children|Completed||Phase 4|283|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:46:12.931565|2017-02-18 14:46:12.931565
NCT00611546|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-01-28|||April 2003||2003-04-01|January 2008|2008-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Perenteral Nutrition and Oxidative Stress in Preterm Infants|Study of the Oxidant-Antioxidant Effects of Parenteral Nutrition in Preterm Neonates|Completed||N/A|80|Actual|Mansoura University||2|||f||||f||||||||||2017-02-18 14:46:13.834392|2017-02-18 14:46:13.834392
NCT00611533|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2017-01-03|||May 2004||2004-05-01|December 2016|2016-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women|A Controlled Trial of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women|Completed||N/A|16|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 14:46:13.927832|2017-02-18 14:46:13.927832
NCT00611520|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2011-01-27|||September 2005||2005-09-01|January 2011|2011-01-01||||December 2005|Actual|2005-12-01||Observational|SYMBOL||Symbicort in Chronic Obstructive Pulmonary Disease|Symbicort in Chronic Obstructive Pulmonary Disease|Completed||N/A|64730|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:46:14.04414|2017-02-18 14:46:14.04414
NCT00611507|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-03-24|||November 2002||2002-11-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|||||Interventional|||A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer|A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer|Completed||Phase 2|21|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:46:14.128597|2017-02-18 14:46:14.128597
NCT00611494|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2009-02-16|||January 2008||2008-01-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|MOTOR-MPA||Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors|A Single Centre, Prospective, Open-Label, Parallel Group, Randomized Study to Compare the Gastrointestinal Tolerability of Mycophenolate Mofetil (MMF, CellCept) and Enteric-Coated Mycophenolate Sodium (EC-MPS, Myfortic) in Maintenance Transplant Patients Treated With Calcineurin Inhibitors|Unknown status|Recruiting|Phase 4|400|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 14:46:14.2225|2017-02-18 14:46:14.2225
NCT00611481|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2011-10-10|||October 2008||2008-10-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Study of Tai Chi Exercise and Balance in Persons With Parkinson's Disease|Phase II Study of Tai Chi Exercise in Relation to Balance in Persons With Parkinson's Disease|Completed||Phase 2|195|Actual|Oregon Research Institute||3|||f||||t||||||||||2017-02-18 14:46:14.336082|2017-02-18 14:46:14.336082
NCT00611468|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2011-08-18|2010-07-01||June 2006||2006-06-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors|A Phase I, Dosage-finding and Pharmacokinetic Study of Intravenous Topotecan and Oral Erlotinib in Adults With Refractory Solid Tumors|Completed||Phase 1|29|Actual|Accelerated Community Oncology Research Network||1|||f||||f||||||||||2017-02-18 14:46:14.444004|2017-02-18 14:46:14.444004
NCT00611455|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2014-05-08|2011-09-21||January 2008||2008-01-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2009|Actual|2009-07-01||Interventional|||Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy|A Double-blind, Randomized, Placebo Controlled, Parallel Group, Multi-center, Phase III Trial of Ofatumumab Investigating Clinical Efficacy in Adult Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy|Terminated||Phase 3|265|Actual|GlaxoSmithKline||2||"Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical~   development of autoimmune indications on the subcutaneous delivery."|f||||f||||||||||2017-02-18 14:46:15.257026|2017-02-18 14:46:15.257026
NCT00611442|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2012-10-03|2012-07-24||October 2007||2007-10-01|October 2012|2012-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy|Single Dose Lubiprostone Along With Split-dose PEG Solution Without Dietary Restrictions for Bowel Cleansing Prior to Colonoscopy, a Randomized, Double-blind, Placebo Controlled Trial|Completed||N/A|191|Actual|Brooke Army Medical Center|This study may be limited by the recruitment of outpatients as the only study participants. The study results might have also been affected by limiting the indication for colonoscopy to colorectal cancer screening.|2|||f||||t||||||||||2017-02-18 14:46:18.709223|2017-02-18 14:46:18.709223
NCT00611429|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2014-12-01|||May 2008||2008-05-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|May 2013|Actual|2013-05-01||Interventional|||An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV|Preparing Patients to Start Antiretroviral Therapy: A Randomized Controlled Trial|Completed||N/A|219|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:46:19.117525|2017-02-18 14:46:19.117525
NCT00611416|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2009-02-06|||November 2005||2005-11-01|February 2009|2009-02-01|February 2006|Actual|2006-02-01|||||Interventional|||The Role of Tea Catechins and Caffeine in Relation to Energy Metabolism|The Role of Tea Catechins and Caffeine in Relation to Energy Metabolism in Man|Completed||N/A|15|Actual|University of Copenhagen||5|||f||||f||||||||||2017-02-18 14:46:19.223593|2017-02-18 14:46:19.223593
NCT00611403|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2011-11-17|2011-11-17||December 2007||2007-12-01|November 2011|2011-11-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients|Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients|Completed||Phase 2|137|Actual|Allergan||2|||f||||||||||||||2017-02-18 14:46:19.335694|2017-02-18 14:46:19.335694
NCT00611390|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-06-13|||January 2008||2008-01-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Treatment of Acute Tracheitis and Laryngitis With Essential Oils of Aromatic Plants|Treatment of Acute Tracheitis and Laryngitis With Essential Oils of Some Aromatic Medical Plants.|Completed||Phase 1/Phase 2|29|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-02-18 14:46:19.724233|2017-02-18 14:46:19.724233
NCT00611377|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-01-28|||January 2007||2007-01-01|January 2008|2008-01-01|March 2008|Anticipated|2008-03-01|February 2008|Anticipated|2008-02-01||Observational|delricu||Study on the Incidence of Delirium in a Respiratory Weaning Centre|Delirium in Patients Admitted to a Respiratory Weaning Centre: Analysis of Incidence and Risk Factor|Unknown status|Recruiting|N/A|200|Anticipated|Fondazione Salvatore Maugeri|||1||f||||f||||||||||2017-02-18 14:46:19.831705|2017-02-18 14:46:19.831705
NCT00611364|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2008-10-17|||March 2004||2004-03-01|January 2008|2008-01-01|December 2005|Actual|2005-12-01|September 2004|Actual|2004-09-01||Interventional|||Physical Therapy for Hypertensive Elderly|Physical Therapy for Hipertensive Elderly: Effects in the Physical Activity and Exercise Adherence|Completed||Phase 4|30|Actual|Universidade Federal de Goias||2|||f||||t||||||||||2017-02-18 14:46:19.916828|2017-02-18 14:46:19.916828
NCT00611351|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2011-02-03|||June 2005||2005-06-01|February 2011|2011-02-01|September 2008|Actual|2008-09-01|February 2008|Actual|2008-02-01||Interventional|||Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer|Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation With a Conditioning Regimen of Targeted Busulfan, Cyclophosphamide, and Thymoglobulin|Completed||Phase 2|5|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:46:20.01397|2017-02-18 14:46:20.01397
NCT00611338|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2009-12-11|||July 2006||2006-07-01|December 2009|2009-12-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Efficacy of Group Intervention to Reduce Stress Symptoms|Efficacy of Group Intervention to Reduce Stress Symptoms|Unknown status|Recruiting|Phase 3|290|Anticipated|Stanford University||3|||f||||||||||||||2017-02-18 14:46:20.12836|2017-02-18 14:46:20.12836
NCT00611325|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2014-02-07|2013-12-18||May 2008||2008-05-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|September 2009|Actual|2009-09-01||Interventional|||Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma|Phase II Trial of Avastin Plus Bortezomib for Patients With Recurrent Malignant Glioma|Completed||Phase 2|56|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:46:20.214808|2017-02-18 14:46:20.214808
NCT00611312|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2012-10-02|||February 2008||2008-02-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Delivery Mode of Cognition Intervention in Early Alzheimer's Disease|Effects of Intense Cognitive Training on Standardized Measures of Cognition in Those With Very Mild Alzheimer's Disease|Completed||Phase 2|25|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 14:46:20.795659|2017-02-18 14:46:20.795659
NCT00611299|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-03-17|||April 2003||2003-04-01|December 2002|2002-12-01|November 2003||2003-11-01|||||Interventional|||Dose-Response Study of Probiotic Bacteria BB-12 and CRL-431 in Healthy Young Adults|Dose-Response Study of Probiotic Bacteria Bifidobacterium Animalis Subsp. Lactis BB-12 and Lactobacillus Paracasei Subsp. Paracasei CRL-341 in Healthy Young Adults|Completed||Phase 1|71||University of Copenhagen|||||f||||||||||||||2017-02-18 14:46:20.898545|2017-02-18 14:46:20.898545
NCT00611286|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-10-06|||December 2006||2006-12-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|December 2010|Actual|2010-12-01||Interventional|PRODIGY||Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention|PROlonging Dual Antiplatelet Treatment In Patients With Coronary Artery Disease After Graded Stent-induced Intimal Hyperplasia studY|Completed||Phase 4|1700|Anticipated|Università degli Studi di Ferrara||2|||f||||t||||||||||2017-02-18 14:46:20.988633|2017-02-18 14:46:20.988633
NCT00611273|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2014-06-23|||September 2007||2007-09-01|June 2014|2014-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing|A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing|Completed||Phase 4|260|Actual|Advanced Cosmetic Intervention||1|||f||||f||||||||||2017-02-18 14:46:21.117221|2017-02-18 14:46:21.117221
NCT00611260|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-03-26|||April 2007||2007-04-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Improvement in Clinical Outcomes in Heart Failure Patients With ICDs That Practice Meditation|Does Meditation Improve Outcomes in Patients With Heart Failure Who Received Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators?|Completed||N/A|27|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 14:46:21.222819|2017-02-18 14:46:21.222819
NCT00611247|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2014-07-07|2014-04-29||December 2007||2007-12-01|July 2014|2014-07-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia|Phase II Study of Two Distinct Tailored Temozolomide Regimens for Patients With Acute Myeloid Leukemia Age > 60 Years and Poor Risk/Refractory Disease|Completed||Phase 2|42|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 14:46:21.345435|2017-02-18 14:46:21.345435
NCT00611221|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2011-04-26|||January 2008||2008-01-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Massage Therapy Study: Massage Therapy and Labour Outcomes|Massage Therapy and Labour Outcomes; A Randomized Controlled Trial|Completed||Phase 3|77|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 14:46:22.022744|2017-02-18 14:46:22.022744
NCT00611208|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-11-28|||January 2008||2008-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|February 2015|Actual|2015-02-01||Interventional|||A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)|A Phase II Study of A-dmDT390-bisFv(UCHT1) Fusion Protein in Patients With Cutaneous T Cell Lymphoma|Completed||Phase 2|32|Actual|Angimmune LLC||1|||f||||t||||||||||2017-02-18 14:46:22.121872|2017-02-18 14:46:22.121872
NCT00611195|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2015-10-29|||January 2008||2008-01-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI|Impact of Remifentanil Administration on Laryngeal Reflex Responses in Pediatric Patients With Upper Respiratory Anesthetized With Propofol|Completed||Phase 4|62|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-02-18 14:46:22.237102|2017-02-18 14:46:22.237102
NCT00611182|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-11-15|||January 2008||2008-01-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Dyspnea in Patients With Pulmonary Fibrosis|Dyspnea in Patients With Pulmonary Fibrosis|Completed||N/A|60|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 14:46:22.349447|2017-02-18 14:46:22.349447
NCT00611169|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-27|2008-02-07|||January 2006||2006-01-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|February 2007|Actual|2007-02-01||Interventional|||The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction|The Effects of Facilitated Percutaeous Coronary Intervention Compared to Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Acute Myocardial Infarction|Completed||Phase 4|40|Actual|Samsung Medical Center||2|||f||||t||||||||||2017-02-18 14:46:22.445547|2017-02-18 14:46:22.445547
NCT00611156|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-02-07|||October 2006||2006-10-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Examination of the Effects of Four Different Spices on Energy Metabolism|Bioactive Food Ingredients and Energy Metabolism: The Effects of Ginger, Black Pepper, Horseradish and Mustard on Meal-Induced Thermogenesis and Fat Oxidation|Completed||N/A|22|Actual|University of Copenhagen||5|||f||||f||||||||||2017-02-18 14:46:22.539019|2017-02-18 14:46:22.539019
NCT00611143|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-27|2008-01-27|||May 2006||2006-05-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery|The Effects of Atorvastatin on the Occurrence of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery|Completed||N/A|124|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 14:46:22.651614|2017-02-18 14:46:22.651614
NCT00611130|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-03-14|2012-04-13||January 2008||2008-01-01|March 2016|2016-03-01|October 2012|Actual|2012-10-01|May 2009|Actual|2009-05-01||Interventional|||Vigabatrin for Treatment of Cocaine Dependence|Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study|Completed||Phase 2|186|Actual|Catalyst Pharmaceuticals, Inc.|Lack of subject medication compliance, site-to-site variability in medication compliance possibly indicative of differing site capabilities to attract subjects sufficiently motivated to stop using cocaine.|2|||f||||f||||||||No||2017-02-18 14:46:22.777512|2017-02-18 14:46:22.777512
NCT00611117|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-01-22|||May 2007||2007-05-01|January 2016|2016-01-01|June 2020|Anticipated|2020-06-01|March 2009|Actual|2009-03-01||Interventional|||Mechanisms of the Effect of Physical Activity on the Adaptation to a High-Fat Diet|Mechanisms of the Effect of Physical Activity on the Adaptation to a High-Fat Diet|Active, not recruiting||N/A|24|Anticipated|Pennington Biomedical Research Center||2|||f||||t||||||||||2017-02-18 14:46:23.176069|2017-02-18 14:46:23.176069
NCT00611104|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2016-04-19|||May 2008||2008-05-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Observational|||Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women|Evaluation of the Aromatase Inhibition Potential of Standardized Grape Extract|Active, not recruiting||N/A|25|Anticipated|Mayo Clinic|||1||f||||t||||||||||2017-02-18 14:46:23.272885|2017-02-18 14:46:23.272885
NCT00611091|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-09-12|||August 2010||2010-08-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|June 2012|Actual|2012-06-01||Interventional|||Improving Posthospital Medication Management of Older Adults Through Health IT|Improving Posthospital Medication Management of Older Adults Through Health IT|Completed||N/A|5077|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-02-18 14:46:23.368248|2017-02-18 14:46:23.368248
NCT00611078|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2011-01-19|||September 2004||2004-09-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study|Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study|Completed||N/A|56|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples With DNA|"~     blood, adipose tissue~   "|||2017-02-18 14:46:23.466169|2017-02-18 14:46:23.466169
NCT00611065|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-12|2009-02-12|||June 2007||2007-06-01|February 2009|2009-02-01||||June 2009|Anticipated|2009-06-01||Interventional|||Imaging of Prostate Cancer Using Two-Dimensional MR Spectroscopy and Diffusion Tensor Imaging|Imaging of Prostate Cancer Using Two-Dimensional MR Spectroscopy and Diffusion Tensor Imaging|Withdrawn||N/A|60|Anticipated|University of California, Irvine||1||There is no funding to proceed.|f||||f||||||||||2017-02-18 14:46:23.548238|2017-02-18 14:46:23.548238
NCT00611052|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-04-19|||March 2008||2008-03-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|CWSA-Fin||Prevention of Adolescent Major Depression|"Adolescents Coping With Stress: Prevention of Adolescent Major Depression in School Health Care"|Terminated||N/A|65|Actual|National Institute for Health and Welfare, Finland||3||"Unsuccessful recruitment, failed training of the group leaders leading into lack of study~   groups"|f||||f||||||||||2017-02-18 14:46:23.630644|2017-02-18 14:46:23.630644
NCT00611039|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2009-10-05|||February 2008||2008-02-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|DRV900100QD||Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy|Clinical Pilot, Open, Comparative and Randomized Trial to Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy|Completed||Phase 4|30|Anticipated|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 14:46:23.735339|2017-02-18 14:46:23.735339
NCT00611026|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2011-01-28|2010-10-12||February 2008||2008-02-01|January 2011|2011-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.|12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder.|Completed||Phase 3|2417|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:46:23.870483|2017-02-18 14:46:23.870483
NCT00611013|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-12|2013-06-19|||June 2002||2002-06-01|June 2013|2013-06-01||||July 2012|Anticipated|2012-07-01||Interventional|||Magnetic Resonance Imaging and Spectroscopy at High Field|Magnetic Resonance Imaging and Spectroscopy at High Field|Withdrawn||N/A|0|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:46:25.987606|2017-02-18 14:46:25.987606
NCT00611000|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2009-02-14|||June 2003||2003-06-01|February 2008|2008-02-01||||January 2006|Actual|2006-01-01||Interventional|||Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia|Effect of Folate on Colonic and Blood Cells|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:46:26.074495|2017-02-18 14:46:26.074495
NCT00610987|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-05-28|2015-02-12||January 2008||2008-01-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Antibiotic Prophylaxis in Orthopaedic Traumatology|Antibiotic Prophylaxis in Orthopaedic Traumatology: A Prospective, Randomized Trial of Duration of Administration|Completed||N/A|178|Actual|University of Missouri-Columbia||2|||f||||f||||||||||2017-02-18 14:46:26.164184|2017-02-18 14:46:26.164184
NCT00610974|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2014-09-24|||March 2008||2008-03-01|September 2014|2014-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Enhancing Walking in People With Incomplete Spinal Cord Injury: a Pilot Study|Enhancing Walking in People With Incomplete Spinal Cord Injury by Improving Swing Phase Activity: a Pilot Study|Completed||N/A|15|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 14:46:26.522944|2017-02-18 14:46:26.522944
NCT00610948|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2016-01-21|||March 2008||2008-03-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|May 2013|Actual|2013-05-01||Interventional|||Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment|A Sequential Phase I Study Of The Combination Of Everolimus (Rad001) With 5-Fu/Lv (De Gramont), Folfox6, And Folfox6/Panitumumab In Patients With Refractory Solid Malignancies|Completed||Phase 1|74|Actual|UNC Lineberger Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 14:46:26.816124|2017-02-18 14:46:26.816124
NCT00610935|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2014-12-15||2011-12-21|January 2007||2007-01-01|December 2014|2014-12-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza|A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza.|Terminated||Phase 3|82|Actual|BioCryst Pharmaceuticals||2||This study was terminated for administrative reasons.|f||||t||||||||||2017-02-18 14:46:26.946416|2017-02-18 14:46:26.946416
NCT00610922|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-02-07|||May 2005||2005-05-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Docosaexahenoic Acid and Gross Motor Milestones in Infants|RCT of Supplemented Docosahexaenoic Acid and Gross Motor Development Milestones in Healthy Infants.|Completed||N/A|1160|Actual|University of Milan||2|||f||||f||||||||||2017-02-18 14:46:27.136033|2017-02-18 14:46:27.136033
NCT00610909|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-06-19|||January 2002||2002-01-01|January 2008|2008-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)|Single-Site, Double-Blind, Flexible-Dose, Placebo-Controlled Study of the Efficacy, Tolerability, & Safety of Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)|Completed||Phase 4|60|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:46:27.218403|2017-02-18 14:46:27.218403
NCT00610896|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2011-08-31|||January 2008||2008-01-01|August 2011|2011-08-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Observational|||CRM and Fusion Beats: Effects of Progressive Fusion on Intra-left Ventricular Mechanical Function|CRM and Fusion Beats: Effects of Progressive Fusion on Intra-left Ventricular Mechanical Function|Completed||N/A|25|Actual|Essentia Health|||1||f||||f||||||||||2017-02-18 14:46:27.495813|2017-02-18 14:46:27.495813
NCT00610883|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-21|2015-12-21||May 1990||1990-05-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma|LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma|Completed||Phase 2|17|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:46:27.607168|2017-02-18 14:46:27.607168
NCT00610870|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-27|2011-03-02|||July 2007||2007-07-01|March 2011|2011-03-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention|Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction|Completed||N/A|173|Actual|Samsung Medical Center||2|||f||||f||||||||||2017-02-18 14:46:27.812678|2017-02-18 14:46:27.812678
NCT00610857|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2016-08-22|2016-03-21||November 2006||2006-11-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||Patients with stage IV melanoma (cutaneous, uveal, or mucosal) and measurable disease, most who had previously received therapy|Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma|Safety and Efficacy of Combination Biotherapy With High-dose Interferon Alfa-2b and Anti-CTLA4 Monoclonal Antibody for Recurrent Inoperable Stage III or Stage IV Melanoma|Completed||Phase 2|37|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:46:27.921678|2017-02-18 14:46:27.921678
NCT00610844|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-02-15|||April 2004||2004-04-01|November 2007|2007-11-01||||May 2006|Actual|2006-05-01||Interventional|||Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors|Evaluation of Effectiveness of Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors|Completed||Phase 2|9|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-02-18 14:46:28.251912|2017-02-18 14:46:28.251912
NCT00610831|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-12|2011-04-01|||May 2007||2007-05-01|April 2011|2011-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD)|Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD)|Completed||N/A|0|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:46:28.349836|2017-02-18 14:46:28.349836
NCT00610818|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-01-28|||July 2007||2007-07-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|Palifermin||Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation|Effect of Palifermin Therapy on Benign and Malignant Skin Tumors in Patients Undergoing High-Dose Chemotherapy With Autologous Stem Cell Transplantation|Terminated||N/A|7|Actual|McGill University Health Center|||1|We did not see any effect of Palifermin on benign or malignant tumor growth|f||||f||||||||||2017-02-18 14:46:28.428403|2017-02-18 14:46:28.428403
NCT00610805|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2016-01-14|||November 2009||2009-11-01|January 2016|2016-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Cardiology Prevention in Systemic Lupus Erythematosus (SLE)|Cardiology Prevention Trial in Systemic Lupus Erythematosus|Withdrawn||N/A|0|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:46:28.528428|2017-02-18 14:46:28.528428
NCT00610792|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2009-07-13|||July 2006||2006-07-01|July 2009|2009-07-01||||September 2009|Anticipated|2009-09-01||Interventional|||Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens|An Open Label, Phase 2 Study of Biweekly VELCADE and Intermittent CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens|Withdrawn||Phase 2|91|Anticipated|Millennium Pharmaceuticals, Inc.||1||Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.|f||||t||||||||||2017-02-18 14:46:28.635547|2017-02-18 14:46:28.635547
NCT00610779|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-06-13|||January 2008||2008-01-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Treatment of Acute Rhino-Sinusitis With Essential Oils of Aromatic Plants|Treatment of Acute Rhino-Sinusitis With Essential Oils of Some Aromatic Medical Plants.|Completed||Phase 1/Phase 2|14|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-02-18 14:46:28.754352|2017-02-18 14:46:28.754352
NCT00609830|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-06-12|||July 2001||2001-07-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|||||Interventional|||GIOP Prevention Among People With Rheumatoid Arthritis|Osteoporosis Prevention Among People With Rheumatoid Arthritis Receiving Oral Glucocorticoid Therapy|Completed||N/A|273|Actual|University of North Carolina, Chapel Hill||4|||f||||f||||||||||2017-02-18 14:46:49.408645|2017-02-18 14:46:49.408645
NCT00610766|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-03-14|||January 2007||2007-01-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Observational|PROTECTION-I||International PRospective Multicenter Study On RadiaTion Dose Estimates Of Coronary CT AngIOgraphy IN Daily Practice|International PRospective Multicenter Study On RadiaTion Dose Estimates Of Coronary CT AngIOgraphy IN Daily Practice|Completed||N/A|1965|Actual|Deutsches Herzzentrum Muenchen|||1||f||||t||||||||||2017-02-18 14:46:28.868947|2017-02-18 14:46:28.868947
NCT00610753|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-02-07|||July 2006||2006-07-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Comparison of Two Types of Family Therapy in the Treatment of Adolescent Anorexia Nervosa|Family Therapy in the Treatment of Adolescent Anorexia Nervosa|Completed||Phase 3|164|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 14:46:28.971674|2017-02-18 14:46:28.971674
NCT00610740|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2012-11-06|2010-05-19||July 2006||2006-07-01|November 2012|2012-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer|WCC# 44: A Pilot Study of CerviPrep, a Novel Drug Delivery Device for the Cervix, in the Local Administration of Gemcitabine, a Radiation Sensitizer|Completed||Phase 2|18|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:46:29.104878|2017-02-18 14:46:29.104878
NCT00610727|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2009-04-27|||August 2004||2004-08-01|September 2008|2008-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Staccato Prochlorperazine Single Dose PK|Tolerability, Safety and Pharmacokinetics of a Single Dose of Staccato™ Prochlorperazine for Inhalation in Normal, Healthy Volunteers|Completed||Phase 1|32|Actual|Alexza Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-02-18 14:46:29.378395|2017-02-18 14:46:29.378395
NCT00610714|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-12-14|2011-05-03||April 2008||2008-04-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|August 2009|Actual|2009-08-01||Interventional|OVERT-1||AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer|A Phase II, Double-blind, Placebo-controlled, Multi-centre, Randomised Study of AZD0530 in Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy|Completed||Phase 2|211|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:46:29.495564|2017-02-18 14:46:29.495564
NCT00610701|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-11-15|2014-04-10||March 2006||2006-03-01|November 2016|2016-11-01|February 2014|Actual|2014-02-01|August 2012|Actual|2012-08-01||Interventional||initially based on power analysis for anticipated quad strength data, final numbers based on those completing study in each group|Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures|Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures|Terminated||N/A|35|Actual|University of Missouri-Columbia||2||Extremely low enrollment and very little follow-up for meaningful data|f||||f||||||||No||2017-02-18 14:46:30.565814|2017-02-18 14:46:30.565814
NCT00610688|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-06-05|2012-05-15||January 2008||2008-01-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|June 2011|Actual|2011-06-01||Interventional|||Controlled Trial of Prenatal Vitamin D3 Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants|High Prevalence of Rickets and Subclinical Maternal and Childhood Vitamin D Deficiency in the Middle East: a Randomized Controlled Trial of Prenatal Vitamin D Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants|Completed||Phase 3|192|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-02-18 14:46:30.90568|2017-02-18 14:46:30.90568
NCT00610675|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-07-13|2014-06-25||December 2006||2006-12-01|July 2015|2015-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Participants treated with Esmirtazapine in Follow up trial P05708|Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)|Fifty-Two Weeks, Open Label Extension Trial to Evaluate Safety and Efficacy of Org 50081 in Outpatients With Chronic Primary Insomnia Who Completed Clinical Trial Protocol 176001 or 176002.|Completed||Phase 3|346|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:46:31.431213|2017-02-18 14:46:31.431213
NCT00610662|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-07|2014-07-17|||December 2010||2010-12-01|April 2014|2014-04-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Observational|||Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear|A Pilot Study: Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia Using a Second Generation Device|Withdrawn||Phase 1|0|Actual|British Columbia Cancer Agency||||Study modified and has been running as CDR0000581286 instead.|f||||f||||||||||2017-02-18 14:46:31.720484|2017-02-18 14:46:31.720484
NCT00610649|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2015-05-11|2014-05-27||September 2007||2007-09-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)|Single Center, Randomized, Placebo-Controlled Trial to Establish Maximum Tolerated Dose, Optimal Titration Schedule, Safety, Tolerability, and Pharmacokinetics of Org 26576 in Patients Diagnosed With Major Depressive Disorder (Protocol No. P174001)|Completed||Phase 2|54|Actual|Merck Sharp & Dohme Corp.||11|||f||||f||||||||||2017-02-18 14:46:31.838736|2017-02-18 14:46:31.838736
NCT00610636|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2012-12-06|||January 2002||2002-01-01|December 2012|2012-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy|Oncologic Outcomes of Surgical Versus Non-surgical Methods for the Treatment of Resectable Colorectal Liver-confined Metastases Converted From Initially Non-resectable Metastases by FOLFOX-4 Neoadjuvant Chemotherapy: A Randomized Clinical Trial|Recruiting||Phase 3|200|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 14:46:35.732007|2017-02-18 14:46:35.732007
NCT00610623|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-01-28|||April 2003||2003-04-01|January 2008|2008-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia|Proof of Concept Study to Investigate the Impact of Azithromycin Administered iv Versus Placebo on the Prevention of Pneumonia in Ventilated Patients Colonized by Pseudomonas Aeruginosa|Terminated||Phase 2|92|Actual|Anbics Management-Services Ag||2||The sponsor decided to stop the study prematurely because of financial issues|f||||t||||||||||2017-02-18 14:46:35.866957|2017-02-18 14:46:35.866957
NCT00610610|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-06-19|||January 2002||2002-01-01|January 2008|2008-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome|Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome: A Randomized, Double Blind, Parallel Group, Flexible Dose, Placebo Controlled Trial.|Completed||Phase 4|120|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:46:35.992978|2017-02-18 14:46:35.992978
NCT00610597|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-01-28|||January 2005||2005-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Observational|||Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease|Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease|Completed||N/A|49|Actual|Erasme University Hospital|||2||f||||f||||||Samples Without DNA|"~     plasma and peripheral blood mononuclear cell culture medium.~   "|||2017-02-18 14:46:36.106002|2017-02-18 14:46:36.106002
NCT00610584|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2012-10-22|||April 2008||2008-04-01|October 2012|2012-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|ACUSAR||Acupuncture for Seasonal Allergic Rhinitis|Acupuncture for Seasonal Allergic Rhinitis (ACUSAR) - A Randomised Controlled Trial|Completed||N/A|422|Actual|Charite University, Berlin, Germany||3|||f||||t||||||||||2017-02-18 14:46:36.199737|2017-02-18 14:46:36.199737
NCT00610571|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-10-23|||April 2004||2004-04-01|October 2013|2013-10-01|April 2012|Actual|2012-04-01|September 2009|Actual|2009-09-01||Interventional|||Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas|Phase I Trial of Oral Topotecan Plus Temodar in the Treatment of Patients With Malignant Gliomas|Completed||Phase 1|62|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:46:36.318549|2017-02-18 14:46:36.318549
NCT00610558|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-12|2013-06-19|||July 2003||2003-07-01|June 2013|2013-06-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|||Neocortical Epilepsies - Do They Progress?|Neocortical Epilepsies - Do They Progress?|Completed||N/A|43|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:46:36.442587|2017-02-18 14:46:36.442587
NCT00610545|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2009-02-13|||July 2007||2007-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|APVS||Atorvastatin in Perioperative Vascular Surgery - Pilot Study|Atorvastatin 80mg Versus Atorvastatin 20mg in Perioperative Vascular Surgery to Evaluate Cardiovascular Outcomes|Completed||Phase 4|100|Anticipated|University of Campinas, Brazil||2|||f||||t||||||||||2017-02-18 14:46:38.855366|2017-02-18 14:46:38.855366
NCT00610532|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-05-13|2012-12-06||March 2006||2006-03-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy|Evaluating Transporter Protein Inhibitors in Patients With Epilepsy|Terminated||Phase 4|8|Actual|Ohio State University|problems with measurement led to uninterpretable data|2||Investigators decided not to continue|f||||f||||||||||2017-02-18 14:46:38.951676|2017-02-18 14:46:38.951676
NCT00610519|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-06-13|||January 2008||2008-01-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Treatment of Acute Pharyngo-Tonsillitis With Essential Oils of Aromatic Plants|Treatment of Acute Pharyngo-Tonsillitis With Essential Oils of Some Aromatic Medical Plants.|Completed||Phase 1/Phase 2|33|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-02-18 14:46:39.182106|2017-02-18 14:46:39.182106
NCT00610506|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2013-05-30|||October 2005||2005-10-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features|A Pilot Study -- An Open-Label, Rater-blinded, Flexible-dose, 8-week Trial of Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features.|Completed||Phase 3|15|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:46:39.28153|2017-02-18 14:46:39.28153
NCT00610493|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-12-19|||January 2008||2008-01-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Interventional|||Bevacizumab and Temsirolimus in Patients With Advanced Malignancy|A Phase I Trial of Bevacizumab and Temsirolimus in Patients With Advanced Malignancy|Active, not recruiting||Phase 1|183|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 14:46:39.388809|2017-02-18 14:46:39.388809
NCT00610480|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-27|2009-07-13|||November 2007||2007-11-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effects of Tear Film Stability After Instillation Of OTC Artificial Drops|Effects of Systane® Versus Optive™ and Soothe™ Lubricating Eye Drops in Maintaining Tear Film Stability at Determined Time Points|Completed||N/A|20|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 14:46:39.500744|2017-02-18 14:46:39.500744
NCT00610467|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-12|2016-12-06|||October 2006||2006-10-01|December 2016|2016-12-01||||October 2016|Actual|2016-10-01||Interventional|||Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis|Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis|Terminated||N/A|120|Anticipated|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:46:39.605292|2017-02-18 14:46:39.605292
NCT00610454|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2013-12-05|||June 2004||2004-06-01|September 2009|2009-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures|Trial Evaluating the Safety and Tolerability of Levetiracetam Intravenous 15-minute Infusion, Administered in b.i.d. Regimen as an Adjunctive Antiepileptic Treatment in Subjects From 16 to 65 Years Suffering From Partial Onset Seizures|Completed||Phase 2|25|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 14:46:39.687443|2017-02-18 14:46:39.687443
NCT00610441|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2015-05-13|2014-05-30||April 2008||2008-04-01|May 2015|2015-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)|A Double Blind, Placebo Controlled, Randomized, Two Period 4-Arm Trial to Investigate the Dose-Related Efficacy and Safety of Org 26576 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|67|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 14:46:39.857909|2017-02-18 14:46:39.857909
NCT00610428|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-01-28|||March 2005||2005-03-01|January 2008|2008-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Staccato Prochlorperazine in Patients With Migraine Headache|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of StaccatoTM Prochlorperazine for Inhalation in Patients With Migraine Headache|Completed||Phase 2|72|Actual|Alexza Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 14:46:41.336555|2017-02-18 14:46:41.336555
NCT00610415|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-06-29|||December 2007||2007-12-01|June 2016|2016-06-01||||October 2012|Actual|2012-10-01||Observational|||Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study|Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study|Completed||N/A|40|Actual|Stanford University|||1||f||||||||||Samples With DNA|"~     Tissue samples~   "|||2017-02-18 14:46:41.448511|2017-02-18 14:46:41.448511
NCT00610402|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2017-02-08|||July 2007||2007-07-01|February 2017|2017-02-01|June 2008|Actual|2008-06-01|July 2007|Actual|2007-07-01||Observational|||Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)|Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)|Completed||N/A|57|Actual|University of California, Irvine|||1||f||||f||||||Samples Without DNA|"~     blood sample tear drop sample~   "|||2017-02-18 14:46:41.532385|2017-02-18 14:46:41.532385
NCT00610389|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2010-05-07|||February 2008||2008-02-01|May 2010|2010-05-01|December 2010|Anticipated|2010-12-01|April 2010|Anticipated|2010-04-01||Interventional|||Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors|Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors|Unknown status|Recruiting|Phase 2|27|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||||2017-02-18 14:46:41.634721|2017-02-18 14:46:41.634721
NCT00610376|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-27|2015-09-21|||September 2000||2000-09-01|January 2008|2008-01-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|JHS||Jerusalem Handwashing Study|A Controlled Trial to Assess the Effect of a Health Promotion Intervention on Hygiene Behavior and Illness Absenteeism in Jerusalem Preschools|Completed||Phase 3|1029|Actual|Hebrew University of Jerusalem||3|||f||||f||||||||||2017-02-18 14:46:41.736258|2017-02-18 14:46:41.736258
NCT00610363|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-09-27||2010-11-23|November 2007||2007-11-01|June 2011|2011-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares|A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study, Tolerability, and Efficacy of Rilonacept for the Prevention of Gout Flares During Initiation of Allopurinol Therapy|Completed||Phase 2|83|Actual|Regeneron Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:46:41.904924|2017-02-18 14:46:41.904924
NCT00610350|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-02-06|||January 2005||2005-01-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Levosimendan and Myocardial Protection|Levosimendan Pre-Treatment in Patients Undergoing Coronary Artery Bypass Graft Surgery: a Double-Blind, Single Center, Prospective, Randomized, Placebo-Controlled Trial|Completed||Phase 4|100|Actual|University of Roma La Sapienza||2|||f||||f||||||||||2017-02-18 14:46:42.179947|2017-02-18 14:46:42.179947
NCT00610337|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-01-16||||||February 2010|2010-02-01||||||||Interventional|||Safety and Efficacy of Cethrin® in Adult Subjects With Acute Cervical Spinal Cord Injury|A Phase IIb, Double-Blind, Randomized, Placebo Controlled, Multicenter Study to Assess the Safety and Efficacy of Intraoperative Epidural Cethrin® in Adult Subjects With Acute Cervical Spinal Cord Injury|Withdrawn||Phase 2|0|Actual|BioAxone BioSciences, Inc.||6||Due to a change of sponsor|f||||t||||||||||2017-02-18 14:46:42.281518|2017-02-18 14:46:42.281518
NCT00610324|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-01-24|||May 2004||2004-05-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients|Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients: an Open-Labelled Randomized Controlled Trial|Completed||Phase 4|512|Actual|King Edward Memorial Hospital||2|||f||||f||||||||||2017-02-18 14:46:42.378062|2017-02-18 14:46:42.378062
NCT00610311|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2015-10-06|2012-03-14||January 2008||2008-01-01|September 2015|2015-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma|Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes and ALVAC Virus Immunization|Terminated||Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)|Early termination leading to a small number of subjects analyzed.|1||The study was terminated due to low accrual.|f||||t||||||||||2017-02-18 14:46:42.497282|2017-02-18 14:46:42.497282
NCT00610298|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-09-12|||October 2001||2001-10-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Whole Body Vibration in Elderly Patients Requiring Rehabilitation: A Pilot Study|Effects of Whole Body Vibration in Elderly Patients Requiring Rehabilitation: A Pilot Study|Withdrawn||N/A|0|Actual|Ohio State University||2||Another institution conducted and published this study.No subjects enrolled.|f||||f||||||||||2017-02-18 14:46:42.875239|2017-02-18 14:46:42.875239
NCT00610285|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2015-12-17|||October 2005||2005-10-01|December 2015|2015-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases|A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases|Completed||N/A|9|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:46:42.98146|2017-02-18 14:46:42.98146
NCT00610272|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-08-06|||January 2008||2008-01-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|bone mets||Optimization of Radiotherapy in Treatment of Painful Bone Metastasis|Investigation of Optimal Radiotherapy Regimen and Type of Irradiation in Treatment of Painful Bone Metastasis|Completed||Phase 3|650|Actual|International Atomic Energy Agency||4|||f||||t||||||||||2017-02-18 14:46:43.083066|2017-02-18 14:46:43.083066
NCT00610259|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2009-09-17|||January 2008||2008-01-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia|Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia - An Assessors-blinded, Randomized Controlled Effectiveness Trial|Completed||Phase 2/Phase 3|40|Anticipated|Nagoya City University||2|||f||||f||||||||||2017-02-18 14:46:43.220062|2017-02-18 14:46:43.220062
NCT00610246|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2011-10-19|||May 2007||2007-05-01|October 2011|2011-10-01||||December 2010|Actual|2010-12-01||Interventional|||A Study of Radiation With Sorafenib in Advanced Cancer|A Phase I Dose Escalation Study of Concurrent Low Dose Radiation With Sorafenib in Three Anatomically-based Independent Cohorts (Thorax, Abdomen, Pelvis)|Completed||Phase 1|36|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 14:46:43.332324|2017-02-18 14:46:43.332324
NCT00610233|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2014-09-18|||June 2005||2005-06-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Deep Brain Stimulation on Lower Urinary Tract Function|Effect of Deep Brain Stimulation (DBS) on Lower Urinary Tract (LUT) Function|Completed||N/A|45|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 14:46:43.442831|2017-02-18 14:46:43.442831
NCT00610220|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2014-05-12|||January 2007||2007-01-01|May 2014|2014-05-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Cast Versus Splint in Children With Acceptably Angulated Wrist Fractures|Cast Versus Splint in Children With Minimally Angulated Fractures of the Distal Radius: a Randomized Controlled Trial.|Completed||Phase 4|96|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 14:46:43.53943|2017-02-18 14:46:43.53943
NCT00610025|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-02-11|||July 2007||2007-07-01|February 2013|2013-02-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Minimally Invasive Trocar Placement in Obesity Surgery|Transgastric Peritoneoscopy for Evaluation of the Abdominal Wall to Direct Laparoscopic Trocar Placement|Completed||N/A|60|Actual|Ohio State University||6|||f||||f||||||||||2017-02-18 14:46:46.500001|2017-02-18 14:46:46.500001
NCT00610207|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-12-29|2011-04-25||March 2007||2007-03-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|SurgiSIS AFP||Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft|Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft (SurgiSIS AFP)|Terminated||N/A|21|Actual|Cook|Early termination did lead to small patient numbers.|1||Study stopped early due to staffing changes at the site.|f||||f||||||||||2017-02-18 14:46:43.652233|2017-02-18 14:46:43.652233
NCT00610194|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-12-30|||November 2007||2007-11-01|December 2014|2014-12-01|August 2012|Actual|2012-08-01|November 2010|Actual|2010-11-01||Interventional|||Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients|A Multi-Center Phase 1, Dose-Escalation Trial to Determine the Safety and Pharmacokinetics/Pharmacodynamics of RDEA119, A MEK Inhibitor, in Advanced Cancer Patients|Completed||Phase 1|69|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:46:43.89519|2017-02-18 14:46:43.89519
NCT00610181|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-06-29|||January 2008||2008-01-01|June 2015|2015-06-01||||June 2015|Actual|2015-06-01||Observational|||Magnetic Resonance Imaging in Patients With Breast Cancer|Magnetic Resonance Imaging (MRI) for Preoperative Staging of Patients With Invasive Lobular Carcinoma of the Breast|Completed||N/A|96|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:46:43.997474|2017-02-18 14:46:43.997474
NCT00610168|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-11-02||2010-12-07|January 2008||2008-01-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.|Evaluation of GSK Biologicals' dTpa Booster Vaccine in Young Adults 10 Years After Previous dTpa Boosting.|Completed||Phase 4|82|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:46:44.109839|2017-02-18 14:46:44.109839
NCT00610155|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-09-19|2012-12-20||September 2008||2008-09-01|September 2013|2013-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Methodology Study Of Brain Imaging Of Pain-Killers In Post-Traumatic Neuropathic Pain Patients|A Methodology Study To Assess The Feasibility Of Using Functional Magnetic Resonance Imaging (fRMI) To Quantify The Effects Of Analgesic Drugs In Post-Traumatic Neuropathic Pain Subjects|Completed||N/A|18|Actual|Pfizer|Results for primary outcome, BOLD activation signals(whole brain) was not available to reported, as DMAa, DMAc, TH and VIS were captured as COPE images only, which could not be included in basic results format.|3|||f||||f||||||||||2017-02-18 14:46:44.256626|2017-02-18 14:46:44.256626
NCT00610142|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2014-06-10|||December 2007||2007-12-01|June 2014|2014-06-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|OCT-AD||Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis|Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis|Completed||Phase 2|20|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-02-18 14:46:45.327436|2017-02-18 14:46:45.327436
NCT00610129|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-10-19|2015-10-19||January 2008||2008-01-01|October 2015|2015-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)|A Phase II Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)|Completed||Phase 2|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:46:45.439849|2017-02-18 14:46:45.439849
NCT00610116|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-09-10|||September 2006||2006-09-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|ERACE||Electronic Repositioning With Acuity and Easytrak Leads|Electronic Repositioning With Acuity and Easytrak Leads|Completed||N/A|400|Actual|Guidant Corporation||1|||f||||f||||||||||2017-02-18 14:46:45.688241|2017-02-18 14:46:45.688241
NCT00610103|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-08-30|||November 2007||2007-11-01|August 2012|2012-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy|A Phase 2 Clinical Study of KW-6500 (Apomorphine Hydrochloride) in Patients With Parkinson's Disease|Completed||Phase 2|16|Actual|Kyowa Hakko Kirin Co., Ltd||2|||f||||f||||||||||2017-02-18 14:46:45.795495|2017-02-18 14:46:45.795495
NCT00610090|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-08-23|||May 2007||2007-05-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|UNITE||Safety Study for the Treatment of Abdominal Aortic Aneurysms|A Phase II, Single-arm, Prospective Study of the Safety of the UniFit Aorto-uni-iliac Endoluminal Stent Graft for the Repair of Abdominal Aortic Aneurysms|Terminated||Phase 2|71|Actual|Duke Vascular, Inc.||1|||f||||t||||||||||2017-02-18 14:46:45.901242|2017-02-18 14:46:45.901242
NCT00610077|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-02-06|||December 2004||2004-12-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Letrozole vs. Clomiphene Citrate in Patients With Anovulatory Infertility|An Open, Randomized, Parallel-Group, Multicentric, Comparative Study of Letrozole With Clomiphene Citrate for Induction of Ovulation in Anovulatory Infertility.|Completed||Phase 3|55|Actual|Sun Pharmaceutical Industries Limited||2|||f||||f||||||||||2017-02-18 14:46:46.042124|2017-02-18 14:46:46.042124
NCT00610064|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2010-02-04|||October 2005||2005-10-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Brain Effects of Sacral Neuromodulation|Brain Effects of Sacral Neuromodulation in Patients With Refractory Lower Urinary Tract Dysfunction|Completed||N/A|30|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 14:46:46.159981|2017-02-18 14:46:46.159981
NCT00610051|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2017-01-30|||December 2012||2012-12-01|January 2017|2017-01-01|December 2022|Anticipated|2022-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Alprostadil Continuous Intravenous Infusion in Bridging Cardiac Transplant in Severe Heart Failure Patients|Phase 3 Study of Alprostadil Continuous Intravenous Infusion in Bridging Cardiac Transplant in Severe Heart Failure Patients|Suspended||Phase 3|500|Anticipated|Biopeutics Co., Ltd||2||DD issue|f||||t|t|f||||||No||2017-02-18 14:46:46.265413|2017-02-18 14:46:46.265413
NCT00610038|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-11-16|||July 2006||2006-07-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|August 2010|Actual|2010-08-01||Interventional|GLIDKIR6-2||Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus|Sulfonylureas in Neonatal Diabetes Mellitus With Mutations of 2 Type of Subunits Kir6.2 and SUR1 of the Pancreatic Beta-cell ATP-sensitive K+ Channel.|Completed||Phase 2|19|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 14:46:46.384012|2017-02-18 14:46:46.384012
NCT00610012|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-06-27|||December 2007||2007-12-01|June 2016|2016-06-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|RCC-Registry||Tumor Registry of Advanced Renal Cell Carcinoma|Clinical Registry Describing Treatment Reality and Therapy Modality of Patients With Metastatic or Locally Advanced Renal Cell Carcinoma Requiring Therapy|Recruiting||N/A|1500|Anticipated|iOMEDICO AG|||1||f||||f||||||||No||2017-02-18 14:46:46.611278|2017-02-18 14:46:46.611278
NCT00609999|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2014-07-15|||January 2008||2008-01-01|April 2012|2012-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Ph I Dasatinib + Erlotinib in Recurrent MG|Phase I Study of Dasatinib Plus Erlotinib in Recurrent Malignant Glioma|Completed||Phase 1|47|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:46:46.717711|2017-02-18 14:46:46.717711
NCT00609986|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-08-21|2013-06-05||July 2007||2007-07-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||The intent-to-treat anaylsis consisted only of the 93 participants that underwent a renal transplant.|IV Insulin Protocol in Diabetes and Renal Transplantation|Intravenous Insulin Protocol in Diabetes and Renal Transplantation Study|Completed||N/A|104|Actual|Medical University of South Carolina|A limitation of the trial was that the majority of the patients enrolled in the study were African American, and therefore the findings cannot be extended to groups of other ethnic groups.|2|||f||||t||||||||||2017-02-18 14:46:46.836784|2017-02-18 14:46:46.836784
NCT00609973|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-03-21|2012-11-12||May 2008||2008-05-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease|Double-blind, Placebo Controlled, Randomized, Multicentre, Pilot Study on the Safety and Efficacy of Ciprofloxacin for Prophylactic Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease Patients|Completed||Phase 2|33|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 14:46:47.324978|2017-02-18 14:46:47.324978
NCT00609960|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-02-06|||January 2006||2006-01-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Clowns as Treatment for Preoperative Anxiety in Children: A Randomized Controlled Trial|Clowns as Treatment for Preoperative Anxietyin Children- a Randomized Controlled Trial|Completed||N/A|65|Actual|Sheba Medical Center||3|||f||||f||||||||||2017-02-18 14:46:47.657451|2017-02-18 14:46:47.657451
NCT00609947|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2015-01-26|2013-06-05||January 2008||2008-01-01|January 2015|2015-01-01|September 2013|Actual|2013-09-01|March 2012|Actual|2012-03-01||Interventional|ENDEAVORSVS||Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries.|A Clinical Evaluation of the Medtronic Endeavor Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries|Completed||N/A|241|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-02-18 14:46:47.771656|2017-02-18 14:46:47.771656
NCT00609934|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-07-22|||December 2007||2007-12-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone|A Phase I/II Study of Sorafenib and Palliative Radiotherapy in Patients With Advanced Renal Cell Carcinoma and Symptomatic Bony Metastases|Completed||Phase 1/Phase 2|12|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 14:46:48.129475|2017-02-18 14:46:48.129475
NCT00609921|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-09-06|||January 2008||2008-01-01|September 2012|2012-09-01||||September 2011|Actual|2011-09-01||Interventional|||A Phase 1 Study of ARQ 197 in Patients With Solid Tumors|A Phase 1 Dose Escalation Study of ARQ 197 in Adult Patients With Advanced/Recurrent Solid Tumors|Completed||Phase 1|42|Anticipated|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-02-18 14:46:48.397426|2017-02-18 14:46:48.397426
NCT00609908|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2015-06-25|||December 2007||2007-12-01|June 2015|2015-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction|The Technique of Skin Stretching for Acute Burn Treatment and Scar Reconstruction: Clinical Applications and Working Mechanisms.|Completed||Phase 3|30|Actual|Association of Dutch Burn Centres||4|||f||||f||||||||||2017-02-18 14:46:48.477866|2017-02-18 14:46:48.477866
NCT00609895|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-03-26|||January 2004||2004-01-01|March 2008|2008-03-01|August 2004|Actual|2004-08-01|||||Interventional|||The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing|The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing|Completed||Phase 4|22|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:46:48.57987|2017-02-18 14:46:48.57987
NCT00609882|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-02-05|||December 2007||2007-12-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|HHFNC||Comparison of Humidified High Flow Nasal Cannula to Nasal CPAP in Neonates|Comparison of Humidified High Flow Nasal Cannula to Nasal Continuous Positive Airway Pressure for Non-Invasive Respiratory Support in Neonates|Completed||N/A|420|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 14:46:48.663667|2017-02-18 14:46:48.663667
NCT00609869|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-09-01|2014-08-20||October 2007||2007-10-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|February 2014|Actual|2014-02-01||Interventional||All enrolled participants|Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab|A Phase II Study of Lenalidomide (REVLIMID®) in Combination With Rituximab for Patients With CD5+/CD20+ Hematologic Malignancies Who Relapse or Progress After Rituximab|Completed||Phase 2|29|Actual|H. Lee Moffitt Cancer Center and Research Institute|The 4 Mantle Cell participants were not evaluated for Outcome Measures due to their low enrollment.|1|||f||||f||||||||||2017-02-18 14:46:48.78323|2017-02-18 14:46:48.78323
NCT00609856|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-01-24|||April 2004||2004-04-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes|Differences in Metabolic and Cardiovascular Effects of Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes|Completed||Phase 4|36|Actual|Skane University Hospital||2|||f||||f||||||||||2017-02-18 14:46:49.182559|2017-02-18 14:46:49.182559
NCT00609843|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2015-12-04|||February 2008||2008-02-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer|Lipiodol Demarcation of the Bladder Tumour in Adaptive Image-guided Radiotherapy: A Pilot Study. (Danish: Lipiodol Til Markering af blæretumoren i Forbindelse Med Adaptiv Billedvejledt strålebehandling: Et Pilotstudie.)|Completed||N/A|5|Actual|University of Aarhus||1|||f||||t||||||||||2017-02-18 14:46:49.294787|2017-02-18 14:46:49.294787
NCT00608647|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-05-18|||December 2006||2006-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:47:12.211865|2017-02-18 14:47:12.211865
NCT00609817|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-06-21|||May 2008||2008-05-01|June 2013|2013-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma|An Open-Label Phase 1/2 Study of the Safety and Efficacy of GCS-100 in Subjects With Relapsed or Relapsed/Refractory Multiple Myeloma|Terminated||Phase 1|9|Actual|La Jolla Pharmaceutical Company||1||Lack of funding|f||||t||||||||||2017-02-18 14:46:49.522559|2017-02-18 14:46:49.522559
NCT00609804|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2016-03-10|2015-04-24||March 2008||2008-03-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|May 2012|Actual|2012-05-01||Interventional|||Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib|Randomized Phase II Trial of Sorafenib and Erlotinib or Sorafenib Alone in Patients With Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib|Completed||Phase 2|53|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 14:46:49.642243|2017-02-18 14:46:49.642243
NCT00609791|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2016-08-29|||January 2008||2008-01-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer|Age-Related Changes in Nanoparticle Albumin Bound (Nab) Paclitaxel Pharmacokinetics and Pharmacodynamics|Active, not recruiting||Phase 2|40|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:46:50.252045|2017-02-18 14:46:50.252045
NCT00609778|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-10-04|||January 2008||2008-01-01|June 2011|2011-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|LINC||A Comparison of Conventional Adult Out-of-hospital Cardiopulmonary Resuscitation Against a Concept With Mechanical Chest Compressions and Simultaneous Defibrillation - LINC Study|A Comparison of Conventional Adult Out-of-hospital Cardiopulmonary Resuscitation Against a Concept With Mechanical Chest Compressions and Simultaneous Defibrillation|Completed||N/A|2500|Actual|Jolife AB||2|||f||||t||||||||||2017-02-18 14:46:50.364762|2017-02-18 14:46:50.364762
NCT00609765|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-11-21|2011-02-21||August 2007||2007-08-01|March 2011|2011-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors|Phase II Study of Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors|Terminated||Phase 2|1|Actual|H. Lee Moffitt Cancer Center and Research Institute|This trial only enrolled one patient and was closed because of development of a new chemotherapy standard of care for treatment of this cancer which we felt rendered the trial obsolete. The trial was open for only 7 months.|1||Development of new chemotherapy standard of care for treatment rendered the trial obsolete.|f||||t||||||||||2017-02-18 14:46:50.467422|2017-02-18 14:46:50.467422
NCT00609752|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-12-29|||February 2008||2008-02-01|December 2008|2008-12-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease|Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease|Unknown status|Recruiting|Phase 4|80|Anticipated|University Hospital Birmingham||2|||f||||t||||||||||2017-02-18 14:46:50.704227|2017-02-18 14:46:50.704227
NCT00609739|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-01-31|2011-11-22||June 1999||1999-06-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation|Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation|Terminated||Phase 1/Phase 2|1|Actual|Masonic Cancer Center, University of Minnesota|Only 1 patient was enrolled (yr 1999) and later died (yr 2000). Study was terminated due to low accrual.|1||Low accrual|f||||t||||||||||2017-02-18 14:46:50.826542|2017-02-18 14:46:50.826542
NCT00609726|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2016-01-21|||December 2015||2015-12-01|January 2015|2015-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography|Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography|Completed||N/A|199|Actual|University of Alabama at Birmingham|||1||f||||t||||||||||2017-02-18 14:46:51.095139|2017-02-18 14:46:51.095139
NCT00609713|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-02-15|||January 2007||2007-01-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Bone Health of Obese Adolescents During Weight Loss|Bone Health of Obese Adolescents During Weight Loss|Completed||N/A|91|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 14:46:51.181117|2017-02-18 14:46:51.181117
NCT00609700|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2011-10-14|||December 2007||2007-12-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Observational|VoLTRAB||Balanced Volume Replacement Therapy With Ringer's Acetate Solution in Burn Injury|Balanced Volume Replacement Therapy With Ringer's Acetate Solution in Burn Injury|Completed||N/A|82|Actual|Klinikum St. Georg gGmbH|||2||f||||f||||||||||2017-02-18 14:46:51.278132|2017-02-18 14:46:51.278132
NCT00609687|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-04-09|||January 2007||2007-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||Diagnostic Yield of Vitreous Biopsy in Sarcoid Uveitis|Diagnostic Yield of Vitreous Biopsy in Sarcoid Uveitis|Completed||N/A|150|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:46:51.372614|2017-02-18 14:46:51.372614
NCT00609674|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2016-11-02|2009-06-22||January 2008||2008-01-01|November 2016|2016-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of Fluticasone Furoate Nasal Spray 110mcg in Adult and Adolescent Subjects 12 Years of Age and Older With Perennial Allergic Rhinitis (PAR)|Completed||Phase 4|315|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:46:51.479588|2017-02-18 14:46:51.479588
NCT00609661|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-10-05|||February 2008||2008-02-01|October 2012|2012-10-01|June 2010|Anticipated|2010-06-01|February 2010|Anticipated|2010-02-01||Observational|||Adult Stem Cell Response to Burn Injury|Comparison of Burn Severity and Patient Outcomes to the Subsets of Mesenchymal Stem Cells Identified in the Blood of Burn Victims|Withdrawn||N/A|0|Actual|Ohio State University|||2|Assay for stem cell analysis not available|f||||f||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 14:46:52.496682|2017-02-18 14:46:52.496682
NCT00609648|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-02-15|||January 2008||2008-01-01|February 2013|2013-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|CARL||Computer Assisted Relaxation Learning for Dental Offices|Distance Psychology for Treating Dental Fear in Rural Communities|Completed||N/A|84|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:46:52.587337|2017-02-18 14:46:52.587337
NCT00609635|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2009-04-03|||November 2007||2007-11-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly|The Association Between Cytokine Genotype Polymorphisms and Severity of RSV-Induced Illness in the Elderly|Completed||N/A|300|Anticipated|West Penn Allegheny Health System|||1||f||||f||||||Samples With DNA|"~     A buccal brushing (cells collected from the inside of the cheek) will be collected and~     stored for DNA analysis.~   "|||2017-02-18 14:46:52.70963|2017-02-18 14:46:52.70963
NCT00609622|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-09-10|2012-07-06||April 2008||2008-04-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer|A Randomized, Phase 2B Study Of Sunitinib Plus Oxaliplatin, 5-Fluorouracil And Leucovorin (FOLFOX) Versus Bevacizumab Plus FOLFOX As First-Line Treatment In Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|191|Actual|Pfizer|Due to early study termination, not all data was analyzable.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:46:52.820259|2017-02-18 14:46:52.820259
NCT00609609|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-02-09|||January 2008||2008-01-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Photopheresis for the Treatment of Acute Graft Versus Host Disease|A Randomized Phase II Study for the Evaluation of Extracorporeal Photopheresis (ECP) in Combination With Corticosteroids for the Initial Treatment of Acute Graft-Versus-Host Disease (GVHD)|Completed||Phase 2|81|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 14:46:54.201842|2017-02-18 14:46:54.201842
NCT00609596|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-11-02|||February 2008||2008-02-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.|An Open Label, Randomized, Repeat Dose, 3 Period Crossover Study to Determine the Bioequivalence of 3 Different Formulations of Tamsulosin at Steady State in Healthy Male Volunteers|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:46:54.314905|2017-02-18 14:46:54.314905
NCT00609570|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2008-10-27|||October 2008||2008-10-01|October 2008|2008-10-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Nutritional Supplements on Blood Pressure 2008|Effects of Nutritional Supplements on Blood Pressure and Heart Rate Variability|Unknown status|Recruiting|Phase 1|60|Anticipated|Logan College of Chiropractic||3|||f||||f||||||||||2017-02-18 14:46:54.420695|2017-02-18 14:46:54.420695
NCT00609557|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-01-24|||September 2004||2004-09-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain|A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain|Completed||Phase 4|25|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:46:54.530005|2017-02-18 14:46:54.530005
NCT00609544|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-04-17||||||April 2011|2011-04-01||||||||Interventional|||Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia|A Multi-Center, Double-Blind, Placebo-Controlled Safety and Preliminary Efficacy Study of IL-1 Trap (Rilonacept) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia|Withdrawn||Phase 2|0|Actual|Regeneron Pharmaceuticals||2||Unable to enroll patients|f||||f||||||||||2017-02-18 14:46:54.615912|2017-02-18 14:46:54.615912
NCT00609531|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-10-05|||January 2007||2007-01-01|October 2012|2012-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders|Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders|Completed||Phase 1|12|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 14:46:57.205702|2017-02-18 14:46:57.205702
NCT00609518|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2010-12-10|2010-10-15||February 2008||2008-02-01|December 2010|2010-12-01|June 2010|Actual|2010-06-01|October 2009|Actual|2009-10-01||Interventional|||A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer|Pemetrexed With Simplified Folate and Dexamethasone Supplementation Versus Pemetrexed With Standard Supplementation as Second-line Chemotherapy for Patients With Non-squamous Non-small Cell Lung Cancer|Completed||Phase 2|111|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:46:57.32628|2017-02-18 14:46:57.32628
NCT00609505|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-02-21|||August 2008||2008-08-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Telemedicine vs. Face-to-Face Cancer Genetic Counseling|Telemedicine vs. Face-to-Face Cancer Genetic Counseling in Rural Oncology Clinics|Completed||N/A|130|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:46:58.188166|2017-02-18 14:46:58.188166
NCT00609492|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-10-11||2009-09-09|January 2008||2008-01-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.|Safety, Reactogenicity and Immunogenicity Following Booster Dose of GSK Biologicals´ Pneumococcal Conjugate Vaccine When Co-administered With a Booster Dose of Infanrix-IPV/Hib in Preterm Born Children at 16-18 Months of Age|Completed||Phase 3|245|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:46:58.52178|2017-02-18 14:46:58.52178
NCT00609479|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2010-04-09|||January 2008||2008-01-01|April 2010|2010-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Comparison of Two Methods for Treatment of Colles´s Fracture|Comparison of External and Internal Fixationmethods for Distal Radius Fracture - a Randomized Study.|Completed||N/A|60|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-02-18 14:46:58.654133|2017-02-18 14:46:58.654133
NCT00609466|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2011-11-10|2009-09-16||September 2007||2007-09-01|November 2011|2011-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy|A Randomized, Double-blind, Parallel-group, Multi-center, Active- and Placebo-controlled Trial to Evaluate the Analgesic Efficacy and Safety of Multiple Doses of CG5503 IR for Postoperative Pain Following Bunionectomy|Completed||Phase 3|291|Actual|Grünenthal GmbH|Lortab (hydrocodone/acetaminophen) was allowed as rescue medication.|3|||f||||f||||||||||2017-02-18 14:46:58.763616|2017-02-18 14:46:58.763616
NCT00445211|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2016-09-19|||January 2006||2006-01-01|September 2016|2016-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|HEROIC||HEROIC (Heparin Requirement in Counterpulsation)|Heparin Requirement in Counterpulsation|Completed||Phase 2|46|Actual|William Beaumont Hospitals||2|||f||||||||||||||2017-02-18 15:47:54.940924|2017-02-18 15:47:54.940924
NCT00609453|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-10-05|||October 2006||2006-10-01|October 2012|2012-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Brain Imaging of Psychotherapy for Depression|"Brain Imaging of Psychotherapy for Depression (Includes, Reward System Recovery Following Behavioral Activation Therapy in Depression)"|Completed||N/A|27|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 14:46:59.453639|2017-02-18 14:46:59.453639
NCT00609440|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2008-10-17|||January 2006||2006-01-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|August 2006|Actual|2006-08-01||Interventional|||Morquio's Syndrome: a Case Study|Morquio's Syndrome: a Case Study|Terminated||Phase 4|1|Actual|Clínica de Hidroterapia e Recuperacao Funcional||1||terminated|f||||f||||||||||2017-02-18 14:46:59.551955|2017-02-18 14:46:59.551955
NCT00609427|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2010-06-01|||May 2008||2008-05-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effects of Cognitive Intervention for Older Adults With Memory Decline: A Pilot Study|Effects of Cognitive Intervention for Older Adults With Memory Decline: A Pilot Study|Completed||Phase 1|30|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-02-18 14:46:59.639392|2017-02-18 14:46:59.639392
NCT00609414|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2011-04-15|||January 2005||2005-01-01|April 2011|2011-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Albumin Use in Burn Patients|Albumin Use in Burn Patients|Completed||N/A|460|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 14:46:59.745242|2017-02-18 14:46:59.745242
NCT00609401|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-02-25|||November 2006||2006-11-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|May 2007|Actual|2007-05-01||Interventional|ROSORC||Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)|A Randomized Open Label Multicenter Phase II Study of First Line Therapy With Sorafenib in Association With IL-2 vs Sorafenib Alone in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma|Completed||Phase 2|90|Actual|Italian Trial in Medical Oncology||2|||f||||t||||||||||2017-02-18 14:46:59.839784|2017-02-18 14:46:59.839784
NCT00609388|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2010-12-07|||January 2008||2008-01-01|December 2007|2007-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|TAC-Infusion||Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation|Evaluation of Tacrolimus (Prograf®) Intraportal Infusion During the Implantation and the Protective Effect on Ischemia-reperfusion Injury in Orthotopic Liver Transplant Recipients - Single Center Study|Completed||Phase 4|26|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:46:59.961245|2017-02-18 14:46:59.961245
NCT00609375|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-02-06|||September 2006||2006-09-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|CEFPK/PD||Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen|Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen in Adult Critically Ill Patients With Gram Negative Bacilli Bacteremia|Completed||Phase 4|30|Actual|Javeriana University||2|||f||||t||||||||||2017-02-18 14:47:00.072114|2017-02-18 14:47:00.072114
NCT00609362|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2011-03-29|2011-02-17||January 2008||2008-01-01|March 2011|2011-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells|The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells|Completed||Phase 2|57|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:47:00.18618|2017-02-18 14:47:00.18618
NCT00609349|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-01-11|||April 2006||2006-04-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Early Recognition of Pulmonary Arterial Hypertension|The Early Recognition of Pulmonary Arterial Hypertension|Completed||N/A|52|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 14:47:00.867918|2017-02-18 14:47:00.867918
NCT00609336|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2017-01-06|||January 2008||2008-01-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|November 2014|Actual|2014-11-01||Interventional|||Combination Chemotherapy, Intensity-Modulated Radiation Therapy, and Surgery in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery|A Phase II Study Induction Chemotherapy, Neoadjuvant Chemoradiotherapy, Surgical Resection and Adjuvant Chemotherapy for Patients With Locally Advanced, Resectable Pancreatic Adenocarcinoma|Completed||Phase 2|35|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:47:00.974763|2017-02-18 14:47:00.974763
NCT00609323|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-03-22||2012-03-22|January 2008||2008-01-01|March 2012|2012-03-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN)|A Randomized, Double-Blind, Crossover Study Comparing Pliaglis™ (Lidocaine and Tetracaine) Cream 7%/7% to Placebo Cream When Applied for 60 Minutes in the Treatment of Patients With Postherpetic Neuralgia|Completed||Phase 2|23|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-02-18 14:47:01.110631|2017-02-18 14:47:01.110631
NCT00609310|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-02-02|||May 2015||2015-05-01|February 2012|2012-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence|Dietary Supplementation With Bioflavonoids for the Prevention of the Recurrence of Neoplasia in Patients With Resected Colorectal Carcinoma|Suspended||Phase 2|382|Anticipated|Technische Universität Dresden||1|||f||||f||||||||||2017-02-18 14:47:01.240521|2017-02-18 14:47:01.240521
NCT00609297|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-06|2012-10-23|||July 2007||2007-07-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|March 2008|Actual|2008-03-01||Observational|||Pain Control in Hospice Patients With Cancer-Related Pain|Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol Stage 2, Part A|Completed||N/A|22|Actual|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-02-18 14:47:01.343883|2017-02-18 14:47:01.343883
NCT00609284|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2015-03-23|||February 2008||2008-02-01|March 2015|2015-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|GORTEC2007-01||Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux|Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux|Active, not recruiting||Phase 3|406|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||2|||f||||t||||||||||2017-02-18 14:47:01.468268|2017-02-18 14:47:01.468268
NCT00609271|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-12-31|||January 2008||2008-01-01|December 2013|2013-12-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|MACRO||Study of Macronutrients and Heart Disease Risk|Macronutrient Composition of Diet and Risk Factors for Cardiovascular Disease|Completed||N/A|148|Actual|Tulane University Health Sciences Center||2|||f||||t||||||||||2017-02-18 14:47:01.580224|2017-02-18 14:47:01.580224
NCT00609245|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2011-03-21|||December 2007||2007-12-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Valproic Acid Concentration on Photic Response|Effect of Small Changes in Plasma Valproic Acid Concentration on the Photoparoxysmal Response|Completed||N/A|13|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:47:01.683602|2017-02-18 14:47:01.683602
NCT00609219|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-02|2012-10-05|||August 2001||2001-08-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|October 2007|Actual|2007-10-01||Interventional|NPC||T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC|Administration of EBV-Specific T-Lymphocytes to Patients With EBV-Positive Nasopharyngeal Carcinoma|Completed||Phase 1|25|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:47:01.800869|2017-02-18 14:47:01.800869
NCT00609193|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2015-12-03|||January 2008||2008-01-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Observational|||Functional and Neurochemical Brain Changes in First-episode Bipolar Mania|Functional and Neurochemical Brain Changes in First-episode Bipolar Mania Following Successful Treatment With Lithium or Quetiapine|Completed||Phase 4|81|Actual|University of Cincinnati|||2||f||||f||||||||||2017-02-18 14:47:01.934996|2017-02-18 14:47:01.934996
NCT00609180|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-04-12|||December 2007||2007-12-01|February 2012|2012-02-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|EDEN-Omega||Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)|Prospective, Randomized, Multi-Center Trial of Initial Trophic Enteral Feeding Followed by Advancement to Full-Calorie Enteral Feeding vs. Early Advancement to Full-Calorie Enteral Feeding in Patients With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS) and Prospective, Randomized, Blinded, Placebo-Controlled, Multi-Center Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Anti-Oxidant Supplementation in the Management of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)|Terminated||Phase 3|272|Actual|National Heart, Lung, and Blood Institute (NHLBI)||4||"The Omega arm of this study was stopped for futility. The EDEN arm continues to recruit~   patients as a separate independent study."|f||||t||||||||||2017-02-18 14:47:02.041956|2017-02-18 14:47:02.041956
NCT00609167|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2011-05-13|2010-11-05||December 2006||2006-12-01|May 2011|2011-05-01|November 2010|Actual|2010-11-01|January 2009|Actual|2009-01-01||Interventional|||Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma|A Phase II Trial of Cyclophosphamide, Bortezomib and Dexamethasone (CYBOR-D) in Patients With Newly Diagnosed Active Multiple Myeloma|Completed||Phase 2|63|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:47:02.216968|2017-02-18 14:47:02.216968
NCT00609154|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-02-05|||November 2007||2007-11-01|January 2008|2008-01-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates|Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates|Unknown status|Recruiting|Phase 1|16|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-02-18 14:47:02.959421|2017-02-18 14:47:02.959421
NCT00609141|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-02|2014-06-18|||January 2008||2008-01-01|June 2014|2014-06-01||||September 2009|Actual|2009-09-01||Interventional|||IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor|A Phase I Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, NSC #742460) in Children With Relapsed/Refractory Solid Tumors|Completed||Phase 1|34|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:47:03.056653|2017-02-18 14:47:03.056653
NCT00609128|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-10-30|||September 2000||2000-09-01|October 2008|2008-10-01|September 2011|Anticipated|2011-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Allergic Eye Disease Tear Mediators|Expression of Inflammatory Mediators in Allergic Conjunctivitis|Unknown status|Recruiting|N/A|40|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 14:47:03.164487|2017-02-18 14:47:03.164487
NCT00609115|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2014-01-16|||September 2007||2007-09-01|January 2014|2014-01-01|December 2014|Anticipated|2014-12-01|June 2014|Anticipated|2014-06-01||Interventional|AMES||Sub-Acute Stroke Rehabilitation With AMES|Sub-Acute Stroke Rehabilitation With Assisted Movement With Enhanced Sensation|Unknown status|Active, not recruiting|Phase 2/Phase 3|132|Anticipated|AMES Technology||3|||f||||t||||||||||2017-02-18 14:47:03.267382|2017-02-18 14:47:03.267382
NCT00609102|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-12-22|||July 2008||2008-07-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Antioxidant Treatment of Type 2 Diabetes||Completed||Early Phase 1|44|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||||||||||||2017-02-18 14:47:03.375421|2017-02-18 14:47:03.375421
NCT00609089|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-08-13|||March 2008||2008-03-01|August 2012|2012-08-01|June 2013|Anticipated|2013-06-01|June 2012|Actual|2012-06-01||Interventional|||Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction|A Stage 1 Study of Community Reinforcement and Family Training for Treatment Drug Abuse Treatment Retention/HIV Risk Reduction|Unknown status|Active, not recruiting|Phase 1/Phase 2|104|Anticipated|University of Cincinnati||2|||f||||f||||||||||2017-02-18 14:47:03.465457|2017-02-18 14:47:03.465457
NCT00609063|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-01-05|||January 2008||2008-01-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|STOMP||The Effect of Statin Medications on Muscle Performance (The STOMP Study)|The Effect of Statins on Skeletal Muscle Function|Completed||N/A|420|Actual|Hartford Hospital||2|||f||||t||||||||||2017-02-18 14:47:03.571731|2017-02-18 14:47:03.571731
NCT00609050|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-02-18|||March 2007||2007-03-01|February 2016|2016-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Exercise Training Study for Patients With Cystic Fibrosis|Self-Regulated Exercise in CF: A Randomized Trial|Completed||N/A|38|Actual|University of Pittsburgh||2|||f||||t||||||||Undecided||2017-02-18 14:47:03.898784|2017-02-18 14:47:03.898784
NCT00609037|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2015-12-10|||January 2006||2006-01-01|December 2015|2015-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Wound Repair and Body Contouring Surgery After Gastric Bypass|A Pilot/Feasibility Study on Wound Repair and Body Contouring Surgery After Gastric By-pass|Completed||N/A|34|Actual|Vanderbilt University|||2||f||||f||||||||||2017-02-18 14:47:04.005248|2017-02-18 14:47:04.005248
NCT00609011|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2010-08-19|||March 2008||2008-03-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma|Dose Finding Phase 1 Study of the Treatment of Metastatic Melanoma With MPC-6827 in Combination With Temozolomide|Completed||Phase 1/Phase 2|22|Actual|Myrexis Inc.||1|||f||||f||||||||||2017-02-18 14:47:04.11512|2017-02-18 14:47:04.11512
NCT00608998|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2011-03-28|||July 2007||2007-07-01|January 2008|2008-01-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Observational|Pre-HD||Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression|Vascular Risk Factors and Coronary Calcifications in Chronic Renal Failure Patients: Identification of Specific Factors Linked to Renal Failure Progression|Unknown status|Recruiting|N/A|120|Anticipated|University Hospital, Montpellier|||1||f||||t||||||Samples With DNA|"~     whole blood white cells serum plasma urine~   "|||2017-02-18 14:47:04.21699|2017-02-18 14:47:04.21699
NCT00608985|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2016-02-11|2012-12-21||March 2008||2008-03-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|RESTORA 1||Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia|Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group Polysomnography Study to Assess the Efficacy and Safety of a 16-day Oral Administration of ACT-078573 in Adult Subjects With Chronic Primary Insomnia|Completed||Phase 3|709|Actual|Midnight Pharma, LLC||4|||f||||f||||||||||2017-02-18 14:47:04.317319|2017-02-18 14:47:04.317319
NCT00608972|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2015-11-05|||May 2008||2008-05-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|June 2015|Actual|2015-06-01||Interventional|||Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer|A Phase II Trial of Doxil, Carboplatin and Bevacizumab in Triple Negative Previously Untreated Metastatic Breast Cancer|Completed||Phase 2|31|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 14:47:05.880598|2017-02-18 14:47:05.880598
NCT00608959|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2010-01-22|2009-06-30||May 2008||2008-05-01|January 2010|2010-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects|A Single- Center, Open-Label, Study of the Persistence of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects|Completed||Phase 3|30|Actual|Mallinckrodt|FDA reviewer noted that there were multiple endpoints that required multiplicity adjustments to control for the overall type I error rate.Based on feedback the 72 hour endpoint was selected for Part 2 as the primary efficacy endpoint.|2|||f||||f||||||||||2017-02-18 14:47:05.996507|2017-02-18 14:47:05.996507
NCT00608946|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-02-05|||March 2004||2004-03-01|January 2008|2008-01-01||||August 2007|Actual|2007-08-01||Interventional|||Treatment With Copper in Patients With Mild Alzheimer´s Dementia||Completed||Phase 2|68|Actual|University Hospital, Saarland||2|||f||||t||||||||||2017-02-18 14:47:06.407736|2017-02-18 14:47:06.407736
NCT00608933|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2016-09-07|||June 2008||2008-06-01|September 2016|2016-09-01||||August 2017|Anticipated|2017-08-01||Interventional|||Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative Medicine|CAM USE and Cancer|Active, not recruiting||Phase 3|1360|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 14:47:06.513703|2017-02-18 14:47:06.513703
NCT00608920|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-05-22|||March 2007||2007-03-01|May 2013|2013-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|SPECT||Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping|SPECT Lymph Node Mapping to Define Nodal Clinical Target Volume in Patients With Prostate Cancer|Completed||N/A|15|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:47:06.623666|2017-02-18 14:47:06.623666
NCT00608907|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-01-26|2011-03-29||September 2007||2007-09-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)|An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)|Completed||Phase 1|61|Actual|Millennium Pharmaceuticals, Inc.||3|||f||||||||||||||2017-02-18 14:47:06.740181|2017-02-18 14:47:06.740181
NCT00608894|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-12-18|||December 2007||2007-12-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis|A Phase II, Open-Label, Multi-Center, Prospective, Randomized Study of LCP-Tacro Tablets vs. Azathioprine, in Combination With Corticosteroids, for the Treatment of Autoimmune Hepatitis|Completed||Phase 2|60|Actual|Veloxis Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:47:07.445444|2017-02-18 14:47:07.445444
NCT00608881|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-02-29|2015-12-07||March 2008||2008-03-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|2CARE||Coenzyme Q10 in Huntington's Disease (HD)|Coenzyme Q10 in Huntington's Disease (HD)|Terminated||Phase 3|609|Actual|Massachusetts General Hospital|An interim analysis for futility revealed a conditional power of < 5% for the primary analysis, and the trial was halted in July, 2014. Only data collected prior to this time were included in the final analyses.|2||Futility analysis failed to showed likelihoo of benefit of CoQ 2400 mg/day.|f||||t||||||||||2017-02-18 14:47:07.791127|2017-02-18 14:47:07.791127
NCT00608868|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-08-29|2010-02-08||January 2007||2007-01-01|August 2012|2012-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|SELINE||SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients|A Phase IV, Multicenter, Non-randomized, Open-labeled Study to Evaluate the Efficacy of Gefitinib (IRESSA®) as a Second-line Therapy in NSCLC Patients|Completed||Phase 4|156|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 14:47:08.822462|2017-02-18 14:47:08.822462
NCT00608855|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2017-01-11|||November 2003||2003-11-01|January 2017|2017-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases|Percutaneous US and CT-guided Cryoablation of Painful Metastases Involving Bone: A Feasibility Study|Completed||N/A|60|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 14:47:09.199238|2017-02-18 14:47:09.199238
NCT00608842|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2015-12-08|2015-12-08||November 2007||2007-11-01|December 2015|2015-12-01|January 2010|Actual|2010-01-01|August 2008|Actual|2008-08-01||Interventional||Modified intent-to-treat (MITT) population included all randomized participants who had received at least 1 dose of study material and who had at least 1 postbaseline observation.|Phase 2 Study for the Treatment of Superficial Lipomas|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Intralipomal Injections for the Treatment of Superficial Lipomas|Completed||Phase 2|62|Actual|Kythera Biopharmaceuticals||4|||f||||f||||||||||2017-02-18 14:47:09.325746|2017-02-18 14:47:09.325746
NCT00608634|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2015-03-27|2011-04-15||May 2004||2004-05-01|March 2014|2014-03-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses|Phase 2a Randomized, Placebo-Controlled, Double-Blind Trial of Topical Perillyl Alcohol in Sun Damaged Skin|Completed||Phase 2|89|Actual|University of Arizona||3|||f||||t||||||||||2017-02-18 14:47:12.269202|2017-02-18 14:47:12.269202
NCT00608829|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-03-04|2010-08-18||February 2007||2007-02-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|August 2009|Actual|2009-08-01||Interventional|||GORE TAG® Thoracic Endoprosthesis - 45 mm for the Treatment of Aneurysms of the Descending Thoracic Aorta|Evaluation of the GORE TAG® Thoracic Endoprosthesis - 45 mm for the Primary Treatment of Aneurysms of the Descending Thoracic Aorta|Completed||Phase 2|23|Actual|W.L.Gore & Associates|Enrollment into this trial was completed prematurely with 23 enrolled subjects. The 45mm TAG Device was approved based on the data collected and a descriptive statistical analysis. Follow up of enrolled subjects continued for 5 years.|1|||f||||f||||||||||2017-02-18 14:47:10.197443|2017-02-18 14:47:10.197443
NCT00608816|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-12-10||||||December 2014|2014-12-01||||||||Interventional|||Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q4|Hypoglycemia Associated Autonomic Failure in Type 1 DM, Question 4|Withdrawn||N/A|0|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:47:10.424771|2017-02-18 14:47:10.424771
NCT00608803|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2009-09-16|||January 2008||2008-01-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors|A Phase I Study of ZIO-201-T in Combination With Doxorubicin in Subjects With Advanced, Refractory Solid Tumors for Which no Standard Therapy Exists and for Whom Treatment With Doxorubicin is Considered Medically Acceptable|Completed||Phase 1|30|Anticipated|Ziopharm||1|||f||||f||||||||||2017-02-18 14:47:10.520463|2017-02-18 14:47:10.520463
NCT00608790|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-07-23|||February 2008||2008-02-01|July 2012|2012-07-01|April 2013|Anticipated|2013-04-01|December 2012|Anticipated|2012-12-01||Interventional|||Rapid Diagnosis of Pulmonary Tuberculosis|Diagnostic Yield of Induced Sputum for Rapid Diagnosis of Pulmonary Tuberculosis|Unknown status|Recruiting|N/A|600|Anticipated|University of Cape Town||1|||f||||f||||||||||2017-02-18 14:47:10.618414|2017-02-18 14:47:10.618414
NCT00608777|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-08-07|2012-03-05||January 2008||2008-01-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)|Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Mild Breakthrough in Moderate to Severe Plaque Psoriasis Patients Receiving Efalizumab ( Raptiva).|Terminated||Phase 4|6|Actual|Derm Research, PLLC|Study terminated due to withdrawal of Raptiva from the market. Study specifically designed to address a side effect associated with the administration of Raptiva. Therefore no data analysis completed for this study and no measuremnet of outcomes.|1||Withdrawal of marketing autorization of efalizumab by the EMEA.|f||||f||||||||||2017-02-18 14:47:10.716668|2017-02-18 14:47:10.716668
NCT00608764|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2017-02-01|||November 2007||2007-11-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|COPDGene||Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)|Genetic Epidemiology of Chronic Obstructive Pulmonary Disease|Recruiting||N/A|10500|Anticipated|Brigham and Women's Hospital|||4||f||||f||||||Samples With DNA|"~     Genomic DNA, serum, and plasma will be collected and stored.~   "|Yes|COPDGene phenotypic and genotypic data are available through dbGaP.|2017-02-18 14:47:10.96354|2017-02-18 14:47:10.96354
NCT00608751|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-05-22|||January 2007||2007-01-01|May 2013|2013-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|IMRT||A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy|A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy in the Definitive Treatment of Head-and-Neck Cancer|Terminated||Early Phase 1|5|Actual|Washington University School of Medicine||1||Lack of accrual and software issues|f||||f||||||||||2017-02-18 14:47:11.116525|2017-02-18 14:47:11.116525
NCT00608738|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-07-09|||July 2001||2001-07-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment|Developing a Nested Whole-Person-Care Guide: Screening and Evaluation Steps (American Cancer Society) ACS|Completed||N/A|750|Anticipated|Northwestern University|||||f||||||||||||||2017-02-18 14:47:11.445767|2017-02-18 14:47:11.445767
NCT00608725|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-08-15|||December 1996||1996-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pathophysiology of Orthostatic Intolerance|Pathophysiology of Orthostatic Intolerance|Recruiting||N/A|100|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:47:11.544809|2017-02-18 14:47:11.544809
NCT00608712|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2011-01-21|||November 2005||2005-11-01|January 2011|2011-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)|Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)|Completed||Phase 4|140|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:47:11.684349|2017-02-18 14:47:11.684349
NCT00608699|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-04-26|||December 2007||2007-12-01|April 2012|2012-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers|A Study to Evaluate the Ability of the HM74A Agonist GSK256073A to Block Niacin-induced Flushing in Healthy Adult Subjects|Completed||Phase 1|24|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 14:47:11.768884|2017-02-18 14:47:11.768884
NCT00608686|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-26|2008-12-18|||May 2004||2004-05-01|December 2008|2008-12-01|March 2009|Anticipated|2009-03-01|January 2009|Anticipated|2009-01-01||Interventional|||Neurosteroids and Acute Alcohol Intoxication in Humans|Neurosteroids and Acute Alcohol Intoxication in Humans|Unknown status|Active, not recruiting|Phase 1|92|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||t||||||||||2017-02-18 14:47:11.87442|2017-02-18 14:47:11.87442
NCT00608673|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-02-06|||April 2006||2006-04-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus|Pimecrolimus 1% Cream vs. Betamethasone Valerate 0.1% Cream in the Treatment of Facial Discoid Lupus Erythematosus: a Double-Blind Randomized, Pilot Study.|Completed||N/A|10|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:47:11.981841|2017-02-18 14:47:11.981841
NCT00608660|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2009-09-15|||October 2006||2006-10-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different Stages|Studying of Acupuncture for Bell's Palsy According to Different Stages|Completed||N/A|900|Actual|Chengdu University of Traditional Chinese Medicine||5|||f||||t||||||||||2017-02-18 14:47:12.097533|2017-02-18 14:47:12.097533
NCT00608621|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-02-05|||January 2007||2007-01-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|ANA06103||Influence of Physostigmine on Patient-Controlled Analgesia (PCA) in Postoperative Intensive Care Patients|Influence of Physostigmine on Patient-Controlled Analgesia (PCA) in Postoperative Intensive Care Patients, Considering Pain Score, Opioid Consumption, Hemodynamics and Cognitive Function|Completed||N/A|60|Actual|Klinikum Ludwigshafen|||2||f||||f||||||||||2017-02-18 14:47:12.848183|2017-02-18 14:47:12.848183
NCT00608595|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2013-03-02|||July 2002||2002-07-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|May 2004|Actual|2004-05-01||Interventional|||Celecoxib in Treating Patients With Early-Stage Rectal Cancer|Pilot COX-2 Activity in Early Stage Rectal Cancer -Short Term Administration of Celecoxib (SPORE)|Terminated||N/A|10|Actual|Vanderbilt-Ingram Cancer Center||1||low accrual|f||||t||||||||||2017-02-18 14:47:12.951392|2017-02-18 14:47:12.951392
NCT00608582|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2016-12-01|2016-09-22||July 2002||2002-07-01|December 2016|2016-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||Number of participants randomized to each treatment arm|Transcranial Magnetic Stimulation to Improve Speech in Aphasia|Transcranial Magnetic Stimulation to Improve Speech|Completed||Phase 1|63|Actual|Boston University||2|||f||||f||||||||No||2017-02-18 14:47:13.077364|2017-02-18 14:47:13.077364
NCT00608569|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2013-11-14|2013-09-05||March 2009||2009-03-01|November 2013|2013-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||Five hundred twenty nine subjects including participants and partners entered the study. Among the 529 subjects, 259 were participants, which include two participants with eligibility violations. Only the 257 eligible participants were included in the analysis.|Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults|International Trial of Modified Directly Observed Therapy Versus Self-Administered Therapy for Participants With First Virologic Failure on a Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Regimen|Completed||N/A|529|Actual|AIDS Clinical Trials Group||2|||f||||||||||||||2017-02-18 14:47:13.706933|2017-02-18 14:47:13.706933
NCT00608556|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2017-01-24|||January 25, 2008||2008-01-25|October 31, 2011|2011-10-31|October 31, 2011||2011-10-31|||||Observational|||Dyskinesia, Heterotaxy and Congenital Heart Disease|Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia With Heterotaxy and Complex Congenital Heart Disease|Completed||N/A|3|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:47:14.845997|2017-02-18 14:47:14.845997
NCT00608543|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-10-24|2011-11-15||October 2005||2005-10-01|March 2012|2012-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression|Aripiprazole Augmentation of SSRI Antidepressant Therapy in Treatment Refractory Depression: Assessment of Symptom Reduction, Psychosocial Function, and Cognitive Function|Completed||Phase 4|17|Actual|University of Texas Southwestern Medical Center|Note that because this is an augmentation trial, reported AEs are due to combined treatment with escitalopram, citalopram, or sertraline AND aripiprazole.|1|||f||||f||||||||||2017-02-18 14:47:14.932369|2017-02-18 14:47:14.932369
NCT00608530|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-03-04|2015-02-18||March 2008||2008-03-01|February 2015|2015-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|TELE|Eligible individuals who were enrolled and attended at least one intervention visit.|Telehealth Outreach for Chronic Back Pain|Telehealth Outreach for Chronic Back Pain|Completed||Phase 1/Phase 2|66|Actual|VA Office of Research and Development|"The trial was viewed as a proof-of-concept and analyses were conducted on those who completed 8 weeks of treatment (ie, per protocol). This, along with of the small sample size and attrition, limits the strength of the evidence."|2|||f||||t||||||||||2017-02-18 14:47:15.259517|2017-02-18 14:47:15.259517
NCT00608517|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-05-12|2010-10-11||September 2005||2005-09-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|March 2008|Actual|2008-03-01||Interventional|||Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil|The Treatment of Hematologic Malignancies With Single or Double Umbilical Cord Blood Unit Transplantation Followed by Graft-versus-Host Prophylaxis With Tacrolimus and Mycophenolate Mofetil|Terminated||N/A|6|Actual|Vanderbilt-Ingram Cancer Center||3||slow accrual|f||||t||||||||||2017-02-18 14:47:15.694384|2017-02-18 14:47:15.694384
NCT00608504|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2012-06-01|||July 2007||2007-07-01|June 2012|2012-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|DSC||Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals.|Biobehavioral Study of Opioid Drug Seeking Behavior: Study 3|Completed||N/A|16|Anticipated|Wayne State University|||1||f||||t||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 14:47:16.404067|2017-02-18 14:47:16.404067
NCT00608491|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-05-15|2013-02-18||March 2008||2008-03-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|CARRESS||Effectiveness of Ultrafiltration in Treating People With Acute Decompensated Heart Failure and Cardiorenal Syndrome (The CARRESS Study)|CARdiorenal REScue Study in Acute Decompensated Heart Failure: CARRESS|Completed||Phase 3|188|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:47:16.506629|2017-02-18 14:47:16.506629
NCT00608465|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-07-14|||May 2006||2006-05-01|July 2016|2016-07-01|May 2011|Actual|2011-05-01|May 2009|Actual|2009-05-01||Interventional|||Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity|Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity|Terminated||Phase 4|4|Actual|Vanderbilt University||2||Lack of enrollment|f||||t||||||||||2017-02-18 14:47:20.873853|2017-02-18 14:47:20.873853
NCT00608452|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2009-11-12|||July 1995||1995-07-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers|A Prospective Study of The Prevalence and Significance of Paraneoplastic Autoantibodies in Small Cell Lung Cancer and Cancer of The Breast, Ovary, Hodgkin's Disease, Neuroblastoma and Other Cancers|Completed||N/A|121|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||t||||||Samples Without DNA|"~     blood samples for autoantibody determinations and HLA typing~   "|||2017-02-18 14:47:20.984292|2017-02-18 14:47:20.984292
NCT00608439|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2012-11-09|||September 2007||2007-09-01|November 2012|2012-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|CAST||Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy|Centella Asiatica Triterpene Extract for Diabetic Neuropathy -- a Pilot Study|Completed||Phase 2|43|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:47:21.096563|2017-02-18 14:47:21.096563
NCT00608426|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-04-06|2014-06-06||October 2009||2009-10-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Interventional|||Proactive Tobacco Treatment for Veterans|Proactive Tobacco Treatment for Diverse Veteran Smokers|Completed||N/A|6400|Actual|VA Office of Research and Development|Smoking abstinence rates were not biochemically verified|2|||f||||t||||||||||2017-02-18 14:47:21.212506|2017-02-18 14:47:21.212506
NCT00608400|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-03-01|||December 2008||2008-12-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|March 2011|Actual|2011-03-01||Interventional|||Effect of Dietary Conjugated Linoleic Acid (CLA) on Parathyroid Hormone in Men|Does Dietary Cis-9, Trans-11 Conjugated Linoleic Acid Reduce Parathyroid Hormone in Men?|Completed||Phase 1|55|Actual|McGill University||3|||f||||f||||||||||2017-02-18 14:47:22.195476|2017-02-18 14:47:22.195476
NCT00608387|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-06-03|||February 2009||2009-02-01|June 2014|2014-06-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians|Web-based, Patient-centered Approach to CVD Risk-factor Management and Reduction|Completed||N/A|149|Actual|Black Hills Center for American Indian Health||2|||f||||t||||||||||2017-02-18 14:47:22.300808|2017-02-18 14:47:22.300808
NCT00608374|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-08-23|||June 2006||2006-06-01|June 2009|2009-06-01|January 2013|Actual|2013-01-01|December 2009|Actual|2009-12-01||Interventional|||Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma|A Randomised Trial of Chlorambucil Versus Fludarabine as Initial Therapy of Waldenström's Macroglobulinaemia and Splenic Lymphoma With Villous Lymphocytes|Completed||Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:47:22.631947|2017-02-18 14:47:22.631947
NCT00608361|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2015-06-30|||October 2008||2008-10-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery|Phase I Pharmacokinetic Study of Dasatinib (BMS-354825) (NSC-732517) in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction|Completed||Phase 1|80|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 14:47:22.782375|2017-02-18 14:47:22.782375
NCT00608348|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2015-06-09|||April 2002||2002-04-01|June 2015|2015-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Sympathetic Nerve Activity During Hypoglycemia and Exercise|Sympathetic Nerve Activity During Hypoglycemia and Exercise|Completed||N/A|36|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:47:22.937721|2017-02-18 14:47:22.937721
NCT00608335|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2013-03-12|||October 2007||2007-10-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug|A Phase 1, Open-Label Study Of The Safety And Pharmacokinetics Of Repeated-Dose Micafungin (FK463) In Children (2-5 Years AND 6-11 Years) And Adolescents (12-16 Years) With Esophageal Candidiasis Or Other Invasive Candidiasis|Completed||Phase 1|84|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:47:23.040585|2017-02-18 14:47:23.040585
NCT00608322|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2013-06-03|2013-04-16||August 2009||2009-08-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis|Randomized Double-blind Placebo-controlled Trial of Inhaled Nitric Oxide for the Treatment of Microcirculatory Dysfunction and Organ Failure in Sepsis|Completed||Phase 3|49|Actual|National Institute of General Medical Sciences (NIGMS)||2|||f||||t||||||||||2017-02-18 14:47:23.171588|2017-02-18 14:47:23.171588
NCT00608296|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-12-22|||January 2008||2008-01-01|December 2014|2014-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Functional and Neurochemical Brain Changes Bipolar Depression|Functional and Neurochemical Brain Changes Following Successful Treatment of Early Course Bipolar Depression|Completed||N/A|120|Anticipated|University of Cincinnati|||2||f||||f||||||||||2017-02-18 14:47:23.572143|2017-02-18 14:47:23.572143
NCT00608283|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-05|2012-12-11|||August 2007||2007-08-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Live Kidney Donor Study|Live Kidney Donor Study (RELIVE-01)|Completed||N/A|8951|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||||||2017-02-18 14:47:23.652921|2017-02-18 14:47:23.652921
NCT00608244|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2015-08-14|2014-06-10||November 2007||2007-11-01|August 2015|2015-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients|A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf® Capsules Twice-A-Day|Completed||Phase 2|59|Actual|Veloxis Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:47:23.769586|2017-02-18 14:47:23.769586
NCT00608231|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-06-30|||January 2008||2008-01-01|June 2014|2014-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation|Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation|Withdrawn||Phase 2/Phase 3|0|Actual|Vanderbilt University||8||Intraoperative recording could not be maintained for required period|f||||t||||||||||2017-02-18 14:47:24.116933|2017-02-18 14:47:24.116933
NCT00608218|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-12-02|||January 2008||2008-01-01|September 2016|2016-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|ARTIST||Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma|Ciclesonide for the Therapy of Asthma During the Cold Season.|Completed||N/A|2100|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:47:24.234123|2017-02-18 14:47:24.234123
NCT00608205|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2016-09-09|2013-07-11||January 2008||2008-01-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|September 2012|Actual|2012-09-01||Interventional|||Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer|A Phase III Randomized Trial Comparing Single Agent Cisplatin With the Combination of 5-Fluorouracil and Cisplatin, Concurrent With Radiation Therapy in Stage III and IV Squamous Cell Head and Neck Cancer|Completed||Phase 3|69|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 14:47:24.718308|2017-02-18 14:47:24.718308
NCT00608192|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2013-01-15|||January 2008||2008-01-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||HIV and Hepatitis Care Coordination in Methadone Treatment|HIV and Hepatitis Care Coordination in Methadone Treatment|Completed||N/A|489|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 14:47:26.113508|2017-02-18 14:47:26.113508
NCT00608179|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2014-12-10|||August 2002||2002-08-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|September 2004|Actual|2004-09-01||Interventional|||Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia|Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia|Completed||N/A|32|Actual|Vanderbilt University||4|||f||||t||||||||||2017-02-18 14:47:26.22321|2017-02-18 14:47:26.22321
NCT00439322|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2015-04-06||||||February 2007|2007-02-01|September 2000|Actual|2000-09-01|||||Observational|||Post Traumatic Stress Disorder Among VA Ambulatory Care Patients|Post Traumatic Stress Disorder Among VA Ambulatory Care Patients|Completed||N/A|473|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 15:50:36.207143|2017-02-18 15:50:36.207143
NCT00608153|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-02-05|||January 2007||2007-01-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Observational|CoCa||Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide|Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide|Completed||N/A|1773|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:47:26.325437|2017-02-18 14:47:26.325437
NCT00608140|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2014-07-09|2013-04-29||March 2008||2008-03-01|July 2013|2013-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|SMMART-HF||Effectiveness of Surgical Mitral Valve Repair Versus Medical Treatment for People With Significant Mitral Regurgitation and Non-ischemic Congestive Heart Failure|Surgery Versus Medical Treatment Alone for Patients With Significant Mitral Regurgitation and Non-ischemic Congestive Heart Failure: SMMART-HF|Terminated||Phase 3|2|Actual|Duke University||3||Unable to recruit sufficient numbers of patients.|f||||t||||||||||2017-02-18 14:47:26.417843|2017-02-18 14:47:26.417843
NCT00608127|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-05-21|||January 2007||2007-01-01|May 2008|2008-05-01|August 2008|Anticipated|2008-08-01|May 2008|Anticipated|2008-05-01||Interventional|||Study to Evaluate the Safety, Tolerability and Short Term Efficacy of Extracorporeal Specific Immunoadsorption LupusorbTM Columns for the Treatment of Systemic Lupus Erythematosus (SLE) Patients|A Single - Arm Open - Label Study to Evaluate the Safety, Tolerability and Short Term Efficacy of Extracorporeal Specific Immunoadsorption LupusorbTM Columns for the Treatment of Systemic Lupus Erythematosus (SLE) Patients|Unknown status|Active, not recruiting|N/A|10|Anticipated|Verto LTD||1|||f||||f||||||||||2017-02-18 14:47:26.818031|2017-02-18 14:47:26.818031
NCT00608101|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-12-10|||September 2010||2010-09-01|December 2014|2014-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus|Hypoglycemia Associated Autonomic Failure in Type 1 DM, Question 1|Withdrawn||N/A|0|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:47:26.915146|2017-02-18 14:47:26.915146
NCT00608088|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-01-24|||March 2003||2003-03-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Evaluation of a Community Health Nurse/Peer Counselor Program to Help Low-Income Women Breastfeed Longer|Support for Low-Income Breastfeeding: Cost and Outcomes|Completed||Phase 3|328|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-02-18 14:47:27.004005|2017-02-18 14:47:27.004005
NCT00608075|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-10-05|||April 2007||2007-04-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2015|Actual|2015-07-01||Interventional|LAMBS/LADS||Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder|Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder|Active, not recruiting||Phase 4|260|Anticipated|University of Cincinnati||2|||f||||f||||||||||2017-02-18 14:47:27.114665|2017-02-18 14:47:27.114665
NCT00608062|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2016-09-15|||March 2007||2007-03-01|September 2016|2016-09-01||||June 2013|Actual|2013-06-01||Interventional|SHAPE||Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women|Biological Mechanisms of Arterial Stiffening With Age and Estrogen Deficiency|Active, not recruiting||N/A|92|Actual|University of Colorado, Denver||8|||f||||f||||||||||2017-02-18 14:47:27.207936|2017-02-18 14:47:27.207936
NCT00608049|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-07-05|||February 2008||2008-02-01|July 2016|2016-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effect of Amount and Type of Dietary Carbohydrates on Risk for Cardiovascular Heart Disease and Diabetes|Optimal Macronutrient Intake - Carbohydrate|Completed||N/A|189|Actual|Brigham and Women's Hospital||8|||f||||t||||||||||2017-02-18 14:47:27.392225|2017-02-18 14:47:27.392225
NCT00608036|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2015-12-07|||May 2008||2008-05-01|December 2015|2015-12-01|May 2012|Actual|2012-05-01|December 2010|Actual|2010-12-01||Observational|||Evaluating the Relationship Between Physical Activity, Diet, Weight, and the Neighborhood Environment for Adolescents|Ecological Analysis of Activity, Eating, and Weight in Adolescents|Completed||N/A|954|Actual|University of California, San Diego|||1||f||||f||||||||||2017-02-18 14:47:27.669309|2017-02-18 14:47:27.669309
NCT00608023|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-03-27|2013-11-27||August 2007||2007-08-01|March 2014|2014-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy|A Multicenter, Double-blind, Randomized, Placebo-controlled Extension Study Assessing the Efficacy and Long-term Safety of a 2 mg Dose of TH9507, a Growth Hormone Releasing Factor Analog, in HIV Subjects With Excess Abdominal Fat Accumulation|Completed||Phase 3|263|Actual|Theratechnologies||3|||f||||||||||||||2017-02-18 14:47:27.767592|2017-02-18 14:47:27.767592
NCT00608010|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-02-05|||October 2006||2006-10-01|January 2008|2008-01-01||||January 2007|Actual|2007-01-01||Interventional|||Day 3 Embryo Cryopreservation: Metabolic and Viability Analysis|Day 3 Embryo Cryopreservation: Metabolic and Viability Analysis|Completed||N/A|186|Actual|V.K.V. American Hospital, Istanbul||2|||f||||||||||||||2017-02-18 14:47:28.372147|2017-02-18 14:47:28.372147
NCT00607997|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-06-05|||April 2008||2008-04-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|March 2010|Actual|2010-03-01||Interventional|||Study of Voreloxin in Older Patients With Untreated Acute Myeloid Leukemia|A Phase 2, Open-Label, Multicenter Clinical Study of the Safety and Efficacy of Voreloxin Injection in Patients Equal to or Greater Than 60 Years of Age With Previously Untreated Acute Myeloid Leukemia|Completed||Phase 2|116|Actual|Sunesis Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:47:28.474708|2017-02-18 14:47:28.474708
NCT00607984|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-02-05|||June 2006||2006-06-01|January 2008|2008-01-01||||December 2010|Anticipated|2010-12-01||Interventional|||Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors|High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors|Unknown status|Recruiting|N/A|20|Anticipated|Rabin Medical Center||1|||f||||f||||||||||2017-02-18 14:47:28.596127|2017-02-18 14:47:28.596127
NCT00607971|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-07-04|||April 2006||2006-04-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)|A Phase III, Multicenter, Open Label, Extension Study to Evaluate the Long-Term Safety of Renzapride 4 mg Once Daily in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)|Terminated||Phase 3|939|Actual|Alizyme||1||Terminated due to insufficient efficacy over placebo in Study ATL1251/038/CL.|f||||t||||||||||2017-02-18 14:47:28.711847|2017-02-18 14:47:28.711847
NCT00607789|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-10-12|2011-03-08||October 2006||2006-10-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression|A 12-Week, Double-Blind, Placebo-Controlled, Trial of Duloxetine Versus Placebo in the Treatment of Binge Eating Disorder and Comorbid Depressive Disorder.|Completed||Phase 4|40|Actual|University of Cincinnati||2|||f||||t||||||||||2017-02-18 14:47:32.560473|2017-02-18 14:47:32.560473
NCT00607958|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2009-07-14|||December 2007||2007-12-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours|Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours|Completed||Phase 4|15|Anticipated|Germans Trias i Pujol Hospital||1|||f||||f||||||||||2017-02-18 14:47:28.945337|2017-02-18 14:47:28.945337
NCT00607945|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2014-03-19|||January 2008||2008-01-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|FACT||Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus|Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus|Completed||Phase 1|48|Actual|Ohio State University||3|||f||||t||||||||||2017-02-18 14:47:29.057972|2017-02-18 14:47:29.057972
NCT00607932|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2016-04-26|||March 2005||2005-03-01|April 2016|2016-04-01|November 2010|Actual|2010-11-01|January 2007|Actual|2007-01-01||Interventional|||Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer|Effects of Bassica or Indole-3-Carbinol on Prostatectomy Patients With PSA Recurrence|Completed||N/A|66|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:47:29.183733|2017-02-18 14:47:29.183733
NCT00607919|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2011-11-11|2011-11-11||March 2008||2008-03-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia|A Double-Blind Placebo Controlled Study of Atomoxetine Hydrochloride for the Treatment of ADHD in Children and Adolescents With ADHD and Comorbid Dyslexia|Completed||Phase 4|209|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 14:47:29.304295|2017-02-18 14:47:29.304295
NCT00607906|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-11-02|||November 2007||2007-11-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050|A Single-blinded, Randomized, Placebo-controlled, Staggered-parallel, Escalating Single Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered SB756050 in Healthy Volunteers and in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|48|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:47:30.650784|2017-02-18 14:47:30.650784
NCT00607893|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2014-07-21|||September 2006||2006-09-01|July 2014|2014-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|SASS||Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea|Oxidative Stress in Sleep Apnea and Cardiac Disease|Completed||N/A|149|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-02-18 14:47:30.750819|2017-02-18 14:47:30.750819
NCT00607880|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2014-04-09|2014-04-09||June 2004||2004-06-01|April 2014|2014-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||All 100 patients accrued to participate in this study were included in the baseline population analysis.|Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy|A Prospective Randomized Study of the Vortex® Implantable Access Port Versus the BardPort™ Implantable Port in Cancer Patients Receiving Adjuvant Intravenous Chemotherapy|Completed||Phase 2|100|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:47:30.863538|2017-02-18 14:47:30.863538
NCT00607867|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-12-10|2014-11-17||April 2008||2008-04-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|LoBAG Diet|Subjects with type 2 diabetes being treated with metformin|LoBAG30 Diet in Patients on Metformin|Metabolic Response to a LoBAG30 Diet in Diabetic Patients on Metformin|Terminated||N/A|20|Actual|VA Office of Research and Development|Funding ended with only 14 subjects studied. With a parallel arm design, we were not able to draw any conclusions from the study. Funds were unavailable for a more sophisticated statistical analysis.|2||The funding ended before the study was completed.|f||||f||||||||||2017-02-18 14:47:31.229308|2017-02-18 14:47:31.229308
NCT00607854|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-10-04|||February 2008||2008-02-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|February 2011|Actual|2011-02-01||Interventional|ZEVALLO||Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)|Safety and Efficacy of Ibritumomab Tiuxetan (Zevalin®) in Association With a Fludarabine Based Reduced Conditioning Regimen and Allogenic Stem Cell Support in Chemo-sensitive Relapsed CD20 Positive Aggressive Non-Hodgkin's Lymphoma Patients.|Completed||Phase 2|31|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-02-18 14:47:31.6303|2017-02-18 14:47:31.6303
NCT00607841|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2010-01-14|||December 2007||2007-12-01|January 2010|2010-01-01||||November 2009|Actual|2009-11-01||Interventional|||A Study of Ispinesib in Metastatic Breast Cancer|A Phase I/II Non-Randomized, Open-Label, Dose-Finding Study of Ispinesib (SB-715992) Followed By a Fixed-Dose Study in Chemotherapy-Naïve Patients With Metastatic Breast Cancer (MBC).|Completed||Phase 1/Phase 2|100|Anticipated|Cytokinetics||1|||f||||f||||||||||2017-02-18 14:47:31.767654|2017-02-18 14:47:31.767654
NCT00607828|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2010-03-23|||November 2007||2007-11-01|March 2010|2010-03-01||||October 2009|Anticipated|2009-10-01||Interventional|||Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer|Feasibility of Hypofractionated Stereotactic Radiotherapy in Patients With Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 1|28|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:47:31.863457|2017-02-18 14:47:31.863457
NCT00607815|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2016-07-19|2015-02-27||June 2009||2009-06-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|February 2015|Actual|2015-02-01||Interventional|||A Comparison of Cognitive Processing Therapy (CPT) Versus Present Centered Therapy (PCT) for Veterans|A Comparison of CPT vs PCT for Veterans|Active, not recruiting||N/A|79|Actual|VA Office of Research and Development|Significant amounts of missing data from patients not attending assessment. Drop out rate from treatment was higher than other clinical trials of CPT and PCT in civilian samples, but in keeping with other studies of Veterans.|2|||f||||f||||||||Undecided||2017-02-18 14:47:31.962104|2017-02-18 14:47:31.962104
NCT00607802|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2017-01-17||||||June 2013|2013-06-01||||||||Interventional|||Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer|White Cell Transfer as Cancer Therapy|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 14:47:32.447129|2017-02-18 14:47:32.447129
NCT00607776|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2008-02-05|||January 2007||2007-01-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Artificial Tears Study in Mild to Moderate Dry Eye Patients|Artificial Tears Study in Mild to Moderate Dry Eye Patients|Completed||Phase 2|110|Actual|Abbott Medical Optics||2|||f||||t||||||||||2017-02-18 14:47:32.956038|2017-02-18 14:47:32.956038
NCT00607763|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-08-19|||October 2007||2007-10-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug|A Phase 1, Open-Label Study Of The Safety And Pharmacokinetics Of Repeated-Dose Micafungin (FK463) In Infants And Toddlers (≥4 Months TO < 24 Months Of Age) With Esophageal Candidiasis Or Other Invasive Candidiasis|Completed||Phase 1|9|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 14:47:33.042656|2017-02-18 14:47:33.042656
NCT00607750|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2010-10-26|||May 2008||2008-05-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF|A Phase 2 Randomized, Double-Masked, Study to Evaluate the Safety and Preliminary Efficacy of ATG003 in Patients With Neovascular Age-Related Macular Degeneration (NV-AMD) Receiving Frequent Maintenance Intravitreal Anti-VEGF Antibody Therapy (Ranibizumab or Bevacizumab)|Completed||Phase 2|60|Actual|CoMentis||2|||f||||f||||||||||2017-02-18 14:47:33.165829|2017-02-18 14:47:33.165829
NCT00607737|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-08-31|||January 2008||2008-01-01|August 2012|2012-08-01|July 2010|Actual|2010-07-01|June 2009|Actual|2009-06-01||Interventional|APPLY||Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes|Doubleblind, Randomised, Single Centre Investigator Sponsored Study of Applications Site Reactions After Deep and Superficial Subcutaneous and Intradermal Injection of Insulin Detemir and Saline in Subjects With Diabetes Mellitus|Completed||Phase 4|40|Actual|Steno Diabetes Center||2|||f||||f||||||||||2017-02-18 14:47:33.261383|2017-02-18 14:47:33.261383
NCT00607724|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2015-09-08|2015-07-22||April 2007||2007-04-01|September 2015|2015-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||Safety-evaluable population included all participants who received any amount of GDC-0449.|GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors|An Open-Label, Phase I Study of Systemic Hedgehog Pathway Antagonist, GDC-0449, in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or For Whom No Standard Therapy Exists|Completed||Phase 1|68|Actual|Genentech, Inc.||7|||f||||||||||||||2017-02-18 14:47:33.379735|2017-02-18 14:47:33.379735
NCT00607711|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2008-04-30|||March 2008||2008-03-01|January 2008|2008-01-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Study of Oral Palifosfamide Tris in Solid Tumors|A Phase I Study of Oral Palifosfamide Tris in Advanced, Refractory, Solid Tumors|Suspended||Phase 1|20|Anticipated|Ziopharm||1||IND was withdrawn|f||||f||||||||||2017-02-18 14:47:36.290434|2017-02-18 14:47:36.290434
NCT00607685|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2010-05-11|||February 2008||2008-02-01|May 2010|2010-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy|Prospective Case-controlled Study Comparing 5-Fluorouracil vs 5-Fluorouracil With Viscoelastic (Hyaluronic Acid) Formulation for the Prevention of Subconjunctival Scarring Post-trabeculectomy|Completed||Phase 4|50|Anticipated|Singapore National Eye Centre||2|||f||||f||||||||||2017-02-18 14:47:36.371888|2017-02-18 14:47:36.371888
NCT00607672|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2012-09-07|2012-08-02||August 2006||2006-08-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||The RAS, Fibrinolysis and Cardiopulmonary Bypass|The RAS, Fibrinolysis and Cardiopulmonary Bypass|Completed||Phase 4|111|Actual|Vanderbilt University|We cannot exclude the possibility that our results may have been different if we studied a homogenous surgery population.|3|||f||||f||||||||||2017-02-18 14:47:36.491133|2017-02-18 14:47:36.491133
NCT00607659|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-04-12|||January 2008||2008-01-01|April 2016|2016-04-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Immunopathogenesis of Chlamydia|Immunopathogenesis of Chlamydia Trachomatis Infection|Completed||N/A|29|Actual|Arkansas Children's Hospital Research Institute|||2||f||||f||||||Samples With DNA|"~     Endocervical or vaginal swabs, rectal swabs, blood (whole and serum),urine~   "|||2017-02-18 14:47:37.404994|2017-02-18 14:47:37.404994
NCT00607646|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2017-02-09|||October 2010||2010-10-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus|Hypoglycemia Associated Autonomic Failure in Type 1 DM, Question 3|Recruiting||Early Phase 1|56|Anticipated|University of Maryland||4|||f||||t||||||||||2017-02-18 14:47:37.522628|2017-02-18 14:47:37.522628
NCT00607633|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-02-05|||January 2007||2007-01-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|||||Observational|CandLE||Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH|Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Essential Hypertension and a Concomitant Disease Left Ventricular Hypertrophy|Completed||N/A|686|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:47:37.650186|2017-02-18 14:47:37.650186
NCT00607620|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2009-11-20|||September 2008||2008-09-01|November 2009|2009-11-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|DO-SBIS||Disseminating Organizational SBI Services at Trauma Centers|Disseminating Organizational SBI Services (DO-SBIS) at Trauma Centers|Unknown status|Recruiting|Phase 2|1100|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||t||||||||||2017-02-18 14:47:37.730124|2017-02-18 14:47:37.730124
NCT00607607|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-01-19|||January 2008||2008-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|June 2011|Actual|2011-06-01||Interventional|||A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer|A Phase 2 Study of Oral MKC-1 Administered Twice Daily for 14 Consecutive Days Every 4 Weeks in Patients With Recurrent or Resistant Epithelial Ovarian Cancer or Advanced Endometrial Cancer|Completed||Phase 2|44|Actual|CASI Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 14:47:37.832008|2017-02-18 14:47:37.832008
NCT00607594|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-01|2014-06-19|2014-06-19||January 2008||2008-01-01|June 2014|2014-06-01|April 2012|Actual|2012-04-01|March 2010|Actual|2010-03-01||Interventional|||Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer|A Phase 2 Study of AZD0530 in Patients With Metastatic or Locally Advanced Gastric Carcinoma|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:47:37.93261|2017-02-18 14:47:37.93261
NCT00607581|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-02-09|||February 2008||2008-02-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis|An Open-label, Phase II Study of Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis|Completed||Phase 2|21|Actual|IRCCS Policlinico S. Matteo||1|||f||||f||||||||||2017-02-18 14:47:38.233722|2017-02-18 14:47:38.233722
NCT00607555|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2009-10-30|||March 2008||2008-03-01|September 2008|2008-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||A Study on the Effects of Feeding and Feeding Methods on Breathing Pattern in Very Low Birth Weight Preterm Infants|Observational Study on the Effects of Enteral Feeding and Feeding Methods on Respiratory Pattern as Assessed by Diaphragm Electrical Activity (EAdi) in Very Low Birth Weight Preterm Infants|Completed||N/A|10|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 14:47:40.860612|2017-02-18 14:47:40.860612
NCT00607542|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2011-12-02|||November 2008||2008-11-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|Best PK/PD||Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity|Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated With Cerebral Palsy|Completed||Phase 1/Phase 2|61|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||t||||||||||2017-02-18 14:47:40.984575|2017-02-18 14:47:40.984575
NCT00607529|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2010-06-03|||August 2007||2007-08-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device|Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device|Completed||N/A|99|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"~     blood~   "|||2017-02-18 14:47:41.10044|2017-02-18 14:47:41.10044
NCT00607516|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2009-06-23|||March 2006||2006-03-01|February 2007|2007-02-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|HEMI-RSADEXA||Radiostereometric Analysis of Acetabular Wear and Periprosthetic Bone Mineral Density Changes in Hemiarthroplasties|Radiostereometric Analysis of Acetabular Wear and Periprosthetic Bone Mineral Density Changes in Cemented and Uncemented Hemiarthroplasties for Femoral Neck Fractures|Unknown status|Active, not recruiting|N/A|22|Actual|Ullevaal University Hospital||2|||f||||f||||||||||2017-02-18 14:47:41.192131|2017-02-18 14:47:41.192131
NCT00607503|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-09-02|||February 2008||2008-02-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes|A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes|Completed||Phase 1|9|Actual|Jaeb Center for Health Research||1|||f||||t||||||||||2017-02-18 14:47:41.300544|2017-02-18 14:47:41.300544
NCT00607490|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-05-20|||September 2000||2000-09-01|January 2008|2008-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Randomized Clinical Trial for Women With Vulvodynia|Cognitive-behavioral Therapy for Vulvodynia: a Clinical Trial|Completed||N/A|50|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 14:47:41.406551|2017-02-18 14:47:41.406551
NCT00607477|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-06-03|2010-11-22||January 2008||2008-01-01|June 2014|2014-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension|A Pilot Study of the Treatment of VEGF-Signaling Pathway Inhibitor-Induced Hypertension With Direct Vasodilators, Minoxidil and Hydralazine|Terminated||N/A|2|Actual|University of Chicago|This study enrolled only 2 subjects and due to poor accrual, enrollment was stopped early. Due to the limited number of subjects available results cannot be assessed.|2||Study has been terminated due to poor accrual.|f||||f||||||||||2017-02-18 14:47:41.506662|2017-02-18 14:47:41.506662
NCT00607464|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-04-21|||September 2004||2004-09-01|April 2016|2016-04-01|October 2012|Actual|2012-10-01|March 2010|Actual|2010-03-01||Interventional|HeLP||Multicentre Randomised Controlled Trial of HELP (Heat Loss Prevention) in the Delivery Room|Multicentre Randomised Controlled Trial of HELP (Heat Loss Prevention) in the Delivery Room|Terminated||N/A|804|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-02-18 14:47:41.785628|2017-02-18 14:47:41.785628
NCT00607451|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-10-08|||March 2008||2008-03-01|September 2014|2014-09-01|November 2016|Anticipated|2016-11-01|August 2016|Anticipated|2016-08-01||Interventional|||Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia|A Double-blind, Placebo Controlled, Crossover, Ascending Single Dose Safety Tolerability, Pharmacokinetic and Pharmacodynamic Study of Neu-120 in Patients With Advanced Phase Idiopathic Parkinson's Disease With Levodopa Induced Dyskinesia|Terminated||Phase 1/Phase 2|8|Actual|Neurim Pharmaceuticals Ltd.||4|||f||||t||||||||||2017-02-18 14:47:42.105855|2017-02-18 14:47:42.105855
NCT00607438|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-05-09|||September 2007||2007-09-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer|A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer|Terminated||Phase 2|16|Actual|Veeda Oncology||1||Low accrual|f||||f||||||||||2017-02-18 14:47:42.211293|2017-02-18 14:47:42.211293
NCT00607425|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-07-15|||August 2007||2007-08-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|SPIT-LC||Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening|Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening|Terminated||N/A|40|Actual|Scottsdale Healthcare|||2|Change in isolation method|f||||f||||||Samples With DNA|"~     Saliva~   "|||2017-02-18 14:47:42.31086|2017-02-18 14:47:42.31086
NCT00607412|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-05-10|||August 2007||2007-08-01|June 2009|2009-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Alcohol Use Disorders (AUDs) and Post-traumatic Stress Disorder (PTSD) Treatment for Victims of Partner Violence|AUDs and PTSD Treatment for Victims of Partner Violence|Completed||Phase 2|50|Anticipated|University of California, San Diego||2|||f||||t||||||||||2017-02-18 14:47:42.389711|2017-02-18 14:47:42.389711
NCT00607399|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-07-22|||January 2008||2008-01-01|July 2008|2008-07-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors|A Phase I, Multi-Center, Open Label, Dose Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Orally Administered SGX523, a Small Molecule Anti-Cancer Agent, Ona Twice Daily, Interrupted Schedule in Patients With Advanced Cancer|Terminated||Phase 1|46|Anticipated|SGX Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:47:42.503194|2017-02-18 14:47:42.503194
NCT00606996|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-04-17|||July 2006||2006-07-01|April 2013|2013-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Group Therapy for Women Prisoners With Comorbid Substance Use and Depression|Group IPT for Women Prisoners With Comorbid Substance Use and Depression|Completed||Phase 2|38|Actual|Brown University||2|||f||||||||||||||2017-02-18 14:47:52.372113|2017-02-18 14:47:52.372113
NCT00607386|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-10-06|2013-09-03||December 2007||2007-12-01|February 2014|2014-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Safety population was defined as all enrolled participants who received at least one study dose (or any portion of a dose) of idursulfase.|Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy|A Multi-Center, Open-Label Study Evaluating Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Enzyme Replacement Therapy|Completed||Phase 4|28|Actual|Shire||1|||f||||f||||||||||2017-02-18 14:47:42.611923|2017-02-18 14:47:42.611923
NCT00607373|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-08-01|2013-02-15||July 2007||2007-07-01|August 2016|2016-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|RADICHOL 1||Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Mipomersen as Add-on Therapy in Homozygous Familial Hypercholesterolemia Subjects|Completed||Phase 3|51|Actual|Kastle Therapeutics, LLC||2|||f||||t||||||||||2017-02-18 14:47:43.121083|2017-02-18 14:47:43.121083
NCT00607360|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2017-01-09|||August 2004||2004-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Integration of the Therapeutic Workplace in Drug Court|Integration of the Therapeutic Workplace in Drug Court|Completed||Phase 1|59|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 14:47:44.642366|2017-02-18 14:47:44.642366
NCT00607347|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-09-16|||February 2008||2008-02-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers|Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers|Completed||N/A|24|Anticipated|University of Florida||1|||f||||t||||||||||2017-02-18 14:47:44.726731|2017-02-18 14:47:44.726731
NCT00607334|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-01-22|||July 2003||2003-07-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Experimental Word Learning in Children With and Without Language Impairment|Experimental Word Learning in Children With Normal Development and Children With Language Impairment|Completed||N/A|51|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 14:47:44.841295|2017-02-18 14:47:44.841295
NCT00607321|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2011-08-01|2011-08-01||February 2008||2008-02-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|BRANCH||Bare Metal Bifurcation Stent Clinical Trial in Humans|The Medtronic Bare Metal Bifurcation Stent Clinical Trial in Humans|Completed||N/A|60|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-02-18 14:47:44.948045|2017-02-18 14:47:44.948045
NCT00607308|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2010-12-06|||February 2008||2008-02-01|December 2010|2010-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease|A Phase 1, Randomized, Placebo-Controlled, Double Blind, Dose-Escalation, Multicenter Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Immunogenicity Of A Single Intravenous Dose Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease|Completed||Phase 1|20|Actual|Pfizer||6|||f||||t||||||||||2017-02-18 14:47:45.250442|2017-02-18 14:47:45.250442
NCT00607295|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2010-07-23|||December 2007||2007-12-01|July 2010|2010-07-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients|Prospective Randomized Study on Efficacy and Safety of Clino-san® in the Management of Vaginal Dryness in Breast Cancer Patients|Completed||Phase 3|98|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:47:45.361902|2017-02-18 14:47:45.361902
NCT00607282|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-09-02|||March 2009||2009-03-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer|Efficacy of Udenafil in Treatment of Erectile Dysfunction After Radical Resection for Sigmoid Colon and Rectal Cancer : a Randomized Controlled Trial|Completed||Phase 2|46|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:47:45.459353|2017-02-18 14:47:45.459353
NCT00607269|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-07-30|2013-04-19||April 2005||2005-04-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|VIPS||Voucher-Based Incentives in a Prevention Setting|Voucher-Based Incentives in a Prevention Setting|Completed||Phase 2/Phase 3|131|Actual|Friends Research Institute, Inc.||2|||f||||f||||||||||2017-02-18 14:47:45.573368|2017-02-18 14:47:45.573368
NCT00607256|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2011-02-15|||October 2007||2007-10-01|February 2011|2011-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia|A Multi-center, Long-term, Open-label Study of [S,S]-Reboxetine (PNU-165442G) Administered Once Daily in Patients With Fibromyalgia|Terminated||Phase 3|500|Anticipated|Pfizer||1|||f||||t||||||||||2017-02-18 14:47:46.032892|2017-02-18 14:47:46.032892
NCT00607243|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2013-07-07|2011-08-02||January 2008||2008-01-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Efficacy of CJ-50300 in Healthy Volunteers|Randomized, Double Blind, a Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of CJ-50300 in Healthy Volunteers|Completed||Phase 2/Phase 3|123|Actual|Seoul National University Hospital|the study was limited to vaccinia-naïve adults, thus yielding no data concerning the efﬁcacy of CJ-50300 in non-naïve adults or in children.|2|||f||||t||||||||||2017-02-18 14:47:46.208056|2017-02-18 14:47:46.208056
NCT00607230|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-11-04|||November 2007||2007-11-01|November 2013|2013-11-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics|Determination of Dosing and Frequency of BCG Administration Necessary to Alter T-Lymphocyte Profiles in Type I Diabetics|Completed||Phase 1|25|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:47:46.850504|2017-02-18 14:47:46.850504
NCT00607217|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2009-01-20|||January 2008||2008-01-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases|Controlled Trial of Serologic and Clinical Efficacy of Influenza Vaccine in Post-Myocardial Infarction Patients and in Those With Stable Angina Pectoris|Completed||Phase 2/Phase 3|360|Anticipated|Shahid Beheshti University of Medical Sciences||3|||f||||t||||||||||2017-02-18 14:47:46.962454|2017-02-18 14:47:46.962454
NCT00607204|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2013-07-30|||October 2005||2005-10-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Examining the Biological Factors That Affect Sleep Duration|Neurobiology of Individual Differences in Sleep Duration|Completed||N/A|119|Actual|Brigham and Women's Hospital|||1||f||||f||||||Samples Without DNA|"~     Plasma samples~   "|||2017-02-18 14:47:47.099304|2017-02-18 14:47:47.099304
NCT00607191|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2010-07-27|||January 2008||2008-01-01|July 2010|2010-07-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Clubfoot DNA Repository|Clubfoot DNA Repository|Recruiting||N/A|500|Anticipated|Texas Scottish Rite Hospital for Children|||1||f||||t||||||Samples With DNA|"~     Each of the study participants (affected and non-affected individuals) will be asked to~     provide DNA from a blood sample. A 10cc sample of blood will be removed on 1 or 2 occasions~     by drawing blood from the arm or by finger stick by research staff. If the participant is a~     child who will be undergoing surgery, the blood sample will be collected at that time to~     eliminate additional stick. If collecting a blood sample is not possible we can also obtain~     DNA by collecting a saliva sample. This second technique does not give us as much DNA as we~     would get from blood. Therefore, if we get saliva samples, we might require more than one~     saliva sample over the course of the study.~   "|||2017-02-18 14:47:47.191502|2017-02-18 14:47:47.191502
NCT00607178|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2009-01-20|||January 2008||2008-01-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|IVCAD||The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases|Randomized, Single-Blind, Placebo-Controlled Study of Influenza Vaccine in Preventing Cardiovascular Events in Post-Myocardial Infarction Patients and in Those With Stable Angina Pectoris|Completed||Phase 2/Phase 3|300|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:47:47.29797|2017-02-18 14:47:47.29797
NCT00607152|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-05-07|||October 2007||2007-10-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Rasburicase (Fasturtec) Registration Trial|A Multi-center, Randomized, Open-label, Active-controlled Clinical Trial to Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Patients With Hematological Malignancies|Terminated||Phase 3|10|Actual|Sanofi||2||the patient enrollment is too difficult|f||||f||||||||||2017-02-18 14:47:47.421541|2017-02-18 14:47:47.421541
NCT00607139|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-09-02|||December 2006||2006-12-01|September 2016|2016-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors|Evaluation of Counter-regulatory Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors in Children With T1DM|Completed||N/A|28|Actual|Jaeb Center for Health Research|||1||f||||t||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:47:47.523151|2017-02-18 14:47:47.523151
NCT00607126|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-07-01|2015-12-30||July 2006||2006-07-01|July 2016|2016-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Locomotor Training in Persons With Multiple Sclerosis|Robotic Locomotor Training in Persons With Multiple Sclerosis|Completed||Phase 1/Phase 2|38|Actual|University of California, Los Angeles|This was a small study and the number of subjects enrolled may not have been sufficient to show an effect.|2|||f||||f||||||||No||2017-02-18 14:47:47.635844|2017-02-18 14:47:47.635844
NCT00607113|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-05-14|2012-12-31||January 2008||2008-01-01|May 2013|2013-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma|Exploratory Study of Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma (AVF3961s) (CRAD001C2481)|Completed||Phase 2|41|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 14:47:48.119052|2017-02-18 14:47:48.119052
NCT00607100|ClinicalTrials.gov processed this data on February 17, 2017|2008-02-04|2008-11-11|||December 2007||2007-12-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|March 2008|Anticipated|2008-03-01||Observational|||High-Resolution Optical Coherence Tomography for Detection of Retinal Nerve Fiber Layer Loss in Band Atrophy of the Optic Nerve|High-Resolution Optical Coherence Tomography for Detection of Retinal Nerve Fiber Layer Loss in Band Atrophy of the Optic Nerve|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Sao Paulo|||2||f||||t||||||||||2017-02-18 14:47:48.486065|2017-02-18 14:47:48.486065
NCT00607087|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2010-08-26|2010-06-30||January 2008||2008-01-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|PUMP||Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus|Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus|Completed||Phase 4|289|Actual|Sanofi||3|||f||||||||||||||2017-02-18 14:47:48.573965|2017-02-18 14:47:48.573965
NCT00607074|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-02-04|||June 2003||2003-06-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|April 2004|Actual|2004-04-01||Interventional|||Impact of Anti-Giardia and Antihelmintic Treatment on Infant Growth in Bangladesh|Effects of Anti-Giardia and Antihelmintic Treatment on Infant Nutritional and Biochemical Status and Intestinal Permeability in Rural Bangladesh|Completed||N/A|410|Actual|University of Cambridge||1|||f||||f||||||||||2017-02-18 14:47:50.132393|2017-02-18 14:47:50.132393
NCT00607061|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-09-27|||October 2007||2007-10-01|September 2013|2013-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|glutathione||Synthesis of Glutathione From Low Birth Weight Newborn Babies|Synthesis of Glutathione in Erythrocytes From Low Birth Weight Newborn Babies : Effect of Cysteine in Vitro|Terminated||N/A|35|Actual|Nantes University Hospital||3|||f||||f||||||||||2017-02-18 14:47:50.449733|2017-02-18 14:47:50.449733
NCT00607048|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-11-26|2012-05-03||November 2007||2007-11-01|November 2013|2013-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors|A Phase 1 Study Of CP- 870,893 In Combination With Paclitaxel And Carboplatin In Patients With Metastatic Solid Tumors|Completed||Phase 1|34|Actual|Hoffmann-La Roche||2|||f||||f||||||||||2017-02-18 14:47:50.551749|2017-02-18 14:47:50.551749
NCT00607035|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-11-19|||May 2006||2006-05-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)|The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)|Completed||Phase 4|220|Actual|Jichi Medical University||2|||f||||t||||||||||2017-02-18 14:47:52.070996|2017-02-18 14:47:52.070996
NCT00607022|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-05-19|||December 2007||2007-12-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Randomized Prospective Clinical Trial Comparing Single Tooth Implant 3 Loading Protocols|the Effects of 3 Loading Protocols on Dental Implant Stability in Healed Ridges|Completed||Phase 4|40|Actual|University of Iowa||3|||f||||t||||||||||2017-02-18 14:47:52.179186|2017-02-18 14:47:52.179186
NCT00606983|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2011-07-18|||May 2007||2007-05-01|July 2011|2011-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Prevention of Acute Voiding Difficulty After Radical Proctectomy|Prevention of Acute Voiding Difficulty After Radical Proctectomy for Rectal Cancer With Tamsulosin|Completed||Phase 3|100|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:47:52.476334|2017-02-18 14:47:52.476334
NCT00606970|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-05-05|||January 2007||2007-01-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|||Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy|Assessment of the Safety of Dietary Supplement Lactobacillus Fermented Extract in Cancer Patients Undergoing Chemotherapy|Withdrawn||Early Phase 1|0|Actual|New Hope Medical Center||2||FDA sent letter to IRB stating it should be done under new drug application|f||||f||||||||||2017-02-18 14:47:52.575561|2017-02-18 14:47:52.575561
NCT00606957|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2011-10-12|||January 2008||2008-01-01|October 2011|2011-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Effect of Vitamin D Repletion on Insulin Resistance|The Effect of Vitamin D Repletion on Insulin Resistance|Completed||N/A|10|Anticipated|Rockefeller University||1|||f||||||||||||||2017-02-18 14:47:52.67836|2017-02-18 14:47:52.67836
NCT00606944|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-07-19|2012-07-19||June 2007||2007-06-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|October 2009|Actual|2009-10-01||Interventional|||Fast-track Rehabilitation After Elective Colorectal and Small Bowel Resection|Randomized Controlled Trial of Fast-Track Rehabilitation After Elective Colorectal and Small Bowel Resection|Completed||N/A|200|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 14:47:52.772546|2017-02-18 14:47:52.772546
NCT00606931|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2009-05-20|2009-03-27||January 2008||2008-01-01|May 2009|2009-05-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|PEM-BX||Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast Abnormalities|Pilot Clinical Study to Evaluate High Resolution PET Imaging- Guidance for Sampling of Breast Abnormalities in Patients With Known or Suspected Breast Cancer|Completed||N/A|22|Actual|Naviscan PET Systems||1|||f||||t||||||||||2017-02-18 14:47:53.135212|2017-02-18 14:47:53.135212
NCT00606918|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2011-05-11|||January 2008||2008-01-01|May 2011|2011-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|ATLIS||Validation of a New Device to Measure Neuromuscular Disease Progression|Validation of a New Device to Measure Neuromuscular Disease Progression|Completed||N/A|120|Anticipated|Massachusetts General Hospital|||2||f||||f||||||||||2017-02-18 14:47:53.381959|2017-02-18 14:47:53.381959
NCT00606905|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-10-03|2010-08-03||November 1999||1999-11-01|August 2010|2010-08-01|January 2010|Actual|2010-01-01|March 2009|Actual|2009-03-01||Interventional|||Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage|Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial|Completed||N/A|82|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 14:47:53.468609|2017-02-18 14:47:53.468609
NCT00606892|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-09-09|2012-03-14||August 2007||2007-08-01|September 2014|2014-09-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional||37 subjects signed consent. 17 subjects received the first treatment. Five subjects dropped out due to non-compliance with study procedures prior to study completion, and therefore were not included in the analysis. The 12 subjects who completed both interventions were included in the analysis.|Varenicline and Nicotine Interactions in Humans (VA)|Varenicline Attenuates Some of the Subjective and Physiological Effects of Intravenous Nicotine in Humans.|Completed||N/A|37|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:47:53.792889|2017-02-18 14:47:53.792889
NCT00606879|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2008-07-22|||January 2008||2008-01-01|July 2008|2008-07-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors|A Phase I, Multi-Center, Open Label, Dose Escalation, Safety, PK and PkD Study of Orally Administered SGX523, a Small Molecule Anti-Cancer Agent, on a Twice Daily, Uninterrupted Schedule in Patients With Advanced Cancer|Terminated||Phase 1|46|Anticipated|SGX Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:47:54.545962|2017-02-18 14:47:54.545962
NCT00606866|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-31|2014-03-26|||July 2004||2004-07-01|March 2014|2014-03-01|June 2008|Actual|2008-06-01|January 2007|Actual|2007-01-01||Interventional|MRI||MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma|Dynamic-Contrast Enhanced MRI Pharmacodynamic Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma|Completed||Phase 3|57|Actual|University of Chicago||3|||f||||t||||||||||2017-02-18 14:47:54.644143|2017-02-18 14:47:54.644143
NCT00606853|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2011-11-17|||October 2003||2003-10-01|November 2011|2011-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Enhanced and Attendance-based Prize CM in Community Settings|Enhanced and Attendance-based Prize CM in Community Settings|Completed||Phase 2|443|Actual|UConn Health||4|||f||||f||||||||||2017-02-18 14:47:54.742009|2017-02-18 14:47:54.742009
NCT00606840|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-04-12|||January 2008||2008-01-01|April 2012|2012-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Weight Gain Prevention|Study to Prevent Weight Gain|Completed||N/A|52|Actual|The Miriam Hospital||2|||f||||||||||||||2017-02-18 14:47:54.843937|2017-02-18 14:47:54.843937
NCT00606827|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-05-06|||January 2005||2005-01-01|May 2012|2012-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy|Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy in Patients Undergoing Coronary Angiography|Completed||Phase 4|500|Actual|Ospedale Misericordia e Dolce||2|||f||||t||||||||||2017-02-18 14:47:54.942042|2017-02-18 14:47:54.942042
NCT00606814|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2012-03-02|||December 2007||2007-12-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors|A Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|60|Actual|Infinity Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 14:47:55.03115|2017-02-18 14:47:55.03115
NCT00606801|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2013-06-24|2012-02-08||June 2007||2007-06-01|February 2012|2012-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Galantamine Effects on Cognitive Function in Abstinent Cocaine Users|Galantamine Effects on Cognitive Function in Abstinent Cocaine Users|Completed||N/A|34|Actual|Yale University|Relatively low medication dose and short duration of treatment. Multiple cognitive tests and outcome measures increase probability of Type 1 errors. Absence of non-addicted controls limits determination of a unique effect in abstinent users.|2|||f||||t||||||||||2017-02-18 14:47:55.139582|2017-02-18 14:47:55.139582
NCT00606788|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-02-12|||November 2005||2005-11-01|January 2008|2008-01-01|February 2007|Anticipated|2007-02-01|January 2007|Anticipated|2007-01-01||Interventional|||Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized Weaning|Comparison of Computer-Driven Protocolized Weaning With Physician-Directed Weaning in Surgical Intensive Care Unit (ICU) Patients|Suspended||N/A|60|Actual|University of Luebeck||2||"Interim analysis indicated that sample size of study patients had to be highly increased to~   obtain significant outcomes."|f||||f||||||||||2017-02-18 14:47:55.680002|2017-02-18 14:47:55.680002
NCT00606775|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-02-04|||December 2007||2007-12-01|December 2007|2007-12-01|December 2012|Anticipated|2012-12-01|December 2008|Anticipated|2008-12-01||Interventional|||The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy|Carvedilol for the Prevention of Minor Cardiac Damage and Cardiac Function in Duchenne Muscular Dystrophy|Unknown status|Recruiting|Phase 4|60|Anticipated|Suzuka Hospital||2|||f||||t||||||||||2017-02-18 14:47:55.790943|2017-02-18 14:47:55.790943
NCT00606762|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-02-04|||October 2006||2006-10-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Comparison Between Low Pressure Versus High Pressure Laparoscopic Cholecystectomy|A Prospective Randomized, Controlled Study Comparing Low Pressure Versus High Pressure Pneumoperitoneum During Laparoscopic Cholecystectomy.|Completed||N/A|26|Actual|Sterling Hospital||1|||f||||f||||||||||2017-02-18 14:47:55.905166|2017-02-18 14:47:55.905166
NCT00606749|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-06-18|||November 2007||2007-11-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Use of KC706 for the Treatment of Pemphigus Vulgaris|A Phase 2 Open-Label Uncontrolled Pilot Study of KC706 in Patients With Stable, Active Pemphigus Vulgaris|Completed||Phase 2|20|Anticipated|Kemia, Inc||1|||f||||f||||||||||2017-02-18 14:47:56.00151|2017-02-18 14:47:56.00151
NCT00606736|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-07-02|||January 2008||2008-01-01|January 2008|2008-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Relativity Study Between Idiopathic Ventricular Arrhythmia and Sex Hormone Levels in Different Stages of Menstrual Cycle|Relativity Study Between Idiopathic Ventricular Arrhythmia and Sex Hormone Levels in Different Stages of Menstrual Cycle|Withdrawn||N/A|0|Actual|Harbin Medical University|||2|it's difficult to recruit enough participants eligible for this study|f||||t||||||Samples With DNA|"~     whole blood, serum~   "|||2017-02-18 14:47:56.097901|2017-02-18 14:47:56.097901
NCT00606723|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2016-11-01|||April 2010||2010-04-01|September 2016|2016-09-01|January 2021|Anticipated|2021-01-01|December 2017|Anticipated|2017-12-01||Interventional|||Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML|Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML; Multi Center Therapy Concept|Active, not recruiting||Phase 3|154|Actual|Hannover Clinical Trial Center GmbH||1|||f||||t||||||||||2017-02-18 14:47:56.210909|2017-02-18 14:47:56.210909
NCT00606710|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-11-21|||February 2008||2008-02-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|Cogent-4||Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following|Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following|Completed||N/A|450|Anticipated|Guidant Corporation|||1||f||||f||||||||||2017-02-18 14:47:56.338964|2017-02-18 14:47:56.338964
NCT00606697|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-11-02||2009-07-22|December 2007||2007-12-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia|A Multi-centre, Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW597599 and GR205171 on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment and Daytime Cognitive Function in Subjects With Primary Insomnia|Completed||Phase 2|48|Anticipated|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:47:56.434172|2017-02-18 14:47:56.434172
NCT00606684|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-11-04|2013-06-12||February 2008||2008-02-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Study B2C111045, A Dose-Finding Study of GW642444 Versus Placebo in Patients With COPD|Completed||Phase 2|602|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:47:56.703441|2017-02-18 14:47:56.703441
NCT00606671|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-02-01|||February 2004||2004-02-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)|Insulin Resistance in Polycystic Ovary Syndrome (PCOS)|Completed||N/A|65|Actual|Hvidovre University Hospital|||8||f||||t||||||Samples With DNA|"~     Fat and muscle biopsies~   "|||2017-02-18 14:47:58.021114|2017-02-18 14:47:58.021114
NCT00606658|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2012-09-18|||January 2008||2008-01-01|September 2012|2012-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Usefulness of Shirodhara for Insomnia|Usefulness of Shirodhara (Oil Dripping Treatment in Ayurveda) for Insomnia - A Case Series|Completed||Early Phase 1|10|Actual|Southern California University of Health Sciences||1|||f||||f||||||||||2017-02-18 14:47:58.117914|2017-02-18 14:47:58.117914
NCT00606645|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-04-18|||December 2007||2007-12-01|April 2014|2014-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma|A Phase 1 Study of Every Other Week XmAb®2513 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Patients With Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma|Completed||Phase 1|23|Actual|Xencor, Inc.||1|||f||||f||||||||||2017-02-18 14:47:58.226942|2017-02-18 14:47:58.226942
NCT00606632|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-03-17|2011-06-07||March 2008||2008-03-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody|A Comparative Study of PET/CT Versus Diagnostic CT for the Detection of Clear Cell Renal Cell Carcinoma in Pre-surgical Patients With Renal Masses Using Iodine-124 Labeled Chimeric G250 (124I-cG250)|Completed||Phase 3|226|Actual|Wilex||1|||f||||f||||||||||2017-02-18 14:47:58.330175|2017-02-18 14:47:58.330175
NCT00606619|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2010-05-27|||July 2008||2008-07-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effects of Early Oral Feeding After Resection of Gastric Cancer|Phase III Clinical Trial for Effect Early Oral Feeding on Recovery After Resection of Gastric Cancer|Completed||Phase 3|58|Actual|The Catholic University of Korea||2|||f||||f||||||||||2017-02-18 14:47:58.666219|2017-02-18 14:47:58.666219
NCT00606606|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2015-03-27|||July 2000||2000-07-01|March 2015|2015-03-01|June 2006|Actual|2006-06-01|February 2005|Actual|2005-02-01||Interventional|||Reducing Adverse Drug Events in the Nursing Home|Reducing Adverse Drug Events in the Nursing Home|Withdrawn||N/A|0|Actual|University of Massachusetts, Worcester||2||"This is not a human subject's study. Protocol registered in error. This protocol studied~   nursing homes as a unit."|f||||f||||||||||2017-02-18 14:47:58.779646|2017-02-18 14:47:58.779646
NCT00606593|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-02-11|2012-12-21||December 2007||2007-12-01|February 2016|2016-02-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia|Multicenter, Double-blind, Randomized, Placebo-controlled, 5-period, 5-treatment Crossover, Dose-finding Study to Evaluate the Efficacy and Safety of Oral Administration of ACT-078573 in Elderly Subjects With Chronic Primary Insomnia|Completed||Phase 2|112|Actual|Midnight Pharma, LLC||10|||f||||f||||||||||2017-02-18 14:47:58.879447|2017-02-18 14:47:58.879447
NCT00606580|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-06-11|2014-05-12||January 2008||2008-01-01|June 2014|2014-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)|A Pivotal, Randomized, Double-blind, Vehicle-controlled Study to Evaluate WR 279,396 and Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)|Completed||Phase 3|375|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||f||||||||||2017-02-18 14:47:59.573003|2017-02-18 14:47:59.573003
NCT00606567|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-07-11|||December 2006||2006-12-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|December 2008|Actual|2008-12-01||Interventional|Medusa SAK||A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic|A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic|Completed||N/A|151|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:48:00.963625|2017-02-18 14:48:00.963625
NCT00606554|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-07-24|2011-02-07||January 2008||2008-01-01|June 2011|2011-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Clinical Trial of a Computer-driven Weaning System for Patients Requiring Mechanical Ventilation|A Randomized Controlled Trial of Computer-Driven Weaning Compared With Standard of Care Weaning in Medical Patients Requiring Mechanical Ventilation|Terminated||N/A|33|Actual|Boston Medical Center|This trial was terminated early due to slow recruitment. It did not reach the target N of 220.|2||Slow recruitment of subjects|f||||f||||||||||2017-02-18 14:48:01.073889|2017-02-18 14:48:01.073889
NCT00606541|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-07-31|||January 2008||2008-01-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|December 2011|Actual|2011-12-01||Interventional|||An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)|An Open Label, Double-blind Discontinuation Study of Quetiapine (Extended Release) XR in Social Anxiety Disorder|Terminated||Early Phase 1|55|Actual|Duke University||2||The study was terminated by the sponsor due to budgetary issues|f||||t||||||||||2017-02-18 14:48:01.430849|2017-02-18 14:48:01.430849
NCT00606528|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2013-07-24|||February 2008||2008-02-01|July 2013|2013-07-01||||July 2013|Actual|2013-07-01||Observational|||FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy|FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy|Completed||N/A|54|Actual|University Health Network, Toronto|||2||f||||f||||||Samples With DNA|"~     Whole Blood Plasma Liver tissue from biopsy~   "|||2017-02-18 14:48:01.536207|2017-02-18 14:48:01.536207
NCT00606515|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2009-02-09|||February 2008||2008-02-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|LPS-PK-H||Pharmacokinetics Study of Liposomal Paclitaxel in Humans|A Clinical Trial to Compare the Pharmacokinetics of Two Formulations of Taxane, Paclitaxel Injection and Liposomal Paclitaxel, in Humans|Completed||Phase 4|16|Anticipated|Shandong Luye Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 14:48:01.645886|2017-02-18 14:48:01.645886
NCT00606502|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-06-02|2010-12-22||January 2008||2008-01-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|May 2010|Actual|2010-05-01||Interventional|||Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment|A Randomized, Phase 2b, Multi-center Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non-small Cell Lung Cancer After Failure of at Least 1 Prior Platinum-based Treatment|Completed||Phase 2|201|Actual|Spectrum Pharmaceuticals, Inc|The date of the CRF database cut-off for patients (no further case report form or query data entry) was 24 Jun 2010. As of the CRF data cut-off date, 3 patients, remained on therapy.|2|||f||||||||||||||2017-02-18 14:48:01.92088|2017-02-18 14:48:01.92088
NCT00606489|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2011-07-18|2011-04-04||November 2007||2007-11-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients|A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Fever and Pain in Burn Patients|Completed||Phase 3|61|Actual|Cumberland Pharmaceuticals||2|||f||||t||||||||||2017-02-18 14:48:02.703808|2017-02-18 14:48:02.703808
NCT00606476|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-10-30||2013-10-30|December 2006||2006-12-01|August 2012|2012-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease|A Phase II, Multicenter, Open-Label, Long-Term Treatment Study to Determine the Safety, Tolerability, and Efficacy of Bapineuzumab (AAB-001) in Patients With Alzheimer's Disease Who Participated in Study AAB-001-201 or AAB-001-102|Terminated||Phase 2|194|Actual|JANSSEN Alzheimer Immunotherapy Research & Development, LLC||3|||f||||t||||||||||2017-02-18 14:48:03.113452|2017-02-18 14:48:03.113452
NCT00605384|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2010-11-15|2010-07-13||August 2008||2008-08-01|November 2010|2010-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection|A Comparative Study of the Antiviral Efficacy and Safety of Entecavir Plus Tenofovir Versus Adefovir Added to Continuing Lamivudine in Adults With Lamivudine- Resistant Chronic Hepatitis B Virus Infection|Terminated||Phase 3|4|Actual|Bristol-Myers Squibb|Following review of business priorities, BMS decided to terminate this study at an early stage. This was a strategic decision, not based on clinical or safety concerns. Due to limited data, no conclusions on safety and efficacy can be made.|2||Business Objectives Have Changed|f||||f||||||||||2017-02-18 14:48:03.2428|2017-02-18 14:48:03.2428
NCT00606424|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2009-01-29|||January 2008||2008-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|HX4||An Exploratory, Open Label, Single Center Study of [F-18]HX4|An Exploratory, Open Label, Single Center Study of [F-18]HX4|Completed||Early Phase 1|10|Anticipated|Siemens Molecular Imaging||1|||f||||f||||||||||2017-02-18 14:48:08.533313|2017-02-18 14:48:08.533313
NCT00605371|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-11-03|||January 2008||2008-01-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Bioequivalence and Food Effect of 250mg of Lamotrigine XR|A Pivotal Single-dose, Randomised, Parallel-group, Open-label Study to Demonstrate Bioequivalence of 250mg Lamotrigine XR Relative to 200mg + 50mg Lamotrigine XR and to Demonstrate Lack of Food Effect on 250mg Lamotrigine XR in Healthy Male and Female Volunteers|Completed||Phase 1|226|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:48:03.764187|2017-02-18 14:48:03.764187
NCT00605358|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2014-12-16|||August 2007||2007-08-01|January 2011|2011-01-01|January 2016|Anticipated|2016-01-01|January 2014|Actual|2014-01-01||Interventional|Open Door||Increasing Use of Mental Health Services|Increasing Use of Mental Health Services by Community Dwelling Adults With Depression|Unknown status|Active, not recruiting|N/A|200|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 14:48:03.868576|2017-02-18 14:48:03.868576
NCT00605345|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-08-17|2016-04-19||December 2007||2007-12-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for Maintenance Treatment of Anemia in Kidney Transplant Recipients.|An Open Label Randomised Controlled Study to Compare the Efficacy, Safety and Tolerability of Once-monthly Administration of Subcutaneous Mircera Versus Darboepoetin Alfa for the Maintenance of Haemoglobin Levels in Renal Transplant Recipients With Chronic Renal Anaemia.|Completed||Phase 3|71|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:48:03.982477|2017-02-18 14:48:03.982477
NCT00605332|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2012-08-03|||October 2007||2007-10-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|Retrieve||Crux Biomedical IVC Filter - Evaluation of the Crux Inferior Vena Cava Filter System (Retrieve)|"Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System - (Retrieve)"|Completed||Phase 2|88|Actual|Crux Biomedical||1|||f||||t||||||||||2017-02-18 14:48:04.461041|2017-02-18 14:48:04.461041
NCT00605319|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2010-10-12|||January 2010||2010-01-01|October 2010|2010-10-01||||January 2011|Anticipated|2011-01-01||Interventional|Toviaz||An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia|An Open Label Study to Measure the Efficacy of Fesoterodine (Toviaz) on Continued Detrusor Overactivity in Patients That Have Undergone Treatment for Bladder Outlet Obstruction|Unknown status|Recruiting|Phase 4|50|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 14:48:04.552361|2017-02-18 14:48:04.552361
NCT00605306|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2013-03-11|2013-03-11||January 2008||2008-01-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Investigate the Safety and Tolerability of 14-days Treatment With an Inhaled Dose of QMF149 (500/800) in Mild to Moderate Asthmatic Patients|Completed||Phase 2|28|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:48:04.659759|2017-02-18 14:48:04.659759
NCT00605293|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-04-08|2016-04-08||January 2008||2008-01-01|October 2013|2013-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Intent-to-treat (ITT) population included all participants who received at least one dose of C.E.R.A. or epoetin alfa after Week 0, and for whom, data for at least one follow-up variable was available.|A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia|An Open Label Randomised Controlled Study to Compare the Efficacy, Safety and Tolerability of Once-monthly Administration of Intravenous C.E.R.A. Versus Epoetin Alfa for the Maintenance of Haemoglobin Levels in Hemodialysis Patients With Chronic Renal Anaemia|Completed||Phase 3|101|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:48:05.119415|2017-02-18 14:48:05.119415
NCT00605280|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-07-05|2010-11-18||September 2005||2005-09-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|November 2009|Actual|2009-11-01||Interventional|||A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.|A Phase 2/3 Randomized, Controlled, Double-Masked, Multi-Center, Comparative Trial, In Parallel Groups, To Compare The Safety And Efficacy Of Intravitreous Injections Of 0.3 Mg Pegaptanib Sodium (Macugen®), Given As Often As Every 6 Weeks For 2 Years, To Sham Injections In Subjects With Diabetic Macular Edema (DME) Involving The Center Of The Macula With An Open-Label Macugen Year 3 Extension.|Completed||Phase 2/Phase 3|317|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:48:05.723713|2017-02-18 14:48:05.723713
NCT00605267|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-08-03|2010-11-26||October 2007||2007-10-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|||Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment|Multi-centre, Randomised, Double-blind, Parallel-group Study to Compare Efficacy and Safety Between Anastrozole (ZD1033) and Tamoxifen in Pre- and Post-operative Administration Under Goserelin Acetate Treatment for Premenopausal Breast Cancer Patients|Completed||Phase 3|197|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:48:07.504381|2017-02-18 14:48:07.504381
NCT00606463|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2011-02-14|||February 2008||2008-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:48:08.24309|2017-02-18 14:48:08.24309
NCT00606450|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-05-29|||April 2006||2006-04-01|May 2013|2013-05-01|May 2007|Actual|2007-05-01|February 2007|Actual|2007-02-01||Interventional|PSOR-003||Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Comparison Study of CC-10004 in Subjects With Moderate-to-Severe Plaque-Type Psoriasis|Completed||Phase 2|260|Actual|Celgene||3|||f||||t||||||||||2017-02-18 14:48:08.307117|2017-02-18 14:48:08.307117
NCT00606437|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-05-15|||September 2005||2005-09-01|May 2014|2014-05-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants|Total Body Irradiation With Fludarabine Conditioning Followed by Transplantation With Combined Umbilical Cord Blood Grafts|Completed||Phase 1|40|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:48:08.435426|2017-02-18 14:48:08.435426
NCT00169026|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-09-10|||May 1999||1999-05-01|September 2005|2005-09-01|January 2004||2004-01-01|||||Interventional|||Alcoholism and Schizophrenia: Effects of Clozapine|Alcoholism and Schizophrenia: Effects of Clozapine|Terminated||Phase 4|64||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 17:20:28.246125|2017-02-18 17:20:28.246125
NCT00606411|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2016-03-22|||January 2008||2008-01-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder|Recruiting||Early Phase 1|40|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:48:08.617158|2017-02-18 14:48:08.617158
NCT00606398|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-01-24|||June 2007||2007-06-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|December 2007|Actual|2007-12-01||Interventional|CRC||Combined Resection of Colorectal Metastases|Combined Resection of Intra- and Extra-Hepatic Metastases From Colorectal Cancer: A Phase II Trial|Completed||Phase 2|56|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 14:48:08.723152|2017-02-18 14:48:08.723152
NCT00606385|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2016-10-27|||December 2007||2007-12-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|HCC||Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC|Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for Patients With Hepatocellular Carcinoma|Enrolling by invitation||N/A|84|Anticipated|Seoul National University Hospital||2|||f||||t||||||||No||2017-02-18 14:48:08.809929|2017-02-18 14:48:08.809929
NCT00606372|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2008-01-22|||June 2006||2006-06-01|January 2008|2008-01-01|December 2009|Anticipated|2009-12-01|December 2008|Actual|2008-12-01||Observational|PRAGUE 6+||On-Pump vs. Off-Pump CABG in High-Risk Patients (EuroSCORE 6+)|Aortocoronary Bypasses in High-Risk Patients (EuroSCORE 6+) With or Without Use of the Cardio-Pulmonary Bypass.|Unknown status|Enrolling by invitation|N/A|220|Anticipated|Charles University, Czech Republic|||2||f||||t||||||||||2017-02-18 14:48:08.912161|2017-02-18 14:48:08.912161
NCT00606359|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-01-10|||November 2007||2007-11-01|January 2014|2014-01-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects|Immunogenicity of the Inactivated Split-Virion Influenza Vaccine Administered by the Intradermal Route in Renal Transplant Subjects|Completed||Phase 2|62|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:48:09.005016|2017-02-18 14:48:09.005016
NCT00606346|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2017-01-20|||May 2007||2007-05-01|January 2017|2017-01-01|December 2035|Anticipated|2035-12-01|December 2035|Anticipated|2035-12-01||Observational|DEVELOP||A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease|A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease|Recruiting||N/A|5000|Anticipated|Janssen Biotech, Inc.|||2||f||||t||||||||||2017-02-18 14:48:09.131276|2017-02-18 14:48:09.131276
NCT00606333|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-10-24|||March 2008||2008-03-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|May 2009|Actual|2009-05-01||Interventional|NEVO RES-I||Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions|A Randomized, Multi-Center, Single-Blind Comparison of the Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution Versus the TAXUS Liberte Paclitaxel-eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Terminated||N/A|394|Actual|Cordis Corporation||2||"The NEVO™ stent will not be commercialized. Cordis have decided to close the study after 3~   years. This decision took the absence of safety signals into account."|f||||t||||||||||2017-02-18 14:48:09.301603|2017-02-18 14:48:09.301603
NCT00606320|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2014-01-16|2013-11-28||January 2008||2008-01-01|January 2014|2014-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||"Full Analysis Population(FAS)：Excluding the following subjects from the randomized subjects:~3 subjects with GCP violation~1 subject whose post dose efficacy were not available"|A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode|A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode|Completed||Phase 3|59|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 14:48:09.421133|2017-02-18 14:48:09.421133
NCT00606307|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2013-05-23|||December 2007||2007-12-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases|A Phase IIA Study of the Histone-deacetylase Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases|Completed||Phase 2|29|Actual|Italfarmaco||1|||f||||f||||||||||2017-02-18 14:48:12.188014|2017-02-18 14:48:12.188014
NCT00606294|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2017-02-01|||June 2004|Actual|2004-06-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients|A Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients|Active, not recruiting||N/A|216|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||t||||||||||2017-02-18 14:48:12.296447|2017-02-18 14:48:12.296447
NCT00606281|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2014-01-16|2013-11-28||January 2008||2008-01-01|January 2014|2014-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||"Full Analysis Population(FAS)：~Excluding the following subjects from the randomized subjects:~2 subjects who did not take the study medication (Aripipirazole:1, Placebo:1)~8 subjects with GCP violation (Aripipirazole:5, Placebo:3)~1 subject whose post dose efficacy were not available (Placebo:1)"|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group-Comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode|Completed||Phase 3|258|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 14:48:12.409739|2017-02-18 14:48:12.409739
NCT00606268|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-08-19|||November 2007||2007-11-01|August 2014|2014-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant|A Phase 1 Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin as an Antifungal Prophylaxis in Children and Adolescents Undergoing Hematopoietic Stem Cell Transplant|Completed||Phase 1|42|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 14:48:12.944624|2017-02-18 14:48:12.944624
NCT00606255|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-28|2008-01-31|||January 2008||2008-01-01|January 2008|2008-01-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Observational|CAT||Compliance of Antihypertensive Treatment Study (CAT Study)|Compliance of Antihypertensive Treatment Study|Unknown status|Active, not recruiting|N/A|1062|Anticipated|The Catholic University of Korea|||3||f||||t||||||||||2017-02-18 14:48:13.071583|2017-02-18 14:48:13.071583
NCT00606242|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-03-06|||January 2000||2000-01-01|March 2014|2014-03-01|December 2007|Actual|2007-12-01|December 2002|Actual|2002-12-01||Interventional|FluSAL||Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma|A Randomized Double Blind Study of the Dose Response Effects of Fluticasone Propionate on Hypertonic-saline Induced Bronchoconstriction in Asthmatic Subjects|Completed||Phase 4|44|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:48:13.375324|2017-02-18 14:48:13.375324
NCT00606229|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2014-02-11|2013-12-19||January 2008||2008-01-01|February 2014|2014-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||Results obtained from the LOCF dataset of 40 subjects of the Full Analysis Set (FAS) (excluding 1 subject whose post-dose data of efficacy endpoint were not available from the 41 treated subjects)|A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode|A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode|Completed||Phase 3|41|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 14:48:13.476504|2017-02-18 14:48:13.476504
NCT00606216|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2015-12-09|||January 2007||2007-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy|Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy|Completed||N/A|66|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 14:48:13.744848|2017-02-18 14:48:13.744848
NCT00606203|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2008-10-15|||September 2007||2007-09-01|October 2008|2008-10-01|September 2011|Anticipated|2011-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke?||Unknown status|Recruiting|N/A|120|Anticipated|Chang Gung Memorial Hospital||2|||f||||f||||||||||2017-02-18 14:48:13.852388|2017-02-18 14:48:13.852388
NCT00606190|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2017-02-15|||June 2003||2003-06-01|February 2017|2017-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Prospective Randomized Study of Brain Protection During Aortic Arch Replacement|Prospective Randomized Study of Brain Protection During Aortic Arch Replacement|Completed||N/A|123|Actual|The Cleveland Clinic||2|||f||||t||||||||No||2017-02-18 14:48:13.959554|2017-02-18 14:48:13.959554
NCT00606177|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2014-01-16|2013-11-28||January 2008||2008-01-01|January 2014|2014-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||"Full Analysis Population(FAS)：Excluding 3 subject with GCP violation from the randomized subjects.~(Aripiprazole:1, Placebo:2)"|A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode|A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode|Completed||Phase 3|99|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 14:48:14.060654|2017-02-18 14:48:14.060654
NCT00606164|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2008-01-21|||April 2008||2008-04-01|January 2008|2008-01-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups, Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bryostatin 1 in Patients With Mild to Moderate Alzheimer's Disease|Unknown status|Not yet recruiting|Phase 2|9|Anticipated|Blanchette Rockefeller Neurosciences Insitute||3|||f||||f||||||||||2017-02-18 14:48:14.622329|2017-02-18 14:48:14.622329
NCT00606151|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2009-03-25|||January 2008||2008-01-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||PeriOperative Bridging - Perioperative Anticoagulation in the Setting of Recent Intracoronary Drug Eluting Stents|Short-Term Outcomes of Perioperative Anticoagulation in the Setting of Recent Intracoronary Drug Eluting Stents|Terminated||N/A|60|Anticipated|The Cleveland Clinic|||1|subject enrollment goals not met|f||||f||||||||||2017-02-18 14:48:14.731689|2017-02-18 14:48:14.731689
NCT00606138|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2014-11-04|2012-12-07||January 2008||2008-01-01|November 2014|2014-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging|Investigation of Ranibizumab for the Treatment of Persistent Diabetic Neovascularization as Assessed by Super Wide-Field Angiography (Optos)|Completed||Phase 1/Phase 2|8|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 14:48:14.823191|2017-02-18 14:48:14.823191
NCT00606125|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-06-20|||May 2007||2007-05-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|||Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors|Phase I Study With Sorafenib in Combination With Carboplatin and Paclitaxel to Evaluate the Safety and Pharmacokinetics of This Combination in Patients With Solid Tumors|Completed||Phase 1|16|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:48:15.251974|2017-02-18 14:48:15.251974
NCT00606112|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2009-04-14|||January 2008||2008-01-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|June 2008|Actual|2008-06-01||Interventional|||A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers|A Phase I, Double-Blind, Randomized, Placebo-Controlled Ascending IV Single-Dose Tolerance and Pharmacokinetic Study of Trodusquemine (MSI-1436) in Obese Type 2 Diabetics|Completed||Phase 1|28|Actual|Genaera Corporation||4|||f||||f||||||||||2017-02-18 14:48:15.358524|2017-02-18 14:48:15.358524
NCT00606099|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2012-05-01|||November 2007||2007-11-01|May 2012|2012-05-01||||November 2009|Actual|2009-11-01||Interventional|||Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B|A 26 Week Randomized, Open Label, Multi-center Study of the Efficacy and Safety of Telbivudine 600 mg Once Daily Versus Adefovir Dipivoxil 10mg Once Daily in Subjects With Compensated Chronic Hepatitis B and Sub-optimal Response to at Least 48 Weeks of Adefovir Dipivoxil 10 mg|Withdrawn||Phase 4|0|Actual|Novartis||2||study was cancelled|f||||||||||||||2017-02-18 14:48:15.452715|2017-02-18 14:48:15.452715
NCT00606086|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2014-06-17|2014-05-05||December 2007||2007-12-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection|A Phase 2 Randomized, Open Label, Multi-center, Therapeutic Trial of the Efficacy, Immunogenicity, and Safety of GI-5005; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing a Hepatitis C Virus NS3-Core Fusion Protein, Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone, and GI-5005 Salvage of Standard of Care Failures, in Patients With Genotype 1 Chronic Hepatitis C Infection|Completed||Phase 2|140|Actual|GlobeImmune||2|||f||||t||||||||||2017-02-18 14:48:15.781647|2017-02-18 14:48:15.781647
NCT00606073|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2008-01-21|||February 2008||2008-02-01|January 2008|2008-01-01||||August 2009|Anticipated|2009-08-01||Interventional|||The Influence of Different Concentrations of Glucose in Culture Media on Fertilization and Embryo Quality|The Influence of Different Concentrations of Glucose in Culture Media(i.e: ISM1 vs. IVF) on Fertilization and Embryo Quality|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hillel Yaffe Medical Center||4|||f||||t||||||||||2017-02-18 14:48:16.357401|2017-02-18 14:48:16.357401
NCT00606060|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2010-04-12|||July 2004||2004-07-01|April 2010|2010-04-01|May 2005|Actual|2005-05-01|||||Interventional|||BAY14-2222 Continuous Infusion in Surgeries|Safety and Efficacy of Continuous Infusion of Recombinant Factor VIII - Sucrose-formulated (BAY 14 2222) Concentrate in Patients With Hemophilia A Undergoing Major Elective Surgery.|Completed||Phase 3|15|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:48:16.432951|2017-02-18 14:48:16.432951
NCT00606047|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-05-28|||August 2007||2007-08-01|May 2014|2014-05-01||||August 2016|Anticipated|2016-08-01||Observational|||Prevalence of Femoroacetabular Impingement in Asymptomatic Patients|Prevalence of Femoroacetabular Impingement in Asymptomatic Patients|Unknown status|Active, not recruiting|N/A|200|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:48:16.536498|2017-02-18 14:48:16.536498
NCT00606034|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2014-01-07|2012-07-26||December 2007||2007-12-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod|A Prospective Trial of U500 Regular Insulin by Continuous Subcutaneous Insulin Infusion in Patients With Type 2 Diabetes and Severe Insulin Resistance Who Have Failed Previous Insulin Regimens|Completed||Phase 4|21|Actual|Mountain Diabetes and Endocrine Center|Small sample size. Also an uncontrolled pilot study.|1|||f||||f||||||||||2017-02-18 14:48:16.632831|2017-02-18 14:48:16.632831
NCT00606021|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2011-11-21|2011-10-03||January 2008||2008-01-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer|A Randomized Phase 2 Study Comparing Pemetrexed Plus Best Supportive Care With Best Supportive Care as Maintenance, Following First-Line Treatment With Pemetrexed-Cisplatin, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer|Completed||Phase 2|106|Actual|Eli Lilly and Company|Due to a mistake in the randomization parameters form, the randomization was actually implemented in the ratio of 1:1 instead of the planned ratio of 2:1.|2|||f||||||||||||||2017-02-18 14:48:16.910792|2017-02-18 14:48:16.910792
NCT00606008|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2012-11-13|2012-10-02||March 2007||2007-03-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma|A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma Multiforme|Completed||Phase 2|30|Actual|H. Lee Moffitt Cancer Center and Research Institute|No definitive conclusions can be made regarding outcome differences between bevacizumab vs. bevacizumab-naive study patients, due to not enough patients who received bevacizumab prior to study enrollment (2 AA, 3 GB).|1|||f||||t||||||||||2017-02-18 14:48:17.802563|2017-02-18 14:48:17.802563
NCT00605995|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2012-04-27|||February 2008||2008-02-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|ASSIST||Add-on Simvastatin in Schizophrenia Trial|Add-on Simvastatin in Schizophrenia Trial|Terminated||N/A|23|Actual|New York State Psychiatric Institute||2||"Study was stopped because enrollment was slower than anticipated by the investigators and the~   foundation funding the study."|f||||f||||||||||2017-02-18 14:48:18.344304|2017-02-18 14:48:18.344304
NCT00605982|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2016-12-16|||October 2006||2006-10-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Breast MRI as a Preoperative Tool for DCIS|Breast MRI as a Preoperative Tool for DCIS|Active, not recruiting||N/A|115|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:48:18.448362|2017-02-18 14:48:18.448362
NCT00605969|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2014-01-14|||May 2007||2007-05-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Dynamic Imaging of the Hip for Pre-operative Planning|Hip Reconstruction and Modeling for Surgical Pre-Operative Planning|Completed||N/A|30|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 14:48:18.758384|2017-02-18 14:48:18.758384
NCT00605956|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2008-07-31|||January 2008||2008-01-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers|An Evaluation of the Photoallergy Potential of NatrOVA Creme Rinse - 1% in Healthy Volunteers|Completed||Phase 1|65|Anticipated|ParaPRO LLC||3|||f||||f||||||||||2017-02-18 14:48:18.851051|2017-02-18 14:48:18.851051
NCT00605943|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2017-01-24|||January 16, 2008||2008-01-16|August 4, 2009|2009-08-04|August 4, 2009|Actual|2009-08-04|August 4, 2009|Actual|2009-08-04||Observational|||Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab|Pilot Study for the Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab Avastin or Ranibizumab Lucentis|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:48:18.956776|2017-02-18 14:48:18.956776
NCT00605930|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2014-04-02|||April 2004||2004-04-01|April 2014|2014-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.|Energy Metabolism in Neurodegenerative Diseases: A Randomized, Double Blind, Placebo-Controlled Clinical Pilot Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.|Completed||Phase 1|20|Actual|University of Louisville||2|||f||||f||||||||||2017-02-18 14:48:19.049885|2017-02-18 14:48:19.049885
NCT00605917|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-08-20|2012-08-20||April 2007||2007-04-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Special Investigation Of J Zoloft For Panic Disorder Patients|Special Investigation Of J Zoloft For Panic Disorder Patients|Completed||N/A|997|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:48:19.165997|2017-02-18 14:48:19.165997
NCT00605904|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-30|2012-05-23|2011-09-21||January 2008||2008-01-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics|Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics|Completed||Phase 2|37|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 14:48:19.858463|2017-02-18 14:48:19.858463
NCT00605891|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2010-08-24||2010-08-18|October 2006||2006-10-01|August 2010|2010-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Dose Finding Study of CHF 4226 for Treating Patients With COPD|A Randomized, Controlled,14-Treatment Day, Multicenter Study to Determine the Optimal Efficacious and Safe Dose of CHF 4226 in a Metered Dose Inhaler in Treating Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|278|Actual|Chiesi Farmaceutici S.p.A.||5|||f||||f||||||||||2017-02-18 14:48:20.489458|2017-02-18 14:48:20.489458
NCT00605878|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2017-01-24|||January 18, 2008||2008-01-18|October 12, 2016|2016-10-12||||||||Observational|||Studies of Skin Microbes in Healthy People and in People With Skin Conditions|Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients|Recruiting||N/A|530|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:48:20.66163|2017-02-18 14:48:20.66163
NCT00605865|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-08-28|2012-08-28||April 2007||2007-04-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Drug Use Investigation of Jzoloft.|Drug Use Investigation of Jzoloft.|Completed||N/A|2272|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:48:20.782063|2017-02-18 14:48:20.782063
NCT00605852|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-11-02|||October 2007||2007-10-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects|A Double-blind, Placebo-controlled, Randomized Cross-over Single Dose Escalation Study and a Double-blind, Placebo-controlled, Randomised Parallel Group 7-days Once Daily Repeat Dose Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral H1/H3 Dual Antagonist Compound in Healthy Male Subjects|Completed||Phase 1|40|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:48:21.557928|2017-02-18 14:48:21.557928
NCT00605839|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-11-16|2012-09-12||January 2008||2008-01-01|November 2015|2015-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Mobile Communication Technology for Adolescents With Diabetes|Adapting Mobile Communication Technology to Improve the Management of Adolescents With Diabetes|Completed||N/A|105|Actual|Indiana University|This was a small pilot study to generate results for further work.|3|||f||||f||||||||||2017-02-18 14:48:21.671343|2017-02-18 14:48:21.671343
NCT00605826|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2011-07-13|||August 2006||2006-08-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|December 2009|Actual|2009-12-01||Interventional|||A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence|A Randomized, Subject and Evaluator Blinded, Sham Controlled, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx for the Treatment of Fecal Incontinence|Unknown status|Active, not recruiting|N/A|200|Anticipated|Q-Med Scandinavia, Inc.||2|||f||||f||||||||||2017-02-18 14:48:22.091241|2017-02-18 14:48:22.091241
NCT00605813|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-08-09|2012-08-09||September 2007||2007-09-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Special Investigation Of Long Term Use Of Sertraline.|Special Investigation Of Long Term Use Of J ZOLOFT.|Completed||N/A|542|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:48:22.194598|2017-02-18 14:48:22.194598
NCT00605800|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2009-03-18|||March 2006||2006-03-01|March 2009|2009-03-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Observational|||Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function|Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function|Withdrawn||N/A|0|Actual|Memorial Sloan Kettering Cancer Center|||2|Study was closed due to logistical issues.|f||||||||||Samples With DNA|"~     Blood~   "|||2017-02-18 14:48:22.822557|2017-02-18 14:48:22.822557
NCT00605787|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-17|||January 2002||2002-01-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|June 2003|Actual|2003-06-01||Interventional|TODDY||TTA in Treatment of Diabetes and Dyslipidemia|TTA in Treatment of Diabetes and Dyslipidemia|Completed||Phase 2|16|Actual|Haukeland University Hospital||1|||f||||t||||||||||2017-02-18 14:48:22.919632|2017-02-18 14:48:22.919632
NCT00605774|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2014-12-10||||||December 2014|2014-12-01||||||||Interventional|||Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q5|Hypoglycemia Associated Autonomic Failure in Type 1 DM, Question 5|Withdrawn||N/A|0|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:48:23.020598|2017-02-18 14:48:23.020598
NCT00605761|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-03-15|||February 2008||2008-02-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||SD Cystic Fibrosis Study|An Open Label Dose Ascending, Single Dose Study to Investigate the Pharmacokinetics of SB-656933 in Subjects With Cystic Fibrosis.|Completed||Phase 1|9|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:48:23.136722|2017-02-18 14:48:23.136722
NCT00605748|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2008-08-26|||December 2007||2007-12-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|PAVAV||Pulmonary Vein (PV) -Isolation: Arrhythmogenic Vein(s) Versus All Veins|PV-Isolation for Paroxysmal Atrial Fibrillation: Isolation of the Arrhythmogenic Vein(s) vs. Isolation of All Veins|Unknown status|Recruiting|Phase 4|212|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 14:48:23.241068|2017-02-18 14:48:23.241068
NCT00605735|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2015-09-23||2010-09-10|March 2008||2008-03-01|September 2015|2015-09-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||PoC in Rheumatoid Arthritis With Methotrexate|A Randomized, Parallel Group, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of BMS-582949 Given Orally to Subjects With Rheumatoid Arthritis Having an Inadequate Response to Methotrexate|Completed||Phase 2|121|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 14:48:23.354395|2017-02-18 14:48:23.354395
NCT00605722|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2014-06-12|2014-06-12||March 2008||2008-03-01|June 2014|2014-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.|A Single Arm, Open Label Study of First Line Treatment With Tarceva Plus Avastin on Progression-free Survival in Patients With Advanced or Metastatic Liver Cancer|Completed||Phase 2|51|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:48:23.489226|2017-02-18 14:48:23.489226
NCT00605696|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2009-09-04|||April 2008||2008-04-01|September 2009|2009-09-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Evaluating the Effectiveness of Early Insulin Therapy in People at Risk for Developing Acute Lung Injury/Acute Respiratory Distress Syndrome|Early Insulin Therapy and Development of Acute Respiratory Distress Syndrome|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 14:48:23.906783|2017-02-18 14:48:23.906783
NCT00605683|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-10-28|||November 2007||2007-11-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|MOTION||MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist|A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist|Completed||Phase 3|679|Actual|Newron||3|||f||||||||||||||2017-02-18 14:48:24.023338|2017-02-18 14:48:24.023338
NCT00605670|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-11-13|||June 2005||2005-06-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery|Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery: Development and Validation of a Patient-Reported Outcomes Instrument|Completed||N/A|722|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:48:24.26247|2017-02-18 14:48:24.26247
NCT00605657|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-02-14|2013-02-14||January 2008||2008-01-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)|Pilot (Phase I-II) Study of Valproic Acid (Depakote) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)|Completed||Phase 1/Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 14:48:24.358045|2017-02-18 14:48:24.358045
NCT00605644|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2011-07-22||2009-03-02|January 2008||2008-01-01|July 2011|2011-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Nonmalignant Pain|Completed||Phase 2|120|Actual|Valeant Pharmaceuticals International, Inc.||5|||f||||f||||||||||2017-02-18 14:48:24.619623|2017-02-18 14:48:24.619623
NCT00605631|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-02-02|||May 2005||2005-05-01|February 2017|2017-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study|The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study|Completed||N/A|105|Actual|Boston Scientific Corporation||3|||f||||t||||||||||2017-02-18 14:48:24.705514|2017-02-18 14:48:24.705514
NCT00605618|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2011-01-24|||March 2008||2008-03-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors|A Phase I/II Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1/Phase 2|8|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:48:24.801023|2017-02-18 14:48:24.801023
NCT00605605|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2008-01-30|||March 2005||2005-03-01|January 2008|2008-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Vascular Endothelial Protection Effects of Dextromethorphan|Anti-Inflammation & Vascular Endothelial Protection Effects of Dextromethorphan on Heavy Smoker|Completed||Phase 4|40|Actual|National Cheng-Kung University Hospital||1|||f||||f||||||||||2017-02-18 14:48:24.891263|2017-02-18 14:48:24.891263
NCT00605592|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2009-02-16|||January 2007||2007-01-01|February 2009|2009-02-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||UVA Islet Cell Transplantation in Patients With Type I Diabetes|UVA Islet Cell Transplantation in Patients With Type I Diabetes|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|University of Virginia||1|||f||||t||||||||||2017-02-18 14:48:24.999973|2017-02-18 14:48:24.999973
NCT00605566|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-03-14|||January 2008||2008-01-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors|Tailored-dose Sorafenib Plus Metronomic Cyclophosphamide in Advanced Neuroendocrine Tumors (NET): a Phase II Clinical Trial Based on Individual Pharmacodynamic Assessment|Completed||Phase 2|22|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 14:48:25.09506|2017-02-18 14:48:25.09506
NCT00605553|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2015-06-19||2009-12-03|April 2008||2008-04-01|May 2014|2014-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study to Evaluate SYN115 in Parkinson's Disease|A Randomized, Double-blind, Placebo Controlled, Two-way Cross-over Study to Explore the Effects of 7 Days of Dosing With SYN115 20 mg p.o. BID or 60 mg p.o. BID on Clinical and fMRI Response to Intravenous Levodopa in Patients With Mild to Moderate Parkinson's Disease|Completed||Phase 2|30|Actual|Biotie Therapies Inc.||2|||f||||f||||||||||2017-02-18 14:48:25.195552|2017-02-18 14:48:25.195552
NCT00605540|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2014-09-02|2009-06-22||January 2008||2008-01-01|May 2014|2014-05-01|February 2012|Actual|2012-02-01|March 2010|Actual|2010-03-01||Observational|||Chronic Obstructive Pulmonary Disease Markers and Prognosis|Three-years Follow-up of Diagnostic and Prognostic Markers in Chronic Obstructive Pulmonary Disease|Completed||N/A|133|Actual|UPECLIN HC FM Botucatu Unesp|We excluded patients with comorbidities; therefore, many patients seen in clinical practice may not have been well represented in our study.||1||f||||t||||||||||2017-02-18 14:48:25.30542|2017-02-18 14:48:25.30542
NCT00605527|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2015-10-30|||November 2007||2007-11-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|PALI||Understanding the Role of Genes and Biomarkers in the Blood Clotting Process in Children With Acute Lung Injury|Targeted Genomic Analysis of Coagulation Pathways in Acute Lung Injury|Recruiting||N/A|450|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     Blood and plasma samples will be analyzed~   "|||2017-02-18 14:48:25.584101|2017-02-18 14:48:25.584101
NCT00605514|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2017-01-24|||January 25, 2008||2008-01-25|June 21, 2010|2010-06-21|June 21, 2010|Actual|2010-06-21|June 21, 2010|Actual|2010-06-21||Interventional|||Ebola and Marburg Virus Vaccines|VRC 206: A Phase I Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Plasmid Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults|Completed||Phase 1|20|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:48:25.693148|2017-02-18 14:48:25.693148
NCT00605488|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-05-04|||April 2006||2006-04-01|May 2016|2016-05-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer|Pilot Study Investigating the Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer|Active, not recruiting||N/A|20|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:48:25.808592|2017-02-18 14:48:25.808592
NCT00605475|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2012-01-10|2011-09-01||December 2007||2007-12-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes|A Multi Center, Randomized, Double Blind, Placebo-controlled, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 Administered Intravenously to Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|231|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:48:25.927586|2017-02-18 14:48:25.927586
NCT00605449|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2010-10-14||2010-10-14|January 2008||2008-01-01|October 2010|2010-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Drug Interaction Study Between Simvastatin and GSK376501|Phase I, Randomized, Open-Label, 3 Period Crossover Drug Interaction Study Between Simvastatin and GSK376501 in Healthy Subjects|Completed||Phase 1|39|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 14:48:28.304783|2017-02-18 14:48:28.304783
NCT00605436|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-01-30|||October 2006||2006-10-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Yoga for the Treatment of Metabolic Syndrome|Restorative Yoga for Therapy of the Metabolic Syndrome: A Pilot Trial|Completed||Phase 1|26|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 14:48:28.404325|2017-02-18 14:48:28.404325
NCT00605423|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2014-03-10|2013-09-20||January 2008||2008-01-01|March 2014|2014-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|MAP||The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot|A Single Masked, Randomized Comparison of the Safety and Efficacy of 0.2 and 0.5 µg/Day Fluocinolone Acetonide/Medidur™ in Patients With Exudative Age Related Macular Degeneration Who Have Received Lucentis™|Completed||Phase 2|6|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:48:28.514093|2017-02-18 14:48:28.514093
NCT00605410|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2009-01-06|||January 2008||2008-01-01|July 2008|2008-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness|Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness|Completed||Phase 4|12|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-02-18 14:48:28.939271|2017-02-18 14:48:28.939271
NCT00605397|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2015-12-23|||January 2007||2007-01-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Cu-64 HER2+||PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer|Pilot Trial of PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer|Completed||Phase 1|11|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:48:29.050889|2017-02-18 14:48:29.050889
NCT00605254|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-26|2017-01-24|||January 24, 2008||2008-01-24|September 4, 2014|2014-09-04|September 4, 2014||2014-09-04|||||Observational|||PET Imaging of P-glycoprotein Function Using [11C]dLop|Brain and Whole Body Imaging of P-Glycoprotein Function Using [11C]dLop|Completed||N/A|58|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:48:29.16285|2017-02-18 14:48:29.16285
NCT00605241|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-10-26|||February 2008||2008-02-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward|A Randomized, Double-bind, Placebo Controlled, Two-way Cross-over Study to Assess the Effects of a Single Dose of GSK598809, a Selective DRD3 Antagonist, in Modulating Nicotine Reward|Completed||Phase 1|40|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:48:29.253172|2017-02-18 14:48:29.253172
NCT00605228|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-29|||May 2007||2007-05-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|NORMO||A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation|A Randomised, Multicentre, Single-Blind, Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation.|Completed||Phase 4|400|Actual|Norgine||2|||f||||f||||||||||2017-02-18 14:48:29.366613|2017-02-18 14:48:29.366613
NCT00605215|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2013-08-16||2013-08-16|April 2008||2008-04-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|BRAVO||BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)|A Multinational, Multicenter, Randomized, Parallel-group Study Performed in Subjects With RRMS to Assess the Efficacy, Safety and Tolerability of Laquinimod Over Placebo in a Double-blind Design and a Reference Arm of Interferon β-1a (Avonex®) in a Rater-blinded Design.|Completed||Phase 3|1331|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-02-18 14:48:29.559423|2017-02-18 14:48:29.559423
NCT00605202|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2009-12-10|2009-08-13||February 2008||2008-02-01|December 2009|2009-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effect of Licorice and Hydrochlorothiazide on Plasma Potassium|Effect of Licorice and Hydrochlorothiazide on Plasma Potassium|Completed||Phase 4|10|Actual|University of Oulu||2|||f||||f||||||||||2017-02-18 14:48:32.219971|2017-02-18 14:48:32.219971
NCT00605189|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-10-10|||July 2007||2007-07-01|October 2013|2013-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Trial Examining Cellular Energetics Related to Various Wound Treatment Therapies|A Randomized, Controlled Trial Examining Cellular Energetics Related To Various Wound Treatment Therapies|Terminated||N/A|26|Actual|KCI USA, Inc.||2||Study no longer met business objectives|f||||f||||||||||2017-02-18 14:48:32.470574|2017-02-18 14:48:32.470574
NCT00605176|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2010-06-22|2010-04-15||January 2008||2008-01-01|June 2010|2010-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)|A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Four Weeks of Treatment With Imiquimod Creams for Actinic Keratoses|Completed||Phase 3|479|Actual|Graceway Pharmaceuticals, LLC||3|||f||||f||||||||||2017-02-18 14:48:32.567369|2017-02-18 14:48:32.567369
NCT00605163|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-03-26|||August 2006||2006-08-01|March 2008|2008-03-01||||August 2010|Anticipated|2010-08-01||Observational|PostCEPT||A Longitudinal Observational Follow-up of the PRECEPT Study Cohort|A Longitudinal Observational Follow-up of the PRECEPT Study Cohort|Unknown status|Enrolling by invitation|N/A|530|Anticipated|The Parkinson Study Group|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 14:48:33.402638|2017-02-18 14:48:33.402638
NCT00605150|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2015-02-03|2013-08-23||January 2008||2008-01-01|February 2015|2015-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC|A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma|Completed||N/A|10|Actual|Carolinas Healthcare System|||1||f||||t||||||||||2017-02-18 14:48:33.546818|2017-02-18 14:48:33.546818
NCT00605137|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-06-19|||May 2004||2004-05-01|June 2012|2012-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Safety of Insulin Detemir in Children With Type 1 Diabetes|Safety of Insulin Detemir and Insulin NPH in Children With Type 1 Diabetes Mellitus|Completed||Phase 3|83|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:48:33.761182|2017-02-18 14:48:33.761182
NCT00605124|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2013-03-04|||January 2008||2008-01-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|||Progressive Exercise After Total Knee Arthroplasty (TKA)|Progressive Exercise After Total Knee Arthroplasty: A Randomised Controlled Trial|Completed||N/A|120|Actual|Jyväskylä Central Hospital||2|||f||||f||||||||||2017-02-18 14:48:33.855349|2017-02-18 14:48:33.855349
NCT00605111|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2017-01-10|||December 2003||2003-12-01|January 2017|2017-01-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes|Efficacy and Safety of Initiation of Biphasic Insulin Aspart 30 Treatment in Subjects With Type 2 Diabetes Mellitus Failing OAD Therapy|Completed||Phase 4|193|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:48:33.966354|2017-02-18 14:48:33.966354
NCT00605098|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2013-10-25|||February 2008||2008-02-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy|Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy in HIV-infected Women|Completed||Phase 4|60|Actual|Oswaldo Cruz Foundation||2|||f||||f||||||||||2017-02-18 14:48:34.093188|2017-02-18 14:48:34.093188
NCT00605085|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2012-10-19|2012-06-01||October 2005||2005-10-01|October 2012|2012-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Safety and Tolerability of the Japanese Encephalitis Vaccine IC51|Safety and Tolerability of the Japanese Encephalitis Vaccine IC51. Double Blind, Randomized, Placebo Controlled Phase 3 Study|Completed||Phase 3|2675|Actual|Valneva Austria GmbH||2|||f||||||||||||||2017-02-18 14:48:34.210213|2017-02-18 14:48:34.210213
NCT00605072|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-01-14|2012-12-04||January 2008||2008-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|AVEC||The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial|The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial (AVEC Trial)|Completed||Phase 2|53|Actual|University of Southern California|The main limitation is the small sample size. The validity of TCD measurements as an index of cerebral blood flow is based on the assumption that cerebral vessel diameters are constant but we didn't have brain imaging to validate this assumption.|3|||f||||f||||||||||2017-02-18 14:48:34.616473|2017-02-18 14:48:34.616473
NCT00605059|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2010-10-05|||August 2007||2007-08-01|October 2010|2010-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|AV94||Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Evaluation of [123I] AV94 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Terminated||Phase 1|3|Actual|Institute for Neurodegenerative Disorders||1||Scans showed no visual difference between affected subjects & healthy volunteers|f||||f||||||||||2017-02-18 14:48:35.328205|2017-02-18 14:48:35.328205
NCT00605046|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2010-10-05|||August 2007||2007-08-01|October 2010|2010-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|AV151||Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects|Evaluation of [123I] AV151 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease (AD) in Comparison to Healthy Subjects|Terminated||Phase 1|1|Actual|Institute for Neurodegenerative Disorders||1||Scans showed no visual difference between affected subjects & healthy volunteers|f||||f||||||||||2017-02-18 14:48:35.439246|2017-02-18 14:48:35.439246
NCT00605033|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-09-09|2010-05-27||March 2008||2008-03-01|September 2016|2016-09-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)|A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects|Completed||Phase 4|241|Actual|Indivior Inc.||2|||f||||f||||||||||2017-02-18 14:48:35.55868|2017-02-18 14:48:35.55868
NCT00605020|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-06-19|||December 2003||2003-12-01|June 2012|2012-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|PreFER||Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes|Comparison of Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus|Completed||Phase 3|719|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:48:35.901712|2017-02-18 14:48:35.901712
NCT00605007|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-11-20|||February 2006||2006-02-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|||Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD|The Impact of Corticosteroid-induced Hyperglycemia on Clinical Outcome (Length of Stay, Disposition, APACHE Score, Need for Ventilatory Support and ICU Admission, Mortality) in Patients With COPD Exacerbation|Completed||N/A|450|Actual|Emory University|||1||f||||f||||||||||2017-02-18 14:48:36.002977|2017-02-18 14:48:36.002977
NCT00604994|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-13|2013-08-18|||June 2008||2008-06-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|January 2013|Actual|2013-01-01||Observational|LEGS||Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer|Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer|Completed||N/A|761|Actual|Queensland Centre for Gynaecological Cancer|||2||f||||f||||||||||2017-02-18 14:48:36.092097|2017-02-18 14:48:36.092097
NCT00604981|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-29|||May 2005||2005-05-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Multisystemic Therapy (MST) for Obesity in African American Youth|Adapting Multisystemic Therapy to Improve Food Choices and Health Outcomes in Obese African American Youth|Completed||N/A|49|Actual|Wayne State University||2|||f||||f||||||||||2017-02-18 14:48:36.203406|2017-02-18 14:48:36.203406
NCT00604968|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2015-04-29|2011-01-27||February 2007||2007-02-01|April 2015|2015-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)|Caelyx(R) in Breast Cancer in the Elderly. Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer.|Terminated||Phase 4|25|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:48:36.306332|2017-02-18 14:48:36.306332
NCT00604955|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2014-10-02|||October 2007||2007-10-01|October 2014|2014-10-01|January 2010|Actual|2010-01-01|December 2008|Actual|2008-12-01||Interventional|||Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis|A Phase 4 Study to Expand Access Program While Assessing the Safety and Efficacy of Paromomycin IM Injection in an Outpatient Setting for the Treatment of Visceral Leishmaniasis|Completed||Phase 4|2000|Actual|PATH||1|||f||||t||||||||||2017-02-18 14:48:36.671273|2017-02-18 14:48:36.671273
NCT00604942|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2009-07-31|||November 2007||2007-11-01|July 2009|2009-07-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|vMII||vMII for Measurement of Oesophageal Bolus Transport and Reflux|Volume Sensitive Multichannel Intraluminal Impedance (vMII) for the Measurement of Oesophageal Bolus Transport and Reflux|Terminated||N/A|140|Anticipated|Guy's and St Thomas' NHS Foundation Trust||4||prototype catheter never delivered|f||||f||||||||||2017-02-18 14:48:36.791089|2017-02-18 14:48:36.791089
NCT00604929|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-04-13|||August 2008||2008-08-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Nutrition on Muscle Protein Synthesis|The Effect of Carbohydrate and Protein Intake on Muscle Protein Synthesis During Endurance Exercise|Completed||N/A|12|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 14:48:36.917602|2017-02-18 14:48:36.917602
NCT00604916|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-01-16|||March 2007||2007-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|VAP||Oral Care Protocol for Preventing Ventilator- Associated Pneumonia|The Effectiveness of an Oral Care Protocol in Preventing Ventilator- Associated Pneumonia for Intensive Care Unit Patient|Completed||Early Phase 1|53|Actual|Mackay Memorial Hospital||2|||f||||t||||||||||2017-02-18 14:48:37.005892|2017-02-18 14:48:37.005892
NCT00604903|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2017-02-16|||August 23, 2006|Actual|2006-08-23|February 2012|2012-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|PAPIRUSII||Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal|Remon CHF Medical Device Clinical Investigation PAPIRUS II: Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal|Completed||N/A|42|Actual|Boston Scientific Corporation||1|||f||||f|f|f||||||No||2017-02-18 14:48:37.100652|2017-02-18 14:48:37.100652
NCT00604890|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-07-24|||March 2008||2008-03-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma|Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma|Completed||Phase 2|186|Actual|Berg, LLC||4|||f||||t||||||||||2017-02-18 14:48:37.189847|2017-02-18 14:48:37.189847
NCT00604877|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-17|||August 2003||2003-08-01|January 2008|2008-01-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Effects of Exercise on Endothelial Function in Stroke Patients|Effects of Exercise on Endothelial Function in Stroke Patients|Unknown status|Active, not recruiting|N/A|140|Actual|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 14:48:37.298313|2017-02-18 14:48:37.298313
NCT00604864|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-29|||February 2004||2004-02-01|January 2008|2008-01-01|November 2005|Actual|2005-11-01|February 2005|Actual|2005-02-01||Interventional|Infliximab||Effect of Anti TNFa Upon Deep Endometriosis Associated Pain|Anti TNFa Treatment for Deep Endometriosis Associated Pain : a Randomised Placebo Controlled Trial.|Completed||Phase 2|20|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-02-18 14:48:37.414625|2017-02-18 14:48:37.414625
NCT00604851|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2014-01-14|2013-07-10||September 2006||2006-09-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SARCA||Study of Acid Reflux Therapy for Children With Asthma|Study of Acid Reflux Therapy for Children With Asthma|Completed||N/A|306|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:48:37.525015|2017-02-18 14:48:37.525015
NCT00604838|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-29|||May 2006||2006-05-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Pivotal Study of the Al-Sense Study Protocol|Pivotal Study of the Al-ASense Study Protocol|Completed||Phase 1/Phase 2|330|Actual|Western Galilee Hospital-Nahariya||1|||f||||t||||||||||2017-02-18 14:48:38.099307|2017-02-18 14:48:38.099307
NCT00604825|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-08-27||2009-07-22|July 2007||2007-07-01|August 2015|2015-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)|A Parallel-group, Double-blind, Randomized, Placebo-controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Two Doses of GSK232802 Administered Orally as Monotherapy for 12 Weeks in Healthy Postmenopausal Women With Moderate to Extremely Severe Vasomotor Symptoms|Completed||Phase 2|359|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 14:48:38.207229|2017-02-18 14:48:38.207229
NCT00604812|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2015-11-09|2009-06-03||December 2007||2007-12-01|November 2015|2015-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Single-Dose Pharmacokinetics of MK0462 in Subjects With Migraines Aged 6 to 17 Years|Completed||Phase 1|31|Actual|Merck Sharp & Dohme Corp.|Pharmacokinetic data presented are preliminary data.|6|||f||||f||||||||||2017-02-18 14:48:38.427416|2017-02-18 14:48:38.427416
NCT00604799|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-07-16|||July 2003||2003-07-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2006|Actual|2006-06-01||Interventional|VALOR||VALOR: The Talent Thoracic Stent Graft System Clinical Study|Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms|Completed||Phase 2/Phase 3|379|Actual|Medtronic Endovascular||4|||f||||t||||||||||2017-02-18 14:48:39.008043|2017-02-18 14:48:39.008043
NCT00604786|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2009-10-27|||July 2007||2007-07-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Effect of Omalizumab on Responses to Cat Allergen Challenge|Pilot Study of the Effect of Omalizumab on Basophil and Mast Responses to Intranasal Cat Allergen Challenge|Completed||N/A|18|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:48:39.134219|2017-02-18 14:48:39.134219
NCT00604773|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2010-08-30|||February 2008||2008-02-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Incidence of Delirium in Critically Ill Patients in a Dutch University Hospital|Incidence of Delirium in Critically Ill Patients in a Dutch University Hospital|Completed||N/A|700|Anticipated|Radboud University|||2||f||||f||||||Samples With DNA|"~     blood, urine~   "|||2017-02-18 14:48:39.271902|2017-02-18 14:48:39.271902
NCT00604760|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-12-05|||December 2007||2007-12-01|December 2008|2008-12-01||||February 2009|Anticipated|2009-02-01||Interventional|||Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia|A Phase 2a, Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia|Unknown status|Active, not recruiting|Phase 2|160|Anticipated|Memory Pharmaceuticals||4|||f||||f||||||||||2017-02-18 14:48:39.360433|2017-02-18 14:48:39.360433
NCT00604747|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-29|||August 2006||2006-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Practice Structure on Motor Learning in Post-Stroke Patients|The Effects of Practice Structure on Motor Learning in Post-Stroke Patients|Completed||N/A|34|Actual|University of Sao Paulo||1|||f||||t||||||||||2017-02-18 14:48:39.513674|2017-02-18 14:48:39.513674
NCT00604734|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-23|2016-01-08|||October 2004||2004-10-01|January 2016|2016-01-01|October 2017|Anticipated|2017-10-01|October 2007|Actual|2007-10-01||Interventional|||A Prospective Clinical Study On A Total Hip Resurfacing System|A Prospective Clinical Study On A Total Hip Resurfacing System|Active, not recruiting||N/A|280|Actual|Zimmer Biomet||1|||f||||f||||||||||2017-02-18 14:48:39.618807|2017-02-18 14:48:39.618807
NCT00604721|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2014-05-12|2012-06-22||November 2007||2007-11-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer|A Phase 2 Study of AZD6244 in Advanced or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)|The study was stopped at the interim analysis due to lack of radiographic response.|1|||f||||||||||||||2017-02-18 14:48:39.726456|2017-02-18 14:48:39.726456
NCT00604708|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-05-03|2012-05-24||September 2005||2005-09-01|May 2016|2016-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Immunogenicity Study of the Japanese Encephalitis Vaccine IC51|Observer Blinded, Randomized Phase 3 Study to Investigate the Non-Inferiority of IC51 vs. JE-VAX as Vaccines for Japanese Encephalitis in Healthy Subjects|Completed||Phase 3|867|Actual|Valneva Austria GmbH||2|||f||||t||||||||||2017-02-18 14:48:39.999402|2017-02-18 14:48:39.999402
NCT00604695|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-08-06|2012-05-15||July 2008||2008-07-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|ICE T-TIMI 49||A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks|A Randomized Trial Evaluating Low-Dose IntraCoronary AdjunctivE Tenecteplase During Primary PCI for ST-Elevation Myocardial Infarction (ICE T)|Completed||Phase 2|40|Actual|Brigham and Women's Hospital|This pilot study was not adequately powered to exclude a modest increase in bleeding events. Study drug could not be administered to 4 patients and 7 patients were excluded for not meeting the inclusion criteria of TIMI Flow Grade 0/1 at enrollment.|2|||f||||t||||||||||2017-02-18 14:48:40.378705|2017-02-18 14:48:40.378705
NCT00604682|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-11-21|||January 2005||2005-01-01|November 2016|2016-11-01|December 2005|Actual|2005-12-01|October 2005|Actual|2005-10-01||Interventional|PSOR-001||Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis|Open-Label, Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC10004 in Subjects With Severe Plaque Type Psoriasis|Completed||Phase 2|19|Actual|Celgene Corporation||1|||f||||f||||||||||2017-02-18 14:48:40.930805|2017-02-18 14:48:40.930805
NCT00604669|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-11-20|2008-12-08||June 2007||2007-06-01|November 2013|2013-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients|Total Parenteral Nutrition(TPN)-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients|Completed||N/A|170|Actual|Emory University|||1||f||||t||||||||||2017-02-18 14:48:41.039724|2017-02-18 14:48:41.039724
NCT00604656|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-11-21|||May 2003||2003-05-01|November 2013|2013-11-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes|A Six Months, Multi-centre, Open, Randomised, Parallel Safety and Efficacy Comparison of NovoRapid® Produced by the Current Process and Insulin Aspart With the Same Formulation as NovoRapid®, Produced by the NN2000 Process in Subjects With Type 1 Diabetes on a Basal/Bolus Regimen|Completed||Phase 3|241|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:48:41.266232|2017-02-18 14:48:41.266232
NCT00604643|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-07-31|||October 2002||2002-10-01|July 2015|2015-07-01|April 2012|Anticipated|2012-04-01|July 2008|Actual|2008-07-01||Expanded Access|||Talent Aortic Cuff Stent Graft System Compassionate Use Registry|Compassionate Use of the TALENT Aortic Cuff in the Treatment of Patients Previously Treated With the AneuRx Stent Graft System With Sub-Optimal Stent Graft Outcomes|No longer available||N/A|||Medtronic Endovascular|||||f||||f||||||||||2017-02-18 14:48:41.583191|2017-02-18 14:48:41.583191
NCT00604630|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-10-21|||January 2003||2003-01-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|ESS||Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke|German Multicenter EPO Stroke Trial (Phase II/III)|Completed||Phase 2/Phase 3|522|Actual|Max-Planck-Institute of Experimental Medicine||2|||f||||t||||||||||2017-02-18 14:48:41.730677|2017-02-18 14:48:41.730677
NCT00604617|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2010-08-02|||August 2007||2007-08-01|August 2010|2010-08-01|July 2013|Anticipated|2013-07-01|December 2012|Anticipated|2012-12-01||Observational|||Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children|The Utility of Interferon-Gamma Release Assays in TB-HIV Co-infected Children|Unknown status|Recruiting|Phase 4|800|Anticipated|Case Western Reserve University|||1||f||||f||||||||||2017-02-18 14:48:41.874506|2017-02-18 14:48:41.874506
NCT00604604|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-06-02|||August 2004||2004-08-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Postpartum Depression Prevention Trial|An RCT to Evaluate the Effectiveness of Peer (Mother-to-Mother) Support for the Prevention of Postpartum Depression|Completed||N/A|702|Actual|University of Toronto||2|||f||||t||||||||||2017-02-18 14:48:41.967741|2017-02-18 14:48:41.967741
NCT00604591|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2016-06-14|||July 2011||2011-07-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|August 2015|Actual|2015-08-01||Interventional|||Effects of Tolcapone on Frontotemporal Dementia|Investigation of the Dopamine System in Frontotemporal Dementia|Active, not recruiting||Phase 2|28|Actual|Columbia University||2|||f||||f||||||||Undecided||2017-02-18 14:48:42.079563|2017-02-18 14:48:42.079563
NCT00604578|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2017-01-24|||January 4, 2008||2008-01-04|October 30, 2009|2009-10-30|October 30, 2009|Anticipated|2009-10-30|October 30, 2009|Anticipated|2009-10-30||Interventional|||Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma|A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Allergic Asthma|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:48:42.204084|2017-02-18 14:48:42.204084
NCT00604565|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-08-05|2015-03-11||January 2008||2008-01-01|August 2015|2015-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients|A Prospective, Randomized, Open-label, Multi-center, Controlled Clinical Trial of the Safety and Efficacy of Physiological Iron Maintenance in End Stage Renal Disease (ESRD) Subjects by Delivery of Soluble Ferric Pyrophosphate (SFP) Via Hemodialysate|Terminated||N/A|11|Actual|Charles Drew University of Medicine and Science|Study suspended after 1st 11 subjects enrolled. Study design changed significantly upon re-initiation, so 1st 11 subjects analyzed for safety only; no efficacy. Efficacy analysis from study after re-initiation is found under protocol NIH-FP-01 PRIME.|2||major planned changes to study design|f||||f||||||||||2017-02-18 14:48:42.309964|2017-02-18 14:48:42.309964
NCT00604552|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-06-24|2013-02-21||July 2003||2003-07-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||AneuRx Post Market Study in the Treatment of AAA|AneuRx Post Market Surveillance Registry|Terminated||N/A|349|Actual|Medtronic Endovascular|Early termination leading to small numbers of subjects analyzed; Technical problems with measurement leading to unreliable or uninterpretable data.|2||Mutual agreement between FDA closed the 522 postmarket surveillance Registry.|f||||f||||||||||2017-02-18 14:48:42.941132|2017-02-18 14:48:42.941132
NCT00604539|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2011-12-16|||February 2008||2008-02-01|December 2011|2011-12-01||||November 2009|Actual|2009-11-01||Interventional|||Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee|Study of the Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee|Completed||Phase 3|70|Anticipated|Bioiberica||2|||f||||f||||||||||2017-02-18 14:48:43.24358|2017-02-18 14:48:43.24358
NCT00604526|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-01-04|||September 2006||2006-09-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy|Pilot Study of High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy|Completed||Phase 1|42|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:48:43.361527|2017-02-18 14:48:43.361527
NCT00604513|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-07-10|||September 2006||2006-09-01|July 2012|2012-07-01|May 2007|Actual|2007-05-01|||||Interventional|RSA||Ready. Set. ACTION! A Theater-Based Obesity Prevention Program for Children|A Theater-Based Obesity Prevention Program for Children|Completed||N/A|181|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 14:48:43.462367|2017-02-18 14:48:43.462367
NCT00604500|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-21|2015-09-10|2010-07-15||March 2008||2008-03-01|September 2015|2015-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)|An Open-Label, Multi-Center, Patient Handling Study of Mometasone Furoate/Formoterol Fumarate MDI With an Integrated Dose Counter in Adolescent and Adult Subjects and Adult With Asthma or COPD|Completed||Phase 3|272|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:48:43.558786|2017-02-18 14:48:43.558786
NCT00604487|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-02-18|||January 2008||2008-01-01|February 2016|2016-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Induction of Labor in Patients With Unfavorable Cervical Conditions||Completed||N/A|300|Actual|Hillel Yaffe Medical Center||3|||f||||f||||||||||2017-02-18 14:48:43.804919|2017-02-18 14:48:43.804919
NCT00604474|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-02-02|||October 2007||2007-10-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants|Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants|Withdrawn||N/A|0|Actual|University of California, San Francisco||1||Not sufficient enrollment|f||||f||||||||||2017-02-18 14:48:43.895693|2017-02-18 14:48:43.895693
NCT00604461|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-11-21|2011-11-17||October 2007||2007-10-01|November 2011|2011-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)|Phase I/II Trial of Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)|Terminated||Phase 1/Phase 2|13|Actual|H. Lee Moffitt Cancer Center and Research Institute|This trial was closed early due to slow patient accrual. The planned accrual had been 44.|1||Slow Accrual|f||||t||||||||||2017-02-18 14:48:44.000101|2017-02-18 14:48:44.000101
NCT00604448|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-06-14|||February 2008||2008-02-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|August 2008|Actual|2008-08-01||Interventional|||The Effect of Eating Pulses for 8 Weeks on Satiety and Metabolic Syndrome Risk Factors in Overweight Individuals|The Effect of Frequent Consumption of Pulses for Eight Weeks on Blood Lipids and on Glycemic and Satiety Hormones Response in Overweight and Obese Subjects|Completed||N/A|44|Actual|University of Toronto||2|||f||||f||||||||||2017-02-18 14:48:44.265502|2017-02-18 14:48:44.265502
NCT00604435|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2010-01-18|||February 2008||2008-02-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Neoadjuvant Endostatin and Chemotherapy for Breast Cancer|Phase II Trial of Neoadjuvant Recombinant Human Endostatin, Docetaxel and Epirubicin as First-line Therapy in Patients With Breast Cancer|Completed||Phase 2|69|Actual|Xijing Hospital||2|||f||||t||||||||||2017-02-18 14:48:44.375485|2017-02-18 14:48:44.375485
NCT00604422|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2010-03-10|||April 2007||2007-04-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Observational|||Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis|Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis|Completed||N/A|97|Actual|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 14:48:44.509235|2017-02-18 14:48:44.509235
NCT00604409|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-09-03|||April 2006||2006-04-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|June 2014|Actual|2014-06-01||Interventional|||Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer|Phase I Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer|Completed||Phase 1|34|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-02-18 14:48:44.611508|2017-02-18 14:48:44.611508
NCT00604396|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2017-01-26|||March 2003||2003-03-01|January 2017|2017-01-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes|Safety and Efficacy of Insulin Detemir Combined With OAD Versus Insulin NPH Combined With OAD in Type 2 Mellitus|Completed||Phase 3|477|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:48:44.921724|2017-02-18 14:48:44.921724
NCT00604383|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-08-25|2015-12-22||March 2001||2001-03-01|August 2016|2016-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional||All randomized participants.|Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study|Phase 3, Multicenter,Parallel,Randomized Dbl-masked,Placebo-controlled Study of the Effects of 32 mg/dy Ruboxistaurin Vision Loss in Patients With Type 1 or Type 2 Diabetes Mellitus and an Early Treatment Diabetic Retinopathy Study Level Between 47A and 53E.|Completed||Phase 3|685|Actual|Chromaderm, Inc.||2|||f||||f||||||||||2017-02-18 14:48:45.105777|2017-02-18 14:48:45.105777
NCT00604370|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-02-09|||February 2008||2008-02-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|February 2010|Actual|2010-02-01||Observational|||Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge|VTE Prophylaxis Across the Continuum of Care: High Risk Patients at Hospital Discharge|Completed||N/A|2500|Actual|Brigham and Women's Hospital|||2||f||||f||||||||||2017-02-18 14:48:46.774123|2017-02-18 14:48:46.774123
NCT00604357|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2014-12-15|||December 2008||2008-12-01|December 2014|2014-12-01|August 2012|Actual|2012-08-01|July 2011|Actual|2011-07-01||Interventional|PATRON07||CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment|A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients With Impaired Renal Function. (PATRON-Study)|Completed||Phase 3|27|Actual|University of Regensburg||1|||f||||f||||||||||2017-02-18 14:48:46.858923|2017-02-18 14:48:46.858923
NCT00604344|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2017-01-26|||April 2003||2003-04-01|January 2017|2017-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes|A 48-week, Randomised, Multi-centre, Openlabelled, Parallel-group Trial to Compare the Efficacy and the Safety of NN304 (Insulin Detemir) and NPH Human Insulin in Subjects With Insulin Requiring Diabetes Mellitus on a Basal-bolus Regimen|Completed||Phase 3|401|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:48:46.973164|2017-02-18 14:48:46.973164
NCT00604331|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2010-12-07|||August 2008||2008-08-01|December 2010|2010-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation|Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation|Completed||Phase 2|8|Actual|Herzzentrum Goettingen||1|||f||||f||||||||||2017-02-18 14:48:47.064971|2017-02-18 14:48:47.064971
NCT00604318|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-01-09|||February 2008||2008-02-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer|Is it Possible to Increase Quality of Life, Using Recombinant TSH Instead of Withdrawal of Thyroid Hormone Treatment, Before Iodine Uptake in Patients With Thyroid Cancer?|Completed||Phase 4|56|Actual|Copenhagen University Hospital at Herlev||2|||f||||t||||||||||2017-02-18 14:48:47.171902|2017-02-18 14:48:47.171902
NCT00604305|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-06-10|||March 2008||2008-03-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Comperative Trial Between an Accommodative Iol and Monofocal Iol|A Randomized Single Blind Comparative Study of the Acuity's C-Well Accommodating Intra Occular Lens (AIOL) Against Alcon's Acrysof|Withdrawn||N/A|0|Actual|Shaare Zedek Medical Center||2||Company could not supply the accommodating intraocular lenses for the study|f||||f||||||||||2017-02-18 14:48:47.278074|2017-02-18 14:48:47.278074
NCT00604292|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-29|2010-03-10|||June 2007||2007-06-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Evaluation of the PillCam Colon Capsule Endoscopy (PCCE) Preparation and Procedure|Evaluation of the PillCam Colon Capsule Endoscopy Preparation and Procedure|Completed||N/A|50|Actual|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 14:48:47.359151|2017-02-18 14:48:47.359151
NCT00604279|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-06-04|2013-02-21||January 2008||2008-01-01|June 2013|2013-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia|A Randomized, Open-Label, Parallel Group Comparative Study of Paliperidone Palmitate (50, 100, 150 mg eq) and Risperidone LAI (25, 37.5, or 50 mg) in Subjects With Schizophrenia|Completed||Phase 3|452|Actual|Xian-Janssen Pharmaceutical Ltd.||2|||f||||f||||||||||2017-02-18 14:48:47.451911|2017-02-18 14:48:47.451911
NCT00604266|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-06-26|||August 2007||2007-08-01|June 2008|2008-06-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Observational|PET/MRCP||Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study|Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study.|Withdrawn||N/A|15|Anticipated|University of Toronto|||1||f||||f||||||||||2017-02-18 14:48:48.041328|2017-02-18 14:48:48.041328
NCT00604253|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2017-01-26|||December 2003||2003-12-01|January 2017|2017-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone|Comparison of Efficacy and the Safety of Insulin Detemir and Insulin NPH as add-on to Current OHA Therapy in Subjects With type2 Diabetes Mellitus|Completed||Phase 3|362|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:48:48.129368|2017-02-18 14:48:48.129368
NCT00604240|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2009-01-26|||November 2007||2007-11-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Telephone Follow-up From an Intensive Care Nursery|Telephone Follow-up From an Intensive Care Nursery: What do Parents Actually Remember?|Completed||N/A|175|Actual|Christiana Care Health Services|||1||f||||f||||||||||2017-02-18 14:48:48.237515|2017-02-18 14:48:48.237515
NCT00604227|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-29|||July 2005||2005-07-01|November 2007|2007-11-01|August 2005|Actual|2005-08-01|||||Interventional|||Pulmonary Function at High-Altitude|Interstitial Pulmonary Edema After Rapid Ascent to High Altitude (Margherita Hut, 4559 m)|Completed||N/A|34|Actual|Heidelberg University||1|||f||||f||||||||||2017-02-18 14:48:48.316594|2017-02-18 14:48:48.316594
NCT00604214|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-08-20|2012-08-20||March 2008||2008-03-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|September 2011|Actual|2011-09-01||Interventional|||Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock|A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of Drotrecogin Alfa (Activated) Administered as a Continuous 96-hr Infusion to Adult Patients With Septic Shock|Completed||Phase 3|1696|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 14:48:48.425151|2017-02-18 14:48:48.425151
NCT00604201|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2017-01-24|||January 4, 2008||2008-01-04|December 6, 2016|2016-12-06|December 31, 2018|Anticipated|2018-12-31|June 30, 2018|Anticipated|2018-06-30||Interventional|||Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome|Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated With Severe Neutropenia Refractory to Immunosuppressive Therapy|Recruiting||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:48:53.254567|2017-02-18 14:48:53.254567
NCT00604188|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-06-23|2010-12-07||February 2008||2008-02-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)|A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users|Completed||Phase 4|188|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:48:53.584583|2017-02-18 14:48:53.584583
NCT00604175|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-08-11|2013-07-15||February 2008||2008-02-01|August 2015|2015-08-01|November 2012|Actual|2012-11-01|January 2012|Actual|2012-01-01||Interventional||All participants, except 4: one was found to be ineligible after enrollment (Stratum A) and 3 failed to start intervention (2 in Stratum A, 1 in Stratum C).|Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women|A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females|Completed||Phase 2|319|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 14:48:54.126253|2017-02-18 14:48:54.126253
NCT00604162|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-06-10|2010-07-07||October 2006||2006-10-01|August 2010|2010-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|MA-53||PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon|Evaluation of PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon|Completed||Phase 3|332|Actual|Given Imaging Ltd.||1|||f||||f||||||||||2017-02-18 14:48:56.003512|2017-02-18 14:48:56.003512
NCT00604149|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2015-06-24|||January 2008||2008-01-01|June 2015|2015-06-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|CARTAGENE||Cardiac AResT And GENEtic|Etude Multicentrique en Population de la susceptibilité génétique à Faire Une Mort Subite|Completed||N/A|2332|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||3||f||||f||||||Samples With DNA|"~     whole blood to obtain DNA~   "|||2017-02-18 14:48:56.590206|2017-02-18 14:48:56.590206
NCT00604136|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-08-19|||July 2008||2008-07-01|August 2015|2015-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy|Treatment of Metastatic Melanoma Patients With Tumor Infiltrating Lymphocytes and IL-2 Following a Regimen of Non-myeloablative Lymphocyte Depleting Chemotherapy|Recruiting||Phase 2|20|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-02-18 14:48:56.6651|2017-02-18 14:48:56.6651
NCT00604123|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2015-04-07||2011-08-12|January 2008||2008-01-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults|A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adult Men or Women Allergic to Mountain Cedar Pollen|Completed||Phase 2|74|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-02-18 14:48:56.756074|2017-02-18 14:48:56.756074
NCT00604110|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-01-29|||February 2008||2008-02-01|January 2008|2008-01-01|October 2008|Anticipated|2008-10-01|September 2008|Anticipated|2008-09-01||Interventional|||Biventricular Epicardial Pacing Post Cardiac Surgery in Patients With Left Ventricular Ejection Fractions Less Than 45%|Interest in Biventricular Epicardial Pacing Post Cardiac Surgery in Patients With Left Ventricular Ejection Fractions Less Than 45%|Unknown status|Enrolling by invitation|Phase 3|12|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 14:48:56.859065|2017-02-18 14:48:56.859065
NCT00604097|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2012-12-13|||September 2004||2004-09-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|May 2007|Actual|2007-05-01||Interventional|||Preventing Youth Suicide in Primary Care: A Family Model|Preventing Youth Suicide in Primary Care: A Family Model|Completed||Phase 3|66|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-02-18 14:48:56.952253|2017-02-18 14:48:56.952253
NCT00604084|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2009-03-09|||May 2007||2007-05-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|VSEEP||Veron Scabies Education and Eradication Program|Veron Scabies Education and Eradication Program|Completed||N/A|1057|Actual|Edward Via Virginia College of Osteopathic Medicine||2|||f||||t||||||||||2017-02-18 14:48:57.064115|2017-02-18 14:48:57.064115
NCT00604071|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2015-04-13|||November 2007||2007-11-01|April 2015|2015-04-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Observational|HMP||Sensitivity of the Home Macular Perimeter (HMP)|Sensitivity of the Home Macular Perimeter (HMP) in the Detection of Visual Field Abnormalities in Patients With Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD)- PILOT Study|Completed||N/A|99|Actual|Notal Vision Ltd|||1||f||||t||||||||||2017-02-18 14:48:57.185492|2017-02-18 14:48:57.185492
NCT00604058|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2014-01-20|||January 2008||2008-01-01|January 2014|2014-01-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly|Immunogenicity and Safety of Fractional Doses of Sanofi Pasteur's Inactivated Poliomyelitis Vaccine Administered Intradermally vs Full Doses of Inactivated Poliomyelitis Vaccine Administered Intramuscularly in Healthy Philippines Infants|Completed||Phase 2|236|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:48:57.293839|2017-02-18 14:48:57.293839
NCT00604045|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2014-02-11|2013-12-13||May 2009||2009-05-01|January 2008|2008-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||DoD PTSD November 13 - Information Processing Modification in the Treatment of PTSD|Information Processing Modification in the Treatment of PTSD|Completed||N/A|25|Actual|San Diego State University||2|||f||||t||||||||||2017-02-18 14:48:57.401692|2017-02-18 14:48:57.401692
NCT00604032|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-03-26|||January 2008||2008-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%|Clinical Evaluation of the Phototoxic Potential of Atralin (Tretinoin) Gel, 0.05%|Completed||Phase 1|60|Actual|Coria Laboratories, Ltd.||1|||f||||f||||||||||2017-02-18 14:48:57.755005|2017-02-18 14:48:57.755005
NCT00604019|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-02-26|2011-07-20||March 2003||2003-03-01|February 2013|2013-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock|Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock|Completed||Phase 3|252|Actual|Rush University Medical Center||2|||f||||t||||||||||2017-02-18 14:48:57.855099|2017-02-18 14:48:57.855099
NCT00604006|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2015-06-02|||September 2008||2008-09-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|August 2014|Actual|2014-08-01||Interventional|||SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)|SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)|Completed||Phase 3|20|Actual|Monash University||2|||f||||f||||||||||2017-02-18 14:48:58.242416|2017-02-18 14:48:58.242416
NCT00603993|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2011-06-17|2009-10-16||March 2006||2006-03-01|June 2011|2011-06-01||||November 2006|Actual|2006-11-01||Interventional|||Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis|A Non-Randomized, Open-Label, Roll-Over Study With Self Injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis|Completed||Phase 3|88|Actual|Abbott|Due to the small population, statistical tests were not performed.|1|||f||||f||||||||||2017-02-18 14:48:58.366817|2017-02-18 14:48:58.366817
NCT00603980|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2009-03-20|||January 2008||2008-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Abuse Liability of Staccato Alprazolam|Abuse Liability Study of Staccato® Alprazolam for Inhalation in Subjects With Histories of Sedative Abuse|Completed||Phase 1|14|Anticipated|Alexza Pharmaceuticals, Inc.||7|||f||||f||||||||||2017-02-18 14:48:59.025654|2017-02-18 14:48:59.025654
NCT00603967|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2013-05-22|||March 2006||2006-03-01|May 2013|2013-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effect of Aromatase Inhibitors on Bones and Genes|Aromatase Inhibitors: Skeletal Effects and the Role of CYP19 Gene Polymorphisms|Completed||N/A|151|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:48:59.13006|2017-02-18 14:48:59.13006
NCT00603954|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-01-26|||December 2007||2007-12-01|January 2015|2015-01-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings|Allogeneic Hematopoietic Cell Transplantation With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings|Completed||Phase 2|97|Actual|University Hospital of Liege||2|||f||||f||||||||||2017-02-18 14:48:59.259727|2017-02-18 14:48:59.259727
NCT00603941|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-02-06||2013-02-01|January 2008||2008-01-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy|A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy Administered Every Three Weeks by Venous Infusion by Patients With Anaplastic Thyroid Cancer|Completed||Phase 1/Phase 2|19|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 14:48:59.403618|2017-02-18 14:48:59.403618
NCT00603928|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-11-19|||November 2007||2007-11-01|November 2008|2008-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Placebo Interventions in General Practice|Placebo Interventions in General Practice|Completed||N/A|600|Anticipated|University of Zurich|||1||f||||f||||||||||2017-02-18 14:48:59.740908|2017-02-18 14:48:59.740908
NCT00603915|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2011-10-06|2011-05-06||June 2006||2006-06-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer|Phase II Trial of Gemcitabine and Cisplatin/Carboplatin (GC) Plus Erlotinib in Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer|Completed||Phase 2|20|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 14:48:59.823755|2017-02-18 14:48:59.823755
NCT00603902|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2013-01-04|2013-01-04||January 2008||2008-01-01|January 2013|2013-01-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management|A 52-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients|Completed||Phase 3|4008|Actual|Arena Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:49:00.115729|2017-02-18 14:49:00.115729
NCT00603889|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-01-18|2011-06-21||March 2008||2008-03-01|January 2012|2012-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Development of a Skin Test for the Na-ASP-2 Hookworm Antigen|Development of a Skin Test to Detect Immediate-type Hypersensitivity to the Experimental Na-ASP-2 Hookworm Antigen|Completed||N/A|12|Actual|Albert B. Sabin Vaccine Institute||1|||f||||f||||||||||2017-02-18 14:49:00.966145|2017-02-18 14:49:00.966145
NCT00603876|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2013-05-20|||July 2008||2008-07-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of Almonds Added to Chronic Statin Therapy|Efficacy of Almonds Added to Chronic Statin Therapy|Completed||Phase 4|50|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:49:01.239552|2017-02-18 14:49:01.239552
NCT00603863|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2014-01-22|||January 2008||2008-01-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer|A Phase Ib Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Patients With Previously Untreated Advanced Pancreatic Cancer.|Completed||Phase 1/Phase 2|80|Anticipated|Immunomedics, Inc.||1|||f||||f||||||||||2017-02-18 14:49:01.350466|2017-02-18 14:49:01.350466
NCT00603850|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2015-04-13|||January 2008||2008-01-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|HMP||Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)|Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) in Intermediate Age Related Macular Degeneration Patients|Completed||N/A|25|Actual|Notal Vision Ltd|||1||f||||t||||||||||2017-02-18 14:49:01.500313|2017-02-18 14:49:01.500313
NCT00602953|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2013-01-22|||September 2007||2007-09-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Role of Pancreatic Triglyceride Content in Beta-cell Function|Role of Pancreatic Triglyceride Content in Beta-cell Function|Completed||N/A|101|Actual|University of Texas Southwestern Medical Center|||5||f||||t||||||||||2017-02-18 14:49:39.779491|2017-02-18 14:49:39.779491
NCT00603837|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2009-10-12|2009-07-24||May 2007||2007-05-01|October 2009|2009-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Warming Mattress Versus Polyethylene Wrapping to Prevent Hypothermia in Preterm Newborns.|Thermal Defense of Extremely Low Gestational Age Newborns (ELGANs) During Resuscitation: Exothermic Mattresses vs. Polyethylene Wrap|Completed||N/A|36|Actual|University of Oklahoma|Technical difficulties with the polyethylene wrap were the main limitations (variation of use, heat loss during pulse oximeter adjustment).|2|||f||||t||||||||||2017-02-18 14:49:01.620512|2017-02-18 14:49:01.620512
NCT00603824|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-09-12|||January 2008||2008-01-01|June 2009|2009-06-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)|Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia|Withdrawn||Phase 4|0|Actual|Methodist Healthcare||2||PI relocated|f||||f||||||||||2017-02-18 14:49:02.047484|2017-02-18 14:49:02.047484
NCT00603811|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-09-22|||September 2007||2007-09-01|September 2014|2014-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults|A Multicenter, Double-blind, Randomized, Escalating Dose-ranging Study to Investigate the Safety and Immunogenicity of the VAX102 Influenza Vaccine in Healthy Adults|Completed||Phase 1|60|Actual|VaxInnate Corporation||2|||f||||t||||||||||2017-02-18 14:49:02.163129|2017-02-18 14:49:02.163129
NCT00603798|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2010-06-22|2010-04-15||January 2008||2008-01-01|June 2010|2010-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)|A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter, Efficacy and Safety Study of Six Weeks of Treatment With Imiquimod Creams for Actinic Keratoses|Completed||Phase 3|490|Actual|Graceway Pharmaceuticals, LLC||3|||f||||f||||||||||2017-02-18 14:49:02.291337|2017-02-18 14:49:02.291337
NCT00603785|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2014-06-10|||January 2008||2008-01-01|June 2014|2014-06-01|April 2008|Anticipated|2008-04-01|April 2008|Anticipated|2008-04-01||Interventional|||Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis|Effects of Anti-IgE Antibody Omalizumab (Xolair) on Patients With Chronic Sinusitis and a Positive Allergen Test|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||2||Insufficient funds available|f||||f||||||||||2017-02-18 14:49:02.962144|2017-02-18 14:49:02.962144
NCT00603772|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-05-05|||January 2008||2008-01-01|February 2008|2008-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Clinical Evaluation of the Photoallergy Potential of Atralin Gel|Clinical Evaluation of the Photoallergy Potential of Atralin Gel (Tretinoin Gel 0.05%)|Completed||Phase 1|40|Anticipated|Coria Laboratories, Ltd.||1|||f||||f||||||||||2017-02-18 14:49:03.065585|2017-02-18 14:49:03.065585
NCT00603759|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-01-16|||April 2006||2006-04-01|January 2008|2008-01-01|August 2009|Anticipated|2009-08-01|August 2007|Actual|2007-08-01||Interventional|||COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma|the Role of COX-2 Inhibitor(CELECOXIB) in Combination With Chemoradiation in Locally Advanced Head & Neck Carcinoma, Phase III Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 3|122|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:49:03.164583|2017-02-18 14:49:03.164583
NCT00603746|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-11-04|2013-06-12||December 2007||2007-12-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.|A Randomized Double-Blind, Double Dummy, Placebo-Controlled, Parallel-Group, Multicenter Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticasone Propionate Inhalation Powder 500mcg Twice Daily Compared With Placebo for 8 Weeks in Adolescent an|Completed||Phase 2|627|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:49:03.292447|2017-02-18 14:49:03.292447
NCT00603733|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-04-21|2015-03-04||October 2007||2007-10-01|April 2016|2016-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|CAMMP|Baseline characteristics were reported for the Per Protocol population who participated in the Active phase and in the maintenance phase of this study.|Canadian Active & Maintenance Modified Pentasa Study|A Multicentre, Randomised, Double-blind, Non-inferiority Trial Comparing the Efficacy and Safety of a New Modified Oral Extended Release Pentasa® (Mesalamine) 500 mg Tablet to the Currently Marketed Pentasa® (Mesalamine) 500 mg Tablet in Subjects With Active Mild to Moderate Ulcerative Colitis Treated With 4 g/Day for 8 Weeks and in Maintenance of Remission of Ulcerative Colitis in Subjects Treated With 2 g/Day for 24 Weeks|Completed||Phase 3|288|Actual|Ferring Pharmaceuticals|Study was amended to modify sample size as subject enrolment was lower than anticipated. A data lock was imposed, pending completion of the Maintenance Phase by 12 subjects to report all Active Phase efficacy data & all available safety data.|2|||f||||f||||||||||2017-02-18 14:49:06.85314|2017-02-18 14:49:06.85314
NCT00603720|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-01-24|||September 2005||2005-09-01|January 2016|2016-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling|PET Detection of the Effects of Aging on the Human Heart. Aim#1-Impact of Aging on Myocardial Remodeling: Role of Nitric Oxide|Completed||N/A|59|Actual|Washington University School of Medicine||5|||f||||f||||||||Undecided||2017-02-18 14:49:07.404299|2017-02-18 14:49:07.404299
NCT00603707|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-08-28|||October 2006||2006-10-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|WholeGut||Assessment of Whole Gut Transit Time Using the SmartPill Capsule|Assessment of Whole Gut Transit Time Using the SmartPill Capsule: a Multi-Center Study|Completed||Phase 3|178|Actual|The SmartPill Corporation|||2||f||||f||||||||||2017-02-18 14:49:07.522174|2017-02-18 14:49:07.522174
NCT00603694|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-06-21|||September 2007||2007-09-01|June 2016|2016-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Hippocampal Radiation Exposure and Memory|Hippocampal Radiation Exposure and Memory: A Pilot Study|Completed||N/A|1|Actual|University Health Network, Toronto|||3||f||||t||||||||||2017-02-18 14:49:07.616274|2017-02-18 14:49:07.616274
NCT00603681|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-10-06|||January 2008||2008-01-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|PEGorion||Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation|Non-Inferiority Study; Comparison of Polyethylene Glycol Solution With and Without Electrolytes for Treatment of Chronic Constipation in Elderly Institutionalised Patients: a Double-Blind, Randomised, Parallel-Group, Multicentre Study|Completed||Phase 4|67|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-02-18 14:49:07.691357|2017-02-18 14:49:07.691357
NCT00603668|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2013-03-25|||August 2008||2008-08-01|March 2013|2013-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL|A Phase I/II Study of Immunotherapy With Milatuzumab (hLL1) in Patients With Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 1/Phase 2|19|Actual|Immunomedics, Inc.||1|||f||||f||||||||||2017-02-18 14:49:08.014273|2017-02-18 14:49:08.014273
NCT00603655|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-12-30|||January 2007||2007-01-01|December 2008|2008-12-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Effect of Glycemic Load on Body Composition|Assessment of Glycemic Load on Body Composition Among Overweight and Obese Adults During 12 Month Period|Terminated||Early Phase 1|29|Actual|Universidad Autonoma de Baja California||2||Higher drop out than expected. Lower Statistical Power.|f||||t||||||||||2017-02-18 14:49:08.134749|2017-02-18 14:49:08.134749
NCT00603642|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2011-02-04|2010-11-18||October 2007||2007-10-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura|A Randomized, Double Blind, Placebo Controlled Phase 3 Study Evaluating the Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura|Completed||Phase 3|34|Actual|Amgen||2|||f||||||||||||||2017-02-18 14:49:08.245685|2017-02-18 14:49:08.245685
NCT00603629|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2011-09-20|||January 2008||2008-01-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|MAST-X||Mechanisms of Acute Asthma Exacerbations Through Molecular Analysis of Airway Secretions and Tissues|A Pilot Study Determining Mechanisms of Acute Asthma Exacerbations Through Detailed Molecular Analysis of Airway Secretions and Tissues|Completed||N/A|23|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     whole blood, DNA, RNA, sputum, nasopharyngeal swab~   "|||2017-02-18 14:49:08.74221|2017-02-18 14:49:08.74221
NCT00603616|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-05-10|||November 2008||2008-11-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Induction of Clinical Response Using Rifaximin in Crohn's Disease|A Randomized, Prospective, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of Rifaximin for the Treatment of Moderate to Severe Crohn's Disease|Recruiting||Phase 2|40|Anticipated|University of Washington||2|||f||||f||||||||||2017-02-18 14:49:08.850882|2017-02-18 14:49:08.850882
NCT00603603|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-06-20|||February 2008||2008-02-01|June 2016|2016-06-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|Peri-Op||Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity|Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity|Completed||N/A|606|Actual|Washington University School of Medicine||2|||f||||f||||||||No||2017-02-18 14:49:08.995238|2017-02-18 14:49:08.995238
NCT00603590|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2009-09-22|2009-04-13||November 2006||2006-11-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|Polypill||Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease|Phase II Study of Heart Polypill in Primary Prevention of Cardiovascular Disease - Safety and Efficacy|Completed||Phase 2|475|Actual|Tehran University of Medical Sciences|Incomplete follow up Because of differences in systolic blood pressure at baseline, final analysis will take account of baseline differences|2|||f||||t||||||||||2017-02-18 14:49:09.116|2017-02-18 14:49:09.116
NCT00603577|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-04-06||2016-04-06|January 2008||2008-01-01|April 2016|2016-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|XENON||Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens|A Multi-center, Randomized, Double Blind, Placebo Controlled Phase III Study to Assess the Efficacy of Xaliproden in Patients With Oxaliplatin-induced Peripheral Sensory Neuropathy (PSN) Following Adjuvant Chemotherapy for Colon Cancer|Terminated||Phase 3|102|Actual|Sanofi||2||development of product discontinued|f||||t||||||||||2017-02-18 14:49:09.53554|2017-02-18 14:49:09.53554
NCT00603564|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2009-10-26|2009-09-11||January 2006||2006-01-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|CAPOVeRSO||Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRSO|A Comparison of CPAP Delivered by Helmet and O2 Therapy With Venturi Mask for the Treatment of Acute Respiratory Failure in Community-acquired Pneumonia|Terminated||N/A|47|Actual|University of Milan|Limitations of our study are mainly related to the early reaching of the end-point of the CPAP group. We were not able to evaluate the safety of the CPAP application and to address conclusions on its efficacy on outcomes.|2||"The study was prematurely interrupted because patients randomized to CPAP reached the endpoint~   quicker than anticipated in the protocol"|f||||t||||||||||2017-02-18 14:49:09.640788|2017-02-18 14:49:09.640788
NCT00603551|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2008-07-18|||November 2006||2006-11-01|July 2008|2008-07-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Observational|||Screening of Bone Mineral Density in Women Who Have Received Chemotherapy|Screening of Bone Mineral Density in Women Who Have Received Chemotherapy|Unknown status|Recruiting|N/A|100|Anticipated|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 14:49:10.05852|2017-02-18 14:49:10.05852
NCT00603538|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-03-05|2013-01-18||January 2008||2008-01-01|March 2013|2013-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer|Phase 1, Dose Escalation Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|19|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 14:49:10.151863|2017-02-18 14:49:10.151863
NCT00603525|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2014-05-22|2011-10-20||January 2008||2008-01-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|March 2011|Actual|2011-03-01||Interventional|||Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy|A Double-blind, Randomized, Placebo Controlled, Parallel Group, Multi-center, Phase III Trial of Ofatumumab Investigating Clinical Efficacy in Patients With Active Rheumatoid Arthritis Who Have Previously Had an Inadequate Response to One or More TNF Antagonist Therapies|Terminated||Phase 3|169|Actual|GlaxoSmithKline||2||"Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical~   development of autoimmune indications on the subcutaneous delivery."|f||||f||||||||||2017-02-18 14:49:11.136119|2017-02-18 14:49:11.136119
NCT00602940|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2010-05-20|||January 2006||2006-01-01|May 2010|2010-05-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Acupuncture for Polycystic Ovarian Syndrome|The Influence of Acupuncture on Ovulation and Reproductive Hormones|Unknown status|Active, not recruiting|N/A|78|Anticipated|University of Virginia||2|||f||||f||||||||||2017-02-18 14:49:39.888195|2017-02-18 14:49:39.888195
NCT00603512|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2012-12-16|2012-11-14||January 2008||2008-01-01|December 2012|2012-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan|A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Confirm Dose Responsiveness Following 12 Weeks of the Administration of CP-690,550 (4 Doses) or Placebo in Subjects With Active Rheumatoid Arthritis Inadequately Controlled With Methotrexate Alone|Completed||Phase 2|140|Actual|Pfizer||5|||f||||t||||||||||2017-02-18 14:49:14.509934|2017-02-18 14:49:14.509934
NCT00603499|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-01-16|||July 2006||2006-07-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||Magnesium and Metabolic Syndrome|Hypomagnesemia as a Risk Factor for Development of Metabolic Syndrome|Completed||Phase 4|85|Actual|Instituto Mexicano del Seguro Social||2|||f||||t||||||||||2017-02-18 14:49:21.699866|2017-02-18 14:49:21.699866
NCT00603486|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-07-22|||November 2007||2007-11-01|July 2008|2008-07-01|July 2008|Anticipated|2008-07-01|May 2008|Actual|2008-05-01||Observational|||SuperSTAT Noninvasive Blood Pressure Monitor Evaluation|SuperSTAT Noninvasive Blood Pressure Monitor Evaluation|Unknown status|Active, not recruiting|N/A|20|Anticipated|GE Healthcare|||1||f||||f||||||||||2017-02-18 14:49:21.788697|2017-02-18 14:49:21.788697
NCT00603473|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2011-01-24|2010-12-06||January 2008||2008-01-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures|An Open-Label, Multicenter Study Evaluating, The Efficacy, Safety And Pharmacokinetics Of Gabapentin As Adjunctive Therapy In Pediatric Patients With Partial Seizures When Other Antiepileptics Do Not Provide Satisfactory Effects|Completed||Phase 3|92|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:49:21.869401|2017-02-18 14:49:21.869401
NCT00603460|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-08-15|||January 2012||2012-01-01|August 2016|2016-08-01|March 2013|Anticipated|2013-03-01|January 2013|Anticipated|2013-01-01||Interventional|||DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer|A Phase-I/II Randomized Trial of Maintenance Vaccination Combined With Metronomic Cyclophosphamide w/wo Adoptive Transfer of CD3/CD28-CoStimulated T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer Previously Vaccinated DCVax-L|Withdrawn||Phase 1/Phase 2|0|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:49:22.344621|2017-02-18 14:49:22.344621
NCT00603447|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-03-10|2015-05-15||May 2008||2008-05-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|May 2013|Actual|2013-05-01||Interventional|||Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma|Phase 1b Multicenter Dose Escalation Study of Carfilzomib With Lenalidomide and Dexamethasone for Safety and Activity in Relapsed Multiple Myeloma|Completed||Phase 1|84|Actual|Onyx Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:49:22.485043|2017-02-18 14:49:22.485043
NCT00603434|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2017-01-11|||January 2008||2008-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)|Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)|Completed||Phase 1|16|Anticipated|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 14:49:25.460248|2017-02-18 14:49:25.460248
NCT00603421|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-02-24|||February 2009||2009-02-01|February 2016|2016-02-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Effectiveness of a 24 Hour Phone Line on the Rate of Suicide Attempts in Borderline Patients|Effectiveness of a 24 Hour Phone Line on the Rate of Suicide Attempts in Borderline Patients|Completed||N/A|318|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||No||2017-02-18 14:49:25.56489|2017-02-18 14:49:25.56489
NCT00603408|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-07-08|2016-07-08||December 2007||2007-12-01|July 2016|2016-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer|Effect of Neoadjuvant Cisplatin Based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: Clinical Outcome and Correlation to Biological Parameters|Terminated||Phase 2|5|Actual|Washington University School of Medicine||1||Study was discontinued due to lack of accrual.|f||||f||||||||||2017-02-18 14:49:25.674337|2017-02-18 14:49:25.674337
NCT00603395|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-23|2014-05-15|||September 2004||2004-09-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|September 2012|Actual|2012-09-01||Interventional|||A Prospective Clinical Study On A Total Hip Resurfacing System|A Prospective Clinical Study On A Total Hip Resurfacing System|Completed||N/A|298|Actual|St. Anna Ziekenhuis, Geldrop, Netherlands||1|||f||||f||||||||||2017-02-18 14:49:26.032393|2017-02-18 14:49:26.032393
NCT00603382|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-11-04|2013-06-06||December 2007||2007-12-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.|A Randomized Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Administered Once Daily and Fluticasone Propionate Inhalation Powder 100mcg Twice Daily Compared With Placebo for 8 Weeks in Adolescent and Adult Subjects With Persistent Asthma Symptomatic on Non-Steroidal, Asthma Therapy|Completed||Phase 2|599|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:49:26.14513|2017-02-18 14:49:26.14513
NCT00603369|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2009-02-05|||September 1999||1999-09-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|Project STAR||HIV, Abuse, and Psychiatric Disorders Among Youth|HIV, Abuse, and Psychiatric Disorders Among Youth|Completed||Phase 1|212|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-02-18 14:49:29.51158|2017-02-18 14:49:29.51158
NCT00603356|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-09-26|||November 2007||2007-11-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|||Phase I Study of OSI-930 and Erlotinib in Cancer Tumors|A Phase 1 Dose Escalation Study of Daily Oral OSI-930 and Erlotinib (Tarceva) in Patients With Advanced Solid Tumors|Completed||Phase 1|60|Anticipated|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 14:49:29.603323|2017-02-18 14:49:29.603323
NCT00603343|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-01-16|||June 2004||2004-06-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence|Treatment With Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence: Results of a Randomized Placebo-Controlled Phase III Clinical Trial|Completed||Phase 3|303|Actual|APOGEPHA Arzneimittel GmbH||2|||f||||t||||||||||2017-02-18 14:49:29.693993|2017-02-18 14:49:29.693993
NCT00603330|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-11-08|||January 2008||2008-01-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function|Infusion of Mesenchymal Stem Cells as Treatment for Steroid-Resistant Grade II to IV Acute GVHD or Poor Graft Function: a Multicenter Phase II Study|Recruiting||Phase 2|100|Anticipated|University Hospital of Liege||3|||f||||f||||||||||2017-02-18 14:49:29.794011|2017-02-18 14:49:29.794011
NCT00603317|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2010-07-09|||March 2008||2008-03-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|INWARA||Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid|Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid|Completed||Phase 4|13|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 14:49:29.942696|2017-02-18 14:49:29.942696
NCT00603304|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-09-12|2012-04-26||February 2008||2008-02-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|CAMUS||Complementary and Alternative Medicine for Urological Symptoms(CAMUS)|Complementary and Alternative Medicine for Urological Symptoms (CAMUS)|Completed||Phase 3|369|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 14:49:30.056154|2017-02-18 14:49:30.056154
NCT00603291|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-01-04|2013-01-04||December 2007||2007-12-01|January 2013|2013-01-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|||BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus|A 52-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Overweight and Obese Patients With Type 2 Diabetes Mellitus Managed With Oral Hypoglycemic Agent(s)|Completed||Phase 3|604|Actual|Arena Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:49:31.033584|2017-02-18 14:49:31.033584
NCT00603278|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-11-04|2013-06-06||December 2007||2007-12-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.|A Randomized Double-Blind, Double Dummy, Placebo-Controlled, Parallel-Group, Multicenter Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticasone Propionate Inhalation Powder 250mcg Twice Daily Compared With Placebo for 8 Weeks in Adolescent and Adult Subjects With Persistent Asthma Symptomatic on Low-Dose ICS Therapy|Completed||Phase 2|622|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:49:31.776408|2017-02-18 14:49:31.776408
NCT00603265|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-06-04|2015-04-21||November 2007||2007-11-01|June 2015|2015-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional||All participants who were randomized and treated with study medication.|Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|A Phase 2a, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Assess the Safety and Efficacy of ADL5859 100 mg BID in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|Completed||Phase 2|226|Actual|Cubist Pharmaceuticals LLC||3|||f||||f||||||||||2017-02-18 14:49:35.081471|2017-02-18 14:49:35.081471
NCT00603252|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-11-02|||January 2008||2008-01-01|November 2016|2016-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults|Evaluate the Effect of Risk Factors That Influence the Immunogenicity of GSK Biologicals' Twinrix Compared to Hepatitis A and Hepatitis B Vaccines Given Separately and to Show the Non-inferiority Between the Vaccines in Adults|Completed||Phase 4|213|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:49:35.890585|2017-02-18 14:49:35.890585
NCT00603239|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2015-03-19|2010-07-20||January 2008||2008-01-01|March 2015|2015-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin|Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin|Completed||Phase 3|165|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:49:36.020487|2017-02-18 14:49:36.020487
NCT00603226|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2008-01-16|||January 2008||2008-01-01|January 2008|2008-01-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Observational|||Slow Coronary Artery Flow: Influence on Morbidity and Mortality|Slow Coronary Artery Flow: Influence on Morbidity and Mortality|Unknown status|Recruiting|N/A|50|Anticipated|Hillel Yaffe Medical Center|||2||f||||t||||||||||2017-02-18 14:49:36.898569|2017-02-18 14:49:36.898569
NCT00603213|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2013-05-21|||January 2007||2007-01-01|May 2013|2013-05-01|February 2011|Actual|2011-02-01|October 2010|Actual|2010-10-01||Observational|Optivol||Correlation of Intrathoracic Impedance Measures With Blood Plasma Volume in Congestive Heart Failure|Correlation of Intrathoracic Impedance Measure With Blood Plasma Volume in Congestive Heart Failure|Completed||N/A|25|Actual|Medical University of South Carolina|||1||f||||f||||||Samples Without DNA|"~     15 mls of blood will be drawn to assay for plasma analytes including but not limited to~     MMPs, TIMPs and collagen propeptides.~   "|||2017-02-18 14:49:36.985273|2017-02-18 14:49:36.985273
NCT00603200|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2010-11-04|||January 2008||2008-01-01|November 2010|2010-11-01|December 2009|Anticipated|2009-12-01|June 2008|Anticipated|2008-06-01||Observational|||Effect of Large Volume Paracentesis on Fatigue in Cirrhosis|The Effect of Large Volume Paracentesis on Fatigue in Cirrhosis|Unknown status|Recruiting|N/A|10|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 14:49:37.088393|2017-02-18 14:49:37.088393
NCT00603187|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-05-10|2011-01-10||January 2008||2008-01-01|May 2011|2011-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|ACY-7||ACY-7 Oral Administration of Acyline|Oral Administration of the GnRH Antagonist Acyline in Normal Men Part II: Multiple-dose Pharmacokinetics (Acyline-7/MER 104-02)|Completed||Phase 1/Phase 2|4|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:49:37.179348|2017-02-18 14:49:37.179348
NCT00603174|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2012-09-18|||January 2008||2008-01-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|NAVA||Use of Neurally Adjusted Ventilatory Assist in Infants Respiratory Failure|Use of Neurally Adjusted Ventilatory Assist in Infants With Acute Respiratory Failure: a Case Study on Servo I|Completed||N/A|10|Actual|St. Justine's Hospital||1|||f||||f||||||||||2017-02-18 14:49:37.471114|2017-02-18 14:49:37.471114
NCT00603148|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2013-12-16|||September 2006||2006-09-01|December 2013|2013-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications|The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications in Patients Undergoing Invasive Procedures in the Hybrid Cardiac Catheterization/Cardiac Surgery Suite|Completed||N/A|475|Anticipated|Vanderbilt University|||1||f||||t||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 14:49:37.580212|2017-02-18 14:49:37.580212
NCT00603135|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-03-09|||January 2008||2008-01-01|March 2015|2015-03-01|March 2010|Anticipated|2010-03-01|July 2009|Anticipated|2009-07-01||Interventional|Keppra||Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status Epilepticus|Intravenous Levetiracetam as First-line Anticonvulsive Treatment in Patients With Non-convulsive Status Epilepticus|Withdrawn||Phase 2|0|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-02-18 14:49:37.674034|2017-02-18 14:49:37.674034
NCT00603122|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-05-18|||March 2005||2005-03-01|May 2014|2014-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Acclimatization Mechanisms During Ascent to 7500m|Acclimatization Mechanisms During Ascent to 7500m. Effects of Ascent Protocol on Acute Mountain Sickness and Cardiorespiratory Physiology|Completed||N/A|37|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 14:49:37.784444|2017-02-18 14:49:37.784444
NCT00603109|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-01-03|||August 2007||2007-08-01|January 2011|2011-01-01|August 2008|Anticipated|2008-08-01|June 2008|Anticipated|2008-06-01||Interventional|PWS||Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome|Effect of Rimonabant, a Cannabinoid Receptor 1 Antagonist on Weight Gain and Body Composition in Adults With Prader Willi Syndrome.|Unknown status|Recruiting|Phase 3|18|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 14:49:37.872898|2017-02-18 14:49:37.872898
NCT00603096|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-15|||June 2006||2006-06-01|January 2008|2008-01-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|NIV-OHS||Use of Polysomnography for Non-Invasive Ventilation Settings' Optimization|Interest of Using Nocturnal Polysomnography for Non-Invasive Ventilation (NIV) Settings' Optimization in Obesity-Hypoventilation Syndrome (OHS)|Unknown status|Recruiting|N/A|45|Anticipated|Tyco Healthcare Group||2|||f||||f||||||||||2017-02-18 14:49:38.092363|2017-02-18 14:49:38.092363
NCT00603083|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2011-12-08|||January 2008||2008-01-01|December 2011|2011-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Postoperative Pain Treatment in Total Hip Arthroplasty: A Study to Assess the Effect of Local Analgesia|Postoperative Pain Treatment in Total Hip Arthroplasty A Randomized Double-blinded Placebo-controlled Study to Assess the Effect of Local Analgesia|Completed||Phase 4|60|Actual|Vejle Hospital||2|||f||||t||||||||||2017-02-18 14:49:38.190621|2017-02-18 14:49:38.190621
NCT00603070|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2012-02-17|||March 2008||2008-03-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Electronic Prescribing and Electronic Transmission of Discharge Medication Lists|Electronic Prescribing and Electronic Transmission of Discharge Medication Lists to Improve Ambulatory Medication Safety|Completed||N/A|130|Actual|Weill Medical College of Cornell University|||2||f||||f||||||||||2017-02-18 14:49:38.308504|2017-02-18 14:49:38.308504
NCT00603057|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2017-01-18|||May 2007||2007-05-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|September 2013|Actual|2013-09-01||Observational|||Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer|Using Functional Image and Circulating Molecular Markers to Predict Tumor Response and Lung Toxicity in Treatment of Lung Cancer|Active, not recruiting||Phase 2|140|Anticipated|University of Michigan Cancer Center|||1||f||||t||||||||||2017-02-18 14:49:38.411307|2017-02-18 14:49:38.411307
NCT00603044|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-04-29|2015-04-13||January 2008||2008-01-01|April 2015|2015-04-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Interventional|||Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome|Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome|Completed||Phase 4|24|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 14:49:38.522729|2017-02-18 14:49:38.522729
NCT00603031|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-01-20|||January 2008||2008-01-01|August 2009|2009-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus|Effect of GLP-1 and GIP on the Maximal Insulin Secretory Capacity in Type-1 Diabetes Mellitus|Completed||N/A|9|Actual|Hvidovre University Hospital||3|||f||||f||||||||||2017-02-18 14:49:38.890986|2017-02-18 14:49:38.890986
NCT00603018|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-08-02|2016-01-25||June 2007||2007-06-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||PET Imaging Study of Recovered Anorexics|PET Imaging of Dopaminergic Transmission and Serotonin Markers in Anorexia Nervosa|Completed||N/A|23|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 14:49:38.982827|2017-02-18 14:49:38.982827
NCT00603005|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2010-02-23|||October 2007||2007-10-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Adherence Improvement in Glaucoma Patients|Adherence Improvement in Glaucoma Patients|Completed||N/A|802|Actual|Maastricht University Medical Center||4|||f||||t||||||||||2017-02-18 14:49:39.365952|2017-02-18 14:49:39.365952
NCT00602992|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-06-21|||August 2006||2006-08-01|June 2016|2016-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Exploring the Role of 3T MRI in Gamma Knife Radiosurgery|Exploring the Role of 3T MRI in Gamma Knife Radiosurgery: A Pilot Study|Completed||N/A|45|Actual|University Health Network, Toronto|||1||f||||t||||||||||2017-02-18 14:49:39.488016|2017-02-18 14:49:39.488016
NCT00602979|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-06-13|||April 2008||2008-04-01|June 2013|2013-06-01|July 2011|Actual|2011-07-01|September 2009|Actual|2009-09-01||Interventional|||Comparison Study in Adult Surgical Patients of 5 Airway Devices|Prospective, Randomized Comparison of Intubating Conditions With Airtraq Optical, Storz DCI Video, McGRATH Video, GlideScope Video, & Macintosh Laryngoscope in Randomly Selected Elective Adult Surgical Patients|Completed||N/A|240|Actual|Weill Medical College of Cornell University||5|||f||||f||||||||||2017-02-18 14:49:39.564953|2017-02-18 14:49:39.564953
NCT00602966|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-10-26|||July 2006||2006-07-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|October 2009|Actual|2009-10-01||Observational|||Oocyte Cryopreservation: Slow Cooling Versus Vitrification Techniques on Oocyte Survival|Oocyte Cryopreservation: Comparison of Slow Cooling Versus Vitrification Techniques on Oocyte Survival, Fertilization, and Embryo Development|Completed||N/A|14|Actual|UConn Health|||2||f||||f||||||||||2017-02-18 14:49:39.673564|2017-02-18 14:49:39.673564
NCT00602927|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-05-06|2010-10-06||November 2007||2007-11-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effects of Varenicline on Brain Activity During Nicotine Abstinence|Neural Substrates of Varenicline's (Chantix®) Efficacy for Smoking Cessation|Completed||N/A|38|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:49:39.99834|2017-02-18 14:49:39.99834
NCT00602914|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-30|2013-05-08|||March 2008||2008-03-01|April 2008|2008-04-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|MicronJet||A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle|An Open Label Study in Healthy Volunteers and Diabetes Mellitus Type II Subjects to Determine the Safety, Pharmacokinetics and Pharmacodynamics Profile of Insulin Injected by the MicronJet Device|Completed||Early Phase 1|23|Actual|NanoPass Technologies Ltd||2|||f||||f||||||||||2017-02-18 14:49:40.488627|2017-02-18 14:49:40.488627
NCT00602901|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2015-09-03|||July 2004||2004-07-01|September 2015|2015-09-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Interventional|HRSA4||Elderly Back Pain: Comparing Chiropractic to Medical Care|Elderly Back Pain: Comparing Chiropractic to Medical Care|Completed||Phase 2|240|Actual|Palmer College of Chiropractic||3|||f||||f||||||||||2017-02-18 14:49:40.597312|2017-02-18 14:49:40.597312
NCT00602862|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-11-29|||July 2007||2007-07-01|February 2012|2012-02-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250|The Effect of Sorafenib (Nexavar®) on 111-Indium Labeled Chimeric Monoclonal Antibody G250 or 111-Indium Labeled Bevacizumab (Avastin®) Uptake in Patients With Clear Cell RCC (ccRCC)|Completed||N/A|26|Actual|Radboud University||3|||f||||t||||||||||2017-02-18 14:49:40.721837|2017-02-18 14:49:40.721837
NCT00602849|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-05|||June 2003||2003-06-01|February 2008|2008-02-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Bioequivalency Study of Sertraline Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Sertraline Tablets 100 mg Under Fasting Conditions|Completed||N/A|38|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:40.842667|2017-02-18 14:49:40.842667
NCT00602836|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-12|2016-04-19|2012-03-15||February 2008||2008-02-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2010|Actual|2010-12-01||Interventional|||Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab Followed by Consolidation With Lenalidomide for Previously Untreated B-Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)|Active, not recruiting||Phase 2|45|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:49:40.937235|2017-02-18 14:49:40.937235
NCT00602823|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2008-01-25|||February 2006||2006-02-01|February 2006|2006-02-01|May 2006||2006-05-01|||||Observational|||Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)|Ex Vivo Monocyte and Lymphocyte Stimulation Tests and Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)|Completed||N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 14:49:41.336054|2017-02-18 14:49:41.336054
NCT00602797|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-04-01|||December 2007||2007-12-01|April 2014|2014-04-01||||December 2014|Anticipated|2014-12-01||Interventional|||Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer|Phase II Study of Weekly Vinorelbine and Paclitaxel in Elderly Patients With Advanced Non-small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|29|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:49:41.397145|2017-02-18 14:49:41.397145
NCT00602784|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2012-10-18|||November 2002||2002-11-01|October 2012|2012-10-01|September 2004|Actual|2004-09-01|May 2004|Actual|2004-05-01||Interventional|||Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine|Double Blind, Randomized, Multicenter, Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine Together With Polyarginine, HCV Peptide Vaccine Alone, or Polyarginine Alone, in Patients With Chronic HCV Having Not Responded to or Relapsed From Primary Standard HCV Therapy|Completed||Phase 2|66|Actual|Valneva Austria GmbH||5|||f||||f||||||||||2017-02-18 14:49:41.512341|2017-02-18 14:49:41.512341
NCT00602771|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2014-10-01|2013-01-08||January 2008||2008-01-01|June 2014|2014-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia|A Randomized Phase II Trial of Tipifarnib (R115777, ZARNESTRA, NSC #702818) in Combination With Oral Etoposide (VP-16) in Elderly Adults With Newly Diagnosed, Previously Untreated Acute Myelogenous Leukemia (AML)|Completed||Phase 2|84|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 14:49:41.60992|2017-02-18 14:49:41.60992
NCT00602758|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-05-19|||December 2004||2004-12-01|May 2016|2016-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV|ART Adherence: Enhanced Counseling and Observed Therapy|Completed||N/A|252|Actual|University of Missouri, Kansas City||3|||f||||f||||||||||2017-02-18 14:49:42.000124|2017-02-18 14:49:42.000124
NCT00602745|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2016-04-27||2016-04-27|February 2008||2008-02-01|April 2016|2016-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|S-1 Pancreas||S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen|A Multicenter, Open-Label, Randomized Study Comparing Efficacy and Safety of S-1 as Single Agent Versus 5-FU Bolus for the Treatment of Patients With Metastatic Pancreatic Cancer Previously Treated With a Gemcitabine-Based Regimen|Terminated||Phase 3|61|Actual|Sanofi||2||"Following the termination of development and commercialization agreement for S-1 with Taiho~   Pharmaceutical"|f||||t||||||||||2017-02-18 14:49:42.121002|2017-02-18 14:49:42.121002
NCT00602732|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-03-27|||September 2005||2005-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse|Intervention for Low-income Pregnant Women With Partner Abuse|Completed||Phase 1|60|Actual|Butler Hospital||2|||f||||t||||||||||2017-02-18 14:49:42.338432|2017-02-18 14:49:42.338432
NCT00602719|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-05|||March 2004||2004-03-01|February 2008|2008-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Bioequivalency Study of Zolpidem Tartrate Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of Zolpidem Tartrate Tablets 10 MG Under Fed Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:42.454308|2017-02-18 14:49:42.454308
NCT00602706|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-05-13|||January 2000||2000-01-01|May 2011|2011-05-01|July 2010|Actual|2010-07-01|June 2003|Actual|2003-06-01||Interventional|||Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant|A Phase I/II Dose Escalation Study Assessing the Toxicity and Efficacy of 153-Samarium-EDTMP in Place of TBI in the Conditioning Regimen for PBSCT for Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|76|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 14:49:42.540589|2017-02-18 14:49:42.540589
NCT00602693|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2017-02-09|||July 23, 2007|Actual|2007-07-23|February 2017|2017-02-01|April 16, 2015|Actual|2015-04-16|September 25, 2014|Actual|2014-09-25||Interventional|||T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer|Phase I Study of Infusion of Umbilical Cord Blood (UCB) Derived CD25+CD4+ T-Regulatory (Treg) Cells After Nonmyeloablative Cord Blood Transplantation|Completed||Phase 1|39|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 14:49:42.634947|2017-02-18 14:49:42.634947
NCT00602680|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2009-07-17|||January 2008||2008-01-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease|A Multicenter, Double-blind, Parallel-group, Placebo-controlled Study of the Effect on Cognitive Performance and Safety/Tolerability of SSR180711C for 4 Weeks, Using Donepezil as Calibrator, in Patients With Mild Alzheimer's Disease|Terminated||Phase 2|1|Actual|Sanofi||5||Insufficient expected benefit risk|f||||t||||||||||2017-02-18 14:49:42.762325|2017-02-18 14:49:42.762325
NCT00602667|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-12-06|||November 2007||2007-11-01|December 2016|2016-12-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma|Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma|Recruiting||N/A|315|Anticipated|St. Jude Children's Research Hospital||3|||f||||f||||||||||2017-02-18 14:49:42.874362|2017-02-18 14:49:42.874362
NCT00602641|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-11-14|2015-05-05||February 2008||2008-02-01|November 2016|2016-11-01|November 2021|Anticipated|2021-11-01|January 2014|Actual|2014-01-01||Interventional|||Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma|An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide (MPT) Versus Melphalan, Prednisone and Lenalidomide (Revlimid™) (MPR) in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for High-Dose Therapy|Active, not recruiting||Phase 3|306|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 14:49:43.057255|2017-02-18 14:49:43.057255
NCT00602628|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2013-06-25|||November 2007||2007-11-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|||Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast|WILL MULTIFUNCTIONAL MAGNETIC RESONANCE TECHNIQUES, DETAILED HISTOPATHOLOGICAL ANALYSIS AND PRONE TREATMENT POSITION IMPROVE ACCURACY OF TARGET VOLUME LOCALISATION & DEFINITION AND REDUCE EXPOSURE OF NORMAL TISSUES IN BREAST RADIOTHERAPY?|Completed||N/A|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:49:46.859042|2017-02-18 14:49:46.859042
NCT00602615|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-05|||September 2003||2003-09-01|February 2008|2008-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Bioequivalency Study of Torsemide Tablets Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of 20 mg Torsemide Tablets Under Fed Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:46.95893|2017-02-18 14:49:46.95893
NCT00602602|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2017-01-24|||March 2007||2007-03-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer|A Phase II Study of Gemcitabine, Oxaliplatin and Bevacizumab Followed by 5-Fluorouracil, Oxaliplatin, Bevacizumab and Radiotherapy in Patients With Locally Advanced Pancreatic Cancer|Active, not recruiting||Phase 2|99|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||||||||||||2017-02-18 14:49:47.042834|2017-02-18 14:49:47.042834
NCT00602589|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-12-21|||October 2002||2002-10-01|April 2010|2010-04-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects|An Open-label, Randomized, 3-way Crossover Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects|Completed||Phase 1|72|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:49:47.154183|2017-02-18 14:49:47.154183
NCT00602576|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2009-08-12|||January 2005||2005-01-01|August 2009|2009-08-01||||March 2008|Anticipated|2008-03-01||Interventional|||Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma|RANDOMIZED PHASE II STUDY COMPARING TWO SCHEDULES OF TEMOZOLOMIDE IN COMBINATION WITH BAY43-9006 IN PATIENTS WITH ADVANCED MELANOMA|Unknown status|Active, not recruiting|Phase 2|167|Anticipated|National Cancer Institute (NCI)||2|||||||||||||||||2017-02-18 14:49:47.454818|2017-02-18 14:49:47.454818
NCT00602563|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2016-12-06|||December 2007||2007-12-01|December 2016|2016-12-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Attention Training for Generalized Anxiety Disorder|Attention Training for Generalized Anxiety Disorder (Attention Training and Relaxation for GAD: Testing the Efficacy of Home-Delivery)|Completed||N/A|193|Actual|San Diego State University||4|||f||||t||||||||||2017-02-18 14:49:47.566536|2017-02-18 14:49:47.566536
NCT00602550|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2008-02-07|||June 2003||2003-06-01|February 2008|2008-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Bioequivalency Study of Zidovudine Under Fasting Conditions|A Single Dose, Two Treatment, Two Period, Two Sequence, Crossover Bioequivalency Study of 300 mg Zidovudine Tablets Under Fasting Conditions|Completed||N/A|52|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:47.872871|2017-02-18 14:49:47.872871
NCT00602537|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2016-08-29|||December 2007||2007-12-01|August 2016|2016-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Antidepressant Therapy in Treating Bipolar Type II Major Depression|Treatment of Bipolar Type II Major Depression|Completed||Phase 4|140|Actual|University of Pennsylvania||2|||f||||t||||||||No||2017-02-18 14:49:47.958512|2017-02-18 14:49:47.958512
NCT00438919|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2009-12-02|||May 2006||2006-05-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|||||Interventional|E-SELECT||A Multi-center Post-Market Surveillance Registry|The e-SELECT Registry a MULTICENTER POST-MARKET SURVEILLANCE|Completed||Phase 4|15000|Anticipated|Cordis Corporation||1|||f||||t||||||||||2017-02-18 15:50:47.935229|2017-02-18 15:50:47.935229
NCT00602524|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-05|||August 2004||2004-08-01|February 2008|2008-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Sequence Crossover Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:48.066034|2017-02-18 14:49:48.066034
NCT00602511|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-02-08|||October 2007||2007-10-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma|Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma|Completed||Phase 3|300|Anticipated|Nordic Myeloma Study Group||2|||f||||f||||||||||2017-02-18 14:49:48.144312|2017-02-18 14:49:48.144312
NCT00602498|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2008-02-05|||March 2003||2003-03-01|February 2008|2008-02-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Bioequivalency Study of Clarithromycin Tablets Under Fed Conditions|A Single Dose, Two-Treatment, Two-Period, Two-Sequence Crossover Bioequivalency Study of 500 mg Clarithromycin Tablets Under Fed Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:48.287297|2017-02-18 14:49:48.287297
NCT00602485|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2009-09-17|||June 2007||2007-06-01|September 2009|2009-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||The Effect of Action Control Based Intervention on Adherence After Cardiac Rehabilitaiton|The Effect of Action Control Based Interventions on Adherence to Prescribed Exercise and Diet Regimens for Patients Completing a Cardiac Rehabilitation Program Intervetnion on|Completed||Phase 1|80|Anticipated|Summa Health System||1|||f||||f||||||||||2017-02-18 14:49:48.364487|2017-02-18 14:49:48.364487
NCT00602472|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-02-27|2011-05-13||February 2008||2008-02-01|February 2014|2014-02-01||||May 2009|Actual|2009-05-01||Interventional|||BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes|A Randomised, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg) Administered Orally Once Daily Over 24 Weeks, With an Open-label Extension to One Year (Placebo Patients Switched to BI 1356), in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite a Therapy of Metformin in Combination With a Sulphonylurea|Completed||Phase 3|1058|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:49:48.463152|2017-02-18 14:49:48.463152
NCT00602459|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2015-04-22|||January 2008||2008-01-01|November 2014|2014-11-01||||December 2014|Actual|2014-12-01||Interventional|||Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia|A Genetic Risk-Stratified, Randomized Phase II Study of Four Fludarabine/Antibody Combinations for Patients With Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia|Unknown status|Active, not recruiting|Phase 2|418|Actual|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 14:49:49.553577|2017-02-18 14:49:49.553577
NCT00602446|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2012-11-06|2010-03-16||August 2007||2007-08-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant|Open-Label Single-Arm Pilot Study of Deferasirox (Exjade®) in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload|Terminated||Phase 2|4|Actual|Masonic Cancer Center, University of Minnesota||1||Due to slow accrual of patients|f||||t||||||||||2017-02-18 14:49:50.074885|2017-02-18 14:49:50.074885
NCT00602433|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2011-04-14|||December 2007||2007-12-01|April 2011|2011-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib|Evaluation of Hormonal Changes in Women on Erlotinib Therapy|Completed||N/A|10|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"~     blood will be tested for different sex hormones as well as glucose metabolism~   "|||2017-02-18 14:49:50.345302|2017-02-18 14:49:50.345302
NCT00602420|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-10-13|2014-06-24||June 2008||2008-06-01|October 2015|2015-10-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional||At least 145 evaluable patients in each treatment group, thus 290 evaluable patients in total, required for an 80% power analysis.|Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)|Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial|Completed||Phase 3|510|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 14:49:50.441305|2017-02-18 14:49:50.441305
NCT00602407|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||February 2004||2004-02-01|January 2008|2008-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions|A Single Dose, Randomized, Two-Period, Two-Treatment, Crossover Bioequivalency Study of Cilostazol 50 mg Tablets Under Fasting Conditions|Completed||N/A|36|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:51.604136|2017-02-18 14:49:51.604136
NCT00602394|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||May 2003||2003-05-01|January 2008|2008-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:51.693919|2017-02-18 14:49:51.693919
NCT00602381|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2008-01-31|||November 2002||2002-11-01|January 2008|2008-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions|A Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:51.780304|2017-02-18 14:49:51.780304
NCT00602368|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2017-01-30|||December 2010||2010-12-01|January 2017|2017-01-01|May 2015|Actual|2015-05-01|December 2014|Actual|2014-12-01||Interventional|||Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia|Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia: A Pilot Study|Completed||N/A|114|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-02-18 14:49:51.870365|2017-02-18 14:49:51.870365
NCT00602355|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-07-29|2016-06-01||February 2008||2008-02-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression|Placebo Controlled Trial of Sertraline and Interpersonal Psycho-Therapy for Postpartum Depression|Completed||Phase 2|162|Actual|Women and Infants Hospital of Rhode Island||3|||f||||t||||||||||2017-02-18 14:49:51.974712|2017-02-18 14:49:51.974712
NCT00169013|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-11|||May 2002||2002-05-01|April 2007|2007-04-01|June 2006||2006-06-01|||||Interventional|||Gabapentin in Phantom and Stump Pain|Gabapentin in the Prevention of Phantom Limb Pain|Completed||Phase 4|||Danish Pain Research Center|||||f||||t||||||||||2017-02-18 17:20:28.340085|2017-02-18 17:20:28.340085
NCT00602342|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-05|||March 2004||2004-03-01|February 2008|2008-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 250 mg Terbinafine Hydrochloride Tablets Under Fasting Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:53.022089|2017-02-18 14:49:53.022089
NCT00602329|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2009-07-07|||February 2006||2006-02-01|July 2009|2009-07-01||||December 2009|Anticipated|2009-12-01||Interventional|||MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer|A Phase II Study Assessing Tumor Blood Flow as Measured by Dynamic Contrast Enhanced MRI in Patients With Metastatic Colorectal Cancer Receiving FOLFOX Alone Versus Patients Randomized to Receive FOLFOX Plus Bevacizumab at 5mg/kg or 10mg/kg.|Unknown status|Recruiting|Phase 2|120|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 14:49:53.103145|2017-02-18 14:49:53.103145
NCT00602316|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-16|2013-08-23|||November 2007||2007-11-01|June 2009|2009-06-01||||September 2009|Anticipated|2009-09-01||Interventional|||Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer|Using Magnetic Resonance Techniques to Improve the Characterisation and Localisation of Breast Cancer. A Pilot Observational Study Testing the Accuracy of Multifunctional Magnetic Resonance Techniques in Predicting the Presence, Distribution and Nature of Breast Lesions in Women With Known Breast Cancer|Unknown status|Recruiting|N/A|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:49:53.220841|2017-02-18 14:49:53.220841
NCT00602303|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-07|||September 2003||2003-09-01|February 2008|2008-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Bioequivalency Study of Torsemide Tablets Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of 20 mg Torsemide Tablets Under Fasting Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:53.310207|2017-02-18 14:49:53.310207
NCT00602290|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-08-28|2014-06-08||February 2008||2008-02-01|August 2014|2014-08-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|||Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression|The Use of Methylphenidate to Improve Clinical Outcomes in Geriatric Depression: A Double-blind Placebo-Controlled Trial of Methylphenidate (Ritalin) Augmentation of Citalopram (Celexa) in Depressed Elderly Patients|Completed||Phase 4|181|Actual|University of California, Los Angeles||3|||f||||t||||||||||2017-02-18 14:49:53.38992|2017-02-18 14:49:53.38992
NCT00602277|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2016-08-05|||April 2008||2008-04-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy|A Phase 1 Study of Reovirus Serotype 3 - Dearing Strain (REOLYSIN®) (NSC 729968) in Patients With Ovarian, Primary Peritoneal and Fallopian Tube Carcinoma|Completed||Phase 1|70|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:49:53.832049|2017-02-18 14:49:53.832049
NCT00602264|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-25|||February 2006||2006-02-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|||||Observational|||Adipokines and Ghrelin Concentrations in Different Stages of Anorexia Nervosa|Adipocytokine and Ghrelin Concentrations in Different Stages of Anorexia Nervosa|Completed||N/A|41|Actual|Istanbul University|||4||f||||f||||||||||2017-02-18 14:49:53.93178|2017-02-18 14:49:53.93178
NCT00602251|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-05|||March 2004||2004-03-01|February 2008|2008-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Bioequivalency Study of Terbinafine Tablets Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 250 mg Terbinafine Hydrochloride Tablets Under Fed Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:54.018224|2017-02-18 14:49:54.018224
NCT00602225|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2015-05-05|||December 2007||2007-12-01|May 2015|2015-05-01||||March 2010|Actual|2010-03-01||Interventional|||Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|Dose Escalation Study of Clofarabine in Combination With Cytarabine (Ara-C) and G-CSF Priming for Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients|Completed||Phase 1/Phase 2|50|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:49:54.101533|2017-02-18 14:49:54.101533
NCT00602212|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-09-08|||February 2008||2008-02-01|January 2008|2008-01-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|INTREPID||Virtual Reality as Anxiety Management Tool for Generalized Anxiety Disorder|The Potential of Virtual Reality as Anxiety Management Tool: a Randomised Controlled Study in a Sample of Patients Affected by Generalized Anxiety Disorder|Completed||N/A|24|Actual|Istituto Auxologico Italiano||2|||f||||f||||||||||2017-02-18 14:49:54.415653|2017-02-18 14:49:54.415653
NCT00602199|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2011-05-13|||November 2004||2004-11-01|May 2011|2011-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||ABT-510 in Treating Patients With Metastatic Melanoma|A Phase II Study of Anti-angiogenesis Therapy for Metastatic Melanoma Using ABT-510|Completed||Phase 2|42|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 14:49:54.541818|2017-02-18 14:49:54.541818
NCT00602186|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2008-01-26|||July 2005||2005-07-01|January 2008|2008-01-01|March 2008|Anticipated|2008-03-01|March 2007|Anticipated|2007-03-01||Interventional|||Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction|Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction|Unknown status|Active, not recruiting|Phase 1/Phase 2|80|Actual|Tabriz University||2|||f||||t||||||||||2017-02-18 14:49:54.635099|2017-02-18 14:49:54.635099
NCT00602173|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||May 2003||2003-05-01|January 2008|2008-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions|A Single Dose, Randomized, Three-Period, Three-Treatment, Crossover Bioequivalency Study of Cilostazol 100 mg Tablets Under Fasting Conditions|Completed||N/A|32|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:54.731658|2017-02-18 14:49:54.731658
NCT00602160|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2010-11-03|||December 2007||2007-12-01|November 2010|2010-11-01|June 2012|Anticipated|2012-06-01|May 2012|Anticipated|2012-05-01||Interventional|FAHF-2||Therapeutic Effect of Chinese Herbal Medicine on Food Allergy|Investigation of the Efficacy of the Food Allergy Herbal Formula (FAHF-2TM) in Patients With Food Allergy - Phase II Trial|Unknown status|Recruiting|Phase 2|68|Anticipated|Li, Xiu-Min, M.D.||2|||f||||t||||||||||2017-02-18 14:49:54.813546|2017-02-18 14:49:54.813546
NCT00601770|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-02-10|||February 2006||2006-02-01|February 2014|2014-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Virological Response Study of the HCV Vaccine IC41|Open-label, Multicenter Trial With IC41, a Therapeutic HCV Vaccine in Patients With Chronic HCV|Completed||Phase 2|71|Actual|Valneva Austria GmbH||1|||f||||f||||||||||2017-02-18 14:50:02.082817|2017-02-18 14:50:02.082817
NCT00602147|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2013-03-12|||July 2007||2007-07-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|January 2009|Actual|2009-01-01||Observational|||Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan|Genetic Analysis of Toxicity Associated With High-Dose Melphalan|Terminated||N/A|95|Actual|Vanderbilt-Ingram Cancer Center|||2|The original PI on this study left VICC, thus study was closed.|f||||f||||||Samples With DNA|"~     Blood sample or cheek cells will be collected.~   "|||2017-02-18 14:49:54.926283|2017-02-18 14:49:54.926283
NCT00602134|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2008-02-05|||November 2002||2002-11-01|February 2008|2008-02-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions|A Pharmacokinetic Study to Assess the Single-Dose Bioequivalence of a Potential Generic Formulation of a 6-Mercaptopurine 50 mg Tablet Compared to a Marketed 6-Mercaptopurine 50 mg Tablet, Purinethol®, When Administered to Healthy Male Subjects, in the Fasted State|Completed||N/A|54|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:55.035858|2017-02-18 14:49:55.035858
NCT00602108|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2011-08-09|||January 2005||2005-01-01|August 2011|2011-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast Cancer|Phase II Study of Intra-operative Electron Irradiation and Hypofractionated External Beam Irradiation After Lumpectomy in Patients With Stage T1N0M0 or T2N0M0 Breast Cancer|Completed||Phase 2|50|Actual|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:49:55.118398|2017-02-18 14:49:55.118398
NCT00602095|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-01-15|||December 2004||2004-12-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|LI||Labour Induction With Misoprostol, Dinoprostone and Bard Catheter|A Randomised Comparison Between Intravaginal Dinoprostone Intravaginal Misoprostol and Transcervical Balloon Catheter for Labour Induction|Completed||Phase 3|592|Actual|Karolinska University Hospital||3|||f||||t||||||||||2017-02-18 14:49:55.21159|2017-02-18 14:49:55.21159
NCT00602082|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-08-06|||August 2005||2005-08-01|June 2009|2009-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors|A Randomised Phase II Study Comparing Capecitabine Plus Streptozocin With or Without Cisplatin Chemotherapy as Treatment for Unresectable or Metastatic Neuroendocrine Tumors|Completed||Phase 2|84|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:49:55.312048|2017-02-18 14:49:55.312048
NCT00602069|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2013-06-21|||May 2008||2008-05-01|June 2013|2013-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Cognitive Behavioral Therapy for Treating Recently Abused Women With Post-Traumatic Stress Disorder|Treatment of PTSD in Recently Battered Women Living in Shelters|Completed||Phase 1|60|Actual|The University of Akron||2|||f||||t||||||||||2017-02-18 14:49:55.43558|2017-02-18 14:49:55.43558
NCT00602056|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-13|2008-01-13|||November 2005||2005-11-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Low Cost Interventions to Improve Adherence to Childhood Immunization Schedule|A Randomized Controlled Trial of Low Cost Interventions to Improve Adherence to Childhood Immunization Schedule in a Low Literacy Population in Pakistan|Completed||N/A|1506|Actual|University of Alabama at Birmingham||4|||f||||t||||||||||2017-02-18 14:49:55.556677|2017-02-18 14:49:55.556677
NCT00602043|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2014-12-16|2014-12-16||September 2008||2008-09-01|August 2014|2014-08-01|September 2014|Actual|2014-09-01|August 2011|Actual|2011-08-01||Interventional|||F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer|A Phase 2 Study of [18F] Fluoroestradiol (FES) as a Marker of Hormone Sensitivity of Metastatic Breast Cancer|Completed||Phase 2|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:49:55.661795|2017-02-18 14:49:55.661795
NCT00602030|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-04-18|||December 2007||2007-12-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|February 2010|Actual|2010-02-01||Interventional|||Study to Evaluate Erlotinib With or Without SNDX-275 in the Treatment of Patients With Advanced NSCLC|A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 2 Study With a Lead in Phase of Erlotinib With or Without SNDX-275 in Patients With NSCLC After Failure In Up to Two Prior Chemotherapeutic Regimens for Advanced Disease|Completed||Phase 1/Phase 2|132|Actual|Syndax Pharmaceuticals||3|||f||||t||||||||||2017-02-18 14:49:55.922304|2017-02-18 14:49:55.922304
NCT00602017|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||April 2004||2004-04-01|January 2008|2008-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 10 mg Amlodipine Besylate Tablets Under Fasting Conditions|Completed||N/A|40|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:49:56.062491|2017-02-18 14:49:56.062491
NCT00602004|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2015-05-08|||October 2006||2006-10-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|August 2014|Actual|2014-08-01||Interventional|||Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan|Early and Late Cardiac Effects of Arteriovenous Fistula Creation for Haemodialysis in End-stage Renal Failure and Their Possible Attenuation|Completed||N/A|52|Anticipated|Melbourne Health||1|||f||||t||||||||||2017-02-18 14:49:56.15352|2017-02-18 14:49:56.15352
NCT00601991|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-03-29|||March 2007||2007-03-01|March 2013|2013-03-01|October 2009|Actual|2009-10-01|March 2009|Anticipated|2009-03-01||Interventional|||A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia|A Multi-Center Phase 2 Study of Vascular Endothelial Growth Factor (VEGF) Trap as a Single Agent in Acute Myeloid Leukemia|Withdrawn||Phase 2|0|Actual|Vanderbilt-Ingram Cancer Center||1||Another study was opened.|f||||t||||||||||2017-02-18 14:49:56.254992|2017-02-18 14:49:56.254992
NCT00601978|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2012-04-27|||August 2008||2008-08-01|April 2012|2012-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off|A 12-Week, Multi-center, Randomized, Prospective, Open-Label, Blinded Rater, Crossover Study of the Effects of Immediate-Release Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event-Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease and End-of-Dose Wearing Off|Withdrawn||Phase 4|0|Actual|Novartis||2||Business decision brand strategy; no patients enrolled|f||||t||||||||||2017-02-18 14:49:56.366224|2017-02-18 14:49:56.366224
NCT00601757|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2014-01-29|||January 2006||2006-01-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Depression Prevention for Pregnant Women on Public Assistance|Depression Intervention for Financially Disadvantaged Pregnant Women.|Completed||Phase 2|207|Actual|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||||2017-02-18 14:50:02.356518|2017-02-18 14:50:02.356518
NCT00601965|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2016-07-14|2014-09-03||October 2007||2007-10-01|July 2016|2016-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||please see Wetherell et al. (2013), Antidepressant Medication Augmented with Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults, American Journal of Psychiatry, 170:782-9.|Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults|CBT Augmentation of SSRI Treatment for Geriatric GAD|Completed||N/A|73|Actual|Veterans Medical Research Foundation||4|||f||||t||||||||No||2017-02-18 14:49:56.479831|2017-02-18 14:49:56.479831
NCT00601952|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-12-13|2013-12-13||July 2012||2012-07-01|July 2009|2009-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Information Processing Modification in PTSD (Oct. 18)|Information Processing Modification in PTSD|Completed||N/A|37|Actual|San Diego State University||2|||f||||t||||||||||2017-02-18 14:49:57.186964|2017-02-18 14:49:57.186964
NCT00601939|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2016-07-21|||March 2008||2008-03-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships|Group Interventions for Abused, Suicidal Black Women|Recruiting||Phase 4|190|Anticipated|Emory University||2|||f||||t||||||||||2017-02-18 14:49:57.561175|2017-02-18 14:49:57.561175
NCT00601926|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2015-05-18|2014-06-20||February 2008||2008-02-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|August 2011|Actual|2011-08-01||Interventional|||Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer|A Phase II Trial Of Avastin (Bevacizumab) In Patients With Metastatic Papillary Renal Cell Carcinoma|Terminated||Phase 2|5|Actual|Ohio State University Comprehensive Cancer Center|This trial closed early due to poor patient accrual. Attempts to open this trial at other sites were not successful.|1||Poor patient accrual. Attempts to open at other sites unsuccessful.|f||||t||||||||||2017-02-18 14:49:57.675831|2017-02-18 14:49:57.675831
NCT00601913|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2016-02-10|||March 2008||2008-03-01|February 2016|2016-02-01||||October 2014|Actual|2014-10-01||Interventional|||Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery|CCCWFU 60307 - Pilot Study to Evaluate the Anti-tumor Effect of Erlotnib Administered Befor Surgery in Operable Patients With Squamous Cell Carcinoma of the Head and Neck (HNSCC)|Active, not recruiting||Early Phase 1|24|Actual|Wake Forest University Health Sciences||1|||f||||t||||||||Undecided||2017-02-18 14:49:57.995518|2017-02-18 14:49:57.995518
NCT00601900|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-11-14|2016-05-16||May 2008||2008-05-01|November 2016|2016-11-01||||June 2014|Actual|2014-06-01||Interventional|||Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer|Endocrine Therapy With or Without Anti-VEGF Therapy: A Randomized, Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy Plus Bevacizumab (NSC 704865) for Women With Hormone Receptor-Positive Advanced Breast Cancer|Active, not recruiting||Phase 3|394|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 14:49:58.120329|2017-02-18 14:49:58.120329
NCT00601887|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||March 2005||2005-03-01|January 2008|2008-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Bioequivalency Study of Meloxicam Tablets Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 15 mg Meloxicam Tablets Under Fed Conditions|Completed||N/A|48|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:00.057444|2017-02-18 14:50:00.057444
NCT00601874|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||September 2003||2003-09-01|January 2008|2008-01-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions|A Single Dose, Two-Treatment, Two-Period, Two Sequence Crossover Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:00.162897|2017-02-18 14:50:00.162897
NCT00601861|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-10-24|||February 2008||2008-02-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer|A Single Arm, Single-centre, Open-label, Exploratory Trial of Recombinant Interleukin-21 Administered Subcutaneously for 4 Weeks as Neo-adjuvant Treatment Prior to Sentinel Lymph Node/Complete Lymph Node Dissection Followed by 8 Weeks of Adjuvant Treatment in Subjects With Stage III Malignant Melanoma|Terminated||Phase 2|1|Actual|Novo Nordisk A/S||1||See termination reason in detailed description|f||||f||||||||||2017-02-18 14:50:00.254514|2017-02-18 14:50:00.254514
NCT00601848|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2016-09-23|||November 2004||2004-11-01|September 2016|2016-09-01||||July 2012|Actual|2012-07-01||Interventional|||Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura|A Phase II Study of Pleural Photodynamic Therapy for Patients With Non-small Cell Lung Cancer and Pleural Spread|Active, not recruiting||Phase 2|9|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 14:50:00.368411|2017-02-18 14:50:00.368411
NCT00601835|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2016-04-12|2009-11-16||May 2004||2004-05-01|April 2016|2016-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td|Immunogenicity and Safety of Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) for Adult Use Vaccine Compared With U.S. Manufactured Tetanus and Diphtheria Toxoids Adsorbed for Adult Use Vaccine In Persons 60 Years of Age and Older and Immunogenicity and Safety of Canadian Td Vaccine in Persons 11 Through 59 Years of Age|Completed||Phase 4|3651|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 14:50:00.487238|2017-02-18 14:50:00.487238
NCT00601822|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2012-04-09|||January 2008||2008-01-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effectiveness of Cognitive Remediation Therapy in Improving Treatment Retention in People With Anorexia Nervosa|Cognitive Remediation Therapy for Anorexia Nervosa|Completed||Phase 1|46|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 14:50:01.302056|2017-02-18 14:50:01.302056
NCT00601809|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-25|||September 2003||2003-09-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|||||Interventional|GUSBOCA||(Gastrografin Use in Small Bowel Obstruction Caused by Adherences)|Gastrografin Use in Small Bowel Obstruction Caused by Adherences|Completed||Phase 4|76|Actual|University of Bologna||2|||f||||f||||||||||2017-02-18 14:50:01.603764|2017-02-18 14:50:01.603764
NCT00601796|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-19|2013-05-15|2013-02-27||October 2006||2006-10-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||24 participants were accrued at a single center from 10/2006 to 6/2008. There were 14 participants with evaluable peripheral blood mononuclear cells (PBMCs).|Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer|Combination Immunotherapy for Lung Cancer|Completed||Phase 2|24|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 14:50:01.71953|2017-02-18 14:50:01.71953
NCT00601744|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-01-09|||January 2008||2008-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Social-Psychological Aspects of Orbital Exenteration|Social-Psychological Aspects of Survivorship in Cancer Patients After Orbital Exenteration: Issues Stemming From Alterations of Normal Facial Appearance|Completed||N/A|33|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 14:50:02.471462|2017-02-18 14:50:02.471462
NCT00601731|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-10-14|2011-10-28||February 2008||2008-02-01|October 2014|2014-10-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months|A Phase 2, Open-label, Controlled, Multi-center Study to Evaluate Meningococcal ACWY Antibody Response in Children Aged 40 and 60 Months Who Have Previously Received Novartis MenACWY Conjugate Vaccine as Infants|Completed||Phase 2|382|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:50:02.600447|2017-02-18 14:50:02.600447
NCT00601718|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2014-09-02|||December 2007||2007-12-01|September 2014|2014-09-01||||June 2010|Actual|2010-06-01||Interventional|||Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma|A Phase I/II Study of Vorinostat Plus Rituximab, Ifosphamide, Carboplatin, and Etoposide for Patients With Relapsed or Refractory Lymphoid Malignancies or Untreated T- or Mantle Cell Lymphoma|Completed||Phase 1/Phase 2|29|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 14:50:04.193982|2017-02-18 14:50:04.193982
NCT00601705|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2016-02-04|||January 2008||2008-01-01|February 2016|2016-02-01||||June 2012|Actual|2012-06-01||Interventional|||Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach|A Phase II Trial of Induction Chemotherapy With Epirubicin, Oxaliplatin and Fluorouracil (EOF) Followed by Esophagogastrectomy and Post-operative Concurrent Chemoradiotherapy With Fluorouracil and Cisplatin, in Patients With Loco-regionally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction and Gastric Cardia|Active, not recruiting||Phase 2|61|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:50:04.322326|2017-02-18 14:50:04.322326
NCT00601692|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2013-03-21|||April 2003||2003-04-01|March 2013|2013-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer|A Phase I Trial of Irinotecan, Radiation Therapy and Escalating Doses of Docetaxel With Cisplatin in Locally Advanced Esophageal Cancer|Completed||Phase 1|27|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:50:04.427894|2017-02-18 14:50:04.427894
NCT00601679|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2015-10-13|||December 2007||2007-12-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|EXIMPROVECHF||Improvement of Patients With Chronic Heart Failure Using NT-proBNP|Improvement in Clinical Outcomes of Patients With Chronic Heart Failure Using Serial NT-proBNP Monitoring: The EX-IMPROVE-CHF Study|Active, not recruiting||Phase 4|400|Anticipated|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 14:50:04.532573|2017-02-18 14:50:04.532573
NCT00601666|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-05|||March 2004||2004-03-01|February 2008|2008-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Bioequivalency Study of Zolpidem Tartrate Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of Zolpidem Tartrate Tablets 10 MG Under Fasting Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:04.639288|2017-02-18 14:50:04.639288
NCT00601653|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-07-20|||September 2007||2007-09-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effectiveness of Cognitive Behavioral Therapy Plus Nutritional Counseling in Promoting Weight Loss in People With Binge Eating Disorder|CBT and Dieting: Effects on Psychopathology and Weight in BED|Completed||N/A|50|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:50:04.714214|2017-02-18 14:50:04.714214
NCT00601640|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-22|2010-09-28|||January 2007||2007-01-01|September 2010|2010-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin|Phase IIB Study to Evaluate the Safety and Efficacy of Topical Difluoromethylornithine and Topical Diclofenac in the Treatment of Sun-Damaged Skin on the Forearm|Completed||Phase 2|184|Actual|University of Arizona||3|||f||||t||||||||||2017-02-18 14:50:04.810237|2017-02-18 14:50:04.810237
NCT00601627|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-18|2016-07-01|||June 2009||2009-06-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|July 2011|Actual|2011-07-01||Interventional|||Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery|Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 2|52|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 14:50:04.92127|2017-02-18 14:50:04.92127
NCT00601614|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-24|2014-03-06|||January 2008||2008-01-01|March 2014|2014-03-01||||January 2010|Anticipated|2010-01-01||Interventional|||Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery|Phase I Study of ZD6474 and Temozolomide in Patients With Advanced Cancer|Withdrawn||Phase 1|0|Actual|Mayo Clinic||||no enrollment|f||||||||||||||2017-02-18 14:50:05.556547|2017-02-18 14:50:05.556547
NCT00601601|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-03-07|||December 2004||2004-12-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|April 2009|Actual|2009-04-01||Observational|||Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix|Genomics Approach to Id Novel Targets & Markers for Early Detection And Intervention In Cancer (Cervical)|Completed||N/A|80|Actual|British Columbia Cancer Agency|||1||f||||||||||||||2017-02-18 14:50:05.647874|2017-02-18 14:50:05.647874
NCT00601588|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-02-05|||June 2003||2003-06-01|February 2008|2008-02-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Bioequivalency Study of Sertraline Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Sertraline Tablets 100 mg Under Fed Conditions|Completed||N/A|43|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:05.72933|2017-02-18 14:50:05.72933
NCT00601575|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2008-01-31|||October 2002||2002-10-01|January 2008|2008-01-01|November 2002|Actual|2002-11-01|October 2002|Actual|2002-10-01||Interventional|||Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions|A Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions|Completed||N/A|30|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:05.822297|2017-02-18 14:50:05.822297
NCT00004457|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||March 1998||1998-03-01|January 2001|2001-01-01||||||||Observational|||Determinants of Disease Severity in Amyotrophic Lateral Sclerosis||Unknown status|Active, not recruiting|N/A|75||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:39.059375|2017-02-18 18:16:39.059375
NCT00601562|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2008-02-07|||June 2003||2003-06-01|February 2008|2008-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Bioequivalency Study of Zidovudine Under Fed Conditions|A Single Dose, Two Treatment, Two Period, Two Sequence, Crossover Bioequivalency Study of 300 mg Zidovudine Tablets Under Fed Conditions|Completed||N/A|52|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:05.904968|2017-02-18 14:50:05.904968
NCT00601549|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2012-12-05|||January 2000||2000-01-01|December 2012|2012-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Randomized Controlled Clinical Trial Comparing Oncological Results and Functional Recovery Between Laparoscopic and Open Method for the Treatment of Advanced Rectal Cancer After Concurrent Chemoradiation Therapy (CCRT)|A Randomized Controlled Clinical Trial Comparing Oncological Results and Functional Recovery Between Laparoscopic and Open Method for the Treatment of Advanced Rectal Cancer After Concurrent Chemoradiation Therapy (CCRT)|Recruiting||Phase 3|600|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 14:50:05.997633|2017-02-18 14:50:05.997633
NCT00601536|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||April 2003||2003-04-01|January 2008|2008-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions.|Completed||N/A|29|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:06.10918|2017-02-18 14:50:06.10918
NCT00601523|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-06-03|2011-06-06||January 2008||2008-01-01|March 2014|2014-03-01||||June 2010|Actual|2010-06-01||Interventional||Treated Set, all patients randomized and received treatment|Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).|Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).|Completed||Phase 3|511|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:50:06.207459|2017-02-18 14:50:06.207459
NCT00601510|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-03-18|||November 2007||2007-11-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|||Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer|A Phase I Study of Capecitabine, Cisplatin and Imatinib in Patients With Unresectable or Metastatic Gastric Cancer.|Completed||Phase 1|38|Actual|Technische Universität München||1|||f||||||||||||||2017-02-18 14:50:07.412337|2017-02-18 14:50:07.412337
NCT00601497|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-12|2008-01-25|||December 2004||2004-12-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effects of Electrical Stimulation on Osteoarthritis of the Knee|Effects of Electrical Stimulation on Osteoarthritis of the Knee|Completed||N/A|39|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 14:50:07.519813|2017-02-18 14:50:07.519813
NCT00601484|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2011-01-04||2010-12-21|March 2008||2008-03-01|January 2011|2011-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis|A Phase 2, 16 Week, Multicenter, Randomized, Double Blind Placebo Controlled, Parallel Group Proof Of Concept Study Evaluating The Efficacy And Safety Of PF-04383119 For The Treatment Of Pain Associated With Interstitial Cystitis|Completed||Phase 2|65|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:50:07.616144|2017-02-18 14:50:07.616144
NCT00601471|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2010-06-23|||April 2007||2007-04-01|June 2010|2010-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effects of Proximal and Distal Tibiofibular Joint Manipulation on Lower Extremity Muscle Activation, Ankle Range of Motion, and Functional Outcome Scores in Individuals With Chronic Ankle Instability|Effects of Proximal and Distal Tibiofibular Joint Manipulation on Lower Extremity Muscle Activation, Ankle Range of Motion, and Functional Outcome Scores in Individuals With Chronic Ankle Instability|Completed||N/A|61|Actual|University of Virginia||3|||f||||f||||||||||2017-02-18 14:50:07.754607|2017-02-18 14:50:07.754607
NCT00601458|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2015-03-23|2009-12-23||July 2007||2007-07-01|March 2015|2015-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Bunionectomy Study (0000-063)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Pregabalin and Naproxen Sodium on Postoperative Pain After Bunionectomy|Completed||Phase 1|100|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 14:50:07.866575|2017-02-18 14:50:07.866575
NCT00601445|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2008-05-28|||September 1999||1999-09-01|May 2008|2008-05-01|March 2004|Actual|2004-03-01|||||Interventional|||Homeostatic Sleep Regulation in Older Persons|Homeostatic Sleep Regulation in Older Persons|Completed||N/A|58|Anticipated|National Institute on Aging (NIA)|||||f||||f||||||||||2017-02-18 14:50:08.454824|2017-02-18 14:50:08.454824
NCT00601432|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-12-21|||October 2002||2002-10-01|April 2010|2010-04-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study to Evaluate the Effect of Food on Levofloxacin Pharmacokinetics From an Oral Solution Formulation|An Open-label, Randomized, 2-way Crossover Study to Evaluate the Effect of Food on Levofloxacin Pharmacokinetics From an Oral Solution Formulation|Completed||Phase 1|24|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 14:50:08.543328|2017-02-18 14:50:08.543328
NCT00601419|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-12-17|2013-12-17||March 2007||2007-03-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Drug Use Investigation of Somatropin for GHD-ADULTS.|Drug Use Investigation of GENOTROPIN for GHD-ADULTS.|Completed||N/A|230|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:50:08.624972|2017-02-18 14:50:08.624972
NCT00601406|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2013-08-23|||March 2006||2006-03-01|April 2008|2008-04-01||||February 2008|Anticipated|2008-02-01||Interventional|||Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer|Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of Radiotherapy (RAPPER)|Unknown status|Recruiting|N/A|2200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:50:09.051715|2017-02-18 14:50:09.051715
NCT00601393|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2012-01-25|||September 2006||2006-09-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effectiveness of Internet-Based Cognitive Behavioral Therapy for Treating Mothers With Depression|Interactive Internet Intervention for Depressed Mothers|Completed||N/A|70|Actual|Oregon Research Institute||2|||f||||f||||||||||2017-02-18 14:50:09.270796|2017-02-18 14:50:09.270796
NCT00601367|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-05-20|2014-04-22||January 2008||2008-01-01|May 2014|2014-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder|A Twenty-Eight Week, Open-Label, Safety Study of Flibanserin 50 Mgs to 100 Mgs Daily in Premenopausal European Women With HSDD|Completed||Phase 3|480|Actual|Sprout Pharmaceuticals, Inc||1|||f||||t||||||||||2017-02-18 14:50:09.370364|2017-02-18 14:50:09.370364
NCT00601354|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2013-06-26|2013-06-18||September 2007||2007-09-01|June 2013|2013-06-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder|Comparing Orlistat/Alli to Orlistat/Alli Plus Guided Self-help Group Therapy in Overweight Binge Eaters|Completed||N/A|17|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 14:50:09.683182|2017-02-18 14:50:09.683182
NCT00601341|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2010-06-23|||May 2005||2005-05-01|June 2010|2010-06-01|November 2009|Actual|2009-11-01|May 2009|Anticipated|2009-05-01||Interventional|||Effects of Lumbosacral Joint Mobilization/Manipulation on Lower Extremity Muscle Neuromuscular Response|Effects of Lumbosacral Joint Mobilization/Manipulation on Lower Extremity Muscle Neuromuscular Response|Terminated||N/A|106|Actual|University of Virginia||3||Anticipated that results would not be conclusive|f||||f||||||||||2017-02-18 14:50:10.243903|2017-02-18 14:50:10.243903
NCT00601328|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||July 2003||2003-07-01|January 2008|2008-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Bioequivalency Study of Calcitriol Tablets Under Fasting Conditions|A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Calcitriol Tablets, 0.25 mg, Under Fasting Conditions|Completed||N/A|36|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:10.356469|2017-02-18 14:50:10.356469
NCT00601315|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2008-02-05|||April 2003||2003-04-01|February 2008|2008-02-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Bioequivalency Study of Clarithromycin Tablets Under Fasting Conditions|A Single Dose, Two-Treatment, Two-Period, Two-Sequence Crossover Bioequivalency Study of 250 mg Clarithromycin Tablets Under Fasting Conditions|Completed||N/A|40|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:10.442357|2017-02-18 14:50:10.442357
NCT00601302|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||April 2004||2004-04-01|January 2008|2008-01-01|May 2004|Actual|2004-05-01|April 2004|Actual|2004-04-01||Interventional|||Bioequivalency Study of Amlodipine Tablets Under Fed Conditions|A Single Dose, Two-Period, Two-Treatment, 2-Way Crossover Bioequivalency Study of 10 mg Amlodipine Besylate Tablets Under Fed Conditions|Completed||N/A|40|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:10.521932|2017-02-18 14:50:10.521932
NCT00601289|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-25|2012-07-27|||December 2009||2009-12-01|July 2012|2012-07-01||||October 2010|Actual|2010-10-01||Interventional|||Temozolomide in Treating Patients With Invasive Pituitary Tumors|An Open Label, Multicenter, Phase II Study Evaluating the Safety and Efficacy of Temozolomide Treatment in Patients With Invasive Pituitary Tumors|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||1||funding term ended|f||||t||||||||||2017-02-18 14:50:10.611966|2017-02-18 14:50:10.611966
NCT00601276|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2009-07-10|||December 2007||2007-12-01|December 2007|2007-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|PCNET||Comparison of Two Pharmacological Treatments of Pedophilia|Comparative Controlled Clinical Trial of Two Pharmacological Treatments of Pedophilia|Terminated||Phase 3|48|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-02-18 14:50:10.711894|2017-02-18 14:50:10.711894
NCT00601263|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2009-12-29|||October 2006||2006-10-01|December 2009|2009-12-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Safety Study of Chinese Herbal Therapy to Treat Asthma|Center for Chinese Herbal Therapy for Asthma. Project #2-Clinical Effect of a Chinese Herbal Therapy in Human Asthma-Phase I|Completed||Phase 1|35|Actual|Icahn School of Medicine at Mount Sinai||6|||f||||f||||||||||2017-02-18 14:50:10.826637|2017-02-18 14:50:10.826637
NCT00601250|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-12-11|2011-05-13||January 2008||2008-01-01|December 2013|2013-12-01||||May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes|A Randomised, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 1356 (One Dose, e.g. 5 mg), Administered Orally Once Daily Over 24 Weeks, With an Open Label Extension to 80 Weeks (Placebo Patients Switched to BI 1356), in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy|Completed||Phase 3|701|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:50:10.953745|2017-02-18 14:50:10.953745
NCT00601237|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2015-04-01|||October 2008||2008-10-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention|Text Messaging for Abstinence and HIV Risk Prevention: The 411 on Safe Text|Completed||N/A|103|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-02-18 14:50:11.940524|2017-02-18 14:50:11.940524
NCT00601224|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-03-28|||June 2007||2007-06-01|March 2013|2013-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia|Social Cognition and Interaction Training for Schizophrenia|Completed||Phase 1|66|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 14:50:12.046158|2017-02-18 14:50:12.046158
NCT00601211|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-31|||September 2003||2003-09-01|January 2008|2008-01-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions|A Single Dose, Two-Treatment, Two-Period, Two Sequence Crossover Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fed Conditions|Completed||N/A|28|Actual|Roxane Laboratories|||||f||||f||||||||||2017-02-18 14:50:12.153479|2017-02-18 14:50:12.153479
NCT00601198|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2010-03-22|||October 2006||2006-10-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer|Phase II Study of the Efficacy of Amifostine (Ethyol) in Reducing the Incidence and Severity of Oxaliplatin-Induced Neuropathy in Patients With Colorectal Cancer|Terminated||Phase 2|97|Anticipated|University of Cincinnati||1||Funding support withdrawn|f||||f||||||||||2017-02-18 14:50:12.232029|2017-02-18 14:50:12.232029
NCT00601185|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2016-11-03|||February 2006||2006-02-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.|Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo|Recruiting||N/A|170|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:50:12.337806|2017-02-18 14:50:12.337806
NCT00601172|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-01-04||2010-03-17|March 2008||2008-03-01|March 2011|2011-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.|A Study of Single Dose Intravenous Casopitant in Combination With Ondansetron and Dexamethasone for the Prevention of Oxaliplatin Induced Nausea and Vomiting.|Completed||Phase 3|710|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 14:50:12.455908|2017-02-18 14:50:12.455908
NCT00004364|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2006-02-21|||December 1995||1995-12-01|February 2006|2006-02-01||||||||Observational|||Study of Novel Types of Familial Diabetes Insipidus||Unknown status|Active, not recruiting|N/A|5||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:45.418374|2017-02-18 18:16:45.418374
NCT00601159|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-07-01|||September 2007||2007-09-01|June 2011|2011-06-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC|Phase Ⅱ Study of Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC|Completed||Phase 2|70|Actual|Fudan University||1|||f||||f||||||||||2017-02-18 14:50:12.743993|2017-02-18 14:50:12.743993
NCT00601146|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2016-02-17|2016-01-19||November 2006||2006-11-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2010|Actual|2010-12-01||Observational|||Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease|Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease|Active, not recruiting||N/A|39|Actual|Dana-Farber Cancer Institute|||1||f||||f||||||||No||2017-02-18 14:50:12.855323|2017-02-18 14:50:12.855323
NCT00601133|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-01-09|||January 2008||2008-01-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Function and Balance for Inpatient Rehabilitation|Quantitative and Clinical Description of Postural Instability in Patient Who Underwent Acute Inpatient Rehabilitation and at Follow-Up|Completed||N/A|24|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:50:13.07627|2017-02-18 14:50:13.07627
NCT00601120|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2013-02-26|||June 2007||2007-06-01|February 2013|2013-02-01||||June 2010|Anticipated|2010-06-01||Interventional|||RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma|Pilot Feasibility Protocol of RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma|Withdrawn||N/A|0|Actual|Dana-Farber Cancer Institute||1||This protocol was never officially opened and no patients were recruited.|f||||t||||||||||2017-02-18 14:50:13.186497|2017-02-18 14:50:13.186497
NCT00601107|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-04-02|2014-04-02||April 2008||2008-04-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional||Safety Set included all randomized participants who received at least 1 dose of study medication.|A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis|A Multicenter, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy and Safety of Doxercalciferol Capsules in the Treatment of Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|111|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 14:50:13.303292|2017-02-18 14:50:13.303292
NCT00601094|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-10-03|||February 2009||2009-02-01|October 2016|2016-10-01||||January 2014|Actual|2014-01-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Phase I Trial of CCL21 Gene Modified Dendritic Cells In Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1|21|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 14:50:14.38085|2017-02-18 14:50:14.38085
NCT00601081|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-07-23|||November 2007||2007-11-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Human Milk Fortifier and Cytokine Profile|Alterations in the Cytokine Profile of Premature Infants After Human Milk Fortifier|Completed||N/A|24|Actual|Christiana Care Health Services|||1||f||||f||||||Samples With DNA|"~     Blood and stool~   "|||2017-02-18 14:50:14.501745|2017-02-18 14:50:14.501745
NCT00601068|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-01-03|||December 2007||2007-12-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis|Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis of the Jaws (BON)|Completed||N/A|35|Actual|University of Florida|||1||f||||t||||||Samples With DNA|"~     biopsy tissue submitted from bone biopsies~   "|||2017-02-18 14:50:14.601843|2017-02-18 14:50:14.601843
NCT00601055|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2016-07-13|||February 2008||2008-02-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease|Treating Older Patients With Major Depression and Severe COPD|Completed||N/A|101|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||Undecided||2017-02-18 14:50:14.73466|2017-02-18 14:50:14.73466
NCT00601042|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-12-10|||January 2008||2008-01-01|December 2013|2013-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|2SRT||Serbian Smoking Reduction/Cessation Trial (2SRT)|"Randomized, Placebo-controlled, Double-blind, Phase IV Trial to Assess the Efficacy of a Traditional Swedish Smokeless Tobacco Product (Snus) to Reduce or Replace Cigarette Smoking Among Adult Smokers in Serbia"|Completed||Phase 4|319|Actual|Swedish Match AB||2|||f||||t||||||||||2017-02-18 14:50:14.845516|2017-02-18 14:50:14.845516
NCT00601029|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2012-04-18|||January 2008||2008-01-01|April 2012|2012-04-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Observational|||Rhabdomyolysis in Basic Training|Rhabdomyolysis in Basic Training|Completed||N/A|499|Actual|Martin Army Community Hospital|||2||f||||f||||||Samples With DNA|"~     Serum and stored blood~   "|||2017-02-18 14:50:14.955171|2017-02-18 14:50:14.955171
NCT00601016|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-24|||March 2005||2005-03-01|January 2008|2008-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy|A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy|Completed||Phase 2|18|Actual|St. Justine's Hospital||1|||f||||f||||||||||2017-02-18 14:50:15.065378|2017-02-18 14:50:15.065378
NCT00601003|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2016-09-08|||February 2008||2008-02-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma|A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma or Medulloblastoma.|Recruiting||Phase 2|100|Anticipated|Spectrum Health Hospitals||1|||f||||t||||||||||2017-02-18 14:50:15.183197|2017-02-18 14:50:15.183197
NCT00600990|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2017-01-19|||December 2004||2004-12-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients|Phase II Multicenter, Dose Ranging Study on the Safety and Antiemetic Efficacy of One Day Intraveous Dosing of GW597599 Administered With Ondansetron HCL in a Female Subjects Undergoing Surgical Procedures of High Emetogenic Risk|Completed||Phase 2|624|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 14:50:15.358052|2017-02-18 14:50:15.358052
NCT00600977|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2008-06-25|||March 2002||2002-03-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|||||Interventional|||Liposomal Anthracyclin in the Treatment of Elderly ALL|A Multicentric Phase II-III Randomized Study Safety of Intraveinous Liposomal Pegylated Doxorubicin Versus Continuous Infusion of Doxorubicin During Induction Treatment of Acute Lymphoblastic Leukemia in Patients|Completed||Phase 2|60|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||||2017-02-18 14:50:15.505654|2017-02-18 14:50:15.505654
NCT00600964|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-05-09|||September 2004||2004-09-01|May 2014|2014-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Phase I/II Study of GX15-070MS in Untreated CLL|A Multi-Center, Open-Label, Phase I/II Study of Single-Agent GX15-070MS Administered Every 2 to 3 Weeks to Patients With Previously-Treated Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 1|26|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 14:50:15.60414|2017-02-18 14:50:15.60414
NCT00600951|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2014-10-31|||January 2008||2008-01-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease|A Prospective Cohort Study Evaluating the Incidence of Nephrogenic Systemic Fibrosis in Patients With Stages 3 to 5 Chronic Kidney Disease Undergoing MRI With the Injection of MultiHance|Completed||N/A|366|Actual|Bracco Diagnostics, Inc|||2||f||||f||||||Samples Without DNA|"~     fixed tissue samples~   "|||2017-02-18 14:50:15.715959|2017-02-18 14:50:15.715959
NCT00600938|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2014-08-13|2014-02-21||November 2007||2007-11-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CORDELIA|Per Protocol Set (PPS): randomized patients who received at least 6 months of study drug, had a T2* value assessed at least 150 days after randomization, and had no major protocol deviations. A total of 25 patients (7 in the deferasirox arm and 18 in the DFO arm) were excluded from PPS|Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload|A Multicenter, Randomized, Open-label Phase II Trial Evaluating Deferasirox Compared With Deferoxamine in Patients With Cardiac Iron Overload Due to Chronic Blood Transfusions|Completed||Phase 2|197|Actual|Novartis||4|||f||||t||||||||||2017-02-18 14:50:15.808317|2017-02-18 14:50:15.808317
NCT00600925|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2012-03-22|||January 2008||2008-01-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|March 2009|Actual|2009-03-01||Interventional|||A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection|A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge in General Surgical Subjects at Higher Risk for Surgical Wound Infection|Completed||Phase 3|600|Actual|Innocoll||2|||f||||t||||||||||2017-02-18 14:50:17.284546|2017-02-18 14:50:17.284546
NCT00600912|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2009-12-02|||December 2006||2006-12-01|December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function|Inflammatory Response and Hepatic Function in Patients Requiring Parenteral Nutrition: Comparison of a Lipid Emulsion Based ob Soybean Oil, Medium-Chain Triglycerides, Olive Oil and Fish Oil Versus a Lipid Emulsion Based on Olive and Soybean Oil|Completed||Phase 4|42|Actual|Klinikum Ludwigshafen||2|||f||||f||||||||||2017-02-18 14:50:17.434802|2017-02-18 14:50:17.434802
NCT00600899|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2009-01-28|||September 2008||2008-09-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Home Infusors for Analgesia After Foot Surgery|Use of Home Pumps for Analgesia After Ambulatory Foot Surgery - Comparison of Two Infusion Rates - a Randomized, Double-Blind Study|Unknown status|Enrolling by invitation|Phase 4|40|Anticipated|Frederiksberg University Hospital||2|||f||||t||||||||||2017-02-18 14:50:17.746744|2017-02-18 14:50:17.746744
NCT00600886|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2016-05-23|2014-12-19||February 2008||2008-02-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly|A Multicenter, Randomized, Blinded Study to Assess Safety and Efficacy of Pasireotide LAR vs. Octreotide LAR in Patients With Active Acromegaly|Completed||Phase 3|358|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:50:20.370336|2017-02-18 14:50:20.370336
NCT00600873|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-05|2010-09-10|||August 2007||2007-08-01|September 2010|2010-09-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||R(+)PPX High Dose Treatment of ALS|Pharmacokinetics and Nitrative-Oxidative Stress Pharmacodynamics in Amyotrophic Lateral Sclerosis Subjects Taking Daily High-Dose R(+) Pramipexole Dihydrochloride for Six Months|Completed||Phase 1/Phase 2|10|Actual|Bennett, James P., Jr., M.D., Ph.D.||1|||t||||t||||||||||2017-02-18 14:50:21.732488|2017-02-18 14:50:21.732488
NCT00600860|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2016-11-23|||April 2008||2008-04-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Observational|EUMDS||A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes|A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes (MDS), Including Acute Myeloid Leukaemia With 20-30 Percent Marrow Blasts (Former RAEB-t), and Chronic Myelomonocytic Leukaemia (CMML)|Recruiting||N/A|4000|Anticipated|Radboud University|||1||f||||f||||||Samples With DNA|"~     Blood and Bone marrow~   "|No|The study results (aggregated data) will be published in an academic journal and presented at scientific meetings. A study newsletter will be produced regularly and will be available to read on the EUMDS website.|2017-02-18 14:50:21.845554|2017-02-18 14:50:21.845554
NCT00600847|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-15|||November 2006||2006-11-01|January 2008|2008-01-01||||November 2007|Actual|2007-11-01||Interventional|AUDACU||A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions|An Exploratory Phase IV, Randomised, Double-Blind, Placebo Controlled Crossover Study to Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Experimentally Induced Urticaria Lesions|Completed||Phase 4|33|Actual|Charite University, Berlin, Germany||3|||f||||t||||||||||2017-02-18 14:50:21.97193|2017-02-18 14:50:21.97193
NCT00600834|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2014-10-31|||February 2008||2008-02-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease|A Prospective Cohort Study Evaluating the Incidence of Nephrogenic Systemic Fibrosis in Patients With Stages 3 to 5 Chronic Kidney Disease Undergoing MRI With the Injection of ProHance|Completed||N/A|172|Actual|Bracco Diagnostics, Inc|||2||f||||f||||||None Retained|"~     Fixed tissue samples~   "|||2017-02-18 14:50:22.092792|2017-02-18 14:50:22.092792
NCT00600821|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-10-16|2012-04-20||April 2008||2008-04-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|April 2011|Actual|2011-04-01||Interventional||Intent-to-treat (ITT) population included all participants who were randomized, with study drug assignment designated according to initial randomization, regardless of whether participants received study drug, or received a different drug from that to which they were randomized.|A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.|Randomized Phase 2 Trial Of AG013736 Or Bevacizumab In Combination With Paclitaxel And Carboplatin As First Line Treatment For Patients With Advanced Non Small Cell Lung Cancer|Completed||Phase 2|118|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 14:50:22.204303|2017-02-18 14:50:22.204303
NCT00600808|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2008-01-15|||June 2003||2003-06-01|July 2007|2007-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Sustained Release Formulation of Somatropin (rDNA Origin)for Injection|A Phase II/IIIa, Assessor Blinded (Partially Blinded), Randomised, Active-Controlled, Multicentre, Parallel-Group Study of the Safety, Efficacy and pk/pd of LB03002 Administered Weekly in Children With Growth Failure Due to GH Deficiency.|Completed||Phase 2/Phase 3|51|Actual|BioPartners GmbH||1|||f||||t||||||||||2017-02-18 14:50:24.402236|2017-02-18 14:50:24.402236
NCT00600795|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2011-04-01|||January 2008||2008-01-01|April 2011|2011-04-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Observational|||Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus|Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus|Unknown status|Recruiting|N/A|50|Anticipated|Vanderbilt University|||1||f||||t||||||Samples Without DNA|"~     CSF~   "|||2017-02-18 14:50:24.481949|2017-02-18 14:50:24.481949
NCT00600782|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2009-09-03||2009-09-03|February 2008||2008-02-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region|Immunogenicity and Safety of GSK Biologicals' Candidate Tuberculosis (TB) Vaccine (692342) When Administered to Healthy Adults Aged 21 to 40 Years.|Completed||Phase 2|45|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 14:50:24.581378|2017-02-18 14:50:24.581378
NCT00600769|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-14|||January 1991||1991-01-01|November 2007|2007-11-01||||November 2010|Anticipated|2010-11-01||Interventional|||Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)|Open Study of Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)|Unknown status|Active, not recruiting|Phase 4|210|Actual|The University of Texas Health Science Center at Tyler||1|||f||||f||||||||||2017-02-18 14:50:24.687315|2017-02-18 14:50:24.687315
NCT00600756|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-10-02|2010-10-20||January 2008||2008-01-01|October 2012|2012-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|RECOVER||Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone|A One-Year Randomized, Prospective, Parallel, Open Comparison of Subjective Well-being in Schizophrenic Out-patients Treated With Quetiapine XR (SEROQUEL XR™) or Oral Risperidone at Flexible Dose in a Naturalistic Setting|Completed||Phase 3|798|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 14:50:24.797738|2017-02-18 14:50:24.797738
NCT00600743|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2010-03-03|||January 2008||2008-01-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|GSK||Effect of a CCK-1R Agonist on Food Intake in Humans|Effect of a CCK-1R Agonist on Food Intake in Humans|Completed||Phase 2|40|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||f||||||||||2017-02-18 14:50:26.089177|2017-02-18 14:50:26.089177
NCT00600730|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2015-06-09||||||June 2015|2015-06-01||||||||Interventional|||The Effects of Antecedent Hypoglycemia or Exercise on the Response of the Brain to Subsequent Hypoglycemia|The Effects of Antecedent Hypoglycemia or Exercise on the Response of the Brain to Subsequent Hypoglycemia|Withdrawn||N/A|0|Actual|Vanderbilt University||2||Funding not available. Could not start this study.|f||||f||||||||||2017-02-18 14:50:26.193462|2017-02-18 14:50:26.193462
NCT00600717|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2012-02-08|||November 2006||2006-11-01|February 2012|2012-02-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|MEG||Normative High-frequency MEG Database for Children|Localizing Sensorimotor, Auditory, Visual and Language Cortices With Magnetoencephalography|Unknown status|Recruiting|N/A|120|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||||||2017-02-18 14:50:26.290669|2017-02-18 14:50:26.290669
NCT00600704|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2011-05-09|2011-03-04||November 2007||2007-11-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|November 2008|Actual|2008-11-01||Interventional|||Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery|Impact of Fluid Restriction Policy Added to Intra-Operative Cell Salvage in Reducing the Use of Red Cells in Cardiac Surgery|Completed||N/A|192|Actual|Larissa University Hospital||2|||f||||f||||||||||2017-02-18 14:50:26.392793|2017-02-18 14:50:26.392793
NCT00600691|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2014-01-29|||March 2008||2008-03-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy|The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy|Terminated||Phase 2|29|Actual|University of British Columbia||1||Did not achieve enrollment goal and decided to terminate early|f||||f||||||||||2017-02-18 14:50:26.801099|2017-02-18 14:50:26.801099
NCT00600678|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-05-14|||November 2007||2007-11-01|May 2008|2008-05-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Gastric Emptying Study After Administration of a High Caloric Sip Feed|Characterisation of Gastric Emptying of a High Caloric Sip Feed Using the Paracetamol Absorption Method: Intraindividual Comparison of Paracetamol Pharmacokinetics After Oral co-Administration With Sip-Feed and After Intravenous Administration in Healthy Volunteers of Both Genders in an Open, Single Centre Study|Completed||N/A|12|Actual|Fresenius Kabi||1|||f||||f||||||||||2017-02-18 14:50:26.922317|2017-02-18 14:50:26.922317
NCT00600665|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2015-05-26|||February 2007||2007-02-01|May 2015|2015-05-01|June 2014|Actual|2014-06-01|June 2013|Actual|2013-06-01||Interventional|||Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease|Computerized PAINRelieveIt for Adult Sickle Cell Disease|Completed||N/A|279|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-02-18 14:50:27.009108|2017-02-18 14:50:27.009108
NCT00600652|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2008-01-24|||December 2006||2006-12-01|January 2008|2008-01-01||||December 2010|Actual|2010-12-01||Observational|||FCM Analysis GR in Steroid-Treatment Patients|Flow Cytometric Analysis of Glucocorticoid Receptor Using Monoclonal Antibody and Fluoresceinated Ligand Probes in Glucocorticoid-Resistant and -Sensitive Patients|Unknown status|Enrolling by invitation|N/A|150|Anticipated|Changhai Hospital|||3||f||||t||||||Samples With DNA|"~     introcellular and exocellular proteins in peripheral blood mononuclear cells of subjects~   "|||2017-02-18 14:50:27.115791|2017-02-18 14:50:27.115791
NCT00600639|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2012-07-16|||January 2004||2004-01-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Non-Invasive Mechanical Ventilation in Elderly Patients|Non-Invasive Mechanical Ventilation in Elderly Patients Affected by Acute Hypercapnic Respiratory Failure:A Randomized Control Study vs Standard Medical Therapy A Multicentric Randomized Controlled Trial|Terminated||Phase 4|82|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||2|||f||||t||||||||||2017-02-18 14:50:27.196318|2017-02-18 14:50:27.196318
NCT00164554|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-25|||October 2001||2001-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Fetal Alcohol Syndrome/ARND Research Consortion|Fetal Alcohol Syndrome/ARND Research Consortion-Oklahoma|Completed||Phase 1/Phase 2|100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:42.496284|2017-02-18 17:21:42.496284
NCT00600626|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2017-01-05|||January 2004||2004-01-01|January 2017|2017-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes|Comparison of Basal Bolus Treatment With Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes Mellitus|Completed||Phase 3|394|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:50:27.311101|2017-02-18 14:50:27.311101
NCT00600613|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2015-04-17|2015-04-07||January 2006||2006-01-01|April 2015|2015-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Assess the Feasibility of Cone Beam CT to Localize Liver Metastases Immediately Prior to Radiotherapy|A Pilot Study to Assess the Feasibility of Cone Beam CT to Localize Liver Metastases Immediately Prior to Radiotherapy|Completed||N/A|6|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:50:27.479672|2017-02-18 14:50:27.479672
NCT00600600|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-14|||April 2002||2002-04-01|January 2008|2008-01-01||||April 2010|Anticipated|2010-04-01||Interventional|||Tigecycline for Treatment of Rapidly Growing Mycobacteria|Use of Tigecycline for Treatment of Serious Infection Due to Rapidly Growing Mycobacteria (Especially M.Abscessus)|Unknown status|Active, not recruiting|Phase 2|8|Actual|The University of Texas Health Science Center at Tyler||1|||f||||f||||||||||2017-02-18 14:50:27.700715|2017-02-18 14:50:27.700715
NCT00600587|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-06-23|||September 2007||2007-09-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)|Phase Ⅱ Study of Induction Erlotinib Therapy in Stage III A(N2) Non-small Cell Lung Cancer Proceeding to Mediastinoscopy/PET and Thoracotomy/Radiotherapy|Completed||Phase 2|24|Actual|Guangdong Provincial People's Hospital||2|||f||||t||||||||||2017-02-18 14:50:27.812559|2017-02-18 14:50:27.812559
NCT00600574|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2014-12-01|||January 2007||2007-01-01|December 2014|2014-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Ai Chi Versus Stretching in Fibromyalgia Management|A Randomized Controlled Trial Comparing the Efficay and Tolerability of Ai Chi Versus Stretching in Fibromyalgia Management: a Six Months Study|Completed||Phase 4|94|Actual|Universidad de Granada||2|||f||||f||||||||||2017-02-18 14:50:27.934628|2017-02-18 14:50:27.934628
NCT00600561|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-14|||June 2005||2005-06-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|MBSR||Mindfulness Meditation Training in HIV|Biobehavioral Effects of Mindfulness-Based Stress Reduction in HIV|Completed||Phase 2|50|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:50:28.053563|2017-02-18 14:50:28.053563
NCT00600548|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2010-04-14|||July 2007||2007-07-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)|Clinical Trial to Assess Efficacy and Safety of Orally Administered Miltefosine in Brazilian Patients With Cutaneous Leishmaniasis Compared to the Standard Care as Active Control|Completed||Phase 2|180|Actual|Hospital Universitário Professor Edgard Santos||4|||f||||t||||||||||2017-02-18 14:50:28.175075|2017-02-18 14:50:28.175075
NCT00600535|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-04-16|||July 2007||2007-07-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer|A Pharmacokinetics Study to Assess the Oral Administration of CB7630 (Abiraterone Acetate) Capsule Formulation and Tablet Formulation in Patients With Prostate Cancer|Completed||Phase 1|31|Actual|Cougar Biotechnology, Inc.||2|||f||||f||||||||||2017-02-18 14:50:28.298211|2017-02-18 14:50:28.298211
NCT00600522|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-14|||January 2004||2004-01-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|January 2007|Actual|2007-01-01||Observational|||Alternative Surgical Policy for Central Liver Tumors|Ultrasound-Guided Conservative Heopatecomy for Tumors Invading the Middle Hepatic Vein at the Caval Confluence as Alternative to Mesohepatectomy and Trisectionectomy|Completed||N/A|15|Actual|University of Milan|||1||f||||f||||||||||2017-02-18 14:50:28.428579|2017-02-18 14:50:28.428579
NCT00600509|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2013-09-16|||January 2001||2001-01-01|September 2009|2009-09-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method|Bridging Study of L059(Levetiracetam) in Patients With Epilepsy by Double Blind Method|Completed||Phase 2|216|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 14:50:28.542303|2017-02-18 14:50:28.542303
NCT00600496|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2017-01-19|||December 2007||2007-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2010|Actual|2010-08-01||Interventional|||A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)|A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) When Given in Combination With Standard Doses of Selected Chemotherapies to Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|211|Actual|AstraZeneca||4|||f||||t||||||||||2017-02-18 14:50:28.634105|2017-02-18 14:50:28.634105
NCT00600483|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2012-03-22|||December 2007||2007-12-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection|A Randomized, Controlled, Phase 3 Study of Gentamicin-Collagen Sponge in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection|Completed||Phase 3|1502|Actual|Innocoll||2|||f||||t||||||||||2017-02-18 14:50:28.762525|2017-02-18 14:50:28.762525
NCT00600470|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2015-05-29|||September 2000||2000-09-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|SKIP||Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders|Collaborative Mental Health Services for Behavior Disorders in Primary Care|Completed||Phase 1/Phase 2|858|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:50:28.927714|2017-02-18 14:50:28.927714
NCT00600457|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-23|2008-12-15|||March 2007||2007-03-01|December 2008|2008-12-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Observational|||Modified Polyurethane Film Dressing For Skin Graft Donor Sites|Modified Polyurethane Film Dressing For Skin Graft Donor Sites|Completed||N/A|30|Actual|Klinik Bogenhausen|||1||f||||f||||||||||2017-02-18 14:50:29.037885|2017-02-18 14:50:29.037885
NCT00600444|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2010-01-26|||February 2008||2008-02-01|May 2008|2008-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|PORTAS2||PORTAS 2, Comparing Venae Sectio Versus Punction of Vena Subclavia for Insertion of a Totally Implantable Access Port|Randomized Controlled Trial Comparing Venae Sectio Versus Punction of Vena Subclavia for Insertion of a Totally Implantable Access Port|Completed||N/A|100|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-02-18 14:50:29.140835|2017-02-18 14:50:29.140835
NCT00600431|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-24|||February 2006||2006-02-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Melanocytic Nevi in Children Under Chemotherapy|Melanocytic-Nevi-Counts During Chemotherapy of Children With Malignancies.|Completed||N/A|32|Actual|Medical University of Graz|||2||f||||f||||||||||2017-02-18 14:50:29.230085|2017-02-18 14:50:29.230085
NCT00600418|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2013-09-03|||April 2007||2007-04-01|September 2013|2013-09-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Observational|||Identifying Toddlers and Their Parents Who Are Suffering From Posttraumatic Distress Following War and Terror|Identifying Posttraumatic Distress Among Toddlers and Their Parents Following Ongoing Exposure to Terrorism or War|Completed||Early Phase 1|500|Actual|Herzog Hospital|||1||f||||t||||||||||2017-02-18 14:50:29.329709|2017-02-18 14:50:29.329709
NCT00600405|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-14|||August 2006||2006-08-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients|The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients|Completed||N/A|81|Actual|Maine Medical Center||2|||f||||f||||||||||2017-02-18 14:50:29.422502|2017-02-18 14:50:29.422502
NCT00600392|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2016-01-15|||January 2006||2006-01-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|October 2008|Actual|2008-10-01||Observational|Medusa PH||DNA/RNA Analysis of Blood and Skeletal Muscle in Patients Undergoing Cardiac Resynchronization Therapy (CRT)|Transcriptomal Analysis of Peripheral Blood and Skeletal Muscle in Patients Undergoing CRT Using Oligonucleotide Arrays|Completed||N/A|30|Actual|Duke University|||1||f||||f||||||Samples With DNA|"~     Serum TNF alpha, IL-1, IL6, CRP, uric acid, albumin, BNP, IGF-1 and growth hormone at~     baseline and at 6 months.~      50 ml of blood will be collected at baseline and at 6 months. It will be divided into~     aliquots as follows; 10 ml in Pax-gene tubes for mRNA extraction, 20 ml for various other~     biomarkers, 10 ml for proteomics and 10 ml will be stored for any future use.~      Approximately a 5x5 - 7x7mm muscle biopsy will be obtained from the mid thigh region of each~     subject at baseline and at six months~   "|||2017-02-18 14:50:29.542715|2017-02-18 14:50:29.542715
NCT00600379|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2011-06-15|||January 2008||2008-01-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|||Virtual Reality Training Program for Ambulatory Patients With Chronic Gait Deficits After Stroke|A Randomized Controlled Trial of a Virtual Reality Training Program for Ambulatory Patients With Mild-to-moderate Chronic Gait Deficits After Stroke|Completed||Phase 2|48|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 14:50:29.630529|2017-02-18 14:50:29.630529
NCT00600366|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2017-01-05|||March 2004||2004-03-01|January 2017|2017-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes|Efficacy and Safety of Biphasic Insulin Aspart 30 in Insulin Naive Type 2 Diabetic Patients With Secondary OHA Failure|Completed||Phase 4|71|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:50:29.732402|2017-02-18 14:50:29.732402
NCT00600353|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2011-02-18|||October 2007||2007-10-01|February 2011|2011-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Multi-day Doses in Prevention of Nausea and Emesis|Combined Use of Multi-Day Doses of Palonosetron and Aprepitant With Low Doses Dexamethasone in Prevention of Nausea and Emesis Among Patients With Multiple Myeloma and Lymphoma Undergoing Autologous Stem Cell Transplant: A Pilot Study|Completed||Phase 2|20|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-02-18 14:50:29.833519|2017-02-18 14:50:29.833519
NCT00600340|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2016-02-17|||April 2008||2008-04-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|October 2015|Actual|2015-10-01||Interventional|||2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab|A Randomized Phase III 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab for the First-line Treatment of HER2-negative Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 3|560|Actual|Central European Cooperative Oncology Group||2|||f||||t||||||||||2017-02-18 14:50:30.163027|2017-02-18 14:50:30.163027
NCT00600327|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-14|||December 2001||2001-12-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|March 2005|Actual|2005-03-01||Interventional|CABERNET||Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™|Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™|Completed||Phase 3|488|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 14:50:30.321387|2017-02-18 14:50:30.321387
NCT00600314|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2010-10-07|||April 2005||2005-04-01|October 2010|2010-10-01|April 2012|Anticipated|2012-04-01|||||Observational|||Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease|Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease|Unknown status|Recruiting|N/A|60|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||||||2017-02-18 14:50:30.447261|2017-02-18 14:50:30.447261
NCT00600301|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-01-23||||||January 2008|2008-01-01||||||||Interventional|||Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study||Unknown status|Recruiting|Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 14:50:30.544104|2017-02-18 14:50:30.544104
NCT00600288|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2014-12-21||2011-03-24|January 2008||2008-01-01|December 2014|2014-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)|A Multi-Center, Parallel-Group, Double-Masked, Randomized, Placebo-Controlled Study of the Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% and Placebo in Subjects With Dry Eye Disease|Completed||Phase 3|261|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 14:50:30.625939|2017-02-18 14:50:30.625939
NCT00600275|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2012-11-26||2012-05-01|December 2007||2007-12-01|November 2012|2012-11-01||||March 2010|Actual|2010-03-01||Interventional|||A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer|A Phase I/II, Multi-center, Open-label Study of BGT226, Administered Orally in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer|Completed||Phase 1/Phase 2|57|Actual|Novartis||1|||f||||||||||||||2017-02-18 14:50:30.719522|2017-02-18 14:50:30.719522
NCT00600262|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-01-23|||December 2005||2005-12-01|January 2008|2008-01-01|June 2006||2006-06-01|||||Interventional|||Intravitreal Bevacizumab for Diabetic Retinopathy|Efficacy of Intravitreal Bevacizumab for Severe Nonproliferative and Proliferative Diabetic Retinopathy.|Completed||Phase 2/Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 14:50:30.830956|2017-02-18 14:50:30.830956
NCT00600249|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2014-03-19|||January 2008||2008-01-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||"Assessment of the Efficacy of a Neoadjuvant Combination: Chemotherapy-targeted Therapy in Breast Cancer."|"Phase II Pilot Study Evaluating the Neoadjuvant Combination Taxotere (Docetaxel) and Erbitux (Cetuximab) in Operable and Triple Negative Breast Cancer Patients. TENEO Study."|Completed||Phase 2|35|Anticipated|Centre Jean Perrin||1|||f||||f||||||||||2017-02-18 14:50:30.914974|2017-02-18 14:50:30.914974
NCT00600236|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-01-23|||September 2004||2004-09-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population|HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population|Completed||Phase 3|300|Anticipated|Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 14:50:31.025439|2017-02-18 14:50:31.025439
NCT00600223|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2010-10-08|||October 2005||2005-10-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches|Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Reconstruction Approaches|Completed||N/A|5|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:50:31.110638|2017-02-18 14:50:31.110638
NCT00600210|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-09-23|||January 2008||2008-01-01|September 2013|2013-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer|AVF3963s Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer|Withdrawn||Phase 2|0|Actual|Leo W. Jenkins Cancer Center||1||low patient accrual|f||||t||||||||||2017-02-18 14:50:31.218466|2017-02-18 14:50:31.218466
NCT00600197|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-13|2009-11-17|||July 2008||2008-07-01|November 2009|2009-11-01|September 2012|Anticipated|2012-09-01|April 2010|Anticipated|2010-04-01||Interventional|||Biopsychosocial Education and Chronic Low Back Pain|The Effectiveness of Biopsychosocial Education on Quality of Life and Disability of Individuals Suffering From Chronic Low Back Pain|Unknown status|Active, not recruiting|N/A|170|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:50:31.358862|2017-02-18 14:50:31.358862
NCT00600184|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2016-12-07|||January 2008||2008-01-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|November 2009|Actual|2009-11-01||Interventional|AMES||Clinic-Based AMES Treatment of Stroke|Clinic-Based Assisted Movement and Enhanced Sensation Treatment of Stroke|Terminated||Phase 1/Phase 2|2|Actual|AMES Technology||1||Funding unavailable at this time for this particular study.|f||||t||||||||||2017-02-18 14:50:31.468753|2017-02-18 14:50:31.468753
NCT00600171|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2016-11-04|2013-06-06||December 2007||2007-12-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.|A Randomised, Double-blind, Placebo Controlled, Parallel Group, Dose Ranging Study Evaluating the Efficacy and Safety of GW642444M Administered Once Daily Compared With Placebo for 28 Days in Adolescent and Adult Subjects With Persistent Asthma|Completed||Phase 2|614|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:50:31.594938|2017-02-18 14:50:31.594938
NCT00600158|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-01-23|||April 2005||2005-04-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effects of Intravenous Local Anesthetic on Bowel Function After Colectomy|Effects of Intravenous Local Anesthetic on Bowel Function After Colectomy|Completed||Phase 3|45|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 14:50:33.159028|2017-02-18 14:50:33.159028
NCT00600145|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2011-04-26|||September 2007||2007-09-01|April 2011|2011-04-01|July 2010|Anticipated|2010-07-01|December 2009|Anticipated|2009-12-01||Interventional|||Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward|Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward|Withdrawn||N/A|0|Actual|University of Virginia||2||PI decision|f||||t||||||||||2017-02-18 14:50:33.260863|2017-02-18 14:50:33.260863
NCT00600119|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2015-05-28|2014-10-13||December 2007||2007-12-01|May 2015|2015-05-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional||Baseline characteristics are summarized based on the MITT analysis population, which consisted of all randomized patients who received at least 1 dose of double-blind study treatment, had a baseline value and Visit 6 evaluable data (where Visit 6 was the Week 1 visit during the double-blind study treatment period).|A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose, Dose Escalation Study to Evaluate the Efficacy, Safety and Tolerability of NKTR-118 in Patients With Opioid-Induced Constipation (OIC)|Completed||Phase 2|207|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 14:50:33.378646|2017-02-18 14:50:33.378646
NCT00600106|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2012-08-24|||April 2006||2006-04-01|August 2012|2012-08-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study|WISE Ancillary Study Data Analyses:Efficacy of Hormone Replacement on Myocardial Ischemia in Postmenopausal Women With Normal/Minimal Coronary Artery Disease: Data Analysis|Unknown status|Active, not recruiting|N/A|48|Anticipated|Cedars-Sinai Medical Center|||1||f||||t||||||||||2017-02-18 14:50:34.744232|2017-02-18 14:50:34.744232
NCT00600093|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-13|2011-07-24|||January 2008||2008-01-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine|Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine|Terminated||Phase 2|20|Anticipated|Rabin Medical Center||1||PI leaving the institute for a fellowship.|f||||f||||||||||2017-02-18 14:50:34.845777|2017-02-18 14:50:34.845777
NCT00600080|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-05-05|2011-10-20||December 2007||2007-12-01|May 2015|2015-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||Subjects are those who were enrolled and randomized to a study arm. Sixty subjects were enrolled and sixty subjects completed.|A Comparison of Two Daily Disposable Contact Lenses|The Comparative Clinical Performance of the Etafilcon A Lens and the DAILIES AquaComfort Plus Lens|Completed||N/A|60|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:50:34.950964|2017-02-18 14:50:34.950964
NCT00164320|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||May 2004||2004-05-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Interventional|||Project TEAM: Teaching HIV Prevention in the HIV Clinic|Project TEAM: Teaching HIV Prevention in the HIV Clinic|Completed||Phase 2|600||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:44.425488|2017-02-18 17:21:44.425488
NCT00600067|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2012-09-05|2012-07-31||January 2008||2008-01-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults|A Randomized, Double Blind Multicenter Study to Evaluate the Long-term Safety and Efficacy of VI-0521 Relative to Placebo in Providing and Maintaining Glycemic Control in Type 2 Diabetic Adults|Completed||Phase 2|130|Actual|VIVUS, Inc.||2|||f||||f||||||||||2017-02-18 14:50:35.257874|2017-02-18 14:50:35.257874
NCT00600054|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2011-07-04|||October 2007||2007-10-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma|Phase 2 Study of Safety and Efficacy of Nimotuzumab (TheraCIM®) in Pediatric Patients With Recurrent Diffuse Intrinsic Pontine Glioma|Completed||Phase 2|44|Actual|YM BioSciences||1|||f||||t||||||||||2017-02-18 14:50:35.68143|2017-02-18 14:50:35.68143
NCT00600041|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-03-22|||May 2005||2005-05-01|February 2008|2008-02-01|November 2006|Actual|2006-11-01|January 2006|Actual|2006-01-01||Interventional|HIPPO||Placebo-Controlled Crossover Study for the Investigation of the Effect of Pantoprazole on Cardiac Contractility|Heart Issues of PantoPrazOle (HIPPO)|Completed||Phase 1|20|Actual|Herzzentrum Goettingen||2|||f||||f||||||||||2017-02-18 14:50:35.796611|2017-02-18 14:50:35.796611
NCT00600028|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2012-09-18|||December 2007||2007-12-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide|Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide|Completed||Phase 3|25|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:50:35.908067|2017-02-18 14:50:35.908067
NCT00600015|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-08-22|2012-08-22||February 2008||2008-02-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)|A Randomized Double-Blind Placebo-Controlled Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|166|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 14:50:36.017837|2017-02-18 14:50:36.017837
NCT00600002|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-17|2016-11-29|||June 2004||2004-06-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma|A Phase I Clinical Trial of GM-CSF Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma|Active, not recruiting||Phase 1|30|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 14:50:36.462673|2017-02-18 14:50:36.462673
NCT00599989|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-07-08|||January 2005||2005-01-01|July 2009|2009-07-01||||January 2010|Anticipated|2010-01-01||Interventional|||Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer|Accelerated Partial Breast Irradiation|Unknown status|Active, not recruiting|N/A|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:50:36.559498|2017-02-18 14:50:36.559498
NCT00599976|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-01-23|||November 2002||2002-11-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|PABA CHF||Comparison of Pulmonary Vein Isolation Versus AV Nodal Ablation With Biventricular Pacing for Patients With Atrial Fibrillation With Congestive Heart Failure (PABA CHF)|Randomized Controlled Trial of Pulmonary Vein Antrum Isolation vs. AV Node Ablation With Bi-Ventricular Pacing for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure (PABA CHF)|Completed||N/A|81|Actual|Azienda Policlinico Umberto I||2|||f||||f||||||||||2017-02-18 14:50:36.654518|2017-02-18 14:50:36.654518
NCT00599963|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-07-31|||January 2008||2008-01-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|||Paricalcitol for the Treatment of Immunoglobulin A Nephropathy|Paricalcitol for the Treatment of Immunoglobulin A Nephropathy - A Randomized Cross-Over Study|Withdrawn||Phase 3|0|Actual|Chinese University of Hong Kong||2||Funding problem.|f||||t||||||||||2017-02-18 14:50:36.723992|2017-02-18 14:50:36.723992
NCT00599950|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-23|||January 2007||2007-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|January 2007|Actual|2007-01-01||Interventional|||Anterior Stromal Changes After PRK by Using Intraoperative Mitomicin C|Anterior Stromal Changes After PRK by Using Intraoperative Mitomicin C.|Completed||Phase 4|10|Actual|Asociación para Evitar la Ceguera en México||2|||f||||t||||||||||2017-02-18 14:50:36.816396|2017-02-18 14:50:36.816396
NCT00599937|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2008-01-23|||January 1993||1993-01-01|December 2007|2007-12-01|December 1998|Actual|1998-12-01|December 1998|Actual|1998-12-01||Interventional|||APL93: Timing of CxT and Role of Maintenance|Assessment of the Optimal Timing of Chemotherapy With or After ATRA and the Role of Maintenance|Completed||Phase 3|576|Actual|Groupe d'etude et de travail sur les leucemies aigues promyelocytaires||7|||f||||f||||||||||2017-02-18 14:50:36.917995|2017-02-18 14:50:36.917995
NCT00599924|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2015-06-22|2009-11-04||September 2005||2005-09-01|June 2015|2015-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors|Phase I Study Of SU011248 In Combination With Oxaliplatin, Leucovorin, And 5-Fluorouracil In Patients With Advanced Solid Malignancies|Completed||Phase 1|53|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:50:37.037576|2017-02-18 14:50:37.037576
NCT00599911|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-11-07|||October 2007||2007-10-01|November 2016|2016-11-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Dose-finding Study With Lu AA24530 in Major Depressive Disorder|Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-referenced, Dose-finding Study of Lu AA24530 in Major Depressive Disorder|Completed||Phase 2|652|Actual|H. Lundbeck A/S||5|||f||||f||||||||||2017-02-18 14:50:38.839376|2017-02-18 14:50:38.839376
NCT00599898|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2012-03-12|||January 2008||2008-01-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Nifedipine Compared to Atosiban for Treating Preterm Labor|Nifedipine Compared to Atosiban for Treating Preterm Labor. A Randomized Controlled Trial.|Completed||Phase 4|145|Actual|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-02-18 14:50:41.518394|2017-02-18 14:50:41.518394
NCT00599885|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2015-09-02|||September 2007||2007-09-01|September 2015|2015-09-01||||July 2008|Actual|2008-07-01||Interventional|||Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes||Completed||Phase 4|72|Actual|Korea University Anam Hospital||2|||f||||||||||||||2017-02-18 14:50:41.626843|2017-02-18 14:50:41.626843
NCT00599092|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-07-08|||January 1997||1997-01-01|July 2009|2009-07-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Pituitary Tumor Surveillance: Pathogenic Correlation|Pituitary Tumor Surveillance: Pathogenetic Correlation|Unknown status|Recruiting|N/A|1250|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 14:50:53.535389|2017-02-18 14:50:53.535389
NCT00599872|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-01-06|2011-07-07||March 2008||2008-03-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies|Parallel, Randomized, Double-Blind, Placebo-Controlled Trial in Adults for the Sublingual-Oral Immunotherapy (SLIT) of Allergic Rhinoconjunctivitis With or Without Asthma Caused By Ragweed Pollen|Completed||Phase 3|430|Actual|Greer Laboratories||2|||f||||f||||||||||2017-02-18 14:50:41.72588|2017-02-18 14:50:41.72588
NCT00599859|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2009-09-18|||September 2006||2006-09-01|September 2009|2009-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|ELM||Effects of Lactose on Fecal Microflora|Differential Biologic Impact of Lactose Consumption in Lactase Persistent and Non-persistent Populations: Evaluation of Microflora and Insulin/Glycemic Response|Completed||N/A|57|Actual|Sir Mortimer B. Davis - Jewish General Hospital||2|||f||||t||||||||||2017-02-18 14:50:42.459686|2017-02-18 14:50:42.459686
NCT00599846|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-13|2010-02-26|||December 2007||2007-12-01|February 2010|2010-02-01||||December 2009|Actual|2009-12-01||Observational|||The Natural History of Geographic Atrophy Progression (GAP) Study||Terminated||N/A|1000|Anticipated|Alcon Research|||1||f||||f||||||||||2017-02-18 14:50:42.573052|2017-02-18 14:50:42.573052
NCT00599833|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-06-25|||May 2007||2007-05-01|August 2009|2009-08-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery|Locally Advanced Pancreatic Cancer: Phase II Study of Cetuximab and 3-D Conformal Image Guided Radiotherapy (PACER)|Completed||Phase 2|44|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:50:42.65374|2017-02-18 14:50:42.65374
NCT00599820|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-01-23|||November 2005||2005-11-01|January 2008|2008-01-01|May 2006||2006-05-01|||||Interventional|||Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks|OCT, Visual Outcome and Angiographic Analysis of Choroidal Neovascularization in Six Eyes With Angioid Streaks Treated With a Single Intravitreal Injection of Bevacizumab|Unknown status|Active, not recruiting|Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 14:50:42.749058|2017-02-18 14:50:42.749058
NCT00599807|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2014-10-27|||January 2008||2008-01-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Zurich Multiple Endpoint Vitamin D Trial in Knee OA Patients|Role of Vitamin D in Secondary Prevention of Knee Osteoarthritis: A Double-blind Randomized Controlled Trial|Completed||Phase 4|273|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 14:50:42.842648|2017-02-18 14:50:42.842648
NCT00599794|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-01-23|||January 2006||2006-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Observational|||A Simple Clinical Tool to Help Assess Patient Volume (Fluid) Status|A Simple Clinical Tool to Help Assess Patient Volume (Fluid) Status|Completed||N/A|84|Actual|Mayo Clinic|||2||f||||f||||||||||2017-02-18 14:50:42.966989|2017-02-18 14:50:42.966989
NCT00599781|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-23|||March 1992||1992-03-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|July 2006|Actual|2006-07-01||Interventional|||Gene Therapy for ADA-SCID|Treatment of ADA-SCID by Gene Therapy on Somatic Cells|Completed||Phase 1/Phase 2|8|Actual|IRCCS San Raffaele||1|||f||||f||||||||||2017-02-18 14:50:43.053357|2017-02-18 14:50:43.053357
NCT00599768|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-11-19||2009-11-19|March 2008||2008-03-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.|Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.|Completed||N/A|325|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:50:43.150803|2017-02-18 14:50:43.150803
NCT00599755|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-10-08|2012-04-10||January 2009||2009-01-01|October 2015|2015-10-01|April 2011|Actual|2011-04-01|June 2010|Actual|2010-06-01||Interventional|||Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)|A Multicenter Phase Ib Trial to Measure [18F]-Fluorodeoxyglucose Uptake by Positron Emission Tomography in Stage IIIB and IV Non-Small Cell Lung Cancer Before and After Chemotherapy With Gemcitabine and Cisplatin or Carboplatin|Completed||Phase 1|68|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 14:50:43.249935|2017-02-18 14:50:43.249935
NCT00599742|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-01-23|||December 2007||2007-12-01|January 2008|2008-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Comorbidity Between Balance and Childhood Anxiety|Comorbidity Between Balance and Childhood Anxiety: Treatment of Anxiety by Training of Balance|Unknown status|Recruiting|N/A|64|Anticipated|Lev-Hasharon Mental Healtlh Center||2|||f||||t||||||||||2017-02-18 14:50:43.580696|2017-02-18 14:50:43.580696
NCT00599729|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2008-01-23|||January 2008||2008-01-01|December 2007|2007-12-01||||July 2008|Anticipated|2008-07-01||Observational|||Measurement of Gait Spatio-Temporal Characteristics in Knee Osteoarthritis Patients||Unknown status|Recruiting|N/A|30|Anticipated|Assaf-Harofeh Medical Center|||1||f||||f||||||||||2017-02-18 14:50:43.691386|2017-02-18 14:50:43.691386
NCT00599716|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-01-08|||December 2006||2006-12-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome|A Phase 3, Multicenter, Randomized, Double-Masked Study of Safety and Efficacy of Vismed® in Dry Eye Syndrome|Completed||Phase 3|300|Anticipated|Lantibio||2|||f||||f||||||||||2017-02-18 14:50:43.777719|2017-02-18 14:50:43.777719
NCT00599703|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-07-07|||May 2005||2005-05-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Language Function in Patients With Brain Tumors|Reorganization of Language Function in Patients With Brain Tumors|Completed||N/A|7|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:50:44.10986|2017-02-18 14:50:44.10986
NCT00599690|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-28|||January 2006||2006-01-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|January 2006|Actual|2006-01-01||Interventional|||Epi-LASIK : A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma.|Epi-LASIK : A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma.|Completed||N/A|10|Actual|Asociación para Evitar la Ceguera en México||1|||f||||t||||||||||2017-02-18 14:50:44.204812|2017-02-18 14:50:44.204812
NCT00599677|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-11-08|||November 2007||2007-11-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Randomized Controlled Trial of Acupuncture for Functional Dyspepsia|Randomized Controlled Trial of Acupuncture for Functional Dyspepsia|Completed||N/A|720|Actual|Chengdu University of Traditional Chinese Medicine||6|||f||||t||||||||||2017-02-18 14:50:44.304682|2017-02-18 14:50:44.304682
NCT00004363|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||December 1995||1995-12-01|December 2003|2003-12-01||||||||Observational|||Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:45.493637|2017-02-18 18:16:45.493637
NCT00599664|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2010-04-28|||December 2007||2007-12-01|April 2010|2010-04-01|September 2008|Actual|2008-09-01|||||Interventional|||Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones|Double-Blind, Placebo-Controlled, Two-Center, Pharmacokinetic Study Evaluating the Systemic Absorption and Safety of OMS201 in Subjects Undergoing Ureteroscopic Treatment of Unilateral Ureteral- or Renal Collecting System-Located Stones|Completed||Phase 1|11|Actual|Omeros Corporation||2|||f||||f||||||||||2017-02-18 14:50:44.416115|2017-02-18 14:50:44.416115
NCT00599651|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-29|2010-05-06|||June 2005||2005-06-01|May 2010|2010-05-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)|Randomized Controlled Trial of Surfactant Administration by Laryngeal Mask Airway (LMA)|Terminated||N/A|380|Anticipated|University of Virginia||2||Study was closed due to extremely low enrollment|f||||f||||||||||2017-02-18 14:50:44.517476|2017-02-18 14:50:44.517476
NCT00599638|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2009-10-07||2009-04-06|March 2008||2008-03-01|October 2009|2009-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia|A Two Week Double-Blind Placebo-Controlled Crossover Study To Compare The Efficacy And Safety Of A Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Patients With Post-Herpetic Neuralgia|Completed||Phase 2|130|Anticipated|Pfizer||3|||f||||||||||||||2017-02-18 14:50:44.63124|2017-02-18 14:50:44.63124
NCT00599625|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-03-04|||October 2004||2004-10-01|March 2011|2011-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot Study|Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|University of Virginia||1|||f||||f||||||||||2017-02-18 14:50:44.771478|2017-02-18 14:50:44.771478
NCT00599612|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2012-01-19|||January 2008||2008-01-01|January 2012|2012-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males|An Open Label Study to Determine the Safety, Tolerability, Excretion Balance and Pharmacokinetics of [14C]GW856553, Administered as a Single Dose of an Oral Solution to Healthy Adult Male Subjects.|Completed||Phase 1|6|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 14:50:44.883145|2017-02-18 14:50:44.883145
NCT00599599|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-03-04|||April 2005||2005-04-01|March 2009|2009-03-01|February 2010|Anticipated|2010-02-01|February 2009|Anticipated|2009-02-01||Interventional|PEACH||Stress-Reducing Interventions in HIV+ Patients: Pilot|Pilot Intervention for PTSD, Nonadherence, and HIV Risk|Unknown status|Active, not recruiting|N/A|70|Anticipated|Kent State University||2|||f||||t||||||||||2017-02-18 14:50:44.971339|2017-02-18 14:50:44.971339
NCT00599586|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2010-06-27|||November 2007||2007-11-01|June 2010|2010-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Randomized Controlled Trial of Treating Migraine With Acupuncture|Randomized Controlled Trial of Treating Migraine With Acupuncture|Completed||N/A|480|Actual|Chengdu University of Traditional Chinese Medicine||4|||f||||t||||||||||2017-02-18 14:50:45.082834|2017-02-18 14:50:45.082834
NCT00599573|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-04-12|||October 2007||2007-10-01|April 2010|2010-04-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|||Pharmacotherapy for HIV+ Stimulant Dependent Individuals|Pharmacotherapy for HIV+ Stimulant Dependent Individuals|Unknown status|Recruiting|N/A|12|Anticipated|University of Virginia||1|||f||||t||||||||||2017-02-18 14:50:45.217397|2017-02-18 14:50:45.217397
NCT00599560|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-03-28|||April 1998||1998-04-01|January 2008|2008-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Vasopressin and V2 Receptor in Meniere's Disease|Vasopressin and V2 Receptor in Meniere's Disease|Completed||N/A|135|Actual|Osaka University||2|||f||||f||||||||||2017-02-18 14:50:45.3315|2017-02-18 14:50:45.3315
NCT00599547|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2016-01-13|||November 2002||2002-11-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients|Allogeneic Stem Cell Transplantation After Dose-reduced Intensity Conditioning Regimen for Patients With Myelofibrosis With Myeloid Metaplasia (MMM): A Phase II-study|Completed||Phase 2|106|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-02-18 14:50:45.456478|2017-02-18 14:50:45.456478
NCT00599534|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-08-06|||December 2007||2007-12-01|August 2009|2009-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome|A Randomized Double Blind Controlled Trial on the Effect of Treatment in Children With Obstructive Sleep Apnea Syndrome.|Terminated||Phase 2|80|Anticipated|University of Louisville||2||Principal Investigator has transferred to another Institution|f||||f||||||||||2017-02-18 14:50:45.558911|2017-02-18 14:50:45.558911
NCT00599521|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2011-03-21|2010-04-16||November 2007||2007-11-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%|A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared With Vehicle Lotion in Subjects With Acne Vulgaris|Completed||Phase 3|1067|Actual|Galderma||2|||f||||f||||||||||2017-02-18 14:50:45.670023|2017-02-18 14:50:45.670023
NCT00599508|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-10-07|||June 2006||2006-06-01|October 2016|2016-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Nutritional Supplementation in Cognitive Aging|Nutritional Supplementation in Cognitive Aging|Completed||N/A|120|Actual|University of Cincinnati||5|||f||||f||||||||||2017-02-18 14:50:46.162292|2017-02-18 14:50:46.162292
NCT00599495|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2015-11-30|||November 2002||2002-11-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT|Allogeneic Stem Cell Transplantation From Unrelated Donors After Dose-reduced Intensity Conditioning Regimen for Patients With Multiple Myeloma and Relapse After Autologous Stem Cell Transplantation: A Phase II-study|Completed||Phase 2|50|Actual|Universitätsklinikum Hamburg-Eppendorf||1|||f||||f||||||||||2017-02-18 14:50:46.271014|2017-02-18 14:50:46.271014
NCT00599482|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-01-02|||January 2008||2008-01-01|January 2009|2009-01-01|January 2009|Anticipated|2009-01-01|September 2008|Anticipated|2008-09-01||Interventional|||Far Infrared Radiation for Sickle Cell Pain Management|Phase 1 Study to Examine the Use of Far Infrared Radiation for Pain Management During Sickle Cell Crisis|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:50:46.363274|2017-02-18 14:50:46.363274
NCT00599469|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-08-14|||February 2008||2008-02-01|August 2009|2009-08-01|April 2009|Anticipated|2009-04-01|March 2009|Anticipated|2009-03-01||Interventional|||Far Infrared Treatment for Alzheimer's Disease|Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Treatment of Alzheimer's Disease.|Unknown status|Active, not recruiting|Phase 1|4|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:50:46.459813|2017-02-18 14:50:46.459813
NCT00599456|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-09-16|||September 2007||2007-09-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.|A Placebo Controlled Double Blinded Prospective Study to Investigate the Usefulness of Omega 3 Fatty Acids in the Relief of Vasomotor Symptoms of Menopausal Women|Completed||N/A|100|Anticipated|Christiana Care Health Services||2|||f||||f||||||||||2017-02-18 14:50:46.559532|2017-02-18 14:50:46.559532
NCT00599443|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2008-06-27|||October 2007||2007-10-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years|Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years.|Completed||Phase 1|120|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 14:50:46.663321|2017-02-18 14:50:46.663321
NCT00599430|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-01-11|||November 2005||2005-11-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections|Probiotics and Effects on Illness-Related Symptoms for Pre-School Age Children|Completed||N/A|326|Actual|Danisco||3|||f||||f||||||||||2017-02-18 14:50:46.962241|2017-02-18 14:50:46.962241
NCT00599417|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-09-18|||December 2007||2007-12-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||PulmonarOM (Bacterial Lysates) in Respiratory Tract Infections|Prospective, Pivotal Unicentre, Randomized Double-bind, Placebo-controlled Study, to Evaluate Efficacy and Safety of Bacterial Lysates (Pulmonarom) in the Prevention of Respiratory Tract Infections|Completed||Phase 4|80|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:50:47.06215|2017-02-18 14:50:47.06215
NCT00599404|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-04-23|||January 2008||2008-01-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400|An Open-Label, 2-Period Pharmacokinetic Study to Evaluate the Intra-Subject Variability in Esomeprazole Plasma Levels in Healthy Subjects Following Oral Administration of PN 400 Tablets|Completed||Phase 1|18|Actual|POZEN||1|||f||||f||||||||||2017-02-18 14:50:47.162503|2017-02-18 14:50:47.162503
NCT00599391|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-01-02|||February 2008||2008-02-01|January 2009|2009-01-01|February 2009|Anticipated|2009-02-01|October 2008|Anticipated|2008-10-01||Interventional|||Far Infrared Treatment for Kidney Diseases|Phase 1 Study to Examine the Use of Far Infrared Radiation for Renal Failure.|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:50:47.24327|2017-02-18 14:50:47.24327
NCT00599378|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2013-09-06|||September 2007||2007-09-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Implementation Intentions to Promote Colon Cancer Screening in Rural Primary Care Practice|Implementation Intentions to Promote Colon Cancer Screening in Rural Primary Care Practice|Completed||N/A|373|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 14:50:47.345056|2017-02-18 14:50:47.345056
NCT00599365|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-02-14|||December 2007||2007-12-01|November 2007|2007-11-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|CAMP||Impact of CAMP in an Ambulatory Renal Clinic|Impact of a Pharmacist's Collaborative Management, Adherence,and Medication Education Program (CAMP) in an Ambulatory Renal Clinic|Unknown status|Recruiting|N/A|100|Anticipated|San Francisco Veterans Affairs Medical Center||2|||f||||t||||||||||2017-02-18 14:50:47.44146|2017-02-18 14:50:47.44146
NCT00599352|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-05-28|||January 2008||2008-01-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease Patients|Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease Patients|Terminated||N/A|14|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 14:50:47.559407|2017-02-18 14:50:47.559407
NCT00599339|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2015-07-27|2015-04-10||June 2006||2006-06-01|July 2015|2015-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|TRUST|Baseline Characterisitcs refer to the Enrolled Set [ES]. 2195 patients were enrolled in this study, of which 36 patients had no valid data consent. Data from these patients were not used for analysis.|Transdermal Rotigotine User Surveillance Study|A Naturalistic, Multisite, Observational Study of Rotigotine Transdermal Patch and Other Currently Prescribed Therapies in Patients With Idiopathic Parkinson's Disease|Completed||N/A|2195|Actual|UCB Pharma|||5||f||||f||||||||||2017-02-18 14:50:47.687037|2017-02-18 14:50:47.687037
NCT00599326|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2014-01-09|2013-08-21||January 2008||2008-01-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda|Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda|Completed||Phase 3|10|Actual|University of Texas Southwestern Medical Center|10 patients were enrolled, of which 8 were compliant with therapy and had evaluable data. Of the 2 patients dropped from the study, one patient was lost to follow-up after 2 months and another was noncompliant with medication dosing.|1|||f||||f||||||||||2017-02-18 14:50:50.116733|2017-02-18 14:50:50.116733
NCT00599313|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2016-10-13|2016-01-20||March 2007||2007-03-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||Total participants|Phase II Sunitinib Prog Met AIPC|Phase II Trial of Sunitinib Malate for the Therapy of Progressive Metastatic Androgen Independent Prostate Cancer (AIPC) Following Docetaxel-based Chemotherapy|Completed||Phase 2|36|Actual|US Oncology Research||1|||f||||f||||||||||2017-02-18 14:50:50.402731|2017-02-18 14:50:50.402731
NCT00599287|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2008-05-27|||February 2008||2008-02-01|February 2008|2008-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients|Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients: a Randomized, Mono-Blind Pilot Trial|Terminated||Phase 3|80|Anticipated|UMC Utrecht||4||"Inclusion rate too low due to a lack of eligible patients and difficulties obtaining informed~   consent."|f||||t||||||||||2017-02-18 14:50:50.767467|2017-02-18 14:50:50.767467
NCT00144924|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-06-12|||June 2004||2004-06-01|June 2008|2008-06-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||Open vs Laparoscopic Pyloromyotomy for Pyloric Stenosis||Unknown status|Recruiting|N/A|200|Anticipated|Institute of Child Health||1|||f||||||||||||||2017-02-18 17:27:54.446622|2017-02-18 17:27:54.446622
NCT00599274|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2010-01-26|||August 2002||2002-08-01|January 2010|2010-01-01|May 2003|Actual|2003-05-01|||||Observational|PROOF||Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis|A Multicenter, Prospective and Retrospective, Long-Term Observational Study of AVONEX® and Rebif® to Determine the Efficacy, Tolerability, and Safety in Subjects With Relapsing Multiple Sclerosis (MS)|Completed||N/A|136|Actual|Biogen|||2||f||||t||||||||||2017-02-18 14:50:50.875911|2017-02-18 14:50:50.875911
NCT00599261|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-01-08|||January 2008||2008-01-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||MAKE IT CLEAN, Impact of Pocket Revision on the Rate of Infection and Other Complications in Patients Requiring Pocket Manipulation for Generator Replacement and/or Lead Replacement or Revision: A Prospective Randomized Study|Impact of Pocket Revision on the Rate of Infection and Other Complications in Patients Requiring Pocket Manipulation for Generator Replacement and/or Lead Replacement or Revision: A Prospective Randomized Study|Completed||Phase 4|265|Anticipated|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 14:50:50.991647|2017-02-18 14:50:50.991647
NCT00599248|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2016-05-23|2016-05-23||January 2007||2007-01-01|May 2016|2016-05-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|TGC-03-01|Adults 18 or older with degenerative joint disease of the knee (confirmed by Kellgren and Lawrence criteria) refractory to existing drug therapies who were scheduled for total knee arthroplasty.|Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee|A Phase 1 Study to Determin the Safety and Biological Activity of Cell-Mediated Gene Therapy Using TissueGene-C in Patients With Degenerative Joint Disease Prior to Total Knee Arthroplasty|Completed||Phase 1|12|Actual|TissueGene, Inc.|This study was designed a a preliminary assessment of safety in a limited population (12 subjects: 9 active 3 placebo) therefore statistical analysis is limited.|2|||f||||t||||||||||2017-02-18 14:50:51.102412|2017-02-18 14:50:51.102412
NCT00599235|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2010-04-07|||March 2007||2007-03-01|January 2008|2008-01-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional|||Sildenafil and Exercise Capacity in Hypertension|Effects of the Selective Phosphodiesterase Type 5 Inhibitor Sildenafil Citrate on Exercise Capacity and Vascular Function in Hypertensive Subjects|Completed||N/A|30|Actual|University of Edinburgh||2|||f||||||||||||||2017-02-18 14:50:51.507026|2017-02-18 14:50:51.507026
NCT00599222|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2011-11-21|||February 2008||2008-02-01|November 2011|2011-11-01|February 2010|Actual|2010-02-01|November 2009|Actual|2009-11-01||Interventional|||The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study|A Prospective, Randomized, Controlled Study on Intravitreal Ranibizumab (Lucentis) Combined With Transpupillary Thermotherapy (TTT) for Neovascular Age-related Macular Degeneration (AMD)|Completed||Phase 3|100|Actual|St. Erik Eye Hospital||2|||f||||f||||||||||2017-02-18 14:50:51.616678|2017-02-18 14:50:51.616678
NCT00599209|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2011-08-02|||September 2004||2004-09-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Health Information Technology in the Nursing Home|Health Information Technology in the Nursing Home|Completed||N/A|23|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-02-18 14:50:51.806595|2017-02-18 14:50:51.806595
NCT00599196|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2014-09-24|2009-12-11||August 2002||2002-08-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease|An Open-Label Extension to the Double-Blind SP513 Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Subjects With Early-Stage Idiopathic Parkinson's Disease|Completed||Phase 3|381|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:50:51.912433|2017-02-18 14:50:51.912433
NCT00599183|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-07-29|||August 2006||2006-08-01|July 2013|2013-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Diffusion Tensor (Magnetic Resonance) Imaging and Tractography in Herniation of the Cervical Spine|Diffusion Tensor (Magnetic Resonance) Imaging and Tractography in Herniation of the Cervical Spine: An Investigator-Initiated Pilot Study|Completed||N/A|12|Actual|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-02-18 14:50:52.771936|2017-02-18 14:50:52.771936
NCT00599170|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2016-01-31|||January 2008||2008-01-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma|Rituximab Plus CHOP Given Every Two Weeks With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma|Active, not recruiting||Phase 2|52|Actual|University of Southern California||1|||f||||f||||||||||2017-02-18 14:50:52.874867|2017-02-18 14:50:52.874867
NCT00599144|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2008-01-22|||January 2007||2007-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effectiveness of Bupivacaine After Laparoscopic Cholecystectomy|Effectiveness for Postoperative Pain After Laparoscopic Cholecystectomy of 0,5% Bupivacaine-Soaked Tabotamp Placed in the Gallbladder Bed|Completed||N/A|45|Actual|Santa Maria alla Gruccia Hospital||3|||f||||t||||||||||2017-02-18 14:50:52.969547|2017-02-18 14:50:52.969547
NCT00599131|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-11-04|2014-04-16||August 2007||2007-08-01|November 2015|2015-11-01|October 2010|Actual|2010-10-01|July 2008|Actual|2008-07-01||Interventional|||Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)|A Phase II Organ Preservation Trial Using Cetuximab and Radiation Therapy in Advanced Laryngeal Cancer Patients Who Have Responded to One Cycle of Induction Chemotherapy With Taxotere, Cisplatin, 5-Fluorouracil (TPF), and Cetuximab|Terminated||Phase 2|4|Actual|University of Michigan Cancer Center|The study was discontinued prematurely due to an early stopping rule.|1||The study was discontinued prematurely due to early stopping rules.|f||||t||||||||||2017-02-18 14:50:53.082652|2017-02-18 14:50:53.082652
NCT00599118|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-06-01|||August 2005||2005-08-01|June 2010|2010-06-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation|Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation|Unknown status|Active, not recruiting|N/A|1300|Anticipated|The Cleveland Clinic|||2||f||||t||||||Samples With DNA|"~     plasma, serum, buffy coat, DNA~   "|||2017-02-18 14:50:53.36879|2017-02-18 14:50:53.36879
NCT00599105|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-11-17|||November 2000||2000-11-01|November 2010|2010-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Angiogenesis in Early Breast Cancer for Prognosis Prediction|Angiogenesis in Early Breast Cancer for Prognosis Prediction|Completed||N/A|700|Anticipated|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:50:53.458237|2017-02-18 14:50:53.458237
NCT00599079|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-01-11|||February 1993||1993-02-01|January 2008|2008-01-01||||August 2010|Anticipated|2010-08-01||Interventional|||Azithromycin in the Treatment of M. Avium Complex Lung Disease|Open, Noncomparative Trial of Azithromycin in the Treatment of M.Avium Complex (MAC) Lung Disease|Unknown status|Active, not recruiting|Phase 4|66|Actual|The University of Texas Health Science Center at Tyler||1|||f||||f||||||||||2017-02-18 14:50:53.622689|2017-02-18 14:50:53.622689
NCT00599066|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-10-29|||September 2007||2007-09-01|October 2013|2013-10-01|April 2009|Actual|2009-04-01|June 2008|Actual|2008-06-01||Interventional|||Intraoperative M-Entropy Measurements|Same-patient Reproducibility of Intraoperative M-Entropy Measurements|Completed||N/A|22|Actual|University of Oklahoma||1|||f||||t||||||||||2017-02-18 14:50:53.721772|2017-02-18 14:50:53.721772
NCT00599053|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2012-11-28|2012-05-30||May 2007||2007-05-01|August 2012|2012-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates|Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates|Terminated||Phase 1/Phase 2|7|Actual|University of Alabama at Birmingham|Early termination due to small number enrolled.|2||"Enrollment was terminated early due to a change in practice on the obstetrical side that~   included administering azithromycin to women with preterm labor."|f||||t||||||||||2017-02-18 14:50:53.831011|2017-02-18 14:50:53.831011
NCT00599040|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2013-03-15|||September 2005||2005-09-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|DINE||The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)|The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)|Completed||Phase 4|113|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-02-18 14:50:54.209249|2017-02-18 14:50:54.209249
NCT00599027|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2015-03-27|2010-04-08||May 2008||2008-05-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma|An Exploratory Study of Mometasone Furoate Nasal Spray in Patients With Moderate-severe Persistent Allergic Rhinitis and Intermittent Asthma: Effects on the Quality of Life Evaluated With the Rhinasthma Questionnaire|Completed||Phase 3|51|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:50:54.305607|2017-02-18 14:50:54.305607
NCT00599014|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2015-10-04|2013-11-13||November 2007||2007-11-01|August 2015|2015-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|TACC||Heart Failure Study: The Atlanta Cardiomyopathy Consortium|The Atlanta Cardiomyopathy Consortium|Completed||N/A|335|Actual|Emory University|Long baseline visit with several questionnaires to be completed made more difficult for the patients to be enrolled. Adverse Events data was not collected as part of this observational registry.||1||f||||f||||||Samples With DNA|"~     Blood for DNA/RNA/Proteomics analysis and Urine for proteomic analysis~   "|||2017-02-18 14:50:54.615665|2017-02-18 14:50:54.615665
NCT00599001|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2016-08-23|||January 2008||2008-01-01|August 2016|2016-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal Males|A Phase 1, Randomized, Single-Blind, Placebo-Controlled Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal Male Volunteers|Completed||Phase 1|26|Actual|Dynavax Technologies Corporation||2|||f||||f||||||||Undecided|a/o August 2016, decision is still pending|2017-02-18 14:50:54.837593|2017-02-18 14:50:54.837593
NCT00598988|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2009-01-08|||January 2008||2008-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|AIM||Acupuncture for Infectious Mononucleosis Trial|Acupuncture for Infectious Mononucleosis Trial|Completed||Phase 2/Phase 3|36|Anticipated|University of Alberta||2|||f||||t||||||||||2017-02-18 14:50:54.948195|2017-02-18 14:50:54.948195
NCT00598975|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2014-08-12||2014-08-12|January 2008||2008-01-01|August 2014|2014-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase 2a/2b Multicenter, Open-Label Study to Evaluate NKTR 102 in Combination With Cetuximab Versus Irinotecan in Combination With Cetuximab in Second Line Colorectal Cancer Patients|A Multicenter, Open-Label, Phase 2 Study to Determine the Dose, Safety and Efficacy of NKTR 102 (PEG-Irinotecan) in Combination With Cetuximab in Patients With Solid Tumors Refractory to Standard Treatment and to Evaluate the Safety and Efficacy of NKTR 102 or Irinotecan in Combination With Cetuximab in Second Line, Irinotecan and Cetuximab Naïve, Colorectal Cancer Patients With Metastatic or Locally Advanced Disease|Completed||Phase 2|18|Actual|Nektar Therapeutics||1|||f||||f||||||||||2017-02-18 14:50:55.044665|2017-02-18 14:50:55.044665
NCT00598962|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-01-11|||December 1994||1994-12-01|November 2007|2007-11-01||||November 2010|Anticipated|2010-11-01||Interventional|||Use of Azithromycin and Rifabutin Administered Three Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease|Open, Noncomparative Trial of Multidrug Regimens Containing Azithromycin and Rifabutin Administered Three Times Per Week for the Treatment of M. Avium Complex (MAC) Lung Disease|Unknown status|Active, not recruiting|Phase 4|58|Actual|The University of Texas Health Science Center at Tyler||1|||f||||f||||||||||2017-02-18 14:50:55.146474|2017-02-18 14:50:55.146474
NCT00598949|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2010-12-14|||January 2003||2003-01-01|December 2010|2010-12-01||||December 2015|Anticipated|2015-12-01||Observational|||Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma|Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma|Unknown status|Recruiting|N/A|600|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||Samples With DNA|"~     cell lines are established for future genetic analysis~   "|||2017-02-18 14:50:55.281396|2017-02-18 14:50:55.281396
NCT00598936|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2011-09-01|||November 2007||2007-11-01|September 2011|2011-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients|A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients|Terminated||Phase 1|21|Actual|University of California, Irvine|||1|Investigator considered the device with no clinical utility.|f||||t||||||||||2017-02-18 14:50:55.369188|2017-02-18 14:50:55.369188
NCT00598923|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-01-22|||November 2004||2004-11-01|January 2008|2008-01-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|PEPTO||Preventing Epilepsy After Traumatic Brain Injury With Topiramate|Preventing Epilepsy After Traumatic Brain Injury: A Pilot, Single-Center Randomized Trial of Topiramate to Prevent Seizures After Moderate to Severe TBI|Unknown status|Recruiting|Phase 2|90|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 14:50:55.476614|2017-02-18 14:50:55.476614
NCT00004334|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||July 1994||1994-07-01|December 2003|2003-12-01||||||||Observational|||Study of Depression, Peptides, and Steroids in Cushing's Syndrome||Unknown status|Recruiting|N/A|8||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:47.626485|2017-02-18 18:16:47.626485
NCT00598910|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2009-03-27|||August 2007||2007-08-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Omacor on Triglycerides in HIV Infected Subjects|A Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Investigate the Effect of Omacor (n-3 PUFA) on Lipid Parameters in HIV Infected Subjects Treated With HAART|Terminated||Phase 4|51|Actual|Solvay Pharmaceuticals||2||The study was discontinued prematurely on December 18 2008 due to slow recruitment|f||||f||||||||||2017-02-18 14:50:55.584672|2017-02-18 14:50:55.584672
NCT00598897|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2008-01-11|||August 1995||1995-08-01|January 2008|2008-01-01||||July 2010|Anticipated|2010-07-01||Interventional|||Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease|Open, Noncomparative Trial of Multidrug Regimens Containing Clarithromycin and Rifabutin Administered Three Times Per Week for the Treatment of M. Avium Complex (MAC) Lung Disease|Unknown status|Active, not recruiting|Phase 4|89|Actual|The University of Texas Health Science Center at Tyler||1|||f||||f||||||||||2017-02-18 14:50:55.683294|2017-02-18 14:50:55.683294
NCT00598884|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2013-06-21|||August 2009||2009-08-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effectiveness of an Internet-Based Self-Management Program in Treating Prolonged Grief Disorder|Internet-Based Self-Management Intervention for Prolonged Grief|Completed||Phase 1|135|Actual|Boston University||2|||f||||t||||||||||2017-02-18 14:50:55.865442|2017-02-18 14:50:55.865442
NCT00598871|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-06-10|2010-02-22||December 2007||2007-12-01|November 2012|2012-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds|A Randomized, Double-Mask, Placebo-Controlled, Dose Response, Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Diabetic Patients' Corneal Wounds Resulting From Epithelial Debridement During Vitrectomy|Terminated||Phase 2|12|Actual|ReGenTree, LLC||2||slow recruitment|f||||f||||||||||2017-02-18 14:50:55.962171|2017-02-18 14:50:55.962171
NCT00598858|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-12-06|||January 2009||2009-01-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|2007-5904||Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate|Phase II Study to Determine the Effects of Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate in Patients Who Are Scheduled for Radical Prostatectomy With Genomic Correlates of Pathological Response|Withdrawn||Phase 2|0|Actual|University of California, Irvine||1||Halted due to zero accrual and lack of funding|f||||t||||||||||2017-02-18 14:50:56.307996|2017-02-18 14:50:56.307996
NCT00598845|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-12-22|||April 2001||2001-04-01|December 2014|2014-12-01|December 2017|Anticipated|2017-12-01|December 2015|Anticipated|2015-12-01||Observational|MoMaTEC||Molecular Markers in Treatment in Endometrial Cancer|Prospective Study of Endometrial Cancer Treatment in Relation to Molecular Markers in Curettage Specimens.|Recruiting||N/A|1000|Anticipated|University of Bergen|||1||f||||f||||||Samples With DNA|"~     Tumor specimens from endometrial carcinoma, from curettage and hysterectomy specimens,~     formalin-fixed and paraffin-embedded and fresh frozen, stored at minus 80 °C, corresponding~     blood samples with normal DNA~   "|||2017-02-18 14:50:56.429831|2017-02-18 14:50:56.429831
NCT00598832|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2011-03-21|2010-04-16||November 2007||2007-11-01|March 2011|2011-03-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%|A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared With Vehicle Lotion in Subjects With Acne Vulgaris|Completed||Phase 3|1075|Actual|Galderma||2|||f||||f||||||||||2017-02-18 14:50:56.745262|2017-02-18 14:50:56.745262
NCT00598819|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-08-15|2010-01-15||October 2007||2007-10-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers|A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Healthy Volunteers|Completed||Phase 1|14|Actual|University of California, Irvine|No Adverse Events (AE's) or Serious Adverse Events (SAE's) were reported in this study.|1|||f||||t||||||||||2017-02-18 14:50:57.292405|2017-02-18 14:50:57.292405
NCT00598806|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2015-05-26||2013-12-18|September 2007||2007-09-01|May 2015|2015-05-01|March 2012|Actual|2012-03-01|December 2009|Actual|2009-12-01||Interventional|||Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant Instilled in the Early Postoperative Period in Patients Undergoing Transurethral Resection for Noninvasive Bladder Cancer|Completed||Phase 3|813|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 14:50:57.590005|2017-02-18 14:50:57.590005
NCT00598793|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2017-01-06|||November 2002||2002-11-01|January 2017|2017-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|INITIATE||Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy|Biphasic Insulin Aspart 70/30 + Metformin Compared to Insulin Glargine + Metformin in Type 2 Diabetes Failing OAD Therapy|Completed||Phase 3|242|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:50:57.811024|2017-02-18 14:50:57.811024
NCT00598780|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2012-05-25|||September 2007||2007-09-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study|Long-term Evaluation of Safety and Treatment Satisfaction With Levocetirizine in Routine Clinical Practice in the Czech and Slovak Republics - Non-interventional Study|Completed||N/A|7870|Actual|UCB Pharma|||1||f||||f||||||||||2017-02-18 14:50:57.953388|2017-02-18 14:50:57.953388
NCT00598767|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-01-10|||June 2003||2003-06-01|January 2008|2008-01-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||Three Dimensional Imaging and Wireless Technologies to Enhance Medical Care in Space|Multimodality 3D Imaging and Wireless Technologies To Enhance Medical Care in Space|Terminated||N/A|3|Actual|The Cleveland Clinic|||1|funding issues|f||||f||||||||No||2017-02-18 14:50:58.065|2017-02-18 14:50:58.065
NCT00598754|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-01-10|||June 2001||2001-06-01|January 2008|2008-01-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||Diagnostic Three Dimensional Echocardiography Study Protocol|Diagnostic Two and Three Dimensional Echocardiography Study Protocol|Withdrawn||N/A|0|Actual|The Cleveland Clinic|||1|Funding issues|f||||f||||||||No||2017-02-18 14:50:58.153035|2017-02-18 14:50:58.153035
NCT00598741|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2014-04-09|||July 2004||2004-07-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors|Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors|Completed||N/A|61|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:50:58.253948|2017-02-18 14:50:58.253948
NCT00598728|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-04-26|||May 2005||2005-05-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Quality of Life Among Survivors of Hodgkin Lymphoma|A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin Lymphoma|Completed||N/A|255|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:50:58.366533|2017-02-18 14:50:58.366533
NCT00598715|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-12-16|||October 2007||2007-10-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|DESIRE-2||Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents|Randomized Trial of Paclitaxel- vs Sirolimus-eluting Stents for Treatment of Coronary Restenosis in Sirolimus-eluting Stents|Completed||Phase 4|450|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 14:50:58.479476|2017-02-18 14:50:58.479476
NCT00598702|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-05-14|2009-09-25||January 2008||2008-01-01|May 2015|2015-05-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients|A Phase III Multi-Center, Open-Label, Prospective, Repeated Dose, Multi-Day Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients.|Completed||Phase 3|100|Actual|Mallinckrodt|The original protocol required 50 subjects that completed 5 days of treatment. With protocol amendment 2, the criteria for enrollment/completion was reduced to 1 day of treatment. Subjects were required to have a minimum of 3 IV APAP doses per day.|1|||f||||f||||||||||2017-02-18 14:50:58.62699|2017-02-18 14:50:58.62699
NCT00598689|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-02-10|2015-01-27||October 2007||2007-10-01|February 2016|2016-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||Consented subjects with a best corrected visual acuity of 20/40 or better in each eye.|GenTeal in Perioperative Treatment of Laser Assisted in Situ Keratomileusis LASIK Patients|Efficacy, Tolerability and Comfort of GenTeal and GenTeal Gel, (0.3% Hypromellose) in the Pre- and Post- Operative Treatment of Patients Undergoing LASIK Surgery|Completed||Phase 4|80|Actual|Augusta University||2|||f||||t||||||||||2017-02-18 14:51:00.275603|2017-02-18 14:51:00.275603
NCT00598676|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-03-12|||September 2007||2007-09-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|ISAR-TEST-4||3 Limus Agent Eluting Stents With Different Polymer Coating|Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting STents (ISAR-TEST 4): Prospective, Randomized Trial of 3-limus Agent-eluting Stents With Different Polymer Coatings|Completed||Phase 4|2600|Actual|Deutsches Herzzentrum Muenchen||3|||f||||t||||||||||2017-02-18 14:51:00.721531|2017-02-18 14:51:00.721531
NCT00598663|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2010-09-17|||January 2008||2008-01-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SWITCH||SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c|Randomized, Cross Over, Controlled, Multi-centric Study to Assess Whether Type 1 Diabetic Patients in Sub-optimal Glycemic Control Can Improve Using the Continuous Glucose Values of the MiniMed Paradigm REAL-Time Insulin Pump System Versus the MiniMed Paradigm Insulin Pump|Completed||Phase 4|154|Actual|Medtronic||2|||f||||f||||||||||2017-02-18 14:51:00.833596|2017-02-18 14:51:00.833596
NCT00598650|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2014-08-29|2014-08-08||February 2008||2008-02-01|August 2014|2014-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies|A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies|Completed||Phase 2|160|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 14:51:00.951819|2017-02-18 14:51:00.951819
NCT00598637|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2013-07-01|||December 2007||2007-12-01|July 2013|2013-07-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|LEFT-MAIN-2||Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease|Prospective Randomized Trial of Everolimus- and Zotarolimus-eluting Stents for Treatment of Unprotected Left Main Coronary Artery Disease: ISAR-LEFT-MAIN-2|Completed||Phase 4|650|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 14:51:01.244661|2017-02-18 14:51:01.244661
NCT00598624|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2009-08-10|||September 2005||2005-09-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|AlloTreo||Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)|Clinical Phase II Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies|Unknown status|Recruiting|Phase 2|175|Anticipated|IRCCS San Raffaele||1|||f||||f||||||||||2017-02-18 14:51:01.379018|2017-02-18 14:51:01.379018
NCT00598611|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2012-05-30|||September 2007||2007-09-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|AUD2OCU||Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)|An Exploratory Phase III, Randomised, Double-blind, Therapeutic Single Dose-related Effect, Parallel Group Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)|Completed||Phase 3|29|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 14:51:01.489066|2017-02-18 14:51:01.489066
NCT00598598|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2017-01-10|||October 2003||2003-10-01|January 2008|2008-01-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||Echocardiographic Assessment of Cardiovascular Changes in Long Term Space Flight|Echocardiographic Assessment of Cardiovascular Adaptation and Counter Measures n Microgravity|Terminated||N/A|1|Actual|The Cleveland Clinic|||1|funding issues|f||||f||||||||No||2017-02-18 14:51:04.124065|2017-02-18 14:51:04.124065
NCT00598585|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-02-23|||July 2002||2002-07-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS|Phase 4 Study of the Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With Chronic Fatigue Syndrome.|Unknown status|Recruiting|Phase 4|30|Anticipated|Charles Drew University of Medicine and Science||2|||f||||t||||||||||2017-02-18 14:51:04.209028|2017-02-18 14:51:04.209028
NCT00598572|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2017-01-17|||July 2008||2008-07-01|January 2017|2017-01-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|DFO In ICH||Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage|Safety and Tolerability of Deferoxamine in Acute Cerebral Hemorrhage|Completed||Phase 1|20|Actual|Beth Israel Deaconess Medical Center||1|||f||||t||||||||No||2017-02-18 14:51:04.311022|2017-02-18 14:51:04.311022
NCT00598338|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2008-05-28|||April 1999||1999-04-01|January 2008|2008-01-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic Constipation|A Two-Period, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of re-Treatment of Prucalopride on Efficacy and Safety in Subjects With Chronic Constipation.|Completed||Phase 3|516|Actual|Movetis||2|||f||||f||||||||||2017-02-18 14:51:08.99586|2017-02-18 14:51:08.99586
NCT00598559|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-09-08|2009-09-25||January 2008||2008-01-01|September 2016|2016-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients|A Phase III, Multi-Center, Open-Label, Prospective, Repeated Dose, Randomized, Controlled, Multi-Day Study of the Safety and Efficacy of Intravenous Acetaminophen in Adult Inpatients|Completed||Phase 3|213|Actual|Mallinckrodt|No separate efficacy analyses were performed for the fever because only 1 subject in each active group had fever as an indication, and no subject had both pain and fever as indications for treatment with IV acetaminophen.|3|||f||||f||||||||||2017-02-18 14:51:04.424259|2017-02-18 14:51:04.424259
NCT00598546|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2009-07-09|||September 2004||2004-09-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Quality of Life Among Long-Term Survivors of Resected Gastric Cancer|Quality of Life Among Long-Term Survivors of Resected Gastric Cancer|Completed||N/A|212|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||t||||||||||2017-02-18 14:51:05.045541|2017-02-18 14:51:05.045541
NCT00598533|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2012-01-03|||February 2008||2008-02-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|ISAR-TEST-5||Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis|Prospective, Randomized Trial of Rapamycin- and Zotarolimus-eluting Stents for the Reduction of Coronary Restenosis|Completed||Phase 4|3002|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 14:51:05.365864|2017-02-18 14:51:05.365864
NCT00598507|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2013-11-15|2013-09-12||May 2007||2007-05-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Participants treated with at least one dose of sagopilone.|Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma|Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma|Completed||Phase 2|35|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 14:51:05.48007|2017-02-18 14:51:05.48007
NCT00598494|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-01-26|||February 2007||2007-02-01|January 2017|2017-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Effect of Bedrest With and Without Exercise on the Heart|Effect of Bedrest With and Without Exercise on Cardiac Atrophy: Synergistic Supplemental Testing With the Cleveland Clinic Bedrest Study|Terminated||N/A|6|Actual|The Cleveland Clinic|||1|Main bedrest study moved to Texas. No enrollment at Cleveland Clinic.|f||||f|f|f||||||No||2017-02-18 14:51:05.794811|2017-02-18 14:51:05.794811
NCT00598481|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-04-21|||October 2002||2002-10-01|April 2016|2016-04-01|June 2019|Anticipated|2019-06-01|July 2011|Actual|2011-07-01||Interventional|Gene-ADA||ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID|ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID|Active, not recruiting||Phase 2|18|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 14:51:05.88424|2017-02-18 14:51:05.88424
NCT00598455|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2012-08-01|||February 2008||2008-02-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Observational|||Tuberous Sclerosis Complex Natural History Study: Renal Manifestations|Tuberous Sclerosis Complex Natural History Study: Renal Manifestations|Unknown status|Recruiting|N/A|450|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-02-18 14:51:06.000283|2017-02-18 14:51:06.000283
NCT00598442|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2013-02-06|2012-04-26||November 2007||2007-11-01|February 2013|2013-02-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|PEARL 2||Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis|AFX01-13: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Correction of Anemia in Patients With Chronic Renal Failure (CRF) Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment|Completed||Phase 3|493|Actual|Affymax||3|||f||||t||||||||||2017-02-18 14:51:06.128556|2017-02-18 14:51:06.128556
NCT00598429|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-12-08|||May 2008||2008-05-01|July 2015|2015-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|IPGE1||Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure|Randomized Clinical Trial of Inhaled PGE1 (IPGE1) in Neonatal Hypoxemic Respiratory Failure. A Protocol for the NICHD Neonatal Research Network|Withdrawn||Phase 2|0|Actual|NICHD Neonatal Research Network||3||Withdrawn due to lack of recruitment|f||||t||||||||||2017-02-18 14:51:08.003772|2017-02-18 14:51:08.003772
NCT00598416|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2014-11-03|||September 2006||2006-09-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Psychoeducation for Hepatitis and Alcohol Behaviors|Psychoeducation for HCV and Alcohol Behaviors|Completed||N/A|556|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||t||||||||||2017-02-18 14:51:08.138605|2017-02-18 14:51:08.138605
NCT00598403|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2010-06-28|||November 2007||2007-11-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis|Multicentre, Prospective, Comparative, Randomized, Double-blind, Double-dummy Study to Assess the Efficacy and Safety of Cefditoren Pivoxil vs. Ciprofloxacin in Uncomplicated Acute Cystitis|Completed||Phase 3|611|Actual|Tedec-Meiji Farma, S.A.||2|||f||||f||||||||||2017-02-18 14:51:08.251453|2017-02-18 14:51:08.251453
NCT00598390|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2017-01-24|||January 8, 2008||2008-01-08|January 22, 2013|2013-01-22|January 22, 2013|Actual|2013-01-22|January 22, 2013|Actual|2013-01-22||Interventional|||PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP|PET Test/Retest Brain Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP|Completed||Phase 1/Phase 2|19|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:51:08.398353|2017-02-18 14:51:08.398353
NCT00598377|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2009-02-17|||September 2006||2006-09-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease|Assessment of Adrenal Functions in Patients With Autosomal Dominant Polycystic Kidney Disease|Completed||N/A|49|Actual|Istanbul University||2|||f||||f||||||||||2017-02-18 14:51:08.492844|2017-02-18 14:51:08.492844
NCT00598364|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2014-12-05|||February 2007||2007-02-01|December 2014|2014-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01|13 Years|Observational [Patient Registry]|||Molecular Markers in Thyroid Cancer|Molecular Markers in the Diagnostic and Prognostic Evaluation of Thyroid Cancer|Completed||N/A|847|Actual|OHSU Knight Cancer Institute|||1||f||||f||||||||||2017-02-18 14:51:08.601365|2017-02-18 14:51:08.601365
NCT00598351|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2017-01-24|||January 8, 2008||2008-01-08|October 6, 2016|2016-10-06||||||||Observational|||Natural History Study of Patients With Neurofibromatosis Type 2|A Prospective Natural History Study of Patients With Neurofibromatosis Type 2 (NF2)|Active, not recruiting||N/A|169|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:51:08.691281|2017-02-18 14:51:08.691281
NCT00598325|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-05-08|||January 2008||2008-01-01|May 2012|2012-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Antibody and Safety Study of 6 Doses of NicVAX in Smokers|Phase 2 Single Center, Open-label Study to Assess Immunogenicity and Safety of 6 Doses of 3'-Aminomethylnicotine-P. Aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX®)in Smokers|Completed||Phase 1/Phase 2|74|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-02-18 14:51:09.098863|2017-02-18 14:51:09.098863
NCT00598312|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-09-02||2009-07-10|April 2007||2007-04-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer|A Phase 3, Open-Label, Multi-Center, Safety And Efficacy Study of Oakwood Laboratories' Leuprolide Acetate For Injectable Suspension 22.5 mg In Patients With Prostate Cancer|Completed||Phase 3|201|Actual|Oakwood Laboratories, LLC||1|||f||||f||||||||||2017-02-18 14:51:09.201906|2017-02-18 14:51:09.201906
NCT00598299|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2008-11-02|||April 2007||2007-04-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|||||Observational|||Comparison of the Effects on Promoting Corneal Epithelial Wound Healing Between Human Auto-Serum and Cord Blood Serum|Department of Ophthalmology, National Taiwan University Hospital|Completed||N/A|100|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-02-18 14:51:09.295824|2017-02-18 14:51:09.295824
NCT00598286|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2012-05-09|||January 2008||2008-01-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2|Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2|Completed||Phase 1|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:51:09.398469|2017-02-18 14:51:09.398469
NCT00598273|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2013-02-06|2012-04-26||October 2007||2007-10-01|February 2013|2013-02-01|February 2010|Actual|2010-02-01|March 2009|Actual|2009-03-01||Interventional|PEARL 1||Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis|AFX01-11: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Correction of Anemia in Patients With Chronic Renal Failure (CRF) Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment|Completed||Phase 3|490|Actual|Affymax||3|||f||||t||||||||||2017-02-18 14:51:09.500089|2017-02-18 14:51:09.500089
NCT00598260|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2011-05-09|||June 2006||2006-06-01|May 2011|2011-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Active Management Of Risk In Pregnancy At Term to Reduce Rate of Cesarean Deliveries|Active Management Of Risk In Pregnancy At Term - a Prospective Study|Terminated||N/A|222|Actual|Albert Einstein Healthcare Network||2|||f||||t||||||||||2017-02-18 14:51:11.05127|2017-02-18 14:51:11.05127
NCT00598247|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2014-02-05|||January 2008||2008-01-01|February 2014|2014-02-01|July 2011|Actual|2011-07-01|September 2008|Actual|2008-09-01||Interventional|||A Pilot Study of PPX in Women With Metastatic Colorectal Cancer|A Pilot Study of PPX (Paclitaxel Poliglumex, CT-2103) in Women With Metastatic Colorectal Cancer|Completed||Phase 1|15|Actual|University of Southern California||1|||f||||f||||||||||2017-02-18 14:51:11.154739|2017-02-18 14:51:11.154739
NCT00598234|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-06-20|||September 2006||2006-09-01|June 2010|2010-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty|Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty|Completed||Phase 4|120|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 14:51:11.260755|2017-02-18 14:51:11.260755
NCT00598208|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2015-06-01|||May 2003||2003-05-01|June 2015|2015-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)|A Phase 2, Open Label, Randomized Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or ICSI.|Completed||Phase 2|325|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 14:51:11.364392|2017-02-18 14:51:11.364392
NCT00598195|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-02-26|||June 2006||2006-06-01|February 2013|2013-02-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|||Ketamine Pharmacokinetics in Children Having Heart Surgery|Ketamine Pharmacokinetics in Children Undergoing Cardiac Surgery|Completed||N/A|18|Actual|Arkansas Children's Hospital Research Institute||1|||f||||f||||||||||2017-02-18 14:51:11.469623|2017-02-18 14:51:11.469623
NCT00598182|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-05-16|||September 2007||2007-09-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|||||Observational|||Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study|From Immediate-release MPH to OROS MPH: The Impact Upon Family of Children and Adolescents With ADHD|Completed||N/A|64|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 14:51:11.580702|2017-02-18 14:51:11.580702
NCT00598169|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2016-04-04|||November 2007||2007-11-01|April 2016|2016-04-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma|Safety and Efficacy Pilot Trial of the Anti-Viral and Anti-Tumor Activity of Velcade Combined With (R)ICE in Subjects With EBV and/or HHV-8 Positive Relapsed/Refractory AIDS-Associated Non-Hodgkin's Lymphoma|Completed||Phase 1|23|Actual|AIDS Malignancy Consortium||2|||f||||f||||||||||2017-02-18 14:51:11.826586|2017-02-18 14:51:11.826586
NCT00598156|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2013-04-19|||June 2007||2007-06-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|October 2009|Actual|2009-10-01||Interventional|ACT||Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva|Avastin and Chemotherapy Followed by Avastin Alone or in Combination With Tarceva for the Treatment of Metastatic Colorectal Cancer.|Completed||Phase 3|249|Actual|Lund University Hospital||2|||f||||t||||||||||2017-02-18 14:51:11.972364|2017-02-18 14:51:11.972364
NCT00598143|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-05-27|||February 2005||2005-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Biomarkers of Molecular Risk in Smokers|Biomarkers of Molecular Risk in Smokers|Completed||N/A|45|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     Saliva Samples~   "|||2017-02-18 14:51:12.095736|2017-02-18 14:51:12.095736
NCT00598130|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-23|2009-11-05|||February 2008||2008-02-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|Fleece||Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy|A Prospective, Randomized, Single-Blind, Standard Care Controlled, Multi-Center, Phase II Study Evaluating the Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy|Completed||Phase 2|30|Anticipated|OMRIX Biopharmaceuticals||2|||f||||t||||||||||2017-02-18 14:51:12.198938|2017-02-18 14:51:12.198938
NCT00598117|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2013-06-26|||August 2003||2003-08-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Quality Of Life Outcomes Following Treatment for Esophageal Cancer|Quality Of Life Outcomes Following Treatment for Esophageal Cancer|Completed||N/A|409|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||||||2017-02-18 14:51:12.302063|2017-02-18 14:51:12.302063
NCT00598104|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2016-03-02|||January 2008||2008-01-01|March 2016|2016-03-01||||December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma|A Randomized, Double-blinded, Placebo Controlled, Parallel Group, Multi-center Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Intravenous Doses of QAX576 in Moderate Persistent Allergic Asthmatics Following Inhaled Corticosteroid Withdrawal|Withdrawn||Phase 1/Phase 2|0|Actual|Novartis||2||"Due to the lack of enrolment and complexity of design, this study in asthma was terminated. No~   subjects have been dosed for this study."|||||f||||||||||2017-02-18 14:51:12.40658|2017-02-18 14:51:12.40658
NCT00598091|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-09-04|||April 2007||2007-04-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|June 2010|Actual|2010-06-01||Interventional|Gem/Dsat||A Phase I/Expansion Study of Dasatinib|A Phase I Study of the Combination of Gemcitabine Plus Dasatinib in Patients With Refractory Solid Tumors With an Expanded Cohort in Advanced Pancreatic Cancer|Terminated||Phase 1|30|Actual|Duke University||2||Low accrual, unable to meet endpoint in timely manner|f||||t||||||||||2017-02-18 14:51:12.501554|2017-02-18 14:51:12.501554
NCT00598078|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2011-12-15|2011-09-13||December 2007||2007-12-01|December 2011|2011-12-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor|Multiple-dose, Double-blind, Placebo-controlled, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Sodium Oxybate (Xyrem) in Subjects With Moderate to Severe Essential Tremor|Completed||Phase 2|19|Actual|Jazz Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:51:12.631399|2017-02-18 14:51:12.631399
NCT00598065|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2009-12-02|||March 2004||2004-03-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules|The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules|Completed||N/A|26|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:51:12.980327|2017-02-18 14:51:12.980327
NCT00598052|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-03-30|||December 2007||2007-12-01|January 2008|2008-01-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy|Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy- a Double-Blind Placebo-Controlled Study|Unknown status|Recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||t||||||||||2017-02-18 14:51:13.077199|2017-02-18 14:51:13.077199
NCT00598026|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-02-23|||January 2008||2008-01-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|EVATEL||"Evaluation of the  Tele-follow-up  for the Follow-up of Implantable Defibrillators"|"Evaluation of the  Tele-follow-up  for the Follow-up of Implantable Defibrillators"|Completed||N/A|1501|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-02-18 14:51:13.182738|2017-02-18 14:51:13.182738
NCT00598013|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-01-17|||November 2004||2004-11-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes|A Randomized Controlled Trial of Pioglitazone on Insulin Resistance, Insulin Secretion and Atherosclerosis in Renal Allograft Recipients Without History of Diabetes|Completed||N/A|83|Actual|Yonsei University||2|||f||||t||||||||||2017-02-18 14:51:13.31362|2017-02-18 14:51:13.31362
NCT00598000|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-04-22|||February 2005||2005-02-01|April 2015|2015-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Anatomic Lung Resection Versus Thoracotomy and Anatomic Lung Resection|Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Anatomic Lung Resection Versus Thoracotomy and Anatomic Lung Resection|Completed||N/A|216|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:51:13.418802|2017-02-18 14:51:13.418802
NCT00597987|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-09-12|||September 2004||2004-09-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||BRCA1 Haploinsufficiency and Gene Expression|BRCA1 Haploinsufficiency and Gene Expression|Completed||N/A|120|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Blood samples from cases will be collected from patients who have previously undergone~     genetic counseling through the Clinical Genetics Service at MSKCC and tested positive for a~     germline mutation in BRCA1. Blood samples from controls will be obtained from two sources.~      First from specimens already collected under IRB Protocol #99-030, entitled Collection of~     Tissue, Blood, and Cells to be Used for Studying the Causes, Prevention, Diagnosis, and~     Treatment of Breast Cancer (T. King, PI). Controls will also be collected from patients who~     have previously undergone genetic counseling through the Clinical Genetics Service at MSKCC~     and tested negative for germline mutations in BRCA1. Isolation of total RNA from blood will~     be performed using the PAXgene™ Blood RNA System. This study will use lymphocyte RNA samples~     from 50 individuals with BRCA1 mutations and 50 age-matched controls. Gene expression~     profiling will be performed in the Genomics Core Laboratory of MSKCC.~   "|||2017-02-18 14:51:13.522643|2017-02-18 14:51:13.522643
NCT00597974|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-06-02|||September 2003||2003-09-01|June 2015|2015-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|CAS||Neurological Outcome With Carotid Artery Stenting|Evaluation of Neurological Outcome in Patients Undergoing Cerebral Angiography and Revascularization Using Angioplasty and Stent-Supported Angioplasty|Completed||N/A|108|Actual|Columbia University|||2||f||||f||||||Samples With DNA|"~     plasma serum DNA (obtained via buccal samples using a buccal cell collection swab)~   "|||2017-02-18 14:51:13.61173|2017-02-18 14:51:13.61173
NCT00597961|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2016-09-19|||August 2003||2003-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Health Communication in Families|Health Communication in Families|Active, not recruiting||N/A|42|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||t||||||||||2017-02-18 14:51:13.725679|2017-02-18 14:51:13.725679
NCT00593515|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-01-03|||March 2000||2000-03-01|January 2008|2008-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Effects of Parental Behavior on Child Anxiety Regulation|Effects of Parental Behavior on Child Anxiety Regulation|Completed||Phase 2|40|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 14:52:56.507234|2017-02-18 14:52:56.507234
NCT00597948|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-02-23|||April 2007||2007-04-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|HLID||Healthy Lifestyles for People With Intellectual Disabilities|Efficacy of a Health Intervention for People With Intellectual Disabilities|Completed||N/A|131|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 14:51:13.823182|2017-02-18 14:51:13.823182
NCT00597935|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2013-09-27|||February 2008||2008-02-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|OPTIMAL||Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial|Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial: A Randomized Trial of Sacrospinous Ligament Fixation (SSLF) Versus Uterosacral Ligament Suspension (ULS) With and Without Perioperative Behavioral Therapy/Pelvic Muscle Training|Completed||Phase 3|439|Actual|NICHD Pelvic Floor Disorders Network||4|||f||||t||||||||||2017-02-18 14:51:13.920629|2017-02-18 14:51:13.920629
NCT00597922|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2014-06-26|||September 2007||2007-09-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|VIRGO||Examining Heart Attacks in Young Women|Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction (AMI) Patients (VIRGO)|Completed||N/A|2985|Actual|Yale University|||2||f||||f||||||Samples With DNA|"~     Blood specimens for biomarker analysis and storage for future genetic studies~   "|||2017-02-18 14:51:14.038149|2017-02-18 14:51:14.038149
NCT00597909|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2016-03-01|2016-02-03||December 2007||2007-12-01|March 2016|2016-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Two Doses of AMMONUL® (Sodium Phenylacetate and Sodium Benzoate) Injection 10% / 10% in Subjects With Grade 3 or 4 Hepatic Encephalopathy|Terminated||Phase 2|1|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland|One participant was enrolled but did not receive drug or was randomized.|3||Study was terminated due to lack of enrollment and business decisions.|f||||t||||||||||2017-02-18 14:51:14.320604|2017-02-18 14:51:14.320604
NCT00597896|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2015-06-10|2013-01-04||October 2005||2005-10-01|June 2015|2015-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Cognitive Enhancement in Bipolar Disorder|Cognitive Enhancement in Bipolar Disorder|Completed||Phase 4|50|Actual|Northwell Health||2|||f||||f||||||||||2017-02-18 14:51:14.611277|2017-02-18 14:51:14.611277
NCT00597883|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-02-04|||March 2003||2003-03-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|CEA||Neuropsychometric Outcome After Carotid Endarterectomy|Neurologic and Neuropsychometric Outcome in Patients Undergoing Carotid Endarterectomy|Completed||N/A|585|Actual|Columbia University|||1||f||||f||||||Samples With DNA|"~     serum plasma DNA (via buccal samples will be obtained using a buccal cell collection swab)~   "|||2017-02-18 14:51:15.21598|2017-02-18 14:51:15.21598
NCT00597870|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-09-07|||May 2002||2002-05-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions|Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions|Recruiting||N/A|200|Anticipated|Los Angeles Biomedical Research Institute||1|||f||||t||||||||||2017-02-18 14:51:15.473706|2017-02-18 14:51:15.473706
NCT00597857|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2009-01-27|||June 2005||2005-06-01|January 2009|2009-01-01|November 2009|Anticipated|2009-11-01|August 2009|Anticipated|2009-08-01||Interventional|||Prevention of Posttraumatic Stress Disorder (PTSD) With Early Hydrocortisone Treatment: Pilot|Prevention of PTSD With Early Hydrocortisone Treatment: Pilot|Unknown status|Recruiting|N/A|65|Anticipated|Kent State University||2|||f||||t||||||||||2017-02-18 14:51:15.598156|2017-02-18 14:51:15.598156
NCT00597844|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2013-09-04|||July 2005||2005-07-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Improving Functional Outcomes in Patients With Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging|Improving Functional Outcomes in Patients With Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging|Completed||N/A|20|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:51:15.718919|2017-02-18 14:51:15.718919
NCT00597831|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2010-10-25|||January 2008||2008-01-01|October 2010|2010-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Regulation of Intracerebral Pressure During Electroconvulsive Therapy|Regulation of Intracerebral Pressure During Electroconvulsive Therapy. Does Systemic Bloodpressure Reflect the Intracranial Pressure?|Completed||N/A|16|Anticipated|Rijnstate Hospital|||1||f||||f||||||||||2017-02-18 14:51:15.82568|2017-02-18 14:51:15.82568
NCT00597818|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2010-06-02|||August 2007||2007-08-01|June 2010|2010-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury|A Multi-center, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone for the Prevention of NSAID-induced Gastroduodenal Injury in Patients With Osteoarthritis and/or Rheumatoid Arthritis Patients|Completed||Phase 2|120|Anticipated|Sucampo Pharma Americas, LLC||4|||f||||f||||||||||2017-02-18 14:51:15.919426|2017-02-18 14:51:15.919426
NCT00597805|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2017-02-15|||January 2005|Actual|2005-01-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Quality of Life in Patients Undergoing Total Pelvic Exenteration|A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration|Recruiting||N/A|136|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:51:16.06915|2017-02-18 14:51:16.06915
NCT00597792|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-05-29|||August 2004||2004-08-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Registry Study of the NDO Surgical Plicator for the Treatment of GERD|Registry Study of the NDO Surgical Plicator for the Treatment of GERD|Terminated||N/A|131|Actual|NDO Surgical, Inc.||1||Sponsoring company ceased business operations|f||||f||||||||||2017-02-18 14:51:16.205929|2017-02-18 14:51:16.205929
NCT00597779|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2014-08-14|||February 2007||2007-02-01|August 2014|2014-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|EMvsIM||Randomized Comparison of 2 Fixation Techniques for Unstable Intertrochanteric Hip Fractures|Extramedullary vs. Intramedullary Devices in the Treatment of Unstable Intertrochanteric Hip Fractures|Completed||Phase 3|200|Actual|McGill University Health Center||2|||f||||f||||||||||2017-02-18 14:51:16.32118|2017-02-18 14:51:16.32118
NCT00142402|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-09-25|||June 2003||2003-06-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Modafinil in Multiple Sclerosis|Modafinil for Improving New Learning and Memory in Multiple Sclerosis|Completed||N/A|20||Kessler Foundation|||||f||||||||||||||2017-02-18 17:28:46.382211|2017-02-18 17:28:46.382211
NCT00597766|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2011-12-22|||December 2007||2007-12-01|December 2011|2011-12-01|February 2012|Anticipated|2012-02-01|February 2012|Anticipated|2012-02-01||Interventional|||Subacromial Corticosteroid Injection for Hemiplegic Shoulder Pain|Clinical Trials in Stroke Rehabilitation|Unknown status|Recruiting|Phase 2|105|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||f||||||||||2017-02-18 14:51:16.446611|2017-02-18 14:51:16.446611
NCT00597753|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2013-02-06|2012-04-26||September 2007||2007-09-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|July 2009|Actual|2009-07-01||Interventional|EMERALD 1||Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis|AFX01-12: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated With Epoetin Alfa|Completed||Phase 3|803|Actual|Affymax||2|||f||||t||||||||||2017-02-18 14:51:16.60123|2017-02-18 14:51:16.60123
NCT00597740|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2013-12-02|||December 2007||2007-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|September 2010|Actual|2010-09-01||Observational|SPIN||Propofol Sedation Study|"Clinical Utility of Propofol Sedations Without and With a Formal ICU Sedation Protocol in Intubated Neurotrauma Patients"|Completed||N/A|57|Actual|Scottsdale Healthcare|||1||f||||f||||||||||2017-02-18 14:51:18.282821|2017-02-18 14:51:18.282821
NCT00597727|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-10-20|||January 2008||2008-01-01|October 2016|2016-10-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|SLB||A Study of Sublingual Immunotherapy in Peanut-allergic Children|A Double-blinded, Placebo-controlled Study of Peanut Sublingual Immunotherapy in Children - DBPC Peanut SLIT|Completed||N/A|33|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||No||2017-02-18 14:51:18.358995|2017-02-18 14:51:18.358995
NCT00597714|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-14|2014-05-02|2014-02-05||February 2008||2008-02-01|February 2014|2014-02-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional||Participants who proceeded to therapy and transplant.|Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant|Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplantation|Completed||Phase 2|264|Actual|Duke University||3|||f||||t||||||||||2017-02-18 14:51:18.473218|2017-02-18 14:51:18.473218
NCT00597701|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2011-07-25|2011-06-29||April 2003||2003-04-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Treating Alcohol Withdrawal With Oral Baclofen|Treating Alcohol Withdrawal With Oral Baclofen: a Randomized, Double Blind, Placebo Controlled Trial|Completed||N/A|79|Actual|Essentia Health||2|||f||||f||||||||||2017-02-18 14:51:21.707188|2017-02-18 14:51:21.707188
NCT00597688|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2011-03-22|||November 2007||2007-11-01|February 2009|2009-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Role of Oral Chlorhexidine Gel in Prevention of Ventilator Associated Pneumonia|Oral Mucosal Decontamination With Chlorhexidine for Prevention of Ventilator Associated Pneumonia in Children - A Randomized Controlled Trial|Completed||Phase 3|86|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 14:51:22.287186|2017-02-18 14:51:22.287186
NCT00597675|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-06-06||2012-09-14|March 2007||2007-03-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|MIT||Mucosal Immunotherapy for Peanut Allergy|Mucosal Immunotherapy for Peanut Allergy|Completed||Phase 2|10|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 14:51:22.393503|2017-02-18 14:51:22.393503
NCT00597662|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-06-09|||January 2008||2008-01-01|June 2008|2008-06-01||||April 2008|Actual|2008-04-01||Interventional|||Safety Study of Polylactide-Caprolactone-Trimethylenecarbonate Copolymer for Post-Operative Adhesion Prophylaxis|Safety Study of Polylactide-Caprolactone-Trimethylenecarbonate Copolymer for Post-Operative Adhesion Prophylaxis|Completed||Phase 1|30|Anticipated|University Hospital Tuebingen||2|||f||||||||||||||2017-02-18 14:51:22.499374|2017-02-18 14:51:22.499374
NCT00597649|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2009-06-29|||October 2007||2007-10-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|An Open-Label 52-Week Safety Study of Bicifadine SR in Adult Outpatients With Chronic Peripheral Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|Terminated||Phase 2|250|Anticipated|XTL Biopharmaceuticals||2||The 001 trial did not show benefit versus placebo|f||||f||||||||||2017-02-18 14:51:22.600894|2017-02-18 14:51:22.600894
NCT00597636|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2016-12-16|||June 2005||2005-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Genetic Susceptibility to Lung Cancer in Never Smokers|Genetic Susceptibility to Lung Cancer in Never Smokers|Active, not recruiting||N/A|238|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     Blood~   "|||2017-02-18 14:51:22.702853|2017-02-18 14:51:22.702853
NCT00597623|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-15|2012-07-25|||January 2008||2008-01-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|DORA||Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis|Randomized Double Blind Placebo-controlled Trial of the Efficacy of an Anti-TNF Alpha Agent (Adalimumab, Humira®) in Patients With Incapacitating Hand Osteoarthritis Refractory to Usual Treatment|Completed||Phase 3|84|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:51:22.879719|2017-02-18 14:51:22.879719
NCT00597610|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-09-26|||November 2003||2003-11-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal Ultrasound|Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal Ultrasound (3-D TRUS) - A Pilot Project|Completed||N/A|84|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:51:23.159372|2017-02-18 14:51:23.159372
NCT00597597|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-12-31|||April 2007||2007-04-01|December 2012|2012-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer|A Phase II Open-Label Trial to Evaluate the Efficacy and Toxicity of Tarceva (Erlotinib) in Women With Metastatic, Hormone Receptor Negative and Her2-Negative Breast Cancer|Terminated||Phase 2|11|Actual|Rush University Medical Center||1||not enough patients enrolled|f||||t||||||||||2017-02-18 14:51:23.268711|2017-02-18 14:51:23.268711
NCT00596765|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-05-24|||September 2007||2007-09-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|October 2014|Actual|2014-10-01||Interventional|||Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury|Phase 2 Study of Neuropsychological Therapy for Patients With Acquired Brain Injury Focusing on the Role of Psychosocial Adjustment Using a Cognitive Behavioral Approach|Completed||N/A|62|Actual|Philipps University Marburg Medical Center||2|||f||||f||||||||||2017-02-18 14:51:45.832304|2017-02-18 14:51:45.832304
NCT00597584|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2013-03-06|2012-04-26||October 2007||2007-10-01|March 2013|2013-03-01|January 2010|Actual|2010-01-01|July 2009|Actual|2009-07-01||Interventional|EMERALD 2||Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis|AFX01-14: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated With Epoetin|Completed||Phase 3|823|Actual|Affymax||2|||f||||t||||||||||2017-02-18 14:51:23.407091|2017-02-18 14:51:23.407091
NCT00596505|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-16|||April 2007||2007-04-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy|Intravitreal Bevacizumab (Avastin) Pretreatment for Reducing Intraoperative and Postoperative Preretinal Hemorrhage in Primary Diabetic Vitrectomy With Silicone Oil Infusion|Completed||N/A|41|Actual|National Taiwan University Hospital|||2||f||||t||||||||||2017-02-18 14:51:25.18569|2017-02-18 14:51:25.18569
NCT00596492|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2009-02-27|||May 2008||2008-05-01|February 2009|2009-02-01|December 2008|Anticipated|2008-12-01|September 2008|Anticipated|2008-09-01||Interventional|AQNA-DY002||DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery|AQNA-DY002: A Double-Masked, Randomized Study of the Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery|Terminated||Phase 3|200|Anticipated|Aqumen Biopharmaceuticals, N.A.||2||Terminated due to reasons unrelated to safety|f||||f||||||||||2017-02-18 14:51:25.283639|2017-02-18 14:51:25.283639
NCT00596479|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2015-06-15|||November 2004||2004-11-01|June 2015|2015-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Filgrastim for the Promotion of Collateral Growth in Patients With CAD|Subcutaneous Delivery of Filgrastim (rG-CSF) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease|Completed||N/A|50|Anticipated|University Hospital Inselspital, Berne|||||f||||||||||||||2017-02-18 14:51:25.40986|2017-02-18 14:51:25.40986
NCT00596466|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2012-08-10|2012-06-22||April 2008||2008-04-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures|An Open-Label Multicenter Extension Study To Determine Long Term Safety And Efficacy Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures|Completed||Phase 3|75|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:51:25.510333|2017-02-18 14:51:25.510333
NCT00596453|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-11-28|2016-08-16||January 2008||2008-01-01|November 2016|2016-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Impact of Antibiotic Treatment on Prostate-Specific Antigen (PSA) Variability|Impact of Antibiotic Treatment on PSA Variability|Terminated||Phase 4|31|Actual|Johns Hopkins University||2||Unable to recruit enough patients|f||||f||||||||||2017-02-18 14:51:25.795022|2017-02-18 14:51:25.795022
NCT00596440|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2015-08-20|2015-05-27||August 2007||2007-08-01|August 2015|2015-08-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Observational|TM||Assessment of a Teachable Moment for Smoking Cessation|Assessment of a Teachable Moment for Smoking Cessation|Completed||N/A|234|Actual|University of Pennsylvania|||2||f||||f||||||||||2017-02-18 14:51:26.1491|2017-02-18 14:51:26.1491
NCT00596427|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2012-10-10|2012-04-19||November 2007||2007-11-01|October 2012|2012-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Mechanisms of Glucose Lowering Effect of Colesevelam HCl|Effects of Colesevelam HCl on Hepatic Insulin Sensitivity, Gluconeogenesis, Glucose Absorption and Lipid Synthesis in Subjects With Type 2 Diabetes Mellitus|Completed||N/A|60|Actual|KineMed||2|||f||||f||||||||||2017-02-18 14:51:26.68399|2017-02-18 14:51:26.68399
NCT00597571|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-04-27|||June 2003||2003-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:51:27.524186|2017-02-18 14:51:27.524186
NCT00597558|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-06|2016-04-08|2016-04-07||February 2003||2003-02-01|April 2016|2016-04-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|EggOIT||Treatment of Egg Allergy in Children Through Oral Desensitization (EGG OIT)|Treatment of Egg Allergy in Children Through Oral Desensitization (EGG OIT)|Completed||N/A|13|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||No||2017-02-18 14:51:27.575959|2017-02-18 14:51:27.575959
NCT00597545|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-06-19|2015-06-02||March 2007||2007-03-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Effect of Raised CBF During CEA on Cognition in DM Patients|Effect of Augmentation of Cerebral Blood Flow on Neuropsychometric Performance After Carotid Endarterectomy in Type II Diabetic Patients|Terminated||N/A|10|Actual|Columbia University||2||Half of DM patients had EEG changes and therefore were excluded.|f||||f||||||||||2017-02-18 14:51:27.79932|2017-02-18 14:51:27.79932
NCT00597532|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-04-12|||August 2002||2002-08-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study|Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study|Completed||N/A|140|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:51:28.182686|2017-02-18 14:51:28.182686
NCT00597519|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-01-14|2016-01-14||March 2006||2006-03-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy|A Myeloablative Conditioning Regimen Consisting of Cyclophosphamide, Fludarabine and Total Body Irradiation Followed by the Transplantation of Unrelated Donor Double Unit Umbilical Cord Blood Grafts for Patients With Hematological Malignancy.|Completed||Phase 2|28|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:51:28.284693|2017-02-18 14:51:28.284693
NCT00597506|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-12-21|2012-07-10||October 2007||2007-10-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|BEV/EV||Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus|Expanded Cohort of Patients With Refractory Metastatic Colorectal Cancer (MCRC) Treated With Bevacizumab and Everolimus|Completed||Phase 2|50|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:51:28.542654|2017-02-18 14:51:28.542654
NCT00597493|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2013-05-03|2013-05-03||September 2007||2007-09-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|February 2009|Actual|2009-02-01||Interventional|||Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM|Phase 2 Study of Sorafenib Plus Protracted Temozolomide in Recurrent Glioblastoma Multiforme|Completed||Phase 2|32|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:51:28.833847|2017-02-18 14:51:28.833847
NCT00597480|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-04-20|||January 2008||2008-01-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|SGA||Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)|Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH) by Comparison of Two Regimens of rhGH Administration to SGA Children. Pharmacogenetics of Metabolic Responses to rhGH|Terminated||Phase 4|10|Actual|Assistance Publique - Hôpitaux de Paris||2||no more inclusions|f||||t||||||||||2017-02-18 14:51:29.250338|2017-02-18 14:51:29.250338
NCT00597467|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2008-12-19|||March 2006||2006-03-01|December 2008|2008-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Soft Contact Lens Use With 7 Day Extended Wear|An Open-Labeled, Multi-Center, Randomized Investigation of the VISA (Comfilcon A) Silicone Hydrogel Soft (Hydrophilic) Contact Lens for Use in a 7 Day Extended Wear Regimen|Completed||Phase 3|455|Actual|Coopervision, Inc.||2|||f||||f||||||||||2017-02-18 14:51:29.390681|2017-02-18 14:51:29.390681
NCT00597454|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2012-07-25|||July 2004||2004-07-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery|An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery With Emphasis on the Coordination of Care Within and Between an Outpatient Screening Facility and a Diagnostic and Treatment Center|Completed||N/A|150|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:51:29.518521|2017-02-18 14:51:29.518521
NCT00597441|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2012-11-13|||November 2005||2005-11-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation|Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation|Terminated||Phase 1|6|Actual|Duke University||1||accrual of evaluable subjects too low|f||||t||||||||||2017-02-18 14:51:29.645349|2017-02-18 14:51:29.645349
NCT00597428|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-11-02|2013-11-22||August 2007||2007-08-01|November 2015|2015-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|OPAL|Baseline analysis based on ITT population, which included 212 placebo-treated subjects and 223 lubiprostone-treated subjects.|Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone|A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)|Completed||Phase 3|437|Actual|Sucampo Pharma Americas, LLC|Post-study, it was determined that lubiprostone efficacy was dose-dependently decreased with concomitant methadone use (30% higher morphine equivalent daily dose (MEDD) than parallel pivotal study NCT00595946).|2|||f||||f||||||||||2017-02-18 14:51:29.755866|2017-02-18 14:51:29.755866
NCT00597415|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-01-09|||December 2004||2004-12-01|December 2007|2007-12-01|March 2008|Anticipated|2008-03-01|February 2008|Anticipated|2008-02-01||Interventional|||Efficacy of Celecoxib 200mg in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee|A Double-Blind, Placebo-Controlled, Randomized, Crossover Pilot Study of the Efficacy of Celecoxib 200 mg QD in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee.|Unknown status|Recruiting|Phase 2|30|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-02-18 14:51:30.579711|2017-02-18 14:51:30.579711
NCT00597402|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-10|2014-04-22|2012-12-12||July 2007||2007-07-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|August 2011|Actual|2011-08-01||Interventional|||Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas|Avastin in Combination With Radiation and Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma Multiformes and Gliosarcomas|Completed||Phase 2|125|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:51:30.706562|2017-02-18 14:51:30.706562
NCT00597389|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-01-17|||February 2004||2004-02-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|November 2005|Actual|2005-11-01||Interventional|||Propranolol Administration and Prevention of Child PTSD in Child Trauma Victims|The Efficacy of Early Propranolol Administration at Preventing/Reducing PTSD Symptoms in Child Trauma Victims: Pilot.|Completed||N/A|29|Actual|Kent State University||2|||f||||t||||||||||2017-02-18 14:51:31.225073|2017-02-18 14:51:31.225073
NCT00597376|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2013-05-20|2013-01-25||November 2007||2007-11-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints|A Six-month, Double-blind, Placebo-controlled, Single Site Study of Cerefolin NAC on Blood Homocysteine, Oxidative Stress, and Beta-amyloid Biomarkers That May Potentiate Inflammation and Neuronal Damage in Older Individuals With Memory Complaints Who Have Not Been Clinically Diagnosed With Mild Cognitive Impairment, Vascular Dementia, or Alzheimer's Disease|Completed||N/A|104|Actual|Rush University Medical Center|No limitations or caveats to report.|2|||f||||f||||||||||2017-02-18 14:51:31.339019|2017-02-18 14:51:31.339019
NCT00597363|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-01-17|||January 2006||2006-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Interventional|||Neptune Pad ® Compared to Conventional Manual Compression|Neptune Pad ® Compared to Conventional Manual Compression for Access Site Management After Peripheral Percutaneous Transluminal Procedures|Completed||N/A|201|Actual|Vienna General Hospital||2|||f||||t||||||||||2017-02-18 14:51:31.926003|2017-02-18 14:51:31.926003
NCT00597350|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2015-12-17|||November 2007||2007-11-01|December 2015|2015-12-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Observational|Fenugreek||Effect of Fenugreek on Blood Sugar and Insulin in Diabetic Humans|Pilot Study of the Effect of Fenugreek on Blood Sugar and Insulin in Diabetic Humans|Completed||N/A|8|Actual|Pennington Biomedical Research Center|||1||f||||f||||||Samples Without DNA|"~     Whole blood drawn for glucose and insulin levels.~   "|||2017-02-18 14:51:32.028715|2017-02-18 14:51:32.028715
NCT00597337|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-12-17|||November 2007||2007-11-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effectiveness of the FearNot!v.2.0 Software in Reducing Bullying Victimisation Among Primary School Children|Using a Virtual Learning Environment to Reduce Bullying: Evaluation of the FearNot!v.2.0 Intervention in Primary Schools in England and Germany|Completed||N/A|1129|Actual|University of Warwick||2|||f||||f||||||||||2017-02-18 14:51:32.143586|2017-02-18 14:51:32.143586
NCT00597324|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-10-26|||October 2007||2007-10-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|June 2009|Actual|2009-06-01||Interventional|RADAR||Predictive Value of Allen's Test Result in Elective Patients Undergoing Coronary Catheterization Through Radial Approach|Should Intervention Through RADial Approach be Denied to Patients With Negative Allen's Test Results?|Completed||Phase 3|203|Actual|Università degli Studi di Ferrara||3|||f||||t||||||||||2017-02-18 14:51:32.259152|2017-02-18 14:51:32.259152
NCT00597311|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-01-09|||January 2007||2007-01-01|January 2008|2008-01-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer|Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer|Unknown status|Recruiting|Phase 3|150|Anticipated|Kaunas University of Medicine||2|||f||||f||||||||||2017-02-18 14:51:32.365697|2017-02-18 14:51:32.365697
NCT00597298|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2009-02-03|||January 2008||2008-01-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|DIATRACS||Diaphragm Training Post-Cardiac Surgery|Randomized Controlled Trial on the Diaphragm Training With Threshold for Patient With Post-Cardiac Surgery Diaphragmatic Paralysis|Completed||N/A|48|Actual|Ospedali Riuniti Trieste||2|||f||||f||||||||||2017-02-18 14:51:32.464202|2017-02-18 14:51:32.464202
NCT00597285|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2017-01-24|||January 3, 2008||2008-01-03|November 1, 2013|2013-11-01|November 1, 2013||2013-11-01|||||Observational|||Relationship of HHV-6B Virus to Seizures and Brain Injury|HHV6B in Epilepsy Imaging and CSF Studies|Terminated||N/A|33|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:51:32.593192|2017-02-18 14:51:32.593192
NCT00597272|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-08-10|2015-10-20||December 2007||2007-12-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma|Pilot Trials With a KLH Conjugated Bivalent GangliosideVaccine Mixed With Immunological Adjuvants QS-DG or OPT-821in Patients With Disease Free AJCC Stage III or IV|Completed||N/A|34|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:51:32.72001|2017-02-18 14:51:32.72001
NCT00597259|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2010-06-28|||January 2008||2008-01-01|June 2010|2010-06-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B|Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B|Unknown status|Recruiting|Phase 4|294|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 14:51:33.600873|2017-02-18 14:51:33.600873
NCT00597246|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2016-06-17|||May 2003||2003-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Imaging Brain Tumors With FACBC and Methionine|Imaging Brain Tumors With FACBC and Methionine|Active, not recruiting||N/A|30|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:51:33.712811|2017-02-18 14:51:33.712811
NCT00597233|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2016-12-20|||October 2002||2002-10-01|December 2016|2016-12-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Human Insulin NPH and Insulin Aspart in Type 1 Diabetes|Comparative Evaluation of Human NPH Insulin + Insulin Aspart and Human NPH Insulin + Human Soluble Insulin in Type 1 Diabetes Mellitus|Completed||Phase 4|91|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:51:33.825688|2017-02-18 14:51:33.825688
NCT00597220|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2011-06-21|||January 2008||2008-01-01|June 2011|2011-06-01|August 2011|Anticipated|2011-08-01|July 2011|Anticipated|2011-07-01||Interventional|FORWARD||Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation|Randomized, Prospective, Placebo-controlled, Multi-center Study to Test the Efficacy of n-3 PUFA for the Maintenance of Normal Sinus Rhythm in Patients With Persistent Atrial Fibrillation|Unknown status|Active, not recruiting|Phase 3|1600|Anticipated|Fundacion GESICA||2|||f||||t||||||||||2017-02-18 14:51:33.923283|2017-02-18 14:51:33.923283
NCT00597207|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2014-04-11|2014-03-08||January 2008||2008-01-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|February 2011|Actual|2011-02-01||Interventional|CIRC||Circulation Improving Resuscitation Care (CIRC)|A Randomized Controlled Study Comparing Autopulse To Manual CPR In A CPR-First Protocol For Out-Of-Hospital Cardiac Arrest|Completed||N/A|4231|Actual|Zoll Medical Corporation||2|||f||||t||||||||||2017-02-18 14:51:34.036963|2017-02-18 14:51:34.036963
NCT00597194|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-16|||October 2002||2002-10-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Day Case Inguinal Hernia Repair in Children. Is Laparoscopic Approach Justified?|Day Case Inguinal Hernia Repair in Children. Is Laparoscopic Approach Justified?|Completed||N/A|89|Actual|Hospital for Children and Adolescents, Finland||2|||f||||f||||||||||2017-02-18 14:51:34.375292|2017-02-18 14:51:34.375292
NCT00597181|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2010-09-16|||November 2007||2007-11-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|January 2009|Actual|2009-01-01||Interventional|Optonol||A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy|A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open-Angle Glaucoma|Terminated||Phase 4|40|Anticipated|Indiana University||2||Patient population limited|f||||f||||||||||2017-02-18 14:51:34.478981|2017-02-18 14:51:34.478981
NCT00597168|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2010-06-08|||October 2007||2007-10-01|June 2010|2010-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|Quality||Quality of Life in Schizophrenic Patients|QUALITY: A Non-interventional Study Evaluating Quality Of Life in Schizophrenic Patients Treated With Atypical Antipsychotics, in the Ambulatory Setting. A 9-month, Observational, Multicentric Prospective Study.|Completed||N/A|124|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:51:34.648222|2017-02-18 14:51:34.648222
NCT00597142|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2014-11-20|||January 2004||2004-01-01|November 2014|2014-11-01|October 2009|Actual|2009-10-01|July 2005|Actual|2005-07-01||Interventional|RENAISSANCE||A Prospective, Multi-center, Single Arm Study Evaluating the Express™ Renal Premounted Stent System in the Treatment of Atherosclerotic Lesions in the Aortorenal Ostium.|A Prospective, Multi-center, Single Arm Study Evaluating the Express™ Renal Premounted Stent System in the Treatment of Atherosclerotic Lesions in the Aortorenal Ostium.|Completed||Phase 4|100|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-02-18 14:51:34.950827|2017-02-18 14:51:34.950827
NCT00597129|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-08|||August 2004||2004-08-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy Study of 90Y-hPAM4 at Different Doses|A Phase I, Dose-Escalating Study to Investigate the Safety, Tolerability, Pharmacokinetics and Dosimetry of a Single Dose of 90YHumanized PAM4 IgG in Patients With Locally Advanced/Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|21|Actual|Immunomedics, Inc.||1|||f||||f||||||||||2017-02-18 14:51:35.079895|2017-02-18 14:51:35.079895
NCT00595478|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-08-18|||August 2007||2007-08-01|August 2014|2014-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Family Based Contingency Management for Adolescent Alcohol Abuse|Family Based Contingency Management for Adolescent Alcohol Abuse|Completed||N/A|120|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 14:52:03.264989|2017-02-18 14:52:03.264989
NCT00597116|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2016-08-29|2011-04-27||December 2007||2007-12-01|August 2016|2016-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma|A Randomized Phase II Trial To Evaluate The Efficacy And Safety Of Vandetanib (ZD6474, ZACTIMA ™) Versus Vinorelbine In Patients With Inoperable Or Relapsed Malignant Mesothelioma.|Terminated||Phase 2|25|Actual|Sanofi|Early termination leading to small number of subjects analyzed.|2||Recruitment stopped according to early stopping rule (by protocol)|f||||f||||||||||2017-02-18 14:51:35.214945|2017-02-18 14:51:35.214945
NCT00597103|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-08|||December 2007||2007-12-01|December 2007|2007-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Comparison of Dialysis Therapies on Cognitive Function|Comparison of Dialysis Therapies on Cognitive Function|Unknown status|Recruiting|N/A|100|Anticipated|Satellite Healthcare|||3||f||||f||||||||||2017-02-18 14:51:35.776813|2017-02-18 14:51:35.776813
NCT00597090|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2011-01-19|||February 2003||2003-02-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections|The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections|Completed||N/A|319|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples With DNA|"~     We will genotype the genes of innate immune receptors to identify genetic polymorphisms~     associated with higher frequency of invasive infections or susceptibility to lymphoma. All~     specimens will be processed in the Infectious Diseases Laboratory at MSKCC. RNA will be~     extracted from peripheral blood mononuclear cells (PBMCs). Genotyping will be done from~     genomic DNA or from cDNA generated from RNA by RT-PCR. Cell lines will be created from PBMCs~     and will be analyzed in functional assays for responses to bacterial and fungal products~     (cytokine secretion, upregulation of cell surface molecules). All patient samples including~     genomic DNA, RNA, cDNA and cell lines will be banked in the Infectious Disease laboratory at~     MSKCC.~   "|||2017-02-18 14:51:35.881345|2017-02-18 14:51:35.881345
NCT00597077|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-02-01|||April 2001||2001-04-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|June 2007|Actual|2007-06-01||Interventional|||Atrial Fibrillation and Congestive Heart Failure Trial|Atrial Fibrillation and Congestive Heart Failure (AF-CHF)Trial|Completed||Phase 4|1376|Actual|Montreal Heart Institute||2|||f||||t||||||||||2017-02-18 14:51:35.993822|2017-02-18 14:51:35.993822
NCT00597064|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-16|||July 2006||2006-07-01|November 2007|2007-11-01|March 2008|Anticipated|2008-03-01|March 2008|Anticipated|2008-03-01||Interventional|APITA||Inflammatory, Functional and Image Composite Measure to Define Asthma Control|Inflammatory, Functional and Image Composite Measure to Define Asthma Control|Unknown status|Recruiting|Phase 4|70|Anticipated|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 14:51:36.104889|2017-02-18 14:51:36.104889
NCT00597051|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-16|||October 2005||2005-10-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|ARD-0403-001||Study of 3 Doses of ARD-0403 in Testosterone Deficient Men|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Multi-Centre Study of the Pharmacokinetics and Tolerability of 3 Different Doses of ARD-0403 in Testosterone Deficient Men|Completed||Phase 2|42|Actual|Ardana Bioscience Ltd|||||f||||f||||||||||2017-02-18 14:51:36.216292|2017-02-18 14:51:36.216292
NCT00597038|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2013-11-21|2012-05-22||November 2007||2007-11-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Phase I/II Study of Dasatinib and Dacarbazine|A Phase I/II Study of Dasatinib and Dacarbazine in Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|50|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-02-18 14:51:36.318533|2017-02-18 14:51:36.318533
NCT00597025|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-08|||December 2007||2007-12-01|December 2007|2007-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin|Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin|Unknown status|Recruiting|N/A|375|Anticipated|Satellite Healthcare||5|||f||||f||||||||||2017-02-18 14:51:36.887269|2017-02-18 14:51:36.887269
NCT00597012|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-01-11|2013-08-02||May 2008||2008-05-01|January 2016|2016-01-01|August 2016|Anticipated|2016-08-01|February 2012|Actual|2012-02-01||Interventional||Analysis was completed on the 330 active participants in the study at 6 months.|Comparing Knee Cartilage Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis|Partial Meniscectomy Versus Nonoperative Management in Meniscal Tear With OA: A Randomized Controlled Trial (MeTeOR)|Active, not recruiting||Phase 2|351|Actual|Brigham and Women's Hospital|Surgical randomized controlled trials present methodological challenges, including crossover from one group to the other.|2|||f||||t||||||||||2017-02-18 14:51:37.000896|2017-02-18 14:51:37.000896
NCT00596999|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2012-04-09|||May 2007||2007-05-01|November 2007|2007-11-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Observational|HPDSC||A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders|A Single-Arm Study to Assess the Safety of Transplantation With Umbilical Cord Blood Augmented With Human Placental-Derived Stem Cells From Partially Matched Related Donors in Subjects With Certain Malignant Hematologic Diseases and Non-Malignant Disorders|Unknown status|Enrolling by invitation|Phase 1|6|Anticipated|Celgene|||1||f||||t||||||||||2017-02-18 14:51:37.648727|2017-02-18 14:51:37.648727
NCT00596986|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2009-07-31|||October 2008||2008-10-01|July 2009|2009-07-01||||September 2009|Anticipated|2009-09-01||Interventional|GETTY||Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic Depression|Impact of Therapeutical Strategies on Emotional Processing in Depression: Neurofunctional and Clinical Issues in the Context of Affective Bias|Unknown status|Active, not recruiting|N/A|30|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-02-18 14:51:37.73781|2017-02-18 14:51:37.73781
NCT00596973|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2014-11-14|||January 2008||2008-01-01|November 2014|2014-11-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients|Phase IV Study of Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients|Withdrawn||Phase 4|0|Actual|Medtronic - MITG||1||Business Reasons|f||||t||||||||||2017-02-18 14:51:37.861821|2017-02-18 14:51:37.861821
NCT00596960|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2014-11-26|2014-11-12||November 2008||2008-11-01|November 2014|2014-11-01|July 2012|Actual|2012-07-01|June 2012|Actual|2012-06-01||Interventional|||Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients|Motivating Chronic Hepatitis C Patients to Reduce Alcohol Use|Completed||N/A|139|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:51:37.957512|2017-02-18 14:51:37.957512
NCT00596947|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2011-02-18|2011-02-18||October 2005||2005-10-01|February 2011|2011-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant|Randomized, Prospective Single-center Study Comparing a Rapid Discontinuation of Corticosteroids (Steroid Withdrawal) With Corticosteroid Therapy in Kidney Transplantation Using Mycophenolate Mofetil and Tacrolimus Maintenance Therapy|Terminated||Phase 4|18|Actual|University of Pennsylvania|The trial was terminated early due to low enrollment. Therefore no results beyond basic results section are reported due to uninterpretable data.|2||due to low study enrollment|f||||f||||||||||2017-02-18 14:51:38.579024|2017-02-18 14:51:38.579024
NCT00596934|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-10-17|2016-08-22||February 2006||2006-02-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)|Nonalcoholic Steatohepatitis: is Leptin an Etiological Factor (Phase 2).|Completed||Phase 2|9|Actual|University of Michigan|This is a non-blinded, non-placebo controlled proof of concept trial. Out of the 9 patients, there were 7 completers.|1|||f||||f||||||||Undecided||2017-02-18 14:51:39.29985|2017-02-18 14:51:39.29985
NCT00596921|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-16||||||January 2008|2008-01-01||||||||Observational|||Bedside Ultrasound Measurement of the Inferior Vena Cava Correlates to Central Venous Pressure|Bedside Ultrasound Measurement of the Inferior Vena Cava Correlates to Central Venous Pressure|Unknown status|Not yet recruiting|N/A|100|Anticipated|Brooke Army Medical Center|||1||f||||f||||||||||2017-02-18 14:51:42.214323|2017-02-18 14:51:42.214323
NCT00596908|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2009-05-28|||December 2007||2007-12-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|||||Observational|AIM||123I-ALTROPANE® Reference Image Acquisition in Subjects With Diagnostically Uncertain Tremor|123I-ALTROPANE® Reference Image Acquisition in Subjects With Diagnostically Uncertain Tremor (AIM)|Completed||N/A|54|Actual|Alseres Pharmaceuticals, Inc|||2||f||||f||||||Samples Without DNA|"~     2 blood draws and 2 urine collections per subject.~   "|||2017-02-18 14:51:42.294699|2017-02-18 14:51:42.294699
NCT00596895|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2011-09-16|||November 2003||2003-11-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer|Phase II Trial of Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer After Previous Local Therapy.|Completed||Phase 2|20|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 14:51:42.393823|2017-02-18 14:51:42.393823
NCT00596882|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2009-12-01|||February 2008||2008-02-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study|Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study|Completed||Phase 4|100|Anticipated|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 14:51:42.503691|2017-02-18 14:51:42.503691
NCT00596856|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2013-03-15|||April 2011||2011-04-01|March 2013|2013-03-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|PORRT||Development and Dissemination of Oral Health Risk Assessment and Referral Guidelines|Development and Dissemination of Oral Health Risk Assessment and Referral Guidelines - PORRT|Withdrawn||N/A|0|Actual|University of North Carolina, Chapel Hill||3||"Published study provided evidence that intervention would provide little effect; study not~   approved by provider community."|f||||f||||||||||2017-02-18 14:51:42.600658|2017-02-18 14:51:42.600658
NCT00596843|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-11-13|||September 2003||2003-09-01|November 2008|2008-11-01|February 2008|Anticipated|2008-02-01|November 2006|Actual|2006-11-01||Interventional|||Chronic Hepatitis Intervention Project for Drug Users|Chronic Hepatitis Intervention Project for Drug Users|Unknown status|Active, not recruiting|Phase 3|851|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 14:51:42.700259|2017-02-18 14:51:42.700259
NCT00596830|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-12-11|2013-09-25||April 2008||2008-04-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|March 2011|Actual|2011-03-01||Interventional|||Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology|Randomized, Open Label, Phase III Trial Of CP- 751,871 In Combination With Paclitaxel And Carboplatin Versus Paclitaxel And Carboplatin In Patients With Non Small Cell Lung Cancer|Terminated||Phase 3|681|Actual|Pfizer|The study was terminated early due to futility. CP-751,871 will not undergo further development in the indication of advanced non-adenocarcinoma non-small cell lung cancer (NSCLC).|2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 14:51:43.036762|2017-02-18 14:51:43.036762
NCT00596817|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2014-02-13|2013-10-28||December 2007||2007-12-01|February 2014|2014-02-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional||"The total number of patients under Baseline Measures is not 1035 as automatically calculated, but 639 as stated in the Open-label Period (APTS) column and 396 in the “Double-blind Period (FAS)”.~The Total column of each Baseline Measure is Double-blind Period (FAS)."|Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes|A Double-blind, Randomised, Placebo-controlled, Multicentre, Relapse-prevention Study With Two Doses of [Vortioxetine] Lu AA21004 in Patients With Major Depressive Disorder|Completed||Phase 3|639|Actual|H. Lundbeck A/S||2|||f||||f||||||||||2017-02-18 14:51:44.518654|2017-02-18 14:51:44.518654
NCT00596804|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2012-02-02|||March 2004||2004-03-01|February 2012|2012-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma|A Phase I Study of Immunotherapy With hA20 Administered Once Weekly for 4 Consecutive Weeks in Patients With CD20+ Non- Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|39|Actual|Immunomedics, Inc.||1|||f||||f||||||||||2017-02-18 14:51:45.555489|2017-02-18 14:51:45.555489
NCT00596791|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2009-01-09|||January 2008||2008-01-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops|Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops|Completed||Phase 3|150|Anticipated|Santen Oy||1|||f||||f||||||||||2017-02-18 14:51:45.659667|2017-02-18 14:51:45.659667
NCT00596778|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-16|||February 2004||2004-02-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Chest Physiotherapy on Immediate Postoperative in Patients Submitted to High Abdominal Surgery|Chest Physiotherapy on Immediate Postoperative in Patients Submitted to High Abdominal Surgery|Terminated||N/A|31|Actual|University of Sao Paulo||1||terminated|f||||f||||||||||2017-02-18 14:51:45.750436|2017-02-18 14:51:45.750436
NCT00004333|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1994||1994-11-01|July 2000|2000-07-01||||||||Interventional|||Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I||Completed||Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:50.660586|2017-02-18 18:16:50.660586
NCT00596752|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-02-26|2014-05-05||March 2004||2004-03-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|May 2013|Actual|2013-05-01||Interventional|ESPECIAL|Baseline Characteristics refer to the Safety Set including all randomized subjects who received at least one dose of trial medication. Subjects were analyzed according to the actual treatment received. 4 PBO subjects were treated with Alprostadil, 3 Alprostadil subjects were treated with PBO.1 PBO subject withdrew prior to start of study treatment.|Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV|Multinational, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Assess the Efficacy and Safety of Prostaglandin E1 in Subjects With Critical Limb Ischemia (Fontaine Stage IV)|Completed||Phase 4|840|Actual|UCB Pharma||2|||f||||t||||||||||2017-02-18 14:51:45.952473|2017-02-18 14:51:45.952473
NCT00596739|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-08-15|||November 2007||2007-11-01|August 2016|2016-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||A Study of the Pre- and Post-operative Semen Analyses and Reproductive Hormone Levels of Men Undergoing Weight-reduction Surgery|Weight Loss Surgery and Male Fertility|Completed||N/A|60|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"~     Blood and Sperm~   "|||2017-02-18 14:51:46.869405|2017-02-18 14:51:46.869405
NCT00596726|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2010-05-25|||August 2006||2006-08-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|RECOVER I||RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study|RECOVER I: IMPELLA® RECOVER® LP/LD 5.0 Support System: A Clinical Safety & Feasibility Study|Completed||Phase 2|17|Actual|Abiomed Inc.||1|||f||||f||||||||||2017-02-18 14:51:46.954569|2017-02-18 14:51:46.954569
NCT00596713|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2012-07-11|||June 2007||2007-06-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Epidemiology of Sleep Disturbances Among the Adult Population of the Sao Paulo City|Epidemiology of Sleep Disturbances Among the Adult Population of the Sao Paulo City|Completed||N/A|1100|Actual|Associação Fundo de Incentivo à Pesquisa|||1||f||||t||||||||||2017-02-18 14:51:47.057312|2017-02-18 14:51:47.057312
NCT00596700|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2014-04-28|||January 2007||2007-01-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Capsule Endoscopy Crohn's Disease Activity Index - Validation Multi Center Study|Capsule Endoscopy Crohn's Disease Activity Index - Validation Multi Center Study|Completed||Phase 3|100|Anticipated|Rabin Medical Center||1|||f||||t||||||||||2017-02-18 14:51:47.141596|2017-02-18 14:51:47.141596
NCT00596687|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2014-02-07|2013-07-09||December 2007||2007-12-01|February 2014|2014-02-01|July 2013|Actual|2013-07-01|December 2009|Actual|2009-12-01||Interventional|RABBIT 2-SX||Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery|RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)|Completed||Phase 4|234|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:51:47.467743|2017-02-18 14:51:47.467743
NCT00596674|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2012-04-24|||July 2003||2003-07-01|April 2012|2012-04-01|May 2008|Actual|2008-05-01|January 2007|Actual|2007-01-01||Interventional|||Health Promotion for Women With Fibromyalgia|Health Promotion for Women With Fibromyalgia|Completed||N/A|177|Actual|University of Texas at Austin||2|||f||||f||||||||||2017-02-18 14:51:47.857008|2017-02-18 14:51:47.857008
NCT00596661|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2008-10-10|||May 2004||2004-05-01|October 2008|2008-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||The TRIMAXX Coronary Stent Trial|A Prospective, Multi-Center, Non-Randomized, Single-Arm Trial to Evaluate the Safety and Feasibility of the TriMaxx Coronary Stent in de Novo Coronary Artery Lesions.|Completed||Phase 1|100|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 14:51:47.956727|2017-02-18 14:51:47.956727
NCT00596648|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2013-09-17|||December 2007||2007-12-01|September 2013|2013-09-01||||August 2012|Actual|2012-08-01||Interventional|||A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer|A Phase 1b/2 Study of XL184 With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|92|Actual|Exelixis||3|||f||||||||||||||2017-02-18 14:51:48.073428|2017-02-18 14:51:48.073428
NCT00596635|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2013-03-19|2010-06-30||January 2007||2007-01-01|March 2013|2013-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|PACS||Cranberry for UTI Prevention in Residents of Long Term Care Facilities|Cranberry for UTI Prevention in Residents of Long Term Care Facilities|Completed||N/A|56|Actual|Yale University|The inability to follow all participants for the full six months reflects the vulnerability of the population.|3|||f||||f||||||||||2017-02-18 14:51:48.185253|2017-02-18 14:51:48.185253
NCT00596622|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-08-23|2016-07-08||August 2007||2007-08-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|January 2012|Actual|2012-01-01||Interventional|||FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder|Dysfunctional Cortico-Limbic Activity and Connectivity in Bipolar Disorder Before and After Lithium Treatment: An fMRI Study|Completed||Phase 4|46|Actual|Indiana University|Small number of subjects|3|||f||||f||||||||No||2017-02-18 14:51:48.719682|2017-02-18 14:51:48.719682
NCT00596609|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2009-09-14|||August 2007||2007-08-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|EIM||Intrathecal Morphine on Transcranial Electric Motor-Evoked Potentials|Effects of Intrathecal Morphine on Transcranial Electric Motor-Evoked Potentials in Patients Undergoing Posterior Spine Fusion|Completed||N/A|36|Actual|Children's Hospital of Philadelphia|||2||f||||f||||||||||2017-02-18 14:51:49.098661|2017-02-18 14:51:49.098661
NCT00596596|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-05-28|||September 1996||1996-09-01|January 2008|2008-01-01|June 1997|Actual|1997-06-01|June 1997|Actual|1997-06-01||Interventional|||Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation|A Double-Blind, Placebo-Controlled, Dose-Finding Trial to Evaluate the Efficacy and Safety of Prucalopride (R093877) in Subjects With Chronic Idiopathic Constipation|Completed||Phase 2|313|Actual|Movetis||5|||f||||f||||||||||2017-02-18 14:51:49.207312|2017-02-18 14:51:49.207312
NCT00596583|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-09|2009-02-27|||April 2007||2007-04-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery|AQNA-DY001: A Double-Masked, Randomized Study of the Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery|Completed||Phase 3|300|Anticipated|Aqumen Biopharmaceuticals, N.A.||2|||f||||f||||||||||2017-02-18 14:51:49.31702|2017-02-18 14:51:49.31702
NCT00596570|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2010-06-29|||January 2007||2007-01-01|December 2007|2007-12-01|February 2010|Actual|2010-02-01|||||Observational|AFCAS||Management of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting|Management of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: A Multicenter, Prospective Registry|Completed||N/A|996|Actual|University of Turku|||1||f||||f||||||Samples Without DNA|"~     Anticoagulation samples~   "|||2017-02-18 14:51:49.437312|2017-02-18 14:51:49.437312
NCT00596557|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2011-07-28|||February 2008||2008-02-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|February 2009|Actual|2009-02-01||Interventional|CRAD001AILO2||Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up|Phase IV: Effect of Everolimus and CNI Minimalization on Renal Function.|Completed||Phase 4|20|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-02-18 14:51:49.534462|2017-02-18 14:51:49.534462
NCT00596544|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2015-11-25|||November 2004||2004-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Sexual Functioning After Primary Treatment of Ovarian Cancer|Sexual Functioning After Primary Treatment of Ovarian Cancer|Terminated||N/A|18|Actual|Memorial Sloan Kettering Cancer Center|||2|Lack of accrual|f||||||||||||||2017-02-18 14:51:49.642324|2017-02-18 14:51:49.642324
NCT00596531|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-11-07|||January 2008||2008-01-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Clinical Trial of Acamprosate for Tinnitus|Clinical Trial of Acamprosate for Tinnitus|Completed||Phase 1|154|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:51:49.750589|2017-02-18 14:51:49.750589
NCT00596518|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2010-06-10|||October 2007||2007-10-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function|A Phase 1, Open-Label Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of PF-00734200 Administered To Subjects With Various Degrees Of Renal Impairment And Normal Renal Function|Completed||Phase 1|30|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 14:51:49.869187|2017-02-18 14:51:49.869187
NCT00596414|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-16|||May 2003||2003-05-01|December 2007|2007-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial|Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial|Completed||Phase 4|180|Actual|Erasme University Hospital||3|||f||||t||||||||||2017-02-18 14:51:49.977576|2017-02-18 14:51:49.977576
NCT00596401|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-04-17|||September 2007||2007-09-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer|The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town|Active, not recruiting||N/A|3000|Actual|Showa Inan General Hospital|||3||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 14:51:50.087139|2017-02-18 14:51:50.087139
NCT00596388|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2013-05-14|||March 2008||2008-03-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Observational|HMP||Usage of the Home Macular Perimeter (HMP)|Usage of the Home Macular Perimeter (HMP) in Intermediate Age Related Macular Degeneration Patients Pilot Study|Completed||N/A|20|Actual|Notal Vision Ltd|||1||f||||f||||||||||2017-02-18 14:51:50.166232|2017-02-18 14:51:50.166232
NCT00596375|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2008-01-16|||August 2006||2006-08-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Lidocaine Lubricant in Pediatric Urethral Catheterization|Lidocaine Lubricant Use as an Anesthetic Agent in Emergency Room Urethral Catheterization|Completed||N/A|47|Actual|Children's Healthcare of Atlanta||3|||f||||f||||||||||2017-02-18 14:51:50.26978|2017-02-18 14:51:50.26978
NCT00596362|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2016-05-16|2015-03-31||April 2007||2007-04-01|May 2016|2016-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Treatment With Intravitreal Avastin for Large Uveal Melanomas|Neoadjuvant Treatment With Intravitreal Avastin for Large Uveal Melanomas|Completed||N/A|1|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:51:50.379106|2017-02-18 14:51:50.379106
NCT00596349|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2009-02-25|||November 2004||2004-11-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Women Surviving Ovarian Cancer|Quality of Life in Women Surviving Ovarian Cancer|Completed||N/A|62|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 14:51:50.607561|2017-02-18 14:51:50.607561
NCT00596336|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-08|2012-11-29|||October 2007||2007-10-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|CLLIFVAC||Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients|A Randomized Phase II Trial to Determine Whether the Application of Imiquimod Cream to the Vaccination Site Can Improve the Immune Responsiveness to Influenza Vaccination in Patients With Untreated Chronic Lymphocytic Leukemia|Unknown status|Active, not recruiting|Phase 2|102|Anticipated|The Royal Bournemouth Hospital||3|||f||||f||||||||||2017-02-18 14:51:50.698326|2017-02-18 14:51:50.698326
NCT00596323|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2009-12-01|||June 2007||2007-06-01|December 2009|2009-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Implantable Antenna Sensors for Continuous Glucose Monitoring|Implantable Antenna Sensors for Continuous Glucose Monitoring|Completed||N/A|10|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 14:51:50.802403|2017-02-18 14:51:50.802403
NCT00596310|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2017-01-07|||November 2004||2004-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2016|Actual|2016-12-01||Interventional|||Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning|Early Detection of Lung Cancer in a High-Risk Population Defined by Pulmonary Function Testing, Biomarkers, and Computerized Tomography Scanning|Active, not recruiting||N/A|1000|Anticipated|University of Kentucky||1|||f||||f||||||||||2017-02-18 14:51:50.886444|2017-02-18 14:51:50.886444
NCT00596297|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-10-02|||November 2007||2007-11-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|IBEVI||Preoperative Bevacizumab for Vitreous Hemorrhage|Intra-Operative and Postoperative Intraocular Bleeding After Pars Plana Vitrectomy for Vitreous Hemorrhage in Diabetic Patients Previously Treated With Intravitreal Bevacizumab|Completed||Phase 1/Phase 2|16|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 14:51:50.986208|2017-02-18 14:51:50.986208
NCT00596284|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-08-12|||January 2008||2008-01-01|August 2015|2015-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Cognitive Behavior Therapy for Treating Anxiety in People With Dementia|Cognitive Behavior Therapy for Anxiety in Dementia|Completed||Phase 1|34|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 14:51:51.092899|2017-02-18 14:51:51.092899
NCT00596271|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-04-09|2013-11-12||September 2005||2005-09-01|April 2014|2014-04-01|August 2008|Actual|2008-08-01|July 2006|Actual|2006-07-01||Interventional|||Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440|Safety and Immunogenicity of Concomitant Vaccination With IC51 and HARVIX® 1440 in Healthy Subjects. A Single-blind Randomized, Controlled Phase 3 Study|Completed||Phase 3|192|Actual|Valneva Austria GmbH||3|||f||||f||||||||||2017-02-18 14:51:51.408631|2017-02-18 14:51:51.408631
NCT00596258|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2009-05-21|||November 2007||2007-11-01|May 2009|2009-05-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|TG-003||A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)|A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix|Completed||Phase 2|11|Actual|Tigris Pharmaceuticals||1|||f||||f||||||||||2017-02-18 14:51:51.916544|2017-02-18 14:51:51.916544
NCT00596245|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-04-14|||October 2007||2007-10-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets|Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets Administered Two Hours Apart on Chromosomal Aberrations in Peripheral Blood Lymphocytes|Completed||Phase 1|42|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-02-18 14:51:52.040413|2017-02-18 14:51:52.040413
NCT00596232|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-04-28|||April 2003||2003-04-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|December 2015|Actual|2015-12-01||Observational|Mucinase||Investigating Mucinase Activity in Airway Disease|Investigating Mucinase Activity in Airway Disease|Completed||N/A|211|Actual|University of California, San Francisco|||3||f||||f||||||Samples Without DNA|"~     Sputum~   "|||2017-02-18 14:51:52.161654|2017-02-18 14:51:52.161654
NCT00596219|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-12-21|||December 2003||2003-12-01|December 2015|2015-12-01|October 2010|Actual|2010-10-01|October 2006|Actual|2006-10-01||Interventional|||Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma|Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma|Completed||N/A|12|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:51:52.261294|2017-02-18 14:51:52.261294
NCT00596206|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2010-10-11|||December 2007||2007-12-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|LEADER||Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis|Assessment of the Early Efficacy Response Rate of Leflunomide According to the Initial Dosing Regimen in the Treatment of Naive-DMARD (Disease Modifying Anti-Rheumatic Drug) Early RA (Rheumatoid Arthritis)-Patients|Completed||Phase 3|124|Actual|Sanofi||2|||f||||||||||||||2017-02-18 14:51:52.372781|2017-02-18 14:51:52.372781
NCT00596193|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-03-07|||May 2001||2001-05-01|March 2012|2012-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Neuropeptide Y (NPY) Regulation of Nociceptors|NPY Regulation of Nociceptors in Clinical Inflammation|Completed||N/A|11|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||f||||||||||2017-02-18 14:51:52.483915|2017-02-18 14:51:52.483915
NCT00596180|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-01-01|||January 2007||2007-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning|Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning|Unknown status|Recruiting|Phase 1|40|Anticipated|Louisiana State University Health Sciences Center in New Orleans||1|||f||||f||||||||||2017-02-18 14:51:52.572605|2017-02-18 14:51:52.572605
NCT00596167|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-02-24|2013-04-03||September 2007||2007-09-01|February 2016|2016-02-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||Intradialytic Drug Removal by Short-daily Hemodialysis|Intradialytic Drug Removal by Short-daily Hemodialysis|Completed||N/A|6|Actual|Indiana University|Overall limitation is the relatively small sample size.|1|||f||||t||||||||No||2017-02-18 14:51:52.688359|2017-02-18 14:51:52.688359
NCT00596154|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-08-15|||December 2004||2004-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|PCNSL||Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma|Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma (PCNSL)|Active, not recruiting||Phase 2|33|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:51:52.937555|2017-02-18 14:51:52.937555
NCT00596141|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-05|2013-05-06|||February 2008||2008-02-01|May 2013|2013-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Pilot Study to Evaluate the Use of OroScience Topical Oral Wound Emulsion in Post Operative Wound Healing|Pilot Study to Evaluate the Use of OroScience Topical Oral Wound Emulsion in Post Operative Wound Healing|Completed||N/A|17|Actual|OroScience, Inc.||2|||f||||f||||||||||2017-02-18 14:51:53.053276|2017-02-18 14:51:53.053276
NCT00596128|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-06-04|||December 2006||2006-12-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Standard Operating Procedures in Daily Clinical Routine|Does Implementation of a Standard Operating Procedure for Blood Sugar Control Into Daily Clinical Routine Improve Care of Patients|Completed||N/A|800|Actual|University of Schleswig-Holstein||2|||f||||t||||||||||2017-02-18 14:51:53.14835|2017-02-18 14:51:53.14835
NCT00596115|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-05|2012-07-24||||||July 2012|2012-07-01||||||||Expanded Access|||Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day|Open Label Extension for Treating ALS With R(+) Pramipexole at 60 Milligrams Per Day|Temporarily not available||N/A|||Bennett, James P., Jr., M.D., Ph.D.|||||||||||||||||||2017-02-18 14:51:53.25959|2017-02-18 14:51:53.25959
NCT00596102|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-06-27|2013-11-14||October 2005||2005-10-01|June 2014|2014-06-01||||March 2011|Actual|2011-03-01||Observational|||Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51|Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51. An Uncontrolled Phase 3 Follow-up Study|Completed||Phase 3|3258|Actual|Valneva Austria GmbH|||1||f||||||||||||||2017-02-18 14:51:53.343195|2017-02-18 14:51:53.343195
NCT00596089|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-10-01|||October 2007||2007-10-01|January 2008|2008-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Use of Jumping Mechanography as a Method to Assess Musculoskeletal Status in Older Adults|Use of Jumping Mechanography as a Method to Assess Musculoskeletal Status in Older Adults: A Pilot Study|Completed||N/A|80|Anticipated|University of Wisconsin, Madison|||2||f||||f||||||||||2017-02-18 14:51:54.006918|2017-02-18 14:51:54.006918
NCT00596076|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-05|2010-08-13|||February 2008||2008-02-01|August 2010|2010-08-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||Back School Efficacy on Low Back Pain and Quality of Life of Workers. COPCORD STUDY (Stage II)|The Efficacy of Back School on Low Back Pain and Quality of Life of Workers of a Pharmaceutics Company in Tehran Suburb. COPCORD Study (Stage II)|Completed||Phase 3|30|Anticipated|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-02-18 14:51:54.094957|2017-02-18 14:51:54.094957
NCT00596063|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-12-26|||January 2008||2008-01-01|December 2012|2012-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.|A Randomized, Single Center, Double Blind, Two Period, Crossover Glucose Clamp Study to Test for Bioequivalence Between Two Recombinant Human Soluble Insulins- Wockhardts Insulin Human Regular for Injection and Novolin R in Healthy Subjects|Completed||Phase 1|25|Actual|Wockhardt||2|||f||||f||||||||||2017-02-18 14:51:54.192455|2017-02-18 14:51:54.192455
NCT00596050|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-08-13|||August 2006||2006-08-01|September 2013|2013-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions|Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions|Completed||Phase 4|50|Actual|Drexel University||2|||f||||f||||||||||2017-02-18 14:51:54.30434|2017-02-18 14:51:54.30434
NCT00596037|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-10-04|||August 2006||2006-08-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Adults With Growth Hormone Deficiency|A Phase III, Open-label, Uncontrolled, Multicentre, Rollover Study to Assess Safety and Efficacy of LB03002 Administered Weekly in Adults With Growth Hormone Deficiency|Completed||Phase 3|136|Actual|LG Life Sciences||2|||f||||t||||||||||2017-02-18 14:51:54.41195|2017-02-18 14:51:54.41195
NCT00596024|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-01-04|||December 2007||2007-12-01|January 2008|2008-01-01||||December 2008|Anticipated|2008-12-01||Interventional|LAD||Lutein and Alzheimer's Disease Study|Lutein and Oxidative Stress in Alzheimer's Disease - A Pilot Study|Unknown status|Recruiting|Phase 2|16|Anticipated|Oregon Health and Science University||2|||f||||f||||||||||2017-02-18 14:51:54.505732|2017-02-18 14:51:54.505732
NCT00596011|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-11-15|2014-08-15||December 2007||2007-12-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|March 2014|Actual|2014-03-01||Interventional||All participants|Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia|Phase II, Randomized, Double-blind, Multi-centered Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia (HGPIN) or Atypical Small Acinar Proliferation (ASAP)|Active, not recruiting||Phase 2|97|Actual|H. Lee Moffitt Cancer Center and Research Institute|Primary Endpoint: Progression to PCa. Recent evidence demonstrates ASAP is a stronger diagnostic predictor associated with PCa compared to HGPIN. Due to this evidence and recruitment challenges, we revised inclusion criteria to include men with ASAP.|2|||f||||f||||||||||2017-02-18 14:51:54.610441|2017-02-18 14:51:54.610441
NCT00595998|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-06|2009-01-27|||January 2008||2008-01-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Observational|HMP||Sensitivity and Specificity of the Home Macular Perimeter (HMP)|Sensitivity and Specificity of the Home Macular Perimeter|Completed||N/A|42|Actual|Notal Vision Ltd|||2||f||||t||||||||||2017-02-18 14:51:55.164098|2017-02-18 14:51:55.164098
NCT00595985|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2009-07-06|||July 2007||2007-07-01|July 2009|2009-07-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer|Phase II Trial of Sorafenib as Second Line Therapy in Patients With Advanced or Metastatic Gastric Cancer|Terminated||Phase 2|5|Actual|Fudan University||1||low response rate, no evidence of PFS or OS improved.|f||||f||||||||||2017-02-18 14:51:55.253252|2017-02-18 14:51:55.253252
NCT00595972|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-06-27|||November 2007||2007-11-01|September 2010|2010-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer|Phase II Trial of Epirubicin Cisplatin and FU Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer|Completed||Phase 2|25|Actual|Fudan University||1|||f||||f||||||||||2017-02-18 14:51:55.363502|2017-02-18 14:51:55.363502
NCT00595959|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-06-13|2009-02-23||November 2006||2006-11-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2007|Actual|2007-04-01||Interventional|CELLO||CELLO - CLiRpath® Excimer Laser System to Enlarge Lumen Openings|CLiRpath® Excimer Laser System to Enlarge Lumen Openings|Completed||Phase 3|65|Actual|Spectranetics Corporation|Non-randomized study|1|||f||||t||||||||||2017-02-18 14:51:55.477622|2017-02-18 14:51:55.477622
NCT00595946|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-12-21|2013-11-22||August 2007||2007-08-01|December 2015|2015-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|OPAL|Baseline analysis based on ITT population, which included 217 placebo-treated subjects and 221 lubiprostone-treated subjects.|Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone|A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)|Completed||Phase 3|439|Actual|Sucampo Pharma Americas, LLC||2|||f||||f||||||||||2017-02-18 14:51:56.042794|2017-02-18 14:51:56.042794
NCT00595933|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-05-26|||March 2005||2005-03-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Comparing Over-the-counter Dry Mouth Remedies After Radiation|A Comparative Trial of Over-the-counter Dry Mouth Remedies for Dry Mouth After Radiation to the Head and Neck|Completed||Phase 1|28|Actual|University of Oklahoma||1|||f||||f||||||||||2017-02-18 14:51:56.647593|2017-02-18 14:51:56.647593
NCT00595920|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2016-02-16|2014-01-13||November 2007||2007-11-01|February 2014|2014-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|OLTERMS|Randomized and received at least one dose.|Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis|An Open-Label Extension Study to Evaluate the Safety, Tolerability and Efficacy of Subcutaneous Tovaxin in Subjects Previously Treated in the TERMS Study 2005-00|Terminated||Phase 2|116|Actual|Opexa Therapeutics, Inc.||1||Financial Constraints|f||||t||||||||||2017-02-18 14:51:56.766811|2017-02-18 14:51:56.766811
NCT00595907|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-01-07|||October 2004||2004-10-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis|Observational Study of Production of IFN-Gamma by Peripheral Lymphocytes in Response to Specific Antigens Before and After Treatment for Tuberculosis|Completed||N/A|89|Actual|University Hospital, Geneva|||1||f||||t||||||Samples Without DNA|"~     Peripheral blood lymphocytes cultured over-night; ELISPOT for detection of interferon-gamma~     production~   "|||2017-02-18 14:51:57.04235|2017-02-18 14:51:57.04235
NCT00595894|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2013-06-18|||July 2004||2004-07-01|March 2011|2011-03-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Observational|||Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans|RA Comorbidity: Bone Health in Men and African Americans|Completed||N/A|1745|Actual|University of Nebraska|||2||f||||t||||||Samples With DNA|"~     Baseline sera and DNA collected~   "|||2017-02-18 14:51:57.142898|2017-02-18 14:51:57.142898
NCT00595881|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-12-27|2011-07-13||July 2008||2008-07-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Emergency Bedside Ultrasound for Pediatric Soft Tissue Infections|Emergency Bedside Ultrasound for the Evaluation of Soft Tissue Infections in the Pediatric Emergency Department|Completed||N/A|420|Actual|Children's Hospital of Philadelphia|"Potential misclassification of lesions based on reference standard. Biased lesion outcome, as ultrasound results were not incorporated into patient care.~Single institution"||1||f||||f||||||||||2017-02-18 14:51:57.253727|2017-02-18 14:51:57.253727
NCT00595868|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-11-22|2011-09-07||March 2008||2008-03-01|November 2011|2011-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy of Varenicline in Ambivalent Smokers|Efficacy of Varenicline in Ambivalent Smokers|Completed||Phase 2|220|Actual|University of Vermont Medical Center||2|||f||||f||||||||||2017-02-18 14:51:57.500814|2017-02-18 14:51:57.500814
NCT00595855|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-01-07|||October 1997||1997-10-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|January 2007|Actual|2007-01-01||Interventional|||A Comparison Between Deep Sclerectomy and Trabeculectomy|Deep Sclerectomy Versus Trabeculectomy. A 7 Year Prospective Randomised Clinical Trial|Completed||N/A|70|Actual|University of Parma||2|||f||||f||||||||||2017-02-18 14:51:57.922448|2017-02-18 14:51:57.922448
NCT00595842|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-03-07|||February 2007||2007-02-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Artificial Root-End Barriers|Clinical Success of Artificial Root-End Barriers With Mineral Trioxide Aggregate in Teeth With Immature Apices|Completed||N/A|10|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-02-18 14:51:58.034265|2017-02-18 14:51:58.034265
NCT00595829|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-08-19|||December 2007||2007-12-01|August 2015|2015-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Phase 1 Study of XL019 in Adults With Polycythemia Vera|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL019 Administered to Subjects With Polycythemia Vera|Terminated||Phase 1|3|Actual|Exelixis||1|||f||||||||||||||2017-02-18 14:51:58.116391|2017-02-18 14:51:58.116391
NCT00595816|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-01-04|||July 2007||2007-07-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|VASTE||Injury Prevention Among Conscripts|Prevention of Musculoskeletal Injuries in Finnish Conscripts. A Cluster Randomized Controlled Trial.|Completed||N/A|800|Anticipated|UKK Institute||1|||f||||t||||||||||2017-02-18 14:51:58.207624|2017-02-18 14:51:58.207624
NCT00595790|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-04-09|2013-12-05||September 2005||2005-09-01|April 2014|2014-04-01|November 2007|Actual|2007-11-01|February 2006|Actual|2006-02-01||Interventional|||Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51|Phase 3 Study to Compare a Rapid Immunization Regime With the Standard Regime of IC51 as Vaccine for Japanese Encephalitis|Completed||Phase 3|374|Actual|Valneva Austria GmbH||3|||f||||f||||||||||2017-02-18 14:51:58.310899|2017-02-18 14:51:58.310899
NCT00595777|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-09-25|||December 2007||2007-12-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|EPAT©||Edinburgh Pain Assessment Tool (EPAT©) Study|Does the Institutionalisation of Pain Assessment Using the EPAT© Package Reduce the Pain in Cancer In-patients More Than Usual Care; a Cluster Randomised Trial.|Completed||N/A|1928|Actual|University of Edinburgh||2|||f||||t||||||||||2017-02-18 14:51:58.720444|2017-02-18 14:51:58.720444
NCT00595764|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2014-09-30|2013-07-18||August 2005||2005-08-01|September 2014|2014-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Counseling for Primary Care Office-based Buprenorphine|Counseling for Primary Care Office-based Buprenorphine|Completed||Phase 4|141|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:51:58.843333|2017-02-18 14:51:58.843333
NCT00595751|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-07-29|||December 2007||2007-12-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|NEBA||NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study|Best Estimate Diagnosis Used to Evaluate EEG in Association With ADHD in a Multi-Site, Clinical Sample of Children and Adolescents|Completed||N/A|300|Anticipated|Lexicor Medical Technology, LLC|||1||f||||f||||||||||2017-02-18 14:51:59.308669|2017-02-18 14:51:59.308669
NCT00595738|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2011-07-19|||December 2007||2007-12-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|August 2010|Actual|2010-08-01||Observational|||Peripheral Venous Oxygen Saturation and Biomarkers to Estimate Cardiac Output and Filling Pressures in Heart Failure|Use of Peripheral Venous Oxygen Saturation and Biomarkers to Estimate Cardiac Output and Filling Pressures in Patients With Advanced Heart Failure|Completed||N/A|30|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples Without DNA|"~     We will be banking serum collected from peripheral blood draws, and blood draws from a~     pulmonary artery catheter and arterial line.~   "|||2017-02-18 14:51:59.403014|2017-02-18 14:51:59.403014
NCT00595725|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2011-09-07|||February 2003||2003-02-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma|Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma|Completed||N/A|151|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:51:59.496888|2017-02-18 14:51:59.496888
NCT00595712|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-05|2010-05-22|||September 2007||2007-09-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|February 2008|Actual|2008-02-01||Interventional|||Results of Opening-wedge High Tibial Osteotomy Using Iliac Crest Allograft Compared to Iliac Crest Autograft||Completed||Phase 3|40|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:51:59.614727|2017-02-18 14:51:59.614727
NCT00595699|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2011-07-14||2010-05-25|November 2006||2006-11-01|January 2008|2008-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy|Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy. A Double-blind, Placebo-controlled Study.|Completed||Phase 4|8|Actual|Conrad, Erich J., M.D.||2|||f||||f||||||||||2017-02-18 14:51:59.711216|2017-02-18 14:51:59.711216
NCT00595686|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-05-15|||January 2008||2008-01-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies|A Phase 1, Open-label, Dose-Escalation Study Of The Safety And Pharmacokinetics Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies|Completed||Phase 1|25|Actual|Esanex Inc.||1|||f||||f||||||||||2017-02-18 14:51:59.823848|2017-02-18 14:51:59.823848
NCT00595673|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-07-01|||July 2002||2002-07-01|July 2008|2008-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007||Completed||Phase 3|428|Actual|Point Biomedical||1|||f||||t||||||||||2017-02-18 14:51:59.935842|2017-02-18 14:51:59.935842
NCT00595660|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-01-15|||February 2008||2008-02-01|January 2008|2008-01-01||||February 2010|Anticipated|2010-02-01||Interventional|||Best Needle Size for FNA of Palpable Breast Mass:Randomised Controlled Study|Best Needle Size for FNA of Palpable Breast Mass:Randomised Controlled Study|Unknown status|Not yet recruiting|N/A|250|Anticipated|Kashani Social Security Hospital||4|||f||||f||||||||||2017-02-18 14:52:00.07307|2017-02-18 14:52:00.07307
NCT00595647|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-04-19|||February 2008||2008-02-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|BASKET-SAVAGE||Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions|BAsel Stent Kosten Effektivitäts Trial - SAphenous Venous Graft Angioplasty Using Glycoprotein IIb/IIIa Receptor Inhibitors and Drug-Eluting Stents|Terminated||Phase 4|162|Actual|University Hospital, Basel, Switzerland||2||insufficient enrollment|f||||t||||||||||2017-02-18 14:52:00.189944|2017-02-18 14:52:00.189944
NCT00595634|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-03-31|||January 2008||2008-01-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|INTUIT||INTUIT Hip Fracture Outcome Study|Intramedullary Nailing for Treatment of Unstable InterTrochanteric (INTUIT) Hip Fracture Outcome Study.|Terminated||N/A|92|Actual|Smith & Nephew, Inc.|||1|Could not power primary endpoint due to lost to follow-up rate|f||||f||||||||||2017-02-18 14:52:00.29777|2017-02-18 14:52:00.29777
NCT00595621|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-05-01|||February 2006||2006-02-01|May 2015|2015-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis|Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis|Completed||N/A|22|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 14:52:00.609894|2017-02-18 14:52:00.609894
NCT00595608|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-01-15|||February 2008||2008-02-01|December 2007|2007-12-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Sterimar vs Saline Sprays in Nasal Surgical Aftercare - a Blinded, Randomised Trial|Sterimar vs Saline Sprays in Nasal Surgical Aftercare - a Blinded, Randomised Trial|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|NHS Grampian||2|||f||||t||||||||||2017-02-18 14:52:00.721542|2017-02-18 14:52:00.721542
NCT00595595|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-09-14|||February 2007||2007-02-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Development of a Model to Evaluate Regenerative Endodontic Techniques Using Extract Human Teeth|Development of a Model to Evaluate Regenerative Endodontic Techniques|Completed||N/A|1080|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples With DNA|"~     extracted teeth 10ml of blood for DNA banking~   "|||2017-02-18 14:52:00.838119|2017-02-18 14:52:00.838119
NCT00595582|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2012-05-25|2011-10-11||May 2005||2005-05-01|May 2012|2012-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine|Early Intervention in Mild Cognitive Impairment (MCI) With Curcumin + Bioperine|Terminated||N/A|10|Actual|Louisiana State University Health Sciences Center Shreveport|2 patients withdrew due to Dyspepsia (intolerance to supplement).|1||For various reasons.|f||||f||||||||||2017-02-18 14:52:00.934643|2017-02-18 14:52:00.934643
NCT00595569|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2008-01-15|||April 2002||2002-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Flexible, Intensive Insulin Therapy in Patients With Type 1 Diabetes|Flexible, Intensive Insulin Management in Patients With Type 1 Diabetes and Changes in Metabolic Control, Quality of Life, Locus of Control and Diabetes Knowledge|Completed||N/A|45|Actual|University of Lausanne Hospitals|||1||f||||f||||||||||2017-02-18 14:52:01.185509|2017-02-18 14:52:01.185509
NCT00595556|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-06|2010-09-28|2010-05-15||July 2006||2006-07-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Zonisamide vs. Placebo in the Treatment of Alcohol Dependence|Zonisamide vs. Placebo in the Treatment of Alcohol Dependence|Completed||Phase 4|40|Actual|UConn Health|The small sample size and the short duration of treatment are limitations. High rates of retention in the treatment and adherence to the medication regimen are strengths. The concomitant psychotherapy may have caused a ceiling effect on medication.|2|||f||||f||||||||||2017-02-18 14:52:01.30126|2017-02-18 14:52:01.30126
NCT00595543|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2009-03-17|||January 2008||2008-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%||Completed||Phase 4|166|Anticipated|Bp Consulting, Inc||3|||f||||||||||||||2017-02-18 14:52:01.846325|2017-02-18 14:52:01.846325
NCT00595530|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-02-29|2015-07-27||January 2008||2008-01-01|February 2016|2016-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||Unfortunately, there was a lack of interest for enrollment and this study never reached a reportable effect size. It was closed for this reason.|Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain|Use of Low-Dose Ketamine Infusion in Acute Painful Episodes of Sickle Cell Disease: A Pilot Study|Terminated||Phase 2|3|Actual|Connecticut Children's Medical Center||1||Lack of enrollment and patient interest in study|f||||t||||||||No|There is no plan to share data as the low enrollment makes the results of this study non-generalizable.|2017-02-18 14:52:01.96197|2017-02-18 14:52:01.96197
NCT00595517|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-08-20|2010-08-04||October 2007||2007-10-01|August 2012|2012-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer|A Long Term Study to Investigate the Efficacy and Safety Study of D961H (Esomeprazole) (20 mg Once Daily) for the Prevention of Gastric and/or Duodenal Ulcers Associated With Daily Nonsteroidal Anti-inflammatory Drug (NSAID) Use|Completed||Phase 3|395|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:52:02.329158|2017-02-18 14:52:02.329158
NCT00595504|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-08-14|2012-04-26||January 2008||2008-01-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia|Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia|Completed||Phase 4|25|Actual|Massachusetts General Hospital|The limitations of this study include the relatively small sample size and short intervention period (8 weeks).|2|||f||||t||||||||||2017-02-18 14:52:02.650089|2017-02-18 14:52:02.650089
NCT00595491|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-09-28|||January 2008||2008-01-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|November 2017|Anticipated|2017-11-01||Interventional|||Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation|Inflammatory Cellular Trafficking in Asthma in Response to Segmental Allergen Challenge|Recruiting||Phase 1|178|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:52:03.135993|2017-02-18 14:52:03.135993
NCT00595465|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-05-05|2012-06-01||December 2007||2007-12-01|May 2014|2014-05-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51|Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51. Double Blind, Randomized, Controlled Phase 3 Study.|Completed||Phase 3|389|Actual|Valneva Austria GmbH||3|||f||||f||||||||||2017-02-18 14:52:03.374868|2017-02-18 14:52:03.374868
NCT00595439|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2017-01-24|||December 21, 2007||2007-12-21|October 5, 2009|2009-10-05||||October 5, 2009|Actual|2009-10-05||Observational|||Association Between Focal Dystonia and Complex Regional Pain Syndrome|The Association Between Focal Dystonia (FD) and Complex Regional Pain Syndrome (CRPS)|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:52:03.893782|2017-02-18 14:52:03.893782
NCT00595426|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2013-03-19||2010-05-26|May 2008||2008-05-01|May 2010|2010-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|PEARL||A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery|A Phase 2b, Double-Blind, Double-Dummy, Randomized, Parallel Group Study to Evaluate the Safety and Efficacy of Twice Daily Dosing and Once Daily Dosing of YM150 in Subjects Undergoing Primary Elective Knee Arthroplasty|Completed||Phase 2|685|Actual|Astellas Pharma Inc||5|||f||||t||||||||||2017-02-18 14:52:03.981102|2017-02-18 14:52:03.981102
NCT00595413|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-01-19|2016-01-19||September 2007||2007-09-01|January 2016|2016-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|AUGUST II|Intention-to-treat (ITT) population included all randomized participants who received at least 1 study treatment dose.|Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)|A Randomised, Double-blind, Placebo Controlled, Multi-centre Phase II Study of Atacicept in Anti-TNFα-naïve Patients With Moderate to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate|Completed||Phase 2|311|Actual|EMD Serono||4|||f||||f||||||||||2017-02-18 14:52:04.195912|2017-02-18 14:52:04.195912
NCT00595387|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-04-28|||September 2006||2006-09-01|April 2015|2015-04-01|January 2013|Actual|2013-01-01|September 2011|Actual|2011-09-01||Interventional|||Effectiveness of Cognitive Behavioral Therapy for Treating Depression in People With Bipolar I Disorder|Cognitive-Behavior Therapy for Bipolar Disorder|Completed||N/A|54|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:52:04.893871|2017-02-18 14:52:04.893871
NCT00595374|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-06-19|||December 2003||2003-12-01|June 2012|2012-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy and Safety of Insulin Detemir in Type 1 Diabetes|Efficacy and Safety Comparison of Insulin Detemir Plus Insulin Aspart to Insulin NPH Plus Insulin Aspart in Adults With Type 1 Diabetes Mellitus|Completed||Phase 3|114|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:52:05.004207|2017-02-18 14:52:05.004207
NCT00595361|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-09-21|2014-07-16||January 2008||2008-01-01|September 2015|2015-09-01|March 2012|Actual|2012-03-01|May 2011|Actual|2011-05-01||Interventional|SECS||How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment|The Effect of Beta-2 Adrenergic Polymorphisms on the Bronchoprotective Effects of Regular Salmeterol Treatment in Asthma|Completed||N/A|30|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 14:52:05.101785|2017-02-18 14:52:05.101785
NCT00595348|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-06|2011-05-09|||November 2007||2007-11-01|May 2011|2011-05-01|May 2017|Anticipated|2017-05-01|May 2012|Anticipated|2012-05-01||Observational|KOHBRA||Korean Hereditary Breast Cancer Study|Korean Hereditary Breast Cancer Study|Recruiting||N/A|2250|Anticipated|Korean Breast Cancer Study Group|||1||f||||t||||||Samples With DNA|"~     DNA, Serum, plasma, Whole blood~   "|||2017-02-18 14:52:07.959932|2017-02-18 14:52:07.959932
NCT00595335|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2015-12-30|2014-03-26||April 2008||2008-04-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|March 2013|Actual|2013-03-01||Interventional|||Trial of Rituximab for Graves' Ophthalmopathy|Phase 2/3 Study of Rituximab for Graves' Ophthalmopathy|Completed||Phase 2/Phase 3|25|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:52:08.087576|2017-02-18 14:52:08.087576
NCT00595322|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-12-16|||December 2005||2005-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma|Safety of Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma: A Pilot Study|Active, not recruiting||N/A|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:52:08.648456|2017-02-18 14:52:08.648456
NCT00595309|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-05-05|2012-05-24||December 2007||2007-12-01|May 2014|2014-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51|Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 on Long Term Immunogenicity. An Uncontrolled, Open-label Phase 3 Study.|Completed||Phase 3|198|Actual|Valneva Austria GmbH||1|||f||||f||||||||||2017-02-18 14:52:08.753983|2017-02-18 14:52:08.753983
NCT00595296|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-01-11|||December 2007||2007-12-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study|GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study|Terminated||N/A|461|Actual|Janssen Diagnostics, LLC|||1|GeneSearch™ BLN Assay has been voluntarily withdrawn from the US market.|f||||f||||||Samples With DNA|"~     Samples of the lymph node tissue homogenate and RNA extract are collected if the subject~     gives permission via the informed consent form.~   "|||2017-02-18 14:52:09.246771|2017-02-18 14:52:09.246771
NCT00595283|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2013-03-20|||October 2007||2007-10-01|March 2013|2013-03-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||Effectiveness of Parent-Child Interaction and Emotion Development Therapy in Treating Preschool Children With Depression|Early Intervention in Depression: Dyadic Emotion Development Therapy for Preschool Children|Completed||N/A|38|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 14:52:09.363527|2017-02-18 14:52:09.363527
NCT00595270|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-02-05|2013-12-05||October 2005||2005-10-01|February 2014|2014-02-01|April 2009|Actual|2009-04-01|September 2007|Actual|2007-09-01||Interventional|||Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51|Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51|Completed||Phase 3|349|Actual|Valneva Austria GmbH||1|||f||||f||||||||||2017-02-18 14:52:09.482645|2017-02-18 14:52:09.482645
NCT00595257|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-03-08|||December 2007||2007-12-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||Feasability Study of Autologous Bone Marrow Aspirate Concentrate for Treatment of CLI|Feasibility Study of the Safety and Activity of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the Treatment of Non Reconstructable Critical Limb Ischemia Due to Peripheral Arterial Occlusive Disease|Completed||Phase 1/Phase 2|60|Actual|Harvest Technologies||2|||f||||f||||||||||2017-02-18 14:52:10.030121|2017-02-18 14:52:10.030121
NCT00595244|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-07-01|||July 2002||2002-07-01|July 2008|2008-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease|CSP 127-006 A Phase 3 Clinical Trial to Assess Perfusion and Obstruction Identified by Non-Invasive Technology Using PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Arter Disease|Completed||Phase 3|456|Actual|Point Biomedical||1|||f||||t||||||||||2017-02-18 14:52:10.128725|2017-02-18 14:52:10.128725
NCT00595231|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-01-13||2009-12-03|March 2008||2008-03-01|February 2014|2014-02-01||||October 2008|Actual|2008-10-01||Interventional|||Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)|A Multi-Center,Randomized, Double-Blind, Placebo-Controlled, Phase 2, Exploratory Study to Evaluate the Effect of Rufinamide on Anxiety in Patients With Moderate to Severe Generalized Anxiety Disorder|Completed||Phase 2|239|Actual|Biotie Therapies Inc.||2|||f||||f||||||||||2017-02-18 14:52:10.240086|2017-02-18 14:52:10.240086
NCT00595218|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-12-23|||April 2006||2006-04-01|December 2015|2015-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Patient Preference Survey for Radiation Oncologists|How Can Radiation Oncologists Better Serve Their Patients? A Randomized Study to Determine Whether Radiation Oncologists Can Improve Patient Satisfaction by Attempting to Meet Their Patients' Preferences|Completed||N/A|500|Actual|University of Pittsburgh||2|||f||||||||||||||2017-02-18 14:52:10.33527|2017-02-18 14:52:10.33527
NCT00595205|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2012-03-15|||January 2008||2008-01-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Intussusception Surveillance After Rotarix Introduction in Mexico|Post-Authorization Safety Study (PASS) of Post-Marketing Surveillance for Intussusception Following Rotarix™ Introduction Into the Instituto Mexicano Del Seguro Social (IMSS) in Mexico|Completed||N/A|786|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 14:52:10.435939|2017-02-18 14:52:10.435939
NCT00595179|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2012-04-04|||December 2007||2007-12-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|||||Observational|||Intraperative Assessment of Renal Perfusion Using Infrared Imaging|Intraoperative Assessment of Renal Perfusion Using Infrared Imaging|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:52:10.544242|2017-02-18 14:52:10.544242
NCT00595166|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-04-04|||June 2007||2007-06-01|April 2016|2016-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Using a Sheathed Speculum to Visualize and Access the Cervix in Women With Excessive Vaginal Tissue|Using a Sheathed Speculum to Visualize and Access the Cervix in Women With Excessive Vaginal Tissue|Terminated||N/A|38|Actual|University of South Florida|||1|Design changed to observational, not RCT. PI left USF; study closed.|f||||f||||||||||2017-02-18 14:52:10.625661|2017-02-18 14:52:10.625661
NCT00595153|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-12-05|2013-09-25||April 2007||2007-04-01|December 2013|2013-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|MAST||Study of the Mechanisms of Asthma|Determining Mechanisms of Asthma Through Detailed Analysis of Airway Secretions and Tissues|Completed||Phase 1|127|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-02-18 14:52:10.721996|2017-02-18 14:52:10.721996
NCT00595140|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-03-31|||January 2008||2008-01-01|January 2008|2008-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Acute Application of Pegvisomant and Octreotide in Acromegaly|The Effect of Acute Application of Pegvisomant Alone and in Combination With Octreotide on Endogenous GH Levels During a 6 Hour Test in Patients With Acromegaly on Constant Pegvisomant Treatment|Completed||Phase 4|10|Actual|Ludwig-Maximilians - University of Munich||3|||f||||f||||||||||2017-02-18 14:52:11.15877|2017-02-18 14:52:11.15877
NCT00595127|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-06-29|2015-12-22||June 2001||2001-06-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine|A Pilot Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine|Completed||N/A|21|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:52:11.478952|2017-02-18 14:52:11.478952
NCT00595114|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-09-04|2016-05-23||December 2007||2007-12-01|September 2016|2016-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Association Between Increased Oxidative Stress, Anti-Inflammatory Fatty Acid Formation, and Airway Infection in People With Asthma and Chronic Obstructive Pulmonary Disease|Ancillary Study of Oxidative Stress and Anti-Inflammatory Lipids in Airway Disease in the MIA (ACRN) and LEUKO (CCRN) Trials|Completed||Early Phase 1|43|Actual|Brigham and Women's Hospital|||6||f||||t||||||Samples With DNA|"~     Blood and sputum samples with DNA~   "|||2017-02-18 14:52:11.946534|2017-02-18 14:52:11.946534
NCT00595101|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2013-11-20||2013-11-20|December 2007||2007-12-01|November 2013|2013-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.|A Phase 2, 28-Day Parallel-Group, Double-Masked, Dose Finding Study Comparing The Safety And Efficacy Of PF-03187207 To Latanoprost In Patients With Primary Open Angle Glaucoma Or Ocular Hypertension.|Completed||Phase 2|128|Actual|Bausch & Lomb Incorporated||4|||f||||f||||||||||2017-02-18 14:52:12.652613|2017-02-18 14:52:12.652613
NCT00595088|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-07-16|2013-06-16||January 2008||2008-01-01|July 2014|2014-07-01|October 2014|Anticipated|2014-10-01|January 2013|Actual|2013-01-01||Interventional|||Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer|Phase 2b, Multicenter Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer|Unknown status|Active, not recruiting|Phase 2|47|Actual|BioCancell Ltd.||1|||f||||f||||||||||2017-02-18 14:52:12.7733|2017-02-18 14:52:12.7733
NCT00595075|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-10-24|2010-07-22||December 2007||2007-12-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Ramelteon for a Nap Prior to a Night Shift|Effects of Ramelteon on Sleep and Neurobehavioral Performance in a Simulated Night Shift Preceded by a Sleep Opportunity|Completed||N/A|11|Actual|Brigham and Women's Hospital|Circadian phase was not measured.|2|||f||||f||||||||||2017-02-18 14:52:13.055747|2017-02-18 14:52:13.055747
NCT00595062|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-12-21|||October 2002||2002-10-01|December 2015|2015-12-01|July 2013|Actual|2013-07-01|January 2006|Actual|2006-01-01||Interventional|||Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study|Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study|Completed||N/A|51|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:52:13.532653|2017-02-18 14:52:13.532653
NCT00595049|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-04-28|||May 2006||2006-05-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|December 2008|Actual|2008-12-01||Interventional|||Pulmonary Artery Remodelling With Bosentan|Open Label, Non Comparative Study to Investigate the Effect of Bosentan on Pulmonary Artery Remodelling in Pulmonary Arterial Hypertension (PAH).|Completed||Phase 4|11|Actual|Actelion||1|||f||||||||||||||2017-02-18 14:52:13.644942|2017-02-18 14:52:13.644942
NCT00595023|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-01-11|||December 2007||2007-12-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||GeneSearch Breast Lymph Node (BLN) Assay Timing Study|GeneSearch Breast Lymph Node (BLN) Assay Timing Study|Terminated||Phase 4|233|Actual|Janssen Diagnostics, LLC|||1|GeneSearch™ BLN Assay has been voluntarily withdrawn from the US market.|f||||f||||||||||2017-02-18 14:52:13.764592|2017-02-18 14:52:13.764592
NCT00595010|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-06-08|||September 2007||2007-09-01|June 2016|2016-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Effectiveness of a Multi-Component Evidence-Based Parent Training Program in Reducing Child Maltreatment|Developing Multi-Component Evidence Based Practice in Child Abuse Service Systems|Completed||Phase 1|26|Actual|University of Oklahoma||1|||f||||t||||||||No||2017-02-18 14:52:13.874062|2017-02-18 14:52:13.874062
NCT00594997|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-07-29|||April 2004||2004-04-01|July 2015|2015-07-01|December 2015|Anticipated|2015-12-01|March 2008|Actual|2008-03-01||Interventional|||A School-Based Intervention to Reduce Lyme Disease|A School-Based Intervention to Reduce Lyme Disease|Active, not recruiting||N/A|4101|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 14:52:13.962907|2017-02-18 14:52:13.962907
NCT00594984|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-10-12||2015-09-23|May 2008||2008-05-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Phase I/II Combination With Irinotecan- Erbitux|A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|38|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 14:52:14.060294|2017-02-18 14:52:14.060294
NCT00594971|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2011-01-10|||April 2008||2008-04-01|January 2011|2011-01-01|November 2010|Anticipated|2010-11-01|October 2009|Anticipated|2009-10-01||Interventional|||A Shared Care Approach for Seriously Ill Cancer Patients Between General Practice, Discharge Department and a Specialist Palliative Care Team|A Shared Care Approach for Seriously Ill Cancer Patients Between General Practice, Discharge Department and a Specialist Palliative Care Team|Withdrawn||N/A|270|Anticipated|University of Aarhus||3||"Recruitment problems has forced us to change the design of this study from a clinical trial to~   a comparative study of 3 different groups of patients."|f||||t||||||||||2017-02-18 14:52:14.173965|2017-02-18 14:52:14.173965
NCT00594958|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-03-29|2013-12-05||September 2006||2006-09-01|March 2016|2016-03-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional||Safety population, i.e. subjects who received at least one vaccination|Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51|Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51. Double Blind, Randomized, Controlled Phase 3 Study.|Completed||Phase 3|639|Actual|Valneva Austria GmbH||3|||f||||f||||||||||2017-02-18 14:52:14.272801|2017-02-18 14:52:14.272801
NCT00594945|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-05-29|2013-06-26||December 2007||2007-12-01|May 2014|2014-05-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional||There were 9 subjects total and 2 subjects were enrolled in both Cohorts.|Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures|A Phase 2a, Open-label,Proof -Of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures|Completed||Phase 2|45|Actual|Jazz Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:52:14.711798|2017-02-18 14:52:14.711798
NCT00594932|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2012-12-26|||November 2006||2006-11-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|July 2008|Actual|2008-07-01||Interventional|||Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis|Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis|Completed||N/A|27|Actual|Oklahoma Medical Research Foundation||3|||f||||f||||||||||2017-02-18 14:52:15.526255|2017-02-18 14:52:15.526255
NCT00594919|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2009-02-03|||October 2007||2007-10-01|February 2009|2009-02-01||||||||Observational|||Neutrophil Gelatinase-Associated Lipocalin: Biomarker of Acute Kidney Injury After Cardiac Surgery|Neutrophil Gelatinase-Associated Lipocalin(NGAL): Early Biomarker of Acute Kidney Injury After Cardiac Surgery|Unknown status|Recruiting|N/A|150|Anticipated|Hospital de Base|||2||f||||f||||||||||2017-02-18 14:52:15.645272|2017-02-18 14:52:15.645272
NCT00594906|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-12-03|2012-10-24||January 2008||2008-01-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Use of Teriparatide to Accelerate Fracture Healing|Use of Teriparatide to Accelerate Fracture Healing|Terminated||N/A|10|Actual|University of Rochester|Early termination leading to small numbers of subjects analyzed.|2||The study was terminated due to poor enrollment.|f||||f||||||||||2017-02-18 14:52:15.951898|2017-02-18 14:52:15.951898
NCT00594893|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-08-29|||June 2006||2006-06-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study Comparing Mini-Incision Versus 2-Incision Approach for Total Hip Replacement|A Prospective Randomized Trial of Mini Incision and 2-Incision Total Hip Arthroplasty|Completed||N/A|72|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 14:52:16.347467|2017-02-18 14:52:16.347467
NCT00594880|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-01-28|2013-01-24||January 2008||2008-01-01|January 2015|2015-01-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|||Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection|Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection|Completed||Phase 2|23|Actual|The Wistar Institute|"The follwing limitations of this study should be noted:~Small number of participants enrolled~Lack of a control arm interrupting ART without immunotherapy"|2|||f||||t||||||||||2017-02-18 14:52:16.459095|2017-02-18 14:52:16.459095
NCT00594867|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-01-04|||December 2006||2006-12-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|December 2007|Actual|2007-12-01||Interventional|||The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers|Does Acetaminophen Potentiate the Gastroduodenal Mucosal Injury of Aspirin? A Prospective, Randomized, Pilot Study.|Completed||Phase 4|94|Actual|University of Illinois at Chicago||3|||f||||f||||||||||2017-02-18 14:52:16.947481|2017-02-18 14:52:16.947481
NCT00594659|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2013-12-03|2013-04-16||November 2008||2008-11-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Development and Efficacy Test of Computerized Treatment for Marijuana Dependence|Development and Efficacy Test of Computerized Treatment for Marijuana Dependence|Completed||N/A|75|Actual|Dartmouth-Hitchcock Medical Center||3|||f||||f||||||||||2017-02-18 14:52:19.334535|2017-02-18 14:52:19.334535
NCT00594854|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-08-27|2010-05-28||September 2007||2007-09-01|August 2010|2010-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec|6-Month, Randomized, Double-blind, Parallel-group, Controlled, Multi-center Study of Gastric Ulcer Incidence With PN400 (Esomeprazole/Naproxen) Versus Diclofenac/Misoprostol in Subjects at High Risk for Developing NSAID-Associated Ulcers|Terminated||Phase 3|20|Actual|POZEN|Early termination due to small number of subjects.|2||POZEN agreed with FDA to stop study due to low and inadequate enrollment|f||||t||||||||||2017-02-18 14:52:17.078829|2017-02-18 14:52:17.078829
NCT00594841|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-12-06|||January 2008||2008-01-01|December 2016|2016-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|ACJoint||Non-operative Versus Operative Treatment of Acute Acromioclavicular Joint Dislocation|A Multicenter Randomized Clinical Trial of Non-operative Versus Operative Treatment of Acute Acromioclavicular Joint Dislocation|Completed||N/A|83|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-02-18 14:52:17.5557|2017-02-18 14:52:17.5557
NCT00594828|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-01-07|||July 2006||2006-07-01|January 2008|2008-01-01|April 2008|Anticipated|2008-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Patient Self Testing of Warfarin Therapy|Randomized Controlled Trial of Patient Self-Testing of Warfarin Therapy Using an Internet Based Expert System|Unknown status|Active, not recruiting|Phase 4|163|Actual|University College Cork||2|||f||||f||||||||||2017-02-18 14:52:17.662064|2017-02-18 14:52:17.662064
NCT00594815|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-02-25|||August 2002||2002-08-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma|A Pilot Study of Combined Immunochemotherapy Followed by Reduced Dose RT for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma|Completed||N/A|52|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||f||||||||||2017-02-18 14:52:17.775653|2017-02-18 14:52:17.775653
NCT00594802|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2010-08-05|||August 2006||2006-08-01|July 2008|2008-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|chackos||Systemic Reactions to Allergen Immunotherapy Amd Skin Testing|Systemic Reactions to Allergen Immunotherapy Amd Skin Testing|Completed||N/A|100|Anticipated|University of South Florida|||1||f||||f||||||||||2017-02-18 14:52:17.88984|2017-02-18 14:52:17.88984
NCT00594789|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2016-10-24|||June 2008||2008-06-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|March 2011|Actual|2011-03-01||Interventional|||Closing The Post Fracture Care Gap In Manitoba|Closing The Post Fracture Care Gap In Manitoba|Active, not recruiting||N/A|4264|Actual|University of Manitoba||3|||f||||f||||||||||2017-02-18 14:52:17.971607|2017-02-18 14:52:17.971607
NCT00594776|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-02-08|||November 2006||2006-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Vascular CT Assessment of Structural Autograft and Allograft Healing|Vascular CT Assessment of Structural Autograft and Allograft Healing|Completed||N/A|8|Actual|University of Rochester|||1||f||||f||||||||||2017-02-18 14:52:18.091491|2017-02-18 14:52:18.091491
NCT00594763|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-01-31|||June 2006||2006-06-01|January 2008|2008-01-01|April 2008|Anticipated|2008-04-01|April 2008|Anticipated|2008-04-01||Observational|||Venous Thrombosis in Turner Syndrome|The Risk of Venous Thrombosis in Women With Turner Syndrome|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Aarhus|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 14:52:18.198968|2017-02-18 14:52:18.198968
NCT00594750|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-06-01|||May 2006||2006-05-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Observational|MECA||Mechanisms of Exacerbation of Asthma|Mechanisms of Exacerbation of Asthma|Recruiting||N/A|115|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples Without DNA|"~     Sputum, whole blood~   "|||2017-02-18 14:52:18.298278|2017-02-18 14:52:18.298278
NCT00594737|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2012-06-01|||October 2007||2007-10-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia|An Open Label Pilot Study of the Effects of Memantine Administration on FDG-PET in Frontotemporal Dementia|Completed||Phase 3|17|Actual|Rotman Research Institute at Baycrest||1|||f||||t||||||||||2017-02-18 14:52:18.407633|2017-02-18 14:52:18.407633
NCT00594724|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2014-06-11|||November 2002||2002-11-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging|Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging|Completed||N/A|99|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:52:18.517926|2017-02-18 14:52:18.517926
NCT00594711|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2011-10-28|||January 2000||2000-01-01|October 2011|2011-10-01|December 2008|Actual|2008-12-01|||||Observational|||Monoamine Transporter Function and Autonomic Regulation During Psychodynamic Psychotherapy||Completed||N/A|26|Actual|Kuopio University Hospital|||2||f||||t||||||Samples With DNA|"~     DNA, creatine, B-vitamin,BP from blood samples.~   "|||2017-02-18 14:52:18.628485|2017-02-18 14:52:18.628485
NCT00594698|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-07-01|||February 2002||2002-02-01|January 2008|2008-01-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Familiarization and Safety Study of PB127 Ultrasound Contrast Agent|A Familiarization and Safety Study of Myocardial Perfusion Contrast Echocardiography With PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Artery Disease|Completed||Phase 2/Phase 3|150|Actual|Point Biomedical||1|||f||||t||||||||||2017-02-18 14:52:18.712881|2017-02-18 14:52:18.712881
NCT00594685|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2013-03-11|2009-10-01||January 2008||2008-01-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|HOT||Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)|HIT Observational Thromboembolism Study (A TMH CTN Study)|Terminated||N/A|10|Actual|New England Research Institutes|Early termination of study due to low enrollment. Due to the early termination, the central laboratory tests necessary for analyzing outcomes 11, 12, and 13 were not performed.||1|Low accrual rate|f||||t||||||Samples With DNA|"~     Serum, plasma, and packed cells will be retained at Day 1 and Day 35 (+/- 7 days)~   "|||2017-02-18 14:52:18.854356|2017-02-18 14:52:18.854356
NCT00594672|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2017-01-24|||January 2, 2008||2008-01-02|November 3, 2016|2016-11-03||||||||Observational|||Age-Related Eye Disease Study (AREDS) Follow-Up|Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up|Enrolling by invitation||N/A|111|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:52:19.237981|2017-02-18 14:52:19.237981
NCT00594646|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2015-08-10|2015-08-10||February 2008||2008-02-01|August 2015|2015-08-01|August 2010|Actual|2010-08-01|March 2010|Actual|2010-03-01||Interventional|||HIV Non Occupational Post-Exposure Prophylaxis (PEP)|A Phase IV Open-Label Evaluation of Safety, Tolerability and Patient Acceptance of Raltegravir (MK-0518) Combined With a Fixed-Dose Formulation of Tenofovir Following Potential Exposure to HIV-1|Completed||Phase 4|100|Actual|Fenway Community Health|"Limitations of the current study included:~Reliance on self-reports to measure adherence~Study population almost exclusively male (reflecting the demographics of people who call Fenway Health's hotline after an acute sexual exposure)"|1|||f||||f||||||||||2017-02-18 14:52:20.077831|2017-02-18 14:52:20.077831
NCT00594633|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2016-01-13|||October 2004||2004-10-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors|Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors|Completed||Phase 1|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:52:20.39958|2017-02-18 14:52:20.39958
NCT00594620|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2011-05-10|||August 2004||2004-08-01|May 2011|2011-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy|A Prospective Trial of Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy|Completed||Phase 2|11|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:52:20.511306|2017-02-18 14:52:20.511306
NCT00594607|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2011-07-03|||September 2004||2004-09-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis|A Comparing Study of Nephral 400 ST and Fx8 Dialysis Membranes on Coagulation During Hemodialysis|Completed||N/A|12|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 14:52:20.627785|2017-02-18 14:52:20.627785
NCT00594594|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2009-07-06|||September 2007||2007-09-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Adjuntive Probiotic Therapy in Treating Urinary Tract Infections in Spinal Cord Injury|A Multi-Centered, Randomized, Double-Blind, Placebo-Controlled Trial for Efficacy in the Use of Adjuntive Probiotic Therapy in Reducing Urinary Tract Infections in Those Individual With Spinal Cord Injury|Terminated||Phase 1|2|Actual|Lawson Health Research Institute||1||Unable to recruit enough patients to continue on with the study.|f||||t||||||||||2017-02-18 14:52:20.747116|2017-02-18 14:52:20.747116
NCT00594581|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2008-01-02|||October 2003||2003-10-01|January 2008|2008-01-01|March 2005|Actual|2005-03-01|||||Interventional|||Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males|A Single-Site, Double-Blind, Phase II Trial to Investigate the Safety, Toleration, Systemic Exposure and Anti-Scarring Potential of Different Applications of Intradermal Juvista (Avotermin) in Male Subjects Aged 18-45 Years|Completed||Phase 2|71|Actual|Renovo||2|||f||||f||||||||||2017-02-18 14:52:20.85767|2017-02-18 14:52:20.85767
NCT00594568|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-11|2015-03-13|2013-11-06||March 2008||2008-03-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Effect of LY450139 on the Long Term Progression of Alzheimer's Disease|Effect of γ-Secretase Inhibition on the Progression of Alzheimer's Disease: LY450139 Versus Placebo|Completed||Phase 3|1537|Actual|Eli Lilly and Company|Outcomes with 4-week after study drug cessation timeframe=All dosing stopped after protocol-specified interim review showed dose-dependent cognitive/functional worsening for LY450139 participants; followed for 32 weeks; not all assessments were made.|3|||f||||t||||||||||2017-02-18 14:52:21.000629|2017-02-18 14:52:21.000629
NCT00594555|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-10-29|||November 2007||2007-11-01|October 2008|2008-10-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia|A Phase II Study of CLAG Regimen in Combination With Imatinib Mesylate (Gleevec) in Refractory or Relapsed Acute Myeloid Leukemia|Withdrawn||Phase 2|20|Anticipated|University of Cincinnati||1||"Principal Investigator resigned position with the University of Cincinnati, closing study at~   this site will reopen study in new position"|f||||f||||||||||2017-02-18 14:52:26.049616|2017-02-18 14:52:26.049616
NCT00594542|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-01-03|||June 2007||2007-06-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of the Total Dose and Efficacy of Two Lidocaine Concentrations Needed for Cutaneous Surgery Local Anesthesia|A Randomized, Double Blind Comparison of the Total Dose of 1.0% Lidocaine With 1:100,000 Epinephrine Versus 0.5% Lidocaine With 1:200,000 Epinephrine Needed to Achieve Effective Anesthesia During Mohs Micrographic Surgery|Completed||N/A|149|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 14:52:26.169488|2017-02-18 14:52:26.169488
NCT00594529|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-06-22|||January 2008||2008-01-01|August 2009|2009-08-01|May 2013|Anticipated|2013-05-01|May 2010|Actual|2010-05-01||Interventional|||Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers||Unknown status|Recruiting|Phase 2|27|Anticipated|Kyoto University||1|||f||||||||||||||2017-02-18 14:52:26.311616|2017-02-18 14:52:26.311616
NCT00594516|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-03-26|2009-04-28||December 2007||2007-12-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain|A Randomized, Double-Blind, 2-Period, Crossover Study to Establish the Dose Equivalence and Direct Conversion Between Immediate Release (IR) and Extended-Release (ER) CG5503 in Subjects With Moderate-to-Severe, Chronic Low Back Pain|Completed||Phase 3|117|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-02-18 14:52:26.412093|2017-02-18 14:52:26.412093
NCT00594503|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-01-01|||January 2007||2007-01-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Traumatic Brain Injury|Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Traumatic Brain Injury|Unknown status|Recruiting|Phase 1|45|Anticipated|Louisiana State University Health Sciences Center in New Orleans||1|||f||||f||||||||||2017-02-18 14:52:26.801045|2017-02-18 14:52:26.801045
NCT00594490|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2012-11-11|||January 2001||2001-01-01|November 2012|2012-11-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|||Evaluating the Effectiveness and Outcomes of Silicone Breast Prosthetics|Adjunct Study for Silicone Gel-Filled Mammary Prosthesis|Active, not recruiting||N/A|20|Actual|University of California, Irvine|||1||f||||t||||||||||2017-02-18 14:52:26.914665|2017-02-18 14:52:26.914665
NCT00594477|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-08-31|||January 2008||2008-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|August 2016|Actual|2016-08-01||Interventional|IMRT||Intensity Modulated Radiotherapy for Breast Cancer|Intensity Modulated Radiation Therapy for Breast Cancer: A Phase I Feasibility Study|Active, not recruiting||Phase 1|100|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:52:27.007536|2017-02-18 14:52:27.007536
NCT00594464|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-09-24|2009-05-11||September 2007||2007-09-01|December 2010|2010-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|NEUPOS||A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery|An Explorative, Multicenter, Open-label Pilot Trial With Neupro® (Rotigotine Transdermal Patch) Once Daily Treatment Administered Perioperatively in Patients With Idiopathic Parkinson's Disease|Completed||Phase 4|14|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:52:27.147149|2017-02-18 14:52:27.147149
NCT00594451|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-06-18|||October 2006||2006-10-01|January 2010|2010-01-01|January 2013|Actual|2013-01-01|April 2010|Actual|2010-04-01||Observational|||Gene-Environment Interactions in Rheumatoid Arthritis Autoimmunity Disease Severity|Gene-Environment Interactions in RA Autoimmunity Disease Severity|Completed||N/A|800|Actual|University of Nebraska|||2||f||||t||||||Samples With DNA|"~     All subjects will provide baseline serum and DNA.~   "|||2017-02-18 14:52:29.967969|2017-02-18 14:52:29.967969
NCT00594438|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-11-23|||January 2007||2007-01-01|November 2013|2013-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|RIA||Randomized, Prospective Comparison of Two Femoral Reaming Systems|Randomized, Prospective Comparison of Two Femoral Reaming Systems|Completed||N/A|20|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:52:30.06575|2017-02-18 14:52:30.06575
NCT00594425|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-08-07|2013-03-14||February 2007||2007-02-01|August 2013|2013-08-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne||Completed||Phase 2|150|Actual|Photocure||3|||f||||f||||||||||2017-02-18 14:52:30.180991|2017-02-18 14:52:30.180991
NCT00594412|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2017-01-24|||December 20, 2007||2007-12-20|June 15, 2011|2011-06-15|June 15, 2011|Actual|2011-06-15|July 1, 2010|Actual|2010-07-01||Interventional|||MRI to Measure Liver Fat Content|Validation of (1)H-Magnetic Resonance Spectroscopy for Quantification of Hepatic Triglyceride Content|Completed||N/A|53|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 14:52:32.241541|2017-02-18 14:52:32.241541
NCT00594399|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-04-06|2014-10-01||October 2008||2008-10-01|August 2014|2014-08-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional||The average age of the sample was 67 year with a range of 60 to 89. Participant were in a normal usual walking speed for their ages but were at the 10th percentile in norms for six-minute walk distance indicating poor aerobic capacity for their age.|Enhancing Fitness in Older Pre-diabetic Veterans|Enhancing Fitness in Older Overweight Vets With Impaired Fasting Glucose|Completed||Phase 2/Phase 3|302|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 14:52:32.358385|2017-02-18 14:52:32.358385
NCT00594386|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2014-09-24|2009-11-16||August 2002||2002-08-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|SP715||An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease|An Open-Label Extension to the Double-Blind SP650 Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Subjects With Advanced-Stage Idiopathic Parkinson's Disease.|Completed||Phase 3|258|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:52:34.235267|2017-02-18 14:52:34.235267
NCT00594373|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-09-23||||||September 2013|2013-09-01|April 2010|Actual|2010-04-01|November 2009|Actual|2009-11-01||Interventional|||Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women|Effect of Repeated Applications of Tenofovir Gel on Mucosal Mediators of Immunity and Intrinsic Antimicrobial Activity of Cervicovaginal Secretions in Women at Low Risk for HIV-1 Infection|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 14:52:35.035193|2017-02-18 14:52:35.035193
NCT00594360|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-01-03|||November 2005||2005-11-01|December 2007|2007-12-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|EoP||Evaluation of Effect of Exercise on Prescription - a Psychological Perspective|Exercise on Prescription: Effects and Comparison of Psychological Parameters Physical Activity, Physical Fitness, and Health Physical Between Participants in a Danish Version of Exercise on Prescription.|Unknown status|Active, not recruiting|Phase 2/Phase 3|200|Anticipated|University of Southern Denmark||1|||f||||t||||||||||2017-02-18 14:52:35.164509|2017-02-18 14:52:35.164509
NCT00594347|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-06-16|||November 2007||2007-11-01|June 2015|2015-06-01|April 2009|Actual|2009-04-01|March 2008|Actual|2008-03-01||Interventional|||Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar|Immunogenicity and Safety of a Booster Dose of Polysaccharide Pneumococcal Vaccine (Pneumo 23®) in 12 to 18 Months-Old Children Primed With Three Doses of Pneumococcal Conjugate Vaccine (Prevnar®) in Thailand.|Completed||Phase 3|339|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 14:52:35.268921|2017-02-18 14:52:35.268921
NCT00594334|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2009-02-25|||January 2008||2008-01-01|February 2009|2009-02-01|January 2011|Anticipated|2011-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Effect of Actonel on Periodontal Health of Postmenopausal Women|Effect of Actonel on Periodontal Health of Postmenopausal Women|Unknown status|Recruiting|Phase 4|240|Anticipated|University Hospitals Cleveland Medical Center||1|||t||||f||||||||||2017-02-18 14:52:35.377822|2017-02-18 14:52:35.377822
NCT00594321|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-08-31|||July 2007||2007-07-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|EFFECTS||Evaluation of Fracture Fixation With Energy and Cement in Tumors of the Spine|Evaluation of Fracture Fixation With Energy and Cement in Tumors of the Spine|Withdrawn||N/A|0|Actual|University of California, Davis||2||Sponsor closed the trial before it began|f||||t||||||||||2017-02-18 14:52:35.485387|2017-02-18 14:52:35.485387
NCT00594308|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-09-26|2011-08-05||October 2007||2007-10-01|September 2014|2014-09-01||||October 2008|Actual|2008-10-01||Interventional|||In-Vivo Activated T-Cell Depletion to Prevent GVHD|In-Vivo Activated T-Cell Depletion to Prevent GVHD|Terminated||N/A|10|Actual|Indiana University|Four patients experienced grade 3-4 GVHD and this study was stopped.|1||Treatment ineffective|f||||t||||||||||2017-02-18 14:52:35.592812|2017-02-18 14:52:35.592812
NCT00594295|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-10-01|||June 2007||2007-06-01|April 2010|2010-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Follow-up of Bone Quality in Long-Term Bone Marrow Transplant Survivors|Follow-up of Bone Quality in Long-Term Bone Marrow Transplant Survivors|Completed||N/A|15|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||Samples Without DNA|"~     whole blood, serum~   "|||2017-02-18 14:52:35.861663|2017-02-18 14:52:35.861663
NCT00594282|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-09-10|||September 2005||2005-09-01|September 2008|2008-09-01||||July 2007|Actual|2007-07-01||Interventional|||Use of a Radiolucent Pad to Reduce Mammography Among African Americans|Use of a Radiolucent Pad to Reduce Mammography Among African Americans|Completed||N/A|300|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 14:52:35.936018|2017-02-18 14:52:35.936018
NCT00594269|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2011-02-22|||August 2008||2008-08-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|DESEP||Dementia Antipsychotics And Antidepressants Discontinuation Study|Discontinuation of Antipsychotics and Antidepressants Among Patients With Dementia and BPSD Living in Nursing Homes - a 24 Weeks Double Blind RCT.|Completed||Phase 4|149|Actual|Sykehuset Innlandet HF||1|||f||||t||||||||||2017-02-18 14:52:36.034009|2017-02-18 14:52:36.034009
NCT00594256|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2016-01-05|2011-06-06||May 2008||2008-05-01|January 2016|2016-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Sodium Oxybate in Schizophrenia With Insomnia|Open Label, Pilot Study of Adjunctive Xyrem (Sodium Oxybate) for the Treatment of Schizophrenia and Associated Sleep Disturbances|Completed||Phase 2|8|Actual|Nathan Kline Institute for Psychiatric Research|Open Label Small sample|1|||f||||f||||||||||2017-02-18 14:52:36.172356|2017-02-18 14:52:36.172356
NCT00594243|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-01-14|||May 2004||2004-05-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Feasibility of Mindfulness Meditation for Adults 65+ With Chronic Low Back Pain||Completed||Phase 2/Phase 3|37|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 14:52:36.473634|2017-02-18 14:52:36.473634
NCT00594230|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-10-08|2012-08-22||January 2008||2008-01-01|October 2015|2015-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||LBH589 in Refractory Myelodysplastic Syndromes (MDS)|A Phase II Trial of LBH589 in Refractory Myelodysplastic Syndromes (MDS) Patients|Terminated||Phase 2|26|Actual|SCRI Development Innovations, LLC|Results of a planned interim analysis demonstrated that the regimen did not demonstrate sufficient evidence of efficacy necessary to justify further enrollment. Per protocol, the results of this analysis led to early termination of the study.|2||"Per protocol, the results of a planned interim analysis demonstrated insufficient efficacy and~   led to early termination of the study."|f||||f||||||||||2017-02-18 14:52:36.559513|2017-02-18 14:52:36.559513
NCT00594217|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-05-10|||November 2007||2007-11-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|CRM001||Determining How Quickly Progesterone Slows LH Pulse Frequency|Determining the Rapidity With Which Exogenous P Suppresses Daytime LH (GnRH) Pulse Frequency in Women During the Follicular Phase of the Menstrual Cycle|Recruiting||N/A|72|Anticipated|University of Virginia||2|||f||||f||||||||||2017-02-18 14:52:37.089209|2017-02-18 14:52:37.089209
NCT00594204|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2010-07-14|2010-05-27||April 2008||2008-04-01|July 2010|2010-07-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking|A 12-Week, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study With Follow-Up Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555-18) 1 Mg Bid For Smoking Cessation (Protocol A3051080)|Completed||Phase 4|593|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:52:37.210351|2017-02-18 14:52:37.210351
NCT00594191|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-01-03|||March 2004||2004-03-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension|Phase IV-II Randomized, Multicenter, Placebo-Controlled Double-Blind Clinical Trial Evaluating the Effects of Continuous Simvastatin Administration on Hepatic and Systemic Hemodynamics in Patients With Cirrhosis.|Completed||Phase 2|59|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 14:52:37.877268|2017-02-18 14:52:37.877268
NCT00594178|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2010-12-13|2010-10-01||October 2003||2003-10-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|July 2008|Actual|2008-07-01||Interventional|||Palliative Strategies in Spinal Cord Injury (SCI)|Palliative Strategies in Spinal Cord Injury (SCI)|Completed||N/A|17|Actual|University of Arkansas|This was a pilot study to determine if a passive exercise bicycle would suppress the H-reflex after a spinal cord injury. We were not able to collect stable H-reflex data. However, the Dual-Energy X-ray Absortiometry (DEXA) scan data was useable.|1|||f||||f||||||||||2017-02-18 14:52:37.999651|2017-02-18 14:52:37.999651
NCT00594165|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2014-09-24|2009-11-06||June 2002||2002-06-01|September 2010|2010-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|SP512OL||An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.|An Open-Label Extension to the Double-Blind SP512 Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Subjects With Early-Stage Idiopathic Parkinson's Disease.|Completed||Phase 3|217|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:52:38.259966|2017-02-18 14:52:38.259966
NCT00594152|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-01-14|||January 1993||1993-01-01|January 2008|2008-01-01|January 1995|Actual|1995-01-01|||||Interventional|||Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)|Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)|Completed||Phase 3|71|Actual|Joslin Diabetes Center||2|||f||||f||||||||||2017-02-18 14:52:38.819715|2017-02-18 14:52:38.819715
NCT00594139|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-11-02|||January 2008||2008-01-01|November 2015|2015-11-01||||||||Interventional|||Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence|An Open Label Multi-center Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence|Withdrawn||Phase 2|0|Actual|Tengion||1||Reprioritization of study programs|f||||t||||||||||2017-02-18 14:52:38.928268|2017-02-18 14:52:38.928268
NCT00594126|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-12-22|||November 2007||2007-11-01|December 2015|2015-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma|A Phase 1 Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of GRN163L in Patients With Refractory or Relapsed Multiple Myeloma|Completed||Phase 1|20|Actual|Geron Corporation||1|||f||||f||||||||||2017-02-18 14:52:39.033106|2017-02-18 14:52:39.033106
NCT00594113|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2012-06-18|||August 2007||2007-08-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|May 2010|Actual|2010-05-01||Interventional|||"Touch 2 Screen Multi-media Colorectal Cancer Screening Intervention"|Tailored Touch-Screens for Colorectal Cancer Prevention in Urban Core Clinics|Completed||N/A|470|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 14:52:39.154202|2017-02-18 14:52:39.154202
NCT00594100|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-12-02|2009-03-19||July 2006||2006-07-01|December 2013|2013-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|EMPiRE||GORE Embolic Protection With Reverse Flow|The Embolic Protection With Reverse Flow Study of the GORE Neuro Protection System in Carotid Stenting of Subjects At High Risk for Carotid Endarterectomy|Completed||Phase 3|245|Actual|W.L.Gore & Associates||1|||f||||t||||||||||2017-02-18 14:52:39.269826|2017-02-18 14:52:39.269826
NCT00594087|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-12-31|||December 2006||2006-12-01|December 2008|2008-12-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)|Eszopiclone for Improving Sleep Continuity in MS Patients With Sleep Disturbances and Its Impact on Daytime Fatigue|Completed||N/A|30|Actual|University of Vermont||2|||f||||t||||||||||2017-02-18 14:52:39.702815|2017-02-18 14:52:39.702815
NCT00594074|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2013-07-23|||April 2007||2007-04-01|July 2013|2013-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Alcohol in the Treatment of Obesity|Alcohol in the Treatment of Obesity|Terminated||N/A|18|Actual|Duke University||2||Unable to recruit subjects|f||||f||||||||||2017-02-18 14:52:39.823761|2017-02-18 14:52:39.823761
NCT00594061|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-06-04|||December 2007||2007-12-01|June 2015|2015-06-01|May 2020|Anticipated|2020-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Iowa/Nucleus 10/10 mm and Nucleus Freedom Feasibility Study|Iowa/Nucleus 10/10 mm and Nucleus Freedom Cochlear Implants Implanted Bilaterally in Children Ages 12-24 Months|Enrolling by invitation||N/A|10|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:52:39.917469|2017-02-18 14:52:39.917469
NCT00594048|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-10-25|||January 2008||2008-01-01|October 2011|2011-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension|The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension. A Randomized, Single-blind, Controlled Trial|Completed||N/A|30|Anticipated|Medical Research Foundation, The Netherlands||2|||f||||f||||||||||2017-02-18 14:52:40.013354|2017-02-18 14:52:40.013354
NCT00594035|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-09-04|2009-10-30||September 2005||2005-09-01|September 2014|2014-09-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Study to Evaluate Safety and Effectiveness of Spinal Sealant|A Prospective, Multi-Center, Randomized Controlled Study to Compare the Spinal Sealant System as an Adjunct to Sutured Dural Repair With Standard of Care Methods During Spinal Surgery|Completed||N/A|158|Actual|Integra LifeSciences Corporation||2|||f||||t||||||||||2017-02-18 14:52:40.123747|2017-02-18 14:52:40.123747
NCT00594022|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-07-13|2016-07-13||October 2007||2007-10-01|July 2016|2016-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|VSOM||Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness|The Effect of Vestibular Stimulation on Transient Insomnia Induced by a Five-hour Phase Advance of Sleep Time|Completed||N/A|349|Actual|Philips Respironics||2|||f||||f||||||||||2017-02-18 14:52:40.700626|2017-02-18 14:52:40.700626
NCT00594009|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2015-09-08|||January 2008||2008-01-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|VVCCO2R||Venovenous CO2 Removal in Patients With COPD and Acute Respiratory Failure|Safety and Efficacy of Venovenous Carbon Dioxide Removal in Patients With Chronic Obstructive Pulmonary Disease and Acute Respiratory Failure|Terminated||N/A|2|Actual|The University of Texas Medical Branch, Galveston||1||due to loss of key personnel due to illness and sabbatical of thePI|f||||f||||||||||2017-02-18 14:52:41.246454|2017-02-18 14:52:41.246454
NCT00593996|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-10-01|||July 2006||2006-07-01|May 2010|2010-05-01||||May 2010|Actual|2010-05-01||Interventional|||Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study|Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study|Completed||N/A|50|Anticipated|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 14:52:41.360981|2017-02-18 14:52:41.360981
NCT00593983|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2012-05-08|||May 2007||2007-05-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)|Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials|Completed||Phase 2|540|Actual|New York University||2|||f||||f||||||||||2017-02-18 14:52:41.455589|2017-02-18 14:52:41.455589
NCT00593970|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2016-04-22|||November 2007||2007-11-01|April 2016|2016-04-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Influenza Vaccine in Pregnancy Part 2|Knowledge Possessed by Pregnant Women Regarding Influenza Vaccination During Pregnancy|Completed||N/A|100|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-02-18 14:52:41.548745|2017-02-18 14:52:41.548745
NCT00593957|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2014-03-26|2013-03-08||August 2004||2004-08-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Trial of Dextromethorphan in Rett Syndrome|Trial of Dextromethorphan in Rett Syndrome|Terminated||Phase 2|38|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|The trial was terminated due to the FDA requiring a placebo controlled trial instead of the ongoing open label trial. As recruitment was delayed,the total number of participants was also less than anticipated.|3||Study changed to a placebo controlled trial of dextromethorphan|f||||t||||||||||2017-02-18 14:52:41.808761|2017-02-18 14:52:41.808761
NCT00593944|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-05-21|||August 2008||2008-08-01|May 2013|2013-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|MDX1342-02||Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)|A Phase 1, Open-Label, Multiple-Dose, Dose-Escalation Study of MDX-1342 in Patients With CD19-Positive Refractory/Relapsed Chronic Lymphocytic Leukemia|Completed||Phase 1|15|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:52:42.512018|2017-02-18 14:52:42.512018
NCT00593931|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-11-30|||May 1999||1999-05-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Development Of New Techniques For Functional Magnetic Resonance Imaging Of The Brain|Development Of New Techniques For Functional Magnetic Resonance Imaging Of The Brain|Terminated||N/A|215|Actual|University of California, Davis||1||Principal Investigator is deceased|f||||f||||||||||2017-02-18 14:52:42.63354|2017-02-18 14:52:42.63354
NCT00593918|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-09-30|2009-06-19||November 2003||2003-11-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Observational|IIRI||Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children|Innate Immunity and RSV Infection in Children|Completed||N/A|91|Actual|University of Wisconsin, Madison|Subject withdraw before blood draw on second visit and small numbers recruited lead to small numbers of subjects analyzed.||2||f||||t||||||Samples With DNA|"~     Nasal samples Supernatant from Peripheral mononuclear cell stimulation cultures DNA~   "|||2017-02-18 14:52:42.730929|2017-02-18 14:52:42.730929
NCT00593905|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2012-01-20|||July 2005||2005-07-01|January 2012|2012-01-01|July 2013|Anticipated|2013-07-01|July 2012|Anticipated|2012-07-01||Observational|||Pharmacogenomics in Pulmonary Arterial Hypertension|Pharmacogenomics in Pulmonary Arterial Hypertension: A Multi-Center International Study to Determine Whether in PAH Patients Clinical Associations Exist Between the Efficacy and Toxicity of Endothelin Receptor Antagonists and Several Gene Polymorphisms in Several Key Disease-Specific and Therapy Specific Genes|Unknown status|Recruiting|N/A|1300|Anticipated|West Penn Allegheny Health System|||2||f||||t||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 14:52:43.145839|2017-02-18 14:52:43.145839
NCT00593892|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-10-27|||May 2007||2007-05-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|Cytokine||Inflammatory Cytokine Variations in Traumatic Injury Responses|Cytokine Liberation From Secondary Surgery in the Setting of the Second Hit Syndrome|Completed||N/A|90|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 14:52:43.284401|2017-02-18 14:52:43.284401
NCT00593879|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2008-01-02|||February 2005||2005-02-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder|A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group, Flexible Dose Titration, Add-On Study of Mecamylamine 5.0 to 10 mg, in the Treatment of Major Depressive Disorder With Subjects Who Are Partial or Non- Responders to Citalopram Therapy.|Completed||Phase 2|450|Actual|Targacept Inc.||2|||f||||f||||||||||2017-02-18 14:52:43.395012|2017-02-18 14:52:43.395012
NCT00593866|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-08-28|2014-08-12||June 2006||2006-06-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|May 2012|Actual|2012-05-01||Interventional|||Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer|A Phase I/II Radiation Dose-Escalation Study of Intensity-Modulated Radiotherapy (IMRT) With Concurrent Gemcitabine in Patients With Unresectable Pancreatic Cancer|Completed||Phase 1/Phase 2|50|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 14:52:43.499966|2017-02-18 14:52:43.499966
NCT00593853|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2014-06-03|||January 2008||2008-01-01|June 2014|2014-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy|A Phase II, Randomized, Double-blind, Placebo Controlled Trial of Methylphenidate Hydrochloride for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH-Agonist Therapy|Terminated||Phase 2|33|Actual|University Health Network, Toronto||2||Slow Accrual|f||||t||||||||||2017-02-18 14:52:43.861119|2017-02-18 14:52:43.861119
NCT00593840|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-03-23|||April 2007||2007-04-01|March 2015|2015-03-01|February 2019|Anticipated|2019-02-01|February 2014|Actual|2014-02-01||Interventional|||Phase II Trial Evaluating Elimination of Radiation Therapy|Phase II Trial Evaluating Elimination of Radiation Therapy To Pathological N0 Neck(s) With Intensity Modulated Postoperative Radiation Therapy|Active, not recruiting||Phase 2|74|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:52:43.972985|2017-02-18 14:52:43.972985
NCT00593827|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-02-09|2012-03-14||May 2008||2008-05-01|February 2016|2016-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer|Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients|Completed||Phase 2|176|Actual|R-Pharm||2|||f||||f||||||||||2017-02-18 14:52:44.089104|2017-02-18 14:52:44.089104
NCT00593814|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-07-13|2010-04-20||June 2005||2005-06-01|July 2010|2010-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||GORE EXCLUDER® Endoprosthesis - Low Permeability in Treatment of Abdominal Aortic Aneurysms|A Clinical Evaluation of the GORE EXCLUDER® Bifurcated Endoprosthesis - Low Permeability in the Primary Treatment of Infrarenal Abdominal Aortic Aneurysms|Completed||Phase 4|139|Actual|W.L.Gore & Associates||1|||f||||f||||||||||2017-02-18 14:52:45.114719|2017-02-18 14:52:45.114719
NCT00593801|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-01-04|||May 1998||1998-05-01|January 2008|2008-01-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|EPO||Erythropoietin Treatment in Extremely Low Birth Weight Infants|Multicentre, Blinded, Randomised, Controlled Study on the Efficacy and Safety of Early or Late Epoetin Beta Treatment in Premature Infants (500- 999g Birth Weight)for Prevention or Treatment of Anaemia of Prematurity|Completed||N/A|219|Actual|Charite University, Berlin, Germany||3|||f||||t||||||||||2017-02-18 14:52:45.399598|2017-02-18 14:52:45.399598
NCT00593788|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-01-14|||March 2003||2003-03-01|January 2008|2008-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Observational|||The Gaps-in-Noise Test: Gap Detection Thresholds in Normal-Hearing Young Adults|The Gaps-in-Noise Test: Gap Detection Thresholds in Normal-Hearing Young Adults|Completed||N/A|100|Actual|University of Sao Paulo|||1||f||||f||||||||||2017-02-18 14:52:45.508315|2017-02-18 14:52:45.508315
NCT00593775|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-01-14|||February 2006||2006-02-01|December 2007|2007-12-01||||July 2008|Anticipated|2008-07-01||Interventional|||The Effect of Laser Assisted Hatching in Thawing Cycles: a Prospective Randomized Controlled Study|The Effect of Laser Assisted Hatching in Thawing Cycles: a Prospective Randomized Controlled Study|Unknown status|Recruiting|N/A|540|Anticipated|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-02-18 14:52:45.586939|2017-02-18 14:52:45.586939
NCT00593762|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2010-03-15|||May 2005||2005-05-01|January 2008|2008-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures|Investigation of Laboratory Resistance to Aspirin and Clopidogrel and Its Clinical Relevance in Patients With Peripheral Arterial Occlusive Disease Requiring Interventional Procedures|Suspended||N/A|200|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum~   "|||2017-02-18 14:52:45.673238|2017-02-18 14:52:45.673238
NCT00593749|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-06-28|||September 2007||2007-09-01|January 2008|2008-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|HCSI||Healthy Corner Store Initiative|Healthy Corner Store Initiative|Completed||N/A|2000|Anticipated|Temple University||2|||f||||f||||||||||2017-02-18 14:52:45.757423|2017-02-18 14:52:45.757423
NCT00593736|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2012-02-27|2009-07-31||October 2007||2007-10-01|February 2012|2012-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome|A Randomized, Double-Blind, Placebo-Controlled, Parallel, Proof of Concept Study to Evaluate the Effectiveness of Ramelteon to Advance the Timing of Sleep in Individuals With Delayed Sleep Phase Syndrome (DSPS)|Completed||Phase 2|132|Actual|Takeda||4|||f||||f||||||||||2017-02-18 14:52:45.87703|2017-02-18 14:52:45.87703
NCT00593723|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-04-03|||December 2006||2006-12-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|January 2014|Actual|2014-01-01||Interventional|IMRT||IMRT Tomotherapy for Esophagus Cancer|IMRT Tomotherapy for Esophagus Cancer: A Phase I Feasibility Study in Non-Operative Patients|Completed||Phase 1|26|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:52:52.454658|2017-02-18 14:52:52.454658
NCT00593710|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2012-07-11|||January 2008||2008-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|October 2010|Actual|2010-10-01||Interventional|||Losartan Versus Atenolol for the Treatment of Marfan Syndrome|A Randomized Double-blind Study Assessing the Effects of Losartan Versus Atenolol on Pulse Wave Velocity and the Biophysical Properties of the Aorta in Patients With Marfan Syndrome|Completed||Phase 2|17|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 14:52:52.556338|2017-02-18 14:52:52.556338
NCT00593697|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-03-05|||January 2008||2008-01-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|SOLD||The Synergism Or Long Duration (SOLD) Study|A Randomized Phase III Study Comparing Trastuzumab Plus Docetaxel (HT) Followed by 5-FU, Epirubicin, and Cyclophosphamide (FEC) to the Same Regimen Followed by Single-agent Trastuzumab as Adjuvant Treatments for Early Breast Cancer|Completed||Phase 3|2168|Actual|Finnish Breast Cancer Group||2|||f||||t||||||||||2017-02-18 14:52:52.667044|2017-02-18 14:52:52.667044
NCT00593684|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2015-07-27|2012-02-16||April 2006||2006-04-01|July 2015|2015-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants||Completed||N/A|50|Actual|Baylor Research Institute||2|||f||||||||||||||2017-02-18 14:52:52.756751|2017-02-18 14:52:52.756751
NCT00593671|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-01-14|||June 2002||2002-06-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Preimplantation Genetic Screening in Women Over 35 Year|Preimplantation Genetic Screening for Aneuploidy in Embryos After in Vitro Fertilization in Women Over 35: a Prospective Controlled Randomized Study.|Completed||N/A|100|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-02-18 14:52:53.26201|2017-02-18 14:52:53.26201
NCT00593658|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-03-06|||June 2004||2004-06-01|January 2008|2008-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome|Open Label Single Arm Pilot Study of Pentoxifylline in Advanced Hepatopulmonary Syndrome|Terminated||Phase 1|9|Actual|University of Alabama at Birmingham||1||Poor tolerability of drug and side effects|f||||t||||||||||2017-02-18 14:52:53.352908|2017-02-18 14:52:53.352908
NCT00593645|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-09-05|2014-07-18||November 2007||2007-11-01|September 2014|2014-09-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|||Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation|A Non-Myeloablative Conditioning Regimen for Allogeneic Transplantation With Clofarabine, Cytarabine, and Thymoglobulin for Myelodysplastic Syndrome and Acute Myeloid Leukemia|Terminated||Phase 2|7|Actual|Washington University School of Medicine|Enrollment was halted after 3 of the first 7 patients expired on days 15/26/32. Predefined early stopping rules were defined that if three deaths occurred in the first 11 patients then it was unlikely to achieve a low treatment-related mortality.|1||toxicities were worse than expected|f||||t||||||||||2017-02-18 14:52:53.667244|2017-02-18 14:52:53.667244
NCT00593632|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-06-09|||January 2008||2008-01-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|||A Randomized Controlled Trial of High Dietary Fiber Intake on Serum Lipids|A Randomized Controlled Trial of High Dietary Fiber Intake on Serum Lipids|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|The Cleveland Clinic||1|||f||||f||||||||||2017-02-18 14:52:54.113514|2017-02-18 14:52:54.113514
NCT00593619|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2009-03-02|||January 2008||2008-01-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Trial Comparing the Safety of Two Different Intravenous Iron Formulations|A Randomized Double-Blind Safety Comparison of Intravenous Iron Dextran Versus Iron Sucrose in an Adult Non-Hemodialysis Outpatient Population: A Pilot Study|Suspended||Phase 4|200|Anticipated|London Health Sciences Centre||2||Interim Analysis and review by Data Safety Monitoring Board|f||||t||||||||||2017-02-18 14:52:54.220435|2017-02-18 14:52:54.220435
NCT00593606|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-09-24|2008-12-17||July 2007||2007-07-01|October 2011|2011-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine|A Phase 3b, Open-Label, Multicenter Trial to Assess the Safety and Tolerability of Switching Korean Subjects From Ropinirole to the Rotigotine Transdermal System and Its Effect on Symptoms in Idiopathic Parkinson's Disease|Completed||Phase 3|124|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 14:52:54.356896|2017-02-18 14:52:54.356896
NCT00593593|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-10-13|||December 2004||2004-12-01|October 2008|2008-10-01||||||||Observational|||Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia|A Pharmacovigilance Study to Evaluate Safety of AVODART (Dutasteride) Administration 0,5 mg Once Daily, for 52 Weeks, in Subjects With Benign Prostate Hyperplasia|Completed||N/A|1000||GlaxoSmithKline|||||f||||||||||||||2017-02-18 14:52:55.887575|2017-02-18 14:52:55.887575
NCT00593580|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-06-27|||February 2008||2008-02-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|FOSAVANCE||Bone Health in Gynecologic Cancers-does FOSAVANCE Help?|The Impact of Bisphosphonates on Bone Loss in Patients Undergoing Surgery and Postoperative Chemotherapy for Gynecologic Malignancies.|Completed||Phase 2|60|Anticipated|British Columbia Cancer Agency||2|||f||||t||||||||||2017-02-18 14:52:55.964919|2017-02-18 14:52:55.964919
NCT00593567|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2012-03-22|||December 2007||2007-12-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer|A Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge Compared to Levofloxacin in Diabetic Patients With a Mild Infection of a Lower Extremity Skin Ulcer|Completed||Phase 2|70|Actual|Innocoll||2|||f||||f||||||||||2017-02-18 14:52:56.075212|2017-02-18 14:52:56.075212
NCT00593554|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2017-01-30|||August 7, 2007|Actual|2007-08-07|January 2017|2017-01-01|May 5, 2016|Actual|2016-05-05|May 5, 2016|Actual|2016-05-05||Interventional|||Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies|A Phase II Trial of Haplotype Mismatched Hematopoietic Stem Cell Transplantation Using Highly Purified CD34 Cells in Patients With Hematological Malignancies|Terminated||Phase 2|9|Actual|Indiana University||2||Slow accrual|f||||t||||||||||2017-02-18 14:52:56.184237|2017-02-18 14:52:56.184237
NCT00593541|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-11-30|||May 1999||1999-05-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|CVMRI||Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging|Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging|Terminated||N/A|42|Actual|University of California, Davis|||1|Principal Investigator is deceased|f||||f||||||||||2017-02-18 14:52:56.301117|2017-02-18 14:52:56.301117
NCT00593528|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2015-04-08|||February 2008||2008-02-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||PTFE Covered Stents Versus Naked Stents in the TIPS (Transjugular Intra-hepatic Porto-systemic Shunt)|Randomized Study With Medico-economic Evaluation Comparing the Use of PTFE Covered Stents vs Naked Stent in the TIPS (Transjugular Intra-hepatic Porto-systemic Shunt)|Completed||N/A|138|Actual|University Hospital, Tours||2|||f||||f||||||||||2017-02-18 14:52:56.386535|2017-02-18 14:52:56.386535
NCT00593502|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2009-06-18|||February 2008||2008-02-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|ETOPOM||Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age|A Double-Blind, Randomized, Placebo-Controlled Study of Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age|Completed||Phase 4|409|Actual|Hospital District of Southwestern Finland||2|||f||||t||||||||||2017-02-18 14:52:56.615905|2017-02-18 14:52:56.615905
NCT00593489|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2009-07-06|||July 2006||2006-07-01|July 2009|2009-07-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|AIM@GP||Advancing Insulin Prescribing in General Practice|Advancing INSIGHT Methods in General Practice|Unknown status|Active, not recruiting|N/A|240|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 14:52:56.727763|2017-02-18 14:52:56.727763
NCT00593476|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-06-28|||March 2007||2007-03-01|January 2008|2008-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|NS||Pilot Study to Assess Pre-packaged, Portion-controlled Meal Plan on Weight Loss|A Pilot Study to Assess the Effects of a Pre-packaged, Portion Controlled Meal Plan on Type 2 Diabetes and Glycemic Control|Completed||N/A|50|Actual|Temple University||2|||f||||f||||||||||2017-02-18 14:52:56.849248|2017-02-18 14:52:56.849248
NCT00593463|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-03-10|||September 2006||2006-09-01|March 2011|2011-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|OMDD1||Drug Discrimination in Methadone-Maintained Humans Study 1|Drug Discrimination in Methadone-Maintained Humans Study 1|Completed||Phase 1|40|Anticipated|University of Arkansas||1|||f||||t||||||||||2017-02-18 14:52:56.954775|2017-02-18 14:52:56.954775
NCT00593450|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2016-10-10|2012-06-18||February 2008||2008-02-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|December 2010|Actual|2010-12-01||Interventional|||Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial|Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial (CATT)|Active, not recruiting||Phase 3|1208|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 14:52:57.09166|2017-02-18 14:52:57.09166
NCT00593437|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-10-01|||February 2006||2006-02-01|April 2010|2010-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|Wildwood||T-score Comparability Between GE Lunar Prodigy and Norland Excel Densitometers|T-score Comparability Between GE Lunar Prodigy and Norland Excel Densitometers|Completed||N/A|35|Anticipated|University of Wisconsin, Madison|||3||f||||f||||||||||2017-02-18 14:52:59.108594|2017-02-18 14:52:59.108594
NCT00593424|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2011-09-01|||August 2002||2002-08-01|September 2011|2011-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effect of Changing Diet on Fasting and Post Fat Load Lipoproteins|Effect of Changing the Diet to Low Fat/High Carbohydrate or High Monounsaturated Fat/Low Carbohydrate on Fasting and Post Fat Load Lipoproteins of Diabetics With Moderate Hypertriglyceridemia|Completed||N/A|15|Actual|University of Arkansas||2|||f||||f||||||||||2017-02-18 14:52:59.198457|2017-02-18 14:52:59.198457
NCT00593411|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2011-04-01|||June 2005||2005-06-01|April 2011|2011-04-01|June 2015|Anticipated|2015-06-01|||||Observational|MDAnalyze||Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database|Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database|Unknown status|Recruiting|N/A|10000|Anticipated|University of California, Irvine|||1||f||||t||||||||||2017-02-18 14:52:59.297906|2017-02-18 14:52:59.297906
NCT00593398|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2010-12-12|||September 2008||2008-09-01|December 2010|2010-12-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Observational|||Malarial Immunity in Pregnant Cameroonian Women|Malarial Immunity in Pregnant Cameroonian Women|Unknown status|Recruiting|N/A|1376|Anticipated|University of Hawaii|||1||f||||f||||||Samples With DNA|"~     Serum samples and biopsies of placental tissue~   "|||2017-02-18 14:52:59.388079|2017-02-18 14:52:59.388079
NCT00593385|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-06-09||2012-08-02|October 2007||2007-10-01|June 2016|2016-06-01|May 2014|Actual|2014-05-01|August 2011|Actual|2011-08-01||Interventional|iCARUS||Atrium iCAST Iliac Stent Pivotal Study|Atrium iCAST Iliac Stent Pivotal Study|Completed||N/A|165|Actual|Atrium Medical Corporation||1|||f||||t||||||||Undecided||2017-02-18 14:52:59.475728|2017-02-18 14:52:59.475728
NCT00593372|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-11-17|2010-04-27||August 2003||2003-08-01|November 2016|2016-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Treatment of Language and Memory in Patients With Alzheimer's Disease|Treatment of Language and Memory in Patients With Alzheimer's Disease: A Comparison Between Drug Therapy and Drug Therapy Plus Behavioral Intervention|Completed||Phase 1|11|Actual|University of Arkansas|Recruitment of participants was the major limitation of the trial. Alzheimer's patients at facility were asked to participate in so many studies, that participation in this one was challenging.|2|||f||||f||||||||||2017-02-18 14:52:59.607174|2017-02-18 14:52:59.607174
NCT00593359|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-02-19|||December 2007||2007-12-01|February 2016|2016-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Intraocular Pressure During Spine Surgery|The Effect of Lactated Ringer's Solution Versus Albumin and the Alpha-2 Agonist Brimonidine Versus Placebo on Intraocular Pressure During Prone Spine Surgery|Completed||N/A|60|Actual|The Cleveland Clinic|||4||f||||f||||||||||2017-02-18 14:53:00.145264|2017-02-18 14:53:00.145264
NCT00593346|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-06-01|2015-04-13||March 2004||2004-03-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Evaluation of Accelerated Partial Breast Brachytherapy|Evaluation of Accelerated Partial Breast Brachytherapy as the Sole Method of Radiation Therapy for Stage 0, 1 and II Lymph Node Negative Breast Carcinoma|Completed||N/A|151|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:53:00.259475|2017-02-18 14:53:00.259475
NCT00593333|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-09-05|2013-09-05||June 2003||2003-06-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|TROCHNAIL||Intramedullary Nailing of the Femur:Trochanteric vs Piriformis Starting Portals|Intramedullary Nailing of the Femur: A Comparison of the Trochanteric and Piriformis Starting Portals|Completed||N/A|110|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:53:00.722678|2017-02-18 14:53:00.722678
NCT00593320|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-02-18|2015-02-18||September 2007||2007-09-01|February 2015|2015-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|SRS||Stereotactic Radiosurgery (SRS) for Spine Metastases|Stereotactic Radiosurgery (SRS) for One or Two Localized Spine Metastases|Terminated||N/A|2|Actual|Washington University School of Medicine||2||Due to low accrual|f||||f||||||||||2017-02-18 14:53:01.162607|2017-02-18 14:53:01.162607
NCT00593307|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-06-28|||January 2006||2006-01-01|January 2008|2008-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|Breakfast||The Breakfast Study|The Effects of Low and High Glycemic Index Foods and Protein on Glycemic Response and Hunger|Completed||N/A|24|Actual|Temple University||4|||f||||f||||||||||2017-02-18 14:53:01.58068|2017-02-18 14:53:01.58068
NCT00593294|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2008-01-14|||January 2006||2006-01-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Oral Contraceptive and Cardiovascular Risk in PCOS|Comparison of Oral Contraceptive Versus Physical Exercise Effects on Cardiovascular and Metabolic Risk Factors in PCOS Women|Completed||Phase 4|150|Actual|Federico II University||3|||f||||f||||||||||2017-02-18 14:53:01.689696|2017-02-18 14:53:01.689696
NCT00593281|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-01-11|||January 2006||2006-01-01|January 2008|2008-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|INFUSE||INFUSE Morphine Study|INcreased Flow Utilizing Subcutaneously Enabled Morphine (INFUSE-Morphine) With and Without Human Recombinant Hyaluronidase (HYLENEX) and Intravenously|Completed||Phase 3|13|Actual|Halozyme Therapeutics||3|||f||||f||||||||||2017-02-18 14:53:01.817|2017-02-18 14:53:01.817
NCT00593268|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-06-14|||June 2004||2004-06-01|January 2008|2008-01-01|November 2013|Anticipated|2013-11-01|November 2013|Anticipated|2013-11-01||Observational|||Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage|Biological Markers of Vasospasm in Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage|Unknown status|Active, not recruiting|N/A|150|Anticipated|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     cerebrospinal fluid and blood~   "|||2017-02-18 14:53:01.922404|2017-02-18 14:53:01.922404
NCT00593255|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-12-21|||July 2004||2004-07-01|December 2016|2016-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes|A Multi-centre, Randomised, Parallel, Open Labelled Study to Compare the Efficiency and Safety Profile of Insulin Aspart (NovoRapid®) and Human Soluble Insulin (Novolin® R) as Meal Related Insulin in a Three Times Daily Regimen With One Injection of Novolin® N at Bedtime in Chinese Type 1 and 2 Diabetics|Completed||Phase 4|220|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:53:02.027661|2017-02-18 14:53:02.027661
NCT00593242|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-03-11|||January 2008||2008-01-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy|Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy Study 1. Phase I Study of Feasibility and Safety.|Active, not recruiting||Phase 1|52|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:53:02.134932|2017-02-18 14:53:02.134932
NCT00593229|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-06-18|||January 2007||2007-01-01|June 2013|2013-06-01||||October 2011|Actual|2011-10-01||Observational|||International Registry and Biorepository for TMA(Thrombotic Microangiopathy)|An Observational Study of All Forms of Thrombotic Microangiopathy in Pediatric Patients|Terminated||N/A|6|Actual|Northwell Health|||4|study stopped at this site, as investigator left the institution|f||||f||||||Samples With DNA|"~     Serum, plasma, urine, and DNA~   "|||2017-02-18 14:53:02.246774|2017-02-18 14:53:02.246774
NCT00593216|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2011-06-21|||July 2007||2007-07-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Diagnosis Of Vertigo With New Imaging|New Diagnosis Of Vestibular Vertigo With Functional MRI|Completed||N/A|4|Actual|Boston University|||2||f||||f||||||||||2017-02-18 14:53:02.351312|2017-02-18 14:53:02.351312
NCT00593203|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-01-02|||May 2003||2003-05-01|January 2008|2008-01-01||||December 2010|Anticipated|2010-12-01||Observational|||Brain Tissue Specimen Collection|Molecular Neurosurgical Tissue Bank|Unknown status|Enrolling by invitation|N/A|500|Anticipated|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     Brain Tissue, blood and cerebral spinal fluid~   "|||2017-02-18 14:53:02.459461|2017-02-18 14:53:02.459461
NCT00593190|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2008-01-11|||January 2008||2008-01-01|January 2008|2008-01-01||||December 2008|Anticipated|2008-12-01||Interventional|||Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus||Unknown status|Recruiting|N/A|10|Anticipated|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-02-18 14:53:02.533036|2017-02-18 14:53:02.533036
NCT00593177|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-08-18|||October 2007||2007-10-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis|A Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of 0.10% or 0.05% PTH (1-34) Gel Versus Placebo Gel in the Treatment of Mild to Moderate Plaque Psoriasis.|Completed||Phase 2|61|Actual|Manhattan Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:53:02.624008|2017-02-18 14:53:02.624008
NCT00593164|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-09-06|||February 2017||2017-02-01|September 2016|2016-09-01|April 2018|Anticipated|2018-04-01|February 2018|Anticipated|2018-02-01||Interventional|||Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients With Intravenous Infusion of Magnesium Sulfate|Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients With Intravenous Infusion of Magnesium Sulfate|Not yet recruiting||Phase 2|14|Anticipated|Life Recovery Systems||2|||f||||t||||||||||2017-02-18 14:53:02.743387|2017-02-18 14:53:02.743387
NCT00593151|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2012-02-01|||January 2008||2008-01-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|PLUS||Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C|An Open-Label, 3-Panel, Dose-Escalation Study to Assess the Safety and Tolerability, Pharmacokinetics, and Viral Kinetics of Two Doses of LocteronTM (Poly ActiveTM - Interferon Alpha 2b) Given Every 2 Weeks for 4-12 Weeks in Comparison With PEG-Intron Given Weekly for 4-12 Weeks in Patients With Chronic Hepatitis C|Completed||Phase 1/Phase 2|32|Actual|Biolex Therapeutics, Inc.||3|||f||||t||||||||||2017-02-18 14:53:02.866736|2017-02-18 14:53:02.866736
NCT00593138|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-10-21|||December 2006||2006-12-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate|A Randomized Open-label Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate (20 mg, 30 mg, and 40 mg) as Measured With C-11 Altropane in Healthy Adult Volunteers|Completed||Phase 1/Phase 2|23|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 14:53:02.994772|2017-02-18 14:53:02.994772
NCT00593125|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2017-01-11|||January 2007||2007-01-01|September 2016|2016-09-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|Keppra||Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.|Levetiracetam (Keppra) Tolerability and Efficacy in Cocaine Abusing Methadone-maintained Patients.|Completed||Phase 2|15|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 14:53:03.110629|2017-02-18 14:53:03.110629
NCT00592280|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2010-04-16|||October 2007||2007-10-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Two-Layer Method Preservation and Resuscitation of the Cadaveric Pancreas Before Transplantation|Two-Layer Method Preservation and Resuscitation of the Cadaveric Pancreas Before Transplantation|Terminated||Phase 1|7|Actual|University of Nebraska||1||Logistic problems with adequately timely organ collection and transport|f||||t||||||||||2017-02-18 14:53:19.119637|2017-02-18 14:53:19.119637
NCT00593112|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-08-22|2011-01-07||November 2006||2006-11-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate|A Pilot Study of Proton Magnetic Spectroscopy in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) Before and After Treatment With Osmotic-controlled Release Oral Delivery System (OROS) Methylphenidate|Completed||Phase 4|39|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:53:03.215965|2017-02-18 14:53:03.215965
NCT00593099|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2017-01-10|||April 2004||2004-04-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder|A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder|Completed||Phase 1/Phase 2|5|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 14:53:03.596389|2017-02-18 14:53:03.596389
NCT00593086|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-02-25|||June 2007||2007-06-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Interventional|||Virtual Reality in Burn Pain Management|The Use of Virtual Reality Video Games to Control Procedural Pain During Burn Wound Care|Completed||N/A|26|Actual|United States Army Institute of Surgical Research||2|||f||||f||||||||||2017-02-18 14:53:03.699017|2017-02-18 14:53:03.699017
NCT00593073|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2008-09-10|||July 2005||2005-07-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Use of Novel Tailored Reminders in Rural Primary Care|Use of Novel Tailored Reminders in Rural Primary Care|Completed||N/A|707|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 14:53:03.90753|2017-02-18 14:53:03.90753
NCT00593060|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2011-12-01|||October 2007||2007-10-01|December 2011|2011-12-01|October 2010|Actual|2010-10-01|October 2009|Actual|2009-10-01||Interventional|||Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer|A Phase I Trial of Temsirolimus (CCI-779, Torisel) Combined With Cetuximab (Erbitux) in Cetuximab-Refractory Colorectal Cancer|Completed||Phase 1|30|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:53:04.003289|2017-02-18 14:53:04.003289
NCT00593047|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-11-27|||November 2007||2007-11-01|May 2008|2008-05-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin|A Phase II, Placebo-Controlled, Double-Blind, Randomised, 12-Week, Parallel-Group Study to Assess the Efficacy of Different Doses of KB2115 as Add on to Statin Treatment in Patients With Dyslipidemia|Completed||Phase 2|180|Anticipated|Karo Bio AB||4|||f||||t||||||||||2017-02-18 14:53:04.102724|2017-02-18 14:53:04.102724
NCT00593034|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2011-03-07|||February 2007||2007-02-01|March 2011|2011-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Medical Office Intervention for Adolescent Drug Use - Attention Study Supplement|Medical Office Intervention for Adolescent Drug Use - Research Supplement for Under-represented Minorities|Completed||N/A|42|Actual|Boston Children’s Hospital|||1||f||||t||||||||||2017-02-18 14:53:04.1995|2017-02-18 14:53:04.1995
NCT00593021|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-08-07|||October 2007||2007-10-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Diagnostic Evaluation of Obscure Gastrointestinal Bleeding|Diagnostic Evaluation of Obscure Gastrointestinal Bleeding|Withdrawn||N/A|0|Actual|Brigham and Women's Hospital|||1|Lack of funding|f||||f||||||||||2017-02-18 14:53:04.29648|2017-02-18 14:53:04.29648
NCT00593008|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2011-12-01|||October 2007||2007-10-01|December 2011|2011-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer|A Phase 1 Study of Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer|Terminated||Phase 1|5|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:53:04.374432|2017-02-18 14:53:04.374432
NCT00592995|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2014-01-10||2014-01-10|December 2007||2007-12-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PRECREST||Creatine Safety and Tolerability in Premanifest HD: PRECREST|Creatine Safety and Tolerability in Premanifest HD: PRECREST|Completed||Phase 2|64|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:53:04.471045|2017-02-18 14:53:04.471045
NCT00592982|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-10-24|||October 2006||2006-10-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging|Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging|Completed||N/A|25|Actual|University of Arkansas|||1||f||||f||||||||||2017-02-18 14:53:04.578206|2017-02-18 14:53:04.578206
NCT00592969|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-10-18|||December 2003||2003-12-01|October 2013|2013-10-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes|Evaluation of Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart or Insulin NPH in Subjects With Type 2 Diabetes|Completed||Phase 4|164|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:53:04.664709|2017-02-18 14:53:04.664709
NCT00592943|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-10-21|2011-02-15||October 2007||2007-10-01|October 2013|2013-10-01|May 2010|Actual|2010-05-01|May 2008|Actual|2008-05-01||Interventional|||PET Study Examining the Dopaminergic Activity of Armodafinil in Adults|A PET Study Examining the Dopaminergic Activity of Armodafinil in Adults|Completed||Phase 1/Phase 2|12|Actual|Massachusetts General Hospital|Extracellular dopamine could compete with [11C] altropane, causing an overestimation of DAT occupancy. Time between scans and menstrual cycle could be sources of variability. Brain pathology although unlikely in normal subjects, is possible.|2|||f||||f||||||||||2017-02-18 14:53:04.758692|2017-02-18 14:53:04.758692
NCT00592930|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-01-11|||June 2000||2000-06-01|January 2008|2008-01-01|December 2004||2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Olanzapine in the Treatment of Anorexia Nervosa|Pilot Study of the Efficacy of Olanzapine in the Treatment of Anorexias Nervosa|Completed||Phase 4|20||Northwell Health||2|||f||||f||||||||||2017-02-18 14:53:05.53444|2017-02-18 14:53:05.53444
NCT00592917|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2008-01-11|||August 2002||2002-08-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|OSTPRE-FPS||OSTPRE-Fracture Prevention Study|OSTPRE-FPS Prevention of Fractures and Falls in Postmenopausal Women With Calcium and Vitamin-D Supplementation - a Randomised Study|Completed||Phase 4|3432|Actual|Kuopio University Hospital||4|||f||||f||||||||||2017-02-18 14:53:05.6455|2017-02-18 14:53:05.6455
NCT00592267|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-10-05|||September 2001||2001-09-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Screening Protocol for Children and Adolescents With Bipolar and Bipolar Spectrum Disorder|A Screening Protocol for Children and Adolescents With Bipolar and Bipolar Spectrum Disorder|Recruiting||N/A|1000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-02-18 14:53:19.226737|2017-02-18 14:53:19.226737
NCT00592904|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2015-12-17|2012-10-23||January 2008||2008-01-01|November 2015|2015-11-01|July 2011|Actual|2011-07-01|November 2009|Actual|2009-11-01||Interventional|||Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)|A Multi-Center, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)|Completed||Phase 2/Phase 3|262|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 14:53:05.789316|2017-02-18 14:53:05.789316
NCT00592891|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-01-01|||April 2002||2002-04-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Oxygen Toxicity of HBOT in Chronic Brain Injury|Oxygen Toxicity Effects Using Los-Pressure Hyperbaric Oxygen Therapy in the Treatment of Chronic Brain Injury|Unknown status|Recruiting|Phase 1|45|Anticipated|Louisiana State University Health Sciences Center in New Orleans||1|||f||||f||||||||||2017-02-18 14:53:06.884226|2017-02-18 14:53:06.884226
NCT00592865|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-07|2008-01-11|||October 2003||2003-10-01|January 2008|2008-01-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|||Risk Factors for Adult-Onset Brain Tumors|Genetic Epidemiology of Adult Brain Tumors|Unknown status|Enrolling by invitation|N/A|750|Anticipated|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     Mouthwash and salvia samples. Toenail samples are also collected.~   "|||2017-02-18 14:53:06.991589|2017-02-18 14:53:06.991589
NCT00592852|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-11-13|2011-07-28||December 2005||2005-12-01|November 2012|2012-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder|A Pilot Treatment Study of Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder|Terminated||Phase 4|13|Actual|Massachusetts General Hospital||1||Slow subject recruitment.|f||||f||||||||||2017-02-18 14:53:07.079117|2017-02-18 14:53:07.079117
NCT00592839|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-07-12|2010-02-04||December 2007||2007-12-01|July 2013|2013-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women|A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of SCE-B on Nocturnal Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 4|157|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-02-18 14:53:07.346113|2017-02-18 14:53:07.346113
NCT00592826|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2015-04-13|||November 2007||2007-11-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||HMP (Home Macular Perimeter) -Usability Trial|Phase III Study of the Usability of the HMP Device|Completed||N/A|25|Actual|Notal Vision Ltd|||1||f||||t||||||||||2017-02-18 14:53:07.965597|2017-02-18 14:53:07.965597
NCT00592813|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-04-22|||April 2008||2008-04-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy of a Post-Rehabilitation Exercise Intervention|Efficacy of a Post-Rehabilitation Exercise Intervention|Completed||N/A|232|Actual|Boston University||2|||f||||t||||||||||2017-02-18 14:53:08.042469|2017-02-18 14:53:08.042469
NCT00592800|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2009-09-14|||August 2007||2007-08-01|September 2009|2009-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Understanding Probability in Children|Evaluation of the Understanding of Probability in Children|Terminated||N/A|165|Actual|Children's Hospital of Philadelphia|||3|Lack of study funding & resources|f||||f||||||||||2017-02-18 14:53:08.150125|2017-02-18 14:53:08.150125
NCT00592774|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-02-07|2012-10-23||January 2008||2008-01-01|February 2013|2013-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Tolerability Titration Study To Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)|Completed||Phase 2|146|Actual|Eisai Inc.||5|||f||||||||||||||2017-02-18 14:53:08.242961|2017-02-18 14:53:08.242961
NCT00592761|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2010-07-27|2010-01-25||July 2003||2003-07-01|July 2010|2010-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Dysphagia Using the Mendelsohn Maneuver|Treatment of Dysphagia Using the Mendelsohn Maneuver|Completed||Phase 1/Phase 2|18|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:53:09.63287|2017-02-18 14:53:09.63287
NCT00592748|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2009-08-07|||June 1999||1999-06-01|August 2009|2009-08-01||||January 2006|Actual|2006-01-01||Interventional|||Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine|Randomized Study of Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine|Unknown status|Active, not recruiting|Phase 1/Phase 2|274|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:53:09.903355|2017-02-18 14:53:09.903355
NCT00592735|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2016-06-05|||May 2007||2007-05-01|June 2016|2016-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|BOS||Effects of Medical and Surgical Weight Loss on Metabolism|The Role of Adipocyte-derived Inflammatory Cytokines in the Pathogenesis of Diabetes, Dyslipidaemia, Atherosclerosis and Gastro-oesophageal Reflux Disease: the Effects of Medical and Surgical Weight Loss|Completed||N/A|20|Actual|Garvan Institute of Medical Research|||1||f||||f||||||Samples With DNA|"~     serum, tissue~   "|||2017-02-18 14:53:10.002511|2017-02-18 14:53:10.002511
NCT00592722|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2009-07-02|||December 2007||2007-12-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Observational|||A Multi-Centre Clinical Study in Chronic Spinal Cord Injury Patients|A Multi-Centre Clinical Study in Chronic Spinal Cord Injury Patients|Completed||N/A|60|Actual|China Spinal Cord Injury Network|||1||f||||f||||||||||2017-02-18 14:53:12.559388|2017-02-18 14:53:12.559388
NCT00592709|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2013-06-14|||May 2003||2003-05-01|June 2013|2013-06-01||||December 2010|Actual|2010-12-01||Observational|||Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry|Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry|Completed||N/A|150|Anticipated|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     Brain Tissue~   "|||2017-02-18 14:53:12.666558|2017-02-18 14:53:12.666558
NCT00592696|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-03-27|||December 2006||2006-12-01|March 2014|2014-03-01|February 2010|Actual|2010-02-01|May 2008|Actual|2008-05-01||Observational|||TRIAD Project: Qualitative Study of Adolescent Depression and Smoking|TRIAD Project: Qualitative Study of Adolescent Depression and Smoking|Completed||N/A|30|Actual|Drexel University|||1||f||||f||||||||||2017-02-18 14:53:12.746185|2017-02-18 14:53:12.746185
NCT00592254|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-10-05|||December 2002||2002-12-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Screening Protocol for Adults With ADHD|A Screening Protocol for Adults With Attention Deficit Hyperactivity Disorder|Recruiting||N/A|3000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-02-18 14:53:19.376166|2017-02-18 14:53:19.376166
NCT00592683|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-03-09|2011-07-15||December 2007||2007-12-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents|A Randomized Placebo Controlled Clinical Trial of Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents Ages 6-17 With Bipolar Spectrum Disorder|Terminated||Phase 4|20|Actual|Massachusetts General Hospital||2||Supply Omega-3 Fatty Acids expired and supplier no longer made same composition.|f||||f||||||||||2017-02-18 14:53:12.838401|2017-02-18 14:53:12.838401
NCT00592670|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2014-12-10|||March 2005||2005-03-01|December 2014|2014-12-01|October 2008|Actual|2008-10-01|June 2007|Actual|2007-06-01||Interventional|||Hypoglycemia Associated Autonomic Failure in Type 1 DM|Hypoglycemia Associated Autonomic Failure in Type 1 DM, Question 6|Completed||N/A|48|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:53:13.264466|2017-02-18 14:53:13.264466
NCT00592657|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2008-07-25|||January 2008||2008-01-01|July 2008|2008-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions|Incidence of Rhabdomyolysis Among Pediatric and Adolescent Patients Admitted for Jimsonweed (Datura Stramonium) Ingestions|Completed||N/A|46|Actual|Akron Children's Hospital|||2||f||||f||||||||||2017-02-18 14:53:13.390279|2017-02-18 14:53:13.390279
NCT00592644|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2011-03-29|||March 2005||2005-03-01|March 2011|2011-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Laser Treatment Of Vascular Lesions On Vocal Cords|Laser Atraumatic Treatment Of Ectasias On Vocal Cords|Completed||Phase 2|7|Actual|Boston University||2|||f||||f||||||||||2017-02-18 14:53:13.500655|2017-02-18 14:53:13.500655
NCT00592631|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-01-12|2015-11-12||February 2005||2005-02-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Assessment Of The Effects Of Short and Long Term Use Of CPAP|Assessment of the Effects of Short and Long Term Use of Continuous Positive Airway Pressure on Airway Reactivity in Children and Adults With and Without Asthma|Terminated||N/A|27|Actual|Indiana University||2||Key investigator resigned|f||||f||||||||||2017-02-18 14:53:13.615503|2017-02-18 14:53:13.615503
NCT00592618|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2008-01-11||||||May 2007|2007-05-01||||||||Interventional|||Effect of NAC on Sleep Apnea||Unknown status|Not yet recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 14:53:14.142878|2017-02-18 14:53:14.142878
NCT00592605|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-06-30|||May 2007||2007-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Thyroid Disease Serum Repository|Thyroid Disease Serum Repository|Suspended||N/A|1000|Anticipated|University of Arkansas|||1|Suspended by institution for further review|f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:53:14.250724|2017-02-18 14:53:14.250724
NCT00592592|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-09-01|||October 2004||2004-10-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2020|Anticipated|2020-06-01||Interventional|||Proton RT for the Treatment of Pediatric Rhabdomyosarcoma|A Phase II Trial of Proton RT for the Treatment of Pediatric Rhabdomyosarcoma|Recruiting||Phase 2|110|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:53:14.332488|2017-02-18 14:53:14.332488
NCT00592579|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2009-02-25|||March 2001||2001-03-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma|Phase 2, Open-Label, Safety, and Efficacy Study of 2-Methoxyestradiol Administered to Patients With Plateau Phase or Relapsed Multiple Myeloma|Completed||Phase 2|60|Actual|CASI Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 14:53:14.481178|2017-02-18 14:53:14.481178
NCT00592566|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2008-01-11|||July 2003||2003-07-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis|An Open Randomized Controlled Trial of Desmopressin, and Dexamethasone as Adjunctive Therapy in Patients With Pulmonary Hemorrhage Associated With Leptospirosis|Terminated||Phase 2/Phase 3|64|Actual|Mahidol University||3||Numbe of eligible patients has been decreased over time.|f||||f||||||||||2017-02-18 14:53:14.586028|2017-02-18 14:53:14.586028
NCT00592553|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2013-09-06||2011-07-11|February 2008||2008-02-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)|A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy|Completed||Phase 2/Phase 3|174|Actual|PTC Therapeutics||3|||f||||t||||||||||2017-02-18 14:53:14.700738|2017-02-18 14:53:14.700738
NCT00592540|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-11-22|||June 2006||2006-06-01|November 2016|2016-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Unrelated Donor BMT for Treatment of Patients With PGK Deficiency|Unrelated Donor Bone Marrow Transplantation for Definitive Treatment of Patients With Phosphoglycerate Kinase (PGK) Deficiency|Completed||N/A|2|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 14:53:14.847437|2017-02-18 14:53:14.847437
NCT00592527|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2017-01-26|||April 2004||2004-04-01|January 2017|2017-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes|Evaluation of Insulin Detemir in Combination With OADs in Type 2 Diabetes Mellitus|Completed||Phase 3|132|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:53:14.948552|2017-02-18 14:53:14.948552
NCT00592514|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2011-08-31|||July 2005||2005-07-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Thyroid Dysfunction in Head and Neck Surgery Patients|Thyroid Dysfunction in Head and Neck Surgery Patients Treated With Intraoperative Oral Administration With Povidone-iodine 10% Solution|Completed||N/A|14|Actual|University of Arkansas|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:53:15.053689|2017-02-18 14:53:15.053689
NCT00592501|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-03-15|||October 2006||2006-10-01|March 2016|2016-03-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma|A Phase II Study of Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma|Active, not recruiting||Phase 2|25|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:53:15.167946|2017-02-18 14:53:15.167946
NCT00592488|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-01-16|2011-03-17||August 2006||2006-08-01|January 2014|2014-01-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|ALC||Acetyl-L-Carnitine in the Treatment of Septic Shock|Prospective, Randomized, Placebo-controlled, Double-Blinded, Phase II Pilot Study of Acetyl-L-carnitine in the Treatment of Patients With Septic Shock|Completed||Phase 1/Phase 2|13|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:53:15.280279|2017-02-18 14:53:15.280279
NCT00592475|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-04-30|2010-05-24||December 2007||2007-12-01|April 2014|2014-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients|A Phase 2, Randomized, Double Blind, Placebo Controlled, Dose Escalation Study to Assess the Safety and Effects of Intravenous Conivaptan on the Hepatic Hemodynamic Response in Stable Euvolemic or Hypervolemic Cirrhotic Patients|Completed||Phase 2|20|Actual|Cumberland Pharmaceuticals|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|3|||f||||f||||||||||2017-02-18 14:53:15.637171|2017-02-18 14:53:15.637171
NCT00592462|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2016-10-26|||December 2007||2007-12-01|October 2016|2016-10-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases|Whole Body MRI for Detection of Cancer Metastases|Completed||N/A|32|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 14:53:16.717956|2017-02-18 14:53:16.717956
NCT00592449|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2014-03-10|||April 2008||2008-04-01|March 2014|2014-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|SOAP||Sleep in Osteoarthritis Project|Sleep Disturbance, Central Pain Modulation, and Clinical Pain in Osteoarthritis (The SOAP Study)|Completed||Phase 2|190|Anticipated|Johns Hopkins University||6|||f||||t||||||||||2017-02-18 14:53:16.829175|2017-02-18 14:53:16.829175
NCT00592436|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-05-05|||March 2003||2003-03-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder|A Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder|Terminated||N/A|663|Actual|Massachusetts General Hospital|||1|New protocol developed for recruitment of children for all child studies|f||||f||||||||||2017-02-18 14:53:16.938463|2017-02-18 14:53:16.938463
NCT00592423|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2009-09-14|||January 2005||2005-01-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||CPAP and Lateral Neck Rotation on Anesthetized Children|Effect of Neck Rotation and Continuous Positive Airway Pressure (CPAP) on Upper Airway Anatomy in Anesthetized Children - an MRI Study|Terminated||N/A|12|Actual|Children's Hospital of Philadelphia||1||Preliminary data was inconclusive to warrant keeping the study open.|f||||f||||||||||2017-02-18 14:53:17.050154|2017-02-18 14:53:17.050154
NCT00592410|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-08-04|||February 2007||2007-02-01|August 2011|2011-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||The Effects of Intensive Insulin on Somatic and Visceral Protein Turnover in Acute Kidney Injury (AKI)|The Effects of Intensive Insulin on Somatic and Visceral Protein Turnover in Acute Kidney Injury (AKI)|Withdrawn||Phase 2|0|Actual|Vanderbilt University||1||no enrollment|f||||f||||||||||2017-02-18 14:53:17.138464|2017-02-18 14:53:17.138464
NCT00592397|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2017-01-27|||March 2006||2006-03-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Prestudy: Lifestyle and Cardiovascular Disease|Prestudy: Lifestyle and Cardiovascular Disease|Completed||N/A|5|Actual|Norwegian University of Science and Technology||1|||f||||t||||||||No||2017-02-18 14:53:17.228588|2017-02-18 14:53:17.228588
NCT00592384|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2014-12-31|2014-06-11||July 2007||2007-07-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|PRISMS||Project to Improve Symptoms and Mood in People With Spinal Cord Injury|A Controlled Trial of Venlafaxine XR for Major Depression After Spinal Cord Injury: A Multi-site Study|Completed||Phase 4|133|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 14:53:17.341773|2017-02-18 14:53:17.341773
NCT00592371|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2012-09-04|||March 2006||2006-03-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Head and Neck Cancer Screening and Serum Repository|Head and Neck Cancer Screening and Serum Repository|Completed||N/A|300|Actual|University of Arkansas|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:53:17.989958|2017-02-18 14:53:17.989958
NCT00592358|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-06-04|2012-03-09||November 2007||2007-11-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder|Open-Label Study of Invega for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Terminated||Phase 4|17|Actual|Massachusetts General Hospital||1||Slow enrollment.|f||||f||||||||||2017-02-18 14:53:18.078289|2017-02-18 14:53:18.078289
NCT00592345|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2017-02-02|||May 1999||1999-05-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2005|Actual|2005-03-01||Interventional|||High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum|High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum|Completed||Phase 1/Phase 2|50|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:53:18.351649|2017-02-18 14:53:18.351649
NCT00592332|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2014-12-10|||June 2005||2005-06-01|December 2014|2014-12-01|June 2009|Actual|2009-06-01|June 2007|Actual|2007-06-01||Interventional|||Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2|Hypoglycemia Associated Autonomic Failure in Type 1 DM, Question 2|Completed||N/A|56|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:53:18.450272|2017-02-18 14:53:18.450272
NCT00592319|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2012-08-24|2012-05-03||May 2005||2005-05-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Celebrex (Celecoxib) Treatment of Laryngeal Papilloma|Voice-preserving Treatment of Laryngeal Papilloma|Terminated||Phase 2|10|Actual|Boston University|We failed to recruit a total of 30 cases, due to (1) This disease is relative less common in clinic; and (2) particularly, more and more of patients now had a serious concern in safety of Celebrex due to news and warnings to public in recent years.|2||03/01/2009,due to date close to termination of this funding/study period|f||||f||||||||||2017-02-18 14:53:18.552428|2017-02-18 14:53:18.552428
NCT00592306|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2008-06-04|||January 2006||2006-01-01|June 2008|2008-06-01|September 2009|Anticipated|2009-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation|A Prospective Single Center Randomized Trial of Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation.|Unknown status|Recruiting|Phase 3|120|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 14:53:18.913563|2017-02-18 14:53:18.913563
NCT00592293|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-09-01|||September 2006||2006-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas|Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas|Active, not recruiting||Phase 2|70|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:53:19.016022|2017-02-18 14:53:19.016022
NCT00592241|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-04-06|||November 2007||2007-11-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Self Operating of the ADI Insulin Pump By Intended Users - A Usability Study|Self Operating of the ADI Insulin Pump By Intended Users - A Usability Study|Completed||N/A|30|Anticipated|NiliMedix||1|||f||||t||||||||||2017-02-18 14:53:19.62857|2017-02-18 14:53:19.62857
NCT00592228|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2010-12-20|||January 2007||2007-01-01|December 2010|2010-12-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|DEFER-DES||Proper Fractional Flow Reserve Criteria for Intermediate Lesions in the Era of Drug-eluting Stent|Deferral of Angioplasty According to Fractional Flow Reserve vs. Routine Drug-eluting Stent Implantation in Intermediate Coronary Stenosis|Terminated||N/A|250|Anticipated|Seoul National University Hospital||2||due to slow enrollment|f||||t||||||||||2017-02-18 14:53:19.7322|2017-02-18 14:53:19.7322
NCT00592215|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2009-06-09|||March 2008||2008-03-01|June 2009|2009-06-01|October 2010|Anticipated|2010-10-01|April 2010|Anticipated|2010-04-01||Interventional|||Second Trimester Labor Induction|A Pilot Study of Mifepristone Followed by Misoprostol in Women Undergoing Second Trimester Abortion|Terminated||Phase 1|0|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 14:53:19.82665|2017-02-18 14:53:19.82665
NCT00592202|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2014-03-31|||December 2004||2004-12-01|March 2014|2014-03-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents|Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents|Completed||N/A|37|Actual|University of Illinois at Chicago||1|||f||||f||||||||||2017-02-18 14:53:20.123296|2017-02-18 14:53:20.123296
NCT00592189|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-06-23|||December 1999||1999-12-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|Amnion||Study of Donated Amnion, Fetal Placental Membrane, as Skin Substitute for Burn Patients|Fetal Membrane as a New Coverage Material|Completed||Early Phase 1|1164|Actual|The University of Texas Medical Branch, Galveston||1|||f||||f||||||||||2017-02-18 14:53:20.223272|2017-02-18 14:53:20.223272
NCT00592176|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-05-20|2012-05-21||August 2007||2007-08-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Effect of Bevacizumab (Avastin) on Pterygium|The Effect of Bevacizumab (Avastin) on Pterygium|Completed||Phase 2|5|Actual|University of Alabama at Birmingham|Initially we aimed for 10 to 15 subjects but only enrolled 5 subjects.|1|||f||||f||||||||||2017-02-18 14:53:20.317276|2017-02-18 14:53:20.317276
NCT00592163|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-18|||December 2007||2007-12-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas|Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|Ziopharm||1|||f||||||||||||||2017-02-18 14:53:20.561649|2017-02-18 14:53:20.561649
NCT00592150|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-01-22|||June 2007||2007-06-01|January 2013|2013-01-01|June 2013|Anticipated|2013-06-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Gene Variants on Dopamine Receptor Natriuretic Responses|Effect of Gene Variants on Dopamine Receptor Natriuretic Responses (RMC033)|Unknown status|Active, not recruiting|Phase 1|44|Anticipated|University of Virginia||2|||f||||f||||||||||2017-02-18 14:53:20.656891|2017-02-18 14:53:20.656891
NCT00592137|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2010-01-12|||April 2004||2004-04-01|January 2010|2010-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Calcium, Dairy, and Body Fat in Adolescents|Calcium, Dairy, and Body Fat in Adolescents|Completed||N/A|43|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 14:53:20.769682|2017-02-18 14:53:20.769682
NCT00592124|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2013-06-24|||June 2008||2008-06-01|June 2013|2013-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women|Phase 2 Adherence and Pharmacokinetics Study of Oral and Vaginal Preparations of Tenofovir|Completed||Phase 2|168|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-02-18 14:53:20.882886|2017-02-18 14:53:20.882886
NCT00592111|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-21|||March 1996||1996-03-01|December 2015|2015-12-01|January 2008|Actual|2008-01-01|February 1999|Actual|1999-02-01||Interventional|||A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)|A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)|Completed||Phase 2|21|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 14:53:21.018061|2017-02-18 14:53:21.018061
NCT00592098|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-29|2008-01-10|||August 2007||2007-08-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain.|A Double-Blind, Placebo-Controlled Cross-Over Study to Evaluate the Efficacy of 2PX (Topical Strontium Chloride Hexahydrate) in Patients With Persistent, Moderate-to-Severe Lower Limb Post-Amputation Stump Pain.|Completed||Phase 2|22|Anticipated|SantoSolve AS||2|||f||||f||||||||||2017-02-18 14:53:21.138296|2017-02-18 14:53:21.138296
NCT00592085|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-07-18|||December 2007||2007-12-01|September 2009|2009-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Combined Treatment for Tobacco and Alcohol Use|Combined Treatment for Tobacco and Alcohol Use|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||2||No patients registered; study terminated.|f||||t||||||||||2017-02-18 14:53:21.234916|2017-02-18 14:53:21.234916
NCT00592072|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-01-08|2013-02-04||July 2005||2005-07-01|January 2015|2015-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||The baseline number of subjects reflects the number of subjects with baseline data|Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes|Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes|Completed||N/A|12|Actual|Yale University|No technical limitations were seen.|2|||f||||f||||||||||2017-02-18 14:53:21.348097|2017-02-18 14:53:21.348097
NCT00592059|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2007-12-31|||November 2007||2007-11-01|December 2007|2007-12-01|November 2012|Anticipated|2012-11-01|November 2009|Anticipated|2009-11-01||Observational|||Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer|A Phase II Study of Systemic Consolidation Therapy With Paclitaxel Plus Carboplatin Following Radical Hysterectomy and Adjuvant Chemoradiation for High Risk Early Stage Cervical Cancer|Unknown status|Recruiting|N/A|77|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-02-18 14:53:22.000115|2017-02-18 14:53:22.000115
NCT00592033|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2012-03-21|||May 2007||2007-05-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Oxygen in Normoxaemic COPD Patients Who Desaturate During Exercise|Effect of Ambulatory Oxygen in Normoxaemic COPD Patients Who Desaturate During Exercise. A Randomised Placebo Controlled Trial of Patients Who Participate in Pulmonary Rehabilitation|Completed||Phase 4|45|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 14:53:22.17958|2017-02-18 14:53:22.17958
NCT00592020|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2011-05-20|||January 2008||2008-01-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Short Transverse Versus Conventional Hockey Stick Incision in Kidney Transplantation|"Short Transverse Versus Conventional Hockey Stick Incision in Kidney Transplantation"|Completed||N/A|50|Anticipated|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 14:53:22.281227|2017-02-18 14:53:22.281227
NCT00592007|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-12|||September 2007||2007-09-01|July 2012|2012-07-01|July 2012|Anticipated|2012-07-01|January 2012|Actual|2012-01-01||Interventional|||Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer|Phase II Trial Evaluating Addition of Fulvestrant to Erlotinib in Patients With Stage IIIB/IV NSCLC Who Are Stable on Erlotinib and Exhibit Positivity for Estrogen or Progesterone Receptor|Terminated||Phase 2|7|Actual|University of California, San Diego||1||Study was terminated due to slow subject accrual|f||||t||||||||||2017-02-18 14:53:22.380029|2017-02-18 14:53:22.380029
NCT00591994|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-03-06|||November 2006||2006-11-01|December 2007|2007-12-01||||December 2007|Actual|2007-12-01||Interventional|piribedil||Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography|Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography|Completed||N/A|100|Actual|Faculdade de Medicina de Valenca||1|||f||||f||||||||||2017-02-18 14:53:22.497944|2017-02-18 14:53:22.497944
NCT00591981|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-07-22|||August 2007||2007-08-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|TOGA||Thoracic OncoGeriatric Assessment (TOGA) Trials|Preoperative Oncogeriatric Assessment for Thoracic Malignancies|Completed||N/A|14|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 14:53:22.602092|2017-02-18 14:53:22.602092
NCT00591968|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2009-05-06|||January 2008||2008-01-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community|Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community|Completed||N/A|106|Actual|Edward Via Virginia College of Osteopathic Medicine||2|||f||||f||||||||||2017-02-18 14:53:22.71316|2017-02-18 14:53:22.71316
NCT00591955|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-07-11|||January 2006||2006-01-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|October 2008|Actual|2008-10-01||Observational|||Infected Elders in the Emergency Department: Outcomes and Processes of Care|Infected Elders in the Emergency Department: Outcomes and Processes of Care|Completed||N/A|213|Actual|Ohio State University|||1||f||||f||||||||||2017-02-18 14:53:22.827415|2017-02-18 14:53:22.827415
NCT00591942|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-08-02|||November 2004||2004-11-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Outcome Evaluation of Ceramic Crowns Using Two Different Dental Cements|Outcome Evaluation of All Ceramic Crowns and Fixed Partial Dentures Bonded With Two Different Dental Cements.|Completed||Phase 3|36|Actual|University of Iowa||1|||f||||f||||||||||2017-02-18 14:53:22.916334|2017-02-18 14:53:22.916334
NCT00591929|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-03-11|||December 2006||2006-12-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|||Use of Continuous Passive Motion in the Post-Operative Treatment of Intra-articular Knee Fractures|Use of Continuous Passive Motion in the Post-Operative Treatment of Intra-articular Knee Fractures|Completed||N/A|40|Actual|Greenville Health System||2|||f||||f||||||||||2017-02-18 14:53:23.011112|2017-02-18 14:53:23.011112
NCT00591916|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-12-10|||January 2006||2006-01-01|December 2012|2012-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|Donors||New Treatment for Donor Sites|New Treatment for Donor Sites|Withdrawn||Phase 2/Phase 3|0|Actual|The University of Texas Medical Branch, Galveston||3||"Donor site material (scarlet red ) came back on the market, therefore new treatements for~   donor sites was not needed."|f||||f||||||||||2017-02-18 14:53:23.387305|2017-02-18 14:53:23.387305
NCT00591903|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-24|||December 14, 2007||2007-12-14|September 23, 2011|2011-09-23|September 23, 2011||2011-09-23|||||Observational|||Pilot Study to Assess the Proteome in Human Atrial Tissue|Pilot Study to Assess the Proteome in Human Atrial Tissue|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:53:23.490832|2017-02-18 14:53:23.490832
NCT00591890|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-18|||October 2007||2007-10-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|June 2008|Actual|2008-06-01||Interventional|||Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans|Phase IB Study to Evaluate the Biological Activity of Indibulin Using Positron-Emission Tomography (PET) Scans|Completed||Phase 1|20|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 14:53:23.568338|2017-02-18 14:53:23.568338
NCT00591877|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2012-10-25|||December 2012||2012-12-01|October 2012|2012-10-01|January 2015|Anticipated|2015-01-01|May 2014|Anticipated|2014-05-01||Interventional|||A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients|A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients|Withdrawn||N/A|0|Actual|Midwest Biomedical Research Foundation||3||Unable to enroll elegible subjects. No subjects enrolled, study closed.|f||||f||||||||||2017-02-18 14:53:23.656658|2017-02-18 14:53:23.656658
NCT00591864|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-06-06|2014-03-07||September 2008||2008-09-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|MBI||Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation|Comparison of Magnetic Resonance Imaging and Molecular Breast Imaging in Breast Diagnostic Evaluation|Completed||N/A|89|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:53:23.772773|2017-02-18 14:53:23.772773
NCT00591851|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-11-24|2014-11-24||December 2004||2004-12-01|November 2014|2014-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility|Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility|Completed||Phase 2|70|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:53:24.218936|2017-02-18 14:53:24.218936
NCT00591643|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-23|||July 1977||1977-07-01|December 2015|2015-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)|Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)|Completed||Phase 1|93|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:53:27.776526|2017-02-18 14:53:27.776526
NCT00591838|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2017-02-08|||September 21, 2006|Actual|2006-09-21|February 2017|2017-02-01|August 31, 2019|Anticipated|2019-08-31|August 31, 2017|Anticipated|2017-08-31||Interventional|SBRT||A Phase I/II Trial of Stereotactic Body Radiation Therapy|A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT) Dose Escalation in the Treatment of Patients With Inoperable Stage I/II Non-Small Cell Lung Cancer Arising Within the Zone of the Proximal Bronchial Tree|Recruiting||Phase 1/Phase 2|80|Anticipated|Washington University School of Medicine||2|||f||||t|f|t|f|f|f|||No||2017-02-18 14:53:24.491778|2017-02-18 14:53:24.491778
NCT00591825|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-04-12|||March 2006||2006-03-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||fMRI Study Examining Effects of D-cycloserine in Specific Phobia|An fMRI Study Investigating the Effects of Acute D-cycloserine Administration on Brain Activations and Cognitive Functioning in Spider Phobia.|Completed||Phase 2|64|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 14:53:24.625016|2017-02-18 14:53:24.625016
NCT00591812|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-08-23|||April 2000||2000-04-01|August 2016|2016-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Evaluation of the Compress Distal Femoral Replacement System|Evaluation of the Compress Distal Femoral Replacement System|Completed||Phase 1|26|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:53:24.732465|2017-02-18 14:53:24.732465
NCT00591799|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-09-20||2013-09-18|April 2005||2005-04-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Jarvik 2000 Heart as a Bridge to Cardiac Transplantation - Pivotal Trial|Clinical Protocol for Evaluation of the Jarvik 2000 Heart Assist System|Completed||Phase 2/Phase 3|150|Actual|Jarvik Heart, Inc.||1|||f||||t||||||||||2017-02-18 14:53:24.823318|2017-02-18 14:53:24.823318
NCT00591786|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-05-02|||December 2005||2005-12-01|May 2016|2016-05-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||A Bridging Trial Comparing Org 25969 at 1-2 PTC in Japanese and Caucasian Subjects. Part A: Japanese Subjects (19.4.209A)(P05957)(COMPLETED)|A Multi -Center, Randomized, Open -Label, Prospective Bridging, Parallel Dose-Finding Trial Comparing Efficacy, Safety and Pharmacokinetics of 4 Doses of Org 25969 and Placebo Administered at 1-2 PTC After Rocuronium or Vecuronium in Japanese and Caucasian Subjects. Part A: Japanese Subjects.|Completed||Phase 2|100|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:53:24.930907|2017-02-18 14:53:24.930907
NCT00591773|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2011-03-24|2011-03-24||September 2007||2007-09-01|March 2011|2011-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 When Co-administered With Chlorthalidone in Subjects With Essential Hypertension|Completed||Phase 3|551|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:53:25.04957|2017-02-18 14:53:25.04957
NCT00591760|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-10-17|2009-03-23||December 2004||2004-12-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial|Correction of Growth Hormone Deficiency in Patients With Chronic Heart Failure: a Randomized, Controlled, Single-blind Study|Completed||Phase 2|56|Actual|Federico II University||2|||f||||f||||||||||2017-02-18 14:53:26.07445|2017-02-18 14:53:26.07445
NCT00591747|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2015-05-26|||November 2005||2005-11-01|May 2015|2015-05-01|June 2011|Actual|2011-06-01|January 2009|Actual|2009-01-01||Interventional|||Strength Training for Older Breast Cancer Survivors|Strength Training for Older Breast Cancer Survivors|Completed||N/A|106|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-02-18 14:53:26.436336|2017-02-18 14:53:26.436336
NCT00591734|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-01-22|2013-01-22||January 2008||2008-01-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||RAD001 Plus Bevacizumab in Metastatic Melanoma|A Phase II Trial of RAD001 Plus Bevacizumab in the Treatment of Patients With Metastatic Melanoma|Completed||Phase 2|57|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 14:53:26.551016|2017-02-18 14:53:26.551016
NCT00591721|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-02-27|2011-08-19||November 2007||2007-11-01|February 2013|2013-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Teleconference Fatigue Management for People With Multiple Sclerosis|Effectiveness of a Teleconference Delivered Fatigue Management Program for People With Multiple Sclerosis|Completed||N/A|190|Actual|University of Illinois at Chicago|Use of self-report rather than objective measures of MS disability. Only the participants were blinded to their allocation status. Co-intervention was tracked, but there is no way to know whether other interventions contributed to the results.|2|||f||||f||||||||||2017-02-18 14:53:26.909726|2017-02-18 14:53:26.909726
NCT00591708|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-01-10|||July 2004||2004-07-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Calcium Metabolism in Asian Adolescents|Calcium Metabolism in Asian Adolescents|Completed||N/A|34|Actual|Purdue University||2|||f||||t||||||||||2017-02-18 14:53:27.278588|2017-02-18 14:53:27.278588
NCT00591695|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-29|2016-01-20|||January 2008||2008-01-01|January 2016|2016-01-01|July 2018|Anticipated|2018-07-01|July 2015|Actual|2015-07-01||Interventional|ESCO||Enteral Stents for Colonic Obstruction|Prospective, Randomised European Multicentric Study, Comparing Enteral Stent Followed by Elective Surgery Versus Emergency Surgical Treatment in Malignant Colonic Obstruction|Active, not recruiting||Phase 4|144|Actual|European Association for Endoscopic Surgery||2|||f||||t||||||||||2017-02-18 14:53:27.390067|2017-02-18 14:53:27.390067
NCT00591682|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2008-03-24|||November 2007||2007-11-01|March 2008|2008-03-01|March 2009|Anticipated|2009-03-01|December 2008|Anticipated|2008-12-01||Interventional|||MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors|Phase I Dose Escalation Study to Determine the Safety and Pharmacokinetics of MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors|Suspended||Phase 1|27|Anticipated|Metastatix, Inc.||1|||f||||f||||||||||2017-02-18 14:53:27.503429|2017-02-18 14:53:27.503429
NCT00591669|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-04-25|||May 2006||2006-05-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Non-invasive Imaging of GI Inflammation Using Microbubble Contrast Enhanced Ultrasonography|Non-invasive Imaging of GI Inflammation Using Microbubble Contrast Enhanced Ultrasonography|Terminated||N/A|10|Actual|University of Virginia||2||Data storage damage plus unexpected loss of funding|f||||f||||||||||2017-02-18 14:53:27.594744|2017-02-18 14:53:27.594744
NCT00591656|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2007-12-31|||November 2007||2007-11-01|December 2007|2007-12-01|November 2012|Anticipated|2012-11-01|November 2009|Anticipated|2009-11-01||Observational|||Systemic Consolidation Therapy After Primary Chemoradiation Therapy for Locally Advanced Cervical Cancer|A Phase II Study of Systemic Consolidation Therapy With Paclitaxel Plus Carboplatin Following Primary Chemoradiation for Locally Advanced Cervical Cancer|Unknown status|Recruiting|N/A|69|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-02-18 14:53:27.699388|2017-02-18 14:53:27.699388
NCT00591630|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-02-18|||November 2007||2007-11-01|February 2016|2016-02-01||||November 2017|Anticipated|2017-11-01||Interventional|||Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation|Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab Maintenance in Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphomas|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 14:53:27.894165|2017-02-18 14:53:27.894165
NCT00591617|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-01-28|||September 2006||2006-09-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Interventional|OpBup||Optimizing Outcomes Using Suboxone for Opiate Dependence|Optimizing Outcomes Using Suboxone for Opiate Dependence|Completed||N/A|202|Actual|University of California, Los Angeles||4|||f||||t||||||||||2017-02-18 14:53:28.032283|2017-02-18 14:53:28.032283
NCT00591604|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-11-13|||February 2007||2007-02-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|VitaminD||High-Dose Vitamin D Deficiency in Burn Injury|Use of High-Dose Vitamin D to Treat Vitamin D Deficiency Following Severe Burn Injury in Children I: A Pilot Study|Withdrawn||Phase 3|0|Actual|The University of Texas Medical Branch, Galveston||1||"hurricane caused closure of hospital with PI not associated with Shriners Hospital for~   children"|f||||f||||||||||2017-02-18 14:53:28.14135|2017-02-18 14:53:28.14135
NCT00591591|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-03-10|2010-09-22||August 2007||2007-08-01|February 2011|2011-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|NIRS-OSAS||Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers|Absolute Near-Infrared Brain Oximeter|Completed||Phase 3|309|Actual|ISS, Inc.||2|||f||||t||||||||||2017-02-18 14:53:28.288227|2017-02-18 14:53:28.288227
NCT00591578|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2012-01-31|2011-03-24||December 2007||2007-12-01|January 2012|2012-01-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension|A Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Valsartan in Subjects With Essential Hypertension|Completed||Phase 3|984|Actual|Takeda|For the Non-Serious Adverse Event Table, the total number of participants affected is based on the AEs with ≥5% in each phase, calculated separately.|3|||f||||f||||||||||2017-02-18 14:53:28.943072|2017-02-18 14:53:28.943072
NCT00591565|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-12-09|2012-09-06||June 2006||2006-06-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants|An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants|Completed||N/A|13|Actual|State University of New York - Upstate Medical University|open label design without placebo control|1|||f||||||||||||||2017-02-18 14:53:30.269691|2017-02-18 14:53:30.269691
NCT00591552|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-01-10|||December 2007||2007-12-01|December 2007|2007-12-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy.|Use of Harmonic Scalpel to Decrease Lymphatic and Chest Tube Drainage After Lymph Node Dissection With Lobectomy. A Single Center Prospective Randomized Controlled Study.|Unknown status|Recruiting|N/A|50|Anticipated|Sentara Cardiovascular Research Institute||2|||f||||f||||||||||2017-02-18 14:53:30.500583|2017-02-18 14:53:30.500583
NCT00591539|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-07-27|||December 2007||2007-12-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Carotid Artery Disease in Childhood Cancer Survivors|Carotid Artery Disease in Long-Term Survivors of Childhood Cancer|Terminated||N/A|3|Actual|M.D. Anderson Cancer Center|||1|Slow Accrual.|f||||f||||||||||2017-02-18 14:53:30.608134|2017-02-18 14:53:30.608134
NCT00591526|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2008-01-11|||June 2000||2000-06-01|January 2008|2008-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)|A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed Acute Promyelocytic Leukemia (APL)|Completed||Phase 3|250|Actual|Groupe d'etude et de travail sur les leucemies aigues promyelocytaires||4|||f||||t||||||||||2017-02-18 14:53:30.716859|2017-02-18 14:53:30.716859
NCT00591513|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2015-07-14|||February 1998||1998-02-01|July 2015|2015-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Autologous Engineered Skin Substitutes for Closure of Skin Wounds|Autologous Engineered Skin Substitutes for Closure of Burn Wounds|Terminated||Phase 2/Phase 3|144|Actual|University of Cincinnati||3|||f||||||||||||||2017-02-18 14:53:30.828601|2017-02-18 14:53:30.828601
NCT00591500|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-04-28|||November 1999||1999-11-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||A Model for Genetic Susceptibility: Melanoma|A Model for Genetic Susceptibility: Melanoma|Active, not recruiting||N/A|4082|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     buccal swabs tissue~   "|||2017-02-18 14:53:30.928467|2017-02-18 14:53:30.928467
NCT00591487|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2008-01-10|||December 2007||2007-12-01|December 2007|2007-12-01||||December 2008|Anticipated|2008-12-01||Interventional|||Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy|Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy With Tumescent Technique. A Randomized, Double Blinded, Controlled Trial.|Unknown status|Enrolling by invitation|Phase 3|60|Anticipated|Hospital Militar de Santiago||2|||f||||f||||||||||2017-02-18 14:53:31.054118|2017-02-18 14:53:31.054118
NCT00591474|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2008-01-10|||December 2007||2007-12-01|December 2007|2007-12-01||||November 2008|Anticipated|2008-11-01||Interventional|||The Influence of Probiotics on Vancomycin-Resistant Enterococcus|The Influence of Probiotics on Vancomycin-Resistant Enterococcus|Unknown status|Recruiting|N/A|30|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:53:31.165883|2017-02-18 14:53:31.165883
NCT00591461|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2009-09-28|||December 2007||2007-12-01|September 2009|2009-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Study of Endoscopic Barrett's Esophagus Diagnosis|A Prospective Study on the Interobserver Agreement of Endoscopic Barrett's Esophagus|Suspended||N/A|200|Anticipated|Oregon Health and Science University|||1|Suspended to modify recruitment process|f||||f||||||Samples Without DNA|"~     Esophageal biopsies~   "|||2017-02-18 14:53:31.328745|2017-02-18 14:53:31.328745
NCT00590473|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2007-12-26|||April 2007||2007-04-01|December 2007|2007-12-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Sacral Neuromodulation in Patients With IC|Sacral Neuromodulation: Bilateral Placement vs. Unilateral Placement in Patients With Interstitial Cystitis|Unknown status|Recruiting|N/A|50|Anticipated|Drexel University||2|||f||||f||||||||||2017-02-18 14:53:50.924919|2017-02-18 14:53:50.924919
NCT00591448|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-10-16|||October 2007||2007-10-01|October 2012|2012-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study in the Use of Virtual Reality as an Adjunct to Pain Control in Burn Patients|Improvement of Pain Management in Burn Patients Using Virtual Reality in Conjunction With Standard Opioids and Sedatives|Completed||N/A|10|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 14:53:31.425333|2017-02-18 14:53:31.425333
NCT00591435|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2010-03-23|||January 2007||2007-01-01|November 2007|2007-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Influence of Resident Training on Intra-operative Workflow|Resident Training Affects Intra-Operative Workflow and Costs|Completed||N/A|600|Actual|University of Schleswig-Holstein|||3||f||||t||||||||||2017-02-18 14:53:31.526524|2017-02-18 14:53:31.526524
NCT00591422|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-18|||August 2007||2007-08-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas|Phase I Study of Oral Darinaparsin (ZIO-101-C) in Advanced Solid Tumors and Non-Hodgkin's Lymphomas|Unknown status|Active, not recruiting|Phase 1|23|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 14:53:31.613989|2017-02-18 14:53:31.613989
NCT00591409|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-05-02|||January 2006||2006-01-01|May 2016|2016-05-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||A Bridging Trial Comparing Org 25969 at Reappearance of T2 in Japanese and Caucasian Subjects. Part A: Japanese Subjects (19.4.208A)(P05956)|A Multi-Center, Randomized, Open-Label, Prospective Bridging, Parallel Dose-Finding Trial Comparing Efficacy, Safety and Pharmacokinetics of 4 Doses of Org 25969 and Placebo Administered at Reappearance of T2 After Rocuronium or Vecuronium in Japanese and Caucasian Subjects. Part A: Japanese Subjects|Completed||Phase 2|100|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-02-18 14:53:31.722646|2017-02-18 14:53:31.722646
NCT00591396|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-18|||July 2005||2005-07-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Phase I Trial of ZIO-101 in Solid Tumors|A Phase I Trial of ZIO-101 in Solid Tumors: Protocol # SGL1002|Completed||Phase 1|40|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 14:53:31.833552|2017-02-18 14:53:31.833552
NCT00591383|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-18|||January 2008||2008-01-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors|Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|10|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 14:53:31.926692|2017-02-18 14:53:31.926692
NCT00591370|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-10-17|2015-01-08||January 2005||2005-01-01|October 2015|2015-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma|Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma|Completed||Phase 2|51|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:53:32.041319|2017-02-18 14:53:32.041319
NCT00591357|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2016-05-02|||October 2007||2007-10-01|May 2016|2016-05-01||||December 2013|Actual|2013-12-01||Interventional|loperamide||Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy|Study of the Efficacy of Loperamide in Treating Patients for Clostridium Difficile Colitis and Diarrheal Disease of Unknown Cause Associated With Prior Antibiotic Therapy.|Suspended||Phase 4|120|Anticipated|VA Medical Center, Houston||2||Lack of personnel to complete trial|f||||f||||||||||2017-02-18 14:53:32.320561|2017-02-18 14:53:32.320561
NCT00591344|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-02-16|2014-12-23||October 2007||2007-10-01|February 2015|2015-02-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||The Effect of Exercise on Individuals With Parkinson's Disease|The Effect of Exercise on Individuals With Parkinson's Disease|Completed||N/A|51|Actual|University of Illinois at Chicago||2|||f||||f||||||||||2017-02-18 14:53:34.904021|2017-02-18 14:53:34.904021
NCT00591331|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2008-05-16|||December 2007||2007-12-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Phototoxicity Potential of NatrOVA Creme Rinse - 1%|Phase 1 Evaluation of the Phototoxic Potential of NatrOVA Creme Rinse - 1% in Healthy Volunteers|Completed||Phase 1|37|Actual|ParaPRO LLC||3|||f||||f||||||||||2017-02-18 14:53:35.368823|2017-02-18 14:53:35.368823
NCT00591318|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2009-09-17|||August 2007||2007-08-01|September 2009|2009-09-01||||August 2010|Anticipated|2010-08-01||Interventional|||A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis|IV Ceftriaxone for Refractory Psychosis: a Controlled Trial|Unknown status|Recruiting|Phase 1/Phase 2|28|Anticipated|Research Foundation for Mental Hygiene, Inc.||2|||f||||f||||||||||2017-02-18 14:53:35.48432|2017-02-18 14:53:35.48432
NCT00591305|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2014-07-17|||September 2007||2007-09-01|July 2014|2014-07-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||New Therapy of Laryngeal Papilloma In Children|Voice Preserving Therapy of Laryngeal Papilloma In Children|Terminated||Phase 2|1|Actual|Boston University||2||insuffient resource for recruitment|f||||t||||||||||2017-02-18 14:53:35.6195|2017-02-18 14:53:35.6195
NCT00591292|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-18|||June 2007||2007-06-01|July 2012|2012-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Phase I Study in Advanced Solid Tumors|IBL1002:Phase I Study of Indibulin in Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|22|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 14:53:35.729598|2017-02-18 14:53:35.729598
NCT00591279|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-01-31|||February 1981|Actual|1981-02-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Cancer Control Following Polypectomy|Cancer Control Following Polypectomy|Completed||N/A|110|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||Samples With DNA|"~     fecal occult blood~   "|||2017-02-18 14:53:36.037296|2017-02-18 14:53:36.037296
NCT00591266|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2011-07-18|2011-03-24||October 2007||2007-10-01|July 2011|2011-07-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 When Co-administered With Amlodipine 5 mg in Subjects With Essential Hypertension|Completed||Phase 3|566|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:53:36.151525|2017-02-18 14:53:36.151525
NCT00591253|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2011-03-24|2011-03-24||October 2007||2007-10-01|March 2011|2011-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Black Subjects With Essential Hypertension|Completed||Phase 3|413|Actual|Takeda||3|||f||||f||||||||||2017-02-18 14:53:37.134982|2017-02-18 14:53:37.134982
NCT00591240|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-06-24|2016-06-24||July 2007||2007-07-01|June 2016|2016-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational||Research subjects recruited from spinal cord injury unit.|A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection|A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection|Completed||N/A|338|Actual|VA Office of Research and Development|The trial is non-interventional. Future studies will focused on developing advanced prototypes with the option of using the biosensor platform to direct patient care in comparison with standard microbiology.||2||f||||f||||||Samples With DNA|"~     urine~   "|No||2017-02-18 14:53:38.331936|2017-02-18 14:53:38.331936
NCT00591227|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2011-04-08|2011-04-08||May 2008||2008-05-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.|Management of Hyperglycemia in the Emergency Room: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care|Completed||Phase 4|176|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 14:53:38.664626|2017-02-18 14:53:38.664626
NCT00591214|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-04-15|2012-09-19||December 2007||2007-12-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and PK Study of MP-424 to Treat Chronic Hepatitis C|A Phase I, Open-Label, Single-Dose Study of MP-424 in Patients With Genotype 1b Hepatitis C|Completed||Phase 1|10|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-02-18 14:53:39.057122|2017-02-18 14:53:39.057122
NCT00591201|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2008-01-16|||June 2002||2002-06-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies|Efficacy, Safety, and Tolerability of Infliximab (Remicade; Schering-Plough) in Juvenile Spondyloarthropathies: a Three-Month, Randomized, Double-Blind, Placebo-Controlled Trial and 52-Week Open Extension.|Completed||Phase 2/Phase 3|26|Actual|Hospital General de Mexico||2|||f||||t||||||||||2017-02-18 14:53:39.381765|2017-02-18 14:53:39.381765
NCT00591188|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2009-04-30|||December 2006||2006-12-01|April 2009|2009-04-01||||May 2008|Actual|2008-05-01||Interventional|||Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens|Phase II Study of Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens|Completed||Phase 2|49|Anticipated|Kidney Cancer Research Bureau||1|||f||||t||||||||||2017-02-18 14:53:39.494427|2017-02-18 14:53:39.494427
NCT00591175|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-11-03|||December 2001||2001-12-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic Smokers|A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic Smokers|Active, not recruiting||N/A|1072|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||f||||||Samples Without DNA|"~     Salvia~   "|||2017-02-18 14:53:39.602368|2017-02-18 14:53:39.602368
NCT00591162|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-06-05|||October 1992||1992-10-01|June 2014|2014-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Bone Disease in Severely Burned Children|Bone Disease in Severely Burned Children|Terminated||Phase 2/Phase 3|254|Actual|The University of Texas Medical Branch, Galveston||1||terminated due to PI lab/duties affected by natural disaster.|f||||f||||||||||2017-02-18 14:53:39.700041|2017-02-18 14:53:39.700041
NCT00591149|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-04-02|||June 2007||2007-06-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer|Phase II Trial Of Oxaliplatin With Docetaxel Followed By Epidermal Growth Factor Antibody (EGFR-AB) Cetuximab In Patients With Recurrent Or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)|Terminated||Phase 2|6|Actual|University of Kansas Medical Center||1||Study was stopped due to termination of funding|f||||t||||||||||2017-02-18 14:53:39.908486|2017-02-18 14:53:39.908486
NCT00591136|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-07-18|||April 2003||2003-04-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Phase I Study of Indibulin in Patients With Solid Tumors|Dose-finding and Pharmacokinetic Trial of Orally Administered D-24851 to Patients With Solid Tumors|Completed||Phase 1|47|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 14:53:40.037176|2017-02-18 14:53:40.037176
NCT00591123|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-10-30|||December 2007||2007-12-01|October 2015|2015-10-01||||June 2011|Actual|2011-06-01||Interventional|||Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia|A Phase II Study of Erlotinib and Modified FOLFOX-6 (5-Fluorouracil, Leucovorin and Oxaliplatin) in Previously Untreated Patients With Unresectable or Metastatic Adenocarcinoma of the Esophagus and Gastric Cardia|Completed||Phase 2|38|Actual|Translational Oncology Research International||1|||f||||t||||||||||2017-02-18 14:53:40.146797|2017-02-18 14:53:40.146797
NCT00591110|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-06-26|||June 2008||2008-06-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|inCharge||Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education Program|Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education Program|Completed||N/A|177|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:53:40.264113|2017-02-18 14:53:40.264113
NCT00591097|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-12-17|||October 2006||2006-10-01|December 2013|2013-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Normal Reference Ranges for Urinary Metabolites and Supersaturation Indices in Pediatric Populations|Determining Normal Reference Ranges for Urinary Metabolites and Supersaturation Indices in the Pediatric Population|Completed||N/A|300|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 14:53:40.365904|2017-02-18 14:53:40.365904
NCT00591084|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2010-08-30|||September 2005||2005-09-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|June 2006|Actual|2006-06-01||Interventional|||Ginsenoside-Rd for Acute Ischemic Stroke|Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke: A Randomized, Double-blind, Placebo-controlled, Phase Ⅱ, Multicenter Trial|Completed||Phase 2|199|Actual|Xijing Hospital||3|||f||||t||||||||||2017-02-18 14:53:40.458082|2017-02-18 14:53:40.458082
NCT00591071|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-02-13|||January 2008||2008-01-01|December 2007|2007-12-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|INSUREA||Impact of 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted in ICU|Multicentre Randomized Trial Assessing the Impact of Maintaining 2 Blood Glucose Levels on Hospital Mortality in Patients Admitted to the ICU (INSUREA STUDY)|Unknown status|Recruiting|Phase 3|440|Anticipated|Poissy-Saint Germain Hospital||2|||f||||t||||||||||2017-02-18 14:53:40.807253|2017-02-18 14:53:40.807253
NCT00591058|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2009-07-16|||February 2008||2008-02-01|July 2009|2009-07-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma|A Phase I Dose Escalation Study Evaluating the Safety and Biologically Active Dose of TM-601 Based on Perfusion MRI Imaging Criteria in Patients With Progressive and/or Recurrent Malignant Glioma|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|TransMolecular||6|||f||||||||||||||2017-02-18 14:53:40.928903|2017-02-18 14:53:40.928903
NCT00591045|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2008-01-10|||January 2008||2008-01-01|December 2007|2007-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer|A Randomized Phase II Multicenter Controlled Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer|Unknown status|Not yet recruiting|Phase 2|263|Anticipated|Peking University||2|||f||||t||||||||||2017-02-18 14:53:41.084132|2017-02-18 14:53:41.084132
NCT00591032|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-08-05|||May 2007||2007-05-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Observational|AQUA FONTIS||Approach to a Quantitative Follow-up of Non-thyroidal Illness Syndrome|Development of Rational and Standardized Diagnostics and Staging for a Differentiated Risk Stratification of Non-thyroidal Illness Syndrome|Active, not recruiting||N/A|590|Actual|Ruhr University of Bochum|||1||f||||t||||||Samples Without DNA|"~     Kryobase with serum and urine samples~   "|||2017-02-18 14:53:41.203493|2017-02-18 14:53:41.203493
NCT00591019|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2015-09-23|2011-02-28||August 2006||2006-08-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Use of Modafinil in the Treatment of Tinnitus|Use of Modafinil in the Treatment of Tinnitus|Terminated||Phase 1|7|Actual|University of Arkansas|Study was terminated early due to lack of change in primary and secondary outcome measures.|2||Terminated early due to lack of change in primary and secondary outcome measures.|f||||f||||||||||2017-02-18 14:53:41.319223|2017-02-18 14:53:41.319223
NCT00591006|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2015-08-12|2013-07-08||January 2008||2008-01-01|August 2015|2015-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes|Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes|Completed||Phase 3|17|Actual|University of Texas Southwestern Medical Center|The sample size in this pilot study was modest; The duration of exposure to hydrocortisone was subacute;|1|||f||||f||||||||||2017-02-18 14:53:41.641902|2017-02-18 14:53:41.641902
NCT00590993|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-02-27|||December 2000||2000-12-01|February 2013|2013-02-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Magnetic Resonance Imaging and Spectroscopy of the Prostate|Magnetic Resonance Imaging and Spectroscopy of the Prostate|Completed||N/A|1005|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||||||2017-02-18 14:53:42.298472|2017-02-18 14:53:42.298472
NCT00590980|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-01-30|||July 2008||2008-07-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|July 2014|Actual|2014-07-01||Observational|VERiTAS||Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)|The Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Study|Completed||N/A|82|Actual|University of Illinois at Chicago|||1||f||||f||||||||||2017-02-18 14:53:42.403226|2017-02-18 14:53:42.403226
NCT00590967|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2016-07-18|2016-06-02||May 2003||2003-05-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy|A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy With Concurrent Weekly Cisplatin in Patients With Stage I-IVA Cervical Cancer Who Have FDG PET Positive Pelvic or Para-Aortic Lymph Nodes|Terminated||Phase 2|69|Actual|Washington University School of Medicine||2||Due to low accrual|f||||f||||||||||2017-02-18 14:53:42.528736|2017-02-18 14:53:42.528736
NCT00590954|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-06-01|||May 2006||2006-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas|Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas|Active, not recruiting||Phase 2|31|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:53:43.231197|2017-02-18 14:53:43.231197
NCT00590941|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-05-14|||February 2005||2005-02-01|May 2013|2013-05-01|April 2011|Actual|2011-04-01|July 2008|Actual|2008-07-01||Interventional|||Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma|Candidate Gene Polymorphisms and Response to Rituximab-CHOP in Patients With Diffuse Large Cell Lymphoma|Completed||N/A|52|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 14:53:43.347056|2017-02-18 14:53:43.347056
NCT00590928|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2007-12-26|||July 2004||2004-07-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Gastric pH in Critically Ill Patients|Effect of Intravenous Esomeprazole Versus Ranitidine on Gastric pH in Critically Ill Patients - a Prospective, Randomized, Double-Blind Study.|Completed||Phase 4|75|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:53:43.479862|2017-02-18 14:53:43.479862
NCT00590915|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-04-11||||||April 2012|2012-04-01||||||||Expanded Access|EMTP||Erwinase Master Treatment Protocol|Erwinase Master Treatment Protocol|No longer available||N/A|||Phoenix Children's Hospital|||||||||||||||||||2017-02-18 14:53:43.577447|2017-02-18 14:53:43.577447
NCT00590902|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-15|2015-12-15||March 2002||2002-03-01|December 2015|2015-12-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer|Multicenter Phase II Trial of OSI-774 (Erlotinib, Tarceva) In Patients With Advanced Bronchioloalveolar Cell Lung Cancer|Completed||Phase 2|81|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:53:43.656657|2017-02-18 14:53:43.656657
NCT00590889|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-11-18|2015-06-22||July 1998||1998-07-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|AVERT|1 subject age is missing|Artificial Valve Endocarditis Reduction Trial|Artificial Valve Endocarditis Reduction Trial|Terminated||N/A|807|Actual|St. Jude Medical|This study was terminated early. No final report was created.|2||"A post-PMA begun in 1998; enrollment halted in 2000 due to an anomaly in one study arm. The~   protocol required annual study visits after 2000."|f||||t||||||||||2017-02-18 14:53:43.895252|2017-02-18 14:53:43.895252
NCT00132574|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2006-09-20|||August 2005||2005-08-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Pilot Study of a Dietary Intervention to Prevent Acne Recurrence|Milk Minimization and Acne Recurrence Trial (MMART)|Terminated||Phase 2|30||Harvard School of Public Health|||||f||||||||||||||2017-02-18 17:31:44.709836|2017-02-18 17:31:44.709836
NCT00590876|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-10-26|||December 2008||2008-12-01|October 2011|2011-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||The Impact of Pancreatic Islet Cell Allotransplantation on Cognitive Function in Type 1 Diabetes Mellitus|The Impact of Pancreatic Islet Cell Allotransplantation on Cognitive Function and Brain Fuel Utilization in Patients With Type 1 Diabetes and Hypoglycemia Unawareness|Completed||N/A|36|Anticipated|Yale University|||3||f||||f||||||||||2017-02-18 14:53:44.462063|2017-02-18 14:53:44.462063
NCT00590863|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-04-21|2012-11-28||March 2008||2008-03-01|April 2009|2009-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|CO-MED|Sociodemographic Characteristics|Combining Medications to Enhance Depression Outcomes|Combining Medications to Enhance Depression Outcomes|Completed||Phase 4|665|Actual|National Institute of Mental Health (NIMH)|Detailed results avaiable. A. J. Rush et al. Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and long-term outcomes: a single-blind randomized study. American Journal of Psychiatry, 2011; 168:689-701.|3|||f||||t||||||||||2017-02-18 14:53:44.55405|2017-02-18 14:53:44.55405
NCT00590850|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-02-10|||October 2003||2003-10-01|February 2016|2016-02-01||||December 2017|Anticipated|2017-12-01||Interventional|||Non-Operative Versus Operative Treatment for High-Energy Midshaft Clavicle Fractures|A Multicenter, Prospective, Randomized Trial of Non-Operative Versus Operative Treatment for High-Energy Midshaft Clavicle Fractures|Enrolling by invitation||N/A|480|Anticipated|Greenville Health System||3|||f||||f||||||||||2017-02-18 14:53:45.114395|2017-02-18 14:53:45.114395
NCT00590837|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2014-04-01|||February 2008||2008-02-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|LAM-SA 2007||Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old|Randomized Prospective Study of Adding Lomustine to Idarubicin and Cytarabine for Induction and Post-remission Chemotherapy in Older Patients With Acute Myeloid Leukaemia, and Feasibility of Allogeneic Transplantation for Patients From 60 to 65 Years Old|Completed||Phase 3|459|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 14:53:45.213639|2017-02-18 14:53:45.213639
NCT00590824|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-06-14|||December 2007||2007-12-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma|A Pilot Trial of HU14.18-IL2 (EMD273063) in Subjects With Completely Resectable Recurrent Stage III or Stage IV Melanoma|Active, not recruiting||Phase 2|23|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 14:53:45.354023|2017-02-18 14:53:45.354023
NCT00590811|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2010-08-31|||January 2008||2008-01-01|January 2010|2010-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Prevalence of Menstrual Cycle Related Pain Complains in Adolescents and Young Adults|Prevalence of Menstrual Cycle Related Pain Complains in Adolescents and Young Adults|Completed||N/A|200|Anticipated|University Hospital, Gasthuisberg|||2||f||||f||||||||||2017-02-18 14:53:45.452045|2017-02-18 14:53:45.452045
NCT00590798|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-04-09|||April 2007||2007-04-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|STRUT||Star-Close Early Ambulation Trial|Star-Close Early Ambulation Trial|Completed||N/A|58|Actual|Ohio State University||1|||f||||f||||||||||2017-02-18 14:53:45.558392|2017-02-18 14:53:45.558392
NCT00590785|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-02-15|||August 13, 1996||1996-08-13|November 2016|2016-11-01|January 13, 2015|Actual|2015-01-13|June 10, 1997|Actual|1997-06-10||Interventional|||Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)|Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)|Completed||Phase 3|60|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:53:45.665138|2017-02-18 14:53:45.665138
NCT00590772|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-10-20|2009-07-21||May 2003||2003-05-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Role of Montelukast in Rhinitis and Sleep|Phase 4- The Role of Montelukast on Perennial Rhinitis and Associated Sleep Disturbance and Daytime Somnolence|Completed||Phase 4|31|Actual|Penn State University||2|||f||||f||||||||||2017-02-18 14:53:45.778713|2017-02-18 14:53:45.778713
NCT00590759|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-08-06|2014-06-10||August 2005||2005-08-01|August 2014|2014-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms|A Clinical Evaluation of the GORE TAG Thoracic Endoprosthesis in the Primary Treatment of Descending Thoracic Aortic Aneurysms|Completed||N/A|150|Actual|W.L.Gore & Associates||1|||f||||f||||||||||2017-02-18 14:53:46.028599|2017-02-18 14:53:46.028599
NCT00590746|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-02-11|||December 2007||2007-12-01|February 2014|2014-02-01|September 2009|Actual|2009-09-01|October 2008|Actual|2008-10-01||Observational|||Bedside Assessment of Fall Risk in Emergency Department Elders|Bedside Assessment of Fall Risk in Emergency Department Elders|Completed||N/A|53|Actual|Ohio State University|||1||f||||f||||||||||2017-02-18 14:53:46.276006|2017-02-18 14:53:46.276006
NCT00590720|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-02-04|2013-10-22||March 2008||2008-03-01|February 2014|2014-02-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma|A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Effect on Exercise Challenge Testing of Multiple Fixed Subcutaneous Doses of MEDI-528, A Humanized Anti-Interleukin-9 Monoclonal Antibody, in Adults With Stable Asthma and Exercise-Induced Bronchoconstriction|Terminated||Phase 2|11|Actual|MedImmune LLC||2||Study is replaced by MI-CP198 per CPM.|f||||t||||||||||2017-02-18 14:53:46.370635|2017-02-18 14:53:46.370635
NCT00590707|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-06-06|||January 2005||2005-01-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|STRIDE||Post-Operative Delirium in Elderly Surgical Patients|A Strategy to Reduce the Incidence of Post-Operative Delirium in Elderly Patients|Active, not recruiting||N/A|200|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 14:53:47.033774|2017-02-18 14:53:47.033774
NCT00590694|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-04-10|||October 2006||2006-10-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|DETAIL||Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments|Determining Optimal Treatment Algorithms for Macular Degeneration Pigment Epithelial Detachments Treated With Intraocular Lucentis|Completed||Phase 2/Phase 3|15|Actual|Pacific Eye Associates||2|||f||||f||||||||||2017-02-18 14:53:47.142966|2017-02-18 14:53:47.142966
NCT00590681|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-09-02|||February 2007||2007-02-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme|Avastin and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme: A Phase II Study|Completed||Phase 2|62|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 14:53:47.254071|2017-02-18 14:53:47.254071
NCT00590668|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-02-02|||May 2004|Actual|2004-05-01|February 2017|2017-02-01|April 2013|Actual|2013-04-01|April 2008|Actual|2008-04-01||Observational|ROTEA||Safety Monitoring of Patients Having Pulmonary Vein Ablation|Pulmonary Vein Ablation for Atrial Fibrillation: Safety Monitoring by Transesphoageal Echo, Intracardiac Echo and Computed Tomography and Assessment of Predictors of Recurrence and of Hypercoagulable State|Completed||N/A|42|Actual|The Cleveland Clinic|||1||f||||f|f|f||||||No||2017-02-18 14:53:47.364389|2017-02-18 14:53:47.364389
NCT00590655|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-01-09|||August 2002||2002-08-01|December 2007|2007-12-01|May 2006|Actual|2006-05-01|||||Interventional|||Maintenance Programme After Weight Loss|Effect of Maintenance Programme on the Long Term Weight Reduction in Severely Obese Patients. A Randomized Controlled Trial|Completed||N/A|201|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 14:53:47.458764|2017-02-18 14:53:47.458764
NCT00590642|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2009-11-27|||April 2006||2006-04-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Augmentation in Tx-resistant OCD: an Open Label Trial|Augment in Treatment-resistent Obsessive-compulsive Disorder: an Open-label Trial|Completed||Phase 4|30|Anticipated|Creighton University|||1||f||||f||||||||||2017-02-18 14:53:47.556684|2017-02-18 14:53:47.556684
NCT00590629|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-09-13|||June 2002||2002-06-01|December 2007|2007-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women||Completed||Phase 4|43|Actual|Cedars-Sinai Medical Center|||||f||||f||||||||||2017-02-18 14:53:47.662301|2017-02-18 14:53:47.662301
NCT00590616|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2014-08-11|||February 2005||2005-02-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study|Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study|Completed||N/A|125|Actual|Creighton University|||1||f||||f||||||||||2017-02-18 14:53:47.747205|2017-02-18 14:53:47.747205
NCT00590603|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-01-07|||July 2008||2008-07-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|AAV||Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma|Phase I/II Study of Arsenic Trioxide (Trisenox), Ascorbic Acid and Bortezomib Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma|Terminated||Phase 1|25|Actual|Duke University||1||Poor accrual - terminated during Phase I; Phase II never started.|f||||t||||||||||2017-02-18 14:53:47.847374|2017-02-18 14:53:47.847374
NCT00590590|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-02-29|2010-06-30||October 2007||2007-10-01|February 2012|2012-02-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort||Completed||Phase 2|105|Actual|Lumara Health, Inc.|The study was discontinued following enrollment of 106 of the planned 140 participants due to slow recruitment.|3|||f||||||||||||||2017-02-18 14:53:47.963414|2017-02-18 14:53:47.963414
NCT00590577|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-05-21|2009-08-21||March 2007||2007-03-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Subjects With Schizophrenia|Completed||Phase 3|652|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|No information on long-term (ie, more than 13-week) treatment; not designed to detect differences between doses of paliperidone palmitate; not designed to demonstrate efficacy for specific subgroups, such as subjects from a particular country|4|||f||||||||||||||2017-02-18 14:53:48.969626|2017-02-18 14:53:48.969626
NCT00590564|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-12-14|2015-12-14||October 2002||2002-10-01|December 2015|2015-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study|SHO-SAIKO-TO for Patients With Chronic Hepatitis C Who Are Intolerant to or Have Contraindication to Interferon-Based Therapy: A Phase II Study|Completed||Phase 2|42|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:53:50.029207|2017-02-18 14:53:50.029207
NCT00590551|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2008-12-30|||December 2007||2007-12-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Slings and Their Effect on Skin Pressure|Slings and Repositioning Devices: Their Effects on Skin Pressure|Terminated||N/A|240|Anticipated|Christiana Care Health Services||1||unable to recruit patients for study|f||||f||||||||||2017-02-18 14:53:50.270791|2017-02-18 14:53:50.270791
NCT00590538|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2011-06-29|2010-11-15||February 2003||2003-02-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis)|A Pilot Trial of Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygous Cystic Fibrosis Patients|Terminated||Phase 1/Phase 2|9|Actual|Children's Hospital of Philadelphia|No analysis was completed on data collected; More clinically efficacious compounds have been identified which suggested that completion of this study might not be as critical as when initially proposed; therefore, the study was terminated by PI.|2||12/15/2008 Voluntarily placed on inactive status-requested by the PI|f||||t||||||||||2017-02-18 14:53:50.373572|2017-02-18 14:53:50.373572
NCT00590525|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2009-11-27|||October 2004||2004-10-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Inflammation as a Predictor in Cardioversion of Atrial Fibrillation|Inflammation as a Predictor in Cardioversion of Atrial Fibrillation|Completed||N/A|45|Actual|Creighton University|||1||f||||f||||||||||2017-02-18 14:53:50.639893|2017-02-18 14:53:50.639893
NCT00590512|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-08-28|||March 2005||2005-03-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Dietary Salt Intake and Vascular Function|Dietary Salt Intake and Vascular Function|Completed||Early Phase 1|133|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 14:53:50.734002|2017-02-18 14:53:50.734002
NCT00590499|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-01-29|||July 2012||2012-07-01|January 2014|2014-01-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Observational|||Agitation in Post Operative Neurosurgical Patients|A Prospective Survey of Emergent Agitation Following Craniotomy: Incidence, Risk Factors and Outcomes|Completed||N/A|120|Actual|Capital Medical University|||2||f||||||||||||||2017-02-18 14:53:50.829781|2017-02-18 14:53:50.829781
NCT00590460|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-11-21|2012-07-02||July 2001||2001-07-01|November 2013|2013-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|Mafia||Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia|Cd45 (Yth-24 and Yth 54) and Cd52 (Campath-1H) Monoclonal Antibody Conditioning Regimen for Allogeneic Donor Stem Cell Transplantation of Patients With Fanconi Anemia|Terminated||Phase 1/Phase 2|5|Actual|Baylor College of Medicine||1||slow accrual|f||||t||||||||||2017-02-18 14:53:51.09145|2017-02-18 14:53:51.09145
NCT00590447|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-01-07|||December 2006||2006-12-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Interventional|PTLD-1/3||Risk Stratified Sequential Treatment for CD20-positive PTLD|Treatment of Patients With Posttransplant Lymphoproliferative Disorder (PTLD) With a Sequential Treatment Consisting of Anti-CD20 Antibody Rituximab and CHOP+GCSF Chemotherapy (PTLD-1/3)|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 14:53:51.398089|2017-02-18 14:53:51.398089
NCT00590434|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-10-25|||August 2006||2006-08-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Yield and Safety of Colonoscopy in Patients Older Than 80 Years|The Yield and Safety of Screening and Surveillance Colonoscopy in Elderly Patients (> 80 Years)|Completed||N/A|169|Actual|Midwest Biomedical Research Foundation|||2||f||||f||||||||||2017-02-18 14:53:51.519341|2017-02-18 14:53:51.519341
NCT00590421|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2008-10-16|||July 2004||2004-07-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|January 2007|Actual|2007-01-01||Observational|||Carotid Atherosclerotic Disease Following Childhood Scalp Irradiation|Carotid Atherosclerotic Disease Following Childhood Scalp Irradiation|Completed||N/A|295|Actual|Assaf-Harofeh Medical Center|||2||f||||f||||||Samples Without DNA|"~     Blood samples, 10 ml, were procured for assessment of creatinine, total cholesterol, high~     density lipoproteins (HDL), triglycerides (TG), calculated low density lipoproteins (LDL)~     and homocysteine.~   "|||2017-02-18 14:53:51.62799|2017-02-18 14:53:51.62799
NCT00590408|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2009-11-27|||March 2006||2006-03-01|November 2009|2009-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety of Coenzyme Q10 in the Treatment of Statin-Associated Myalgia||Terminated||Phase 4|10|Actual|Creighton University||2||Lack of recruitment|f||||||||||||||2017-02-18 14:53:51.722026|2017-02-18 14:53:51.722026
NCT00590395|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2010-08-24|||July 2007||2007-07-01|December 2007|2007-12-01|July 2010|Actual|2010-07-01|January 2010|Actual|2010-01-01||Interventional|||FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis|The Utility of FDG-PET and PET/CT in the Evaluation of Patients With Suspected Cholecystitis|Completed||N/A|20|Actual|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-02-18 14:53:51.819496|2017-02-18 14:53:51.819496
NCT00590382|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-01-28||||||August 2009|2009-08-01||||||||Expanded Access|||Emergency/Compassionate Use - Muscular VSD Occluder||Approved for marketing||N/A|||St. Jude Medical|||||||||||||||||||2017-02-18 14:53:51.925325|2017-02-18 14:53:51.925325
NCT00590369|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-03-30|2011-06-22||January 2006||2006-01-01|March 2012|2012-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Negative Pressure Wound Therapy: Are All Systems Alike?|Negative Pressure Wound Therapy: Are All Systems Alike?|Terminated||Phase 3|11|Actual|The Cleveland Clinic|small sample size; early termination; did not reach expected sample size. Single center|2||Recruitment challenges|f||||f||||||||||2017-02-18 14:53:51.991399|2017-02-18 14:53:51.991399
NCT00590356|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2016-12-06|||March 2007||2007-03-01|December 2016|2016-12-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|CLOSE||Star-Close Versus Angio-Seal for Femoral Artery Hemostasis|A Randomized Comparison of Percutaneous CLip-based Vascular Occluder (Star-Close) Versus Bio-absorble Hemostatic Device (Angio-SEal) for Femoral Artery Hemostasis After Percutaneous Coronary Intervention|Withdrawn||Phase 4|0|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 14:53:54.948727|2017-02-18 14:53:54.948727
NCT00590343|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-06-28|||November 2004||2004-11-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|March 2010|Actual|2010-03-01||Interventional|PTK787||Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors|An Open-label Phase II Study Evaluating the Safety and Efficacy of PTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors That Have Evidence of Progressive Disease or an Increase in Disease Related Syndrome Symptoms.|Completed||Phase 2|23|Actual|Louisiana State University Health Sciences Center in New Orleans||1|||f||||t||||||||||2017-02-18 14:53:55.059815|2017-02-18 14:53:55.059815
NCT00590330|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-05-12|||October 2007||2007-10-01|May 2011|2011-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs|Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs|Completed||N/A|55|Actual|Boston Children’s Hospital|||1||f||||f||||||Samples With DNA|"~     sputum or throat culture~   "|||2017-02-18 14:53:55.169629|2017-02-18 14:53:55.169629
NCT00590317|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2014-04-23|2013-09-17||March 2005||2005-03-01|April 2014|2014-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department|Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department|Completed||Phase 2|64|Actual|Emory University|Small sample size due to limited enrollment. Fewer patient in the Odansetron group were discharged home suggesting a possibly sicker baseline group. Complete data sets were not available for all patients due to sedation and participation.|2|||f||||f||||||||||2017-02-18 14:53:55.25348|2017-02-18 14:53:55.25348
NCT00590304|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2017-01-03|||October 2006||2006-10-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|December 2009|Actual|2009-12-01||Observational|ADRA||Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors|Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors|Completed||N/A|116|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||Samples With DNA|"~     Optional buccal swab samples will be obtained from participants. This is done by touching~     the inside of the participant's cheek to collect a sample of the cells in his/her mouth with~     a cotton swab type applicator.~   "|No|There is no plan to share individual data.|2017-02-18 14:53:55.680869|2017-02-18 14:53:55.680869
NCT00590122|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2009-03-12|||October 2006||2006-10-01|March 2009|2009-03-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study|COMPARISON OF ORALLY DISSOLVING LEVODOPA (PARCOPA®) TO CONVENTIONAL ORAL LEVODOPA: A SINGLE DOSE, DOUBLE-BLIND, PLACEBO CONTROLLED, CROSS-OVER TRIAL|Completed||Phase 4|20|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 14:53:58.007048|2017-02-18 14:53:58.007048
NCT00590291|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2017-02-02|||January 1995||1995-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|GeneQuest||Molecular Determinants of Coronaruy Artery Disease|Genetic Studies of Coronary Artery Disease and Arteriovenous Malformation (GeneQuest) Molecular Determinants of Coronary Artery Disease|Recruiting||N/A|2980|Anticipated|The Cleveland Clinic|||2||f||||t||||||Samples With DNA|"~     For each participant, 10 ml of blood for lymphoblastoid cell line immortalization, 10-20 ml~     blood for DNA extraction, or two buccal swabs. If gene identified, blood samples from~     children to identify the children affected with this gene will be obtained. When available,~     biopsy tissues for extracting DNA, RNA, protein, or for cell biological studies will be~     obtained. Human genomic DNA will be prepared from peripheral blood lymphocytes, biopsy~     tissue, or cell lines derived from Epstein Barr virus transformed lymphocytes 15. DNA will~     be used for a variety of purposes including linkage analysis and mutational screening.~   "|||2017-02-18 14:53:55.791999|2017-02-18 14:53:55.791999
NCT00590278|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-01-23|||August 2002||2002-08-01|January 2008|2008-01-01||||||||Interventional|TOMUDEX||A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer|A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer|Completed||Phase 2|49|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 14:53:56.108797|2017-02-18 14:53:56.108797
NCT00590265|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-07-28|||January 2008||2008-01-01|July 2014|2014-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|BPII-DEP-LT||Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression|Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression: Double-Blind, Placebo-Controlled Study to Establish Efficacy and Safety|Unknown status|Recruiting|N/A|50|Anticipated|Douglas Mental Health University Institute||2|||f||||t||||||||||2017-02-18 14:53:56.205533|2017-02-18 14:53:56.205533
NCT00590252|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-05-14|||July 2007||2007-07-01|May 2012|2012-05-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||Clinical Testing of New MR Pulse Sequences|Clinical Testing of New MR Pulse Sequences|Unknown status|Recruiting|N/A|500|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||None Retained|"~     There are no biospecimens~   "|||2017-02-18 14:53:56.3314|2017-02-18 14:53:56.3314
NCT00590239|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-09-23|||May 2007||2007-05-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|BERN||Barrett's Esophagus Related Neoplasia (BERN) Project|Endoscopic Detection of Early Neoplasia in Patients With Barrett's Esophagus|Recruiting||N/A|150|Anticipated|Midwest Biomedical Research Foundation|||1||f||||f||||||||||2017-02-18 14:53:56.424847|2017-02-18 14:53:56.424847
NCT00590226|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2014-06-06|2013-11-12||December 2006||2006-12-01|May 2014|2014-05-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|DEAN||Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes|Comparative Trial Between Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Type 2 Diabetes|Completed||Phase 4|130|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:53:56.540746|2017-02-18 14:53:56.540746
NCT00590213|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2008-01-23|||June 2003||2003-06-01|January 2008|2008-01-01||||||||Interventional|COMART||Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX|An Open Randomised Trial to Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX Monotherapy Induced Gynaecomastia and/or Breast Pain in Prostate Cancer Patients|Completed||Phase 4|125|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 14:53:56.95507|2017-02-18 14:53:56.95507
NCT00590200|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-01-20|||January 2001||2001-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|July 2007|Actual|2007-07-01||Observational|GATC||GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease|Molecular Determinants of Coronary Artery Disease|Active, not recruiting||N/A|15000|Anticipated|The Cleveland Clinic|||1||f||||t||||||Samples With DNA|"~     Approximately 70 mls of blood will be dispensed as follows (Approximately 80 mls if cell~     lines are drawn or if the patient is having a cardiac CT scan):~      4 x 10 mls EDTA Tube (DNA will be amplified in order to preserve quantity)~        1. x 10ml Lithium Heparin Tube (drawn on selected patient populations at CCF only- See~          Appendix E. for cell line protocol)~        2. x 5 mls Serum Tube~      1 x 7 mls Serum Tube~      1 x 2.7 mls Sodium Citrate Tube (CCF Only. See Appendix D)~      1 x 4.5 mls CTAD tube (platelet release inhibited)~      1 x 4.5 mls SCAT-1 tube (coagulation activation inhibited) (Blood may be dispensed in the~     above tubes in different quantities if functional studies are needed on a subset of samples)~   "|No||2017-02-18 14:53:57.0589|2017-02-18 14:53:57.0589
NCT00590187|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-23|2011-11-07|||December 2007||2007-12-01|November 2011|2011-11-01||||November 2011|Anticipated|2011-11-01||Interventional|||Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients|A Randomized Phase 2 Study of Oral Sapacitabine in Elderly Patients With Acute Myeloid Leukemia Previously Untreated or in First Relapse, or Previously Treated Myelodysplastic Syndromes|Unknown status|Recruiting|Phase 2|300|Anticipated|Cyclacel Pharmaceuticals, Inc.||9|||f||||f||||||||||2017-02-18 14:53:57.153879|2017-02-18 14:53:57.153879
NCT00590174|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2014-03-19|||October 2007||2007-10-01|March 2014|2014-03-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|ZEST-LATE||Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation|Evaluation of the Long-term Safety After Zotarolimus-Eluting Stent, Sirolimus-Eluting Stent, or PacliTaxel-Eluting Stent Implantation for Coronary Lesions - Late Coronary Arterial Thrombotic Events|Completed||Phase 4|1175|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 14:53:57.27658|2017-02-18 14:53:57.27658
NCT00590161|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-08-05|2012-03-07||December 2006||2006-12-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Pentoxifylline in Patients With Nonalcoholic Steatohepatitis|Treatment Efficacy of Pentoxifylline in Patients With Nonalcoholic Steatohepatitis: A Double-blind Randomized Placebo Controlled Trial|Completed||Phase 2|55|Actual|Case Western Reserve University||2|||f||||t||||||||||2017-02-18 14:53:57.438162|2017-02-18 14:53:57.438162
NCT00590148|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-07-29|||January 2008||2008-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Assessing Function in Pediatric Patients With Sickle Cell Disease|Assessing Function in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain Using the FIM Instrument|Completed||N/A|25|Actual|Connecticut Children's Medical Center|||1||f||||f||||||||||2017-02-18 14:53:57.808856|2017-02-18 14:53:57.808856
NCT00590135|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-01-09|||August 2000||2000-08-01|May 2007|2007-05-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||The Effect of Lipitor on Aortic Stenosis|The Effect of Statin Therapy (Atorvastatin) on the Progression of Calcific Valvular Aortic Stenosis|Unknown status|Active, not recruiting|Phase 4|59|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-02-18 14:53:57.892493|2017-02-18 14:53:57.892493
NCT00590109|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-01-04|||March 1997||1997-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer|Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer|Active, not recruiting||N/A|5600|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     blood samples~   "|||2017-02-18 14:53:58.114473|2017-02-18 14:53:58.114473
NCT00590096|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2009-08-24|||January 1991||1991-01-01|January 2007|2007-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma|I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma|Completed||N/A|1380|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-02-18 14:53:58.431779|2017-02-18 14:53:58.431779
NCT00590083|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-02-14|||July 2003||2003-07-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|LYPTAIST||Administration of Virus-Specific Cytotoxic T-Lymphocytes|Administration of Virus-Specific Cytotoxic T-Lymphocytes for the Prophylaxis and Therapy of Adenovirus Infection Post Allogeneic Stem Cell Transplant|Completed||Phase 1|14|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:53:58.523241|2017-02-18 14:53:58.523241
NCT00590070|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2012-03-25|||January 2008||2008-01-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|June 2011|Actual|2011-06-01||Interventional|REOPEN-AMI||THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction|Randomized Evaluation Of Intracoronary Nitroprusside vs Adenosine After Thrombus-aspiration During Primary PErcutaneous Coronary Intervention for the Prevention of No Reflow in Acute Myocardial Infarction|Completed||Phase 2/Phase 3|240|Actual|Catholic University of the Sacred Heart||3|||f||||t||||||||||2017-02-18 14:53:58.632011|2017-02-18 14:53:58.632011
NCT00590044|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-11-12|2009-01-30||December 2007||2007-12-01|November 2013|2013-11-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)|Basal Insulin in the Management of Patients With Diabetic Ketoacidosis|Completed||Phase 4|74|Actual|Emory University||2|||f||||t||||||||||2017-02-18 14:53:58.758543|2017-02-18 14:53:58.758543
NCT00590031|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-18|2015-12-18||November 2002||2002-11-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.|Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.|Completed||Phase 2|61|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:53:59.156544|2017-02-18 14:53:59.156544
NCT00590018|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-04-20|2016-02-23||February 2003||2003-02-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|Corti||Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease|Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease|Completed||Phase 2|18|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 14:53:59.460957|2017-02-18 14:53:59.460957
NCT00590005|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2014-01-14|2013-07-10||January 2003||2003-01-01|January 2014|2014-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|SARP||Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program)|Redox Determinants of Severe Asthma: A Substudy of the NHLBI Severe Asthma Research Program|Completed||N/A|225|Actual|Emory University|||2||f||||t||||||||||2017-02-18 14:54:00.111513|2017-02-18 14:54:00.111513
NCT00589992|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-01-27|||October 2007||2007-10-01|January 2012|2012-01-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|IBAD-AFIB||Ibutilide Administration During Pulmonary Vein Ablation|Atrial Fibrillation Mechanism Analysis Through Ibutilide Administration During Pulmonary Vein Ablation.|Unknown status|Recruiting|N/A|50|Anticipated|Ball Memorial Hospital||1|||f||||f||||||||||2017-02-18 14:54:00.387412|2017-02-18 14:54:00.387412
NCT00589979|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-06-23|2009-12-22||March 2007||2007-03-01|June 2016|2016-06-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee|Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen|Completed||Phase 2|169|Actual|Endo Pharmaceuticals|Due to operational issues, the modified intent-to-treat (MITT) population, consisting of all intent-to-treat (ITT) patients randomized on or after January 22, 2008, was added to the analysis plan; all efficacy data are presented for this population.|2|||f||||f||||||||||2017-02-18 14:54:00.492354|2017-02-18 14:54:00.492354
NCT00589966|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2013-02-28|||May 2007||2007-05-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|CAAPS||Coping in African American Prostate Cancer Survivors|Coping Skills Training Groups to Enhance Recovery From Prostate Cancer in African American Men|Completed||N/A|62|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:54:01.984837|2017-02-18 14:54:01.984837
NCT00589953|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-07-29|||July 2007||2007-07-01|July 2013|2013-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study|High-Dose Erythropoietin in Very Low Birth Weight Infants for the Potential Treatment of Prematurity-Related Cerebral Hemorrhagic-Ischemic Injury: A Phase II Safety/Tolerability Study|Terminated||Phase 2|22|Actual|Atlantic Health System||2|||f||||t||||||||||2017-02-18 14:54:02.111903|2017-02-18 14:54:02.111903
NCT00589927|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2010-03-17|||December 2007||2007-12-01|July 2009|2009-07-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|DECLARELONG||Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent|Comparison of Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent Implantation For Long Coronary Lesions|Completed||Phase 4|486|Anticipated|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 14:54:02.245811|2017-02-18 14:54:02.245811
NCT00589914|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-06-11|2011-08-30||March 2007||2007-03-01|June 2014|2014-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia|A Randomized, Double-Blind, Parallel-Group, Comparative Study of Flexible Doses of Paliperidone Palmitate and Flexible Doses of Risperidone Long-Acting Intramuscular Injection in Subjects With Schizophrenia|Completed||Phase 3|1221|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Of 1221 patients randomized, one patient was enrolled twice and assigned 2 patient numbers. Only the first patient number is included in the results reported for 1220 randomized patients.|2|||f||||f||||||||||2017-02-18 14:54:02.379972|2017-02-18 14:54:02.379972
NCT00589901|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-04-17|||August 2006||2006-08-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||An All-Oral Combination of Capecitabine and Cyclophosphamide in Patients With Metastatic Breast Cancer (MBC)|Phase II Study of an All-Oral Combination of Capecitabine (X) and Cyclophosphamide (C) in Patients With Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|60|Anticipated|Fudan University||1|||f||||f||||||||||2017-02-18 14:54:03.326916|2017-02-18 14:54:03.326916
NCT00589888|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2014-06-06|2014-03-24||August 2006||2006-08-01|May 2014|2014-05-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional||obese, healthy subjects.|FFA-Induced Hypertension and Endothelial Dysfunction|Free Fatty Acids-Induced Hypertension and Endothelial Dysfunction in Obese Subjects|Completed||N/A|13|Actual|Emory University||5|||f||||t||||||||||2017-02-18 14:54:03.441036|2017-02-18 14:54:03.441036
NCT00589875|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2017-02-06|||March 2007||2007-03-01|February 2017|2017-02-01|August 2016|Actual|2016-08-01|December 2015|Actual|2015-12-01||Interventional|BrTK02||Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)|A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma|Completed||Phase 2|52|Actual|Advantagene, Inc.||1|||f||||t||||||||||2017-02-18 14:54:03.768323|2017-02-18 14:54:03.768323
NCT00589862|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2015-11-27|||October 2007||2007-10-01|November 2015|2015-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents||Withdrawn||Phase 4|0|Actual|Creighton University||1||Failure to secure adequate funding|f||||||||||||||2017-02-18 14:54:03.889877|2017-02-18 14:54:03.889877
NCT00589849|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2011-09-02|2011-08-03||May 2006||2006-05-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy|T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy|Completed||N/A|32|Actual|Creighton University|||1||f||||f||||||||||2017-02-18 14:54:04.200802|2017-02-18 14:54:04.200802
NCT00589836|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-10-22|||June 2005||2005-06-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|LVTorsion||Assessment of Left Ventricular Torsion by Echocardiography Study|Assessment of LV Torsion by Tissue Doppler Echocardiography|Unknown status|Active, not recruiting|N/A|40|Anticipated|The Cleveland Clinic|||2||f||||f||||||||||2017-02-18 14:54:04.422561|2017-02-18 14:54:04.422561
NCT00589823|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2010-01-20||2010-01-20|June 2007||2007-06-01|January 2010|2010-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids|A Multicentre, Double-Blind, Double-Dummy, Two-Phase Crossover Study of Fentanyl Citrate Nasal Spray Compared to Immediate Release Morphine Sulphate in the Treatment of BTCP in Subjects Taking Regular Opioid Therapy|Completed||Phase 3|135|Actual|Archimedes Development Ltd||2|||f||||f||||||||||2017-02-18 14:54:04.534214|2017-02-18 14:54:04.534214
NCT00589810|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2007-12-26|||August 2007||2007-08-01|December 2007|2007-12-01|April 2008|Anticipated|2008-04-01|||||Observational|CardioGene||NIH Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal|NIH Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal|Unknown status|Enrolling by invitation|N/A|500|Anticipated|The Cleveland Clinic|||2||f||||f||||||Samples With DNA|"~     DNA~   "|||2017-02-18 14:54:04.647794|2017-02-18 14:54:04.647794
NCT00589797|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-02-23|||January 2007||2007-01-01|February 2013|2013-02-01|July 2017|Anticipated|2017-07-01|December 2012|Actual|2012-12-01||Interventional|||Activ-L™ Artificial Disc Treatment of Degenerative Disc Disease in the Treatment of Degenerative Disc Disease|Clinical Study to Evaluate the Safety and Effectiveness of the Aesculap Activ-L™ Artificial Disc in the Treatment of Degenerative Disc Disease|Active, not recruiting||Phase 3|414|Anticipated|Aesculap Implant Systems||2|||f||||f||||||||||2017-02-18 14:54:04.762258|2017-02-18 14:54:04.762258
NCT00589784|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-21|2015-12-21||October 2007||2007-10-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma|Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma|Completed||Phase 2|50|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:04.885605|2017-02-18 14:54:04.885605
NCT00589771|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-10-14|||January 2010||2010-01-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SB-IBS||Saccharomyces Boulardii in Irritable Bowel Syndrome|Clinical and Cytokine Response to Saccharomyces Boulardii Therapy in Diarrhea Dominant Irritable Bowel Syndrome|Completed||Phase 3|72|Actual|Aga Khan University||2|||f||||t||||||||||2017-02-18 14:54:05.248434|2017-02-18 14:54:05.248434
NCT00589758|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2017-01-31|||July 2006|Actual|2006-07-01|January 2017|2017-01-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Observational|TARVA||Tissue Doppler Assessment of Right Ventricular Performance in Acute Heeart Failure|Tissue Doppler Assessment of Right Ventricular Performance in Acute Heeart Failure|Completed||N/A|75|Actual|The Cleveland Clinic|||1||f||||f|f|f||||Samples Without DNA|"~     Blood and Urine~   "|No||2017-02-18 14:54:05.355628|2017-02-18 14:54:05.355628
NCT00589745|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2017-01-05|||September 2003||2003-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis|Measurement of Transepithelial Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis|Recruiting||N/A|25|Anticipated|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 14:54:05.46206|2017-02-18 14:54:05.46206
NCT00589732|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2012-08-07|||September 2006||2006-09-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|VAL-SUPPRES||Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent|Valsartan for SUPpression of Plaque Volume and Restenosis After Drug-Eluting Stent (The VAL-SUPPRESS TRial)|Completed||Phase 4|220|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 14:54:05.581022|2017-02-18 14:54:05.581022
NCT00589719|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2008-08-25|||August 2005||2005-08-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|May 2006|Actual|2006-05-01||Observational|||Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity|Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity|Completed||N/A|964|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-02-18 14:54:05.695004|2017-02-18 14:54:05.695004
NCT00589511|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-23|2014-08-07|||October 2006||2006-10-01|August 2014|2014-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study||Completed||N/A|69|Actual|Cochlear|||1||f||||||||||||||2017-02-18 14:54:09.630872|2017-02-18 14:54:09.630872
NCT00589706|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2010-06-15|||January 1985||1985-01-01|December 2007|2007-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas|A Phase II Study o the Adjuvant Use of Anti-Epidermal Growth Factor Receptor-425 (Anti-EGFR-425) Monoclonal Antibody Radiolabeled With I-125 for High Grade Gliomas|Suspended||Phase 2|500|Anticipated|Drexel University||1|||f||||t||||||||||2017-02-18 14:54:05.793905|2017-02-18 14:54:05.793905
NCT00589693|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-12-24|2012-06-13||April 2008||2008-04-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia|A Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Study to Assess the Safety and Efficacy of Doripenem Compared With Imipenem-Cilastatin in the Treatment of Subjects With Ventilator-Associated Pneumonia|Terminated||Phase 3|274|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|41 patients (21 doripenem, 20 imipenem-cilastatin) were enrolled at 5 sites that were found to be Good Clinical Practice non-compliant and were excluded from the primary efficacy and safety analyses.|2||Observed lower cure rates and higher mortality rates in one of the treatment groups.|f||||t||||||||||2017-02-18 14:54:05.894803|2017-02-18 14:54:05.894803
NCT00589680|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-01-09|||December 2007||2007-12-01|December 2007|2007-12-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Observational|||Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis|Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis|Unknown status|Active, not recruiting|N/A|60|Anticipated|Marshall University|||2||f||||f||||||||||2017-02-18 14:54:06.897866|2017-02-18 14:54:06.897866
NCT00589667|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-03-05|2014-01-23||September 2006||2006-09-01|March 2014|2014-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)|A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)|Completed||Phase 2|26|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:07.175445|2017-02-18 14:54:07.175445
NCT00589654|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2017-01-04|||December 1997||1997-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Menstrual Cycle Maintenance and Quality of Life: A Prospective Study|Menstrual Cycle Maintenance and Quality of Life: A Prospective Study|Active, not recruiting||N/A|810|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:54:07.479092|2017-02-18 14:54:07.479092
NCT00589641|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-31|2014-07-09|||July 2005||2005-07-01|June 2010|2010-06-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|CBT-RP||Relapse Prevention for Suicidal Dually Diagnosed Youths|Relapse Prevention for Suicidal Dually Diagnosed Youths|Completed||Phase 1|13|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:54:07.580884|2017-02-18 14:54:07.580884
NCT00589628|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2013-08-22|2013-02-21||September 2007||2007-09-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis|Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis|Completed||Phase 4|13|Actual|Duke University|Study recruitment was difficult and slow. Optimal number not achieved in this descriptive study.|2|||f||||t||||||||||2017-02-18 14:54:07.689552|2017-02-18 14:54:07.689552
NCT00589615|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-01-09|||January 1996||1996-01-01|December 2007|2007-12-01||||||||Interventional|||Effectiveness of an Educational Program in the Prevention of Osteoporosis and Fractures|Effectiveness of an Educational Program in the Prevention of Osteoporosis and Fractures|Completed||N/A|2181|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 14:54:08.079456|2017-02-18 14:54:08.079456
NCT00589602|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2013-10-18|||January 2004||2004-01-01|October 2013|2013-10-01||||December 2015|Anticipated|2015-12-01||Interventional|||T-Cell Depletion, Donor HSCT, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases|Phase II Feasibility Study of T-Cell Depletion in Allogeneic Unrelated Bone Marrow Transplantation (MUD ALLO BMT) Followed by Delayed T-Cell Infusions|Unknown status|Active, not recruiting|Phase 2|13|Actual|The Cleveland Clinic||1|||f||||t||||||||||2017-02-18 14:54:08.180821|2017-02-18 14:54:08.180821
NCT00589589|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2015-09-01|||January 2008||2008-01-01|September 2015|2015-09-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|EndoTool||Computer Decision Support to Achieve Glycemic Control in the ICU|Computer Decision Support to Achieve Glycemic Control in the ICU|Completed||Phase 1|24|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-02-18 14:54:08.301894|2017-02-18 14:54:08.301894
NCT00589563|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-09-03|2014-07-21||May 2007||2007-05-01|September 2014|2014-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer|A Phase II Study of Sirolimus, Tacrolimus and Thymoglobulin, as Graft-versus-Host Prophylaxis in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplantation|Completed||Phase 2|32|Actual|City of Hope Medical Center||3|||f||||t||||||||||2017-02-18 14:54:08.426594|2017-02-18 14:54:08.426594
NCT00589550|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-05|2015-06-04|2015-05-06||February 2008||2008-02-01|June 2015|2015-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer|A Phase I Study Of Peginterferon Alfa-2b (PEG-INTRON) With Sorafenib (Nexavar) In Patients With Unresectable Or Metastatic Clear Cell Renal Carcinoma (RCC).|Terminated||Phase 1|1|Actual|Ohio State University Comprehensive Cancer Center|Trial was terminated due to low patient accrual|1||low accrual|f||||t||||||||||2017-02-18 14:54:09.176351|2017-02-18 14:54:09.176351
NCT00589537|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2013-08-06|||March 2008||2008-03-01|July 2009|2009-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle|Trial of Imaging and Schedule in Seminoma Testis|Unknown status|Recruiting|Phase 3|660|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:54:09.433987|2017-02-18 14:54:09.433987
NCT00589524|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-01-12|||November 2007||2007-11-01|January 2012|2012-01-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Comparison of Coronary CT With IVUS in Heart Transplant Population|Comparison of Non-invasive Coronary CT With IVUS for the Detection of Coronary Artery Vasculopathy in a Cardiac Transplant Population|Withdrawn||N/A|0|Actual|Mayo Clinic||1||Difficult recruitment -|f||||f||||||||||2017-02-18 14:54:09.548255|2017-02-18 14:54:09.548255
NCT00589485|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-07-28|||November 2006||2006-11-01|July 2015|2015-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Total Knee Replacement Using Simplex® or Cobalt™ Bone Cement|Total Knee Replacement Using Simplex® or Cobalt™ Bone Cement|Withdrawn||N/A|0|Actual|Zimmer Biomet|||2|Sponsor did not fund the study|f||||f||||||||||2017-02-18 14:54:09.908624|2017-02-18 14:54:09.908624
NCT00589472|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-07-22|||November 2007||2007-11-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|TARGET||Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer|Neoadjuvant Androgen Depletion in Combination With Vorinostat Followed by Radical Prostatectomy for Localized Prostate Cancer: Total Androgen-Receptor Gene Expression Targeted Therapy (TARGET)|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:54:10.019422|2017-02-18 14:54:10.019422
NCT00589459|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2008-01-08|||October 2001||2001-10-01|December 2007|2007-12-01|December 2008|Anticipated|2008-12-01|September 2005|Anticipated|2005-09-01||Observational|||Gender Differences in Prevalence of Undiagnosed Diabetes in ACS|A Pilot Study of Gender Differences in the Prevalence of Undiagnosed Diabetes in Acute Coronary Syndromes (ACS)|Unknown status|Active, not recruiting|N/A|103|Actual|Yale University|||2||f||||f||||||||||2017-02-18 14:54:10.174826|2017-02-18 14:54:10.174826
NCT00589446|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2009-06-28|||January 2006||2006-01-01|June 2009|2009-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Investigation of Embryoscopy in Recurrent Pregnancy Loss|Investigation of Embryoscopy in Recurrent Pregnancy Loss|Completed||N/A|20|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 14:54:10.263275|2017-02-18 14:54:10.263275
NCT00589433|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2013-03-21||||||March 2013|2013-03-01||||||||Observational|||Follow Up Study of Tear in the Rotator Culf|Follow Up Study of Tear in the Rotator Culf|Terminated||N/A|50|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 14:54:10.363888|2017-02-18 14:54:10.363888
NCT00589420|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2009-07-07|||October 2006||2006-10-01|July 2009|2009-07-01||||December 2009|Anticipated|2009-12-01||Interventional|||Sorafenib and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy|A Phase II Study of Sorafenib in Combination With Docetaxel in Patients With Androgen-Independent Prostate Cancer|Unknown status|Recruiting|Phase 2|69|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:54:10.435325|2017-02-18 14:54:10.435325
NCT00589407|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-23|2013-03-21||||||March 2013|2013-03-01||||||||Observational|||Unilateral Blindness/ Unilateral Deafness-relation to Neck Pain|Unilateral Blindness/ Unilateral Deafness-relation to Neck Pain|Terminated||N/A|300|Anticipated|Hadassah Medical Organization|||1|there is a problem in recruting the paricipents|f||||||||||||||2017-02-18 14:54:10.53755|2017-02-18 14:54:10.53755
NCT00589394|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-01-08|||July 2007||2007-07-01|January 2016|2016-01-01|January 2010|Actual|2010-01-01|December 2008|Actual|2008-12-01||Interventional|||Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine|Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine|Completed||Phase 1|100|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:54:10.622473|2017-02-18 14:54:10.622473
NCT00589381|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-03-07|||August 2007||2007-08-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma|Phase I Trial of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder (4-HPR/LXS Oral Powder) (4-HPR) in Adults With Solid Tumors and Lymphomas|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 14:54:10.728842|2017-02-18 14:54:10.728842
NCT00589368|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2012-10-05|||May 2006||2006-05-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Transfer of Grasp Control Across Hands After Stroke|Interhemispheric Transfer of Grasp Control After Stroke|Completed||N/A|58|Actual|New York University School of Medicine|||2||f||||f||||||||||2017-02-18 14:54:10.986686|2017-02-18 14:54:10.986686
NCT00589355|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2007-12-27|||January 2002||2002-01-01|December 2007|2007-12-01|October 2008|Anticipated|2008-10-01|June 2003|Actual|2003-06-01||Observational|||C-Reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance|C-Reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance|Unknown status|Active, not recruiting|N/A|46|Actual|Yale University|||2||f||||f||||||||||2017-02-18 14:54:11.102837|2017-02-18 14:54:11.102837
NCT00589329|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2012-10-23|||December 2007||2007-12-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Antibiotics and the Prolongation of Pregnancy in Preterm Labor With an Advanced Cervical Exam|Antibiotics and the Prolongation of Pregnancy in Preterm Labor With an Advanced Cervical Exam|Terminated||N/A|50|Actual|MetroHealth Medical Center||2||published data suggest potential harm in other investigations.|f||||t||||||||||2017-02-18 14:54:11.200716|2017-02-18 14:54:11.200716
NCT00589316|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2016-12-06|||October 2007||2007-10-01|December 2016|2016-12-01||||September 2017|Anticipated|2017-09-01||Interventional|||Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome|Hematopoietic Bone Marrow Transplantation for Patients With High-risk Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), or Myelodysplastic Syndrome (MDS) Using Related HLA-Mismatched Donors: A Trial Using Radiolabeled Anti-CD45 Antibody Combined With Immunosuppression Before and After Transplantation|Recruiting||Phase 1|50|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 14:54:11.308661|2017-02-18 14:54:11.308661
NCT00589303|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-02-25|2013-02-25||December 2007||2007-12-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|PACIFIC||AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study|Pacing and AV Node Ablation Compared to Drug Therapy in Symptomatic Elderly Patients With Atrial Fibrillation Clinical Trial (PACIFIC) - Pilot Study|Terminated||Phase 3|27|Actual|Mayo Clinic|The study was terminated when about half of the subjects were enrolled due to lack of funding.|2||Lack of funding|f||||t||||||||||2017-02-18 14:54:11.475064|2017-02-18 14:54:11.475064
NCT00589290|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2015-09-29|2011-10-28||December 2007||2007-12-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|July 2013|Actual|2013-07-01||Interventional|||Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage|A Multicenter Phase II Study of Belinostat (PXD-101) in Previously Chemotherapy Treated Thymoma and Thymic Carcinoma|Completed||Phase 2|41|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 14:54:11.926216|2017-02-18 14:54:11.926216
NCT00589277|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-01-02|2013-01-02||August 2007||2007-08-01|January 2013|2013-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Message Framing for Telephone Quitline Callers|Promoting Tobacco and Cancer Control: Message Framing for Telephone Quitline Callers|Completed||Phase 1/Phase 2|2032|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:54:12.347168|2017-02-18 14:54:12.347168
NCT00589264|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2014-09-08|||July 2004||2004-07-01|September 2014|2014-09-01|June 2009|Actual|2009-06-01|May 2008|Actual|2008-05-01||Interventional|||Zinc and Biobehavioral Development in Early Childhood|Zinc and Biobehavioral Development in Early Childhood|Completed||N/A|251|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-02-18 14:54:12.654726|2017-02-18 14:54:12.654726
NCT00589251|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-01-08|||June 2008||2008-06-01|January 2016|2016-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Equivalency of Penicilloate Skin Test Reactivity Prepared by a Modified Alkaline Hydrolysis Technique|Equivalency of Penicilloate Skin Test Reactivity Prepared by a Modified Alkaline Hydrolysis Technique|Withdrawn||N/A|0|Actual|Mayo Clinic||1||Lack of funding|f||||f||||||||Undecided||2017-02-18 14:54:12.749021|2017-02-18 14:54:12.749021
NCT00589238|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-06-18|||January 2008||2008-01-01|June 2013|2013-06-01||||July 2012|Actual|2012-07-01||Interventional|||Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery|Randomised Phase II Trial of Neoadjuvant Weekly Paclitaxel Plus Carboplatin Compared to Weekly Paclitaxel Alone Followed in Both Arms by Doxorubicin and Cyclophosphamide for Operable or Locally Advanced Basal-like Subtype Breast Cancer Correlating BRCA-1 mRNA and Protein Expression With Carboplatin Response|Terminated||Phase 2|16|Actual|National Cancer Centre, Singapore||2|||f||||||||||||||2017-02-18 14:54:12.846847|2017-02-18 14:54:12.846847
NCT00589225|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2016-07-05|||December 2003||2003-12-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Primary Hyperoxaluria Mutation Genotyping|Correlation of Disease Expression With Specific Genetic Mutations in Primary Hyperoxaluria|Completed||Phase 1|902|Actual|Mayo Clinic|||1||f||||t||||||Samples With DNA|"~     DNA samples~   "|No||2017-02-18 14:54:12.951775|2017-02-18 14:54:12.951775
NCT00589212|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2008-06-09|||October 2003||2003-10-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||GliaSite 1-3 Mets Study|A Phase II Study Utilizing Focal Radiation in Patients With 1-3 Brain Metastases|Completed||Phase 2|50|Anticipated|Hologic, Inc.||1|||f||||t||||||||||2017-02-18 14:54:13.051191|2017-02-18 14:54:13.051191
NCT00589199|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-05-23|||December 1993||1993-12-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Functional Electrical Stimulation for Production of Artificial Cough|Functional Electrical Stimulation for Production of Artificial Cough|Completed||N/A|5|Actual|Case Western Reserve University||1|||f||||f||||||||||2017-02-18 14:54:13.172174|2017-02-18 14:54:13.172174
NCT00589186|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-12-17|||November 2007||2007-11-01|December 2008|2008-12-01||||December 2009|Anticipated|2009-12-01||Interventional|||Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer|Phase II Clinical Trial of Tumour Vaccination By Intradermal Delivery of Autologous Dendritic Cells Transduced With Adenoviral Vector (AD5F35) Expressing Latent Membrane Protein-1 (LMP-1) and Latent Membrane Protein-2 (LMP-2) Genes in Combination With Celecoxib in Patient With Metastatic Nasopharyngeal Carcinoma|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:54:13.263766|2017-02-18 14:54:13.263766
NCT00589173|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2012-07-22|||September 2007||2007-09-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care|An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care|Completed||N/A|5500|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-02-18 14:54:13.351886|2017-02-18 14:54:13.351886
NCT00589147|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-05-25|||August 2003||2003-08-01|May 2012|2012-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Prospective, Randomized, Controlled Study Comparing Three Tibial Component Designs in Total Knee Arthoplasty|A Prospective, Randomized, Controlled Study Comparing Three Tibial Component Designs in Total Knee Arthoplasty|Completed||N/A|397|Actual|Mayo Clinic||3|||f||||f||||||||||2017-02-18 14:54:13.44938|2017-02-18 14:54:13.44938
NCT00589134|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2010-07-15|||January 2006||2006-01-01|July 2010|2010-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration|The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration|Completed||N/A|26|Actual|Yale University||1|||f||||||||||||||2017-02-18 14:54:13.635584|2017-02-18 14:54:13.635584
NCT00589121|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-05|2015-11-14|||March 2008||2008-03-01|November 2015|2015-11-01||||December 2012|Actual|2012-12-01||Interventional|||Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg|A Phase II Trial of Image Guided Preoperative Radiotherapy for Primary Soft Tissue Sarcomas of the Extremity|Active, not recruiting||Phase 2|98|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 14:54:13.736383|2017-02-18 14:54:13.736383
NCT00589108|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-12-10|2012-12-10||January 2001||2001-01-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Comparison of A Mobile-Bearing Total Knee System With A Fixed-Bearing Total Knee System In Cemented Total Knee Arthroplasty|A Prospective, Randomized, Controlled Study Comparing A Mobile-Bearing Total Knee System With A Fixed-Bearing Total Knee System In Cemented Total Knee Arthroplasty|Completed||N/A|240|Actual|Mayo Clinic||3|||f||||f||||||||||2017-02-18 14:54:13.866584|2017-02-18 14:54:13.866584
NCT00589095|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-07-01|||November 2006||2006-11-01|July 2014|2014-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities|Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities|Terminated||N/A|5|Anticipated|Yale University|||1||f||||f||||||||||2017-02-18 14:54:14.375788|2017-02-18 14:54:14.375788
NCT00589082|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2008-01-08|||October 2001||2001-10-01|December 2007|2007-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML|DaunoXome (Liposomal Daunorubicin) Plus Ara-C Versus Daunorubicin Plus Ara-C in Elderly AML Patients.A Randomized Phase III Study.|Completed||Phase 3|||Gruppo Italiano Malattie EMatologiche dell'Adulto||2|||f||||f||||||||||2017-02-18 14:54:14.47445|2017-02-18 14:54:14.47445
NCT00589069|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2015-05-15|||February 2003||2003-02-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:54:14.565816|2017-02-18 14:54:14.565816
NCT00589056|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2016-09-23|||June 2007||2007-06-01|September 2016|2016-09-01||||March 2012|Actual|2012-03-01||Interventional|||Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery|A Phase I/II Trial of Protease Inhibitor, Nelfinavir, Given With Concurrent Thoracic Chemoradiotherapy in Patients With Locally-Advanced Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1/Phase 2|55|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 14:54:14.615708|2017-02-18 14:54:14.615708
NCT00589043|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2015-08-24|||October 2015||2015-10-01|August 2015|2015-08-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|CTLM||Computed Tomography Laser Mammography Breast Imaging Device|Computed Tomography Laser Mammography Breast Imaging Device Model 1020|Not yet recruiting||N/A|600|Anticipated|Imaging Diagnostic Systems|||1||f||||f||||||||||2017-02-18 14:54:14.717607|2017-02-18 14:54:14.717607
NCT00589030|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2017-02-13|||April 2007||2007-04-01|February 2017|2017-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Expanded Access|||Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere (Yttrium-90 Glass Microspheres): A HDE Treatment Use Protocol|No longer available||N/A|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 14:54:14.781753|2017-02-18 14:54:14.781753
NCT00588991|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-01-31|||November 2007||2007-11-01|December 2016|2016-12-01||||February 2014|Actual|2014-02-01||Interventional|||Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders|A Phase I Study of ABT-888 in Combination With Topotecan Plus Carboplatin for High-Risk Myeloproliferative Disorders and AML Out of Myeloproliferative Disorders|Active, not recruiting||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:54:14.873258|2017-02-18 14:54:14.873258
NCT00588978|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2008-01-08|||August 2003||2003-08-01|December 2007|2007-12-01|December 2008|Anticipated|2008-12-01|February 2007|Actual|2007-02-01||Interventional|||Impact of Diet and/or Exercise-Induced Weight Loss on Cardiovascular Risk Factors|Longitudinal Impact of Diet and/or Exercise-Induced Weight Loss on Metabolic Markers of Cardiovascular Disease|Unknown status|Active, not recruiting|N/A|30|Anticipated|Yale University||3|||f||||f||||||||||2017-02-18 14:54:14.993833|2017-02-18 14:54:14.993833
NCT00588965|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-07-29|2012-05-01||August 2007||2007-08-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects|Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects|Completed||N/A|36|Actual|MetroHealth Medical Center||2|||f||||f||||||||||2017-02-18 14:54:15.089623|2017-02-18 14:54:15.089623
NCT00588952|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2015-09-08|||March 2001||2001-03-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Ketamine/Placebo Family History Positive Study|GABA Mechanisms Underlying the Vulnerability for Alcohol Dependence|Completed||N/A|102|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:54:15.332812|2017-02-18 14:54:15.332812
NCT00588939|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2013-05-17|||November 2008||2008-11-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Confocal Laser Microscopy in Non Erosive Reflux Disease|Confocal Laser Microscopy in Non Erosive Reflux Disease|Completed||N/A|60|Actual|Mayo Clinic|||1||f||||t||||||Samples Without DNA|"~     esophageal biopsy~   "|||2017-02-18 14:54:15.430854|2017-02-18 14:54:15.430854
NCT00588926|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-30|2007-12-30||||||December 2007|2007-12-01||||||||Interventional|||Changes of the Neuronal Activity in the Subthalamic Nucleus Under Remifentanil Sedation During Stereotactic Electrode Implantation||Unknown status|Active, not recruiting|N/A|20|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 14:54:15.538292|2017-02-18 14:54:15.538292
NCT00588913|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-07-09|||January 2006||2006-01-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases|Phase I/II Study of Adoptive Immunotherapy Comprising Pyrophosphomonoester Antigen-stimulated T Cells, IL-2, and Nitrogen-containing Bisphosphonates in Patients With Stage IV Renal Cell Carcinoma|Completed||Phase 1/Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:54:15.6348|2017-02-18 14:54:15.6348
NCT00588900|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-12-09|||March 2008||2008-03-01|December 2016|2016-12-01|November 2011|Actual|2011-11-01|May 2010|Actual|2010-05-01||Interventional|||Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab|A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab|Terminated||Phase 2|5|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 14:54:18.255995|2017-02-18 14:54:18.255995
NCT00588887|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-08-14|||June 2005||2005-06-01|August 2012|2012-08-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Observational|||Total Knee Replacement With Duracon® and Vanguard™ Prostheses||Terminated||N/A|150|Actual|Zimmer Biomet|||2||f||||f||||||||||2017-02-18 14:54:18.399177|2017-02-18 14:54:18.399177
NCT00588874|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2008-01-08|||October 2000||2000-10-01|December 2007|2007-12-01|December 2008|Anticipated|2008-12-01|July 2002|Actual|2002-07-01||Observational|||Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis|Pilot Study to Assess the Skeletal Effects of Age-Related Changes in Calcium and Vitamin D Metabolism in Men|Unknown status|Active, not recruiting|N/A|24|Actual|Yale University|||1||f||||f||||||||||2017-02-18 14:54:18.690625|2017-02-18 14:54:18.690625
NCT00588861|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-01-26|2010-06-14||September 2002||2002-09-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement|Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Acetabular Shell Using Simplex® or Palacos® Bone Cement|Terminated||N/A|400|Actual|Zimmer Biomet|Study was terminated prematurely after sponsor no longer distributed the products involved and follow-up failed to produce sufficient data to be analyzed.|2||Study was terminated due to insufficient data and lack of patient follow-up|f||||f||||||||||2017-02-18 14:54:18.782211|2017-02-18 14:54:18.782211
NCT00588640|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-06-29|2015-12-17||October 2004||2004-10-01|June 2016|2016-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of D-Methadone in Patients With Chronic Pain|A Phase I/II Study of D-Methadone in Patients With Chronic Pain|Completed||Phase 1/Phase 2|10|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 14:54:24.073929|2017-02-18 14:54:24.073929
NCT00588848|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-07-18|2012-10-28||January 2008||2008-01-01|July 2013|2013-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Comparison of Continuous Positive Airway Pressure (CPAP) With Autoadjusting CPAP in the Treatment of Obstructive Sleep Apnea (OSA) in the Postoperative Setting|Postoperative Management of Obstructive Sleep Apnea With CPAP vs. an Autoadjusting CPAP Device: a Randomized Controlled Single Center Trial|Terminated||N/A|11|Actual|MetroHealth Medical Center|"Trial limitations include:~1. Insufficient enrollment to adequately analyze data"|2||Difficulty with enrollment|f||||f||||||||||2017-02-18 14:54:19.131141|2017-02-18 14:54:19.131141
NCT00588835|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2010-03-01|||March 2008||2008-03-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|ACE||Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients|A Pharmacokinetic Evaluation of the Addition of Aprepitant to the Cisplatin - Etoposide (CE) Treatment of Patients With Metastatic Lung Carcinoma (ACE).|Terminated||Phase 4|20|Anticipated|Radboud University||2|||f||||f||||||||||2017-02-18 14:54:19.740358|2017-02-18 14:54:19.740358
NCT00588822|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-04-03|2014-02-12||January 2005||2005-01-01|April 2014|2014-04-01|February 2011|Actual|2011-02-01|January 2009|Actual|2009-01-01||Interventional|||Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance|A Phase II Trial of Rituximab for Peripheral Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)|Terminated||Phase 2|21|Actual|Mayo Clinic|The study was discontinued at the first stage to the high response rate and slow accrual.|1||Discontinuation due to the high response rate at the 1st stage and slow accrual.|f||||t||||||||||2017-02-18 14:54:19.854358|2017-02-18 14:54:19.854358
NCT00588809|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-07-06|2015-07-06||December 2007||2007-12-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia|A Phase 2 Study of AZD6244 in Relapsed or Refractory AML|Completed||Phase 2|47|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:54:20.128964|2017-02-18 14:54:20.128964
NCT00588796|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2015-02-02|||February 2005||2005-02-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Study of Fibrinogen Metabolism During Severe Trauma and Burns|Alteration in Fibrinogen Metabolism in Patients With Severe Burns and Traumatic Injuries|Completed||N/A|30|Actual|United States Army Institute of Surgical Research|||3||f||||f||||||||||2017-02-18 14:54:20.520941|2017-02-18 14:54:20.520941
NCT00588783|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-07-22|||August 2006||2006-08-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||I-beam and Cruciate Tibial Components Used in Total Knee Replacement||Terminated||N/A|100|Actual|Zimmer Biomet|||2||f||||f||||||||||2017-02-18 14:54:20.631432|2017-02-18 14:54:20.631432
NCT00588770|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2017-02-16|||August 2008||2008-08-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Interventional|||Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma|A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer|Active, not recruiting||Phase 3|400|Anticipated|National Cancer Institute (NCI)||8|||f||||f||||||||||2017-02-18 14:54:20.761843|2017-02-18 14:54:20.761843
NCT00588757|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2008-01-08|||March 2008||2008-03-01|December 2007|2007-12-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Comparison Between Two Optional IVC Filters Regardind Ease of Use,Complications and Outcome|Prospective Comparison Between OptEase and Gunter-Tulip|Unknown status|Not yet recruiting|N/A|100|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 14:54:22.122655|2017-02-18 14:54:22.122655
NCT00588731|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-29|2014-04-01|||February 2009||2009-02-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia|Cannabinoid Receptor Antagonist Treatment of Cognitive Dysfunction in Schizophrenia|Completed||Phase 2|36|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:54:22.224482|2017-02-18 14:54:22.224482
NCT00588718|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2017-02-16|||April 2007|Actual|2007-04-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|NEC||A Biologic Validation of Biomarkers of Progressive NEC & Sepsis|A Biologic Sample Study for the Validation of Biomarkers of Progressive NEC & Sepsis|Active, not recruiting||N/A|740|Anticipated|Nationwide Children's Hospital|||2||f||||f||||||Samples With DNA|"~     Blood and Urine~   "|||2017-02-18 14:54:22.317639|2017-02-18 14:54:22.317639
NCT00588705|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2017-01-27|||December 2007||2007-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer|The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer|Completed||N/A|27|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:54:22.421|2017-02-18 14:54:22.421
NCT00588692|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-04-07|2014-01-30||July 2007||2007-07-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|SACAR|Only the participants who completed the trial were included in the baseline analysis.|Strategies for Aggressive Central Afterload Reduction in Patients With Heart Failure|Strategies for Aggressive Central Afterload Reduction in Patients With Heart Failure|Completed||N/A|60|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:54:22.538171|2017-02-18 14:54:22.538171
NCT00588679|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2016-04-26|||August 2006||2006-08-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla|Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla|Active, not recruiting||N/A|265|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:23.413422|2017-02-18 14:54:23.413422
NCT00588666|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-16|2015-12-16||May 2006||2006-05-01|December 2015|2015-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma|Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma|Completed||Phase 2|51|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:23.514457|2017-02-18 14:54:23.514457
NCT00588653|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2008-01-07|||January 2004||2004-01-01|December 2007|2007-12-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Diagnostic Accuracy of Capsule Endoscopy in Small Bowel Crohn's Disease|Diagnostic Accuracy of Capsule Endoscopy in Small Bowel Crohn's Disease|Completed||Phase 4|41|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:54:23.968805|2017-02-18 14:54:23.968805
NCT00588627|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2010-03-08|||March 2006||2006-03-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Capsaicin Cough Threshold in Chronic Cough Due to Postnasal Drip|Capsaicin Cough Sensitivity, Airway Inflammation and Neurogenic Peptides in Chronic Cough Associated With Postnasal Drip|Completed||Phase 2|25|Actual|Mayo Clinic|||2||f||||t||||||Samples Without DNA|"~     Mucus will be quantified and protease inhibitors will be added after collection. The~     specimen will be coded to deidentify. It will be transported to laboratory for storage and~     analysis. The mucus collected from the posterior nasopharynx will be frozen and assayed~     simultaneously. Substance P and Neurokinin A will be measured by ELISA at the end of the~     study period.~   "|||2017-02-18 14:54:24.318805|2017-02-18 14:54:24.318805
NCT00588614|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-05-29|||April 2006||2006-04-01|May 2012|2012-05-01|February 2011|Actual|2011-02-01|December 2007|Actual|2007-12-01||Observational|||High Risk Screening Breast MR Using a Rapid Imaging Exam|High Risk Screening Breast MR Using a Rapid Imaging Exam|Completed||N/A|140|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 14:54:24.430819|2017-02-18 14:54:24.430819
NCT00588601|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-10-11|||November 2005||2005-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:54:24.515517|2017-02-18 14:54:24.515517
NCT00588588|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2012-01-24|||January 2007||2007-01-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Bronchoscopy vs. Clinical Pulmonary Infection Score Guided Approach in Suspected Ventilator-Associated Pneumonia (VAP)|Bronchoscopy Versus Clinical Pulmonary Infection Score Guided Approach in Suspected Ventilator-Associated Pneumonia (VAP): Randomized Clinical Trial|Withdrawn||Phase 3|0|Actual|Mayo Clinic||2||Due to inability to get support for the study|f||||f||||||||||2017-02-18 14:54:24.569074|2017-02-18 14:54:24.569074
NCT00588575|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-01-05|||October 2004||2004-10-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|May 2007|Actual|2007-05-01||Observational|||Ramanspectroscopy in Barrett's Esophagus|In-Vivo Raman Spectroscopy of Barrett's Esophagus|Completed||N/A|119|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"~     esophageal biopsy~   "|||2017-02-18 14:54:24.673431|2017-02-18 14:54:24.673431
NCT00588562|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-07-05|||July 2003||2003-07-01|July 2016|2016-07-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|RKSC||Rare Kidney Stone Consortium Patient Registry|Rare Kidney Stone Consortium Registry for Hereditary Kidney Stone Diseases|Recruiting||N/A|730|Anticipated|Mayo Clinic|||4||f||||t||||||||Yes|Using limited data set, data will be shared through the Data Monitoring and Coordinating Center of the Rare Diseases Clinical Research Network.|2017-02-18 14:54:24.767647|2017-02-18 14:54:24.767647
NCT00588549|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2009-03-18|||July 1998||1998-07-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases|Utility of Whole-Body 18-Fluorodeoxyglucose Positron Emission Tomography (PET) In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases|Completed||N/A|204|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||||||2017-02-18 14:54:24.908623|2017-02-18 14:54:24.908623
NCT00588536|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-04-16|2015-04-16||January 1995||1995-01-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|July 2008|Actual|2008-07-01||Interventional|||Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH|Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With Langerhans Cell in Histiocytosis (LCH)|Completed||Phase 2|5|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:24.995768|2017-02-18 14:54:24.995768
NCT00588523|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-10-10|||September 2002||2002-09-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma|A Phase II Trial of Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma|Active, not recruiting||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:25.236111|2017-02-18 14:54:25.236111
NCT00588510|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2011-09-01|||January 2000||2000-01-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction|Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction|Completed||N/A|59|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||||||2017-02-18 14:54:25.345214|2017-02-18 14:54:25.345214
NCT00588497|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2011-05-20|||February 2004||2004-02-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||Characterization of the Essure System Tubal Sterilization Using Ultrasound and X-Ray|Characterization of the Essure System Tubal Sterilization Using Ultrasound and X-Ray|Completed||N/A|25|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 14:54:25.461955|2017-02-18 14:54:25.461955
NCT00588484|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2012-11-07|||December 2002||2002-12-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Ultrasound-based Intima-Media Thickness Measurements|Determination of the Precision and Clinical Utility of Ultrasound-based Intima-Media Thickness Measurements|Completed||N/A|128|Actual|Mayo Clinic|||2||f||||f||||||||||2017-02-18 14:54:25.57943|2017-02-18 14:54:25.57943
NCT00588471|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2012-10-09|2012-10-09||November 2002||2002-11-01|October 2012|2012-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention|The Effect of Acute Statin Treatment on Inflammation and Peripheral Arterial Tone in Patients Undergoing Percutaneous Coronary Intervention.|Terminated||N/A|57|Actual|Mayo Clinic|The study was terminated early because not enough subjects could be recruited.|2||The study was terminated because not enough subjects could be recruited.|f||||f||||||||||2017-02-18 14:54:25.681429|2017-02-18 14:54:25.681429
NCT00588458|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-04-27|||March 2007||2007-03-01|April 2015|2015-04-01|February 2009|Anticipated|2009-02-01|November 2008|Anticipated|2008-11-01||Interventional|||The Value of CT Cholangiography in Primary Sclerosing Cholangitis|Primary Sclerosing Cholangitis: Value of Computerized Tomographic Cholangiography and Intraductal Volumetric Measurement in Determining the Prognosis|Withdrawn||Phase 2|0|Actual|Mayo Clinic||1||"There is no participant enrolled in this study since developing this trial and other~   cholangiographic techniques are more available in our institute."|f||||t||||||||||2017-02-18 14:54:26.045521|2017-02-18 14:54:26.045521
NCT00438165|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-02-18|||September 2003||2003-09-01|February 2016|2016-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|MemphisY12||Age 12 Follow-up of Early Preventive Intervention (Memphis)|Age 12 Follow-up of Early Preventive Intervention|Completed||N/A|609|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 15:51:03.301482|2017-02-18 15:51:03.301482
NCT00588445|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-17|2015-12-17||June 2004||2004-06-01|December 2015|2015-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene|Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene in Patients With NSCLC|Completed||Phase 2|65|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:26.140646|2017-02-18 14:54:26.140646
NCT00588432|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2009-12-03|||April 2003||2003-04-01|December 2009|2009-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Characterization of Skeletal Muscle Using Magnetic Resonance Elastography (MRE)|Characterization of Skeletal Muscle Using Magnetic Resonance Elastography (MRE)|Completed||N/A|300|Anticipated|Mayo Clinic|||4||f||||||||||||||2017-02-18 14:54:26.403509|2017-02-18 14:54:26.403509
NCT00588419|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2016-12-16|||June 2006||2006-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Quantification of Breast Sensation Following Postmastectomy Breast Reconstruction|Quantification of Breast Sensation Following Postmastectomy Breast Reconstruction|Active, not recruiting||N/A|153|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:54:26.491477|2017-02-18 14:54:26.491477
NCT00588406|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-12-15|2015-10-12||September 2007||2007-09-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.|Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial|Completed||Phase 3|95|Actual|Northwell Health||2|||f||||f||||||||||2017-02-18 14:54:26.59841|2017-02-18 14:54:26.59841
NCT00588393|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2010-04-15|||September 2006||2006-09-01|April 2010|2010-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||FolateScan in Autoimmune Disease|Study of the Efficacy and Safety of FolateScan (Technetium TC99m EC20) in Patients With Rheumatoid Arthritis and Other Inflammatory Diseases|Completed||Phase 2|75|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 14:54:27.038257|2017-02-18 14:54:27.038257
NCT00588380|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2011-12-14|2011-04-04||November 2007||2007-11-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||GLP1R Polymorphisms and Response to GLP1|A Pilot Study Examining How Common Genetic Variation in GLP1R Alters Response to GLP1 Infusion|Completed||N/A|88|Actual|Mayo Clinic|This is a pilot study with limited power to detect / replicate effects. It will require independent replication of study results.|1|||f||||f||||||||||2017-02-18 14:54:27.210419|2017-02-18 14:54:27.210419
NCT00588367|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2015-04-14|||April 2006||2006-04-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||CT Pancreas Perfusion|CT Perfusion of Pancreatic Cancer and Chronic Pancreatitis: Feasibility Study|Completed||N/A|30|Actual|Mayo Clinic|||3||f||||f||||||||||2017-02-18 14:54:27.448026|2017-02-18 14:54:27.448026
NCT00588354|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-12-06|2011-06-03||October 2006||2006-10-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Epidural Clonidine for Lumbosacral Radiculopathy|Pilot Study of Transforaminal Epidural Injection of Clonidine for the Treatment of Acute Lumbosacral Radiculopathy|Terminated||N/A|26|Actual|Mayo Clinic|Early termination leading to small numbers of subjects analyzed; did not measure analgesia during the expected analgesic peak of bolus administration, but 10 days after last injection; compared clonidine with an active control, rather than placebo.|2||Targeted enrollment was not reached.|f||||f||||||||||2017-02-18 14:54:27.564773|2017-02-18 14:54:27.564773
NCT00588341|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-22|2015-12-22||September 2005||2005-09-01|December 2015|2015-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection|Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection|Completed||Phase 2|24|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:28.432745|2017-02-18 14:54:28.432745
NCT00588328|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-12-23|||March 2000||2000-03-01|December 2015|2015-12-01|May 2010|Actual|2010-05-01|July 2008|Actual|2008-07-01||Interventional|||The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning|The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning|Completed||Phase 1|35|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:28.662243|2017-02-18 14:54:28.662243
NCT00588315|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2017-02-01|||November 1999|Actual|1999-11-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin|In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin|Recruiting||N/A|1500|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||||||2017-02-18 14:54:28.757538|2017-02-18 14:54:28.757538
NCT00588302|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2011-05-20|||June 2003||2003-06-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Moexipril for Primary Biliary Cirrhosis|Open-Label Pilot Investigation of Moexipril for the Treatment of Primary Biliary Cirrhosis (PBC)|Completed||Phase 2|20|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:54:28.862207|2017-02-18 14:54:28.862207
NCT00588289|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2013-10-08|||September 1999||1999-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA|CCG-LTFI: A Groupwide Protocol for Collecting Follow- up Data|Completed||N/A|102|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:54:28.978598|2017-02-18 14:54:28.978598
NCT00588276|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2015-12-23|||June 2005||2005-06-01|December 2015|2015-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors|Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors|Completed||Phase 1|15|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:29.072728|2017-02-18 14:54:29.072728
NCT00588094|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-10-27|2015-10-27||October 2003||2003-10-01|October 2015|2015-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL|A Phase II Study of Dose Augmented Rituximab and Ice for Patients With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell Non-Hodgkin's Lymphoma Undergoing Second-Line Therapy Prior to Stem Cell Transplantation|Completed||Phase 2|20|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:54:31.36563|2017-02-18 14:54:31.36563
NCT00588263|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-08-12|||July 2000||2000-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer|Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individual With Cancer|Recruiting||N/A|1905|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blocks or extracted DNA from patients who have identified themselves as Jewish will be~     obtained and a determination will be made as to whether there is adequate material to~     proceed without exhausting the block or extracted DNA.~      Four unstained sections (research specimens) or paraffin curls will be cut from each~     block. In those cases where a block containing normal resection margin or any other biopsy~     of normal tissue are available, tissue will be cut from this block so as to preserve tumor~     tissue for later investigators. It is not necessary for sections to be reviewed to confirm~     that tumor is present in the section, since any germline DNA is adequate for this analysis.~   "|||2017-02-18 14:54:29.17503|2017-02-18 14:54:29.17503
NCT00588250|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2015-04-06|||May 2003||2003-05-01|April 2015|2015-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates|Prospective Randomized Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates|Terminated||N/A|150|Actual|Mayo Clinic||2||Implantation rate significantly lower in treatment group than Controls.|f||||f||||||||||2017-02-18 14:54:29.284708|2017-02-18 14:54:29.284708
NCT00588237|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2015-12-15|2015-12-15||August 2006||2006-08-01|December 2015|2015-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|A Phase II Study of Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|Completed||Phase 2|42|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:29.392699|2017-02-18 14:54:29.392699
NCT00588224|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2009-07-20|||October 2007||2007-10-01|July 2009|2009-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|3DUSstomach||3D Ultrasound Validation for Measuring Stomach Volume|Validation and Application of 3-dimensional Ultrasound for Measurement of Gastric Volumes in Healthy Subjects|Completed||N/A|36|Actual|Mayo Clinic|||2||f||||f||||||||||2017-02-18 14:54:29.687254|2017-02-18 14:54:29.687254
NCT00588211|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2016-11-29|||September 2001||2001-09-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Measurement of Cancer-Related Risk Perception in Smokers|Measurement of Cancer-Related Risk Perception in Smokers|Active, not recruiting||N/A|1514|Actual|Memorial Sloan Kettering Cancer Center|||4||f||||||||||||||2017-02-18 14:54:29.79814|2017-02-18 14:54:29.79814
NCT00588198|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2009-10-01|||October 1991||1991-10-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma|Study of Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma|Completed||N/A|754|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples With DNA|"~     Bone marrow and blood~   "|||2017-02-18 14:54:29.909309|2017-02-18 14:54:29.909309
NCT00588185|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-12-16|||February 2003||2003-02-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer|[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer|Recruiting||N/A|300|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:54:30.018544|2017-02-18 14:54:30.018544
NCT00588172|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2010-08-16|||June 2010||2010-06-01|August 2010|2010-08-01|June 2011|Anticipated|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Genetic Variation in OCT1 and Response to Metformin|Genetic Variation in OCT1 and Response to Metformin|Withdrawn||Phase 4|0|Actual|Mayo Clinic||2||No funding|f||||f||||||||||2017-02-18 14:54:30.1462|2017-02-18 14:54:30.1462
NCT00588159|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-03-29|2010-12-28||June 2007||2007-06-01|March 2016|2016-03-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Preoperative Gabapentin for Acute and Chronic Post-thoracotomy Analgesia|Preoperative Gabapentin for Acute and Chronic Post-thoracotomy Analgesia: A Randomized, Double-blinded, Placebo-controlled Study|Completed||N/A|146|Actual|Mayo Clinic||2|||f||||t||||||||No||2017-02-18 14:54:30.251775|2017-02-18 14:54:30.251775
NCT00588146|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-02-19|2012-12-20||January 2007||2007-01-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia|Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia|Terminated||Phase 2|10|Actual|Mayo Clinic|The study was terminated early because Schering-Plough discontinued supplying study drug.|2||Schering-Plough discontinued supplying study drug.|f||||t||||||||||2017-02-18 14:54:30.725337|2017-02-18 14:54:30.725337
NCT00588133|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2009-11-09|||January 2004||2004-01-01|November 2009|2009-11-01|August 2008|Actual|2008-08-01|December 2007|Actual|2007-12-01||Interventional|||A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery|A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery|Completed||Phase 3|20|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:54:31.01069|2017-02-18 14:54:31.01069
NCT00588120|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-11-30|||December 1998||1998-12-01|November 2015|2015-11-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria|Investigations Into the Genotype and Phenotype of Unclassified Hyperoxaluria: Enteric Oxalate Absorption Study|Active, not recruiting||Phase 1|125|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:54:31.140313|2017-02-18 14:54:31.140313
NCT00588107|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2014-12-30|||September 2005||2005-09-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional|PFH2||A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors|Partnership for Health: A Web-Based Smoking Intervention For Cancer Survivors|Completed||N/A|374|Actual|Dana-Farber Cancer Institute||2|||f||||f||||||||||2017-02-18 14:54:31.252584|2017-02-18 14:54:31.252584
NCT00587652|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-01-05|||December 2002||2002-12-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Methylene Blue Chromoendoscopy in Barrett's Esophagus|A Prospective Trial of Methylene Blue Chromoendoscopy in Barrett's Esophagus|Completed||N/A|100|Actual|Mayo Clinic|||2||f||||f||||||||||2017-02-18 14:54:37.951592|2017-02-18 14:54:37.951592
NCT00588081|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-08-09|||May 2001||2001-05-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function|Immediate Vaginal Reconstruction Following Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function|Completed||N/A|27|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:54:31.636702|2017-02-18 14:54:31.636702
NCT00588068|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2017-02-01|||September 26, 2000||2000-09-26|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome|Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome|Recruiting||N/A|1500|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples With DNA|"~     Tumor, marrow and blood samples~   "|||2017-02-18 14:54:31.734477|2017-02-18 14:54:31.734477
NCT00588042|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-06-03|||October 2007||2007-10-01|June 2014|2014-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|RemoteMIPH||Remote Myocardial Ischemic Preconditioning in Humans|Remote Myocardial Ischemic Preconditioning in Humans|Completed||N/A|156|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:54:31.852074|2017-02-18 14:54:31.852074
NCT00588029|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2016-10-03|||July 1999||1999-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer|Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer|Active, not recruiting||N/A|7000|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||Samples With DNA|"~     Blood, Cerebro-Spinal Fluid and Saliva~   "|||2017-02-18 14:54:31.960924|2017-02-18 14:54:31.960924
NCT00588016|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-04-12|||April 2007||2007-04-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Concentration of Itraconazole Solution in Nasal Secretions|Concentration of Itraconazole Solution in Nasal Secretions|Completed||Phase 1|6|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:54:32.053149|2017-02-18 14:54:32.053149
NCT00588003|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2015-12-23|||March 2004||2004-03-01|December 2015|2015-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer|Analysis of Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer|Completed||Phase 1|45|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:54:32.16441|2017-02-18 14:54:32.16441
NCT00587990|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2015-10-02|2015-01-30||November 2007||2007-11-01|October 2015|2015-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|PROMETHEUS||Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)|A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Intramyocardial Injection of Autologous Human Mesenchymal Stem Cells (MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction (MI) Undergoing Cardiac Surgery for Coronary Artery Bypass Grafting (CABG)|Completed||Phase 1/Phase 2|9|Actual|University of Miami||3|||f||||t||||||||||2017-02-18 14:54:32.275966|2017-02-18 14:54:32.275966
NCT00587977|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2012-11-07|||November 2004||2004-11-01|November 2012|2012-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|FAMRI||Aortic Distensibility|ECG-Gated Multidetector CT of Aortic Distensibility FAMRI|Completed||N/A|67|Actual|Mayo Clinic|||3||f||||f||||||||||2017-02-18 14:54:32.963867|2017-02-18 14:54:32.963867
NCT00587964|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-01-22|2015-12-14||June 2004||2004-06-01|January 2016|2016-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases|Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases|Completed||Phase 2|51|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:33.087281|2017-02-18 14:54:33.087281
NCT00587951|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2008-01-07|||December 2005||2005-12-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||The Influence of SISCOM on Intracranial Electrode Implantation in Epilepsy Surgical Candidates|The Influence of SISCOM on Intracranial Electrode Implantation in Epilepsy Surgical Candidates|Completed||N/A|50|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 14:54:33.496036|2017-02-18 14:54:33.496036
NCT00587938|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2007-12-26|||December 2003||2003-12-01|December 2007|2007-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Observational|||BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED|BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED: A Clinical Development Project|Completed||N/A|200|Actual|Mayo Clinic|||2||f||||f||||||Samples Without DNA|"~     Original protocol specifies a single 10 ml of blood is collected and frozen from each study~     participant (N=200), to be available for research assays.~   "|||2017-02-18 14:54:33.603492|2017-02-18 14:54:33.603492
NCT00587925|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2009-02-25|||March 2005||2005-03-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer|A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer|Completed||N/A|7|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:33.714008|2017-02-18 14:54:33.714008
NCT00587912|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2011-04-20|||June 1997||1997-06-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||AIDS and Cancer Specimen Bank (ACSB)|AIDS and Cancer Specimen Bank (ACSB)|Completed||N/A|65|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Blood, urine, other bodily fluids (eg, pleural fluid), and tumor tissue obtained from~     patients.~   "|||2017-02-18 14:54:33.83106|2017-02-18 14:54:33.83106
NCT00587899|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2011-04-12|||January 2007||2007-01-01|April 2011|2011-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Prophylactic Pulmonary Vein Isolation Study|A Randomized, Single-blind Prophylactic Pulmonary Vein Isolation Procedure Utilizing Bipolar Radiofrequency Ablation in Patients Undergoing Mitral Valve Surgery|Terminated||N/A|41|Actual|Mayo Clinic||2||"enrollment has been lower than anticipated due to growth in the minimally invasive mitral~   valve repair practice."|f||||f||||||||||2017-02-18 14:54:33.938915|2017-02-18 14:54:33.938915
NCT00587886|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2017-01-18|||September 25, 2001|Actual|2001-09-25|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Estrogen, Diet, Genetics and Endometrial Cancer|Estrogen, Diet, Genetics and Endometrial Cancer|Active, not recruiting||N/A|1315|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     Buccal specimen~   "|||2017-02-18 14:54:34.0524|2017-02-18 14:54:34.0524
NCT00587873|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2009-06-10|||March 1994||1994-03-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|December 2003|Actual|2003-12-01||Interventional|||Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)|Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)|Completed||Phase 2|18|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:34.176363|2017-02-18 14:54:34.176363
NCT00587860|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2010-03-02|2009-10-26||February 2006||2006-02-01|March 2010|2010-03-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome|A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome|Completed||Phase 2|70|Actual|Mayo Clinic|"A majority of the participants were local females with mild symptoms~The number of participants limits power of conclusions~We evaluated the efficacy of SJW in all subtypes of IBS not allowing specific conclusions regarding subtypes"|2|||f||||f||||||||||2017-02-18 14:54:34.298921|2017-02-18 14:54:34.298921
NCT00587847|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-09-16|2013-05-29||August 2005||2005-08-01|September 2015|2015-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||This was a pilot study with enrollment goal of 20 based on our patient population with potential to meet inclusion criteria. This goal was not met due to patient preferance for no further treatment which is standard of care.|Campath Maintenance in Chronic Lymphocytic Leukemia|Maintenance Alemtuzumab in Refractory Chronic Lymphocytic Leukemia|Terminated||N/A|12|Actual|Northwell Health|Trial was terminated early due to poor accrual.|1||Insufficient recruitment.|f||||f||||||||||2017-02-18 14:54:34.894924|2017-02-18 14:54:34.894924
NCT00587834|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-10-09|2012-04-04||October 2007||2007-10-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration|A Clinical Trial to Evaluate Gintuit (TM) (Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen) as an Alternative to Tissue From the Palate to Enhance Oral Soft Tissue Regeneration and Wound Healing|Completed||Phase 3|96|Actual|Organogenesis|Secondary outcome measures were tested with a closed testing strategy; therefore pain was not tested (no p-value) because previous endpoint (site sensitivity) failed.|2|||f||||f||||||||||2017-02-18 14:54:35.159797|2017-02-18 14:54:35.159797
NCT00587821|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-12-18|||January 2006||2006-01-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Peptide Profiles of Women Undergoing Breast Biopsy|Peptide Profiles of Women Undergoing Breast Biopsy|Completed||N/A|571|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:54:35.632494|2017-02-18 14:54:35.632494
NCT00587808|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-02-06|||November 2007||2007-11-01|May 2011|2011-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|HFpEF||Mechanisms in Heart Failure With Normal EF|Invasive Characterization of the Mechanisms Underlying Exertional Intolerance and Increased Filling Pressures in Patients With Heart Failure and a Preserved EF|Completed||N/A|14|Actual|Mayo Clinic|||2||f||||f||||||||||2017-02-18 14:54:35.746433|2017-02-18 14:54:35.746433
NCT00587795|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-10-23|||April 2006||2006-04-01|April 2012|2012-04-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Orthopedic Study of the Aircast StabilAir Wrist Fracture Brace|Orthopedic Study of the Aircast StabilAir Wrist Fracture Brace|Completed||N/A|80|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:54:35.847566|2017-02-18 14:54:35.847566
NCT00587769|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-04-16|2010-10-05||July 2007||2007-07-01|April 2013|2013-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|ChanBan||Chantix & Bupropion for Smoking Cessation|Combination Pharmacotherapy With Chantix & Bupropion for Smoking Cessation (ChanBan)|Completed||Phase 3|38|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:54:35.955369|2017-02-18 14:54:35.955369
NCT00587756|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2008-01-07|||September 2001||2001-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|May 2007|Actual|2007-05-01||Observational|||Alternative to Two-Stage Hepatectomy|One-Stage Ultrasound-Guided Hepatectomy for Multiple Bilobar Colorectal Metastases: a Feasible and Effective Alternative to Two-Stage Hepatectomy|Completed||N/A|19|Actual|University of Milan|||1||f||||f||||||||||2017-02-18 14:54:36.182195|2017-02-18 14:54:36.182195
NCT00587730|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-04-21|||July 2001||2001-07-01|April 2015|2015-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|Hawkeye||Attenuation Corrected Cardiac SPECT Using the GE Hawkeye Camera System|Attenuation Corrected Cardiac SPECT Using the GE Hawkeye Camera System|Terminated||Phase 2/Phase 3|608|Actual|Mayo Clinic||1||Recruiting or enrolling participants has halted prematurely and will not resume.|f||||f||||||||||2017-02-18 14:54:36.28805|2017-02-18 14:54:36.28805
NCT00587717|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-02-14|||September 2002||2002-09-01|February 2011|2011-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue|The Acute Effect of Inflammatory Markers of Atherosclerotic Plaque in Humans|Completed||N/A|35|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:54:36.382032|2017-02-18 14:54:36.382032
NCT00587704|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-02-22|||July 2007||2007-07-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|PVB||Paravertebral Blocks: Pilot Study to Compare Nerve Stimulation vs. Anatomic Landmarks in Inguinal Hernia Repair|Paravertebral Blocks Techniques: A Pilot Study to Compare Nerve Stimulation vs. Anatomic Landmarks for Patients Undergoing Inguinal Hernia Repair|Completed||N/A|50|Actual|Mayo Clinic||2|||f||||||||||||||2017-02-18 14:54:36.472468|2017-02-18 14:54:36.472468
NCT00587691|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-09|||July 2002||2002-07-01|January 2017|2017-01-01|December 2008|Actual|2008-12-01|June 2007|Actual|2007-06-01||Interventional|DES||Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis|An Open-Label, Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis|Completed||Phase 1/Phase 2|16|Actual|Opexa Therapeutics, Inc.||3|||f||||t||||||||No||2017-02-18 14:54:36.567374|2017-02-18 14:54:36.567374
NCT00587678|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-01-03|2011-08-02||January 2006||2006-01-01|January 2012|2012-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Comprehensive Magnetic Resonance of Peripheral Arterial Disease|Comprehensive Magnetic Resonance of Peripheral Arterial Disease|Completed||N/A|85|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 14:54:36.761847|2017-02-18 14:54:36.761847
NCT00587665|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||August 2006||2006-08-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Low Dose Ketamine as an Adjunct to Fentanyl in Outpatient Tonsillectomy|A Prospective Study of Low Dose Ketamine as an Adjunct to Fentanyl in Pediatric Patients Following Outpatient Tonsillectomy and Adenoidectomy|Completed||N/A|122|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:54:37.852387|2017-02-18 14:54:37.852387
NCT00587639|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-03-08|2011-07-20||May 2007||2007-05-01|March 2012|2012-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression|An Evaluation of Safety and Feasibility Using rTMS in Adolescents With Depression|Completed||N/A|8|Actual|Mayo Clinic|Limitations of the study include its open design, and small number of total participants.|1|||f||||t||||||||||2017-02-18 14:54:38.064391|2017-02-18 14:54:38.064391
NCT00587626|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-06-24|||August 2007||2007-08-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||Proposal to Evaluate the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder Pain|Proposal to Evaluate the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder Pain|Completed||Phase 2|80|Anticipated|McMaster University||2|||f||||||||||||||2017-02-18 14:54:38.322406|2017-02-18 14:54:38.322406
NCT00586781|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||September 2001||2001-09-01|December 2007|2007-12-01||||December 2006|Actual|2006-12-01||Interventional|||Study of the Scandinavian Total Ankle Replacement (STAR) for the Treatment of Bilateral Degenerative Ankle Disease|Investigational Device Exemption for the Scandinavian Total Ankle Replacement (STAR) - Bilateral Arm|Completed||Phase 3|21|Actual|Link America, Inc.||1|||f||||f||||||||||2017-02-18 14:54:38.436357|2017-02-18 14:54:38.436357
NCT00586755|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-07-16|||February 1998||1998-02-01|July 2014|2014-07-01|November 2008|Actual|2008-11-01|October 2007|Actual|2007-10-01||Interventional|||Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell Lymphoma|Intensive Induction Therapy Followed by Early High Dose Chemotherapy and Bone Marrow Transplantation for Mantle Cell Lymphoma|Completed||Phase 2|48|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:54:38.542607|2017-02-18 14:54:38.542607
NCT00586742|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-05-24|||January 2008||2008-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||SLAP Lesions; a Comparison of Conservative and Operative Treatment. A Prospective, Randomized Study|SLAP Lesions; a Comparison of Conservative and Operative Treatment. A Prospective, Randomized Study|Completed||N/A|118|Actual|Lovisenberg Diakonale Hospital||3|||f||||f||||||||||2017-02-18 14:54:38.64109|2017-02-18 14:54:38.64109
NCT00586729|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-09-07|2012-08-09||July 2009||2009-07-01|September 2012|2012-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Vashe Wound Therapy Study|Pilot Study to Evaluate Effectiveness of Vashe™ Wound Therapy as an Antimicrobial Irrigant in Burn Wound Management|Completed||N/A|23|Actual|Maricopa Integrated Health System||2|||f||||f||||||||||2017-02-18 14:54:41.193835|2017-02-18 14:54:41.193835
NCT00586716|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-11-17|2014-05-29||November 2004||2004-11-01|April 2016|2016-04-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients|IVIG Treatment for Live-donor Renal Transplant Patients With a Positive Crossmatch and in Patients With High PRA|Terminated||N/A|22|Actual|Loma Linda University|A limitation to this study is early termination leading to small numbers of subjects analyzed.|2||Insufficient recruitment|f||||f||||||||No||2017-02-18 14:54:41.670645|2017-02-18 14:54:41.670645
NCT00587613|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-08-07|||March 2006||2006-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:54:41.972404|2017-02-18 14:54:41.972404
NCT00587600|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-10-20|||December 2002||2002-12-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|September 2012|Actual|2012-09-01||Interventional|BIOBAR||Biomarkers in Phototherapy of Barrett's Esophagus|Biomarkers in Phototherapy of Barrett's Esophagus|Active, not recruiting||Phase 2/Phase 3|208|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:54:42.019222|2017-02-18 14:54:42.019222
NCT00587587|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-08-16|2011-06-07||December 2007||2007-12-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids|A Prospective, Randomized, Controlled Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids|Completed||Phase 1/Phase 2|30|Actual|Organogenesis||2|||f||||f||||||||||2017-02-18 14:54:42.127636|2017-02-18 14:54:42.127636
NCT00587574|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2008-01-04|||October 2007||2007-10-01|October 2007|2007-10-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Observational|||Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT|Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic Hematopoietic Stem Cell Transplantation and Immunomodulatory Consequences of Chronic Graft-Versus-Host Disease and Therapy|Unknown status|Recruiting|N/A|150|Anticipated|Medical University of Vienna|||2||f||||f||||||Samples With DNA|"~     peripheral blood mononuclear cells as cell pellets and DNA, plasma and serum samples, tissue~     biopsy samples, urine~   "|||2017-02-18 14:54:43.077276|2017-02-18 14:54:43.077276
NCT00587561|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-08-05|||January 2008||2008-01-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|||Efficacy of Social Cognition Training in Schizophrenia|Efficacy of Social Cognition Training in Schizophrenia|Active, not recruiting||Phase 2/Phase 3|75|Anticipated|VA Connecticut Healthcare System||2|||f||||f||||||||||2017-02-18 14:54:43.170686|2017-02-18 14:54:43.170686
NCT00587548|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-09-27|||January 2006||2006-01-01|September 2010|2010-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Intraoperative Gamma Probe Localization of the Ureter|Intraoperative Gamma Probe Localization of the Ureter|Terminated||N/A|16|Actual|Mayo Clinic||1||Decided not pursue the study|f||||t||||||||||2017-02-18 14:54:43.277105|2017-02-18 14:54:43.277105
NCT00587535|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-01-20|||August 2003||2003-08-01|January 2016|2016-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration|Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration|Completed||N/A|18|Actual|Mayo Clinic|||2||f||||f||||||||No||2017-02-18 14:54:43.372986|2017-02-18 14:54:43.372986
NCT00587522|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||August 2001||2001-08-01|December 2007|2007-12-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease|Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease|Completed||N/A|64|Actual|NDO Surgical, Inc.||1|||f||||f||||||||||2017-02-18 14:54:43.475792|2017-02-18 14:54:43.475792
NCT00587509|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-12-01|||July 2003||2003-07-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:54:43.607555|2017-02-18 14:54:43.607555
NCT00587496|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||April 2006||2006-04-01|December 2007|2007-12-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers|A 30-Day Double-Masked Study to Determine the Effect of Oral Valacyclovir or Oral Valacyclovir Plus Aspirin on the Shedding of Herpes Simplex Virus DNA in the Tears and Saliva of Volunteers Without Clinical Signs of Ocular Herpetic Disease|Unknown status|Recruiting|Phase 1|60|Anticipated|National Eye Institute (NEI)||3|||f||||t||||||||||2017-02-18 14:54:43.657807|2017-02-18 14:54:43.657807
NCT00587483|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-08-09|2011-07-13||November 2007||2007-11-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Amiodarone for the Prevention of Reperfusion Ventricular Fibrillation|The Use of Amiodarone vs. Lidocaine and Placebo for the Prevention of Ventricular Fibrillation After Myocardial Reperfusion During Cardiopulmonary Bypass|Completed||N/A|342|Actual|Mayo Clinic|Included a heterogeneous group of operations which possibly make our results applicable to “real world” perioperative care; dosing of amiodarone was higher than in previous investigations, but the dose may not have been large enough.|3|||f||||f||||||||||2017-02-18 14:54:43.78632|2017-02-18 14:54:43.78632
NCT00587470|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-10-14|||August 1998||1998-08-01|October 2010|2010-10-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Angiotensin-II Blockade in Mitral Regurgitation|Angiotensin-II Blockade in Mitral Regurgitation|Completed||Phase 4|60|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:54:44.805642|2017-02-18 14:54:44.805642
NCT00587457|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-01-03|||March 2007||2007-03-01|January 2012|2012-01-01|January 2012|Anticipated|2012-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase I,Multicenter, Dose Escalation Study of CAT-8015 in Patients With Chronic Leukemia|A Phase I, Multicenter, Dose-Escalation Study of CAT-8015 in Patients With Relapsed or Refactory Chronic Lymphocytic Leukemia (CLL) Prolymphocytic Leukemia (PLL) or, Small Lymphocytic Leukemia (SLL)|Suspended||Phase 1|11|Actual|MedImmune LLC||1||On hold due to lack of CTM supply|f||||f||||||||||2017-02-18 14:54:44.913081|2017-02-18 14:54:44.913081
NCT00587444|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-10-14|||June 2001||2001-06-01|October 2009|2009-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|Heparin Dosing||Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass|Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass|Completed||Phase 3|270|Actual|Mayo Clinic||3|||f||||t||||||||||2017-02-18 14:54:45.024727|2017-02-18 14:54:45.024727
NCT00587431|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-08-05|2014-01-21||July 2003||2003-07-01|August 2014|2014-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer|Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer|Completed||Phase 2|102|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:54:45.142962|2017-02-18 14:54:45.142962
NCT00587418|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-08-30|||November 2008||2008-11-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2011|Actual|2011-07-01||Interventional|||L-arginine for Prevention of Kidney Damage in Liver Transplant Recipients|L-arginine Supplement for the Prevention of Calcineurin Inhibitor Nephrotoxicity|Completed||N/A|24|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:54:45.816761|2017-02-18 14:54:45.816761
NCT00587405|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-01-05|||December 2007||2007-12-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Cyrotherapy vs. APC in GAVE|Prospective Randomized Study of Cryotherapy Versus Argon Plasma Coagulation Therapy for Treatment Of Watermelon Stomach|Completed||Phase 2/Phase 3|60|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:54:45.925686|2017-02-18 14:54:45.925686
NCT00587392|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||December 2004||2004-12-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|LTFU||Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results|Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results|Completed||N/A|33|Actual|NDO Surgical, Inc.|||1||f||||f||||||||||2017-02-18 14:54:46.040571|2017-02-18 14:54:46.040571
NCT00587379|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-01-12|||June 2004||2004-06-01|January 2012|2012-01-01|May 2008|Anticipated|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Chronic Statin and Viagra Therapy in Persons With Endothelial Cell Dysfunction|The Effect of Chronic Statin Therapy on Peripheral Arterial Tone Response to Sildenafil Citrate (Viagra), and on Erectile Function in Men With Coronary Artery Endothelial Cell Dysfunction|Withdrawn||N/A|0|Actual|Mayo Clinic||2||Study closed per the request of PI due to lack of participant accrual|f||||f||||||||||2017-02-18 14:54:46.159669|2017-02-18 14:54:46.159669
NCT00587353|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-05-01|||January 2008||2008-01-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Tobacco Use Intervention Among Radiation Oncology Patients|Tobacco Use Intervention Among Radiation Oncology Patients|Completed||Phase 2|26|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:54:46.258363|2017-02-18 14:54:46.258363
NCT00587340|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-09-16|||August 2006||2006-08-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||A Survey of Sleep Problems in Survivors of Breast Cancer|A Survey of Sleep Problems in Survivors of Breast Cancer|Completed||N/A|256|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||f||||||||||2017-02-18 14:54:46.358381|2017-02-18 14:54:46.358381
NCT00587327|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-04-16|||November 2007||2007-11-01|April 2013|2013-04-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|OVANCON||Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions|A Randomised, Double-blind, Parallel Groups, Placebo-controlled, Multi-centre Study Assessing the Effects of a Selective Oxytocin Antagonist (Barusiban) and a Mixed Oxytocin Antagonist - Vasopressin V1a Antagonist (Atosiban) Administered Intravenously on Luteal Phase Uterine Contractions in Oocyte Donors Supplemented With Vaginal Progesterone|Completed||Phase 2|125|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-02-18 14:54:46.454286|2017-02-18 14:54:46.454286
NCT00587314|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-24|||January 2004||2004-01-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2020|Anticipated|2020-01-01||Observational|ablation IN BE||The Effect of Ablation Therapy on Barrett's Esophagus|The Effect of Ablation Therapy on Barrett's Esophagus|Enrolling by invitation||N/A|400|Anticipated|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"~     Esophageal Biopsy~   "|||2017-02-18 14:54:46.563498|2017-02-18 14:54:46.563498
NCT00587301|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-09-13|||June 2005||2005-06-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|ALAGB||Lap-Band Surgery on Adolescents for Safety and Efficacy|A Prospective, Open-label Study to Evaluate the Safety and Efficacy of Lap-Band® Adjustable Gastric Band (LAGB®) Operations in the Treatment of Morbidly Obese Adolescents (Ages 14-17)|Recruiting||Phase 2/Phase 3|120|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 14:54:46.676304|2017-02-18 14:54:46.676304
NCT00587288|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-04|2016-07-18|2016-03-23||April 2008||2008-04-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma|An Efficacy and Safety Study of Reslizumab in the Treatment of Poorly Controlled Asthma in Subjects With Eosinophilic Airway Inflammation|Completed||Phase 2|106|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-02-18 14:54:46.793393|2017-02-18 14:54:46.793393
NCT00587275|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-06-02||2013-07-26|October 2007||2007-10-01|June 2014|2014-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI|A Double-Blind, Randomized, Placebo-Controlled Crossover Study to Assess the Efficacy of AST-120 in Patients With Gastroesophageal Reflux Disease (GERD) Who Continue to be Symptomatic on a Standard Dose of Proton Pump Inhibitor (PPI)|Terminated||Phase 2|4|Actual|Ocera Therapeutics||2||Terminated for lack of enrollment|f||||f||||||||||2017-02-18 14:54:47.339927|2017-02-18 14:54:47.339927
NCT00587262|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-12-30|||October 2006||2006-10-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Scalar Localization Cochlear Electrode Array Using 64 Slice CT|Scalar Localization of Cochlear Implant Electrode Array in Hearing Preservation Patients Using 64 Slice CT|Completed||N/A|5|Actual|Mayo Clinic|||3||f||||f||||||||||2017-02-18 14:54:47.447816|2017-02-18 14:54:47.447816
NCT00587249|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-03|2013-04-11|||July 2002||2002-07-01|March 2013|2013-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||ICC-1132 - Candidate Vaccine Against P Falciparum Malaria|Phase I Trial of ICC-1132, a Candidate Vaccine Against Plasmodium Falciparum Malaria Based on a Viral-like Particle Comprising Recombinant Hepatitis B Core Antigen and Circumsporozoite Epitopes, to Assess Vaccine Safety and Immunogenicity in Healthy Adult Volunteers|Completed||Phase 1|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 14:54:47.547709|2017-02-18 14:54:47.547709
NCT00587236|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-01-13|||March 2006||2006-03-01|January 2016|2016-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis|A Blinded Comparison of Conventional Colonoscopy to Endoscopic AFI and NBI for Dysplasia Detection in Patients With Ulcerative Colitis and Sclerosing Cholangitis or Known Colorectal Dysplasia or Cancer- A Pilot Clinical Study|Completed||N/A|65|Actual|Mayo Clinic|||2||f||||f||||||||||2017-02-18 14:54:47.657675|2017-02-18 14:54:47.657675
NCT00587223|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-06-25|2010-03-29||December 2007||2007-12-01|June 2010|2010-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)|A Prospective, Multicenter, Within Subject Controlled Study to Evaluate the Effect of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa|Terminated||Phase 3|1|Actual|Organogenesis|Study terminated early, the 1 enrolled subject subsequently discontinued study at Day 7.|2||Insufficient patient enrollment|f||||t||||||||||2017-02-18 14:54:47.853505|2017-02-18 14:54:47.853505
NCT00587210|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-01-20|||June 2004||2004-06-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel|Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel|Completed||N/A|34|Actual|Mayo Clinic|||1||f||||f||||||||No||2017-02-18 14:54:48.188387|2017-02-18 14:54:48.188387
NCT00587197|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-11-09|||January 2003||2003-01-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|October 2005|Actual|2005-10-01||Observational|||A Prospective Evaluation of Computerized Tomographic(CT) Scanning as a Screening Modality for Esophageal Varices|The Accuracy of Contrast Abdominal CT for the Detection of High-Grade Esophageal and Gastric Varices in Patients With Cirrhosis|Completed||N/A|134|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 14:54:48.280168|2017-02-18 14:54:48.280168
NCT00587184|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-11-23|||July 2006||2006-07-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Observational|||Confocal Microscopy in Barrett's Esophagus|The Use of Confocal Microscopy in Barrett's Esophagus|Completed||N/A|92|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 14:54:48.368005|2017-02-18 14:54:48.368005
NCT00587171|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-07-07|2011-04-22||April 2008||2008-04-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|March 2009|Actual|2009-03-01||Interventional|ATS12||Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia|A Randomized Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia in Children 7 to <13 Years Old|Terminated||Phase 3|19|Actual|Jaeb Center for Health Research|The study was stopped prior to achieving the goal of 45 subjects enrolled due to slow recruitment, leaving only 19 subjects enrolled.|2||This study was stopped due to insufficient recruitment.|f||||t||||||||||2017-02-18 14:54:48.66786|2017-02-18 14:54:48.66786
NCT00587158|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-05-09|2013-01-24||January 2007||2007-01-01|May 2013|2013-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Oral Paricalcitol in Kidney Transplant Recipients|Oral Paricalcitol in Kidney Transplant Recipients Receiving a Corticosteroid-free Immunosuppressive Regimen|Completed||N/A|100|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:54:49.874743|2017-02-18 14:54:49.874743
NCT00587145|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||May 2006||2006-05-01|December 2007|2007-12-01|May 2009|Anticipated|2009-05-01|March 2009|Anticipated|2009-03-01||Interventional|||Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer|Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|44|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 14:54:51.009678|2017-02-18 14:54:51.009678
NCT00587132|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-06-19|2013-04-29||November 2006||2006-11-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma|Pilot Study Using Secretin and Iodinated Intravenous Contrast and 64-Channel CT in Patients at High Risk for Pancreatic Adenocarcinoma|Terminated||Phase 1/Phase 2|4|Actual|Mayo Clinic|The study was terminated early due to lack of funding.|4||Lack of funding|f||||f||||||||||2017-02-18 14:54:51.115288|2017-02-18 14:54:51.115288
NCT00587119|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-10-01|||December 2007||2007-12-01|October 2010|2010-10-01|July 2009|Anticipated|2009-07-01|July 2009|Actual|2009-07-01||Interventional|PBC||Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis|Open-Label Pilot Study Evaluating Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis.|Withdrawn||N/A|0|Actual|Mayo Clinic||1||Lack of enrollment|f||||f||||||||||2017-02-18 14:54:51.501872|2017-02-18 14:54:51.501872
NCT00587106|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-03-27|||April 1988||1988-04-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Studies of Neurological Paraneoplastic Syndromes|Studies of Neurological Paraneoplastic Syndromes|Completed||N/A|51|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     blood and/or spinal fluid~   "|||2017-02-18 14:54:51.611439|2017-02-18 14:54:51.611439
NCT00587093|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-04-28|||July 2001||2001-07-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer|Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer|Active, not recruiting||N/A|600|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||f||||||||||2017-02-18 14:54:51.706937|2017-02-18 14:54:51.706937
NCT00587080|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||January 2004||2004-01-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Observational|||Stapled TransAnal Rectal Resection (STARR): Clinical and Radiological Outcome|Stapled TransAnal Rectal Resection (STARR): Correlation Between Clinical and Radiological Outcome|Completed||N/A|24|Actual|University of Zurich|||1||f||||f||||||||||2017-02-18 14:54:51.80895|2017-02-18 14:54:51.80895
NCT00587067|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-02-06|||June 2003||2003-06-01|May 2016|2016-05-01|May 19, 2016|Actual|2016-05-19|May 19, 2016|Actual|2016-05-19||Interventional|||A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy|A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy|Completed||Phase 2|34|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:51.887384|2017-02-18 14:54:51.887384
NCT00587054|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-05-17|||June 2001||2001-06-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders|Phase II Trial of Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Treatment of Adult Patients (>18 Years) With Lymphohematopoietic Disorders|Completed||Phase 2|129|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:54:51.997477|2017-02-18 14:54:51.997477
NCT00587041|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-04-28|2011-09-19||February 2006||2006-02-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Use of Oral Probiotics to Reduce Urinary Oxalate Excretion|Use of Oral Probiotics to Reduce Urinary Oxalate Excretion|Completed||Phase 1/Phase 2|40|Actual|Mayo Clinic|Small sample size, low oxalate levels in diet|3|||f||||t||||||||||2017-02-18 14:54:52.107471|2017-02-18 14:54:52.107471
NCT00587028|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-01-20|||February 2007||2007-02-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Cathartic-Free DECT Colonography for Detection of Colonic Polyps|Cathartic-Free Dual Energy Computerized Tomography (DECT) Colonography.|Terminated||N/A|12|Actual|Mayo Clinic|||4|Administrative closed due to funding|f||||f||||||||No||2017-02-18 14:54:52.527932|2017-02-18 14:54:52.527932
NCT00587015|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-11-21|||August 2007||2007-08-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|March 2008|Actual|2008-03-01||Interventional|||A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)|A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)|Terminated||Phase 1|50|Anticipated|MedImmune LLC||1||"Due to a lack of IP supply and then terminated because they were combined into one new study~   with the new IP formulation."|f||||f||||||||||2017-02-18 14:54:52.843037|2017-02-18 14:54:52.843037
NCT00587002|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-04-13|||March 2007||2007-03-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction|Differences in Epicardial Plaque and Microvascular Function in Women With an Acute Myocardial Infarction|Completed||N/A|65|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:54:52.954498|2017-02-18 14:54:52.954498
NCT00586989|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-01-05|||December 2007||2007-12-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|February 2010|Actual|2010-02-01||Observational|ETMI||Endoscopic Tri-Modal Imaging in Patients With Barrett's Esophagus|Endoscopic Tri-Modal Imaging for the Detection of High-Grade Dysplasia and Early Adenocarcinoma in Patients With Barrett's Esophagus: A Randomized Crossover Multi-center Study|Completed||N/A|60|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"~     esophageal biopsies~   "|||2017-02-18 14:54:53.067293|2017-02-18 14:54:53.067293
NCT00586976|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-04-06|||July 2005||2005-07-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery|A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery|Terminated||Phase 2/Phase 3|125|Actual|Mayo Clinic||2||Stopped by DSMB due to increased wound infection rate.|f||||t||||||||||2017-02-18 14:54:53.178025|2017-02-18 14:54:53.178025
NCT00586963|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-08-20|||January 2008||2008-01-01|August 2010|2010-08-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Observational|EE||Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis|How Does Proton Pump Inhibitor Therapy Impact Quality of Life in Patients Newly Diagnosed With Erosive Reflux Esophagitis?|Completed||N/A|65|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 14:54:53.47596|2017-02-18 14:54:53.47596
NCT00586950|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-09-12|||June 2006||2006-06-01|February 2009|2009-02-01|September 2011|Actual|2011-09-01|November 2010|Actual|2010-11-01||Observational|B-SAFE||123I-BMIPP SPECT Analysis for Decreasing Cardiac Events in Hemodialysis Patients|Outcome Study on BMIPP SPECT Analysis for Decreasing Cardiac Events in Hemodialysis Patients|Completed||N/A|1000|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||t||||||||||2017-02-18 14:54:53.55939|2017-02-18 14:54:53.55939
NCT00586937|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-07-25|||June 2005||2005-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Quality of Life in Lung Cancer Survivors|Quality of Life in Lung Cancer Survivors|Active, not recruiting||N/A|193|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:54:53.637039|2017-02-18 14:54:53.637039
NCT00586924|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-08-06|||May 2007||2007-05-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia|A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Relapsed or Refractory Hairy Cell Leukemia (HCL)|Completed||Phase 1|50|Actual|MedImmune LLC||1|||f||||f||||||||||2017-02-18 14:54:53.742454|2017-02-18 14:54:53.742454
NCT00586911|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-04-06|||January 2003||2003-01-01|April 2015|2015-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Betaine in Patients With Nonalcoholic Steatohepatitis|A Randomized, Placebo-Controlled Trial of Betaine in Patients With Nonalcoholic Steatohepatitis (NASH)|Completed||Phase 2|26|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:54:53.854003|2017-02-18 14:54:53.854003
NCT00586898|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-02-24|2015-12-16||July 2001||2001-07-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle|Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle|Completed||Phase 2|36|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:53.963012|2017-02-18 14:54:53.963012
NCT00586885|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-10-09|||February 2004||2004-02-01|October 2012|2012-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Effects of Alanine in Patients With Nonalcoholic Steatohepatitis|A Pilot Study: Therapeutic Effect of L-Alanine in Patients With Nonalcoholic Steatohepatitis|Completed||N/A|9|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:54:54.207065|2017-02-18 14:54:54.207065
NCT00586872|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-24|||October 2007||2007-10-01|January 2017|2017-01-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Endoscopic Mucosal Resection (EMR) in Barrett's Esophagus|Endoscopic Mucosal Resection in Barrett's Esophagus|Enrolling by invitation||N/A|1800|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-02-18 14:54:54.309404|2017-02-18 14:54:54.309404
NCT00586859|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2008-05-29|||May 2006||2006-05-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Multi-Center Study of the NDO Surgical Plicator Utilizing Multiple Implants for the Treatment of GERD|Multi-Center Study of the NDO Surgical Plicator Utilizing Multiple Implants|Terminated||N/A|41|Actual|NDO Surgical, Inc.||1||Sponsoring company ceased business operations.|f||||f||||||||||2017-02-18 14:54:54.419222|2017-02-18 14:54:54.419222
NCT00586846|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-12-15|2015-12-15||July 2003||2003-07-01|December 2015|2015-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma|Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma|Completed||Phase 2|40|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:54:54.523034|2017-02-18 14:54:54.523034
NCT00586833|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-10-13|||April 2007||2007-04-01|October 2010|2010-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Heart Failure and a Preserved Ejection Fraction|The Role of Vascular Dysfunction in Limiting Cardiovascular Reserve in Patients With Heart Failure and a Preserved Ejection Fraction|Completed||N/A|51|Actual|Mayo Clinic|||3||f||||f||||||Samples With DNA|"~     Blood is drawn to evaluate BNP and cGMP pre and post exercise.~   "|||2017-02-18 14:54:54.799217|2017-02-18 14:54:54.799217
NCT00586820|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-07-03|2014-04-21||May 2005||2005-05-01|June 2014|2014-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|BQ-123|12 subjects were enrolled on the BQ-123 arm, but 1 subject was excluded due to unsuccessful PCI.|Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI|Role of Endothelin in Microvascular Dysfunction Following Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction|Completed||Phase 2|23|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:54:54.917281|2017-02-18 14:54:54.917281
NCT00586807|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-01-29|||June 2005||2005-06-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Metabolic Response to Infliximab in Pediatric Ulcerative Colitis|Metabolic Response to Infliximab in Pediatric Ulcerative Colitis|Terminated||N/A|10|Anticipated|Indiana University||1||poor enrollment|f||||t||||||||||2017-02-18 14:54:55.277301|2017-02-18 14:54:55.277301
NCT00586794|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-06-05|||December 2007||2007-12-01|October 2010|2010-10-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients|Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients|Terminated||Phase 3|24|Actual|Competence Network for Congenital Heart Defects||2|||f||||f||||||||||2017-02-18 14:54:55.377897|2017-02-18 14:54:55.377897
NCT00586703|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-06-06|2014-02-05||April 2005||2005-04-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional||Participants who were eligible for study.|Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT|Safety Trial of Natural Killer (NK) Cell Donor Lymphocyte Infusions (DLI) From 3-5/6 Human Leukocyte Antigen (HLA) Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation (ASCT)|Completed||Phase 1|21|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:54:55.530347|2017-02-18 14:54:55.530347
NCT00586690|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-25|2014-02-05||May 2005||2005-05-01|January 2017|2017-01-01|November 2013|Actual|2013-11-01|May 2013|Actual|2013-05-01||Interventional||Eligible adult patients were those who engrafted following a fludarabine based T cell depleted non-myeloablative allogeneic transplant regimen with alemtuzumab. Donors were the same HLA 6/6 matched family member used for the allogeneic transplantation.|Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT|Safety Trial of Natural Killer (NK) Cell Donor Lymphocyte Infusions(DLI) From 6/6 Human Leukocyte Antigen (HLA) Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation (ASCT)|Completed||Phase 1|47|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:54:55.870017|2017-02-18 14:54:55.870017
NCT00586677|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-09-19|||May 2005||2005-05-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Evaluation of Parenting Interventions to Decrease Family Risk for Child Maltreatment|Evaluation of Parenting Interventions to Decrease Family Risk for Child|Completed||N/A|123|Actual|Duke University||2|||f||||f||||||||||2017-02-18 14:54:56.50136|2017-02-18 14:54:56.50136
NCT00586664|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-02-04|2009-10-08||October 2007||2007-10-01|February 2013|2013-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis||Completed||Phase 3|130|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-02-18 14:54:56.617378|2017-02-18 14:54:56.617378
NCT00586651|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-09-22||2013-08-22|December 2007||2007-12-01|September 2015|2015-09-01|September 2010|Actual|2010-09-01|October 2009|Actual|2009-10-01||Interventional|||Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis|An Open-Label Study of Oral CEP-701 in Patients With Polycythemia Vera or Essential Thrombocytosis With the JAK2 V617F Mutation|Completed||Phase 2|39|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 14:54:57.842558|2017-02-18 14:54:57.842558
NCT00586638|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-08-03|||December 2007||2007-12-01|August 2015|2015-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Training Cognitive Control Processes in Older Adults|Pilot Study Using a Video Game to Train Cognitive Control Processes in Healthy Older Adults|Completed||N/A|60|Actual|Columbia University||3|||f||||f||||||||||2017-02-18 14:54:57.951261|2017-02-18 14:54:57.951261
NCT00586625|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-02-13|2009-10-08||October 2007||2007-10-01|February 2013|2013-02-01||||May 2008|Actual|2008-05-01||Interventional|||Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers||Completed||Phase 3|861|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:54:58.067138|2017-02-18 14:54:58.067138
NCT00586612|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-10-18|2009-12-17||December 2007||2007-12-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|December 2008|Actual|2008-12-01||Interventional|||Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants|Immunogenicity & Safety Study in Preterm & Full-term Infants of GSK Biologicals' Hib-MenC Vaccine, Menitorix™ Co-administered With Infanrix™ Penta & Prevenar™ at 2, 4, 6 Months & as a Booster With Infanrix™ IPV & Prevenar™ at 16-18 Months|Completed||Phase 3|313|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:54:58.437727|2017-02-18 14:54:58.437727
NCT00586599|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-04-01|||August 2007||2007-08-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional|||Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis|Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis|Completed||N/A|51|Actual|Indiana University||3|||f||||f||||||||||2017-02-18 14:54:59.456233|2017-02-18 14:54:59.456233
NCT00586586|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-07-12|||January 2008||2008-01-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|ATACA||Effectiveness Study of CBT for Anxiety in Children|Assessment and Treatment - Anxiety in Children and Adults (Child Part)|Completed||Phase 2|222|Actual|Haukeland University Hospital||3|||f||||t||||||||||2017-02-18 14:54:59.551743|2017-02-18 14:54:59.551743
NCT00586573|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-05-02|2011-01-05||March 2007||2007-03-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS|An Open-Label Pilot Study of Namenda (Memantine Hydrochloride) in Adult Subjects With Attention Deficit Hyperactivity Disorder (ADHD) and ADHD NOS|Completed||Phase 4|34|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 14:54:59.649004|2017-02-18 14:54:59.649004
NCT00586560|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-05-11|||February 2007||2007-02-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|KTN10010||Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)|A Phase 1 Trial of Escalating Doses of Karenitecin Plus Cyclophosphamide Administered Intravenously Daily for 5 Consecutive Days in Pediatric Patients With Refractory or Recurrent Solid Tumors|Completed||Phase 1|15|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 14:54:59.879423|2017-02-18 14:54:59.879423
NCT00586547|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-12-02|||July 2000||2000-07-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluating the Use of RFT5-dgA to Deplete Alloreactive Cells Prior to Haploidentical Stem Cell Transplantation|A Phase I Trial Evaluating The Use of RFT5-dgA to Deplete Alloreactive Cells PriorTo Haploidentical Stem Cell Transplantation|Completed||Phase 1|24|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:54:59.97803|2017-02-18 14:54:59.97803
NCT00586534|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-03-17|||January 2007||2007-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|||Developing Computer Based Treatments for Addiction|Developing Computer Based Treatments for Addiction|Completed||N/A|216|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:55:00.132078|2017-02-18 14:55:00.132078
NCT00586521|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-10-27|2009-04-03||February 2006||2006-02-01|October 2014|2014-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)|A Prospective Controlled Study on the Effect on Bleeding Events and Joint Function in Young Adults With Severe Hemophilia A After a 6 Month Prophylaxis Treatment Compared to on Demand Treatment|Completed||Phase 4|20|Actual|Bayer|The short observation period of 6 months may be responsible for the lack of statistical significance between treatments in the subject's overall assessment of disease-related quality of life; however, a positive trend was noted.|1|||f||||f||||||||||2017-02-18 14:55:00.258437|2017-02-18 14:55:00.258437
NCT00586508|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2014-01-07||2014-01-07|November 2007||2007-11-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Trial of Enzastaurin and Bevacizumab in Adults With Recurrent Malignant Gliomas|A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas|Completed||Phase 2|120|Anticipated|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:55:00.603435|2017-02-18 14:55:00.603435
NCT00586495|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-11-19|2009-10-08||December 2005||2005-12-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Long-term Extension From RCC Phase II (11515)|Extension Study for BAY43-9006 in Japanese Patients With Renal Cell Carcinoma|Completed||Phase 2|95|Actual|Bayer||1|||f||||f||||||||||2017-02-18 14:55:00.71761|2017-02-18 14:55:00.71761
NCT00586482|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-12-19|2014-11-26||August 2006||2006-08-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Pilot Study: Preoperative Nicotine Lozenges|The Role of Nicotine Lozenges in Reducing Preoperative Exposure to Cigarette Smoke|Completed||Phase 4|46|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:55:03.657714|2017-02-18 14:55:03.657714
NCT00586469|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-11-03|2009-01-14||December 2007||2007-12-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk|Observer-blind, Post-Marketing Study to Compare the Safety and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2007-2008 Season) Made With New vs. Aged Bulk Material, in Adults Ranging in Age From 18 to 60 Years|Completed||Phase 4|1000|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:55:04.406964|2017-02-18 14:55:04.406964
NCT00586456|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-06-14|||May 2007||2007-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:55:04.936192|2017-02-18 14:55:04.936192
NCT00586443|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-11-18|||November 2007||2007-11-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|BEP||BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)|A Phase I Study of Bevacizumab, Everolimus, and Panitumumab for Patients With Advanced Solid Tumors|Completed||Phase 1|56|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:55:04.98186|2017-02-18 14:55:04.98186
NCT00586430|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||December 2005||2005-12-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The Impact of Lorazepam on Cognition in APOE e4 Carriers|The Impact of Lorazepam on Cognition in APOE e4 Carriers|Completed||N/A|36|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:55:05.093748|2017-02-18 14:55:05.093748
NCT00586417|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-12-02|||January 2007||2007-01-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments|A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments.|Terminated||N/A|61|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:55:05.205605|2017-02-18 14:55:05.205605
NCT00586404|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-10-19|||November 2007||2007-11-01|October 2015|2015-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|BEST||The Study of Barrett's Esophagus: What Are the Factors of Progression|Barrett's Esophagus Study (BEST) Trial - a Multi-Center and Endoscopic Outcomes Project|Suspended||N/A|2500|Anticipated|Midwest Biomedical Research Foundation|||1|The protocol is being reviewed and potentially revised. Recruitment is currently suspended.|f||||t||||||||||2017-02-18 14:55:05.298972|2017-02-18 14:55:05.298972
NCT00586391|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-08-23|||February 2009||2009-02-01|August 2016|2016-08-01|July 2029|Anticipated|2029-07-01|July 2014|Actual|2014-07-01||Interventional|CRETI-NH||CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL|Phase I Study Of CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, Acute Lymphocytic Leukemia, and Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 1|14|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:55:05.426269|2017-02-18 14:55:05.426269
NCT00586378|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-03-01|||April 2006||2006-04-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|Post-Ovatio||Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study|Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study|Completed||Phase 3|85|Actual|ELA Medical, Inc.||1|||f||||f||||||||||2017-02-18 14:55:05.535016|2017-02-18 14:55:05.535016
NCT00586365|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-03-20|||October 2007||2007-10-01|March 2012|2012-03-01|October 2010|Actual|2010-10-01|January 2010|Actual|2010-01-01||Interventional|Naproxen||Naproxen for the Prevention of HO After Complex Elbow Trauma|Effectiveness of Naproxen for the Prevention of Heterotopic Ossification After Complex Elbow Trauma: a Prospective Randomized Trial|Withdrawn||Phase 4|0|Actual|Massachusetts General Hospital||2||Too difficult to satisfy all the inclusion criteria.|f||||f||||||||||2017-02-18 14:55:05.616186|2017-02-18 14:55:05.616186
NCT00586352|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-07-29|||January 2006||2006-01-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease|Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease|Completed||N/A|31|Actual|Indiana University||3|||f||||t||||||||||2017-02-18 14:55:05.720459|2017-02-18 14:55:05.720459
NCT00586339|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-08-29|2012-02-16||January 2008||2008-01-01|August 2016|2016-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females|Evaluation of the Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in Adult Human Immunodeficiency Virus (HIV) Infected Female Subjects|Completed||Phase 2|150|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:55:06.083208|2017-02-18 14:55:06.083208
NCT00586326|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-11-02|2012-09-20||August 2003||2003-08-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|January 2006|Actual|2006-01-01||Interventional|DCIS||MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ|MammoSite Radiation Therapy System (RTS) as the Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ (DCIS)|Completed||Phase 2|133|Actual|Hologic, Inc.||1|||f||||f||||||||||2017-02-18 14:55:10.709768|2017-02-18 14:55:10.709768
NCT00586313|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-08-31|2014-03-17||January 2007||2007-01-01|August 2016|2016-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|NAFLD|13 females|Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)|Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)|Completed||N/A|21|Actual|Indiana University|The small sample size and low-risk population.|1|||f||||t||||||||No||2017-02-18 14:55:11.026801|2017-02-18 14:55:11.026801
NCT00586300|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2012-06-20|||June 2003||2003-06-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Community-Based Programs for Improving Physical Function in People With Early Knee Osteoarthritis|Multidimensional Intervention in Early Osteoarthritis (The Knee Study)|Completed||N/A|294|Actual|University of Arizona||3|||f||||f||||||||||2017-02-18 14:55:11.485253|2017-02-18 14:55:11.485253
NCT00586287|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-03-29|||January 2007||2007-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon|Prospective Randomized Trial of a Clinical Algorithm to Predict the Loading Dose of Phenprocoumon|Completed||Phase 4|302|Actual|Cantonal Hospital of St. Gallen||3|||f||||f||||||||||2017-02-18 14:55:11.603887|2017-02-18 14:55:11.603887
NCT00586274|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-03-03|||March 2002||2002-03-01|March 2014|2014-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|RAFHAS||Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT|A Phase I Study Evaluating The Use Of Rft5-Dga To Deplete Alloreactive Cells For Patients With Fanconi Anemia After Haploidentical Stem Cell Transplantation|Terminated||Phase 1|1|Actual|Baylor College of Medicine||1||Poor accrual|f||||t||||||||||2017-02-18 14:55:11.726281|2017-02-18 14:55:11.726281
NCT00586261|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-03-13|2012-11-13||March 2006||2006-03-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|||Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function|Does Chronic Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function in Non-Diabetic Patients With Chronic Kidney Disease?|Terminated||N/A|36|Actual|Mayo Clinic|The study was stopped early due to low enrollment because of the specifics of the inclusion criteria.|2||Low enrollment because of the specifics of the inclusion criteria|f||||f||||||||||2017-02-18 14:55:11.841331|2017-02-18 14:55:11.841331
NCT00586248|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||March 2006||2006-03-01|May 2007|2007-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||A Pilot Study on Pacemaker Interference From Peripheral Nerve Stimulator for Regional Anesthesia|A Pilot Study on Pacemaker Interference From Peripheral Nerve Stimulator for|Completed||N/A|14|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 14:55:12.243698|2017-02-18 14:55:12.243698
NCT00586235|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-05-25|||February 2007||2007-02-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Registration and Fusion of Real-Time Ultrasound With CT for Lesion Localization and Characterization|Registration and Fusion of Real-Time Ultrasound With CT for Lesion Localization and Characterization|Completed||N/A|80|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 14:55:12.338515|2017-02-18 14:55:12.338515
NCT00586222|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-01-24|||January 2007||2007-01-01|January 2012|2012-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Omega 3 Fatty Acid Trial|Neurometabolic Effects of the Essential Polyunsaturated Fatty Acids in Early-Onset Bipolar Disorder: A Magnetic Resonance Spectroscopy Study|Completed||Phase 1|19|Actual|Mayo Clinic||3|||f||||f||||||||||2017-02-18 14:55:12.432559|2017-02-18 14:55:12.432559
NCT00586209|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-06-27|||January 2003||2003-01-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|January 2009|Actual|2009-01-01||Interventional|||L-Glutamine Therapy for Sickle Cell Anemia|A Phase II, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study of L Glutamine Therapy for Sickle Cell Anemia and Sickle ß0-Thalassemia|Completed||Phase 2|15|Actual|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-02-18 14:55:12.559216|2017-02-18 14:55:12.559216
NCT00586196|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-08-21|2013-02-28||January 2007||2007-01-01|August 2014|2014-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|SHARP||Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period|Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period|Completed||Phase 2|16|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 14:55:12.674085|2017-02-18 14:55:12.674085
NCT00586183|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||March 2006||2006-03-01|March 2006|2006-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Cardiac Sympathetic Activity in Patients With the Apical Ballooning Syndrome|Cardiac Sympathetic Activity in Patients With the Apical Ballooning Syndrome|Completed||N/A|1|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:55:13.102232|2017-02-18 14:55:13.102232
NCT00586170|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-04-11|2016-03-09||November 2007||2007-11-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||A Double-Blind Study on Adjunctive Use of PEMF in the Treatment of 5th Metatarsal Non-Union Fractures|A Prospective, Randomized, Double-Blind Study on Adjunctive Use of Pulsed Electromagnetic Fields in the Treatment of 5th Metatarsal Non-Union Fractures: Effect on Clinical Outcome and Growth Factor Synthesis|Terminated||N/A|8|Actual|Zimmer Biomet||2||Slow enrollment|f||||f||||||||Undecided||2017-02-18 14:55:13.245241|2017-02-18 14:55:13.245241
NCT00586157|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-11-09|2010-11-22||September 2006||2006-09-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Medication Patch to Treat Children Ages 6-12 With ADHD|Efficacy and Safety/Tolerability of Methylphenidate Transdermal System (MTS) for Before-School Dysfunction in Children With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 4|36|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:55:13.604995|2017-02-18 14:55:13.604995
NCT00586131|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-09-29|||September 2003||2003-09-01|September 2014|2014-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Arterial pH and N-balances in APD|Effect of Arterial pH on N-balances of Patients Undergoing Automated Peritoneal Dialysis|Completed||Phase 4|8|Actual|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-02-18 14:55:14.052194|2017-02-18 14:55:14.052194
NCT00586118|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2008-01-03|||December 2006||2006-12-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Inhalative Sedation in ICU With Sevoflurane Via Anaesthetic Conserving Device Compared to Propofol||Completed||N/A|120|Actual|Klinikum Ludwigshafen|||2||f||||f||||||||||2017-02-18 14:55:14.164256|2017-02-18 14:55:14.164256
NCT00586105|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-03-25|2010-02-01||December 2005||2005-12-01|March 2014|2014-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)|A Multicenter Uncontrolled Study of Sorafenib in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma|Completed||Phase 3|39|Actual|Bayer|The median for ´Overall Survival (OS)´ and the median for ´Overall Response Duration´ reported are the median of each distribution including the censored data. The correct estimates of these medians were not evaluable.|1|||f||||f||||||||||2017-02-18 14:55:14.280134|2017-02-18 14:55:14.280134
NCT00586092|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-04-04|||September 2005||2005-09-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors|A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid|Completed||Phase 1|45|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:55:14.893525|2017-02-18 14:55:14.893525
NCT00586079|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-03-17|||July 2007||2007-07-01|April 2015|2015-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Deep Brain Stimulation in Patients With Parkinson's Disease|The Effect of Deep Brain Stimulation on Movement-Related Cortical Potentials in Patients With Parkinson's Disease|Completed||N/A|20|Actual|Mayo Clinic||2|||f||||f||||||||No||2017-02-18 14:55:15.005859|2017-02-18 14:55:15.005859
NCT00586066|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-07-01|||November 2005||2005-11-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Memantine and Cognitive Dysfunction in Bipolar Disorder|Memantine and Cognitive Dysfunction in Bipolar Disorder|Completed||Phase 4|40|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 14:55:15.11765|2017-02-18 14:55:15.11765
NCT00586053|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-02-10|||August 2000||2000-08-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Observational|||Unprepped CT Colonography|"CTC of the Unprepped Colon: Optimization & Validation"|Completed||N/A|1255|Actual|Mayo Clinic|||3||f||||f||||||||||2017-02-18 14:55:15.234551|2017-02-18 14:55:15.234551
NCT00586040|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-04-09|||September 2007||2007-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|PTB||Photochemical Tissue Bonding|Photochemical Tissue Bonding (PTB) for Excisional Wound Healing|Completed||Phase 2|40|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:55:15.341525|2017-02-18 14:55:15.341525
NCT00584701|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2012-06-18|2011-09-06||January 2008||2008-01-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|PG||Pharmacogenomics in Autism Treatment|Pharmacogenomics in Autism Treatment|Completed||Phase 2/Phase 3|49|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 14:55:37.476751|2017-02-18 14:55:37.476751
NCT00586027|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-11-23|||July 2008||2008-07-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Observational|||Is There a Correlation of Natriuretic Propeptide Type B With an Intraoperative Low Cardiac Output?|Prospective Observational Study in Patients Undergoing Cardiac Surgery: Part 2: Is There a Correlation of Natriuretic Propeptide Type B With an Intraoperative Low Cardiac Output?|Completed||N/A|150|Anticipated|Klinikum Ludwigshafen|||1||f||||f||||||||||2017-02-18 14:55:15.451905|2017-02-18 14:55:15.451905
NCT00586014|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-07-07|||May 1997||1997-05-01|May 2013|2013-05-01|February 2008|Actual|2008-02-01|January 2006|Actual|2006-01-01||Interventional|||High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma|High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma|Completed||Phase 2|91|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:55:15.550434|2017-02-18 14:55:15.550434
NCT00586001|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-11-29|||September 2005||2005-09-01|March 2011|2011-03-01|November 2010|Actual|2010-11-01|November 2008|Actual|2008-11-01||Interventional|||A Unified Treatment for Anxiety Disorders|Phase 3 of The Development of A Unified Treatment for Anxiety Disorders|Completed||Phase 3|40|Actual|Boston University||2|||f||||f||||||||||2017-02-18 14:55:15.658087|2017-02-18 14:55:15.658087
NCT00585988|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-06-27|||June 2007||2007-06-01|June 2012|2012-06-01|September 2010|Anticipated|2010-09-01|September 2009|Anticipated|2009-09-01||Interventional|||A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty|Functional Recovery Following Hip Resurfacing or Total Hip Arthroplasty in Patients Matched By Age, Gender, and Activity Level|Withdrawn||N/A|0|Actual|Zimmer Biomet||2|||f||||f||||||||||2017-02-18 14:55:15.786949|2017-02-18 14:55:15.786949
NCT00585975|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-02-13|2011-11-07||October 2007||2007-10-01|February 2013|2013-02-01||||July 2008|Actual|2008-07-01||Interventional|||Efficacy and Safety of Bromfenac Ophthalmic Solution||Completed||Phase 2|568|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 14:55:15.883605|2017-02-18 14:55:15.883605
NCT00585962|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2007-12-27|||February 2004||2004-02-01|December 2007|2007-12-01||||March 2006|Actual|2006-03-01||Interventional|||Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate|A Phase II Study Using Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|85|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:55:16.211169|2017-02-18 14:55:16.211169
NCT00585949|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-18|||July 2006||2006-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|AGE-PCI||Age and Endothelial Progenitor Cell Mobilization|"The Effects of Age on Endothelial Progenitor Cell Mobilization in Humans"|Active, not recruiting||N/A|136|Anticipated|Emory University|||2||f||||f||||||||||2017-02-18 14:55:16.309282|2017-02-18 14:55:16.309282
NCT00585936|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-11-09|||September 2007||2007-09-01|November 2011|2011-11-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Observational|||Imaging Inflammation in Autoimmune Diabetes|Evaluation of Magnetic Nanoparticle Enhanced Imaging in Autoimmune Diabetes|Completed||N/A|30|Anticipated|Joslin Diabetes Center|||4||f||||t||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 14:55:16.41163|2017-02-18 14:55:16.41163
NCT00585923|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-03-15|2009-11-11||April 2002||2002-04-01|May 2012|2012-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Slotted Hole Versus Fixed Hole C-Tek|A Multi-Center Clinical Investigation of Slotted Hole Versus Fixed Hole C-Tek™ Anterior Cervical Plates|Terminated||N/A|115|Actual|Zimmer Biomet|Early termination of this study because the doctor involved in the study decided that he did not want to participate in the study any more. The site also did not have very good follow-up on all of their patients|2||Due to lack of follow-up information|f||||f||||||||Undecided||2017-02-18 14:55:16.509267|2017-02-18 14:55:16.509267
NCT00585910|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-11-08|2009-09-22||January 2004||2004-01-01|November 2012|2012-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD|Efficacy and Safety/Tolerability of OROS MPH (Concerta) Plus Atomoxetine (ATMX) in Children and Adolescents (Age 6-17) With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 4|94|Actual|Massachusetts General Hospital|"Open trial so may have been biased;~Small sample size which may have underestimated findings;~Used a priori definition of partial response. However, our definition of ATMX partial responders has not been validated."|1|||f||||f||||||||||2017-02-18 14:55:16.96072|2017-02-18 14:55:16.96072
NCT00585897|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-10-11|||January 2007||2007-01-01|December 2012|2012-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effect of Discontinuation of Sugar Sweetened Beverages|Title: Effects of Discontinuation of Sugar Sweetened Beverages on Hemoglobin A1c, Fasting and Post Prandial Blood Glucose in Type 2 Diabetics|Completed||N/A|5|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:55:17.217913|2017-02-18 14:55:17.217913
NCT00585884|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-02-06|||January 2000||2000-01-01|February 2013|2013-02-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|||Following the Use of Gel Prosethetics in Breast Reconstruction|Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Gel-filled Mammary Prostheses in Patients Who Are Undergoing Primary Breast Reconstruction or Revision|Active, not recruiting||N/A|20|Actual|University of California, Irvine|||1||f||||t||||||||||2017-02-18 14:55:17.322955|2017-02-18 14:55:17.322955
NCT00585871|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-29|2013-12-09|||May 2006||2006-05-01|August 2013|2013-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing|Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing|Terminated||N/A|8|Actual|University of Iowa||2||could not recruit|f||||t||||||||||2017-02-18 14:55:17.402776|2017-02-18 14:55:17.402776
NCT00585858|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-05-10|||September 2006||2006-09-01|May 2016|2016-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant|Cytokine Kinetics Assay to Assess the Presence or Absence of Tolerance in Organ Transplant Recipients|Terminated||N/A|15|Actual|University of Wisconsin, Madison|||3|PI leaving institution|f||||f||||||||No||2017-02-18 14:55:17.51317|2017-02-18 14:55:17.51317
NCT00585845|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2009-02-19|||December 2007||2007-12-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment|A Phase 1, Open-Label, Dose-Escalation, Multiple Dose Study of the Safety, Tolerability, and Immune Response of CRS-207 in Adult Subjects With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment|Terminated||Phase 1|17|Actual|Anza Therapeutics, Inc.||1|||f||||t||||||||||2017-02-18 14:55:17.587262|2017-02-18 14:55:17.587262
NCT00585832|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2016-07-15|||February 2008||2008-02-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|October 2013|Actual|2013-10-01||Interventional|DASH-4-Teens||Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure|Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure|Completed||N/A|207|Actual|University of Cincinnati||2|||f||||t||||||||Undecided||2017-02-18 14:55:17.688208|2017-02-18 14:55:17.688208
NCT00585819|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-12-30|||May 2007||2007-05-01|December 2011|2011-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study|Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot Study|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison||2||lack of interest|f||||t||||||||||2017-02-18 14:55:17.79592|2017-02-18 14:55:17.79592
NCT00585806|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-10-01|||December 2005||2005-12-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|DobStress||Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)|Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)|Completed||N/A|19|Actual|University of Wisconsin, Madison|||2||f||||f||||||||||2017-02-18 14:55:17.885464|2017-02-18 14:55:17.885464
NCT00585793|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-09-29|||July 2008||2008-07-01|September 2015|2015-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|RELATES||Relationship Between HIV-1 Subtype and ARV Response|Study of the Relationship Between HIV-1 Subtype and Antiretroviral (ARV) Response in Ugandan Children|Completed||N/A|108|Actual|University of Wisconsin, Madison|||1||f||||f||||||Samples Without DNA|"~     Plasma obtained from participants~   "|||2017-02-18 14:55:18.073441|2017-02-18 14:55:18.073441
NCT00585780|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2016-11-28|||September 2009||2009-09-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse|Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse|Recruiting||Phase 1/Phase 2|120|Anticipated|Yale University||2|||f||||t||||||||||2017-02-18 14:55:18.176745|2017-02-18 14:55:18.176745
NCT00585767|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-05-15|||April 2001||2001-04-01|December 2007|2007-12-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Functional, Dynamic, and Anatomic MR Urography|Functional, Dynamic, and Anatomic MR Urography|Withdrawn||N/A|0|Actual|University of California, Davis|||2||f||||f||||||||||2017-02-18 14:55:18.28618|2017-02-18 14:55:18.28618
NCT00585754|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-11-28|||April 2006||2006-04-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse|Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse|Completed||Phase 1|75|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:55:18.361316|2017-02-18 14:55:18.361316
NCT00585741|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-02-22|||December 2006||2006-12-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pilot Study of 18F-FLT PET|Pilot Study of 18F-FLT Pet Imaging in Cancer Patients|Terminated||N/A|15|Actual|University of Wisconsin, Madison||5|||f||||t||||||||||2017-02-18 14:55:18.449681|2017-02-18 14:55:18.449681
NCT00585728|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-08-26|||September 2007||2007-09-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer|CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer|Completed||N/A|20|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:55:18.548883|2017-02-18 14:55:18.548883
NCT00585715|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-09-04|2011-06-17||October 2006||2006-10-01|August 2015|2015-08-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|IH062905||Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening|Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening|Completed||Phase 1/Phase 2|22|Actual|University of California, Irvine|Small sample size|2|||f||||t||||||||||2017-02-18 14:55:18.650738|2017-02-18 14:55:18.650738
NCT00585702|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2013-09-30|||August 2006||2006-08-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|AMUP||Antimanic Drug Use in Pregnancy|Antimanic Drug Use in Pregnancy|Completed||N/A|201|Actual|University of Pittsburgh|||2||f||||f||||||||||2017-02-18 14:55:19.029077|2017-02-18 14:55:19.029077
NCT00585689|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-11-03|2014-05-05||December 2007||2007-12-01|November 2015|2015-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer|A Phase Two Trial of Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder|Completed||Phase 2|29|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 14:55:19.124852|2017-02-18 14:55:19.124852
NCT00585676|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-02|2014-12-05|||November 2007||2007-11-01|December 2014|2014-12-01||||May 2011|Actual|2011-05-01||Observational|||Impact of Antenatal Betamethasone on Plasma Glucose Levels|Impact of Antenatal Betamethasone on Plasma Glucose Levels|Unknown status|Recruiting|N/A|45|Anticipated|University of California, Irvine|||3||f||||f||||||||||2017-02-18 14:55:19.704817|2017-02-18 14:55:19.704817
NCT00585650|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-10-05|2011-05-12||May 2007||2007-05-01|October 2011|2011-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet|Double-blind, Randomized, Placebo-controlled Study of Recombinant Human Tumor Necrosis Factor Receptor (p75) Fusion Protein Etanercept (Enbrel) in Patients With Moderate to Severe Plaque Psoriasis of the Hands and/or Feet|Completed||Phase 1/Phase 2|20|Actual|University of California, Irvine||2|||f||||t||||||||||2017-02-18 14:55:19.805139|2017-02-18 14:55:19.805139
NCT00585637|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2015-03-18|2015-03-03||October 2007||2007-10-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional||Participants were drawn from the Open Doors to Health, which is a colorectal cancer prevention study in 1554 subjects from 12 public-housing communities and community- and faith-based organizations in Boston.|Vitamin D for Chemoprevention|Defining Optimal Doses of Vitamin D for Chemoprevention in Blacks.|Completed||Phase 1|328|Actual|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-02-18 14:55:20.17036|2017-02-18 14:55:20.17036
NCT00585624|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-10-06|||April 2007||2007-04-01|October 2015|2015-10-01|October 2009|Actual|2009-10-01|||||Interventional|||Preoperative Nutritional Support in Esophagectomy or Pancreaticoduodenectomy|Preoperative Nutritional Support Reduces Postoperative Stay and Incidence of Complications in Patients Undergoing an Esophagectomy or Pancreaticoduodenectomy|Completed||N/A|344|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 14:55:21.001473|2017-02-18 14:55:21.001473
NCT00004332|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||May 1993||1993-05-01|January 2000|2000-01-01||||||||Observational|||Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly||Completed||N/A|148||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:50.755824|2017-02-18 18:16:50.755824
NCT00585611|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-10-01|||December 2005||2005-12-01|May 2011|2011-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients|Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure Patients|Terminated||N/A|1|Actual|University of Wisconsin, Madison||2||Unable to recruit into the study|f||||t||||||||||2017-02-18 14:55:21.091671|2017-02-18 14:55:21.091671
NCT00585598|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-10-06|||August 2006||2006-08-01|October 2015|2015-10-01|July 2010|Actual|2010-07-01|||||Observational|||Evaluation of Supralaryngeal Airway Removal During Initial Resuscitation of the Trauma Patient|Evaluation of Supralaryngeal Airway Removal During Initial Resuscitation of the Trauma Patient|Completed||N/A|50|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 14:55:21.199366|2017-02-18 14:55:21.199366
NCT00585585|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2011-01-27|||December 2006||2006-12-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features|A Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features|Completed||Phase 2|5|Anticipated|University of Cincinnati||1|||f||||t||||||||||2017-02-18 14:55:21.284654|2017-02-18 14:55:21.284654
NCT00585572|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-10-22|||March 2007||2007-03-01|October 2014|2014-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|WBDP||Wisconsin Brain Donor Program|University of Wisconsin-Madison: Wisconsin Brain Donor Program (WBDP)|Enrolling by invitation||N/A|500|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||Samples Without DNA|"~     Brain tissue, blood, cerebrospinal fluid, spinal cord, peripheral nerves, and skeletal~     muscles, central/peripheral nervous tissue, as well as skeletal muscle tissue.~   "|||2017-02-18 14:55:21.371328|2017-02-18 14:55:21.371328
NCT00585559|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-04|||April 2007||2007-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|July 2016|Anticipated|2016-07-01||Interventional|||Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm|Inhibition of Lipid Peroxidation and Cerebral Vasospasm by an Acetaminophen-Based Regimen in Patients With Aneurysmal Subarachnoid Hemorrhage|Enrolling by invitation||N/A|120|Anticipated|Vanderbilt University||5|||f||||t||||||||||2017-02-18 14:55:21.453742|2017-02-18 14:55:21.453742
NCT00585546|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-11-22|||July 2007||2007-07-01|November 2016|2016-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|HARPS||Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure|Harefield Recovery Protocol Study (HARPS): A Nonrandomized, Open Label, Multicenter Evaluation of Potential Recovery of Heart Function in Patients With Refractory Chronic Heart Failure by Treatment With Combination of Left Ventricular Assist Device (LVAD), Drugs to Induce Maximal Reverse Remodeling and the Beta-2 Adrenergic Receptor Agonist Clenbuterol.|Terminated||N/A|18|Actual|University of Michigan||1||No longer could obtain clenbuterol|f||||t||||||||||2017-02-18 14:55:21.56528|2017-02-18 14:55:21.56528
NCT00585533|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-07-23|2012-06-04||June 2004||2004-06-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer|A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|40|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:55:21.685073|2017-02-18 14:55:21.685073
NCT00585520|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2014-02-10|||September 2007||2007-09-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues|Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues|Completed||Phase 1|60|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:55:22.025312|2017-02-18 14:55:22.025312
NCT00585507|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-01-20|||April 2004||2004-04-01|January 2016|2016-01-01|November 2016|Anticipated|2016-11-01|September 2016|Anticipated|2016-09-01||Interventional|||Efficacy and Safety of 500mg of Fulvestrant|A Phase II Multi-Center Study to Evaluate the Efficacy and Safety of 500mg of Fulvestrant (Faslodex) as a First Line Hormonal Treatment in Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer|Active, not recruiting||Phase 2|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 14:55:22.117664|2017-02-18 14:55:22.117664
NCT00585494|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-27|2015-10-01|2008-11-07||December 2007||2007-12-01|January 2011|2011-01-01|August 2010|Actual|2010-08-01|December 2008|Actual|2008-12-01||Observational|||Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes|Prevalence of Inpatient Hyperglycemia: Risks, Complications and Outcomes|Completed||N/A|302|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 14:55:22.230191|2017-02-18 14:55:22.230191
NCT00585481|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2011-12-15|||January 2008||2008-01-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children|Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children - BREVI (Brazilian Respiratory Virus in Premature Infants) Study|Completed||N/A|310|Actual|Abbott|||1||f||||f||||||Samples With DNA|"~     white cells and nasopharyngal aspirate~   "|||2017-02-18 14:55:22.431354|2017-02-18 14:55:22.431354
NCT00585468|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-04-01|2013-09-10||December 2007||2007-12-01|April 2016|2016-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State|Pharmacokinetic Profile of Myfortic (Enteric Coated Mycophenolate Sodium) in a Rapid Steroid Withdrawal Protocol in Combination With Tacrolimus in Stable Renal Transplant Recipients in the Fed and Fasting State|Completed||Phase 4|21|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 14:55:22.545504|2017-02-18 14:55:22.545504
NCT00585455|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2009-07-22|||January 2006||2006-01-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Vascular Effects of Sertraline in Heart Failure|Effects of Chronic Sertraline Hydrochloride Administration on Vascular Endothelial and Autonomic Function in Patients With Chronic Heart Failure|Terminated||N/A|4|Actual|Yale University|||1|PI change in institution|f||||f||||||Samples Without DNA|"~     Plasma and serum~   "|||2017-02-18 14:55:22.955345|2017-02-18 14:55:22.955345
NCT00585442|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-05-25|||May 2007||2007-05-01|March 2016|2016-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effects of Vitamin D on Renin Expression in Hypertensive Patients|Effects of Calcitriol (1α, 25-[OH]2 Vitamin D3) on Renin Expression in Hypertensive Patients Without Vitamin D Deficiency|Terminated||Early Phase 1|12|Actual|University of Utah||2||Lack of quality data|f||||t||||||||||2017-02-18 14:55:23.060672|2017-02-18 14:55:23.060672
NCT00004331|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1992||1992-11-01|December 2003|2003-12-01||||||||Observational|||Studies in Porphyria I: Characterization of Enzyme Defects||Unknown status|Recruiting|N/A|25||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:50.833048|2017-02-18 18:16:50.833048
NCT00585429|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-05-10|||September 2006||2006-09-01|May 2016|2016-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Evaluation of Kidney Disease in Liver Transplant Recipients|Kidney Disease in Advanced Liver Disease Patients: A Study of Kidney Damage by a Urinary Cytokine/Chemokine Multiplex Assay|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison|||3|key personnel left institution|f||||f||||||||||2017-02-18 14:55:23.242119|2017-02-18 14:55:23.242119
NCT00585416|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-09-30|||June 2006||2006-06-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|November 2007|Actual|2007-11-01||Interventional|||Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer|A Phase II Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer (47-02-001)|Terminated||Phase 2|23|Actual|University of Wisconsin, Madison||1||Further evaluation of phase I dosing|f||||t||||||||||2017-02-18 14:55:23.320645|2017-02-18 14:55:23.320645
NCT00585403|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2010-11-05|||September 2004||2004-09-01|November 2010|2010-11-01|February 2015|Anticipated|2015-02-01|January 2015|Anticipated|2015-01-01||Observational|||Exercise Changes to Peripheral Blood Mononuclear Cells in Children|PBMC, Exercise and Children: Initial Mechanisms|Unknown status|Recruiting|N/A|160|Anticipated|University of California, Irvine|||1||f||||t||||||Samples With DNA|"~     Peripheral blood mononuclear cells, plasma, serum, mRNA~   "|||2017-02-18 14:55:23.414113|2017-02-18 14:55:23.414113
NCT00585390|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-28|2011-08-01|||January 2008||2008-01-01|July 2011|2011-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia|Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Essential Fatty Acid Deficiency Replacement in Early Schizophrenia|Completed||Phase 2/Phase 3|0|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 14:55:23.489932|2017-02-18 14:55:23.489932
NCT00585377|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-08-21|2015-07-23||August 2007||2007-08-01|August 2015|2015-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer|AVF4236s: Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer|Completed||Phase 2|50|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:55:23.594311|2017-02-18 14:55:23.594311
NCT00585364|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2016-02-12|||March 2005||2005-03-01|February 2016|2016-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|ABPA||Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA|SCCOR in Host Factors in Chronic Lung Diseases: Mechanisms of Immune Tolerance and Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) in Patients With Cystic Fibrosis|Completed||N/A|79|Actual|University of Pittsburgh|||3||f||||f||||||Samples With DNA|"~     The CF subject's blood will be processed to establish a cell line (lymphocyte~     transformation) for a source of DNA for future genetic studies.~   "|No|This was an observational trial that involved no device or drug.|2017-02-18 14:55:23.86809|2017-02-18 14:55:23.86809
NCT00585351|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-01-15|2011-08-16||January 2007||2007-01-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|AIRDOC||Extending Acute Stroke Trials to the Aerial Inter-hospital Transfer Setting|Extending Acute Stroke Trials to the Aerial Inter-hospital Transfer Setting (AIRDOC)|Completed||N/A|100|Actual|University of Iowa|Some procedural errors by the helicopter crew at the start of the trial, reliability of the stroke diagnosis from the outside hospital, and the possibility for a lower consent rate if a higher risk profile medication were used instead of Ranitidine.|4|||f||||t||||||||||2017-02-18 14:55:26.465007|2017-02-18 14:55:26.465007
NCT00585338|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2017-02-08|||December 2007||2007-12-01|February 2017|2017-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser|Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser|Completed||Phase 1|1|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:55:27.236203|2017-02-18 14:55:27.236203
NCT00585325|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-08-04|||October 2004||2004-10-01|August 2011|2011-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes|Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes.|Completed||N/A|11|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 14:55:27.336605|2017-02-18 14:55:27.336605
NCT00585312|ClinicalTrials.gov processed this data on February 17, 2017|2008-01-01|2014-10-28|2014-10-28||September 2006||2006-09-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|CHIP|The intent-to-treat (ITT) population (N: 106) consisted of all participants who were randomized, with study drug assignment designated according to initial randomization, regardless of whether the participants received any study drug or received a different drug from that to which they were randomized.|Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)|A Phase III Placebo-Controlled Trial Of Celecoxib In Genotype Positive Subjects With Familial Adenomatous Polyposis|Terminated||Phase 3|106|Actual|Pfizer|The study was early terminated and, due to the low number of participants, no efficacy analysis was performed. Only descriptive statistics was performed.|2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 14:55:27.449512|2017-02-18 14:55:27.449512
NCT00585299|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2014-06-16|||October 2006||2006-10-01|June 2014|2014-06-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD|Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD|Completed||N/A|4|Actual|Yale University||2|||f||||f||||||||||2017-02-18 14:55:28.186899|2017-02-18 14:55:28.186899
NCT00585286|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-12-13|2011-06-17||March 2007||2007-03-01|December 2013|2013-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||Of 30 patients enrolled between two research centers, 15 subjects were enrolled at the UC Irvine General Clinical Research Center|Fractional Resurfacing Device for Treatment of Acne Scarring|Evaluation of a Novel Fractional Resurfacing Device for the Treatment of Acne Scarring|Completed||Phase 1/Phase 2|15|Actual|University of California, Irvine|There were no major limitations to this trial. The trial was completed without any technical problems or major complications.|1|||f||||t||||||||||2017-02-18 14:55:28.303315|2017-02-18 14:55:28.303315
NCT00585273|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-12-02|||September 2007||2007-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Observational|||Antipsychotics and Blood Vessel Function|Cardiovascular Complications of First-line, Second-generation Antipsychotics|Completed||N/A|44|Actual|University of Iowa|||2||f||||f||||||||||2017-02-18 14:55:28.59012|2017-02-18 14:55:28.59012
NCT00585260|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-10-06|||December 2007||2007-12-01|October 2015|2015-10-01|January 2011|Actual|2011-01-01|||||Interventional|||Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN|Mannitol Bronchoprovocation Challenge Ancillary Study Protocol to Best Adjustment Strategy for Asthma Over Long Term|Completed||N/A|320|Anticipated|University of Wisconsin, Madison||3|||f||||f||||||||||2017-02-18 14:55:28.716319|2017-02-18 14:55:28.716319
NCT00585247|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-08-05|||November 2006||2006-11-01|August 2015|2015-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|Aldara||Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks|Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks|Completed||N/A|20|Actual|University of California, Irvine||2|||f||||t||||||||||2017-02-18 14:55:28.829354|2017-02-18 14:55:28.829354
NCT00585234|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-12-08|||December 2005||2005-12-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Tools for the Objective Clinical Assessment of Pediatric Spinal Deformity|Tools for Objective Clinical Assessment of Pediatric Spinal Deformity and the Results of Surgical Intervention--Simultaneous Measurement of Sagittal and Coronal Balance and Symmetry With Digital Photography.|Withdrawn||N/A|0|Actual|University of Utah|||1|Study has been withdrawn.|f||||f||||||||||2017-02-18 14:55:28.965674|2017-02-18 14:55:28.965674
NCT00585221|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-12-20|2012-06-15||July 2007||2007-07-01|December 2016|2016-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients|A Phase II Study Combining Targeted Therapy With Immunotherapy Using Imatinib Plus Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients|Terminated||Phase 2|8|Actual|University of Utah||1||PI terminated at the recommendation of DSMC & IRB|f||||t||||||||||2017-02-18 14:55:29.079157|2017-02-18 14:55:29.079157
NCT00585208|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-05-08|||December 2007||2007-12-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance|A Randomized, Double-Blind, Placebo-Controlled Study of Add-On Ramelteon in Ambulatory Bipolar I Disorder With Clinically Significant Sleep Disturbance|Terminated||Phase 3|21|Actual|Lindner Center of HOPE||2||sponsor terminated study|f||||f||||||||||2017-02-18 14:55:29.343904|2017-02-18 14:55:29.343904
NCT00585195|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-29|2017-01-30|||April 2006||2006-04-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|PROFILE 1001||A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer|Phase 1 Safety, Pharmacokinetic And Pharmacodynamic Study Of Pf-02341066, A C-met/Hgfr Selective Tyrosine Kinase Inhibitor, Administered Orally To Patients With Advanced Cancer|Recruiting||Phase 1|580|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 14:55:29.469878|2017-02-18 14:55:29.469878
NCT00585182|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-08-02|2011-08-02||January 2007||2007-01-01|August 2011|2011-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT|Venous Thromboembolism Prevention in the Morbidly Obese Medically Ill Patient: A Pharmacological Analysis of the Predictability of Prophylactic Weight-Based Enoxaparin Dosing.|Completed||Phase 4|35|Actual|University of Utah|This study was limited by a relatively small sample size, lack of long-term clinical outcome data, and the use of only a single anti-Xa level, rather than repeat measures.|1|||f||||t||||||||||2017-02-18 14:55:29.617528|2017-02-18 14:55:29.617528
NCT00585169|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2013-03-05|2013-01-29||December 2007||2007-12-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Memantine Treatment Study of Pathological Gambling|A Phase II Open-Label Multi-Center Trial of Memantine (Namenda(TM)) Treatment of Pathological Gambling|Completed||Phase 2|29|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:55:29.883028|2017-02-18 14:55:29.883028
NCT00585156|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-03-11|||June 2008||2008-06-01|March 2016|2016-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||The Effects of Celecoxib on Bone Ingrowth|The Effects of Celecoxib on Bone Ingrowth in Porous Coated Titanium Ceramic Implants in Humans|Terminated||Early Phase 1|9|Actual|University of Utah||1||New clinical finding with Celebrex and cardiac concerns.|f||||f||||||||||2017-02-18 14:55:30.458971|2017-02-18 14:55:30.458971
NCT00585143|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2012-09-27|||January 2008||2008-01-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly|Pharmacokinetics of ABT-335 and Rosuvastatin in Subjects With Normal Renal Function and Renal Impairment|Completed||Phase 1|37|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:55:30.569403|2017-02-18 14:55:30.569403
NCT00585117|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-02-22|||December 2006||2006-12-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients||Terminated||N/A|9|Actual|University of Wisconsin, Madison||5||change in imaging priorities|f||||t||||||||||2017-02-18 14:55:30.676335|2017-02-18 14:55:30.676335
NCT00585104|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-05-14|2010-02-11||September 2006||2006-09-01|May 2013|2013-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Myocardial Hemodynamic Effects of Levosimendan|Myocardial Hemodynamic Effects of Levosimendan|Completed||Phase 2|10|Actual|University of Utah|Of the ten (10) patients enrolled, only 6 patients completed the study protocol for which we collected data. The data is insufficient to provide a formal summary for publication.|1|||f||||t||||||||||2017-02-18 14:55:30.778309|2017-02-18 14:55:30.778309
NCT00585091|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-06-12|||October 2003||2003-10-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|||The Development of Tolerance to α1-Adrenoceptor Blockade With Chronic Carvedilol Treatment|The Development of Tolerance to α1-Adrenoceptor Blockade With Chronic Carvedilol Treatment|Completed||N/A|15|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 14:55:31.003921|2017-02-18 14:55:31.003921
NCT00585078|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2016-08-30|||April 2004||2004-04-01|August 2016|2016-08-01|November 2016|Anticipated|2016-11-01|July 2014|Actual|2014-07-01||Interventional|||Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma|Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|37|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 14:55:31.109061|2017-02-18 14:55:31.109061
NCT00585065|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-01-07|||January 2006||2006-01-01|January 2016|2016-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||CRT Pilot Study for Children With Heart Failure|Cardiac Resynchronization Therapy for Children and Adolescents With Advanced Hearth Failure: A Pilot Study|Completed||N/A|7|Actual|University of Utah|||1||f||||f||||||||||2017-02-18 14:55:31.226194|2017-02-18 14:55:31.226194
NCT00585052|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-12-20|||August 2003||2003-08-01|December 2010|2010-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer|A Phase II Study of the Synergistic Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer|Unknown status|Recruiting|Phase 2|16|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:55:31.313077|2017-02-18 14:55:31.313077
NCT00585039|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-09-02|2011-03-17||September 2005||2005-09-01|September 2011|2011-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|Xopenex||Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)|Comparison of Hospital Admission Rates and Plasma(s)-Albuterol Levels in Children Treated With Racemic Albuterol Versus Levalbuterol for Acute Asthma Exacerbations: A Randomized Double-Blind Clinical Trial|Completed||Phase 4|101|Actual|Phoenix Children's Hospital||1|||f||||t||||||||||2017-02-18 14:55:31.422837|2017-02-18 14:55:31.422837
NCT00585026|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-06-14|||October 2006||2006-10-01|December 2009|2009-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Randomized Clinical Trial of Bifocal Lenses Versus Computer-specific Progressive Addition Lenses|Randomized Clinical Trial of Bifocal Lenses Versus Computer-specific Progressive Addition Lenses on Symptoms and Performance on a Computer|Terminated||Phase 3|40|Anticipated|University of Alabama at Birmingham||||PI left UAB; protocol administratively terminated by UAB IRB.|f||||||||||||||2017-02-18 14:55:31.810971|2017-02-18 14:55:31.810971
NCT00585013|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-11-03|2012-12-19||January 2008||2008-01-01|November 2015|2015-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass|A Trial of Inhaled Nitric Oxide (NO) as an Anti-Inflammatory and Anti-Reperfusion Agent in the Treatment of Infants and Children Undergoing Cardiopulmonary Bypass for Repair of Congenital Heart Disease|Completed||Phase 1/Phase 2|17|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 14:55:31.908436|2017-02-18 14:55:31.908436
NCT00585000|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-06-05|||December 2007||2007-12-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma|A Phase 1, Open Label, Single Arm Study To Establish The Safety Of Administering CP 675,206 As A One Hour Infusion In Patients With Surgically Incurable Stage III Or Stage IV Melanoma|Terminated||Phase 1|49|Actual|AstraZeneca||1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 14:55:32.431804|2017-02-18 14:55:32.431804
NCT00584987|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-10-31|2013-07-08||June 2007||2007-06-01|October 2013|2013-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Intranasal Steroids and Oxymetazoline in Allergic Rhinitis|A Combination of Intranasal Steroid/Oxymetazoline Leads to Faster Relief of Nasal Congestion Without Inducing Rhinitis Medicamentosa|Completed||Phase 4|64|Actual|University of Chicago||4|||f||||t||||||||||2017-02-18 14:55:32.540409|2017-02-18 14:55:32.540409
NCT00584974|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-02-21||2009-12-16|December 2007||2007-12-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Safety, Efficacy and Tolerability Study of SEP-225289|A Double-Blind, Placebo-Controlled Study Examining The Safety, Efficacy, and Tolerability of SEP-225289 in Subjects With Major Depressive Disorder (Including Atypical and Melancholic Features)|Completed||Phase 2|523|Actual|Sunovion||4|||f||||f||||||||||2017-02-18 14:55:33.116411|2017-02-18 14:55:33.116411
NCT00584961|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-02-09|||May 2007||2007-05-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|BIMET||BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder|BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder|Completed||N/A|553|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:55:33.474091|2017-02-18 14:55:33.474091
NCT00584948|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2010-06-25|||September 2007||2007-09-01|June 2010|2010-06-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome|Characterization and Treatment of CNS Abnormalities in Premutation Carriers: A Double-Blind Placebo-Controlled Trial of Memantine|Unknown status|Recruiting|N/A|180|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-02-18 14:55:33.571264|2017-02-18 14:55:33.571264
NCT00584935|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2011-08-05|2011-02-15||January 2006||2006-01-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid|Phase I/II Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid|Completed||Phase 1/Phase 2|3|Actual|University of Alabama at Birmingham|Genentech closed trial before site was able to enroll 5 patients.|1|||f||||f||||||||||2017-02-18 14:55:33.672728|2017-02-18 14:55:33.672728
NCT00584922|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-03-02|||January 2007||2007-01-01|March 2011|2011-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation|Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation|Unknown status|Recruiting|N/A|200|Anticipated|University of Oklahoma|||1||f||||f||||||||||2017-02-18 14:55:33.892775|2017-02-18 14:55:33.892775
NCT00584909|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-25|2011-09-21||March 2006||2006-03-01|January 2017|2017-01-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|||A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus|A Phase II Study of Paclitaxel and Carboplatin in Patients With Intermediate-Risk Adenocarcinoma of the Endometrium|Terminated||Phase 2|13|Actual|University of Alabama at Birmingham|This study was terminated early due to slow accrual. 4 patients withdrew from the study due to side-effects from the treatment. All 9 patients were evaluable for toxicity and PFS.|1||low accrual|f||||t||||||||||2017-02-18 14:55:33.998399|2017-02-18 14:55:33.998399
NCT00584896|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-07-01|||October 2007||2007-10-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|POINT II||Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease|A Phase 3 Clinical Trial to Assess Perfusion and Obstruction Identified by Non-Invasive Technology Using PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Artery Disease II|Terminated||Phase 3|1000|Anticipated|Point Biomedical||1||Discontinued PB127 development program for business reasons|f||||t||||||||||2017-02-18 14:55:34.243773|2017-02-18 14:55:34.243773
NCT00584090|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-11-30|||November 2007||2007-11-01|October 2010|2010-10-01||||April 2011|Anticipated|2011-04-01||Interventional|||Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease||Withdrawn||Phase 4|0|Actual|University of South Florida||2||Study withdrawn with intent of persuing larger, multi-site study.|f||||f||||||||||2017-02-18 14:55:43.278323|2017-02-18 14:55:43.278323
NCT00584883|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2012-05-16|||August 2003||2003-08-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme|A Phase I Study of ABT 510 and Concurrent Temozolomide and Radiotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1|24|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 14:55:34.382343|2017-02-18 14:55:34.382343
NCT00584870|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-10-01||2009-10-01|July 2007||2007-07-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||RN624 In Adult Patients With Chronic Low Back Pain|Phase II Randomized, Double-Blind, Placebo And Active Controlled, Multicenter, Parallel Group Proof Of Concept Study Of The Analgesic Effects Of RN624 In Adult Patients With Chronic Low Back Pain|Completed||Phase 2|225|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 14:55:34.471237|2017-02-18 14:55:34.471237
NCT00584857|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-25|2011-09-23||July 2004||2004-07-01|January 2017|2017-01-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer|A Phase II Study of Combination Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Advanced Stage or Recurrent Carcinoma of the Endometrium|Completed||Phase 2|30|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 14:55:34.610644|2017-02-18 14:55:34.610644
NCT00584844|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-08-08|||October 2004||2004-10-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine|A Longitudinal Phase 2 Study for the Continued Evaluation of the Safety and Immunogenicity of a Live Francisella Tularensis Vaccine, NDBR 101, Lot 4|Completed||Phase 2|484|Actual|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 14:55:34.850675|2017-02-18 14:55:34.850675
NCT00584831|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-05-05|2009-09-24||October 2007||2007-10-01|May 2015|2015-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effect of Eye Movement on Toric Lens Orientation and Visual Acuity|Development and Implementation of a Clinical Test to Investigate the Change in Vision With Soft Toric Contact Lenses During Eye Movements|Completed||N/A|40|Actual|Johnson & Johnson Vision Care, Inc.||19|||f||||f||||||||||2017-02-18 14:55:34.962106|2017-02-18 14:55:34.962106
NCT00584818|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-04-23|||November 2006||2006-11-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease|A Phase 2 Dose-Finding Clinical Trial of CARDIOsphere® (PB127) in Normal Volunteers and in Patients With Known or Suspected Coronary Artery Disease|Completed||Phase 2|205|Actual|Point Biomedical||1|||f||||f||||||||||2017-02-18 14:55:35.621855|2017-02-18 14:55:35.621855
NCT00584805|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-11-15|||February 2008||2008-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|November 2016|Anticipated|2016-11-01||Interventional|EEE||Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine|A Multi-Site Phase 2 Open-Label, Safety and Immunogenicity Study of Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104 in Healthy Adults At Risk for Exposure to Eastern Equine Encephalitis Virus|Active, not recruiting||Phase 2|500|Anticipated|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 14:55:35.73276|2017-02-18 14:55:35.73276
NCT00584792|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2007-12-22|||August 2006||2006-08-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Diet, Genetic Variation and Prostate Cancer Among African Americans|Diet, Genetic Variation and Prostate Cancer Among African Americans|Completed||N/A|102|Actual|University of California, Davis|||2||f||||t||||||Samples With DNA|"~     Serum collected for Ancestry Imformative Markers (AIMS) testing along with PSA and CRP.~   "|||2017-02-18 14:55:35.843168|2017-02-18 14:55:35.843168
NCT00584779|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-03-11|||October 2007||2007-10-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis|An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis|Terminated||Phase 4|8|Actual|Pfizer||4||See detailed description for termination reason|f||||f||||||||||2017-02-18 14:55:35.916658|2017-02-18 14:55:35.916658
NCT00584766|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-05-28|||October 1987||1987-10-01|May 2015|2015-05-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer|Intensive Combination Chemotherapy With Autologous Bone Marrow Rescue for Metastatic Breast Cancer After Intitial Cytoreduction With Standard Agents: A Phase II Study|Completed||Phase 2|21|Actual|University of Oklahoma||1|||f||||f||||||||||2017-02-18 14:55:36.02361|2017-02-18 14:55:36.02361
NCT00584753|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-01-11|||April 2007||2007-04-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Molecular Imaging of Breast Cancer With Breast PET/CT|Molecular Imaging of Breast Cancer With Breast PET/CT|Terminated||Phase 1|4|Actual|University of California, Davis||3||Low enrollment|f||||f||||||||||2017-02-18 14:55:36.119281|2017-02-18 14:55:36.119281
NCT00584740|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-03-24|2015-01-28||August 2008||2008-08-01|March 2015|2015-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of Two Single iv Infusions of AIN457 10 mg/kg (Anti IL-17 Monoclonal Antibody) in Patients With Moderate to Severe Active Crohn's Disease|Terminated||Phase 2|59|Actual|Novartis||2||"The study was terminated prematurely after futility criterion was met at planned interim~   analysis of 41 patients."|f||||f||||||||||2017-02-18 14:55:36.234835|2017-02-18 14:55:36.234835
NCT00584727|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-05-05|2008-12-05||September 2007||2007-09-01|May 2015|2015-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact Lens|Evaluation of Fit and Visual Acuity of the Cypress Toric Lens in Two Phases: Part A: A Non-Dispensing Comparison to SofLens66® Toric and Acuvue® 2|Completed||N/A|96|Actual|Johnson & Johnson Vision Care, Inc.||6|||f||||f||||||||||2017-02-18 14:55:36.681616|2017-02-18 14:55:36.681616
NCT00584714|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-07-01|||October 2007||2007-10-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent|Long-Term Follow-Up of Selected Patients Enrolled in Phase 3 Clinical Trial 127-014 Using PB127 Ultrasound Imaging Agent|Terminated||N/A|300|Anticipated|Point Biomedical|||1|Discontinued PB127 development program for business reasons|f||||f||||||||||2017-02-18 14:55:37.354279|2017-02-18 14:55:37.354279
NCT00584688|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-06-14|||February 2007||2007-02-01|March 2009|2009-03-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study|A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study|Terminated||Phase 2|24|Actual|University of South Florida||1||Lack of Enrollment|f||||t||||||||||2017-02-18 14:55:37.732155|2017-02-18 14:55:37.732155
NCT00584675|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-06-18|||February 2007||2007-02-01|June 2015|2015-06-01|February 2008|Anticipated|2008-02-01|January 2008|Anticipated|2008-01-01||Interventional|||Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers|Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers|Withdrawn||N/A|0|Actual|University of California, Davis||1||Funding was never received so no patients were enrolled.|f||||f||||||||||2017-02-18 14:55:37.841444|2017-02-18 14:55:37.841444
NCT00584662|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-06-27|||January 2005||2005-01-01|July 2008|2008-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal Congestion|Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal Congestion|Terminated||N/A|42|Actual|University of South Florida||1|||f||||f||||||||||2017-02-18 14:55:37.933825|2017-02-18 14:55:37.933825
NCT00584649|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-11-18|||April 2004||2004-04-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|IST||Ablation of Inappropriate Sinus Tachycardia|Ablation of Inappropriate Sinus Tachycardia Syndrome by Targeting Cardiac Neural Input|Recruiting||N/A|25|Anticipated|University of Oklahoma||1|||f||||f||||||||||2017-02-18 14:55:38.044001|2017-02-18 14:55:38.044001
NCT00584636|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-09-02|||October 2007||2007-10-01|September 2011|2011-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|Budesonide||Pulmicort Respules on Relapse Rates After Treatment in the ED|Nebulized Budesonide After Discharge From a Pediatric Emergency Department in Preventing Asthma Relapse: A Randomized, Double-Blind, Placebo Controlled Trial.|Withdrawn||Phase 4|0|Actual|Phoenix Children's Hospital||1||study halted prematurely before enrollment of first patient|f||||t||||||||||2017-02-18 14:55:38.394956|2017-02-18 14:55:38.394956
NCT00584623|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-06|||March 2007||2007-03-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Simultaneous Fluoroscopic and Endoscopic Examination of the Oropharyngeal Phase of Deglutition|Simultaneous Fluoroscopic and Endoscopic Examination of the Oropharyngeal Phase of Deglutition|Withdrawn||N/A|0|Actual|University of California, Davis|||1|Did not find interested patients.|f||||f||||||||||2017-02-18 14:55:38.512061|2017-02-18 14:55:38.512061
NCT00584610|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-01-15|||December 2007||2007-12-01|January 2010|2010-01-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots|The Effect of a Levonorgestrel-releasing Intrauterine Device Versus a Copper Containing Intrauterine Device on Coagulation Parameters|Unknown status|Recruiting|N/A|50|Anticipated|University of Vermont||2|||f||||t||||||||||2017-02-18 14:55:38.601109|2017-02-18 14:55:38.601109
NCT00584597|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-12-10|||October 2005||2005-10-01|December 2010|2010-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|TRAUMEEL||A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis|The Safety and Efficacy of the Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis|Completed||Phase 1|14|Actual|University of Oklahoma||4|||f||||t||||||||||2017-02-18 14:55:38.711879|2017-02-18 14:55:38.711879
NCT00584584|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-09-01|||December 2007||2007-12-01|September 2010|2010-09-01||||August 2008|Actual|2008-08-01||Interventional|||An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever|A Proof of Concept Study of the Effects of QAX576 (an Interleukin-13 Monoclonal Antibody) on Allergic Inflammation Following Out of Allergy Season Repeated Nasal Allergen Challenge in Subjects With Seasonal Allergic Rhinitis Sensitive to Timothy Grass Pollen|Completed||Phase 2|36|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:55:38.824021|2017-02-18 14:55:38.824021
NCT00584571|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-03-10|||December 2007||2007-12-01|March 2015|2015-03-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Randomized Controlled Trial of Treating Rectal Hypersensitivity - Comparing Escitalopram With Sensory Adaptation Training||Recruiting||Phase 2|60|Anticipated|Augusta University||2|||f||||f||||||||||2017-02-18 14:55:38.924055|2017-02-18 14:55:38.924055
NCT00584558|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-03-02|||December 2000||2000-12-01|March 2011|2011-03-01|November 2050|Anticipated|2050-11-01|November 2050|Anticipated|2050-11-01||Observational|||Long-Term Follow-Up of Patients Undergoing Catheter Ablation|Long-Term Follow-Up of Patients Undergoing Catheter Ablation|Recruiting||N/A|5000|Anticipated|University of Oklahoma|||1||f||||f||||||||||2017-02-18 14:55:39.031678|2017-02-18 14:55:39.031678
NCT00584545|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-12-06|||June 2007||2007-06-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Simultaneous Fluoroscopic and Manometric Measures of the Oropharyngeal Phase of Deglutition|Simultaneous Fluoroscopic and Manometric Measures of the Oropharyngeal Phase of Deglutition|Withdrawn||N/A|0|Actual|University of California, Davis|||1|Study never got started.|f||||f||||||||||2017-02-18 14:55:39.138975|2017-02-18 14:55:39.138975
NCT00584532|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2007-12-22|||November 2003||2003-11-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2005|Actual|2005-12-01||Interventional|GCP||Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.|Effects of a Genistein Concentrated Polysaccharide (GCP) on Patients With a Diagnosis of Prostate Cancer on Active Surveillance.|Completed||Phase 2/Phase 3|66|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 14:55:39.214551|2017-02-18 14:55:39.214551
NCT00584519|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-07-06|||June 2007||2007-06-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|CRESSOB||Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight|Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight (CRESSOB)|Completed||N/A|430|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 14:55:39.307361|2017-02-18 14:55:39.307361
NCT00584506|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2010-12-16|||November 2007||2007-11-01|December 2010|2010-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Computer Aided Evaluation of Orbital Volume|Computer Aided Evaluation of Orbital Volume|Completed||N/A|250|Actual|University of California, Davis|||1||f||||t||||||||||2017-02-18 14:55:39.405161|2017-02-18 14:55:39.405161
NCT00584493|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-12-11|||May 2008||2008-05-01|December 2009|2009-12-01||||||||Expanded Access|||Treatment Use Study for Advanced Melanoma.|Treatment Use Study of CP-675,206 for Advanced Melanoma|No longer available||Phase 3|||Pfizer|||||||||f||||||||||2017-02-18 14:55:39.490733|2017-02-18 14:55:39.490733
NCT00584480|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2012-08-01|2011-09-13||October 2007||2007-10-01|August 2012|2012-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|HBOT||Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism|Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism|Completed||Phase 3|10|Actual|University of California, San Francisco|1) Small sample size 2) Lack of control group prevented an examination of whether changes in clinical measure of disease severity were due to HBOT or other factors.|1|||f||||t||||||||||2017-02-18 14:55:39.585175|2017-02-18 14:55:39.585175
NCT00584467|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2008-06-04|||January 2005||2005-01-01|June 2008|2008-06-01|November 2009|Anticipated|2009-11-01|||||Observational|GEM||Genetic and Inflammatory Markers in Cardiovascular Disease (GEM) Registry|Genetic and Inflammatory Markers in Cardiovascular Disease (GEM) Registry|Unknown status|Active, not recruiting|N/A|21|Actual|University of California, Davis|||1||f||||t||||||Samples With DNA|"~     blood/serum~   "|||2017-02-18 14:55:39.808628|2017-02-18 14:55:39.808628
NCT00584454|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-11-15||2016-11-15|February 2006||2006-02-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|July 2009|Actual|2009-07-01||Interventional|||Safety Evaluation of a Q-fever Vaccine, NDBR 105|Continued Evaluation of the Safety of Q Fever Vaccine, Phase I, Inactivated, Freeze Dried, NDBR 105, in Those at Risk of Exposure to Coxiella Burnetii, A Phase 2 Study|Completed||Phase 2|10|Actual|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 14:55:39.893942|2017-02-18 14:55:39.893942
NCT00584441|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-02-11|||September 2007||2007-09-01|February 2013|2013-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Menstrual Differences in Airway Inflammation in Asthma|Menstrual Differences in Airway Inflammation in Asthma|Completed||N/A|6|Actual|The University of Texas Medical Branch, Galveston|||3||f||||f||||||Samples Without DNA|"~     Serum Eosinophil Cationic Protein (ECP) samples will be obtained. The 5ml blood samples for~     measuring ECP levels will be collected in silica gel-containing tubes. After centrifuging,~     the supernatant will be frozen and ECP levels will bemeasured using an ELISA kit~   "|||2017-02-18 14:55:39.996116|2017-02-18 14:55:39.996116
NCT00584428|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-05-26|||June 1992||1992-06-01|May 2015|2015-05-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer|High Dose Chemotherapy With Autologous Bone Marrow Transplantation in the Treatment of Metastatic Breast Cancer|Completed||N/A|61|Actual|University of Oklahoma||1|||f||||f||||||||||2017-02-18 14:55:40.088836|2017-02-18 14:55:40.088836
NCT00584415|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-07-01|2013-07-05||February 2004||2004-02-01|July 2014|2014-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Navi-Star Thermo-Cool Catheter For Ablation of Atrial Fibrillation|Navi-Star Thermo-Cool Catheter For Ablation of Atrial Fibrillation|Completed||N/A|119|Actual|University of Oklahoma||1|||f||||f||||||||||2017-02-18 14:55:40.196242|2017-02-18 14:55:40.196242
NCT00584402|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-12-19|||April 2007||2007-04-01|December 2012|2012-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation|Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation|Completed||N/A|8|Actual|University of California, Davis||1|||f||||f||||||||||2017-02-18 14:55:40.449179|2017-02-18 14:55:40.449179
NCT00584389|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-04-16|||July 2007||2007-07-01|April 2010|2010-04-01|May 2010|Anticipated|2010-05-01|April 2009|Anticipated|2009-04-01||Interventional|||The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition|The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition|Terminated||Phase 4|14|Actual|University of Surrey||2||Suspension of licence for rimonabant by European Medicines Agency|f||||f||||||||||2017-02-18 14:55:40.557815|2017-02-18 14:55:40.557815
NCT00584376|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-06-15|||December 2007||2007-12-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Pregabalin (Lyrica) for the Treatment of Essential Tremor|A Multi-site, Double-blind, Randomized, Placebo-controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of Essential Tremor|Completed||Phase 4|29|Actual|University of South Florida||2|||f||||t||||||||||2017-02-18 14:55:40.67893|2017-02-18 14:55:40.67893
NCT00584363|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2016-09-10|||June 2004||2004-06-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|SPORE||Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection|Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection (UAB/UMN SPORE in Pancreatic Cancer)|Recruiting||N/A|600|Anticipated|University of Alabama at Birmingham|||1||f||||t||||||Samples With DNA|"~     Specimens are frozen and stored~   "|||2017-02-18 14:55:40.784643|2017-02-18 14:55:40.784643
NCT00584350|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-02-11|||November 2007||2007-11-01|February 2015|2015-02-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|NEPHRON||Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP|Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP|Unknown status|Recruiting|Phase 4|330|Anticipated|Université de Sherbrooke||3|||f||||t||||||||||2017-02-18 14:55:40.873251|2017-02-18 14:55:40.873251
NCT00584337|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-06-13|||January 2008||2008-01-01|June 2016|2016-06-01|June 2010|Anticipated|2010-06-01|June 2009|Anticipated|2009-06-01||Observational|CTPRIME||Coronary CT Angiography as the Primary Initial Method of Evaluating Patients With Subacute Chest Pain (CT PRIME)|Coronary CT Angiography as the Primary Initial Method of Evaluating Patients With Subacute Chest Pain (CT PRIME)|Withdrawn||N/A|0|Actual|William Beaumont Hospitals|||2|It was decided to not proceed with the study at this time.|f||||t||||||||||2017-02-18 14:55:40.978024|2017-02-18 14:55:40.978024
NCT00584324|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-02-01|||March 2006||2006-03-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Depth of Anesthesia on Implicit Memory|The Effect of Depth of Anesthesia on Implicit Memory|Completed||N/A|70|Actual|University of Oklahoma||2|||f||||t||||||||||2017-02-18 14:55:41.069808|2017-02-18 14:55:41.069808
NCT00584311|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-06-06|||June 2007||2007-06-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs||Completed||N/A|33|Actual|University of South Florida||1|||f||||||||||||||2017-02-18 14:55:41.178797|2017-02-18 14:55:41.178797
NCT00584077|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-08-24|2013-07-03||April 2000||2000-04-01|July 2013|2013-07-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Observational|||Assessment of Cough Reflex in Lung Transplant Recipients|Assessment of Cough Reflex in Lung Transplant Recipients|Completed||N/A|15|Actual|The University of Texas Medical Branch, Galveston|The limitations of this trial are that the results apply to lung transplant recipients||1||f||||f||||||||||2017-02-18 14:55:43.391514|2017-02-18 14:55:43.391514
NCT00584298|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-05-07|||January 2008||2008-01-01|May 2009|2009-05-01||||April 2009|Actual|2009-04-01||Interventional|||Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Women With Irritable Bowel Syndrome to Evaluate Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide.|Completed||Phase 1|50|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:55:41.273872|2017-02-18 14:55:41.273872
NCT00584285|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||November 2007||2007-11-01|December 2007|2007-12-01||||December 2010|Anticipated|2010-12-01||Interventional|||Corneal Topographer Fluorescein Patterns|Objective and Subjective Correlation Between Clinical Fluoroscein Patterns and Theoretical Patterns Using the Medmont Corneal Topographer|Unknown status|Recruiting|N/A|0|Anticipated|University of Iowa||1|||f||||f||||||||||2017-02-18 14:55:41.383916|2017-02-18 14:55:41.383916
NCT00584272|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2016-11-07|||March 2007||2007-03-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Retrospective Study on the Outcome of Cleft Palate Repair: Comparing US Surgical and Ethicon Suture Materials|Retrospective Study on the Outcome of Cleft Palate Repair: Comparing US Surgical and Ethicon Suture Materials|Completed||N/A|88|Actual|University of California, Davis|||1||f||||f||||||||||2017-02-18 14:55:41.494443|2017-02-18 14:55:41.494443
NCT00584259|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2010-07-12|||May 2006||2006-05-01|July 2010|2010-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of Coffee on Gastro-Esophageal Disease in Patients With Symptoms of Reflux|Effect of Coffee on Gastro-Esophageal Disease in Patients With Symptoms of Reflux|Completed||N/A|7|Actual|University of California, Davis||1|||f||||f||||||||||2017-02-18 14:55:41.574141|2017-02-18 14:55:41.574141
NCT00584246|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2008-06-02|||November 2007||2007-11-01|June 2008|2008-06-01||||August 2008|Anticipated|2008-08-01||Interventional|||Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome|Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome|Withdrawn||Phase 4|22|Anticipated|University of South Florida||2||Study withdrawn due to budget (personnel) limitations.|f||||f||||||||||2017-02-18 14:55:41.664478|2017-02-18 14:55:41.664478
NCT00584233|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-12-18|||December 2004||2004-12-01|December 2015|2015-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Evaluation of Breast CT|Evaluation of Breast CT|Recruiting||Phase 2|400|Anticipated|University of California, Davis||1|||f||||f||||||||||2017-02-18 14:55:41.765168|2017-02-18 14:55:41.765168
NCT00584220|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-05-05|2009-08-21||September 2007||2007-09-01|May 2015|2015-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional||Baseline summary was conducted on enrolled subjects who completed the study.|Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear|Evaluation of Fit and Visual Acuity of the Investigational Toric Lens in Two Phases: Part B: A Dispensing Cross-over Comparison to SofLens66 Toric|Completed||N/A|96|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||f||||||||||2017-02-18 14:55:42.079831|2017-02-18 14:55:42.079831
NCT00584207|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-04-21|||March 2004||2004-03-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|March 2007|Actual|2007-03-01||Interventional|||Radiofrequency Ablation of Uterine Fibroids|Radiofrequency Ablation of Uterine Fibroids|Terminated||Early Phase 1|15|Actual|University of California, Davis||1||Unsufficient referrals for recruitment|f||||f||||||||||2017-02-18 14:55:42.325893|2017-02-18 14:55:42.325893
NCT00584194|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-02-02||2017-02-02|June 2004||2004-06-01|February 2017|2017-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|RVF||Safety and Immunogenicity Study of Rift Valley Fever Vaccine|Parts A&B: Evaluation of the Safety and Immunogenicity of Rift Valley Fever Vaccine, Inactivated, Dried (TSI-GSD 200), A Phase 2 Study|Completed||Phase 2|278|Actual|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||No||2017-02-18 14:55:42.422898|2017-02-18 14:55:42.422898
NCT00584181|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-05-10|||August 2007||2007-08-01|May 2016|2016-05-01||||December 2016|Anticipated|2016-12-01||Observational|||High-resolution Computed Tomography (HRCT) Evaluation of Airway Distensibility in Lung Transplant Recipients|High Resolution Computed Tomographic Evaluation of Airway Distensibility in Lung Transplant Recipients: A Pilot Study|Active, not recruiting||N/A|10|Anticipated|The University of Texas Medical Branch, Galveston|||1||f||||f||||||||||2017-02-18 14:55:42.535057|2017-02-18 14:55:42.535057
NCT00584168|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-02-01|||March 2005||2005-03-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Using Dexamethasone After Uvulopalatopharyngoplasty|Decreasing Morbidity After Uvulopalatopharyngoplasty With the Use of Dexamethasone - A Randomized Double Blinded Placebo Controlled Trial|Completed||Phase 1|15|Actual|University of Oklahoma||2|||f||||f||||||||||2017-02-18 14:55:42.617087|2017-02-18 14:55:42.617087
NCT00584155|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-05-26|||July 2006||2006-07-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Protection From Cisplatin Ototoxicity by Lactated Ringers|Evaluation of Lactated Ringers for Protection From Cisplatin Ototoxicity.|Withdrawn||Phase 1|0|Actual|University of Oklahoma||2||PI left the university.|f||||f||||||||||2017-02-18 14:55:42.725447|2017-02-18 14:55:42.725447
NCT00584142|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-06-14|||March 2006||2006-03-01|December 2007|2007-12-01|June 2012|Actual|2012-06-01|February 2012|Actual|2012-02-01||Interventional|||Mindfulness-based Stress Reduction in Breast Cancer Recovery|Effects of MBSR in Early Stage Breast Cancer Recovery|Completed||N/A|84|Actual|University of South Florida||2|||f||||t||||||||||2017-02-18 14:55:42.841575|2017-02-18 14:55:42.841575
NCT00584129|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-03-12|||February 2006||2006-02-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia|Determining the Efficacy of Pre-treatment Swallowing Therapy as a Means to Improve Dysphagia Quality of Life When Compared to Post-Treatment Therapy.|Completed||N/A|52|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:55:42.955783|2017-02-18 14:55:42.955783
NCT00584116|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-01-31|||March 2006||2006-03-01|January 2014|2014-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|BAV-SAVR||Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement|Balloon Aortic Valvuloplasty During Surgical Aortic Valve Replacement|Completed||N/A|2|Actual|University of California, Davis|||1||f||||t||||||||||2017-02-18 14:55:43.058705|2017-02-18 14:55:43.058705
NCT00584103|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-12-10|||January 2007||2007-01-01|December 2013|2013-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Evaluation of Upper Extremity Prosthesis|Evaluation of an Inexpensive Upper Extremity Prosthesis|Completed||N/A|1|Actual|University of Oklahoma||1|||f||||f||||||||||2017-02-18 14:55:43.165225|2017-02-18 14:55:43.165225
NCT00584051|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-02-10|||October 2007||2007-10-01|February 2010|2010-02-01|October 2009|Actual|2009-10-01|January 2009|Anticipated|2009-01-01||Observational|||Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity|The Purpose of This Study is to Examine the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity|Terminated||N/A|90|Anticipated|University of South Florida|||3|investigator closed study|f||||f||||||Samples With DNA|"~     CHEEK SWAB FOR DNA SAMPLES, BLOOD SAMPLES FOR IGE AND ANP LEVELS~   "|||2017-02-18 14:55:43.698921|2017-02-18 14:55:43.698921
NCT00584038|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-05-23|||January 2006||2006-01-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|December 2010|Actual|2010-12-01||Interventional|||Improving Adolescent Adherence to Hormonal Contraception|Improving Adolescent Adherence to Hormonal Contraception|Completed||N/A|1155|Actual|The University of Texas Medical Branch, Galveston||3|||f||||t||||||||||2017-02-18 14:55:43.795854|2017-02-18 14:55:43.795854
NCT00584025|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2008-06-02|||December 2007||2007-12-01|June 2008|2008-06-01||||August 2008|Anticipated|2008-08-01||Interventional|||Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease||Withdrawn||Phase 4|20|Anticipated|University of South Florida||2||Study withdrawn due to personnel limitations.|f||||f||||||||||2017-02-18 14:55:43.9041|2017-02-18 14:55:43.9041
NCT00584012|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-06-18|||April 2004||2004-04-01|June 2009|2009-06-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer|A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer|Terminated||Phase 1/Phase 2|96|Anticipated|University of Iowa||1||Funding issues|f||||t||||||||||2017-02-18 14:55:44.009146|2017-02-18 14:55:44.009146
NCT00583999|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-11-01|||January 2006||2006-01-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|NASH||The Role of Leptin Receptors in NASH|Leptin, Soluble Leptin Receptor and Adiponectin in Non Alcoholic Steatohepatitis|Completed||N/A|104|Actual|University of California, Davis|||1||f||||t||||||Samples With DNA|"~     Liver biopsy specimes, serum~   "|||2017-02-18 14:55:44.107948|2017-02-18 14:55:44.107948
NCT00583986|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-02-21|||September 2005||2005-09-01|February 2012|2012-02-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD|A Study to Determine the Reliability of a Top Mount Actuation Indicator When Used With Levalbuterol Tartrate HFA MDI in Adult and Pediatric Subjects With Asthma or Chronic Obstructive Pulmonary Disease|Completed||Phase 3|150|Actual|Sunovion||1|||f||||f||||||||||2017-02-18 14:55:44.210348|2017-02-18 14:55:44.210348
NCT00583973|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2007-12-31|||January 2007||2007-01-01|December 2007|2007-12-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Observational|||Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic Hemodialysis|The Effect of Parenteral Iron Therapy on the Systemic Inflammatory Response and Oxidative Stress in Chronic Hemodialysis Patients|Unknown status|Recruiting|N/A|20|Anticipated|University of California, Davis|||1||f||||t||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 14:55:44.352208|2017-02-18 14:55:44.352208
NCT00583960|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-06-09||||||June 2015|2015-06-01||||||||Observational|||Office-based Radial Expansion Balloon Dilation of the Esophagus and Trachea|Office-based Radial Expansion Balloon Dilation of the Esophagus and Trachea|Withdrawn||N/A|0|Actual|University of California, Davis|||1|PI chose not to proceed with study.|f||||f||||||||||2017-02-18 14:55:44.438318|2017-02-18 14:55:44.438318
NCT00583947|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-02-21|2009-11-30||January 2008||2008-01-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects|A Cumulative Dose Safety and Tolerability Crossover Study of Arformoterol Tartrate Inhalation Solution and Levalbuterol Hydrochloride Inhalation Solution in Pediatric Subjects (Aged 2 to 11 Years of Age) With Asthma|Completed||Phase 2|53|Actual|Sunovion|Sample size was determined outside of statistical considerations. All data recorded at/after Visit 8 for 6 subjects, misdosed with ARF 7.5mcg instead of ARF 15mcg in open-label period, were excluded from the planned efficacy, PK and safety analyses.|2|||f||||f||||||||||2017-02-18 14:55:44.531192|2017-02-18 14:55:44.531192
NCT00583934|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-07-12|||September 2007||2007-09-01|July 2010|2010-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?|Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?|Completed||N/A|19|Actual|University of California, Davis|||1||f||||f||||||Samples With DNA|"~     tissue~   "|||2017-02-18 14:55:45.908932|2017-02-18 14:55:45.908932
NCT00583921|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-03-26||||||March 2013|2013-03-01||||||||Observational|VRR||Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF|Randomized Study of Ventricular Rate Regularization for Improved Quality of Life in Patients With Congestive Heart Failure and Atrial Fibrillation.|Withdrawn||N/A|0|Actual|University of California, Davis|||1|no subjects enrolled|f||||t||||||||||2017-02-18 14:55:45.995644|2017-02-18 14:55:45.995644
NCT00583908|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-05-05|2009-08-18||November 2007||2007-11-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of Orientation and Visual Acuity of Four Toric Soft Contact Lenses When Head is Tilted at 90 Degrees|Clinical and Theoretical Evaluation of Factors Affecting Soft Toric Lens Performance: Part 3|Completed||N/A|14|Actual|Johnson & Johnson Vision Care, Inc.||12|||f||||f||||||||||2017-02-18 14:55:46.08873|2017-02-18 14:55:46.08873
NCT00583895|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-02-26|||December 2007||2007-12-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis|Phase IIa, Randomized, Double-blind, Placebo-controlled, Intra-individual Left-right Limb Comparison Trial in 25 Patients With Moderate Atopic Dermatitis to Investigate the Efficacy, Local Irritation, Safety, Tolerability and Pharmacokinetics of Twice Daily Topical Applications With 10% ImCOOH Cream for 14 Days With an Additional Morning Application on Day 15.|Terminated||Phase 2|25|Anticipated|Valletta Health B.V.||2||Recruitment problems; insufficient number of new recruits|f||||f||||||||||2017-02-18 14:55:49.429897|2017-02-18 14:55:49.429897
NCT00583882|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2007-12-26|||July 2006||2006-07-01|December 2007|2007-12-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Central Venous Catheter Replacement Strategies in Patients With Acute Burn Injury|A Prospective, Randomized Study to Evaluate the Risks Related to Central Venous Catheter Replacement Strategies in Patients With Acute Burn Injury|Unknown status|Recruiting|N/A|300|Anticipated|Shriners Hospitals for Children||3|||f||||f||||||||||2017-02-18 14:55:49.530033|2017-02-18 14:55:49.530033
NCT00583869|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-01-05|||May 2007||2007-05-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|LYRICA||Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients|The Role of Pregabalin in the Treatment of Post-Operative Pain in Fracture Patients|Completed||Early Phase 1|86|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-02-18 14:55:49.640058|2017-02-18 14:55:49.640058
NCT00583856|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2010-12-16|||January 2007||2007-01-01|December 2010|2010-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Computer Modeling With Reconstruction of Maxillofacial Skeleton|Is Computer Modeling and Intra-Operative Navigation Helpful With Reconstruction of the Maxillofacial Skeleton?|Completed||N/A|3|Actual|University of California, Davis|||1||f||||f||||||||||2017-02-18 14:55:49.758311|2017-02-18 14:55:49.758311
NCT00583843|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-01-14|||June 2006||2006-06-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|April 2009|Actual|2009-04-01||Observational|||Ultrasound Targeting for the Lumpectomy Cavity|Evaluation of Change in the Lumpectomy Cavity During Radiation Therapy by Weekly Ultrasound and by Daily Ultrasound During the Radiation Boost Dose|Completed||N/A|20|Actual|University of Iowa|||1||f||||t||||||||||2017-02-18 14:55:50.060135|2017-02-18 14:55:50.060135
NCT00583830|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-08-01||2011-03-30|January 2007||2007-01-01|August 2013|2013-08-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|NSCLC||A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer|A Phase 2, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy and Safety of Mapatumumab in Combination With Carboplatin and Paclitaxel as First Line Therapy in Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|111|Actual|Human Genome Sciences Inc.||3|||f||||f||||||||||2017-02-18 14:55:50.173371|2017-02-18 14:55:50.173371
NCT00583817|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-10-03|||May 2001||2001-05-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Endovascular Exclusion of Thoracic Aortic Aneurysms|Endovascular Exclusion of Thoracic Aortic Aneurysms|Recruiting||Phase 1|459|Anticipated|The Cleveland Clinic||1|||f||||t||||||||No||2017-02-18 14:55:50.323812|2017-02-18 14:55:50.323812
NCT00583804|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-04-14|||April 1989||1989-04-01|April 2015|2015-04-01|January 2019|Anticipated|2019-01-01|January 2015|Actual|2015-01-01||Interventional|||Implanted Myoelectric Control for Restoration of Hand Function in Spinal Cord Injury|Implanted Myoelectric Control for Restoration of Hand Function in Spinal Cord Injury|Active, not recruiting||N/A|50|Anticipated|MetroHealth Medical Center||1|||f||||f||||||||||2017-02-18 14:55:50.452952|2017-02-18 14:55:50.452952
NCT00583791|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-07-24|||July 2000||2000-07-01|December 2007|2007-12-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Closure of Muscular Ventricular Septal Defects With The AMPLATZER® Muscular VSD Occluder||Unknown status|Active, not recruiting|Phase 1|100|Actual|St. Jude Medical||1|||t||||t||||||||||2017-02-18 14:55:50.571853|2017-02-18 14:55:50.571853
NCT00583778|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-08-19|||August 2004||2004-08-01|December 2007|2007-12-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation|A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation|Completed||N/A|142|Actual|MetroHealth Medical Center||2|||f||||t||||||||||2017-02-18 14:55:50.677233|2017-02-18 14:55:50.677233
NCT00583765|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-06-02|||April 2005||2005-04-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration|Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration|Completed||N/A|20|Actual|University of Alberta|||1||f||||t||||||||||2017-02-18 14:55:50.78634|2017-02-18 14:55:50.78634
NCT00583752|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-09-11|||December 2007||2007-12-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|APP21||Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21|Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy|Active, not recruiting||Phase 2|70|Anticipated|University of Iowa||2|||f||||t||||||||||2017-02-18 14:55:50.916186|2017-02-18 14:55:50.916186
NCT00583739|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-12-03|||August 2007||2007-08-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Yoga to Reduce Cancer Fatigue|Effect of a Yoga Intervention on Fatigue, Distress, and Quality of Life in Breast Cancer Patients: A Randomized Pilot Study|Completed||Phase 2|66|Anticipated|University of Iowa||2|||f||||t||||||||||2017-02-18 14:55:51.026623|2017-02-18 14:55:51.026623
NCT00583726|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-11-30|||December 2007||2007-12-01|December 2012|2012-12-01|November 2011|Actual|2011-11-01|August 2010|Actual|2010-08-01||Interventional|||The Women's Healthy Lifestyle Study|Motivational Interviewing for Weight Maintenance|Completed||N/A|40|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 14:55:51.138348|2017-02-18 14:55:51.138348
NCT00583713|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-10-29|2010-09-17||August 2007||2007-08-01|October 2010|2010-10-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters||Completed||Phase 1/Phase 2|18|Actual|Braintree Laboratories||3|||f||||f||||||||||2017-02-18 14:55:51.253266|2017-02-18 14:55:51.253266
NCT00583700|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-12-18|2012-10-18||February 2003||2003-02-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|May 2010|Actual|2010-05-01||Interventional|||Trental & Vitamin E for Radiation-Induced Fibrosis|Development of Radiation Fibrosis in Patients Treated With Pentoxyphylline and Vitamin E: a Prospective Randomized Study|Completed||Phase 2|54|Actual|University of Iowa|Small, single-institutional study. Smaller clinical trials are prone to imbalances in patient characteristics across treatment arms. t tests applied to small studies can be unduly influenced by data that contain outliers or are skewed.|2|||f||||t||||||||||2017-02-18 14:55:51.82033|2017-02-18 14:55:51.82033
NCT00583687|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-04-27|||December 2007||2007-12-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pulse Contour Analysis and Tissue Oxymetry in Changing Vascular Tone|Pulse Contour Analysis and Tissue Oxymetry in Changing Vascular Tone|Completed||N/A|30|Actual|University Hospital Inselspital, Berne||1|||f||||||||||||||2017-02-18 14:55:52.219866|2017-02-18 14:55:52.219866
NCT00583466|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2007-12-20|||May 2007||2007-05-01|December 2007|2007-12-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection|Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection|Unknown status|Recruiting|Phase 2|18|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 14:55:55.475459|2017-02-18 14:55:55.475459
NCT00583674|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-04-21||2014-02-07|December 2007||2007-12-01|April 2014|2014-04-01|June 2012|Actual|2012-06-01|March 2010|Actual|2010-03-01||Interventional|||Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma|A Randomized, Double Blind, Multi-Center, Phase 2 Study to Estimate the Efficacy and Evaluate the Safety and Tolerability of Cisplatin & Capecitabine (CX) in Combination With AMG 386 or Placebo in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma|Completed||Phase 2|171|Actual|Amgen||3|||f||||||||||||||2017-02-18 14:55:52.530606|2017-02-18 14:55:52.530606
NCT00583661|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-03-13|2012-01-25||May 2007||2007-05-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device|A Prospective, Multi-center, Single Arm Study to Access the Safety and Probable Benefit of the Berlin Heart EXCOR® Pediatric Ventricular Assist Device [EXCOR Pediatric]|Completed||N/A|48|Actual|Berlin Heart, Inc||1|||t||||t||||||||||2017-02-18 14:55:52.652171|2017-02-18 14:55:52.652171
NCT00583648|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-05-12|||February 2008||2008-02-01|May 2016|2016-05-01|February 2009|Anticipated|2009-02-01|||||Interventional|||Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?|A Randomized Controlled Trial Showing the Effect of Patient Lenght of Stay in the Emergency Department Through Utilizing a Urinalysis Nursing Protocol.|Withdrawn||N/A|0|Actual|University of California, Los Angeles||2||lack of funding|f||||f||||||||||2017-02-18 14:55:52.960201|2017-02-18 14:55:52.960201
NCT00583635|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-10-03|||May 2004||2004-05-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia|Minimizing Early Pregnancy Oxidative Stress to Maximize Healthy Pregnancy Outcome: Reducing Preeclampsia and Reproductive Loss With Antioxidant-Rich Tablet Supplementation Initiated in the First Trimester|Completed||N/A|684|Actual|University of Mississippi Medical Center|||4||f||||f||||||Samples Without DNA|"~     Blood to be analyzed for various markers, then discarded, none to be retained.~   "|||2017-02-18 14:55:53.067833|2017-02-18 14:55:53.067833
NCT00583622|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-04-10|2013-02-26||December 2007||2007-12-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients|Bevacizumab Combined With High-Dose Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Patients With Advanced Epithelial Ovarian Cancer|Terminated||Phase 2|13|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f||||||||||2017-02-18 14:55:53.168562|2017-02-18 14:55:53.168562
NCT00583609|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-09-24||2009-09-24|September 2007||2007-09-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children||Completed||Phase 4|20|Anticipated|Braintree Laboratories||1|||f||||f||||||||||2017-02-18 14:55:53.419157|2017-02-18 14:55:53.419157
NCT00583596|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-01-28|2014-01-17||October 1999||1999-10-01|January 2015|2015-01-01|February 2009|Actual|2009-02-01|April 2008|Actual|2008-04-01||Interventional|||Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder||Completed||N/A|436|Actual|St. Jude Medical||1|||t||||t||||||||||2017-02-18 14:55:53.521869|2017-02-18 14:55:53.521869
NCT00583583|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-01-28||||||January 2015|2015-01-01||||||||Expanded Access|||Emergency/Compassionate Use - AMPLATZER Duct Occluder||No longer available||N/A|||St. Jude Medical|||||||||||||||||||2017-02-18 14:55:53.761147|2017-02-18 14:55:53.761147
NCT00583570|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-03-31|||May 2007||2007-05-01|March 2009|2009-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Phosphorus Improvement Pilot Study|Phosphorus Improvement Pilot Study|Completed||N/A|279|Actual|MetroHealth Medical Center||1|||f||||f||||||||||2017-02-18 14:55:53.821823|2017-02-18 14:55:53.821823
NCT00583557|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-08-01|2011-04-07||January 2005||2005-01-01|August 2013|2013-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01|A Multi-Center, Open-Label, Continuation Trial of LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) Who Completed the Phase 2 Protocol LBRA01|Terminated||Phase 2|155|Actual|Human Genome Sciences Inc.||1||Sponsor decision - not related to safety|f||||t||||||||||2017-02-18 14:55:53.92467|2017-02-18 14:55:53.92467
NCT00583544|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-07-17|||January 2007||2007-01-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|SRD||A Safety and Tolerability Single Ascending Dose Study in Healthy Volunteers|A Double Blind, Sequential, Ascending Single Dose, Placebo-Controlled Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Study of TC-2216 in Healthy Young Male Volunteers.|Completed||Phase 1|72|Anticipated|Targacept Inc.||2|||f||||f||||||||||2017-02-18 14:55:54.329047|2017-02-18 14:55:54.329047
NCT00583531|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-06-02||2013-07-26|March 2007||2007-03-01|June 2014|2014-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis|A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis|Terminated||Phase 2|2|Actual|Ocera Therapeutics||1||Lack of enrollment|f||||f||||||||||2017-02-18 14:55:54.42759|2017-02-18 14:55:54.42759
NCT00583518|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-05-04|||November 2007||2007-11-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)|Open Label, Multi-centre, Longitudinal, Prospective, Phase IV Clinical Trial to Compare Two Image Technologies (ImaTx and DXA) Assessing the Anabolic Effects of PTH(1-84) in Postmenopausal Women With Primary Osteoporosis|Completed||Phase 4|129|Actual|Nycomed||1|||f||||t||||||||||2017-02-18 14:55:54.550492|2017-02-18 14:55:54.550492
NCT00583505|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-10-21||||||October 2015|2015-10-01||||||||Expanded Access|||Emergency/Compassionate Use - Membranous VSD Occluder||No longer available||N/A|||St. Jude Medical|||||||||||||||||||2017-02-18 14:55:54.641976|2017-02-18 14:55:54.641976
NCT00583492|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-02-18|2015-04-13||December 2007||2007-12-01|February 2016|2016-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|ReCAP||Randomized Trial of Suicide Gene Therapy and Prostate Cancer|A Randomized, Controlled Trial of Replication-Competent Adenovirus-Mediated Suicide Gene Therapy in Combination With IMRT Versus IMRT Alone for the Treatment of Newly-Diagnosed Prostate Cancer With an Intermediate Risk Profile|Completed||Phase 2|44|Actual|Henry Ford Health System||2|||f||||t||||||||||2017-02-18 14:55:54.924368|2017-02-18 14:55:54.924368
NCT00583453|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-12-11|||July 2007||2007-07-01|December 2013|2013-12-01|December 2014|Anticipated|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Celecoxib as a Post-tonsillectomy Pain Medication|Perioperative Use of Celecoxib to Improve Pain Control in Patients Undergoing Tonsillectomy: a Randomized, Double Blind, Placebo-controlled Trial|Unknown status|Active, not recruiting|Phase 2|18|Actual|University of Iowa||2|||f||||f||||||||||2017-02-18 14:55:55.580282|2017-02-18 14:55:55.580282
NCT00583440|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-01-28|||September 2005||2005-09-01|January 2013|2013-01-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|TSFDD||12-step Facilitation for the Dually Diagnosed|12-step Facilitation for the Dually Diagnosed|Completed||Phase 1/Phase 2|121|Actual|University of New Mexico||2|||f||||f||||||||||2017-02-18 14:55:55.694406|2017-02-18 14:55:55.694406
NCT00583427|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-06-10|||December 2007||2007-12-01|June 2015|2015-06-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Sulodexide Treatment in Patients With Dense Deposit Disease|Sulodexide Treatment in Patients With Dense Deposit Disease|Withdrawn||Phase 1|0|Actual|University of Iowa||1||This study put on inactive status due to no identifiable subjects to enter the protocol.|f||||t||||||||||2017-02-18 14:55:55.799379|2017-02-18 14:55:55.799379
NCT00583414|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-10-03|||September 1998||1998-09-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients|Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients|Recruiting||N/A|450|Anticipated|The Cleveland Clinic||1|||f||||t||||||||No||2017-02-18 14:55:55.910593|2017-02-18 14:55:55.910593
NCT00583401|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-07-20||||||July 2016|2016-07-01||||||||Expanded Access|||PFO ACCESS Registry|Patent Foramen Ovale Closure With the AMPLATZER PFO OCCLUDER in Patients With Recurrent Cryptogenic Stroke Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale Who Have Failed Conventional Drug Therapy|Available||N/A|||St. Jude Medical|||||||||||||||||||2017-02-18 14:55:56.023436|2017-02-18 14:55:56.023436
NCT00583388|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-04-27|||June 2010||2010-06-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||The Role of L-arginine in the Endothelial Dysfunction|The Efficacy of L-arginine in Preventing Early Morning Endothelial Dysfunction|Withdrawn||N/A|0|Actual|Mayo Clinic|||1|PI is leaving the Institution, IRB will close the protocol.|f||||t||||||Samples Without DNA|"~     whole blood~   "|||2017-02-18 14:55:56.104893|2017-02-18 14:55:56.104893
NCT00583375|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-05-03|||April 2007||2007-04-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||GEM OS™1 Bone Graft Compared to Autologous Bone Graft in Foot and Ankle Fusions|A Prospective, Randomized, Controlled, Multi-Center, Pivotal Human Clinical Trial to Evaluate the Safety and Effectiveness of GEM OS™1 Compared to Autologous Bone Graft as a Bone Regeneration Device in Foot and Ankle Fusions|Completed||N/A|396|Anticipated|BioMimetic Therapeutics||2|||f||||t||||||||||2017-02-18 14:55:56.197828|2017-02-18 14:55:56.197828
NCT00583362|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-05-26|||May 2005||2005-05-01|May 2016|2016-05-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02|A Multi-Center, Open-Label, Continuation Trial LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed the Phase 2 Protocol LBSL02|Completed||Phase 2|298|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-02-18 14:55:56.334184|2017-02-18 14:55:56.334184
NCT00583349|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-11-02|||December 2007||2007-12-01|November 2012|2012-11-01||||June 2013|Anticipated|2013-06-01||Interventional|Abraxane||Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer|A Combined Phase I & II Trial of Intravesicular Abraxane, a Nanoparticle Albumin-bound Paclitaxel, for Treatment-refractory Transitional Cell Carcinoma of the Urinary Bladder|Unknown status|Recruiting|Phase 1/Phase 2|47|Anticipated|Columbia University||1|||f||||t||||||||||2017-02-18 14:55:56.514261|2017-02-18 14:55:56.514261
NCT00583336|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-06-22|||September 2007||2007-09-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|July 2015|Anticipated|2015-07-01||Interventional|||Physician Preference Study of ShuntCheck - Madsen|Physician Preference Study of the Utility of ShuntCheck to Detect Cerebrospinal Fluid (CSF) in Patients With Ventriculo-Peritoneal CSF Shunts|Recruiting||N/A|200|Anticipated|NeuroDx Development||1|||f||||f||||||||||2017-02-18 14:55:56.618375|2017-02-18 14:55:56.618375
NCT00583323|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-08-20|||February 2003||2003-02-01|August 2014|2014-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET|Diphenoxylate / Atropine to Decrease Bowel Activity During F-18 FDG PET|Completed||Phase 3|60|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:55:56.712682|2017-02-18 14:55:56.712682
NCT00583310|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-11-18|||January 2007||2007-01-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|February 2010|Actual|2010-02-01||Interventional|||Telephone-Based Lifestyle Intervention to Reduce Blood Pressure in Prehypertensive Patients|Telephone-Based Lifestyle Intervention to Reduce Blood Pressure in Prehypertensive Patients|Terminated||Phase 2|125|Actual|New York University School of Medicine||2||PI left institution|f||||f||||||||||2017-02-18 14:55:56.805939|2017-02-18 14:55:56.805939
NCT00583297|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-06-06|||January 2007||2007-01-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Observational|||Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial|Identifying Genetic Markers That Predict Microvolt T-wave Alternans Status and Arrhythmia Risk in Patients With Ischemic Heart Disease|Completed||N/A|400|Anticipated|CardioDx|||1||f||||t||||||Samples With DNA|"~     Whole blood and saliva.~   "|||2017-02-18 14:55:56.918269|2017-02-18 14:55:56.918269
NCT00583284|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-01-19|||November 2006|Actual|2006-11-01|January 2017|2017-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||The Use of CT to Identify Damaged Heart Muscle in Patients Undergoing Ventricular Tachycardia Ablation.|Utility of Delayed-Enhancement Multi-Detector Computed Tomography Imaging in Identifying Arrhymogenic Substrate in Patients Undergoing Catheter Ablation for Ventricular Tachycardia|Terminated||N/A|4|Actual|The Cleveland Clinic|||1|key study staff left foundation|f||||f|f|f||||||No||2017-02-18 14:55:57.015076|2017-02-18 14:55:57.015076
NCT00583271|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-09-03|||June 2002||2002-06-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||A Prospective Study of EUS Guided Celiac Block|A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness|Completed||N/A|127|Actual|Indiana University|||2||f||||f||||||||||2017-02-18 14:55:57.101443|2017-02-18 14:55:57.101443
NCT00132353|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2017-01-24|||August 16, 2005||2005-08-16|October 6, 2016|2016-10-06||||||||Observational|||Training for Diagnosing Neurological Disorders|Clinical Neurophysiology: Training and Normative Values|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:31:46.970502|2017-02-18 17:31:46.970502
NCT00583258|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-07-30|||October 2007||2007-10-01|July 2015|2015-07-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones|A Randomized, Double-Blinded Placebo-Controlled Trial of Alfuzosin (Xatral)in the Management of Distal Ureteral Calculi|Withdrawn||N/A|0|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 14:55:57.193084|2017-02-18 14:55:57.193084
NCT00583245|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-06-24|||December 2007||2007-12-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||Improving Walking in Older Adults With Knee Osteoarthritis|Optimizing Mobility in Older Adults With Knee Osteoarthritis|Completed||N/A|27|Actual|University of Iowa||1|||f||||f||||||||||2017-02-18 14:55:57.289105|2017-02-18 14:55:57.289105
NCT00583232|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-07-29|||February 2006||2006-02-01|July 2016|2016-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Protein and Energy Metabolism in Pediatric Crohn's Disease|Protein and Energy Metabolism in Pediatric Crohn's Disease|Completed||N/A|15|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 14:55:57.383612|2017-02-18 14:55:57.383612
NCT00583219|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-03-14|2014-03-14||March 2006||2006-03-01|March 2014|2014-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Botulin-A Toxin Instillations and Overactive Bladder|Botulin-A Toxin/Dimethyl Sulfoxide Bladder Instillations for Treatment of Voiding Dysfunction Secondary to Detrusor Hyperreflexia and Detrusor Instability in Women|Completed||Phase 1/Phase 2|25|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 14:55:57.494777|2017-02-18 14:55:57.494777
NCT00583206|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-07-22|||December 2007||2007-12-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Muscle Atrophy in Sepsis|Biochemical Pathways to Skeletal Muscle Atrophy in Human Sepsis|Unknown status|Recruiting|N/A|25|Anticipated|University of Iowa|||1||f||||f||||||Samples Without DNA|"~     Muscle RNA; blood~   "|||2017-02-18 14:55:57.932907|2017-02-18 14:55:57.932907
NCT00583193|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2007-12-20|||December 2005||2005-12-01|December 2007|2007-12-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder|A Study of the Effectiveness and Tolerability of Duloxetine (Cymbalta) in the Treatment of PTSD.|Unknown status|Recruiting|Phase 3|20|Anticipated|New Mexico VA Healthcare System||1|||f||||t||||||||||2017-02-18 14:55:58.066951|2017-02-18 14:55:58.066951
NCT00583180|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-01-29|||January 2008||2008-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|||||Observational|||Sensory Function After Wound Instillation of Capsaicin|Cutaneous Sensory Function After Wound Instillation of Capsaicin During Groin Hernia Repair|Completed||N/A|42|Anticipated|Rigshospitalet, Denmark|||2||f||||f||||||||||2017-02-18 14:55:58.345347|2017-02-18 14:55:58.345347
NCT00583167|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2014-05-27|||March 2006||2006-03-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|June 2009|Actual|2009-06-01||Observational|||CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDS|CNS Viral Dynamics and Cellular Immunity During AIDS|Completed||N/A|4|Actual|Vanderbilt University|||3||f||||t||||||Samples With DNA|"~     whole blood, plasma, CSF~   "|||2017-02-18 14:55:58.454814|2017-02-18 14:55:58.454814
NCT00583154|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-09-24||2009-09-24|October 2007||2007-10-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults|A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults|Completed||Phase 2|60|Anticipated|Braintree Laboratories||4|||f||||f||||||||||2017-02-18 14:55:58.54247|2017-02-18 14:55:58.54247
NCT00583128|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-06-02||2013-07-26|August 2007||2007-08-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome|A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome|Completed||Phase 2|117|Actual|Ocera Therapeutics||2|||f||||f||||||||||2017-02-18 14:55:58.647581|2017-02-18 14:55:58.647581
NCT00583115|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-09-28|2015-07-21||October 2007||2007-10-01|September 2015|2015-09-01|December 2013|Actual|2013-12-01|August 2013|Actual|2013-08-01||Interventional|||Safety Study of Gleevec® in Children With Pulmonary Hypertension|A Phase II Study of Gleevec® (Imatinib Mesylate, NSC 716051 Formerly ST1571) in Children With Pulmonary Hypertension|Terminated||Phase 2|1|Actual|Indiana University||1||Unable to enroll subjects|f||||t||||||||||2017-02-18 14:55:58.772508|2017-02-18 14:55:58.772508
NCT00583102|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-12-20|||June 2001||2001-06-01|December 2010|2010-12-01|June 2021|Anticipated|2021-06-01|June 2011|Anticipated|2011-06-01||Interventional|||Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML|A Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Patients With Refractory or Relapsed Acute Myeloid Leukemia|Recruiting||Phase 1/Phase 2|30|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:55:58.9817|2017-02-18 14:55:58.9817
NCT00583089|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-02-02|||March 2006||2006-03-01|February 2017|2017-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Decompensation Detection Study|Decompensation Detection Study|Completed||N/A|699|Actual|Boston Scientific Corporation|||2||f||||f||||||||||2017-02-18 14:55:59.092736|2017-02-18 14:55:59.092736
NCT00583076|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-06-02||2013-07-26|February 2007||2007-02-01|June 2014|2014-06-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of AST-120 in the Treatment of Pouchitis|A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis|Completed||Phase 2|19|Actual|Ocera Therapeutics||1|||f||||t||||||||||2017-02-18 14:55:59.171636|2017-02-18 14:55:59.171636
NCT00583063|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-06-11|||October 2007||2007-10-01|March 2011|2011-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers|A Pharmacokinetic Interaction Study of Rapamycin (Sirolimus) and SU11248 (Sunitinib) in Patients With Advanced Solid Tumors|Completed||Early Phase 1|23|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 14:55:59.292846|2017-02-18 14:55:59.292846
NCT00583050|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-10-03|||February 2001||2001-02-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts|Endovascular Exclusion of Thoracoabdominal Aortic Aneurysms or Abdominal Aneurysms Utilizing Fenestrated/Branched Stent-Grafts|Recruiting||Phase 1|1340|Anticipated|The Cleveland Clinic||1|||f||||t||||||||No||2017-02-18 14:55:59.395443|2017-02-18 14:55:59.395443
NCT00583037|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-05-29|||May 2006||2006-05-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||24-Hour NAVA Ventilation in Acute Respiratory Failure|FEASIBILITY OF 24 Hrs VENTILATION WITH NEURALLY ADJUSTED VENTILATORY ASSIST (NAVA) IN PATIENTS WITH ACUTE RESPIRATORY FAILURE|Completed||N/A|15|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-02-18 14:55:59.504003|2017-02-18 14:55:59.504003
NCT00583024|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-09-11|||December 2007||2007-12-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Interventional|APP22||Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer|Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer|Active, not recruiting||Phase 2|66|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:55:59.622899|2017-02-18 14:55:59.622899
NCT00583011|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-06-12|||October 2007||2007-10-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Local Anesthesia and Pain Perception During an Amniocentesis|Local Anesthesia and Pain Perception During Amniocentesis: A Randomized Placebo-controlled Trial|Completed||N/A|70|Actual|University of Oklahoma||2|||f||||f||||||||||2017-02-18 14:55:59.73723|2017-02-18 14:55:59.73723
NCT00582998|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-09-18|||June 2001||2001-06-01|September 2013|2013-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|VAC-ST||Vacuum Assisted Closure as a Treatment for Soft Tissue Injuries|Vacuum Assisted Closure as a Treatment for Soft Tissue Injuries Sustained as a Result of Calcaneus, Tibial Plateau and Pilon Fractures|Completed||N/A|189|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:55:59.837175|2017-02-18 14:55:59.837175
NCT00582985|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-03-02|||December 2007||2007-12-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer|An Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Advanced or Metastatic Solid Cancer for Whom Curative Therapy is Unavailable|Completed||Phase 1|51|Actual|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||||2017-02-18 14:55:59.950036|2017-02-18 14:55:59.950036
NCT00582972|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-02-14|2012-07-06||January 2008||2008-01-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Does Omeprazole Decrease Intestinal Calcium Absorption?|Does Omeprazole Decrease Intestinal Calcium Absorption?|Completed||Phase 4|23|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:00.073382|2017-02-18 14:56:00.073382
NCT00582959|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-02-05|||April 2004||2004-04-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Feasibility Study of Cone Beam Imaging for Radiation Therapy Treatment Verification|Feasibility Study of Cone Beam Imaging for Radiation Therapy Treatment Verification|Completed||N/A|19|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:56:00.347019|2017-02-18 14:56:00.347019
NCT00582946|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-09-30|2013-10-29||May 2006||2006-05-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding|Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding|Completed||Phase 1|16|Actual|EarLens Corporation||1|||f||||t||||||||No|Please see publication for summary results.|2017-02-18 14:56:00.47012|2017-02-18 14:56:00.47012
NCT00582933|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-12-22|2015-12-22||May 2001||2001-05-01|December 2015|2015-12-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor|Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor For the Treatment of Lymphohematopoietic Disorders|Completed||Phase 2|96|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 14:56:00.715927|2017-02-18 14:56:00.715927
NCT00582920|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-12-23|||January 2006||2006-01-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer|Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer|Completed||Phase 1|10|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:56:00.963775|2017-02-18 14:56:00.963775
NCT00582907|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-02-05|2012-08-25||August 2008||2008-08-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Rilonacept for Treatment of Familial Mediterranean Fever (FMF)|Phase 2 Study of IL-1 Trap (Rilonacept) for Treatment of Familial Mediterranean Fever (FMF)|Completed||Phase 2|14|Actual|The Cleveland Clinic|"Small sample size - accounted for in study design and analysis plan.~Carry over/lag effect of rilonacept - sensitivity analysis of shifting course time frame showed similar results.~Heterogeneity of FMF mutations~Different age groups"|2|||f||||t||||||||||2017-02-18 14:56:01.074982|2017-02-18 14:56:01.074982
NCT00582894|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-03-23|2011-01-10||February 2005||2005-02-01|March 2011|2011-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases|Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases|Completed||N/A|17|Actual|University of Oklahoma||1|||f||||t||||||||||2017-02-18 14:56:01.754265|2017-02-18 14:56:01.754265
NCT00582881|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-11-14|||October 2007||2007-10-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus|Immune Response to Small Nuclear Ribonucleoprotein Autoantigens|Recruiting||N/A|400|Anticipated|University of Miami|||1||f||||f||||||Samples With DNA|"~     Serum, cells, DNA, urine~   "|||2017-02-18 14:56:02.031653|2017-02-18 14:56:02.031653
NCT00582868|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-10-01|||May 2007||2007-05-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|||||Observational|||Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH|Brain Oxygen Tension Level, Cerebral Perfusion and Cleaved-tau Protein for Detection of Cerebral Vasospasm and Independent Predictor of Poor Outcome After Aneurysmal Subarachnoid Hemorrhage|Terminated||N/A|10|Actual|University of Wisconsin, Madison|||1|Insufficient subject enrollment|f||||t||||||Samples With DNA|"~     Cerebrospinal fluid Whole blood~   "|||2017-02-18 14:56:02.129459|2017-02-18 14:56:02.129459
NCT00582855|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-04-15|||December 2007||2007-12-01|April 2016|2016-04-01||||February 2009|Actual|2009-02-01||Interventional|||Effect of AQW051 in Patients With Memory Impairment|A 4-week, Parallel-group, Randomized, Double-blind, Placebo-controlled, Adaptive Proof of Concept Study of AQW051 at up to Three Dose Levels for the Treatment of Patients With Findings Consistent With Mild Alzheimer's Disease (AD) or Amnestic Mild Cognitive Impairment (Amnestic MCI)|Terminated||Phase 2|54|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:56:02.231002|2017-02-18 14:56:02.231002
NCT00582842|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-08-23|||May 2002||2002-05-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer|Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer|Active, not recruiting||N/A|1800|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||||||2017-02-18 14:56:02.333537|2017-02-18 14:56:02.333537
NCT00582829|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2008-11-06|||June 2003||2003-06-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients|Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients|Completed||Early Phase 1|213|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 14:56:02.441355|2017-02-18 14:56:02.441355
NCT00582816|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-04-20|||August 2008||2008-08-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors|Reduced Intensity Haploidentical Transplantation With NK Cell Infusion for Pediatric Acute Leukemia and High Risk Solid Tumors, BMT06407|Terminated||Phase 1/Phase 2|9|Actual|University of Wisconsin, Madison||1||toxicity|f||||t||||||||||2017-02-18 14:56:02.551468|2017-02-18 14:56:02.551468
NCT00582803|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-07-09|||May 2003||2003-05-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Adherence to Intensive Surveillance for Hereditary Breast Cancer|Adherence to Intensive Surveillance for Hereditary Breast Cancer|Completed||N/A|85|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:02.648037|2017-02-18 14:56:02.648037
NCT00582790|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-03-18|2011-09-30||August 2003||2003-08-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer|Phase II Study of Interleukin-2 in Combination With Zoledronic Acid in Patients With Untreated Metastatic Renal Cell Carcinoma|Terminated||Phase 2|12|Actual|University of Wisconsin, Madison||1||slow accrual|f||||t||||||||||2017-02-18 14:56:02.968958|2017-02-18 14:56:02.968958
NCT00582777|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-04-12|||November 2007||2007-11-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||African American Study of Kidney Disease and Hypertension ABPM Pilot Study|African American Study of Kidney Disease and Hypertension ABPM Pilot Study|Completed||Phase 2/Phase 3|180|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 14:56:03.293811|2017-02-18 14:56:03.293811
NCT00582764|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-07-07|||September 2005||2005-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Quantitative Dynamic Contrast Enhanced Breast MRI|Quantitative Dynamic Contrast Enhanced Breast MRI|Completed||N/A|116|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:03.43695|2017-02-18 14:56:03.43695
NCT00582751|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-11-01|||November 2007||2007-11-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Volumetric Analysis in the Assessment of Therapy Response by CT|Volumetric Analysis in the Assessment of Therapy Response by CT|Completed||N/A|26|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:03.547363|2017-02-18 14:56:03.547363
NCT00582738|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2012-08-02|2012-01-10||December 2007||2007-12-01|August 2012|2012-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|REVERT||Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection|A Randomized, Controlled, Open Label, Two Arms, Exploratory Study to Evaluate the Effect of Everolimus on Histologically Assessed Fibrosis Progression (Ishak-Knodell) in Liver Transplant Recipients With Recurrent Hepatitis C Viral Infection as Compared to Standard Treatment.|Terminated||Phase 2|43|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:56:03.646521|2017-02-18 14:56:03.646521
NCT00582725|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-05-23|||March 2002||2002-03-01|May 2014|2014-05-01|November 2010|Actual|2010-11-01|December 2005|Actual|2005-12-01||Interventional|||R-CHOP + GM-CSF for Previously Untreated LCL in Elderly|Phase II Trial of Rituximab-CHOP (R-CHOP) Plus GM-CSF for Previously Untreated Diffuse Large Cell Lymphoma in the Elderly|Completed||Phase 2|38|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:04.268666|2017-02-18 14:56:04.268666
NCT00582712|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-10-18|2016-10-18||January 2008||2008-01-01|October 2016|2016-10-01|April 2012|Actual|2012-04-01|May 2009|Actual|2009-05-01||Interventional||This study enrolled participants with Medullary Thyroid Cancer (MTC).|An Initial Study of Lithium in Patients With Medullary Thyroid Cancer|An Initial Study of Lithium in Patients With Medullary Thyroid Cancer|Terminated||Phase 2|5|Actual|University of Wisconsin, Madison||1||Budget/Funding|f||||t||||||||||2017-02-18 14:56:04.3764|2017-02-18 14:56:04.3764
NCT00582699|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-04-09|||November 2005||2005-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Depression, Cytokines and Pancreatic Cancer|Depression, Cytokines and Pancreatic Cancer|Completed||N/A|80|Actual|Memorial Sloan Kettering Cancer Center|||4||f||||||||||||||2017-02-18 14:56:04.688723|2017-02-18 14:56:04.688723
NCT00582686|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-09-28|||May 2000||2000-05-01|September 2013|2013-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|CALCANEUS||Open Reduction Internal Fixation of Calcaneus Fractures With and Without Bone Graft|Prospective Comparison of Open Reduction Internal Fixation of Calcaneus Fractures With and Without Tricortical Iliac Crest Bone Grafting|Completed||N/A|49|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:56:04.802467|2017-02-18 14:56:04.802467
NCT00582673|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-05-13|||October 2007||2007-10-01|May 2010|2010-05-01||||May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa|A Multi-centre, Randomized, Double-blind, Placebo Controlled, Parallel-group, Multiple Oral Dose Titration Study in Patients With Parkinson's Disease to Assess the Efficacy of AFQ056 in Reducing L-dopa Induced Dyskinesias, and the Safety and Tolerability of AFQ056 in Combination With L-dopa|Completed||Phase 2|31|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:56:04.932572|2017-02-18 14:56:04.932572
NCT00582660|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-07-15|2011-02-02||December 2001||2001-12-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|UAB0040||Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib|Randomized, Placebo-Controlled, Phase 2B Evaluation of Cyclooxygenase-2 Activity in Surgically Resected Primary Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib|Completed||Phase 2|40|Actual|University of Alabama at Birmingham|The most prominent factor that limited enrollment was this period of time was at the point that the FDA released its finding about the possible cardiac risks associated with Rofecoxib (VIOXX).|2|||f||||t||||||||||2017-02-18 14:56:05.036673|2017-02-18 14:56:05.036673
NCT00582647|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-09-26|||March 2000||2000-03-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract|Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites.|Active, not recruiting||N/A|6000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Tissue, Blood, Peritoneal, Pleural, Cyst, and Other gastrointestinal fluid~   "|||2017-02-18 14:56:05.431375|2017-02-18 14:56:05.431375
NCT00582634|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-09-30|||September 2004||2004-09-01|September 2015|2015-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer|Phase II Study of Adjuvant Cisplatin and Docetaxel in Non-small Cell Lung Cancer|Completed||Phase 2|4|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:05.516317|2017-02-18 14:56:05.516317
NCT00582621|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-12-16|||July 2000||2000-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders|Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders|Recruiting||N/A|500|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Blood or alternatively, subjects may provide a saliva or buccal cell sample~   "|||2017-02-18 14:56:05.620126|2017-02-18 14:56:05.620126
NCT00582608|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-06-04|||October 2001||2001-10-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9|Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9|Completed||N/A|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:56:05.709538|2017-02-18 14:56:05.709538
NCT00582595|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-01-07|||January 2007||2007-01-01|January 2016|2016-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||LABS-3 Psychosocial|Psychosocial Issues and Bariatric Surgery|Active, not recruiting||N/A|250|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 14:56:05.818765|2017-02-18 14:56:05.818765
NCT00582582|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-09-30|||April 2002||2002-04-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer|Phase II Evaluation of Docetaxel Randomized With Doxercalciferol or Placebo in Patients With Advanced Prostate Cancer|Terminated||Phase 2|70|Actual|University of Wisconsin, Madison||2||Lack of drug supply for doxercalciferol for this study|f||||t||||||||||2017-02-18 14:56:05.89274|2017-02-18 14:56:05.89274
NCT00582569|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-05-09|||February 2006||2006-02-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Breast MRI Spectroscopy, Department of Defense (DOD)|Breast MRI Spectroscopy, Department of Defense (DOD)|Completed||N/A|146|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:06.003874|2017-02-18 14:56:06.003874
NCT00582556|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-06-02|2014-02-24||April 2003||2003-04-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2011|Actual|2011-03-01||Interventional|||Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy|Phase II Trial of Zometa on Bone Mineral Density on Patients With Stage D Prostate Cancer Undergoing Androgen Ablation Therapy|Completed||Phase 2|44|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-02-18 14:56:06.149451|2017-02-18 14:56:06.149451
NCT00582543|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-10-14|||October 2005||2005-10-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||MRI/MRSI in Risk Assessment of Prostate Cancer Patients|MRI/MRSI in Risk Assessment of Prostate Cancer Patients|Completed||N/A|357|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:56:06.876056|2017-02-18 14:56:06.876056
NCT00582530|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-08-30|||December 2004||2004-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Men Undergoing Radical Prostatectomy|Serum Protein Profiling to Characterize Patient Risk in Men Undergoing Radical Prostatectomy|Active, not recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples Without DNA|"~     Whole Blood~   "|||2017-02-18 14:56:06.986671|2017-02-18 14:56:06.986671
NCT00582517|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2013-09-18|2013-09-18||August 2000||2000-08-01|September 2013|2013-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CKH||Compass Hinge Stabilization of Knee Dislocations: A Randomized Trial|Compass Hinge Stabilization of Knee Dislocations: A Randomized Trial|Completed||N/A|100|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:56:07.099286|2017-02-18 14:56:07.099286
NCT00582504|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-08-18|||September 2007||2007-09-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Interventional|VEE TC-83||Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine|A Phase 2 Open-Label, Safety and Immunogenicity Study of a Single Dose of Venezuelan Equine Encephalomyelitis Vaccine, Live, Attenuated, Dried, TC-83, NDBR-102, as Primary Immunization in Healthy Adults At Risk for Exposure to Virulent Venezuelan Equine Encephalomyelitis Virus|Enrolling by invitation||Phase 2|500|Anticipated|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||||2017-02-18 14:56:09.932258|2017-02-18 14:56:09.932258
NCT00582491|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-09-06|2012-08-06||August 2006||2006-08-01|September 2012|2012-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Modafinil, Sleep, and Cognition in Cocaine Dependence|Modafinil, Sleep, and Cognition in Cocaine Dependence|Completed||N/A|44|Actual|Yale University||2|||f||||t||||||||||2017-02-18 14:56:10.028246|2017-02-18 14:56:10.028246
NCT00582478|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-11-03|||October 2001||2001-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients|Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients|Active, not recruiting||N/A|650|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:10.470701|2017-02-18 14:56:10.470701
NCT00582465|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-10-25|||September 2003||2003-09-01|October 2014|2014-10-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Observational|BMD||Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus|Bone Mineral Density of Children and Adolescents With Systemic Lupus Erythematosus|Unknown status|Active, not recruiting|N/A|425|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     Serum~   "|||2017-02-18 14:56:10.581197|2017-02-18 14:56:10.581197
NCT00582452|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-12-09|||November 2004||2004-11-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Attitudes Towards Prophylactic Colectomy in Hereditary Non-polyposis Colorectal Cancer (HNPCC) Patients|Attitudes Towards Prophylactic Colectomy in HNPCC Patients|Completed||N/A|16|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:56:10.675387|2017-02-18 14:56:10.675387
NCT00582439|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-09-28|||January 2007||2007-01-01|September 2013|2013-09-01|September 2009|Actual|2009-09-01|May 2007|Actual|2007-05-01||Interventional|RIA||The Use of RIA to Harvest Bone Graft for Treatment of Non-unions and Fractures|The Use of the Reamer-Irrigator-Aspirator (RIA) to Harvest Bone Graft for Treatment of Non-unions and Fractures|Completed||N/A|21|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-02-18 14:56:10.788495|2017-02-18 14:56:10.788495
NCT00582426|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-04-13|2011-09-01||April 2008||2008-04-01|April 2015|2015-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|LARCID||Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea|LARCID: Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea|Completed||Phase 3|139|Actual|Novartis|Limitations were the small number of patients who received irinotecan and small proportion of patients with grade III and IV diarrhea. It is not possible to generalize our results for these populations. Study wasn’t blinded or placebo-controlled.|2|||f||||||||||||||2017-02-18 14:56:10.906549|2017-02-18 14:56:10.906549
NCT00582413|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-10-15|||December 2004||2004-12-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity|Prospective Evaluation of Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity|Completed||N/A|164|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:11.806327|2017-02-18 14:56:11.806327
NCT00582400|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-02-18|2015-07-01||September 2004||2004-09-01|January 2010|2010-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver|A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver|Terminated||Phase 2|9|Actual|The University of Texas Medical Branch, Galveston||1||"recruiting or enrolling participants has halted prematurely and will not resume; participants~   are no longer being examined or treated"|f||||f||||||||||2017-02-18 14:56:11.910553|2017-02-18 14:56:11.910553
NCT00582387|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-12-16|||March 2004||2004-03-01|December 2015|2015-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer|Pilot Study: Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer|Completed||N/A|116|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     blood, urine and tissue~   "|||2017-02-18 14:56:12.163267|2017-02-18 14:56:12.163267
NCT00582374|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2008-12-11|||March 2005||2005-03-01|June 2008|2008-06-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Observational|||Periodontal Disease and Preterm Birth|Periodontal Disease, Inflammatory Markers, and Preterm Birth|Terminated||N/A|300|Anticipated|University of Oklahoma|||1||f||||f||||||None Retained|"~     Gingival crevicular fluid (GCF) and Vaginal Fluid~   "|||2017-02-18 14:56:12.264408|2017-02-18 14:56:12.264408
NCT00582361|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-08-05|2011-07-27||June 2001||2001-06-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|September 2008|Actual|2008-09-01||Interventional|VAC-OF||Vacuum Assisted Closure as a Treatment for Open Fractures|Vacuum Assisted Closure as a Treatment for Open Fractures|Completed||N/A|63|Actual|University of Alabama at Birmingham|None Noted.|2|||f||||f||||||||||2017-02-18 14:56:12.362078|2017-02-18 14:56:12.362078
NCT00582348|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-11-29|||September 2005||2005-09-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Physical Activity and Inactivity in Lung Cancer Survivors|Physical Activity and Inactivity in Lung Cancer Survivors|Active, not recruiting||N/A|188|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:12.761469|2017-02-18 14:56:12.761469
NCT00582335|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-04|||February 1998||1998-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Identification of New Colorectal Cancer Genes|Identification of New Colorectal Cancer Genes|Active, not recruiting||N/A|337|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Blood Tissue (tumor)~   "|||2017-02-18 14:56:12.85131|2017-02-18 14:56:12.85131
NCT00582322|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-07-17|||February 1992||1992-02-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Genetic Studies in Breast Cancer|Genetic Studies in Breast Cancer|Completed||N/A|483|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     blood~   "|||2017-02-18 14:56:12.943551|2017-02-18 14:56:12.943551
NCT00582309|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-05-26|2009-09-12||August 2007||2007-08-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparative Trial Between 3 Types of Insulin Infusion Protocols|Comparative Trial Between Computer-Guided Intravenous Infusion Protocol Versus a Standard Insulin Infusion Algorithm Versus a Simple Calculated Infusion Protocol in Medical and Surgical ICU|Completed||N/A|151|Actual|University of New Mexico|Limitations of trial. Variable length of stay the first 48 hours was analyzed as the sample size decreased after that.|3|||f||||f||||||||||2017-02-18 14:56:13.235213|2017-02-18 14:56:13.235213
NCT00582296|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-10-12|||December 2004||2004-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Multi-Organ Screening Recommendations in Patients With Lynch Syndrome|Adherence to Comprehensive, Multi-Organ Screening Recommendations in Patients With Lynch Syndrome|Recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:56:13.785608|2017-02-18 14:56:13.785608
NCT00582283|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-01-25|||January 2004||2004-01-01|January 2017|2017-01-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||NM404 as an Imaging Agent in Patients With NSCLC|NM404 as an Imaging Agent in Patients With Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||N/A|21|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-02-18 14:56:13.894806|2017-02-18 14:56:13.894806
NCT00582270|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-08-13|||February 2003||2003-02-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma|Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma|Completed||N/A|56|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:56:13.989021|2017-02-18 14:56:13.989021
NCT00582257|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-12-28|||December 2005||2005-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Early Onset and Familial Gastric Cancer Registry|Early Onset and Familial Gastric Cancer Registry|Recruiting||N/A|2500|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     Germline DNA and Tissue~   "|||2017-02-18 14:56:14.084476|2017-02-18 14:56:14.084476
NCT00582244|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2007-12-19|||January 2008||2008-01-01|December 2007|2007-12-01|December 2010|Anticipated|2010-12-01|||||Interventional|EVA project||Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial|Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial|Unknown status|Not yet recruiting|Phase 3|325|Anticipated|The Netherlands Cancer Institute||4|||f||||f||||||||||2017-02-18 14:56:14.214564|2017-02-18 14:56:14.214564
NCT00582231|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-12-16|||February 2007||2007-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Penile Injection Anxiety|Penile Injection Anxiety|Active, not recruiting||N/A|126|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:14.307237|2017-02-18 14:56:14.307237
NCT00582218|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-01-13|||February 2003||2003-02-01|January 2009|2009-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Family Access to Care Study (FACS)|Family Access to Care Study (FACS)|Completed||N/A|3200|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:14.416708|2017-02-18 14:56:14.416708
NCT00582205|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-05-20|||January 2006||2006-01-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma|Feasibility Trial of Intraperitoneal Chemotherapy in Stage IA, IB, IC, II, III, IV and Recurrent Platinum Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma and Stage III and IV Uterine Cancer|Terminated||Phase 2|21|Actual|University of Oklahoma||1||Study completed per investigator.|f||||f||||||||||2017-02-18 14:56:14.506313|2017-02-18 14:56:14.506313
NCT00582192|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-04-30|||July 2007||2007-07-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Seeking Informed Consent to Phase I Cancer Clinical Trials: Identifying Oncologists'Communication Styles|Seeking Informed Consent to Phase I Cancer Clinical Trials: Identifying Oncologists' Communication Styles|Completed||N/A|17|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:14.613214|2017-02-18 14:56:14.613214
NCT00582179|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-09-28|||September 2001||2001-09-01|September 2013|2013-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|VAC-DH||Vacuum Assisted Closure as a Treatment for Draining Hematomas|Vacuum Assisted Closure as a Treatment For Draining Hematomas (Vacuum Assisted Closure in the Management of Traumatic Extremity Wounds)|Completed||N/A|94|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:56:14.714989|2017-02-18 14:56:14.714989
NCT00582166|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-06-02|||September 2004||2004-09-01|June 2014|2014-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Zevalin(Ibritumomab Tiuxetan)+ Rituximab Maintenance|Ibritumomab Tiuxetan Plus Rituximab as Initial Therapy for Patients With High Tumor Burden, Indolent Histology Non-Hodgkin's Lymphoma|Completed||Phase 2|18|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:14.824885|2017-02-18 14:56:14.824885
NCT00582140|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-07-22|||March 2005||2005-03-01|July 2015|2015-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer|Phase I Study of a DNA-based Vaccine Targeting Prostatic Acid Phosphatase (PAP) in Patients With Stage D0 Prostate Cancer|Completed||Phase 1|22|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-02-18 14:56:14.930866|2017-02-18 14:56:14.930866
NCT00582127|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-12-22|||January 2008||2008-01-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.|Evaluation of a Handheld Evoked Response Potentials (ERP) System as an Effective Method to Diagnose Alzheimer's Disease|Completed||N/A|50|Anticipated|Neuronetrix, Inc.|||2||f||||f||||||||||2017-02-18 14:56:15.038998|2017-02-18 14:56:15.038998
NCT00582114|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-12-14|2015-10-05||August 2005||2005-08-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Hypertension in Hemodialysis Patients (Aim 3)|Hypertension in Hemodialysis Patients|Terminated||Phase 3|200|Actual|Indiana University||2||Stopped by data safety monitoring board|f||||t||||||||||2017-02-18 14:56:15.154746|2017-02-18 14:56:15.154746
NCT00582101|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-06-05|||May 2007||2007-05-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Family-Based HIV Prevention for Latinos|Family-Based HIV Prevention for Latinos|Completed||Phase 1|80|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-02-18 14:56:16.490146|2017-02-18 14:56:16.490146
NCT00582088|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-08-18|||January 2008||2008-01-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Interventional|VEE C-84||Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83|A Phase 2 Open-Label, Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI-GSD 205 When Used as a Booster After TC-83 Primary Immunization in Healthy Adults At-Risk for Exposure to Virulent Venezuelan Equine Encephalomyelitis Virus|Suspended||Phase 2|500|Anticipated|U.S. Army Medical Research and Materiel Command||1||temporary hold|f||||f||||||||||2017-02-18 14:56:16.603069|2017-02-18 14:56:16.603069
NCT00582075|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-08-17|2015-07-06||July 2002||2002-07-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|October 2008|Actual|2008-10-01||Interventional|RAD0102||Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases|Phase II Study of Gamma Knife Radiosurgery and Temozolomide (Temodar) for Newly Diagnosed Brain Metastases|Completed||Phase 2|25|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 14:56:16.71625|2017-02-18 14:56:16.71625
NCT00582062|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-04-28|||March 2006||2006-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples|Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples|Active, not recruiting||N/A|144|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:56:17.220895|2017-02-18 14:56:17.220895
NCT00004330|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||March 1987||1987-03-01|December 2003|2003-12-01||||||||Interventional|||Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:50.907798|2017-02-18 18:16:50.907798
NCT00582049|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2008-07-03|||August 2003||2003-08-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Research on the Environment and Children's Health: Retinoblastoma|Research on the Environment and Children's Health: Retinoblastoma|Completed||N/A|78|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     Blood~   "|||2017-02-18 14:56:17.325877|2017-02-18 14:56:17.325877
NCT00582036|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-03-23|2011-01-06||February 2007||2007-02-01|March 2011|2011-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Glucose Control In Hematopoetic Stem Cell Transplant|Glucose Control In Hematopoetic Stem Cell Transplant|Terminated||N/A|11|Actual|University of Oklahoma|This study was terminated early due to lack of enrollment.|2||study terminated due to lack of enrollment|f||||f||||||||||2017-02-18 14:56:17.430107|2017-02-18 14:56:17.430107
NCT00582023|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-11-21|||September 2004||2004-09-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|CHAI||Role of Positive Affect in Adjustment to HIV|CHAI Study: Coping, HIV, and Affect Interview Study|Completed||N/A|160|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 14:56:17.793655|2017-02-18 14:56:17.793655
NCT00582010|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-11-05|2013-09-30||April 2008||2008-04-01|October 2014|2014-10-01|October 2012|Actual|2012-10-01|March 2009|Actual|2009-03-01||Interventional|||Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation|Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation|Completed||Phase 2/Phase 3|80|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:56:17.891576|2017-02-18 14:56:17.891576
NCT00581997|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-05-02||2012-05-02|December 2007||2007-12-01|May 2012|2012-05-01||||April 2009|Actual|2009-04-01||Interventional|||QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis|A Randomized, Double-blinded, Placebo Controlled, Multiple-dose, Multi-center Pilot Study, to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous Doses of QAX576 in Patients With Pulmonary Fibrosis Secondary to System Sclerosis|Terminated||Phase 2|8|Actual|Novartis||2||"Concerns about risk of bronchoscopy procedure in the selected patient population and frequency~   of SAEs observed to date."|f||||f||||||||||2017-02-18 14:56:18.378793|2017-02-18 14:56:18.378793
NCT00581984|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-10-14|||September 1998||1998-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||McGhan Medical Silicone-Filled Breast Implant Adjunct Study|McGhan Medical Silicone-Filled Breast Implant Adjunct Study|Completed||N/A|1016|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:18.473494|2017-02-18 14:56:18.473494
NCT00581971|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-03-13|2012-05-30||September 2002||2002-09-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|December 2007|Actual|2007-12-01||Interventional|RAD0201||Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer|Radiosensitization With a COX-2 Inhibitor (Celecoxib), With Chemoradiation for Cancer of the Head and Neck|Completed||Phase 1/Phase 2|30|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 14:56:18.563698|2017-02-18 14:56:18.563698
NCT00581958|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-10-13|||November 2007||2007-11-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)|Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)|Recruiting||N/A|200|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:56:18.875405|2017-02-18 14:56:18.875405
NCT00581945|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-06-28|2011-05-26||January 2007||2007-01-01|June 2011|2011-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients|A Randomized, Double-blind, Placebo Controlled, Exploratory Study to Assess the Safety and Efficacy of Multiple Doses of ACZ885 in Chronic Obstructive Pulmonary Disease (COPD) Patients|Completed||Phase 1/Phase 2|147|Actual|Novartis||2|||f||||f||||||||||2017-02-18 14:56:18.996465|2017-02-18 14:56:18.996465
NCT00581932|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-06-22|||October 2001||2001-10-01|June 2012|2012-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine|Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine|Unknown status|Recruiting|N/A|80|Anticipated|University of Iowa|||1||f||||f||||||Samples With DNA|"~     whole blood, saliva~   "|||2017-02-18 14:56:19.480503|2017-02-18 14:56:19.480503
NCT00581919|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-11-21|2016-07-14||February 2004||2004-02-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|December 2010|Actual|2010-12-01||Interventional|||Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma|Phase II Trial of Bortezomib, Low Dose Dexamethasone, and Doxorubicin With Acetyl-L-Carnitine for Neuroprotection in Patients With Previously Treated Multiple Myeloma|Completed||Phase 2|32|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:19.584163|2017-02-18 14:56:19.584163
NCT00581906|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-11-03|||February 2006||2006-02-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors|Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors|Recruiting||N/A|335|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:19.907615|2017-02-18 14:56:19.907615
NCT00581893|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2007-12-27|||August 2005||2005-08-01|December 2007|2007-12-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Phenytoin and Driving Safety|Phenytoin and Driving Safety|Unknown status|Recruiting|Phase 4|30|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:56:20.014484|2017-02-18 14:56:20.014484
NCT00581880|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-01-14|||January 2005||2005-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Measuring Hope and Hopelessness in Cancer|Measuring Hope and Hopelessness in Cancer|Completed||N/A|288|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:20.121333|2017-02-18 14:56:20.121333
NCT00581867|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-07-10|2014-01-09||October 2007||2007-10-01|July 2015|2015-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|MAIN|31 total participants were enrolled in the study. 29 completed the study and had, in a counterbalanced order, one-dose of intranasal insulin followed by fMRI and over 48 hours later a dose of intranasal saline followed by fMRI.|Memory and Insulin in Early Alzheimer's Disease|Intranasal Insulin and Memory in Early Alzheimer's Disease|Completed||Phase 1/Phase 2|31|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 14:56:20.220777|2017-02-18 14:56:20.220777
NCT00581854|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-06-25|2011-12-02||June 2000||2000-06-01|June 2014|2014-06-01|March 2010|Actual|2010-03-01|June 2006|Actual|2006-06-01||Interventional|||Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma|Phase II Pilot Study of Hyper-CVAD Plus Rituximab for Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|22|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:20.68711|2017-02-18 14:56:20.68711
NCT00581841|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-05-16|||November 2002||2002-11-01|May 2013|2013-05-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Observational|||Repeatability of X-Ray, MRI, and Gait Analysis|Repeatability of X-Ray, MRI, and Gait Analysis|Completed||N/A|60|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-02-18 14:56:20.918539|2017-02-18 14:56:20.918539
NCT00581828|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-09-13|2012-07-06||January 2005||2005-01-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Does Treatment of Hypovitaminosis D Increase Calcium Absorption?|Does Treatment of Hypovitaminosis D Increase Calcium Absorption?|Completed||Phase 4|19|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:21.022007|2017-02-18 14:56:21.022007
NCT00581815|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-12-23|||February 1997||1997-02-01|December 2015|2015-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Spectroscopy With Surface Coils and Decoupling|Spectroscopy With Surface Coils and Decoupling|Completed||Phase 1|582|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:56:21.251223|2017-02-18 14:56:21.251223
NCT00581802|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-05-02|||January 2007||2007-01-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|||||Observational|||HIV Resistance and Treatment Strategies|Cohort Study to Understand Resistance and HIV Eradication (CURE): Observational Studies of Antiretroviral Drug Treatment Success and Failure|Completed||N/A|89|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||5||f||||||||||Samples With DNA|"~     Plasma, white cells, and whole blood~   "|||2017-02-18 14:56:21.358246|2017-02-18 14:56:21.358246
NCT00581789|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-02-10|||August 2007||2007-08-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|February 2010|Actual|2010-02-01||Interventional|||Erlotinib and Sunitinib in NSCLC|Phase I Study of Erlotinib and Sunitinib in Non-small Cell Lung Cancer|Completed||Phase 1|11|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:21.460242|2017-02-18 14:56:21.460242
NCT00581776|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-05-12|2010-12-09||May 2005||2005-05-01|May 2016|2016-05-01|May 2015|Actual|2015-05-01|November 2012|Actual|2012-11-01||Interventional|||Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma|Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma|Completed||Phase 2|30|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:21.563384|2017-02-18 14:56:21.563384
NCT00581763|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-06-11|||May 2001||2001-05-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|||||Observational|APL||Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies|Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies|Completed||N/A|110|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     Serum~   "|||2017-02-18 14:56:21.858712|2017-02-18 14:56:21.858712
NCT00581750|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-08-08|||October 2001||2001-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Observational|||Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ|Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ|Active, not recruiting||N/A|550|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples Without DNA|"~     Tissue~   "|||2017-02-18 14:56:21.955422|2017-02-18 14:56:21.955422
NCT00581737|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-03-02|||July 2000||2000-07-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Cognitive Functioning and Quality of Life in CNS Lymphoma|Cognitive Functioning and Quality of Life in CNS Lymphoma|Completed||N/A|50|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Blood~   "|||2017-02-18 14:56:22.06709|2017-02-18 14:56:22.06709
NCT00581724|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-01-25|||May 2007||2007-05-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Pain in Cancer Survivors|Pain in Cancer Survivors|Completed||N/A|200|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:22.150203|2017-02-18 14:56:22.150203
NCT00581711|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-06-15|||December 2007||2007-12-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|OMHIT||Improving Otitis Media Care With Clinical Decision Support|Improving Otitis Media Care With EHR-based Clinical Decision Support and Feedback|Completed||Phase 3|55779|Actual|Children's Hospital of Philadelphia||4|||f||||f||||||||||2017-02-18 14:56:22.255444|2017-02-18 14:56:22.255444
NCT00581698|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-09-14|||January 1991||1991-01-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue|Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue|Completed||N/A|876|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     tissue (lymph node)~   "|||2017-02-18 14:56:22.358374|2017-02-18 14:56:22.358374
NCT00581685|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-06-07|||January 2008||2008-01-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Does Optimal Control of Pre-operative Chronic and Acute Pain Predict Improved Function After Orthopedic Surgery?|Does Optimal Pain Control With Pregabalin and Celecoxib Predict Improved Function After Total Hip Arthroplasty?|Completed||Phase 3|31|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-02-18 14:56:22.45161|2017-02-18 14:56:22.45161
NCT00581672|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2017-01-18|||July 25, 2010|Actual|2010-07-25|January 2017|2017-01-01|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Observational|||Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men|Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men|Active, not recruiting||N/A|225|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:22.541224|2017-02-18 14:56:22.541224
NCT00581659|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2007-12-19|||November 2007||2007-11-01|December 2007|2007-12-01|March 2008|Anticipated|2008-03-01|March 2008|Anticipated|2008-03-01||Observational|||Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions|Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions|Unknown status|Recruiting|N/A|24|Anticipated|National Advanced Driving Simulator|||1||f||||f||||||||||2017-02-18 14:56:22.644719|2017-02-18 14:56:22.644719
NCT00004329|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1999||1999-11-01|December 2003|2003-12-01||||||||Observational|||Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy||Completed||N/A|12||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:50.990772|2017-02-18 18:16:50.990772
NCT00581646|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-07-07|||September 2006||2006-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance|Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance|Completed||N/A|179|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||f||||||||||2017-02-18 14:56:22.73677|2017-02-18 14:56:22.73677
NCT00581633|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-08-15|||February 2007||2007-02-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Acute Salt Handling in Orthostatic Intolerance|Acute Renal Salt Handling in Orthostatic Intolerance|Active, not recruiting||N/A|30|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 14:56:22.845893|2017-02-18 14:56:22.845893
NCT00581620|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||November 2002||2002-11-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Study Evaluating Prevenar Immunogenicity in High Risk Children|To Evaluate the Humoral Immune Response to a Conjugated Pneumococcus Vaccine 7-Valent (Prevenar®) in Children From High Risk Groups.|Completed||Phase 4|160|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-02-18 14:56:22.960826|2017-02-18 14:56:22.960826
NCT00581607|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2013-04-10|||April 2008||2008-04-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|BOSAPAH||Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension|Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension|Completed||Phase 2/Phase 3|43|Actual|University of Cincinnati||2|||f||||t||||||||||2017-02-18 14:56:23.069091|2017-02-18 14:56:23.069091
NCT00581594|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-08-05|||January 2006||2006-01-01|August 2010|2010-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Traditional vs. Graft-augmented Posterior Colporrhaphy|Traditional vs. Graft-augmented Posterior Colporrhaphy: A Randomized Prospective Study|Terminated||N/A|128|Anticipated|University of California, Irvine||2||Could not meet recruitment, technology advancement.|f||||t||||||||||2017-02-18 14:56:23.19626|2017-02-18 14:56:23.19626
NCT00581581|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-03-07|2011-01-24||September 2007||2007-09-01|March 2013|2013-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||CoolCap Followup Study-Coordination of Participating Centers|Long-term Follow-up After Head Cooling for Neonatal Encephalopathy|Completed||N/A|62|Actual|University of Rochester|||2||f||||f||||||||||2017-02-18 14:56:23.309016|2017-02-18 14:56:23.309016
NCT00581568|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-02-08|||January 2004||2004-01-01|February 2017|2017-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|CSC||Cutaneous Effects of Cryogen Spray Cooling|Cutaneous Effects of Cryogen Spray Cooling|Completed||Phase 1|53|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:56:23.70556|2017-02-18 14:56:23.70556
NCT00581555|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2012-03-28|2010-11-17||October 2007||2007-10-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy|A Randomized Pilot Study Evaluating the Efficacy and Safety of Etanercept in Patients With Moderate to Severe Plaque Psoriasis After Cessation of Ciclosporin Therapy|Completed||Phase 4|120|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:56:23.818545|2017-02-18 14:56:23.818545
NCT00581542|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-12-11|2015-04-15||March 2007||2007-03-01|December 2015|2015-12-01|March 2012|Actual|2012-03-01|March 2009|Actual|2009-03-01||Interventional|||Moxifloxacin vs. Polytrim for Conjunctivitis|A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.|Completed||Phase 4|124|Actual|University of Rochester|No adverse events|2|||f||||f||||||||||2017-02-18 14:56:24.627419|2017-02-18 14:56:24.627419
NCT00581529|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-10-14|2014-08-14||November 2004||2004-11-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|October 2010|Actual|2010-10-01||Interventional||34 for patients were enrolled and treated. 2 patients were excluded from all analysis due to fair baseline cosmesis. 2 additional patients underweant mastectomies and were therefore excluded from analysis (comsesis could not be assessed at 5 years). 30 patients were analyzed.|Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy|Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy in Early Stage Breast Cancer After Breast-Conserving Surgery|Terminated||Phase 2|34|Actual|University of Michigan Cancer Center|The trial was terminated early because fair/poor cosmesis developed in 7 of 32 women.|1||The trial was terminated early because fair/poor cosmesis developed in 7 of 32 women.|f||||t||||||||||2017-02-18 14:56:24.956927|2017-02-18 14:56:24.956927
NCT00581516|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2009-06-03|||March 2007||2007-03-01|June 2009|2009-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Molecular Urine Tests for Prostate Cancer||Completed||N/A|100|Actual|University of California, Irvine|||1||f||||f||||||Samples Without DNA|"~     Blood and Urine~   "|||2017-02-18 14:56:25.457334|2017-02-18 14:56:25.457334
NCT00581503|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-02-08|||March 2007||2007-03-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer|Optical Coherence Tomography for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer|Recruiting||N/A|40|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:56:25.543102|2017-02-18 14:56:25.543102
NCT00581490|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-06-24|||August 2003||2003-08-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|PP||Biochemical and Radiological Indicators of Cardiovascular Morbidity in Children With Premature Pubarche|Biochemical and Radiological Indicators of Cardiovascular Morbidity in Children With Premature Pubarche|Completed||N/A|24|Anticipated|Vanderbilt University|||1||f||||t||||||Samples With DNA|"~     DNA sample from consented subjects and controls~   "|||2017-02-18 14:56:25.682384|2017-02-18 14:56:25.682384
NCT00581477|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-10-14|||January 2004||2004-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Orthostatic Hypotension|Treatment of Hypotensive Patients Having a Unique Pattern of Autonomic Symptoms|Enrolling by invitation||Phase 3|25|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:56:25.784922|2017-02-18 14:56:25.784922
NCT00581464|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-01-21|||November 2009||2009-11-01|January 2010|2010-01-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Interventional|HABITS||Healthier Hearts and Brains in Treating Smoking: The HABITS Study|Healthier Hearts and Brains in Treating Smoking: The HABITS Study|Unknown status|Recruiting|N/A|80|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 14:56:25.917186|2017-02-18 14:56:25.917186
NCT00581451|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-07-08|||October 2007||2007-10-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Evaluating the Tolerability of Bifeprunox in Healthy Subjects|A 3-Part, Randomized, Multiple-Dose, Sequential Design Study of Bifeprunox in Healthy Subjects in Order to Establish a Titration Regimen With an Improved Tolerability Profile|Completed||Phase 1|144|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-02-18 14:56:26.023168|2017-02-18 14:56:26.023168
NCT00581438|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-26|||June 2007||2007-06-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Study Evaluating Approach to Treatment of Haemophilia A and B in Spain|Actual Approach to Treatment of Haemophilia A and B in Spain|Completed||N/A|52|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 14:56:26.110929|2017-02-18 14:56:26.110929
NCT00581425|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-01-23|||December 2007||2007-12-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)|Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp|Completed||Phase 4|49|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-02-18 14:56:26.206224|2017-02-18 14:56:26.206224
NCT00581412|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-01-07|||September 2007||2007-09-01|January 2010|2010-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates|Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates|Completed||N/A|60|Anticipated|University of California, Irvine|||1||f||||t||||||||||2017-02-18 14:56:26.318413|2017-02-18 14:56:26.318413
NCT00581399|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-10-27|2011-04-25||September 2006||2006-09-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|NO-NUMO||A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery|A Prospective, Randomized, Multicenter Clinical Study on the High Vacuum Body Cavity Drainage Systems Following Open Heart Surgery|Completed||Phase 2|94|Actual|University of California, Irvine||2|||f||||t||||||||||2017-02-18 14:56:26.432615|2017-02-18 14:56:26.432615
NCT00581386|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-08-11|2009-07-28||May 2007||2007-05-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Clinical Comparison of the Airway Devices|A Randomized Clinical Comparison Of The King Systems Disposable Laryngeal Tube Suction (LTS-D), The Esophageal Tracheal Combitube (ETC) And The Proseal Laryngeal Mask Airway (PLMA) In Adult Patients|Completed||N/A|218|Actual|The University of Texas Health Science Center, Houston||3|||f||||f||||||||Undecided||2017-02-18 14:56:26.811829|2017-02-18 14:56:26.811829
NCT00581373|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-08-15|||August 2007||2007-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Water and the Gastropressor Response - Diurnal Variability|Water and the Gastropressor Response - Diurnal Variability (Specific Aim 1.3)|Active, not recruiting||N/A|20|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 14:56:27.435554|2017-02-18 14:56:27.435554
NCT00581360|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-09-19|2016-01-14||November 2007||2007-11-01|September 2016|2016-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck|Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Head and Neck Adenoid Cystic Carcinoma|Completed||Phase 2|10|Actual|University of Pittsburgh||1|||f||||t||||||||No||2017-02-18 14:56:27.553884|2017-02-18 14:56:27.553884
NCT00581347|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-08-17|2010-08-12||October 2007||2007-10-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PCAIR||Primary Care and Adolescent Immunization for Rochester||Completed||N/A|7546|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-02-18 14:56:27.896501|2017-02-18 14:56:27.896501
NCT00581334|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-07-18|||May 2007||2007-05-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Robotic-assisted Laparoscopic Sacrocolpopexy|Robotic-assisted Laparoscopic Sacrocolpopexy: A Feasibility Study|Completed||N/A|20|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 14:56:28.261195|2017-02-18 14:56:28.261195
NCT00581321|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-08-15|||January 2006||2006-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Oral Water Ingestion in Heart Transplant Patients|Acute Hemodynamic Effects of Oral Water in a Stable Cardiac Transplant Population|Active, not recruiting||N/A|40|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 14:56:28.352997|2017-02-18 14:56:28.352997
NCT00581308|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-04-21|2012-01-04||August 2006||2006-08-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2009|Actual|2009-10-01||Interventional|||Long-term Safety Study of the GORE® HELEX® Septal Occluder|GORE® HELEX® Septal Occluder Post-Approval Study|Completed||Phase 4|215|Actual|W.L.Gore & Associates||1|||f||||t||||||||||2017-02-18 14:56:28.45258|2017-02-18 14:56:28.45258
NCT00581295|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-02-08|||March 2007||2007-03-01|February 2017|2017-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Use of Diffuse Optical Spectroscopy for Evaluation of the Trauma/Critically Care Patients|Use of Diffuse Optical Spectroscopy for Evaluation of the Trauma/Critically Care Patients|Completed||N/A|93|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:56:28.871368|2017-02-18 14:56:28.871368
NCT00581282|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-10-14|||October 2006||2006-10-01|October 2010|2010-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Brain Imaging Studies of the Effects of Cocaine Abstinence|Brain Imaging Studies of the Effects of Cocaine Abstinence|Recruiting||N/A|30|Anticipated|University of California, Irvine|||2||f||||f||||||||||2017-02-18 14:56:28.970733|2017-02-18 14:56:28.970733
NCT00581269|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-11-01|||December 2007||2007-12-01|November 2010|2010-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease|Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease|Terminated||Phase 2|3|Actual|Vanderbilt University||3||the Fellow conducting the study left the institution in 2009|f||||f||||||||||2017-02-18 14:56:29.133799|2017-02-18 14:56:29.133799
NCT00581256|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-10-07|2016-06-23||April 2006||2006-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|April 2015|Actual|2015-04-01||Interventional|||A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer|A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer|Active, not recruiting||Phase 1/Phase 2|54|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-02-18 14:56:29.235011|2017-02-18 14:56:29.235011
NCT00581243|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-07-20|||January 2008||2008-01-01|July 2009|2009-07-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients|An Ascending Multiple-Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SLV-313 Sustained-Release (SR) Tablets Administered Orally to Subjects With Schizophrenia and Schizoaffective Disorder|Terminated||Phase 1|32|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-02-18 14:56:29.667479|2017-02-18 14:56:29.667479
NCT00581230|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-08-11|2011-04-12||December 2007||2007-12-01|August 2016|2016-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|RAMP||Evaluation of the Rapid Airway Management Positioner|An Evaluation Of The Rapid Airway Management Positioner (RAMP) In Obese Patients Undergoing Gastric Bypass Or Laparoscopic Gastric Banding (Lap-Band) Surgery|Completed||N/A|51|Actual|The University of Texas Health Science Center, Houston|major limitations of the study was the lack of a blinded observer for the purpose of rating the laryngoscopic view & how easily, quickly & consistently this position can be achieved as well as to return the patient to a neutral position for surgery.|2|||f||||f||||||||Undecided||2017-02-18 14:56:29.757864|2017-02-18 14:56:29.757864
NCT00581217|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-05-11|||December 2007||2007-12-01|May 2010|2010-05-01|September 2010|Anticipated|2010-09-01|March 2010|Actual|2010-03-01||Observational|||A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings|A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings With Regards to Healing Time, Cosmesis, Infection Rate, and Patient's Perceived Pain: a Pilot Study.|Unknown status|Active, not recruiting|N/A|20|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:56:30.034309|2017-02-18 14:56:30.034309
NCT00581204|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-02-08|||December 2011||2011-12-01|February 2017|2017-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans|Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans|Completed||N/A|8|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:56:32.595041|2017-02-18 14:56:32.595041
NCT00581191|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-08-03|||January 2008||2008-01-01|August 2009|2009-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating the Safety and Tolerability of Single Ascending Dose (SAD) SLV-351 in Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SLV-351 Administered Orally to Healthy Subjects|Terminated||Phase 1|72|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||9|||f||||f||||||||||2017-02-18 14:56:32.721249|2017-02-18 14:56:32.721249
NCT00581178|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-06-24|||April 2008||2008-04-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Study to Determine if There Are Specific Clinical Factors to Determine Stent Encrustation|Study to Determine if There Are Specific Clinical Factors to Determine Stent Encrustation|Terminated||N/A|16|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:56:32.810547|2017-02-18 14:56:32.810547
NCT00581165|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-26|||February 2006||2006-02-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept|Evaluating Safety in Patients With Moderate to Severe Psoriasis Treated With Etanercept|Completed||Phase 4|500|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:56:32.889754|2017-02-18 14:56:32.889754
NCT00581152|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2007-12-19|||August 2007||2007-08-01|December 2007|2007-12-01|August 2010|Anticipated|2010-08-01|||||Observational|||The Role of TBX3 in Human ES Cell Differentiation|The Role of TBX3 in Human ES Cell Differentiation|Unknown status|Active, not recruiting|N/A|4|Anticipated|University of California, Irvine|||1||f||||f||||||Samples With DNA|"~     NIH-approved cell lines will be available at the Sue and Bill Gross Stem Cell Research Core~     Facility at the University of California, Irvine. Non-NIH-approved cell lines will be~     obtained from Sue & Bill Gross Stem Cell Core at UC Irvine.~   "|||2017-02-18 14:56:32.970741|2017-02-18 14:56:32.970741
NCT00581139|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2008-10-27|||April 2003||2003-04-01|October 2008|2008-10-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|NIH||Psychological Influences on Postoperative Recovery|Psychological Influences on Postoperative Recovery|Unknown status|Recruiting|Phase 2|377|Anticipated|Yale University||4|||f||||t||||||||||2017-02-18 14:56:33.056615|2017-02-18 14:56:33.056615
NCT00581126|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-26|||December 2001||2001-12-01|December 2007|2007-12-01|July 2004|Actual|2004-07-01|||||Interventional|||Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B|Evaluation of Efficacy and Safety of Benefix®- Coagulation Factor ix, Recombinant, in Previously Treated Patients With Hemophilia b.|Completed||Phase 4|14|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:56:33.166026|2017-02-18 14:56:33.166026
NCT00581113|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-05-15|2010-10-06||March 2007||2007-03-01|May 2015|2015-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases|A Study of Neural Stem Cell (NSC) Preserving Whole Brain Radiation Therapy (WBRT) and Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases|Terminated||Phase 3|8|Actual|Virginia Commonwealth University|Trial not completed. Insufficient data to analyze.|2||New research priorities|f||||t||||||||||2017-02-18 14:56:33.258089|2017-02-18 14:56:33.258089
NCT00581100|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-02-20|2010-08-03||September 2007||2007-09-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis|Randomised, Open-label Preliminary Study to Assess the Effects of 2 Regimens of Etanercept on Nail and Skin Symptoms in Patients With Nail Psoriasis and Plaque Psoriasis|Completed||Phase 4|136|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:56:33.624892|2017-02-18 14:56:33.624892
NCT00581087|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-26|2015-01-13|||January 2007||2007-01-01|January 2015|2015-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|DHEA-HTAP||Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults|Double-blind, Randomised, Placebo-controlled Phase III Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults|Unknown status|Active, not recruiting|Phase 3|60|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 14:56:34.620225|2017-02-18 14:56:34.620225
NCT00580892|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-02-08|||July 2007||2007-07-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Optical Coherence Tomography of Airway and Pleural Disorders|Optical Coherence Tomography of Airway and Pleural Disorders|Recruiting||N/A|170|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:56:37.52775|2017-02-18 14:56:37.52775
NCT00581074|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2011-07-25|||March 2006||2006-03-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|GJW||Effects of Grapefruit or Grapefruit Juice on Anthropometry, Dietary Intakes, Appetite, and Metabolic Profile in Overweight and Obese Young and Middle-Aged Adults|Effects of Grapefruit or Grapefruit Juice on Anthropometry, Dietary Intakes, Appetite, and Metabolic Profile in Overweight and Obese Young and Middle-Aged Adults|Completed||N/A|90|Anticipated|Vanderbilt University||3|||f||||f||||||||||2017-02-18 14:56:34.731533|2017-02-18 14:56:34.731533
NCT00581061|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-10-05|2010-03-11||June 2008||2008-06-01|October 2010|2010-10-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|||Study to Determine Effects of Vesicare on Return to Continence Post- Radical Prostatectomy|Vesicare™ (Solifenacin) in the Treatment of Urinary Incontinence After Radical Prostatectomy|Terminated||N/A|13|Actual|University of California, Irvine||1||Study subjects were not compliant with study protocols.|f||||t||||||||||2017-02-18 14:56:34.829526|2017-02-18 14:56:34.829526
NCT00581048|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2012-07-12|||December 2006||2006-12-01|July 2012|2012-07-01|October 2011|Actual|2011-10-01|April 2011|Actual|2011-04-01||Interventional|||Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics|Oxidant Stress and Allergic Asthma|Completed||N/A|43|Actual|Vanderbilt University||1|||f||||t||||||||||2017-02-18 14:56:35.068146|2017-02-18 14:56:35.068146
NCT00581035|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-26|||January 2006||2006-01-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time|A Randomised Open Label Phase 4 Study to Evaluate the Safety and Immunogenicity of Concomitant Prevenar and Meningitec Compared to Prevenar Alone and Meningitec Alone When Used as Part of the Routine Vaccination Series in Healthy Infants|Completed||Phase 4|712|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 14:56:35.161851|2017-02-18 14:56:35.161851
NCT00581022|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-08-15|||November 2006||2006-11-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Objective Sleep Disturbances in Orthostatic Intolerance|Assessment of Objective Sleep Disturbances in Orthostatic Intolerance|Active, not recruiting||N/A|100|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-02-18 14:56:35.253491|2017-02-18 14:56:35.253491
NCT00581009|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-11-01|||March 2001||2001-03-01|November 2010|2010-11-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients|The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients|Recruiting||Phase 1/Phase 2|180|Anticipated|University of California, Irvine||3|||f||||f||||||||||2017-02-18 14:56:35.366005|2017-02-18 14:56:35.366005
NCT00580996|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-22|2016-08-15|||July 2006||2006-07-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Water and the Gastropressor Response - Tachyphylaxis|Water and the Gastropressor Response - Tachyphylaxis (Specific Aim 1.2)|Active, not recruiting||N/A|20|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 14:56:35.505865|2017-02-18 14:56:35.505865
NCT00580983|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2016-07-28|2014-11-05||August 2003||2003-08-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||90 patients were enrolled. Only 80 patients were treated and 7 patients did not complete the 12 month post-Radiation Therapy (RT) swallowing studies. Therefore only 73 participants were included in the baseline analysis.|Optimized Intensity Modulated Irradiation for Head and Neck Cancer|Optimized Intensity Modulated Irradiation for Head and Neck Cancer|Completed||N/A|90|Actual|University of Michigan Cancer Center|No modeling of observer-rated posttherapy dysphagia was performed because of the small number (four) of patients with greater than, or equal to, Grade 2 after 6 months.|1|||f||||t||||||||||2017-02-18 14:56:35.828028|2017-02-18 14:56:35.828028
NCT00580970|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-09-28|2016-06-03||April 2007||2007-04-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||Between April 12, 2007 and May 30, 2013, 73 consecutive patients enrolled in the study. A total of 20 patients did not complete at least 6 months of Lovastatin treatment and were deemed ineligible for the purpose of assessing late rectal toxicity and additional patients were enrolled in order to achieve the accrual goal of 53 evaluable patients.|Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury|A Phase II Study to Prevent Radiation-Induced Rectal Injury With Lovastatin|Completed||Phase 2|73|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-02-18 14:56:36.213345|2017-02-18 14:56:36.213345
NCT00580957|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-07-06|2015-05-29||August 2008||2008-08-01|July 2016|2016-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||The Autonomic Nervous System and the Metabolic Syndrome|The Autonomic Nervous System and the Metabolic Syndrome|Completed||N/A|56|Actual|Vanderbilt University||2|||f||||f||||||||Undecided||2017-02-18 14:56:36.711031|2017-02-18 14:56:36.711031
NCT00580944|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2017-02-08|||April 2007||2007-04-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks|Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks|Withdrawn||Phase 1|0|Actual|University of California, Irvine||1||No participant enrolled|f||||f||||||||||2017-02-18 14:56:37.0918|2017-02-18 14:56:37.0918
NCT00580931|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-24|2017-01-23|||January 2008|Actual|2008-01-01|January 2017|2017-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Safety Study of Nicotinamide to Treat Alzheimer's Disease|Efficacy of Nicotinamide for the Treatment of Alzheimer's Disease|Completed||Phase 1/Phase 2|50|Actual|University of California, Irvine||2|||f||||f||||||||||2017-02-18 14:56:37.189858|2017-02-18 14:56:37.189858
NCT00580918|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-10-14|||October 2003||2003-10-01|October 2010|2010-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients|Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients|Recruiting||N/A|40|Anticipated|University of California, Irvine|||2||f||||f||||||||||2017-02-18 14:56:37.298965|2017-02-18 14:56:37.298965
NCT00580905|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2017-01-13|||June 2007||2007-06-01|January 2017|2017-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Role of Adenosine in the Release of VEGF and Cytokines|Role of Adenosine in the Release of VEGF and Cytokines|Terminated||Phase 1|8|Actual|Vanderbilt University Medical Center||2||Not enough volunteer recruited before funding could be secured.|f||||f||||||||||2017-02-18 14:56:37.414442|2017-02-18 14:56:37.414442
NCT00580879|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-01-07|||January 2005||2005-01-01|January 2010|2010-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Does Antenatal Fetal Head Circumference Predict Anal Sphincter Injury, a Prospective Study|Does Antenatal Fetal Head Circumference Predict Anal Sphincter Injury, a Prospective Study|Completed||N/A|80|Anticipated|University of California, Irvine|||1||f||||t||||||||||2017-02-18 14:56:37.643368|2017-02-18 14:56:37.643368
NCT00580866|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-07-22|2015-11-10||September 2006||2006-09-01|July 2016|2016-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|JAS||Progressive Splinting Status Post Elbow Fractures and Dislocations|Multi-Center Controlled Trial of Static Progressive Splinting Status Post Elbow Fractures and Dislocations|Terminated||N/A|17|Actual|Vanderbilt University||2||low accrual|f||||f||||||||||2017-02-18 14:56:37.73698|2017-02-18 14:56:37.73698
NCT00580853|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2016-05-06|||April 2007||2007-04-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior|The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior|Active, not recruiting||Phase 2|60|Anticipated|Yale University||3|||f||||t||||||||||2017-02-18 14:56:38.101589|2017-02-18 14:56:38.101589
NCT00580840|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2014-08-26|2011-12-14||December 2007||2007-12-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|DoseFlex||Dosing Flexibility Study in Patients With Rheumatoid Arthritis|A Phase IIIb Open-label run-in Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety/Efficacy of Certolizumab Pegol Administered Concomitantly With Stable-dose Methotrexate in Patients With Active Rheumatoid Arthritis.|Completed||Phase 4|333|Actual|UCB Pharma||3|||f||||f||||||||||2017-02-18 14:56:38.216026|2017-02-18 14:56:38.216026
NCT00580827|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2007-12-25|||September 2003||2003-09-01|December 2007|2007-12-01||||March 2004|Actual|2004-03-01||Interventional|||Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers|Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers|Completed||N/A|126|Actual|Yale University||4|||f||||t||||||||||2017-02-18 14:56:39.844756|2017-02-18 14:56:39.844756
NCT00580814|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2011-04-06|||February 2006||2006-02-01|April 2011|2011-04-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|Brookhaven||Brain Dopamine Function in Adults With ADHD|Brain Dopamine Function in Adults With ADHD|Completed||N/A|24|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:56:39.952834|2017-02-18 14:56:39.952834
NCT00580801|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-08-27|2013-03-07||January 2008||2008-01-01|August 2013|2013-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection|A Phase IIa Randomized, Partially Blinded Trial of Telaprevir (VX-950) in Treatment-Naive Subjects With Chronic Genotype 4 Hepatitis C Infection|Completed||Phase 2|24|Actual|Tibotec BVBA||3|||f||||f||||||||||2017-02-18 14:56:40.074318|2017-02-18 14:56:40.074318
NCT00580788|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-02-09|2014-04-25||January 2008||2008-01-01|February 2016|2016-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study|Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone-related Protein(1-36): Effects on Bone Formation|Completed||Early Phase 1|14|Actual|University of Pittsburgh|Small number of subjects in each group Study limited to Caucasians Only one timepoint for follow-up was measure Study did not include saline infused controls|4|||f||||t||||||||No||2017-02-18 14:56:40.944486|2017-02-18 14:56:40.944486
NCT00580775|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-01-20|||September 2005||2005-09-01|January 2015|2015-01-01|December 2010|Actual|2010-12-01|July 2008|Actual|2008-07-01||Observational|KEEPS||Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death|Effects of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death: Autonomic Function and Ventricular Repolarization Heterogeneity ( A KEEPS Ancillary Study)|Completed||N/A|25|Actual|Yale University|||2||f||||f||||||||||2017-02-18 14:56:42.441218|2017-02-18 14:56:42.441218
NCT00580762|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-09-02|||October 2005||2005-10-01|September 2016|2016-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Bariatric Surgery for ESRD Patients vs Control|Obesity, End-Stage Renal Disease and Kidney Transplantation|Terminated||N/A|5|Actual|Yale University||2||Lack of enrollment|f||||t||||||||||2017-02-18 14:56:42.548388|2017-02-18 14:56:42.548388
NCT00580749|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-01-26|||January 2010||2010-01-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SNAP||Study of Nutrition in Acute Pancreatitis|Feeding and Pancreatic Rest in Acute Pancreatitis|Terminated||N/A|23|Actual|University of Pittsburgh||2||not meeting enrollment criteria|f||||t||||||||||2017-02-18 14:56:42.649979|2017-02-18 14:56:42.649979
NCT00580736|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2017-02-08|||March 2004||2004-03-01|February 2017|2017-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Optical Clearing of the Skin in Conjunction With Laser Treatments|Optical Clearing of the Skin in Conjunction With Laser Treatments|Completed||Phase 1|35|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 14:56:42.7608|2017-02-18 14:56:42.7608
NCT00580723|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2013-12-16|2013-03-18||April 2007||2007-04-01|December 2013|2013-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effects of PRK 124 Lotion in Acne Rosacea|Effects of PRK 124 (0.125%) Lotion in Acne Rosacea|Completed||Phase 1/Phase 2|24|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 14:56:42.873603|2017-02-18 14:56:42.873603
NCT00580710|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-01-24|||August 2001||2001-08-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Observational|||Investigation Into the Effects Upon Brain Response to Change in Cirucating Glose Levels in Diabetes Mellitus|Investigation Into the Effects Upon Brain Response to Change in Cirucating Glose Levels in Diabetes Mellitus|Recruiting||N/A|250|Anticipated|Yale University|||7||f||||t||||||||||2017-02-18 14:56:43.153657|2017-02-18 14:56:43.153657
NCT00580697|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-05-06|||January 2006||2006-01-01|May 2010|2010-05-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Prevalence of Lower Urinary Tract Symptoms in Women With Gynecologic Malignancy Planning to Undergo Surgical Management|Prevalence of Lower Urinary Tract Symptoms in Women With Gynecologic Malignancy Planning to Undergo Surgical Management|Unknown status|Active, not recruiting|N/A|100|Anticipated|University of California, Irvine|||1||f||||t||||||||||2017-02-18 14:56:43.26377|2017-02-18 14:56:43.26377
NCT00580684|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||September 2003||2003-09-01|December 2007|2007-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children|Long-Term Efficacy of Pneumococcal Conjugate 7-Valent Vaccine Versus Plain Polisaccharide Pneumococcus Vacine in Reducing Pneumococcal Nasopharyngeal Carriage of Children.|Completed||Phase 4|101|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 14:56:43.352717|2017-02-18 14:56:43.352717
NCT00580645|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-25|2016-11-22|||April 2007||2007-04-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 2: Do Varenicline (Chantix) and Bupropion (Zyban) Change Alcohol Drinking?|Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 2: Do Varenicline (Chantix) and Bupropion (Zyban) Change Alcohol Drinking?|Active, not recruiting||Phase 2|308|Anticipated|Yale University||3|||f||||t||||||||||2017-02-18 14:56:44.085857|2017-02-18 14:56:44.085857
NCT00580632|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2010-05-13|||January 2007||2007-01-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis|Workload, Clinical and Therapeutic Management of Psoriatic Arthritis|Completed||N/A|300|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 14:56:44.195969|2017-02-18 14:56:44.195969
NCT00580619|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2017-01-16|||April 2007||2007-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|CFS&ANS||Autonomic Nervous System and Chronic Fatigue Syndrome|Autonomic Nervous System and Chronic Fatigue Syndrome|Completed||Phase 1|170|Actual|Vanderbilt University Medical Center||4|||f||||t||||||||No||2017-02-18 14:56:44.268837|2017-02-18 14:56:44.268837
NCT00580606|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-12-15|2012-09-28||December 2007||2007-12-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2010|Actual|2010-12-01||Interventional|||A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial|Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract|Completed||Phase 1/Phase 2|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Refer to the original results published in the Journal of Allergy and Clinical Immunology, Vol 135, Number 5, page 1247 for a full description of the limitations of the current study.|2|||f||||t||||||||||2017-02-18 14:56:44.40652|2017-02-18 14:56:44.40652
NCT00580593|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-07-09|||April 2007||2007-04-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)|Pilot Placebo-Controlled Trial of Early Noninvasive Ventilation for ALS|Completed||Phase 1|60|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 14:56:45.647955|2017-02-18 14:56:45.647955
NCT00580580|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-07-19|||February 2012||2012-02-01|July 2012|2012-07-01|March 2014|Anticipated|2014-03-01|March 2013|Anticipated|2013-03-01||Interventional|||Detection of Coronary Stenosis With Intravenous Microbubbles|The Detection of Coronary Stenosis With Intravenous Mircrobubbles and Contrast Pulse Sequence Low Mechanical Index Imaging|Withdrawn||N/A|0|Actual|University of Nebraska||3|||f||||f||||||||||2017-02-18 14:56:45.758403|2017-02-18 14:56:45.758403
NCT00580567|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-06-03|||March 2007||2007-03-01|June 2013|2013-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Impulsivity in Pathological Gambling|Impulsivity in Pathological Gambling: A Cross Sectional Analysis on Tests of Impulsivity Between Pathological Gamblers and a Non-pathological Control Group.|Completed||N/A|120|Actual|University of California, Los Angeles|||2||f||||f||||||||||2017-02-18 14:56:45.856568|2017-02-18 14:56:45.856568
NCT00580541|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-04-19|||August 2007||2007-08-01|December 2007|2007-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Liking on Fruit Intake||Completed||N/A|20|Actual|The Miriam Hospital||1|||f||||f||||||||||2017-02-18 14:56:45.955797|2017-02-18 14:56:45.955797
NCT00580528|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2013-05-20|||August 2006||2006-08-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||Reducing Blood Pressure in Prehypertensive Older Rural Women Also Known as Wellness for Women: DASHing Toward Health|Modifying Lifestyle in Prehypertensive Older Rural Women|Completed||N/A|289|Actual|University of Nebraska||3|||f||||f||||||||||2017-02-18 14:56:46.257597|2017-02-18 14:56:46.257597
NCT00580515|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-01-16|||November 2005||2005-11-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Trial of Family Focused Grief Therapy in Palliative Care and Bereavement|Randomized Controlled Trial of Family Focused Grief Therapy in Palliative Care and Bereavement|Active, not recruiting||N/A|700|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 14:56:46.369032|2017-02-18 14:56:46.369032
NCT00580502|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-03-16|2014-12-29||March 2004||2004-03-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|LBMI||Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2|A Prospective Study to Evaluate the Safety and Efficacy of LAP-BAND® Adjustable Gastric Band (LAGB®) Operations for Patients With BMI Between 30-40 kg/m2 With Co-morbidities|Completed||Phase 2/Phase 3|50|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 14:56:46.482698|2017-02-18 14:56:46.482698
NCT00580489|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||August 2006||2006-08-01|December 2007|2007-12-01||||December 2008|Anticipated|2008-12-01||Interventional|||Lifeflight: Fentanyl Versus Morphine|Efficacy and Adverse Events of Morphine and Fentanyl in an Aeromedical Setting|Unknown status|Recruiting|N/A|200|Anticipated|MetroHealth Medical Center||2|||f||||f||||||||||2017-02-18 14:56:46.739525|2017-02-18 14:56:46.739525
NCT00580476|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-12-16|||September 2006||2006-09-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Assessing Depression in a Geriatric Cancer Population|Assessing Depression in a Geriatric Cancer Population|Active, not recruiting||N/A|201|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||||||2017-02-18 14:56:46.843287|2017-02-18 14:56:46.843287
NCT00580463|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-03-18|||January 2000||2000-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors|Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors|Completed||N/A|1128|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Blood Spinal fluid~   "|||2017-02-18 14:56:46.941528|2017-02-18 14:56:46.941528
NCT00580450|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||December 2007||2007-12-01|November 2007|2007-11-01|December 2010|Anticipated|2010-12-01|December 2007|Actual|2007-12-01||Interventional|||Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies|Phase I/II Clinical Trial on Thymosin Alfa 1 of Allogeneic Hematopoietic Transplantation|Unknown status|Not yet recruiting|Phase 1/Phase 2|9|Anticipated|University Of Perugia||2|||f||||t||||||||||2017-02-18 14:56:47.035108|2017-02-18 14:56:47.035108
NCT00580099|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-04-08|||September 2005||2005-09-01|April 2011|2011-04-01|March 2012|Anticipated|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||Assisted Exercise in Prematurity; Effects and Mechanisms|Assisted Exercise in Prematurity; Effects and Mechanisms|Unknown status|Recruiting|N/A|100|Anticipated|University of California, Irvine||2|||f||||t||||||||||2017-02-18 14:56:52.057101|2017-02-18 14:56:52.057101
NCT00580437|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2011-08-02|||April 2003||2003-04-01|August 2011|2011-08-01|April 2012|Anticipated|2012-04-01|March 2012|Anticipated|2012-03-01||Interventional|||Pre-operative Evaluation of Kidney & Pancreas Transplant Patients|The Analysis of Data Collected During Angiography and Dobutamine Stress Contrast Echocardiograms in the Pre-Evaluation of Kidney and Pancreas Transplant Patients|Unknown status|Active, not recruiting|N/A|150|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:56:47.13389|2017-02-18 14:56:47.13389
NCT00580424|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-06-24|||December 2007||2007-12-01|December 2007|2007-12-01|July 2009|Anticipated|2009-07-01|||||Interventional|||The Effect of the Mini-pill on Blood Factors in Women at Increased Risk for Forming Blood Clots|The Effect of Oral Norethindrone on Coagulation Parameters in Women at Increased Risk for Venous Thromboembolic Events|Terminated||N/A|20|Anticipated|University of Vermont||1|||f||||t||||||||||2017-02-18 14:56:47.233716|2017-02-18 14:56:47.233716
NCT00580411|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-01-10|||March 2007||2007-03-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||A Timeline Study of Alcohol Use and Its Relationship to Insomnia|A Timeline Study of Alcohol Use and Its Relationship to Insomnia|Completed||Phase 2|75|Actual|National Institute on Drug Abuse (NIDA)|||2||f||||f||||||||||2017-02-18 14:56:47.321985|2017-02-18 14:56:47.321985
NCT00580398|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-11-20|2013-05-15||January 2008||2008-01-01|November 2014|2014-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Smoking Cessation Intervention for Thoracic Patients|A Pilot Smoking Cessation Study for Newly Diagnosed Lung Cancer Patients|Completed||Phase 1/Phase 2|49|Actual|Massachusetts General Hospital|The generalizability of the findings are limited by a single study site. The statistical power to detect differences was limited by the small sample size of this pilot study.|2|||f||||f||||||||||2017-02-18 14:56:47.406067|2017-02-18 14:56:47.406067
NCT00580385|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-09-30|||August 1997||1997-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors|Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors|Recruiting||N/A|750|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:56:47.908805|2017-02-18 14:56:47.908805
NCT00580372|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-08-01|2016-08-01||August 2002||2002-08-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||"UARK 89-001 Phase II Study of Intensive TOTAL THERAPY For Untreated or Minimally Treated Patients With Multiple Myeloma"|"Phase II Study of Intensive TOTAL THERAPY for Untreated or Minimally Treated Patients With Multiple Myeloma"|Completed||Phase 2|231|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:56:48.021666|2017-02-18 14:56:48.021666
NCT00580359|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-26|||May 2007||2007-05-01|December 2007|2007-12-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer|A Randomized Phase II Study of S-1 Versus Capecitabine as First-Line Chemotherapy in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer|Unknown status|Recruiting|Phase 2|96|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 14:56:48.331424|2017-02-18 14:56:48.331424
NCT00580346|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-02-17|||August 2004||2004-08-01|January 2009|2009-01-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Dynamic Laryngotracheal Separation for Aspiration|Dynamic Laryngotracheal Separation for Aspiration. Prevention of Silent Aspiration Pneumonia During Swallowing by an Implanted Stimulator|Suspended||Phase 1|3|Anticipated|University Hospitals Cleveland Medical Center||1||Protocol currently reviewed for updating|f||||f||||||||||2017-02-18 14:56:48.437378|2017-02-18 14:56:48.437378
NCT00580333|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-04-29|||September 2007||2007-09-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2010|Actual|2010-12-01||Interventional|||Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer|A Phase II Trial of Preoperative Cisplatin and Bevacizumab in ER-, PR-, Her-2 Negative Breast Cancer|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:56:48.548984|2017-02-18 14:56:48.548984
NCT00580320|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-08-17|||September 2004||2004-09-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|October 2009|Actual|2009-10-01||Interventional|||Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma|Phase I Trial of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma|Completed||Phase 1|17|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-02-18 14:56:48.659738|2017-02-18 14:56:48.659738
NCT00580307|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-09-29|||December 2007||2007-12-01|September 2016|2016-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|RHINO||Rhinogenic Headache Improvement After Nasal Operation|Surgical Correction of Contact Point Headaches - Randomized Controlled Trial. [Rhinogenic Headache Improvement After Nasal Operation] Trial|Terminated||N/A|6|Actual|University of Missouri-Columbia||2||slow accrual|f||||f||||||||Undecided||2017-02-18 14:56:48.775321|2017-02-18 14:56:48.775321
NCT00580294|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-01-04|2015-11-25||November 2007||2007-11-01|January 2016|2016-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)|A Pilot Study of Rapid Opioid Rotation and Titration of Oxymorphone|Completed||N/A|12|Actual|Icahn School of Medicine at Mount Sinai|This was a pilot open-label study in a small number of participants. A larger randomized study with long-term follow-up and comparison to traditional protocols is necessary to affirm safety. (12 pts had 6 different chronic non-cancer pain diagnoses.)|1|||f||||f||||||||||2017-02-18 14:56:48.889374|2017-02-18 14:56:48.889374
NCT00580281|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-10-23|||November 2006||2006-11-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors|Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors.|Completed||N/A|33|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:56:49.106172|2017-02-18 14:56:49.106172
NCT00580268|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-08-11|||August 2005||2005-08-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|December 2010|Actual|2010-12-01||Observational|||Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity|Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity|Completed||N/A|118|Actual|Massachusetts General Hospital|||1||f||||t||||||Samples With DNA|"~     serum, plasma, urine, whole blood, saliva, amniotic fluid, breast milk~   "|||2017-02-18 14:56:49.221081|2017-02-18 14:56:49.221081
NCT00577252|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-11-23|||October 2007||2007-10-01|November 2009|2009-11-01|April 2008|Actual|2008-04-01|||||Observational|||Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis|Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis|Completed||N/A|40|Anticipated|Akron Children's Hospital|||1||f||||f||||||||||2017-02-18 14:57:59.290268|2017-02-18 14:57:59.290268
NCT00580255|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-01-07|||October 2006||2006-10-01|January 2013|2013-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Comparison Study of BNP and Thoracic Impedance Measurements on Arrhythmias|Does Elevated Brain Natriuretic Peptide (BNP) Reflect Changes in Thoracic Impedance Levels and Affect Occurrence of Atrial and Ventricular Arrhythmias?|Withdrawn||N/A|0|Actual|University of California, Davis|||1|resources not available|f||||f||||||Samples Without DNA|"~     Teaspoon of blood drawn for testing of BNP levels.~   "|||2017-02-18 14:56:49.306604|2017-02-18 14:56:49.306604
NCT00580242|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-03-06|||November 2007||2007-11-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia|A Phase I Dose Escalating Study of Bortezomib and Lenalidomide in Patients With Untreated or Previously Treated, Primary and Secondary Non 5q- Del Myelodysplasia|Completed||Phase 1|23|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 14:56:49.397334|2017-02-18 14:56:49.397334
NCT00580229|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-08-10|2013-05-28||December 2007||2007-12-01|May 2016|2016-05-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.|A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.|Completed||Phase 2/Phase 3|50|Actual|University of South Florida|An area of weakness to the study was the lack of direct comparison group.This was a single university study with two sites the cost,practicality of performing a noninferiority trial comparing these two pretreatment strategies was not feasible.|1|||f||||f||||||||No||2017-02-18 14:56:49.514801|2017-02-18 14:56:49.514801
NCT00580216|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-02-19||2016-02-19|December 2007||2007-12-01|February 2016|2016-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|BOREALIS-AF||Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation|A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation|Terminated||Phase 3|3773|Actual|Sanofi||2||early discontinuation based on strategic sponsor decision not driven by any safety concern|f||||t||||||||||2017-02-18 14:56:49.767783|2017-02-18 14:56:49.767783
NCT00580203|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-12-16|||February 2004||2004-02-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers|Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers|Active, not recruiting||N/A|1307|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Tissue and peripheral blood~   "|||2017-02-18 14:56:50.737858|2017-02-18 14:56:50.737858
NCT00580190|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-09-11|||September 2007||2007-09-01|September 2009|2009-09-01|February 2008|Actual|2008-02-01|||||Interventional|||Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy Subjects|A Phase I, Randomized, Placebo Controlled, Parallel Group, Single Dose Study To Evaluate The Effects Of PF-00572778 And Alprazolam On A Naloxone Challenge In Healthy Adult Subjects|Terminated||Phase 1|47|Actual|Pfizer||3||"Date of termination was Feb. 7, 2008. Reasons of termination were due to elevation of liver~   function tests and long elimination half-life of the compound."|f||||f||||||||||2017-02-18 14:56:50.833161|2017-02-18 14:56:50.833161
NCT00580177|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2007-12-21|||January 2000||2000-01-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|BOOP||PHS, Lichtenstein Mesh, and PerFixPlug for Primary Inguinal Hernia Repair - 3 Years Results|Prolene Hernia System, Lichtenstein Mesh, and Plug-and-Patch for Primary Inguinal Hernia Repair - Three Year Outcome of a Prospective Randomised Controlled Trial|Completed||Phase 4|472|Actual|Göteborg University||3|||f||||f||||||||||2017-02-18 14:56:50.930294|2017-02-18 14:56:50.930294
NCT00580164|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-12-29|||January 2006||2006-01-01|December 2015|2015-12-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Observational|||The Role of Splinting in Fingertip Injuries|The Role of Splinting in Fingertip Injuries|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||2|Very few subjects were enrolled. Therefore, the study was terminated.|f||||f||||||||||2017-02-18 14:56:51.051553|2017-02-18 14:56:51.051553
NCT00580151|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-02-10|2013-02-08||June 2004||2004-06-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|clonidine||The Use of Clonidine in Pain and Anxiety Associated With Acute Burn Injury in Children|The Use of Clonidine in Pain and Anxiety Associated With Acute Burn Injury in Children|Terminated||N/A|9|Actual|The University of Texas Medical Branch, Galveston|No Adverse Events Recorded.|2||Closed due to no response from PI to IRB|f||||f||||||||||2017-02-18 14:56:51.138307|2017-02-18 14:56:51.138307
NCT00580138|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-11-09|2010-05-06||May 2005||2005-05-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Real-Time Internet Evaluation of Swallowing|Real-Time Internet Evaluation of Oropharyngeal Dysphagia|Completed||N/A|30|Actual|University of Arkansas|||1||f||||f||||||||||2017-02-18 14:56:51.466107|2017-02-18 14:56:51.466107
NCT00580125|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-04-16||2009-09-09|November 2007||2007-11-01|January 2011|2011-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia|A Phase 2, Multicenter, Double-Blind, Randomized, Fixed Dose, Parallel Group, 3-Week Inpatient Treatment Study To Evaluate The Dose-Response Relationship, Safety, Efficacy, And Pharmacokinetics Of PF-00217830 Compared With Placebo, Using Aripiprazole As A Positive Control, In The Treatment Of Acute Exacerbation Of Schizophrenia|Completed||Phase 2|164|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 14:56:51.688379|2017-02-18 14:56:51.688379
NCT00580112|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-02-24|||June 2007||2007-06-01|February 2014|2014-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer|Phase II, Multicenter, Open-label, Clinical Trial of Trabectedin (Yondelis) in Metastatic Breast Cancer Patients With Triple Negative Profile (ER-, PR-, HER2-), HER2 Overexpressing Tumors and BRCA1 or BRCA2 Mutation Carriers|Completed||Phase 2|127|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 14:56:51.909946|2017-02-18 14:56:51.909946
NCT00122486|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2006-07-28|||July 2004||2004-07-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV|Phase 2 Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV|Completed||Phase 2|1200||FHI 360|||||f||||||||||||||2017-02-18 17:35:06.533618|2017-02-18 17:35:06.533618
NCT00580086|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-12-23|||November 2006||2006-11-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy|Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy|Completed||N/A|19|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||t||||||||||2017-02-18 14:56:52.158982|2017-02-18 14:56:52.158982
NCT00580073|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2010-10-15|||December 2007||2007-12-01|October 2010|2010-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum|A Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of the Rectum|Completed||Phase 2|6|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:56:52.273535|2017-02-18 14:56:52.273535
NCT00580060|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-06-09|||December 2003||2003-12-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity|Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity|Completed||Early Phase 1|20|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:56:52.37776|2017-02-18 14:56:52.37776
NCT00580047|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-01-02|||December 2003||2003-12-01|January 2014|2014-01-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants|Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplant|Unknown status|Active, not recruiting|N/A|110|Anticipated|University of Nebraska||3|||f||||t||||||||||2017-02-18 14:56:52.479953|2017-02-18 14:56:52.479953
NCT00580034|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-05-02|2014-02-05||February 2003||2003-02-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||Cohort of patients who actually received at least 1 donor lymphocyte infusion (DLI). DLI dosages thus ranged from 1×104 CD3+ cells/kg to 3.27 ×108 CD3+ cells/kg.|Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath|Allogeneic (Allo) Non-Myeloablative Stem Cell Transplantation (SCT) Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath-1H|Completed||Phase 2|176|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:56:52.599625|2017-02-18 14:56:52.599625
NCT00580021|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-01-27|||January 2006||2006-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Clinical Outcomes in Hereditary Cancer|Clinical Outcomes in Hereditary Cancer|Withdrawn||N/A|0|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Once potential subjects are identified, pathology records will be reviewed to establish~     which of the potential subjects have archived pathology material available at MSKCC. It is~     important to note that the material does not have to be tumor and, in fact, benign tissue,~     such as uninvolved lymph node, will be sought by preference. However, tumor tissue will be~     used if no benign tissue is available.~   "|||2017-02-18 14:56:52.882338|2017-02-18 14:56:52.882338
NCT00580008|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2016-04-19|||December 2007||2007-12-01|April 2016|2016-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|ELUCIDATE)||Evaluation Using Computed Tomography Angiography (CTA) to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)|Evaluation Using CTA to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)|Completed||N/A|178|Actual|William Beaumont Hospitals|||1||f||||t||||||Samples With DNA|"~     Serum banking~   "|||2017-02-18 14:56:52.986647|2017-02-18 14:56:52.986647
NCT00579995|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-06-25|||May 2005||2005-05-01|June 2010|2010-06-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|PROTECt||A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate|A Prospective, Randomized Trial Comparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Cardiac Catheterization|Unknown status|Recruiting|N/A|140|Anticipated|University of Nebraska||2|||f||||f||||||||||2017-02-18 14:56:53.074993|2017-02-18 14:56:53.074993
NCT00579982|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-11-02|2009-06-04||January 2008||2008-01-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder|An Open-Label Trial Measuring Satisfaction and Convenience of Two Formulations of Lamotrigine in Subjects With a Mood Disorder|Completed||Phase 3|97|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:56:53.190464|2017-02-18 14:56:53.190464
NCT00579969|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-01-29|||December 2003||2003-12-01|January 2010|2010-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Comparison of Latanoprost Vs. Timolol|Comparison of the Effects of Latanoprost and Timolol on Aqueous Humor Dynamics in Ocular Hypertensive Patients|Completed||Phase 2|30|Anticipated|University of Nebraska||2|||f||||f||||||||||2017-02-18 14:56:56.066145|2017-02-18 14:56:56.066145
NCT00579956|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2008-06-03|||December 2007||2007-12-01|August 2007|2007-08-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|ATOM||A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis|A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis|Unknown status|Recruiting|N/A|750|Anticipated|University of Oxford||2|||f||||t||||||||||2017-02-18 14:56:56.166184|2017-02-18 14:56:56.166184
NCT00579943|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2008-06-03|||May 2001||2001-05-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants|Development of Cerebral Autoregulation in Very Low Birth Weight Infants|Completed||N/A|200|Anticipated|University of Arkansas|||1||f||||f||||||||||2017-02-18 14:56:56.276449|2017-02-18 14:56:56.276449
NCT00579930|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-02-24|||December 1993||1993-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Cytogenetic and Molecular Genetic Studies in Bone Sarcomas|Cytogenetic and Molecular Genetic Studies in Bone Sarcomas|Completed||N/A|1|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Tumor Tissue~   "|||2017-02-18 14:56:56.371785|2017-02-18 14:56:56.371785
NCT00579917|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2009-01-05|||January 2005||2005-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|BMT/SCT||Behavioral Intervention For BMT/SCT Survivors|Cognitive Behavioral Intervention for BMT/SCT Survivors: Looking Forward|Completed||N/A|133|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:56:56.459035|2017-02-18 14:56:56.459035
NCT00579904|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-08-01|||April 2006||2006-04-01|January 2008|2008-01-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||CCRC: The Effects of Walnuts, Walnut-Oil, Almonds and Fish Oils on Glucose Homeostasis in Polycystic Ovary Syndrome (PCOS)|CCRC: Walnuts, Walnut-Oil, Glucose Homeostasis, PCOS|Unknown status|Recruiting|N/A|96|Anticipated|University of California, Davis||2|||f||||t||||||||||2017-02-18 14:56:56.560405|2017-02-18 14:56:56.560405
NCT00579891|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-02-02|||March 1989||1989-03-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Tissue and Serum Collection From Colorectal Cancer Patients|Tissue and Serum Collection From Colorectal Cancer Patients|Active, not recruiting||N/A|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     serum tissue~   "|||2017-02-18 14:56:56.669624|2017-02-18 14:56:56.669624
NCT00579878|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-01-02|||December 1999||1999-12-01|January 2014|2014-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis|Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations (Leflunomide-Hydroxychloroquine-Sulfasalazine or Methotrexate-Hydroxychloroquine-Sulfasalazine) in the Treatment of Rheumatoid Arthritis|Completed||Phase 3|70|Actual|University of Nebraska||3|||f||||t||||||||||2017-02-18 14:56:59.150232|2017-02-18 14:56:59.150232
NCT00579865|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-01-13|||May 2005||2005-05-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Quality Of Life in Patients With Malignant Biliary Obstruction|Impact of Biliary Drainage on Quality Of Life in Patients With Malignant Biliary Obstruction|Completed||N/A|124|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:56:59.275587|2017-02-18 14:56:59.275587
NCT00579852|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-01-31|||November 2006||2006-11-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer Tumors|A Prospective Trial to Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer Tumors|Completed||N/A|37|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:56:59.38104|2017-02-18 14:56:59.38104
NCT00579839|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-01-19|||October 2006||2006-10-01|January 2012|2012-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Trial of Immediate vs. Delayed Cord Clamping in the Preterm Neonate|A Randomized Controlled Trial of Immediate Versus Delayed Cord Clamping in the Preterm Neonate|Completed||N/A|200|Actual|University of Oklahoma||2|||f||||t||||||||||2017-02-18 14:56:59.489575|2017-02-18 14:56:59.489575
NCT00579826|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-05-11|||October 2006||2006-10-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study of Breast Cancer Prevention by Letrozole in High Risk Women|Study of Breast Cancer Prevention by Letrozole in High Risk Women|Completed||Phase 2|55|Actual|University of Kansas Medical Center||2|||f||||t||||||||No|Global results will be published.|2017-02-18 14:56:59.601606|2017-02-18 14:56:59.601606
NCT00579813|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-08-22|2011-02-22||April 2005||2005-04-01|August 2011|2011-08-01|January 2011|Actual|2011-01-01|January 2009|Actual|2009-01-01||Interventional|||Mechanisms Underlying Metabolic Syndrome in Obesity|Mechanisms Underlying Metabolic Syndrome in Obesity|Completed||Phase 4|70|Actual|University of Arkansas||2|||f||||f||||||||||2017-02-18 14:56:59.71424|2017-02-18 14:56:59.71424
NCT00579800|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-05-09|||July 2007||2007-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation|Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation|Completed||N/A|76|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:57:00.116982|2017-02-18 14:57:00.116982
NCT00579787|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-11-30|||January 2004||2004-01-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Prospective Study Assessing Emotional, Sexual and Quality of Life Concerns Of Women Undergoing Removal of the Cervix Versus Removal of the Uterus,Ovaries and Fallopian Tubes For Treatment Of Early Stage Cervical Cancer|A Prospective Study Assessing the Emotional, Sexual and Quality of Life Concerns Of Women Undergoing Radical Trachelectomy Versus Radical Hysterectomy For Treatment Of Early Stage Cervical Cancer|Completed||N/A|72|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:57:00.221272|2017-02-18 14:57:00.221272
NCT00579774|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-04-08|||January 2007||2007-01-01|April 2014|2014-04-01|October 2011|Actual|2011-10-01|October 2009|Actual|2009-10-01||Interventional|||Effects of Glycoxidative Stress on Human Aging|Effects of Glycoxidative Stress on Human Aging|Completed||N/A|438|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 14:57:00.32029|2017-02-18 14:57:00.32029
NCT00579761|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2015-12-10||||||December 2015|2015-12-01||||||||Observational|||Retrospective Review of Management of Infective Endocarditis|A Retrospective Review of the Management of Infective Endocarditis in Patients at Virginia Commonwealth University Medical Center From 1996-2006|Withdrawn||N/A|0|Actual|Virginia Commonwealth University|||1|Per PI on 12/9/15 - No patients were ever enrolled in this study|f||||f||||||||||2017-02-18 14:57:00.640557|2017-02-18 14:57:00.640557
NCT00579748|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2007-12-21|||June 2005||2005-06-01|December 2007|2007-12-01|August 2008|Anticipated|2008-08-01|||||Observational|OCT||Optical Coherence Tomography of the Gastrointestinal Tract|Optical Coherence Tomography of the Gastrointestinal Tract|Unknown status|Active, not recruiting|N/A|4|Actual|University of California, Irvine|||1||f||||t||||||Samples Without DNA|"~     pinch biopsies blood~   "|||2017-02-18 14:57:00.725752|2017-02-18 14:57:00.725752
NCT00579735|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-03-03|||March 2005||2005-03-01|March 2015|2015-03-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Observational|||Histologic Diagnoses of Incidentally Detected Lesions on MRI|Histologic Diagnoses of Incidentally Detected Lesions on MRI|Withdrawn||N/A|0|Actual|University of Arkansas|||1|No subjects were ever enrolled. This study was closed at the IRB.|f||||f||||||||||2017-02-18 14:57:00.815418|2017-02-18 14:57:00.815418
NCT00579709|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-09-22|||July 2002||2002-07-01|September 2016|2016-09-01|June 2027|Anticipated|2027-06-01|December 2006|Actual|2006-12-01||Interventional|884||Thymus Transplantation With Immunosuppression|Thymus Transplantation With Immunosuppression, #884|Active, not recruiting||Phase 1|15|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:57:00.897358|2017-02-18 14:57:00.897358
NCT00579696|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-12-16|||February 2007||2007-02-01|December 2015|2015-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||The Queens Library HealthLink Project|The Queens Library HealthLink Project|Completed||N/A|2789|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:57:01.028932|2017-02-18 14:57:01.028932
NCT00579683|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-02-03|||August 2004||2004-08-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer|A Prospective Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer|Completed||N/A|228|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Tumor biopsy material will be processed to obtain RNA for analysis of EGFR sequence.~     Sequencing of additional candidate genes and other studies will follow if sufficient~     material is available.~   "|||2017-02-18 14:57:01.121973|2017-02-18 14:57:01.121973
NCT00579670|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-09-16|2010-04-02||October 2007||2007-10-01|September 2010|2010-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|TRITON||Treatment of Schizophrenic Patients With Ziprasidone|Treatment of Schizophrenic Patients With Geodon; Capsules/Oral Suspension/Solution for Injection (Ziprasidone)|Completed||N/A|450|Actual|Pfizer|Additional descriptive tables were identified as required after review of the originally planned study tables; many subjects included in the tables had received ziprasidone doses above those specified in the summary of product characteristics (SmPC).||1||f||||f||||||||||2017-02-18 14:57:01.277128|2017-02-18 14:57:01.277128
NCT00579657|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2016-03-06|||August 2007||2007-08-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|March 2010|Actual|2010-03-01||Interventional|PROFIMET||Protein, Fiber, and Metabolic Syndrome - The PROFIMET Study|Effects of High Protein and High Cereal Fiber Diets on Insulin Sensitivity in Overweight and Obese Subjects With the Metabolic Syndrome - The PROFIMET Study|Completed||N/A|111|Actual|German Institute of Human Nutrition||4|||f||||f||||||||||2017-02-18 14:57:04.825279|2017-02-18 14:57:04.825279
NCT00579644|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-01-12|||January 2001||2001-01-01|January 2010|2010-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Treatment of Early RA: Minocycline in Combination With Methotrexate vs Methotrexate Alone|Treatment of Early Rheumatoid Arthritis: Minocycline in Combination With Methotrexate Versus Methotrexate Alone|Completed||Phase 3|80|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-02-18 14:57:04.94942|2017-02-18 14:57:04.94942
NCT00579631|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2017-01-13|||June 2004||2004-06-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Adolescent Survivors of Cancer or Similar Illnesses|Health Behaviors in Adolescent Survivors of Cancer or Similar Illnesses|Active, not recruiting||N/A|148|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:57:05.048443|2017-02-18 14:57:05.048443
NCT00579618|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-08-04|||September 2006||2006-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging|Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging|Active, not recruiting||N/A|53|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Saliva or blood samples~   "|||2017-02-18 14:57:05.143238|2017-02-18 14:57:05.143238
NCT00579605|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2007-12-21|||August 2006||2006-08-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Motivational Interviewing to Promote Sustained Breastfeeding|Motivational Interviewing to Promote Sustained Breastfeeding (Native American Women)|Completed||N/A|11|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:57:05.236996|2017-02-18 14:57:05.236996
NCT00579592|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2012-06-22|||April 2006||2006-04-01|June 2012|2012-06-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation|A Pilot Study of Campath-1H Induction Therapy Combined With Rituximab®, Myfortic™ and a Short Course of Calcineurin Inhibitor Therapy to Allow for a Long Term Calcineurin Inhibitor Free Regimen After Renal Transplantation|Terminated||N/A|11|Actual|University of Wisconsin, Madison||1||Higher than expected rate of acute rejection|f||||t||||||||||2017-02-18 14:57:05.332801|2017-02-18 14:57:05.332801
NCT00579579|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-11-18|||November 2006||2006-11-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer|Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer|Active, not recruiting||N/A|229|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||t||||||||||2017-02-18 14:57:05.435532|2017-02-18 14:57:05.435532
NCT00579566|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-12-16|||June 2002||2002-06-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma|Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma|Recruiting||N/A|3000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples With DNA|"~     Tissue, Blood~   "|||2017-02-18 14:57:05.762148|2017-02-18 14:57:05.762148
NCT00579553|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-05-20|||October 2006||2006-10-01|May 2014|2014-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Comparing IM vs. Vaginal Progesterone for Pre-term Birth|Comparing Intramuscular Versus Vaginal Progesterone for Prevention of Preterm Birth.|Completed||N/A|264|Actual|University of Oklahoma||2|||f||||t||||||||||2017-02-18 14:57:05.88928|2017-02-18 14:57:05.88928
NCT00579540|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2012-10-25|||September 2007||2007-09-01|October 2012|2012-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|PCOS||Compare Effects of Flax Seed Oil, and Fish Oil on Blood Sugar Levels|CCRC: Prevention of Post-Prandial Hypoglycemia Using n-3/n-6 PUFA in PCOS|Completed||N/A|66|Actual|University of California, Davis||3|||f||||t||||||||||2017-02-18 14:57:05.994792|2017-02-18 14:57:05.994792
NCT00579527|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-12-22||2015-12-10|March 2006||2006-03-01|December 2016|2016-12-01|June 2027|Anticipated|2027-06-01|December 2011|Actual|2011-12-01||Interventional|#950||Phase I/II Thymus Transplantation With Immunosuppression #950|Phase I/II Trial of Thymus Transplantation With Immunosuppression, #950|Active, not recruiting||Phase 1/Phase 2|28|Actual|Duke University||3|||f||||t||||||||||2017-02-18 14:57:06.1049|2017-02-18 14:57:06.1049
NCT00579514|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-10-12|||March 2000||2000-03-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Interventional|||Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients|Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients|Recruiting||N/A|2530|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:57:06.25883|2017-02-18 14:57:06.25883
NCT00579501|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-04-22|2014-01-28||April 2007||2007-04-01|April 2014|2014-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma|A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (Yondelis) in Patients With Localized Myxoid / Round Cell Liposarcoma|Completed||Phase 2|29|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||t||||||||||2017-02-18 14:57:06.601207|2017-02-18 14:57:06.601207
NCT00579488|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-12-07|||July 1996||1996-07-01|December 2016|2016-12-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Clinical Significance of Germline BRCA Mutations|Clinical Significance of Germline BRCA Mutations|Recruiting||N/A|20000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Blood, Saliva, Buccal cell, Urine or Stool Tissue analysis and correlation of germline~     findings with somatic alterations within the tumor will be performed on a subset of~     individuals who have tumor tissue stored under protocol #06-107. Patients will be asked to~     fill out a baseline questionnaire on other medical, hormonal, and environmental risk~     factors.~   "|||2017-02-18 14:57:06.926026|2017-02-18 14:57:06.926026
NCT00579475|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2015-05-22|||November 2004||2004-11-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||The Effect of Mifepristone on Uterine Fibroids and Breast Tissue|The Effect of Preoperative Treatment With Mifepristone on Uterine Fibroids and Breast Tissue|Completed||Phase 1|30|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 14:57:07.022955|2017-02-18 14:57:07.022955
NCT00579462|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-11-30|||January 2003||2003-01-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer|Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer|Completed||N/A|281|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 14:57:07.122258|2017-02-18 14:57:07.122258
NCT00579449|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2014-09-19|||March 2005||2005-03-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Evaluation of a Home Visiting Program for First Time Parents|Evaluation of a Home Visiting Program for First Time Parents|Completed||N/A|343|Actual|Duke University||4|||f||||f||||||||||2017-02-18 14:57:07.233798|2017-02-18 14:57:07.233798
NCT00579436|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-08-22|||January 2007||2007-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Effects of Fish Oils on Inflammation and Insulin Resistance|Effects of Fish Oils on Inflammation and Insulin Resistance|Active, not recruiting||N/A|135|Anticipated|University of Kentucky||2|||f||||t||||||||||2017-02-18 14:57:07.334647|2017-02-18 14:57:07.334647
NCT00579423|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-03-17|||November 2000||2000-11-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|May 2003|Actual|2003-05-01||Interventional|||Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer|A Pilot Multivalent Conjugate Vaccine Trial for Patients With Biochemically Relapsed Prostate Cancer|Completed||Phase 2|30|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 14:57:07.44513|2017-02-18 14:57:07.44513
NCT00579410|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2011-03-21|||May 2004||2004-05-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule|Evaluation of Esophageal and Gastric Acid Levels in Patients Presenting With Upper Gastrointestinal Symptoms Using a Novel PH System|Completed||N/A|85|Actual|Kansas City Veteran Affairs Medical Center|||3||f||||f||||||||||2017-02-18 14:57:07.552472|2017-02-18 14:57:07.552472
NCT00579397|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-21|2009-05-26|||April 2007||2007-04-01|May 2009|2009-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Markers of Inflammation in Hematopoietic Stem Cell Transplant|Markers of Inflammation in Hematopoietic Stem Cell Transplant|Completed||N/A|30|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||2||f||||f||||||Samples With DNA|"~     2.5 mL's of whole blood are obtained one time a week for the first 100 days of transplant~   "|||2017-02-18 14:57:07.662619|2017-02-18 14:57:07.662619
NCT00579384|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-04-03||2011-08-12|October 2007||2007-10-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy|A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram Response in Patients With Photosensitive Epilepsy|Completed||Phase 2|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 14:57:07.770535|2017-02-18 14:57:07.770535
NCT00579371|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2010-06-25|||January 2008||2008-01-01|June 2010|2010-06-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|||Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus|Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus|Unknown status|Enrolling by invitation|Phase 1/Phase 2|10|Anticipated|University of Nebraska||1|||f||||f||||||||||2017-02-18 14:57:07.882479|2017-02-18 14:57:07.882479
NCT00579358|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-11-05|||November 2007||2007-11-01|November 2010|2010-11-01|November 2010|Anticipated|2010-11-01|||||Observational|||Molecular Basis of Congenital Heart Defects|Molecular Basis of Congenital Heart Defects|Unknown status|Recruiting|N/A|150|Anticipated|University of California, Irvine|||1||f||||f||||||Samples With DNA|"~     blood samples~   "|||2017-02-18 14:57:07.977545|2017-02-18 14:57:07.977545
NCT00579345|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-11-30|2011-09-05||October 2007||2007-10-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup|A Phase III, Single-Blind, Multi-Center, Extension Study to Evaluate Safety and Tolerability of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adult and Elderly Subjects Who Participated in Study V58P4, With Subset Analyses of Immunogenicity and Evaluation of Concomitant Polysaccharide Pneumococcal Vaccine (Elderly).|Completed||Phase 3|1522|Actual|Novartis||4|||f||||f||||||||||2017-02-18 14:57:08.183153|2017-02-18 14:57:08.183153
NCT00579332|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-04-26|||January 2005||2005-01-01|April 2016|2016-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Effects of Brassica or Indole-3-carbinol on Prostatectomy Patients With PSA Recurrence|Effects of Brassica or Indole-3-Carbinol on Prostatectomy Patients With PSA Recurrenc|Completed||Phase 2/Phase 3|16|Actual|Vanderbilt University||3|||f||||t||||||||||2017-02-18 14:57:10.123316|2017-02-18 14:57:10.123316
NCT00579319|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-03-03|||April 2005||2005-04-01|March 2015|2015-03-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Observational|||Use of Breast MRI for Local Staging|Use of Breast MRI for Local Staging|Withdrawn||N/A|0|Actual|University of Arkansas|||1|There were no subjects ever enrolled. Study was closed at the IRB.|f||||f||||||||||2017-02-18 14:57:10.230084|2017-02-18 14:57:10.230084
NCT00579306|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-05-05|||June 2005||2005-06-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|April 2012|Actual|2012-04-01||Observational|LIMITS||Levels of Inflammatory Markers in the Treatment of Stroke—An SPS3 Ancillary Study|Levels of Inflammatory Markers in the Treatment of Stroke|Active, not recruiting||N/A|1244|Actual|Columbia University|||1||f||||t||||||Samples Without DNA|"~     blood serum (ancillary study)~   "|Undecided||2017-02-18 14:57:10.316862|2017-02-18 14:57:10.316862
NCT00579293|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-07-24|||August 2004||2004-08-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer|Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer|Completed||N/A|100|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:57:10.566214|2017-02-18 14:57:10.566214
NCT00579280|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-01-13|||July 2007||2007-07-01|February 2009|2009-02-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD|A Randomized, Double-blind, Placebo-controlled Study of Quetiapine SR and Divalproex Sodium ER on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder.|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|University of South Florida||3|||f||||f||||||||||2017-02-18 14:57:10.646131|2017-02-18 14:57:10.646131
NCT00579267|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-02-13|||February 2004||2004-02-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)|Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)|Completed||N/A|230|Actual|University of South Florida|||1||f||||f||||||||||2017-02-18 14:57:10.756546|2017-02-18 14:57:10.756546
NCT00579254|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-06-18|2009-05-01||December 2007||2007-12-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|EXCEL||Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors|Real Life Experience With Caduet Evaluating Effectiveness, Safety and Tolerability in the Management of Cardiovascular Risk Factors (EXCEL Study)|Terminated||Phase 4|112|Actual|Pfizer|The objectives for this terminated study could not be assessed due to limited data available. (Efficacy parameters were to include BP, heart rate, lipid profile, urine albumin.)||1|See the termination reason in detailed description.|f||||f||||||||||2017-02-18 14:57:10.848973|2017-02-18 14:57:10.848973
NCT00579241|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-07-19|||April 2006||2006-04-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|March 2010|Actual|2010-03-01||Interventional|||Detection of Ultrasound Contrast Signals in the Cerebral Circulation|Detection of Ultrasound Contrast Signals in the Cerebral Circulation During Stress Echocardiography|Withdrawn||N/A|0|Actual|University of Nebraska||1|||f||||f||||||||||2017-02-18 14:57:11.020295|2017-02-18 14:57:11.020295
NCT00579228|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2008-06-02|||March 2007||2007-03-01|June 2008|2008-06-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Vascular Risk Progression in Normal and Diabetic Control Subjects.|Vascular Risk Progression in Normal and Diabetes Control Subjects|Unknown status|Recruiting|N/A|90|Anticipated|University of Nebraska|||3||f||||f||||||||||2017-02-18 14:57:11.124862|2017-02-18 14:57:11.124862
NCT00579215|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2009-03-17|||November 2006||2006-11-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Lung Cancer Informational Study (LCIS)|Lung Cancer Informational Study (LCIS)|Completed||N/A|8|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:57:11.217459|2017-02-18 14:57:11.217459
NCT00579202|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2007-12-26|||October 2007||2007-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer|The Gambro Polyflux HD-C4 Small Ease of Use Study|Completed||N/A|24|Actual|Gambro Renal Products, Inc.|||1||f||||f||||||||||2017-02-18 14:57:11.333633|2017-02-18 14:57:11.333633
NCT00579189|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-11-29||2012-11-28|January 2006||2006-01-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes|Safety and Efficacy of a Topical Otic Formulation in the Treatment of Acute Otitis Media With Otorrhea Through Tympanostomy Tubes (AOMT)|Completed||Phase 3|776|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:57:11.421805|2017-02-18 14:57:11.421805
NCT00579176|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2008-08-07|||December 2007||2007-12-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:57:11.533227|2017-02-18 14:57:11.533227
NCT00579163|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-09-06|||December 1994||1994-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers|Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers|Recruiting||Phase 1/Phase 2|1000|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Blood, Saliva, Tumor Tissue, Normal Tissue~   "|||2017-02-18 14:57:11.577259|2017-02-18 14:57:11.577259
NCT00579150|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-05-24|||January 2009||2009-01-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|Exenatide||Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy|Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy|Terminated||Phase 4|7|Actual|AstraZeneca|||2||f||||t||||||||||2017-02-18 14:57:11.683044|2017-02-18 14:57:11.683044
NCT00579137|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-06-28|2013-03-30||October 2007||2007-10-01|June 2013|2013-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|MASCI||Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders|CD45 and Alemtuzumab Monoclonal Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Severe Combined Immunodeficiency Disease (SCID) And Other Primary Immunodeficiency Disorders|Terminated||Phase 1/Phase 2|3|Actual|Baylor College of Medicine||1||slow accrual|f||||t||||||||||2017-02-18 14:57:11.874078|2017-02-18 14:57:11.874078
NCT00579124|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-11-14|||March 2005||2005-03-01|November 2016|2016-11-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|CliniMACs||CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion|CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation With the CliniMACs Device for T and B Cell Depletion|Active, not recruiting||Phase 2|85|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-02-18 14:57:12.131157|2017-02-18 14:57:12.131157
NCT00579111|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-03-29|2012-07-03||June 2007||2007-06-01|March 2016|2016-03-01|October 2010|Actual|2010-10-01|February 2009|Actual|2009-02-01||Interventional|||Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)|Reduced-Intensity Preparative Regiment With Fludarabine, Busulfan, And Alemtuzumab (Campath 1H) Followed By Allogeneic Hematopoietic Stem Cell Transplant For Malignant And Non-Malignant Hematological Diseases|Terminated||Phase 1/Phase 2|4|Actual|Baylor College of Medicine||2||slow accrual|f||||t||||||||||2017-02-18 14:57:12.244132|2017-02-18 14:57:12.244132
NCT00579098|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-03-21|2013-04-04||December 2007||2007-12-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ATTAC||The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation|Atorvastatin for Prevention of Atrial Fibrillation Recurrence Following Pulmonary Veins Isolation: A Double-Blind, Placebo-Controlled, Randomized Pilot Trial|Completed||Phase 4|125|Actual|Mayo Clinic|The population was restricted to patients who did not have an indication for statin treatment. The lack of transtelephonic or prolonged Holter monitoring likely resulted in underestimation of the rate of asymptomatic episodes of AF.|2|||f||||f||||||||||2017-02-18 14:57:12.582698|2017-02-18 14:57:12.582698
NCT00579085|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2010-06-15|||September 2006||2006-09-01|June 2010|2010-06-01|November 2009|Actual|2009-11-01|September 2008|Actual|2008-09-01||Interventional|||Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS|Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS|Completed||Phase 2|40|Anticipated|Drexel University||2|||f||||t||||||||||2017-02-18 14:57:13.814818|2017-02-18 14:57:13.814818
NCT00579072|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-09-07|||August 2006||2006-08-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older|The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older|Recruiting||N/A|220|Anticipated|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||||||2017-02-18 14:57:13.918074|2017-02-18 14:57:13.918074
NCT00579059|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2012-02-29|2009-05-20||May 2004||2004-05-01|February 2012|2012-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Maxim® Knee Pop-Top® Tibia vs. Regular Maxim® Knee Tibia|A Randomized Data Collection of the Maxim® Knee System With Removable Molded Polyethylene Tibia and the Regular Maxim® Knee System|Terminated||N/A|31|Actual|Zimmer Biomet|Study was terminated after enrollment failed to produce sufficient data to be analyzed.|2||The study sponsor canceled the study.|f||||f||||||||||2017-02-18 14:57:14.041449|2017-02-18 14:57:14.041449
NCT00579046|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-10-29|||November 2008||2008-11-01|October 2013|2013-10-01|October 2009|Anticipated|2009-10-01|October 2009|Actual|2009-10-01||Interventional|ELAB||Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease|Erythropoietin Treatment of Anemia Complicating Chronic Obstructive Pulmonary Disease: Functional Impact During Exertion|Withdrawn||Phase 3|0|Actual|Assistance Publique - Hôpitaux de Paris||1||no patient recruiting|f||||t||||||||||2017-02-18 14:57:14.38012|2017-02-18 14:57:14.38012
NCT00579033|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-19|||May 2007||2007-05-01|March 2007|2007-03-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Somatosensory Processing in Focal Hand Dystonia|Tactile Operant Conditioning To Alleviate Focal Hand Dystonia Symptoms|Unknown status|Recruiting|N/A|24|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 14:57:14.495378|2017-02-18 14:57:14.495378
NCT00579020|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-12-03||2012-12-03|December 2007||2007-12-01|December 2012|2012-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates|An Evaluation of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates|Terminated||Phase 2|144|Actual|Alcon Research||3||Management decision|f||||f||||||||||2017-02-18 14:57:14.598912|2017-02-18 14:57:14.598912
NCT00579007|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-04-28|||March 2003||2003-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations|Decision-making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Counseling and Testing for BRCA1/2 Mutations|Active, not recruiting||N/A|224|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||||||2017-02-18 14:57:14.703172|2017-02-18 14:57:14.703172
NCT00578994|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-05-13|||March 2006||2006-03-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Observational|||A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System|A Prospective, Non-randomized, Multicenter Study of the Oxford® Meniscal Unicompartmental Knee System|Active, not recruiting||N/A|388|Actual|Zimmer Biomet|||1||f||||t||||||||Undecided||2017-02-18 14:57:14.813917|2017-02-18 14:57:14.813917
NCT00578981|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-02-01|||August 2007||2007-08-01|February 2016|2016-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women|Wiser Choices in Osteoporosis Trial: The OSTEOPOROSIS CHOICE Decision Aid to Support the Decision to Use or Not Use Bisphosphonates in Postmenopausal Women at Risk of Osteoporotic Fractures.|Completed||N/A|100|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:57:14.930122|2017-02-18 14:57:14.930122
NCT00578968|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-05-22|2012-05-22||October 2006||2006-10-01|May 2012|2012-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation|Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation|Completed||Phase 4|36|Actual|Mayo Clinic||3|||f||||f||||||||||2017-02-18 14:57:15.059114|2017-02-18 14:57:15.059114
NCT00578955|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-01-27||2012-01-26|December 2007||2007-12-01|January 2012|2012-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis|A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical and Anti-Microbial Efficacy and Safety of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone in the Treatment of Subjects With Blepharoconjunctivitis|Completed||Phase 3|417|Actual|InSite Vision||3|||f||||f||||||||||2017-02-18 14:57:16.126859|2017-02-18 14:57:16.126859
NCT00578942|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-05-23|2014-04-25||May 2005||2005-05-01|May 2016|2016-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||"Cohort of subjects who actually received at least 1 donor lymphocyte infusion (DLI).~DLI dosages thus ranged from 1×104 CD3+ cells/kg to 3.27 ×108 CD3+ cells/kg."|Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath|Allogeneic Non-myeloablative Stem Cell Transplantation Utilizing Matched Family Member Stem Cells Purged Using Campath-1H|Completed||Phase 2|48|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:57:16.221441|2017-02-18 14:57:16.221441
NCT00578929|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-02-23|2010-01-14||September 2007||2007-09-01|February 2010|2010-02-01||||November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients|Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients|Completed||Phase 3|2388|Actual|Alcon Research||4|||f||||f||||||||||2017-02-18 14:57:16.563319|2017-02-18 14:57:16.563319
NCT00578916|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2008-07-30|||January 2008||2008-01-01|July 2008|2008-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects|Pharmacokinetics and Metabolism of [14C] BMS-690514 in Healthy Male Subjects|Completed||Phase 1|17|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 14:57:17.157336|2017-02-18 14:57:17.157336
NCT00578903|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-03-24|2013-08-04||February 2002||2002-02-01|March 2016|2016-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia|Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia, Using Matched Unrelated Donors and Mismatched Related Donors (SAA MUD)|Terminated||Phase 2|22|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:57:17.266002|2017-02-18 14:57:17.266002
NCT00578890|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-09-14|||June 2008||2008-06-01|June 2011|2011-06-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|DIPIOS||a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis|Comparison of Medical and Medical-surgical Management of Diabetic Foot Osteomyelitis|Withdrawn||Phase 4|0|Actual|Assistance Publique - Hôpitaux de Paris||1||not enough recruitment|f||||f||||||||||2017-02-18 14:57:17.600922|2017-02-18 14:57:17.600922
NCT00578877|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-03-15|||January 2008||2008-01-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Contraceptive Effectiveness and Safety of the SILCS Diaphragm|Contraceptive Effectiveness and Safety Study of the SILCS Diaphragm: the Pivotal Study|Completed||Phase 2/Phase 3|450|Actual|CONRAD||2|||f||||t||||||||||2017-02-18 14:57:17.708914|2017-02-18 14:57:17.708914
NCT00578864|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-06-25|2012-10-05||March 2007||2007-03-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|July 2009|Actual|2009-07-01||Interventional|PEPI||Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma|PEPI: Protracted Etoposide in a Phase II Upfront Window for Induction Therapy for High Risk Neuroblastoma|Completed||Phase 2|13|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-02-18 14:57:17.98391|2017-02-18 14:57:17.98391
NCT00578851|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-08-12|||April 2006||2006-04-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Observational|||A Clinical Investigation of the C2a-Taper™ Acetabular System|Post Approval Study of the C2a-Taper™ Acetabular System|Completed||N/A|28|Actual|Zimmer Biomet|||1||f||||f||||||||No||2017-02-18 14:57:18.490634|2017-02-18 14:57:18.490634
NCT00578838|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-05-06|||August 2006||2006-08-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Magnetic Resonance Study of Liver in Chemotherapy|Magnetic Resonance Study of Liver in Chemotherapy|Completed||N/A|55|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||f||||||||||2017-02-18 14:57:18.602546|2017-02-18 14:57:18.602546
NCT00578825|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2013-08-21||||||August 2013|2013-08-01||||||||Interventional|||A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome|A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome|Unknown status|Not yet recruiting|N/A|340|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 14:57:18.715152|2017-02-18 14:57:18.715152
NCT00578812|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-06-08|2012-11-29||January 2005||2005-01-01|June 2015|2015-06-01|August 2014|Actual|2014-08-01|March 2010|Actual|2010-03-01||Interventional|||PCM Cervical Disc System|A Prospective, Randomized, Controlled Clinical Investigation Comparing PCM® Cervical Disc Arthroplasty to Anterior Cervical Discectomy and Fusion: 2 Year Results From the US IDE Clinical Trial|Completed||Phase 3|494|Actual|NuVasive||2|||f||||f||||||||||2017-02-18 14:57:18.833258|2017-02-18 14:57:18.833258
NCT00578799|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-07-01|||July 2008||2008-07-01|July 2009|2009-07-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Effects of Probiotics in Patients With Ulcerative Colitis|Effects of Probiotics in Patients With Ulcerative Colitis.|Terminated||Phase 1|40|Anticipated|University of California, Irvine||2||Low recruitment|f||||t||||||||||2017-02-18 14:57:19.666593|2017-02-18 14:57:19.666593
NCT00578786|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-01-14|2012-04-12||February 2004||2004-02-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)|A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 (NCT00423748) or AMB-321 (NCT00423202)|Completed||Phase 3|383|Actual|Gilead Sciences|Analysis included those not enrolling in this study but received AMB in 1 of the 2 parent studies. At Year 3, almost half of those randomized to 2.5 mg were titrated to 5 mg and 10 mg; a third starting at 5 mg were titrated to 10 mg.|1|||f||||t||||||||||2017-02-18 14:57:19.804391|2017-02-18 14:57:19.804391
NCT00578773|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-11-29||2012-11-28|November 2007||2007-11-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea|Safety and Efficacy of a Topical Otic Formulation in the Treatment of Peri-Operative Tube Otorrhea|Completed||Phase 2|303|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 14:57:25.140788|2017-02-18 14:57:25.140788
NCT00578760|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2007-12-19|||February 2008||2008-02-01|December 2007|2007-12-01|February 2010|Anticipated|2010-02-01|||||Interventional|||Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?|Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?|Unknown status|Not yet recruiting|N/A|110|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 14:57:25.240933|2017-02-18 14:57:25.240933
NCT00578747|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-09-02|||January 2008||2008-01-01|September 2015|2015-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Do Skin Markings Reflect the Location of the Surgical Cavity During Daily Radiotherapy Treatment?|Development of Improved Target Volume Localization for Accelerated Partial Breast Irradiation- Stage I|Completed||N/A|21|Actual|British Columbia Cancer Agency|||1||f||||f||||||||||2017-02-18 14:57:25.347473|2017-02-18 14:57:25.347473
NCT00578734|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-05-01|2012-04-02||June 2007||2007-06-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|KL4-AHRF-01||Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old|A Multicenter, Randomized, Masked, Placebo-Controlled Trial to Assess the Safety and Efficacy of Lucinactant in Acute Hypoxemic Respiratory Failure in Children Up to Two Years of Age|Completed||Phase 2|165|Actual|Windtree Therapeutics||2|||f||||t||||||||||2017-02-18 14:57:25.433844|2017-02-18 14:57:25.433844
NCT00578721|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2013-01-28|||September 2008||2008-09-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Interventional|||Trial of Aspirin and Arginine Restriction in Colorectal Cancer|Phase IIA Clinical Biomarker Trial of Aspirin and Arginine Restriction in Colorectal Cancer Patients|Unknown status|Recruiting|Phase 2|24|Anticipated|University of California, Irvine||1|||f||||t||||||||||2017-02-18 14:57:26.153191|2017-02-18 14:57:26.153191
NCT00578708|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2015-03-16|||September 2003||2003-09-01|March 2015|2015-03-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|||Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER||Completed||Phase 1|35|Actual|St. Jude Medical||1|||f||||t||||||||||2017-02-18 14:57:26.255998|2017-02-18 14:57:26.255998
NCT00578695|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-06-20||2011-06-20|January 2007||2007-01-01|November 2010|2010-11-01||||June 2010|Actual|2010-06-01||Interventional|||THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation|THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation|Completed||Phase 3|652|Actual|CardioKine Inc.||2|||f||||t||||||||||2017-02-18 14:57:26.373151|2017-02-18 14:57:26.373151
NCT00578682|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-11-22|||December 2007||2007-12-01|November 2011|2011-11-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557|A Phase I, Randomized, Double-Blind, Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557, A Humanized Monoclonal Antibody With an Extended Half-Life Against Respiratory Syncytial Virus (RSV), in Healthy Adults|Completed||Phase 1|31|Actual|MedImmune LLC||4|||f||||||||||||||2017-02-18 14:57:27.010842|2017-02-18 14:57:27.010842
NCT00578669|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-08-26|||April 2008||2008-04-01|March 2012|2012-03-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms|Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms|Completed||Phase 3|206|Anticipated|Butler Hospital||2|||f||||t||||||||||2017-02-18 14:57:27.118344|2017-02-18 14:57:27.118344
NCT00578656|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-07-30|||June 2004||2004-06-01|July 2012|2012-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||An Interventional Study of Milk Allergy|The Impact of the Diet Containing Limited Amounts of Processed Milk Protein on the Natural History of IgE-Mediated Milk Hypersensitivity|Completed||Early Phase 1|220|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 14:57:27.233959|2017-02-18 14:57:27.233959
NCT00578643|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-01-20|||March 2004||2004-03-01|January 2017|2017-01-01|July 2018|Anticipated|2018-07-01|November 2017|Anticipated|2017-11-01||Interventional|MUNCHR||Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease|HLA Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease|Recruiting||Phase 2|15|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:57:27.34145|2017-02-18 14:57:27.34145
NCT00578630|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-06-30|||October 2003||2003-10-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients|Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Oncology/Bone Marrow Transplantation Patients|Active, not recruiting||N/A|128|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     peripheral blood and buccal swab~   "|||2017-02-18 14:57:27.476596|2017-02-18 14:57:27.476596
NCT00578617|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-12-03|2011-07-20||September 2006||2006-09-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|February 2009|Actual|2009-02-01||Interventional|CABANA||Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial|Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation - Pilot Trial|Completed||N/A|60|Actual|Mayo Clinic|Limited number enrolled. Study was designed to demonstrate feasibility for a pivotal trial, but small enrollment limits the final conclusions that can be drawn from a simple 'time to first atrial fibrillation recurrence.'|2|||f||||t||||||||||2017-02-18 14:57:27.58538|2017-02-18 14:57:27.58538
NCT00578604|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-05-24|||September 2007||2007-09-01|May 2011|2011-05-01||||||||Observational|||Non-Invasive Assessment of Wound Healing With Optical Methods|Non-Invasive Assessment of Wound Healing With Optical Methods|Unknown status|Recruiting|N/A|100|Anticipated|Drexel University|||2||f||||f||||||||||2017-02-18 14:57:28.018208|2017-02-18 14:57:28.018208
NCT00578591|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-07-06|||June 2007||2007-06-01|July 2012|2012-07-01||||||||Interventional|Rituximab GVHD||Rituximab for GVHD|CHIMERIC MONOCLONAL CD-20 ANTIBODY (RITUXIMAB) FOR STEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE (SR-AGVHD): A PILOT STUDY|Withdrawn||Phase 2|0|Actual|Baylor College of Medicine||1||No eligible patients were identified so the study was terminated.|f||||t||||||||||2017-02-18 14:57:28.106423|2017-02-18 14:57:28.106423
NCT00578578|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2007-12-19|||September 2005||2005-09-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|June 2007|Actual|2007-06-01||Interventional|Omega-3||Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels|Protocol for a Randomized, Placebo-Controlled, Double-Blinded Trial to Study the Effects of Supplementary Omega-3 Fatty Acids on Serum C-Reactive Protein Levels|Terminated||Phase 4|53|Actual|The Cleveland Clinic||2||CRP is no longer SOC - enrollment halted and will analyze available data.|f||||t||||||||||2017-02-18 14:57:28.216924|2017-02-18 14:57:28.216924
NCT00578565|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-09-25|2012-05-21||May 2007||2007-05-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Rituximab in Rheumatoid Arthritis Lung Disease|Rituximab for the Treatment of Rheumatoid Arthritis-Associated Interstitial Pneumonia: A Pilot Study|Completed||Phase 3|10|Actual|Mayo Clinic|Given the small number of patients, it could not be determined whether patients with nonspecific interstitial pneumonia (NSIP) or usual interstitial pneumonia (UIP) were more likely to respond. Further research is needed in less advanced disease.|1|||f||||f||||||||||2017-02-18 14:57:28.330331|2017-02-18 14:57:28.330331
NCT00578552|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-04-15|2010-11-01||October 2007||2007-10-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||Gabapentin for Smoking Cessation|Gabapentin for Smoking Abstinence|Completed||Phase 2|80|Actual|Mayo Clinic|The original intent was to enroll a total of 120 subjects. However, due to the high study dropout rate, a review of the primary endpoint was performed after 80 subjects were enrolled and a decision was made to discontinue further enrollment.|3|||f||||f||||||||||2017-02-18 14:57:28.722554|2017-02-18 14:57:28.722554
NCT00578539|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-03-24|2014-08-28||October 2007||2007-10-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|REGALE|A total of 24 patients were enrolled on the study and all of them received the conditioning treatment and the transplant.|T-Reg Cell Kinetics, Stem Cell Transplant, REGALE|T-Regulatory Cell Kinetics for Patients Receiving Alemtuzamb and Undergoing Stem Cell Transplantation From HLA Mismatched-Related, or HLA Matched, or One Antigen Mismatched-Unrelated Donors|Terminated||N/A|24|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:57:29.206042|2017-02-18 14:57:29.206042
NCT00578526|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-01-18|||April 2008||2008-04-01|September 2011|2011-09-01||||||||Interventional|SPRUCE||SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial|A Randomized, Placebo-controlled Phase II Study to Compare the Efficacy and Safety of SU011248 Versus Placebo in Patients With Advanced Urothelial Transitional Cell Carcinoma Who Have Failed or Are Intolerant to Cisplatin-based Chemotherapy|Unknown status|Active, not recruiting|Phase 2|64|Anticipated|AHS Cancer Control Alberta||2|||f||||t||||||||||2017-02-18 14:57:29.490327|2017-02-18 14:57:29.490327
NCT00578513|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-02-11|||June 2000||2000-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:57:29.760573|2017-02-18 14:57:29.760573
NCT00578500|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2007-12-19|||January 2000||2000-01-01|January 2002|2002-01-01|January 2010|Anticipated|2010-01-01|||||Interventional|HFPP||Fertility Preservation by Ovarian and Oocyte Cryopreservation|Study That Establishes the Potential of Fertility Preservation in Young Female Patients by Oocyte in Vitro Maturation and Cryopreservation and Ovarian Cortex Cryopreservation and Transplantation|Unknown status|Recruiting|Phase 2/Phase 3|200|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-02-18 14:57:29.806762|2017-02-18 14:57:29.806762
NCT00578487|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-02-11|||November 2005||2005-11-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:57:29.913316|2017-02-18 14:57:29.913316
NCT00578474|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-11-29||2012-11-28|December 2005||2005-12-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes|Safety and Efficacy of a Topical Otic Formulation in the Treatment of Acute Otitis Media With Otorrhea Through Tympanostomy Tubes (AOMT)|Completed||Phase 3|911|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:57:29.96109|2017-02-18 14:57:29.96109
NCT00578461|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-03-24|2014-08-28||October 2007||2007-10-01|March 2016|2016-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|REGKINE|A total of 26 patients were enrolled on the study and all of them received the conditioning treatment and the transplant.|T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE|T-Regulatory Cell Kinetics Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation|Terminated||N/A|26|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 14:57:30.072833|2017-02-18 14:57:30.072833
NCT00578448|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-12-16|2013-10-28||March 2008||2008-03-01|December 2013|2013-12-01|September 2012|Actual|2012-09-01|March 2009|Actual|2009-03-01||Interventional||Participants treated with study drug after renal transplant.|Belatacept Pharmacokinetic Trial in Renal Transplantation|An Open-label Pharmacokinetic Study in De Novo Renal Transplant Subjects Receiving a Belatacept Based Immunosuppressant Regimen|Completed||Phase 2|14|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 14:57:30.386518|2017-02-18 14:57:30.386518
NCT00578435|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2008-09-10|||January 1994||1994-01-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis|Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis|Completed||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:57:30.941898|2017-02-18 14:57:30.941898
NCT00578422|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2017-02-06|||December 2003|Actual|2003-12-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Clinical Implications of Peripheral Plaque Morphology|Clinical Implications of Peripheral Plaque Morphology|Completed||N/A|143|Actual|The Cleveland Clinic|||2||f||||f|f|f||||||No||2017-02-18 14:57:31.043136|2017-02-18 14:57:31.043136
NCT00578409|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-12-16|||May 2004||2004-05-01|December 2015|2015-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data|Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data|Completed||N/A|758|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     In a first analytical step, using only the clinical and pathological variables used in the~     original clinical mets castrate disease nomogram as inputs, supervised multivariate~     analytical techniques (SMA) were used to generate a new predictive model for patient~     survival. A similar approach will then be used to analyze a second group of approximately~     223 pts in the state of a rising PSA14 after surgery or radiation therapy treated on a~     sequential series of IRB approved trials testing conjugate vaccines also consented on IRB~     protocol 90-40.~   "|||2017-02-18 14:57:31.149143|2017-02-18 14:57:31.149143
NCT00578396|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-05-04|||January 2008||2008-01-01|May 2009|2009-05-01|January 2010|Anticipated|2010-01-01|May 2009|Anticipated|2009-05-01||Interventional|||Phase I Biomarker Study of Dietary Grape-Derived Low Dose Resveratrol for Colon Cancer Prevention|Phase I Biomarker Study of Dietary Grape-Derived Low Dose Resveratrol for Colon Cancer Prevention|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|University of California, Irvine||3|||f||||t||||||||||2017-02-18 14:57:31.234657|2017-02-18 14:57:31.234657
NCT00578383|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-04-12|2013-10-09||November 2007||2007-11-01|April 2016|2016-04-01|March 2013|Actual|2013-03-01|March 2011|Actual|2011-03-01||Interventional|LFMS|Enrolled participants are excluded from statistical results if they had baseline Hamilton Depression Rating scores under 17 or co-morbid disorders.|Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device|Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device|Completed||N/A|107|Actual|Mclean Hospital|A limitation of the current trial was that it was underpowered to detect moderate but clinically significant benefits of LFMS in diagnostic subgroups.|4|||f||||f||||||||||2017-02-18 14:57:31.349973|2017-02-18 14:57:31.349973
NCT00577044|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2008-12-15|||June 2004||2004-06-01|June 2008|2008-06-01|December 2007|Anticipated|2007-12-01|||||Observational|||Non Alcoholic Fatty Liver Disease (NAFLD) in Hong Kong|Non Alcoholic Fatty Liver Disease (NAFLD) in Hong Kong: Natural History and Development of Liver Complications|Unknown status|Active, not recruiting|N/A|600|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 14:58:04.148928|2017-02-18 14:58:04.148928
NCT00578370|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2008-11-04|||November 2007||2007-11-01|November 2008|2008-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test|A Phase I, Single-Center, Randomized, Vehicle-Controlled Study, Double-Blind for the Study Preparations and Observer-Blind for the Comparators to Determine the Antipsoriatic Efficacy and Tolerability of Topical Formulations With Ciclosporin in a Psoriasis Plaque Test|Completed||Phase 1/Phase 2|25|Anticipated|ISDIN||5|||f||||f||||||||||2017-02-18 14:57:32.122102|2017-02-18 14:57:32.122102
NCT00578357|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-07-25|||December 2007||2007-12-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Interventional|||A Personalized Feedback Intervention for Problem Gamblers|A Personalized Feedback Intervention for Problem Gamblers|Completed||N/A|209|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 14:57:32.34555|2017-02-18 14:57:32.34555
NCT00578344|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-04-22|||July 2005||2005-07-01|April 2014|2014-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|SCALLOP||Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP|Allogeneic Bone Marrow Transplantation From HLA Identical Related Donors for Patients With Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, or Hemoglobin SB0/+ Thalassemia|Terminated||N/A|8|Actual|Baylor College of Medicine||1||Terminated due to no new subject enrollment during the last 3 year period.|f||||t||||||||||2017-02-18 14:57:32.457622|2017-02-18 14:57:32.457622
NCT00578331|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-02-23|2009-07-07||December 2006||2006-12-01|February 2010|2010-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety Study of Olopatadine Nasal Spray|Safety Study of Olopatadine Nasal Spray|Completed||Phase 3|890|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:57:32.571057|2017-02-18 14:57:32.571057
NCT00578318|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-05-15|2013-01-28||June 2007||2007-06-01|May 2013|2013-05-01|December 2011|Actual|2011-12-01|January 2010|Actual|2010-01-01||Interventional|AAKOMA||African American Knowledge Optimized for Mindfully Healthy Adolescents|Treatment Engagement in Psychiatric Clinical Research and Care for Depressed African American Adolescents|Completed||N/A|16|Actual|Georgetown University|We lost 3 participants prior to intervention completion of the intervention which impacted results.|2|||f||||t||||||||||2017-02-18 14:57:32.9838|2017-02-18 14:57:32.9838
NCT00578305|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-03-26|2015-02-19||November 2007||2007-11-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|November 2009|Actual|2009-11-01||Interventional|SCORE|Safety population: All participants who received any part of an infusion of the study drug during the main study.|A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate|A Randomized, Placebo Controlled, Multicenter Clinical Study Investigating Efficacy of Rituximab in the Inhibition of Joint Structural Damage Assessed by Magnetic Resonance Imaging in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate|Completed||Phase 3|185|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 14:57:33.519747|2017-02-18 14:57:33.519747
NCT00578292|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-07-20|||February 2004||2004-02-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|THALLO||Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO|Pilot Study of Allogeneic Stem Cell Transplantation From Unrelated Donors for Patients With Severe Homozygous Beta 0/+ Thalassemia or Severe Variants of Beta 0/+ Thalassemia|Terminated||N/A|10|Actual|Baylor College of Medicine||1||"Over the course of this study stem cell transplant was determined to be standard of care for~   this disease and as such the study is no longer relevant."|f||||t||||||||||2017-02-18 14:57:34.941387|2017-02-18 14:57:34.941387
NCT00578279|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-09-18|2010-09-23||March 2007||2007-03-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study|Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN) With Alcohol in Patients With Locally Advanced and Unresectable Pancreatic Adenocarcinoma: A Randomized Pilot Study|Completed||Phase 4|20|Actual|Indiana University||2|||f||||f||||||||||2017-02-18 14:57:35.059544|2017-02-18 14:57:35.059544
NCT00578266|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2016-03-23|||February 2007||2007-02-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia|Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia, Using Matched Unrelated Donors and Mismatched Related Donors|Recruiting||Phase 1|24|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:57:35.374082|2017-02-18 14:57:35.374082
NCT00578240|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-08-18|||April 1990||1990-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Molecular Studies and Clinical Correlations in Human Prostatic Disease|Molecular Studies and Clinical Correlations in Human Prostatic Disease|Active, not recruiting||N/A|5290|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     Human tissue, body fluids, and blood Fresh tissue will be obtained from patients undergoing~     a biopsy or surgical procedure as part of their standard therapy or as part of an~     investigational research protocol. Previously stored pathology specimens may also be used.~     Peripheral blood, bone marrow, urine, and other bodily fluids and samples will also be~     obtained as needed.~   "|||2017-02-18 14:57:35.494621|2017-02-18 14:57:35.494621
NCT00578227|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-10-11|2009-11-27||December 2007||2007-12-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects|Immunogenicity and Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) Co-administered With a Commercially Available Vaccine in Healthy Female Adolescents|Completed||Phase 3|814|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:57:35.599874|2017-02-18 14:57:35.599874
NCT00578214|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2012-02-08|2012-01-13||March 2007||2007-03-01|February 2012|2012-02-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery|Randomized Controlled and Prospective Studies of Safety and Efficacy of Oral Midazolam for Perioperative Anxiolysis of Patients Undergoing Mohs Micrographic Surgery.|Completed||N/A|75|Actual|Mayo Clinic|The study was hindered by slow accrual and fell short of reaching the target number of patients.|3|||f||||t||||||||||2017-02-18 14:57:36.682097|2017-02-18 14:57:36.682097
NCT00572520|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2013-04-17|||July 2007||2007-07-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effectiveness of Behavioral Treatments for Obesity and Major Depression in Women|Treating Co-morbid Obesity and Major Depressive Disorder|Completed||Phase 2|161|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 14:59:37.31648|2017-02-18 14:59:37.31648
NCT00578201|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2011-03-30|||November 2007||2007-11-01|May 2007|2007-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|FOLFOX||FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer|Phase II Trial of FOLFOX in Combination With Cetuximab and Concomitant Radiotherapy in the Treatment of Esophageal Cancer Stage III|Completed||Phase 2|80|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 14:57:37.774398|2017-02-18 14:57:37.774398
NCT00578188|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-04-12|||February 2006||2006-02-01|April 2016|2016-04-01|January 2008|Anticipated|2008-01-01|January 2008|Anticipated|2008-01-01||Observational|||Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract|Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract|Withdrawn||N/A|0|Actual|Arkansas Children's Hospital Research Institute|||1|Study redesigned and re-submitted to UAMS IRB under different study title and IRB number.|f||||f||||||Samples With DNA|"~     Serum, whole blood, tissue~   "|||2017-02-18 14:57:37.896835|2017-02-18 14:57:37.896835
NCT00578175|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-20|2016-10-11|2010-03-05||November 2007||2007-11-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age|Immunogenicity of GlaxoSmithKline Biologicals' MMRV Vaccine (208136) vs. ProQuad®, When Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children 12-14 Months of Age.|Completed||Phase 2|1851|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 14:57:37.99924|2017-02-18 14:57:37.99924
NCT00578162|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-01-06|||April 2005||2005-04-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||A Study of Survivorship Service Capacities Among Health Care Agencies in New York City|A Study of Survivorship Service Capacities Among Health Care Agencies in New York City|Completed||N/A|||Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:57:39.524909|2017-02-18 14:57:39.524909
NCT00578149|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2007-12-19|||May 2006||2006-05-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer|Bevacizumab and Carboplatin/Paclitaxel and Radiation in Stage III Non-Small Cell Lung Cancer|Completed||Phase 2|45|Anticipated|Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 14:57:39.63692|2017-02-18 14:57:39.63692
NCT00578136|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-07-30|2012-12-07||November 2006||2006-11-01|July 2014|2014-07-01|December 2011|Actual|2011-12-01|December 2009|Actual|2009-12-01||Interventional|||Analgesic Efficacy After Umbilical Hernia Repair in Children|A Randomized-Double Blinded Trial Comparing the Analgesic Efficacy and Side Effects of Rectus Sheath Block vs. Infiltration of Surgical Site for Post Operative Pain Control After Umbilical Hernia Repair Surgery|Completed||N/A|52|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 14:57:39.749574|2017-02-18 14:57:39.749574
NCT00578123|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-08-02|||July 2005||2005-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical Prostatectomy|Prospective Assessment of Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical Prostatectomy|Active, not recruiting||N/A|959|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:57:40.15482|2017-02-18 14:57:40.15482
NCT00578110|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-04-01|||January 2008||2008-01-01|April 2010|2010-04-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|IGDM||Instrument for Glaucoma Early Detection and Monitoring|SBIR II Instrument for Glaucoma Early Detection and Monitoring|Unknown status|Recruiting|N/A|180|Anticipated|Synabridge Corporation||3|||f||||f||||||||||2017-02-18 14:57:40.262671|2017-02-18 14:57:40.262671
NCT00578097|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-11-30|||February 2008||2008-02-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder|A Phase II, International, Multi-centre, Prospective, Randomised, Parallel-group, Double-blind, Dose-ranging, Placebo-controlled, 12-week, Study to Assess the Efficacy and Safety of a One Injection Cycle With Either Botulinum Toxin Type-A (Dysport® 125, 250 or 500 Units) or Placebo Followed by an Optional 6-month Extension Phase in the Symptomatic Treatment of Micturition Urgency and Frequency in Continent Female Subjects Suffering From Idiopathic Overactive Bladder.|Terminated||Phase 2|81|Actual|Ipsen||4||The study was terminated early due to poor recruitment.|f||||f||||||||||2017-02-18 14:57:40.388451|2017-02-18 14:57:40.388451
NCT00578084|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-10-07|||June 2006||2006-06-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Observational|||Lung Cancer Location: a Repository|Lung Cancer Location: A Prospective Repository|Terminated||N/A|200|Anticipated|Indiana University|||4||f||||f||||||||||2017-02-18 14:57:40.681164|2017-02-18 14:57:40.681164
NCT00578071|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-05-22|2012-04-10||December 2007||2007-12-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|July 2011|Actual|2011-07-01||Interventional|POXX||Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer|A Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin Chemotherapy With External Beam Radiation Therapy for the Treatment of Resectable, Locally Advanced/Unresectable or Metastatic Esophageal Cancer|Completed||Phase 1/Phase 2|29|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:57:40.77431|2017-02-18 14:57:40.77431
NCT00578058|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-08-02|||January 2004||2004-01-01|August 2011|2011-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Randomized Trial Of Tinnitus Retraining Therapy|Randomized Trial Of Tinnitus Retraining Therapy|Completed||Phase 2|180|Anticipated|University of Iowa||6|||f||||t||||||||||2017-02-18 14:57:41.084335|2017-02-18 14:57:41.084335
NCT00578045|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-10-23|||July 2006||2006-07-01|October 2015|2015-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies|UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies|Withdrawn||Phase 1|0|Actual|University of Arkansas||1||no accrual|f||||f||||||||||2017-02-18 14:57:41.192133|2017-02-18 14:57:41.192133
NCT00578032|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-10-07|||December 2007||2007-12-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Reconstructive Surgery For Head And Neck Cancer Patients|Reconstructive Surgery For Head And Neck Cancer Patients: A Prospective Analysis Of Quality Of Life And Symptom Relief|Active, not recruiting||N/A|130|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 14:57:41.303746|2017-02-18 14:57:41.303746
NCT00578019|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2013-09-28|||December 1999||1999-12-01|September 2013|2013-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|LISS||Comparison Between LISS Plating and Intramedullary (IM) Nailing for Supracondylar Femur Fractures|Prospective Comparison Between Less Invasive Stabilization System (LISS) Plating and Intramedullary Nailing for the Treatment of Supracondylar Femur Fractures|Completed||N/A|80|Anticipated|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 14:57:41.437803|2017-02-18 14:57:41.437803
NCT00578006|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2017-01-09|||March 2004||2004-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Internet-based System for Cancer Patients to Self-report Toxicity|Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life|Completed||N/A|1007|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||f||||||||||2017-02-18 14:57:41.571331|2017-02-18 14:57:41.571331
NCT00577993|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-09-12|||March 1998||1998-03-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients|Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Chimeric Anti-CD20 Monoclonal Antibody (Rituximab) for Stage IV Indolent Lymphoma|Active, not recruiting||Phase 3|210|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 14:57:41.689656|2017-02-18 14:57:41.689656
NCT00577980|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2013-04-25|||December 2007||2007-12-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Testosterone in Castration-Resistant Prostate Cancer|Testosterone Replacement Therapy in Castration-Resistant Prostate Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Zero accrual and failure to generate multicenter interest.|f||||f||||||||||2017-02-18 14:57:41.845375|2017-02-18 14:57:41.845375
NCT00577967|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-07-06|||October 2005||2005-10-01|July 2010|2010-07-01|March 2006|Anticipated|2006-03-01|||||Interventional|||Gabapentin - A Solution to Uremic Pruritus?|Gabapentin - A Solution to Uremic Pruritus? A Prospective, Randomized, Placebo-controlled, Double-blind Study|Unknown status|Not yet recruiting|N/A|80|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 14:57:41.968509|2017-02-18 14:57:41.968509
NCT00577954|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-12-10|||October 2006||2006-10-01|December 2008|2008-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|MRI-Coma||Multimodal Resonance Imaging for Outcome Prediction on Coma Patients|Multimodal Magnetic Resonance (MRI) Development in Comatose Patients for an Algorithm in the Prediction of Consciousness Recovery|Completed||N/A|417|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 14:57:42.064104|2017-02-18 14:57:42.064104
NCT00577928|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-08-07|||April 2006||2006-04-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Value of Fecal Calprotectin|Correlation of Fecal Calprotectin Level With the Clinical, Endoscopic, Histologic and Radiologic Activity in Inflammatory Bowel diseaseThe Value of Fecal Calprotectin for the Diagnosis and Assessment of Inflammatory Bowel Disease|Completed||N/A|171|Actual|Indiana University|||2||f||||f||||||||||2017-02-18 14:57:42.190452|2017-02-18 14:57:42.190452
NCT00577915|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-11-28|||May 2003||2003-05-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Breast MRI Spectroscopy|Breast MRI Spectroscopy|Completed||N/A|150|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:57:42.273447|2017-02-18 14:57:42.273447
NCT00577902|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-02-08|||June 2005||2005-06-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation|Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation|Completed||N/A|37|Actual|University of Arkansas|||1||f||||f||||||Samples Without DNA|"~     Blood samples will be collected and nutritional risk evaluated, using the Patient-Generated~     Subjective Global Assessment tool (PG-SGA). The PG-SGA and blood tests will be performed~     before, at the end of XRT treatment and four to six weeks after treatment is completed.~   "|||2017-02-18 14:57:42.384735|2017-02-18 14:57:42.384735
NCT00577889|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-07-23|2013-09-20||March 2008||2008-03-01|September 2013|2013-09-01|May 2013|Actual|2013-05-01|January 2011|Actual|2011-01-01||Interventional||One patient in Arm I canceled prior to treatment and was not used in baseline summary.|Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer|A Phase II Trial of 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Combination With Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 14:57:42.505458|2017-02-18 14:57:42.505458
NCT00577876|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-10-25|||September 2006||2006-09-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Assessment of the Functional Significance of Accessory Pudendal Arteries|Assessment of the Functional Significance of Accessory Pudendal Arteries|Completed||N/A|38|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:57:43.186148|2017-02-18 14:57:43.186148
NCT00577863|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-07-13|2009-05-05||January 2008||2008-01-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy|B3D-MC-GHDF: Community Experience of Subjects With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy|Completed||Phase 3|200|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 14:57:43.29999|2017-02-18 14:57:43.29999
NCT00577850|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-04-15|||November 2002||2002-11-01|April 2013|2013-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose|Study to Determine the Pharmacokinetics of a Single 14C-labeled Intravenous Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose to Postmenopausal Women With Osteopenia or Osteoporosis|Completed||Phase 1|32|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 14:57:44.637958|2017-02-18 14:57:44.637958
NCT00577837|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-04-15|||April 2004||2004-04-01|April 2013|2013-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD|Active-controlled, Double-blind, Randomized, Sequential Escalating Dose Study to Assess Safety, Pharmacokinetics and Efficacy of 100, 150, and 200 mg Oral Risedronate Administered Monthly in Postmenopausal Women With Low Bone Mineral Density|Completed||Phase 2|370|Actual|Warner Chilcott||4|||f||||f||||||||||2017-02-18 14:57:44.745274|2017-02-18 14:57:44.745274
NCT00121511|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2015-05-26|||July 2005||2005-07-01|May 2015|2015-05-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effect of Efudex Treatment on Photoaged Skin|The Effect of Efudex (5-fluorouracil) Treatment on Photoaged Skin|Completed||N/A|21|Actual|University of Michigan|||||f||||f||||||||||2017-02-18 17:35:40.426862|2017-02-18 17:35:40.426862
NCT00577824|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-03-20|2009-11-23||January 2008||2008-01-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)|Efficacy and Safety of LY2148568 in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) But Not Well Controlled|Completed||Phase 3|181|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:57:44.879076|2017-02-18 14:57:44.879076
NCT00577811|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-01-14|||February 2003||2003-02-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans|Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans|Completed||N/A|628|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||f||||||||||2017-02-18 14:57:45.995191|2017-02-18 14:57:45.995191
NCT00577798|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2010-08-19|||November 2007||2007-11-01|August 2010|2010-08-01||||December 2012|Anticipated|2012-12-01||Interventional|||Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin|Cardiac MRI for Assessment of Cardiac Structure and Function Following Doxorubicin Based Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma|Unknown status|Active, not recruiting|N/A|15|Anticipated|University of Nebraska||1|||f||||f||||||||||2017-02-18 14:57:46.10059|2017-02-18 14:57:46.10059
NCT00577785|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-12-20|||August 2007||2007-08-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Study to Obtain Full Thickness Bladder Tissue From Subjects Undergoing Cystectomy Surgery|A Multi-Center Study to Obtain Full Thickness Bladder Tissue Specimen From Subjects Undergoing Cystectomy Surgery|Completed||N/A|52|Actual|Tengion|||1||f||||f||||||Samples Without DNA|"~     Tissue~   "|||2017-02-18 14:57:46.227762|2017-02-18 14:57:46.227762
NCT00577772|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2012-10-01|2012-08-30||November 2007||2007-11-01|October 2012|2012-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Transit Time and Bacterial Overgrowth Using SmartPill Capsule|An Exploratory Assessment of Small Bowel Transit Time and Small Bowel Bacterial Overgrowth Using the SmartPill Capsule|Terminated||N/A|17|Actual|Mayo Clinic|The study was terminated early because enrollment goals were not met.|2||Enrollment Goal Not Met|f||||f||||||||||2017-02-18 14:57:46.328482|2017-02-18 14:57:46.328482
NCT00577759|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-02-12|||February 2008||2008-02-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|C2P2||Community and Clinician Partnership for Prevention|Community and Clinician Partnership for Prevention|Completed||N/A|9|Actual|Duke University||3|||f||||f||||||||||2017-02-18 14:57:46.734344|2017-02-18 14:57:46.734344
NCT00577746|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-09-03|||June 2006||2006-06-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Observational|||Clinical Impact of EUS in Staging NSCLC|The Clinical Impact of Endoscopic Ultrasound (EUS) in Staging Non-small Cell Lung Cancer (NSCLC)|Completed||N/A|110|Actual|Indiana University|||2||f||||f||||||||||2017-02-18 14:57:46.849687|2017-02-18 14:57:46.849687
NCT00577733|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-09-17|||January 2008||2008-01-01|December 2007|2007-12-01|November 2010|Actual|2010-11-01|June 2010|Actual|2010-06-01||Observational|BOA||Study of the Physiology of the Asthma of the Obese Subjects. Breathing Obesity Asthma Study (BOA)|Pathophysiological Study of Obesity-related Asthma|Completed||N/A|204|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||||||2017-02-18 14:57:46.936635|2017-02-18 14:57:46.936635
NCT00577720|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-12-06|2011-08-12||July 2006||2006-07-01|November 2011|2011-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate|Study to Assess the Efficacy, Safety and Pharmacokinetics of Risedronate Upon Oral Administration of a 35 mg Delayed-Release, a 50 mg Delayed-Release or a 35 mg Immediate-Release Administered Weekly for 13 Weeks to Postmenopausal Women|Completed||Phase 2|181|Actual|Warner Chilcott||4|||f||||f||||||||||2017-02-18 14:57:47.054221|2017-02-18 14:57:47.054221
NCT00577707|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-10-19|2015-10-19||November 2007||2007-11-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)|A Phase II Study of Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)|Completed||Phase 2|8|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:57:48.195679|2017-02-18 14:57:48.195679
NCT00577694|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-10-07|||November 2007||2007-11-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|July 2010|Actual|2010-07-01||Interventional|||Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Nonrandomized Dose-escalation Study of Clofarabine in Combination With Gemtuzumab Ozogamicin for Relapsed/Refractory Acute Myeloid Leukemia (AML) for Patients Less Than 60 Years-old|Terminated||Phase 1|21|Actual|UNC Lineberger Comprehensive Cancer Center||1||funding unavailable|f||||t||||||||||2017-02-18 14:57:48.442686|2017-02-18 14:57:48.442686
NCT00577681|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-12-11|||January 2002||2002-01-01|December 2014|2014-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Understanding the Increased Risk of Cardiovascular Disease in People With HIV|Lipoproteins, HIV, and Antiretroviral Therapy in SMART|Completed||Phase 4|5472|Actual|University of Minnesota - Clinical and Translational Science Institute|||3||f||||t||||||Samples Without DNA|"~     The plasma specimens will be collected using EDTA plasma tubes. For each specimen, four~     transport tubes (Sarstedt 2.0 mL Micro Tube), each containing 1 mL of plasma, will be~     prepared and labeled with preprinted bar coded labels. The preprinted bar coded labels~     specify the patient identification code (PID), visit and specimen type, and the protocol and~     vial ID. Specimens will be frozen at negative 70 degrees Celcius and shipped on dry ice to a~     central repository, Advanced Biomedical Laboratories, Cinnaminson, New Jersey, where they~     will be scanned and put into storage. Paperwork documenting the specimens will be processed~     by the SDMC, and electronic files will be sent to the central repository.~   "|||2017-02-18 14:57:48.550676|2017-02-18 14:57:48.550676
NCT00577668|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-05-02|||April 2007||2007-04-01|May 2011|2011-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)|UARK 2007-01, A Phase II Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD) and Autologous Transplantation for Patients Relapsing or Progressing After Tandem Transplantation|Withdrawn||Phase 2|0|Actual|University of Arkansas||1||Poor accrual|f||||f||||||||||2017-02-18 14:57:48.651029|2017-02-18 14:57:48.651029
NCT00577655|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-09-02|2009-07-21||August 2007||2007-08-01|September 2016|2016-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Albuterol HFA MDI in Pediatric Participants With Asthma|Phase 3 Study to Evaluate the Chronic-dose Safety and Efficacy of Albuterol-HFA-MDI Relative to Placebo in Pediatric Asthmatics|Completed||Phase 3|103|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 14:57:48.754787|2017-02-18 14:57:48.754787
NCT00577642|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2013-05-07|||October 2007||2007-10-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates|A Phase II Study of Bone Marker Assessment of Multiple Myeloma Patients Treated With AminoBisphosphonates|Completed||Phase 2|28|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 14:57:52.148027|2017-02-18 14:57:52.148027
NCT00577629|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-06-20|2013-03-04||June 2005||2005-06-01|June 2016|2016-06-01|February 2021|Anticipated|2021-02-01|February 2012|Actual|2012-02-01||Interventional|||Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma|Dose-Intensive Chemotherapy Combined With Monoclonal Antibody Therapy and Targeted Radioimmunotherapy for Untreated Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 2|39|Actual|Duke University||1|||f||||f||||||||||2017-02-18 14:57:52.252855|2017-02-18 14:57:52.252855
NCT00577616|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-10-22|||December 2007||2007-12-01|July 2013|2013-07-01|February 2014|Actual|2014-02-01|February 2013|Actual|2013-02-01||Interventional|ECAR||Ruptured Aorta-iliac Aneurysms: Endo vs. Surgery|Randomized Study Comparing Endovascular Repair Versus Conventional Repair for Ruptured Aorta-iliac Aneurysms|Completed||N/A|107|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 14:57:52.832998|2017-02-18 14:57:52.832998
NCT00577603|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2013-04-24|||January 2006||2006-01-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Evaluate and Compare the Rate of Para-Stomal Herniation After Permanent Stoma Formation|A Controlled, Randomized Study to Evaluate and Compare the Rate of Para-Stomal Herniation After Permanent Stoma Formation With and Without Reinforcement With a Collagen Mesh|Completed||N/A|40|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 14:57:52.943808|2017-02-18 14:57:52.943808
NCT00577590|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-05-02|||October 2003||2003-10-01|May 2014|2014-05-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|||Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes|Cyclotron Produced Isotopes in Biology and Medicine, Project 3: Specific Aim 1A and 1B Effects of Fatty Acid Delivery on Myocardial Metabolism and Function in Type 2 Diabetes|Completed||N/A|146|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 14:57:53.04837|2017-02-18 14:57:53.04837
NCT00577577|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2008-07-21|||December 2007||2007-12-01|July 2008|2008-07-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1|A Placebo Controlled, Randomized, Double-Blind Phase II Clinical Trial to Evaluate Tolerability, Safety and Efficacy Endpoints After Administration of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) for 24 Weeks in Adults With Myotonic Dystrophy Type 1|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Insmed Incorporated||1|||f||||t||||||||||2017-02-18 14:57:53.164899|2017-02-18 14:57:53.164899
NCT00577564|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2012-09-11|||July 2006||2006-07-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|||||Observational|||EUS-CPN: A Retrospective Review|Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN): A Retrospective Review of Safety|Completed||N/A|||Indiana University|||1||f||||f||||||||||2017-02-18 14:57:53.273266|2017-02-18 14:57:53.273266
NCT00577538|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2015-08-07|||April 2006||2006-04-01|August 2015|2015-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Prevalence of Lymphoma in IBD|Prevalence and Risk Factor for Lymphoproliferative Disease in Patients With Inflammatory Bowel Disease|Completed||N/A|7|Actual|Indiana University|||2||f||||f||||||||||2017-02-18 14:57:53.357157|2017-02-18 14:57:53.357157
NCT00577525|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-02-26|||December 2007||2007-12-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|July 2010|Actual|2010-07-01||Observational|Nephrovir||Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome|Viral Infection of Lymphoid Cells Occuring at the First Manifestation of Idiopathic Nephrotic Syndrome|Completed||N/A|401|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"~     whole blood, serum, red cells and DNA~   "|||2017-02-18 14:57:53.442603|2017-02-18 14:57:53.442603
NCT00577512|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-04-19|2011-04-19||April 2007||2007-04-01|April 2011|2011-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||UARK 2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE|UARK 2006-32: Phase II Study of Rapidly Recycled High Dose DTPACE (HD-DTPACE) for Untreated or Previously Treated, High-Risk Multiple Myeloma (MM)|Completed||Phase 2|4|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:57:53.549884|2017-02-18 14:57:53.549884
NCT00577499|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-03-03|||October 2007||2007-10-01|March 2015|2015-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis|Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis|Terminated||N/A|7|Actual|University of Arkansas|||1|Recruitment was suboptimal|f||||f||||||||||2017-02-18 14:57:53.785394|2017-02-18 14:57:53.785394
NCT00577473|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-09-14|2011-05-24||February 2001||2001-02-01|September 2011|2011-09-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|ASCEND I||Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)|A Double-blind, Randomized, 6 Week, Parallel-group Design Clinical Trial in Patients With Mildly to Moderately Active Ulcerative Colitis to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day|Completed||Phase 3|301|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 14:57:53.898445|2017-02-18 14:57:53.898445
NCT00577460|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-05-07|2011-06-16||December 2007||2007-12-01|April 2014|2014-04-01||||June 2010|Actual|2010-06-01||Interventional||Treated Set, all patients dispensed study drug and documented to have taken at least one dose|Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD|Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Advanced Parkinson's Disease (PD)|Completed||Phase 3|391|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 14:57:54.877197|2017-02-18 14:57:54.877197
NCT00577447|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-04-27|||October 2005||2005-10-01|April 2015|2015-04-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Docosahexaenoic Acid in the Treatment of Autism|A Randomized, Double-Blind, Placebo-Controlled Trial of Docosahexaenoic Acid Supplementation in Children With Autism|Completed||N/A|48|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:57:56.600666|2017-02-18 14:57:56.600666
NCT00577434|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-03-11|||April 2006||2006-04-01|July 2008|2008-07-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Observational|||Pharmacokinetics and Pharmacodynamics of Pentobarbital in Neonates, Infants, and Children Following Open Heart Surgery|The Pharmacokinetics and Pharmacodynamics of a Single Dose of Pentobarbital for Clinically Indicated Sedation for Neonates, Infants, and Children Recovering From Open Heart Surgery|Terminated||N/A|37|Actual|Children's Hospital of Philadelphia|||1|Sluggish enrollment|f||||f||||||None Retained|"~     Blood~   "|||2017-02-18 14:57:56.701815|2017-02-18 14:57:56.701815
NCT00577421|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2011-09-27|||June 2003||2003-06-01|September 2011|2011-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO|An Extension Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO|Completed||Phase 3|32|Actual|Warner Chilcott||1|||f||||f||||||||||2017-02-18 14:57:56.777485|2017-02-18 14:57:56.777485
NCT00577408|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-10-16|||September 2007||2007-09-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|Depot-BNT||Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial. A Free Treatment for Opiate Abuse.|Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial|Completed||Phase 3|56|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 14:57:56.883044|2017-02-18 14:57:56.883044
NCT00577395|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2013-04-15|2009-11-18||July 2008||2008-07-01|April 2013|2013-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Bone Microarchitecture in Osteopenic Postmenopausal Women|A 12-month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing 150 mg Once-a-month Risedronate and Placebo Using 3-dimensional Micro MRI (Magnetic Resonance Imaging).|Terminated||Phase 4|13|Actual|Warner Chilcott|NOTE: The study was terminated early (after 5 months), prior to acquiring any efficacy endpoints; consequently, NO subject efficacy analyses were performed|2|||f||||f||||||||||2017-02-18 14:57:57.000103|2017-02-18 14:57:57.000103
NCT00577382|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-10-16|2016-08-22||August 2007||2007-08-01|June 2016|2016-06-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||The analysis dataset is comprised of treated patients.|SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma|A Phase II Study of SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma|Completed||Phase 2|52|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 14:57:57.622704|2017-02-18 14:57:57.622704
NCT00577369|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-09-14|||December 2007||2007-12-01|September 2009|2009-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Pilot Study to Measure Blood Levels of Desflurane in Children|A Pilot Study to Measure Blood Levels of Desflurane in Children|Completed||N/A|7|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 14:57:58.34569|2017-02-18 14:57:58.34569
NCT00577356|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-01-18|2010-09-13||February 2008||2008-02-01|November 2010|2010-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer|Phase II Trial of Neoadjuvant Docetaxel and CG1940/CG8711 Followed by Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer|Terminated||Phase 2|6|Actual|Benaroya Research Institute|the trial was closed prior to planned accrual of 30 patients due to an external report from the randomized trial of docetaxel and CG1940/CG8711 resulting in a higher incidence of deaths compared to docetaxel alone in metastatic prostate cancer.|1||Safety reasons, though no safety issues arose.|f||||t||||||||||2017-02-18 14:57:58.449187|2017-02-18 14:57:58.449187
NCT00577343|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-02-29|||April 2009||2009-04-01|February 2016|2016-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Hospital Acquired and Community Acquired MRSA in GI Lab|Hospital Acquired and Community Acquired Methicillin Resistant Staph Aureus in the Outpatient Gastrointestinal Lab: A Prospective Study of Prevalence|Withdrawn||N/A|0|Actual|Indiana University|||1|study lacked funding to recruit|f||||f||||||Samples Without DNA|"~     buccal swab for saliva~   "|||2017-02-18 14:57:58.662811|2017-02-18 14:57:58.662811
NCT00577330|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2007-12-19|||May 2006||2006-05-01|December 2007|2007-12-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Efficacy of Myalgesin™ to Support Joint Function in Patients With Knee Osteoarthritis|The Efficacy of Myalgesin™ for the Support of Joint Function in Patients With Osteoarthritis of the Knee — A Prospective Randomized Controlled Study|Unknown status|Active, not recruiting|Phase 3|110|Anticipated|ProThera, Inc.||2|||f||||f||||||||||2017-02-18 14:57:58.735118|2017-02-18 14:57:58.735118
NCT00577317|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2014-12-29|||December 2007||2007-12-01|December 2014|2014-12-01||||July 2009|Actual|2009-07-01||Interventional|||Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer|A Prospective Randomized Single Blind Phase III Trial Comparing Flexitouch Home Maintenance Therapy to Standard Home Maintenance Therapy for Lower Extremity Lymphedema Resulting From Treatment of Gynecologic Malignancy|Terminated||Phase 3|2|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-02-18 14:57:58.839438|2017-02-18 14:57:58.839438
NCT00577304|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-02-03|||December 2007||2007-12-01|April 2008|2008-04-01|March 2008|Anticipated|2008-03-01|March 2008|Anticipated|2008-03-01||Interventional|||A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon|A Study of a Topical Formulation of Nitroglycerin, MQX-503, and Matching Vehicle in the Treatment and Prevention of Raynaud's Phenomenon|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|MediQuest Therapeutics||2|||f||||f||||||||||2017-02-18 14:57:58.954181|2017-02-18 14:57:58.954181
NCT00577278|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-19|2016-11-23|||January 2007||2007-01-01|November 2016|2016-11-01||||April 2017|Anticipated|2017-04-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Indium In-111 Ibritumomab Tiuxetan, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin Lymphoma|A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for B-Cell Non-Hodgkin Lymphoma Using Zevalin, Fludarabine and Melphalan|Active, not recruiting||Phase 2|54|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:57:59.080683|2017-02-18 14:57:59.080683
NCT00577265|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-01-27|||November 2004||2004-11-01|January 2011|2011-01-01||||||||Observational|INVOLVE||An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication|An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication According to Instructions Received From Their Physician (AMD).|Completed||N/A|||AstraZeneca|||1||f||||f||||||||||2017-02-18 14:57:59.219407|2017-02-18 14:57:59.219407
NCT00577226|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-05-04|||April 2005||2005-04-01|May 2016|2016-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Shilla Growth Permitting Spinal Instrumentation System for Treatment of Scoliosis in the Immature Spine|Use of the Shilla Growth Permitting Spinal Instrumentation System/Technique for the Treatment of Scoliosis in the Immature Spine|Terminated||N/A|50|Actual|Arkansas Children's Hospital Research Institute|||1|IRB has requested additional information regarding IDE|f||||f||||||||||2017-02-18 14:57:59.402171|2017-02-18 14:57:59.402171
NCT00577213|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-10-25|||February 2007||2007-02-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Diagnosis of Hemangiomas and Vascular Malformations|Diagnosis of Hemangiomas and Vascular Malformations Using Non-invasive Imaging Devices|Completed||N/A|56|Actual|University of Arkansas|||1||f||||t||||||||||2017-02-18 14:57:59.502562|2017-02-18 14:57:59.502562
NCT00577200|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-04-26|||January 2008||2008-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|MACDrive||Safety of Driving After Minor Surgery With Monitored Anesthesia Care|The Safety of Driving in Patients After Minor Surgery With Monitored Anesthesia Care|Active, not recruiting||Phase 4|625|Anticipated|Rush University Medical Center||3|||f||||f||||||||||2017-02-18 14:57:59.576101|2017-02-18 14:57:59.576101
NCT00577187|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-06-11|||June 2008||2008-06-01|June 2012|2012-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Placement of CS/LV Pacing Leads With EnSite NavX Guidance|Placement of Coronary Sinus/Left Ventricular Leads With EnSite NavX Guidance|Withdrawn||Early Phase 1|0|Actual|St. Jude Medical||1||Lack of enrollment|f||||f||||||||||2017-02-18 14:57:59.687632|2017-02-18 14:57:59.687632
NCT00577174|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-04-27|||June 2007||2007-06-01|April 2012|2012-04-01|October 2012|Anticipated|2012-10-01|August 2011|Actual|2011-08-01||Observational|||Mitochondrial Function in Pediatric Obesity|Mitochondrial Function in Pediatric Obesity|Unknown status|Active, not recruiting|N/A|110|Anticipated|Massachusetts General Hospital|||2||f||||f||||||Samples With DNA|"~     Whole blood, serum, white blood cells~   "|||2017-02-18 14:57:59.778119|2017-02-18 14:57:59.778119
NCT00577161|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-09-19|||September 2007||2007-09-01|September 2008|2008-09-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL|Fludarabine, BBR 2778 (Pixantrone) and Rituximab (FP-R) vs Fludarabine and Rituximab (F-R) for Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|Terminated||Phase 3|300|Anticipated|CTI BioPharma||2||closed to enrollment|f||||t||||||||||2017-02-18 14:57:59.874473|2017-02-18 14:57:59.874473
NCT00577148|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-04-18||2016-04-18|February 2008||2008-02-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes|A Double-blind, Randomized, Placebo-controlled, Parallel Group Study of Rimonabant 20 mg Daily for the Treatment of Type 2 Diabetic Patients With Nonalcoholic Steatohepatitis (NASH).|Terminated||Phase 3|89|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 14:57:59.978714|2017-02-18 14:57:59.978714
NCT00577135|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-07-15|2013-01-23||February 2008||2008-02-01|April 2013|2013-04-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)|Diuretic Optimal Strategy Evaluation in Acute Heart Failure (The DOSE-AHF Study)|Completed||Phase 3|308|Actual|Duke University||4|||f||||t||||||||||2017-02-18 14:58:00.198564|2017-02-18 14:58:00.198564
NCT00577122|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-09-24|2014-09-16||July 2007||2007-07-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer|MPA Revisited: A Phase II Study of Anti-Metastatic, Anti-Angiogenic Therapy in Postmenopausal Patients With Hormone Receptor Negative Breast Cancer. A Translational Breast Cancer Research Consortium (TBCRC) Trial|Completed||Phase 2|30|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 14:58:01.973849|2017-02-18 14:58:01.973849
NCT00577109|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-08-23||||||August 2016|2016-08-01|June 2012|Actual|2012-06-01|||||Interventional|||A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.|An Open Label Study to Assess the Effect of FOLFIRI Plus Avastin and Cetuximab on Progression-free Survival in Patients With Previously Untreated Metastatic Colorectal Cancer.|Withdrawn||Phase 2|0|Actual|Hoffmann-La Roche||1||Study was cancelled before patient enrollment|f||||||||||||||2017-02-18 14:58:02.753732|2017-02-18 14:58:02.753732
NCT00577096|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2015-04-02|2011-03-17||October 2001||2001-10-01|April 2015|2015-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Effects of Exercise in Combination With Epoetin Alfa|Effects of Exercise in Combination With Epoetin Alfa During High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma|Completed||N/A|120|Actual|University of Arkansas|Patients with hemoglobin <8 g/dl received RBC transfusions according to the transplantation protocol. Analysis may have missed specific disease-related influences on hemoglobin. Randomization should have distributed disease risks equally for groups.|2|||f||||t||||||||||2017-02-18 14:58:02.864451|2017-02-18 14:58:02.864451
NCT00577083|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-02-24|2015-07-27||November 2006||2006-11-01|February 2016|2016-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Cap-fitted Colonoscopy: a Randomized, Tandem Colonoscopy Study of Adenoma Miss Rates|Cap-fitted Colonoscopy: a Randomized, Tandem Colonoscopy Study of Adenoma Miss Rates|Completed||N/A|100|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 14:58:03.606841|2017-02-18 14:58:03.606841
NCT00577070|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2009-10-05|||January 2008||2008-01-01|January 2009|2009-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression||Completed||Phase 2|40|Anticipated|BeerYaakov Mental Health Center||2|||f||||f||||||||||2017-02-18 14:58:03.960068|2017-02-18 14:58:03.960068
NCT00577057|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2013-08-21|||September 2006||2006-09-01|August 2013|2013-08-01|August 2013|Anticipated|2013-08-01|||||Interventional|||Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer|Randomized Trial to Evaluate the Therapeutic Gain by Changing the Chemoradiotherapy From Concurrent-adjuvant to Induction-concurrent Sequence, and the Radiotherapy From Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma|Unknown status|Not yet recruiting|N/A|798|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 14:58:04.053819|2017-02-18 14:58:04.053819
NCT00577031|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-07-21|2014-07-15||February 2008||2008-02-01|July 2015|2015-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||Safety population: all enrolled participants who received at least 1 dose of all study medications.|OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.|Open-label, Efficacy and Safety Study of Bevacizumab (Avastin®) in Combination With XELOX (Oxaliplatin Plus Xeloda®) for the First-line Treatment of Patients With Metastatic Cancer of the Colon or Rectum - 'OBELIX'|Completed||Phase 4|205|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:58:04.234913|2017-02-18 14:58:04.234913
NCT00577018|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-05-28|||August 1998||1998-08-01|December 2007|2007-12-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation|A Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dose-Titration on the Safety and Efficacy and R108512 Tablets in Subjects With Chronic Constipation|Completed||Phase 3|755|Actual|Movetis||3|||f||||f||||||||||2017-02-18 14:58:05.107986|2017-02-18 14:58:05.107986
NCT00577005|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-08-11|||July 2007||2007-07-01|August 2008|2008-08-01|October 2008|Anticipated|2008-10-01|June 2008|Actual|2008-06-01||Interventional|Keppra-DB||Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients|Levetiracetam (Keppra) Treatment for Cocaine Dependence in Methadone-Maintained Patients|Unknown status|Active, not recruiting|Phase 2|28|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 14:58:05.2124|2017-02-18 14:58:05.2124
NCT00576992|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-09-23|||January 2003||2003-01-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|September 2018|Anticipated|2018-09-01||Observational|||Demographics and Findings of Upper Endoscopy Patients|A Clinical Study of Demographics and Findings During Endoscopy in Patients With Abdominal Pain, Dyspepsia, GERD, and Associated Symptoms|Recruiting||N/A|3000|Anticipated|Midwest Biomedical Research Foundation|||1||f||||f||||||||||2017-02-18 14:58:05.324216|2017-02-18 14:58:05.324216
NCT00576979|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-09-07|||February 2008||2008-02-01|September 2016|2016-09-01||||February 2017|Anticipated|2017-02-01||Interventional|||Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia|Phase I-II Study of Escalating Doses of Large Field Image-Guided Intensity Modulated Radiation Therapy (IMRT) Using Helical Tomotherapy in Combination With Etoposide (VP16) and Cytoxan as a Preparative Regimen for Allogeneic Hematopoietic Stem Cell (HSC) Transplantation for Patients With Poor Risk Acute Lymphocytic Leukemia (ALL) or Poor Risk Acute Myelogenous Leukemia (AML)|Active, not recruiting||Phase 1/Phase 2|87|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 14:58:05.439189|2017-02-18 14:58:05.439189
NCT00576953|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-11-11|||May 2007||2007-05-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 14:58:05.56585|2017-02-18 14:58:05.56585
NCT00576940|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2007-12-18|||June 2004||2004-06-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|ImmuniEteral||Standard and Immunostimulating Enteral Nutrition in Surgical Patients|Standard and Immunostimulating Enteral Nutrition in Patients After Extended Gastrointestinal Surgery - A Prospective, Randomized, Controlled Clinical Trial|Completed||Phase 4|196|Actual|Jagiellonian University||2|||f||||f||||||||||2017-02-18 14:58:05.620186|2017-02-18 14:58:05.620186
NCT00576927|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-08-12|2013-09-17||October 2007||2007-10-01|August 2014|2014-08-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional||Subjects entered a clinical assessment phase (CAP) after consent, which eliminated 36 subjects. Then 43 subjects entered baseline which excluded 13 subjects. 30 subjects started sleep hygiene intervention, but only 23 subjects completed. 1 more subject withdrew during placebo. Then 22 started drug and those 22 completed randomization.|Improving Sleep in Nursing Homes|Improving Sleep in Nursing Homes|Completed||Phase 4|79|Actual|Emory University|Low power to detect statistically significant effects of the interventions on outcomes; Inability to examine predictors of responsiveness because of the small sample size and the large number of predictors of response.|2|||f||||t||||||||||2017-02-18 14:58:05.754207|2017-02-18 14:58:05.754207
NCT00576914|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-03-08|||June 2007||2007-06-01|March 2009|2009-03-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer|Adjuvant Vinorelbine Plus Cisplatin Versus Vinorelbine Plus Cisplatin Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer (Phase III Study, Randomized, Open, Multi-center)|Unknown status|Recruiting|Phase 3|1108|Anticipated|Chinese Academy of Sciences||2|||f||||t||||||||||2017-02-18 14:58:06.207949|2017-02-18 14:58:06.207949
NCT00576901|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-07-17|2014-05-16||November 2007||2007-11-01|July 2014|2014-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||Intent-to-treat (ITT) population. The ITT population included all enrolled participants.|A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.|"An Open Label Study to Assess the Effect of Neoadjuvant Treatment With Docetaxel + Xeloda + Avastin on Pathological Response Rate in Inflammatory or Locally Advanced Breast Cancer"|Terminated||Phase 2|23|Actual|Hoffmann-La Roche||1||"The sample for statistical analysis of results could not be recruited within the specified~   timeframe upon retirement of the original principal investigator."|f||||||||||||||2017-02-18 14:58:06.333501|2017-02-18 14:58:06.333501
NCT00576888|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-03-16|||November 2007||2007-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|VAC||Registry for Vascular Anomalies Associated With Coagulopathy|International Registry for Vascular Anomalies Associated With Coagulopathy|Recruiting||N/A|30|Anticipated|Medical College of Wisconsin|||1||f||||f||||||Samples With DNA|"~     Buccal swab, tissue biopsy if available~   "|||2017-02-18 14:58:06.591223|2017-02-18 14:58:06.591223
NCT00576875|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-02-20|||August 2006||2006-08-01|February 2012|2012-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Duke Conte Center for the Neuroscience of Depression in Late Life|Conte Centers for the Neuroscience of Depression|Completed||N/A|795|Actual|Duke University|||2||f||||f||||||Samples With DNA|"~     Blood for DNA; Post-mortem brain tissue~   "|||2017-02-18 14:58:06.732433|2017-02-18 14:58:06.732433
NCT00576862|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-28|||November 2002||2002-11-01|December 2007|2007-12-01|April 2004|Actual|2004-04-01|||||Interventional|||Extension to Study HMR1964A/3011 in Belgium|Multicenter,Open,Uncontrolled,Clinical Extension Trial in Subjects With Type I Diabetes Previously Participating in Study HMR1964A/3011 in Belgium|Completed||Phase 4|32|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:58:06.825914|2017-02-18 14:58:06.825914
NCT00576849|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2010-05-25|||December 2007||2007-12-01|January 2009|2009-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients|Phase 4 Study of a Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients|Completed||Phase 4|50|Anticipated|Klinikum Ludwigshafen||2|||f||||t||||||||||2017-02-18 14:58:06.921656|2017-02-18 14:58:06.921656
NCT00576836|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2016-04-20||2012-09-10|February 2006||2006-02-01|April 2016|2016-04-01|June 2027|Anticipated|2027-06-01|August 2010|Actual|2010-08-01||Interventional|||Thymus Transplantation Dose in DiGeorge #932|Dose Study of Thymus Transplantation in DiGeorge Anomaly, IND 9836, #932.1|Active, not recruiting||Phase 2|28|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:58:07.010157|2017-02-18 14:58:07.010157
NCT00576823|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-10-21|2011-01-13||December 2007||2007-12-01|October 2014|2014-10-01|October 2009|Actual|2009-10-01|January 2009|Actual|2009-01-01||Interventional|Alfahydro||Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology|12-week, Multicenter, Open-label, Non-comparative Study to Investigate Pharmacodynamic and Safety of Alfuzosin 0.2 mg/kg/Day in the Treatment of Children and Adolescents 2 - 16 Years of Age With Hydronephrosis Associated With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology Followed by a 40-week Open-label Extension|Completed||Phase 3|25|Actual|Sanofi|This was an exploratory, open-label, non-comparative trial. Analyses were purely descriptive.|3|||f||||t||||||||||2017-02-18 14:58:07.133607|2017-02-18 14:58:07.133607
NCT00576810|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2014-04-30||2014-04-30|October 2007||2007-10-01|April 2014|2014-04-01||||January 2009|Actual|2009-01-01||Interventional|||Sodium Picosulphate vs. Placebo in Functional Constipation|A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 4 Weeks Treatment With Sodium Picosulfate [Dulcolax®, Laxoberal®]Drops 10 mg Administered Orally, Once Daily, in Patients With Functional Constipation|Completed||Phase 3|367|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 14:58:08.121903|2017-02-18 14:58:08.121903
NCT00576797|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2016-02-01|||May 2008||2008-05-01|February 2016|2016-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|VM||Genomic Tools for Studying the Ecology of the Human Vaginal Microflora|Genomic Tools for Studying the Ecology of the Human Vaginal Microflora|Completed||N/A|396|Actual|Emory University|||1||f||||f||||||Samples With DNA|"~     vaginal secretions~   "|||2017-02-18 14:58:08.264873|2017-02-18 14:58:08.264873
NCT00576784|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-17|||April 2005||2005-04-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|PIOswitch||Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin|Multi Center, Open Label Study to Evaluate the Influence of Pioglitazone Treatment Over 6 Months on Metabolic Control in Type II Diabetic Patients Previously Treated With Insulin|Completed||Phase 4|100|Actual|IKFE Institute for Clinical Research and Development||1|||f||||f||||||||||2017-02-18 14:58:08.352097|2017-02-18 14:58:08.352097
NCT00576771|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-04-27|||August 2013||2013-08-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Different Assisted Mechanical Ventilation in Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) Patients: Pressure Support Ventilation (PSV), Neurally Adjusted Ventilatory Assist (NAVA) and Controlled by Patient|Effects of Different Assisted Mechanical Ventilation in ALI/ARDS Patients: PSV, NAVA and Controlled by Patient|Completed||N/A|15|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 14:58:08.461418|2017-02-18 14:58:08.461418
NCT00576758|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-08-15|2013-11-27||January 2008||2008-01-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|September 2011|Actual|2011-09-01||Interventional|||GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma|An Open-label, Multi-center, Randomized Study to Evaluate the Efficacy on Tumor Response of GA101 (RO5072759) Monotherapy Versus Rituximab Monotherapy in Patients With Relapsed CD20+ Indolent Non-Hodgkin's Lymphoma|Completed||Phase 2|175|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 14:58:08.567966|2017-02-18 14:58:08.567966
NCT00576745|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-07-17|||September 2007||2007-09-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||A Comparison Of The 3M TM S Surgical Skin Closure System To The Standard Vicryl Suture Closure of Sternotomy Incisions During Cardiac Surgery|Comparison Of The 3M Surgical Skin Closure System To The Standard Vicryl Suture Closure Of Sternotomy Incisions|Completed||Phase 1|36|Actual|American Heart Association||2|||f||||t||||||||||2017-02-18 14:58:09.741513|2017-02-18 14:58:09.741513
NCT00576732|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-04-24|2010-09-02||December 2007||2007-12-01|April 2014|2014-04-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|||A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder|Risperidone in the Treatment of Children and Adolescents With Autistic Disorder: A Double-Blind, Placebo-Controlled Study of Efficacy and Safety, Followed by an Open-Label Extension Study of Safety|Completed||Phase 4|96|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 14:58:09.852614|2017-02-18 14:58:09.852614
NCT00576719|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-02-19|||March 2005||2005-03-01|February 2014|2014-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia|Intensive Treatment of Adolescent Panic and Agoraphobia|Completed||Phase 2|63|Actual|Boston University||3|||f||||t||||||||||2017-02-18 14:58:10.788829|2017-02-18 14:58:10.788829
NCT00576706|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2011-11-15|||December 2007||2007-12-01|November 2011|2011-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|PRESENT||PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity|A Phase III, Randomized, Double-dummy, Double Blind, Misoprostol-comparative Clinical Trial to Evaluate the Efficacy and Safety of Mucosta® Tablet in the Prevention of NSAID-induced Gastrointestinal Complications|Completed||Phase 3|396|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 14:58:10.892589|2017-02-18 14:58:10.892589
NCT00576693|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2014-06-10|2014-05-06||October 2008||2008-10-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|SAMMPRIS||Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis|Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis|Completed||Phase 3|451|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 14:58:11.014653|2017-02-18 14:58:11.014653
NCT00576680|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2016-04-12|||May 2008||2008-05-01|April 2016|2016-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|||RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors|Phase I/II Study of RAD001 in Combination With Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors|Active, not recruiting||Phase 1/Phase 2|12|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 14:58:12.082862|2017-02-18 14:58:12.082862
NCT00576667|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-04-18||2016-04-18|January 2008||2008-01-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes|A Double-blind, Randomized, Placebo-controlled, Parallel Group Study of Rimonabant 20 mg Daily for the Treatment of Non-diabetic Patients With Nonalcoholic Steatohepatitis (NASH)|Terminated||Phase 3|165|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 14:58:12.190938|2017-02-18 14:58:12.190938
NCT00576654|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2017-02-13|||December 2007||2007-12-01|January 2017|2017-01-01||||February 2017|Anticipated|2017-02-01||Interventional|||Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery|A Phase I Dose-Escalation Study of Oral ABT-888 (NSC #737664) Plus Intravenous Irinotecan (CPT-11, NSC#616348) Administered in Patients With Advanced Solid Tumors|Recruiting||Phase 1|48|Anticipated|National Cancer Institute (NCI)||3|||f||||f||||||||||2017-02-18 14:58:12.332654|2017-02-18 14:58:12.332654
NCT00576641|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-10-29|||May 2007||2007-05-01|October 2014|2014-10-01|April 2012|Actual|2012-04-01|January 2010|Actual|2010-01-01||Interventional|||Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma|A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma|Completed||Phase 1|22|Actual|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-02-18 14:58:12.483066|2017-02-18 14:58:12.483066
NCT00576628|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-10-07|2016-07-21||May 2008||2008-05-01|October 2016|2016-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||The intent-to-treat (ITT) population included all participants who received at least one dose of C.E.R.A. (Week 0) and for whom data for at least one follow-up variable were available.|A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.|A Single Arm Open Label Multicentre Study to Assess the Efficacy, Safety and Tolerability of Monthly Administration of Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anaemia in Pre-dialysis Patients, Not Currently Treated With ESA|Completed||Phase 3|133|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:58:12.599581|2017-02-18 14:58:12.599581
NCT00576615|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-05-05|||May 2002||2002-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||Propofol's Hypnotic and Memory Effects|CNS Targets of Propofol's Hypnotic and Memory Effects|Completed||N/A|102|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 14:58:15.604983|2017-02-18 14:58:15.604983
NCT00576602|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-11-03|||December 2007||2007-12-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant|A Randomized, Open Label Study to Evaluate the Effect of Subcutaneous Mircera, Versus no ESA Therapy, on Hemoglobin Levels in Chronic Kidney Disease Patients With Anemia After Kidney Transplant.|Terminated||Phase 4|1|Actual|Hoffmann-La Roche||2||poor recruitment|f||||||||||||||2017-02-18 14:58:15.714643|2017-02-18 14:58:15.714643
NCT00576589|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2010-01-14|||January 2008||2008-01-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|||||Interventional|||Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones|A Phase 1, 2-Part, Randomized, Subject And Investigator Blinded, Placebo-Controlled, Cross-Over Trial To Evaluate The Safety, Tolerability And Pharmacokinetics Of CE-326,597 In Obese, Adult Subjects With Asymptomatic Cholelithiasis|Completed||Phase 1|41|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:58:15.833504|2017-02-18 14:58:15.833504
NCT00576576|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2013-11-27|2012-11-28||July 2007||2007-07-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Evaluation of Atorvastatin on Atherosclerosis Composition|The Evaluation of Atorvastatin on Wall Shear Stress, Atherosclerosis Composition, and Microvascular Function in Patients With Moderate Coronary Disease|Completed||N/A|27|Actual|Emory University|No adverse events to report.|1|||f||||t||||||||||2017-02-18 14:58:15.961295|2017-02-18 14:58:15.961295
NCT00576563|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-04-20|||March 2007||2007-03-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|January 2015|Actual|2015-01-01||Interventional|||Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer|Rectal Cancer: Determination of the Predictive Value by Use of FDG-PET-CT Scans and Blood Proteins for the Prognosis of Patients With Rectal Cancer|Completed||N/A|103|Actual|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-02-18 14:58:16.451462|2017-02-18 14:58:16.451462
NCT00576550|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2008-10-10|||October 2007||2007-10-01|December 2007|2007-12-01|May 2008|Actual|2008-05-01|||||Interventional|||A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema|A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema|Completed||Phase 4|53|Actual|ACO Hud Nordic AB||4|||f||||f||||||||||2017-02-18 14:58:16.566571|2017-02-18 14:58:16.566571
NCT00576537|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2013-02-18|||March 2001||2001-03-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors|Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System|Completed||Phase 2|50|Actual|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-02-18 14:58:16.689898|2017-02-18 14:58:16.689898
NCT00576524|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2013-01-22|2012-12-12||September 2008||2008-09-01|January 2013|2013-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|ITD||Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis|Application of Impedance Threshold Device Technologies to Treat and Prevent Intradialytic Hypotension in Children Undergoing Hemodialysis|Terminated||Phase 2|2|Actual|Children's Hospital of Philadelphia||2||Completion not feasible. THERE ARE NO RESULTS FROM THIS TRIAL|f||||f||||||||||2017-02-18 14:58:16.805716|2017-02-18 14:58:16.805716
NCT00576511|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-05-28|||December 1994||1994-12-01|December 2007|2007-12-01|February 1996|Actual|1996-02-01|February 1996|Actual|1996-02-01||Interventional|||Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation|A Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Severe Chronic Constipation|Completed||Phase 2|53|Actual|Movetis||2|||f||||f||||||||||2017-02-18 14:58:17.163481|2017-02-18 14:58:17.163481
NCT00576498|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-10-25|||October 2005||2005-10-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Novel Imaging Techniques in Barrett's Esophagus|Detection Of Intestinal Metaplasia And High Grade Dysplasia In Barrett's Esophagus Using Novel Imaging Techniques - A Randomized Controlled Trial.|Completed||N/A|130|Actual|Midwest Biomedical Research Foundation||2|||f||||f||||||||||2017-02-18 14:58:17.270302|2017-02-18 14:58:17.270302
NCT00576485|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2008-10-17|||February 2005||2005-02-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|IOLs||Spherical Aberration and Contrast Sensitivity in IOLs|Spherical Aberration and Contrast Sensitivity in Eyes Implanted With Aspheric and Spherical Intraocular Lenses: Clinical Comparative Study|Completed||Phase 4|25|Actual|Federal University of Minas Gerais||2|||f||||t||||||||||2017-02-18 14:58:17.409169|2017-02-18 14:58:17.409169
NCT00576472|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-02-27|2011-10-28||January 2000||2000-01-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Learning Impairments Among Survivors of Childhood Cancer|Learning Impairments Among Survivors of Childhood Cancer|Completed||Phase 4|469|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 14:58:17.537926|2017-02-18 14:58:17.537926
NCT00576459|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-12-07|||March 2003||2003-03-01|July 2011|2011-07-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema|A Randomized, Controlled Pilot Study to Evaluate the Safety and Efficacy of Intravitreal Fluocinolone Acetonide (0.5mg and 2mg) Implants in Patients With Clinically Significant Diabetic Macular Edema|Completed||Phase 2|40|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-02-18 14:58:19.499126|2017-02-18 14:58:19.499126
NCT00576446|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2013-02-18|||April 2007||2007-04-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|Gliadel Wafer||Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients|A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma|Completed||Phase 1|35|Actual|Cedars-Sinai Medical Center||1|||f||||t||||||||||2017-02-18 14:58:19.611994|2017-02-18 14:58:19.611994
NCT00576433|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-11-01|||December 2007||2007-12-01|November 2016|2016-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.|An Open Label Study to Evaluate the Safety and Effect on Treatment Response of MabThera in Patients With Rheumatoid Arthritis Following Inadequate Response to One Prior Anti-TNF Inhibitor|Completed||Phase 4|60|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:58:19.708023|2017-02-18 14:58:19.708023
NCT00576420|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2012-10-26|2012-09-13||December 2007||2007-12-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Fibrin Sealant Vascular Surgery Study|Clinical Evaluation of Efficacy and Safety of FS VH S/D 500 S-apr for Hemostasis in Subjects Undergoing Vascular Surgery|Completed||Phase 2|101|Actual|Baxter Healthcare Corporation||3|||f||||f||||||||||2017-02-18 14:58:19.838347|2017-02-18 14:58:19.838347
NCT00576407|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2016-09-22||2012-09-06|November 2001||2001-11-01|September 2016|2016-09-01|June 2027|Anticipated|2027-06-01|February 2008|Actual|2008-02-01||Interventional|||Thymus Transplantation in DiGeorge Syndrome #668|Phase II Study of Thymus Transplantation in Complete DiGeorge Syndrome #668|Active, not recruiting||Phase 2|26|Actual|Duke University||1|||f||||t||||||||||2017-02-18 14:58:21.870908|2017-02-18 14:58:21.870908
NCT00576394|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2015-06-22|||October 2006||2006-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients|Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients|Completed||Phase 1|108|Actual|American Heart Association||2|||f||||t||||||||||2017-02-18 14:58:22.025215|2017-02-18 14:58:22.025215
NCT00576381|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2013-04-10|2012-12-13||April 2006||2006-04-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Dex||Understanding Dexmedetomidine in Neonates After Open Heart Surgery|The Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Neonates Following Open Heart Surgery|Completed||Phase 1|30|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 14:58:22.133639|2017-02-18 14:58:22.133639
NCT00576368|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-28|||June 2003||2003-06-01|December 2007|2007-12-01|April 2004|Actual|2004-04-01|||||Interventional|||An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice|An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice|Completed||Phase 4|4464|Actual|Sanofi||1|||f||||||||||||||2017-02-18 14:58:22.372582|2017-02-18 14:58:22.372582
NCT00576355|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2012-06-19|||December 2007||2007-12-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder|Adjunctive Psychotherapy for Teens With Bipolar Disorder|Completed||N/A|36|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:58:22.465176|2017-02-18 14:58:22.465176
NCT00576342|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-07-09||2014-07-09|December 2007||2007-12-01|July 2014|2014-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Patient Preference Study|A Single Dose Patient Preference Study Comparison in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|129|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:58:22.569779|2017-02-18 14:58:22.569779
NCT00576329|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-05-12|||November 2006||2006-11-01|May 2014|2014-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Topical 0.4% Ketorolac and Vitreoretinal Surgery|Topical 0.4% Ketorolac for the Inhibition of Miosis During Vitreoretinal Surgery: a Randomized, Placebo-controlled, Double-masked Study|Completed||Phase 2/Phase 3|76|Actual|Emory University||2|||f||||f||||||||||2017-02-18 14:58:22.663372|2017-02-18 14:58:22.663372
NCT00576316|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2010-11-30|2009-11-19||January 2008||2008-01-01|November 2010|2010-11-01|November 2008|Actual|2008-11-01|||||Interventional|SMARTER||Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia|Symbicort Maintenance And Reliever Therapy - Experience in Real Life Setting in Malaysia - SMARTER Study|Completed||Phase 4|201|Actual|AstraZeneca|||||f||||f||||||||||2017-02-18 14:58:22.766277|2017-02-18 14:58:22.766277
NCT00576303|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2016-04-20|2016-04-20||April 2008||2008-04-01|April 2016|2016-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.|A Single-arm, Open Label Multicenter Study to Assess the Efficacy, Safety and Tolerability of Once Monthly Administration of C.E.R.A. for the Maintenance of Hemoglobin Levels in Dialysis Patients With Chronic Renal Anemia|Completed||Phase 3|200|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:58:22.979692|2017-02-18 14:58:22.979692
NCT00575887|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2013-11-03|2013-11-03||August 2006||2006-08-01|November 2013|2013-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma|Efficacy of a Protracted Temozolomide Schedule in Patients With Progression After Standard Dose Temozolomide for High-grade Gliomas|Completed||Phase 2|25|Actual|Marmara University||1|||f||||t||||||||||2017-02-18 14:58:27.723451|2017-02-18 14:58:27.723451
NCT00576277|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-17|||September 2006||2006-09-01|April 2007|2007-04-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain|A Prospective, Double-Blind, Randomized, Placebo-Controlled Trial of AV411 to Assess Its Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in the Treatment of Neuropathic Pain|Completed||Phase 1/Phase 2|36|Anticipated|Avigen|||||f||||t||||||||||2017-02-18 14:58:23.43314|2017-02-18 14:58:23.43314
NCT00576264|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2011-06-24|||April 2007||2007-04-01|December 2007|2007-12-01|February 2012|Anticipated|2012-02-01|||||Observational|||Stem Cells Found in the Abdominal Cavity in Humans|Peritoneal Cavity Derived Stem Cells: A Pilot Study|Unknown status|Recruiting|N/A|50|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||Samples With DNA|"~     peritoneal fluid~   "|||2017-02-18 14:58:23.51945|2017-02-18 14:58:23.51945
NCT00576251|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2010-02-23|2009-09-25||October 2007||2007-10-01|February 2010|2010-02-01|March 2008||2008-03-01|February 2008|Actual|2008-02-01||Interventional|||TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension||Completed||Phase 3|221|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 14:58:23.606656|2017-02-18 14:58:23.606656
NCT00576238|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2008-10-10|||January 2004||2004-01-01|October 2008|2008-10-01|February 2008|Actual|2008-02-01|||||Interventional|||Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser|A Multi Centre, Parallel, Randomised Study of the Skin Tolerance of Betamethasone Creams on Atopic Eczema and the Influence of Moisturiser Treatment on the Recurrence of Eczema|Completed||Phase 3|55|Actual|ACO Hud Nordic AB||4|||f||||f||||||||||2017-02-18 14:58:23.928738|2017-02-18 14:58:23.928738
NCT00576225|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2013-05-20|||September 2007||2007-09-01|May 2013|2013-05-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL|Paclitaxel Poliglumex (CT-2103)/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer (NSCLC) in Women With Estradiol > 25 pg/mL|Unknown status|Active, not recruiting|Phase 3|450|Anticipated|CTI BioPharma||2|||f||||t||||||||||2017-02-18 14:58:24.044583|2017-02-18 14:58:24.044583
NCT00576212|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2009-07-29|||September 2007||2007-09-01|July 2009|2009-07-01|September 2009|Anticipated|2009-09-01|||||Interventional|TOPFA||Impact of a Telephone-based Support Intervention on the Long-term Well-being of Women Undergoing Termination of Pregnancy for Fetal Anomaly|The Impact of a Telephone-based Support Intervention on the Long-term Well-being of Women Undergoing Termination of Pregnancy for Fetal Anomaly|Withdrawn||N/A|100|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2||Study halted prematurely, prior to enrollment of first participant.|f||||f||||||||||2017-02-18 14:58:24.181589|2017-02-18 14:58:24.181589
NCT00576199|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-18|2014-08-18|2014-08-18||February 2008||2008-02-01|August 2014|2014-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||Intent-to-treat population: All participants who received study medication.|A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer|A Phase II Single Arm, Multi-centre Study of Bevacizumab (Avastin®) Pre- and Post-transarterial Chemoembolisation (TACE) Treatment for Localized Unresectable Hepatocellular Carcinoma (HCC)|Completed||Phase 2|30|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 14:58:24.283002|2017-02-18 14:58:24.283002
NCT00576186|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2016-06-21|||February 2005||2005-02-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Observational|||Validation of the Gated Blood Pool SPECT: ERNA vs 3D Echo|Validation of the Gated Blood Pool SPECT: Comparison to ERNA and 3-dimensional Echocardiography.|Completed||N/A|30|Actual|Yale University|||1||f||||f||||||||||2017-02-18 14:58:24.81404|2017-02-18 14:58:24.81404
NCT00576173|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2010-04-26|||December 2005||2005-12-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|||||Interventional|||An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients|An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients|Completed||Phase 4|60|Actual|Johnson & Johnson Taiwan Ltd||1|||f||||||||||||||2017-02-18 14:58:24.918428|2017-02-18 14:58:24.918428
NCT00576160|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-05-13|||August 2007||2007-08-01|May 2015|2015-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Improving Medication Adherence in Post-ACS Patients|Improving Med Adherence in Post-ACS Patients: Phase 1B Dose-Finding RCT|Terminated||Phase 1|22|Actual|Columbia University||2||"This was a dosing study to determine acceptability. Participants found protocol burdensome and~   so we terminated."|f||||t||||||||||2017-02-18 14:58:25.003395|2017-02-18 14:58:25.003395
NCT00576147|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2013-12-19|2012-04-11||July 2006||2006-07-01|December 2013|2013-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection|A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection|Completed||N/A|431|Actual|InfraScan, Inc.||1|||f||||f||||||||||2017-02-18 14:58:25.103863|2017-02-18 14:58:25.103863
NCT00576134|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-01-22|||February 2008||2008-02-01|January 2015|2015-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement|Artificial Larynx : Intralaryngeal Prosthesis With Valve in Major Swallowing Troubles|Completed||Phase 1|10|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-02-18 14:58:25.377291|2017-02-18 14:58:25.377291
NCT00576121|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2016-06-22|||July 2008||2008-07-01|June 2016|2016-06-01|August 2012|Anticipated|2012-08-01|August 2011|Anticipated|2011-08-01||Observational|||Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction|Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction|Withdrawn||N/A|0|Actual|Yale University|||3||f||||f||||||||||2017-02-18 14:58:25.461397|2017-02-18 14:58:25.461397
NCT00576108|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2008-07-18|||November 2007||2007-11-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)||Completed||Phase 2|48|Anticipated|Kalypsys, Inc.||2|||f||||f||||||||||2017-02-18 14:58:25.560951|2017-02-18 14:58:25.560951
NCT00576095|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2014-03-12|||August 2005||2005-08-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Clinical and Biological Characteristics of Psychotic Depression|Hypothalamic-Pituitary-Adrenal (HPA)/ Dopamine Axis in Psychotic Depression|Completed||N/A|73|Actual|Stanford University|||3||f||||f||||||Samples With DNA|"~     serum~   "|||2017-02-18 14:58:25.661091|2017-02-18 14:58:25.661091
NCT00576082|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2016-06-08|||March 2008||2008-03-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Borrelia Species in Cutaneous Lyme Borreliosis|DIVERSITY OF BORRELIA SPECIES INVOLVED IN CUTANEOUS MANIFESTATIONS OF LYME BORRELIOSIS IN FRANCE|Recruiting||N/A|600|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||Samples With DNA|"~     Cutaneous biopsy specimen~   "|||2017-02-18 14:58:25.758064|2017-02-18 14:58:25.758064
NCT00576069|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2015-03-13|||October 2007||2007-10-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma|Evaluation of Mechanism(s)Limiting Expiratory Airflow in Chronic, Stable Asthmatics Who Are Non-smokers|Recruiting||Phase 4|40|Anticipated|Gelb, Arthur F., M.D.|||1||f||||t||||||||||2017-02-18 14:58:25.862609|2017-02-18 14:58:25.862609
NCT00576056|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-12-28|2016-05-23||January 2008||2008-01-01|November 2016|2016-11-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC|Phase II Trial of Transcatheter Arterial Chemoembolization (TACE) Plus Oral Sorafenib (BAY 43-9006, Nexavar®) for Unresectable Hepatocellular Carcinoma (HCC)|Terminated||Phase 2|19|Actual|University of Pittsburgh||1||Bayer Healthcare is no supplying the study drug|f||||t||||||||No||2017-02-18 14:58:26.000692|2017-02-18 14:58:26.000692
NCT00576043|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-03-25|||March 2004||2004-03-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|endosim||Effect of Virtual Endoscopy Simulator Training on Real Patient Endoscopy|Effect of Virtual Endoscopy Simulator Training on Real Patient Endoscopy: A Randomized, Controlled Trial|Completed||N/A|24|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 14:58:26.307997|2017-02-18 14:58:26.307997
NCT00576030|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2010-07-02|||January 2007||2007-01-01|August 2009|2009-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Action of Caffeinated and Decaffeinated Espresso on Autonomic Function|Short-term Autonomic Effects of Caffeinated and Decaffeinated Espresso in Young Healthy Individuals|Terminated||N/A|77|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-02-18 14:58:26.405702|2017-02-18 14:58:26.405702
NCT00576017|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2011-05-18|||October 2003||2003-10-01|April 2010|2010-04-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).|Randomised Study to Evaluate the Efficacy and Safety of Fentanyl-TTS Versus Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDs (Non-steroidal Anti-inflammatory Drugs).|Completed||Phase 4|19|Actual|Janssen-Cilag, S.A.|||||f||||||||||||||2017-02-18 14:58:26.491842|2017-02-18 14:58:26.491842
NCT00576004|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-17|||January 2002||2002-01-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Pelvic Organ Prolapse Repair With or Without Concomitant Burch Colposuspension in Patients With Urinary Incontinence|Pelvic Organ Prolapse Repair With or Without Concomitant Burch Colposuspension in Patients With Urinary Incontinence: A Randomised Surgical Trial|Completed||N/A|67|Actual|University Of Perugia||2|||f||||f||||||||||2017-02-18 14:58:26.582404|2017-02-18 14:58:26.582404
NCT00575991|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-03-12|||January 2007||2007-01-01|March 2012|2012-03-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Conjugated Linoleic Acid on Body Fat in Overweight Children|Effect of CLA Supplementation on Body Fat Accretion Among Children Who Are Overweight or at Risk of Overweight|Completed||N/A|62|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 14:58:26.69466|2017-02-18 14:58:26.69466
NCT00575978|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-03-03|||June 2004||2004-06-01|March 2015|2015-03-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Hydralazine as Demethylating Agent in Breast Cancer|Hydralazine as Demethylating Agent in Breast Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|University of Arkansas||1||IRB request|f||||f||||||||||2017-02-18 14:58:26.804709|2017-02-18 14:58:26.804709
NCT00575965|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-16|2015-11-11|2012-12-19||November 2007||2007-11-01|November 2015|2015-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Simvastatin in Waldenstrom's Macroglobulinemia|Phase II Study of Simvastatin in Waldenstrom's Macroglobulinemia|Terminated||Phase 2|18|Actual|Dana-Farber Cancer Institute|Slow accrual led to early study termination.|1||Slow accrual led to early study termination.|f||||t||||||||||2017-02-18 14:58:26.903763|2017-02-18 14:58:26.903763
NCT00575952|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2016-10-26|||January 2008||2008-01-01|October 2016|2016-10-01||||January 2016|Actual|2016-01-01||Interventional|||Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer|A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients at High Risk for Peritoneal Failure|Active, not recruiting||Phase 1|27|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 14:58:27.175292|2017-02-18 14:58:27.175292
NCT00575939|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2014-12-18|||November 2007||2007-11-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|July 2013|Actual|2013-07-01||Observational|||Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV|Assessment of the Use of a Metabolically-friendly Antiretroviral Regimen to Slow Down the Rate of Progression in Carotid Artery Intima-medial Thickness in Adults With HIV|Completed||N/A|120|Actual|University Hospitals Cleveland Medical Center|||2||f||||f||||||Samples Without DNA|"~     Stored plasma and serum~   "|||2017-02-18 14:58:27.336078|2017-02-18 14:58:27.336078
NCT00575926|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-17|||September 2002||2002-09-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Lingzhi for Cancer Children|A Randomized, Double-Blind, Placebo-Controlled, Parallel Study of the Clinical Effects of Ganoderma Lucidum (Ling Zhi) in Children With Cancer|Completed||Phase 3|58|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 14:58:27.425531|2017-02-18 14:58:27.425531
NCT00575913|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-04-08|||September 2003||2003-09-01|April 2008|2008-04-01|March 2005|Actual|2005-03-01|||||Interventional|ALEX-XL||Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study|ALEX-XL: Alfuzosin XL-Lower Urinary Tract Symptoms Efficacy and Sexuality Study|Completed||Phase 4|118|Actual|Sanofi|||||f||||||||||||||2017-02-18 14:58:27.530861|2017-02-18 14:58:27.530861
NCT00575900|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-16|2007-12-16|||March 2005||2005-03-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Low Carbohydrates in Obese Adolescents|Comparison Between Low Carbohydrate Low Fat, Low Carbohydrate High Fat and Balanced Low Fat Diets in the Treatment of Obesity in Adolescents- a Randomized Controlled Trail.|Completed||N/A|55|Actual|Rabin Medical Center||3|||f||||f||||||||||2017-02-18 14:58:27.622049|2017-02-18 14:58:27.622049
NCT00575874|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-02-06|||August 2007||2007-08-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|RAISE||Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Dose and Active Comparator-Controlled Dose-Response Study of Rivoglitazone (CS-011) in Patients With Type 2 Diabetes|Completed||Phase 2|150|Anticipated|Daiichi Sankyo Inc.||5|||f||||f||||||||||2017-02-18 14:58:27.947836|2017-02-18 14:58:27.947836
NCT00575861|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2007-12-18|||September 2005||2005-09-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Zileuton and Exhaled Nitric Oxide in Asthmatics|Evaluation of Additive Effects of Zileuton to Advair on Total Exhaled, Bronchial, and Alveolar Nitric Oxide in Asthmatics|Completed||Phase 4|19|Actual|Gelb, Arthur F., M.D.||1|||f||||t||||||||||2017-02-18 14:58:28.053428|2017-02-18 14:58:28.053428
NCT00575848|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-11-25|||December 2007||2007-12-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia|A Trial of the Effects of Glycine Loading on Clinical Symptoms and Logical Memory in Patients With Schizophrenia|Terminated||Phase 1|16|Anticipated|North Suffolk Mental Health Association||2||"Slow enrollment and due to personnel change there was no viable way to quantify glycine levels~   through imaging"|f||||f||||||||||2017-02-18 14:58:28.164178|2017-02-18 14:58:28.164178
NCT00575835|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-26|||October 2006||2006-10-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Oral Vitamin D Supplementation in Elderly Women|Oral Vitamin D Supplementation in Elderly Women: Twice a Day or Three Times a Year? A Randomised Controlled Trial|Completed||N/A|40|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 14:58:28.28455|2017-02-18 14:58:28.28455
NCT00575822|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2008-07-15|||January 2005||2005-01-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD|Endoscopic Full-Thickness Plication for the Treatment of Gastroesophageal Reflux Disease: A Randomized, Sham-Controlled Trial|Terminated||N/A|159|Actual|NDO Surgical, Inc.||2||Sponsoring company ceased business operations.|f||||f||||||||||2017-02-18 14:58:28.374487|2017-02-18 14:58:28.374487
NCT00575809|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2016-08-15|||May 2005||2005-05-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Incidence and Factors Associated With the Development and Severity of Oral Mucositis|Incidence and Factors Associated With the Development and Severity of Oral Mucositis in Patients Undergoing High-Dose Chemotherapy and Peripheral Blood Stem Cell Transplantation|Recruiting||N/A|800|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-02-18 14:58:28.49135|2017-02-18 14:58:28.49135
NCT00575796|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-05-31|||October 2007||2007-10-01|May 2016|2016-05-01|October 2019|Anticipated|2019-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)|Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)|Active, not recruiting||Phase 2|50|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||||2017-02-18 14:58:28.60546|2017-02-18 14:58:28.60546
NCT00575783|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-01-25|||August 2005||2005-08-01|January 2012|2012-01-01|August 2008|Actual|2008-08-01|||||Observational|||Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM|Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM|Completed||N/A|51|Anticipated|Yale University|||3||f||||t||||||||||2017-02-18 14:58:28.718551|2017-02-18 14:58:28.718551
NCT00575757|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-08-17|||July 2007||2007-07-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|||Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV|Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV|Completed||N/A|12|Actual|Virginia Commonwealth University|||1||f||||t||||||Samples Without DNA|"~     sera, liver tissue~   "|||2017-02-18 14:58:28.808872|2017-02-18 14:58:28.808872
NCT00575744|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-10-26|||December 1998||1998-12-01|October 2016|2016-10-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation|Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation|Completed||Phase 2|699|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:58:28.912955|2017-02-18 14:58:28.912955
NCT00575731|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-16|2015-05-18|||July 2006||2006-07-01|May 2015|2015-05-01|May 2009|Actual|2009-05-01|April 2008|Actual|2008-04-01||Interventional|||Behavioral Strategies for Weight Management|Behavioral Strategies for Weight Management|Completed||N/A|40|Actual|Stanford University||2|||f||||||||||||||2017-02-18 14:58:29.079507|2017-02-18 14:58:29.079507
NCT00575718|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-11-01|||October 2002||2002-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Smoking Cessation Intervention for Cancer Patients|Presurgical Smoking Cessation Intervention for Cancer Patients: The Resolve Study|Active, not recruiting||N/A|204|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 14:58:29.171644|2017-02-18 14:58:29.171644
NCT00575705|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2011-03-15|||November 2005||2005-11-01|March 2011|2011-03-01|November 2010|Anticipated|2010-11-01|||||Observational|UAB RPKDCC||UAB Recessive PKD Research and Translational Core Center|The ARPKD Clinical and Genetic Resource (UAB Recessive PKD Research and Translational Core Center)|Unknown status|Active, not recruiting|N/A|200|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||f||||||Samples With DNA|"~     Blood-derived DNA and lymphocytes for EBV-immortalized cell lines.~   "|||2017-02-18 14:58:29.438816|2017-02-18 14:58:29.438816
NCT00575692|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-05-27|||December 2006||2006-12-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension|Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension|Completed||N/A|240|Actual|Medical University of Graz|||2||f||||t||||||||||2017-02-18 14:58:29.538533|2017-02-18 14:58:29.538533
NCT00575679|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-10-27|||January 2008||2008-01-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|BADS||Behavior and Driving Safety Study|Behavior and Driving Safety Study|Unknown status|Active, not recruiting|N/A|800|Anticipated|University of California, Davis||2|||f||||f||||||||||2017-02-18 14:58:29.643802|2017-02-18 14:58:29.643802
NCT00575666|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-11-15|2012-04-27||December 2007||2007-12-01|November 2012|2012-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Intranasal Insulin Treatment in Patients With Schizophrenia|Intranasal Insulin Treatment in Patients With Schizophrenia|Completed||Phase 4|45|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 14:58:29.762364|2017-02-18 14:58:29.762364
NCT00575653|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-19|||March 2005||2005-03-01|December 2007|2007-12-01|August 2008|Anticipated|2008-08-01|||||Observational|||Safety Study of GBS Following Menactra Meningococcal Vaccination|Risk of Guillain-Barré Syndrome Following Meningococcal Conjugate (MCV4) Vaccination|Unknown status|Active, not recruiting|N/A|6000000|Anticipated|Harvard Pilgrim Health Care|||2||f||||f||||||||||2017-02-18 14:58:30.474954|2017-02-18 14:58:30.474954
NCT00575640|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-03-03|||November 2004||2004-11-01|March 2015|2015-03-01||||May 2008|Actual|2008-05-01||Interventional|||Hydralazine as a Demethylating Agent in Rectal Cancer|Hydralazine as a Demethylating Agent in Rectal Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|University of Arkansas||1||No enrollment|f||||f||||||||||2017-02-18 14:58:30.588043|2017-02-18 14:58:30.588043
NCT00575627|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2008-06-03|||September 2007||2007-09-01|June 2008|2008-06-01|September 2010|Anticipated|2010-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels|Treatment of Chronic Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels With Peginterferon α-2a (40 kDa) Plus Ribavirin|Unknown status|Recruiting|Phase 4|150|Anticipated|University of Turin, Italy||2|||f||||t||||||||||2017-02-18 14:58:30.6921|2017-02-18 14:58:30.6921
NCT00575614|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-05-28|||April 1997||1997-04-01|December 2007|2007-12-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||Prucalopride in Patients With Chronic Idiopathic Constipation|Study to Evaluate the Effect of a 1 mg o.d. Dose of Prucalopride in Patients With Chronic Idiopathic Constipation|Completed||Phase 2|87|Actual|Movetis||2|||f||||f||||||||||2017-02-18 14:58:30.801701|2017-02-18 14:58:30.801701
NCT00575601|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2009-06-30|||August 2007||2007-08-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|||||Interventional|||Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients|Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients : A Prospective Randomized Double Blind Placebo Controlled Trial|Completed||Phase 3|120|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 14:58:30.912874|2017-02-18 14:58:30.912874
NCT00575588|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-03-20|2010-08-10||December 2007||2007-12-01|March 2012|2012-03-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|||52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period|A 52-Week International, Multi-centre, Randomized, Parallel-group, Double-blind, Active-controlled, Phase III Study With a 52-Week Extension Period to Evaluate the Safety and Efficacy of Saxagliptin in Combination With Metformin Compared With Sulphonylurea in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Metformin Therapy Alone.|Completed||Phase 3|891|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 14:58:31.038041|2017-02-18 14:58:31.038041
NCT00575575|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2009-02-25|||June 2007||2007-06-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Research on Suicidal Ideation of University Students in Harbin City and Cognitive Behavior Therapy|the Research on Suicidal Ideation of University Students in Harbin City and Intervention on Them|Completed||N/A|355|Actual|Harbin Medical University||1|||f||||t||||||||||2017-02-18 14:58:31.860792|2017-02-18 14:58:31.860792
NCT00575562|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2010-06-22|||June 2007||2007-06-01|December 2007|2007-12-01||||||||Interventional|||Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer|Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer|Completed||Phase 1|28|Anticipated|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||f||||||||||2017-02-18 14:58:31.949722|2017-02-18 14:58:31.949722
NCT00575549|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-07-19||||||July 2012|2012-07-01||||||||Expanded Access|||Prospective Analysis and Comparison of Stress Echo to Real-Time Myocardial Contrast Stress Echo|Prospective Analysis and Comparison of Conventional Stress Echocardiograms and Real-Time Myocardial Contrast Stress Echocardiogram; for Bristol-Myers Squibb Medical Imaging: The Definity RT-P During DSE Database|Available||N/A|||University of Nebraska|||||f||||||||||||||2017-02-18 14:58:32.101502|2017-02-18 14:58:32.101502
NCT00575536|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2014-12-19|||January 2006||2006-01-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Observational|Rhizotomy||Optical Stimulation Rhizotomy Study|Optical Stimulation in Peripheral Nerves in Selective Rhizotomy Cases|Unknown status|Recruiting|N/A|20|Anticipated|Vanderbilt University|||1||f||||f||||||Samples Without DNA|"~     abnormal spinal nerves that have been surgically removed~   "|||2017-02-18 14:58:32.19553|2017-02-18 14:58:32.19553
NCT00575523|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-01-23|||October 2003||2003-10-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|||||Interventional|atropinePEI||Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy|Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy|Completed||Phase 4|31|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 14:58:32.30086|2017-02-18 14:58:32.30086
NCT00575510|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2014-07-28|2014-05-19||October 2005||2005-10-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Intervention to Improve Follow-up of Abnormal Pap Test|Intervention to Improve Follow-up of Abnormal Pap Test|Completed||N/A|341|Actual|The University of Texas Medical Branch, Galveston||3|||f||||t||||||||||2017-02-18 14:58:32.401959|2017-02-18 14:58:32.401959
NCT00575497|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2007-12-17|||January 2005||2005-01-01|December 2007|2007-12-01|January 2010|Anticipated|2010-01-01|||||Interventional|MFD||More Frequent Dialysis (>3 Treatments Per Week)|Study of Clinical Outcomes of More Frequent Hemodialysis|Unknown status|Recruiting|Phase 4|300|Anticipated|Satellite Healthcare||7|||f||||f||||||||||2017-02-18 14:58:32.798169|2017-02-18 14:58:32.798169
NCT00575484|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-01-22|||November 2007||2007-11-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction|Hypertonic Saline With Furosemide and a Normosodic Diet for the Treatment of Decompensated Congestive Heart Failure With Prerenal Physiology|Terminated||Phase 2|11|Actual|Barnes-Jewish Hospital||2|||f||||t||||||||||2017-02-18 14:58:32.909193|2017-02-18 14:58:32.909193
NCT00575471|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2009-02-27|||July 2007||2007-07-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled 12-Week Dose-Response Study of Rivoglitazone (CS-011) in Patients With Type 2 Diabetes.|Completed||Phase 2|250|Actual|Daiichi Sankyo Inc.||4|||f||||f||||||||||2017-02-18 14:58:33.020195|2017-02-18 14:58:33.020195
NCT00575458|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2010-11-15|||June 2005||2005-06-01|November 2010|2010-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Splinting for Dupuytren's Contracture Release|Prospective Randomized Comparison of Dynamic Versus Static Splinting After Dupuytren's Contracture Release|Completed||N/A|60|Anticipated|Massachusetts General Hospital|||2||f||||f||||||||||2017-02-18 14:58:33.116666|2017-02-18 14:58:33.116666
NCT00575445|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-03-24|||November 2007||2007-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2009|Actual|2009-12-01||Observational|||The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients||Terminated||N/A|100|Anticipated|Akron Children's Hospital|||1|Nitric Oxide analyzer not functioning properly|f||||f||||||||||2017-02-18 14:58:33.197089|2017-02-18 14:58:33.197089
NCT00575432|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2016-11-02|||November 2004||2004-11-01|November 2016|2016-11-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|||Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy|Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy in Renal Transplantation and Kidney Disease|Recruiting||N/A|200|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||Undecided||2017-02-18 14:58:33.28073|2017-02-18 14:58:33.28073
NCT00575419|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-11-28|||November 2007||2007-11-01|November 2012|2012-11-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|CIN-NAC||Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure|Dose Escalation Study Of I.V. And Intra-Aortic N-Acetylcysteine For The Prevention Of Contrast Induced Nephropathy In Patients With Stage 3 Renal Failure Undergoing Contrast Imaging Studies: A Phase I Trial|Unknown status|Recruiting|Phase 1|60|Anticipated|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 14:58:35.864024|2017-02-18 14:58:35.864024
NCT00575406|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2013-08-29|||December 2007||2007-12-01|August 2013|2013-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|NHL-14||Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma|Multicentre Study to Determine the Cardiotoxicity of R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristin and Prednisolone) Compared to R-COMP (Rituximab, Cyclophosphamide, Liposomal Doxorubicin, Vincristin and Prednisolone) in Patients With Diffuse Large B-Cell Lymphoma (NHL-14)|Completed||Phase 2|94|Actual|Arbeitsgemeinschaft medikamentoese Tumortherapie||2|||f||||f||||||||||2017-02-18 14:58:35.991747|2017-02-18 14:58:35.991747
NCT00575393|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2016-12-20|||January 2007||2007-01-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Interventional|||Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer|A Phase I Dose Escalation Study of the PKC Inhibitor, Aurothiomalate (ATM) in Patients With Advanced Non-Small Cell Lung Cancer|Active, not recruiting||Phase 1|27|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 14:58:36.112894|2017-02-18 14:58:36.112894
NCT00575380|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-09-20|2009-06-09||December 2007||2007-12-01|September 2011|2011-09-01||||June 2008|Actual|2008-06-01||Interventional|||Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery|A Multi-Center, Open-Label, Randomized Study of the Pharmacokinetics of Azithromycin Versus Moxifloxacin in Conjunctiva and Aqueous Humor Following Single or Multiple Ocular Administration of AzaSite Ophthalmic Solution, 1% or Vigamox in Subjects Undergoing Routine Cataract Surgery|Completed||Phase 4|116|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:58:36.212631|2017-02-18 14:58:36.212631
NCT00575367|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2011-09-20|2009-08-10||March 2008||2008-03-01|September 2011|2011-09-01||||October 2008|Actual|2008-10-01||Interventional|||Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers|A Single-Center, Open-Label, Randomized Study of the Pharmacokinetics of AzaSite Ophthalmic Solution Versus Vigamox in the Tears of Healthy Volunteers Following a Single Ocular Administration|Completed||Phase 4|37|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 14:58:36.572011|2017-02-18 14:58:36.572011
NCT00575354|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2008-04-18|||March 2007||2007-03-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|CSIABTEC||Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision|Anesthesia With Sevoflurane and Isoflurane for Excision Surgeries in Benign Breast Tumors|Completed||Phase 4|500|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 14:58:37.052569|2017-02-18 14:58:37.052569
NCT00575341|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2007-12-17|||October 2003||2003-10-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|DHEA2000||Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency|Dehydroepiandrosterone(DHEA) Substitution in Adolescent and Young Women With Central Adrenal Insufficiency. A Multicenter, Randomised Double Blind Trial|Completed||Phase 3|23|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-02-18 14:58:37.164547|2017-02-18 14:58:37.164547
NCT00575328|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2011-06-10|||November 2007||2007-11-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females|A Double-Blind, Placebo Controlled Study of Maca Root for the Treatment of Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females|Completed||Phase 3|80|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 14:58:37.293767|2017-02-18 14:58:37.293767
NCT00575315|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2014-08-19|||July 2004||2004-07-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||HIV-HCV Coinfection: Impact of Immune Dysfunction|HIV-HCV Coinfection: Impact of Immune Dysfunction|Completed||N/A|634|Actual|Virginia Commonwealth University|||1||f||||t||||||Samples With DNA|"~     Sera~   "|||2017-02-18 14:58:37.389787|2017-02-18 14:58:37.389787
NCT00575302|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2010-04-12|||December 2007||2007-12-01|April 2010|2010-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age|Study of Optimal Posology of Gonadotrophins in Patients With Insufficient Ovarian Response Due to Age|Withdrawn||Phase 4|400|Anticipated|Centre Hospitalier Chretien||2||"36 cases were included and the 4 centers and they are unable to increase their recruitment to~   obtain the 400 cases necessary to reach statistical significance."|f||||f||||||||||2017-02-18 14:58:37.48755|2017-02-18 14:58:37.48755
NCT00575276|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2012-03-07|||August 2006||2006-08-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Study of Pain Perception Between Males and Females Following Laparoscopic Cholecystectomy|Sex-Dependent Modulation of Clinical Outcomes Following Laparoscopic Cholecystectomy|Completed||N/A|102|Actual|The University of Texas Health Science Center at San Antonio|||4||f||||f||||||Samples With DNA|"~     1 cm biopsies of the body and fundus of the excised gallbladder. Two 4ml blood samples~     collected for DNA analysis with future studies.~   "|||2017-02-18 14:58:37.596138|2017-02-18 14:58:37.596138
NCT00573612|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2012-04-05|||December 2007||2007-12-01|March 2011|2011-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Exercise-based Motivational Interviewing for Fibromyalgia|Exercise-based Motivational Interviewing for Fibromyalgia|Completed||N/A|200|Anticipated|Indiana University||2|||f||||f||||||||||2017-02-18 14:59:11.965108|2017-02-18 14:59:11.965108
NCT00575263|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2015-09-21|||January 2006||2006-01-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Sodium Channel Expression in Human Teeth|Sodium Channel Expression in Human Teeth|Completed||N/A|250|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||f||||||Samples Without DNA|"~     Extracted teeth including pulpal tissue~   "|||2017-02-18 14:58:37.691156|2017-02-18 14:58:37.691156
NCT00575250|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2007-12-17|||January 2004||2004-01-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Education for Osteoporosis in Persons With Existing Fractures|Osteoporosis Education Clinic Study|Completed||N/A|152|Actual|University of Adelaide||2|||f||||f||||||||||2017-02-18 14:58:37.793262|2017-02-18 14:58:37.793262
NCT00575237|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2007-12-17|||February 2004||2004-02-01|December 2007|2007-12-01|February 2005|Actual|2005-02-01|||||Interventional|||A Simple Clinical Maneuver to Reduce Laparoscopy Induced Shoulder Pain|A Simple Clinical Maneuver to Reduce Laparoscopy Induced Shoulder Pain: A Randomized Clinical Trial|Completed||N/A|100|Actual|Phelps, Paul, M.D.||2|||f||||f||||||||||2017-02-18 14:58:37.905207|2017-02-18 14:58:37.905207
NCT00575224|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-15|2009-11-23|||October 2004||2004-10-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9|Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9: a Phase IV, Randomized, Open-labeled, Multicenter Trial Comparing 24-week vs. 48-week Therapy|Completed||Phase 4|60|Actual|Pacific Health Foundation||2|||f||||f||||||||||2017-02-18 14:58:38.016107|2017-02-18 14:58:38.016107
NCT00575211|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-01-14|||January 2004||2004-01-01|January 2016|2016-01-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Observational|||Study Looking at the Recovery of New Onset Cardiomyopathy|Genetic Modulation of Left Ventricular Recovery in Recent Onset Cardiomyopathy|Completed||N/A|373|Actual|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     At time of enrollment, 30cc of blood will be obtained: 10cc for plasma banking for~     neurohormones and cytokine analysis, 10 cc for DNA banking and genotyping, 5 cc for~     evaluation of gene expression of inflammatory markers from circulating leukocytes and 5 cc~     for serum banking. Ten ccs of blood for cytokine analysis will also be collected at one~     month and six months after entry. A blood specimen for repeat analysis of serum mediator~     (5ccs in a red top tube) will be drawn at six months and sent to the University of~     Pittsburgh. All blood samples will be kept for 10 years. Access to the banked DNA will be~     limited to investigations at the University of Pittsburgh and each site of this multi-center~     trial. These samples will be available without any identifying information (name, social~     security number and medical record number). In addition, a Certificate of Confidentiality~     has been obtained from the NIH for further subject protection.~   "|||2017-02-18 14:58:38.135602|2017-02-18 14:58:38.135602
NCT00575198|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-10-26|||December 2007||2007-12-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|September 2012|Actual|2012-09-01||Interventional|DARTT||Drainage Amount for Removal of Thoracostomy Tube|Non-inferiority Randomized Trial Evaluating Removal of Thoracostomy Tubes Independent of the Drainage Amount Versus Removal When the Drainage Amount Is Low|Unknown status|Active, not recruiting|N/A|280|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 14:58:38.245817|2017-02-18 14:58:38.245817
NCT00575185|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-07-29|2014-12-03||November 2007||2007-11-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|Mono6|College students infected with mono|Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection|Randomized, Placebo-Controlled, Double-Blind Study to Assess Clinical and Antiviral Activity of Valomaciclovir (EPB 348) in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection (Mono 6)|Completed||Phase 1/Phase 2|23|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 14:58:38.35444|2017-02-18 14:58:38.35444
NCT00575172|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2008-01-07|||March 2003||2003-03-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Observational|||Nippon Ultra-Rapid Insulin and Diabetic Complication Evaluation-Study (NICE-Study)|To Investigate Whether the Postprandial Blood Sugar Level as Achieved Using Ultrarapid-Acting Type Insulin Could Prevent Great Vessel Disorder in Japanese Type 2 Diabetic Patients.|Completed||N/A|346|Actual|Osaka Saiseikai Nakatsu Hospital|||2||f||||t||||||||||2017-02-18 14:58:38.731366|2017-02-18 14:58:38.731366
NCT00575159|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2013-05-13||2012-03-29|March 2008||2008-03-01|May 2013|2013-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus|A Double-blind, Randomized, Single Ascending Dose Escalation, Placebo-controlled, Crossover Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK189075 Administered to Subjects With Type 1 Diabetes Mellitus|Completed||Phase 2|14|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 14:58:38.832481|2017-02-18 14:58:38.832481
NCT00575146|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-17|2014-04-16|2013-06-18||December 2007||2007-12-01|April 2014|2014-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|ERGO||Ketogenic Diet for Recurrent Glioblastoma|Ketogenic Diet for Patients With Recurrent Glioblastoma|Completed||Phase 1|20|Actual|University Hospital Tuebingen|Because of the small number of patients efficacy cannot be concluded by the results of the study|1|||f||||f||||||||||2017-02-18 14:58:38.930307|2017-02-18 14:58:38.930307
NCT00575133|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2012-02-23|||December 2007||2007-12-01|February 2012|2012-02-01|November 2027|Anticipated|2027-11-01|||||Observational|||Prospective Cohort Study in Patients With NAFLD|Multicentric, Prospective, Non-interventional, Long-term Cohort Study in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)|Recruiting||N/A|150|Anticipated|University of Zurich|||1||f||||f||||||Samples With DNA|"~     Liver biopsy~   "|||2017-02-18 14:58:39.390154|2017-02-18 14:58:39.390154
NCT00575120|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-10-02|||September 2007||2007-09-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|EFBOLD-MRI||Endothelial Function Assessed With BOLD-MRI|Assessment of Endothelial Function Using Blood Oxygen Level-Dependent MRI (BOLD-MRI)|Completed||N/A|15|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 14:58:39.488487|2017-02-18 14:58:39.488487
NCT00575107|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2011-08-03|||September 2007||2007-09-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|LCT||A System for Lengthening Contraction Training of Muscle|A System for Lengthening Contraction Training of Muscle|Completed||N/A|36|Anticipated|University of Michigan||2|||f||||f||||||||||2017-02-18 14:58:39.589433|2017-02-18 14:58:39.589433
NCT00121498|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2005-09-12|||November 2002||2002-11-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Preemptive Analgesia for Abdominal Hysterectomy|Preemptive Analgesia for Post Abdominal Hysterectomy Pain Management|Completed||N/A|32||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:35:40.537137|2017-02-18 17:35:40.537137
NCT00575094|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2011-06-02|2009-03-31||November 2007||2007-11-01|June 2011|2011-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects|A Phase 3, Multicenter, Open-label Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects With Community-acquired Pneumonia|Completed||Phase 3|9|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 14:58:39.683669|2017-02-18 14:58:39.683669
NCT00575081|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-05-11|||August 2006||2006-08-01|May 2016|2016-05-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|Brain Atlas||Physiological Brain Atlas Development|Physiological Brain Atlas Development|Recruiting||N/A|5000|Anticipated|Vanderbilt University|||1||f||||t||||||||Undecided||2017-02-18 14:58:39.915596|2017-02-18 14:58:39.915596
NCT00575068|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2012-06-07|||January 2002||2002-01-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|September 2002|Actual|2002-09-01||Interventional|||Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma|A Phase I/II Trial of Anti-CD80 Monoclonal Antibody (IDEC-114) Therapy for Patients With Relapsed or Refractory Follicular Lymphoma|Completed||Phase 1/Phase 2|42|Actual|Biogen||1|||f||||f||||||||||2017-02-18 14:58:40.041197|2017-02-18 14:58:40.041197
NCT00575055|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2013-10-30||2013-09-27|December 2007||2007-12-01|October 2013|2013-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Carriers.|Completed||Phase 3|1121|Actual|JANSSEN Alzheimer Immunotherapy Research & Development, LLC||3|||f||||||||||||||2017-02-18 14:58:40.148197|2017-02-18 14:58:40.148197
NCT00575042|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2011-12-02|2011-12-02||August 2007||2007-08-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|||Use of Fenofibrate for Primary Biliary Cirrhosis|Pilot Study of Fenofibrate for Primary Biliary Cirrhosis|Completed||Phase 2|20|Actual|University of Florida|A major limitation is the uncontrolled nature of this study.|1|||f||||f||||||||||2017-02-18 14:58:40.437697|2017-02-18 14:58:40.437697
NCT00575029|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2011-07-27|2011-03-31||April 2004||2004-04-01|July 2011|2011-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate|Evaluation of the Time Course of Adrenal Suppression and Adrenal Recovery After Ingestion of Megestrol Acetate|Completed||N/A|7|Actual|University of Arkansas|funding became an issue limiting the number of patients enrolled|1|||f||||f||||||||||2017-02-18 14:58:40.716551|2017-02-18 14:58:40.716551
NCT00575016|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-09-17|2011-09-09||December 2007||2007-12-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder||Terminated||Phase 2|74|Actual|Allergan|Due to recruitment difficulties, study enrollment was stopped early.|4||The study was terminated early due to enrollment challenges.|f||||||||||||||2017-02-18 14:58:40.960837|2017-02-18 14:58:40.960837
NCT00575003|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-04-24|||December 2007||2007-12-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis|Double-Blind, Placebo-Controlled Study to Investigate an Immunomodulatory Therapy (CYT003-QbG10) in Adult Patients With Perennial Allergic Rhinoconjunctivitis|Completed||Phase 2|64|Anticipated|Cytos Biotechnology AG||2|||f||||||||||||||2017-02-18 14:58:41.912727|2017-02-18 14:58:41.912727
NCT00574990|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-05-22|2014-10-01||January 2008||2008-01-01|May 2015|2015-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|MED-COMM||Minimizing Harm From ADEs by Improving Nurse-Physician Communication|Minimizing Harm From ADEs by Improving Nurse-Physician Communication|Completed||N/A|39|Actual|VA Office of Research and Development|||3||f||||f||||||||||2017-02-18 14:58:42.022391|2017-02-18 14:58:42.022391
NCT00574977|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-12-23|||May 2008||2008-05-01|December 2015|2015-12-01|July 2014|Actual|2014-07-01|January 2013|Actual|2013-01-01||Interventional|||Safety Study of Modified Vaccinia Virus to Cancer|A Phase I Dose-escalation Trial of vvDD-CDSR (Double-deleted Vaccinia Virus Plus CD/ SMR) Administered by Intratumoral Injection or Intravenous Injection|Completed||Phase 1|26|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 14:58:42.454651|2017-02-18 14:58:42.454651
NCT00574964|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-10-25|||October 2005||2005-10-01|March 2010|2010-03-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|Temodar||Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme|Phase II Treatment of Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme Treated With Gliadel Wafers, Surgery and Limited Field Radiation Plus Concomitant Temozolomide Followed by Temozolomide|Terminated||Phase 2|50|Anticipated|University of Iowa||1||PI left the institution.|f||||t||||||||||2017-02-18 14:58:42.566327|2017-02-18 14:58:42.566327
NCT00574951|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-05-29|||December 2007||2007-12-01|May 2015|2015-05-01||||July 2013|Actual|2013-07-01||Interventional|||AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase II Evaluation of AMG 706 (IND # 79,697) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Completed||Phase 2|23|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 14:58:42.677479|2017-02-18 14:58:42.677479
NCT00574925|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2007-12-17|||November 2003||2003-11-01|December 2007|2007-12-01|October 2007||2007-10-01|||||Interventional|||Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients|Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 4|||University of Zurich|||||f||||f||||||||||2017-02-18 14:58:42.810367|2017-02-18 14:58:42.810367
NCT00574912|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-07-02|2014-12-18||March 2007||2007-03-01|July 2015|2015-07-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional||One group of participants may have participated in more than one arm/group.|Characteristics of Glargine in Type 2 Diabetics|A Comparison of PK/PD Dose Response Characteristics of Glargine in Type 2 Diabetics|Completed||N/A|20|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 14:58:42.900195|2017-02-18 14:58:42.900195
NCT00574899|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-10-18|||May 2007||2007-05-01|October 2015|2015-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Prostate Biomarker Study|Multi-Institutional Inter-SPORE Prostate Biomarker Study|Completed||N/A|32|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     tissue, serum, plasma, and lymphocytes~   "|||2017-02-18 14:58:43.231672|2017-02-18 14:58:43.231672
NCT00574886|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2013-12-13|||July 2000||2000-07-01|December 2013|2013-12-01|April 2008|Actual|2008-04-01|March 2002|Actual|2002-03-01||Interventional|||Idiotype Vaccine Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Patients With Lymphoma Who Had Failed Induction Chemotherapy|Pilot Trial for Idiotype Vaccine Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Patients With Lymphoma Who Had Failed Induction Chemotherapy|Completed||N/A|2|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:58:43.344228|2017-02-18 14:58:43.344228
NCT00574873|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-08-22|2012-10-04||February 2008||2008-02-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|August 2010|Actual|2010-08-01||Interventional||Intent-to-treat (ITT) population - included all participants who were randomized to test article.|Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML|A Phase 3 Randomized, Open-Label Study Of Bosutinib Versus Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive Chronic Myelogenous Leukemia|Completed||Phase 3|502|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:58:43.45979|2017-02-18 14:58:43.45979
NCT00574860|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2013-09-17||2013-09-09|December 2007||2007-12-01|September 2013|2013-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer|A Phase 3, Multi-center, Randomized, Double-Blind, Placebo- Controlled Study to Assess the Efficacy and Safety of EN3285 for the Prevention or Delay to Onset of Severe Oral Mucositis in Patients With Head and Neck Cancer Receiving Chemoradiotherapy|Terminated||Phase 3|240|Actual|Endo Pharmaceuticals||3||Additional research|f||||t||||||||||2017-02-18 14:58:44.785476|2017-02-18 14:58:44.785476
NCT00574847|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-07-08|2015-06-11||September 2006||2006-09-01|July 2015|2015-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|REMIT||Responses of Myocardial Ischemia to Escitalopram Treatment|Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT Trial)|Completed||Phase 4|127|Actual|Duke University||2|||f||||t||||||||||2017-02-18 14:58:44.90484|2017-02-18 14:58:44.90484
NCT00574834|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-12-20|2015-12-10||March 2007||2007-03-01|December 2016|2016-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes|Mechanisms of Reduced Ramipril on the Onset of Type 2 Diabetes Mellitis|Terminated||N/A|17|Actual|University of Maryland|Early termination leading to small numbers of subjects analyzed. No conclusions drawn.|3||Lack of funding|f||||t||||||||||2017-02-18 14:58:45.523187|2017-02-18 14:58:45.523187
NCT00574821|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-11-16|||July 2007||2007-07-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Use of Magnetic Field Mapping in the Evaluation of Patients With Hypertrophic Heart Disease (Thick Heart Muscle)|Assessing the Utility of Magnetocardiography in Patients With Hypertrophic Cardiomyopathy|Withdrawn||N/A|20|Anticipated|Cedars-Sinai Medical Center|||1|sponsor funding|f||||f||||||||||2017-02-18 14:58:46.144378|2017-02-18 14:58:46.144378
NCT00574808|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2014-10-03|||April 2007||2007-04-01|October 2014|2014-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|IDOCC||Improved Delivery of Cardiovascular Care Through Outreach Facilitation|Improved Delivery of Cardiovascular Preventive Care (IDOCC) Through Outreach Facilitation|Completed||Phase 1|194|Actual|Bruyere Research Institute||2|||f||||f||||||||||2017-02-18 14:58:46.234976|2017-02-18 14:58:46.234976
NCT00574795|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2012-06-28|2010-03-26||September 2007||2007-09-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants|A Phase 3, Open-Label Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Japan|Completed||Phase 3|193|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 14:58:46.364503|2017-02-18 14:58:46.364503
NCT00574782|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2007-12-12|||September 2003||2003-09-01|December 2007|2007-12-01||||||||Observational|CHALLENGE||Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)|Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)|Completed||N/A|2660|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 14:58:47.480736|2017-02-18 14:58:47.480736
NCT00574769|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-10-24|||September 2007||2007-09-01|October 2015|2015-10-01|September 2017|Anticipated|2017-09-01|August 2016|Anticipated|2016-08-01||Interventional|||Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer|Phase Ib/II Evaluation of RAD001 With Docetaxel and Bevacizumab in Patients With Metastatic Androgen Independent Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|27|Actual|University of Southern California||1|||f||||t||||||||||2017-02-18 14:58:47.559242|2017-02-18 14:58:47.559242
NCT00574756|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2007-12-14|||December 2007||2007-12-01|December 2007|2007-12-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction|The Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction|Unknown status|Recruiting|N/A|20|Anticipated|University of California, San Diego||2|||f||||||||||||||2017-02-18 14:58:47.685107|2017-02-18 14:58:47.685107
NCT00574743|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2011-11-01|||January 2002||2002-01-01|November 2011|2011-11-01||||April 2004|Actual|2004-04-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients|A 12-month, Single-blind, Randomized, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of ERL080A Compared With MMF in de Novo Heart Recipients|Completed||Phase 4|162|Actual|Novartis||2|||f||||||||||||||2017-02-18 14:58:47.797226|2017-02-18 14:58:47.797226
NCT00574730|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2013-01-08|||May 2001||2001-05-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|August 2005|Actual|2005-08-01||Interventional|||CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma|CHOP/Rituximab Followed by Maintenance Pegylated Interferon-Alpha (PEG Intron)With the Treatment of Patients With Anthracycline Naïve Indolent/Follicular Non-Hodgkin's Lymphoma|Completed||N/A|27|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:58:47.908504|2017-02-18 14:58:47.908504
NCT00574717|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2012-10-18|||December 2007||2007-12-01|October 2012|2012-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Enhancement of Emmetropization in Hyperopic Infants|Enhancement of Emmetropization in Hyperopic Infants|Terminated||Phase 1/Phase 2|6|Actual|Ohio State University||1||Lack of funding support for continued recruitment, enrollment, treatment|f||||f||||||||||2017-02-18 14:58:48.003901|2017-02-18 14:58:48.003901
NCT00434811|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2016-08-29||2011-11-28|October 2006||2006-10-01|August 2016|2016-08-01|May 2014|Actual|2014-05-01|September 2012|Actual|2012-09-01||Interventional|||Islet Transplantation in Type 1 Diabetes|Islet Transplantation in Type 1 Diabetes|Completed||Phase 3|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 15:52:13.449973|2017-02-18 15:52:13.449973
NCT00574704|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2013-06-04|2013-02-14||September 2006||2006-09-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis|Double Blind Placebo Controlled Study to Assess Efficacy and Safety of a Combined Allergen Vaccine (CYT005-AllQbG10) and Its Single Components in Patients With House Dust Mite Allergy|Completed||Phase 2|40|Actual|Cytos Biotechnology AG||4|||f||||||||||||||2017-02-18 14:58:48.121897|2017-02-18 14:58:48.121897
NCT00574691|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2012-02-27|||June 2007||2007-06-01|February 2012|2012-02-01|October 2007|Actual|2007-10-01|||||Interventional|ECLIPSE||ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU|ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis) Trial|Completed||Phase 1|93|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 14:58:48.637453|2017-02-18 14:58:48.637453
NCT00574678|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-02-02|||December 2006||2006-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|ACT||Analyzing the Composition of Tears to Identify Cancer|ACT: Analyzing the Composition of Tears to Identify Cancer (Breast, Ovarian, Colon)|Completed||Phase 1/Phase 2|150|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:58:48.752646|2017-02-18 14:58:48.752646
NCT00574665|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2014-12-10|||October 2006||2006-10-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1|SCCOR in Hemostatic and Thrombotic Diseases Project 5 - Metabolic Causes of Thrombosis in Type 2 Diabetes|Completed||N/A|32|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 14:58:48.852726|2017-02-18 14:58:48.852726
NCT00574652|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2013-01-23|||March 2008||2008-03-01|January 2008|2008-01-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|||Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients|ANRS HC 21 VASCU IL-2, Evaluation of the Cellular Immune Response, Clinical Efficacy and Tolerance After IL-2 Therapy in HCV-related Vasculitis Patients, Resistant to Conventional Therapy.|Completed||Phase 1/Phase 2|10|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-02-18 14:58:48.950624|2017-02-18 14:58:48.950624
NCT00574639|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2017-02-09|||July 2007||2007-07-01|February 2017|2017-02-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|Alp Ex||Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2|Mechanisms of Hypoglycemia-Associated Autonomic Dysfunction. The Effect of Alprazolam on Exercise Induced Hypoglycemia.|Completed||Early Phase 1|14|Actual|University of Maryland||4|||f||||t||||||||||2017-02-18 14:58:49.06034|2017-02-18 14:58:49.06034
NCT00574626|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-08-31|||December 1991||1991-12-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Randomized Trial Comparing Autologous PBSCT to BMT for Pts Receiving High-Dose Chemo & Transplant for Recurrent NHL|Randomized Trial Comparing Autologous Peripheral Blood Stem Cell Transplantation to Bone Marrow Transplantation for Patients Receiving High-Dose Chemotherapy and Transplantation for Recurrent Non-Hodgkin's Lymphoma|Completed||N/A|51|Actual|University of Nebraska||2|||f||||f||||||||||2017-02-18 14:58:49.175983|2017-02-18 14:58:49.175983
NCT00574613|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2013-02-08|||September 2007||2007-09-01|February 2013|2013-02-01|September 2010|Actual|2010-09-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis|Phase II, Multicenter, Randomized, Double-blind, Intraindividually Placebo Controlled Clinical Trial, to Evaluate Efficacy and Safety of p144 Topical Administration for Skin Fibrosis in Patients With Systemic Sclerosis|Completed||Phase 2|56|Actual|ISDIN||2|||f||||f||||||||||2017-02-18 14:58:49.280033|2017-02-18 14:58:49.280033
NCT00574600|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-06-01|||November 2008||2008-11-01|June 2016|2016-06-01|January 2013|Actual|2013-01-01|October 2010|Actual|2010-10-01||Interventional|||Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults|A Phase 1 Placebo-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of SAAVI DNA-C2 Vaccine Boosted by SAAVI MVA-C Vaccine, in HIV Uninfected Healthy Vaccinia Naive Adult Participants in South Africa and the United States|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 14:58:49.413393|2017-02-18 14:58:49.413393
NCT00574587|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-07-13|||December 2007||2007-12-01|July 2015|2015-07-01|January 2016|Anticipated|2016-01-01|May 2014|Actual|2014-05-01||Interventional|||Trial for Locally Advanced Her2 Positive Breast Cancer Using Paclitaxel, Trastuzumab, Doxorubicin and Cyclophasmide on a Weekly Basis|Phase I-II Trial of Vorinostat Plus Weekly Paclitaxel and Trastuzumab Followed by Doxorubicin-cyclophosphamide in Patients With Locally Advanced Breast Cancer|Active, not recruiting||Phase 1/Phase 2|54|Anticipated|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-02-18 14:58:49.526686|2017-02-18 14:58:49.526686
NCT00574574|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-07-10|||August 2007||2007-08-01|July 2009|2009-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk|Biological Effects of an Anthocyanin Rich Dietary Supplement on Skin Ageing and Markers of Inflammation in Post-Menopausal Women|Completed||N/A|62|Anticipated|University of East Anglia||2|||f||||f||||||||||2017-02-18 14:58:49.628003|2017-02-18 14:58:49.628003
NCT00574561|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-11-16|||July 2007||2007-07-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Magnetocardiography (MCG) in Subjects Undergoing CT Angiography (CTA)|Magnetocardiography (MCG) in Subjects Undergoing CT Angiography (CTA)|Withdrawn||N/A|300|Anticipated|Cedars-Sinai Medical Center|||1|sponsor funding|f||||f||||||||||2017-02-18 14:58:49.720249|2017-02-18 14:58:49.720249
NCT00574548|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2011-07-18|2011-02-01||November 2007||2007-11-01|July 2011|2011-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS|A Phase 3, Randomized, Active-Controlled, Modified Double-blind Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine When Administered Over 12 Months Either as a 2-Dose Regimen or With 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Adults 60 to 64 Years of Age Who Are Naive to 23vPS|Completed||Phase 3|720|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 14:58:49.846671|2017-02-18 14:58:49.846671
NCT00574535|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2012-08-24|||January 1995||1995-01-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Reproductive Hormones And Pre-Clinical Cardiovascular Disease (CVD) In Women|Reproductive Hormones And Pre-Clinical CVD In Women|Completed||N/A|269|Actual|Cedars-Sinai Medical Center|||1||f||||t||||||||||2017-02-18 14:58:54.582137|2017-02-18 14:58:54.582137
NCT00574522|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-08-14|||February 2008||2008-02-01|August 2009|2009-08-01|November 2009|Anticipated|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||Energy Specific Far Infrared Radiation Treatment for AIDS|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for HIV/AIDS|Unknown status|Active, not recruiting|Phase 1|3|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:58:54.667243|2017-02-18 14:58:54.667243
NCT00574509|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2013-01-08|||March 1996||1996-03-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|August 2015|Anticipated|2015-08-01||Interventional|||BEAM+131I-Anti-B1 & Autologous Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma|BEAM + 131Iodine-Anti-B1 Radioimmunotherapy and Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Recurrent Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|34|Actual|University of Nebraska||1|||f||||f||||||||||2017-02-18 14:58:54.768189|2017-02-18 14:58:54.768189
NCT00574496|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-10-19|||November 2007||2007-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma|An Intention-to-Treat Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin Lymphoma|Active, not recruiting||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:58:54.87789|2017-02-18 14:58:54.87789
NCT00574483|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-07-31|||November 2007||2007-11-01|January 2008|2008-01-01|January 2008|Anticipated|2008-01-01|January 2008|Anticipated|2008-01-01||Interventional|||Treatment of Advanced Renal Cell Carcinoma With Quinacrine|An Open-label, Fixed-dose, Clinical Study of Quinacrine Safety and Efficacy in the Treatment of Advanced Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|Cleveland BioLabs||1||reevaluation of compound development|f||||f||||||||||2017-02-18 14:58:55.007686|2017-02-18 14:58:55.007686
NCT00574470|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2011-11-28|||January 2006||2006-01-01|October 2007|2007-10-01|January 2009||2009-01-01|||||Interventional|||Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD|Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD|Completed||Phase 4|37|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 14:58:55.145326|2017-02-18 14:58:55.145326
NCT00574457|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-09-29|||September 2007||2007-09-01|September 2015|2015-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|MERC-CIMT||Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study|Improving Cardiovascular Risk Prediction Using Hand-Held Carotid Ultrasonography Study|Completed||Phase 4|355|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 14:58:55.237089|2017-02-18 14:58:55.237089
NCT00574444|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-09-29|||January 2008||2008-01-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Transvaginal Diagnostic Study in Women With Pelvic Pain|Laparoscopic Assisted Transvaginal Endoscopic Diagnostic Peritoneoscopy in Women With Pelvic Pain|Withdrawn||Phase 1|0|Actual|University of Missouri-Columbia||1||Investigator moved to another institution.|f||||f||||||||No||2017-02-18 14:58:55.339138|2017-02-18 14:58:55.339138
NCT00574431|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-07-13|||February 2008||2008-02-01|March 2011|2011-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||ICU Nutrition Study Bern|Implementation of an Evidence-based Nutritional Management Protocol in Critically Ill Patients:Does Clinical Outcome Improve?|Completed||Phase 4|200|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 14:58:55.433739|2017-02-18 14:58:55.433739
NCT00574418|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-01-02|||January 2006||2006-01-01|January 2009|2009-01-01|September 2008|Anticipated|2008-09-01|March 2008|Anticipated|2008-03-01||Interventional|||Far Infrared Radiation Treatment for Uterine Fibroids|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Uterine Fibroids|Unknown status|Active, not recruiting|Phase 1|2|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:58:55.544811|2017-02-18 14:58:55.544811
NCT00574405|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-11-23|2011-07-14||April 2005||2005-04-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|ktpump||Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy|Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy|Completed||N/A|24|Actual|Arkansas Children's Hospital Research Institute|Post hoc analysis demonstrated that the study design was weakened by an underestimation of the sample size per group needed to determine a statistically significant result for our primary outcome measure.|2|||f||||f||||||||||2017-02-18 14:58:55.657931|2017-02-18 14:58:55.657931
NCT00574392|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-12-17|||November 2006||2006-11-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo|Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo|Completed||N/A|50|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||f||||||||||2017-02-18 14:58:56.247289|2017-02-18 14:58:56.247289
NCT00574379|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-01-09|||December 2007||2007-12-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR|A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen|Completed||Phase 2|805|Actual|Faes Farma, S.A.||5|||f||||f||||||||||2017-02-18 14:58:56.357406|2017-02-18 14:58:56.357406
NCT00574366|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-05-06|||December 2005||2005-12-01|May 2016|2016-05-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer|A Phase I/II Trial of an Oral MTOR Protein Kinase Inhibitor (Everolimus, RAD001) in Combination With an Oral EGFR Tyrosine Kinase Inhibitor (Erlotinib, Tarceva™) In Patients With Metastatic Breast Cancer|Completed||Phase 1|14|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 14:58:56.470511|2017-02-18 14:58:56.470511
NCT00574353|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-09-29|||December 2007||2007-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients|A Feasibility Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients|Recruiting||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:58:56.581841|2017-02-18 14:58:56.581841
NCT00574340|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2015-01-09|2014-05-27||May 2007||2007-05-01|January 2015|2015-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4|SCCOR in Hemostatic and Thrombotic Diseases Project 5 - Metabolic Causes of Thrombosis in Type 2 Diabetes|Completed||N/A|28|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 14:58:56.699914|2017-02-18 14:58:56.699914
NCT00574327|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-09-23|||January 2006||2006-01-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|October 2019|Anticipated|2019-10-01||Observational|||Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry|A Prospective Study To Define The Role Of Various Factors In Development And Progression Of Gastroesophageal Reflux Disease (GERD) And Barrett's Esophagus And The Creation Of A Registry.|Recruiting||N/A|3000|Anticipated|Midwest Biomedical Research Foundation|||3||f||||f||||||Samples With DNA|"~     Serum samples from participating patients will be collected and frozen for measurements of~     insulin, glucose, lipid panel, CRP and adiponectin levels. Biopsies obtained from esophagus~     during endoscopy and blood samples will be frozen for future biomarker and cDNA microarray~     studies and histochemistry.~   "|||2017-02-18 14:58:56.946804|2017-02-18 14:58:56.946804
NCT00574314|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2015-08-10|||July 2004||2004-07-01|August 2015|2015-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Women's Health Research Registry|Women's Health Research Registry|Terminated||N/A|839|Actual|Cedars-Sinai Medical Center|||1|No more funding|f||||f||||||||||2017-02-18 14:58:57.067877|2017-02-18 14:58:57.067877
NCT00574301|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2013-07-24|||March 2002||2002-03-01|July 2013|2013-07-01|October 2011|Actual|2011-10-01|October 2007|Actual|2007-10-01||Interventional|||Percutaneous Removal and Margin Ablation for Breast Cancer|Percutaneous Removal and Margin Ablation for Breast Cancer|Completed||Phase 1/Phase 2|32|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:58:57.169429|2017-02-18 14:58:57.169429
NCT00574288|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-08-25|||March 2008||2008-03-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|January 2015|Actual|2015-01-01||Interventional|||Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma|Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma - Open Label, Dose-escalation Followed by Open Label, Single-arm Study|Active, not recruiting||Phase 2|104|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-02-18 14:58:57.282318|2017-02-18 14:58:57.282318
NCT00574275|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2016-05-04|2012-08-17||December 2007||2007-12-01|May 2016|2016-05-01|November 2010|Actual|2010-11-01|October 2009|Actual|2009-10-01||Interventional|VANILLA||Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer|A Multinational, Randomized, Double-blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks Versus Placebo in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer|Terminated||Phase 3|546|Actual|Sanofi|"As the study was terminated due to futility, some changes were made to the planned analyses, and the analyses for the following outcome measures were not performed:~Objective Response Rate (ORR)~Clinical Benefit"|2||"Data Monitoring Committee concluded after a planned interim analysis that aflibercept added to~   gemcitabine would be unable to demonstrate improved survival"|f||||t||||||||||2017-02-18 14:58:57.433665|2017-02-18 14:58:57.433665
NCT00574262|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2010-01-12|||October 2007||2007-10-01|November 2007|2007-11-01|April 2009|Anticipated|2009-04-01|||||Observational|QuASt||Quality Assessment in Acute Stroke Care|Quality of Acute Stroke Care Evaluated With a Clinical Pathway on a 16 Bed Stroke Unit - a Prospective Trial|Unknown status|Recruiting|N/A|400|Anticipated|University Hospital Muenster|||1||f||||f||||||||||2017-02-18 14:58:59.405029|2017-02-18 14:58:59.405029
NCT00574249|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-04-11|2009-10-29||November 2007||2007-11-01|April 2011|2011-04-01||||October 2008|Actual|2008-10-01||Interventional|BELIEVE||Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment|A Multi-center, Randomized, Vehicle-Controlled Study to Assess the Efficacy and Safety of Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment (BELIEVE)|Completed||Phase 3|730|Actual|Abbott||2|||f||||f||||||||||2017-02-18 14:58:59.518203|2017-02-18 14:58:59.518203
NCT00574236|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2013-01-16|||February 2006||2006-02-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer|A Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer|Terminated||Phase 2|4|Actual|University of Wisconsin, Madison||1||no additional funding|f||||t||||||||||2017-02-18 14:59:00.945511|2017-02-18 14:59:00.945511
NCT00574223|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-04-24|||November 2007||2007-11-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis|Double-Blind, Placebo-Controlled Study to Investigate Safety, Tolerability, Immunogenicity and Clinical Efficacy of a Specific Immunotherapy Combining Allergen With CYT003-QbG10 (CYT005-AllQbG10) in Adult Patients With Perennial Allergic Rhinoconjunctivitis Due to House Dust Mite Allergy|Completed||Phase 2|100|Anticipated|Cytos Biotechnology AG||2|||f||||||||||||||2017-02-18 14:59:01.047743|2017-02-18 14:59:01.047743
NCT00574210|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2009-01-09|||October 2007||2007-10-01|January 2009|2009-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-Arm)|A Randomized, Double-Blind, Placebo-Controlled, 5-Arm Parallel Study to Evaluate the Pharmacokinetics/ Pharmacodynamics and Steady State Efficacy of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in the Treatment of the Symptoms of Seasonal Allergic Rhinitis in an Environmental Exposure Chamber (EEC) Mode|Completed||Phase 2|502|Actual|Faes Farma, S.A.||5|||f||||t||||||||||2017-02-18 14:59:01.143524|2017-02-18 14:59:01.143524
NCT00574197|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2010-07-21|||June 2006||2006-06-01|August 2009|2009-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients|Assessment of Gastrointestinal Tolerability and Efficacy of Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients|Completed||Phase 4|11|Actual|Cedars-Sinai Medical Center||1|||f||||f||||||||||2017-02-18 14:59:01.412495|2017-02-18 14:59:01.412495
NCT00574184|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2008-03-25|||August 2005||2005-08-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|||||Observational|PANPI||Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)|Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)|Completed||N/A|10|Actual|University of California, Davis|||1||f||||t||||||||||2017-02-18 14:59:01.526117|2017-02-18 14:59:01.526117
NCT00574171|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-02-19|2014-06-05||September 2007||2007-09-01|February 2016|2016-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma|A Phase II Trial of Lapatinib and Capectiabine for Patients With Refractory Advanced Colorectal Adenocarcinoma (LAP109859)|Completed||Phase 2|29|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 14:59:01.624335|2017-02-18 14:59:01.624335
NCT00574158|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2014-09-25|||July 2005||2005-07-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|November 2011|Actual|2011-11-01||Observational|||Pathogenesis and Genetics of Environmental Asthma Ozone Study|Project 2: Genetic Regulation of Ozone Induced Inflammation in Humans.|Completed||N/A|170|Actual|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||f||||||Samples With DNA|"~     plasma, and ebc collected.~   "|||2017-02-18 14:59:01.855205|2017-02-18 14:59:01.855205
NCT00574145|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-14|2012-08-04|2012-03-15||February 2007||2007-02-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer|Examining the Effect of Healing Touch on Radiotherapy-induced Fatigue|Completed||N/A|44|Actual|Vanderbilt-Ingram Cancer Center||2|||f||||t||||||||||2017-02-18 14:59:01.944202|2017-02-18 14:59:01.944202
NCT00574132|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2013-10-30||2013-09-27|December 2007||2007-12-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non- Carriers.|Completed||Phase 3|1331|Actual|JANSSEN Alzheimer Immunotherapy Research & Development, LLC||3|||f||||||||||||||2017-02-18 14:59:02.401606|2017-02-18 14:59:02.401606
NCT00574119|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-12-12|||December 2007||2007-12-01|December 2016|2016-12-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of Aldosterone on Energy Starvation in Heart Failure|Effect of Aldosterone on Energy Starvation in Heart Failure|Active, not recruiting||Phase 4|20|Anticipated|Vanderbilt University Medical Center||1|||f||||f||||||||No||2017-02-18 14:59:02.766592|2017-02-18 14:59:02.766592
NCT00574106|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-08-14|||February 2008||2008-02-01|August 2009|2009-08-01|October 2009|Anticipated|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||A Study to Evaluate the Effect of Far Infrared Radiation for Cancer Treatment|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation for Cancer Treatment|Unknown status|Active, not recruiting|Phase 1|3|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:02.87797|2017-02-18 14:59:02.87797
NCT00574093|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2009-10-29|||January 2008||2008-01-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|Luvi||Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD|12 Months Case Series Open Study to Assess the Safety and Efficacy of Intravitreal Injection of Lucentis (Ranibizumab 0.5 mg)Used in Combination With Visudyne (Verteporfin PDT) in Naive Subjects With Subfoveal CNV Secondary to AMD|Completed||Phase 2|15|Anticipated|Fondazione G.B. Bietti, IRCCS||1|||f||||t||||||||||2017-02-18 14:59:03.100199|2017-02-18 14:59:03.100199
NCT00574080|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-06-01|2011-05-04||July 2006||2006-07-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide|UARK 2006-15: A Phase III Randomized Study of Tandem Transplants With or Without Bortezomib (Velcade) and Thalidomide (Thalomid) to Evaluate Its Effect on Response Rate and Durability of Response in Multiple Myeloma Patients|Terminated||Phase 3|20|Actual|University of Arkansas|Early termination led to small numbers of subjects to be analyzed. Less than 10% of the target accrual were enrolled before termination of study.|2||low accrual|f||||f||||||||||2017-02-18 14:59:03.206626|2017-02-18 14:59:03.206626
NCT00574067|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-03-11|2015-08-11||September 2008||2008-09-01|March 2016|2016-03-01|November 2013|Actual|2013-11-01|March 2013|Actual|2013-03-01||Interventional|||Buprenorphine for Prisoners|Buprenorphine for Prisoners|Completed||Phase 3|213|Actual|Friends Research Institute, Inc.||4|||f||||t||||||||||2017-02-18 14:59:03.594116|2017-02-18 14:59:03.594116
NCT00574054|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-08-14|||February 2008||2008-02-01|August 2009|2009-08-01|March 2009|Anticipated|2009-03-01|January 2009|Anticipated|2009-01-01||Interventional|||Far Infrared Radiation Treatment of Dementia and Other Mental Illness|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Dementia and Other Related Mental Illness.|Unknown status|Active, not recruiting|Phase 1|4|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:04.295958|2017-02-18 14:59:04.295958
NCT00574041|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2008-09-02|||June 2007||2007-06-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|TODAY||How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose|An Open-Label Study to Examine the Difference in Tolerability Associated With Titration Of Dose on Initiation of Avonex therapY (TODAY)|Terminated||Phase 4|19|Actual|Biogen||2||Terminated due to poor recruitment|f||||f||||||||||2017-02-18 14:59:04.568789|2017-02-18 14:59:04.568789
NCT00574028|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2014-12-09|||August 2007||2007-08-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Inflammatory Bowel Disease Research Registry|The University of California Irvine Medical Center Inflammatory Bowel Disease Research Registry|Completed||N/A|138|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:59:04.681869|2017-02-18 14:59:04.681869
NCT00574015|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2014-03-21|||December 2007||2007-12-01|September 2010|2010-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache|The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache|Completed||Phase 4|18|Actual|Albany Medical College||2|||f||||f||||||||||2017-02-18 14:59:04.779552|2017-02-18 14:59:04.779552
NCT00574002|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2017-01-05|||December 2007||2007-12-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Observational|||Establishing Safe Drainage Limits for Pleural Chest Tube Removal.|Defining the Threshold for Safe Chest Tube Removal.|Withdrawn||N/A|0|Actual|University of Missouri, Kansas City|||2|Low study enrollment; re-evaluating study protocol and study selection criteria.|f||||f||||||||||2017-02-18 14:59:04.901235|2017-02-18 14:59:04.901235
NCT00573599|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2007-12-13|||February 2007||2007-02-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department|Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department|Completed||N/A|66|Actual|United States Naval Medical Center, Portsmouth||2|||f||||t||||||||||2017-02-18 14:59:12.079036|2017-02-18 14:59:12.079036
NCT00573989|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2017-01-17|||March 2008||2008-03-01|August 2016|2016-08-01||||March 2017|Anticipated|2017-03-01||Interventional|||Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer|Phase I/II Clinical Trial of Combined Pre-Irradiation With Pemetrexed and Erlotinib Followed by Maintenance Erlotinib for Recurrent and Second Primary Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 1/Phase 2|27|Actual|Wake Forest University Health Sciences||1||Drug Supply Issue|f||||t||||||||||2017-02-18 14:59:04.995831|2017-02-18 14:59:04.995831
NCT00573976|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2010-11-02|||September 2007||2007-09-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|||||Observational|||Study to Assess the Validity and Reliability of the Spinal Cord Independence Measure (SCIM III)|United States Multi-Center Study to Assess the Validity and Reliability of the Spinal Cord Independence Measure (SCIM III)|Completed||N/A|660|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:59:05.128194|2017-02-18 14:59:05.128194
NCT00573963|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-07-29|||December 2007||2007-12-01|July 2009|2009-07-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy of the Transversus Abdominus Plane (TAP) Block for Post-Cesarean Delivery Analgesia|Determination of the Efficay of the Transversus Abdominis Plane (TAP) Block as Part of a Multimodal Regimen for Post-cesarean Delivery Analgesia: a Double Blinded Placebo-controlled Study.|Completed||N/A|100|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-02-18 14:59:05.223017|2017-02-18 14:59:05.223017
NCT00573950|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2007-12-13|||December 2007||2007-12-01|December 2007|2007-12-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness|Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness in Type 2 Diabetes Patient With Metabolic Syndrome (Randomized, Double-Blind, Placebo-Controled, Cross-Over Study)|Unknown status|Recruiting|Phase 4|48|Anticipated|Korea University Anam Hospital||2|||f||||f||||||||||2017-02-18 14:59:05.350458|2017-02-18 14:59:05.350458
NCT00573937|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-01-21|2010-10-04||August 2007||2007-08-01|January 2016|2016-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Methadone Versus Morphine for Cancer-Related Pain|Methadone Versus Morphine for Moderate to Severe Cancer-Related Pain: A Double-Blind Randomized Parallel Group Study|Terminated||Phase 2|1|Actual|Mayo Clinic|Due to slow accrual of subjects, the study was terminated after one subject started in the standard control group (morphine). No subject received investigational study drug (methadone). Therefore no data were analyzed.|2||Slow accrual.|f||||f||||||||||2017-02-18 14:59:05.467863|2017-02-18 14:59:05.467863
NCT00573924|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2011-02-04|||February 2006||2006-02-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|||||Interventional|||Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers|Prospective Randomized Comparison of the Effect of Frequent Oral Dosing Versus Constant IV Infusion of Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers|Completed||N/A|66|Actual|University of Southern California||2|||f||||f||||||||||2017-02-18 14:59:05.773812|2017-02-18 14:59:05.773812
NCT00573911|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2013-01-16|||August 2007||2007-08-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus|Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus|Completed||Phase 1|16|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:59:05.875579|2017-02-18 14:59:05.875579
NCT00573898|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-02-17|||March 2008||2008-03-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|||||Observational|||Daptomycin Study - Collection of Pharmacokinetic Samples in Patients With Renal Failure|Pharmacokinetics of Daptomycin in Patients Receiving Continuous Veno-Venous Hemodiafiltration (CVVHDF)|Completed||N/A|5|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     All of your biologic samples will be under the control of the principal investigator of this~     research project. To protect your confidentiality, all personal identifiers (i.e., name,~     social security number, and birth date) will be removed (de-identified) and replaced with a~     specific code number. The information linking these code numbers to the corresponding~     subjects' identities will be kept in a separate, secure location. The investigators on this~     study will keep the samples indefinitely. Samples will be kept in the investigator's~     laboratory located in Scaife Hall, room 812, 3500 Terrace Street. You may request to have~     your samples destroyed if you withdraw. The request must be in writing and samples collected~     and not already processed will be destroyed.~   "|||2017-02-18 14:59:05.977903|2017-02-18 14:59:05.977903
NCT00573885|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2012-03-07|||January 2008||2008-01-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum|Phase II Trial of Polyphenon E in Former Smokers With Abnormal Sputa|Completed||Phase 2|53|Actual|British Columbia Cancer Agency||2|||f||||t||||||||||2017-02-18 14:59:06.066787|2017-02-18 14:59:06.066787
NCT00573872|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2017-01-25|||April 2005|Actual|2005-04-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|RAD0408||A Study of Spinal Radiosurgery|A Phase II Study of Spinal Radiosurgery|Completed||N/A|44|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 14:59:06.17196|2017-02-18 14:59:06.17196
NCT00573859|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-09-23|2011-08-15||September 2006||2006-09-01|September 2011|2011-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||The Reinforcing Mechanisms of Smoking in Adult ADHD|The Reinforcing Mechanisms of Smoking in Adult ADHD|Completed||Phase 1/Phase 2|27|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 14:59:06.282939|2017-02-18 14:59:06.282939
NCT00573846|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-01-26|||July 2007||2007-07-01|January 2015|2015-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-centered US Study|Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-centered US Study|Withdrawn||N/A|0|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 14:59:06.552829|2017-02-18 14:59:06.552829
NCT00573833|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2014-09-11|||November 2007||2007-11-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Internal Radiation Therapy in Treating Patients With Prostate Cancer|A Pilot Study of High Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer|Completed||N/A|23|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 14:59:06.642714|2017-02-18 14:59:06.642714
NCT00572741|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-05-03|||June 2008||2008-06-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Treating Oxidative Stress and the Metabolic Pathology of Autism|Treating Oxidative Stress and the Metabolic Pathology of Autism|Completed||N/A|39|Actual|Arkansas Children's Hospital Research Institute||2|||f||||t||||||||||2017-02-18 14:59:33.411493|2017-02-18 14:59:33.411493
NCT00573820|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-08-14|||January 2006||2006-01-01|August 2009|2009-08-01|December 2008|Anticipated|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Far Infrared Radiation Treatment for Prostate Cancer|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Prostate Cancer|Unknown status|Active, not recruiting|Phase 1|4|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:06.754556|2017-02-18 14:59:06.754556
NCT00573807|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-01-02|||January 2006||2006-01-01|January 2009|2009-01-01|December 2008|Anticipated|2008-12-01|March 2008|Anticipated|2008-03-01||Interventional|||Energy Specific Far Infrared Radiation Treatment for Sciatica|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Sciatica.|Unknown status|Active, not recruiting|Phase 1|2|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:06.975941|2017-02-18 14:59:06.975941
NCT00573794|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2017-01-03|||November 2007||2007-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|October 2016|Actual|2016-10-01||Interventional|||Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis|A Multicenter, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Ulcerative Colitis|Completed||Phase 3|592|Actual|AbbVie||1|||f||||f||||||||||2017-02-18 14:59:07.096855|2017-02-18 14:59:07.096855
NCT00573781|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2012-04-16|||September 2007||2007-09-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Sysdimet||Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism|Systems Biology Approach to Understand Dietary Modulation of Gene Expression and Metabolic Pathways in Subjects With Abnormal Glucose Metabolism (Sysdimet)|Completed||Phase 2|106|Actual|University of Eastern Finland||3|||f||||f||||||||||2017-02-18 14:59:07.329051|2017-02-18 14:59:07.329051
NCT00573768|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2012-04-18|2010-07-28||November 2007||2007-11-01|October 2010|2010-10-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain|A Randomized, Double-blind, Multi-center, Vehicle-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Once or Twice Daily in Patients With Acute Ankle Sprain|Completed||Phase 2|271|Actual|Novartis||3|||f||||f||||||||||2017-02-18 14:59:07.431879|2017-02-18 14:59:07.431879
NCT00573755|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-01-07|2014-02-10||December 2007||2007-12-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer|Phase II Randomized Study of Sorafenib Compared to Placebo When Administered in Combination With Aromatase Inhibitors for Postmenopausal Women With Metastatic Breast Cancer|Terminated||Phase 2|4|Actual|Mayo Clinic||2||lack of participant accrual|f||||t||||||||||2017-02-18 14:59:07.834651|2017-02-18 14:59:07.834651
NCT00573742|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2010-08-18|||September 2007||2007-09-01|August 2010|2010-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients|Non-interventional Study on Uncontrolled Hypertensive Patients for Evaluating Efficacy of Candesartan Cilexetil as Monotherapy or add-on Therapy.|Completed||N/A|1940|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 14:59:10.910327|2017-02-18 14:59:10.910327
NCT00573729|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2017-02-08|||March 2007||2007-03-01|February 2017|2017-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths|Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths|Completed||Phase 1|56|Actual|University of California, Irvine||2|||f||||f||||||||||2017-02-18 14:59:11.005171|2017-02-18 14:59:11.005171
NCT00573716|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-08-03|||October 2006||2006-10-01|August 2011|2011-08-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Observational|||Comparison of Bone Mineral Density Changes During Tx With Risperidone or Aripiprazole in Adolescents|A Comparison of Bone Mineral Density Changes During Treatment With Risperidone or Aripiprazole in Adolescents|Completed||N/A|60|Anticipated|Creighton University|||3||f||||f||||||||||2017-02-18 14:59:11.11019|2017-02-18 14:59:11.11019
NCT00573703|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2013-04-05|||September 2007||2007-09-01|April 2013|2013-04-01||||December 2007|Actual|2007-12-01||Interventional|||Laparoscopic Burch Colposuspension Versus Transobturatory Tape for the Treatment of Female Urinary Stress Incontinence|A Comparison Between Laparoscopic Burch Colposuspension and Transobturatory Tape (TOT) for the Treatment of Female Urinary Stress Incontinence|Withdrawn||Phase 4|0|Actual|University Magna Graecia||2|||f||||t||||||||||2017-02-18 14:59:11.197787|2017-02-18 14:59:11.197787
NCT00573690|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2012-04-20|||September 2007||2007-09-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|June 2009|Actual|2009-06-01||Interventional|||Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors|A Two Arm Phase I Trial of Sorafenib in Combination With Cisplatin/Etoposide or Carboplatin/Pemetrexed in Patients With Solid Tumors|Completed||Phase 1|31|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 14:59:11.300013|2017-02-18 14:59:11.300013
NCT00573664|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-07-29|||November 2007||2007-11-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||The Effectiveness and Safety of Gabapentin for Post-operative Pain After Cesarean Section|The Effectiveness and Safety of Gabapentin for Post-operative Pain After Cesarean Section: A Randomized Placebo-controlled Trial|Terminated||N/A|46|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2||Interim analysis showed a significant reduction in the pain scores|f||||f||||||||||2017-02-18 14:59:11.411955|2017-02-18 14:59:11.411955
NCT00573651|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2013-06-17|||November 2007||2007-11-01|June 2013|2013-06-01|November 2014|Anticipated|2014-11-01|May 2014|Anticipated|2014-05-01||Interventional|CHASE||Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis|Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis|Unknown status|Recruiting|Phase 4|72|Anticipated|University Hospitals Cleveland Medical Center||3|||f||||t||||||||||2017-02-18 14:59:11.525665|2017-02-18 14:59:11.525665
NCT00573638|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2008-08-07|||February 2005||2005-02-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|||||Interventional|Xal-Ease||Effects of Xal-Ease on Patient Compliance With Xalatan|The Effects of the Xal-Ease Delivery Aid Device on Patient Compliance With Xalatan Eye Drops|Unknown status|Recruiting|N/A|50|Anticipated|Augusta University||1|||f||||f||||||||||2017-02-18 14:59:11.644063|2017-02-18 14:59:11.644063
NCT00573586|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2010-03-05||||||March 2010|2010-03-01|March 2009|Anticipated|2009-03-01|||||Interventional|||Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada|Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate® 500 (SB-500) System in Canada|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|SonaCare Medical||1|||f||||f||||||||||2017-02-18 14:59:12.191974|2017-02-18 14:59:12.191974
NCT00573573|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-03-23|||January 2007||2007-01-01|March 2009|2009-03-01|July 2009|Anticipated|2009-07-01|March 2009|Anticipated|2009-03-01||Interventional|||Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.|Unknown status|Active, not recruiting|Phase 1|2|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:12.280332|2017-02-18 14:59:12.280332
NCT00573560|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2014-07-21|||December 2007||2007-12-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|January 2010|Actual|2010-01-01||Interventional|PARACHUTE||Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients|A Feasibility Trial to Evaluate the VPD Implant System - Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease|Completed||Phase 1|20|Anticipated|CardioKinetix, Inc||1|||f||||t||||||||||2017-02-18 14:59:12.384107|2017-02-18 14:59:12.384107
NCT00573547|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-08-15|||February 2007||2007-02-01|August 2011|2011-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease|A 12-Week Open-Label Trial of Once-Weekly Fluoxetine for the Treatment of Depression in Patients With End-Stage Renal Disease|Withdrawn||Phase 4|0|Actual|Creighton University||1||Principal Investigator decided not to initiate the study.|f||||f||||||||||2017-02-18 14:59:12.476396|2017-02-18 14:59:12.476396
NCT00573534|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2012-12-09|2011-08-15||March 2008||2008-03-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse|Pilot Study of Vyvanse™ (Lisdexamfetamine Dimesylate) in Adolescents (Ages 11-15) With ADHD and an Older Sibling With ADHD and Substance Dependence|Completed||Phase 4|8|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 14:59:12.575842|2017-02-18 14:59:12.575842
NCT00573521|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-12-16|||November 2007||2007-11-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms|Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms|Active, not recruiting||N/A|450|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 14:59:12.812779|2017-02-18 14:59:12.812779
NCT00573508|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2010-09-07|2010-02-02||August 2007||2007-08-01|September 2010|2010-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|VIBRANT||Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 4, Multi-center Study of VESIcare® (Solifenacin Succinate) in Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life VIBRANT: VESIcare® Investigation of BotheR And Quality of Life iN subjecTs With OAB|Completed||Phase 4|768|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||f||||||||||2017-02-18 14:59:12.915961|2017-02-18 14:59:12.915961
NCT00573495|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-09-27|||November 2007||2007-11-01|September 2016|2016-09-01|February 2013|Actual|2013-02-01|July 2011|Actual|2011-07-01||Interventional|||Multipeptide Vaccine for Advanced Breast Cancer|A Study of hTERT/Survivin Multi-peptide Vaccine With Daclizumab and Prevnar for Patients With Metastatic Breast Cancer|Completed||Phase 1|11|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 14:59:14.12193|2017-02-18 14:59:14.12193
NCT00573482|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2010-02-24|||September 2002||2002-09-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|||||Interventional|Cafeteria||A Cafeteria Based Study of Weight Gain Prevention|A Cafeteria Based Study of Weight Gain Prevention|Completed||N/A|106|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 14:59:14.23377|2017-02-18 14:59:14.23377
NCT00573469|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2012-07-02|2009-03-18||October 2006||2006-10-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease|A Multicentre, Double-blind, Randomised, Parallel-group, Phase II Study to Assess Efficacy and Safety of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease|Completed||Phase 2|75|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:59:14.347622|2017-02-18 14:59:14.347622
NCT00573456|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-08-14|||May 2006||2006-05-01|August 2009|2009-08-01|April 2009|Anticipated|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Far Infrared Radiation Treatment for Diabetes|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Diabetes|Unknown status|Active, not recruiting|Phase 1|2|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:14.883083|2017-02-18 14:59:14.883083
NCT00573443|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2013-06-05|2011-07-18||December 2007||2007-12-01|June 2013|2013-06-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|STAR||Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS)|Completed||Phase 3|326|Actual|Avanir Pharmaceuticals||3|||f||||t||||||||||2017-02-18 14:59:15.007353|2017-02-18 14:59:15.007353
NCT00573430|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2011-08-19|2010-06-17||December 2007||2007-12-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|PCR||ARIA (Atacand Renoprotection In NephropAthy Pt.)|A 28-week, Randomised, Open-label, Parallel-Group, Multi-Center Study To Find the Effective Dose of Candesartan Cilexetil (Atacand) for Renoprotection in Korean Hypertensive Patients With Non-diabetic Nephropathy|Completed||Phase 4|128|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 14:59:16.085714|2017-02-18 14:59:16.085714
NCT00573417|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2009-08-11|||September 2003||2003-09-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia|A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia|Completed||Phase 4|40|Actual|North Suffolk Mental Health Association||2|||f||||f||||||||||2017-02-18 14:59:16.593518|2017-02-18 14:59:16.593518
NCT00573404|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2011-11-12|||July 2007||2007-07-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|September 2009|Actual|2009-09-01||Interventional|||Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors|A Phase I Study of Imatinib Mesylate and SU011248 for Patients With Gastrointestinal Stromal Tumors|Terminated||Phase 1|6|Actual|Vanderbilt-Ingram Cancer Center||1||slow accrual|f||||t||||||||||2017-02-18 14:59:16.703078|2017-02-18 14:59:16.703078
NCT00573391|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-07-18|2011-04-15||August 2006||2006-08-01|July 2011|2011-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2|A Phase III Study for Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2 (TT2, UARK 98-026): Bortezomib, Thalidomide and Dexamethasone Versus Bortezomib, Melphalan, and Dexamethasone|Terminated||Phase 3|5|Actual|University of Arkansas|early termination due to low accrual, no analyses|2||low accrual|f||||t||||||||||2017-02-18 14:59:16.823874|2017-02-18 14:59:16.823874
NCT00573378|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-06-23|||October 2007||2007-10-01|June 2016|2016-06-01|October 2016|Anticipated|2016-10-01|November 2015|Actual|2015-11-01||Interventional|||Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia|A Combination of Imatinib or Nilotinib Together With Pegylated Interferon-α2b in Chronic-Phase Chronic Myeloid Leukemia: A Phase II Pilot Study Targeting Both the Primitive and Differentiated CML Progenitor Populations|Withdrawn||Phase 2|0|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 14:59:17.190883|2017-02-18 14:59:17.190883
NCT00573365|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2013-06-21|||March 2007||2007-03-01|June 2013|2013-06-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis|LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis: A Prospective, Randomized, Controlled Study|Completed||N/A|33|Actual|University of California, Irvine||2|||f||||t||||||||||2017-02-18 14:59:17.310837|2017-02-18 14:59:17.310837
NCT00573352|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-01-02|||September 2006||2006-09-01|January 2009|2009-01-01|December 2008|Anticipated|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Far Infrared Radiation Treatment for Osteoarthritis|Phase 1 Study to Determine the Efficacy of Using Energy Specific Far Infrared (FIR) Radiation for the Treatment of Arthritis and Other Related Diseases|Unknown status|Active, not recruiting|Phase 1|2|Anticipated|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:17.422412|2017-02-18 14:59:17.422412
NCT00573339|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-10-18|||May 2007||2007-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing|Cardiac Magnetic Resonance Imaging Normal Reference Control Group Testing - Ancillary Study to Coronary Endothelial Function and Microvascular Disease in Women|Recruiting||N/A|20|Anticipated|Cedars-Sinai Medical Center|||1||f||||f||||||None Retained|"~     BUN and Creatinine blood tests~   "|||2017-02-18 14:59:17.53526|2017-02-18 14:59:17.53526
NCT00573326|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2009-09-02|||February 2009||2009-02-01|September 2009|2009-09-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement|Low-Dose Oral Imatinib in the Treatment of Scleroderma Pulmonary Involvement: A Phase II Pilot Study|Unknown status|Recruiting|Phase 2|30|Anticipated|Azienda Ospedaliera Universitaria Policlinico||1|||f||||t||||||||||2017-02-18 14:59:17.660121|2017-02-18 14:59:17.660121
NCT00573313|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2013-06-07|2013-02-06||September 2005||2005-09-01|June 2013|2013-06-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional||294 patients were screened of whom 37 were selected for the SAMe v sugar pill trial. Of those excluded, 128 did not meet inclusion criteria, 105 met inclusion criteria but were excluded because of lack of reliable contact information, and 24 subjects declined to participate, leaving 37 subjects, 18 and 19 in each respective group at baseline.|Effects of SAMe in Patients With Alcoholic Liver Disease|Effects of SAMe in Patients With Alcoholic Liver Disease|Completed||Phase 3|94|Actual|University of California, Davis|Relatively small numbers of subjects analyzed with 13 each completers in the treatment and placebo groups. Within each group, violation of protocal by resumption of alcohol intake accounted for dropouts.|2|||f||||f||||||||||2017-02-18 14:59:17.769801|2017-02-18 14:59:17.769801
NCT00573300|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2009-08-11|||January 2006||2006-01-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study|Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative RT-PCR Study|Completed||N/A|60|Anticipated|North Suffolk Mental Health Association|||2||f||||f||||||Samples Without DNA|"~     Whole blood~   "|||2017-02-18 14:59:18.331826|2017-02-18 14:59:18.331826
NCT00573287|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2013-03-01|2013-01-16||June 2006||2006-06-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||First Episode Schizophrenia and Cannabis-Related Disorder Study|Clozapine Vs. Risperidone for People With First Episode Schizophrenia and Co-Occurring Substance Use Disorder|Completed||N/A|14|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 14:59:18.445607|2017-02-18 14:59:18.445607
NCT00573274|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-07-29|||November 2007||2007-11-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Measuring Cardiac Output and Stroke Volume Using the Physioflow Impedance Device in Pregnant Patients|Pilot Study Measuring Cardiac Output and Stroke Volume Using Non-Invasive Thoracic Impedance With the Physioflow Impedance Device in Pregnant Patients Undergoing Cesarean Section Under Spinal Anesthesia|Completed||N/A|20|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||1||f||||f||||||||||2017-02-18 14:59:18.898588|2017-02-18 14:59:18.898588
NCT00573261|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2014-07-11|2012-12-21||March 2006||2006-03-01|July 2013|2013-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|Pregabalin||A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy|A Randomized, Double-Blind, Placebo-Controlled, Single Center Study Designed to Assess the Effects of Pregabalin on Change in Patients With Diabetic Neuropathy|Completed||Phase 4|40|Actual|Duke University|The study has a high dropout, which might have reduced the power of the analysis. One of the major reasons that many patients were not able to participate was an inability to commit to the relatively intense and frequent assessments.|2|||f||||f||||||||||2017-02-18 14:59:19.004629|2017-02-18 14:59:19.004629
NCT00573248|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-09-01|2011-04-01||August 2005||2005-08-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Nicotine and Behavior in Adult ADHD|Nicotine and Behavioral Regulation in Adult ADHD|Completed||N/A|78|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 14:59:19.636054|2017-02-18 14:59:19.636054
NCT00573235|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-12-16|||October 2007||2007-10-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli|Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli|Active, not recruiting||N/A|300|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     All samples provided to the investigators are deidentified by the honest broker and will be~     coded with numbers. The information linking these code numbers to the corresponding~     subjects' identities will be kept in a separate, secure location that only the honest broker~     has access to. The investigators on this study will keep the samples indefinitely. Samples~     will be kept in the investigator's laboratory located in Scaife Hall, room 812, 3500 Terrace~     Street. At no time with the research investigators have access to any patient identifers.~   "|||2017-02-18 14:59:20.081399|2017-02-18 14:59:20.081399
NCT00573222|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2010-11-30|||November 2007||2007-11-01|November 2010|2010-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma|Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma|Completed||N/A|330|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 14:59:20.187994|2017-02-18 14:59:20.187994
NCT00573209|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-08-14|||August 2007||2007-08-01|August 2009|2009-08-01|May 2009|Anticipated|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction.|Unknown status|Active, not recruiting|Phase 1|3|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:20.285127|2017-02-18 14:59:20.285127
NCT00573196|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-08-14|||September 2006||2006-09-01|August 2009|2009-08-01|June 2008|Anticipated|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Far Infrared Radiation Treatment for Bipolar Condition|Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Bipolar Condition|Unknown status|Active, not recruiting|Phase 1|3|Actual|GAAD Medical Research Institute Inc.||1|||f||||t||||||||||2017-02-18 14:59:20.392227|2017-02-18 14:59:20.392227
NCT00573183|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2016-10-24|2013-06-04||January 2008||2008-01-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|STAGE-12||Stimulant Abuser Groups to Engage in 12-Step|Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement|Completed||Phase 3|471|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 14:59:20.716381|2017-02-18 14:59:20.716381
NCT00573170|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2010-11-30|2010-08-16||February 2008||2008-02-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults|A Randomized, Double-blind, Double-dummy, Placebo-controlled, Crossover Study to Evaluate the Efficacy of TREXIMET® (Sumatriptan + Naproxen Sodium) vs. Butalbital-containing Combination Medications for the Acute Treatment of Migraine When Administered During the Moderate-Severe Migraine Pain, Studies 1 and 2 of 2|Completed||Phase 3|375|Actual|GlaxoSmithKline|Enrolled participants included all those entering the screening part of the study. Randomized participants included only those who completed screening and completed the 2-week butalbital wash-out, and were successfully randomized to study drug.|6|||f||||f||||||||||2017-02-18 14:59:21.28456|2017-02-18 14:59:21.28456
NCT00573157|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-02-22|2016-02-22||December 2007||2007-12-01|February 2016|2016-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional||Baseline analysis population included all the participants randomized in the trial.|The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis|A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.|Terminated||Phase 2/Phase 3|6|Actual|EMD Serono|The study was terminated due to unanticipated safety issues.|2||The study was terminated due to unanticipated safety issues|f||||t||||||||||2017-02-18 14:59:22.675253|2017-02-18 14:59:22.675253
NCT00573144|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-13|2014-09-02|2014-09-02||September 2006||2006-09-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|Believe II|Baseline values are reported for subjects completing the study (28 in placebo group and 25 in nesiritide group).|Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction|Nesiritide Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction|Completed||Phase 2|59|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 14:59:23.11659|2017-02-18 14:59:23.11659
NCT00573131|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-01-12|2014-04-17||January 2008||2008-01-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer|A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer|Terminated||Phase 2|154|Actual|BTG International Inc.|Study prematurely terminated due to lack of efficacy in primary endpoint.|2||OncoGel did not show any impact on overall tumor response|f||||t||||||||||2017-02-18 14:59:23.570956|2017-02-18 14:59:23.570956
NCT00573118|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2007-12-12|||January 2000||2000-01-01|December 2007|2007-12-01|January 2008|Anticipated|2008-01-01|||||Observational|||Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity|A Retrospective Analysis of Possible Association Between Severe Pregnancy Complications and Elevated Factor VIII Plasma Activity.|Unknown status|Active, not recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||f||||||||||2017-02-18 14:59:24.186928|2017-02-18 14:59:24.186928
NCT00573105|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-01-25|||February 2008||2008-02-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Laparoscopic Ventral Hernia Repair by Heavy Weight or Lighter Weight Mesh (COMPOSIX-trial)|Laparoscopic Ventral Hernia Repair by Heavy Weight or Lighter Weight Mesh (COMPOSIX-trial)|Terminated||N/A|110|Actual|University Hospital, Ghent||2||slow inclusion rate|f||||f||||||||||2017-02-18 14:59:24.32686|2017-02-18 14:59:24.32686
NCT00573092|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-11-07|||September 2007||2007-09-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs|Genome-Wide Case-Only Study of Antihypertensive Drug-Gene Interactions|Withdrawn||N/A|0|Actual|University of Washington|||1|Withdrawn|f||||f||||||||||2017-02-18 14:59:24.603945|2017-02-18 14:59:24.603945
NCT00573079|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-02-01|||December 2007||2007-12-01|February 2011|2011-02-01||||December 2010|Actual|2010-12-01||Observational|||Acute Kidney Injury in Premature Infants|Acute Kidney Injury in Premature Infants|Completed||N/A|237|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 14:59:24.70262|2017-02-18 14:59:24.70262
NCT00573066|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2013-02-28|2010-03-12||May 2004||2004-05-01|February 2013|2013-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|InfantDex||Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery|The Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics of Dexmedetomidine In Infants Post-Operative From Cardiac Surgery|Completed||Phase 1|56|Actual|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-02-18 14:59:24.802474|2017-02-18 14:59:24.802474
NCT00573053|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-04-18|||November 2007||2007-11-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effects of Targeting Lower Arterial Oxygen Saturations on the Development of Control of Breathing in Very Preterm Infants|Effects of Targeting Lower Arterial Oxygen Saturations on the Development of Control of Breathing in Very Preterm Infants|Completed||Phase 2/Phase 3|26|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-02-18 14:59:25.068516|2017-02-18 14:59:25.068516
NCT00573040|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2010-07-20|||August 2005||2005-08-01|July 2010|2010-07-01|June 2008|Actual|2008-06-01|||||Observational|BRONC MLD||Radiotherapy for NSCLC to a Individualized MLD|Radiotherapy for Stage I-III Non-small Cell Lung Cancer to an Individualized MLD|Completed||N/A|180|Anticipated|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-02-18 14:59:25.186182|2017-02-18 14:59:25.186182
NCT00573027|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-10-18|||November 2005||2005-11-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Heart Disease of the Small Arteries in Women and Men|Coronary Microvascular Disease and Endothelial Function in Women and Men|Recruiting||Early Phase 1|634|Anticipated|Cedars-Sinai Medical Center||1|||f||||t||||||||Undecided||2017-02-18 14:59:25.294762|2017-02-18 14:59:25.294762
NCT00573014|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2007-12-12|||October 2006||2006-10-01|December 2007|2007-12-01|September 2008|Anticipated|2008-09-01|||||Observational|CSclearance||Cervical Spine Clearance in Obtunded Trauma Patients|Evaluating the Need for Magnetic Resonance Imaging of the Cervical Spine in Obtunded Trauma Patients|Unknown status|Recruiting|N/A|200|Anticipated|MetroHealth Medical Center|||1||f||||f||||||||||2017-02-18 14:59:25.421689|2017-02-18 14:59:25.421689
NCT00573001|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2012-05-14|||July 2008||2008-07-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|DAYANA||Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)|Phase 3 Randomized Trial Evaluating the Virological Efficacy and the Tolerance of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Dakar and Yaounde|Completed||Phase 3|120|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||4|||f||||t||||||||||2017-02-18 14:59:25.521899|2017-02-18 14:59:25.521899
NCT00572988|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-01-12|||May 2002||2002-05-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|||||Observational|||Symptom Management Intervention in Elderly Coronary Artery Bypass Patients|Symptom Management Intervention in Elderly CABG Patients|Completed||N/A|232|Actual|University of Nebraska|||1||f||||f||||||||||2017-02-18 14:59:25.651821|2017-02-18 14:59:25.651821
NCT00572975|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2008-09-26|||August 2006||2006-08-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|MBT||Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea|MALABSORPTION BLOOD TEST: Toward a Novel Approach to Quantify Steatorrhea|Completed||Phase 4|9|Actual|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-02-18 14:59:25.740517|2017-02-18 14:59:25.740517
NCT00572962|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2014-12-04|||January 2008||2008-01-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Prospective Clinical Observational Cohort Study to Evaluate the Use of a Tissue Separating Mesh (Proceed®) in Laparoscopic Ventral Hernia Repair|Prospective Clinical Observational Cohort Study to Evaluate the Use of a Tissue Separating Mesh (Proceed®) in Laparoscopic Ventral Hernia Repair|Unknown status|Active, not recruiting|N/A|200|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 14:59:25.85103|2017-02-18 14:59:25.85103
NCT00572949|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-11-16|||October 2004||2004-10-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Magnetocardiography (MCG) in the Diagnosis of Chest Pain Syndrome|Magnetocardiography (MCG) in the Diagnosis of Chest Pain Syndrome|Withdrawn||N/A|398|Anticipated|Cedars-Sinai Medical Center|||1|sponsor funding|f||||f||||||||||2017-02-18 14:59:25.961866|2017-02-18 14:59:25.961866
NCT00572936|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2010-01-29|||November 2005||2005-11-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Circadian Rhythms of Aqueous Humor Dynamics in Humans|Circadian Rhythms of Aqueous Humor Dynamics in Humans|Completed||Phase 2|30|Anticipated|University of Nebraska||1|||f||||f||||||||||2017-02-18 14:59:26.061777|2017-02-18 14:59:26.061777
NCT00572923|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-06-16|||August 2006||2006-08-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|||||Observational|BRONC 45 15||Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans|Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans|Completed||N/A|52|Anticipated|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-02-18 14:59:26.183435|2017-02-18 14:59:26.183435
NCT00572910|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-03-16|2011-07-20||August 2008||2008-08-01|March 2015|2015-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of Merck Staphylococcus Aureus Vaccine (V710) in Adult Patients With End-Stage Renal Disease on Chronic Hemodialysis|Completed||Phase 2|206|Actual|Merck Sharp & Dohme Corp.||6|||f||||||||||||||2017-02-18 14:59:26.302351|2017-02-18 14:59:26.302351
NCT00572897|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-04-21|2014-11-21||August 2007||2007-08-01|April 2016|2016-04-01|August 2020|Anticipated|2020-08-01|August 2011|Actual|2011-08-01||Interventional||Patients with myelofibrosis who received a stem cell transplant from either a sibling or unrelated donor.|Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis|Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis|Active, not recruiting||Phase 2|66|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-02-18 14:59:28.435405|2017-02-18 14:59:28.435405
NCT00572884|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2007-12-11|||February 2006||2006-02-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Metabolism of the Insecticide Permethrin|CCRC:Identification and Development of Biological Markers of Human Exposure to the Insecticide Permethrin|Completed||N/A|6|Actual|University of California, Davis||1|||f||||f||||||||||2017-02-18 14:59:29.408514|2017-02-18 14:59:29.408514
NCT00572871|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-09-30|||December 2007||2007-12-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Hormonal and Bone Turnover Marker Response to an Acute Bout of Resistance or Plyometric Exercise|Hormonal and Bone Turnover Marker Response to an Acute Bout of Resistance or Plyometric Exercise|Completed||N/A|12|Actual|University of Missouri-Columbia|||3||f||||f||||||Samples Without DNA|"~     serum plasma~   "|No||2017-02-18 14:59:29.510085|2017-02-18 14:59:29.510085
NCT00572858|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-10-18|||January 2005||2005-01-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women|Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women|Recruiting||N/A|75|Anticipated|Cedars-Sinai Medical Center|||1||f||||t||||||None Retained|"~     Blood Hormone draw for FSH, E2; Urine Pregnancy test; Fasting lipid (cholesterol) panel,~     fasting insulin and fasting blood glucose levels; Reproductive hormones (FSH, LH, E1, E2,~     bioE2, PO, freeT, SHBG, DHEA-S); Plasma levels of inflammatory and endothelial function~     markers including but not limited to hsCRP, serum amyloid, endothelin-1, and ELAM; Fasting~     Salivary Cortisol (stress hormone).~   "|||2017-02-18 14:59:29.599847|2017-02-18 14:59:29.599847
NCT00572845|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-02-19|||January 2008||2008-01-01|February 2016|2016-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation|Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation|Terminated||N/A|20|Actual|Virginia Commonwealth University||1||Unable to recruit enough participants.|f||||f||||||||||2017-02-18 14:59:29.720996|2017-02-18 14:59:29.720996
NCT00572832|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-08-11|2009-09-03||September 2007||2007-09-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Interventional|||Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting|Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting|Completed||N/A|200|Actual|University of Pittsburgh|One participant in the Standard group did not respond to any of the vaccine HPV types. Eleven participants in the Alternate group either did not receive Dose 3 or were out of window, compared with only one participant in the Standard group.|2|||f||||t||||||||||2017-02-18 14:59:32.328122|2017-02-18 14:59:32.328122
NCT00572819|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-05-22|||January 2008||2008-01-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial|Does Self-Administered Vaginal Misoprostol Result in Cervical Ripening in Postmenopausal Women After 14 Days Pre-Treatment With Estradiol?|Completed||Phase 3|100|Anticipated|Ullevaal University Hospital||2|||f||||t||||||||||2017-02-18 14:59:32.882739|2017-02-18 14:59:32.882739
NCT00572806|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2012-06-05|||February 2003||2003-02-01|September 2011|2011-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Initiation of Insulin Aspart in Type 2 Diabetes|Evaluation of the Initiation of Insulin Treatment Using Insulin Aspart on Blood Glucose Profile in Type 2 Diabetes Mellitus|Completed||Phase 4|6|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:59:32.983166|2017-02-18 14:59:32.983166
NCT00572793|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-07-07|||November 2007||2007-11-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk|A Nested Case-Controlled Study Evaluating the Utility of Placental Protein 13 (PP13) In-vitro Diagnostic Kit as a Diagnostic Aiding Tool in Assessment of the Risk for Developing Preeclampsia Necessitating Delivery Before 37 Weeks (Early-preeclampsia) Based on First Trimester Blood Testing of Pregnant Women With Low and Unknown Risk|Completed||N/A|431|Actual|University of Kansas Medical Center|||1||f||||f||||||Samples Without DNA|"~     Maternal serum - placental protein 13 level~   "|||2017-02-18 14:59:33.07469|2017-02-18 14:59:33.07469
NCT00572780|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-08-07|||August 2007||2007-08-01|August 2015|2015-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Can CT Enteroclysis Predict the Outcome of Crohn's Disease|Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease|Completed||N/A|125|Actual|Indiana University|||1||f||||f||||||||||2017-02-18 14:59:33.153839|2017-02-18 14:59:33.153839
NCT00572767|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2007-12-12|||January 2001||2001-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Evaluation of the Effect of Dextro-Amphetamin Added to Physiotherapy in Patients After Stroke|Evaluation of the Therapeutic Effect of Amphetamine in Association to Physiotherapy on Motor Recovery After Stroke: a Randomised, Double-Blinded, Placebo-Controlled Trial|Terminated||Phase 4|16|Actual|Reha Rheinfelden||2||Intended length of study ended|f||||f||||||||||2017-02-18 14:59:33.235897|2017-02-18 14:59:33.235897
NCT00572754|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2007-12-12|||November 2007||2007-11-01|December 2007|2007-12-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Phase II Trial to Evaluate the Safety and Efficacy of the Dry Circumcision Method|Phase II Trial to Evaluate the Safety and Efficacy of the Dry Circumcision|Unknown status|Recruiting|Phase 2|15|Anticipated|Progressus||1|||f||||t||||||||||2017-02-18 14:59:33.332835|2017-02-18 14:59:33.332835
NCT00572728|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-12-28|2015-03-18||December 2008||2008-12-01|December 2016|2016-12-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional||Registered|Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer|3'-Deoxy-3'-18F Fluorothymidine PET/CT in Predicting Response To Chemotherapy Before Surgery in Patients With Locally Advanced Breast Cancer|Completed||Phase 2|90|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 14:59:33.595672|2017-02-18 14:59:33.595672
NCT00572715|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-03-05|||January 2010||2010-01-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|||||Observational|||Acute Kidney Injury in Neonates|Acute Kidney Injury in Neonates|Withdrawn||N/A|0|Actual|University of Alabama at Birmingham|||1|Investigator's decision:Did not open to enrollment|f||||f||||||||||2017-02-18 14:59:34.243792|2017-02-18 14:59:34.243792
NCT00572702|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-07-31|||January 2007||2007-01-01|July 2009|2009-07-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Randomized,Multicentric Study to Treat Prolapse After Hysterectomy With Amreich Procedure or Total Prolift Procedure|Open, Randomized, Prospective, Comparative, Multicentric to Treat Prolapse of Vaginal Cuff After Hysterectomy With Amreich Procedure or Total Prolift Procedure|Unknown status|Recruiting|N/A|200|Anticipated|Charles University, Czech Republic||2|||f||||f||||||||||2017-02-18 14:59:34.334584|2017-02-18 14:59:34.334584
NCT00572689|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2015-08-20|||August 2013||2013-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes|Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes|Withdrawn||Phase 4|0|Actual|Georgetown University||2|||f||||t||||||||||2017-02-18 14:59:34.443527|2017-02-18 14:59:34.443527
NCT00572663|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2007-12-12|||January 2005||2005-01-01|December 2007|2007-12-01||||||||Interventional|||Optimalization of Nephroprotection Using N-Acetylcysteine|The Effect of N-Acetylcysteine on Proteinuria and Markers of Tubular Injury in Non-Diabetic Patientswith Chronic Kidney Disease-Placebo Controlled, Randomized,Open, Cross-Over Study|Completed||N/A|||Medical University of Gdansk|||||f||||||||||||||2017-02-18 14:59:34.54889|2017-02-18 14:59:34.54889
NCT00572650|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2012-04-30|||October 2007||2007-10-01|April 2012|2012-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients|An Open-label, Parallel-group Study to Determine the Single and Multiple Dose Pharmacokinetics of LAF237 and Its Metabolites in Mild Renal Impaired Patients Compared to Age, Sex and Weight-matched Healthy Volunteers Following Daily Doses of 100 mg LAF237 for 14 Days|Completed||Phase 1|29|Actual|Novartis||1|||f||||f||||||||||2017-02-18 14:59:34.635653|2017-02-18 14:59:34.635653
NCT00572637|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2010-05-19|||November 2007||2007-11-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas|An Open-Label, Dose-escalation, Phase I Study to Determine the Maximum Tolerated Dose, Recommended Dose, Pharmacokinetics, and Pharmacodynamics of the Proteosome Inhibitor CEP 18770 Given Intravenously as Single Agent in Patients With Advanced Solid Tumours or Non-Hodgkin's Lymphomas|Completed||Phase 1|55|Anticipated|Ethical Oncology Science||1|||f||||f||||||||||2017-02-18 14:59:34.733123|2017-02-18 14:59:34.733123
NCT00572624|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-05-11|||June 2003||2003-06-01|May 2011|2011-05-01|December 2011|Anticipated|2011-12-01|June 2011|Anticipated|2011-06-01||Observational|||Effect of Abdominal Obesity on Heart Metabolism and Function|Altered Myocardial Fatty Acid Metabolism In Obesity|Unknown status|Recruiting|N/A|136|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples With DNA|"~     1 tablespoon of blood with DNA~   "|||2017-02-18 14:59:34.832672|2017-02-18 14:59:34.832672
NCT00572611|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2012-09-25|||November 2007||2007-11-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Human Mass Balance Study With Bilastine|A Phase I Study to Investigate the Absorption, Metabolism and Excretion of [14C]-Bilastine Following Oral Administration to Healthy Volunteers|Completed||Phase 1|6|Actual|Faes Farma, S.A.||1|||f||||f||||||||||2017-02-18 14:59:34.943777|2017-02-18 14:59:34.943777
NCT00572598|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2012-01-11|||May 2005||2005-05-01|January 2012|2012-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Pilot Study of 18F Fluoropaclitaxel (FPAC)|Pilot Study of 18F Fluoropaclitaxel (FPAC) in Breast Cancer Patients and Normal Volunteers: Dosimetry and Imaging Feasibility|Completed||Early Phase 1|6|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 14:59:35.043201|2017-02-18 14:59:35.043201
NCT00572585|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2016-09-22|||April 2010||2010-04-01|September 2016|2016-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis|A Randomized, Double Blind, Placebo Controlled, Parallel Group Design Study to Explore the Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis|Completed||Phase 2|60|Actual|Novartis||2|||f||||f||||||||No||2017-02-18 14:59:35.143451|2017-02-18 14:59:35.143451
NCT00572572|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-03-08|2015-12-17||December 2007||2007-12-01|March 2016|2016-03-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors|Phase III, Double-Blind, Placebo-Controlled, Crossover Study Evaluating Aprepitant in Combination With a 5HT3 & Dexamethasone in Patients With Germ Cell Tumors Undergoing 5 Day Cisplatin-Based Chemotherapy Regimen|Completed||Phase 3|69|Actual|Hoosier Cancer Research Network||2|||f||||t||||||||||2017-02-18 14:59:35.259674|2017-02-18 14:59:35.259674
NCT00572559|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-06-08|||November 2002||2002-11-01|June 2010|2010-06-01|January 2005|Actual|2005-01-01|||||Interventional|||Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus|A Randomized, Open Label, Multi-Center Clinical Trial, Comparing Microbiologic Response To Linezolid And Vancomycin In Ventilator-Associated Pneumonia (VAP) Due To Methicillin Resistant Staphylococcus Aureus (MRSA)|Completed||Phase 4|149|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 14:59:36.355795|2017-02-18 14:59:36.355795
NCT00572533|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2012-12-19|2012-10-15||April 2011||2011-04-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|||Intelligent Control Approach to Anemia Management|Intelligent Control Approach to Anemia Management (AIM 4)|Completed||N/A|62|Actual|University of Louisville|"Single-center design~Small sample size~Homogenous population~Only maintenance dosing phase tested"|2|||f||||f||||||||||2017-02-18 14:59:36.503145|2017-02-18 14:59:36.503145
NCT00429819|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2014-12-15|||December 2006||2006-12-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|June 2014|Actual|2014-06-01||Observational|||Neurovascular Coupling in Eyes of Glaucoma Patients|Neurovascular Coupling in Eyes of Glaucoma Patients|Completed||N/A|100|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 15:54:19.287635|2017-02-18 15:54:19.287635
NCT00572507|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-05-27|||December 2007||2007-12-01|May 2015|2015-05-01|July 2009|Actual|2009-07-01|August 2008|Actual|2008-08-01||Interventional|ISSAAC||Multi-center Study to Evaluate the Safety and Efficacy of Aesculap MonoMax® for Abdominal Wall Closure|A Historically-controlled Single-arm Multi-center Prospective Trial to Evaluate the Safety and Efficacy of Aesculap MonoMax® Suture Material for Abdominal Wall Closure After Primary Median Laparotomy|Completed||N/A|150|Actual|Aesculap AG||1|||f||||f||||||||||2017-02-18 14:59:37.421665|2017-02-18 14:59:37.421665
NCT00572494|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2008-02-07|||July 2005||2005-07-01|February 2008|2008-02-01|January 2007|Actual|2007-01-01|||||Interventional|AMS-INSIGHT1||AMS INSIGHT 1 Study - Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment|Bioabsorbable Metal Stent Investigation in Chronic Limb Ischemia Treatment|Completed||Phase 2|117|Actual|Flanders Medical Research Program||2|||f||||t||||||||||2017-02-18 14:59:37.742132|2017-02-18 14:59:37.742132
NCT00572481|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-08-25|||May 2007||2007-05-01|August 2016|2016-08-01|May 2018|Anticipated|2018-05-01|May 2017|Anticipated|2017-05-01||Interventional|ARM||Axillary Reverse Mapping|ARM: Axillary Reverse Mapping|Active, not recruiting||Phase 2|1000|Anticipated|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:59:37.851297|2017-02-18 14:59:37.851297
NCT00572468|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2014-08-18|||December 2007||2007-12-01|August 2014|2014-08-01|December 2014|Anticipated|2014-12-01|October 2013|Actual|2013-10-01||Interventional|||Statin Therapy Versus Placebo Prior to Prostatectomy|Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer|Unknown status|Active, not recruiting|N/A|44|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 14:59:37.962293|2017-02-18 14:59:37.962293
NCT00572455|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-02-25||2011-02-17|December 2007||2007-12-01|February 2011|2011-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.|A 2-Stage, Phase 2, Double-Masked, Randomized, Vehicle Controlled, Dose Response Trial Of PF-04217329 And The Marketed Formulation Of Latanoprost In Patients With Primary Open Angle Glaucoma Or Ocular Hypertension.|Completed||Phase 2|317|Actual|Pfizer||14|||f||||t||||||||||2017-02-18 14:59:38.075504|2017-02-18 14:59:38.075504
NCT00572442|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-11-16|||December 2007||2007-12-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Observational|||Magnetocardiography (MCG) in Asymptomatic Individuals - Pilot Trial|Magnetocardiography (MCG) in Asymptomatic Individuals - Pilot Trial|Withdrawn||N/A|40|Anticipated|Cedars-Sinai Medical Center|||4|sponsor funding|f||||f||||||||||2017-02-18 14:59:38.442286|2017-02-18 14:59:38.442286
NCT00572429|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2012-12-17|||July 2008||2008-07-01|December 2012|2012-12-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|HIV||Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART|Effects of Mixed Exercise Regime and L-Carnitine Supplementation on Kinetics of Triglyceride-rich Lipoproteins in HIV Patients on HAART|Withdrawn||N/A|0|Actual|University of California, Davis||1||no subjects enrolled,study never started|f||||f||||||||||2017-02-18 14:59:38.533065|2017-02-18 14:59:38.533065
NCT00572416|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2007-12-12|||April 2003||2003-04-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Fatigue in Breast Cancer: A Behavioral Sleep Intervention|Fatigue in Breast Cancer:A Behavioral Sleep Intervention|Completed||Phase 3|220|Actual|University of Nebraska||2|||f||||f||||||||||2017-02-18 14:59:38.637431|2017-02-18 14:59:38.637431
NCT00572403|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2011-03-04|||December 2007||2007-12-01|March 2011|2011-03-01|April 2008|Actual|2008-04-01|||||Observational|||Risk Factors Contributing to the Development of Microalbuminuria|Risk Factors Contributing to the Development of Microalbuminuria Over a 5 Year Period|Completed||N/A|10|Actual|Sunnybrook Health Sciences Centre|||1||f||||||||||||||2017-02-18 14:59:38.744079|2017-02-18 14:59:38.744079
NCT00572390|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2007-12-12|||January 2001||2001-01-01|December 2007|2007-12-01|February 2002|Actual|2002-02-01|||||Interventional|||Oestrogen Withdrawal in Hypopituitary Women|Oestrogen Withdrawal in Hypopituitary Women|Completed||N/A|38|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 14:59:38.830207|2017-02-18 14:59:38.830207
NCT00572377|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2008-06-19|||May 2007||2007-05-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder|Safety and Efficacy of Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder|Terminated||Phase 1|10|Anticipated|Cedars-Sinai Medical Center||2||"The investigator at Cedars stopped this study due to problems collecting payment from the~   sponsor."|f||||t||||||||||2017-02-18 14:59:38.937151|2017-02-18 14:59:38.937151
NCT00572364|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-08-19|||November 2007||2007-11-01|August 2009|2009-08-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Open Label, Dose Escalation Phase I Study of AZD2281|A Phase I, Open-label, Dose Escalation Study to Assess the Safety and Tolerability of AZD2281 Following Single and Multiple Oral Doses in Patients in Japan With Advanced Solid Malignancies|Completed||Phase 1|18|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 14:59:39.04705|2017-02-18 14:59:39.04705
NCT00572351|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2012-08-27|||January 2006||2006-01-01|August 2012|2012-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Effects of Red Wine and White Wine on Blood Estrogen and Progesterone Levels|The Effects of Red Wine and White Wine on Blood Estrogen and Progesterone Levels|Completed||Phase 3|44|Actual|Cedars-Sinai Medical Center||2|||f||||t||||||||||2017-02-18 14:59:39.145645|2017-02-18 14:59:39.145645
NCT00572338|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-08-12|||August 2003||2003-08-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||Therapeutic Research in Multiple Myeloma|UARK 91-004 Therapeutic Research in Multiple Myeloma|Completed||N/A|6388|Actual|University of Arkansas|||1||f||||f||||||Samples With DNA|"~     -  A bone marrow aspirate and biopsy~        -  Blood~        -  Fine Needle aspirates~        -  Swabs of skin, throat, other sites~   "|||2017-02-18 14:59:39.239816|2017-02-18 14:59:39.239816
NCT00572325|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2010-07-20|||August 2006||2006-08-01|July 2010|2010-07-01|May 2009|Actual|2009-05-01|||||Observational|BRONC CONC MLD||Concurrent Chemo-radiation Form NSCLC to a Individualized MLD|Concurrent Chemo-radiotherapy for Stage III Non-small Cell Lung Cancer ta an Individualized MLD|Completed||N/A|180|Actual|Maastricht Radiation Oncology|||1||f||||f||||||||||2017-02-18 14:59:39.333219|2017-02-18 14:59:39.333219
NCT00572312|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2007-12-12|||February 2005||2005-02-01|December 2007|2007-12-01||||||||Interventional|||Optimalization of Nephroprotection Using Atorvastatin (Sortis)|Influence of Adding Atorvastatin to Dual Renin-Angiotensin-Aldosterone System Blockade on Proteinuria|Completed||N/A|||Medical University of Gdansk|||||f||||||||||||||2017-02-18 14:59:39.424009|2017-02-18 14:59:39.424009
NCT00429429|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-06-16||2012-09-14|April 2006||2006-04-01|June 2016|2016-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Immunotherapy for Peanut Allergy|Immunotherapy for Peanut Allergy|Completed||N/A|7|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||No||2017-02-18 15:54:23.936073|2017-02-18 15:54:23.936073
NCT00572299|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-08-29|||January 2004||2004-01-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Glucocorticoids Promote Osteoclast Survival|Glucocorticoids Promote Osteoclast Survival|Terminated||N/A|3|Actual|University of Arkansas|||2|Terminated due to recruitment problems|f||||f||||||Samples Without DNA|"~     bone biopsy specimens~   "|||2017-02-18 14:59:39.506547|2017-02-18 14:59:39.506547
NCT00572286|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2009-11-16|||October 2005||2005-10-01|November 2009|2009-11-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Non-invasive Evaluation of Heart Transplant Rejection- Pilot Study|Evaluation of Non-invasive Methods for the Detection of Acute Rejection in Heart Transplant Patients: Use of Echocardiography and Magnetocardiography (MCG) -Pilot Study|Withdrawn||N/A|20|Anticipated|Cedars-Sinai Medical Center|||1|sponsor funding|f||||f||||||||||2017-02-18 14:59:39.610295|2017-02-18 14:59:39.610295
NCT00572260|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-12|2014-07-17|2011-03-29||January 2008||2008-01-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Pilot Study of Daptomycin for Antimicrobial Prophylaxis|A Pilot Study of Daptomycin for Antimicrobial Prophylaxis in Patients Undergoing Cardiac Valve Replacement and Coronary Artery Bypass Grafting (CABG) Who Are at Increased Risk for Infection Due to Methicillin-resistant Staphylococcus Aureus (MRSA)|Terminated||Phase 4|11|Actual|Duke University|Premature termination of the study due to departure of the PI resulted in falling short of enrollment goal (enrolled - 11 enrolled/goal - 100) leading to uninterpretable data.|1||Study closed. PI left the institution.|f||||f||||||||||2017-02-18 14:59:39.714386|2017-02-18 14:59:39.714386
NCT00572247|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2012-03-05|||January 2007||2007-01-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|||The Psychiatric Rehabilitation Approach to Weight Loss|The Intervention Involves Education on Nutrition and Physical Activity. Outcomes Evaluate Changes in BMI.|Completed||N/A|133|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 14:59:39.934376|2017-02-18 14:59:39.934376
NCT00572234|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-01-13|||June 2007||2007-06-01|January 2010|2010-01-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Bupropion in the Treatment of Methamphetamine Dependence|Bupropion in the Treatment of Methamphetamine Dependence|Unknown status|Recruiting|N/A|60|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-02-18 14:59:40.052404|2017-02-18 14:59:40.052404
NCT00572221|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2013-03-18|||February 2006||2006-02-01|March 2013|2013-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Improving the Quality of Care in Nursing Homes|Improving the Quality of Care in Nursing Homes|Completed||N/A|4316|Actual|Hebrew Rehabilitation Center, Boston||2|||f||||f||||||||||2017-02-18 14:59:40.156569|2017-02-18 14:59:40.156569
NCT00572208|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2009-02-12|||January 2008||2008-01-01|February 2009|2009-02-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Gabapentin for Postoperative Pain Management After Cardiac Surgery With Median Sternotomy|Gabapentin for Postoperative Pain Management After Cardiac Surgery With Median Sternotomy|Unknown status|Recruiting|N/A|64|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-02-18 14:59:40.268093|2017-02-18 14:59:40.268093
NCT00572195|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-09-20|||April 2006||2006-04-01|September 2016|2016-09-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|||RNS® System LTT Study|RNS® System Long-term Treatment (LTT) Clinical Investigation|Active, not recruiting||Phase 3|230|Actual|NeuroPace||1|||f||||t||||||||||2017-02-18 14:59:40.379057|2017-02-18 14:59:40.379057
NCT00572182|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2012-03-02|||July 2008||2008-07-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer|A Phase I Study of MK-0752 in Pediatric Patients With Recurrent or Refractory CNS Malignancies|Terminated||Phase 1|33|Actual|Pediatric Brain Tumor Consortium||1||"This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the~   discontinuation of support from MERCK."|f||||t||||||||||2017-02-18 14:59:40.524056|2017-02-18 14:59:40.524056
NCT00572169|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-10-11|||November 2006||2006-11-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy|A Phase II Study Incorporating Bone Marrow Microenvironment (ME) - Co-Targeting Bortezomib Into Tandem Melphalan-Based Autotransplants With DTPACE for Induction/Consolidation and Thalidomide + Dexamethasone for Maintenance|Active, not recruiting||Phase 3|177|Actual|University of Arkansas||1|||f||||t||||||||||2017-02-18 14:59:40.635298|2017-02-18 14:59:40.635298
NCT00572156|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2015-11-10|2015-08-06||December 2007||2007-12-01|November 2015|2015-11-01|March 2012|Actual|2012-03-01|April 2010|Actual|2010-04-01||Interventional||All Subjects|rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency|Recombinant Human Growth Hormone (rhGH) and Recombinant Human Insulin-like Growth Factor-1 rhIGF-1) Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency: A Six-year, Randomized, Multi-center, Open-label, Parallel-group, Active Treatment Controlled, Dose Selection Trial|Terminated||Phase 2|106|Actual|Ipsen|The study was prematurely terminated once the last subject had completed three years of treatment (compared to the six years planned in protocol Amendment) for strategic reasons.|4||The study was prematurely terminated due to strategic reasons.|f||||t||||||||||2017-02-18 14:59:40.777422|2017-02-18 14:59:40.777422
NCT00572143|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-01-26|||June 2007||2007-06-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|ONKOLINK||Follow-up After Surgery for Colon Cancer. General Practice vs. Surgical-based Follow-up?|Should the Surgeon or the General Practitioner (GP) Follow up Patients After Surgery for Colon Cancer? A Randomized Controlled Trial Focusing on Quality of Life, Cost-effectiveness and Serious Clinical Events.|Completed||N/A|180|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-02-18 14:59:42.890262|2017-02-18 14:59:42.890262
NCT00572130|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-06-09|||December 2007||2007-12-01|February 2010|2010-02-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|||Phase II Study of Intravenous Rexin-G in Osteosarcoma|A Phase II Study of Intravenous Rexin-G in Recurrent or Metastatic Osteosarcoma|Completed||Phase 2|22|Actual|Epeius Biotechnologies||2|||f||||t||||||||||2017-02-18 14:59:42.986714|2017-02-18 14:59:42.986714
NCT00572117|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-11-09|2016-08-17||August 2007||2007-08-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder|Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder|Completed||Phase 4|12|Actual|Stanford University||2|||f||||f||||||||No||2017-02-18 14:59:43.093578|2017-02-18 14:59:43.093578
NCT00572104|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-10-06|||January 2008||2008-01-01|October 2016|2016-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia|Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia|Completed||N/A|38|Actual|University of Missouri-Columbia||2|||f||||t||||||||No||2017-02-18 14:59:43.407295|2017-02-18 14:59:43.407295
NCT00572091|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2008-11-05|||February 2007||2007-02-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|PTOLEMY||Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation|An Open-Label, Single-Arm Pilot Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device Used to Reduce Mitral Regurgitation|Completed||Phase 1/Phase 2|4|Actual|Viacor||1|||f||||t||||||||||2017-02-18 14:59:43.507578|2017-02-18 14:59:43.507578
NCT00572078|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-05-19|||July 2008||2008-07-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|April 2010|Actual|2010-04-01||Interventional|||Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors|Phase I Dose-Escalation Drug-Interaction Study of Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors|Active, not recruiting||Phase 1|27|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 14:59:43.609649|2017-02-18 14:59:43.609649
NCT00572065|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-09-24|||December 2007||2007-12-01|September 2010|2010-09-01|December 2010|Anticipated|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis|Prospective Pilot Trial of Arsenic Trioxide (Trisenox®) in Combination With Cytosine Arabinoside in Patients With Advanced or Transformed Myelofibrosis|Unknown status|Active, not recruiting|Early Phase 1|20|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 14:59:43.714339|2017-02-18 14:59:43.714339
NCT00572052|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2017-01-18|||December 2002||2002-12-01|January 2017|2017-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Comparison of Glycemic Control Achieved With 2 Different Needles|Comparison of Glycemic Control Achieved With a 31 Gauge x 6 mm NovoFine® Needle vs. a BD 29 Gauge x 12.7 mm Ultra-Fine® Needle in Subjects With Diabetes Mellitus and a BMI Exceeding 30 kg/m2: An Open Label, Randomized, Two-Period Crossover Study|Completed||Phase 4|62|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:59:43.812204|2017-02-18 14:59:43.812204
NCT00572039|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2015-09-14|2015-08-11||August 2005||2005-08-01|September 2015|2015-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|IF-AMD||Improving Function in Age-Related Macular Degeneration|Improving Function in Age-Related Macular Degeneration|Completed||Phase 3|241|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 14:59:43.906643|2017-02-18 14:59:43.906643
NCT00572026|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-09-02|||July 2007||2007-07-01|September 2009|2009-09-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|||Enhancing ADHD Driving Performance With Stimulant Medication|Enhancing ADHD Driving Performance With Stimulant Medication|Unknown status|Recruiting|N/A|14|Anticipated|University of Virginia||2|||f||||f||||||||||2017-02-18 14:59:44.536507|2017-02-18 14:59:44.536507
NCT00572013|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2013-12-13|||May 1998||1998-05-01|December 2013|2013-12-01|September 2009|Actual|2009-09-01|January 2001|Actual|2001-01-01||Interventional|||Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma|A Phase I/II Trial of Rituxan and BEAM High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma|Completed||Phase 1/Phase 2|32|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:59:44.654469|2017-02-18 14:59:44.654469
NCT00572000|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2007-12-11|||November 2007||2007-11-01|October 2007|2007-10-01|June 2008|Anticipated|2008-06-01|||||Interventional|HPV-022 PRI||Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule|Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule|Unknown status|Recruiting|N/A|222|Anticipated|National Institute for Control of Vaccine and Biologicals||1|||f||||t||||||||||2017-02-18 14:59:44.76515|2017-02-18 14:59:44.76515
NCT00571987|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-10-28|2015-07-29||September 2004||2004-09-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|eRFA||Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operation|Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operation|Completed||Phase 1/Phase 2|107|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 14:59:44.844608|2017-02-18 14:59:44.844608
NCT00571974|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-03-04|2012-05-11||January 2007||2007-01-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Treatment of Oral Premalignant Lesions With 5-ALA PDT|A Combined Phase I/II Single Site Study to Determine the Safety and Efficacy of Photodynamic Therapy (PDT) Utilizing 5-aminolevulinic Acid (5-ALA) and PDT in the Treatment of Premalignant Oral and/or Oropharynx Lesions.|Completed||Phase 1/Phase 2|29|Actual|University of Arkansas|Since all but one subject responded to treatment, no correlative analysis of response with change in expression of p53 or Ki-67 was undertaken.|2|||f||||f||||||||||2017-02-18 14:59:45.06225|2017-02-18 14:59:45.06225
NCT00571961|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2012-10-19|2012-05-25||January 2007||2007-01-01|October 2012|2012-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)|Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)|Completed||N/A|12|Actual|Yale University||1|||f||||f||||||||||2017-02-18 14:59:45.469904|2017-02-18 14:59:45.469904
NCT00571948|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-05-04|2009-05-01||September 2005||2005-09-01|May 2015|2015-05-01|March 2008|Actual|2008-03-01|July 2007|Actual|2007-07-01||Interventional|DINO||Modification in Complementary Food Composition to Improve the Status of Iron and Fatty Acids in Infants.|Dortmund Intervention Trial for Optimization of Infant Nutrition|Completed||N/A|132|Actual|Research Institute of Child Nutrition, Dortmund||2|||f||||f||||||||||2017-02-18 14:59:45.838155|2017-02-18 14:59:45.838155
NCT00571935|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-12-20|||August 2003||2003-08-01|December 2016|2016-12-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes|Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes Mellitus|Completed||Phase 4|61|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:59:46.160871|2017-02-18 14:59:46.160871
NCT00571727|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2015-09-29|||January 1990||1990-01-01|September 2015|2015-09-01|December 2011|Actual|2011-12-01|October 2004|Actual|2004-10-01||Interventional|||Long-Term Treatment With rhIGF-1 in GHIS|A Study of the Long-Term Human Recombinant Insulin-Like Growth Factor-1 (rhIGF-1) Treatment in Children With Short Stature Due to Growth Hormone Insensitivity Syndrome (GHIS)|Completed||Phase 2/Phase 3|92|Actual|Ipsen||1|||f||||||||||||||2017-02-18 14:59:48.110847|2017-02-18 14:59:48.110847
NCT00571922|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-03-07|2016-02-05||July 2007||2007-07-01|March 2016|2016-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|AcampMet||A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction|A Placebo-controlled, Double Blind, Randomized Trial of Acamprosate for the Treatment of Methamphetamine Dependence|Completed||Phase 1/Phase 2|72|Actual|New York University School of Medicine|Sadly, the PI of this study passed away on 4/20/2010. Data was not analyzed and is unavailable.|2|||f||||f||||||||||2017-02-18 14:59:46.259931|2017-02-18 14:59:46.259931
NCT00571909|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2015-04-06|||May 2007||2007-05-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study|Evaluation and Treatment of Chronic Pain in Autosomal Dominant Polycystic Kidney Disease|Recruiting||Phase 2|20|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 14:59:46.608132|2017-02-18 14:59:46.608132
NCT00571896|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2012-01-03|||January 2008||2008-01-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Use of SennaS for Prevention of Post-operative Constipation After Urogynecologic Surgery|The Use of SennaS for Prevention of Post-operative Constipation After Urogynecologic Surgery: a Randomized Double Blinded Placebo Controlled Trial|Completed||Phase 2/Phase 3|72|Actual|Hartford Hospital||2|||f||||f||||||||||2017-02-18 14:59:46.720207|2017-02-18 14:59:46.720207
NCT00571883|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-12-11|||January 2007||2007-01-01|July 2009|2009-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Neck Surgery in Treating Patients With Early-Stage Oral Cancer|SEND Trial The Role of Selective Neck Dissection Used Electively in Patients With Early Oral Squamous Cell Carcinoma (1-3cm Primary Size) and No Clinical Evidence of Lymph Node Metastases in the Neck|Unknown status|Active, not recruiting|N/A|652|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 14:59:46.838829|2017-02-18 14:59:46.838829
NCT00571870|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-08-20|||November 2007||2007-11-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Gonadotropin-releasing Hormone Antagonist on Triggering Day: A Randomized Controlled Study|Study on the Effect of GnRH Antagonist on hCG Day on Outcomes of Controlled Ovarian Hyperstimulation With GnRH Antagonist Flexible Multiple-dose Protocols|Completed||N/A|80|Anticipated|Seoul National University Bundang Hospital||2|||f||||f||||||||||2017-02-18 14:59:46.954814|2017-02-18 14:59:46.954814
NCT00571844|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2014-07-11|||October 2003||2003-10-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2009|Actual|2009-07-01||Interventional|ENCORE||ENCORE: Exercise and Nutritional Interventions for Cardiovascular Health|Behavioral Treatment of High Blood Pressure|Completed||N/A|144|Actual|Duke University||3|||f||||t||||||||||2017-02-18 14:59:47.065026|2017-02-18 14:59:47.065026
NCT00571831|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2007-12-11|||February 2003||2003-02-01|December 2007|2007-12-01|March 2005|Actual|2005-03-01|||||Interventional|||The Effect of a Blue Light Filtering IOL|The Effect of a Blue Light Filtering Intraocular Lens on Blood Retinal Barrier After Cataract Surgery|Completed||N/A|50|Actual|Showa University||1|||f||||f||||||||||2017-02-18 14:59:47.182156|2017-02-18 14:59:47.182156
NCT00571818|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-05-26|||November 2000||2000-11-01|May 2015|2015-05-01|June 2010|Actual|2010-06-01|March 2008|Actual|2008-03-01||Interventional|||The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients|The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients|Completed||N/A|31|Actual|University of Nebraska||4|||f||||f||||||||||2017-02-18 14:59:47.283879|2017-02-18 14:59:47.283879
NCT00571805|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-04-08|||September 2007||2007-09-01|April 2015|2015-04-01||||||||Interventional|VarenSmoke||Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt|Placebo-controlled Study of Varenicline Effects on Nicotine Withdrawal Followed by a Test of Smoking Topography, Reward, and Reinforcement|Withdrawn||Phase 1/Phase 2|0|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-02-18 14:59:47.381078|2017-02-18 14:59:47.381078
NCT00571792|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2007-12-11|||August 2006||2006-08-01|December 2007|2007-12-01|September 2008|Anticipated|2008-09-01|||||Observational|||Evaluation of Airway Gene Expression in COPD and Controlled Populations|Evaluation of Airway Gene Expression in COPD and Controlled Populations|Unknown status|Recruiting|N/A|30|Anticipated|University of Nebraska|||3||f||||f||||||Samples With DNA|"~     Genetic testing involves identification of potential proteins and biomarkers produced from~     the DNA and RNA analysis. Included are MMP12 and MMP9, Nrf-2 gene, heme oxygenases,~     glutathione, sythesizing enzymes, thioredoxin reductase, NADPH dependent quinone reductase 1~     as well as certain p450 members.~   "|||2017-02-18 14:59:47.482864|2017-02-18 14:59:47.482864
NCT00571779|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-02-18||||||February 2011|2011-02-01||||||||Interventional|RESTORE SR IIB||AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB|Thoracoscopically-Assisted Epicardial Bilateral Pulmonary Vein Isolations Using the AtriCure Bipolar System and Exclusion of the Left Atrial Appendage for the Treatment of Atrial Fibrillation|Withdrawn||Phase 2|||AtriCure, Inc.|||||f||||||||||||||2017-02-18 14:59:47.577819|2017-02-18 14:59:47.577819
NCT00571766|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2009-09-09|||November 2007||2007-11-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy|Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy|Completed||Phase 3|80|Anticipated|University of Modena and Reggio Emilia||2|||f||||t||||||||||2017-02-18 14:59:47.642584|2017-02-18 14:59:47.642584
NCT00571753|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-02-25|||June 2008||2008-06-01|February 2011|2011-02-01|February 2012|Anticipated|2012-02-01|December 2011|Anticipated|2011-12-01||Interventional|||Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)|A Double-blind, Multicentre, Parallel Group, Randomised, Controlled Trial to Evaluate the Possible Benefit of Isoniazid Dose Adjustment According to the Genotype for NAT2 (Arylamine N-acetyltransferase Type 2) in Patients With Pulmonary Tuberculosis|Terminated||Phase 3|900|Anticipated|University of Cologne||2||Enrolling participants has halted prematurely due to a low recruitment rate.|f||||t||||||||||2017-02-18 14:59:47.736771|2017-02-18 14:59:47.736771
NCT00571740|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-07-01||||||July 2016|2016-07-01||||||||Interventional|||Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer|Randomized Phase II Trial of Cetuximab/Bevacizumab (CB) as Palliative First-Line Therapy in Patients With Advanced Colorectal Cancer Followed by FOLFOX+CB vs. FOLFOX+B|Withdrawn||Phase 2|0|Actual|Alliance for Clinical Trials in Oncology||2||The study was not activated|f||||||||||||||2017-02-18 14:59:48.004088|2017-02-18 14:59:48.004088
NCT00409201|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2006-12-07|||March 2006||2006-03-01|March 2006|2006-03-01|November 2006||2006-11-01|||||Interventional|||Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia|Phase 1 Study of Reboxetine Adjuvant Therapy and Cognitive and Behavioral Measures|Unknown status|Recruiting|Phase 1|30||Abarbanel Mental Health Center|||||f||||||||||||||2017-02-18 16:02:32.745854|2017-02-18 16:02:32.745854
NCT00571714|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-06-23|||April 2008||2008-04-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients|Comparison of Standard Therapy,Peginterferon Alpha-2a + Ribavirin for 48 Weeks VS Peginterferon Alph-2a + Ribavirin + Betaine for 12 Weeks Followed by 36 Weeks Standard Therapy in Untreated Adults With Chronic Hepatitis C Genotype 1|Terminated||N/A|44|Anticipated|University of Nebraska||2||lack of enrollment|f||||t||||||||||2017-02-18 14:59:48.214195|2017-02-18 14:59:48.214195
NCT00571701|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2015-05-13|||February 2008||2008-02-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis|A Multicentered Randomized Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis|Completed||Phase 2|51|Actual|Northwell Health||2|||f||||t||||||||||2017-02-18 14:59:48.334339|2017-02-18 14:59:48.334339
NCT00571688|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-06-01|||November 2007||2007-11-01|June 2015|2015-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|Consta||Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?|Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?|Completed||Phase 4|50|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 14:59:48.452907|2017-02-18 14:59:48.452907
NCT00571675|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-11-08|||October 2007||2007-10-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 2|220|Actual|Ascenta Therapeutics||2|||f||||f||||||||||2017-02-18 14:59:48.555075|2017-02-18 14:59:48.555075
NCT00571662|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2010-12-02|2010-10-19||December 2000||2000-12-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant|Allogeneic Peripheral Blood Stem Cell Transplantation With Minimally Myelosuppressive Regimen of Pentostatin and Low-dose Total-body Irradiation|Completed||Phase 2|76|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:59:48.698692|2017-02-18 14:59:48.698692
NCT00571649|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-08-03|2012-02-16||December 2007||2007-12-01|August 2016|2016-08-01|November 2010|Actual|2010-11-01|August 2010|Actual|2010-08-01||Interventional|MAGELLAN||Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients|Multicenter, Randomized, Parallel-group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients Comparing Rivaroxaban With Enoxaparin. The MAGELLAN Study|Completed||Phase 3|8101|Actual|Bayer|A heterogeneous population (with different acute medical illnesses and severity of illness) was included in the trial. VTE risk in acute medical illnesses is moderate [with no thromboprophylaxis] .|2|||f||||t||||||||||2017-02-18 14:59:49.196985|2017-02-18 14:59:49.196985
NCT00571636|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-10-08|||December 2007||2007-12-01|October 2011|2011-10-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|||Continuous Infusion of Fentanyl in Preterm on MV|Efficacy and Safety of Continuous Infusion of Fentanyl for Pain Control in Preterm Newborn on Mechanical Ventilation|Completed||Phase 3|128|Anticipated|St. Orsola Hospital||2|||f||||t||||||||||2017-02-18 14:59:53.258377|2017-02-18 14:59:53.258377
NCT00571623|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2014-07-08|||September 2007||2007-09-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|ACTION-ICP||Automated Chest Physiotherapy to Improve Outcomes in Neuro|Automated Chest Physiotherap to Improve Outcomes in Neurocritical Care: An Intracranial Pressure Study|Completed||N/A|40|Anticipated|Duke University|||1||f||||f||||||||||2017-02-18 14:59:53.368151|2017-02-18 14:59:53.368151
NCT00571610|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2008-11-05|||April 2006||2006-04-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|PTOLEMY||Montreal Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device|A Single-Center, Open-Label, Single-Arm Pilot Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Implantable Device Used to Reduce Mitral Valve Regurgitation.|Completed||Phase 1|5|Actual|Viacor||1|||f||||t||||||||||2017-02-18 14:59:53.47417|2017-02-18 14:59:53.47417
NCT00571597|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2014-04-10|||March 2007||2007-03-01|April 2014|2014-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Short Term Outcomes From Minimally Invasive Surgery for the Treatment of Atrial Fibrillation|Prospective Analysis of the Wolf Minimaze Procedure for Treatment of Atrial Fibrillation|Completed||N/A|118|Actual|Virginia Commonwealth University|||1||f||||f||||||||||2017-02-18 14:59:53.576549|2017-02-18 14:59:53.576549
NCT00571584|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2017-01-11|||November 2002||2002-11-01|January 2017|2017-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors|rFVIIa (NovoSeven®) for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors: A Double-blind Study of a Single High Dose Versus Standard Multiple Doses of rFVIIa|Completed||Phase 4|24|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 14:59:53.659792|2017-02-18 14:59:53.659792
NCT00571571|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2011-01-03|||October 2007||2007-10-01|January 2011|2011-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|TFP-A||Application and Evaluation of Transference Focused Psychotherapy Modified for Adolescents|Application and Evaluation of Transference Focused Psychotherapy Modified for Adolescents|Unknown status|Recruiting|N/A|20|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 14:59:53.7649|2017-02-18 14:59:53.7649
NCT00571558|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2014-10-08|||March 2008||2008-03-01|February 2013|2013-02-01|November 2010|Actual|2010-11-01|June 2010|Actual|2010-06-01||Interventional|||Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia|Phase I Study of Photodynamic Therapy Using Pulsed Dye Laser and Oral Aminolevulinic Acid in Patients With Oral Leukoplakia|Terminated||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 14:59:53.870443|2017-02-18 14:59:53.870443
NCT00571545|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2017-02-02|||April 2004||2004-04-01|February 2017|2017-02-01|October 2007|Actual|2007-10-01|||||Interventional|||The Effect of Exercise on Mood After Traumatic Brain Injury|The Effect of Exercise on Mood After Traumatic Brain Injury|Completed||N/A|78|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 14:59:53.975636|2017-02-18 14:59:53.975636
NCT00571519|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2013-02-06||2013-02-01|November 2007||2007-11-01|February 2013|2013-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus|A Randomized, Double-blind, Placebo, and Active Comparator-controlled, Parallel-group Study of the Efficacy and Safety of Rivoglitazone as Monotherapy Treatment of Type 2 Diabetes Mellitus|Terminated||Phase 3|94|Actual|Daiichi Sankyo Inc.||8||DSPD focussing on Study 301 to confirm clinical profile before proceeding.|f||||t||||||||||2017-02-18 14:59:54.152972|2017-02-18 14:59:54.152972
NCT00571506|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-12-08|||May 2004||2004-05-01|December 2009|2009-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effect of Thiazolidinedione Treatment Vascular Risk Markers|A Pilot Study to Determine the Effects of Short-term Thiazolidinedione Treatment on Vascular Risk Markers in Type 2 Diabetes Patients|Completed||Phase 4|25|Actual|University of Arkansas||2|||f||||f||||||||||2017-02-18 14:59:54.287825|2017-02-18 14:59:54.287825
NCT00571493|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2015-08-11|||April 2006||2006-04-01|August 2015|2015-08-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma|Phase I/II Study of VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Indolent Non-Hodgkin's Lymphoma, Transformed or Mantle Cell Lymphoma|Completed||Phase 1/Phase 2|44|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 14:59:54.40574|2017-02-18 14:59:54.40574
NCT00571480|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-07-17|||February 2005||2005-02-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Use Ear Acupuncture as Treatment for Low Back Pain During Pregnancy|Acupuncture and Low Back Pain During Pregnancy|Completed||N/A|159|Actual|Yale University||3|||f||||f||||||||||2017-02-18 14:59:54.511612|2017-02-18 14:59:54.511612
NCT00571467|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2012-11-01|||December 2007||2007-12-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP|An Open Label, Sequential, Dose Escalation, Repeat-dose Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRTX-100 in Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)|Terminated||Phase 1|9|Actual|Protalex, Inc.||1||Terminated due to recruitment not meeting expectations.|f||||t||||||||||2017-02-18 14:59:54.622254|2017-02-18 14:59:54.622254
NCT00571454|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-10-28|||May 2007||2007-05-01|October 2009|2009-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Culturally Sensitive Depression Care Management for Latino Primary Care Patients|Culturally Sensitive Depression Care Management for Latino Primary Care Patients|Completed||Phase 2|38|Actual|Butler Hospital||2|||f||||t||||||||||2017-02-18 14:59:54.721227|2017-02-18 14:59:54.721227
NCT00571441|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-01-20|||December 2007||2007-12-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Observational|EVOLVE||Estimating Volume Using LiDCO|Estimating Volume Using LiDCO Versus Other Measures of Volume|Completed||N/A|34|Actual|Duke University|||1||f||||f||||||||||2017-02-18 14:59:54.820051|2017-02-18 14:59:54.820051
NCT00571428|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2012-02-21|2009-03-13||November 2007||2007-11-01|February 2012|2012-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD|Modified-blind, Randomized, Multicenter, Single Dose, Two-way Crossover Study of Arformoterol Tartrate Inhalation Solution 15 Micrograms Twice A Day Versus 30 Micrograms Once A Day in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|33|Actual|Sunovion|Single day/dose; small numbers of subjects; difference between arms (2mL vs 4mL per dose); Predefined +/-0.07L equivalence is arbitrarily lower than the clinically recognized 0.1L. Hence, clinical efficacy & safety conclusions are difficult to reach.|2|||f||||f||||||||||2017-02-18 14:59:54.928634|2017-02-18 14:59:54.928634
NCT00571415|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2016-05-27|||March 2009||2009-03-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|May 2013|Actual|2013-05-01||Observational|||Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition|Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition|Terminated||N/A|21|Actual|Virginia Commonwealth University|||1|Due to competing studies no further subjects could be recruited.|f||||f||||||||||2017-02-18 14:59:58.548765|2017-02-18 14:59:58.548765
NCT00571402|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2014-03-24|||July 2001||2001-07-01|March 2014|2014-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder|Family-Focused Psychoeducation for Bipolar Adolescents|Completed||Phase 1/Phase 2|58|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 14:59:58.631152|2017-02-18 14:59:58.631152
NCT00571389|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-11-09|||November 2007||2007-11-01|November 2009|2009-11-01|June 2012|Anticipated|2012-06-01|||||Observational|||Isolation and Culture of Circulating Tumor Cells From Peripheral Blood|A Pilot Study to Facilitate Development of an Ex Vivo Device Kit for Circulating Tumor Cell Harvesting, Banking, and Apoptosis-Viability Assay|Unknown status|Recruiting|N/A|500|Anticipated|BioCytics, Inc.|||1||f||||t||||||Samples With DNA|"~     Blood cells, tumor cells, plasma, discarded tissue (inc. tissue obtained from biopsies,~     paracentesis, pleuracentesis), leukapheresis products~   "|||2017-02-18 14:59:58.739414|2017-02-18 14:59:58.739414
NCT00571376|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2013-06-17|||July 2008||2008-07-01|June 2013|2013-06-01|December 2013|Anticipated|2013-12-01|October 2013|Anticipated|2013-10-01||Observational|||Evaluating the Impact on Quality and Costs of Regional Clinical Data Exchange Programs in New York State|Evaluating the Impact on Quality and Costs of Regional Clinical Data Exchange Programs in New York State|Unknown status|Enrolling by invitation|N/A|10000|Anticipated|Weill Medical College of Cornell University|||2||f||||f||||||||||2017-02-18 14:59:58.822578|2017-02-18 14:59:58.822578
NCT00571363|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2007-12-11|||January 2004||2004-01-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma|A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma|Completed||N/A|30|Actual|NHS Tayside||2|||f||||t||||||||||2017-02-18 14:59:58.924631|2017-02-18 14:59:58.924631
NCT00571350|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2007-12-10|||January 2005||2005-01-01|December 2007|2007-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Anterior Vaginal Wall Reconstruction|Anterior Vaginal Wall Reconstruction: Anterior Colporrhaphy Reinforced With Tension Free Vaginal Tape Underneath Bladder Base|Unknown status|Enrolling by invitation|Phase 1/Phase 2|50|Actual|Hippocration General Hospital||1|||f||||f||||||||||2017-02-18 14:59:59.02546|2017-02-18 14:59:59.02546
NCT00571337|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2010-07-22|||December 2005||2005-12-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|STORI||Stop Infliximab in Patients With Crohn's Disease|Prospective Study of Predictive Factors of Sustained Remission of Crohn's Disease After Stopping Infliximab|Completed||Phase 3|126|Actual|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||1|||f||||f||||||||||2017-02-18 14:59:59.148502|2017-02-18 14:59:59.148502
NCT00571324|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-09-22|2016-07-29||August 2007||2007-08-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism|An Open Label Pilot Study of the Effects of the Glucagon-like Peptide-1 Receptor Antagonist, Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism|Completed||Phase 1/Phase 2|9|Actual|Children's Hospital of Philadelphia|Due to safety concerns subjects with symptomatic hypoglycemia were rescued with dextrose to maintain glucose levels >60mg/dL limiting detectable treatment effect.|2|||f||||f||||||||||2017-02-18 14:59:59.262212|2017-02-18 14:59:59.262212
NCT00571311|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-11|2017-01-24|||December 5, 2007||2007-12-05|December 14, 2016|2016-12-14||||||||Observational|||Parental Permission and Adolescent Assent and Decision-Making in Clinical Research|Parental Permission and Adolescent Assent and Decision Making in Clinical Research|Completed||N/A|356|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 14:59:59.857863|2017-02-18 14:59:59.857863
NCT00571298|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2017-01-19|||November 2007||2007-11-01|January 2017|2017-01-01|June 2015|Actual|2015-06-01|November 2011|Actual|2011-11-01||Interventional|||Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma|A Phase I Trial of Extrapleural Pneumonectomy/Pleurectomy Decortication, Intrathoracic/Intraperitoneal Hyperthermic (IOHC) Cisplatin and Gemcitabine With Intravenous Amifostine and Sodium Thiosulfate Cytoprotection for Patients With Resectable Malignant Pleural Mesothelioma|Completed||Phase 1|141|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-02-18 14:59:59.947886|2017-02-18 14:59:59.947886
NCT00571285|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2017-01-23|||June 2007||2007-06-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|January 2011|Actual|2011-01-01||Interventional|VIDIP PILOT||Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease|Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease|Terminated||Phase 4|31|Actual|Emory University||2|||f||||f||||||||||2017-02-18 15:00:00.11113|2017-02-18 15:00:00.11113
NCT00571272|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-09-20|||November 2007||2007-11-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|LOGIC||Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)|Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis|Recruiting||N/A|1150|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||5||f||||t||||||Samples With DNA|"~     Blood plasma and serum samples with DNA~   "|Yes|The data will be transferred to NIDDK at the end of the study.|2017-02-18 15:00:00.235778|2017-02-18 15:00:00.235778
NCT00571259|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-12-15|||September 2003||2003-09-01|December 2011|2011-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|ALLOCK||Prophylactic Antimicrobial Catheter Lock|Prophylactic Antimicrobial Catheter Lock in Hemodialysis Patients: A Randomized Controlled Clinical Trial|Completed||Phase 4|303|Actual|Satellite Healthcare||2|||f||||f||||||||||2017-02-18 15:00:00.426199|2017-02-18 15:00:00.426199
NCT00571246|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2012-08-30|||June 2012||2012-06-01|August 2012|2012-08-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder|The Use of Anticonvulsants for Treatment of Patients With Alcohol Dependence and Post Traumatic Stress Disorder|Withdrawn||Phase 3|0|Actual|Yale University||1|||f||||t||||||||||2017-02-18 15:00:00.522464|2017-02-18 15:00:00.522464
NCT00571233|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-05-13|||February 2007||2007-02-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|December 2011|Actual|2011-12-01||Observational|BHFSVP||Biomarker Study for Heart Failure in Children With Single Ventricle Physiology|Identification of Biomarkers for Heart Failure in Children With Single Ventricle Physiology|Completed||N/A|71|Actual|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"~     Serum~   "|||2017-02-18 15:00:00.621576|2017-02-18 15:00:00.621576
NCT00571220|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2011-02-09|||September 2005||2005-09-01|February 2011|2011-02-01|December 2010|Anticipated|2010-12-01|||||Observational|||Mechanisms of Diabetes Control After Weight Loss Surgery|Mechanisms of Diabetes Control After Weight Loss Surgery|Unknown status|Active, not recruiting|N/A|20|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||t||||||Samples Without DNA|"~     blood samples~   "|||2017-02-18 15:00:00.720112|2017-02-18 15:00:00.720112
NCT00571207|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-08-31|||April 2008||2008-04-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|||||Observational|||Oral Fluid Screening Devices|Scientific Evaluation of Oral Fluid Screening Devices and Preceding Selection Procedures|Completed||N/A|250|Anticipated|National Institute for Health and Welfare, Finland|||2||f||||f||||||Samples With DNA|"~     Oral fluid and whole blood are collected. However, no DNA testing will be carried out. The~     research focuses on drug and medicine concentrations in these matrices.~   "|||2017-02-18 15:00:00.822095|2017-02-18 15:00:00.822095
NCT00571194|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-08-31|||September 2007||2007-09-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients|A Single-dose Pilot Study to Evaluate the Pharmacokinetics of Pravastatin Given as an Oral Dose in Pediatric and Adolescent Subjects 12 Months to 16 Years of Age Receiving Continuous Cycling Peritoneal Dialysis|Completed||N/A|7|Anticipated|Arkansas Children's Hospital Research Institute||1|||f||||f||||||||||2017-02-18 15:00:00.916664|2017-02-18 15:00:00.916664
NCT00571181|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-09|2016-09-22|||December 2007||2007-12-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Automated Anesthesia During Bronchoscopy|Target-Controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by the Index Bispectral: Comparison Between Manual Perfusion and Automated Perfusion During Rigid Bronchoscopy|Completed||Phase 4|66|Actual|Hopital Foch||2|||f||||f||||||||||2017-02-18 15:00:01.009402|2017-02-18 15:00:01.009402
NCT00570973|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-05-20|||November 2004||2004-11-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|ENDOvsTIPS||Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy|A Randomized, Controlled, Multicentric Trial Comparing Endoscopic Band Ligation Versus Ransjugular Intrahepatic Portosystemic Stent Shunt in Cirrhotic Patients With Recurrent Variceal Bleeding Non Responding to Medical Therapy|Completed||Phase 4|40|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:00:04.508112|2017-02-18 15:00:04.508112
NCT00571168|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2010-01-11|||July 2005||2005-07-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|EmNa||Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy|Randomised, Placebo Controlled, Single-center, Double-blind Clinical Trial to Investigate Efficacy and Safety of Aprepitant Combined With Kevatril and Dexamethasone Versus Placebo Combined With Kevatril and Dexamethasone in Prevention of Acute and Delayed High-dose Chemotherapy-induced Nausea and Vomiting in Subjects With Multiple Myeloma Receiving an Autologous Peripheral Blood Stemcell Transplantation.|Unknown status|Recruiting|Phase 3|362|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-02-18 15:00:01.117594|2017-02-18 15:00:01.117594
NCT00571155|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-08-19|||December 2007||2007-12-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery|Prospective Trial of Intravenous Levetiracetam in Patients With Primary Brain Tumors and at Least One Symptomatic Seizure Who Undergo Biopsy or Cytoreductive Surgery (HELLO-study)|Completed||Phase 4|30|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||||2017-02-18 15:00:01.227718|2017-02-18 15:00:01.227718
NCT00571142|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2007-12-07|||November 2007||2007-11-01|December 2007|2007-12-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema|Pars Plana Vitrectomy and Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema (A Pilot Study)|Unknown status|Recruiting|Phase 3|20|Anticipated|Asociación para Evitar la Ceguera en México||2|||f||||f||||||||||2017-02-18 15:00:01.335072|2017-02-18 15:00:01.335072
NCT00571129|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-03-10|||September 2004||2004-09-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2011|Actual|2011-12-01||Interventional|||Endoscopic Dacryocystorhinostomy Prospective Research|Recovery After Endoscopic Dacryocystorhinostomy|Active, not recruiting||N/A|80|Anticipated|Kuopio University Hospital||1|||f||||f||||||||||2017-02-18 15:00:01.657302|2017-02-18 15:00:01.657302
NCT00571116|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-12-31|||September 2006||2006-09-01|December 2016|2016-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy|Evaluation of Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy (Phase 1b)|Terminated||Phase 1/Phase 2|15|Actual|University of California, Irvine||1||Halted because of slow accrual and lack of study funding|f||||t||||||||No||2017-02-18 15:00:01.765272|2017-02-18 15:00:01.765272
NCT00571103|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-10-01|||October 2007||2007-10-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Acamprosate in the Treatment of Pathological Gambling|Open Label, Flexible Dose 12-Week Clinical Trial of the Safety and Efficacy of Acamprosate in the Treatment of Pathological Gambling|Completed||Phase 4|30|Anticipated|University of Iowa||1|||f||||f||||||||||2017-02-18 15:00:01.898556|2017-02-18 15:00:01.898556
NCT00571090|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2014-03-28|||June 2003||2003-06-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Observational|||Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules|Evaluation of Thyroid Fine Needle Aspiration Biopsies: Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules|Completed||N/A|735|Actual|Istanbul Science University|||1||f||||f||||||||||2017-02-18 15:00:02.041229|2017-02-18 15:00:02.041229
NCT00571077|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2008-05-12|||January 2002||2002-01-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Observational|||Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study|Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study|Completed||N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||f||||||None Retained|"~     No biospecimens are retained~   "|||2017-02-18 15:00:02.180932|2017-02-18 15:00:02.180932
NCT00571064|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2013-10-29|||January 2008||2008-01-01|October 2013|2013-10-01||||December 2008|Actual|2008-12-01||Interventional|||The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility|A 12-Week, Multicenter, Open Label Study To Evaluate The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility|Completed||Phase 4|97|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 15:00:02.296225|2017-02-18 15:00:02.296225
NCT00571051|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2009-08-13|||October 2007||2007-10-01|August 2009|2009-08-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|||MEG Study of Mindfulness Based Stress Reduction|MEG Study of Mindfulness Based Stress Reduction|Unknown status|Recruiting|N/A|40|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||||||||||||2017-02-18 15:00:02.456635|2017-02-18 15:00:02.456635
NCT00571038|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2015-04-06|2014-10-10||February 2008||2008-02-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|POWER||Working With Veterans Organizations to Improve Blood Pressure|Working With Veterans Organizations to Improve Blood Pressure|Completed||N/A|404|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:00:02.581815|2017-02-18 15:00:02.581815
NCT00571025|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2009-07-22|||August 2000||2000-08-01|July 2009|2009-07-01|April 2004|Actual|2004-04-01|||||Interventional|REVEAL I||Risk Evaluation and Education for Alzheimer's Disease|Genetic Risk Assessment and Counseling for Alzheimer's Disease|Completed||N/A|301|Actual|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 15:00:03.53153|2017-02-18 15:00:03.53153
NCT00571012|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2009-11-24|||October 2007||2007-10-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Aqueous Outflow Facility Changes With Posture|Aqueous Outflow Facility Changes With Posture|Completed||N/A|20|Anticipated|Mayo Clinic|||1||f||||f||||||||||2017-02-18 15:00:03.885709|2017-02-18 15:00:03.885709
NCT00570999|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2012-05-09|||February 2008||2008-02-01|May 2012|2012-05-01|January 2013|Anticipated|2013-01-01|||||Interventional|KGF Haplo Allo||Palifermin After Haploidentical PBSCT|Randomised Placebo-Controlled Double-Blind Phase II Study Applying Palifermin to Improve T-cell Immune Reconstitution After Haploidentical Allogeneic Peripheral Blood Progenitor Cell (PBPC) Transplantation|Withdrawn||Phase 2|0|Actual|European Group for Blood and Marrow Transplantation||2|||f||||t||||||||||2017-02-18 15:00:03.976338|2017-02-18 15:00:03.976338
NCT00570986|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2013-02-06||2011-08-18|November 2007||2007-11-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|1465|Actual|AbbVie||3|||f||||t||||||||||2017-02-18 15:00:04.085163|2017-02-18 15:00:04.085163
NCT00570960|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2014-12-01|2013-01-14||June 2007||2007-06-01|December 2014|2014-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis|Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis|Terminated||Phase 4|8|Actual|University of Virginia|The study was terminated early because the manufacturer of Dextran 70 ceased all production of the study drug approximately 10 months into the study. It was felt by the principle investigator that continuation of the study was impossible.|2||drug product became unavilable|f||||t||||||||||2017-02-18 15:00:04.62124|2017-02-18 15:00:04.62124
NCT00570947|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2012-04-25|||December 2007||2007-12-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||CPR Prescription Program|CPR Prescription Program|Completed||N/A|162|Actual|Lehigh Valley Hospital||1|||f||||t||||||||||2017-02-18 15:00:05.007285|2017-02-18 15:00:05.007285
NCT00570934|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-10-07|||March 1995||1995-03-01|October 2016|2016-10-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA|Effect of Supplementation With 2000 International Units (IU) Vitamin D, 1gm Calcium or Both on Calcium Absorption and Bone Mineralization in Children With Juvenile Rheumatoid Arthritis|Completed||Phase 3|24|Actual|University of Missouri-Columbia||4|||f||||f||||||||No||2017-02-18 15:00:05.107416|2017-02-18 15:00:05.107416
NCT00570921|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-08-11|2014-12-18||April 2008||2008-04-01|August 2016|2016-08-01|January 2015|Actual|2015-01-01|February 2013|Actual|2013-02-01||Interventional|BRE-43|2 were not evaluable as described in participant flow and not included in demographic table.|Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure|A Phase II Study of Combined Fulvestrant (Faslodex) and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure|Completed||Phase 2|33|Actual|University of Kentucky|Potential toxicities of mammalian target of rapamycin (mTOR) inhibitors and our observation that a third of patients had no benefit from this strategy, we need to identify biomarkers that correlate with treatment benefit for better patient selection.|1|||f||||t||||||||||2017-02-18 15:00:05.236743|2017-02-18 15:00:05.236743
NCT00570908|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2014-09-08|2014-07-22||February 2009||2009-02-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional||12 patients were enrolled and started treatment|Brain Mets - Capecitabine Plus Sunitinib and WBRT|A Phase 2 Trial of Capecitabine Concomitantly With Whole Brain Radiotherapy(WBRT) Followed by Capecitabine and Sunitinib for Central Nervous System, (CNS) Metastases in Breast Cancer|Terminated||Phase 2|12|Actual|Baylor Breast Care Center||1||Due to poor accrual this study is being closed to accrual|f||||t||||||||||2017-02-18 15:00:05.778458|2017-02-18 15:00:05.778458
NCT00570895|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2008-06-03|||January 2008||2008-01-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Vitamin C on Iron Absorption|Effect of Ascorbic Acid on Iron Absorption From Ferrous Fumarate|Completed||N/A|22|Anticipated|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 15:00:06.109345|2017-02-18 15:00:06.109345
NCT00570882|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2014-09-22|||October 2007||2007-10-01|September 2014|2014-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)|A Randomized Phase II Trial Of Sunitinib Administered Daily For 4 Weeks, Followed By 2-Week Rest Vs. 2-Week On And 1-Week Off In Metastatic Renal Cell Carcinoma|Completed||Phase 2|76|Actual|Asan Medical Center||2|||f||||f||||||||||2017-02-18 15:00:06.217263|2017-02-18 15:00:06.217263
NCT00570869|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2012-04-25|||January 2008||2008-01-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Training Mothers of Infants in Infant Cardiopulmonary Resuscitation (CPR)|Training Mothers of Infants in Infant Cardiopulmonary Resuscitation (CPR) Using a 22-Minute Instructional DVD and Infant Manikin|Completed||N/A|126|Actual|Lehigh Valley Hospital||1|||f||||t||||||||||2017-02-18 15:00:06.327771|2017-02-18 15:00:06.327771
NCT00570856|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2007-12-14|||June 2005||2005-06-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Trial of Folic Acid Effect on Hcy and cIMT After Kidney Tx|Clinical Trial of Effectiveness of Folic Acid Therapy on Homocysteine Level and Carotid Intima-Media Thickness After Kidney Transplantation|Terminated||Phase 4|60|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:00:06.436062|2017-02-18 15:00:06.436062
NCT00570843|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2010-02-19|||March 2008||2008-03-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses|Phase 4 Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses|Completed||Phase 4|50|Anticipated|Bp Consulting, Inc||2|||f||||||||||||||2017-02-18 15:00:06.527362|2017-02-18 15:00:06.527362
NCT00570830|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2014-08-29|||September 2006||2006-09-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional|||Retisert and Cataract Surgery in Patients With Severe Uveitis|Combined Fluocinolone Acetonide Sustained Drug Delivery System Implantation and Phacoemulsification/Intraocular Lens Implantation in Patients With Severe Uveitis|Completed||N/A|21|Actual|Duke University||1|||f||||t||||||||||2017-02-18 15:00:06.618906|2017-02-18 15:00:06.618906
NCT00570817|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-11-04|||June 2007||2007-06-01|January 2011|2011-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Prevention of Methotrexate Induced Nephrotoxicity and Prolonged Drug Elimination Time With 12 Hours Prehydration|Nephrotoxicity Induced by High-Dose Methotrexate Infusions to Children With Malignant Diseases|Completed||N/A|47|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 15:00:06.734009|2017-02-18 15:00:06.734009
NCT00570804|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-11-28|||December 2007||2007-12-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Combined Treatment for Tobacco and Alcohol Use in Puerto Rico|Oral Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use|Active, not recruiting||N/A|370|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:00:06.869077|2017-02-18 15:00:06.869077
NCT00570791|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-05-10|||February 2004||2004-02-01|May 2016|2016-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|CCT||Effect of Central Corneal Thickness On IOP Using Various Tonometers|The Effect of Central Corneal Thickness On Intraocular Pressure Measurements With the Goldman Applanation Tonometer, Ocular Blood Flow Pneumatonometer,Tono Pen,Pascal Dynamic Contour Tonometer, and Schiotz Tonometer|Completed||N/A|166|Actual|University of Nebraska|||2||f||||f||||||||||2017-02-18 15:00:06.998502|2017-02-18 15:00:06.998502
NCT00570778|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2013-01-23|2012-10-23||December 2007||2007-12-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Placebo Controlled, Multicentre Study to Determine the Effect of QVA149 on Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|154|Actual|Novartis||4|||f||||||||||||||2017-02-18 15:00:07.106606|2017-02-18 15:00:07.106606
NCT00570765|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2012-01-09|2011-06-09||November 2007||2007-11-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of INT-747 as Monotherapy in Patients With PBC|A Study of INT-747 (6-ECDCA) Monotherapy in Patients With Primary Biliary Cirrhosis|Completed||Phase 2|59|Actual|Intercept Pharmaceuticals||3|||f||||t||||||||||2017-02-18 15:00:07.516765|2017-02-18 15:00:07.516765
NCT00570752|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2015-11-06||2012-03-24|December 2008||2008-12-01|November 2015|2015-11-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis|A 12-Week, Randomized, Semi Double-Blinded Study Evaluating the Effects of Daily Oral High-Dose Atorvastatin or BMS-582949 on Atherosclerotic Plaque Inflammation as Determined by FDG-PET in High Risk Atherosclerotic Patients|Completed||Phase 2|72|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-02-18 15:00:08.413587|2017-02-18 15:00:08.413587
NCT00570739|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2010-07-19|2010-04-06||November 2007||2007-11-01|July 2010|2010-07-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.|Effects of Metformin HCl in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, as Initial Therapy in Drug naïve Subjects With Type 2 Diabetes Mellitus, and the Effects of Colesevelam HCl on the Lipid Profile in Subjects With Pre Diabetes|Completed||Phase 3|502|Actual|Daiichi Sankyo Inc.||4|||f||||f||||||||||2017-02-18 15:00:08.577706|2017-02-18 15:00:08.577706
NCT00570726|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-09|2014-10-14|||June 2000||2000-06-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Treatment of Failing Blebs With Ranibizumab|Effect of Needle Bleb Revision With Ranibizumab as a Primary Intervention in a Failing Bleb Following Trabeculectomy|Completed||Phase 1|6|Anticipated|The New York Eye & Ear Infirmary|||||f||||f||||||||||2017-02-18 15:00:12.405105|2017-02-18 15:00:12.405105
NCT00570713|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2015-09-04|2011-12-08||December 2007||2007-12-01|September 2015|2015-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer|A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.|Completed||Phase 2|155|Actual|Morphotek||2|||f||||t||||||||||2017-02-18 15:00:12.522661|2017-02-18 15:00:12.522661
NCT00570700|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-03-23|||July 2007||2007-07-01|March 2016|2016-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer|BMS CA180-097: A Phase II Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer, Previously Treated With Chemotherapy|Completed||Phase 2|39|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 15:00:15.942414|2017-02-18 15:00:15.942414
NCT00570687|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2014-10-09|2014-07-22||September 2007||2007-09-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes||Completed||Phase 2|30|Actual|Mannkind Corporation||1|||f||||||||||||||2017-02-18 15:00:16.102905|2017-02-18 15:00:16.102905
NCT00570674|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-10-18|2016-10-18||November 2007||2007-11-01|October 2016|2016-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||The analysis dataset is comprised of all treated patients.|Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck|A Phase I/II Trial of Abraxane in Combination With Carboplatin, Erbitux and Intensity Modulated Radiation Therapy (IMRT)for Treatment of Locally Advanced Squamous Cancer of the Head and Neck|Completed||Phase 1/Phase 2|29|Actual|Dana-Farber Cancer Institute|The phase II portion planned to enroll 34 participants including the expansion cohort but the study did not continue beyond phase I given the importance of HPV status as a prognostic factor to guide treatment decisions.|5|||f||||t||||||||No|No plans to share individual participant data. However, cumulative results will be posted here and also published.|2017-02-18 15:00:16.864865|2017-02-18 15:00:16.864865
NCT00570661|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2013-05-23|||August 2006||2006-08-01|January 2012|2012-01-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|SOJIA||Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA)|Phase II, Open Label, International, Multicentre Clinical Trial to Investigate Safety and Efficacy of Oral ITF2357 in Patients With Active Systemic Onset Juvenile Idiopathic Arthritis (SOJIA)|Completed||Phase 2|17|Actual|Italfarmaco||1|||f||||f||||||||||2017-02-18 15:00:17.554387|2017-02-18 15:00:17.554387
NCT00570648|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2008-08-06|||June 2007||2007-06-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|||||Interventional|||A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization|A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization|Completed||N/A|50|Anticipated|University of Virginia||2|||f||||f||||||||||2017-02-18 15:00:17.645089|2017-02-18 15:00:17.645089
NCT00570635|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2013-05-30||2013-05-30|December 2007||2007-12-01|May 2013|2013-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib|A Phase 2 Study of XL820 in Subjects With Advanced Gastrointestinal Stromal Tumors Resistant to or Intolerant of Imatinib and/or Sunitinib|Completed||Phase 2|16|Actual|Exelixis||2|||f||||t||||||||||2017-02-18 15:00:17.747314|2017-02-18 15:00:17.747314
NCT00570622|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2008-11-24|||December 2004||2004-12-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis|Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis|Completed||Phase 4|20|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:00:17.842434|2017-02-18 15:00:17.842434
NCT00570609|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2012-04-25|||January 2008||2008-01-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||CPR Training in 7th Grade Students|CPR Training in 7th Grade Students|Completed||N/A|8|Actual|Lehigh Valley Hospital||1|||f||||t||||||||||2017-02-18 15:00:17.955469|2017-02-18 15:00:17.955469
NCT00570583|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-06-24|||December 1995||1995-12-01|June 2016|2016-06-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|NCODE||Neurocognitive Outcomes of Depression in the Elderly|Geriatric Depression: Risk Factors for Adverse Outcomes|Active, not recruiting||N/A|795|Anticipated|Duke University|||2||f||||f||||||Samples With DNA|"~     serum, white cells~   "|||2017-02-18 15:00:18.063426|2017-02-18 15:00:18.063426
NCT00570570|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2015-08-19|||May 2008||2008-05-01|August 2015|2015-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|RenforcHémi||Muscular Strengthening for Paretic Knee Flexor and Extensor by Conventional Physiotherapy on Chronic Hemiplegic Stroke Patients|Muscular Strengthening for Paretic Knee Flexor and Extensor by Conventional Physiotherapy on Chronic Hemiplegic Stroke Patients|Completed||N/A|91|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 15:00:18.169405|2017-02-18 15:00:18.169405
NCT00570557|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2012-01-09|||September 2007||2007-09-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia|Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia|Completed||N/A|96|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-02-18 15:00:18.273106|2017-02-18 15:00:18.273106
NCT00570544|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2008-08-13|||August 2004||2004-08-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Observational|||Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema|Effectiveness of Tiotropium to Maintain Inspiratory Capacity Against Metronome Paced Hyperventilation Induced Dynamic Hyperinflation in COPD Patients With Lung CT Scored Emphysema|Completed||Phase 4|29|Actual|Gelb, Arthur F., M.D.|||1||f||||t||||||||||2017-02-18 15:00:18.378779|2017-02-18 15:00:18.378779
NCT00570531|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2016-04-19|2015-01-05||June 2007||2007-06-01|April 2016|2016-04-01|June 2013|Actual|2013-06-01|October 2010|Actual|2010-10-01||Interventional|||Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma|Phase II Trial of Pre-Operative Chemoradiation Plus Bevacizumab, Followed by Surgery, and Post-Operative Adjuvant Bevacizumab for Patients With Loco-Regional Esophageal Carcinoma|Terminated||Phase 2|6|Actual|University of Michigan Cancer Center|The study was unable the accrue the required number of patients within a reasonable time and therefore the primary objective was not analyzed.|1||The study was unable the accrue the required number of patients within a reasonable time.|f||||t||||||||||2017-02-18 15:00:18.493931|2017-02-18 15:00:18.493931
NCT00570518|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-09-30|||September 2007||2007-09-01|September 2011|2011-09-01|October 2011|Anticipated|2011-10-01|||||Observational|||Alcohol and Other Psychoactive Substances in Road Traffic - a Case-control Study|DRUID Work Package 2 - Epidemiology|Unknown status|Recruiting|N/A|4500|Anticipated|National Institute for Health and Welfare, Finland|||2||f||||f||||||Samples With DNA|"~     Whole blood and oral fluid are collected for the study. However, no DNA determinations are~     done at any point of the study. The laboratory where the samples are analysed does not~     analyse DNA. DNA is not relevant for this study.~   "|||2017-02-18 15:00:18.803531|2017-02-18 15:00:18.803531
NCT00570505|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2015-03-12|2012-07-23||November 2007||2007-11-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|October 2009|Actual|2009-10-01||Interventional|||Effectiveness and Safety Study of LAP-BAND Treatment in Subjects With BMI >/= 30 kg/m2 and < 40 kg/m2||Completed||N/A|151|Actual|Apollo Endosurgery, Inc.||1|||f||||t||||||||||2017-02-18 15:00:18.901669|2017-02-18 15:00:18.901669
NCT00570492|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-11-29|2011-11-03||November 2007||2007-11-01|November 2016|2016-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Effects of a One-Year Course of Fluticasone Furoate Nasal Spray 110mcg QD on Growth in Pre-Pubescent, Pediatric Subjects With Perennial Allergic Rhinitis|Completed||Phase 4|474|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:00:19.473389|2017-02-18 15:00:19.473389
NCT00570479|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-09|2012-06-03|||September 2006||2006-09-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Prophylactic Anecortave Acetate in Patients With a Retisert Implant|Prevention of Steroid-induced Glaucoma Using Anecortave Acetate|Completed||Phase 1|12|Actual|Texas Retina Associates||4|||f||||f||||||||||2017-02-18 15:00:20.7527|2017-02-18 15:00:20.7527
NCT00570466|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2014-09-25|||January 2008||2008-01-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|May 2009|Actual|2009-05-01||Interventional|||Computer Based Intervention for Type 2 Diabetes in Youth|Computer Based Intervention for Type 2 Diabetes in Youth: Phase 2|Completed||N/A|153|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 15:00:20.857917|2017-02-18 15:00:20.857917
NCT00570440|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2011-10-28|||August 2007||2007-08-01|October 2011|2011-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Continuous Use of COCs|Continuous Versus Cyclic Use of Combined Oral Contraceptive Pills|Completed||Phase 4|362|Anticipated|FHI 360||2|||f||||||||||||||2017-02-18 15:00:20.964936|2017-02-18 15:00:20.964936
NCT00570427|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2009-02-24|||February 2007||2007-02-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Improving Depression Treatment for Older Minority Adults|Improving Depression Treatment for Older Minority Adults|Completed||N/A|30|Anticipated|National Institute on Aging (NIA)||1|||f||||t||||||||||2017-02-18 15:00:21.07555|2017-02-18 15:00:21.07555
NCT00570414|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-10|2009-01-14|||March 2007||2007-03-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Airway Management in Children Undergoing Adenotonsillectomies|Airway Management in Children Undergoing Adenotonsillectomies Under General Anesthesia; a Comparison of the Endotracheal Tube and the Laryngeal Mask Airway|Completed||N/A|128|Anticipated|Sykehuset Telemark||2|||f||||t||||||||||2017-02-18 15:00:21.186893|2017-02-18 15:00:21.186893
NCT00570401|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2015-12-16|2015-12-16||June 2006||2006-06-01|December 2015|2015-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib|A Phase 2 Trial of Dasatinib in Patients With Lung Adenocarcinoma With Acquired Resistance to Erlotinib or Gefitinib|Completed||Phase 2|22|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:00:21.299983|2017-02-18 15:00:21.299983
NCT00570388|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2008-01-15|||March 2007||2007-03-01|January 2008|2008-01-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence|Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence|Unknown status|Recruiting|N/A|120|Anticipated|Institute of Addiction Medicine||2|||f||||f||||||||||2017-02-18 15:00:21.758429|2017-02-18 15:00:21.758429
NCT00570375|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-04-16|||November 2007||2007-11-01|April 2009|2009-04-01|November 2012|Anticipated|2012-11-01|November 2009|Anticipated|2009-11-01||Interventional|||The Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic Syndrome|Phase II of Erlotinib an Epidermal Growth Factor Receptor Inhibitor in the Treatment of Myelodysplastic Syndrome|Withdrawn||Phase 2|35|Anticipated|University of Cincinnati||1||"Rami Komrokji, MD author of this protocol no longer is at the University of Cincinnati and~   this study has been withdrawn."|f||||f||||||||||2017-02-18 15:00:21.870371|2017-02-18 15:00:21.870371
NCT00570362|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2010-07-14|2010-06-11||March 2008||2008-03-01|December 2007|2007-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Systemic Glutathione Level in Normal Tension Glaucoma|Evaluation of Systemic Glutathione Level in Patients With Normal Tension Glaucoma|Completed||N/A|49|Actual|The Catholic University of Korea|||1||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 15:00:21.980746|2017-02-18 15:00:21.980746
NCT00570349|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-05-12|2010-10-01||July 2004||2004-07-01|May 2016|2016-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis|Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis|Completed||Phase 1/Phase 2|18|Actual|Mallinckrodt||3|||f||||t||||||||||2017-02-18 15:00:22.335274|2017-02-18 15:00:22.335274
NCT00570336|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2010-09-14||2010-08-31|December 2007||2007-12-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study of CTS-1027 in Hepatitis C Patients|A Dose Response Study of CTS-1027 in Hepatitis C Patients|Completed||Phase 2|87|Actual|Conatus Pharmaceuticals Inc.||5|||f||||t||||||||||2017-02-18 15:00:22.882212|2017-02-18 15:00:22.882212
NCT00570323|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-08-26|||December 2007||2007-12-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|July 2017|Anticipated|2017-07-01||Interventional|PACT001||Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer|A Phase II Trial of Neoadjuvant Arimidex With or Without Faslodex in Postmenopausal Women With Hormone Receptor Positive Breast Cancer|Recruiting||Phase 2|112|Anticipated|Baylor Breast Care Center||2|||f||||t||||||||||2017-02-18 15:00:23.015676|2017-02-18 15:00:23.015676
NCT00570310|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2015-04-20|2010-01-13||December 2007||2007-12-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Neuropathic Pain Syndrome Patient Study (MK-0000-072)|A Double-Blind, Placebo-Controlled, Enriched-Enrollment, Randomized Withdrawal Study to Evaluate an Optimal Methodology for Conducting Proof of Concept Trials in Patients With Chronic Neuropathic Pain Syndromes Using Pregabalin as a Test Drug|Completed||Phase 1|104|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:00:23.157074|2017-02-18 15:00:23.157074
NCT00570297|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2017-01-31|||December 2007||2007-12-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Observational|||Genetic Influences of Albuterol Response In Children With Bronchiolitis|Genetic Influences of Albuterol Response In Children With Bronchiolitis|Active, not recruiting||N/A|55|Anticipated|Connecticut Children's Medical Center|||1||f||||f|f|f||||||No||2017-02-18 15:00:23.620021|2017-02-18 15:00:23.620021
NCT00570284|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-08-17|||November 2007||2007-11-01|August 2016|2016-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors|A Phase Ib Open-label, Multicenter Cross-over Study to Investigate the Effect of Food on the Rate and Extent of Oral LBH589 Absorption in Patients With Advanced Solid Tumors|Completed||Phase 1|36|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:00:23.720501|2017-02-18 15:00:23.720501
NCT00570271|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2007-12-07|||April 2007||2007-04-01|November 2007|2007-11-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Placebo Effects on Blood Pressure|Physiological Effects of Placebo Interventions to Increase or Decrease Blood Pressure|Unknown status|Recruiting|N/A|90|Anticipated|Charite University, Berlin, Germany||6|||f||||f||||||||||2017-02-18 15:00:23.827117|2017-02-18 15:00:23.827117
NCT00570258|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2017-01-18|||September 2006||2006-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy|Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy|Active, not recruiting||Phase 2|130|Anticipated|University of Arkansas||2|||f||||f|f|f||||||||2017-02-18 15:00:23.927433|2017-02-18 15:00:23.927433
NCT00570245|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-10-18|||April 2005||2005-04-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation|A Pilot, Single Center Prospective, With Parallel Groups, Controlled and Open to Evaluate the Efficacy of Nitric Oxide for Inhalation in Lung Donors and in the Prevention of Reperfusion Injury.|Completed||Phase 2|49|Actual|Mallinckrodt||3|||f||||t||||||||||2017-02-18 15:00:24.042608|2017-02-18 15:00:24.042608
NCT00570232|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2015-05-04|2015-03-24||December 2007||2007-12-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|UAB0718||UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer|Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer|Completed||Phase 2|31|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 15:00:24.152009|2017-02-18 15:00:24.152009
NCT00570219|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2008-10-16|||February 2005||2005-02-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effect of Valproate on Benzodiazepine Withdrawal Severity|The Effect of Valproate Treatment on Withdrawal Severity in Benzodiazepine Dependent Opioid Maintenance Treatment Patients|Completed||N/A|30|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 15:00:24.706193|2017-02-18 15:00:24.706193
NCT00570206|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-12-21|||January 2008||2008-01-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|March 2009|Actual|2009-03-01||Interventional|ENCORE||An Evaluation of Motivational Interviewing to Increase Compliance in a Probation Setting|An Evaluation of Motivational Interviewing to Increase Compliance in a Probation Setting (Enhancing Communication and Officer Responsivity; ENCORE)|Completed||N/A|300|Anticipated|The University of Texas Health Science Center, Houston||3|||f||||||||||||||2017-02-18 15:00:24.816318|2017-02-18 15:00:24.816318
NCT00569556|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2009-06-11|||September 2006||2006-09-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Care Management on Diabetes Outcomes|Effect of Care Management on Diabetes Outcomes|Completed||N/A|550|Anticipated|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-02-18 15:00:37.948086|2017-02-18 15:00:37.948086
NCT00570193|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2012-07-06|||December 2006||2006-12-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|PBS||Photodynamic and Pharmacologic Treatment of CNV|Photodynamic and Pharmacologic Treatment of Choroidal Neovascularization (Photodynamic Booster Study)|Completed||Phase 1/Phase 2|41|Actual|Mid-Atlantic Retina Consultations, Inc.||2|||f||||||||||||||2017-02-18 15:00:24.908954|2017-02-18 15:00:24.908954
NCT00570180|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-12-01|||November 2007||2007-11-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma|An Open-label Phase II Study of the Efficacy of Combination Bortezomib-containing Regimens in the Treatment of Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma|Completed||Phase 2|36|Actual|University Health Network, Toronto||1|||f||||t||||||||Yes|Un-identified data will be submitted to the DSMB for review. Sites will be provided with the DSMB letter after a meeting has been held to review data.|2017-02-18 15:00:24.999023|2017-02-18 15:00:24.999023
NCT00570167|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2009-08-03|||November 2006||2006-11-01|August 2009|2009-08-01||||||||Interventional|||Comparison of Hip Resurfacing and Cementless Metal-on-metal Total Hip Arthroplasty|Comparison of Hip Resurfacing and Cementless Metal-on-metal Total Hip Arthroplasty - Prospective Randomized Clinival Trial|Completed||Phase 4|71|Anticipated|Helsinki University||2|||f||||f||||||||||2017-02-18 15:00:25.113279|2017-02-18 15:00:25.113279
NCT00570154|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2017-01-24|||November 27, 2007||2007-11-27|October 19, 2009|2009-10-19||||October 19, 2009|Actual|2009-10-19||Observational|||Relation of White Blood Cell Function to Diabetes|Pilot Study of Monocyte Biology in Insulin Sensitive, Resistant and Diabetic Subjects|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:00:25.223657|2017-02-18 15:00:25.223657
NCT00570141|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2011-06-07|2010-06-09||October 2007||2007-10-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||OASIS Wound Matrix (Oasis) Mechanism of Action|Case Study Documentation of Subjects With Either Diabetic Foot Ulcers or Venous Stasis Ulcers Being Treated With OASIS|Completed||Phase 4|13|Actual|Healthpoint||1|||f||||f||||||||||2017-02-18 15:00:25.307219|2017-02-18 15:00:25.307219
NCT00570128|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-08-04|||December 2007||2007-12-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome|A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome|Completed||Phase 2|150|Anticipated|Eisai Inc.||2|||f||||||||||||||2017-02-18 15:00:25.608721|2017-02-18 15:00:25.608721
NCT00570115|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2012-05-07|||June 2007||2007-06-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Observational|||Left Atrial Volume and Function Evaluation in Patients With Obstructive Sleep Apnea|Left Atrial Volume and Function in Patients With Obstructive Sleep Apnea Assessed by Real Time Three Dimensional Echocardiography|Completed||N/A|106|Actual|Associação Fundo de Incentivo à Pesquisa|||1||f||||f||||||||||2017-02-18 15:00:25.909529|2017-02-18 15:00:25.909529
NCT00570102|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2012-11-27|||February 1995||1995-02-01|November 2012|2012-11-01|January 2008|Actual|2008-01-01|March 2004|Actual|2004-03-01||Interventional|MIP||Nutritional Prevention Pilot Trial for Type 1 Diabetes|Trial to Reduce IDDM in the Genetically at Risk (TRIGR): the Pilot Study|Completed||Phase 2|230|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 15:00:26.010913|2017-02-18 15:00:26.010913
NCT00570089|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-01-14|2011-07-19||April 2007||2007-04-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Microvascular Coronary Disease In Women: Impact Of Ranolazine|Microvascular Coronary Disease In Women: Impact Of Ranolazine|Completed||Phase 2|20|Actual|Cedars-Sinai Medical Center|This was a pilot study.|2|||f||||t||||||||||2017-02-18 15:00:26.146742|2017-02-18 15:00:26.146742
NCT00570063|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-09-25||2009-09-25|November 2007||2007-11-01|September 2009|2009-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo|A Phase 2, Multicenter, Double Blind, Randomized, Fixed Dose, Parallel Group, 3 Week Inpatient Treatment Study To Evaluate The Safety, Efficacy And Pharmacokinetics Of PF-02545920 Compared With Placebo In The Treatment Of Acute Exacerbation Of Schizophrenia|Terminated||Phase 2|35|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:00:26.441891|2017-02-18 15:00:26.441891
NCT00570050|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2015-02-20|||June 2013||2013-06-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder|A Randomized, Double-blind, Placebo-controlled Cross-over Trial Evaluating the Effect of Intranasal Insulin on Depressive Symptoms in Individuals With Major Depressive Disorder Insufficiently Responsive to Antidepressant Therapy|Completed||Phase 3|35|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 15:00:26.553158|2017-02-18 15:00:26.553158
NCT00570037|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2013-06-17|2010-10-06||October 2007||2007-10-01|January 2011|2011-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|Piiitch||Feasibility of Cocooning Immunization Strategy With Influenza Vaccine|Prevention of Influenza in Infants by Immunization of Their Contacts in the Household|Completed||N/A|544|Actual|Duke University||2|||f||||f||||||||||2017-02-18 15:00:26.666208|2017-02-18 15:00:26.666208
NCT00570024|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2012-08-24|||January 2006||2006-01-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease|The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease|Completed||Phase 3|145|Actual|Cedars-Sinai Medical Center||3|||f||||t||||||||||2017-02-18 15:00:27.057215|2017-02-18 15:00:27.057215
NCT00570011|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2007-12-10|||June 1997||1997-06-01|December 2007|2007-12-01|December 1998|Actual|1998-12-01|||||Interventional|||Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients|Efficacy of Two Different Dose Regimens of Somatropin in Growth Hormone Deficient Adult Patients|Completed||Phase 3|112|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:00:27.168101|2017-02-18 15:00:27.168101
NCT00569998|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2017-01-18|||August 2003||2003-08-01|January 2017|2017-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin|An Open-label, Multi-centre, Multi-national, Comparative, Randomised, Cross-over Trial Evaluating Preference as Well as Performance, Acceptance, Handling and Safety of NovoPen™ 4 (MS236) Versus NovoPen 3® in Insulin Treated Diabetic Patients|Completed||Phase 3|208|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:00:27.281529|2017-02-18 15:00:27.281529
NCT00569985|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2016-08-12|||June 2007||2007-06-01|August 2016|2016-08-01||||July 2017|Anticipated|2017-07-01||Interventional|||Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma|A Pilot Study of Safety and Feasibility of Stem Cell Therapy for Aids Lymphoma Using Stem Cells Treated With a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs|Active, not recruiting||N/A|10|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 15:00:27.396355|2017-02-18 15:00:27.396355
NCT00569972|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2012-07-17||2009-12-10|October 2007||2007-10-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia|PD 0200390 Dose Ranging Trial: A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia|Completed||Phase 2|682|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 15:00:27.520969|2017-02-18 15:00:27.520969
NCT00569959|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2015-11-25|||November 2006||2006-11-01|December 2008|2008-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients|Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients|Completed||N/A|50|Actual|HealthPartners Institute||2|||f||||f||||||||||2017-02-18 15:00:27.706081|2017-02-18 15:00:27.706081
NCT00569946|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2014-07-16|2012-02-25||December 2007||2007-12-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|February 2010|Actual|2010-02-01||Interventional|||Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)|Phase 2 Study Of AG-013736 As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer|Completed||Phase 2|64|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:00:27.81204|2017-02-18 15:00:27.81204
NCT00569933|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2015-05-21|||December 2007||2007-12-01|May 2015|2015-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Audio Recording for Improved Surgical Outcome (ARISO)|Audio Recording for Improved Surgical Outcome|Completed||Phase 1|30|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:00:28.477836|2017-02-18 15:00:28.477836
NCT00569920|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2009-01-14|||September 2007||2007-09-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Nausea and Pain Prophylaxis During Thyroid Surgery|Nausea and Pain Prophylaxis During Thyroid Surgery, a Comparison of Low-Dose and High-Dose Dexamethasone to Placebo|Completed||N/A|120|Anticipated|Sykehuset Telemark||3|||f||||t||||||||||2017-02-18 15:00:28.593832|2017-02-18 15:00:28.593832
NCT00569907|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2015-11-25|||January 2007||2007-01-01|August 2010|2010-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide|Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide|Completed||N/A|18|Actual|HealthPartners Institute|||1||f||||f||||||||||2017-02-18 15:00:28.700561|2017-02-18 15:00:28.700561
NCT00569894|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2012-03-06|||October 2007||2007-10-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||A Post Marking Study to Evaluate the Safety of FluMist in Children|A Post Marketing Evaluation of the Safety of FluMist in Children 24-59 Months of Age in a Managed Care Setting|Completed||Phase 4|29296|Actual|MedImmune LLC|||3||f||||f||||||||||2017-02-18 15:00:28.795558|2017-02-18 15:00:28.795558
NCT00569881|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2007-12-07|||January 2007||2007-01-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Observational|||Effect of Topical Fluoroquinolones on Epithelial Wound Healing After PRK|Effect of Gatifloxacin 0.3% and Moxifloxacin 0.5% on Epithelial Wound Healing After Photorefractive Keratectomy|Completed||N/A|22|Actual|Donnenfeld, Eric, M.D.|||2||f||||t||||||||||2017-02-18 15:00:28.895682|2017-02-18 15:00:28.895682
NCT00569868|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-07|2011-07-18|2011-04-14||August 2005||2005-08-01|July 2011|2011-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma|UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma|Completed||N/A|11|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 15:00:29.004981|2017-02-18 15:00:29.004981
NCT00569855|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2011-02-03|2011-01-12||February 2001||2001-02-01|February 2011|2011-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery|Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery|Completed||Phase 2|785|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 15:00:29.448244|2017-02-18 15:00:29.448244
NCT00569842|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2014-09-10|||November 2007||2007-11-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|February 2010|Actual|2010-02-01||Observational|||Investigation of the Cylex® ImmuKnow® Assay|Investigation of the Cylex® ImmuKnow® Assay|Completed||N/A|45|Actual|Indiana University|||1||f||||t||||||None Retained|"~     None to be retained.~   "|||2017-02-18 15:00:29.686739|2017-02-18 15:00:29.686739
NCT00569829|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-03-28|||January 2004||2004-01-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|KATES||Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School Settings|A Randomized, Controlled Trial of Modular CBT for Child Anxiety Disorders in Elementary School Settings|Completed||Phase 2|60|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 15:00:29.776353|2017-02-18 15:00:29.776353
NCT00569816|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2007-12-06|||January 2005||2005-01-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||Continuous Versus Repetitive Sevoflurane Administration for Preconditioning|A Comparison Between Continuous and Repetitive Sevoflurane Administration for Preconditioning During Coronary Artery Bypass Surgery|Completed||Phase 4|50|Actual|University of Schleswig-Holstein||3|||f||||f||||||||||2017-02-18 15:00:29.874016|2017-02-18 15:00:29.874016
NCT00569803|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2016-08-16|2016-07-05||December 2007||2007-12-01|August 2016|2016-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Subcutaneous Pharmacokinetics of Belatacept|Pharmacokinetics, Safety and Immunogenicity of Single Doses of Belatacept Administered Subcutaneously to Healthy Subjects|Completed||Phase 1|153|Actual|Bristol-Myers Squibb||8|||f||||f||||||||||2017-02-18 15:00:29.998644|2017-02-18 15:00:29.998644
NCT00569790|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-11-01|||October 2007||2007-10-01|November 2012|2012-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer|Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer|Completed||Phase 2|53|Actual|Taiho Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-02-18 15:00:32.074336|2017-02-18 15:00:32.074336
NCT00569777|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2015-02-18|2010-10-04||October 2007||2007-10-01|February 2015|2015-02-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers|A Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study Evaluating the Safety of a Novel Contact Lens Used Daily in Healthy, Normal Volunteers|Completed||Phase 3|310|Actual|Vistakon Pharmaceuticals||2|||f||||||||||||||2017-02-18 15:00:32.180324|2017-02-18 15:00:32.180324
NCT00569764|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-06-09|||December 2007||2007-12-01|June 2009|2009-06-01|October 2009|Anticipated|2009-10-01|||||Observational|||Effect on Metabolic Parameters of Abilify in SPR|The Effects of Metabolic Parameters of Aripiprazole in Patients With Schizophrenia|Unknown status|Recruiting|N/A|100|Anticipated|Seoul National Hospital|||1||f||||f||||||Samples Without DNA|"~     blood sampling~   "|||2017-02-18 15:00:32.882227|2017-02-18 15:00:32.882227
NCT00569751|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2008-09-25|||October 2004||2004-10-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|November 2006|Actual|2006-11-01||Interventional|ARRIVE 2||TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program|TAXUS ARRIVE 2: A Multi-Center Safety Surveillance Program|Completed||Phase 4|5016|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 15:00:32.983517|2017-02-18 15:00:32.983517
NCT00569738|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-02-16|||December 2008||2008-12-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|||||Observational|||Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors|Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors|Unknown status|Recruiting|N/A|20|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 15:00:33.117408|2017-02-18 15:00:33.117408
NCT00569712|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2012-03-07|||January 2007||2007-01-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol|A Pilot Comparative Study of the Genomic Molecular and Clinical Profiles of Patients With Lung Cancer, COPD, or Asthma Treated With Symbicort Turbuhaler|Completed||Phase 1|30|Actual|British Columbia Cancer Agency||1|||f||||f||||||||||2017-02-18 15:00:33.210085|2017-02-18 15:00:33.210085
NCT00569699|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-11-01|||October 2007||2007-10-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)|Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)|Completed||Phase 2|56|Actual|Taiho Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-02-18 15:00:33.318058|2017-02-18 15:00:33.318058
NCT00569686|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2010-03-03|||September 2007||2007-09-01|March 2010|2010-03-01|February 2010|Anticipated|2010-02-01|December 2009|Anticipated|2009-12-01||Interventional|||Lovaza Therapy of Peripheral Arterial Disease|Lovaza Therapy of Peripheral Arterial Disease|Withdrawn||N/A|60|Anticipated|University of Virginia||2||No subject meeting criteria|f||||f||||||||||2017-02-18 15:00:35.923279|2017-02-18 15:00:35.923279
NCT00569673|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2014-05-27|2014-05-27||March 2008||2008-03-01|May 2014|2014-05-01||||January 2012|Actual|2012-01-01||Interventional||Total number eligible and evaluable|Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer|A Phase II Evaluation of Docetaxel (NSC #628503) Plus Trabectedin (Yondelis®), R279741, IND # 101018) With Growth Factor Support in the Third-Line Treatment of Recurrent or Persistent Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Completed||Phase 2|71|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 15:00:36.021605|2017-02-18 15:00:36.021605
NCT00569660|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2012-08-01|2009-09-21||June 2005||2005-06-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Ph II Study of Azacitidine in Myelofibrosis|Phase II Study of Azacitidine in Myelofibrosis|Completed||Phase 2|34|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:00:36.720797|2017-02-18 15:00:36.720797
NCT00569647|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2007-12-06|||November 2005||2005-11-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Preoperative Anxiety in Pediatric Reconstructive Burn Patients: The Role of Virtual Reality Hypnosis|Preoperative Anxiety in Pediatric Reconstructive Burn Patients: The Role of Virtual Reality Hypnosis|Completed||N/A|25|Actual|Shriners Hospitals for Children||2|||f||||t||||||||||2017-02-18 15:00:37.00475|2017-02-18 15:00:37.00475
NCT00569634|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-08-26|||January 2008||2008-01-01|August 2016|2016-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|AVANTI||Agreement Between Venous and Arterial Blood Gas Measurements in the Intensive Care Unit|Agreement Between Venous and Arterial Blood Gas Measurements in the Intensive Care Unit|Completed||N/A|40|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-02-18 15:00:37.116122|2017-02-18 15:00:37.116122
NCT00569621|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2007-12-05|||March 2007||2007-03-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow|A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow|Completed||Phase 2|16|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:00:37.228081|2017-02-18 15:00:37.228081
NCT00569608|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2007-12-06|||January 2005||2005-01-01|June 2005|2005-06-01|October 2006|Actual|2006-10-01|||||Interventional|EDNEO||Early Hospital Discharge Program in Neonatology|Early Discharge Program From a Regional Reference Neonatal Intensive Care Unit|Completed||N/A|140|Actual|Fundacion Para La Investigacion Hospital La Fe||2|||f||||f||||||||||2017-02-18 15:00:37.322791|2017-02-18 15:00:37.322791
NCT00569595|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2011-06-06|||November 2008||2008-11-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Improving Health Habits in Impoverished Populations|Improving Health Habits in Impoverished Populations|Completed||Phase 3|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 15:00:37.426161|2017-02-18 15:00:37.426161
NCT00569582|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2013-08-12|2012-04-04||December 2007||2007-12-01|August 2013|2013-08-01||||January 2011|Actual|2011-01-01||Interventional|SEISMIC||A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome|An Open-label Study of the Efficacy and Safety of CORLUX (Mifepristone) in the Treatment of the Signs and Symptoms of Endogenous Cushing's Syndrome|Completed||Phase 3|50|Actual|Corcept Therapeutics||1|||f||||t||||||||||2017-02-18 15:00:37.530046|2017-02-18 15:00:37.530046
NCT00569569|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2007-12-06|||February 2006||2006-02-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Retaane® in Age-Related Macular Degeneration|Retaane® in Age-Related Macular Degeneration|Completed||Phase 2/Phase 3|20|Actual|Rudolf Foundation Clinic||1|||f||||f||||||||||2017-02-18 15:00:37.871525|2017-02-18 15:00:37.871525
NCT00569543|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2013-05-14|||May 2005||2005-05-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Undergoing Treatment for Newly Diagnosed Breast Cancer|Effects of Therapeutic Agents on Estrogens in the Breast|Completed||N/A|27|Actual|University of Nebraska|||1||f||||f||||||Samples With DNA|"~     Urine~   "|||2017-02-18 15:00:38.041911|2017-02-18 15:00:38.041911
NCT00569530|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2016-05-18|2016-02-29||January 2008||2008-01-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|TOLSURFPilot||Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide|Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide|Completed||Phase 3|85|Actual|University of California, San Francisco|More frequent dosing, with the resultant improvements in lung function, may allow for more rapid weaning from mechanical ventilation, leading to improved pulmonary outcomes, both short-term and long-term. Modifications to protocol being investigated.|2|||f||||f||||||||No||2017-02-18 15:00:38.359691|2017-02-18 15:00:38.359691
NCT00569517|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2009-03-19|||January 2008||2008-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Cognitive Behavioral Therapy for Obesity|The Effect of Brief Group Cognitive Behavioral Therapy on Decreasing Metabolic Syndrome Risk Factors in Obese Patients Treated With Atypical Antipsychotics|Completed||N/A|32|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:00:38.986279|2017-02-18 15:00:38.986279
NCT00569504|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-06-11|||December 2007||2007-12-01|June 2009|2009-06-01|September 2009|Anticipated|2009-09-01|||||Observational|||Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics|Prevalence of the Metabolic Syndrome in Patients With Schizophrenia Taking Antipsychotics|Unknown status|Recruiting|N/A|1000|Anticipated|Seoul National Hospital|||1||f||||f||||||Samples Without DNA|"~     blood sampling~   "|||2017-02-18 15:00:39.095071|2017-02-18 15:00:39.095071
NCT00569491|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2008-09-24|||February 2004||2004-02-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|ARRIVE||TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program|TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program|Completed||Phase 4|2585|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 15:00:39.191157|2017-02-18 15:00:39.191157
NCT00569478|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2012-12-03|||October 2007||2007-10-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|August 2009|Actual|2009-08-01||Interventional|ICD-rehab||The Effect of Rehabilitation for Patients Living With an Implantable Cardioverter Defibrillator|The Effect of Rehabilitation for Patients Living With an ICD|Completed||Phase 2|196|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 15:00:39.332595|2017-02-18 15:00:39.332595
NCT00569465|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2007-12-06|||January 2005||2005-01-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|NACARGPAO||N-Acetylcysteine and Arginine Administration in Diabetic Patients|Effects of Arginine and N-Acetylcysteine Administration on Nitric Oxide Production and Arterial Blood Pressure in Hypertensive Diabetic Patients.|Terminated||Phase 4|24|Actual|University of Turin, Italy||2||End of the study|f||||f||||||||||2017-02-18 15:00:39.436943|2017-02-18 15:00:39.436943
NCT00569452|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-03-01|||January 2006||2006-01-01|June 2010|2010-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal Rate|Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal Rate|Completed||N/A|12|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:00:39.54557|2017-02-18 15:00:39.54557
NCT00569439|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2007-12-06|||November 2000||2000-11-01|June 2006|2006-06-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study on the Effects of Dextrose Solutions on the Course of Labor|A Randomized Controlled Trial Comparing Normal Saline With and Without Dextrose on the Course of Labor in Nulliparas|Completed||Phase 2|301|Actual|MemorialCare||3|||f||||f||||||||||2017-02-18 15:00:39.654125|2017-02-18 15:00:39.654125
NCT00569426|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2017-01-18|||April 2005||2005-04-01|January 2017|2017-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Evaluating the Use of Two Different Needles in Subjects With Diabetes|An Open-label, Randomised, Multi-centre Cross-over Trial in Diabetes Patients Evaluating Preference, Injection Pressure, Pain Perception and Handling When Injections Are Performed With Two Different Needles i.e. NovoFine® 32 Gauge Tip x 6mm and NovoFine® 30 Gauge x 8mm Using a FlexPen® Disposable Insulin Injection Pen|Completed||Phase 4|119|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:00:39.762763|2017-02-18 15:00:39.762763
NCT00569413|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2010-06-09|||April 2011||2011-04-01|June 2010|2010-06-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Observational|||A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality|A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality|Suspended||N/A|40|Anticipated|Hadassah Medical Organization|||2||f||||t||||||||||2017-02-18 15:00:39.875479|2017-02-18 15:00:39.875479
NCT00569400|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-07-04|||May 2003||2003-05-01|September 2011|2011-09-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes|Comparison of Efficacy and Safety of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes Mellitus|Completed||Phase 3|241|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:00:39.962997|2017-02-18 15:00:39.962997
NCT00569387|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-05-29||2014-08-28|December 2007||2007-12-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|March 2011|Actual|2011-03-01||Interventional|||Vaccine Study for Surgically Resected Pancreatic Cancer|A Phase II Study of Algenpantucel-L (HyperAcute Pancreas) Cancer Vaccine in Subjects With Surgically Resected Pancreatic Cancer|Completed||Phase 2|73|Actual|NewLink Genetics Corporation||1|||f||||t||||||||||2017-02-18 15:00:40.074895|2017-02-18 15:00:40.074895
NCT00569374|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2010-09-30|2009-11-06||September 2007||2007-09-01|September 2010|2010-09-01||||September 2008|Actual|2008-09-01||Interventional|||Safety and Tolerability of Modafinil for Methamphetamine Dependence|Safety and Tolerability of Modafinil for Methamphetamine Dependence|Completed||Phase 2|8|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 15:00:40.197379|2017-02-18 15:00:40.197379
NCT00569361|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2009-06-08|||November 2004||2004-11-01|June 2009|2009-06-01|October 2005|Actual|2005-10-01|||||Interventional|||Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic Disease|Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic|Completed||N/A|80|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 15:00:40.483221|2017-02-18 15:00:40.483221
NCT00569335|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-11-01|||October 2007||2007-10-01|November 2012|2012-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer|Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer|Completed||Phase 2|52|Actual|Taiho Pharmaceutical Co., Ltd.||1|||f||||t||||||||||2017-02-18 15:00:40.592593|2017-02-18 15:00:40.592593
NCT00569322|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-11-25|||December 2003||2003-12-01|September 2007|2007-09-01|September 2004|Actual|2004-09-01|||||Observational|||Admission Glucose ICU Study|Evaluation of Admission Blood Glucose Levels in the Intensive Care Unit|Completed||N/A|||HealthPartners Institute|||||f||||f||||||||||2017-02-18 15:00:40.696588|2017-02-18 15:00:40.696588
NCT00569309|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2016-10-13|||December 2007||2007-12-01|October 2016|2016-10-01||||July 2011|Actual|2011-07-01||Interventional|||Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma|Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation for High-Risk Lymphoma and Myeloma|Active, not recruiting||N/A|31|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:00:40.793843|2017-02-18 15:00:40.793843
NCT00569296|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2015-03-24|||November 2007||2007-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer|A Phase I Study of Anti-CD3 x Cetuximab-Armed Activated T Cells, Low Dose IL-2, and GM-CSF for EGFR-Positive, Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1|5|Actual|Roger Williams Medical Center||1||Funding ended|f||||t||||||||||2017-02-18 15:00:41.139559|2017-02-18 15:00:41.139559
NCT00569283|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2013-03-25|||May 2007||2007-05-01|January 2008|2008-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant|Donor Natural Killer Cell Infusion for the Prevention of Relapse or Graft Failure After HLA-Haploidentical Familial Donor Bone Marrow Transplantation-A Phase I Study|Completed||Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:00:41.259675|2017-02-18 15:00:41.259675
NCT00569270|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2012-10-04|2011-08-20||October 2006||2006-10-01|October 2012|2012-10-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Dynamic Hyperinflation and Tiotropium|Simplified Detection of Dynamic Hyperinflation Using Metronome Paced Hyperventilation and the Effect of Tiotropium in Patients With COPD|Completed||Phase 4|30|Actual|Gelb, Arthur F., M.D.||2|||f||||t||||||||||2017-02-18 15:00:41.375943|2017-02-18 15:00:41.375943
NCT00569257|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2011-12-12|||December 2007||2007-12-01|December 2011|2011-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors|Antitumoral Activity and Safety of AEZS-108 (AN-152), a LHRH Agonist Linked Doxorubicin, in Women With LHRH Receptor Positive Gynecological Tumors|Completed||Phase 2|85|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 15:00:42.179681|2017-02-18 15:00:42.179681
NCT00569244|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2014-10-28|||December 2007||2007-12-01|October 2014|2014-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||SH T00186 in the Treatment of Primary Dysmenorrhea|A Multi-center, Open-label, Randomized, Controlled, Parallel-group Study to Assess Efficacy and Safety of an Extended Flexible Regimen of the Combined Oral Contraceptive SH T00186D (0.02 mg Ethinylestradiol as Beta-cyclodextrin Clathrate and 3 mg Drospirenone) Compared to the Conventional Regimen of SH T00186D in the Treatment of Primary Dysmenorrhea|Completed||Phase 3|223|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:00:42.305166|2017-02-18 15:00:42.305166
NCT00569231|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-06|2010-12-29|2010-11-23||February 2007||2007-02-01|December 2010|2010-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study With Candida Antigen for Treatment of Warts|A Phase 1 Study to Evaluate the Immunologic Mechanisms Underlying Wart Resolution After Intralesional Immunotherapy With Candida Antigen|Completed||Phase 1|18|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 15:00:42.45404|2017-02-18 15:00:42.45404
NCT00569192|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2013-12-09|2013-08-19||December 2007||2007-12-01|December 2013|2013-12-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children|A Randomized, Double Blind, Placebo Controlled, Parallel Group, Study Investigating the Safety and Efficacy Over 12 Weeks Treatment Period of MAP0010 in Asthmatic Infants and Children 12 Months to 8 Years of Age|Completed||Phase 3|360|Actual|Allergan||3|||f||||f||||||||||2017-02-18 15:00:42.765663|2017-02-18 15:00:42.765663
NCT00569179|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-08-28|||August 2007||2007-08-01|August 2015|2015-08-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies|A PHASE I TRIAL OF ALLOREACTIVE NK CELLS INFUSION FOLLOWING TRANSPLANTATION OF HAPLOTYPE MISMATCHED, KIR MISMATCHED HIGHLY PURIFIED CD34 CELLS IN PATIENTS WITH ADVANCED OR REFRACTORY MYELOID MALIGNANCIES|Terminated||Phase 1|1|Actual|Indiana University||1||Slow accrual|f||||t||||||||||2017-02-18 15:00:43.358711|2017-02-18 15:00:43.358711
NCT00569166|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2016-04-18|2011-09-13||March 2007||2007-03-01|November 2011|2011-11-01||||February 2010|Actual|2010-02-01||Interventional|||Three Different Programs of Paced Breathing in Treating Hot Flashes in Women|Paced Breathing for Hot Flashes: A Randomized Phase II Study|Completed||Phase 2|105|Actual|Mayo Clinic||3|||f||||||||||||||2017-02-18 15:00:43.465769|2017-02-18 15:00:43.465769
NCT00569153|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-03-04||2016-03-04|April 2008||2008-04-01|March 2016|2016-03-01|February 2013|Actual|2013-02-01|January 2013|Actual|2013-01-01||Interventional|TAK-700||Safety Study of TAK-700 in Subjects With Prostate Cancer.|A Phase 1/2, Open-Label, Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of TAK-700 in Metastatic, Androgen-Independent Prostate Cancer Subjects|Completed||Phase 1/Phase 2|123|Actual|Millennium Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 15:00:44.27896|2017-02-18 15:00:44.27896
NCT00569140|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2010-01-21|||December 2007||2007-12-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|||||Interventional|||A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration|A Phase 1, Single Ascending Dose Trial to Establish the Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) Monotherapy and of E10030 Given in Combination With Lucentis®0.5 Mg/Eye in Subjects With Neovascular Age-Related Macular Degeneration|Completed||Phase 1|18|Anticipated|Ophthotech Corporation||1|||f||||f||||||||||2017-02-18 15:00:44.39319|2017-02-18 15:00:44.39319
NCT00569127|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2016-11-14|2016-02-18||December 2007||2007-12-01|November 2016|2016-11-01||||January 2015|Actual|2015-01-01||Interventional|S0518|Eligible patients|Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor|Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients|Active, not recruiting||Phase 3|427|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:00:44.503795|2017-02-18 15:00:44.503795
NCT00569114|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2010-03-16|||October 2007||2007-10-01|March 2010|2010-03-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|||Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients|A Phase 1 Dose-Escalation Pharmacokinetic and Pharmacodynamic Study of TG01 Tablets in Combination With Erlotinib in Non-Small Cell Lung Cancer Patients|Completed||Phase 1|45|Anticipated|Tragara Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:00:46.776204|2017-02-18 15:00:46.776204
NCT00569101|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2007-12-04|||September 2007||2007-09-01|December 2007|2007-12-01|March 2008|Anticipated|2008-03-01|||||Interventional|||A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis|A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis|Unknown status|Active, not recruiting|Phase 2|9|Anticipated|Seoul National University Hospital||1|||f||||t||||||||||2017-02-18 15:00:46.868646|2017-02-18 15:00:46.868646
NCT00569088|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2009-07-07|||November 2007||2007-11-01|July 2009|2009-07-01|December 2010|Anticipated|2010-12-01|April 2010|Anticipated|2010-04-01||Interventional|||"Study of the Pathogenesis and Molecular Mechanism of YURE in Internal Intractable Diseases"|"973 Project for Pathology of Traditional Chinese Medicine"|Unknown status|Recruiting|Phase 2|300|Anticipated|Nanjing University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-02-18 15:00:46.965592|2017-02-18 15:00:46.965592
NCT00569075|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2010-06-24|||October 2006||2006-10-01|February 2009|2009-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Apoptic Biomarkers of Periodontal Disease|Apoptotic Biomarkers of Periodontal Disease|Completed||Phase 1|60|Actual|University of Michigan|||2||f||||f||||||Samples Without DNA|"~     saliva and plaque~   "|||2017-02-18 15:00:47.076265|2017-02-18 15:00:47.076265
NCT00569062|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-06-08||2009-07-22|September 2007||2007-09-01|June 2015|2015-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of GW856553X For the Treatment of Depression|A Randomized, Double Blind, Placebo Controlled Study to Explore the Antidepressant Properties of P38a Kinase Inhibitor GW856553X 15mg Compared to PBO in Subjects With Major Depressive Disorder Exhibiting Symptoms of Loss of Energy and Interest and Psychomotor Retardation, for a Six Week Treatment Period|Terminated||Phase 2|30|Actual|GlaxoSmithKline||2||"Negative data from a GSK PoC study in RA combined with evidence of greater sensitivity of~   toll-like receptor pathways to p38 inhibition."|f||||f||||||||||2017-02-18 15:00:47.161922|2017-02-18 15:00:47.161922
NCT00569049|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2012-04-04|||May 1996||1996-05-01|April 2012|2012-04-01||||May 2050|Anticipated|2050-05-01||Observational|||Molecular Analysis of Breast Cancer|Molecular Analysis of Breast Cancer|Active, not recruiting||N/A|99999|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"~     tumor, normal tissue and blood~   "|||2017-02-18 15:00:47.369476|2017-02-18 15:00:47.369476
NCT00569036|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2013-08-13|||April 2008||2008-04-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors|A Phase I Multiple Ascending Dose Study of BMS-754807 in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|63|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:00:47.454434|2017-02-18 15:00:47.454434
NCT00569023|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-06-26|||July 2007||2007-07-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|August 2009|Actual|2009-08-01||Interventional|||Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene|Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene|Completed||N/A|7|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 15:00:47.557616|2017-02-18 15:00:47.557616
NCT00569010|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-07-26|2011-01-21||December 2005||2005-12-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)|"Randomized Phase I/II Study of 5-Azacytidine in Combination With Cytosine Arabinoside in Patients With Relapsed/Refractory Acute Myelogenous Leukemia or High Risk Myelodysplastic Syndrome - SPORE"|Completed||Phase 1/Phase 2|36|Actual|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 15:00:47.657866|2017-02-18 15:00:47.657866
NCT00568997|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-01-20|||June 2004||2004-06-01|March 2013|2013-03-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|PEER||10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus|A Prospective 10 Year Observational Registry of Pediatric Subjects (Age Greater Than or Equal to Two Years to Age Less Than or Equal to 17 Years) With Atopic Dermatitis Who Have Used Elidel Cream 1% (Pimecrolimus)|Recruiting||N/A|8000|Anticipated|Valeant Pharmaceuticals International, Inc.|||1||f||||t||||||||||2017-02-18 15:00:48.149627|2017-02-18 15:00:48.149627
NCT00568984|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2012-06-05|||November 2002||2002-11-01|January 2012|2012-01-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes|Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes Mellitus|Completed||Phase 4|324|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:00:48.249346|2017-02-18 15:00:48.249346
NCT00568971|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2010-01-26|||April 2007||2007-04-01|August 2009|2009-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Weekly DCF to Treat Advanced Gastric Cancer|Phase II Study of Weekly Docetaxol Combined With Cisplatin and 5-Fu in Patients With Advanced Gastric Cancer|Terminated||Phase 2|40|Actual|Fudan University||1||The study has finished.|f||||f||||||||||2017-02-18 15:00:48.34037|2017-02-18 15:00:48.34037
NCT00568958|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2014-07-22|2014-03-04||February 2008||2008-02-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Naltrexone for Heavy Drinking in Young Adults|Naltrexone for Heavy Drinking in Young Adults|Completed||Phase 4|140|Actual|Yale University||2|||f||||t||||||||||2017-02-18 15:00:48.616155|2017-02-18 15:00:48.616155
NCT00568737|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2007-12-05|||November 2002||2002-11-01|December 2007|2007-12-01|February 2005|Actual|2005-02-01|||||Interventional|||The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death|Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Early Stage Severe Sepsis|Completed||Phase 3|2640|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:00:52.157418|2017-02-18 15:00:52.157418
NCT00568945|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2014-10-28|||January 2008||2008-01-01|October 2014|2014-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.|Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation by Administration of Capadenoson in a Dose of 4 mg Once Daily for Five Days|Completed||Phase 2|28|Actual|Bayer||1|||f||||f||||||||||2017-02-18 15:00:49.132239|2017-02-18 15:00:49.132239
NCT00568906|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2010-07-02|||February 2002||2002-02-01|July 2010|2010-07-01|June 2011|Anticipated|2011-06-01|November 2010|Anticipated|2010-11-01||Observational|||Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma|Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma|Unknown status|Recruiting|N/A|150|Anticipated|Stanford University|||1||f||||||||||Samples With DNA|"~     Lung tissue or pleural fluid.~   "|||2017-02-18 15:00:49.24026|2017-02-18 15:00:49.24026
NCT00568893|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2007-12-05|||January 2003||2003-01-01|December 2007|2007-12-01|October 2003|Actual|2003-10-01|||||Interventional|||An Open Label Study of Severe Sepsis in Adults|An Open Label Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis and Multiple Organ Dysfunctions A Phase IV Protocol|Completed||Phase 4|130|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:00:49.326308|2017-02-18 15:00:49.326308
NCT00568880|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2009-07-07|||November 2007||2007-11-01|July 2009|2009-07-01||||November 2009|Anticipated|2009-11-01||Interventional|||Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase I/II Trial of Hydroxychloroquine Added to Bortezomib for Relapsed/Refractory Myeloma|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:00:49.453114|2017-02-18 15:00:49.453114
NCT00568867|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-04-07|||September 2006||2006-09-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample|Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample|Completed||N/A|300|Actual|Stanford University|||1||f||||t||||||Samples With DNA|"~     tumor tissue sample~   "|||2017-02-18 15:00:49.563905|2017-02-18 15:00:49.563905
NCT00568854|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-06-30|2016-04-12||April 2007||2007-04-01|June 2016|2016-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Immunobiology of Diabetes and Tuberculosis|Converging Epidemics: Immunobiology of Diabetes Mellitus and Tuberculosis Infection|Terminated||N/A|10|Actual|Stanford University|This was a pilot/feasibility study to lay groundwork for a larger scale study of differences in immune responses in persons with diabetes versus persons without diabetes. The study aimed to optimize laboratory procedures for the full study.|2||Additional funding was not secured|f||||t||||||||No||2017-02-18 15:00:49.649795|2017-02-18 15:00:49.649795
NCT00568841|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2009-09-16|||October 2007||2007-10-01|September 2009|2009-09-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|ERLOPET||Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)|A Phase-II Clinical Trial to Evaluate the Accuracy of FDG-/FLT-PET for Early Prediction of Non-progression in Patients With Advanced NSCLC Treated With Erlotinib and to Associate PET Findings With Molecular Markers|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|Lung Cancer Group Cologne||1|||f||||t||||||||||2017-02-18 15:00:50.095941|2017-02-18 15:00:50.095941
NCT00568828|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2007-12-05|||December 2007||2007-12-01|December 2007|2007-12-01|February 2008|Anticipated|2008-02-01|||||Observational|MacTEL-Supp||MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin|Pilot Study to Evaluate the Changes of Macular Pigment Optical Density in Patients With Idiopathic Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin|Unknown status|Recruiting|N/A|12|Anticipated|The Lowy Medical Research Institute Limited|||1||f||||f||||||||||2017-02-18 15:00:50.209165|2017-02-18 15:00:50.209165
NCT00568815|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-02-16|||April 2007||2007-04-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)|Phase II Study of Rituximab Combined With ESHAP in Patients With Relapse or Refractory DLBCL|Completed||Phase 2|31|Actual|Fudan University||1|||f||||f||||||||||2017-02-18 15:00:50.290801|2017-02-18 15:00:50.290801
NCT00568802|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2008-12-02|||January 2004||2004-01-01|December 2008|2008-12-01||||||||Interventional|||A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients|A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients|Unknown status|Active, not recruiting|Phase 1/Phase 2|24||Stanford University|||||||||||||||||||2017-02-18 15:00:50.403401|2017-02-18 15:00:50.403401
NCT00568789|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2012-02-27|||June 2006||2006-06-01|February 2012|2012-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Safety of Ramelteon in Elderly Subjects|A Study of the Safety of Ramelteon in Elderly Subjects|Completed||Phase 4|33|Actual|Takeda||1|||f||||f||||||||||2017-02-18 15:00:50.497857|2017-02-18 15:00:50.497857
NCT00568776|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-04-11|2011-09-27||December 2007||2007-12-01|April 2016|2016-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||ELND005 in Patients With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Safety and Efficacy Study of Oral ELND005 (AZD-103) in Alzheimer's Disease|Completed||Phase 2|353|Actual|Transition Therapeutics Ireland Limited|The two high dose groups of ELND005 were discontinued before study end, so the efficacy analysis was based only on placebo and ELND005 250 mg bid groups.|4|||f||||t||||||||||2017-02-18 15:00:50.633642|2017-02-18 15:00:50.633642
NCT00568763|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-03-31|||November 2005||2005-11-01|March 2015|2015-03-01||||September 2015|Anticipated|2015-09-01||Interventional|||Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma|Endogenous Heat-shock Vaccines for Melanoma A Feasibility Study|Active, not recruiting||N/A|23|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 15:00:51.860317|2017-02-18 15:00:51.860317
NCT00568750|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2016-04-14|||December 2007||2007-12-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|November 2011|Actual|2011-11-01||Interventional|||Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors|Dasatinib First-Line Treatment in Gastrointestinal Stromal Tumors. A Multi Center Phase II Trial|Active, not recruiting||Phase 2|47|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||No||2017-02-18 15:00:51.971063|2017-02-18 15:00:51.971063
NCT00567593|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-07-03|2013-12-20||October 2007||2007-10-01|July 2016|2016-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|GReaT||Gene Regulation by Thiazolidinediones|Gene Regulation by Thiazolidinediones|Completed||Phase 4|12|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-02-18 15:01:12.866054|2017-02-18 15:01:12.866054
NCT00568724|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-09-13|||November 2007||2007-11-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Urinary Biomarkers as Predictors on Renal Function in Congenital Hydronephrosis|Urinary Biomarkers as Predictors on Renal Function in Congenital Hydronephrosis|Completed||N/A|45|Actual|University of Aarhus|||4||f||||f||||||Samples With DNA|"~     Urine and frozen pelvic tissue~   "|||2017-02-18 15:00:52.498397|2017-02-18 15:00:52.498397
NCT00568711|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2007-12-05|||September 2006||2006-09-01|December 2007|2007-12-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Controlled Trial: 5-Day Course of Rifampin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus|Controlled Trial: 5-Day Course of Rifampin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus|Unknown status|Recruiting|N/A|476|Anticipated|Chosun University Hospital||2|||f||||t||||||||||2017-02-18 15:00:52.595785|2017-02-18 15:00:52.595785
NCT00568698|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2009-07-07|||January 2004||2004-01-01|July 2009|2009-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients|A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients|Completed||Phase 1/Phase 2|18|Anticipated|Stanford University||2|||f||||||||||||||2017-02-18 15:00:52.701524|2017-02-18 15:00:52.701524
NCT00568685|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2010-01-19|2009-11-11||November 2007||2007-11-01|January 2010|2010-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Phase 3b, Randomized, Open-Label Assessment of Response to Various Doses of Atomoxetine Hydrochloride in Korean Pediatric Outpatients With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|153|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 15:00:52.803007|2017-02-18 15:00:52.803007
NCT00568672|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2008-04-23|||October 2007||2007-10-01|April 2008|2008-04-01|April 2008|Anticipated|2008-04-01|||||Interventional|OLA-D||Optimal Duration of Olanzapine Add-on Therapy in Major Depression|Optimal Duration of Olanzapine Add-on Therapy in Major Depression: a Placebo-Controlled, Randomized, Phase III, Pilot Study in Parallel Group Design|Withdrawn||Phase 3|30|Anticipated|Charite University, Berlin, Germany||2||Withdrawn because of personal ressources before inclusion of the first patient|f||||t||||||||||2017-02-18 15:00:53.751712|2017-02-18 15:00:53.751712
NCT00568659|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-04-27|||December 2007||2007-12-01|April 2015|2015-04-01|January 2015|Actual|2015-01-01|November 2010|Actual|2010-11-01||Interventional|||The Specific Lung Elastance in Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) Patients in Supine and Prone Position|The Specific Lung Elastance in ALI/ARDS Patients in Supine and Prone Position|Completed||N/A|15|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 15:00:53.867292|2017-02-18 15:00:53.867292
NCT00568646|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-08-03|||November 2007||2007-11-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer|A Phase 2 Study of Oral MKC 1, Administered Twice Daily for 14 Consecutive Days in a 28-Day Cycle, in Patients With Unresectable or Metastatic Pancreatic Cancer Who Have Failed at Least One Prior Chemotherapy Regimen in Either the Neoadjuvant, Adjuvant, or First-line Metastatic Setting|Completed||Phase 2|33|Anticipated|CASI Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 15:00:53.973385|2017-02-18 15:00:53.973385
NCT00568633|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-11-17|||August 2007||2007-08-01|November 2013|2013-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML|A California Cooperative Clinical Study Comparing Allogeneic Hematopoietic Cell Transplantation Using Nonmyeloablative Host Conditioning With Total Lymphoid Irradiation and Anti-thymocyte Globulin Versus Best Standard of Care in Acute Myeloid Leukemia (AML) in First Complete Remission|Terminated||Phase 3|150|Anticipated|Stanford University||1||Poor accrual|f||||t||||||||||2017-02-18 15:00:54.067134|2017-02-18 15:00:54.067134
NCT00568620|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-10-31|||May 2008||2008-05-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|June 2012|Actual|2012-06-01||Interventional|||The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Mellitus|The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Mellitus|Completed||N/A|19|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 15:00:54.195831|2017-02-18 15:00:54.195831
NCT00568607|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2010-09-07|||March 2007||2007-03-01|September 2010|2010-09-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma|Phase II Study of a Combination Chemotherapy of DICE in the Patients With NK/T Cell Lymphoma|Unknown status|Recruiting|Phase 2|60|Anticipated|Fudan University||1|||f||||f||||||||||2017-02-18 15:00:54.274396|2017-02-18 15:00:54.274396
NCT00568594|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-10-22||2012-10-22|November 2007||2007-11-01|October 2012|2012-10-01||||September 2009|Actual|2009-09-01||Interventional|||Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)|A First-in-human, Randomized, Double-blind, Placebo-controlled, Single-ascending Dose (Healthy Volunteers and CHD Patients) and Multiple Dose (CHD Patients) Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180|Completed||Phase 1/Phase 2|176|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:00:54.379533|2017-02-18 15:00:54.379533
NCT00568568|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2013-01-18|||December 2007||2007-12-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Metabolic Studies- Interactions Between GH and Insulin in GHDA|Metabolic Studies- Interactions Between GH and Insulin in GHDA. Insulin Resistance and GH Treatment: Dependence of Ambient GH Level Among Patients Treated With GH and Healthy Control Subjects|Completed||N/A|8|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 15:00:54.487111|2017-02-18 15:00:54.487111
NCT00568555|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2015-09-21|2013-04-10||June 2007||2007-06-01|September 2015|2015-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||"2 participants in the low dose naltrexone group did not have data to analyze (1 withdrew by patient choice, 1 had a malfunction with the data collection device)~1 participant in the placebo condition did not have data to analyze (withdrew by patient choice)"|Effects of Low Dose Naltrexone in Fibromyalgia|Effects of Low Dose Naltrexone in Fibromyalgia|Completed||N/A|53|Actual|Stanford University||2|||f||||||||||||||2017-02-18 15:00:54.597834|2017-02-18 15:00:54.597834
NCT00568542|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2009-08-03|||May 2006||2006-05-01|August 2009|2009-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|EPOHeart||Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy|Pilot Study to Assess the Effect of Low Dose Epoetin Beta Administered for Six Month in Patients With Ischemic Heart Failure Subjected to Percutaneous Coronary Intervention (PCI)|Completed||Phase 4|28|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 15:00:55.034656|2017-02-18 15:00:55.034656
NCT00568529|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2010-05-25|||October 2007||2007-10-01|August 2009|2009-08-01|February 2010|Anticipated|2010-02-01|June 2009|Actual|2009-06-01||Interventional|||Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer|Phase II Study on Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer|Suspended||Phase 2|30|Anticipated|Fudan University||1||There are not enough patients enrolled.|f||||f||||||||||2017-02-18 15:00:55.158412|2017-02-18 15:00:55.158412
NCT00568516|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2014-10-28|||October 2007||2007-10-01|October 2014|2014-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase II Study of ASP3550 in Patients With Prostate Cancer|Phase II Study of ASP3550 - A Maintenance-dose Finding Study in Patients With Prostate Cancer|Completed||Phase 2|273|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 15:00:55.271209|2017-02-18 15:00:55.271209
NCT00568503|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2011-04-27|||October 2007||2007-10-01|April 2011|2011-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.|A Partially Blinded, Single-dose, Cross-over Proof of Concept Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide (Positive Control) and Placebo in Mild-to-moderate COPD Patients|Completed||Phase 1|29|Actual|Novartis||5|||f||||f||||||||||2017-02-18 15:00:55.390306|2017-02-18 15:00:55.390306
NCT00568490|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-07-11|||September 1998||1998-09-01|July 2016|2016-07-01|April 2022|Anticipated|2022-04-01|April 2022|Anticipated|2022-04-01||Observational|||Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers|Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers|Recruiting||N/A|600|Anticipated|Stanford University|||1||f||||||||||Samples Without DNA|"~     blood, tumor tissue~   "|||2017-02-18 15:00:55.502376|2017-02-18 15:00:55.502376
NCT00568477|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2009-09-30|||December 2007||2007-12-01|January 2008|2008-01-01|December 2010|Anticipated|2010-12-01|||||Interventional|Rituximab 2006||Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation|Prospective, Randomized, Open, 2-arm National Multi-center Study to Evaluate the Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation.|Terminated||Phase 2|200|Anticipated|Technische Universität München||2||lacking recruitment|f||||t||||||||||2017-02-18 15:00:55.608627|2017-02-18 15:00:55.608627
NCT00568464|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2009-07-06|||March 2007||2007-03-01|July 2009|2009-07-01|September 2009|Anticipated|2009-09-01|May 2009|Actual|2009-05-01||Interventional|||Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)|Phase II Study of VCD/IE in the Treatment of the Patients With Ewing's Sarcoma Family of Tumors|Terminated||Phase 2|10|Actual|Fudan University||1||The enrollment is slower than expected|f||||f||||||||||2017-02-18 15:00:55.710629|2017-02-18 15:00:55.710629
NCT00568451|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2015-11-25|2011-11-01||June 2006||2006-06-01|March 2014|2014-03-01|April 2012|Actual|2012-04-01|May 2009|Actual|2009-05-01||Interventional|||Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma|Releasing the Cancer Patient's Immune System From Down-regulation With Timed Delivery of Standard Chemotherapy|Terminated||Phase 2|12|Actual|Mayo Clinic|This trial was stopped prior to achieving its accrual goals due to slow enrollment rate. Early termination leading to small numbers of subjects analyzed.|4||Slow accrual.|f||||t||||||||||2017-02-18 15:00:55.812591|2017-02-18 15:00:55.812591
NCT00568438|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-10-12|||October 2000||2000-10-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample|Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival and Frozen Human Tissue Samples|Recruiting||N/A|300|Anticipated|Stanford University|||1||f||||t||||||Samples Without DNA|"~     Cases will be identified from clinic patient medical records and linked to pathology~     reports. The surgical pathology record number will thus be obtained and used to retrieve the~     archival blocks and slides. Approximately three representative blocks will be selected and~     4-6 four micron thick sections will be cut on a microtome. Cases with limited archived~     diagnostic material will not be selected nor blocks where there is little materials.~   "|||2017-02-18 15:00:56.483811|2017-02-18 15:00:56.483811
NCT00568425|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2012-11-29|||September 2005||2005-09-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT|Quality of Life and Functional Outcomes After Combined Modality Therapy for Anal Cancer: A Comparison of Conventional Versus Intensity-Modulated Radiation Therapy (ANAL0002)|Terminated||N/A|10|Actual|Stanford University|||1|Inadequate response to SRC letter|f||||t||||||||||2017-02-18 15:00:56.58576|2017-02-18 15:00:56.58576
NCT00568412|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2015-02-15|||December 2007||2007-12-01|February 2015|2015-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis|A Multicenter, Randomized, Double-blind Clinical Study to Examine the Efficacy and Safety of Zarzenda in Comparison to Elidel in the Management of Mild to Moderate Atopic Dermatitis in Children and Adolescents|Completed||Phase 4|80|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:00:56.668131|2017-02-18 15:00:56.668131
NCT00568399|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-11-08|2011-09-26||December 2007||2007-12-01|November 2012|2012-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Sodium Thiosulfate Treatment of Vascular Calcification in ESRD|The Effect of Sodium Thiosulfate Treatment on Vascular Calcification in End Stage Renal Failure Patients|Completed||N/A|48|Actual|Washington University School of Medicine|This study did not enroll a prospective, randomized, placebo controlled, double-blind control group; therefore conclusive statements about the risks and benefits of thiosulfate cannot be made.|1|||f||||t||||||||||2017-02-18 15:00:56.780061|2017-02-18 15:00:56.780061
NCT00568386|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2012-01-31|2008-12-18||November 2007||2007-11-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Acute Comfort and Blur of Systane and Optive|Acute Comfort and Blurring Profile Evaluation Comparing Systane Lubricant Eye Drops to Optive Lubricant Eye Drops|Completed||N/A|40|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 15:00:57.044764|2017-02-18 15:00:57.044764
NCT00568373|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2015-07-20|||June 2007||2007-06-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|HUD||Gastric Pacemaker Implantation for Gastroparesis|Gastric Electric Stimulation-Enterra Therapy for the Treatment of Chronic Intractable (Drug Refractory) Nausea and Vomiting Secondary to Gastroparesis of Diabetic or Idiopathic Etiology|Recruiting||N/A|200|Anticipated|Indiana University||1|||f||||f||||||||||2017-02-18 15:00:57.379152|2017-02-18 15:00:57.379152
NCT00568360|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2012-05-16|||February 2004||2004-02-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Observational|||Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer|Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer|Terminated||N/A|8|Actual|Stanford University|||1|Research cancelled; equipment broke|f||||||||||||||2017-02-18 15:00:57.495784|2017-02-18 15:00:57.495784
NCT00568347|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2015-03-13|||January 2006||2006-01-01|March 2015|2015-03-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Observational|||Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange|Evaluation of the Effects of Varying Doses of Inhaled Corticosteroids on Suppression of Total Exhaled, Bronchial, and Alveolar Nitric Oxide as Markers of Endogenous Inflammation in Patients With Moderate-to-severe COPD|Completed||N/A|39|Actual|Gelb, Arthur F., M.D.|||3||f||||t||||||||||2017-02-18 15:00:57.589158|2017-02-18 15:00:57.589158
NCT00568334|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2016-11-02||2009-09-03|November 2007||2007-11-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Study of Two Formulations of GSK Biologicals' Varicella Vaccine|Study of Two Formulations of GSK Biologicals' Varicella Vaccine Given as a 2-dose Course in the Second Year of Life|Completed||Phase 2|244|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:00:57.8718|2017-02-18 15:00:57.8718
NCT00568321|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2009-10-21||2009-04-06|November 2007||2007-11-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||RN624 For Pain Of Post-Herpetic Neuralgia|A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Proof Of Concept Study Of The Analgesic Effects Of RN624 In Adult Patients With Post-Herpetic Neuralgia|Completed||Phase 2|99|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 15:00:57.991411|2017-02-18 15:00:57.991411
NCT00568308|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-06-13|||December 2007||2007-12-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|PATHWAY||Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma|A Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, International, Multicentre Phase III Trial of PI-88 in the Adjuvant Treatment of Post-resection Hepatocellular Carcinoma|Terminated||Phase 3|600|Anticipated|Progen Pharmaceuticals||2||Commercial decision to discontinue the study|f||||t||||||||||2017-02-18 15:00:58.128042|2017-02-18 15:00:58.128042
NCT00568295|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-08-19|||October 1999||1999-10-01|August 2011|2011-08-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|||A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee|A Four-Week Comparative Study Evaluating Acetaminophen Extended Release (3900 mg/Day) and Rofecoxib (12.5 mg/Day and 25 mg/Day)in the Treatment of Osteoarthritis of the Knee|Completed||Phase 3|403|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||f||||||||||2017-02-18 15:00:58.264367|2017-02-18 15:00:58.264367
NCT00568282|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2013-10-23|||February 2007||2007-02-01|October 2013|2013-10-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients|Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients (Old Title: Significance of CD44 and or Epithelial Specific Antigen Positive Cells in the Peripheral Blood of Lung Cancer Patients) (LUN0017)|Unknown status|Recruiting|N/A|100|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 15:00:58.373236|2017-02-18 15:00:58.373236
NCT00568269|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-05|2007-12-05|||November 1996||1996-11-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Randomized Multicentre Study Comparing TEP With Lichtenstein Repair for Primary Inguinal Hernia|Randomized Multicentre Study Comparing TEP With Lichtenstein Repair for Primary Inguinal Hernia|Completed||N/A|1513|Actual|Uppsala University Hospital||2|||f||||||||||||||2017-02-18 15:00:58.467322|2017-02-18 15:00:58.467322
NCT00568256|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2012-02-24|||November 2007||2007-11-01|February 2012|2012-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Mind/Body Medicine and IBD Flare-Up|Mind/Body Medicine and IBD Flare-Up|Completed||Phase 1|55|Actual|Rush University Medical Center||2|||f||||t||||||||||2017-02-18 15:00:58.582612|2017-02-18 15:00:58.582612
NCT00568243|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2017-01-24|||November 28, 2007||2007-11-28|December 6, 2016|2016-12-06||||||||Observational|||Visual Motor Coordination|Visual Motor Coordination|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:00:58.695374|2017-02-18 15:00:58.695374
NCT00568230|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2008-11-05|||April 2006||2006-04-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|PTOLEMY||Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation|An Open-Label, Single-Arm Feasibility Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty (PTMA) Device Used to Reduce Mitral Regurgitation.|Completed||Phase 1|12|Actual|Viacor||1|||f||||t||||||||||2017-02-18 15:00:58.791697|2017-02-18 15:00:58.791697
NCT00568217|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2007-12-08|||September 1997||1997-09-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Interventional|||Antipyretics for Preventing Recurrences of Febrile Seizures|Antipyretics for Preventing Recurrences of Febrile Seizures|Completed||Phase 4|231|Actual|University of Oulu||5|||f||||f||||||||||2017-02-18 15:00:58.895037|2017-02-18 15:00:58.895037
NCT00568204|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2013-10-16|||March 2002||2002-03-01|October 2013|2013-10-01|September 2005|Actual|2005-09-01|||||Interventional|Mexyn-A||Study of Effectiveness of Mexyn-A|Proof of Concept of MEXYN-A|Completed||N/A|279|Actual|Evangelical Synod Medical Centre||1|||f||||t||||||||||2017-02-18 15:00:58.998152|2017-02-18 15:00:58.998152
NCT00568191|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2007-12-04|||October 2007||2007-10-01|December 2007|2007-12-01|December 2007|Anticipated|2007-12-01|||||Observational|||Stratus Versus Cirrus OCT in AMD|Reliability of Threshold Algorithm in Age-Related Macular Degeneration: Stratus Versus Cirrus OCT|Unknown status|Recruiting|N/A|100|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|||2||f||||f||||||||||2017-02-18 15:00:59.105742|2017-02-18 15:00:59.105742
NCT00568178|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2015-04-07|2009-08-11||June 2007||2007-06-01|April 2015|2015-04-01|March 2011|Actual|2011-03-01|September 2008|Actual|2008-09-01||Interventional|||An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))|A Randomized, Double-Blind, Parallel, Placebo or Amlodipine-Controlled Study of the Effects of Losartan on Proteinuria in Pediatric Patients With or Without Hypertension|Completed||Phase 3|306|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:00:59.212507|2017-02-18 15:00:59.212507
NCT00568165|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2010-10-25|||February 2008||2008-02-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|EMEPIC||EMEPIC : Value of a Mobile Team of Cardiologist Using Echocardiography for Managing Patients With Acute Heart Failure|Value of a Mobile Team of Cardiologist Using Echocardiography for Managing Patients With Acute Heart Failure|Completed||N/A|504|Actual|University Paris 7 - Denis Diderot||2|||f||||f||||||||||2017-02-18 15:01:00.638261|2017-02-18 15:01:00.638261
NCT00568152|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2013-03-05|||May 2006||2006-05-01|March 2013|2013-03-01|May 2008|Actual|2008-05-01|||||Interventional|FLAVO||Effect of Apple Flavanols on Risk of Cardiovascular Disease|Effect of Apple Flavanols on Risk of Cardiovascular Disease|Completed||N/A|26|Actual|Institute of Food Research||3|||f||||t||||||||||2017-02-18 15:01:00.739639|2017-02-18 15:01:00.739639
NCT00568139|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-10-28|||January 2008||2008-01-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Evaluation of Side Effects of Mitotane|Evaluierung Von Nebenwirkungen Einer Therapie Mit Mitotane Beim Nebennierenkarzinom- Evaluation of Side Effects of Mitotane in Adrenocortical Carcinoma|Recruiting||N/A|200|Anticipated|University of Wuerzburg|||2||f||||f||||||Samples Without DNA|"~     Serum, plasma, and urine samples will be collected.~   "|||2017-02-18 15:01:00.850624|2017-02-18 15:01:00.850624
NCT00568126|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2011-06-10|||November 2007||2007-11-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|MGH||Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females|A Double-Blind, Placebo Controlled Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females|Completed||Phase 3|80|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 15:01:01.039656|2017-02-18 15:01:01.039656
NCT00568113|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2007-12-04|||July 2007||2007-07-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|NAC||N-Acetyl Cysteine for Prevention of Preterm Birth|Oral N-Acetyl Cysteine Can Prevent Preterm Labour in Multiparae With Previous Preterm Labour|Completed||Phase 4|120|Actual|Assiut University||2|||f||||f||||||||||2017-02-18 15:01:01.139815|2017-02-18 15:01:01.139815
NCT00568100|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2015-04-27|||April 2010||2010-04-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effect of Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist (NAVA) in Chronic Obstructive Pulmonary Disease (COPD) Patients|Effect of Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist (NAVA) in COPD Patients|Completed||N/A|15|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 15:01:01.258307|2017-02-18 15:01:01.258307
NCT00568087|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2013-08-28|2013-06-14||December 2007||2007-12-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||N-acetylcysteine in Alcohol Dependence|N-acetylcysteine in Alcohol Dependence|Completed||Phase 1/Phase 2|46|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||t||||||||||2017-02-18 15:01:01.368951|2017-02-18 15:01:01.368951
NCT00568074|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2009-09-23|||December 2003||2003-12-01|September 2009|2009-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes|Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|131|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:01:01.792769|2017-02-18 15:01:01.792769
NCT00568061|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-05-12|2010-08-03||June 2006||2006-06-01|May 2016|2016-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|NOMI||Nitric Oxide in Myocardial Infarction Size|The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size|Terminated||Phase 2|29|Actual|Mallinckrodt||1||Slow Enrollment|f||||t||||||||||2017-02-18 15:01:01.893534|2017-02-18 15:01:01.893534
NCT00568048|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2013-04-09|||December 2007||2007-12-01|April 2013|2013-04-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Interventional|||Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery|Temozolomide Combined With Bevacizumab in Metastatic Melanoma. A Multicenter Phase II Trial|Completed||Phase 2|62|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||||2017-02-18 15:01:02.343079|2017-02-18 15:01:02.343079
NCT00568035|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2009-01-07|||December 2006||2006-12-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy|Phase II Study of QR-333 for the Treatment of Symptomatic Diabetic Peripheral Neuropathy|Completed||Phase 2|140|Anticipated|Quigley Pharma, Inc.||2|||f||||f||||||||||2017-02-18 15:01:02.46918|2017-02-18 15:01:02.46918
NCT00568022|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-02-09|2011-06-03||February 2008||2008-02-01|February 2016|2016-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer|A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane|Completed||Phase 1|9|Actual|R-Pharm||1|||f||||t||||||||||2017-02-18 15:01:02.596927|2017-02-18 15:01:02.596927
NCT00568009|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2008-04-18|||October 2007||2007-10-01|April 2008|2008-04-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Observational|||Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function|Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Sequential Cohort Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function|Terminated||N/A|300|Anticipated|Solvay Pharmaceuticals|||5|additional enrolment criteria made patients' recruitment not feasible anymore|f||||t||||||None Retained|"~     Not aplicable~   "|||2017-02-18 15:01:05.993504|2017-02-18 15:01:05.993504
NCT00567996|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-07-22|2011-07-22||November 2007||2007-11-01|July 2011|2011-07-01||||January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control|A 26-week Treatment, Multi-center, Randomized, Double-blind, Double- Dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy, and Safety of Indacaterol (150 µg o.d.) in Patients With Chronic Obstructive Pulmonary Disease, Using Salmeterol (50 µg b.i.d.) as an Active Control|Completed||Phase 3|1002|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:01:06.160733|2017-02-18 15:01:06.160733
NCT00567983|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2008-09-23|||December 2007||2007-12-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Topical Cyclosporine and Disease Progression|Topical Cyclosporine and Disease Progression|Completed||Phase 4|80|Anticipated|Innovative Medical||2|||f||||||||||||||2017-02-18 15:01:07.167595|2017-02-18 15:01:07.167595
NCT00567970|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-04-19|||April 2007||2007-04-01|April 2016|2016-04-01||||September 2016|Anticipated|2016-09-01||Interventional|||Stereotactic Radiation Therapy in Treating Patients With Liver Metastases|A Phase I Dose Finding Pilot Study of Stereotactic Body Radiotherapy for the Treatment of Liver Metastasis|Active, not recruiting||Phase 1|18|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 15:01:07.263697|2017-02-18 15:01:07.263697
NCT00567957|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2007-12-04|||February 2008||2008-02-01|December 2007|2007-12-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Remifentanil for General Anesthesia in Preeclamptics|Remifentanil for c-Section With General Anesthesia in Severe Preeclamptic Patients|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Istanbul University||2|||f||||||||||||||2017-02-18 15:01:07.354478|2017-02-18 15:01:07.354478
NCT00567944|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2012-06-27|||June 2007||2007-06-01|June 2012|2012-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Use of the BrainPort® Balance Device to Improve Balance in Adults With Balance Deficits Due to Stroke|A Substitute Vestibular Information System Using the BrainPort® Balance Device for Adults With Chronic Vestibular Dysfunction Following Stroke|Completed||N/A|29|Actual|Wicab||1|||f||||f||||||||||2017-02-18 15:01:07.474691|2017-02-18 15:01:07.474691
NCT00567931|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2014-07-23|||October 2007||2007-10-01|July 2014|2014-07-01|September 2012|Actual|2012-09-01|July 2012|Actual|2012-07-01||Interventional|||1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery|A Phase 1 Study of 1-Methyl-D-tryptophan in Patients With Advanced Malignancies|Completed||Phase 1|52|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:01:07.582001|2017-02-18 15:01:07.582001
NCT00567918|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2008-04-03|||May 2004||2004-05-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis|Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients|Completed||Phase 3|52|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-02-18 15:01:07.688984|2017-02-18 15:01:07.688984
NCT00567905|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2009-01-12|||September 2007||2007-09-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|GTT-DM||Effect of Green Tea Extract on Type 2 Diabetes|Effect of Green Tea Extract on Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 2/Phase 3|32|Anticipated|Taipei Hospital, Taiwan||2|||f||||t||||||||||2017-02-18 15:01:07.808176|2017-02-18 15:01:07.808176
NCT00567892|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2012-08-23|2012-04-11||January 2008||2008-01-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|CTRWU||Collaborative Tinnitus Research at Washington University|Collaborative Tinnitus Research at Washington University|Completed||Phase 2|55|Actual|Washington University School of Medicine|Excluding subjects with Beck Depression Index of above 14 we treated an exclusive group of the Very bothered tinnitus patients, which may not be representative of the tinnitus population as a whole.|2|||f||||t||||||||||2017-02-18 15:01:07.924898|2017-02-18 15:01:07.924898
NCT00567879|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-04-04|2016-04-04||April 2008||2008-04-01|March 2016|2016-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab|A Phase Ib/IIa Trial of Panobinostat in Combination With Trastuzumab in Adult Female Patients With HER2 Positive Metastatic Breast Cancer Whose Disease Has Progressed During or Following Therapy With Trastuzumab|Terminated||Phase 1/Phase 2|56|Actual|Novartis||1||The study was terminated early due to insufficient evidence of clinical benefit.|f||||||||||||||2017-02-18 15:01:08.647116|2017-02-18 15:01:08.647116
NCT00567866|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2010-07-12|||January 2008||2008-01-01|July 2010|2010-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Methamphetamine-Quetiapine Interactions in Humans|Methamphetamine-Quetiapine Interaction in Humans: A Pilot Study|Terminated||Early Phase 1|10|Actual|University of Arkansas||3||Study was terminated due to insufficient funds|f||||t||||||||||2017-02-18 15:01:10.019134|2017-02-18 15:01:10.019134
NCT00567853|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2015-01-22|||August 2007||2007-08-01|January 2015|2015-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|MEMO3D||Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair|Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair|Completed||Phase 3|278|Actual|Sorin Group USA, Inc.||1|||f||||f||||||||||2017-02-18 15:01:10.11847|2017-02-18 15:01:10.11847
NCT00567840|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-01-12|||August 2007||2007-08-01|August 2015|2015-08-01|December 2007|Actual|2007-12-01|||||Interventional|||PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis|A Phase IIa Trial to Evaluate the Safety, Tolerability, Extended Early Bactericidal Activity and Pharmacokinetics of 14 Days' Treatment With Four Oral Doses of PA-824 in Adult Participants With Newly Diagnosed, Uncomplicated, Smear-Positive, Pulmonary Tuberculosis|Completed||Phase 2|68|Actual|Global Alliance for TB Drug Development||5|||f||||f||||||||||2017-02-18 15:01:10.212957|2017-02-18 15:01:10.212957
NCT00567827|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2010-06-23|||December 2007||2007-12-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|||Pathogen Identification of Bacterial Pneumonia Via DNA Detection|Identification of Bacterial Species and Their Antibiotic-Resistant Spectrum in Sputum Specimen From the Patients With Pneumonia Via Nuclear Acid Detection Assay|Completed||N/A|2896|Actual|Peking University People's Hospital|||1||f||||t||||||Samples With DNA|"~     DNA extracted from sputum specimen~   "|||2017-02-18 15:01:10.310824|2017-02-18 15:01:10.310824
NCT00567814|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2008-12-30|||December 2007||2007-12-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction|A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Two Dose Combinations of Metyrapone and Oxazepam in the Treatment of Cocaine Addiction|Completed||N/A|45|Anticipated|Embera NeuroTherapeutics, Inc.||3|||f||||f||||||||||2017-02-18 15:01:10.385247|2017-02-18 15:01:10.385247
NCT00567801|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2008-07-25|||September 2002||2002-09-01|July 2008|2008-07-01|September 2010|Anticipated|2010-09-01|September 2009|Anticipated|2009-09-01||Interventional|CRAIL||CRAIL - Controlled Reperfusion of the Acutely Ischemic Limb|Prospektive, Randomisierte Multicenter-Studie Zur Optimierung Der Therapie Der Akuten Ischämie Der Unteren Extremitäten Durch Die Kontrollierte Extremitätenreperfusion (Prospective, Randomized Multicenter - Study for Optimization of Therapy of the Acute Ischemic Limb by Controlled Reperfusion)|Terminated||Phase 3|250|Anticipated|University Hospital Freiburg||2|||f||||t||||||||||2017-02-18 15:01:10.494474|2017-02-18 15:01:10.494474
NCT00567788|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2007-12-04|||July 2006||2006-07-01|November 2007|2007-11-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study|Comparison of Bimatoprost and Lataprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study|Unknown status|Active, not recruiting|N/A|60|Anticipated|Singapore National Eye Centre||2|||f||||t||||||||||2017-02-18 15:01:10.823711|2017-02-18 15:01:10.823711
NCT00567775|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2012-07-09|||October 2002||2002-10-01|July 2012|2012-07-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes|Comparison of Pharmacokinetic Profiles of Human Soluble Insulin With Insulin Inhalation Solution in Paediatric Type 1 Diabetes Mellitus|Completed||Phase 2|27|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:01:10.934526|2017-02-18 15:01:10.934526
NCT00567762|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2014-08-29|||February 2004||2004-02-01|August 2014|2014-08-01|September 2004|Actual|2004-09-01|||||Interventional|||Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis|A Randomized, Placebo-controlled, Double-masked Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Vernal Keratoconjunctivitis|Completed||Phase 3|56|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 15:01:11.043009|2017-02-18 15:01:11.043009
NCT00567749|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2008-06-25|||December 2007||2007-12-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population|Clinical Sensitivity of the Clearview® COMPLETE HIV 1/2, PMA # BP050009 and the Clearview® HIV 1/2 STAT-PAK®, PMA #BP050010 in the 12 - 17 Year Old Pediatric Population|Completed||N/A|10|Actual|Chembio Diagnostic Systems, Inc.|||1||f||||t||||||Samples Without DNA|"~     Whole blood, plasma and serum~   "|||2017-02-18 15:01:11.168252|2017-02-18 15:01:11.168252
NCT00567736|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2012-07-10|||August 2007||2007-08-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|DISCI||Efficacy of Disci/Rhus Toxicodendron Comp.®, in Patients With Chronic Low Back Pain|Prospective Randomized Controlled Multicentre Trial for Patients With Chronic Low Back Pain Comparing Disci/Rhus Toxicodendron Comp.®, Placebo and Waiting List Group|Completed||Phase 3|150|Actual|Charite University, Berlin, Germany||3|||f||||f||||||||||2017-02-18 15:01:11.266709|2017-02-18 15:01:11.266709
NCT00567723|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-06-15|||April 2006||2006-04-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)|A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)|Completed||N/A|2105|Actual|Shire|||3||f||||f||||||||||2017-02-18 15:01:11.387794|2017-02-18 15:01:11.387794
NCT00567710|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2010-06-27|||July 2008||2008-07-01|June 2010|2010-06-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study|A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study to Determine the Efficacy, Tolerability and Safety of Low and High Non-overlapping Dose Ranges of BL-1020 Compared to Placebo and Risperidone|Completed||Phase 2|360|Anticipated|BioLineRx, Ltd.||4|||||||f||||||||||2017-02-18 15:01:11.821093|2017-02-18 15:01:11.821093
NCT00567697|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2012-01-18|||March 2007||2007-03-01|January 2012|2012-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO|A Randomized Study Comparing the Safty Anf Efficacy of Ranibizumab (Lucentis®) to Sham in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO|Completed||Phase 3|32|Actual|Aleris Helse||2|||f||||t||||||||||2017-02-18 15:01:11.931623|2017-02-18 15:01:11.931623
NCT00567684|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-10-03|||November 2007||2007-11-01|October 2016|2016-10-01||||November 2018|Anticipated|2018-11-01||Interventional|||Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors|Pilot Study Assessing the Technical Efficacy of Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) With Particular Focus on Patients at Risk of Urothelial Tumors|Active, not recruiting||N/A|135|Anticipated|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:01:12.043365|2017-02-18 15:01:12.043365
NCT00567671|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2010-09-01|||December 2007||2007-12-01|July 2009|2009-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|CL||Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia|Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia or Progressive Keratoconus|Completed||Phase 2/Phase 3|160|Anticipated|Emory University||2|||f||||t||||||||||2017-02-18 15:01:12.153175|2017-02-18 15:01:12.153175
NCT00567658|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2013-09-04|||February 2008||2008-02-01|August 2013|2013-08-01|January 2010|Anticipated|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas|Effect of Aggressive Acid Suppression With Esomeprazole on Vocal Cord Granulomas: Randomized Placebo-Controlled Trial|Withdrawn||Phase 3|0|Actual|Vanderbilt University||2||"The decision of terminate the study was reached due to difficulties surrounding recruitment~   and enrollment of subjects since the inception of the study."|f||||f||||||||||2017-02-18 15:01:12.264493|2017-02-18 15:01:12.264493
NCT00567645|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-05-12|||July 2007||2007-07-01|May 2016|2016-05-01||||||||Observational|PET-CRT||Sympathetic Innervation of the Heart and Cardiac Resynchronization Therapy(CRT)|Identification of the Role of Sympathetic Innervation in Heart Failure Patients Treated With Cardiac Resynchronization Therapy. A Pilot Study|Withdrawn||N/A|0|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-02-18 15:01:12.363294|2017-02-18 15:01:12.363294
NCT00567632|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-01-14|||October 2006||2006-10-01|October 2007|2007-10-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Observational|||Generation of Standard Laboratory Values for Pneumococci Antibodies|Generation of Standard Laboratory Values for Pneumococci Antibodies|Completed||N/A|500|Actual|Johann Wolfgang Goethe University Hospital|||1||f||||t||||||Samples Without DNA|"~     human serum~   "|||2017-02-18 15:01:12.440558|2017-02-18 15:01:12.440558
NCT00567619|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2008-02-14|||July 2007||2007-07-01|February 2008|2008-02-01||||||||Observational|||LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)|LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)|Completed||N/A|900||AstraZeneca|||||f||||||||||||||2017-02-18 15:01:12.528083|2017-02-18 15:01:12.528083
NCT00567606|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2010-01-12|||April 2002||2002-04-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Prevention of Osteoporosis in Breast Cancer Survivors|Prevention of Osteoporosis in Breast Cancer Survivors|Completed||Phase 4|249|Actual|University of Nebraska||2|||f||||t||||||||||2017-02-18 15:01:12.597348|2017-02-18 15:01:12.597348
NCT00567580|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-09-28|||February 2008||2008-02-01|September 2016|2016-09-01||||December 2020|Anticipated|2020-12-01||Interventional|||Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer|A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy|Active, not recruiting||Phase 3|1792|Actual|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-02-18 15:01:13.19958|2017-02-18 15:01:13.19958
NCT00567567|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2017-01-13|||November 2007||2007-11-01|January 2017|2017-01-01||||February 2015|Actual|2015-02-01||Interventional|||Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma|Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk Neuroblastoma|Active, not recruiting||Phase 3|665|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 15:01:13.884963|2017-02-18 15:01:13.884963
NCT00567554|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2016-02-09|||October 2007||2007-10-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|August 2011|Actual|2011-08-01||Interventional|GeparQuinto||Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer|A Phase III Trials Program Exploring the Integration of Bevacizumab, Everolimus (RAD001), and Lapatinib Into Current Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer|Completed||Phase 3|2600|Actual|German Breast Group||6|||f||||t||||||||||2017-02-18 15:01:14.438834|2017-02-18 15:01:14.438834
NCT00567541|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-03-02|2016-02-04||June 2007||2007-06-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|BBPM|fifteen of 16 subjects were randomized and their devices activated. One subject experienced and AE prior to device activation and was exited from the study|An Implantable Microneuromodulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke Subjects|Feasibility Study of the Bioness Battery-Powered Microneuromodulator (BBPM) to Treat Chronic Shoulder Pain in Chronic Post-Stroke Subjects|Completed||Phase 2|16|Actual|Bioness Inc|Further study plans terminated due to high migration/adverse event rates Small sample size Didn't include socio-environmental factors which could affect subject’s overall functionality Three different sites/subtle stimulator implantation variances|2|||f||||f||||||||No||2017-02-18 15:01:14.56253|2017-02-18 15:01:14.56253
NCT00567528|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2015-01-13|||May 2006||2006-05-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes|Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes|Terminated||N/A|60|Actual|Akron Children's Hospital||2||Study was not producing meaningful data.|f||||f||||||||||2017-02-18 15:01:14.971762|2017-02-18 15:01:14.971762
NCT00567515|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2013-02-12|||September 2007||2007-09-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Effectiveness of Left Atrial Appendage Occlusion||Completed||Phase 2|41|Actual|AtriCure, Inc.||1|||f||||t||||||||||2017-02-18 15:01:15.089463|2017-02-18 15:01:15.089463
NCT00567502|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2015-10-15|2015-03-25||May 2005||2005-05-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational||First Treatment Safety Population included all participants who received at least 1 dose of cytoreductive treatment. Data of 2 participants were missing in the Other (Cytoreductives) treatment arm.|Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments|A Non-Interventional, Post Authorisation Safety Study, to Continuously Monitor Safety and Pregnancy Outcomes in a Cohort of At-Risk Essential Thrombocythaemia (ET) Subjects Exposed to Xagrid Compared to Other Conventional Cytoreductive Treatments|Completed||N/A|3647|Actual|Shire|Results for other adverse events (excluding SAEs) was reported under OM 1 due to limitation in basic result’s format, as SAEs and non-SAEs were not planned to be reported separately.||3||f||||t||||||||||2017-02-18 15:01:15.202013|2017-02-18 15:01:15.202013
NCT00567489|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-08-01|||January 2008||2008-01-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|Impendia||IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients|Multi-Center, Prospective, Randomized Trial To Demonstrate Improved Metabolic Control of PEN VS Dianeal Only in Diabetic CAPD and APD Patients - The Impendia Trial|Completed||Phase 4|236|Anticipated|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-02-18 15:01:16.411084|2017-02-18 15:01:16.411084
NCT00567476|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-06-28|2011-04-26||November 2007||2007-11-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma|A Randomized, Open-label, Multicenter Study to Evaluate the Effect of Xolair (Omalizumab) as Add-on Therapy to Inhaled Corticosteroid + Long-Acting Beta Agonist in Fixed or Flexible Dosing Compared to Isolated Inhaled Corticosteroid + Long-Acting Beta Agonist in Fixed or Flexible Dosing in the Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma|Completed||Phase 4|116|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:01:16.705067|2017-02-18 15:01:16.705067
NCT00567463|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-02-10|||December 1998||1998-12-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|||||Interventional|EATA||Early Antiinflammatory Treatment of Asthma|Early Anti-inflammatory Treatment of Asymptomatic or Mildly Symptomatic Airway Hyperresponsiveness|Terminated||N/A|83|Actual|Laval University||1||Completed|f||||f||||||||||2017-02-18 15:01:17.340957|2017-02-18 15:01:17.340957
NCT00567450|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2009-01-27|||September 2007||2007-09-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Ropivacaine Versus Ropivacaine Plus Mepivacaine for Sciatic Block|Ropivacaine 0.75% vs Ropivacaine 0.75% Plus Mepivacaine 1.5% for Subgluteal Sciatic Bloc: a Prospective Double Blind Randomized Controlled Study|Completed||Phase 4|30|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-02-18 15:01:17.450818|2017-02-18 15:01:17.450818
NCT00567437|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2012-10-23|||December 2007||2007-12-01|November 2008|2008-11-01|December 2008|Actual|2008-12-01|||||Interventional|AS-BNP||Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis|Utility of Exercise-induced NT-pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis|Terminated||N/A|110|Anticipated|Duke University||2||Poor patient enrollment from clinic secondary to investigator illness.|f||||f||||||||||2017-02-18 15:01:17.559315|2017-02-18 15:01:17.559315
NCT00567424|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2013-04-01|||July 2006||2006-07-01|April 2013|2013-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures|An Open-label Evaluation of Drug Interactions, Safety, Tolerability and Efficacy of GW273225 Add-on Treatment of Partial Seizures, Whether or Not Secondarily Generalized|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||||No longer viable|||||||||||||||2017-02-18 15:01:17.666904|2017-02-18 15:01:17.666904
NCT00567411|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2007-12-04|||August 2006||2006-08-01|November 2007|2007-11-01|June 2009|Anticipated|2009-06-01|||||Interventional|||Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty|Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty|Unknown status|Recruiting|N/A|43|Anticipated|Walter Reed Army Medical Center||2|||f||||t||||||||||2017-02-18 15:01:17.787581|2017-02-18 15:01:17.787581
NCT00567398|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-04|2011-08-01|||April 2008||2008-04-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|Impendia||IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients|Multi-center,Prospective, Randomized Trial ToDemonstrate Improved Metabolic Control of PEN VS Dianeal In Diabetic CAPD and APD Patients - The Impendia Trial|Completed||Phase 3|236|Anticipated|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-02-18 15:01:17.905169|2017-02-18 15:01:17.905169
NCT00567385|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2012-06-28|||March 2003||2003-03-01|June 2012|2012-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Liquid Somatropin Formulation in Children With Growth Hormone Deficiency|An Open, Multi-centre Trial Evaluating Acceptance of the New Liquid Growth Hormone Formulation - Norditropin® SimpleXx® in Children With GH Deficiency|Completed||Phase 4|176|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:01:18.037027|2017-02-18 15:01:18.037027
NCT00567372|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2008-12-05|||June 2008||2008-06-01|December 2008|2008-12-01|June 2009|Anticipated|2009-06-01|November 2008|Anticipated|2008-11-01||Interventional|||POSTERIOR SUB-TENON'S Avastin|POSTERIOR SUB-TENON'S CAPSULE INJECTION OF BEVACIZUMAB FOR TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA|Unknown status|Recruiting|Phase 4|7|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||f||||||||||2017-02-18 15:01:18.139939|2017-02-18 15:01:18.139939
NCT00567359|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2017-01-27|||December 2007||2007-12-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR|A Phase II Trial of Adjuvant Erlotinib in Patients With Resected, Early Stage Non-Small Cell Lung Cancer (NSCLC) With Confirmed Mutations in the Epidermal Growth Factor Receptor (EGFR)|Active, not recruiting||Phase 2|100|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:01:18.230176|2017-02-18 15:01:18.230176
NCT00567346|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2010-05-04|||December 2006||2006-12-01|May 2010|2010-05-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Grass Pollen Sublingual Immunotherapy|A Randomised, DB, Plcb Controlled, Multicentre, Multinational Phase II/III Study to Assess the Efficacy and Safety of Three Different Dose Regimens of Oralgen Grass Pollen in Patients With Grass Pollen Related Allergic Rhinoconjunctivitis|Completed||Phase 2/Phase 3|605|Actual|Artu Biologicals||4|||f||||t||||||||||2017-02-18 15:01:18.349898|2017-02-18 15:01:18.349898
NCT00567333|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2015-05-09|||June 2007||2007-06-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional|||Individualized Chiropractic and Integrative Care for Low Back Pain|Individualized Chiropractic and Integrative Care for Low Back Pain|Completed||N/A|201|Actual|Northwestern Health Sciences University||2|||f||||t||||||||||2017-02-18 15:01:18.507195|2017-02-18 15:01:18.507195
NCT00567320|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2013-01-31|2012-02-08||March 2007||2007-03-01|January 2013|2013-01-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of Varenicline in Methadone-Stabilized Cocaine Users|Efficacy of Varenicline in Methadone-Stabilized Cocaine Users|Completed||N/A|31|Actual|Yale University||2|||f||||t||||||||||2017-02-18 15:01:18.618632|2017-02-18 15:01:18.618632
NCT00567307|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2016-10-24|2016-10-24||January 2009||2009-01-01|February 2009|2009-02-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Polypill For Prevention of Cardiovascular Disease|The Feasibility of a Polypill Clinical Trial for Primary Prevention of Cardiovascular Disease: A Pilot Study|Completed||Phase 2|216|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 15:01:18.938635|2017-02-18 15:01:18.938635
NCT00567294|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2012-05-14|||November 2007||2007-11-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|December 2009|Actual|2009-12-01||Interventional|||Evaluating Ways to Improve Medication Use Among People With Osteoporosis|Improving Medication Adherence for Osteoporosis: A Community-Based Randomized Controlled Trial|Completed||Phase 3|2087|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-02-18 15:01:19.270039|2017-02-18 15:01:19.270039
NCT00567281|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-08-23|||October 2007||2007-10-01|August 2016|2016-08-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations|Bilateral rTMS Clinical Trial for Persistent Auditory Hallucinations|Recruiting||Phase 2|40|Anticipated|Yale University||3|||f||||t||||||||||2017-02-18 15:01:19.377874|2017-02-18 15:01:19.377874
NCT00567268|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2015-09-30|2015-04-23||August 2007||2007-08-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||"In total, 1194 participants were enrolled in the study. Of the 1194 participants, a total of 50 participants were excluded from the baseline analysis for the following reasons: protocol violation, lost to follow-up, no visit after first day of treatment, no drug administration, and safety evaluation Not Assessable."|Drug Use Investigation Of Gabapentin|Drug Use Investigation Of Gabapen|Completed||Phase 4|1273|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:01:19.501354|2017-02-18 15:01:19.501354
NCT00567255|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2014-11-18|2014-10-08||December 2007||2007-12-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||All randomized subjects|A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects|A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Naltrexone Sustained Release (SR)/Bupropion Sustained Release (SR) and Placebo in Obese Subjects|Completed||Phase 3|1496|Actual|Orexigen Therapeutics, Inc||2|||f||||t||||||||||2017-02-18 15:01:20.325714|2017-02-18 15:01:20.325714
NCT00567242|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2012-04-30|2012-03-06||March 2007||2007-03-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Treating Intention In Aphasia: Neuroplastic Substrates|Treating Intention In Aphasia: Neuroplastic Substrates|Completed||Phase 1/Phase 2|14|Actual|University of Florida|"Patients who had aphasia were enrolled. Groups were equated for anomia severity, but not type of aphasia. Aphasia types were not evenly distributed between groups which may affect results.~Intention subjects were older than Control Subjects."|2|||f||||t||||||||||2017-02-18 15:01:21.772906|2017-02-18 15:01:21.772906
NCT00567229|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-01|2015-10-19|2015-10-19||November 2007||2007-11-01|October 2015|2015-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma|Phase II Study of Lenalidomide and Rituximab for Patients With Relapsed and/or Refractory CD20+ Multiple Myeloma|Terminated||Phase 2|3|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of Accrual|f||||||||||||||2017-02-18 15:01:22.238893|2017-02-18 15:01:22.238893
NCT00567216|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-02|2010-06-06|||April 2007||2007-04-01|June 2010|2010-06-01|July 2010|Anticipated|2010-07-01|||||Interventional|GVO-nadolol||Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding|A Randomized Tril of Endoscopic Cyanoacrylate Obliteration vs. Nadolol|Unknown status|Recruiting|Phase 4|120|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-02-18 15:01:22.471998|2017-02-18 15:01:22.471998
NCT00567203|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2008-10-01|||November 2007||2007-11-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia|A Phase 1B Inpatient, Randomized, Double-Blind, Placebo-Controlled, Crossover Study Of The Safety And Efficacy Of Two Fixed Doses Of PF-3463275 In Adjunctive Treatment Of Cognitive Deficits In Schizophrenia|Completed||Phase 1|36|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 15:01:22.569615|2017-02-18 15:01:22.569615
NCT00567190|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-04-06|2012-08-14||February 2008||2008-02-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|May 2011|Actual|2011-05-01||Interventional|CLEOPATRA|ITT population|A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer (CLEOPATRA)|A Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer|Active, not recruiting||Phase 3|808|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:01:22.678657|2017-02-18 15:01:22.678657
NCT00567177|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2010-07-29|||November 2007||2007-11-01|July 2010|2010-07-01|April 2008|Actual|2008-04-01|||||Interventional|||Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease|Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease|Completed||Phase 4|40|Anticipated|Innovative Medical||2|||f||||||||||||||2017-02-18 15:01:23.825159|2017-02-18 15:01:23.825159
NCT00567164|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2014-01-28|2013-10-07||October 2007||2007-10-01|January 2014|2014-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ|A Multicenter, Open-label, Three-arm, Active-controlled Study to Assess the Efficacy and Safety of the Oral Contraceptive SH T00186D (0.02 mg Ethinyl Estradiol as Betadex Clathrate and 3 mg Drospirenone) in Two Flexible Extended Regimens and a Conventional Regimen of YAZ in 1756 Healthy Females for 1 Year|Completed||Phase 3|1887|Actual|Bayer|The Flexible (extended) Regimen no. 1 Group was enrolled under slightly different eligibility criteria for age, BMI, and fertility status than the other two treatment groups. This did not affect the results or interpretation of the results.|3|||f||||f||||||||||2017-02-18 15:01:23.934136|2017-02-18 15:01:23.934136
NCT00567151|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-02|2009-06-20|||December 2007||2007-12-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Co-Infection of NTM in Patients With Smear Positive Pulmonary TB|Detection of Nontuberculous Mycobacterial co-Infection Using Duplex PCR for Mycobacterial Hsp 65 Gene and Its Clinical Significance in Patients With Smear Positive Pulmonary Tuberculosis|Completed||N/A|200|Anticipated|Seoul National University Hospital|||1||f||||f||||||Samples Without DNA|"~     Sputa with positive AFB smear~   "|||2017-02-18 15:01:27.544343|2017-02-18 15:01:27.544343
NCT00567125|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-01|2007-12-03|||January 2006||2006-01-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Observational|||Comparison of Systemic Response After Laparoscopies Performed With Standard and Low-Pressure Pneumoperitoneum|A Comparative Study of Angiogenic and Cytokine Responses After Laparoscopic Cholecystectomy Performed With Standard-Pressure and Low-Pressure Pneumoperitoneum|Completed||N/A|40|Actual|Medical University of Lublin|||2||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 15:01:27.617616|2017-02-18 15:01:27.617616
NCT00567112|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2015-03-12|2012-07-17||November 2007||2007-11-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)|An Open-Label, Randomized, Partially Fixed-Sequence, 4-Period Crossover Study to Assess the Pharmacokinetics After Administration of the DFC and OCT Formulations and the Food Effect on the OCT Formulation of MK-0941 in Patients With Type 2 Diabetes|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:01:27.713652|2017-02-18 15:01:27.713652
NCT00567099|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2010-05-24|||August 2003||2003-08-01|December 2007|2007-12-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole|Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole|Unknown status|Recruiting|N/A|20|Anticipated|New Mexico VA Healthcare System||1|||f||||t||||||||||2017-02-18 15:01:28.252278|2017-02-18 15:01:28.252278
NCT00567086|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2007-12-03|||October 2006||2006-10-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine|A Double-Blind, Placebo-Controlled, Parallel Group Multicenter Study to Assess the Safety, Tolerance and Efficacy of a Single Subcutaneous Dose of TEZAMPANEL in Patients With Acute Migraine|Completed||Phase 2|306|Actual|TorreyPines Therapeutics||4|||f||||f||||||||||2017-02-18 15:01:28.524755|2017-02-18 15:01:28.524755
NCT00567073|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-01|2016-04-29|||November 2011||2011-11-01|April 2016|2016-04-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|||Pompe Pregnancy Sub-Registry|A Sub-Registry to Observe the Effect of Myozyme (Alglucosidase Alfa) Treatment on Pregnancy and Infant Growth in Women With Pompe Disease|Recruiting||Phase 4|20|Anticipated|Sanofi|||4||f||||f||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 15:01:28.639078|2017-02-18 15:01:28.639078
NCT00567060|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2013-12-13|||May 2000||2000-05-01|September 2009|2009-09-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)|A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of 9600 and 4800 mg/Day Piracetam Taken for 12 Months by Subjects Suffering From Mild Cognitive Impairment (MCI)|Completed||N/A|676|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:01:28.75315|2017-02-18 15:01:28.75315
NCT00567047|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2009-03-24|||July 2007||2007-07-01|March 2009|2009-03-01||||January 2009|Actual|2009-01-01||Interventional|||Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment|An Open-Label, Parallel-Group Study to Determine the Single and Multiple Dose Pharmacokinetics of Vildagliptin and Its Metabolites in Mild, Moderate or Severe Renal Impaired Patients Compared to Age, Sex and Weight-Matched Healthy Volunteers Following Daily Doses of 50 mg Vildagliptin for 14 Days|Completed||Phase 1|96|Anticipated|Novartis||1|||f||||f||||||||||2017-02-18 15:01:28.835761|2017-02-18 15:01:28.835761
NCT00567034|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2013-10-24|||December 2006||2006-12-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|Zyprexa||Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects|Augmenting Zyprexa With Naltrexone: Normalization of the Weight Gain Side Effect and the CNS Reward and Sensory Function|Completed||Phase 1|30|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 15:01:28.95372|2017-02-18 15:01:28.95372
NCT00567021|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2008-01-28|||September 2005||2005-09-01|January 2008|2008-01-01|December 2005|Actual|2005-12-01|||||Observational|||German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms|German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms|Completed||N/A|67130|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:01:29.061728|2017-02-18 15:01:29.061728
NCT00567008|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2013-10-14|2013-07-17||December 2007||2007-12-01|October 2013|2013-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Chantix for Treating Cocaine Dependence|A Double-Blind Placebo-Controlled Pilot Trial of Varenicline (Chantix) for the Treatment of Cocaine Dependence|Completed||Phase 2|37|Actual|University of Pennsylvania|This study was a small preliminary trial, and thus was underpowered for anything less than large effects.|2|||f||||t||||||||||2017-02-18 15:01:29.155507|2017-02-18 15:01:29.155507
NCT00566995|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-01|2015-03-19|2015-02-12||November 2007||2007-11-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|June 2014|Actual|2014-06-01||Interventional|||Phase II Study of Vandetanib in Individuals With Kidney Cancer|A Phase 2 Study of ZD6474 (Vandetanib) in Patients With Von Hippel Lindau Disease and Renal Tumors|Completed||Phase 2|37|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 15:01:29.542194|2017-02-18 15:01:29.542194
NCT00566982|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2013-05-21|2013-03-19||October 2007||2007-10-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Clinical Study to Evaluate the Safety of Ospemifene|Efficacy and Long-Term Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women: A 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing 60 MG Oral Daily Dose of Ospemifene With Placebo|Completed||Phase 3|426|Actual|Shionogi Inc.||2|||f||||||||||||||2017-02-18 15:01:29.985217|2017-02-18 15:01:29.985217
NCT00566969|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2016-08-16|2016-08-16||September 2007||2007-09-01|August 2016|2016-08-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|Carvedilol|106 subjects meeting inclusion criteria who were without exclusions and randomized to an intervention.|Cocaine Withdrawal and Pharmacotherapy Response|Cocaine Withdrawal and Pharmacotherapy Response|Completed||N/A|106|Actual|Yale University||3|||f||||t||||||||No||2017-02-18 15:01:31.055234|2017-02-18 15:01:31.055234
NCT00566956|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2015-07-20|||October 1999||1999-10-01|November 2007|2007-11-01|June 2004|Actual|2004-06-01|||||Interventional|||Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection|Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection Improves Pregnancy Outcome in In-vitro Fertilization: a Randomised Controlled Trial|Terminated||Phase 2|66|Actual|Birmingham Women's NHS Foundation Trust||2||The study was terminated because it is very difficult to recruit more patients.|f||||t||||||||||2017-02-18 15:01:31.641984|2017-02-18 15:01:31.641984
NCT00566943|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2012-05-23|2009-12-18||March 2006||2006-03-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|RESULTS||Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix|Synovis Life Technologies, Inc., Peri-Strips Dry With Veritas Collagen Matrix Staple Line Reinforcement. The RESULTS Trial|Completed||Phase 4|101|Actual|Synovis Surgical Innovations||2|||f||||f||||||||||2017-02-18 15:01:31.755459|2017-02-18 15:01:31.755459
NCT00566930|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2012-09-13|2012-06-12||October 2007||2007-10-01|September 2012|2012-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Preventive Care of Chronic Cervical Pain and Disabilities|Preventive Care of Chronic Cervical Pain and Disabilities; Comparison of Spinal Manipulative Therapy and Individualized Home Exercise Programs|Completed||N/A|117|Actual|Université du Québec à Trois-Rivières||3|||f||||t||||||||||2017-02-18 15:01:32.180149|2017-02-18 15:01:32.180149
NCT00566917|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2010-01-28|||December 2007||2007-12-01|May 2008|2008-05-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Comparison Between Transvaginal Mesh and Traditional Surgery for Pelvic Organ Prolapse|A Randomised Controlled Trial of Transvaginal Mesh (PROLIFT) Versus Anterior Colporrhaphy in Anterior Vaginal Wall Prolapse|Completed||Phase 4|400|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 15:01:32.639547|2017-02-18 15:01:32.639547
NCT00566904|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2011-08-29|||September 2006||2006-09-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||New Topical Treatment for Continued Pain After Shingles|Phase 1 Novel Topical Treatment for Post-herpetic Neuralgia|Completed||Phase 1|30|Actual|Biomedical Development Corporation||1|||f||||t||||||||||2017-02-18 15:01:32.800596|2017-02-18 15:01:32.800596
NCT00566891|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2011-02-01|||December 2007||2007-12-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|SANTISS||Safety of High-dose Tirofiban During Coronary Angioplasty|Safety of High-dose Tirofiban in Patient Undergoing Coronary Angioplasty.|Completed||Phase 4|2000|Actual|S. Anna Hospital||2|||f||||t||||||||||2017-02-18 15:01:32.917866|2017-02-18 15:01:32.917866
NCT00566878|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-01|2016-10-20|||March 2012||2012-03-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|November 2021|Anticipated|2021-11-01||Observational|||Pompe Lactation Sub-Registry|A Sub-Registry to Determine the Presence of Alglucosidase Alfa in Breast Milk From Women With Pompe Disease Treated With Alglucosidase Alfa.|Recruiting||Phase 4|5|Anticipated|Sanofi|||1||f||||f||||||||||2017-02-18 15:01:33.027302|2017-02-18 15:01:33.027302
NCT00566865|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2009-02-16|||November 2007||2007-11-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil|A Double-Blind, Placebo-Controlled Study to Assess the Effect of Gemfibrozil Co-Administration on the Pharmacokinetics and Pharmacodynamics of Mitiglinide in Healthy Volunteers|Completed||Phase 1|14|Actual|Elixir Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:01:33.140278|2017-02-18 15:01:33.140278
NCT00566852|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-01|2015-03-26|||March 2008||2008-03-01|March 2015|2015-03-01||||November 2011|Actual|2011-11-01||Interventional|||Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors|A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy|Active, not recruiting||Phase 3|554|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 15:01:33.254416|2017-02-18 15:01:33.254416
NCT00566839|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2007-11-30|||December 2002||2002-12-01|October 2007|2007-10-01|October 2005|Actual|2005-10-01|||||Interventional|||Randomized Comparison of Awake Nonresectional Versus Nonawake Resectional Lung Volume Reduction Surgery|Randomized Comparison of Thoracoscopic Lung Volume Reduction Surgery Performed by Resectional Surgical Technique Under General Anesthesia or by a Non-Resectional Technique in Awake Patients Under Sole Epidural Anesthesia|Completed||Phase 2|60|Actual|University of Rome Tor Vergata||2|||f||||t||||||||||2017-02-18 15:01:33.807866|2017-02-18 15:01:33.807866
NCT00566826|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2013-02-24|||June 2008||2008-06-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Perioperative Intervention to Improve Post-TKR Support and Function|Perioperative Intervention to Improve Post-TKR Support and Function|Completed||Phase 2|196|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 15:01:33.924705|2017-02-18 15:01:33.924705
NCT00566813|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2011-08-05|||November 2004||2004-11-01|October 2007|2007-10-01|December 2013|Anticipated|2013-12-01|December 2008|Actual|2008-12-01||Interventional|||Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression|Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression|Unknown status|Active, not recruiting|Phase 1/Phase 2|10|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-02-18 15:01:34.030868|2017-02-18 15:01:34.030868
NCT00566800|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-01|2013-09-16|||July 2007||2007-07-01|January 2008|2008-01-01||||||||Interventional|||Erlotinib in Treating Patients With Barrett Esophagus|Chemoprevention Trial Using Erlotinib in Barrett's Esophagus With High-Grade Dysplasia|Unknown status|Recruiting|Phase 1|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:01:34.150094|2017-02-18 15:01:34.150094
NCT00566787|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2012-01-23|||January 2005||2005-01-01|January 2012|2012-01-01|November 2010|Actual|2010-11-01|December 2007|Actual|2007-12-01||Interventional|RESTORE SR||Concomitant Treatment of Permanent Atrial Fibrillation|A Prospective, Multi-center Study With Case Matched Controls to Evaluate the Safety and Efficacy of the AtriCure Bipolar System for the Treatment of Continuous Atrial Fibrillation as Adjunct Therapy to Elective Open Heart Surgery|Completed||Phase 3|39|Actual|AtriCure, Inc.||1|||f||||||||||||||2017-02-18 15:01:34.248791|2017-02-18 15:01:34.248791
NCT00566774|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2016-01-07|||November 2007||2007-11-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|MI FREEE||A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies|Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial: a Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies|Completed||Phase 4|5860|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 15:01:34.344879|2017-02-18 15:01:34.344879
NCT00566761|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2007-11-30|||June 2007||2007-06-01|November 2007|2007-11-01|March 2008|Anticipated|2008-03-01|||||Interventional|MECROV||Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO|Combined Treatment of Intravitreous Bevacizumab and Triamcinolone for the Treatment or Macular Edema Secondary to Central Retinal Vein Occlusion|Unknown status|Recruiting|Phase 4|10|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||t||||||||||2017-02-18 15:01:34.466866|2017-02-18 15:01:34.466866
NCT00566735|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-03|2012-11-02|2012-06-05||July 2004||2004-07-01|November 2012|2012-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|Galantamine||The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning|The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning|Completed||Phase 3|39|Actual|Massachusetts General Hospital|The limitations of this study include a small sample size, absence of an optimal galantamine dose determination, and the inclusion of a heterogenous population including MDD, bipolar disorder, and schizoaffective order.|2|||f||||f||||||||||2017-02-18 15:01:34.579446|2017-02-18 15:01:34.579446
NCT00566722|ClinicalTrials.gov processed this data on February 17, 2017|2007-12-01|2011-04-08|2010-04-28||January 2008||2008-01-01|April 2011|2011-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy|Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy|Completed||Phase 3|152|Actual|Abbott||1|||f||||f||||||||||2017-02-18 15:01:35.098581|2017-02-18 15:01:35.098581
NCT00566709|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-03-21|2015-11-20||June 2009||2009-06-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional||"Patient included into to Intention to treat analysis"|Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients|Phase II Study of Usefulness of Near Infrared Spectroscopy to Optimize Red Blood Cells Transfusion in Neuro Critical Ill Patients With Severe Traumatic Brain Injury, Subarachnoid Hemorrhage or Intracerebral Hemorrhage.|Completed||Phase 2|102|Actual|Hospitales Universitarios Virgen del Rocío|Limited adherence to the protocol in the rSO2 arm|2|||f||||t||||||||||2017-02-18 15:01:36.160811|2017-02-18 15:01:36.160811
NCT00566696|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-05-03|2016-01-27||November 2007||2007-11-01|March 2016|2016-03-01|January 2017|Anticipated|2017-01-01|January 2015|Actual|2015-01-01||Interventional|||Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies|A Reduced Intensity Conditioning Regimen With CD3-Depleted Hematopoietic Stem Cells to Improve Survival for Patients With Hematologic Malignancies Undergoing Haploidentical Stem Cell Transplantation|Active, not recruiting||Phase 2|73|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 15:01:36.861119|2017-02-18 15:01:36.861119
NCT00566683|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2007-11-30|||July 2005||2005-07-01|November 2007|2007-11-01|June 2006|Actual|2006-06-01|||||Interventional|||Comparison Between Nurse-Administered Propofol Sedation and Diazemuls / Pethidine in Outpatient Colonoscopy|Nurse-Administered Propofol Sedation by PCA Pump Versus Diazemuls / Pethidine in Outpatient Colonoscopy: A Randomized Controlled Study|Completed||N/A|194|Actual|North District Hospital||2|||f||||f||||||||||2017-02-18 15:01:37.471632|2017-02-18 15:01:37.471632
NCT00566501|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2014-06-26|2012-05-16||December 2007||2007-12-01|May 2012|2012-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease|Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease|Completed||Phase 3|915|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 15:01:39.811565|2017-02-18 15:01:39.811565
NCT00566670|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-08-09|||September 2007||2007-09-01|August 2016|2016-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease|Protein Intake, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease (CKD)|Completed||N/A|145|Actual|University of Utah|||1||f||||t||||||Samples With DNA|"~     30 ml of blood drawn four times (months 1, 6, 12 and 18) for plasma/serum/DNA samples.~      Urine Collection: If patients are making more than ½ cup (200 ml) of urine a day.~   "|||2017-02-18 15:01:37.569679|2017-02-18 15:01:37.569679
NCT00566657|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2016-03-30||2016-03-30|November 2007||2007-11-01|March 2016|2016-03-01|August 2012|Actual|2012-08-01|August 2010|Actual|2010-08-01||Interventional|TAMARIS||Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions|A Randomized Double-Blind Placebo-Controlled Parallel Group Study of the Efficacy and Safety of XRP0038/NV1FGF on Amputation or Any Death in Critical Limb Ischemia Patients With Skin Lesions|Completed||Phase 3|525|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:01:37.666627|2017-02-18 15:01:37.666627
NCT00566644|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2013-07-09|||July 2007||2007-07-01|October 2008|2008-10-01|August 2009|Actual|2009-08-01|October 2008|Actual|2008-10-01||Interventional|||Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome|Prevention of Endometrial Tumors (POET)|Terminated||Phase 3|600|Anticipated|National Cancer Institute (NCI)||||Withdrawn due to poor accrual|f||||||||||||||2017-02-18 15:01:37.819448|2017-02-18 15:01:37.819448
NCT00566631|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2013-06-27|2013-04-03||July 2007||2007-07-01|June 2013|2013-06-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|PERTAIN||An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia|Tolerability, Safety and Treatment Response of Flexible Doses of Paliperidone ER in Acutely Exacerbated Subjects With Schizophrenia|Completed||Phase 3|294|Actual|Janssen-Cilag International NV||1|||f||||f||||||||||2017-02-18 15:01:37.942087|2017-02-18 15:01:37.942087
NCT00566618|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-12-08|||November 2007||2007-11-01|December 2016|2016-12-01||||March 2018|Anticipated|2018-03-01||Interventional|||Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis|Phase I/II Study of Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis|Active, not recruiting||Phase 1/Phase 2|28|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:01:38.481119|2017-02-18 15:01:38.481119
NCT00566605|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2007-11-30|||August 2007||2007-08-01|November 2007|2007-11-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Outcomes in a Comparison of Manual Penetrating Keratoplasty and the IntraLase® Enabled Keratoplasty|Visual Outcomes in a Comparison of Manual Penetrating Keratoplasty and the IntraLase® Enabled Keratoplasty|Unknown status|Active, not recruiting|Phase 1|60|Actual|Hospital Oftalmologico de Sorocaba||2|||f||||t||||||||||2017-02-18 15:01:38.608988|2017-02-18 15:01:38.608988
NCT00566592|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2014-09-23|||January 2005||2005-01-01|September 2014|2014-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||The Effect of Ethanol on Overnight Glucose Regulation in Type 2|The Effect of Ethanol on Overnight Glucose Regulation in Type 2 Diabetes Mellitus|Completed||N/A|24|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||f||||||||||2017-02-18 15:01:38.701768|2017-02-18 15:01:38.701768
NCT00566579|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2010-08-02|2010-06-01||December 2007||2007-12-01|December 2007|2007-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|Cryotherapy||Cryotherapy for Human Papillomavirus Clearance in Biopsy-confirmed Cervical Low-grade Squamous Intraepithelial Lesions|Cryotherapy for Human Papillomavirus Clearance in Biopsy-confirmed Cervical Low-grade Squamous Intraepithelial Lesions: a Randomized Controlled Trial|Terminated||N/A|100|Actual|Khon Kaen University||2||Lack of additional funding|f||||f||||||||||2017-02-18 15:01:38.803756|2017-02-18 15:01:38.803756
NCT00566566|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2007-11-30|||January 2008||2008-01-01|November 2007|2007-11-01|December 2008|Anticipated|2008-12-01|||||Observational|||Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors|Adipocytokines as Predictors of the Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia|Unknown status|Not yet recruiting|N/A|150|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples Without DNA|"~     Serum leptin, resistin ,adiponectin ,CRP, PAI ,TNF-α, IL-6 will be taken as part of initial~     blood test screening in patients following an overnight fast. Adiponectin and leptin levels~     will be determined by RIA (Linco, St. Charles, MO), Insulin, will be determined by~     chemiluminescent immunometric method (Immulite 2000, Diagnostic Products Corporation, Los~     Angeles, CA).~   "|||2017-02-18 15:01:39.196498|2017-02-18 15:01:39.196498
NCT00566553|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2012-01-04|||February 2008||2008-02-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women|The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women: A Pilot Study|Completed||N/A|39|Actual|Mayo Clinic||4|||f||||f||||||||||2017-02-18 15:01:39.288762|2017-02-18 15:01:39.288762
NCT00566540|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2016-10-20|||December 2007||2007-12-01|October 2016|2016-10-01||||February 2010|Actual|2010-02-01||Interventional|||Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer|Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Hypopharynx: Incorporation of Intensity Modulated Radiotherapy and Submandibular Gland Transfer to Minimize Treatment Morbidity; Correlative Imaging/Molecular Markers.|Active, not recruiting||Phase 2|50|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:01:39.416335|2017-02-18 15:01:39.416335
NCT00566527|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2009-04-03|||November 2007||2007-11-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparative Study of Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHA|An Open-Label, Randomised, Comparative, Multi-Centre Study of the Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHA Administered to Healthy Children From 9 Months of Age|Completed||Phase 3|1260|Anticipated|MCM Vaccines B.V.||3|||f||||f||||||||||2017-02-18 15:01:39.555097|2017-02-18 15:01:39.555097
NCT00566514|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2008-03-10|||July 2006||2006-07-01|March 2008|2008-03-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||The Role of Ribose in Patients Diagnosed With Fibromyalgia|The Role of D-RIbose in Patients Diagnosed With Fibromyalgia|Suspended||N/A|200|Anticipated|Bioenergy Life Science, Inc.||2||Protocol Under Review|f||||f||||||||||2017-02-18 15:01:39.694524|2017-02-18 15:01:39.694524
NCT00408941|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2006-12-07|||December 2006||2006-12-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||EEG and Auditory Evoked Potentials During Local Anesthesia|EEG and Auditory Evoked Potentials During Local Anesthesia|Unknown status|Not yet recruiting|Phase 4|15||Technische Universität München|||||f||||||||||||||2017-02-18 16:02:42.880641|2017-02-18 16:02:42.880641
NCT00566488|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2016-09-23|||January 2005||2005-01-01|September 2016|2016-09-01|June 2027|Anticipated|2027-06-01|August 2007|Actual|2007-08-01||Interventional|||Parathyroid and Thymus Transplantation in DiGeorge #931|Parathyroid and Thymus Transplantation in DiGeorge Syndrome, #931|Active, not recruiting||Phase 1|25|Actual|Duke University||1|||f||||t||||||||||2017-02-18 15:01:40.837151|2017-02-18 15:01:40.837151
NCT00566475|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2009-12-29|||January 2007||2007-01-01|December 2009|2009-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||School Centered Telemedicine Program for Children With Type 1 Diabetes Mellitus|School Centered Telemedicine Program for Children With Type 1 Diabetes Mellitus|Completed||N/A|41|Actual|State University of New York - Upstate Medical University||2|||f||||f||||||||||2017-02-18 15:01:40.981866|2017-02-18 15:01:40.981866
NCT00566462|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2012-11-20|2012-11-20||October 2007||2007-10-01|November 2012|2012-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT|Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT|Terminated||Phase 2|1|Actual|Eisai Inc.|This study was terminated at the sponsor request after only 1 subject was enrolled and completed the study and therefore the data is limited. Similiar research in this area have required a minimum of 5-6 completers to develop a valid analysis.|2||Study stopped due to lack of efficacy.|f||||||||||||||2017-02-18 15:01:41.094063|2017-02-18 15:01:41.094063
NCT00566449|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2014-04-24||2011-06-02|December 2007||2007-12-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.|A Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Investigate the Safety and Efficacy of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 2|32|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 15:01:41.344964|2017-02-18 15:01:41.344964
NCT00566436|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2007-11-29|||October 2004||2004-10-01|November 2007|2007-11-01|March 2012|Anticipated|2012-03-01|||||Interventional|REVAS||Remote Endarterectomy Versus Suprageniculate Femoropopliteal Bypass|The Surgical Treatment of Long Occlusions of the Superficial Femoral Artery: Initial Success and Long Term Results of Remote Endarterectomy Versus Suprageniculate Bypass Surgery|Unknown status|Active, not recruiting|N/A|126|Actual|St. Antonius Hospital||2|||f||||f||||||||||2017-02-18 15:01:41.48329|2017-02-18 15:01:41.48329
NCT00566423|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2011-06-22|||May 2007||2007-05-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|May 2008|Actual|2008-05-01||Interventional|Biomarkers||Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)|Biomarkers in the Diagnosis and Assessment of PAH|Completed||N/A|75|Actual|Northwell Health||1|||f||||f||||||||||2017-02-18 15:01:41.614409|2017-02-18 15:01:41.614409
NCT00566410|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-03-10|||December 2007||2007-12-01|March 2016|2016-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|DCA||A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours|A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours|Completed||Phase 1|23|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 15:01:41.808397|2017-02-18 15:01:41.808397
NCT00566397|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2013-03-19||2013-03-19|December 2007||2007-12-01|March 2013|2013-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease|A Double Blind, Placebo Controlled, Randomized, Multicenter Study Evaluating The Efficacy And Safety Of Eighteen Months Of Treatment With PF 04494700 (TTP488) In Participants With Mild To Moderate Alzheimer's Disease|Completed||Phase 2|402|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 15:01:41.908088|2017-02-18 15:01:41.908088
NCT00566384|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2014-11-30|||November 2007||2007-11-01|November 2014|2014-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido|Multi-center, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Daily Oral 100 mg Dehydroepiandrosterone (DHEA) Over 6 Treatment Cycles as a Concomitant Therapy to Oral Contraceptives (OC) to Alleviate Complaints of Reduced Libido in Women With Acquired Female Sexual Dysfunction (FSD) Associated With OC-use|Completed||Phase 2|100|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:01:42.073354|2017-02-18 15:01:42.073354
NCT00566371|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2010-08-13|||June 2005||2005-06-01|November 2007|2007-11-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents|The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia|Completed||Phase 4|36|Anticipated|Rhode Island Hospital||2|||f||||f||||||||||2017-02-18 15:01:42.184998|2017-02-18 15:01:42.184998
NCT00566358|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2010-07-20|||January 2006||2006-01-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion|Lightening the Hormonal Mechanisms of Surgical Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Surgery|Completed||Phase 1/Phase 2|18|Actual|University of Campinas, Brazil||1|||f||||f||||||||||2017-02-18 15:01:42.28396|2017-02-18 15:01:42.28396
NCT00566345|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2009-07-21||2009-07-21|November 2007||2007-11-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)|Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine (VCIV) to Prevent Culture Confirmed Influenza Infection (CCII)|Completed||Phase 3|3670|Actual|Baxter Healthcare Corporation||2|||f||||t||||||||||2017-02-18 15:01:42.402367|2017-02-18 15:01:42.402367
NCT00566332|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2015-08-18|||June 2001||2001-06-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|September 2009|Actual|2009-09-01||Interventional|||Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia|Randomized Trial Comparing the Efficacy of Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia,Lymphoplasmacytic Lymphoma or Splenic Marginal Zone Lymphoma|Completed||Phase 3|414|Actual|French Study Group on Chronic Lymphoid Leukemia||2|||f||||t||||||||||2017-02-18 15:01:42.534664|2017-02-18 15:01:42.534664
NCT00563225|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-23|||October 2002||2002-10-01|November 2007|2007-11-01|April 2004|Actual|2004-04-01|||||Interventional|||20 Week Bridging Study in Type II DM|A Multicenter, Non-Comparative, Open, Phase III Study to Evaluate the Efficacy and Safety of Insulin Glargine on Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|90|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:02:51.803701|2017-02-18 15:02:51.803701
NCT00566319|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2008-11-25|||October 2006||2006-10-01|November 2007|2007-11-01|April 2008|Actual|2008-04-01|||||Interventional|PREPARE||Can Structured Education Promote Physical Activity in Those Identified With an Increased Risk of Developing Diabetes|A Randomised Controlled Trial to Investigate the Effect of a Structured Educational Programme on Physical Activity Levels and Glucose Tolerance in People With Impaired Glucose Tolerance|Completed||N/A|103|Actual|University Hospitals, Leicester||2|||f||||t||||||||||2017-02-18 15:01:42.638954|2017-02-18 15:01:42.638954
NCT00566306|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2008-08-25|||February 2007||2007-02-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation|Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation|Completed||N/A|200|Anticipated|Helsinki University||2|||f||||f||||||||||2017-02-18 15:01:42.785382|2017-02-18 15:01:42.785382
NCT00566280|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2012-01-04|||October 2006||2006-10-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Molecular Breast Imaging in Patients With a History of Bloody Nipple Discharge|Molecular Breast Imaging: Evaluation of a New Technique Using Scintimammography as an Additional Diagnostic Tool for Women Presenting With a History of Bloody Nipple Discharge and Negative Routine Imaging Studies - A Pilot Study|Completed||N/A|14|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 15:01:42.883835|2017-02-18 15:01:42.883835
NCT00566267|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2007-11-30|||April 2006||2006-04-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|LOCUST||A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet|A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet|Completed||Phase 2/Phase 3|58|Actual|Corporal Michael J. Crescenz VA Medical Center||1|||f||||f||||||||||2017-02-18 15:01:42.99602|2017-02-18 15:01:42.99602
NCT00566254|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2013-05-09|2012-11-12||December 2008||2008-12-01|February 2013|2013-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)|A Double-blind, Randomised, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures|Completed||Phase 3|207|Actual|Eisai Inc.||2|||f||||f||||||||||2017-02-18 15:01:43.098587|2017-02-18 15:01:43.098587
NCT00566241|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2013-01-25|||June 2008||2008-06-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||IGF-1 Therapy in Patients With Cystic Fibrosis|An Investigation Into the Use of IGF-1 Therapy in Patients With Cystic Fibrosis|Terminated||Phase 1|15|Actual|Stony Brook University||2||Insufficient recruitment|f||||t||||||||||2017-02-18 15:01:43.550402|2017-02-18 15:01:43.550402
NCT00566228|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2016-07-18|||December 2007||2007-12-01|April 2016|2016-04-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma|Randomized, Double-Blind Phase III Clinical Trial Comparing Outcomes of Immunologic Autograft Engineering Versus Standard Autograft Collection in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma|Completed||Phase 3|122|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 15:01:46.136485|2017-02-18 15:01:46.136485
NCT00566215|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2010-07-22|||July 2007||2007-07-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study|Clinical and Hormonal Study of a New Surgical Treatment of Type 2 Diabetes Mellitus: Duodenal Exclusion Associated With Omentectomy|Terminated||Phase 1/Phase 2|6|Actual|University of Campinas, Brazil||2||"Benefit of duodenal exclusion alone less than expected for treatment of type 2 diabetes; an~   additional effect of combination with omentectomy not observed"|f||||f||||||||||2017-02-18 15:01:46.26877|2017-02-18 15:01:46.26877
NCT00566202|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2014-08-01||2010-01-04|December 2007||2007-12-01|August 2014|2014-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression|A Phase IIa Multicenter, Randomized, Double-blind, Double-dummy, and Placebo- and Active Controlled Study to Investigate the Safety and Efficacy of JNJ-18038683 Administered to Subjects With Major Depressive Disorder|Completed||Phase 2|67|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||||||||||||2017-02-18 15:01:46.609552|2017-02-18 15:01:46.609552
NCT00566189|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2013-03-07|||August 2007||2007-08-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|August 2011|Actual|2011-08-01||Interventional|||New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I|New Frontiers on Bariatric Surgical Procedures. Classical Bypass for Type 2 Diabetic Patients With BMI Between 30 and 34.9 kg/m2|Completed||Phase 2/Phase 3|36|Actual|University of Campinas, Brazil||1|||f||||f||||||||||2017-02-18 15:01:46.740524|2017-02-18 15:01:46.740524
NCT00566176|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2013-02-04|||October 2005||2005-10-01|February 2013|2013-02-01|February 2017|Anticipated|2017-02-01|December 2007|Actual|2007-12-01||Interventional|RESTORE SR II||Sole-Therapy Treatment of Atrial Fibrillation|Thoracoscopically-Assisted Epicardial Bilateral Pulmonary Vein Isolations Using the AtriCure Bipolar System and Exclusion of the Left Atrial Appendage for the Treatment of Atrial Fibrillation|Unknown status|Active, not recruiting|Phase 2|25|Actual|AtriCure, Inc.||1|||f||||||||||||||2017-02-18 15:01:46.866811|2017-02-18 15:01:46.866811
NCT00566150|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-08-23|2009-10-02||October 2005||2005-10-01|August 2016|2016-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Levetiracetam in the Management of Bipolar Depression|Levetiracetam in the Management of Bipolar Depression|Completed||N/A|35|Actual|Yale University||2|||f||||f||||||||||2017-02-18 15:01:46.964728|2017-02-18 15:01:46.964728
NCT00566137|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2010-03-08|||February 2006||2006-02-01|March 2010|2010-03-01|February 2007|Actual|2007-02-01|||||Observational|Scleroderma||Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient|Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient|Completed||N/A|50|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 15:01:47.697176|2017-02-18 15:01:47.697176
NCT00566124|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2007-11-30|||January 2005||2005-01-01|November 2007|2007-11-01|May 2005|Actual|2005-05-01|||||Interventional|||Basal Insulins - Pharmacodynamics|No Evidence for Essential Differences Between the Effects of Insulin Glargine, Insulin Detemir and NPH Insulin on Glucose Metabolism After a Single Injection as Assessed by 24-h Euglycemic Clamp Studies in Healthy Humans|Completed||Phase 4|10|Actual|University of Aarhus||3|||f||||f||||||||||2017-02-18 15:01:47.78152|2017-02-18 15:01:47.78152
NCT00566111|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-08-25|2016-08-25||September 2007||2007-09-01|August 2016|2016-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Ceftriaxone in the Management of Bipolar Depression|Modulation of Glutamatergic Neurotransmission in the Treatment of Bipolar Depression|Terminated||N/A|5|Actual|Yale University||2||Early indication of an unfavorable risk/benefit ratio.|f||||t||||||||||2017-02-18 15:01:47.905273|2017-02-18 15:01:47.905273
NCT00566098|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2015-10-30|||November 2007||2007-11-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Activated White Blood Cells in Treating Patients Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Stage II or Stage III Multiple Myeloma|Adoptive Immunotherapy Utilizing Activated Marrow Infiltrating Lymphocytes in the Autologous Transplant Setting in Multiple Myeloma|Completed||Phase 1/Phase 2|25|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 15:01:48.353875|2017-02-18 15:01:48.353875
NCT00566085|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2012-01-04|||January 2008||2008-01-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer|Molecular Breast Imaging: Evaluation of a New Technique Using Scintimammography as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer - A Pilot Study|Completed||N/A|20|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 15:01:48.457648|2017-02-18 15:01:48.457648
NCT00566072|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2007-12-04|||May 2001||2001-05-01|December 2007|2007-12-01|May 2003|Actual|2003-05-01|||||Interventional|||The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial|The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial|Completed||N/A|21|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 15:01:48.567319|2017-02-18 15:01:48.567319
NCT00566059|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-30|2007-11-30|||May 2006||2006-05-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Observational|CARDUCCI||Computed Tomographic Angiography or Conventional Coronary Angiography in Clinical Decision Making|Comparison Between Invasive Coronary Angiography and Dual-Source Computed Tomography|Completed||N/A|60|Actual|University Medical Center Groningen|||1||f||||f||||||||||2017-02-18 15:01:48.669288|2017-02-18 15:01:48.669288
NCT00566046|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2012-06-20|||November 2007||2007-11-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|TRACK||Prevention of Post-traumatic Seizures With Levetiracetam|Prospective, Randomized, Double-blind Study Assessing the Effects of Levetiracetam Compared to Placebo in the Prevention of Early Epileptic Seizures and Late Epilepsy in Patients With Severe Traumatic Brain Injury|Terminated||Phase 3|23|Actual|Rennes University Hospital||2||Sponsor decision because of to small enrollment|f||||t||||||||||2017-02-18 15:01:48.749626|2017-02-18 15:01:48.749626
NCT00566033|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2012-01-27|||January 2006||2006-01-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|MAURO||Multiple Intervention and AUdit in Renal Diseases to Optimize Care|Multiple Intervention and AUdit in Renal Diseases to Optimize Care: the MAURO Study.|Completed||Phase 4|788|Actual|"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"||2|||f||||t||||||||||2017-02-18 15:01:48.860233|2017-02-18 15:01:48.860233
NCT00566020|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2015-04-23|2011-06-30||May 2008||2008-05-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) -|Study SCA106052, a Clinical Evaluation of BW430C (Lamotrigine) in Bipolar I Disorder- Long-term Extension Study (Extension of Study SCA104779 (NCT00550407))|Completed||Phase 3|92|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:01:48.997353|2017-02-18 15:01:48.997353
NCT00566007|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2014-03-11|||December 2008||2008-12-01|March 2014|2014-03-01|April 2014|Anticipated|2014-04-01|March 2014|Anticipated|2014-03-01||Interventional|||The Effect of Ozone Therapy for Lumbar Herniated Disc|Trial on the Effect of Ozone Therapy for Lumbar Herniated Disc With Criteria for Surgery|Suspended||Phase 2|156|Anticipated|Kovacs Foundation||3|||f||||t||||||||||2017-02-18 15:01:50.792479|2017-02-18 15:01:50.792479
NCT00565994|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2010-09-27|||January 2008||2008-01-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal Failure|A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal Failure According to Their Method of Vascular Access|Completed||N/A|60|Actual|University of Oklahoma|||3||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 15:01:50.90272|2017-02-18 15:01:50.90272
NCT00565981|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2008-06-04|||March 2004||2004-03-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|October 2007|Actual|2007-10-01||Interventional|||A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response|Subcutaneous MabCampath® (Alemtuzumab) and Oral Fludara® (Fludarabinephosphate) for the Treatment of Refractory or Relapsed Chronic Lymphocytic Leukemia in 2nd or 3rd Line of Treatment: A Pilot Trial (FLUSALEM) for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response|Unknown status|Active, not recruiting|Phase 2|28|Anticipated|Arbeitsgemeinschaft medikamentoese Tumortherapie||1|||f||||t||||||||||2017-02-18 15:01:51.005205|2017-02-18 15:01:51.005205
NCT00565968|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2015-03-05|||October 2007||2007-10-01|March 2015|2015-03-01||||August 2009|Actual|2009-08-01||Interventional|||Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg|A Phase I Dose Escalation Trial to Evaluate Safety and Efficacy of Oral Sorafenib (Nexavar) With Regional Melphalan Via Normothermic Isolated Limb Infusion (ILI) in Patients With Intransit Extremity Melanoma|Completed||Phase 1|20|Actual|Duke University||1|||f||||||||||||||2017-02-18 15:01:51.118877|2017-02-18 15:01:51.118877
NCT00565955|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2008-11-13|||March 2007||2007-03-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|Montelukast||Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children|Effect Of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children Between 5-15 Years of Age - A Randomized, Double Blind, Placebo Controlled Trial|Completed||Phase 3|116|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 15:01:51.233747|2017-02-18 15:01:51.233747
NCT00565942|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2007-11-28|||September 2004||2004-09-01|November 2007|2007-11-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Exploring Integrative Medicine in Swedish Primary Care|Integrative Medicine for Back and Neck Pain - A Pragmatic Randomized Clinical Pilot Trial|Unknown status|Active, not recruiting|N/A|80|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 15:01:51.343784|2017-02-18 15:01:51.343784
NCT00565929|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2013-08-01|||September 2008||2008-09-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Safety, Reactogenicity and Immunogenicity of MVA in Hematopoietic Stem Cell Transplant (HSCT) Subjects|MVA-BN (IMVAMUNE®) Immunization in Persons Who Have Undergone Prior Hematopoietic Stem Cell Transplant (HSCT): A Phase I, Placebo-Controlled Study of the Safety, Reactogenicity and Immunogenicity of MVA Immunization|Completed||Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 15:01:51.453946|2017-02-18 15:01:51.453946
NCT00565916|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2012-04-27|||August 2004||2004-08-01|April 2012|2012-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|Estrogen||Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism|Role of Estrogen/SERMS on Cardiac Fatty Acid Metabolism (Aim #1- Human Studies)|Completed||N/A|38|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 15:01:51.562774|2017-02-18 15:01:51.562774
NCT00565903|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-07-28|||March 2005||2005-03-01|July 2016|2016-07-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Observational|PPB||Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome|Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome|Recruiting||N/A|2000|Anticipated|Children's Research Institute|||1||f||||f||||||Samples With DNA|"~     We are collecting blood samples or saliva samples. When available, we also collect tumor~     samples from prior surgical procedures.~   "|Yes|Sequence data deposited in ClinVar upon publication. Publication of all final results in NIHMS|2017-02-18 15:01:51.677135|2017-02-18 15:01:51.677135
NCT00565890|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2013-06-03|||December 2005||2005-12-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|March 2011|Actual|2011-03-01||Interventional|||Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia|Randomized Controlled Clinical Trial of Thyroxine Supplementation for Very-low-birth-weight Infants With Hypothyroxinemia During the First Month of Age|Completed||N/A|100|Anticipated|Tokyo Women's Medical University||1|||f||||t||||||||||2017-02-18 15:01:51.785898|2017-02-18 15:01:51.785898
NCT00565877|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2014-03-17|||October 2004||2004-10-01|March 2014|2014-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||The Application of Neck Ultrasound in the Assessment of Peripherally Inserted Central Catheter (PICC) Tip Position|A Randomized, Controlled Trial Evaluating Post-Insertion Neck Ultrasound in Peripherally Inserted Central Catheter Procedures|Completed||N/A|300|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 15:01:51.883498|2017-02-18 15:01:51.883498
NCT00565864|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2013-11-07|||August 2008||2008-08-01|November 2013|2013-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Neurocognitive and Metabolic Effects of Mild Hypothyroidism|Neurocognitive and Metabolic Effects of Mild Hypothyroidism|Completed||N/A|324|Actual|Oregon Health and Science University||6|||f||||f||||||||||2017-02-18 15:01:51.989536|2017-02-18 15:01:51.989536
NCT00565851|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2017-02-16|||December 2007||2007-12-01|October 2016|2016-10-01||||March 2019|Anticipated|2019-03-01||Interventional|||Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)|Recruiting||Phase 3|1038|Anticipated|National Cancer Institute (NCI)||4|||f||||f||||||||||2017-02-18 15:01:52.1438|2017-02-18 15:01:52.1438
NCT00565838|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2007-11-28|||January 2001||2001-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||Quality-of-Life Outcomes After Autologous Fascial Sling and TVT: a Prospective Randomized Trial|Clinical and Quality-of-Life Outcomes After Autologous Fascial Sling and Tension-Free Vaginal Tape: a Prospective Randomized Trial|Completed||N/A|40|Actual|UPECLIN HC FM Botucatu Unesp|||1||f||||f||||||||||2017-02-18 15:01:54.464223|2017-02-18 15:01:54.464223
NCT00565812|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-11-01|2016-06-22||November 2007||2007-11-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|ITIC|Full analysis set (FAS) included all participants randomized to the study.|A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee|A Long-Term, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Radiographic Study To Investigate The Safety And Efficacy Of Orally Administered SD-6010 In Subjects With Symptomatic Osteoarthritis Of The Knee|Completed||Phase 2|1457|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 15:01:54.628934|2017-02-18 15:01:54.628934
NCT00565799|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2015-11-18|||November 2007||2007-11-01|November 2015|2015-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|OMT||A Pilot Study of Metabolic Effects of Omentectomy|A Pilot Study of Metabolic Effects of Omentectomy in Obese Patients With Type 2 Diabetes Mellitus Treated With Laparoscopic Adjustable Gastric Banding (LAGB)|Terminated||Phase 2|11|Actual|New York University School of Medicine||2||Conflicting interim data|f||||t||||||||||2017-02-18 15:02:00.273085|2017-02-18 15:02:00.273085
NCT00565786|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2016-08-01|||July 2004||2004-07-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|November 2016|Anticipated|2016-11-01||Observational|||ArCom® and ArComXL® Polyethylene Data Collection|A Prospective Clinical Data Collection of ArCom® and ArComXL® Polyethylene|Active, not recruiting||N/A|150|Actual|Zimmer Biomet|||2||f||||f||||||||||2017-02-18 15:02:00.387179|2017-02-18 15:02:00.387179
NCT00565773|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2017-02-16|||December 2007||2007-12-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Interventional|||Belatacept Post Depletional Repopulation to Facilitate Tolerance|Use of Belatacept During Post Depletional Repopulation to Facilitate Tolerance in Renal Allograft Recipients|Active, not recruiting||Phase 2|40|Actual|Emory University||2|||f||||t||||||||||2017-02-18 15:02:00.489677|2017-02-18 15:02:00.489677
NCT00565760|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2012-05-15||2010-08-25|November 2007||2007-11-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain|A Double-Blind, Multi-Center Extension Study to Evaluate the Safety and Efficacy of Q8003 in Patients With Acute Moderate to Severe Pain|Completed||Phase 3|16|Actual|QRxPharma Inc.||2|||f||||f||||||||||2017-02-18 15:02:00.600024|2017-02-18 15:02:00.600024
NCT00565747|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2015-04-28|2013-05-07||November 2007||2007-11-01|April 2015|2015-04-01|September 2011|Actual|2011-09-01|November 2010|Actual|2010-11-01||Interventional|GM-CSF||Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF|The Effect of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) During in Vitro Culture of Human Embryos on Subsequent Implantation Rates.|Completed||Phase 3|1332|Actual|Origio A/S||2|||f||||f||||||||||2017-02-18 15:02:00.713084|2017-02-18 15:02:00.713084
NCT00565734|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2015-03-05|||November 2007||2007-11-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Observational|||Surgical Treatment of Cervical Spondylotic Myelopathy|An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy|Completed||Phase 4|479|Actual|AO Clinical Investigation and Documentation|||2||f||||f||||||||||2017-02-18 15:02:01.202677|2017-02-18 15:02:01.202677
NCT00565721|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2014-08-13|2014-06-03||November 2007||2007-11-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Interventional||33 subjects enrolled/ started the study. 25 subjects were used in this study analysis.|A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis|A Phase 2, Open-label, Proof-of-concept Study to Assess the Ability to Detect Tumours and Angiogenesis Via the Expression of ανβ3/5 Integrin Receptors by [18F]AH-111585 PET Imaging|Completed||Phase 2|33|Actual|GE Healthcare||1|||f||||f||||||||||2017-02-18 15:02:01.301516|2017-02-18 15:02:01.301516
NCT00565708|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2017-01-16|||December 2008||2008-12-01|January 2017|2017-01-01|June 2023|Anticipated|2023-06-01|December 2022|Anticipated|2022-12-01||Interventional|ASCOLT||Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers|Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial|Recruiting||Phase 3|1200|Anticipated|National Cancer Centre, Singapore||2|||f||||t||||||||||2017-02-18 15:02:01.733602|2017-02-18 15:02:01.733602
NCT00565695|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2010-10-01|||October 2007||2007-10-01|October 2010|2010-10-01|September 2008|Actual|2008-09-01|||||Observational|||Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction|Evaluation of the Aspheric ReSTOR IOL After Routine Cataract Extraction|Completed||N/A|20|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 15:02:02.199881|2017-02-18 15:02:02.199881
NCT00565682|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2007-11-29|||April 2006||2006-04-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Pain Post Abdominal Laparoscopy Prevention With Arcoxia|Pain Post Abdominal Laparoscopy Prevention With Arcoxia|Completed||Phase 4|60|Actual|Hospital Vozandez||1|||f||||f||||||||||2017-02-18 15:02:02.292346|2017-02-18 15:02:02.292346
NCT00565669|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-05-03|||October 2007||2007-10-01|October 2010|2010-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms|Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms|Completed||N/A|20|Actual|Medical University of South Carolina||1|||f||||f||||||||||2017-02-18 15:02:02.393862|2017-02-18 15:02:02.393862
NCT00565656|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2011-12-07|||July 2007||2007-07-01|June 2009|2009-06-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts|A Phase II Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to IPSS) With Excess of Marrow Blasts|Terminated||Phase 2|40|Anticipated|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 15:02:02.512079|2017-02-18 15:02:02.512079
NCT00565643|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2016-03-22|2015-12-30||November 2007||2007-11-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Seprafilm® Adhesion Barrier and Cesarean Delivery|A Multicenter, Randomized, Controlled Trial of Seprafilm® Adhesion Barrier to Reduce Adhesion Formation Following Cesarean Delivery|Completed||Phase 4|753|Actual|Winthrop University Hospital||2|||f||||t||||||||No||2017-02-18 15:02:02.635513|2017-02-18 15:02:02.635513
NCT00565630|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2009-02-24|||January 2008||2008-01-01|November 2007|2007-11-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops|Pilot Study on Bioavailability of Vigamox Administered as Drops vs. as Spray|Withdrawn||N/A|16|Anticipated|Advanced Ophthalmic Pharma||2||Replaced with ongoing study|f||||f||||||||||2017-02-18 15:02:03.253718|2017-02-18 15:02:03.253718
NCT00565617|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2009-07-06|||October 2007||2007-10-01|July 2009|2009-07-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|EpCS-D||Epidural Cortical Stimulation for Depression|A Pilot Safety and Efficacy Study of Epidural Prefrontal Cortical Stimulation (EpCS) in Severe Treatment Resistant Depression|Unknown status|Active, not recruiting|Phase 3|5|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 15:02:03.354657|2017-02-18 15:02:03.354657
NCT00565604|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2015-12-08|2010-01-26||October 2007||2007-10-01|December 2015|2015-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|RELIEVE||Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins|Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins The RELIEVE Study|Completed||N/A|43|Actual|Vascular Solutions, Inc||1|||f||||f||||||||||2017-02-18 15:02:03.470963|2017-02-18 15:02:03.470963
NCT00565591|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2008-02-12|||November 2007||2007-11-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI|A Stepwise, Rising Dose Study of Male Subjects With Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI Compared With Placebo Acu-30™ DPI|Completed||Phase 1|12|Actual|Respirics Inc.||1|||f||||f||||||||||2017-02-18 15:02:03.730283|2017-02-18 15:02:03.730283
NCT00565565|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-08-09|||October 2007||2007-10-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Single Dose Escalation Study in Patients With Chronic Heart Failure|Proof of Concept Study to Investigate Safety, Tolerability, Pharmacokinetics and the Impact on Pulmonary and Systemic Hemodynamics of a Single Oral Dose of BAY60-4552 in Patients With Biventricular Chronic Heart Failure and Pulmonary Hypertension in a Non-randomized, Non-blinded, Dose Escalation Design.|Completed||Phase 1|55|Actual|Bayer||5|||f||||f||||||||||2017-02-18 15:02:03.842534|2017-02-18 15:02:03.842534
NCT00565552|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2007-11-29|||January 2007||2007-01-01|November 2007|2007-11-01|January 2009|Anticipated|2009-01-01|||||Interventional|||Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage|Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage for Standardised Total Ear Reconstruction|Unknown status|Recruiting|N/A|20|Anticipated|University of Schleswig-Holstein||1|||f||||f||||||||||2017-02-18 15:02:03.969319|2017-02-18 15:02:03.969319
NCT00565357|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2007-11-27|||June 2002||2002-06-01|November 2007|2007-11-01|August 2005|Actual|2005-08-01|||||Interventional|||Silicone Earplugs for VLBW Newborns in Intensive Care|Silicone Earplugs for VLBW Newborns in Intensive Care: Feasibility, Sound Attenuation, and Outcomes From a Randomized Clinical Trial|Completed||N/A|34|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||||||||||||2017-02-18 15:02:16.140354|2017-02-18 15:02:16.140354
NCT00565539|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2009-10-06|||December 2007||2007-12-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection|A Phase 1 Study to Assess the Safety and Antiviral Activity of PEG-rIL-29 Administered as a Single Agent and in Combination With Ribavirin in Treatment-Relapsed and Treatment-Naive Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 1|56|Actual|ZymoGenetics||1|||f||||t||||||||||2017-02-18 15:02:04.078717|2017-02-18 15:02:04.078717
NCT00565526|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2017-01-24|||November 26, 2007||2007-11-26|April 10, 2014|2014-04-10|April 10, 2014||2014-04-10|||||Observational|||Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome|Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren's Syndrome|Completed||N/A|28|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:02:04.205912|2017-02-18 15:02:04.205912
NCT00565513|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2007-11-29|||April 2002||2002-04-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Cryptorchidism: Impact of in Utero Exposure to Xenobiotics With Hormonal Action|Cryptorchidism: Impact of in Utero Exposure to Xenobiotics With Hormonal Action and Multidisciplinary|Completed||N/A|283|Actual|Centre Hospitalier Universitaire de Nice||1|||f||||f||||||||||2017-02-18 15:02:04.300397|2017-02-18 15:02:04.300397
NCT00565500|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2007-11-29|||April 2003||2003-04-01|November 2007|2007-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin|A Placebo-Controlled, Double-Blind, Randomized Study of the Potential Interaction Between Aspirin and Ibuprofen or Celecoxib.|Completed||Phase 4|24|Actual|G. d'Annunzio University||3|||f||||f||||||||||2017-02-18 15:02:04.403931|2017-02-18 15:02:04.403931
NCT00565487|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2012-11-30|||December 2007||2007-12-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer|Phase I Study of Combination of Capecitabine and Erlotinib Concurrent With Radiotherapy in Patients With Non-Operable Locally Advanced Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1|27|Anticipated|Penn State University||1|||f||||t||||||||||2017-02-18 15:02:04.719173|2017-02-18 15:02:04.719173
NCT00565474|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2016-04-20|||September 2001||2001-09-01|April 2016|2016-04-01||||October 2007|Actual|2007-10-01||Interventional|||Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant|A Multicenter, Prospective, Double-blind, Randomized, Placebo-controlled, 6-month Study to Establish the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vascular Graft Disease in de Novo Renal Transplant Patients|Completed||Phase 4|84|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:02:04.828614|2017-02-18 15:02:04.828614
NCT00565461|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2014-03-17|2014-01-30||November 2007||2007-11-01|March 2014|2014-03-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||LT Vaccine Patch Self-Administration Study|A Phase 2, Randomized, Open-Label Study to Compare the Immunogenicity and Safety of a Self-Administered LT Vaccine Patch With an LT Vaccine Patch Administered by a Clinician|Completed||Phase 2|160|Actual|Intercell USA, Inc.||4|||f||||f||||||||||2017-02-18 15:02:04.943357|2017-02-18 15:02:04.943357
NCT00565448|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2015-07-02|2010-03-05||November 2007||2007-11-01|July 2015|2015-07-01|January 2012|Actual|2012-01-01|March 2009|Actual|2009-03-01||Interventional||ITT population: all randomized participants.|Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents|International Randomized Study to Evaluate the Addition of Docetaxel to the Combination of Cisplatin-5-fluorouracil (TCF) vs. Cisplatin-5-fluorouracil (CF) in the Induction Treatment of Nasopharyngeal Carcinoma (NPC) in Children and Adolescents|Completed||Phase 2|75|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:02:05.862257|2017-02-18 15:02:05.862257
NCT00565435|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2008-11-13|||May 2002||2002-05-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|||||Observational|||Chiari Study Looking at Use of Duragen Versus Duraguard|Duragen vs. Duraguard in Chiari Surgery|Unknown status|Enrolling by invitation|N/A|100|Anticipated|University of Illinois at Chicago|||1||f||||f||||||||||2017-02-18 15:02:06.723794|2017-02-18 15:02:06.723794
NCT00565422|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2008-05-23|||December 2002||2002-12-01|May 2008|2008-05-01|October 2004|Actual|2004-10-01|||||Interventional|||Efficacy of Escitalopram in the Treatment of Internet Addiction|Efficacy of Escitalopram in the Treatment of Internet Addiction|Completed||Phase 4|31|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-02-18 15:02:06.816734|2017-02-18 15:02:06.816734
NCT00565409|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2015-08-04|2012-05-07||March 2008||2008-03-01|August 2015|2015-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|PRESERVE||Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis|A Randomized, Double-Blind Study Comparing the Safety & Efficacy of Once-Weekly Etanercept 50 mg, Etanercept 25 mg, & Placebo in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis|Completed||Phase 4|834|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 15:02:06.966971|2017-02-18 15:02:06.966971
NCT00565396|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2007-11-29|||September 2004||2004-09-01|November 2007|2007-11-01|July 2008|Anticipated|2008-07-01|||||Interventional|FLIP||Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3|Multi-Center,Double-Blind,Randomized,Controlled Clinical Trial of Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3|Unknown status|Active, not recruiting|N/A|400|Anticipated|Shanghai Municipal Health Bureau||4|||f||||t||||||||||2017-02-18 15:02:15.618669|2017-02-18 15:02:15.618669
NCT00565383|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-29|2013-06-12|||August 2002||2002-08-01|June 2013|2013-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|Version||The Effect of Combined Spinal-Epidural Analgesia on the Success of External Cephalic Version (ECV) for Breech Position|The Effect of Combined Spinal-Epidural Analgesia on the Success of External Cephalic Version for Breech Position|Completed||N/A|101|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 15:02:15.747787|2017-02-18 15:02:15.747787
NCT00565370|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2015-08-01|2013-12-15||November 2007||2007-11-01|August 2015|2015-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|XP+Sorafenib|All enrolled patients were analyzed for analysis.|Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC)|A Phase I-II Study of Sorafenib (Nexavar®) in Combination With Capecitabine and Cisplatin (XP) in Patients With Advanced Gastric Cancer|Completed||Phase 1/Phase 2|21|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 15:02:15.866293|2017-02-18 15:02:15.866293
NCT00565344|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2013-06-13|||July 2007||2007-07-01|November 2007|2007-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Medicaid Disenrollment: Intrastate Emergency Department Impact|Medicaid Disenrollment: Intrastate Emergency Department Impact|Completed||N/A|5000000|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 15:02:16.224106|2017-02-18 15:02:16.224106
NCT00565331|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2015-11-09|||December 2007||2007-12-01|November 2015|2015-11-01|June 2015|Actual|2015-06-01|December 2013|Actual|2013-12-01||Interventional|||Rituximab for Prevention of Rejection After Renal Transplantation|A Prospective Randomized Study on the Efficacy and Safety of the Prophylactic Use of Rituximab, Added to Standard Immunosuppressive Treatment in Comparison With Standard Immunosuppressive Treatment Alone in Renal Transplantation|Completed||Phase 2/Phase 3|280|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:02:16.302417|2017-02-18 15:02:16.302417
NCT00565318|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2009-11-13|||December 2007||2007-12-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Benfo||Benfotiamine in Diabetic Nephropathy|A Double-Blind Clinical Trial of Benfotiamine Treatment in Diabetic Nephropathy|Completed||Phase 4|86|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-02-18 15:02:16.410175|2017-02-18 15:02:16.410175
NCT00565305|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2017-01-30|||July 2003|Actual|2003-07-01|January 2017|2017-01-01|November 2009|Actual|2009-11-01|June 2008|Actual|2008-06-01||Interventional|||Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment|Quality of Life and Immunity During Breast Cancer Treatment|Completed||N/A|150|Actual|University of Iowa||2|||f||||t||||||||No||2017-02-18 15:02:16.527156|2017-02-18 15:02:16.527156
NCT00565292|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2015-02-24|||July 2006||2006-07-01|February 2015|2015-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)||Completed||Phase 1|50|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:02:16.647974|2017-02-18 15:02:16.647974
NCT00565279|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2008-06-02|||December 2007||2007-12-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis|Efficacy and Safety of ASF 1057 Cream 0.5% in the Treatment of Seborrhoeic Dermatitis: A Phase III Randomised, Double-Blind, Vehicle and Placebo Controlled, Parallel Groups, Multi-Centre Trial.|Completed||Phase 3|300|Anticipated|Astion Pharma A/S||3|||f||||f||||||||||2017-02-18 15:02:16.736051|2017-02-18 15:02:16.736051
NCT00565266|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2013-04-05|2012-04-30||May 2008||2008-05-01|April 2013|2013-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|TALC||Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)|Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)|Completed||Phase 3|210|Actual|Milton S. Hershey Medical Center||6|||f||||t||||||||||2017-02-18 15:02:16.851765|2017-02-18 15:02:16.851765
NCT00565253|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2010-06-22|||March 2005||2005-03-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Inhaled Nitric Oxide in Pulmonary Embolism|Inhaled Nitric Oxide in Pulmonary Embolism, a Randomized, Double-Blind Placebo-Controlled Study|Completed||Phase 2|30|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-02-18 15:02:17.162641|2017-02-18 15:02:17.162641
NCT00565240|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2010-04-20|||November 2007||2007-11-01|April 2010|2010-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women|Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women Protocol: WHIRL-07-2971|Completed||N/A|41|Actual|University of Saskatchewan||4|||f||||||||||||||2017-02-18 15:02:17.262608|2017-02-18 15:02:17.262608
NCT00565227|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2016-12-01|||April 2007||2007-04-01|December 2016|2016-12-01|September 2009|Actual|2009-09-01|November 2008|Actual|2008-11-01||Interventional|||Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.|A Phase I Study of Suberoylanilide Hydroxamic Acid (Vorinostat) (NSC 701852) in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies|Terminated||Phase 1|12|Actual|University of Michigan Cancer Center||1||closed due to toxicity|f||||t||||||||||2017-02-18 15:02:17.447457|2017-02-18 15:02:17.447457
NCT00565214|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2016-10-31|||September 2007||2007-09-01|October 2016|2016-10-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers|Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers|Completed||N/A|46|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||Undecided||2017-02-18 15:02:17.555174|2017-02-18 15:02:17.555174
NCT00565201|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2013-08-09|||October 2007||2007-10-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2009|Actual|2009-12-01||Interventional|Botox/Rehab||Evaluation of BOTOX® With Rehabilitation Therapy for the Treatment of Wrist and Hand Spasticity in Post-Stroke Patients|Evaluation of BOTOX® (Botulinum Toxin Type A) in Combination With Rehabilitation Therapy for the Treatment of Wrist and Hand Muscle Overactivity in Post-Stroke Patients|Completed||Early Phase 1|25|Actual|Emory University||2|||f||||f||||||||||2017-02-18 15:02:17.670584|2017-02-18 15:02:17.670584
NCT00565188|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2016-10-24|||March 2002||2002-03-01|November 2007|2007-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Application of ATP Infusions in Palliative Home Care|Application of Adenosine 5'-Triphosphate (ATP) Infusions in Palliative Home Care|Completed||Phase 3|100|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 15:02:17.777887|2017-02-18 15:02:17.777887
NCT00565175|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2012-03-19|||January 2008||2008-01-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia|Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia|Completed||Phase 4|30|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 15:02:17.867134|2017-02-18 15:02:17.867134
NCT00565162|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2008-08-22|||November 2003||2003-11-01|August 2008|2008-08-01|June 2005|Actual|2005-06-01|||||Interventional|||Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus|A Multicentre, Multinational, Randomised, Open Study to Establish the Optimal Method for Initiating Lantus(Insulin Glargine) Therapy to Determine Metabolic and Economic Outcomes, Safety, and Satisfaction in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|124|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:02:17.994071|2017-02-18 15:02:17.994071
NCT00565149|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2016-01-22|||March 2005||2005-03-01|January 2016|2016-01-01|March 2016|Anticipated|2016-03-01|March 2008|Actual|2008-03-01||Interventional|PROOF||PROOF: PROtein OverFeeding Effect on Body Weight|Dietary Protein Content Determines Weight Gain During High Fat Overfeeding|Active, not recruiting||N/A|60|Anticipated|Pennington Biomedical Research Center||3|||f||||t||||||||||2017-02-18 15:02:18.243776|2017-02-18 15:02:18.243776
NCT00565136|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2016-04-21|2013-05-01||September 2007||2007-09-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|TOPAS|20-30 subjects were targeted for enrollment. There was no sample size and power analysis performed for this study.|Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms|Evaluation of the Outcomes of Restoring Pelvic Floor Support Using TOPAS, AMS Pelvic Floor Support System, in Women With Moderate Fecal Incontinence Symptoms|Completed||Phase 1/Phase 2|29|Actual|ASTORA Women's Health|This study was not powered to statistically evaluate device performance.|1|||f||||f||||||||No||2017-02-18 15:02:18.351417|2017-02-18 15:02:18.351417
NCT00565123|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2007-11-28|||September 2004||2004-09-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis|A Single- Centre, Randomised Study Of The Clinical And Microbiological Efficacy Of Decreasing The Dosage Of Levofloxacin 0,5% Eye Drops As Compared To Standard Eye Drop Dosage In Patients With Bacterial Conjunctivitis|Completed||Phase 2/Phase 3|119|Actual|Laser Microsurgery Centre, Poland||2|||f||||f||||||||||2017-02-18 15:02:19.068442|2017-02-18 15:02:19.068442
NCT00565110|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2014-05-19|||July 2004||2004-07-01|May 2014|2014-05-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|ADAPt-C||Treating Depression Among Low-Income Patients With Cancer|Effectiveness Study of a Stepped Care Depression Algorithm for Patients With Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|472|Actual|University of Southern California||2|||f||||t||||||||||2017-02-18 15:02:19.164194|2017-02-18 15:02:19.164194
NCT00565097|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2009-02-16|||October 2007||2007-10-01|February 2009|2009-02-01||||||||Interventional|LOCKCYST||Lanreotide as Treatment of Polycystic Livers|Long-Acting Lanreotide as a Volume Reducing Treatment of Polycystic Livers|Completed||Phase 2/Phase 3|38|Anticipated|Radboud University||2|||f||||f||||||||||2017-02-18 15:02:19.272211|2017-02-18 15:02:19.272211
NCT00565084|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2015-03-23|2008-11-18||March 2007||2007-03-01|March 2015|2015-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Tolerability and Efficacy of Ibuprofen 800 mg in a Walking Model of Osteoarthritis Pain (0000-057)|A Randomized, Placebo-Controlled Single-Dose 3-Period Crossover Study to Assess the Tolerability and Efficacy of Ibuprofen 800 mg in a Walking Model of Osteoarthritis Pain|Completed||Phase 1|33|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 15:02:19.377878|2017-02-18 15:02:19.377878
NCT00565071|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2012-03-27|||October 2006||2006-10-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|March 2012|Anticipated|2012-03-01||Interventional|||Parasite-based Diagnosis for Malaria in Uganda: Feasibility and Cost-Effectiveness|Parasite-based Diagnosis for Malaria in Uganda: Feasibility and Cost-Effectiveness|Unknown status|Recruiting|N/A|102087|Anticipated|Makerere University||3|||f||||t||||||||||2017-02-18 15:02:19.66685|2017-02-18 15:02:19.66685
NCT00565058|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2015-06-29|2015-06-29||August 2007||2007-08-01|April 2015|2015-04-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional||A total of 27 acute myeloid leukemia patients with either relapse (> 6 months) after First complete remission (CR1) or refractory/early relapse CR1 duration < 6 months were enrolled into the study from 6 sites.|Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)|A Phase II Simon Two-stage Multicenter Study and Pilot Pharmacodynamic Investigation of GTI 2040 in Combination With High Dose Cytarabine (HiDAC) in Refractory and Relapsed Acute Myeloid Leukemia (AML)|Completed||Phase 2|27|Actual|Aptose Biosciences Inc.||2|||f||||f||||||||||2017-02-18 15:02:19.785454|2017-02-18 15:02:19.785454
NCT00565045|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2016-10-06|2012-04-26||July 2007||2007-07-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Treatments for Recovery of Hand Function in Acute Stroke Survivors|Contralaterally Controlled Functional Electrical Stimulation for Hemiparetic Hand|Completed||Phase 1/Phase 2|21|Actual|MetroHealth Medical Center||2|||f||||f||||||||No||2017-02-18 15:02:20.376031|2017-02-18 15:02:20.376031
NCT00565032|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2010-01-26|||January 2000||2000-01-01|January 2010|2010-01-01|August 2001|Actual|2001-08-01|||||Observational|||Postpartum Thyroid Measures and Mood|Postpartum Thyroid Measures and Mood|Completed||N/A|75|Actual|Oklahoma State University Center for Health Sciences|||1||f||||f||||||||||2017-02-18 15:02:20.830731|2017-02-18 15:02:20.830731
NCT00565019|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2013-12-12|||November 2007||2007-11-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|August 2011|Actual|2011-08-01||Interventional|||Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture|The Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Patients With Dupuytren's Contracture: a Randomized Controlled Study|Completed||Phase 3|51|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 15:02:20.913316|2017-02-18 15:02:20.913316
NCT00565006|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2015-02-25|||July 2006||2006-07-01|February 2015|2015-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)||Completed||Phase 1|22|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:02:21.005317|2017-02-18 15:02:21.005317
NCT00564993|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2012-06-05|||November 2007||2007-11-01|August 2011|2011-08-01|May 2012|Actual|2012-05-01|May 2011|Actual|2011-05-01||Interventional|||Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot|Cardiac Imaging Under Exercise Stress Test for Early Assessment of Right Ventricular Function in Patients With Tetralogy of Fallot and Pulmonary Regurgitation|Terminated||Phase 3|53|Actual|Competence Network for Congenital Heart Defects||2|||f||||f||||||||||2017-02-18 15:02:21.084627|2017-02-18 15:02:21.084627
NCT00564980|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2015-05-19|||July 2007||2007-07-01|May 2015|2015-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|UAS||PRCT: Comparing Two Procedures for Ulno-Carpal Abutment Syndrome.|A Randomized Prospective Study Comparing TFCC Debridement and Wafer Procedure With TFCC Debridement and Ulnar Shortening Osteotomy for Ulno-Carpal Abutment Syndrome. (UAS Study)|Terminated||N/A|3|Actual|Simon Fraser Orthopaedic Fund||2||Inability to recruit required number of subjects.|f||||f||||||||||2017-02-18 15:02:21.274712|2017-02-18 15:02:21.274712
NCT00564967|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2010-10-25|||November 2007||2007-11-01|August 2009|2009-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|IS1||A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural Therapy|A Comparison Between Internet-based Self-help Therapy and Group Therapy for Social Phobia - A Clinical Equivalence Trial Using Cognitive Behavioural Therapy (CBT)|Completed||Phase 3|128|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 15:02:21.385595|2017-02-18 15:02:21.385595
NCT00564954|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2012-04-20|2008-11-25||October 2007||2007-10-01|April 2012|2012-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Multi-center, Double-blind, Cross-over Study Comparing the Efficacy and Safety of Focalin® XR 20 mg Versus Placebo at the 0.5 Hour Timepoint (Post-dose) in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting|Completed||Phase 4|86|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:02:21.493096|2017-02-18 15:02:21.493096
NCT00564941|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2011-09-08|||December 2007||2007-12-01|September 2011|2011-09-01||||July 2011|Actual|2011-07-01||Interventional|||Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload|Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload|Completed||Phase 4|309|Anticipated|Novartis||1|||f||||||||||||||2017-02-18 15:02:22.091442|2017-02-18 15:02:22.091442
NCT00564928|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2012-12-07||2012-12-06|November 2007||2007-11-01|December 2012|2012-12-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|IPI-504-04||A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer|A Phase 2 Open-Label Study to Investigate the Pharmacodynamics and Clinical Activity of IPI-504 in Patients With Castration-Resistant Prostate Cancer Stratified by Prior Chemotherapy|Completed||Phase 2|19|Actual|Infinity Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 15:02:22.202783|2017-02-18 15:02:22.202783
NCT00564915|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2007-11-28|||December 2001||2001-12-01|November 2007|2007-11-01|July 2006|Actual|2006-07-01|||||Interventional|||RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy|RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy|Completed||Phase 4|145|Actual|Institute of Child Health||1|||f||||f||||||||||2017-02-18 15:02:22.312479|2017-02-18 15:02:22.312479
NCT00564902|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2012-03-28|2011-11-11||November 2007||2007-11-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|ZVF||The Zeaxanthin and Visual Function Study|Randomized, Double Blind, Lutein Controlled Study of Zeaxanthin and Visual Function in Atrophic Age Related Macular Degeneration Patients|Completed||N/A|60|Actual|Chrysantis, Inc.||3|||f||||t||||||||||2017-02-18 15:02:22.397542|2017-02-18 15:02:22.397542
NCT00564889|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-28|2013-04-10|2011-07-19||December 2007||2007-12-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|February 2009|Actual|2009-02-01||Interventional|||Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis|A Phase II Trial of Lenalidomide (Revlimid®), Cyclophosphamide and Dexamethasone in Patients With Primary Systemic Amyloidosis|Completed||Phase 2|35|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 15:02:23.424808|2017-02-18 15:02:23.424808
NCT00564876|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2015-01-27|2011-02-16||November 2007||2007-11-01|January 2015|2015-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|TOP0706||Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer|Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC).|Terminated||Phase 2|2|Actual|Duke University|Limitations for this trial were the trial was stopped due to poor enrollment.|1||Lack of accrual, study closed.|f||||t||||||||||2017-02-18 15:02:23.864868|2017-02-18 15:02:23.864868
NCT00564863|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-27|||September 2007||2007-09-01|November 2007|2007-11-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Dose-Finding Study of CS19 Expressing ETEC Challenge Strains|Strain and Dose-Finding Study of DS26-1 and WS0115A Enterotoxigenic E. Coli (ETEC) Challenge Strains That Express CS19 Fimbriae|Unknown status|Recruiting|Phase 1|25|Anticipated|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||||2017-02-18 15:02:24.220687|2017-02-18 15:02:24.220687
NCT00564850|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2012-02-09|2011-11-01||October 2007||2007-10-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|DECAPUB||Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty|Phase III, Multicentre, Non-comparative, Open and Single Stage Study to Assess the Efficacy and Safety of Pamoate of Triptorelin 11.25 MG in Children With Precocious Puberty|Completed||Phase 3|37|Actual|Ipsen||1|||f||||f||||||||||2017-02-18 15:02:24.325799|2017-02-18 15:02:24.325799
NCT00564837|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2010-01-11|||September 1999||1999-09-01|January 2010|2010-01-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Home Vs. Physiotherapy Supervised Rehabilitation After ACL Reconstruction|Comparison of Home Vs. Physiotherapy-Supervised Rehabilitation Programs Following Reconstruction of the Anterior Cruciate Ligament (ACL)|Completed||N/A|145|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 15:02:24.764515|2017-02-18 15:02:24.764515
NCT00564824|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2010-02-24|||November 2007||2007-11-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease|The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects & in Patients With Ischemic Heart Disease|Completed||Phase 3|80|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 15:02:24.860489|2017-02-18 15:02:24.860489
NCT00564811|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2015-05-27|||March 2003||2003-03-01|May 2015|2015-05-01|September 2004|Actual|2004-09-01|||||Interventional|||Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom)|Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) on the Nutritional State and Liver Biochemistry in Hepatitis C Patients.|Completed||N/A|10|Actual|UPECLIN HC FM Botucatu Unesp||2|||f||||t||||||||||2017-02-18 15:02:24.97484|2017-02-18 15:02:24.97484
NCT00564798|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2012-01-27|||January 2008||2008-01-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Shapedown BC Program Evaluation|Shapedown BC Program Evaluation|Completed||N/A|119|Actual|University of British Columbia|||2||f||||t||||||||||2017-02-18 15:02:25.078293|2017-02-18 15:02:25.078293
NCT00564785|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2007-11-27|||February 2007||2007-02-01|January 2007|2007-01-01|March 2007|Actual|2007-03-01|||||Interventional|||Synera™ for Epidural Needle Insertion|A Randomized, Double-Blind, Controlled Trial of the Synera™ vs. Lidocaine for Epidural Needle Insertion in Laboring Women|Completed||Phase 4|33|Actual|IWK Health Centre||2|||f||||f||||||||||2017-02-18 15:02:25.16352|2017-02-18 15:02:25.16352
NCT00564772|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2008-06-16|||November 2007||2007-11-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|RAL-KAL||Raltegravir Kaletra Pharmacokinetics|An Open-Label, Sequential, 3-Period Study to Evaluate Pharmacokinetics of Coadministered Raltegravir (Isentress) and Lopinavir-Ritonavir (Kaletra) in Healthy Adults|Completed||Phase 4|15|Actual|Allina Hospitals and Clinics||1|||f||||f||||||||||2017-02-18 15:02:25.244568|2017-02-18 15:02:25.244568
NCT00564759|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-27|||January 2004||2004-01-01|November 2007|2007-11-01|December 2008|Anticipated|2008-12-01|||||Interventional|CGD||Gene Therapy for Chronic Granulomatous Disease|Phase I/II Gene Therapy Study for X-Linked Chronic Granulomatous Disease|Unknown status|Active, not recruiting|Phase 1/Phase 2|2|Actual|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||||2017-02-18 15:02:25.348662|2017-02-18 15:02:25.348662
NCT00564746|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2014-10-02|||September 2007||2007-09-01|January 2012|2012-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]SB-681323 in Healthy Adult Males|An Open Label Study to Determine the Excretion Balance and Pharmacokinetics of [14C]SB-681323, Administered as a Single Dose of an Oral Solution to Healthy Adult Male Subjects.|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:02:25.439154|2017-02-18 15:02:25.439154
NCT00564733|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2016-12-16|2016-08-29||October 2007||2007-10-01|December 2016|2016-12-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional||All patients that signed consent and received at least one dose of chemotherapy.|FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer|FDG-PET Based Chemotherapy Selection for Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|55|Actual|University of Washington||1|||f||||f||||||||No||2017-02-18 15:02:25.542418|2017-02-18 15:02:25.542418
NCT00564720|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2013-02-14|||December 2006||2006-12-01|February 2013|2013-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer|Phase II Study of Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Terminated||Phase 2|140|Actual|Hellenic Oncology Research Group||2||Due to poor accrual of the study|f||||f||||||||||2017-02-18 15:02:25.80665|2017-02-18 15:02:25.80665
NCT00564707|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-26|||August 2007||2007-08-01|November 2007|2007-11-01|August 2009|Anticipated|2009-08-01|||||Interventional|||Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome|Comparison of Biofeedback Therapy and Botulinum Toxin Type A Injections for Treatment of Painful Levator Ani Syndrome in Women: A Randomized, Prospective Trial|Unknown status|Recruiting|N/A|84|Anticipated|Walter Reed Army Medical Center||2|||f||||t||||||||||2017-02-18 15:02:25.991417|2017-02-18 15:02:25.991417
NCT00564694|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2013-10-28|||May 2007||2007-05-01|August 2009|2009-08-01||||June 2009|Actual|2009-06-01||Observational|||Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer|Validation of an EORTC Quality of Life Questionnaire Module for Patients With Colorectal Cancer|Completed||N/A|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:02:26.07951|2017-02-18 15:02:26.07951
NCT00564681|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2015-12-04|2012-11-14||December 2007||2007-12-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia||Completed||Phase 2|242|Actual|Allergan||4|||f||||f||||||||||2017-02-18 15:02:26.179439|2017-02-18 15:02:26.179439
NCT00564668|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2013-11-21|||June 2004||2004-06-01|November 2013|2013-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes|A 24-week, Randomised, Multi-centre, Double-blind, Parallel-group Trial to Investigate the Safety and the Efficacy of NN2000-Mix30 Compared to NN-X14Mix30 NovoRapid®30Mix) in Subjects With Type 2 Diabetes Mellitus on a Twice Daily Regimen|Completed||Phase 3|126|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:02:27.072153|2017-02-18 15:02:27.072153
NCT00564655|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2013-07-23|||October 2007||2007-10-01|July 2013|2013-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Regional Anesthesia Block of the Transversus Abdominis Plane in Children Undergoing Gastric Tube Insertion|Regional Anesthesia Block of the Transversus Abdominis Plane in Children Undergoing Gastric Tube Insertion|Terminated||Phase 3|3|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 15:02:27.170976|2017-02-18 15:02:27.170976
NCT00564642|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2009-04-21|||November 2007||2007-11-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity|Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity|Completed||N/A|60|Actual|National Research Institute of Tuberculosis and Lung Disease, Iran||1|||f||||t||||||||||2017-02-18 15:02:27.280932|2017-02-18 15:02:27.280932
NCT00564629|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2016-10-18|2009-09-25||August 2007||2007-08-01|October 2016|2016-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of the Efficacy and Safety of Intravenous vs Oral Acetaminophen for Treatment of Fever in Healthy Adult Males|A Phase III, Randomized, Double-Blind, Double-Dummy, Single-Dose Study of the Efficacy and Safety of Intravenous Acetaminophen Versus Oral Acetaminophen for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males|Completed||Phase 3|105|Actual|Mallinckrodt|Protocol and statistical analysis plan were amended to clarify endpoints prior to database lock and analysis.|2|||f||||f||||||||||2017-02-18 15:02:27.383378|2017-02-18 15:02:27.383378
NCT00564616|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-26|||April 2007||2007-04-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Simulation-Based Study of Adding Video Communication to Dispatch Instruction|A Randomized Controlled Study Focused on Impact of Adding Video Communication to Dispatch Instruction on the Quality of CPR, Including Chest Compressions and Rescue Breaths, in Simulated Cardiac Arrests|Completed||N/A|96|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 15:02:27.957627|2017-02-18 15:02:27.957627
NCT00564603|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2008-04-17|||August 2007||2007-08-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|DTMPCA||Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy|Intravenous Continuous Infusion of Dexamethasone Plus Tramadol Combined With Standard Morphine Patient-Controlled Analgesia After Total Abdominal Hysterectomy|Completed||Phase 4|300|Actual|Nanjing Medical University||2|||f||||t||||||||||2017-02-18 15:02:28.056245|2017-02-18 15:02:28.056245
NCT00564590|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-26|||October 2008||2008-10-01|November 2007|2007-11-01|January 2011|Anticipated|2011-01-01|||||Interventional|||SThe Effects of Melatonin on GERD Symptoms|The Effects of Melatonin on GERD Symptoms and Esophageal Acid Exposure|Unknown status|Not yet recruiting|Phase 1/Phase 2|150|Anticipated|Rabin Medical Center||3|||f||||f||||||||||2017-02-18 15:02:28.167997|2017-02-18 15:02:28.167997
NCT00562874|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-04-03|||June 2006||2006-06-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|HNP||Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their Children|Increasing Animal Source Foods in Diets of HIV-Infected Kenyan Women and Their Children|Completed||N/A|808|Actual|Indiana University||3|||f||||f||||||||||2017-02-18 15:02:55.405748|2017-02-18 15:02:55.405748
NCT00564577|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-27|||September 2006||2006-09-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Dose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli ETEC Challenge Strains That Express CS17|Dose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli (ETEC) Challenge Strains That Express CS17|Completed||Phase 1|13|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||||2017-02-18 15:02:28.289769|2017-02-18 15:02:28.289769
NCT00564564|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2008-02-04|||January 2006||2006-01-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|QCAT||Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-Compulsive Disorder Patients|Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-Trial.|Completed||Phase 4|21|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 15:02:28.399913|2017-02-18 15:02:28.399913
NCT00564551|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2010-01-19|||October 2007||2007-10-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin Resistance|Impact of High Milk Product and Calcium Intake During Weight Loss on Markers of Insulin Resistance|Completed||N/A|49|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 15:02:28.522931|2017-02-18 15:02:28.522931
NCT00564538|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2007-11-27|||December 2007||2007-12-01|November 2007|2007-11-01|December 2009|Anticipated|2009-12-01|||||Interventional|thymo||A Study of Thymoglobulin and Tacrolimus in Liver Transplant|A Study Comparing Thymoglobulin to Tacrolimus in Liver Transplant and Impact on Renal Function|Unknown status|Enrolling by invitation|Phase 4|100|Anticipated|University of Nebraska||2|||f||||t||||||||||2017-02-18 15:02:28.640432|2017-02-18 15:02:28.640432
NCT00564525|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2007-11-27|||October 2002||2002-10-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of Medication for Functional Abdominal Pain in Children|Evaluation of the Efficacy of Amitriptyline in Children With Abdominal Pain of Non-Organic Origin|Completed||Phase 4|95|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-02-18 15:02:28.750134|2017-02-18 15:02:28.750134
NCT00564512|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2013-07-24|||November 2007||2007-11-01|April 2009|2009-04-01|July 2013|Actual|2013-07-01|January 2009|Actual|2009-01-01||Interventional|||Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP|Randomized Phase-III Trial Comparing Fludarabine and Cyclophosphamide Plus Rituximab (FCR) to FC and MabCampath (FCCam) for Previously Untreated Fit Patients With Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 3|178|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||||2017-02-18 15:02:28.854605|2017-02-18 15:02:28.854605
NCT00564109|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2008-03-17|||August 2005||2005-08-01|November 2007|2007-11-01|January 2008||2008-01-01|||||Observational|||Are the Pancreatic Serum Proteins Pancreatic Stone Protein (PSP) and Pancreatitis-Associated Protein (PAP) Predictive for the Development of Sepsis? Retrospective Study in Trauma Patients With Soft Tissue Defects.||Unknown status|Recruiting|N/A|15|Anticipated|University of Zurich|||1||f||||f||||||||||2017-02-18 15:02:28.966981|2017-02-18 15:02:28.966981
NCT00564499|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2011-01-27|||March 2006||2006-03-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|||||Observational|SRP COPD||SYMBICORT® in the Treatment of COPD|A Scientific Research Program to Evaluate the Efficacy of SYMBICORT® 320/9μg in the Treatment of COPD in Real Life Environment by General Practitioners|Completed||N/A|||AstraZeneca|||1||f||||f||||||||||2017-02-18 15:02:29.04026|2017-02-18 15:02:29.04026
NCT00564486|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2016-09-08|2009-09-25||November 2007||2007-11-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain|Phase 3 Randomized, Double-Blind Placebo-Controlled, Multicenter, Parallel-Group, Repeated-Dose Study of the Analgesic Efficacy & Safety of IV Acetaminophen Versus Placebo for the Treatment of Postop Pain|Completed||Phase 3|244|Actual|Mallinckrodt|One subject was randomized to receive IV APAP 1 g, but was administered IV APAP 650 mg. The subject was included in 1g IV APAP group for efficacy purposes and included in IV APAP 650 mg safety group for AE purposes.|4|||f||||f||||||||||2017-02-18 15:02:29.107526|2017-02-18 15:02:29.107526
NCT00564473|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2010-10-28|||June 2008||2008-06-01|October 2010|2010-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Use of Herbal Medicine in Internal Medicine Wards|Use of Herbal Medicine Among Patients Hospitalized in a Department of Internal Medicine: A Cross-Sectional Survey|Completed||N/A|200|Anticipated|Shaare Zedek Medical Center|||1||f||||f||||||||||2017-02-18 15:02:29.639891|2017-02-18 15:02:29.639891
NCT00564460|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2009-11-04|||February 2008||2008-02-01|November 2009|2009-11-01|February 2011|Anticipated|2011-02-01|||||Interventional|||On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)|On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)|Withdrawn||Phase 3|310|Anticipated|University of Alberta||2||Change of practice pattern. Green light laser|f||||f||||||||||2017-02-18 15:02:29.818147|2017-02-18 15:02:29.818147
NCT00564447|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-09-20|2011-06-27||December 2007||2007-12-01|September 2011|2011-09-01||||December 2007|Actual|2007-12-01||Interventional|||Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers|A Single-Center, Open-Label, Randomized Study of the Pharmacokinetics of AzaSite Ophthalmic Solution Versus Vigamox in the Conjunctiva of Healthy Volunteers Following a Single Ocular Administration|Completed||Phase 4|48|Actual|Merck Sharp & Dohme Corp.||8|||f||||||||||||||2017-02-18 15:02:29.933766|2017-02-18 15:02:29.933766
NCT00564434|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2007-11-27|||May 2005||2005-05-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Observational|||Postoperative Delirium in Hip Fracture Patients|Postoperative Delirium in Hip Fracture Patients|Completed||N/A|364||Ullevaal University Hospital|||||f||||f||||||Samples With DNA|"~     whole blood, serum~   "|||2017-02-18 15:02:30.616667|2017-02-18 15:02:30.616667
NCT00564421|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2016-02-24||2011-05-20|December 2007||2007-12-01|February 2016|2016-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)|A Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple Dose Safety and Efficacy Study of Epinastine Nasal Spray vs. Placebo in Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|798|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 15:02:30.697481|2017-02-18 15:02:30.697481
NCT00114491|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2006-10-30|||September 2003||2003-09-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Observational|||Rosuvastatin Affecting Aortic Valve Endothelium|Rosuvastatin Affecting Aortic Valve Endothelium - RAAVE|Completed||Phase 4|200||Hospital Pedro Hispano|||||f||||||||||||||2017-02-18 17:38:13.181149|2017-02-18 17:38:13.181149
NCT00564408|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2009-07-31|||August 2007||2007-08-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients|Experimental Study That Investigates the Effect of an Acetylcholine Analogue in Terms of Headache and Changes in Intra- and Extra-cerebral Vessels During and After Infusion of Carbachol|Completed||N/A|12|Anticipated|Danish Headache Center||1|||f||||f||||||||||2017-02-18 15:02:30.793684|2017-02-18 15:02:30.793684
NCT00564395|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-27|2015-09-10|||August 2007||2007-08-01|September 2015|2015-09-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Detemir: Role in Type 1 Diabetes|Detemir: Role in Type 1 Diabetes|Completed||Phase 4|13|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 15:02:30.899125|2017-02-18 15:02:30.899125
NCT00564382|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2011-10-02|||November 2007||2007-11-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||CMR in the Assessment of Patient With ACS in the Emergency Room|Cardiac MRI for the Diagnosis of Unstable Angina/ NSTEMI in the Emergency Room|Completed||N/A|100|Anticipated|University of Calgary||1|||f||||t||||||||||2017-02-18 15:02:30.991265|2017-02-18 15:02:30.991265
NCT00564369|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2013-11-25|||July 2007||2007-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||CDC HIV Testing Guidelines: Unresolved Ethical Concerns|CDC HIV Testing Guidelines: Unresolved Ethical Concerns|Completed||N/A|1000|Anticipated|Rhode Island Hospital||2|||f||||f||||||||||2017-02-18 15:02:31.102933|2017-02-18 15:02:31.102933
NCT00564356|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2009-07-19|||July 2007||2007-07-01|July 2009|2009-07-01|December 2010|Anticipated|2010-12-01|August 2008|Actual|2008-08-01||Interventional|||The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment|The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment|Unknown status|Recruiting|N/A|75|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 15:02:31.201243|2017-02-18 15:02:31.201243
NCT00564343|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-25|2008-12-15|||November 2007||2007-11-01|November 2007|2007-11-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Observational|||a Water Training Program to Improve Balance in Chronic Stroke Patients|a Water Training Program to Improve Balance in Chronic Stroke Patients: Cross- Sectional Pre-Post Study Design|Completed||N/A|20|Anticipated|Soroka University Medical Center|||1||f||||t||||||||||2017-02-18 15:02:31.308918|2017-02-18 15:02:31.308918
NCT00564330|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2014-08-25|||November 2007||2007-11-01|August 2014|2014-08-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||In Vivo Quantification of Dental Demineralisation Using OCT With and Without Esomeprazole|In Vivo Quantification of Dental Demineralisation Using Optical Coherence Tomography Before and After Double-blind, Randomised Treatment With Esomeprazole or Placebo of Patients With Dental Erosions|Completed||Phase 1/Phase 2|30|Actual|Brain-Gut Research Group||2|||f||||f||||||||||2017-02-18 15:02:31.404692|2017-02-18 15:02:31.404692
NCT00564317|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-26|||September 2004||2004-09-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Trial for the Treatment of Traumatized Children After War in Sri Lanka|KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Trial for the Treatment of Traumatized Children After War in Sri Lanka|Completed||Phase 3|48|Actual|University of Konstanz||4|||f||||f||||||||||2017-02-18 15:02:31.508979|2017-02-18 15:02:31.508979
NCT00564304|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-25|2007-11-26|||March 2008||2008-03-01|November 2007|2007-11-01|March 2010|Anticipated|2010-03-01|||||Observational|||NPD Measurement in Infants|Nasal Potential Difference Measurement in Infants|Unknown status|Not yet recruiting|N/A|50|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 15:02:31.620466|2017-02-18 15:02:31.620466
NCT00564291|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2016-10-24|||January 2007||2007-01-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)|Evaluation of Retinal Structure With High Resolution OCT|Recruiting||N/A|700|Anticipated|University Hospital Inselspital, Berne|||7||f||||f||||||||||2017-02-18 15:02:31.682339|2017-02-18 15:02:31.682339
NCT00564278|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2016-02-11|2015-08-06||February 2008||2008-02-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional||Patients who signed written informed consent and participated in baseline medication visit.|Effects of Adding Motivational Interviewing to Antidepressant Treatment for Hispanic Adults With Depression|Motivational Antidepressant Therapy for Hispanics|Completed||N/A|217|Actual|New York State Psychiatric Institute|Focused only on Hispanics, so applicability to other populations unknown.|2|||f||||f||||||||No||2017-02-18 15:02:31.798195|2017-02-18 15:02:31.798195
NCT00564265|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2011-08-09|2008-11-03||January 2008||2008-01-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Observational|||Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo|Outcomes of Surgical Treatment of Gastrointestinal Stromal Tumors in the IV Region of Chile|Completed||N/A|24|Actual|Cirujanos la Serena|||1||f||||f||||||||||2017-02-18 15:02:34.929413|2017-02-18 15:02:34.929413
NCT00564252|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-26|||February 2006||2006-02-01|November 2007|2007-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Topical Finasteride in the Treatment of Idiopathic Hirsutism|The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism|Completed||N/A|56|Actual|Iran University of Medical Sciences||1|||f||||t||||||||||2017-02-18 15:02:35.149295|2017-02-18 15:02:35.149295
NCT00564239|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2010-08-27|||November 2007||2007-11-01|August 2010|2010-08-01|May 2012|Anticipated|2012-05-01|May 2011|Anticipated|2011-05-01||Interventional|||Psychological Prevention of Internalizing Disorders|Efficacy of Child-centered Cognitive-Behavioral Prevention of Internalizing Disorders and the Impact of Simultaneous Parent Training|Unknown status|Recruiting|Phase 3|120|Anticipated|Philipps University Marburg Medical Center||3|||f||||f||||||||||2017-02-18 15:02:35.222046|2017-02-18 15:02:35.222046
NCT00564226|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2016-04-27||2016-04-27|November 2007||2007-11-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|BILADY||SSR240600C Treatment in Women With Overactive Bladder|A Placebo Controlled Randomized, 12-week, Dose-ranging, Double-blind Study Versus Placebo Using Tolterodine as a Study Calibrator, to Evaluate Efficacy and Safety of SSR240600C in Women With Overactive Bladder Including Urge Urinary Incontinence|Completed||Phase 2|345|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 15:02:35.322447|2017-02-18 15:02:35.322447
NCT00563823|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2013-08-01|||February 2006||2006-02-01|April 2008|2008-04-01|October 2010|Actual|2010-10-01|September 2008|Actual|2008-09-01||Interventional|||Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery|A Phase II Study to Evaluate the Efficacy and Safety of PTK787 in Patients With Metastatic Cutaneous Melanoma|Completed||Phase 2|34|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:02:38.837023|2017-02-18 15:02:38.837023
NCT00564213|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2008-11-25|||March 2005||2005-03-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|BQ-01-07-ARVO||Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds|Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds|Completed||Phase 4|36|Anticipated|Instituto de Olhos de Goiania||2|||f||||t||||||||||2017-02-18 15:02:35.444277|2017-02-18 15:02:35.444277
NCT00564200|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2014-10-27|||November 2007||2007-11-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|July 2014|Actual|2014-07-01||Interventional|MINIALO-VELCAD||MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning|MINIALO-VELCADE2005: A Phase II National, Open-label, Multicenter, no Controlled Study of Treated With Bortezomib (Velcade) Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning|Completed||Phase 2|30|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:02:35.528966|2017-02-18 15:02:35.528966
NCT00564187|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-27|||February 2003||2003-02-01|November 2007|2007-11-01|December 2004|Actual|2004-12-01|||||Interventional|||Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice|Prospective, Multicentric, Randomized, Open, Comparative Phase IV Study Evaluating the Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice|Completed||Phase 4|115|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:02:35.862416|2017-02-18 15:02:35.862416
NCT00564174|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-26|||March 2000||2000-03-01|November 2007|2007-11-01|September 2005|Actual|2005-09-01|||||Interventional|HepASA||Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT|A Randomized Controlled Trial Comparing Low Molecular Weight Heparin and Aspirin to Aspirin Alone in Women With Unexplained Recurrent Pregnancy Loss|Terminated||N/A|88|Actual|Mount Sinai Hospital, Canada||2||interim analysis found no difference in LB rate and lower than expected event rate|f||||t||||||||||2017-02-18 15:02:35.956382|2017-02-18 15:02:35.956382
NCT00564161|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-25|2016-09-01|||January 2008||2008-01-01|November 2007|2007-11-01|January 2009|Anticipated|2009-01-01|||||Observational|||VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants|VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants|Withdrawn||N/A|0|Actual|Hadassah Medical Organization|||2||f||||f||||||Samples Without DNA|"~     CSF.~   "|||2017-02-18 15:02:36.06934|2017-02-18 15:02:36.06934
NCT00564148|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2011-07-20|||July 2007||2007-07-01|June 2008|2008-06-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|SITE-App||Intravitreal Avastin in Proliferative Retinopathies|Intravitreal Injections With Avastin in Proliferative Retinopathies Related to the Production of VEGF Having Different Causes|Completed||Phase 2|100|Anticipated|Ophthalmological Association Edelweiss||1|||f||||f||||||||||2017-02-18 15:02:36.147305|2017-02-18 15:02:36.147305
NCT00564135|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-25|2015-06-02|||March 2007||2007-03-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|January 2008|Actual|2008-01-01||Interventional|||Postoperative Urinary Retention and Urinary Track Infection (UTI) After Laparoscopic Assisted Vaginal Hysterectomy (LAVH) for Benign Disease|Postoperative Urinary Retention and UTI After LAVH for Benign Disease|Completed||N/A|150|Actual|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-02-18 15:02:36.255825|2017-02-18 15:02:36.255825
NCT00564122|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2011-10-31|||December 2007||2007-12-01|October 2011|2011-10-01|June 2008|Actual|2008-06-01|||||Observational|||The Accuracy of an Artificially-intelligent Stethoscope|A Comparison of the Accuracy of an Artificially-Intelligent Stethoscope Versus Pediatric Cardiologists in the Assessment of Pediatric Patients Referred to a Cardiologist for the Assessment of a Heart Murmur|Completed||N/A|300|Anticipated|Akron Children's Hospital|||1||f||||t||||||||||2017-02-18 15:02:36.351223|2017-02-18 15:02:36.351223
NCT00564096|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-25|2010-03-02|||October 2008||2008-10-01|October 2009|2009-10-01|December 2011|Anticipated|2011-12-01|November 2011|Anticipated|2011-11-01||Interventional|||Transcranial Magnetic Stimulation (TMS) in Schizophrenia|A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H1-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Schizophrenia Experiencing Auditory Hallucinations|Unknown status|Recruiting|Phase 2/Phase 3|20|Anticipated|BeerYaakov Mental Health Center||2|||f||||f||||||||||2017-02-18 15:02:36.462166|2017-02-18 15:02:36.462166
NCT00564083|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2011-03-21|||December 2005||2005-12-01|November 2007|2007-11-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Randomized Controlled Trial Comparing Acellular Collagen Biomesh (Pelvisoft) to Polypropylene Mesh(Pelvitex) for Sacral Colpopexy||Completed||N/A|120|Actual|Atlantic Health System||1|||f||||f||||||||||2017-02-18 15:02:36.562284|2017-02-18 15:02:36.562284
NCT00564070|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2013-03-07|||June 2007||2007-06-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||CBT for Adherence and Depression in Diabetes|CBT for Adherence and Depression in Diabetes|Completed||N/A|87|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 15:02:36.652028|2017-02-18 15:02:36.652028
NCT00564057|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-12-05|||September 2007||2007-09-01|November 2007|2007-11-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine|Effects of Antihypertensive Treatment on Cardiac Remodelling and Metabolic Profile in HIV Infected Patients: Randomized Longitudinal Study With Candesartan Versus Lercanidipine|Unknown status|Recruiting|Phase 4|30|Anticipated|Università degli Studi dell'Insubria||2|||f||||f||||||||||2017-02-18 15:02:36.760767|2017-02-18 15:02:36.760767
NCT00564044|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-25|2007-11-26|||August 2007||2007-08-01|August 2007|2007-08-01|July 2009|Anticipated|2009-07-01|||||Interventional|||The Immune Reactivity of Biofilms in Vaginal Mesh Erosion.|Does the Immune Reactivity of Bacteria Cause Vaginal Mesh (Polypropylene) Erosion? - A Ultrastructural, Microbiological and Immunohistochemical Analysis.|Unknown status|Active, not recruiting|N/A|82|Anticipated|Chang Gung Memorial Hospital||1|||f||||f||||||||||2017-02-18 15:02:36.874081|2017-02-18 15:02:36.874081
NCT00564031|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2007-11-26|||January 2003||2003-01-01|November 2007|2007-11-01|August 2004|Actual|2004-08-01|||||Interventional|HRT||Hormonal Replacement Therapy and Small Artery Function|Hormonal Replacement Therapy and Small Artery Function|Completed||Phase 3|66|Actual|Karolinska University Hospital||4|||f||||f||||||||||2017-02-18 15:02:36.981733|2017-02-18 15:02:36.981733
NCT00563615|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||November 2004||2004-11-01|July 2010|2010-07-01|October 2006|Anticipated|2006-10-01|||||Interventional|||Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method|Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method|Unknown status|Recruiting|N/A|60|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:43.080749|2017-02-18 15:02:43.080749
NCT00564018|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2012-06-12|||September 2006||2006-09-01|November 2007|2007-11-01|April 2011|Actual|2011-04-01|February 2009|Actual|2009-02-01||Interventional|||Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH|Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH|Terminated||N/A|33|Actual|University of Texas Southwestern Medical Center||3||Presumed loss of clinical equipoise between the agents being investigated|f||||f||||||||||2017-02-18 15:02:37.093331|2017-02-18 15:02:37.093331
NCT00564005|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-25|2015-02-10|||January 2008||2008-01-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Mechanism and Efficacy of Rehabilitation Approaches|Mechanisms and Long-term Effects of Separate vs. Coupled Rehabilitation Approaches After Stroke|Completed||N/A|90|Actual|Chang Gung Memorial Hospital||4|||f||||f||||||||||2017-02-18 15:02:37.206155|2017-02-18 15:02:37.206155
NCT00563992|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2012-04-30|||January 2001||2001-01-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder|Pharmacotherapy of High-Risk Bipolar Disorder|Completed||Phase 1|98|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 15:02:37.304053|2017-02-18 15:02:37.304053
NCT00563979|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2015-06-10|||July 2007||2007-07-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|EMPOLS||Enhancement of Macular Pigment Density by Oral Lutein Supplementation|Enhancement of Macular Pigment Density by Oral Lutein Supplementation|Completed||N/A|80|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 15:02:37.407246|2017-02-18 15:02:37.407246
NCT00563966|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-25|2008-05-09|||April 2008||2008-04-01|November 2007|2007-11-01|December 2008|Anticipated|2008-12-01|||||Observational|||The Stress Responses of Fetuses and Infants Whose Mothers Smoked During Pregnancy|The Stress Responses of Fetuses and Infants Whose Mothers Smoked During Pregnancy: Genes, Hormones and Psychological Modulators|Unknown status|Recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"~     DNA samples + salivery cortisol~   "|||2017-02-18 15:02:37.507882|2017-02-18 15:02:37.507882
NCT00563953|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2016-12-21|||September 2007||2007-09-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|February 2011|Actual|2011-02-01||Interventional|CAPRICE||Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years|A Phase II, Open-Label, Multicenter Clinical Trial of Pegylated Liposomal Doxorubicin (Caelyx®) as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease or Age Over 65 Years.|Completed||Phase 2|50|Actual|SOLTI Breast Cancer Research Group||1|||f||||f||||||||||2017-02-18 15:02:37.590166|2017-02-18 15:02:37.590166
NCT00563940|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-26|2011-09-05|||March 2007||2007-03-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|||||Observational|||Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema|Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema|Completed||N/A|30|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-02-18 15:02:37.705914|2017-02-18 15:02:37.705914
NCT00563927|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||March 1999||1999-03-01|July 2010|2010-07-01|October 2009|Anticipated|2009-10-01|||||Interventional|||Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)|Prospective Randomized Study on Therapeutic Gain Achieved By Addition of Chemotherapy for T1-4N2-3M0 Nasopharyngeal Carcinoma|Unknown status|Active, not recruiting|N/A|340|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:37.806306|2017-02-18 15:02:37.806306
NCT00563914|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2009-12-18|||October 2007||2007-10-01|December 2009|2009-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated Malaria|An Open Label, 4 Escalating Dose, Randomized Multicentre Study Evaluating the Safety and Activity of Ferroquine Associated With Artesunate Versus a Positive Calibrator (Amodiaquine Associated With Artesunate) in African Adult Patients With Uncomplicated Malaria|Completed||Phase 1/Phase 2|72|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:02:38.110097|2017-02-18 15:02:38.110097
NCT00563901|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2014-03-02|||September 2000||2000-09-01|January 2008|2008-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Observational|||Analyzing How Genetics May Affect Response to High Blood Pressure Medications|GenHAT - Genetics of Hypertension Associated Treatments - Ancillary to ALLHAT|Completed||N/A|37939|Actual|University of Alabama at Birmingham|||1||f||||||||||Samples With DNA|"~     Blood samples with DNA~   "|||2017-02-18 15:02:38.227012|2017-02-18 15:02:38.227012
NCT00563888|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2007-11-23|||January 2007||2007-01-01|November 2007|2007-11-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Change of Neural Network Indicators Through Narrative Treatment of PTSD in Torture Victims|Change of Neural Network Indicators Through Narrative Treatment of PTSD in Torture Victims|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Konstanz||2|||f||||f||||||||||2017-02-18 15:02:38.339246|2017-02-18 15:02:38.339246
NCT00563875|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2008-06-09|||November 2007||2007-11-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Laboratory Aspirin Resistance in Diabetics and Non-Diabetics|Laboratory Aspirin Resistance in Coronary Artery Disease Patients With or Without Diabetes Mellitus|Completed||N/A|210|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-02-18 15:02:38.433313|2017-02-18 15:02:38.433313
NCT00563862|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-14|||July 1999||1999-07-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)|Prospective Randomized Study on Therapeutic Gain Achieved By Chemoradiation And/Or Accelerated Radiation For T3-4N0-1M0 Nasopharyngeal Carcinoma|Terminated||N/A|465|Actual|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:38.528947|2017-02-18 15:02:38.528947
NCT00563849|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-12-03|||May 2003||2003-05-01|December 2007|2007-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Leflunomide + Methotrexate in Rheumatoid Arthritis|An Open-Label, Multi-Center Study to Evaluation of Leflunomide Plus Methotexate for the Treatment of Rheumatoid Arthritis in DMARDs:(Disease-Modifying Antirheumatic Drug) na¿ve or Restart (Skip DMARDs More Than 4 Weeks) Subjects.|Completed||Phase 4|74|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:02:38.630351|2017-02-18 15:02:38.630351
NCT00563836|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2012-10-02|||November 2007||2007-11-01|August 2012|2012-08-01|August 2010|Actual|2010-08-01|September 2008|Actual|2008-09-01||Interventional|||Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer|Multicenter, Single-arm, Phase II Study of the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3) Administered Intra- and Postoperatively in Patients With Epithelial Ovarian Cancer|Completed||Phase 2|41|Anticipated|Neovii Biotech||1|||f||||t||||||||||2017-02-18 15:02:38.72085|2017-02-18 15:02:38.72085
NCT00563810|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-23|||October 2004||2004-10-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029|An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029 Administered Intravenously as a 30-Minute Infusion to Healthy Subjects|Completed||Phase 1|72||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:02:38.936182|2017-02-18 15:02:38.936182
NCT00563797|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-03-21|2015-11-16||August 2007||2007-08-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Participants were included in the study if they met criteria for major depression and alcohol dependence, had been on a stable antidepressant dose for 2 weeks, and were either smokers or nonsmokers.|Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence|Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence|Completed||Phase 3|21|Actual|Yale University||2|||f||||t||||||||||2017-02-18 15:02:39.015102|2017-02-18 15:02:39.015102
NCT00563784|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-04-25|||November 2007||2007-11-01|April 2016|2016-04-01||||May 2017|Anticipated|2017-05-01||Interventional|||TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)|A Phase II Study of TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|48|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:02:39.607503|2017-02-18 15:02:39.607503
NCT00563771|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2008-01-24|||March 2003||2003-03-01|January 2008|2008-01-01|January 2004|Actual|2004-01-01|||||Interventional|||Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome|Phase IV, Compassionate Use Program of Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome|Completed||Phase 4|38|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:02:39.735771|2017-02-18 15:02:39.735771
NCT00563758|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2011-06-14|||December 2004||2004-12-01|June 2011|2011-06-01|February 2006|Actual|2006-02-01|||||Interventional|||A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation|A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation|Terminated||N/A|250|Actual|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:39.814642|2017-02-18 15:02:39.814642
NCT00563745|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2015-03-05|||April 2004||2004-04-01|March 2015|2015-03-01|April 2007|Actual|2007-04-01|April 2005|Actual|2005-04-01||Interventional|||Telemedicine for Patients With Chronic Respiratory Insufficiency|Randomised Trial on Telemedicine to Save Health Care Requests for Patients With Severe Chronic Respiratory Failure.|Completed||N/A|240|Actual|Fondazione Salvatore Maugeri||2|||f||||f||||||||||2017-02-18 15:02:39.901137|2017-02-18 15:02:39.901137
NCT00563732|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2008-09-08|||December 2007||2007-12-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin|An Open-Label, Nonrandomized Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Lecozotan SR and a Single Oral Dose of Digoxin When Administered Orally to Healthy Adult Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:02:40.027173|2017-02-18 15:02:40.027173
NCT00563706|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2014-02-03|2014-02-03||December 2007||2007-12-01|February 2014|2014-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional||Safety population included all randomized participants who received at least 1 dose of double-blind test article.|Study Evaluating Vabicaserin in Subjects With Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Risperidone-Referenced, Parallel-Group, Adaptive-Design Study of the Efficacy, Safety, and Tolerability of Vabicaserin (SCA-136) in Subjects With Acute Exacerbations of Schizophrenia|Completed||Phase 2|199|Actual|Pfizer|Because of the failure of all vabicaserin doses to meet the primary efficacy objective, the study was terminated prematurely and planned analyses of secondary efficacy endpoints were not performed.|3|||f||||t||||||||||2017-02-18 15:02:40.132015|2017-02-18 15:02:40.132015
NCT00563693|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2015-12-02|||September 2007||2007-09-01|December 2015|2015-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|3C||Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-study)|Open Randomized Study of Patients With Chronic Heart Failure and Cheyne Stokes Respiration Pattern, Treated With ASV. (Adaptive Servo Ventilator).|Completed||N/A|40|Actual|University of Oslo||2|||f||||f||||||||||2017-02-18 15:02:42.419054|2017-02-18 15:02:42.419054
NCT00563680|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-10-26||2015-01-16|October 2007||2007-10-01|October 2016|2016-10-01|August 2012|Actual|2012-08-01|August 2009|Actual|2009-08-01||Interventional|||QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors|A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors|Completed||Phase 2|38|Actual|NantCell, Inc.||2|||f||||||||||||||2017-02-18 15:02:42.529875|2017-02-18 15:02:42.529875
NCT00563667|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||December 2003||2003-12-01|July 2010|2010-07-01|December 2004|Anticipated|2004-12-01|||||Interventional|||Effect of Pterygium Excision on Intraocular Lens Power Calculation for Subsequent Cataract Operation|Effect of Pterygium Excision on IOL Power Calculation: Concurrent Cataract and Pterygium|Unknown status|Active, not recruiting|N/A|40|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:42.653888|2017-02-18 15:02:42.653888
NCT00563654|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-15|||October 2005||2005-10-01|June 2011|2011-06-01|November 2006|Actual|2006-11-01|||||Interventional|||Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up|Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo on the Successful Rate of Trial Without Catheter in Patients With Acute Urinary Retention With Long Term Follow up|Terminated||N/A|48|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:42.746514|2017-02-18 15:02:42.746514
NCT00563641|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2007-11-23|||January 2004||2004-01-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|CNRNCPAP||Very Early Surfactant and NCPAP for Premature Infants With RDS|Very Early Surfactant Without Mandatory Ventilation In Premature Infants Treated With Early Continuous Positive Airway Pressure-A Randomized Controlled Trial|Completed||Phase 3|278|Actual|Colombian Neonatal Research Network||2|||f||||t||||||||||2017-02-18 15:02:42.867812|2017-02-18 15:02:42.867812
NCT00563628|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2007-11-23|||October 2007||2007-10-01|November 2007|2007-11-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Changes in Macular Thickness After Patterns Scan Laser|Pattern Scan Laser System vs Regular Photocoagulation System: Changes in Macular Edema Post Treatment.|Unknown status|Recruiting|Phase 4|8|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||f||||||||||2017-02-18 15:02:42.982304|2017-02-18 15:02:42.982304
NCT00563602|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-22|||August 2007||2007-08-01|November 2007|2007-11-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Treatment for Prevention of Variceal Rebleeding Guided by the Hemodynamic Response|Randomized and Controlled Study of Endoscopic Ligation, Nadolol and Isosorbide Mononitrate vs Endoscopic Ligation and Nadolol Alone, or Associated With Isosorbide Mononitrate or Prazosin, Depending of the Hemodinamyc Response|Unknown status|Recruiting|Phase 4|140|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-02-18 15:02:43.173|2017-02-18 15:02:43.173
NCT00563589|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||August 2003||2003-08-01|July 2010|2010-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation|A Randomized Single-center Trial of Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation|Unknown status|Recruiting|N/A|30|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:43.278694|2017-02-18 15:02:43.278694
NCT00563576|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2012-12-11|2010-10-11||September 2007||2007-09-01|December 2012|2012-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation|Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation|Completed||N/A|71|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 15:02:43.381186|2017-02-18 15:02:43.381186
NCT00563563|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2012-10-31||2012-10-25|October 2007||2007-10-01|October 2012|2012-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent|An Open-Label Study Assessing the Safety and Efficacy of Naltrexone Sustained Release (SR) in Combination With Bupropion Sustained Release (SR) in Overweight and Obese, Nicotine-Dependent Subjects|Completed||Phase 2|30|Actual|Orexigen Therapeutics, Inc||1|||f||||f||||||||||2017-02-18 15:02:43.799292|2017-02-18 15:02:43.799292
NCT00563537|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2010-03-18|||January 2007||2007-01-01|March 2010|2010-03-01|December 2010|Anticipated|2010-12-01|||||Interventional|||Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis|Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis|Unknown status|Recruiting|Phase 1|30|Anticipated|University Hospital, Tours||1|||f||||t||||||||||2017-02-18 15:02:43.906231|2017-02-18 15:02:43.906231
NCT00563524|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-03-09|||December 2007||2007-12-01|March 2011|2011-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis|An Ascending Multiple Dose Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Clinical Efficacy Of ILV-094 Administered Subcutaneously Or Intravenously To Subjects With Psoriasis|Completed||Phase 1|76|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:02:44.018186|2017-02-18 15:02:44.018186
NCT00563511|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-15|||January 2004||2004-01-01|June 2011|2011-06-01|August 2006|Actual|2006-08-01|||||Interventional|||A Randomized Controlled Trial on Smoking Cessation and Adherence Intervention on Patients With Erectile Dysfunction|A Randomized Controlled Trial on Smoking Cessation and Adherence Intervention on Patients With Erectile Dysfunction|Completed||N/A|1210|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:44.140224|2017-02-18 15:02:44.140224
NCT00563498|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||July 2004||2004-07-01|July 2010|2010-07-01|June 2006|Anticipated|2006-06-01|||||Interventional|||Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients|A Randomized Control Studies on the Effects of Glutamine on the Clinical Outcome of Bone Marrow Transplant Recipients With Special Reference to Veno-occlusive Disease and Mucositis.|Unknown status|Recruiting|N/A|40|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:44.24082|2017-02-18 15:02:44.24082
NCT00563485|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-15|||October 2005||2005-10-01|June 2011|2011-06-01|November 2006|Actual|2006-11-01|||||Interventional|||Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up|Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily in the Successful Rate of Trial Without Catheter in Acute Urinary Retention With Long Term Follow up|Terminated||N/A|120|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:44.538682|2017-02-18 15:02:44.538682
NCT00563472|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2012-05-04|||November 2007||2007-11-01|May 2012|2012-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Feasibility Study Into the Contraceptive Effect of Estetrol|A Feasibility Study Into the Contraceptive Effect of Estetrol Alone or Combined With Either Progesterone or Desogestrel by Daily Oral Administration to Healthy Female Volunteers for 28 Days.|Completed||Phase 2|52|Actual|Pantarhei Bioscience||4|||f||||f||||||||||2017-02-18 15:02:44.627066|2017-02-18 15:02:44.627066
NCT00563459|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-01-25||2013-01-15|November 2007||2007-11-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.|A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety, and Tolerability of Carisbamate, Topiramate and Levetiracetam as Adjunctive Therapy in Subjects With Partial Onset Seizures|Terminated||Phase 3|89|Actual|SK Life Science||3||"Carisbamate partial onset seizures studies lacked consistent efficacy data so trials in this~   indication were terminated."|f||||t||||||||||2017-02-18 15:02:44.731303|2017-02-18 15:02:44.731303
NCT00563446|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-14|||July 2005||2005-07-01|June 2011|2011-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia|Conversion From Once Weekly Recombinant Human Erythropoietin to Once Monthly Darbepoetin Alfa for the Treatment of Renal Anemia in Continuous Ambulatory Peritoneal Dialysis Patients|Completed||N/A|16|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:44.844486|2017-02-18 15:02:44.844486
NCT00563433|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-21|||August 1994||1994-08-01|November 2007|2007-11-01|July 1996|Actual|1996-07-01|||||Interventional|||MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers|MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers|Completed||Phase 3|342|Actual|MacroChem Corporation||2|||f||||f||||||||||2017-02-18 15:02:44.935905|2017-02-18 15:02:44.935905
NCT00563238|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2008-07-22|||November 2007||2007-11-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Beta-Blocker Before Extubation|Use of Prophylactic Beta Blockade to Prevent Peri-Extubation Cardiac Ischemia and Congestive Heart Failure|Unknown status|Recruiting|N/A|50|Anticipated|University of Iowa||2|||f||||f||||||||||2017-02-18 15:02:51.705411|2017-02-18 15:02:51.705411
NCT00563420|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-10-22|||November 2002||2002-11-01|October 2013|2013-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer|Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer|Completed||N/A|400|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:45.06326|2017-02-18 15:02:45.06326
NCT00563407|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-02-23|||July 2006||2006-07-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy|Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy|Terminated||N/A|16|Actual|AHS Cancer Control Alberta|||1|accrual goal met|f||||t||||||||||2017-02-18 15:02:45.161522|2017-02-18 15:02:45.161522
NCT00563394|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-21|||August 1994||1994-08-01|November 2007|2007-11-01|July 1996|Actual|1996-07-01|||||Interventional|||MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers|MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers|Completed||Phase 3|584|Actual|MacroChem Corporation||2|||f||||f||||||||||2017-02-18 15:02:45.255613|2017-02-18 15:02:45.255613
NCT00563381|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2013-11-27|2011-03-29||January 2008||2008-01-01|July 2012|2012-07-01||||April 2010|Actual|2010-04-01||Interventional|||Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.|Effect of Inhalation of Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients (a Randomised, Double-blind, Double-dummy, Parallel Group, One-year Study).|Completed||Phase 4|7376|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:02:45.405975|2017-02-18 15:02:45.405975
NCT00563368|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2015-03-10|2012-07-31||December 2007||2007-12-01|March 2015|2015-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults|A Phase III, Randomized, Double-Blind, Parallel-Design Study Comparing Multiple Doses of VI-0521 to Placebo and Their Single-Agent Phentermine and Topiramate Constituents for the Treatment of Obesity in Adults|Completed||Phase 3|756|Actual|VIVUS, Inc.||7|||f||||t||||||||||2017-02-18 15:02:48.986825|2017-02-18 15:02:48.986825
NCT00563355|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-14|||February 2001||2001-02-01|June 2011|2011-06-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients|A Prospective Randomised Controlled Trial to Study the Effects of Recombinant Human Erythropoietin on the Progression of Atherosclerosis, Cardiovascular Function, Nutrition and Residual Renal Function in Pre-dialysis Chronic Renal Failure Patients|Completed||N/A|66|Actual|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:49.934016|2017-02-18 15:02:49.934016
NCT00563342|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2008-10-07|||June 2007||2007-06-01|October 2008|2008-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Ethanol||Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients|Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients|Terminated||Phase 2|40|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:02:50.028442|2017-02-18 15:02:50.028442
NCT00563329|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-10-22|||October 2004||2004-10-01|October 2013|2013-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Smoking Reduction Intervention for Smokers Not Willing to Quit Smoking: a Randomised Control Trial|Smoking Reduction Intervention for Smokers Not Willing to Quit Smoking: a Randomised Control Trial|Completed||N/A|3826|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:50.138819|2017-02-18 15:02:50.138819
NCT00563316|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-03-14|2016-03-14||March 2008||2008-03-01|March 2016|2016-03-01|June 2010|Actual|2010-06-01|March 2009|Actual|2009-03-01||Interventional||Safety analysis set (all participants who received at least 1 dose of panitumumab or irinotecan)|Effect of Panitumumab on the Pharmacokinetics of Irinotecan|A Phase I, Open-label Study to Determine the Effect of Panitumumab on the Pharmacokinetics of Irinotecan in Subjects With Unresectable Metastatic Colorectal Cancer|Completed||Phase 1|28|Actual|Amgen||1|||f||||||||||||||2017-02-18 15:02:50.231992|2017-02-18 15:02:50.231992
NCT00563303|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2010-04-20|||November 2006||2006-11-01|April 2010|2010-04-01|July 2009|Actual|2009-07-01|November 2006|Actual|2006-11-01||Interventional|Hypolyte||Treatment of Polytraumatisms With Corticoids|Interest of Treatment of Polytraumatisms With Corticoids (Hydrocortisone) for Patient With Relative Adrenocortical Insufficiency|Completed||Phase 2/Phase 3|150|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-02-18 15:02:50.709346|2017-02-18 15:02:50.709346
NCT00563290|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2015-05-21|2013-09-10||November 2007||2007-11-01|March 2015|2015-03-01|October 2014|Actual|2014-10-01|April 2012|Actual|2012-04-01||Interventional|||Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia|A Phase 2 Study of Dasatinib in Patients With Transplant and Non-Transplant Related Unresectable or Metastatic Cutaneous Squamous Cell Carcinoma and RAI Stage 0-1 Chronic Lymphocytic Leukemia|Completed||Phase 2|7|Actual|National Cancer Institute (NCI)|3 patients were treated with Dasatinib 100 mg PO twice daily and 4 patients were treated with Daatinib 70 mg PO twice daily.|2|||f||||f||||||||||2017-02-18 15:02:50.903189|2017-02-18 15:02:50.903189
NCT00563277|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||October 2004||2004-10-01|July 2010|2010-07-01|December 2006|Anticipated|2006-12-01|||||Interventional|||Surgical Treatment of Concurrent Cataract and Primary Pterygium|Surgical Treatment of Concurrent Cataract and Primary Pterygium: A Randomized Control Trial|Unknown status|Recruiting|N/A|75|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:51.409613|2017-02-18 15:02:51.409613
NCT00563264|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2014-07-10|||October 2007||2007-10-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|KAN-DO||KAN-DO: A Family-based Intervention to Prevent Childhood Obesity|KAN-DO: A Family-based Intervention to Prevent Childhood Obesity|Completed||N/A|832|Actual|Duke University||2|||f||||t||||||||||2017-02-18 15:02:51.504097|2017-02-18 15:02:51.504097
NCT00563251|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-14|||April 2005||2005-04-01|June 2011|2011-06-01|March 2007|Actual|2007-03-01|||||Interventional|||Effectiveness of Azithromycin Therapy in Improvement of Symptoms and Lung Function in Patients With Bronchiolitis Obliterans After Bone Marrow Transplantation|Azithromycin Therapy for Bronchiolitis Obliterans Syndrome After Allogenic Bone Marrow Transplantation|Completed||N/A|30|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:51.613142|2017-02-18 15:02:51.613142
NCT00563212|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-08-18|||January 2007||2007-01-01|August 2016|2016-08-01|March 2017|Anticipated|2017-03-01|June 2010|Actual|2010-06-01||Interventional|||A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis|A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis|Active, not recruiting||Phase 1|12|Anticipated|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 15:02:51.882115|2017-02-18 15:02:51.882115
NCT00563199|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-14|||March 2002||2002-03-01|June 2011|2011-06-01|December 2005|Actual|2005-12-01|||||Interventional|||A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients|A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients|Completed||N/A|1824|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:52.151947|2017-02-18 15:02:52.151947
NCT00563186|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2009-03-06|||June 2007||2007-06-01|March 2009|2009-03-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial|Physical Plant Design and Engineering Controls and the Prevention of Nosocomial Infections and Antibiotic Resistant Organism Colonization Events - A Proposal for a Prospective Controlled Trial|Unknown status|Recruiting|Phase 3|3600|Anticipated|University of Calgary||2|||f||||f||||||||||2017-02-18 15:02:52.245966|2017-02-18 15:02:52.245966
NCT00563173|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2010-02-09|||October 2007||2007-10-01|February 2010|2010-02-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients|A Phase I/IIa Open-Label, Dose Ranging, Parallel, Safety, Tolerability and Efficacy Study of i.m. Administered CHRONVAC-C® in Combination With Electroporation in Chronic HCV Genotype 1 Infected and Treatment Naïve Patients With Low Viral Load|Unknown status|Active, not recruiting|Phase 1/Phase 2|12|Anticipated|Tripep AB||3|||f||||t||||||||||2017-02-18 15:02:52.357934|2017-02-18 15:02:52.357934
NCT00563160|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||May 2005||2005-05-01|July 2010|2010-07-01|February 2007|Anticipated|2007-02-01|||||Interventional|||Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery|Phase II Study of the Response Rate of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small Cell Lung Cancer Before Surgery|Unknown status|Recruiting|Phase 2|50|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:52.45309|2017-02-18 15:02:52.45309
NCT00563147|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-09-30|||November 2007||2007-11-01|September 2011|2011-09-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma|A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma|Completed||Phase 1|28|Actual|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:02:52.547996|2017-02-18 15:02:52.547996
NCT00563134|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||October 2005||2005-10-01|July 2010|2010-07-01|December 2006|Anticipated|2006-12-01|||||Interventional|||A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in Adult|A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults|Suspended||N/A|1800|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:52.659723|2017-02-18 15:02:52.659723
NCT00563121|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-23|||March 2007||2007-03-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V|Vascular Endothelial Growth Factor Levels in Aqueous, Vitreous and Subretinal Fluid in Patients With Retinopathy of Prematurity Stage IV and V|Completed||Phase 4|16|Actual|Asociación para Evitar la Ceguera en México||1|||f||||t||||||||||2017-02-18 15:02:52.750816|2017-02-18 15:02:52.750816
NCT00563108|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||June 2004||2004-06-01|July 2010|2010-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation|A Double-blind Randomized Single-center Trial of Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation.|Unknown status|Recruiting|N/A|60|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:52.846554|2017-02-18 15:02:52.846554
NCT00563095|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||March 2004||2004-03-01|July 2010|2010-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer|A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|100|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:52.93354|2017-02-18 15:02:52.93354
NCT00563082|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2014-03-20|||May 2000||2000-05-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|||||Observational|||Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus Erythematosus|Prothrombin Gene Varitaion and Risk of SLE and CHD|Completed||N/A|1254|Actual|University of Pittsburgh|||2||f||||t||||||Samples With DNA|"~     DNA and serum~   "|||2017-02-18 15:02:53.025118|2017-02-18 15:02:53.025118
NCT00563069|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||September 2005||2005-09-01|July 2010|2010-07-01|December 2006|Anticipated|2006-12-01|||||Interventional|||Premedication With Oral Midazolam in Patients Undergoing Rigid Cystoscopy: A Randomized, Double-blind, Placebo-controlled Trial|Premedication With Oral Midazolam in Patients Undergoing Rigid Cystoscopy: A Randomized, Double-blind, Placebo-controlled Trial|Unknown status|Recruiting|N/A|120|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:53.109857|2017-02-18 15:02:53.109857
NCT00563056|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2012-08-09|||September 2007||2007-09-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma|Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy & Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent & Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma|Completed||Phase 3|227|Actual|Mundipharma Research Limited||2|||f||||||||||||||2017-02-18 15:02:53.204157|2017-02-18 15:02:53.204157
NCT00563043|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2007-12-05|||October 2007||2007-10-01|December 2007|2007-12-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment|Pattern Scan Laser System vs Regular Photocoagulation System: Changes in Electroretinograms and Contrast Sensitivity Post Treatment.|Unknown status|Recruiting|Phase 4|8|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||f||||||||||2017-02-18 15:02:53.323673|2017-02-18 15:02:53.323673
NCT00563030|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2009-11-02|||December 2007||2007-12-01|November 2009|2009-11-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Observational|||Bands in Peripheral Blood After Coronary Artery Bypass Grafting With and Without Cardiopulmonary Bypass|Comparison of Granulocyte Subsets in Peripheral Blood After Coronary Bypass Grafting Operations With and Without Use of Cardiopulmonary Bypass|Completed||N/A|44|Actual|Medical University of Gdansk|||2||f||||f||||||Samples Without DNA|"~     blood on EDTA vials for automatical morphology analysis and manual blood-smear preparation.~   "|||2017-02-18 15:02:53.448544|2017-02-18 15:02:53.448544
NCT00563017|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2010-07-06|||October 2004||2004-10-01|July 2010|2010-07-01|November 2005|Anticipated|2005-11-01|||||Interventional|||Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone|Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone|Unknown status|Recruiting|N/A|30|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:53.558966|2017-02-18 15:02:53.558966
NCT00563004|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2013-02-27|||August 2008||2008-08-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|December 2009|Actual|2009-12-01||Interventional|||The Effect of DBcare, a Food Supplement on Diabetes Control|A Double-blind Placebo Controlled Study Studying the Efficacy of DBCARE in Improving Diabetes Control|Completed||N/A|35|Actual|Meir Medical Center||2|||f||||f||||||||||2017-02-18 15:02:53.659639|2017-02-18 15:02:53.659639
NCT00562991|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-06-15|||October 2007||2007-10-01|November 2007|2007-11-01|December 2009|Actual|2009-12-01|||||Observational|NOASTHMA||Monitoring Asthma Treatment Using Exhaled Nitric Oxide|Monitoring Asthma Treatment Using Exhaled Nitric Oxide|Completed||N/A|99|Actual|University Hospital, Antwerp|||2||f||||f||||||||||2017-02-18 15:02:53.979871|2017-02-18 15:02:53.979871
NCT00562978|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-22|2017-01-12|||September 1999||1999-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma|A Phase I/II Trial of Escalating Dose of Yttrium-90-labeled Anti-CD20 Monoclonal Antibody in Combination With High-Dose Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplantation for Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1/Phase 2|54|Actual|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 15:02:54.091062|2017-02-18 15:02:54.091062
NCT00562965|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2012-12-22||2012-12-19|November 2007||2007-11-01|December 2012|2012-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)|An Open-Label, Randomized, Phase 3 Study Of Inotuzumab Ozogamicin (CMC-544) Administered In Combination With Rituximab Compared To A Defined Investigator's Choice Therapy In Subjects With Relapsed Or Refractory, CD22-Positive, Follicular B-Cell Non-Hodgkin's Lymphoma|Terminated||Phase 3|29|Actual|Pfizer||2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 15:02:54.215153|2017-02-18 15:02:54.215153
NCT00562952|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2012-05-02|||November 2007||2007-11-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|PONTIAC||Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients|Nt-proBNP Guided Prevention of Cardiovascular Events in a Population of Diabetic Patients Without a History of Cardiac Disease|Completed||Phase 2/Phase 3|300|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 15:02:54.378768|2017-02-18 15:02:54.378768
NCT00562939|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-23|2009-01-20|||January 2008||2008-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|ITAP||Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults|Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults|Completed||Phase 1/Phase 2|97|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:02:54.492249|2017-02-18 15:02:54.492249
NCT00562926|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-08-20|||July 2004||2004-07-01|August 2013|2013-08-01|June 2006|Actual|2006-06-01|||||Observational|||Single Nucleotide Polymorphism (SNP) in Schizophrenia and Schizophrenia Spectrum Disorders: a Population Association Analysis With Hong Kong Chinese|Single Nucleotide Polymorphism (SNP) in Schizophrenia and Schizophrenia Spectrum Disorders: a Population Association Analysis With Hong Kong Chinese|Completed||N/A|32|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:54.614018|2017-02-18 15:02:54.614018
NCT00562913|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-11-24|||December 2007||2007-12-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|June 2009|Actual|2009-06-01||Interventional|||Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin|Phase I Open-label, Non-randomized, Non-placebo Controlled Study to Determine the Safety, Pharmacokinetics, and Tumor Response Profile of Sorafenib as Continuous Dosing in Combination With Cyclophosphamide and Doxorubicin in Patients With Advanced, Refractory Solid Tumors|Completed||Phase 1|21|Actual|Bayer||1|||f||||f||||||||||2017-02-18 15:02:54.707892|2017-02-18 15:02:54.707892
NCT00562900|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2007-11-23|||December 2004||2004-12-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|||||Interventional|||Robotic Assisted Versus Laparoscopic Cholecystectomy - Outcome and Cost Analyses of a Case-Matched Control Study|Robotic Assisted Versus Laparoscopic Cholecystectomy -|Completed||Phase 4|50|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 15:02:54.968333|2017-02-18 15:02:54.968333
NCT00562887|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-08-18||2011-08-18|November 2007||2007-11-01|August 2011|2011-08-01||||April 2010|Actual|2010-04-01||Interventional|||Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease|A Phase 2B, Multi-Center, Randomized, Double-blind, Parallel Group, Placebo-controlled, Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs. Placebo in Subjects With Moderately to Severely Active Crohn's Disease.|Terminated||Phase 2|246|Actual|Abbott||3|||f||||t||||||||||2017-02-18 15:02:55.225171|2017-02-18 15:02:55.225171
NCT00562861|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2016-12-20|2016-07-07||November 2007||2007-11-01|December 2016|2016-12-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||These subjects met inclusion/exclusion criteria and were randomized to citalopram versus placebo.|Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram|Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram|Completed||Phase 2/Phase 3|119|Actual|Tufts Medical Center||2|||f||||t||||||||No||2017-02-18 15:02:55.521644|2017-02-18 15:02:55.521644
NCT00562848|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2017-01-31|||September 2007||2007-09-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040|A First-Time-in-Human Randomized Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of the Oral Motilin Receptor Agonist GSK962040, in Male and Female Healthy Subjects|Completed||Phase 1|49|Anticipated|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:02:56.02808|2017-02-18 15:02:56.02808
NCT00562835|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-21|||February 2008||2008-02-01|November 2007|2007-11-01|February 2009|Anticipated|2009-02-01|||||Interventional|||Steroids in Patients With Early ARDS|Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Evaluate the Safety and Efficacy of Low-Dose Glucocorticoid Infusion in Acute Respiratory Distress Syndrome (ARDS)|Unknown status|Not yet recruiting|Phase 2/Phase 3|400|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-02-18 15:02:56.134995|2017-02-18 15:02:56.134995
NCT00562822|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2014-05-21|||January 1999||1999-01-01|May 2014|2014-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|MRC Knee||Surgery Versus No Surgery for Osteoarthritis (OA) of the Knee|Arthroscopic vs. Non-surgical Treatment of Osteoarthritis of the Knee|Completed||Phase 3|188|Actual|University of Western Ontario, Canada||2|||f||||t||||||||||2017-02-18 15:02:56.260248|2017-02-18 15:02:56.260248
NCT00562809|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-26|||July 2003||2003-07-01|November 2007|2007-11-01|August 2004|Actual|2004-08-01|||||Interventional|||The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension|A Multicenter, Open-Label Study Assessing the Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Hypertension Not Controlled by Monotherapy|Completed||Phase 4|1005|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:02:56.36985|2017-02-18 15:02:56.36985
NCT00562796|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-08-22|||November 2007||2007-11-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|December 2009|Actual|2009-12-01||Observational|||Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity|Prevalence and Metabolic Consequences of Relative Growth Hormone Deficiency in Abdominal Obesity|Completed||N/A|149|Actual|Massachusetts General Hospital|||3||f||||f||||||Samples With DNA|"~     Samples will include serum, plasma, whole blood, and white blood cells~   "|||2017-02-18 15:02:56.470112|2017-02-18 15:02:56.470112
NCT00562783|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2013-10-22|||January 2005||2005-01-01|October 2013|2013-10-01|May 2006|Actual|2006-05-01|||||Interventional|||A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis|A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis|Completed||Phase 2|90|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:02:56.576094|2017-02-18 15:02:56.576094
NCT00562770|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2012-07-27|||September 2003||2003-09-01|July 2012|2012-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Oral Valganciclovir Versus Valacyclovir|Open Label, Phase II Randomized Study of Oral Valganciclovir Versus Valacyclovir for Prophylaxis of Cytomegalovirus Reactivation in Patients Receiving Alemtuzumab (Campath).|Completed||Phase 2|46|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:02:56.673685|2017-02-18 15:02:56.673685
NCT00562757|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-20|||September 2003||2003-09-01|November 2007|2007-11-01|October 2009|Anticipated|2009-10-01|||||Observational|HIP||Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias|The Harbinger ICD Patient (HIP) Study|Unknown status|Active, not recruiting|N/A|320|Actual|Harbinger Medical, Inc.|||1||f||||f||||||||||2017-02-18 15:02:56.790215|2017-02-18 15:02:56.790215
NCT00562744|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-21|||January 2006||2006-01-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Effect of Simulation on PALS Training|The Effect of High-Fidelity Simulation on Pediatric Advanced Life Support Training in Pediatric Housestaff: a Randomized Trial|Completed||N/A|51|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 15:02:56.888158|2017-02-18 15:02:56.888158
NCT00562731|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2008-03-28|||October 2007||2007-10-01|March 2008|2008-03-01|June 2008|Anticipated|2008-06-01|||||Interventional|ARD-0403-010||Open-Label Study of ARD-0403 in Testosterone Deficient Men|A Phase III, Open-Label Follow-on Study for Long-Term Safety and Efficacy of Testosterone Cream, in Testosterone Deficinet Men Completing Study ARD-0403-004|Terminated||Phase 3|150|Anticipated|Ardana Bioscience Ltd||1||Company strategic decision|f||||||||||||||2017-02-18 15:02:56.981903|2017-02-18 15:02:56.981903
NCT00562718|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2009-09-24|||September 2004||2004-09-01|September 2009|2009-09-01||||September 2009|Anticipated|2009-09-01||Interventional|||Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery|A Pilot Safety And Feasibility Study Of Concurrent Capecitabine (Xeloda) And External Beam Irradiation In The Adjuvant Treatment Of High Risk Early Stage Breast Cancer.|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:02:57.077183|2017-02-18 15:02:57.077183
NCT00562705|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-07-15|||January 2008||2008-01-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effects of Growth Hormone (GH) Treatment on Eating Regulation|Effects of Growth Hormone Treatment on Eating Regulation and Comparison Between the Growth Responses With or Without Nutritional Intervention in Short Stature Children|Completed||N/A|32|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 15:02:57.179148|2017-02-18 15:02:57.179148
NCT00562692|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2015-06-23|||September 2007||2007-09-01|June 2015|2015-06-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|BNP in OAD||Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease|Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease|Terminated||Phase 3|6|Actual|The Alfred||2||Recruitment very difficult. Study drug expired so we have stopped the study.|f||||f||||||||||2017-02-18 15:02:57.290321|2017-02-18 15:02:57.290321
NCT00562679|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2008-07-01|||March 1992||1992-03-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|||||Observational|||Coronary Artery Disease and Sleep Apnea|Long Term Effects of Sleep Apnea in Patients With Coronary Artery Disease|Completed||N/A|408|Actual|Umeå University|||1||f||||||||||||||2017-02-18 15:02:57.390455|2017-02-18 15:02:57.390455
NCT00562666|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2012-06-21|||February 2008||2008-02-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|ICAR||Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells|Immunotherapy of Hepatocellular Carcinoma by Hepatic Intra Arterial Injection of Autologous Gamma-delta T Lymphocytes: A Phase I Study|Terminated||Phase 1|2|Actual|Rennes University Hospital||4|||f||||t||||||||||2017-02-18 15:02:57.686485|2017-02-18 15:02:57.686485
NCT00562653|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-21|||November 2007||2007-11-01|November 2007|2007-11-01|November 2008|Anticipated|2008-11-01|||||Observational|||Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients|Study of Autoantibodies in Infective Endocarditis|Unknown status|Not yet recruiting|N/A|100|Anticipated|Tel-Aviv Sourasky Medical Center|||3||f||||t||||||None Retained|"~     serum~   "|||2017-02-18 15:02:57.799424|2017-02-18 15:02:57.799424
NCT00562640|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-12-14|||October 2007||2007-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)|A Phase I Dose Escalation Safety and Feasibility Study of WT1-Specific T Cells for the Treatment of Patients With Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Carcinomas|Active, not recruiting||Phase 1|21|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:02:57.901145|2017-02-18 15:02:57.901145
NCT00562627|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-08-05|2011-05-24||November 2007||2007-11-01|August 2011|2011-08-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of Multimodal Peri- and Intraarticular Drug Injections in Total Knee Arthroplasty|Efficacy of Multimodal Peri- and Intraarticular Drug Injections in Total Knee Arthroplasty|Completed||Phase 4|102|Actual|Asker & Baerum Hospital||3|||f||||f||||||||||2017-02-18 15:02:58.026437|2017-02-18 15:02:58.026437
NCT00562614|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2015-01-08|||June 2007||2007-06-01|January 2015|2015-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension|A Pilot Phase IIa Randomised, Double-blind, Placebo-controlled, Crossover Study to Examine the Safety, Tolerability and Pharmacodynamic Effects on Blood Pressure of Repeat Oral Doses of SLx-2101 5 mg or 10 mg Once Daily for up to 14 Days in Patients With Hypertension|Completed||Phase 2|38|Actual|Kadmon Corporation, LLC||2|||f||||f||||||||||2017-02-18 15:02:58.589099|2017-02-18 15:02:58.589099
NCT00562601|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2017-01-24|||October 8, 1987||1987-10-08|February 19, 2016|2016-02-19||||||||Observational|||LCI Apheresis to Obtain Plasma or White Blood Cells|Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies|Enrolling by invitation||N/A|858|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:02:58.69356|2017-02-18 15:02:58.69356
NCT00562588|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2014-01-31|2010-01-29||July 2007||2007-07-01|January 2014|2014-01-01||||February 2009|Actual|2009-02-01||Interventional|||EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA|EARLY: Prospective, Randomised, National, Multi-centre, Open-label, Blinded Endpoint Study to Compare Aggrenox b.i.d. (200 mg Dipyridamole MR + 25 mg Acetylsalicylic Acid) When Started Within 24 Hours of Stroke Onset on an Acute Stroke Unit, and Aggrenox b.i.d. When Started After a 7-day Therapy With ASA 100 mg Once Daily Outside Off an Acute Stroke Unit, in Symptomatic Ischaemic Stroke Patients Over a Three Months Treatment Period an Exploratory Study|Completed||Phase 4|551|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:02:58.784627|2017-02-18 15:02:58.784627
NCT00562575|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2015-01-26||2014-12-09|May 2007||2007-05-01|January 2015|2015-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides|A Randomised, Double-blind, Placebo Controlled Study to Evaluate the Pharmacodynamics, Safety, Tolerability and Pharmacokinetics Profile of SLx-4090 Over 14 Days Dosing in Subjects With High Triglyceride Values|Completed||Phase 2|24|Actual|Kadmon Corporation, LLC||2|||f||||f||||||||||2017-02-18 15:02:59.67113|2017-02-18 15:02:59.67113
NCT00562562|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-21|||September 2007||2007-09-01|November 2007|2007-11-01|August 2008|Anticipated|2008-08-01|||||Interventional|MRI-OMT||A Pilot MRI Study of Osteopathic Manipulative Treatment of Acute Low Back Pain|A Pilot MRI Study of Osteopathic Manipulative Treatment of Acute Low Back Pain|Unknown status|Recruiting|N/A|6|Anticipated|Ohio University||1|||f||||f||||||||||2017-02-18 15:02:59.782158|2017-02-18 15:02:59.782158
NCT00562549|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2015-01-08|||July 2007||2007-07-01|January 2015|2015-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension|A Pilot Phase IIa Randomised, Double-blind, Placebo-controlled, Crossover Study to Examine the Safety, Tolerability and Pharmacodynamic Effects on Blood Pressure of Repeat Oral Doses of SLx-2101 5, 10 or 20 mg Once Daily for up to 14 Days in Patients With Hypertension|Completed||Phase 2|26|Actual|Kadmon Corporation, LLC||2|||f||||f||||||||||2017-02-18 15:02:59.869819|2017-02-18 15:02:59.869819
NCT00562536|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-21|||November 2007||2007-11-01|November 2007|2007-11-01|November 2010|Anticipated|2010-11-01|||||Interventional|DUC||Delayed Umbilical Cord Clamping in Infants Less Than 32 Weeks|Delayed Umbilical Cord Clamping in Infants Less Than 32 Weeks: A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|296|Anticipated|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-02-18 15:02:59.972026|2017-02-18 15:02:59.972026
NCT00562523|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-05-22|||November 2007||2007-11-01|May 2013|2013-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Sorafenib/Docetaxel Dose Escalation Trial|A Phase I Dose Escalation Study With Sorafenib Administered Continuously in Combination With Docetaxel Administered Once Every Three Weeks in Patients With Advanced Solid Tumors.|Completed||Phase 1|17|Actual|Bayer||1|||f||||f||||||||||2017-02-18 15:03:00.081262|2017-02-18 15:03:00.081262
NCT00562510|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2015-06-05|||August 2008||2008-08-01|June 2015|2015-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery|A Phase 3, Randomized, Double Blinded, Placebo Controlled Study of Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery|Terminated||Phase 3|20|Actual|The Huesped Foundation||2||recruitment lower than estimated|f||||t||||||||||2017-02-18 15:03:00.209364|2017-02-18 15:03:00.209364
NCT00562315|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2016-06-17|2015-07-23||October 2007||2007-10-01|June 2016|2016-06-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Participants completed both the FACBC PET-CT and the ProstaScint CT.|FACBC PET/CT for Recurrent Prostate Cancer|18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma (CA129356-01).|Completed||Phase 2|128|Actual|Emory University||1|||f||||t||||||||||2017-02-18 15:03:04.776214|2017-02-18 15:03:04.776214
NCT00562497|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2014-12-02|||September 2007||2007-09-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety of Prochymal™ Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute GVHD|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal™ Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute GVHD|Completed||Phase 3|184|Actual|Mesoblast, Ltd.||2|||f||||t||||||||||2017-02-18 15:03:00.344931|2017-02-18 15:03:00.344931
NCT00562484|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2016-07-17|2011-07-08||March 2008||2008-03-01|August 2011|2011-08-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|CSL's IVV||A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults|A Phase IV, Randomized, Observer-Blind, Placebo-Controlled, Multi-Centre Study to Evaluate the Efficacy, Safety and Tolerability of CSL Limited's Influenza Virus Vaccine in Adults Aged ≥ 18 to < 65 Years.|Completed||Phase 4|7500|Actual|Seqirus||2|||f||||||||||||||2017-02-18 15:03:00.539773|2017-02-18 15:03:00.539773
NCT00562471|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-21|||July 2003||2003-07-01|November 2007|2007-11-01|January 2005|Actual|2005-01-01|||||Interventional|||Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation|A Controlled Randomized Multicenter Study to Assess the Safety and Performance of Adhibit™ Adhesion Prevention Gel in Myomectomy Surgery|Completed||Phase 1/Phase 2|76|Actual|Angiotech Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:03:01.570282|2017-02-18 15:03:01.570282
NCT00562458|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-02-04|||December 2006||2006-12-01|February 2013|2013-02-01||||||||Observational|||Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer|ARIMIDEX Study ( Non-interventional Study to Evaluate Arimidex in Adjuvant Therapy in Partial or Complete Response or Stabilized Disease After First Line Chemotherapy in Postmenopausal Women With Advanced Breast Cancer)|Completed||N/A|200|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:03:01.792245|2017-02-18 15:03:01.792245
NCT00562445|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2007-11-21|||May 2007||2007-05-01|November 2007|2007-11-01|May 2008|Anticipated|2008-05-01|||||Observational|||Adrenal Insufficiency in Critical Emergencies in Digestive Diseases|Evaluation of the Incidence and Relevance of the Adrenal Insufficiency in Critical Emergencies in Digestive Diseases (GI Bleeding and Acute Pancreatitis)|Unknown status|Recruiting|N/A|75|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||3||f||||t||||||||||2017-02-18 15:03:01.869951|2017-02-18 15:03:01.869951
NCT00562432|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-03-08|||February 2008||2008-02-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Randomized Study to Demonstrate the Safety and Feasibility of Plexisyl-AF in Patients Undergoing Coronary Artery Bypass Grafting (CABG)|A Randomized Study to Demonstrate the Safety and Feasibility of Plexisyl-AF Administered to the Epicardial Fat Pads in Patients Undergoing Open-chest Coronary Artery Bypass Grafting (CABG)|Completed||N/A|32|Actual|LoneStar Heart, Inc.||2|||f||||f||||||||||2017-02-18 15:03:01.969226|2017-02-18 15:03:01.969226
NCT00562419|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2010-10-26|||October 2007||2007-10-01|October 2010|2010-10-01|December 2011|Anticipated|2011-12-01|June 2011|Anticipated|2011-06-01||Interventional|||CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan|Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 2|72|Anticipated|Adnexus, A Bristol-Myers Squibb R&D Company||2|||f||||f||||||||||2017-02-18 15:03:02.093384|2017-02-18 15:03:02.093384
NCT00562406|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2011-07-20|||November 2007||2007-11-01|July 2011|2011-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|RABAMES||Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)|Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)|Completed||N/A|30|Actual|Klinikum Ludwigshafen||3|||f||||f||||||||||2017-02-18 15:03:02.202422|2017-02-18 15:03:02.202422
NCT00562393|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2015-07-13|||April 2007||2007-04-01|July 2015|2015-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|EXCESS||Effects of Excess Energy Intake on Metabolic Risk|Effects of Excess Energy Intake on Metabolic Risk|Completed||N/A|41|Actual|Garvan Institute of Medical Research||1|||f||||f||||||||||2017-02-18 15:03:02.3339|2017-02-18 15:03:02.3339
NCT00562380|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2013-07-17|||October 2005||2005-10-01|April 2010|2010-04-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma|A Phase 1, Open-Label, Dose Finding Study Evaluating the Safety and Pharmacokinetics of AMG 479 in Subjects With Advanced Solid Tumors|Completed||Phase 1|64|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 15:03:02.443266|2017-02-18 15:03:02.443266
NCT00562367|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-21|||October 2001||2001-10-01|November 2007|2007-11-01|September 2004|Actual|2004-09-01|||||Interventional|||Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones|Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones|Completed||N/A|30|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 15:03:02.549709|2017-02-18 15:03:02.549709
NCT00562354|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-10-05|2011-08-11||October 2007||2007-10-01|October 2011|2011-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Adults Aged >= 50 Years|A Phase 3, Open-Label Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a 13vPnC When Administered to Healthy Japanese Adults Aged >= 65 Years and 50 to 64 Years in Japan Who Have Not Received a Previous Dose of 23-Valent Pneumococcal Polysaccharide Vaccine|Completed||Phase 3|271|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:03:02.833543|2017-02-18 15:03:02.833543
NCT00562341|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-21|||November 2007||2007-11-01|September 2007|2007-09-01|December 2009|Anticipated|2009-12-01|||||Observational|||Effect of Lap-Band Induced Weight Loss on Serum PSA Levels|Effect of Lap-Band Induced Weight Loss on Serum PSA Levels, Testosterone, Estrogen and Other Serum Markers|Unknown status|Recruiting|N/A|20|Anticipated|Maimonides Medical Center|||1||f||||f||||||Samples Without DNA|"~     blood samples~   "|||2017-02-18 15:03:04.278252|2017-02-18 15:03:04.278252
NCT00562328|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-04-19|2012-04-11||January 2008||2008-01-01|June 2015|2015-06-01||||August 2010|Actual|2010-08-01||Interventional|||Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia|Antibody Therapy With Alemtuzumab, Rituximab and GM-CSF for Initial Treatment of High Risk Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 2|33|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 15:03:04.368779|2017-02-18 15:03:04.368779
NCT00562302|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2013-03-26|2013-02-04||April 2005||2005-04-01|March 2013|2013-03-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure|A Prospective, Randomized, Multi-centered Safety and Efficacy Evaluation of the Bio-Seal Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy|Completed||Phase 3|339|Actual|Angiotech Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:03:05.340389|2017-02-18 15:03:05.340389
NCT00562289|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2017-02-02|||December 2007||2007-12-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|CLOSE||Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence|Closure of Patent Foramen Ovale or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence|Completed||Phase 3|664|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-02-18 15:03:05.930939|2017-02-18 15:03:05.930939
NCT00562276|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2012-09-12|||May 2007||2007-05-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|PAIR||Immediate Versus Delayed Intrauterine Device (IUD) Insertion Following First Trimester Suction Aspiration Procedures|Immediate Versus Delayed IUD Insertion Following Suction Aspiration Between 5 and 12 Weeks Gestation: a Randomized Trial|Completed||Phase 4|578|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 15:03:06.049965|2017-02-18 15:03:06.049965
NCT00562263|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2014-03-28|||October 2007||2007-10-01|March 2014|2014-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|TEENS||Barriers to Effective Weight Loss in Overweight Adolescents|Barriers to Effective Weight Loss in Overweight Adolescents Enrolled in an Intensive, Team-based, Family-centered Lifestyle Modification Program|Completed||N/A|257|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 15:03:06.153716|2017-02-18 15:03:06.153716
NCT00562250|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-21|2016-10-14|||May 2008||2008-05-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects|Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects|Completed||Phase 1|11|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:03:06.265551|2017-02-18 15:03:06.265551
NCT00562237|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2008-10-24|||July 2007||2007-07-01|October 2008|2008-10-01|September 2008|Anticipated|2008-09-01|November 2007|Actual|2007-11-01||Interventional|||Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine|Randomized, Observer-Blind, Placebo-Controlled Study to Assess the Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Surface Antigen Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years.|Terminated||Phase 1|400|Anticipated|Solvay Pharmaceuticals||7||"This trial discontinued on 20 JUN 2008 because the interim immunogenicity results do not~   justify these formulations as pandemic vaccine candidates"|f||||f||||||||||2017-02-18 15:03:06.377694|2017-02-18 15:03:06.377694
NCT00562224|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2011-09-26|||November 2007||2007-11-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients|Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of PCI-24781 Administered Orally in Patients With Advanced Cancer|Completed||Phase 1|36|Anticipated|Pharmacyclics LLC.||1|||f||||f||||||||||2017-02-18 15:03:06.488951|2017-02-18 15:03:06.488951
NCT00562211|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2014-05-05|||November 2007||2007-11-01|November 2007|2007-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy of a New Topical Anesthetic|A Single-blind, Randomized, Controlled Trial to Assess the Efficacy of a New Topical Anesthetic in Reducing Pain Associated With Venipuncture in Children.|Completed||Phase 1/Phase 2|40|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-02-18 15:03:08.967099|2017-02-18 15:03:08.967099
NCT00562198|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2008-06-12|||January 2008||2008-01-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding|Effects of Single Doses of Stalevo 200 and Levodopa/Carbidopa 200/50mg on Striatal 11C-Raclopride Binding Potential in Parkinson's Disease Patients With Wearing-Off Symptoms;an Open, Randomised, Active-Controlled,Two-Period Crossover Study.|Terminated||Phase 2|16|Anticipated|Orion Corporation, Orion Pharma||1||Illogistical results found in interim evaluation.|f||||f||||||||||2017-02-18 15:03:09.104829|2017-02-18 15:03:09.104829
NCT00562185|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2009-03-19|||May 2008||2008-05-01|March 2009|2009-03-01||||March 2009|Actual|2009-03-01||Interventional|||Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer|A Phase I/II Study of Intravenous Doxil and Intraperitoneal Carboplatin as Salvage Therapy in Patients With Recurrent Ovarian Cancer|Completed||Phase 1/Phase 2|61|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:03:09.206329|2017-02-18 15:03:09.206329
NCT00562172|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2012-07-16|||September 2007||2007-09-01|July 2012|2012-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)|Lantus vs Sulfonylurea as add-on Therapy in Type 2 Diabetic Patients Failing Metformin Monotherapy: Comparison of Effects on Beta Cell Function and Metabolic Profile.|Completed||Phase 4|75|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:03:09.307484|2017-02-18 15:03:09.307484
NCT00562159|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2015-10-09|2012-08-07||November 2007||2007-11-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Grass (Phleum Pratense) Sublingual Tablet (SCH 697243) in Adult Subjects With a History of Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma|Completed||Phase 3|439|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:03:09.412391|2017-02-18 15:03:09.412391
NCT00562146|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2008-10-27|||December 2007||2007-12-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Rate of Postpyloric Migration of Spiral Nasojejunal Tubes in Brain Injured Patients|Rate of Postpyloric Migration of Spiral Nasojejunal Tubes in Brain Injured Patients|Completed||N/A|120|Actual|Capital Medical University|||2||f||||t||||||||||2017-02-18 15:03:09.84799|2017-02-18 15:03:09.84799
NCT00562133|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-20|||December 2006||2006-12-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes|Effect of Prandial Treatment With Insulin Glulisine Compared to Regular Human Insulin on Postprandial Endothelial Function and Microvascular Stress in Type 2 Diabetic Patients|Completed||Phase 3|15|Actual|IKFE Institute for Clinical Research and Development||2|||f||||f||||||||||2017-02-18 15:03:09.941289|2017-02-18 15:03:09.941289
NCT00562120|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2014-03-10|2014-03-10||December 2007||2007-12-01|March 2014|2014-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional||Safety analysis set included all participants randomized at baseline and who received at least 1 dose of double-blind treatment.|A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge|A Randomized, Double Blind, Double Dummy, Placebo Controlled, Four Way Crossover Study To Determine The Effects Of An H3 Receptor Antagonist (PF-03654746) On Congestion Following A Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis.|Completed||Phase 2|21|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 15:03:12.435081|2017-02-18 15:03:12.435081
NCT00562107|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2014-09-26|||December 2007||2007-12-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|March 2011|Actual|2011-03-01||Interventional|ANSWER||Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication|Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication|Completed||Phase 4|650|Actual|LivaNova||2|||f||||t||||||||||2017-02-18 15:03:13.319083|2017-02-18 15:03:13.319083
NCT00562094|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2012-05-04|2010-09-01||October 2007||2007-10-01|May 2012|2012-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|PULS||Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)|Pantoprazole for the Treatment of GERD Associated Symptoms Focusing on Sleep Disorders.|Completed||N/A|8616|Actual|Nycomed|||1||f||||f||||||||||2017-02-18 15:03:13.512454|2017-02-18 15:03:13.512454
NCT00562081|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2016-04-28|||March 2005||2005-03-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|VAC||The Virtual Asthma Clinic|Evaluation of an Internet-based Approach to Long-term Treatment of Asthma.|Terminated||Phase 4|27|Actual|University of Alberta||2||Poor recruitment.|f||||f||||||||||2017-02-18 15:03:15.872958|2017-02-18 15:03:15.872958
NCT00562068|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2013-08-23|||May 2007||2007-05-01|November 2008|2008-11-01||||May 2009|Anticipated|2009-05-01||Interventional|||Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma|CHOP-Campath, A Pilot Study of CHOP Plus Campath for the Primary Treatment of ALK-ve Peripheral T Cell Lymphoma [CHOP-CAMPATH]|Unknown status|Recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:03:15.984425|2017-02-18 15:03:15.984425
NCT00562055|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2008-06-19|||November 2007||2007-11-01|June 2008|2008-06-01||||||||Interventional|||Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.|Phase 2, Randomized, Double-Blind, Parallel-Group, Four Week, Efficacy And Safety Trial Of [S,S]-Reboxetine (PNU-165442g) And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.|Withdrawn||Phase 2|96|Anticipated|Pfizer||2||This study was withdrawn due to business reasons.|f||||||||||||||2017-02-18 15:03:16.099931|2017-02-18 15:03:16.099931
NCT00562042|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-20|||June 2004||2004-06-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Observational|||Risk Stratification for Patients Presenting With Acute Pulmonary Embolism (PE)|Risk Stratification for Patients Presenting With Acute Pulmonary Embolism (PE)|Terminated||N/A|28|Actual|Walter Reed Army Medical Center|||1|Study was stopped due to slow accrual of patients.|f||||f||||||||||2017-02-18 15:03:16.185101|2017-02-18 15:03:16.185101
NCT00562029|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-05-19|||November 2007||2007-11-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|DJB||Study of Duodenal-Jejunal Bypass(DJB) as a Potential Cure for Type 2 Diabetes Mellitus|"Modified Duodenal Switch Procedure Duodenal-Jejunal Bypass (Diabetes Surgery) As A Potential Cure for Type 2 Diabetes Mellitus in Non-Obese Patients- a Pilot Project to Validate a Prospective Randomized Control Trial"|Completed||N/A|10|Anticipated|Sound Shore Medical Center of Westchester||1|||f||||t||||||||||2017-02-18 15:03:16.272346|2017-02-18 15:03:16.272346
NCT00562016|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2011-03-18|||October 2007||2007-10-01|March 2011|2011-03-01|September 2011|Anticipated|2011-09-01|April 2011|Anticipated|2011-04-01||Interventional|PROTECT II||Protect II, A Prospective, Multicenter Randomized Controlled Trial|PROTECT II: A Prospective, Multi-center, Randomized Controlled Trial of the IMPELLA RECOVER LP 2.5 System Versus Intra Aortic Balloon Pump (IABP)in Patients Undergoing Non Emergent High Risk PCI|Terminated||Phase 3|452|Actual|Abiomed Inc.||2||"Futility on primary endpoint.Study confounded by statistically significant differences between~   the two arms re: atherectomy, duration of support."|f||||t||||||||||2017-02-18 15:03:16.395567|2017-02-18 15:03:16.395567
NCT00562003|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-01-25|||June 2007||2007-06-01|January 2011|2011-01-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|Ad5Delta24RGD||Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients|A Phase I Study of a Tropism Modified Conditionally Replicative Adenovirus Vector (Ad5-Delta 24 RGD)for Intraperitoneal Delivery in Ovarian and Extraovarian Cancer Patients (Infectivity Enhanced Virotherapy for Ovarian Cancer)|Completed||Phase 1|26|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 15:03:16.545217|2017-02-18 15:03:16.545217
NCT00561990|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2015-10-13|||September 2007||2007-09-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|||Nimotuzumab in Adults With Pancreatic Cancer|A RANDOMIZED, MULTICENTER, PHASE IIB/IIIA STUDY OF GEMCITABINE AND THE MONOCLONAL ANTIBODY NIMOTUZUMAB (OSAG 101) VERSUS GEMCITABINE AND PLACEBO FOR THE TREATMENT OF CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER|Completed||Phase 2/Phase 3|188|Anticipated|Oncoscience AG||2|||f||||t||||||||||2017-02-18 15:03:16.651192|2017-02-18 15:03:16.651192
NCT00561977|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-08-02|2010-01-18||May 2007||2007-05-01|August 2011|2011-08-01|February 2009|Actual|2009-02-01|May 2008|Actual|2008-05-01||Interventional|CanDo||Cancer Dietary Objectives Study|Finding a Simple Message to Improve Dietary Quality for Cancer and Heart Disease|Completed||N/A|36|Actual|University of Massachusetts, Worcester||3|||f||||f||||||||||2017-02-18 15:03:16.765405|2017-02-18 15:03:16.765405
NCT00561964|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-22|||January 2004||2004-01-01|November 2007|2007-11-01|July 2005|Actual|2005-07-01|||||Interventional|PRIME||Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria|Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria|Completed||Phase 3|241|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:03:17.774731|2017-02-18 15:03:17.774731
NCT00561951|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2011-07-11|2010-01-11||November 2007||2007-11-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo In Patients With Overactive Bladder.|Completed||Phase 2|951|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 15:03:17.865914|2017-02-18 15:03:17.865914
NCT00561925|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2014-03-07|2011-12-13||November 2007||2007-11-01|March 2014|2014-03-01||||November 2011|Actual|2011-11-01||Interventional|||VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients|A Randomised, Double Blind, Double Dummy, Parallel Group, Active Controlled Trial to Evaluate the Antiviral Efficacy of 400 mg QD neVirapine Extended Release Formulation in Comparison to 200 mg BID neVirapinE Immediate Release in Combination With Truvada® in Antiretroviral Therapy naïve HIV-1 Infected Patients (VERxVE)|Completed||Phase 3|1068|Actual|Boehringer Ingelheim|For the lead-in-period with NVP IR 200mg QD, MedDRA Version 12.1 was used for AE/SAE reporting.|2|||f||||||||||||||2017-02-18 15:03:19.075078|2017-02-18 15:03:19.075078
NCT00561912|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-11-22|2011-11-22||October 2007||2007-10-01|November 2011|2011-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma|Phase II Study of Low Dose Decitabine (5-Aza-Deoxycytidine) With Interferon Alfa-2b in Advanced Renal Cell Carcinoma|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Low accrual.|f||||f||||||||||2017-02-18 15:03:22.46531|2017-02-18 15:03:22.46531
NCT00561899|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2017-01-25|||August 2007||2007-08-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Children|Comparison of Safety, Tolerability and Efficacy of Three Drug Combinations for Intermittent Preventive Treatment in Children Aged 1-5 Years in an Area of Seasonal Malaria Transmission in Upper River Division, The Gambia|Completed||Phase 2/Phase 3|1295|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-02-18 15:03:22.70792|2017-02-18 15:03:22.70792
NCT00561886|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-20|||April 2007||2007-04-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Change of Inspiratory Peak Flow in COPD|Change of Inspiratory Peak Flow After Bronchial Dilatation on Patients With Moderate to Severe COPD|Completed||Phase 4|40|Actual|Johannes Gutenberg University Mainz||1|||f||||t||||||||||2017-02-18 15:03:22.823692|2017-02-18 15:03:22.823692
NCT00561873|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-20|||June 2004||2004-06-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|||||Observational|||Nimotuzumab in Children With HGG|Phase-II-Study of Efficacy of OSAG 101 (Theraloc®) for Adolscent Patients With Recurrent High Grade Glioma|Completed||N/A|45|Actual|Oncoscience AG|||1||f||||t||||||||||2017-02-18 15:03:22.930487|2017-02-18 15:03:22.930487
NCT00561860|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2014-03-14|||November 2007||2007-11-01|March 2014|2014-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Use of a Remote-Monitoring System to Diagnose and Treat Obstructive Sleep Apnea|Use of a Remote-Monitoring System to Diagnose and Treat Obstructive Sleep Apnea|Completed||N/A|75|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 15:03:23.026185|2017-02-18 15:03:23.026185
NCT00561847|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2013-04-02|||January 2007||2007-01-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 15:03:23.220729|2017-02-18 15:03:23.220729
NCT00561834|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2016-08-23|2014-03-03||November 2007||2007-11-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|NAION||Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy|Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy (NAION)|Completed||Phase 1|2|Actual|University of Colorado, Denver||1|||f||||f||||||||No||2017-02-18 15:03:23.278383|2017-02-18 15:03:23.278383
NCT00561821|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-06-11|2014-06-30||November 2007||2007-11-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||All Subjects Treated (AST) population consisted of participants who received at least one dose of study medication.|Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)|A Double-Blind, Randomized, Parallel Group, Placebo- Controlled Sleep Laboratory Efficacy and Safety Study With Org 50081 in Elderly Subjects With Chronic Primary Insomnia|Completed||Phase 3|538|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:03:23.508231|2017-02-18 15:03:23.508231
NCT00561808|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2010-03-08|||January 2008||2008-01-01|March 2010|2010-03-01|January 2009|Actual|2009-01-01|||||Interventional|IVM||In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVF|In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVF|Completed||N/A|30|Actual|Hillel Yaffe Medical Center||1|||f||||t||||||||||2017-02-18 15:03:24.630851|2017-02-18 15:03:24.630851
NCT00561795|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2012-03-15|2009-11-19||September 2007||2007-09-01|March 2011|2011-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors|A Phase I/II, Open-Label, Multicenter, Two-Arm, Feasibility Study of Pazopanib, Carboplatin, and Paclitaxel in Women With Newly Diagnosed, Previously Untreated, Gynaecological Tumors|Completed||Phase 2|12|Actual|GlaxoSmithKline|As defined in the protocol, a review of the safety data in Arm A showed that >=2 participants in each regimen of Arm A experienced dose-limiting toxicities. Thus the study was closed to further enrollment and no participants were enrolled into Arm B.|2|||f||||f||||||||||2017-02-18 15:03:24.731953|2017-02-18 15:03:24.731953
NCT00561782|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2014-09-16|||October 2007||2007-10-01|September 2014|2014-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|MRS||MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI|MR Spectroscopy (MRS) as a Diagnostic and Outcome Measure in Pain and SCI|Completed||N/A|94|Actual|VA Office of Research and Development|||4||f||||f||||||||||2017-02-18 15:03:25.342142|2017-02-18 15:03:25.342142
NCT00561769|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2007-11-20|||January 2005||2005-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||Luteal Phase Commencing of Growth Hormone|Growth Hormone co-Treatment Within a GnRH Agonist Long Protocol in Patients With Poor Ovarian Response|Completed||Phase 4|61|Actual|Gulhane School of Medicine|||1||f||||t||||||||||2017-02-18 15:03:25.449313|2017-02-18 15:03:25.449313
NCT00561756|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2015-11-16|||October 2007||2007-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma|Phase I Trial to Assess Safety and Immunogenicity of Xenogeneic CD20 DNA Vaccination With Patients With B-Cell Lymphoma|Completed||Phase 1|8|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:03:25.545105|2017-02-18 15:03:25.545105
NCT00561743|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2011-06-07||2011-06-07|November 2005||2005-11-01|April 2010|2010-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients|A Phase II Study to Assess the Safety and Efficacy of DBd Combination Therapy (DOXIL/CAELYX) [Doxorubicin HCL Liposome Injection], VELCADE [Bortezomib] and Dexamethasone) for Previously Untreated Multiple Myeloma Patients|Completed||Phase 2|50|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 15:03:25.816637|2017-02-18 15:03:25.816637
NCT00561730|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2012-05-04|2010-08-23||October 2007||2007-10-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|||||Observational|PANTHER||Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)|Pantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)|Completed||N/A|1995|Actual|Nycomed|||1||f||||f||||||||||2017-02-18 15:03:25.926119|2017-02-18 15:03:25.926119
NCT00561717|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2013-05-05|||October 2007||2007-10-01|May 2013|2013-05-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|GEYSER||A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis|A Four-Way Double-Blind, Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of Azelastine Nasal Spray and Antihistaminic Agents in Adult Subjects With Allergen Induced Seasonal Allergic Rhinitis|Completed||Phase 4|70|Actual|Bayer||4|||f||||f||||||||||2017-02-18 15:03:27.02051|2017-02-18 15:03:27.02051
NCT00561704|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2007-11-20|||April 2007||2007-04-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Adiponectin in Obese Women With T2DN and Effects by RAS Blocker|Adiponectin in Obese Women With T2DN and Effects by RAS Blocker|Completed||N/A|80|Actual|Shanghai Jiao Tong University School of Medicine|||||f||||t||||||||||2017-02-18 15:03:27.153221|2017-02-18 15:03:27.153221
NCT00561691|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2013-03-27|||April 2006||2006-04-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|||||Observational|||Nimotuzumab in Children With Intrinsic Pontine Glioma|Phase III Study on the Effectiveness of OSAG 101 (Theraloc®)in Newly Diagnosed Intrinsic Pontine Gliomas of Children and Adolescents|Completed||N/A|41|Actual|Oncoscience AG|||1||f||||t||||||||||2017-02-18 15:03:27.266665|2017-02-18 15:03:27.266665
NCT00561678|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2014-05-14|||February 2008||2008-02-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve|Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve|Completed||Phase 4|403|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 15:03:27.380153|2017-02-18 15:03:27.380153
NCT00561652|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-01-23|2014-11-06||April 2008||2008-04-01|January 2015|2015-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Education/Exercise and Chiropractic for Chronic Back Pain|Education/Exercise and Chiropractic for Chronic Back Pain|Completed||N/A|30|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:03:27.500698|2017-02-18 15:03:27.500698
NCT00561639|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2010-07-08|||December 2007||2007-12-01|July 2010|2010-07-01|November 2008|Actual|2008-11-01|||||Observational|SEPTIFAST||Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis|Benefit of Septifast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis|Completed||N/A|76|Actual|University Hospital, Grenoble|||1||f||||t||||||Samples Without DNA|"~     serum tube will routinely be kept in the serum bank for subsequent analysis~   "|||2017-02-18 15:03:28.079459|2017-02-18 15:03:28.079459
NCT00561626|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2008-12-11|||January 2008||2008-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Effects of High-Fat and Low-Fat Diet on the Gut|Effects of a High-Fat and a Low-Fat Diet on Early Biomarkers of Metabolic Stress in Blood and Gene Expression in the Small Intestine of Healthy Subjects|Completed||N/A|10|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 15:03:28.159791|2017-02-18 15:03:28.159791
NCT00561613|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2007-12-19|||August 2003||2003-08-01|December 2007|2007-12-01|October 2004|Actual|2004-10-01|||||Interventional|||Postcoital Testing of the SILCS Diaphragm|A Phase I Postcoital Testing and Safety Study of the SILCS Diaphragm, Prototype VI|Completed||Phase 1|40|Actual|CONRAD||2|||f||||f||||||||||2017-02-18 15:03:28.253041|2017-02-18 15:03:28.253041
NCT00561600|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2014-04-07|2014-02-05||November 2006||2006-11-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|ASR||Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System|A Randomized, Prospective, Comparative, Multi-Center Clinical Evaluation of the DePuy ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System Study|Completed||N/A|265|Actual|DePuy Orthopaedics|At study inception, information on whether or not an adverse event was deemed to be serious was not collected. Because of this caveat, the Sponsor has reported all adverse events that occurred.|2|||f||||f||||||||||2017-02-18 15:03:28.35307|2017-02-18 15:03:28.35307
NCT00561587|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-04-15|||November 2007||2007-11-01|January 2008|2008-01-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study|Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study|Completed||Phase 2|40|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||2|||f||||f||||||||||2017-02-18 15:03:29.674421|2017-02-18 15:03:29.674421
NCT00561574|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-05-18|2014-06-05||January 2008||2008-01-01|May 2015|2015-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|Jade||A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)|A Randomized Long-Term Safety Study of Org 50081 in Elderly Outpatients With Chronic Primary Insomnia Examining the Effects of 1.5 mg or 3.0 mg of Org 50081|Completed||Phase 3|259|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:03:29.800453|2017-02-18 15:03:29.800453
NCT00561561|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2016-10-13|||June 2001||2001-06-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|July 2013|Actual|2013-07-01||Observational|||Sensorimotor Gating in Schizophrenia|Sensorimotor Gating in Schizophrenia|Active, not recruiting||N/A|500|Anticipated|Emory University|||4||f||||f||||||Samples With DNA|"~     Blood and extracted DNA~   "|||2017-02-18 15:03:30.415663|2017-02-18 15:03:30.415663
NCT00561548|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-05-27|||May 2007||2007-05-01|February 2009|2009-02-01|April 2009|Actual|2009-04-01|May 2008|Actual|2008-05-01||Interventional|||Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease|Impact of Anti-TNF Antibodies on the T-lymphocyte and Macrophage Cooperation in the Crohn Disease|Terminated||N/A|20|Anticipated|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 15:03:30.529001|2017-02-18 15:03:30.529001
NCT00561535|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-01-26|||October 2007||2007-10-01|January 2011|2011-01-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients|Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS|Completed||Phase 2|60|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:03:30.646448|2017-02-18 15:03:30.646448
NCT00561522|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2010-07-20|||November 2007||2007-11-01|August 2009|2009-08-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection|Capecitabine as Adjuvant Chemotherapy to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection: a Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 2/Phase 3|290|Anticipated|Fudan University||2|||f||||t||||||||||2017-02-18 15:03:30.770001|2017-02-18 15:03:30.770001
NCT00561509|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2009-07-13|||November 2007||2007-11-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|||||Observational|||Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months|A Prospective, Observational Study Comparing the Frequency of Treatment-Emergent Sexual Dysfunction Over 8 Weeks in Patients With Major Depressive Disorder Treated With Either Duloxetine Hydrochloride or a Selective Serotonin Reuptake Inhibitor Antidepressant and Evaluated Over 6 Months|Completed||N/A|1626|Actual|Eli Lilly and Company|||2||f||||f||||||||||2017-02-18 15:03:30.882087|2017-02-18 15:03:30.882087
NCT00561496|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2008-05-27|||March 2007||2007-03-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel|Single Dose and 14-Day Once or Twice-Daily Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel|Completed||Phase 1|49|Actual|CONRAD||2|||f||||f||||||||||2017-02-18 15:03:31.033757|2017-02-18 15:03:31.033757
NCT00561483|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2017-01-05|||November 2007||2007-11-01|January 2017|2017-01-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Observational|||Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure|Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure|Completed||N/A|64|Actual|The Cleveland Clinic|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|No||2017-02-18 15:03:31.140164|2017-02-18 15:03:31.140164
NCT00561470|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2012-09-27|2012-08-17||November 2007||2007-11-01|March 2012|2012-03-01|June 2012|Actual|2012-06-01|February 2011|Actual|2011-02-01||Interventional|VELOUR||Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen|A Multinational, Randomized, Double-blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks Versus Placebo in Patients With Metastatic Colorectal Cancer (MCRC) Treated With Irinotecan / 5-FU Combination (FOLFIRI) After Failure of an Oxaliplatin Based Regimen|Completed||Phase 3|1226|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:03:31.254738|2017-02-18 15:03:31.254738
NCT00561457|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-04-06|2009-05-26||June 2003||2003-06-01|April 2011|2011-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|Luminexx||A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System|A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System|Completed||N/A|134|Actual|C. R. Bard||1|||f||||f||||||||||2017-02-18 15:03:33.66731|2017-02-18 15:03:33.66731
NCT00561444|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2017-02-09|||November 2007|Actual|2007-11-01|February 2017|2017-02-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Quality of Life Study for Prostate Cancer Patients|A Comprehensive, Multimodality Quality of Life Study for Prostate Cancer Patients|Recruiting||N/A|1448|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:03:33.919108|2017-02-18 15:03:33.919108
NCT00561431|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-03-24|2009-11-11||July 2003||2003-07-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|CVVHDF||High Dose CVVHDF Compared to Standard Dose CVVHDF|A Randomized Prospective Study Comparing High Dose Continuous Venovenous Hemodiafiltration (CVVHDF) to Standard Dose CVVHDF in Critically Ill Patients With Acute Renal Failure at the University of Alabama at Birmingham|Completed||Phase 3|200|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 15:03:34.042109|2017-02-18 15:03:34.042109
NCT00561418|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2015-07-10|2015-04-20||November 2007||2007-11-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|November 2012|Actual|2012-11-01||Interventional|||Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma|Histone Deacetylase (HDAC) Inhibition Using Vorinostat (SAHA) After Autologous Hematopoietic Stem Cell Transplantation for High Risk Lymphoma|Completed||Phase 1|23|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:03:34.439991|2017-02-18 15:03:34.439991
NCT00561405|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2011-09-23|||December 2006||2006-12-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||A Comparison of Two Intensive Walking Training Interventions in Community Dwelling Individuals With History of Stroke|A Motor Learning Based Walking Program Versus Body Weight Supported Treadmill Training in Community Dwelling Adults Within One Year of Stroke Onset: A Randomized Controlled Trial|Completed||Phase 2|71|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 15:03:34.867669|2017-02-18 15:03:34.867669
NCT00561392|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2012-04-10|2010-12-15||November 2007||2007-11-01|April 2012|2012-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|ADEPT||Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease|A 24-week, Multi-center, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (MMSE10-26)|Completed||Phase 4|208|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:03:34.98585|2017-02-18 15:03:34.98585
NCT00561379|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-20|2013-06-12|||April 2005||2005-04-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab|Frontline Therapy of Diffuse Large B Cell Lymphoma of the Adult ( 18 to 60 Years Old): Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14 -Rituximab. Multicentric Randomized Prospective Trial.|Completed||N/A|350|Anticipated|Nantes University Hospital||2|||f||||||||||||||2017-02-18 15:03:35.338299|2017-02-18 15:03:35.338299
NCT00561366|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2012-02-08||||||February 2012|2012-02-01||||||||Interventional|||A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS|A Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With Amyotrophic Lateral Sclerosis (ALS)|Withdrawn||Phase 2|0|Actual|CytRx||2||Not moving forward with program.|f||||t||||||||||2017-02-18 15:03:35.446279|2017-02-18 15:03:35.446279
NCT00561353|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2014-05-14|2013-12-18||January 2008||2008-01-01|May 2014|2014-05-01|May 2010|Actual|2010-05-01|December 2008|Actual|2008-12-01||Interventional|||A Study of TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection|A Blinded, Randomized, Placebo-controlled Trial in Genotype 1 Hepatitis C-Infected Subjects to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeated Doses of TMC435350, With or Without Peginterferon Alpha-2a and Ribavirin|Completed||Phase 2|121|Actual|Tibotec Pharmaceuticals, Ireland||10|||f||||t||||||||||2017-02-18 15:03:35.785226|2017-02-18 15:03:35.785226
NCT00561340|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2015-01-25|2014-12-29||January 2006||2006-01-01|January 2015|2015-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||A total of 25 subjects were eligible for randomization. 4 subjects were not appropriate for randomization to caloric supplementation with pediasure so were included in the counseling only arm.|Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication|Caloric Supplementation During Long-Term Pharmacological Treatment of ADHD in Young Children|Completed||Phase 4|29|Actual|University of Nebraska|This is a follow-up study of 5 and 6 year olds who completed a DBPC study of atomoxetine for ADHD. Data is confounded by subjects having entered the study on different pre-study and concurrent pharmacotherapy. The population is small.|2|||f||||f||||||||||2017-02-18 15:03:40.482548|2017-02-18 15:03:40.482548
NCT00561327|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2007-11-16|||September 2007||2007-09-01|July 2007|2007-07-01||||||||Observational|||PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites||Unknown status|Recruiting|N/A|||German Heart Institute|||2||f||||f||||||||||2017-02-18 15:03:41.076351|2017-02-18 15:03:41.076351
NCT00561314|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-17|2013-08-23|||July 2007||2007-07-01|July 2009|2009-07-01|January 2012|Actual|2012-01-01|February 2009|Actual|2009-02-01||Interventional|||High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer|An Evaluation of Focal Ablation Therapy Using High-Intensity Focused Ultrasound in the Treatment of Localized Adenocarcinoma of the Prostate|Completed||Phase 2|33|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:03:41.167311|2017-02-18 15:03:41.167311
NCT00561301|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-18|2007-11-18|||November 2006||2006-11-01|November 2007|2007-11-01|October 2009|Anticipated|2009-10-01|||||Interventional|||Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma|Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma|Unknown status|Recruiting|Phase 2|43|Anticipated|Cooperative Study Group A for Hematology||1|||f||||f||||||||||2017-02-18 15:03:41.266583|2017-02-18 15:03:41.266583
NCT00561288|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2008-06-23|||November 2007||2007-11-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Acetaminophen on Hurt Feelings|Effects of Acetaminophen on Hurt Feelings|Completed||N/A|60|Actual|University of Toronto||2|||f||||f||||||||||2017-02-18 15:03:41.37352|2017-02-18 15:03:41.37352
NCT00561275|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2008-07-10|||October 2007||2007-10-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Safety Study of Multiple Peptide Vaccine to Esophageal Cancer|Phase 1 Study of Multiple Peptide Vaccine Therapy and GM-CSF in Treating Patients With Esophageal Cancer|Completed||Phase 1|6|Actual|Japanese Foundation for Cancer Research||1|||f||||f||||||||||2017-02-18 15:03:44.064046|2017-02-18 15:03:44.064046
NCT00561262|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-17|2013-08-23|||May 2006||2006-05-01|June 2009|2009-06-01|April 2011|Actual|2011-04-01|October 2009|Actual|2009-10-01||Interventional|||High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer|An Evaluation of Hemi-ablation Therapy Using High-Intensity Focused Ultrasound in the Treatment of Localized Adenocarcinoma of the Prostate|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:03:44.158282|2017-02-18 15:03:44.158282
NCT00561249|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2014-01-24|||December 2007||2007-12-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Randomized Prospective Trial on the Use of Laser Assisted Hatching (LAH) for Transfer of Frozen/Thawed Embryos in Human IVF/ICSI|Randomized Prospective Trial on the Use of Laser Assisted Hatching (LAH) for Transfer of Frozen/Thawed Embryos in Human IVF/ICSI|Completed||N/A|293|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 15:03:44.255867|2017-02-18 15:03:44.255867
NCT00561236|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-18|2016-09-07|||April 2007||2007-04-01|September 2016|2016-09-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Observational|||Does Intravitreal Injection of Triamcinolone Acetonide Impairs the Adrenal Function|Low Dose (1mcg ) ACTH Stimulation Test for Assessment of the Hypothalamo- Pituitary- Adrenal Axis in Patients Treated With Intravitreal Injection of Triamcinolone Acetonide|Completed||N/A|28|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||No||2017-02-18 15:03:44.341653|2017-02-18 15:03:44.341653
NCT00561223|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2014-01-06|||September 2006||2006-09-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|Iloprost||Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)|The Effect of Iloprost on Gas Exchange and Pulmonary Mechanics in Patients With COPD|Completed||N/A|10|Actual|University of Oklahoma||1|||f||||t||||||||||2017-02-18 15:03:44.419684|2017-02-18 15:03:44.419684
NCT00561210|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2013-11-18|||November 2003||2003-11-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effect of Early Enteral Tube Feeding Nutrition With an Immune Enhancing Diet in Severe Burn Patients|Effect of Early Enteral Tube Feeding Nutrition With an Immune Enhancing Diet in Severe Burn Patients|Completed||Phase 4|57|Actual|Nestlé||2|||f||||||||||||||2017-02-18 15:03:44.529582|2017-02-18 15:03:44.529582
NCT00561197|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2013-01-03|||August 2007||2007-08-01|January 2013|2013-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer|An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer|Terminated||Phase 1/Phase 2|13|Actual|Ascenta Therapeutics||1||Drug not being developed for this indication|f||||f||||||||||2017-02-18 15:03:44.630681|2017-02-18 15:03:44.630681
NCT00561184|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-11-30|||October 2007||2007-10-01|February 2012|2012-02-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine|A Phase II, Open-label, Multi-Center Study to Evaluate Safety and Immunogenicity of a Booster Dose of -H5N1 (Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccine in Non-elderly Adult and Elderly Subjects|Completed||Phase 2|47|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:03:44.733363|2017-02-18 15:03:44.733363
NCT00561171|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2008-11-20|||November 2007||2007-11-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria|A Phase IIa, Double-Blind, Randomized, Parallel-Design, Four-Week Study to Investigate the Efficacy and Safety of Two Different Doses of the Renin-Inhibitor SPP635 Once Daily in Type II Diabetic Patients With Mild to Moderate Hypertension and Albuminuria|Completed||Phase 2|50|Anticipated|Speedel Pharma Ltd.||2|||f||||f||||||||||2017-02-18 15:03:44.846378|2017-02-18 15:03:44.846378
NCT00561145|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2016-02-12|2012-03-20||October 2007||2007-10-01|February 2016|2016-02-01|March 2012|Actual|2012-03-01|March 2010|Actual|2010-03-01||Interventional|Balance||Impaired Regulation of Energy Balance in Elderly People (Balance Study)|Impaired Regulation of Energy Balance in Elderly People and the Underlying Physiological Mechanisms.|Completed||N/A|32|Actual|Wageningen University||2|||f||||f||||||||||2017-02-18 15:03:45.122342|2017-02-18 15:03:45.122342
NCT00561132|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2007-11-19|||November 2003||2003-11-01|November 2007|2007-11-01|November 2004|Actual|2004-11-01|||||Interventional|||Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance|Effect of Vanadium on Insulin Sensitivity in Patients With Impaired Glucose Tolerance|Completed||Phase 3|14|Actual|Unidad de Investigacion Medica en Epidemiologia Clinica||2|||f||||t||||||||||2017-02-18 15:03:45.644634|2017-02-18 15:03:45.644634
NCT00561119|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-18|2010-11-08|||May 2007||2007-05-01|November 2010|2010-11-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer|Phase III, Multicenter, Randomized Trial of Maintenance Versus Observation After Achieving Clinical Response in Pts With Metastatic or Recurrent Breast Cancer Who Received 6 Cycles of Gemcitabine Plus Paclitaxel(GP) as 1st-line Chemotherapy|Unknown status|Active, not recruiting|Phase 3|326|Anticipated|Samsung Medical Center||2|||f||||t||||||||||2017-02-18 15:03:45.756919|2017-02-18 15:03:45.756919
NCT00561106|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2007-11-19|||December 2002||2002-12-01|November 2007|2007-11-01|December 2003|Actual|2003-12-01|||||Interventional|PVBP||Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s Palsy|Treatment Bell´s Palsy: Prednisone vs Prednisone Valacyclovir|Completed||N/A|42|Actual|Universidad de la Republica||2|||f||||f||||||||||2017-02-18 15:03:45.881751|2017-02-18 15:03:45.881751
NCT00561093|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-05-20|||February 2008||2008-02-01|May 2015|2015-05-01|May 2011|Actual|2011-05-01|October 2010|Actual|2010-10-01||Interventional|AIONID||Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients|Pilot/Feasibility Randomized Control Trial to Examine the Effect of Oral Nutritional Supplements With Anti-inflammatory/Anti-oxidative Properties and Pentoxiphylline on Malnutrition-inflammation-cachexia Syndrome in Maintenance Hemodialysis Patients|Completed||Phase 3|93|Actual|Los Angeles Biomedical Research Institute||4|||f||||t||||||||||2017-02-18 15:03:45.984267|2017-02-18 15:03:45.984267
NCT00561080|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2009-09-17|||October 2007||2007-10-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Subjects ≥ 70 Years|An Open-label, Randomised, Comparative, Multi-centre Study of the Immunogenicity and Safety of a 1-dose Regimen and Different 2-dose Regimens of a Zoster Vaccine (Live), ZOSTAVAX ®, in Subjects ≥ 70 Years of Age|Completed||Phase 3|750|Anticipated|MCM Vaccines B.V.||3|||f||||||||||||||2017-02-18 15:03:46.127493|2017-02-18 15:03:46.127493
NCT00561067|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2012-02-20|||April 2008||2008-04-01|February 2012|2012-02-01||||July 2008|Actual|2008-07-01||Interventional|||Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP)|Evaluation of the Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study VS Methylprednisolone (MP)|Suspended||Phase 3|100|Anticipated|Niguarda Hospital||2||Italian Medicines Agency decision|f||||t||||||||||2017-02-18 15:03:46.26422|2017-02-18 15:03:46.26422
NCT00561054|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2007-11-19|||March 2007||2007-03-01|November 2007|2007-11-01||||||||Interventional|Coimbra||Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC|Open-Label, Uncontrolled, Multicenter, Phase II Study Evaluating the Efficacy and Safety of Cetuximab in Combination With Cisplatin & Gemcitabine as First-Line Therapy in Patients With Advanced Non Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|47|Anticipated|Grupo Portugues de Estudo do Cancro do Pulmao||1|||f||||f||||||||||2017-02-18 15:03:46.390722|2017-02-18 15:03:46.390722
NCT00561041|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2007-11-19|||November 2005||2005-11-01|November 2007|2007-11-01|November 2006|Actual|2006-11-01|||||Interventional|||Aftercare for Adolescents Treated for Alcohol Abuse and Dependence|Maintenance of Treatment Gains in Adolescents With Alcohol Related Disorders|Completed||Phase 2|177|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||3|||f||||f||||||||||2017-02-18 15:03:46.499809|2017-02-18 15:03:46.499809
NCT00561028|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2007-11-19|||March 2002||2002-03-01|November 2007|2007-11-01|November 2004|Actual|2004-11-01|||||Observational|||Chlamydia and Mycoplasma in Coronary Artery Disease|Prevalence of Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Different Forms of Obstructive Coronary Artery Disease|Completed||N/A|138|Actual|Hospital de Base|||4||f||||f||||||Samples Without DNA|"~     Blood sample - serum~   "|||2017-02-18 15:03:46.610702|2017-02-18 15:03:46.610702
NCT00561015|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2013-06-07|2013-03-08||December 2007||2007-12-01|June 2013|2013-06-01|May 2009|Actual|2009-05-01|June 2008|Actual|2008-06-01||Interventional|||A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection|A Phase IIa Randomized, Partially Blinded Trial of Telaprevir (VX-950) in Treatment-Naive Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection|Completed||Phase 2|52|Actual|Tibotec BVBA||6|||f||||f||||||||||2017-02-18 15:03:46.720565|2017-02-18 15:03:46.720565
NCT00561002|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2016-04-12|2009-07-20||October 2007||2007-10-01|April 2016|2016-04-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine|Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2007-2008 Formulation)|Completed||Phase 4|34|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:03:48.626919|2017-02-18 15:03:48.626919
NCT00560989|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2014-09-24|||March 2007||2007-03-01|September 2014|2014-09-01|March 2007|Actual|2007-03-01|||||Observational|||Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis|Shared Genetic Susceptibility in CBD and Sarcoidosis|Completed||N/A|400|Actual|National Jewish Health|||4||f||||f||||||Samples With DNA|"~     DNA specimens~   "|||2017-02-18 15:03:49.283296|2017-02-18 15:03:49.283296
NCT00560976|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-18|2013-04-17|||December 2005||2005-12-01|April 2013|2013-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration|Serum Neutrophil Gelatinase Associated Lipocalin (NGAL) Levels in Hemodialysis (HD) Patients; Relation to Iron Status, Hemodialysis, and Intravenous (IV) Iron Administration|Unknown status|Recruiting|N/A|100|Anticipated|Soroka University Medical Center||1|||f||||f||||||||||2017-02-18 15:03:49.3838|2017-02-18 15:03:49.3838
NCT00560963|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2012-11-14|||October 2007||2007-10-01|November 2012|2012-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine|Combination of Antiangiogenic Therapy Using the mTOR-inhibitor RAD001 and Low Dose Chemotherapy for Locally Advanced and/or Metastatic Pancreatic Cancer - a Dose Finding Study|Completed||Phase 1/Phase 2|21|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:03:49.504883|2017-02-18 15:03:49.504883
NCT00560950|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-02-26|2009-03-30||July 2007||2007-07-01|February 2015|2015-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)|A Multicenter, Open-Label Study of the Safety, Tolerability, and Immunogenicity of Revaccination With PNEUMOVAX(TM) 23 Vaccine (Pneumococcal Vaccine Polyvalent, Merck & Co., Inc.) in Older Adults|Completed||Phase 3|143|Actual|Merck Sharp & Dohme Corp.|Open-label non-randomized group of subjects enrolled in this extension. Subjects recruited from original study which completed five years previously.|2|||f||||||||||||||2017-02-18 15:03:49.619726|2017-02-18 15:03:49.619726
NCT00560937|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-08-11|2009-03-31||June 2005||2005-06-01|August 2015|2015-08-01|April 2008|Actual|2008-04-01|April 2006|Actual|2006-04-01||Interventional|||Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia|Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia|Completed||N/A|28|Actual|Durham VA Medical Center||2|||f||||||||||||||2017-02-18 15:03:50.253158|2017-02-18 15:03:50.253158
NCT00560924|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2012-03-19|||March 2003||2003-03-01|March 2012|2012-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women|Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women (RUTI) in Post-menopausal Women With Signs of Urogenital Ageing (UGA)|Terminated||Phase 3|6|Actual|Novo Nordisk A/S||||Trial prematurely discontinued due to slow recruitment|f||||f||||||||||2017-02-18 15:03:50.767123|2017-02-18 15:03:50.767123
NCT00560911|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-17|2007-11-17|||March 2002||2002-03-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|||||Interventional|SPOG60+||Major Outcomes in Elderly Patients With Self-Management of Oral Anticoagulation (SPOG60+)|Impact of Self-Management of Oral Anticoagulation in the Elderly in Terms of Mortality and Morbidity: a Randomized Controlled Trial - SPOG 60+|Completed||Phase 4|216|Actual|Medical University of Graz||2|||f||||f||||||||||2017-02-18 15:03:50.85837|2017-02-18 15:03:50.85837
NCT00560898|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2008-05-19|||September 2007||2007-09-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function|Comparison of Two Multi-Purpose Solution and Contact Lens Material Combinations on Human Corneal Barrier Function|Completed||Phase 4|25|Anticipated|Southern California College of Optometry||4|||f||||f||||||||||2017-02-18 15:03:50.962458|2017-02-18 15:03:50.962458
NCT00560885|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2013-03-20|2013-02-11||November 2007||2007-11-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2009|Actual|2009-12-01||Interventional|ABLATE||AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation|AtriCure Synergy Bipolar RF Energy Lesions for Permanent Atrial Fibrillation Treatment During Concomitant On-Pump Endo/Epicardial Cardiac Surgery|Completed||Phase 3|55|Actual|AtriCure, Inc.||1|||f||||t||||||||||2017-02-18 15:03:51.139969|2017-02-18 15:03:51.139969
NCT00560872|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2009-12-22|||August 2007||2007-08-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Remote Magnetic Navigation For Cavotricuspid Isthmus Ablation|Randomized Controlled Study of Remote Magnetic Catheter Navigation for Cavotricuspid Isthmus Mapping and Ablation in Patients With Typical Atrial Flutter|Completed||N/A|100|Anticipated|University Hospital Goettingen||2|||f||||f||||||||||2017-02-18 15:03:51.675958|2017-02-18 15:03:51.675958
NCT00560859|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-11-10|2015-07-13||October 2007||2007-10-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|CHAT|These numbers represent all children randomized .|Childhood Adenotonsillectomy Study for Children With OSAS|A Randomized Controlled Study of Adenotonsillectomy for Children With Obstructive Sleep Apnea Syndrome|Completed||N/A|453|Actual|University of Pennsylvania|Children under 5 years of age, in whom OSAS is common, were not included. Children on medications for ADHD or with prolonged oxygen-hemoglobin desaturation were also excluded, so results cannot be extrapolated to such children.|2|||f||||t||||||||||2017-02-18 15:03:51.78719|2017-02-18 15:03:51.78719
NCT00560846|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2013-09-04|||November 2007||2007-11-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery|Perioperative Nutrition in Upper GI Cancer Surgery (Oesophagectomy or Gastrectomy)|Terminated||N/A|43|Actual|University Hospital, Geneva||2||Insufficient recruitment over time.|f||||f||||||||||2017-02-18 15:03:52.701074|2017-02-18 15:03:52.701074
NCT00560833|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2015-05-11|2014-05-28||October 2004||2004-10-01|May 2015|2015-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional||All participants who received any study drug (placebo or esmertazapine), whether or not randomized.|Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)|A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Four Different Doses of Org 50081 in the Treatment of Moderate to Severe Vasomotor Symptoms Associated With the Menopause|Completed||Phase 3|943|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 15:03:52.815163|2017-02-18 15:03:52.815163
NCT00560820|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2016-06-17|||September 2007||2007-09-01|June 2016|2016-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload|Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload|Completed||Phase 1|11|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:03:53.839688|2017-02-18 15:03:53.839688
NCT00560807|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-09-22||||||September 2015|2015-09-01||||||||Interventional|||Manual Therapy Dosage Factorial Study|Manual Therapy Dosage Factorial Study|Withdrawn||Phase 2/Phase 3|0|Actual|McMaster University||12||The study was stopped because the study never received funding|f||||||||||||||2017-02-18 15:03:53.948115|2017-02-18 15:03:53.948115
NCT00560235|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-10-06|2013-10-24||March 2008||2008-03-01|October 2015|2015-10-01|October 2012|Actual|2012-10-01|March 2010|Actual|2010-03-01||Interventional|||Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors|A Phase 1/Phase 2 Study Of CP-751,871 In Patients With Relapsed And/Or Refractory Ewing's Sarcoma Family Of Tumors|Completed||Phase 1/Phase 2|138|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:04:13.075339|2017-02-18 15:04:13.075339
NCT00560794|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-01-12|2014-12-23||January 2008||2008-01-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|September 2009|Actual|2009-09-01||Interventional||Full Analysis Set included all participants who received ≥ 1 infusion of blinatumomab who completed at least the first treatment cycle and for whom at least one minimal residual disease (MRD) response assessment was available.|Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)|Open-label, Multicenter Phase II Study to Investigate the Efficacy, Safety, and Tolerability of the Bispecific T-cell Engager (BiTE®) MT103 in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia|Completed||Phase 2|21|Actual|Amgen Research (Munich) GmbH||1|||f||||t||||||||||2017-02-18 15:03:54.066062|2017-02-18 15:03:54.066062
NCT00560781|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2014-02-25|||April 2006||2006-04-01|February 2014|2014-02-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs|Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs|Completed||N/A|27|Actual|Durham VA Medical Center||2|||f||||||||||||||2017-02-18 15:03:54.613137|2017-02-18 15:03:54.613137
NCT00560768|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-01-09|||December 2007||2007-12-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|August 2012|Actual|2012-08-01||Interventional|Prediction||Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications|Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications|Completed||Phase 4|198|Anticipated|LivaNova||1|||f||||f||||||||||2017-02-18 15:03:54.716856|2017-02-18 15:03:54.716856
NCT00560755|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2009-04-03|||October 2007||2007-10-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||ProQuad® rHA Safety|An Open-Label, Multi-Centre Study of the Safety of a 2-Dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad®) Manufactured With Recombinant Human Albumin (rHA) When Administered to Children in Their Second Year of Life|Completed||Phase 3|3340|Anticipated|MCM Vaccines B.V.||1|||f||||f||||||||||2017-02-18 15:03:55.074129|2017-02-18 15:03:55.074129
NCT00560742|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2007-11-16|||November 2002||2002-11-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Efficacy Study of Intramuscular or Intracoronary Injection of Autologous Bone Marrow Cells to Treat Scarred Myocardium|Efficacy of the Mode of Delivery of Autologous Bone Marrow Cells Into Heart Scar Muscle for the Recovery of Contractile Function|Completed||Phase 2|63|Actual|University Hospitals, Leicester||3|||f||||||||||||||2017-02-18 15:03:55.245445|2017-02-18 15:03:55.245445
NCT00560729|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2013-11-18|||October 2003||2003-10-01|November 2013|2013-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effectiveness and Cost of a Quantitative and Qualitative Nutritional Supplementation in Elderly Patients|Effectiveness and Cost of a Quantitative and Qualitative Nutritional Supplementation in Elderly Patients|Terminated||Phase 3|63|Actual|Nestlé||4|||f||||f||||||||||2017-02-18 15:03:55.34135|2017-02-18 15:03:55.34135
NCT00560716|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2009-10-21|||June 2007||2007-06-01|November 2007|2007-11-01|November 2009|Anticipated|2009-11-01|January 2009|Actual|2009-01-01||Interventional|||A Phase I Pharmacologic Study of CYC116, an Oral Aurora Kinase Inhibitor, in Patients With Advanced Solid Tumors|A Phase I Pharmacologic Study of CYC116, an Oral Aurora Kinase Inhibitor, in Patients With Advanced Solid Tumors|Terminated||Phase 1|40|Anticipated|Cyclacel Pharmaceuticals, Inc.||1||Sponsor decision|f||||f||||||||||2017-02-18 15:03:55.438094|2017-02-18 15:03:55.438094
NCT00560703|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2011-12-09|2011-04-28||November 2007||2007-11-01|December 2011|2011-12-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Treatment of Patients With Blepharitis and Facial Rosacea|Efficacy and Safety of COL-101 for the Treatment of Blepharitis in Patients With Facial Rosacea|Completed||Phase 2|70|Actual|Galderma||2|||f||||f||||||||||2017-02-18 15:03:55.540292|2017-02-18 15:03:55.540292
NCT00560690|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2015-04-02|||December 2007||2007-12-01|April 2015|2015-04-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||The Effect of Adding Metformin to the Treatment of Hepatitis C|Effect and Safety of Adding Metformin to the Standard Treatment of Hepatitis C on Sustained Viral Response|Completed||Phase 4|140|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:03:55.945618|2017-02-18 15:03:55.945618
NCT00560677|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2016-01-20|||March 2007||2007-03-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|SAPPHIRE||Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study)|Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation|Active, not recruiting||N/A|400|Anticipated|Durham VA Medical Center|||1||f||||f||||||Samples With DNA|"~     Serum and cells collected.~   "|||2017-02-18 15:03:56.052877|2017-02-18 15:03:56.052877
NCT00560664|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2014-07-30|||April 2007||2007-04-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|October 2012|Actual|2012-10-01||Interventional|Cartipatch||Comparison of Autologous Chondrocyte Implantation Versus Mosaicoplasty: a Randomized Trial|Phase 3 Study Comparison of Autologous Chondrocyte Implantation Versus Mosaicoplasty|Completed||Phase 3|58|Actual|University Hospital, Brest||2|||f||||f||||||||||2017-02-18 15:03:56.150582|2017-02-18 15:03:56.150582
NCT00560651|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2016-10-16|||November 2007||2007-11-01|October 2016|2016-10-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||German Corneal Cross Linking Register|German Corneal Cross Linking Register|Recruiting||N/A|7500|Anticipated|St. Franziskus Hospital|||1||f||||f||||||||||2017-02-18 15:03:56.267088|2017-02-18 15:03:56.267088
NCT00560638|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2011-07-14|||November 2005||2005-11-01|July 2011|2011-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye|A Double-Masked, Randomized, Placebo-Controlled Study of Loteprednol Etabonate Ophthalmic Suspension, 0.5% for the Treatment of Dry Eye Used Either TID or QID for a 2 Week Period|Completed||Phase 2|119|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-02-18 15:03:56.392087|2017-02-18 15:03:56.392087
NCT00560625|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-18|2016-09-07|||May 2007||2007-05-01|September 2016|2016-09-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Observational|||Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?|Low Dose(1mcg) ACTH Stimulation Test for Assessment of the Hypothalamus-pituitary-adrenal Axis in Patients Treated With Inhaled Busedonide or Fluticasone.|Terminated||N/A|50|Anticipated|HaEmek Medical Center, Israel|||1|recruiting subjects did not start.|f||||f||||||||||2017-02-18 15:03:56.493051|2017-02-18 15:03:56.493051
NCT00560612|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-19|2011-03-31|2010-11-30||January 2006||2006-01-01|March 2011|2011-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)|Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)|Completed||Phase 4|12|Actual|Durham VA Medical Center||2|||f||||||||||||||2017-02-18 15:03:56.572213|2017-02-18 15:03:56.572213
NCT00560599|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2013-09-25|||April 2007||2007-04-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|February 2012|Actual|2012-02-01||Interventional|PRIMO||A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection|A 2X2 Phase III Open-label Clinical Trial of Therapy for Patients With Recurrent Methicillin Resistant Staphylococcus Aureus Infections: Topical Nasal & Body Decolonization and/or Environmental Decontamination vs. Standard of Care|Completed||Phase 3|350|Anticipated|Los Angeles Biomedical Research Institute||4|||f||||t||||||||||2017-02-18 15:03:56.983157|2017-02-18 15:03:56.983157
NCT00560586|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-16|||August 2005||2005-08-01|July 2007|2007-07-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome|Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome|Unknown status|Active, not recruiting|Phase 4|62|Actual|University of Louisville||1|||f||||f||||||||||2017-02-18 15:03:57.103453|2017-02-18 15:03:57.103453
NCT00560573|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2013-03-15|2013-01-18||November 2007||2007-11-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|June 2008|Actual|2008-06-01||Interventional|||Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer|Phase 1, Dose Escalation Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|46|Actual|Pfizer|A total of 46 patients were enrolled in this study but only 45 of them were evaluable because 1 patient was enrolled but did not participate due to early symptomatic deterioration prior to starting treatment.|1|||f||||f||||||||||2017-02-18 15:03:57.223739|2017-02-18 15:03:57.223739
NCT00560560|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2013-05-16|2013-01-18||December 2007||2007-12-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments|A Phase II, Single Arm Study Of CP-751,871 In Patients With Refractory Metastatic Adenocarcinoma Of The Colon Or Rectum|Completed||Phase 2|168|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:03:59.344065|2017-02-18 15:03:59.344065
NCT00560547|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-08-23|||October 2007||2007-10-01|August 2016|2016-08-01|October 2009|Anticipated|2009-10-01|||||Interventional|||A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.|An Open Label Study to Assess the Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Monthly Administration of Mircera in Hemodialysis Patients With Chronic Renal Anemia.|Withdrawn||Phase 3|0|Actual|Hoffmann-La Roche||1||The study was cancelled before any patients were enrolled, due to operational reasons.|f||||||||||||||2017-02-18 15:04:00.444137|2017-02-18 15:04:00.444137
NCT00560534|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2009-08-18|||June 2008||2008-06-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|||||Observational|||Whole Body Magnetic Resonance Angiography With Subsystolic Venous Compression|Whole Body Magnetic Resonance Angiography in Patients With Symptomatic Peripheral Ischemia. Experience With Venous Compression.|Completed||N/A|36|Anticipated|Copenhagen University Hospital at Herlev|||2||f||||t||||||||||2017-02-18 15:04:00.555898|2017-02-18 15:04:00.555898
NCT00560521|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2007-11-16|||March 2005||2005-03-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Continuous Positive Airway Pressure on Tuberculosis Pleural Effusion|Effect of Continuous Positive Airway Pressure on Fluid Absorption Among Patients With Pleural Effusion Due to Tuberculosis|Completed||N/A|20|Actual|Universidade Federal do Rio de Janeiro||1|||f||||t||||||||||2017-02-18 15:04:00.650339|2017-02-18 15:04:00.650339
NCT00560508|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2014-07-29|2010-11-25||November 2007||2007-11-01|July 2014|2014-07-01||||November 2009|Actual|2009-11-01||Interventional|||A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period|A Double-blind, Double-dummy, Randomised, Parallel-group Study to Investigate the Safety, Tolerability, Trough Plasma Concentration, and Efficacy of Pramipexole ER Versus Pramipexole Immediate Release (IR) Administered Orally for 12 Weeks in Patients With Parkinson's Disease (PD) on L-dopa Therapy, Followed by a 52-week Open-label Long-term Treatment Period to Evaluate the Long-term Safety and Efficacy of Pramipexole ER|Completed||Phase 2/Phase 3|112|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:04:00.766494|2017-02-18 15:04:00.766494
NCT00560495|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2012-02-08|||May 2007||2007-05-01|February 2012|2012-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|The Combination of Radiotherapy With the Anti-Angiogenic Agent Tetrathiomolybdate (TM) in the Treatment of Stage I-IIIB Non-Small Cell Lung Cancer (NSCLC): A Phase I Study|Withdrawn||Phase 1|0|Actual|Roswell Park Cancer Institute|||||||||||||||||||2017-02-18 15:04:01.736799|2017-02-18 15:04:01.736799
NCT00560482|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-10-02||2014-06-02|December 2007||2007-12-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy Study of ABR-215050 to Treat Prostate Cancer|Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer|Completed||Phase 2|206|Actual|Active Biotech AB||2|||f||||f||||||||||2017-02-18 15:04:01.850805|2017-02-18 15:04:01.850805
NCT00560469|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2011-02-01|||January 2008||2008-01-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Impaired Adipogenesis in Insulin Resistance: Pilot Clinical and In Vitro Studies|Impaired Adipogenesis in Insulin Resistance: Pilot Clinical and In Vitro Studies|Completed||N/A|20|Actual|University of Vermont|||2||f||||f||||||Samples With DNA|"~     Adipose tissue, plasma~   "|||2017-02-18 15:04:02.026749|2017-02-18 15:04:02.026749
NCT00560456|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2010-04-19|||November 2007||2007-11-01|April 2010|2010-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|PRIVASOM||Chronic Sleep Restriction and Driving|Chronic Sleep Restriction and Driving in Healthy Subjects or Snorers : Interindividual Vulnerability and Recovery Factors|Completed||N/A|40|Anticipated|University Hospital, Bordeaux||4|||f||||f||||||||||2017-02-18 15:04:02.142166|2017-02-18 15:04:02.142166
NCT00560443|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2009-01-28|||April 2009||2009-04-01|January 2009|2009-01-01|October 2010|Anticipated|2010-10-01|December 2009|Anticipated|2009-12-01||Interventional|||RCT on Ketorolac and Tramadol in Bone Fractures Pain of Child|Randomized Controlled Trial on Effectiveness of Ketorolac and Tramadol in Not Compound Fractures of Child|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|IRCCS Burlo Garofolo||2|||f||||t||||||||||2017-02-18 15:04:04.798513|2017-02-18 15:04:04.798513
NCT00560430|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2010-07-14|||November 2007||2007-11-01|May 2008|2008-05-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|METATEL||Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients|Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients|Completed||Phase 3|56|Actual|Ludwig-Maximilians - University of Munich||3|||f||||f||||||||||2017-02-18 15:04:04.910315|2017-02-18 15:04:04.910315
NCT00560417|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-01-12|2010-11-12||November 2007||2007-11-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide|A Randomized Trial Comparing Insulin Lispro Protamine Suspension With Insulin Glargine in Subjects With Type 2 Diabetes on Oral Antihyperglycemic Medications and Exenatide|Completed||Phase 3|339|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:04:05.035368|2017-02-18 15:04:05.035368
NCT00560404|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-03-14|2016-01-19||April 2008||2008-04-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||Intent-to-treat (ITT) population included participants who have received at least one dose of C.E.R.A. (Week 0) and for whom data for at least one follow-up is available.|A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.|A Randomized, Open Label Study to Compare the Effect of Once Monthly Administration of Subcutaneous Mircera Versus Epoetin Alfa on Maintenance of Hemoglobin Levels, Safety and Tolerability in Dialysis Patients With Chronic Renal Anemia.|Completed||Phase 3|233|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:04:06.408324|2017-02-18 15:04:06.408324
NCT00560391|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-07-06|2012-06-15||May 2008||2008-05-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|October 2011|Actual|2011-10-01||Interventional|||Dasatinib in Combination With Revlimid (and Dexamethasone)|A Phase I Single Arm Dose Escalation Study of the Combination of Dasatinib (Sprycel®) With Lenalidomide (Revlimid®) and Dexamethasone in Subjects With Relapsed and/ or Refractory Multiple Myeloma|Completed||Phase 1|35|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-02-18 15:04:07.50269|2017-02-18 15:04:07.50269
NCT00560378|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2014-09-17|||June 1998||1998-06-01|September 2014|2014-09-01|June 2005|Actual|2005-06-01|||||Interventional|||Long-term Safety of Protopic in Atopic Eczema|A Long-term, Open Label, Noncomparative Study to Evaluate the Safety of 0.1% Tacrolimus (FK506) Ointment for Treatment of Atopic Dermatitis|Completed||Phase 3|789|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-02-18 15:04:10.298011|2017-02-18 15:04:10.298011
NCT00560365|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2011-08-05|||March 2004||2004-03-01|August 2009|2009-08-01||||December 2013|Anticipated|2013-12-01||Observational|||Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer|A Randomised Controlled Trial to Assess the Cost-effectiveness of Intensive Versus no Scheduled Follow-up in Patients Who Have Undergone Resection for Colorectal Cancer With Curative Intent. (FACS - Follow-up After Colorectal Surgery)|Unknown status|Recruiting|N/A|4760|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:04:10.47312|2017-02-18 15:04:10.47312
NCT00560352|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2012-07-23|2012-04-02||February 2008||2008-02-01|July 2012|2012-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma|A Phase I Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma|Terminated||Phase 1|16|Actual|Bristol-Myers Squibb|The study was terminated due to an unexpectedly low recruitment rate, and no participants were enrolled in a planned dose-expansion phase.|1|||f||||f||||||||||2017-02-18 15:04:10.607659|2017-02-18 15:04:10.607659
NCT00560339|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-15|||September 2005||2005-09-01|November 2007|2007-11-01|January 2009|Anticipated|2009-01-01|||||Observational|IMPEDE-HF||Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?|Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?|Unknown status|Recruiting|N/A|100|Anticipated|Southern New Jersey Cardiac Specialists|||1||f||||f||||||||||2017-02-18 15:04:11.528117|2017-02-18 15:04:11.528117
NCT00560326|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2014-08-28|||June 2003||2003-06-01|August 2014|2014-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis|A Long-term, Non-comparative Study to Evaluate the Safety and Efficacy of Tacrolimus Oint¬Ment in Paediatric Patients|Completed||Phase 2|50|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 15:04:11.615277|2017-02-18 15:04:11.615277
NCT00560313|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-03-03|2011-06-06||July 2007||2007-07-01|March 2016|2016-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults|A Phase 2, Multi-Center, Open-label Study of the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2, 6-Month Schedule and of a Single Dose of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy At-risk Adults 18-50 Years of Age|Completed||Phase 2|54|Actual|Novartis||2|||f||||t||||||||||2017-02-18 15:04:11.740666|2017-02-18 15:04:11.740666
NCT00560300|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2010-01-12|||November 2000||2000-11-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|||||Interventional|||Regulation of Bone Formation in Renal Osteodystrophy|Regulation of Bone Formation in Renal Osteodystrophy|Completed||Phase 2|61|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||f||||||||||2017-02-18 15:04:12.267835|2017-02-18 15:04:12.267835
NCT00560287|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2010-03-26|||January 2008||2008-01-01|March 2010|2010-03-01|August 2010|Anticipated|2010-08-01|August 2009|Actual|2009-08-01||Interventional|||Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis|Role of Non-invasive Ventilation in Amyotrophic Lateral Sclerosis: Volume Versus Pressure Mode|Unknown status|Recruiting|Phase 4|50|Anticipated|Fondazione Salvatore Maugeri||2|||f||||t||||||||||2017-02-18 15:04:12.388187|2017-02-18 15:04:12.388187
NCT00560274|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-02-01|||March 2008||2008-03-01|February 2016|2016-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.|An Open Label Study to Evaluate the Safety of NeoRecormon in the Treatment of Anemia in Patients With Chronic Hepatitis C Who Are Treated With Pegylated Interferon + Ribavirin Combination Therapy|Completed||Phase 4|190|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:04:12.724224|2017-02-18 15:04:12.724224
NCT00560261|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2012-08-02|||February 2008||2008-02-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|VOLCADREP||Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease|Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease|Completed||Phase 3|120|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:04:12.843817|2017-02-18 15:04:12.843817
NCT00560248|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2010-02-18|||November 2007||2007-11-01|February 2010|2010-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|BEACON||The BEACON Registry: Best Expert Agreement for Care of Occult Myocardial Infarction (MI) Nationally|The BEACON Registry: Best Expert Agreement for Care of Occult MI Nationally|Terminated||N/A|1897|Actual|The Cleveland Clinic|||1|Loss of funding|f||||t||||||||||2017-02-18 15:04:12.95089|2017-02-18 15:04:12.95089
NCT00560222|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-10-31|||February 2008||2008-02-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Interventional|||Randomized, Controlled Trial - Lactoferrin Prevention of Diarrhea in Children|Randomized, Controlled Trial - Lactoferrin Prevention of Diarrhea in Children|Completed||Phase 3|555|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 15:04:16.465108|2017-02-18 15:04:16.465108
NCT00560209|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2012-06-12|||November 2007||2007-11-01|June 2012|2012-06-01||||November 2008|Actual|2008-11-01||Interventional|||Study of ONO-1101 in Patients Scheduled for Coronary Angiography|Study of ONO-1101 in Patients Scheduled for Coronary Angiography, a Double-Blind, Randomized,Placebo-Controlled, Parallel Group, Multi-Center Study|Completed||Phase 2|183|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||||||||||||2017-02-18 15:04:16.596794|2017-02-18 15:04:16.596794
NCT00560196|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-01-20|||November 2007||2007-11-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Observational|||Pain Processing in Anxiety and Depression|Pain, Anxiety and Depression in Patients With Panic Anxiety Disorders Without Pain or Depression Without Pain Compared With Healthy Volunteers|Completed||N/A|71|Actual|Danish Pain Research Center|||3||f||||t||||||||||2017-02-18 15:04:16.706453|2017-02-18 15:04:16.706453
NCT00560183|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-05-15||2010-08-25|November 2007||2007-11-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain|A Placebo-controlled, Randomized, Double-blind Study of the Safety and Efficacy of Q8003 in the Management of Post-bunionectomy Pain|Completed||Phase 3|256|Actual|QRxPharma Inc.||2|||f||||f||||||||||2017-02-18 15:04:16.811778|2017-02-18 15:04:16.811778
NCT00560170|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2010-02-23|||September 2007||2007-09-01|February 2010|2010-02-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis|Rho-kinase in Patients With Atherosclerosis: Effects of Statins A Randomized Clinical Trial Comparing Ezetimibe/Simvastatin and Simvastatin|Completed||Phase 4|40|Actual|National Cheng-Kung University Hospital||2|||f||||f||||||||||2017-02-18 15:04:16.920587|2017-02-18 15:04:16.920587
NCT00560157|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2013-11-18|||December 2002||2002-12-01|November 2013|2013-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Nutritional and Metabolic Evaluation of a Tube Feeding Immune Enhancing Diet in ICU Patients|Nutritional and Metabolic Evaluation of a Tube Feeding Immune Enhancing Diet in ICU Patients|Completed||Phase 4|22|Actual|Nestlé||2|||f||||f||||||||||2017-02-18 15:04:17.033748|2017-02-18 15:04:17.033748
NCT00560144|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-10-29|||December 2007||2007-12-01|October 2016|2016-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.|Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.|Completed||Phase 1|34|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 15:04:17.127921|2017-02-18 15:04:17.127921
NCT00560131|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2008-10-10|||June 2007||2007-06-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|||||Observational|||Evaluation of Autonomic Cardiac Function in Patients With CRPS|Evaluation of Autonomic Cardiac Function in Patients With Complex Regional Pain Syndrome|Completed||N/A|40|Actual|Danish Pain Research Center|||1||f||||f||||||||||2017-02-18 15:04:17.229791|2017-02-18 15:04:17.229791
NCT00560118|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2011-05-13|||August 2003||2003-08-01|December 2008|2008-12-01||||May 2011|Actual|2011-05-01||Interventional|||Fotemustine in Treating Patients With Metastatic Melanoma|Phase II Study of the Predictive Value of the Expression of Tumoral MGMT With Respect to the Therapeutic Response of Fotemustine in Patients With Metastatic Malignant Melanoma|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:04:17.489752|2017-02-18 15:04:17.489752
NCT00560105|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-03-04|2012-11-16||November 2007||2007-11-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Randomized Controlled Eight-Week Study of the Safety and Efficacy of the Lung Flute|A Proof of Principal Randomized Controlled Eight-Week Study of the Safety and Efficacy of the Lung Flute in Adults With Chronic Obstructive Pulmonary Disease. A FDA 510(k) Equivalency Study|Completed||N/A|40|Actual|Medical Acoustics LLC||2|||f||||f||||||||||2017-02-18 15:04:17.582304|2017-02-18 15:04:17.582304
NCT00560092|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2013-04-02|||January 2004||2004-01-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Intrathecal Magnesium and Postoperative Analgesia|Effects of a Single Dose of Intrathecal Magnesium Sulfate on Postoperative Morphine Consumption After Total Hip Replacement|Completed||Phase 3|40|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:04:18.019313|2017-02-18 15:04:18.019313
NCT00560079|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2016-08-15|||November 2003||2003-11-01|August 2016|2016-08-01|April 2006|Actual|2006-04-01|April 2005|Actual|2005-04-01||Interventional|||Efficacy of Allopurinol and Dypiridamole in Acute Mania|A Double-blind, Randomized, Placebo-controlled 4-week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole in Acute Bipolar Mania.|Completed||Phase 4|180|Actual|Hospital Espirita de Porto Alegre||3|||f||||f||||||||||2017-02-18 15:04:18.118449|2017-02-18 15:04:18.118449
NCT00560066|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-01-19|2012-11-21||November 2007||2007-11-01|January 2016|2016-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions|A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture (Optaflu®) or in Embryonated Hen Eggs (Agrippal®) in Adults and Elderly With and Without Underlying Medical Conditions, and to Evaluate the Immunogenicity in a Subset of Subjects With Underlying Medical Conditions|Completed||Phase 4|1398|Actual|Novartis|Because cTIV was not available, the second part of the study was not performed. In addition, as deviations from protocol procedures and GCP were identified at some sites, data collected for this study were not used to support licensure of cTIV.|2|||f||||||||||||||2017-02-18 15:04:18.230894|2017-02-18 15:04:18.230894
NCT00560053|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2008-11-26|||January 2000||2000-01-01|November 2008|2008-11-01|February 2005|Actual|2005-02-01|||||Interventional|||Pethema Multiple Myeloma 2000|Multiple Myeloma 2000. Multicentric Evaluation of a Therapeutic Strategy Optimized in Multiple Myeloma. Analysis of Efficiency and Possible Pronostic Impact of Minimal Residual Disease (Measured By PCR And Citometry of Flow) in Patients With Complete Response|Completed||Phase 3|500|Actual|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:04:18.961621|2017-02-18 15:04:18.961621
NCT00560040|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-16|||January 2006||2006-01-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Observational|||Myocardial Injury is Not Related to Training Levels Among Recreational Participants in the Silicon Valley Marathon|Myocardial Injury is Not Related to Training Levels Among Recreational Participants in the Silicon Valley Marathon|Completed||N/A|53|Actual|Stanford University|||||f||||t||||||||||2017-02-18 15:04:19.043002|2017-02-18 15:04:19.043002
NCT00560027|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2015-05-26|||July 2010||2010-07-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Case Management Study for Postpartum Depression and Intimate Partner Violence|Screening, Referral and Case Management for Postpartum Depression and Intimate Partner Violence in an Urban Pediatric Practice|Completed||N/A|173|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 15:04:19.116631|2017-02-18 15:04:19.116631
NCT00560014|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2007-11-16|||September 1997||1997-09-01|October 2007|2007-10-01|May 2005|Actual|2005-05-01|||||Interventional|||Nutrient Levels Alter Transplant Outcome|Role of Immunonutrient Levels in Preventing Complications After Renal Transplantation|Completed||N/A|54|Actual|University of Cincinnati||3|||f||||f||||||||||2017-02-18 15:04:19.210716|2017-02-18 15:04:19.210716
NCT00560001|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2009-10-07|||January 2006||2006-01-01|November 2007|2007-11-01|May 2008|Anticipated|2008-05-01|||||Interventional|||MD.2 Medication Dispenser Medication Adherence Study|Medication Dispenser: MD2: Improving Health Outcomes|Unknown status|Recruiting|Phase 3|600|Anticipated|Interactive Medical Developments||2|||f||||t||||||||||2017-02-18 15:04:19.304007|2017-02-18 15:04:19.304007
NCT00559988|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2014-06-23|2014-05-20||February 2008||2008-02-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|IMPACT|All enrolled subjects|Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk|The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices|Terminated||Phase 4|2718|Actual|Biotronik, Inc.|This study was stopped early when the primary endpoint met futility criteria. Continuation might possibly have changed the outcome; however, it was unlikely to demonstrate a meaningful clinical benefit for the intervention under investigation.|2|||f||||t||||||||||2017-02-18 15:04:19.556036|2017-02-18 15:04:19.556036
NCT00559975|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2009-11-04|||October 2007||2007-10-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|||||Interventional|||Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine|A Phase 1, Randomized, Controlled, Observer-Blinded, Dose Escalation Study of the Safety, Tolerability and Immunogenicity of a Single Dose of Adjuvanted Influenza Vaccine Combined With CpG7909 in Healthy Adults|Completed||Phase 1|60|Anticipated|Novartis||5|||f||||||||||||||2017-02-18 15:04:19.988255|2017-02-18 15:04:19.988255
NCT00559962|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2014-01-15|2013-01-18||October 2007||2007-10-01|January 2014|2014-01-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Low Doses of the MTP-Inhibitor AEGR-733 on Hepatic Fat Accumulation as Measured by Magnetic Resonance Spectroscopy|Completed||Phase 2|260|Actual|Aegerion Pharmaceuticals, Inc.||8|||f||||t||||||||||2017-02-18 15:04:20.267433|2017-02-18 15:04:20.267433
NCT00559949|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-16|2016-12-02|2016-12-02||December 2007||2007-12-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional||All participants, unless specified differently in an Outcome Measure.|Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine|Phase 2 Study of Selumetinib Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements|Completed||Phase 2|39|Actual|National Cancer Institute (NCI)|Actuarial OS cannot be estimated due to long survival times in this disease.|1|||f||||t||||||||||2017-02-18 15:04:21.657898|2017-02-18 15:04:21.657898
NCT00559936|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-10-02|2012-08-21||February 2007||2007-02-01|October 2012|2012-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Topical Avastin for Treatment of Corneal Neovascularization|Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization|Completed||Phase 1|24|Actual|Massachusetts Eye and Ear Infirmary||1|||f||||f||||||||||2017-02-18 15:04:22.032646|2017-02-18 15:04:22.032646
NCT00559910|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-04-22|||February 2008||2008-02-01|April 2011|2011-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 (0.5, 3, 6 And 10 MG) In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 2|230|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:04:22.278529|2017-02-18 15:04:22.278529
NCT00559897|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-01-26|2015-01-26||March 2008||2008-03-01|January 2015|2015-01-01|April 2011|Actual|2011-04-01|April 2010|Actual|2010-04-01||Interventional|||Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase II Study Evaluating the Effect of Zolendronic Acid on Standardized Uptake Value (SUV) on FLT PET Scans in Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|6|Actual|Barbara Ann Karmanos Cancer Institute|None of the participants were evaluable.|1||Slow accrual|f||||t||||||||||2017-02-18 15:04:22.420609|2017-02-18 15:04:22.420609
NCT00559884|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-05-31|||November 2007||2007-11-01|February 2011|2011-02-01||||||||Interventional|||A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects|An Open-label, Randomized, Single Dose, Crossover Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Modified Release Formulations of GSK189075 in Healthy Volunteers|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:04:22.642257|2017-02-18 15:04:22.642257
NCT00559871|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2009-06-02|||October 2007||2007-10-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|Fjord||Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose Response Study of the Efficacy, Safety and Tolerability of Fipamezole as an Oromucosal Fast Dissolving Tablet in the Treatment of Parkinson's Disease Patients.|Completed||Phase 2|180|Actual|Juvantia Pharma Ltd||4|||f||||t||||||||||2017-02-18 15:04:22.731709|2017-02-18 15:04:22.731709
NCT00559858|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2013-08-01|||December 2004||2004-12-01|December 2008|2008-12-01||||December 2009|Anticipated|2009-12-01||Interventional|||Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer|A Randomised Placebo-controlled Study Evaluating the Role of Pyridoxine in Controlling Capecitabine-induced Hand-foot Syndrome|Unknown status|Active, not recruiting|Phase 3|270|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:04:22.978952|2017-02-18 15:04:22.978952
NCT00559845|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2016-05-04|||February 2008||2008-02-01|May 2016|2016-05-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer.|An Open Label Neoadjuvant Study to Assess the Effect of Avastin on Tumor Response in Patients With Inflammatory or Locally Advanced Breast Cancer|Completed||Phase 2|57|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:04:23.088893|2017-02-18 15:04:23.088893
NCT00559832|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-15|||March 2006||2006-03-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Prevention of Acute Mountain Sickness by Intermittent Hypoxia|Prevention of Acute Mountain Sickness by Sleeping at Simulated Altitude (Normobaric Hypoxia)|Completed||N/A|75|Actual|Heidelberg University||2|||f||||f||||||||||2017-02-18 15:04:23.200786|2017-02-18 15:04:23.200786
NCT00559819|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2016-11-08|||February 2008||2008-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|ALCDrive||Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving|Validation of Driving Simulator Measures and Calibration to Blood Alcohol Concentration Standards for Impaired Driving|Active, not recruiting||Phase 3|40|Anticipated|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 15:04:23.287209|2017-02-18 15:04:23.287209
NCT00559806|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-15|||January 2007||2007-01-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||The Effect of Aging and Immobilisation on Muscle|The Effect of Aging and Immobilisation on Muscle|Completed||N/A|20|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-02-18 15:04:23.39899|2017-02-18 15:04:23.39899
NCT00559780|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-15|||May 2000||2000-05-01|November 2007|2007-11-01|December 2003|Actual|2003-12-01|||||Interventional|||Muscle Function in Elderly Postoperative Patients|Muscle Function in the Elderly After Hip-Replacement Surgery - Effects of Long Term Disuse and Physical Training|Completed||N/A|36|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-02-18 15:04:23.486573|2017-02-18 15:04:23.486573
NCT00559767|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2017-01-24|||June 30, 2006||2006-06-30|April 10, 2012|2012-04-10|April 10, 2012||2012-04-10|||||Observational|||Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium|Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium|Completed||N/A|2860|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:04:23.573955|2017-02-18 15:04:23.573955
NCT00559754|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2014-11-05|2014-05-16||December 2007||2007-12-01|November 2014|2014-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||Intent to Treat (ITT) Population: all participants included in the study.|A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.|An Open Label Study to Assess the Effect of a Combination of Avastin and Docetaxel and Sequential Chemotherapy on Pathological Response in Patients With Primary Operable HER2 Negative Breast Cancer|Completed||Phase 2|72|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:04:23.826462|2017-02-18 15:04:23.826462
NCT00559741|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-05-12|||October 2005||2005-10-01|May 2011|2011-05-01||||May 2011|Actual|2011-05-01||Interventional|||Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer|Phase 2 Study to Improve Tolerance of Chemotherapy Involving Cetuximab and Multidrug FOLFIRI, With Pharmacokinetic and Pharmacogenetic Studies, in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:04:24.342999|2017-02-18 15:04:24.342999
NCT00559728|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-09-03|||July 2008||2008-07-01|September 2015|2015-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Magnetic Resonance Imaging (MRI) Analysis of Coronary Artery Plaque Components||Completed||N/A|100|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 15:04:24.445371|2017-02-18 15:04:24.445371
NCT00559715|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2009-03-25|||August 2008||2008-08-01|March 2009|2009-03-01|August 2010|Anticipated|2010-08-01|August 2009|Anticipated|2009-08-01||Interventional|VIBERA||Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab|Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting|Unknown status|Recruiting|Phase 3|366|Anticipated|Klinikum Bremen-Mitte, gGmbH||2|||f||||t||||||||||2017-02-18 15:04:24.510402|2017-02-18 15:04:24.510402
NCT00559702|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2014-09-05|||October 2007||2007-10-01|September 2014|2014-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)|A Randomized, Open-Label, Dose-Ranging Study to Evaluate the Pharmacokinetics and Initial Safety of Subcutaneous and Intramuscular Natalizumab in Subjects With Multiple Sclerosis|Completed||Phase 1|76|Actual|Biogen||6|||f||||f||||||||||2017-02-18 15:04:24.623721|2017-02-18 15:04:24.623721
NCT00559689|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2009-03-13|||November 2005||2005-11-01|March 2009|2009-03-01|March 2007|Actual|2007-03-01|||||Observational|||Study of Inhaled Glucocorticosteroid Administration in Asthma Patients|Phase 4 Study of Once-Daily Inhaled Glucocorticosteroid Administration in Asthma Patients|Completed||Phase 4|24|Actual|Hamamatsu University|||2||f||||f||||||||||2017-02-18 15:04:24.76098|2017-02-18 15:04:24.76098
NCT00559676|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-05-13|||March 2005||2005-03-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer|Phase 4 Study to Characterize and Evaluate Markers of Chemoresistance in Patients With Metastatic Colorectal Cancer|Completed||Phase 4|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:04:24.874106|2017-02-18 15:04:24.874106
NCT00559663|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-16|||September 2006||2006-09-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|FEAST-CAL||Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile|Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile|Completed||N/A|35|Actual|LifeBridge Health||2|||f||||t||||||||||2017-02-18 15:04:24.97089|2017-02-18 15:04:24.97089
NCT00559650|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-09-22||2015-09-22|December 2007||2007-12-01|December 2014|2014-12-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667|Placebo Controlled, Randomized, Double-blind, Multi-center, Multinational Phase IIb Study to Investigate the Efficacy and Tolerability of BAY58-2667 Given Intravenously in Patients With Decompensated Chronic Congestive Heart Failure|Terminated||Phase 2|150|Actual|Bayer||2|||f||||t||||||||||2017-02-18 15:04:25.231805|2017-02-18 15:04:25.231805
NCT00381277|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2011-02-18|||March 2006||2006-03-01|February 2011|2011-02-01|September 2006|Actual|2006-09-01|March 2006|Actual|2006-03-01||Interventional|||The Effects of Sports Drinks on Urinary Lithogenicity|The Effects of Sports Drinks on Urinary Lithogenicity|Completed||N/A|10||VA New York Harbor Healthcare System|||||f||||f||||||||||2017-02-18 16:13:29.229113|2017-02-18 16:13:29.229113
NCT00559637|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2016-03-08|2016-03-08||January 2008||2008-01-01|March 2016|2016-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|MERCUR|Safety population included all participants who received at least one dose of study medication.|A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis|Single-arm, Open Study to Investigate the Efficacy, Safety and Tolerability of Monthly Subcutaneously Administered C.E.R.A. in Patients With Renal Anemia Not Yet Subject to Dialysis and Not Yet Permanently Treated With ESAs|Completed||Phase 3|184|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:04:25.422057|2017-02-18 15:04:25.422057
NCT00559624|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-05-09|||December 2007||2007-12-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients|A Phase I/II Open Label Dose Escalation Study to Investigate the Safety and Tolerability of Acadesine in Patients With B-cell Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|40|Anticipated|Advancell - Advanced In Vitro Cell Technologies, S.A.||1|||f||||t||||||||||2017-02-18 15:04:26.044374|2017-02-18 15:04:26.044374
NCT00559611|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2016-09-12|||October 2007||2007-10-01|September 2016|2016-09-01||||October 2018|Anticipated|2018-10-01||Interventional|||Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC)|Prospective Comparison of Endobronchial Ultrasound Needle Biopsy Versus Mediastinoscopy for Staging of Mediastinal Nodes in Patients With Clinical Stage IIIA Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:04:26.14956|2017-02-18 15:04:26.14956
NCT00559598|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2012-03-07|||August 2004||2004-08-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|||||Observational|||Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer|Use of Serum Proteome on the Early Diagnosis of Malignant Biliary-Pancreatic Disease|Completed||N/A|502|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:04:26.259218|2017-02-18 15:04:26.259218
NCT00559585|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-11-05|2011-04-29||January 2008||2008-01-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|November 2009|Actual|2009-11-01||Interventional||Per-protocol Population in ST Period.|Methotrexate-Inadequate Response Study|A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate|Completed||Phase 3|2492|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 15:04:26.384257|2017-02-18 15:04:26.384257
NCT00559572|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2013-01-14|||November 2007||2007-11-01|January 2013|2013-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Motivating People With Schizophrenia to Exercise|Motivating Persons With Schizophrenia to Exercise|Completed||N/A|80|Actual|The University of Tennessee, Knoxville||2|||f||||t||||||||||2017-02-18 15:04:29.409148|2017-02-18 15:04:29.409148
NCT00559559|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-08-06|||December 2007||2007-12-01|August 2015|2015-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Panoramic||PAtient NOtifier Feature for Reduction of Anxiety|PAtient NOtifier Feature for Reduction of Anxiety: A Multicenter ICD Study|Completed||N/A|362|Actual|St. Jude Medical||2|||f||||f||||||||||2017-02-18 15:04:29.519209|2017-02-18 15:04:29.519209
NCT00559546|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-15|||March 2007||2007-03-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|MONTAS||Montelukast as a Controller of Atopic Syndrome|Montelukast as a Controller of Atopic Syndrome|Completed||Phase 4|61|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 15:04:29.704099|2017-02-18 15:04:29.704099
NCT00559533|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2016-11-01|||December 2007||2007-12-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors|A Multi-center, Open-label, Phase I Study of Single Agent R7112 Administered Orally in Patients With Advanced Malignancies, Except All Forms of Leukaemia|Completed||Phase 1|106|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:04:29.809203|2017-02-18 15:04:29.809203
NCT00559520|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2011-12-08|||February 2002||2002-02-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery|The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery|Completed||Phase 4|250|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 15:04:29.910784|2017-02-18 15:04:29.910784
NCT00559507|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2014-04-02|2013-08-14||October 2007||2007-10-01|December 2013|2013-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery|A Phase II Study of AZD0530 in Hormone Receptor-Negative, Metastatic or Unresectable, Locally Advanced Breast Cancer|Completed||Phase 2|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:04:30.040968|2017-02-18 15:04:30.040968
NCT00559494|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2013-03-15|||June 2004||2004-06-01|March 2013|2013-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Minocycline and Perfusion Pressure Augmentation in Acute Spinal Cord Injury|A Pilot Study to Assess Clinical Safety and Tolerance of Minocycline and Spinal Perfusion Pressure Augmentation in Acute Spinal Cord Injury|Completed||Phase 1/Phase 2|52|Actual|University of Calgary||4|||f||||t||||||||||2017-02-18 15:04:30.315616|2017-02-18 15:04:30.315616
NCT00559481|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2013-01-31|||October 2007||2007-10-01|January 2013|2013-01-01||||September 2008|Actual|2008-09-01||Interventional|||Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy|Effect of Oral Ketoconazole on the Pharmacokinetics of Oral Dexamethasone and Oral Hydrocortisone in Patients With Androgen Independent Prostate Cancer|Withdrawn||N/A|0|Actual|Roswell Park Cancer Institute||||Withdrawn due to low accrual|f||||||||||||||2017-02-18 15:04:30.441228|2017-02-18 15:04:30.441228
NCT00559468|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2016-05-02|||December 2006||2006-12-01|May 2016|2016-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Org 25969 After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (19.4.312)(P05949)|A Multi -Center, Randomized, Parallel Group, Safety Assessor Blinded Trial Comparing Efficacy and Safety of 4.0 mg.Kg-1 Org 25969, Administered at T1 3-10% After Continuous Infusion of Rocuronium, and Pharmacokinetics of Rocuronium, Between Subjects Receiving Maintenance Anesthesia Using Propofol and Subjects Receiving Maintenance Anesthesia Using Sevoflurane|Completed||Phase 3|52|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:04:30.533594|2017-02-18 15:04:30.533594
NCT00559455|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-06-27|||September 2007||2007-09-01|June 2011|2011-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma|Phase II Study of Oxaliplatin + 5-FluoroUracil/Leucovorin (Eloxatin+5-FU/LV) in Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|38|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:04:30.631187|2017-02-18 15:04:30.631187
NCT00559442|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2013-09-05|||June 2007||2007-06-01|November 2007|2007-11-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction|Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Pulmonary Artery Pressure During Exercise in Normoxia and at Rest in Hypoxia|Completed||N/A|30|Actual|Heidelberg University||1|||f||||f||||||||||2017-02-18 15:04:30.887641|2017-02-18 15:04:30.887641
NCT00559429|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2008-12-16|||December 2004||2004-12-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|Tax-Sam||Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer|Phase I Trial With a Combination of Docetaxel +153 Sm-EDTMP (Samarium 153) in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 1|13|Actual|Sidney Kimmel Comprehensive Cancer Center||4|||f||||t||||||||||2017-02-18 15:04:30.984253|2017-02-18 15:04:30.984253
NCT00559416|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2017-01-24|||November 8, 2007||2007-11-08|September 30, 2016|2016-09-30|September 30, 2016|Actual|2016-09-30|September 30, 2016|Actual|2016-09-30||Interventional|||Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy|"Immunologic and Virologic Response in HIV Infected Progressors After Infusion of Lymphocytes From HIV Infected Elite Long-Term Non-Progressors"|Terminated||Phase 1|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:04:31.102852|2017-02-18 15:04:31.102852
NCT00559403|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2015-09-23|||October 2004||2004-10-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effect of HIV/STD Risk Reduction Program on South African Adolescents|South African Adolescent Health Promotion Project|Completed||Phase 2/Phase 3|1057|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 15:04:31.204419|2017-02-18 15:04:31.204419
NCT00559390|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2013-04-03|||July 2006||2006-07-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|PCOS||Research Study for Children With a Mother or Sister With Polycystic Ovary Syndrome|Metabolic Syndrome in PCOS: Precursors and Interventions|Completed||N/A|136|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||2||f||||t||||||Samples With DNA|"~     Whole Blood, Serum and Plasma~   "|||2017-02-18 15:04:31.314036|2017-02-18 15:04:31.314036
NCT00559377|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2016-12-28|2014-10-29||November 2007||2007-11-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|July 2012|Actual|2012-07-01||Interventional|||FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer|A Phase 2 Study of Positron Emission Tomography Imaging With [18F]-Fluoromisonidazole (FMISO) and [18F]-Fluorodeoxyglucose (FDG) for Assessment of Tumor Hypoxia in Cervical Cancer|Completed||Phase 2|16|Actual|National Cancer Institute (NCI)|Small number of subjects enrolled and events limit meaningful statistical analysis.|1|||f||||f||||||||||2017-02-18 15:04:31.41966|2017-02-18 15:04:31.41966
NCT00559364|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2014-01-27|2014-01-27||November 2007||2007-11-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||Intent-to-treat (ITT) population included all randomized patients.|Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea|A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled, Phase III Study to Assess the Safety and Efficacy of Viokase® 16 for the Correction of Steatorrhea in Patients With Exocrine Pancreatic Insufficiency|Completed||Phase 3|50|Actual|Forest Laboratories|Results for percentage of stool characteristics per bowel movement and number of days with at least 1 stool of specific characteristic were not reported due to change in planned analysis.|2|||f||||f||||||||||2017-02-18 15:04:31.743958|2017-02-18 15:04:31.743958
NCT00559351|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-15|||December 2001||2001-12-01|September 2007|2007-09-01|April 2004|Actual|2004-04-01|||||Interventional|||RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus|Possibilities for Improvement of an Outcome of the Treatment in Squamous Cell Carcinoma of the Thoracic Esophagus - a Multicenter Randomized Clinical Phase III Trial.|Terminated||Phase 3|84|Actual|Ministry of Scientific Research and Information Technology, Poland||3||difficulty in recruitment|f||||f||||||||||2017-02-18 15:04:32.158415|2017-02-18 15:04:32.158415
NCT00559338|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2007-11-15|||December 2003||2003-12-01|November 2007|2007-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department|Acutely Decompensated Heart Failure in a County Emergency Department: A Double Blind Randomized Controlled Comparison of Nesiritide vs. Placebo Treatment|Completed||Phase 4|104|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 15:04:32.277585|2017-02-18 15:04:32.277585
NCT00559312|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-12-14|||December 2007||2007-12-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD|A 6-week Randomized, Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Fluticasone 250μg/Salmeterol 50μg Combination (FSC 250/50) on Exertional Dyspnea in Patients With Symptomatic Mild COPD|Completed||N/A|18|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 15:04:32.389779|2017-02-18 15:04:32.389779
NCT00559299|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-03-15|||November 2007||2007-11-01|February 2011|2011-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Patient Tolerability Study of GSK163090|A Randomized, Single-blind, Placebo-controlled, 2 Part Study to Evaluate the Safety and Tolerability of GSK163090 at Single and Repeat Doses in Subjects With MDD|Completed||Phase 1|20|Anticipated|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:04:32.501069|2017-02-18 15:04:32.501069
NCT00559286|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2009-01-28|||December 2007||2007-12-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|ITEM||Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels|Influence of the Angiotensin Receptor Blocker Telmisartan on the Red Blood Cell Function and the Microcirculatory Perfusion|Terminated||Phase 4|40|Anticipated|RWTH Aachen University||2||logistic reasons, patients could not be recruited|f||||t||||||||||2017-02-18 15:04:32.600451|2017-02-18 15:04:32.600451
NCT00558896|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2016-04-19|2014-01-22||November 2007||2007-11-01|June 2015|2015-06-01||||September 2012|Actual|2012-09-01||Interventional|||CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis|A Phase II Trial of CC-4047 Plus Dexamethasone in Patients With Relapsed of Refractory Multiple Myeloma or Amyloidosis|Active, not recruiting||Phase 2|378|Actual|Mayo Clinic||7|||f||||t||||||||||2017-02-18 15:04:37.019115|2017-02-18 15:04:37.019115
NCT00559273|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2016-09-13|2016-09-13||December 2007||2007-12-01|September 2016|2016-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||Safety population included all randomized participants who received at least 1 dose of study medication and attended safety follow-up, whether they withdrew prematurely or not. Participants were assigned to the treatment group as treated. One participant randomized to Mircera, received darbepoetin alfa and included in darbepoetin alfa arm.|A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis|An Open-label, Randomized, Multicenter, Parallel-group Study to Demonstrate Correction of Anemia Using Once Every 4 Weeks Subcutaneous Injections of RO0503821 in Patients With Chronic Kidney Disease Who Are Not on Dialysis|Completed||Phase 3|307|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:04:32.722039|2017-02-18 15:04:32.722039
NCT00559260|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2008-09-12|||January 2003||2003-01-01|September 2008|2008-09-01||||||||Observational|||Evaluation of Cardiorespiratory Events in Subjects Undergoing an Upper and/or Lower Endoscopy Under Current Sedation Practices|Evaluation of Cardiorespiratory Events in Subjects Undergoing an Upper and/or Lower Endoscopy Under Current Sedation Practices While Being Passively Monitored|Completed||N/A|300||Ethicon Endo-Surgery|||||f||||||||||||||2017-02-18 15:04:33.577128|2017-02-18 15:04:33.577128
NCT00559247|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2010-09-10||2010-09-10|January 2008||2008-01-01|September 2010|2010-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects|Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BMS-650032 in Subjects Chronically Infected With Hepatitis C Virus Genotype 1|Completed||Phase 1/Phase 2|24|Anticipated|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 15:04:33.647921|2017-02-18 15:04:33.647921
NCT00559234|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2017-01-24|||November 9, 2007||2007-11-09|October 3, 2008|2008-10-03|October 3, 2008||2008-10-03|||||Observational|||Potential Research Participants for Future Studies of Inherited Eye Diseases|Evaluation and Treatment Protocol for Potential Research Participants With Inherited Ophthalmic Diseases|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:04:33.747466|2017-02-18 15:04:33.747466
NCT00559221|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2008-10-13|||December 2004||2004-12-01|November 2007|2007-11-01|June 2008|Anticipated|2008-06-01|||||Interventional|||FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML|Fludarabine and Cytarabine as Continuous Infusion Plus Idarubicin With Granulocyte-Colony Stimulating Factor (G-CSF) Priming for Patients Younger Than 60 Years With Resistant Acute Myeloid Leukemia|Unknown status|Recruiting|Phase 2|37|Anticipated|Cooperative Study Group A for Hematology||1|||f||||f||||||||||2017-02-18 15:04:33.831739|2017-02-18 15:04:33.831739
NCT00559208|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-06-22|||October 2006||2006-10-01|November 2009|2009-11-01|December 2010|Actual|2010-12-01|||||Observational|||Children's Aid Societies: Differential Response and Wraparound Prevention Trial|The Comparative Effects and Expense of Augmenting Usual Children's Aid Society (CAS) Care With a Regional Differential Response and Wraparound Prevention Service for Children|Completed||N/A|135|Actual|Hamilton Children's Aid Society|||1||f||||t||||||||||2017-02-18 15:04:34.101887|2017-02-18 15:04:34.101887
NCT00559195|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-05-13|||November 2005||2005-11-01|May 2011|2011-05-01||||May 2011|Actual|2011-05-01||Interventional|||Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors|Phase 2 Study Evaluating the Efficacy of Epoetin Beta (Neocormon®) For Fatigue and Quality of Life of Patients Receiving Palliative Care for a Solid Malignant Tumor|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:04:34.194427|2017-02-18 15:04:34.194427
NCT00559182|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2015-07-17|||December 2007||2007-12-01|July 2015|2015-07-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)|A Phase I Dose Escalation Study of MK-8033 in Patients With Advanced Solid Tumors|Completed||Phase 1|47|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:04:34.291643|2017-02-18 15:04:34.291643
NCT00559169|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2010-04-07|||February 2009||2009-02-01|November 2007|2007-11-01|December 2010|Anticipated|2010-12-01|||||Interventional|||Verapamil and Catamenial Epilepsy|Study of Verapamil in Refractory Catamenial Epilepsy|Withdrawn||N/A|12|Anticipated|University Health Network, Toronto||1||"protocol changed and a new study using verapamil in epilepsy will be started in the near~   future"|f||||f||||||||||2017-02-18 15:04:34.393263|2017-02-18 15:04:34.393263
NCT00559156|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-05-13|||June 2005||2005-06-01|May 2011|2011-05-01||||May 2011|Actual|2011-05-01||Interventional|||Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy|Phase 2 Study Assessing the Impact of Parenteral Administration of the Immunomodulater Oral IMPACT® for Postoperative Radiochemotherapy in Patients With Carcinoma of the Head and Neck|Completed||Phase 2|46|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:04:34.484219|2017-02-18 15:04:34.484219
NCT00559143|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-06-07|||November 2007||2007-11-01|June 2011|2011-06-01|July 2011|Anticipated|2011-07-01|November 2009|Anticipated|2009-11-01||Interventional|BETTER||Biventricular Alternative Pacing|Better Pacing - Biventricular Pacing as Alternative Method in Patients With Disturbances of AV Conduction and Preserved LV Function|Withdrawn||Phase 4|38|Anticipated|Medtronic Hellas Medical Devices ΑEE||2||No patients enrolled for long period of time. No scientific interest any more|f||||f||||||||||2017-02-18 15:04:34.582158|2017-02-18 15:04:34.582158
NCT00559130|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2011-06-06|||November 2007||2007-11-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis|Multi-Center, Efficacy Study of the MedaSorb CytoSorb™ Hemoperfusion Device as an Adjunctive Therapy in Subjects With Acute Respiratory Distress Syndrome (ARDS) or Acute Lung Injury (ALI) in the Setting of Sepsis|Completed||N/A|100|Anticipated|MedaSorb Technologies, Inc||1|||f||||t||||||||||2017-02-18 15:04:34.690614|2017-02-18 15:04:34.690614
NCT00559117|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-03-26|||November 2007||2007-11-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer|A Phase I, Open-Label, Dose Ranging Study to Assess the Safety and Distribution of Single or Multiple Doses of VB-111 in Patients With Advanced Metastatic Cancer|Active, not recruiting||Phase 1|48|Anticipated|Vascular Biogenics Ltd. operating as VBL Therapeutics||1|||f||||t||||||||||2017-02-18 15:04:34.800155|2017-02-18 15:04:34.800155
NCT00553982|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-04-14|||October 2007||2007-10-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|June 2015|Actual|2015-06-01||Interventional|||Patellar Resurfacing in Total Knee Arthroplasty|Patellar Resurfacing in Total Knee Arthroplasty. A Prospective, Randomised and Double Blind Study.|Completed||N/A|130|Actual|Sykehuset Innlandet HF||2|||f||||||||||||||2017-02-18 15:06:47.516542|2017-02-18 15:06:47.516542
NCT00559104|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2015-07-17|2015-07-17||October 1998||1998-10-01|July 2015|2015-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma|High-Dose Therapy and Autologous Stem Cell Transplantation During Remission in Poor-Risk Age-Adjusted International Prognostic Index High and High-Intermediate Risk Group Patients With Intermediate Grade and High-Grade Non-Hodgkin's Lymphoma Including Mantle Cell Lymphoma|Completed||Phase 2|60|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 15:04:34.906715|2017-02-18 15:04:34.906715
NCT00559091|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2011-05-06|||April 2007||2007-04-01|September 2009|2009-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|Borden-001||A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia|A Phase II Study of Ribavirin in Refractory of Relapsed Acute Myelocytic Leukemia M4 and M5 Subtypes|Completed||Phase 2|25|Anticipated|Jewish General Hospital||1|||f||||f||||||||||2017-02-18 15:04:35.47657|2017-02-18 15:04:35.47657
NCT00559078|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2009-11-06|||July 2007||2007-07-01|November 2009|2009-11-01|May 2009|Actual|2009-05-01|||||Observational|CAH||Qualitative Research on Women With Congenital Adrenal Hyperplasia|Health-related Quality of Life, Mental Health and Psychotherapeutic Considerations for Women Diagnosed With a Disorder of Sexual Development: Congenital Adrenal Hyperplasia|Completed||N/A|16|Anticipated|Lehigh University|||1||f||||f||||||||||2017-02-18 15:04:35.600974|2017-02-18 15:04:35.600974
NCT00559065|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2017-01-24|||July 9, 2006||2006-07-09|October 27, 2016|2016-10-27||||||||Observational|||A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China|A Case - Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China|Completed||N/A|3860|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:04:35.70989|2017-02-18 15:04:35.70989
NCT00559052|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2010-02-09|||March 2008||2008-03-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)|An Open-Label Cross-over Study to Evaluate the Intraduodenal Delivery of Lipase, Protease and Amylase From Administration of VIOKASE16 in Chronic Pancreatitis Subjects With Exocrine Pancreatic Insufficiency (EPI).|Completed||Phase 2|22|Anticipated|Axcan Pharma||2|||f||||f||||||||||2017-02-18 15:04:35.806941|2017-02-18 15:04:35.806941
NCT00559039|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2012-03-07|||October 2000||2000-10-01|March 2012|2012-03-01|October 2006|Actual|2006-10-01|||||Observational|||Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women|Fetal, Infant and Early Childhood Antecedents of Cancer in Women: Maternal Cohort Study of the Nurses' Health Studies|Completed||N/A|128700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:04:35.924853|2017-02-18 15:04:35.924853
NCT00559026|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-15|||September 2004||2004-09-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|DTIC-melvacc||Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients|Phase I/II Clinical Trial for the Evaluation of the Interaction Between Chemotherapy and Immunotherapy in Melanoma Patients|Completed||Phase 1|10|Actual|Istituto Superiore di Sanità||2|||f||||t||||||||||2017-02-18 15:04:36.01592|2017-02-18 15:04:36.01592
NCT00559013|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-05-23|2009-12-15||March 2007||2007-03-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery|Peri-Strips Dry With Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery|Completed||Phase 4|38|Actual|Synovis Surgical Innovations||1|||f||||f||||||||||2017-02-18 15:04:36.115239|2017-02-18 15:04:36.115239
NCT00559000|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2007-11-15|||December 2003||2003-12-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||The Efficacy of KIDNET in the Treatment of Traumatized Refugee Children in Germany|The Efficacy of KIDNET in the Treatment of Traumatized Refugee Children in Germany|Completed||Phase 3|25|Actual|University of Konstanz||2|||f||||f||||||||||2017-02-18 15:04:36.341864|2017-02-18 15:04:36.341864
NCT00558987|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2009-01-28|||February 2008||2008-02-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Parenting Videos In Primary Care|Enhancing Anticipatory Guidance About Discipline for Low-Income Families: A Video Intervention Project|Completed||N/A|122|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 15:04:36.441949|2017-02-18 15:04:36.441949
NCT00558961|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-15|2010-04-14|||October 2005||2005-10-01|November 2007|2007-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|GL-CLB-001||Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients|A Phase I-II Trial of Gleevec (Imatinib Mesylate) in Combination With Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia (CLL) Patients|Terminated||Phase 1/Phase 2|13|Actual|Jewish General Hospital||1||Unsatisfactory enrollment|f||||f||||||||||2017-02-18 15:04:36.539513|2017-02-18 15:04:36.539513
NCT00558948|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2009-08-18|||May 2007||2007-05-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Musculoskeletal Outcomes After Bone Marrow Transplant|Musculoskeletal Outcomes After Bone Marrow Transplant|Completed||N/A|48|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||t||||||||||2017-02-18 15:04:36.646779|2017-02-18 15:04:36.646779
NCT00558935|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2011-05-09|||October 2007||2007-10-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of Alcohol on ABCA1 Expression and Lipid Metabolism||Terminated||N/A|20|Anticipated|Bayside Health||1||It was found that 20g of alcohol daily had no effect on ABCA1 expression or HDL levels.|f||||||||||||||2017-02-18 15:04:36.734585|2017-02-18 15:04:36.734585
NCT00558922|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2009-07-29|||September 2007||2007-09-01|July 2009|2009-07-01|October 2009|Anticipated|2009-10-01|August 2009|Anticipated|2009-08-01||Interventional|||A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer|A Phase 1-2, Multicenter, Open-Label Study of the X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 Given in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|54|Actual|Aegera Therapeutics||1||Unacceptable Neurotoxicity (2 cases)|f||||f||||||||||2017-02-18 15:04:36.811983|2017-02-18 15:04:36.811983
NCT00558909|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2014-04-30|||June 2007||2007-06-01|April 2014|2014-04-01||||November 2007|Actual|2007-11-01||Interventional|||4 Weeks Treatment of Type II Diabetic Patients With BI 44847|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 4 Weeks Treatment With Three Selected Oral Doses of BI 44847 as Tablet in Female and Male Patients With Type 2 Diabetes.|Completed||Phase 1|80|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:04:36.912117|2017-02-18 15:04:36.912117
NCT00558883|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2008-04-10|||January 2005||2005-01-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|||||Interventional|||AI(I)DA Acarbose and the Subclinical Inflammation|Placebo Controlled Investigation on Action of Acarbose on the Sub-Clinical Inflammation and Immune Response in Early Type 2 Diabetes and Atherosclerosis Risk|Completed||Phase 3|104|Actual|GWT-TUD GmbH||2|||f||||t||||||||||2017-02-18 15:04:39.43682|2017-02-18 15:04:39.43682
NCT00558870|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2016-03-07|2016-02-01||November 2007||2007-11-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Role of Methadone As Co-Opioid Analgesic|Role of Methadone As Co-Opioid Analgesic in Cancer Patients|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center|The study sample size is too low for any of the differences or non-differences between the groups to be statistically significant.|2||Low Accrual.|f||||t||||||||||2017-02-18 15:04:39.545313|2017-02-18 15:04:39.545313
NCT00558857|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2011-02-16|||July 2007||2007-07-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|DSM||Dynamic Substrate Mapping (DSM) for Ischemic VT|Clinical Feasibility of Using Dynamic Substrate Mapping to Guide Ablation of Ischemic Ventricular Tachycardia|Terminated||Phase 1|5|Actual|St. Jude Medical||1||Low enrollment|f||||f||||||||||2017-02-18 15:04:40.063037|2017-02-18 15:04:40.063037
NCT00558844|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2016-10-06||2016-09-29|January 2008||2008-01-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Multidose Safety and Tolerability Study of Liposomal Amikacin for Inhalation (Arikace™) In Cystic Fibrosis Patients|Phase 1b/2a Multidose Safety and Tolerability Study of Liposomal Amikacin for Inhalation (Arikace™) in Cystic Fibrosis Patient With Chronic Infections Due to Pseudomonas Aeruginosa.|Completed||Phase 1/Phase 2|46|Actual|Insmed Incorporated||2|||f||||t||||||||||2017-02-18 15:04:40.17731|2017-02-18 15:04:40.17731
NCT00558831|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2011-01-12|2010-10-12||October 2007||2007-10-01|January 2011|2011-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris|A Split-face, Paired-comparison Pilot Study to Evaluate the Safety and Efficacy of Topical Benzoyl Peroxide 2.5% Cream Alone Versus Benzoyl Peroxide 2.5% Cream Plus Moisturizing Lotion for Mild to Moderate Acne Vulgaris|Completed||N/A|11|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 15:04:40.312152|2017-02-18 15:04:40.312152
NCT00558818|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-07-24|||June 2007||2007-06-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Long-term Study With Clevudine|A Phase lV Study to Evaluate the Long-term Safety and Efficacy of Clevudine in the Patients Chronically Infected With Hepatitis B Virus|Completed||Phase 4|150|Anticipated|Bukwang Pharmaceutical||1|||f||||f||||||||||2017-02-18 15:04:40.66128|2017-02-18 15:04:40.66128
NCT00558805|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2007-11-14|||October 2003||2003-10-01|October 2007|2007-10-01||||||||Interventional|FISP||Family Intervention for Suicidal Youth: Emergency Care|Family Intervention for Suicidal Youth: Emergency Care|Completed||Phase 2|||Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 15:04:40.74557|2017-02-18 15:04:40.74557
NCT00558792|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2012-10-18|2012-08-13||November 2007||2007-11-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Coronary MDCTA With Iopamidol Injection 370|A Phase II Multicenter Randomized Double Blind Dose Finding Study of Iopamidol Injection 370 in Multidetector Computed Tomographic Angiography (MDCTA) in Patients With Suspected Coronary Artery Stenosis|Completed||Phase 2|210|Actual|Bracco Diagnostics, Inc||3|||f||||f||||||||||2017-02-18 15:04:40.848298|2017-02-18 15:04:40.848298
NCT00558779|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2007-11-21|||November 2007||2007-11-01|November 2007|2007-11-01|May 2010|Anticipated|2010-05-01|||||Interventional|||Surgical Manipulation of the Aorta and Cerebral Infarction|Surgical Manipulation of the Ascending Aorta and Cerebral Infarction Following CABG|Unknown status|Recruiting|Phase 2|200|Anticipated|University of Wuerzburg||2|||f||||t||||||||||2017-02-18 15:04:41.744866|2017-02-18 15:04:41.744866
NCT00558766|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2017-01-24|||November 8, 2007||2007-11-08|June 13, 2011|2011-06-13|June 13, 2011||2011-06-13|||||Observational|||Motor Cortex Reward Signaling in Parkinson Disease|Motor Cortex Reward Signaling in Parkinson Disease|Completed||N/A|35|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:04:41.851282|2017-02-18 15:04:41.851282
NCT00558753|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2016-04-26|2012-01-11||April 2006||2006-04-01|April 2016|2016-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PregTKA||Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset CRPS After TKA|A Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset Complex Regional Pain Syndrome After Total Knee Arthroplasty|Completed||Phase 2|240|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 15:04:41.949099|2017-02-18 15:04:41.949099
NCT00558740|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-02-09|||January 2009||2009-01-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Effects of Dietary Proteins on Hepatic Lipid Metabolism|Effects of Dietary Proteins on Hepatic Lipid Metabolism|Completed||N/A|22|Actual|University of Lausanne|||1||f||||f||||||||||2017-02-18 15:04:42.340405|2017-02-18 15:04:42.340405
NCT00558727|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2013-05-08|||November 2007||2007-11-01|May 2013|2013-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|Protocol RH-1-002: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Dose-escalation Study of RH-1 Administered as a 3-hour Intravenous Infusion in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|Terminated||Phase 1|12|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||||||||||||2017-02-18 15:04:42.451422|2017-02-18 15:04:42.451422
NCT00558701|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2016-04-26|2015-08-21||December 2007||2007-12-01|August 2015|2015-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Microcurrent for Healing Autogenous Skin Donor Sites|Prospective, Randomized, Controlled Study of the Efficacy of a Silver-coated Nylon Dressing Plus Active or Sham Microcurrent for Healing Autogenous Skin Donor Sites|Completed||N/A|30|Actual|United States Army Institute of Surgical Research||2|||f||||f||||||||No||2017-02-18 15:04:45.117348|2017-02-18 15:04:45.117348
NCT00558688|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-02-19|||August 2007||2007-08-01|February 2015|2015-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Photodynamic Therapy for Treatment of Actinic Keratoses|A Photodynamic Therapy for Treatment of Actinic Keratoses|Completed||N/A|20|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 15:04:45.423072|2017-02-18 15:04:45.423072
NCT00558493|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-07-24|||November 2007||2007-11-01|July 2012|2012-07-01||||||||Interventional|||Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients|Phase lV Study to Evaluate the Safety and Effectiveness of Switching Treatment From Lamivudine to Clevudine in the Chronic Hepatitis B Patients With Suboptimal Virologic Response During Lamivudine Treatment|Completed||Phase 4|100|Anticipated|Bukwang Pharmaceutical||1|||f||||f||||||||||2017-02-18 15:04:49.533463|2017-02-18 15:04:49.533463
NCT00558675|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-02-19|||December 2009||2009-12-01|November 2012|2012-11-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|||A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy|A Phase I/II Study of Intentionally Mis-Matched, Allogeneic Th1 Memory Cells (AlloStim) Conjugated With CD3/CD28-coated Microbeads in Patients With Relapsed or Refractory Hematological Malignancy|Completed||Phase 1/Phase 2|25|Anticipated|Immunovative Therapies, Ltd.||4|||f||||f||||||||||2017-02-18 15:04:45.520242|2017-02-18 15:04:45.520242
NCT00558662|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2011-11-17|||November 2007||2007-11-01|March 2011|2011-03-01|September 2011|Actual|2011-09-01|April 2009|Actual|2009-04-01||Interventional|||Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers|Randomized Controlled Clinical Study to Assess the Clinical Efficacy of the 3M™ Coban™ 2 Layer Compression System Compared to a Short-stretch Compression Bandage in the Treatment of Venous Leg Ulcers|Completed||N/A|234|Actual|3M||2|||f||||t||||||||||2017-02-18 15:04:45.636879|2017-02-18 15:04:45.636879
NCT00558649|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-27|2013-05-08|||May 2007||2007-05-01|November 2007|2007-11-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|NANOVAX||A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines|A Pilot, Controlled, Comparative and Single Blinded Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines Administered Intradermally Using Microneedle Injectors as Compared With Standard Dose Intramuscular Flu Vaccines as Reference.|Completed||N/A|180|Actual|NanoPass Technologies Ltd||3|||f||||f||||||||||2017-02-18 15:04:45.756932|2017-02-18 15:04:45.756932
NCT00558636|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-12-02|2009-11-13||September 2007||2007-09-01|December 2013|2013-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)|A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 3|91|Actual|Bayer|Due to early termination of the study, no comparison of treatments was possible. This study also provided limited opportunity to distinguish between Adverse Events associated with sorafenib and events associated with the underlying lung disease.|2||"Terminated early when the results from Study NCT00300885 showed an overall lack of efficacy in~   NSCLC and increased mortality in subjects with squamous subtype."|f||||t||||||||||2017-02-18 15:04:45.864996|2017-02-18 15:04:45.864996
NCT00558623|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2007-11-14|||January 2001||2001-01-01|November 2007|2007-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Dietary Calcium Supplementation to Reduce Blood Lead in Pregnancy|Controlled Trial in Pregnancy of Dietary Supplements for Suppression of Bone Resorption and Mobilization of Lead Into Plasma|Completed||N/A|670|Actual|National Institute of Environmental Health Sciences (NIEHS)||1|||f||||f||||||||||2017-02-18 15:04:46.91276|2017-02-18 15:04:46.91276
NCT00558597|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2011-07-19|||March 2008||2008-03-01|September 2008|2008-09-01|December 2011|Anticipated|2011-12-01|||||Observational|||Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation|Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation|Unknown status|Recruiting|N/A|60|Anticipated|Hannover Medical School|||2||f||||f||||||Samples Without DNA|"~     BAL (broncho alveolar lavage) urine~   "|||2017-02-18 15:04:47.034984|2017-02-18 15:04:47.034984
NCT00558584|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2016-11-22|||December 2007||2007-12-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy|Multicentre, Randomized, Double-blind, Prospective Investigation on the Effects of Immunoadsorption on Cardiac Function in Patients With Dilated Cardiomyopathy|Recruiting||Phase 4|200|Anticipated|University Medicine Greifswald||2|||f||||t||||||||||2017-02-18 15:04:47.148076|2017-02-18 15:04:47.148076
NCT00558571|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2014-07-16|2014-05-16||January 2008||2008-01-01|July 2014|2014-07-01||||April 2008|Actual|2008-04-01||Interventional|||4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes|Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 4 Weeks Treatment With Three Oral Doses of BI 10773 as Tablets in Female and Male Patients With Type 2 Diabetes|Completed||Phase 1|78|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 15:04:47.342959|2017-02-18 15:04:47.342959
NCT00558558|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2016-04-06|2011-09-02||October 2007||2007-10-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Haelan and Nutrition in Cancer Patients|A Phase II Study Examining the Role of Fermented Soy Beverage for Improving Cancer-Associated Anorexia and Cachexia|Terminated||Phase 2|6|Actual|M.D. Anderson Cancer Center||1||Study terminated due to low recruitment.|f||||f||||||||||2017-02-18 15:04:48.868635|2017-02-18 15:04:48.868635
NCT00558545|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2009-11-30|||November 2007||2007-11-01|November 2009|2009-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer|A Phase 1-2, Multicenter, Open-Label Study of the X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 Given in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer|Terminated||Phase 1/Phase 2|61|Anticipated|Aegera Therapeutics||1||Avastin approved for first-in-line treatment.|f||||f||||||||||2017-02-18 15:04:49.083187|2017-02-18 15:04:49.083187
NCT00558532|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2016-06-10|||October 2007||2007-10-01|June 2016|2016-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment|Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment|Withdrawn||N/A|0|Actual|University of Cincinnati|||2|Investigator Retired.|f||||f||||||Samples With DNA|"~     Whole blood, plasma, fat tissue~   "|||2017-02-18 15:04:49.188103|2017-02-18 15:04:49.188103
NCT00558519|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2017-01-20|||November 2007|Actual|2007-11-01|January 2017|2017-01-01||||June 2017|Anticipated|2017-06-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|An Intergroup Phase II Clinical Trial for Adolescents and Young Adults With Untreated Acute Lymphoblastic Leukemia (ALL)|Active, not recruiting||Phase 2|300|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:04:49.28461|2017-02-18 15:04:49.28461
NCT00558506|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2008-02-25|||January 2008||2008-01-01|September 2007|2007-09-01|December 2009|Anticipated|2009-12-01|October 2009||2009-10-01||Interventional|Aba-AS-01||Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis|Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis|Unknown status|Recruiting|Phase 2|30|Anticipated|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-02-18 15:04:49.412913|2017-02-18 15:04:49.412913
NCT00558480|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2015-04-08|||July 2009||2009-07-01|April 2015|2015-04-01|December 2012|Anticipated|2012-12-01|July 2011|Anticipated|2011-07-01||Interventional|||Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis|A Double Blind, Placebo Controlled Randomized Trial of Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Children Aged 5-14 Years With Latent Tuberculosis.|Withdrawn||N/A|0|Actual|Medical Research Council Unit, The Gambia||2|||f||||f||||||||||2017-02-18 15:04:49.613382|2017-02-18 15:04:49.613382
NCT00558467|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2014-05-07|2010-06-18||January 2008||2008-01-01|March 2014|2014-03-01||||June 2009|Actual|2009-06-01||Interventional|||Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria|A Randomized, Double-blind, Placebo-controlled, Flexible Dose Study to Evaluate Efficacy and Safety of Pramipexole Immediate Release (0.125-0.5mg/Day) Versus Placebo for 6 Weeks in Children and Adolescents (Age 6-17 Inclusive) Diagnosed With Tourette Disorder According to DSM IV Criteria.|Completed||Phase 2|63|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:04:49.731328|2017-02-18 15:04:49.731328
NCT00558454|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2012-06-04|||March 2004||2004-03-01|June 2012|2012-06-01|November 2014|Anticipated|2014-11-01|June 2008|Actual|2008-06-01||Interventional|JOHN||Iron Supplementation of Marginally Low Birth Weight Infants|Randomized, Controlled Study of Iron Supplementation of Infants With Birth Weights 2000-2500 g|Unknown status|Active, not recruiting|Phase 4|380|Actual|Umeå University||3|||f||||t||||||||||2017-02-18 15:04:50.93581|2017-02-18 15:04:50.93581
NCT00558441|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2007-11-14|||November 2007||2007-11-01|November 2007|2007-11-01|November 2013|Anticipated|2013-11-01|||||Interventional|MIRACLE||Prospective Data Collection of IVMRI Cases|Prospective Data Collection in Clinical Cases Where Coronary Plaque Lipid Characterization by IVMRI Was Performed During Diagnostic or Interventional Catheterization Procedures|Unknown status|Not yet recruiting|N/A|1000|Anticipated|TopSpin Medical||1|||f||||f||||||||||2017-02-18 15:04:51.062924|2017-02-18 15:04:51.062924
NCT00558428|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2014-06-17|2009-11-13||October 2007||2007-10-01|May 2014|2014-05-01||||September 2008|Actual|2008-09-01||Interventional|||Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension|An Eight-week Randomized, 4-arm, Double-blind Study to Compare the Efficacy and Safety of Combinations of Telmisartan 40mg + Amlodipine 5mg Versus Telmisartan 80mg + Amlodipine 5mg Versus Amlodipine 5mg Versus Amlodipine 10mg Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Amlodipine 5mg Monotherapy|Completed||Phase 3|1098|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:04:51.371228|2017-02-18 15:04:51.371228
NCT00558402|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-14|2014-10-27|||November 2007||2007-11-01|October 2014|2014-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Meditation or Education for Alzheimer Caregivers|Meditation for Alzheimer Caregivers: Stress & Physiology|Completed||Phase 2|72|Actual|Oregon Health and Science University||3|||f||||t||||||||||2017-02-18 15:04:52.206058|2017-02-18 15:04:52.206058
NCT00558376|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2009-05-04|||January 2008||2008-01-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy|Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy - An Investigator Blinded Prospective Controlled Trial|Terminated||N/A|23|Actual|Sheba Medical Center||2||Study terminated due to FDA alert regarding Fleet phosphosoda|f||||f||||||||||2017-02-18 15:04:52.309692|2017-02-18 15:04:52.309692
NCT00558363|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2012-03-15|2011-11-10||November 2007||2007-11-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|ARTS||ARTS - AVODART After Radical Therapy For Prostate Cancer Study|A Randomised, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride (AVODART™) 0.5 mg in Extending the Time to PSA Doubling in Men With Prostate Cancer and Biochemical Failure (PSA Increase) After Radical Therapy With Curative Intent|Completed||Phase 2|294|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:04:52.427232|2017-02-18 15:04:52.427232
NCT00558350|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2012-03-14|||April 2007||2007-04-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Systemic, Intrapulmonary and Pleural Inflammatory Reaction in Patients Undergoing Thoracic Surgery|Systemic, Intrapulmonary and Pleural Inflammatory Reaction in Patients Undergoing Thoracic Surgery|Completed||N/A|15|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 15:04:53.471479|2017-02-18 15:04:53.471479
NCT00558337|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2009-01-13|||November 2007||2007-11-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease|An Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Relationship Study of L-Dopa/Carbidopa in a Novel Release Formulation in Parkinson's Disease Patients|Completed||Phase 2|78|Actual|Osmotica Pharmaceutical US LLC||2|||f||||t||||||||||2017-02-18 15:04:53.560664|2017-02-18 15:04:53.560664
NCT00558324|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2007-11-12|||February 2007||2007-02-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Corneal Flap Thickness Planed vs Measured After LASIK by Using Tree Different Systems Cut|Corneal Flap Thickness Planed vs Measured After LASIK by Using Tree Different Systems Cut|Completed||N/A|43|Actual|Asociación para Evitar la Ceguera en México||3|||f||||t||||||||||2017-02-18 15:04:53.674031|2017-02-18 15:04:53.674031
NCT00558311|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2012-03-09||2011-03-25|November 2007||2007-11-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|CONSCIOUS-2||Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping|A Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping.|Completed||Phase 3|1157|Actual|Actelion||2|||f||||t||||||||||2017-02-18 15:04:53.786109|2017-02-18 15:04:53.786109
NCT00558298|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2011-05-16|||February 2000||2000-02-01|April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.|Risperidone Depot (Microspheres) in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder - an Open Label Follow up Trial of RIS-INT-57 and RIS-INT-61.|Completed||Phase 3|811|Actual|Janssen, LP|||||f||||||||||||||2017-02-18 15:04:54.229072|2017-02-18 15:04:54.229072
NCT00550186|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2016-06-27|||October 2007||2007-10-01|June 2016|2016-06-01||||December 2007|Actual|2007-12-01||Interventional|||Effect of Preload on Bladder Retention Volume During Spinal Anesthesia|The Effect of Intravascular Preload on Bladder Retention Volume During Spinal Anesthesia Induced Detrusor Blockade|Completed||N/A|144|Actual|Rijnstate Hospital||3|||f||||f||||||||||2017-02-18 15:08:33.596241|2017-02-18 15:08:33.596241
NCT00558285|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2012-11-28|2012-10-23||November 2007||2007-11-01|November 2012|2012-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Determine the Effect of QVA149 on Mean 24-hours Heart Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|257|Actual|Novartis||5|||f||||||||||||||2017-02-18 15:04:54.321887|2017-02-18 15:04:54.321887
NCT00558272|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2013-05-23|2011-05-27||February 2008||2008-02-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|January 2010|Actual|2010-01-01||Interventional|||Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease|A Phase II, Randomised, Open-Label, Pilot Study to Evaluate the Safety and Effects on Bone Resorption of AZD0530 in Patients With Prostate Cancer or Breast Cancer With Metastatic Bone Disease.|Completed||Phase 2|139|Actual|AstraZeneca|Non-compliant patients were excluded from the biomarker analysis, in order to accurately assess effects due to treatment. The compliance criteria did not apply to the zoledronic acid arm, which led to an imbalance in the number of subjects analysed.|2|||f||||t||||||||||2017-02-18 15:04:55.180971|2017-02-18 15:04:55.180971
NCT00558259|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2014-06-17|2012-01-31||November 2007||2007-11-01|February 2014|2014-02-01||||February 2011|Actual|2011-02-01||Interventional|RE-SONATE||Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE|Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long-term Prevention of Recurrent Symptomatic Proximal Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis or Pulmonary Embolism.|Completed||Phase 3|1353|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:04:55.889373|2017-02-18 15:04:55.889373
NCT00558246|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2012-06-13|2012-06-13||August 2007||2007-08-01|June 2012|2012-06-01|October 2009|Actual|2009-10-01|September 2008|Actual|2008-09-01||Interventional|||Study of Prineo (Dermabond Protape) Versus Sutures in Breast Procedures|Multi-centre Study to Show Equivalence of Prineo (DERMABOND PROTAPE) to Intradermal Sutures for Skin Closure of Full-thickness Surgical Incisions Associated With Breast Procedures|Completed||Phase 4|79|Actual|Ethicon, Inc.|Limitations of this study include the fact that the patient served as her own control. Additionally, as in many device studies, because of the obvious difference in the investigated and the control devices, blinding was limited.|2|||f||||f||||||||||2017-02-18 15:04:56.958711|2017-02-18 15:04:56.958711
NCT00558233|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2017-02-03|||November 2007||2007-11-01|February 2017|2017-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|InfoPC||Effectiveness Study of a Computer-Based Colorectal Cancer Screening Decision Aid|Overcoming Literacy Barriers in Colorectal Cancer Screening|Completed||N/A|264|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 15:04:57.365349|2017-02-18 15:04:57.365349
NCT00558220|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2007-11-10|||May 2002||2002-05-01|November 2007|2007-11-01|October 2006|Actual|2006-10-01|||||Interventional|R-MCEB||R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas|Phase II Study of Intensive Induction (R-MegaCHOP/ESHAP)Followed By Intensive Consolidation (BEAM) In Treatment Of High-Risk Aggressive B-Cell Lymphomas|Completed||Phase 2|106|Actual|Czech Lymphoma Study Group||1|||f||||f||||||||||2017-02-18 15:04:57.494061|2017-02-18 15:04:57.494061
NCT00558207|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2013-02-21||2013-02-21|November 2007||2007-11-01|February 2013|2013-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma|A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|43|Actual|ArQule||2|||f||||f||||||||||2017-02-18 15:04:57.627048|2017-02-18 15:04:57.627048
NCT00558194|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2011-03-15|||August 2009||2009-08-01|March 2011|2011-03-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment (Part 2)|Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment|Unknown status|Active, not recruiting|N/A|120|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 15:04:57.75655|2017-02-18 15:04:57.75655
NCT00558181|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2010-02-22|||September 2007||2007-09-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|LT-CLL-001||High-dose Methylprednisolone and Rituximab in High Risk B-CLL|Phase II Study of High-dose Methylprednisolone and Rituximab in Previously Treated Patients With High Risk Chronic B Lymphocytic Leukemia|Completed||Phase 2|29|Actual|Vilnius University||1|||f||||f||||||||||2017-02-18 15:04:57.85792|2017-02-18 15:04:57.85792
NCT00558168|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2008-07-25|||January 2004||2004-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|||||Observational|E-SAFE||Electronic Study for Anastrozole Pharmacovigilance Evaluation|Electronic Study for Anastrozole Pharmacovigilance Evaluation|Completed||N/A|1850|Actual|AstraZeneca|||||f||||f||||||||||2017-02-18 15:04:57.973446|2017-02-18 15:04:57.973446
NCT00558155|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-13|||June 2001||2001-06-01|November 2007|2007-11-01|December 2005|Actual|2005-12-01|||||Interventional|||The Impact of Immunostimulating Nutrition on the Outcome of Surgery|Title: The Impact of Immunostimulating Nutrition on Infectious Complications After Upper Gastrointestinal Surgery - A Prospective, Randomized, Clinical Trial.|Completed||Phase 4|214|Actual|Jagiellonian University||4|||f||||f||||||||||2017-02-18 15:04:58.045127|2017-02-18 15:04:58.045127
NCT00558142|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-06-04|||February 2008||2008-02-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material|Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material|Completed||Phase 4|90|Actual|University of Edinburgh||4|||f||||f||||||||||2017-02-18 15:04:58.161874|2017-02-18 15:04:58.161874
NCT00558129|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2012-01-20|||November 2007||2007-11-01|January 2012|2012-01-01|November 2011|Anticipated|2011-11-01|||||Interventional|EXELS||Effects of X-STOP® Versus Laminectomy Study|Prospective Randomized Trial Comparing X-STOP® Interspinous Process Decompression® System Versus Laminectomy for Treatment of Neurogenic Intermittent Claudication|Withdrawn||Phase 4|0|Actual|Medtronic Spine LLC||2|||f||||f||||||||||2017-02-18 15:04:58.291665|2017-02-18 15:04:58.291665
NCT00558116|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2008-05-10|||May 2007||2007-05-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|November 2008|Anticipated|2008-11-01||Interventional|||Treatment of Carpal Tunnel Syndrome With Dynamic Splinting|Treating Carpal Tunnel Syndrome With Dynamic Splinting: A Randomized, Controlled, Trial|Unknown status|Recruiting|N/A|80|Anticipated|Advanced Centers for Orthopaedic Surgery and Sports Medicine||2|||f||||f||||||||||2017-02-18 15:04:58.407711|2017-02-18 15:04:58.407711
NCT00558103|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-01-31|2012-05-17||December 2007||2007-12-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer|A Randomized, Multicenter, Phase III Study Comparing the Combination of Pazopanib and Lapatinib Versus Lapatinib Monotherapy in Patients With ErbB2 Over-expressing Inflammatory Breast Cancer|Completed||Phase 2|163|Actual|GlaxoSmithKline||3|||f||||t||||||||||2017-02-18 15:04:58.536979|2017-02-18 15:04:58.536979
NCT00558090|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2010-03-29|||February 2008||2008-02-01|October 2008|2008-10-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|OPCIC||The Optimization of Procedural Pain Control in Intensive Care Unit (ICU) Patients|Randomised Clinical Trial of the Optimization of Procedural Pain Control in ICU Patients|Completed||N/A|150|Anticipated|St. Antonius Hospital||1|||f||||f||||||||||2017-02-18 15:05:00.232134|2017-02-18 15:05:00.232134
NCT00558077|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2007-11-13|||February 2003||2003-02-01|November 2007|2007-11-01|October 2005||2005-10-01|||||Interventional|||Second-Line Treatments for Anovulatory Infertility in PCOS Patients|Laparoscopic Ovarian Diathermy or Metformin Plus Clomiphene Citrate Administration as Second-Line Treatment for Infertile Anovulatory Patients With Polycystic Ovary Syndrome: a Randomized Controlled Trial|Completed||Phase 4|50|Actual|University Magna Graecia||2|||f||||t||||||||||2017-02-18 15:05:00.365179|2017-02-18 15:05:00.365179
NCT00558064|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2014-06-24|2009-11-10||October 2007||2007-10-01|December 2013|2013-12-01||||September 2008|Actual|2008-09-01||Interventional|||Filtered Trial for Amlodipine Non-responder|Filtered Trial for Amlodipine Non-responder|Completed||Phase 3|531|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:05:03.032866|2017-02-18 15:05:03.032866
NCT00558051|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2016-03-31|||January 2008||2008-01-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|December 2011|Actual|2011-12-01||Interventional|||Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer|Phase I Evaluation of Semi-continuous Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer|Completed||Phase 1|15|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 15:05:03.509216|2017-02-18 15:05:03.509216
NCT00558038|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2014-05-27||2013-07-26|September 2007||2007-09-01|May 2014|2014-05-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|AST015||Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy|Comparison of Different Treatment Regimens in Patients With Stage 1-2 Type C Hepatic Encephalopathy: AST-120 vs Lactulose|Completed||Phase 2|40|Actual|Ocera Therapeutics||2|||f||||f||||||||||2017-02-18 15:05:03.617666|2017-02-18 15:05:03.617666
NCT00558025|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2014-05-07|2009-05-26||October 2007||2007-10-01|May 2012|2012-05-01||||May 2008|Actual|2008-05-01||Interventional|||Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease|A Double-blind, Double-dummy, Randomized, Parallel Groups Study to Assess the Efficacy, Safety and Tolerability of Switching Patients With Early Parkinson's Disease (PD) From Pramipexole IR to Pramipexole ER or Pramipexole IR|Completed||Phase 3|156|Actual|Boehringer Ingelheim|There were no serious adverse events in the trial and no non-serious adverse events with an incidence >5%.|2|||f||||||||||||||2017-02-18 15:05:03.807168|2017-02-18 15:05:03.807168
NCT00558012|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-07-09|2015-06-15||December 2007||2007-12-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|ZEST||Zoledronic Acid for Osteoporosis in the Elderly|Maintenance of Skeletal Integrity in Frail Elders|Completed||N/A|181|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:05:04.472403|2017-02-18 15:05:04.472403
NCT00557999|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2007-11-13|||March 2006||2006-03-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Mechanical Ventilation Weaning Protocol in the Coronary Care Unit|Evaluation of the Effects of the Use of Mechanical Ventilation Weaning Protocol in the Coronary Care Unit: A Randomized Study|Completed||N/A|36|Actual|Hospital de Base||2|||f||||f||||||||||2017-02-18 15:05:05.082688|2017-02-18 15:05:05.082688
NCT00557986|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2016-08-10|||November 2007||2007-11-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Local Surgery for Metastatic Breast Cancer|The Effect of Primary Surgical Treatment on Survival in Patients With Metastatic Breast Cancer at Diagnosis|Completed||N/A|281|Actual|Federation of Breast Diseases Societies||2|||f||||t||||||||||2017-02-18 15:05:05.182392|2017-02-18 15:05:05.182392
NCT00557973|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2016-09-12||2010-09-08|December 2007||2007-12-01|September 2016|2016-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury|Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury|Completed||Phase 2|37|Actual|Indivior Inc.||3|||f||||f||||||||||2017-02-18 15:05:05.302636|2017-02-18 15:05:05.302636
NCT00557960|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2010-12-10|||February 2004||2004-02-01|March 2009|2009-03-01|October 2004|Actual|2004-10-01|||||Interventional|||ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD|A Phase IIIb Study to Evaluate the Efficacy and Time Course of Treatment With ADDERALL XR and STRATTERA Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|36|Actual|Shire|||||f||||f||||||||||2017-02-18 15:05:05.443733|2017-02-18 15:05:05.443733
NCT00557947|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2012-06-13|2012-06-13||August 2007||2007-08-01|June 2012|2012-06-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Prineo (Dermabond Protape) Versus Sutures for Full-thickness Surgical Incisions|Multi-centre Study to Show Equivalence of Prineo (Dermabond Protape) to Intradermal Sutures for Skin Closure of Full-thickness Surgical Incisions|Completed||Phase 4|83|Actual|Ethicon, Inc.|Limitations of this study include the fact that the patient served as her own control. Additionally, as in many device studies, because of the obvious difference in the investigated and the control devices, blinding was limited.|2|||f||||f||||||||||2017-02-18 15:05:05.551116|2017-02-18 15:05:05.551116
NCT00557934|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2008-09-17|||October 2007||2007-10-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|TOF-Cond||Right Ventricular Contractility Reserve Following Repair of Tetralogy of Fallot|Evaluation of Right Ventricular Contractility Reserve Function During Dobutamine Stress in Patients Following Surgical Repair of Tetralogy of Fallot|Completed||N/A|16|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-02-18 15:05:06.277197|2017-02-18 15:05:06.277197
NCT00557739|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2008-09-24|||November 2007||2007-11-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study of CRx-191 to Assess Activity in Plaque Psoriasis|A Single-Center, Randomized, Double-Blind, Vehicle-Controlled Study to Assess the Activity of CRx-191 in Reducing the Psoriatic Infiltrate Band Thickness in Plaque Psoriasis|Completed||Phase 2|20|Anticipated|Zalicus||6|||f||||f||||||||||2017-02-18 15:05:13.273214|2017-02-18 15:05:13.273214
NCT00557921|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2009-01-27|||December 2007||2007-12-01|January 2009|2009-01-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|COGENT-1||Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)|A Randomized, Double-Blind, Double-Dummy, Parallel Group, Phase 3 Efficacy and Safety Study of CGT-2168 Compared With Clopidogrel to Reduce Upper Gastrointestinal Events Including Bleeding and Symptomatic Ulcer Disease|Terminated||Phase 3|5000|Anticipated|Cogentus Pharmaceuticals||2||Terminated by Sponsor|f||||t||||||||||2017-02-18 15:05:06.411346|2017-02-18 15:05:06.411346
NCT00557908|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-04-06|||June 2007||2007-06-01|April 2015|2015-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|VIP||The Von Willebrand Disease (VWD) International Prophylaxis Study|The VWD International Prophylaxis (VIP) Study|Completed||N/A|105|Actual|Skane University Hospital||1|||f||||t||||||||||2017-02-18 15:05:07.283332|2017-02-18 15:05:07.283332
NCT00557895|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-10|2017-01-24|||August 23, 1996||1996-08-23|November 18, 2016|2016-11-18||||||||Observational|||Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders|Evaluation and Long Term Follow-up of Patients With Allergic and Inflammatory Disorders|Enrolling by invitation||N/A|288|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:05:07.407462|2017-02-18 15:05:07.407462
NCT00557882|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-09-21|||June 2007||2007-06-01|September 2015|2015-09-01|November 2011|Actual|2011-11-01|October 2009|Actual|2009-10-01||Interventional|VAMP-A||Efficacy Study of Vaginal Mesh for Anterior Prolapse|A Randomized Clinical Trial of Vaginal Mesh for Anterior Prolapse|Completed||Phase 4|8|Actual|Medstar Health Research Institute||2|||f||||t||||||||||2017-02-18 15:05:07.517849|2017-02-18 15:05:07.517849
NCT00557869|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2011-12-18|||October 2002||2002-10-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Optimization of Cardiac-MR Protocols|Optimization of Native Cardiac-MR Protocols|Completed||N/A|122|Actual|Medical University of Graz|||1||f||||t||||||||||2017-02-18 15:05:07.638233|2017-02-18 15:05:07.638233
NCT00557856|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2015-09-27|2015-07-16||November 2007||2007-11-01|September 2015|2015-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Safety population included all enrolled participants who received at least one dose of study drug.|A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors|A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of Pf-03446962 In Patients With Advanced Solid Tumors|Completed||Phase 1|70|Actual|Pfizer|Results for tumor vascular function adopting dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI) was not reported as per change in planned analysis.|1|||f||||f||||||||||2017-02-18 15:05:07.755043|2017-02-18 15:05:07.755043
NCT00557843|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2016-07-18|||November 2007||2007-11-01|July 2016|2016-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Continuous Bupivacaine Infusion Following Colonic Surgery|Influence of Continuous Bupivacaine Infusion on Tissue Oxygenation Following Colonic Surgery|Completed||N/A|40|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 15:05:11.097817|2017-02-18 15:05:11.097817
NCT00557830|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-07-17|2012-12-03||January 2008||2008-01-01|July 2013|2013-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma|Randomized Phase IIb Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma (RCC)|Terminated||Phase 2|12|Actual|Accelerated Community Oncology Research Network|The decision to close the study was made by the funder , Bayer HealthCare Pharmaceuticals, in collaboration with ACORN due to the low rate of accrual in light of study timelines and the lack of funds beyond the current level of support from Bayer.|2||"The study was closed to enrollment when it became clear that enrollment was too slow to~   complete the full enrollment target within the time frame allowed."|f||||f||||||||||2017-02-18 15:05:11.226892|2017-02-18 15:05:11.226892
NCT00557817|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2010-01-08|||March 2004||2004-03-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)|Darbepoetin-alpha and i.v. Iron Administration After Autologous Hematopoietic Stem Cell Transplantation : a Prospective Randomized Trial|Completed||Phase 2/Phase 3|125|Actual|University Hospital of Liege||3|||f||||f||||||||||2017-02-18 15:05:12.710769|2017-02-18 15:05:12.710769
NCT00557804|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2010-02-02|||December 2007||2007-12-01|February 2010|2010-02-01||||December 2009|Actual|2009-12-01||Observational|MUSIC||Monitoring in Congestive Heart Failure Study|Multi-Sensor Monitoring in Congestive Heart Failure Study|Completed||N/A|362|Actual|Corventis, Inc.|||1||f||||f||||||||||2017-02-18 15:05:12.830037|2017-02-18 15:05:12.830037
NCT00557791|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-03-05|||November 2009||2009-11-01|February 2011|2011-02-01|July 2012|Anticipated|2012-07-01|July 2011|Anticipated|2011-07-01||Interventional|CARBON||Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)|A Phase 3, Randomized, Double-masked, Parallel-assignment and Dose-finding Study of Intravitreal Bevasiranib Sodium, Administered Every 8 Weeks as Maintenance Therapy Following Three Injections of Lucentis® Compared With Lucentis® Monotherapy Every 4 Weeks in Patients With Exudative Age-Related Macular Degeneration (AMD).|Withdrawn||Phase 3|0|Actual|OPKO Health, Inc.||4||Study never initiated|f||||t||||||||||2017-02-18 15:05:12.915535|2017-02-18 15:05:12.915535
NCT00557778|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2011-04-27|||November 2007||2007-11-01|April 2011|2011-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|PRECAVER||Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia|Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia|Completed||N/A|600|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 15:05:13.011989|2017-02-18 15:05:13.011989
NCT00557765|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2007-11-13|||October 2004||2004-10-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Observational|||Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area|Production of Gamma-Interferon by Circulating Lymphocytes Exposed to Antigens Specific of Mycobacterium Tuberculosis: Contribution to the Identification of Latent Tuberculosis Infection in Contact Tracing|Completed||N/A|295|Actual|University Hospital, Geneva|||1||f||||t||||||||||2017-02-18 15:05:13.096773|2017-02-18 15:05:13.096773
NCT00557752|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2009-02-06|||September 2005||2005-09-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of Non-Invasive Mechanical Ventilation in Early Hypoxia Secondary to Thoracic Trauma|Non-Invasive Ventilation in Early Severe Posttraumatic Hypoxia: a Randomized Controlled Trial|Terminated||Phase 4|50|Actual|Hospital Virgen de la Salud||2||Review Board stopped the study after interim analysis reaching stopping rule for efficacy.|f||||t||||||||||2017-02-18 15:05:13.179472|2017-02-18 15:05:13.179472
NCT00557713|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2007-11-13|||February 2007||2007-02-01|November 2007|2007-11-01|October 2013|Anticipated|2013-10-01|||||Interventional|||XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma|Treatment of Induction With XELOX-Bevacizumab in Locally Advanced Rectal Adenocarcinoma: Phase II Study|Unknown status|Recruiting|Phase 2|44|Anticipated|Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials||1|||f||||f||||||||||2017-02-18 15:05:13.476445|2017-02-18 15:05:13.476445
NCT00557700|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2010-06-15|||January 2008||2008-01-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma|Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma|Completed||Phase 2|15|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 15:05:13.579661|2017-02-18 15:05:13.579661
NCT00557687|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-02-25|||May 2005||2005-05-01|February 2015|2015-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Prediction of Ovarian Response|Prediction of Ovarian Response After Ovarian Stimulation for in Vitro Fertilization|Completed||N/A|100|Actual|Aristotle University Of Thessaloniki|||1||f||||||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 15:05:13.686709|2017-02-18 15:05:13.686709
NCT00557661|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2009-03-23|||November 2007||2007-11-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|||||Interventional|||Safety Study of CD-NP in Heart Failure|A Multi-Center, Ascending Dose Trial to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CD-NP Infusions in Patients With Congestive Heart Failure|Completed||Phase 1|20|Actual|Nile Therapeutics||1|||f||||f||||||||||2017-02-18 15:05:13.782361|2017-02-18 15:05:13.782361
NCT00557648|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2014-05-23|||October 2002||2002-10-01|May 2014|2014-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Evaluating the Effectiveness of Early Cognitive Behavioral Therapy With or Without Parental Involvement in Treating Anxious Children|Early Interventions for Anxious Children|Completed||N/A|61|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||f||||||||||2017-02-18 15:05:14.014941|2017-02-18 15:05:14.014941
NCT00557635|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2009-09-22|||January 2008||2008-01-01|September 2009|2009-09-01|December 2011|Anticipated|2011-12-01|November 2011|Anticipated|2011-11-01||Interventional|||Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow|Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow|Suspended||Phase 2|50|Anticipated|University Hospital, Clermont-Ferrand||1||no recruited patients|f||||||||||||||2017-02-18 15:05:14.124003|2017-02-18 15:05:14.124003
NCT00557622|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2016-11-04|2009-09-02||January 2008||2008-01-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)|Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD) - A Placebo-controlled, Single-Blind Comparative Study -|Terminated||Phase 2|5|Actual|GlaxoSmithKline||2||difficulty in achieving target enrollment numbers|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:05:14.217471|2017-02-18 15:05:14.217471
NCT00557609|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2013-02-06||2013-02-06|October 2007||2007-10-01|February 2013|2013-02-01|February 2011|Actual|2011-02-01|December 2010|Actual|2010-12-01||Interventional|||Phase 2 Study in Patients With MiT Tumors|A Phase 2 Study of ARQ 197 in Patients With Microphthalmia Transcription Factor Associated Tumors|Completed||Phase 2|47|Actual|ArQule||1|||f||||f||||||||||2017-02-18 15:05:14.873435|2017-02-18 15:05:14.873435
NCT00557596|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2009-11-30|||September 2007||2007-09-01|November 2009|2009-11-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer|A Phase 1-2, Multicenter, Open-Label Study of The X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 Given in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer|Terminated||Phase 1/Phase 2|48|Anticipated|Aegera Therapeutics||1|||f||||f||||||||||2017-02-18 15:05:15.135724|2017-02-18 15:05:15.135724
NCT00557583|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2013-12-27|||November 2007||2007-11-01|December 2013|2013-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults|A Randomized, Double-blinded, Placebo-controlled, Sequential, Single Ascending Dose Evaluation of the Safety and Pharmacokinetics of VBY-376 in Healthy Adults|Completed||Phase 1|48|Actual|Virobay Inc.||1|||f||||f||||||||||2017-02-18 15:05:15.253192|2017-02-18 15:05:15.253192
NCT00557570|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-10|2017-01-24|||February 11, 1995||1995-02-11|October 29, 2009|2009-10-29||||October 29, 2009|Actual|2009-10-29||Observational|||Evaluation and Monitoring of Patients With HIV Infectionn|Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients With Known or Suspected HIV Infection|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:05:15.348871|2017-02-18 15:05:15.348871
NCT00557557|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2015-12-23|||July 2007||2007-07-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|March 2012|Actual|2012-03-01||Interventional|||Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases|A Phase I Trial of Isolated Hepatic Perfusion With Oxaliplatin and 5-fluorouracil (5-FU) Followed by Hepatic Arterial Infusion of FUDR for Patients With Unresectable Colorectal Liver Metastases|Completed||Phase 1|14|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 15:05:15.430737|2017-02-18 15:05:15.430737
NCT00557544|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2009-01-28|||February 2009||2009-02-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood|Randomized Controlled Trial on the Effectiveness of Metoclopramide Alone or in Combination With Ketoprofen in Acute Migraine of Child|Unknown status|Not yet recruiting|Phase 3|120|Anticipated|IRCCS Burlo Garofolo||3|||f||||t||||||||||2017-02-18 15:05:15.542539|2017-02-18 15:05:15.542539
NCT00557531|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2012-02-02|||March 2008||2008-03-01|February 2012|2012-02-01|January 2014|Anticipated|2014-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Feasibility of the Injectable BL-1040 Implant|Safety and Feasibility of the Injectable BL-1040 Implant|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|BioLineRx, Ltd.||1|||f||||t||||||||||2017-02-18 15:05:15.654766|2017-02-18 15:05:15.654766
NCT00557518|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2009-01-29|||November 2007||2007-11-01|January 2009|2009-01-01|November 2009|Anticipated|2009-11-01|September 2009|Anticipated|2009-09-01||Interventional|||Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria|A Randomized, Placebo-Controlled Trial of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria|Terminated||Phase 2|80|Anticipated|Synvista Therapeutics, Inc||2||Study has been terminated early due to financial constraints.|f||||f||||||||||2017-02-18 15:05:15.767145|2017-02-18 15:05:15.767145
NCT00557505|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2012-02-21|2012-01-10||December 2007||2007-12-01|February 2012|2012-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study Of PF-03732010 In Patients With Advanced Solid Tumors|A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of PF-03732010 In Patients With Advanced Solid Tumors|Completed||Phase 1|43|Actual|Pfizer|Results are not provided because development of the study drug was terminated, as neither anti-tumor activity nor pharmacodynamic modulation was observed.|1|||f||||f||||||||||2017-02-18 15:05:15.892374|2017-02-18 15:05:15.892374
NCT00557492|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2016-10-19|2016-08-10||December 2006||2006-12-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer|Phase II Study of the Anti-Vascular Endothelial Growth Factor (α-VEGF) Monoclonal Antibody Bevacizumab in Combination With Fixed Dose Rate (FDR) Gemcitabine and Rapid-Fractionation Radiotherapy in the Pre-operative Treatment of Potentially- Resectable Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|59|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 15:05:18.360084|2017-02-18 15:05:18.360084
NCT00557466|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2012-12-12|2012-11-12||October 2007||2007-10-01|November 2012|2012-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Multi-center, Parallel Group, Double Blind, Placebo and Formoterol Controlled 14 Day Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Patients With COPD|Completed||Phase 2|568|Actual|Novartis||6|||f||||||||||||||2017-02-18 15:05:18.827245|2017-02-18 15:05:18.827245
NCT00557453|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-11|2010-07-12|||April 2008||2008-04-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||The Role of Antibiotic Treatment in Patients With Acute Mild Cholecystitis - A Prospective Randomized Controlled Trial|The Role of Antibiotic Treatment in Patients With Acute Mild Cholecystitis - A Prospective Randomized Controlled Trial|Completed||N/A|120|Anticipated|Hadassah Medical Organization|||2||f||||t||||||||||2017-02-18 15:05:19.977882|2017-02-18 15:05:19.977882
NCT00557440|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2013-02-15|2013-02-15||November 2007||2007-11-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma|A Multi-center, Randomized, Double-blind, Double Dummy, Placebo and Active Controlled Crossover Study, to Investigate the 24 Hour FEV1 Profile of a Single Dose of QMF TWISTHALER Device in Adult Patients With Persistent Asthma|Completed||Phase 2|37|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:05:20.091021|2017-02-18 15:05:20.091021
NCT00557427|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2011-06-23|||January 2009||2009-01-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression|Open-labeled Randomized Comparative Study of the Efficacy and Tolerability of Two Times Daily 250mg Hypericum Versus Once Daily 20 - 40 mg Fluoxetine in Adolescent Patients With Mild to Moderate Depression|Terminated||Phase 4|30|Anticipated|Rafa Laboratories||2||Lack of enrollment|f||||f||||||||||2017-02-18 15:05:20.682773|2017-02-18 15:05:20.682773
NCT00557414|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2008-05-08|||October 2007||2007-10-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|||||Observational|||Serial Changes of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Levels in Patients With Acute Respiratory Distress Syndrome|Serial Changes of sTREM-1 Levels in Patients With Acute Respiratory Distress Syndrome|Completed||N/A|63|Actual|National Taiwan University Hospital|||2||f||||t||||||Samples Without DNA|"~     serum~   "|||2017-02-18 15:05:20.789763|2017-02-18 15:05:20.789763
NCT00557401|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2016-09-09||2010-09-08|November 2007||2007-11-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD|A Multi-Center Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Study of XP19986 in Subjects With Symptomatic Gastroesophageal Reflux Disease (GERD)|Completed||Phase 2|156|Actual|Indivior Inc.||5|||f||||f||||||||||2017-02-18 15:05:20.876943|2017-02-18 15:05:20.876943
NCT00557388|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2011-09-13|||December 2007||2007-12-01|September 2011|2011-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly|Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly|Completed||N/A|120|Actual|Maastricht University Medical Center||10|||f||||t||||||||||2017-02-18 15:05:20.98691|2017-02-18 15:05:20.98691
NCT00557375|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-13|2009-09-17|||June 2007||2007-06-01|September 2009|2009-09-01|November 2009|Anticipated|2009-11-01|||||Observational|||Brain Tumor Treatment Satisfaction Survey|Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers|Unknown status|Recruiting|N/A|700|Anticipated|Methodist Healthcare|||2||f||||f||||||||||2017-02-18 15:05:21.096351|2017-02-18 15:05:21.096351
NCT00557362|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-11-18|2013-06-14||November 2007||2007-11-01|November 2013|2013-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|MUTT_TE||Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer|Mycotic Ulcer Treatment Trial Therapeutic Exploratory Study|Completed||Phase 1/Phase 2|120|Actual|University of California, San Francisco||4|||f||||f||||||||||2017-02-18 15:05:21.1913|2017-02-18 15:05:21.1913
NCT00557349|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2016-11-22|2009-02-27||November 2006||2006-11-01|September 2016|2016-09-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Interventional|||Ulcer Prevention Study in Post Gastric Bypass Patients|A Randomized, Double-blind Clinical Trial Comparing Zegerid Capsule to Famotidine in Preventing Anastomotic (Marginal) Ulcers in Post Gastric Bypass Patients|Completed||Phase 4|40|Actual|University of Missouri-Columbia||2|||f||||f||||||||Undecided||2017-02-18 15:05:21.78376|2017-02-18 15:05:21.78376
NCT00557336|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2012-06-28|||July 2003||2003-07-01|June 2012|2012-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age|Evaluation of Efficacy and Safety of Somatropin in SGA Children Due to IUGR|Completed||Phase 3|160|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:05:22.167707|2017-02-18 15:05:22.167707
NCT00557323|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-12|2015-03-04|2011-05-19||August 2005||2005-08-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Long-term Effect of Lanthanum Carbonate on Bone|A Long-term, Observational Study to Monitor Mortality, Bone-related Adverse Events and the Safety of Subjects Who Were Recruited Into Study SPD405-309|Completed||N/A|34|Actual|Shire|||1||f||||f||||||||||2017-02-18 15:05:22.267729|2017-02-18 15:05:22.267729
NCT00557310|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2011-10-07|2011-10-07||November 2007||2007-11-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|October 2010|Actual|2010-10-01||Interventional|||A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide|The Effects of Teriparatide on Bone Microarchitecture as Determined by High Resolution Magnetic Resonance Imaging and Digital Topological Analysis|Completed||Phase 4|35|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:05:22.720161|2017-02-18 15:05:22.720161
NCT00557297|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2008-09-24|||October 2007||2007-10-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|||||Observational|SYMCO||NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler|NIS for Patients Using Symbicort Turbuhaler for Maintenance and Reliever Therapy in a Single Inhaler|Completed||N/A|250|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 15:05:23.534514|2017-02-18 15:05:23.534514
NCT00557284|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2015-03-31|2013-07-30||March 2008||2008-03-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy of Montelukast (Singulair) in Participants Ages 1 - 8 Years Diagnosed With Atopic Dermatitis Induced by Food Allergens|Completed||Phase 4|20|Actual|IMMUNOe International Research Centers||2|||f||||f||||||||||2017-02-18 15:05:23.64753|2017-02-18 15:05:23.64753
NCT00557258|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2009-02-12|||November 2007||2007-11-01|February 2009|2009-02-01||||November 2007|Actual|2007-11-01||Observational|||Cross-Sectional Study: Prevalence of Restless Legs Syndrome in Patients With Unpleasant Sensations of the Legs|Prevalence of Restless Legs Syndrome in Patients With Unpleasant Sensations of the Legs|Completed||N/A|14956|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 15:05:24.395206|2017-02-18 15:05:24.395206
NCT00557245|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2014-11-20|2014-10-30||May 2008||2008-05-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|Partners PrEP|All randomized participants, less those who were found to be ineligible (n=11)|Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples|Parallel Comparison of Tenofovir and Emtricitabine/Tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples|Completed||Phase 3|4758|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 15:05:24.886651|2017-02-18 15:05:24.886651
NCT00557232|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2011-11-25|||November 2006||2006-11-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Intraocular Bevacizumab (Avastin) for Rubeosis Iridis|The RAVE (Rubeosis Anit-VEgf) Trial, Utilizes Monthly Intravitreal Bevazizumab (Avastin) Injections for 12 Months to See if Total VEGF Blockade Will Prevent Neovascular Glaucoma and Eliminate the Need for Panretinal Photocoagulation in Patients With Ischemic Central Retinal Vein Occlusion|Completed||Phase 4|25|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-02-18 15:05:26.48609|2017-02-18 15:05:26.48609
NCT00557219|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2016-11-14|||April 2008||2008-04-01|November 2016|2016-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac Surgery|Influence of Fenoldopam and Ketanserin on Function and Kidney Injury Parameters in Patients With Increased Risk of Acute Kidney Failure After Cardiac Surgery|Terminated||Phase 3|60|Actual|Medical University of Gdansk||3||Main cooperator finished cooperation|f||||f||||||||Undecided|Upon reasonable request IPD can be made available to other researcher.|2017-02-18 15:05:26.575097|2017-02-18 15:05:26.575097
NCT00557206|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-11-04|||April 2005||2005-04-01|November 2013|2013-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer|Multicenter Phase II Trial of Oxaliplatin and Docetaxel for Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck|Terminated||Phase 2|35|Actual|Minneapolis Veterans Affairs Medical Center||1||Funding was terminated|f||||f||||||||||2017-02-18 15:05:26.69613|2017-02-18 15:05:26.69613
NCT00557193|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2016-09-23|||January 2008||2008-01-01|September 2016|2016-09-01||||September 2018|Anticipated|2018-09-01||Interventional|||Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|A Phase III Study of Risk Directed Therapy for Infants With Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; NSC#617807)|Active, not recruiting||Phase 3|242|Anticipated|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 15:05:26.812348|2017-02-18 15:05:26.812348
NCT00557180|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2014-09-24|||October 2007||2007-10-01|September 2014|2014-09-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications|Obesity, Inflammation and Response to Therapy in Asthma - Ancillary to Asthma Clinical Research Network (ACRN) Trials|Completed||N/A|33|Actual|National Jewish Health|||2||f||||t||||||Samples Without DNA|"~     Plasma Serum~   "|||2017-02-18 15:05:27.225826|2017-02-18 15:05:27.225826
NCT00557154|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2017-02-13|||August 2003||2003-08-01|November 2007|2007-11-01|July 2004|Actual|2004-07-01|||||Interventional|||Ultrasound Assisted Peripheral Venous Access in Young Children|Ultrasound Assisted Peripheral Venous Access in Young Children: A Pilot and Feasibility Randomized Controlled Trial|Completed||N/A|44|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 15:05:27.348463|2017-02-18 15:05:27.348463
NCT00557141|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2009-01-08|||January 2008||2008-01-01|January 2009|2009-01-01|August 2009|Anticipated|2009-08-01|May 2009|Anticipated|2009-05-01||Observational|||Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients|AsthmaCare Study Covering Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients|Unknown status|Active, not recruiting|N/A|1100|Anticipated|Heidelberg Metasystems GmbH|||1||f||||f||||||||||2017-02-18 15:05:27.43841|2017-02-18 15:05:27.43841
NCT00557128|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2010-10-13||2010-10-13|November 2007||2007-11-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.|A Randomized, Open-label, Single-dose, 3-period Crossover Study to Assess the Effect of Food on the Pharmacokinetics of the Final Fixed Dose Combination Formulation of COREG CR and Lisinopril in the Fed and Fasted State.|Completed||Phase 1|24|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:05:27.531032|2017-02-18 15:05:27.531032
NCT00557115|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-09|||January 2006||2006-01-01|November 2007|2007-11-01|January 2009|Anticipated|2009-01-01|||||Interventional|||Early Pulmonary Rehabilitation Following Acute COPD Exacerbation|Early Pulmonary Rehabilitation (PR) Following Hospitalisation For Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Recruiting|Phase 3|60|Anticipated|King's College Hospital NHS Trust||2|||f||||f||||||||||2017-02-18 15:05:27.63106|2017-02-18 15:05:27.63106
NCT00557102|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2012-12-10|||September 2007||2007-09-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|ERBIFORT||Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung|"Frontline Chemotherapy Reinforced for Cancers of the Colon and Rectum With Potentially Resectable Hepatic and/or Pulmonary Metastases: Association of FOLFIRI and ERBITUX"|Completed||Phase 2|24|Actual|National Cancer Institute, France||1|||f||||||||||||||2017-02-18 15:05:27.742026|2017-02-18 15:05:27.742026
NCT00557089|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-08-30|||January 2008||2008-01-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis|Randomized, Placebo-controlled Trial on the Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis|Completed||Phase 4|17|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 15:05:28.013238|2017-02-18 15:05:28.013238
NCT00557076|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2014-11-03|2014-10-21||July 2008||2008-07-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|FAST||The Efficacy of Familiar Voice Stimulation During Coma Recovery|Can Neural Adaptation After Severe Brain Injury be Facilitated?|Completed||Phase 1/Phase 2|21|Actual|VA Office of Research and Development|A limitation is achieved sample size. Given restrictive eligibility criteria, enrollment was lower than planned.|2|||f||||t||||||||||2017-02-18 15:05:28.13177|2017-02-18 15:05:28.13177
NCT00557050|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-09|||January 2008||2008-01-01|September 2007|2007-09-01|March 2009|Anticipated|2009-03-01|||||Interventional|||Acute Hamstring Strains in Danish Elite Soccer - Prevention and Rehabilitation|Acute Hamstring Strains in Danish Elite Soccer - Prevention and Rehabilitation|Unknown status|Enrolling by invitation|N/A|1000|Anticipated|Amager Hospital||1|||f||||f||||||||||2017-02-18 15:05:28.756935|2017-02-18 15:05:28.756935
NCT00557037|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2010-04-06|||November 2007||2007-11-01|April 2010|2010-04-01|November 2009|Actual|2009-11-01|||||Interventional|||A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer|A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer|Completed||Phase 2|60|Anticipated|MEI Pharma, Inc.||2|||f||||||||||||||2017-02-18 15:05:28.841313|2017-02-18 15:05:28.841313
NCT00557024|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2008-11-17|||November 2007||2007-11-01|November 2008|2008-11-01|July 2010|Anticipated|2010-07-01|November 2009|Anticipated|2009-11-01||Interventional|RT-RFA||Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|80|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 15:05:28.93161|2017-02-18 15:05:28.93161
NCT00557011|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2011-05-23|||September 2004||2004-09-01|May 2011|2011-05-01|December 2004|Actual|2004-12-01|||||Interventional|||NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD|A Phase 2, Randomized, Double-Blind, Placebo- and Active-Controlled, 3-Treatment, 3-Period, Crossover Study With One Week Per Treatment and Once-a-Day Dosing of Either NRP104, Adderall XR, or Placebo in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2|52|Actual|New River Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:05:29.03896|2017-02-18 15:05:29.03896
NCT00556998|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2016-03-31|2010-08-02||June 2008||2008-06-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents|An Open-Label, Intravenous To Oral Switch, Multiple Dose Study To Evaluate The Pharmacokinetics, Safety And Tolerability Of Voriconazole In Immunocompromised Adolescents Aged 12 To <17 Years Who Are At High Risk For Systemic Fungal Infection|Completed||Phase 2|26|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:05:29.145757|2017-02-18 15:05:29.145757
NCT00556972|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2012-11-29|2011-08-02||January 2008||2008-01-01|November 2012|2012-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Feasibility Study of a Fecal Incontinence Management System for Medical Use|A Feasibility Study of a Fecal Incontinence Management System for Medical Use|Terminated||Phase 1/Phase 2|4|Actual|Coloplast A/S|No overall conclusions could be drawn, due to the limited amount of data (N=4 due to delays and low recruitment rate). A new study, with a higher sample size needs to be executed, if the objectives set in this study are to be investigated thoroughly.|1||Due to numerous delays in study start-up process...|f||||f||||||||||2017-02-18 15:05:29.979271|2017-02-18 15:05:29.979271
NCT00556959|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2010-03-23|||October 2007||2007-10-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|A Phase III, Dose-Response Evaluation of the Efficacy and Safety of CLONICEL® (Clonidine HCl Sustained Release) vs. Placebo in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|236|Actual|Addrenex Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 15:05:30.245078|2017-02-18 15:05:30.245078
NCT00556946|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2016-03-17|2016-02-05||August 2005||2005-08-01|March 2016|2016-03-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|PDT/PDL||Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains|Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains|Completed||N/A|17|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 15:05:30.363347|2017-02-18 15:05:30.363347
NCT00556933|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2015-02-16|2015-01-29||April 2004||2004-04-01|February 2015|2015-02-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional||Two patients were enrolled into the study erroneously in a violation of protocol and were identified and excluded before any study-related interventions. (Additional patients excluded from outcome analyses are accounted for in the Participant Flow and Outcome modules.)|Improved Induction and Maintenance Immunosuppression in Kidney Transplantation|Prospective, Randomized 2 x 2 Factorial Trial of Rabbit Anti-thymocyte Globulin Induction (Single vs. Alternate Day Administration) at Renal Transplantation, With Delayed Calcineurin-inhibitor Withdrawal vs. Minimization|Completed||Phase 4|180|Actual|University of Nebraska|The trial is designed for analysis as 1st, rATG dosing, and 2nd, CNI withdrawal status. Results published as analysis of 2 induction protocols followed by analysis of 2 CNI maintenance regimens. Potential limitations = single-center & non-blinded.|4|||f||||f||||||||||2017-02-18 15:05:30.571114|2017-02-18 15:05:30.571114
NCT00556920|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2010-10-13||2010-10-13|October 2007||2007-10-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components|A Randomized, Open-label, Single-dose, Three-period, Crossover Study to Demonstrate the Bioequivalence of the Fixed Dose Combination (FDC) of COREG CR™ and Lisinopril to COREG CR and ZESTRIL|Completed||Phase 1|50|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:05:32.185475|2017-02-18 15:05:32.185475
NCT00556907|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2016-04-06|||October 2007||2007-10-01|April 2016|2016-04-01|November 2016|Anticipated|2016-11-01|March 2015|Actual|2015-03-01||Interventional|||Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast|Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast (TARGIT-DCIS Trial): Use of Mammography and Breast MRI to Identify Candidates for IORT.|Terminated||Phase 2|22|Actual|University of Southern California||1||Lack of Funding|f||||f||||||||||2017-02-18 15:05:32.440313|2017-02-18 15:05:32.440313
NCT00556894|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2015-02-24|2015-02-24||February 2008||2008-02-01|August 2011|2011-08-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotrexate, in Patients With Active Rheumatoid Arthritis|Completed||Phase 2|230|Actual|Can-Fite BioPharma||3|||f||||f||||||||||2017-02-18 15:05:32.555194|2017-02-18 15:05:32.555194
NCT00556868|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-09|||October 2005||2005-10-01|November 2007|2007-11-01|December 2005|Actual|2005-12-01|||||Interventional|||The Influence of Having Breakfast on Cognitive Performance and Mood|The Influence of Having Breakfast on Cognitive Performance and Mood in High School Students|Completed||N/A|104|Actual|University of Ulm||2|||f||||f||||||||||2017-02-18 15:05:33.269164|2017-02-18 15:05:33.269164
NCT00556855|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2009-01-09|||December 2007||2007-12-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Comparison Study With E-DO in Chronic Hand Dermatitis|A 4-Week Randomized, Double-Blind, Placebo-Controlled, Right-Left Comparison Study With E-DO in Chronic Hand Dermatitis|Completed||N/A|67|Actual|HenKan Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 15:05:33.359793|2017-02-18 15:05:33.359793
NCT00556842|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2016-05-25|||March 2009||2009-03-01|May 2016|2016-05-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|HEALTH||Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Adults With Displaced Hip Fractures|Hip Fracture Evaluation With Alternatives of Total Hip Arthroplasty Versus Hemi-Arthroplasty: A Multi-Centre Randomized Trial Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Patients With Displaced Femoral Neck Fractures|Recruiting||N/A|1434|Anticipated|McMaster University||2|||f||||t||||||||Undecided||2017-02-18 15:05:33.491344|2017-02-18 15:05:33.491344
NCT00556816|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2015-09-17|||September 2007||2007-09-01|September 2015|2015-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|COPD-C||Chronic Obstructive Pulmonary Disease (COPD) Outpatient on Demand Clinic|COPD-C: COPD Outpatient on Demand Clinic. Study to Determine the Efficacy and Safety of on Demand Outpatient Clinics in COPD Patients|Completed||N/A|100|Actual|Isala||2|||f||||t||||||||||2017-02-18 15:05:33.624681|2017-02-18 15:05:33.624681
NCT00556803|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2008-11-17|||November 2007||2007-11-01|November 2008|2008-11-01|June 2010|Anticipated|2010-06-01|November 2009|Anticipated|2009-11-01||Interventional|TACE-RFA||TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma|Transcatheter Arterial Chemoembolization as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|120|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 15:05:33.72504|2017-02-18 15:05:33.72504
NCT00556790|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-09|||November 2004||2004-11-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Fast Track in Open Colonic Surgery - A Multicentric Randomized Controlled Trial|Fast Track in Open Colonic Surgery - A Multicentric Randomized Controlled Trial|Terminated||N/A|150|Actual|University of Lausanne Hospitals||2||interim analysis|f||||f||||||||||2017-02-18 15:05:33.834837|2017-02-18 15:05:33.834837
NCT00556777|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2011-05-12|||January 2004||2004-01-01|December 2007|2007-12-01||||May 2011|Actual|2011-05-01||Interventional|||Radiation Therapy During Surgery in Treating Older Women With Stage I Breast Cancer|Phase 2 Study Evaluating the Feasibility and the Reproducibility of Concentrated Radiotherapy and Focalized Electrontherapy During Surgery for the Treatment of Older Patients With Breast Cancer|Completed||Phase 2|42|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:05:33.934923|2017-02-18 15:05:33.934923
NCT00556764|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-02-08|||July 2007||2007-07-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|ANAM||Development of Cognitive Assessment Tools in Parkinson Disease|Development of Cognitive Assessment Tools in Parkinson Disease|Completed||Early Phase 1|75|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 15:05:34.031551|2017-02-18 15:05:34.031551
NCT00556751|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2016-02-17|||January 1985||1985-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|||||Observational|CARDIA ECG||Evaluating Electrocardiogram (ECG) Abnormalities From Young Adulthood Through Middle Age|Epidemiology and Mechanisms of ECG Abnormalities: Young Adulthood to Middle Age|Completed||N/A|5115|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||f||||||||||2017-02-18 15:05:34.155062|2017-02-18 15:05:34.155062
NCT00556738|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2010-05-12|||November 2007||2007-11-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|HFPV||Intrapulmonary Percussive Ventilation (IPV) Versus Nasal Continuous Positive Airway Pressure Ventilation (nCPAP) in Transient Respiratory Distress of the Newborn|Intrapulmonary Percussive Ventilation and Nasal Continuous Positive Airway Pressure Ventilation in Transient Respiratory Distress of the Newborn: A Randomized Controlled Trial|Completed||N/A|100|Anticipated|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 15:05:34.244608|2017-02-18 15:05:34.244608
NCT00556712|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2015-01-27|2014-12-04||January 2006||2006-01-01|January 2015|2015-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||Full analysis set (FAS): all randomized participants presented according to the therapy that they were randomized to receive|A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)|A Randomized, Double-blind Study to Evaluate the Effect of Tarceva or Placebo Following Platinum-based CT on Overall Survival and Disease Progression in Patients With Advanced, Recurrent or Metastatic NSCLS Who Have Not Experienced Disease Progression or Unacceptable Toxicity During Chemotherapy|Completed||Phase 3|889|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:05:34.382243|2017-02-18 15:05:34.382243
NCT00556699|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2014-03-18|||December 2007||2007-12-01|November 2011|2011-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma|An Open-Label, Phase Ib Study of the Safety, Pharmacokinetics, and Activity of the Anti-CD40 Monoclonal Antibody SGN-40 Administered in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma Who Have Relapsed Following Previous Rituximab Therapy|Completed||Phase 1|22|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 15:05:38.804725|2017-02-18 15:05:38.804725
NCT00556686|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2015-04-20|||August 2006||2006-08-01|April 2015|2015-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Salivary Catecholamines in Aphthous Stomatitis (Canker Sores)|Salivary Catecholamines in Aphthous Stomatitis|Withdrawn||N/A|0|Actual|University of California, Davis|||2|We are currently modifying the study|f||||f||||||Samples Without DNA|"~     saliva~   "|||2017-02-18 15:05:38.903915|2017-02-18 15:05:38.903915
NCT00556673|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-03-11|2013-03-11||October 2007||2007-10-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma|An Exploratory, Multi-centre, Double-blind, Placebocontrolled Crossover Study, to Investigate the Bronchodilatory Efficacy of a Single Dose of Indacaterol in Fixed Combination With Mometasone Furoate Delivered Via a MDDPI (Twisthaler®) in Adult Patients With Persistent Asthma Using Open Label Seretide® Accuhaler® (50/250 Mcg b.i.d.) as an Active Control|Completed||Phase 2|31|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:05:38.995904|2017-02-18 15:05:38.995904
NCT00556660|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2008-07-23|||September 2007||2007-09-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of [123I] AV51 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects||Completed||Phase 1|20|Anticipated|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 15:05:39.806193|2017-02-18 15:05:39.806193
NCT00556647|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-04-05|||September 2006||2006-09-01|April 2013|2013-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Fast-track Diagnosis for Lung Cancer Suspects With PET-CT and EUS|A Prospective, Open, Single Center, Study of One-day Diagnostic Track for Lung Cancer Suspects From Chest X-ray Using PET-CT and Subsequent Multiple Endoscopic Investigations. (Including Bronchoscopy, EUS-FNA)|Completed||N/A|297|Actual|Isala|||1||f||||t||||||||||2017-02-18 15:05:39.916101|2017-02-18 15:05:39.916101
NCT00556634|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2009-01-14|||April 2006||2006-04-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage|Randomized, Double-Blinded Clinical Trial to Evaluate the Incidence and Severity of Neuropsychiatric Side Effects and Antiviral Efficacy of Efavirenz Given as a Stepped Dosage Over 2 Weeks Versus the Usual Dosage in HIV-Infected Patients.|Completed||Phase 4|114|Actual|Sociedad Andaluza de Enfermedades Infecciosas||2|||f||||t||||||||||2017-02-18 15:05:40.031259|2017-02-18 15:05:40.031259
NCT00556621|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2015-07-29|||June 2005||2005-06-01|July 2015|2015-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|GEMCIRAV||Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer|Phase 1-2 Study of the Association of Gemzar ® - Cisplatin-concurrent Radiotherapy in Patients With Non-metastatic Tumors of the Bladder|Completed||Phase 1/Phase 2|14|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||1|||f||||f||||||||||2017-02-18 15:05:40.139316|2017-02-18 15:05:40.139316
NCT00556608|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2012-12-03|||November 2007||2007-11-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy Study of Intra-articular Hyaluronic Acid in the Knee Osteoarthritis|Efficacy Evaluation of Intra-articular Hyaluronic Acid (Sinovial®) vs Synvisc® in the Treatment of Symptomatic Knee Osteoarthritis. A Double-blind, Controlled, Randomised, Parallel-group Non-inferiority Study|Completed||Phase 4|381|Actual|IBSA Institut Biochimique SA||2|||f||||f||||||||||2017-02-18 15:05:40.264417|2017-02-18 15:05:40.264417
NCT00556595|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-09|||November 2007||2007-11-01|November 2007|2007-11-01|December 2008|Anticipated|2008-12-01|||||Interventional|CPVA-PAF||Primary Anatomical Versus Primary Electrophysiological Approach in Circumferential Pulmonary Vein Ablation|Circumferential Pulmonary Vein Ablation in Paroxysmal Atrial Fibrillation: Randomized Comparison Between a Primary Anatomical Versus a Primary Electrophysiological Approach|Unknown status|Not yet recruiting|N/A|200|Anticipated|University Hospital, Bonn||2|||f||||f||||||||||2017-02-18 15:05:40.398077|2017-02-18 15:05:40.398077
NCT00556569|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2012-12-12|||December 2007||2007-12-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Evaluation of CHAM JAM (Previously Known as the Moving Smart) Intervention in Increasing Physical Activity in Bronx Elementary School Students|Evaluation of CHAM JAM (Previously Known as the Moving Smart) Intervention in Increasing Physical Activity in Bronx Elementary School Students|Completed||N/A|10098|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-02-18 15:05:40.49198|2017-02-18 15:05:40.49198
NCT00556543|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2011-06-07|2011-03-17||November 2006||2006-11-01|June 2011|2011-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Study of the U-Plate Fracture Repair System to Treat Rib Fractures|Clinical Evaluation of the U-plate Fracture Repair System for the Fixation of Rib Fractures|Completed||N/A|10|Actual|Oregon Health and Science University||1|||f||||t||||||||||2017-02-18 15:05:40.596368|2017-02-18 15:05:40.596368
NCT00556530|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2017-01-23|||July 2016||2016-07-01|January 2017|2017-01-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|||Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome|Genetic Modifiers of 22q11.2 Deletion Syndrome|Active, not recruiting||N/A|1000|Anticipated|Albert Einstein College of Medicine, Inc.|||1||f||||f||||||Samples With DNA|"~     Blood and saliva samples~   "|||2017-02-18 15:05:40.951203|2017-02-18 15:05:40.951203
NCT00556517|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-09|||January 2008||2008-01-01|September 2007|2007-09-01|March 2009|Anticipated|2009-03-01|||||Observational|||Acute Hamstring Strains in Danish Elite Soccer - Diagnosis and Biomechanical Tests|Acute Hamstring Strains in Danish Elite Soccer - Diagnosis and Biomechanical Tests|Unknown status|Enrolling by invitation|N/A|100|Anticipated|Amager Hospital|||1||f||||f||||||||||2017-02-18 15:05:41.049283|2017-02-18 15:05:41.049283
NCT00555802|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2008-01-25|||April 2006||2006-04-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||The Effect of Motor Control Exercise Versus General Exercise on Lumbar Local Stabilizing Muscles Thickness|The Effect of Motor Control Exercise Versus General Exercise on Lumbar Local Stabilizing Muscles Thickness|Completed||N/A|49|Actual|Zahedan University of Medical Sciences||1|||f||||f||||||||||2017-02-18 15:06:04.468117|2017-02-18 15:06:04.468117
NCT00556504|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2014-08-04|2013-06-05||July 2007||2007-07-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|TCM-700C||The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection|TCM-700C Phase II Trial The Effects of Adding a Chinese Formulation (TCM-700C) on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection|Completed||Phase 2|84|Actual|TCM Biotech International Corp.||2|||f||||f||||||||||2017-02-18 15:05:41.124286|2017-02-18 15:05:41.124286
NCT00556491|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2015-03-05|2015-01-11||December 2007||2007-12-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|July 2011|Actual|2011-07-01||Interventional|||Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery|Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery|Completed||N/A|40|Actual|St. Louis University||2|||f||||t||||||||||2017-02-18 15:05:42.024968|2017-02-18 15:05:42.024968
NCT00556478|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2016-09-07|2016-09-07||October 2007||2007-10-01|September 2016|2016-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation|A Phase IIb, Multi-center, Randomized, Double-blind, Placebo-controlled Study, With Open-label Follow on, to Evaluate the Efficacy, Safety and Tolerability of PSD502 in Subjects With Premature Ejaculation (PE)|Completed||Phase 2/Phase 3|256|Actual|Plethora Solutions Ltd||3|||f||||f||||||||No||2017-02-18 15:05:42.581195|2017-02-18 15:05:42.581195
NCT00556465|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-09|||January 2007||2007-01-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy|Study of N-Acetylcysteine for Treatment of Overt Diabetic Nephropathy|Completed||Phase 2/Phase 3|60|Actual|Shiraz University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:05:43.466181|2017-02-18 15:05:43.466181
NCT00556452|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2015-01-02|2014-11-26||October 2007||2007-10-01|January 2015|2015-01-01|September 2012|Actual|2012-09-01|June 2011|Actual|2011-06-01||Interventional||Experimental: Clo/BU4|Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen|Phase I/II Study of Myeloablative Allogeneic Stem Cell Transplantation for Aggressive Hematologic Malignancies Using Clofarabine and Busulfan x 4 (Clo/BU4) Regimen|Completed||Phase 1/Phase 2|46|Actual|University of Michigan Cancer Center||1|||f||||f||||||||||2017-02-18 15:05:43.575454|2017-02-18 15:05:43.575454
NCT00556439|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2015-12-22|||December 2008||2008-12-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis|Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu's Arteritis to Examine the Safety, Efficacy, and Immunologic Effects of Abatacept (CTLA4-Ig) in Large Vessel Vasculitis|Completed||Phase 2|98|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||2|||f||||t||||||||||2017-02-18 15:05:44.149284|2017-02-18 15:05:44.149284
NCT00556426|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-05-25|2009-05-26||December 2005||2005-12-01|May 2012|2012-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|EVEREST||Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.|The Bard® Recovery® Filter Registry (EVEREST) for Patients Who Are Candidates for an Optional (Retrievable) Inferior Vena Cava Filter That Undergo Placement of the Bard® Recovery® Filter.|Completed||N/A|100|Actual|C. R. Bard||1|||f||||t||||||||||2017-02-18 15:05:44.277752|2017-02-18 15:05:44.277752
NCT00556413|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2011-05-13|||September 2005||2005-09-01|May 2011|2011-05-01||||May 2011|Actual|2011-05-01||Interventional|||Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer|Phase II Study Evaluating the Efficacy and Safety of cétuximab Associated With the Protocol FOLFIRINOX (LV5FU Simplified Combined With Irinotecan and Oxaliplatin) in the First Line Treatment in Patients With Metastatic Colorectal Cancer Expressing EGFR or Not|Completed||Phase 2|39|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:05:44.842584|2017-02-18 15:05:44.842584
NCT00556400|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-07-11|2013-05-21||November 2007||2007-11-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones|Treatment of Menorrhagia in Women With Thrombocytopenia: Comparison of Platelet Transfusion Alone to Platelet Transfusion With Continuous Oral Contraceptive Pills|Terminated||Phase 1/Phase 2|1|Actual|National Institutes of Health Clinical Center (CC)|Early termination because of insufficient accrual. With only one study participant, data could not be analyzed.|2||Early termination because of insufficient accrual.|f||||f||||||||||2017-02-18 15:05:44.945922|2017-02-18 15:05:44.945922
NCT00556387|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-10-31|||December 2008||2008-12-01|October 2013|2013-10-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection|Possible Neuroprotective Effects of Ketamine in Children With Severe Traumatic Brain Injury|Withdrawn||Phase 2|0|Actual|University of Arkansas||2||"This study has been withdraw from the IRB. The PI has transferred to another university. The~   IND was transferred."|f||||f||||||||||2017-02-18 15:05:45.292526|2017-02-18 15:05:45.292526
NCT00556374|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2016-12-09|2015-10-06||December 2006||2006-12-01|December 2016|2016-12-01|July 2020|Anticipated|2020-07-01|March 2014|Actual|2014-03-01||Interventional|||Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy|A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Phase 3 Study to Determine the Treatment Effect of Denosumab in Subjects With Non-Metastatic Breast Cancer Receiving Aromatase Inhibitor Therapy.|Active, not recruiting||Phase 3|3420|Actual|Amgen||2|||f||||t||||||||||2017-02-18 15:05:45.40771|2017-02-18 15:05:45.40771
NCT00556361|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2007-11-09|||July 2004||2004-07-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Use of Ketamine Prior to Cardiopulmonary Bypass in Children|Use of Ketamine Prior to Cardiopulmonary Bypass in Children|Completed||Phase 2|24|Actual|Arkansas Children's Hospital Research Institute||2|||f||||||||||||||2017-02-18 15:05:47.678224|2017-02-18 15:05:47.678224
NCT00556348|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2011-11-19|||November 2005||2005-11-01|November 2011|2011-11-01|November 2008|Actual|2008-11-01|October 2007|Actual|2007-10-01||Interventional|||Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration|Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration|Completed||Phase 4|500|Actual|Instituto de Olhos de Goiania||1|||f||||t||||||||||2017-02-18 15:05:47.784924|2017-02-18 15:05:47.784924
NCT00556335|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2013-04-05|||April 2007||2007-04-01|April 2013|2013-04-01|April 2011|Actual|2011-04-01|April 2010|Actual|2010-04-01||Interventional|pneumothorax||Pneumothorax Therapy: Manual Aspiration Versus Conventional Chest Tube Drainage|A Prospective, Randomised Trial in Pneumothorax Therapy: Manual Aspiration Versus Conventional Chest Tube Drainage|Completed||N/A|56|Actual|Isala||2|||f||||t||||||||||2017-02-18 15:05:47.892402|2017-02-18 15:05:47.892402
NCT00556322|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-09|2015-02-04|2014-12-03||March 2006||2006-03-01|February 2015|2015-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Full Analysis Set (FAS): All participants randomized were included according to the therapy that they were randomized to receive in the FAS population.|A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)|An Open-label, Randomized Study to Evaluate the Effect of Tarceva, Compared With Alimta (Pemetrexed) or Taxotere (Docetaxel),on Survival in Patients With Advanced, Recurrent or Metastatic Non-small Cell Lung Cancer Who Have Experienced Disease Progression During Platinum-based Chemotherapy|Completed||Phase 3|424|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:05:48.018305|2017-02-18 15:05:48.018305
NCT00556309|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2017-02-08|||January 2007||2007-01-01|February 2017|2017-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|OCT||Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.|Optical Coherence Tomography Imaging of Post Coil Aneurysm Healing.|Completed||N/A|3|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:05:48.98894|2017-02-18 15:05:48.98894
NCT00556296|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2011-06-20|||October 2004||2004-10-01|June 2011|2011-06-01|September 2005|Actual|2005-09-01|||||Interventional|||Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD|A Phase 3, Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Study of NRP104 in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder|Completed||Phase 3|297|Actual|New River Pharmaceuticals||4|||f||||||||||||||2017-02-18 15:05:49.091086|2017-02-18 15:05:49.091086
NCT00556283|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2013-12-17|||February 2004||2004-02-01|December 2013|2013-12-01|May 2007|Actual|2007-05-01|||||Interventional|ODS II||RCT: STARR vs Biofeedback|Outcomes of Stapled Trans-Anal Rectal Resection (STARR) vs. Biofeedback in the Treatment of Outlet Obstruction Associated With Rectal Intussusception and Rectocele: A Multi-center Randomized Controlled Trial|Completed||Phase 4|121|Actual|Ethicon Endo-Surgery (Europe) GmbH||2|||f||||t||||||||||2017-02-18 15:05:49.188605|2017-02-18 15:05:49.188605
NCT00556270|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-05-04|||November 2007||2007-11-01|May 2012|2012-05-01|May 2008|Actual|2008-05-01|||||Observational|MATRIX II||Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic Pain|Matrifen for Therapy of Severe, Chronic Pain.|Completed||N/A|3000|Anticipated|Nycomed|||1||f||||f||||||||||2017-02-18 15:05:49.314097|2017-02-18 15:05:49.314097
NCT00556257|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2008-05-27|||August 2007||2007-08-01|May 2008|2008-05-01||||||||Interventional|||Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients|A Pilot Randomized, Multicenter, Open-Label, Active Comparator-Controlled Trial Of A CP-690,550-Based Regimen In De Novo Kidney Allograft Recipients|Withdrawn||Phase 2|0|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:05:50.593592|2017-02-18 15:05:50.593592
NCT00556244|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2007-11-08|||April 2007||2007-04-01|April 2007|2007-04-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling|Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane Peeling|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 15:05:50.688183|2017-02-18 15:05:50.688183
NCT00556231|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2013-01-02|||November 2007||2007-11-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Multi-site Near Infrared Spectroscopy (NIRS) Monitoring of Children During Exercise|Use of Multi-site Near Infrared Spectroscopy (NIRS) Monitoring for Global Hemodynamic Assessment During Exercise Testing in Children With and Without Heart Disease|Completed||N/A|51|Actual|Medical College of Wisconsin|||6||f||||f||||||||||2017-02-18 15:05:50.778094|2017-02-18 15:05:50.778094
NCT00556218|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2016-09-30|||October 2007||2007-10-01|September 2016|2016-09-01||||October 2018|Anticipated|2018-10-01||Interventional|||Meditation and Cognitive Function in Women With Breast Cancer|Feasibility Study of Meditation, Cognitive Function, and Quality of Life in Women With Breast Cancer|Active, not recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:05:50.880411|2017-02-18 15:05:50.880411
NCT00556205|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2016-03-23|||September 2009||2009-09-01|March 2016|2016-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma|Phase II, Randomized Trial of Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||2||Toxicity of combination from other trials|f||||f||||||||No|No data to share|2017-02-18 15:05:50.978807|2017-02-18 15:05:50.978807
NCT00556192|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-02-10|||June 2006||2006-06-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus|Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy Restore Peripheral B Cell Abnormalities in Systemic Lupus Erythematosus(SLE)?|Completed||Phase 2|20|Anticipated|Chinese University of Hong Kong||3|||f||||f||||||||||2017-02-18 15:05:51.083594|2017-02-18 15:05:51.083594
NCT00556179|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2009-01-21|||September 2007||2007-09-01|January 2009|2009-01-01||||December 2008|Actual|2008-12-01||Interventional|||Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis|Local, National (Brazil), Multicentric, Open, Non-Controlled, Phase IV, Study of Lactoserum (Dermacyd Femina®), in Women at Reproductive Age, to Prevent Recurrence of Bacterial Vaginosis, During Three Months, After Standard Treatment With Metronidazole.|Completed||Phase 4|122|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:05:51.191926|2017-02-18 15:05:51.191926
NCT00556166|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2016-06-22|2016-04-18||October 2004||2004-10-01|June 2016|2016-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|Enterra||Enterra Therapy Gastric Stimulation System|Enterra Therapy Gastric Stimulation System|Terminated||Phase 4|4|Actual|Columbia University||1||Principal investigator left institution.|f||||f||||||||No|No data available to share as the PI left the institution before the study could finish.|2017-02-18 15:05:51.29443|2017-02-18 15:05:51.29443
NCT00556153|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2013-01-07|||February 2013||2013-02-01|January 2013|2013-01-01|February 2013|Anticipated|2013-02-01|||||Observational|||[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children|[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children|Withdrawn||N/A|0|Actual|Children's Hospital Medical Center, Cincinnati|||1|No participants ever enrolled.|f||||f||||||||||2017-02-18 15:05:51.522409|2017-02-18 15:05:51.522409
NCT00553436|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2010-04-20|2009-10-20||November 2007||2007-11-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy|Evaluation of an Endoscopic Suturing System for Tissue Apposition in Colonic Polypectomy|Completed||N/A|7|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-02-18 15:07:03.167428|2017-02-18 15:07:03.167428
NCT00556140|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-07-11|2012-06-01||June 2003||2003-06-01|July 2012|2012-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|Abilify||The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression|The Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in the Acute Treatment of Psychotic Major Depression: Efficacy and Tolerability|Completed||Phase 3|16|Actual|Massachusetts General Hospital|We had several limitations to the study. The sample size was small, and we used an open and uncontrolled study design. We also excluded subjects who currently or recently abused alcohol, recreational drugs, and/or prescription drugs.|1|||f||||f||||||||||2017-02-18 15:05:51.619293|2017-02-18 15:05:51.619293
NCT00556127|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2007-11-08|||June 2002||2002-06-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|DLBCL||Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma|Programma di Terapia Per Pazienti Affetti da Linfoma Diffuso a Grandi Cellule B CD20 Positive|Completed||Phase 2|94|Actual|Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie||1|||f||||f||||||||||2017-02-18 15:05:51.851238|2017-02-18 15:05:51.851238
NCT00556114|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2017-02-08|||January 2007||2007-01-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging|A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging|Completed||N/A|23|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:05:51.975848|2017-02-18 15:05:51.975848
NCT00556101|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2009-08-18|||November 2007||2007-11-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|||||Observational|||Patient Acceptance of Whole Body Magnetic Resonance Angiography|Whole Body Magnetic Resonance Angiography: Questionnaire Examination of Patient Acceptance.|Completed||N/A|81|Anticipated|Copenhagen University Hospital at Herlev|||1||f||||t||||||||||2017-02-18 15:05:52.071421|2017-02-18 15:05:52.071421
NCT00556088|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2010-12-29|||December 2007||2007-12-01|December 2010|2010-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors|A Phase I Study of LBH589 in Combination With Paclitaxel and Carboplatin +/- Bevacizumab the Treatment of Solid Tumors|Completed||Phase 1|40|Anticipated|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 15:05:52.153311|2017-02-18 15:05:52.153311
NCT00556075|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2014-08-08|2014-06-24||November 2007||2007-11-01|August 2014|2014-08-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional||Safety population|Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis|A Phase II, Three-Arm, Parallel Design, Dose-Ranging Placebo-Controlled, Randomized, Double-Blind, Multicenter Study Evaluating the Safety and Efficacy of Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis|Terminated||Phase 2|67|Actual|Repros Therapeutics Inc.|The study was prematurely terminated for safety reasons (Proellex studies were put on clinical hold due to liver toxicity). Sponsor was unable to pay vendor, and was therefore not provided with complete study data.|3||Clinical hold for safety|f||||t||||||||||2017-02-18 15:05:52.251307|2017-02-18 15:05:52.251307
NCT00556062|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2007-11-08|||September 2007||2007-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Phase IV Clinical Trial of an Influenza Split Vaccine Anflu|The Clinical Trial for Three Consecutive Lots of Influenza Split Vaccine Anflu by Randomized, Double-Blind and Controlled Design|Completed||Phase 4|566|Actual|Sinovac Biotech Co., Ltd||4|||f||||||||||||||2017-02-18 15:05:55.280301|2017-02-18 15:05:55.280301
NCT00556049|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2016-03-23|2015-03-24||December 2007||2007-12-01|March 2016|2016-03-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma|Phase II, Single Arm Trial of Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|72|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-02-18 15:05:55.368626|2017-02-18 15:05:55.368626
NCT00556036|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2011-12-15|||March 2006||2006-03-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea|Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea|Completed||N/A|61|Actual|Massachusetts General Hospital|||4||f||||t||||||Samples Without DNA|"~     whole blood, serum, urine, saliva, optional DNA substudy.~   "|||2017-02-18 15:05:55.610606|2017-02-18 15:05:55.610606
NCT00556023|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-06-05|||June 2008||2008-06-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer|A Phase 1 Dose Escalation Trial Of CP-675,206 In Combination With Gemcitabine In Patients With Chemotherapy Naive Metastatic Pancreatic Cancer|Completed||Phase 1|37|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 15:05:55.702851|2017-02-18 15:05:55.702851
NCT00556010|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-07-19|||January 2009||2009-01-01|April 2011|2011-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Intraoperative Three Dimensional Fluoroscopy Compared to Standard Fluoroscopy for the Assessment of Reduction of Ankle Fractures With Syndesmosis Disruption|Intraoperative Three Dimensional Fluoroscopy Compared to Standard Fluoroscopy for the Assessment of Reduction of Ankle Fractures With Syndesmosis Disruption|Completed||N/A|40|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 15:05:55.80523|2017-02-18 15:05:55.80523
NCT00555997|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2014-06-23|2013-07-09||March 2008||2008-03-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|Geodon||A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Sequential Trial of Ziprasidone as Monotherapy for Major Depressive Disorder|Completed||Phase 2|120|Actual|Massachusetts General Hospital||3|||f||||f||||||||||2017-02-18 15:05:58.287388|2017-02-18 15:05:58.287388
NCT00555984|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2012-08-01|||September 2007||2007-09-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|TIVA||Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors|Effect of Total Intravenous Anesthesia Versus Anesthesia With Volatile Agents on Inflammatory Markers Following Elective Craniotomy for Primary Brain Tumor|Completed||N/A|30|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 15:05:58.852583|2017-02-18 15:05:58.852583
NCT00555412|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2013-06-24|||October 2007||2007-10-01|June 2013|2013-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Staccato Loxapine Multidose PK|Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Staccato® Loxapine for Inhalation in Subjects on Chronic, Stable Antipsychotic Regimens|Completed||Phase 1|40|Actual|Alexza Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 15:06:13.746169|2017-02-18 15:06:13.746169
NCT00555971|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2016-02-29|||May 2006||2006-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization|A Placebo Controlled, Double-Blind Investigation of the Therapeutic Utility of Xolair (Omalizumab) for Attenuating Aspirin Induced Bronchospasm in Patients With Aspirin Exacerbated Respiratory Disease (AERD) Undergoing Aspirin Desentization|Completed||Phase 4|16|Actual|The Cleveland Clinic||2|||f||||f||||||||No||2017-02-18 15:05:58.965391|2017-02-18 15:05:58.965391
NCT00555958|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-02-01|||November 2005||2005-11-01|February 2012|2012-02-01|September 2014|Anticipated|2014-09-01|September 2011|Actual|2011-09-01||Interventional|||Vagal Blocking for Obesity Control|VBLOC™ Clinical Trial: Vagal Block for Obesity Control|Unknown status|Active, not recruiting|N/A|120|Anticipated|EnteroMedics||1|||f||||t||||||||||2017-02-18 15:05:59.07656|2017-02-18 15:05:59.07656
NCT00555945|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2011-06-24|||May 2007||2007-05-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|REGAIN||Re-Evaluation of GAmma3 Intramedullary Nails in Hip Fracture (REGAIN)|Re-Evaluation of GAmma3 Intramedullary Nails in Hip Fracture: A Multi-Centre Randomized Controlled Trial of Gamma3 Intramedullary Nails Versus Sliding Hip Screws in the Management of Intertrochanteric Fractures of the Hip|Completed||N/A|90|Actual|Stryker Trauma GmbH||2|||f||||f||||||||||2017-02-18 15:05:59.18887|2017-02-18 15:05:59.18887
NCT00555932|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2015-05-19|||May 2007||2007-05-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Modern Ultrasound Techniques in the Evaluation of Cerebral Venous Sinuses in Neonates|Utility of Modern Ultrasound Techniques in the Evaluation of Cerebral Venous Sinuses in Neonates|Completed||N/A|58|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-02-18 15:05:59.310377|2017-02-18 15:05:59.310377
NCT00555919|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2014-10-09|||March 2008||2008-03-01|October 2014|2014-10-01|March 2011|Actual|2011-03-01|April 2010|Actual|2010-04-01||Interventional|||ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer|Randomized Phase II Study to Investigate the Efficacy, Safety and Tolerability of ZK 230211 (25 mg vs. 100 mg) as Second-line Endocrine Therapy for Postmenopausal Women With Hormone Receptor-positive Metastatic Breast Cancer|Completed||Phase 2|68|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:05:59.638831|2017-02-18 15:05:59.638831
NCT00555906|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2015-03-04|2015-03-04||January 2008||2008-01-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|August 2012|Actual|2012-08-01||Interventional||Full analysis set (FAS) included all enrolled participants.|An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.|Phase 1/2 Open-label Study Of The Safety And Efficacy Of Pd 0332991 In Combination With Bortezomib And Dexamethasone In Patients With Refractory Multiple Myeloma|Completed||Phase 2|53|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:05:59.823712|2017-02-18 15:05:59.823712
NCT00555893|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2015-01-13|2015-01-07||January 2008||2008-01-01|January 2015|2015-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Efficacy Study of Early Versus Late Oseltamivir Administration for Treating and Preventing Influenza|Monitoring Influenza Severity on Tamiflu (MIST)|Completed||N/A|194|Actual|Marshfield Clinic Research Foundation||2|||f||||f||||||||||2017-02-18 15:06:02.632131|2017-02-18 15:06:02.632131
NCT00555880|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2015-05-05|2015-04-13||September 2004||2004-09-01|June 2010|2010-06-01|March 2005|Actual|2005-03-01|||||Interventional||The Safety and Full Analysis Set (FAS) populations, defined as all participants who received at least one dose of investigational product (Safety) and all participants who were randomized, received at least one dose of investigational product, and had at least one measurement of the time to near syncope during a tilt table test (FAS).|Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension|A Multi-Center, Double-Blind, Randomized, Placebo-controlled, Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Subjects With Moderate to Severe Neurogenic Orthostatic Hypotension|Completed||Phase 4|24|Actual|Shire||2|||f||||||||||||||2017-02-18 15:06:03.042739|2017-02-18 15:06:03.042739
NCT00555867|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2011-12-22|||October 2006||2006-10-01|December 2011|2011-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|PACT||Patient's Anastrozole Compliance to Therapy Programme|A Randomised in Practice Evaluation of the Influence of Patient's Understanding of Her Disease and Therapy on Persistence and Compliance to Adjuvant Therapy for Post-menopausal Hormone Sensitive Early Breast Cancer|Terminated||N/A|4923|Actual|AstraZeneca|||2|"High drop-out rate leads to the conclusion: not enough data will be available to perform~   proper analyses of data collected after follow-up month 24 visit"|f||||f||||||||||2017-02-18 15:06:03.976171|2017-02-18 15:06:03.976171
NCT00555854|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2011-02-23|||December 2005||2005-12-01|May 2008|2008-05-01|November 2010|Actual|2010-11-01|||||Interventional|||Self-care Behaviour Treatment in Patients With Diabetes - a Randomised Controlled Trial|Can a Behavioural Modifying Intervention Increase the Self-care and the Effect of the Diabetes Treatment in Chronically Ill Patients With Diabetes|Completed||N/A|349|Actual|Odense University Hospital||1|||f||||f||||||||||2017-02-18 15:06:04.080884|2017-02-18 15:06:04.080884
NCT00555841|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2012-08-27|||March 2007||2007-03-01|August 2012|2012-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue|Safety and Efficacy of Oral Acetyl-l-carnitine (ALC) in Non-anemic Potentially Curable Breast Cancer Subjects Undergoing Adjuvant Radiation Therapy Who Have Moderate to Severe Fatigue|Terminated||Phase 2|27|Actual|Sigma-Tau Research, Inc.||2||Sponsor decision|f||||t||||||||||2017-02-18 15:06:04.17173|2017-02-18 15:06:04.17173
NCT00555828|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2010-02-16|||March 2008||2008-03-01|June 2009|2009-06-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction|A Phase 1b/2a Dose Escalation Study to Assess the Safety and Feasibility of Transendocardial Delivery of 3 Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction|Unknown status|Recruiting|Phase 1/Phase 2|25|Anticipated|Angioblast Systems||6|||f||||t||||||||||2017-02-18 15:06:04.277741|2017-02-18 15:06:04.277741
NCT00555815|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2007-11-08|||July 2005||2005-07-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Observational|||Intraoperative Hygiene Measures and Surgical Site Infections|Intraoperative Hygiene Measures and Rates of Surgical Wound Infection in General Surgery|Completed||N/A|1032|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-02-18 15:06:04.38257|2017-02-18 15:06:04.38257
NCT00380107|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2009-08-05|||October 2006||2006-10-01|August 2009|2009-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Volume Deficit Prior to Surgery|Estimation of Volume Deficit in Patients Prior to Surgery|Completed||Phase 4|4|Actual|Rigshospitalet, Denmark|||4||f||||||||||||||2017-02-18 16:13:49.395422|2017-02-18 16:13:49.395422
NCT00555789|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2012-07-31||2012-07-09|October 2007||2007-10-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients|A 24 Month Extension to a 12-month Open Label, Randomized, Multicenter Study Evaluating Efficacy, Safety and Tolerability of Oral AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), vs. Mycophenolic Acid Plus Tacrolimus in de Novo Renal Transplant Recipients|Terminated||Phase 2|137|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:06:04.787864|2017-02-18 15:06:04.787864
NCT00555776|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2009-01-05|||January 2007||2007-01-01|August 2008|2008-08-01|October 2008|Anticipated|2008-10-01|April 2008|Anticipated|2008-04-01||Interventional|||Effect of Gabapentin on Idiopathic Subjective Tinnitus|Phase 2 Effect of Gabapentin on Idiopathic Subjective Tinnitus|Unknown status|Active, not recruiting|Phase 2|70|Anticipated|Islamic Azad University of Mashhad||2|||f||||t||||||||||2017-02-18 15:06:04.913562|2017-02-18 15:06:04.913562
NCT00555763|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2011-07-13|||August 2007||2007-08-01|July 2011|2011-07-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Assessment of a New Goldmann Applanation Tonometer|Assessment of a New Goldmann Applanation Tonometer|Completed||Phase 3|157|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 15:06:05.026638|2017-02-18 15:06:05.026638
NCT00555750|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2013-11-15|2013-05-21||March 2006||2006-03-01|November 2013|2013-11-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Sleep Loss and Mechanisms of Impaired Glucose Metabolism|The Effects of Eszopiclone Treatment (3mg for Two Months) to Counteract the Adverse Metabolic Consequences of Primary Insomnia|Completed||N/A|20|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 15:06:05.129405|2017-02-18 15:06:05.129405
NCT00555737|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2009-03-25|||November 2003||2003-11-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Observational|||Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23)|Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy|Completed||N/A|102|Actual|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 15:06:05.762052|2017-02-18 15:06:05.762052
NCT00555724|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2017-01-05|||January 2008||2008-01-01|January 2017|2017-01-01|July 2010|Actual|2010-07-01|April 2010|Actual|2010-04-01||Interventional|||Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors|A Phase 1, Open Label, Dose Escalation Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Subjects With Relapsed or Refractory Solid Tumors|Completed||Phase 1|40|Actual|Biogen||1|||f||||||||||||||2017-02-18 15:06:05.859931|2017-02-18 15:06:05.859931
NCT00555711|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2017-02-08|||November 2008||2008-11-01|February 2017|2017-02-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Observational|MI||Monitoring Neural Tissues Properties by Modulated Imaging (MI)|Monitoring Neural Tissues Properties by Modulated Imaging (MI)|Withdrawn||N/A|0|Actual|University of California, Irvine|||1|no subject|f||||f||||||||||2017-02-18 15:06:05.959968|2017-02-18 15:06:05.959968
NCT00555698|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2017-01-04|||January 2004||2004-01-01|January 2017|2017-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Feasibility, Safety and Efficacy of Deep Brain Stimulation for Depression|Feasibility, Safety and Efficacy of Deep Brain Stimulation of the Internal Capsule for Severe and Medically Refractory Major Depression|Completed||Early Phase 1|8|Actual|The Cleveland Clinic||1|||f||||t||||||||No||2017-02-18 15:06:06.060222|2017-02-18 15:06:06.060222
NCT00555685|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2014-06-06|||February 2008||2008-02-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Hypertonic Saline Solution in Heart Failure|Hypertonic Saline Solution in Decompensated Heart Failure|Completed||Phase 2|34|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 15:06:06.172336|2017-02-18 15:06:06.172336
NCT00555672|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-08|2011-12-12|2010-12-15||August 2008||2008-08-01|December 2011|2011-12-01|August 2010|Actual|2010-08-01|December 2009|Actual|2009-12-01||Interventional|||Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer|A Phase I Study Of Sunitinib Malate In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer|Completed||Phase 1|34|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:06:06.290915|2017-02-18 15:06:06.290915
NCT00555659|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2013-08-08|||September 2007||2007-09-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|Aegis||Prospective Clinical Evaluation of the New Aegis Plate for Anterior Interbody Fusions|Prospective Clinical Evaluation of the New Aegis Plate for Anterior Interbody|Completed||N/A|104|Actual|Columbia Orthopaedic Group, LLP|||1||f||||t||||||||||2017-02-18 15:06:07.051797|2017-02-18 15:06:07.051797
NCT00555646|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2009-07-07|||November 2007||2007-11-01|July 2009|2009-07-01|July 2009|Anticipated|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis|A Phase 2 Study of Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for the Treatment of Plaque Psoriasis|Terminated||Phase 2|25|Anticipated|Provectus Pharmaceuticals||1||Change of dose regimen (new protocol)|f||||f||||||||||2017-02-18 15:06:07.137264|2017-02-18 15:06:07.137264
NCT00555633|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2009-09-29|||October 2004||2004-10-01|September 2009|2009-09-01|February 2006|Actual|2006-02-01|||||Observational|||Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients|Regular Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients, Particularly in Xeroderma Pigmentosum and Basal Cell Nevus Syndrome|Completed||N/A|13|Actual|Medical University of Graz|||1||f||||f||||||||||2017-02-18 15:06:07.23023|2017-02-18 15:06:07.23023
NCT00555620|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2013-01-07|2011-08-04||May 2008||2008-05-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|August 2010|Actual|2010-08-01||Interventional|||Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer|A Phase 1 Study Of Sunitinib Malate In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer|Completed||Phase 1|76|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:06:07.523668|2017-02-18 15:06:07.523668
NCT00555607|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2015-09-14|||March 2002||2002-03-01|June 2011|2011-06-01|December 2017|Anticipated|2017-12-01|April 2005|Actual|2005-04-01||Interventional|BIOAIR||Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease|Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease|Active, not recruiting||N/A|233|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 15:06:09.600597|2017-02-18 15:06:09.600597
NCT00554008|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2012-05-25|||December 2007||2007-12-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Comparative Study of Laparoscopic Versus Open Appendectomy in Children|Randomized, Prospective, Single Blinded Trial of Laparoscopic Versus Open Appendectomy in Children|Completed||N/A|400|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 15:06:47.3185|2017-02-18 15:06:47.3185
NCT00555594|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2007-11-07|||September 2006||2006-09-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization|Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization|Completed||Phase 2/Phase 3|18|Actual|Asociación para Evitar la Ceguera en México||2|||f||||t||||||||||2017-02-18 15:06:09.719316|2017-02-18 15:06:09.719316
NCT00555581|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2013-01-31|||August 2007||2007-08-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis|Phase IIA Study of the Safety and Tolerability of the Use of Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Hospital for Special Surgery, New York||1|||f||||t||||||||||2017-02-18 15:06:09.922592|2017-02-18 15:06:09.922592
NCT00555568|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2015-06-22|2015-02-20||January 2007||2007-01-01|June 2015|2015-06-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|Peer Support|veterans treated for a mental health condition at one of 2 VA medical centers|Mechanisms of Action and Outcome|Mechanisms of Action and Outcome in Peer Support Groups|Completed||N/A|298|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 15:06:10.02876|2017-02-18 15:06:10.02876
NCT00555555|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2017-01-20|||September 2007|Actual|2007-09-01|January 2017|2017-01-01|March 2021|Anticipated|2021-03-01|December 2020|Anticipated|2020-12-01||Interventional|||Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients|A Post-marketing Observation Study to Assess the Efficacy and Safety of the FVIII/VWF Complex (Human,) Alphanate(R), in Preventing Excessive Bleeding During Surgery in Subjects With Congenital Type 3 Von Willebrand Disease|Recruiting||Phase 4|15|Anticipated|Grifols Biologicals Inc.||1|||f||||t||||||||No||2017-02-18 15:06:10.868977|2017-02-18 15:06:10.868977
NCT00555542|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2008-05-07|||July 2006||2006-07-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||An Analysis of Peripheral Blood T Cell Subsets on Rheumatoid Arthritis|B Cell Depletion Therapy in Rheumatoid Arthritis: An Analysis of Peripheral Blood T Cell Subsets|Completed||Phase 2|10|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-02-18 15:06:10.987873|2017-02-18 15:06:10.987873
NCT00555529|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2007-11-07|||January 2006||2006-01-01|November 2007|2007-11-01|November 2008|Anticipated|2008-11-01|||||Observational|||Systemic Endothelial Abnormalities in COPD|Systemic Endothelial Abnormalities in COPD Measured by Radial Artery Applanation Tonometry (RAAP)|Unknown status|Active, not recruiting|N/A|36|Anticipated|Imperial College London|||2||f||||||||||||||2017-02-18 15:06:11.091387|2017-02-18 15:06:11.091387
NCT00555516|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2007-11-07|||November 2007||2007-11-01|November 2007|2007-11-01|June 2009|Anticipated|2009-06-01|||||Interventional|||A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy|A Phase I/II Double-Blind, Randomized, Placebo-Control Pilot Study to Evaluate the Safety and Pharmacodynamic Activities of EW02 in Reducing Neutropenia Caused by Breast Cancer Chemotherapy|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Tri-Service General Hospital||2|||f||||t||||||||||2017-02-18 15:06:11.391788|2017-02-18 15:06:11.391788
NCT00555503|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2016-12-01|||November 2007||2007-11-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Observational|||Registry of Mastectomy for Breast Cancer Risk Reduction|Registry of Mastectomy for Breast Cancer Risk Reduction|Completed||N/A|261|Actual|Georgetown University|||1||f||||f||||||Samples With DNA|"~     Patient operative specimens, blood samples, and saliva samples.~   "|||2017-02-18 15:06:11.499906|2017-02-18 15:06:11.499906
NCT00555490|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2007-11-07|||April 2001||2001-04-01|November 2007|2007-11-01|September 2005|Actual|2005-09-01|||||Interventional|||Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy|Soy-Protein Intake, Cardio-Renal Indices and C-Reactive Protein in Type 2 Diabetes With Nephropathy: a 4-y Randomized Clincal Trial|Completed||Phase 1|41|Actual|Isfahan University of Medical Sciences||1|||f||||||||||||||2017-02-18 15:06:11.762918|2017-02-18 15:06:11.762918
NCT00555477|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2014-05-19|2014-04-16||August 2007||2007-08-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|December 2011|Actual|2011-12-01||Interventional||Initiated treatment with Anastrozole, 1 mg orally daily.|Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure|Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure|Terminated||Phase 2|69|Actual|University of Michigan Cancer Center|Because of poor accrual, the trial was closed after 69 of a planned 150 patients were enrolled.|1||The study was stopped after 69 subjects were enrolled because of poor accrual.|f||||t||||||||||2017-02-18 15:06:11.866111|2017-02-18 15:06:11.866111
NCT00555464|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2013-06-04|2013-02-19||November 2007||2007-11-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas|A Phase II, Randomized, Clinical Trial Assessing Efficacy And Safety Of Oral Prednisolone vs Intravenous Vincristine In The Treatment Of Infantile|Terminated||Phase 2|8|Actual|Medical College of Wisconsin|The limitations of this trial include early termination of enrollment leading to small numbers of subjects analyzed.|2||The introduction of oral propranolol as a highly efficacious agent for infantile hemangiomas|f||||t||||||||||2017-02-18 15:06:12.200491|2017-02-18 15:06:12.200491
NCT00555451|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2010-05-11|||October 2007||2007-10-01|May 2010|2010-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects|A Phase I, Double-Blind, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Potential Activity of HE3286 When Administered Orally to Obese Adult Subjects for 28 Days|Completed||Phase 1|66|Anticipated|Harbor Therapeutics||1|||f||||f||||||||||2017-02-18 15:06:12.628052|2017-02-18 15:06:12.628052
NCT00555438|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2011-07-22|2010-09-15||June 2007||2007-06-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|PROPICE||Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.|Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux,in Venous Thromboembolic Events Prevention in Patients With Renal Impairment and Undergoing a Major Orthopaedic Surgery. PROPICE Study|Completed||Phase 4|451|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-02-18 15:06:12.733108|2017-02-18 15:06:12.733108
NCT00555425|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2016-11-29|2016-01-25||July 2008||2008-07-01|September 2016|2016-09-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence|Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence|Completed||Phase 4|113|Actual|Yale University||2|||f||||f||||||||||2017-02-18 15:06:13.098137|2017-02-18 15:06:13.098137
NCT00555399|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2016-09-26|||November 2007||2007-11-01|March 2016|2016-03-01||||November 2017|Anticipated|2017-11-01||Interventional|||Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)|Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme|Active, not recruiting||Phase 1/Phase 2|135|Anticipated|M.D. Anderson Cancer Center||5|||f||||t||||||||||2017-02-18 15:06:13.8648|2017-02-18 15:06:13.8648
NCT00555386|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2008-09-24|||April 2007||2007-04-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional|||Soy, Selenium and Breast Cancer Risk|A Pilot Study to Determine the Effect of Dietary Intervention on Novel Biomarkers of Breast Cancer Risk.|Completed||N/A|27|Actual|University of East Anglia||2|||f||||||||||||||2017-02-18 15:06:13.993573|2017-02-18 15:06:13.993573
NCT00555373|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2013-02-22|||November 2007||2007-11-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|CNI-W||Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression|Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression|Completed||N/A|52|Actual|Pediatric Nephrology of Alabama||1|||f||||t||||||||||2017-02-18 15:06:14.111043|2017-02-18 15:06:14.111043
NCT00555360|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2015-08-12|2015-01-15||June 2009||2009-06-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|January 2013|Actual|2013-01-01||Interventional|||Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study|Enhancing Caregiver Support for Patients With Heart Failure|Completed||N/A|372|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:06:14.22385|2017-02-18 15:06:14.22385
NCT00555347|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2015-05-26|||October 2007||2007-10-01|April 2013|2013-04-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Use of Armodafinil for Fatigue in Sarcoidosis|Use of Armodafinil (R-modafinil) for Fatigue in Sarcoidosis|Completed||Phase 2/Phase 3|20|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 15:06:14.700373|2017-02-18 15:06:14.700373
NCT00555334|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2009-03-31|||November 2007||2007-11-01|March 2009|2009-03-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|LAM-RFA||Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|200|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 15:06:14.94196|2017-02-18 15:06:14.94196
NCT00555321|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2012-09-17|2012-09-17||January 2008||2008-01-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional|||Belatacept in Liver Transplant Recipients|Evaluation of Belatacept as First Line Immunosuppression in De Novo Liver Transplant Recipients|Terminated||Phase 2|260|Actual|Bristol-Myers Squibb||5|||f||||t||||||||||2017-02-18 15:06:15.124824|2017-02-18 15:06:15.124824
NCT00555308|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2009-07-21|||November 2007||2007-11-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Emergency Department Targeted Ultrasound for the Detection of Hydronephrosis|Emergency Department Targeted Ultrasound for the Detection of Hydronephrosis|Completed||N/A|200|Actual|Queen's University||1|||f||||f||||||||||2017-02-18 15:06:23.20965|2017-02-18 15:06:23.20965
NCT00555295|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-27|2007-11-07|||December 2007||2007-12-01|June 2007|2007-06-01|February 2008|Anticipated|2008-02-01|||||Observational|||Laparoscopic Colorectal Surgery For Cancer- Long Term Survival|Survival After Laparoscopic Colorectal Surgery|Unknown status|Not yet recruiting|N/A|200|Anticipated|Tel-Aviv Sourasky Medical Center|||1||f||||f||||||Samples Without DNA|"~     Colonic Resection~   "|||2017-02-18 15:06:23.310434|2017-02-18 15:06:23.310434
NCT00555282|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2010-02-04|||November 2005||2005-11-01|February 2010|2010-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of Two Different Central Venous Catheters (CVC)|Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of a Standard Central Venous Catheter (CVC) in Comparison to a Coated CVC|Completed||Phase 4|680|Actual|B. Braun Melsungen AG||2|||f||||||||||||||2017-02-18 15:06:23.371957|2017-02-18 15:06:23.371957
NCT00555269|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2009-04-20|||October 2004||2004-10-01|April 2009|2009-04-01|December 2005|Actual|2005-12-01|||||Observational|||Membrane Blue Versus Infracyanine Green|Comparison of Macular Function and Visual Fields After Membrane Blue or Infracyanine Green Staining in Vitreoretinal Surgery|Completed||N/A|30|Actual|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|||2||f||||f||||||||||2017-02-18 15:06:23.484087|2017-02-18 15:06:23.484087
NCT00555256|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2016-05-05|||November 2007||2007-11-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|February 2010|Actual|2010-02-01||Interventional|SU/Rapamycin||A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|19|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 15:06:23.559009|2017-02-18 15:06:23.559009
NCT00555243|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2013-01-18|||August 2005||2005-08-01|November 2007|2007-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Laparoscopic Simulator Training and Its Impact on Surgical Education|An Evaluation of Validated Laparoscopic Skills Simulators and the Impact on Operating Room Performance|Completed||N/A|108|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 15:06:26.24863|2017-02-18 15:06:26.24863
NCT00555230|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2011-01-26|||July 2007||2007-07-01|December 2008|2008-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis|Effects of HMG-coA Reductase Inhibitor on Progression of Carotid Intima-Media Thickness and Arterial Stiffness in Rheumatoid Arthritis|Completed||Phase 2|150|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 15:06:26.353769|2017-02-18 15:06:26.353769
NCT00555217|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2015-05-08|2015-04-17||July 2008||2008-07-01|May 2015|2015-05-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|VA NEPHRON-D||VA NEPHRON-D: Diabetes iN Nephropathy Study|CSP #565 - Combination Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D Study)|Terminated||Phase 3|1448|Actual|VA Office of Research and Development|In October, 2012 the DMC recommended that study treatment be stopped primarily because of safety concerns along with low conditional power to detect a treatment effect on the primary outcome.|2||"It was stopped primarily because of safety concerns along with low conditional power to detect~   a treatment effect on the primary outcome."|f||||t||||||||||2017-02-18 15:06:26.48526|2017-02-18 15:06:26.48526
NCT00555204|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2011-08-19||2011-08-19|November 2007||2007-11-01|August 2011|2011-08-01||||June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled Study Using a Bayesian Adaptive Design to Evaluate the Efficacy and Safety of ABT-089 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors|Terminated||Phase 2|337|Actual|Abbott||7|||f||||t||||||||||2017-02-18 15:06:29.109334|2017-02-18 15:06:29.109334
NCT00555191|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2016-05-23|||September 2007||2007-09-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|FINN||Fructose Malabsorption in Northern Norway|Fructose Malabsorption in Northern Norway. Fructose Malabsorption and Irritable Bowel Syndrome.|Completed||Phase 2/Phase 3|182|Actual|University Hospital of North Norway||2|||f||||f||||||||Yes|Data already published in two articles published in Scandinavian Journal of Gastroenterology 2013 48: 936-943 DOI: 10.2109/00365521.2013.812139 andWorld Journal of Gastroenterology 2015 May 14;21(18) 5445-5754 DOI: 10.3748/ wjg.v21.i18.5677|2017-02-18 15:06:29.28294|2017-02-18 15:06:29.28294
NCT00555178|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-07|2015-05-06|||March 2008||2008-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Regulatory T Cells (Tregs) in Polymorphic Light Eruption|Regulatory T Cells (Tregs) in Polymorphic Light Eruption|Completed||N/A|92|Anticipated|Medical University of Graz|||4||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 15:06:29.377696|2017-02-18 15:06:29.377696
NCT00555165|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2012-11-13|||November 2007||2007-11-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMD|A Prospective Multicenter Clinical Study of the Implantable Miniature Telescope* in Patients With Central Vision Impairment Associated With AMD: IMT-UK Protocol (*IMT by Dr. Isaac Lipshitz)|Completed||N/A|18|Actual|VisionCare, Inc.||1|||f||||f||||||||||2017-02-18 15:06:29.474705|2017-02-18 15:06:29.474705
NCT00555152|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2015-10-22|2015-07-24||January 2008||2008-01-01|August 2014|2014-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ|Neoadjuvant Trial of Lapatinib for the Treatment of Women With DCIS Breast Cancer|Completed||N/A|22|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 15:06:29.580106|2017-02-18 15:06:29.580106
NCT00555139|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2010-10-13||2010-10-13|March 2007||2007-03-01|October 2010|2010-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder|Double-blind, Randomized, Placebo and Alprazolam-controlled Three-period Crossover Incomplete Block Design Study to Compare Putative Anxiolytic-like fRMI Activity of GW876008 and GSK561679 After Single-dose Administration in Subjects With Social Anxiety Disorder (SAD)|Completed||Phase 1|35|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:06:30.44905|2017-02-18 15:06:30.44905
NCT00555126|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2010-07-27|||May 2008||2008-05-01|July 2010|2010-07-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|FAEWPP||Forced Air Versus Endovascular Warming in Polytrauma Patients|A Comparison of Forced-air With Endovascular Warming for Treatment of Accidental Hypothermia in Polytrauma Victims|Suspended||Phase 4|100|Anticipated|Medical University of Vienna||2||Not enough patients|f||||t||||||||||2017-02-18 15:06:30.549717|2017-02-18 15:06:30.549717
NCT00555113|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2007-11-06|||January 2000||2000-01-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Observational|||Evolution of Visual Impairment During Pseudoxanthoma Elasticum|Evolution of Visual Impairment During Pseudoxanthoma Elasticum|Completed||N/A|38|Actual|European Georges Pompidou Hospital|||1||f||||f||||||||||2017-02-18 15:06:30.650008|2017-02-18 15:06:30.650008
NCT00555100|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2016-11-30|||July 2007||2007-07-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma|A Multicenter, Phase I Study to Determine the Maximum Tolerated Dose, Safety, Pharmacokinetics and Efficacy of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma|Completed||Phase 1|15|Actual|Celgene Corporation||1|||f||||t||||||||||2017-02-18 15:06:30.736329|2017-02-18 15:06:30.736329
NCT00555087|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2007-11-05|||May 2007||2007-05-01|November 2007|2007-11-01|January 2008|Anticipated|2008-01-01|||||Interventional|Nebidolocal||Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate|Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate i.m. 1000 mg. A Prospective, Multi-Center Clinical Study Phase IV.|Unknown status|Recruiting|Phase 4|50|Anticipated|Hospital Santa Fe||1|||f||||t||||||||||2017-02-18 15:06:30.886646|2017-02-18 15:06:30.886646
NCT00555074|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2010-03-30|||November 2007||2007-11-01|May 2008|2008-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|TROTA-1||Sodium Tungstate in Obesity|Efficacy of Oral Sodium Tungstate (200 mg/Day)on Weight Loss in Subjects With Grade I-II Obesity|Completed||Phase 2|44|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 15:06:31.152956|2017-02-18 15:06:31.152956
NCT00555061|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2016-11-04|2009-08-10||September 2007||2007-09-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.|An Open-Label, Non-Comparative Study to Assess the Pharmacokinetics, Safety and Efficacy of Topical Retapamulin (SB-275833) Ointment, 1%, Twice Daily for Five Days in the Treatment of Uncomplicated Skin and Skin Structure Infections in Pediatric Subjects Aged 2 to 24 Months|Completed||Phase 4|60|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:06:31.251978|2017-02-18 15:06:31.251978
NCT00555048|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2011-01-04|||September 2007||2007-09-01|January 2011|2011-01-01||||October 2010|Actual|2010-10-01||Interventional|||Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer|A Prospective Trial to Evaluate the Role of In Vivo T Cell Depletion by Campath® (Alemtuzumab) in Reduction of Transplant Related Mortality in Transplantation From HLA-Class I or Class II Mismatched, Unrelated Donors|Terminated||Phase 1/Phase 2|1|Actual|Fred Hutchinson Cancer Research Center||1||Low accrual|f||||f||||||||||2017-02-18 15:06:31.580689|2017-02-18 15:06:31.580689
NCT00555035|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2010-10-13||2010-10-13|November 2007||2007-11-01|October 2010|2010-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||GSK1349572 First Time in Human Study|A Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1349572 in Healthy Subjects|Completed||Phase 1|20|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:06:31.690257|2017-02-18 15:06:31.690257
NCT00555022|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2010-10-14||2010-10-14|December 2007||2007-12-01|October 2010|2010-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of GSK1160724 In Healthy Volunteers|A Randomized Double-blind, Placebo-controlled, Crossover, Dose Escalation Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of GSK1160724 and Tiotropium Bromide|Completed||Phase 1|20|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:06:31.778148|2017-02-18 15:06:31.778148
NCT00555009|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2010-06-01|2009-12-22||March 2008||2008-03-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury|Placebo Controlled Trial on the Efficacy of Growth Hormone Replacement Therapy in Patients With Growth Hormone Deficiency After Traumatic Brain Injury.|Terminated||Phase 4|10|Actual|Pfizer||2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 15:06:31.870557|2017-02-18 15:06:31.870557
NCT00554996|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2015-09-25|2015-07-16||August 2012||2012-08-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional||See Eligibility section.|Bacterial Interference for Prevention of Catheter-Associated UTI: Geriatric Pilot Study|Bacterial Interference for Prevention of Catheter-Associated UTI|Completed||Phase 1|10|Actual|VA Office of Research and Development|Our trial was a small study with no control group.|1|||f||||t||||||||||2017-02-18 15:06:32.531627|2017-02-18 15:06:32.531627
NCT00554983|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2013-11-07|||September 2007||2007-09-01|November 2013|2013-11-01|May 2012|Actual|2012-05-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy and Safety From a Recombinant Folding Variant of Bet v 1|A Multicentre Randomised Placebo-controlled Double-blind Pivotal Clinical Trial for the Evaluation of Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Recombinant Hypoallergenic Derivative of the Major Birch Pollen Allergen, rBet v 1-FV|Completed||Phase 3|255|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 15:06:32.745783|2017-02-18 15:06:32.745783
NCT00554970|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2013-12-09|2013-08-19||November 2007||2007-11-01|December 2013|2013-12-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|P202||A Study of 2 Doses of MAP0010 in Adult Asthmatics|A Randomized, Open Label, Active-Controlled, 4-Treatment, 2-Period, 2 Parallel Block Crossover Pharmacokinetic and Safety Study of 2 Doses of MAP0010 in Adult Asthmatics|Completed||Phase 2|32|Actual|Allergan||4|||f||||f||||||||||2017-02-18 15:06:32.843139|2017-02-18 15:06:32.843139
NCT00554957|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2009-02-12|||April 2007||2007-04-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|||||Observational|||Perception of Musculoskeletal Injury in Professional Dancers|Perception of Musculoskeletal Injury in Professional Dancers, an International Comparison|Completed||N/A|266|Actual|University Health Network, Toronto|||6||f||||f||||||||||2017-02-18 15:06:33.441129|2017-02-18 15:06:33.441129
NCT00554944|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2017-01-20|||June 2007||2007-06-01|January 2017|2017-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Intraoperative Goal-directed Fluid Management|Intraoperative Goal-directed Fluid Management in Lean and Obese Patients|Withdrawn||N/A|0|Actual|The Cleveland Clinic||1||not progressing as anticipated|f||||t||||||||||2017-02-18 15:06:33.53912|2017-02-18 15:06:33.53912
NCT00554918|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2013-08-06|||February 2005||2005-02-01|April 2008|2008-04-01|June 2013|Actual|2013-06-01|December 2008|Actual|2008-12-01||Interventional|||Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy|A Randomised Phase II Feasibility Study of Docetaxel (Taxotere®) Plus Prednisolone vs. Docetaxel (Taxotere®) Plus Prednisolone Plus Zoledronic Acid (Zometa®) vs. Docetaxel (Taxotere®) Plus Prednisolone Plus Strontium-89 vs. Docetaxel (Taxotere®) Plus Prednisolone Plus Zoledronic Acid (Zometa®) Plus Strontium-89 in Hormone Refractory Prostate Cancer Metastatic to Bone.|Completed||Phase 2|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:06:33.797921|2017-02-18 15:06:33.797921
NCT00554905|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2009-02-06|||October 2006||2006-10-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|February 2009|Anticipated|2009-02-01||Interventional|RFA and TACE||Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma|Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 4|180|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 15:06:33.937332|2017-02-18 15:06:33.937332
NCT00554892|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2010-06-29|||September 2007||2007-09-01|June 2010|2010-06-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|PREPACOL||Rectal Cancer Surgery Without Mechanical Bowel Preparation|ClinicalTrial in Rectal Cancer Surgery Without Mechanical Bowel Preparation|Completed||N/A|186|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:06:34.055661|2017-02-18 15:06:34.055661
NCT00554879|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2011-08-26|||November 2007||2007-11-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Acupuncture Treatment of Dry Eye|Acupuncture Treatment of Dry Eye|Completed||N/A|20|Actual|Walter Reed Army Medical Center||2|||f||||t||||||||||2017-02-18 15:06:34.181353|2017-02-18 15:06:34.181353
NCT00554866|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2015-10-27|||July 2007||2007-07-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2009|Actual|2009-12-01||Interventional|||L-arginine Concentrations and CPS Polymorphisms in VLBW Infants|Carbamoyl-phosphate Synthase Gene Polymorphisms Influencing Plasma L-arginine Concentrations in Preterm Infants|Completed||N/A|477|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 15:06:34.292678|2017-02-18 15:06:34.292678
NCT00554853|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2016-12-07|2013-12-18||November 2007||2007-11-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|RAPPAR||PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease|Peroxisome Proliferator-activated Receptor-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease|Completed||Phase 3|143|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 15:06:34.408434|2017-02-18 15:06:34.408434
NCT00554840|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2008-06-05|||November 2007||2007-11-01|June 2008|2008-06-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|||Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia|Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia|Unknown status|Enrolling by invitation|Phase 2|44|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 15:06:35.110016|2017-02-18 15:06:35.110016
NCT00554827|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2013-05-08|||August 2007||2007-08-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma|A Phase 1, Open-label Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma|Completed||Phase 1|55|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||||||||||||2017-02-18 15:06:35.208692|2017-02-18 15:06:35.208692
NCT00554814|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2008-11-14|||November 2007||2007-11-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|November 2008|Anticipated|2008-11-01||Interventional|||Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency|Interest of Biofer ® Compound Used in Blédilait Follow on Milk and Growing Milk on Iron Status Evolution in Infant With Latent Iron Deficiency|Suspended||N/A|249|Anticipated|Bledina||3||insufficient recruitment|f||||t||||||||||2017-02-18 15:06:35.320555|2017-02-18 15:06:35.320555
NCT00554801|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2014-11-12|2014-11-04||October 2007||2007-10-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional||All participants who completed the study|Central Auditory Processing Disorders Associated With Blast Exposure|Central Auditory Processing Disorders Associated With Blast Exposure|Completed||N/A|84|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:06:35.416779|2017-02-18 15:06:35.416779
NCT00554788|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2017-02-08|||February 2008||2008-02-01|February 2017|2017-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma|A Trial of Intensive Multi-Modality Therapy for Extra-Ocular Retinoblastoma|Active, not recruiting||Phase 3|60|Anticipated|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 15:06:35.732555|2017-02-18 15:06:35.732555
NCT00554775|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2011-12-09|||January 2008||2008-01-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|TACTIC||WBRT & Erlotinib in Advanced NSCLC and Brain Metastases|A Randomised Phase II Double Blind Placebo Controlled Trial of Whole Brain Radiotherapy (WBRT) and Tarceva (OSI-774, Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Multiple Brain Metastases [TACTIC]|Terminated||Phase 2|80|Actual|University College, London||2||"IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was~   not met."|f||||t||||||||||2017-02-18 15:06:36.027792|2017-02-18 15:06:36.027792
NCT00554762|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2015-02-12|||November 2007||2007-11-01|February 2015|2015-02-01|March 2008|Anticipated|2008-03-01|March 2008|Anticipated|2008-03-01||Interventional|||Dose Response and Efficacy of GW842166 in Pain|A Phase I, Placebo Controlled, Randomised, Double Blind Two-way Crossover Study to Investigate the Dose Response and Efficacy of Single and Repeat Doses of GW842166 in Healthy Volunteers Using Pharmacodynamic Pain Assessments.|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||||Compound terminated|f||||f||||||||||2017-02-18 15:06:36.146274|2017-02-18 15:06:36.146274
NCT00554749|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2010-11-18|2009-07-02||November 2007||2007-11-01|November 2010|2010-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||What Treatment Works for Children With Selective Mutism?|What Treatment Works for Children With Selective Mutism? A Treatment Pilot Study|Completed||N/A|7|Actual|Regionsenter for barn og unges psykiske helse||1|||f||||f||||||||||2017-02-18 15:06:36.226467|2017-02-18 15:06:36.226467
NCT00554736|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2015-04-20|||May 2006||2006-05-01|April 2015|2015-04-01|August 2008|Anticipated|2008-08-01|December 2007|Anticipated|2007-12-01||Interventional|||Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen|A Randomized, Double-blind, Placebo-controlled Trial of Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen|Withdrawn||Phase 3|0|Actual|University of California, Davis||1||Sponsor suspended study do to funding|f||||t||||||||||2017-02-18 15:06:36.51001|2017-02-18 15:06:36.51001
NCT00554723|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2014-04-30|||May 2007||2007-05-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|CHIMES||CHInese Medicine NeuroAid Efficacy on Stroke Recovery|A Double Blind, Placebo Controlled, Randomized, Multicenter Study to Investigate CHInese Medicine NeuroAid Efficacy on Stroke Recovery|Completed||Phase 3|1100|Actual|CHIMES Society||2|||f||||t||||||||||2017-02-18 15:06:36.624425|2017-02-18 15:06:36.624425
NCT00554710|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2007-11-06|||May 2001||2001-05-01|November 2007|2007-11-01|January 2004|Actual|2004-01-01|||||Interventional|||Top Down Versus Step Up Strategies in Crohn's Disease|The Ideal Management of Crohn's Disease: Top Down Versus Step Up Strategies. A Prospective Controlled Trial in the Benelux|Completed||Phase 4|129|Actual|Belgian IBD Research Group||2|||f||||f||||||||||2017-02-18 15:06:36.940311|2017-02-18 15:06:36.940311
NCT00554697|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2009-02-05|||November 2007||2007-11-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Diabetes Mellitus Type II and Tissue Oxygenation|Influence of Diabetes Mellitus Type II on Tissue Oxygenation in the Perioperative Period|Terminated||N/A|60|Actual|Outcomes Research Consortium|||2|Unable to recruit subjects|f||||t||||||||||2017-02-18 15:06:37.06164|2017-02-18 15:06:37.06164
NCT00554684|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2012-08-22|||July 2007||2007-07-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|||||Observational|||Treatment Intensity/Factors Predicting Short and Long Term Outcomes in Elderly Critically Ill Patients|Treatment Intensity and Factors Predicting Short and Long Term Outcomes in Elderly and Very Elderly Patients Admitted to Intensive Care Units|Completed||N/A|399|Actual|St. Luke's-Roosevelt Hospital Center|||1||f||||f||||||||||2017-02-18 15:06:37.145549|2017-02-18 15:06:37.145549
NCT00554671|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2015-04-06|2014-12-04||May 2008||2008-05-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|MEDIC-1 year||Pharmacist-led Group Medical Visits to Help With Diabetes Management|Group Intervention for DM Guideline Implementation|Completed||Phase 4|250|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:06:37.235662|2017-02-18 15:06:37.235662
NCT00554658|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2011-10-21|||March 2008||2008-03-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients|Quetiapine Induced Neuroplasticity in Schizophrenic Patients: A Combined Transcranial Magnetic Stimulation (TMS) and Voxel-based Morphometry (VBM) Study|Completed||Phase 4|30|Actual|University of Regensburg||1|||f||||f||||||||||2017-02-18 15:06:37.727141|2017-02-18 15:06:37.727141
NCT00554645|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2007-11-05|||January 2004||2004-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|GRIB-2004||GRIB Forsoeget-2004|Multi-Disciplinary Group Intervention Versus Traditional Information Towards Severely Overweight Children and Their Families -|Completed||Phase 2|45|Actual|Forskningspuljen||2|||f||||f||||||||||2017-02-18 15:06:37.83809|2017-02-18 15:06:37.83809
NCT00554632|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2007-11-06|||April 2003||2003-04-01|October 2007|2007-10-01|August 2005|Actual|2005-08-01|||||Interventional|PvP||Birth Control Pill vs Birth Control Patch Study|The Effects of Oral Contraceptive Pills vs Hormonal Patch on Coagulation Parameters|Completed||N/A|24|Actual|University of Vermont||2|||f||||t||||||||||2017-02-18 15:06:37.947798|2017-02-18 15:06:37.947798
NCT00554619|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2012-11-01|2011-10-20||February 2008||2008-02-01|October 2012|2012-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study to Evaluate GSK1325760A - a Long-Term Extension Study|Study AMB107818, Clinical Evaluation of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension (PAH)- An Open Label Study of GSK1325760A to Evaluate the Safety and Efficacy of GSK1325760A - a Long-term Extension Study -|Completed||Phase 3|21|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:06:38.055189|2017-02-18 15:06:38.055189
NCT00554606|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2012-05-01|||October 2007||2007-10-01|May 2012|2012-05-01||||August 2009|Actual|2009-08-01||Interventional|||Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis|A 54-week, Phase II, Multi-center, Open-label Extension Study to Evaluate the Efficacy, Safety and Tolerability of ACZ885 (Anti-interleukin-1B Monoclonal Antibody) in Patients With Rheumatoid Arthritis|Completed||Phase 2|115|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:06:38.521036|2017-02-18 15:06:38.521036
NCT00554580|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2010-03-29|||October 2004||2004-10-01|March 2010|2010-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|CPAP||Continuous Positive Airway Pressure for Acute Pulmonary Edema|Effect of Continuous Positive Airway Pressure on Short Term Inhospital Prognosis for Acute Pulmonary Edema|Completed||Phase 3|208|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:06:38.665008|2017-02-18 15:06:38.665008
NCT00554567|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2016-03-07|||January 2007||2007-01-01|December 2008|2008-12-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||Utilization of HIV Clinical Services in Rural India|Utilization of Decentralized HIV Testing and Care Services in Rural Maharashtra, India|Completed||Phase 3|1300|Actual|Institute of Health Management, Pachod, India||1|||f||||t||||||||||2017-02-18 15:06:38.764272|2017-02-18 15:06:38.764272
NCT00554541|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2017-01-29|||November 2007|Actual|2007-11-01|January 2017|2017-01-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Observational|||Lower Extremity Venous Hemodynamics in Obese Patients Without Clinically Significant Venous Disease|Lower Extremity Venous Hemodynamics in Obese Patients Without Clinically Significant Venous Disease|Terminated||N/A|16|Actual|The Cleveland Clinic|||3|Lack of study subjects|f||||f|f|f||||||No||2017-02-18 15:06:38.880195|2017-02-18 15:06:38.880195
NCT00554528|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2015-09-29|||May 2007||2007-05-01|September 2015|2015-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PROCERV||Arthroplasty Versus Fusion in Anterior Cervical Surgery: Prospective Study of the Impact on the Adjacent Level|Arthroplasty Versus Fusion in Anterior Cervical Surgery: Prospective Study of the Impact on the Adjacent Level|Completed||Phase 4|200|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||f||||||||||2017-02-18 15:06:38.98249|2017-02-18 15:06:38.98249
NCT00554515|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2017-02-06|||November 2006||2006-11-01|February 2017|2017-02-01|November 2018|Anticipated|2018-11-01|February 2015|Actual|2015-02-01||Interventional|SELECT||"The High-Dose Aldesleukin (IL-2) Select Trial for Patients With Metastatic Renal Cell Carcinoma"|"The High-Dose Aldesleukin (IL-2) Select Trial: A Trial Designed to Prospectively Validate Predictive Models of Response to High Dose IL-2 Treatment in Patients With Metastatic Renal Cell Carcinoma"|Active, not recruiting||Phase 2|110|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:06:39.101339|2017-02-18 15:06:39.101339
NCT00554502|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-09-21|||February 2008||2008-02-01|September 2015|2015-09-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|STOP-IgAN||Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy|Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy|Completed||Phase 3|148|Anticipated|RWTH Aachen University||2|||f||||t||||||||||2017-02-18 15:06:39.22251|2017-02-18 15:06:39.22251
NCT00554489|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2012-07-12|||July 2007||2007-07-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|November 2008|Actual|2008-11-01||Interventional|||Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy|A Feasibility Study of a Physical Activity Intervention in Older Adult Inpatients With Acute Leukemia|Completed||N/A|26|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 15:06:39.471248|2017-02-18 15:06:39.471248
NCT00554476|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2007-11-05|||January 2003||2003-01-01|November 2007|2007-11-01|April 2006||2006-04-01|||||Interventional|||Comparison of Two Combined Therapeutic Methods for Treatment of Lateral Epicondylitis|Comparison of Two Combined Therapeutic Methods for Treatment of Lateral Epicondylitis: A Randomized Clinical Trial|Terminated||Phase 4|50||Azad University of Medical Sciences||||Because the sample volume was completed during three years.|f||||t||||||||||2017-02-18 15:06:39.577976|2017-02-18 15:06:39.577976
NCT00554463|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-06|2015-10-13|2014-09-23||January 2008||2008-01-01|October 2015|2015-10-01||||August 2011|Actual|2011-08-01||Interventional||All eligible patients.|G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer|A Phase II Trial of Combined Modality Therapy With Growth Factor Support for Patients With Limited Stage Small Cell Lung Cancer|Completed||Phase 2|5|Actual|Radiation Therapy Oncology Group|This study stopped accrual early due to unmet targeted accrual goals, therefore no analyses were performed. The small number of patients would not have provided meaningful results.|1|||f||||t||||||||||2017-02-18 15:06:39.693254|2017-02-18 15:06:39.693254
NCT00554450|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2016-10-14|||March 2006||2006-03-01|October 2016|2016-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Renal Impairment in Type 2 Diabetic Subjects|The Pharmacodynamics, Pharmacokinetics, and Safety of Dapagliflozin in Type 2 Diabetic Subjects With Mild, Moderate, and Severe Renal Impairment|Completed||Phase 1|40|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:06:39.95037|2017-02-18 15:06:39.95037
NCT00554437|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2015-10-01|||May 2002||2002-05-01|November 2008|2008-11-01|June 2004|Actual|2004-06-01|||||Interventional|||Kenosha County Falls Prevention Study|Kenosha County Falls Prevention Study: An Intermediate-intensity, Community-based, Multifactorial Intervention|Completed||N/A|349|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 15:06:40.225374|2017-02-18 15:06:40.225374
NCT00554424|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-03|2007-11-05|||March 2002||2002-03-01|November 2007|2007-11-01|July 2002|Actual|2002-07-01|||||Interventional|||Local Anaesthetic for Transvaginal Egg Collection in IVF|A Randomised Controlled Trial of Intravaginal Lignocaine Injection Versus Placebo for Analgesia During Oocyte Recovery in an IVF Cycle|Completed||N/A|75|Actual|The Fertility Centre, New Zealand||2|||f||||t||||||||||2017-02-18 15:06:40.322773|2017-02-18 15:06:40.322773
NCT00554411|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2017-01-26|||November 2007||2007-11-01|January 2017|2017-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Assessing Ocular Surface Changes After Changing Glaucoma Medications|Assessing Changes at the Ocular Surface Following the Switch From Xalatan to Travatan Z.|Completed||N/A|22|Actual|University of Colorado, Denver|||1||f||||f||||||||No||2017-02-18 15:06:40.439696|2017-02-18 15:06:40.439696
NCT00554398|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2009-11-12|||November 2007||2007-11-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|||Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression|Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression|Completed||Phase 3|69|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 15:06:40.536928|2017-02-18 15:06:40.536928
NCT00554385|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2011-08-18||2011-08-18|November 2007||2007-11-01|August 2011|2011-08-01||||August 2008|Actual|2008-08-01||Interventional|||A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)|The Long-term Safety and Tolerability of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): An Open-Label Extension Study|Terminated||Phase 2|283|Actual|Abbott||1|||f||||t||||||||||2017-02-18 15:06:40.655812|2017-02-18 15:06:40.655812
NCT00554372|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-01-06|2015-05-12||August 2008||2008-08-01|October 2011|2011-10-01|February 2013|Actual|2013-02-01|December 2011|Actual|2011-12-01||Interventional|||A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma|A Phase II-a, Open-Label, Randomized Study of JX-594 (Thymidine Kinase-deleted Vaccinia Virus Plus GM-CSF) Administered by Intratumoral Injection in Patients With Unresectable Primary Hepatocellular Carcinoma|Completed||Phase 2|30|Actual|SillaJen, Inc.||2|||f||||t||||||||||2017-02-18 15:06:40.77738|2017-02-18 15:06:40.77738
NCT00554359|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-04|2011-02-22|||August 2007||2007-08-01|February 2011|2011-02-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery|A Phase I, Randomized, Double-Blind, Dose Escalation Trial of the Safety and Pharmacokinetics of a Single Intravenous Injection of I5NP in Patients Undergoing Major Cardiovascular Surgery|Completed||Phase 1|16|Actual|Quark Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:06:41.313193|2017-02-18 15:06:41.313193
NCT00554346|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-04|2010-06-20|||May 2008||2008-05-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Randomized, Double Blind, Placebo-controlled Study to Assess the the Preemptive Benefit of Etoricoxib in Patients Receiving Anterior Cruciate Ligament Reconstruction|A Randomized, Double Blind, Placebo-controlled Study to Assess the the Preemptive Benefit of Etoricoxib in Patients Receiving Anterior Cruciate Ligament Reconstruction|Completed||Phase 4|64|Anticipated|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 15:06:41.426934|2017-02-18 15:06:41.426934
NCT00554333|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2009-04-03|||October 2007||2007-10-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|||||Interventional|||Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine|An Open-Label, Multi-Centre, Randomised, Comparative Study of the Immunogenicity and Safety of an Inactivated Split-Virion Influenza Vaccine Administered by Intradermal Route (Flu-ID 15μg) Versus an Inactivated Adjuvanted Influenza Vaccine Administered by Intramuscular Route in Subjects 65 Years of Age or Older|Completed||Phase 3|790|Anticipated|MCM Vaccines B.V.||2|||f||||f||||||||||2017-02-18 15:06:41.524709|2017-02-18 15:06:41.524709
NCT00554320|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2009-09-17|||January 2009||2009-01-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain|Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain|Completed||N/A|24|Anticipated|Summa Health System||2|||f||||f||||||||||2017-02-18 15:06:41.629927|2017-02-18 15:06:41.629927
NCT00554307|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2015-01-22|||November 2007||2007-11-01|January 2015|2015-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Brain, Gut and Kidney Blood Flow During Medical Closure of PDA|Comparison of Cerebral, Renal and Mesenteric Perfusion Using Near Infrared Spectroscopy in Neonates During Patent Ductus Arteriosus Closure With Ibuprofen or Indomethacin.|Withdrawn||N/A|0|Actual|University of Louisville|||3|Not able to enroll patients|f||||f||||||||||2017-02-18 15:06:41.726617|2017-02-18 15:06:41.726617
NCT00554294|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2009-05-27|2009-03-31||April 2006||2006-04-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|June 2007|Actual|2007-06-01||Interventional|trinkfit||Promoting Water Consumption for Prevention of Overweight in School Children in a Controlled Intervention Trial|Promoting Water Consumption for Prevention of Overweight in School Children in a Controlled Intervention Trial|Completed||N/A|2950|Actual|Research Institute of Child Nutrition, Dortmund||2|||f||||||||||||||2017-02-18 15:06:41.830916|2017-02-18 15:06:41.830916
NCT00554281|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2011-09-12|||October 2006||2006-10-01|September 2011|2011-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Using Glucose Sensors to Prevent Hypoglycemia|Paradigm Real Time Continuous Glucose Monitoring Device for the Prevention of Hypoglycemia|Completed||Phase 3|16|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 15:06:42.158534|2017-02-18 15:06:42.158534
NCT00554268|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-02-17|||October 2007||2007-10-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Trial of PBI-05204 in Advanced Cancer Patients|An Open Label Phase I Trial of PBI-05204 in Advanced Cancer Patients|Completed||Phase 1|58|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:06:42.27883|2017-02-18 15:06:42.27883
NCT00554255|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2013-04-11|||October 2006||2006-10-01|April 2012|2012-04-01||||||||Interventional|||A Study of SB751689 in Japanese Postmenopausal Women|Phase I Study of SB751689 - Single and Multiple Oral Dose Study in Japanese Postmenopausal Women -|Completed||Phase 1|18|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:06:42.387504|2017-02-18 15:06:42.387504
NCT00554242|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2009-06-16|||July 2007||2007-07-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function|Chronic Study of the Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function in Patients With Coronary Artery Disease|Completed||N/A|40|Anticipated|Boston University||1|||f||||f||||||||||2017-02-18 15:06:42.473015|2017-02-18 15:06:42.473015
NCT00554229|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-01-15|2012-04-26||November 2007||2007-11-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|July 2010|Actual|2010-07-01||Interventional|ENTHUSE M1||A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases|A Phase III Trial to Test the Efficacy of ZD4054(Zibotentan), an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.|Completed||Phase 3|896|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 15:06:42.580268|2017-02-18 15:06:42.580268
NCT00553995|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2013-07-23|||May 2008||2008-05-01|July 2013|2013-07-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Effect of Salsalate on Bed Rest-Induced Vascular Dysfunction|Effect of Physical Inactivity on Endothelial Function|Unknown status|Active, not recruiting|N/A|40|Anticipated|Boston University||2|||f||||f||||||||||2017-02-18 15:06:47.416322|2017-02-18 15:06:47.416322
NCT00554216|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-03|2012-09-05|2012-07-31||November 2007||2007-11-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults|A Phase III Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Determine the Safety and Efficacy of VI-0521 in the Treatment of Obesity in an Adult Population With BMI ≥ 35|Completed||Phase 3|1267|Actual|VIVUS, Inc.||3|||f||||t||||||||||2017-02-18 15:06:43.957534|2017-02-18 15:06:43.957534
NCT00554203|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2008-05-13|||July 2003||2003-07-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Sulfasalazine and Endothelial Function|Effect of Sulfasalazine on Endothelial Function|Completed||N/A|60|Anticipated|Boston University||1|||f||||f||||||||||2017-02-18 15:06:44.581329|2017-02-18 15:06:44.581329
NCT00554190|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2009-04-22|2008-11-14||May 2007||2007-05-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel|A Prospective, Multi-Center, Randomized, Controlled, Subject-Blinded Study to Evaluate the Safety and Effectiveness of AdvaCoat Sinus Gel Following Endoscopic Ethmoid Sinus Surgery|Completed||Phase 4|29|Actual|Carbylan Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 15:06:44.674315|2017-02-18 15:06:44.674315
NCT00554177|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-03-15|||September 2007||2007-09-01|March 2016|2016-03-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|MATTER||A Clinical Trial for Post Traumatic Stress Disorder|Mifepristone After Trauma to Enhance Resilience|Completed||Phase 1|5|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||No||2017-02-18 15:06:44.950547|2017-02-18 15:06:44.950547
NCT00554164|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2016-11-08|||November 2007||2007-11-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|PETAL||Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas|Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas|Active, not recruiting||Phase 3|696|Anticipated|University Hospital, Essen||4|||f||||t||||||||||2017-02-18 15:06:45.074241|2017-02-18 15:06:45.074241
NCT00554151|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2011-06-20|||July 2007||2007-07-01|February 2010|2010-02-01|April 2010|Actual|2010-04-01|March 2009|Actual|2009-03-01||Interventional|MAARS||Mitral Adjustable Annuloplasty Ring Feasibility and Safety Study|Mitral Adjustable Annuloplasty Ring Feasibility and Safety Study (MAARS) for Treatment of Patients With Mitral Valve Regurgitation in Open Surgical Repair|Completed||N/A|55|Anticipated|St. Jude Medical||1|||f||||t||||||||||2017-02-18 15:06:45.204183|2017-02-18 15:06:45.204183
NCT00554138|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2008-09-22|||November 2007||2007-11-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||The Effect of Rosuvastatin on Adenosine Metabolism|Rosuvastatin Augments Dipyridamole Induced Vasodilation by Increased Adenosine Receptor Stimulation.|Completed||N/A|24|Actual|Radboud University||2|||f||||||||||||||2017-02-18 15:06:45.304812|2017-02-18 15:06:45.304812
NCT00554125|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2007-11-05|||August 2007||2007-08-01|October 2007|2007-10-01|August 2013|Anticipated|2013-08-01|||||Interventional|||Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria|A Prospective Randomised, Open-Labeled Study Comparing Sirolimus Versus FK506 In OLT for Patients With HCC Exceeding Milan Criteria|Unknown status|Recruiting|Phase 3|220|Anticipated|Fudan University||1|||f||||t||||||||||2017-02-18 15:06:45.414697|2017-02-18 15:06:45.414697
NCT00554112|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2011-08-10|||November 2007||2007-11-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Regulation of B-Cell Function & Glucose Tolerance in Older People|Regulation of B-Cell Function & Glucose Tolerance in Older People|Terminated||N/A|90|Anticipated|VA Office of Research and Development||3||PI left the VA, per Central Office|f||||t||||||||||2017-02-18 15:06:45.517215|2017-02-18 15:06:45.517215
NCT00554099|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2013-04-15|2011-03-14||November 2007||2007-11-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Asacol Acute Diverticulitis(DIVA)Study|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of a 12 Week Treatment of Acute Diverticulitis With Asacol® 2.4 g/Day (400 mg Mesalamine Tablet), Followed by a 9 Month Treatment-free Observation Period|Completed||Phase 2|117|Actual|Warner Chilcott||3|||f||||f||||||||||2017-02-18 15:06:45.630948|2017-02-18 15:06:45.630948
NCT00554086|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2011-05-13|||November 2005||2005-11-01|May 2011|2011-05-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|CHICS||Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.|Phase 2 Trial of Maximum Androgen Blockade (MAB) Dose Escalation From 50 mg to 150 mg Bicalutamide (Casodex) for Biochemical Failure in Prostate Cancer Patients|Completed||Phase 2|65|Actual|Canadian Urology Research Consortium||1|||f||||f||||||||||2017-02-18 15:06:46.846578|2017-02-18 15:06:46.846578
NCT00554073|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2009-08-18|||May 2008||2008-05-01|August 2009|2009-08-01|August 2009|Anticipated|2009-08-01|||||Observational|||Whole Body Magnetic Resonance Angiography in Ischemic Patients at 1.5 and 3T|Whole Body Magnetic Resonance Angiography in Patients With Symptomatic Peripheral Ischemia: A Comparison Between 1.5 and 3T MRI-systems|Suspended||N/A|12|Anticipated|Copenhagen University Hospital at Herlev|||1|"It was not possible to perform 2 MRI studies in each patient due to practical problems. The~   study was not suspended due to safety issues."|f||||t||||||||||2017-02-18 15:06:46.93604|2017-02-18 15:06:46.93604
NCT00554047|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2011-01-07|||December 2007||2007-12-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|||||Interventional|AD-Euro||Comparison of Effectiveness and Costs of Post-diagnosis Treatment in Dementia|Effectiveness and Costs of Post-diagnosis Treatment in Dementia Coordinated by Multidisciplinary Memory Clinics in Comparison to Treatment Coordinated by General Practitioners|Completed||N/A|220|Anticipated|Radboud University||2|||f||||f||||||||||2017-02-18 15:06:47.025098|2017-02-18 15:06:47.025098
NCT00554034|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2010-12-19|||November 2007||2007-11-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Herbal Extracts on Gingival Inflammation|The Effect of Herbal Extracts on Inflammatory Enzymes in the Gingiva: a Dose Finding Study.|Completed||Phase 2|60|Anticipated|Shaare Zedek Medical Center||1|||f||||||||||||||2017-02-18 15:06:47.139293|2017-02-18 15:06:47.139293
NCT00554021|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2009-06-10|||November 2007||2007-11-01|June 2009|2009-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|CVL||Infections Related Central Venous Catheters|Infections Associated With the Use of Central Venous Catheters Related in Critical Care Center.|Completed||N/A|60|Anticipated|National Defense Medical College, Japan|||1||f||||t||||||Samples With DNA|"~     We will use the DNA from the only clinical isolated bacteria.~   "|||2017-02-18 15:06:47.225443|2017-02-18 15:06:47.225443
NCT00553969|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2014-12-09|2013-12-16||November 2007||2007-11-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|DETECT||Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease|Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease. DETECT (DEtection and Treatment of Early Cardiovascular Disease Trial)|Completed||Phase 1/Phase 2|101|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||f||||||||||2017-02-18 15:06:50.129775|2017-02-18 15:06:50.129775
NCT00553956|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2007-11-05|||August 2007||2007-08-01|November 2007|2007-11-01|February 2009|Anticipated|2009-02-01|||||Interventional|||A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Rwandan Genocide|Phase 1:Epidemiological Study of PTSD and Comorbid Disorders in Widows and Orphans Who Experienced the Rwandan Genocide Phase 2: A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Genocide Carried Out by Trained Local Psychologists -NET/IPT Versus Waiting List-|Unknown status|Recruiting|Phase 1|150|Anticipated|University of Konstanz||2|||f||||||||||||||2017-02-18 15:06:50.69926|2017-02-18 15:06:50.69926
NCT00553943|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2010-10-22|||July 2007||2007-07-01|October 2010|2010-10-01|June 2013|Anticipated|2013-06-01|June 2011|Anticipated|2011-06-01||Interventional|||Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis|Prospective Multicentre Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® by Intrathecal Injection in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis|Unknown status|Recruiting|Phase 2|106|Anticipated|Lymphoma Study Association||1|||f||||t||||||||||2017-02-18 15:06:50.79216|2017-02-18 15:06:50.79216
NCT00553930|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-03|2010-05-16|||November 2007||2007-11-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|SAEI_IFN_1||Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients|Efficacy of Low Dose Pegylated Interferon-α 2a Plus Ribavirin for the Treatment of Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients.|Completed||Phase 4|71|Anticipated|Sociedad Andaluza de Enfermedades Infecciosas||1|||f||||t||||||||||2017-02-18 15:06:50.922595|2017-02-18 15:06:50.922595
NCT00553917|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2011-06-21|||November 2007||2007-11-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|||||Observational|||Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes|Study of the Pharmacokinetics and Pharmacogenetics of Selective Serotonin Reuptake Inhibitors During Pregnancy|Terminated||N/A|18|Actual|Indiana University|||4|Poor recruitment to experimental arms and study remained unfunded|f||||t||||||Samples With DNA|"~     whole Blood Plasma human milk~   "|||2017-02-18 15:06:51.033175|2017-02-18 15:06:51.033175
NCT00553904|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2009-06-16|||February 2008||2008-02-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Cranberry Juice on Endothelial Function|Long-Term Effects of Cranberry Juice on Endothelial Function in Patients With Coronary Artery Disease|Completed||N/A|40|Anticipated|Boston University||1|||f||||f||||||||||2017-02-18 15:06:51.12307|2017-02-18 15:06:51.12307
NCT00553891|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2015-08-12|||May 2006||2006-05-01|August 2015|2015-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED)|Double Blind, Placebo Controlled Trial, Evaluating the Role of Nasonex® in the Management of Nasal Obstruction Secondary to Adenoids Hypertrophy in Children|Terminated||Phase 4|285|Anticipated|Merck Sharp & Dohme Corp.||2||No enrollment because of war in the study country.|f||||f||||||||||2017-02-18 15:06:51.210593|2017-02-18 15:06:51.210593
NCT00553878|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2016-10-13|||March 2007||2007-03-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|September 2009|Actual|2009-09-01||Interventional|AVIAS||Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer|Multi Center Double Blind Study Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Intermittent Androgen Ablation Therapy for Prostate Cancer|Completed||Phase 2/Phase 3|100|Anticipated|Canadian Urology Research Consortium||1|||f||||t||||||||Yes|plan to share in publication|2017-02-18 15:06:51.528553|2017-02-18 15:06:51.528553
NCT00553865|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-03|2016-06-27|||November 2007||2007-11-01|September 2014|2014-09-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets|A 8-Week, Randomized, Double-blind, Parallel Designed, Phase II Multi-center Clinical Trial to Evaluate the Antihypertensive Efficacy and the Safety of OJP-2028 Tablets in Patients With the Uncomplicated Essential Hypertension|Completed||Phase 2|120|Actual|Jeil Pharmaceutical Co., Ltd.||5|||f||||f||||||||No||2017-02-18 15:06:51.648484|2017-02-18 15:06:51.648484
NCT00553852|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2008-03-27|||July 2007||2007-07-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|GH&LASGB||Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity|Evaluation of GH/IGF-I Axis and of Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity: Relationships With Body Composition|Completed||Phase 3|24|Actual|Federico II University||2|||f||||t||||||||||2017-02-18 15:06:51.756686|2017-02-18 15:06:51.756686
NCT00553839|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2016-02-04|2016-02-04||July 2007||2007-07-01|August 2014|2014-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||Children between 6 months to 18 years of age with cardiac diseases in order to rationalize an effective 2-h anesthetic medication personalized based on cardiac function and age|Pharmacokinetics of Ketamine in Infants and Children|Pharmacokinetics of Ketamine in Infants and Children|Completed||N/A|21|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 15:06:51.877918|2017-02-18 15:06:51.877918
NCT00553813|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-01-09||2012-07-16|October 2007||2007-10-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|September 2009|Actual|2009-09-01||Interventional|||A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer|A Phase 2, Open Label, Single Arm Trial of TPI 287 in Patients With Advanced, Unresectable Pancreatic Cancer After Prior Treatment With a Gemcitabine-based Therapy|Terminated||Phase 2|23|Actual|Cortice Biosciences, Inc.||1||Insufficient funding|f||||||||||||||2017-02-18 15:06:52.134312|2017-02-18 15:06:52.134312
NCT00553800|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2016-02-04|||March 2007||2007-03-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|October 2013|Actual|2013-10-01||Interventional|NSCLC||Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer|Phase II Study of Bevacizumab and Erlotinib in Elderly Patients With Advanced Non-Small Lung Cancer|Active, not recruiting||Phase 2|33|Anticipated|Fox Chase Cancer Center||1|||f||||f||||||||||2017-02-18 15:06:52.239676|2017-02-18 15:06:52.239676
NCT00553787|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-03|2012-09-05|2012-07-31||November 2007||2007-11-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions|A Phase III Randomized, Double-Blind, Placebo Controlled Multicenter Study to Determine the Safety and Efficacy of VI-0521 in the Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions|Completed||Phase 3|2487|Actual|VIVUS, Inc.||3|||f||||t||||||||||2017-02-18 15:06:52.364118|2017-02-18 15:06:52.364118
NCT00553774|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-10-25|||March 2007||2007-03-01|October 2016|2016-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|Cocoa||Effect of Cocoa Flavanols on Vascular Function|Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation|Completed||Phase 1|16|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:06:53.08352|2017-02-18 15:06:53.08352
NCT00553761|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2011-08-04|||August 2006||2006-08-01|November 2007|2007-11-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Observational|||PERG and mfPERG in Band Atrophy|Pattern Electroretinogram and Multifocal Pattern Electroretinogram For the Detection of Neural Loss in Patients With Permanent Temporal Visual Field Defect From Chiasmal Compression|Completed||N/A|30|Anticipated|University of Sao Paulo|||1||f||||f||||||||||2017-02-18 15:06:53.179532|2017-02-18 15:06:53.179532
NCT00553748|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2008-07-01|||November 2007||2007-11-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Phase I, Open Label, Single Center Safety Study of [F-18]FLT|A Phase I, Open Label, Single Center Safety Study of [F-18]FLT|Completed||Phase 1|11|Actual|Siemens Molecular Imaging||1|||f||||f||||||||||2017-02-18 15:06:53.258164|2017-02-18 15:06:53.258164
NCT00553735|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2012-04-19|||August 2007||2007-08-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye|The Prophylactic Use of Topical Cyclosporine A 0.05% (Restasis) to Prevent Onset and Progression of Graft-versus-host Disease-related Dry Eye|Completed||Phase 4|8|Actual|Massachusetts Eye and Ear Infirmary||1|||f||||f||||||||||2017-02-18 15:06:53.35415|2017-02-18 15:06:53.35415
NCT00553722|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-05|2007-11-05|||November 2007||2007-11-01|October 2007|2007-10-01|November 2009|Anticipated|2009-11-01|||||Interventional|||Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?|Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?|Unknown status|Not yet recruiting|Phase 4|27|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-02-18 15:06:53.447652|2017-02-18 15:06:53.447652
NCT00553709|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2009-09-28|||October 2007||2007-10-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|NicoPONV||Study of Nicotine for the Prevention of PONV|The Role of Transcutaneous Nicotine in the Prevention of Postoperative Nausea and Vomiting in Non-smokers|Terminated||Phase 2|200|Anticipated|University Hospital, Geneva||2||Unexpected difficult recruitment. Study drug expired|f||||t||||||||||2017-02-18 15:06:53.770854|2017-02-18 15:06:53.770854
NCT00553696|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2015-03-03|2015-03-03||November 2007||2007-11-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|July 2009|Actual|2009-07-01||Interventional|||Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer|A Phase 1 Study Of Sunitinib In Combination With S-1 And Cisplatin In Patients With Advanced Or Metastatic Gastric Cancer|Completed||Phase 1|27|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 15:06:53.893193|2017-02-18 15:06:53.893193
NCT00553683|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-01-11|||October 2007||2007-10-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|February 2014|Anticipated|2014-02-01||Interventional|||Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer|Phase I/II Study of Autologous Tumor Cell Vaccination Using Metronomic Cyclophosphamide, 3-Dimensional Conformal Radiotherapy, Intra/Peri-Tumor Injection of Poly ICLC With Trans-Hepatic Arterial Embolization Followed by Poly ICLC Boosting in Patients With Unresectable, Recurrent, or Metastatic Cancers in the Liver (Hepatoma, Cholangiocarcinoma, Neuroendocrine, Breast, Colon, Gastric, and Esophageal Cancer)|Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Anticipated|Rutgers, The State University of New Jersey||1|||f||||||||||||||2017-02-18 15:06:55.058182|2017-02-18 15:06:55.058182
NCT00553670|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2011-03-28|||November 2007||2007-11-01|March 2011|2011-03-01|May 2009|Actual|2009-05-01|||||Observational|PRESSURE||Mechanism and Predictor of Side Branch Jailing|Predictor and Mechanism of a Side Branch Jail After Main Branch Stent Implantation in Bifurcation Lesions|Completed||N/A|100|Anticipated|Seoul National University Hospital|||1||f||||t||||||||||2017-02-18 15:06:55.188834|2017-02-18 15:06:55.188834
NCT00553657|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2010-10-13||2010-10-13|August 2007||2007-08-01|October 2010|2010-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Standardization of Fluid Intake on the Variability of Measured Voiding Parameters in Female Patients With Idiopathic Overactive Bladder|Completed||Phase 1|55|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:06:55.260433|2017-02-18 15:06:55.260433
NCT00553644|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-11-29|2014-01-06||November 2007||2007-11-01|October 2016|2016-10-01||||December 2012|Actual|2012-12-01||Interventional|||Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma|A Phase II Trial of Bortezomib (NSC #681239) + Lenalidomide (Revlimid™, CC-5013) (NSC #703813) for Relapsed/Refractory Mantle Cell Lymphoma|Active, not recruiting||Phase 2|53|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:06:55.351872|2017-02-18 15:06:55.351872
NCT00553631|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2015-07-16|2010-07-12||January 2008||2008-01-01|February 2014|2014-02-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease|A Multicenter, Randomized, Double-Blind, Parallel-Group Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy Compared With Imiglucerase in Patients With Type I Gaucher Disease|Completed||Phase 3|34|Actual|Shire|Participants aged 2-4 years: 4 participants (23.5%) in imiglucerase group and 0 participants in GA-GCB group.|2|||f||||f||||||||||2017-02-18 15:06:56.073652|2017-02-18 15:06:56.073652
NCT00553618|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2016-11-21|||August 2007||2007-08-01|November 2016|2016-11-01|August 2020|Anticipated|2020-08-01|August 2017|Anticipated|2017-08-01||Interventional|DTIC||Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients|Adjuvant Interleukin2 (Proleukin)and 5-(3,3 Dimethyl-1-Triazeno) Imidazole-4-Carboxamide (DTIC) in Resected High-Risk Primary and Regionally Metastatic Melanoma|Active, not recruiting||Phase 2|160|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-02-18 15:06:56.967735|2017-02-18 15:06:56.967735
NCT00553605|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2012-12-20|2012-12-20||June 2007||2007-06-01|December 2012|2012-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|NAP||Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic|A Double-Blind, Double-Dummy, Randomized, Multicenter Study Comparing The Analgesic Efficacy And Safety Of Parecoxib 40mg I.V. To Ketoprofen 100mg I.V. In Renal Colic|Completed||Phase 4|340|Actual|Pfizer|PR at all time points, proportion of participants with >= 1 grade improvement in PR 30 min were replaced by PR at 30 and 120 min; number of participants with response in PI included; time to RM reported as number, due to change in planned analysis.|2|||f||||f||||||||||2017-02-18 15:06:57.086121|2017-02-18 15:06:57.086121
NCT00553592|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2007-11-02|||September 2007||2007-09-01|November 2007|2007-11-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes|A Double-Blind, Randomized, Placebo-Controlled, Parallel, Multicenter Study of the Safety and Efficacy of Two Dosages of Bicifadine SR in Adult Outpatients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|Unknown status|Recruiting|Phase 2|336|Anticipated|XTL Biopharmaceuticals||3|||f||||f||||||||||2017-02-18 15:06:57.852231|2017-02-18 15:06:57.852231
NCT00553579|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2008-05-19|||June 2007||2007-06-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||The Relationship of Residence Time and Visual Effect of Optive and Systane in Dry Eye Subjects|The Relationship of Residence Time and Visual Effect of Optive and Systane in Dry Eye Subjects|Completed||N/A|18|Anticipated|Southern California College of Optometry|||1||f||||f||||||||||2017-02-18 15:06:57.946958|2017-02-18 15:06:57.946958
NCT00553566|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-01-09|||December 2005||2005-12-01|February 2010|2010-02-01||||||||Observational|||Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer|Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [COHORT]|Unknown status|Recruiting|Phase 3|1600||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:06:58.025644|2017-02-18 15:06:58.025644
NCT00553553|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2008-12-30|||September 2007||2007-09-01|December 2008|2008-12-01|June 2008|Anticipated|2008-06-01|May 2008|Anticipated|2008-05-01||Interventional|RITM-IVM||Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery|Efficacy Of IV Morphine vs Remifentanil-Intrathecal Morphine Analgesia During Hepatic Resection Surgery|Unknown status|Recruiting|N/A|45|Anticipated|St Vincent's University Hospital, Ireland||2|||f||||f||||||||||2017-02-18 15:06:58.120437|2017-02-18 15:06:58.120437
NCT00553540|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2015-02-19|||October 2006||2006-10-01|June 2008|2008-06-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|||A Randomized Prospective Study to Evaluate the Effectiveness of Orthopedic Spinal Supports in the Treatment of Low Back Pain|A Randomized Prospective Study to Evaluate the Effectiveness of Orthopedic Spinal Supports in the Treatment of Low Back Pain|Completed||N/A|50|Actual|Cleveland Clinic Florida||2|||f||||t||||||||||2017-02-18 15:06:58.23364|2017-02-18 15:06:58.23364
NCT00553527|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2009-08-05|||July 2007||2007-07-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Biomet Humeral Stem Data Collection|Biomet Humeral Stem Data Collection|Terminated||N/A|2|Actual|Vanderbilt University||1||Sponsor decided to terminate the project due to low multi-center enrollment.|f||||f||||||||||2017-02-18 15:06:58.34487|2017-02-18 15:06:58.34487
NCT00553514|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2014-01-20|2013-05-29||December 2007||2007-12-01|January 2014|2014-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||AS900672-Enriched in Ovulation Induction|A Phase II, Multicentre, Randomised, Assessor-blinded, Active-comparator, Parallel-group Dose Finding Trial to Evaluate AS900672-enriched Versus Follitropin Alfa (GONAL-f®) in Oligo-anovulatory Infertile Women Undergoing Ovulation Induction (OI)|Terminated||Phase 2|71|Actual|Merck KGaA|The study was terminated after Merck Serono had taken the decision not to pursue the development of AS900672-enriched in ovulation induction|5||"The study was terminated after Merck Serono had taken the decision not to pursue the~   development of AS900672-enriched in ovulation induction"|f||||||||||||||2017-02-18 15:06:58.438282|2017-02-18 15:06:58.438282
NCT00553501|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-07-01|2014-06-26||March 2008||2008-03-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2010|Actual|2010-07-01||Interventional|||Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma|A Phase II Trial of Extended Induction Epratuzumab (Anti-CD22 Monoclonal Antibody) (CALGB IND #XXXXX) Plus Rituximab in Previously Untreated Follicular Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|60|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:06:59.453511|2017-02-18 15:06:59.453511
NCT00553488|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2008-08-21|||September 2007||2007-09-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating|A Mono Center Open Labeled, Randomized Study Examining the Effects of Intra-Dermal vs Subcutaneous Application of Regular Insulin or Rapid Acting Insulin Analogue on Postprandial Glycemic Excursions in Patients With Type 1 Diabetes|Completed||Phase 2|30|Actual|Becton, Dickinson and Company||5|||f||||f||||||||||2017-02-18 15:06:59.962416|2017-02-18 15:06:59.962416
NCT00553475|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2010-07-16|2010-03-10||October 2007||2007-10-01|July 2010|2010-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy|Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin (CI-1008) In The Treatment For Pain Associated With Diabetic Peripheral Neuropathy|Completed||Phase 3|314|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 15:07:00.09987|2017-02-18 15:07:00.09987
NCT00553462|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-11-23|2016-11-23||March 2008||2008-03-01|November 2016|2016-11-01||||January 2014|Actual|2014-01-01||Interventional||Three participants did not receive any protocol treatment and were excluded from all analyses.|Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery|A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|78|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:07:02.085413|2017-02-18 15:07:02.085413
NCT00553449|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2011-05-16|||July 2004||2004-07-01|March 2010|2010-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.|A Randomised, Controlled, Parallel-group, Open-label Study to Evaluate Different Dosing Regimens of Rabeprazole in Controlling Nocturnal Heartburn Symptoms in Patients With Gastroesophageal Reflux Disease.|Completed||Phase 3|48|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 15:07:03.06086|2017-02-18 15:07:03.06086
NCT00553423|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2007-11-02|||November 2007||2007-11-01|October 2007|2007-10-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage|Randomized Double Blind Placebo Controlled Trial of Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage|Unknown status|Recruiting|Phase 3|128|Anticipated|Aga Khan University||2|||f||||t||||||||||2017-02-18 15:07:03.469474|2017-02-18 15:07:03.469474
NCT00553410|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-09-26|||August 2007||2007-08-01|September 2016|2016-09-01||||December 2021|Anticipated|2021-12-01||Interventional|SOLE||Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer|SOLE, Study of Letrozole Extension, A Phase III Trial Evaluating the Role of Continuous Letrozole Versus Intermittent Letrozole Following 4 to 6 Years of Prior Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone-Receptor Positive, Node Positive Early Stage Breast Cancer|Active, not recruiting||Phase 3|4884|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-02-18 15:07:03.582068|2017-02-18 15:07:03.582068
NCT00553397|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2013-06-05|||October 2007||2007-10-01|June 2013|2013-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Live Lung Donor Retrospective Study|Live Lung Donor Retrospective Study (RELIVE-02)|Completed||N/A|369|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||||||2017-02-18 15:07:03.878234|2017-02-18 15:07:03.878234
NCT00553384|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2012-02-16|||December 2007||2007-12-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Physiological Effects of Androstadienone Exposure|Physiological Effects of Androstadienone Exposure|Completed||N/A|68|Actual|Rockefeller University|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 15:07:03.983213|2017-02-18 15:07:03.983213
NCT00553371|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2013-08-23|||April 2006||2006-04-01|October 2007|2007-10-01||||||||Observational|||Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer|Assessment of the Utility of CT Follow Up in the Long Term Follow Up of Patients With Metastatic Non Seminomatous Germ Cell Tumour (NSGCT)|Unknown status|Recruiting|N/A|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:07:04.070537|2017-02-18 15:07:04.070537
NCT00553358|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2016-08-15|2011-05-26||January 2008||2008-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|May 2010|Actual|2010-05-01||Interventional|Neo ALTTO||Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study|Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study: A Randomised, Multicenter Open-label Phase III Study of Neoadjuvant Lapatinib, Trastuzumab and Their Combination Plus Paclitaxel in Women With HER2/ErbB2 Positive Primary Breast Cancer|Active, not recruiting||Phase 3|455|Actual|Novartis||3|||f||||t||||||||||2017-02-18 15:07:04.171948|2017-02-18 15:07:04.171948
NCT00553345|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-01-09|||December 2005||2005-12-01|February 2010|2010-02-01||||||||Interventional|||Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer|Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [TREATMENT]|Unknown status|Recruiting|Phase 3|515||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:07:08.504224|2017-02-18 15:07:08.504224
NCT00553332|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-03-22|2015-09-11||November 2007||2007-11-01|March 2016|2016-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||All patients had metastatic disease.|Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery|A Phase 2 Study of AZD6244 in Biliary Cancers|Completed||Phase 2|29|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:07:08.598422|2017-02-18 15:07:08.598422
NCT00553319|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-05-16|2014-08-20||December 2007||2007-12-01|May 2016|2016-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|CAMP|Description of 126 participants randomized to study arms.|Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence|A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence|Completed||Phase 2/Phase 3|139|Actual|New York State Psychiatric Institute|The dropout rate was relatively low, however, there were dropouts, and this does introduce uncertainly into the outcome assessment. Since all patients received CBT we cannot conclude whether CBT is necessary to derive benefit from the medication.|3|||f||||t||||||||||2017-02-18 15:07:09.208233|2017-02-18 15:07:09.208233
NCT00553306|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2017-02-13||2017-02-13|September 2007||2007-09-01|February 2017|2017-02-01|March 2012|Actual|2012-03-01|August 2010|Actual|2010-08-01||Interventional|||Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma|Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following Cyclophosphamide Conditioning For Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|10|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 15:07:09.84448|2017-02-18 15:07:09.84448
NCT00553293|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2007-11-02|||August 2003||2003-08-01|November 2007|2007-11-01|November 2004|Actual|2004-11-01|||||Interventional|||Nordic Luveris Study|Recombinant LH Supplementation to Recombinant FSH During the Final Days of Controlled Ovarian Stimulation for IVF: a Multicentre, Prospective, Randomized, Controlled Trial|Completed||Phase 4|526|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 15:07:09.958908|2017-02-18 15:07:09.958908
NCT00553280|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2011-04-22|2010-12-07||February 2008||2008-02-01|April 2011|2011-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy|An Open-Label Extension Safety And Efficacy Study Of Pregabalin (CI-1008) For Pain Associated With Diabetic Peripheral Neuropathy|Completed||Phase 3|123|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:07:10.070737|2017-02-18 15:07:10.070737
NCT00553267|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2013-12-16|2009-11-18||November 2007||2007-11-01|December 2013|2013-12-01||||October 2008|Actual|2008-10-01||Interventional|||Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension|An Eight-week Randomised, Double-blind Study to Compare the Fixed-dose Combination of Telmisartan 40mg + Amlodipine 10mg Versus Telmisartan 80mg + Amlodipine 10mg Versus Amlodipine 10mg Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Amlodipine 10mg Monotherapy|Completed||Phase 3|947|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:07:10.428376|2017-02-18 15:07:10.428376
NCT00553072|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-10-12|||September 2004||2004-09-01|November 2013|2013-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|Magsulf||Magnesium Sulphate in Perinatal Asphyxia|Magnesium Sulphate in Perinatal Asphyxia: A Randomized Placebo Controlled Trial.|Completed||Phase 3|40|Actual|Sheri Kashmir Institute of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:07:14.005293|2017-02-18 15:07:14.005293
NCT00553254|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-08-06||2011-11-15|February 2008||2008-02-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|August 2010|Actual|2010-08-01||Interventional|||Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer|A Phase 1/2, Open Label, Single Arm Trial To Determine The Recommended Phase 2 Dose And Evaluate The Efficacy Of Pf 00299804 In Patients In Korea With Kras Wild Type Advanced NSCLC, Which Is Refractory To Chemotherapy And Erlotinib Or Gefitinib|Completed||Phase 1/Phase 2|55|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:07:11.379898|2017-02-18 15:07:11.379898
NCT00553241|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2009-01-29|||June 2007||2007-06-01|January 2009|2009-01-01|January 2009|Anticipated|2009-01-01|||||Observational|||Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score|Phase 1 of Clinical Trial of Risk Factor, Prognosis, Imaging and Standard Management of Transient Ischemic Attack.|Unknown status|Recruiting|N/A|1|Anticipated|Capital Medical University|||1||f||||f||||||||||2017-02-18 15:07:11.48451|2017-02-18 15:07:11.48451
NCT00553228|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-06-22|||November 2007||2007-11-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Pertussis Maternal Immunization Study|Immunization of Women With Diphtheria and Tetanus Toxoids Combined With Acellular Pertussis (Tdap) During the Mid Third Trimester of Pregnancy: An Evaluation of the Potential for Immunological Protection for the Neonate|Active, not recruiting||Phase 2/Phase 3|440|Anticipated|Dalhousie University||2|||f||||t||||||||||2017-02-18 15:07:11.586748|2017-02-18 15:07:11.586748
NCT00553215|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-01-09|||December 2005||2005-12-01|February 2010|2010-02-01||||||||Observational|||Quality of Life in Patients With Bladder Cancer|Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [QOL]|Unknown status|Recruiting|Phase 3|2700||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:07:11.696673|2017-02-18 15:07:11.696673
NCT00553202|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-07-01|||January 2008||2008-01-01|July 2016|2016-07-01||||June 2016|Actual|2016-06-01||Interventional|||Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia|Killer Immunoglobulin-like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Cell Transplantation (SCT) for AML With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory and Relapsed Acute Myelogenous Leukemia (AML) in Children: A Children's Oncology Group (COG) Study|Active, not recruiting||Phase 2|158|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 15:07:11.793464|2017-02-18 15:07:11.793464
NCT00553189|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2017-01-24|||August 9, 2007||2007-08-09|September 28, 2011|2011-09-28|September 28, 2011|Actual|2011-09-28|February 1, 2008|Actual|2008-02-01||Interventional|||Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas|A Phase I Study of ABT-888 in Combination With Topotecan Hydrochloride in Adults With Refractory Solid Tumors and Lymphomas|Completed||Phase 1|31|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:07:12.003724|2017-02-18 15:07:12.003724
NCT00553176|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2013-03-01|||August 1999||1999-08-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|TREAT||The Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry|Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry|Completed||Phase 4|6273|Actual|Janssen Biotech, Inc.|||1||f||||f||||||||||2017-02-18 15:07:12.104723|2017-02-18 15:07:12.104723
NCT00553163|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2013-11-07|||October 2007||2007-10-01|November 2013|2013-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial|Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial|Terminated||N/A|29|Actual|Queen Mary University of London||2||Unable to recruit sufficient numbers of patinets in the time available|f||||t||||||||||2017-02-18 15:07:12.207026|2017-02-18 15:07:12.207026
NCT00553150|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-11-14|2016-11-14||March 2009||2009-03-01|November 2016|2016-11-01||||January 2012|Actual|2012-01-01||Interventional|||Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma|Phase I/II Evaluation of Everolimus (RAD001), Radiation and Temozolomide (TMZ) Followed by Adjuvant Temozolomide and Everolimus in Newly Diagnosed Glioblastoma|Active, not recruiting||Phase 1/Phase 2|122|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:07:12.348795|2017-02-18 15:07:12.348795
NCT00553137|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2008-05-02|||November 2006||2006-11-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|SDVS2WK||Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania|Oral Candidiasis in HIV Infected Individuals in Tanzania|Completed||Phase 4|220|Actual|Netherlands Organisation for Scientific Research||2|||f||||t||||||||||2017-02-18 15:07:13.417181|2017-02-18 15:07:13.417181
NCT00553124|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-01-09|||December 2005||2005-12-01|October 2007|2007-10-01||||||||Interventional|||Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer|Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial)|Unknown status|Recruiting|Phase 3|3400||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:07:13.527254|2017-02-18 15:07:13.527254
NCT00553111|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2007-11-02|||November 2006||2006-11-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Video Tool to Promote Knowledge of Syphilis as Facilitator of HIV Transmission|Video Tool to Promote Knowledge of Syphilis as Facilitator of HIV Transmission|Completed||N/A|168|Actual|Jacobi Medical Center||4|||f||||||||||||||2017-02-18 15:07:13.639309|2017-02-18 15:07:13.639309
NCT00553098|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2016-02-26|||June 2006||2006-06-01|February 2016|2016-02-01||||March 2015|Actual|2015-03-01||Interventional|||Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders|Hematopoietic Cell Transplantation for Treatment of Patients With Primary Immunodeficiencies and Other Nonmalignant Inherited Disorders Using Low-Dose TBI and Fludarabine With or Without Campath®|Active, not recruiting||Phase 2|29|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 15:07:13.752851|2017-02-18 15:07:13.752851
NCT00553085|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-06-19|||September 2007||2007-09-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|December 2009|Actual|2009-12-01||Observational|||Anxiety Disorders in Children - Association With Neurodevelopmental Delay/Disorder|Anxiety Disorders in Children - Association With Neurodevelopmental Delay/Disorder and Temperament/Personality. A Clinical Case-control Study|Completed||N/A|141|Actual|Regionsenter for barn og unges psykiske helse|||3||f||||f||||||Samples Without DNA|"~     Saliva for measuring Cortisol~   "|||2017-02-18 15:07:13.899369|2017-02-18 15:07:13.899369
NCT00379184|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2014-03-28|||September 2006||2006-09-01|March 2014|2014-03-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Observational|||Sensitization in Osteoarthritic Knees|Quantitative Assessment of Central Sensitization in Osteoarthritis Patients|Completed||N/A|72|Actual|Northern Orthopaedic Division, Denmark|||3||f||||f||||||||||2017-02-18 16:14:23.20289|2017-02-18 16:14:23.20289
NCT00553059|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-02|2014-09-04|||May 2008||2008-05-01|September 2014|2014-09-01||||August 2014|Actual|2014-08-01||Interventional|||Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer|Randomized, Double-Blind, Placebo-Controlled Trial of Palonosetron/Dexamethasone With or Without Dronabinol for the Prevention of Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy|Completed||Phase 3|62|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:07:14.114314|2017-02-18 15:07:14.114314
NCT00553046|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-02-03|||January 2005||2005-01-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Observational|||Last 3 Months of Life in Home Ventilated Patients|Italian Multicenter Survey on the Last 3 Months of Life in Patients Ventilated at Home|Completed||N/A|180|Actual|Fondazione Salvatore Maugeri|||1||f||||f||||||||||2017-02-18 15:07:14.24096|2017-02-18 15:07:14.24096
NCT00553033|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2007-11-01|||September 2005||2005-09-01|October 2007|2007-10-01|December 2008|Anticipated|2008-12-01|||||Observational|||Laparoscopic Liver Resection|Prospective Evaluation of Laparoscopic Liver Resection|Unknown status|Recruiting|N/A|40|Anticipated|IRCCS San Raffaele|||1||f||||||||||||||2017-02-18 15:07:14.350335|2017-02-18 15:07:14.350335
NCT00553020|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2007-10-31|||April 2004||2004-04-01|October 2007|2007-10-01|July 2005|Actual|2005-07-01|||||Interventional|||Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes|Assessment of Duration of Metabolic Effect of a Single Bolus of Subcutaneous Injected Lantus Compared to NPH-Insulin(Protaphan)in Patients With Type 2 Diabetes|Completed||Phase 4|16|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:07:14.451928|2017-02-18 15:07:14.451928
NCT00553007|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2007-11-01|||October 2007||2007-10-01|October 2007|2007-10-01|October 2009|Anticipated|2009-10-01|||||Interventional|||The Relation Between Periodontal Disease and Metabolic Syndrome|The Relation Between Periodontal Disease and Metabolic Syndrome|Unknown status|Recruiting|N/A|80|Anticipated|Aichi Gakuin University||1|||f||||f||||||||||2017-02-18 15:07:14.531771|2017-02-18 15:07:14.531771
NCT00552994|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2010-07-09|||August 2007||2007-08-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|DIABEDES IV||Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients|A Danish Prospective Randomized Multicenter Comparison of the Xience V and the Cypher Select+ Stents in Unselective Patients With Diabetes Mellitus. An Intravascular Ultrasound Study.|Completed||N/A|150|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-02-18 15:07:14.612983|2017-02-18 15:07:14.612983
NCT00552981|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2012-07-09|||November 2007||2007-11-01|July 2012|2012-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|HELI||Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study)|Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study)|Completed||N/A|157|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 15:07:14.717688|2017-02-18 15:07:14.717688
NCT00552968|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-10-12|||September 2007||2007-09-01|October 2016|2016-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Pain Prevalence in the Trauma Population|Pain Prevalence in the Trauma Population at Sunnybrook Hospital|Completed||N/A|44|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 15:07:14.815535|2017-02-18 15:07:14.815535
NCT00552955|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2017-01-24|||October 26, 2007||2007-10-26|March 21, 2016|2016-03-21|March 21, 2016||2016-03-21|||||Observational|||Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women|Effect of Fasting on the Size of Lymphangioleiomyomas in Patients With Lymphangioleiomyomatosis|Completed||N/A|35|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:07:14.89713|2017-02-18 15:07:14.89713
NCT00552942|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2007-11-01|||July 2006||2006-07-01|November 2007|2007-11-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices|Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices|Unknown status|Recruiting|Phase 3|40|Anticipated|Legacy Health System||2|||f||||f||||||||||2017-02-18 15:07:14.986205|2017-02-18 15:07:14.986205
NCT00552929|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-05-05|||October 2005||2005-10-01|May 2016|2016-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Bridging Trial Comparing Org 25969 at 1-2 PTC in Japanese and Caucasian Subjects. Part B: Caucasian Subjects (19.4.209B)(P05974)|A Multi -Center, Randomized, Open -Label, Prospective Bridging, Parallel Dose-Finding Trial Comparing Efficacy, Safety and Pharmacokinetics of 4 Doses of Org 25969 and Placebo Administered at 1-2 PTC After Rocuronium or Vecuronium in Japanese and Caucasian Subjects. Part B: Caucasian Subjects.|Completed||Phase 2|100|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:07:15.075316|2017-02-18 15:07:15.075316
NCT00552916|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2008-08-19|||October 2007||2007-10-01|August 2008|2008-08-01|November 2010|Anticipated|2010-11-01|October 2010|Anticipated|2010-10-01||Interventional|||Functional Electrical Stimulation (FES) Assisted Walking: Enhancement of Walking Function After Stroke|Functional Electrical Stimulation (FES)-Assisted Walking: Enhancement of Voluntary Walking Function Among Persons With Severe Hemiplegia Post-Stroke|Unknown status|Recruiting|Phase 4|40|Anticipated|Toronto Rehabilitation Institute||2|||f||||f||||||||||2017-02-18 15:07:15.175015|2017-02-18 15:07:15.175015
NCT00552903|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2009-02-03|||November 2007||2007-11-01|February 2009|2009-02-01|May 2010|Anticipated|2010-05-01|November 2009|Anticipated|2009-11-01||Interventional|TerVa||Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart Disease|Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart Disease|Unknown status|Active, not recruiting|Phase 3|1500|Anticipated|Paijat-Hame Hospital District||2|||f||||||||||||||2017-02-18 15:07:15.279214|2017-02-18 15:07:15.279214
NCT00552890|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2007-11-01|||December 2001||2001-12-01|December 2001|2001-12-01|February 2004|Actual|2004-02-01|||||Interventional|||Modified Atkins Diet and Type 2 Diabetic Patients|Influende of a Modified Atkins Diet on Glucose Metabolism and Weight Loss in Obese Type 2 Diabetic Patients - A Randomized Controlled Trial|Completed||N/A|52|Actual|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 15:07:15.382973|2017-02-18 15:07:15.382973
NCT00552877|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2009-08-12|||August 2007||2007-08-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|SORT OUT IV||The SOURT OUT IV TRIAL|Randomized Clinical Comparison of the Xience V and the Cypher Coronary Stents in Non-selected Patients With Coronary Heart Disease|Completed||N/A|2678|Anticipated|Odense University Hospital||2|||f||||t||||||||||2017-02-18 15:07:15.462819|2017-02-18 15:07:15.462819
NCT00552864|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2007-10-31|||January 2003||2003-01-01|October 2007|2007-10-01|June 2005|Actual|2005-06-01|||||Interventional|||Comparison of Ropivacaine and Levobupivacaine in High Thoracic Epidural Anesthesia|High Thoracic Epidural Anesthesia and Postoperative Analgesia With Ropivacaine or Levobupivacaine for Coronary Surgery: A Prospective Randomized Double-Blind Comparison|Completed||Phase 4|61|Actual|Centro Cardiologico Monzino||2|||f||||f||||||||||2017-02-18 15:07:15.779791|2017-02-18 15:07:15.779791
NCT00552851|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2010-09-23|||June 2006||2006-06-01|September 2010|2010-09-01|December 2010|Anticipated|2010-12-01|||||Interventional|||Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant|Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant: an Open-labelled, Prospective Study|Unknown status|Recruiting|Phase 4|4|Anticipated|University of Wuerzburg||1|||f||||t||||||||||2017-02-18 15:07:15.891838|2017-02-18 15:07:15.891838
NCT00552838|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-31|||October 2002||2002-10-01|September 2007|2007-09-01|August 2003|Actual|2003-08-01|||||Interventional|||The Impact of an Antimicrobial Utilization Program on Antimicrobial Use|The Impact of an Antimicrobial Utilization Program on Antimicrobial Use in a Large Public Hospital: A Randomized Controlled Trial|Completed||N/A|785|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 15:07:15.999368|2017-02-18 15:07:15.999368
NCT00552825|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2007-11-01|||October 2005||2005-10-01|November 2007|2007-11-01|October 2006|Actual|2006-10-01|||||Observational|||Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children|Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years|Completed||N/A|35|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:07:16.100239|2017-02-18 15:07:16.100239
NCT00552812|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-02-14|2014-09-19||October 2007||2007-10-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|December 2012|Actual|2012-12-01||Interventional|COAST||Coarctation Of the Aorta Stent Trial|Coarctation Of the Aorta Stent Trial|Completed||N/A|105|Actual|Johns Hopkins University||1|||f||||t||||||||No|Individual patient data is confidential and is not shared.|2017-02-18 15:07:16.184722|2017-02-18 15:07:16.184722
NCT00552799|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2012-07-23|||July 2006||2006-07-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|PATCH1||RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg|Randomised Controlled Trial to Investigate Whether Prophylactic Antibiotics Can Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg (PATCH I)|Completed||Phase 4|274|Actual|University of Nottingham||2|||f||||t||||||||||2017-02-18 15:07:16.446713|2017-02-18 15:07:16.446713
NCT00552786|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2010-07-01|2009-03-29||November 2007||2007-11-01|November 2009|2009-11-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Antioxidation Medication for Noise-induced Hearing Loss|Antioxidation Medication for Noise-induced Hearing Loss|Completed||Phase 2|53|Actual|National Taiwan University Hospital|No text entered.|2|||f||||f||||||||||2017-02-18 15:07:16.586396|2017-02-18 15:07:16.586396
NCT00552773|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2013-05-31|||November 2007||2007-11-01|November 2011|2011-11-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||Pilot Study to Determine Efficacy of Cyclamen Europaeum Extract Nasal Spray in Patients With Acute Sinusitis|A Randomized, Double-blind, Placebo Controlled, Parallel Group Trial of Cyclamen Europaeum Extract Nasal Spray 10% (v/v) in the Treatment of Subjects With Acute Sinusitis|Completed||N/A|48|Actual|Dey||2|||f||||t||||||||||2017-02-18 15:07:17.022877|2017-02-18 15:07:17.022877
NCT00552760|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2014-03-17|2010-05-29||November 2007||2007-11-01|March 2014|2014-03-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|Ram-TIME||Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder|A Double-Blind, Randomized, Placebo-Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder.|Completed||Phase 4|90|Actual|Lehigh Valley Hospital||2|||f||||t||||||||||2017-02-18 15:07:17.145018|2017-02-18 15:07:17.145018
NCT00552747|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2011-03-09|||October 2007||2007-10-01|May 2008|2008-05-01|January 2011|Actual|2011-01-01|March 2010|Actual|2010-03-01||Interventional|||Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease|The Effect of Fenofibrate on Endothelial Function and HDL in Patients With Coronary Heart Disease and LDL-C at Goal|Completed||Phase 4|76|Actual|National Heart Institute, Mexico||2|||f||||t||||||||||2017-02-18 15:07:17.71483|2017-02-18 15:07:17.71483
NCT00552734|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2015-08-10|||July 2005||2005-07-01|August 2015|2015-08-01|May 2007|Actual|2007-05-01|||||Observational|||Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software|Glycemic Control and Prevention of Hypoglycemia in Intensively Treated Subjects With Type 1 Diabetes Using Accu-Chek® Advisor Insulin Guidance Software|Completed||N/A|123|Actual|University of Colorado, Denver|||2||f||||f||||||||||2017-02-18 15:07:17.843102|2017-02-18 15:07:17.843102
NCT00552721|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2009-09-04|||October 2007||2007-10-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|||||Interventional|||Physical Therapy After Anti-spastic Treatment in Children With Cerebral Palsy|Physical Therapy With Versus Without Strength Training After Botulinum-toxin Treatment in Children With Cerebral Palsy|Completed||N/A|14|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-02-18 15:07:17.960179|2017-02-18 15:07:17.960179
NCT00552708|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2010-10-13||2010-10-13|September 2007||2007-09-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.|A Randomized, Open-label, Single-dose, Crossover Study to Demonstrate the Bioequivalence of the Final Fixed Dose Combination (FDC) Formulation (COREG CR & Lisinopril) to COREG CR & ZESTRIL Employed in the Phase III Factorial Study|Completed||Phase 1|55|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:07:18.074292|2017-02-18 15:07:18.074292
NCT00552695|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2012-10-19|2009-10-16||August 2007||2007-08-01|October 2012|2012-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Lidocaine Patches Prior to Intravenous Insertion|Phase II Study of Lidoderm Patches Prior to Intravenous Catheter Insertion.|Completed||Phase 2|45|Actual|Stony Brook University||2|||f||||f||||||||||2017-02-18 15:07:18.171764|2017-02-18 15:07:18.171764
NCT00552682|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2009-07-20|||January 2007||2007-01-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+|Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+|Completed||Phase 3|10|Actual|Germans Trias i Pujol Hospital||2|||f||||t||||||||||2017-02-18 15:07:18.569487|2017-02-18 15:07:18.569487
NCT00552669|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2010-05-27|2009-03-31||January 2006||2006-01-01|May 2009|2009-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|ORAR III||Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents|Phase 4 Study of Randomized Comparison Among Oral Rapamycin Plus Bare Metal Stents Versus Drug Eluting Stents in de Novo Coronary Lesions.|Completed||Phase 4|200|Actual|Centro de estudios en Cardiologia Intervencionista|It was an open label design. Multiple approved DES designs were used. Health Care system in Argentina differs from other world ones.|2|||f||||t||||||||||2017-02-18 15:07:18.685869|2017-02-18 15:07:18.685869
NCT00552656|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2008-08-11|||January 2007||2007-01-01|August 2008|2008-08-01|August 2010|Anticipated|2010-08-01|||||Observational|FIREMAN||Long Term Efficacy and Safety of Firebird Sirolimus-Eluting Stent In Complex Coronary Lesions|Prospective, Multicenter Study of Firebird Sirolimus-Eluting Stent for Treatment of Complex Coronary Lesions. Clinical and Angiographic Outcomes of FIREMAN Study|Unknown status|Enrolling by invitation|N/A|1000|Anticipated|Xijing Hospital|||1||f||||t||||||||||2017-02-18 15:07:19.164286|2017-02-18 15:07:19.164286
NCT00552643|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2009-10-27|||May 2008||2008-05-01|October 2009|2009-10-01||||May 2009|Anticipated|2009-05-01||Interventional|||Study to Evaluate Polyheal-1 in Treatment of Recalcitrant Wounds|Study to Evaluate Polyheal-1 in Treatment of Recalcitrant Wounds|Unknown status|Recruiting|N/A|60|Anticipated|Polyheal Ltd.||2|||f||||f||||||||||2017-02-18 15:07:19.28155|2017-02-18 15:07:19.28155
NCT00552630|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2015-03-24|||September 2007||2007-09-01|December 2007|2007-12-01||||||||Interventional|||Penicillamine Chelation for Children With Lead Poisoning|A Phase 2/3 Trial of d-Penicillamine Chelation in Lead-Poisoned Children|Withdrawn||Phase 2/Phase 3|0|Actual|FDA Office of Orphan Products Development||2|||f||||t||||||||||2017-02-18 15:07:19.389565|2017-02-18 15:07:19.389565
NCT00552617|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-05-05|||September 2005||2005-09-01|May 2016|2016-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Bridging Trial Comparing Org 25969 at Reappearance of T2 in Japanese and Caucasian Subjects. Part B: Caucasian Subjects (19.4.208B)(P05971)|A Multi-Center, Randomized, Open-Label, Prospective Bridging, Parallel Dose-Finding Trial Comparing Efficacy, Safety and Pharmacokinetics of 4 Doses of Org 25969 and Placebo Administered at Reappearance of T2 After Rocuronium or Vecuronium in Japanese and Caucasian Subjects. Part B: Caucasian Subjects|Completed||Phase 2|100|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-02-18 15:07:19.493997|2017-02-18 15:07:19.493997
NCT00552604|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2015-03-24|||June 2006||2006-06-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|MUSEC||MUltiple Sclerosis and Extract of Cannabis (MUSEC) Study|Randomised, Double-blind, Placebo-controlled Phase III Trial to Determine the Efficacy and Safety of a Standardised Oral Extract of Cannabis Sativa for the Symptomatic Relief of Muscle Stiffness and Pain in Multiple Sclerosis.|Terminated||Phase 3|279|Actual|Institut fur Klinische Forschung, Germany||2||due to recruitment problems / based on recommendation of Independent Review Board|f||||t||||||||||2017-02-18 15:07:19.595007|2017-02-18 15:07:19.595007
NCT00552591|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2011-12-07|||September 2007||2007-09-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|FHHP-RCT||Family Heart Health Program: Randomized, Controlled Trial|Family Heart Health Program: Randomized, Controlled Trial|Completed||N/A|426|Actual|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-02-18 15:07:19.687941|2017-02-18 15:07:19.687941
NCT00552578|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2011-02-14|2009-01-21||October 2007||2007-10-01|February 2011|2011-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Buprenorphine as a Treatment in Opiate Dependent Pain Patients|A Randomized Controlled Trial Testing Buprenorphine as a Treatment in Opiate Dependent Pain Patients|Terminated||Phase 4|12|Actual|State University of New York at Buffalo||2||"Tapering doses protocol arm was not effective for treatment retention outcome."|f||||f||||||||||2017-02-18 15:07:19.795454|2017-02-18 15:07:19.795454
NCT00552565|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2009-06-10|||September 2007||2007-09-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|ARDIS-1||Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)|A Randomized, Double-Blind, Placebo-Controlled Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)|Completed||Phase 3|711|Actual|AGI Therapeutics, Inc.||4|||f||||f||||||||||2017-02-18 15:07:20.211422|2017-02-18 15:07:20.211422
NCT00552552|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2007-11-01|||January 2008||2008-01-01|October 2007|2007-10-01|December 2009|Anticipated|2009-12-01|||||Interventional|FIBS||Development and Evaluation of a Cancer-Related Fatigue Patient Education Program|Development and Evaluation of a Cancer-Related Fatigue Patient Education Program|Unknown status|Not yet recruiting|N/A|300|Anticipated|University of Bremen||2|||f||||||||||||||2017-02-18 15:07:20.537504|2017-02-18 15:07:20.537504
NCT00552539|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2007-10-31|||June 2006||2006-06-01|October 2007|2007-10-01|August 2006|Actual|2006-08-01|||||Interventional|||Syphilis Video Tool to Promote Knowledge and Testing in the ED|Video Tool to Promote Syphilis Knowledge and Testing in the Emergency Department|Completed||N/A|220|Actual|Jacobi Medical Center||4|||f||||f||||||||||2017-02-18 15:07:20.650279|2017-02-18 15:07:20.650279
NCT00552526|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2009-03-18|||November 2007||2007-11-01|March 2009|2009-03-01|December 2013|Anticipated|2013-12-01|January 2011|Anticipated|2011-01-01||Interventional|||Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy|Comparing Ketogenic Diet With the Most Appropriate Antiepileptic Drug- a Randomized Study of Children With Mental Retardation and Drug Resistant Epilepsy|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 15:07:20.765516|2017-02-18 15:07:20.765516
NCT00552513|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2014-05-27|2014-05-27||May 2005||2005-05-01|May 2014|2014-05-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|TIMACS||Early Versus Delayed Timing of Intervention in Patients With Acute Coronary Syndromes|An International Randomised Trial of Early Versus Delayed Invasive Strategies in Patients With Non-ST Segment Elevation Acute Coronary Syndromes|Completed||N/A|3031|Actual|Population Health Research Institute||2|||f||||t||||||||||2017-02-18 15:07:20.895145|2017-02-18 15:07:20.895145
NCT00552500|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2010-03-16|||February 2003||2003-02-01|March 2010|2010-03-01|December 2010|Anticipated|2010-12-01|December 2004|Actual|2004-12-01||Interventional|DepIVGTT||Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia|Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia|Unknown status|Active, not recruiting|N/A|120|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 15:07:21.263123|2017-02-18 15:07:21.263123
NCT00552487|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2007-10-31|||October 2005||2005-10-01|October 2007|2007-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis|Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis|Completed||N/A|62|Actual|University of Wuerzburg||4|||f||||t||||||||||2017-02-18 15:07:21.372973|2017-02-18 15:07:21.372973
NCT00552474|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2015-11-17||2012-04-27|October 2005||2005-10-01|November 2015|2015-11-01|June 2016|Anticipated|2016-06-01|October 2010|Actual|2010-10-01||Interventional|||Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease|A Clinical Evaluation of Bilateral Stimulation of the Subthalamic Nucleus (STN) Using the ANS Totally Implantable Deep Brain Stimulation System as an Adjunctive Treatment for Reducing Some of the Symptoms of Advanced, Levodopa-responsive Parkinson's Disease That Are Not Adequately Controlled With Medication.|Active, not recruiting||N/A|136|Actual|St. Jude Medical||2|||f||||t||||||||||2017-02-18 15:07:21.696968|2017-02-18 15:07:21.696968
NCT00552461|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2008-05-06|||January 2007||2007-01-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|July 2009|Anticipated|2009-07-01||Interventional|PAP||Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis|Prospective Open-Label Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis|Unknown status|Recruiting|Phase 2|10|Anticipated|East Carolina University||1|||f||||t||||||||||2017-02-18 15:07:21.830456|2017-02-18 15:07:21.830456
NCT00552448|ClinicalTrials.gov processed this data on February 17, 2017|2007-11-01|2016-09-12|2016-07-07||October 2007||2007-10-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||Use of High Frequency Chest Compression in Pediatric Status Asthmaticus|Use of High Frequency Chest Compression (HFCC) in Pediatric Status Asthmaticus|Terminated||N/A|36|Actual|Texas Tech University Health Sciences Center||2||Continuing review not submitted to IRB within 365 days.|f||||t||||||||Undecided||2017-02-18 15:07:21.953664|2017-02-18 15:07:21.953664
NCT00552435|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2008-05-06|||March 2007||2007-03-01|May 2008|2008-05-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Micropulse 810 Nanomolar (nm), Diode Laser for Diffuse Diabetic Macular Edema|Phase 2 Study of Micropulse 810nm Diode Laser Photocoagulation for Treatment of Diffuse Diabetic Macular Edema|Unknown status|Recruiting|Phase 2|50|Anticipated|Federal University of São Paulo||2|||f||||||||||||||2017-02-18 15:07:22.651917|2017-02-18 15:07:22.651917
NCT00552422|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2015-06-17|2015-06-02||March 2007||2007-03-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Domperidone for Gastroparesis in Solid Organ Transplantation|Domperidone for Gastroparesis Associated With Solid Organ Transplantation|Terminated||N/A|6|Actual|Columbia University||1||Lack of perceived need for domperidone in this population|f||||f||||||||||2017-02-18 15:07:22.749585|2017-02-18 15:07:22.749585
NCT00552409|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2014-04-09|2013-06-18||December 2007||2007-12-01|April 2014|2014-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease|Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease|Completed||Phase 2/Phase 3|22|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:07:22.962801|2017-02-18 15:07:22.962801
NCT00552396|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2016-03-03|2012-03-02||May 2007||2007-05-01|March 2016|2016-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma|An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Multiple Dose Administrations of Anti-KIR (1-7F9) Human Monoclonal Antibody in Subjects With Multiple Myeloma|Completed||Phase 1|32|Actual|Innate Pharma||1|||f||||t||||||||||2017-02-18 15:07:23.592562|2017-02-18 15:07:23.592562
NCT00552383|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2007-10-31|||September 1998||1998-09-01|October 2007|2007-10-01|December 2004|Actual|2004-12-01|||||Interventional|NIDCAP||The Edmonton Randomised Controlled Trial of NIDCAP - Based Developmental Care|The Impact of Developmental Care in the Neonatal Intensive Care Unit: The Edmonton Randomised Controlled Trial of NIDCAP (Newborn Individualised Developmental Care and Assessment Program)|Completed||N/A|120|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 15:07:24.852925|2017-02-18 15:07:24.852925
NCT00552370|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2009-07-20|||March 2003||2003-03-01|July 2009|2009-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|GOT||Glycemic Optimization Treatment Study|A Randomized, Open-Label, Parallel-Design Trial. Glycemia Optimization Treatment: Safety of Glucose Control Using Dosing Algorithms With Lantus®(Insulin Glargine [rDNA Origin[) in Adult Individuals With Type 2 Diabetes.|Completed||Phase 4|5062|Actual|Sanofi||5|||f||||||||||||||2017-02-18 15:07:24.954692|2017-02-18 15:07:24.954692
NCT00552357|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2017-01-10|||December 2007||2007-12-01|January 2017|2017-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation|Clinical Risk Factors for Primary Graft Dysfunction|Recruiting||N/A|1150|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 15:07:25.033992|2017-02-18 15:07:25.033992
NCT00552344|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-01-29|2015-12-14||May 2008||2008-05-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Baseline Characteristics refer to the Safety Population including all enrolled subjects who received at least 1 open-label injection of study medication. Demographics presented below were collected at Screening of the feeder study C87085.|A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease|A Phase IIIb, Multinational, Open-label, follow-on Trial to C87085 Designed to Assess the Long-term Safety of Certolizumab Pegol, a Pegylated Fab' Fragment of a Humanized Anti-TNF-alpha Monoclonal Antibody, Administered at Weeks 0, 2 and 4, and Then Every 4 Weeks Thereafter, in Subjects With Moderately to Severely Active Crohn's Disease Who Have Participated in Study C87085|Completed||Phase 3|403|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:07:25.132976|2017-02-18 15:07:25.132976
NCT00552331|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2011-06-27|||March 2003||2003-03-01|May 2009|2009-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of the Effects of Less Invasive Stabilization System (LISS) Plating Techniques in Distal Femoral Fractures|Prospective Randomized Clinical Study to Evaluate the Effects of Less Invasive Stabilization System (LISS) Plating Techniques in Distal Femoral Fractures|Completed||Phase 4|150|Anticipated|Nova Scotia Health Authority||2|||f||||f||||||||||2017-02-18 15:07:28.220825|2017-02-18 15:07:28.220825
NCT00552305|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2014-09-19|2011-02-23||August 2001||2001-08-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures|An Open-label Extension Trial to Determine Tolerability and Efficacy of Long-term Oral SPM 927 as Adjunctive Therapy in Patients With Partial Seizures|Completed||Phase 2|370|Actual|UCB Pharma||1|||f||||||||||||||2017-02-18 15:07:28.322128|2017-02-18 15:07:28.322128
NCT00551746|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2011-09-13|2011-07-11||July 2007||2007-07-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||The Purple Grape Juice Study|Anti-thrombotic Effects of Long Term Consumption of Purple Grape Juice in Healthy People|Completed||N/A|70|Actual|Intermountain Health Care, Inc.||2|||f||||f||||||||||2017-02-18 15:07:41.517614|2017-02-18 15:07:41.517614
NCT00552292|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-12-05|||December 2007||2007-12-01|December 2016|2016-12-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Observational|||Complications in Hypertension and Obesity|National Investigation of Cardiovascular Complications in Arterial Hypertension and Obesity|Recruiting||N/A|30000|Anticipated|Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health|||1||f||||f||||||Samples With DNA|"~     Blood, urine, serum~   "|||2017-02-18 15:07:29.169193|2017-02-18 15:07:29.169193
NCT00552279|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-10-11|2010-02-12||November 2007||2007-11-01|October 2016|2016-10-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age|Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV Vaccine GSK580299 Administered According to an Alternative Dosing Schedule as Compared to the Standard Dosing Schedule in Young Female Subjects Aged 15-25 Years|Completed||Phase 3|805|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:07:29.267752|2017-02-18 15:07:29.267752
NCT00552266|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2007-10-31|||October 2007||2007-10-01|October 2007|2007-10-01|October 2009|Anticipated|2009-10-01|||||Interventional|||Methylphenidate in ADHD With Trichotillomania|Methylphenidate Treatment of Children and Adolescents Diagnosed With ADHD and Its Influence on Comorbid Trichotillomania|Unknown status|Recruiting|Phase 4|30|Anticipated|Geha Mental Health Center||1|||f||||f||||||||||2017-02-18 15:07:30.042956|2017-02-18 15:07:30.042956
NCT00552253|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2010-12-21|||October 2007||2007-10-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Levothyroxine Treatment in Thyroid Benign Nodular Goiter|Levothyroxine Treatment in Thyroid Benign Nodular Goiter|Completed||N/A|10|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 15:07:30.140935|2017-02-18 15:07:30.140935
NCT00552240|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2013-12-09|2011-03-16||September 2007||2007-09-01|December 2013|2013-12-01||||March 2010|Actual|2010-03-01||Interventional||Full Analysis Set (FAS)|Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)|Comparison Atazanavir/Ritonavir (ATV/r) vs Nevirapine (NVP) Twice a Day (Bid) on Truvada Backbone|Completed||Phase 4|154|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:07:30.261443|2017-02-18 15:07:30.261443
NCT00552227|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-07-25|||September 2002||2002-09-01|July 2016|2016-07-01|July 2005|Actual|2005-07-01|||||Interventional|||Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus|The Effect of Protein Kinase C (PKC) β Specific Inhibitor on Oxidant Stress in Patient With Type 2 Diabetes Mellitus|Completed||Phase 1|48|Actual|Chromaderm, Inc.||2|||f||||f||||||||||2017-02-18 15:07:31.746065|2017-02-18 15:07:31.746065
NCT00552214|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2007-11-05|||August 2007||2007-08-01|October 2007|2007-10-01||||||||Interventional|||Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens|Evaluation of a TMA Assay for the Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens|Unknown status|Enrolling by invitation|N/A|10500|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:07:31.854428|2017-02-18 15:07:31.854428
NCT00552201|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2010-05-26|||April 2006||2006-04-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|January 2008|Actual|2008-01-01||Interventional|||TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic|Randomized Therapeutic Study of a Treatment by Tacrolimus Adapted or Not According to the Genotype of the Cytochrome P450 3A5 After Renal Transplantation|Completed||Phase 4|280|Actual|Centre Hospitalier Universitaire, Amiens||1|||f||||t||||||||||2017-02-18 15:07:31.936505|2017-02-18 15:07:31.936505
NCT00552188|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2013-06-06|2013-06-06||October 2007||2007-10-01|June 2013|2013-06-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Effect of VIA-2291, a 5-Lipoxygenase Inhibitor, on Vascular Inflammation in Patients After an Acute Coronary Syndrome Event|Completed||Phase 2|52|Actual|Tallikut Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 15:07:32.064122|2017-02-18 15:07:32.064122
NCT00552175|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2010-03-26|2010-03-26||November 2007||2007-11-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study for the Treatment of Diabetic Peripheral Neuropathic Pain|A Superiority Study of LY248686 Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain|Completed||Phase 3|339|Actual|Eli Lilly and Company|The protocol-specified primary analyses for this study were comparisons between combined duloxetine arms (40 mg + 60 mg) and placebo. The study was powered on combined duloxetine arms and statistical comparisons were not performed among single arms.|3|||f||||t||||||||||2017-02-18 15:07:32.755875|2017-02-18 15:07:32.755875
NCT00552162|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-04-13|||June 2008||2008-06-01|April 2016|2016-04-01|July 2020|Anticipated|2020-07-01|January 2018|Anticipated|2018-01-01||Interventional|||NOTES Transvaginal Cholecystectomy and Appendectomy|NOTES Transvaginal Cholecystectomy and Appendectomy|Recruiting||N/A|40|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 15:07:34.492844|2017-02-18 15:07:34.492844
NCT00552149|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2012-06-12|||October 2007||2007-10-01|October 2007|2007-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin|A Multicenter, Randomized Phase II Trial Assessing the Activity of Gemcitabine - Oxaliplatin Chemotherapy Alone or in Combination With Cetuximab in Patients With Advanced Biliary Cancer.|Completed||Phase 2|150|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t||||||||||2017-02-18 15:07:34.613799|2017-02-18 15:07:34.613799
NCT00552136|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-06-02|||February 2005||2005-02-01|June 2016|2016-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||Canadian Orthopaedic Foot and Ankle Society Surgical Treatment of Ankle Arthritis Outcome Study|Canadian Orthopaedic Foot and Ankle Society Surgical Treatment of Ankle Arthritis Outcome Study|Recruiting||Phase 4|100|Anticipated|Nova Scotia Health Authority||1|||f||||||||||||||2017-02-18 15:07:34.721463|2017-02-18 15:07:34.721463
NCT00552110|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2015-05-27|2009-05-15||July 2007||2007-07-01|May 2015|2015-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)|Efficacy and Safety of Concurrent Administration of Mometasone Furoate Nasal Spray (MFNS) and Oxymetazoline Nasal Spray Administered Once Daily (QD) vs. Oxymetazoline Twice Daily (BID), Mometasone Furoate QD, and Placebo in the Treatment of Subjects With Seasonal Allergic Rhinitis|Completed||Phase 2|707|Actual|Merck Sharp & Dohme Corp.|Subject symptom data were not collected during the post-treatment period. Thus, daily diary data for rebound congestion was not analyzed.|5|||f||||f||||||||||2017-02-18 15:07:34.85306|2017-02-18 15:07:34.85306
NCT00552097|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2015-04-22|||June 2002||2002-06-01|April 2015|2015-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|ENHANCE||Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)|Effect of Combination Ezetimibe and High-Dose Simvastatin vs Simvastatin Alone on the Atherosclerotic Process in Subjects With Heterozygous Familial Hypercholesterolemia (The ENHANCE Trial)|Completed||Phase 3|720|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:07:35.478373|2017-02-18 15:07:35.478373
NCT00552084|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2014-11-18|2014-11-10||November 2007||2007-11-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation|Fish Oil for Atrial Fibrillation - Effect and Mechanisms|Completed||Phase 4|190|Actual|Vanderbilt University|We determined recurrence of Atrial Fibrillation(AF) by both routine and symptomatic TTM transmissions. We did not examine the effect of therapy on total AF burden. Sample size was relatively small, and included a heterogeneous patient population.|2|||f||||t||||||||||2017-02-18 15:07:35.585168|2017-02-18 15:07:35.585168
NCT00552071|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2010-08-18|||July 2007||2007-07-01|August 2010|2010-08-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Ultrasound Guided Sandostatin LAR Injection in Acromegaly|Does Ultrasound-Guidance Improve the Delivery and Efficacy of Intramuscular (IM) Injection of Sandostatin LAR in the Treatment of Acromegaly|Unknown status|Recruiting|N/A|20|Anticipated|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-02-18 15:07:36.1882|2017-02-18 15:07:36.1882
NCT00552058|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2011-10-14|2010-10-08||March 2008||2008-03-01|October 2011|2011-10-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease|Phase IIIb, Multinational, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Certolizumab Pegol, a Pegylated Fab' Fragment of a Humanized Anti-Tumor Necrosis Factor(TNF)-Alpha Monoclonal Antibody, Administered in Subjects With Moderately to Severely Active Crohn's Disease.|Completed||Phase 3|439|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 15:07:36.309997|2017-02-18 15:07:36.309997
NCT00552045|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2014-01-15|||November 2007||2007-11-01|January 2014|2014-01-01|April 2014|Anticipated|2014-04-01|December 2013|Actual|2013-12-01||Observational|EPGP||Epilepsy Phenome/Genome Project|Epilepsy Phenome/Genome Project: A Phenotype/Genotype Analysis of Epilepsy|Unknown status|Active, not recruiting|N/A|4150|Actual|University of California, San Francisco|||1||f||||t||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 15:07:37.759824|2017-02-18 15:07:37.759824
NCT00552032|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2016-02-23|2011-12-22||August 2007||2007-08-01|February 2016|2016-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|SNORE||Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)|A Double-blind Placebo-controlled, Randomized, Parallel-group, Multicenter Clinical Trial to Evaluate Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy SNORE Study|Completed||Phase 3|132|Actual|Merck Sharp & Dohme Corp.|The results of this study as presented are drawn from the clinical study report and should be reviewed with caution as there were inaccuracies in the database resulting from medication errors in some participants.|2|||f||||f||||||||||2017-02-18 15:07:37.891972|2017-02-18 15:07:37.891972
NCT00552019|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2009-11-17|||October 2007||2007-10-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Intraocular Pressure (IOP) Assessed by Dynamic Contour Tonometer (DCT) and Goldman Applanation Tonometry (GAT)|Inflammatory Changes of Corneal Thickness and Influence on Assessment of Intraocular Pressure|Completed||N/A|30|Actual|St. Franziskus Hospital|||1||f||||f||||||||||2017-02-18 15:07:38.789169|2017-02-18 15:07:38.789169
NCT00552006|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2011-03-07|||November 2007||2007-11-01|July 2008|2008-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Treatment of Formerly Abducted Children (FAC) in Uganda|A Randomized Controlled Clinical Trial (RCCT) to Test the Effectiveness of Narrative Exposure Therapy (NET) Versus an Attention Control Condition (AC) in Reducing Trauma Related Symptoms in Formerly Abducted Children and Former Child Soldiers Suffering From Posttraumatic Stress Disorder (PTSD)|Completed||N/A|85|Actual|University of Konstanz||3|||f||||f||||||||||2017-02-18 15:07:38.87742|2017-02-18 15:07:38.87742
NCT00551993|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2014-02-18|||September 2006||2006-09-01|February 2014|2014-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Laparoscopic Versus Robotic Assisted Laparoscopic Sacrocolpopexy for Vaginal Prolapse|Conventional Laparoscopic Versus Robotic Assisted Laparoscopic Sacrocolpopexy: a Randomized Controlled Trial|Completed||N/A|78|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 15:07:38.98507|2017-02-18 15:07:38.98507
NCT00551980|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2009-11-12|||October 2007||2007-10-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||The Efficacy of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Working Community|Effectiveness of a Workplace Cognitive and Physical Program in Reducing Headache,Neck and Shoulder Pain in an Extensive Working Community. A Randomized Controlled Trial|Completed||Phase 3|2895|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-02-18 15:07:39.092095|2017-02-18 15:07:39.092095
NCT00551967|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2015-04-14|||October 2007||2007-10-01|April 2015|2015-04-01|December 2022|Anticipated|2022-12-01|December 2022|Anticipated|2022-12-01||Interventional|||Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA|Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary Total Hip Arthroplasty Using Radiostereometric Analysis (RSA)|Recruiting||N/A|50|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 15:07:39.199327|2017-02-18 15:07:39.199327
NCT00551954|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-31|2013-02-28|||July 2006||2006-07-01|February 2013|2013-02-01||||July 2007|Actual|2007-07-01||Interventional|||Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes||Completed||Phase 3|||Technische Universität Dresden||2|||f||||f||||||||||2017-02-18 15:07:39.306611|2017-02-18 15:07:39.306611
NCT00551941|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2015-06-03|||October 2007||2007-10-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||A Prospective Randomized Controlled Trial on the Use of Bone Morphogenetic 7 (BMP-7) (OP-1®) and Demineralized Bone Matrix in Tibial Non-union|A Prospective Randomised Controlled Trial on the Use of BMP-7 (OP-1®) and Demineralised Bone Matrix in Tibial Non-union|Suspended||Phase 4|30|Anticipated|University Hospital, Ghent||2||Recruitment problems|f||||f||||||||||2017-02-18 15:07:39.392213|2017-02-18 15:07:39.392213
NCT00376974|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2006-09-13|||March 2005||2005-03-01|September 2006|2006-09-01|May 2006||2006-05-01|||||Interventional|||The Effect of Education on Patient Compliance|The Effect of Patient Education on Glaucoma Medication Compliance|Unknown status|Active, not recruiting|Phase 4|40||Michael Debakey Veterans Affairs Medical Center|||||f||||||||||||||2017-02-18 16:15:09.885264|2017-02-18 16:15:09.885264
NCT00551928|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-05-09|||June 2007||2007-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|MPRvsMEL200||Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients|A PHASE 3, MULTICENTRE, RANDOMIZED, CONTROLLED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF LENALIDOMIDE, MELPHALAN AND PREDNISONE (MPR) Versus MELPHALAN (200 mg/m2) FOLLOWED BY STEM CELL TRANSPLANT IN NEWLY DIAGNOSED MULTIPLE MYELOMA SUBJECTS|Active, not recruiting||Phase 3|402|Actual|Fondazione Neoplasie Sangue Onlus||2|||f||||t||||||||||2017-02-18 15:07:39.486112|2017-02-18 15:07:39.486112
NCT00551915|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-10-29|||May 2001||2001-05-01|October 2015|2015-10-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)|Safety, Tolerability, and Immunogenicity of 3 Different Formulations of a Liquid Hexavalent Combination Vaccine, HR5I When Administered to Healthy Hepatitis B Vaccine-Naive Infants at 2, 4, 6, and 12-14 Months of Age|Completed||Phase 2|756|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:07:39.590061|2017-02-18 15:07:39.590061
NCT00551902|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-09-21|||September 2007||2007-09-01|September 2015|2015-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes|Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes|Withdrawn||Phase 1|0|Actual|Queen's University||2||Efficacy study indicated that further study is not warranted|f||||f||||||||||2017-02-18 15:07:39.697151|2017-02-18 15:07:39.697151
NCT00551889|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2012-11-08|||September 2001||2001-09-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer|Phase I Trial of Oral Cyclophosphamide in Combination With Celecoxib in Patients With Advanced Malignancies|Completed||Phase 1|57|Actual|City of Hope Medical Center|||||f||||||||||||||2017-02-18 15:07:39.79976|2017-02-18 15:07:39.79976
NCT00551876|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-10-13|||December 2001||2001-12-01|October 2015|2015-10-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)|A Randomized, Double-Blind, Parallel, Multicenter Study to Evaluate the Efficacy and Safety of Simvastatin Monotherapy Compared With Simvastatin Plus Ezetimibe (SCH 58235) in Type 2 Diabetic Patients Treated With Thiazolidinediones|Completed||Phase 3|214|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:07:39.885749|2017-02-18 15:07:39.885749
NCT00551863|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2015-08-04|||June 2004||2004-06-01|August 2015|2015-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Developing Violence Prevention Therapy for Substance Abusers|Development of Violence Therapy for Substance Abusers|Completed||Phase 1/Phase 2|131|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 15:07:39.971909|2017-02-18 15:07:39.971909
NCT00551850|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2011-09-30|||October 2007||2007-10-01|September 2011|2011-09-01|May 2010|Actual|2010-05-01|October 2009|Actual|2009-10-01||Interventional|||A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients|A Phase I, Multi-Center, Dose-Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of AV-412 Administered Orally Three Times Weekly to Subjects With Advanced Solid Tumors|Completed||Phase 1|37|Actual|AVEO Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:07:40.073803|2017-02-18 15:07:40.073803
NCT00551837|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2008-05-05|||November 2006||2006-11-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Observational|||Immune Response to Influenza Vaccination|Immune Response to Influenza Vaccination|Completed||N/A|350|Anticipated|The Cleveland Clinic|||1||f||||||||||||||2017-02-18 15:07:40.177902|2017-02-18 15:07:40.177902
NCT00551824|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2008-04-07|||October 2007||2007-10-01|October 2007|2007-10-01|March 2009|Anticipated|2009-03-01|December 2008|Anticipated|2008-12-01||Interventional|||Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children|Evaluation of Topical Mitomycin C as Adjuvant Drug to Endoscopic Esophageal Dilation in Children|Unknown status|Recruiting|N/A|10|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 15:07:40.250246|2017-02-18 15:07:40.250246
NCT00551811|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2010-10-14||2010-10-14|October 2007||2007-10-01|October 2010|2010-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone.|A Randomised, Double-blind, Placebo Controlled, 3-way Crossover Study to Evaluate the Pharmacodynamics of SB-656933-AAA Following Single Doses in Healthy Adult Subjects Undergoing Ozone Challenge.|Completed||Phase 1|24|Anticipated|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:07:40.406156|2017-02-18 15:07:40.406156
NCT00551798|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2011-05-16|||March 2005||2005-03-01|March 2005|2005-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|MIBI||Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade|Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade|Completed||N/A|90|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-02-18 15:07:40.49602|2017-02-18 15:07:40.49602
NCT00551785|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2015-03-24|||September 2007||2007-09-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|EMPOWER||Surveillance Study of Women Taking Intrinsa®|The Multinational Postmarketing Observational Study of Women Prescribed Intrinsa|Terminated||Phase 4|328|Actual|Center for Epidemiology and Health Research, Germany|||2|The marketing authorization for Intrinsa was withdrawn.|f||||t||||||||||2017-02-18 15:07:40.761782|2017-02-18 15:07:40.761782
NCT00551772|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2008-12-23|||August 2007||2007-08-01|December 2008|2008-12-01||||||||Interventional|||A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.|An Open-Label, Randomised, Two-Part Crossover Study to Assess the Pharmacokinetics of a Single Dose of SB-742457 Formulated as a Capsule and a Tablet in Healthy Elderly Volunteers.|Completed||Phase 1|12|Anticipated|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:07:40.870632|2017-02-18 15:07:40.870632
NCT00551759|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2014-04-02|2014-01-17||June 2008||2008-06-01|April 2014|2014-04-01|April 2016|Anticipated|2016-04-01|October 2011|Actual|2011-10-01||Interventional||Eligible and treated patients|Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer|A Phase II Study to Measure Response Rate and Toxicity of Neo-adjuvant Chemoradiotherapy With Oxaliplatin (OX) and Infusional 5-Fluorouracil (5-FU) Plus Cetuximab Followed by Post-Operative Docetaxel and Cetuximab in Patients With Operable Adenocarcinoma of the Esophagus|Terminated||Phase 2|22|Actual|Eastern Cooperative Oncology Group||1||"The study used a two-stage design. After stage one, the study was terminated due to excess~   toxicity."|f||||f||||||||||2017-02-18 15:07:40.969329|2017-02-18 15:07:40.969329
NCT00551733|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2010-12-15|||August 2007||2007-08-01|April 2008|2008-04-01||||||||Interventional|||Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|Paclitaxel Poliglumex (CT-2103)/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer (NSCLC) in Women With Estradiol >30 pg/mL|Unknown status|Recruiting|Phase 3|450|Anticipated|National Cancer Institute (NCI)||2|||||||||||||||||2017-02-18 15:07:41.908104|2017-02-18 15:07:41.908104
NCT00551720|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2017-01-11|||January 1999||1999-01-01|October 2007|2007-10-01|December 2004|Actual|2004-12-01|||||Interventional|Positive PATHS||Motivation and Patch Treatment for HIV-positive Smokers|Motivation and Patch Treatment for HIV-positive Smokers|Completed||Phase 3|444|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 15:07:42.082651|2017-02-18 15:07:42.082651
NCT00551707|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2014-03-27|2014-02-10||October 2007||2007-10-01|March 2014|2014-03-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|MARS-1||Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Superiority of CRx-102 Over Each of Its Components When Given to Subjects With Active Rheumatoid Arthritis (RA)|Completed||Phase 2|51|Actual|Zalicus||5|||f||||t||||||||||2017-02-18 15:07:42.201347|2017-02-18 15:07:42.201347
NCT00551694|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2012-05-31|||October 2007||2007-10-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Second Study to Determine the Effect of GSK256073A on HVTs|A Second Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single and a Repeat Oral Dose of GSK256073A in Healthy Adult Subjects|Completed||Phase 1|4|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:07:42.782573|2017-02-18 15:07:42.782573
NCT00551681|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-04-20|||November 2007||2007-11-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|February 2015|Actual|2015-02-01||Interventional|CONTRACT||Effects of Left Ventricular Pacing Optimilization on Cardiac Perfusion, Contractile Force, and Clinical Performance in Patients With Ventricular Dysfunction and Heart Failure|Effects of Left Ventricular Pacing Optimilization on Cardiac Perfusion, Contractile Force, and Clinical Performance in Patients With Ventricular Dysfunction and Heart Failure|Completed||N/A|52|Actual|R&D Cardiologie||2|||f||||f||||||||||2017-02-18 15:07:42.882351|2017-02-18 15:07:42.882351
NCT00551668|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2007-10-30|||January 1998||1998-01-01|October 2007|2007-10-01|December 2000|Actual|2000-12-01|||||Interventional|||A Prospective, Randomized Study of Operative and Nonoperative Treatment for Primary Traumatic Patellar Dislocation|A Prospective, Randomized Study of Operative and Nonoperative Treatment for Primary Traumatic Patellar Dislocation in Young Adults With a Median 7-Year Follow-Up|Completed||N/A|40|Actual|Finnish Defense Forces||2|||f||||f||||||||||2017-02-18 15:07:42.976419|2017-02-18 15:07:42.976419
NCT00551655|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2007-11-05|||May 2007||2007-05-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Observational|||Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients|Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients|Completed||Phase 4|684|Actual|AIDS Arms Inc.|||1||f||||f||||||||||2017-02-18 15:07:43.100459|2017-02-18 15:07:43.100459
NCT00551642|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-11-03|2010-09-03||May 2005||2005-05-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies|The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants|Completed||Phase 3|800|Actual|Mallinckrodt||2|||f||||t||||||||||2017-02-18 15:07:43.194837|2017-02-18 15:07:43.194837
NCT00551629|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-10-29|||May 2001||2001-05-01|October 2015|2015-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)|Safety, Tolerability, and Immunogenicity of Four Different Formulations of a Liquid Hexavalent Combination Vaccine, HR5I (Haemophilus Influenzae Type b Conjugate, Recombinant Hepatitis B Surface Antigen, Diphtheria Toxoid, Tetanus Toxoid, 5-Component Acellular Pertussis Vaccine, and Inactivated Poliovirus Type 1, 2, and 3), When Administered to Healthy Hepatitis B Vaccine-Naïve Infants at 2, 3, 4, and 12 to 14 Months of Age|Completed||Phase 2|708|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-02-18 15:07:43.873252|2017-02-18 15:07:43.873252
NCT00551616|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2010-06-16|||April 2007||2007-04-01|June 2010|2010-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception||Completed||Phase 3|2321|Actual|HRA Pharma||2|||f||||t||||||||||2017-02-18 15:07:43.978513|2017-02-18 15:07:43.978513
NCT00551603|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2009-08-03|||July 2006||2006-07-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|VAES||Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules|Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules|Completed||Phase 4|300|Anticipated|Anemia Working Group Romania||2|||f||||f||||||||||2017-02-18 15:07:44.100731|2017-02-18 15:07:44.100731
NCT00551590|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2011-10-03|||December 2007||2007-12-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus|A Randomized, Placebo-Controlled, 4-period, Crossover Study to Assess the Impact of MK-0431 (Sitagliptin) on Incretin Effect and the Role of Specific Incretin Hormones in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|24|Actual|Ludwig-Maximilians - University of Munich||4|||f||||t||||||||||2017-02-18 15:07:44.299146|2017-02-18 15:07:44.299146
NCT00551577|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2007-10-30|||March 2003||2003-03-01|October 2007|2007-10-01|January 2008|Anticipated|2008-01-01|||||Interventional|PRIMOVAR-1||Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial|Prospective, Randomized Phase II Clinical Trial to Select Primary Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer Stage FIGO IIIC and IV|Unknown status|Recruiting|Phase 2|100|Anticipated|University Hospital, Bonn||2|||f||||f||||||||||2017-02-18 15:07:44.411714|2017-02-18 15:07:44.411714
NCT00551395|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-09-21|||September 2007||2007-09-01|September 2015|2015-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion|Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion|Terminated||Phase 3|20|Actual|Queen's University||2||Poor recruitment|f||||f||||||||||2017-02-18 15:07:49.378076|2017-02-18 15:07:49.378076
NCT00551564|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2016-10-28|||July 2007||2007-07-01|October 2016|2016-10-01|September 2008|Actual|2008-09-01|||||Interventional|||Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate|A Single-Center, Non-Randomized, Open-Label, Comparative Study to Assess the Utility of Novel Technologies and Biomarkers as Methods for Measuring Human Pharmacodynamic Response to 8 Weeks of Administration of Rosiglitazone Maleate 4mg BID in Healthy Normal or Overweight Controls, Healthy Obese Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:07:47.053977|2017-02-18 15:07:47.053977
NCT00551551|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2013-07-25|||November 2007||2007-11-01|July 2013|2013-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Prenatal Pelvic Floor Prevention (3PN)|Urinary Postpartum Handicap Prevention: Pelvic Floor Exercises vs Control. Multicentric Randomized Trial|Completed||Phase 3|280|Actual|Centre Hospitalier Universitaire de la Réunion||2|||f||||f||||||||||2017-02-18 15:07:47.182508|2017-02-18 15:07:47.182508
NCT00551538|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2010-10-12|||May 2003||2003-05-01|October 2010|2010-10-01|December 2004|Actual|2004-12-01|||||Interventional|||24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine|Twenty-Four-Hour Plasma Glucose Profiles Observed in Patients With Type 2 Diabetes During Therapy Consisting of Oral Agent(s) Plus Twice-Daily Insulin Lispro Low Mixture or Once-Daily Insulin Glargine|Completed||Phase 4|15|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:07:47.31325|2017-02-18 15:07:47.31325
NCT00551525|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-03-03|||April 2008||2008-04-01|March 2016|2016-03-01||||September 2014|Actual|2014-09-01||Interventional|||Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer|A Phase II Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy|Active, not recruiting||Phase 2|67|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 15:07:47.447261|2017-02-18 15:07:47.447261
NCT00551512|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2011-10-31|||November 2006||2006-11-01|October 2011|2011-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Phase I Clinical and Pharmacokinetic (PK) Study of CBP501 and Cisplatin Every 3 Weeks in Patients With Advanced Refractory Solid Tumors|Phase I Clinical and Pharmacokinetic Study of CBP501 and Cisplatin Every 3 Weeks in Patients With Advanced Refractory Solid Tumors|Completed||Phase 1|13|Anticipated|CanBas Co. Ltd.||1|||f||||f||||||||||2017-02-18 15:07:47.587386|2017-02-18 15:07:47.587386
NCT00551499|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2007-10-30|||June 2005||2005-06-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|Morpheus||Cardiac Resynchronisation Therapy in Combination With Overdrive Pacing in the Treatment of Central Sleep Apnea in CHF|Cardiac Resynchronisation Therapy in Combination With Overdrive Pacing in the Treatment of Central Sleep Apnea in CHF|Completed||Phase 4|44|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-02-18 15:07:47.68654|2017-02-18 15:07:47.68654
NCT00551486|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2007-10-30|||June 2006||2006-06-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Observational|||Pyrosequencing of the BRAFV600E Mutation|Diagnostic Value of Pyrosequencing for the BRAFV600E Mutation in Ultrasound-Guided Fine-Needle Aspiration Biopsy Samples of Thyroid Incidentalomas|Completed||N/A|101|Actual|Chungnam National University|||1||f||||t||||||Samples With DNA|"~     Fine needle aspiration samples of thyroid nodule~   "|||2017-02-18 15:07:47.80406|2017-02-18 15:07:47.80406
NCT00551473|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2012-05-31|||May 2007||2007-05-01|February 2011|2011-02-01||||||||Interventional|||Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.|An Open-Label Study of the Development of Pharmacodynamic Tolerance to 7-days Administration of Lavoltidine 40mg|Completed||Phase 1|18|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:07:47.893297|2017-02-18 15:07:47.893297
NCT00551460|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-10-06|||November 2007||2007-11-01|October 2016|2016-10-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia|S0535, A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients With Previously Untreated High-Risk Acute Promyelocytic Leukemia|Active, not recruiting||Phase 2|70|Anticipated|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 15:07:48.219568|2017-02-18 15:07:48.219568
NCT00551447|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-10-12|||January 2002||2002-01-01|October 2015|2015-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)|A Comparison of Treatment With Ezetimibe (SCH 58235) and Simvastatin Coadministration Versus Simvastatin in Attaining the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Coronary Heart Disease (CHD) or CHD Risk Equivalent Strata Low-Density Lipoprotein Cholesterol (LDL-c)|Completed||Phase 3|616|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:07:48.549223|2017-02-18 15:07:48.549223
NCT00551434|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2007-10-30|||August 2002||2002-08-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Effect of Creatine and L-Arginine on Endothelial Function|Effect of Creatine and L-Arginine on Endothelial Function in Patients With Coronary Artery Disease|Completed||N/A|119|Actual|Boston University||4|||f||||f||||||||||2017-02-18 15:07:48.635074|2017-02-18 15:07:48.635074
NCT00551421|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2015-03-11|2014-12-17||October 2007||2007-10-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|November 2010|Actual|2010-11-01||Interventional|||Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer|A Phase I/II Trial of Pertuzumab in Combination With Cetuximab and Irinotecan in Previously Treated Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|17|Actual|National Cancer Institute (NCI)|Combination intolerable due to overlapping toxicities of diarrhea, rash and mucositis; a unique rash with desquamation seen in most patients across all dose levels. Correlative study inconclusive with too few patients and timepoints with results.|1|||f||||t||||||||||2017-02-18 15:07:48.724856|2017-02-18 15:07:48.724856
NCT00551408|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-30|||August 2007||2007-08-01|October 2007|2007-10-01|February 2008|Anticipated|2008-02-01|||||Observational|||Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension|The Determination of Endothelial Progenitor Cells in Pulmonary Idiopathic Arterial Hypertension.|Unknown status|Active, not recruiting|N/A|25|Anticipated|Unidad de Investigacion Clinica en Medicina S.C.|||2||f||||f||||||Samples With DNA|"~     whole blood.~   "|||2017-02-18 15:07:49.296175|2017-02-18 15:07:49.296175
NCT00551382|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2010-03-16|||November 2007||2007-11-01|March 2010|2010-03-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study|Phase 3 Study of Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children|Unknown status|Recruiting|Phase 3|500|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 15:07:49.489206|2017-02-18 15:07:49.489206
NCT00551369|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-30|2016-09-06|2016-09-06||December 2007||2007-12-01|September 2016|2016-09-01||||May 2012|Actual|2012-05-01||Interventional||All eligible patients who started study treatment|Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery|A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients With Operable Stage I/II Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|33|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 15:07:49.608379|2017-02-18 15:07:49.608379
NCT00551356|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-29|||November 2002||2002-11-01|October 2007|2007-10-01|July 2003|Actual|2003-07-01|||||Interventional|IOOL||Lispro Mix 25 vs. Glargine in Type 2 Diabetics|Comparison of the Insulin Therapies: Insulin Lispro Low Mix (25%) and Insulin Glargine in Patients With Diabetes Mellitus Type 2|Completed||Phase 3|53|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:07:49.917138|2017-02-18 15:07:49.917138
NCT00551343|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-29|||October 2007||2007-10-01|October 2007|2007-10-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome|Contribution of a GLP-1 Agonist to Appetite Regulation, Metabolism and Body Composition in Subjects With Prader-Willi Syndrome.|Unknown status|Recruiting|N/A|20|Anticipated|Garvan Institute of Medical Research||2|||f||||f||||||||||2017-02-18 15:07:50.041464|2017-02-18 15:07:50.041464
NCT00551330|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-12-18|||September 2007||2007-09-01|December 2015|2015-12-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)|Vicriviroc in Combination Treatment With an Optimized ART Regimen in Treatment-Experienced Subjects With R5/X4 HIV Infection (VICTOR-E2; Protocol No. P05057)|Completed||Phase 2|111|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:07:50.152542|2017-02-18 15:07:50.152542
NCT00551317|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2016-12-02|||July 2007||2007-07-01|December 2016|2016-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men|A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of Darapladib (SB480848) in Healthy Japanese Male Subjects|Completed||Phase 1|18|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:07:50.245407|2017-02-18 15:07:50.245407
NCT00551304|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2012-11-02|||October 2007||2007-10-01|November 2012|2012-11-01||||||||Interventional|||Native Kidney Denervation in Patients With End Stage Renal Disease|Native Kidney Denervation in Patients With End Stage Renal Disease|Completed||Phase 1|||Medtronic Vascular|||||f||||t||||||||||2017-02-18 15:07:50.356012|2017-02-18 15:07:50.356012
NCT00551291|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2016-06-24|2016-05-16||August 2007||2007-08-01|June 2016|2016-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.|An Open Label Study of the Effects of a Combination of NeoRecormon, CellCept and Prednisone on Hematological Parameters and Cytogenesis in Patients With Low or Intermediate Risk Myelodysplastic Syndromes.¿|Completed||Phase 2|10|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:07:50.442246|2017-02-18 15:07:50.442246
NCT00551278|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2016-01-11|||October 2007||2007-10-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer|GeneSearch™ Breast Lymph Node (BLN) Assay for Molecular Testing Protocol|Completed||N/A|80|Actual|Janssen Diagnostics, LLC|||1||f||||f||||||Samples With DNA|"~     Samples of the tissue homogenate and extracted RNA will be retained and may be used for for~     further testing.~   "|||2017-02-18 15:07:50.708265|2017-02-18 15:07:50.708265
NCT00551265|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2015-05-07|||October 2007||2007-10-01|May 2015|2015-05-01||||January 2009|Actual|2009-01-01||Interventional|||Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy|A Randomized Pilot Trial of Consolidation With an Adjuvant Ovarian Cancer Vaccine Oregovomab (Ovarex ®) With/Without Single-Dose Cyclophosphamide After a Complete Clinical Response to Second-Line Taxane/Platinum-Based Therapy to Determine Immune Response and Time to Progression in Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Withdrawn||N/A|0|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-02-18 15:07:50.816557|2017-02-18 15:07:50.816557
NCT00551252|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-29|||January 2008||2008-01-01|October 2007|2007-10-01|December 2009|Anticipated|2009-12-01|||||Interventional|||A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma|A Phase II Study of the Association of Glivec® (Imatinib Mesylate, Formerly Known as STI 571) Plus Gemzar® (Gemcitabine) in Patients With Unresectable, Refractory, Malignant Mesothelioma Expressing Either PDGFR-Beta or C-Kit|Unknown status|Not yet recruiting|Phase 2|56|Anticipated|Gruppo Italiano MEsotelioma||1|||f||||t||||||||||2017-02-18 15:07:50.931182|2017-02-18 15:07:50.931182
NCT00551239|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2011-05-20|||August 2007||2007-08-01|April 2008|2008-04-01||||||||Interventional|||Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma|A Randomized Phase III Trial Comparing the Combination of Fludarabine, BBR 2778 (Pixantrone) and Rituximab (FP-R) With the Combination of Fludarabine and Rituximab (F-R) in the Treatment of Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)||2|||||||||||||||||2017-02-18 15:07:51.041963|2017-02-18 15:07:51.041963
NCT00551226|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-27|2007-10-29|||November 2007||2007-11-01|October 2007|2007-10-01|November 2008|Anticipated|2008-11-01|||||Observational|||Follow up of Autoantibodies in Active Tuberculosis|Follow up of Autoantibodies in Active Tuberculosis|Unknown status|Not yet recruiting|N/A|50|Anticipated|Tel-Aviv Sourasky Medical Center|||2||f||||f||||||Samples Without DNA|"~     Serum of patients~   "|||2017-02-18 15:07:51.159727|2017-02-18 15:07:51.159727
NCT00551213|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-12-22|2015-11-10||November 2007||2007-11-01|December 2015|2015-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)|A Fixed-Sequence, Open-Label Study to Determine the Activity of SCH 717454 as Assessed by Positron Emission Tomography in Subjects With Relapsed or Recurrent Colorectal Cancer|Completed||Phase 2|67|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:07:51.268222|2017-02-18 15:07:51.268222
NCT00551200|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2017-01-13|2013-08-28||October 2007||2007-10-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders|A Phase 2, Open-Label, Switch-Over, Dose-Escalation Study of the Safety and Tolerability of HPN-100 Compared to Buphenyl® (Sodium Phenylbutyrate) in Patients With Urea Cycle Disorders|Completed||Phase 2|14|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||1|||f||||t||||||||||2017-02-18 15:07:52.200764|2017-02-18 15:07:52.200764
NCT00551187|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-06-05|||October 2007||2007-10-01|June 2015|2015-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)|A Randomized, Double-Blinded, Tolerability and Immunogenicity Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered Concomitantly With GARDASIL to 16- to 26- Year-Old Women|Completed||Phase 2|620|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:07:52.556348|2017-02-18 15:07:52.556348
NCT00551174|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2011-07-20|2009-06-30||October 2004||2004-10-01|July 2011|2011-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment|Open Label, Parallel Group, Multicenter Study of Two Intravenous (IV) Ibandronate Dose Regimens (2 mg Every 2 Months and 3 mg Every 3 Months) in Women With Postmenopausal Osteoporosis Who Completed Trial BM16550|Completed||Phase 4|781|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:07:52.671213|2017-02-18 15:07:52.671213
NCT00551161|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2013-12-20|2013-04-30||August 2007||2007-08-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease|An Open-label Exploratory Study With Memantine: Correlation Between Proton Magnetic Resonance Spectroscopy, Cerebrospinal Fluid Biomarkers, and Cognition in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 4|12|Actual|Northwell Health||1|||f||||f||||||||||2017-02-18 15:07:53.554039|2017-02-18 15:07:53.554039
NCT00551148|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-27|2012-07-17||2009-03-20|October 2007||2007-10-01|July 2012|2012-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia|PD 0200390 Dose-ranging Trial: A Randomized, Double-blind, Placebo-controlled, 5-way Crossover, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia|Completed||Phase 2|92|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 15:07:53.811661|2017-02-18 15:07:53.811661
NCT00551135|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2010-06-08|2010-06-08||January 2008||2008-01-01|June 2010|2010-06-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Surgical Pain After Inguinal Hernia Repair (SPAIHR)|A Randomized, Double Blind Multi Center Dose Ranging Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo In The Adjunctive Treatment Of Post Surgical Pain After Primary Inguinal Hernia Repair|Completed||Phase 3|425|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 15:07:54.170687|2017-02-18 15:07:54.170687
NCT00551122|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2013-01-22|||November 2006||2006-11-01|October 2007|2007-10-01||||April 2013|Anticipated|2013-04-01||Interventional|GemTIP||Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors|Phase I/II Multicentre Trial of Salvage Chemotherapy With Gem-TIP for Relapsed Germ Cell Cancer|Unknown status|Recruiting|Phase 1/Phase 2|23|Anticipated|University of Southampton||1|||f||||t||||||||||2017-02-18 15:07:57.836131|2017-02-18 15:07:57.836131
NCT00551109|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2008-12-17|||November 2007||2007-11-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|||||Interventional|||SA4503 8-Week Study in Major Depressive Disorder (MDD)|A Phase II, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Safety and Efficacy of Treatment With SA4503, Once Daily for 8 Weeks, in Subjects With Major Depressive Disorder|Completed||Phase 2|150|Anticipated|M's Science Corporation||3|||f||||t||||||||||2017-02-18 15:07:57.959132|2017-02-18 15:07:57.959132
NCT00551096|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2013-12-23|||October 2007||2007-10-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors|A Phase I Study of Gemcitabine, Capecitabine and ZD6474 (ZACTIMA) in Patients With Advanced Solid Tumors With an Expanded Cohort of Patients With Biliary or Pancreatic Malignancies.|Completed||Phase 1|23|Actual|University of Colorado, Denver||1|||f||||t||||||||||2017-02-18 15:07:58.068142|2017-02-18 15:07:58.068142
NCT00551083|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-29|||March 2005||2005-03-01|October 2007|2007-10-01|June 2006|Actual|2006-06-01|||||Interventional|CDSS-D||Efficacy Study of a Computer Decision Support System to Treat Depression|A Pilot Efficacy Trial of a Computer Decision Support System Compared to Usual Care for Depression Treatment in Primary Care|Completed||N/A|60|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 15:07:58.193133|2017-02-18 15:07:58.193133
NCT00551070|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2016-11-01|2015-06-10||December 2007||2007-12-01|November 2016|2016-11-01||||July 2013|Actual|2013-07-01||Interventional||Eligible and treated patients.|Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer|A Phase II Trial of AZD6244 (NSC #748727) in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum|Active, not recruiting||Phase 2|52|Actual|National Cancer Institute (NCI)|Study began with 100mg BID mix & drink (MD) formulation. AstraZeneca (AZ) switched to hydrogen-sulfate capsule (HC). AZ deemed 100mg BID MD equivalent to 50mg BID HC. As of 12/31/2010, patients got 50mg BID HC; four patients were on treatment then.|1|||f||||||||||||||2017-02-18 15:07:58.29595|2017-02-18 15:07:58.29595
NCT00551057|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2010-09-16|||October 2007||2007-10-01|October 2007|2007-10-01|October 2012|Anticipated|2012-10-01|||||Observational|||Expression of Inflammatory Proteins in Pancreatic Cancer|Expression of Inflammatory Proteins in Pancreatic Cancer|Unknown status|Recruiting|N/A|150|Anticipated|University of Zurich|||1||f||||f||||||None Retained|"~     To investigate the expression of different inflammatory proteins in cancer and normal~     pancreatic tissue~   "|||2017-02-18 15:07:59.019217|2017-02-18 15:07:59.019217
NCT00370578|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2007-08-27|||September 2006||2006-09-01|August 2006|2006-08-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Aspiration Device in Myocardial Infarction Trial|Aspiration Device Myocardial Infarction Trial|Unknown status|Recruiting|N/A|100|Anticipated|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-02-18 16:17:32.388967|2017-02-18 16:17:32.388967
NCT00551044|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-29|||August 2003||2003-08-01|August 2007|2007-08-01|August 2005|Actual|2005-08-01|||||Interventional|||Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer|Bicalutamide Monotherapy Preserves Bone Mineral Density, Muscle Strength and Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer|Completed||N/A|42|Actual|Wirral University Teaching Hospital NHS Trust||1|||f||||t||||||||||2017-02-18 15:07:59.109046|2017-02-18 15:07:59.109046
NCT00551031|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2016-04-12|2011-10-13||October 2007||2007-10-01|April 2016|2016-04-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|||Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects|Immunogenicity and Safety of Two Dosages of the Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route in the Elderly Compared With Standard Fluzone® in Adults and Elderly Subjects.|Completed||Phase 2|2098|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 15:07:59.227231|2017-02-18 15:07:59.227231
NCT00551018|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-02-05|||December 2007||2007-12-01|February 2015|2015-02-01|October 2010|Actual|2010-10-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)|Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects|Completed||Phase 2|218|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:08:00.754997|2017-02-18 15:08:00.754997
NCT00551005|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2012-11-21|||December 2001||2001-12-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Etoposide and Celecoxib in Patients With Advanced Cancer|Phase I Trial of Oral Etoposide in Combination With Celecoxib in Patients With Advanced Malignancies|Completed||Phase 1|58|Actual|City of Hope Medical Center|||||f||||||||||||||2017-02-18 15:08:00.869356|2017-02-18 15:08:00.869356
NCT00550992|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2014-02-14|||June 2007||2007-06-01|February 2014|2014-02-01||||June 2014|Anticipated|2014-06-01||Interventional|Interfant06||Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia|International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic or Biphenotypic Leukemia|Unknown status|Recruiting|N/A|445|Anticipated|Dutch Childhood Oncology Group|||||f||||t||||||||||2017-02-18 15:08:00.972698|2017-02-18 15:08:00.972698
NCT00550979|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2013-08-28|||September 2007||2007-09-01|August 2013|2013-08-01|January 2014|Anticipated|2014-01-01|October 2013|Anticipated|2013-10-01||Observational|||Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk|Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk|Unknown status|Recruiting|N/A|96|Anticipated|Brigham and Women's Hospital|||4||f||||f||||||Samples With DNA|"~     blood and urine~   "|||2017-02-18 15:08:01.119761|2017-02-18 15:08:01.119761
NCT00550966|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-29|||September 2007||2007-09-01|September 2007|2007-09-01|February 2010|Anticipated|2010-02-01|||||Interventional|FIBRO-Qol||Efficacy of a Psychoeducative Program for Improving Quality of Life in Fibromyalgic Patients [Study Protocol]|Efficacy of a Psychoeducative Program for Improving Quality of Life in Fibromyalgic Patients [Study Protocol]|Unknown status|Enrolling by invitation|N/A|109|Anticipated|Institut Catala de Salut||1|||f||||f||||||||||2017-02-18 15:08:01.251972|2017-02-18 15:08:01.251972
NCT00550953|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2013-12-12|2009-11-12||October 2007||2007-10-01|December 2013|2013-12-01||||July 2008|Actual|2008-07-01||Interventional|||Filtered Trial for Telmisartan 40mg Non-responder|Filtered Trial for Telmisartan 40mg Non-responder|Completed||Phase 3|314|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:08:01.478366|2017-02-18 15:08:01.478366
NCT00550940|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2012-05-16|||July 2007||2007-07-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|||||Observational|||Emotion/Behavior Problems, Neuropsychological Functioning, and Parental Adjustment in Children With Epilepsy|Emotion/Behavior Problems, Neuropsychological Functioning, and Parental Adjustment in Children and Adolescents With Epilepsy|Completed||N/A|65|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:08:01.948131|2017-02-18 15:08:01.948131
NCT00550927|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2013-05-14|||November 2006||2006-11-01|June 2012|2012-06-01|September 2012|Actual|2012-09-01|March 2010|Actual|2010-03-01||Interventional|||Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer|A Phase 1 Safety Evaluation of Oral Enzastaurin in Combination With Bevacizumab in Patients With Advanced/Metastatic Cancer|Completed||Phase 1|42|Anticipated|Eli Lilly and Company|||||||||||||||||||2017-02-18 15:08:02.058023|2017-02-18 15:08:02.058023
NCT00550914|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2010-07-06|||January 2007||2007-01-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|||||Observational|||Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP|A Multi-Center, Randomized, Controlled Trial of the Pulsed Dye Laser for Juvenile Onset Recurrent Respiratory Papillomatosis|Completed||N/A|34|Anticipated|Massachusetts Eye and Ear Infirmary|||2||f||||f||||||||||2017-02-18 15:08:02.165142|2017-02-18 15:08:02.165142
NCT00550901|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2015-06-03|||February 2001||2001-02-01|June 2015|2015-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors|Phase I Study of Cis-Diamminedicholoroplatinum in Combination With ICRF-187 in the Treatment of Advanced Malignancies|Completed||Phase 1|25|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-02-18 15:08:02.254169|2017-02-18 15:08:02.254169
NCT00550888|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2010-06-08|||August 2005||2005-08-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|EXT||Comparison of Uterine Exteriorization Versus in Situ Repair at Cesarean Section: a Randomized Clinical Trial||Completed||Phase 3|||Instituto Materno Infantil Prof. Fernando Figueira||2|||f||||||||||||||2017-02-18 15:08:02.339211|2017-02-18 15:08:02.339211
NCT00550875|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2011-07-12|||June 2007||2007-06-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|GPIT||Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis|A Randomised Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Sublingual Immunotherapy With a Depigmented and Polymerized Grass Pollen Extracts in Patients Suffering From Allergic Rhinoconjunctivitis.|Completed||Phase 2|90|Anticipated|Laboratorios Leti, S.L.||3|||f||||t||||||||||2017-02-18 15:08:02.421742|2017-02-18 15:08:02.421742
NCT00550862|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-27|2012-02-10|2011-06-10||October 2007||2007-10-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|August 2009|Actual|2009-08-01||Interventional|||Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)|A Study of INT 747 (6α-ethyl Chenodeoxycholic Acid (6-ECDCA)) in Combination With Ursodeoxycholic Acid (URSO®, UDCA) in Patients With Primary Biliary Cirrhosis|Completed||Phase 2|165|Actual|Intercept Pharmaceuticals||4|||f||||t||||||||||2017-02-18 15:08:02.536174|2017-02-18 15:08:02.536174
NCT00370370|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-06-25|||November 2005||2005-11-01|June 2008|2008-06-01||||||||Interventional|||Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD||Unknown status|Active, not recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 16:17:35.645732|2017-02-18 16:17:35.645732
NCT00550849|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2007-11-06|||April 2007||2007-04-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction|Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 (CDDO-Me) Administered Orally for 14 Days in Patients With Hepatic Dysfunction|Terminated||Phase 1/Phase 2|16|Actual|Reata Pharmaceuticals, Inc.||3||Enrollment discontinued after second cohort completed.|f||||f||||||||||2017-02-18 15:08:03.548768|2017-02-18 15:08:03.548768
NCT00550836|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2016-08-12|||March 2009||2009-03-01|August 2016|2016-08-01|May 2013|Actual|2013-05-01|November 2010|Actual|2010-11-01||Interventional|||Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer|Randomized Phase II Trial of Panitumumab, Erlotinib and Gemcitabine vs. Erlotinib and Gemcitabine in Patients With Untreated, Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|104|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 15:08:03.665716|2017-02-18 15:08:03.665716
NCT00550823|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-27|2007-10-29|||November 2007||2007-11-01|October 2007|2007-10-01|November 2008|Anticipated|2008-11-01|||||Interventional|cardiac CT||Cardiac Computarized Tomography in Infective Endocarditis|The Use of Cardiac Computarized Tomography in Infective Endocarditis|Unknown status|Not yet recruiting|N/A|20|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 15:08:06.809131|2017-02-18 15:08:06.809131
NCT00550810|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2011-12-06|||October 2007||2007-10-01|September 2011|2011-09-01|November 2012|Anticipated|2012-11-01|||||Interventional|SMART||Sutent Maintenance After Response to Taxotere|A Phase II Study of SU011248 for Maintenance Therapy in Hormone Refractory Prostate Cancer After First Line Chemotherapy|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 15:08:06.88819|2017-02-18 15:08:06.88819
NCT00550797|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2013-11-18|||January 2008||2008-01-01|November 2013|2013-11-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Study to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With Asthma|A Multi-center, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of 14-day Inhaled TPI ASM8 in Subjects With Asthma|Completed||Phase 2|18|Actual|Pharmaxis||2|||f||||f||||||||||2017-02-18 15:08:06.991694|2017-02-18 15:08:06.991694
NCT00550784|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2014-10-03|||January 2001||2001-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|Phase I Trial of Tandem Chemotherapy Cycles as Consolidation Therapy for High-Risk Epithelial Ovarian and Primary Peritoneal Cancer Utilizing Intraperitoneal Paclitaxel/IV Cyclophosphamide Followed by IV Topotecan/Intraperitoneal Cisplatin/IV Melphalan Using Hematopoietic Stem Cell Support|Completed||Phase 1|8|Actual|City of Hope Medical Center|||||f||||||||||||||2017-02-18 15:08:07.100688|2017-02-18 15:08:07.100688
NCT00550771|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-10-01|2011-08-26||July 2007||2007-07-01|October 2015|2015-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)|Randomized Phase II Multinational Trial to Evaluate the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy in Patients With HER2-positive Breast Cancer: Caelyx + Cyclophosphamide + Trastuzumab (C+C+H) or Doxorubicin + Cyclophosphamide (A+C), Each Followed by Paclitaxel + Trastuzumab (T+H) BACH|Completed||Phase 2|181|Actual|Merck Sharp & Dohme Corp.|Any follow-up data from this study should be considered with caution as the planned 2-year follow-up was curtailed because of administrative reasons.|2|||f||||||||||||||2017-02-18 15:08:07.201836|2017-02-18 15:08:07.201836
NCT00550758|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-20|2007-10-29|||May 2004||2004-05-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|MCH-preschool||Spirometry and Methacholine Challenge Test in Asthmatic Children Age 3-6years|The Effect of Singular (Montelukast) 4mg on Hypersensitivity of the Airways in Children 3-5 Years Old. + Extended Study Hyprsensitivity of the Airways in Asthmatic Children Age 3-6years|Terminated||N/A|84|Actual|Rambam Health Care Campus||1||the study has recently ended, all information gathred as planed|f||||t||||||||||2017-02-18 15:08:07.936146|2017-02-18 15:08:07.936146
NCT00550745|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-06-02|2010-01-07||September 2007||2007-09-01|June 2015|2015-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)|A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX™ in Subjects ≥ 60 Years of Age|Completed||Phase 4|11999|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:08:08.042697|2017-02-18 15:08:08.042697
NCT00550732|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-08-04|2013-09-11||December 2007||2007-12-01|August 2015|2015-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|TIP||A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)|"A Phase II Study on Treatment of Refractory Fungal Infections With Posaconazole. The TIP Study."|Completed||Phase 2|40|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 15:08:09.457845|2017-02-18 15:08:09.457845
NCT00550706|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2013-06-10|||October 2007||2007-10-01|June 2013|2013-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Drug Utilization Prevalence in a Pediatric Care Medical Center|Drug Utilization Prevalence in a Pediatric Care Medical Center|Completed||N/A|567|Actual|Rambam Health Care Campus|||2||f||||f||||||||||2017-02-18 15:08:10.053066|2017-02-18 15:08:10.053066
NCT00550693|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-29|||April 2004||2004-04-01|October 2007|2007-10-01|March 2005|Actual|2005-03-01|||||Interventional|||Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients|A Crossover Intervention Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients|Completed||Phase 4|121|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 15:08:10.151935|2017-02-18 15:08:10.151935
NCT00550680|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2016-02-29|2016-02-29||January 2008||2008-01-01|February 2016|2016-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||Safety Population: All participants who received at least one dose of Mircera/CERA and had at least one safety follow-up assessment.|A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia|A Single Arm, Open Label Study to Assess the Efficacy, Safety, and Tolerability of Once-Monthly Administration of Intravenous C.E.R.A. for the Maintenance of Haemoglobin Levels in Dialysis Patients With Chronic Renal Anaemia|Completed||Phase 3|208|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:08:10.256447|2017-02-18 15:08:10.256447
NCT00550667|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2012-05-16|||October 2007||2007-10-01|April 2012|2012-04-01|June 2013|Anticipated|2013-06-01|||||Observational|||Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood|Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood|Unknown status|Recruiting|N/A|1120|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:08:10.597009|2017-02-18 15:08:10.597009
NCT00550654|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2016-11-16|2012-08-20||October 2007||2007-10-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain|A Phase II Study of Hypofractionated Highly Conformal Radiation With Helical Tomotherapy for Extra-Cranial Oligo|Terminated||Phase 2|1|Actual|National Institutes of Health Clinical Center (CC)||1||Study was terminated due to poor accrual.|f||||f||||||||No||2017-02-18 15:08:10.692275|2017-02-18 15:08:10.692275
NCT00550641|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2010-04-05|||March 2006||2006-03-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|||||Interventional|||Pool-based Exercise in Fibromyalgia Management|Pool-based Exercise in Fibromyalgia Management: a Prospective Randomized Comparison Between Stretching and Ai Chi|Completed||Phase 4|90|Actual|Universidad de Granada||2|||f||||f||||||||||2017-02-18 15:08:11.073869|2017-02-18 15:08:11.073869
NCT00550628|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2015-12-22|||September 2007||2007-09-01|December 2015|2015-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer|Pilot Study of Ex-Vivo Molecular Polyp Imaging Using 18-F Fluorodeoxyglucose (FGD) Positron Emission Tomography (PET) in the Determination of Protein and Gene Expression Signatures of Premalignant Polyps|Completed||N/A|8|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||Samples With DNA|"~     tissue~   "|||2017-02-18 15:08:11.178201|2017-02-18 15:08:11.178201
NCT00550615|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2013-12-13|||September 2007||2007-09-01|December 2013|2013-12-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I/II Study of Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) (BMS Protocol 180129)|Unknown status|Active, not recruiting|Phase 1/Phase 2|47|Anticipated|University of Nebraska||3|||f||||t||||||||||2017-02-18 15:08:11.308622|2017-02-18 15:08:11.308622
NCT00550602|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2017-02-02|||January 2002||2002-01-01|April 2010|2010-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Tracheobronchomalacia: Treatment Outcomes|Tracheobronchomalacia: Treatment Outcomes|Completed||N/A|150|Anticipated|Beth Israel Deaconess Medical Center|||1||f||||f||||||||||2017-02-18 15:08:11.432502|2017-02-18 15:08:11.432502
NCT00550589|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2015-11-17|2011-05-24||September 2007||2007-09-01|November 2015|2015-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus|Phase IIA Trial of 1% Topical Cidofovir for Treatment of High-Grade Perianal Squamous Intraepithelial Lesions in HIV-Infected Men and Women|Completed||Phase 2|33|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-02-18 15:08:11.537495|2017-02-18 15:08:11.537495
NCT00550576|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2013-06-10|||October 2007||2007-10-01|June 2013|2013-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Antibodies to Digoxin for Bipolar Disorder|Antibodies to Digoxin for Bipolar Disorder|Completed||Phase 2|18|Actual|Rambam Health Care Campus||1|||f||||f||||||||||2017-02-18 15:08:11.911737|2017-02-18 15:08:11.911737
NCT00550563|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2015-06-22|||August 2007||2007-08-01|June 2015|2015-06-01|July 2010|Actual|2010-07-01|April 2009|Actual|2009-04-01||Interventional|||DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements|Identification of 24-Hydroxylase Polymorphisms and Splicing Variants That Modulate Vitamin D Oxidative Metabolism and Serum Pharmacokinetics in Patients With Colorectal Cancer on Cholecalciferol Therapy|Completed||N/A|50|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 15:08:12.021569|2017-02-18 15:08:12.021569
NCT00550550|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2015-10-09|2012-08-07||November 2007||2007-11-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Sublingual Immunotherapy With SCH 697243 (Phleum Pratense) in Children 5 to <18 Years of Age With a History of Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma|Completed||Phase 3|345|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:08:12.146472|2017-02-18 15:08:12.146472
NCT00550537|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2011-07-20|||October 2007||2007-10-01|July 2011|2011-07-01||||December 2012|Anticipated|2012-12-01||Interventional|||Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Feasibility Study Investigating Translational Science in Chemotherapy-Naive Patients With Stage IIIb or IV Non-Small Cell Lung Cancer (NSCLC) Treated With the EGFR-TKI, Erlotinib|Unknown status|Active, not recruiting|Phase 2|125|Anticipated|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:08:12.805085|2017-02-18 15:08:12.805085
NCT00550524|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-27|2010-11-19|||December 2007||2007-12-01|November 2010|2010-11-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Interventional|||Stem Cell Transplantation for the Treatment of Knee Osteoarthritis|Phase 1 Study of Bone Marrow - Derived Stem Cell for the Treatment of Knee Osteoarthritis|Unknown status|Enrolling by invitation|Phase 1|5|Anticipated|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-02-18 15:08:12.947943|2017-02-18 15:08:12.947943
NCT00550511|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2007-10-29|||February 2004||2004-02-01|October 2007|2007-10-01|June 2005|Actual|2005-06-01|||||Interventional|||Randomized Study Evaluating the Role of Surgeon-Performed Ultrasound in the Management of the Acute Abdomen|Randomized Study Evaluating the Role of Surgeon-Performed Ultrasound in the Management of the Acute Abdomen|Completed||N/A|800|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 15:08:13.044424|2017-02-18 15:08:13.044424
NCT00550498|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-27|2015-11-09|||December 2007||2007-12-01|November 2015|2015-11-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Stem Cell Transplantation in Ocular Lesions of Behcet's Disease|Phase 1 Study of Bone Marrow - Derived Stem Cell in the Treatment of Ocular Lesions of Behcet's Disease|Terminated||Phase 1|5|Actual|Tehran University of Medical Sciences||1||No improvement obtained in 3 cases. Retinal detachment observed in 2 cases|f||||t||||||||||2017-02-18 15:08:13.138784|2017-02-18 15:08:13.138784
NCT00549978|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2010-07-21|||October 2007||2007-10-01|July 2010|2010-07-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Pharmacokinetics of Probucol and Cilostazol|Phase IV, Safety and Pharmacokinetics of Probucol and Cilostazol When Coadministered in Healthy Subjects|Completed||Phase 4|32|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 15:08:38.327557|2017-02-18 15:08:38.327557
NCT00550485|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-29|2016-09-12|||October 2007||2007-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|March 2012|Actual|2012-03-01||Interventional|||Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene|Blood-brain-barrier Permeability of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene: Effect on Sleep and Procedural Learning|Suspended||N/A|300|Anticipated|Max-Planck-Institute of Psychiatry||2||Reconsidering study methods and design|f||||f||||||||||2017-02-18 15:08:13.250495|2017-02-18 15:08:13.250495
NCT00550472|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2008-04-10|||December 2004||2004-12-01|April 2008|2008-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||The Effect of a Probiotic Intervention in Healthy Subjects and Patients With Atopic Dermatitis|Intervention Study on the Effects of a Probiotic Yoghurt Drink on the Immune System and Further Physiological Parameters in Patients With Atopic Dermatitis and Healthy Persons|Completed||N/A|30|Actual|University of Jena||1|||f||||t||||||||||2017-02-18 15:08:13.345699|2017-02-18 15:08:13.345699
NCT00550459|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2011-04-26|2010-08-05||August 2007||2007-08-01|April 2011|2011-04-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|INSIGHT||Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients|A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients|Completed||Phase 3|57|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|Pilot study powered only for serum Na+ improvements. Trial lacked sufficient power to detect changes in neurocognitive test scores and SF-12 and HDS outcomes.|2|||f||||t||||||||||2017-02-18 15:08:13.457451|2017-02-18 15:08:13.457451
NCT00550446|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2012-11-29|2012-11-29||September 2007||2007-09-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis|A Phase 2b, Randomized, Double Blind, Placebo Controlled Active Comparator, Multicenter Study To Compare 5 Dose Regimens Of CP- 690,550 And Adalimumab Versus Placebo, Administered For 6 Months In The Treatment Of Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|386|Actual|Pfizer||7|||f||||f||||||||||2017-02-18 15:08:14.501962|2017-02-18 15:08:14.501962
NCT00550433|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2008-01-11|||September 2007||2007-09-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Study Evaluating Bazedoxifene/CE in Postmenopausal Women|An Open-Label, Single-Dose, Randomized, 4-Period, Crossover, Bioequivalence Study of Clinical and Commercial Formulations of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||f||||||||||2017-02-18 15:08:26.54199|2017-02-18 15:08:26.54199
NCT00550420|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2016-10-26||2010-03-29|October 2007||2007-10-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers|An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-5)|Terminated||Phase 3|383|Actual|GlaxoSmithKline||1||Based on preliminary parent study results|f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:08:26.616149|2017-02-18 15:08:26.616149
NCT00550407|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2016-10-11|2010-05-24||November 2007||2007-11-01|October 2016|2016-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients|Study SCA104779, an Evaluation of BW430C (Lamotrigine) Versus Placebo in the Prevention of Mood Episodes in Bipolar I Disorder Patients|Completed||Phase 3|215|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:08:26.807374|2017-02-18 15:08:26.807374
NCT00550394|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2014-10-01|||April 2008||2008-04-01|October 2014|2014-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults|Quetiapine Plus Topiramate or Placebo for Bipolar Mania & Alcohol Use in Adolescents & Young Adults|Completed||Phase 4|31|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 15:08:27.816813|2017-02-18 15:08:27.816813
NCT00550381|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2009-07-08|||January 2008||2008-01-01|July 2009|2009-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects|Ascending Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of HKI-357 Administered Orally to Healthy Subjects|Completed||Phase 1|72|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||10|||f||||f||||||||||2017-02-18 15:08:27.925799|2017-02-18 15:08:27.925799
NCT00550368|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2016-10-13|2016-02-23||August 2005||2005-08-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Clinical Experiment of Helicobacter Pylori Transmission|Effect of Gastric Acid and H. Pylori Infection on Infection With Enteropathogenic E. Coli|Completed||N/A|45|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 15:08:28.012413|2017-02-18 15:08:28.012413
NCT00550355|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2009-07-13|||August 2007||2007-08-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis|A Randomized, Subject and Investigator-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Intravenously Administered Doses of PD-0360324 in Patients With Rheumatoid Arthritis Receiving Methotrexate|Completed||Phase 1|78|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 15:08:28.565524|2017-02-18 15:08:28.565524
NCT00550342|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2012-04-12|||January 2008||2008-01-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Rituximab Treatment of Focal Segmental Glomerulosclerosis|Anti-CD20, Rituximab, for the Treatment of Recurrent or Primary Resistant Focal Segmental Glomerulosclerosis (FSGS)|Completed||Phase 2|10|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 15:08:28.696199|2017-02-18 15:08:28.696199
NCT00550329|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2008-10-17|||October 2007||2007-10-01|October 2008|2008-10-01|November 2007|Actual|2007-11-01|||||Observational|||Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets|An Open-Label, Randomized, Single-Dose, Two-Way Crossover Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets Manufactured At Brooklyn, New York Versus At Barceloneta, Puerto Rico In Healthy Subjects|Completed||Phase 1|32||Pfizer|||||f||||||||||||||2017-02-18 15:08:28.809403|2017-02-18 15:08:28.809403
NCT00550303|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2007-12-18|||October 2007||2007-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens|An Open-Label, Single-Dose, Non-Randomized, 4-Period Crossover Bioavailability Study of Bazedoxifene Contained in Bazedoxifene/Conjugated Estrogen Tablets Administered to Healthy Postmenopausal Women|Completed||Phase 1|28|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:08:28.894322|2017-02-18 15:08:28.894322
NCT00550290|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2009-06-24|||October 2007||2007-10-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy|Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy|Completed||N/A|160|Anticipated|Aultman Health Foundation||2|||f||||f||||||||||2017-02-18 15:08:28.959701|2017-02-18 15:08:28.959701
NCT00550277|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2012-10-31|2012-08-22||January 2008||2008-01-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||LBH589 Treatment for Refractory Clear Cell Renal Carcinoma|A Phase II Study of LBH589 in the Treatment of Patients With Refractory Clear Cell Renal Carcinoma|Completed||Phase 2|20|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 15:08:29.17785|2017-02-18 15:08:29.17785
NCT00550264|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2011-06-27|||February 2007||2007-02-01|June 2011|2011-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study of Physician Awareness of and Communication About Patient Readmissions to the Hospital|Physician Awareness of and Communication About Hospital Readmissions|Completed||N/A|500|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 15:08:29.440162|2017-02-18 15:08:29.440162
NCT00550251|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2016-11-04|||July 2010||2010-07-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study|Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? Formal Study|Recruiting||N/A|58|Anticipated|Sue Ryder Care||2|||f||||f||||||||||2017-02-18 15:08:29.534891|2017-02-18 15:08:29.534891
NCT00550238|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2016-05-17|||July 2007||2007-07-01|May 2016|2016-05-01||||December 2017|Anticipated|2017-12-01||Interventional|||A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis|A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson's Disease|Active, not recruiting||Phase 3|500|Anticipated|ACADIA Pharmaceuticals Inc.||1|||f||||||||||||||2017-02-18 15:08:29.656152|2017-02-18 15:08:29.656152
NCT00550225|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2016-11-02|||November 2007||2007-11-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Succinate Salt Version of GSK961081 for Healthy Volunteers|A Randomised, Double-blind, Dose Escalating Study in Healthy Volunteers to Assess the Safety, Tolerability, Extra Pulmonary Pharmacodynamics and Pharmacokinetics of Single Doses of GSK961081 (Succinate Salt)|Completed||Phase 1|18|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:08:30.032718|2017-02-18 15:08:30.032718
NCT00547820|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-20|2009-10-27|||July 2007||2007-07-01|October 2007|2007-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Urinary Sensor for Cystourethrography|Urinary Sensor for Cystourethrography|Completed||N/A|20|Anticipated|Rambam Health Care Campus||2|||f||||||||||||||2017-02-18 15:08:30.125392|2017-02-18 15:08:30.125392
NCT00547807|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2009-02-25|||January 2007||2007-01-01|February 2009|2009-02-01||||February 2009|Actual|2009-02-01||Interventional|||Non-Nutritive Sucking and Swaddling for Pain Relief in Term Neonates: Randomised Controlled Trial|Non-Nutritive Sucking and Swaddling for Pain Relief in Term Neonates: a Randomised Controlled Trial|Unknown status|Recruiting|N/A|34|Anticipated|Sociedade Hospital Samaritano||1|||f||||f||||||||||2017-02-18 15:08:30.224999|2017-02-18 15:08:30.224999
NCT00547794|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2015-05-06|||June 2007||2007-06-01|May 2015|2015-05-01|November 2010|Actual|2010-11-01|August 2010|Actual|2010-08-01||Observational|AVERT-AF||AVJ Ablation Followed by Resynchronization Therapy in Patients With CHF and AF|AVERT-AF: Atrio-VEntricular Junction Ablation Followed by Resynchronization Therapy in Patients With Congestive Heart Failure and Atrial Fibrillation|Terminated||N/A|14|Actual|St. Jude Medical|||2|Difficulty in patient enrollment|f||||t||||||||||2017-02-18 15:08:30.314529|2017-02-18 15:08:30.314529
NCT00547781|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2012-03-30|||July 2007||2007-07-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Implantation Failure and PGD||Completed||Phase 4|250|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||||||||||||2017-02-18 15:08:30.420832|2017-02-18 15:08:30.420832
NCT00547768|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2011-01-10|||November 2002||2002-11-01|January 2011|2011-01-01|December 2002|Actual|2002-12-01|||||Interventional|||Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.||Completed||Phase 4|36|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:08:30.499069|2017-02-18 15:08:30.499069
NCT00547742|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2010-07-16|||July 2005||2005-07-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Observational|||Correlation of PET-CT Studies With Serum Protein Analysis|Correlation of PET-CT Studies With Serum Protein Analysis|Completed||N/A|1500|Anticipated|Stanford University|||1||f||||||||||Samples Without DNA|"~     blood~   "|||2017-02-18 15:08:30.583184|2017-02-18 15:08:30.583184
NCT00547729|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2016-06-09||2016-05-18|March 2005||2005-03-01|June 2016|2016-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|HOMEOSTASIS||Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS)|Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients: A Prospective, Multi-center, Non-randomized, Open Label Study.|Completed||Phase 1/Phase 2|40|Actual|St. Jude Medical||1|||f||||t||||||||No||2017-02-18 15:08:30.65967|2017-02-18 15:08:30.65967
NCT00547716|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2017-01-05|||June 2009||2009-06-01|January 2017|2017-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C Infection|The Effect of Omega-3 Fatty Acids (Omacor@) on the Response Rate to Antiviral Therapy in Patients With Chronic Hepatitis C Infection|Withdrawn||N/A|0|Actual|University of Missouri, Kansas City||2||Lack of study enrollment.|f||||f||||||||||2017-02-18 15:08:30.777741|2017-02-18 15:08:30.777741
NCT00550199|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-26|2013-08-15|||November 2007||2007-11-01|August 2013|2013-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||LBH589 and Gemcitabine in the Treatment of Solid Tumors|A Phase I Study of LBH589 in Combination With Gemcitabine in the Treatment of Solid Tumors|Terminated||Phase 1|17|Actual|SCRI Development Innovations, LLC||1||Study terminated due to LBH589 toxicity.|f||||f||||||||||2017-02-18 15:08:33.499699|2017-02-18 15:08:33.499699
NCT00547703|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2012-06-07|2012-02-20||February 2008||2008-02-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia|Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia|Terminated||N/A|5|Actual|Cleveland Clinic Florida|We were unable to recruit an adequate number of patients to make any meaningful conclusion.|2||Not enough participants - only 5 since the study started|f||||f||||||||||2017-02-18 15:08:30.890583|2017-02-18 15:08:30.890583
NCT00547690|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2012-06-04|||April 2003||2003-04-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Acupuncture in Stroke Rehabilitation|Electro-acupuncture and Strengthening Exercise for Hemiplegic Elbow and Wrist Joints|Terminated||Phase 2|20|Anticipated|University of Kansas Medical Center||2||Expired IRB approval|f||||f||||||||||2017-02-18 15:08:31.269498|2017-02-18 15:08:31.269498
NCT00547677|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2009-02-06|||July 2004||2004-07-01|January 2008|2008-01-01||||December 2007|Anticipated|2007-12-01||Interventional|||Stereotactic Radiosurgery in Treating Patients With Liver Metastases|A Phase I Trial of Stereotactic Radiosurgery for Patients With Hepatic Metastases (SBRT Liver)|Unknown status|Active, not recruiting|Phase 1|27|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:08:31.363249|2017-02-18 15:08:31.363249
NCT00547664|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2014-02-27|||January 2008||2008-01-01|February 2014|2014-02-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy of Hylenex in the Treatment of Pain Among Hospice Patients||Completed||N/A|88|Actual|HPC Healthcare, Inc.||2|||f||||t||||||||||2017-02-18 15:08:31.47331|2017-02-18 15:08:31.47331
NCT00547651|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2016-10-31||2011-07-19|September 2007||2007-09-01|October 2016|2016-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy|AMR PH GL 2007 CL001 Phase 3 A Randomized, Open-Label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients With Extensive or Limited and Sensitive or Refractory Small Cell Lung Cancer After Failure of First-Line Chemotherapy|Completed||Phase 3|637|Actual|Celgene Corporation||2|||f||||t||||||||||2017-02-18 15:08:31.585952|2017-02-18 15:08:31.585952
NCT00547638|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2013-08-02|2013-03-01||August 2007||2007-08-01|August 2013|2013-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Show Equivalence of DERMABOND PROTAPE to DERMABOND HVD for Wound Closure|Multicenter, Prospective, Randomized Controlled Study to Show Equivalence of DERMABOND PROTAPE to DERMABOND HVD for Closure of Simple, Thoroughly Cleansed, Trauma-induced Wounds in the Emergency Department|Completed||Phase 2|216|Actual|Ethicon, Inc.|The percentages of participants who withdrew prematurely from the study from each group could represent a possible study limitation.|2|||f||||f||||||||||2017-02-18 15:08:31.939435|2017-02-18 15:08:31.939435
NCT00547625|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||October 2004||2004-10-01|October 2007|2007-10-01|July 2005|Actual|2005-07-01|||||Interventional|PILUTS||Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems|A Multicenter, Parallel-Arm, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Tadalafil Administered Once Daily to Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia|Completed||Phase 2|275|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:08:32.60911|2017-02-18 15:08:32.60911
NCT00547612|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2012-03-14|||September 2007||2007-09-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer|Pilot Trial of the NK1 Receptor Radio-Ligand [18F]SPA-RQ: Imaging Pancreatic Ductal Adenocarcinoma|Completed||Phase 1|33|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 15:08:32.724376|2017-02-18 15:08:32.724376
NCT00547599|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||April 2003||2003-04-01|October 2007|2007-10-01|January 2004|Actual|2004-01-01|||||Interventional|||Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects|Does Presence of Distress Due to Erectile Dysfunction Affect the Effect of Tadalafil on Sexual Life and Life Satisfaction?|Completed||Phase 4|659|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:08:32.824498|2017-02-18 15:08:32.824498
NCT00547586|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2011-07-22||2009-03-02|October 2007||2007-10-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain|A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study of Oral MOA-728 for the Treatment of Opioid- Induced Bowel Dysfunction in Subjects With Chronic Nonmalignant Pain|Completed||Phase 2|120|Actual|Valeant Pharmaceuticals International, Inc.||5|||f||||t||||||||||2017-02-18 15:08:32.936361|2017-02-18 15:08:32.936361
NCT00547573|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||April 2003||2003-04-01|October 2007|2007-10-01|December 2003|Actual|2003-12-01|||||Interventional|||Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection|"A Multinational, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil Administered On Demand to Asian Men With Erectile Dysfunction"|Completed||Phase 3|367|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 15:08:33.083512|2017-02-18 15:08:33.083512
NCT00547560|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2011-04-01|||August 2007||2007-08-01|April 2011|2011-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population|An Ascending Multiple Dose Study Of The Safety, Pharmacokinetics, And Pharmacodynamics Of GSI-953 Administered Orally To Healthy Elderly Subjects|Completed||Phase 1|49|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:08:33.193214|2017-02-18 15:08:33.193214
NCT00547547|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2015-11-04|||April 2006||2006-04-01|November 2015|2015-11-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer|A Phase I Study of a Combination of High Selenium Brassica Juncea With Irinotecan and Capecitabine|Completed||Phase 1|22|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 15:08:33.305835|2017-02-18 15:08:33.305835
NCT00550212|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2012-05-10|||March 2008||2008-03-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study Evaluating Oral Administrations of HKI-272 in Healthy Male Subjects|An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]-Labeled HKI-272 in Healthy Male Subjects|Completed||Phase 1|6|Actual|Puma Biotechnology, Inc.||1|||f||||f||||||||||2017-02-18 15:08:33.417016|2017-02-18 15:08:33.417016
NCT00550173|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2013-01-10|2013-01-10||November 2007||2007-11-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer|A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed Alone, and Erlotinib Alone, as Second-Line Treatment for Non-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer|Completed||Phase 2|247|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 15:08:33.717632|2017-02-18 15:08:33.717632
NCT00550160|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2015-09-17|||April 2007||2007-04-01|September 2015|2015-09-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|KNUST-COMDIS||The Synergistic Effects of Home-management and Intermittent Preventive Treatment of Malaria in Children|The Clinical Impact of Seasonal Intermittent Preventive Treatment (IPT) and Home Management of Malaria (HMM) Using AQ+AS in Ghanaian Children Under 5 Years of Age - a Cluster Randomised Placebo Controlled Trial.|Completed||Phase 4|1490|Actual|Kwame Nkrumah University of Science and Technology||2|||f||||f||||||||||2017-02-18 15:08:35.450447|2017-02-18 15:08:35.450447
NCT00550147|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2015-05-08|2009-04-03||February 2004||2004-02-01|May 2015|2015-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.|An Open-Label Study of Quetiapine Added to Oros Methylphenidate in the Treatment of ADHD and Aggressive Behavior|Completed||Phase 2|30|Actual|Indiana University|There were no unanticipated limitations/caveats. All of the typical caveats of open-label studies apply: As a result, bias, placebo effects, demand characteristics, and other non-treatment related effects may have contributed to results.|1|||f||||t||||||||||2017-02-18 15:08:35.550866|2017-02-18 15:08:35.550866
NCT00550134|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2016-12-16|||October 2007||2007-10-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Cognitive Changes Associated With Breast Cancer Treatment|Cognitive Changes Associated With Breast Cancer Treatment|Active, not recruiting||N/A|80|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||Samples With DNA|"~     blood~   "|||2017-02-18 15:08:36.095696|2017-02-18 15:08:36.095696
NCT00550121|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2008-10-13|||August 2007||2007-08-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|||||Interventional|||Does Ascorbic Acid Reduce Sympathoexcitation in CHF?||Completed||N/A|||Radboud University||2|||f||||||||||||||2017-02-18 15:08:36.228449|2017-02-18 15:08:36.228449
NCT00550108|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2008-06-23|||October 2007||2007-10-01|June 2008|2008-06-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||Management of Incidentally Discovered Pancreatic Cysts|A Prospective Study of the Management of Incidentally Discovered Pancreatic Cysts|Terminated||Phase 3|0|Actual|Massachusetts General Hospital||2||Inability to enroll subjects.|f||||t||||||||||2017-02-18 15:08:36.331408|2017-02-18 15:08:36.331408
NCT00550095|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2012-05-06|||June 2007||2007-06-01|May 2012|2012-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus|A 24 Week, Multi-centre, Open Label, Non Controlled Study to Assess the Efficacy of Valsartan in Reducing Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|509|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:08:36.451666|2017-02-18 15:08:36.451666
NCT00550082|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2012-02-09|||July 2007||2007-07-01|February 2012|2012-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||3 Screen Electronic Alert|Multi-Screen Electronic Alert for Venous Thromboembolism Prevention|Completed||N/A|880|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 15:08:36.550131|2017-02-18 15:08:36.550131
NCT00550069|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2007-12-24|||December 2007||2007-12-01|December 2007|2007-12-01|January 2009|Anticipated|2009-01-01|||||Observational|||Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year|Late Preterm Infants:Clinical Course and Outcome From Birth Through Out the First Year of Life.|Unknown status|Not yet recruiting|N/A|300|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:08:36.656473|2017-02-18 15:08:36.656473
NCT00550056|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2007-10-25|||January 2003||2003-01-01|October 2007|2007-10-01|April 2004|Actual|2004-04-01|||||Interventional|||Treatment of Posttraumatic Stress Disorder by Trained Lay Counsellors in an African Refugee Settlement|Talking About Traumatic Events - A Randomized Controlled Dissemination Study of the Treatment of PTSD in an African Refugee Settlement|Completed||Phase 3|277|Actual|University of Konstanz||3|||f||||f||||||||||2017-02-18 15:08:36.757275|2017-02-18 15:08:36.757275
NCT00550043|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2015-03-09|2015-02-09||October 2007||2007-10-01|March 2015|2015-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis|A Double-blind, Placebo-controlled Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|50|Actual|Incyte Corporation||5|||f||||f||||||||||2017-02-18 15:08:36.867353|2017-02-18 15:08:36.867353
NCT00550030|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2012-03-15|||August 2006||2006-08-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Etanercept Plus UVB-311nm Phototherapy in Psoriasis|Prospective, Randomized Half-side Study on the Efficacy of UVB-311nm Phototherapy in Patients With Psoriasis Undergoing Etanercept Treatment|Completed||N/A|6|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 15:08:37.880435|2017-02-18 15:08:37.880435
NCT00550017|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2015-09-23||2011-06-21|December 2007||2007-12-01|September 2015|2015-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2)|A Phase 1/2, Ascending Multiple-Dose Study to Evaluate the Safety, Efficacy and Pharmacokinetics of BMS-753493 in Subjects With Advanced Cancer (Schedule 2)|Terminated||Phase 1/Phase 2|39|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:08:37.988204|2017-02-18 15:08:37.988204
NCT00550004|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2011-06-06|||September 2007||2007-09-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|RP101||Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine|Randomized, Double Blind, Placebo Controlled, Phase 2 Study Evaluating the Efficacy & Safety of RP101 or Placebo in Combination With Gemcitabine Administered as First-Line Treatment to Subjects With Unresectable, Locally Advanced, or Metastatic Pancreatic Adenocarcinoma|Terminated||Phase 2|153|Anticipated|SciClone Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:08:38.08719|2017-02-18 15:08:38.08719
NCT00549991|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2013-11-26|||August 2007||2007-08-01|April 2009|2009-04-01|June 2012|Actual|2012-06-01|||||Observational|||Analyzing Genes That May Increase the Risk of Developing High Blood Pressure|Fine Mapping of Hypertension Genes Detected by Admixture Mapping in the FBPP|Completed||N/A|8687|Actual|Case Western Reserve University|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 15:08:38.240436|2017-02-18 15:08:38.240436
NCT00549965|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-26|||October 2003||2003-10-01|October 2007|2007-10-01||||||||Interventional|||Satisfaction and Compliance of Risedronate in PMO|A Multicenter, Prospective, Randomized, 2-Way Crossover, Open-Label Phase IV Study in Postmenopausal Women With Osteoporosis Examining Subject Satisfaction and Compliance When Actonel(Rosedronate) is Administered 35mg Once a Week or 5mg|Completed||Phase 4|202|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:08:38.425831|2017-02-18 15:08:38.425831
NCT00549952|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2007-10-25|||October 2007||2007-10-01|October 2007|2007-10-01|March 2008|Anticipated|2008-03-01|||||Observational|||Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients|Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients|Unknown status|Recruiting|N/A|||Korea Otsuka Pharmaceutical Co., Ltd.|||||f||||f||||||||||2017-02-18 15:08:38.510368|2017-02-18 15:08:38.510368
NCT00549939|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2014-10-21|2011-01-13||October 2007||2007-10-01|October 2014|2014-10-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|ALFACHIN||Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction|12-week, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy, Pharmacodynamic and Safety of 2 Doses of Alfuzosin (0.1 mg/kg/Day, 0.2 mg/kg/Day) in the Treatment of Children and Adolescents 2-16 Years With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology Followed by a 40-week Open-label Extension|Completed||Phase 3|172|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 15:08:38.611158|2017-02-18 15:08:38.611158
NCT00549926|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2010-02-16|||October 2007||2007-10-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|||||Interventional|Yokohama-ACS||Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)|Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)|Completed||Phase 4|200|Anticipated|Yokohama City University Medical Center||4|||f||||f||||||||||2017-02-18 15:08:39.915036|2017-02-18 15:08:39.915036
NCT00549913|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2014-11-06|||October 2007||2007-10-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)|A Dose-escalation Study to Assess the Feasibility and Safety of 3 Different Doses of NeoFuse When Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion With Instrumentation.|Completed||Phase 1/Phase 2|6|Actual|Mesoblast, Ltd.||6|||f||||t||||||||||2017-02-18 15:08:40.019606|2017-02-18 15:08:40.019606
NCT00549900|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2016-10-27|2009-11-12||December 2007||2007-12-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females|Safety and Immunogenicity Study of the HPV Vaccine (GSK-580299) in Healthy, Chinese, Female Subjects|Completed||Phase 1|30|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:08:40.173474|2017-02-18 15:08:40.173474
NCT00549887|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2010-03-15|||September 2007||2007-09-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|SWING||An Observational Study Evaluating Patient Satisfaction and Quality of Life Associated With Switching Insulin|Resource Utilisation and Patient Satisfaction With SWitching INsulin (SWING)|Completed||N/A|2459|Actual|Eli Lilly and Company|||2||f||||f||||||||||2017-02-18 15:08:40.710815|2017-02-18 15:08:40.710815
NCT00549874|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-11-08|||February 2002||2002-02-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes|Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes|Completed||N/A|27|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 15:08:40.857836|2017-02-18 15:08:40.857836
NCT00549861|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2011-10-02|||September 2007||2007-09-01|October 2011|2011-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR|Characterization of Irreversible Myocardial Injury in Dilated Forms of Cardiomyopathies by Gadobutrol (Gadovist®)-Enhanced Cardiovascular Magnetic Resonance Imaging|Completed||N/A|40|Actual|University of Calgary||1|||f||||t||||||||||2017-02-18 15:08:40.965692|2017-02-18 15:08:40.965692
NCT00549848|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2016-08-29|||October 2007||2007-10-01|August 2016|2016-08-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Recruiting||Phase 3|531|Anticipated|St. Jude Children's Research Hospital||2|||f||||t||||||||||2017-02-18 15:08:41.088434|2017-02-18 15:08:41.088434
NCT00549835|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2015-04-07|||August 2007||2007-08-01|March 2015|2015-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Acupuncture for Mucositis Pain in Cancer Care|Acupuncture for Mucositis Pain in Cancer Care|Withdrawn||N/A|0|Actual|Johns Hopkins University||2||Inadequate funding|f||||f||||||||||2017-02-18 15:08:41.237777|2017-02-18 15:08:41.237777
NCT00549822|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2015-10-06|||October 2007||2007-10-01|October 2015|2015-10-01|September 2013|Actual|2013-09-01|May 2010|Actual|2010-05-01||Interventional|||Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer|A Phase II Clinical Trial of Intermittent Letrozole Therapy in Postmenopausal Women With CA 15-3 Positive, Hormone Receptor Positive, Metastatic Breast Cancer|Completed||Phase 2|3|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:08:41.34772|2017-02-18 15:08:41.34772
NCT00549809|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2008-06-27|||October 2005||2005-10-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|||Comparison Between IMV and SIMV/PS for Ventilatory Support of Children: a Randomized Clinical Trial|Comparison Between IMV and SIMV/PS for Ventilatory Support of Children: a Randomized Clinical Trial|Completed||Phase 3|70|Actual|UPECLIN HC FM Botucatu Unesp||1|||f||||f||||||||||2017-02-18 15:08:41.475445|2017-02-18 15:08:41.475445
NCT00549796|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2014-09-10|||April 2006||2006-04-01|September 2014|2014-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Randomized Comparison Angioplasty Outcomes at Hospitals With and Without On-site Cardiac Surgery|Randomized Comparison Angioplasty Outcomes at Hospitals With and Without On-site Cardiac Surgery|Completed||N/A|18876|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 15:08:41.588073|2017-02-18 15:08:41.588073
NCT00549783|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2012-07-18|2011-11-14||October 2007||2007-10-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|January 2010|Actual|2010-01-01||Interventional|||BOTOX® Economic Spasticity Trial (BEST)||Completed||Phase 4|274|Actual|Allergan||2|||f||||f||||||||||2017-02-18 15:08:41.759883|2017-02-18 15:08:41.759883
NCT00549770|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-08-11|2012-08-10||September 2007||2007-09-01|August 2015|2015-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy and Safety of LCZ696A in Patients With Essential Hypertension|A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Range Study to Evaluate the Efficacy and Safety of LCZ696 Comparatively to Valsartan, and to Evaluate AHU377 to Placebo After 8 Week Treatment in Patients With Essential Hypertension|Completed||Phase 2|1334|Actual|Novartis||8|||f||||f||||||||||2017-02-18 15:08:42.555018|2017-02-18 15:08:42.555018
NCT00549757|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2014-04-01|2014-02-03||October 2007||2007-10-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|ALTITUDE|Full Analysis Set (FAS) : All patients randomized except mis-randomized patients who did not receive study drug.|Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine Whether, in Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, Aliskiren, on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality|Terminated||Phase 3|8606|Actual|Novartis||2||Lack of benefit and safety concern|f||||||||||||||2017-02-18 15:08:44.290188|2017-02-18 15:08:44.290188
NCT00549744|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2012-05-31||2009-07-22|November 2007||2007-11-01|February 2011|2011-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing|A Randomized, Double-blind, Double-dummy, Placebocontrolled,Three-period, Incomplete Block, Crossover Study, to a Investigate the Effect of 14 Days Repeat Inhaled Dosing With GSK256066 in Mild/Moderate Asthmatic Patients.|Completed||Phase 2|72|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:08:53.168336|2017-02-18 15:08:53.168336
NCT00549731|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-05-31|||June 2005||2005-06-01|April 2012|2012-04-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Observational|||Participant Database for Autism Research Studies|Participant Database for Persons Interested in Autism Research Studies: Recruiting, Pre-Screening and Diagnostic Assessment|Unknown status|Recruiting|N/A|5000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-02-18 15:08:53.265635|2017-02-18 15:08:53.265635
NCT00549718|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2014-06-05|2010-11-08||October 2007||2007-10-01|June 2014|2014-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia|A Phase 3 Randomized, Placebo-Controlled, CLinical Trial to Study the Safety and Efficacy of Three Doses of Lurasidone HCl in Acutely Psychotic Patients With Schizophrenia|Completed||Phase 3|489|Actual|Sunovion||4|||f||||t||||||||||2017-02-18 15:08:53.368338|2017-02-18 15:08:53.368338
NCT00549705|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-09-15|||July 2007||2007-07-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Registry of Hospitalized Patients Treated With Fondaparinux|Registry of Hospitalized Patients Treated With Fondaparinux|Completed||N/A|220|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 15:08:54.160781|2017-02-18 15:08:54.160781
NCT00549692|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2012-09-25|||November 2007||2007-11-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|August 2012|Actual|2012-08-01||Interventional|IgAN||Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy|Minimization, Double-blind, Placebo-controlled, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of IgA Nephropathy|Completed||Phase 3|152|Actual|Kuhnil Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 15:08:54.255733|2017-02-18 15:08:54.255733
NCT00549679|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2012-10-25||2009-11-30|October 2007||2007-10-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients|A Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety and Tolerability of Inhaled GSK256066 in Mild to Moderate COPD Patients|Completed||Phase 2|104|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 15:08:54.362706|2017-02-18 15:08:54.362706
NCT00549666|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2011-09-12|||August 2007||2007-08-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|OC-DDI||A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects|A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects|Completed||Phase 1|23|Actual|Sunovion||3|||f||||t||||||||||2017-02-18 15:08:54.613167|2017-02-18 15:08:54.613167
NCT00549653|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2012-05-31|||October 2007||2007-10-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men|A Randomized, Single Blind, Repeat Dose, Placebo-controlled, Single-period, Parallel Group Study to Investigate the Safety, Tolerability and Potential Pharmacokinetic Interactions Between GW856553 and Rosuvastatin (10mg), When Co-administered in Healthy Adult Male Subjects|Completed||Phase 1|44|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:08:54.72082|2017-02-18 15:08:54.72082
NCT00549640|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2011-04-15|2010-09-08||January 2008||2008-01-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|||Testing Methylphenidate for Smoking Abstinence|Efficacy of Methylphenidate for Treating Tobacco Dependence|Completed||Phase 2|80|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 15:08:54.811196|2017-02-18 15:08:54.811196
NCT00549627|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-02-03|||August 2005||2005-08-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of the PediGuard™ for Pedicle Screw Insertion|Evaluation of the PediGuard™ for Pedicle Screw Insertion|Suspended||N/A|108|Actual|Shriners Hospitals for Children||1||New funding sources being sought|f||||f||||||||||2017-02-18 15:08:55.283116|2017-02-18 15:08:55.283116
NCT00549614|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2009-10-06|||October 2007||2007-10-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|ACME||Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart Failure|Effect of 4 Weeks Treatment With Acipimox on Left Ventricular Function, Work Capacity, Insulin Sensitivity and Substrate Metabolism in Patients With Chronic Heart Failure|Completed||N/A|28|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:08:55.36102|2017-02-18 15:08:55.36102
NCT00549419|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2009-12-21|||October 2007||2007-10-01|January 2009|2009-01-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|REPEAT||Arterial Pressure Based Cardiac Output for Goal-Directed Therapy in Abdominal Surgery|Randomized Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Therapy in Patients Undergoing Major Abdominal Surgery|Completed||Phase 4|60|Actual|Klinikum Ludwigshafen||2|||f||||t||||||||||2017-02-18 15:08:59.594658|2017-02-18 15:08:59.594658
NCT00549601|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2011-02-24|2011-01-05||September 2007||2007-09-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|KAPA||Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease|A Multi-center, Randomised, Open-label Study to Evaluate Convenience and Safety of Change in the Mode of Administration of Rivastigmine (From Capsules to a Transdermal Patch) in Patients With Alzheimer's Disease|Completed||Phase 4|142|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:08:55.462454|2017-02-18 15:08:55.462454
NCT00549588|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-09-29|||February 2004||2004-02-01|September 2009|2009-09-01|August 2006|Actual|2006-08-01|June 2004|Actual|2004-06-01||Interventional|||Sunscreen and After-sun-lotion Protection in Polymorphic Light Eruption|The Efficacy of a Sunscreen With SPF30 and a After-sun-lotion in the Prevention of Polymorphic Light Eruption|Completed||N/A|14|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 15:08:56.212345|2017-02-18 15:08:56.212345
NCT00549575|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-25|||July 2000||2000-07-01|October 2007|2007-10-01|June 2006|Actual|2006-06-01|||||Interventional|||L-Arginine Treatment for Severe Vascular Fetal Intrauterine Growth Restriction: a Randomized Double Bind Controlled Trial (L Arginine in IUGR)|L-Arginine Treatment for Severe Vascular Fetal Intrauterine Growth Restriction: a Randomized Double Bind Controlled Trial|Terminated||Phase 3|44|Actual|Nantes University Hospital||2||terminated|f||||||||||||||2017-02-18 15:08:56.323133|2017-02-18 15:08:56.323133
NCT00549562|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2015-05-14|||November 2007||2007-11-01|May 2015|2015-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of Paliperidone ER in Adolescents and Young Adults With Autism|A Prospective, Open-Label Study of Paliperidone ER in Adolescents and Young Adults With Autism|Completed||Phase 3|30|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 15:08:56.418676|2017-02-18 15:08:56.418676
NCT00549549|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2011-01-27|2010-12-17||February 2008||2008-02-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Celebrex In Acute Gouty Arthritis Study|A Phase 3, Randomized, Double-Blind, Multicenter, Active-Controlled Trial To Evaluate The Efficacy And Safety Of Celecoxib (Celebrex®) And Indomethacin In The Treatment Of Moderate To Severe Acute Gouty Arthritis|Completed||Phase 3|402|Actual|Pfizer|Patients Global Evaluation of study medication data was collected at Day 9 only.|4|||f||||t||||||||||2017-02-18 15:08:56.555284|2017-02-18 15:08:56.555284
NCT00549536|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-25|2008-07-02|||January 2007||2007-01-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure|The Effect of Oral Calcium Supplementation on Insulin Sensitivity, Intracellular Cationic Concentrations and the Transmembrane Sodium/Hydrogen Exchanger Activity in Subjects With Type 2 Diabetes and Hypertension|Completed||Phase 4|31|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-02-18 15:08:58.666163|2017-02-18 15:08:58.666163
NCT00549523|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2016-10-07|||April 2008||2008-04-01|October 2016|2016-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults|A Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of Lessertia Frutescens (L.)Goldblatt and J.C. Manning (Syn. Sutherlandia Frutescens (L.)R. Br.)in HIV-infected South African Adults|Completed||Phase 1/Phase 2|133|Actual|University of Missouri-Columbia||4|||f||||t||||||||No||2017-02-18 15:08:58.775644|2017-02-18 15:08:58.775644
NCT00549510|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2010-10-13||2010-10-13|October 2007||2007-10-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.|A Non-randomized, Open-label, Single-dose, Crossover Study to Evaluate the Dose Proportionality of the Final Fixed Dose Combination Formulation of COREG CR™ and Lisinopril.|Completed||Phase 1|29|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:08:58.905837|2017-02-18 15:08:58.905837
NCT00549497|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2017-02-02|||September 2007|Actual|2007-09-01|February 2011|2011-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers|A Randomized, Double-blind, Placebo-controlled, Dose Ascending, 3-cohort Parallel Group Study to Measure the Systemic Cortisol Profile and Evaluate the Safety, Tolerability and Pharmacokinetics of GW870086X, Administered as Single Doses (12mg and 15mg), and Repeat Doses Over 3 Days (6mg, 12mg and 15mg) in Healthy Male Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:08:58.997807|2017-02-18 15:08:58.997807
NCT00549484|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2008-01-16|||May 2003||2003-05-01|January 2008|2008-01-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Observational|||Thrombopoietin Levels and Platelet Transfusion in Neonates|Thrombopoietin Levels Following Platelet Transfusion in Neonates With Thrombocytopenia|Completed||N/A|20|Actual|Christiana Care Health Services|||2||f||||f||||||Samples With DNA|"~     Blood samples were collected pre and post platelet transfusion. Samples included platelet~     count, thrombopoietin, and platelet factor 4.~   "|||2017-02-18 15:08:59.096211|2017-02-18 15:08:59.096211
NCT00549471|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2011-04-20|||September 2007||2007-09-01|April 2011|2011-04-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Improvement After Botulinum Toxin Injections to the Arms in Children With Cerebral Palsy|Improvement After Botulinum Toxin A Injections to the Upper Extremities in Children With Cerebral Palsy|Terminated||Phase 4|3|Actual|Shaare Zedek Medical Center||2||no funding|f||||f||||||||||2017-02-18 15:08:59.190162|2017-02-18 15:08:59.190162
NCT00549458|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-09-17|||April 2006||2006-04-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Randomized Controlled Trial Comparing Traditional Pelvic Floor Rehabilitation to Pilates in Increasing Pelvic Muscles Strength.||Completed||N/A|60|Anticipated|Atlantic Health System||1|||f||||f||||||||||2017-02-18 15:08:59.301323|2017-02-18 15:08:59.301323
NCT00549445|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2012-08-29|||August 2007||2007-08-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|||||Observational|||Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)|Effect of Macrolide Treatment on a Novel Pathway of Neutrophilic Inflammation in COPD|Completed||N/A|53|Actual|University of Alabama at Birmingham|||2||f||||f||||||Samples Without DNA|"~     Serum and Plasma~   "|||2017-02-18 15:08:59.385218|2017-02-18 15:08:59.385218
NCT00549432|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-05-14|||October 2002||2002-10-01|May 2009|2009-05-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|l||Clinical Study of Abdominal Aortic Aneurysm Exclusion (TALENT Abdominal)|Clinical Study of Abdominal Aortic Aneurysm Exclusion Using the TALENT Enhanced LPS Endoluminal Stent-Graft System|Unknown status|Active, not recruiting|N/A|75|Anticipated|Arizona Heart Institute||1|||f||||f||||||||||2017-02-18 15:08:59.485871|2017-02-18 15:08:59.485871
NCT00549406|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2014-12-19|||June 2008||2008-06-01|December 2014|2014-12-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Interventional|||Visual Training Program to Improve Balance and Prevent Falls in Older Adults|"Visual Processing and Postural Reactions: Development and Pilot Testing of a Visual Training Program to Improve Balance Control and Prevent Falls in Older Adults"|Completed||Phase 1|33|Actual|Sunnybrook Health Sciences Centre||3|||f||||f||||||||||2017-02-18 15:08:59.686557|2017-02-18 15:08:59.686557
NCT00549393|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2015-09-01|2015-03-31||February 2008||2008-02-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Interventional|||Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit|Impact of Daily Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit|Completed||Phase 2/Phase 3|5659|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 15:08:59.790961|2017-02-18 15:08:59.790961
NCT00549380|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2010-05-25|||October 1999||1999-10-01|May 2009|2009-05-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|Endologix||Clinical Study of Aneurysm Exclusion|A Clinical Study of Aneurysm Exclusion Using Endologix, Inc. Endoluminal Technology|Unknown status|Active, not recruiting|Phase 1|88|Anticipated|Arizona Heart Institute||1|||f||||f||||||||||2017-02-18 15:09:02.85233|2017-02-18 15:09:02.85233
NCT00549367|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2017-01-17|||November 2007||2007-11-01|April 2016|2016-04-01|December 2022|Anticipated|2022-12-01|December 2019|Anticipated|2019-12-01||Interventional|TACH001||The Role of Diet Education and Nutritional Counselling in the Ongoing Care of People Living With HIV in Thailand|The Role of Diet Education and Nutritional Counselling in the Ongoing Care of People Living With HIV in Thailand (TACH001)|Active, not recruiting||Phase 1|153|Anticipated|Thai Red Cross AIDS Research Centre||1|||f||||f||||||||||2017-02-18 15:09:02.946861|2017-02-18 15:09:02.946861
NCT00549354|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2015-06-02|||August 2000||2000-08-01|October 2007|2007-10-01|December 2012|Anticipated|2012-12-01|||||Interventional|||Abdominal Aortic/Aorto-Iliac Aneurysm Endoluminal Graft Study|Endologix Bifurcated PowerLink System Clinical Study|Unknown status|Active, not recruiting|Phase 2|34|Actual|Arizona Heart Institute||2|||f||||f||||||||||2017-02-18 15:09:03.041739|2017-02-18 15:09:03.041739
NCT00549341|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2016-03-25|||May 2006||2006-05-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|||PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia|A Phase I, Single-dose, Double-blind, Placebo Controlled, Dose Escalation Study to Evaluate the Safety of PurTox for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia and to Explore Dose-associated Efficacy|Completed||Phase 1|70|Actual|Mentor Worldwide, LLC||2|||f||||f||||||||||2017-02-18 15:09:03.149971|2017-02-18 15:09:03.149971
NCT00549328|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2014-11-06|2009-12-22||February 2008||2008-02-01|November 2014|2014-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer|A Phase II, Non-randomized, Multi-center Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) in Subjects With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|14|Actual|GlaxoSmithKline||1||"Study enrolment was delayed in starting and too slow to support further development in this~   setting"|f||||||||||||||2017-02-18 15:09:03.251336|2017-02-18 15:09:03.251336
NCT00549315|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-05-14|||October 2002||2002-10-01|May 2009|2009-05-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|Valiant||Clinical Study of Thoracic Aortic Aneurysm Exclusion|Clinical Study of Thoracic Aortic Aneurysm Exclusion Using the VALIANT System|Unknown status|Recruiting|N/A|60|Anticipated|Arizona Heart Institute||1|||f||||f||||||||||2017-02-18 15:09:03.826259|2017-02-18 15:09:03.826259
NCT00549302|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2013-04-01|2013-01-16||December 2005||2005-12-01|April 2013|2013-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs|An Extension Study to Evaluate the Long-Term Safety and Efficacy of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment of Patients With Pulmonary Arterial Hypertension|Completed||Phase 3|357|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:09:03.942753|2017-02-18 15:09:03.942753
NCT00547534|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2015-07-15|2011-04-06||October 2007||2007-10-01|July 2015|2015-07-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|BVR||Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma|Pilot Study of Bortezomib, Bendamustine and Rituximab for Patients With Relapsed or Refractory, Indolent or Mantle Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|31|Actual|University of Rochester|19 patients received a full 6 cycles of therapy. All patients received at least one cycle of therapy, 25 patients received at least 4 cycles. Reasons for early termination included progressive disease and toxicity|1|||f||||t||||||||||2017-02-18 15:09:05.437412|2017-02-18 15:09:05.437412
NCT00547521|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2015-03-13|2010-10-15||December 2007||2007-12-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|December 2008|Actual|2008-12-01||Interventional|||Phase IIIB Subcutaneous Abatacept Monotherapy Study|A Phase IIIb, Multi-center, Stratified, Open-Label Study to Evaluate the Immunogenicity, Steady State Trough Level, and Safety of Subcutaneous Abatacept (BMS-188667) in Subjects With Rheumatoid Arthritis Administered With or Without Background Methotrexate|Completed||Phase 3|119|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 15:09:05.763416|2017-02-18 15:09:05.763416
NCT00547508|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||October 2002||2002-10-01|October 2007|2007-10-01|September 2003|Actual|2003-09-01|||||Interventional|||To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking|A Randomized, Double-Blind, Parallel, Placebo-Controlled Study in Men With Erectile Dysfunction to Evaluate the Efficacy and Safety of Tadalafil When Sexual Attempts Occur at Specific Time Points After Dosing|Completed||Phase 3|485|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-02-18 15:09:07.76114|2017-02-18 15:09:07.76114
NCT00547495|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||March 2004||2004-03-01|October 2007|2007-10-01|November 2004|Actual|2004-11-01|||||Interventional|||Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection|"A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Tadalafil Administered On Demand to Patients With Erectile Dysfunction"|Completed||Phase 3|343|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 15:09:07.870323|2017-02-18 15:09:07.870323
NCT00549289|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-24||||||October 2007|2007-10-01||||||||Interventional|||Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)||Completed||Phase 3|||Sirion Therapeutics, Inc.|||||||||||||||||||2017-02-18 15:09:07.975024|2017-02-18 15:09:07.975024
NCT00549263|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2015-02-19|||February 2008||2008-02-01|February 2015|2015-02-01||||||||Interventional|||Bioequivalence Study of SB797620 in Healthy Japanese Volunteers|A Bioequivalence Study With a Combination Tablet Formulation of Rosiglitazone (RSG) and Glimepiride (GLIM)(4mg/2mg) Compared to Concomitant Dosing of RSG 4mg Tablet and GLIM 1mg Commercial Tablet x 2 (4mg+2mg) in Japanese Healthy Male Subjects|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||||No subjects enrolled, bio equivalence study, canceled before active.|f||||f||||||||||2017-02-18 15:09:08.124731|2017-02-18 15:09:08.124731
NCT00549250|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2010-07-01|||November 2007||2007-11-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|June 2008|Actual|2008-06-01||Observational|||Human Papillomavirus 6/11 in the Lower Airway of Neonates|Human Papillomavirus 6/11 in the Lower Airway of Neonates|Completed||N/A|114|Actual|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     Bronchial lavage fluid~   "|||2017-02-18 15:09:08.202531|2017-02-18 15:09:08.202531
NCT00549237|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2013-09-05|||November 2007||2007-11-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Perioperative Nutrition in Gastric Bypass Surgery|Perioperative Nutrition in Gastric Bypass Surgery for Morbid Obesity|Completed||N/A|200|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 15:09:08.292797|2017-02-18 15:09:08.292797
NCT00549211|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2012-03-15|||October 2007||2007-10-01|February 2011|2011-02-01||||||||Interventional|||A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.|A Two-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of GSK557296 in a Randomized, Single-Blind, Placebo-Controlled, Dose-Rising Design, and to Evaluate the Effect of Food on Single Oral Doses of GSK557296 in Healthy Adult Subjects|Completed||Phase 1|42|Anticipated|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:09:08.398591|2017-02-18 15:09:08.398591
NCT00549198|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2011-04-07|2010-09-23||June 2007||2007-06-01|April 2011|2011-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ASSERT||KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects|Study of Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz in Antiretroviral-Naive, HIV-1 Infected Adult Subjects|Completed||Phase 4|392|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 15:09:08.524758|2017-02-18 15:09:08.524758
NCT00549185|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2012-02-13|||October 2007||2007-10-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma|An Open-label Multi-dose-escalation, Safety and Pharmacokinetic Study of SAR3419 Administered as a Single Agent by Intravenous Infusion Every 3 Weeks in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 1|39|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:09:11.378407|2017-02-18 15:09:11.378407
NCT00549172|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2015-03-16|2015-03-16||October 2007||2007-10-01|August 2013|2013-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Age, Sex, Weight, Height, BMI, Duration of medial knee pain, Type of onset of symptoms, Radiographic assessment (Kellfren-Lawrence), Clinical meniscal tests|Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear|Efficacy of Arthroscopic Partial Resection for the Degenerative Tear of the Medial Meniscus of a Knee|Completed||Phase 2/Phase 3|146|Actual|University of Tampere||2|||f||||t||||||||||2017-02-18 15:09:11.477175|2017-02-18 15:09:11.477175
NCT00549159|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2008-05-19|||October 2007||2007-10-01|May 2008|2008-05-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||CavatermTM vs TCRE in Women With DUB|Multicenter Randomized Clinical Trial to Evaluate the Safety and Effectiveness of Cavaterm TM Thermal Balloon Endometrial Ablation in Women With Dysfunctional Uterine Bleeding Compared to Transcervical Resection of the Endometrium (TCRE)|Unknown status|Recruiting|Phase 4|158|Anticipated|Pnn Medical A/S||2|||f||||f||||||||||2017-02-18 15:09:12.153993|2017-02-18 15:09:12.153993
NCT00549146|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2017-01-19|||November 2003|Actual|2003-11-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease|Multi-centre, DB, R and Stratified Parallel Group Study to Compare the Efficacy and Safety of FP 500mcg Bid vs. SRT 50/250mcg Via Diskus in COPD Pts With Partial Reversible Obstruction|Completed||Phase 3|290|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:09:12.259188|2017-02-18 15:09:12.259188
NCT00549133|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-24|||October 2003||2003-10-01|October 2007|2007-10-01|April 2005|Actual|2005-04-01|||||Interventional|IREDIS||Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol|Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol|Completed||Phase 4|44|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:09:12.380836|2017-02-18 15:09:12.380836
NCT00549120|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2016-10-27|||August 2007||2007-08-01|October 2016|2016-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Optimising the Propranolol Block Model|A Study to Optimise the Propranolol Block Model for Assessment of the Pharmacological Activity of Bronchodilators in Healthy Volunteers.|Completed||Phase 1|18|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:09:12.466046|2017-02-18 15:09:12.466046
NCT00549107|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-24|||September 2007||2007-09-01|October 2007|2007-10-01||||||||Interventional|Levomil||Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants|Phase 2 Prospective, Randomized, Double-Blind Pilot Study on Cardiac Output Following Corrective Open Heart Surgery in Children Less Than One Year: Use of Levosimendan Versus Milrinone.|Unknown status|Recruiting|Phase 2|40|Anticipated|Ludwig Boltzmann Gesellschaft||2|||f||||t||||||||||2017-02-18 15:09:12.592066|2017-02-18 15:09:12.592066
NCT00549081|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-24|||January 2008||2008-01-01|October 2007|2007-10-01|December 2008||2008-12-01|||||Interventional|||DHEA Supplementation for Low Ovarian Response IVF Patients||Unknown status|Not yet recruiting|N/A|||Shaare Zedek Medical Center||2|||f||||f||||||||||2017-02-18 15:09:12.703616|2017-02-18 15:09:12.703616
NCT00549068|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-12-04|||February 2003||2003-02-01|December 2009|2009-12-01|November 2004|Actual|2004-11-01|||||Interventional|||POWER Point of Care Effect on Satisfaction of Treatment|Impact of NTx Point of Care (POC) Device on Patient Satisfication With Actonel 35mg Once a Seek Treatment a Multicenter Prospective Open Label Randomized Controlled Community Practice-based Study|Completed||Phase 4|2433|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:09:12.788969|2017-02-18 15:09:12.788969
NCT00547170|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2008-05-14|||January 2007||2007-01-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Tu Du Doxy||Doxycycline Prophylaxis at Vacuum Aspiration Trial|Efficacy and Side-Effects of Two Dosing Regimens of Doxycycline at Surgical Abortion: A Randomized Double-Blind Trial|Completed||Phase 4|1000|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 15:09:40.218998|2017-02-18 15:09:40.218998
NCT00549055|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2011-02-15|2010-10-01||November 2007||2007-11-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|MACURELI||A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.|A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration (AMD) In Real Life (Macureli Study).|Completed||N/A|38|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:09:12.870236|2017-02-18 15:09:12.870236
NCT00549042|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2012-03-20|||September 2007||2007-09-01|March 2012|2012-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain|A Phase III, Variable-Dose Titration Followed by a Randomized Double-Blind Study of Controlled-Release OROS® Hydromorphone HCl (NMED-1077) Compared to Placebo in Patients With Chronic Low Back Pain|Completed||Phase 3|266|Actual|Mallinckrodt||2|||f||||||||||||||2017-02-18 15:09:13.172624|2017-02-18 15:09:13.172624
NCT00549029|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-24|||August 2007||2007-08-01|October 2007|2007-10-01|January 2008|Anticipated|2008-01-01|||||Observational|||The Association of Genetic Polymorphisms With Statin-Induced Myopathy.|Association Analysis Between Single Nucleotide Polymorphisms in Statin-Related Genes and The Incidence of Myopathy Among Statin-Treated Patients|Unknown status|Recruiting|N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 15:09:13.362488|2017-02-18 15:09:13.362488
NCT00549016|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-05-14|||November 2002||2002-11-01|May 2009|2009-05-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|EndoMed||Clinical Study of Aneurysm Exclusion|Clinical Study of Aneurysm Exclusion Using PTFE Encapsulation of Nitinol Stents|Unknown status|Recruiting|N/A|150|Anticipated|Arizona Heart Institute||1|||f||||f||||||||||2017-02-18 15:09:13.474788|2017-02-18 15:09:13.474788
NCT00549003|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-24|||February 2005||2005-02-01|October 2007|2007-10-01|August 2005|Actual|2005-08-01|||||Interventional|ZRDT||Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar|Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar|Completed||Phase 4|9346|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-02-18 15:09:13.58253|2017-02-18 15:09:13.58253
NCT00548990|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2009-01-23|||August 2002||2002-08-01|January 2009|2009-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|ImFIT||The Immune Function Intervention Trial|Physical Activity, Aging and Immune Function|Completed||N/A|150|Actual|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 15:09:13.665125|2017-02-18 15:09:13.665125
NCT00548977|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2007-10-24|||January 2001||2001-01-01|October 2007|2007-10-01|February 2005|Actual|2005-02-01|||||Observational|||Genetic Studies Spermatogenic Failure||Completed||N/A|283|Actual|National Cheng-Kung University Hospital|||2||f||||t||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 15:09:13.762591|2017-02-18 15:09:13.762591
NCT00548964|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-24|2014-05-22|||October 2007||2007-10-01|May 2014|2014-05-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Continuation Ketamine in Major Depression|Continuation Intravenous Ketamine in Major Depressive Disorder - Modification: Lithium for Relapse Prevention|Completed||Phase 1|36|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 15:09:13.851538|2017-02-18 15:09:13.851538
NCT00548951|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-14|||September 2005||2005-09-01|December 2015|2015-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Alzheimer Patients and the Snoezelen Program|The Connection Between Sensory Deprivation and Social Withdrawal in Clients of a Long Term Care Facility Living With Alzheimer's Disease and the Effects of a Snoezelen Program.|Completed||Phase 1|18|Actual|Queen's University||3|||f||||f||||||||||2017-02-18 15:09:13.963642|2017-02-18 15:09:13.963642
NCT00548938|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2009-09-17|||October 2007||2007-10-01|September 2009|2009-09-01|October 2010|Anticipated|2010-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM|A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed by Metronomic Therapy With Temozolomide for Newly Diagnosed Malignant High Grade Glioma|Terminated||Phase 2|40|Anticipated|Methodist Healthcare||1||Principal Investigator has left the institution|f||||t||||||||||2017-02-18 15:09:14.23096|2017-02-18 15:09:14.23096
NCT00548925|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2013-01-11||2011-09-21|November 2007||2007-11-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain|A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894 Versus Placebo in Subjects With Diabetic Neuropathic Pain|Completed||Phase 2|124|Actual|AbbVie||2|||f||||f||||||||||2017-02-18 15:09:14.347182|2017-02-18 15:09:14.347182
NCT00548912|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2007-10-23||||||October 2007|2007-10-01||||||||Interventional|||Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease||Completed||Phase 4|||West Penn Allegheny Health System|||||f||||||||||||||2017-02-18 15:09:14.493662|2017-02-18 15:09:14.493662
NCT00548899|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2015-03-06|||November 2007||2007-11-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|SOFIA||Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer|Phase II Study of Neoadjuvant Epirubicin, Cyclophosphamide (EC) + Sorafenib Followed by Paclitaxel (P) + Sorafenib in Women With Previously Untreated|Completed||Phase 2|36|Actual|German Breast Group||1|||f||||t||||||||||2017-02-18 15:09:14.590904|2017-02-18 15:09:14.590904
NCT00548886|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2015-02-20|2015-02-20||February 2008||2008-02-01|February 2015|2015-02-01|June 2012|Actual|2012-06-01|January 2012|Actual|2012-01-01||Interventional|LEAP||Low-dose Epinephrine Infusion Tests in Adolescent and Pediatric Patients|Low-dose Epinephrine Infusion Tests in Adolescent and Pediatric Patients|Terminated||N/A|7|Actual|Emory University|Slow enrollment lead to an early termination of the study|1||Lack of enrollment|f||||f||||||||||2017-02-18 15:09:14.72139|2017-02-18 15:09:14.72139
NCT00548860|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2015-07-08|2013-10-08||October 2007||2007-10-01|July 2015|2015-07-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients|A Multi-center, Randomized Controlled Study to Investigate the Safety and Tolerability of IV Ferric Carboxymaltose (FCM) vs Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients|Completed||Phase 3|2018|Actual|Luitpold Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:09:14.945626|2017-02-18 15:09:14.945626
NCT00546962|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2011-05-12|||April 1999||1999-04-01|May 2011|2011-05-01||||||||Observational|||Tissue Bank for Pulmonary Diseases|Tissue Bank for Pulmonary Diseases|Unknown status|Recruiting|N/A|400|Anticipated|Boston Children’s Hospital|||1||f||||t||||||||||2017-02-18 15:09:42.973317|2017-02-18 15:09:42.973317
NCT00548847|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2016-09-18|2016-07-08||January 2007||2007-01-01|September 2016|2016-09-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation|A Pilot Phase II Study of Immunotherapy for the Treatment of AML, ALL, BP CML, and MDS Relapsed After Allogeneic Transplantation|Completed||Phase 2|15|Actual|Emory University||1|||f||||t||||||||||2017-02-18 15:09:15.362728|2017-02-18 15:09:15.362728
NCT00548834|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-09-03|||June 2003||2003-06-01|February 2010|2010-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis|Efficacy and Safety of CDP870 400 mg Subcutaneously Versus Placebo in the Treatment of the Signs and Symptoms of Patients With Rheumatoid Arthritis Who Have Previously Failed at Least One DMARD|Completed||Phase 3|220|Anticipated|UCB Pharma|||||f||||f||||||||||2017-02-18 15:09:15.710086|2017-02-18 15:09:15.710086
NCT00548821|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2008-05-13||||||May 2008|2008-05-01||||||||Interventional|||Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer|A Phase III Randomized Trial Between 5 Day 3 Weekly and Weekly Cisplatin Based Chemotherapy for Patients With Locally Advanced Cervical Cancer|Unknown status|Not yet recruiting|Phase 3|||National University Hospital, Singapore||2|||f||||t||||||||||2017-02-18 15:09:15.804688|2017-02-18 15:09:15.804688
NCT00548808|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2010-08-20|2010-08-20||November 2007||2007-11-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study for Type 2 Diabetic Patients|Comparison of Insulin Lispro Low Mixture With Insulin Glargine When Initiating and Intensifying Insulin Therapy As Required in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Oral Antihyperglycemic Medication|Completed||Phase 4|426|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:09:15.92988|2017-02-18 15:09:15.92988
NCT00548795|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2014-09-26|||August 2007||2007-08-01|July 2009|2009-07-01|July 2012|Actual|2012-07-01|January 2011|Actual|2011-01-01||Observational|||Viral-Related Neutrophil Response and Condition Severity in People With ARDS|A Prospective Assessment of Viral-induced Adaptation of Neutrophil Response in ARDS - Ancillary to ARDS Network Trials|Completed||N/A|132|Actual|National Jewish Health|||1||f||||t||||||||||2017-02-18 15:09:17.098497|2017-02-18 15:09:17.098497
NCT00548782|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2013-06-20|||September 2007||2007-09-01|June 2013|2013-06-01||||June 2013|Actual|2013-06-01||Interventional|||Paleolithic Diets vs T2D and Improvements in the Metabolic Syndrome|Paleolithic Diets and Metabolic Control in Type 2 Diabetes Mellitus|Completed||N/A|22|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:09:17.190835|2017-02-18 15:09:17.190835
NCT00548769|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2017-01-18|||April 2007||2007-04-01|January 2017|2017-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients|An Open-label, Randomised, Four Period Crossover Study to Investigate the Relative Pharmacokinetic Profiles of Tablets From Three Batches of Firategrast With Different Surface Areas and Two Different Tablet Formulations Containing the Same Batch of Firategrast, Given as Single 900mg Doses to Male and Female Subjects With a Diagnosis of Multiple Sclerosis|Completed||Phase 1|37|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:09:17.294155|2017-02-18 15:09:17.294155
NCT00548756|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2016-12-14|||January 2001||2001-01-01|December 2016|2016-12-01||||December 2018|Anticipated|2018-12-01||Interventional|||Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy|A Phase III Prospective Randomized Trial Comparing Radiosurgery With Versus Without Whole Brain Radiotherapy for 1-3 Newly Diagnosed Brain Metastases|Active, not recruiting||Phase 3|152|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:09:17.390846|2017-02-18 15:09:17.390846
NCT00548743|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2007-12-03|||September 2005||2005-09-01|October 2007|2007-10-01|August 2010|Anticipated|2010-08-01|||||Interventional|TRIPPD||Translating Research Into Practice for Postpartum Depression|Practice Based Clinical Trial of Screening, Diagnosis and Follow up Management for Postpartum Depression in Family Medicine Practices.|Unknown status|Recruiting|N/A|3000|Anticipated|Olmsted Medical Center||2|||f||||t||||||||||2017-02-18 15:09:17.499559|2017-02-18 15:09:17.499559
NCT00548730|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2009-02-06|||October 2007||2007-10-01|January 2009|2009-01-01|December 2010|Anticipated|2010-12-01|||||Observational|NWA||Comparison Trial of White Light, Autofluorescence and Narrow Band Imaging Bronchoscopy|A Clinical Comparison Trial of White Light Bronchoscopy, Autofluorescence Bronchoscopy and Narrow Band Imaged Bronchoscopy|Unknown status|Recruiting|N/A|100|Anticipated|Maimonides Medical Center|||1||f||||f||||||Samples Without DNA|"~     Endobronchial biopsies of normal and abnormal mucosa for histopathology~   "|||2017-02-18 15:09:17.605697|2017-02-18 15:09:17.605697
NCT00548717|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2014-10-20|2014-09-29||October 2007||2007-10-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation|Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease Prophylaxis After Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation|Terminated||Phase 2|15|Actual|Dana-Farber Cancer Institute|Early termination leading to small numbers of subjects analyzed. Results are reported for transparency only, and should not be used to extrapolate significant conclusions.|2||"First two patients enrolled after trial reopened, developed grade III-IV acute GVHD and~   subsequently passed away."|f||||t||||||||||2017-02-18 15:09:17.720591|2017-02-18 15:09:17.720591
NCT00548704|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2015-10-20|||April 2002||2002-04-01|November 2013|2013-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines|A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents|Completed||Phase 2/Phase 3|57|Actual|Onxeo||1|||f||||f||||||||||2017-02-18 15:09:18.210594|2017-02-18 15:09:18.210594
NCT00548691|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2015-05-11|2013-09-16||October 2007||2007-10-01|May 2015|2015-05-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional||Safety population - of the 517 total subjects randomized, 4 subjects randomized to FCM were discontinued from the study prior to dosing due to selection critirea/study compliance (3 subjects) and subject request (1 subject)|Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients|A Multi-center, Randomized Controlled Study to Investigate the Safety and Tolerability of IV Ferric Carboxymaltose (FCM) vs Standard Medical Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients|Completed||Phase 3|513|Actual|Luitpold Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:09:18.341897|2017-02-18 15:09:18.341897
NCT00548678|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2008-07-15|||October 2007||2007-10-01|July 2008|2008-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers|Open-Label, Randomized, Single-Dose, Four-Treatment Crossover Study to Evaluate Platelet Function in Healthy Adult Males After Administration of IV Diclofenac Sodium, Oral Diclofenac Potasssium, IV Ketorolac Tromethamine, and Acetylsalicylic Acid|Completed||Phase 1|30|Actual|Javelin Pharmaceuticals||4|||f||||f||||||||||2017-02-18 15:09:21.312319|2017-02-18 15:09:21.312319
NCT00548665|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2014-12-02|||November 2007||2007-11-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|CAROSS||Carotid Plaque Screening Trial in Smokers|Impact of Carotid Plaque Screening on Smoking Cessation and Control of Other Cardiovascular Risk Factors: A Randomized Controlled Trial.|Completed||Phase 4|536|Actual|University of Lausanne||2|||f||||f||||||||||2017-02-18 15:09:21.423724|2017-02-18 15:09:21.423724
NCT00548652|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2014-03-19|||August 2007||2007-08-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Role of Apathy in the Effectiveness of Weight Loss Interventions|Role of Apathy in the Effectiveness of Weight Loss Interventions in Obese Patients|Completed||N/A|125|Actual|VA Nebraska Western Iowa Health Care System||5|||f||||f||||||||||2017-02-18 15:09:21.551355|2017-02-18 15:09:21.551355
NCT00548639|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2009-05-04|||August 2007||2007-08-01|May 2009|2009-05-01||||April 2010|Anticipated|2010-04-01||Interventional|||The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients|The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients|Unknown status|Active, not recruiting|N/A|152|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 15:09:21.666277|2017-02-18 15:09:21.666277
NCT00548626|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2015-12-18|||October 2007||2007-10-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|EMUNE-07||Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer|EMUNE-07 Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer|Completed||N/A|47|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 15:09:21.773583|2017-02-18 15:09:21.773583
NCT00548613|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2011-04-27|||October 2007||2007-10-01|April 2011|2011-04-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Combination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium|Phase I Study to Determine the Safety and Feasibility of the Use of a Combination Stem Cell Therapy in Patients With Acute Myocardial Infarction|Completed||Phase 1|20|Anticipated|TCA Cellular Therapy||2|||f||||f||||||||||2017-02-18 15:09:21.889177|2017-02-18 15:09:21.889177
NCT00548600|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2007-10-22|||May 1992||1992-05-01|October 2007|2007-10-01|September 2006|Actual|2006-09-01|||||Interventional|||Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate|A Randomized Clinical Trial Comparing Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy Using a Combination of a Temporaory Iridium Implant Plus External Beam Radiation in Surgically Staged B2 and C Carcinoma of the Prostate|Completed||Phase 3|112|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-02-18 15:09:21.996114|2017-02-18 15:09:21.996114
NCT00548587|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2016-01-05||2013-05-21|October 2007||2007-10-01|November 2015|2015-11-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary Syndrome|A Randomised, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and Its Effects on Clinical Events and Biomarkers in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome|Completed||Phase 2|600|Actual|Eisai Inc.||4|||f||||t||||||||||2017-02-18 15:09:22.50813|2017-02-18 15:09:22.50813
NCT00548574|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2015-03-03|||December 2003||2003-12-01|November 2007|2007-11-01|July 2005|Actual|2005-07-01|||||Interventional|||Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis|A Phase III, Randomized, Multi-Centre, Double-blind, Double Dummy, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to ASACOL 0.8g Three Times Daily, in Subjects With Mild to Moderate Ulcerative Colitis|Completed||Phase 3|343|Actual|Shire|||||f||||f||||||||||2017-02-18 15:09:22.60991|2017-02-18 15:09:22.60991
NCT00548561|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2015-10-20|||June 2001||2001-06-01|November 2013|2013-11-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines|A Clinical Trial on TopotectTM (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents|Completed||Phase 2/Phase 3|23|Actual|Onxeo|||||f||||f||||||||||2017-02-18 15:09:22.710767|2017-02-18 15:09:22.710767
NCT00548548|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2015-02-26|2011-12-15||September 2007||2007-09-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2009|Actual|2009-11-01||Interventional|AVAGAST||A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer|A Double-blind, Randomised, Multicenter, Phase III Study of Bevacizumab in Combination With Capecitabine and Cisplatin Versus Placebo in Combination With Capecitabine and Cisplatin, as First-line Therapy in Patients With Advanced Gastric Cancer|Completed||Phase 3|774|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:09:22.828683|2017-02-18 15:09:22.828683
NCT00547482|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2010-12-15|||September 2007||2007-09-01|April 2008|2008-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study|The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study|Terminated||N/A|300|Actual|MetaCure (USA), Inc.||2||Protocol design under review.|f||||t||||||||||2017-02-18 15:09:23.795492|2017-02-18 15:09:23.795492
NCT00547469|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2008-04-07|||October 2007||2007-10-01|April 2008|2008-04-01||||||||Interventional|||A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Effectiveness of DDP733 in Female Patients With Irritable Bowel Syndrome With Constipation|Unknown status|Recruiting|Phase 2/Phase 3|360|Anticipated|Dynogen Pharmaceuticals||4|||f||||t||||||||||2017-02-18 15:09:24.137216|2017-02-18 15:09:24.137216
NCT00547456|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2015-11-13|2015-05-27||October 2005||2005-10-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Consequences of Nocturnal and Daytime Hypoxemia in COPD||Terminated||N/A|20|Actual|Northwell Health||1|||f||||f||||||||||2017-02-18 15:09:24.296763|2017-02-18 15:09:24.296763
NCT00547443|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2010-10-19|||July 2007||2007-07-01|October 2008|2008-10-01||||July 2009|Anticipated|2009-07-01||Interventional|||Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Randomized Phase I/II Study Of Sorafenib In Combination With High Does Chemoradiation In Patients With Stage IIIA/B Non-small Cell Lung Cancer (NSCLC)|Terminated||Phase 1/Phase 2|84|Anticipated|National Cancer Institute (NCI)||2||Withdrawn as the sponsor has stopped the drug for NSCLC population|||||||||||||||2017-02-18 15:09:24.540161|2017-02-18 15:09:24.540161
NCT00547417|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||July 2003||2003-07-01|October 2007|2007-10-01|March 2004|Actual|2004-03-01|||||Interventional|||To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections|"An Open-Label Study to Evaluate the Efficacy and Safety of Tadalafil Administered On Demand to Men of Various Populations With Erectile Dysfunction"|Completed||Phase 3|1933|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:09:24.666832|2017-02-18 15:09:24.666832
NCT00547404|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2009-04-21|||December 2008||2008-12-01|April 2009|2009-04-01|July 2010|Anticipated|2010-07-01|December 2009|Anticipated|2009-12-01||Interventional|||Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma|An Open Label, Multicenter Phase I Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma|Withdrawn||Phase 1|35|Anticipated|Piramal Enterprises Limited||1||Not to expose the patients to subtherapeutic dose|f||||f||||||||||2017-02-18 15:09:24.768433|2017-02-18 15:09:24.768433
NCT00547391|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2012-04-17|||November 2007||2007-11-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Recurrent Throat Infections and Tonsillectomy|Recurrent Throat Infections and Tonsillectomy|Completed||Phase 4|87|Actual|Oulu University Hospital||2|||f||||f||||||||||2017-02-18 15:09:24.856351|2017-02-18 15:09:24.856351
NCT00547378|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2016-11-30|||October 2007||2007-10-01|November 2016|2016-11-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|InSite - OAB||InSite for Over Active Bladder|Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)|Completed||Phase 4|571|Actual|MedtronicNeuro||2|||f||||f||||||||||2017-02-18 15:09:24.966881|2017-02-18 15:09:24.966881
NCT00547365|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2013-09-16|2013-02-04||October 2007||2007-10-01|September 2013|2013-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Patients with cardiac-dominant AL amyloidosis, as determined from standard clinical tests (IVS, BNP),were entered on study.|Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction|Therapeutic Potential of Human Immune Globulin Intravenous (IGIV) in Patients With Cardiac-Associated Light Chain (AL) Amyloidosis|Completed||Phase 1/Phase 2|10|Actual|University of Tennessee||1|||f||||f||||||||||2017-02-18 15:09:25.064579|2017-02-18 15:09:25.064579
NCT00547352|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||June 2004||2004-06-01|October 2007|2007-10-01|June 2005|Actual|2005-06-01|||||Interventional|||Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection|Switching From Sildenafil Citrate to Tadalafil in Treatment of Erectile Dysfunction: Assessment of Treatment Preference|Completed||Phase 4|160|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:09:25.290632|2017-02-18 15:09:25.290632
NCT00547339|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2011-02-18|||July 2006||2006-07-01|June 2010|2010-06-01||||October 2010|Anticipated|2010-10-01||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer|A Phase I and II Study of Stereotactic Body Radiation Therapy (SBRT) for Low and Intermediate Risk Prostate Cancer (SBRT Prostate)|Unknown status|Recruiting|Phase 1/Phase 2|97|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:09:25.390812|2017-02-18 15:09:25.390812
NCT00547326|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2008-04-07||||||April 2008|2008-04-01||||||||Interventional|||The Effect of Osteopatic Cranial Techniques on the Audiometric and Tympanometric Values in Children Suffering From Otitis Media With Effusion.|The Effect of Osteopatic Cranial Techniques on the Audiometric and Tympanometric Values in Children Suffering From Otitis Media With Effusion.|Withdrawn||N/A|60|Anticipated|University Hospital, Ghent||2||Ethics Committee approval denied|f||||f||||||||||2017-02-18 15:09:25.484642|2017-02-18 15:09:25.484642
NCT00547300|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2009-01-12|||October 2007||2007-10-01|January 2009|2009-01-01|October 2008||2008-10-01|||||Interventional|||Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension|Tolerability of Nebivolol Compared With Metoprolol ER in Patients With Mild to Moderate Hypertension Taking Hydrochlorothiazide|Completed||Phase 3|400|Anticipated|Forest Laboratories|||||||||||||||||||2017-02-18 15:09:25.576335|2017-02-18 15:09:25.576335
NCT00547287|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||November 2002||2002-11-01|October 2007|2007-10-01|May 2004|Actual|2004-05-01|||||Interventional|||Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations|Switching From Sildenafil Citrate to Tadalafil in Treatment of Erectile Dysfunction: Multinational Assessment of Treatment Preference|Completed||Phase 3|2760|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:09:25.697581|2017-02-18 15:09:25.697581
NCT00547274|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2015-06-11|||July 2003||2003-07-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Dyslipidemia in Type 2 Diabetes (0767-034)||Terminated||Phase 3|111|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:09:25.798419|2017-02-18 15:09:25.798419
NCT00547261|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2009-04-16|||October 2007||2007-10-01|April 2009|2009-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer|Phase I Dose Escalation and Pharmacokinetic Study of SSR97225 Administered as a 1 Hour IV Infusion D1 Every 3 Weeks (Arm A) or Administered as a 1hour IV Infusion D1, D8, D15 Every 3 Weeks (Arm B) in Patients With Refractory Solid Tumors|Terminated||Phase 1|6|Actual|Sanofi||2||Due to lack of supply of the investigational product.|f||||||||||||||2017-02-18 15:09:25.866315|2017-02-18 15:09:25.866315
NCT00547248|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2016-10-26||2009-05-20|October 2007||2007-10-01|October 2016|2016-10-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines|Booster Vaccination Course With the Pneumococcal Vaccine GSK 1024850A, DTPw-HBV/Hib and OPV or IPV in Children Who Completed the Primary Vaccination Course in Study 107007|Completed||Phase 3|756|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:09:25.95971|2017-02-18 15:09:25.95971
NCT00097097|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2014-07-29|||October 2004||2004-10-01|July 2014|2014-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Neonatal Resuscitation in Zambia|Neonatal Resuscitation in Zambia|Completed||Phase 3|40000||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 17:46:01.240888|2017-02-18 17:46:01.240888
NCT00547235|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2010-08-23|||September 2007||2007-09-01|August 2010|2010-08-01||||December 2012|Anticipated|2012-12-01||Expanded Access|||Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection|Protocol For The Emergency Use Of Adoptive Immunotherapy With CMV-Specific T Cells Following HLA-Matched Unrelated Donor Bone Marrow Transplant Of An Infant With ADA-SCIDs And Pre Transplant CMV Infection|No longer available||N/A|||Fred Hutchinson Cancer Research Center||||No accrual|||||||||||||||2017-02-18 15:09:26.103533|2017-02-18 15:09:26.103533
NCT00547209|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2016-09-23|||October 2007||2007-10-01|September 2016|2016-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|Drone-N2O||Effect of Nitrous Oxide on Intravenous Closed-loop Anesthesia|"Anesthésie Totale Intraveineuse en  Boucle d'Asservissement  guidée Par l'Index Bispectral : Effet de l'Adjonction de Protoxyde d'Azote (Effect of Nitrous Oxide on Intravenous Closed-loop Anesthesia)"|Completed||Phase 4|672|Actual|Hopital Foch||2|||f||||f||||||||||2017-02-18 15:09:26.198615|2017-02-18 15:09:26.198615
NCT00547196|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2017-02-10|||August 2005||2005-08-01|February 2017|2017-02-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Study of Four Different Chemotherapy Regimens With or Without Total-Body Irradiation Followed by Umbilical Cord Blood Transplant in Treating Patients With Relapsed or Refractory Hematologic Cancer|Allogeneic Stem Cell Transplantation for Patients With Hematological Malignancies Using Multiple Unrelated Cord Blood Units|Active, not recruiting||N/A|10|Anticipated|City of Hope Medical Center||4|||f||||t||||||||||2017-02-18 15:09:26.376374|2017-02-18 15:09:26.376374
NCT00547183|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||October 2004||2004-10-01|October 2007|2007-10-01|May 2005|Actual|2005-05-01|||||Interventional|||Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection|A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil (2.5 mg and 5 mg) Administered Once Daily to Men With Diabetes Mellitus and Erectile Dysfunction|Completed||Phase 3|298|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 15:09:26.678688|2017-02-18 15:09:26.678688
NCT00548535|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2007-10-23|||January 2007||2007-01-01|October 2007|2007-10-01|January 2008||2008-01-01|||||Observational|||Is Self-Reported Quality Assessment in Surgery Reliable?||Unknown status|Recruiting|N/A|||University of Zurich|||||f||||f||||||||||2017-02-18 15:09:26.786011|2017-02-18 15:09:26.786011
NCT00548522|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2014-05-20|||August 2007||2007-08-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Pancreatic Islet Mass in Pregnancy in Type 1 Diabetes|Pancreatic Islet Mass in Pregnancy - Pilot Study|Terminated||N/A|12|Actual|University of Alberta|||4|Difficulty in finding staff to help with study|f||||f||||||Samples Without DNA|"~     Plasma Samples kept for batching of antibody assays~   "|||2017-02-18 15:09:26.864921|2017-02-18 15:09:26.864921
NCT00548509|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2007-10-23|||February 2002||2002-02-01|October 2007|2007-10-01||||||||Interventional|||The Effect of Vitamin K2 on Bone Turnover|Short-Term Menatetrenone Therapy Increases Gamma-Carboxylation Of Osteocalcin With A Moderate Increase Of Bone Turnover In Postmenopausal Osteoporosis: A Randomized Prospective Study|Completed||Phase 4|100||Eisai Inc.|||||f||||||||||||||2017-02-18 15:09:26.973087|2017-02-18 15:09:26.973087
NCT00548496|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2016-12-02|||September 2007||2007-09-01|December 2016|2016-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius|A Proof-of-Concept Study Of SB-751689 In Men And Post-menopausal Women With A Fractured Distal Radius|Terminated||Phase 2|86|Actual|GlaxoSmithKline||1||Lack of efficacy|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:09:27.066806|2017-02-18 15:09:27.066806
NCT00548483|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2008-05-27|||April 2007||2007-04-01|May 2008|2008-05-01|May 2008|Anticipated|2008-05-01|March 2008|Anticipated|2008-03-01||Interventional|||Comparison of High Dose and Low Dose Dexamethasone in Preventing Post-Extubation Airway Obstruction in Adults|Phase 2 Study of Comparison of High Dose and Low Dose Dexamethasone in Preventing Post-Extubation Airway Obstruction in Adults|Unknown status|Recruiting|Phase 2|80|Anticipated|Mackay Memorial Hospital||2|||f||||t||||||||||2017-02-18 15:09:27.213774|2017-02-18 15:09:27.213774
NCT00548470|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2012-05-17|||June 2007||2007-06-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|September 2009|Actual|2009-09-01||Interventional|||Varenicline Effects In Schizophrenic Smokers|Evaluation of Varenicline's Clinical Efficacy for Continued Smoking Abstinence When Used in the Clinical Treatment of Schizophrenic Patients Hospitalized in an Institution With a Ban on Cigarette Smoking|Completed||Phase 4|18|Actual|Nathan Kline Institute for Psychiatric Research||1|||f||||f||||||||||2017-02-18 15:09:27.323295|2017-02-18 15:09:27.323295
NCT00548457|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2008-01-28|||May 2006||2006-05-01|January 2008|2008-01-01||||||||Observational|||Endothelial Function in Patients With Ectatic Compared to Normal Coronary Arteries|Endothelial Function in Patients With Ectatic Compared to Normal Coronary Arteries|Unknown status|Recruiting|N/A|76|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:09:27.425839|2017-02-18 15:09:27.425839
NCT00548444|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2010-01-15|||October 2007||2007-10-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||T−Cell Turnover Following Vaccination With MVA85A|Measurement of Human T−Cell Turnover Following Vaccination With the Tuberculosis Vaccine MVA85A|Completed||Phase 1|12|Actual|University of Oxford||3|||f||||f||||||||||2017-02-18 15:09:27.504652|2017-02-18 15:09:27.504652
NCT00548431|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2016-11-19|2009-06-24||December 2007||2007-12-01|November 2016|2016-11-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|||NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia|Phase II Study of Individual 6-mercaptopurine(6MP) Dose Increments in Children With Acute Lymphoblastic Leukemia (ALL) Receiving High-dose Methotrexate (HDM) and PEG-asparaginase|Completed||Phase 2|38|Actual|Rigshospitalet, Denmark||1|||f||||t||||||||Yes|Data published (Frandsen et al, Br J Haematol Oct 2011) Anonymised data on individual patients can be provided by study chair (kschmiegelow@rh.dk) including studyno, gender, age, thiopurine methyltransferase status, immunophenotype, white blood cell count at diagnosis, dose increments at time point 1 and 2 for dose adjustment, and dose-limiting toxicities|2017-02-18 15:09:27.61974|2017-02-18 15:09:27.61974
NCT00548418|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2014-07-28|2014-06-27||February 2007||2007-02-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer|Phase II Trial of Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer|Completed||Phase 2|27|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 15:09:27.879822|2017-02-18 15:09:27.879822
NCT00548405|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2015-01-06|2014-11-17||October 2007||2007-10-01|January 2015|2015-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|CARE-MS II|Full analysis set (FAS) population included all randomized participants who received at least 1 dose of study drug as per initial randomization.|Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two|A Phase 3, Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and High-Dose Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta 1a (Rebif®) in Patients With Relapsing Remitting Multiple Sclerosis Who Have Relapsed On Therapy|Completed||Phase 3|840|Actual|Sanofi|Efficacy analysis was not performed for Alemtuzumab 24 mg as recruitment to this arm was closed early to reduce overall sample size, duration of enrollment period, overall duration of study.|3|||f||||t||||||||||2017-02-18 15:09:28.345091|2017-02-18 15:09:28.345091
NCT00548392|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2008-12-29|||May 2007||2007-05-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement|Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement|Completed||N/A|25|Anticipated|Fred Hutchinson Cancer Research Center|||1||f||||f||||||None Retained|"~     none/not applicable~   "|||2017-02-18 15:09:30.172994|2017-02-18 15:09:30.172994
NCT00548379|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-23|2008-05-15|||November 2007||2007-11-01|May 2008|2008-05-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Interventional|||Kabul Vitamin D Supplementation Trial|The Effect of Vitamin D Supplementation on the Incidence of Pneumonia in Children in Afghanistan: a Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 3|3048|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 15:09:30.257561|2017-02-18 15:09:30.257561
NCT00548366|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2010-09-10|||October 2007||2007-10-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Interventional|||Sodium Restriction in the Management of Cirrhotic Ascites|Comparison of Efficacy of 2 Gram Versus 4 Gram Sodium Restriction in the Management of Cirrhotic Ascites|Terminated||Phase 4|68|Anticipated|University of Texas Southwestern Medical Center||2||Failure to recruit.|f||||f||||||||||2017-02-18 15:09:30.372087|2017-02-18 15:09:30.372087
NCT00548353|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2014-12-18|||August 2007||2007-08-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|April 2008|Actual|2008-04-01||Interventional|||A Study of Gastric Delay in Migraine Patients (3207-003)|A Randomized, Double-Blind, Placebo Controlled, 2-Period, Fixed-Sequence Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Orally Administered MK3207 in Patients During and Between Their Acute Migraine Attacks|Completed||Phase 1|22|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:09:30.478458|2017-02-18 15:09:30.478458
NCT00548340|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2014-10-08|2014-02-28||November 2007||2007-11-01|October 2014|2014-10-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||VEC-162 Study in Adult Patients With Primary Insomnia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Efficacy and Safety of VEC-162 (20 mg/Day and 50 mg/Day) in the Treatment of Primary Insomnia|Completed||Phase 3|322|Actual|Vanda Pharmaceuticals||3|||f||||||||||||||2017-02-18 15:09:30.568082|2017-02-18 15:09:30.568082
NCT00548327|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2013-04-30|2013-02-13||October 2007||2007-10-01|April 2013|2013-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|Atomoxetine||The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype|Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Atomoxetine on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype|Terminated||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||2||The scientific director decided to terminate: low priority study with slow accrual|f||||f||||||||||2017-02-18 15:09:31.173315|2017-02-18 15:09:31.173315
NCT00548314|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2011-03-23|||October 2007||2007-10-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|May 2010|Actual|2010-05-01||Interventional|VAC-M||Dermal Substitute and Topical Negative Pressure in Burns|Application of a Dermal Substitute and Topical Negative Pressure to Improve the Healing of Burn Wounds|Completed||Phase 3|86|Actual|Association of Dutch Burn Centres||4|||f||||t||||||||||2017-02-18 15:09:31.85272|2017-02-18 15:09:31.85272
NCT00548301|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2011-06-29||||||June 2011|2011-06-01||||||||Interventional|||Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)||Completed||Phase 3|||Sirion Therapeutics, Inc.|||||||||||||||||||2017-02-18 15:09:31.965295|2017-02-18 15:09:31.965295
NCT00548288|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2007-10-22|||November 2007||2007-11-01|October 2007|2007-10-01||||||||Interventional|||Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty|Phase 1 Study of the Effect of Local Pamidronate Application in Preventing Periprosthetic Bone Loss After Total Cemented Hip Arthroplasty|Unknown status|Not yet recruiting|Phase 1|40|Anticipated|General and Teaching Hospital Celje|||||f||||f||||||||||2017-02-18 15:09:32.06635|2017-02-18 15:09:32.06635
NCT00548275|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2014-07-08|||July 2006||2006-07-01|July 2014|2014-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Project RED||Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence|Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence|Completed||Phase 2|22|Actual|Yale University||2|||f||||f||||||||||2017-02-18 15:09:32.145814|2017-02-18 15:09:32.145814
NCT00548262|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2010-12-15|2010-10-06||February 2008||2008-02-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis|Open-Label, Non-Comparative, Study Of Intravenous Anidulafungin, Followed Optionally By Oral Voriconazole, For Treatment Of Documented Candidemia/Invasive Candidiasis In Hospitalized Patients|Completed||Phase 4|54|Actual|Pfizer|Protocol registration indicated timeframes for EIVT and/or Week 2 F/U for time to event, mortality, vital signs, and labs; however, analyses were continuous and reported from baseline to EIVT (up to Day 42), Week 2 F/U, or Week 6 telephone F/U visit.|1|||f||||f||||||||||2017-02-18 15:09:32.272178|2017-02-18 15:09:32.272178
NCT00548249|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2011-02-07|2010-11-10||August 2007||2007-08-01|February 2011|2011-02-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis|A Dose Ranging Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) Versus Control in Subjects With ESRD Receiving Chronic Hemodialysis.|Completed||Phase 2|131|Actual|Rockwell Medical Technologies, Inc.|"AE tabulation best summarizes the primary safety outcome.~Lack of accuracy in analytical method for measuring iron concentration in inflow and outflow from dialysis machine impaired ability to assess secondary outcome of amount SFP transferred."|5|||f||||t||||||||||2017-02-18 15:09:33.633159|2017-02-18 15:09:33.633159
NCT00548236|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2016-06-01|||October 2007||2007-10-01|June 2016|2016-06-01|July 2017|Anticipated|2017-07-01|March 2010|Actual|2010-03-01||Interventional|AACT||The Active After Cancer Trial (AACT)|Pilot Study of a Multicenter, Telephone-Based Exercise Intervention for Patients With Early-Stage Breast and Colorectal Cancer: The Active After Cancer Trial (AACT)|Active, not recruiting||N/A|120|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 15:09:35.019008|2017-02-18 15:09:35.019008
NCT00548223|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2013-08-05|||December 2007||2007-12-01|August 2013|2013-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|SPIRITDZSM1||The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule|Model Study on the Comprehensive Treating Protocol and Effect Evaluation of Ischemic Stroke With Traditional Chinese Medicine|Completed||Phase 4|3143|Actual|Guangzhou University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-02-18 15:09:35.126941|2017-02-18 15:09:35.126941
NCT00548210|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2007-10-22||||||October 2007|2007-10-01||||||||Observational|||Effectivity of Dermatix in Promoting Scar Maturation|Dermatix; A Randomized Controlled Trial Measuring Effectivity of Dermatix in Promoting Scar Maturation of Hypertrophic Scars.|Unknown status|Recruiting|Phase 3|25|Anticipated|Association of Dutch Burn Centres|||||f||||||||||||||2017-02-18 15:09:35.439999|2017-02-18 15:09:35.439999
NCT00548197|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2007-10-22|||February 2007||2007-02-01|October 2007|2007-10-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment|Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment|Unknown status|Recruiting|Phase 1|50|Anticipated|Iran University of Medical Sciences||1|||f||||f||||||||||2017-02-18 15:09:35.524047|2017-02-18 15:09:35.524047
NCT00548184|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2014-07-22|2012-05-01||September 2008||2008-09-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2011|Actual|2011-01-01||Interventional|||Lapatinib and Trastuzumab With or Without Endocrine Therapy|A Phase II Trial of Lapatinib and Trastuzumab With or Without Endocrine Therapy in Locally Advanced HER2 Overexpressing Breast Cancer Patients|Completed||Phase 2|65|Actual|Baylor Breast Care Center||1|||f||||t||||||||||2017-02-18 15:09:35.650446|2017-02-18 15:09:35.650446
NCT00548171|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2016-11-02||2009-09-09|November 2007||2007-11-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination|Evaluation of GSK Biologicals' dTpa Booster Vaccine in Adults, Given 10 Years After Previous dTpa Boosting.|Completed||Phase 4|205|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:09:36.057924|2017-02-18 15:09:36.057924
NCT00548158|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2007-10-19|||October 2004||2004-10-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Observational|||Effect of Pioglitazone Therapy for Type 2 Diabetes on Vision|Preliminary Safety Study of Pioglitazone Therapy for Diabetes on Macular Thickness and Vision in Type 2 Diabetes|Completed||N/A|19|Actual|University of California, San Diego|||2||f||||f||||||||||2017-02-18 15:09:36.168712|2017-02-18 15:09:36.168712
NCT00548145|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2012-05-14|2011-12-28||November 2007||2007-11-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|PIT-ROAD||The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease||Terminated||N/A|38|Actual|Osaka University||2|||f||||||||||||||2017-02-18 15:09:36.246622|2017-02-18 15:09:36.246622
NCT00548132|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2013-08-28|2013-06-12||February 2006||2006-02-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|February 2008|Actual|2008-02-01||Interventional|||Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)|Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)|Completed||Phase 4|1088|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 15:09:36.557971|2017-02-18 15:09:36.557971
NCT00548119|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2014-03-25||2012-08-16|December 2006||2006-12-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|November 2009|Actual|2009-11-01||Interventional|||NeoCart Phase 2 Clinical Trial|A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee|Completed||Phase 2|30|Actual|Histogenics Corporation||2|||f||||f||||||||||2017-02-18 15:09:36.901747|2017-02-18 15:09:36.901747
NCT00548106|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2012-06-13||||||July 2010|2010-07-01||||||||Interventional|||Safety Study of Infant Formula With Partially Hydrolized Whey|Evaluation of a New Cow's Milk Infant Formula Containing Partially Hydrolized Whey|Withdrawn||N/A|0|Actual|Soroka University Medical Center||2||Study withdrawn due to the company decision|f||||t||||||||||2017-02-18 15:09:36.990267|2017-02-18 15:09:36.990267
NCT00548093|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2012-06-04||2011-06-03|April 2008||2008-04-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|March 2010|Actual|2010-03-01||Interventional|||PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib|A Phase 2, Open Label, Two Arm Trial To Evaluate The Efficacy Of PF-00299804 In Patients With Advanced NSCLC After Failure Of At Least One Prior Chemotherapy And Erlotinib|Completed||Phase 2|66|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:09:37.100082|2017-02-18 15:09:37.100082
NCT00548080|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2015-12-16|||March 2006||2006-03-01|December 2015|2015-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)|A Non-Comparative, Multicenter, Open-Label, Study to Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia|Completed||Phase 3|131|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:09:37.221518|2017-02-18 15:09:37.221518
NCT00548067|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2010-09-24|||September 2007||2007-09-01|September 2010|2010-09-01|March 2008|Actual|2008-03-01|||||Interventional|||Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension|A Multi-center, Multiple Dose, Open-label, Four-cohort, Parallel Study to Assess the Pharmacokinetic Drug Interaction Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension.|Completed||Phase 3|111|Actual|Novartis||4|||f||||f||||||||||2017-02-18 15:09:37.300175|2017-02-18 15:09:37.300175
NCT00548054|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-21|2015-05-01|||December 2015||2015-12-01|May 2015|2015-05-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants|Safety and Immunogenicity of a Killed Oral Cholera Vaccine Among Infants 10 Weeks to Less Than 12 Months of Age When Given Concomitantly With EPI Vaccines|Not yet recruiting||Phase 2|300|Anticipated|International Vaccine Institute||6|||f||||t||||||||||2017-02-18 15:09:37.40185|2017-02-18 15:09:37.40185
NCT00548015|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2009-09-30|||March 2008||2008-03-01|October 2007|2007-10-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Helping Hands: Promoting Hand Hygiene in Hospital Nurses|HELPING HANDS: a Comparison of Short- and Long Term Effects of Alternative Strategies for Promoting Hand Hygiene in Hospital Nurses.|Unknown status|Active, not recruiting|N/A|900|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 15:09:37.74187|2017-02-18 15:09:37.74187
NCT00548002|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2007-10-22|||January 1999||1999-01-01|October 2007|2007-10-01|August 2002|Actual|2002-08-01|||||Observational|FINLEVO||Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia||Completed||Phase 4|430|Actual|Helsinki University|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 15:09:37.836318|2017-02-18 15:09:37.836318
NCT00547989|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2014-06-10|||October 2006||2006-10-01|June 2014|2014-06-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|||Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?|Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?|Completed||Phase 3|46|Actual|Maastricht University Medical Center||3|||f||||f||||||||||2017-02-18 15:09:37.94498|2017-02-18 15:09:37.94498
NCT00547976|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-20|2012-04-26|||October 2007||2007-10-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis|PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis|Completed||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:09:38.055061|2017-02-18 15:09:38.055061
NCT00547963|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2008-10-07|||December 2003||2003-12-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Brief Counseling to Reduce Injuries Among Emergency Department Patients Who Report Alcohol and Substance Use|Reducing Injury, ETOH and THC Use Among ED Patients|Unknown status|Active, not recruiting|Phase 2/Phase 3|554|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||t||||||||||2017-02-18 15:09:38.143741|2017-02-18 15:09:38.143741
NCT00547950|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2007-10-28|||November 2007||2007-11-01|October 2007|2007-10-01|October 2009|Anticipated|2009-10-01|||||Interventional|||A Multiple-Centered, Prospective Cohort Study: the Second Prevention Trial for Ischemic Stroke With Deng Zhan Sheng Mai Capsule（SPIRIT—DZSM-2）|A Model Study on the Comprehensive Treating Protocol of Secondary Prevention and Effect Evaluation of Ischemic Stroke With Traditional Chinese Medicine|Unknown status|Not yet recruiting|N/A|12000|Anticipated|Guangzhou University of Traditional Chinese Medicine||1|||f||||t||||||||||2017-02-18 15:09:38.240656|2017-02-18 15:09:38.240656
NCT00547937|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2007-11-07|||May 2001||2001-05-01|October 2007|2007-10-01|December 2003|Actual|2003-12-01|||||Interventional|||Sleep Apnea and Oxidative Stress and Nitric Oxide|Nitrate and Oxidative Stress in Sleep Apnea Syndrome. Effect of Continuous Positive Airway Pressure|Completed||Phase 4|31|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||t||||||||||2017-02-18 15:09:38.329224|2017-02-18 15:09:38.329224
NCT00547924|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2014-04-09|||April 2006||2006-04-01|April 2014|2014-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Transoesophageal Echocardiography in Liver Transplantation|Transoesophageal Echocardiography in Liver Transplantation: Left Ventricular Function During Reperfusion|Completed||N/A|17|Anticipated|University of Zurich|||1||f||||f||||||||||2017-02-18 15:09:38.44241|2017-02-18 15:09:38.44241
NCT00547911|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2014-06-17|2014-06-17||October 2007||2007-10-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Augmenting Effects of L-DOPS With Carbidopa and Entacapone|L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions With Carbidopa and Entacapone|Terminated||Phase 1/Phase 2|14|Actual|National Institutes of Health Clinical Center (CC)|Study was prematurely terminated due to a small amount of DOPAL contamination in the droxidopa. Because of the early termination only a small number of subjects were enrolled in each condition. Recently, the FDA has approved droxidopa.|6||Study terminated due to contamination droxidopa|f||||f||||||||||2017-02-18 15:09:38.659797|2017-02-18 15:09:38.659797
NCT00547898|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-21|2011-12-22|||October 2007||2007-10-01|December 2011|2011-12-01||||||||Interventional|ADVENT||Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea|Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Two-Stage Study to Assess the Efficacy and Safety of 3 Doses of Crofelemer Orally Twice Daily for the Treatment of HIV-Associated Diarrhea|Completed||Phase 3|350|Anticipated|Valeant Pharmaceuticals International, Inc.||4|||f||||t||||||||||2017-02-18 15:09:39.38842|2017-02-18 15:09:39.38842
NCT00547885|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2014-12-30|||October 2007||2007-10-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Randomized Controlled Double Blind Trial of Short vs Long Acting Dihydrocodeine in Chronic Non-malignant Pain|Randomized Controlled Double Blind Trial of Short vs Long Acting Dihydrocodeine in Chronic Non-Malignant Pain|Completed||Phase 4|60|Actual|Norwegian University of Science and Technology||2|||f||||t||||||||||2017-02-18 15:09:39.737335|2017-02-18 15:09:39.737335
NCT00547872|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2012-11-19|||September 2007||2007-09-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|DADDY-D||Exercise Testing to Screen for Unknown Coronary Artery Disease in Diabetic Patients: Does it Contribute to a Risk Reduction in Very High Risk Patients?|Screening Asymptomatic Patients With Diabetes for Unknown Coronary Artery Disease: an Open-label Randomized Study Comparing Exercise Testing Strategy With Management Based on Pharmacological/Behavioral Treatment of Traditional Risk Factors|Completed||Phase 3|400|Actual|Azienda Unita' Sanitaria Locale Di Modena||2|||f||||t||||||||||2017-02-18 15:09:39.837055|2017-02-18 15:09:39.837055
NCT00547859|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2008-11-25|||November 2007||2007-11-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Observational|||Relationship Between Microcirculatory Flow Alterations and Tissue Metabolism|Correlation Between Microcirculatory Flow and Rectal Anaerobe Cellular CO2 Production in Patients After Cardiac Surgery|Completed||N/A|30|Anticipated|Medical Centre Leeuwarden|||1||f||||f||||||||||2017-02-18 15:09:39.950362|2017-02-18 15:09:39.950362
NCT00547846|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-22|2009-01-08|||October 2007||2007-10-01|January 2009|2009-01-01||||||||Interventional|||A Phase II Clinical Study of PDC-748 in Patients With Acute Cough|A Phase II Clinical Study of PDC-748 in Patients With Acute Cough|Completed||Phase 2|||PhytoHealth Corporation|||||f||||t||||||||||2017-02-18 15:09:40.039728|2017-02-18 15:09:40.039728
NCT00547833|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2016-09-30|||May 2006||2006-05-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Partial Word Knowledge Growth in Children With LLD|Partial Word Knowledge Growth in Children With LLD|Completed||N/A|81|Actual|University of Missouri-Columbia|||3||f||||f||||||||No||2017-02-18 15:09:40.12066|2017-02-18 15:09:40.12066
NCT00547157|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2014-07-10|2013-12-16||November 2007||2007-11-01|July 2014|2014-07-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck|A Phase 2 Randomized Trial of Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|152|Actual|Amgen||2|||f||||t||||||||||2017-02-18 15:09:40.333063|2017-02-18 15:09:40.333063
NCT00547144|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2012-11-06|||October 2005||2005-10-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer|A Phase I/II Trial of Intratumoral Dendritic Cell Immunotherapy in Combination With Gemcitabine and Stereotactic Radiosurgery in Unresectable Pancreatic Cancer|Completed||Phase 1|2|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 15:09:41.222998|2017-02-18 15:09:41.222998
NCT00547131|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2011-10-18|||January 2006||2006-01-01|October 2011|2011-10-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors|A Pilot Feasibility Study of Intracerebral Microdialysis to Determine the Neuropharmacokinetics of Temozolomide|Completed||N/A|12|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-02-18 15:09:41.328221|2017-02-18 15:09:41.328221
NCT00547118|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2015-02-24|2014-05-05||November 2007||2007-11-01|February 2015|2015-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||Eighteen participants signed consent and 17 were randomized to study medication (rimonabant n=8, placebo n=9). One participant from each groupwaswithdrawn prior to the receipt of studymedication. One placebo participant refused the neurocognitive assessments. The remaining 14 participants (rimonabant n=7, placebo n=7) completed.|The Effects of Rimonabant, on Weight and Metabolic Risk Factors|The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia|Terminated||Phase 2|17|Actual|University of Maryland||2||Withdrawn due to medication withdrawal from the EMEA|f||||t||||||||||2017-02-18 15:09:41.432129|2017-02-18 15:09:41.432129
NCT00547105|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-19|2010-06-22|||June 2007||2007-06-01|June 2010|2010-06-01||||July 2010|Anticipated|2010-07-01||Interventional|||Erlotinib and Stereotactic Body Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Non-Small Call Lung Cancer|A Phase II Trial of Erlotinib (Tarceva®) in Combination With Stereotactic Body Radiation Therapy (SBRT) for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|24|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 15:09:41.832603|2017-02-18 15:09:41.832603
NCT00547092|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||October 2003||2003-10-01|October 2007|2007-10-01|November 2004|Actual|2004-11-01|||||Interventional|||Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection|A Multicenter Open-Label Study to Determine Treatment Preference of Tadalafil (IC351, LY450190) or Sildenafil Citrate in the Oral Treatment of Erectile Dysfunction|Completed||Phase 4|386|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:09:41.923576|2017-02-18 15:09:41.923576
NCT00547066|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2016-03-18|||November 2007||2007-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Study of Veltuzumab (hA20) at Different Doses in Patients With ITP|A Phase I/II Study of Immunotherapy With Humanized Anti-CD20 Antibody, IMMU-106 (hA20), in Adult Patients With Chronic Immune Thrombocytopenic Purpura|Active, not recruiting||Phase 1/Phase 2|66|Anticipated|Immunomedics, Inc.||1|||f||||f||||||||||2017-02-18 15:09:42.027668|2017-02-18 15:09:42.027668
NCT00547053|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2011-05-12|||December 2006||2006-12-01|May 2011|2011-05-01|January 2011|Actual|2011-01-01|January 2008|Actual|2008-01-01||Interventional|||Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis|A Six Month Open Label Study of Amiloride Solution for Inhalation and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis|Completed||Phase 1|25|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 15:09:42.146851|2017-02-18 15:09:42.146851
NCT00547040|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2011-10-05|||October 2006||2006-10-01|October 2011|2011-10-01|October 2013|Anticipated|2013-10-01|||||Observational|ASCIT||Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients|Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients|Unknown status|Recruiting|N/A|100|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"~     serum, plasma, urine~   "|||2017-02-18 15:09:42.228203|2017-02-18 15:09:42.228203
NCT00547027|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2015-03-04|||April 2006||2006-04-01|March 2015|2015-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Promoting Physical Activity Among Patients With Type 2 Diabetes|Promoting Physical Activity Among Patients With Type 2 Diabetes in a Community-Based Clinic|Completed||Phase 2/Phase 3|85|Actual|Florida State University||1|||f||||f||||||||||2017-02-18 15:09:42.319414|2017-02-18 15:09:42.319414
NCT00547014|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2009-03-18|||September 2007||2007-09-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|||||Interventional|||First Safety Study in Humans of a Single Dose of CPG 52364|Oral Administration Of CPG 52364 In Healthy Subjects: A Phase 1, Within-Cohort Randomized, Double-Blinded, Placebo-Controlled, Ascending Single-Dose, Single-Center Study|Completed||Phase 1|61|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 15:09:42.408827|2017-02-18 15:09:42.408827
NCT00547001|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2008-07-17|||August 2007||2007-08-01|July 2008|2008-07-01|November 2009|Anticipated|2009-11-01|||||Interventional|||Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes|A Comparison of Hormonal Therapy: Tapering Regimens for Mediating Hot Flashes|Unknown status|Recruiting|N/A|235|Anticipated|Hartford Hospital||3|||f||||f||||||||||2017-02-18 15:09:42.638749|2017-02-18 15:09:42.638749
NCT00546988|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2007-10-17|||October 2001||2001-10-01|October 2007|2007-10-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years|Multizentrische Therapiestudie Des Multiplen Myeloms DSMM V Therapieoptimierungs-Studie Der Deutschen Studiengruppe Multiples Myelom für Patienten Bis 60 Jahre im Stadium II/III|Unknown status|Recruiting|Phase 3|600|Anticipated|University of Wuerzburg||4|||f||||f||||||||||2017-02-18 15:09:42.747488|2017-02-18 15:09:42.747488
NCT00546975|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2011-06-24|||October 2007||2007-10-01|October 2007|2007-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effect of Oral Nutritional Supplements With Specialized Nutrients on Functional Recovery and Morbidity After Gastrointestinal Surgery||Terminated||N/A|||Charite University, Berlin, Germany||3||Compliance unacceptably low.|f||||t||||||||||2017-02-18 15:09:42.875269|2017-02-18 15:09:42.875269
NCT00546949|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2016-02-24|||March 2007||2007-03-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|September 2011|Actual|2011-09-01||Interventional|LSSS||Treatment of Lumbar Spinal Stenosis; Comparison of Two Different Surgical Methods; Mini-invasive Decompression to X-stop|Treatment of Lumbar Spinal Stenosis; Comparison of Two Different Surgical Methods; Mini-Invasive Decompression to X-Stop (LSSS)|Terminated||N/A|96|Actual|Norwegian University of Science and Technology||2||analysis at 50% inclusion showed 4 times larger reoperation rate in X-stop group|f||||t||||||||||2017-02-18 15:09:43.05466|2017-02-18 15:09:43.05466
NCT00546936|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2009-04-15|||October 2007||2007-10-01|April 2009|2009-04-01|April 2010|Anticipated|2010-04-01|October 2009|Anticipated|2009-10-01||Interventional|||Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis|Ranibizumab vs PDT for Presumed Ocular Histoplasmosis|Unknown status|Recruiting|Phase 2|30|Anticipated|Barnes Retina Institute||2|||f||||t||||||||||2017-02-18 15:09:43.168922|2017-02-18 15:09:43.168922
NCT00546923|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||August 2004||2004-08-01|October 2007|2007-10-01|June 2006|Actual|2006-06-01|||||Interventional|||Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients|A Randomized, Double-Blind, Placebo-Controlled, Pilot Study To Evaluate The Efficacy And Safety Of Venlafaxine Extended-Release In Depressed And Anxious Patients With Multiple, Unexplained Somatic Symptoms|Completed||Phase 4|210||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:09:43.279985|2017-02-18 15:09:43.279985
NCT00546910|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2010-08-04|2010-05-21||October 2007||2007-10-01|August 2010|2010-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double Blind Comparison of the Effects of Atomoxetine Versus Placebo on Neuropsychological Outcomes Across the Day in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) by Use of a Computer Based Continuous Performance Test (cb CPT)|Completed||Phase 4|125|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:09:43.381411|2017-02-18 15:09:43.381411
NCT00546897|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2014-09-26|2014-09-19||February 2007||2007-02-01|September 2014|2014-09-01|March 2012|Actual|2012-03-01|June 2010|Actual|2010-06-01||Interventional|||Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities|Phase II Trial of Lenalidomide in Older Patients (>/= 60 Years) With Untreated Acute Myeloid Leukemia Without Chromosome 5q Abnormalities|Completed||Phase 2|48|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 15:09:44.744275|2017-02-18 15:09:44.744275
NCT00546884|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2009-02-24|||November 2007||2007-11-01|February 2009|2009-02-01|November 2010|Anticipated|2010-11-01|May 2010|Anticipated|2010-05-01||Interventional|SELPH||Intervention to Improve Expression of End of Life Preferences for Homeless Persons|Intervention to Improve Expression of End of Life Preferences for Homeless Persons|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 15:09:45.817146|2017-02-18 15:09:45.817146
NCT00546871|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2015-06-26|2011-11-15||October 2007||2007-10-01|April 2015|2015-04-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects|Tolerability and Pharmacokinetic Comparison of Immune Globulin Intravenous (Human) 10% (IGIV, 10%) Administered Intravenously or Subcutaneously in Subjects With Primary Immunodeficiency Diseases|Completed||Phase 2/Phase 3|49|Actual|Baxalta US Inc.||1|||f||||f||||||||||2017-02-18 15:09:46.274142|2017-02-18 15:09:46.274142
NCT00546858|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2009-05-04|||October 2007||2007-10-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Relationship of Interstitial Cystitis to Vulvodynia|Part A: STUDY OF THE RELATIONSHIP OF INTERSTITIAL CYSTITIS TO VULVODYNIA|Completed||N/A|350|Anticipated|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 15:09:59.043578|2017-02-18 15:09:59.043578
NCT00546845|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2011-08-04|||September 2007||2007-09-01|October 2007|2007-10-01|June 2014|Anticipated|2014-06-01|March 2012|Anticipated|2012-03-01||Interventional|XXS||Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study|Xpert Stent Versus Balloon Angioplasty in Complex Lesions of Small Arteries Below the Knee|Unknown status|Recruiting|Phase 4|180|Anticipated|University Hospital Tuebingen||1|||f||||f||||||||||2017-02-18 15:09:59.130963|2017-02-18 15:09:59.130963
NCT00546832|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2010-10-11|||October 2007||2007-10-01|October 2010|2010-10-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial II|The Efficacy and Safety of TDS-943 in the Treatment of Osteoarthritis of the Knee: Pivotal Study II|Completed||Phase 3|650|Actual|Mika Pharma GmbH||3|||f||||f||||||||||2017-02-18 15:09:59.214747|2017-02-18 15:09:59.214747
NCT00546819|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2016-02-02|2011-07-20||October 2007||2007-10-01|February 2016|2016-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)|A Phase IIb Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of Zoster Vaccine Live (Oka/Merck) in Patients on Chronic/Maintenance Corticosteroids|Completed||Phase 2|309|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:09:59.374615|2017-02-18 15:09:59.374615
NCT00546806|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2012-05-23|||February 2008||2008-02-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|WIT||University Health Network Whiplash Intervention Trial|The University Health Network Whiplash Intervention Trial: A Randomized Controlled Trial of the Effectiveness and Cost-effectiveness of Three Programs of Care for the Treatment of Whiplash-associated Disorders|Completed||Phase 3|340|Actual|University Health Network, Toronto||3|||f||||f||||||||||2017-02-18 15:10:00.011104|2017-02-18 15:10:00.011104
NCT00546793|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2013-03-25|||January 2008||2008-01-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL|Phase I/II Study of Subcutaneously Administered Veltuzumab (hA20) in Patients With CD20+ Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|32|Actual|Immunomedics, Inc.||1|||f||||f||||||||||2017-02-18 15:10:00.155633|2017-02-18 15:10:00.155633
NCT00546780|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2011-06-21||2011-06-21|February 2008||2008-02-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|BMS TIME-1||A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse|Phase 3 Randomized, Open-Label Clinical Trial of Tanespimycin (KOS-953) Plus Bortezomib Compared to Bortezomib Alone in Patients With Multiple Myeloma in First Relapse|Completed||Phase 3|31|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 15:10:00.286065|2017-02-18 15:10:00.286065
NCT00088569|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-29|2008-03-03|||July 2004||2004-07-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Observational|||Effect of Direct Current Polarization on Brain Function|Measuring the Brain Effects of DC Polarization With O-15 PET|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:00.732374|2017-02-18 17:50:00.732374
NCT00546767|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2014-09-15|||September 2007||2007-09-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|HBA||Home-Based Assessment for Alzheimer Disease Prevention|Multi-Center Trial to Evaluate Home-Based Assessment Methods for Alzheimer Disease Prevention Research in People Over 75 Years Old|Completed||N/A|640|Actual|Alzheimer's Disease Cooperative Study (ADCS)||4|||f||||t||||||||||2017-02-18 15:10:00.439984|2017-02-18 15:10:00.439984
NCT00546754|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2015-10-09|2010-03-26||May 2007||2007-05-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|EASE||BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)|BP-EASE-A 12-Week, Multicenter, Open-Label, Randomized, Controlled Trial To Compare The Effectiveness of Losartan 50 mg/HCTZ 12.5 mg Titrated as Needed to Losartan 100 mg/HCTZ 25 mg or Valsartan 160 mg/HCTZ 25 mg, in Patients With Essential Hypertension Who Have Not Achieved Target Blood Pressure With|Completed||Phase 3|808|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:10:00.58362|2017-02-18 15:10:00.58362
NCT00546741|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2016-12-19|||November 2007||2007-11-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Drug Interaction With Metformin|Pharmacokinetic Drug Interaction Study With Dapagliflozin and Metformin in Healthy Subjects|Completed||Phase 1|18|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:10:01.60957|2017-02-18 15:10:01.60957
NCT00546728|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2013-09-05|2012-04-23||October 2007||2007-10-01|September 2013|2013-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes|The Chronic and Acute Postprandial Vascular Effects of Exenatide vs. Metformin in Abdominally Obese Patients With Impaired Glucose Tolerance|Completed||Phase 4|50|Actual|St. Paul Heart Clinic|unblinded study design|2|||f||||f||||||||||2017-02-18 15:10:01.722531|2017-02-18 15:10:01.722531
NCT00546715|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2015-10-20|2015-08-10||November 2007||2007-11-01|October 2015|2015-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||The analysis was performed in the safety population defined as all participants who received any study drug treatment.|A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects|Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BMS-790052 in Subjects Chronically Infected With Hepatitis C Virus Genotype 1|Completed||Phase 1/Phase 2|95|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 15:10:02.155808|2017-02-18 15:10:02.155808
NCT00546702|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2009-06-12|||September 2004||2004-09-01|June 2009|2009-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Glulisine + Lantus in Type I Patients|Multicenter, Open, Non-Randomised Phase III Clinical Study of Efficacy and Safety of Insulin Glulisine (HMR1964) Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus Using Also Insulin Glargine During 26 Weeks of Therapy|Completed||Phase 3|142|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:10:03.298961|2017-02-18 15:10:03.298961
NCT00546689|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2008-04-17|||March 2007||2007-03-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Observational|||Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS|Phase 1 Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS|Completed||N/A|30|Actual|UPECLIN HC FM Botucatu Unesp|||1||f||||t||||||Samples Without DNA|"~     Sample of Blood Sample of Feces~   "|||2017-02-18 15:10:03.397311|2017-02-18 15:10:03.397311
NCT00546676|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-11-13|||May 2004||2004-05-01|November 2007|2007-11-01|December 2004|Actual|2004-12-01|||||Interventional|||Ketek in CAP / AECB in Ambulatory Adult Patients|A Canadian Multicenter, Prospective, Open Label, Non-Comparative Study of the Effectiveness and Safety of Oral Telithromycin, 800mg Once Daily in the Treatment of Either Community Acquired Pneumonia or Acute Exacerbation of Chronic Bronchitis in Ambulator|Completed||Phase 4|174|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:10:03.479868|2017-02-18 15:10:03.479868
NCT00546663|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2011-08-22|||September 2007||2007-09-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|ISIS Pilot||Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis|A Pilot Study to Evaluate the Tolerability of Inhaled 7% Hypertonic Saline in Infants With Cystic Fibrosis|Completed||N/A|19|Actual|CF Therapeutics Development Network Coordinating Center||1|||f||||t||||||||||2017-02-18 15:10:03.557695|2017-02-18 15:10:03.557695
NCT00546650|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2016-02-02|||November 2007||2007-11-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®|A Phase I, Single Center, Open Label, Randomized, Single-Dose, Five-Way Crossover Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® in Healthy Volunteers|Completed||Phase 1|25|Actual|Teva Pharmaceutical Industries||5|||f||||f||||||||||2017-02-18 15:10:03.671628|2017-02-18 15:10:03.671628
NCT00546637|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2011-02-15|2010-01-11||November 2007||2007-11-01|February 2011|2011-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||"Fesoterodine add-on Male Overactive Bladder Study"|"A Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Fesoterodine As An Add-On Therapy In Men With Persistent Overactive Bladder Symptoms Under Monotherapy Of Alpha Blocker For Lower Urinary Tract Symptoms."|Completed||Phase 3|947|Actual|Pfizer||2|||f||||||||||||||2017-02-18 15:10:03.791758|2017-02-18 15:10:03.791758
NCT00546624|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2015-10-30|||November 2002||2002-11-01|October 2015|2015-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)||Completed||Phase 2|38|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:10:05.540741|2017-02-18 15:10:05.540741
NCT00546611|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2016-01-26|||October 2007||2007-10-01|January 2016|2016-01-01||||||||Interventional|||The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)|A Phase I, Single-Centre, Open-Label, Fixed-Dose Study of the Safety and Efficacy of up- to Three-Days Application of 0.05% PEP005 Topical Gel in the Treatment of Patients With Common Wart(s) (Verruca[e] Vulgaris) on the Dorsal Hand|Withdrawn||Phase 1|0|Actual|Peplin||1||No enrolement|f||||f||||||||||2017-02-18 15:10:05.616525|2017-02-18 15:10:05.616525
NCT00546598|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2014-06-25|||January 2006||2006-01-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System|DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System PMA Post-approval Study|Terminated||Phase 4|106|Actual|DePuy Orthopaedics||1||Sponsor withdrew PMA|f||||f||||||||||2017-02-18 15:10:05.710081|2017-02-18 15:10:05.710081
NCT00546585|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2013-08-15||2011-07-20|March 2008||2008-03-01|January 2010|2010-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults|A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H7N7 Vaccine in Healthy Adults|Completed||Phase 1/Phase 2|126|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-02-18 15:10:05.824001|2017-02-18 15:10:05.824001
NCT00546572|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2011-07-12|2011-04-29||November 2007||2007-11-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)|A Phase 3, Randomized, Active-Controlled, Modified Double-Blind Trial, Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) Compared To A 23-Valent Pneumococcal Polysaccharide (23vPS) Vaccine in Ambulatory Elderly Individuals Aged 70 Years And Older Who Received One Dose of 23vPS At Least 5 Years Prior To Study Enrollment|Completed||Phase 3|938|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 15:10:05.967679|2017-02-18 15:10:05.967679
NCT00546559|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2008-08-28|||January 2004||2004-01-01|August 2008|2008-08-01|March 2008||2008-03-01|||||Observational|||Differential Metabolic Effects of Statins||Completed||N/A|||Gachon University Gil Medical Center|||||f||||t||||||||||2017-02-18 15:10:10.264111|2017-02-18 15:10:10.264111
NCT00546546|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2015-04-26|||July 2005||2005-07-01|August 2011|2011-08-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|RAPID||Early Immunosuppressants in Crohn's Disease|Effect of Early Prescription of Immunosuppressants on First Three-year Course of Crohn's Disease|Completed||Phase 4|120|Actual|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||2|||f||||f||||||||||2017-02-18 15:10:13.118687|2017-02-18 15:10:13.118687
NCT00546533|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||January 2003||2003-01-01|October 2007|2007-10-01|February 2005|Actual|2005-02-01|||||Interventional|||Study Evaluating the Efficacy and Safety of Etanercept|Open-Label Evaluation Of The Efficacy And Safety Of Etanercept In Patients With Active Rheumatoid Arthritis (RA)|Completed||Phase 4|40||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:10:13.270033|2017-02-18 15:10:13.270033
NCT00546520|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2016-12-05|||April 2002||2002-04-01|December 2016|2016-12-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)|A 3-period Double-blind, Cross-over Study on the Onset of Action of Inhaled Ciclesonide (7 Days of 400 mcg Sid Versus 800 mcg Bid Versus Placebo) on Airway Responsiveness to Adenosine Monophosphate (AMP), Sputum Eosinophiles and Exhaled Breath Nitric Oxide (NO) in Patients With Asthma|Completed||Phase 3|21|Actual|AstraZeneca|||||f||||f||||||||||2017-02-18 15:10:13.346289|2017-02-18 15:10:13.346289
NCT00546507|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2010-10-11|||October 2007||2007-10-01|October 2010|2010-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial I|The Efficacy and Safety of TDS-943 in the Treatment of Osteoarthritis of the Knee: Pivotal Study I|Completed||Phase 3|650|Actual|Mika Pharma GmbH||3|||f||||f||||||||||2017-02-18 15:10:13.460508|2017-02-18 15:10:13.460508
NCT00546494|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2007-10-18|||February 2004||2004-02-01|October 2007|2007-10-01|March 2005|Actual|2005-03-01|||||Interventional|||Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission|A Study Of The Utility Of Effexor® (Venlafaxine) In Achieving Response And Maintaining Remission Among Taiwanese Patients With Depression|Completed||Phase 4|350||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:10:13.595993|2017-02-18 15:10:13.595993
NCT00546481|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2016-08-09|2016-04-12||November 2007||2007-11-01|August 2016|2016-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||The Intent-to-Treat (ITT) population included all randomized participants.|A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.|An Open-label, Randomized, Multi-center, Parallel Group Study to Demonstrate Correction of Anemia Using Intravenous Injections of RO0503821 in Patients With Chronic Kidney Disease Who Are on Dialysis|Completed||Phase 3|80|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:10:13.672084|2017-02-18 15:10:13.672084
NCT00546468|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-18|2012-05-22|||June 2003||2003-06-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|November 2005|Actual|2005-11-01||Interventional|NCC052||Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301)|Prospective Randomized Trial of Laparoscopy-assisted Distal Gastrectomy (LADG) Versus Open Distal Gastrectomy (ODG) in Patients With Early Gastric Cancer (EGC)|Completed||Phase 3|164|Actual|National Cancer Center, Korea||2|||f||||t||||||||||2017-02-18 15:10:14.615823|2017-02-18 15:10:14.615823
NCT00546455|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2013-02-11|||December 2007||2007-12-01|July 2010|2010-07-01|April 2015|Anticipated|2015-04-01|February 2015|Anticipated|2015-02-01||Interventional|||A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity|Phase 2 Study of the Assessment of the Insulin Sensitizing Activity of Fenretinide in Subjects With Insulin Resistance With BMI >30Kg/m2, and Liver Inflammation Related to Non-alcoholic Fatty Liver|Unknown status|Recruiting|Phase 2|120|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-02-18 15:10:14.736839|2017-02-18 15:10:14.736839
NCT00546442|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2007-10-17|||May 2006||2006-05-01|October 2007|2007-10-01|January 2007|Actual|2007-01-01|||||Interventional|TRIC-1||Treatment Insulin Resistence in HCV G-1 Patient|Effect of Treatment of Insulin Resistance in Patients With Chronic Hepatitis C Genotype 1 Treated With Peginterferon Alfa-2a in Combination With Ribavirin in Current Clinical Practice|Completed||Phase 4|126|Actual|Valme University Hospital||2|||f||||t||||||||||2017-02-18 15:10:14.83817|2017-02-18 15:10:14.83817
NCT00546429|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2012-02-28|2010-09-29||September 2006||2006-09-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|ATN||DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial|Clinical Trial to Monitor the Clinical Effectiveness of the DePuy ATN Trochanteric Nailing System in the Treatment of Trochanteric Fractures of the Proximal Femur|Completed||Phase 4|62|Actual|DePuy Orthopaedics||1|||f||||f||||||||||2017-02-18 15:10:14.955489|2017-02-18 15:10:14.955489
NCT00546403|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2009-02-20|||February 2003||2003-02-01|October 2007|2007-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia|An Eight Week, Double-Blind, Placebo Controlled, Adjunctive Study of the Primary Effects of the Use of Flexible Doses of Modafinil 50mg to 200mg, on the Negative Symptoms, Cognition, and Excessive Daytime Sleepiness in Schizophrenic Patients|Completed||N/A|26|Actual|Veterans Medical Research Foundation||2|||f||||f||||||||||2017-02-18 15:10:15.198986|2017-02-18 15:10:15.198986
NCT00546390|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-02-14|||November 2007||2007-11-01|February 2012|2012-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study|Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study|Completed||N/A|100|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 15:10:15.306278|2017-02-18 15:10:15.306278
NCT00546377|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2016-04-07|2015-12-17||July 2005||2005-07-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer|A Phase I-II Study of Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Previously Treated Patients With Chronic Lymphocytic Leukemia and Other Low Grade B-Cell Neoplasms|Completed||Phase 1/Phase 2|50|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||f||||||||||2017-02-18 15:10:15.410406|2017-02-18 15:10:15.410406
NCT00546364|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2016-02-09|2011-05-06||February 2008||2008-02-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|IXTEND||Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer|IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer|Terminated||Phase 2|62|Actual|R-Pharm||3||Slow Accrual|f||||f||||||||||2017-02-18 15:10:15.970398|2017-02-18 15:10:15.970398
NCT00546351|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2014-09-19|2011-12-21||May 2004||2004-05-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.|A Multi-center, Open-label, follow-on Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Including a Double-blind, Randomized Time Point Withdrawal Subtrial.|Completed||Phase 3|621|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:10:17.348475|2017-02-18 15:10:17.348475
NCT00546325|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2010-12-09|||October 2007||2007-10-01|December 2010|2010-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|REASSURE||REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents|REASURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents|Completed||Phase 3|358|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:10:18.483196|2017-02-18 15:10:18.483196
NCT00546312|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2010-05-25|||February 2000||2000-02-01|May 2009|2009-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|Gore Thoracic||Clinical Study of Thoracic Excluder Endoprosthesis to Treat Descending Thoracic Aortic Diseases|A Clinical Study Evaluating Use of the Thoracic EXCLUDER Endoprosthesis in the Treatment of Descending Thoracic Aortic Diseases|Unknown status|Active, not recruiting|N/A|332|Anticipated|Arizona Heart Institute||1|||f||||f||||||||||2017-02-18 15:10:18.593742|2017-02-18 15:10:18.593742
NCT00546299|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2007-10-17|||February 2003||2003-02-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities Only|Ambulatory Gas Usage in Patients With COPD and Exertional Hypoxemia|Completed||N/A|27|Actual|West Park Healthcare Centre||1|||f||||f||||||||||2017-02-18 15:10:18.703845|2017-02-18 15:10:18.703845
NCT00546286|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-04-07|||May 2006||2006-05-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)|A 12 Week, Open-Label, Study to Evaluate the Effectiveness of Dorzolamide-Timolol as First Line Therapy to Reduce Intraocular Pressure in Patients With Untreated Open Angle Glaucoma (OAG) or Ocular Hypertension (OH)|Completed||Phase 3|170|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:10:18.782814|2017-02-18 15:10:18.782814
NCT00546273|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2009-05-14|2008-10-31||April 2007||2007-04-01|May 2009|2009-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers|Double-Blind, Randomized, Placebo-Controlled Phase I Study, to Study the Tolerability and Immunogenicity of 4 RUTI Antituberculous Vaccine Different Doses (5, 25, 100 y 200µg of FCMtb) in Healthy Volunteers|Completed||Phase 1|24|Actual|Germans Trias i Pujol Hospital||5|||f||||t||||||||||2017-02-18 15:10:18.895624|2017-02-18 15:10:18.895624
NCT00546260|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2010-12-28|2010-11-23||November 2007||2007-11-01|December 2010|2010-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|ERASE-MI||Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI|Randomized Trial to Evaluate Effect of Adjunctive Antiplatelet Therapy With Intravenous PRT060128, a Selective P2Y12-Receptor Inhibitor, Before Primary Percutaneous Intervention (PCI) in ST-Elevation Myocardial Infarction (STEMI) Patients|Terminated||Phase 2|70|Actual|Portola Pharmaceuticals|Because Part II of the study was not completed and Part I had a small sample size, no conclusions could be drawn regarding efficacy.|2||Administrative reasons.|f||||t||||||||||2017-02-18 15:10:19.530828|2017-02-18 15:10:19.530828
NCT00546247|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2015-09-23||2011-06-21|January 2008||2008-01-01|September 2015|2015-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1)|A Phase 1/2, Ascending Multiple-Dose Study to Evaluate the Safety, Efficacy and Pharmacokinetics of BMS-753493 in Subjects With Advanced Cancer (Schedule 1)|Terminated||Phase 1/Phase 2|26|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:10:20.002328|2017-02-18 15:10:20.002328
NCT00546234|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-05-24|||November 2007||2007-11-01|August 2014|2014-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Tiotropium for Smoking Asthmatics Study|Assessing Treatment Options for Smokers With Asthma.|Withdrawn||Phase 4|0|Actual|University of Alberta||2||No subjects enrolled and no ongoing funding.|f||||f||||||||||2017-02-18 15:10:20.1024|2017-02-18 15:10:20.1024
NCT00546221|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2011-03-02|||November 2007||2007-11-01|March 2011|2011-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Promoting Wellbeing for Women With Depression: A Pragmatic Randomised Controlled Trial (RCT) of an Exercise Programme|Pragmatic Randomised Controlled Trial of a Preferred Intensity Exercise Programme to Improve Physiological and Associated Psychological, Social, and Wellbeing Outcomes of Women Living With Depression|Completed||Phase 2|43|Actual|University of Nottingham||2|||f||||f||||||||||2017-02-18 15:10:20.29404|2017-02-18 15:10:20.29404
NCT00546208|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2008-03-13|||February 2008||2008-02-01|March 2008|2008-03-01||||||||Observational|ureterostomy||Unilateral Cutaneous Ureterostomy - Long Term Follow up|Bladder Function Following Temporary Unilateral Cutaneous Ureterostomy - Long Term Follow up|Unknown status|Recruiting|N/A|30|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:10:20.404858|2017-02-18 15:10:20.404858
NCT00546195|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2017-01-24|||October 15, 2007||2007-10-15|March 29, 2011|2011-03-29|March 29, 2011||2011-03-29|||||Observational|||Infant Immune Response to Bacterial Infection|Expression Profiling of Bacterial Lipopolysaccharide Activated Neutrophil in Pre-Term, Term Infants and Adults|Completed||N/A|45|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:10:20.482977|2017-02-18 15:10:20.482977
NCT00546182|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2007-10-17|||January 2004||2004-01-01|October 2007|2007-10-01||||||||Observational|||Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity|Phase 4 Study of Simvastatin That Affects Insulin Sensitivity|Completed||N/A|||Gachon University Gil Medical Center|||||f||||t||||||||||2017-02-18 15:10:20.559658|2017-02-18 15:10:20.559658
NCT00546169|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2012-05-04|||June 2007||2007-06-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||Non-interventional Trial About Treatment of Haemorrhages in Cholecystectomy With TachoSil (TC-027-DE)|Non-interventional Trial About Treatment of Haemorrhages in Cholecystectomy With TachoSil (TC-027-DE)|Completed||N/A|500|Anticipated|Nycomed|||1||f||||t||||||||||2017-02-18 15:10:20.644796|2017-02-18 15:10:20.644796
NCT00546156|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2013-03-22|2013-03-22||October 2007||2007-10-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|October 2011|Actual|2011-10-01||Interventional|||Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer|A Phase II Study of Preoperative Dose-dense (dd) Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel (T) With Bevacizumab in ER+ and/or PR+, HER2-negative Operable Breast Cancer|Completed||Phase 2|104|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 15:10:20.744887|2017-02-18 15:10:20.744887
NCT00546143|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2010-09-01|||July 2007||2007-07-01|September 2010|2010-09-01||||August 2008|Actual|2008-08-01||Interventional|||Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma|Multi-center, Open-label, Multiple Dose Study in Mild to Moderate Asthmatics (With IgE/Body Weight Combinations Above That in the SmPC Dosing Table) to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Omalizumab|Completed||Phase 4|32|Actual|Novartis||3|||f||||f||||||||||2017-02-18 15:10:21.307764|2017-02-18 15:10:21.307764
NCT00546130|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2008-09-02|||November 2007||2007-11-01|August 2008|2008-08-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|RNCLC||Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer|Feasibility Study for Multicenter Randomized Controlled Phase III Clinical Trial of Cisplatin + Irinotecan Therapy and Cisplatin + Irinotecan + Krestin Therapy for Extensive-Stage Disease (ED) Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|45|Anticipated|University of Toyama||1|||f||||t||||||||||2017-02-18 15:10:21.429082|2017-02-18 15:10:21.429082
NCT00546117|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2011-09-27|2010-12-10||October 2007||2007-10-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion|A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion|Completed||N/A|16|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 15:10:21.562399|2017-02-18 15:10:21.562399
NCT00546104|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2013-07-15|2013-01-22||October 2007||2007-10-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Phase II Dasatinib Study in Advanced Breast Cancer|A Phase II Trial of Dasatinib to Treat Women With Stage IV or Inoperable Stage III Advanced Breast Cancer|Completed||Phase 2|31|Actual|Duke University||1|||f||||f||||||||||2017-02-18 15:10:21.984648|2017-02-18 15:10:21.984648
NCT00546091|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2017-01-24|||October 15, 2007||2007-10-15|October 19, 2012|2012-10-19|October 19, 2012||2012-10-19|||||Observational|||Calibrating Imaging Techniques to Study Blood Flow|Calibration of Non-Invasive Non-Ionizing Imaging Techniques to Study Vasculature of Healthy Volunteers|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:10:22.331879|2017-02-18 15:10:22.331879
NCT00546078|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2016-10-06|2009-11-12||January 2008||2008-01-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America|Safety and Immunogenicity Study of an Additional Dose of HPV Vaccine (580299) in Young, Adult Women in North America.|Completed||Phase 2|116|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:10:22.424364|2017-02-18 15:10:22.424364
NCT00546065|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2011-11-25|||August 2006||2006-08-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|APE||APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation|APE-Study: Tumor-free Survival After Ablation of Barrett's Mucosa Plus Esomeprazole vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs Placebo for Symptomatic Reflux Control After Successful Ablation of Barrett's Mucosa|Terminated||N/A|68|Actual|HSK Wiesbaden||2||"Intermediate results have shown a significant difference in the outcome of ablation and~   non-ablation patients. Therefore, the study was stopped."|f||||t||||||||||2017-02-18 15:10:23.244817|2017-02-18 15:10:23.244817
NCT00546052|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2015-06-23|2009-01-08||September 2005||2005-09-01|June 2015|2015-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)|52 Week Study to Evaluate the Effects of LOSARTAN 50 mg, 100 mg, 100/12.5 mg HCTZ, 100/25 mg HCTZ on Metabolic Parameters, Blood Pressure and Safety in Hypertensive Patients With Metabolic Syndrome|Completed||Phase 3|1738|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:10:23.356461|2017-02-18 15:10:23.356461
NCT00546039|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2008-09-29|||April 2007||2007-04-01|September 2008|2008-09-01|January 2009|Anticipated|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer|Effects of Synthetic Genistein Supplementation on Blood and Tissue Biomarkers in Patients With Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|47|Actual|University Hospital, Aker||2|||f||||t||||||||||2017-02-18 15:10:24.04967|2017-02-18 15:10:24.04967
NCT00546026|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2007-10-17||||||October 2007|2007-10-01||||||||Interventional|||Does Mid-Gestation Placental Function Assessment Reduce Psychological Distress in Women With High-Risk Pregnancies?|Does Mid-Gestation Placental Function Assessment Reduce Psychological Distress in Women With High-Risk Pregnancies?|Unknown status|Not yet recruiting|Phase 1|160|Anticipated|Mount Sinai Hospital, Canada||1|||f||||f||||||||||2017-02-18 15:10:24.163585|2017-02-18 15:10:24.163585
NCT00546013|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2007-10-17|||December 2001||2001-12-01|October 2007|2007-10-01|July 2002|Actual|2002-07-01|||||Observational|||Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome|Abdominal Aortic Aneurysms Are Associated With Pseudoexfoliation Syndrome|Terminated||N/A|208|Actual|European Georges Pompidou Hospital|||1|all patients required included|f||||f||||||||||2017-02-18 15:10:24.423143|2017-02-18 15:10:24.423143
NCT00546000|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2014-06-25|2014-06-25||July 2007||2007-07-01|June 2014|2014-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Cutivate Lotion HPA Axis Pediatric Study|A Multi-Center, Open-Label Study to Evaluate the Effect of ALTANA Inc's Cutivate (Fluticasone Propionate) Lotion 0.05% on the Hypothalmic Pituitary Adrenal (HPA) Axis in the Treatment of Atopic Dermatitis in a Pediatric Population|Completed||Phase 4|56|Actual|Fougera Pharmaceuticals Inc.||1|||f||||f||||||||||2017-02-18 15:10:24.534685|2017-02-18 15:10:24.534685
NCT00545987|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2011-05-04|||September 2007||2007-09-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|October 2009|Actual|2009-10-01||Interventional|ADVAX-EP||Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers|Evaluation of Local and Systemic Reactogenicity Following Serial Administration of ADVAX, a Clade C DNA Vaccine, ADVAX e/g + ADVAX p/N-t, by Ichor TriGrid™ in Vivo Electroporation to HIV-Uninfected, Healthy Volunteers|Completed||Phase 1|40|Anticipated|Rockefeller University||2|||f||||t||||||||||2017-02-18 15:10:24.871303|2017-02-18 15:10:24.871303
NCT00545974|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2013-12-13|2013-04-22||October 2007||2007-10-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia|A Prospective, Randomized, Multi-Center, Double-Blind, 26 Week, Placebo-Controlled Trial of Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia|Completed||Phase 4|81|Actual|University of California, San Francisco|Lower enrollment than planned may have limited ability detect a treatment effect; Small size of semantic dementia group limits generalizability of results to FTD syndrome;Newer tools have been developed to better capture FTD-specific behaviors.|2|||f||||t||||||||||2017-02-18 15:10:25.011484|2017-02-18 15:10:25.011484
NCT00545961|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-17|2007-10-18|||November 2007||2007-11-01|October 2007|2007-10-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Middle Meatal Bacteriology During Acute Respiratory Infection in Children|Clinical Relevance of Middle Meatal Bacteriology During Acute Respiratory Infection in Children - Randomised, Double-Blinded Clinical Study|Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Oulu University Hospital||2|||f||||f||||||||||2017-02-18 15:10:25.491124|2017-02-18 15:10:25.491124
NCT00545948|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2014-06-25|2014-05-07||December 2007||2007-12-01|June 2014|2014-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|TOP0703|One patient in each of the vinorelbine and pemetrexed arms did not undergo protocol-based treatment, resulting in 22 total patients who were treated with either vinorelbine or pemetrexed. These two enrolled patients who were not administered treatment were added to the 7 original screen failures.|Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer|Phase II Prospective Study Evaluating the Role of Directed Cisplatin Based Chemo With Either Vinorelbine or Pemetrexed for the Adj Tx of Early Stage NSCLC in Patients Using Genomic Expression Profiles of Chemo Sensitivity to Guide Therapy|Terminated||Phase 2|31|Actual|Duke University||2||Study terminated due to reproducibility issues with genomics prediction model.|f||||t||||||||||2017-02-18 15:10:25.620704|2017-02-18 15:10:25.620704
NCT00545935|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2009-02-02|||July 2007||2007-07-01|February 2009|2009-02-01|October 2007||2007-10-01|||||Interventional|||Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso|Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso: RCT in the Frame of the A8 Project of SFB 544|Completed||Phase 2|186||Heidelberg University||3|||f||||||||||||||2017-02-18 15:10:26.222766|2017-02-18 15:10:26.222766
NCT00545922|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2007-11-14|||April 2005||2005-04-01|October 2007|2007-10-01|November 2007|Actual|2007-11-01|||||Interventional|||Cognitive Behavioral Therapy for Anxiety and Depression in COPD|Cognitive Behavior Therapy for Anxiety and Depression for Patients With Chronic Obstructive Pulmonary Disease (COPD): A Randomized, Controlled Clinical Trial in an Outpatient Pulmonary Clinic.|Completed||Phase 2|51|Actual|University of Bergen||2|||f||||f||||||||||2017-02-18 15:10:26.332416|2017-02-18 15:10:26.332416
NCT00545909|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-11-01|||March 2006||2006-03-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis|A Randomised, Open Label Study to Investigate the Impact of Bone Marker Feedback at 2 Months on Adherence to Monthly Oral Bonviva (Ibandronate) in Women With Post-menopausal Osteoporosis.|Completed||Phase 4|585|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:10:26.445008|2017-02-18 15:10:26.445008
NCT00545896|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2011-07-15|||September 2003||2003-09-01|August 2009|2009-08-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Extracorporeal Shockwave Treatment for Chronic Soft Tissue Wounds|Safety and Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Chronic Soft Tissue Wounds|Completed||Phase 2|282|Actual|AUVA||1|||f||||f||||||||||2017-02-18 15:10:26.596338|2017-02-18 15:10:26.596338
NCT00545883|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2012-01-25|||June 2006||2006-06-01|January 2012|2012-01-01|March 2008|Actual|2008-03-01|||||Observational|Alegria||Impact of GERD on Daily Life (NIS)|An Epidemiological, Observational Study to Describe Symptom Control and Impact on Daily Life of GERD in Patients With Erosive Gastroesophageal Reflux Disease.|Completed||N/A|2001|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:10:26.685386|2017-02-18 15:10:26.685386
NCT00545870|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-04-14|||June 2008||2008-06-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Bevacizumab Versus Ranibizumab for Diabetic Retinopathy|A Randomized, Double-masked Study With Intraocular Bevacizumab Compared With Intravitreal Ranibizumab in Patients With Persistent Diabetic Macular Edema or Persistent Active Neovascularisation Following Lasercoagulation|Completed||Phase 3|30|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 15:10:26.996993|2017-02-18 15:10:26.996993
NCT00545857|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-05-30|||June 2002||2002-06-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus|Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus|Completed||Phase 1|15|Actual|Stony Brook University||2|||f||||t||||||||||2017-02-18 15:10:27.118494|2017-02-18 15:10:27.118494
NCT00369174|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2013-02-12|||June 2006||2006-06-01|January 2013|2013-01-01||||August 2007|Actual|2007-08-01||Interventional|||Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia|Phase IIA Trial of Rosiglitazone (Avandia) for Oral Leukoplakia|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:18:05.411111|2017-02-18 16:18:05.411111
NCT00545844|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-04-07|2008-12-19||April 2007||2007-04-01|April 2016|2016-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Singulair(R) In Asthma And Allergic Rhinitis (0476-383)|An 8 Week Study to Evaluate the Effectiveness of Adding Montelukast to Inhaled Corticosteroid (ICS) to the ICS/Long-Acting Beta 2-Agonist Therapy in Adult Subjects With Asthma and Allergic Rhinitis|Completed||Phase 4|313|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:10:27.234796|2017-02-18 15:10:27.234796
NCT00545831|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2013-03-04|||October 2007||2007-10-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|Nutrilock||Effect of Taurolidin on Prevention of Bloodstream Infection|Prevention of Central Veinous Device Related Sepsis Relapse With Taurolidine in Patients on Parenteral Nutrition in Long-term Home|Terminated||N/A|39|Actual|University Hospital, Rouen||2||lack of recruitment|f||||f||||||||||2017-02-18 15:10:27.788651|2017-02-18 15:10:27.788651
NCT00545818|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-09-15|||November 2007||2007-11-01|September 2016|2016-09-01||||May 2016|Actual|2016-05-01||Interventional|||Study Comparing OsseoSpeed™ Implants of Two Different Lengths in the Upper and Lower Posterior Jaw|An Open, Prospective, Randomized, Multi-center Study Comparing OsseoSpeed™ Implant 6 mm With OsseoSpeed™ Implant 11 mm in the Posterior Maxilla and Mandible. A 5-year Follow-up Study.|Completed||N/A|97|Actual|Dentsply Sirona Implants||2|||f||||f||||||||||2017-02-18 15:10:27.897659|2017-02-18 15:10:27.897659
NCT00545805|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2013-02-17|||October 2005||2005-10-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity|Effects of the Surgical Removal of Visceral Fat Tissue (Omentectomy) on Insulin Sensitivity in Grade III Obese Volunteers Subjected to Bariatric Surgery|Completed||Phase 2/Phase 3|20|Actual|University of Campinas, Brazil||2|||f||||f||||||||||2017-02-18 15:10:28.015811|2017-02-18 15:10:28.015811
NCT00545792|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2015-09-10|2013-06-14||May 2007||2007-05-01|September 2015|2015-09-01|October 2013|Actual|2013-10-01|November 2010|Actual|2010-11-01||Interventional||Modified intention to treat (ITT), i.e., include all subjects that received and completed treatment.|Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers|A Pilot Study Evaluating The Safety Of Avastin And Pelvic Radiation In Women With Pelvic-Confined Recurrence of Gynecological Cancers|Completed||Phase 2|21|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:10:28.144967|2017-02-18 15:10:28.144967
NCT00545779|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-09-09|2016-07-19||December 2006||2006-12-01|September 2016|2016-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Analysis population included all enrolled participants in Part A who provided the baseline information.|BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.|'Open, Prospective, Multi-center, Two-part Study of Patient Preference With Monthly Ibandronate Therapy in Women With Postmenopausal Osteoporosis Switched From Once-daily or Once Weekly Alendronate or Risendronate - BONCURE (BONviva for Current Bisphosphonate Users - Regional European Trial)'|Completed||Phase 3|677|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:10:28.457571|2017-02-18 15:10:28.457571
NCT00545766|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2016-03-10|2013-02-25||May 2007||2007-05-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|||Vinflunine in Hormone Refractory Prostate Cancer (HRPC)|A Phase II Trial of Vinflunine as Salvage Chemotherapy in Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 2|41|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 15:10:28.841334|2017-02-18 15:10:28.841334
NCT00545753|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2012-09-10|2012-08-02||September 2007||2007-09-01|September 2012|2012-09-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice|A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects >6 Months of Age or Older With Pediculosis Capitis|Completed||Phase 3|558|Actual|ParaPRO LLC||3|||f||||f||||||||||2017-02-18 15:10:29.161595|2017-02-18 15:10:29.161595
NCT00545740|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2014-06-06|2012-12-19||November 2007||2007-11-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|PREVENT1||Prevention of Recurrence of Diverticulitis|A Phase III, Randomised, Double-Blind, Dose-Response, Stratified, Placebo-Controlled Study Evaluating the Safety and Efficacy of SPD476 Versus Placebo Over 104 Weeks in the Prevention of Recurrence of Diverticulitis.|Completed||Phase 3|590|Actual|Shire||4|||f||||f||||||||||2017-02-18 15:10:29.743131|2017-02-18 15:10:29.743131
NCT00545727|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2007-10-16|||July 2006||2006-07-01|September 2007|2007-09-01|August 2006|Actual|2006-08-01|||||Interventional|||Blood Glucose Response to Meals of Varying Glycemic Index in Youth With Type 1 & 2 Diabetes|Blood Glucose Response to Meals of Varying Glycemic Index in Youth With Type 1 & 2 Diabetes|Completed||N/A|36|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 15:10:31.699213|2017-02-18 15:10:31.699213
NCT00545714|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-11-01|||November 2007||2007-11-01|November 2016|2016-11-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)|Multicentre, Non-randomised, Open-label Phase II Study to Evaluate the Efficacy and Safety of Induction Treatment With Rituximab, Fludarabine, Cyclophosphamide, Followed by Rituximab Maintenance Therapy (R-Fc-Rm) in the First Line Treatment of Chronic Lymphocytic Leukaemia|Completed||Phase 2|90|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:10:31.805049|2017-02-18 15:10:31.805049
NCT00545701|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2014-01-10|||October 2007||2007-10-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults||Completed||Phase 2|100|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:10:31.982161|2017-02-18 15:10:31.982161
NCT00545688|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-11-01|2015-12-16||June 2006||2006-06-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional||Intent-To-Treat (ITT) Population included all randomized participants who received any amount of study medication. Analysis was performed according to initial randomization.|A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.|A Randomized, Open Label Study to Compare the Complete Pathological Response Rate Achieved With 4 Combinations of Herceptin, Docetaxel and Pertuzumab in Patients With Locally Advanced, Inflammatory or Early Stage HER2 Positive Breast Cancer|Completed||Phase 2|417|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 15:10:32.122835|2017-02-18 15:10:32.122835
NCT00073138|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-17|2007-11-28|||August 2003||2003-08-01|November 2007|2007-11-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of ABT-751 in Patients With Colorectal Cancer|A Phase 2 Study of ABT-751 in Subjects With Refractory Colorectal Carcinoma|Completed||Phase 2|40||Abbott||1|||f||||f||||||||||2017-02-18 17:55:37.910831|2017-02-18 17:55:37.910831
NCT00545675|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2010-08-10|||December 2007||2007-12-01|December 2009|2009-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SMART-M||Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness|Multi-center, Double-blind, Randomized, Comparative Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify and Depakote in 24-week Treatment of Mania in Patients With Bipolar Disorder Remitted After 6-week Treatment With Abilify and Depakote|Completed||Phase 4|146|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 15:10:33.790596|2017-02-18 15:10:33.790596
NCT00545662|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-11-16|2011-11-29||July 2007||2007-07-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|COBRIT||Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)|Citicoline Brain Injury Treatment Trial|Terminated||Phase 3|1213|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2||Trial stopped due to futility.|f||||t||||||||||2017-02-18 15:10:33.893285|2017-02-18 15:10:33.893285
NCT00545649|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2007-10-16|||May 2004||2004-05-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Development of Treatments Aiming at Improvement of Function in Patients With Chronic Widespread Pain|Development of Treatments Aiming at Improvement of Function in Patients With Chronic Widespread Pain|Completed||N/A|164|Actual|Göteborg University||2|||f||||f||||||||||2017-02-18 15:10:34.330068|2017-02-18 15:10:34.330068
NCT00545636|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-06-07|||March 2008||2008-03-01|June 2012|2012-06-01||||March 2009|Anticipated|2009-03-01||Interventional|||The Influence of Education of Medical Team on Duration of Fasting Before Elective Medical Interventions Performed Under General Anesthesia in Children|The Influence of Education of Medical Team on Duration of Fasting Before Elective Medical Interventions Performed Under General Anesthesia in Children|Withdrawn||N/A|0|Actual|Sheba Medical Center||1||unfortunately lacked manpower to carry out the study|f||||f||||||||||2017-02-18 15:10:34.445534|2017-02-18 15:10:34.445534
NCT00545623|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2014-08-31|2014-07-25||April 2007||2007-04-01|August 2014|2014-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||A total of 15 patients did not start the intervention after enrollment, 1, 4, 6, and 4 patients in ACUP+RR, SHAM+RR, ACUP+EDU, and SHAM+EDU arms respectively. As such there are a total of 115 patients with baseline data.|Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence|Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence|Completed||Phase 2|130|Actual|Boston University||4|||f||||f||||||||||2017-02-18 15:10:34.539745|2017-02-18 15:10:34.539745
NCT00545610|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-06-26|||October 2007||2007-10-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Observational|||ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)|A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])|Completed||N/A|150|Anticipated|Baxalta US Inc.|||3||f||||f||||||||||2017-02-18 15:10:34.993067|2017-02-18 15:10:34.993067
NCT00545597|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-03-01|||March 2005||2005-03-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy|A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy|Terminated||Phase 3|240|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Upon recommendation of DSMB|f||||t||||||||||2017-02-18 15:10:35.094613|2017-02-18 15:10:35.094613
NCT00545584|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-08-13|2011-04-19||April 2007||2007-04-01|August 2015|2015-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)|Multicenter, Open, Pragmatic, Randomized Trial Comparing the Efficacy of 3 Different Lifestyle Interventions After Addition of Sitagliptin to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy|Completed||Phase 3|1512|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 15:10:35.208121|2017-02-18 15:10:35.208121
NCT00545571|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-05-19|2016-04-12||October 2007||2007-10-01|May 2016|2016-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||Intent-to-Treat (ITT) Population: All participants who received at least one dose of study drug and for whom data were available from at least one follow-up variable.|MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia|A Single Arm, Open Label, Interventional Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Once-Monthly Administration of Intravenous C.E.R.A. for the Maintenance of Hemoglobin Levels in Hemodialysis Patients With Chronic Renal Anemia|Completed||Phase 3|120|Actual|Hoffmann-La Roche|The Study was prematurely terminated in Austria as a consequence of Mircera reimbursement denial. However, the Study completed regularly in Switzerland and the overall status of the Study is considered completed.|1|||f||||||||||||||2017-02-18 15:10:38.211667|2017-02-18 15:10:38.211667
NCT00545558|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2014-08-08|||April 2006||2006-04-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|ART and HCV||Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV|Antiretroviral Therapy and the Hepatitis C Virus|Completed||Phase 1|18|Actual|University of Cincinnati||1|||f||||f||||||||||2017-02-18 15:10:38.674452|2017-02-18 15:10:38.674452
NCT00545545|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2010-03-30|||October 2007||2007-10-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma|A Phase 1b, Safety, PK, and Efficacy, Multicenter, Dose-Escalating Study of Imprime PGG in Combination With Cetuximab With and Without Irinotecan Therapy in Patients With Recurrent/Progressive Colorectal Carcinoma Following Treatment With a 5-FU Regimen.|Completed||Phase 1/Phase 2|48|Anticipated|Biothera||6|||f||||t||||||||||2017-02-18 15:10:38.789521|2017-02-18 15:10:38.789521
NCT00545532|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2017-01-19|||February 2008||2008-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.|A Double-blind, Randomized, Stratified Multi-center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza|Recruiting||Phase 3|225|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:10:39.131874|2017-02-18 15:10:39.131874
NCT00545519|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2013-04-22|||October 2006||2006-10-01|April 2013|2013-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma|A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma|Completed||Phase 1|6|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 15:10:39.462638|2017-02-18 15:10:39.462638
NCT00545506|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2010-08-30|2010-07-22||November 2007||2007-11-01|August 2010|2010-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||The Influence of a Warmed Surgical Bandage System on Subcutaneous Tissue Oxygen Tension After Cardiac Surgery|The Influence of a Warmed Surgical Bandage System on Subcutaneous Tiisue Oxygen Tension After Cardiac Surgery|Terminated||Phase 3|3|Actual|Medical University of Vienna|Tissue oxygen tension maybe difficult to measure in the sternal wound|2||lack of eligible patients|f||||t||||||||||2017-02-18 15:10:39.574934|2017-02-18 15:10:39.574934
NCT00545493|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2009-04-09|||November 2002||2002-11-01|April 2009|2009-04-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis|Efficacy of Tacrolimus and i.v.-Immunoglobulins in Rasmussen Encephalitis With Start of Treatment in the Acute Disease Stage. Prospective, Randomised, Open Parallel Group Study|Unknown status|Active, not recruiting|Phase 2/Phase 3|16|Anticipated|University Hospital, Bonn||2|||f||||f||||||||||2017-02-18 15:10:40.141538|2017-02-18 15:10:40.141538
NCT00545480|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-08-17|||July 2006||2006-07-01|August 2015|2015-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.|A Randomized, Open-label Study to Investigate the Impact of Bone Marker Feedback on Persistence to Once Monthly Oral Bonviva (Ibandronate) Treatment for Post-menopausal Osteoporosis.|Completed||Phase 4|596|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:10:40.281272|2017-02-18 15:10:40.281272
NCT00545467|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2012-05-16|||August 2007||2007-08-01|January 2012|2012-01-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents|Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents: Combination of Pharmacogenomics and Therapeutic Drug Monitoring|Completed||Phase 4|79|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 15:10:40.597527|2017-02-18 15:10:40.597527
NCT00545454|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2009-01-15|||October 2007||2007-10-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|ACCORD-RA||Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis|Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis (RA): A 4-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Study of 90 µg Administered Once Daily and 90 µg Once Every Other Day|Completed||Phase 2|79|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 15:10:40.715203|2017-02-18 15:10:40.715203
NCT00545441|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2014-12-02|2014-10-24||June 2008||2008-06-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|Surgisis® AFP|Patients that were not treated were not included in the analysis. There was 1 patient in the Surgisis arm and 3 patients in the Flap arm that were not treated.|A Randomized Clinical Trial Comparing Surgisis AFP to Advancement Flap for the Repair of Anal Fistulas|A Randomized Clinical Trial Comparing Surgisis AFP to Advancement Flap for the Repair of Anal Fistulas|Completed||N/A|86|Actual|Cook||2|||f||||f||||||||||2017-02-18 15:10:40.820843|2017-02-18 15:10:40.820843
NCT00545428|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2009-02-03|||April 2006||2006-04-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Mastoid Bone Autograft for Dorsal Nasal Augmentation|Mastoid Bone Autograft for Dorsal Nasal Augmentation|Completed||N/A|15|Actual|Federal University of Uberlandia||1|||f||||f||||||||||2017-02-18 15:10:41.152142|2017-02-18 15:10:41.152142
NCT00545415|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2009-07-15|||January 2008||2008-01-01|July 2009|2009-07-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||The Effect of Fruit and Fruit Juice on Plasma Total Antioxidant Capacity|The Effect of Fruit and Fruit Juice on Plasma Total Antioxidant Capacity|Completed||N/A|24|Actual|Maastricht University Medical Center||6|||f||||f||||||||||2017-02-18 15:10:41.255794|2017-02-18 15:10:41.255794
NCT00545402|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2014-06-09|2014-06-09||November 2007||2007-11-01|June 2014|2014-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Intent to treat (ITT) population includes all randomized participants who received at least 1 dose of MMF.|A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.|A Randomized, Open Label Study Comparing the Effect of CellCept With Therapeutic Drug Monitoring, Tacrolimus and a Corticosteroid-sparing Regimen Versus Fixed Dose CellCept, Tacrolimus and Corticosteroids Maintained up to 6 Months, on Acute Rejection and Safety in Liver Transplant Patients.|Completed||Phase 4|180|Actual|Hoffmann-La Roche|Nonserious adverse events presented in this record include all adverse events reported during the study, not just nonserious events.|2|||f||||||||||||||2017-02-18 15:10:41.374598|2017-02-18 15:10:41.374598
NCT00545389|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2009-06-18|||February 2003||2003-02-01|November 2007|2007-11-01|October 2004|Actual|2004-10-01|||||Interventional|||Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476|A Phase II, Randomized, Multi-Centre, Double-Blind, Parallel-Group, Dose-Ranging, Exploratory Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 (Mesalazine) Once Daily|Completed||Phase 2|38|Actual|Shire|||||f||||||||||||||2017-02-18 15:10:43.021926|2017-02-18 15:10:43.021926
NCT00545376|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2008-02-11|||October 2007||2007-10-01|September 2007|2007-09-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Effect of OMT on Asthma Symptoms in Southwest Virginia|The Use of Osteopathic Manipulation in a Clinic and Home Setting to Address Pulmonary Distress as Related to Asthma in Southwest Virginia|Completed||N/A|32|Actual|Edward Via Virginia College of Osteopathic Medicine||3|||f||||t||||||||||2017-02-18 15:10:43.115862|2017-02-18 15:10:43.115862
NCT00545363|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-08-31|2016-07-02||April 2006||2006-04-01|August 2016|2016-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||Safety population included participants who received at least 1 dose of study drug.|A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)|A Randomized Open-Label Study to Investigate the Impact of Bone Marker Feedback at 3 Months on Adherence to Monthly Oral Bonviva in Women With Post-Menopausal Osteoporosis Supported by a Patient Relationship Program|Completed||Phase 4|716|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:10:43.231352|2017-02-18 15:10:43.231352
NCT00545350|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2014-04-02|||November 2007||2007-11-01|May 2012|2012-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|Ossébo||Exercise Intervention to Prevent Fall-related Fractures and Other Injuries : The Ossébo Study|Randomized Controlled Trial of Prevention of Fall-related Fractures and Other Injuries by Physical Exercise Among Community Dwelling Elderly Women|Completed||N/A|706|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:10:44.088718|2017-02-18 15:10:44.088718
NCT00545337|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2009-10-15|||September 2004||2004-09-01|October 2009|2009-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Glulisine + Lantus in Type I Patients|26-week, International Multicenter, Open, Non-randomized Phase III Clinical Trial for Evaluation of Efficacy and Safety of Insulin Glulisine (HMR1964) Injected Subcutaneously in Subjects With Type 1 Diabetes Mellitus Also Using Insulin Glargine|Completed||Phase 3|60|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:10:44.219041|2017-02-18 15:10:44.219041
NCT00545324|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-03-11|||September 2002||2002-09-01|March 2015|2015-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|FIRST||First Step With Singulair® Therapy (0476-323)|"A 12 Week Multicenter, Open-Label, Randomized, Observational Study Comparing Singulair® 10 Mg As Controller Monotherapy In Adults With Mild Asthma To Low Dose Inhaled Corticosteroid Treatment"|Completed||Phase 4|399|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:10:44.297592|2017-02-18 15:10:44.297592
NCT00545311|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2007-12-27|||July 2007||2007-07-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients|A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Inhaled NVA237 Doses at Four Dose Levels in COPD Patients|Completed||Phase 1|40|Actual|Novartis||5|||f||||f||||||||||2017-02-18 15:10:44.380871|2017-02-18 15:10:44.380871
NCT00545298|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-10-18|2012-08-08||October 2007||2007-10-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers|An Investigation of the Topical Application of Gaseous Nitric Oxide on Safety and Efficacy in Venous Stasis Leg Ulcers of the Lower Extremities|Terminated||Phase 2|4|Actual|Nitric BioTherapeutics, Inc|Early termination due to small number of subjects enrolled|3||Strategic direction of the sponsor changed|f||||t||||||||||2017-02-18 15:10:44.492646|2017-02-18 15:10:44.492646
NCT00545285|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2014-09-24|||November 2007||2007-11-01|September 2014|2014-09-01|May 2023|Anticipated|2023-05-01|May 2023|Anticipated|2023-05-01||Interventional|||Long-Term Multi-center Evaluation of E-Poly and Regenerex|Long-Term Multi-center Evaluation of E-Poly and Regenerex Cementless Acetabular Components: Clinical and Radiographic Outcomes|Active, not recruiting||N/A|1000|Anticipated|Massachusetts General Hospital||4|||f||||f||||||||||2017-02-18 15:10:44.997536|2017-02-18 15:10:44.997536
NCT00545272|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-12-12|2012-11-12||October 2007||2007-10-01|November 2012|2012-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma|A Randomized, Multi-center, Parallel Group, Double Blind, Placebo and Formoterol Controlled 14 Day Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma|Completed||Phase 2|392|Actual|Novartis||6|||f||||||||||||||2017-02-18 15:10:45.140514|2017-02-18 15:10:45.140514
NCT00545259|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2011-04-08|||October 2007||2007-10-01|February 2008|2008-02-01||||February 2009|Actual|2009-02-01||Interventional|||Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation|An Open-label, Two-period, Multi-center, Single Dose Study to Assess the Pharmacokinetics of AEB071 in de Novo Liver Transplant Patients|Completed||Phase 1|13|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:10:46.0245|2017-02-18 15:10:46.0245
NCT00545246|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2013-10-12|||October 2007||2007-10-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients|A Phase I, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Aflibercept in Combination With Intravenous Docetaxel Administered Every 3 Weeks in Patients With Advanced Solid Malignancies|Completed||Phase 1|12|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:10:46.221977|2017-02-18 15:10:46.221977
NCT00545233|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2012-04-10|2012-02-08||January 2008||2008-01-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.|A Randomized, Open-label Study of the Effect of PEGASYS ® Plus COPEGUS® With or Without Concomitant Pioglitazone (Actos®) on Early Viral Kinetics in Treatment-naive Patients With Chronic Hepatitis C, Genotype-1, and Insulin Resistance|Completed||Phase 4|155|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:10:46.355752|2017-02-18 15:10:46.355752
NCT00545220|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2016-02-17|||October 2007||2007-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Problem Solving Training and Low Vision Rehabilitation|Problem Solving Training and Low Vision Rehabilitation|Completed||N/A|430|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-02-18 15:10:47.831447|2017-02-18 15:10:47.831447
NCT00545207|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2017-01-25||||||January 2017|2017-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.|A Randomized, Double-blind Study of the Effect of Oral Monthly Bonviva on in Vivo Bone Micro-architecture Parameters in Post-menopausal Women With Osteopenia|Completed||Phase 3|150|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:10:47.936179|2017-02-18 15:10:47.936179
NCT00545194|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2007-10-16|||January 2002||2002-01-01|October 2007|2007-10-01|October 2004|Actual|2004-10-01|||||Interventional|||Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess|Randomized Study on Removable PGE2 Vaginal Insert Versus PGE2 Intravaginal Gel for Cervical Priming and Labour Induction in Term Pregnancy|Completed||Phase 3|446|Actual|Institut National de la Santé Et de la Recherche Médicale, France||2|||f||||t||||||||||2017-02-18 15:10:48.045631|2017-02-18 15:10:48.045631
NCT00545181|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2010-01-06|2009-12-02||September 2007||2007-09-01|January 2010|2010-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial|Recurrent Bacterial Vaginosis (RBV): Efficiency of Metronidazole in Comparison to Metronidazole and Intravaginal Acidifying Gel: A Randomized Investigator-blinded Controlled Trial|Completed||N/A|55|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 15:10:48.147843|2017-02-18 15:10:48.147843
NCT00545168|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2012-09-10|2012-08-02||September 2007||2007-09-01|September 2012|2012-09-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice|A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects > 6 Months of Age With Pediculosis Capitis|Completed||Phase 3|480|Actual|ParaPRO LLC||3|||f||||f||||||||||2017-02-18 15:10:48.528378|2017-02-18 15:10:48.528378
NCT00545155|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-05-22|2011-08-02||June 2007||2007-06-01|May 2015|2015-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Screening and Interventions in an Acute Care Setting|Screening and Interventions in an Acute Care Setting|Completed||N/A|187|Actual|University of Rochester|"administration of one measure was done by individuals not blinded to another, potentially improving the concurrent criterion validity results.~a number of subjects did not consent or could not consent to participate in the study."||1||f||||f||||||||||2017-02-18 15:10:49.043269|2017-02-18 15:10:49.043269
NCT00545142|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2010-06-24|||October 2007||2007-10-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|SMART-A||Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness|Multi-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder|Completed||Phase 4|280|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 15:10:49.323485|2017-02-18 15:10:49.323485
NCT00545129|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-01-10||2013-01-10|April 2009||2009-04-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone|Phase II Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy And Safety Study Of Tanezumab As Add-On Therapy To Opioid Medication In Patients With Pain Due To Bone Metastases|Completed||Phase 2|59|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:10:49.42281|2017-02-18 15:10:49.42281
NCT00545116|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-10-05|||October 2007||2007-10-01|January 2014|2014-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women|Short-term Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women: a Randomized Placebo-controlled Trial|Completed||Phase 2|144|Actual|Nestlé||4|||f||||f||||||||||2017-02-18 15:10:49.676691|2017-02-18 15:10:49.676691
NCT00545103|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2014-06-06|2012-10-11||December 2007||2007-12-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|PREVENT2||Prevention of Recurrence of Diverticulitis|A Phase III, Randomised, Double-Blind, Dose-Response, Stratified, Placebo-Controlled Study Evaluating the Safety and Efficacy of SPD476 Versus Placebo Over 104 Weeks in the Prevention of Recurrence of Diverticulitis.|Completed||Phase 3|592|Actual|Shire||4|||f||||f||||||||||2017-02-18 15:10:49.796845|2017-02-18 15:10:49.796845
NCT00545090|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-11-08|||August 2006||2006-08-01|November 2016|2016-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.|An Open-label, Clinical Observation Extension Study to Assess Continuing Safety and Adherence in Patients With Postmenopausal Osteoporosis Receiving Monthly Oral Bonviva|Completed||Phase 4|561|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:10:51.623651|2017-02-18 15:10:51.623651
NCT00545077|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-05-18|||November 2007||2007-11-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line Treatment in Postmenopausal Patients With Advanced or Metastatic Breast Cancer|Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Endocrine Treatment Compared to Endocrine Treatment Alone, in Postmenopausal Women With Advanced or Metastatic Cancer With Indication of Hormonotherapy as First-line Treatment|Completed||Phase 3|378|Actual|Spanish Breast Cancer Research Group||2|||f||||t||||||||||2017-02-18 15:10:51.737947|2017-02-18 15:10:51.737947
NCT00545064|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2015-04-07|2009-08-20||May 2007||2007-05-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|DISCOVER||Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)|A Multicenter, Open-Label Study To Evaluate The Tolerability Of Preservative Free Dorzolamide-Timolol Therapy In Patients Untreated With Open-Angle Glaucoma Or Ocular Hypertension And Dry Eye(s)|Completed||Phase 4|176|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:10:52.036857|2017-02-18 15:10:52.036857
NCT00545051|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-16|2016-04-05|2016-04-05||May 2006||2006-05-01|April 2016|2016-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional||The intent-to-treat (ITT) population included all participants randomized and who had at least one follow up efficacy data time point available.|A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.|A Randomized, Double-blind Study to Evaluate the Effect of Once Monthly Bonviva on Lumbar Bone Mineral Density in the Prevention of Glucocorticoid-induced Osteoporosis in Post-menopausal Women|Completed||Phase 4|140|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:10:52.313171|2017-02-18 15:10:52.313171
NCT00545025|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2016-11-03|2013-03-21||October 2007||2007-10-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Revaccination With Influenza Vaccine GSK1247446A|Safety and Immunogenicity of a Second Vaccination With GSK Biologicals' Influenza Vaccine GSK1247446A in Subjects 18-60 Years Previously Vaccinated in Study 108656|Completed||Phase 2|243|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:10:52.807185|2017-02-18 15:10:52.807185
NCT00545012|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-09-16|||May 2000||2000-05-01|September 2009|2009-09-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures|A 30-month Safety and Efficacy Follow-up Study With Levetiracetam at Individualized Optimal Dose in Children (4-17 Years Old at Inclusion) Suffering From Typical Absences in Childhood Absence Epilepsy (CAE) or Juvenile Absence Epilepsy (JAE)|Completed||Phase 2|4|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:10:53.325881|2017-02-18 15:10:53.325881
NCT00544999|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2013-09-16|||September 2007||2007-09-01|July 2009|2009-07-01||||April 2010|Anticipated|2010-04-01||Interventional|||Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia|Phase I Study Evaluating the Chemosensitizing Effect of Everolimus Administered With Cytarabine and Daunorubicin in Patients With Acute Myeloid Leukemia in Relapse|Unknown status|Recruiting|Phase 1|21|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:10:53.415517|2017-02-18 15:10:53.415517
NCT00544986|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2013-01-29|||June 2005||2005-06-01|January 2013|2013-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer|A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer|Completed||Phase 4|||AstraZeneca|||||f||||f||||||||||2017-02-18 15:10:53.512065|2017-02-18 15:10:53.512065
NCT00544960|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2010-08-24||2010-08-12|September 2007||2007-09-01|August 2010|2010-08-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer|A Phase 2, Randomized, 2-Arm, Double-Blind Study of AT-101 in Combination With Docetaxel Versus Docetaxel Plus Placebo in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|106|Actual|Ascenta Therapeutics||2|||f||||f||||||||||2017-02-18 15:10:53.591752|2017-02-18 15:10:53.591752
NCT00544947|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2009-02-03|||October 2007||2007-10-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids for Caesarean Section|Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids: a Comparison Between Diamorphine and Fentanyl Combined With Postoperative Morphine PCA Using a Carbon Dioxide Tension and Pulse Oximetry Sensor (TOSCA)|Completed||N/A|90|Actual|NHS Greater Clyde and Glasgow|||1||f||||f||||||||||2017-02-18 15:10:56.271538|2017-02-18 15:10:56.271538
NCT00544934|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2016-02-09|||February 2007||2007-02-01|February 2016|2016-02-01|October 2007|Actual|2007-10-01|||||Interventional|||Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects|A Dose-ranging Study to Evaluate the Safety, Metabolism and Therapeutic Dosing of Three Multiple Dose Levels of GLY-230 in Healthy and Diabetic Subjects|Completed||Phase 1/Phase 2|42|Actual|Glycadia||4|||f||||f||||||||||2017-02-18 15:10:56.365261|2017-02-18 15:10:56.365261
NCT00544921|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2016-02-09|||October 2005||2005-10-01|February 2016|2016-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects|Phase 1 Study of Anti-glycation Agent GLY-230|Completed||Phase 1|54|Actual|Glycadia||7|||f||||f||||||||||2017-02-18 15:10:56.450011|2017-02-18 15:10:56.450011
NCT00544908|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2015-09-18|2015-08-19||September 2007||2007-09-01|September 2015|2015-09-01||||October 2012|Actual|2012-10-01||Interventional|||Dasatinib in Treating Patients With Stage IV Pancreatic Cancer|A Phase II Clinical Trial of Dasatinib in Patients With Metastatic Pancreatic Cancer|Terminated||Phase 2|7|Actual|City of Hope Medical Center|Study was terminated early due to toxicity.|1||Toxicity|f||||||||||||||2017-02-18 15:10:56.549299|2017-02-18 15:10:56.549299
NCT00544895|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2011-06-22|||October 2007||2007-10-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|||||Observational|NEOBRAIN||Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants|Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants|Completed||N/A|600|Anticipated|Hannover Medical School|||1||f||||f||||||Samples With DNA|"~     whole blood, urine~   "|||2017-02-18 15:10:56.808623|2017-02-18 15:10:56.808623
NCT00544882|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2016-08-04|2014-05-08||October 2007||2007-10-01|August 2016|2016-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||The Intent-to-treat (ITT) cohort consisted of all randomized participants who took at least one dose of randomized study medication and had at least one post-baseline efficacy measurement for at least one of the primary efficacy endpoints (FSH, inhibin-B, or estradiol).|A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021|A Prospective, Multicenter, Randomized, Double-Blind Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With the Oral Contraceptive Regimen DR-1021|Completed||Phase 3|61|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 15:10:56.918062|2017-02-18 15:10:56.918062
NCT00544869|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-12-24|2013-11-05||October 2007||2007-10-01|December 2013|2013-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional||"1 Subject of Arm Continued at 15 mg/day was excluded from analysis because of GCP incompliance"|A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)|Phase 3 Open-label, Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure) — an Investigation of the Safety of Treatment Beyond 7 Days and the Effect of Dose Escalation to 30 mg|Completed||Phase 3|52|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 15:10:57.943287|2017-02-18 15:10:57.943287
NCT00544856|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2009-01-28|||October 2007||2007-10-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effects of a Complex Cognitive Training in Mild Cognitive Impairment and Mild Alzheimer's Disease||Completed||N/A|39||Ludwig-Maximilians - University of Munich||2|||f||||||||||||||2017-02-18 15:10:58.498977|2017-02-18 15:10:58.498977
NCT00544830|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2017-02-03|||July 18, 2006|Actual|2006-07-18|February 2017|2017-02-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Androgen Deprivation Therapy for Metastatic Prostate Cancer|Androgen Deprivation and Localized Radiotherapy to Metastases in Patients With Oligometastatic Hormone - Sensitive Prostate Cancer|Active, not recruiting||Phase 2|29|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 15:10:58.595599|2017-02-18 15:10:58.595599
NCT00544817|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2016-07-21|2012-11-15||April 2007||2007-04-01|July 2016|2016-07-01|August 2010|Actual|2010-08-01|June 2008|Actual|2008-06-01||Interventional|||Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme|A Phase II Trial of Concurrent Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib in the First-Line Treatment of Patients With Glioblastoma Multiforme|Completed||Phase 2|47|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 15:10:58.710589|2017-02-18 15:10:58.710589
NCT00544804|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2014-07-01|||August 2007||2007-08-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|June 2013|Actual|2013-06-01||Interventional|||Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2|A Phase I Dose Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy With Biomarker Analysis in Patients With HER2-Overexpressing Breast Cancer|Completed||Phase 1|41|Actual|University of California, San Francisco||1|||f||||||||||||||2017-02-18 15:10:59.269348|2017-02-18 15:10:59.269348
NCT00544791|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-14|2007-10-15|||October 2007||2007-10-01|June 2007|2007-06-01|October 2010|Anticipated|2010-10-01|||||Interventional|MCI||The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment|The Effect of Melatonin on Memory and Other Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment (MCI): A Placebo- Controlled Study.|Unknown status|Recruiting|Phase 2|50|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 15:10:59.383115|2017-02-18 15:10:59.383115
NCT00544596|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2014-04-01|||September 2007||2007-09-01|June 2012|2012-06-01||||July 2013|Actual|2013-07-01||Interventional|||R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer|A Phase 1 Study of R-(-)-Gossypol (AT-101) in Combination With Cisplatin and Etoposide in Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer|Completed||Phase 1|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:11:02.632307|2017-02-18 15:11:02.632307
NCT00544778|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2014-08-19|2014-06-12||August 2001||2001-08-01|August 2014|2014-08-01||||November 2011|Actual|2011-11-01||Interventional|||Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma|Phase II Trial of Neoadjuvant Dose-Dense Doxorubicin, Ifosfamide, and Irinotecan (CPT-11) for Advanced Soft Tissue and Recurrent Bone Sarcomas|Terminated||Phase 2|7|Actual|City of Hope Medical Center|The study was terminated…protocol objectives not met. It was closed prematurely due to withdrawal of support by the sponsor. Subjects have been followed, but there is not enough data generated to continue following the subjects.”|1||The study was terminated prematurely due to withdrawal of support by the sponsor.|f||||||||||||||2017-02-18 15:10:59.484561|2017-02-18 15:10:59.484561
NCT00544765|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2016-02-09|||September 2002||2002-09-01|February 2016|2016-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|GeparTrio||Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer|A Multi-center Randomized Phase III Study Evaluating 4 Cycles of Docetaxel, Doxorubicin and Cyclophosphamide Versus 4 Cycles of Vinorelbine and Capecitabine in Patients Not Sufficiently Responding to 2 Cycles of TAC and 4 Cycles of TAC Versus 6 Cycles of TAC in Patients Sufficiently Responding to 2 Cycles of TAC as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer|Completed||Phase 3|2014|Actual|German Breast Group||4|||f||||t||||||||||2017-02-18 15:10:59.752633|2017-02-18 15:10:59.752633
NCT00544752|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2011-04-13|||January 2005||2005-01-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Indoor Temperature and Sleep Apnea|Indoor Temperature and Sleep Apnea|Completed||N/A|40|Actual|Umeå University||3|||f||||||||||||||2017-02-18 15:10:59.870771|2017-02-18 15:10:59.870771
NCT00544739|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2012-01-16|||April 2005||2005-04-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Observational|PRECADIW||Premature Coronary Artery Disease in Women - Risk Factors and Prognosis|Premature Coronary Artery Disease in Women - Risk Factors and Prognosis|Completed||N/A|670|Actual|Institute of Cardiology, Warsaw, Poland|||2||f||||f||||||Samples With DNA|"~     whole blood, serum~   "|||2017-02-18 15:10:59.974229|2017-02-18 15:10:59.974229
NCT00544726|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2008-04-06|||February 2008||2008-02-01|October 2007|2007-10-01||||||||Interventional|||Rehabilitation for Patients With Pulmonary Arterial Hypertension||Unknown status|Enrolling by invitation|N/A|45|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 15:11:00.086134|2017-02-18 15:11:00.086134
NCT00544713|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2011-11-09|2009-06-29||September 2007||2007-09-01|November 2011|2011-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery||Completed||N/A|228|Actual|Allergan||2|||f||||f||||||||||2017-02-18 15:11:00.213606|2017-02-18 15:11:00.213606
NCT00544700|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2016-04-14|||October 2007||2007-10-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|May 2012|Actual|2012-05-01||Interventional|||Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer|Bevacizumab Maintenance Versus no Maintenance After Stop of First-line Chemotherapy in Patients With Metastatic Colorectal Cancer. A Randomized Multicenter Phase III Non-inferiority Trial|Active, not recruiting||Phase 3|265|Actual|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||No||2017-02-18 15:11:00.841061|2017-02-18 15:11:00.841061
NCT00544687|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2007-11-14|||September 2007||2007-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Phase I Study of Topical CRx-191 in Normal Healthy Volunteers|A Phase I, Single-Center, Randomized, Vehicle and Active-Controlled Study to Assess and Compare the Atrophy-Causing Potential of Topical CRx-191 Formulations in Healthy Volunteers|Completed||Phase 1|20|Actual|Zalicus||6|||f||||f||||||||||2017-02-18 15:11:00.975253|2017-02-18 15:11:00.975253
NCT00544674|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2012-12-06|2011-06-13||August 2007||2007-08-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|||PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer|A Phase II, Multi-Center, Open-Label, Trial of PR104 in Treatment Naive and Sensitive-relapse Small Cell Lung Cancer|Terminated||Phase 2|5|Actual|Proacta, Incorporated|Decision to close study early based on new data showing that PR104A could also be activated under oxic conditions in tumors that express high levels of AKR1C3. SCLC does not express meaningful levels of the enzyme aldo keto reductase 1C3 (AKR1C3).|1||Terminated early due to discovery of new mechanism of activation.|f||||||||||||||2017-02-18 15:11:01.145408|2017-02-18 15:11:01.145408
NCT00544648|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2014-05-21|2014-03-19||November 2007||2007-11-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Consented patients|Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC|A Phase I/II Study of Nab-Paclitaxel and Carboplatin With Concurrent Radiation Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer (NSCLC)|Terminated||Phase 1/Phase 2|13|Actual|Vanderbilt-Ingram Cancer Center|This Phase I/II study progressed into Phase II, but terminated shortly thereafter due to lack of funding.|1||"Ph I completed. Funding became unavailable causing Ph II to cease after two patients were~   enrolled."|f||||t||||||||||2017-02-18 15:11:01.600788|2017-02-18 15:11:01.600788
NCT00544635|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2014-07-25|||November 2005||2005-11-01|July 2014|2014-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Effect Of Light On Scar Appearance|The Effect Of Light On Scar Appearance|Terminated||N/A|50|Anticipated|Northwestern University||2||Study personnel left institution before study completion.|f||||f||||||||||2017-02-18 15:11:02.331043|2017-02-18 15:11:02.331043
NCT00544622|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2008-10-16|||January 2002||2002-01-01|October 2008|2008-10-01|March 2003||2003-03-01|||||Interventional|||Structured Stroke Management Improves Outcome at 6 Months|Structured Stroke Management Improves Outcome at 6 Months|Completed||N/A|||Kantonsspital Baden|||||f||||t||||||||||2017-02-18 15:11:02.440542|2017-02-18 15:11:02.440542
NCT00544609|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2014-10-01|||December 2007||2007-12-01|October 2014|2014-10-01|May 2012|Actual|2012-05-01|August 2010|Actual|2010-08-01||Interventional|SOGUG-07-01||Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent|Phase I Trial of Sorafenib in Combination With Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent|Completed||Phase 1|10|Actual|Spanish Oncology Genito-Urinary Group||1|||f||||t||||||||||2017-02-18 15:11:02.523592|2017-02-18 15:11:02.523592
NCT00544583|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2010-01-26|||November 2007||2007-11-01|January 2010|2010-01-01|April 2012|Anticipated|2012-04-01|April 2011|Anticipated|2011-04-01||Interventional|CONTINT||Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy|Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy: CONTINT - A Randomized Controlled Study|Unknown status|Recruiting|Phase 2/Phase 3|80|Anticipated|Heidelberg University||2|||f||||t||||||||||2017-02-18 15:11:02.755885|2017-02-18 15:11:02.755885
NCT00544570|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2010-02-05|||April 1998||1998-04-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma|High Dose Sequential Therapy for Poor Risk Recurrent or Refractory Hodgkin's Disease|Completed||N/A|30|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-02-18 15:11:02.866923|2017-02-18 15:11:02.866923
NCT00544557|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2015-04-23|2015-04-23||October 2007||2007-10-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational||Safety population included all treated participants with available post-baseline safety data.|Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis|Observational Study Of The Use Of Enbrel (Registered) (Etanercept) In Routine Clinical Practice To Treat Ankylosing Spondylitis (as) Patients: An Effectiveness, Safety, And Health Economic Evaluation|Completed||Phase 4|1715|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:11:02.985219|2017-02-18 15:11:02.985219
NCT00544544|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2012-03-09|2010-06-24||June 2007||2007-06-01|March 2012|2012-03-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Riluzole in the Treatment of Bipolar Depression|Riluzole in the Treatment of Bipolar Depression: A Study of the Association Between Clinical Response and Change in Brain Glutamate Levels as Measured by Proton Magnetic Resonance Spectroscopy|Completed||N/A|14|Actual|Mclean Hospital||1|||f||||f||||||||||2017-02-18 15:11:04.433041|2017-02-18 15:11:04.433041
NCT00544531|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-14|2007-10-15|||October 2005||2005-10-01|September 2005|2005-09-01|March 2007|Actual|2007-03-01|||||Observational|||The Cytogenetic Constitution of Embryos Resulting From Immature Oocytes (M1)||Completed||N/A|23907|Actual|Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:11:04.705288|2017-02-18 15:11:04.705288
NCT00544518|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2008-05-21|||October 2007||2007-10-01|May 2008|2008-05-01|October 2008|Anticipated|2008-10-01|September 2008|Anticipated|2008-09-01||Interventional|||Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients||Unknown status|Active, not recruiting|Phase 2|240|Anticipated|Fourth Military Medical University||2|||f||||t||||||||||2017-02-18 15:11:04.780978|2017-02-18 15:11:04.780978
NCT00544505|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2011-12-11|||September 2007||2007-09-01|December 2011|2011-12-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)||Unknown status|Active, not recruiting|N/A|10|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:11:04.886025|2017-02-18 15:11:04.886025
NCT00544492|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2011-12-17|||October 2007||2007-10-01|December 2011|2011-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients|Study of Pain, Anxiety, Complications Related to AV Fistula Cannulation in Chronic Hemodialysis Patients. A. Buttonhole vs. Rope Ladder Technique B. Catheters With Cylindrical Point vs. Catheters With Bevel Point in Rope Ladder Technique|Completed||Phase 4|40|Actual|Universitaire Ziekenhuizen Leuven||4|||f||||t||||||||||2017-02-18 15:11:04.961287|2017-02-18 15:11:04.961287
NCT00544479|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2015-05-19|||March 2015||2015-03-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational|||No Routine CXR After Bronchoscopy|Is Routine Chest-X-Ray Necessary After Bronchoscpy With Thransbronchial Biopsie? A Prospective Study|Completed||N/A|250|Actual|Shaare Zedek Medical Center|||1||f||||||||||||||2017-02-18 15:11:05.078385|2017-02-18 15:11:05.078385
NCT00544466|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2016-09-16|||June 2006||2006-06-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies|Allogeneic Stem Cell Transplant With a Novel Conditioning Therapy Using Helical Tomotherapy, Melphalan, and Fludarabine in Hematological Malignancies|Active, not recruiting||N/A|100|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 15:11:05.159204|2017-02-18 15:11:05.159204
NCT00544453|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2009-08-20|||October 2007||2007-10-01|August 2009|2009-08-01|July 2008|Actual|2008-07-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC|Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Terminated||Phase 1|2|Actual|Molecular NeuroImaging||1||Preliminary data showed [123I] MNI-308 not a useful tool in detection of AD.|f||||f||||||||||2017-02-18 15:11:05.284124|2017-02-18 15:11:05.284124
NCT00544440|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2014-07-03|2013-08-28||October 2007||2007-10-01|July 2014|2014-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma|An Observational Study of Continuous Oral Dosing of an Irreversible CYP17 Inhibitor, Abiraterone Acetate (CB7630), in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma|Completed||Phase 2|57|Actual|Janssen Research & Development, LLC||1|||f||||t||||||||||2017-02-18 15:11:05.38462|2017-02-18 15:11:05.38462
NCT00544427|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2017-02-08|||August 2003||2003-08-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Near Infrared Optical Coherence Tomography of the Upper Aero-Digestive Tract|Near Infrared Optical Coherence Tomography of the Upper Aero-Digestive Tract|Recruiting||N/A|800|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:11:05.757487|2017-02-18 15:11:05.757487
NCT00544414|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2017-01-12|||April 2000||2000-04-01|January 2017|2017-01-01||||January 2018|Anticipated|2018-01-01||Interventional|||Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer|Multimodality Management of Head and Neck Cancer: A Phase II Trial of Induction Chemotherapy, Organ Preservation Surgery, and Concurrent Chemoradiotherapy|Active, not recruiting||Phase 2|30|Anticipated|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 15:11:05.87322|2017-02-18 15:11:05.87322
NCT00544401|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2010-06-08|||November 2008||2008-11-01|June 2010|2010-06-01||||August 2010|Anticipated|2010-08-01||Interventional|||Hypnopuncture for In Vitro Fertilization (IVF)|Effect of Hypnosis and Acupuncture (Hypnopuncture) on Pregnancy Rates Following Assisted Reproductive Treatment (IVF/ICSI): A Pilot Study|Terminated||Phase 2/Phase 3|6|Actual|Shaare Zedek Medical Center||2||Lack of participants|f||||f||||||||||2017-02-18 15:11:05.989743|2017-02-18 15:11:05.989743
NCT00544388|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-12-13|||April 2004||2004-04-01|September 2009|2009-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects|Trial to Compare the Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects Exposed to Pollen Challenge in an Environmental Exposure Unit (EEU).|Completed||Phase 3|570|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:11:06.089565|2017-02-18 15:11:06.089565
NCT00544375|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2017-02-08|||June 2002||2002-06-01|February 2017|2017-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Measurements of Anemia and Physiologic Tissue Response to Blood Transfusions in VLBW Infants Using Quantitative NIRS|Non-Invasive Measurements of Anemia and Physiologic Tissue Response to Blood Transfusions in Very Low Birth Weight Infants Using Quantitative Near-Infrared Spectroscopy|Completed||N/A|120|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:11:06.177212|2017-02-18 15:11:06.177212
NCT00544362|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2016-05-27|||July 2007||2007-07-01|May 2016|2016-05-01|March 2013|Actual|2013-03-01|January 2011|Actual|2011-01-01||Interventional|||Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery|Neoadjuvant Treatment for Operable Esophageal Cancer With 5-fluorouracil, Cisplatin, and Cetuximab and Concurrent Radiotherapy: Phase I/II Study|Completed||Phase 1/Phase 2|33|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||f||||||||||2017-02-18 15:11:06.273335|2017-02-18 15:11:06.273335
NCT00544349|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2011-05-14|||October 2006||2006-10-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery|Phase II Study Evaluating the Effectiveness of the Association of Chemotherapy LV5FU2 Simplified and Cetuximab With Intra-arterial Hepatic Chemotherapy Using Oxaliplatin in Patients With Colorectal Cancer and Nonresectable Hepatic Metastases|Completed||Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:11:06.487578|2017-02-18 15:11:06.487578
NCT00544336|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2012-09-07|||August 2007||2007-08-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Observational|||Family Quality of Life Among Families With a Member Who is a Cancer Patient|Assessment of Family Quality of Life Among Families With a Member Who is a Cancer Patient|Completed||N/A|366|Actual|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-02-18 15:11:06.606217|2017-02-18 15:11:06.606217
NCT00544323|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-14|2009-02-01|||November 2007||2007-11-01|October 2007|2007-10-01||||||||Interventional|||Alveolar Bone Loss Around 3 Different Designs of Dental Implant: Prospective Comparative Clinical Trail|Alveolar Bone Loss Around 3 Different Designs of Dental Implant: Prospective Comparative Clinical Trail|Unknown status|Not yet recruiting|N/A|25||Hadassah Medical Organization||1|||f||||||||||||||2017-02-18 15:11:06.752293|2017-02-18 15:11:06.752293
NCT00544310|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2008-08-19|||January 2008||2008-01-01|August 2008|2008-08-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil|A Prospective, Controlled, Randomized, Multi-Center, Exploratory Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil|Unknown status|Active, not recruiting|Phase 1/Phase 2|25||OMRIX Biopharmaceuticals||1|||f||||||||||||||2017-02-18 15:11:07.055271|2017-02-18 15:11:07.055271
NCT00544297|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-14|2015-03-13||2010-07-13|October 2007||2007-10-01|March 2015|2015-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand|A Multi-center, Open-label Study to Examine the Safety and Toleration of 0.05% PEP005 Topical Gel in Patients With Actinic Keratoses on the Dorsum of the Hand|Completed||Phase 2|12|Actual|Peplin||1|||f||||f||||||||||2017-02-18 15:11:07.156097|2017-02-18 15:11:07.156097
NCT00544284|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2013-02-14|||January 2005||2005-01-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment|A Phase I Study of Bortezomib and Temozolomide in Patients With Refractory Solid Tumors|Completed||Phase 1|25|Actual|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 15:11:07.437133|2017-02-18 15:11:07.437133
NCT00544271|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2016-09-06|||May 2003||2003-05-01|September 2016|2016-09-01|January 2004|Actual|2004-01-01|||||Interventional|||Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.|Phase IIIb Study to Evaluate Immunogenicity, Antibody Persistency and Reactogenicity of DTPa - INFANRIX and dTpa - BOOSTRIX Vaccines Administered to Healthy Children Previously Primed With 3 Doses of DTPa Vaccine Compared to Placebo (HAVRIX®JUNIOR)|Terminated||Phase 4|720|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:11:07.555619|2017-02-18 15:11:07.555619
NCT00544258|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-14|2015-02-11|||October 2007||2007-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005|A Phase I, Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005, When Applied as 0.05% PEP005 Topical Gel to a 100 cm2 (5 cm x 20 cm) Contiguous Actinic Keratosis(AK) Treatment Area on the Extensor (Dorsal Aspect) Forearm.|Completed||Phase 1|8|Actual|Peplin||1|||f||||f||||||||||2017-02-18 15:11:07.663015|2017-02-18 15:11:07.663015
NCT00544245|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2011-08-14|||October 2007||2007-10-01|August 2011|2011-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|UHPAWS||Is Monitoring Activity Important for Short- and Long-term Weight Loss?||Completed||N/A|83|Actual|University of Hawaii||1|||f||||f||||||||||2017-02-18 15:11:07.773852|2017-02-18 15:11:07.773852
NCT00544232|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2016-02-12|||August 2002||2002-08-01|February 2016|2016-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)|Randomized Comparison of a Preoperative, Dose-Intensified, Interval-Shortened, Sequential Chemotherapy With Epirubicin, Paclitaxel and CMF ± Darbepoetin Alfa Versus a Preoperative, Sequential Chemotherapy With Epirubicin and Cyclophosphamide Followed by Paclitaxel in Standard Dosage ± Darbepoetin Alfa in Patients With Primary Breast Cancer|Completed||Phase 3|720|Actual|German Breast Group||2|||f||||t||||||||||2017-02-18 15:11:07.877817|2017-02-18 15:11:07.877817
NCT00543829|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2007-10-16|||April 1998||1998-04-01|October 2007|2007-10-01|June 1999|Actual|1999-06-01|||||Interventional|||German Preoperative Adriamycin Docetaxel Study|A Randomised, Controlled, Open Phase II b Study Comparing a Combination of Dose-Intensified Doxorubicin and Docetaxel With or Without Tamoxifen as Preoperative Therapy in Patients With Operable Carcinoma of the Breast (T>=3cm N0-2 M0)|Completed||Phase 2|250|Actual|German Breast Group||2|||f||||t||||||||||2017-02-18 15:11:12.276769|2017-02-18 15:11:12.276769
NCT00544219|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2016-06-14|||September 2007||2007-09-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|September 2012|Actual|2012-09-01||Interventional|||PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone|Prospective Evaluation of the Predictive Value of PET in Patients With Diffuse Large B-cell-lymphoma Under R-CHOP-14. A Multicenter Study|Completed||N/A|156|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||||2017-02-18 15:11:07.988652|2017-02-18 15:11:07.988652
NCT00544206|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2008-09-22|||October 2007||2007-10-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes|Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes|Completed||Phase 2|11|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-02-18 15:11:08.133513|2017-02-18 15:11:08.133513
NCT00544193|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2015-06-03|||December 1997||1997-12-01|June 2015|2015-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer|Pilot Study of Gemcitabine and IORT/EBRT in Locally Advanced Upper Gastrointestinal Malignancies|Completed||Phase 1|16|Actual|City of Hope Medical Center|||||f||||||||||||||2017-02-18 15:11:08.231038|2017-02-18 15:11:08.231038
NCT00544180|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2009-09-24|||May 2005||2005-05-01|September 2009|2009-09-01||||September 2006|Actual|2006-09-01||Interventional|||ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week|Record on Satisfaction of Patients With Actonel 35 mg Once a Week|Terminated||Phase 4|7|Actual|Sanofi||1||The trial was terminated due to lack of compliance with GCP regulations.|f||||f||||||||||2017-02-18 15:11:08.326876|2017-02-18 15:11:08.326876
NCT00544167|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-03-25|2012-12-19||May 2007||2007-05-01|March 2013|2013-03-01|April 2011|Actual|2011-04-01|January 2008|Actual|2008-01-01||Interventional|||Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer|A Pilot Study of Adjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel Plus Sorafenib in Women With Node Positive or High-Risk Early Stage Breast Cancer|Completed||N/A|45|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 15:11:08.42296|2017-02-18 15:11:08.42296
NCT00544154|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-09-03|||October 2002||2002-10-01|September 2009|2009-09-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis|Efficacy and Safety of CDP870 400 mg in Combination With Methotrexate Compared to Methotrexate Alone in the Treatment of the Signs and Symptoms of Patients With Rheumatoid Arthritis Who Are Partial Responders to Methotrexate|Completed||Phase 3|247|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:11:08.713367|2017-02-18 15:11:08.713367
NCT00544141|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-14|2008-04-23||||||April 2008|2008-04-01||||||||Observational|||Clinical Evaluation of the Care On Line Thermometer||Unknown status|Recruiting|N/A|||Medisim Ltd|||||f||||f||||||||||2017-02-18 15:11:08.799246|2017-02-18 15:11:08.799246
NCT00544128|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2015-03-27|||October 2007||2007-10-01|March 2015|2015-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment|A Randomized, Open Label, Multicenter Study Comparing the Safety and Efficacy of Once Daily Regimen Containing Epzicom or Truvada Combined With Ritonavir Boosted Atazanavir as Initial Therapy for HIV-1 Infection (ET Study)|Completed||Phase 4|109|Actual|International Medical Center of Japan||2|||f||||t||||||||||2017-02-18 15:11:08.866599|2017-02-18 15:11:08.866599
NCT00544115|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2016-09-16|||September 2001||2001-09-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders|A Phase II Trial of Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Unrelated Donors in Patients With Advanced Hematologic Malignancies and Hematological Disorders|Active, not recruiting||Phase 2|260|Anticipated|City of Hope Medical Center||6|||f||||||||||||||2017-02-18 15:11:08.988743|2017-02-18 15:11:08.988743
NCT00544102|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-14|2017-01-24|||October 11, 2007||2007-10-11|April 29, 2016|2016-04-29||||||||Observational|||Insulin Resistance and Atherosclerosis in Women With Lupus|Insulin Resistance and Atherosclerosis in a Sample of Women With Systemic Lupus Erythematosus|Completed||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:11:09.137454|2017-02-18 15:11:09.137454
NCT00544089|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-14|2007-10-15|||March 2006||2006-03-01|March 2006|2006-03-01|September 2007|Actual|2007-09-01|||||Observational|||Chromosomal and Morphological Structure of Mature and Immature Male Germ Cells and Recognition of IL-18 in Testicular Tissue of Azoospermic Men||Completed||N/A|25907|Actual|Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:11:09.241267|2017-02-18 15:11:09.241267
NCT00544076|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2015-06-03|||January 2006||2006-01-01|June 2015|2015-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Sildenafil Citrate and Alprostadil in Treating Patients Undergoing Bilateral Nerve-Sparing Robotic-Assisted Prostatectomy for Nonmetastatic Prostate Cancer|Erectile Dysfunction Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy (BNS-RAP) for Prostate Cancer|Completed||N/A|110|Actual|City of Hope Medical Center||3|||f||||t||||||||||2017-02-18 15:11:09.315318|2017-02-18 15:11:09.315318
NCT00544063|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2009-12-13|||October 2006||2006-10-01|July 2009|2009-07-01||||December 2011|Anticipated|2011-12-01||Interventional|||Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer|Phase I Study Evaluating the Feasibility of Chemotherapy With Capecitabine, Irinotecan, and Oxaliplatin in Patients With Metastatic Carcinoma|Unknown status|Recruiting|Phase 1|33|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:11:09.436922|2017-02-18 15:11:09.436922
NCT00544050|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2013-11-14|||September 2002||2002-09-01|September 2009|2009-09-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old|An Open-Label, Single Dose, Pharmacokinetic Study of 20 mg/kg of Levetiracetam Oral Solution in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old|Completed||Phase 2|13|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:11:09.535276|2017-02-18 15:11:09.535276
NCT00544037|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-15|2012-03-02|||September 2007||2007-09-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||BENEFIT Extension Study|Extension Study of the BENEFIT (304747) and BENEFIT Follow-up (305207) Studies to Further Evaluate the Progress of Patients With First Demyelinating Event Suggestive of Multiple Sclerosis|Completed||N/A|283|Actual|Bayer|||1||f||||f||||||None Retained|"~     Population of Benefit Studies~   "|||2017-02-18 15:11:09.614993|2017-02-18 15:11:09.614993
NCT00544024|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2007-10-12|||March 2004||2004-03-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Observational|||Mefloquine Bioequivalence Among 3 Commercially Available Tablets.|Mefloquine Bioequivalence Among Three Commercial Tablet Formulations in Peruvian Subjects With Uncomplicated Plasmodium Falciparum Malaria|Completed||N/A|39|Actual|Centers for Disease Control and Prevention|||3||f||||f||||||None Retained|"~     Whole blood was obtained for analysis, but has been subsequently disposed after completion~     of drug analysis.~   "|||2017-02-18 15:11:09.730124|2017-02-18 15:11:09.730124
NCT00544011|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-13|2011-06-23|||April 2007||2007-04-01|July 2009|2009-07-01||||||||Interventional|||Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer|Phase II Study Evaluating the Association of Bevacizumab and Chemotherapy of the Type Modified FOLFIRI 3 in Patients With Metastatic Colorectal Adenocarcinoma|Unknown status|Recruiting|Phase 2|47|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:11:09.818268|2017-02-18 15:11:09.818268
NCT00543998|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2017-02-08|||May 2003||2003-05-01|February 2017|2017-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Observational|||Near Infrared Transillumination of the Paranasal Sinuses|Near Infrared Transillumination of the Paranasal Sinuses|Completed||N/A|33|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:11:10.049506|2017-02-18 15:11:10.049506
NCT00543985|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2016-11-21|2010-01-11||October 2007||2007-10-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Exercise,Metabolic Syndrome and Weight Regain (Echocardiography Substudy)|Exercise in Patients With Metabolic Syndrome and Weight Regain - Echocardiography Substudy|Completed||N/A|36|Actual|University of Missouri-Columbia||1|||f||||f||||||||||2017-02-18 15:11:10.152481|2017-02-18 15:11:10.152481
NCT00543972|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2009-05-13|||September 2007||2007-09-01|May 2009|2009-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia|An Open Label, Dose-Escalation Safety and Pharmacokinetic Study of AVE9633 Administered as a Single Agent by Intravenous Infusion on Day 1, Day 4 and Day 7 of a 4-Week Cycle in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia (AML)|Terminated||Phase 1|12|Actual|Sanofi||1||due to absence of evidence of clinical activity up to toxic doses|f||||f||||||||||2017-02-18 15:11:10.407318|2017-02-18 15:11:10.407318
NCT00543959|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-22|||June 2006||2006-06-01|June 2015|2015-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)|An Efficacy and Tolerability Study of MK0533 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Terminated||Phase 2|346|Actual|Merck Sharp & Dohme Corp.||7||"This study is being discontinued based on data suggesting that none of the doses tested~   demonstrated both glycemic & body fluid benefits vs. the comparitor"|f||||||||||||||2017-02-18 15:11:10.497637|2017-02-18 15:11:10.497637
NCT00543946|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2009-01-28|||October 2007||2007-10-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Single Ascending Dose of GAP-134 as a 24-Hour IV Infusion in Healthy Japanese Males|Ascending Single Dose Study of The Safety, Tolerability, Pharmacokinetics, of GAP-134 Administered Intravenously as a 24-Hour Infusion to Healthy Japanese Male Subjects|Completed||Phase 1|56|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 15:11:10.595064|2017-02-18 15:11:10.595064
NCT00543933|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2017-01-26|||October 2007|Actual|2007-10-01|January 2017|2017-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease|Acute Effect of Inhaled Nitric Oxide on Pulmonary Insufficiency in Congenital Heart Disease|Terminated||Early Phase 1|18|Actual|The Cleveland Clinic||1||Investigator left institution|f||||f|t|f|||t|||No||2017-02-18 15:11:10.673523|2017-02-18 15:11:10.673523
NCT00543920|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-11-25|||August 2002||2002-08-01|November 2015|2015-11-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)||Completed||Phase 2|60|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:10.77447|2017-02-18 15:11:10.77447
NCT00543907|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2016-07-18|||September 2007||2007-09-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Outcomes of a Deep Inferior Epigastric Perforator Flap Program|Outcomes of a Deep Inferior Epigastric Perforator Flap Program|Recruiting||N/A|2400|Anticipated|Beth Israel Deaconess Medical Center|||2||f||||f||||||||||2017-02-18 15:11:10.84877|2017-02-18 15:11:10.84877
NCT00543894|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2008-08-11|||February 2006||2006-02-01|June 2007|2007-06-01||||||||Observational|ANTHICUS||Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients|Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A Prospective, Observational, Multicenter Study (ANTHICUS)|Completed||N/A|500|Actual|AstraZeneca|||||f||||f||||||||||2017-02-18 15:11:10.947667|2017-02-18 15:11:10.947667
NCT00543881|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2016-12-20|||January 2008||2008-01-01|December 2016|2016-12-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|TIM-HF||Telemedical Interventional Monitoring in Heart Failure|Telemedical Interventional Monitoring in Heart Failure (TIM-HF)|Completed||Phase 3|710|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 15:11:11.186908|2017-02-18 15:11:11.186908
NCT00543868|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-10|||June 2004||2004-06-01|June 2015|2015-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)||Completed||Phase 2|462|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:11.323273|2017-02-18 15:11:11.323273
NCT00543855|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2013-03-05|2013-01-16||November 2007||2007-11-01|March 2013|2013-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)|Double-blind Study of E2020 in Patients With Dementia With Lewy Bodies - Phase II|Completed||Phase 2|167|Actual|Eisai Inc.||4|||f||||||||||||||2017-02-18 15:11:11.399596|2017-02-18 15:11:11.399596
NCT00543842|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2015-02-24|||December 2007||2007-12-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer|Phase I/II Trial of Preoperative Radiotherapy With Concurrent Bevacizumab, Erlotinib and Capecitabine for Locally Advanced Rectal Cancer|Completed||Phase 1|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:11:12.16106|2017-02-18 15:11:12.16106
NCT00543816|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-22|||August 2003||2003-08-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)||Terminated||Phase 3|100|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:12.364207|2017-02-18 15:11:12.364207
NCT00543803|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2014-05-13|2010-12-17||February 2006||2006-02-01|May 2014|2014-05-01||||December 2009|Actual|2009-12-01||Observational||FAS - All patients were considered for the full analysis set.|Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients|Observational Non-interventional Study Evaluating the Safety and Efficacy of Truvada + Nevirapine|Completed||N/A|334|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 15:11:12.448278|2017-02-18 15:11:12.448278
NCT00543790|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2010-10-27|||November 2007||2007-11-01|October 2010|2010-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women|A Randomized, Placebo-Controlled, Double-Blind, Sponsor-Unblinded, Multiple-Dose Study Of The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PRA-027 Administered Orally To Cycling Or Postmenopausal Women|Completed||Phase 1|48|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:11:12.864745|2017-02-18 15:11:12.864745
NCT00543777|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2016-05-13|||September 2007||2007-09-01|May 2016|2016-05-01||||September 2017|Anticipated|2017-09-01||Interventional|||Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease|Validation Study of Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:11:12.966326|2017-02-18 15:11:12.966326
NCT00543764|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2012-05-25|2010-10-19||January 2005||2005-01-01|May 2012|2012-05-01|February 2011|Actual|2011-02-01|December 2008|Actual|2008-12-01||Observational|||Intraoperative Pathway in DIEP Flap Breast Reconstruction|Intraoperative Pathway in DIEP Flap Breast Reconstruction|Completed||N/A|150|Actual|Beth Israel Deaconess Medical Center|More patient enrollment is necessary to ascertain long term outcomes||2||f||||f||||||||||2017-02-18 15:11:13.083843|2017-02-18 15:11:13.083843
NCT00543751|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-16|||January 2003||2003-01-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)||Terminated||Phase 3|610|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:13.406816|2017-02-18 15:11:13.406816
NCT00543738|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-16|||June 2003||2003-06-01|June 2015|2015-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||MK0767 and Metformin Combination Study (0767-028)||Terminated||Phase 3|114|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:13.595693|2017-02-18 15:11:13.595693
NCT00543725|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2016-03-03|2011-06-14||June 2008||2008-06-01|March 2016|2016-03-01|February 2012|Actual|2012-02-01|January 2010|Actual|2010-01-01||Interventional|||TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors|A Phase III, Randomized, Double-blind Trial of TMC278 25mg q.d. Versus Efavirenz 600mg q.d. in Combination With a Background Regimen Containing 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-naive HIV-1 Infected Subjects.|Completed||Phase 3|680|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-02-18 15:11:13.692745|2017-02-18 15:11:13.692745
NCT00543712|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2013-06-19||2013-06-19|June 2007||2007-06-01|June 2013|2013-06-01||||May 2008|Actual|2008-05-01||Interventional|||A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)|A Phase II, Open-Label, Multicenter Study of the Efficacy and Safety of Single-Agent PRO95780 in Patients With Advanced Chondrosarcoma|Terminated||Phase 2|90|Anticipated|Genentech, Inc.||||Efficacy not evident in this population.|f||||||||||||||2017-02-18 15:11:14.864298|2017-02-18 15:11:14.864298
NCT00543686|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2009-02-03|||August 2007||2007-08-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|LOS||Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma|A Randomised Controlled Open-Label Phase IV Mono Centre Study to Compare the Response Profiles of Montelukast Versus Fluticasone in Children With Pre-School Asthma|Completed||Phase 2|100|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||t||||||||||2017-02-18 15:11:14.956176|2017-02-18 15:11:14.956176
NCT00543673|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2008-07-03|||September 2007||2007-09-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Tolerance of Healthy, Term Infants to Infant Formulas|Tolerance of Healthy, Term Infants to Infant Formulas|Completed||Phase 2/Phase 3|180|Actual|Abbott Nutrition||4|||f||||f||||||||||2017-02-18 15:11:15.063379|2017-02-18 15:11:15.063379
NCT00543660|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2015-06-02|||March 1998||1998-03-01|June 2015|2015-06-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|DSAEK||Descemet Stripping (Automated) Endothelial Keratoplasty (DSEK or DSAEK)|Descemet Stripping (Automated) Endothelial Keratoplasty (DSEK or DSAEK)|Recruiting||N/A|1000|Anticipated|Netherlands Institute for Innovative Ocular Surgery||1|||f||||t||||||||||2017-02-18 15:11:15.190098|2017-02-18 15:11:15.190098
NCT00543647|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2015-01-16|||August 2002||2002-08-01|October 2007|2007-10-01|March 2003|Actual|2003-03-01|||||Interventional|||Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People|A Double-blind, Cross-over, Placebo-controlled Study Evaluating the Effect of Fenofibrate 160 mg Tablets on Glomerular Filtration Rate and Other Renal Function Test in Healthy Subjects|Completed||Phase 1|24|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:11:15.317793|2017-02-18 15:11:15.317793
NCT00543634|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2010-06-17|||October 2007||2007-10-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women|Open-Label, Single-Dose, Partially Randomized, 6-Period, 6-Treatment, Crossover Bioavailability Study of 3 Pilot Formulations of Premarin®/Medroxyprogesterone Acetate (MPA) Compared With Reference Formulations of Premarin®/MPA (PREMPRO®) and MPA Suspension (Provera®) in Healthy Postmenopausal Women|Completed||Phase 1|30|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 15:11:15.40999|2017-02-18 15:11:15.40999
NCT00543621|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2007-10-12|||May 2005||2005-05-01|October 2007|2007-10-01||||||||Interventional|||An Intervention Program to Control Diabetes|An Intervention Program to Control Diabetes|Completed||Phase 4|150|Actual|Abbott Nutrition|||||f||||f||||||||||2017-02-18 15:11:15.508219|2017-02-18 15:11:15.508219
NCT00543608|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2009-02-12|||November 2007||2007-11-01|February 2009|2009-02-01|May 2009|Anticipated|2009-05-01|April 2009|Anticipated|2009-04-01||Interventional|||Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia|Randomized, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia Suspected or Confirmed to be Due to Gram-Positive Pathogens|Terminated||Phase 2|135|Anticipated|Arpida AG||3||Trial terminated due to financial resource limitations|f||||t||||||||||2017-02-18 15:11:15.587993|2017-02-18 15:11:15.587993
NCT00543582|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2015-06-04||2015-06-04|October 2007||2007-10-01|June 2015|2015-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma|A Phase 2, Open-label Trial to Evaluate the Efficacy and Safety of MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma, and to Evaluate the Pharmacokinetics of Different Formulations of MGCD0103|Terminated||Phase 2|23|Actual|Mirati Therapeutics Inc.||1||"Celgene terminated its collaboration agreement with MethylGene for the development of~   MGCD0103. All Celgene-sponsored trials with MGCD0103 will be closed."|f||||f||||||||||2017-02-18 15:11:15.754366|2017-02-18 15:11:15.754366
NCT00543569|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2015-11-06|2015-11-06||February 2008||2008-02-01|November 2015|2015-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional||Full Analysis Set (FAS): All randomized participants who received at least 1 dose of study drug.|A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients|A Phase 2, Randomized, Open-Label, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients|Completed||Phase 2|323|Actual|Astellas Pharma Inc||4|||f||||t||||||||||2017-02-18 15:11:15.892868|2017-02-18 15:11:15.892868
NCT00543556|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-12|||October 2001||2001-10-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||MK0767 in Type 2 Diabetes (0767-012)||Terminated||Phase 2|514|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:19.010493|2017-02-18 15:11:19.010493
NCT00543543|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2016-08-22|2014-12-12||September 2007||2007-09-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|April 2013|Actual|2013-04-01||Interventional|||Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)|A Randomized, International, Double-Blinded (With In-House Blinding), Controlled With GARDASIL, Dose-Ranging, Tolerability, Immunogenicity, and Efficacy Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 16- to 26- Year-Old Women|Completed||Phase 3|14840|Actual|Merck Sharp & Dohme Corp.||6|||f||||t||||||||||2017-02-18 15:11:19.08813|2017-02-18 15:11:19.08813
NCT00543530|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-11-26|||March 2001||2001-03-01|November 2015|2015-11-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Pediatric Expanded Access Program-Oral Solution (0831-908)|A Noncomparative,Open, Multisite Study to Monitor the Safety and Tolerability of Efavirenz Oral Solution Given in Combination Antiretroviral Therapy (ART) in ART-naive or Experienced HIV-1 Infected Patients Age 3 to 16 Years Who Have Failed Therapy or Are Intorerant to Their Current ART Regimen|Completed||Phase 3|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:20.606332|2017-02-18 15:11:20.606332
NCT00543517|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-02-09|||February 2003||2003-02-01|February 2015|2015-02-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Study A - MK0767 Monotherapy Study||Terminated||Phase 3|99|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:20.851821|2017-02-18 15:11:20.851821
NCT00543504|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2016-07-28|||October 2007||2007-10-01|July 2016|2016-07-01||||October 2017|Anticipated|2017-10-01||Interventional|||Bevacizumab in Multiple Phase I Combinations|A Phase 1 Study of Bevacizumab in Combination With 1) Sunitinib, 2) Sorafenib, 3) Erlotinib and Cetuximab, 4) Trastuzumab and Lapatinib|Active, not recruiting||Phase 1|354|Anticipated|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-02-18 15:11:20.918718|2017-02-18 15:11:20.918718
NCT00543491|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-11|||May 2003||2003-05-01|June 2015|2015-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||MK0767 and Sulfonylurea Combination Study (0767-027)||Terminated||Phase 3|129|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:21.048457|2017-02-18 15:11:21.048457
NCT00543478|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2007-10-12|||October 2007||2007-10-01|October 2007|2007-10-01|July 2008|Anticipated|2008-07-01|||||Interventional|SBIBS||Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome|Role Of Saccharomyces Boulardii In Diarrhea Dominant Irritable Bowel Syndrome|Unknown status|Recruiting|Phase 4|42|Anticipated|Aga Khan University||2|||f||||t||||||||||2017-02-18 15:11:21.119327|2017-02-18 15:11:21.119327
NCT00543465|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-01|||August 2004||2004-08-01|June 2015|2015-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003)||Terminated||Phase 2|49|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:21.220804|2017-02-18 15:11:21.220804
NCT00543452|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2011-04-06|||February 2005||2005-02-01|March 2011|2011-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Effect of Oxygen on Core Temperature|Effect of Oxygen on Core Temperature|Completed||N/A|40|Actual|Umeå University||2|||f||||||||||||||2017-02-18 15:11:21.301864|2017-02-18 15:11:21.301864
NCT00543439|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2017-02-02|||December 2007||2007-12-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII|An Open-label Study To Evaluate Prophylaxis Treatment, And To Characterize The Efficacy, Safety, And Pharmacokinetics Of B-domain Deleted Recombinant Factor Viii Albumin Free (Moroctocog Alfa [Af-cc]) In Children With Hemophilia A|Active, not recruiting||Phase 3|80|Anticipated|Pfizer||2|||f||||t||||||||||2017-02-18 15:11:21.412556|2017-02-18 15:11:21.412556
NCT00543426|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2013-03-06|||September 2007||2007-09-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis|Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis|Completed||Phase 4|200|Actual|Shanghai University of Traditional Chinese Medicine||2|||f||||t||||||||||2017-02-18 15:11:21.552864|2017-02-18 15:11:21.552864
NCT00543413|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-10-15|||October 2007||2007-10-01|October 2015|2015-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)|A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Study to Assess the Efficacy and Tolerability of MK8141 in Hypertensive Patients|Completed||Phase 2|160|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 15:11:21.652602|2017-02-18 15:11:21.652602
NCT00543400|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2013-04-30|||September 2007||2007-09-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|EMINENCE||Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)|A Randomized, Multi-center, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of the Rationally Engineered Heparin M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI) And A Pharmacokinetic, Pharmacodynamic and Heparin Antibody Substudy|Completed||Phase 2|503|Actual|Momenta Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 15:11:21.754265|2017-02-18 15:11:21.754265
NCT00543387|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-12|2016-01-21|||March 2008||2008-03-01|January 2016|2016-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001 AM4)|A Phase I Investigation of MK-5108 and MK-5108 With Docetaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|37|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:11:21.891541|2017-02-18 15:11:21.891541
NCT00543374|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2016-10-12||2010-08-24|October 2007||2007-10-01|October 2016|2016-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease|A Phase III, Multicenter, Placebo-controlled, Randomized, Double-blind Durability and Retreatment Study to Evaluate the Safety and Efficacy of PROCHYMAL® (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Maintenance and Re-induction of Clinical Benefit and Remission in Subjects Experiencing Treatment-refractory Moderate-to-severe Crohn's Disease|Completed||Phase 3|98|Actual|Mesoblast, Ltd.||3|||f||||t||||||||||2017-02-18 15:11:22.214175|2017-02-18 15:11:22.214175
NCT00543361|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-11|||May 2003||2003-05-01|June 2015|2015-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)|A Double-Blind, Randomized, Active-Controlled MK0767 and Metformin Comparator Study in Type 2 Diabetic Patients Inadequately Controlled on Diet and Exercise|Terminated||Phase 3|382|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:22.384028|2017-02-18 15:11:22.384028
NCT00543348|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2007-10-11|||September 2007||2007-09-01|October 2007|2007-10-01||||||||Interventional|||RCT of the Cutting Balloon Versus a High Pressure Balloon for the Treatment of Arteriovenous Fistula Stenoses|A Randomised-Controlled Study Comparing the Peripheral Cutting BalloonTM (Boston Scientific Co.) With a High Pressure Balloon for the Treatment of Arteriovenous Fistula Stenoses|Unknown status|Recruiting|N/A|100|Anticipated|Henry Ford Health System||2|||f||||f||||||||||2017-02-18 15:11:22.462513|2017-02-18 15:11:22.462513
NCT00543335|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2012-07-05|||January 2008||2008-01-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer|Phase I Trial of Sorafenib With Concurrent Thoracic Radiotherapy for Poor Prognosis Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|10|Actual|M.D. Anderson Cancer Center||1||Lack of Accrual.|f||||f||||||||||2017-02-18 15:11:22.552267|2017-02-18 15:11:22.552267
NCT00543322|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2007-10-11|||July 2001||2001-07-01|October 2007|2007-10-01|July 2006|Actual|2006-07-01|||||Observational|||PET Study of the Nicotinic Receptors in Human|PET Study of the Nicotinic Receptors in Human : Brain Distribution and Quantification|Terminated||Phase 1/Phase 2|||Commissariat A L'energie Atomique|||||f||||||||||||||2017-02-18 15:11:22.670094|2017-02-18 15:11:22.670094
NCT00543309|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2013-11-01|||October 2007||2007-10-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery|Impact of Empiric Nesiritide or Milrinone Infusion on Early Postoperative Recovery Following Fontan Surgery: a Randomized, Double-blind, Placebo-controlled Clinical Trial|Terminated||Phase 2|106|Actual|Boston Children’s Hospital||3||DSMB recommended termination based on interim outcomes analysis|f||||t||||||||||2017-02-18 15:11:22.757584|2017-02-18 15:11:22.757584
NCT00543296|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2015-03-12|2013-08-08||March 2004||2004-03-01|June 2014|2014-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional||Of 21 consented subjects only 14 completed the 9 months follow-up in whom fluocinolone acetonide implants were replaced or who needed a second implant.|Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment|Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment|Completed||Phase 4|21|Actual|Duke University||1|||f||||f||||||||||2017-02-18 15:11:22.882083|2017-02-18 15:11:22.882083
NCT00543270|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2010-02-22|||October 2005||2005-10-01|February 2010|2010-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Powerlink Bifurcated Stent Graft Long-Term Follow-up Study|Endologix Powerlink Long-Term Follow-up Study|Completed||Phase 2/Phase 3|231|Anticipated|Endologix||2|||f||||t||||||||||2017-02-18 15:11:23.307655|2017-02-18 15:11:23.307655
NCT00543257|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2009-03-26|||December 2007||2007-12-01|March 2009|2009-03-01|June 2009|Anticipated|2009-06-01|March 2009|Actual|2009-03-01||Observational|||Parents at the Center: Information Management in ADHD - Clinical Trial|Parents at the Center: Information Management in ADHD - Clinical Trial|Unknown status|Active, not recruiting|N/A|224|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||||2017-02-18 15:11:23.441959|2017-02-18 15:11:23.441959
NCT00543244|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2008-11-20|||January 2006||2006-01-01|February 2008|2008-02-01|December 2008|Anticipated|2008-12-01|October 2008|Anticipated|2008-10-01||Observational|||Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan|Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:11:23.54512|2017-02-18 15:11:23.54512
NCT00543231|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-11|||December 2005||2005-12-01|December 2005|2005-12-01|December 2006||2006-12-01|||||Interventional|||A Phase I Study of G3139 Subcutaneous in Solid Tumors|A Pharmacokinetic and Safety Assessment of G3139 Administered by Subcutaneous Injection to Patients With Solid Tumors|Completed||Phase 1|8|Anticipated|Genta Incorporated|||||f||||||||||||||2017-02-18 15:11:23.688999|2017-02-18 15:11:23.688999
NCT00543218|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||December 2002||2002-12-01|October 2007|2007-10-01|June 2004|Actual|2004-06-01|||||Interventional|||PTH Comparison in Post Menopausal Women|Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 3|63|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:11:23.769159|2017-02-18 15:11:23.769159
NCT00543205|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2011-11-04|||August 2005||2005-08-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment|A Pharmacokinetic Study of Genasense® (Bcl-2 Antisense Oligonucleotide) in Combination With Dacarbazine (DTIC) in Subjects With Advanced Melanoma and Normal or Impaired Hepatic Function|Terminated||Phase 2/Phase 3|6|Actual|Genta Incorporated||1||Terminated due to very slow enrollment|f||||f||||||||||2017-02-18 15:11:23.880338|2017-02-18 15:11:23.880338
NCT00543192|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2015-09-30|||October 2007||2007-10-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Sexual Functioning in Endometrial Cancer|Sexual Functioning in Endometrial Cancer Survivors|Completed||N/A|73|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 15:11:23.953783|2017-02-18 15:11:23.953783
NCT00543166|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2007-11-02|||February 2003||2003-02-01|October 2007|2007-10-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue|Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue|Unknown status|Active, not recruiting|Phase 4|107|Actual|Helsinki University||1|||f||||t||||||||||2017-02-18 15:11:24.117185|2017-02-18 15:11:24.117185
NCT00543153|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2012-07-27|||August 2007||2007-08-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||The Exceptional Patient in Cancer Care|The Exceptional Patient in Cancer Care|Completed||N/A|13|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:11:24.230228|2017-02-18 15:11:24.230228
NCT00543140|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2016-02-09|2016-01-11||August 2006||2006-08-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|SAGB-PM|All subjects implanted with the SAGB.|Post Implantation/Post Market Evaluation of the Swedish Adjustable Gastric Band|A Post Implantation/Post Market Evaluation of Safety and Quality of Life in Subjects Implanted With the Swedish Adjustable Gastric Band (SAGB) During Protocol CI-02-0006|Completed||Phase 4|303|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||No|There is no plan to share IPD. Cumulative data from the study will be published.|2017-02-18 15:11:24.541741|2017-02-18 15:11:24.541741
NCT00543127|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2011-10-25|||November 2007||2007-11-01|October 2011|2011-10-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Fulvestrant (Faslodex) + Anastrozol (Arimidex) vs Anastrozol|A Randomized, Multicentral, Phase III Study of Parallel Groups to Compare the Efficiency and Tolerance of Fulvestrant Administered for Three Years in Combination With Anastrozol for 5 Years Versus Anastrozol for 5 Years as Adjuvant Hormonotherapy in Postmenopausal Women With Early Breast Cancer and + HRs.|Terminated||Phase 3|872|Actual|Spanish Breast Cancer Research Group||2||Unjustified decision of company that funded the trial.|f||||f||||||||||2017-02-18 15:11:25.144341|2017-02-18 15:11:25.144341
NCT00543114|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2016-05-26|||October 2007||2007-10-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|June 2009|Actual|2009-06-01||Interventional|||Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL|A Phase I Dose Escalation Study of Lenalidomide (Revlimid) in Combination With Fludarabine-Rituximab (Rituxan) for Previously Untreated CLL/SLL|Terminated||Phase 1|9|Actual|Dana-Farber Cancer Institute||1||lack of efficacy and tolerability|f||||t||||||||||2017-02-18 15:11:25.255655|2017-02-18 15:11:25.255655
NCT00543101|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2012-02-09|2010-04-12||October 2007||2007-10-01|February 2012|2012-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|DVD||Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors|A Randomized, Controlled Trial to Evaluate the Efficacy of Substituting Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors in Individuals With Virologic Suppression for at Least 12 Weeks|Completed||Phase 4|24|Actual|Community Research Initiative of New England|The foremost problem was the small number of participants enrolled. By the time we were open for enrollment, most clinicians in the community had already switched their patients from dual boosted regimens to darunavir/ritonavir.|2|||f||||t||||||||||2017-02-18 15:11:25.37533|2017-02-18 15:11:25.37533
NCT00543088|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2009-04-22|||January 2007||2007-01-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|||||Observational|Serenity||Effectiveness of Anti-Psychotic in GPs Setting|SERENITY: Evaluating the Effectiveness of Atypical Antipsychotics in the Community - a Prospective, Multicentre, Observational Study to Evaluate the Impact on Quality of Life of GP-Bases Management of Antipsychotic Treatment in Belgium.|Completed||N/A|250||AstraZeneca|||1||f||||f||||||||||2017-02-18 15:11:25.92532|2017-02-18 15:11:25.92532
NCT00543075|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2012-03-11|||May 2006||2006-05-01|June 2008|2008-06-01|September 2009|Actual|2009-09-01|November 2007|Actual|2007-11-01||Interventional|||Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function|A Phase I Pharmacokinetic Study of Genasense® in Subjects With Normal Renal Function and Mildly and Moderately Impaired Renal Function|Completed||Phase 1|23|Actual|Genta Incorporated||1|||f||||f||||||||||2017-02-18 15:11:26.237981|2017-02-18 15:11:26.237981
NCT00543062|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2017-01-31|||October 2007||2007-10-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Staccato Prochlorperazine Thorough QT/QTc|Thorough QT/QTc Study of Staccato® Prochlorperazine for Inhalation in Healthy Volunteers|Completed||Phase 1|48|Actual|Alexza Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:11:26.347226|2017-02-18 15:11:26.347226
NCT00543049|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2014-03-06|||September 2007||2007-09-01|March 2014|2014-03-01||||June 2012|Actual|2012-06-01||Interventional|||Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor|Phase II Trial in Platinum-refractory Ovarian Cancer: A Randomized Multicenter Trial With SU11248 to Evaluate Dosage, Tolerability, Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor Monotherapy|Completed||Phase 2|73|Actual|AGO Study Group||2|||f||||f||||||||||2017-02-18 15:11:26.462195|2017-02-18 15:11:26.462195
NCT00543036|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2007-10-11||||||August 2007|2007-08-01||||||||Interventional|||Efficacy and Safety of the Hcoil Deep TMS for the Treatment of Cannabis Addiction||Unknown status|Recruiting|Phase 1/Phase 2|||Shalvata Mental Health Center|||||f||||||||||||||2017-02-18 15:11:26.604228|2017-02-18 15:11:26.604228
NCT00543023|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||June 2003||2003-06-01|October 2007|2007-10-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study of the Treatment of Postmenopausal Women With Osteoporosis|Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 3|104|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:11:26.690025|2017-02-18 15:11:26.690025
NCT00543010|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-11|||November 2002||2002-11-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)||Terminated||Phase 3|247|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:26.794288|2017-02-18 15:11:26.794288
NCT00542997|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2011-08-02|2011-02-08||September 2007||2007-09-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy|A Multicentre Study of the Efficacy, Tolerability, Safety, and Pharmacokinetics of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency|Completed||Phase 3|51|Actual|CSL Behring||1|||f||||f||||||||||2017-02-18 15:11:26.875625|2017-02-18 15:11:26.875625
NCT00542984|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||August 2003||2003-08-01|October 2007|2007-10-01|November 2004|Actual|2004-11-01|||||Interventional|||Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis|Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 3|70|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:11:27.314595|2017-02-18 15:11:27.314595
NCT00542971|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2012-06-12|2012-06-12||October 2007||2007-10-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)|Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006), an Oral VEGF, RAF and FLT3 Inhibitor, in Patients With High-risk MDS and AML|Completed||Phase 1/Phase 2|78|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:11:27.425835|2017-02-18 15:11:27.425835
NCT00542958|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2013-03-18|||March 2007||2007-03-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|April 2008|Actual|2008-04-01||Interventional|||Study of NK012 in Patients With Refractory Solid Tumors|A Phase I Dose-escalation Study of NK012 Administered Intravenously as a Single Dose Every Three Weeks in Patients With Refractory Solid Tumors|Completed||Phase 1|39|Actual|Nippon Kayaku Co.,Ltd.||1|||f||||f||||||||||2017-02-18 15:11:27.701161|2017-02-18 15:11:27.701161
NCT00542945|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2015-03-05|||December 2007||2007-12-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|DANISH||Danish ICD Study in Patients With Dilated Cardiomyopathy|A DANish Randomized, Controlled, Multicenter Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality. The DANISH Study|Active, not recruiting||Phase 4|1000|Anticipated|Danish Study Group||2|||f||||t||||||||||2017-02-18 15:11:27.805669|2017-02-18 15:11:27.805669
NCT00542932|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2007-10-11|||October 2005||2005-10-01|October 2007|2007-10-01|October 2006|Actual|2006-10-01|||||Interventional|||The Effects of a Home Exercise Video Programme for Patients With COPD|The Effects of a Home Exercise Video Programme for Patients With Chronic Obstructive Pulmonary Disease:Pilot Study|Completed||Phase 2|27|Actual|King's College Hospital NHS Trust||2|||f||||t||||||||||2017-02-18 15:11:27.914803|2017-02-18 15:11:27.914803
NCT00542919|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2016-06-02||2011-02-25|November 2007||2007-11-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|March 2010|Actual|2010-03-01||Interventional|||A Study for Patients With Non-Hodgkin's Lymphomas|A Multicenter, Open-label, Noncomparative Study of Enzastaurin in Patients With Non-Hodgkin's Lymphomas|Active, not recruiting||Phase 2|64|Anticipated|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 15:11:28.008318|2017-02-18 15:11:28.008318
NCT00542906|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2009-06-16|||October 2007||2007-10-01|June 2009|2009-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Functional Organization of Somatosensory Responses in the Secondary Somatosensitive Area and Insula|Functional Organization of Somatosensory Responses in the Secondary Somatosensitive Area (SII) and Insula : an fMRI Study|Completed||N/A|25|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-02-18 15:11:28.137981|2017-02-18 15:11:28.137981
NCT00542893|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2012-03-11|||April 2006||2006-04-01|March 2012|2012-03-01|September 2007|Actual|2007-09-01|||||Interventional|||A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine|A Randomized, Open-label, Cross-over Pharmacokinetic Study of Dacarbazine in Combination With Genasense® in Subjects With Advanced Melanoma|Completed||Phase 1|||Genta Incorporated||2|||f||||f||||||||||2017-02-18 15:11:28.249698|2017-02-18 15:11:28.249698
NCT00542880|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2012-07-27|2009-08-04||September 2007||2007-09-01|July 2012|2012-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|SPEED||Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®|A Double-blind, Randomised, Cross-over, Multi-centre Study, to Evaluate Onset of Effect in the Morning in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort®Turbuhaler® 320/9 μg, Compared With Seretide® Diskus® 50/500 μg, Both Given as One Inhalation Twice Daily for One Week Each.|Completed||Phase 4|442|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:11:28.459787|2017-02-18 15:11:28.459787
NCT00542867|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2007-11-19|||January 2006||2006-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|CEPHEUS||Pan-European Survey on the Under Treatment of Hypercholesterolemia|Pan-European Survey on the Under Treatment of Hypercholesterolemia|Completed||N/A|6500|Actual|AstraZeneca|||||f||||f||||||||||2017-02-18 15:11:29.261461|2017-02-18 15:11:29.261461
NCT00542854|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2009-01-27|||October 2007||2007-10-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||iPod and Other MP3 Players on ICDs and Pacemakers in Children|A Pilot Study on the Effects of Digital Music Players on Implantable Cardioverter Defibrillators and Pacemakers in Pediatrics and Congenital Heart Disease|Completed||N/A|100|Anticipated|Boston Children’s Hospital|||1||f||||f||||||||||2017-02-18 15:11:29.3395|2017-02-18 15:11:29.3395
NCT00542841|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2015-12-10|||August 2007||2007-08-01|December 2015|2015-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Examining Genetic Differences Among People With 21-Hydroxylase Deficiency|Modifier Genes in 21-Hydroxylase Deficiency|Completed||N/A|99|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-02-18 15:11:29.449706|2017-02-18 15:11:29.449706
NCT00542828|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2015-03-17|2010-04-07||October 2007||2007-10-01|March 2015|2015-03-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|RISE||Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome|A Phase II Study of the Efficacy of Rabbit Anti-thymocyte Globulin (rATG) in Patients With Low and Intermediate-1 Risk Myelodysplastic Syndrome|Terminated||Phase 2|16|Actual|Sanofi|The study was terminated early due to a slow enrollment rate; therefore, only safety data were collected from participants for 45 days following the last day of infusion (Day 5).|1||Study terminated due to slow enrollment.|f||||f||||||||||2017-02-18 15:11:29.571127|2017-02-18 15:11:29.571127
NCT00542815|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2014-09-24|2014-09-16||November 2007||2007-11-01|September 2014|2014-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia|A Phase III, Multicentre, Open Label, Flexible Dose, Long Term Safety Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia|Completed||Phase 3|632|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 15:11:30.081044|2017-02-18 15:11:30.081044
NCT00542802|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2008-05-26|||September 2007||2007-09-01|May 2008|2008-05-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|EpIc||Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis|Multicenter, Comparative, Randomized, Open Trial to Evaluate Efficacy and Safety of Levetiracetam Versus Carbamazepine in Post Stroke Late Onset Crisis|Unknown status|Recruiting|Phase 3|630|Anticipated|Scienze Neurologiche Ospedaliere||2|||f||||f||||||||||2017-02-18 15:11:31.275886|2017-02-18 15:11:31.275886
NCT00368238|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2006-08-23|||October 2005||2005-10-01|August 2006|2006-08-01|July 2006||2006-07-01|||||Interventional|||Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects|Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects|Completed||Phase 2|96||Yale University|||||f||||||||||||||2017-02-18 16:18:27.142042|2017-02-18 16:18:27.142042
NCT00542789|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-11|2010-05-10|2010-02-16||August 2007||2007-08-01|May 2010|2010-05-01|February 2009|Actual|2009-02-01|||||Interventional|||Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID|A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Comparative Efficacy and Safety Study of Esomeprazole(20 mg Once Daily) Versus Placebo for the Prevention of Gastric and/or Duodenal Ulcers Associated With Daily Nonsteroidal Anti-inflammatory Drug (NSAID) Use|Completed||Phase 3|343|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:11:31.532938|2017-02-18 15:11:31.532938
NCT00542776|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2008-04-30|||October 2007||2007-10-01|December 2007|2007-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine|Impact of Immunosuppression in Patients With Inflammatory Bowel Disease on Responsiveness to Influenza Vaccine|Completed||N/A|146|Actual|Boston Children’s Hospital|||2||f||||t||||||Samples Without DNA|"~     Blood for seroprotection rate and antibody titers~   "|||2017-02-18 15:11:32.030827|2017-02-18 15:11:32.030827
NCT00542763|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||April 2005||2005-04-01|August 2004|2004-08-01|September 2007|Actual|2007-09-01|||||Interventional|||Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome|Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome - An Open Label Pilot Trial|Completed||Phase 1|12|Actual|University Hospital Muenster|||||f||||f||||||||||2017-02-18 15:11:32.145447|2017-02-18 15:11:32.145447
NCT00542750|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2009-02-12|||January 2008||2008-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|NAC MJ Pilot||An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents|An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents|Completed||Phase 1/Phase 2|24|Actual|Medical University of South Carolina||1|||||||t||||||||||2017-02-18 15:11:32.412797|2017-02-18 15:11:32.412797
NCT00542737|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2013-07-09|||February 2009||2009-02-01|August 2010|2010-08-01|July 2014|Anticipated|2014-07-01|September 2013|Anticipated|2013-09-01||Interventional|LINK||Evaluating a Web-Based Ventilator Management Educational Program for Clinicians (The Lung Injury Knowledge Network [LINK] Study)|Improving Ventilator Management and Preventing Injury to Patients With Acute Respiratory Failure|Unknown status|Active, not recruiting|N/A|120|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-02-18 15:11:32.532084|2017-02-18 15:11:32.532084
NCT00542724|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-07-30||2010-01-21|September 2006||2006-09-01|July 2015|2015-07-01||||July 2008|Actual|2008-07-01||Interventional|||An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus|An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus|Completed||Phase 3|462|Actual|Biodel||2|||f||||f||||||||||2017-02-18 15:11:32.644871|2017-02-18 15:11:32.644871
NCT00542711|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2015-08-19||||||August 2015|2015-08-01||||||||Interventional|||Bio-availability of a New Liquid Tumeric Extract|Liquid Tumeric Extract for Increasing Bio-availability of Curcumin in the Human Body: Pharmacokinetic Study.|Withdrawn||Phase 1|0|Actual|Hadassah Medical Organization||1||Technical difficulties|f||||||||||||||2017-02-18 15:11:32.761629|2017-02-18 15:11:32.761629
NCT00542698|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||July 2004||2004-07-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose Monitoring|Changing Activity Behavior With Glucose Sensor Feedback|Completed||Phase 1|52|Actual|National Institute of Nursing Research (NINR)||2|||f||||||||||||||2017-02-18 15:11:32.86381|2017-02-18 15:11:32.86381
NCT00542685|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2012-11-09||2009-12-10|October 2007||2007-10-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder|A Phase 3, Randomized, Double-Blind, Placebo Controlled, Parallel Group, 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|551|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 15:11:32.975503|2017-02-18 15:11:32.975503
NCT00542672|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2013-05-20|||August 2008||2008-08-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Evaluating Parental Influences on Obesity Among Mexican American Children|Parental Influences on Obesity Among Mexican American Children|Completed||N/A|831|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 15:11:33.143326|2017-02-18 15:11:33.143326
NCT00542659|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2011-07-22|||February 2005||2005-02-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Observational|||Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure|Plasma ANP and NT-pro-BNP, Atrial Anatomical Change May Determine the Outcome of Maze Operation|Completed||N/A|86|Anticipated|Samsung Medical Center|||1||f||||f||||||Samples Without DNA|"~     plasma mRNA~   "|||2017-02-18 15:11:33.23677|2017-02-18 15:11:33.23677
NCT00542646|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-11-27|||November 2006||2006-11-01|November 2007|2007-11-01|November 2010|Anticipated|2010-11-01|||||Interventional|||Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery System|Pilot Study to Evaluate the Safety and Preliminary Efficacy of the Peritec Peritoneal Lined Stent and Delivery System|Unknown status|Recruiting|Early Phase 1|45|Anticipated|PeriTec Biosciences Ltd.||1|||f||||f||||||||||2017-02-18 15:11:33.325028|2017-02-18 15:11:33.325028
NCT00542633|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2015-07-28||2010-01-21|December 2006||2006-12-01|July 2015|2015-07-01||||August 2008|Actual|2008-08-01||Interventional|||An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus|An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|472|Actual|Biodel||2|||f||||f||||||||||2017-02-18 15:11:33.410147|2017-02-18 15:11:33.410147
NCT00542620|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2014-10-24|2011-12-05||September 2007||2007-09-01|October 2014|2014-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|MIXING||Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial|A Randomised, Multicentric, Open Labelled, Parallel Group Trial With Insulin Aspart and Insulin Detemir, Investigating the Glycaemic Effect and Profile in Children With Type 1 Diabetes, of Two Separate Levemir® + NovoRapid® Injections and Extemporaneous Mixing - The Paediatric MIXING Trial|Completed||Phase 4|25|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 15:11:33.525877|2017-02-18 15:11:33.525877
NCT00542607|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2013-12-11|||September 2002||2002-09-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis|Trial to Compare the Efficacy and Safety of Levocetirizine 5 mg od and Fexofenadine 120 mg od in Reducing Symptoms of Seasonal Allergic Rhinitis in Grass Pollen Sensitized Adults|Completed||Phase 4|94|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:11:34.638825|2017-02-18 15:11:34.638825
NCT00542594|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2013-02-06|||November 2005||2005-11-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|ARIES||Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy|A Report Upon a Cohort of Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy for Hormone-dependant Breast Cancer. Long-term Tolerance Evaluation|Terminated||N/A|1840|Actual|AstraZeneca|||1|No results are avaialble as the study did not complete according to the protocol|f||||f||||||||||2017-02-18 15:11:34.722316|2017-02-18 15:11:34.722316
NCT00542581|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2016-05-03|||October 2007||2007-10-01|October 2010|2010-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|TORILIOL||Acrysof Toric SN60T3corneal Astigmatism Between 0.75 and 1.00 D.|Evaluation of the Acrysof Toric SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.00 D.|Completed||N/A|4|Actual|Medical University of South Carolina||1|||f||||f||||||||||2017-02-18 15:11:34.796472|2017-02-18 15:11:34.796472
NCT00542568|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2014-04-16|||August 2008||2008-08-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|July 2012|Actual|2012-07-01||Interventional|||Safety and Efficacy of Sustained Erythropoietin Therapy|Safety and Efficacy of Sustained Erythropoietin Therapy of Anemia in Chronic Kidney Disease Patients Using EPODURE Biopump|Completed||Phase 1/Phase 2|19|Actual|Medgenics Medical Israel Ltd.||3|||f||||t||||||||||2017-02-18 15:11:34.89761|2017-02-18 15:11:34.89761
NCT00542555|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2011-06-16|||December 2005||2005-12-01|June 2011|2011-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee|301: A Phase 3 Study of the Analgesic Efficacy and Safety of HCT 3012: A Parallel, Randomized, Double Blind, 13 Week Placebo and Naproxen Controlled, Multicenter Study of HCT 3012 (375 mg Bid and 750 mg Bid) in Patients With Osteoarthritis of the Knee, Followed by Its Extension (301E): A Parallel, Randomized, Open-Label, Multicenter, 52-Week Follow-up Safety Study of HCT 3012 (375 mg Bid and 750 mg Bid) in Subjects With Osteoarthritis of the Knee|Completed||Phase 3|918|Actual|NicOx||4|||f||||t||||||||||2017-02-18 15:11:35.004565|2017-02-18 15:11:35.004565
NCT00542542|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2015-03-31|2015-03-31||September 2007||2007-09-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||One participant was removed prior to study randomization.|Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery|Prospective Randomized Clinical Trial to Evaluate the Use of Paravertebral Blocks in Reconstructive Breast Surgery|Completed||Phase 3|89|Actual|M.D. Anderson Cancer Center|The study completed with measurement reporting issues (inconsistencies) leading to uninterpretable data.|2|||f||||t||||||||||2017-02-18 15:11:35.103902|2017-02-18 15:11:35.103902
NCT00542529|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||November 2006||2006-11-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Phase I/II, Randomized, Double-Blind, Study of the Progenitor Cell Mobilizing Effects of Imprime PGG™ Injection Administered at Varied Dosing Regimens With G-CSF Versus G-CSF Alone|Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Single-Center Study of the Progenitor Cell Mobilizing Effects of Imprime PGG™ Injection Administered at Varied Dosing Regimens With G-CSF Versus G-CSF Alone in Healthy Subjects|Completed||Phase 1/Phase 2|66|Actual|Biothera||2|||f||||t||||||||||2017-02-18 15:11:35.413091|2017-02-18 15:11:35.413091
NCT00542516|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2009-02-18|||September 2006||2006-09-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|||||Interventional|||Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty|Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty: Hydroxyethyl Starch Versus Ringer's Lactate|Completed||Phase 4|48|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 15:11:35.491841|2017-02-18 15:11:35.491841
NCT00542503|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2014-12-10|||June 2007||2007-06-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|PREDICT||Using Magnetic Resonance Imaging to Predict People Who Are Likely to Develop Flash Pulmonary Edema (The PREDICT Study)|Vascular Stiffness and Pulmonary Congestion|Completed||N/A|579|Actual|Wake Forest University Health Sciences|||1||f||||t||||||||||2017-02-18 15:11:35.608799|2017-02-18 15:11:35.608799
NCT00542490|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2017-01-10|||September 2007||2007-09-01|January 2017|2017-01-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer|Phase II Trial of Vaginal Cuff Brachytherapy Followed by Carboplatin and Paclitaxel Chemotherapy in Patients With Stage I-IIb Papillary Serous, Clear Cell and Endometrioid Endometrial Cancer With High-Intermediate Risk Factors|Completed||Phase 2|25|Actual|University of Oklahoma||1|||f||||f||||||||||2017-02-18 15:11:35.69648|2017-02-18 15:11:35.69648
NCT00542477|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2008-04-29|||June 2008||2008-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 15:11:35.800376|2017-02-18 15:11:35.800376
NCT00542464|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||May 2006||2006-05-01|October 2007|2007-10-01|September 2006|Actual|2006-09-01|||||Interventional|||Multiple-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Imprime PGG™ Injection|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Intravenous Imprime PGG™ Injection in Healthy Adult Subjects|Completed||Phase 1|12|Actual|Biothera||3|||f||||t||||||||||2017-02-18 15:11:35.84604|2017-02-18 15:11:35.84604
NCT00542451|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2016-04-25|||October 2007||2007-10-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer|A Phase II Trial of Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer|Active, not recruiting||Phase 2|420|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:11:35.932729|2017-02-18 15:11:35.932729
NCT00542438|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2016-08-24|||October 2007||2007-10-01|August 2016|2016-08-01||||October 2018|Anticipated|2018-10-01||Interventional|||Home-Based Measures of Physical Activity and Body Composition|Feasibility and Validity of Home-Based Measures of Physical Activity and Body Composition|Active, not recruiting||N/A|75|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:11:36.061196|2017-02-18 15:11:36.061196
NCT00542425|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2010-06-30|2010-06-30||April 2007||2007-04-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis|A Randomized, Parallel-Group, Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 2|222|Actual|Radius Health, Inc.||5|||f||||f||||||||||2017-02-18 15:11:36.176846|2017-02-18 15:11:36.176846
NCT00542412|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||January 2001||2001-01-01|October 2007|2007-10-01|December 2004|Actual|2004-12-01|||||Interventional|||CARE Canadian ALS Riluzole Evaluation|Care (Canadian ALS Riluzole Evaluation) Multicentre Phase IV Comparative Study of the Effects of Riluzole 50mg Bid on the Survival of ALS Subjects Compared to Historical Controls|Completed||Phase 4|414|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:11:39.534957|2017-02-18 15:11:39.534957
NCT00542399|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2011-11-01|||November 2007||2007-11-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections|Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections in Children and Adolescence With Type 1 Diabetes Mellitus.|Completed||Phase 4|50|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 15:11:39.623835|2017-02-18 15:11:39.623835
NCT00542386|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2014-09-30|2014-04-10||December 2007||2007-12-01|September 2014|2014-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||Each one subject in the MCI-196 9 g group, MCI-196 12 g group, and MCI-196 15 g group were randomised but did not receive any study medication. Therefore these 3 subjects were excluded in the baseline characteristics analysis population.|A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia|A Phase III, Multi-centre, Double-blind, Randomised, Placebo-controlled Multiple Fixed-dose Study of MCI-196 Versus Placebo in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia (Incorporating Two Parallel High Dose Groups)|Completed||Phase 3|642|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||t||||||||||2017-02-18 15:11:39.752201|2017-02-18 15:11:39.752201
NCT00542373|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2016-08-12|||August 2007||2007-08-01|August 2016|2016-08-01||||August 2018|Anticipated|2018-08-01||Interventional|||Fluorescence & Reflectance Imaging to Detect Oral Neoplasia|Fluorescence & Reflectance Imaging to Detect Oral Neoplasia|Recruiting||N/A|300|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:11:41.708435|2017-02-18 15:11:41.708435
NCT00542360|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2015-03-05|||October 2007||2007-10-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||Marketing Fall Prevention Classes to Older Adults in Faith-Based Congregations|Marketing Fall Prevention Classes to Older Adults in Faith-Based Congregations: Cluster Randomized Controlled Trial|Completed||N/A|51|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 15:11:41.830113|2017-02-18 15:11:41.830113
NCT00542347|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2016-12-15|||September 2007||2007-09-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|May 2017|Anticipated|2017-05-01||Interventional|||Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole|Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole|Recruiting||Phase 3|20|Anticipated|Queen's University||2|||f||||f||||||||||2017-02-18 15:11:41.927102|2017-02-18 15:11:41.927102
NCT00542334|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2010-01-25|||September 2008||2008-09-01|November 2008|2008-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Prevalence of Nocturnal Hypoglycemia in Children on a Type 1 Diabetes (TID) Insulin Regimen Using a Continuous Glucose Monitoring System (CGMS)|Prevalence of Nocturnal Hypoglycemia in Children and Adolescents With Type 1 Diabetes on a Standard (TID) Insulin Regimen Using a Continuous Glucose Monitoring System (CGMS) - A Pilot Study|Completed||N/A|30|Actual|Children's Hospital of Eastern Ontario|||1||f||||f||||||||||2017-02-18 15:11:42.025024|2017-02-18 15:11:42.025024
NCT00542321|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2016-03-08|2012-10-02||September 2007||2007-09-01|March 2016|2016-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Pilot Study of Lateral Rotation Interventions for Efficacy and Safety in ICU Care|Multi-site Randomized Clinical Trial of Horizontal Positioning to Prevent and Treat Pulmonary Complications in Mechanically Ventilated Critically Ill Patients|Completed||N/A|16|Actual|The University of Texas Health Science Center, Houston|Reliance on chest X-ray interpretation only for detection of preventable pulmonary complications; small pilot study; kinetic therapy bed turn angle was less than 45 degrees|2|||f||||t||||||||||2017-02-18 15:11:42.329526|2017-02-18 15:11:42.329526
NCT00542308|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2014-08-12|2014-08-12||January 2008||2008-01-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||All patients attending Visit 2 were included in the full analysis set irrespective of their compliance with the planned course of zalutumumab.|Zalutumumab in Non-curable Patients With SCCHN|An Open Label Single Arm Trial Investigating Zalutumumab, a Human Monoclonal Anti-EGF Receptor Antibody, in Combination With Best Supportive Care, in Patients With Non-Curable Squamous Cell Carcinoma of the Head and Neck Who Have Failed Standard Platinum-based Chemotherapy.|Completed||Phase 2|90|Actual|Genmab|This was an uncontrolled single-arm open-label trial with no formal statistical tests planned.|1|||f||||t||||||||||2017-02-18 15:11:43.083775|2017-02-18 15:11:43.083775
NCT00542295|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2008-09-30|||July 2007||2007-07-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome|Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome. a 4-Week, Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase IV Trial|Completed||Phase 4|400|Anticipated|Laboratoires Mayoly Spindler||2|||f||||t||||||||||2017-02-18 15:11:43.442623|2017-02-18 15:11:43.442623
NCT00542282|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2009-06-15|||November 2006||2006-11-01|June 2009|2009-06-01|August 2007|Actual|2007-08-01|||||Observational|||Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and Asthma|Evaluation of Vibration Response Imaging (VRI) in Chronic Obstructive Pulmonary Disease and Asthma Patients Before and After Bronchodilators|Completed||N/A|75|Anticipated|Deep Breeze|||1||f||||f||||||||||2017-02-18 15:11:43.551969|2017-02-18 15:11:43.551969
NCT00542269|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2011-04-26|2011-01-06||March 2008||2008-03-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|ALTO||Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome|A Twelve Week, Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren/Ramipril/Amlodipine (300/10/5-10 mg) Compared to the Combinations of Ramipril/Amlodipine (10/5-10 mg) and Aliskiren/Amlodipine (300/5-10 mg) in Patients With Essential Hypertension and Metabolic Syndrome Not Adequately Responsive to Amlodipine 5-10 mg|Terminated||Phase 4|178|Actual|Novartis||3||Early termination of the study due to slow recruitment.|f||||f||||||||||2017-02-18 15:11:43.815241|2017-02-18 15:11:43.815241
NCT00542256|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2008-05-09|||September 2007||2007-09-01|May 2008|2008-05-01||||||||Interventional|||tDCS and Physical Therapy in Stroke|Effects of Transcranial DC Stimulation Coupled With Constraint Induced Movement Therapy on Motor Function in Stroke Patients|Unknown status|Recruiting|Phase 2|50|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 15:11:44.41794|2017-02-18 15:11:44.41794
NCT00542243|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2015-12-07|||February 2008||2008-02-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|Prostress||A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy|A Phase III, Randomized, Double-Blind, Placebo Controlled Trial of PROSCAR in Men With Initial Negative Prostate Biopsies|Completed||Phase 3|19|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 15:11:44.519388|2017-02-18 15:11:44.519388
NCT00542230|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2017-01-31|||October 1, 2007||2007-10-01|March 18, 2016|2016-03-18||||||||Observational|||Blood Sampling for Research Related to Sickle Cell Disease|High Sensitivity Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease|Enrolling by invitation||N/A|32|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:11:44.633666|2017-02-18 15:11:44.633666
NCT00542217|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-10|2007-10-10|||December 2005||2005-12-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||Phase Ia Dose-Escalation Safety, Pharmacodynamic and Pharmacokinetic Study of Imprime PGG™ Injection|Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Intravenous Imprime PGG™ Injection in Healthy Adult Subjects|Completed||Phase 1|24|Actual|Biothera||5|||f||||t||||||||||2017-02-18 15:11:44.725841|2017-02-18 15:11:44.725841
NCT00542204|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2015-04-27|||March 2008||2008-03-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|March 2011|Actual|2011-03-01||Interventional|EMPOWER-D||Use of Online Personalized Health Record System to Promote Self-Management of Diabetes|Patient-Centered Online Disease Management Using a Personal Health Record System|Completed||N/A|415|Actual|Palo Alto Medical Foundation||2|||f||||t||||||||||2017-02-18 15:11:44.809332|2017-02-18 15:11:44.809332
NCT00542191|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2014-10-23|||July 2007||2007-07-01|October 2014|2014-10-01|June 2018|Anticipated|2018-06-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer|Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer|Recruiting||Phase 2|30|Anticipated|Leo W. Jenkins Cancer Center||1|||f||||f||||||||||2017-02-18 15:11:45.088545|2017-02-18 15:11:45.088545
NCT00542178|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2013-11-22|2012-04-27||October 2003||2003-10-01|November 2013|2013-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||All participants were enrolled in either the intensive or standard glycemia control arms. In addition, participants were included as either part of the blood pressure trial (randomized to intensive or standard) OR the lipid trial (fibrate or fibrate placebo). We completed analysis on participants for whom we had baseline and follow-up data.|Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)|Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study|Completed||Phase 3|3472|Actual|National Heart, Lung, and Blood Institute (NHLBI)|The glycemia trial was stopped early, potentially underestimating the reported effect of glycemia treatment on diabetic retinopathy.|6|||f||||t||||||||||2017-02-18 15:11:45.233782|2017-02-18 15:11:45.233782
NCT00542165|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2007-10-10|||March 2004||2004-03-01|October 2007|2007-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy|Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL) in Patients With Benign Prostatic Hypertrophy|Completed||Phase 4|166|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:11:46.992289|2017-02-18 15:11:46.992289
NCT00542152|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2011-08-30|||June 2007||2007-06-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|June 2007|Actual|2007-06-01||Interventional|CYSIF||Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis|A Randomized, Multicenter Open Label Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis|Completed||Phase 4|115|Actual|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives||2|||f||||f||||||||||2017-02-18 15:11:47.082266|2017-02-18 15:11:47.082266
NCT00542139|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-07|2008-11-09|||December 2007||2007-12-01|October 2007|2007-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of Diprospan Injection to the Knee on Rehabilitation of Patients After TKR of the Contralateral Knee|Evaluation of the Efficacy of Diprospan Injection to the Knee on Rehabilitation of Patients With Bilateral Knee Osteoarthritis After TKR of the Contralateral Knee.|Completed||Phase 4|50|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 15:11:47.247564|2017-02-18 15:11:47.247564
NCT00542126|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-10-09|||December 2007||2007-12-01|September 2007|2007-09-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Luteal-Phase GnRH Agonist Administration in Frozen-Thawed IVF Embryo Transfer Cycles||Unknown status|Not yet recruiting|N/A|||Shaare Zedek Medical Center||2|||f||||f||||||||||2017-02-18 15:11:47.342176|2017-02-18 15:11:47.342176
NCT00542113|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2014-11-05|||September 2001||2001-09-01|November 2014|2014-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|DvtENERGY||Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment|Diabetes Virtual Trek Prevention: Obesity and Diabetes Prevention Through Science Enrichment|Completed||N/A|1703|Actual|Colorado State University||3|||f||||f||||||||||2017-02-18 15:11:47.430705|2017-02-18 15:11:47.430705
NCT00542100|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-07|2007-10-09|||November 2007||2007-11-01|October 2007|2007-10-01|November 2008|Anticipated|2008-11-01|||||Interventional|PCMRI||PCMRI - an MRI/TRUS System for the Evaluation of the Prostate||Unknown status|Not yet recruiting|N/A|50|Anticipated|TopSpin Medical||2|||f||||f||||||||||2017-02-18 15:11:47.533973|2017-02-18 15:11:47.533973
NCT00542087|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-04-08|||March 2002||2002-03-01|April 2015|2015-04-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)|A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Etoricoxib 60 mg and Diclofenac Sodium 150 mg in Patient With Osteoarthritis of the Knee or Hip|Completed||Phase 3|516|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:47.624117|2017-02-18 15:11:47.624117
NCT00542074|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2007-10-29|||June 2003||2003-06-01|October 2007|2007-10-01|August 2005|Actual|2005-08-01|||||Interventional|||Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence|Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence|Completed||N/A|223|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 15:11:47.708568|2017-02-18 15:11:47.708568
NCT00542061|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2010-03-08|||March 2005||2005-03-01|October 2007|2007-10-01|April 2008|Actual|2008-04-01|February 2007|Actual|2007-02-01||Interventional|Monaco||Monitoring Asthma and COPD in Primary Care|Clinical Effectiveness and Cost-effectiveness of a Monitoring System for Patients With COPD and Asthma With Persistent Obstruction in Primary Care; a Multicentre Randomised Nested Clinical Trial|Completed||N/A|200||Radboud University||2|||f||||f||||||||||2017-02-18 15:11:47.933149|2017-02-18 15:11:47.933149
NCT00542048|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2010-02-08|||November 2007||2007-11-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases|An Open-label, Uncontrolled, Phase II Trial Evaluating the Single-dose and Steady-state Pharmacokinetics of EndoTAG®-1 and Its Effect on the Blood Supply and the Angiogenesis of Hepatic Metastases in Patients With a Carcinomatous Primary Tumor Other Than Hepatocellular (HCC), Biliary or Bile Duct Carcinoma|Completed||Phase 2|20|Actual|MediGene||1|||f||||f||||||||||2017-02-18 15:11:48.040765|2017-02-18 15:11:48.040765
NCT00542035|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-01-06||2009-12-09|October 2007||2007-10-01|January 2012|2012-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction||Completed||Phase 2|103|Actual|Array BioPharma||3|||f||||f||||||||||2017-02-18 15:11:48.154436|2017-02-18 15:11:48.154436
NCT00542022|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-10-19|||June 2004||2004-06-01|October 2015|2015-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)|A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, Safety, and Tolerability of MK0812 in Rheumatoid Arthritis Patients|Completed||Phase 2|149|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:48.252586|2017-02-18 15:11:48.252586
NCT00542009|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-11-05||2009-08-12|December 2007||2007-12-01|November 2012|2012-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight|A 12-Week, Phase 2A, Randomized, Subject And Investigator Blinded, Placebo-Controlled Trial To Evaluate The Safety, Tolerability And Efficacy Of CE-326,597 On Glucose Control And Body Weight In Overweight Adult Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|252|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 15:11:48.333048|2017-02-18 15:11:48.333048
NCT00541996|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2007-12-03|||August 2007||2007-08-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Comparing Bioavailability of Oral Formulations of Vabicaserin|A Randomized, Open-Label, Single-Dose, 4-Period Crossover, Comparative Bioavailability Study of 3 Sustained- Release Formulations and an Immediate- Release Formulation of Vabicaserin (SCA-136) in Healthy Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:11:48.506655|2017-02-18 15:11:48.506655
NCT00541983|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2010-05-02|||September 2007||2007-09-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|||Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mellitus|A Phase I, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|36|Anticipated|XOMA (US) LLC||2|||f||||t||||||||||2017-02-18 15:11:48.58346|2017-02-18 15:11:48.58346
NCT00541970|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2016-09-22|2012-10-18||October 2007||2007-10-01|September 2016|2016-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs|Evaluation of the Safety and Immunogenicity of GSK Biologicals' HPV Vaccine 580299 When Administered in Healthy Females Aged 9 - 25 Years Using an Alternative Schedule and an Alternative Dosing as Compared to the Standard Schedule and Dosing|Completed||Phase 1|961|Actual|GlaxoSmithKline|If appropriate, describe significant limitations of the trial. Examples: Early termination leading to small number of subjects analyzed; Technical problems with measurement leading to unreliable or uninterpretable data.|4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:11:48.883968|2017-02-18 15:11:48.883968
NCT00541957|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2011-07-06|||April 2007||2007-04-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Randomized Trial of Psychotherapy for Persistently Depressed Primary Care Patients|Randomized Trial of Psychotherapy for Persistently Depressed Primary Care Patients|Completed||Phase 1|40|Anticipated|Butler Hospital||2|||f||||f||||||||||2017-02-18 15:11:51.604104|2017-02-18 15:11:51.604104
NCT00541944|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2008-04-25|||April 2007||2007-04-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|||||Observational|CONA||Establishment of an Algorithm for a Clinical Classfication of Hypoosmolar Hyponatremia||Unknown status|Recruiting|N/A|120|Anticipated|University of Wuerzburg|||6||f||||f||||||Samples Without DNA|"~     Serum, plasma and urine~   "|||2017-02-18 15:11:51.702836|2017-02-18 15:11:51.702836
NCT00541931|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-12-12|||October 2007||2007-10-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|March 2008|Actual|2008-03-01||Interventional|||Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women|Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women|Completed||N/A|71|Actual|Stanford University||2|||f||||||||||||||2017-02-18 15:11:51.788359|2017-02-18 15:11:51.788359
NCT00541918|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2015-10-27|||June 2007||2007-06-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||COGNITIVE - Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-heart Operations|COGNITIVE - Comparison of Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-heart Operations|Withdrawn||Phase 4|0|Actual|Medical University of Gdansk||2||study suspended due to staff indisposition|f||||f||||||||||2017-02-18 15:11:51.892034|2017-02-18 15:11:51.892034
NCT00541905|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2013-06-03|||September 2007||2007-09-01|June 2013|2013-06-01|May 2010|Actual|2010-05-01|October 2008|Actual|2008-10-01||Interventional|||Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia|Prospective, Single-arm, Multicenter Trial to Investigate the Efficacy and Safety of NT 201 and the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Patients With Cervical Dystonia|Completed||Phase 4|82|Actual|Merz Pharmaceuticals GmbH||1|||f||||||||||||||2017-02-18 15:11:52.009957|2017-02-18 15:11:52.009957
NCT00540566|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-02-08|||June 1999||1999-06-01|February 2017|2017-02-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Observational|||Optical Biopsy of Human Skin in Conjunction With Laser Treatment|Optical Biopsy of Human Skin in Conjunction With Laser Treatment|Completed||N/A|113|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:12:17.680074|2017-02-18 15:12:17.680074
NCT00541892|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2015-05-19|||September 2007||2007-09-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine|Sibling Oocyte Study of Medium for IVF/ICSI With no Human Serum Albumine|Withdrawn||Phase 2|0|Actual|Sykehuset Telemark||2||senior coworker retired|f||||||||||||||2017-02-18 15:11:52.269952|2017-02-18 15:11:52.269952
NCT00541879|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2014-11-05|||August 2001||2001-08-01|November 2014|2014-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|DKENERGY||Obesity and Diabetes Prevention Through Science Enrichment|Type 2 Diabetes Knowledge: Obesity and Diabetes Prevention Through Science Enrichment|Completed||N/A|2909|Actual|Colorado State University||2|||f||||f||||||||||2017-02-18 15:11:52.377988|2017-02-18 15:11:52.377988
NCT00541866|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2012-06-05|||August 2007||2007-08-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans|Phase 1b/2, Open-Label, Multicenter, Dose-Escalating, Clinical Study of the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Profiles of Voreloxin Injection in Combination With Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|115|Actual|Sunesis Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:11:52.490273|2017-02-18 15:11:52.490273
NCT00541853|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2007-10-17|||December 2007||2007-12-01|October 2007|2007-10-01|November 2012|Anticipated|2012-11-01|||||Interventional|||CCB Safety Study in Treatment of Hypertension of ADPKD|Comparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertensive ADPKD Patients|Unknown status|Not yet recruiting|Phase 4|150|Anticipated|Kyorin University||3|||f||||t||||||||||2017-02-18 15:11:52.609058|2017-02-18 15:11:52.609058
NCT00541840|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2008-05-08|||October 2007||2007-10-01|May 2008|2008-05-01|April 2010|Anticipated|2010-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma|Phase I-II, Not-Randomized, Multicenter Clinical Trial to Evaluate Safety and Efficacy of Sorafenib (BAY-43-9006) in Combination With Ifosfamide in Soft Tissue Sarcoma.|Unknown status|Recruiting|Phase 1/Phase 2|24|Anticipated|Grupo Espanol de Investigacion en Sarcomas||1|||f||||t||||||||||2017-02-18 15:11:52.719695|2017-02-18 15:11:52.719695
NCT00541827|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2013-09-26|||October 2007||2007-10-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Observational|||Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis|Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis|Completed||N/A|50|Actual|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||1||f||||t||||||Samples With DNA|"~     muscle tissue, platelets, plasma~   "|||2017-02-18 15:11:52.822459|2017-02-18 15:11:52.822459
NCT00541814|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2008-09-05|||October 2007||2007-10-01|September 2008|2008-09-01|February 2010|Anticipated|2010-02-01|||||Interventional|CNIM-SRT||Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function|Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function: A Prospective Randomised Controlled Trial|Unknown status|Recruiting|Phase 4|90|Anticipated|University Hospital Birmingham||2|||f||||t||||||||||2017-02-18 15:11:52.910085|2017-02-18 15:11:52.910085
NCT00541801|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2011-06-22|||March 2007||2007-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography|Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography in Patients With Cytostatic Therapies|Completed||N/A|||Luzerner Kantonsspital||1|||f||||t||||||||||2017-02-18 15:11:53.023165|2017-02-18 15:11:53.023165
NCT00541788|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2010-09-16|||October 2007||2007-10-01|September 2010|2010-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation|Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation|Completed||Phase 1|10|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 15:11:53.115094|2017-02-18 15:11:53.115094
NCT00541775|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-08-21|2010-05-17||June 2006||2006-06-01|August 2015|2015-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)|A Multicenter, Double-Blind, Placebo and Active Controlled, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin 100 mg Once Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Monotherapy|Completed||Phase 3|273|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 15:11:53.230608|2017-02-18 15:11:53.230608
NCT00541762|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2015-03-09|||January 2006||2006-01-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Regulation of Fat-stimulated Neurotensin Secretion in Healthy Subjects|Mechanistic Study (Physiology)|Completed||N/A|34|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-02-18 15:11:53.856366|2017-02-18 15:11:53.856366
NCT00541749|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-07|2011-09-21|||February 2007||2007-02-01|September 2011|2011-09-01||||||||Interventional|||A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Escalating Single- and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus|Completed||Phase 1|60|Anticipated|Genentech, Inc.|||||f||||||||||||||2017-02-18 15:11:53.966745|2017-02-18 15:11:53.966745
NCT00541736|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2008-05-28|||October 2007||2007-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine|Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine|Completed||N/A|30|Actual|Danish Headache Center||2|||f||||f||||||||||2017-02-18 15:11:54.052654|2017-02-18 15:11:54.052654
NCT00541723|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2012-03-07|||September 2007||2007-09-01|March 2012|2012-03-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles|A Prospective, Randomized, Double-Blind, Multicenter Trial to Investigate the Efficacy and Safety of NT 201 in Comparison to Placebo and to Compare Two Different Application Schemes of NT 201 in the Treatment of Lateral Periorbital Wrinkles|Completed||Phase 3|111|Actual|Merz Pharmaceuticals GmbH||4|||f||||f||||||||||2017-02-18 15:11:54.162729|2017-02-18 15:11:54.162729
NCT00541710|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2012-09-13|||October 2007||2007-10-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|January 2011|Actual|2011-01-01||Interventional|||Effect of Genistein in Women With Metabolic Syndrome|Genistein Use in Postmenopausal Women With Metabolic Syndrome|Completed||Phase 2/Phase 3|120|Actual|University of Messina||2|||f||||f||||||||||2017-02-18 15:11:54.276931|2017-02-18 15:11:54.276931
NCT00541697|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-10-30|||January 2005||2005-01-01|October 2015|2015-10-01|October 2005|Actual|2005-10-01|September 2005|Actual|2005-09-01||Interventional|||Eze/Simva Switch Study in Diabetics (0653A-807)|A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination Tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) Compared to Atorvastatin 20mg in Patients With Type II Diabetes.|Completed||Phase 3|648|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:54.616973|2017-02-18 15:11:54.616973
NCT00541684|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2014-12-19|||July 2001||2001-07-01|December 2014|2014-12-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Health Assessment Study (0954-946)|A Randomized, Double-Blind, Two Arm, Parallel Group Health Assessment Study of Losartan or Atenolol in Patients With Mild to Moderate Hypertension|Completed||Phase 3|143|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:54.704826|2017-02-18 15:11:54.704826
NCT00541671|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2014-03-12|2012-05-29||February 2007||2007-02-01|March 2014|2014-03-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional||Not enough subjects were enrolled into this study. No analysis of data was performed.|Prevention of Narcotic-Induced Nausea|Prevention of Narcotic-induced Nausea With Promethazine, a Randomized, Double-blind Placebo-controlled Trial|Terminated||N/A|25|Actual|Christiana Care Health Services|Early termination due to small numbers of subjects and incomplete data for analysis|2||"Terminated: recruiting or enrolling participants has halted prematurely and will not resume;~   participants are no longer being examined or treated"|f||||f||||||||||2017-02-18 15:11:54.79756|2017-02-18 15:11:54.79756
NCT00541658|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2013-04-15|2011-04-13||October 2007||2007-10-01|April 2013|2013-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis|A Non-inferiority Comparison of 35 mg Delayed-release Risedronate, Given Once-weekly Either Before or After Breakfast, & 5 mg Immediate-release Risedronate, Given Once-daily Before Breakfast, in the Treatment of Postmenopausal Osteoporosis.|Completed||Phase 3|923|Actual|Warner Chilcott||3|||f||||f||||||||||2017-02-18 15:11:55.103158|2017-02-18 15:11:55.103158
NCT00541645|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-07|2008-03-17||||||March 2008|2008-03-01||||||||Observational|||Transient Osteoporosis of Pregnancy: A Possible Peptide Mediator||Suspended||N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:11:58.307064|2017-02-18 15:11:58.307064
NCT00541632|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-06|2008-05-14|||October 2007||2007-10-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|||||Observational|||BacLite Rapid MRSA Clinical Performance|BacLite Rapid MRSA Clinical Performance|Terminated||N/A|||3M||||performance variability|f||||f||||||||||2017-02-18 15:11:58.364199|2017-02-18 15:11:58.364199
NCT00541619|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2013-04-16|||October 2007||2007-10-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Sympathetic Overactivity in Essential Hypertension|Sympathetic Overactivity in Essential Hypertension|Withdrawn||N/A|0|Actual|University of Erlangen-Nürnberg Medical School|||1|No patients could be recruited.|f||||||||||||||2017-02-18 15:11:58.440206|2017-02-18 15:11:58.440206
NCT00541606|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2009-05-15|||September 2000||2000-09-01|May 2009|2009-05-01|July 2004|Actual|2004-07-01|||||Interventional|PAMPERED||Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes|Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED)|Completed||N/A|285|Actual|Lahey Clinic||2|||f||||t||||||||||2017-02-18 15:11:58.52225|2017-02-18 15:11:58.52225
NCT00541593|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-07|2013-09-03|2011-06-23||September 2007||2007-09-01|September 2013|2013-09-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic Pseudocysts|Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic Pseudocysts|Terminated||N/A|5|Actual|Baystate Medical Center|Early termination due to the company that made the device going out of business; the company that acquired it chose not to market the device. Given the lack of clinical support, we chose to terminate the study.|1||SurgAssist device is no longer clinically available.|f||||f||||||||||2017-02-18 15:11:58.615178|2017-02-18 15:11:58.615178
NCT00541580|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-07|2011-09-15||||||September 2011|2011-09-01||||||||Observational|||Comparative Results of Conservatively and Surgically Treated Adolescents With Triplane and Juvenile Tillaux Ankle Fractures After Skeletal Maturity||Terminated||N/A|||Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 15:11:58.934509|2017-02-18 15:11:58.934509
NCT00541567|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2008-01-08|||March 2008||2008-03-01|January 2008|2008-01-01|June 2010|Anticipated|2010-06-01|||||Interventional|||BMS-646256 in Obese and Overweight Type 2 Diabetics|A Placebo-Controlled, Randomized, Double-Blind, Parallel Arm, Multicenter, Dose-Ranging Phase IIb Trial to Assess Glycemic and Weight Loss Efficacy and Safety of BMS-646256 in Overweight and Obese Patients With Type 2 Diabetes Inadequately Controlled by Diet and Exercise Only or With Metformin or Sulfonylurea Monotherapy|Withdrawn||Phase 2/Phase 3|600|Anticipated|Solvay Pharmaceuticals||4|||f||||t||||||||||2017-02-18 15:11:58.999205|2017-02-18 15:11:58.999205
NCT00541554|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2007-10-09|||October 2007||2007-10-01|October 2007|2007-10-01|February 2009|Anticipated|2009-02-01|||||Interventional|||Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia|Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia by Aripiprazole Add-on Therapy in the Treatment of Schizophrenia and Bipolar Disorder: An Open-Label Trial|Unknown status|Not yet recruiting|Phase 4|||Genovate Biotechnology Co., Ltd.,||1|||f||||f||||||||||2017-02-18 15:11:59.09153|2017-02-18 15:11:59.09153
NCT00541541|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2013-04-16|||February 2007||2007-02-01|April 2013|2013-04-01||||May 2012|Actual|2012-05-01||Interventional|||Acoustic Cardiographic Assessment of Heart Function and the Role of Phrenic Nerve Stimulation|Acoustic Cardiographic Assessment of Heart Function and the Role of Phrenic Nerve Stimulation Following Open Heart Surgery|Completed||N/A|||Luzerner Kantonsspital||1|||f||||t||||||||||2017-02-18 15:11:59.172295|2017-02-18 15:11:59.172295
NCT00541515|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2016-04-07|||October 2007||2007-10-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|July 2015|Actual|2015-07-01||Interventional|||Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm|Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm|Completed||N/A|38|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-02-18 15:11:59.255062|2017-02-18 15:11:59.255062
NCT00541502|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2007-10-09|||November 2007||2007-11-01|October 2007|2007-10-01|October 2008|Anticipated|2008-10-01|||||Observational|||Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder|A Obervational, Prospective Study to Evaluate the Effectiveness of Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder in Taiwan|Unknown status|Not yet recruiting|N/A|||Genovate Biotechnology Co., Ltd.,|||||f||||f||||||||||2017-02-18 15:11:59.355839|2017-02-18 15:11:59.355839
NCT00541489|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2009-02-19|||June 2007||2007-06-01|February 2009|2009-02-01||||September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip|A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip|Completed||Phase 3|800|Anticipated|NicOx||3|||f||||t||||||||||2017-02-18 15:11:59.424356|2017-02-18 15:11:59.424356
NCT00541476|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2008-11-20|||June 2007||2007-06-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica|Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Undergoing Symptomatic Treatment With Lyrica|Completed||Phase 4|746|Actual|Pfizer|||||f||||||||||||||2017-02-18 15:11:59.576992|2017-02-18 15:11:59.576992
NCT00541463|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2017-02-16|||January 2001||2001-01-01|February 2017|2017-02-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)|A Multicenter, Open-Label, Randomized, Study to Compare the Efficacy and Safety of Indinavir 800 mg b.i.d. Plus Ritonavir 100 mg b.i.d. Plus Two NRTIs vs. Nelfinavir 1250 mg b.i.d. Plus Two NRTIs in HIV-1 Seropositive Patients Who Have Failed or Are Intolerant to an NNRTI Containing Regimen|Completed||Phase 2|330|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:11:59.806403|2017-02-18 15:11:59.806403
NCT00541450|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-05-04|2011-01-13||January 2008||2008-01-01|May 2015|2015-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)|A Phase III Randomized, Active-Comparator (Pioglitazone) Controlled Clinical Trial to Study the Efficacy and Safety of Sitagliptin and MK0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|492|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:11:59.895573|2017-02-18 15:11:59.895573
NCT00541437|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2007-10-09|||May 2006||2006-05-01|October 2007|2007-10-01|February 2007|Actual|2007-02-01|||||Observational|||Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet|An Open-Label Study to Investigate the Efficacy and Safety of Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet|Completed||N/A|12|Actual|Genovate Biotechnology Co., Ltd.,|||||f||||f||||||||||2017-02-18 15:12:00.530284|2017-02-18 15:12:00.530284
NCT00541424|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2012-12-05|||September 2007||2007-09-01|December 2012|2012-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma|Feasibility of Combined CT Colonography and PET Imaging for Detection of Colonic Involvement by Mantle Cell Lymphoma|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||1|No study recruitment due to time constraints and lack of support.|f||||f||||||||||2017-02-18 15:12:00.623095|2017-02-18 15:12:00.623095
NCT00541411|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2012-04-16|||June 2003||2003-06-01|April 2012|2012-04-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma||Unknown status|Active, not recruiting|N/A|10|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:12:00.734818|2017-02-18 15:12:00.734818
NCT00541398|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2009-10-30|||January 2008||2008-01-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|January 2009|Actual|2009-01-01||Interventional|||Antipsychotic Polypharmacy: Prevalence, Background and Consequences|Antipsychotic Polypharmacy: Prevalence, Background and Consequences|Completed||N/A|222|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||f||||||||||2017-02-18 15:12:00.811287|2017-02-18 15:12:00.811287
NCT00541385|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2009-01-21|||October 2007||2007-10-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients|Phase III Comparative, Open-Labelled, Randomised, Clinical Study to Assess a Fixed Dose of Oral Pyronaridine Artesunate Granule Formulation vs. Coartem® Crushed Tablets in Infants With Acute Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 3|534|Anticipated|Medicines for Malaria Venture||2|||f||||t||||||||||2017-02-18 15:12:00.918126|2017-02-18 15:12:00.918126
NCT00541372|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2009-03-13|||September 2007||2007-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|INOBESE||Needle Length In Obese Insulin-Using Diabetic Subjects|The Influence of the Needle Length on Long Term Glycaemic Control in Insulin Using Obese Diabetic Subjects|Completed||Phase 4|130|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-02-18 15:12:01.05244|2017-02-18 15:12:01.05244
NCT00541359|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-06-03|||January 2004||2004-01-01|June 2015|2015-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors|A Phase I Trial of PS-341 in Combination With Topotecan in Advanced Solid Tumor Malignancies|Completed||Phase 1|40|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 15:12:01.149635|2017-02-18 15:12:01.149635
NCT00541346|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-08|2013-12-19|2010-11-15||September 2007||2007-09-01|December 2013|2013-12-01|February 2010|Actual|2010-02-01|May 2009|Actual|2009-05-01||Interventional|||A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms|Phase III Study of Autism Co-Morbid for Attention Deficit Hyperactivity Disorder|Completed||Phase 3|16|Actual|University of Oklahoma||1|||f||||t||||||||||2017-02-18 15:12:01.276654|2017-02-18 15:12:01.276654
NCT00541333|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2013-05-02|||December 2007||2007-12-01|May 2013|2013-05-01||||December 2012|Actual|2012-12-01||Interventional|||Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration|Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration|Suspended||Phase 1|15|Actual|The New York Eye & Ear Infirmary||2||Reviewing data|f||||t||||||||||2017-02-18 15:12:01.712524|2017-02-18 15:12:01.712524
NCT00541320|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2013-04-01|||February 2007||2007-02-01|April 2013|2013-04-01||||||||Interventional|||Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)|Dose Ranging Trial for the Evaluation of the Safety and Efficacy of GW813893 in the Prophylaxis of Venous Thromboembolism Post Total Knee Replacement Surgery.|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||||No longer viable|f||||||||||||||2017-02-18 15:12:01.82109|2017-02-18 15:12:01.82109
NCT00071669|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-04-12|||November 2001||2001-11-01|November 2005|2005-11-01||||||||Interventional|||Acupuncture as a Supplemental Treatment for Bipolar Depression|Adjunctive Acupuncture as a Treatment for Bipolar Depression|Completed||Phase 2|30||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 17:56:10.663342|2017-02-18 17:56:10.663342
NCT00541307|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2012-11-26|2012-06-22||October 2007||2007-10-01|November 2012|2012-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|VIPER||GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)|Post Marketing Study of the GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease (VIPER)|Completed||N/A|119|Actual|W.L.Gore & Associates||1|||f||||f||||||||||2017-02-18 15:12:01.925895|2017-02-18 15:12:01.925895
NCT00541294|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2010-08-02|||October 2007||2007-10-01|August 2010|2010-08-01|September 2010|Anticipated|2010-09-01|||||Observational|ThrasherIGRA||Diagnosis of Tuberculosis Infection in HIV Co-infected Children|Diagnosis of Tuberculosis Infection in HIV Co-infected Children|Unknown status|Recruiting|N/A|250|Anticipated|Case Western Reserve University|||2||f||||f||||||||||2017-02-18 15:12:02.429131|2017-02-18 15:12:02.429131
NCT00541281|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2009-10-26|||December 2003||2003-12-01|October 2009|2009-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer|Randomized Phase Ii Trial Of Weekly Docetaxel, Estramustine And Prednisone Versus Docetaxel And Prednisone In Patient With Hormone-Resistant Prostate Cancer|Completed||Phase 2|150|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||f||||||||||2017-02-18 15:12:02.533221|2017-02-18 15:12:02.533221
NCT00541268|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2016-06-17|||February 2008||2008-02-01|June 2016|2016-06-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|DANISH||Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality|A DANish Randomized, Controlled, Multicenter Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality. The DANISH Study|Active, not recruiting||Phase 4|1000|Anticipated|Danish Study Group||2|||f||||t||||||||||2017-02-18 15:12:02.682604|2017-02-18 15:12:02.682604
NCT00541255|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2015-10-06|||September 2007||2007-09-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|May 2012|Actual|2012-05-01||Observational|||A Long-Term Examination of Asthma From Childhood Through Adolescence|Epidemiology of Asthma and Allergic Disease: Risk and Prognosis in a Cohort From Birth to Adolescence|Active, not recruiting||N/A|1200|Anticipated|Isle of Wight NHS Trust|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, saliva, urine~   "|||2017-02-18 15:12:02.802561|2017-02-18 15:12:02.802561
NCT00541242|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2011-09-19|2011-09-19||December 2007||2007-12-01|September 2011|2011-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 4|586|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:12:02.905176|2017-02-18 15:12:02.905176
NCT00541229|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-02-24|2009-06-05||August 2007||2007-08-01|February 2015|2015-02-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)|A Phase 1b, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover Clinical Trial of Sitagliptin 100 mg and Sitagliptin 200 mg in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet and Exercise|Completed||Phase 1|103|Actual|Merck Sharp & Dohme Corp.|The pre-specified rule for non-superiority of sitagliptin 200 mg compared with 100 mg was met at the planned interim analysis. As such, the trial was terminated as pre-specified.|3|||f||||||||||||||2017-02-18 15:12:03.285594|2017-02-18 15:12:03.285594
NCT00541216|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-07|2007-10-09|||October 2007||2007-10-01|October 2007|2007-10-01||||||||Interventional|||Ephedrine for the Treatment of Congenital Myasthenia||Unknown status|Enrolling by invitation|Phase 1/Phase 2|15|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 15:12:04.223228|2017-02-18 15:12:04.223228
NCT00541203|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2012-03-20|||October 2007||2007-10-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|CT-MPACT||Cardiac Computed Tomography In the Management of Patients With indeterminAte or inConclusive Stress Tests|Cardiac Computed Tomography In the Management of Patients With indeterminAte or inConclusive Stress Tests|Completed||N/A|45|Actual|William Beaumont Hospitals|||1||f||||t||||||||||2017-02-18 15:12:04.312727|2017-02-18 15:12:04.312727
NCT00541190|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-04-27|2011-08-09||October 2007||2007-10-01|April 2016|2016-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Absorptive Clearance in the Cystic Fibrosis Airway|Absorptive Clearance in the Cystic Fibrosis Airway|Completed||N/A|21|Actual|University of Pittsburgh||2|||f||||t||||||||Yes||2017-02-18 15:12:04.403065|2017-02-18 15:12:04.403065
NCT00541177|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-06|2007-10-09|||April 2007||2007-04-01|October 2007|2007-10-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Study of Myopia Prevention in Children With Low Concentration of Atropine|Pilot Study of Prevention Myopia in Children With Low Concentration of Atropine|Unknown status|Recruiting|Phase 4|60|Anticipated|Min-Sheng General Hospital||2|||f||||t||||||||||2017-02-18 15:12:04.806498|2017-02-18 15:12:04.806498
NCT00541164|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-09|2013-07-11|||September 2007||2007-09-01|June 2010|2010-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease|Effects of Coenzyme Q10 (CoQ10) on Subjects With Charcot-Marie-Tooth Disease (CMT):A Double Blind, Randomized, Controlled Trial With an Open Label Follow-up Study|Completed||Phase 1/Phase 2|23|Actual|Memorial Medical Center||2|||f||||f||||||||||2017-02-18 15:12:04.920798|2017-02-18 15:12:04.920798
NCT00541151|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2010-08-26|||September 2007||2007-09-01|August 2010|2010-08-01|November 2010|Anticipated|2010-11-01|August 2010|Anticipated|2010-08-01||Observational|MiniArc||MiniArc Study: Long-Term Effectiveness Trial for AMS Sling Systems|Long-Term Effectiveness Trial for AMS Sling Systems|Unknown status|Active, not recruiting|Phase 4|188|Actual|American Medical Systems|||1||f||||f||||||||||2017-02-18 15:12:05.054161|2017-02-18 15:12:05.054161
NCT00541138|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2011-09-20|||May 2003||2003-05-01|September 2011|2011-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors|A Pilot Study of Tamoxifen, Carboplatin and Topotecan in the Treatment of Recurrent or Refractory Primary Brain or Spinal Cord Tumors or Metastatic Epithelial Cancers With Central Nervous System Metastases|Completed||Phase 2|50|Anticipated|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 15:12:05.165938|2017-02-18 15:12:05.165938
NCT00540969|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-12-07|2016-12-07||February 2008||2008-02-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Not enough patients were accrued. In order to avoid identification of patients, no results will be entered.|Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases|A Phase III Randomized Trial of Cryoablation vs. Radiation for the Palliation of Painful Bone Metastases|Completed||Phase 3|3|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 15:12:07.36373|2017-02-18 15:12:07.36373
NCT00541125|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-05-27|||November 2007||2007-11-01|May 2016|2016-05-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer|Phase II, Multicenter Study Evaluating G-CSF as Primary Prophylaxis for Neutropenia Associated With First-line Chemotherapy Regimen FOLFIRI and Bevacizumab in Patients With Metastatic Colorectal Cancer Who Are Homozygous for UGT1A1*28 Polymorphism, the Promoter of the Gene Encoding for the Enzyme UGT1A1|Completed||Phase 2|20|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||t||||||||||2017-02-18 15:12:05.283951|2017-02-18 15:12:05.283951
NCT00541112|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2009-02-19|||July 2007||2007-07-01|October 2007|2007-10-01||||||||Interventional|||Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery|Phase II Multicenter Study of the Impact of the Therapeutic Sequence of Radiochemotherapy (50 Gy + Capecitabine + Oxaliplatin + Cetuximab) Followed by Total Mesorectal Excision Surgery Then Post-Surgery Chemotherapy (FOLFOX 4 + Cetuximab) in Synchronous Locally Advanced or Metastatic Cancers of the Rectum With Metastases Resectable From the Start (T3-4 Nx or T2 N+ M1).|Unknown status|Recruiting|Phase 2|103|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:12:05.50083|2017-02-18 15:12:05.50083
NCT00541099|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2014-08-05|2014-08-05||January 2008||2008-01-01|August 2014|2014-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Evaluation of Bevacizumab and Weekly Docetaxel in Elderly (≥ 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|8|Actual|Barbara Ann Karmanos Cancer Institute|The increased use of pemetrexed in the front line setting affected accrual.|1|||f||||t||||||||||2017-02-18 15:12:05.628855|2017-02-18 15:12:05.628855
NCT00541086|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2015-01-20|||March 2007||2007-03-01|January 2015|2015-01-01||||March 2016|Anticipated|2016-03-01||Interventional|||Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery|A Phase III Study Comparing Anastrozole, Letrozole and Exemestane, Upfront (for 5 Years) or Sequentially (for 3 Years After 2 Years of Tamoxifen), as Adjuvant Treatment of Postmenopausal Patients With Endocrine-responsive Breast Cancer|Unknown status|Active, not recruiting|Phase 3|3600|Anticipated|Gruppo Italiano Mammella (GIM)||6|||f||||t||||||||||2017-02-18 15:12:05.935303|2017-02-18 15:12:05.935303
NCT00541073|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2011-05-14|||June 2007||2007-06-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery|Phase 2 Pharmacological Study of Pemetrexed Administered With Cisplatin and a Vitamin Supplement in Patients With Nonresectable Pleural Mesothelioma|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:12:06.079224|2017-02-18 15:12:06.079224
NCT00541060|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2010-12-17|||October 2007||2007-10-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|Cariogene||Study of Factors of Genetic Susceptibility Associated to Severe Caries Phenotype|Study of Factors of Genetic Susceptibility Associated to Severe Caries Phenotype in Young Patients. First Approach by Systematic Screening of Candidate Genes|Completed||N/A|390|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:12:06.183523|2017-02-18 15:12:06.183523
NCT00541047|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-02-19|||October 2007||2007-10-01|July 2009|2009-07-01||||||||Interventional|||Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS)|RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery|Unknown status|Recruiting|Phase 3|4000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:12:06.295586|2017-02-18 15:12:06.295586
NCT00541034|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-01-07|||May 2005||2005-05-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia|Phase II Study of Pentostatin With Cyclophosphamide and Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|49|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:12:06.576269|2017-02-18 15:12:06.576269
NCT00541021|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2009-12-13|||December 2006||2006-12-01|July 2009|2009-07-01||||December 2010|Anticipated|2010-12-01||Interventional|||Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|Phase III Randomized, Double-blind Study Comparing Gemcitabine and Sorafenib or a Placebo in Patients With Locally Advanced or Metastatic Cancer of the Pancreas.|Unknown status|Recruiting|Phase 3|104|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:12:06.698515|2017-02-18 15:12:06.698515
NCT00541008|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2011-08-13|||September 2007||2007-09-01|August 2011|2011-08-01||||||||Interventional|||Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer|Phase II of Sunitinib (SUTENT®) in First Line for Patients With Locally Advanced or Metastatic Papillary Renal Cell Carcinoma - SUPAP|Unknown status|Recruiting|Phase 2|92|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:12:06.803491|2017-02-18 15:12:06.803491
NCT00540995|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-10-07|||October 2006||2006-10-01|October 2016|2016-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer|Phase I/II Study of Intravenous (IV) Busulfan and Etoposide (VP-16) Combined With Escalated Doses of Large Field Image-Guided Intensity Modulated Radiation Therapy (IMRT) Using Helical Tomotherapy as a Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Advanced Myeloid Malignancies|Active, not recruiting||Phase 1/Phase 2|25|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 15:12:06.918797|2017-02-18 15:12:06.918797
NCT00540982|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-07-16|||December 1996||1996-12-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction|Pilot Pharmacokinetic Study of Dose Adjustment of Vinorelbine in Patients With Varying Degree of Liver Dysfunction|Completed||N/A|47|Actual|City of Hope Medical Center||4|||f||||t||||||||||2017-02-18 15:12:07.060041|2017-02-18 15:12:07.060041
NCT00540774|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-02-08|||April 2003||2003-04-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Optical Sensor for Photodynamic Detection of Oral Pathology|Optical Sensor for Photodynamic Detection of Oral Pathology|Recruiting||N/A|150|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:12:09.092092|2017-02-18 15:12:09.092092
NCT00540956|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2011-05-13|||November 2006||2006-11-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Natural Killer Cells in Older Patients With Acute Myeloid Leukemia|Descriptive Study Evaluating the Presence and Function of Natural Killer Cells in Elderly Patients With Acute Myeloid Leukemia in First Remission.|Completed||N/A|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:12:07.639967|2017-02-18 15:12:07.639967
NCT00540943|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-03-15|||July 2007||2007-07-01|February 2011|2011-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer|A Phase I, Open Label, Study of the Safety, Tolerability and Pharmacokinetics of Pazopanib in Combination With Irinotecan and Cetuximab for the Relapsed or Refractory Metastatic Colorectal Cancer|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:12:07.741867|2017-02-18 15:12:07.741867
NCT00540930|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2007-10-05|||April 2007||2007-04-01|October 2007|2007-10-01|April 2009|Anticipated|2009-04-01|||||Interventional|||Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy|A Randomized Control Trial of Intravitreal Ranibizumab (Lucentis) for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy for Choroidal Melanoma|Unknown status|Active, not recruiting|Phase 4|400|Anticipated|Shields, Shields and Associates||1|||f||||t||||||||||2017-02-18 15:12:07.847263|2017-02-18 15:12:07.847263
NCT00540917|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-02-08|||July 2002||2002-07-01|February 2017|2017-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Measurement Skin Temperature During Pulsed Laser Exposure|Phase II Clinical Trial is to Compare Epidermal Temperature Measurements During 1.Laser Treatment at Standard Treatment Energies 2.Cryogen Spray Cooling (CSC) Plus Laser Treatment. 3.Contact Cooling Plus Laser Treatment.|Completed||Phase 2|118|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 15:12:07.934165|2017-02-18 15:12:07.934165
NCT00540904|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2014-02-27|||September 2007||2007-09-01|February 2014|2014-02-01|September 2009|Actual|2009-09-01|August 2008|Actual|2008-08-01||Interventional|||Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate|Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate|Completed||Phase 2|27|Actual|Barretos Cancer Hospital||2|||f||||t||||||||||2017-02-18 15:12:08.031917|2017-02-18 15:12:08.031917
NCT00540891|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2007-10-04|||February 2003||2003-02-01|October 2007|2007-10-01|October 2004|Actual|2004-10-01|||||Interventional|ALF-ACUTE||The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score|The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score|Completed||Phase 3|372|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:12:08.136521|2017-02-18 15:12:08.136521
NCT00540878|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2009-05-15|||April 2007||2007-04-01|May 2009|2009-05-01||||||||Interventional|||A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women|An Open-Label, Randomized, Five Period Crossover Study to Estimate the Relative Bioavailability of Five Formulations of 400mg SB-751689 (a Calcium-Sensing Receptor Antagonist) Administered as a Single Oral Dose to Healthy Postmenopausal Females|Completed||Phase 1|25|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:12:08.23249|2017-02-18 15:12:08.23249
NCT00540865|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2014-12-09|||May 2007||2007-05-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Effectiveness of Case Management Versus Case Management Plus Problem-solving Therapy to Treat Depression in Low-income Elders|Case Management and Problem Solving Therapy for Depressed, Homebound, Low-Income Elders|Completed||N/A|187|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 15:12:08.330634|2017-02-18 15:12:08.330634
NCT00540852|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-02-08|||June 2002||2002-06-01|February 2017|2017-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy|Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy|Completed||N/A|77|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:12:08.44784|2017-02-18 15:12:08.44784
NCT00540839|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2015-06-09|||November 2007||2007-11-01|June 2015|2015-06-01||||March 2008|Actual|2008-03-01||Interventional|||A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)|A Phase III Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Prospectively Evaluate Efficacy of Montelukast in Patients Aged 6 Months to 5 Years With Chronic Asthma|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||2||"Based on input from regulatory agencies, it is not necessary to conduct this study. An ongoing~   study was sufficient for regulatory purposes."|f||||f||||||||||2017-02-18 15:12:08.55763|2017-02-18 15:12:08.55763
NCT00540826|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2009-08-26|||November 2007||2007-11-01|August 2009|2009-08-01|June 2009|Actual|2009-06-01|||||Observational|COMPLY||Treatment Compliance in Children and Adolescents on ADHD Medication|Treatment Adherence and Compliance in Children and Adolescents on ADHD Medication and Emotional Expression in Clinical Practice|Completed||N/A|518|Actual|Eli Lilly and Company|||2||f||||f||||||||||2017-02-18 15:12:08.669255|2017-02-18 15:12:08.669255
NCT00540813|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-02-18|||October 2007||2007-10-01|February 2016|2016-02-01|October 2016|Anticipated|2016-10-01|May 2011|Actual|2011-05-01||Interventional|PEPCAD V||Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions|Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions|Active, not recruiting||Phase 2/Phase 3|25|Anticipated|Heart Centre Rotenburg||1|||f||||f||||||||||2017-02-18 15:12:08.762403|2017-02-18 15:12:08.762403
NCT00540800|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-01-13|||February 2004||2004-02-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|BREAST-10||BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer|Phase III Multicenter Study of the Effects on Quality of Life of Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer|Completed||Phase 3|139|Actual|National Cancer Institute, Naples||2|||f||||f||||||||||2017-02-18 15:12:08.866941|2017-02-18 15:12:08.866941
NCT00540787|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2012-02-21|||August 2003||2003-08-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation|A Randomized Comparison of the Efficacy of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation for the Maintenance of Sinus Rhythm In Patients With Paroxysmal Atrial Fibrillation|Completed||Phase 4|112|Actual|Biosense Webster, Inc.||2|||f||||||||||||||2017-02-18 15:12:08.986178|2017-02-18 15:12:08.986178
NCT00540761|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-10-26|||May 2007||2007-05-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique|Natural History of Vulnerable Coronary Plaques|Recruiting||Phase 1|320|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 15:12:09.211588|2017-02-18 15:12:09.211588
NCT00540748|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2010-04-15|||October 2007||2007-10-01|May 2009|2009-05-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|oxystudien||Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful?|Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful ?|Completed||N/A|400|Anticipated|Asker & Baerum Hospital||2|||f||||f||||||||||2017-02-18 15:12:09.323443|2017-02-18 15:12:09.323443
NCT00540735|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2010-02-03|||April 2008||2008-04-01|October 2007|2007-10-01|November 2009||2009-11-01|||||Interventional|CK/PDT||Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas|Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas - A Prospective, Multicentric and Randomized Study.|Terminated||Phase 3|80||University Hospital, Angers||2||Big difficulties to enroll patients|f||||t||||||||||2017-02-18 15:12:09.425656|2017-02-18 15:12:09.425656
NCT00540722|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-12-27|||January 2008||2008-01-01|December 2016|2016-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme|A Phase 2 Study of R-(-)-Gossypol (Ascenta's AT-101) in Recurrent Glioblastoma Multiforme|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||No||2017-02-18 15:12:09.685886|2017-02-18 15:12:09.685886
NCT00540709|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-02-15|||November 2002||2002-11-01|February 2012|2012-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro||Completed||Phase 4|58|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:12:09.8052|2017-02-18 15:12:09.8052
NCT00540696|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2013-04-24|||September 2001||2001-09-01|April 2013|2013-04-01|September 2003|Actual|2003-09-01|June 2003|Actual|2003-06-01||Interventional|||Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa|An Open-label, Randomized Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa (NESP)|Completed||Phase 2|300|Anticipated|Amgen||1|||f||||||||||||||2017-02-18 15:12:09.890955|2017-02-18 15:12:09.890955
NCT00540683|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-02-08|||October 2004||2004-10-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Measurement of the Distribution of Optical Properties in Adult Human Muscle|Measurement of the Distribution of Optical Properties in Adult Human Muscle|Recruiting||N/A|140|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:12:10.003783|2017-02-18 15:12:10.003783
NCT00540670|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2013-05-09|||October 2007||2007-10-01|February 2010|2010-02-01||||March 2009|Actual|2009-03-01||Interventional|||A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease|A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease|Completed||Phase 2|240|Actual|Eisai Inc.||4|||f||||||||||||||2017-02-18 15:12:10.116548|2017-02-18 15:12:10.116548
NCT00540657|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2008-07-21|||October 2007||2007-10-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||A Phase II Study of CCX282-B in Patients With Celiac Disease|A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Testing CCX282-B in the Treatment of Celiac Disease|Completed||Phase 2|90|Anticipated|ChemoCentryx||2|||f||||f||||||||||2017-02-18 15:12:10.247331|2017-02-18 15:12:10.247331
NCT00540644|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-05-12|2016-04-05||October 2007||2007-10-01|May 2016|2016-05-01|August 2014|Actual|2014-08-01|December 2012|Actual|2012-12-01||Interventional|||Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma|Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone (RCP) for Patients With Newly Diagnosed Multiple Myeloma|Completed||Phase 2|70|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 15:12:10.360492|2017-02-18 15:12:10.360492
NCT00540631|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2013-02-08|||October 2007||2007-10-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|August 2010|Actual|2010-08-01||Interventional|ACRI||Multicenter Trial of Immunotherapy With House Dust Mite Allergoid|A Multicentre Randomized Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of a Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of House Dust Mite (Dermatophagoides Pteronyssinus) in Patients With Rhinitis/Rhinoconjunctivitis and/or Allergic Asthma Bronchiale|Completed||Phase 3|108|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 15:12:11.39158|2017-02-18 15:12:11.39158
NCT00540618|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2007-11-27|||September 2001||2001-09-01|November 2007|2007-11-01|July 2003|Actual|2003-07-01|||||Interventional|||A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis|A Phase II Randomized, Placebo-Controlled, Double-Blind Study of MEDI-507, A Humanized Monoclonal Antibody That Binds to the CD2 Receptor, Administered by Subcutaneous Injection to Adults With Plaque Psoriasis.|Completed||Phase 2|420|Actual|MedImmune LLC||4|||f||||f||||||||||2017-02-18 15:12:11.509941|2017-02-18 15:12:11.509941
NCT00540605|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-05-17||||||May 2012|2012-05-01|January 2010|Actual|2010-01-01|||||Interventional|||Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery|Phase I Study of the Maternal Single-Dose Pharmacokinetics and Placental Transfer of Tenofovir 1% Vaginal Gel Among Healthy Term Gravidas|Completed||Phase 1|21|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 15:12:11.662801|2017-02-18 15:12:11.662801
NCT00540592|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2016-10-27|2012-04-26||October 2007||2007-10-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A|Observer Blind Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Influenza Vaccine GSK576389A With Various Formulations in Adults Aged 65 Years and Above|Completed||Phase 2|2007|Actual|GlaxoSmithKline||10|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:12:11.821195|2017-02-18 15:12:11.821195
NCT00540579|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2013-02-08|2013-02-08||November 2007||2007-11-01|February 2013|2013-02-01|January 2011|Actual|2011-01-01|December 2008|Actual|2008-12-01||Interventional|||CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas|A Phase I/II Study of CC-4047 in Combination With Gemcitabine in Subjects With Untreated Advanced Carcinoma of the Pancreas|Completed||Phase 1/Phase 2|23|Actual|SCRI Development Innovations, LLC||1|||f||||t||||||||||2017-02-18 15:12:17.270072|2017-02-18 15:12:17.270072
NCT00540553|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2012-03-15|||August 2007||2007-08-01|February 2011|2011-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males|A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK971086 After a Single Dose and 7 Days of Repeat Dosing in Healthy Adult Male Volunteers|Completed||Phase 1|126|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:12:17.786399|2017-02-18 15:12:17.786399
NCT00540540|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-02-08|||December 1995||1995-12-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|||Measurements of Breast Tissue Optical Properties|Measurements of Breast Tissue Optical Properties|Recruiting||N/A|653|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:12:17.878186|2017-02-18 15:12:17.878186
NCT00540527|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-10-24|||January 2004||2004-01-01|October 2012|2012-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS)|SYNTHESIS: a Randomized Controlled Trial on Intra-arterial Versus Intravenous Thrombolysis in Acute Ischemic Stroke. Start up Phase.|Completed||Phase 3|54|Actual|Niguarda Hospital||2|||f||||t||||||||||2017-02-18 15:12:17.991654|2017-02-18 15:12:17.991654
NCT00540514|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2016-11-29|2013-06-07||November 2007||2007-11-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|October 2009|Actual|2009-10-01||Interventional|||Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer|A Randomized, Phase III Trial of ABI-007 and Carboplatin Compared With Taxol and Carboplatin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|1052|Actual|Celgene Corporation||2|||f||||t||||||||||2017-02-18 15:12:18.130552|2017-02-18 15:12:18.130552
NCT00540501|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2010-05-27|||October 2007||2007-10-01|May 2010|2010-05-01|October 2007|Anticipated|2007-10-01|October 2007|Anticipated|2007-10-01||Interventional|||A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects|Phase 1, Open-Label Study to Evaluate Potential Pharmacokinetic Interactions Between Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Thai Adult Subjects|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||4||Contract agreement not reached|f||||||||||||||2017-02-18 15:12:19.884843|2017-02-18 15:12:19.884843
NCT00540488|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2007-10-12|||August 2002||2002-08-01|October 2007|2007-10-01||||||||Interventional|||Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas|Randomized, Double Blind, Three Way Crossover Comparison of Glucose and Insulin Responses During a Meal Glucose Tolerance Test in Subjects With Type 2 Diabetes Consuming Disease-Specific Versus Standard Nutritional Formula|Completed||Phase 3|54|Actual|Abbott Nutrition|||||f||||||||||||||2017-02-18 15:12:19.977828|2017-02-18 15:12:19.977828
NCT00540475|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2016-01-04|||September 2007||2007-09-01|January 2016|2016-01-01|November 2050|Anticipated|2050-11-01|December 2020|Anticipated|2020-12-01|5 Years|Observational [Patient Registry]|PA-IPF||Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry|The Pennsylvania Idiopathic Pulmonary Fibrosis State-wide Research Registry|Recruiting||N/A|9999|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:12:20.057594|2017-02-18 15:12:20.057594
NCT00540462|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2008-11-13|||August 2007||2007-08-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|August 2008|Anticipated|2008-08-01||Interventional|T2DM||Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus|Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus|Unknown status|Recruiting|Phase 4|120|Anticipated|Min-Sheng General Hospital||3|||f||||t||||||||||2017-02-18 15:12:20.171238|2017-02-18 15:12:20.171238
NCT00540449|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2016-03-01|2011-06-14||May 2008||2008-05-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|February 2010|Actual|2010-02-01||Interventional||The analysis population included intent to treat (ITT) population defined as all randomized participants who received at least one dose of the study medication.|TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.|A Phase III, Randomized, Double-blind Trial of TMC278 25 mg q.d. Versus Efavirenz 600mg q.d. in Combination With a Fixed Background Regimen Consisting of Tenofovir Disoproxil Fumarate and Emtricitabine in Antiretroviral-naive HIV-1 Infected Subjects.|Completed||Phase 3|694|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-02-18 15:12:20.505777|2017-02-18 15:12:20.505777
NCT00540436|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2012-10-11|2009-08-10||August 2007||2007-08-01|October 2012|2012-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension|Study AMB107816, Clinical Evaluation of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension (PAH)- An Open-Label Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A -<Classification: Exploratory and Confirmatory Clinical Trial>|Completed||Phase 2|25|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:12:21.723381|2017-02-18 15:12:21.723381
NCT00540423|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2011-03-29|2009-08-11||September 2007||2007-09-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)|Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) -A Multicenter Study in Subjects With Chronic ITP Receiving a Double-Blind, Placebo-Controlled, Short-Term Treatment Followed by an Open-Label, Uncontrolled, Long-Term Treatment- <Phase II/III Study>|Completed||Phase 3|23|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:12:22.105357|2017-02-18 15:12:22.105357
NCT00540410|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2010-06-22|||September 2007||2007-09-01|June 2010|2010-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks|A Randomized Study to Compare Artesunate + Amiodaquine Versus Artemether + Lumefantrine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks Occurring During 2 Years in a Cohort in Senegal|Completed||Phase 4|366|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:12:23.204185|2017-02-18 15:12:23.204185
NCT00538759|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2013-05-09|||September 2007||2007-09-01|May 2013|2013-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|RADAR||Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis|RADiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis|Terminated||Phase 2/Phase 3|21|Actual|Minneapolis Heart Institute Foundation||1||Funding shortfall|f||||t||||||||||2017-02-18 15:12:23.305805|2017-02-18 15:12:23.305805
NCT00538746|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2007-10-02|||February 2005||2005-02-01|October 2007|2007-10-01||||||||Interventional|||Effect of Increased Muscular Work During Different Weaning Strategies in Critically Ill Patients||Unknown status|Recruiting|N/A|||Università degli Studi dell'Insubria||3|||f||||||||||||||2017-02-18 15:12:23.415599|2017-02-18 15:12:23.415599
NCT00538733|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2017-02-13|||October 2007|Actual|2007-10-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|July 2010|Actual|2010-07-01||Interventional|T-BiRD||Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma|A Phase II Study of Thalidomide (THALOMID®), Clarithromycin (BIAXIN®), Lenalidomide(REVLIMID®), and Dexamethasone (DECADRON®) for Subjects With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 2|25|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 15:12:23.509779|2017-02-18 15:12:23.509779
NCT00538720|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2016-09-20|||October 2007||2007-10-01|September 2016|2016-09-01||||October 2018|Anticipated|2018-10-01||Interventional|||Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)|Pilot Study to Detect and Assess the Effect of Vitamin D Replacement on Gland Size by 4DCT in Patients With Primary Hyperparathyroidism (PHPT)|Active, not recruiting||Phase 1|22|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:12:23.632709|2017-02-18 15:12:23.632709
NCT00538707|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2010-02-09|||September 2007||2007-09-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Mental Stress on Platelet Function|Effect of Mental Stress on Platelet Function in Healthy Subjects|Completed||N/A|32|Anticipated|University of Zurich||2|||f||||f||||||||||2017-02-18 15:12:23.753313|2017-02-18 15:12:23.753313
NCT00538694|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-07-16|||October 2000||2000-10-01|October 2007|2007-10-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia|A Randomized, Double-Blind, Phase III, Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae|Completed||Phase 3|||Cubist Pharmaceuticals LLC|||||||||||||||||||2017-02-18 15:12:23.858262|2017-02-18 15:12:23.858262
NCT00538681|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2009-10-16||2009-10-16|September 2007||2007-09-01|October 2009|2009-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study for Patients With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo|Randomized, Double-Blind, Placebo Controlled, Phase 2 Study of Pemetrexed and Cisplatin Plus Enzastaurin Versus Pemetrexed and Cisplatin Plus Placebo in Chemonaive Patients With Advanced, Unresectable, or Metastatic (Stage IIIB or IV) Nonsquamous Non-Small Cell Lung Cancer|Completed||Phase 2|27|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:12:23.930215|2017-02-18 15:12:23.930215
NCT00538668|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2017-02-01|||August 2007|Actual|2007-08-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|October 2015|Actual|2015-10-01||Interventional|||Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody|Radioimmunotherapy Phase I Dose-Escalation Studies in Prostate Cancer Using 177Lu-J591 Antibody: Dose Fractionation Regimen|Active, not recruiting||Phase 1|54|Actual|Weill Medical College of Cornell University||9|||f||||t||||||||No||2017-02-18 15:12:24.234235|2017-02-18 15:12:24.234235
NCT00538655|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2013-05-30|||January 2008||2008-01-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|January 2009|Actual|2009-01-01||Interventional|||A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence|A Pilot Trial of Modafinil for Treatment of Methamphetamine Dependence|Completed||Phase 2|20|Actual|California Pacific Medical Center Research Institute||1|||f||||t||||||||||2017-02-18 15:12:24.358932|2017-02-18 15:12:24.358932
NCT00538642|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2012-11-27|2012-09-13||August 2007||2007-08-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|April 2011|Actual|2011-04-01||Interventional|||Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone|Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone|Completed||N/A|24|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-02-18 15:12:24.475332|2017-02-18 15:12:24.475332
NCT00538629|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2009-08-21|2009-04-30||October 2007||2007-10-01|July 2009|2009-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Noninterventional Study in Bipolar Disorder and Schizophrenia With Zeldox|Noninterventional Study (NIS) in Patients With Bipolar Disorder (Manic or Mixed Episodes) and Schizophrenia Undergoing Treatment With Zeldox|Completed||N/A|471|Actual|Pfizer|In this noninterventional study, patients received Zeldox in compliance with the Summary of Product Characteristics (SPC) and based solely on therapeutic need. Data were included from 2 patients <18 years; the SPC does not address this age group.||2||f||||f||||||||||2017-02-18 15:12:25.226867|2017-02-18 15:12:25.226867
NCT00538616|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2013-03-01|2012-12-12||January 2008||2008-01-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|February 2008|Actual|2008-02-01||Interventional|PrePARE||Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion|A Phase IV Single Center Cross Over Clinical Study Comparing Two Different Sedations Strategies for Mechanically Ventilated Patients With Neurological Critical Illness|Completed||Phase 1/Phase 2|8|Actual|Duke University||2|||f||||f||||||||||2017-02-18 15:12:26.737917|2017-02-18 15:12:26.737917
NCT00538603|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-12-16|||June 2005||2005-06-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)|Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)|Completed||N/A|8|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:12:27.138666|2017-02-18 15:12:27.138666
NCT00538590|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-29|2012-04-01|2012-01-19||July 2007||2007-07-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery|Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery|Completed||Phase 4|20|Actual|Pro Top & Mediking Company Limited|Stat Methods and limited sample size.|2|||f||||t||||||||||2017-02-18 15:12:27.233175|2017-02-18 15:12:27.233175
NCT00538577|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-30|2009-10-04|||September 2007||2007-09-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Observational|||Outcome and Related Factors of Necrotizing Fasciitis of the Limb||Completed||N/A|25|Anticipated|Tehran University of Medical Sciences|||1||f||||t||||||||||2017-02-18 15:12:27.727921|2017-02-18 15:12:27.727921
NCT00538811|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2010-10-26||||||October 2010|2010-10-01||||||||Interventional|||Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders|Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Patients Who Are Non-responders to Interferon Alpha Plus Ribavirin|Completed||Phase 2/Phase 3|40|Anticipated|Aga Khan University||2|||f||||t||||||||||2017-02-18 15:13:08.821061|2017-02-18 15:13:08.821061
NCT00538564|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2016-09-20|||November 2006||2006-11-01|September 2016|2016-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia|Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia|Withdrawn||Phase 2|0|Actual|Johns Hopkins University||2||Trial closed just prior to study receiving Investigational Review Board approval|f||||f||||||||||2017-02-18 15:12:27.815749|2017-02-18 15:12:27.815749
NCT00538551|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-12-11|||January 2007||2007-01-01|December 2011|2011-12-01|July 2015|Anticipated|2015-07-01|July 2012|Anticipated|2012-07-01||Observational|||Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases|Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases|Unknown status|Recruiting|N/A|350|Anticipated|King Faisal Specialist Hospital & Research Center|||1||f||||t||||||||||2017-02-18 15:12:27.926917|2017-02-18 15:12:27.926917
NCT00538538|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2016-08-04|||September 2007||2007-09-01|August 2016|2016-08-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)|Use of Subretinal Ranibizumab (Lucentis) in the Management of Submacular Hemorrhage in Neovascular Age-Related Macular Degeneration (AMD)|Withdrawn||Phase 1|0|Actual|William Beaumont Hospitals||2||This condition can now be managed in the office with an injection of Lucentis.|f||||f||||||||||2017-02-18 15:12:28.02157|2017-02-18 15:12:28.02157
NCT00535366|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2014-05-22||2014-04-30|October 2007||2007-10-01|May 2014|2014-05-01||||September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD|A Randomised, Phase II, Double-Blind, Double-Dummy, Four-period Crossover Efficacy and Safety Comparison of 4-Week Treatment Periods of Blinded Fluticasone (500 mcg Bid, MDI), Ciclesonide (400 mcg qd, MDI), Ciclesonide (800 mcg qd, MDI) or Placebo in Free Combination With Open-Label Tiotropium (18 mcg qd, HandiHaler) and Salmeterol (50 mcg Bid, Diskus) in Patients With COPD.|Completed||Phase 2|103|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 15:12:28.134581|2017-02-18 15:12:28.134581
NCT00535353|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-05-02|||August 2007||2007-08-01|February 2015|2015-02-01|February 2015|Actual|2015-02-01|September 2012|Actual|2012-09-01||Interventional|||AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer|A Phase I Study of AZD2281 in Combination With Irinotecan in Patients With Locally Advanced or Metastatic Incurable Colorectal Cancer|Completed||Phase 1|26|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 15:12:28.258585|2017-02-18 15:12:28.258585
NCT00540397|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2007-10-05||||||October 2007|2007-10-01||||||||Interventional|||TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis|Traditional Chinese Medicine Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis|Unknown status|Recruiting|N/A|||Shanghai University of Traditional Chinese Medicine|||||f||||t||||||||||2017-02-18 15:12:28.363437|2017-02-18 15:12:28.363437
NCT00540384|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2013-05-06|||July 1999||1999-07-01|May 2013|2013-05-01|June 2002|Actual|2002-06-01|March 2002|Actual|2002-03-01||Interventional|||Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy|A Randomised, Double-blind, Placebo-controlled, Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) Administered by Subcutaneous (SC) Injection for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy|Completed||Phase 1/Phase 2|405|Anticipated|Amgen||6|||f||||||||||||||2017-02-18 15:12:28.439516|2017-02-18 15:12:28.439516
NCT00540371|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-02-08|||December 1999||1999-12-01|February 2017|2017-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences|Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain|Completed||N/A|136|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:12:28.545514|2017-02-18 15:12:28.545514
NCT00540358|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2012-12-21||2011-07-21|October 2007||2007-10-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer|A Phase 2, Multi-center, Open-Label, Randomized Trial of Gemcitabine/ Carboplatin, With or Without BSI-201, in Patients With ER, PR and HER2-negative Metastatic Breast Cancer|Completed||Phase 2|123|Actual|Sanofi||2|||t||||f||||||||||2017-02-18 15:12:28.633807|2017-02-18 15:12:28.633807
NCT00540345|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-05|2014-12-24|||October 2006||2006-10-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C|Four Arms, Multicenter, Open Label Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C|Completed||Phase 4|300|Actual|Kaohsiung Medical University Chung-Ho Memorial Hospital||4|||f||||t||||||||||2017-02-18 15:12:28.769364|2017-02-18 15:12:28.769364
NCT00540332|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2009-02-27|||October 2007||2007-10-01|January 2009|2009-01-01|September 2008|Anticipated|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy|A Phase 1/2 Study to Evaluate Safety, Pharmacokinetics and Preliminary Efficacy of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer (HNC) Receiving Postoperative Radiotherapy|Withdrawn||Phase 1/Phase 2|0|Actual|Swedish Orphan Biovitrum||2||The 20070201 study was terminated based on evaluation of Palifermin solid tumor data.|f||||||||||||||2017-02-18 15:12:28.885937|2017-02-18 15:12:28.885937
NCT00540319|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2013-08-05|||June 2006||2006-06-01|August 2013|2013-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|HIP||The Health in Pregnancy (HIP) Study|Prevention for Prenatal Health: the Health in Pregnancy (HIP) Study|Completed||N/A|410|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:12:28.993466|2017-02-18 15:12:28.993466
NCT00540306|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-02-08|||February 2006||2006-02-01|February 2017|2017-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Monitoring Functional Variation in the Breast During Menstrual Cycle by Using Diffuse Optical Spectroscopy|Monitoring Functional Variation in the Breast During Menstrual Cycle by Using Diffuse Optical Spectroscopy|Completed||N/A|13|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:12:29.206294|2017-02-18 15:12:29.206294
NCT00539214|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2013-10-31|||March 2007||2007-03-01|October 2013|2013-10-01||||December 2007|Actual|2007-12-01||Observational|||Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease|Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment|Completed||N/A|1192|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 15:12:58.204358|2017-02-18 15:12:58.204358
NCT00540293|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2009-08-14|2009-05-08||October 2007||2007-10-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|AT GOAL||Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study|A Multicenter, Eight-Week Treatment, Single-Step Titration Open-Label Study Assessing The Percentage Of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target With Atorvastatin Starting Doses Of 10 MG, 20 MG, And 40 MG.|Completed||Phase 4|425|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:12:29.315752|2017-02-18 15:12:29.315752
NCT00540280|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2011-03-06|||October 2003||2003-10-01|March 2011|2011-03-01|October 2013|Anticipated|2013-10-01|October 2003|Anticipated|2003-10-01||Interventional|||Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer||Suspended||Phase 3|10|Anticipated|King Faisal Specialist Hospital & Research Center||1||Follow up only|f||||||||||||||2017-02-18 15:12:30.460379|2017-02-18 15:12:30.460379
NCT00540267|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2008-11-03|||November 2007||2007-11-01|October 2008|2008-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Bone Density in Patients With Schizophrenia|Bone Mineral Density in the Korean Patients With Chronic Schizophrenia With Alcohol Abuse|Completed||N/A|300|Anticipated|Inje University|||1||f||||f||||||||||2017-02-18 15:12:30.569534|2017-02-18 15:12:30.569534
NCT00540254|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2013-02-28|||September 2007||2007-09-01|March 2010|2010-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Behavioral Insomnia Therapy With Chronic Fatigue Syndrome|Behavioral Insomnia Therapy With Chronic Fatigue Syndrome|Completed||Phase 1/Phase 2|24|Actual|Duke University||2|||f||||t||||||||||2017-02-18 15:12:30.703627|2017-02-18 15:12:30.703627
NCT00540241|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2011-03-28|||September 2007||2007-09-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Observational|PERFORMANCE||Performance Status During Treatment With Pemetrexed in Patients With NSCLC|Performance Status and Influencing Factors During Second-Line Treatment With Pemetrexed in Patients With Stage III/IVNon Small Cell Lung Cancer|Completed||N/A|542|Actual|Eli Lilly and Company|||1||f||||f||||||||||2017-02-18 15:12:30.831163|2017-02-18 15:12:30.831163
NCT00540228|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2016-11-02|2013-03-14||October 2007||2007-10-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study to Evaluate an Influenza Vaccine Candidate|Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Influenza Vaccine GSK1247446A With Various Formulations in Subjects Aged 18-64 Years|Completed||Phase 2|1006|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:12:30.955241|2017-02-18 15:12:30.955241
NCT00540215|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2011-02-10|||October 2007||2007-10-01|October 2007|2007-10-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||GLP-2 (Glucagonlike Peptide-2) and Blood Flow|The Role of GLP-2 in Univercal Changes in Blood Flow in Humans|Completed||N/A|15|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-02-18 15:12:32.610833|2017-02-18 15:12:32.610833
NCT00540202|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2007-10-04|||September 2007||2007-09-01|October 2007|2007-10-01|April 2008|Anticipated|2008-04-01|||||Interventional|QALE||Effectiveness of Oral Quinine and Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria in Ugandan Children|Effectiveness of Oral Quinine and Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria in Ugandan Children|Unknown status|Recruiting|Phase 4|302|Anticipated|Makerere University||2|||f||||t||||||||||2017-02-18 15:12:32.709005|2017-02-18 15:12:32.709005
NCT00540189|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2016-12-16|||May 2008||2008-05-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Initial Versus Delayed Operation for Treatment of Complicated Appendicitis In Children|Initial Versus Delayed Operation for Treatment of Complicated Appendicitis In Children|Terminated||N/A|23|Actual|University of Michigan||2||Unable to adequatly recruit|f||||f||||||||||2017-02-18 15:12:33.033008|2017-02-18 15:12:33.033008
NCT00540176|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2014-10-10|||October 2007||2007-10-01|February 2010|2010-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||The Safety and Efficacy of DCA for the Treatment of Brain Cancer|A Phase II Open-labeled, Double-arm Clinical Study of Dichloroacetate (DCA) in Malignant Gliomas and Glioblastome Multiforme (GBM) Patients|Completed||Phase 2|40|Actual|University of Alberta||2|||f||||t||||||||||2017-02-18 15:12:33.130284|2017-02-18 15:12:33.130284
NCT00540163|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2013-11-27|||April 2007||2007-04-01|October 2013|2013-10-01||||November 2007|Actual|2007-11-01||Observational|||Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea|Improvement in Physical Functioning (SF-36 Activity Score) in COPD Patients With Exercise-induced Dyspnoea on Treatment With Spiriva® 18 Microgram (Capsules Containing 18 μg Tiotropium).|Completed||N/A|1296|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 15:12:33.2387|2017-02-18 15:12:33.2387
NCT00540150|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2007-10-04|||May 2004||2004-05-01|September 2007|2007-09-01|March 2005|Actual|2005-03-01|||||Interventional|||Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy|Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy in a Randomized Study Depending on Mite-Depot Supplement in Children and Adolescents With Allergic Bronchial Asthma.|Completed||Phase 3|34|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||t||||||||||2017-02-18 15:12:33.487166|2017-02-18 15:12:33.487166
NCT00540137|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2014-05-20|||July 2007||2007-07-01|May 2010|2010-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects|A Randomised Prospective Study Assessing Changes in Neurocognitive Function, Using a Computerised Test Battery, in Treatment Naïve HIV-1 Positive Subjects Commencing Two Different Antiretroviral Regimens|Completed||Phase 4|21|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 15:12:33.593291|2017-02-18 15:12:33.593291
NCT00540124|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2010-11-18|2009-06-01||October 2007||2007-10-01|November 2010|2010-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Pilot Study to Evaluate the Efficacy and Safety of Tadalafil and Tamsulosin Once-a-Day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 2|151|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 15:12:33.711991|2017-02-18 15:12:33.711991
NCT00538798|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2017-01-24|||September 28, 2007||2007-09-28|March 17, 2015|2015-03-17|March 17, 2015|Actual|2015-03-17|||||Interventional|||PET Imaging of Brain mGluR5 Receptors Using [18F]SP203|PET Imaging of Brain mGluR5 Receptors Using [18F]SP203 and [11C]SP203|Completed||Phase 1|50|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:13:08.916305|2017-02-18 15:13:08.916305
NCT00540111|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2010-02-09|||March 2005||2005-03-01|February 2010|2010-02-01|October 2007|Actual|2007-10-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.|Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals on Highly Active Antiretroviral Therapy|Completed||N/A|19|Actual|UPECLIN HC FM Botucatu Unesp||1|||f||||t||||||||||2017-02-18 15:12:38.133712|2017-02-18 15:12:38.133712
NCT00540098|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2007-10-04|||September 2001||2001-09-01|October 2007|2007-10-01|June 2005|Actual|2005-06-01|||||Interventional|Exparox||Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder|A Randomized, Controlled Trial on the Effects of Paroxetine Versus Placebo in Combination With Aerobic Exercise or Relaxation Training in the Treatment of Panic Disorder|Completed||Phase 4|75|Actual|University of Göttingen||4|||f||||f||||||||||2017-02-18 15:12:38.243558|2017-02-18 15:12:38.243558
NCT00540085|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2009-10-15|||October 2007||2007-10-01|October 2009|2009-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Pharmacodynamic Trial on Rocuronium in Obese Patients|Pharmacodynamic Trial on Rocuronium in Obese Patients|Completed||Phase 4|51|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-02-18 15:12:38.36443|2017-02-18 15:12:38.36443
NCT00540072|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2015-07-16|||July 2001||2001-07-01|October 2007|2007-10-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae||Completed||Phase 3|||Cubist Pharmaceuticals LLC|||||f||||||||||||||2017-02-18 15:12:38.467719|2017-02-18 15:12:38.467719
NCT00540059|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2007-10-04|||June 2005||2005-06-01|August 2007|2007-08-01||||||||Observational|||Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial|Quality Assurance Project in Patients With Advanced Prostate Carcinoma - Evaluation of Tolerability, Quality of Life and Usage of Zoladex 10,8 SafeSystem|Completed||N/A|1950|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:12:38.543504|2017-02-18 15:12:38.543504
NCT00540046|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2015-01-23|2015-01-01||April 2007||2007-04-01|January 2015|2015-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||215 subjects were enrolled and randomized to the A/Immediate or B/Delayed group.|Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation|Immediate vs. Delayed Post-abortal Copper T 380A IUD Insertion in Cases Over 12 Weeks of Gestation|Completed||N/A|215|Actual|New York University School of Medicine|"IUD presence not always confirmed by a provider at 6-month visit but self-reported.~Study not powered to detect a difference in expulsion rates due to prohibitively high sample size.~Very high-risk population."|2|||f||||f||||||||||2017-02-18 15:12:38.618516|2017-02-18 15:12:38.618516
NCT00540033|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2007-10-04|||February 2005||2005-02-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Probiotics Reduce Incidence of Necrotizing Enterocolitis for Very Low Birth Weight Infants|Phase 2 Study of Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis for Very Low Birth Weight Infants -Multi-Center Randomized Control Trial|Terminated||Phase 2|217|Actual|China Medical University Hospital||1||terminated because of enough case number|f||||t||||||||||2017-02-18 15:12:39.05965|2017-02-18 15:12:39.05965
NCT00540020|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2007-10-04|||July 1996||1996-07-01|October 2007|2007-10-01|May 2003|Actual|2003-05-01|||||Interventional|||Rehabilitation of Traumatic Brain Injury in Active Duty Military Personnel and Veterans|Rehabilitation of Traumatic Brain Injury in Active Duty Military Personnel and Veterans: DVBIC Randomized Clinical Trial of Two Rehabilitation Approaches|Completed||N/A|360|Actual|Walter Reed Army Medical Center||2|||f||||||||||||||2017-02-18 15:12:39.163629|2017-02-18 15:12:39.163629
NCT00540007|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-01-26|||September 6, 2007|Actual|2007-09-06|January 2017|2017-01-01|September 1, 2016|Actual|2016-09-01|September 1, 2016|Actual|2016-09-01||Interventional|||Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma|A Phase II Multicenter Study of Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma|Completed||Phase 2|80|Actual|Washington University School of Medicine||2|||f||||t|t|f||||||No||2017-02-18 15:12:39.261556|2017-02-18 15:12:39.261556
NCT00539994|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2016-11-02|2009-01-09||September 2007||2007-09-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus|Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Efficacy of Retapamulin Ointment, 1% Applied Twice Daily for 3 or 5 Days to the Anterior Nares of Healthy Adult Subjects Nasally Colonized With Staphylococcus Aureus|Completed||Phase 2|57|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:12:39.399633|2017-02-18 15:12:39.399633
NCT00539981|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2011-05-16||2011-04-28|September 2007||2007-09-01|May 2011|2011-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok|Evaluation of the Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok® Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine In Healthy Adults Aged 18 to 49|Completed||Phase 3|4648|Actual|Protein Sciences Corporation||2|||f||||f||||||||||2017-02-18 15:12:40.659969|2017-02-18 15:12:40.659969
NCT00539968|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2015-02-04|||June 2007||2007-06-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)|An Open-Label, Two-Part Study to Determine the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel|Terminated||Phase 1/Phase 2|5|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 15:12:40.808229|2017-02-18 15:12:40.808229
NCT00539955|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2012-12-17|||July 2003||2003-07-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Brief Intervention to Reduce Drinking Among Batterers|Brief Intervention to Reduce Drinking Among Batterers|Unknown status|Active, not recruiting|Phase 2|253|Anticipated|The University of Tennessee, Knoxville||2|||f||||t||||||||||2017-02-18 15:12:40.90488|2017-02-18 15:12:40.90488
NCT00536913|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2012-04-05|2009-02-16||September 2007||2007-09-01|April 2012|2012-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|Spacer||Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma|A 4-week, Open-label, Randomized, Multi-centre, Parallel-group Study Evaluating the Safety and Efficacy of 4 Actuations Symbicort® (Budesonide/Formoterol) HFA pMDI 40/2.25 μg Twice Daily, With and Without Spacer, in Children (6-11 Years) With Asthma|Completed||Phase 3|107|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:12:43.544794|2017-02-18 15:12:43.544794
NCT00539942|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2012-02-07|2012-02-07||April 2007||2007-04-01|February 2012|2012-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Arixtra to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy|Extended Deep Venous Thrombosis Prophylaxis in Gynecologic Oncology Surgery With Intermittent Compression Devices (ICD) With or Without Postoperative Arixtra: A Randomized Controlled Trial|Terminated||Phase 3|7|Actual|University of Alabama at Birmingham|This trial was terminated early due to poor enrollment and recruitment and the very small number of subjects analyzed. As such, the data is uninterpretable.|2||Problems with accrual|f||||t||||||||||2017-02-18 15:12:41.01678|2017-02-18 15:12:41.01678
NCT00539929|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2017-02-03||2013-05-21|September 2007||2007-09-01|January 2017|2017-01-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis|Proof of Principle, Randomized, Parallel-Group, Double-Blind, Vehicle-Controlled, Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis|Completed||Phase 2|100|Actual|Eisai Inc.||4|||f||||f||||||||||2017-02-18 15:12:41.414408|2017-02-18 15:12:41.414408
NCT00539916|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2008-08-15|||October 2007||2007-10-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|AGRUVASC||Effects of Regular and Consequent Citrus Fruits Consumption on Vascular Protection|Effects of Regular and Consequent Citrus Fruit Consumption on Vascular Protection Specific Role of the Component Phytomicronutrients|Completed||N/A|30|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 15:12:41.520324|2017-02-18 15:12:41.520324
NCT00539903|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2009-02-05|||August 2008||2008-08-01|February 2009|2009-02-01||||||||Interventional|FAM||Physical Activity and Immigrant Health||Completed||N/A|||Norwegian School of Sport Sciences|||||f||||||||||||||2017-02-18 15:12:41.623709|2017-02-18 15:12:41.623709
NCT00539890|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2009-10-12|||November 2005||2005-11-01|October 2009|2009-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus|A Phase 3 Randomized, Open Label, Multi-Center Comparative Study of Technosphere /Insulin Versus Rapid Acting Insulin in Subjects With Type-2 Diabetes Mellitus Receiving Lantus as Basal Insulin|Completed||Phase 3|0||Mannkind Corporation|||||f||||||||||||||2017-02-18 15:12:41.713596|2017-02-18 15:12:41.713596
NCT00539877|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2010-06-22|||October 2004||2004-10-01|June 2010|2010-06-01|August 2007|Actual|2007-08-01|December 2006|Actual|2006-12-01||Interventional|||Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding|Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding|Completed||Phase 1|17|Actual|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 15:12:41.840699|2017-02-18 15:12:41.840699
NCT00539864|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2011-07-25|2011-05-16||September 2007||2007-09-01|July 2011|2011-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV|Evaluation of Safety and Reactogenicity of FluBlok, Trivalent Recombinant Influenza Vaccine, and Comparison of the Immunogenicity, Efficacy and Effectiveness of FluBlok to a Licensed Egg-Grown Influenza Vaccine in Adults Aged 50 to 64|Completed||Phase 3|602|Actual|Protein Sciences Corporation||2|||f||||f||||||||||2017-02-18 15:12:41.935731|2017-02-18 15:12:41.935731
NCT00539851|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2010-03-18|||November 2005||2005-11-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Observational|||Risk Factors for Diabetes After Stem Cell Transplantation|Risk Factors for Developing Diabetes Mellitus After Allogenic Stem Cell Transplantation|Completed||N/A|87|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 15:12:42.426826|2017-02-18 15:12:42.426826
NCT00539838|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2013-01-17||2013-01-17|December 2007||2007-12-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|BEGIN||A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)|A Randomised, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus|Terminated||Phase 3|33|Actual|Genentech, Inc.||2||"The study was terminated prematurely when the decision was made that ocrelizumab was not~   likely to benefit this patient population."|f||||||||||||||2017-02-18 15:12:42.506257|2017-02-18 15:12:42.506257
NCT00539825|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2016-10-28|||September 2007||2007-09-01|October 2016|2016-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effect of GSK704838 In Healthy Volunteers|A Randomized Double-blind, Placebo-controlled, Crossover, Dose Escalation Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of GSK704838 and Tiotropium Bromide|Completed||Phase 1|20|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:12:42.609364|2017-02-18 15:12:42.609364
NCT00539812|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-12-17|||May 2007||2007-05-01|December 2012|2012-12-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Brief Intervention to Reduce Drinking and Intimate Partner Violence in Women|Brief Intervention to Reduce Drinking and Intimate Partner Violence in Women|Unknown status|Recruiting|Phase 2|225|Anticipated|The University of Tennessee, Knoxville||2|||f||||t||||||||||2017-02-18 15:12:42.709015|2017-02-18 15:12:42.709015
NCT00539799|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2008-05-28||||||May 2008|2008-05-01||||||||Interventional|SIMPL||Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis|Corticosteroids in the Maintenance Therapy of Proliferative Lupus Nephritis: a Randomized Pilot Study|Withdrawn||Phase 3|15|Anticipated|Cambridge University Hospitals NHS Foundation Trust||2||Local pharmacy unwilling to comply with study protocol|f||||t||||||||||2017-02-18 15:12:43.07657|2017-02-18 15:12:43.07657
NCT00539786|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2014-05-14|||March 2006||2006-03-01|May 2014|2014-05-01||||April 2011|Actual|2011-04-01||Interventional|||The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD|Clinical Usefulness of Proton Pump Inhibitor Test for Identifying Gastroesophageal Reflux Disease in Patients With Extraesophageal Symptoms|Unknown status|Recruiting|N/A|100|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-02-18 15:12:43.176683|2017-02-18 15:12:43.176683
NCT00536926|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2011-07-19|||July 2007||2007-07-01|October 2008|2008-10-01|July 2009|Actual|2009-07-01|November 2008|Actual|2008-11-01||Interventional|TeleTx||Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation|Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation - an Open, Randomised Trial|Completed||Phase 3|56|Actual|Hannover Medical School||2|||f||||f||||||||||2017-02-18 15:12:43.266675|2017-02-18 15:12:43.266675
NCT00536887|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2012-04-06|||July 2005||2005-07-01|April 2012|2012-04-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction|Phase 4 Study of Atorvastatin 10mg vs. 40mg in Follow-up CFR in AMI Patients|Completed||Phase 4|100|Anticipated|Korea University Anam Hospital||1|||f||||t||||||||||2017-02-18 15:12:44.120578|2017-02-18 15:12:44.120578
NCT00536874|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-11-16|2013-11-27||October 2007||2007-10-01|November 2016|2016-11-01|September 2017|Anticipated|2017-09-01|September 2012|Actual|2012-09-01||Interventional|||Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery|A Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Potentially Resectable Previously Untreated Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|39|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:12:44.22357|2017-02-18 15:12:44.22357
NCT00536861|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2008-05-27|||May 2006||2006-05-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer|A Phase I Study of Radiotherapy Concurrent With Erlotinib (Tarceva®) in the Treatment of Brain Metastases From Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|11|Actual|VU University Medical Center||1|||f||||f||||||||||2017-02-18 15:12:44.581918|2017-02-18 15:12:44.581918
NCT00536848|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2009-01-29|||October 2007||2007-10-01|January 2009|2009-01-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients|The Effect of Probiotic Supplementation With Lactobacillus GR-1 and RC-14,on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients; a Randomised, Placebo Controlled Trial|Unknown status|Active, not recruiting|Phase 2/Phase 3|65|Actual|National Institute for Medical Research, Tanzania||2|||f||||f||||||||||2017-02-18 15:12:44.683961|2017-02-18 15:12:44.683961
NCT00539773|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2015-12-16|||September 2007||2007-09-01|December 2015|2015-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder|Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder|Completed||N/A|10|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:12:44.797918|2017-02-18 15:12:44.797918
NCT00539760|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2012-01-23|||September 2007||2007-09-01|January 2012|2012-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Phase I Rheumatoid Arthritis Study in Healthy Volunteers|A Phase I, Randomized, Observer- and Subject-Blind, Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1827771 in Healthy Volunteers|Completed||Phase 1|45|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:12:44.886735|2017-02-18 15:12:44.886735
NCT00539747|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-04|2017-01-24|||October 1, 2007||2007-10-01|August 5, 2008|2008-08-05|August 5, 2008||2008-08-05|||||Observational|||Making Sense of a Positive Genetic Test Result for Huntington Disease|Meaning Making Among Asymptomatic Individuals With a Positive Presymptomatic Genetic Test Result for Huntington Disease|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:12:44.979457|2017-02-18 15:12:44.979457
NCT00539734|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2011-04-11|2011-02-08||August 2007||2007-08-01|April 2011|2011-04-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration|Electrophysiologic Changes After Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration|Completed||N/A|25|Actual|Prince of Songkla University|Small number of participants|1|||f||||t||||||||||2017-02-18 15:12:45.070264|2017-02-18 15:12:45.070264
NCT00539721|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2013-10-08||2009-04-14|October 2007||2007-10-01|October 2013|2013-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED)|A Randomized, Double-Blind, Double-Dummy, Dose-Ranging, Active- and Placebo-Controlled Study of Single-Dose Oral Rolapitant Monotherapy for the Prevention of Postoperative Nausea and Vomiting (PONV)|Completed||Phase 2|619|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 15:12:45.335761|2017-02-18 15:12:45.335761
NCT00539708|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2008-05-06|||May 2005||2005-05-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Non-Invasive Ventilation After Extubation in Hypercapnic Patients|Non-Invasive Ventilation After Extubation in Hypercapnic Patients|Completed||N/A|106|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 15:12:45.44803|2017-02-18 15:12:45.44803
NCT00539695|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2016-01-11|2014-04-22||June 2007||2007-06-01|January 2016|2016-01-01|March 2014|Actual|2014-03-01|April 2013|Actual|2013-04-01||Interventional|IL2 for GVHD||Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD|Phase II Trial Using Low Dose IL-2 to Induce Regulatory T Cells in Patients After Allogeneic Hematopoietic Stem Cell Transplantation as Graft Versus Host Disease Prophylaxis|Completed||Phase 2|25|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 15:12:45.559264|2017-02-18 15:12:45.559264
NCT00539669|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2007-10-03|||March 2003||2003-03-01|October 2007|2007-10-01||||||||Interventional|||TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian||Completed||Phase 2|47|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:12:45.861698|2017-02-18 15:12:45.861698
NCT00539656|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2013-10-24|||October 2007||2007-10-01|October 2013|2013-10-01||||December 2010|Actual|2010-12-01||Interventional|Cord Blood||Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers|Transplantation of Expanded and Unexpanded Umbilical Cord Blood Units Following Myeloablative Chemotherapy for Hematologic Malignancies|Terminated||Phase 1/Phase 2|3|Actual|Sidney Kimmel Comprehensive Cancer Center||1||The manufacturer discontinued necessary reagents.|f||||f||||||||||2017-02-18 15:12:45.945129|2017-02-18 15:12:45.945129
NCT00539643|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2016-03-01|||November 2007||2007-11-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma|A Randomized Single Blind Controlled Trial of Beads vs. Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma (HCC)|Active, not recruiting||Phase 2|101|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 15:12:46.052795|2017-02-18 15:12:46.052795
NCT00539630|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2007-10-03|||November 2002||2002-11-01|October 2007|2007-10-01||||||||Interventional|||TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN||Completed||Phase 3|86|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:12:46.25868|2017-02-18 15:12:46.25868
NCT00539617|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2012-09-12|2012-09-12||October 2007||2007-10-01|September 2012|2012-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery|A Single-Arm, Phase II Study of Tarceva Plus FOLFOX6 in Patients With Unresectable or Metastatic Cancer of Esophagus or Gastroesophageal Junction|Terminated||Phase 2|7|Actual|University of California, San Francisco|Early termination leading to small numbers of subjects analyzed.|1||For slow accrual|f||||t||||||||||2017-02-18 15:12:46.342026|2017-02-18 15:12:46.342026
NCT00539604|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2007-10-03|||July 2004||2004-07-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||Non Invasive Multicenter Italian Study for Coronary Artery Disease|Phase IV Multicenter, Intra-Individually Controlled, Comparison Study to Evaluate the Negative Predictive Value of 16-64 Slice MDCT Imaging in Patients Scheduled for Coronary Angiography|Completed||Phase 4|350||Società Italiana di Radiologia Medica|||||f||||||||||||||2017-02-18 15:12:46.629404|2017-02-18 15:12:46.629404
NCT00539591|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2016-11-17|2013-09-10||October 2007||2007-10-01|August 2016|2016-08-01|September 2018|Anticipated|2018-09-01|June 2015|Actual|2015-06-01||Interventional|||Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma|Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma|Active, not recruiting||Phase 2|29|Actual|St. Jude Children's Research Hospital|The study closed early due to poor accrual to stratum B1.|2|||f||||f||||||||||2017-02-18 15:12:46.929325|2017-02-18 15:12:46.929325
NCT00539578|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-10-30|||September 2002||2002-09-01|October 2015|2015-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Treatment of Patients With Anxiety Disorder (0777-022)|A Double-Blind, Mulitcenter, Placebo-Controlled, Flexible-Dose Replicate Study of MK0777 Gel Extrusion Module (GEM) 3 mg B.I.D. to 8 mg B.I.D. in the Treatment of Outpatients With Generalized Anxiety Disorder|Completed||Phase 2|270|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:12:48.373942|2017-02-18 15:12:48.373942
NCT00539565|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2007-10-03|||January 2000||2000-01-01|September 2007|2007-09-01|September 2008|Anticipated|2008-09-01|||||Interventional|||RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.|Phase IIIb Study of Corticosteroids as Post-Operative Adjuvant Therapy in Biliary Atresia|Unknown status|Enrolling by invitation|Phase 3|100|Anticipated|King's College Hospital NHS Trust||2|||f||||f||||||||||2017-02-18 15:12:48.445292|2017-02-18 15:12:48.445292
NCT00539539|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2012-05-21|2010-12-30||February 2007||2007-02-01|May 2012|2012-05-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Automated Real-time Feedback on CPR Study|Controlled Study of the Clinical Effectiveness of Automated Real-Time Feedback on CPR Process Conducted at a Subset of ROC Sites|Completed||Phase 2|1586|Actual|University of Washington|Open label study - providers not blinded to intervention. High rates of missing CPR process measures.|2|||f||||t||||||||||2017-02-18 15:12:48.555805|2017-02-18 15:12:48.555805
NCT00539526|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2011-09-22|2011-09-22||September 2007||2007-09-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues||Completed||Phase 4|106|Actual|Allergan||3|||f||||f||||||||||2017-02-18 15:12:49.100816|2017-02-18 15:12:49.100816
NCT00539513|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2013-03-25|2012-12-21||June 2006||2006-06-01|March 2013|2013-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder|A Double-Blind Study of N-Acetylcysteine Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder and Depression|Terminated||Phase 2|10|Actual|Yale University||2||Researchers terminated study due to limited enrollment.|f||||f||||||||||2017-02-18 15:12:49.501441|2017-02-18 15:12:49.501441
NCT00539500|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2012-09-07|||October 2007||2007-10-01|September 2012|2012-09-01||||September 2012|Actual|2012-09-01||Interventional|||Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma|Autologous Stem Cell Rescue With CD133+ Selected Hematopoietic Progenitor Cells in Patients With High-Risk Neuroblastoma|Terminated||Phase 2/Phase 3|3|Actual|M.D. Anderson Cancer Center||1||Slow Accrual.|f||||f||||||||||2017-02-18 15:12:49.898809|2017-02-18 15:12:49.898809
NCT00539487|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2013-11-07|||January 2007||2007-01-01|November 2013|2013-11-01||||November 2007|Actual|2007-11-01||Observational|||Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives|TOP -Study Telmisartan - Therapy of Hypertension and Life-style Changes in Cardiovascular Risk Patients|Completed||N/A|5827|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 15:12:50.159308|2017-02-18 15:12:50.159308
NCT00539474|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2011-12-22|||January 2008||2008-01-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|June 2010|Actual|2010-06-01||Interventional|ROLL||"The Efficacy of 'Radioguided Occult Lesion Localization' (ROLL) Versus 'Wire-guided Localization' (WGL) in Breast Conserving Surgery for Non-palpable Breast Cancer: a Randomized Clinical Trial"|"The Efficacy of 'Radioguided Occult Lesion Localization' (ROLL) Versus 'Wire-guided Localization' (WGL) in Breast Conserving Surgery for Non-palpable Breast Cancer: a Randomized Clinical Trial"|Completed||Phase 3|316|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 15:12:53.965115|2017-02-18 15:12:53.965115
NCT00539461|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2013-10-31|||February 2007||2007-02-01|October 2013|2013-10-01||||November 2007|Actual|2007-11-01||Observational|||Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life|Sifrol® (Pramipexole) Impact on RLS Related Quality of Life: A 12-weeks Observational Study in Patients With Primary RLS|Completed||N/A|2023|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 15:12:54.070121|2017-02-18 15:12:54.070121
NCT00539448|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2009-09-24|||April 2007||2007-04-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|GLANS||Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study|Phase IV, Open Label, Non-comparative, Multi-center, Study of the Effects of Both Insulin Glargine & Insulin Glulisine in Type I Diabetes Mellitus Patients.|Completed||Phase 4|98|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:12:54.760886|2017-02-18 15:12:54.760886
NCT00539435|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2016-08-08|||September 2007||2007-09-01|August 2016|2016-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With Diabetes|Effects of Pulsatile Intravenous Insulin Therapy on Cardiac Disease in Patients With Diabetes|Withdrawn||Phase 3|0|Actual|Florida Atlantic University||1||Administrative|f||||t||||||||||2017-02-18 15:12:54.871784|2017-02-18 15:12:54.871784
NCT00539422|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2007-10-03|||January 2006||2006-01-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Observational|||Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases|Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism, Oxidative Stress and Ferretin in Benign and Malignant Breast Diseases|Completed||N/A|||Mansoura University|||3||f||||f||||||||||2017-02-18 15:12:54.993453|2017-02-18 15:12:54.993453
NCT00539409|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2016-08-08|||November 2006||2006-11-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus|Effects on Diabetic Metabolic Integrity With Treatment of Pulsatile Intravenous Insulin Therapy as Evidenced by Monitoring of Diabetic Complications.|Terminated||Phase 2/Phase 3|152|Actual|Florida Atlantic University||2||Administrative|f||||t||||||||||2017-02-18 15:12:55.100197|2017-02-18 15:12:55.100197
NCT00539396|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2009-10-12|||March 2005||2005-03-01|October 2009|2009-10-01|December 2005|Actual|2005-12-01|||||Interventional|||A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine|A Phase 2 Randomized, Open Label, Multi-Center Study of the Use of Prandial Inhaled Technosphere Insulin in Combination With Basal Subcutaneous Lantus as Basal Insulin Versus Prandial Subcutaneous NovoRapid in Combination With Basal Subcutaneous Lantus Insulin in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 2|110|Anticipated|Mannkind Corporation|||||f||||f||||||||||2017-02-18 15:12:55.21609|2017-02-18 15:12:55.21609
NCT00539383|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2014-07-30|||October 2007||2007-10-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer|A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer|Completed||Phase 1|56|Actual|Angiochem Inc||1|||f||||f||||||||||2017-02-18 15:12:55.298441|2017-02-18 15:12:55.298441
NCT00539370|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2012-06-13|||August 2007||2007-08-01|June 2012|2012-06-01||||||||Observational|||Human Samples and Data Repository|Laboratory of Immunology/National Eye Institute Repository|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:12:55.409435|2017-02-18 15:12:55.409435
NCT00539357|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2016-08-04|||August 2005||2005-08-01|August 2016|2016-08-01|March 2006|Actual|2006-03-01|||||Interventional|||A Pilot Study of Cranial Electrotherapy Stimulation[CES] for Generalized Anxiety Disorder||Completed||Phase 4|12|Actual|University of California, Los Angeles||1|||f||||t||||||||||2017-02-18 15:12:55.491089|2017-02-18 15:12:55.491089
NCT00539344|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2014-07-30|||October 2007||2007-10-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma|A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma|Completed||Phase 1|63|Actual|Angiochem Inc||1|||f||||f||||||||||2017-02-18 15:12:55.577122|2017-02-18 15:12:55.577122
NCT00539331|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2011-05-30|||September 2007||2007-09-01|May 2011|2011-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients|A Two-Part Study in Japanese Patients With Advanced or Metastatic NSCLC. Open-Label Phase I to Assess the Safety & Tolerability of AZD2171 in Combination With Pac/Carb, Then a Phase II, Randomised, Double-Blind Study to Assess the Efficacy of Pac/Carb Alone and in Combination With AZD2171 and Pac/Carb|Terminated||Phase 1|6|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:12:55.691736|2017-02-18 15:12:55.691736
NCT00539318|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2009-08-13|||August 2007||2007-08-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|||||Observational|||Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers|Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers|Terminated||N/A|60|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||1|Low Recruitment|f||||t||||||||||2017-02-18 15:12:55.807818|2017-02-18 15:12:55.807818
NCT00539305|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2014-07-10|2013-03-15||July 2009||2009-07-01|July 2014|2014-07-01|May 2012|Actual|2012-05-01|July 2011|Actual|2011-07-01||Interventional|HIP||Hormone and Information Processing Study|Testosterone Supplementation in Men With MCI|Completed||Phase 3|22|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:12:55.898324|2017-02-18 15:12:55.898324
NCT00539292|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2007-10-02|||September 2005||2005-09-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis|A Multi-Centre, Prospective Randomized Trial to Evaluate Routine Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis|Completed||Phase 2|88|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 15:12:56.356876|2017-02-18 15:12:56.356876
NCT00539279|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2015-08-11|2015-04-29||March 2009||2009-03-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder|Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder|Completed||N/A|87|Actual|VA Office of Research and Development|Early termination leading to smaller numbers of subjects analyzed at post-treatment and follow-up; Results generalize only to older male combat veterans who were treatment-seeking for PTSD|2|||f||||f||||||||||2017-02-18 15:12:56.466731|2017-02-18 15:12:56.466731
NCT00539266|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2011-07-05|||October 2007||2007-10-01|October 2007|2007-10-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|ABC||Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia|Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia A Double Blind, Placebo Controlled, Study in Diabetic and Non-diabetic Patients|Unknown status|Recruiting|Phase 2/Phase 3|108|Anticipated|Leiden University Medical Center||4|||f||||f||||||||||2017-02-18 15:12:57.365697|2017-02-18 15:12:57.365697
NCT00539253|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2014-05-27|||September 2007||2007-09-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|||Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI|Assessment of Liver Cancer Response to Transcatheter Arterial Chemoembolization Using Functional Triple-Phase MultiHance-Enhanced MRI|Completed||N/A|45|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 15:12:57.471886|2017-02-18 15:12:57.471886
NCT00539240|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2014-07-29|2014-02-07||April 2006||2006-04-01|July 2014|2014-07-01|November 2011|Actual|2011-11-01|April 2010|Actual|2010-04-01||Interventional||Number of randomized subjects|Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI|Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI|Completed||Phase 2/Phase 3|236|Actual|VA Office of Research and Development|"Recruitment challenges, including difficulty finding patients who fail PPI but had not already been prescribed doubled dose. Necessitated a no-cost extension to complete recruitment"|3|||f||||t||||||||||2017-02-18 15:12:57.572236|2017-02-18 15:12:57.572236
NCT00539227|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2013-08-23|||October 2007||2007-10-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy|A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy|Completed||N/A|37|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:12:58.09304|2017-02-18 15:12:58.09304
NCT00539201|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2010-10-13||2010-10-13|September 2007||2007-09-01|October 2010|2010-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||GSK706769 A First Time in Human Study For Males and Females|A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single and Repeat Dose Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GSK706769 in Healthy Male and Female Subjects|Terminated||Phase 1|34|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:13:01.372757|2017-02-18 15:13:01.372757
NCT00539188|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2013-03-25|2012-12-21||September 2007||2007-09-01|March 2013|2013-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD|A Double-Blind, Placebo-controlled Pilot Study of NAC Addition to Dialectical Behavioral Therapy for the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder|Terminated||Phase 2|6|Actual|Yale University||2||Study terminated due to poor subject compliance.|f||||f||||||||||2017-02-18 15:13:01.478067|2017-02-18 15:13:01.478067
NCT00539175|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2007-10-03|||October 2004||2004-10-01|October 2007|2007-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Treatment of Painful Diabetic Neuropathy With Photon Stimulation|Treatment of Painful Diabetic Neuropathy With Photon Stimulation|Completed||N/A|120|Actual|East Bay Institute for Research and Education||2|||f||||f||||||||||2017-02-18 15:13:01.922568|2017-02-18 15:13:01.922568
NCT00539162|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2017-01-19|||July 2, 2001|Actual|2001-07-02|January 2017|2017-01-01||||July 1, 2018|Anticipated|2018-07-01||Observational|||Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women|Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women|Recruiting||N/A|8000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Yearly blood draw of 2 to 3 tablespoons, with CA-125 analysis performed each time. Urine~     specimen obtained at each UT MDACC visit.~   "|||2017-02-18 15:13:02.041789|2017-02-18 15:13:02.041789
NCT00539149|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2010-05-21|||April 1996||1996-04-01|October 2007|2007-10-01|March 2001|Actual|2001-03-01|||||Interventional|COMIT1||Long-term Antibiotics for Treatment and Prevention of Otitis Media in Aborignal Children|Amoxycillin Versus Placebo for Resolution of Otitis Media With Effusion and Prevention of Acute Otitis Media With Perforation in Aboriginal Infants: a Randomised Controlled Trial.|Completed||Phase 4|126|Actual|Menzies School of Health Research||2|||f||||t||||||||||2017-02-18 15:13:02.17448|2017-02-18 15:13:02.17448
NCT00539136|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-03|2010-10-14||2010-10-14|October 2007||2007-10-01|October 2010|2010-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers|An Open-label, Single-dose, Non-randomized, Balanced Design Three-way Cross-over Study to Examine the Variability in Absorption of GSK561679 Using Gamma Scintigraphy, PillCam™ SB Capsule and the Acoustic Vest in Healthy Males Volunteers|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:13:02.287555|2017-02-18 15:13:02.287555
NCT00539123|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2009-06-03|||September 2007||2007-09-01|June 2009|2009-06-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia|Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia|Unknown status|Recruiting|Phase 2|240|Anticipated|Yale University||4|||f||||t||||||||||2017-02-18 15:13:02.369777|2017-02-18 15:13:02.369777
NCT00539110|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2016-06-26|2014-05-25||December 2009||2009-12-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|December 2012|Actual|2012-12-01||Interventional|Sleep3|"There were ten patients total, crossover design, so each of the 10 patients received both zolpidem and ramelteon.~Mean age 7.8 years"|Differential Effects of Zolpidem Versus Ramelteon in Burned Children|Differential Effects of Zolpidem Versus Ramelteon on Nocturnal Sleep in Pediatric Burn Patients: A Prospective, Randomized Crossover Trial With Polysomnographic Recordings|Completed||Phase 2|10|Actual|Shriners Hospitals for Children||2|||f||||t||||||||No||2017-02-18 15:13:02.497513|2017-02-18 15:13:02.497513
NCT00539097|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2012-06-18|||June 2005||2005-06-01|June 2012|2012-06-01||||October 2007|Actual|2007-10-01||Interventional|||Evaluation Perioperative Nutrition on Donor Site Healing in Patients Undergoing Reconstructive Burn Surg||Terminated||Phase 2/Phase 3|38|Actual|Shriners Hospitals for Children||2||change in donor site care protocol; donor site healing is a study endpoint|f||||||||||||||2017-02-18 15:13:02.786285|2017-02-18 15:13:02.786285
NCT00539084|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2013-05-08|||October 2007||2007-10-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia|A Controlled Comparative Pilot Study to Assess the Safety and Efficacy of the MicronJet Microneedle Device Following Intradermal Injection of Lidocaine for Local Anesthesia|Completed||N/A|40|Actual|NanoPass Technologies Ltd||2|||f||||f||||||||||2017-02-18 15:13:02.873431|2017-02-18 15:13:02.873431
NCT00539071|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2010-11-01|||April 2008||2008-04-01|November 2010|2010-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone|High Dose Risperidone Consta for Patients With Schizophrenia With Unsatisfactory Response to Standard Dose Risperidone or Long-Acting Injectable|Unknown status|Recruiting|Phase 4|160|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 15:13:02.967531|2017-02-18 15:13:02.967531
NCT00539045|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2010-09-24|||March 2007||2007-03-01|September 2010|2010-09-01|March 2012|Anticipated|2012-03-01|||||Observational|||Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction|Diagnostic Utility of Contrast Echocardiography for Detection of Left Ventricular Thrombi Post ST Elevation Myocardial Infarction|Unknown status|Recruiting|N/A|250|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 15:13:03.082718|2017-02-18 15:13:03.082718
NCT00539032|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2016-04-12|2009-09-09||September 2007||2007-09-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Immunology and Safety of Menactra® in Children in Saudi Arabia|Evaluation of the Response to a Single Dose of Menactra® in Children Aged 5 to 8 Years Who Had Previously Received Two Doses of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide Vaccine Before Age 2 Years in Saudi Arabia|Completed||Phase 3|238|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:13:03.174826|2017-02-18 15:13:03.174826
NCT00539019|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2012-06-18|||October 2006||2006-10-01|June 2012|2012-06-01||||||||Observational|||Quantification and Derivation of Metabolic Needs in Children During Burn Rehabilitation||Withdrawn||N/A|0|Actual|Shriners Hospitals for Children|||1|"indirect calorimetry no longer employed at the institution; calorimeter is not~   accurate/reliable"|f||||||||||||||2017-02-18 15:13:03.63208|2017-02-18 15:13:03.63208
NCT00539006|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2016-10-27|2008-11-14||August 2007||2007-08-01|October 2016|2016-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS|A Randomized, Double-blind, Placebo-controlled, Active Comparator, One-Week, Cross-Over, Multicenter Study to Evaluate the Efficacy and Patient Preference of Nasal Spray Characteristics of Once-Daily, Intranasal Administration of 110mcg Fluticasone Furoate Nasal Spray and 200mcg Fluticasone Propionate Nasal Spray in Adult Subjects With Seasonal Allergic Rhinitis|Completed||Phase 4|377|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:13:03.947677|2017-02-18 15:13:03.947677
NCT00538993|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2007-10-01|||September 2003||2003-09-01|September 2007|2007-09-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Improving Provider Counseling Interventions in HIV Practice||Unknown status|Active, not recruiting|N/A|425|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 15:13:04.898247|2017-02-18 15:13:04.898247
NCT00538980|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2009-10-20|||April 2007||2007-04-01|October 2009|2009-10-01||||October 2009|Actual|2009-10-01||Interventional|||Dasatinib in Polycythemia Vera|The Use of Dasatinib (SPRYCEL) in Treating Patients With Polycythemia Vera (PV): A Phase II, Non-Randomized Study|Completed||Phase 2|24|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 15:13:04.998584|2017-02-18 15:13:04.998584
NCT00538967|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2007-10-02|||May 2002||2002-05-01|October 2007|2007-10-01|August 2005|Actual|2005-08-01|||||Interventional|||The Effect of Doxycycline on Matrix Metalloproteinase Expression and Activity in the Abdominal Aneurysm|The Effect of Doxycycline on Matrix Metalloproteinase Expression and Activity in the Abdominal Aneurysm|Completed||Phase 2|60|Actual|Leiden University Medical Center||4|||f||||f||||||||||2017-02-18 15:13:05.103822|2017-02-18 15:13:05.103822
NCT00538954|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2010-11-04|||August 2006||2006-08-01|October 2007|2007-10-01|August 2008|Actual|2008-08-01|||||Interventional|ORANGE||Optimised Recovery With Accelerated Nutrition and GI Enhancement|A Randomised Controlled Trial of Optimised Surgical Recovery: the Potential Synergy Between Enhanced Gastrointestinal Motility and Oral Nutritional/ Metabolic Support|Completed||N/A|64|Anticipated|University of Edinburgh||4|||f||||f||||||||||2017-02-18 15:13:05.206783|2017-02-18 15:13:05.206783
NCT00538941|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2009-10-27|||November 2005||2005-11-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effects of Chocolate in Patients With Chronic Heart Failure|Effects of Swiss Dark Chocolate on Endothelial and Baroreceptor Function and Markers of Inflammation in Patients With Chronic Heart Failure|Completed||N/A|22|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 15:13:05.303515|2017-02-18 15:13:05.303515
NCT00538928|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2011-03-01|||September 2007||2007-09-01|March 2009|2009-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|Xtravent||Extrapulmonary Interventional Ventilatory Support in Severe Acute Respiratory Distress Syndrome (ARDS)|Extrapulmonary Interventional Ventilatory Support for Lung Protection in Severe Acute Respiratory Distress - a Prospective Randomized Multi Centre Study|Completed||N/A|120|Anticipated|University of Regensburg||2|||f||||t||||||||||2017-02-18 15:13:05.401995|2017-02-18 15:13:05.401995
NCT00538915|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2012-02-23|2012-01-04||September 2007||2007-09-01|February 2012|2012-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)|Open Label, Phase III Safety, Efficacy, and Pharmacokinetic Study of NABI-IGIV 10% [Immune Globulin Intravenous (Human), 10%] in Subjects With Primary Immune Deficiency Disorders (PIDD)|Completed||Phase 3|63|Actual|Biotest Pharmaceuticals Corporation||1|||f||||f||||||||||2017-02-18 15:13:05.515091|2017-02-18 15:13:05.515091
NCT00538902|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-04-07|2009-11-23||August 2007||2007-08-01|April 2011|2011-04-01|December 2009|Actual|2009-12-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate|A Multi-center Randomized, Phase 2/3, Double-blind, Parallel-group, Placebo-controlled Study to Assess the Safety and Efficacy of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate|Completed||Phase 2/Phase 3|302|Actual|Abbott||3|||f||||f||||||||||2017-02-18 15:13:05.782922|2017-02-18 15:13:05.782922
NCT00538889|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2007-12-09|||August 2007||2007-08-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects|Combined Administration of Lecozotan SR and Citalopram: a Double Blind, Multiple Dose Study in Young Healthy Subjects|Completed||Phase 1|40|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:13:07.080146|2017-02-18 15:13:07.080146
NCT00538876|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2011-06-29|||July 2007||2007-07-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML|Phase I Study of Epigenetic Priming Using Decitabine With Induction Chemotherapy in Patients With Acute Myelogenous Leukemia (AML)|Completed||Phase 1|30|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 15:13:07.162963|2017-02-18 15:13:07.162963
NCT00538863|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2013-08-06|2012-09-11||December 2007||2007-12-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||The total number of patients enrolled in the study is 319.|Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain|Open-label Multi-center Safety Trial of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain|Completed||Phase 3|319|Actual|INSYS Therapeutics Inc||2|||f||||f||||||||||2017-02-18 15:13:07.265222|2017-02-18 15:13:07.265222
NCT00538850|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2014-01-14|2013-05-08||October 2007||2007-10-01|January 2014|2014-01-01|October 2010|Actual|2010-10-01|February 2010|Actual|2010-02-01||Interventional|||Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain|A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain|Completed||Phase 3|130|Actual|INSYS Therapeutics Inc||1|||f||||||||||||||2017-02-18 15:13:07.808175|2017-02-18 15:13:07.808175
NCT00538824|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-02|2008-12-02|||December 2007||2007-12-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|DexTR||Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma|A Phase II Study of Dexamethasone (DECADRON®), Thalidomide (THALOMID®), and Lenalidomide (REVLIMID®) for Subjects With Relapsed or Refractory Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 15:13:08.721173|2017-02-18 15:13:08.721173
NCT00538785|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2012-02-14|2012-01-11||October 2005||2005-10-01|February 2012|2012-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease|A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children With Hemodynamically Significant Congenital Heart Disease|Completed||Phase 2|1236|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 15:13:09.017995|2017-02-18 15:13:09.017995
NCT00538772|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2010-11-03|||July 2008||2008-07-01|November 2010|2010-11-01||||||||Observational|||An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy|An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy|Withdrawn||N/A|50|Anticipated|British Columbia Cancer Agency|||1||f||||f||||||Samples With DNA|"~     Approx. 40ml of blood for correlative studies will be drawn at predetermined time points:~     baseline, after cycle 1, at time of treatment failure/discontinuation of protocol therapy.~      10 unstained slides from original patient specimen (nephrectomy specimens only) will be~     collected within 6 months after enrollment.~   "|||2017-02-18 15:13:10.869209|2017-02-18 15:13:10.869209
NCT00538525|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2012-05-26|||September 2007||2007-09-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer||Completed||N/A|10|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:13:11.066115|2017-02-18 15:13:11.066115
NCT00538512|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-08-08|2011-08-08||September 2007||2007-09-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|FLUVACS||Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4|Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4|Completed||Phase 4|1952|Actual|University of Michigan||3|||f||||f||||||||||2017-02-18 15:13:11.157707|2017-02-18 15:13:11.157707
NCT00538499|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2017-02-08|||October 28, 2004|Actual|2004-10-28|February 2017|2017-02-01|September 2009|Actual|2009-09-01|July 27, 2007|Actual|2007-07-27||Interventional|||Fentanyl With or Without Bupivacaine in Reducing Pain in Patients Undergoing Video-Assisted Chest Surgery|Optimal Pain Management After Video-Assisted Thoracic Surgery|Completed||N/A|30|Actual|Roswell Park Cancer Institute||3|||f||||t||||||||||2017-02-18 15:13:11.836665|2017-02-18 15:13:11.836665
NCT00538486|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2013-05-12|||February 2008||2008-02-01|May 2013|2013-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|HOT-ACME||A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients|Which is the Best Treatment for Non-diabetic Hypertension With Obesity: Telmisartan, Amlodipine or Candesartan, Alone or Plus MEtformin? (HOT-ACME 1)|Completed||Phase 4|360|Actual|Third Military Medical University||6|||f||||t||||||||||2017-02-18 15:13:11.960046|2017-02-18 15:13:11.960046
NCT00538473|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2016-11-03|2012-04-19||October 2007||2007-10-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults|Reactogenicity and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK576389A in Elderly Adults (≥67 Years) Previously Vaccinated With the Same Candidate Vaccine. Fluarix™ Will be Used as Reference.|Completed||Phase 2|68|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:13:12.105882|2017-02-18 15:13:12.105882
NCT00538460|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2010-02-26|||September 2007||2007-09-01|February 2010|2010-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|DSTAT||Evaluate the Effectiveness and Cost of Stress Cardiac Magnetic Resonance Imaging (MRI) for Non-invasive Evaluation of Lesions Discovered on Computed Tomography Angiography (CCTA)|Dual-Source CT and STress Cardiac Magnetic Resonance Assessment in the Triage of Patients With Suspected Acute Coronary Syndromes (D-STAT)|Terminated||N/A|1|Actual|William Beaumont Hospitals|||1|Lack of staff and funding.|f||||t||||||||||2017-02-18 15:13:13.010726|2017-02-18 15:13:13.010726
NCT00538447|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-12-11|||June 2007||2007-06-01|December 2011|2011-12-01|June 2020|Anticipated|2020-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Prospective Database for Chronic Myelogenous Leukemia||Active, not recruiting||N/A|2000|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:13:13.093567|2017-02-18 15:13:13.093567
NCT00538434|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2016-07-21|2016-03-23||March 2008||2008-03-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||ITT population: all randomized participants who received any amount of study drug.|Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years|An Efficacy and Safety Study of Reslizumab (CTx55700) in the Treatment of Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years|Completed||Phase 2/Phase 3|227|Actual|Teva Pharmaceutical Industries||4|||f||||t||||||||||2017-02-18 15:13:13.194258|2017-02-18 15:13:13.194258
NCT00538421|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2013-03-08|||March 2008||2008-03-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|ABSENT||Opioid-potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery|Opioid-potentiated Volative Anaesthetic(Sevoflurane)Compared to Remifentanil and Propofol During Abdominal Aortic Aneurysm Surgery|Completed||Phase 4|193|Actual|Sykehuset i Vestfold HF||2|||f||||f||||||||||2017-02-18 15:13:13.985948|2017-02-18 15:13:13.985948
NCT00538408|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2009-02-01|||September 2007||2007-09-01|February 2009|2009-02-01|January 2010|Anticipated|2010-01-01|||||Observational|||Whole Body Magnetic Resonance Angiography in Ischemic Patients|Whole Body Magnetic Resonance Angiography in Patients With Symptomatic Peripheral Ischemia|Unknown status|Recruiting|N/A|80|Anticipated|Copenhagen University Hospital at Herlev|||2||f||||t||||||||||2017-02-18 15:13:14.091743|2017-02-18 15:13:14.091743
NCT00538395|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-12-11|||September 2007||2007-09-01|December 2011|2011-12-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer||Unknown status|Active, not recruiting|N/A|100|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:13:14.188064|2017-02-18 15:13:14.188064
NCT00538252|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2013-12-10|||May 2007||2007-05-01|December 2013|2013-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Parental Involvement and Children's Extra-Familial Contexts|Parental Involvement, Extra-Familial Contexts and Prevention of Drug Use Risk|Completed||N/A|731|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:13:20.104889|2017-02-18 15:13:20.104889
NCT00538382|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2014-07-29|||May 2007||2007-05-01|July 2014|2014-07-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Study of Pharmacokinetics and Pharmacodynamics of Artesunate in Pregnant Women in the Democratic Republic of Congo|Phase I Study of Pharmacokinetics and Pharmacodynamics of Artesunate in Pregnant Women in the Democratic Republic of Congo|Completed||Phase 1|51|Actual|NICHD Global Network for Women's and Children's Health||3|||f||||t||||||||||2017-02-18 15:13:14.266658|2017-02-18 15:13:14.266658
NCT00538369|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-10-11|||November 2006||2006-11-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|COST||Combining Observational and Physiologic Sedation Assessment Tools|Combining Observational and Physiologic Sedation Assessment Tools|Terminated||Phase 4|67|Actual|Duke University||2||Lack of equipoise|f||||t||||||||||2017-02-18 15:13:14.393429|2017-02-18 15:13:14.393429
NCT00538356|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2014-12-19|||July 2007||2007-07-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|March 2012|Actual|2012-03-01||Interventional|IN-TIME||Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function|IN-TIME: Influence of Home Monitoring on the Clinical Status of Heart Failure Patients|Completed||Phase 4|720|Actual|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-02-18 15:13:14.523196|2017-02-18 15:13:14.523196
NCT00538343|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2014-11-13||2012-08-15|October 2007||2007-10-01|November 2014|2014-11-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases|A Phase II Efficacy and Tolerability Study of RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases|Terminated||Phase 2|14|Actual|Reata Pharmaceuticals, Inc.||1||Business Decision|f||||f||||||||||2017-02-18 15:13:14.76317|2017-02-18 15:13:14.76317
NCT00536835|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-10-11|||August 2007||2007-08-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins Lymphoma|A Phase I Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of [GSK461364], a Polo-like Kinase 1 (PLK1) Inhibitor, in Adult Subjects With Advanced Solid Tumor or Non-Hodgkins Lymphoma|Completed||Phase 1|41|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:13:14.895109|2017-02-18 15:13:14.895109
NCT00536822|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2013-06-15|||June 2013||2013-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Antioxidant Status During Burn Rehabilitation|Prospective Assessment of Antioxidant Status of Pediatric Patients During Burn Rehabilitation|Withdrawn||N/A|0|Actual|Shriners Hospitals for Children|||1|Study withdrawn due to hospital emphasis on funded studies.|f||||t||||||None Retained|"~     No specimens.~   "|||2017-02-18 15:13:15.005019|2017-02-18 15:13:15.005019
NCT00536809|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2012-03-15|2010-01-19||September 2007||2007-09-01|February 2011|2011-02-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer|A Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced or Metastatic Colorectal Cancer|Completed||Phase 1|12|Actual|GlaxoSmithKline|Phase II of the study was terminated due to lake of interest. Two participants were enrolled prior to termination. Due to the small sample size in Phase II, the data were not analyzed. The two participants' data were analyzed with Phase I data.|2|||f||||f||||||||||2017-02-18 15:13:15.305502|2017-02-18 15:13:15.305502
NCT00536796|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2014-10-29|||September 2007||2007-09-01|October 2014|2014-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets|Non-interventional Study Investigating How Effective Secondary Prevention Patients Are Treated to Their LDL-C Targets|Completed||N/A|1096|Actual|AstraZeneca|||4||f||||||||||||||2017-02-18 15:13:15.965194|2017-02-18 15:13:15.965194
NCT00536783|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2007-12-20|||April 2004||2004-04-01|September 2007|2007-09-01|March 2006|Actual|2006-03-01|||||Observational|||Schizophrenia Sensory Gating Deficit With Quetiapine|Schizophrenia Sensory Gating Deficit With Quetiapine|Completed||N/A|20|Anticipated|New Mexico VA Healthcare System|||||f||||t||||||||||2017-02-18 15:13:16.076422|2017-02-18 15:13:16.076422
NCT00536770|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-11-02|||September 2007||2007-09-01|November 2007|2007-11-01||||||||Interventional|||A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer|A Randomized Phase 2 Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Subjects With Advanced Pancreatic Adenocarcinoma|Suspended||Phase 2|132|Anticipated|Novacea||4||DSMB|f||||f||||||||||2017-02-18 15:13:16.179927|2017-02-18 15:13:16.179927
NCT00536744|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2014-03-07|2014-03-07||October 2007||2007-10-01|March 2014|2014-03-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers|Use of the dermaPACE™ (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care in the Treatment of Diabetic Foot Ulcers|Completed||Phase 3|206|Actual|SANUWAVE, Inc.||2|||f||||f||||||||||2017-02-18 15:13:16.298929|2017-02-18 15:13:16.298929
NCT00536731|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2012-08-14|2009-04-01||September 2007||2007-09-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|ESTHER||Symbicort Rapihaler Therapeutic Equivalence Study|A 6-week, Phase III, Double-blind, Randomized, Multi-centre, Parallel-group Study Evaluating the Efficacy and Safety of 2 Actuations Symbicort®pMDI® 40/2.25 μg Twice Daily Compared With 1 Inhalation Symbicort Turbuhaler® 80/4.5 μg Twice Daily and 1 Inhalation Pulmicort®Turbuhaler® 100 μg Twice Daily|Completed||Phase 3|742|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:13:16.849085|2017-02-18 15:13:16.849085
NCT00536718|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2013-08-09|||June 2007||2007-06-01|September 2007|2007-09-01||||||||Observational|||Genetics of Women With Lobular Carcinoma in Situ of the Breast|GLACIER: A Study to Investigate the Genetics of LobulAr Carcinoma In Situ in EuRope|Unknown status|Recruiting|N/A|3000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:13:17.625296|2017-02-18 15:13:17.625296
NCT00538239|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2015-02-12|||October 2007||2007-10-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|October 2010|Actual|2010-10-01||Interventional|SUCCEED||Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)|A Pivotal Trial to Determine the Efficacy and Safety of AP23573 When Administered as Maintenance Therapy to Patients With Metastatic Soft-Tissue or Bone Sarcomas|Completed||Phase 3|711|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:13:20.19894|2017-02-18 15:13:20.19894
NCT00536705|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2011-07-26|||January 2009||2009-01-01|January 2009|2009-01-01|March 2011|Actual|2011-03-01|June 2010|Actual|2010-06-01||Observational|||Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma||Completed||N/A|112|Actual|Shanghai Jiao Tong University School of Medicine|||1||f||||||||||Samples Without DNA|"~     Subjects inhaled hypertonic saline (3%) via an ultrasonic nebulizer with the output set at~     maximum for 20 minutes. To collect sputum, subjects were asked to expectorate the sputum~     onto a plastic Petri dish after the 20-min period of inhalation. During the inducing~     procedure, macroscopic characteristics of the sputum were recorded and adequate plugs of~     sputum were separated from saliva and processed immediately after expectoration.The complete~     blood count, platelet count, and serum biochemical analyses were done meanwhile.~   "|||2017-02-18 15:13:17.733995|2017-02-18 15:13:17.733995
NCT00536692|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2008-04-03|||September 2007||2007-09-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|||||Interventional|||Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)|Phase 2 Study of the Safety and Bioactivity of Topical Ocular Mecamylamine for the Treatment of Diabetic Macular Edema (DME)|Completed||Phase 2|||CoMentis||1|||||||f||||||||||2017-02-18 15:13:17.839917|2017-02-18 15:13:17.839917
NCT00536679|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2010-10-13||2010-10-13|September 2007||2007-09-01|October 2010|2010-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers|An Open Label, Randomised, Single Dose, Three-way Crossover Study to Investigate the Relative Bioavailability of Two Different Formulations of GSK163090 and the Effect of Food on the Pharmacokinetics of a Tablet Formulation in Healthy Male and Female Volunteers|Completed||Phase 1|16|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:13:17.933007|2017-02-18 15:13:17.933007
NCT00536666|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2008-10-07|||May 2007||2007-05-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients|A Non-Comparative Open-Label Study of Iron Oligosaccharide in Chronic Kidney Disease Patients With a Need for Parenteral Iron|Completed||Phase 3|182|Actual|Pharmacosmos A/S||1|||f||||f||||||||||2017-02-18 15:13:18.027362|2017-02-18 15:13:18.027362
NCT00536653|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2007-09-27|||October 1999||1999-10-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer|Long Term Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Advanced Prostate Cancer, With Stratification of Treatment Based on Presenting Values|Completed||N/A|618|Actual|Wirral University Teaching Hospital NHS Trust||3|||f||||t||||||||||2017-02-18 15:13:18.138117|2017-02-18 15:13:18.138117
NCT00536640|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2013-06-11|||November 2007||2007-11-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|August 2011|Actual|2011-08-01||Interventional|INNOVATIONS||Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab|Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabin/Cisplatin Plus Bevacizumab|Completed||Phase 2|224|Actual|Aktion Bronchialkarzinom e.V.||2|||f||||t||||||||||2017-02-18 15:13:18.248105|2017-02-18 15:13:18.248105
NCT00536627|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2011-12-16|||January 2008||2008-01-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|VAC-ADN||Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis|Randomised, Opened, Multicentre Phase I/II Trial in Patients With Chronic Hepatitis B With HBV VL < 12 IU/ml and Under Treatment With NRTI, Which Evaluated Efficacy and Tolerance of Vaccination With Naked DNA on Viral Replication After Analogs' Treatment Interruption. ANRS HB02 VAC-ADN|Completed||Phase 1/Phase 2|70|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||t||||||||||2017-02-18 15:13:18.547786|2017-02-18 15:13:18.547786
NCT00538330|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-12-11|||September 2007||2007-09-01|December 2011|2011-12-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer||Active, not recruiting||N/A|2000|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:13:18.672992|2017-02-18 15:13:18.672992
NCT00538317|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2008-11-21|||July 2007||2007-07-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|AGIR2||GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction|Comparison of Administration of Tirofiban in the Ambulance or in the Cathlab in Patients With Acute Myocardial Infarction Treated With Primary Angioplasty|Completed||Phase 4|320|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 15:13:18.769512|2017-02-18 15:13:18.769512
NCT00538304|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2011-09-19|2011-09-19||November 2007||2007-11-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 2|222|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:13:18.891019|2017-02-18 15:13:18.891019
NCT00538291|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2014-08-19|2014-06-12||August 2005||2005-08-01|August 2014|2014-08-01||||February 2009|Actual|2009-02-01||Interventional|||Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment|CA225103: A Phase II Study of a Combination of Cetuximab and Capecitabine in Patients With Metastatic Colorectal Cancer After Progression on Previous Fluoropyrimidine Containing Therapy|Terminated||Phase 2|13|Actual|City of Hope Medical Center|Study was terminated due to a lack of efficacy (less than 2 of 13 patients responded to treatment in the first stage of a Simon's two stage design).|1||Study was terminated early due to lack of efficacy.|f||||||||||||||2017-02-18 15:13:19.34552|2017-02-18 15:13:19.34552
NCT00538278|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-12-11|||October 2007||2007-10-01|December 2011|2011-12-01|October 2020|Anticipated|2020-10-01|October 2020|Anticipated|2020-10-01||Interventional|||Prospective Database for Acute Myeloblastic Leukemia||Active, not recruiting||N/A|2000|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:13:19.860292|2017-02-18 15:13:19.860292
NCT00538265|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-02-02|||May 2005||2005-05-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|BEFIRTH||Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation|Evaluation of the Benefit of Antithymocyte Induction Therapy on Hepatic Fibrosis in de Novo Hepatitis C Virus Liver Transplant Patients.|Completed||Phase 4|100|Anticipated|University Hospital, Toulouse||3|||f||||f||||||||||2017-02-18 15:13:19.973476|2017-02-18 15:13:19.973476
NCT00065338|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2011-04-01|||June 2003||2003-06-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Nutritional Restriction and Activity Thermogenesis|Nutritional Restriction and Activity Thermogenesis|Completed||Phase 1|90|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 17:58:03.796616|2017-02-18 17:58:03.796616
NCT00538226|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-29|2008-03-03|||October 2007||2007-10-01|March 2008|2008-03-01|November 2007|Actual|2007-11-01|||||Interventional|||Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg|To Evaluate the Increase of Local Circulation in the Leg Using the Flowaid Device|Completed||Phase 1|||Rosenblum, Jonathan I., DPM|||||f||||t||||||||||2017-02-18 15:13:20.325935|2017-02-18 15:13:20.325935
NCT00538213|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2016-11-03|2012-04-05||October 2007||2007-10-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Evaluation of Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults|Reactogenicity and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK576389A in Elderly Adults (≥66 Years) Previously Vaccinated With the Same Candidate Vaccine. Fluarix™ Will be Used as Reference|Completed||Phase 2|133|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:13:20.434567|2017-02-18 15:13:20.434567
NCT00538200|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2014-12-05|||January 2008||2008-01-01|December 2014|2014-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Chronic Obstructive Pulmonary Disease (COPD) Nutrition Support Trial|A Randomised Trial of Oral Nutritional Supplements Versus Dietary Advice on Clinical Outcomes in Patients With COPD|Completed||N/A|85|Actual|University of Southampton||2|||f||||f||||||||||2017-02-18 15:13:21.661235|2017-02-18 15:13:21.661235
NCT00538187|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-12-03|||December 2007||2007-12-01|May 2013|2013-05-01||||April 2011|Actual|2011-04-01||Interventional|||Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma|Phase I Study of GX15-070 (NSC # 729280) and Bortezomib in Aggressive Relapsed/Recurrent Non-Hodgkin's Lymphoma|Terminated||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:13:21.764463|2017-02-18 15:13:21.764463
NCT00538174|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-03-20|||November 2007||2007-11-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|MAD||Phase I Multiple-Ascending Dose (Japan)|A Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Dapagliflozin in Diabetic Japanese Subjects|Completed||Phase 1|36|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 15:13:21.888483|2017-02-18 15:13:21.888483
NCT00538161|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-30|2010-03-22|||October 2007||2007-10-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Effect of Low Tidal Volume Ventilation in Improving Oxygenation and Thus Reducing Acute Lung Injury in the Cardiac Surgical Patient|Effect of Low Tidal Volume Ventilation in Improving Oxygenation and Thus Reducing Acute Lung Injury in the Cardiac Surgical Patient|Completed||N/A|120|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-02-18 15:13:21.999797|2017-02-18 15:13:21.999797
NCT00538148|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2012-02-15|||November 2002||2002-11-01|February 2012|2012-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD|A Multicenter, Multinational, Randomized, DB Controlled Study of the Efficacy & Safety of Oral Telithromycin 800 mg Once QD for 5 Days vs Azithromycin in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD.|Completed||Phase 4|668|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:13:22.0958|2017-02-18 15:13:22.0958
NCT00538135|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-29|2007-09-29|||February 2002||2002-02-01|September 2007|2007-09-01|March 2005|Actual|2005-03-01|||||Interventional|BOSCOT||BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder|BOSCOT: A Randomised Control Trial of Cognitive Behavioural Therapy Plus Treatment as Usual Versus Treatment as Usual in the Treatment of Borderline Personality Disorder|Completed||Phase 3|106|Actual|University of Aberdeen||2|||f||||f||||||||||2017-02-18 15:13:22.175034|2017-02-18 15:13:22.175034
NCT00538122|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2009-01-23|||July 2007||2007-07-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Observational|||Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment|Evaluating the Risks of Arrhythmia and Sudden Death Associated With Antipsychotic Drugs by Assessing the T Wave Abnormalities in the Holter Electrocardiogram|Completed||N/A|12|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-02-18 15:13:22.298229|2017-02-18 15:13:22.298229
NCT00538109|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-12-15|||October 2007||2007-10-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase|An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase|Completed||N/A|8|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:13:22.406741|2017-02-18 15:13:22.406741
NCT00538096|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2008-09-04|||September 2007||2007-09-01|September 2008|2008-09-01|May 2010|Anticipated|2010-05-01|March 2010|Anticipated|2010-03-01||Interventional|||A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma|A Phase I, Multicenter, Open-Label, Single-Arm, Dose-Escalation, Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of the Bispecific T-Cell Engager MEDI-538 in Adults With B-Cell Non-Hodgkin's Lymphoma Not Eligible for Curative Therapy|Withdrawn||Phase 1|18|Anticipated|MedImmune LLC||3||Replacing this trial with a new trial.|f||||f||||||||||2017-02-18 15:13:22.488089|2017-02-18 15:13:22.488089
NCT00538083|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2007-09-28|||August 2005||2005-08-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|||||Interventional|Chocolate||Cocoa and Endothelial Function in Adults With Elevated BMI|Dark Chocolate and Cocoa Ingestion and Endothelial Function: A Randomized, Placebo Controlled, Cross-Over Trial|Completed||Phase 1|45|Actual|Griffin Hospital||3|||f||||f||||||||||2017-02-18 15:13:22.808833|2017-02-18 15:13:22.808833
NCT00538070|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2012-09-17|||August 2007||2007-08-01|September 2012|2012-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|Sarc||A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia|The Effects of Glycine Transport Inhibition on Brain Glycine Concentration|Completed||N/A|68|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 15:13:22.912494|2017-02-18 15:13:22.912494
NCT00536588|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2015-03-26|||September 2006||2006-09-01|March 2015|2015-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816)|A Phase 1 Study of the Safety and Tolerability of Intravesical Administration of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder|Completed||Phase 1|17|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 15:13:28.637053|2017-02-18 15:13:28.637053
NCT00538057|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2016-12-02|||October 2007||2007-10-01|December 2016|2016-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects|A Randomised, Double-blind, Placebo-controlled, Four-way Crossover Study to Compare the Pharmacodynamics and Pharmacokinetics of GW685698X and GW642444M When Administered Separately and in Combination as a Single Dose From a Novel Dry Powder Device in Healthy Subjects|Completed||Phase 1|16|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:13:23.147799|2017-02-18 15:13:23.147799
NCT00538044|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2007-10-01|||January 2009||2009-01-01|September 2007|2007-09-01|January 2012|Anticipated|2012-01-01|||||Interventional|||Simvatstatin Used to Treat Pulmonary Hypertension|the Clinical Research Using Simvastatin as a Medication to Treat Advanced Secondary Pulmonary Hypertension|Unknown status|Not yet recruiting|Phase 1|||Capital Medical University||2|||f||||t||||||||||2017-02-18 15:13:23.253863|2017-02-18 15:13:23.253863
NCT00538031|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2017-02-10|||December 2003||2003-12-01|February 2017|2017-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|Randomized Pilot Trial of Oral Cyclophosphamide Versus Oral Cyclophosphamide With Celecoxib for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Active, not recruiting||Phase 2|27|Anticipated|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 15:13:23.356395|2017-02-18 15:13:23.356395
NCT00538018|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2012-02-15|||January 2003||2003-01-01|February 2012|2012-02-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas||Completed||Phase 4|978|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:13:23.476858|2017-02-18 15:13:23.476858
NCT00538005|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2014-01-09|||May 2007||2007-05-01|July 2009|2009-07-01||||July 2009|Anticipated|2009-07-01||Interventional|||Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma|A Phase I/II Trial of Nexavar, Avastin and Eloxatin in Patients With Metastatic Malignant Melanoma|Unknown status|Recruiting|Phase 1/Phase 2|54|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:13:23.557967|2017-02-18 15:13:23.557967
NCT00537992|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2007-10-01|||October 2004||2004-10-01|October 2007|2007-10-01|March 2006|Actual|2006-03-01|||||Interventional|||Blue-Blocking IOLs in Combined Surgery|Blue Light-Filter IOLs in Vitrectomy Combined With Cataract Surgery: Results of a Randomized Controlled Clinical Trial.|Completed||N/A|60|Actual|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|||||f||||f||||||||||2017-02-18 15:13:23.647706|2017-02-18 15:13:23.647706
NCT00537979|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2011-09-16|2011-07-20||September 2007||2007-09-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis|Prospective, Non-randomized, Multicenter Study to Assess the Efficacy and Safety of Oral or Intravenous Paricalcitol Administered Over 6 Months to Patients With Secondary Hyperparathyroidism on Dialysis|Completed||Phase 4|147|Actual|Abbott||2|||f||||f||||||||||2017-02-18 15:13:23.737263|2017-02-18 15:13:23.737263
NCT00537966|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-11-03|||January 2002||2002-01-01|November 2016|2016-11-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Interventional|||Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study|Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study|Recruiting||N/A|2016|Anticipated|University of Zurich||2|||f||||f||||||||||2017-02-18 15:13:26.897041|2017-02-18 15:13:26.897041
NCT00537953|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2007-09-28||||||September 2007|2007-09-01||||||||Interventional|||Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia|EFFICACY AND SAFETY OF A SHORT COURSE OF THE COMBINATION OF MILTEFOSINE AND ANTIMONY TO TREAT CUTANEOUS LEISHMANIASIS IN BOLIVIA|Unknown status|Recruiting|Phase 2|||Centro de Investigaciones Bioclínicas de la Fundación Fader||2|||f||||f||||||||||2017-02-18 15:13:27.041625|2017-02-18 15:13:27.041625
NCT00537940|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2014-11-12|2014-07-15||February 2008||2008-02-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures|A Randomized, Double-blind, Parallel-group Multi-center Comparative Flexible-dose Trial Of Pregabalin Versus Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures.|Completed||Phase 4|484|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:13:27.151029|2017-02-18 15:13:27.151029
NCT00537927|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2009-02-17|||August 2005||2005-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|LACH||LACH-Trial: LAparoscopic Correction of Hernia|The Effect of Mesh Fixation Technique on Postoperative Pain in Laparoscopic Correction of Incisional and Ventral Abdominal Wall Hernias.|Completed||N/A|215|Actual|Ziekenhuisgroep Twente||3|||f||||t||||||||||2017-02-18 15:13:28.082639|2017-02-18 15:13:28.082639
NCT00537914|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2016-10-18|||October 2007||2007-10-01|October 2016|2016-10-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Interventional|||Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)|Long-term Phase IV Multicentre Study on the Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)|Active, not recruiting||Phase 4|278|Actual|Sandoz||1|||f||||f||||||||||2017-02-18 15:13:28.21208|2017-02-18 15:13:28.21208
NCT00536614|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2007-09-27|||May 2005||2005-05-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|SPaCe-01||Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer|A Randomized Phase II Study of Gemcitabine/Cisplatin With or Without Cetuximab to Evaluate the Efficacy in Patients With Locally Advanced or Metastatic EGFR-EGFR-Positive Pancreatic Cancer. SpaCe Trial|Completed||Phase 2|86|Actual|Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente||1|||f||||f||||||||||2017-02-18 15:13:28.349823|2017-02-18 15:13:28.349823
NCT00536601|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-11-07|||June 2006||2006-06-01|November 2016|2016-11-01||||April 2018|Anticipated|2018-04-01||Interventional|||High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors|Autologous Blood and Marrow Transplantation for Hematologic Malignancies and Selected Solid Tumors|Active, not recruiting||N/A|174|Actual|Roswell Park Cancer Institute||7|||f||||t||||||||||2017-02-18 15:13:28.472626|2017-02-18 15:13:28.472626
NCT00536575|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2013-01-23|2013-01-23||November 2007||2007-11-01|January 2013|2013-01-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Interventional|||Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients|Phase I/II Trial of Sorafenib and Weekly Bortezomib in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|13|Actual|SCRI Development Innovations, LLC|The 15% response rate was substantially lower than the designed rate of 60% for this trial. Coupled with the influx of new compounds for the treatment of multiple myeloma it was decided that this study should be closed early.|1|||f||||f||||||||||2017-02-18 15:13:28.751064|2017-02-18 15:13:28.751064
NCT00536562|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2014-03-26|||September 2007||2007-09-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|CR-TIA||Cardiac Rehabilitation for TIA Patients|Comprehensive Cardiac Rehabilitation Programming For Patients Following Transient Ischemic Attack|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-02-18 15:13:29.130018|2017-02-18 15:13:29.130018
NCT00536549|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2008-05-19|||February 2007||2007-02-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 Diabetes||Completed||N/A|127|Actual|Korea University||2|||f||||t||||||||||2017-02-18 15:13:29.41923|2017-02-18 15:13:29.41923
NCT00536536|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2011-08-23|||April 2008||2008-04-01|February 2009|2009-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Evaluating the Transferability of a Successful, Hospital-based, Childhood Obesity Clinic to Primary Care: a Pilot Study|Evaluating the Transferability of a Successful, Hospital-based, Childhood Obesity Clinic to Primary Care: a Pilot Study|Completed||Phase 1|100|Anticipated|University of Bristol||2|||f||||f||||||||||2017-02-18 15:13:29.537302|2017-02-18 15:13:29.537302
NCT00536523|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2014-08-21|||April 2007||2007-04-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Women's Cancer Center Protocol #52: Alterations in Serum Serotonin Levels as a Mechanism for Chemotherapy Induced Constipation|Terminated||N/A|13|Actual|University of Minnesota - Clinical and Translational Science Institute|||1|Funding unavailable|f||||t||||||Samples With DNA|"~     A blood sample (5 ml red top tube) will be drawn before the patient's first chemotherapy~     treatment, after the 3rd cycle of chemotherapy, at the post chemotherapy follow-up visit~     (approximately 30 days after chemotherapy is completed) and approximately 4 months after~     completion of chemotherapy at the time of a routine follow-up visit. Whenever possible, the~     blood will be drawn at the same time blood is being collected for clinical purposes~     therefore flexibility is allowed in the timing of the research related bloods.~   "|||2017-02-18 15:13:29.645372|2017-02-18 15:13:29.645372
NCT00536510|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2015-09-01|2009-02-13||April 2007||2007-04-01|September 2015|2015-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of MK0524A on Cholesterol Levels (0524A-048)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Lipid-Altering Efficacy and Safety and Tolerability of MK0524A in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia|Completed||Phase 3|646|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:13:29.756599|2017-02-18 15:13:29.756599
NCT00536497|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-02-12|||September 2007||2007-09-01|February 2015|2015-02-01||||||||Interventional|||Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.|A 2 Part Open-label, Randomised, Crossover Study to Compare the Effects of Formulation, Food and Particle Size on the Pharmacokinetic Profiles of a Single 175mg Dose of GW842166X in Healthy Male and Female Volunteers|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||||Compound terminated|||||f||||||||||2017-02-18 15:13:30.364175|2017-02-18 15:13:30.364175
NCT00536484|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2009-09-10|2009-03-12||August 2007||2007-08-01|September 2009|2009-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Fesoterodine Flexible Dose Study|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Overactive Bladder.|Completed||Phase 3|896|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:13:30.459842|2017-02-18 15:13:30.459842
NCT00536471|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2009-11-17|2009-05-28||September 2007||2007-09-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients|Duloxetine Versus Placebo in Patients With Major Depressive Disorder (MDD): Assessment of Energy and Vitality in MDD|Completed||Phase 4|776|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:13:31.608964|2017-02-18 15:13:31.608964
NCT00536458|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-10-31|||March 1999||1999-03-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|||||Interventional|||Treatment of Localized Low Grade Lymphomas|Phase III Study of Treatment of Localized Lymphomas: Radiotherapy Versus Radio-Chemotherapie|Completed||Phase 3|132|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||||2017-02-18 15:13:38.648996|2017-02-18 15:13:38.648996
NCT00536445|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-05-30|||October 2007||2007-10-01|May 2016|2016-05-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Use of NAVA in Intubated Preterm|Use of Neurally Adjusted Ventilatory Assist (NAVA) in an Intubated Premature Infant: A Case Control Study on the Servoi Ventilator|Withdrawn||Phase 1/Phase 2|0|Actual|Sunnybrook Health Sciences Centre||1||Another institution performed the study|f||||f||||||||||2017-02-18 15:13:38.74654|2017-02-18 15:13:38.74654
NCT00536432|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2012-06-05|||September 2007||2007-09-01|October 2010|2010-10-01|June 2012|Actual|2012-06-01|September 2011|Actual|2011-09-01||Observational|||Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot|Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot: Prospective Analysis of Myocardial Benefit Using Cardiac MRI and Echocardiography|Completed||N/A|93|Actual|Competence Network for Congenital Heart Defects|||1||f||||f||||||||||2017-02-18 15:13:38.838205|2017-02-18 15:13:38.838205
NCT00536419|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-09-26|||September 2007||2007-09-01|September 2007|2007-09-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents|Association Between Motorcycle Accidents, Attention Deficit/Hyperactivity Disorder and Substance Use Disorder and Motorcycle Accidents|Unknown status|Recruiting|Phase 4|53|Anticipated|Federal University of Rio Grande do Sul||2|||f||||||||||||||2017-02-18 15:13:38.924884|2017-02-18 15:13:38.924884
NCT00537784|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2013-06-17|||September 2007||2007-09-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Platelet Concentrate in Achilles Tendon Repair||Completed||N/A|30|Actual|University Hospital, Linkoeping||2|||f||||f||||||||||2017-02-18 15:13:42.103397|2017-02-18 15:13:42.103397
NCT00536406|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2013-04-19|||August 2007||2007-08-01|April 2013|2013-04-01|November 2013|Anticipated|2013-11-01|July 2013|Anticipated|2013-07-01||Interventional|BE-ACTIV||Evaluating a Behavioral Activities Treatment Program for Depressed Nursing Home Residents|BE-ACTIV: Treating Depression in Nursing Homes|Unknown status|Active, not recruiting|Phase 2|140|Anticipated|University of Louisville||2|||f||||t||||||||||2017-02-18 15:13:39.029574|2017-02-18 15:13:39.029574
NCT00536393|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-10-31|||October 2000||2000-10-01|September 2007|2007-09-01|October 2004|Actual|2004-10-01|||||Interventional|||Treatment of Disseminated High Grade Lymphoma|Phase III Study of Treatment of Disseminated and Agressive Lymphoma R CHOP Versus R CLOP( With Liposomal Doxorubicin)|Completed||Phase 2/Phase 3|100|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||||2017-02-18 15:13:39.139986|2017-02-18 15:13:39.139986
NCT00536380|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2015-10-15|2010-02-24||September 2007||2007-09-01|October 2015|2015-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)|A Study of the Efficacy, Safety, and Quality of Life (QOL) in Patients With Chronic Idiopathic Urticaria Dosed With AERIUS Tablets (Desloratadine 5 mg, 10 mg, or 20 mg Once Daily)|Completed||Phase 4|314|Actual|Merck Sharp & Dohme Corp.|Due to poor enrollment (even after extending the enrollment period), only 314 participants (not 600 participants) were randomized to the study and hence the study was inconclusive due to the lacking of statistical power and robustness.|3|||f||||f||||||||||2017-02-18 15:13:39.365476|2017-02-18 15:13:39.365476
NCT00536367|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2014-06-11|||January 2006||2006-01-01|June 2014|2014-06-01|March 2008|Actual|2008-03-01|July 2007|Actual|2007-07-01||Observational|||Validation of a Mortality Prediction Model for Acutely Decompensated Heart Failure Patients|Validation of a Mortality Prediction Model for Acutely Decompensated Heart Failure Patients|Completed||N/A|226|Actual|Ohio State University|||1||f||||f||||||||||2017-02-18 15:13:39.740033|2017-02-18 15:13:39.740033
NCT00535340|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2009-03-10|||March 2007||2007-03-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|GEMINI||An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder|An Eight-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Fixed Dose of SR58611A 350 mg Twice a Day in Elderly Patients With Generalized Anxiety Disorder With an Optional Twenty-Four Week Extension|Terminated||Phase 3|55|Actual|Sanofi||2||reprioritization of indications|f||||||||||||||2017-02-18 15:13:39.838642|2017-02-18 15:13:39.838642
NCT00537901|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-12-16|||October 2007||2007-10-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study|First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study|Completed||N/A|100|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:13:39.939939|2017-02-18 15:13:39.939939
NCT00537888|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2010-12-13|||September 2007||2007-09-01|July 2009|2009-07-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week|Diagnosis of Pulmonary Candidiasis|Unknown status|Recruiting|Phase 4|200|Anticipated|Capital Medical University||1|||f||||t||||||||||2017-02-18 15:13:40.035919|2017-02-18 15:13:40.035919
NCT00537875|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2015-10-07|||September 2007||2007-09-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens|Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens|Completed||N/A|36|Actual|National Research Institute of Tuberculosis and Lung Disease, Iran||2|||f||||t||||||||||2017-02-18 15:13:40.142002|2017-02-18 15:13:40.142002
NCT00537862|ClinicalTrials.gov processed this data on February 17, 2017|2007-10-01|2011-11-01|||May 2006||2006-05-01|November 2011|2011-11-01||||February 2007|Actual|2007-02-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients|Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients ; A Prospective, Open Label, Multi-center Study|Completed||Phase 4|200|Actual|Novartis|||||f||||||||||||||2017-02-18 15:13:40.25271|2017-02-18 15:13:40.25271
NCT00537849|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2009-09-28|||December 2007||2007-12-01|April 2008|2008-04-01|March 2008|Anticipated|2008-03-01|March 2008|Anticipated|2008-03-01||Interventional|||Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada|Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada|Withdrawn||N/A|||SonaCare Medical||||Sponsor withdrew request to conduct study|f||||f||||||||||2017-02-18 15:13:40.343734|2017-02-18 15:13:40.343734
NCT00537836|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2015-04-08|||October 2007||2007-10-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||ZK283197 for Treatment of Vasomotor Symptoms|A Double-blind, Randomized, Placebo and Active Controlled, Multicenter Study to Investigate Efficacy and Safety After Oral Administration of 2 and 3 mg ZK 283197, 1 mg 17ß-estradiol and Placebo Once Daily for 8 Weeks in Postmenopausal Women With Hot Flushes|Completed||Phase 2|116|Actual|Bayer||4|||f||||f||||||||||2017-02-18 15:13:40.600966|2017-02-18 15:13:40.600966
NCT00537823|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-10-27|2016-08-31||June 2007||2007-06-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|||Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement|Effect of Short-duration Preoperative Neoadjuvant Therapy With FOLFOX Based Therapy on Morbidity After Liver Resection for Colorectal Cancer Metastases|Terminated||Phase 2|9|Actual|Washington University School of Medicine||2||Poor accrual.|f||||f||||||||||2017-02-18 15:13:40.721535|2017-02-18 15:13:40.721535
NCT00537810|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2014-12-11|2014-06-19||September 2007||2007-09-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Treatment of Binge Eating in Obese Patients in Primary Care|Treatment of Binge Eating in Obese Patients in Primary Care|Completed||Phase 4|104|Actual|Yale University||4|||f||||t||||||||||2017-02-18 15:13:41.337192|2017-02-18 15:13:41.337192
NCT00537797|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2014-09-18|||August 2004||2004-08-01|September 2014|2014-09-01|February 2014|Actual|2014-02-01|September 2011|Actual|2011-09-01||Interventional|||Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules|Limited Neck FDG-PET Imaging for Indeterminate Thyroid Nodules|Completed||N/A|84|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 15:13:41.982258|2017-02-18 15:13:41.982258
NCT00537771|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2012-12-20|2012-12-20||September 2007||2007-09-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|HEART||Liver Safety Under Upfront Arimidex vs Tamoxifen|A Prospective, Randomized, Multicentre, Comparative and Open-label Study on Hepatotoxicity of ARIMIDEX Compared With Tamoxifen in Adjuvant Therapy in Postmenopausal Women With Hormone Receptor+ Early Breast Cancer|Completed||Phase 4|384|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:13:42.20825|2017-02-18 15:13:42.20825
NCT00537758|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2007-09-27|||July 2002||2002-07-01|September 2007|2007-09-01||||||||Interventional|||Treatment for Obesity and Binge Eating Disorder|Treatment for Obesity and Binge Eating Disorder|Completed||N/A|125|Actual|Yale University||3|||f||||||||||||||2017-02-18 15:13:42.610466|2017-02-18 15:13:42.610466
NCT00537745|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2012-08-23|2011-07-20||April 2007||2007-04-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders|Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders-a Pilot Study|Completed||Phase 4|14|Actual|Pacific Institute for Research and Evaluation|Fourteen subjects were consented, and began the screening process. Two subjects did not meet entry criteria and 1 withdrew consent prior to injection. Of the remaining 11 subjects, 7 received 3, 2 received 2, and 2 received 1 injection(s).|1|||f||||f||||||||||2017-02-18 15:13:42.708963|2017-02-18 15:13:42.708963
NCT00537732|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2014-02-24|||April 2007||2007-04-01|February 2014|2014-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|GERD||Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing|Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing|Terminated||Phase 4|68|Actual|Robert Bosch Gesellschaft für Medizinische Forschung mbH||2||recruitment problems|f||||t||||||||||2017-02-18 15:13:42.946374|2017-02-18 15:13:42.946374
NCT00537719|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2016-11-02|||December 2007||2007-12-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.|A Single-Blind, Randomized, Placebo-Controlled Study in Healthy Men and Women to Determine the Effect of Single Subcutaneous Injections of GSK716155 on Gastric Emptying Time for Solid and Liquid Components of a Meal|Completed||Phase 1|34|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:13:43.058963|2017-02-18 15:13:43.058963
NCT00537706|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2017-01-24|||September 21, 2007||2007-09-21|October 31, 2011|2011-10-31|October 31, 2011||2011-10-31|||||Observational|||Choosing Healthful Interventions|Engaging Low-Income Urban Residents in Prioritizing Interventions to Address Socio-Economic Determinants of Health|Completed||N/A|442|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:13:43.352487|2017-02-18 15:13:43.352487
NCT00537693|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2010-09-01|||September 2007||2007-09-01|September 2010|2010-09-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Cytokine Removal by CRRT in Pediatric Sepsis|Cytokine Removal by CRRT in Pediatric Sepsis: A Comparison of Convection Versus Diffusion|Completed||N/A|40|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||||||||||||2017-02-18 15:13:43.431378|2017-02-18 15:13:43.431378
NCT00537680|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2012-02-02|2011-06-07||December 2007||2007-12-01|February 2012|2012-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|IONIA||Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia|A Phase III Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients|Completed||Phase 3|70|Actual|Santhera Pharmaceuticals||3|||f||||t||||||||||2017-02-18 15:13:43.544492|2017-02-18 15:13:43.544492
NCT00537667|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2009-11-25|||August 2001||2001-08-01|December 2008|2008-12-01|June 2003|Actual|2003-06-01|March 2003|Actual|2003-03-01||Interventional|||The SPECTRA Study|A Single Centre, Open-Label, Randomised, Study to Evaluate the Effect of Anakinra (r-metHuIL-1ra) Alone and in Combination With PEGylated Recombinant Methionyl Human Soluble Tumour Necrosis Factor Receptor Type I (PEG sTNF-RI) on Synovial Inflammation in Subjects With Rheumatoid Arthritis.|Terminated||Phase 2|22|Actual|Swedish Orphan Biovitrum||2||The safety profile of combination therapy became unacceptable.|f||||||||||||||2017-02-18 15:13:44.019399|2017-02-18 15:13:44.019399
NCT00537654|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2010-10-13||2010-10-13|October 2007||2007-10-01|October 2010|2010-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State|See Detailed Description|Completed||Phase 1|81|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:13:44.116073|2017-02-18 15:13:44.116073
NCT00537641|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2015-07-02|||May 2007||2007-05-01|July 2015|2015-07-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Observational|||Efficacy of Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)|Prevalence and Severity of Nocturnal Oxygenation and Ventilation Failure in Patients With Amyotrophic Lateral Sclerosis Using Noninvasive Ventilation|Completed||N/A|25|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 15:13:44.211409|2017-02-18 15:13:44.211409
NCT00537628|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2008-07-30|||March 2007||2007-03-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Observational|BACH||Biomarkers in Acute Heart Failure|Biomarkers in Acute Heart Failure: An International, Multi-Center Trial Evaluating the Prognostic and Diagnostic Utility of Biomarkers in Patients With Heart Failure Presenting With Shortness of Breath|Completed||N/A|1641|Actual|Brahms AG|||1||f||||f||||||Samples Without DNA|"~     plasma~   "|||2017-02-18 15:13:44.298965|2017-02-18 15:13:44.298965
NCT00537615|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2010-02-16|||September 2007||2007-09-01|February 2010|2010-02-01|October 2007|Actual|2007-10-01|||||Interventional|||An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers|A Phase 1 Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0332334 In Six Healthy Male Volunteers|Completed||Phase 1|6|Actual|Pfizer|||||f||||||||||||||2017-02-18 15:13:44.566298|2017-02-18 15:13:44.566298
NCT00537602|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2010-02-11|||November 2007||2007-11-01|February 2010|2010-02-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Miglustat / OGT 918 in the Treatment of Cystic Fibrosis|Single Center, Double-blind, Randomized, Placebo-controlled, 2-period/2-treatment Crossover Study Investigating the Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the ΔF508 Mutation|Terminated||Phase 2|6|Actual|Actelion||2||Methodology applied did not meet all criteria required per guidelines|f||||f||||||||||2017-02-18 15:13:44.653636|2017-02-18 15:13:44.653636
NCT00537576|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2009-05-06|||November 2007||2007-11-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Safety Study of Lactobacillus Administered Vaginally to Healthy Women|A Phase I Study of the Safety of LACTIN-V Administered Vaginally to Healthy Women|Completed||Phase 1|12|Actual|Osel, Inc.||4|||f||||f||||||||||2017-02-18 15:13:44.854837|2017-02-18 15:13:44.854837
NCT00537563|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2012-02-15|||December 2002||2002-12-01|February 2012|2012-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||AMS VS MOXI Ketek vs Avelox in AMS||Completed||Phase 3|351|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:13:44.977146|2017-02-18 15:13:44.977146
NCT00537550|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2007-09-28|||July 2000||2000-07-01|September 2007|2007-09-01|June 2006|Actual|2006-06-01|||||Interventional|LAL2000||Adult ALL Treatment at Diagnosis|GIMEMA Guidelines for the Treatment of Adult ALL Affected Patients at Diagnosis|Completed||N/A|||Gruppo Italiano Malattie EMatologiche dell'Adulto|||||f||||f||||||||||2017-02-18 15:13:45.078344|2017-02-18 15:13:45.078344
NCT00537537|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-04-20|||August 2007||2007-08-01|April 2016|2016-04-01||||June 2011|Actual|2011-06-01||Interventional|||To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)|An Open Label, Response Adaptive Study of Telbivudine in Adults With HBeAg Positive Compensated CHB|Completed||Phase 4|100|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:13:45.190238|2017-02-18 15:13:45.190238
NCT00537524|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2012-02-14|||September 2007||2007-09-01|February 2012|2012-02-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years|A Phase II, Randomized, Controlled, Observer-blind, Single-center Study to Evaluate the Immunogenicity, Safety and Tolerability of Two Doses of an H5N1 Influenza Vaccine in Subjects Aged 6 Months to 17 Years|Completed||Phase 2|471|Actual|Novartis||2|||f||||t||||||||||2017-02-18 15:13:45.304559|2017-02-18 15:13:45.304559
NCT00537511|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2013-05-07|2013-03-06||February 2008||2008-02-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional||Safety Population|A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide|A Multicenter, Phase I/IIA, Open-Label, Dose-Escalation Study to Determine the Maximum Tolerated Dose and To Evaluate the Safety Profile of CC-4047 Administered in Combination With Cisplatin and Etoposide in Patients With Extensive Disease Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|22|Actual|Celgene||1||This study was terminated for administrative reasons.|f||||f||||||||||2017-02-18 15:13:45.431702|2017-02-18 15:13:45.431702
NCT00537498|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2010-03-24|||February 2002||2002-02-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|||||Interventional|||Urokinase Therapy in Diabetic Foot Syndrome|Phase II Study of Urokinase Therapy for Treatment of Angiopathic or Angioneuropathic Diabetic Foot Syndrome|Completed||Phase 2|77|Actual|medac GmbH||1|||f||||f||||||||||2017-02-18 15:13:46.521147|2017-02-18 15:13:46.521147
NCT00537485|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2014-02-03|2014-02-03||September 2007||2007-09-01|February 2014|2014-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||Excluded 3 subjects (SPM962:2, placebo:1) because lack of assessment of efficacy, and 1 (plasebo) for not matching with the inclusion criteria.|A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients|A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients With Non-concomitant Treatment of L-dopa|Completed||Phase 2/Phase 3|180|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 15:13:46.622203|2017-02-18 15:13:46.622203
NCT00537472|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2009-04-16|||October 2007||2007-10-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Low Dose Spinal Bupivacaine for Total Knee Replacement and Recovery Room Wait Time|Low Dose Spinal Bupivacaine for Total Knee Arthroplasty and Recovery Room Wait Time|Completed||N/A|140|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 15:13:47.401508|2017-02-18 15:13:47.401508
NCT00537459|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-03-15|||December 2006||2006-12-01|February 2011|2011-02-01||||||||Interventional|||A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation|A Randomized, Double-blind, Placebo-controlled, Two-session Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an 16448 in Healthy Males With Premature Ejaculation.|Completed||Phase 2|18|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:13:47.511549|2017-02-18 15:13:47.511549
NCT00537446|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2011-10-12|||September 2007||2007-09-01|October 2011|2011-10-01||||August 2012|Anticipated|2012-08-01||Interventional|||Effect of Noninvasive Ventilation on Lung Function in Amyotrophic Lateral Sclerosis|Effect of Noninvasive Positive Pressure Ventilation on Pulmonary Function Testing in Amyotrophic Lateral Sclerosis|Unknown status|Recruiting|N/A|20|Anticipated|Columbia University||2|||f||||f||||||||||2017-02-18 15:13:47.600878|2017-02-18 15:13:47.600878
NCT00537433|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2007-09-28|||July 2006||2006-07-01|September 2007|2007-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Improving Parental Understanding of Medication Instructions Through a Pictogram-Based Intervention|An RCT to Reduce Liquid Medication Dosing Errors and Improve Adherence in Caregivers of Young Children Through a Pictogram-Based Intervention|Completed||Phase 1|251|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-02-18 15:13:47.705071|2017-02-18 15:13:47.705071
NCT00537420|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2008-09-12|||October 2007||2007-10-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects|A 24-Week, Blinded, Randomized, Placebo-Controlled Dose-Ranging Trial of Nasal PYY3-36 for Weight Loss in Healthy Obese Patients|Completed||Phase 2|551|Actual|Nastech Pharmaceutical Company, Inc.||6|||f||||f||||||||||2017-02-18 15:13:47.802167|2017-02-18 15:13:47.802167
NCT00537407|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2016-02-12|2015-04-01||September 2007||2007-09-01|February 2016|2016-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||Intent-to-treat population: All randomized participants with at least a Baseline and 1 on- or post-treatment hepatitis C virus RNA assessment.|A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment|An Open-label, Randomized, 5-arm, Parallel-group Study of the Effects on Viral Kinetics, Safety and Pharmacokinetics of Different Dosing Regimens of Debio 025 in Combination With Peginterferon Alpha-2a and Ribavirin in Chronic HCV Genotype 1 Patients Who Are Non Responders to Standard Peginterferon Alpha and Ribavirin Treatment|Completed||Phase 2|50|Actual|Debiopharm International SA||5|||f||||t||||||||||2017-02-18 15:13:47.955426|2017-02-18 15:13:47.955426
NCT00535535|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2013-09-19|||August 2007||2007-08-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Fructose-Induced Palmitate Synthesis in Overweight Subjects|Fructose-Induced Palmitate Synthesis in Overweight Subjects|Completed||Phase 1|15|Anticipated|Rockefeller University|||||f||||||||||||||2017-02-18 15:14:22.10669|2017-02-18 15:14:22.10669
NCT00537394|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-05-24|2013-06-14||January 2008||2008-01-01|May 2016|2016-05-01|April 2013|Actual|2013-04-01|May 2012|Actual|2012-05-01||Interventional||Everyone randomized (ITT study sample), plus non-randomized group.|Optimizing Treatment for Treatment-Experienced, HIV-Infected People|The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen|Completed||Phase 3|517|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||t||||||||||||||2017-02-18 15:13:49.563915|2017-02-18 15:13:49.563915
NCT00537381|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2013-06-12|2013-03-28||May 2007||2007-05-01|June 2013|2013-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer|A Randomized, Double-blind, Multicenter, Phase 2 Study of a Human Monoclonal Antibody to Human av Integrins (CNTO 95) in Combination With Docetaxel for the First-Line Treatment of Subjects With Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|131|Actual|Centocor, Inc.|Treatment with intetumumab/placebo was permanently discontinued after a planned, preliminary review of interim analysis data. Therefore, study treatment with intetumumab was not completed for some participants.|2|||f||||t||||||||||2017-02-18 15:13:51.153024|2017-02-18 15:13:51.153024
NCT00537368|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2010-10-21|||September 2007||2007-09-01|October 2010|2010-10-01|March 2010|Actual|2010-03-01|||||Interventional|||First Study of the Safety of CNTO 888 in Patients With Solid Tumors|A Phase 1 Study of CNTO 888, a Human Monoclonal Antibody Against CC-Chemokine Ligand 2 in Subjects With Solid Tumors|Completed||Phase 1|44|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 15:13:54.920862|2017-02-18 15:13:54.920862
NCT00537355|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-11-08|||September 2007||2007-09-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of TOLAMBA™ in the Control of Symptoms of Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber (EEC) Model|Completed||Phase 2|271|Actual|Dynavax Technologies Corporation||2|||f||||f||||||||No|"The IND for Tolamba was withdrawn. There is no intention to conduct clinical studies with this compound. All studies were conducted in Canada, no U.S. sites participated in study. CT PRS states DR status will be removed from study."|2017-02-18 15:13:55.002182|2017-02-18 15:13:55.002182
NCT00537342|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2010-12-16|||October 2007||2007-10-01|December 2010|2010-12-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT)|Prospective, Randomised, Double Blind, Placebo Controlled Study of Treatment With Sublingual Immunotherapy of Depigmented and Polymerised Allergen Extract of O. Europaea in Two Groups of Patients With Allergic Rhinitis /Rhinoconjunctivitis|Completed||Phase 3|83|Actual|Laboratorios Leti, S.L.||2|||f||||f||||||||||2017-02-18 15:13:55.118934|2017-02-18 15:13:55.118934
NCT00537329|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2010-03-04|2010-01-19||January 2008||2008-01-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Anidulafungin In Treatment Of Candidemia In Asian Subjects|A Phase IIIB Pilot Study Of Efficacy And Safety Of Anidulafungin In The Treatment Of Candidemia In Asian Patients|Completed||Phase 3|43|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:13:55.230645|2017-02-18 15:13:55.230645
NCT00537316|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2015-03-30|2011-11-11||July 2007||2007-07-01|March 2015|2015-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)|Comparison of the Efficacy and Safety of Infliximab, as Monotherapy or in Combination With Azathioprine, Versus Azathioprine Monotherapy in Moderate to Severe Active Ulcerative Colitis (Part 1) Comparison of Maintenance Versus Intermittent Infliximab Treatment in Maintaining Remission: A Follow-Up of Efficacy and Safety (Part 2)|Terminated||Phase 3|242|Actual|Merck Sharp & Dohme Corp.||7||"Infusion reactions during re-induction cycles after a period of no treatment in another study~   [P04563, NCT0358670]"|f||||f||||||||||2017-02-18 15:13:56.077224|2017-02-18 15:13:56.077224
NCT00537303|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2014-11-20|2010-07-16||October 2007||2007-10-01|November 2014|2014-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes|Comparison of the Efficacy and Safety of Step-wise Addition of Short Acting Insulin Analogue Insulin Aspart to Once Daily Insulin Detemir and Oral Anti-diabetic Treatment in Patients With Type 2 Diabetes|Completed||Phase 4|296|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 15:13:57.63386|2017-02-18 15:13:57.63386
NCT00537290|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2014-04-04|||September 2007||2007-09-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|RITAPS||A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome|A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome (RITAPS)|Completed||Phase 2|19|Actual|Hospital for Special Surgery, New York||1|||f||||t||||||||||2017-02-18 15:13:58.490372|2017-02-18 15:13:58.490372
NCT00537277|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2014-11-20|2010-07-19||October 2007||2007-10-01|November 2014|2014-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|IMPROVE||Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs|A Titrate-To-Target Study of the Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets on OADs With / Without Once Daily Basal Insulin Therapy|Completed||Phase 4|161|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 15:13:58.602337|2017-02-18 15:13:58.602337
NCT00537264|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2009-06-22|||November 2007||2007-11-01|June 2009|2009-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Comparison of Computerised Versus Interviewer-Administered Approach for Assessing Health-Related Quality of Life|A Randomized Controlled Trial Comparing Computer- Versus Interviewer-Administered Approach for Assessing Health-Related Quality of Life in Multi-Ethnic Singapore|Completed||N/A|4800|Actual|Singapore General Hospital||2|||f||||f||||||||||2017-02-18 15:13:58.913277|2017-02-18 15:13:58.913277
NCT00537251|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2007-09-28|||November 2001||2001-11-01|September 2007|2007-09-01|February 2004|Actual|2004-02-01|||||Interventional|||32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus|32-Week, Open, Randomized, Cross-Over, Local, Multicenter Clinical Trial Comparing Insulin Glargine in Combination With Insulin Analogue (Insulin Lispro) to NPH Insulin in Combination With Regular Insulin in Type 1 Diabetes Mellitus Patients in an Intensified Insulin Regimen.|Completed||Phase 3|80|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:13:59.194788|2017-02-18 15:13:59.194788
NCT00537238|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2013-05-21|2013-05-21||October 2007||2007-10-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pregabalin Versus Levetiracetam In Partial Seizures|A Randomized, Double-Blind, Parallel-Group Multi-Center Comparative Flexible-Dose Study Of Pregabalin Versus Levetiracetam As Adjunctive Therapy To Reduce Seizure Frequency In Subjects With Partial Seizures|Completed||Phase 3|509|Actual|Pfizer|Results for BPRS were provided as change in scores at Week 16 compared to baseline instead of absolute scores as per planned analysis.|2|||f||||t||||||||||2017-02-18 15:13:59.288057|2017-02-18 15:13:59.288057
NCT00537225|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-09-06|||September 2006||2006-09-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|VIGOR2||Multifactor Risk Reduction for Optimal Management of PAD|Multifactor Risk Reduction for Optimal Management of PAD|Active, not recruiting||N/A|300|Actual|Palo Alto Veterans Institute for Research||1|||f||||t||||||||||2017-02-18 15:14:00.273363|2017-02-18 15:14:00.273363
NCT00537212|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-28|2012-02-01|||June 2007||2007-06-01|February 2012|2012-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy|A Single-Center, Prospective, Single-Blinded, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy|Completed||Phase 4|||Bagel, Jerry, M.D.||3|||f||||t||||||||||2017-02-18 15:14:00.377811|2017-02-18 15:14:00.377811
NCT00537199|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2016-04-05|2009-12-11||November 2006||2006-11-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||OraTest in Combination With Visual Examination and Visual Examination Alone|Evaluation of OraTest in Combination With Visual Examination in the Improved Detection of Oral Mucosal Lesions Suspicious of Serious Pathology in High-Risk Patients for the Purpose of Referral to the Health Care Professional Experienced in Oral Cancer: Phase III Clinical Trial Comparing the Sensitivity and Assessing the Specificity of OraTest in Combination With Visual Examination and Visual Examination Alone in Patients at High Risk as Defined by Age and Lifestyle Factors (ZIL-401)|Terminated||Phase 3|1|Actual|M.D. Anderson Cancer Center|Early termination by sponsor resulted in only 1 patient enrolled and no analysis.|1||Study terminated early as per request by sponsor, Zila Biotechnology, Inc.|f||||f||||||||||2017-02-18 15:14:00.49449|2017-02-18 15:14:00.49449
NCT00537186|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2008-10-07|||June 2007||2007-06-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of Iron Oligosaccharide in CHF Patients|A Non-Comparative Open-Label Study of Iron Oligosaccharide in CHF Patients With Iron Deficiency (Either Absolute or Functional) Anaemia and a Need for Parenteral Iron|Completed||Phase 3|20|Actual|Pharmacosmos A/S||1|||f||||f||||||||||2017-02-18 15:14:00.710984|2017-02-18 15:14:00.710984
NCT00537173|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2017-01-24|||September 2007||2007-09-01|January 2017|2017-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer|Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study|Terminated||N/A|11|Actual|Hoosier Cancer Research Network|||1|Lack of Accrual|f||||t||||||Samples With DNA|"~     Blood and tumor samples~   "|||2017-02-18 15:14:00.819527|2017-02-18 15:14:00.819527
NCT00537160|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2012-10-25|||April 2006||2006-04-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Diet and Exercise in Overweight Children Postburn|The Impact of a Diet and Exercise Program in Overweight Pediatric Patients During Burn Rehabilitation|Withdrawn||Early Phase 1|0|Actual|Shriners Hospitals for Children||1|||f||||t||||||||||2017-02-18 15:14:00.935881|2017-02-18 15:14:00.935881
NCT00537147|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2012-12-31|||March 2008||2008-03-01|December 2012|2012-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of a 2-Dose Regimen of West Nile/Dengue 4-3'delta30 Chimeric Virus Vaccine (WN/DEN4delta30), a Live Attenuated Vaccine for West Nile Encephalitis|Completed||Phase 1|26|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 15:14:01.019657|2017-02-18 15:14:01.019657
NCT00537134|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2015-11-02|||September 2006||2006-09-01|July 2015|2015-07-01|September 2021|Anticipated|2021-09-01|September 2020|Anticipated|2020-09-01||Interventional|TEAM||Trial on Endovascular Aneurysm Management|Safety and Efficacy of Endovascular Treatment of Unruptured Intracranial Aneurysms in the Prevention of Aneurysmal Haemorrhages: A Randomized Comparison With Indefinite Deferral of Treatment in 2002 Patients Followed for 10 Years|Suspended||N/A|2002|Anticipated|Centre hospitalier de l'Université de Montréal (CHUM)||2||The CIHR Financial support was withdrawn because of insufficient recruitment|f||||t||||||||||2017-02-18 15:14:01.144056|2017-02-18 15:14:01.144056
NCT00537121|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2013-06-26|||November 2006||2006-11-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|October 2012|Actual|2012-10-01||Interventional|||Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer|Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (VORINOSTAT)] With Irinotecan, 5-Fluorouracil (5-FU) and Leucovorin (FOLFIRI) for Advanced Upper Gastrointestinal Cancers|Completed||Phase 1|23|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 15:14:01.271259|2017-02-18 15:14:01.271259
NCT00537108|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2015-05-26|||August 2007||2007-08-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|BRIDGES||Community-Based Care Management For Teen/Young Adult Mothers and Fathers|BRIDGES: A Randomized Trial of Community-Based Care Management For Teen/Young Adult Mothers and Fathers|Completed||N/A|200|Actual|University of Maryland||2|||f||||f||||||||||2017-02-18 15:14:01.372369|2017-02-18 15:14:01.372369
NCT00537095|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-10-07|2011-04-27||September 2007||2007-09-01|October 2016|2016-10-01|December 2019|Anticipated|2019-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer|A Randomized, Double Blind, Placebo-controlled Phase II, Multi-Centre Study to Assess the Efficacy and Safety of Vandetanib (ZD6474) in Patients With Locally Advanced or Metastatic Papillary or Follicular Thyroid Carcinoma Failing or Unsuitable for Radioiodine Therapy|Active, not recruiting||Phase 2|145|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:14:01.478303|2017-02-18 15:14:01.478303
NCT00537082|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2011-04-19|2011-02-21||September 2007||2007-09-01|April 2011|2011-04-01||||February 2010|Actual|2010-02-01||Interventional|||Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)|A 6-month, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study Comparing Efficacy and Safety of FTY720 0.5 mg and 1.25 mg Administered Orally Once Daily in Patients With Relapsing Multiple Sclerosis|Completed||Phase 2|171|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:14:02.166055|2017-02-18 15:14:02.166055
NCT00537056|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2013-04-04|||October 2007||2007-10-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|||Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI|Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI|Completed||N/A|18|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 15:14:02.909783|2017-02-18 15:14:02.909783
NCT00537043|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2010-10-13||2010-10-13|October 2007||2007-10-01|October 2010|2010-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood Pressure|An Open-label, Randomized, Crossover, Repeat-dose Study to Evaluate the Steady-State Pharmacokinetic Profile of the Final Fixed Dose Combination (FDC) Formulation of COREG CR and Lisinopril as Compared to COREG CR in Subjects With Essential Hypertension|Completed||Phase 1|24|Anticipated|GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:14:03.019743|2017-02-18 15:14:03.019743
NCT00537030|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-12-22|2013-10-07||February 2008||2008-02-01|March 2016|2016-03-01||||February 2011|Actual|2011-02-01||Interventional|||Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia|Pharmacology and Toxicity of Erwinia Asparaginase (Erwinase®; Crisantaspase; IND 290) Following Allergy to PEG-Asparaginase in Treatment of Children With Acute Lymphoblastic Leukemia (ALL)|Active, not recruiting||N/A|59|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 15:14:03.11934|2017-02-18 15:14:03.11934
NCT00537017|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-12-19|2016-10-11||November 2007||2007-11-01|December 2016|2016-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)|A Phase 2, 36-Week, Open-Label, Uncontrolled Safety Follow-up Study Assessing SCH 420814 (Preladenant) 5 mg BID (P05175)|Completed||Phase 2|140|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 15:14:03.466968|2017-02-18 15:14:03.466968
NCT00537004|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2017-01-30|||May 2007||2007-05-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|||Language in Primary Progressive Aphasia|Language in Primary Progressive Aphasia|Recruiting||N/A|300|Anticipated|Northwestern University|||2||f||||f||||||||||2017-02-18 15:14:03.85519|2017-02-18 15:14:03.85519
NCT00536991|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2016-10-26|||October 2006||2006-10-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer|A Phase I/II Study of Oral Calcitriol in Combination With Ketoconazole in Androgen Independent Prostate Cancer|Terminated||Phase 1/Phase 2|40|Actual|Roswell Park Cancer Institute||1||difficult to recruit|f||||t||||||||||2017-02-18 15:14:03.979413|2017-02-18 15:14:03.979413
NCT00536978|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2012-04-23|2012-04-23||September 2007||2007-09-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies|T-Cell or Natural Killer (NK) Cell Adback in Patients With Lymphoid Malignancies Receiving Allogeneic Stem Cell Transplantation With Campath-IH Containing Conditioning Regimens|Completed||Phase 2|22|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:14:04.10232|2017-02-18 15:14:04.10232
NCT00536965|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2014-10-29|||July 2007||2007-07-01|October 2014|2014-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets|Non-interventional Study Investigating How Effective Secondary Prevention Patients Are Treated to Their LDL-C Targets|Completed||N/A|951|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 15:14:04.360441|2017-02-18 15:14:04.360441
NCT00536952|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-27|2013-06-25|||February 2008||2008-02-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|October 2014|Anticipated|2014-10-01||Interventional|||Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy|A Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation and Chemotherapy|Unknown status|Active, not recruiting|Early Phase 1|36|Anticipated|Northwestern University||2|||f||||t||||||||||2017-02-18 15:14:04.442356|2017-02-18 15:14:04.442356
NCT00536939|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2009-10-05||2009-03-26|November 2007||2007-11-01|October 2009|2009-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer|A Randomized, Double-Blind, Phase 2 Trial of Paclitaxel Plus Bevacizumab and Enzastaurin Versus Paclitaxel Plus Bevacizumab and Placebo for Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 2|2|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:14:04.554516|2017-02-18 15:14:04.554516
NCT00536354|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2007-09-26|||August 2005||2005-08-01|September 2007|2007-09-01|December 2005|Actual|2005-12-01|||||Interventional|||Postural Orientation In The Use Of School Backpacks|Effects Of Postural Orientation In The Use Of School Backpacks In Elementary School Students|Completed||Early Phase 1|||University of Sao Paulo|||||f||||t||||||||||2017-02-18 15:14:04.797014|2017-02-18 15:14:04.797014
NCT00536341|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-11-29|2016-03-31||January 2008||2008-01-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|April 2013|Actual|2013-04-01||Interventional||All enrolled and treated patients|Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)|A Phase I/II Study of Fludarabine, Rituximab, and Lenalidomide in Minimally Treated and Untreated Patients With Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|64|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 15:14:04.877616|2017-02-18 15:14:04.877616
NCT00536328|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2008-07-07|||October 2007||2007-10-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|||||Observational|PREDICT||What is the Predictive Value of the Reflux Impact Scale|What is the Value of the Use of Validated Questionnaire (Reflux Impact Scale) for Predicting Treatment Success With PPI|Terminated||N/A|938|Anticipated|AstraZeneca|||1|"due to very low recruitment. For this reason, there will be no further analysis and reporting~   of this study."|f||||||||||||||2017-02-18 15:14:05.400389|2017-02-18 15:14:05.400389
NCT00536315|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2010-02-03|||March 1999||1999-03-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|||||Observational|||Tracheal Mechanics During Bronchoscopy|Tracheal Mechanics During Bronchoscopy|Completed||N/A|150|Anticipated|Beth Israel Deaconess Medical Center|||3||f||||f||||||||||2017-02-18 15:14:05.470927|2017-02-18 15:14:05.470927
NCT00535912|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-10-31|||January 1999||1999-01-01|September 2007|2007-09-01|March 2006|Actual|2006-03-01|||||Interventional|||Phase III Study Treatment of CLL B and C|A Multicentric Phase III Study in Patients With CLL B and C < 60 Years Not Treated: 6 Montly CHOP + 6 CHOP Every 3 Months Versus 3 Montly CHOP + Intensification and Autograft|Completed||Phase 3|140|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||||2017-02-18 15:14:14.198424|2017-02-18 15:14:14.198424
NCT00536302|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2009-02-05|||March 2007||2007-03-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|NMR||A Placebo-Controlled Study of Collagen Hydrolysate in Subjects With Knee Osteoarthritis (OA)|A Single Center, Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Clinical Trial to Evaluate the Sensitivity of Magnetic Resonance Imaging to Detect Change in Cartilage Structure and Composition in 30 Participants Diagnosed With Osteoarthritis of the Knee and Treated With Collagen Hydrolysate|Completed||Phase 2/Phase 3|30|Actual|GELITA||2|||f||||t||||||||||2017-02-18 15:14:05.577612|2017-02-18 15:14:05.577612
NCT00536289|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-09-26|||January 2005||2005-01-01|January 2006|2006-01-01|September 2006|Actual|2006-09-01|||||Interventional|||Blunt Needles do Not Reduce Needlestick Injuries to Doctors During Suturing After Child-Birth|The Use of Blunt Needles Does Not Reduce Needlestick Injury During Obstetrical Laceration Repair|Completed||N/A|438|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 15:14:05.855877|2017-02-18 15:14:05.855877
NCT00536276|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2012-05-08|||March 2003||2003-03-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|December 2009|Actual|2009-12-01||Interventional|VitaminD||Evaluation of Vitamin D Status in Children With Acute Burns|Vitamin D Deficiency in Acutely Injured Pediatric Burn Patients: Incidence, Etiology, Metabolic Sequelae and Prevention|Completed||Phase 1|50|Actual|Shriners Hospitals for Children||1|||f||||t||||||||||2017-02-18 15:14:05.9505|2017-02-18 15:14:05.9505
NCT00536263|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2015-02-25|2010-11-23||September 2007||2007-09-01|February 2015|2015-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)|An Open-label, Randomized Study of PegIntron in the Treatment of HBeAg Positive Chronic Hepatitis B Patients|Completed||Phase 3|671|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 15:14:06.068028|2017-02-18 15:14:06.068028
NCT00536250|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-04-06|||September 2001||2001-09-01|April 2016|2016-04-01|December 2018|Anticipated|2018-12-01|September 2018|Anticipated|2018-09-01||Observational|||Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth|Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth|Recruiting||N/A|255|Anticipated|Yale University|||1||f||||t||||||||||2017-02-18 15:14:06.999652|2017-02-18 15:14:06.999652
NCT00536237|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2015-08-24|||August 2004||2004-08-01|August 2015|2015-08-01|December 2006|Actual|2006-12-01|February 2005|Actual|2005-02-01||Interventional|||MK0524A Phase IIb Study (0524A-011)(COMPLETED)|Part A: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of MK0524 Compared to Placebo Part B: A Dose-Ranging Study to Evaluate the Tolerability of MK0524 and Its Effects on Niacin-Induced Flushing in Lipid Clinic Patients|Completed||Phase 2|154|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:14:07.097415|2017-02-18 15:14:07.097415
NCT00536224|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2009-03-12|||September 2007||2007-09-01|March 2009|2009-03-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Chest Pain Observation Unit Risk Reduction Trial|Brief Intervention to Promote Cardiovascular Risk Reduction in Patients Admitted to Chest Pain Observation Units|Unknown status|Active, not recruiting|Phase 3|240|Anticipated|University of Iowa||2|||f||||t||||||||||2017-02-18 15:14:07.185968|2017-02-18 15:14:07.185968
NCT00536211|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-08-10|||June 2009||2009-06-01|August 2015|2015-08-01|December 2011|Anticipated|2011-12-01|October 2011|Anticipated|2011-10-01||Interventional|||Physical Inactivity and Insulin Resistance in Skeletal Muscle.|Physical Inactivity and Insulin Resistance in Skeletal Muscle.|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||2||protocol not approved by VA R&D|f||||f||||||||||2017-02-18 15:14:07.293995|2017-02-18 15:14:07.293995
NCT00536198|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-11-28|2016-01-05||September 2007||2007-09-01|November 2016|2016-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Analysis included all women enrolled.|Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder|Symptom Onset Antidepressant Treatment for PMDD|Completed||Phase 4|252|Actual|Yale University|Limitations of this study include attrition over time and the restricted dose range of 25-100mg sertraline.|2|||f||||t||||||||No|we will share data with a data request that is reviewed by investigators|2017-02-18 15:14:07.419186|2017-02-18 15:14:07.419186
NCT00536185|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2011-08-03|||December 2006||2006-12-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Heart & Health Study|Variation in the ALOX5 Gene and Response to Omega-3 Fatty Acid Supplements|Completed||N/A|166|Anticipated|USDA, Western Human Nutrition Research Center||2|||f||||f||||||||||2017-02-18 15:14:08.70207|2017-02-18 15:14:08.70207
NCT00536172|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2014-02-20|2013-12-20||December 2007||2007-12-01|February 2014|2014-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|PROTECT||Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment|Prevention of Depression in Patients Being Treated for Head and Neck Cancer|Completed||Phase 4|160|Actual|University of Nebraska||2|||f||||t||||||||||2017-02-18 15:14:08.831067|2017-02-18 15:14:08.831067
NCT00536159|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-26|||January 1997||1997-01-01|September 2007|2007-09-01|August 2000|Actual|2000-08-01|||||Interventional|||Medicaid Enhanced Prenatal/Postnatal Services Using a Nurse-Community Health Worker Team|Improving the Health and Development of Low-Income Pregnant Women|Completed||N/A|613|Actual|Michigan State University||2|||f||||f||||||||||2017-02-18 15:14:09.870372|2017-02-18 15:14:09.870372
NCT00536146|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2017-01-24|||September 24, 2007||2007-09-24|January 29, 2009|2009-01-29|January 29, 2009||2009-01-29|||||Observational|||The Stress-Hormone System in Alcohol-Dependent Subjects|Trauma, Stress and Persistence of HPA Dysregulation in Alcoholism|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:14:09.978333|2017-02-18 15:14:09.978333
NCT00536133|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2009-08-03|||April 2006||2006-04-01|August 2009|2009-08-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Role of Zinc in Recurrent Acute Lower Respiratory Infections|Role of Zinc in Recurrent Acute Lower Respiratory Infections|Completed||Phase 3|208|Actual|Jawaharlal Nehru Medical College||2|||f||||t||||||||||2017-02-18 15:14:10.063367|2017-02-18 15:14:10.063367
NCT00536120|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-12-29|2011-03-17||January 2008||2008-01-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis|A Randomized, Open-Label Study to Assess the Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis|Completed||Phase 4|60|Actual|Biogen||2|||f||||f||||||||||2017-02-18 15:14:10.179794|2017-02-18 15:14:10.179794
NCT00534105|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2013-07-02|2013-07-02||September 2007||2007-09-01|July 2013|2013-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Lipid Metabolism in Gestational Diabetes|Study of Lipid Metabolism in Gestational Diabetes|Completed||N/A|106|Actual|Baystate Medical Center|||2||f||||f||||||||||2017-02-18 15:14:53.756223|2017-02-18 15:14:53.756223
NCT00536107|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2013-08-01|2013-08-01||October 2007||2007-10-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)|A Randomized/Open Label/Parallel Group/Multicenter/Phase IV Study to Assess Safety/Tolerability/Efficacy of Oral Gefitinib 250 mg Versus IV Docetaxel 60 mg/m2 in Patients With Locally Advanced or Metastatic NSCL Cancer of Adenocarcinoma Histology Previous Treated With One Platinum Base Chemotherapy|Terminated||Phase 4|14|Actual|AstraZeneca|This study was terminated early because the purpose of this study had been fulfilled by other supporting data, and due to small number of patients enrolled (14 patients).|2|||f||||f||||||||||2017-02-18 15:14:11.012927|2017-02-18 15:14:11.012927
NCT00536094|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2013-09-23|||October 2006||2006-10-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||School-based Treatment for Anxious Children|School-Based CBT for Anxious African-American Children|Completed||Phase 3|40|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 15:14:11.578004|2017-02-18 15:14:11.578004
NCT00536081|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2009-12-22|||January 2008||2008-01-01|December 2009|2009-12-01|December 2010|Anticipated|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Various G-CSF Regimens to Prevent Infection During Chemotherapy|Primary G-CSF Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Breast Cancer Patients at Risk of Febrile Neutropenia|Terminated||Phase 3|172|Actual|Academisch Ziekenhuis Maastricht||2||"More cases of Febrile Neutropenia were observed in experimental group compared to standard~   treatment."|f||||f||||||||||2017-02-18 15:14:11.695203|2017-02-18 15:14:11.695203
NCT00536068|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-09-27|||August 2006||2006-08-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Platelet Inhibition by Aspirin, Acetaminophen and NSAID||Completed||N/A|11|Actual|Kantonsspital Graubünden||1|||f||||f||||||||||2017-02-18 15:14:11.824124|2017-02-18 15:14:11.824124
NCT00536055|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-09-26|||October 2007||2007-10-01|September 2007|2007-09-01|August 2008|Anticipated|2008-08-01|||||Observational|||Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses|Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses - A Pilot Stdy|Unknown status|Not yet recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 15:14:11.923948|2017-02-18 15:14:11.923948
NCT00536042|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-09-26|||October 1997||1997-10-01|September 2007|2007-09-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Open-Label Trial of the Use of Minocycline in the Treatment of Asthma|Open-Label Trial of the Use of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|State University of New York - Downstate Medical Center|||||f||||f||||||||||2017-02-18 15:14:12.012495|2017-02-18 15:14:12.012495
NCT00536029|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-09-26|||February 2007||2007-02-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Observational|||MicroRNA Expression and Function in Cutaneous Malignant Melanoma|MicroRNA Expression and Function in Cutaneous Malignant Melanoma|Completed||N/A|68|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-02-18 15:14:12.109183|2017-02-18 15:14:12.109183
NCT00536016|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2010-09-20|||September 2007||2007-09-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD|A Phase 1 Open Label Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of Single and Repeated Doses of JSM6427 Following Administration by Intravitreal Injection in Patients With Neovascular AMD|Completed||Phase 1|36|Anticipated|Jerini Ophthalmic||1|||f||||t||||||||||2017-02-18 15:14:12.203757|2017-02-18 15:14:12.203757
NCT00536003|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-06-05|||July 2006||2006-07-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|4P||Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor|Prevention of Preterm Delivery With Vaginal Progesterone in Women With Preterm Labor|Terminated||Phase 3|384|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 15:14:12.306956|2017-02-18 15:14:12.306956
NCT00535990|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-10-24|||September 2007||2007-09-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Minimally Invasive Surgery (MIS) Database for the Purpose of Research|Minimally Invasive Surgery (MIS) Database Looking at Patterns of Care, Outcomes, and Prognostic Analysis for the Purpose of Research|Completed||N/A|250|Actual|University of California, San Diego|||1||f||||f||||||||||2017-02-18 15:14:12.59781|2017-02-18 15:14:12.59781
NCT00535977|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2007-09-26|||April 2005||2005-04-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Broccoli, Peas and PIN|A Human Intervention Trial Studying Gene Expression in High-Grade Prostatic Intraepithelial Neoplasia Following Consumption of Broccoli or Peas|Completed||N/A|22|Actual|Institute of Food Research||2|||f||||f||||||||||2017-02-18 15:14:12.705024|2017-02-18 15:14:12.705024
NCT00535964|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2013-04-09|||June 2007||2007-06-01|April 2013|2013-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents|Anxiety Sensitivity, Tobacco Use, and Panic Among Adolescents|Completed||N/A|180|Actual|University of Arkansas, Fayetteville|||1||f||||f||||||||||2017-02-18 15:14:12.805436|2017-02-18 15:14:12.805436
NCT00535951|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-26|2012-11-26|||November 2007||2007-11-01|November 2012|2012-11-01||||January 2009|Actual|2009-01-01||Interventional|||Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma|A Phase IB, Open-Label, Multicenter Study to Investigate the Effect of Oral LBH589 on Dextromethorphan, a CYP2D6 Substrate, and to Assess the Efficacy and Safety of Oral LBH589 in Patients With Advanced Solid Tumors|Completed||Phase 1|18|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:14:12.909226|2017-02-18 15:14:12.909226
NCT00535938|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2014-09-04|2014-09-04||September 2007||2007-09-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|||MDs on Botox Utility (MOBILITY)||Completed||N/A|1372|Actual|Allergan|||2||f||||f||||||||||2017-02-18 15:14:13.039776|2017-02-18 15:14:13.039776
NCT00535925|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2011-12-20|||March 2003||2003-03-01|December 2011|2011-12-01|September 2012|Anticipated|2012-09-01|July 2012|Anticipated|2012-07-01||Interventional|NID-2||Nephropathy In Type 2 Diabetes and Cardio-renal Events|Nephropathy in Type 2 Diabetes: Effects of an Intensive Multifactorial Intervention Trial on Cardio-renal Events.|Unknown status|Active, not recruiting|Phase 4|850|Actual|Second University of Naples||2|||f||||t||||||||||2017-02-18 15:14:14.054088|2017-02-18 15:14:14.054088
NCT00063479|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-27|2016-11-16|||June 2003||2003-06-01|November 2016|2016-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Bisphosphonate Treatment of Osteogenesis Imperfecta|Bisphosphonate Treatment of Osteogenesis Imperfecta|Completed||Phase 2|158||Novartis|||||||||||||||||||2017-02-18 17:58:37.746581|2017-02-18 17:58:37.746581
NCT00535899|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2008-05-22|||September 2007||2007-09-01|May 2008|2008-05-01||||||||Observational|SPArKLE-AS||Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)|Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)|Terminated||N/A|50|Anticipated|The Cleveland Clinic||||unable to find subjects meeting inclusion criteria|f||||f||||||||||2017-02-18 15:14:14.295895|2017-02-18 15:14:14.295895
NCT00535886|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2008-05-05|||November 2005||2005-11-01|September 2007|2007-09-01|April 2006|Actual|2006-04-01|||||Interventional|||The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study|The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study|Completed||N/A|15|Actual|Children's Hospital & Research Center Oakland||3|||f||||f||||||||||2017-02-18 15:14:14.384155|2017-02-18 15:14:14.384155
NCT00535873|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2013-06-19|2013-06-19||October 2007||2007-10-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||One of the sixty-one participants who signed consent did not receive study medication and was not included in the analysis for this study.|Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older|A Phase II Study of Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia Age 65 or Older.|Completed||Phase 2|61|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:14:14.503193|2017-02-18 15:14:14.503193
NCT00535860|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2009-07-09|||April 2008||2008-04-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis|A Multicenter, Randomized, Parallel Study to Assess the Clinical Efficacy, Safety, and Tolerability of ViaDerm-hPTH (1-34) in Comparison to Subcutaneous Injection of Forteo in Postmenopausal Women With Osteoporosis|Completed||Phase 2|104|Actual|TransPharma Medical||3|||f||||f||||||||||2017-02-18 15:14:14.775531|2017-02-18 15:14:14.775531
NCT00535847|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2014-07-09|2011-06-22||October 2007||2007-10-01|July 2014|2014-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||The full analysis (FA) set included all enrolled subjects who received at least 1 dose of study drug in this study (VX06-950-107 [NCT00535847]).|A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy|A Phase 2 Rollover Protocol of Telaprevir (VX-950) in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Enrolled in the Control Group (Group A) of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Who Did Not Achieve or Maintain an Undetectable HCV RNA Level Through Sustained Viral Response|Completed||Phase 2|117|Actual|Vertex Pharmaceuticals Incorporated||3|||f||||t||||||||||2017-02-18 15:14:14.910566|2017-02-18 15:14:14.910566
NCT00535834|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2012-03-14||||||March 2012|2012-03-01|March 2011|Actual|2011-03-01|||||Observational|||Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154|Data Analysis for 00-C-0154, A Randomized Phase II Study of a PSA-based Vaccine in Patients With Localized Prostate Cancer Receiving Standard Radiotherapy|Completed||N/A|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:14:15.777843|2017-02-18 15:14:15.777843
NCT00535821|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2014-05-22|2014-05-22||June 2007||2007-06-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|MiCHO||Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock|A Multi-center Randomized Comparison of a Minimally-invasive Cardiovascular Hemodynamic Optimization (MiCHO) Protocol Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock Patients Presenting to the Emergency Department|Terminated||Phase 4|5|Actual|Loma Linda University||2||slow enrollement unavailable technology|f||||f||||||||||2017-02-18 15:14:15.864222|2017-02-18 15:14:15.864222
NCT00535808|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2012-07-12|||October 2007||2007-10-01|July 2012|2012-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effect of Strategy for Blood Pressure Control on Cerebral Oxygen Balance During Aortic Coarctation Repair: A Randomized Study|Effect of Strategy for Blood Pressure Control on Cerebral Oxygen Balance During Aortic Coarctation Repair: a Randomized Study|Completed||Phase 2|30|Actual|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 15:14:16.3556|2017-02-18 15:14:16.3556
NCT00535795|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-02-24|||September 2007||2007-09-01|December 2011|2011-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA|A Phase III Study to Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA|Completed||Phase 3|200|Actual|King Faisal Specialist Hospital & Research Center||2|||f||||t||||||||Undecided||2017-02-18 15:14:16.456332|2017-02-18 15:14:16.456332
NCT00535782|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-11-08|2012-08-08||October 2007||2007-10-01|November 2012|2012-11-01|January 2011|Actual|2011-01-01|September 2008|Actual|2008-09-01||Interventional|||A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis|A Mechanism of Action Study to Evaluate the Effects of IL-6 Receptor Blockade With Tocilizumab (TCZ) on Lipids, Arterial Stiffness, and Markers of Atherogenic Risk in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA).|Completed||Phase 3|132|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:14:16.576268|2017-02-18 15:14:16.576268
NCT00535769|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-07-18|2012-05-15||September 2007||2007-09-01|July 2012|2012-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use|Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen Use|Completed||Early Phase 1|70|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 15:14:18.253813|2017-02-18 15:14:18.253813
NCT00535756|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2011-08-16|||April 2008||2008-04-01|August 2011|2011-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Creon After Pancreatic Surgery|One Week Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center Study With Creon® 25000 Minimicrospheres™ in Subjects With Pancreatic Exocrine Insufficiency After Pancreatic Surgery, Followed by an Open-Label Long-Term Extension of 1 Year|Completed||Phase 4|58|Actual|Abbott||2|||f||||f||||||||||2017-02-18 15:14:18.636088|2017-02-18 15:14:18.636088
NCT00535548|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2007-09-24|||January 2007||2007-01-01|September 2007|2007-09-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model|Effect of Hematopoietic Stem Cells in Chronic Wounds Using a Pressure Sore Model: A Pilot Study on Feasibility, Safety and Potential Effects|Unknown status|Recruiting|Phase 1|||University Hospital, Basel, Switzerland|||||f||||t||||||||||2017-02-18 15:14:22.015859|2017-02-18 15:14:22.015859
NCT00535743|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-01-05|||March 2004||2004-03-01|January 2015|2015-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Dose-Finding Trial With Sugammadex at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Subjects of ASA Class 1-3 (19.4.206)(P05944)|A Multi-Center, Randomized, Safety Assessor-Blinded, Placebo- Controlled, Phase II, Parallel Dose-Finding Trial in Subjects of ASA 1-3 to Assess the Efficacy and Safety of 5 Doses of Sugammadex Administered at 3 and 15 Minutes After Administration of 1.0 and 1.2 mg/kg Rocuronium Bromide|Completed||Phase 2|174|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:14:18.755781|2017-02-18 15:14:18.755781
NCT00535730|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2015-04-01|2009-01-21||June 2007||2007-06-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)|A Phase III Double-Blind, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX™ Administered Concomitantly Versus Nonconcomitantly With PNEUMOVAX™ 23 in Subjects 60 Years of Age and Older|Completed||Phase 3|473|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:14:18.860504|2017-02-18 15:14:18.860504
NCT00535717|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2007-09-25||||||September 2007|2007-09-01||||||||Interventional|||Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)|Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)|Completed||Phase 2|||Maharashtra University of Health Sciences|||||f||||t||||||||||2017-02-18 15:14:19.415196|2017-02-18 15:14:19.415196
NCT00535704|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2017-01-10|||November 2007||2007-11-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Preventing Substance Use and Risky Behavior Among Rural African American Youth|Preventing Substance Use and Risky Behavior Among Rural African American Youth|Completed||N/A|502|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 15:14:19.483137|2017-02-18 15:14:19.483137
NCT00535691|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2014-08-28|||April 2003||2003-04-01|August 2014|2014-08-01|December 2004|Actual|2004-12-01|||||Interventional|||Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis|A Randomised, Multi-centre, Double-blind, Pharmacokinetic Study of Tacrolimus Ointment (0.03%) in Paediatric Patients (Aged 3 Months to 24 Months) With Atopic Dermatitis Following First and Repeated Once Daily or Twice Daily Application of the Tacrolimus Ointment|Completed||Phase 2|53|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 15:14:19.582535|2017-02-18 15:14:19.582535
NCT00535678|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2010-05-13|||June 2007||2007-06-01|April 2010|2010-04-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram|A Multicenter Study to Test Digital Breast Tomosynthesis (DBT) Compared to Full-Field Digital Mammography (FFDM) in Detecting Breast Cancer. Part 1. Women Undergoing Screening Mammography|Completed||N/A|400|Anticipated|GE Healthcare|||1||f||||f||||||||||2017-02-18 15:14:19.816929|2017-02-18 15:14:19.816929
NCT00535665|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2007-11-08|||September 2007||2007-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine|The Clinical Trial of Pandemic Influenza Vaccine (Whole-Virion， Inactivated, Adjuvanted) on Healthy Adults by Randomized and Double-Blind Design: a Phase II Study|Completed||Phase 2|402|Actual|Sinovac Biotech Co., Ltd||4|||f||||t||||||||||2017-02-18 15:14:19.919037|2017-02-18 15:14:19.919037
NCT00535652|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-12-16|2015-06-23||September 2007||2007-09-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Concentration of Ertapenem in Colorectal Tissue|Konzentrationen Von Ertapenem in Kolorektalem Gewebe|Completed||Phase 4|23|Actual|University of Ulm||1|||f||||t||||||||||2017-02-18 15:14:20.013502|2017-02-18 15:14:20.013502
NCT00535639|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2008-02-28|||October 2007||2007-10-01|February 2008|2008-02-01||||December 2007|Actual|2007-12-01||Interventional|||Tolerability of ALK Tree Tablet|A Randomised, Multiple Dose, Dose Escalation, Double-Blind, Placebo-Controlled Phase I Study Investigating the Safety of ALK Tree Tablet in Adult Subjects With Birch Pollen Induced Rhinoconjunctivitis (With/Without Asthma).|Completed||Phase 1|||ALK-Abelló A/S|||||f||||||||||||||2017-02-18 15:14:20.23956|2017-02-18 15:14:20.23956
NCT00535626|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-12-29|||November 2006||2006-11-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Trident® Tritanium™ Acetabular Shell Revision Study|A Post-market, Non-randomized, Open Label, Multi-center Clinical Study of the Trident Tritanium Acetabular Shell|Completed||N/A|245|Actual|Stryker Orthopaedics||1|||f||||f||||||||||2017-02-18 15:14:20.322095|2017-02-18 15:14:20.322095
NCT00535613|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-23|2015-10-09|||August 2007||2007-08-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Propofol in Emergence Agitation|Does a Single Dose of Propofol Decrease the Incidence of Emergence Agitation in Children?|Completed||Phase 4|100|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 15:14:20.443993|2017-02-18 15:14:20.443993
NCT00535600|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2017-01-24|||September 21, 2007||2007-09-21|March 19, 2014|2014-03-19|March 19, 2014||2014-03-19|||||Observational|||Effects of Bariatric Surgery on Insulin|Effects of Bariatric Surgery on Changes in Insulin Secretion and Insulin Action|Completed||N/A|72|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:14:20.553934|2017-02-18 15:14:20.553934
NCT00535587|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2011-03-23|2011-03-21||September 2002||2002-09-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Testing Mestinon and Exercise in Fibromyalgia|Maximizing Exercise Effectiveness in Fibromyalgia|Completed||Phase 2|178|Actual|Oregon Health and Science University|"6 discontinued due to medical reasons unrelated to the study 4 were unwilling to complete~1 relocated"|4|||f||||||||||||||2017-02-18 15:14:20.853719|2017-02-18 15:14:20.853719
NCT00535574|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-07-25|||November 2008||2008-11-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|||Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia|Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia: a 6-week, Randomized, Double-blind Placebo-controlled Trial|Completed||Phase 3|90|Actual|Beersheva Mental Health Center||2|||f||||t||||||||||2017-02-18 15:14:21.579028|2017-02-18 15:14:21.579028
NCT00535561|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2012-02-16|||June 2007||2007-06-01|February 2012|2012-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism|Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism: A Randomized, Double Blinded Study|Completed||Phase 1|||Duzce University||2|||f||||f||||||||||2017-02-18 15:14:21.90611|2017-02-18 15:14:21.90611
NCT00062998|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-18|2010-03-17||||||March 2010|2010-03-01||||||||Observational|||Free-Living Physical Activity and Energy Expenditure||Completed||N/A|15||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:42.635683|2017-02-18 17:58:42.635683
NCT00535522|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2011-12-07|||August 2007||2007-08-01|December 2011|2011-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer|A Multicenter, Open-Label, Noncomparative Phase I Clinical and Pharmacokinetic Study of Oral TAK-285 in Patients With Advanced Cancer|Completed||Phase 1|56|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:14:22.19433|2017-02-18 15:14:22.19433
NCT00535509|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-12-16|||June 2007||2007-06-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer|Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer|Completed||N/A|285|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||f||||||||||2017-02-18 15:14:22.290891|2017-02-18 15:14:22.290891
NCT00535496|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-02-26|2013-05-01||September 2007||2007-09-01|February 2015|2015-02-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698)|Comparison of the T4/T1 Ratio Measured by Means of the TOF Watch® SX With the Reappearance of T4 Measured by Means of a Peripheral Nerve Stimulator in Adult Subjects Receiving 4.0 mg.Kg-1 Sugammadex at 15 Minutes After Rocuronium|Completed||Phase 3|91|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:14:22.368118|2017-02-18 15:14:22.368118
NCT00535483|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2014-04-03|||August 2007||2007-08-01|April 2014|2014-04-01|September 2007|Actual|2007-09-01|||||Observational|||Closed Loop Insulin Therapy in Type 1 Diabetics Based on Blood Microdialysis, Online Sensors and an eMPC Algorithm|An Open, Mono-centre Pilot Study to Investigate a Novel Technique to Establish Glycaemic Control for Critically Ill Patients, Tested in Type 1 Diabetic Subjects for a Period of 30 Hours.|Completed||N/A|4|Actual|Medical University of Graz|||||f||||f||||||||||2017-02-18 15:14:22.783821|2017-02-18 15:14:22.783821
NCT00535470|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-08-07|||July 2007||2007-07-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides|An Open Label Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (Mechlorethamine - MCH) 0.04% Formulation in Patients With Stage I-IIA Mycosis Fungoides Who Have Completed 12 Months Treatment Without a Complete Response|Completed||Phase 2|100|Actual|Yaupon Therapeutics||1|||f||||f||||||||||2017-02-18 15:14:22.86173|2017-02-18 15:14:22.86173
NCT00535457|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-23|2012-06-07||||||June 2012|2012-06-01||||||||Interventional|||The Effects of Pre-operative Magic Tricks Performance on Pre-operative Anxiety in Children|The Effects of Pre-operative Magic Tricks Performance on Pre-operative Anxiety in Children|Withdrawn||Phase 1|0|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 15:14:22.99064|2017-02-18 15:14:22.99064
NCT00535444|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-11-07|||September 2006||2006-09-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Health and Faith Working to Control Blood Pressure|Health and Faith Working Together to Control Blood Pressure|Completed||N/A|100|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-02-18 15:14:23.099621|2017-02-18 15:14:23.099621
NCT00535431|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-22|2007-09-22|||December 2005||2005-12-01|September 2007|2007-09-01|October 2006|Actual|2006-10-01|||||Interventional|||Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics|A Study To Investigate The Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatic Subjects|Completed||Phase 2|32|Actual|Aerovance, Inc.||2|||f||||f||||||||||2017-02-18 15:14:23.18047|2017-02-18 15:14:23.18047
NCT00535418|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-04-18|||June 2000||2000-06-01|April 2012|2012-04-01||||July 2002|Actual|2002-07-01||Interventional|||Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers|Pre-operative Hormone Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer: An Uncontrolled Phase IIb/III Trial to Assess Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers|Completed||Phase 2/Phase 3|35|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:14:23.474723|2017-02-18 15:14:23.474723
NCT00535405|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-01-19|2010-04-26||November 2007||2007-11-01|January 2015|2015-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)|A Multicenter, Randomized, Double-Blind, Parallel, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Elderly Patients With Hypercholesterolemia at High or Moderately High Risk for Coronary Heart Disease|Completed||Phase 3|1289|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 15:14:23.591385|2017-02-18 15:14:23.591385
NCT00535392|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2011-08-30|2011-01-28||September 2007||2007-09-01|March 2011|2011-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy|Open-label, Single-arm, Multi-center, Pharmacokinetic, Safety and Tolerability Study of Levetiracetam Intravenous Infusion in Children (4 - 16 Years Old) With Epilepsy.|Completed||Phase 2|33|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:14:24.661408|2017-02-18 15:14:24.661408
NCT00535379|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2010-08-27|||October 2007||2007-10-01|January 2009|2009-01-01|January 2011|Anticipated|2011-01-01|December 2010|Anticipated|2010-12-01||Interventional|SURGE01-07||SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme|SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme An Academic Prospective Single-arm Phase II Clinical Trial Including Ranslational Research Studies|Unknown status|Active, not recruiting|Phase 2|70|Anticipated|Medical University Innsbruck||1|||f||||t||||||||||2017-02-18 15:14:25.183181|2017-02-18 15:14:25.183181
NCT00535327|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2010-05-13|||August 2007||2007-08-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography|A Multicenter Study to Test Digital Breast Tomosynthesis (DBT) Compared to Full-Field Digital Mammography (FFDM) in Detecting Breast Cancer. Part 2. Women Undergoing Diagnostic Mammography|Completed||N/A|220|Anticipated|GE Healthcare|||1||f||||f||||||||||2017-02-18 15:14:25.532461|2017-02-18 15:14:25.532461
NCT00535314|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2014-10-27||||||October 2014|2014-10-01||||||||Interventional|||Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma|A Multicenter, Phase II, Randomized, Open Label Trial of 2 Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma|Withdrawn||Phase 2|0|Actual|Reata Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 15:14:25.612716|2017-02-18 15:14:25.612716
NCT00535301|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-04-02|2011-05-04||January 2005||2005-01-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair|Outcome After Anterior Vaginal Prolapse Repair: A Randomized Controlled Trial|Completed||Phase 4|75|Actual|Kaiser Permanente|-Small number of subjects, Single surgeon, Medium follow-up, Limited ability to detect uncommon adverse events and small differences in quality of life and sexual symptom scores, Concurrent pelvic reconstructive and anti-incontinence procedures|2|||f||||f||||||||||2017-02-18 15:14:25.722514|2017-02-18 15:14:25.722514
NCT00535288|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-05-27|2014-06-16||September 2004||2004-09-01|May 2015|2015-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)|A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Four Different Doses of Org 50081 in the Treatment of Moderate to Severe Vasomotor Symptoms Associated With the Menopause|Completed||Phase 3|946|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 15:14:26.565923|2017-02-18 15:14:26.565923
NCT00535275|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-02-12|||September 2007||2007-09-01|February 2015|2015-02-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy|Comparison of 2 Chemotherapy Regimens in Non-small-cell Lung Cancer (NSCLC) Patients Relapsing After Surgery and Peri-operative Chemotherapy. A Randomized Phase III Study.|Terminated||Phase 3|88|Actual|Intergroupe Francophone de Cancerologie Thoracique||2||Final analysis done, follow-up of patients no more necessary|f||||t||||||||||2017-02-18 15:14:28.242169|2017-02-18 15:14:28.242169
NCT00535262|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2014-10-24|2014-10-01||March 2007||2007-03-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Seeking pilot data|A Pilot Study Assessing EmSam in Bipolar Depression|A Pilot Study Assessing Efficacy, Safety, and Tolerability of EmSam in Bipolar Depression|Terminated||Phase 4|3|Actual|New York State Psychiatric Institute|Early termination due to lack of financial support; only 3 participants were entered into the study; no data was analyzed.|1||Current lack of medication support.|f||||t||||||||||2017-02-18 15:14:28.529547|2017-02-18 15:14:28.529547
NCT00535236|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-10-05|||November 2007||2007-11-01|October 2015|2015-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study of an Investigational V212/Heat-Treated VZV Vaccine in Immunocompromised Adults (V212-002)(COMPLETED)|A Phase I, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults|Completed||Phase 1|341|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:14:28.909365|2017-02-18 15:14:28.909365
NCT00535223|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-03-23|2014-12-22||July 2007||2007-07-01|March 2015|2015-03-01|August 2012|Actual|2012-08-01|July 2010|Actual|2010-07-01||Interventional|||Group Based Exposure Therapy for Combat-Related PTSD|Group Based Exposure Therapy for Combat PTSD: RCT and Feasibility Study|Completed||N/A|81|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:14:29.009875|2017-02-18 15:14:29.009875
NCT00535210|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2014-01-29|||September 2007||2007-09-01|January 2014|2014-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||The Effect of an Exercise Program on Physical Function After a Spinal Cord Injury|The Effects of a Group Exercise Program on Function in Spinal Cord Injury Rehabilitation: A Pilot Randomized Controlled Trial|Terminated||N/A|9|Actual|University of British Columbia||2||Unsuccessful recruiting patients, never got beyond pilot testing of patients|f||||f||||||||||2017-02-18 15:14:29.409975|2017-02-18 15:14:29.409975
NCT00535197|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2016-02-15|||September 2007||2007-09-01|July 2012|2012-07-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|||Autologous Bone Marrow Stem Cells in Ischemic Stroke.|A Phase I/II Safety and Tolerability Study Following the Autologous Infusion of Immuno-selected CD34+ Subset Bone Marrow Stem Cells Into Patients With Acute Total Anterior Circulation Ischaemic Stroke|Completed||Phase 1/Phase 2|5|Actual|Imperial College London||1|||f||||t||||||||||2017-02-18 15:14:29.518629|2017-02-18 15:14:29.518629
NCT00535184|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-03-21|||August 2007||2007-08-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy|A Multicenter Study to Test Digital Breast Tomosynthesis (DBT) Compared to Full-Field Digital Mammography (FFDM) in Detecting Breast Cancer. Part 3. Women Undergoing Breast Biopsy|Completed||N/A|220|Actual|GE Healthcare|||1||f||||f||||||||||2017-02-18 15:14:29.615273|2017-02-18 15:14:29.615273
NCT00535171|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2010-01-21|||June 2007||2007-06-01|January 2010|2010-01-01||||August 2008|Actual|2008-08-01||Observational|||Venous Thromboembolism Taskforce Audit Program|Venous Thromboembolism Taskforce Audit Program|Completed||N/A|8764|Actual|Sanofi|||1||f||||||||||||||2017-02-18 15:14:29.696742|2017-02-18 15:14:29.696742
NCT00535158|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2010-05-03|||September 2010||2010-09-01|May 2010|2010-05-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|D2D||Vitamin D 2 to Dialysis Patients|Vitamin D and Muscle Strength in the Dialysis Population|Unknown status|Not yet recruiting|Phase 4|200|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 15:14:29.775679|2017-02-18 15:14:29.775679
NCT00535145|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2014-07-14|2013-07-17||October 2007||2007-10-01|July 2014|2014-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease|A Single-arm Evaluation of the Safety of Paliperidone Extended-Release (ER) in Subjects With Schizophrenia or Schizoaffective Disorder With Hepatic Disease|Completed||Phase 4|121|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC|Please see the Clinical Study Report Synopsis for results on the primary outcome measure.|1|||f||||f||||||||||2017-02-18 15:14:29.872433|2017-02-18 15:14:29.872433
NCT00535132|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2014-04-24|2009-07-17||October 2007||2007-10-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone|A Blinded-initiation Study of Medication Satisfaction in Subjects With Schizophrenia Treated With Paliperidone ER After Suboptimal Response to Oral Risperidone|Completed||Phase 4|201|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-02-18 15:14:30.372275|2017-02-18 15:14:30.372275
NCT00535119|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-05-21|||September 2007||2007-09-01|April 2015|2015-04-01||||October 2012|Actual|2012-10-01||Interventional|||Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer|A Phase 1 Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Advanced Solid Malignancies|Completed||Phase 1|107|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:14:31.452564|2017-02-18 15:14:31.452564
NCT00535106|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2009-10-18|||May 2006||2006-05-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|SmartCPR||SmartCPR Trial: An Analysis of a Waveform-Based Automated External Defibrillation (AED) Algorithm on Survival From Out-of-Hospital Ventricular Fibrillation|An International, Randomized, Controlled Prehospital Trial of a Waveform-Based Automated External Defibrillation Algorithm for the Management of Ventricular Fibrillation|Completed||N/A|900|Actual|New York City Fire Department||3|||f||||t||||||||||2017-02-18 15:14:31.585357|2017-02-18 15:14:31.585357
NCT00535093|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2010-05-02|||October 2007||2007-10-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||An Assessment of Rapid Streptococcal Tests in Community Clinics in Israel|A Comparison of Available Rapid Streptococcus A Tests in Community Clinics in Israel: Accuracy, Ease of Use and Acceptability.|Completed||N/A|7000|Anticipated|Meir Medical Center||1|||f||||f||||||||||2017-02-18 15:14:31.853895|2017-02-18 15:14:31.853895
NCT00535080|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2009-10-27||||||October 2009|2009-10-01||||||||Expanded Access|||Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease|Compassionate Use of Metvix® (Methyl Aminolevulinate) PDT in Subjects With Field Actinic Keratoses, Large/Multiple Superficial BCCs, or Bowen's Disease|No longer available||N/A|||Galderma|||||f||||||||||||||2017-02-18 15:14:31.96281|2017-02-18 15:14:31.96281
NCT00535067|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2015-01-07|||September 2007||2007-09-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Neuropathic Pain in Survivors of Breast Cancer|Neuropathic Pain in Survivors of Breast Cancer|Completed||N/A|239|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:14:32.061372|2017-02-18 15:14:32.061372
NCT00535054|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-23|2010-02-07|||September 2007||2007-09-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms|An Open Study to Assess the Safety and Patients' Satisfaction Tears Again* in the Treatment of Dry Eye Symptoms|Completed||N/A|125|Anticipated|Trima, Israel Pharmaceutical Products||1|||f||||t||||||||||2017-02-18 15:14:32.174762|2017-02-18 15:14:32.174762
NCT00535041|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2016-01-04|||September 2007||2007-09-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA|Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA|Completed||N/A|200|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:14:32.279921|2017-02-18 15:14:32.279921
NCT00535028|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-21|||January 2005||2005-01-01|September 2007|2007-09-01|May 2005|Actual|2005-05-01|||||Interventional|||A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)|A Phase IIa Study To Investigate The Effects of AER 001 on Antigen Challenge In Atopic Asthmatic Subjects Following Repeated Administration.|Completed||Phase 2|24|Actual|Aerovance, Inc.||2|||f||||f||||||||||2017-02-18 15:14:32.370694|2017-02-18 15:14:32.370694
NCT00535015|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-23|2008-07-19|||October 2007||2007-10-01|July 2008|2008-07-01|August 2008|Anticipated|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer|A Randomized, Double-Blind, Pilot Study Comparing the Safety and Efficacy of Betamarc Plus Chemotherapy to Chemotherapy Alone in the Prevention and Treatment of CACS in Patients With Advanced NSCLC|Terminated||Phase 2|70|Anticipated|Anaborex||1||Objectives of study could not be met within a reasonable timeframe.|f||||t||||||||||2017-02-18 15:14:32.489581|2017-02-18 15:14:32.489581
NCT00535002|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2013-03-27|||September 2007||2007-09-01|March 2013|2013-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||The Effect of Yohimbine on Cocaine Cue Reactivity|SCOR on Sex and Gender Factors Affecting Women's Health|Completed||N/A|113|Actual|Medical University of South Carolina|||4||f||||f||||||Samples With DNA|"~     whole blood saliva~   "|||2017-02-18 15:14:32.614117|2017-02-18 15:14:32.614117
NCT00534989|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-12-16|||September 2007||2007-09-01|December 2015|2015-12-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional|||Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT|Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT|Completed||N/A|10|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||||||||||||2017-02-18 15:14:32.724402|2017-02-18 15:14:32.724402
NCT00534976|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2015-07-07|2011-03-11||February 2008||2008-02-01|July 2015|2015-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Effect of Montelukast on Difficulty in Breathing After Exercise in Pediatric Patients (MK0476-377)(COMPLETED)|A Double-Blind, Placebo-Controlled, Multicenter, Crossover Study to Evaluate the Effects of a Single Oral Dose of Montelukast, Compared With Placebo, on Exercise-Induced Bronchoconstriction (EIB) in Pediatric Patients Aged 4 to 14 Years|Completed||Phase 4|364|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:14:32.808694|2017-02-18 15:14:32.808694
NCT00534963|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-23|2015-10-01|||December 2004||2004-12-01|September 2007|2007-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Optimal Catheter Placement During Sonohysterography: Comparison of Cervical to Uterine Placement|Optimal Catheter Placement During Sonohysterography: A Randomized Clinical Trial Comparing Cervical to Uterine Placement|Completed||N/A|69|Actual|University of Wisconsin, Madison|||||f||||t||||||||||2017-02-18 15:14:33.471605|2017-02-18 15:14:33.471605
NCT00534950|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-02-24|||September 2007||2007-09-01|December 2011|2011-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and Neck||Completed||N/A|200|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:14:33.583567|2017-02-18 15:14:33.583567
NCT00534937|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2013-01-28|2012-11-29||September 2007||2007-09-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Flexitouch Compression System for Venous Stasis Ulcer|A Randomized Trial of the Flexitouch Compression System as an Adjunctive Treatment for Venous Stasis Ulcer|Terminated||Phase 4|89|Actual|West Penn Allegheny Health System|The study was terminated early due to lack of enrollment which ultimately lead to a limited number of subjects to include in an analysis.|2||Ineffective Recruitment (Business Decision)|f||||t||||||||||2017-02-18 15:14:33.67815|2017-02-18 15:14:33.67815
NCT00062985|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-18|2010-11-10|||January 1999||1999-01-01|November 2010|2010-11-01|December 2004||2004-12-01|||||Interventional|||Obesity Treatment in a Managed Care Setting||Completed||N/A|1801||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:42.698574|2017-02-18 17:58:42.698574
NCT00534924|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2007-09-24|||August 2007||2007-08-01|September 2007|2007-09-01||||||||Interventional|IRI in MRI||The Effects of Post-Conditioning and Administration of Vitamin C on Intramuscular High Energy Phosphate Levels|The Effects of Post-Conditioning and Administration of Vitamin C on Intramuscular High Energy Phosphate Levels|Unknown status|Recruiting|N/A|||Medical University of Vienna||3|||f||||t||||||||||2017-02-18 15:14:34.102902|2017-02-18 15:14:34.102902
NCT00534911|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2016-01-04|||September 2007||2007-09-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|||Reducing Depressive Symptoms in Physically Ill Youth|Reducing Depressive Symptoms in Physically Ill Youth|Active, not recruiting||N/A|76|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:14:34.205902|2017-02-18 15:14:34.205902
NCT00534898|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2010-06-28||||||September 2007|2007-09-01||||||||Interventional|||Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients|Comparison Efficacy of Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients: Double-blind Placebo Controlled Study|Withdrawn||Phase 3|||Beersheva Mental Health Center||||The study withdrawn due to lack financial support|f||||t||||||||||2017-02-18 15:14:34.319835|2017-02-18 15:14:34.319835
NCT00534885|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-04-25|||March 2006||2006-03-01|November 2015|2015-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine|The Phase Ⅳ Clinical Trial to Evaluate the Safety, Immunogenicity, and Immune Persistence of Three Consecutive Lots of an Inactivated Hepatitis A Vaccine in Healthy Children|Completed||Phase 4|400|Actual|Sinovac Biotech Co., Ltd||4|||f||||t||||||||||2017-02-18 15:14:34.407759|2017-02-18 15:14:34.407759
NCT00534872|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-04-15|||October 2007||2007-10-01|April 2015|2015-04-01|October 2007|Anticipated|2007-10-01|October 2007|Anticipated|2007-10-01||Interventional|||A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population|"A Single-centre, Open Label, Single-dose, Four Parallel Cohorts Study to Investigate the Pharmacokinetics, Safety and Tolerability of SB-649868 10mg in Healthy Female Non-childbearing Potential, Healthy Male and in Healthy Elderly Subjects"|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||1||The study was stoppend before recruitment start for preclinical safety finding in rats.|f||||||||||||||2017-02-18 15:14:34.525297|2017-02-18 15:14:34.525297
NCT00534859|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2011-03-18|||August 2006||2006-08-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|June 2010|Actual|2010-06-01||Interventional|PROTECT I||PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI|PROTECT I, A Prospective Feasibility Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI|Completed||Phase 2|28|Actual|Abiomed Inc.||1|||f||||f||||||||||2017-02-18 15:14:34.615839|2017-02-18 15:14:34.615839
NCT00534846|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2009-05-12|||April 2007||2007-04-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|May 2008|Actual|2008-05-01||Interventional|||The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia|The Effect of Toremifene Treatment to the Magnetic Resonance Imaging Findings in Women Suffering From Premenstrual Mastalgia|Completed||Phase 3|10|Actual|Satakunta Central Hospital||2|||f||||f||||||||||2017-02-18 15:14:34.702247|2017-02-18 15:14:34.702247
NCT00534833|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2013-09-19|2013-09-19||September 2007||2007-09-01|September 2013|2013-09-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|||Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™|Immunogenicity Study of the Antibody Persistence and Booster Effect of DTaP-Hep B-PRP-T Combined Vaccine or Tritanrix HepB/Hib™ at 15 to 18 Months of Age Following a Primary Series at 6, 10 and 14 Weeks of Age in Healthy Filipino Infants|Completed||Phase 3|362|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:14:34.825135|2017-02-18 15:14:34.825135
NCT00534820|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-12-16|||June 2004||2004-06-01|December 2015|2015-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease||Completed||N/A|450|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:14:35.340804|2017-02-18 15:14:35.340804
NCT00534807|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-25|2015-08-31|||September 2007||2007-09-01|October 2007|2007-10-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer|Effect of Rifampin on the Pharmacokinetics of Intravenous (IV) Vinflunine in Subjects With Advanced Cancer|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb|||||f||||f||||||||||2017-02-18 15:14:35.534808|2017-02-18 15:14:35.534808
NCT00534794|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2015-04-27|2009-01-30||October 2007||2007-10-01|April 2015|2015-04-01||||January 2008|Actual|2008-01-01||Interventional|||Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis|A Single-Center, Masked, Randomized Study Comparing Two Marketed Ocular Anti-Allergy Medications in the Cat Room Model|Completed||Phase 4|79|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:14:35.613639|2017-02-18 15:14:35.613639
NCT00534781|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2013-07-10|||September 2007||2007-09-01|July 2013|2013-07-01|September 2010|Actual|2010-09-01|July 2008|Actual|2008-07-01||Interventional|||Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement|"Radiofrequency-based Plasma Microdebridement Compared to Surgical Microdebridement for Treating Achilles Tendinosis: A Prospective, Randomized, Controlled Multi-Center Study"|Completed||Phase 4|60|Actual|ArthroCare Corporation||2|||f||||f||||||||||2017-02-18 15:14:35.908681|2017-02-18 15:14:35.908681
NCT00534768|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2008-01-11|||January 2003||2003-01-01|January 2008|2008-01-01||||||||Interventional|||Postoperative Treatment After Endoscopic Sinus Surgery|Postoperative Treatment After Endoscopic Sinus Surgery|Completed||N/A|||Kuopio University Hospital||2|||f||||||||||||||2017-02-18 15:14:36.020615|2017-02-18 15:14:36.020615
NCT00533780|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2010-06-01|||January 2005||2005-01-01|June 2010|2010-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer|Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer|Completed||N/A|200|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 15:14:36.107482|2017-02-18 15:14:36.107482
NCT00533767|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2014-12-05|||July 2007||2007-07-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Hantavirus Transmission in Households in Chile|Prospective Follow Up of Household Contacts and Hantavirus Transmission Study Among Index and Additional Cases in Chile|Completed||N/A|197|Actual|University of New Mexico|||1||f||||f||||||||||2017-02-18 15:14:36.189111|2017-02-18 15:14:36.189111
NCT00533754|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-20|||July 2006||2006-07-01|September 2007|2007-09-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population|Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population|Unknown status|Active, not recruiting|N/A|||Rudolf Foundation Clinic|||||f||||f||||||||||2017-02-18 15:14:36.279062|2017-02-18 15:14:36.279062
NCT00533741|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-11-29||||||March 2010|2010-03-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||SARS Coronavirus Vaccine (SARS-CoV)|Phase I, Double-Blinded, Placebo-Controlled Dosage Escalation Study of the Safety and Immunogenicity of Adjuvanted and Non-Adjuvanted Inactivated SARS Coronavirus (SARS-CoV) Vaccine Administered by the Intramuscular Route|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 15:14:36.367089|2017-02-18 15:14:36.367089
NCT00533728|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2009-03-02|||September 2007||2007-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma|A Phase I Study to Determine the Safety and Effect of Soluble Beta-Glucan (SBG) in Combination With Rituximab and COP/CHOP in Patients With Non'Hodgkin's Lymphoma|Completed||Phase 1|12|Anticipated|Biotec Pharmacon ASA|||||f||||f||||||||||2017-02-18 15:14:36.463817|2017-02-18 15:14:36.463817
NCT00533715|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-09-20|||January 2003||2003-01-01|September 2007|2007-09-01|October 2005|Actual|2005-10-01|||||Observational|||Forced Inspiratory Flow Volume Curve in Healthy Young Children|Forced Inspiratory Flow Volume Curve in Healthy Young Children|Completed||N/A|157|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:14:36.533945|2017-02-18 15:14:36.533945
NCT00533702|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2014-07-29|2014-05-16||November 2007||2007-11-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||All enrolled participants who were treated with any quantity of study drug.|A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma|Phase II Randomized, Open-Label Study of IMC-1121B With or Without Dacarbazine in Patients With Metastatic Malignant Melanoma|Completed||Phase 2|106|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:14:36.632639|2017-02-18 15:14:36.632639
NCT00533689|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-20|||January 2008||2008-01-01|September 2007|2007-09-01|January 2010|Anticipated|2010-01-01|||||Interventional|||Study of the Long-Term Effect of Frequent Anti-VEGF Dosing on Retinal Function in Patients With Neovascular AMD||Unknown status|Not yet recruiting|Phase 3|2008|Anticipated|Tel-Aviv Sourasky Medical Center|||||f||||f||||||||||2017-02-18 15:14:37.435345|2017-02-18 15:14:37.435345
NCT00534755|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-02-24|||June 2005||2005-06-01|December 2011|2011-12-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to Present||Completed||Early Phase 1|10000|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:14:40.059166|2017-02-18 15:14:40.059166
NCT00534742|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2011-12-13|||June 2005||2005-06-01|December 2011|2011-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|FISSIC||Fangshan / Family-based Ischemic Stroke Study In China|A Family-based Ischemic Stroke Study on Association and Interactions of Multi-pathway Genetic Polymorphisms|Unknown status|Recruiting|N/A|1500|Anticipated|Peking University|||1||f||||f||||||Samples With DNA|"~     serum, white cells~   "|||2017-02-18 15:14:40.171476|2017-02-18 15:14:40.171476
NCT00534729|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2016-01-04|||September 2007||2007-09-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA||Completed||N/A|200|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:14:40.258222|2017-02-18 15:14:40.258222
NCT00534716|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2008-05-06|||September 2007||2007-09-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Observational|||Cannabis Cigarettes Used for Doping: Delta-9-Tetrahydrocannabinol (THC) Urine Detection|Cannabis and Doping - Pharmacokinetics of Smoked Cannabis Under Controlled Clinical Conditions|Completed||N/A|12|Actual|Federal Office of Sports, Switzerland|||1||f||||t||||||Samples Without DNA|"~     Plasma, urine~   "|||2017-02-18 15:14:40.3421|2017-02-18 15:14:40.3421
NCT00534703|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-02-23|||July 2014||2014-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|SERCA-LVAD||Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure|Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure and a Left Ventricular Assist Device|Terminated||Phase 2|5|Actual|Imperial College London||2||Early termination following Trial Steering Committee recommendation|f||||t||||||||||2017-02-18 15:14:40.425078|2017-02-18 15:14:40.425078
NCT00534690|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2010-01-20|||November 2007||2007-11-01|January 2010|2010-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|REVOLU||Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation?|Lowering VT and Increasing PEP During One-Lung Ventilation (OLV), Impact on Oxygenation|Completed||N/A|88|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 15:14:40.532236|2017-02-18 15:14:40.532236
NCT00534677|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2007-12-04|||May 2004||2004-05-01|September 2007|2007-09-01|July 2005|Actual|2005-07-01|||||Interventional|||The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed|Efficacy And Safety Of Terlipressin Vs Octreotide As Adjuvant Therapy In Bleeding Esophageal Varices|Completed||Phase 4|320|Actual|Aga Khan University||2|||f||||t||||||||||2017-02-18 15:14:40.643895|2017-02-18 15:14:40.643895
NCT00534664|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2007-09-24|||October 2005||2005-10-01|September 2007|2007-09-01|February 2007|Actual|2007-02-01|||||Interventional|TheraBionic||Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma|Phase II Study to Determine the Effectiveness of Intrabuccally Administered Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|40|Actual|University of Sao Paulo|||||f||||f||||||||||2017-02-18 15:14:40.755691|2017-02-18 15:14:40.755691
NCT00534651|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2010-03-15|||November 2006||2006-11-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease|Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease|Completed||Phase 4|37|Actual|University of Zurich||1|||f||||f||||||||||2017-02-18 15:14:40.83071|2017-02-18 15:14:40.83071
NCT00533858|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2008-10-18|||September 2007||2007-09-01|October 2008|2008-10-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients||Unknown status|Recruiting|Phase 4|160|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 15:15:01.25531|2017-02-18 15:15:01.25531
NCT00534638|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2016-05-05|2015-12-17||October 2007||2007-10-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents|Evaluation of the Effectiveness of Two Vaccination Strategies Using GlaxoSmithKline Biologicals' HPV Vaccine GSK580299 (Cervarix™) Administered in Healthy Adolescents|Completed||Phase 4|34206|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 15:14:40.935176|2017-02-18 15:14:40.935176
NCT00534625|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2008-03-19|||September 2007||2007-09-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients|Phase 2 Study of the Assessment of Pulmonary Function, Safety, Tolerability, and PK of Zileuton Injection in Patients With Chronic Stable Asthma|Completed||Phase 2|36|Actual|Critical Therapeutics||3|||f||||f||||||||||2017-02-18 15:14:41.987882|2017-02-18 15:14:41.987882
NCT00534612|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-24|||January 2003||2003-01-01|January 2003|2003-01-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors|Accuracy of Fine Needle Aspiration Biopsy in the Pre-Operative Diagnosis of Malignancy in Patients With Parotid Gland Masses|Unknown status|Recruiting|Early Phase 1|150|Anticipated|National Institute of Cancerología||1|||f||||f||||||||||2017-02-18 15:14:42.083685|2017-02-18 15:14:42.083685
NCT00534599|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2011-04-12|2009-08-13||August 2007||2007-08-01|April 2011|2011-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Generalized Anxiety Disorder Adjunct Study|A Multicenter, Rand., Double-blind, Parallel-group, Pbo-controlled Study of the Efficacy and Safety of SEROQUEL® XR Compared With Pbo as an Adjunct to Treatment in Patients With Generalized Anxiety Disorder Who Demonstrate Partial or No Response to a SSRI or SNRI Alone or in Combination With a Benzo|Completed||Phase 3|409|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:14:42.193895|2017-02-18 15:14:42.193895
NCT00534586|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2007-09-24|||December 2005||2005-12-01|December 2005|2005-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Anesthetics and Auditory, Visceral, and Heat Evoked Potentials|Influence of Anesthetics on Sedation and Antinociception: an Analysis of Auditory Evoked, Visceral Evoked and Heat Evoked Potentials|Completed||Phase 4|60|Actual|Technische Universität München||4|||f||||f||||||||||2017-02-18 15:14:43.223462|2017-02-18 15:14:43.223462
NCT00534573|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2012-07-25|||November 2008||2008-11-01|November 2009|2009-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|CIH||Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation|Comparison of Benzamide Derivates (Amisulpride, Moclobemide and Tiapride) as Treatment of Clozapine-induced Hypersalivation: Pilot Double Phase Study: Open and Double-blind|Completed||Phase 3|54|Actual|Beersheva Mental Health Center||2|||f||||f||||||||||2017-02-18 15:14:43.331106|2017-02-18 15:14:43.331106
NCT00534560|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2009-03-30|||October 2007||2007-10-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|TEMPUS||Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache|Multi-Centre, Parallel Group, Double-Blind, Placebo Controlled, Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache and Open Label Extension|Completed||Phase 2|542|Actual|Minster Research Ltd||3|||f||||f||||||||||2017-02-18 15:14:43.463403|2017-02-18 15:14:43.463403
NCT00534547|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-07-23||||||July 2015|2015-07-01||||||||Interventional|||Duodenal Exclusion for the Treatment of Type 2 Diabetes|Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes (T2DM)|Withdrawn||N/A|0|Actual|Medtronic - MITG||1||business reasons|f||||f||||||||||2017-02-18 15:14:43.57725|2017-02-18 15:14:43.57725
NCT00534534|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-24|||January 2001||2001-01-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Decrease of Recurrent Pancreatitis|Randomized Clinical Trial of the Effect of Standard Versus Intensive Intervention Protocol in Attempting to Reduce Recurrent Episodes of Acute Alcoholic Pancreatitis|Completed||N/A|120|Anticipated|University of Tampere||2|||f||||f||||||||||2017-02-18 15:14:43.66684|2017-02-18 15:14:43.66684
NCT00534521|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2007-09-24|||September 2007||2007-09-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Posterior Tibial Nerve Stimulation vs. Sham|Posterior Tibial Nerve Stimulation vs. Sham|Completed||Phase 3|30|Actual|William Beaumont Hospitals||2|||f||||f||||||||||2017-02-18 15:14:43.753099|2017-02-18 15:14:43.753099
NCT00534508|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2014-09-17|||December 2000||2000-12-01|September 2014|2014-09-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Distribution of Tacrolimus in Skin, Atopic Dermatitis|A Study to Determine the Distribution of Tacrolimus in the Skin and the Systemic Pharmacokinetics of Tacrolimus in Adult Patients With Moderate to Severe Atopic Dermatitis Following First and Repeated Application of the Tacrolimus Ointment.|Completed||Phase 2|14|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 15:14:43.848082|2017-02-18 15:14:43.848082
NCT00534495|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2015-11-05|2015-11-05||November 2008||2008-11-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults|Randomized Placebo Phase Study of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis (RAPPORT)|Completed||Phase 2|71|Actual|Montefiore Medical Center||2|||f||||f||||||||||2017-02-18 15:14:43.95719|2017-02-18 15:14:43.95719
NCT00534482|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-24|2011-05-09|||July 2007||2007-07-01|May 2011|2011-05-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|AIM-HI||"Evaluation of the Americans in Motion - Healthy Interventions Project"|The Impact of Brief Primary Care Counseling and Novel Physiological Measures on Patient Physical and Emotional Health|Completed||N/A|950|Anticipated|American Academy of Family Physicians||4|||f||||f||||||||||2017-02-18 15:14:44.992351|2017-02-18 15:14:44.992351
NCT00534469|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2017-01-31|||October 2000||2000-10-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Busulfan, Etoposide, and Total-Body Irradiation Followed by Autologous Stem Cell Transplant and Aldesleukin in Treating Patients With Acute Myeloid Leukemia in First Remission|Autologous Bone Marrow Transplantation for Non-M3 Acute Myeloid Leukemia (AML) in First Remission in Patients </=60 Years of Age Using Busulfan/Fractionated Total Body Irradiation (FTBI) and VP16 as the Preparative Regimen|Active, not recruiting||Phase 2|50|Anticipated|City of Hope Medical Center||2|||f||||||||||||||2017-02-18 15:14:45.146636|2017-02-18 15:14:45.146636
NCT00534092|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2015-03-23|2011-06-02||December 2006||2006-12-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|||||Observational|||Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®|Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts|Completed||Phase 4|69|Actual|Medtronic Spine LLC|||1||f||||f||||||||||2017-02-18 15:14:54.11544|2017-02-18 15:14:54.11544
NCT00534456|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2011-04-07|||January 2007||2007-01-01|April 2011|2011-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial|Double-Blind, Placebo Controlled, Multicenter Study to Assess the Effect of Darbepoetin Alfa Treatment on Cardiac Function and Disease Specific Biomarkers in Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia: An Exploratory Sub-study for the RED-HF™ Trial|Terminated||Phase 3|12|Actual|Amgen||2||Study terminated|f||||||||||||||2017-02-18 15:14:45.263548|2017-02-18 15:14:45.263548
NCT00534443|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2011-08-08|||February 2007||2007-02-01|June 2008|2008-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment|A Clinical Study of the Efficacy of Esomeprazole or Rabeprazole on the Pattern of Release of Pro- and Anti-inflammatory Cytokines From Gastric Mucosa of Patients With Peptic Ulcer Disease|Completed||Phase 4|150|Actual|University of Athens||1|||f||||t||||||||||2017-02-18 15:14:45.368979|2017-02-18 15:14:45.368979
NCT00534430|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2017-01-31|||January 2000||2000-01-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer|Phase II Study of IV Busulfan Combined With 12 cGy of Fractionated Total Body Irradiation (FTBI) and Etoposide (VP-16) as a Preparative Regimen for Allogeneic Bone Marrow Transplantation for Patients With Advanced Hematological Malignancies|Active, not recruiting||Phase 2|50|Anticipated|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 15:14:45.485313|2017-02-18 15:14:45.485313
NCT00534417|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-12-28|2012-12-28||October 2007||2007-10-01|December 2012|2012-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer|Phase II Trial of Capecitabine in Combination With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer|Completed||Phase 2|41|Actual|Accelerated Community Oncology Research Network||1|||f||||f||||||||||2017-02-18 15:14:45.834414|2017-02-18 15:14:45.834414
NCT00534404|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2015-01-21|2015-01-21||March 2011||2011-03-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|iQS||A Randomized Trial of Internet Access to Nicotine Patches|iQuit Smoking: A Randomized Trial of Internet Access to Nicotine Patches|Completed||N/A|2485|Actual|University of Michigan||3|||f||||t||||||||||2017-02-18 15:14:46.425301|2017-02-18 15:14:46.425301
NCT00534391|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2010-11-22|||September 2007||2007-09-01|November 2010|2010-11-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage|Dose Antibiotic Need in Hordeolum After Incision and Curettage? : A Randomized, Placebo-controlled Trial|Unknown status|Recruiting|Phase 3|120|Anticipated|Chulalongkorn University||2|||f||||t||||||||||2017-02-18 15:14:47.324743|2017-02-18 15:14:47.324743
NCT00534378|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-21|||July 2006||2006-07-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|||||Interventional|AAS||Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector|Phase I, Open-Label, Single-Center Study to Evaluate the Safety and Dose Linearity of Intramuscular Administration of Midazolam Using|Completed||Phase 1|39|Actual|U.S. Army Office of the Surgeon General||1|||f||||t||||||||||2017-02-18 15:14:47.442583|2017-02-18 15:14:47.442583
NCT00534365|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2013-08-27|||August 2007||2007-08-01|August 2013|2013-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|SECURiTy||Study Comparing TVT With TVT-SECUR for the Treatment of Stress Urinary Incontinence|A Randomized Trial Comparing Tension-free Vaginal Tape (TVT) to the TVT-SECUR for the Surgical Treatment of Stress Urinary Incontinence|Completed||Phase 3|281|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 15:14:47.539569|2017-02-18 15:14:47.539569
NCT00534352|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2015-03-26|2009-05-06||January 2008||2008-01-01|March 2015|2015-03-01|March 2009|Actual|2009-03-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).|A Multicenter Study to Evaluate the Pharmacokinetic Profile and Safety of TMC125 Plus Tenofovir DF/Emtricitabine All Dosed Once Daily With and Without Darunavir (PREZISTA™)/ Ritonavir Once Daily in Antiretroviral naïve HIV-1 Infected Subjects|Completed||Phase 2|23|Actual|Tibotec, Inc||1|||f||||||||||||||2017-02-18 15:14:47.661218|2017-02-18 15:14:47.661218
NCT00534339|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2014-10-03|||December 2010||2010-12-01|November 2010|2010-11-01|February 2016|Anticipated|2016-02-01|April 2012|Anticipated|2012-04-01||Interventional|||EasyBand GOAL Trial||Withdrawn||N/A|0|Actual|Allergan||1||"This study was withdrawn to further optimize the device. No patients were enrolled in the~   trial."|f||||||||||||||2017-02-18 15:14:48.482799|2017-02-18 15:14:48.482799
NCT00534326|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-02-10|||December 2006||2006-12-01|February 2016|2016-02-01||||December 2015|Actual|2015-12-01||Interventional|STAFF||Standard Reaming Versus Reaming/Irrigating/Aspirating for Intramedullary Nailing of Femoral Shaft Fractures|Standard Reaming Versus Reaming/Irrigating/Aspirating for Intramedullary Nailing of Femoral Shaft Fractures|Active, not recruiting||N/A|550|Anticipated|Greenville Health System||2|||f||||f||||||||||2017-02-18 15:14:48.56228|2017-02-18 15:14:48.56228
NCT00534313|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-07-25|2010-10-29||November 2007||2007-11-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis|A Phase IIB, Multi-Dose, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Versus Placebo in the Treatment of Psoriatic Arthritis|Terminated||Phase 2|191|Actual|Bristol-Myers Squibb||4||Lack of efficacy with respect to skin-related lesions in the short-term phase|f||||f||||||||||2017-02-18 15:14:48.76601|2017-02-18 15:14:48.76601
NCT00534300|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2015-04-15|||October 2007||2007-10-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker|Intravenous Infusion of n-3 Polyunsaturated Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)|Completed||Phase 1/Phase 2|8|Actual|Aalborg Universitetshospital||2|||f||||t||||||||||2017-02-18 15:14:50.761102|2017-02-18 15:14:50.761102
NCT00533871|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-21|||February 2003||2003-02-01|September 2007|2007-09-01|June 2005|Actual|2005-06-01|||||Observational|||Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia|Utilization of Serum BNP to Distinguish Pre-Eclampsia From Hypertension in Pregnancy|Completed||N/A|61|Actual|Ohio State University|||3||f||||f||||||||||2017-02-18 15:15:01.159078|2017-02-18 15:15:01.159078
NCT00534287|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2012-06-28|||October 2007||2007-10-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|MaxSep||Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock|Prospective, Randomized, Open, Multicentre Study About the Effect of an Empirical Antibiotic Monotherapy With Meropenem (Meronem®) Versus a Combination Therapy With Moxifloxacin (Avalox®) on Organ Dysfunction in Patients With Severe Sepsis and Septic Shock|Completed||Phase 3|600|Actual|Kompetenznetz Sepsis||2|||f||||t||||||||||2017-02-18 15:14:50.863502|2017-02-18 15:14:50.863502
NCT00534274|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2014-12-14|||November 2006||2006-11-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|April 2012|Actual|2012-04-01||Interventional|||Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy|Study of Positron Emission Tomography With 3'-Deoxy-3'-[18F] Fluoro-thymidine ([18F]-FLT) for the Evaluation of Response to Neoadjuvant Chemotherapy for Cancers of the Breast|Completed||N/A|97|Actual|UNICANCER||1|||f||||f||||||||||2017-02-18 15:14:51.05322|2017-02-18 15:14:51.05322
NCT00534261|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-12-11|||November 1999||1999-11-01|December 2007|2007-12-01|February 2004|Actual|2004-02-01|||||Interventional|FLAIR||Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?|Evaluation of the Correlation Between the MS Functional Composite Index and Two Quality of Life Scales (MS54 and AMS Quality of Life) in Relapsing MS Patients Treated With Interferon Beta-1a (AVONEX®)|Completed||Phase 4|284|Actual|Biogen||1|||f||||t||||||||||2017-02-18 15:14:51.180822|2017-02-18 15:14:51.180822
NCT00534248|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2015-08-11|2011-01-04||October 2007||2007-10-01|August 2015|2015-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)|A Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity, Safety and Tolerability of Zostavax™ in Subjects 50-59 Years of Age|Completed||Phase 3|22439|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:14:51.299921|2017-02-18 15:14:51.299921
NCT00534235|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2017-02-02|||October 2012||2012-10-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Post-Approval Clinical Trial Comparing the Long Term Safety and Effectiveness Coflex vs. Fusion to Treat Lumbar Spinal Stenosis|Post-Approval Study to Investigate The Long Term (5-Year) Survivorship of Coflex Compared to Control Fusion Study Patients|Completed||N/A|396|Actual|Paradigm Spine||2|||f||||t||||||||Undecided||2017-02-18 15:14:52.555779|2017-02-18 15:14:52.555779
NCT00534222|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2011-12-13|||September 2005||2005-09-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|||||Observational|UPTAQE||Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect|Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect|Completed||N/A|387|Actual|AstraZeneca|||3||f||||f||||||||||2017-02-18 15:14:52.660862|2017-02-18 15:14:52.660862
NCT00534209|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-12-14|2013-01-17||February 2007||2007-02-01|December 2016|2016-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy|Phase I/II Clinical Trial of Immunotherapy With an Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer That Have Completed First Line Chemotherapy|Terminated||Phase 1/Phase 2|1|Actual|University of Miami|Study closed early due to low enrollment. A minimum of 2 patients were required for Phase 1. Only 1 patient enrolled.|2||Per request of Principal Investigator this study was closed.|f||||t||||||||||2017-02-18 15:14:52.755507|2017-02-18 15:14:52.755507
NCT00534196|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-09-27|||July 2005||2005-07-01|September 2016|2016-09-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|J-POPS||Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer|Japanese Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation [J-POPS]|Active, not recruiting||N/A|6927|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan|||1||f||||t||||||||||2017-02-18 15:14:53.006887|2017-02-18 15:14:53.006887
NCT00534183|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-21|||June 2006||2006-06-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|||||Interventional|MetS||Metabolic Profile and Anthropometric Changes in Schizophrenia|Metabolic Profile and Anthropometric Changes in Schizophrenia|Completed||N/A|2006|Actual|Central Institute of Psychiatry, Ranchi, India||3|||f||||t||||||||||2017-02-18 15:14:53.145057|2017-02-18 15:14:53.145057
NCT00534170|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-21|||June 2007||2007-06-01|June 2007|2007-06-01|January 2008|Anticipated|2008-01-01|||||Interventional|Yakult||Randomized Controlled Field Trial of a Probiotics to Assess Its Role in Preventig Diarrhoea|Randomized Controlled Field Trial of a Probiotics to Assess Its Role in The Prevention of Acute Diarrhoeal Diseases in Children|Unknown status|Active, not recruiting|Phase 3|4000|Actual|Indian Council of Medical Research||1|||f||||t||||||||||2017-02-18 15:14:53.244278|2017-02-18 15:14:53.244278
NCT00534157|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-21|||June 2004||2004-06-01|March 2007|2007-03-01|April 2007|Actual|2007-04-01|||||Observational|||Study of Eye Pressure as a Predictor of Intracranial Pressure in the Acutely Head-Injured Population|Intraocular Pressure as a Predictor of Intracranial Pressure in the Acutely Head-Injured Population|Completed||N/A|37|Actual|Ohio State University|||||f||||f||||||||||2017-02-18 15:14:53.350506|2017-02-18 15:14:53.350506
NCT00534144|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2011-09-22|||September 2007||2007-09-01|September 2011|2011-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Comparison Between Effects of Two Iron Preparations on Protein in the Urine|A Randomized Controlled Trial of the Effect of IV Iron on Proteinuria in Non-Dialysis Chronic Kidney Disease Patients|Completed||Phase 1|74|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:14:53.427524|2017-02-18 15:14:53.427524
NCT00534131|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2010-07-27|||April 2004||2004-04-01|June 2008|2008-06-01|March 2012|Anticipated|2012-03-01|January 2012|Anticipated|2012-01-01||Interventional|APPEAR||Anterior Perineal Plane for Ultra Low Anterior Resection of the Rectum|A Multicentre Trial of the Anterior Perineal PlanE for Ultra Low Anterior Resection of the Rectum (The APPEAR Technique) in the Prevention of Permanent Stoma in Benign and Malignant Disease|Unknown status|Recruiting|N/A|30|Anticipated|Queen Mary University of London||3|||f||||t||||||||||2017-02-18 15:14:53.537627|2017-02-18 15:14:53.537627
NCT00534118|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2017-02-14|||October 1, 2003|Actual|2003-10-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant|Cellular Infusions in Patients With Recurrent or Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplant|Active, not recruiting||N/A|39|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 15:14:53.645734|2017-02-18 15:14:53.645734
NCT00534079|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2014-12-03|||September 2007||2007-09-01|December 2014|2014-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis|Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis - a Double Blind Placebo-controlled Cross-over, Bicenter, Prospective Clinical Study|Completed||Phase 3|23|Actual|University of Jena||2|||f||||t||||||||||2017-02-18 15:14:55.384395|2017-02-18 15:14:55.384395
NCT00534066|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-21|||September 2002||2002-09-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Observational|||Utility of Serial BNP Levels in Emergency Department CHF|The Utility of Serial BNP Levels as a Predictor of Adverse Outcomes in Emergency Department CHF|Completed||N/A|52|Actual|Ohio State University|||2||f||||f||||||||||2017-02-18 15:14:55.696992|2017-02-18 15:14:55.696992
NCT00534053|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-20|||June 2007||2007-06-01|September 2007|2007-09-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial|Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial|Unknown status|Recruiting|N/A|800|Anticipated|University of California, San Diego||2|||f||||f||||||||||2017-02-18 15:14:55.798267|2017-02-18 15:14:55.798267
NCT00534027|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2015-12-14||2015-12-14|January 2008||2008-01-01|December 2015|2015-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer|A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|172|Actual|Amgen||3|||f||||||||||||||2017-02-18 15:14:55.903886|2017-02-18 15:14:55.903886
NCT00534014|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2008-03-31|||January 2006||2006-01-01|March 2008|2008-03-01|May 2007|Actual|2007-05-01|March 2007|Actual|2007-03-01||Interventional|||Vitamin C and Cardiovascular Risk|Vitamin C Therapy in Type 2 Diabetes and Cardiovascular Risk|Completed||N/A|8|Actual|University of New Mexico||4|||f||||t||||||||||2017-02-18 15:14:56.021678|2017-02-18 15:14:56.021678
NCT00534001|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2015-08-27|||January 2006||2006-01-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|May 2008|Actual|2008-05-01||Interventional|||Bupropion in Helping Adults Stop Smoking|A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation|Completed||Phase 2|97|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-02-18 15:14:56.13911|2017-02-18 15:14:56.13911
NCT00533988|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-21|2007-09-28|||January 1996||1996-01-01|September 2007|2007-09-01|December 1999|Actual|1999-12-01|||||Interventional|||Central Venous Catheter-Related Infection|Central Venous Catheter-Related Infection: A Prospective Randomized Double-Blind Study|Completed||Phase 4|118|Actual|University of Witwatersrand, South Africa||2|||f||||f||||||||||2017-02-18 15:14:56.25379|2017-02-18 15:14:56.25379
NCT00533975|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-20|||September 2007||2007-09-01|June 2007|2007-06-01|December 2008|Anticipated|2008-12-01|||||Observational|||A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing Colonoscopy|A Prospective Study of a New Immunochemical Fecal Occult Blood Test in U.S. Veteran Patients Undergoing Colonoscopy|Unknown status|Not yet recruiting|N/A|500|Anticipated|University of California, San Diego|||||f||||f||||||||||2017-02-18 15:14:56.354999|2017-02-18 15:14:56.354999
NCT00533962|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-21|||August 2007||2007-08-01|September 2007|2007-09-01||||||||Interventional|||IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients|Anterior Juxtascleral Depot of Anecortave Acetate: Intraocular Pressure Reduction in Glaucoma Patients|Unknown status|Active, not recruiting|N/A|30|Actual|Federal University of São Paulo|||||f||||f||||||||||2017-02-18 15:14:56.442239|2017-02-18 15:14:56.442239
NCT00533949|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-10-11|||November 2007||2007-11-01|October 2016|2016-10-01||||June 2013|Actual|2013-06-01||Interventional|||High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) in Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer|Active, not recruiting||Phase 3|500|Anticipated|Radiation Therapy Oncology Group||4|||f||||t||||||||||2017-02-18 15:14:56.549066|2017-02-18 15:14:56.549066
NCT00533936|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2013-08-23|||September 2006||2006-09-01|March 2008|2008-03-01||||December 2009|Anticipated|2009-12-01||Interventional|||Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer|Adjuvant Trastuzumab vs Observation in Locally Advanced Breast Cancer Treated With Neoadjuvant Trastuzumab|Unknown status|Recruiting|Phase 2|160|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:14:57.05009|2017-02-18 15:14:57.05009
NCT00533923|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-07-14|||December 2002||2002-12-01|July 2016|2016-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders|Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders|Completed||Phase 2|25|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 15:14:57.151593|2017-02-18 15:14:57.151593
NCT00533910|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2013-03-19|||October 2007||2007-10-01|March 2013|2013-03-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Rifaximin in Minimal Hepatic Encephalopathy|Effect of Rifaximin on Driving Performance, Psychometric Test Performance and Quality of Life in Cirrhotic Patients With Minimal Hepatic Encephalopathy: Randomized, Double-blind, Placebo-controlled Trial.|Completed||N/A|42|Actual|Hunter Holmes Mcguire Veteran Affairs Medical Center||2|||f||||f||||||||||2017-02-18 15:14:57.266624|2017-02-18 15:14:57.266624
NCT00533897|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2015-04-22|2011-01-10||November 2007||2007-11-01|April 2015|2015-04-01|February 2014|Actual|2014-02-01|December 2008|Actual|2008-12-01||Interventional||All Period 1 Non-responders and Period 2 participants who received at least one dose of abatacept during the study were summarized.|Phase IIIB Subcutaneous Missed Dose Study|A Phase IIIb, Multi-Center, Randomized, Withdrawal Study to Evaluate the Immunogenicity and Safety of Subcutaneous Administered Abatacept in Adults With Active Rheumatoid Arthritis|Completed||Phase 3|270|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 15:14:57.42735|2017-02-18 15:14:57.42735
NCT00533884|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2011-08-02|||October 2007||2007-10-01|August 2011|2011-08-01|October 2012|Anticipated|2012-10-01|May 2010|Actual|2010-05-01||Observational|||Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic|Neurocognitive Functioning in Adults With Upper Aerodigestive System Cancers|Unknown status|Active, not recruiting|N/A|100|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-02-18 15:15:01.033057|2017-02-18 15:15:01.033057
NCT00533845|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2013-05-25|||September 2007||2007-09-01|May 2013|2013-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Intraperitoneal Bupivicaine Infusion Using the On-Q Pain Pump After Laparoscopic Surgery|Intraperitoneal Bupivicaine Infusion Using the On-Q Pain Pump After Laparoscopic Surgery|Completed||Phase 4|30|Actual|Maimonides Medical Center||2|||f||||f||||||||||2017-02-18 15:15:01.350429|2017-02-18 15:15:01.350429
NCT00533832|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-21|||July 2000||2000-07-01|September 2007|2007-09-01|July 2005|Actual|2005-07-01|||||Interventional|||Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)|A Multicernter, Pivotal, Safety and Efficacy Study of the NeuroCtybernetic Prosthesis (NCP(R)) System in Patients With Depression|Completed||N/A|266|Actual|Cyberonics, Inc.||2|||f||||t||||||||||2017-02-18 15:15:01.450954|2017-02-18 15:15:01.450954
NCT00533819|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2008-10-14|||September 2007||2007-09-01|October 2008|2008-10-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Exercise Intervention in Female School Children: Effect on Blood Pressure, Body Mass Index (BMI), and Maths Scores|A Phase II Non Randomized Community Intervention Trial in 4 Public Sectors Schools in Karachi. Exercise Intervention in Female School Children: Effect on Blood Pressure, BMI, and Maths Scores|Unknown status|Recruiting|Phase 2|280|Anticipated|Aga Khan University||2|||f||||f||||||||||2017-02-18 15:15:01.544731|2017-02-18 15:15:01.544731
NCT00533806|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2013-03-07|||October 2007||2007-10-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|October 2012|Actual|2012-10-01||Interventional|||Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder|Family Based Treatment for Early Childhood OCD|Completed||Phase 3|127|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-02-18 15:15:01.662913|2017-02-18 15:15:01.662913
NCT00533793|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-03-15|||April 2007||2007-04-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|TSF||Adjunctive Therapy to Treat Tibial Shaft Fractures|A Phase II Randomized, Controlled, Open-labeled (Dose-blinded) Dose Finding Study of the Safety and Efficacy of I-040202 in the Treatment of Patients With Acute Open Tibial Shaft Fractures|Completed||Phase 2|201|Actual|Kuros Biosurgery AG||4|||f||||f||||||||||2017-02-18 15:15:01.782341|2017-02-18 15:15:01.782341
NCT00533676|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2017-02-16|||August 2004||2004-08-01|February 2017|2017-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Endpoint Validation Study (0524A-015)|A Randomized, Double-Blind, Placebo-Controlled Endpoint Selection and Questionnaire Validation Study to Assess the Niacin Induced Flushing Caused by NIASPAN (TM)|Completed||Phase 2|165||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:15:01.935584|2017-02-18 15:15:01.935584
NCT00533663|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2013-06-03|||April 2007||2007-04-01|June 2013|2013-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Healing Touch During Chemotherapy Infusions for Women With Breast Cancer|Healing Touch During Chemotherapy Infusions for Women With Breast Cancer|Completed||N/A|32|Actual|Stanford University||3|||f||||||||||||||2017-02-18 15:15:02.148762|2017-02-18 15:15:02.148762
NCT00533650|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-07-28|||December 2000||2000-12-01|May 2016|2016-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)||Completed||Phase 2|227|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:15:02.263553|2017-02-18 15:15:02.263553
NCT00533637|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2008-02-29|||September 2007||2007-09-01|September 2007|2007-09-01|December 2007|Actual|2007-12-01|||||Interventional|||Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis|A Double-Blind, Randomized, Placebo-Controlled, Cross-Over, Allergen Challenge Study to Evaluate Taste and Local Tolerance of NLA Nasal Spray in Patients With Allergic Rhinitis|Completed||Phase 2|28|Actual|Biolipox AB||3|||f||||f||||||||||2017-02-18 15:15:02.33475|2017-02-18 15:15:02.33475
NCT00533624|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-09-19|||December 2004||2004-12-01|September 2007|2007-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Myfortic vs. Cellcept in Kidney Transplant Recipients|Head to Head Comparison of Myfortic vs. Cellcept in the Treatment of Kidney Transplant Recipients Using Our Current Center Standardized Concomitant Immunosuppressive Protocol|Completed||Phase 2/Phase 3|150|Actual|University of Miami||2|||f||||f||||||||||2017-02-18 15:15:02.440436|2017-02-18 15:15:02.440436
NCT00533611|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2017-02-16|||April 2007||2007-04-01|February 2017|2017-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effect of MK0524A on Flushing Caused by Niacin (0524A-056)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Tolerability and Effect of MK0524A on Niacin-Induced Acute Flushing in Lipid Clinic Patients|Completed||Phase 3|330||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:15:02.549278|2017-02-18 15:15:02.549278
NCT00533598|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-09-06|||September 2002||2002-09-01|September 2016|2016-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)||Completed||Phase 2|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:15:02.634935|2017-02-18 15:15:02.634935
NCT00533585|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-02-09|||May 2006||2006-05-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)|Phase I Dose-Escalating, Open-Label, Non-Placebo Controlled Study of BAY 43-9006 (Sorafenib) in Combination With Carboplatin, Paclitaxel and Bevacizumab in Previously Untreated Patients With Stage IIIB (With Malignant Pleural Effusions) or Stage IV Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|23|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:15:02.710428|2017-02-18 15:15:02.710428
NCT00533572|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2015-05-22|||August 2007||2007-08-01|May 2015|2015-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer|Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer|Terminated||N/A|1|Actual|Stanford University|||1|"Study was suspended until FDA approved the IND. Study has since been terminated and a new~   screening process has been implemented."|f||||||||||||||2017-02-18 15:15:02.832802|2017-02-18 15:15:02.832802
NCT00533559|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2010-06-24|||September 2007||2007-09-01|August 2007|2007-08-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl|Mechanism of Fatty Acid-induced Impairment of Glucose-stimulated Insulin Secretion - Effect of Buphenyl|Completed||Phase 4|10|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 15:15:02.935287|2017-02-18 15:15:02.935287
NCT00533546|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-09-01|2015-10-16||September 2007||2007-09-01|September 2016|2016-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|APCAST||Activated Protein C in Acute Stroke Trial|Activated Protein C in Acute Stroke Trial|Terminated||Phase 2|12|Actual|University of Rochester|Study was terminated after completion of Tier One dosing level (n=12 subjects) due to lack of recruitment.|1||Lack of recruitment|f||||t||||||||||2017-02-18 15:15:03.21393|2017-02-18 15:15:03.21393
NCT00533533|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2009-01-12|||January 2006||2006-01-01|November 2006|2006-11-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|DO for AGC||A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer|A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer|Completed||Phase 1/Phase 2|68|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 15:15:03.544954|2017-02-18 15:15:03.544954
NCT00533520|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2013-11-21|||September 2007||2007-09-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|BGB/IST||Evaluation of Dosing Interval of Higher Doses of Ranibizumab|Evaluation of Dosing Interval of Higher Doses of Ranibizumab|Completed||Phase 4|37|Actual|Tennessee Retina||3|||f||||t||||||||||2017-02-18 15:15:03.65205|2017-02-18 15:15:03.65205
NCT00533507|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-10-27|2009-06-05||September 2007||2007-09-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age|Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Infanrix Hexa and Rotarix|Completed||Phase 3|230|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:15:03.767043|2017-02-18 15:15:03.767043
NCT00533494|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-11-11|||January 2000||2000-01-01|April 2003|2003-04-01|September 2003|Actual|2003-09-01|||||Interventional|||The Effect of Patients' Participation in Improving Diabetes Care||Completed||Phase 3|||Soroka University Medical Center||2|||f||||f||||||||||2017-02-18 15:15:04.220664|2017-02-18 15:15:04.220664
NCT00533481|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-09-15|||February 2004||2004-02-01|September 2016|2016-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)||Completed||Phase 2|497|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:15:04.309515|2017-02-18 15:15:04.309515
NCT00533468|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2011-03-23|||March 2007||2007-03-01|March 2011|2011-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."|"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."|Completed||Phase 4|70|Actual|State University of New York at Buffalo||1|||f||||t||||||||||2017-02-18 15:15:04.385762|2017-02-18 15:15:04.385762
NCT00533455|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-09-21|||March 2004||2004-03-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Gabapentin for the Treatment of Neuroleptic-Induced Tremor|A 4 Week, Parallel-Design, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Treatment of Neuroleptic-Induced Tremor: Clinical and Instrumental Ratings of Outcome.|Terminated||Phase 3|40|Anticipated|Minneapolis Veterans Affairs Medical Center||||Failure to recruit due to polypharmacy|f||||f||||||||||2017-02-18 15:15:04.499354|2017-02-18 15:15:04.499354
NCT00533442|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-06-02|||September 2000||2000-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients|Tacrolimus and Mycophenolate Mofetil vs Tacrolimus and Sirolimus in SPK, Pancreas After Kidney or Pancreas Transplant Alone|Completed||Phase 2|190|Actual|University of Miami||2|||f||||f||||||||||2017-02-18 15:15:04.612622|2017-02-18 15:15:04.612622
NCT00533429|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2010-02-16||2010-02-16|October 2007||2007-10-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy|Protocol H6Q-MC-S034(a) Randomized, Double-Blind, Phase 2 Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Chemonaive Patients With Stage IIIB or IV Non-Small Cell Lung Cancer|Completed||Phase 2|40|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:15:04.738051|2017-02-18 15:15:04.738051
NCT00533416|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2017-01-24|||September 14, 2007||2007-09-14|April 27, 2016|2016-04-27|June 4, 2012|Actual|2012-06-04|June 4, 2012|Actual|2012-06-04||Interventional|||Safety of ON 01910.Na in Patients With Myelodysplasia|A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With RAEB-1 AND RAEB-2 Myelodysplastic Syndrome (MDS) and AML With Trisomy 8|Completed||Phase 1|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:15:04.873574|2017-02-18 15:15:04.873574
NCT00532701|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2014-06-03|||November 2007||2007-11-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR|Peginterferon Alfa-2a Plus Ribavirin in Patients With Genotype 2 Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose Stratified by Rapid Virologic Response|Completed||Phase 4|880|Actual|National Taiwan University Hospital||5|||f||||t||||||||||2017-02-18 15:15:04.976156|2017-02-18 15:15:04.976156
NCT00532688|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-09-19|||September 2007||2007-09-01|September 2007|2007-09-01|February 2008|Anticipated|2008-02-01|||||Interventional|||N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure|Randomised Control Pilot Trial of n-Acetylcysteine in the Treatment of Chronic Heart Failure With Coexistent Chronic Renal Failure.|Unknown status|Recruiting|Phase 2/Phase 3|10|Anticipated|Bayside Health||2|||f||||f||||||||||2017-02-18 15:15:05.329593|2017-02-18 15:15:05.329593
NCT00532675|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2017-02-10|||April 22, 2008|Actual|2008-04-22|February 2017|2017-02-01|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.|A Phase Ib, Multi-center, Open-label, Dose-escalation Study of Oral LBH589 When Administered in Combination With Oral Lenalidomide & Dexamethasone in Adult Patients With Multiple Myeloma|Active, not recruiting||Phase 1|46|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:15:05.441061|2017-02-18 15:15:05.441061
NCT00532662|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2010-11-17|||November 2007||2007-11-01|November 2010|2010-11-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Interventional|||Postoperative Analgesia by Epidural vs IV Ketamine Concurrent With Caudal Anesthesia in Pediatric Orthopedic Surgery|Intravenous Versus Caudal Supplementation of Ketamine for Postoperative Pain Control in Children,A Double-blind Controlled Clinical Trial.|Unknown status|Recruiting|Phase 4|40|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:15:05.55733|2017-02-18 15:15:05.55733
NCT00532636|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2009-03-25|||January 2006||2006-01-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Head Position Angles in Children|Head Position Angles in Children to Open the Upper Airway|Terminated||N/A|78|Actual|Medical University Innsbruck||2||Recruitment completed|f||||t||||||||||2017-02-18 15:15:05.670729|2017-02-18 15:15:05.670729
NCT00532623|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2011-06-24|||May 2004||2004-05-01|September 2007|2007-09-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer|A Phase II Study of Gemcitabine in Combination With Vinorelbine vs. Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer|Completed||Phase 2|82|Actual|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 15:15:05.769078|2017-02-18 15:15:05.769078
NCT00532610|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2012-03-15|||September 2007||2007-09-01|February 2011|2011-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study to Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults|A Randomized, Double-blind, Placebo-Controlled, Cross-Over Trial to Investigate the Effect of GSK189075 on Cardiac Repolarization as Compared to Placebo and a Single Dose of Moxifloxacin in Healthy Adult Subjects|Completed||Phase 1|78|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:15:05.874067|2017-02-18 15:15:05.874067
NCT00532597|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-09-19|||April 2007||2007-04-01|September 2007|2007-09-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Effects of On-Line Hemodiafiltration(HDF) on Vascular Health in Chronic Hemodialysis Patients|Effects of On-Line Hemodiafiltration(HDF) on Endothelial Dysfunction in Chronic Hemodialysis Patients|Unknown status|Recruiting|Phase 4|20|Anticipated|Eulji General Hospital||2|||f||||t||||||||||2017-02-18 15:15:05.969257|2017-02-18 15:15:05.969257
NCT00533403|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2015-06-25|||July 2004||2004-07-01|June 2015|2015-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||MK0686 in Postsurgery Dental Pain (0686-002)||Completed||Phase 2|114|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:15:06.082068|2017-02-18 15:15:06.082068
NCT00533390|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2015-11-07|||January 2007||2007-01-01|November 2015|2015-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|IPEC-EFV||Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg|Anti-retroviral Efficacy, Tolerance and Other Pharmacologic Interactions of the Non Nucleoside Analog Efavirenz in Association With Rifampicin to Treat Tuberculosis and AIDS|Terminated||Phase 4|130|Actual|Oswaldo Cruz Foundation||2||Lack of financial support and low inclusion rate|f||||f||||||||||2017-02-18 15:15:06.153796|2017-02-18 15:15:06.153796
NCT00533377|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-02-15||2012-02-15|January 2008||2008-01-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||ACTiF- Assessment of Closed Tibial Fractures|A Randomized, Placebo-Controlled Study To Evaluate The Efficacy, Safety And Tolerability Of CP-533,536 In Subjects With Closed Fracture Of The Tibial Shaft|Completed||Phase 2|276|Actual|Pfizer||6|||f||||f||||||||||2017-02-18 15:15:06.290797|2017-02-18 15:15:06.290797
NCT00533364|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2010-02-17|||January 2007||2007-01-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Effect of SBG in Patients With Breast Cancer|A Phase I/II Study to Assess the Effect of Soluble Beta-1,3/1,6-glucan in Combination With Standard Therapy in Patients With Breast Cancer|Completed||Phase 1/Phase 2|11|Actual|Biotec Pharmacon ASA||1|||f||||||||||||||2017-02-18 15:15:06.638632|2017-02-18 15:15:06.638632
NCT00533351|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-01-27|2011-12-15||March 2008||2008-03-01|January 2016|2016-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Efficacy of AGN201781 in Neuropathic Pain||Terminated||Phase 2|9|Actual|Allergan|This study was terminated early due to low enrollment (only 9 of the required 40 subjects had been enrolled). Due to the low number of patients who completed the treatment period of the study, no analyses were performed.|2||This study was terminated early due to low enrollment.|f||||f||||||||||2017-02-18 15:15:06.737613|2017-02-18 15:15:06.737613
NCT00533338|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-09-30|||July 2007||2007-07-01|September 2016|2016-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||Weight Gain Prevention for Breast Cancer Survivors|Weight Gain Prevention for Breast Cancer Survivors|Active, not recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:15:07.083334|2017-02-18 15:15:07.083334
NCT00533312|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-02-18|||February 2005||2005-02-01|February 2016|2016-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)|A Multicenter, Randomized, Double-Blinded, Parallel-Design Study to Evaluate the Lipid-Altering Efficacy of 2 Formulations of MK0524A Compared to NIASPAN (TM)|Completed||Phase 2|407|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:15:07.204764|2017-02-18 15:15:07.204764
NCT00533299|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-09-20|||August 2007||2007-08-01|August 2007|2007-08-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Hydralazine Valproate for Ovarian Cancer|Randomized, Double-Blind, Phase III Trial of Chemotherapy Plus the Transcriptional Therapy Hydralazine and Magnesium Valproate Versus Chemotherapy Plus Placebo in Cisplatin-Resistant Recurrent Ovarian Cancer.|Unknown status|Recruiting|Phase 3|211|Anticipated|National Institute of Cancerología||2|||f||||t||||||||||2017-02-18 15:15:07.294675|2017-02-18 15:15:07.294675
NCT00533286|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-20|||August 2002||2002-08-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Do Benzodiazepines Improve the Outcome of Mechanical Physiotherapy for Lumbar Disk Prolapse|Do Benzodiazepines Improve the Outcome of Mechanical Physiotherapy for Lumbar Disk Prolapse: a Prospective Randomized Clinical Trial|Completed||Phase 2|||University Hospital Tuebingen||2|||f||||t||||||||||2017-02-18 15:15:07.392708|2017-02-18 15:15:07.392708
NCT00533273|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-09-14|2010-09-24||August 2007||2007-08-01|August 2016|2016-08-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|CORD-II||Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease|A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of AA4500 in the Treatment of Subjects With Advanced Dupuytren's Disease Followed by an Open-Label Extension Phase|Completed||Phase 3|66|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:15:07.484443|2017-02-18 15:15:07.484443
NCT00533260|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2010-12-07|||July 2007||2007-07-01|December 2010|2010-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|SEQUEL||A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine)|A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel®|Completed||N/A|128|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 15:15:07.968784|2017-02-18 15:15:07.968784
NCT00533247|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-20||||||September 2007|2007-09-01||||||||Interventional|||Arthroplasty Inflammation Prophylaxis With Celecoxib|Preemptive Anti-Inflammatory Use of Celecoxib in Knee Arthroplasty Surgery: a Double Blinded, Placebo-Controlled Study.|Unknown status|Not yet recruiting|N/A|200|Anticipated|Zanbilowicz, Adam, DPM MS||2|||f||||t||||||||||2017-02-18 15:15:08.094647|2017-02-18 15:15:08.094647
NCT00533221|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2013-12-17|||October 2007||2007-10-01|December 2013|2013-12-01|August 2011|Actual|2011-08-01|February 2010|Actual|2010-02-01||Interventional|||Pilot Study of Growth Hormon to Treat SMA Typ II and III|Can Treatment With Human Growth Hormone Increase Strength in Spinal Muscular Atrophy Type II and III?|Completed||Phase 2|20|Actual|University Hospital Freiburg||2|||f||||t||||||||||2017-02-18 15:15:08.30574|2017-02-18 15:15:08.30574
NCT00533208|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2015-12-21|||July 2003||2003-07-01|December 2015|2015-12-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)||Completed||Phase 2|766|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:15:08.432196|2017-02-18 15:15:08.432196
NCT00533195|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2009-01-13|||October 2007||2007-10-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis|UVA1 Phototherapy Versus 5-MOP UVA Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis|Completed||Phase 3|20|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 15:15:08.507863|2017-02-18 15:15:08.507863
NCT00533182|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2017-02-04|||September 19, 2007||2007-09-19|January 19, 2017|2017-01-19||||||||Observational|||Influenza in People With Normal and Weakened Immune Systems|Influenza in the Non-immunocompromised and Immunocompromised Host|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:15:08.621496|2017-02-18 15:15:08.621496
NCT00533169|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2011-12-13|||September 2007||2007-09-01|December 2011|2011-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma|A Phase I Study of ZD6474 (Zactima) Alone and in Combination With Retinoic Acid in Relapsed and Refractory Pediatric Neuroblastoma|Terminated||Phase 1|10|Actual|M.D. Anderson Cancer Center||1||Lack of enrollment.|f||||f||||||||||2017-02-18 15:15:08.729779|2017-02-18 15:15:08.729779
NCT00533156|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2012-02-27|||July 2007||2007-07-01|February 2012|2012-02-01|August 2007|Actual|2007-08-01|||||Interventional|PACS 7F||Plug Arterial Closure System (PACS, 7F)|Feasibility Study of the 7F Ensure Medical Plug Arterial Closure System (PACS, 7F)|Completed||Phase 2|30|Actual|Cordis Corporation||1|||f||||f||||||||||2017-02-18 15:15:08.861851|2017-02-18 15:15:08.861851
NCT00533143|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-07-16|||September 2007||2007-09-01|July 2012|2012-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Non-invasive Ventilation in Terminally Ill Cancer Patients|Multicenter, Randomised Study of the Use of Non-Invasive Ventilation (NIV) Versus Oxygen Therapy (O2) in Reducing Dyspnea in End-stage Solid Cancer Patients With Respiratory Failure and Distress|Completed||Phase 4|200|Actual|Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi||1|||f||||t||||||||||2017-02-18 15:15:08.968949|2017-02-18 15:15:08.968949
NCT00533130|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-20|||August 2007||2007-08-01|September 2007|2007-09-01|July 2008|Anticipated|2008-07-01|||||Observational|AO-PC||Evaluation of the AO Pediatric Classification for Long Bones Fractures Like a Guide for Treatment and Prognosis|Phase 2/3 Eficacy Study of the AO Pediatric Classification in Treatment and Prognosis of Long Bones Fractures|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Hospital Cruz Roja Mexicana|||1||f||||t||||||||||2017-02-18 15:15:09.202514|2017-02-18 15:15:09.202514
NCT00533117|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2013-09-25|||March 2001||2001-03-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|January 2008|Actual|2008-01-01||Interventional|||Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder|Treating Suicidal Behavior and Self-Mutilation in Borderline Personality Disorder|Completed||Phase 4|110|Actual|New York State Psychiatric Institute||4|||f||||t||||||||||2017-02-18 15:15:09.308719|2017-02-18 15:15:09.308719
NCT00533104|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2009-02-05|||October 2004||2004-10-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Cell Therapy in Chronic Limb Ischemia|Critical Limb Ischemia Treatment by Local Intra-Muscular Injection of Autologous Mononuclear Cells|Completed||Phase 1/Phase 2|40|Actual|CHU de Reims||2|||f||||t||||||||||2017-02-18 15:15:09.433261|2017-02-18 15:15:09.433261
NCT00533091|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-05-25|||April 2008||2008-04-01|May 2012|2012-05-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis|A Phase 1B, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Safety of Multiple-Dose, Intravenously Administered MEDI-545, A Fully Human Anti Interferon-Alpha Monoclonal Antibody, In Adult Patients With Dermatomyositis or Polymyositis|Completed||Phase 1|51|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 15:15:09.540507|2017-02-18 15:15:09.540507
NCT00533078|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2015-07-22|||November 2007||2007-11-01|July 2015|2015-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|LUNCH1||Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies|Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies (LUNCH1)|Completed||Phase 2|14|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 15:15:09.660715|2017-02-18 15:15:09.660715
NCT00533065|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2009-08-06|||September 2007||2007-09-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|GH-003||Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone|Effects of the Cholinesterase Inhibitor Donepezil on Organic and Functional Deficits Associated With Age-Related Decrease of Growth Hormone|Completed||N/A|80|Actual|Ludwig Boltzmann Gesellschaft||1|||f||||f||||||||||2017-02-18 15:15:09.761333|2017-02-18 15:15:09.761333
NCT00533052|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2011-01-31|||October 2007||2007-10-01|January 2011|2011-01-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment|Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment|Unknown status|Active, not recruiting|N/A|21|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 15:15:09.855348|2017-02-18 15:15:09.855348
NCT00533039|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2009-10-08|||October 2007||2007-10-01|June 2008|2008-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|SPIDER-PCI||sPLA2 Inhibition to Decrease Enzyme Release After PCI Trial|sPLA2 Inhibition to Decrease Enzyme Release After PCI (SPIDER-PCI) Trial|Completed||Phase 2|164|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 15:15:09.946903|2017-02-18 15:15:09.946903
NCT00533026|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2008-09-26|||July 2007||2007-07-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Duloxetine - Warfarin Pharmacodynamic Study|Evaluation of the Effect of Duloxetine on the Pharmacodynamics of Warfarin at Steady-State in Healthy Subjects|Completed||Phase 1|60|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:15:10.049464|2017-02-18 15:15:10.049464
NCT00533013|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2013-04-25|||August 2007||2007-08-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Comprehensive Heart Failure Disease Management Community Program|Comprehensive Program for Disease Management in Heart Failure Patients in the Community|Completed||N/A|1360|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 15:15:10.156677|2017-02-18 15:15:10.156677
NCT00533000|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2008-06-10|||January 2004||2004-01-01|September 2007|2007-09-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Smoking Cessation and Postoperative Complications|Short Term Perioperative Smoking Cessation and the Effect on Postoperative Complications. A Randomized Clinical Trial.|Unknown status|Active, not recruiting|N/A|584|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 15:15:10.441566|2017-02-18 15:15:10.441566
NCT00532987|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-02-24|||December 2003||2003-12-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer|Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer|Terminated||N/A|22|Actual|Stanford University|||1||f||||t||||||||||2017-02-18 15:15:10.547036|2017-02-18 15:15:10.547036
NCT00532974|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-12-19|||October 2006||2006-10-01|December 2007|2007-12-01|April 2008|Anticipated|2008-04-01|||||Interventional|EP1090||A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)|A Phase 1 Safety and Immunogenicity Study of the Pharmexa-Epimmune HIV-1 CTL Epitope-Based DNA Vaccine (EP HIV-1090) Administered Using a Biojector 2000 Needle Free Immunization Device in HIV-1 Infected Individuals Receiving Potent Combination Antiretroviral Therapy (ART)|Unknown status|Active, not recruiting|Phase 1|32|Anticipated|Epimmune||2|||f||||t||||||||||2017-02-18 15:15:10.657253|2017-02-18 15:15:10.657253
NCT00532961|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2011-12-07|||February 2005||2005-02-01|December 2011|2011-12-01|June 2005|Actual|2005-06-01|April 2005|Actual|2005-04-01||Interventional|||Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex|A Randomized, Double-masked, Parallel Comparison of Ocular Tolerance and IOP Effects of Zylet vs TobraDex Administered Four Times Daily for Four Weeks in Healthy Volunteers|Completed||Phase 4|310|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 15:15:10.753583|2017-02-18 15:15:10.753583
NCT00532948|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2016-10-25|2015-12-28||May 2007||2007-05-01|October 2016|2016-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||Intent to treat population defined as all participants enrolled.|A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas|A Phase I Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas and High Grade Gliomas|Completed||Phase 1|24|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:15:10.878434|2017-02-18 15:15:10.878434
NCT00532935|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2015-12-16|2010-09-23||January 2008||2008-01-01|December 2015|2015-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)|A Phase III Randomized, Active-Comparator (Pioglitazone) Controlled Clinical Trial to Study the Efficacy and Safety of the MK0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|517|Actual|Merck Sharp & Dohme Corp.|Unknown to the Sponsor and the investigators, two patients in the study were randomized twice (each at two different sites). Data for these patients were deemed unreliable and excluded from all analyses (efficacy and safety).|2|||f||||||||||||||2017-02-18 15:15:11.835414|2017-02-18 15:15:11.835414
NCT00532922|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2009-06-08|||April 2007||2007-04-01|June 2009|2009-06-01|November 2007|Actual|2007-11-01|||||Observational|Symb NIS||A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®|A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®|Completed||Phase 4|310|Actual|AstraZeneca|||1||f||||t||||||||||2017-02-18 15:15:12.558971|2017-02-18 15:15:12.558971
NCT00532909|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2012-07-12|||July 2006||2006-07-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer|A Phase I Trial of Vandetanib Combined With Capecitabine, Oxaliplatin and Bevacizumab for the First-Line Treatment of Metastatic Colorectal Cancer|Completed||Phase 1|13|Actual|Stanford University||1|||f||||||||||||||2017-02-18 15:15:12.650268|2017-02-18 15:15:12.650268
NCT00532896|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2012-02-20|||April 2006||2006-04-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Observational|||Impact of Weight Loss Following Bariatric Surgery on Pulmonary Function in Patients With Morbid Obesity|Impact of Weight Loss Following Bariatric Surgery on Pulmonary Function in Patients With Morbid Obesity|Completed||N/A|60|Actual|Laval University|||2||f||||f||||||Samples Without DNA|"~     serum plasma~   "|||2017-02-18 15:15:12.738347|2017-02-18 15:15:12.738347
NCT00532883|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2013-01-14|2010-04-01||January 2007||2007-01-01|January 2010|2010-01-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease|Effectiveness of Hydroxyurea and Magnesium Pidolate Alone and in Combination in Hemoglobin SC Disease: A Phase II Trial|Terminated||Phase 2|44|Actual|St. Jude Children's Research Hospital|This study was stopped early due to slow enrollment. It should therefore be viewed as a pilot study.|4||Enrollment has been terminated due to a slow rate of enrollment.|f||||t||||||||||2017-02-18 15:15:12.834234|2017-02-18 15:15:12.834234
NCT00532870|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-20|2007-09-20|||March 2003||2003-03-01|September 2007|2007-09-01|December 2004|Actual|2004-12-01|||||Interventional|||Laparoscopic Intraperitoneal Mesh Repair of Ventral Hernia: Comparison to Conventional Mesh Repair||Completed||N/A|||Mansoura University||1|||f||||t||||||||||2017-02-18 15:15:13.679145|2017-02-18 15:15:13.679145
NCT00532857|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2012-01-01|||March 2007||2007-03-01|January 2012|2012-01-01|September 2011|Actual|2011-09-01|February 2008|Actual|2008-02-01||Interventional|PGH||Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab|Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab in Patients With HER2 Positive Operable Breast Cancer|Completed||Phase 2|53|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:15:13.774246|2017-02-18 15:15:13.774246
NCT00532844|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2014-12-15|||September 2007||2007-09-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||A Phase 2, Pharmacokinetic Study of the Effects of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction|A Phase 2, Randomized, Open-label, 2-Treatment, 2-Sequence, 2-Period Crossover, Pharmacokinetic (PK) Study to Compare the Plasma Concentrations of BH4 in Subjects With Endothelial Dysfunction Following 14 Days of Treatment by Each of 2 Regimens: 6R-BH4 With Vitamin C and 6R-BH4 Alone|Completed||Phase 2|52|Actual|BioMarin Pharmaceutical||2|||f||||f||||||||||2017-02-18 15:15:13.884486|2017-02-18 15:15:13.884486
NCT00532831|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2012-02-20|||August 2005||2005-08-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|||||Observational|||Characterisation of Asthma in Obese Subjects|Characterisation of Asthma in Obese Subjects. Relationships Between Asthma and Obesity, Potential Mechanisms by Which Obesity Can Contribute to Asthma and Modify Treatment Responses|Completed||N/A|44|Actual|Laval University|||2||f||||f||||||Samples Without DNA|"~     serum plasma~   "|||2017-02-18 15:15:13.989773|2017-02-18 15:15:13.989773
NCT00532818|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2009-03-27|||July 2007||2007-07-01|March 2009|2009-03-01|December 2010|Anticipated|2010-12-01|September 2010|Anticipated|2010-09-01||Interventional|||Hydralazine Valproate for Cervical Cancer|Randomized, Double-Blind, Phase III Trial of Chemotherapy Plus the Transcriptional Therapy Hydralazine and Magnesium Valproate Versus Chemotherapy Plus Placebo in Recurrent and Metastatic Cervical Cancer.|Unknown status|Recruiting|Phase 3|143|Anticipated|National Institute of Cancerología||2|||f||||t||||||||||2017-02-18 15:15:14.07753|2017-02-18 15:15:14.07753
NCT00532805|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2012-12-17|||August 2007||2007-08-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|February 2012|Actual|2012-02-01||Observational|QUANTUM-1||The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency|QUANTitative Chest Computed Tomography UnMasking Emphysema Progression in Alpha-1 Antitrypsin Deficiency|Completed||N/A|49|Actual|Medical University of South Carolina|||1||f||||t||||||Samples With DNA|"~     50 cc of serum at visits baseline, 6 months, 12 months, 18 months, 24 months and 36 months~     will be retained. These are kept at the University of Florida in the laboratory of Dr. Mark~     Brantly.~      There is an associated but independent DNA collection that is done if the patient is willing~     through an independent study and consent process with the University of Florida Alpha-1 DNA~     and Tissue Bank. This is a public resource with a scientific advisory committee with samples~     available for researcher access.~   "|||2017-02-18 15:15:14.198968|2017-02-18 15:15:14.198968
NCT00532792|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2012-03-13|||August 2007||2007-08-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A/H5N1 Dose Ranging Study With Adjuvant Patch|A Randomized, Observer-Blind, Placebo-Controlled Study to Assess the Safety and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine Administered With and Without an Adjuvant Patch in Healthy Adults|Completed||Phase 1|501|Actual|Intercell USA, Inc.||10|||f||||t||||||||||2017-02-18 15:15:14.293755|2017-02-18 15:15:14.293755
NCT00532779|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2014-11-18|2014-10-20||October 2007||2007-10-01|November 2014|2014-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional||All randomized subjects|A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects|A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Two Doses of Naltrexone Sustained Release (SR)/Bupropion Sustained Release (SR) and Placebo in Obese Subjects|Completed||Phase 3|1742|Actual|Orexigen Therapeutics, Inc||3|||f||||t||||||||||2017-02-18 15:15:17.023168|2017-02-18 15:15:17.023168
NCT00532766|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-09-24|||November 2006||2006-11-01|September 2007|2007-09-01|February 2007|Actual|2007-02-01|||||Interventional|||Evaluating Pharmacokinetics and Pharmacodynamics of Jusline|Bioequivalence of Jusline Following Subcutaneous Administration in Healthy Subjects|Completed||N/A|20|Actual|King Saud University||1|||f||||t||||||||||2017-02-18 15:15:18.523389|2017-02-18 15:15:18.523389
NCT00532753|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2008-07-31|||August 2007||2007-08-01|July 2008|2008-07-01|May 2016|Anticipated|2016-05-01|August 2010||2010-08-01||Interventional|||Evaluating the Hunger Project in Ghana|Evaluating the Hunger Project's Scaling-up of Epicenter Strategy in Ghana|Unknown status|Recruiting|Early Phase 1|20000|Anticipated|University of California, Berkeley|||||f||||||||||||||2017-02-18 15:15:18.617274|2017-02-18 15:15:18.617274
NCT00532740|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2017-01-03|||December 2004||2004-12-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Observational|||Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery|A Humanitarian Device Exemption Compassionate Use Protocol of TheraSphere for Treatment of Unresectable Metastatic Cancer to the Liver|Recruiting||Phase 2|500|Anticipated|Northwestern University|||1||f||||t||||||||||2017-02-18 15:15:18.716811|2017-02-18 15:15:18.716811
NCT00532727|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2014-03-21|||January 2008||2008-01-01|March 2014|2014-03-01|July 2015|Anticipated|2015-07-01|July 2014|Anticipated|2014-07-01||Interventional|TNT||Triple Negative Breast Cancer Trial|Triple Negative Trial: A Randomised Phase III Trial of Carboplatin Compared to Docetaxel for Patients With Metastatic or Recurrent Locally Advanced ER-, PR- and HER2- Breast Cancer.|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|Institute of Cancer Research, United Kingdom||2|||f||||t||||||||||2017-02-18 15:15:18.835878|2017-02-18 15:15:18.835878
NCT00532714|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2011-12-27|||August 2006||2006-08-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|April 2008|Actual|2008-04-01||Interventional|||Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC|Phase II Study of Irinotecan Plus Capecitabine in Patients With Antracycline and Taxane Pretreated Metastatic Breast Cancer|Completed||Phase 2|36|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:15:18.953701|2017-02-18 15:15:18.953701
NCT00532584|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-05-03|||February 2011||2011-02-01|May 2016|2016-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Steroids on Gene Expression in the Healthy Smokers Lungs|Effect of Inhaled Steroids in Combination With a Long Acting Bronchodilator on Gene Expression in the Lungs of Healthy Smokers|Withdrawn||Phase 4|0|Actual|Weill Medical College of Cornell University||3||Study not initiated due to funding.|f||||f||||||||Undecided||2017-02-18 15:15:19.059918|2017-02-18 15:15:19.059918
NCT00532571|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-19|||January 2004||2004-01-01|September 2007|2007-09-01|September 2005||2005-09-01|||||Interventional|||Effects of Coenzyme Q10 in PSP and CBD|Effects of Coenzyme Q10 in PSP and CBD, A Randomized, Placebo-Controlled, Double Blind Cross Over Pilot Study|Completed||Phase 2/Phase 3|||Lahey Clinic|||||f||||f||||||||||2017-02-18 15:15:19.174086|2017-02-18 15:15:19.174086
NCT00532558|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2012-05-23|||October 2007||2007-10-01|May 2012|2012-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia|A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg vs Placebo in Subjects With Hypercholesterolemia, With an Optional Open-Label Extension|Terminated||Phase 3|657|Actual|Takeda||2||"Overall profile of the compound does not offer significant clinical advantage to patients over~   currently available lipid lowering agents"|f||||f||||||||||2017-02-18 15:15:19.25512|2017-02-18 15:15:19.25512
NCT00532545|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||April 2003||2003-04-01|September 2007|2007-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis|Bone Marker Changes In One Month Treatment With TERIPARATIDE (LY333334) Injections (rDNA Origin) in Men and Postmenopausal Women With Severe Osteoporosis|Completed||Phase 4|45|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:15:19.412974|2017-02-18 15:15:19.412974
NCT00532532|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2008-11-03|||September 2007||2007-09-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis|AV650-018: A Two-Part (Double-Blind Followed by Open-Label), Placebo Controlled, Randomized Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of AV650 (Tolperisone HCl) in Subjects With Spasticity Associated With Multiple Sclerosis|Terminated||Phase 2|150|Anticipated|Avigen||3|||f||||f||||||||||2017-02-18 15:15:19.521523|2017-02-18 15:15:19.521523
NCT00532519|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2007-09-19||||||September 2007|2007-09-01||||||||Interventional|||Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis||Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||||f||||t||||||||||2017-02-18 15:15:19.875484|2017-02-18 15:15:19.875484
NCT00532506|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2008-10-08||||||October 2008|2008-10-01||||||||Interventional|||Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus||Completed||Phase 2|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 15:15:19.959842|2017-02-18 15:15:19.959842
NCT00532493|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-12-16|2014-04-02||January 2010||2010-01-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|February 2013|Actual|2013-02-01||Interventional|PACT|PTSD clinicians ascertain interest and eligibility among their patients with nightmare. Informed consent obtained; screening assessments to determine eligibility|Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSD|CSP #563 - Prazosin and Combat Trauma PTSD (PACT)|Completed||Phase 3|304|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:15:20.079008|2017-02-18 15:15:20.079008
NCT00532480|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-08-08|2013-04-10||September 2007||2007-09-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine|Duloxetine Effects on Brain fMRI Response to Emotionally Valenced Pictures in the Treatment of Patients With Major Depression|Completed||Phase 4|10|Actual|Indiana University|Small numbers of subjects analyzed.|1|||f||||f||||||||No||2017-02-18 15:15:21.719438|2017-02-18 15:15:21.719438
NCT00532467|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2008-03-11|||September 2007||2007-09-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers|Phase I, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic Study of SRX251 Capsules in Healthy Volunteers|Completed||Phase 1|50|Actual|Azevan Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:15:21.96133|2017-02-18 15:15:21.96133
NCT00532454|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2010-02-09|||June 2006||2006-06-01|September 2007|2007-09-01|December 2007|Actual|2007-12-01|June 2006|Actual|2006-06-01||Interventional|||Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen|A Clinical Study for the Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen in Patients With Metastatic Breast Cancer|Terminated||Phase 2|21|Actual|National Cancer Center, Korea||1||planned to design a prospective study|f||||f||||||||||2017-02-18 15:15:22.046487|2017-02-18 15:15:22.046487
NCT00532441|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-01-14|2015-12-10||September 2007||2007-09-01|January 2016|2016-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas|Phase II Trial of Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas: Hoosier Oncology Group GI06-101|Terminated||Phase 2|25|Actual|Hoosier Cancer Research Network|No statistical correlations with PFS and OS could be performed due to the small number of KRAS mutations.|2||Terminated due to funding issues.|f||||t||||||||||2017-02-18 15:15:22.145233|2017-02-18 15:15:22.145233
NCT00532428|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||April 2003||2003-04-01|September 2007|2007-09-01|September 2003|Actual|2003-09-01|||||Interventional|||Long Term Effects of Raloxifene Treatment on Bone Quality|Long-Term Effects of Raloxifene Treatment on Bone Quality: A Cross-Sectional Study of Postmenopausal Women With Osteoporosis Previously Enrolled in the Continuing Outcomes Relevant to Evista Study|Completed||Phase 4|31|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 15:15:22.91344|2017-02-18 15:15:22.91344
NCT00532415|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2012-04-03|||September 2007||2007-09-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy|Clinical Evaluation of the Safety and Efficacy of Triamcinolone Acetonide Suspension for Visualization During Vitrectomy Surgery|Completed||Phase 3|60|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 15:15:23.028569|2017-02-18 15:15:23.028569
NCT00532402|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2012-10-29|||September 2007||2007-09-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|||||Observational|||Continuous and Discontinuous Determination of Propofol Concentration in Breathing Gas|Continuous and Discontinuous Determination of Propofol Concentration in Breathing Gas - Compared With Propofol Concentration in Plasma (Before and) After Lung Passage and Neurophysiological Parameters|Completed||N/A|16|Anticipated|University of Luebeck|||1||f||||f||||||||||2017-02-18 15:15:23.120486|2017-02-18 15:15:23.120486
NCT00532389|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2014-10-31|||October 2007||2007-10-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma|A Phase Ib, Multi-center, Open-label, Dose-escalation Study of Oral LBH589 When Administered in Combination With Bortezomib in Adult Patients With Multiple Myeloma|Completed||Phase 1|62|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:15:23.214989|2017-02-18 15:15:23.214989
NCT00532376|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2009-02-06|||September 2005||2005-09-01|February 2009|2009-02-01||||||||Observational|||fMRI Investigation of Depression in Patients With Epilepsy|fMRI Investigation of Depression in Patients With Epilepsy|Withdrawn||N/A|250|Anticipated|Weill Medical College of Cornell University||||Enrollment by invitation only|f||||f||||||||||2017-02-18 15:15:23.334615|2017-02-18 15:15:23.334615
NCT00532363|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2012-02-20|||September 2005||2005-09-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|||||Observational|ORPA||Obesity and Asthma:a Specific Phenotype|Obesity-related Pseudo-asthma (ORPA): Description of a Novel Clinical Entity|Completed||N/A|44|Actual|Laval University|||2||f||||f||||||Samples Without DNA|"~     Serum plasma~   "|||2017-02-18 15:15:23.421015|2017-02-18 15:15:23.421015
NCT00532350|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2010-09-01|||July 2007||2007-07-01|September 2010|2010-09-01|January 2008|Actual|2008-01-01|||||Interventional|||Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Efficacious Dose of QAT370 Compared to Open-label Tiotropium Bromide Following Once Daily Dosing for 7 Days in COPD Patients|Completed||Phase 1|22|Actual|Novartis||3|||f||||f||||||||||2017-02-18 15:15:23.511691|2017-02-18 15:15:23.511691
NCT00532337|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2012-06-12|||October 2007||2007-10-01|June 2012|2012-06-01||||July 2010|Actual|2010-07-01||Interventional|||Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis|A Multi-centre, Randomized, Double Blind, Parallel Group Study to Investigate Efficacy and Safety of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis|Completed||Phase 2|285|Actual|Ono Pharmaceutical Co. Ltd||5|||f||||||||||||||2017-02-18 15:15:23.619104|2017-02-18 15:15:23.619104
NCT00532324|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2011-03-10|||January 2008||2008-01-01|April 2009|2009-04-01|January 2010|Anticipated|2010-01-01|December 2009|Anticipated|2009-12-01||Interventional|||Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns|Community-Acquired Methicillin Resistant Staphylococcus Aureus (CA-MRSA) Vaginal and Nasal Colonization in Pregnant Women and Frequency of CA-MRSA Infections in Previously Healthy Term and Near-Term Neonates|Unknown status|Recruiting|N/A|1500|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-02-18 15:15:23.733516|2017-02-18 15:15:23.733516
NCT00532311|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-06-20||2016-06-20|July 2007||2007-07-01|June 2016|2016-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia|A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg or Placebo When Co-administered With Statins in Subjects With Hypercholesterolemia, With an Optional Open-Label Extension|Terminated||Phase 3|411|Actual|Takeda||2||"Overall profile of the compound does not offer significant clinical advantage to patients over~   currently available lipid lowering agents"|f||||f||||||||||2017-02-18 15:15:23.863611|2017-02-18 15:15:23.863611
NCT00532298|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-11-03|2012-04-23||September 2007||2007-09-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over|Non-Inferiority of GlaxoSmithKline Biologicals' Influenza Vaccine (GSK576389A) 1 Container Over 2 Container Presentation in Adults Aged 65 Years and Over|Completed||Phase 2|1596|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:15:24.07942|2017-02-18 15:15:24.07942
NCT00532285|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2011-06-22|||September 2005||2005-09-01|September 2007|2007-09-01|August 2009|Actual|2009-08-01|April 2006|Actual|2006-04-01||Interventional|||Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer|Phase II Study of Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer|Terminated||Phase 2|44|Actual|National Cancer Center, Korea||1||terminated|f||||f||||||||||2017-02-18 15:15:25.649195|2017-02-18 15:15:25.649195
NCT00532272|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2011-06-24|||October 2005||2005-10-01|September 2007|2007-09-01|August 2010|Actual|2010-08-01|April 2008|Actual|2008-04-01||Interventional|||Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC|A Phase II Non-randomized, Parallel Group Study of Goserelin or Leuprorelin Plus Letrozole in Premenopausal Patients Versus Letrozole Alone in Postmenopausal Patients With Metastatic Breast Cancer|Completed||Phase 2|78|Actual|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 15:15:25.913645|2017-02-18 15:15:25.913645
NCT00532259|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2014-09-08|2013-09-22||October 2007||2007-10-01|September 2014|2014-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||CT-011 MAb in DLBCL Patients Following ASCT|Phase II Safety and Efficacy Study of the Monoclonal Antibody CT-011 in Patients With Diffuse Large B-Cell Lymphoma Following Autologous Stem Cell Transplantation|Completed||Phase 2|72|Actual|CureTech Ltd||1|||f||||t||||||||||2017-02-18 15:15:26.026123|2017-02-18 15:15:26.026123
NCT00532246|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||March 2003||2003-03-01|September 2007|2007-09-01|August 2003|Actual|2003-08-01|||||Interventional|||Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo|A Study of Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene HCl or Placebo|Completed||Phase 4|147|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:15:26.562076|2017-02-18 15:15:26.562076
NCT00532233|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2012-11-27|||September 2007||2007-09-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||SD, IL-13 Production Rate in IPF|A Open-label, Multi-center Study, With a Single Intravenous Dose of QAX576 to Determine IL-13 Production in Patients With Idiopathic Puilmonary Fibrosis|Completed||Phase 2|52|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:15:26.671586|2017-02-18 15:15:26.671586
NCT00532220|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2015-08-25|||December 2007||2007-12-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-traumatic Osteonecrosis of the Knee: A Randomized Double-blind, Placebo-controlled Trial|Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-traumatic Osteonecrosis of the Knee: A Randomized Double-blind, Placebo-controlled Trial|Completed||Phase 3|30|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 15:15:26.782766|2017-02-18 15:15:26.782766
NCT00532207|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||November 2003||2003-11-01|September 2007|2007-09-01|December 2004|Actual|2004-12-01|||||Interventional|||Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis|Efficacy and Safety of Teriparatide 20 Micrograms in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 3|50|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:15:26.892661|2017-02-18 15:15:26.892661
NCT00532194|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2015-09-21|||July 2007||2007-07-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|April 2013|Actual|2013-04-01||Interventional|ICON6||An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer|A Randomised, Placebo-controlled, Trial of Concurrent Cediranib [AZD2171] (With Platinum-based Chemotherapy) and Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer|Active, not recruiting||Phase 3|486|Actual|Medical Research Council||3|||f||||t||||||||||2017-02-18 15:15:27.013704|2017-02-18 15:15:27.013704
NCT00532181|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-19|||April 2008||2008-04-01|September 2007|2007-09-01|December 2011|Anticipated|2011-12-01|||||Interventional|||Micro-Health Insurance in Cambodia|A Randomized Control Trial of Micro-Health Insurance in Cambodia|Unknown status|Not yet recruiting|Early Phase 1|||University of California, Berkeley|||||f||||||||||||||2017-02-18 15:15:27.1434|2017-02-18 15:15:27.1434
NCT00532168|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2013-02-21|||September 2007||2007-09-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ADVANZ-3||Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl|Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl. A Prospective, Randomized, Multicentre, Open Clinical Study.|Completed||Phase 4|108|Actual|Hospital Clinic of Barcelona||3|||f||||f||||||||||2017-02-18 15:15:27.227294|2017-02-18 15:15:27.227294
NCT00532155|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-19|2016-05-04|2012-08-17||September 2007||2007-09-01|May 2016|2016-05-01|October 2011|Actual|2011-10-01|January 2011|Actual|2011-01-01||Interventional|VITAL||A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer|A Multinational, Randomized, Double-Blind Study Comparing Aflibercept Versus Placebo in Patients Treated With Second-Line Docetaxel After Failure of One Platinum Based Therapy for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer|Completed||Phase 3|913|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:15:27.34703|2017-02-18 15:15:27.34703
NCT00532142|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2009-10-29|||April 2005||2005-04-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|||||Interventional|||The ROVO Study: Radial Optic Neurotomy for CVO|A Multicenter Trial for Surgical Treatment of Central Retinal Vein Occlusion - Radial Optic Neurotomy for CVO The ROVO Study|Completed||Phase 2/Phase 3|||Rudolf Foundation Clinic||3|||f||||f||||||||||2017-02-18 15:15:28.557639|2017-02-18 15:15:28.557639
NCT00532129|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-03-06|2016-03-06||November 2007||2007-11-01|March 2016|2016-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||Full analysis set (FAS) comprised all participants recruited into the study and known to have received at least one dose of study treatment.|A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.|An Open-Label Study to Characterize the Safety and Response Rate of MabThera (Rituximab) Plus Chlorambucil in Previously Untreated Patients With CD20-Positive B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|100|Actual|Hoffmann-La Roche||1|||f||||t||||||||No||2017-02-18 15:15:28.643519|2017-02-18 15:15:28.643519
NCT00532116|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||April 2007||2007-04-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly|Pharmacokinetic Comparison of the 6mg/24hr and 12mg/24hr EMSAM (Selegiline Transdermal System) in Healthy Elderly and Non-Elderly Volunteers|Completed||Phase 4|32|Actual|Somerset Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:15:29.464108|2017-02-18 15:15:29.464108
NCT00532103|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2008-09-19|||July 2007||2007-07-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|SAMS||Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression|Suicide Assessment Methodology Study (SAMS)|Completed||N/A|300|Anticipated|National Institute of Mental Health (NIMH)|||1||f||||t||||||||||2017-02-18 15:15:29.567888|2017-02-18 15:15:29.567888
NCT00532090|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-11-01|||November 2007||2007-11-01|November 2016|2016-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.|Multiple Ascending Dose (MAD) Study of R4733 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors|Completed||Phase 1|110|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 15:15:29.6787|2017-02-18 15:15:29.6787
NCT00532077|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2010-10-13||2010-10-13|August 2007||2007-08-01|October 2010|2010-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women|An Exploratory, Open Label, Multicenter Parallel Group Study to Evaluate the Effects of Single and Repeat Dosing of SB-751689 (400 mg or 100 mg) or rhPTH(1-34) on the Fractional Renal Excretion of Calcium and Phosphate in Healthy Postmenopausal Females.|Completed||Phase 1|40|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:15:29.790047|2017-02-18 15:15:29.790047
NCT00532064|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-04-07|||September 2007||2007-09-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Observational|||Early Detection of Cardiotoxicity During Sunitinib or Sorafenib Chemotherapy Using Cardiac Biomarkers|Early Detection of Cardiotoxicity During Sunitinib or Sorafenib Chemotherapy Using Cardiac Biomarkers|Active, not recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     During the standard-of-care blood draws, additional blood will be drawn to test troponin I~     and/or T and BNP levels.~   "|||2017-02-18 15:15:29.90479|2017-02-18 15:15:29.90479
NCT00532051|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2015-04-21|||April 2011||2011-04-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Observational|OCT IOL||Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography|Guiding the Treatment of Anterior Eye Diseases With Optical Coherence Tomography|Recruiting||N/A|40|Anticipated|Oregon Health and Science University|||1||f||||t||||||||||2017-02-18 15:15:30.036325|2017-02-18 15:15:30.036325
NCT00532038|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2012-03-14||2012-03-14|September 2007||2007-09-01|March 2012|2012-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase 3 Study to Evaluate the Long-Term Safety of ThermoProfen™ in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee.|An Open-Label, Long-Term Safety Study to Evaluate the Safety of ThermoProfen™ for the Treatment of Mild to Moderate Pain Associated With Osteoarthritis of the Knee|Terminated||Phase 3|179|Actual|ZARS Pharma Inc.||1||Corporate decision|f||||f||||||||||2017-02-18 15:15:30.143672|2017-02-18 15:15:30.143672
NCT00532025|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2009-07-24|||September 2007||2007-09-01|July 2009|2009-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|SIRN||Sorafenib in Resected Non-small Cell Lung Carcinoma|A Phase II Study to Investigate the Efficacy and Safety of Sorafenib as Adjuvant Treatment Following Resection of Non-small Cell Lung Carcinoma (NSCLC) in Patients Not Eligible for Cisplatin-based Adjuvant Chemotherapy|Terminated||Phase 2|134|Anticipated|Johannes Gutenberg University Mainz||1|||f||||t||||||||||2017-02-18 15:15:30.281652|2017-02-18 15:15:30.281652
NCT00532012|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2008-07-15|||September 2007||2007-09-01|July 2008|2008-07-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®|An Open-Label, Partially Randomized, Cross-Over, Monocentric Phase I Study Evaluating the Pharmacokinetic Profile of RhuDex® in Order to Determine Optimum Doses of Meglumine and RhuDex®|Completed||Phase 1|10|Actual|MediGene|||||f||||f||||||||||2017-02-18 15:15:30.388887|2017-02-18 15:15:30.388887
NCT00531999|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2010-08-13|||October 2007||2007-10-01|August 2010|2010-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Raltegravir Insulin Sensitivity Study|An Open Label Study of the Impact on Insulin Sensitivity, Lipid Profile and Vascular Inflammation by Treatment With Lopinavir / Ritonavir (400 / 100 mg Twice Daily) or Raltegravir 400 mg Twice Daily in HIV Negative Male Volunteers.|Completed||Phase 1|18|Actual|St Stephens Aids Trust||2|||f||||f||||||||||2017-02-18 15:15:30.48194|2017-02-18 15:15:30.48194
NCT00531986|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2009-05-29|||January 2007||2007-01-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|MOST||HIV - Monotherapy in Switzerland (MOST-ch)|HIV- Monotherapy in Switzerland (MOST- ch)|Terminated||Phase 4|60|Actual|Cantonal Hospital of St. Gallen||2||Unexpectedely high rates of treatment-failure|f||||t||||||||||2017-02-18 15:15:30.607674|2017-02-18 15:15:30.607674
NCT00531973|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2009-02-17|||January 2007||2007-01-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|August 2008|Anticipated|2008-08-01||Interventional|LITE||A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging|Liposomal Doxorubicin-Investigational Chemotherapy-Tissue Doppler Imaging Evaluation (LITE) Randomized Pilot Study|Unknown status|Recruiting|Phase 4|80|Anticipated|Catholic University, Italy||2|||f||||f||||||||||2017-02-18 15:15:30.736121|2017-02-18 15:15:30.736121
NCT00531960|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2014-11-04|2014-11-04||January 2008||2008-01-01|November 2014|2014-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Full analysis set (FAS): all randomized participants.|A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.|A Randomized, Open-label Study Comparing the Anti-tumor Effect of Treatment With Tarceva Plus Avastin Versus Chemotherapy Plus Avastin in Patients With Advanced Non-small Cell Lung Cancer|Completed||Phase 2|124|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:15:30.857|2017-02-18 15:15:30.857
NCT00531947|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2013-12-12|2012-12-27||July 2007||2007-07-01|December 2013|2013-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression|A Phase IV, Double-Blind, Placebo-Controlled, Randomized, Flexible Dose Study of the Safety and Efficacy of EMSAM in Adolescents With Major Depression|Completed||Phase 4|308|Actual|Somerset Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:15:31.886945|2017-02-18 15:15:31.886945
NCT00531934|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2015-02-05|2014-06-23||October 2007||2007-10-01|February 2015|2015-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional||"Intent-to-Treat population (ITT): all randomized participants who received at least~1 dose of erlotinib."|A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.|A Randomized, Open Label Study to Evaluate the Effect of Doxycycline on Tarceva-induced Skin Rash in Patients With Non-small Cell Lung Cancer After Failure of First Line Chemotherapy|Completed||Phase 2|147|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:15:33.134647|2017-02-18 15:15:33.134647
NCT00531921|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2013-06-03|||September 2007||2007-09-01|June 2013|2013-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival|Correlation of Donor Proinflammatory mRNA Profiles With Early Outcomes of Thoracic and Abdominal Transplantation|Completed||N/A|313|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||t||||||Samples With DNA|"~     Blood and tissue samples to evaluate the heart, kidney, liver, and lung~   "|||2017-02-18 15:15:34.536568|2017-02-18 15:15:34.536568
NCT00531908|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2011-12-06|||September 2007||2007-09-01|August 2008|2008-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|AcromEnaC||Physiopathology of Sodium Retention in Acromegaly|Physiopathology of Sodium Retention in Acromegaly|Completed||N/A|12|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 15:15:34.642113|2017-02-18 15:15:34.642113
NCT00531895|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||April 2006||2006-04-01|August 2007|2007-08-01|March 2007|Actual|2007-03-01|||||Interventional|||An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache|An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache|Completed||Phase 4|30|Actual|Kraepelin Psiquiatria Clinica|||||f||||f||||||||||2017-02-18 15:15:34.751756|2017-02-18 15:15:34.751756
NCT00531882|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2008-08-15|||September 2007||2007-09-01|August 2008|2008-08-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers|A Pilot Study Evaluating the Effect of Pioglitazone, Simvastatin, and Ibuprofen on Neutrophil Migration in Vivo in Healthy Subjects|Unknown status|Recruiting|N/A|10|Anticipated|University Hospitals Cleveland Medical Center||3|||f||||f||||||||||2017-02-18 15:15:34.852315|2017-02-18 15:15:34.852315
NCT00531869|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2008-07-31|||May 2008||2008-05-01|July 2008|2008-07-01|October 2010|Anticipated|2010-10-01|May 2010|Anticipated|2010-05-01||Interventional|||Safe Water Techniques in Kenya|A Study of End-User Preferences for and Use of POU Safe Water Technologies in Kenya|Unknown status|Recruiting|Early Phase 1|||University of California, Berkeley|||||f||||||||||||||2017-02-18 15:15:34.962465|2017-02-18 15:15:34.962465
NCT00531856|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-10-18|||August 2007||2007-08-01|October 2016|2016-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients|A Prospective, Multicenter, Single-blind, Placebo-controlled, Safety and Tolerability Study of the Effects of Carbon Monoxide for Inhalation in Patients Receiving Kidney Transplants.|Withdrawn||Phase 2|0|Actual|Mallinckrodt||2||Clinical Hold pending additional data review and protocol amendment|f||||t||||||||||2017-02-18 15:15:35.053911|2017-02-18 15:15:35.053911
NCT00531843|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2013-10-31|2013-06-10||December 2007||2007-12-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients|The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients|Completed||Phase 2/Phase 3|105|Actual|University of California, San Francisco||4|||f||||f||||||||||2017-02-18 15:15:35.166743|2017-02-18 15:15:35.166743
NCT00531830|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-25|||September 2007||2007-09-01|September 2007|2007-09-01|September 2011|Anticipated|2011-09-01|||||Observational|||Assessment of Factors Which Predict Improvement in Children With PDD After a Year of Integrative Therapy|Assessment of Factors Which Predict Improvement in Children With PDD After a Year of Integrative Therapy|Unknown status|Not yet recruiting|N/A|60|Anticipated|BeerYaakov Mental Health Center|||2||f||||f||||||||||2017-02-18 15:15:35.523347|2017-02-18 15:15:35.523347
NCT00531817|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2012-08-13|2010-07-06||October 2007||2007-10-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|June 2009|Actual|2009-06-01||Interventional|ROSE||A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis|A Randomized, Double-blind, Parallel-group Study to Evaluate the Safety and Efficacy of Tocilizumab (TCZ) Versus Placebo in Combination With Disease Modifying Antirheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)|Completed||Phase 3|619|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:15:35.605944|2017-02-18 15:15:35.605944
NCT00531804|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-11-01|||December 2006||2006-12-01|November 2016|2016-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.|A Multi-center, Multiple-ascending Dose, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO4909832 Following Intravenous Infusion in AD Patients|Completed||Phase 1|60|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:15:39.594081|2017-02-18 15:15:39.594081
NCT00531791|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2011-06-16|||November 2007||2007-11-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation|Effects of Fluticasone/Salmeterol (Advair®) in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation|Completed||Phase 3|14|Actual|Laval University||2|||f||||f||||||||||2017-02-18 15:15:39.697487|2017-02-18 15:15:39.697487
NCT00531778|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2011-01-10|||June 2004||2004-06-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|||||Observational|||NYU Ovarian Cancer Early Detection Program Blood and Genetics|NYU Ovarian Cancer Early Detection Program Blood and Genetics|Terminated||N/A|890|Actual|New York University School of Medicine|||1|insufficient funding and resource|f||||f||||||Samples With DNA|"~     whole blood, serum, plasma, urine, ovarian tissue~   "|||2017-02-18 15:15:39.807168|2017-02-18 15:15:39.807168
NCT00531765|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2010-07-24|||June 2007||2007-06-01|July 2010|2010-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|SIPCIN||Sodium Bicarbonate in Preventing Contrast Induced Nephropathy|Sodium Bicarbonate in Preventing Contrast Induced Nephropathy (SIPCIN): A Randomized Controlled Study|Completed||N/A|220|Anticipated|King Faisal Specialist Hospital & Research Center||2|||f||||f||||||||||2017-02-18 15:15:40.119566|2017-02-18 15:15:40.119566
NCT00531752|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-01-22|2014-04-02||December 2007||2007-12-01|January 2016|2016-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Safety analysis population included all participants who received at least 1 dose of study medication.|A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).|A Phase Iia, Randomized, Double Blind, Placebo Controlled, Three-treatment, Two-period Crossover Study Of The Efficacy And Safety Of Two Doses Of Pf-03654746 In Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 2|66|Actual|Pfizer|Instead of time to sustained response, data for percentage of sustained responders in time-sensitive ADHD symptom scale (TASS) total score was reported as per planned analysis.|3|||f||||f||||||||||2017-02-18 15:15:40.262749|2017-02-18 15:15:40.262749
NCT00531739|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2010-10-05|||March 2006||2006-03-01|October 2010|2010-10-01|July 2009|Actual|2009-07-01|||||Interventional|||SurgiWrapTM to Reduce Soft Tissue Attachment & Incidence Early Post-Operative Bowel Obstruction in Colorectal Surgery|Phase 4 Evaluation of SurgiWrapTM to Minimize Soft Tissue Attachment & Reduce the Incidence of Early Post-Operative Bowel Obstruction in Colorectal Surgery|Completed||Phase 4|60|Anticipated|Cytori Therapeutics||2|||f||||f||||||||||2017-02-18 15:15:42.49975|2017-02-18 15:15:42.49975
NCT00531726|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2011-07-13|||September 2007||2007-09-01|September 2007|2007-09-01|September 2013|Anticipated|2013-09-01|September 2012|Anticipated|2012-09-01||Interventional|BDDS||Berlin Deep Brain Stimulation Depression Study|Investigation of Efficacy and Safety of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression in a Multicenter, Double-blind, Prospectivly-designed Delayed-onset Study (Tiefe Hirnstimulation Zur Behandlung Therapieresistenter Depressionen-eine Multizentrische, Doppelblinde, Prospektive Studie Mit Einem Delayed-onset Design)|Unknown status|Recruiting|Phase 3|20|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 15:15:42.592841|2017-02-18 15:15:42.592841
NCT00531713|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||April 2003||2003-04-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|T4-T3||Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism|Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism,a Double Blind Randomized Cross-Over Study.|Completed||Phase 4|59|Actual|Copenhagen University Hospital at Herlev||2|||f||||f||||||||||2017-02-18 15:15:42.686934|2017-02-18 15:15:42.686934
NCT00531700|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2009-04-30|||October 2007||2007-10-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|Indivo at MIT||Testing a Personally Controlled Health Record to Ameliorate Influenza at MIT|Test of the PING/INDIVO Personal Health Record System at MIT|Completed||N/A|800|Anticipated|Boston Children’s Hospital||4|||f||||||||||||||2017-02-18 15:15:42.7878|2017-02-18 15:15:42.7878
NCT00531687|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-04-05|||September 2007||2007-09-01|April 2016|2016-04-01|April 2016|Anticipated|2016-04-01|February 2012|Actual|2012-02-01||Interventional|||Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer|Phase II Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer|Suspended||Phase 2|25|Anticipated|Rigshospitalet, Denmark||1||slow accrual|f||||f||||||||No||2017-02-18 15:15:42.893461|2017-02-18 15:15:42.893461
NCT00531674|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2014-11-06|||September 2005||2005-09-01|November 2012|2012-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy of 3 Nutritional Supplements to Improve Diverse Outcomes in Children Under 2 Years of Age and Pregnant Women||Completed||N/A|||Mexican National Institute of Public Health||2|||f||||f||||||||||2017-02-18 15:15:43.006282|2017-02-18 15:15:43.006282
NCT00531661|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2015-01-16|2012-11-16||September 2007||2007-09-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|May 2010|Actual|2010-05-01||Interventional|CHAMPION||CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients|CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients|Completed||N/A|550|Actual|CardioMEMS||2|||f||||t||||||||||2017-02-18 15:15:43.118731|2017-02-18 15:15:43.118731
NCT00531648|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||September 2007||2007-09-01|September 2007|2007-09-01|November 2008|Anticipated|2008-11-01|||||Observational|||Relationships Between Toddlers With Feeding Disorder and SPD and Their Parents|The System of Relationships Between Parents and Their Toddlers, With Eating Disorders and Sensory Processing Disorders Within Meal and Play Situations|Unknown status|Not yet recruiting|N/A|6|Anticipated|BeerYaakov Mental Health Center|||1||f||||f||||||||||2017-02-18 15:15:43.65874|2017-02-18 15:15:43.65874
NCT00531635|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2011-12-11|||July 2002||2002-07-01|December 2011|2011-12-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil|Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil|Unknown status|Recruiting|Phase 1|350|Anticipated|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:15:43.732081|2017-02-18 15:15:43.732081
NCT00531622|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-04-25||2016-04-25|September 2007||2007-09-01|April 2016|2016-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder|An Eight-week, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Saredutant 100 mg Once Daily in Combination With Escitalopram 10 mg Once Daily in Patients With Major Depressive Disorder|Completed||Phase 3|643|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 15:15:43.912786|2017-02-18 15:15:43.912786
NCT00531596|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2007-09-18|||April 2007||2007-04-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Evaluation of Adhesion and Dermal Tolerability of EMSAM|A PHASE IV, OPEN-LABEL STUDY OF THE ADHESION AND DERMAL TOLERABILITY OF EMSAM (SELEGILINE TRANSDERMAL SYSTEM) IN HEALTHY ADULT SUBJECTS OF TWO AGE GROUPS (18 - 64 YEARS, AND 65 YEARS AND OLDER)|Completed||Phase 4|300|Actual|Somerset Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:15:44.021589|2017-02-18 15:15:44.021589
NCT00531583|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2016-01-04|||March 2001||2001-03-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor|Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor|Completed||N/A|350|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:15:44.123554|2017-02-18 15:15:44.123554
NCT00531570|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2010-09-22|||February 2005||2005-02-01|September 2010|2010-09-01|April 2009|Actual|2009-04-01|||||Observational|||Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma|Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma|Completed||N/A|100|Anticipated|New York University School of Medicine|||1||f||||f||||||||||2017-02-18 15:15:44.21156|2017-02-18 15:15:44.21156
NCT00531557|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2010-08-13|||September 2007||2007-09-01|August 2010|2010-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Double Protease Inhibitor to Darunavir Switch Study|Phase IV Cohort Study Assessing Feasibility of Substituting Double Ritonavir-boosted Protease Inhibitors With Ritonavir-boosted Darunavir in HIV-infected Individuals With Viral Suppression on Highly Active Antiretroviral Therapy.|Completed||Phase 4|12|Actual|St Stephens Aids Trust||1|||f||||f||||||||||2017-02-18 15:15:44.283945|2017-02-18 15:15:44.283945
NCT00531544|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2016-01-04|||February 2007||2007-02-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248|A SU011248 Expanded Access Protocol for Metastatic RCC Patients Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248|Completed||N/A|350|Actual|King Faisal Specialist Hospital & Research Center||1|||f||||t||||||||||2017-02-18 15:15:44.391731|2017-02-18 15:15:44.391731
NCT00531531|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2011-08-22|||September 2007||2007-09-01|August 2011|2011-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis|Control and Prevention of Respiratory Infections in Cystic Fibrosis Patients: an Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of Infected Persons Through Coughing and Conversation.|Completed||N/A|42|Actual|University of Florence|||1||f||||||||||||||2017-02-18 15:15:44.473529|2017-02-18 15:15:44.473529
NCT00531518|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2016-07-06|2016-01-20||October 2007||2007-10-01|July 2016|2016-07-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|EDIPP|All eligible participants (n=292) were entered into the outcome analysis. This was an intent-to-treat study and statistical analysis.|Early Detection and Intervention for the Prevention of Psychosis|Early Detection and Intervention for the Prevention of Psychosis Project|Completed||N/A|292|Actual|Maine Medical Center||2|||f||||t||||||||Yes|Currently, on request, data will be shared with legitimate organizations for specific analyses approved by the PI and the Maine Medical Center Institutional Review Board.|2017-02-18 15:15:44.736635|2017-02-18 15:15:44.736635
NCT00531505|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-18|2015-10-14|||March 2007||2007-03-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|2a||Obesity and Memory, mRNA, Body Composition, Comorbidity Scale|Morbid Obesity and Memory, Visceral and Subcutaneous mRNA Analysis, Body Composition, and Comorbidity Scale.|Terminated||N/A|13|Actual|Oregon Health and Science University|||1|Surgeon mistakenly removed liver and fat tissue from a non-LABS2a participant|f||||t||||||Samples With DNA|"~     Liver and fatty samples were voluntarily given by participant consent.~   "|||2017-02-18 15:15:45.117277|2017-02-18 15:15:45.117277
NCT00531492|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2011-12-08|||August 2007||2007-08-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|EtudeTK||Efficacy of Continuous Skin to Skin Care (Technique Kangaroo: TK) After Birth for Low Birth Weight (LBW) Infants and Their Mothers in Developing Countries|Randomized Controlled Trial of Continuous Skin to Skin Care (Technique Kangourou: TK) for Low Birth Weight (LBW) Infants and Their Mothers at University Hospital Center of Mahajanga (Centre Hospitalier Universitaire de Mahajanga: CHUM), Madagascar|Completed||N/A|73|Actual|Foundation for Advanced Studies on International Development||2|||f||||f||||||||||2017-02-18 15:15:45.212791|2017-02-18 15:15:45.212791
NCT00531479|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2012-04-03|2012-04-03||July 2008||2008-07-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis|A Prospective, Randomized Trial Comparing The Efficacy Of Anidulafungin And Voriconazole In Combination To That Of Voriconazole Alone When Used For Primary Therapy Of Proven Or Probable Invasive Aspergillosis|Completed||Phase 3|459|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:15:45.33928|2017-02-18 15:15:45.33928
NCT00531466|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2008-11-03|||September 2007||2007-09-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury|AV650-014: A Four Week, Prospective, Randomized, Double Blind, Placebo-Controlled Trial to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV650 in Patients With Spasticity Due to Spinal Cord Injury|Terminated||Phase 2|120|Anticipated|Avigen||2|||f||||f||||||||||2017-02-18 15:15:46.512178|2017-02-18 15:15:46.512178
NCT00531453|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2012-01-25|2010-04-09||October 2007||2007-10-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma|A Phase 2, Randomized Study of VELCADE® (Bortezomib), Dexamethasone, and Thalidomide Versus VELCADE® (Bortezomib), Dexamethasone, Thalidomide, and Cyclophosphamide in Subjects With Previously Untreated Multiple Myeloma Who Are Candidates for Autologous Transplantation|Completed||Phase 2|98|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||||||||||||2017-02-18 15:15:46.629814|2017-02-18 15:15:46.629814
NCT00531440|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2011-11-01|||November 2001||2001-11-01|November 2011|2011-11-01||||August 2005|Actual|2005-08-01||Interventional|||This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.|A 2 Year Extension to a 1 Year Multicenter, Randomized, Open Label, Parallel Group Study of the Safety, Tolerability and Efficacy of Two Doses (1.5 and 3 mg/Day) of Everolimus (RAD001) With Basiliximab, Corticosteroids and Optimized Administration of Cyclosporine in de Novo Renal Transplant Recipients.|Completed||Phase 3|256|Actual|Novartis|||||f||||||||||||||2017-02-18 15:15:47.069098|2017-02-18 15:15:47.069098
NCT00531427|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2012-09-05|2010-07-28||September 2007||2007-09-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|||Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee|Randomized, Double-blind, Placebo-controlled With Open-label Run-in Assessing Efficacy, Tolerability,Safety of BTDS 10 or 20 Compared to Placebo in Opioid-naïve Subjects w/Moderate to Severe, Chronic Pain Due to OA of Knee|Completed||Phase 3|567|Actual|Purdue Pharma LP||2|||f||||f||||||||||2017-02-18 15:15:47.349438|2017-02-18 15:15:47.349438
NCT00531414|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-16|2008-04-07|||November 2007||2007-11-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Inspiratory Flow Using the Osmohaler|Inspiratory Flow and VOlumes in Asthmatic and Healthy Individuals Using the Osmohaler|Completed||N/A|30|Anticipated|Pharmaxis|||||f||||f||||||||||2017-02-18 15:15:48.011301|2017-02-18 15:15:48.011301
NCT00531401|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2011-06-08|||September 2007||2007-09-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study of Salirasib to Treat Non-Small Cell Lung Cancer|Salirasib for Treatment of Advanced Non-Small Cell Lung Cancer: a Phase II Study|Completed||Phase 2|71|Anticipated|Concordia Pharmaceuticals, Inc||1|||f||||f||||||||||2017-02-18 15:15:48.075157|2017-02-18 15:15:48.075157
NCT00531375|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2008-11-17|||September 2007||2007-09-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||The Effect of Silicone Hydrogel Contact Lenses on Conjunctival Flora||Completed||N/A|60|Actual|University of Melbourne||1|||f||||||||||||||2017-02-18 15:15:48.174851|2017-02-18 15:15:48.174851
NCT00531362|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2009-09-28|||September 2007||2007-09-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Enteric Coating as a Factor in Aspirin Resistance|Enteric Coating as a Factor in Aspirin Resistance|Completed||N/A|250|Actual|Royal College of Surgeons, Ireland|||1||f||||f||||||Samples Without DNA|"~     Serum samples will be collected and stored for later analysis~   "|||2017-02-18 15:15:48.263994|2017-02-18 15:15:48.263994
NCT00531349|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2016-05-05|||November 2007||2007-11-01|May 2016|2016-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|ECA/R||Regional Anesthesia and Endometrial Cancer Recurrence|Regional Anesthesia and Endometrial Cancer Recurrence|Withdrawn||Phase 3|0|Actual|The Cleveland Clinic||2||Lack of study population|f||||t||||||||No||2017-02-18 15:15:48.375507|2017-02-18 15:15:48.375507
NCT00531336|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-15|2009-06-30|||July 2006||2006-07-01|October 2008|2008-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen|Comparison of Combined Therapy of Intravitreal Injection of Avastin and Macugen Versus Mono-Therapy The MAAM Study - a Pilot Study|Completed||Phase 2|60|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||3|||f||||f||||||||||2017-02-18 15:15:48.490452|2017-02-18 15:15:48.490452
NCT00531323|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2008-09-04|||September 2007||2007-09-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|||||Interventional|||TMC 125 Blood Levels Study|Evaluation of the Pharmacokinetics and Safety of TMC125 Administered Once and Twice-Daily and Following a 2-Week-Treatment Period With Efavirenz in Male and Female Healthy Volunteers.|Completed||Phase 1|24|Anticipated|St Stephens Aids Trust||2|||f||||f||||||||||2017-02-18 15:15:48.601931|2017-02-18 15:15:48.601931
NCT00531310|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-15|2011-04-12|||January 2003||2003-01-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|December 2007|Actual|2007-12-01||Interventional|CML||Reduced Intensity AlloSCT in(CML) With Persistent Disease|A Pilot Study of Reduced Intensity Allogeneic Stem Cell Transplantation in Patients With Chronic Myeloid Leukemia (CML) and Adoptive Cellular Immunotherapy Only in Patients With Persistent Disease and Matched Family Donors|Terminated||Phase 2|5|Actual|Columbia University||2||Poor accrual|f||||t||||||||||2017-02-18 15:15:48.711217|2017-02-18 15:15:48.711217
NCT00531297|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2013-01-23|||December 2005||2005-12-01|January 2013|2013-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer|Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer|Recruiting||Phase 3|96|Anticipated|Cantonal Hospital of St. Gallen||1|||f||||f||||||||||2017-02-18 15:15:48.822152|2017-02-18 15:15:48.822152
NCT00531284|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2016-09-28|2015-10-05||September 2007||2007-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|October 2014|Actual|2014-10-01||Interventional|||Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma|Phase 1b/2, Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors, Multiple Myeloma or Lymphoma|Active, not recruiting||Phase 1/Phase 2|184|Actual|Onyx Pharmaceuticals||17|||f||||f||||||||||2017-02-18 15:15:48.961058|2017-02-18 15:15:48.961058
NCT00531271|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2009-06-11|||November 2007||2007-11-01|June 2009|2009-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||ABI-008 Trial in Patients With Metastatic Breast Cancer|A Phase I/II Trial of ABI-008 (Nab-Docetaxel) in Patients With Metastatic Breast Cancer|Terminated||Phase 1/Phase 2|85|Anticipated|Celgene Corporation||1|||f||||f||||||||||2017-02-18 15:15:57.197396|2017-02-18 15:15:57.197396
NCT00531258|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2008-05-05|||October 2007||2007-10-01|May 2008|2008-05-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||TMS in the Treatment of the Sequelae of Closed Brain Injury|The Use of Non Invasive Brain Stimulation in the Treatment of the Sequelae of Closed Brain Injury|Unknown status|Recruiting|Phase 2|50|Anticipated|Bayside Health||2|||f||||f||||||||||2017-02-18 15:15:57.287014|2017-02-18 15:15:57.287014
NCT00531245|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2009-06-29|||August 2006||2006-08-01|August 2007|2007-08-01|March 2009|Actual|2009-03-01|June 2008|Actual|2008-06-01||Interventional|||A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer|A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer|Completed||Phase 1/Phase 2|77|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 15:15:57.385134|2017-02-18 15:15:57.385134
NCT00530283|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2012-01-18|||August 2007||2007-08-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|||||Observational|||PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy|The Clinical Utility of PET-CT in the Management of Squamous Cell Carcinoma of the Neck Nodes With Unknown Primary Malignancy|Completed||N/A|58|Anticipated|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 15:16:20.573268|2017-02-18 15:16:20.573268
NCT00531232|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2014-03-17||2011-12-16|September 2007||2007-09-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)|A Phase IIa Open-label, Dose Confirmation Study of Oral Clofarabine in Adult Patients Previously Treated for Myelodysplastic Syndromes(MDS)|Completed||Phase 2|36|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:15:57.485892|2017-02-18 15:15:57.485892
NCT00531219|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2016-10-24|||February 2008||2008-02-01|October 2016|2016-10-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Observational|NOTES||Minimally Invasive Surgery: Using Natural Orifice Translumenal Endoscopic Surgery (NOTES)|Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Transgastric Appendectomy and Cholecystectomy|Recruiting||N/A|20|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-02-18 15:15:57.586701|2017-02-18 15:15:57.586701
NCT00531206|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2014-02-24|2010-01-28||August 2006||2006-08-01|February 2014|2014-02-01||||January 2009|Actual|2009-01-01||Observational|||Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.|Observational Non-interventional Study About Antiretroviral Combination Treatment With Aptivus in Combination With Low-dose Ritonavir in HIV Type 1 Infected Patients|Completed||N/A|65|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 15:15:57.699208|2017-02-18 15:15:57.699208
NCT00531193|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2008-07-29|||September 2007||2007-09-01|July 2008|2008-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers|An Open-Label, Positron Emission Tomography Study to Assess Adenosine A2A Brain Receptor Occupancy of BIIB014 at Multiple Dose Levels in Healthy Male Volunteers|Completed||Phase 1|32|Actual|Biogen||1|||f||||f||||||||||2017-02-18 15:15:58.503621|2017-02-18 15:15:58.503621
NCT00531180|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2016-10-03|||August 2007||2007-08-01|October 2016|2016-10-01||||November 2018|Anticipated|2018-11-01||Observational|||4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Thoracic Malignancies|Phase II Trial Comparing 4-Dimensional Computed Tomography Derived Ventilation Versus SPECT/CT Tc-99m Aerosol Ventilation in Patients With Thoracic Malignancies|Active, not recruiting||N/A|36|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:15:58.603962|2017-02-18 15:15:58.603962
NCT00531167|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2012-10-18|||April 2007||2007-04-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|April 2011|Actual|2011-04-01||Interventional|||Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B|Prospective Randomized Study for the Comparison of Adding Adefovir Dipivoxil and Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B|Completed||Phase 4|219|Actual|Korea University||2|||f||||t||||||||||2017-02-18 15:15:58.708454|2017-02-18 15:15:58.708454
NCT00531154|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2007-09-17||||||September 2007|2007-09-01||||||||Observational|||Evaluation of the Dental Health Condition in Obesity Patients Before and After Bariatric Surgery||Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:15:58.832462|2017-02-18 15:15:58.832462
NCT00531141|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-15|2009-06-23|||May 2007||2007-05-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||The Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD Study|Reproducibility of Retinal Thickness Measurements by Optical Coherence Tomography in Age-Related Macular Degeneration The OCT in AMD Study|Completed||N/A|200|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|||4||f||||f||||||||||2017-02-18 15:15:58.910319|2017-02-18 15:15:58.910319
NCT00531128|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2017-01-24|||September 5, 2007||2007-09-05|May 24, 2016|2016-05-24|July 27, 2012|Actual|2012-07-27|July 27, 2012|Actual|2012-07-27||Interventional|||The Effect of Dietary Sitosterol on Blood Sugar and Cholesterol|A Nutrigenomics Intervention for the Study of the Role of Dietary Sitosterol on Lipid, Glucose and Energy Metabolism|Completed||N/A|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:15:59.010653|2017-02-18 15:15:59.010653
NCT00531115|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2013-02-19|||November 2007||2007-11-01|February 2013|2013-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.|Multicentre, Single-arm, Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With Oxaliplatin and Capecitabine (XELOX) for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.|Terminated||Phase 2|28|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1||"According to the study design, in the first step the number of responses was lower than the~   number required (< 7)."|f||||f||||||||||2017-02-18 15:15:59.121849|2017-02-18 15:15:59.121849
NCT00531102|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2016-10-11|||February 2008||2008-02-01|October 2016|2016-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Effect of Establishing Functional Residual Capacity During Newborn Resuscitation on Oxygenation|Effects of Oxygen and Functional Residual Capacity on the Oxygen Saturations of Infants ≥ 35 Weeks Gestation During Delivery Room Resuscitation.|Terminated||N/A|40|Actual|University of Calgary||2||Slow enrolment|f||||f||||||||No||2017-02-18 15:15:59.240006|2017-02-18 15:15:59.240006
NCT00531089|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2010-05-18|||December 2007||2007-12-01|September 2007|2007-09-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Rituximab in Patients With Relapsed or Refractory TTP-HUS|A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients With Relapsed/Refractory Thrombotic Thrombocytopenic Purpura (TTP) - Hemolytic Uremic Syndrome (HUS)|Unknown status|Recruiting|Phase 2|60|Anticipated|McMaster University||1|||f||||t||||||||||2017-02-18 15:15:59.352346|2017-02-18 15:15:59.352346
NCT00531076|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2011-04-04|||October 2007||2007-10-01|January 2011|2011-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer|Phase I Study of Concurrent Bevacizumab (Avastin) With Involved-field Thoracic Radiotherapy for Inoperable Non-squamous Non-small Cell Lung Cancer, Followed by Both Concurrent and Maintenance Bevacizumab|Terminated||Phase 1|6|Actual|VU University Medical Center||1||Study terminated due to toxicity|f||||f||||||||||2017-02-18 15:15:59.47724|2017-02-18 15:15:59.47724
NCT00530075|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2008-02-13|||December 2003||2003-12-01|September 2007|2007-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis|Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis|Completed||Phase 2|45|Actual|Nippon Kayaku Co.,Ltd.||1|||f||||f||||||||||2017-02-18 15:16:23.541637|2017-02-18 15:16:23.541637
NCT00531063|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2011-11-01|||November 2001||2001-11-01|November 2011|2011-11-01||||August 2005|Actual|2005-08-01||Interventional|||This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus|A 2-year Extension to a 1-year Multicenter, Randomized, Open Label, Parallel Group Study of the Safety, Tolerability and Efficacy of Two Doses (1.5 and 3 mg/Day) of Everolimus With Steroids and Optimized Administration of Cyclosporine in de Novo Renal Transplant Recipients.|Completed||Phase 3|237|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:15:59.572767|2017-02-18 15:15:59.572767
NCT00531050|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2012-04-23|2011-07-29||August 2007||2007-08-01|April 2012|2012-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol|A Double-blind, Randomized, Cross-over, Placebo-controlled, 2-part Study to Compare the Effect of Exercise and High-dose Salbutamol on Maximal Heart-rate in Patients With COPD Following Therapeutic Doses of Inhaled QAB149 and Salmeterol|Completed||Phase 2|27|Actual|Novartis||6|||f||||f||||||||||2017-02-18 15:15:59.662402|2017-02-18 15:15:59.662402
NCT00531037|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2015-01-09|||June 2007||2007-06-01|January 2015|2015-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|NATURE||Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers|Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers|Completed||N/A|1440|Actual|LivaNova|||1||f||||f||||||||||2017-02-18 15:16:00.511021|2017-02-18 15:16:00.511021
NCT00531024|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-15|2009-04-20|||August 2005||2005-08-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|BEAT-AMD||Systemic Avastin Therapy in Age-Related Macular Degeneration|Systemic Bevacizumab (Avastin) Therapy for Exudative Neovascular Age-Related Macular Degeneration|Completed||Phase 2/Phase 3|30|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||2|||f||||f||||||||||2017-02-18 15:16:00.900922|2017-02-18 15:16:00.900922
NCT00531011|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2015-05-12|2011-05-16||September 2007||2007-09-01|May 2015|2015-05-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional|EXecutive||EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease|EXecutive Randomized Controlled Trial (RCT): XIENCE V® Everolimus Eluting Coronary Stent System (XIENCE V® EECSS) in the Treatment of the Specific Setting of Patients With Multi-vessel Coronary Artery Disease.|Completed||Phase 4|200|Actual|Abbott Vascular||2|||f||||f||||||||||2017-02-18 15:16:01.017534|2017-02-18 15:16:01.017534
NCT00530998|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2016-10-24|||September 2007||2007-09-01|October 2016|2016-10-01|September 2019|Anticipated|2019-09-01|September 2019|Anticipated|2019-09-01||Observational|NOTES||Minimally Invasive Surgery: Using Natural Orfices|Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Trans-Vaginal Appendectomy and Cholecystectomy|Recruiting||N/A|120|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-02-18 15:16:01.814742|2017-02-18 15:16:01.814742
NCT00530985|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-16|2009-06-30|||February 2007||2007-02-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Preserving Function Among Disability Applicants|Preserving Function Among Disability Applicants: A Motivational Enhancement Approach to Benefits Counseling|Completed||Phase 1|120|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:16:01.926586|2017-02-18 15:16:01.926586
NCT00530972|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2009-09-04|||March 2006||2006-03-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PILOT-NR||Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies|Treatment of Patients With Chronic Hepatitis C Co-infected With HIV Relapsers or Non Responders, Previous Exposed to Sub-optimal Therapies: Open, Pilot Trial|Completed||Phase 4|50|Actual|Hospital Carlos III, Madrid||1|||f||||t||||||||||2017-02-18 15:16:02.040694|2017-02-18 15:16:02.040694
NCT00530946|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2009-04-28|2009-03-10||September 2007||2007-09-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin|A Multi-Center, Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin In The Treatment Of Concurrent Hypertension And Hyper-LDL-Cholesterolemia|Completed||Phase 3|165|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 15:16:02.16763|2017-02-18 15:16:02.16763
NCT00530933|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-15|2007-09-15|||September 2007||2007-09-01|September 2007|2007-09-01|April 2009|Anticipated|2009-04-01|||||Interventional|||Tibial Nerve Stimulation for Faecal Incontinence|Prospective Randomised Placebo Controlled Study Into Percutaneous and Transcutaneous Tibial Nerve Stimulation for Faecal Incontinence|Unknown status|Recruiting|N/A|66|Anticipated|London North West Healthcare NHS Trust||3|||f||||f||||||||||2017-02-18 15:16:05.876408|2017-02-18 15:16:05.876408
NCT00530920|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2014-05-27|2009-05-15||October 2007||2007-10-01|May 2014|2014-05-01||||May 2008|Actual|2008-05-01||Interventional||Treated Set, includes all patients that were randomized and were documented to have received at least one dose of investigational treatment|Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients|A Multicenter, Randomized, Open Label, Clinical Trial to Evaluate Three Doses of Tipranavir Boosted With Ritonavir (500 mg/200 mg qd, 250 mg/100 mg Bid and 500 mg/100 mg Bid) by Assessing the Steady-state Pharmacokinetics and Short-term Efficacy and Safety in HIV-1 Positive Treatment naïve Patients|Completed||Phase 2|85|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:16:05.988521|2017-02-18 15:16:05.988521
NCT00530907|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2015-01-07|||June 2007||2007-06-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Valproic Acid and Bevacizumab in Patients With Advanced Cancer|Phase I Study of Valproic Acid Given in Combination With Bevacizumab in Patients With Advanced Cancer to Determine Safety and Tolerability|Completed||Phase 1|71|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:16:06.980126|2017-02-18 15:16:06.980126
NCT00530894|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2014-02-07|||April 2007||2007-04-01|February 2014|2014-02-01|March 2017|Anticipated|2017-03-01|||||Interventional|PARTNER||THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial|THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve|Active, not recruiting||N/A|3285|Anticipated|Edwards Lifesciences||4|||||||t||||||||||2017-02-18 15:16:07.097735|2017-02-18 15:16:07.097735
NCT00530881|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2007-09-17|||April 2006||2006-04-01|September 2007|2007-09-01|October 2006|Actual|2006-10-01|||||Interventional|||Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine Safety and Establish Proof of Concept With PHX1149 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|180|Actual|Phenomix||2|||f||||f||||||||||2017-02-18 15:16:07.24449|2017-02-18 15:16:07.24449
NCT00530868|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2016-12-28|||October 2007||2007-10-01|December 2016|2016-12-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer|A Phase II, Randomized, Open Label Trial of Pre-operative (Neoadjuvant)Letrozole (Femara) vs. Letrozole in Combination With Avastin in Post Menopausal Women With Newly Diagnosed Operable Breast Cancer|Active, not recruiting||Phase 2|75|Actual|University of Alabama at Birmingham||2|||f||||t||||||||No||2017-02-18 15:16:07.333988|2017-02-18 15:16:07.333988
NCT00530855|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2015-05-18|2015-05-18||February 2008||2008-02-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Baseline Characteristics refer to the Safety Set, which is defined as all subjects who met the inclusion/exclusion criteria, signed an informed consent form, and took at least 1 dose of Trial medication.|Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures|A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects With Partial-onset Seizures|Completed||Phase 3|322|Actual|UCB Pharma||1|||f||||||||||||||2017-02-18 15:16:07.46975|2017-02-18 15:16:07.46975
NCT00530842|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2013-11-27|2009-12-30||September 2007||2007-09-01|September 2013|2013-09-01||||January 2009|Actual|2009-01-01||Interventional|||Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD|Effect of Inhalation of a Free Combination of Tiotropium Once Daily 18 Mcg and Salmeterol Twice Daily 50 Mcg Versus a Fixed Combination of Fluticasone and Salmeterol Twice Daily (500/50 Mcg) on Static Lung Volumes and Exercise Tolerance in COPD Patients (a Randomised, Double-blind, Double Dummy, 16 (2 x 8) Weeks, Crossover Study).|Completed||Phase 4|344|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:16:08.222083|2017-02-18 15:16:08.222083
NCT00530829|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-17|2010-03-08|||October 2007||2007-10-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Impact of Home Zinc Treatment for Acute Diarrhea in Children|Clinical Effectiveness and Preventive Impact of Home Zinc Treatment for Acute Diarrhea in Children: A Cluster-randomized Field Trial in Rural Western Kenya|Completed||Phase 3|3000|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 15:16:09.744449|2017-02-18 15:16:09.744449
NCT00530816|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2015-10-28|2013-10-15||September 2007||2007-09-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional||Safety Population: All patients enrolled on study and who received at least 1 dose of carfilzomib.|Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma|An Open-label, Single-arm, Phase 2 Study of Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|164|Actual|Onyx Pharmaceuticals||1|||f||||||||||||||2017-02-18 15:16:09.864602|2017-02-18 15:16:09.864602
NCT00530803|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2009-10-26|||September 2007||2007-09-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children|The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children|Completed||N/A|100|Anticipated|Montefiore Medical Center||2|||f||||t||||||||||2017-02-18 15:16:11.469781|2017-02-18 15:16:11.469781
NCT00530790|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2016-11-02|2009-02-02||August 2007||2007-08-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome|Clinical Evaluation of Ropinirole CR-RLS Tablets in Restless Legs Syndrome-Open-Label, Uncontrolled Study. Classification: Clinical Pharmacology, Exploratory|Completed||Phase 2|35|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:16:11.597734|2017-02-18 15:16:11.597734
NCT00530777|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2012-03-22|2012-03-22||April 2008||2008-04-01|March 2012|2012-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|VIP||HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding|HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding|Completed||Phase 2|148|Actual|University of Washington|Unable to evaluate the effect of valacyclovir on MTCT or on change in HIV-1 RNA among women who were eligible for HAART. Underpowered to detect association between treatment and mother to child HIV transmission.|2|||f||||t||||||||||2017-02-18 15:16:12.632038|2017-02-18 15:16:12.632038
NCT00530764|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2013-06-13|2011-03-02||November 2007||2007-11-01|June 2013|2013-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|SPRAY||A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.|A Double Blind, Randomized, Placebo Controlled, Parallel Group Dose-range Exploration Study of Sativex® in Relieving Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy.|Completed||Phase 2|360|Actual|GW Pharmaceuticals Ltd.||4|||f||||t||||||||||2017-02-18 15:16:13.272481|2017-02-18 15:16:13.272481
NCT00530751|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2015-10-01|||March 2007||2007-03-01|October 2015|2015-10-01||||October 2008|Actual|2008-10-01||Observational|||Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation|Patient Perspectives on Sharing Family Medical Histories|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center|||1|PI left|f||||f||||||||||2017-02-18 15:16:14.391376|2017-02-18 15:16:14.391376
NCT00530738|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2014-07-17|||September 2007||2007-09-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety and Efficacy of Longterm HPN With Two Lipid Emulsions|Efficacy, Safety and Quality of Life of a Long-term Home Parenteral Nutrition Regimen With Either LIPIDEM® or LIPOFUNDIN® MCT a Mono-center, Randomized, Double Blind Study|Completed||Phase 4|42|Actual|B. Braun Melsungen AG||2|||f||||f||||||||||2017-02-18 15:16:14.509116|2017-02-18 15:16:14.509116
NCT00530725|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2016-08-15|||August 2006||2006-08-01|August 2016|2016-08-01|June 2020|Anticipated|2020-06-01|December 2018|Anticipated|2018-12-01||Interventional|OPTICC||Management of Occult Pneumothoraces in Mechanically Ventilated Patients|Prospective Randomized Trial of the Management of Occult Pneumothoraces in Mechanically Ventilated Patients|Recruiting||Phase 3|300|Anticipated|University of Calgary||2|||f||||f||||||||No|No plan.|2017-02-18 15:16:14.618432|2017-02-18 15:16:14.618432
NCT00530712|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2015-08-14|2014-07-28||August 2007||2007-08-01|August 2015|2015-08-01|July 2013|Actual|2013-07-01|March 2012|Actual|2012-03-01||Interventional|DURABILITY II||Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis|The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protege EverfLex NitInol STent SYstem II|Completed||Phase 2/Phase 3|287|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-02-18 15:16:14.763962|2017-02-18 15:16:14.763962
NCT00530699|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2009-09-10|||November 2007||2007-11-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)|A Phase I, Open Label, Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD1152 in Japanese Patients With Acute Myeloid Leukaemia.|Completed||Phase 1|30|Anticipated|AstraZeneca||1|||f||||t||||||||||2017-02-18 15:16:15.13956|2017-02-18 15:16:15.13956
NCT00530686|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2017-02-15|||July 2017|Anticipated|2017-07-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment|Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment|Not yet recruiting||Phase 1|15|Anticipated|Baylor Research Institute||1|||f||||t|f|f||||||Undecided||2017-02-18 15:16:15.393916|2017-02-18 15:16:15.393916
NCT00530660|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2015-10-07|||September 2007||2007-09-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)|An Open-label Phase II Study to Assess the Immunogenicity and Safety of a Booster Vaccination With a Heterologous Vero Cell-Derived Whole Virus H5N1 Influenza Vaccine in a Healthy Young Adult Population (Follow Up to Study 810501)|Completed||Phase 2|141|Anticipated|Nanotherapeutics, Inc.||1|||f||||t||||||||||2017-02-18 15:16:15.506141|2017-02-18 15:16:15.506141
NCT00530647|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-13||||||October 2006|2006-10-01||||||||Observational|||fMRI Study of Brain Neural Network and Plasticity After Stroke||Unknown status|Recruiting|N/A|||Samsung Medical Center|||||f||||t||||||||||2017-02-18 15:16:15.613551|2017-02-18 15:16:15.613551
NCT00530634|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2015-10-07|2015-08-19||August 1999||1999-08-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer|Multimodality Therapy for Stages II and III Non-Small Cell Lung Cancer: Surgical Resection Followed by Sequential Administration of Gemcitabine Plus Cisplatin Chemotherapy and Radiation Therapy|Terminated||Phase 2|3|Actual|City of Hope Medical Center|Study was closed early due to poor accrual. Reported data are not statistically powered to provide meaningful conclusions|1||Poor accrual|f||||||||||||||2017-02-18 15:16:15.697857|2017-02-18 15:16:15.697857
NCT00530621|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2009-10-16||2009-10-16|September 2007||2007-09-01|October 2009|2009-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer|A Phase 2 Double-Blind Randomized Study of Oral Enzastaurin HCl Versus Placebo Concurrently With Pemetrexed (Alimta®) as Second-Line Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|149|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:16:15.970632|2017-02-18 15:16:15.970632
NCT00530608|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2010-02-09|||June 2006||2006-06-01|June 2008|2008-06-01|November 2007|Actual|2007-11-01|||||Observational|||Electrophysiological Properties of the Pulmonary Veins|Electrophysiological Properties of the Pulmonary Veins|Completed||N/A|35|Actual|Universitätsklinikum Hamburg-Eppendorf|||1||f||||f||||||||||2017-02-18 15:16:16.108169|2017-02-18 15:16:16.108169
NCT00530595|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-14||||||September 2007|2007-09-01||||||||Interventional|||Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients||Completed||N/A|||Saitama Medical University||2|||f||||f||||||||||2017-02-18 15:16:16.17643|2017-02-18 15:16:16.17643
NCT00530582|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2007-09-14|||November 2003||2003-11-01|September 2007|2007-09-01|July 2004|Actual|2004-07-01|||||Interventional|||Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women|Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women|Completed||Phase 4|10|Actual|Max-Planck-Institute of Psychiatry|||||f||||f||||||||||2017-02-18 15:16:16.255437|2017-02-18 15:16:16.255437
NCT00530569|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2013-01-24|||August 2007||2007-08-01|January 2012|2012-01-01||||||||Observational|HER 2||Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy|Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy|Unknown status|Active, not recruiting|N/A|60|Anticipated|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 15:16:16.350876|2017-02-18 15:16:16.350876
NCT00530556|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2012-02-15|||March 2003||2003-03-01|February 2012|2012-02-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Insomnia and Daytime Function in Osteoarthritis|Effect of Zolpidem vs Placebo on Insomnia and Daytime Function in Patients With Insomnia Associated With Osteoarthritis|Completed||Phase 4|170|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:16:16.442151|2017-02-18 15:16:16.442151
NCT00530543|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-13||||||May 2007|2007-05-01||||||||Interventional|||Effects of Gait Training With Assistance of a Robot-Driven Gait Orthosis in Hemiparetic Patients After Stroke||Unknown status|Recruiting|N/A|||Samsung Medical Center|||||f||||t||||||||||2017-02-18 15:16:16.525068|2017-02-18 15:16:16.525068
NCT00530530|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2014-10-28|||September 2007||2007-09-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||ASP8825 - Study in Patients With Restless Legs Syndrome|ASP8825 Phase ⅡStudy—A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ASP8825 in Patients With Restless Legs Syndrome|Completed||Phase 2|474|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-02-18 15:16:16.609947|2017-02-18 15:16:16.609947
NCT00530517|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2008-02-07|||September 2007||2007-09-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study on the Usability of the Needle-Free Intraject® System in Adult Patients During Acute Migraine Attack|A Multi-Center, Open-Label, Single-Dose, Single-Arm Study to Evaluate the Usability of Subcutaneously Administered Sumatriptan Delivered Via the Intraject® System in Adult Patients During Acute Migraine Attack|Completed||Phase 2|54|Actual|Zogenix, Inc.||1|||f||||t||||||||||2017-02-18 15:16:16.736888|2017-02-18 15:16:16.736888
NCT00530504|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2015-09-24|2015-07-28||May 2007||2007-05-01|August 2015|2015-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|CREATE PAS||Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study|Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study|Completed||Phase 4|1500|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-02-18 15:16:16.855005|2017-02-18 15:16:16.855005
NCT00529880|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2007-09-26|||December 2004||2004-12-01|September 2007|2007-09-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML||Unknown status|Recruiting|Phase 2|19|Anticipated|Cooperative Study Group A for Hematology|||||f||||f||||||||||2017-02-18 15:16:25.797874|2017-02-18 15:16:25.797874
NCT00530491|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2008-02-01|||September 2007||2007-09-01|September 2007|2007-09-01|October 2008|Anticipated|2008-10-01|September 2008|Anticipated|2008-09-01||Interventional|||Prospective Trial to Reduce Morbidity and Mortality After Lung Surgery in Patients With Reduced Pulmonary Capacity|Prospective Randomized Controlled Trial to Reduce Morbidity and Mortality After Lung Surgery in Patients With FEV1 < 70% of Expected Value or < 1.5L|Unknown status|Recruiting|N/A|90|Anticipated|University of Ulm||2|||f||||f||||||||||2017-02-18 15:16:17.111098|2017-02-18 15:16:17.111098
NCT00530478|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-13||||||July 2007|2007-07-01||||||||Interventional|||Effect of Donepezil on the Reorganization of Cognitive Neural Network in Patients With Post-Stroke Cognitive Impairment||Unknown status|Recruiting|N/A|||Samsung Medical Center|||||f||||t||||||||||2017-02-18 15:16:17.210608|2017-02-18 15:16:17.210608
NCT00530452|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2008-06-12|||October 2007||2007-10-01|June 2008|2008-06-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects|Double-Blind, Placebo Controlled Phase II Repeat Dose Study of the Safety and Efficacy of Three Parallel Loading and Maintenance Dose Regimens of CG100649 Versus Placebo for the Treatment of Primary Osteoarthritis in Male Subjects|Unknown status|Recruiting|Phase 2|240|Anticipated|CrystalGenomics, Inc.||4|||f||||f||||||||||2017-02-18 15:16:17.305484|2017-02-18 15:16:17.305484
NCT00530439|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-07-15|2011-06-13||October 2007||2007-10-01|April 2008|2008-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|LiP||Lifestyle and Pregnancy: The Clinical Effect of Lifestyle Intervention During Pregnancy in Obese Women|Lifestyle and Pregnancy: The Clinical Effect of Lifestyle Intervention During Pregnancy in Obese Women|Completed||N/A|360|Actual|Odense University Hospital||2|||f||||f||||||||||2017-02-18 15:16:17.427191|2017-02-18 15:16:17.427191
NCT00530426|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2014-01-30|||September 2001||2001-09-01|October 2007|2007-10-01|February 2005|Actual|2005-02-01|||||Observational|||Heart Failure Registry|ADHERE Core II - Acute Decompensated HEart Failure REgistry|Completed||Phase 4|150000||Scios, Inc.|||||f||||||||||||||2017-02-18 15:16:17.959998|2017-02-18 15:16:17.959998
NCT00530413|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2014-12-09|||March 2007||2007-03-01|December 2014|2014-12-01||||March 2009|Anticipated|2009-03-01||Interventional|||Study of Phenobarbital Inhibition of Catamenial Epilepsy|Study of Phenobarbital Inhibition of Catamenial Epilepsy|Withdrawn||N/A|0|Actual|University of Toledo Health Science Campus||2||IRB needs updated|f||||f||||||||||2017-02-18 15:16:18.047686|2017-02-18 15:16:18.047686
NCT00530400|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-14|||April 1994||1994-04-01|September 2007|2007-09-01|March 2000|Actual|2000-03-01|||||Interventional|||Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery|Prospective, Double-Blind, Randomized, Placebo-Controlled Trial of Single-Dose Cefuroxime Prophylaxis in Herniated Disk Surgery|Completed||Phase 4|1369|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-02-18 15:16:18.159157|2017-02-18 15:16:18.159157
NCT00530387|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-08-03|||July 2008||2008-07-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Multi-Centre European Photopatch Test Study|A Prospective, Open, Multi-Centre Photopatch Test Study of Patients Suspected of Photoallergy to Organic Sunscreens and Topical Nonsteroidal Anti-inflammatory Drugs Used Within Europe.|Completed||N/A|1000|Actual|NHS Tayside||1|||f||||f||||||||||2017-02-18 15:16:18.272059|2017-02-18 15:16:18.272059
NCT00530374|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2009-05-25|||November 2007||2007-11-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent|Impact of Oral Iron Supplementation With Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent - A Non-Inferiority Safety Trial|Completed||Phase 3|268|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 15:16:18.385374|2017-02-18 15:16:18.385374
NCT00530361|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2016-09-19||||||July 2011|2011-07-01|September 2009|Anticipated|2009-09-01|||||Interventional|||An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)|A Double-Blind, Randomized, Placebo-Controlled Study of Nesiritide Administered After Induction of Anesthesia in Heart Failure Patients With Renal Insufficiency Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (NAPA-CS)|Withdrawn||Phase 3|0|Actual|Scios, Inc.||||Study was withdrawn prior to patient dosing based on a business decision.|||||f||||||||||2017-02-18 15:16:18.496644|2017-02-18 15:16:18.496644
NCT00530348|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2014-11-17|2014-11-17||August 2007||2007-08-01|November 2014|2014-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|CARE-MS I|Full analysis set (FAS) population included all randomized participants who received at least 1 dose of study drug.|Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One|A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Treatment-Naïve Patients With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|581|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:16:18.602109|2017-02-18 15:16:18.602109
NCT00530335|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2011-07-25|2009-04-22||September 2007||2007-09-01|July 2011|2011-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)|An Open-Label Pilot Study for Atomoxetine in Adult Subjects With Attention Deficit/Hyperactivity Disorder|Completed||Phase 2|45|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:16:19.723317|2017-02-18 15:16:19.723317
NCT00530322|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-13|||June 2006||2006-06-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Observational|||Adhesion Formation Following Laparoscopic and Open Colorectal Surgery|Adhesion Formation Following Laparoscopic and Open Colorectal Surgery|Completed||N/A|46|Actual|University of Surrey|||2||f||||f||||||||||2017-02-18 15:16:20.275785|2017-02-18 15:16:20.275785
NCT00530309|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2016-11-03|||August 2007||2007-08-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus|Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus -A Phase I/II Study to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of GSK716155 in Japanese Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|40|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:16:20.373221|2017-02-18 15:16:20.373221
NCT00530296|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2007-09-14|||June 2005||2005-06-01|September 2007|2007-09-01|June 2008|Anticipated|2008-06-01|||||Interventional|CBTRPat||CBT to Treat Depression in Renal Patients|Effectiveness of Cognitive Behavioral Therapy in Patients With End-Stage Renal Disease in Hemodialysis and With Depression|Unknown status|Recruiting|N/A|80|Anticipated|Federal University of São Paulo|||||f||||f||||||||||2017-02-18 15:16:20.480244|2017-02-18 15:16:20.480244
NCT00530270|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2013-03-29|2009-07-16||December 2006||2006-12-01|March 2013|2013-03-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|||Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease|Randomized Trial of Oral Dexamethasone for Acute Chest Syndrome|Terminated||Phase 3|12|Actual|Children's Hospital Medical Center, Cincinnati|Primary limitation of this study is that is was terminated prior to enrolling all of the subjects necessary to address the primary question.|2||Study was closed June 23, 2008 due to low enrollment.|f||||t||||||||||2017-02-18 15:16:20.665877|2017-02-18 15:16:20.665877
NCT00530257|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-11-15|2011-03-29||June 2004||2004-06-01|November 2011|2011-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|CHOP||Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory|Effect of OROS-Methylphenidate (Concerta) on Different Domains of Attention and Working Memory in Children With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 4|30|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 15:16:21.263335|2017-02-18 15:16:21.263335
NCT00530244|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2012-02-16|||March 2003||2003-03-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|DHA||Use of Formula Fortified With DHA in Infants With Cystic Fibrosis|The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)|Completed||Phase 2/Phase 3|76|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 15:16:21.790405|2017-02-18 15:16:21.790405
NCT00530231|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-13||||||May 2007|2007-05-01||||||||Observational|||Capsule Endoscopic Miss Rates Determined by Back-to-Back Capsule Endoscopy|Capsule Endoscopic Miss Rates Determined by Back-to-Back Capsule Endoscopy|Unknown status|Recruiting|N/A|||Samsung Medical Center|||||f||||t||||||||||2017-02-18 15:16:22.092204|2017-02-18 15:16:22.092204
NCT00530218|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2014-03-27|||March 1999||1999-03-01|March 2014|2014-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant|Phase II Study of Intravenous Ganciclovir Followed by Oral Ganciclovir in the Treatment of Reactivation of CMV Following Bone Marrow Transplant|Completed||Phase 2|61|Actual|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 15:16:22.161927|2017-02-18 15:16:22.161927
NCT00530205|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-07-13|||February 2007||2007-02-01|July 2011|2011-07-01||||||||Observational|||Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer|An Observation of the Change in Percent Lean Body Mass of Stage III Non-Small Cell Lung Cancer Undergoing Radiation Treatment|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 15:16:22.2728|2017-02-18 15:16:22.2728
NCT00530192|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2009-07-09|||September 2006||2006-09-01|July 2009|2009-07-01|March 2009||2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Molecular Profiling Protocol (SCRI-CA-001)|A Pilot Study Utilizing Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers|Completed||Early Phase 1|86|Actual|Scottsdale Healthcare||1|||f||||t||||||||||2017-02-18 15:16:22.384445|2017-02-18 15:16:22.384445
NCT00530179|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-12-06|||July 2007||2007-07-01|August 2011|2011-08-01||||August 2011|Actual|2011-08-01||Interventional|PET Chop||FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma|FDG-PET-Stratified R-DICEP and R-BEAM/ASCT For Diffuse Large B-Cell Lymphoma|Unknown status|Active, not recruiting|N/A|80|Anticipated|AHS Cancer Control Alberta||2|||f||||t||||||||||2017-02-18 15:16:22.479543|2017-02-18 15:16:22.479543
NCT00530166|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2014-06-03||2011-06-01|July 2007||2007-07-01|June 2014|2014-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.|A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Investigate the Effect of JNJ-18054478 in Subjects With Asthma|Terminated||Phase 2|26|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2||Lack of efficacy following an interim analysis|f||||t||||||||||2017-02-18 15:16:22.590565|2017-02-18 15:16:22.590565
NCT00530153|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2009-09-29|||April 2007||2007-04-01|September 2009|2009-09-01|May 2008|Anticipated|2008-05-01|||||Interventional|||School Intervention Study of Nutrition, Wellbeing and Dental Health|School Intervention Study of Nutrition, Wellbeing and Dental Health|Unknown status|Active, not recruiting|N/A|769|Actual|National Institute for Health and Welfare, Finland|||||f||||||||||||||2017-02-18 15:16:22.741709|2017-02-18 15:16:22.741709
NCT00530140|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2011-10-05|||October 2007||2007-10-01|October 2011|2011-10-01|September 2022|Anticipated|2022-09-01|September 2013|Anticipated|2013-09-01||Interventional|FLIDVAX2006||Idiotypic Vaccination for Follicular Lymphoma Patients|Idiotypic Vaccination for Poor-prognosis Follicular Lymphoma Patients in First Relapse|Recruiting||Phase 2|100|Anticipated|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||||2017-02-18 15:16:22.821469|2017-02-18 15:16:22.821469
NCT00530127|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2010-05-31|||April 2008||2008-04-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia|A Six-month Double-blind, Randomized, Placebo-controlled Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia|Completed||Phase 1/Phase 2|80|Anticipated|ApoPharma||5|||f||||t||||||||||2017-02-18 15:16:22.939061|2017-02-18 15:16:22.939061
NCT00530114|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2016-02-16||2016-02-16|March 2008||2008-03-01|February 2016|2016-02-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Fixed Dose Study of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia|Completed||Phase 2|167|Actual|Amgen||2|||f||||||||||||||2017-02-18 15:16:23.062783|2017-02-18 15:16:23.062783
NCT00530101|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2008-06-03|||July 2004||2004-07-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity|The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity|Completed||Phase 1|3|Actual|University of Miami||1|||f||||f||||||||||2017-02-18 15:16:23.157362|2017-02-18 15:16:23.157362
NCT00530088|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2014-06-03|2014-01-29||October 2001||2001-10-01|June 2014|2014-06-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional||All treated and eligible patients|Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat|Photodynamic Therapy With Photofrin® for Treatment of Dysplasia, Carcinoma In Situ and Stage I Carcinoma of the Oral Cavity and the Larynx: A Pilot Study|Terminated||N/A|30|Actual|Roswell Park Cancer Institute|Due to the study's early termination, as a result of new competing studies, target accrual was not reached.|1||new competing studies|f||||t||||||||||2017-02-18 15:16:23.261826|2017-02-18 15:16:23.261826
NCT00530062|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2017-02-03|||January 2007||2007-01-01|February 2017|2017-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Comparison of Single-Dose Efficacy of an Albuterol Breath Activated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered Dose Inhaler (HFA-MDI) (Both Using the Same Hydrofluoroalkane Propellant) in Asthmatics|Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability|Completed||Phase 4|49|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-02-18 15:16:23.660855|2017-02-18 15:16:23.660855
NCT00530049|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2016-10-10|||August 2007||2007-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|||Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure|Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure|Active, not recruiting||N/A|1745|Anticipated|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 15:16:23.766029|2017-02-18 15:16:23.766029
NCT00530036|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-14|2007-09-14|||January 2004||2004-01-01|August 2007|2007-08-01|December 2007|Anticipated|2007-12-01|||||Observational|||Burden of Urinary Incontinence in Home Care Patients in the State of Geneva||Unknown status|Active, not recruiting|N/A|699|Actual|University Hospital, Geneva|||2||f||||f||||||||||2017-02-18 15:16:23.875905|2017-02-18 15:16:23.875905
NCT00530023|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-05-09|2010-12-17||February 2006||2006-02-01|May 2011|2011-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|STAR2||Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness|Pilot Study To Identify Effective Methods Of Training Pump Naïve Subjects To Use The Paradigm® 722 System And To Describe Clinical Effectiveness Compared To Subjects Continuing With Multiple Dose Injections (MDI) of Insulin|Completed||Phase 4|29|Actual|Medtronic Diabetes||2|||f||||f||||||||||2017-02-18 15:16:23.945638|2017-02-18 15:16:23.945638
NCT00530010|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2016-10-10|||December 2004||2004-12-01|October 2016|2016-10-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|||Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma|Recruiting||N/A|500|Anticipated|Northwestern University|||1||f||||t||||||||||2017-02-18 15:16:24.392849|2017-02-18 15:16:24.392849
NCT00529997|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2010-08-10|||February 2007||2007-02-01|August 2010|2010-08-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Dynamic Stabilization for Lumbar Spinal Stenosis With Stabilimax NZ® Dynamic Spine Stabilization System|Clinical Study Comparing Dynamic Stabilization of the Lumbar Spine With the Stabilimax NZ® Dynamic Spine Stabilization System to Posterolateral Instrumented Fusion - In Patients With Lumbar Spinal Stenosis|Terminated||N/A|480|Anticipated|Applied Spine Technologies||2||Company has ceased operation|f||||t||||||||||2017-02-18 15:16:24.669716|2017-02-18 15:16:24.669716
NCT00529984|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2012-07-11|||September 2007||2007-09-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|CEA(6D)VRP||A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies|A Phase I/II Study of Active Immunotherapy With CEA(6D)VRP Vaccine(AVX701)in Patients With Advanced or Metastatic Malignancies Expressing CEA or Stage III Colon Cancer|Completed||Phase 1/Phase 2|28|Actual|AlphaVax, Inc.||5|||f||||t||||||||||2017-02-18 15:16:24.788963|2017-02-18 15:16:24.788963
NCT00529971|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2007-10-02|||December 2003||2003-12-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|||||Interventional|||A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV|A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV|Completed||Phase 3|117|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-02-18 15:16:24.912738|2017-02-18 15:16:24.912738
NCT00529958|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2016-08-17|||September 2007||2007-09-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2010|Actual|2010-12-01||Interventional|||Comparison of Three Methods for Anterior Cruciate Ligament Reconstruction|A Randomized Clinical Trial Comparing Three Methods for Anterior Cruciate Ligament Reconstruction: Patellar Tendon, Quadruple Semitendinosus/Gracilis and Double-Bundle Semitendinosus/Gracilis Grafts.|Active, not recruiting||N/A|330|Actual|University of Calgary||3|||f||||f||||||||No||2017-02-18 15:16:25.024219|2017-02-18 15:16:25.024219
NCT00529945|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2007-12-18|||August 2007||2007-08-01|December 2007|2007-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|Paradigm IV||PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness|The Paradigm IV Trial - PFx Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness|Suspended||N/A|200|Anticipated|Cierra||1|||f||||f||||||||||2017-02-18 15:16:25.150331|2017-02-18 15:16:25.150331
NCT00529932|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2015-04-21|||September 2007||2007-09-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|SELECT-AMI||A Trial Using CD133 Enriched Bone Marrow Cells Following Primary Angioplasty for Acute Myocardial Infarction|A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Trial Using CD133 Enriched Bone Marrow Cells Following Primary Angioplasty for Acute Myocardial Infarction|Terminated||N/A|19|Actual|Onze Lieve Vrouw Hospital||2||Insufficient recruitment|f||||t||||||||||2017-02-18 15:16:25.242965|2017-02-18 15:16:25.242965
NCT00529919|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2007-09-12|||March 2005||2005-03-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|Muffin||Effects of Medium Chain Triglyceride Oil, Versus Olive Oil, for Weight Loss|The Effects of a Weight Loss Diet Containing Medium Chain Triglyceride Oil, Versus Olive Oil, on Body Composition in Free-Living Adults|Completed||N/A|53|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 15:16:25.353033|2017-02-18 15:16:25.353033
NCT00529906|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2009-12-14|||August 2007||2007-08-01|December 2009|2009-12-01|August 2010|Anticipated|2010-08-01|||||Observational|||Endophenotype, Molecular Genetic Study on Attention-Deficit/Hyperactivity Disorder|Endophenotype, Molecular Genetic Study on Attention-deficit/ Hyperactivity Disorder|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"~     The subjects will receive blood withdrawal. The blood sample will be used for establishing~     lymphoblastoid cell lines, which will be used for molecular genetic experiments~   "|||2017-02-18 15:16:25.444476|2017-02-18 15:16:25.444476
NCT00529893|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2013-10-18|||July 2007||2007-07-01|October 2013|2013-10-01||||April 2013|Actual|2013-04-01||Observational|||Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD|Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD|Unknown status|Active, not recruiting|N/A|30|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:16:25.533915|2017-02-18 15:16:25.533915
NCT00529867|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2008-01-17|||May 2007||2007-05-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria|A Randomized Open-Label Trial of the Efficacy of Artemether-Lumefantrine Suspension Compared With Artemether-Lumefantrine Tablets for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Less Than Five Years in Western Kenya|Completed||Phase 4|267|Actual|Dafra Pharma||2|||f||||f||||||||||2017-02-18 15:16:25.908314|2017-02-18 15:16:25.908314
NCT00529854|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2008-02-26|||October 2007||2007-10-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|SIC-IR||SIC-IR Billing and Documentation|Surgical and Trauma Intensive Care Unit Documentation and Billing Improvements With Medical Informatics|Completed||Phase 1|814|Actual|MetroHealth Medical Center|||2||f||||f||||||||||2017-02-18 15:16:26.027808|2017-02-18 15:16:26.027808
NCT00529841|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2015-09-10|||January 2007||2007-01-01|September 2015|2015-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia|A Novel Therapeutic Modality for Congenital Adrenal Hyperplasia|Completed||N/A|7|Actual|Baylor College of Medicine||1|||f||||f||||||||||2017-02-18 15:16:26.134701|2017-02-18 15:16:26.134701
NCT00529828|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2008-01-10|||September 2007||2007-09-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|CLARINeT||Health Effects of CLA Versus Industrial Trans Fatty Acids|Health Effects of CLA Versus Industrial Trans Fatty Acids in Healthy Volunteers (CLARINeT-Study)|Completed||N/A|60|Anticipated|Wageningen University||3|||f||||f||||||||||2017-02-18 15:16:26.277176|2017-02-18 15:16:26.277176
NCT00529815|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2010-02-24|||September 2007||2007-09-01|June 2009|2009-06-01|September 2010|Anticipated|2010-09-01|March 2010|Anticipated|2010-03-01||Interventional|CGM||Continuous Glucose Monitoring in Patients With Type 2 Diabetes|A Pilot Study to Determine the Impact of Real-Time Continuous Glucose Monitoring (CGM) on Patients With Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Walter Reed Army Medical Center||2|||f||||t||||||||||2017-02-18 15:16:26.373064|2017-02-18 15:16:26.373064
NCT00529802|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2010-08-12|||September 2007||2007-09-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer|An Exploratory Study Evaluating FDG-PET as a Predictive Marker for mTOR Directed Therapy With RAD001 in Metastatic Renal Cell Cancer|Completed||Phase 2|60|Anticipated|University of Chicago||2|||f||||t||||||||||2017-02-18 15:16:26.475259|2017-02-18 15:16:26.475259
NCT00529789|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2011-10-18|2009-09-22||August 2007||2007-08-01|October 2011|2011-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder|F1J-MC-HMFN (a) An Open-Label Study of Tolerability, Safety, and Pharmacokinetics of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder|Completed||Phase 2|72|Actual|Eli Lilly and Company|The Results Record was revised as a result of correcting identified errors in the number of participants with potentially significant changes in blood pressure.|1|||f||||f||||||||||2017-02-18 15:16:26.595606|2017-02-18 15:16:26.595606
NCT00529776|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2008-06-10|||September 2005||2005-09-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|||||Interventional|||Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy|Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy|Completed||N/A|150|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 15:16:27.179784|2017-02-18 15:16:27.179784
NCT00529763|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2016-06-20|2011-01-31||November 2007||2007-11-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|June 2009|Actual|2009-06-01||Interventional|||Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects|A Phase II Study to Determine the Activity of Dasatinib Administered Orally (PO) at a Dose of 100 mg Once Daily (QD) in Chronic Phase Chronic Myelogenous Leukemia (CML), at a Dose of 70 mg Twice Daily (BID) in Advanced Phase Chronic Myelogenous Leukemia (CML) Chinese Subjects Who Are Resistant to or Intolerant of Imatinib Mesylate (Gleevec®)|Active, not recruiting||Phase 2|121|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:16:27.302991|2017-02-18 15:16:27.302991
NCT00529750|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2011-01-11|||July 2002||2002-07-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension|Comparative Trial of the Effects of Irbesartan vs Atenolol on the Endothelial Function of Hypertensive Patients With Metabolic Syndrome|Completed||Phase 4|108|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:16:28.446233|2017-02-18 15:16:28.446233
NCT00529737|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2012-07-26|||December 2006||2006-12-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effect on Clip Markers After Vacuum-Assisted Biopsy by Postprocedure Mammogram|The Effect on Clip Markers Migration After Vacuum-Assisted Biopsy by Postprocedure Mammogram|Completed||N/A|61|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:16:28.530937|2017-02-18 15:16:28.530937
NCT00529724|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-01-18|||September 2007||2007-09-01|January 2011|2011-01-01|June 2009|Anticipated|2009-06-01|May 2009|Anticipated|2009-05-01||Interventional|||Body Weight Gain, Parkinson, Subthalamic Stimulation|Mechanisms of Body Weight Gain in Patients With Parkinson's Disease After Subthalamic Stimulation|Unknown status|Recruiting|Phase 2|32|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||f||||||||||2017-02-18 15:16:28.749382|2017-02-18 15:16:28.749382
NCT00529711|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2007-09-12|||July 2005||2005-07-01|September 2007|2007-09-01|July 2006|Actual|2006-07-01|||||Interventional|||The Efficacy of Hypertonic Lactate Solution in CABG(Coronary Artery Bypass Grafting) Patients|The Efficacy of Hypertonic Lactate Solution in CABG(Coronary Artery Bypass Grafting) Patients|Completed||Phase 3|66|Actual|Innogene Kalbiotech Pte. Ltd||2|||f||||f||||||||||2017-02-18 15:16:28.843224|2017-02-18 15:16:28.843224
NCT00529698|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-02-28|||January 2004||2004-01-01|July 2007|2007-07-01|November 2007|Actual|2007-11-01|||||Interventional|ISSP-001||Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein|A Phase I Safety and Immunogenicity Trial of Recombinant HIV-1 Tat Protein in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|20|Actual|Istituto Superiore di Sanità||2|||f||||t||||||||||2017-02-18 15:16:28.949969|2017-02-18 15:16:28.949969
NCT00529685|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2010-08-26|||||||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 15:16:29.070417|2017-02-18 15:16:29.070417
NCT00529672|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2010-11-15|||May 2007||2007-05-01|November 2010|2010-11-01|May 2011|Anticipated|2011-05-01|May 2011|Anticipated|2011-05-01||Interventional|Magna||Surgery or Noninvasive Therapy for Varicose Veins|Randomized Single Center Comparative Study of the Treatment of Insufficient Greater Saphenous Vein: Surgery vs Ultrasound Guided Sclerotherapy With Foam and Endovenous Laser Therapy|Unknown status|Recruiting|Phase 3|240|Anticipated|Erasmus Medical Center||3|||f||||f||||||||||2017-02-18 15:16:29.118104|2017-02-18 15:16:29.118104
NCT00529659|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2015-01-29|2012-04-06||October 2007||2007-10-01|January 2015|2015-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)|A Phase IIa Randomized, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0773 in Patients With Sarcopenia|Completed||Phase 2|170|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:16:29.227336|2017-02-18 15:16:29.227336
NCT00529646|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2008-12-29|||July 2007||2007-07-01|December 2008|2008-12-01||||||||Interventional|||Single-Dose Safety Study of APD791 in Healthy Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study to Assess the Tolerability, Pharmacokinetics, and Pharmacodynamics of APD791 Administered to Healthy Adult Subjects|Completed||Phase 1|90|Anticipated|Arena Pharmaceuticals|||||f||||f||||||||||2017-02-18 15:16:30.103205|2017-02-18 15:16:30.103205
NCT00529633|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2016-10-27|2016-03-25||September 2007||2007-09-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|ICM||The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients|Phase 3 Study: The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients|Terminated||Phase 3|16|Actual|University of California, Davis|Early termination -- Study is terminated due to low enrollment of subjects willing to enter this study|2||Low enrollment -- We could not recruit patients willing to be enrolled|f||||t||||||||No||2017-02-18 15:16:30.40131|2017-02-18 15:16:30.40131
NCT00529620|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2010-05-26|||September 2007||2007-09-01|May 2010|2010-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Three Alternative Drug Regimens for Malaria Seasonal Preventive Treatment in Senegal|Randomized Trial of Effectiveness and Acceptability of Three Alternative Regimens for Malaria Seasonal Intermittent Preventive Treatment in Senegal|Completed||Phase 3|1833|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-02-18 15:16:31.062364|2017-02-18 15:16:31.062364
NCT00529607|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2009-03-19|||September 2007||2007-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Diagnostics for the Reperfusion Injury Following MI|New Imaging and Diagnostic Techniques for the Assessment of Reperfusion Injury in Myocardial Infarction.|Completed||N/A|200|Anticipated|RWTH Aachen University|||3||f||||t||||||Samples Without DNA|"~     Biomarkers for Infarction and Inflammation~   "|||2017-02-18 15:16:31.175815|2017-02-18 15:16:31.175815
NCT00529594|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-13|||August 2006||2006-08-01|March 2007|2007-03-01|November 2006|Actual|2006-11-01|||||Interventional|||Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation|Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation|Completed||N/A|44|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 15:16:31.276771|2017-02-18 15:16:31.276771
NCT00529581|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2008-05-23|||November 2006||2006-11-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of C105 in Persons With Multiple Sclerosis With Cognitive Impairment|Completed||Phase 2|150|Anticipated|Cognition Pharmaceuticals, LLC|||||f||||f||||||||||2017-02-18 15:16:31.384544|2017-02-18 15:16:31.384544
NCT00529568|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2013-10-10|2012-04-19||October 2007||2007-10-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease|Randomised, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus (HCV) Infection Who Are Otherwise Eligible to Initiate Antiviral Therapy (Peginterferon Alfa-2b Plus Ribavirin)|Completed||Phase 3|759|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:16:31.532182|2017-02-18 15:16:31.532182
NCT00529555|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2014-04-10|2013-07-10||January 2006||2006-01-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Periocline as an Adjunct to Scaling and Root Planing for Adult Periodontitis|A 9 Month,3-arm Multicenter Clinical Trial of Treatment With Periocline Gel (2.1% Minocycline HCl) for Adjunctive Use to Scaling and Root Planing (SRP) in Adults With Periodontal Disease.|Completed||Phase 3|602|Actual|Sunstar Americas||3|||f||||f||||||||||2017-02-18 15:16:36.959836|2017-02-18 15:16:36.959836
NCT00529542|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2014-09-15|2013-02-15||December 2004||2004-12-01|September 2014|2014-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol|A Six-week Double Blinded, Randomized Trial of Atorvastatin for the Treatment of PCOS Women With Elevated LDL Cholesterol|Completed||Phase 2|20|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-02-18 15:16:37.480248|2017-02-18 15:16:37.480248
NCT00529529|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2011-08-25|2011-07-22||September 2007||2007-09-01|August 2011|2011-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma|A 26-week Treatment, Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group Study to Assess the Safety of Indacaterol (300 and 600 µg o.d.) in Patients With Moderate to Severe Persistent Asthma, Using Salmeterol (50 µg b.i.d.) as an Active Control|Completed||Phase 3|805|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:16:38.534485|2017-02-18 15:16:38.534485
NCT00529516|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2016-10-27|2012-04-26||October 2007||2007-10-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults|Observer Blind Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals Influenza Vaccine GSK576389A Administered to Adults Over 65 Years Previously Vaccinated With the Same Vaccine, Compared to Fluarix™|Completed||Phase 3|1252|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:16:39.709435|2017-02-18 15:16:39.709435
NCT00529503|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2015-02-06||2011-06-16|September 2007||2007-09-01|February 2015|2015-02-01|May 2011|Actual|2011-05-01|December 2009|Actual|2009-12-01||Interventional|||A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL|A Randomized Phase IIb Placebo-controlled Study of R-ICE Chemotherapy With and Without SGN-40 (Anti-CD40 Humanized Monoclonal Antibody) for Second-line Treatment of Patients With Diffuse Large B-Cell Lymphoma (DLBCL)|Terminated||Phase 2|151|Actual|Seattle Genetics, Inc.||2|||f||||t||||||||||2017-02-18 15:16:41.2473|2017-02-18 15:16:41.2473
NCT00529490|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2007-09-12|||March 2002||2002-03-01|September 2007|2007-09-01|June 2003|Actual|2003-06-01|||||Interventional|||Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats|The Efficacy and Safety of Hypertonic Lactate Solution as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG (Coronary Artery Bypass Grafting) Patients|Completed||Phase 3|230|Actual|Innogene Kalbiotech Pte. Ltd||2|||f||||f||||||||||2017-02-18 15:16:41.435428|2017-02-18 15:16:41.435428
NCT00529477|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2009-10-20|||September 2007||2007-09-01|October 2009|2009-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||The Effects Of Methacholine Challenge Administered Using Three Different Nebulizers On Small Airways Function|The Effects of Methacholine Challenge Administered Using Three Different Nebulizers on Small Airways Function|Completed||N/A|8|Actual|McMaster University||3|||f||||f||||||||||2017-02-18 15:16:41.546563|2017-02-18 15:16:41.546563
NCT00529464|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2016-04-05|2009-09-01||November 2006||2006-11-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Spectroscopy Versus Standard Care in Cervical Cancer Patients|A Randomized Trial of Spectroscopy Versus Standard Care in Cervical Intraepithelial Neoplasia|Terminated||Phase 3|2|Actual|M.D. Anderson Cancer Center|This study was terminated due to difficulty enrolling subjects.|3||Two participants enrolled, both inevaluable.|f||||t||||||||||2017-02-18 15:16:41.655265|2017-02-18 15:16:41.655265
NCT00529451|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2011-02-28|2010-12-16||September 2007||2007-09-01|February 2011|2011-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg|An Eight Week, Double-blind, Randomized, Multicenter, Parallel Group, Active-controlled Study Comparing the Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg to Ramipril 5 mg in Patients With Essential Hypertension|Completed||Phase 3|1613|Actual|Novartis||4|||f||||f||||||||||2017-02-18 15:16:41.933822|2017-02-18 15:16:41.933822
NCT00529438|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2014-11-04|||April 2006||2006-04-01|November 2014|2014-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies|A Phase I Dose-finding and Pharmacokinetic Study of RTA 402 (CDDOMe) Administered Orally for 21 Days of a 28-day Cycle in Patients With Advanced Solid Tumors or Lymphoid Malignancies|Completed||Phase 1|47|Actual|Reata Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 15:16:42.6831|2017-02-18 15:16:42.6831
NCT00529425|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2010-05-05|||January 2008||2008-01-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|||||Interventional|||Postoperative Analgesia With Local Infiltration After Femoral Neck Fracture|Postoperative Analgesia With Local Infiltration After Femoral Neck Fracture vs. Traditional Treatment of Pain With Opioids|Completed||Phase 4|50|Actual|Odense University Hospital||2|||f||||t||||||||||2017-02-18 15:16:42.794208|2017-02-18 15:16:42.794208
NCT00529412|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-13|||August 2003||2003-08-01|June 2007|2007-06-01|March 2007|Actual|2007-03-01|||||Interventional|||Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction|Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction in Patients With Gastric Cancer. A Randomized Clinical Trial|Completed||Phase 3|150|Actual|Nihon University||2|||f||||t||||||||||2017-02-18 15:16:42.906396|2017-02-18 15:16:42.906396
NCT00529399|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2016-10-15|2016-05-12||February 2009||2009-02-01|October 2016|2016-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects|Effects of Recombinant Human Glutamic Acid Decarboxylase (rhGAD65) Formulated in Alum (GAD-alum) on the Progression of Type 1 Diabetes in New Onset Subjects|Completed||Phase 2|145|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 15:16:43.022463|2017-02-18 15:16:43.022463
NCT00529386|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2011-09-13|||January 2006||2006-01-01|June 2009|2009-06-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)|A Prospective Pilot Randomized Sham Controlled Study to Evaluate the Safety and Efficacy of Botox™ for the Treatment of Men Diagnosed With Chronic Prostatitis/Chronic Pelvic Pain Syndrome|Completed||Phase 2|15|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 15:16:43.707096|2017-02-18 15:16:43.707096
NCT00529373|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2017-02-09|||September 2007||2007-09-01|February 2017|2017-02-01|February 2017|Actual|2017-02-01|November 2012|Actual|2012-11-01||Interventional|||A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)|A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium|Completed||Phase 3|16713|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:16:43.820734|2017-02-18 15:16:43.820734
NCT00529360|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-03-23|||June 2007||2007-06-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|January 2016|Actual|2016-01-01||Interventional|||Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL|Clofarabine in Combination With Cytarabine and Total Body Irradiation Followed by Allogeneic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia and Acute Non-Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|32|Actual|New York Medical College||2|||f||||t||||||||||2017-02-18 15:16:43.939551|2017-02-18 15:16:43.939551
NCT00529347|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2009-09-07|||September 2007||2007-09-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|||Mechanical Ventilation Controlled by the Electrical Activity of the Patient's Diaphragm - Effects of Changes in Ventilator Parameters on Breathing Pattern|The Effect of Positive End Expiratory Pressure (PEEP) on the Breathing Pattern During Neurally Adjusted Ventilatory Assist (NAVA)|Completed||Phase 1|20|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 15:16:44.054025|2017-02-18 15:16:44.054025
NCT00529334|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2013-11-19|||September 2007||2007-09-01|November 2013|2013-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|CK-PBI||A Pilot Study of CyberKnife Radiosurgery Delivered to the Partial Breast|A Pilot Study of CyberKnife Radiosurgery Delivered to the Partial Breast for Women With Stage 0, 1, or IIA (<=3cm) Breast Cancer|Withdrawn||N/A|0|Actual|Georgetown University||1||PI left institution|f||||t||||||||||2017-02-18 15:16:44.146988|2017-02-18 15:16:44.146988
NCT00529321|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2010-09-02|||December 2006||2006-12-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus|Open-label, Dose-escalating, Phase I Study of TG4040 (MVA-HCV) in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus (HCV Genotype 1)|Completed||Phase 1|42|Anticipated|Transgene||1|||f||||||||||||||2017-02-18 15:16:44.237744|2017-02-18 15:16:44.237744
NCT00529308|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2015-08-13|2012-11-13||July 2007||2007-07-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|TMS||Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome|Transcranial Magnetic Stimulation for Individuals With Tourette's Syndrome|Completed||Phase 2|20|Actual|Yale University||2|||f||||f||||||||||2017-02-18 15:16:44.341909|2017-02-18 15:16:44.341909
NCT00529295|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-13|||June 2005||2005-06-01|September 2006|2006-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term||Completed||Phase 3|220|Actual|China Medical University Hospital||2|||f||||f||||||||||2017-02-18 15:16:44.728048|2017-02-18 15:16:44.728048
NCT00529282|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2012-07-26|2010-01-26||October 2007||2007-10-01|July 2012|2012-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Ceftobiprole in Patients With Fever and Neutropenia.|Multicenter, Randomized, Double-Blind Study of Ceftobiprole Versus Comparators in the Treatment of Patients With Fever and Neutropenia|Terminated||Phase 3|2|Actual|Basilea Pharmaceutica|No analysis was performed due to early termination of the study.|2||Study discontinued due to administrative reasons unrelated to safety|f||||f||||||||||2017-02-18 15:16:44.838107|2017-02-18 15:16:44.838107
NCT00529269|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2011-11-01|||December 2006||2006-12-01|November 2011|2011-11-01||||June 2007|Actual|2007-06-01||Interventional|||Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms|Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal Symptoms|Completed||Phase 4|200|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:16:45.256367|2017-02-18 15:16:45.256367
NCT00529256|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2007-09-12|||December 2001||2001-12-01|April 2005|2005-04-01|April 2005|Actual|2005-04-01|||||Interventional|ESCMMP||Evaluation of Organisational Changes to Promote Smoking Cessation|Evaluation of Organisational Changes to Promote Smoking Cessation|Completed||N/A|87|Actual|Great Lakes Research Into Practice Network||1|||f||||t||||||||||2017-02-18 15:16:45.344421|2017-02-18 15:16:45.344421
NCT00529243|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2015-03-10|2011-05-09||September 2007||2007-09-01|March 2015|2015-03-01|September 2009|Actual|2009-09-01|July 2008|Actual|2008-07-01||Interventional|CHEER||Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects|Virologic Outcomes of Changing Enfuvirtide to Raltegravir in HIV-1 Patients Well Controlled on an Enfuvirtide Based Regimen|Completed||Phase 3|52|Actual|Kaiser Permanente|A limitation of our study was the lack of a separate control arm. However, patients did serve as their own control by virtue of at least 6 months of HIV-1 ribonucleic acid(RNA)levels below the level of quantification before enrollment in the study.|1|||f||||f||||||||||2017-02-18 15:16:45.437075|2017-02-18 15:16:45.437075
NCT00529230|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2012-07-31|||December 2001||2001-12-01|July 2012|2012-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes|Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes|Terminated||N/A|46|Actual|M.D. Anderson Cancer Center|||1|Low accrual rate.|f||||f||||||Samples Without DNA|"~     Blood draws to assess gonadal function.~   "|||2017-02-18 15:16:45.845645|2017-02-18 15:16:45.845645
NCT00529217|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2014-09-16|2012-12-13||May 2006||2006-05-01|November 2013|2013-11-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|TMS||Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)|Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)|Completed||Phase 2|10|Actual|New York State Psychiatric Institute||1|||f||||t||||||||||2017-02-18 15:16:45.959011|2017-02-18 15:16:45.959011
NCT00529204|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2014-12-22|2014-12-08||October 2007||2007-10-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|||Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease|Effects Of Exenatide (Byetta®) On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Non-Alcoholic Fatty Liver Disease|Terminated||Phase 2|1|Actual|University of California, Davis||1||Lack of recruitment|f||||t||||||||||2017-02-18 15:16:46.209844|2017-02-18 15:16:46.209844
NCT00529191|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2015-10-07|2012-12-20||July 2007||2007-07-01|October 2015|2015-10-01|July 2013|Actual|2013-07-01|July 2011|Actual|2011-07-01||Interventional|TIDM||Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)|Phase II, Double Blind, Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of Atorvastatin in Subjects With Newly Diagnosed Type 1 Diabetes Mellitus.|Completed||Phase 2|40|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-02-18 15:16:46.519735|2017-02-18 15:16:46.519735
NCT00529178|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2011-04-12||2011-04-12|December 2002||2002-12-01|April 2011|2011-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease|A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel Study to Determine the Efficacy and Safety of Pravastatin 80 mg Administered Once Daily to Hypercholesterolemic Subjects With Chronic, Well Compensated Liver Disease|Completed||Phase 4|232|Anticipated|Bristol-Myers Squibb|||||f||||t||||||||||2017-02-18 15:16:46.92314|2017-02-18 15:16:46.92314
NCT00529165|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2009-01-12|||July 2007||2007-07-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|||The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin||Completed||N/A|100|Anticipated|University of Jena||2|||f||||f||||||||||2017-02-18 15:16:47.159699|2017-02-18 15:16:47.159699
NCT00529152|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2009-08-25|2009-06-26||August 2007||2007-08-01|August 2009|2009-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients|A 24-Week, Open Label, Uncontrolled Study of the Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients With Transfusion-Dependent Anemia|Completed||Phase 3|100|Actual|ApoPharma||1|||f||||t||||||||||2017-02-18 15:16:47.270442|2017-02-18 15:16:47.270442
NCT00529139|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-13|2007-09-14|||July 2003||2003-07-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|||||Interventional|HAND-OUT||Hannover Dialysis Outcome Study|The Hannover-Dialysis-Outcome (HAN-D-OUT)-Study: Comparison of Standard Versus Intensified Extended Dialysis in Treatment of Patients With Acute Kidney Injury in the Intensive-Care Unit|Completed||Phase 4|157|Actual|Hannover Medical School||2|||f||||f||||||||||2017-02-18 15:16:47.532877|2017-02-18 15:16:47.532877
NCT00529126|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2013-07-03|2011-11-23||September 2007||2007-09-01|July 2013|2013-07-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy|A Phase 2 Multicenter, Randomized, Double-blind, Parallel-group, Active-control, Dose-ranging Study to Evaluate the Safety and Efficacy of a Single Administration of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy|Completed||Phase 2|100|Actual|Pacira Pharmaceuticals, Inc||4|||f||||f||||||||||2017-02-18 15:16:47.636241|2017-02-18 15:16:47.636241
NCT00529113|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2014-11-13||2011-06-06|September 2007||2007-09-01|November 2014|2014-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer|A Randomized Phase I/II Study With Gemcitabine and RTA 402 or Gemcitabine and Placebo for Patients With Unresectable Pancreatic Cancer|Terminated||Phase 1/Phase 2|33|Actual|Reata Pharmaceuticals, Inc.||9||To pursue other indications|f||||||||||||||2017-02-18 15:16:48.237244|2017-02-18 15:16:48.237244
NCT00529100|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2013-07-03|2011-08-23||December 2005||2005-12-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|August 2010|Actual|2010-08-01||Interventional||All participants who received study drug in Phase 1, Phase 1 and 2, or Phase 2.|Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer|A Phase I/II Study of Concurrent Pemetrexed/Cisplatin/Radiation in Stage IIIA/B Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|49|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:16:48.382299|2017-02-18 15:16:48.382299
NCT00529087|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2011-09-07|2009-12-24||August 2007||2007-08-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain|A Mulitcenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation in Subjects With Chronic Non-Malignant Pain|Completed||Phase 3|460|Actual|Valeant Pharmaceuticals International, Inc.||3|||f||||||||||||||2017-02-18 15:16:49.466049|2017-02-18 15:16:49.466049
NCT00529074|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-08-15|||February 2006||2006-02-01|May 2016|2016-05-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Epidural Anesthesia /Analgesia Versus PCA for Laparoscopic Complex Ventral Hernia Repair: A Randomized Controlled Trial|Epidural Anesthesia /Analgesia Versus PCA for Laparoscopic Complex Ventral Hernia Repair: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|University of Missouri-Columbia||1||never activated|f||||f||||||||||2017-02-18 15:16:50.914971|2017-02-18 15:16:50.914971
NCT00529061|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2016-07-11|||March 2005||2005-03-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|C-Data||Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])|Comprehensive Sickle Cell Centers Collaborative Data Project (C-Data)|Terminated||N/A|3640|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1|Funds for study ended September 30, 2008.|f||||t||||||||||2017-02-18 15:16:51.022799|2017-02-18 15:16:51.022799
NCT00529048|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2009-10-19|||October 2007||2007-10-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|||||Observational|||Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes|Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes Using Increasing Amounts of Oral Glucose Challenges|Completed||N/A|16|Actual|Herlev Hospital|||2||f||||f||||||Samples With DNA|"~     p-Glucose p-Glucagon p-insulin p-c-pep. p-GLP-1 p-GIP Buffy coat s-paracetamol~   "|||2017-02-18 15:16:51.135752|2017-02-18 15:16:51.135752
NCT00529035|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-08-01|2012-08-09||August 2007||2007-08-01|August 2016|2016-08-01|August 2017|Anticipated|2017-08-01|June 2011|Actual|2011-06-01||Interventional|||Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease|A Phase I Study of Ultra-Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host Disease|Active, not recruiting||Phase 1|29|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:16:51.262931|2017-02-18 15:16:51.262931
NCT00529022|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2013-02-19|||August 2007||2007-08-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer|Phase I Trial of Sequential Azacitidine and Valproic Acid Plus Carboplatin in the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer|Completed||Phase 1|36|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:16:51.629117|2017-02-18 15:16:51.629117
NCT00527241|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2012-02-08|||November 2006||2006-11-01|February 2012|2012-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy Trial of Raices Nuevas|Efficacy Trial of Raices Nuevas|Completed||Phase 2/Phase 3|160|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 15:16:51.75451|2017-02-18 15:16:51.75451
NCT00527228|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-08-31|||September 2003||2003-09-01|August 2015|2015-08-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|||Deflazacort in Dysferlinopathies|Deflazacort in Dysferlinopathies (LGMD2B/MM) - a Double Blind, Placebo-controlled Clinical Study|Completed||Phase 2/Phase 3|25|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-02-18 15:16:51.853779|2017-02-18 15:16:51.853779
NCT00527215|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2009-05-21|||March 2002||2002-03-01|May 2009|2009-05-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Phase 2 Study of Darbepoetin Alfa Extended Dosing|A Study of Darbepoetin Alfa Administered Once Every Four Weeks in Chronic Renal Insufficiency (CRI) Subjects With Anemia|Completed||Phase 2|98|Actual|Amgen||1|||f||||||||||||||2017-02-18 15:16:51.97941|2017-02-18 15:16:51.97941
NCT00527202|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2007-09-07|||June 2004||2004-06-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Efficacy Study of Botox to Treat Neuropathic Pain|Randomized Placebo-Controlled Study of the Efficacy of Botulinum Toxin Type A (Botox) in Spontaneous Pain and Allodynia Related to Traumatic Nerve Injury or Postherpetic Neuralgia|Completed||Phase 4|29|Actual|Hospital Ambroise Paré Paris||2|||f||||f||||||||||2017-02-18 15:16:52.074569|2017-02-18 15:16:52.074569
NCT00527189|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2007-09-07|||January 2006||2006-01-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Balance Impairment and Falls Risk in People With Lower Limb Arthritis, and Can These be Improved With Exercise?|Which Measures of Balance Best Discriminate Balance Impairment and Falls Risk in People With Lower Limb Arthritis, and Can These be Improved With Exercise?|Completed||N/A|||National Ageing Research Institute, Australia|||||f||||f||||||||||2017-02-18 15:16:52.173376|2017-02-18 15:16:52.173376
NCT00527176|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2007-09-07|||September 2007||2007-09-01|September 2007|2007-09-01|September 2007||2007-09-01|||||Observational|||Pulse Corticosteroid Therapy and Effect on Brain Water Diffusivity||Unknown status|Recruiting|N/A|||Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||||f||||t||||||||||2017-02-18 15:16:52.264217|2017-02-18 15:16:52.264217
NCT00527163|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2017-01-24|||September 4, 2007||2007-09-04|March 30, 2015|2015-03-30|March 30, 2015||2015-03-30|||||Observational|||Role of Nitric Oxide in Malaria|Role of Nitric Oxide Scavenging by Plasma Hemoglobin and Identification of Hemolysis-Associated Pulmonary Hypertension in Malaria|Completed||N/A|650|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:16:52.350623|2017-02-18 15:16:52.350623
NCT00527150|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2010-01-07|||October 2007||2007-10-01|January 2010|2010-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers|A Phase 1, Investigator And Subject Blind (Sponsor Open), Randomized, Placebo Controlled, Parallel Group, Multiple Dose Escalation Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Varenicline Amt-8 Controlled Release Formulation In Adult Smokers|Completed||Phase 1|48|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 15:16:52.460989|2017-02-18 15:16:52.460989
NCT00527137|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2013-05-06|||August 2000||2000-08-01|May 2013|2013-05-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||NESP Pediatric Study|An Open-label, Randomized, Non-inferiority Study of Novel Erythropoiesis Stimulating Protein (NESP) and Recombinant Human Erythropoietin (rHuEPO) for the Treatment of Anemia in Pediatric Subjects With Chronic Renal Insufficiency (CRI) or End-stage Renal Disease (ESRD) Receiving Dialysis|Completed||Phase 3|120|Anticipated|Amgen||2|||f||||||||||||||2017-02-18 15:16:52.571769|2017-02-18 15:16:52.571769
NCT00527124|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2015-03-25|2013-07-09||November 2007||2007-11-01|August 2014|2014-08-01|November 2013|Actual|2013-11-01|July 2012|Actual|2012-07-01||Interventional|||Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|A Randomized, Phase II Trial of AZD2171, Docetaxel, and Prednisone Compared to Docetaxel and Prednisone in Patients With Metastatic, Hormone Refractory Prostate Cancer|Terminated||Phase 2|57|Actual|National Cancer Institute (NCI)|Closure was recommended by CTEP due to slow accrual.|2||Closure was recommended by CTEP due to slow accrual.|f||||t||||||||||2017-02-18 15:16:52.670645|2017-02-18 15:16:52.670645
NCT00529009|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2010-05-05|||May 2007||2007-05-01|May 2010|2010-05-01||||||||Interventional|||Pharmacokinetic Investigation of UDCA in Bile and Serum||Completed||Phase 1|||Dr. Falk Pharma GmbH|||||f||||f||||||||||2017-02-18 15:16:53.240454|2017-02-18 15:16:53.240454
NCT00528996|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-12|2014-04-30||2014-04-30|September 2007||2007-09-01|April 2014|2014-04-01||||May 2009|Actual|2009-05-01||Interventional|||An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.|A Multinational, Randomised, Double-blind, Placebo- and Active-controlled, Parallel Group Efficacy and Safety Comparison Over 24 Weeks of Three Doses (50µg, 100µg, 200µg) of BEA 2180 BR to Tiotropium 5µg, Delivered by the Respimat Inhaler and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|2080|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:16:53.454744|2017-02-18 15:16:53.454744
NCT00528983|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-12-05|||September 2007||2007-09-01|December 2016|2016-12-01|April 2016|Actual|2016-04-01|July 2013|Actual|2013-07-01||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia|A Phase 1, Open-label, Dose-Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myelogenous Leukemia (AML).|Completed||Phase 1|133|Actual|Celgene Corporation||2|||f||||f||||||||||2017-02-18 15:16:53.891593|2017-02-18 15:16:53.891593
NCT00528970|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2011-07-22||2009-12-14|August 2007||2007-08-01|July 2011|2011-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study Evaluating IV MOA-728 for the Treatment of POI In Subjects After Ventral Hernia Repair|A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of Post Operative Ileus After Ventral Hernia Repair|Completed||Phase 3|500|Actual|Valeant Pharmaceuticals International, Inc.||3|||f||||||||||||||2017-02-18 15:16:54.046083|2017-02-18 15:16:54.046083
NCT00528957|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2016-12-08|2012-02-15||December 2006||2006-12-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children|A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy|Active, not recruiting||Phase 3|97|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 15:16:54.266067|2017-02-18 15:16:54.266067
NCT00528944|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2015-07-02|||January 2006||2006-01-01|July 2015|2015-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Single-Breath Measurement Underestimates Ventilatory Volume According to Emphysema Severity|Single-Breath Measurement Underestimates Ventilatory Volume According to Emphysema Severity|Completed||N/A|73|Actual|Columbia University|||3||f||||f||||||||||2017-02-18 15:16:55.360604|2017-02-18 15:16:55.360604
NCT00528931|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-09-30|2010-09-24||September 2007||2007-09-01|September 2016|2016-09-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture|A Phase 1, Open-Label Study to Assess the Pharmacokinetics and Safety of a Single Injection of AA4500 0.58 mg in Subjects With Dupuytren's Contracture|Completed||Phase 1|16|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:16:55.459953|2017-02-18 15:16:55.459953
NCT00528918|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2014-07-23|||June 2007||2007-06-01|August 2007|2007-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|Apidra||Comparison of Apidra to Regular Insulin in Hospitalized Patients|Comparison of Apidra to Regular Insulin in Hospitalized Patients|Completed||N/A|300|Actual|Carl T. Hayden VA Medical Center||2|||f||||t||||||||||2017-02-18 15:16:55.772583|2017-02-18 15:16:55.772583
NCT00528905|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2008-11-21|||August 2007||2007-08-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|HALO||Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia|A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia|Completed||Phase 2|400|Anticipated|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:16:55.88349|2017-02-18 15:16:55.88349
NCT00528541|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2011-11-14|2011-11-14||September 2007||2007-09-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia||Completed||Phase 4|145|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:17:08.78105|2017-02-18 15:17:08.78105
NCT00528892|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2010-03-30|||January 2008||2008-01-01|May 2008|2008-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|SPIRAL||Switching From PI to RALtegravir in HIV Stable Patients|An Open-label, Randomized, 48-Week Study to Assess the Safety, Tolerability and Activity of Raltegravir When Replacing the Ritonavir-boosted PI Component of HAART in HIV-Infected Individuals With Viral Load Suppression on a Ritonavir-Boosted PI Containing Regimen.|Completed||Phase 3|282|Actual|Hospital Clinic of Barcelona||2|||f||||t||||||||||2017-02-18 15:16:56.178235|2017-02-18 15:16:56.178235
NCT00528879|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2015-09-30|2014-02-06||September 2007||2007-09-01|September 2015|2015-09-01|May 2010|Actual|2010-05-01|November 2008|Actual|2008-11-01||Interventional||All randomized participants who received at least 1 dose of study medication|A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone|Completed||Phase 3|915|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 15:16:56.30372|2017-02-18 15:16:56.30372
NCT00528866|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2015-03-26|||April 2008||2008-04-01|March 2015|2015-03-01||||December 2013|Actual|2013-12-01||Interventional|||Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy|Adjuvant 3DCRT/IMRT in Combination With Androgen Suppression and Docetaxel for High Risk Prostate Cancer Patients Post-Prostatectomy: A Phase II Trial|Active, not recruiting||Phase 2|80|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 15:16:58.654239|2017-02-18 15:16:58.654239
NCT00528853|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2016-08-18|||August 2007||2007-08-01|August 2016|2016-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation|Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation. Can We Help Diagnose Acute Rejection and Better Predict Bronchiolitis Obliterans?|Completed||N/A|10|Actual|University of Chicago|||1||f||||f||||||||||2017-02-18 15:16:58.94165|2017-02-18 15:16:58.94165
NCT00528840|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-09-07|2010-09-24||October 2007||2007-10-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|October 2008|Actual|2008-10-01||Interventional|JOINT-I||Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease|A Phase 3, Open-Label Study of the Safety and Efficacy of AA4500 in the Treatment of Subjects With Advanced Dupuytren's Disease|Completed||Phase 3|201|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:16:59.038395|2017-02-18 15:16:59.038395
NCT00528827|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-03-15|||September 2007||2007-09-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension|A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With Hypertension|Withdrawn||Phase 2|0|Actual|Facet Biotech||4||"Due to the sale of Cardene IV, the sponsor has stopped enrollment and withdrawn the study. No~   safety issues were identified."|f||||t||||||||||2017-02-18 15:16:59.34791|2017-02-18 15:16:59.34791
NCT00528814|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2016-12-15|||January 2009||2009-01-01|December 2013|2013-12-01|May 2012|Actual|2012-05-01|May 2011|Actual|2011-05-01||Interventional|||Effectiveness of a School-Based Hand Sanitizer Program on Reducing Asthma Exacerbations|Effect of a School Based Hand Sanitizer Program on Asthma|Completed||N/A|527|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 15:16:59.456086|2017-02-18 15:16:59.456086
NCT00528801|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2010-05-12|2009-08-28||December 2004||2004-12-01|December 2009|2009-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease|Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Disease|Completed||N/A|212|Actual|National Heart, Lung, and Blood Institute (NHLBI)|As a cross-sectional study, follow-up of patients not included. Age range of cases and controls not weighted enough to include elder population. Functional or perfusion brain measures not included. Biologic and genetic risk factors not included.||2||f||||t||||||||||2017-02-18 15:16:59.568143|2017-02-18 15:16:59.568143
NCT00528788|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2016-01-20|2013-09-20||September 2007||2007-09-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis|Effect of Doxercalciferol on Endothelial Cell Function in End Stage Renal Disease|Completed||Phase 4|24|Actual|Duke University||1|||f||||t||||||||||2017-02-18 15:17:00.016836|2017-02-18 15:17:00.016836
NCT00528775|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2014-05-09|2014-05-09||August 2007||2007-08-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|November 2009|Actual|2009-11-01||Interventional||All treated and eligible patients|Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages|A Phase II Study of Photodynamic Therapy (PDT) Using 2-[1-hexyloxyethyl]-2 Devinyl Pyropheophorbide-a (HPPH) for Treatment of Advanced Obstructing Endobronchial Lung Cancer|Terminated||Phase 2|6|Actual|Roswell Park Cancer Institute|Due to the study’s early termination and inadequate number of patients, no patients were analyzed.|1||drug cannot be prepared commercially|f||||t||||||||||2017-02-18 15:17:00.252982|2017-02-18 15:17:00.252982
NCT00528762|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2012-07-26|||November 2006||2006-11-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Mexican and African American Family Focus Groups on Puberty|Mexican and African American Family Focus Groups on Puberty|Completed||N/A|37|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:17:03.122053|2017-02-18 15:17:03.122053
NCT00528749|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2007-09-11|||February 2007||2007-02-01|August 2007|2007-08-01||||||||Interventional|||Non-Invasive Measurement of Respiratory Effort|Non-Invasive Measurement of Respiratory Effort|Unknown status|Recruiting|N/A|20|Anticipated|Walter Reed Army Medical Center|||||f||||f||||||||||2017-02-18 15:17:03.222821|2017-02-18 15:17:03.222821
NCT00528736|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2007-09-12|||August 2005||2005-08-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Observational|||Plasma B-Type Natriuretic Peptide Concentrations in Preterm Infants < 28 Weeks||Completed||N/A|82|Actual|Charite University, Berlin, Germany|||||f||||f||||||||||2017-02-18 15:17:03.303482|2017-02-18 15:17:03.303482
NCT00528359|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2008-03-10|||October 2005||2005-10-01|March 2008|2008-03-01|February 2007|Actual|2007-02-01|||||Observational|SANAT||β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS|Phase 1 Study of Insulin Sensitivity, Adjusted β-Cell Function and Adiponectin Among Lean Drug-naïve Schizophrenic Subjects Treated With Atypical Antipsychotic Drugs|Completed||N/A|36|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||||||2017-02-18 15:17:17.834007|2017-02-18 15:17:17.834007
NCT00528723|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2010-04-21|||November 2007||2007-11-01|April 2010|2010-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma|Multicentre, Multinational, Randomised, Double Blind, Double Dummy, Active Drug Controlled, Parallel Group Study Design Clinical Trial of the Efficacy and Tolerability of Beclomethasone Dipropionate 250 Mcg Plus Salbutamol 100 Mcg in HFA pMDI Fixed Combination vs. Beclomethasone Dipropionate 250 Mcg Plus Salbutamol 100 Mcg in CFC pMDI (Clenil® Compositum 250) Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma|Completed||Phase 3|180|Anticipated|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-02-18 15:17:03.401526|2017-02-18 15:17:03.401526
NCT00528710|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2007-09-11|||November 2006||2006-11-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Efficacy of S-Adenosylmethionine in Fibromyalgia|Double-Blind, Placebo-Controlled Trial of the Impact of S-Adenosyl-L-Methionine (SAM-e) on the Mood and Other Symptoms in Fibromyalgia|Completed||Phase 2|70|Actual|Deakin University||1|||f||||f||||||||||2017-02-18 15:17:03.548847|2017-02-18 15:17:03.548847
NCT00528697|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2013-01-21||2011-08-18|September 2007||2007-09-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Dose-Ranging Study of the Safety and Efficacy of ABT-089 in Children With Attention Deficit-Hyperactivity Disorder (ADHD)|Completed||Phase 2|278|Actual|AbbVie||6|||f||||t||||||||||2017-02-18 15:17:03.640459|2017-02-18 15:17:03.640459
NCT00528684|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2014-09-30|||July 2006||2006-07-01|September 2011|2011-09-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas|A Phase I/II Clinical Trial to Evaluate Dose Limiting Toxicity and Efficacy of Intralesional Administration of REOLYSIN® for the Treatment of Patients With Histologically Confirmed Recurrent Malignant Gliomas|Completed||Phase 1|18|Actual|Oncolytics Biotech||1|||f||||t||||||||||2017-02-18 15:17:03.770738|2017-02-18 15:17:03.770738
NCT00528671|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2013-12-10|||January 2006||2006-01-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ESCAT III||Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications|Effects of Very Low Dose Oral Anticoagulation on Thromboembolism and Bleeding Events in Patients With Mechanical Heart Valve Replacement|Terminated||Phase 4|1571|Actual|Heart and Diabetes Center North-Rhine Westfalia||3|||f||||t||||||||||2017-02-18 15:17:04.109263|2017-02-18 15:17:04.109263
NCT00528658|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2009-01-28|||January 2005||2005-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Cost-Effectiveness of Two Painkillers for Treating Pain After Limb Injuries|Cost-Effectiveness Analysis of Oral Paracetamol and Ibuprofen for Treating Pain After Soft Tissue Limb Injuries: Double-Blind, Randomised Controlled Trial|Completed||Phase 2|783|Anticipated|Chinese University of Hong Kong||3|||f||||f||||||||||2017-02-18 15:17:04.247063|2017-02-18 15:17:04.247063
NCT00528645|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2014-05-29|2013-12-05||November 2007||2007-11-01|December 2012|2012-12-01|May 2013|Actual|2013-05-01|November 2008|Actual|2008-11-01||Interventional|||AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer|Phase II Study of the c-SRC Inhibitor AZD0530 After Four Cycles of Cytoreductive Chemotherapy for Patients With Extensive Stage Small Cell Lung Carcinoma|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:17:04.363615|2017-02-18 15:17:04.363615
NCT00528632|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2011-08-09|||March 2008||2008-03-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||Gallbladder Cholesterolosis, Body Mass Index and Serum Cholesterol and Triglycerides|Association of Gallbladder Cholesterolosis to Body Mass Index and Levels of Serum Cholesterol and Triglycerides.|Completed||N/A|406|Actual|Cirujanos la Serena|||2||f||||f||||||||||2017-02-18 15:17:04.63432|2017-02-18 15:17:04.63432
NCT00528619|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2011-04-07|||November 2006||2006-11-01|April 2011|2011-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors|Phase I Study Of SU011248 In Combination With Pemetrexed, Pemetrexed/Cisplatin And Pemetrexed/Carboplatin In Patients With Advanced Solid Malignancies|Completed||Phase 1|96|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:17:04.731605|2017-02-18 15:17:04.731605
NCT00528606|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-09-07|2010-09-24||August 2007||2007-08-01|July 2016|2016-07-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|CORD-I||AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture|A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of AA4500 in the Treatment of Subjects With Dupuytren's Contracture|Completed||Phase 3|308|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:17:04.849411|2017-02-18 15:17:04.849411
NCT00528593|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2011-08-08|||November 2007||2007-11-01|August 2011|2011-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Epoetin Alfa for HIV-Associated Neuropathy Trial|A Randomized, Multi-center Pilot Study to Evaluate the Efficacy and Safety of Epoetin Alfa (Procrit) in the Treatment of HIV-associated Sensory Neuropathy|Withdrawn||Phase 2|0|Actual|Washington University School of Medicine||1||lack of pharmaceutical support|f||||||||||||||2017-02-18 15:17:05.33066|2017-02-18 15:17:05.33066
NCT00528580|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2012-02-23|||February 2008||2008-02-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|March 2012|Anticipated|2012-03-01||Interventional|SETS||Statins for the Early Treatment of Sepsis|Statins for the Early Treatment of Sepsis|Unknown status|Active, not recruiting|Phase 2|250|Anticipated|University of Chicago||2|||f||||t||||||||||2017-02-18 15:17:05.437073|2017-02-18 15:17:05.437073
NCT00528567|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2015-08-05|2013-02-28||December 2007||2007-12-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|February 2012|Actual|2012-02-01||Interventional|||BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer|"An International Multi-centre Open-label 2-arm Phase III Trial of Adjuvant Bevacizumab in Triple Negative Breast Cancer."|Completed||Phase 3|2591|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:17:05.585642|2017-02-18 15:17:05.585642
NCT00528554|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2007-09-17|||September 2007||2007-09-01|September 2007|2007-09-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Laser Acupuncture Against Nausea in Children|Laser Acupuncture to Alleviate Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy. A Prospective, Double-Blinded, Placebo-Controlled Clinical Trial|Unknown status|Recruiting|N/A|25|Anticipated|University Children Hospital Homburg||2|||f||||f||||||||||2017-02-18 15:17:08.666296|2017-02-18 15:17:08.666296
NCT00528528|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2014-06-13|2013-03-18||October 2007||2007-10-01|June 2014|2014-06-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants|A Phase IIa Randomized, Open-Label Study of Telaprevir (VX-950) Administered Every 12 or Every 8 Hours in Combination With Either Peg-IFN alfa2a (Pegasys) and Ribavirin (Copegus) or Peg-IFN alfa2b (PegIntron) and Ribavirin (Rebetol) in Treatment-Naive Subjects With Chronic Genotype 1 Hepatitis C Infection|Completed||Phase 2|166|Actual|Tibotec BVBA||4|||f||||f||||||||||2017-02-18 15:17:09.610056|2017-02-18 15:17:09.610056
NCT00528515|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2008-05-15|||February 2007||2007-02-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Desflurane Versus Propofol Anesthesia for Off-Pump CABG|Comparison of Desflurane and Propofol Anesthesia for Off-Pump Coronary Artery Bypass Grafting Surgery|Completed||Phase 4|80|Actual|Medical University of Gdansk||2|||f||||f||||||||||2017-02-18 15:17:11.048421|2017-02-18 15:17:11.048421
NCT00528502|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2012-12-05|||June 2006||2006-06-01|December 2012|2012-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Lidocaine Supplement for Minimal Invasive Parathyroid Surgery|Prevention of Laryngeal Reflexes in Minimal Invasive Parathyroid Surgery by the Use of Topical Lidocaine|Withdrawn||Phase 3|0|Actual|M.D. Anderson Cancer Center||2||Terminated due to no patient enrollment.|f||||t||||||||||2017-02-18 15:17:11.166061|2017-02-18 15:17:11.166061
NCT00528489|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2013-08-06|||October 2007||2007-10-01|August 2013|2013-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of PENNVAX-B (Gag, Pol, Env) Given Alone, With IL-12 DNA, or With a Dose Escalation of IL-15 DNA, in Healthy, HIV-1-uninfected Adults Participants|Completed||Phase 1|120|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 15:17:11.271834|2017-02-18 15:17:11.271834
NCT00528476|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2007-09-11|||November 2004||2004-11-01|September 2007|2007-09-01|January 2007|Actual|2007-01-01|||||Observational|||Risk Factors for Recurrent Urinary Tract Infection in Children|Role of Clinical and Urodynamic Risk Factors for Recurrent Urinary Tract Infection in 5-18 Years Old Children|Completed||N/A|161|Actual|Kaunas University of Medicine|||2||f||||f||||||||||2017-02-18 15:17:11.397714|2017-02-18 15:17:11.397714
NCT00528463|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2010-02-01|||January 2005||2005-01-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Pre-emptive Sciatic Bloc to Prevent Lower Limb Phantom Pain|a Prospective Case Series of Pre-emptive Pre-amputation Sciatic Nerve Block to Prevent Lower Limb Phantom Pain|Completed||Phase 4|17|Actual|Université de Sherbrooke||1|||f||||f||||||||||2017-02-18 15:17:11.484022|2017-02-18 15:17:11.484022
NCT00528450|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2015-12-23|2015-12-23||September 2007||2007-09-01|December 2015|2015-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia|Phase II Study of Combined All-Trans Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy|Terminated||Phase 2|1|Actual|Memorial Sloan Kettering Cancer Center||1||Lack of accrual|f||||||||||||||2017-02-18 15:17:11.592236|2017-02-18 15:17:11.592236
NCT00528437|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2016-01-25|||October 2005||2005-10-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors|NYU 05-40 PBMTC ONC-032P:High Dose Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy With 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors|Completed||Phase 2|46|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 15:17:11.823211|2017-02-18 15:17:11.823211
NCT00528424|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-09-14|2010-09-24||December 2007||2007-12-01|August 2016|2016-08-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease|A Phase 3, Open-Label Extension Study of the Safety and Efficacy of AA4500 in the Treatment of Subjects With Advanced Dupuytren's Disease|Completed||Phase 3|286|Actual|Endo Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:17:11.955347|2017-02-18 15:17:11.955347
NCT00528411|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-01-12|2011-01-27||October 2007||2007-10-01|January 2012|2012-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin|A Multi-centre Randomised, Double-blind, Double-dummy Parallel Group Study of the Onset and Offset of Antiplatelet Effects of Ticagrelor Compared With Clopidogrel and Placebo With Aspirin as Background Therapy in Patients With Stable Coronary Artery Disease (CAD)|Completed||Phase 2|123|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:17:12.431895|2017-02-18 15:17:12.431895
NCT00528398|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2016-12-12|2016-12-12||September 1994||1994-09-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia|Phase II Trial Utilizing Idarubicin in Combination With High Dose Ara-C for Induction Therapy for Adult Acute Myelogenous Leukemia (AML)|Completed||Phase 2|111|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 15:17:14.001945|2017-02-18 15:17:14.001945
NCT00528385|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2007-09-11|||March 2005||2005-03-01|September 2007|2007-09-01||||||||Interventional|||Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System|Influence of Adding Aldosterone Receptor Blocker to Dual Renin-Angiotensin-Aldosterone System Blockade on Proteinuria|Completed||N/A|||Medical University of Gdansk|||||f||||||||||||||2017-02-18 15:17:14.290023|2017-02-18 15:17:14.290023
NCT00528372|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2015-09-30|2014-02-06||September 2007||2007-09-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|February 2009|Actual|2009-02-01||Interventional||Participants with hemoglobin AIc (HbA1c) concentration ≥7% and ≤10% at enrollment (Group 1) and those with a concentration of HbA1c ≥10.1% and ≤12% at enrollment (Group 2) who received at least 1 dose of study medication.|A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise|Completed||Phase 3|1067|Actual|AstraZeneca|Group 2 (patients with enrollment baseline HbA1c >10% and ≤2%) was an exploratory group, included to obtain initial efficacy and safety data. No comparator arm was included. Thus, only key safety and efficacy analyses were performed for Group 2.|9|||f||||f||||||||||2017-02-18 15:17:14.399002|2017-02-18 15:17:14.399002
NCT00528346|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2011-04-25|||September 2007||2007-09-01|April 2011|2011-04-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Treatment Of Chronic Pain Using Real Time fMRI|Treatment Of Chronic Pain Using Real-time Functional MRI Trial|Unknown status|Active, not recruiting|Phase 2|144|Anticipated|Omneuron||2|||f||||f||||||||||2017-02-18 15:17:18.145298|2017-02-18 15:17:18.145298
NCT00528333|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2014-12-17||2011-10-07|September 2007||2007-09-01|December 2014|2014-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML|A Phase IIB, Randomized, Double-Blinded, Placebo-Controlled Study of Low Dose Cytarabine and Lintuzumab Compared to Low Dose Cytarabine and Placebo in Patients 60 Years of Age and Older With Previously Untreated AML|Completed||Phase 2|211|Actual|Seattle Genetics, Inc.||2|||f||||t||||||||||2017-02-18 15:17:18.258168|2017-02-18 15:17:18.258168
NCT00528320|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2013-11-26||||||November 2013|2013-11-01||||||||Expanded Access|||Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System|Clinical Evaluation of Cardiac Resynchronization Therapy With Implantable Cardioverter-defibrillator Therapy|Approved for marketing||N/A|||ELA Medical, Inc.|||||||||||||||||||2017-02-18 15:17:18.392877|2017-02-18 15:17:18.392877
NCT00528307|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2014-11-04|||October 2007||2007-10-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|SOS||Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-refractory Atrial Fibrillation|Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-refractory Atrial Fibrillation|Terminated||N/A|5|Actual|R&D Cardiologie||2|||f||||f||||||||||2017-02-18 15:17:18.470289|2017-02-18 15:17:18.470289
NCT00528294|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2014-12-04|||February 2007||2007-02-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area|Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area|Unknown status|Active, not recruiting|Phase 1|12|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 15:17:18.568517|2017-02-18 15:17:18.568517
NCT00528281|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2012-05-31|||September 2007||2007-09-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|||A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase|A Single-arm, Two-stage Phase II Study of Lapatinib and Pemetrexed in the Second Line Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1|18|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:17:18.665349|2017-02-18 15:17:18.665349
NCT00528268|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2015-06-14|2015-06-14||July 2007||2007-07-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|STOPSMA||Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy|Prospective Phase I/II Study to Evaluate Effects of Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy|Completed||Phase 1/Phase 2|14|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 15:17:18.775171|2017-02-18 15:17:18.775171
NCT00528255|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-06-15||||||June 2012|2012-06-01||||||||Interventional|Miso-Obs-203||Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100)|A Multicenter, Open-Label, Phase II Study of the Pharmacokinetics and Safety of the100 Mcg Misoprostol Vaginal Insert (MVI 100) in Women Requiring Cervical Ripening and Induction of Labor|Withdrawn||Phase 2|0|Actual|Ferring Pharmaceuticals||1||PK portion will be included in a future protocol|f||||f||||||||||2017-02-18 15:17:19.231563|2017-02-18 15:17:19.231563
NCT00528242|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2015-01-26||2014-12-09|June 2007||2007-06-01|January 2015|2015-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease|A Randomized, Double Blind, Placebo-controlled, Cross-over Pilot Study to Examine the Safety, Tolerability and Pharmacodynamic Profile of Repeat Oral Doses of SLx-2101 Once Daily for up to 14 Days in Subjects With Secondary Raynaud's Disease.|Completed||Phase 2|17|Actual|Kadmon Corporation, LLC||2|||f||||f||||||||||2017-02-18 15:17:19.33982|2017-02-18 15:17:19.33982
NCT00527111|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2016-09-15|2016-01-12||February 2007||2007-02-01|September 2016|2016-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional||ITT population|Pre-op Rectal ChemoRad +/- Cetuximab|A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum|Completed||Phase 2|139|Actual|US Oncology Research||2|||f||||f||||||||||2017-02-18 15:17:19.438944|2017-02-18 15:17:19.438944
NCT00527098|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2013-02-20|2011-04-01||October 2007||2007-10-01|February 2013|2013-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Optimal Fluid Resuscitation for Trauma Patients|Optimal Fluid Resuscitation for Trauma Patients|Completed||N/A|119|Actual|University of Miami|||1||f||||f||||||||||2017-02-18 15:17:20.028784|2017-02-18 15:17:20.028784
NCT00527085|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2013-05-06|||October 2001||2001-10-01|May 2013|2013-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||12-month Study of AMG 073 in Renal Osteodystrophy|A Multicenter, Randomized, Placebo-controlled, Double-blind, 12-month Study to Assess the Effects of an Oral Calcimimetic Agent (AMG 073) on Renal Osteodystrophy in Hemodialysis Patients With Secondary Hyperparathyroidism|Completed||Phase 2|45|Anticipated|Amgen||2|||f||||||||||||||2017-02-18 15:17:20.359433|2017-02-18 15:17:20.359433
NCT00527072|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2012-08-28|2010-05-28||July 2007||2007-07-01|August 2012|2012-08-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Interventional|||PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept|A Multicenter, Open-label Study to Assess the Efficacy and Safety of Infliximab (REMICADE�) Therapy in Patients With Plaque Psoriasis Who Had an Inadequate Response to Etanercept (ENBREL�)|Completed||Phase 3|217|Actual|Centocor Ortho Biotech Services, L.L.C.||1|||f||||f||||||||||2017-02-18 15:17:20.454209|2017-02-18 15:17:20.454209
NCT00527059|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2007-09-07|||October 2007||2007-10-01|September 2007|2007-09-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure|Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure|Unknown status|Not yet recruiting|Phase 4|21|Anticipated|University of Roma La Sapienza||2|||f||||f||||||||||2017-02-18 15:17:20.87962|2017-02-18 15:17:20.87962
NCT00527046|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2012-01-30||2012-01-30|December 1999||1999-12-01|January 2012|2012-01-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults|A Randomized, Double Blind, Placebo Controlled, Five Parallel Group Study Of The Effect Of CP-424,391 On Physical Performance And Body Composition In Older Subjects|Terminated||Phase 2|396|Actual|Pfizer|||||||||||||||||||2017-02-18 15:17:20.978592|2017-02-18 15:17:20.978592
NCT00527033|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2017-02-14|||September 2007||2007-09-01|February 2017|2017-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of YM178 in Patients With Symptomatic Overactive Bladder|A Randomized, Double-blind, Parallel-group, Placebo-controlled Study in Patients With Symptomatic Overactive Bladder|Completed||Phase 2|842|Actual|Astellas Pharma Inc||4|||f||||f||||||||Yes|Details of the IPD sharing plan for this study can be found at www.clinicalstudydatarequest.com.|2017-02-18 15:17:21.078567|2017-02-18 15:17:21.078567
NCT00527020|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2017-02-01|||August 2007||2007-08-01|February 2011|2011-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||First Time in Human Study With GSK1018921|Single-Blind, Randomised, Placebo-controlled First Time in Human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Escalating Doses of GSK1018921 in Healty Volunteers and a Randomized, Double-blind, Double Dummy, Placebo Controlled, Three-way Crossover Study in a Separate Cohort of Healthy Volunteers to Test the Effect of Single Doses of GSK1018921 and Nicotine on qEEG and MMN in Healthy Volunteers|Completed||Phase 1|54|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:17:21.188136|2017-02-18 15:17:21.188136
NCT00527007|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2010-07-21|||October 2007||2007-10-01|August 2008|2008-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|sepsis-cool||External Cooling in Septic Shock Patients|Impact of External Cooling in Septic Shock Patients|Completed||N/A|200|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:17:21.300681|2017-02-18 15:17:21.300681
NCT00526994|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2013-07-29|2013-02-12||May 2008||2008-05-01|July 2013|2013-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Randomized Controlled Trial of Routine Screening for IPV|Randomized Controlled Trial of Routine Screening for Intimate Partner Violence|Completed||Phase 2/Phase 3|2700|Actual|Centers for Disease Control and Prevention|12% lost to follow-up differed in age, education, and insurance status from those retained. Generalizability of the findings is limited by the urban setting; exclusion of some participants.|3|||f||||f||||||||||2017-02-18 15:17:21.413943|2017-02-18 15:17:21.413943
NCT00526981|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2011-09-19|||September 2007||2007-09-01|September 2011|2011-09-01||||December 2011|Anticipated|2011-12-01||Interventional|||Prone Position for Non-intubated Patients With Acute Respiratory Failure|Prone Position for Non-intubated Patients With Acute Respiratory Failure|Unknown status|Recruiting|N/A|24|Anticipated|Karolinska University Hospital||2|||f||||f||||||||||2017-02-18 15:17:22.024689|2017-02-18 15:17:22.024689
NCT00526968|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2008-02-14|||September 2007||2007-09-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function|A Double Blind, Placebo Controlled Study to Investigate the Role of NMDA Receptor NR2B Subunit Selective Antagonism on Cognitive Functions and Neurophysiology in Healthy Subjects as Measured With MRI|Completed||Phase 1|19|Actual|Evotec Neurosciences GmbH||3|||f||||f||||||||||2017-02-18 15:17:22.125756|2017-02-18 15:17:22.125756
NCT00525941|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2015-04-23||2011-06-27|September 2007||2007-09-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||An Exploratory Study of NBI-34060 Capsules and Next Day Functioning|An Exploratory Phase IIIb, Single-Blind, Outpatient Study to Assess Next-Day Functioning in Adult Primary Insomnia Patients Following the Administration of NBI-34060 Capsules During the Night|Withdrawn||Phase 3|0|Actual|Neurocrine Biosciences||1||Study discontinued due to Approvable decision|f||||f||||||||||2017-02-18 15:17:22.226583|2017-02-18 15:17:22.226583
NCT00525928|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2015-07-20|||October 2007||2007-10-01|July 2015|2015-07-01|October 2008|Anticipated|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients|Assessment of Response to Open-label Treatment With Varenicline in Psychiatric Inpatients|Withdrawn||N/A|0|Actual|Butler Hospital||||insufficient recuirment|f||||||||||||||2017-02-18 15:17:22.317498|2017-02-18 15:17:22.317498
NCT00525915|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2015-01-27|2015-01-27||April 2005||2005-04-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Of the 126 randomized, 2 participants in Arm A declined therapy after randomization; and 13 (6 in Arm A and 7 in Arm B) experienced treatment failure before surgery leaving 55 in Arm A participants and 54 in Arm B who underwent surgery.|Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma|An Oxaliplatin-Based Phase II Randomized Study of Induction Chemotherapy Followed by Preoperative Chemoradiotherapy or Preoperative Chemoradiotherapy in Patients With Resectable Esophageal or Gastroesophageal Carcinoma|Completed||Phase 2|126|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:17:22.423065|2017-02-18 15:17:22.423065
NCT00525902|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2012-04-06|2012-02-03||January 2008||2008-01-01|April 2012|2012-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis|An Open-label, Multicenter, Phase II Trial of Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis|Completed||Phase 2|31|Actual|Oregon Health and Science University|2 had to discontinue for methodologic reasons (pregnancy, loss to follow up wk 42), leading to their classification as failures. As a three-center study, differences between the study population are possible.|1|||f||||||||||||||2017-02-18 15:17:23.070494|2017-02-18 15:17:23.070494
NCT00528229|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2007-09-11|||September 2007||2007-09-01|June 2007|2007-06-01||||||||Observational|||Multi-Slice CT of the Chest( MSCT Findings After Lung Transplantation)||Unknown status|Recruiting|N/A|||Rigshospitalet, Denmark|||||f||||t||||||||||2017-02-18 15:17:23.313476|2017-02-18 15:17:23.313476
NCT00528216|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2008-03-04||||||March 2008|2008-03-01||||||||Interventional|||Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function|A Randomized, Controlled, Single-Blind Study to Investigate the Effect of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function In Healthy Volunteers|Completed||Phase 1|20|Anticipated|NeurogesX|||||||||||||||||||2017-02-18 15:17:23.379734|2017-02-18 15:17:23.379734
NCT00528021|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2010-11-30|2009-02-20||August 2007||2007-08-01|November 2010|2010-11-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation|A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation|Completed||Phase 2|230|Actual|BTG International Inc.||4|||f||||f||||||||||2017-02-18 15:17:29.28603|2017-02-18 15:17:29.28603
NCT00528203|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2016-07-11|||August 2007||2007-08-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|Gen/Phen||Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)|Comprehensive Sickle Cell Centers (CSCC) Collaborative Genotype-Phenotype Database and Sample Repository|Terminated||N/A|3640|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1|Funds for study ended September 30, 2008.|f||||t||||||Samples With DNA|"~     Plasma, Lymphocytes, Whole blood, RBC hemolysate, DNA~   "|||2017-02-18 15:17:23.45277|2017-02-18 15:17:23.45277
NCT00528190|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2011-09-23|||October 2007||2007-10-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|August 2010|Actual|2010-08-01||Interventional|||Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis|Treatment of Aspergillus Fumigatus in Patients With Cystic Fibrosis: A Randomized, Double-blind, Placebo-Controlled Trial|Completed||Phase 4|60|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 15:17:23.551589|2017-02-18 15:17:23.551589
NCT00528177|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2011-07-03|||September 2007||2007-09-01|June 2007|2007-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Morphine vs. Oxycodone for Postoperative Pain Management|Phase 4: A Comparison of Intravenous Administration of Morphine vs. Oxycodone for Postoperative Pain Management Following Laparoscopic Hysterectomy or Myomectomy|Completed||Phase 4|90|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 15:17:23.680906|2017-02-18 15:17:23.680906
NCT00528164|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2013-02-15|||September 2006||2006-09-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|Team PLAY||Team PLAY (Positive Lifestyles for Active Youngsters)|Treating Childhood Obesity With Family Lifestyle Change|Completed||Phase 2/Phase 3|270|Actual|University of Tennessee||2|||f||||t||||||||||2017-02-18 15:17:23.788992|2017-02-18 15:17:23.788992
NCT00528151|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2012-12-20|||May 2005||2005-05-01|August 2004|2004-08-01|December 2007|Actual|2007-12-01|||||Interventional|||A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)|A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)|Completed||Phase 3|70|Anticipated|Mahidol University||1|||f||||t||||||||||2017-02-18 15:17:23.892045|2017-02-18 15:17:23.892045
NCT00528138|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2009-11-09|||October 2007||2007-10-01|November 2009|2009-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation|Prospective Study Comparing Hyperbilirubinemia, CRP, White Blood Cell Count, and Other Clinical Parameters for the Preoperative Diagnosis of Perforated Acute Appendicitis|Completed||N/A|132|Actual|Cirujanos la Serena|||2||f||||f||||||||||2017-02-18 15:17:23.991243|2017-02-18 15:17:23.991243
NCT00528125|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2008-03-19|||September 2007||2007-09-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Laser Acupuncture for Pain Prevention in Neonates|Laser Acupuncture for Pain Prevention in Neonates Undergoing Heel Prick. A Prospective, Randomized, Double-Blinded Clinical Trial|Completed||N/A|50|Anticipated|University Children Hospital Homburg||2|||f||||f||||||||||2017-02-18 15:17:24.095182|2017-02-18 15:17:24.095182
NCT00528112|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-11|2016-12-01|2012-07-11||August 2007||2007-08-01|December 2016|2016-12-01|June 2013|Actual|2013-06-01|July 2011|Actual|2011-07-01||Interventional|||Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study|Multi-Center, Open-Label, Randomized Study to Assess the Safety and Contraceptive Efficacy of Two Doses ( in vitro12 µg/24h and 16 µg/24h) of the Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) for a Maximum of 3 Years in Women 18 to 35 Years of Age and an Extension Phase of the 16µg/24h Dose Group (LCS16 Arm) up to 5 Years|Completed||Phase 3|2885|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:17:24.321356|2017-02-18 15:17:24.321356
NCT00528099|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2009-07-22|||October 2007||2007-10-01|July 2009|2009-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study Evaluating IMA-026 in Healthy Japanese Males|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IMA-026 Administered Subcutaneously or Intravenously to Healthy Japanese Male Subjects|Completed||Phase 1|50|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 15:17:28.379107|2017-02-18 15:17:28.379107
NCT00528086|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2010-05-24|||September 2007||2007-09-01|May 2010|2010-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|GROUP-PD||A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson's Disease|A Single Center, Randomized Controlled, Pilot Study Comparing Group Visits Versus Routine Clinical Care for Participants With Parkinson's Disease (PD).|Completed||N/A|40|Anticipated|University of Rochester|||2||f||||t||||||||||2017-02-18 15:17:28.460784|2017-02-18 15:17:28.460784
NCT00528073|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2010-02-19|||September 2007||2007-09-01|February 2010|2010-02-01|October 2009|Actual|2009-10-01|March 2009|Actual|2009-03-01||Interventional|||Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease|A Phase II, Multicentre, Double-blind, Randomised, Dose Range Finding Placebo Controlled Study of Rifaximin-EIR Tablet: Clinical Effectiveness and Tolerability in the Treatment of Moderate, Active Crohn's Disease|Completed||Phase 2|410|Actual|Alfa Wassermann S.p.A.||4|||f||||t||||||||||2017-02-18 15:17:28.57345|2017-02-18 15:17:28.57345
NCT00528060|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2011-12-21|||January 2008||2008-01-01|December 2011|2011-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|ANRS134COPHAR3||Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada|Pilot Study to Measure Exposure to Atazanavir, as a Component of Pharmacokinetic Parameters and Adherence Measured With MEMS in Naive HIV-infected Patients Treated Once Daily With Atazanavir Combined to Ritonavir and to Tenofovir/Emtricitabine. ANRS 134 Cophar 3|Completed||Phase 2|35|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-02-18 15:17:28.960145|2017-02-18 15:17:28.960145
NCT00528047|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2012-01-03|||August 2007||2007-08-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|March 2011|Actual|2011-03-01||Interventional|||Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors|A Phase I, Multi-center, Open-Label, Dose-Escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of PRLX 93936 Administered Intravenously Daily for Five Days Followed by a 23-Day Rest Period in Patients With Advanced Solid Tumors|Completed||Phase 1|37|Actual|Prolexys Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:17:29.069077|2017-02-18 15:17:29.069077
NCT00528034|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-07-31|||September 2002||2002-09-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Lymphoscintigraphy in Patients With Vaginal Cancer|Lymphoscintigraphy and Selective Lymphatic Mapping in Patients With Invasive Vaginal Cancer|Completed||N/A|14|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:17:29.172479|2017-02-18 15:17:29.172479
NCT00528008|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-11-08|||December 2007||2007-12-01|November 2012|2012-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections|Povidone-iodine vs. Chlorhexidine Gluconate - A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections|Terminated||Phase 3|268|Actual|Memorial University of Newfoundland||2||Study was stopped following interim analysis.|f||||f||||||||||2017-02-18 15:17:29.833583|2017-02-18 15:17:29.833583
NCT00527995|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2007-09-10|||August 2001||2001-08-01|September 2007|2007-09-01|June 2003|Actual|2003-06-01|||||Interventional|||Acute Effects of Sildenafil on Endothelial Function in People With Diabetes|Acute Effects of Sildenafil on Flow Mediated Dilatation and Cardiovascular Autonomic Nerve Function in Type 2 Diabetic Patients|Completed||Phase 3|40|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-02-18 15:17:29.94199|2017-02-18 15:17:29.94199
NCT00527982|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-12-04|2011-01-06||September 2005||2005-09-01|December 2012|2012-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer|Celecoxib as Adjuvant Biologic Therapy in Patients With Early Stage Head and Neck and Lung Cancer|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||2||Termination due to poor accrual.|f||||f||||||||||2017-02-18 15:17:30.033741|2017-02-18 15:17:30.033741
NCT00527969|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2008-03-10|||July 2007||2007-07-01|March 2008|2008-03-01||||||||Interventional|REMEMBER-fX||Cognitive, Emotional, Physical and Psychosocial Effects of Panax Quinquefolius L|Cognitive, Emotional, Physical, and Psychosocial Effects of Three Weeks' Prospective Double-Blind Placebo Controlled Cross-Over Exposure to Panax Quinquefolius L (REMEMBER-fX), With Optional Six Months' Open Label Follow-up|Completed||Phase 2|72|Anticipated|Afexa Life Sciences Inc||2|||f||||f||||||||||2017-02-18 15:17:30.357384|2017-02-18 15:17:30.357384
NCT00527956|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2008-06-06|||September 2007||2007-09-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|||||Observational|||Facilitation and Barriers to Breastfeeding in the NICU||Completed||N/A|8|Anticipated|McGill University Health Center|||||f||||f||||||||||2017-02-18 15:17:30.439264|2017-02-18 15:17:30.439264
NCT00527943|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2015-10-08|2014-05-09||December 2007||2007-12-01|October 2015|2015-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER)|Terminated||Phase 3|12944|Actual|Merck Sharp & Dohme Corp.|Prior to the planned study completion, the Data Safety Monitoring Board recommended that all participants stop treatment and that the study be closed-out. The protocol-defined target number of primary efficacy endpoints had been reached by this time.|2||The trial was terminated at the request of the Data and Safety Monitoring Board.|f||||t||||||||||2017-02-18 15:17:30.542306|2017-02-18 15:17:30.542306
NCT00527930|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-08|2013-10-09|||September 2007||2007-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|TORCH||Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer|Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer (MBC) Previously Treated With or Resistant to an Anthracycline and Taxane|Completed||Phase 2|87|Actual|Seoul National University Hospital||1|||f||||f||||||||||2017-02-18 15:17:33.973335|2017-02-18 15:17:33.973335
NCT00527917|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2009-12-07|||September 2007||2007-09-01|December 2009|2009-12-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.|A Multi-Center, Randomized, Double-Blind, Parallel Group Evaluation of the Efficacy and Safety of Uracyst® (Intravesical Sodium Chondroitin Sulfate) Versus Vehicle Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.|Completed||Phase 2|65|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:17:34.070891|2017-02-18 15:17:34.070891
NCT00527904|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2010-08-27|2010-05-28||March 2007||2007-03-01|August 2010|2010-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)|A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 in Subjects Who Are at Risk for Developing NSAID-associated Ulcers|Completed||Phase 3|239|Actual|POZEN||1|||f||||t||||||||||2017-02-18 15:17:34.186884|2017-02-18 15:17:34.186884
NCT00527891|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-07-30|||June 2004||2004-06-01|July 2012|2012-07-01||||September 2007|Actual|2007-09-01||Observational|||Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions|Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions|Completed||Phase 1|16|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:17:34.458645|2017-02-18 15:17:34.458645
NCT00527878|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-08|2013-02-01|2013-02-01||September 2007||2007-09-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||All participants whether or not they were randomized.|Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome|A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study Assessing the Role of Pathogen-Specific IgE and Histamine Release in the Hyper-IgE Syndrome and the Effect of Ranitidine on Laboratory and Clinical Manifestations|Terminated||Phase 2|16|Actual|National Institutes of Health Clinical Center (CC)||2||Failure to enroll adequate patient numbers due to small number of eligible patients|f||||||||||||||2017-02-18 15:17:34.664823|2017-02-18 15:17:34.664823
NCT00527865|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2009-01-06|||October 2007||2007-10-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Single Dose Escalating Study of DAS181 in Adults|Study 181-1-06-01 - Phase 1A Clinical Study With DAS181: Double-Blind, Randomized, Placebo-Controlled, Single Dose Escalating Study in Healthy Adults|Completed||Phase 1|36|Anticipated|Ansun Biopharma, Inc.||4|||f||||||||||||||2017-02-18 15:17:35.050734|2017-02-18 15:17:35.050734
NCT00527852|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2007-09-10|||September 2007||2007-09-01|July 2007|2007-07-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Assessment of Flocked Swabs for the Identification of Group A Streptococcal Pharyngitis||Unknown status|Recruiting|N/A|400|Anticipated|Children's Hospital of Eastern Ontario||1|||f||||t||||||||||2017-02-18 15:17:35.166173|2017-02-18 15:17:35.166173
NCT00526162|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2009-04-21|2009-02-06||October 2007||2007-10-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|January 2008|Actual|2008-01-01||Interventional|||ConsultaTM CRT-D Clinical Evaluation Study|Clinical Study to Evaluate System Safety and Clinical Performance of the ConsultaTM CRT-D Device|Completed||N/A|83|Actual|Medtronic Bakken Research Center||1|||f||||f||||||||||2017-02-18 15:18:10.003809|2017-02-18 15:18:10.003809
NCT00527839|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2015-08-17|||April 2007||2007-04-01|August 2015|2015-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Hospital for Special Surgery Shoulder Arthroplasty Cohort|Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: HSS Shoulder Arthroplasty Cohort|Recruiting||N/A|250|Anticipated|Hospital for Special Surgery, New York|||1||f||||t||||||||||2017-02-18 15:17:35.416773|2017-02-18 15:17:35.416773
NCT00527826|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-10-25|2010-03-10||November 2007||2007-11-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV|A 12 Month Open-label Randomized Parallel Group Study to Investigate the Influence of Salmeterol Xinafoate/Fluticasone Propionate Either in Fixed Combination or Separately Via Diskus Inhalers on the Course of the Disease and Frequency of Exacerbations in Subjects With Severe and Very Severe COPD.|Completed||Phase 4|214|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 15:17:35.551634|2017-02-18 15:17:35.551634
NCT00527813|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2015-05-06|||January 2008||2008-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|Proseva||Effect of Prone Positioning on Mortality in Patients With Severe and Persistent Acute Respiratory Distress Syndrome|Effect of Prone Positioning on Mortality in Patients With Severe and Persistent Acute Respiratory Distress Syndrome|Completed||N/A|474|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 15:17:36.474305|2017-02-18 15:17:36.474305
NCT00527800|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2013-10-09|||August 2007||2007-08-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|TCC||Interactions Between HIV and Malaria in African Children|Interactions Between HIV and Malaria in African Children|Completed||Phase 3|351|Actual|University of California, San Francisco||4|||f||||f||||||||||2017-02-18 15:17:36.577897|2017-02-18 15:17:36.577897
NCT00527787|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2010-11-29|2010-05-27||September 2007||2007-09-01|November 2010|2010-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen|6-Month, Phase 3, Randomized, Double-blind, Parallel-group, Controlled, Multi-center Study Evaluate Gastric Ulcer Incidence Following Administration of PN400 or Naproxen in Subjects Who Are at Risk for Developing NSAID-associated Ulcers|Completed||Phase 3|434|Actual|POZEN||2|||f||||t||||||||||2017-02-18 15:17:36.696926|2017-02-18 15:17:36.696926
NCT00527774|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2016-05-04|||September 2007||2007-09-01|May 2016|2016-05-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Observational|||Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients|Impact of Hepatitis C Virus Infection on Insulin Resistance and Inflammatory Biomarkers in Patients With Maintenance Hemodialysis|Completed||N/A|200|Actual|St. Martin De Porress Hospital|||2||f||||t||||||Samples With DNA|"~     Check HCV viral load and genotype in first month and sixth month~   "|||2017-02-18 15:17:37.206036|2017-02-18 15:17:37.206036
NCT00527761|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-07-26|||August 2004||2004-08-01|July 2012|2012-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Taxotere/Temodar/Cisplatin Study in Melanoma Patients|Phase I Study of TTC (Taxotere/Temodar/Cisplatin) in Metastatic Melanoma Patients|Completed||Phase 1|23|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:17:37.294024|2017-02-18 15:17:37.294024
NCT00527748|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2016-07-01|||September 2007||2007-09-01|July 2016|2016-07-01|February 2012|Actual|2012-02-01|December 2011|Actual|2011-12-01||Interventional|||Foot and Ankle Range of Motion (Stretching) Apparatus|The Use of a New Foot and Ankle Range of Motion (Stretching) Apparatus in Subjects With Stiff Ankles|Terminated||N/A|26|Actual|University of Missouri-Columbia||2||PI no longer with the University of Missouri, the study will not be continued.|f||||f||||||||||2017-02-18 15:17:37.411034|2017-02-18 15:17:37.411034
NCT00527735|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2012-06-11|2012-02-23||February 2008||2008-02-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|October 2009|Actual|2009-10-01||Interventional|||Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)|A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination With Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer|Completed||Phase 2|334|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-02-18 15:17:37.538779|2017-02-18 15:17:37.538779
NCT00527722|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-08-01|2011-05-10||September 2005||2005-09-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of the Bio-Seal Biopsy Track Plug|A Prospective Randomized Multi-Centered Study and Efficacy Evaluation of the Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedures|Completed||Phase 2/Phase 3|77|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:17:41.064381|2017-02-18 15:17:41.064381
NCT00527709|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2014-02-01|||August 2006||2006-08-01|February 2014|2014-02-01||||August 2006||2006-08-01||Observational|||Hold Parameters on Likely Cardiovascular Depressant Medications|Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)|Unknown status|Active, not recruiting|N/A|||Hackensack University Medical Center|||||f||||||||||||||2017-02-18 15:17:41.367303|2017-02-18 15:17:41.367303
NCT00527696|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2016-01-08|||May 2008||2008-05-01|January 2016|2016-01-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Trial Comparing TVT SECUR System and Trans Vaginal Obturator Tape for Surgical Management of Stress Urinary Incontinence|Randomized Clinical Trial Comparing TVT SECUR System (TVT S) and Trans Vaginal Obturator Tape (TVT-O) for Surgical Management of Stress Urinary Incontinence|Terminated||Phase 3|106|Actual|University of Manitoba||2||statistical Significance was reached for primary outcome|f||||t||||||||||2017-02-18 15:17:41.444724|2017-02-18 15:17:41.444724
NCT00527683|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2008-04-07|||April 2007||2007-04-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence|Double-Blind, Randomized, Placebo- Controlled Trial of Vigabatrin for Short Term Abstinence From Cocaine in Cocaine Dependent Parolees|Completed||Phase 2|100|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-02-18 15:17:41.738706|2017-02-18 15:17:41.738706
NCT00527670|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2016-08-05|||August 2007||2007-08-01|August 2016|2016-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Pilot Study to Identify the Influence of Genetic Profile Aberrations on Patients With Recurrent Hernias|Pilot Study to Identify the Influence of Genetic Profile Aberrations on Patients With Recurrent Hernias|Terminated||N/A|41|Actual|University of Missouri-Columbia|||2|PI left institution|f||||f||||||Samples With DNA|"~     Tissue samples.~   "|No||2017-02-18 15:17:41.847211|2017-02-18 15:17:41.847211
NCT00527657|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2013-05-29|||February 2006||2006-02-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients|A Phase I Study of Temozolomide, Thalidomide, and Lomustine (TTL) in Patients With Metastatic Melanoma in the Brain|Completed||Phase 1|17|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:17:41.939795|2017-02-18 15:17:41.939795
NCT00527644|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2016-08-04|||July 2007||2007-07-01|August 2016|2016-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Clinical Evaluation of Spring-Type Laparoscopic Clip Technology|Clinical Evaluation of Spring-Type Laparoscopic Clip Technology|Completed||Phase 1|14|Actual|University of Missouri-Columbia||1|||f||||f||||||||||2017-02-18 15:17:42.169641|2017-02-18 15:17:42.169641
NCT00527631|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2007-09-07|||July 2006||2006-07-01|August 2007|2007-08-01|November 2012|Anticipated|2012-11-01|||||Interventional|OVAR-IMRT-01||Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer|Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer: Pilot Trial of a Phase I/II Study|Unknown status|Recruiting|Phase 1|8|Anticipated|Heidelberg University||1|||f||||f||||||||||2017-02-18 15:17:42.276203|2017-02-18 15:17:42.276203
NCT00527618|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2013-01-18|2012-06-26||December 2007||2007-12-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV|A Randomized, Open-label, Crossover Trial of the Effect of Dosing of Daily HSV-2 Suppressive Therapy on HSV Reactivation and Plasma HIV-1 Levels Among HIV-1/ HSV-2 Co-infected Persons|Completed||Phase 4|28|Actual|University of Washington|Our findings are limited by the high loss to follow up, which is especially problematic in cross-over studies.|2|||f||||f||||||||||2017-02-18 15:17:42.370457|2017-02-18 15:17:42.370457
NCT00527605|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-03-15|2010-02-22||October 2007||2007-10-01|May 2011|2011-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)|A Randomized, Double-blind, Placebo-controlled, Six-month Parallel-group Study to Assess Efficacy and Safety of Dutasteride 0.5mg Once Daily in Chinese Patients With Benign Prostatic Hyperplasia (BPH), Followed by a 12-month Open-label Treatment Phase|Completed||Phase 3|253|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:17:42.754511|2017-02-18 15:17:42.754511
NCT00527592|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-05-11|2009-11-13||May 2007||2007-05-01|May 2012|2012-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 4|54|Actual|Alcon Research|None specified.|2|||f||||f||||||||||2017-02-18 15:17:43.609184|2017-02-18 15:17:43.609184
NCT00527579|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-08|2017-01-24|||September 4, 2007||2007-09-04|November 26, 2013|2013-11-26|November 26, 2013|Actual|2013-11-26|November 26, 2013|Actual|2013-11-26||Interventional|||PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB|PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FBR|Completed||Phase 1|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:17:43.857321|2017-02-18 15:17:43.857321
NCT00527566|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2009-04-16|||September 2007||2007-09-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|MATOCSS||Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome|Mepolizumab As a Steroid Sparing Treatment Option in the Churg Strauss Syndrome|Unknown status|Active, not recruiting|Phase 1/Phase 2|10|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-02-18 15:17:43.955338|2017-02-18 15:17:43.955338
NCT00527553|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2008-12-30|||October 2007||2007-10-01|November 2008|2008-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The Effect of Eggs and Egg Products on Macular Pigment|The Effect of Modified Eggs and Egg Products on the Measurable Macular Pigment in Healthy Subjects|Completed||N/A|100|Actual|Maastricht University Medical Center||5|||f||||f||||||||||2017-02-18 15:17:44.069318|2017-02-18 15:17:44.069318
NCT00527540|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-08|2009-01-18|||February 2007||2007-02-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C|Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C|Completed||Phase 3|60|Anticipated|Tehran Hepatitis Center||1|||f||||t||||||||||2017-02-18 15:17:44.192837|2017-02-18 15:17:44.192837
NCT00527527|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-08|2011-10-07|||September 2007||2007-09-01|October 2011|2011-10-01||||January 2010|Actual|2010-01-01||Interventional|||Chiropractic Dosage for Lumbar Stenosis|Chiropractic Dosage for Lumbar Stenosis|Completed||Phase 2|60|Anticipated|National University of Health Sciences||4|||f||||t||||||||||2017-02-18 15:17:44.302561|2017-02-18 15:17:44.302561
NCT00527514|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2009-11-04|2009-05-05||September 2007||2007-09-01|November 2009|2009-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension|A Prospective, Open-label Study to Assess the Efficacy and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Subjects With Stage 1 and Stage 2 Hypertension|Completed||Phase 3|185|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 15:17:44.398893|2017-02-18 15:17:44.398893
NCT00527501|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2012-04-12|||August 2007||2007-08-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension|IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|136|Actual|Alcon Research|||||f||||f||||||||||2017-02-18 15:17:45.048632|2017-02-18 15:17:45.048632
NCT00527488|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2015-04-14|2010-08-16||October 2007||2007-10-01|April 2015|2015-04-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.|A Single-centre, Open-label, Randomised Explorative Pharmacokinetic/Pharmacodynamic Study of the Gonadotropin-releasing Hormone Receptor Antagonist Degarelix (FE 200486) in Patients With Benign Prostatic Hyperplasia.|Completed||Phase 2|52|Actual|Ferring Pharmaceuticals||4|||f||||f||||||||||2017-02-18 15:17:45.170109|2017-02-18 15:17:45.170109
NCT00527475|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-09|2013-06-05|2013-04-19||May 2007||2007-05-01|June 2013|2013-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|RAP||Ranibizumab and Reduced Fluence PDT for AMD|Ranibizumab and Reduced Fluence Photodynamic Therapy for Choroidal Neovascularization in Age Related Macular Degeneration|Completed||Phase 2|60|Actual|Texas Retina Associates||2|||f||||f||||||||||2017-02-18 15:17:46.246823|2017-02-18 15:17:46.246823
NCT00527462|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-10|2008-04-28|||September 2007||2007-09-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics|Mono-Center, Double-Blind, Cross-Over Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles Versus Filtered Air on Airway Inflammation Induced by Segmental Allergen Challenge in Asthmatics|Completed||N/A|15|Actual|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f||||||||||||||2017-02-18 15:17:46.736459|2017-02-18 15:17:46.736459
NCT00527449|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2010-01-14|||May 2006||2006-05-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|ETCat01||Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel|Neoadjuvant Chemotherapy With 3x Epirubicin/Docetaxel Followed by 3x Carboplatin/Docetaxel in Patients With Primary Breast Cancer|Completed||Phase 2|50|Actual|Klinikum Weissenfels||1|||f||||f||||||||||2017-02-18 15:17:46.823599|2017-02-18 15:17:46.823599
NCT00527436|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2007-09-06||||||September 2007|2007-09-01||||||||Interventional|||Fish Oil and Biomarkers of Cardiovascular Risk|Fish Oil and Biomarkers of Cardiovascular Risk|Unknown status|Not yet recruiting|N/A|||Penn State University|||||f||||t||||||||||2017-02-18 15:17:46.921245|2017-02-18 15:17:46.921245
NCT00527423|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2013-06-10|2012-11-02||August 2007||2007-08-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD|A Randomized, Single-Masked , Long-Term, Safety and Tolerability Study of Intravitreal VEGF Trap-Eye in Subjects With Neovascular Age-related Macular Degeneration|Completed||Phase 2|157|Actual|Regeneron Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:17:47.002832|2017-02-18 15:17:47.002832
NCT00527410|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2014-11-12|||October 2006||2006-10-01|November 2014|2014-11-01||||December 2008|Actual|2008-12-01||Interventional|LMD||A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis|A Phase I Safety and Pharmacokinetic Study of Intravenous RTA 744 Injection in Patients With Recurrent, Progressive or Refractory Neoplastic Meningitis|Terminated||Phase 1|9|Actual|Reata Pharmaceuticals, Inc.||1||Business Decision|f||||f||||||||||2017-02-18 15:17:47.527179|2017-02-18 15:17:47.527179
NCT00527397|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2009-10-05|2009-07-15||August 2007||2007-08-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes|An Open-Label, Uncontrolled Long-Term Safety Study Of CP-464,005 (Inhaled Insulin) In Japanese Patients With Type 1 Or Type 2 Diabetes|Terminated||Phase 3|24|Actual|Pfizer|As a result of Pfizer's decision (18 Oct 2007) to return the worldwide rights for CP-464,005 (insulin human [rDNA origin]) Inhalation Powder) to Nektar, from which Pfizer licensed inhaled insulin technology, it was decided to terminate this study.|3||See termination reason in detailed description.|f||||f||||||||||2017-02-18 15:17:47.626613|2017-02-18 15:17:47.626613
NCT00527384|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-04-13|||October 2007||2007-10-01|April 2015|2015-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Biomarker Analysis of Stress|Biomarker Signatures of Biological, Chemical, or Psychological Stress|Completed||N/A|50|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||f||||||||||2017-02-18 15:17:48.113469|2017-02-18 15:17:48.113469
NCT00527371|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2014-11-19|||January 2008||2008-01-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|February 2013|Actual|2013-02-01||Interventional|PVP||PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate|Prospective Controlled Trial Comparing Photoselective Vaporization of the Prostate (PVP-120W) to Transurethral Resection of the Prostate (TURP) for the Treatment of Benign Hyperplasia of the Prostate (BPH)|Completed||Phase 4|164|Actual|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-02-18 15:17:48.184605|2017-02-18 15:17:48.184605
NCT00527358|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2012-02-08|||September 2006||2006-09-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation of SAFER Latinos' Program to Prevent Youth Violence|Evaluation of SAFER Latinos' Program to Prevent Youth Violence|Completed||Phase 2/Phase 3|1400|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 15:17:48.303048|2017-02-18 15:17:48.303048
NCT00527345|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-04-13|||March 2005||2005-03-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Children's Exposures/Health Effects/Diesel Exhaust|Children's Exposure and Health Effects From Diesel Exhaust Before and After Switch of Schoool Bus Fleets|Completed||N/A|450|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||3||f||||f||||||||||2017-02-18 15:17:48.400027|2017-02-18 15:17:48.400027
NCT00527332|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2012-01-24|2011-11-14||March 2007||2007-03-01|January 2012|2012-01-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Effects of General Anesthesia and Spinal-Morphine Anesthesia on Recovery and Comfort After Benign Abdominal Hysterectomy|General Anesthesia Versus Spinal Anesthesia Combined With Intrathecal Morphine in Abdominal Hysterectomy for Benign Gynecological Diseases. A Randomized Open Controlled Study.|Completed||Phase 4|180|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-02-18 15:17:48.619223|2017-02-18 15:17:48.619223
NCT00527319|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2012-12-19|2012-11-08||January 2007||2007-01-01|December 2012|2012-12-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|VT-122||Regimen for the Treatment of Cachexia in Subjects With NSCLC|A Pilot Open Label Randomized Controlled Study to Evaluate the Dose Tolerance Safety and Efficacy of VT-122 Regimen for the Treatment of Cachexia in Subjects With Stage IV Non-Small Cell Lung Cancer|Completed||Phase 2|37|Actual|Vicus Therapeutics||3|||f||||t||||||||||2017-02-18 15:17:49.031799|2017-02-18 15:17:49.031799
NCT00527306|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2010-03-30|||December 2005||2005-12-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Prevention of Recurrent Aphthous Stomatitis Using Vitamins|Prevention of Recurrent Aphthous Stomatitis Using Vitamins|Completed||Phase 3|160|Actual|UConn Health||2|||f||||f||||||||||2017-02-18 15:17:49.60908|2017-02-18 15:17:49.60908
NCT00527293|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2015-08-21|||June 2007||2007-06-01|August 2015|2015-08-01|February 2015|Actual|2015-02-01|October 2010|Actual|2010-10-01||Interventional|||Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer|Partial Breast Irradiation for Patients Undergoing Breast Conservation Therapy for Early Stage Breast Cancer: A Pilot Study|Completed||Early Phase 1|29|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 15:17:50.282639|2017-02-18 15:17:50.282639
NCT00527280|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2014-01-10|||January 2007||2007-01-01|September 2007|2007-09-01|January 2014|Anticipated|2014-01-01|January 2014|Anticipated|2014-01-01||Interventional|||Face Reconstruction by Allotransplantation of Composite Tissues|Face Reconstruction by Allotransplantation of Composite Tissues|Unknown status|Active, not recruiting|Phase 2|5|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 15:17:50.400961|2017-02-18 15:17:50.400961
NCT00527267|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2009-01-22|||February 2002||2002-02-01|January 2009|2009-01-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects|A Phase 3 Study to Assess the Efficacy and Safety of an Oral Calcimimetic Agent (AMG 073) in Secondary Hyperparathyroidism of End Stage Renal Disease Treated With Hemodialysis|Completed||Phase 3|320|Anticipated|Amgen||2|||f||||||||||||||2017-02-18 15:17:50.502906|2017-02-18 15:17:50.502906
NCT00527254|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2007-09-07|||October 2003||2003-10-01|September 2007|2007-09-01|June 2005|Actual|2005-06-01|||||Interventional|||Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient||Completed||N/A|328|Actual|Province of Malaga Health Department||2|||f||||f||||||||||2017-02-18 15:17:50.608937|2017-02-18 15:17:50.608937
NCT00526955|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2008-08-06|||November 2007||2007-11-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||Duration and Force Variations in Applied Kinesiology Manual Muscle Testing|Duration and Force Variations in Applied Kinesiology Manual Muscle Testing|Completed||N/A|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 15:17:50.7038|2017-02-18 15:17:50.7038
NCT00526942|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2007-09-10|||August 2007||2007-08-01|September 2007|2007-09-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Behavioral and Physiological Effects of Visual Training|Computer-Based Cognitive Training in Normal Healthy Aging: Pilot Study of Behavioral and Physiological Effects of Visual Sweeps Training Exercise, 2-Arm Model|Unknown status|Recruiting|Phase 1/Phase 2|54|Anticipated|Posit Science Corporation||2|||f||||f||||||||||2017-02-18 15:17:50.784155|2017-02-18 15:17:50.784155
NCT00526929|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2009-05-21|||May 2000||2000-05-01|May 2009|2009-05-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Fixed Dose NESP Study in Subjects With CRI|A Pilot Study Evaluating Once Every Other Week Administration of Fixed Doses of Novel Erythropoiesis Stimulating Protein (NESP) to Subjects With Chronic Renal Insufficiency (CRI)|Completed||Phase 2|75|Anticipated|Amgen||1|||f||||||||||||||2017-02-18 15:17:50.900166|2017-02-18 15:17:50.900166
NCT00526916|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2017-01-24|||September 4, 2007||2007-09-04|September 5, 2014|2014-09-05|September 5, 2014|Actual|2014-09-05|||||Interventional|||PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28|PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28|Completed||Phase 1|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:17:50.994538|2017-02-18 15:17:50.994538
NCT00526903|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2016-03-04|||January 2009||2009-01-01|March 2016|2016-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Recurrent Abdominal Pain in Children|Recurrent Abdominal Pain in Children|Completed||Phase 2|168|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 15:17:51.294194|2017-02-18 15:17:51.294194
NCT00526890|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2015-01-08|2015-01-08||October 2006||2006-10-01|January 2015|2015-01-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|Concurrent Carboplatin, Paclitaxel and Selenomethionine in Combination With Radiation for Patients With Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II, Multi-Center Trial|Terminated||Phase 2|16|Actual|Roswell Park Cancer Institute||1||lack of efficacy|f||||t||||||||||2017-02-18 15:17:51.418405|2017-02-18 15:17:51.418405
NCT00526877|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2014-02-27|||July 2007||2007-07-01|February 2014|2014-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment|Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Schizoaffective Disorders, Who is Receiving Psychiatric Home-care Treatment, When Switching From Typical Depot or Oral Antipsychotics to Long-acting Risperidone Microspheres|Completed||Phase 4|31|Actual|Johnson & Johnson Taiwan Ltd||1|||f||||f||||||||||2017-02-18 15:17:51.75888|2017-02-18 15:17:51.75888
NCT00526864|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2015-09-21|||May 2007||2007-05-01|September 2015|2015-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand|Measuring Herpes Zoster and Post-Herpetic Neuralgia Associated Burden of Illness and Health Care Utilization and Costs in Thailand|Completed||N/A|180|Actual|Mahidol University|||3||f||||f||||||||||2017-02-18 15:17:51.864298|2017-02-18 15:17:51.864298
NCT00526851|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2014-02-04|||March 2007||2007-03-01|February 2014|2014-02-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Observational|||Oral Cancer Screening Among Nursing Home Dentists in Ohio|Oral Cancer Screening: Practices, Knowledge and Opinions of Ohio Nursing Home Dentists|Completed||N/A|37|Actual|Case Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 15:17:51.956343|2017-02-18 15:17:51.956343
NCT00526838|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-08-19|||September 2007||2007-09-01|August 2015|2015-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Advanced Malignancies|Terminated||Phase 1|84|Actual|Exelixis||2||Sponsor decision|f||||||||||||||2017-02-18 15:17:52.051258|2017-02-18 15:17:52.051258
NCT00526812|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-07|2014-11-05|||November 2005||2005-11-01|November 2014|2014-11-01||||December 2008|Actual|2008-12-01||Interventional|||A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas|A Phase I Dose-finding and Pharmacokinetic Study of Intravenous RTA 744 Injection in Patients With Recurrent or Refractory Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Anaplastic Mixed Oligo-astrocytoma (AOA), Glioblastoma Multiforme (GBM) or Gliosarcoma (GS), With or Without Concurrent Treatment With Enzyme-inducing Anticonvulsant Therapy|Completed||Phase 1|54|Actual|Reata Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 15:17:52.14743|2017-02-18 15:17:52.14743
NCT00526799|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2016-02-04|2015-12-15||September 2007||2007-09-01|February 2016|2016-02-01|August 2010|Actual|2010-08-01|January 2010|Actual|2010-01-01||Interventional|||Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer|A Phase I/II Study of Sorafenib in Combination With Topotecan for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer or Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN06-111|Terminated||Phase 1/Phase 2|30|Actual|Hoosier Cancer Research Network||2||Study closed to accrual due unfavorable interim analysis|f||||t||||||||No||2017-02-18 15:17:52.25702|2017-02-18 15:17:52.25702
NCT00526188|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-04-13|2009-10-05||August 2007||2007-08-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety of Primovist in Chinese Patients|A Multicenter, Open-label Phase III Study of the Efficacy and Safety of Primovist as a Contrast Agent for Enhanced MR Imaging of Focal Liver Lesions in Chinese Patients|Completed||Phase 3|234|Actual|Bayer||1|||f||||t||||||||||2017-02-18 15:18:09.382082|2017-02-18 15:18:09.382082
NCT00526786|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2014-03-12|||September 2007||2007-09-01|March 2014|2014-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|ICE||Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus|A Prospective, Multi-center, Longitudinal Cohort Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus (LCS Dysplasia)|Terminated||Phase 4|78|Actual|CSA Medical, Inc.||1||Business Reasons|f||||t||||||||||2017-02-18 15:17:53.132007|2017-02-18 15:17:53.132007
NCT00526773|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2010-10-11|||January 2007||2007-01-01|October 2010|2010-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Enhancing Heart Failure Self-Care|Enhancing Heart Failure Self-Care|Completed||N/A|50|Anticipated|Christiana Care Health Services||2|||f||||f||||||||||2017-02-18 15:17:53.251618|2017-02-18 15:17:53.251618
NCT00526760|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2015-06-29|||October 2007||2007-10-01|June 2015|2015-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects|A Phase 3, Open-Label Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects Requiring Greater Than 24 Hours of Continuous Sedation|Completed||Phase 3|80|Actual|Hospira, Inc.||1|||f||||f||||||||||2017-02-18 15:17:53.476043|2017-02-18 15:17:53.476043
NCT00526747|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2013-04-09|||August 2007||2007-08-01|November 2008|2008-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Erythropoietin Resistance in Anemia of Chronic Kidney Disease|Novel Biomarkers of Erythropoietin Resistant Anemia Among Patients With Chronic Kidney Disease|Completed||N/A|32|Actual|Duke University|||2||f||||t||||||||||2017-02-18 15:17:53.588634|2017-02-18 15:17:53.588634
NCT00526734|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2013-08-09|||February 2006||2006-02-01|September 2007|2007-09-01||||||||Interventional|||High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma|A Randomised, International, Open-label, Phase II Study of Peripheral Blood Progenitor Cell (PBPC) Mobilization and Engraftment With Pegfilgrastim or Filgrastim for Autologous Transplantation in Patients With Multiple Myeloma (MM)|Unknown status|Recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:17:53.686916|2017-02-18 15:17:53.686916
NCT00526721|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2012-03-19|||May 2007||2007-05-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|REVORUTION||Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION|An Observational, Non-interventional, Multi-center Study to Evaluate Efficacy and Tolerability of High Dose Rosuvastatin in High Risk Patients After Titration|Completed||N/A|1482|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:17:53.79447|2017-02-18 15:17:53.79447
NCT00526708|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2010-11-30|||May 2007||2007-05-01|November 2010|2010-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|RUSH||Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )|RUSH (Evaluating the Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension in Real World Practice)|Completed||N/A|5000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:17:53.881709|2017-02-18 15:17:53.881709
NCT00526695|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2008-07-17|||January 2005||2005-01-01|July 2008|2008-07-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Effects of Sevoflurane in Subanesthetic Concentrations on the Forearm Perfusion|Effects of Sevoflurane in Subanesthetic Concentrations on the Forearm Perfusion, Leukocyte/Thrombocyte Activation, and Endothelial Function After Tourniquet-Induced Ischemia/Reperfusion Injury in the Forearm of Volunteers|Unknown status|Recruiting|Phase 4|10|Anticipated|University of Zurich||1|||f||||f||||||||||2017-02-18 15:17:53.974522|2017-02-18 15:17:53.974522
NCT00526682|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2007-09-06|||January 2007||2007-01-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||The Use of Irvingia Gabonensis (Bush Mango)and Cissus Quadrangularis to Reduce Weight and Blood Lipids|The Effect of Combining Cissus Quadrangularis and Irvingia Gabonensis on Obesity and Obesity Related Diseases|Completed||N/A|72|Actual|Gateway Health Alliance||1|||f||||t||||||||||2017-02-18 15:17:54.081105|2017-02-18 15:17:54.081105
NCT00526669|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-12-24|2012-02-16||March 2008||2008-03-01|July 2015|2015-07-01|January 2015|Actual|2015-01-01|April 2011|Actual|2011-04-01||Interventional|||Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib|An Exploratory, Phase II Trial to Determine the Association of Lapatinib Induced Fluoropyrimidine Gene Changes With Efficacy Parameters of Lapatinib and Capecitabine in First Line Gastric Cancer|Completed||Phase 2|68|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:17:54.237685|2017-02-18 15:17:54.237685
NCT00526656|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2012-06-14|||September 2007||2007-09-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||Sunitinib in Treating Patients With Locally Advanced Bladder Cancer|Phase II Single Arm, Open Label, Single Institution Study of Neoadjuvant Sunitinib (SUTENT) in Patients With Muscle-Invasive Locally Advanced Transitional Cell Carcinoma of the Bladder|Completed||Phase 2|9|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:17:58.935901|2017-02-18 15:17:58.935901
NCT00526643|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2016-01-13|||November 2007||2007-11-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|December 2012|Actual|2012-12-01||Interventional|CAPPA-2||CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients|Gemcitabine Versus Cisplatin and Gemcitabine in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer in Poor Physical Condition (Performance Status 2)|Suspended||Phase 3|57|Actual|National Cancer Institute, Naples||2|||f||||f||||||||||2017-02-18 15:17:59.052658|2017-02-18 15:17:59.052658
NCT00526630|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2015-04-13|2013-12-09||December 2007||2007-12-01|April 2015|2015-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease|Methylphenidate for the Treatment of Gain Impairment in Parkinson's Disease: a Randomized Double-Blind, Placebo-Controlled, Cross-over Study|Completed||Phase 4|23|Actual|University of Cincinnati||2|||f||||t||||||||||2017-02-18 15:17:59.184391|2017-02-18 15:17:59.184391
NCT00526617|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2012-01-12|||August 2007||2007-08-01|January 2012|2012-01-01||||June 2010|Actual|2010-06-01||Interventional|||A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients|A Phase I Study of ABT-888 in Combination With Temozolomide (TMZ) in Subjects With Non-Hematologic Malignancies (NHM) and Metastatic Melanoma (MM)|Completed||Phase 1|41|Actual|Abbott||1|||f||||f||||||||||2017-02-18 15:17:59.875416|2017-02-18 15:17:59.875416
NCT00526604|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2011-07-03|||January 2008||2008-01-01|December 2008|2008-12-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Work Related Rehabilitation in Patients With Low Back Pain|A Study on the Effect of Employment Follow-up on Return to Work in Sick Listed Patients With Low Back Pain|Terminated||Phase 3|260|Anticipated|Oslo University Hospital||1||The study was stopped, as the another multicentre-RCT on the same patients started.|f||||t||||||||||2017-02-18 15:17:59.992358|2017-02-18 15:17:59.992358
NCT00526591|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2012-06-14|||September 2007||2007-09-01|June 2012|2012-06-01||||July 2011|Actual|2011-07-01||Interventional|||Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer|Randomized Phase II Study of Two Different Doses of RAD-001 (Everolimus) as Neo-Adjuvant Therapy in Patients With Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|17|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 15:18:00.09821|2017-02-18 15:18:00.09821
NCT00526578|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2016-06-10|||June 2002||2002-06-01|June 2016|2016-06-01||||June 2018|Anticipated|2018-06-01||Observational|||Pancreatic Cancer Genetic Epidemiology (PACGENE) Study|Pancreatic Cancer Genetic Epidemiology (PACGENE) Study|Active, not recruiting||N/A|4770|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood sample will be collected.~   "|||2017-02-18 15:18:00.24403|2017-02-18 15:18:00.24403
NCT00526565|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2011-10-04|||January 2008||2008-01-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|LIFE||Randomized Trial of Tapas Acupressure for Weight Loss Maintenance|Randomized Trial of Tapas Acupressure for Weight Loss Maintenance|Completed||Phase 2/Phase 3|472|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 15:18:00.367997|2017-02-18 15:18:00.367997
NCT00526552|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2010-03-29|||June 2007||2007-06-01|March 2010|2010-03-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Observational|RAPID||Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)|RAPID (Evaluating the Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes in Real World Practice)|Completed||N/A|5000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:18:00.464678|2017-02-18 15:18:00.464678
NCT00526539|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2011-07-03||||||September 2007|2007-09-01||||||||Interventional|||Is There Increased Polyethylene Wear and Increased Periprosthetic Bone Loss in Femur in Reverse Hybrid Technique Compared With Conventional Cemented Technique in Total Hip Replacement?||Completed||N/A|||Oslo University Hospital|||||f||||||||||||||2017-02-18 15:18:00.550227|2017-02-18 15:18:00.550227
NCT00526513|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2010-09-10|||July 2007||2007-07-01|September 2010|2010-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|SCALE||Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus|Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus|Completed||Phase 4|188|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:18:00.623538|2017-02-18 15:18:00.623538
NCT00526500|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2008-11-10|||August 2006||2006-08-01|November 2008|2008-11-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||Effect of Passive Gait Training on the Cortical Activity in Patients With Severe Brain Injury.|Effect of Proprioceptive Stimulation With Passive Gait Training on the Cortical Activity in Patients With Impaired Consciousness Due to Severe Brain Injury.|Unknown status|Recruiting|Early Phase 1|60|Anticipated|University of Aarhus||4|||f||||f||||||||||2017-02-18 15:18:00.712829|2017-02-18 15:18:00.712829
NCT00526487|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2016-12-12|||December 2007||2007-12-01|December 2016|2016-12-01|September 2016|Actual|2016-09-01|July 2011|Actual|2011-07-01||Interventional|||Clinical Study to Assess Safety and Effectiveness of the Zenith® Dissection Endovascular System in Patients With Aortic Dissection|Evaluation of the Safety and Effectiveness Performance of the Zenith® Dissection Endovascular System in the Treatment of Patients With Aortic Dissection Involving the Descending Thoracic Aorta|Completed||N/A|60|Actual|Cook||1|||f||||f||||||||||2017-02-18 15:18:00.825289|2017-02-18 15:18:00.825289
NCT00526474|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-04-24|2014-05-16||September 2007||2007-09-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||The Intent to Treat (ITT) Population, defined as all enrolled participants who were randomly assigned to a treatment group.|Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P - TIMI 50)|Completed||Phase 3|26449|Actual|Merck Sharp & Dohme Corp.|Prior to the completion of the study, based on a communication from the Data and Safety Monitoring Board, all participants who had experienced a stroke either before or during the study had study drug discontinued.|2|||f||||t||||||||||2017-02-18 15:18:01.089416|2017-02-18 15:18:01.089416
NCT00526461|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2014-05-06|||February 2004||2004-02-01|May 2014|2014-05-01|April 2014|Actual|2014-04-01|June 2013|Actual|2013-06-01||Interventional|||Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer|A Phase I Study Light Dose for Photodynamic Therapy (PDT) Using 2-[1-hexyloxyethyl]-2 Devinyl Pyropheophorbide-a (HPPH) for Treatment of Non-Small Cell Carcinoma in Situ or Non-Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study|Completed||Phase 1|17|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 15:18:06.169251|2017-02-18 15:18:06.169251
NCT00526448|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2009-01-28|||June 2007||2007-06-01|January 2009|2009-01-01|February 2010|Anticipated|2010-02-01|||||Interventional|PERICO||Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients|Open, Multicentre,Randomized Phase IV Trial to Evaluate Efficacy/Safety to Extend Treatment Duration With Peginterferon Alfa-2a+High Dose of Ribavirin Supporting Epo β in Treatment of CHC in HIV-HCV Patients Who Not Clear Virus at Week 4|Unknown status|Recruiting|Phase 4|384|Anticipated|Hospital Carlos III, Madrid||2|||f||||t||||||||||2017-02-18 15:18:06.278621|2017-02-18 15:18:06.278621
NCT00526435|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2011-03-23|||October 2007||2007-10-01|March 2011|2011-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|WWE||Evaluation of Walk With Ease in Arthritis|Evaluation of the Walk With Ease Program Among People With Arthritis|Completed||Phase 3|468|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 15:18:06.424712|2017-02-18 15:18:06.424712
NCT00526422|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2011-06-14|||February 2006||2006-02-01|June 2011|2011-06-01|January 2007|Actual|2007-01-01|||||Observational|||DPBRN Assessment of Caries Diagnosis & Caries Treatment|Assessment of Caries Diagnosis & Caries Treatment|Completed||N/A|532|Actual|Dental Practice-Based Research Network|||1||f||||f||||||||||2017-02-18 15:18:06.520105|2017-02-18 15:18:06.520105
NCT00526409|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2014-10-27|||June 2005||2005-06-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|LAL-AR-N-2005||LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia|LAL-AR-N-2005: Study Treatment for Children High Risk Acute Lymphoblastic Leukemia|Completed||Phase 4|40|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:18:06.613432|2017-02-18 15:18:06.613432
NCT00526396|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-04-08|||September 2007||2007-09-01|April 2015|2015-04-01|July 2016|Anticipated|2016-07-01|January 2016|Anticipated|2016-01-01||Interventional|STAD-1||STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study|Multicenter Randomized Phase III Study Comparing Fixed Doses Versus Toxicity Adjusted Dosing of Cisplatin and Etoposide for Patients With Small Cell Lung Cancer.|Active, not recruiting||Phase 3|160|Anticipated|National Cancer Institute, Naples||2|||f||||f||||||||||2017-02-18 15:18:06.729795|2017-02-18 15:18:06.729795
NCT00526383|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2014-04-16|||November 2007||2007-11-01|September 2007|2007-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|METADAP||Do Antidepressants Induce Metabolic Syndromes METADAP Study|Do Antidepressants Induce Metabolic Syndromes|Completed||N/A|624|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:18:06.853418|2017-02-18 15:18:06.853418
NCT00526370|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2008-08-12|||August 2007||2007-08-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Observational|||Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests|Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests|Completed||Early Phase 1|72|Actual|University of Aarhus|||2||f||||f||||||Samples With DNA|"~     Tampon self-test from cervix~   "|||2017-02-18 15:18:06.972038|2017-02-18 15:18:06.972038
NCT00526357|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2012-03-15|||August 2007||2007-08-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With Asthma|The Effect of Dietary Supplementation With Encapsulated Fish Oil on Mannitol-induced Airway Sensitivity and Inflammation in Persons With Asthma|Completed||Phase 2|24|Actual|Firestone Institute for Respiratory Health||2|||f||||f||||||||||2017-02-18 15:18:07.063315|2017-02-18 15:18:07.063315
NCT00526344|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2011-02-10|||September 2007||2007-09-01|February 2011|2011-02-01|March 2011|Anticipated|2011-03-01|||||Observational|||Bronchoscopy With Bronchial Biopsies Sub-study of: Persistence of Airway Inflammation and Remodeling in Asthma Remission|Bronchoscopy and Bronchial Biopsies. Sub-study of: Characteristics of Asthma Remissions|Withdrawn||N/A|36|Anticipated|Laval University|||4|No funding, study not done|f||||f||||||Samples With DNA|"~     Tissue (bronchial biopsies)~   "|||2017-02-18 15:18:07.189084|2017-02-18 15:18:07.189084
NCT00526331|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2011-12-08|2011-12-08||August 2007||2007-08-01|December 2011|2011-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy|Randomized Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy|Completed||Phase 4|49|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:18:07.291093|2017-02-18 15:18:07.291093
NCT00526318|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2015-07-15|||January 2007||2007-01-01|July 2015|2015-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma|Trial Protocol for the Treatment of Children With High Risk Neuroblastoma (NB2004-HR)|Recruiting||N/A|360|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:18:07.521913|2017-02-18 15:18:07.521913
NCT00526305|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2010-01-03|||January 2000||2000-01-01|January 2010|2010-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive|LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive|Completed||Phase 4|100|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:18:07.865475|2017-02-18 15:18:07.865475
NCT00526292|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2016-01-14|2016-01-14||August 2007||2007-08-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant|Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant|Completed||Phase 2|12|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:18:08.02809|2017-02-18 15:18:08.02809
NCT00526279|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2010-11-30|||June 2007||2007-06-01|November 2010|2010-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|COMBAT||COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus|A Prospective, Non-interventional, Observational, Multi-center Trial to Evaluate Compliance and Efficacy in Mono and Combination Treatment of Candesartan Cilexetil(Atacand)/ Candesartan Cilexetil 16mg, Hydrochlorothiazide 12.5mg(Atacand Plus) in Hypertension|Completed||N/A|9000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:18:08.450068|2017-02-18 15:18:08.450068
NCT00526266|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-12-24|||September 2007||2007-09-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|June 2018|Anticipated|2018-06-01||Interventional|||Evaluating Physiological Markers of Emotional Trauma: A Randomized Controlled Comparison of Mind-Body Therapies|Evaluating Physiological Markers of Emotional Trauma: A Randomized Controlled Comparison of Mind-Body Therapies|Recruiting||N/A|35|Anticipated|Soul Medicine Institute||3|||f||||t||||||||||2017-02-18 15:18:08.537|2017-02-18 15:18:08.537
NCT00526253|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2017-01-30|||September 2007||2007-09-01|January 2017|2017-01-01||||February 2017|Anticipated|2017-02-01||Interventional|MARVEL||To Assess Safety and Efficacy of Myoblast Implantation Into Myocardium Post Myocardial Infarction|A Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)|Active, not recruiting||Phase 2/Phase 3|170|Anticipated|Bioheart, Inc.||3|||f||||t||||||||||2017-02-18 15:18:08.656251|2017-02-18 15:18:08.656251
NCT00526227|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2009-04-21|2009-01-13||October 2007||2007-10-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|December 2007|Actual|2007-12-01||Interventional|||SecuraTM ICD Clinical Evaluation Study|Clinical Study to Evaluate System Safety and Clinical Performance of the SecuraTM ICD|Completed||N/A|81|Actual|Medtronic Bakken Research Center||1|||f||||f||||||||||2017-02-18 15:18:08.803259|2017-02-18 15:18:08.803259
NCT00526214|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2016-04-14|||October 2007||2007-10-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|ACE-ICH||Administration of Celecoxib for Treatment of Intracerebral Hemorrhage : A Pilot Study|Multi-center, Prospective Randomized, Comparative Open With Blinded Endpoints (PROBE) Trial to Assess the Safety and Effectiveness of Administration of Celecoxib in Patients With Intracerebral Hemorrhage|Completed||N/A|44|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 15:18:09.123926|2017-02-18 15:18:09.123926
NCT00526201|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-06|2015-12-22|||May 2009||2009-05-01|December 2015|2015-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|HARE||Help Arthritis With Exercise in West Virginia|Arthritis Benefits of a Physical Activity Program in West Virginia: Evaluation of EnhanceFitness|Completed||Phase 3|323|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 15:18:09.259328|2017-02-18 15:18:09.259328
NCT00526149|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2013-10-04|||July 2007||2007-07-01|October 2013|2013-10-01||||September 2008|Actual|2008-09-01||Interventional|||BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors|Multicenter Parallel Phase II Trial of BI 2536 Administered as One Hour IV Infusion Every 3 Weeks in Defined Cohorts of Patients With Various Solid Tumors. A New Drug Screening Program of the EORTC Network of Core Institutions (NOCI)|Completed||Phase 2|76|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 15:18:10.334576|2017-02-18 15:18:10.334576
NCT00526136|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2008-12-17|||March 2007||2007-03-01|December 2008|2008-12-01|July 2008|Actual|2008-07-01|||||Interventional|||Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study|Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study|Completed||Phase 2|735|Actual|Cardiome Pharma||4|||f||||f||||||||||2017-02-18 15:18:10.468193|2017-02-18 15:18:10.468193
NCT00526123|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2013-01-03|2012-08-30||September 2007||2007-09-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Dialysis Catheter Comparative Clinical Trial|A Randomized, Open-label Comparison of the Performance and Longevity of a Split-tip Versus a Symmetric Tip Hemodialysis|Completed||N/A|599|Actual|Tyco Healthcare Group||2|||f||||f||||||||||2017-02-18 15:18:10.918929|2017-02-18 15:18:10.918929
NCT00526110|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-09-14|2016-06-28||August 2004||2004-08-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients|A Phase I/II Study of Docetaxel, 5-Fluorouracil and Oxaliplatin (D-FOX) in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction|Completed||Phase 1/Phase 2|98|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:18:11.501409|2017-02-18 15:18:11.501409
NCT00526097|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2013-12-13|2010-05-27||September 2007||2007-09-01|December 2013|2013-12-01||||June 2009|Actual|2009-06-01||Interventional|||Dulcolax vs Placebo in Functional Constipation|A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 4 Weeks Treatment With Bisacodyl (Dulcolax) Tablets 10mg Administered Orally, Once Daily, in Patients With Functional Constipation.|Completed||Phase 3|368|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:18:12.235272|2017-02-18 15:18:12.235272
NCT00526084|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-05|||March 2007||2007-03-01|December 2005|2005-12-01|December 2009|Anticipated|2009-12-01|||||Observational|||Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan|Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan|Unknown status|Recruiting|N/A|500|Anticipated|National Taiwan University Hospital|||||f||||f||||||||||2017-02-18 15:18:18.231239|2017-02-18 15:18:18.231239
NCT00526071|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2013-12-19||2013-07-18|September 2007||2007-09-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Open Label Long-term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study|Open-label Extension Study to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of AT1001 in Patients With Fabry Disease|Completed||Phase 2|23|Actual|Amicus Therapeutics||1|||f||||f||||||||||2017-02-18 15:18:18.315584|2017-02-18 15:18:18.315584
NCT00526058|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2013-07-15|2010-05-25||August 2007||2007-08-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|FUTURA||(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol|Randomized Multicenter Crossover Study to Compare the Plasmat® Futura Heparin Induced Extracorporeal Lower Density Lipo-Protein (LDL) Precipitation (H.E.L.P.) Apheresis System to the Approved Secura System in the Reduction of LDL-c in Patients With Hypercholesterolemia|Completed||N/A|18|Actual|B. Braun Medical Inc.||2|||f||||f||||||||||2017-02-18 15:18:18.430329|2017-02-18 15:18:18.430329
NCT00526045|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2013-05-10|||July 2007||2007-07-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients|A Phase I Dose Escalation, Multi-center, Open-label Study of AUY922 Administered IV on a Once Weekly Schedule in Adult Patients With Advanced Solid Malignancies Including Phase II Expansion Arms in Patients With Either HER2 Positive or ER Positive Locally Advanced or Metastatic Breast Cancer.|Completed||Phase 1/Phase 2|117|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:18:18.885021|2017-02-18 15:18:18.885021
NCT00526032|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2012-01-26|||September 2006||2006-09-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Melanoma Detection by Oblique-Incidence Optical Spectroscopy|Melanoma Detection by Oblique-Incidence Optical Spectroscopy|Completed||N/A|490|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:18:18.994933|2017-02-18 15:18:18.994933
NCT00526019|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2012-02-20|||September 2007||2007-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Observational|||Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma Remission|Characteristics of Symptomatic Asthma Remissions|Completed||N/A|85|Actual|Laval University|||4||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 15:18:19.105542|2017-02-18 15:18:19.105542
NCT00526006|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2007-09-05|||September 2007||2007-09-01|August 2007|2007-08-01|March 2008|Anticipated|2008-03-01|||||Interventional|||PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena||Unknown status|Recruiting|Phase 4|||University Hospital Koge||2|||f||||t||||||||||2017-02-18 15:18:19.430319|2017-02-18 15:18:19.430319
NCT00525993|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2008-10-20|||December 2008||2008-12-01|October 2008|2008-10-01|September 2009|Anticipated|2009-09-01|August 2009|Anticipated|2009-08-01||Interventional|||Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols|Efficacy and Safety of the Non-Steroidal Anti-Inflammatory Drug Etoricoxib in the Treatment of Acute Ankle Sprain in Sports: A Randomized Double-Blind Comparative Study Among 2 Treatments in the Acute Phase|Unknown status|Not yet recruiting|Phase 4|50|Anticipated|Núcleo de Estudos em Esportes e Ortopedia, Brazil||2|||f||||t||||||||||2017-02-18 15:18:19.51867|2017-02-18 15:18:19.51867
NCT00525980|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-04-08|||February 2007||2007-02-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Cancer Genetics CD-ROM for Hispanics|Interactive CD-ROM on Cancer Genetics for Hispanics|Completed||N/A|37|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-02-18 15:18:19.634328|2017-02-18 15:18:19.634328
NCT00525967|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2007-09-05|||February 2006||2006-02-01|September 2007|2007-09-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain|Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain: A Randomized, Double-Blind Study|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Faculdade de Medicina do ABC||2|||f||||f||||||||||2017-02-18 15:18:19.762951|2017-02-18 15:18:19.762951
NCT00525954|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2008-01-03|||September 2007||2007-09-01|January 2008|2008-01-01|December 2007||2007-12-01|||||Interventional|PLASMA 2||PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease|Phospholipase Levels And Serological Markers of Atherosclerosis 2: An Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease|Completed||Phase 2|120|Anticipated|Anthera Pharmaceuticals|||||f||||||||||||||2017-02-18 15:18:19.873459|2017-02-18 15:18:19.873459
NCT00525889|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2017-02-06|||August 2007||2007-08-01|February 2017|2017-02-01|September 2013|Actual|2013-09-01|September 2011|Actual|2011-09-01||Interventional|||Proleukin and Rapamune in Type 1 Diabetes|A Phase I Trial of Proleukin and Rapamune in Recent-onset Type 1 Diabetes Mellitus (ITN018AI)|Completed||Phase 1|9|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 15:18:19.984706|2017-02-18 15:18:19.984706
NCT00525876|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2011-11-02|2011-11-02||January 2005||2005-01-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Non-Myeloablative Allogeneic Stem Cell Transplantation|Allogeneic Stem Cell Transplantation With Rituximab Containing Nonablative Conditioning Regimen for Advanced/Recurrent Mantle Cell Lymphoma|Completed||N/A|49|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:18:20.126963|2017-02-18 15:18:20.126963
NCT00525863|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2008-05-26|||January 2008||2008-01-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Oxygen Therapy in Schizophrenia|Oxygen Therapy in Schizophrenia|Unknown status|Recruiting|Phase 3|20|Anticipated|Beersheva Mental Health Center|||||f||||t||||||||||2017-02-18 15:18:20.508081|2017-02-18 15:18:20.508081
NCT00525850|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2011-08-01|||December 2006||2006-12-01|August 2011|2011-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|HFD||High Fat Diet II on Weight Loss|Effect of High Saturated Fat No Starch Diet vs. Low Saturated Fat, Low Trans Fat, High Fiber Diet on Weight Loss and Markers of Atherosclerotic Cardiovascular Disease|Completed||N/A|20|Anticipated|Christiana Care Health Services||2|||f||||f||||||||||2017-02-18 15:18:20.601501|2017-02-18 15:18:20.601501
NCT00525837|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2014-10-03|2010-10-04||September 2007||2007-09-01|October 2014|2014-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers|Systematic Assessment of Response to Open-label Treatment With Varenicline in Depressed Outpatient Smokers|Completed||N/A|18|Actual|Butler Hospital||1|||f||||f||||||||||2017-02-18 15:18:20.710179|2017-02-18 15:18:20.710179
NCT00525824|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2011-05-11|2009-09-03||August 2007||2007-08-01|May 2011|2011-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|GRAVITY||12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe|A 12-week Open-label, Randomised, Parallel-group, Multicentre, Phase IIIb Study to Compare the Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe and Simvastatin in Patients With Hypercholesterolaemia and CHD|Completed||Phase 3|1743|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:18:20.961345|2017-02-18 15:18:20.961345
NCT00525811|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2008-06-23|||June 2007||2007-06-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Development of a Web-Based Interactive Patient Decision Aid for the Treatment of Acute Low Back Pain and Depression||Completed||N/A|741|Actual|University Hospital Freiburg||2|||f||||t||||||||||2017-02-18 15:18:22.30088|2017-02-18 15:18:22.30088
NCT00525798|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2012-10-22|2012-09-14||March 2007||2007-03-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D|A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D|Completed||Phase 3|4665|Actual|Nordic Bioscience A/S||2|||f||||t||||||||||2017-02-18 15:18:22.417012|2017-02-18 15:18:22.417012
NCT00525785|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-01-20|||January 2004||2004-01-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)|A Phase II Trial of Preoperative Chemotherapy and Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Stomach and Gastroesophageal Junction|Completed||Phase 2|58|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:18:24.18133|2017-02-18 15:18:24.18133
NCT00525772|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2009-10-20|||November 2001||2001-11-01|October 2009|2009-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Ciclesonide on Exercise Induced Bronchoconstriction|Effect of Ciclesonide on Exercise Induced Bronchoconstriction|Completed||Phase 3|26|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 15:18:24.307063|2017-02-18 15:18:24.307063
NCT00525759|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2010-11-03|||July 2007||2007-07-01|November 2010|2010-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|ANZAC||Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer|A Randomised Phase II Feasibility Study Investigating the Biological Effects of the Addition of Zoledronic Acid to Neoadjuvant Combination Chemotherapy on Invasive Breast Cancer|Completed||Phase 2|40|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 15:18:24.417144|2017-02-18 15:18:24.417144
NCT00525746|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-11-02|||March 2006||2006-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Observational|||Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)|Molecular Epidemiology of Treatment-Related Acute Myeloid Leukemia/Myelodysplastic Syndrome|Active, not recruiting||N/A|600|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||Samples With DNA|"~     Saliva or blood sample collected for special tests that will look for biologic factors~     associated with treatment-related AML/MDS.~   "|||2017-02-18 15:18:24.527628|2017-02-18 15:18:24.527628
NCT00525525|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2014-11-05|2014-10-28||September 2007||2007-09-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|AVF4120s||Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma|A Phase II Study of Bevacizumab Plus Temodar and Tarceva After Radiation Therapy and Temodar in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Who Are Stable Following Radiation|Completed||Phase 2|74|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 15:18:27.228851|2017-02-18 15:18:27.228851
NCT00525733|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2015-02-24|2015-01-21||October 2007||2007-10-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||This is an as treated analysis. Baseline characteristics describe subjects available for primary endpoint analysis at week 48. There were 34 subjects available for primary endpoint analysis however 2 subjects were not able to be analyzed due to primer mismatch therefore results are available for 32 subjects in the primary endpoint analysis.|Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)|A Phase II, Randomized Trial of Open-Label Truvada With Darunavir/Ritonavir Versus Multiclass Therapy With Truvada, Darunavir/Ritonavir, Maraviroc and Raltegravir in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects|Completed||N/A|40|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 15:18:24.641229|2017-02-18 15:18:24.641229
NCT00525720|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-11-16|||August 2006||2006-08-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||Brachytherapy for Prostatic Carcinoma Patients|Transperineal Interstitial Permanent Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma|Active, not recruiting||Phase 2|300|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:18:25.025087|2017-02-18 15:18:25.025087
NCT00525707|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2010-02-11||2010-02-11|April 2003||2003-04-01|February 2010|2010-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|VERITAS 1||Tezosentan in Acute Heart Failure|Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.|Completed||Phase 3|735|Actual|Actelion||2|||f||||t||||||||||2017-02-18 15:18:25.148828|2017-02-18 15:18:25.148828
NCT00525694|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2016-07-07|||February 2007||2007-02-01|July 2016|2016-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|GGT||Zero Calorie Drink Products|Determination of Clinically Significant Carbohydrates Added to Zero Calorie Drink Products|Completed||N/A|12|Actual|Christiana Care Health Services||3|||f||||f||||||||||2017-02-18 15:18:25.300783|2017-02-18 15:18:25.300783
NCT00525681|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2014-12-02|||September 2007||2007-09-01|December 2014|2014-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|RIMONA-PILOT||Interaction Between Rimonabant and Cyclosporine and Tacrolimus|The Effect of Rimonabant Treatment on Cardiovascular Risk Factors in Renal Transplant Recipients -- Pilot Safety Study|Completed||Phase 4|18|Actual|University of Oslo School of Pharmacy||2|||f||||f||||||||||2017-02-18 15:18:25.395367|2017-02-18 15:18:25.395367
NCT00525668|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-12-20|||September 2007||2007-09-01|December 2016|2016-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|SuniMS||Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)|Sunphenon EGCg (Epigallocatechin-gallate) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)|Completed||Phase 1/Phase 2|120|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 15:18:25.507871|2017-02-18 15:18:25.507871
NCT00525655|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-05-12|||August 2007||2007-08-01|May 2016|2016-05-01||||February 2018|Anticipated|2018-02-01||Interventional|||Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)|Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)|Active, not recruiting||N/A|55|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:18:25.617136|2017-02-18 15:18:25.617136
NCT00525642|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-04|||June 2003||2003-06-01|August 2007|2007-08-01|June 2015|Anticipated|2015-06-01|||||Interventional|||Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer|A Chinese Multi-Center,Randomized Study of Combination or Sequential Use of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy for Node Positive Breast Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|603|Actual|Fudan University||2|||f||||t||||||||||2017-02-18 15:18:25.727565|2017-02-18 15:18:25.727565
NCT00525629|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-05|2015-11-13|||February 2007||2007-02-01|November 2015|2015-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome|The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome|Completed||Phase 2|60|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-02-18 15:18:25.972772|2017-02-18 15:18:25.972772
NCT00525616|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-09-05|||December 2008||2008-12-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Rituximab2||Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid|Assessment of Rituximab Efficiency and Tolerance in Treatment of Bullous Pemphigoid.|Completed||Phase 3|18|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-02-18 15:18:26.083633|2017-02-18 15:18:26.083633
NCT00525603|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-01-25|2012-10-04||June 2005||2005-06-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||CFAR Study in Patients With Chronic Lymphocytic Leukemia|A Phase II Study of Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) in High-Risk Previously Untreated Patients With CLL|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:18:26.197305|2017-02-18 15:18:26.197305
NCT00525590|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2015-11-16|||September 2007||2007-09-01|November 2015|2015-11-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer|A Phase 2, Multicenter, Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer|Completed||Phase 2|69|Actual|Eisai Inc.||1|||f||||t||||||||||2017-02-18 15:18:26.444812|2017-02-18 15:18:26.444812
NCT00525577|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2008-02-04|||August 2007||2007-08-01|February 2008|2008-02-01|September 2008|Anticipated|2008-09-01|June 2008|Anticipated|2008-06-01||Interventional|ANDES||ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study|AGI-1067 as a Novel Antidiabetic Agent Evaluation Study|Unknown status|Active, not recruiting|Phase 2/Phase 3|1012|Anticipated|AtheroGenics||3|||f||||t||||||||||2017-02-18 15:18:26.564338|2017-02-18 15:18:26.564338
NCT00525564|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-05|||May 2006||2006-05-01|September 2007|2007-09-01|October 2006|Actual|2006-10-01|||||Interventional|||Effects of Salmeterol on Walking Capacity in Patients With COPD|Effects of Salmeterol on Walking Capacity in Patients With COPD|Completed||Phase 4|28|Actual|Laval University||2|||f||||f||||||||||2017-02-18 15:18:26.934897|2017-02-18 15:18:26.934897
NCT00525551|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-09-10|||September 2007||2007-09-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Efficacy of Acetylcysteine in Patients Undergoing Surgery for Otosclerosis|Acetylcystein Vid Stapedotomi|Completed||Phase 4|152|Actual|Karolinska University Hospital||2|||f||||f||||||||||2017-02-18 15:18:27.050007|2017-02-18 15:18:27.050007
NCT00525538|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-04|||August 2006||2006-08-01|August 2007|2007-08-01||||||||Interventional|||Evaluation Conformal Radiotherapy for Gynecologic Cancer||Completed||N/A|||Istanbul University|||||f||||f||||||||||2017-02-18 15:18:27.152498|2017-02-18 15:18:27.152498
NCT00525512|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2013-11-27|2011-06-27||August 2007||2007-08-01|September 2013|2013-09-01||||June 2010|Actual|2010-06-01||Interventional|||Tiotropium In Exercise|A Randomized, Double-blind, Placebo-controlled Two-year Trial to Examine the Changes in Exercise Endurance and COPD Treated With Tiotropium Once Daily (EXACTT)|Completed||Phase 4|519|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:18:27.704746|2017-02-18 15:18:27.704746
NCT00525499|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2011-11-16|2011-01-31||August 2007||2007-08-01|November 2011|2011-11-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris|A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Dose-Ranging Clinical Study to Evaluate the Safety and Efficacy of ASC-J9 Cream Applied Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris|Completed||Phase 2|186|Actual|AndroScience Corp||4|||f||||f||||||||||2017-02-18 15:18:30.955696|2017-02-18 15:18:30.955696
NCT00525486|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-02|2010-12-22|||December 2007||2007-12-01|December 2010|2010-12-01||||||||Interventional|||Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery|Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery:A Prospective Interventional Study|Terminated||N/A|||The Baruch Padeh Medical Center, Poriya||2|||f||||f||||||||||2017-02-18 15:18:31.547299|2017-02-18 15:18:31.547299
NCT00525473|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2012-05-16|||February 2007||2007-02-01|January 2012|2012-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Observational|||Correlation of Genetic Polymorphism of Azathioprine Metabolizing Enzymes and Correlation to Clinical Adverse Effects|Correlation of Genetic Polymorphism of Two Azathioprine Metabolizing Enzymes and Their Correlation to Clinical Adverse Effects|Completed||N/A|166|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:18:31.657574|2017-02-18 15:18:31.657574
NCT00525460|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-11-17|||April 2006||2006-04-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function|A Pilot Study of Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function|Completed||N/A|16|Actual|Dana-Farber Cancer Institute|||1||f||||f||||||||||2017-02-18 15:18:31.743822|2017-02-18 15:18:31.743822
NCT00525447|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2014-10-07|||August 2007||2007-08-01|October 2014|2014-10-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma|A Phase I Study of SGN-40 (Anti-huCD40 mAb), Lenalidomide (Revlimid®, cc 5013), and Dexamethasone in Patients With Multiple Myeloma (MM)|Completed||Phase 1|36|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-02-18 15:18:32.061585|2017-02-18 15:18:32.061585
NCT00525434|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2011-06-08|||November 2008||2008-11-01|May 2008|2008-05-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of Safety and Efficacy of Using Seraffix LTB - System for Excisional Biopsy Wounds Closure|Evaluation of Safety and Efficacy of Using Seraffix LTB - (Laser Tissue Bonding) System for Excisional Biopsy Wounds Closure|Terminated||N/A|10|Anticipated|Seraffix||1||sponsor has decide to pospone this study|f||||f||||||||||2017-02-18 15:18:32.184758|2017-02-18 15:18:32.184758
NCT00525421|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-08-05|2013-05-22||October 2007||2007-10-01|August 2013|2013-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Clinical Study of Curcuminoids in the Treatment of Oral Lichen Planus|A Randomized, Placebo-Controlled, Double-Blind Trial of a Two Week Course of Curcuminoids in Oral Lichen Planus|Completed||Phase 2|20|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:18:32.286905|2017-02-18 15:18:32.286905
NCT00525408|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-01|2012-03-09|||November 2007||2007-11-01|March 2012|2012-03-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Interventional|HRPC||A Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer|Open Label, Randomized Multicentric Phase II Clinical Trial of Mycobacterium w in Combination With Docetaxel Versus Docetaxel in Metastatic Hormone Refractory Prostate Cancer.|Terminated||Phase 2|134|Actual|Cadila Pharnmaceuticals||2||Interim Analysis report indicates trial futility|f||||t||||||||||2017-02-18 15:18:32.995101|2017-02-18 15:18:32.995101
NCT00525395|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2010-06-01|||April 2007||2007-04-01|June 2010|2010-06-01|June 2011|Anticipated|2011-06-01|December 2010|Anticipated|2010-12-01||Interventional|VETF||Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol|Continuative vs Sequential Phototherapy in Non-segmental Vitiligo Patients|Unknown status|Recruiting|Phase 3|200|Anticipated|Istituti Fisioterapici Ospitalieri||2|||f||||t||||||||||2017-02-18 15:18:33.140802|2017-02-18 15:18:33.140802
NCT00525382|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-12-11|||August 2003||2003-08-01|September 2009|2009-09-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria|A Study Evaluating the Efficacy and Safety of 5 mg Levocetirizine Oral Tablets, Once Daily Versus 10 mg Loratadine Oral Tablets, Once Daily for the Treatment of Chronic Idiopathic Urticaria (CIU)|Completed||Phase 3|134|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:18:33.23895|2017-02-18 15:18:33.23895
NCT00525369|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-04||||||September 2007|2007-09-01||||||||Observational|||IL 6 Measurement Using a New Densitometric Bedside (POC) Test||Completed||N/A|||Charite University, Berlin, Germany|||||f||||f||||||||||2017-02-18 15:18:33.326487|2017-02-18 15:18:33.326487
NCT00525356|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2015-10-28|||February 2002||2002-02-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|INSTEAD||INSTEAD Trial: INvestigation of STEnt Grafts in Patients With Type B Aortic Dissection|INvestigation of STEnt Grafts in Patients With Type B Aortic Dissection|Completed||Phase 3|136|Actual|Medtronic Cardiovascular||1|||f||||t||||||||||2017-02-18 15:18:33.399634|2017-02-18 15:18:33.399634
NCT00525343|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2010-03-05|||March 2007||2007-03-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Observational|15yASSURANCE||Avonex 15 Year Long Term Follow-up Study|Avonex® Fifteen Year Long Term Follow Up of Patients With Relapsing Multiple Sclerosis: ASSessment of Drug Utilization, EaRly TreAtmeNt, and Clinical OutcomEs|Completed||Phase 4|122|Actual|Biogen|||2||f||||f||||||||||2017-02-18 15:18:33.510294|2017-02-18 15:18:33.510294
NCT00525330|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2013-08-14||2011-06-07|September 2007||2007-09-01|August 2013|2013-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone|Completed||Phase 2|213|Actual|ActivX Biosciences, Inc.||3|||f||||||||||||||2017-02-18 15:18:33.614644|2017-02-18 15:18:33.614644
NCT00525317|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-12-16|||January 2002||2002-01-01|December 2013|2013-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Does Oral Magnesium Substitution Relieve Pregnancy Induced Leg Cramps ?|Does Oral Magnesium Substitution Relieve Magnesium Induced Leg Cramps ?|Completed||Phase 4|45|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 15:18:33.712159|2017-02-18 15:18:33.712159
NCT00525304|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2015-05-07|||September 2007||2007-09-01|March 2009|2009-03-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition|Optimizing Chronic Illness Self-Management for Individuals With Schizophrenia|Unknown status|Recruiting|N/A|100|Anticipated|University of Maryland||1|||f||||f||||||||||2017-02-18 15:18:33.812094|2017-02-18 15:18:33.812094
NCT00525291|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2009-02-17|||July 2007||2007-07-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|3T-AI||Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence|Prospective, Randomized Multicenter Study to Assess the Outcome of Conservative 3T Treatment With EMG-Biofeedback|Completed||Phase 3|158|Actual|University of Giessen||2|||f||||t||||||||||2017-02-18 15:18:34.088283|2017-02-18 15:18:34.088283
NCT00525278|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-12-13|||August 2003||2003-08-01|September 2009|2009-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis|Study Evaluating the Efficacy and Safety of 5 mg Levocetirizine Oral Tablets, Once Daily Versus 10 mg Loratadine Oral Tablets, Once Daily for the Treatment of Seasonal Allergic Rhinitis (SAR)|Completed||Phase 3|67|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:18:34.191002|2017-02-18 15:18:34.191002
NCT00525265|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2013-11-06|2013-11-01||September 2007||2007-09-01|November 2013|2013-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)|A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)|Completed||Phase 3|20|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 15:18:34.274828|2017-02-18 15:18:34.274828
NCT00525252|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-04|||February 2003||2003-02-01|September 2007|2007-09-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy of Baclofen in the Treatment of Alcohol Addiction|Maintaining Alcohol Abstinence in Alcoholic Patients With Liver Cirrhosis: Efficacy and Safety of Baclofen Administration in a Randomized Double Blind Controlled Study|Completed||Phase 1/Phase 2|86||Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-02-18 15:18:34.707202|2017-02-18 15:18:34.707202
NCT00525239|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2011-03-15|||March 2004||2004-03-01|March 2011|2011-03-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||HIV Antiretroviral Drugs and Metabolism||Unknown status|Recruiting|N/A|60|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 15:18:34.793477|2017-02-18 15:18:34.793477
NCT00525226|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-11-19|||September 2007||2007-09-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Evaluating the Effects of Stress in Pregnancy|Perinatal Stress and Gene Influences: Pathways to Infant Vulnerability|Completed||N/A|1431|Actual|Emory University|||1||f||||t||||||Samples With DNA|"~     Plasm, serum, and urine samples are processed and stored at each research visit.~   "|||2017-02-18 15:18:34.914659|2017-02-18 15:18:34.914659
NCT00525213|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2009-08-20|||October 2007||2007-10-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|ROBUST||Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate|A Phase II, Randomised, Double-blind, International, Multicentre, Placebo-controlled, Dose-ranging, Parallel-group Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Stable Methotrexate|Completed||Phase 2|224|Actual|OxyPharma||4|||f||||f||||||||||2017-02-18 15:18:35.022918|2017-02-18 15:18:35.022918
NCT00525200|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2012-12-20|||June 2007||2007-06-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|PANCHO||p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer|p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer: A Multicenter, Randomized Controlled, Predictive Marker Clinical Trial|Completed||Phase 3|170|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:18:35.173474|2017-02-18 15:18:35.173474
NCT00525187|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2007-09-04|||December 2000||2000-12-01|August 2007|2007-08-01|January 2005|Actual|2005-01-01|||||Observational|||Onychomycosis: Diagnosis and Prevalence in Diabetic Neuropathic Patients|Onychomycosis: Diagnosis and Prevalence in Diabetic Neuropathic Patients|Completed||N/A|100|Actual|Vésale Hospital|||||f||||f||||||||||2017-02-18 15:18:35.316756|2017-02-18 15:18:35.316756
NCT00525174|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2016-07-07|2011-04-22||November 2007||2007-11-01|July 2016|2016-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|ATS10||Full-time Bangerter Filters Versus Part-time Daily Patching for Moderate Amblyopia in Children|A Randomized Trial of Full-time Bangerter Filters Versus Part-time Daily Patching for the Treatment of Moderate Amblyopia in Children|Completed||Phase 3|186|Actual|Jaeb Center for Health Research|Compliance assessment was based on parents' diaries and judgment by the researchers. Because we did not use an objective method to measure occlusion or spectacle wear, we cannot guarantee that the patients adhered to their prescribed regimens.|2|||f||||t||||||||||2017-02-18 15:18:35.421809|2017-02-18 15:18:35.421809
NCT00525161|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2015-01-12|2014-12-18||October 2007||2007-10-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|January 2013|Actual|2013-01-01||Interventional|||Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer|A Phase II Study of Adding the Multikinase Inhibitor Sorafenib (Nexavar) to Existing Endocrine Therapy in Patients With Advanced Breast Cancer|Terminated||Phase 2|11|Actual|University of Kentucky|Early termination of study due to slow accrual.|1||Slow accrual and loss of funding|f||||t||||||||||2017-02-18 15:18:37.318011|2017-02-18 15:18:37.318011
NCT00525148|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2016-07-28|2013-08-08||August 2007||2007-08-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|February 2010|Actual|2010-02-01||Interventional||Treated set: The patients who had taken at least one dose of afatinib were included in the treated set.|"LUX Lung 2 Phase II Single Arm BIBW 2992 Afatinib in NSCLC With EGFR Activating Mutations"|LUX Lung 2 A Phase II Single-arm Trial of BIBW 2992 in Non-small Cell Lung Cancer Patients With EGFR Activating Mutations|Completed||Phase 2|129|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-02-18 15:18:37.788142|2017-02-18 15:18:37.788142
NCT00525135|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2015-01-21|2015-01-21||August 2007||2007-08-01|January 2015|2015-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer|A Phase II Trial of Valproic Acid (Depakote ER ®) in Patients With Advanced Thyroid Cancers of Follicular Origin, Who Are Thyroglobulin Positive/RAI Unresponsive|Terminated||Phase 2|5|Actual|University of California, San Francisco||2||PI left university and study was halted prematurely. No data was analyzed.|f||||t||||||||||2017-02-18 15:18:38.936016|2017-02-18 15:18:38.936016
NCT00525122|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2008-05-21|||September 2007||2007-09-01|May 2008|2008-05-01||||||||Observational|||Treatment of M.Graves With Radioactive Iodine: Follow-up Study||Unknown status|Recruiting|N/A|100|Anticipated|Medisch Centrum Rijnmond-Zuid, Netherlands|||1||f||||f||||||||||2017-02-18 15:18:39.18502|2017-02-18 15:18:39.18502
NCT00525109|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-07-14|||June 2004||2004-06-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Elevated Serum HDL in Four Generations of a Nashville Family|Elevated Serum HDL in Four Generations of a Nashville Family|Terminated||N/A|26|Anticipated|Vanderbilt University|||1|Unable to complete enrollment due lack of family interest.|f||||f||||||Samples With DNA|"~     Plasma, Serum, DNA~   "|||2017-02-18 15:18:39.29416|2017-02-18 15:18:39.29416
NCT00525096|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2011-06-29|||July 2003||2003-07-01|June 2011|2011-06-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer|A Multicenter Randomized Phase III, Double-blind Study Comparing Efficacy of the Association of Exemestane and Celecoxib Versus Exemestane and Placebo in Menopausal Patients With Metastatic Breast Cancer.|Completed||Phase 3|157|Actual|ARCAGY/ GINECO GROUP||2|||f||||f||||||||||2017-02-18 15:18:39.392078|2017-02-18 15:18:39.392078
NCT00525083|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2015-06-01|||June 2005||2005-06-01|June 2015|2015-06-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Observational|||Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C|Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C|Terminated||N/A|10|Actual|Vanderbilt University|||1|PI left for another institution|f||||f||||||Samples With DNA|"~     Plasma, HDL preps, genomic DNA~   "|||2017-02-18 15:18:39.485793|2017-02-18 15:18:39.485793
NCT00525057|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-09-12|||July 2006||2006-07-01|September 2016|2016-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||DVT Prophylaxis in Orthopaedic Oncology Patients - A Safety Study|DVT Prophylaxis in Orthopaedic Oncology Patients - A Safety Study|Active, not recruiting||N/A|70|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:18:39.571857|2017-02-18 15:18:39.571857
NCT00525044|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2014-04-30||2014-04-30|August 2007||2007-08-01|April 2014|2014-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat|Double-blind, Randomized, Placebo-controlled Trial to Investigate the Efficacy and Tolerance of Ambroxol Lozenges 20 mg in the Treatment of Sore Throat in Patients With Acute Viral Pharyngitis|Completed||Phase 3|249|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:18:39.681646|2017-02-18 15:18:39.681646
NCT00525031|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2016-06-16|||August 2006||2006-08-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients|Randomized Phase II Neoadjuvant Study of Temozolomide Alone or With Pegylated Interferon-alpha 2b in Patients With Resectable American Joint Committee on Cancer (AJCC) Stage IIIB/IIIC or Stage IV (M1a) Metastatic Melanoma|Completed||Phase 2|55|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:18:39.769778|2017-02-18 15:18:39.769778
NCT00525018|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2007-09-03|||January 2007||2007-01-01|August 2007|2007-08-01|July 2008|Anticipated|2008-07-01|||||Observational|||Brain Activation During Thermal Stimulation in Neuropathic Pain|Brain Activation During Thermal Stimulation in Neuropathic Pain|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||||f||||t||||||||||2017-02-18 15:18:39.880005|2017-02-18 15:18:39.880005
NCT00525005|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2012-09-20|||August 2007||2007-08-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer|A Phase II Study of Docetaxel, Oxaliplatin and S-1 (DOS) in Patients With Advanced Gastric Cancer|Completed||Phase 2|44|Actual|Hallym University Medical Center||1|||f||||f||||||||||2017-02-18 15:18:39.968818|2017-02-18 15:18:39.968818
NCT00524992|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-01|2017-01-24|||August 29, 2007||2007-08-29|December 24, 2014|2014-12-24|December 24, 2014||2014-12-24|||||Observational|||Evaluation of Albuminuria HIV-Infected Patients|Prospective Evaluation of Albuminuria in HIV Positive Patients|Completed||N/A|134|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:18:40.096346|2017-02-18 15:18:40.096346
NCT00524979|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2008-05-15|||October 2007||2007-10-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|||||Observational|||Digital Voice Analysis in Patients With Schizophrenia|Digital Voice Analysis in Patients With Schizophrenia|Completed||N/A|60|Actual|BeerYaakov Mental Health Center|||3||f||||t||||||||||2017-02-18 15:18:40.313015|2017-02-18 15:18:40.313015
NCT00524966|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2011-07-07|||August 2007||2007-08-01|July 2011|2011-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Randomized Controlled Trial of Bipolar Versus Ultrasonic Hemostasis Techniques in Thyroidectomy|Randomized Controlled Trial of Bipolar Versus Ultrasonic Hemostasis Techniques in Thyroidectomy|Completed||N/A|100|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:18:40.392993|2017-02-18 15:18:40.392993
NCT00524953|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2015-06-10|||September 2007||2007-09-01|August 2007|2007-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT|Phase I - Clinical Trial to Assess Safety of Ultraviolet (UV) Phototherapy for the Prevention of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation|Withdrawn||Phase 1|0|Actual|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 15:18:40.490183|2017-02-18 15:18:40.490183
NCT00524940|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-04-12|2009-02-24||August 2007||2007-08-01|April 2016|2016-04-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Trial to Describe the Safety and Immunogenicity of Fluzone®|Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route)|Completed||Phase 2|124|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:18:40.591673|2017-02-18 15:18:40.591673
NCT00524745|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2012-07-02|2011-08-03||October 2007||2007-10-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil|Comparison of the Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil Vaccine to Prevent HPV Infection|Completed||N/A|903|Actual|PATH||4|||f||||f||||||||||2017-02-18 15:18:45.354673|2017-02-18 15:18:45.354673
NCT00524927|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-02|2010-01-27|||September 2007||2007-09-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|||||Interventional|||Safety and Efficacy of Methoxyflurane for Treatment of Incident Pain|A Phase IV, Randomized, Double Blind, Single Centre, Placebo Controlled Study to Assess the Safety and Efficacy of Methoxyflurane [Penthrox] for the Treatment of Incident Pain in Participants Undergoing a Bone Marrow Biopsy Procedure|Completed||Phase 4|110|Anticipated|Medical Developments International Limited||2|||f||||t||||||||||2017-02-18 15:18:40.875025|2017-02-18 15:18:40.875025
NCT00524914|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2008-04-10|||September 2007||2007-09-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|APODOUL||Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study|Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study.|Completed||N/A|16|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 15:18:40.98094|2017-02-18 15:18:40.98094
NCT00524901|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-02-13|||September 2007||2007-09-01|February 2013|2013-02-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|DREAM||Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia|An Open Label Study to Evaluate the Effect of Intravenous Erythropoietin on Erythropoietin Receptor Signaling and Markers for Apoptosis, Myocardial Damage and Renal Dysfunction in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery|Completed||Phase 2|10|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-02-18 15:18:41.098563|2017-02-18 15:18:41.098563
NCT00524888|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-04|||September 2007||2007-09-01|August 2007|2007-08-01||||||||Interventional|sutvsglu||Suturing vs Biological Adhesive in Simple Lacerations of Hand|Suturing Vs Adhesion for Hand Lacerations in the ER A Randomized Prospective Study|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 15:18:41.212573|2017-02-18 15:18:41.212573
NCT00524875|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-04|||January 2007||2007-01-01|August 2007|2007-08-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients||Unknown status|Recruiting|N/A|80|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:18:41.314414|2017-02-18 15:18:41.314414
NCT00524862|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2015-07-30|||October 2007||2007-10-01|July 2015|2015-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|SMART-ICD||Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death|Selective Strategy to Manage Arrhythmia Risk and Therapy With ICD|Terminated||N/A|5000|Anticipated|St. Michael's Hospital, Toronto||2||Poor recruitment|f||||t||||||||||2017-02-18 15:18:41.423831|2017-02-18 15:18:41.423831
NCT00524849|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2010-09-13|||November 2006||2006-11-01|September 2010|2010-09-01|January 2010|Actual|2010-01-01|August 2008|Actual|2008-08-01||Interventional|||Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis|Randomized Phase 2 Study on the Relationship Between Circulating VEGF and Weekly or Every-four-week Zometa in Breast Cancer Patients With Bone Metastases|Completed||Phase 2/Phase 3|60|Actual|Fudan University||2|||f||||f||||||||||2017-02-18 15:18:41.538551|2017-02-18 15:18:41.538551
NCT00524836|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2013-12-13|||September 2003||2003-09-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis|A Study Evaluating the Efficacy and Safety of 5 mg Levocetirizine Oral Tablets, Once Daily Versus 10 mg Loratadine Oral Tablets, Once Daily for the Treatment of Perennial Allergic Rhinitis.|Completed||Phase 3|71|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:18:41.661361|2017-02-18 15:18:41.661361
NCT00524823|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2007-09-04|||August 2007||2007-08-01|August 2007|2007-08-01||||||||Observational|FACS||Early Detection of Prostate Cancer by FACS||Unknown status|Recruiting|Phase 4|40|Anticipated|Ziv Hospital|||4||f||||t||||||||||2017-02-18 15:18:41.749677|2017-02-18 15:18:41.749677
NCT00524810|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-03|2011-06-29|||February 2004||2004-02-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer|A Multi-center Phase II Study Evaluating the Efficacy and Tolerance of the Association of Liposomal Doxorubicin and Docetaxel in First Line Chemotherapy in Patients With Metastatic Breast Cancer|Completed||Phase 2|67|Actual|ARCAGY/ GINECO GROUP||1|||f||||f||||||||||2017-02-18 15:18:41.831848|2017-02-18 15:18:41.831848
NCT00524797|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-02|2007-09-02|||September 2007||2007-09-01|September 2007|2007-09-01||||||||Interventional|||Profonycia - Honey for Improving Quality of Patient's Life Receiving Chemotherapy|Profonycia - Honey for Improving Quality of Patient's Life Receiving Chemotherapy|Unknown status|Recruiting|N/A|50|Anticipated|Ziv Hospital||1|||f||||f||||||||||2017-02-18 15:18:41.942433|2017-02-18 15:18:41.942433
NCT00524784|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2015-06-10|||June 2009||2009-06-01|June 2009|2009-06-01|April 2016|Anticipated|2016-04-01|December 2012|Actual|2012-12-01||Interventional|||Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD|Phase 1/2a, Multicenter, Open-Label Study Designed to Evaluate the Safety, Tolerability and Preliminary Efficacy of ApoCell Administration, a Donor Apoptotic Cell-Based Product, for the Prevention of Acute Graft Versus Host Disease (GvHD) in Subjects With Hematologic Malignancies Undergoing Allogeneic Sibling HLA-Matched Hematopoietic Stem Cell Transplantation (HSCT)|Unknown status|Active, not recruiting|Phase 1/Phase 2|12|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-02-18 15:18:42.035218|2017-02-18 15:18:42.035218
NCT00524771|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2014-03-03|2014-03-03||September 2007||2007-09-01|March 2014|2014-03-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Observational|TASC|All study participants that were not excluded due to protocol violations.|Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC)|Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC)|Completed||N/A|34100|Actual|Center for Epidemiology and Health Research, Germany|In non-experimental studies the possibility of bias and residual confounding can never be entirely eliminated. The findings may exclude large, but not small relative risks.||2||f||||t||||||||||2017-02-18 15:18:42.142943|2017-02-18 15:18:42.142943
NCT00524758|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2011-10-24|||July 2007||2007-07-01|October 2011|2011-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Oculusgen (Ologen) Glaucoma MMC Control in Estonia|Comprative Study of the Safety and Effectiveness Between Oculusgen (Ologen) Collagen Matrix Implant and Mitomycin-C in Glaucoma Filtering Surgery|Unknown status|Recruiting|Phase 3|20|Anticipated|Pro Top & Mediking Company Limited||2|||f||||t||||||||||2017-02-18 15:18:45.238564|2017-02-18 15:18:45.238564
NCT00524732|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2014-01-10|||September 2004||2004-09-01|January 2014|2014-01-01|September 2005|Actual|2005-09-01|December 2004|Actual|2004-12-01||Observational|||Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age||Completed||N/A|7156|Actual|Sanofi|||9||f||||f||||||||||2017-02-18 15:18:45.95731|2017-02-18 15:18:45.95731
NCT00524719|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2016-03-15|||January 2007||2007-01-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|December 2016|Anticipated|2016-12-01||Interventional|DRF||Comparison of Three Fixation Techniques for Displaced Distal Radius Fractures|A Prospective Randomised Trial Comparing Open Reduction and Internal Fixation, Non-Spanning External Fixation, and Closed Reduction With Percutaneous Fixation in Displaced Distal Radius Fractures With Joint Congruity|Active, not recruiting||Phase 3|324|Anticipated|McGill University Health Center||3|||f||||f||||||||||2017-02-18 15:18:46.080744|2017-02-18 15:18:46.080744
NCT00524706|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2008-11-12|||August 2007||2007-08-01|November 2008|2008-11-01|April 2011|Anticipated|2011-04-01|||||Interventional|||Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer|Phase I/II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) in Patients With Untreated Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|42|Anticipated|Shizuoka Cancer Center|||||f||||t||||||||||2017-02-18 15:18:46.189501|2017-02-18 15:18:46.189501
NCT00524693|ClinicalTrials.gov processed this data on February 17, 2017|2007-09-04|2007-09-04|||January 2006||2006-01-01|September 2007|2007-09-01||||||||Interventional|||Montelukast in Acute RSV Bronchiolitis|A Double-Blind Placebo Controlled Randomized Trial of Montelukast in Acute Respiratory Syncytial Virus Bronchiolitis|Completed||N/A|51|Actual|Ziv Hospital||2|||f||||f||||||||||2017-02-18 15:18:46.286821|2017-02-18 15:18:46.286821
NCT00524680|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2015-09-30|2015-03-17||June 2007||2007-06-01|September 2015|2015-09-01|March 2013|Actual|2013-03-01|May 2011|Actual|2011-05-01||Interventional||All treated and eligible patients|Vitamin D in Treating Patients With Prostate Cancer|Study of Serum 25(OH) D3 Level Variability in Response to Different Doses of Oral Vitamin D Supplementation in Prostate Cancer Patients|Completed||Phase 2|148|Actual|Roswell Park Cancer Institute||4|||f||||t||||||||||2017-02-18 15:18:46.628313|2017-02-18 15:18:46.628313
NCT00524667|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2011-07-18|||January 2008||2008-01-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia|HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia|Terminated||Phase 2|6|Actual|CancerCare Manitoba||1||Terminated due to poor accrual.|f||||f||||||||||2017-02-18 15:18:47.394682|2017-02-18 15:18:47.394682
NCT00524654|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2008-10-16|||August 2007||2007-08-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effects of Cervical Spine Manipulation On Postural Control||Completed||Phase 2|30|Actual|Logan College of Chiropractic|||||f||||||||||||||2017-02-18 15:18:47.503782|2017-02-18 15:18:47.503782
NCT00524641|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2009-07-08|||July 2007||2007-07-01|July 2009|2009-07-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Observational|||"Asthma Control-A Patient Follow up Programme Maintenance and Reliever Therapy in a Single Inhaler"|A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort® as Maintenance and Relief Therapy in a Single Inhaler (Symbicort® SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed)|Completed||N/A|1254|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:18:47.574209|2017-02-18 15:18:47.574209
NCT00524615|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2012-06-19|||September 2007||2007-09-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|ASPIRANT||Addition of Spironolactone in Patients With Resistant Arterial Hypertension|Addition of Spironolactone in Patients With Resistant Arterial Hypertension|Unknown status|Recruiting|Phase 4|160|Anticipated|University Hospital Olomouc||2|||f||||f||||||||||2017-02-18 15:18:47.66007|2017-02-18 15:18:47.66007
NCT00524602|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2011-08-10|||June 2007||2007-06-01|August 2007|2007-08-01|June 2013|Anticipated|2013-06-01|June 2012|Anticipated|2012-06-01||Interventional|||The Use of Remote Magnetic Navigation in Catheter Ablation of Heart Arrythmia|A Nonrandomized Observertionel Study That Will Show the Utility and the Safety by Using the Remote Magnetic Navigation of Ablationcatheters and the Stereotaxis Equipment|Unknown status|Recruiting|N/A|2000|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-02-18 15:18:47.773656|2017-02-18 15:18:47.773656
NCT00524589|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2014-01-27|2014-01-27||April 2006||2006-04-01|January 2014|2014-01-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional||All treated and eligible patients|Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy|Phase II Study of Weekly Intravenous 1,25 Dihydroxycholecelciferol (Calcitriol) + Dexamethasone in Androgen Independent Prostate Cancer|Terminated||Phase 2|18|Actual|Roswell Park Cancer Institute||1||closed due to futility|f||||t||||||||||2017-02-18 15:18:47.871388|2017-02-18 15:18:47.871388
NCT00524576|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2016-11-02|2009-05-14||November 2007||2007-11-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine|Administration of a Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine.|Completed||Phase 4|144|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:18:48.160461|2017-02-18 15:18:48.160461
NCT00524563|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2015-12-16|||July 2007||2007-07-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Clinical Outcomes and Global Epidemiology -Data Coordinating Center|Clinical Outcomes and Global Epidemiology -Data Coordinating Center|Active, not recruiting||N/A|400|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:18:48.8408|2017-02-18 15:18:48.8408
NCT00524550|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2010-08-11|||August 2007||2007-08-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Postprandial Insulin Secretion and Appetite Regulation After Moderate Alcohol Consumption|Effect of Moderate Alcohol Consumption on Postprandial Insulin Secretion, Appetite Regulation, Glucose Homeostasis and Insulin Resistance.|Completed||N/A|24|Anticipated|TNO||1|||f||||||||||||||2017-02-18 15:18:48.930782|2017-02-18 15:18:48.930782
NCT00524537|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2017-01-20|2016-11-18||September 2007||2007-09-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational||All Treated Population: All participants who received at least 1 injection of Humira in the registry|A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)|A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)|Completed||N/A|5025|Actual|AbbVie|||1||f||||f||||||||||2017-02-18 15:18:49.075196|2017-02-18 15:18:49.075196
NCT00524524|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2011-10-17|||August 2007||2007-08-01|October 2011|2011-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors|An Exploratory Biomarker Study of ARQ 501 in Patients With Advanced Solid Tumors|Completed||Phase 1|9|Actual|ArQule||1|||f||||f||||||||||2017-02-18 15:18:51.102584|2017-02-18 15:18:51.102584
NCT00524511|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2013-01-24|2012-10-24||September 2007||2007-09-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Comparison Study of Wound Closure at Time of Cesarean Delivery: Dermabond Glue Versus Surgical Staples|A Comparative Study of Closure Techniques After Cesarean Section: Staples vs. Dermabond|Terminated||N/A|136|Actual|University of Massachusetts, Worcester||2||Poor enrollment, much data was missing as patients were lost to follow up|f||||f||||||||||2017-02-18 15:18:51.196467|2017-02-18 15:18:51.196467
NCT00524498|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2015-10-13|||September 2007||2007-09-01|October 2015|2015-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma|A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma|Completed||Phase 2|60|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-02-18 15:18:51.5264|2017-02-18 15:18:51.5264
NCT00524485|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2013-09-19|||May 2005||2005-05-01|September 2013|2013-09-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional|||Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis|A Pilot Study to Investigate the Use of Topical Levulan® With Vbeam® Laser for the Treatment of Actinic Keratoses|Terminated||N/A|12|Actual|Roswell Park Cancer Institute||5||Withdrawn due to low accrual|f||||t||||||||||2017-02-18 15:18:51.643707|2017-02-18 15:18:51.643707
NCT00524472|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2017-01-31|||July 2007||2007-07-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery|The Effect of Hyperinsulinemic Glucose Control on Outcomes Following Cardiac Surgery|Recruiting||N/A|418|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 15:18:51.759738|2017-02-18 15:18:51.759738
NCT00524459|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2014-08-21|2014-08-06||May 2007||2007-05-01|August 2014|2014-08-01||||August 2008|Actual|2008-08-01||Interventional||All treated and eligible patients|Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery|Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Docetaxel in Locally Advanced Operable Breast Cancer|Terminated||Phase 2|6|Actual|Roswell Park Cancer Institute|Due to the study’s early termination and inadequate number of patients, no patients were analyzed.|1||Terminated by sponsor due to lack of funding|f||||t||||||||||2017-02-18 15:18:51.875647|2017-02-18 15:18:51.875647
NCT00524446|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2014-05-20|||January 2008||2008-01-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|June 2011|Actual|2011-06-01||Interventional|LCNI-5||Controlled Trial to Test the Efficacy of Lipid-based Nutrient Supplements to Prevent Severe Stunting Among Infants|A Single-centre, Randomised, Single-blind, Parallel Group Clinical Trial in Rural Malawi, Testing the Growth Promoting Effect of Long-term Complementary Feeding of Infants With a High-energy, Micronutrient Fortified Spread|Completed||Phase 3|840|Anticipated|University of Tampere||4|||f||||t||||||||||2017-02-18 15:18:52.159642|2017-02-18 15:18:52.159642
NCT00524433|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2010-02-11||2010-02-11|April 2003||2003-04-01|February 2010|2010-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|VERITAS 2||Tezosentan in the Treatment of Acute Heart Failure|Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Tezosentan in Patients With Acute Heart Failure.|Completed||Phase 3|713|Actual|Actelion||2|||f||||||||||||||2017-02-18 15:18:52.288251|2017-02-18 15:18:52.288251
NCT00524420|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2013-04-13|2013-02-13||February 2008||2008-02-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain|Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Widespread Pain (CWP)|Completed||Phase 2|19|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:18:52.661054|2017-02-18 15:18:52.661054
NCT00524407|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2010-04-01|||July 1996||1996-07-01|April 2010|2010-04-01|November 2002|Actual|2002-11-01|||||Interventional|||Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy|The Effects of PROCRIT (Epoetin Alfa) on Hemoglobin, Symptom Distress, and Quality of Life During Chemotherapy in Lymphoma, Chronic Lymphocytic Leukemia or Multiple Myeloma Patients With Mild to Moderate Anemia|Completed||Phase 4|273|Actual|Ortho Biotech Clinical Affairs, L.L.C.|||||f||||||||||||||2017-02-18 15:18:53.209593|2017-02-18 15:18:53.209593
NCT00524394|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2015-11-05|2013-07-17||August 2007||2007-08-01|November 2015|2015-11-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|AOS||Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation|Characteristics of Cord Blood Immunologic Parameters of Infants < 32 Weeks Gestation|Terminated||N/A|2|Actual|The University of Texas Health Science Center, Houston|Early termination leading to small numbers of subjects analyzed||1|recruitment not possible|f||||t||||||Samples Without DNA|"~     Serum only~   "|||2017-02-18 15:18:53.294393|2017-02-18 15:18:53.294393
NCT00524381|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2010-02-22|||August 2007||2007-08-01|February 2010|2010-02-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Etanercept Treatment in the Early Course of Polymyalgia Rheumatica|The Effect of Etanercept on the Early Clinical Course of Polymyalgia Rheumatica (Pilot Study)|Completed||Phase 3|40|Anticipated|Bispebjerg Hospital||1|||f||||t||||||||||2017-02-18 15:18:53.509039|2017-02-18 15:18:53.509039
NCT00524368|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2013-02-12|2010-08-27||October 2007||2007-10-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|August 2009|Actual|2009-08-01||Interventional|ODIN||A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)|A Randomized, Open-label Trial to Compare the Efficacy, Safety and Tolerability of DRV/Rtv (800mg/100mg) q.d Versus DRV/Rtv (600mg/100mg) b.i.d in Early Treatment-experienced HIV-1 Infected Subjects|Completed||Phase 3|590|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-02-18 15:18:53.60558|2017-02-18 15:18:53.60558
NCT00524355|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2009-07-16|||March 2007||2007-03-01|July 2009|2009-07-01|November 2007|Actual|2007-11-01|||||Observational|||Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD|Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of the Gastroesophageal Reflux Disease|Completed||N/A|2717|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:18:54.566369|2017-02-18 15:18:54.566369
NCT00524342|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2014-12-04|2014-06-04||January 2008||2008-01-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia|Phase II Clinical Efficacy Trial of Recombinant Interleukin-11 (rhIL-11, Neumega) in Women With Type 1 Von Willebrand Disease and Refractory Menorrhagia|Completed||Phase 2|7|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 15:18:54.644315|2017-02-18 15:18:54.644315
NCT00524329|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2008-09-25|||January 2006||2006-01-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|March 2007|Actual|2007-03-01||Observational|Synchronise||Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage|SYNCHRONISE: Esomeprazole 20 mg Once Daily for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs in Dutch General Practice: The Influence of Risk-Factors for NSAID-Associated GI Damage on Sympton Response|Completed||N/A|1220|Anticipated|AstraZeneca|||1||f||||||||||||||2017-02-18 15:18:54.897159|2017-02-18 15:18:54.897159
NCT00524316|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2014-05-19|2013-12-26||April 2007||2007-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|December 2010|Actual|2010-12-01||Interventional|||Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|A Phase II Study of SUNITINIB MALATE (Sutent) and Chemoembolization in Patients With Unresectable Hepatocellular Cancer|Terminated||Phase 2|16|Actual|Roswell Park Cancer Institute|Due to the study’s early termination and inadequate number of patients, no patients were analyzed.|1||low accrual|f||||t||||||||||2017-02-18 15:18:54.976362|2017-02-18 15:18:54.976362
NCT00524303|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2016-09-23|2011-07-14||August 2007||2007-08-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|October 2010|Actual|2010-10-01||Interventional|||Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.|Phase II Randomized Trial of Neoadjuvant Trastuzumab and/or Lapatinib Plus Chemotherapy (Sequential FEC75 and Paclitaxel) in Women With ErbB2- (HER2/Neu-) Overexpressing Invasive Breast Cancer|Completed||Phase 2|100|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 15:18:55.517789|2017-02-18 15:18:55.517789
NCT00524290|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2015-12-16|||April 2009||2009-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol|Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol|Recruiting||N/A|100|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:18:56.908599|2017-02-18 15:18:56.908599
NCT00524277|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2015-11-16|||January 2007||2007-01-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Vaccine Therapy in Treating Patients With Breast Cancer|Phase II Trial of the HER2/Neu Peptide GP2 + GM-CSF Vaccine vs GM-CSF Alone in HLA-A2+ OR the Modified HER2/Neu Peptide AE37 + GM-CSF Vaccine vs GM-CSF Alone in HLA-A2- Node-Positive and High-Risk Node-Negative Breast Cancer Patients|Active, not recruiting||Phase 2|600|Anticipated|San Antonio Military Medical Center||4|||f||||t||||||||||2017-02-18 15:18:57.014486|2017-02-18 15:18:57.014486
NCT00524264|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2009-09-29|2009-08-19||October 2007||2007-10-01|August 2009|2009-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery||Completed||Phase 3|248|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:18:57.147972|2017-02-18 15:18:57.147972
NCT00524251|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2008-09-16|||June 2004||2004-06-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|||||Observational|||The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients||Completed||N/A|990|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 15:18:57.543801|2017-02-18 15:18:57.543801
NCT00524238|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2008-02-07|||March 2004||2004-03-01|February 2008|2008-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Metabolic Changes in Hypothyroid Patients|Impact of Hypothyroidism on Glucose, Lipid, and Amino Acid Turnover|Completed||N/A|22|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:18:57.681185|2017-02-18 15:18:57.681185
NCT00524225|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2014-12-19|2014-07-22||February 2008||2008-02-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||IL-11 in Adults With Von Willebrand Disease Undergoing Surgery|Phase II Clinical Efficacy Trial of Recombinant Interleukin-11 (rhIL-11, Neumega) in Subjects With Type 1 Von Willebrand Disease Undergoing Surgery|Terminated||Phase 2|3|Actual|University of Pittsburgh|There were too few subjects for reporting in a manuscript.|1||Recruitment slow as single center conducting in rare disease|f||||t||||||||||2017-02-18 15:18:57.881105|2017-02-18 15:18:57.881105
NCT00524212|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2010-01-19|||March 2007||2007-03-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|||||Observational|||How to Improve Diagnosis in Infective Endocarditis|Ph. D Student, Jane Byriel Knudsen, Aarhus University|Completed||N/A|761|Actual|University of Aarhus|||2||f||||f||||||Samples Without DNA|"~     A venous blood sample was obtained from each patients and all samples were centrifuged and~     immediately frozen.~   "|||2017-02-18 15:18:58.137942|2017-02-18 15:18:58.137942
NCT00524199|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2007-08-31|||March 2007||2007-03-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Effects of Mesna on Homocysteine in Kidney Failure|The Effects of 12 mg/kg Intravenous Mesna on Plasma Total Homocysteine Concentration in Patients With End-Stage Renal Disease Requiring Hemodialysis|Completed||Phase 2|10|Actual|Lawson Health Research Institute||2|||f||||||||||||||2017-02-18 15:18:58.241824|2017-02-18 15:18:58.241824
NCT00524186|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2016-06-20|||May 2007||2007-05-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|August 2013|Actual|2013-08-01||Interventional|||Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer|Phase I Study of Sunitinib With FOLFIRI (Irinotecan, 5-Fluorouracil and Leucovorin) for Advanced Gastroesophageal Cancers|Terminated||Phase 1|23|Actual|Roswell Park Cancer Institute||1||PI left institute|f||||t||||||||||2017-02-18 15:18:58.36033|2017-02-18 15:18:58.36033
NCT00524173|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2017-01-26|||August 29, 2007||2007-08-29|January 4, 2017|2017-01-04|January 4, 2024|Anticipated|2024-01-04|January 4, 2018|Anticipated|2018-01-04||Interventional|||Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B|Tenofovir Disoproxil Fumarate Alone Versus Its Combination With Emtricitabine for Treatment of Chronic Hepatitis B|Recruiting||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 15:18:58.479343|2017-02-18 15:18:58.479343
NCT00524160|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2010-11-24|||July 2001||2001-07-01|November 2010|2010-11-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or Osteoarthritis|Open-Label Study To Assess The Effect On Pain Control Of Durogesic (Fentanyl Transdermic Therapeutic System) Treatment In Subjects With Rheumatoid Arthritis Or Osteoarthritis Of The Knee Or Hip.|Completed||Phase 4|264|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 15:18:58.60776|2017-02-18 15:18:58.60776
NCT00524147|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2010-12-28|||October 2003||2003-10-01|December 2010|2010-12-01|December 2006|Actual|2006-12-01|October 2005|Actual|2005-10-01||Interventional|||Drainage of Tuberculous Pleural Effusions|Drainage of Tuberculous Pleural Effusions|Completed||N/A|64|Actual|Taipei Medical University Hospital|||||f||||f||||||||||2017-02-18 15:18:58.694848|2017-02-18 15:18:58.694848
NCT00524134|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2016-04-21|2016-03-23||December 2008||2008-12-01|April 2016|2016-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.|An Open-label Pilot Study Using Carvedilol-CR as a P-glycoprotein Inhibitor as Adjunct Therapy in the Treatment of Medically-refractory Epilepsy|Terminated||Phase 2/Phase 3|6|Actual|Columbia University||1||PI left the institution.|f||||t||||||||||2017-02-18 15:18:58.791736|2017-02-18 15:18:58.791736
NCT00524121|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2016-03-14|2013-08-23||March 2006||2006-03-01|March 2016|2016-03-01|October 2011|Actual|2011-10-01|May 2010|Actual|2010-05-01||Interventional||All Treated Patients|Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer|Phase II Study of Erlotinib (Tarceva®) and Radiotherapy for Elderly Patients With Esophageal Carcinoma|Completed||Phase 2|22|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 15:18:59.03586|2017-02-18 15:18:59.03586
NCT00524108|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2012-08-14|||August 2007||2007-08-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Retrospective Analysis of Clinical Features in Ventriculoperitoneal Shunt Infectionsin Adults|Retrospective Analysis of Clinical Features in Ventriculoperitoneal Shunt Infections and Time to Re-Implantation in Adults|Completed||N/A|350|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:18:59.548935|2017-02-18 15:18:59.548935
NCT00524095|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2009-03-12|||September 2006||2006-09-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|||Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis|Bronchiectasis in COPD Patients : Role of Prophylaxis With Inhaled Steroids and Antibiotic on the Natural History of the Disease|Terminated||Phase 2|210|Actual|University of Milan||3||we decided not to go on treatment phase|f||||t||||||||||2017-02-18 15:18:59.635691|2017-02-18 15:18:59.635691
NCT00524069|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2013-01-31|||January 2007||2007-01-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery|A Pilot Study of Bevacizumab Based Peri-Operative Therapy for Operable Pancreatic Adenocarcinoma|Withdrawn||N/A|0|Actual|Roswell Park Cancer Institute||||Withdrawn due to no accrual|f||||||||||||||2017-02-18 15:19:02.346284|2017-02-18 15:19:02.346284
NCT00524056|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2013-01-15||2013-01-15|August 2007||2007-08-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor|A Randomized, Double Blind, Placebo-Controlled, Crossover, Proof of Concept Study to Evaluate the Effectiveness and Safety of Carisbamate in the Treatment of Essential Tremor|Completed||Phase 2|62|Actual|SK Life Science||2|||f||||||||||||||2017-02-18 15:19:02.457286|2017-02-18 15:19:02.457286
NCT00524043|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2014-05-21|2009-11-19||September 2007||2007-09-01|May 2014|2014-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia|A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of a Fixed Dosage of 1.5 mg/Day of Paliperidone Extended Release (ER) in the Treatment of Subjects With Schizophrenia|Completed||Phase 4|201|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|No information from this study about efficacy and safety with treatment beyond 6 weeks. Study not designed to establish efficacy of 6 mg dose relative to 1.5 mg dose. No information on efficacy of paliperidone ER doses between 1.5 and 3 mg.|3|||f||||||||||||||2017-02-18 15:19:02.573346|2017-02-18 15:19:02.573346
NCT00524030|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2012-05-15|2012-04-11||September 2007||2007-09-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures|A Double-Blind, Randomized, Multicenter Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures|Terminated||Phase 3|161|Actual|Pfizer|External Data Monitoring Committee (DMC) determined study met criteria to stop early for positive efficacy. Exit rate was the basis for primary analysis and is what is reported here.|2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 15:19:03.507125|2017-02-18 15:19:03.507125
NCT00524017|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2012-01-27|||May 2007||2007-05-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract|Phase II Study of Single-Agent Cetuximab for Treatment of High-Risk Pre-malignant Upper Aerodigestive Lesions|Completed||Phase 2|35|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 15:19:04.341541|2017-02-18 15:19:04.341541
NCT00524004|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2007-11-26|||February 2007||2007-02-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|BIgGII||Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD|Protective Efficacy of Orally Delivered Bovine Immunoglobulin, Specific for CS17 Fimbriae and CS17 Minor Fimbrial Adhesin CsbD Against Challenge With a CS17 Strain of Enterotoxigenic Escherichia Coli (ETEC)|Completed||Phase 2|36|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||f||||||||||2017-02-18 15:19:04.477687|2017-02-18 15:19:04.477687
NCT00523991|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2014-05-12|2011-07-01||April 2007||2007-04-01|May 2014|2014-05-01||||July 2010|Actual|2010-07-01||Interventional|||Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).|A 24 Week, Randomized, Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of 18 MCG of Tiotropium Inhalation Capsules Administered by HandiHaler Once-daily Plus PRN Albuterol (Salbutamol) vs. Placebo Plus PRN Albuterol (Salbutamol) in Chronic Obstructive Pulmonary Disease Subjects Naive to Maintenance Therapy|Completed||Phase 4|457|Actual|Boehringer Ingelheim|For individual outcome measures, only timepoints that had data collected are presented here.|2|||f||||||||||||||2017-02-18 15:19:04.651862|2017-02-18 15:19:04.651862
NCT00523978|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2012-07-25|2012-04-10||October 2006||2006-10-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|Stop-AF||A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation|A Randomized, Controlled Clinical Trial of Catheter Cryoablation in the Treatment of Paroxysmal Atrial Fibrillation.|Completed||Phase 3|245|Actual|Medtronic Atrial Fibrillation Solutions||2|||f||||f||||||||||2017-02-18 15:19:08.566552|2017-02-18 15:19:08.566552
NCT00523965|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2010-05-25|||September 2007||2007-09-01|January 2009|2009-01-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Combination Therapy in Indian Visceral Leishmaniasis|A Randomised, Open-label, Parallel-group, Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens (Co-administration), of AmBisome, Paromomycin and Miltefosine in Visceral Leishmaniasis (VL)|Completed||Phase 3|624|Anticipated|Banaras Hindu University||4|||f||||t||||||||||2017-02-18 15:19:09.129313|2017-02-18 15:19:09.129313
NCT00523952|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2014-08-28|||January 2004||2004-01-01|August 2014|2014-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients|A 12-week, Exploratory, Non-comparative, Multi-centre Study to Evaluate the Efficacy and Safety of 0.1% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis|Completed||Phase 3|303|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 15:19:09.240291|2017-02-18 15:19:09.240291
NCT00523939|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2013-06-07|2011-02-16||June 2006||2006-06-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||DepoCyt for Active Lymphomatous or Leukemic Meningitis|Phase II Study of Intrathecal Therapy With DepoCyt for Active Lymphomatous or Leukemic Meningitis|Terminated||Phase 2|4|Actual|Duke University|Adverse events for both arms, lymphomatous and leukemic, were combined due to low accrual and early study termination.|2||Low accrual.|f||||f||||||||||2017-02-18 15:19:09.378681|2017-02-18 15:19:09.378681
NCT00523926|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2012-08-14|||May 2005||2005-05-01|August 2012|2012-08-01|October 2005|Actual|2005-10-01|||||Interventional|||TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis|An Open-label Study to Evaluate the Extended Early Bactericidal Activity, Safety, Tolerability and Pharmacokinetics of Multiple Oral Doses of TMC207 in Treatment-na�ve Subjects With Sputum Smear Positive Pulmonary Tuberculosis.|Completed||Phase 2|75|Actual|Tibotec BVBA|||||f||||||||||||||2017-02-18 15:19:09.885911|2017-02-18 15:19:09.885911
NCT00523913|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2016-10-26|||November 2005||2005-11-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study Of BRL49653C For The Treatment Of Type 2 Diabetes|Clinical Evaluation of Rosiglitazone Malate (BRL49653C) in Patients With Type 2 Diabetes Mellitus -Long-term Study of Rosiglitazone Maleate-|Completed||Phase 3|70|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:19:09.978301|2017-02-18 15:19:09.978301
NCT00523900|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2009-10-19|||August 2007||2007-08-01|August 2007|2007-08-01|December 2008|Actual|2008-12-01|||||Interventional|||Effectiveness of Quaker Complete Nutrition Supplements for Malnourished Adults|Effectiveness of Quaker Complete Nutrition Supplements for Malnourished Adults|Completed||N/A|40|Anticipated|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||||2017-02-18 15:19:10.081112|2017-02-18 15:19:10.081112
NCT00523887|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2010-04-26|||August 2005||2005-08-01|April 2010|2010-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Fentanyl for Treatment Pain Caused by Radiotherapy|Post-Marketing Surveillance of Durogesic for Treatment Pain Caused by Radiotherapy|Completed||Phase 4|163|Actual|Johnson & Johnson Taiwan Ltd||1|||f||||||||||||||2017-02-18 15:19:10.186828|2017-02-18 15:19:10.186828
NCT00523874|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2007-08-31|||January 2001||2001-01-01|January 2001|2001-01-01|May 2007|Actual|2007-05-01|||||Observational|||Recurrence of Acute Alcoholic Pancreatitis|Recurrence of Acute Alcoholic Pancreatitis|Completed||N/A|120|Actual|University of Tampere|||||f||||f||||||||||2017-02-18 15:19:10.280077|2017-02-18 15:19:10.280077
NCT00523861|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2007-09-10|||May 2005||2005-05-01|August 2007|2007-08-01|June 2005|Actual|2005-06-01|||||Interventional|||Moderate Alcohol Consumption, Glucose Metabolism and Gastric Emptying|The Effect of Moderate Alcohol Consumption on Glucose Metabolism and Gastric Emptying in Healthy, Lean and Overweight Young Men|Completed||N/A|17|Actual|TNO|||||f||||||||||||||2017-02-18 15:19:10.3575|2017-02-18 15:19:10.3575
NCT00523848|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2013-07-12|2013-07-12||June 2006||2006-06-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|September 2011|Actual|2011-09-01||Interventional||Evaluable Patients|Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma|Phase II Study of VDT (VELCADE, Doxil® and Thalidomide) as Frontline Therapy for Patients With Previously Untreated Multiple Myeloma (MM)|Completed||Phase 2|46|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 15:19:10.462493|2017-02-18 15:19:10.462493
NCT00523835|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2007-08-31|||April 2002||2002-04-01|August 2007|2007-08-01|November 2004|Actual|2004-11-01|||||Observational|||Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter Syndrome||Completed||N/A|140||University of Aarhus|||2||f||||f||||||||||2017-02-18 15:19:11.194322|2017-02-18 15:19:11.194322
NCT00523822|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2008-08-01||||||August 2008|2008-08-01||||||||Interventional|||Sacroiliac Orthopedic Blocking and Cervical Spine Function||Completed||N/A|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 15:19:11.282965|2017-02-18 15:19:11.282965
NCT00523809|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-31|2012-12-21|2012-12-21||August 2007||2007-08-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor|Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 15:19:11.369821|2017-02-18 15:19:11.369821
NCT00523796|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2011-02-15|||February 2007||2007-02-01|February 2011|2011-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||InPractice Survey on the Treatment of Hypercholesterolemia|InPractice Survey on the Treatment of Hypercholesterolemia|Completed||N/A|2500|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:19:11.620803|2017-02-18 15:19:11.620803
NCT00523783|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2008-10-03|||May 2007||2007-05-01|August 2007|2007-08-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Observational|SELECT||Seroquel Long-Term NIS for Schizophrenia Patients|24-Week Naturalistic Observational Study of Efficacy of Quetiapine in Patients With Schizophrenia or Schizoaffective Disorder|Completed||N/A|1000|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 15:19:11.702177|2017-02-18 15:19:11.702177
NCT00523770|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2017-02-07|||September 2007||2007-09-01|February 2017|2017-02-01||||September 2007|Actual|2007-09-01||Observational|||Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. Pneumoniae|An Exploratory Study in Healthy Elderly Subjects to Collect Urine for the Development of Assays to Detect Streptococcus Pneumoniae.|Completed||N/A|50|Actual|GlaxoSmithKline|||1||f||||f||||||Samples With DNA|"~     Urine sample~   "|||2017-02-18 15:19:11.790197|2017-02-18 15:19:11.790197
NCT00523757|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2010-04-05|||August 2007||2007-08-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|||||Interventional|ARCTIC-D||Aldosterone Blockade in Heart Failure|Aldosterone-blockade Randomized Controlled Trial In CHF - Diastolic|Completed||Phase 3|10|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 15:19:11.884411|2017-02-18 15:19:11.884411
NCT00059111|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-17|2008-04-22|||April 2003||2003-04-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Mechanisms Mediating Cardiovascular Disease in Children With Obstructive Sleep Apnea||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:59:43.206309|2017-02-18 17:59:43.206309
NCT00523744|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2011-06-08|2011-01-10||July 2007||2007-07-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension|An Open-label, Multicenter Study to Evaluate the Efficacy and Tolerability of a 4 Week Therapy With the Fixed Dose Combination of Amlodipine 10 mg Plus Valsartan 160 mg in Hypertensive Patients Not Adequately Responding to a 4 Week Therapy With the Free Combination of an Angiotensin Receptor Blocker (Olmesartan 20 mg) Plus Amlodipine 10 mg|Completed||Phase 3|257|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:19:12.206288|2017-02-18 15:19:12.206288
NCT00523731|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2007-08-30|||January 2006||2006-01-01|February 2007|2007-02-01|March 2007|Actual|2007-03-01|||||Interventional|||ACPs in Severe PAD/CLI by Direct Intramuscular Injection|A Study of Blood-Borne Autologous Angiogenic Cells Precursors Therapy in Patients With Critical Limb Ischemia|Completed||Phase 1|6|Actual|TheraVitae Ltd.||1|||f||||t||||||||||2017-02-18 15:19:12.601103|2017-02-18 15:19:12.601103
NCT00523718|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2016-05-25|2016-02-22||September 2006||2006-09-01|May 2016|2016-05-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional||One individual was excluded from analysis (they were in the riluzole group) before unblinding due to a protocol violation.|Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder|A Double-blind Study of Riluzole Augmentation in Serotonin Reuptake Inhibitor-refractory Obsessive-compulsive Disorder and Depression|Completed||Phase 2|40|Actual|Yale University||2|||f||||f||||||||||2017-02-18 15:19:12.691423|2017-02-18 15:19:12.691423
NCT00523705|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2014-05-29|2012-06-13||February 2008||2008-02-01|June 2012|2012-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study|Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study|Terminated||Phase 4|11|Actual|University of Pennsylvania||2||Enrollment too slow.|f||||f||||||||||2017-02-18 15:19:13.147508|2017-02-18 15:19:13.147508
NCT00523692|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2007-08-30|||September 2007||2007-09-01|August 2007|2007-08-01||||||||Interventional|RIVERA||Remission Induction in Very Early Rheumatoid Arthritis|Remission Induction in Very Early Rheumatoid Arthritis: a Comparison of Etanercept Plus Methotrexate Plus Steroid With Standard Therapy|Unknown status|Not yet recruiting|Phase 4|20|Anticipated|University Hospital Birmingham||2|||f||||f||||||||||2017-02-18 15:19:13.588012|2017-02-18 15:19:13.588012
NCT00523679|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-07-10|||July 2007||2007-07-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|||||Observational|SMART||Symbicort SMART (Symbicort Maintenance And Reliever Therapy)|SMART (Symbicort Maintenance And Reliever Therapy): Reassure Program for Patients Using Symbicort Turbuhaler as Maintenance and Reliever Therapy in Korean Clinical Practice|Completed||N/A|2000|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:19:13.845802|2017-02-18 15:19:13.845802
NCT00523666|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2007-08-29|||September 2006||2006-09-01|August 2007|2007-08-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)|Diffusion Tensor Weighted MRI in Alzheimer's Disease: Prediction and Mapping of Symptomatic and Disease Modifying Treatment Effects of Galantamine (Reminyl®)|Unknown status|Recruiting|Phase 4|20|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-02-18 15:19:13.935179|2017-02-18 15:19:13.935179
NCT00523653|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2008-03-17|||January 2008||2008-01-01|March 2008|2008-03-01|December 2008|Anticipated|2008-12-01|||||Observational|||The Genetics of Dilated Cardiomyopathy: A Quebec-Based Study||Unknown status|Recruiting|N/A|200|Anticipated|McGill University Health Center|||1||f||||f||||||||||2017-02-18 15:19:14.039694|2017-02-18 15:19:14.039694
NCT00523640|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2014-01-16|2011-08-15||March 2005||2005-03-01|January 2014|2014-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma|A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma|Terminated||Phase 2|30|Actual|University of Chicago|Trial was designed with a maximum target accrual of 55 patients. The trial was halted early because emerging data with VEGF inhibitors challenged clinical relevance of the study and availability of multiple therapies challenged accrual.|1||Too slow accrual|f||||t||||||||||2017-02-18 15:19:14.126227|2017-02-18 15:19:14.126227
NCT00523627|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2017-01-24|||August 29, 2007||2007-08-29|January 11, 2017|2017-01-11||||||||Observational|||Effects of Diet Changes on Metabolism|Study of Short-Term Metabolic Adaptation: Prediction of Weight Change and Effects of Macronutrient Manipulations|Recruiting||N/A|350|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:19:14.589477|2017-02-18 15:19:14.589477
NCT00523614|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2010-03-19|2009-06-22||July 2007||2007-07-01|March 2010|2010-03-01|June 2008|Actual|2008-06-01|||||Observational|||Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism|Use of OCs Containing Dienogest and Risk of Venous Thromboembolism|Completed||N/A|3400|Actual|Center for Epidemiology and Health Research, Germany|This is an observational study. The possibility of bias and residual confounding cannot be entirely eliminated.||2||f||||f||||||||||2017-02-18 15:19:14.680789|2017-02-18 15:19:14.680789
NCT00523601|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2008-10-03|||June 2007||2007-06-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Observational|QUEEN||Quetiapine Efficacy in Bipolar Depression Study|A 8-Week, Multicenter, Open-Label, Observational Study of the Efficacy of Quetiapine Fumarate (SEROQUEL) Immediate-Release Tablets in Adult Patients With Bipolar Depression|Completed||N/A|2000|Anticipated|AstraZeneca|||||f||||f||||||||||2017-02-18 15:19:15.050435|2017-02-18 15:19:15.050435
NCT00523588|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2010-06-24|||March 2007||2007-03-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|February 2009|Actual|2009-02-01||Interventional|||Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser|Single Blind, Controlled, Single-Center Study of Laser Treatment in Cutaneous Lupus Erythematosus|Completed||Phase 2|10|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 15:19:15.298966|2017-02-18 15:19:15.298966
NCT00523575|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2011-07-19|||August 2007||2007-08-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Nutritional Intervention in Hip Fracture Patients|Effectiveness and Cost-effectiveness of Nutritional Screening and Intervention in Elderly Subjects After Hip Fracture|Completed||N/A|210|Anticipated|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 15:19:15.40283|2017-02-18 15:19:15.40283
NCT00523562|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2010-10-27|||July 2006||2006-07-01|June 2010|2010-06-01|January 2009|Actual|2009-01-01|April 2008|Actual|2008-04-01||Interventional|MACRONUTR||Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity|Study of the Role of Insulin Resistance in the Pathogenesis of the Metabolic Syndrome and of Non-alcoholic Steatohepatitis|Completed||N/A|41|Actual|University of Lausanne||4|||f||||f||||||||||2017-02-18 15:19:15.511014|2017-02-18 15:19:15.511014
NCT00523549|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2012-04-19|2010-12-06||November 2006||2006-11-01|April 2012|2012-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction|A Multi-center, Prospective, Randomized, Open-label Study With Blinded Outcome Evaluation to Evaluate the Effects of Systolic Blood Pressure Lowering to Different Targets (Less Than 130 mmHg vs. Less Than 140 mmHg) on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction|Completed||Phase 4|229|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:19:15.627552|2017-02-18 15:19:15.627552
NCT00523536|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2013-08-29|||May 2007||2007-05-01|April 2009|2009-04-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of a Navigator-Nurse Care Team on the Management of High Blood Pressure and Cardiovascular Disease Risk|Latinos Using Cardio Health Actions to Reduce Risk (LUCHAR): Evaluation of a Navigator-Nurse Care Team on Hypertension and Cardiovascular Disease Risk|Completed||N/A|800|Actual|Denver Health and Hospital Authority||2|||f||||f||||||||||2017-02-18 15:19:16.083732|2017-02-18 15:19:16.083732
NCT00523523|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2012-02-03|||August 2007||2007-08-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Training the Arm and Hand After Stroke Using Auditory Rhythm Cues|Auditory Rhythm Cues + Task Practice: Effects on UE Motor Function Post-stroke|Completed||Phase 1/Phase 2|11|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 15:19:16.188289|2017-02-18 15:19:16.188289
NCT00523510|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2012-02-13|||March 2008||2008-03-01|February 2012|2012-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|Flash-heat||Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania|Feasibility and Pilot Efficacy of Flash-heated Breast Milk for Reduction of Maternal-to-Child Transmission of HIV in Tanzania|Completed||N/A|144|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 15:19:16.301197|2017-02-18 15:19:16.301197
NCT00523497|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2007-08-30||||||August 2007|2007-08-01||||||||Interventional|NIMV AND SCAP||Efects of Noninvasive Mechanical Ventilation and Conventional Mechanical Ventilation in Patients With Severe Comunity Pneumonia|Noninvasive Mechanical Ventilation in Severe Community-Acquired Pneumonia and Acute Hypoxemic Respiratory Failure. A Prospective, Randomized and Controlled Study|Terminated||N/A|||Hospital Privado del Sur||||"Interim analysis of the present study showed a significant decrease in mortality rate (p=~   0.04) as well as in the number of days at the ICU p=0.0002."|f||||t||||||||||2017-02-18 15:19:16.635983|2017-02-18 15:19:16.635983
NCT00523484|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2010-01-25|||May 2007||2007-05-01|January 2010|2010-01-01||||November 2008|Actual|2008-11-01||Observational|CHAMPION||Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts|An Observational Study to Assess Correlation Between Prostate Specific Antigen & Beck Anxiety Index in Prostate Cancer Patients Under Hormonal Therapy|Completed||N/A|1200|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:19:16.723748|2017-02-18 15:19:16.723748
NCT00523471|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2016-02-24|||July 2007||2007-07-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Blood Test to Measure DNA Damage in Blood|Gamma-H2AX as a Molecular Predictor of Prostate Cancer Radiosensitivity|Terminated||N/A|40|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 15:19:16.812498|2017-02-18 15:19:16.812498
NCT00523458|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2011-07-20|||July 2007||2007-07-01|July 2011|2011-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|OPTI-NNRTI||A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV||Terminated||Phase 4|5|Actual|Stanford University||4||"A delay in protocol approval and approval of laboratory sites in Salvador, Brazil left too~   little time for completion of enrollment into the study."|f||||t||||||||||2017-02-18 15:19:16.896411|2017-02-18 15:19:16.896411
NCT00523445|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2009-08-03|||September 2007||2007-09-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia|Varenicline, an Alpha 4 Beta 2 Nicotinic Acetylcholine Receptor Partial Agonist, on Cognitive Dysfunction in 120 Patients With Schizophrenia: a Randomized, Double Blind, 8 Weeks Trial|Completed||Phase 3|120|Anticipated|Inje University||2|||f||||t||||||||||2017-02-18 15:19:17.009322|2017-02-18 15:19:17.009322
NCT00523432|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2013-09-04|||August 2007||2007-08-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|September 2009|Actual|2009-09-01||Interventional|||A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies|A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies|Completed||Phase 1|15|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 15:19:17.135142|2017-02-18 15:19:17.135142
NCT00523419|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2011-06-24|2010-06-23||September 2007||2007-09-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Chemotherapy for Patients With Osteosarcoma|Phase II Trial of Pemetrexed in Second Line Advanced/Metastatic Osteosarcomas|Completed||Phase 2|32|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:19:17.250781|2017-02-18 15:19:17.250781
NCT00523406|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2013-05-02|||August 2005||2005-08-01|May 2013|2013-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)||Completed||Phase 3|40|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 15:19:17.768526|2017-02-18 15:19:17.768526
NCT00523393|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-02-12|||August 2007||2007-08-01|February 2009|2009-02-01|May 2010|Anticipated|2010-05-01|December 2009|Anticipated|2009-12-01||Interventional|||Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells|Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells in Patients With Type 2 Diabetes: a Partially Double-Blind, Randomized, Three-Arm Unicenter Study|Unknown status|Recruiting|Phase 4|75|Anticipated|Heidelberg University||3|||f||||f||||||||||2017-02-18 15:19:17.876458|2017-02-18 15:19:17.876458
NCT00523380|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2013-10-24|||October 2007||2007-10-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer|An Open-Label Phase 2 Trial of Pegylated Liposomal Doxorubicin and rIL-21 in Ovarian Cancer Patients With Persistent or Progressive Disease After, or Relapse Within One Year of, Completion of Standard First Line Therapy|Completed||Phase 2|10|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 15:19:17.987785|2017-02-18 15:19:17.987785
NCT00522977|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2008-02-25|||August 2007||2007-08-01|February 2008|2008-02-01|September 2009|Anticipated|2009-09-01|||||Observational|||Echo-Cardiographic Assessment of Cardiovascular Characteristics During Pregnancy and Postpartum Periods||Unknown status|Recruiting|N/A|400|Anticipated|Hillel Yaffe Medical Center|||||f||||f||||||||||2017-02-18 15:19:25.723199|2017-02-18 15:19:25.723199
NCT00523367|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2013-01-15|2012-03-08||August 2007||2007-08-01|January 2013|2013-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|GERD/COPD||COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI|COPD Patients Diagnosed With Gastro Esophageal Reflux Disease Have Decreased Rates of COPD Exacerbations After Treatment With High Dose Proton Pump Inhibitor Therapy (Esomeprazole or Lansoprazole)|Terminated||N/A|25|Actual|University of Florida||1||terminated due to enrollment|f||||t||||||||||2017-02-18 15:19:18.230944|2017-02-18 15:19:18.230944
NCT00523354|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2009-04-06|||August 2007||2007-08-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|IEE||Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis|Phase 2 Proof-of-Concept Study to Analyze the Efficacy of in TNF-Alpha Blockade in Adult Patients With Severe, Corticosteroid-Dependent Eosinophilic Esophagitis|Completed||Phase 2|||Swiss EE Study Group||1|||f||||t||||||||||2017-02-18 15:19:18.501966|2017-02-18 15:19:18.501966
NCT00523341|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2016-07-27|2016-06-01||August 2007||2007-08-01|July 2016|2016-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis|An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety and Sustained Efficacy of Denosumab (AMG162) in the Treatment of Postmenopausal Osteoporosis|Completed||Phase 3|4550|Actual|Amgen||1|||f||||f||||||||||2017-02-18 15:19:18.656706|2017-02-18 15:19:18.656706
NCT00523328|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2015-12-17||2015-12-17|August 2007||2007-08-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)|An Open-Label Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination With Methotrexate to Subjects With Rheumatoid Arthritis Who Previously Participated in Study 104RA203|Terminated||Phase 2|72|Actual|Biogen||1||Analysis of data from 104RA203 failed to meet primary endpoint.|f||||t||||||||||2017-02-18 15:19:22.532735|2017-02-18 15:19:22.532735
NCT00523315|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2011-05-19|||May 2007||2007-05-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|APOLLO||APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)|A Prospective Observational Study of Compliance in the Patients Receiving Aromatase Inhibitor as an Adjuvant Therapy in Postmenopausal Early Breast Cancer|Completed||N/A|862|Actual|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:19:22.644838|2017-02-18 15:19:22.644838
NCT00523302|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2012-01-24|||July 2007||2007-07-01|January 2012|2012-01-01||||||||Interventional|||A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia|A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia|Completed||N/A|20|Anticipated|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 15:19:22.750971|2017-02-18 15:19:22.750971
NCT00523289|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-02-18|||October 2007||2007-10-01|February 2009|2009-02-01|July 2009|Anticipated|2009-07-01|March 2009|Anticipated|2009-03-01||Interventional|||Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block||Unknown status|Active, not recruiting|Phase 4|48|Anticipated|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 15:19:22.86125|2017-02-18 15:19:22.86125
NCT00523276|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2013-04-25||||||April 2011|2011-04-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Observational|||SARS Survivor Evaluations|Immune Responses, Transmission and Nucleotide Polymorphisms in Families With SARS Virus Infections|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||||||||Samples With DNA|"~     Sera, PBMCs~   "|||2017-02-18 15:19:22.9726|2017-02-18 15:19:22.9726
NCT00523263|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2007-08-30|||January 1996||1996-01-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|DaDa||Dacron vs Dardik for Fem-Pop Bypass|Heparin Bonded and Collagen Coated Polyester or Human Umbilical Vein for Femoropopliteal Bypass: a Prospective Randomised Multicentre Trial.|Completed||Phase 3|||Radboud University||2|||f||||f||||||||||2017-02-18 15:19:23.063157|2017-02-18 15:19:23.063157
NCT00523250|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2014-04-18||2014-02-17|September 2007||2007-09-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Ocular Hypotensive Efficacy of AR-102|A Phase II, First-in-human Dose-escalation, Double-masked, Randomized, Vehicle-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-102 in Subjects With Elevated Intraocular Pressure|Completed||Phase 2|82|Actual|Aerie Pharmaceuticals||5|||f||||f||||||||||2017-02-18 15:19:23.165128|2017-02-18 15:19:23.165128
NCT00523237|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2011-10-31|2011-07-20||October 2007||2007-10-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|March 2009|Actual|2009-03-01||Interventional|||RAL-eve Study: Raltegravir Substitution Study|Raltegravir Substitution for Enfuvirtide in Patients Suffering From Injection Site Reactions (ISRs): The Raleve Pilot Study|Completed||N/A|14|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 15:19:23.283743|2017-02-18 15:19:23.283743
NCT00523224|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2007-08-30|||January 2006||2006-01-01|May 2007|2007-05-01|September 2007|Anticipated|2007-09-01|||||Interventional|||ACPs Combined With CABG in Patients With CHF|A Study of Combined Coronary Artery Bypass Grafting (CABG) and Blood-Borne Autologous Angiogenic Cell Precursors Therapy in Patients With Congestive Heart Failure Due to Ischemic Heart Disease|Unknown status|Recruiting|Phase 1|5|Anticipated|TheraVitae Ltd.||1|||f||||t||||||||||2017-02-18 15:19:23.50445|2017-02-18 15:19:23.50445
NCT00523211|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2015-09-24|||July 2007||2007-07-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|June 2009|Actual|2009-06-01||Interventional|||Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)|Vicriviroc in Combination Treatment With an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E3)|Completed||Phase 3|506|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:19:23.611422|2017-02-18 15:19:23.611422
NCT00523198|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2014-12-02|||February 2007||2007-02-01|December 2014|2014-12-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Observational|||Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic Shock|Correlation Between Salivary Cortisol and Free Serum Cortisol Compared to Total Serum Cortisol in MICU Patients With Septic Shock|Completed||N/A|60|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-02-18 15:19:23.713847|2017-02-18 15:19:23.713847
NCT00523185|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2007-08-29|||May 2003||2003-05-01|August 2007|2007-08-01|November 2004|Actual|2004-11-01|||||Interventional|||A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal|A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal|Completed||N/A|55|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 15:19:23.806244|2017-02-18 15:19:23.806244
NCT00522002|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2010-07-14|||August 2007||2007-08-01|July 2009|2009-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|CLUE||CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study|Connective Tissue Disease Leg Ulcer Etiology Study|Completed||N/A|300|Anticipated|Georgetown University|||1||f||||f||||||||||2017-02-18 15:19:46.782905|2017-02-18 15:19:46.782905
NCT00523172|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2010-07-16|||October 2007||2007-10-01|July 2010|2010-07-01|October 2010|Anticipated|2010-10-01|January 2010|Actual|2010-01-01||Interventional|||Clinical Assessment of Two Manipulative Protocols in Treatment of Hip Osteoarthritis|A Randomized Clinical Trial Comparing Two Manipulative Protocols to Assess Changes in Pain, ROM, Quality of Life, Cost and Risk for Falls in Subjects With Hip Osteoarthritis|Unknown status|Active, not recruiting|Early Phase 1|120|Anticipated|Cleveland Chiropractic College||3|||f||||f||||||||||2017-02-18 15:19:23.910155|2017-02-18 15:19:23.910155
NCT00523159|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2012-07-09|||May 2007||2007-05-01|February 2010|2010-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|IMA901-202||IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease|Phase 2, Randomized, Open Label, Multicenter Study of Intradermal IMA901 Plus GM-CSF With or Without Low Dose Cyclophosphamide Pre-treatment in Advanced Renal Cell Carcinoma Patients With Measurable Disease|Completed||Phase 2|68|Actual|immatics Biotechnologies GmbH||2|||f||||t||||||||||2017-02-18 15:19:24.021289|2017-02-18 15:19:24.021289
NCT00523146|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2010-02-02|||April 2007||2007-04-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Treatment of Primary Menstrual Pain With Kanion Capsule|Treatment of Primary Dysmenorrhea With Kanion Capsule (GF) A Randomized, Double-blind, Placebo-controlled, Repeated-Dose and Multi-Center Clinical Phase II Trial|Completed||Phase 2|||Lianyungang Kanion Group, Ltd.|||||f||||t||||||||||2017-02-18 15:19:24.170617|2017-02-18 15:19:24.170617
NCT00523133|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-30|2007-08-30|||September 2000||2000-09-01|August 2007|2007-08-01|July 2005|Actual|2005-07-01|||||Interventional|RITA||Research on Individualized Treatment for Alcoholism|Posttreatment Effects of Naltrexone|Completed||Phase 2|185|Actual|Indiana University||4|||f||||t||||||||||2017-02-18 15:19:24.252854|2017-02-18 15:19:24.252854
NCT00523120|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2016-04-18|||September 2008||2008-09-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Topical Voltaren in Otitis Externa|Topical Voltaren as an Alternative Treatment for Otitis Externa|Terminated||Phase 2|20|Actual|Sieff Medical Center||2|||f||||f||||||||||2017-02-18 15:19:24.438863|2017-02-18 15:19:24.438863
NCT00523107|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2015-11-03|||August 2007||2007-08-01|June 2009|2009-06-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care|PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care|Completed||Phase 2/Phase 3|91|Actual|PhytoHealth Corporation||2|||f||||f||||||||||2017-02-18 15:19:24.555614|2017-02-18 15:19:24.555614
NCT00523094|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-06-15|||September 2007||2007-09-01|June 2009|2009-06-01|July 2008|Anticipated|2008-07-01|||||Observational|||Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure|Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure|Suspended||N/A|75|Anticipated|Deep Breeze|||1|Enrollment was too slow and principal investigator moved to another country|f||||f||||||||||2017-02-18 15:19:24.655742|2017-02-18 15:19:24.655742
NCT00523081|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2014-01-30|||October 2006||2006-10-01|July 2012|2012-07-01|January 2014|Actual|2014-01-01|March 2012|Actual|2012-03-01||Interventional|STAND||Study of Adolescence and Depression|Brief, Primary Care Cognitive Behavioral Therapy (CBT) for Unmedicated Youth|Completed||Phase 3|212|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 15:19:24.745622|2017-02-18 15:19:24.745622
NCT00523068|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2007-11-06|||September 2007||2007-09-01|August 2007|2007-08-01|January 2010|Anticipated|2010-01-01|||||Interventional|||Pharmacological vs Surgical Treatment for Mixed Incontinence|Randomized Pilot Study on the Treatment of Mixed Urinary Incontinence: Pharmacological Treatment (Tolterodine SR) vs Surgery With Tension Free Vaginal Tape|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Imperial College London||2|||f||||f||||||||||2017-02-18 15:19:24.965215|2017-02-18 15:19:24.965215
NCT00523055|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2011-04-25|||May 2008||2008-05-01|April 2011|2011-04-01||||April 2012|Anticipated|2012-04-01||Interventional|||Ultrasound-guided Supraclavicular Brachial Plexus Blockade|Ultrasound-guided Supraclavicular Brachial Plexus Blockade: A Pharmacokinetic Study of Lidocaine and Adrenaline|Unknown status|Recruiting|N/A|30|Anticipated|University of Manitoba||1|||f||||t||||||||||2017-02-18 15:19:25.078448|2017-02-18 15:19:25.078448
NCT00523042|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2015-04-17|||August 2007||2007-08-01|March 2014|2014-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|iINHALE 9||Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma|Inhaled Preprandial Human Insulin With the AERx® iMS Versus Subcutaneous Injected Insulin Aspart in Subjects With Diabetes and Asthma: A 52-week, Open-label, Multinational, Randomised, Parallel Trial to Investigate Long-term Safety|Terminated||Phase 3|10|Actual|Novo Nordisk A/S||2||See termination reason in detailed description|f||||f||||||||||2017-02-18 15:19:25.184775|2017-02-18 15:19:25.184775
NCT00523029|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2013-12-09|||February 2006||2006-02-01|December 2013|2013-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Developing a Self-Management Program for People With Depression and Chronic Medical Illness|Self-Management of Depression and Medical Illness|Completed||N/A|104|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 15:19:25.306369|2017-02-18 15:19:25.306369
NCT00523016|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2013-05-20|||September 2007||2007-09-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|APSCI||Acupuncture Treatment to Reduce Burning Pain in Spinal Cord Injury|A Pilot Study Investigating the Feasibility of Using Acupuncture Treatment to Reduce Below-Level Neuropathic Pain in Spinal Cord Injury.|Completed||N/A|33|Actual|Toronto Rehabilitation Institute||2|||f||||t||||||||||2017-02-18 15:19:25.406817|2017-02-18 15:19:25.406817
NCT00523003|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2008-10-16|||May 2004||2004-05-01|October 2008|2008-10-01|March 2006|Actual|2006-03-01|||||Interventional|||A Controlled Trial of Protein Enrichment of Meal Replacements for Weight Reduction With Retention of Lean Body Mass|A Controlled Trial of Protein Enrichment of Meal Replacements for Weight Reduction With Retention of Lean Body Mass|Completed||N/A|100|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 15:19:25.516411|2017-02-18 15:19:25.516411
NCT00522990|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2016-01-08||2016-01-08|September 2006||2006-09-01|January 2016|2016-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias|A Phase I/IIa Open-label Study to Assess the Safety, Tolerability and Preliminary Efficacy of AT9283, a Small Molecule Inhibitor of Aurora Kinases, in Patients With Refractory Hematological Malignancies|Terminated||Phase 1/Phase 2|48|Actual|Astex Pharmaceuticals||1||Recommended Phase II dose determined|f||||f||||||||||2017-02-18 15:19:25.612081|2017-02-18 15:19:25.612081
NCT00059098|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-17|2016-07-11|||March 2003||2003-03-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Identification of Genes Predisposing to Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:59:43.279634|2017-02-18 17:59:43.279634
NCT00522964|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2009-08-16|||May 2006||2006-05-01|August 2009|2009-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ABC||Educational Intervention on Weight Management in Chinese-American Children|Educational Intervention on Weight Management in Chinese American Children|Completed||Phase 3|80|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:19:25.962218|2017-02-18 15:19:25.962218
NCT00522951|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2013-10-22|2011-07-05||August 2007||2007-08-01|October 2013|2013-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study|Multi-center, Randomized, Controlled, Single-blind, Intra-individual Comparisons of 2 Dose of Gadobutrol 1.0 Molar and Gadoteridol (ProHance) Crossover Studies With Corresponding Blinded Image Evaluation Following Multiple Injections of 0.1 mmol/kg bw of Gadobutrol and Gadoteridol in Patients With Known or Suspected Brain Metastasis|Completed||Phase 3|165|Actual|Bayer||3|||f||||f||||||||||2017-02-18 15:19:26.077596|2017-02-18 15:19:26.077596
NCT00522938|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2012-06-27|||December 2007||2007-12-01|February 2012|2012-02-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer|A Phase I-II, Multicenter, Open-label Trial of Co-administered CHR-2797 and Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer|Terminated||Phase 1/Phase 2|2|Actual|Chroma Therapeutics||1||Very poor recruitment of patients to the study|f||||t||||||||||2017-02-18 15:19:26.803161|2017-02-18 15:19:26.803161
NCT00522925|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2011-09-13|2010-01-18||August 2007||2007-08-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension|Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of a Novel Dual Angiotensin and Endothelin Receptor Antagonist (PS433540) in Subjects With Stage I and II Hypertension|Completed||Phase 2|280|Actual|Ligand Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:19:26.92914|2017-02-18 15:19:26.92914
NCT00522912|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2012-01-11|||March 2008||2008-03-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Trial of Epilation Verses Surgery for Minor Trichiasis|A Randomised Controlled Trial of Epilation Verses Immediate Surgery for the Management of Minor Trachomatous Trichiasis|Completed||N/A|1300|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 15:19:27.485877|2017-02-18 15:19:27.485877
NCT00522899|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2012-04-06|||August 2007||2007-08-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional|MAX||The Mental Activity and eXercise Trial for Seniors|The Effects of Mental Activity and Exercise on Cognitive Function in Older Adults Who Self-Report a Recent Decline in Memory or Thinking|Completed||N/A|126|Actual|University of California, San Francisco||4|||f||||t||||||||||2017-02-18 15:19:27.603567|2017-02-18 15:19:27.603567
NCT00522886|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2011-07-18|||April 2007||2007-04-01|July 2011|2011-07-01||||July 2011|Actual|2011-07-01||Interventional|||Phase I Cetuximab and Concurrent Radio-chemotherapy|Determination of the Toxicity of Standard Dose Cetuximab Together With Concurrent Individualised, Isotoxic Accelerated Radiotherapy and Cisplatin-vinorelbine for Patients With Stage III Non-small Cell Lung Cancer: A Phase I Study|Completed||Phase 1|24|Anticipated|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-02-18 15:19:27.732927|2017-02-18 15:19:27.732927
NCT00522873|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2014-12-10|2012-03-23||August 2007||2007-08-01|December 2014|2014-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Endometrial Safety Study|A Double-blind, Randomized, Multi-center Study to Investigate the Endometrial Safety of a Continuous, Combined, Oral Estrogen/Progestin Preparation (17b-estradiol [E2] / Drospirenone [DRSP]) and to Compare the Bleeding Pattern of Subjects Treated With E2 / DRSP With the Bleeding Pattern of Subjects Treated With E2 / Norethisterone Acetate (NETA) When Used for Hormone Therapy (HT) for 1 Year in Post-menopausal Women|Completed||Phase 3|662|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:19:27.847995|2017-02-18 15:19:27.847995
NCT00522860|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2012-01-11|||March 2008||2008-03-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery|A Randomised Controlled Trial of Non-absorbable (Silk) Sutures Verses Absorbable (Vicryl) Sutures During the Surgical Treatment of Trachomatous Trichiasis|Completed||Phase 4|1300|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 15:19:28.412367|2017-02-18 15:19:28.412367
NCT00522847|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-02-12|||May 2007||2007-05-01|February 2009|2009-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|GARNET||Biochemical Factors for a Dry Eyed Population|Biochemical Factors for a Dry Eyed Population|Completed||N/A|40|Actual|University of Waterloo|||1||f||||f||||||Samples Without DNA|"~     Tears~   "|||2017-02-18 15:19:28.639303|2017-02-18 15:19:28.639303
NCT00522834|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2014-01-31||2014-01-31|August 2007||2007-08-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma|A Randomized, Double-blind, Phase 3 Trial of Elesclomol (STA-4783) in Combination With Paclitaxel Versus Paclitaxel Alone for Treatment of Chemotherapy-Naïve Subjects With Stage IV Metastatic Melanoma (SYMMETRY)|Terminated||Phase 3|630|Actual|Synta Pharmaceuticals Corp.||2|||f||||t||||||||||2017-02-18 15:19:28.72097|2017-02-18 15:19:28.72097
NCT00522821|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2015-04-03|||November 2007||2007-11-01|April 2015|2015-04-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|Subklasse||Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response|Treatment in Patients With Recurrent Infections and IgG Subclass Deficiency, and/or Deficient Anti-Polysaccharide Antibody Response|Completed||Phase 4|55|Actual|Sanquin||2|||f||||f||||||||||2017-02-18 15:19:28.92543|2017-02-18 15:19:28.92543
NCT00522808|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2008-09-26|||August 2007||2007-08-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|CP104||A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers|A Clinical Pharmacology Study to Determine the Pharmacokinetic , Safety and Tolerability Profile and Antiviral Activity of Multiple Oral Doses of A-831 in Otherwise Healthy Male Hepatitis C Carriers With Compensated Liver Disease|Terminated||Phase 1/Phase 2|36|Anticipated|Arrow Therapeutics||||Need for re-formulation|f||||t||||||||||2017-02-18 15:19:29.042779|2017-02-18 15:19:29.042779
NCT00522795|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2014-06-26|2013-05-21||August 2007||2007-08-01|June 2014|2014-06-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|||Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)|BrUOG-E-215-Neoadjuvant Paclitaxel Poliglumex (PPX; CT-2103), Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial. (CTI#X64001|Completed||Phase 2|40|Actual|Brown University||1|||f||||t||||||||||2017-02-18 15:19:29.138089|2017-02-18 15:19:29.138089
NCT00522782|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2009-01-22|||August 2007||2007-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children|Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma|Completed||Phase 4|16|Actual|AAADRS Clinical Research Center||1|||f||||t||||||||||2017-02-18 15:19:29.394371|2017-02-18 15:19:29.394371
NCT00522769|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2010-02-12|||September 2005||2005-09-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|claire||Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents|Development of CBT Model for Adolescent Bulimia Nervosa|Completed||Phase 1/Phase 2|26|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-02-18 15:19:29.5054|2017-02-18 15:19:29.5054
NCT00522756|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2012-10-22|||May 2006||2006-05-01|October 2012|2012-10-01|March 2013|Anticipated|2013-03-01|December 2012|Anticipated|2012-12-01||Interventional|PARACHUTE||Preventing Acute Renal Failure After Cardiac Surgery in High Risk Patients Using Sodium Bicarbonate Therapy|Preventing Acute Renal Failure After Cardiac Surgery in High Risk Patients Using Sodium Bicarbonate Therapy (PARACHUTE) - Pilot Study|Unknown status|Recruiting|Phase 3|200|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-02-18 15:19:29.61595|2017-02-18 15:19:29.61595
NCT00522743|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2010-07-13|||May 2005||2005-05-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.|Two Arms, Open, Controlled, Prospective, Intervention Study to Evaluate the Growth and Metabolic Response to Growth Hormone and Gonadotropin-releasing Hormone Agonist Treatment Versus Growth Hormone Alone in Boys Born SGA|Completed||N/A|17|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 15:19:29.726337|2017-02-18 15:19:29.726337
NCT00522730|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-09-02|||August 2007||2007-08-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|SELLIFA||Safety and Tolerance on Lipids of Parenteral and Enteral Nutrition in Critically Ill Patients With Liver Failure|Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (SELLIFA). Randomized Controlled Trial Comparing the Tolerance on Lipids and Safety of Isocaloric Parenteral Nutrition With Enteral Nutrition.|Completed||Phase 4|45|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||2|||f||||t||||||||||2017-02-18 15:19:29.836561|2017-02-18 15:19:29.836561
NCT00522717|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2015-11-30|||July 2005||2005-07-01|November 2015|2015-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Enhancing Recovery After Cardiac Surgery|Enhancing Recovery After Cardiac Surgery|Completed||N/A|808|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 15:19:32.41689|2017-02-18 15:19:32.41689
NCT00522704|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2014-11-04|||March 2008||2008-03-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|April 2015|Anticipated|2015-04-01||Observational|||Correlation Between Access Blood Flow and Extracorporeal Blood Flow|Correlation Between Access Blood Flow and Extracorporeal Blood Flow|Unknown status|Recruiting|N/A|30|Anticipated|Instituto Nacional de Cardiologia Ignacio Chavez|||1||f||||t||||||||||2017-02-18 15:19:32.520133|2017-02-18 15:19:32.520133
NCT00522691|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2015-06-23|||September 2007||2007-09-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|SNStest||Efficacy of Sacral Nerve Stimulation Before Definitive Implantation|Efficacy of Sacral Nerve Stimulation Before Definitive Implantation: a Multicenter Randomized, Double Blind, Crossover Trial|Withdrawn||N/A|0|Actual|University of Lausanne Hospitals||2||slow recruitment|f||||t||||||||||2017-02-18 15:19:32.623353|2017-02-18 15:19:32.623353
NCT00522678|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-10-26|||February 2007||2007-02-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers|A Randomised, Double Blind, Placebo Controlled, Parallel Group, 14 Day Repeat Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled GW685698X Containing Magnesium Stearate in Healthy Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:19:32.736496|2017-02-18 15:19:32.736496
NCT00522665|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2015-05-14|||August 2007||2007-08-01|May 2015|2015-05-01|February 2015|Actual|2015-02-01|May 2011|Actual|2011-05-01||Interventional|||Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer|Phase I / Randomized Phase II Study of Second Line Therapy With Irinotecan and Cetuximab With or Without RAD001, an Oral mTOR Inhibitor for Patients With Metastatic Colorectal Cancer: Hoosier Oncology Group GI05-102|Completed||Phase 1/Phase 2|41|Actual|Hoosier Cancer Research Network||2|||f||||t||||||||||2017-02-18 15:19:32.836064|2017-02-18 15:19:32.836064
NCT00522652|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2010-05-14|||August 2007||2007-08-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Phase I Trial of PX-478|A Phase 1 Trial of Oral PX-478 (a HIF-1α Inhibitor) in Patients With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|45|Anticipated|Cascadian Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 15:19:32.970822|2017-02-18 15:19:32.970822
NCT00522639|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-06-29|||October 2008||2008-10-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|||||Interventional|FDG-PET lung||Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation|Determination of the Predictive Value of FDG-PET-CT Scans, Blood Proteins and Blood Cells for the Prognosis for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation|Terminated||Phase 3|120|Anticipated|Maastricht Radiation Oncology||1||Poor accrual|f||||f||||||||||2017-02-18 15:19:33.076835|2017-02-18 15:19:33.076835
NCT00522626|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2016-02-29|2012-04-25||August 2006||2006-08-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Observational|||Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment|Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment|Completed||N/A|19|Actual|Johns Hopkins University|Difficulty in recruiting leading to small number of subjects analyzed||1||f||||f||||||||||2017-02-18 15:19:33.179083|2017-02-18 15:19:33.179083
NCT00522613|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-02-03|||July 2005||2005-07-01|September 2006|2006-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Recovery Group Pilot|Recovery Group Pilot|Completed||N/A|50|Actual|Kaiser Permanente|||||f||||f||||||||||2017-02-18 15:19:35.834663|2017-02-18 15:19:35.834663
NCT00522600|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-29|2009-07-21|||February 2007||2007-02-01|July 2009|2009-07-01|July 2007|Actual|2007-07-01|||||Observational|||Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations|Evaluation of Eye Drop Administration in Glaucoma Patients|Completed||N/A|200|Actual|Robin, Alan L., M.D.|||3||f||||f||||||||||2017-02-18 15:19:35.930466|2017-02-18 15:19:35.930466
NCT00522587|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2013-01-29|||April 2008||2008-04-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|July 2009|Actual|2009-07-01||Interventional|||Sevoflurane-Remifentanil Interaction: Multiple Response Surfaces, Validation of Calibration Stimuli, Validation of the Intraoperative Isobole Concept and Investigating Remifentanil Induced Opioid Tolerance|Sevoflurane-Remifentanil Interaction: Multiple Response Surfaces, Validation of Calibration Stimuli, Validation of the Intraoperative Isobole Concept and Investigating Remifentanil Induced Opioid Tolerance|Completed||Phase 2|40|Actual|University Hospital, Ghent||12|||f||||f||||||||||2017-02-18 15:19:36.019021|2017-02-18 15:19:36.019021
NCT00522574|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2011-04-04|||August 2007||2007-08-01|April 2011|2011-04-01||||||||Interventional|||A Safety Study of XL019 in Adults With Myelofibrosis|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL019 Administered to Subjects With Myelofibrosis|Terminated||Phase 1|100|Anticipated|Exelixis||1||Due to emerging safety data|f||||t||||||||||2017-02-18 15:19:36.130877|2017-02-18 15:19:36.130877
NCT00522561|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2009-06-09|||January 2008||2008-01-01|June 2009|2009-06-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Lower Limb Mechanical Characteristics: Effect on Running Mechanics and Energetics|Lower Limb Mechanical Characteristics: Effect on Running Mechanics and Energetics|Completed||N/A|20|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-02-18 15:19:36.218601|2017-02-18 15:19:36.218601
NCT00522548|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2011-02-18|||March 2007||2007-03-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study of Gastrointestinal Side Effects in African American Kidney Transplant Recipients Treated With CellCept or Myfortic|A Phase IV Randomized, Open Label, Comparative, Single Center Study to Assess Gastrointestinal Adverse Effect Outcomes of De Novo African American Kidney Transplant Recipients Treated With Prograf (Tacrolimus) or Its Generic Equivalent/CellCept (Mycophenolate Mofetil) or Its Generic Equivalent/Corticosteroids Versus Prograf (Tacrolimus) or Its Generic Equivalent/Myfortic (Enteric Coated Mycophenolate Sodium)/Corticosteroids|Terminated||Phase 4|37|Actual|University of Pennsylvania||2||enrollment halted in order to have all patients complete follow-up by Jan 2011|f||||f||||||||||2017-02-18 15:19:36.312092|2017-02-18 15:19:36.312092
NCT00522535|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-06-17|||April 2006||2006-04-01|June 2015|2015-06-01|January 2018|Anticipated|2018-01-01|September 2011|Actual|2011-09-01||Interventional|PYTHAGORAS||Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft|Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft|Active, not recruiting||N/A|210|Anticipated|Lombard Medical||3|||f||||t||||||||||2017-02-18 15:19:36.420671|2017-02-18 15:19:36.420671
NCT00522522|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2012-05-29|||February 2008||2008-02-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy|Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy Until Being Confirmed (EPILIVE Study)|Completed||N/A|400|Actual|UCB Pharma|||1||f||||t||||||||||2017-02-18 15:19:36.80934|2017-02-18 15:19:36.80934
NCT00522509|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2007-08-28|||December 1995||1995-12-01|May 2007|2007-05-01||||||||Observational|||Preoperative Hepatic Arterial Infusion Chemotherapy|Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases|Unknown status|Active, not recruiting|N/A|||IRCCS San Raffaele|||||f||||||||||||||2017-02-18 15:19:36.912902|2017-02-18 15:19:36.912902
NCT00522496|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2009-02-20|||July 2007||2007-07-01|February 2009|2009-02-01|August 2009|Anticipated|2009-08-01|||||Observational|||Proteomics of Severe Traumatic Brain Injury: A Feasibility Study|Proteomics of Severe Traumatic Brain Injury: A Feasibility Study|Unknown status|Recruiting|N/A|8|Anticipated|University of Calgary|||1||f||||f||||||||||2017-02-18 15:19:37.024102|2017-02-18 15:19:37.024102
NCT00522470|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2008-05-07||||||May 2008|2008-05-01||||||||Interventional|||Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels|Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels in Diabetic Women|Completed||Phase 4|||Baskent University|||||f||||t||||||||||2017-02-18 15:19:37.118525|2017-02-18 15:19:37.118525
NCT00522457|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2011-04-28|2011-03-01||January 2008||2008-01-01|April 2011|2011-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy|Phase II Study Of The Trifunctional Bispecific Anti-HER-2/Neu x Anti-CD3 Antibody Ertumaxomab In Patients With HER-2/Neu Overexpressing (3+ Or 2+/FISH+) Metastatic Breast Cancer Progressing After Trastuzumab Treatment|Terminated||Phase 2|19|Actual|Neovii Biotech|The study was prematurely terminated. This decision was based on strategic changes in the company's research and development program and resulted in limited patient data.|1||change in development plan, not due to safety concerns.|f||||t||||||||||2017-02-18 15:19:37.210263|2017-02-18 15:19:37.210263
NCT00522444|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2014-02-05|||September 2007||2007-09-01|August 2007|2007-08-01||||||||Interventional|||Nebulized Magnesium Sulfate in Pediatric Asthma|Nebulized Magnesium Sulfate Compared to Saline in Addition to Albuterol and Ipratropium Treatments in Moderate to Severe Pediatric Asthmatic Patients: A Randomized Controlled Clinical Trial|Terminated||Phase 3|34|Actual|Children's Hospital Medical Center, Cincinnati||||institution in Canada is conducting a similar clinical trial with potential of validating use.|t||||t||||||||||2017-02-18 15:19:37.581947|2017-02-18 15:19:37.581947
NCT00522431|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2014-01-24|2014-01-24||August 2007||2007-08-01|January 2014|2014-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||All Patients|A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone|An Open Label Phase 3 Study of Fortigel Testosterone Gel 2% in Hypogonadal Males|Completed||Phase 3|149|Actual|Prostrakan Pharmaceuticals||1|||f||||||||||||||2017-02-18 15:19:37.692265|2017-02-18 15:19:37.692265
NCT00522418|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-01-09|2010-04-02||February 2006||2006-02-01|October 2012|2012-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||All participants who completed the baseline assessment and at least one postbaseline follow-up QOLIE-89 assessment, and met local IRB consent requirements|Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients|An Open Prospective Randomised Long-Term Effectiveness Study, Comparing Best Medical Practice With or Without Adjunctive VNS Therapy in Patients 16 Years and Older With Pharmaco-resistant Partial Epilepsy|Terminated||Phase 4|122|Actual|Cyberonics, Inc.|This study was terminated as a result of a decision by Cyberonics, Inc. The decision to terminate the study was primarily due to insufficient enrollment. The decision was not the result of a safety or efficacy signal.|2||Insufficient enrollment|f||||t||||||||||2017-02-18 15:19:37.942573|2017-02-18 15:19:37.942573
NCT00522405|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2012-07-13|||October 2007||2007-10-01|August 2007|2007-08-01|October 2014|Anticipated|2014-10-01|August 2014|Anticipated|2014-08-01||Interventional|||Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma||Unknown status|Recruiting|Phase 2/Phase 3|||All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 15:19:39.140609|2017-02-18 15:19:39.140609
NCT00522392|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2015-06-23|2015-03-05||September 2007||2007-09-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|August 2012|Actual|2012-08-01||Interventional||All randomized patients.|Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone|Randomized Phase III Trial of Consolidation Therapy With Bortezomib (Velcade®)-Lenalidomide (Revlimid®) -Dexamethasone (VRD) Versus Bortezomib (Velcade®)-Dexamethasone (VD) for Patients With Multiple Myeloma Who Have Completed a Dexamethasone Based Induction Regimen|Terminated||Phase 3|48|Actual|National Cancer Institute (NCI)||2||Slow accrual|f||||t||||||||||2017-02-18 15:19:39.273949|2017-02-18 15:19:39.273949
NCT00522379|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2014-10-17|2012-07-03||July 2007||2007-07-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch|A Multicenter, Randomized, Double-blind, Placebo-controlled, 5-arm, Parallel-group Trial to Assess Rotigotine Transdermal System Dose Response in Subjects With Advanced-stage Parkinson's Disease|Completed||Phase 3|514|Actual|UCB Pharma||5|||f||||f||||||||||2017-02-18 15:19:40.314433|2017-02-18 15:19:40.314433
NCT00522353|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2008-05-21|||January 2007||2007-01-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||Prebiotic Fiber as a Modifier of Satiety Hormones and Body Weight in Overweight and Obese Adults|Effect of Oligofructose Versus Placebo on Body Weight and Satiety Hormone Secretion in Overweight and Obese Adults.|Completed||N/A|48|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 15:19:42.217793|2017-02-18 15:19:42.217793
NCT00522340|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2014-11-07|||November 2007||2007-11-01|November 2014|2014-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Exercise After an ICD|Anti-Arrhythmic Effects of Exercise After an Implantable Cardioverter Defibrillator (ICD)|Completed||Phase 2|160|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:19:42.326775|2017-02-18 15:19:42.326775
NCT00522327|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-07-02|||November 2004||2004-11-01|July 2015|2015-07-01|October 2006|Actual|2006-10-01|||||Interventional|RSMI||Remote Simultaneous Medical Interpreting and Medical Outcomes|Remote Simultaneous Medical Interpretation: Medical Outcomes|Completed||N/A|1200|Actual|New York University School of Medicine||3|||f||||f||||||||||2017-02-18 15:19:42.429939|2017-02-18 15:19:42.429939
NCT00522314|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2007-08-28|||October 2003||2003-10-01|August 2007|2007-08-01|April 2006|Actual|2006-04-01|||||Interventional|||Airway Clearance in Bronchiectasis: is Non-Invasive Ventilation a Useful Adjunct in Moderate to Severe Disease?|Airway Clearance in Bronchiectasis: is Non-Invasive Ventilation a Useful Adjunct in Moderate to Severe Disease?A Pilot Study.|Completed||N/A|20|Actual|University of Ulster||2|||f||||t||||||||||2017-02-18 15:19:42.509476|2017-02-18 15:19:42.509476
NCT00522301|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2016-02-01|2015-10-21||July 2007||2007-07-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission|A Phase II Trial of Oral Sorafenib (Bay43-9006) In Women With Epithelial Ovarian, Fallopian Tube Or Peritoneal Carcinoma In Second Or Greater Remission|Terminated||Phase 2|6|Actual|Memorial Sloan Kettering Cancer Center|Early termination as it would not meet it's primary endpoint of improved survival. None of the patients completed the study.|1|||f||||||||||||||2017-02-18 15:19:42.685801|2017-02-18 15:19:42.685801
NCT00522288|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2011-03-17|||September 2003||2003-09-01|March 2011|2011-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|ACHIEVE||Effects of Contact Lens Wear on Children's Self-Perceptions|Adolescent and Child Health Initiative to Encourage Vision Empowerment (ACHIEVE) Study|Completed||N/A|484|Actual|Ohio State University||2|||f||||t||||||||||2017-02-18 15:19:43.082068|2017-02-18 15:19:43.082068
NCT00522275|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-04-07|2010-10-28||October 2004||2004-10-01|April 2015|2015-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures|An Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral SPM 927 in Patients With Partial Seizures|Completed||Phase 3|308|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:19:43.219394|2017-02-18 15:19:43.219394
NCT00522262|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-01-14|||June 2002||2002-06-01|January 2015|2015-01-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial|Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial|Completed||N/A|320|Actual|AHS Cancer Control Alberta||2|||f||||f||||||||||2017-02-18 15:19:43.741306|2017-02-18 15:19:43.741306
NCT00522249|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2016-03-15|||May 2007||2007-05-01|March 2016|2016-03-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC|A Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 1/Phase 2|10|Actual|The Methodist Hospital System||1||PI decision|f||||f||||||||No||2017-02-18 15:19:43.85435|2017-02-18 15:19:43.85435
NCT00522236|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2012-01-24|||June 2007||2007-06-01|January 2012|2012-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects|A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Elderly Subjects|Completed||Phase 2|56|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:19:43.980196|2017-02-18 15:19:43.980196
NCT00522223|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2016-09-30|||September 2002||2002-09-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Observational|||Sexual Functioning in Cervical Cancer Survivors|Sexual Functioning and Quality of Life in Women With Cervical Cancer|Active, not recruiting||N/A|165|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:19:44.084176|2017-02-18 15:19:44.084176
NCT00522210|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2014-08-29|||March 2008||2008-03-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes|A Comparison of Insulin Detemir in a BID Insulin Regimen Versus a TID Insulin Regimen in Children With Type 1 Diabetes: A Randomized Controlled Trial|Completed||N/A|18|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 15:19:44.195526|2017-02-18 15:19:44.195526
NCT00522197|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2012-03-07|||September 2002||2002-09-01|March 2012|2012-03-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia|A Phase II Trial of ACAPHA in Former Smokers With Intraepithelial Neoplasia|Completed||Phase 2|90|Actual|British Columbia Cancer Agency||2|||f||||t||||||||||2017-02-18 15:19:44.314735|2017-02-18 15:19:44.314735
NCT00522184|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2007-08-27|||February 2005||2005-02-01|August 2007|2007-08-01|November 2006|Actual|2006-11-01|||||Interventional|||Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study|Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study for Evaluation of Efficacy and Safety of Etanercept Versus Intra-Articular Steroid Injection in Acute Synovitis|Completed||Phase 3|34|Actual|Centre Hospitalier Universitaire de Nice||2|||f||||t||||||||||2017-02-18 15:19:44.413932|2017-02-18 15:19:44.413932
NCT00522171|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2009-11-30|2009-10-19||September 2007||2007-09-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Observational|LBL||Harmonic Versus Electro Surgery in Lower Body Lift Procedures|A Randomized, Prospective, Parallel Group Study Comparing the Harmonic™ to Electro Surgery in Lower Body Lift Procedures|Terminated||Phase 4|30|Actual|Ethicon Endo-Surgery|||1|This study was terminated early due to lack of adequate enrollment.|f||||f||||||||||2017-02-18 15:19:44.516803|2017-02-18 15:19:44.516803
NCT00522158|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2007-08-28||||||August 2007|2007-08-01||||||||Interventional|||Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition||Completed||Phase 4|||Baskent University|||||f||||t||||||||||2017-02-18 15:19:45.011437|2017-02-18 15:19:45.011437
NCT00522145|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2012-01-24||2012-01-24|May 2007||2007-05-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|||Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib|A Phase 2 Study of XL647 in Subjects With Non-Small Cell Lung Cancer Who Have Progressed After Responding to Treatment With Either Gefitinib or Erlotinib|Completed||Phase 2|41|Actual|Kadmon Corporation, LLC||1|||f||||t||||||||||2017-02-18 15:19:45.082014|2017-02-18 15:19:45.082014
NCT00522132|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2011-09-15|||September 2007||2007-09-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Phase II Artesunate Study in Severe Malaria|Phase II Randomized, Double-Blind Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of Intravenous Artesunate in Children With Severe Malaria|Completed||Phase 2|200|Anticipated|Medicines for Malaria Venture||2|||f||||t||||||||||2017-02-18 15:19:45.195956|2017-02-18 15:19:45.195956
NCT00522119|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2008-07-15|||August 2003||2003-08-01|August 2007|2007-08-01|July 2006|Actual|2006-07-01|||||Observational|||Analysis of Genes That Predispose People to Develop High Blood Pressure|Genetic and Functional Analyses of Chromosome 1 Hypertension Susceptibility|Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||f||||||||||2017-02-18 15:19:45.306645|2017-02-18 15:19:45.306645
NCT00522106|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2007-08-28|||May 2001||2001-05-01|August 2007|2007-08-01|May 2008|Anticipated|2008-05-01|||||Interventional|GRADIT||The Effectiveness of Behavioral Graded Activity in Patients With Osteoarthritis of the Hip and/or Knee|The Effectiveness of Behavioral Graded Activity in Patients With Osteoarthritis of the Hip and/or Knee: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|200|Actual|Netherlands Instititute for Health Services Research||2|||f||||f||||||||||2017-02-18 15:19:45.377268|2017-02-18 15:19:45.377268
NCT00522093|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2011-08-21|||August 2007||2007-08-01|October 2009|2009-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of TJ-100 in the Treatment of Chronic Constipation||Completed||N/A|60|Anticipated|Showa Inan General Hospital||1|||f||||t||||||||||2017-02-18 15:19:45.48604|2017-02-18 15:19:45.48604
NCT00522080|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2007-08-27|||March 2005||2005-03-01|August 2007|2007-08-01|December 2005|Actual|2005-12-01|||||Observational|||Screening for Hip and Knee Osteoarthritis in the General Population: Predictive Value of a Questionnaire and Prevalence Estimates|Screening for Hip and Knee Osteoarthritis in the General Population: Predictive Value of a Questionnaire and Prevalence Estimates|Terminated||N/A|||Centre Hospitalier Universitaire de Nice||||terminated study|f||||t||||||||||2017-02-18 15:19:45.579879|2017-02-18 15:19:45.579879
NCT00522067|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2016-11-30|||June 2007||2007-06-01|January 2012|2012-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.|A Phase II, Open Label, Uncontrolled, Multi-Center Study to Support Annual Strain Update and to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects Aged 18-64 Years Affected by Chronic Diseases|Completed||Phase 2|52|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:19:45.654734|2017-02-18 15:19:45.654734
NCT00522054|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2007-08-27|||September 2004||2004-09-01|August 2007|2007-08-01|March 2005|Actual|2005-03-01|||||Interventional|||Tai Chi for Patients With Rheumatoid Arthritis|Tai Chi for Patients With Rheumatoid Arthritis: A Quantitative and Qualitative Study|Completed||N/A|15|Actual|Diakonhjemmet Hospital||1|||f||||f||||||||||2017-02-18 15:19:45.760899|2017-02-18 15:19:45.760899
NCT00522041|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2016-09-15|2014-01-27||August 2007||2007-08-01|September 2016|2016-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||Safety population: All participants who received at least 1 application of study medication.|A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures|A Randomized. Double-blind, Placebo-controlled, Multi-national Study to Determine the Effect of Cellegesic Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With a Chronic Anal Fissure|Completed||Phase 3|248|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 15:19:45.860589|2017-02-18 15:19:45.860589
NCT00522028|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-28|2016-05-20|||October 1998||1998-10-01|June 1996|1996-06-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|SIPH||Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial|Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial|Completed||N/A|191|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-02-18 15:19:46.574042|2017-02-18 15:19:46.574042
NCT00522015|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2008-02-14|||February 2008||2008-02-01|August 2007|2007-08-01|February 2010||2010-02-01|December 2009||2009-12-01||Interventional|psp||Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy|Rivastigmine (Exelon®) for Treatment of Dementia in Patient With Progressive Supranuclear Paresis Open Label Phase 2 Study|Unknown status|Recruiting|Phase 2|20|Anticipated|University Hospital Tuebingen||1|||f||||t||||||||||2017-02-18 15:19:46.671736|2017-02-18 15:19:46.671736
NCT00521989|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2014-03-26|2014-02-10||August 2007||2007-08-01|March 2014|2014-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|COMET-1||CRx-102 Osteoarthritis Multicenter Evaluation Trial|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of CRx-102 in Subjects With Symptomatic Knee Osteoarthritis and Optional One-Year Extension|Terminated||Phase 2|279|Actual|Zalicus||5||CRx-102-006 study results, negative|f||||t||||||||||2017-02-18 15:19:46.877518|2017-02-18 15:19:46.877518
NCT00521976|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-05-19|2009-01-09||November 2002||2002-11-01|May 2015|2015-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|RACS||Risk Markers in the Acute Coronary Syndromes|An Investigation of Activated Factor XII (Fxlla) as a Prognostic Marker.|Completed||N/A|871|Actual|Helse Stavanger HF|||1||f||||f||||||Samples Without DNA|"~     Serum, Citrated plasma, EDTA-plasma and packed red blood cells are kept in suitable aliquots~     at -80 degrees Celcius.~   "|||2017-02-18 15:19:47.687904|2017-02-18 15:19:47.687904
NCT00521963|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2015-06-25|||March 2010||2010-03-01|June 2015|2015-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Intraarticular Injection of Infliximab|Interventional Study: Administration of Intraarticular Injection of Infliximab in Patients With Inflammatory Arthritis Who Failed Intraarticular Injection of Corticosteroids|Withdrawn||Phase 2/Phase 3|0|Actual|HaEmek Medical Center, Israel||1||poor accrual|f||||f||||||||||2017-02-18 15:19:47.937576|2017-02-18 15:19:47.937576
NCT00521950|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2014-03-27|||September 2007||2007-09-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|TOPIC||Cost-effectiveness of TPMT Pharmacogenetics|Pharmacogenetic Testing in the Clinical Setting: is Screening for TPMT Genotype a Cost-effective Treatment Strategy? - The First Prospective Randomized Controlled Trial Within the Dutch Health Care System.|Completed||N/A|853|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:19:48.056568|2017-02-18 15:19:48.056568
NCT00521937|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2010-12-14|||January 2009||2009-01-01|December 2010|2010-12-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|DERMAGEN®||Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer|A Prospective, Randomised, Multi-centre, Blind-observer, Controlled, Parallel-group Study Comparing the Efficacy and Safety of DERMAGEN® Versus Conventional Treatment in the Treatment of Diabetic Neuropathic Foot Ulcer|Unknown status|Active, not recruiting|Phase 3|388|Anticipated|Laboratoires Genévrier||2|||f||||f||||||||||2017-02-18 15:19:48.192356|2017-02-18 15:19:48.192356
NCT00521924|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-03-18|2009-04-03||June 2007||2007-06-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)|Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab-therapy|Terminated||Phase 3|8|Actual|Merck Sharp & Dohme Corp.||2||Slow Enrollment|f||||f||||||||||2017-02-18 15:19:48.299352|2017-02-18 15:19:48.299352
NCT00521911|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2008-12-24|||August 2007||2007-08-01|December 2008|2008-12-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Detection and Treatment of Depression in Patients Admitted to the General Hospital||Unknown status|Recruiting|Phase 2|60|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 15:19:48.559789|2017-02-18 15:19:48.559789
NCT00521898|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2015-06-02|||February 2005||2005-02-01|June 2015|2015-06-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|DMEK||Descemet Membrane Endothelial Keratoplasty (DMEK)|Prospective Clinical Study on Descemet Membrane Endothelial Keratoplasty (DMEK)|Recruiting||N/A|100|Anticipated|Netherlands Institute for Innovative Ocular Surgery||1|||f||||t||||||||||2017-02-18 15:19:48.664929|2017-02-18 15:19:48.664929
NCT00521885|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2014-09-18|||September 2007||2007-09-01|September 2014|2014-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|BRiEF||Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients|Arixtra(Fondaparinux) vs. Lovenox (Enoxaparin) in Prevention of DVT in Acute Medically Ill, Non-surgical Patients|Terminated||N/A|50|Anticipated|Lehigh Valley Hospital||1||Study stopped due to lack of accrual|f||||t||||||||||2017-02-18 15:19:48.788326|2017-02-18 15:19:48.788326
NCT00521872|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2008-06-25|||April 2004||2004-04-01|August 2007|2007-08-01|October 2007|Actual|2007-10-01|||||Interventional|||Stapled Trans Anal Rectal Resection (STARR) for Outlet Obstruction: Functional and Morphological Outcome|Stapled Trans Anal Rectal Resection (STARR) for Outlet Obstruction: Functional and Morphological Outcome|Completed||Phase 4|||University of Zurich|||||f||||f||||||||||2017-02-18 15:19:48.895975|2017-02-18 15:19:48.895975
NCT00521859|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2012-07-27|||August 2007||2007-08-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies|Dose Escalation Trial of Cloretazine (VNP40101M) and Hematopoietic Cell Transplantation for Patients With Selected, Poor-Prognosis Hematologic Malignancies|Completed||Phase 1|5|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:19:48.977152|2017-02-18 15:19:48.977152
NCT00521846|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2017-01-24|||August 2007||2007-08-01|January 2017|2017-01-01|August 2020|Anticipated|2020-08-01|August 2020|Anticipated|2020-08-01||Observational|||ExploR™ Modular Radial Head Data Collection|ExploR™ Modular Radial Head Data Collection|Recruiting||N/A|50|Anticipated|Vanderbilt University Medical Center|||1||f||||f|f|t|f|f||||No|Will not be shared.|2017-02-18 15:19:49.091453|2017-02-18 15:19:49.091453
NCT00521833|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2007-09-04|||June 2005||2005-06-01|August 2007|2007-08-01|August 2006|Actual|2006-08-01|||||Interventional|||Surgically Induced Astigmatism of Temporal Versus Nasal Clear Corneal Phacoemulsification||Completed||N/A|20|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:19:49.213365|2017-02-18 15:19:49.213365
NCT00521820|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-25|2012-02-27|||June 2000||2000-06-01|February 2012|2012-02-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure|A Randomized, Double-Blind, Comparator-Controlled Study of Pioglitazone HCl vs Glyburide in the Treatment of Subjects With Type 2 (Non-Insulin Dependent) Diabetes Mellitus and Mild to Moderate Congestive Heart Failure|Terminated||Phase 3|518|Actual|Takeda||2||"Higher incidence of hospitalization for congestive heart failure in pioglitazone-treated~   subjects compared to glyburide treated subjects."|f||||t||||||||||2017-02-18 15:19:49.304189|2017-02-18 15:19:49.304189
NCT00521807|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2008-10-17|||March 2001||2001-03-01|August 2007|2007-08-01|May 2005|Actual|2005-05-01|||||Interventional|||Hypnosis as a Treatment of Chronic Widespread Pain in General Practice. A Pilot Study.||Completed||N/A|18|Actual|University of Oslo||2|||f||||f||||||||||2017-02-18 15:19:49.525734|2017-02-18 15:19:49.525734
NCT00521794|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2013-01-15|||November 2007||2007-11-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Characteristics of Andersen-Tawil Syndrome|Andersen-Tawil Syndrome: Genotype-Phenotype Correlation and Longitudinal Study|Completed||N/A|28|Actual|University of Rochester|||1||f||||t||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 15:19:49.615761|2017-02-18 15:19:49.615761
NCT00521781|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2016-03-15|||August 2007||2007-08-01|March 2016|2016-03-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer|Phase II Trial of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Adenocarcinoma of the Prostate|Terminated||Phase 2|14|Actual|The Methodist Hospital System||1||Sponsor decision|f||||f||||||||No||2017-02-18 15:19:49.725357|2017-02-18 15:19:49.725357
NCT00521768|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-07-06||||||July 2015|2015-07-01||||||||Interventional|||Effectiveness of Prolonged Exposure of PTSD in a Community Setting of PTSD Sufferers||Withdrawn||N/A|0|Actual|HaEmek Medical Center, Israel|||||f||||||||||||||2017-02-18 15:19:49.837136|2017-02-18 15:19:49.837136
NCT00521755|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-26|2011-06-08|||December 2008||2008-12-01|June 2009|2009-06-01|February 2010|Actual|2010-02-01|November 2009|Actual|2009-11-01||Interventional|||Evaluation of Safety and Efficacy of Using Seraffix LTB - (Laser Tissue Bonding) System|Evaluation of Safety and Efficacy of Using Seraffix LTB - (Laser Tissue Bonding) System|Completed||N/A|15|Anticipated|Seraffix||1|||f||||f||||||||||2017-02-18 15:19:49.926647|2017-02-18 15:19:49.926647
NCT00521742|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-25|2012-02-27|||March 2001||2001-03-01|February 2012|2012-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease|A Randomized, Double-Blind, Comparator-Controlled Study of Pioglitazone HCl vs Glyburide in the Treatment of Patients With Type 2 (Non-Insulin-Dependent) Diabetes Mellitus and Mild Cardiac Disease (NYHA I)|Completed||Phase 3|300|Actual|Takeda||4|||f||||t||||||||||2017-02-18 15:19:50.029238|2017-02-18 15:19:50.029238
NCT00521729|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-25|2017-01-24|||August 24, 2007||2007-08-24|January 3, 2017|2017-01-03|January 12, 2015|Actual|2015-01-12|January 12, 2015|Actual|2015-01-12||Interventional|||Metabolism and Thyroid Hormone Changes During Exposure to Cold Temperatures|Thyroid Hormones Homeostasis and Energy Metabolism Changes During Exposure to Cold Temperature in Humans|Completed||N/A|160|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:19:50.152096|2017-02-18 15:19:50.152096
NCT00521716|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-26|2009-01-09|||September 2007||2007-09-01|February 2008|2008-02-01|December 2009|Anticipated|2009-12-01|March 2008|Anticipated|2008-03-01||Interventional|||Safety and Efficacy of the WaisFix100i for Intracapsular Femoral Fracture Fixation|A Single Arm, Uni-Center, Prospective Clinical Investigation to Evaluate Safety and Efficacy of the WaisFix100i for Intracapsular Femoral Fracture Fixation|Suspended||N/A|20|Anticipated|OrthoMediTec||1|||f||||t||||||||||2017-02-18 15:19:50.250462|2017-02-18 15:19:50.250462
NCT00521703|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2008-05-22|||August 2007||2007-08-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|||||Interventional|||Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children|Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children and Teenagers|Completed||Phase 3|78|Actual|Hospital Infantil Cândido Fontoura||2|||f||||f||||||||||2017-02-18 15:19:50.362353|2017-02-18 15:19:50.362353
NCT00521690|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2014-11-25|||December 2006||2006-12-01|November 2014|2014-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD|Safety and Therapeutic Effect of Insulin Detemir in Taiwanese Patients With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets With OAD With/Without Once-daily NPH Insulin Treatment|Completed||Phase 4|25|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:19:50.474932|2017-02-18 15:19:50.474932
NCT00521677|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-06-21|||September 2007||2007-09-01|June 2015|2015-06-01|October 2009|Actual|2009-10-01|February 2009|Actual|2009-02-01||Interventional|||Comparison Between Two Methods of Oral Care on the Incidence of VAP||Completed||N/A|108|Actual|HaEmek Medical Center, Israel||2|||f||||t||||||||||2017-02-18 15:19:50.574035|2017-02-18 15:19:50.574035
NCT00521664|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2011-05-18|||September 2004||2004-09-01|May 2011|2011-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups|Prospective Randomized Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups: 1)in Patients With Acute Myeloid Leukemia After Intensive Chemotherapy and 2) After Autologous Blood Stem Cell Transplantation|Completed||Phase 3|400|Actual|Technische Universität Dresden||2|||f||||t||||||||||2017-02-18 15:19:50.680748|2017-02-18 15:19:50.680748
NCT00521651|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-25|2013-05-02|||July 2005||2005-07-01|November 2012|2012-11-01||||||||Observational|||PRelationship Between Physical Activity and Cancer Ris|Physical Activity and Its Components in Relation to Plasma Inflammatory Markers of Cancer Risk Among Chinese Adults|Completed||N/A|620|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:19:50.78509|2017-02-18 15:19:50.78509
NCT00521638|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2013-01-07||2013-01-07|September 2007||2007-09-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma|A Phase 1/2 Dose Escalation Study of TRU-015 in Subjects With Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|120|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:19:50.875356|2017-02-18 15:19:50.875356
NCT00521625|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2008-05-21|||June 2007||2007-06-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|||||Observational|PALIVE1||Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury|Epidemiologic Multicenter Study on Mechanical Ventilation Management in Children With Acute Lung Injury - Phase 1 PALIVE 1 (for Pediatric Acute Lung Injury Mechanical VEntilation Strategies)|Completed||N/A|||St. Justine's Hospital|||||f||||f||||||||||2017-02-18 15:19:50.982675|2017-02-18 15:19:50.982675
NCT00521612|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2007-12-26|||September 2007||2007-09-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Sevoflurane vs. Isoflurane for Low-Flow General Anaesthesia for Abdominal Surgery|Prospective Randomised Controled Trial: Comparison of Volatile Anaesthetics Sevoflurane vs. Isoflurane for Low-Flow General Anaesthesia for Abdominal Surgery|Completed||N/A|82|Actual|General Hospital Dubrovnik||2|||f||||t||||||||||2017-02-18 15:19:53.660351|2017-02-18 15:19:53.660351
NCT00520832|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2008-10-16|||September 2007||2007-09-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys|A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys|Completed||Phase 2|20|Anticipated|Logan College of Chiropractic||2|||f||||||||||||||2017-02-18 15:20:14.01758|2017-02-18 15:20:14.01758
NCT00521599|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2015-09-18|2010-02-26||May 2007||2007-05-01|September 2015|2015-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)|A Study of the Therapeutic Equivalency of MF DPI 100 mcg and 200 mcg Inhalers in Corticosteroid-Dependent Subjects With Moderate Asthma|Completed||Phase 4|672|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 15:19:53.782057|2017-02-18 15:19:53.782057
NCT00521586|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2015-04-07|2014-12-10||September 2007||2007-09-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Safety analysis set included all randomized participants who had received at least 1 dose of study treatment.|Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine|A Phase 3, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A 13-valent Pneumococcal Conjugate Vaccine (13vpnc) When Administered Concomitantly With Trivalent Inactivated Influenza Vaccine In Healthy Adults 50-59 Years Of Age Who Are Naive To 23-valent Pneumococcal Polysaccharide Vaccine And To Evaluate The Immune Response Of A Second Dose Of 13vpnc Administered 5 Years After Initial 13vpnc Vaccination|Completed||Phase 3|1116|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:19:54.324434|2017-02-18 15:19:54.324434
NCT00521573|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2007-08-27||||||August 2007|2007-08-01||||||||Interventional|||Effects of Chocolate on Coronary Vasomotion in Patients After Heart Transplantation||Completed||Phase 1|||University of Zurich|||||f||||f||||||||||2017-02-18 15:19:59.472879|2017-02-18 15:19:59.472879
NCT00521560|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2013-02-13|||March 2006||2006-03-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|August 2009|Actual|2009-08-01||Interventional|escZ-BEAM||A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas|Phase I/II Study Concomitant High-Dose Radio-Immuno- and Chemotherapy With Simultaneous Application of Zevalin and BEAM Followed by Autologous Peripheral Stem Cell Transplantation in Relapsed and Refractory CD 20+ Non-Hodgkin's Lymphoma|Completed||Phase 2|28|Actual|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||1|||f||||t||||||||||2017-02-18 15:19:59.536566|2017-02-18 15:19:59.536566
NCT00521547|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2007-08-27|||September 2003||2003-09-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||To Study the Mechanisms of Acupuncture Through Functional Magnetic Resonance Imaging and Peripheral Neurosensory Testing|Healthy Subject Studies to Assess the Effect of Different Electroacupuncture Parameters on Analgesia, Peripheral Sensory Thresholds and Central Pain Processing.|Completed||N/A|40|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 15:19:59.639878|2017-02-18 15:19:59.639878
NCT00521534|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2012-09-17|||March 2006||2006-03-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Observational|IMPACT||Impact of Resynchronization Therapy on Sleep Disordered Breathing in Advanced Congestive Heart Failure|Impact of Resynchronization Therapy on Sleep Disordered Breathing in Advanced Congestive Heart Failure|Completed||N/A|19|Actual|VA Pittsburgh Healthcare System|||2||f||||f||||||||||2017-02-18 15:19:59.713648|2017-02-18 15:19:59.713648
NCT00521521|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2009-12-04|||July 2001||2001-07-01|December 2009|2009-12-01||||May 2006|Actual|2006-05-01||Interventional|TAX200006||Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer|A Multicenter, Randomized, Phase II Study of the Combination of Docetaxel (TAXOTERE) and Concomitant Radiotherapy With or Without Cisplatin in Patients With Locally Advanced Head and Neck Cancer|Completed||Phase 2|86|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:20:00.062152|2017-02-18 15:20:00.062152
NCT00521508|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2010-09-28|||April 2008||2008-04-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|April 2010|Actual|2010-04-01||Interventional|||Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy|Role of CD4+CD25+FoxP3+ Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy|Completed||N/A|45|Anticipated|Centre Hospitalier Universitaire de Saint Etienne||3|||f||||f||||||||||2017-02-18 15:20:00.15718|2017-02-18 15:20:00.15718
NCT00521495|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2009-11-23|||September 2006||2006-09-01|November 2009|2009-11-01|August 2009|Anticipated|2009-08-01|June 2009|Anticipated|2009-06-01||Interventional|CTS/SMF||Carpal Tunnel Syndrome and Static Magnetic Field Therapy|Carpal Tunnel Syndrome and Static Magnetic Field Therapy|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National College of Natural Medicine||3|||f||||f||||||||||2017-02-18 15:20:00.283931|2017-02-18 15:20:00.283931
NCT00521482|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-27|2007-08-27|||September 2007||2007-09-01|August 2007|2007-08-01|January 2009|Anticipated|2009-01-01|||||Interventional|||Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma|Intensive Dose Temozolomide Treatment or Temozolomide With Thalidomide Treatment in Recurrent Glioblastoma After Standard Therapy:a Randomized Phase II Trial|Unknown status|Not yet recruiting|Phase 2|40|Anticipated|University of Zurich||2|||f||||f||||||||||2017-02-18 15:20:00.394414|2017-02-18 15:20:00.394414
NCT00521469|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2008-10-16|||March 2007||2007-03-01|August 2007|2007-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Randomized Controlled Single-Blind Study of the Effects of Instrument-Applied Spinal Manipulative Therapy on Postural Control|A Randomized Controlled Single-Blind Study of the Effects of Instrument-Applied Spinal Manipulative Therapy on Postural Control|Completed||Phase 2|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 15:20:00.504478|2017-02-18 15:20:00.504478
NCT00521456|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2009-09-29|2009-08-19||October 2007||2007-10-01|August 2009|2009-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery||Completed||Phase 3|263|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:20:00.591851|2017-02-18 15:20:00.591851
NCT00521443|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2007-08-24||||||August 2007|2007-08-01||||||||Observational|||Cryosurvival of Embryos From Dysmorphic Oocytes||Completed||N/A|||V.K.V. American Hospital, Istanbul|||12||f||||||||||||||2017-02-18 15:20:00.989177|2017-02-18 15:20:00.989177
NCT00521430|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2013-03-25|||April 2004||2004-04-01|October 2007|2007-10-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease|NON-T-CELL DEPLETED HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION AFTER REDUCED INTENSITY CONDITIONING|Completed||N/A|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:20:01.072973|2017-02-18 15:20:01.072973
NCT00521417|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2016-04-29|||August 2005||2005-08-01|April 2016|2016-04-01|August 2020|Anticipated|2020-08-01|August 2018|Anticipated|2018-08-01||Interventional|KOLG-P||Short- and Long-term Group Psychotherapy|A Randomized Controlled Study of the Efficacy of Analytic Oriented Group Psychotherapy for Psychiatric Outpatients|Active, not recruiting||Phase 2|140|Anticipated|University of Oslo||2|||f||||t||||||||||2017-02-18 15:20:01.207191|2017-02-18 15:20:01.207191
NCT00521404|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2010-10-27||2010-10-27|August 2007||2007-08-01|October 2010|2010-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Open-label Study of CS1008 for Subjects With Untreated and Unresectable Pancreatic Cancer|Phase 2 Multicenter, Open-Label Study of CS-1008, A Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5), In Combination With Gemcitabine in Chemotherapy Naive Subjects With Unresectable or Metastatic Pancreatic Cancer|Completed||Phase 2|65|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 15:20:01.327156|2017-02-18 15:20:01.327156
NCT00521391|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2007-08-24|||April 2003||2003-04-01|August 2007|2007-08-01|December 2005|Actual|2005-12-01|||||Interventional|PHASMO||Physical Activity as an Aid for Smoking Cessation|Physical Activity as an Aid for Smoking Cessation: a Randomized Controlled Trial|Terminated||Phase 3|600|Actual|University of Lausanne Hospitals||2||End of the recruitment|f||||f||||||||||2017-02-18 15:20:01.68745|2017-02-18 15:20:01.68745
NCT00521378|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2009-01-10||||||January 2009|2009-01-01||||||||Observational|||A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus|A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus|Completed||N/A|20|Anticipated|Diasome Pharmaceuticals|||||f||||f||||||||||2017-02-18 15:20:01.826872|2017-02-18 15:20:01.826872
NCT00521365|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2012-06-12|2010-08-11||May 2008||2008-05-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|EMMY||Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.|A Phase IV STudy of the Effectiveness of Quetiapine Extended Release 600mg Once a Day to Control the Symptoms of Manic Phase of Bipolar Disorder.|Completed||Phase 4|88|Actual|AstraZeneca|Open label, non comparative study|1|||f||||||||||||||2017-02-18 15:20:01.928426|2017-02-18 15:20:01.928426
NCT00521352|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2014-09-16|2012-12-13||October 2007||2007-10-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|rTMS||Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression|Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder (PD) With Comorbid Major Depression|Completed||Phase 2|25|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 15:20:02.363835|2017-02-18 15:20:02.363835
NCT00521339|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2016-10-27|2014-10-14||August 2007||2007-08-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional||Safety population consisted of all participants who were enrolled and received at least one dose of study medication.|Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis|A Phase 2, Open-label Multi-center Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Apremilast in Subjects With Recalcitrant Plaque-type Psoriasis|Completed||Phase 2|31|Actual|Celgene Corporation||1|||f||||t||||||||||2017-02-18 15:20:02.985681|2017-02-18 15:20:02.985681
NCT00521326|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2007-08-24|||August 2007||2007-08-01|March 2007|2007-03-01||||||||Observational|||Diagnosis and Characterization of Coronary Artery Stenosis by Doppler Ultrasound|Diagnosis and Characterization of Coronary Artery Stenosis by Transthoracic Doppler Ultrasound|Unknown status|Not yet recruiting|N/A|||Hillel Yaffe Medical Center|||1||f||||f||||||||||2017-02-18 15:20:04.051891|2017-02-18 15:20:04.051891
NCT00521300|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2014-05-30|||September 1999||1999-09-01|May 2014|2014-05-01|May 2010|Actual|2010-05-01|June 2005|Actual|2005-06-01||Interventional|POTA||Preoperative Octreotide Treatment of Acromegaly|Preoperative Octreotide Treatment of Patients With Growth Hormone Producing Pituitary Adenomas|Completed||Phase 4|62|Actual|St. Olavs Hospital||2|||f||||f||||||||||2017-02-18 15:20:04.140226|2017-02-18 15:20:04.140226
NCT00521287|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2008-02-29|||October 2006||2006-10-01|August 2007|2007-08-01|December 2009|Anticipated|2009-12-01|September 2007|Actual|2007-09-01||Interventional|||Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection|Adjustment of Optimal Immune System by Using Cytokine Cocktails Before Applying DC Vaccine|Unknown status|Recruiting|Phase 2|150|Anticipated|Mackay Memorial Hospital||3|||f||||f||||||||||2017-02-18 15:20:04.274277|2017-02-18 15:20:04.274277
NCT00521274|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2016-03-15|||August 2007||2007-08-01|March 2016|2016-03-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer|A Phase II Trial to Assess the Activity of MVA 5T4 (Trovax®) Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer (HRPC)|Terminated||Phase 2|11|Actual|The Methodist Hospital System||2||Oxford BioMedica halted TroVax injections|f||||f||||||||No||2017-02-18 15:20:04.384948|2017-02-18 15:20:04.384948
NCT00521261|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2014-03-04|||October 2007||2007-10-01|March 2014|2014-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Immune Consolidation With Allogeneic Activated T Cells Armed With OKT3 x Rituxan (Anti-CD3 x Anti-CD20) Bispecific Antibody (CD20Bi) After Allogeneic Peripheral Blood Stem Cell Transplant for High Risk CD20+ Non-Hodgkin's Lymphoma (Phase I)|Withdrawn||Phase 1|0|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 15:20:04.629704|2017-02-18 15:20:04.629704
NCT00521248|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2017-01-11|||April 2004||2004-04-01|December 2009|2009-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Buprenorphine for the Treatment of Neonatal Abstinence Syndrome|Buprenorphine for the Treatment of Neonatal Abstinence Syndrome|Completed||Phase 1|60|Anticipated|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 15:20:04.725011|2017-02-18 15:20:04.725011
NCT00521235|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2011-08-10|||June 2012||2012-06-01|August 2011|2011-08-01|December 2012|Anticipated|2012-12-01|||||Observational|||Effect of Different Working Conditions on Risk Factors in Dentists Versus Trainers|Effects of Different Working Condition on Risk Factors in Dentists Versus Trainers. A Combined Crosssectional and Longitudinal Trial With Student and Senior Employees.|Unknown status|Not yet recruiting|N/A|300|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||||||2017-02-18 15:20:04.84588|2017-02-18 15:20:04.84588
NCT00521222|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2013-06-07|||June 2007||2007-06-01|June 2013|2013-06-01|November 2013|Anticipated|2013-11-01|November 2010|Actual|2010-11-01||Interventional|ARGARG||Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes|Arg/Arg Genotype and Long Acting Beta Agonists in Asthma. Improved Quality of Care for Patients With Asthma.|Unknown status|Active, not recruiting|N/A|89|Actual|Columbia University||4|||f||||t||||||||||2017-02-18 15:20:04.926496|2017-02-18 15:20:04.926496
NCT00520819|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2007-08-24|||February 2003||2003-02-01|August 2007|2007-08-01|March 2005|Actual|2005-03-01|||||Interventional|||Oslo Antioxidant Study|Dietary Antioxidant Intervention in Smoking Middle-Aged and Elderly Men|Completed||Phase 1/Phase 2|102|Actual|University of Oslo||3|||f||||f||||||||||2017-02-18 15:20:14.120022|2017-02-18 15:20:14.120022
NCT00521209|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2016-02-12|||March 2008||2008-03-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Patient-Directed Lifestyle Change and Health Promotion Program or Usual Care in Low-Income, Uninsured Participants in Los Angeles County, California|Improving Health Habits: Self-Care Priorities|Active, not recruiting||N/A|97|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||No||2017-02-18 15:20:05.052505|2017-02-18 15:20:05.052505
NCT00521196|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2008-12-01|||July 2007||2007-07-01|December 2008|2008-12-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine)|Phase 2 Study of the Effect of Transcranial Direct Current Stimulation (tDCS) on Pain and Headache Frequency in Migraine.|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|Beth Israel Deaconess Medical Center||4|||f||||t||||||||||2017-02-18 15:20:05.163938|2017-02-18 15:20:05.163938
NCT00521183|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2014-11-24|||June 2007||2007-06-01|November 2014|2014-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain|Translational Phase I Trial of Escalating Doses of 5-Chloro-2'-Deoxycytidine (CldC) With a Fixed Dose of Tetrahydrouridine Combined With External Brain Radiation for Metastatic Carcinoma to the Brain|Completed||Phase 1|2|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:20:05.284158|2017-02-18 15:20:05.284158
NCT00521170|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2013-12-13|||November 2004||2004-11-01|September 2009|2009-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.|Randomized, Monocenter, Double Blind, Placebo-controlled, Single Oral Dose, Three-way Cross Over Study, to Compare Levocetirizine and Desloratadine on Allergen-induced Wheal and Flare Reaction During 24 Hours in 18 Adult Allergic Volunteers.|Completed||Phase 1|||UCB Pharma|||||f||||||||||||||2017-02-18 15:20:05.393203|2017-02-18 15:20:05.393203
NCT00521157|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2009-05-04|||January 2006||2006-01-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction|Naltrexone Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction - a Randomised Study|Completed||Phase 2/Phase 3|56|Actual|University of Oslo||2|||f||||f||||||||||2017-02-18 15:20:05.496226|2017-02-18 15:20:05.496226
NCT00521144|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2015-04-14|2013-10-11||August 2007||2007-08-01|December 2013|2013-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors|Phase I/II Study of Obatoclax Mesylate (GX15-070MS), a Bcl-2 Antagonist, Plus Topotecan in Relapsed Small Cell Lung Carcinoma|Completed||Phase 1/Phase 2|22|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:20:05.61406|2017-02-18 15:20:05.61406
NCT00521131|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2013-12-13|||September 2002||2002-09-01|September 2009|2009-09-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites|Evaluation of Efficacy, Using the Number of Comfortable Days and the Safety of Levocetirizine Dihydrochloride, Administered Once Daily in the Evening for 30 Days, to Subjects Suffering From Perennial Allergic Rhinitis to House Dust Mites|Completed||Phase 4|453|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:20:06.729764|2017-02-18 15:20:06.729764
NCT00521118|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2011-03-29|||October 2007||2007-10-01|March 2011|2011-03-01||||June 2010|Anticipated|2010-06-01||Interventional|||Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor|A Phase II Study to Determine the Response to Second Curettage as Initial Management for Persistent Low Risk, Non-Metastatic Gestational Trophoblastic Neoplasia|Unknown status|Recruiting|Phase 2|66|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:20:06.821123|2017-02-18 15:20:06.821123
NCT00521105|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2011-10-05|||August 2005||2005-08-01|October 2011|2011-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Assessment of an Alternative Model of Follow-up of Children and Adolescents With Type 1 Diabetes|Assessment of an Alternative Model Using Telemedicine Follow-up of Children and Adolescents With Type 1 Diabetes|Completed||N/A|82|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 15:20:06.946422|2017-02-18 15:20:06.946422
NCT00521092|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2014-05-02|||January 2009||2009-01-01|December 2012|2012-12-01||||October 2010|Actual|2010-10-01||Interventional|||Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma|Phase II Study of Sunitinib (SU11248) in Patients With Kaposi's Sarcoma in East Africa|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)||1||No participants enrolled.|f||||||||||||||2017-02-18 15:20:07.057558|2017-02-18 15:20:07.057558
NCT00521079|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2008-09-05|||August 2007||2007-08-01|September 2008|2008-09-01|June 2013|Anticipated|2013-06-01|||||Interventional|EMPOWER||EMPOWER Clinical Trial: Vagal Blocking for Obesity Control|EMPOWER Clinical Trial: Vagal Blocking for Obesity Control|Unknown status|Active, not recruiting|N/A|300|Anticipated|EnteroMedics||2|||f||||t||||||||||2017-02-18 15:20:07.171776|2017-02-18 15:20:07.171776
NCT00521066|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2014-05-05|||June 2007||2007-06-01|May 2014|2014-05-01|June 2010|Actual|2010-06-01|October 2008|Actual|2008-10-01||Observational|||GYNECARE PROSIMA* Pelvic Floor Repair System for Pelvic Organ Prolapse|A Prospective, Multi-centre Study to Evaluate the Clinical Performance of the GYNECARE PROSIMA* Pelvic Floor Repair System as a Procedure for Pelvic Organ Prolapse|Completed||N/A|150|Actual|Ethicon, Inc.|||1||f||||f||||||||||2017-02-18 15:20:07.300759|2017-02-18 15:20:07.300759
NCT00521053|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2014-08-07|2014-06-12||September 2007||2007-09-01|August 2014|2014-08-01|June 2012|Actual|2012-06-01|May 2010|Actual|2010-05-01||Interventional|||Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma|A Phase 2 Study of Intralesional PV-10 in the Treatment of Metastatic Melanoma|Completed||Phase 2|80|Actual|Provectus Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:20:07.443494|2017-02-18 15:20:07.443494
NCT00521040|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2013-12-11|||February 2004||2004-02-01|September 2009|2009-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR|Evaluation of the Efficacy and Safety of Levocetirizine During 8 Weeks Preceding and Following the Anticipated Onset of the Grass Pollen Season in Subjects Suffering From Seasonal Allergic Rhinitis Associated With Pollen-induced Asthma|Completed||N/A|459|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:20:07.935336|2017-02-18 15:20:07.935336
NCT00520624|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2013-11-05||||||November 2013|2013-11-01||||||||Interventional|EIL||Treatment of Exercise-induced Laryngomalacia in Elite Athletes||Unknown status|Not yet recruiting|N/A|95|Anticipated|Bispebjerg Hospital||5|||f||||f||||||||||2017-02-18 15:20:17.972637|2017-02-18 15:20:17.972637
NCT00521027|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2007-08-23|||April 2006||2006-04-01|August 2007|2007-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers|A Prospective, Comparative, Single-Centre Clinical Evaluation to Investigate the Skin-to-Skin Time of the First Surgical Debridement of Lower Extremity Ulcers With VERSAJET™ Hydrosurgery System and Conventional Debridement Techniques.|Completed||Phase 4|46|Actual|Smith & Nephew Medical Ltd||2|||f||||f||||||||||2017-02-18 15:20:08.146633|2017-02-18 15:20:08.146633
NCT00521014|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2015-11-18|2015-10-19||October 2007||2007-10-01|November 2015|2015-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma|A Phase II Study of GM-CSF (Sargramostim) and Rituximab Following Autologous Transplantation For Relapsed Follicular Lymphoma|Completed||Phase 2|14|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:20:08.259139|2017-02-18 15:20:08.259139
NCT00521001|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2016-08-12|||January 2008||2008-01-01|August 2016|2016-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery|A Phase II Study of Temozolomide and Everolimus (RAD001) Therapy for Metastatic Melanoma|Completed||Phase 2|49|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:20:08.526077|2017-02-18 15:20:08.526077
NCT00520988|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2012-04-26|||March 2006||2006-03-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Improving Blood Pressure in Colorado|Improving Blood Pressure in Colorado|Completed||N/A|290|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-02-18 15:20:08.997794|2017-02-18 15:20:08.997794
NCT00520975|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2016-12-12|2016-10-05||November 2007||2007-11-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional||All randomized patients|Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU|A Randomized Phase III Double-Blind Placebo-Controlled Trial of First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab for Patients With HER-2/NEU Over-Expressing Metastatic Breast Cancer|Terminated||Phase 3|96|Actual|National Cancer Institute (NCI)||2||Closed early due to slow accrual|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-02-18 15:20:09.122842|2017-02-18 15:20:09.122842
NCT00520962|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2007-08-24|||June 1997||1997-06-01|August 2007|2007-08-01|May 2006|Actual|2006-05-01|||||Observational|||Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk|New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)|Completed||N/A|1997|Actual|IRCCS San Raffaele|||2||f||||t||||||||||2017-02-18 15:20:10.519752|2017-02-18 15:20:10.519752
NCT00520949|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2009-04-07|||October 2006||2006-10-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|QT-Hp||Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection|Quadruple Therapy Using Esomeprazole, Colloidal Bismuth Subcitrate, Amoxicillin-Clavulanate, and Furazolidone in Patients Who Failed to Eradicate H. Pylori With Triple Therapy|Completed||N/A|176|Actual|Aga Khan University||1|||f||||t||||||||||2017-02-18 15:20:10.603389|2017-02-18 15:20:10.603389
NCT00520936|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2011-02-23|2011-02-01||September 2007||2007-09-01|February 2011|2011-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of Pemetrexed in Children With Recurrent Cancer|A Phase II Study of Pemetrexed in Children With Recurrent Malignancies|Completed||Phase 2|72|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 15:20:10.70823|2017-02-18 15:20:10.70823
NCT00520923|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2009-10-16||2009-10-16|September 2007||2007-09-01|October 2009|2009-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study for Patients With Schizophrenia|A Multi-Center, Inpatient, Phase 2, Double-blind, Placebo-Controlled Dose Ranging Study of LY2140023 in Patients With DSM-IV Schizophrenia|Completed||Phase 2|654|Actual|Eli Lilly and Company||6|||f||||f||||||||||2017-02-18 15:20:12.807898|2017-02-18 15:20:12.807898
NCT00520910|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2010-10-18|||August 2007||2007-08-01|June 2008|2008-06-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|Heliocare||Single-Blind Study Determining the Efficacy of Polypodium Leucotomos Extract Supplement in Decreasing Ultraviolet A (UVA) Premutagenic and Photoaging Markers|Single-Blind Study Determining the Efficacy of Polypodium Leucotomos Extract Supplement in Decreasing UVA Premutagenic and Photoaging Markers|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|University of Miami||2|||f||||f||||||||||2017-02-18 15:20:12.950488|2017-02-18 15:20:12.950488
NCT00520897|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2012-06-04|||April 2007||2007-04-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|February 2009|Actual|2009-02-01||Interventional|||Integrase Inhibitor (MK-0518) Viral Decay|Effect of Integrase Inhibitor (MK-0518) on Decay of Low Level Viral Replication in HIV Reservoirs in Infected Individuals Who Initiated Conventional Antiretroviral Therapy During the Chronic Phase of Infection|Completed||Phase 2|24|Actual|Canadian Immunodeficiency Research Collaborative||2|||f||||||||||||||2017-02-18 15:20:13.063624|2017-02-18 15:20:13.063624
NCT00520884|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2011-05-23|||March 2007||2007-03-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Ghrelin in Older Women|A Pilot Study of Ghrelin in Healthy and Frail Older Women|Completed||Phase 1/Phase 2|10|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 15:20:13.347782|2017-02-18 15:20:13.347782
NCT00520871|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2007-08-24|||March 2003||2003-03-01|August 2007|2007-08-01|April 2004|Actual|2004-04-01|||||Interventional|||The Water-Blueberry Study|The Effect of Blueberry Juice on Cardiovascular Risk Factors, and Markers of Antioxidant Status, Oxidative Stress Status and Inflammation.|Completed||Phase 1/Phase 2|62|Actual|University of Oslo||2|||f||||f||||||||||2017-02-18 15:20:13.448163|2017-02-18 15:20:13.448163
NCT00520858|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2008-04-21|||September 2003||2003-09-01|April 2008|2008-04-01||||||||Interventional|||Effects of Exercise Modality on Abdominal Obesity and Health Risk Factors in Older Men and Women|Effects of Exercise Modality on Abdominal Obesity and Health Risk Factors in Older Men and Women|Completed||N/A|145|Actual|Queen's University||4|||f||||f||||||||||2017-02-18 15:20:13.537277|2017-02-18 15:20:13.537277
NCT00520845|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2016-10-25|2014-10-05||October 2007||2007-10-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer|"A Phase II Trial of Celecoxib Plus Chemotherapy [Docetaxel or Pemetrexed] in Patients With Previously Treated, COX Dependent Recurrent Non-Small Cell Lung Cancer"|Terminated||Phase 2|23|Actual|Vanderbilt-Ingram Cancer Center||1||slow accrual|f||||t||||||||||2017-02-18 15:20:13.653165|2017-02-18 15:20:13.653165
NCT00520806|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2012-10-26|||October 2007||2007-10-01|May 2012|2012-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|RELAX-AHF||Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure|A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure|Completed||Phase 2/Phase 3|1161|Actual|Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies||2|||f||||t||||||||||2017-02-18 15:20:14.208163|2017-02-18 15:20:14.208163
NCT00520780|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2009-10-15|||April 2007||2007-04-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|FAIR-HF||Ferinject® Assessment in Patients With IRon Deficiency and Chronic Heart Failure (FAIR-HF)|A Randomised Double-blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Iron Carboxymaltose (Ferinject®) With Placebo in Patients With Chronic Heart Failure and Iron Deficiency|Completed||Phase 3|456|Actual|Vifor Inc.||2|||f||||t||||||||||2017-02-18 15:20:14.326189|2017-02-18 15:20:14.326189
NCT00520767|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2016-02-12|2015-03-18||September 2007||2007-09-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|October 2010|Actual|2010-10-01||Interventional|||Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease|A Multicenter Phase II Trial of Bortezomib (Velcade), Melphalan, and Dexamethasone (V-MD) in Patients With Symptomatic AL-Amyloidosis or Light Chain Deposition Disease|Active, not recruiting||Phase 2|35|Actual|Barbara Ann Karmanos Cancer Institute|Mix of previously treated & newly diagnosed pts (populations which may have different prognoses), plus the relatively small trial size limit conclusions one can draw re: relative efficacy of MDV (vs CyBorD or Mel-Dex, for example)|1|||f||||t||||||||||2017-02-18 15:20:14.474196|2017-02-18 15:20:14.474196
NCT00520754|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2013-12-11|||December 2001||2001-12-01|September 2009|2009-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children|The Efficacy and Safety of Levocetirizine Dihydrochloride Oral Drops Given 0.125 mg/kg b.i.d. During 90 Days in the Treatment of Recurrent Cough Associated With Other Allergic Symptoms, e.g. Wheezing, in Children Aged 1-2 Years.|Completed||Phase 2|15|Actual|UCB Pharma|||||f||||f||||||||||2017-02-18 15:20:14.766947|2017-02-18 15:20:14.766947
NCT00520741|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-24|2015-07-13|2013-11-26||August 2007||2007-08-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|ALEX-MT|The Baseline Analysis Population refers to the Safety Set (SS) which includes the unique randomized subjects who took at least one dose of study medication.|Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures|A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400 mg/Day Monotherapy in Subjects With Partial-onset Seizures|Completed||Phase 3|426|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 15:20:14.859723|2017-02-18 15:20:14.859723
NCT00520728|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2015-09-01|||August 2007||2007-08-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy of an Occupational Time Use Intervention for People With Serious Mental Illness|Efficacy of an Occupational Time Use Intervention|Completed||Phase 1|18|Actual|Queen's University||1|||f||||t||||||||||2017-02-18 15:20:15.890409|2017-02-18 15:20:15.890409
NCT00520715|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2015-06-22|||June 2007||2007-06-01|June 2015|2015-06-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Observational|||Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards|Epidemiology and Risk Factors Study of the Carriage of Fluoroquinolone Resistant Bacteria in the Commensal Flora of Patients Hospitalised in Medical Wards|Completed||N/A|640|Actual|Association Pour le Recherche en Infectiologie et en Médecine Interne|||1||f||||f||||||||||2017-02-18 15:20:15.986932|2017-02-18 15:20:15.986932
NCT00520702|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2016-09-30|||August 2007||2007-08-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy|A Randomized Trial to Compare Time to Common Toxicity Criteria for Adverse Effect (CTC AEC) 3.0 Grade. 3 Treatment Related Pneumonitis (TRP) in Patients With Locally Advanced Non-Small Cell Lung Carcinoma (NSCLC) Receiving Concurrent Chemoradiation Radiation Treated With 3-Dimensional Conformal Radiation Therapy (3D CRT, ARM 1) Versus Intensity Modulated Radiation Therapy (IMRT, ARM 2) Using 4-Dimensional CT Planning and Image Guided Adaptive Radiation Therapy (IGART)|Active, not recruiting||Phase 2|168|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:20:16.250227|2017-02-18 15:20:16.250227
NCT00520689|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2009-02-12|||September 2007||2007-09-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|Amethyst||Multipurpose Disinfecting Solution Compatibility With a Silicone Hydrogel Contact Lens|Multipurpose Solution Compatibility With a Silicone Hydrogel Lens|Completed||Phase 3|25|Actual|University of Waterloo||4|||f||||f||||||||||2017-02-18 15:20:16.369759|2017-02-18 15:20:16.369759
NCT00520676|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2011-08-08|2011-06-17||October 2007||2007-10-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer|A Randomized Phase 3 Study Comparing Pemetrexed-Carboplatin With Docetaxel-Carboplatin as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|260|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:20:16.493522|2017-02-18 15:20:16.493522
NCT00520663|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2012-05-31|||June 2007||2007-06-01|February 2011|2011-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug|An Open-label Study to Determine the Excretion, Balance and Pharmacokinetics of SB649868 After a Single Oral Administration of 14C-SB649868 in Healthy Volunteers|Completed||Phase 1|8|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:20:17.669098|2017-02-18 15:20:17.669098
NCT00520650|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2009-12-15|||August 2006||2006-08-01|December 2009|2009-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|HEALTH||Health Evaluation of Abilify Long-term Therapy|Health Evaluation of Abilify Long-term Therapy|Completed||Phase 4|245|Actual|Taiwan Otsuka Pharm. Co., Ltd||1|||f||||f||||||||||2017-02-18 15:20:17.767151|2017-02-18 15:20:17.767151
NCT00520637|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2009-10-08|||May 2007||2007-05-01|October 2009|2009-10-01||||||||Interventional|||A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01)|A Phase I, Multicenter, Open-Label, Dose-Escalation Study Evaluating the Safety and Tolerability of Intravenous EZN-2208 (PEG-SN38) Administered Every 3 Weeks in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01)|Completed||Phase 1|34||Enzon Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 15:20:17.885305|2017-02-18 15:20:17.885305
NCT00520611|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2015-06-10|||June 2007||2007-06-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Evaluating the Effectiveness of Financial Incentives in Promoting Weight Loss Among Obese Individuals.|Evaluating the Effectiveness of Financial Incentives in Promoting Weight Loss Among Obese Individuals.|Completed||N/A|57|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-02-18 15:20:18.07265|2017-02-18 15:20:18.07265
NCT00520598|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2015-11-25|||October 2007||2007-10-01|November 2015|2015-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)|A Phase IIa Randomized, Double-Blind Controlled With Gardasil, Clinical Trial to Study theTolerability and Immunogenicity of V505 (a Multivalent Human Papilloma Virus [HPV] L1 Virus Like Particle [VLP] Vaccine) in Healthy 16 to 26 Year Old Women|Completed||Phase 2|511|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 15:20:18.182114|2017-02-18 15:20:18.182114
NCT00520585|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2007-08-22|||August 2007||2007-08-01|August 2007|2007-08-01|November 2007|Anticipated|2007-11-01|||||Interventional|ATORVA||Study of Influence of Atorvastatin on the Repolarisation Phase of Cardiomyocytes|Study of Influence of Atorvastatin on the Repolarisation Phase of Cardiomyocytes|Unknown status|Not yet recruiting|N/A|||Masaryk University|||||f||||f||||||||||2017-02-18 15:20:18.280432|2017-02-18 15:20:18.280432
NCT00520572|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2013-01-31|2010-07-22||August 2007||2007-08-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|||||Interventional|||A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)|A Randomised, Double-Blind (With Open Comparator Etanercept Limb), Placebo-Controlled, Phase IIb, Multicentre Study to Evaluate the Efficacy of 4 Doses of AZD9056 Administered for 6 Months on the Signs and Symptoms of Rheumatoid Arthritis in Patients With Active Disease Receiving Background Methotrexate or Sulphasalazine|Completed||Phase 2|385|Actual|AstraZeneca|Hybrid ACR, ACRn, individual ACR components, Erythrocyte sedimentation rate, Short-form-36, Rheumatoid Arthritis Quality of Life, Patient Assessment of Fatigue and DEXA X-ray scanning did not provide extra information so are not presented|6|||f||||||||||||||2017-02-18 15:20:18.375627|2017-02-18 15:20:18.375627
NCT00520559|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2007-08-23|||January 2007||2007-01-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Observational|||T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients|Incidence of Cardiac Complications in Patients With Cardiac Siderosis During 1 Year Follow−up and the Normal T2* Ranges in LVF, MI and Normal Population.|Completed||N/A|665|Actual|Imperial College London|||||f||||f||||||||||2017-02-18 15:20:19.338973|2017-02-18 15:20:19.338973
NCT00520546|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2012-06-03|2011-07-20||December 2007||2007-12-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|FEC-PET/MRI||Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer|Clinical Value of [18]Fluoroethylcholine Positron-Emission-Tomography Combined With Endorectal Magnetic Resonance Imaging by Software Fusion for Pre-therapeutic Staging of Prostate Cancer|Completed||Phase 3|44|Actual|German Federal Armed Forces||1|||f||||t||||||||||2017-02-18 15:20:19.405808|2017-02-18 15:20:19.405808
NCT00520533|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2013-02-27|||February 2008||2008-02-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|July 2011|Actual|2011-07-01||Interventional|||Study of Safety and Effects of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma|A Pilot Study of the Safety, Efficacy, and Effects on Functional Imaging of the Combination of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma|Terminated||N/A|6|Actual|Ludwig Institute for Cancer Research||1||Closed prematurely due to toxicity|f||||f||||||||||2017-02-18 15:20:19.921755|2017-02-18 15:20:19.921755
NCT00519844|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2015-11-11|||July 2005||2005-07-01|November 2015|2015-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction|Assessment of Satisfaction With Growth Hormone Treatment in Children Born Small for Gestational Age: Benefits of Galenic Form of the Product|Completed||Phase 4|5|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:20:20.029515|2017-02-18 15:20:20.029515
NCT00519831|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2016-07-01|||August 2007||2007-08-01|January 2016|2016-01-01|November 2009|Actual|2009-11-01|February 2008|Actual|2008-02-01||Interventional|NRR||Vinflunine and Cetuximab as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Vinflunine and Cetuximab in the Second Line Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer|Terminated||Phase 2|18|Actual|UNC Lineberger Comprehensive Cancer Center||1||Drug unavailable|f||||t||||||||||2017-02-18 15:20:20.127076|2017-02-18 15:20:20.127076
NCT00519818|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2016-02-26|2011-06-28||August 2007||2007-08-01|February 2016|2016-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia|A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Versus Cortef in Patients With CAH|Completed||Phase 1/Phase 2|20|Actual|Diurnal Limited||1|||f||||f||||||||||2017-02-18 15:20:22.849498|2017-02-18 15:20:22.849498
NCT00519805|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2011-08-05|||August 2007||2007-08-01|March 2008|2008-03-01||||August 2012|Anticipated|2012-08-01||Interventional|||Dalteparin in Preventing Blood Clots in Patients With Lung Cancer|FRAGMATIC - A Randomised Phase III Clinical Trial Investigating the Effect of FRAGMin Added to Standard Therapy In Patients With Lung Cancer|Unknown status|Recruiting|Phase 3|2200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:20:23.142895|2017-02-18 15:20:23.142895
NCT00519792|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2011-06-06|||August 2007||2007-08-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment|Phase Ib Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Omega DUROS® and Ribavirin in Subjects With Chronic Hepatitis C Previously Treated With Pegylated Interferon and Ribavirin|Completed||Phase 1|60|Actual|Intarcia Therapeutics||2|||f||||f||||||||||2017-02-18 15:20:23.305617|2017-02-18 15:20:23.305617
NCT00519779|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2012-03-22|2011-11-07||July 2007||2007-07-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention|Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention|Completed||Phase 2|68|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||f||||||||||2017-02-18 15:20:23.413475|2017-02-18 15:20:23.413475
NCT00519766|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2014-05-22|||September 1997||1997-09-01|May 2014|2014-05-01|November 2002|Actual|2002-11-01|March 1999|Actual|1999-03-01||Observational|SCRIPT||Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPT|Assessment of Nicotine Metabolism Among Underserved Pregnant Women From NE SCRIPT|Completed||N/A|252|Actual|Memorial Hospital of Rhode Island|||1||f||||f||||||||||2017-02-18 15:20:24.186669|2017-02-18 15:20:24.186669
NCT00519753|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2016-11-17|||August 2007||2007-08-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav|Safety and Efficacy of Switching to the Travoprost/Timolol Maleate Fixed Combination (DUOTRAV®) From Prior Mono or Two-Drug Therapy in Germany|Completed||Phase 4|522|Actual|Alcon Research||1|||f||||f||||||||||2017-02-18 15:20:24.280964|2017-02-18 15:20:24.280964
NCT00519740|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2009-02-03|||August 2006||2006-08-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen|Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen After Low-Dosed Specific Bronchial Provocation|Completed||N/A|120|Actual|Johann Wolfgang Goethe University Hospital||1|||f||||t||||||||||2017-02-18 15:20:24.390318|2017-02-18 15:20:24.390318
NCT00519727|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-08-15|||August 2007||2007-08-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Safety Study of ISIS 325568 in Healthy Volunteers|A Phase I, Double-Blind, Placebo-Controlled, Dose- Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 325568 Administered to Healthy Volunteers|Completed||Phase 1|60|Anticipated|Ionis Pharmaceuticals, Inc.||8|||f||||f||||||||||2017-02-18 15:20:24.484931|2017-02-18 15:20:24.484931
NCT00519714|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2010-06-18|||September 2007||2007-09-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multi-Center Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)|Completed||Phase 2/Phase 3|195|Anticipated|Montreal Heart Institute||3|||f||||f||||||||||2017-02-18 15:20:24.594143|2017-02-18 15:20:24.594143
NCT00519701|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2007-08-22|||April 2002||2002-04-01|August 2007|2007-08-01|February 2007|Actual|2007-02-01|||||Interventional|||Hydroxyurea in Young Children With Sickle Cell Anemia|Effects of Hydroxyurea on the Prevention of Chronic Organ Damage in Young Children With Sickle Cell Anemia|Completed||N/A|14|Actual|Duke University||1|||f||||f||||||||||2017-02-18 15:20:24.700875|2017-02-18 15:20:24.700875
NCT00519688|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2011-10-13|||July 2006||2006-07-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma|A Phase II Study of Tegafur/Uracil(UFUR) Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)|Completed||Phase 2|44|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 15:20:24.808515|2017-02-18 15:20:24.808515
NCT00519675|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2010-07-16|||May 2007||2007-05-01|July 2010|2010-07-01||||||||Interventional|||Alitretinoin in the Treatment of Chronic Hand Eczema|Open Label Treatment of Patients With Chronic Hand Dermatitis Who Have Participated in a Previous Clinical Trial Involving Oral Alitretinoin|Completed||Phase 3|150|Anticipated|Basilea Pharmaceutica||1|||f||||f||||||||||2017-02-18 15:20:24.950157|2017-02-18 15:20:24.950157
NCT00519662|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2017-02-01|||August 2007||2007-08-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors|Phase 1 Open-Label Multicenter, Dose-Escalating, Clinical Study of the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Profiles of SNS-314, a Novel Aurora Kinase Inhibitor, Administered to Patients With Advanced Solid Tumors|Completed||Phase 1|32|Actual|Sunesis Pharmaceuticals||1|||f||||f||||||||No||2017-02-18 15:20:25.044313|2017-02-18 15:20:25.044313
NCT00519649|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2016-11-03|2008-12-17||August 2007||2007-08-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.|An Open, Phase IV, Single-group, Multicentre Study to Assess the Long-term Persistence of Antibodies Against Hepatitis B and the Immune Response to a Hepatitis B (HBV) Vaccine Challenge in Children Aged 7-8 Years of Age and Previously Vaccinated in Infancy With GSK Biologicals' HBV Vaccine (Engerix™-B).|Completed||Phase 4|301|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:20:25.15974|2017-02-18 15:20:25.15974
NCT00520520|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2015-08-03|||December 2009||2009-12-01|July 2009|2009-07-01||||||||Observational|INCA||Influence of Mild Therapeutic Hypothermia on Leukocyte Count||Terminated||N/A|||Charite University, Berlin, Germany|||1||f||||||||||||||2017-02-18 15:20:25.681513|2017-02-18 15:20:25.681513
NCT00520507|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2015-12-14|||October 2007||2007-10-01|December 2015|2015-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients|An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients|Completed||Phase 4|27|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 15:20:25.763292|2017-02-18 15:20:25.763292
NCT00520494|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2013-06-12|2013-03-18||March 2007||2007-03-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency|A Multicenter Study on the Efficacy and Safety of Vivaglobin® in Previously Untreated Patients (PUPs) With Primary Immunodeficiency (PID)|Completed||Phase 4|18|Actual|CSL Behring||1|||f||||f||||||||||2017-02-18 15:20:25.878371|2017-02-18 15:20:25.878371
NCT00520481|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2014-01-22||2010-11-09|August 2007||2007-08-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|January 2012|Actual|2012-01-01||Interventional|||Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer|Phase 2 Single Arm, Open-Label Study of IMC-A12 in Asymptomatic, Chemotherapy-Naïve Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 2|41|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:20:26.466145|2017-02-18 15:20:26.466145
NCT00520468|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2012-08-01|2009-09-24||June 2004||2004-06-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS|Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS|Completed||Phase 2|15|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:20:26.573038|2017-02-18 15:20:26.573038
NCT00520455|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2007-11-13|||January 2004||2004-01-01|November 2007|2007-11-01|June 2005|Actual|2005-06-01|||||Interventional|||Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia|Randomized Controlled Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia|Completed||N/A|177|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 15:20:26.842129|2017-02-18 15:20:26.842129
NCT00520442|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2008-03-06|||September 2003||2003-09-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Acute Pediatric Fracture Analgesia Study|Ibuprofen Versus Acetaminophen With Codeine In Acute Pediatric Forearm Fractures|Completed||N/A|335|Anticipated|Medical College of Wisconsin||2|||f||||f||||||||||2017-02-18 15:20:26.93774|2017-02-18 15:20:26.93774
NCT00520429|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2009-01-05|||August 2007||2007-08-01|July 2008|2008-07-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Transforming Psychotherapy for Chronically Ill Patients|Transforming Psychotherapy for Chronically Ill Patients|Completed||Phase 1/Phase 2|23|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 15:20:27.047016|2017-02-18 15:20:27.047016
NCT00520416|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2007-08-22|||October 2006||2006-10-01|August 2007|2007-08-01|August 2008|Anticipated|2008-08-01|||||Observational|||Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair||Unknown status|Recruiting|N/A|||University of Southern California|||1||f||||f||||||||||2017-02-18 15:20:27.151525|2017-02-18 15:20:27.151525
NCT00520403|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2014-10-09|2014-08-14||September 2007||2007-09-01|October 2014|2014-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||Safety Population: included all participants, even those who withdrew from the study prematurely and who received at least 1 dose of bevacizumab and had a safety follow-up visit.|A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.|An Open-label Study to Assess the Effect of First-line Treatment With Avastin in Combination With Standard Therapy on Progression-free Survival in Patients With Metastatic Renal Cell Cancer.|Completed||Phase 2|25|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:20:27.234878|2017-02-18 15:20:27.234878
NCT00520390|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2010-04-01|||May 2007||2007-05-01|April 2010|2010-04-01||||||||Interventional|||A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02)|A Phase I, Multicenter, Open-Label, Dose-Escalation Study Evaluating the Safety and Tolerability of Intravenous EZN-2208 PEG-SN38) Administered Weekly for 3 Weeks in 4-Week Cycles in Patients With Advanced Solid Tumors or Ymphoma (EZN-2208-02)|Completed||Phase 1|34||Enzon Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:20:27.564111|2017-02-18 15:20:27.564111
NCT00520377|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2008-04-22|||January 2005||2005-01-01|April 2008|2008-04-01|May 2008|Anticipated|2008-05-01|December 2007|Actual|2007-12-01||Interventional|||Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation|Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation|Unknown status|Active, not recruiting|Phase 2|31|Actual|Scil Technology GmbH||2|||f||||f||||||||||2017-02-18 15:20:27.869753|2017-02-18 15:20:27.869753
NCT00520364|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2016-09-24|||September 2014||2014-09-01|September 2016|2016-09-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||In Vitro Fertilization and Pregnancy After Use of Chemotherapy||Enrolling by invitation||N/A|100|Anticipated|New York Medical College|||2||f||||f||||||Samples Without DNA|"~     serum~   "|||2017-02-18 15:20:27.982547|2017-02-18 15:20:27.982547
NCT00520351|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2010-08-20|2010-03-26||August 2007||2007-08-01|August 2010|2010-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Lens Care Regimens With a Silicone Hydrogel Lens (Emerald)|Comparison of Lens Care Regimens With a Silicone Hydrogel Lens (Emerald)|Completed||Phase 3|30|Actual|University of Waterloo||2|||f||||f||||||||||2017-02-18 15:20:28.083082|2017-02-18 15:20:28.083082
NCT00520338|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2010-11-06|||August 2007||2007-08-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial|Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial|Completed||Phase 4|80|Anticipated|Mahidol University||2|||f||||f||||||||||2017-02-18 15:20:28.69903|2017-02-18 15:20:28.69903
NCT00520325|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2012-09-04|||June 2007||2007-06-01|February 2009|2009-02-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia|A Multi-Center Study of the Safety, Tolerability, Pharmacokinetics, and Dose Escalation of Intravenous Recombinant Human Mannose-Binding-Lectin (rhMBL) in MBL Deficient Pediatric Hematology/Oncology Patients With Fever and Neutropenia|Withdrawn||Phase 1|0|Actual|Enzon Pharmaceuticals, Inc.||2||Sponsor decision to terminate the study|f||||||||||||||2017-02-18 15:20:28.807585|2017-02-18 15:20:28.807585
NCT00520312|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2014-04-07|||October 2007||2007-10-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease|Magnetic Resonance in Peripheral Arterial Disease|Completed||N/A|519|Actual|Northwestern University|||1||f||||t||||||Samples With DNA|"~     Plasma, serum, and whole blood samples are stored for future analysis~   "|||2017-02-18 15:20:28.907057|2017-02-18 15:20:28.907057
NCT00520299|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2011-05-09||2011-05-09|July 2007||2007-07-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Phase I/II Study of ADI-SS PEG 20,000mw in Patients With Advanced Metastatic Melanoma|Phase I/II Study of ADI-SS PEG 20,000mw in Patients With Advanced Metastatic Melanoma|Completed||Phase 1/Phase 2|31|Actual|Ludwig Institute for Cancer Research||3|||f||||f||||||||||2017-02-18 15:20:28.998415|2017-02-18 15:20:28.998415
NCT00520286|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-23|2016-08-09|||December 2007||2007-12-01|August 2016|2016-08-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Ph2 Modafinil Meth - 1|Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence|Completed||Phase 2|210|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 15:20:29.113853|2017-02-18 15:20:29.113853
NCT00520273|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2016-03-01|||August 2007||2007-08-01|June 2010|2010-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA|A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA|Completed||N/A|100000|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:20:29.218886|2017-02-18 15:20:29.218886
NCT00520260|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2009-02-17|||August 2007||2007-08-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase|Bromfenac 0.09% vs. Ketorolac 0.4% During the Induction Phase of Treatment With Topical Cyclosporine for Chronic Dry Eye Patients|Completed||Phase 4|42|Actual|Florida Eye Microsurgical Institute||2|||f||||t||||||||||2017-02-18 15:20:29.303996|2017-02-18 15:20:29.303996
NCT00520247|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2007-08-22|||September 2005||2005-09-01|August 2007|2007-08-01|February 2006|Actual|2006-02-01|||||Interventional|||Effect of Enalapril Plus Folic Acid on Blood Pressure and Glycometabolism|Efficacy of Antihypertensive and Plasma Total Homocysteine Lowering Combined Therapy With Enalapril and Folic Acid in Hypertensive Patients:A Multicenter Double Blind Randomized Clinical Trial|Completed||Phase 2|443|Actual|Anhui Medical University||3|||f||||t||||||||||2017-02-18 15:20:29.403703|2017-02-18 15:20:29.403703
NCT00520234|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2011-04-08|2011-03-15||August 2007||2007-08-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|MSG-01||Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)|A Randomized, Double-blind, Placebo Controlled Trial of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in High-risk Adults in the Critical Care Setting|Completed||Phase 4|222|Actual|Mycoses Study Group||2|||f||||t||||||||||2017-02-18 15:20:29.509938|2017-02-18 15:20:29.509938
NCT00520221|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2007-08-22|||January 2004||2004-01-01|January 2004|2004-01-01|July 2007|Actual|2007-07-01|||||Observational|||Intrapleural Minocycline Following Simple Aspiration for Primary Spontaneous Pneumothorax|Intrapleural Minocycline Following Simple Aspiration for Initial Treatment of Primary Spontaneous Pneumothorax: a Retrospective Study|Completed||N/A|64|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 15:20:30.223196|2017-02-18 15:20:30.223196
NCT00520208|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2013-02-11|||September 2007||2007-09-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|STAR-1||Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL|A Phase II Study of Oral Tamibarotene in Acute Promyelocytic Leukemia Patients Who Have Received Prior Therapy With ATRA and Arsenic Trioxide (STAR-1)|Completed||Phase 2|15|Actual|CytRx||1|||f||||f||||||||||2017-02-18 15:20:30.312757|2017-02-18 15:20:30.312757
NCT00520195|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2007-08-21|||March 2007||2007-03-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Stair Instead of Elevator Use at Work: Cardiovascular Primary Preventive Effects on Hospital Employees.||Completed||N/A|77|Actual|University Hospital, Geneva|||||f||||f||||||||||2017-02-18 15:20:30.414982|2017-02-18 15:20:30.414982
NCT00520182|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2007-09-19|||March 2004||2004-03-01|September 2007|2007-09-01|February 2008|Anticipated|2008-02-01|||||Interventional|DIPAC||Dietary Interventions in Type 2 Obese Diabetic Patients in the Community|Community Trial to Assess the Effect of Nutritional Intervention Models on Medical Outcomes Among Obese Type 2 Diabetic Patients|Unknown status|Active, not recruiting|Phase 3|259|Actual|Ben-Gurion University of the Negev||3|||f||||f||||||||||2017-02-18 15:20:30.499568|2017-02-18 15:20:30.499568
NCT00520169|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-01-09|||July 2007||2007-07-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine|A Randomized, Open Label, Single Center, Single-Dose, Cross-Over Study to Determine the Absolute Bioavailability and the Nasopharyngeal Absorption of PMI-150 (Intranasal Ketamine) in Healthy Adult Volunteers|Completed||Phase 1|32|Actual|Javelin Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:20:30.604872|2017-02-18 15:20:30.604872
NCT00520156|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2007-08-21|||August 2007||2007-08-01|August 2007|2007-08-01|August 2008|Anticipated|2008-08-01|||||Observational|||Analysis of the Prevalence and Characteristics of Concomitant Sleep and Headache Disorders, and the Efficacy of CPAP Treatment for Headache Among Those Patients Diagnosed With Obstructive Sleep Apnea|Analysis of the Prevalence and Characteristics of Co-Morbid Sleep and Headache Disorders in Patients Being Evaluated at the WRAMC Sleep Disorders Laboratory, and the Efficacy of CPAP Treatment on Headache Burden in Obstructive Sleep Apnea Patients With a Co-Morbid Headache Disorder|Unknown status|Not yet recruiting|N/A|600|Anticipated|Walter Reed Army Medical Center|||||f||||t||||||||||2017-02-18 15:20:30.715234|2017-02-18 15:20:30.715234
NCT00520143|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2014-02-04||||||February 2014|2014-02-01||||||||Expanded Access|ATAP||Alglucosidase Alfa Temporary Access Program|Alglucosidase Alfa Temporary Access Program|Approved for marketing||N/A|||Sanofi|||||||||||||||||||2017-02-18 15:20:30.796662|2017-02-18 15:20:30.796662
NCT00520130|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2016-05-11|||July 2007||2007-07-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|October 2015|Actual|2015-10-01||Interventional|||Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System|Phase II Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using 8/8 and 7/8 HLA-matched Unrelated Donors and Utilizing Two Graft-versus-Host Disease Prophylaxis Regimens for the Treatment of Leukemias, Lymphomas, and Pre-malignant Blood Disorders|Active, not recruiting||Phase 1/Phase 2|92|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 15:20:31.190046|2017-02-18 15:20:31.190046
NCT00520117|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2013-12-27|||June 2007||2007-06-01|August 2007|2007-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Assessing the Psychosocial Burden in Women With an Abnormal Pap Results After Screening Interventions|Assessing the Psychosocial Burden in Women With an Abnormal Pap Results After Screening Interventions|Completed||Phase 4|151|Actual|Mahidol University|||2||f||||f||||||||||2017-02-18 15:20:31.326225|2017-02-18 15:20:31.326225
NCT00520104|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-02-27|||August 2007||2007-08-01|August 2007|2007-08-01|March 2008|Anticipated|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine|A Randomized, Open Label, Single Center, Single-Dose Study to Assess the Effects of Certain Nasal Medications on the Pharmacokinetics, Safety and Tolerability of PMI-150 (Intranasal Ketamine Hydrochloride) 30 mg|Unknown status|Active, not recruiting|Phase 1|48|Anticipated|Javelin Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:20:31.417527|2017-02-18 15:20:31.417527
NCT00520091|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2012-05-16|||March 2005||2005-03-01|May 2012|2012-05-01|September 2010|Actual|2010-09-01|November 2006|Actual|2006-11-01||Interventional|||Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer|A Pilot Study of the Biologic Efficacy and Safety of the Addition of Celecoxib to a Program of Induction Chemotherapy and Neo-Adjuvant Chemo-Radiotherapy for the Treatment of Esophageal Cancer|Completed||Phase 2|14|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 15:20:31.523571|2017-02-18 15:20:31.523571
NCT00520078|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2007-08-21|||August 2007||2007-08-01|February 2007|2007-02-01|August 2008|Anticipated|2008-08-01|||||Observational|||Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection|Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||t||||||||||2017-02-18 15:20:31.638952|2017-02-18 15:20:31.638952
NCT00520065|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-07-02|||August 2007||2007-08-01|August 2007|2007-08-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of Nutritional Products for People With Type 2 Diabetes|Comparison of Nutritional Products for People With Type 2 Diabetes|Completed||Phase 2|33|Actual|Abbott Nutrition||2|||f||||f||||||||||2017-02-18 15:20:31.728805|2017-02-18 15:20:31.728805
NCT00520052|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2007-08-22|||August 2003||2003-08-01|August 2007|2007-08-01|August 2005|Actual|2005-08-01|||||Interventional|||Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer|Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer|Completed||N/A|58|Actual|Wirral University Teaching Hospital NHS Trust||2|||f||||t||||||||||2017-02-18 15:20:31.846816|2017-02-18 15:20:31.846816
NCT00520039|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2015-10-05|||September 2007||2007-09-01|November 2009|2009-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|OOMRS||Osteopathic Otitis Media Research Study|Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry|Completed||Phase 1/Phase 2|60|Anticipated|West Virginia School of Osteopathic Medicine||2|||f||||t||||||||||2017-02-18 15:20:31.964473|2017-02-18 15:20:31.964473
NCT00520026|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2007-08-22|||January 2001||2001-01-01|August 2007|2007-08-01|June 2006|Actual|2006-06-01|||||Interventional|SUPLI||Suicide Prevention by Lithium - the Lithium Intervention Study||Terminated||N/A|167|Actual|University of Schleswig-Holstein||2||number of enrolled individuals after 5 years still off the estimated sample size|f||||f||||||||||2017-02-18 15:20:32.08351|2017-02-18 15:20:32.08351
NCT00520013|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2016-06-13|2015-04-08||August 2007||2007-08-01|June 2016|2016-06-01|November 2013|Actual|2013-11-01|October 2010|Actual|2010-10-01||Interventional||The analysis dataset is comprised of treated patients.|Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors|A Randomized Phase II Trial of Avastin (A) or Avastin and Erlotinib (AE) as First Line Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Newly Diagnosed Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors|Completed||Phase 2|60|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-02-18 15:20:32.219325|2017-02-18 15:20:32.219325
NCT00520000|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2012-03-05|||December 2004||2004-12-01|March 2012|2012-03-01|September 2007|Actual|2007-09-01|May 2006|Actual|2006-05-01||Interventional|||Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I Trial of Carboplatin and Abraxane in Patients With Solid Tumors|Completed||Phase 1|47|Actual|UNC Lineberger Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 15:20:32.990698|2017-02-18 15:20:32.990698
NCT00519987|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-01-09|||June 2007||2007-06-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Multiple Dose Pharmacokinetics of Intranasal Ketamine|An Open Label, Single Center Study to Assess the Pharmacokinetics, Safety and Tolerability of Multiple Administrations of 30 mg PMI-150 (Intranasal Ketamine) in Healthy Adult Volunteers|Completed||Phase 1|18|Actual|Javelin Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:20:33.113664|2017-02-18 15:20:33.113664
NCT00519974|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2015-09-29|||July 2007||2007-07-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women|Decision-Making About Breast Reconstruction After Mastectomy Among Ethnic Minority Women: An Exploratory Study of Qualitative Themes|Completed||N/A|55|Actual|Memorial Sloan Kettering Cancer Center|||1||f||||||||||||||2017-02-18 15:20:33.215622|2017-02-18 15:20:33.215622
NCT00519961|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2011-03-15|||February 2007||2007-02-01|March 2011|2011-03-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery|A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery|Unknown status|Recruiting|N/A|1800|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:20:33.318166|2017-02-18 15:20:33.318166
NCT00519948|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-06-16||||||June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Comfort and Cleaning Evaluation of Multipurpose Solutions in Contact Lens Patients||Completed||Phase 4|20|Actual|Innovative Medical|||||f||||||||||||||2017-02-18 15:20:33.420711|2017-02-18 15:20:33.420711
NCT00519935|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2016-03-29|||July 2001||2001-07-01|March 2016|2016-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Testing MST to Improve Adherence Among Youth With Chronic Poor Metabolic Control|Adherence to IDDM Regimen in Urban Youth|Completed||N/A|127|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||No||2017-02-18 15:20:33.50247|2017-02-18 15:20:33.50247
NCT00519922|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-07-21|||January 2008||2008-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|KBA Exercise||A Study of the Effectiveness of Different Types of Exercise for People With Knee Osteoarthritis|Efficacy of Kinesthesia, Balance and Agility Exercise Training as Treatment of Knee Osteoarthritis: A Pilot Study|Completed||N/A|30|Anticipated|The Arthritis Research Institute of America||2|||f||||f||||||||||2017-02-18 15:20:33.615238|2017-02-18 15:20:33.615238
NCT00519909|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2007-08-22|||August 2007||2007-08-01|August 2007|2007-08-01|February 2008|Anticipated|2008-02-01|||||Interventional|||The Effect of Calcium on Fecal Fat and Energy Excretion||Unknown status|Recruiting|N/A|15|Anticipated|University of Copenhagen||5|||f||||f||||||||||2017-02-18 15:20:33.7123|2017-02-18 15:20:33.7123
NCT00519896|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2015-09-28|||July 2007||2007-07-01|September 2015|2015-09-01|September 2015|Actual|2015-09-01|May 2015|Actual|2015-05-01||Interventional|||Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer|Phase II Study of Sunitinib in Iodine Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of Thyroid With Functional Imaging Correlation|Completed||Phase 2|35|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 15:20:33.818571|2017-02-18 15:20:33.818571
NCT00519883|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-22|2014-08-21|||December 2007||2007-12-01|August 2014|2014-08-01||||July 2010|Actual|2010-07-01||Interventional|RAE||Randomized Anastrozole Exercise Trial|Randomized Anastrozole Exercise Trial (The RAE Study)|Unknown status|Active, not recruiting|Phase 3|72|Anticipated|British Columbia Cancer Agency||2|||f||||f||||||||||2017-02-18 15:20:33.939384|2017-02-18 15:20:33.939384
NCT00519857|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2017-02-16|||July 2001||2001-07-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|LIFT||Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468)|A Multinational, Multicenter, Randomized, Double-Blind, Parallel Group,Placebo Controlled Clinical Trial of the Effects of Tibolone (Org OD-14 1.25mg) on the Incidence of New Vertebral Fractures in Osteoporotic Postmenopausal Women.|Completed||Phase 3|4534|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:20:34.132008|2017-02-18 15:20:34.132008
NCT00519636|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2016-10-27|2008-11-07||August 2007||2007-08-01|October 2016|2016-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS|A Randomized, Double-blind, Placebo-controlled, Active Comparator, One-Week, Cross-Over, Multicenter Study to Evaluate the Efficacy and Patient Preference of Nasal Spray Characteristics of Once-Daily, Intranasal Administration of 110mcg Fluticasone Furoate Nasal Spray and 200mcg Fluticasone Propionate Nasal Spray in Adult Subjects With Seasonal Allergic Rhinitis|Completed||Phase 4|360|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:20:34.235534|2017-02-18 15:20:34.235534
NCT00519623|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2010-12-03|2010-12-03||August 2007||2007-08-01|December 2010|2010-12-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Transdermal Basal Insulin Patch Study in Type 1 Diabetes|Pharmacokinetic/Pharmacodynamic Study of the PassPort(R) Transdermal Insulin Delivery System in Type 1 Diabetes Patients|Completed||Phase 1/Phase 2|9|Actual|Altea Therapeutics|This was a small exploratory study to evaluate the PK, PD and tolerability of a selected Basal Insulin PassPort(r) System configuration in C-peptide negative type 1 diabetes subjects.|1|||f||||f||||||||||2017-02-18 15:20:35.492861|2017-02-18 15:20:35.492861
NCT00519610|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2012-08-14|||July 2007||2007-07-01|August 2012|2012-08-01|July 2010|Actual|2010-07-01|||||Observational|PHTN||Assessing Outcome After H-graft Shunt Placement|A Study Assessing Patient Outcomes After Placement of H-graft Portacaval Shunts for the Treatment of Portal Hypertension|Completed||N/A|66|Actual|University of South Florida|||1||f||||f||||||||||2017-02-18 15:20:35.742521|2017-02-18 15:20:35.742521
NCT00519597|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2013-07-08|||December 2005||2005-12-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|March 2013|Actual|2013-03-01||Interventional|RICCADSA||Continuous Positive Airway Pressure (CPAP) Treatment in Coronary Artery Disease and Sleep Apnea|Randomized Intervention With CPAP in Coronary Artery Disease and Sleep Apnea - RICCADSA Trial|Completed||Phase 4|511|Actual|Skaraborg Hospital||4|||f||||t||||||||||2017-02-18 15:20:35.84417|2017-02-18 15:20:35.84417
NCT00519584|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2016-12-15|||July 2007||2007-07-01|December 2016|2016-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|Ropivacaine||Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone|Duration of Interscalene Nerve Blocks With Ropivacaine Alone, Ropivacaine Mixed With Dexamethasone, and Ropivacaine Alone Combined With Systemic Dexamethasone|Terminated||N/A|94|Actual|The Cleveland Clinic||3||Collected study data was not usable due to process miscommunications|f||||f||||||||||2017-02-18 15:20:35.959905|2017-02-18 15:20:35.959905
NCT00519571|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2008-05-08|||July 2008||2008-07-01|May 2008|2008-05-01|July 2009|Anticipated|2009-07-01|June 2009|Anticipated|2009-06-01||Interventional|||Evaluation of the Safety and Efficacy of Using ImplantLock Device - Dental Implant Accessory|Evaluation of the Safety and Efficacy of Using ImplantLock Device - Dental Implant Accessory|Unknown status|Not yet recruiting|N/A|15|Anticipated|Innovative Implant Solutions||1|||f||||f||||||||||2017-02-18 15:20:36.08958|2017-02-18 15:20:36.08958
NCT00519558|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2012-06-28|||May 2003||2003-05-01|June 2012|2012-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Growth Hormone Deficiency in Adults (GHDA)|Investigation of the Efficacy and Safety of NN-220 for 24 Weeks in Adults With Growth Hormone Deficiency|Completed||Phase 3|121|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:20:36.200878|2017-02-18 15:20:36.200878
NCT00519545|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2012-01-23|||March 2006||2006-03-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Prayer as a Possible Adjuvant Treatment for Breast Cancer|Prayer as a Possible Adjuvant Treatment for Breast Cancer - A Randomized Partially Blinded Controlled Clinical Trial Evaluating the Effect of Prayer on Humoral and Biochemical Parameters in Stage I-IV Breast Cancer|Completed||N/A|15|Actual|Southwestern Regional Medical Center||2|||f||||f||||||||||2017-02-18 15:20:36.29281|2017-02-18 15:20:36.29281
NCT00519532|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2014-10-17|2010-03-17||July 2007||2007-07-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease|A Multicenter, Multinational, Phase 3b, Open-label Extension Trial to Evaluate the Long-term Effect of the 24-hour Transdermal Delivery of Rotigotine on Motor Function, Sleep Quality, and Nocturnal and Non-motor Symptoms in Subjects With Idiopathic Parkinson's Disease|Terminated||Phase 3|84|Actual|UCB Pharma|Because the manufacturing process for rotigotine patches was changed, enrollment into SP915 was stopped in April 2008 to ensure sufficient trial medication for all subjects enrolled at that time to complete the trial according to the protocol.|1||Due to clinical trial supplies shortage|f||||f||||||||||2017-02-18 15:20:36.405777|2017-02-18 15:20:36.405777
NCT00519519|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2017-02-08|||July 2004||2004-07-01|February 2017|2017-02-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers|Intravenous Infusion of High Dose Omeprazole Versus Regular Dose Omeprazole on Recurrent Bleeding After Endoscopic Treatment of Bleeding Peptic Ulcers|Completed||Phase 3|126|Actual|Singapore General Hospital||1|||f||||f||||||||||2017-02-18 15:20:36.825498|2017-02-18 15:20:36.825498
NCT00519506|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2009-04-12|||September 2007||2007-09-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli|A Phase II Study to Evaluate the Efficacy of Anti-Fibrin Humanized Monoclonal Antibody(DI-DD3B6/22-80B3) Fab' Fragment (ThromboView®) Conjugated With Technetium-99m in the Detection of Pulmonary Emboli|Completed||Phase 2|61|Actual|Agen Biomedical||1|||f||||f||||||||||2017-02-18 15:20:36.941243|2017-02-18 15:20:36.941243
NCT00519493|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2010-10-18|||August 2007||2007-08-01|June 2008|2008-06-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|||A Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids|A Two Part Study: An Investigator-initiated, Single-center, Single-blinded, Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids|Unknown status|Active, not recruiting|Phase 4|15|Anticipated|University of Miami||2|||f||||f||||||||||2017-02-18 15:20:37.029062|2017-02-18 15:20:37.029062
NCT00519480|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2012-05-31|||September 2007||2007-09-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin|A Two-Week, Randomized, Double-Blind, Repeat-Dose, Parallel-Group Study to Evaluate the Safety and Tolerability of Metformin > 2000mg Co-Administered With Either GSK189075 500mg BID or GSK 189075 750mg BID to Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|48|Actual|GlaxoSmithKline||3|||||||f||||||||||2017-02-18 15:20:37.141196|2017-02-18 15:20:37.141196
NCT00519467|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2016-12-02|||June 2003||2003-06-01|December 2016|2016-12-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria|An Open, Randomised, Multi-centre Dose Ranging Phase II Study to Evaluate LAPDAP in Combination With Three Different Doses of Artesunate|Completed||Phase 2|120|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:20:37.251678|2017-02-18 15:20:37.251678
NCT00519454|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2010-09-03|||April 2005||2005-04-01|September 2010|2010-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Estrogen and Gender Biased Autoimmunity|Estrogen and Gender Biased Autoimmunity in Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|75|Anticipated|The Center for Rheumatic Disease, Allergy, & Immunology|||1||f||||f||||||||||2017-02-18 15:20:37.34689|2017-02-18 15:20:37.34689
NCT00519441|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2012-08-14|||June 2007||2007-06-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Do Patients Who Have Had Surgery for Achalasia Suffer From Reflux|Gastroesophageal Reflux in Patients With Achalasia|Completed||N/A|100|Actual|University of South Florida||1|||f||||f||||||||||2017-02-18 15:20:37.651607|2017-02-18 15:20:37.651607
NCT00519428|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2012-06-26|||August 2007||2007-08-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|July 2011|Actual|2011-07-01||Interventional|||Does Dual Therapy Hasten Antidepressant Response?|Combining Antidepressants to Hasten Remission From Depression|Completed||Phase 4|245|Actual|New York State Psychiatric Institute||3|||f||||t||||||||||2017-02-18 15:20:37.764026|2017-02-18 15:20:37.764026
NCT00519415|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2008-12-18|||September 2007||2007-09-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Comparative Results of Maxillary Deficiency Treatment by Tongue Plate and Facemask in Growing Patients|This Study is to Apply the Tongue Force to Correct the Dentofacial Deformities|Completed||Phase 3|20|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:20:37.887546|2017-02-18 15:20:37.887546
NCT00519402|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-03-26||||||August 2007|2007-08-01||||||||Observational|||Outcomes of Partial Versus Complete Tonsillectomy for Obstructive Sleep Disordered Breathing||Withdrawn||N/A|||The Cleveland Clinic|||||f||||||||||||||2017-02-18 15:20:37.990207|2017-02-18 15:20:37.990207
NCT00519389|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2013-06-12||2013-06-12|July 2007||2007-07-01|March 2012|2012-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety, Reactogenicity and Immunogenicity of an H5N1 VLP|A Phase I/IIa Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of an H5N1 Virus-Like Particle (VLP) Influenza Vaccine (Recombinant)|Completed||Phase 1/Phase 2|230|Actual|Novavax||4|||f||||t||||||||||2017-02-18 15:20:38.065009|2017-02-18 15:20:38.065009
NCT00519376|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2013-12-05|2013-06-12||August 2007||2007-08-01|September 2013|2013-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.|A Randomised, Single-dose, Dose Ascending, Double-blind, Placebo Controlled, Four-way, Incomplete Block Crossover Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled Doses of GW642444M With Magnesium Stearate in COPD Patients.|Completed||Phase 2|20|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-02-18 15:20:38.282253|2017-02-18 15:20:38.282253
NCT00519363|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2010-03-23|||September 2007||2007-09-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors|Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors.|Completed||Phase 1/Phase 2|15|Anticipated|The Center for Rheumatic Disease, Allergy, & Immunology||1|||f||||f||||||||||2017-02-18 15:20:40.675994|2017-02-18 15:20:40.675994
NCT00519350|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2010-03-30|||August 2007||2007-08-01|March 2010|2010-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Towards a High-fat Feeding Intervention Study: Identification of Markers for Inflammation and Organ Damage|Towards a High-fat Feeding Intervention Study: Identification of Markers for Inflammation and Organ Damage|Completed||N/A|24|Actual|Maastricht University Medical Center|||3||f||||t||||||Samples Without DNA|"~     plasma~   "|||2017-02-18 15:20:40.798151|2017-02-18 15:20:40.798151
NCT00519337|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2012-01-03|||October 2008||2008-10-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|October 2009|Actual|2009-10-01||Interventional|AFIST||Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation|The Impact of Ascorbic Acid Therapy on Inflammatory Mediators in Cardiothoracic Surgery Patients: The Atrial Fibrillation Suppression Trial IV (AFIST IV) Pilot Study|Completed||Phase 4|25|Actual|Hartford Hospital||2|||f||||t||||||||||2017-02-18 15:20:40.908893|2017-02-18 15:20:40.908893
NCT00519324|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2016-11-16|||August 2007||2007-08-01|November 2016|2016-11-01||||January 2009|Actual|2009-01-01||Interventional|||Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer|A Single Arm, Multi-center Phase II Study of RAD001 in Patients With Advanced Gastric Carcinoma Whose Cancer Has Progressed Despite Prior Treatment|Completed||Phase 2|54|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:20:41.030112|2017-02-18 15:20:41.030112
NCT00519311|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2017-01-11|||January 2006||2006-01-01|May 2015|2015-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|Ask||Health Intervention for Adolescents With Intellectual Disability|RCT of an Intervention to Improve the Health of Adolescents With Intellectual Disability|Completed||N/A|732|Actual|The University of Queensland||2|||f||||f||||||||||2017-02-18 15:20:41.150111|2017-02-18 15:20:41.150111
NCT00519298|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2008-04-21|||October 2007||2007-10-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects|A Double-Blind, Placebo-Controlled, Balanced, 4-Way, Incomplete Block Design to Evaluate the Effects of a Single Administration of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG (qEEG) in Healthy Subjects|Completed||Phase 1|25|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||||||||||||2017-02-18 15:20:41.275852|2017-02-18 15:20:41.275852
NCT00519285|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2016-06-21|2013-04-25||August 2007||2007-08-01|June 2016|2016-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|VENICE||Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer|A Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of Aflibercept Versus Placebo Administered Every 3 Weeks in Patients Treated With Docetaxel/ Prednisone for Metastatic Androgen-independent Prostate Cancer|Completed||Phase 3|1224|Actual|Sanofi|Pain response initially defined as a key secondary endpoint together with PSA response, time to occurence of SRE and PFS was finally considered as an exploratory endpoint in final statistical analysis plan.|2|||f||||t||||||||||2017-02-18 15:20:41.393795|2017-02-18 15:20:41.393795
NCT00519272|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2016-06-17|||July 2006||2006-07-01|June 2016|2016-06-01||||July 2018|Anticipated|2018-07-01||Observational|||A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients|A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients|Active, not recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:20:43.266686|2017-02-18 15:20:43.266686
NCT00519259|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2017-01-10|||February 2006||2006-02-01|June 2006|2006-06-01||||||||Interventional|||Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1|Tolerability, Safety, and Pharmacokinetics of Repeated Sublingual Doses of Lobeline|Unknown status|Active, not recruiting|Phase 1|12||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 15:20:43.380645|2017-02-18 15:20:43.380645
NCT00519246|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2009-03-30|||February 2007||2007-02-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|COPTEAM||Comparison of Pain Therapeutic Effects After Benign Mastectomy|Clinical Comparison of Postoperative Pain Therapeutic Effects After Benign Mastectomy|Completed||Phase 4|2000|Actual|Nanjing Medical University||7|||f||||t||||||||||2017-02-18 15:20:43.461693|2017-02-18 15:20:43.461693
NCT00519233|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2014-04-30|||September 2007||2007-09-01|April 2014|2014-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer|A Phase I Investigation of the Intravenous Administration of AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer|Completed||Phase 1|13|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-02-18 15:20:43.585162|2017-02-18 15:20:43.585162
NCT00519220|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2012-08-14|||December 2006||2006-12-01|August 2012|2012-08-01|December 2017|Anticipated|2017-12-01|||||Observational|Achalasia||Outcome of Symptoms in Patients Undergoing a Heller Myotomy|Short and Long Term Outcomes of Heller Myotomy|Recruiting||N/A|800|Anticipated|University of South Florida|||1||f||||f||||||||||2017-02-18 15:20:43.70224|2017-02-18 15:20:43.70224
NCT00519207|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2011-07-18|||August 2007||2007-08-01|July 2011|2011-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Evaluation of Topical Liposomal Lidocaine and Oral Sucrose for Treatment of Pain in Newborns Undergoing Venipuncture|Evaluation of Topical Liposomal Lidocaine and Oral Sucrose for Treatment of Pain in Newborn Infants Undergoing Venipuncture: A Randomized Controlled Trial|Completed||Phase 3|330|Actual|The Hospital for Sick Children||3|||f||||t||||||||||2017-02-18 15:20:43.810028|2017-02-18 15:20:43.810028
NCT00519194|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2014-05-14|2014-03-31||April 2009||2009-04-01|May 2014|2014-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|CONVERT-AF|Subjects treated|CONcomitant eValuation of Epicor Left atRial Therapy for AF|CONcomitant eValuation of Epicor Left atRial Therapy for AF|Terminated||N/A|112|Actual|St. Jude Medical||1|||f||||t||||||||||2017-02-18 15:20:43.924688|2017-02-18 15:20:43.924688
NCT00519181|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2007-08-20|||March 2006||2006-03-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|VALPROHAM||Safety and Efficiency Study of Valproic Acid In HAM/TSP|Open Label Study of the Clinical and Laboratory Effects of Valproic Acid In HAM/TSP|Terminated||N/A|19|Actual|University Hospital Pierre Zobda-Quitman||1|||f||||t||||||||||2017-02-18 15:20:44.147672|2017-02-18 15:20:44.147672
NCT00519168|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2016-04-22|||September 2006||2006-09-01|April 2016|2016-04-01|August 2017|Anticipated|2017-08-01|August 2011|Actual|2011-08-01||Observational|||Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival|Sleep, Circadian, Hormonal Dysregulation, and Breast Cancer Survival|Active, not recruiting||N/A|125|Anticipated|Stanford University|||1||f||||t||||||Samples Without DNA|"~     Saliva and blood~   "|||2017-02-18 15:20:44.234359|2017-02-18 15:20:44.234359
NCT00519155|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2008-04-21|||July 2007||2007-07-01|April 2008|2008-04-01|November 2008|Anticipated|2008-11-01|October 2008|Anticipated|2008-10-01||Interventional|||Pilot Study on MD05 in Comparison With Open Flap Debridement in Patients Undergoing Periodontal Surgery|Pilot Study on Safety and Explorative Efficacy of MD05 in Comparison With Open Flap Debridement in Patients Undergoing Periodontal Surgery to Treat Deep Intrabony Defects|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Scil Technology GmbH||2|||f||||f||||||||||2017-02-18 15:20:44.317127|2017-02-18 15:20:44.317127
NCT00519142|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2009-09-16||2009-09-16|August 2007||2007-08-01|September 2009|2009-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus|A Rapid Onset and Short Duration Insulin Secretogogue, Mitiglinide, in Combination With Metformin Versus Metformin Alone in Patients With Type 2 Diabetes Mellitus: A Randomized, Double-blind, Placebo-controlled Trial for 6 Months|Completed||Phase 3|367|Actual|Elixir Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:20:44.411884|2017-02-18 15:20:44.411884
NCT00519129|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-21|2011-08-17|||August 2007||2007-08-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Improving Quality of Colonoscopy Using a 3D-imager|Magnetic Endoscopic Imaging Versus Standard Colonoscopy in a Routine Colonoscopy Setting: A Randomised Controlled Trial|Completed||Phase 3|800|Actual|Sorlandet Hospital HF||1|||f||||t||||||||||2017-02-18 15:20:44.740984|2017-02-18 15:20:44.740984
NCT00519116|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2007-08-20|||October 2000||2000-10-01|August 2007|2007-08-01|August 2001||2001-08-01|||||Interventional|||Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients|An Open-Label, Concentration-Controlled, Randomized, 6-Month Study of 'Standard Dose' Tacrolimus + Sirolimus + Corticosteroids Compared to 'Reduced-Dose' Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients|Completed||Phase 4|150||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:20:44.836199|2017-02-18 15:20:44.836199
NCT00519103|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2007-08-29|||December 2002||2002-12-01|August 2007|2007-08-01|March 2003|Actual|2003-03-01|||||Interventional|||Resistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositis Patients||Completed||N/A|8|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-02-18 15:20:44.913011|2017-02-18 15:20:44.913011
NCT00519090|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2011-11-04|2010-11-11||October 2007||2007-10-01|November 2011|2011-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|ENEST||Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|A Phase III Randomized, Open- Label Multi-center Study of Nilotinib Versus Imatinib in Adult Patients With Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Who Have a Suboptimal Cytogenetic Response (CyR) on Imatinib|Terminated||Phase 3|6|Actual|Novartis||2||This study was terminated due to limited enrollment.|f||||t||||||||||2017-02-18 15:20:45.022755|2017-02-18 15:20:45.022755
NCT00519077|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2016-06-02|2013-08-14||March 2005||2005-03-01|June 2016|2016-06-01|May 2013|Actual|2013-05-01|May 2008|Actual|2008-05-01||Interventional|||Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck|Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) as Monotherapy in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|44|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 15:20:45.829397|2017-02-18 15:20:45.829397
NCT00519064|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2016-11-30|||November 2006||2006-11-01|February 2012|2012-02-01|May 2007|Actual|2007-05-01|December 2006|Actual|2006-12-01||Interventional|||Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases|A Phase III, Randomized, Controlled, Observer-blind, Single-center Study to Compare Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases|Completed||Phase 3|361|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:20:46.116796|2017-02-18 15:20:46.116796
NCT00519051|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2007-08-20|||March 2004||2004-03-01|August 2007|2007-08-01|December 2006|Actual|2006-12-01|||||Interventional|DMH||A Randomized Clinical Trial for Depressed Mothers at Primary Care Level|Efectividad de la Farmacoterapia Monitorizada en Pacientes Deprimidas de la atención Primaria de Salud y su repercusión Sobre la Salud Mental de Sus Hijos|Completed||N/A|345|Actual|Fondo Nacional de Desarrollo Científico y Tecnológico, Chile||1|||f||||f||||||||||2017-02-18 15:20:46.226813|2017-02-18 15:20:46.226813
NCT00519038|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2007-08-20|||March 2003||2003-03-01|August 2007|2007-08-01|December 2006|Actual|2006-12-01|||||Interventional|EPSEEIC2004||Experimental Prospective Study on the Effectiveness and Efficiency of the Implementation of Clinical Pathways|Experimental Prospective Study on the Effectiveness and Efficiency of the Implementation of Clinical Pathways|Completed||N/A|424|Actual|Agenzia Regionale Sanitaria delle Marche||2|||f||||t||||||||||2017-02-18 15:20:46.336975|2017-02-18 15:20:46.336975
NCT00519025|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2015-12-16|||August 2007||2007-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Risk Factors for Linezolid Resistance in Staphylococcus Aureus|Risk Factors for Linezolid Resistance in Staphylococcus Aureus|Active, not recruiting||N/A|360|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:20:46.428596|2017-02-18 15:20:46.428596
NCT00519012|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2009-09-26|||August 2007||2007-08-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Benefits of Switching Antidepressants Following Early Nonresponse|Prospective 24-week Study, Comparing Clinical Outcomes Between Switching Antidepressants and Maintaining the Same Antidepressant in Patients With Major Depressive Disorder Who do Not Show a 20% Reduction in Symptoms at Week 2|Unknown status|Recruiting|Phase 4|200|Anticipated|Oizumi Hospital||2|||f||||t||||||||||2017-02-18 15:20:46.517945|2017-02-18 15:20:46.517945
NCT00518999|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2007-08-20|||August 2007||2007-08-01|August 2007|2007-08-01|August 2008|Anticipated|2008-08-01|||||Observational|||Emotional and Cognitive Abilites of Schizophrenia Patients at Various Time Points|Emotional and Cognitive Abilites of Schizophrenia Patients at Various Time Points|Unknown status|Not yet recruiting|N/A|120|Anticipated|Shalvata Mental Health Center|||1||f||||t||||||||||2017-02-18 15:20:46.628685|2017-02-18 15:20:46.628685
NCT00518986|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2013-07-12|2010-03-30||October 2007||2007-10-01|July 2013|2013-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression|Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome With Major Depressive Disorder or Dysthymic Disorder|Completed||Phase 4|249|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 15:20:46.719724|2017-02-18 15:20:46.719724
NCT00518973|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2010-02-16|||July 2006||2006-07-01|December 2009|2009-12-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||Trial of Quetiapine in Anorexia Nervosa|Double-blind Placebo-controlled Trial of Quetiapine in Anorexia Nervosa|Unknown status|Recruiting|N/A|10|Anticipated|University of California, San Diego||1|||f||||f||||||||||2017-02-18 15:20:49.327723|2017-02-18 15:20:49.327723
NCT00518960|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2007-08-17|||April 2007||2007-04-01|August 2007|2007-08-01|September 2007|Anticipated|2007-09-01|||||Interventional|||The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome|The Effects of ProAlgaZyme Novel Algae Infusion on HDL Cholesterol and C-Reactive Protein in Individuals With Metabolic Syndrome|Unknown status|Active, not recruiting|N/A|28|Actual|Health Enhancement Products, Inc.||2|||f||||f||||||||||2017-02-18 15:20:49.416556|2017-02-18 15:20:49.416556
NCT00518947|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2011-02-24|||November 1994||1994-11-01|February 2011|2011-02-01|June 1999|Actual|1999-06-01|||||Interventional|TRM||Pharmacotherapy of Treatment-Resistant Mania|Pharmacotherapy of Treatment-Resistant Mania|Completed||Phase 3|45|Actual|University of Pittsburgh||3|||f||||f||||||||||2017-02-18 15:20:49.501973|2017-02-18 15:20:49.501973
NCT00518934|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-19|2007-08-20||||||May 2007|2007-05-01||||||||Interventional|||Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell||Unknown status|Recruiting|Phase 1/Phase 2|||Samsung Medical Center|||||f||||||||||||||2017-02-18 15:20:49.603231|2017-02-18 15:20:49.603231
NCT00518921|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2011-01-12|||March 2008||2008-03-01|January 2011|2011-01-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Capadenoson in Angina Pectoris|Phase IIa Efficacy and Safety Trial of Capadenoson in Patients With Chronic Stable Angina|Withdrawn||Phase 2|0|Actual|Bayer||4|||f||||f||||||||||2017-02-18 15:20:49.692724|2017-02-18 15:20:49.692724
NCT00518908|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2011-07-18|||January 2008||2008-01-01|July 2011|2011-07-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Organ Protection With Sevoflurane Postconditioning|Role of Volatile Anesthetics for Hepatic Protection in Ischemia-reperfusion: Postconditioning|Completed||N/A|125|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 15:20:49.822231|2017-02-18 15:20:49.822231
NCT00518895|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2011-11-04|||July 2007||2007-07-01|April 2009|2009-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|AGENDA||Trial of Dacarbazine With or Without Genasense in Advanced Melanoma|A Multicenter, Randomized, Double-blind Study of Dacarbazine With or Without Genasense in Chemotherapy-naive Subjects With Advanced Melanoma and Low LDH (The AGENDA Trial)|Completed||Phase 3|300|Anticipated|Genta Incorporated||2|||f||||t||||||||||2017-02-18 15:20:49.924684|2017-02-18 15:20:49.924684
NCT00518882|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2014-11-13|2010-02-23||August 2007||2007-08-01|November 2014|2014-11-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|LEAD-6||Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Liraglutide or Exenatide Added to a Background Treatment of Metformin, Sulphonylurea or a Combination of Both on Glycaemic Control in Subjects With Type 2 Diabetes|Completed||Phase 3|467|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 15:20:50.243427|2017-02-18 15:20:50.243427
NCT00518869|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-18|2015-11-03|||September 2007||2007-09-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue||Terminated||Phase 2/Phase 3|210|Anticipated|PhytoHealth Corporation||2||Sponsor's decision|f||||f||||||||||2017-02-18 15:20:52.52022|2017-02-18 15:20:52.52022
NCT00518856|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2011-03-29|||September 2006||2006-09-01|March 2011|2011-03-01|July 2009|Actual|2009-07-01|September 2008|Actual|2008-09-01||Interventional|LUNESP||Lufwanyama Neonatal Survival Project|Lufwanyama Neonatal Survival Project|Completed||N/A|3559|Actual|Boston University||2|||f||||f||||||||||2017-02-18 15:20:52.634626|2017-02-18 15:20:52.634626
NCT00518843|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2013-09-04|||April 2001||2001-04-01|September 2013|2013-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Family Therapy for Adolescent Bulimia Nervosa|Family Therapy for Adolescent Bulimia Nervosa: A Controlled Comparison|Completed||Phase 2|80|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 15:20:52.725657|2017-02-18 15:20:52.725657
NCT00518830|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2007-08-20|||March 2004||2004-03-01|July 2007|2007-07-01|July 2006|Actual|2006-07-01|||||Interventional|DPP||Treatment of Postnatal Depression for Low-Income Mothers in Primary Care in Santiago, Chile|Randomized Clinical Trial for the Treatment of Postnatal Depression|Completed||N/A|230|Actual|Fondo Nacional de Desarrollo Científico y Tecnológico, Chile||2|||f||||f||||||||||2017-02-18 15:20:52.830538|2017-02-18 15:20:52.830538
NCT00518817|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2007-08-20|||August 2007||2007-08-01|August 2007|2007-08-01|August 2009|Anticipated|2009-08-01|||||Observational|||The Cardiovascular Genetic and Therapeutic Implications of Muscular Dystrophy||Unknown status|Not yet recruiting|N/A|60|Anticipated|Baylor College of Medicine|||||f||||f||||||||||2017-02-18 15:20:52.928644|2017-02-18 15:20:52.928644
NCT00518804|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2008-12-04|||August 2007||2007-08-01|July 2008|2008-07-01|August 2009|Anticipated|2009-08-01|||||Interventional|||Functional Behavioural Skill Training for Young Children With Severe Autism||Unknown status|Recruiting|N/A|32|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 15:20:53.009606|2017-02-18 15:20:53.009606
NCT00518791|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2010-11-04|||August 2007||2007-08-01|October 2010|2010-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial|Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled Trial|Completed||Phase 3|301|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:20:53.233077|2017-02-18 15:20:53.233077
NCT00518778|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2009-12-02|||August 2007||2007-08-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|||||Observational|||Fusariosis in Solid-Organ Transplant Recipients|Fusariosis in Solid-Organ Transplant Recipients|Completed||N/A|50|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:20:53.353922|2017-02-18 15:20:53.353922
NCT00518765|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2010-10-05|||October 2005||2005-10-01|October 2010|2010-10-01||||August 2007|Actual|2007-08-01||Interventional|||Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet|"A Single-center, Placebo-controlled Study of the Effects of Ascending Single Oral Doses of Aliskiren Compared With Captopril on Renal Hemodynamics in Healthy Volunteers on a Low and High Sodium Diet Renin Inhibition and the Kidney"|Completed||Phase 3|32|Actual|Novartis||4|||t||||f||||||||||2017-02-18 15:20:53.441992|2017-02-18 15:20:53.441992
NCT00518752|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2013-01-14|||May 2007||2007-05-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|March 2011|Actual|2011-03-01||Interventional|||Effects of Oral Care in the Neuroscience ICU|Comprehensive Oral Care for the Intubated Neuroscience ICU Patient: A Comparison of the Safety and Efficacy Between 2 Protocols|Completed||N/A|113|Actual|St. Joseph's Hospital and Medical Center, Phoenix||2|||f||||f||||||||||2017-02-18 15:20:53.548364|2017-02-18 15:20:53.548364
NCT00518739|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2015-03-26|||February 2007||2007-02-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED)|A Phase I Dose Escalation Study of MK2461 in Patients With Advanced Cancer|Completed||Phase 1|25|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:20:53.653836|2017-02-18 15:20:53.653836
NCT00518726|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2016-11-30|||June 2007||2007-06-01|November 2011|2011-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects|A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Surface Antigen, Inactivated, Formulation 2007-2008, When Administered to Non-Elderly Adult and Elderly Subjects|Completed||Phase 2|125|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:20:53.728875|2017-02-18 15:20:53.728875
NCT00518713|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2012-01-06|2011-11-07||August 2007||2007-08-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Clobazam in Patients With Lennox-Gastaut Syndrome|Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam in Patients With Lennox-Gastaut Syndrome|Completed||Phase 3|238|Actual|Lundbeck LLC||4|||f||||t||||||||||2017-02-18 15:20:53.841002|2017-02-18 15:20:53.841002
NCT00518700|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2008-04-21||||||April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients||Completed||Phase 4|24|Actual|Innovative Medical|||||f||||||||||||||2017-02-18 15:20:55.417698|2017-02-18 15:20:55.417698
NCT00518687|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2015-10-01|2012-10-02||December 2007||2007-12-01|October 2015|2015-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)|A Randomized, Multicenter, Double-Blind, Group-Sequential Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine (V710) in Adult Patients Scheduled for Cardiothoracic Surgery|Terminated||Phase 2/Phase 3|8031|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:20:55.502239|2017-02-18 15:20:55.502239
NCT00518674|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2007-08-20|||January 2007||2007-01-01|July 2007|2007-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Local Anesthetics After Total Knee Arthroplasty|Local Anesthetics After Total Knee Arthroplasty: Intra- vs. Extraarticular Administration? A Randomized, Double-Blind, Placebo-Controlled Study|Unknown status|Active, not recruiting|N/A|32|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 15:20:56.373528|2017-02-18 15:20:56.373528
NCT00518661|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2015-12-16|||August 2007||2007-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species|Risk Factors for Quinolone Resistance Among Extended-Spectrum Beta-Lactamase-Producing Klebsiella Species|Active, not recruiting||N/A|500|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:20:56.445793|2017-02-18 15:20:56.445793
NCT00518648|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2010-11-22|||August 2007||2007-08-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|REFINE-PD||Reduction of Falls in the Elderly - Parkinson's Disease|Reduction of Falls in the Elderly - Parkinson's Disease|Completed||Phase 3|187|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:20:56.53132|2017-02-18 15:20:56.53132
NCT00518635|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2013-02-18|||October 2010||2010-10-01|February 2013|2013-02-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Low Dose Growth Hormone in Obese PCOS Women|Effects of Low Dose Growth Hormone (GH) Therapy on Insulin Sensitivity, Metabolic Profile, Adipocyte IGF-I and Insulin Signaling, Intramyocellular Lipids, and Cortisol Metabolism in Obese Women With Polycystic Ovary Syndrome (PCOS)|Withdrawn||N/A|0|Actual|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 15:20:56.644389|2017-02-18 15:20:56.644389
NCT00518622|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2015-08-11|2009-08-10||July 2007||2007-07-01|August 2015|2015-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED)|A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of MK7009 in Hepatitis C Infected Patients|Completed||Phase 1|40|Actual|Merck Sharp & Dohme Corp.||8|||f||||f||||||||||2017-02-18 15:20:56.768454|2017-02-18 15:20:56.768454
NCT00518609|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2014-07-29|||July 2003||2003-07-01|July 2014|2014-07-01|July 2006|Actual|2006-07-01|||||Observational|||Prevention of Infection in Indian Neonates - Phase I Observational Study|Prevention of Infection in Indian Neonates - Phase I Observational Study|Completed||Phase 1|1326|Actual|NICHD Global Network for Women's and Children's Health|||1||f||||t||||||||||2017-02-18 15:20:58.200135|2017-02-18 15:20:58.200135
NCT00518596|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-20|2013-12-16|||July 2005||2005-07-01|December 2013|2013-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Prevention of Infection in Indian Neonates - Phase II Probiotics Study|Prevention of Infection in Indian Neonates - Phase II Probiotics Study|Completed||Phase 2|284|Actual|NICHD Global Network for Women's and Children's Health||2|||f||||||||||||||2017-02-18 15:20:58.311535|2017-02-18 15:20:58.311535
NCT00518583|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2010-01-14|||October 2006||2006-10-01|January 2010|2010-01-01|September 2009|Anticipated|2009-09-01|January 2009|Anticipated|2009-01-01||Interventional|||Phase II Study in Patients With Operable Breast Cancer|A Phase II Study of Pre-Operative Pegylated Liposomal Doxorubicin (PLD), Paclitaxel, and Trastuzumab in Patients With Operable Breast Cancer Over-expressing Her2-neu|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Aptium Oncology Research Network||1|||f||||f||||||||||2017-02-18 15:20:58.43194|2017-02-18 15:20:58.43194
NCT00518570|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2007-08-17|||November 2003||2003-11-01|August 2007|2007-08-01|October 2006|Actual|2006-10-01|||||Interventional|pmdd||Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)|A Pilot Study: Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder|Completed||N/A|7|Actual|Berkshire Health Systems||1|||f||||f||||||||||2017-02-18 15:20:58.538291|2017-02-18 15:20:58.538291
NCT00518557|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2009-01-21|||April 2007||2007-04-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|||||Interventional|TACE HCC||Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis|Combination Treatment of TACE With Recombinant Human Endostatin Administrated Via Hepatic Artery in Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|60|Anticipated|Southeast University, China||2|||f||||t||||||||||2017-02-18 15:20:58.635245|2017-02-18 15:20:58.635245
NCT00518544|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2007-08-16|||July 2007||2007-07-01|August 2007|2007-08-01||||||||Interventional|||Hemostatic Effect of Various Colloid Solutions|Hemostatic Effect of Various Colloid Solutions According to Blood Types|Unknown status|Recruiting|N/A|||Samsung Medical Center|||||f||||t||||||||||2017-02-18 15:21:01.323976|2017-02-18 15:21:01.323976
NCT00518531|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2014-07-14|2010-07-01||September 2007||2007-09-01|July 2014|2014-07-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Denosumab Adherence Preference Satisfaction Study|A Multicenter, Randomized, Cross-Over, Open-label Study to Evaluate the Adherence, Preference, and Satisfaction of Denosumab and Alendronate in Postmenopausal Women With Low Bone Mineral Density|Completed||Phase 3|250|Actual|Amgen||2|||f||||||||||||||2017-02-18 15:21:01.426287|2017-02-18 15:21:01.426287
NCT00518518|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2009-05-14|||March 2006||2006-03-01|May 2009|2009-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen|Safety and Efficacy of Ultra-Rush High-Dose Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen - Prospective, Randomized, Placebo Controlled Study.|Completed||Phase 4|50|Actual|Medical Universtity of Lodz||2|||f||||t||||||||||2017-02-18 15:21:02.525793|2017-02-18 15:21:02.525793
NCT00518505|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2012-08-14|||December 2006||2006-12-01|August 2012|2012-08-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|GERD||Assessing Outcomes After Surgery for Gastroesophageal Reflux Disorder|Long and Short Term Outcomes After Laparoscopic Surgery for Gastroesophageal Reflux Disease|Recruiting||N/A|1500|Anticipated|University of South Florida||1|||f||||f||||||||||2017-02-18 15:21:02.637054|2017-02-18 15:21:02.637054
NCT00518492|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2009-09-15|||August 2007||2007-08-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study Evaluating the Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500|Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500|Completed||Phase 1|73|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:21:02.74905|2017-02-18 15:21:02.74905
NCT00518479|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2012-08-15|||September 2003||2003-09-01|August 2012|2012-08-01|April 2004|Actual|2004-04-01|||||Interventional|||Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression|Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression|Completed||N/A|42|Actual|University of Leeds||2|||f||||f||||||||||2017-02-18 15:21:02.843018|2017-02-18 15:21:02.843018
NCT00518466|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2011-06-06|||July 2007||2007-07-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults|A Phase Ib, Open Label, Parallel-Design Single- and Multiple-Dose Study Comparing Modified Release Topiramate Formulations to Immediate Release Formulations of Topiramate Dosed in Combination With Immediate Release Phentermine in Obese Adults|Completed||Phase 1|64|Actual|VIVUS, Inc.||4|||f||||f||||||||||2017-02-18 15:21:02.954806|2017-02-18 15:21:02.954806
NCT00518453|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2016-11-30|||July 2007||2007-07-01|November 2011|2011-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008|A Phase II, Open-Label, Uncontrolled, Single Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Ph.Eur, Formulation 2007-2008, When Administered to Non-Elderly Adult and Elderly Subjects|Completed||Phase 2|129|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:21:03.066239|2017-02-18 15:21:03.066239
NCT00518440|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2016-10-24|||January 1998||1998-01-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|ALFSG||A Multi-Center Trial to Study Acute Liver Failure in Adults|A Multi-Center Trial to Study Acute Liver Failure in Adults|Recruiting||N/A|3000|Anticipated|University of Texas Southwestern Medical Center|||1||f||||t||||||Samples With DNA|"~     Serum, Plasma, Urine, DNA and Tissue if available are collected and stored at the NIDDK~     Central Repository~   "|||2017-02-18 15:21:03.179548|2017-02-18 15:21:03.179548
NCT00518427|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2009-12-04|||October 2005||2005-10-01|December 2009|2009-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|QoL||Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine|A Multicenter Clinical Trial to Evaluate Quality of Life in Patients With Type 2 Diabetes Before and After Changing Therapy to a Combination of Insulin Glargine and Oral Antidiabetic Drugs in a Real Life Situation|Completed||Phase 4|26|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:21:03.34601|2017-02-18 15:21:03.34601
NCT00518414|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2015-09-24|||April 2007||2007-04-01|September 2015|2015-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Evaluation of Cow Milk-Based Formulas|The Evaluation of Cow Milk-Based Formulas - Study A|Completed||N/A|136|Actual|Mead Johnson Nutrition||3|||f||||f||||||||||2017-02-18 15:21:03.440221|2017-02-18 15:21:03.440221
NCT00518401|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2011-04-27|||June 2007||2007-06-01|February 2010|2010-02-01|October 2009|Actual|2009-10-01|August 2008|Actual|2008-08-01||Interventional|mesendo||Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia|Phase I Study of A Combination Stem Cell Therapy is Safe and Feasible in the Development of Mature Stable Vessels in Ischemic Limbs|Completed||Phase 1|10|Actual|TCA Cellular Therapy||1|||f||||f||||||||||2017-02-18 15:21:03.540259|2017-02-18 15:21:03.540259
NCT00518388|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-01-14|||August 2007||2007-08-01|January 2016|2016-01-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Perceptions of Cervical Cancer Among Asian Americans|Perceptions of Cervical Cancer and Human Papillomavirus Among Asian Americans|Completed||N/A|52|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:21:03.63688|2017-02-18 15:21:03.63688
NCT00518375|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2007-08-16|||April 2000||2000-04-01|August 2007|2007-08-01|May 2001||2001-05-01|||||Interventional|||Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus|A Comparative, Open-Label Study to Evaluate Graft Function in de Novo Renal Allograft Recipients Treated With Either a 'Reduced Dose' or a 'Standard Dose' of Cyclosporine in Combination With Sirolimus and Corticosteroids|Completed||Phase 4|250||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:21:03.748161|2017-02-18 15:21:03.748161
NCT00518362|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2010-05-25|||July 2007||2007-07-01|April 2009|2009-04-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|||To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)|To Compare the Efficacy and Safety of TW vs Valsartan in the DN|Completed||N/A|67|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 15:21:03.823887|2017-02-18 15:21:03.823887
NCT00518349|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2009-03-19|||August 2003||2003-08-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|December 2007|Actual|2007-12-01||Interventional|||Colonoscope Passive Bending Function|Evaluation of a Novel Colonoscope Designed for Easier Passage Through Flexures: A Randomised Study|Unknown status|Active, not recruiting|Phase 2|120|Actual|Norwegian Department of Health and Social Affairs||2|||f||||f||||||||||2017-02-18 15:21:03.927555|2017-02-18 15:21:03.927555
NCT00518336|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2016-10-27|2010-07-12||November 2007||2007-11-01|October 2016|2016-10-01|September 2010|Actual|2010-09-01|July 2008|Actual|2008-07-01||Interventional|||Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil|Follow-up Study to Evaluate the Long-term Efficacy of a HPV Vaccine (580299) in Healthy Young Adult Women in Brazil|Completed||Phase 2|433|Actual|GlaxoSmithKline|Interim analysis at Year 7 and Year 8 are superseded by the final analysis at Year 9.|2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:21:04.070743|2017-02-18 15:21:04.070743
NCT00518323|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2014-03-25|2010-03-23||August 2007||2007-08-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients|A Randomized, Multicenter, Double-Blind, Weight-Based, Fixed-Dose, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Extended Release Paliperidone for the Treatment of Schizophrenia in Adolescent Subjects, 12 to 17 Years of Age|Completed||Phase 3|201|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|No information about longer-term (ie, >6 weeks) efficacy and safety in adolescents or in young (<12 years) children with schizophrenia. Results with doses less than 1.5 mg or more than 12 mg cannot be extrapolated from the data.|4|||f||||||||||||||2017-02-18 15:21:07.158967|2017-02-18 15:21:07.158967
NCT00518310|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2007-08-16|||May 2005||2005-05-01|August 2007|2007-08-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis|Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: a Randomized, Double-Blind, Controlled Study|Unknown status|Recruiting|N/A|100|Anticipated|Thorax National Institute||2|||f||||t||||||||||2017-02-18 15:21:08.072954|2017-02-18 15:21:08.072954
NCT00517231|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2015-07-06|||June 2005||2005-06-01|July 2015|2015-07-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Observational|||Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment||Withdrawn||N/A|0|Actual|UPECLIN HC FM Botucatu Unesp||||The investigator left the research center and the study was not carried out|f||||f||||||||||2017-02-18 15:21:38.665465|2017-02-18 15:21:38.665465
NCT00518297|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2010-02-03|||August 2007||2007-08-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||DDI HV (ATV - Merck)|Open Label, Multiple Dose, Sequential, Drug-Drug Interaction Study to Assess the Pharmacokinetics and Safety of Atazanavir and Raltegravir Co-Administered Twice Daily in Healthy Subjects|Completed||Phase 1|22|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 15:21:08.183744|2017-02-18 15:21:08.183744
NCT00518284|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2012-02-21|2012-02-21||January 2008||2008-01-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Prevention of Restenosis Following Revascularization|A Phase II Trial of ABI-007 (Paclitaxel Albumin-bound Particles) for the Prevention of Restenosis Following Revascularization of the Superficial Femoral Artery (SFA)|Terminated||Phase 2|6|Actual|Celgene||4||"Study was terminated due to changing sponsor priorities, and was not based on safety or~   outcomes data."|f||||f||||||||||2017-02-18 15:21:08.293954|2017-02-18 15:21:08.293954
NCT00518271|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2007-08-16|||April 2000||2000-04-01|August 2007|2007-08-01|June 2002|Actual|2002-06-01|||||Interventional|||Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients|A Phase II, Open-Label, Concentration-Controlled, Randomized, 6-Month Study of 'Standard Dose' Tacrolimus + Sirolimus + Corticosteroids Compared to 'Reduced Dose' Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients|Completed||Phase 2|120|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:21:09.076496|2017-02-18 15:21:09.076496
NCT00518258|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2013-05-16|||July 2006||2006-07-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Neuroimaging Studies of Depression in Parkinson's Disease|Neuroimaging Studies of Depression in Parkinson's Disease|Completed||N/A|120|Anticipated|University of Kentucky|||2||f||||f||||||||||2017-02-18 15:21:09.160597|2017-02-18 15:21:09.160597
NCT00518245|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-01-26|||August 2007||2007-08-01|January 2016|2016-01-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|IDEAL||Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)|A Prospective, Open Label, Randomized, Parallel-group Investigation to Evaluate the Efficacy and Safety of Enoxaparin Versus no Enoxaparin in Subjects With Chest Pain Syndrome and no ECG or Biomarker Abnormalities|Terminated||Phase 4|11|Actual|Canadian Heart Research Centre||2||Low rate of patient recruitment. Cannot achieve sample size.|f||||t||||||||No|insufficient data|2017-02-18 15:21:09.242746|2017-02-18 15:21:09.242746
NCT00518232|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2010-04-26|||September 2006||2006-09-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder|The Effective and Tolerable Titration Scheme and Dosage in Children With Attention-deficit Hyperactivity Disorder Treated With OROS-Methylphenidate|Completed||Phase 4|520|Actual|Johnson & Johnson Taiwan Ltd|||||f||||||||||||||2017-02-18 15:21:09.410511|2017-02-18 15:21:09.410511
NCT00518219|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2010-05-25|||July 2007||2007-07-01|March 2009|2009-03-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)|To Compare the Efficacy and Safety of TW vs Valsartan in the MN|Completed||Phase 4|68|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 15:21:09.668265|2017-02-18 15:21:09.668265
NCT00518206|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2013-02-27|||December 2003||2003-12-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|January 2010|Actual|2010-01-01||Interventional|||Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma|A Phase II Study of the Clinical and Immunological Effects of NY-ESO-1 ISCOM® Vaccine in Patients With Measurable Stage III and IV Malignant Melanoma|Completed||Phase 2|46|Actual|Ludwig Institute for Cancer Research||2|||f||||f||||||||||2017-02-18 15:21:09.781525|2017-02-18 15:21:09.781525
NCT00518193|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2011-06-29|||April 2007||2007-04-01|June 2011|2011-06-01|September 2008|Actual|2008-09-01|July 2007|Actual|2007-07-01||Interventional|ERBUS||Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix||Terminated||Phase 2|44|Actual|ARCAGY/ GINECO GROUP||1||high rate of medullar aplasia with infectious troubles.|f||||t||||||||||2017-02-18 15:21:09.894574|2017-02-18 15:21:09.894574
NCT00518180|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2016-04-18|2010-03-19||July 2007||2007-07-01|April 2016|2016-04-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents|A Phase 3, Single-Center, Open-label, Controlled, Randomized Study to Evaluate the Safety and Immunogenicity of Novartis Men ACWY Vaccine Administered Either Alone or Concomitantly With a Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine and Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine in Healthy Adolescents|Completed||Phase 3|1620|Actual|Novartis||3|||f||||f||||||||||2017-02-18 15:21:10.00589|2017-02-18 15:21:10.00589
NCT00518167|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2011-08-31|||November 1993||1993-11-01|August 2011|2011-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|DPS||The Finnish Diabetes Prevention Study|The Finnish Diabetes Prevention Study: A Follow-up Study on the Effect of a Dietary and Exercise Intervention in the Prevention of Diabetes and Its Vascular Complications|Unknown status|Active, not recruiting|N/A|522|Actual|National Institute for Health and Welfare, Finland||2|||f||||t||||||||||2017-02-18 15:21:11.127975|2017-02-18 15:21:11.127975
NCT00518154|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2009-04-16|||September 2007||2007-09-01|April 2009|2009-04-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response|Pilot Study of an ACh-E Inhibitor Upon Immune Activation Markers in HIV-1 Infected Patients Receiving Highly Active Antiretroviral Therapy (HAART) Showing an Incomplete Immune Response.|Completed||Phase 2|7|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||1|||f||||f||||||||||2017-02-18 15:21:11.249645|2017-02-18 15:21:11.249645
NCT00518141|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2011-07-20|||March 2006||2006-03-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)|Use of Acetylsalicylic Acid and Terbutalin in ART|Completed||N/A|300|Actual|Sykehuset Telemark||6|||f||||f||||||||||2017-02-18 15:21:11.377001|2017-02-18 15:21:11.377001
NCT00518128|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2012-05-18|||July 2007||2007-07-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Measuring Effectiveness in Sleep Apnea Surgery|Measuring Effectiveness in Sleep Apnea Surgery|Completed||N/A|60|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:21:11.498919|2017-02-18 15:21:11.498919
NCT00518115|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-17|2016-11-03|2014-05-01||April 2007||2007-04-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only|A 16-Week, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of Multiple Doses and Multiple Treatment Regimens of GSK716155, With Byetta as an Open Label Active Reference, in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|361|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:21:11.650115|2017-02-18 15:21:11.650115
NCT00518102|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-07-15|||January 2003||2003-01-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])|A Matched Cohort Study of Regranex (Becaplermin) and the Risk of Cancer|Completed||N/A|4431|Actual|Ethicon, Inc.|||2||f||||||||||||||2017-02-18 15:21:16.773799|2017-02-18 15:21:16.773799
NCT00518089|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2011-10-24|2010-06-15||February 2008||2008-02-01|October 2011|2011-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis||Completed||Phase 3|859|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:21:16.877983|2017-02-18 15:21:16.877983
NCT00518076|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2007-08-17|||September 2006||2006-09-01|August 2007|2007-08-01||||||||Observational|||Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant||Unknown status|Recruiting|N/A|||University of Sao Paulo|||||f||||t||||||||||2017-02-18 15:21:17.325995|2017-02-18 15:21:17.325995
NCT00518050|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2015-07-15|||October 2006||2006-10-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns|Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns|Completed||N/A|160|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||||||2017-02-18 15:21:17.560799|2017-02-18 15:21:17.560799
NCT00518037|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2014-05-22|||June 2006||2006-06-01|May 2014|2014-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Quality of Life in Patients With Nonmelanoma Skin Cancer|Quality of Life in Patients With Nonmelanoma Skin Cancer|Completed||N/A|112|Actual|Northwestern University|||1||f||||f||||||||||2017-02-18 15:21:17.67399|2017-02-18 15:21:17.67399
NCT00518024|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2010-06-28||||||June 2010|2010-06-01||||||||Interventional|||Safety and Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus|Safety and Effectiveness of Bilateral Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation) in the Treatment of Chronic Tinnitus|Completed||Phase 2|48|Anticipated|University Hospital Tuebingen||3|||f||||t||||||||||2017-02-18 15:21:17.817851|2017-02-18 15:21:17.817851
NCT00518011|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-04-11|2015-12-31||August 2007||2007-08-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional||Intention-to-treat (ITT) population included all randomized participants.|A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.|A Randomized, Open Label Study Comparing the Effect of First-line Therapy With Tarceva + Gemcitabine Versus Gemcitabine Monotherapy on Treatment Response in Treatment-naïve Patients With Advanced Non-small Cell Lung Cancer|Completed||Phase 2|17|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:21:17.920148|2017-02-18 15:21:17.920148
NCT00517998|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2010-01-14|||May 2007||2007-05-01|January 2010|2010-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study|Phase 1 Study of the Biologic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema|Completed||Phase 1|16|Actual|Aeris Therapeutics||2|||f||||t||||||||||2017-02-18 15:21:18.575501|2017-02-18 15:21:18.575501
NCT00517985|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2012-07-05|||February 2007||2007-02-01|July 2012|2012-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Duloxetine for Perimenopausal Depression|Duloxetine for Perimenopausal Depression|Completed||Phase 4|7|Actual|University of Arizona||1|||f||||f||||||||||2017-02-18 15:21:18.686261|2017-02-18 15:21:18.686261
NCT00517972|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2012-03-27||||||March 2012|2012-03-01||||||||Interventional|||Omacor for Perimenopausal Depression|Omacor for Perimenopausal Depression|Withdrawn||Phase 2|0|Actual|University of Arizona|||||f||||f||||||||||2017-02-18 15:21:18.782782|2017-02-18 15:21:18.782782
NCT00517959|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2012-12-08|||May 2001||2001-05-01|June 2012|2012-06-01|June 2017|Anticipated|2017-06-01|March 2013|Anticipated|2013-03-01||Interventional|SCRT||SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors|Efficacy of Stereotactic Conformal Radiotherapy (SCRT) Compared to Conventional Radiotherapy in Minimising Late Sequelae in Children and Young Adults With Brain Tumours: a Randomised Clinical Trial|Active, not recruiting||Phase 3|200|Actual|Tata Memorial Hospital||2|||f||||t||||||||||2017-02-18 15:21:18.871623|2017-02-18 15:21:18.871623
NCT00517946|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2013-08-30|||March 2007||2007-03-01|August 2013|2013-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.|An Investigation to Evaluate the Technique of MRI as an Assessment of the Effect of Anti-allergy Drug Treatment on Internal Nasal and Sinus Mucosal Anatomy Following Intranasal Allergen Challenge in Subjects With Seasonal Allergic Rhinitis.|Completed||N/A|21|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 15:21:18.986143|2017-02-18 15:21:18.986143
NCT00517933|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2015-06-22|2010-11-05||August 2007||2007-08-01|June 2015|2015-06-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Interventional|STEP-IPF||Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis|Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis|Completed||Phase 3|180|Actual|Duke University|Findings are limited to patients with advanced IPF. It is unknown if treatment effect was driven by particular subgroup of patients. Study was too short and enrolled too few to assess duration of effect.|2|||f||||t||||||||||2017-02-18 15:21:19.31756|2017-02-18 15:21:19.31756
NCT00517920|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2013-01-02||2012-06-29|September 2007||2007-09-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)|An Open-Label, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)|Completed||Phase 2|44|Actual|AbbVie||1|||f||||f||||||||||2017-02-18 15:21:20.622565|2017-02-18 15:21:20.622565
NCT00516620|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2015-12-08|||January 2005||2005-01-01|December 2015|2015-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Fruits, Vegetables, and Whole Grains: A Community-based Intervention|Fruits, Vegetables, and Whole Grains: A Community-based Intervention|Completed||Phase 1|960|Actual|University of Toronto||4|||f||||f||||||||||2017-02-18 15:21:46.545305|2017-02-18 15:21:46.545305
NCT00517907|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2015-06-10|||January 2016||2016-01-01|August 2008|2008-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|PIF1GVHD||Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)|Phase I Clinical Trial to Assess Safety of Synthetic Preimplantation Factor (PIF-1) in Patients With Steroid-Resistant Acute Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Stem-Cell Transplantation|Not yet recruiting||Phase 1|6|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-02-18 15:21:20.725926|2017-02-18 15:21:20.725926
NCT00517894|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2007-08-15||||||August 2007|2007-08-01||||||||Expanded Access|||Dose-Dense Therapy in Aggressive Lymphoma|Phase 3 Study of Dose-Dense Therapy Versus CHOP in Aggressive Non-Hodgkin's Lymphoma|No longer available||N/A|||Arbeitsgemeinschaft medikamentoese Tumortherapie|||||f||||||||||||||2017-02-18 15:21:20.844218|2017-02-18 15:21:20.844218
NCT00517881|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-04-21|2016-04-21||June 2007||2007-06-01|April 2016|2016-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional||The safety population included all participants who were treated with at least 1 dose of the study drug and a safety follow-up, whether withdrawn prematurely or not.|Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia|A Single Arm Open Label Study to Assess the Efficacy, Safety and Tolerability of Once Monthly Administration of Subcutaneous C.E.R.A. for the Maintenance of Haemoglobin Levels in Pre-dialysis Patients With Chronic Renal Anaemia|Terminated||Phase 3|29|Actual|Hoffmann-La Roche|The study was terminated early due to the slow recruitment rate.|1||The study was terminated due to the slow recruitment rate.|f||||f||||||||||2017-02-18 15:21:20.925039|2017-02-18 15:21:20.925039
NCT00517868|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2008-04-07|||August 2007||2007-08-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis|URG101 Pharmacodynamic and Safety Study: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Cross-Over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.|Completed||Phase 2|28|Actual|Urigen||2|||f||||f||||||||||2017-02-18 15:21:21.232414|2017-02-18 15:21:21.232414
NCT00517855|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2008-05-01|||June 2007||2007-06-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of PRTX-100 in Healthy Adult Volunteers|A Phase 1 Double-Blind, Randomized, Placebo-Controlled, Single-Dose Escalation Study of the Safety and Pharmacokinetics of Intravenous Doses of PRTX-100 in Healthy Adult Subjects|Completed||Phase 1|20|Anticipated|Protalex, Inc.||3|||f||||f||||||||||2017-02-18 15:21:21.340315|2017-02-18 15:21:21.340315
NCT00517842|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2013-09-03|||October 2005||2005-10-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|||||Interventional|||A Triple-blinded, Randomised, Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinson's Disease|A Triple-blinded, Randomised, Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinson's Disease|Completed||N/A|160|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:21.422174|2017-02-18 15:21:21.422174
NCT00517829|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2016-10-14|2016-01-12||July 2007||2007-07-01|October 2016|2016-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||ITT population|Docetaxel+Oxali+/-Cetux Met Gastric/GEJ|Phase II Trial of Docetaxel Plus Oxaliplatin (DOCOX) With or Without Cetuximab in Patients With Metastatic Gastric and/or Gastroesophageal Junction Adenocarcinoma|Completed||Phase 2|150|Actual|US Oncology Research||2|||f||||f||||||||No||2017-02-18 15:21:21.538696|2017-02-18 15:21:21.538696
NCT00517816|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-11-01|||October 2007||2007-10-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.|A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma|Completed||Phase 1|43|Actual|Hoffmann-La Roche||8|||f||||||||||||||2017-02-18 15:21:22.357735|2017-02-18 15:21:22.357735
NCT00517803|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2009-07-06|||September 2007||2007-09-01|July 2009|2009-07-01|August 2009|Anticipated|2009-08-01|August 2008|Anticipated|2008-08-01||Interventional|||Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies|Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies: A Randomized, Placebo-Controlled Trial|Unknown status|Active, not recruiting|N/A|30|Anticipated|Lawson Health Research Institute||2|||f||||t||||||||||2017-02-18 15:21:22.460095|2017-02-18 15:21:22.460095
NCT00517790|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2013-03-29||2012-07-13|August 2007||2007-08-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)|An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|140|Actual|AbbVie||2|||f||||f||||||||||2017-02-18 15:21:22.580079|2017-02-18 15:21:22.580079
NCT00517777|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2007-08-15|||August 2007||2007-08-01|August 2007|2007-08-01|August 2010|Anticipated|2010-08-01|||||Interventional|||Continuous Positive Airway Pressure in Sleep Apnea Syndrome: Effects on Metabolic Syndrome and Cardiac Damage|Effects of the Continuous Positive Airway Pressure Ventilation on the Prevalence of the Metabolic Syndrome and Cardiac Morpho-Functional Characteristics in Sleep Apnea Syndrome|Unknown status|Recruiting|Phase 4|100|Anticipated|Università degli Studi dell'Insubria||2|||f||||t||||||||||2017-02-18 15:21:22.701812|2017-02-18 15:21:22.701812
NCT00517764|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2013-08-06|||December 2006||2006-12-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression|The Role of Childhood Adversity and Genetic Polymorphisms in the Serotonin and Brain-Derived Neurotrophic Factor Systems in the Sensitization to Stress in First-Onset Major Depression (Blue Sky Project)|Completed||N/A|299|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-02-18 15:21:22.800267|2017-02-18 15:21:22.800267
NCT00517751|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2016-01-14|2015-12-01||August 2007||2007-08-01|January 2016|2016-01-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional|COAST||Condition of Approval Study|Treatment of Lumbar Spinal Stenosis With X-STOP® PEEK Spacer in Moderately Symptomatic Patients|Terminated||Phase 4|176|Actual|Medtronic Spine LLC|Study strengths include collection of 5-year data and radiographic examinations. Study weaknesses include single-arm design and early termination of the study without reaching the desired sample size.|1||"Due to Medtronic's voluntary withdrawal of PMA P040001 for X-STOP systems; post-approval study~   costs outweighed business benefits for marketing X-STOP in US."|f||||f||||||||||2017-02-18 15:21:23.092522|2017-02-18 15:21:23.092522
NCT00517738|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2015-10-07|||February 2007||2007-02-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional|||Effect of Physical Training Program on Health-related Quality of Life in Cirrhosis|Impact and Safety of a Physical Training Program on Health-related Quality of Life in Patients With Cirrhosis and Portal Hypertension|Completed||Phase 2|29|Actual|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran||4|||f||||f||||||||||2017-02-18 15:21:24.037781|2017-02-18 15:21:24.037781
NCT00517725|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2010-09-15|||July 2007||2007-07-01|September 2010|2010-09-01|May 2010|Actual|2010-05-01|||||Interventional|CARNEBI||Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure|Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure: Effects on Exercise Capacity and Hypoxia, Chemoreceptor Response, Pulmonary Function|Completed||Phase 4|60|Actual|Centro Cardiologico Monzino||3|||f||||f||||||||||2017-02-18 15:21:24.15247|2017-02-18 15:21:24.15247
NCT00517712|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2007-08-16|||June 2004||2004-06-01|August 2007|2007-08-01|July 2009|Anticipated|2009-07-01|||||Interventional|IAPLSG04||Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia|Molecular Remission With Arsenic Trioxide in Acute Promyelocytic Leukemia: Indian APL Study Group - IAPLSG|Unknown status|Recruiting|Phase 2/Phase 3|400|Anticipated|Christian Medical College, Vellore, India||2|||f||||f||||||||||2017-02-18 15:21:24.265517|2017-02-18 15:21:24.265517
NCT00517699|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2014-07-15|2014-06-09||September 2007||2007-09-01|July 2014|2014-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||Safety population: all participants who received any amount of study drug.|A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.|An Open Label Study of the Effect of Rituxan, High Dose Methotrexate and High Dose Cytarabine on Response Rate in Patients With Primary Central Nervous System Lymphoma.|Terminated||Phase 2|5|Actual|Hoffmann-La Roche|The study was terminated early due to lack of enrollment.|1||Study was terminated early due to lack of enrollment.|f||||||||||||||2017-02-18 15:21:24.388289|2017-02-18 15:21:24.388289
NCT00517686|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2012-08-01|||July 2008||2008-07-01|August 2012|2012-08-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|FIT||Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk (FIT)|Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk (FIT)|Completed||N/A|16584|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 15:21:24.669073|2017-02-18 15:21:24.669073
NCT00517673|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2012-03-15|||July 2007||2007-07-01|October 2011|2011-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects|A Two-Part Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of GSK945237 and the Effect of Food on Single Oral Doses of GSK945237 in Healthy Adult Subjects|Completed||Phase 1|68|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:21:24.770515|2017-02-18 15:21:24.770515
NCT00517660|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2013-08-21|||March 2006||2006-03-01|August 2013|2013-08-01|June 2006|Actual|2006-06-01|||||Observational|||Source Profiling of Biohazardous Aerosols in Hospitals|Source Profiling of Biohazardous Aerosols in Hospitals|Completed||N/A|60|Actual|Hospital Authority, Hong Kong|||1||f||||||||||||||2017-02-18 15:21:24.864368|2017-02-18 15:21:24.864368
NCT00517647|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2012-07-05|||April 2004||2004-04-01|July 2012|2012-07-01||||March 2008|Actual|2008-03-01||Interventional|||Atomoxetine Pilot Study in Preschool Children With ADHD|Atomoxetine Pilot Study in Preschool Children With ADHD|Completed||Phase 4|31|Actual|University of Arizona||1|||f||||f||||||||||2017-02-18 15:21:24.960773|2017-02-18 15:21:24.960773
NCT00517634|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-11-03|2009-07-23||August 2007||2007-08-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects|A 12-week, Randomised, Double-blind, Placebo-controlled, Three-period, Cross-over Pilot Study Comparing the Effect of Salmeterol/Fluticasone Propionate, Fluticasone Propionate and Placebo on Perpheral Blood Eosinophils and Serum IL-5 in Response to Allergen Challenge in Asthma Subjects When Allergen Challenge is Administered at 1 Hour or 11-12 Hours Post-dose of the Dosing Interval|Completed||Phase 4|23|Actual|GlaxoSmithKline||6|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:21:25.059866|2017-02-18 15:21:25.059866
NCT00517621|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2011-02-24|||February 2006||2006-02-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire|A Multicenter Prospective Phase II Study Evaluating Peripheral Neurotoxicity by Using FACT-GOG/NTX Questionnaire in Patients With Ovarian Cancer in Relapse Treated by Paclitaxel +/- EPO. Validation of a French Version of This Questionnaire|Completed||Phase 2|100|Anticipated|ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-02-18 15:21:25.593901|2017-02-18 15:21:25.593901
NCT00516607|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2015-02-09|||July 2007||2007-07-01|February 2015|2015-02-01||||November 2008|Actual|2008-11-01||Interventional|||Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas|Phase I Study of Enzastaurin and Temozolomide in Patients With Gliomas|Unknown status|Active, not recruiting|Phase 1|28|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 15:21:25.679225|2017-02-18 15:21:25.679225
NCT00516594|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2009-01-16||||||January 2009|2009-01-01||||||||Interventional|||The Effect of Altering Colonic Microflora After Fiber (FOS) Consumption|"The Effect of Altering Colonic Microflora After Fiber (FOS) Consumption on Blood Lipids Risk Factors for Heart Disease in Healthy Normal and Hyperlipidemic Subjects"|Completed||Phase 2|||University of Toronto|||||f||||||||||||||2017-02-18 15:21:25.780237|2017-02-18 15:21:25.780237
NCT00516581|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2008-09-04|||February 2003||2003-02-01|September 2008|2008-09-01|February 2005|Actual|2005-02-01|||||Observational|||Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART|Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the Highly Active Antiretroviral Therapy|Completed||Phase 3|376|Actual|UPECLIN HC FM Botucatu Unesp|||2||f||||t||||||||||2017-02-18 15:21:25.872871|2017-02-18 15:21:25.872871
NCT00516555|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2013-03-18|||October 2007||2007-10-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||EBIS: The Eindhoven Breech Intervention Study|Ebis: The Eindhoven Breech Intervention Study|Completed||N/A|250|Actual|Catharina Ziekenhuis Eindhoven|||1||f||||t||||||Samples Without DNA|"~     Blood samples for thyroid hormone status (Tsh, Ft4, anti-TPO)~   "|||2017-02-18 15:21:25.965083|2017-02-18 15:21:25.965083
NCT00515008|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-02-09|2015-11-04||June 2007||2007-06-01|February 2016|2016-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Tai Chi Mind-Body Therapy for Fibromyalgia|Tai Chi Mind-Body Therapy for Fibromyalgia: a Pilot Single-Blind Randomized Controlled Trial.|Completed||N/A|66|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-02-18 15:22:19.89085|2017-02-18 15:22:19.89085
NCT00516542|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2012-07-23|||June 2007||2007-06-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|July 2009|Actual|2009-07-01||Interventional|||Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer|A Phase I Study of DHEA in Combination With Letrozole in ER- Breast Cancer|Terminated||Phase 1|6|Actual|OHSU Knight Cancer Institute||1||Study was terminated due to lack of accrual|f||||t||||||||||2017-02-18 15:21:26.056933|2017-02-18 15:21:26.056933
NCT00516516|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2007-08-14|||August 2007||2007-08-01|August 2007|2007-08-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Oral Carnitine for Cramps in Pregnancy|Oral L-Carnitine for the Treatment of Muscle Cramps in Pregnancy: A Randomized, Controlled Trial|Unknown status|Not yet recruiting|Phase 2|150|Anticipated|University of Southern California||2|||f||||t||||||||||2017-02-18 15:21:26.150374|2017-02-18 15:21:26.150374
NCT00516503|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2015-07-03|||February 2008||2008-02-01|July 2015|2015-07-01|January 2010|Actual|2010-01-01|April 2009|Actual|2009-04-01||Interventional|||Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer|The Use of Topical Baclofen, Amitriptyline HCI, and Ketamine (BAK) in a PLO Gel vs. Placebo for the Treatment of Chemotherapy Induced Peripheral Neuropathy: A Phase III Randomized Double-Blind Placebo Controlled Study|Completed||Phase 3|211|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 15:21:26.252048|2017-02-18 15:21:26.252048
NCT00516490|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2007-08-14|||September 2006||2006-09-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles||Completed||N/A|570|Actual|V.K.V. American Hospital, Istanbul||2|||f||||f||||||||||2017-02-18 15:21:26.744796|2017-02-18 15:21:26.744796
NCT00516477|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2016-04-12|||September 2007||2007-09-01|April 2016|2016-04-01|July 2024|Anticipated|2024-07-01|July 2024|Anticipated|2024-07-01||Interventional|||Safety Study in Subjects With Leber Congenital Amaurosis|A Phase 1 Safety Study in Subjects With Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 Into the Retinal Pigment Epithelium (RPE) [AAV2-hRPE65v2-101]|Active, not recruiting||Phase 1|12|Anticipated|Spark Therapeutics||3|||f||||t||||||||||2017-02-18 15:21:26.856585|2017-02-18 15:21:26.856585
NCT00516464|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2007-08-14|||August 2007||2007-08-01|August 2007|2007-08-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy|Evaluation of Ranibizumab on the Ease of Procedure and Complication Rate in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy|Unknown status|Recruiting|Phase 3|40|Anticipated|Retina Associates, Kansas City||2|||f||||f||||||||||2017-02-18 15:21:26.983489|2017-02-18 15:21:26.983489
NCT00516451|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2008-10-10|||November 2007||2007-11-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors|Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors|Completed||Phase 1|9|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 15:21:27.08113|2017-02-18 15:21:27.08113
NCT00516438|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2010-12-07|||July 2007||2007-07-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|||Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan|A Phase I, Open-Label, Study of the Safety and Tolerability of KU-0059436 and Topotecan in the Treatment of Patients With Advanced Solid Tumours|Completed||Phase 1|48|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 15:21:27.192129|2017-02-18 15:21:27.192129
NCT00516425|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2013-08-06|||January 2007||2007-01-01|September 2007|2007-09-01||||||||Interventional|||Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer|Adjuvant Cytotoxic Chemotherapy In Older Women|Unknown status|Recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:21:27.303829|2017-02-18 15:21:27.303829
NCT00516412|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2015-09-28|||August 2007||2007-08-01|September 2015|2015-09-01|August 2012|Actual|2012-08-01|January 2010|Actual|2010-01-01||Interventional|||Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma|Master Protocol for Mantle Cell Lymphoma A Multicenter Phase II Trial Testing Everolimus (RAD001) for the Treatment of Patients With Relapsed or Therapy Resistant Mantle Cell Lymphoma|Completed||Phase 2|35|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 15:21:27.416957|2017-02-18 15:21:27.416957
NCT00516399|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2014-12-03|||March 2008||2008-03-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine|A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine|Terminated||Phase 3|78|Actual|University of California, Los Angeles||2||"The DSMC decided it appeared futile to attempt to demonstrate non-inferiority of~   povidone-iodine to Natamycin."|f||||t||||||||||2017-02-18 15:21:27.568712|2017-02-18 15:21:27.568712
NCT00516386|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2013-12-10|2010-11-23||March 2007||2007-03-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents|Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents|Completed||Phase 1/Phase 2|16|Actual|Massachusetts General Hospital|A limitation of our study is that this was not a randomized controlled trial of rhIGF-1 versus placebo.|1|||f||||t||||||||||2017-02-18 15:21:27.689334|2017-02-18 15:21:27.689334
NCT00516373|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2016-12-27|||July 2005||2005-07-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)|A Phase I, Pharmacokinetic and Biological Evaluation of a Small Molecule Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP-1), KU-0059436, in Patients With Advanced Tumours.|Active, not recruiting||Phase 1|95|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 15:21:27.978091|2017-02-18 15:21:27.978091
NCT00517608|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2007-08-20|||August 2005||2005-08-01|August 2007|2007-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Monopolar Scissors vs Bipolar Vessel Sealer vs Ultrasonic Shears: A Prospective Randomized Study in Laparoscopic Colorectal Surgery||Completed||N/A|||University of Zurich|||||f||||f||||||||||2017-02-18 15:21:28.091149|2017-02-18 15:21:28.091149
NCT00517595|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2012-03-08|2011-10-11||August 2007||2007-08-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC|A Phase II Study of Pemetrexed and Gemcitabine Plus Bevacizumab as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|48|Actual|Accelerated Community Oncology Research Network||1|||f||||f||||||||||2017-02-18 15:21:28.17486|2017-02-18 15:21:28.17486
NCT00517582|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2015-12-16|||September 2007||2007-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|September 2011|Actual|2011-09-01||Interventional|||Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema|Study of a Bradykinin Receptor Blocker in Angiotensin Converting Enzyme Inhibitor-Associated Angioedema|Terminated||Phase 1|13|Actual|Vanderbilt University||2||This study was stopped to allow initiation of a mult-center study|f||||f||||||||||2017-02-18 15:21:28.760904|2017-02-18 15:21:28.760904
NCT00517569|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2008-05-08|||August 2006||2006-08-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients|Phase I Study for Assessment of Safety of Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients|Unknown status|Recruiting|Phase 1|12|Anticipated|Genexine, Inc.||1|||f||||f||||||||||2017-02-18 15:21:28.873999|2017-02-18 15:21:28.873999
NCT00517556|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2015-01-16|||August 2007||2007-08-01|January 2015|2015-01-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|Dysmenorrhea||Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea|Continuous Administration of a Monophasic Oral Contraceptive in the Treatment of Primary Dysmenorrhea|Completed||Phase 1/Phase 2|38|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-02-18 15:21:28.977077|2017-02-18 15:21:28.977077
NCT00517543|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2010-10-13||2010-10-13|August 2007||2007-08-01|October 2010|2010-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability|A Randomized, Open Label, 4 Period Crossover Study in Healthy Subjects to Determine the Effect of Particle Size on the Pharmacokinetics of a Single mg Dose of GW856553|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:21:29.10421|2017-02-18 15:21:29.10421
NCT00517530|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-08-18|2015-07-14||September 2007||2007-09-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Safety population: All enrolled participants who had received at least 1 dose of obinutuzumab.|A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN)|An Open-label, Multicentre, Nonrandomized, Dose-escalating Phase I/II Study, With a Randomized Phase II Part, to Investigate the Safety and Tolerability of RO5072759 Given as Monotherapy in Patients With CD20+ Malignant Disease.|Completed||Phase 1/Phase 2|134|Actual|Hoffmann-La Roche|Pharmacodynamic results were limited because number of participants was inversely proportional to length of follow-up. In other words, there were fewer participants still in the trial as the follow-up period became longer.|8|||f||||f||||||||||2017-02-18 15:21:29.208926|2017-02-18 15:21:29.208926
NCT00517517|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2015-10-07|||July 2007||2007-07-01|September 2011|2011-09-01|February 2008|Actual|2008-02-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)|An Open-Label Phase I/II Study to Assess the Safety and Immunogenicity of Two Doses of a Vero Cell Derived, Whole Virus Clade 2 H5N1 Influenza Vaccine in Healthy Volunteers Aged 21 to 45 Years|Completed||Phase 1/Phase 2|110|Actual|Nanotherapeutics, Inc.||2|||f||||t||||||||||2017-02-18 15:21:30.408329|2017-02-18 15:21:30.408329
NCT00517504|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2012-07-03|||May 2001||2001-05-01|July 2012|2012-07-01||||March 2008|Actual|2008-03-01||Interventional|||Methylphenidate Study in Young Children With Developmental Disorders|Methylphenidate Study in Young Children With Developmental Disorders|Completed||Phase 4|48|Actual|University of Arizona||1|||f||||f||||||||||2017-02-18 15:21:30.518371|2017-02-18 15:21:30.518371
NCT00517491|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2015-09-29|||May 2008||2008-05-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)|A Pilot Study to Evaluate the Correlation Between Plasma Lanreotide Levels and GH/IGF-1 Dynamics and Clinical Improvement in Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)|Withdrawn||Phase 2|0|Actual|Ipsen||1||Administrative reasons|f||||||||||||||2017-02-18 15:21:30.609596|2017-02-18 15:21:30.609596
NCT00517478|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2007-08-16|||August 2007||2007-08-01|July 2007|2007-07-01|February 2008|Anticipated|2008-02-01|||||Observational|||Thromboelastography As A Tool for Possible Clopidogrel Resistance in The Patients Treated With Primary PCI for STEMI||Unknown status|Not yet recruiting|N/A|50|Anticipated|Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:21:33.187835|2017-02-18 15:21:33.187835
NCT00517465|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-11-01|||September 2007||2007-09-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.|A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multiple-ascending-dose Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of R1511 in Type 2 Diabetic (T2D) Patients|Completed||Phase 1|41|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 15:21:33.308726|2017-02-18 15:21:33.308726
NCT00517452|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2011-01-04|||May 2007||2007-05-01|January 2011|2011-01-01|December 2007|Actual|2007-12-01|||||Observational|PRP||Platelet Rich Plasma Study in Lower Extremity Bypass Surgery|Phase 2-3 Observational Wound Care Study Comparing Application of Platelet Rich Plasma With Standard of Care Wound Closure in Vascular Patients Requiring a Groin Incision.|Completed||Phase 2/Phase 3|81|Actual|Lawson Health Research Institute|||2||f||||f||||||||||2017-02-18 15:21:33.416121|2017-02-18 15:21:33.416121
NCT00517439|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-11-01||2016-07-07|December 2007||2007-12-01|November 2016|2016-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.|A Randomized, Double-blinded Study to Evaluate the Safety and Effect on Sustained Virological Response of HCV Polymerase Inhibitor Pro-drug in Combination With PEGASYS Plus Copegus, Compared With the Currently Approved Combination of PEGASYS Plus Copegus, in Treatment-naïve Patients With Chronic he|Completed||Phase 2|516|Actual|Hoffmann-La Roche||7|||f||||||||||||||2017-02-18 15:21:33.494321|2017-02-18 15:21:33.494321
NCT00517426|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-01-27|||July 2007||2007-07-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|July 2011|Actual|2011-07-01||Interventional|||Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart Failure||Completed||Phase 4|20|Actual|Centro Cardiologico Monzino||1|||f||||f||||||||||2017-02-18 15:21:33.667646|2017-02-18 15:21:33.667646
NCT00517218|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2008-02-07|||June 2006||2006-06-01|August 2007|2007-08-01|June 2009||2009-06-01|||||Interventional|||This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)|A Randomized Phase 3 Study of Fludarabine and Rituximab With or Without Genasense® (Oblimersen Sodium) in Previously Untreated Subjects With Chronic Lymphocytic Leukemia|Withdrawn||Phase 3|||Genta Incorporated||2|||f||||||||||||||2017-02-18 15:21:38.740313|2017-02-18 15:21:38.740313
NCT00517413|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2016-03-29|2016-02-24||October 2007||2007-10-01|March 2016|2016-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||The Intention To Treat (ITT) population included participants who received at least 1 dose of C.E.R.A. (Week 0) and for whom data for at least one follow-up variable were available.|LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.|A Single-Arm Open-Label Study to Assess the Efficacy, Safety, and Tolerability of Once-Monthly Administration of Intravenous and/or Subcutaneous C.E.R.A for the Maintenance of Hemoglobin Levels in Dialysis Patients With Chronic Renal Anemia|Completed||Phase 3|163|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:21:36.255784|2017-02-18 15:21:36.255784
NCT00517400|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-16|2015-04-19|||February 2008||2008-02-01|July 2010|2010-07-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Deep Transcranial Magnetic Stimulation (TMS)- Treatment for Post Traumatic Stress Disorder|Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device- Treatment for Post Traumatic Stress Disorder|Completed||Phase 1/Phase 2|30|Actual|Hadassah Medical Organization||3|||f||||||||||||||2017-02-18 15:21:37.117234|2017-02-18 15:21:37.117234
NCT00517387|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2010-11-12|||September 2007||2007-09-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression|The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression|Completed||Phase 3|64|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 15:21:37.2344|2017-02-18 15:21:37.2344
NCT00517374|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2015-09-24|||September 2005||2005-09-01|September 2015|2015-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||A Multi-Centre Clinical Study in Spinal Cord Injury Patients in Mainland China and Hong Kong|A Multi-Centre Clinical Study in Spinal Cord Injury Patients in Mainland China and Hong Kong|Completed||N/A|600|Actual|China Spinal Cord Injury Network|||1||f||||f||||||||||2017-02-18 15:21:37.34417|2017-02-18 15:21:37.34417
NCT00517361|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2014-03-10|2014-01-22||August 2007||2007-08-01|March 2014|2014-03-01|April 2012|Actual|2012-04-01|April 2011|Actual|2011-04-01||Interventional|||Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer|A Phase II Study of Carboplatin and Bevacizumab (Avastin) Combination Therapy for ER Negative, PR Negative, and HER2/Neu Negative Metastatic Breast Cancer|Terminated||Phase 2|11|Actual|University of Chicago||1||This study has been terminated due to poor accrual|f||||t||||||||||2017-02-18 15:21:37.442324|2017-02-18 15:21:37.442324
NCT00517348|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2009-06-24|||September 2007||2007-09-01|June 2009|2009-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating IMA-026 in Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IMA-026 Administered Subcutaneously or Intravenously to Healthy Subjects|Completed||Phase 1|50|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:21:37.71027|2017-02-18 15:21:37.71027
NCT00517335|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2016-03-07|||May 2005||2005-05-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Evaluating the Brain's Response to Natural Versus Artificial Sweetener in Women Who Have Had an Eating Disorder|The Evaluation of Brain Neuronal Activity in Response to Natural (Sucrose) and Artificial (Sucralose) Taste Stimuli- Does Caloric Content Matter to the Brain?|Completed||N/A|60|Actual|University of California, San Diego|||3||f||||||||||Samples With DNA|"~     If desired subjects have a chance to be a part of a DNA blood draw aspect of the study~   "|||2017-02-18 15:21:37.810405|2017-02-18 15:21:37.810405
NCT00517322|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2007-08-15|||August 2007||2007-08-01|August 2007|2007-08-01|August 2010|Anticipated|2010-08-01|||||Interventional|||Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan|Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan|Unknown status|Recruiting|Phase 4|80|Anticipated|Università degli Studi dell'Insubria||2|||f||||t||||||||||2017-02-18 15:21:37.921657|2017-02-18 15:21:37.921657
NCT00517309|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2015-06-04|||December 2001||2001-12-01|June 2015|2015-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|FUTURE||Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)|Immunogenicity and Safety of Quadrivalent HPV L1 Virus-Like Particle (VLP) Vaccine in 16- to 23-Year-Old Women When Administered Alone or Concomitantly With Hepatitis B Vaccine (Recombinant)--the F.U.T.U.R.E. Study (Females United to Unilaterally Reduce Endo/Ectocervical Disease|Completed||Phase 3|1877|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:21:38.031401|2017-02-18 15:21:38.031401
NCT00517296|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2011-07-14|||January 2008||2008-01-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|August 2011|Anticipated|2011-08-01||Interventional|||Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas|EUS Guided Treatment With Humira for Crohn's Perianal Fistulas|Unknown status|Active, not recruiting|N/A|30|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 15:21:38.124115|2017-02-18 15:21:38.124115
NCT00517283|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2015-02-20|||January 2005||2005-01-01|January 2015|2015-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes|A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes|Completed||Phase 1|17|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:21:38.235619|2017-02-18 15:21:38.235619
NCT00517270|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2010-07-06|||March 2003||2003-03-01|July 2010|2010-07-01|April 2008|Anticipated|2008-04-01|||||Interventional|||A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study|High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study.|Unknown status|Recruiting|N/A|200|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:38.359983|2017-02-18 15:21:38.359983
NCT00517257|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2008-06-23|||August 2007||2007-08-01|June 2008|2008-06-01|September 2009|Anticipated|2009-09-01|||||Interventional|ATORVO||Atorvastatin for the Treatment of Retinal Vein Occlusion|Atorvastatin Toronto Retinal Vein Occlusion Study (ATORVO)|Unknown status|Recruiting|Phase 3|180|Anticipated|University of Toronto||2|||f||||t||||||||||2017-02-18 15:21:38.458517|2017-02-18 15:21:38.458517
NCT00517244|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2016-03-10|||October 2006||2006-10-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders|Child Anxiety Disorders: Parenting and Temperament Effects|Completed||N/A|180|Actual|Rhode Island Hospital|||3||f||||f||||||||||2017-02-18 15:21:38.569098|2017-02-18 15:21:38.569098
NCT00517205|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2011-06-14|||October 2004||2004-10-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|||||Observational|||Study on 'The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcomes of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter'|The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcome of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter|Completed||N/A|100|Anticipated|Hospital Authority, Hong Kong|||1||f||||||||||||||2017-02-18 15:21:38.805505|2017-02-18 15:21:38.805505
NCT00517192|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2014-04-25|2009-09-18||September 2007||2007-09-01|April 2014|2014-04-01||||September 2008|Actual|2008-09-01||Interventional|||Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI|A Prospective, Randomized, Open-labelled, Multi-centre Trial Comparing the Safety and Efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to That of Prezista® (Darunavir, DRV/r) in Three-class (NRTI, NNRTI, and PI) Treatment-experienced Patients With Resistance to More Than One PI. POTENT: PrOspecTive EvaluatioN of Tipranavir vs. Darunavir in Treatment Experienced Patients|Terminated||Phase 3|40|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:21:39.132106|2017-02-18 15:21:39.132106
NCT00517179|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2011-06-14|||April 2006||2006-04-01|June 2011|2011-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS|Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS for the Treatment of Benign Prostatic Hyperplasia|Completed||N/A|40|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:39.848989|2017-02-18 15:21:39.848989
NCT00517166|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2011-12-19|||August 2006||2006-08-01|December 2011|2011-12-01|March 2008|Actual|2008-03-01|||||Observational|||Survey of Tourniquet Use in a Combat Support Hospital|Survey of Tourniquet Use in a Combat Support Hospital|Completed||N/A|584|Actual|United States Army Institute of Surgical Research|||1||f||||f||||||||||2017-02-18 15:21:39.939752|2017-02-18 15:21:39.939752
NCT00517153|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2010-03-24||2010-02-11|January 2002||2002-01-01|March 2010|2010-03-01|January 2008|Actual|2008-01-01|September 2006|Actual|2006-09-01||Interventional|||Miglustat in Niemann-Pick Type C Disease|A Phase II Randomized Controlled Study of Miglustat in Adult and Juvenile Patients With Niemann-Pick Type C Disease|Completed||Phase 2|29|Actual|Actelion||2|||f||||f||||||||||2017-02-18 15:21:40.060697|2017-02-18 15:21:40.060697
NCT00517140|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2011-06-14|||September 2003||2003-09-01|June 2011|2011-06-01|April 2007|Actual|2007-04-01|||||Interventional|||Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function|Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function|Completed||N/A|262|Actual|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:40.173212|2017-02-18 15:21:40.173212
NCT00517127|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2016-03-21|||September 2006||2006-09-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|December 2016|Anticipated|2016-12-01||Interventional|CC||Crystalloids Versus Colloids During Surgery|A Comparison of Crystalloids vs. Colloids for Intraoperative Goal-directed Fluid Management|Recruiting||Phase 4|1112|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:21:40.263246|2017-02-18 15:21:40.263246
NCT00517114|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2013-10-22|||January 2005||2005-01-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|||||Interventional|||Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients|Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients|Completed||N/A|200|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:40.386615|2017-02-18 15:21:40.386615
NCT00517101|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2007-08-15|||September 2007||2007-09-01|August 2007|2007-08-01||||||||Observational|||Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy||Unknown status|Not yet recruiting|N/A|||Tel-Aviv Sourasky Medical Center|||||f||||t||||||||||2017-02-18 15:21:40.473618|2017-02-18 15:21:40.473618
NCT00517088|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2014-05-29|||May 2006||2006-05-01|August 2007|2007-08-01|March 2007|Actual|2007-03-01|||||Interventional|PABC||Level of Physical Activities in Patients Before and After Breast Cancer Treatment|Level of Physical Activities in Patients Before and After Breast Cancer Treatment|Completed||N/A|2007|Actual|UPECLIN HC FM Botucatu Unesp||1|||t||||t||||||||||2017-02-18 15:21:40.543565|2017-02-18 15:21:40.543565
NCT00517075|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2017-01-12|2017-01-12||September 2004||2004-09-01|January 2017|2017-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||P.I. has left the institution and NYSPI has no access to the data. Results will not be analyzed or presented.|Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)|Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms and Social Dysfunction in Schizophrenia Patients|Terminated||Phase 2|14|Actual|New York State Psychiatric Institute||4||Unable to adequately recruit subjects.|f||||f||||||||||2017-02-18 15:21:40.63379|2017-02-18 15:21:40.63379
NCT00517062|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2012-05-02|||January 2006||2006-01-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates|Effects of Low Dose Growth Hormone (GH) Therapy on Insulin Sensitivity, Adipocyte Insulin-like Growth Factor-I (IGF-I) and IGF-I/Insulin Receptor Density and Regulation of Cortisol Metabolism in GH Deficient Adults|Completed||Early Phase 1|16|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 15:21:41.119932|2017-02-18 15:21:41.119932
NCT00517049|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2010-06-18||2010-06-18|March 2008||2008-03-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)|A Phase II, Single-Arm, Open-Label Study of the Safety, Pharmacokinetics, and Efficacy of Multiple Doses of PRO95780 Administered Intravenously in Combination With Rituximab in Patients With Follicular, CD20-Positive B-Cell Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy|Completed||Phase 2|49|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 15:21:41.244351|2017-02-18 15:21:41.244351
NCT00517036|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2013-04-02|||July 2006||2006-07-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Omega-3 Fatty Acids for Treating Adults With Major Depression|Omega-3 Fatty Acids for Treatment of Major Depression: Differential Effects of EPA and DHA, and Associated Biochemical and Immune Parameters|Completed||Phase 3|196|Actual|Cedars-Sinai Medical Center||3|||f||||t||||||||||2017-02-18 15:21:41.34155|2017-02-18 15:21:41.34155
NCT00514995|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2011-06-21|||August 2007||2007-08-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Sodium Oxybate in the Treatment of Binge Eating Disorder||Completed||Phase 2/Phase 3|15|Anticipated|Lindner Center of HOPE||1|||f||||||||||||||2017-02-18 15:22:20.667965|2017-02-18 15:22:20.667965
NCT00517010|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2016-06-28|2015-12-02||May 2007||2007-05-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration|Phase 1 Pilot Open Label Prospective Observational Study of Safety and Tolerability of Lucentis Combined With Proton Beam Irradiation in Treating Exudative Age-related Macular Degeneration|Completed||Early Phase 1|6|Actual|University of California, Davis||1|||f||||f||||||||Yes|Findings have been presented at national and international venues and published in scientific peer-reviewed journal|2017-02-18 15:21:41.567507|2017-02-18 15:21:41.567507
NCT00516997|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2016-05-13|||June 2005||2005-06-01|August 2007|2007-08-01|February 2007|Actual|2007-02-01|||||Interventional|||Increase Infusion Rates of Intravenous Fat Emulsions|Tolerance of Increased Infusion Rates of Intravenous Fat Emulsions in Very Low Birth Weight Infants During the First Week of Life|Completed||N/A|110|Actual|OSF Healthcare System||2|||f||||f||||||||||2017-02-18 15:21:41.811112|2017-02-18 15:21:41.811112
NCT00516984|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2008-08-21|||January 2005||2005-01-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|||||Interventional|||Osteopathic Manipulative Treatment and Its Relationship to Autonomic Nervous System Activity|Osteopathic Manipulative Treatment and Its Relationship to Autonomic Nervous System Activity as Demonstrated by Heart Rate Variability|Completed||N/A|30|Actual|University of Oklahoma||3|||f||||f||||||||||2017-02-18 15:21:42.149835|2017-02-18 15:21:42.149835
NCT00516971|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2010-07-06|||January 2003||2003-01-01|July 2010|2010-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population|The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population|Unknown status|Recruiting|N/A|200|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:42.252428|2017-02-18 15:21:42.252428
NCT00516958|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2008-01-07|||May 2007||2007-05-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections|An Open Label, Three Arm, Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care vs. Oral Levofloxacin vs. Combined Therapy for Mild Diabetic Foot Infections|Completed||Phase 2|65|Anticipated|Oculus Innovative Sciences, Inc.||3|||f||||f||||||||||2017-02-18 15:21:42.349789|2017-02-18 15:21:42.349789
NCT00516945|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2013-09-03|||September 2004||2004-09-01|July 2013|2013-07-01|June 2008|Actual|2008-06-01|||||Interventional|||A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers|A Randomized Controlled Study Comparing the Impact of Prophylactic Versus Deferred Lamivudine on the Delivery of Cytotoxic Chemotherapy in Hepatitis B Surface-antigen Positive Patients With Malignant Solid Tumor|Completed||N/A|110|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:42.502966|2017-02-18 15:21:42.502966
NCT00516932|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2015-04-16|||May 2007||2007-05-01|April 2015|2015-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|PARCA||Pharmacogenomics of Antidepressant Response in Children and Adolescents|Pharmacogenomics of Antidepressant Response in Children and Adolescents|Completed||N/A|211|Actual|Duke University|||1||f||||t||||||Samples With DNA|"~     Salivary DNA retained at the Duke Center for Human Genetics~   "|||2017-02-18 15:21:42.599426|2017-02-18 15:21:42.599426
NCT00516919|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2013-01-07|2012-07-31||August 2007||2007-08-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons|Controlled Trial of Orlistat With Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons|Completed||Phase 4|79|Actual|Yale University||2|||f||||f||||||||||2017-02-18 15:21:42.702999|2017-02-18 15:21:42.702999
NCT00516906|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2012-07-25|2010-03-03||October 2007||2007-10-01|July 2012|2012-07-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Clinical Performance of a Chlorhexidine Antimicrobial Dressing|Clinical Performance of a Chlorhexidine Antimicrobial Dressing|Completed||Phase 2/Phase 3|68|Actual|3M|This trial evaluated the dressing for it's securement and ease of use adaption into healthcare practices compared to a standard transparent dressing. The sample size was too small to evaluate any effect on Catheter Related-Bloodstream Infection.|2|||f||||f||||||||||2017-02-18 15:21:43.000473|2017-02-18 15:21:43.000473
NCT00516893|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2014-05-01|2009-06-30||October 2006||2006-10-01|May 2014|2014-05-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Natalizumab High Titer Immunogenicity and Safety|A Multicenter, Open-Label Immunogenicity and Safety Study of Natalizumab High Titer Material (BG00002-E) in Subjects With Relapsing Forms of Multiple Sclerosis|Completed||Phase 2|113|Actual|Biogen||1|||f||||f||||||||||2017-02-18 15:21:43.433757|2017-02-18 15:21:43.433757
NCT00516880|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2010-07-06|||March 2006||2006-03-01|July 2010|2010-07-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?|Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?|Unknown status|Recruiting|N/A|160|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:43.816607|2017-02-18 15:21:43.816607
NCT00516867|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2007-08-15|||February 2006||2006-02-01|August 2007|2007-08-01|April 2006|Actual|2006-04-01|||||Interventional|||Does Sunbed Radiation With Mainly UVA Provoke Cutaneous Vitamin D Synthesis in Humans?|Sunbed Radiation Provoke Cutaneous Vitamin D Synthesis in Humans, a Randomized Controlled Trial|Completed||N/A|41|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-02-18 15:21:43.911125|2017-02-18 15:21:43.911125
NCT00516854|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-15|2010-07-06|||June 2002||2002-06-01|July 2010|2010-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||A Study of the Use of Combination of Anti-cholinergic and Minor Tranquilliser in the Treatment of Non-cardiac Chest Pain - a Double Blind Placebo Controlled Study|A Study of the Use of Combination of Anti-cholinergic and Minor Tranquilliser in the Treatment of Non-cardiac Chest Pain - a Double Blind Placebo Controlled Study|Unknown status|Recruiting|N/A|100|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:21:43.998941|2017-02-18 15:21:43.998941
NCT00516841|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2012-08-21|||August 2007||2007-08-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer||Terminated||Phase 2|16|Actual|Facet Biotech||1||Decision to terminate recruitment based on lack of efficacy|f||||f||||||||||2017-02-18 15:21:44.09173|2017-02-18 15:21:44.09173
NCT00516828|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2015-10-05|||July 2007||2007-07-01|July 2012|2012-07-01|January 2013|Actual|2013-01-01|March 2010|Actual|2010-03-01||Interventional|||Sorafenib and Low Dose Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome|A Phase I/II Study of Sorafenib (BAY 43-9006) in Combination With Low Dose ARA-C (CYTARABINE) in Elderly Patients With AML or High-Risk MDS|Completed||Phase 1/Phase 2|21|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 15:21:44.233328|2017-02-18 15:21:44.233328
NCT00516802|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2009-05-14|||January 2007||2007-01-01|May 2009|2009-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine|A Phase I, Open Label, Study of the Safety and Tolerability of KU-0059436 and Dacarbazine in the Treatment of Patients With Advanced Solid Tumours|Completed||Phase 1|40|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 15:21:44.360786|2017-02-18 15:21:44.360786
NCT00516776|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2016-08-16|||June 2007||2007-06-01|August 2016|2016-08-01|December 2023|Anticipated|2023-12-01|December 2017|Anticipated|2017-12-01||Observational|||The Innate Immune System and Inflammatory Bowel Disease|The Innate Immune System and Inflammatory Bowel Disease|Recruiting||N/A|400|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"~     Intestinal biopsies Plasma/serum Peripheral blood monocytes~   "|No||2017-02-18 15:21:44.469654|2017-02-18 15:21:44.469654
NCT00516750|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2013-07-09|||July 2007||2007-07-01|March 2008|2008-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin|Phase II Clinical Trial Concerning Gene Expression Profiling to Predict the Chemosensitivity of Invasive Bladder Cancer|Terminated||Phase 2|100|Anticipated|National Cancer Institute (NCI)||||Withdrawn due to lack of enrollment.|f||||||||||||||2017-02-18 15:21:44.552221|2017-02-18 15:21:44.552221
NCT00516737|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2015-07-21|2009-03-12||October 2007||2007-10-01|July 2015|2015-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Clinical Trial to Study the Efficacy and Safety of MK0462 / Rizatriptan 10 mg for the Early Treatment of Acute Migraine|Completed||Phase 3|207|Actual|Merck Sharp & Dohme Corp.|In the Adverse Events section, all non-serious adverse experiences reported are post-treatment, up to the time of taking rescue medication or 14 days post-dose, whichever comes first.|2|||f||||||||||||||2017-02-18 15:21:44.659919|2017-02-18 15:21:44.659919
NCT00516724|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2016-12-27|||June 2007||2007-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|January 2013|Actual|2013-01-01||Interventional|||Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel|A Phase I, Open-Label Study to Assess the Safety and Tolerability of KU-0059436 in Combination With Carboplatin, KU-0059436 in Combination With a Paclitaxel/Carboplatin T/C Doublet and KU-0059436 in Combination With Paclitaxel in the Treatment of Patients With Advanced Solid Tumours|Active, not recruiting||Phase 1|192|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:21:45.414052|2017-02-18 15:21:45.414052
NCT00516711|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2010-09-14|||March 2006||2006-03-01|August 2007|2007-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Role of Volatile Anesthetics for Hepatic Protection|Role of Volatile Anesthetics for Hepatic Protection in Ischemia-reperfusion|Completed||N/A|||University of Zurich|||||f||||f||||||||||2017-02-18 15:21:45.545155|2017-02-18 15:21:45.545155
NCT00516698|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2016-07-12|||September 2007||2007-09-01|July 2016|2016-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer|Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy|Completed||N/A|140|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     blood samples~   "|||2017-02-18 15:21:45.651454|2017-02-18 15:21:45.651454
NCT00516685|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2011-09-29|||July 2007||2007-07-01|September 2011|2011-09-01||||||||Interventional|NSCLC||Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV|A Phase II/III Trial to Assess the Safety, Immunogenicity and Preliminary Efficacy of Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine Administered to Patients With Non-Small-Cell Lung Cancer (NSCLC) After Receiving Conventional First Line Chemotherapy|Terminated||Phase 2/Phase 3|230|Anticipated|Bioven Sdn. Bhd.||2||"Due to inability of patient enrollment, decision taken to terminate in the interests of~   patients and later Malaysia is incorporated into global Phase 3 trial."|f||||||||||||||2017-02-18 15:21:45.967801|2017-02-18 15:21:45.967801
NCT00516672|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2016-03-21|||September 2007||2007-09-01|March 2016|2016-03-01|October 2015|Actual|2015-10-01|August 2011|Actual|2011-08-01||Interventional|||Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors.|A Phase I, Open-Label, Multiple Dose of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors.|Completed||Phase 1|36|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:21:46.082156|2017-02-18 15:21:46.082156
NCT00516659|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2012-03-13|||May 2006||2006-05-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|January 2007|Actual|2007-01-01||Interventional|Trek||ETEC Logistics Trial (TREK)|A Phase II, Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Epidemiology of Natural Infection With Enterotoxigenic Escherichia Coli Occurring After Transcutaneous Immunization in a Field Setting|Completed||Phase 2|201|Actual|Intercell USA, Inc.||2|||f||||t||||||||||2017-02-18 15:21:46.190025|2017-02-18 15:21:46.190025
NCT00516646|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2010-01-12|||August 2007||2007-08-01|April 2009|2009-04-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|BENEFICIAL||The BENEFICIAL Study: Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart Failure|A Double-blind, Placebo-controlled, Randomized Trial Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart Failure|Completed||Phase 2|100|Anticipated|Synvista Therapeutics, Inc||2|||f||||f||||||||||2017-02-18 15:21:46.32091|2017-02-18 15:21:46.32091
NCT00516633|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-08-14|||April 1998||1998-04-01|August 2007|2007-08-01|December 2005|Actual|2005-12-01|||||Interventional|||Intervention Study to Improve Adherence in Asthma|Does Improved Information in the Form of Group Discussions With Parents of Newly Diagnosed Asth-Matic Children Lead to a Better Quality of Life for the Families, an Improved Adherence and Better Devel-Opment of the Lung Function of the Children?|Completed||N/A|60|Actual|Värmland County Council, Sweden||2|||f||||t||||||||||2017-02-18 15:21:46.430202|2017-02-18 15:21:46.430202
NCT00048659|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-04|2012-06-06||||||June 2012|2012-06-01|June 2004|Actual|2004-06-01|||||Interventional|||YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy||Terminated||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:02:45.857445|2017-02-18 18:02:45.857445
NCT00516360|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2008-05-28|||July 2007||2007-07-01|August 2007|2007-08-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants|Chlorhexidine and the Prevention of Central Catheter Related Infections in Neonates|Unknown status|Recruiting|Phase 4|150|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 15:21:46.663789|2017-02-18 15:21:46.663789
NCT00516347|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2013-08-09|||June 2002||2002-06-01|October 2007|2007-10-01||||||||Observational|||Studying Genes for Barrett's Esophagus in Brothers and Sisters|A Sibling Pair Study To Identify Barrett's Oesophagus Susceptibility Genes|Unknown status|Recruiting|N/A|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:21:46.780022|2017-02-18 15:21:46.780022
NCT00516334|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2012-07-26|||May 2006||2006-05-01|July 2012|2012-07-01|May 2013|Anticipated|2013-05-01|May 2009|Actual|2009-05-01||Observational|BrainZ||Study of Bedside EEG to Evaluate Brain Injury in Premature Newborns|Advanced Electrophysiological Studies of the Premature Newborn Infant Brain: Understanding Brain Injury|Unknown status|Active, not recruiting|N/A|100|Anticipated|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 15:21:46.873599|2017-02-18 15:21:46.873599
NCT00516321|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2013-10-10|2012-03-22||October 2007||2007-10-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease|Randomised, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Eltrombopag in Thrombocytopenic Subjects With Hepatitis C Virus (HCV) Infection Who Are Otherwise Eligible to Initiate Antiviral Therapy (Peginterferon Alfa-2a Plus Ribavirin|Completed||Phase 3|687|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:21:46.999026|2017-02-18 15:21:46.999026
NCT00516308|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2008-01-16|||August 2007||2007-08-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|NightHawk||A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease|A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease|Terminated||Phase 2|100|Anticipated|FoxHollow Technologies||||Other|f||||f||||||||||2017-02-18 15:21:49.753389|2017-02-18 15:21:49.753389
NCT00516295|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2014-08-20|2013-12-18||February 2008||2008-02-01|July 2014|2014-07-01|January 2010|Actual|2010-01-01|August 2009|Actual|2009-08-01||Interventional|||Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma|A Randomized Phase II Study of Bevacizumab (NSC 704865) Combined With Vincristine, Topotecan and Cyclophosphamide in Patients With First Recurrent Ewing Sarcoma|Completed||Phase 2|7|Actual|National Cancer Institute (NCI)|In preparing to re-open for randomized enrollment in November, 2008 the study committee was asked to amend the study and the decision was made to close AEWS0521 for administrative purpose.|3|||f||||t||||||||||2017-02-18 15:21:49.845758|2017-02-18 15:21:49.845758
NCT00516282|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2011-08-24|||August 2007||2007-08-01|August 2011|2011-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma|A Phase I/II Trial of Cloretazine® (VNP40101M) and Temodar® (Temozolomide) for Patients With Malignant Glioma in First Relapse or Progression|Terminated||Phase 1|14|Actual|Northwestern University||1||"The pharmaceutical collaborator filed for bankruptcy and as a result, the study was unable to~   move into the phase II portion."|f||||t||||||||||2017-02-18 15:21:50.496974|2017-02-18 15:21:50.496974
NCT00516269|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2014-03-28|2012-09-18||August 2004||2004-08-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Methylphenidate Study in Breast or Gastrointestinal Cancer Patients|A Randomized, Double Blind, Two Period, Placebo-Controlled Crossover Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Breast or Gastrointestinal Cancer Patients|Terminated||Phase 3|42|Actual|M.D. Anderson Cancer Center|Early termination due to slow accrual.|2|||f||||t||||||||||2017-02-18 15:21:50.778225|2017-02-18 15:21:50.778225
NCT00516256|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2016-09-30|||July 2007||2007-07-01|September 2016|2016-09-01||||July 2018|Anticipated|2018-07-01||Interventional|||CHESS: Human and Computer Mentors for Prostate Cancer Patients|CHESS: Human and Computer Mentors for Prostate Cancer Patients|Active, not recruiting||N/A|654|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 15:21:51.205114|2017-02-18 15:21:51.205114
NCT00516243|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2014-09-11|||July 2007||2007-07-01|April 2014|2014-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer|Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women With a History of Hormone Receptor-Negative Breast Cancer|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 15:21:51.334147|2017-02-18 15:21:51.334147
NCT00516230|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-08-13|||January 2006||2006-01-01|August 2007|2007-08-01|December 2011|Anticipated|2011-12-01|||||Observational|||Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer|Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer|Unknown status|Recruiting|N/A|200|Anticipated|Samsung Medical Center|||||f||||t||||||||||2017-02-18 15:21:51.45738|2017-02-18 15:21:51.45738
NCT00516217|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2016-07-01|2015-01-26||June 2008||2008-06-01|July 2016|2016-07-01|February 2015|Actual|2015-02-01|September 2011|Actual|2011-09-01||Interventional|||Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase II Study of Galiximab (Anti-CD80) for Patients With Relapsed/Refractory Hodgkin Lymphoma|Completed||Phase 2|30|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:21:51.553054|2017-02-18 15:21:51.553054
NCT00516204|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2014-10-29|||July 2007||2007-07-01|October 2014|2014-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Diabetic Under 70 (Diabetics Below 70)|Diabetic Under 70 (Diabetics Below 70)|Completed||N/A|685|Actual|AstraZeneca|||4||f||||||||||||||2017-02-18 15:21:52.118377|2017-02-18 15:21:52.118377
NCT00516191|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2015-03-03|||October 2004||2004-10-01|March 2015|2015-03-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|DMV||A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma|A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma|Withdrawn||Phase 1/Phase 2|0|Actual|University of California, San Francisco||1||low accrual|f||||t||||||||||2017-02-18 15:21:52.387633|2017-02-18 15:21:52.387633
NCT00516178|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-14|2016-02-14|||January 2008||2008-01-01|February 2016|2016-02-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|FO-cardiac||Intravenous Fish Oil in Critically Ill Cardiac Patients|Effects of Intravenous n-3 Polyunsaturated Fatty Acid Administration in Critically Ill Cardiac Surgery and Myocardial Infarction Patients|Completed||Phase 3|31|Actual|Centre Hospitalier Universitaire Vaudois||2|||f||||f||||||||||2017-02-18 15:21:52.507348|2017-02-18 15:21:52.507348
NCT00516165|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2016-12-14|2014-12-03||August 2007||2007-08-01|December 2016|2016-12-01|November 2011|Actual|2011-11-01|January 2010|Actual|2010-01-01||Interventional|||RAD001 in Advanced Hepatocellular Carcinoma|A Phase I/II Study of RAD001 in Advanced Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|28|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-02-18 15:21:52.627609|2017-02-18 15:21:52.627609
NCT00516152|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2009-01-22|||November 2002||2002-11-01|January 2009|2009-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT|Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation|Completed||Phase 2|36|Anticipated|University of California, San Francisco|||||f||||t||||||||||2017-02-18 15:21:52.995096|2017-02-18 15:21:52.995096
NCT00516139|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2016-11-30|2011-07-15||August 2007||2007-08-01|November 2016|2016-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Lamotrigine Extended-Release In Elderly Patients With Epilepsy|Lamotrigine Extended-Release in Elderly Patients With Epilepsy|Completed||Phase 3|122|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:21:53.116711|2017-02-18 15:21:53.116711
NCT00516126|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2013-01-10|||June 2009||2009-06-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery|Goal-orientated Therapy of Perioperative Disturbance in Hemostasis With MULTIPLATE and ROTEM in Cardiac Surgery Patients Under Platelets Inhibitors|Completed||Phase 4|200|Actual|University Hospital, Basel, Switzerland|||2||f||||t||||||||||2017-02-18 15:21:54.214149|2017-02-18 15:21:54.214149
NCT00516113|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-12-06|||October 2000||2000-10-01|August 2007|2007-08-01|November 2002|Actual|2002-11-01|||||Interventional|||A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria|A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine When Used for the Treatment of Premenstrual Dysphoria|Completed||Phase 4|24|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 15:21:54.317285|2017-02-18 15:21:54.317285
NCT00516100|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2010-01-14|||January 2006||2006-01-01|January 2010|2010-01-01|August 2012|Anticipated|2012-08-01|January 2010|Anticipated|2010-01-01||Interventional|||Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC|Phase I/II Clinical Trial of Bortezomib (Velcade) + Pemetrexed (Alimta) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|62|Anticipated|Aptium Oncology Research Network||1|||f||||f||||||||||2017-02-18 15:21:54.429852|2017-02-18 15:21:54.429852
NCT00516087|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2017-02-03|||August 2007||2007-08-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|NATELLA||LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)|Administration of LMP1- and LMP2-Specific Cytotoxic T-Lymphocytes to Patients With EBV-Positive Nasopharyngeal Carcinoma|Completed||Phase 1|23|Actual|Baylor College of Medicine||1|||f||||t|t|f||||||||2017-02-18 15:21:54.540396|2017-02-18 15:21:54.540396
NCT00516074|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2015-03-19|2009-04-24||September 2007||2007-09-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes|A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes|Completed||Phase 3|54|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:21:54.656262|2017-02-18 15:21:54.656262
NCT00516061|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-08-13|||December 2006||2006-12-01|December 2006|2006-12-01|December 2007|Anticipated|2007-12-01|||||Observational|||Relationship of Peritoneal Solute Transport Rate With VEGF in Children Undergoing Peritoneal Dialysis||Unknown status|Recruiting|N/A|40|Anticipated|Samsung Medical Center|||||f||||t||||||||||2017-02-18 15:21:55.148445|2017-02-18 15:21:55.148445
NCT00516048|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2015-03-19|2009-04-29||August 2007||2007-08-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes|An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes|Completed||Phase 3|58|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:21:55.337662|2017-02-18 15:21:55.337662
NCT00516035|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2015-05-15|||September 2007||2007-09-01|May 2015|2015-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults|Phase 1 Inpatient Study of the Safety and Immunogenicity of Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/Chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for the Prevention of Avian Influenza H7N3 Infection in the Event of a Pandemic|Completed||Phase 1|22|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||f||||||||||2017-02-18 15:21:55.832291|2017-02-18 15:21:55.832291
NCT00516022|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2011-09-26|||April 2007||2007-04-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|Iscador||Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.|Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination: Randomized Phase II Study|Completed||Phase 2|79|Actual|Rambam Health Care Campus||2|||f||||f||||||||||2017-02-18 15:21:55.95039|2017-02-18 15:21:55.95039
NCT00516009|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-08-13|||August 2007||2007-08-01|August 2007|2007-08-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica|Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica|Unknown status|Recruiting|N/A|40|Anticipated|Ziv Hospital||2|||f||||f||||||||||2017-02-18 15:21:56.06431|2017-02-18 15:21:56.06431
NCT00515801|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2012-03-08|||June 2007||2007-06-01|March 2012|2012-03-01||||||||Interventional|||Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM|Effect of a Sulfonylurea Compound on the Glucagon Response to Insulin-induced Hypoglycemia in Type 1 Diabetes Mellitus|Completed||Phase 2/Phase 3|18|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 15:21:58.599644|2017-02-18 15:21:58.599644
NCT00515996|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-08-13|||January 2006||2006-01-01|August 2007|2007-08-01|December 2008|Anticipated|2008-12-01|||||Observational|||Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy|Genetic Abnormalities and Changes of Autonomic Nervous System, Serotonin System, and Neuroendocrine System According to Pharmacotherapy in Panic Disorder|Unknown status|Recruiting|N/A|80|Anticipated|Samsung Medical Center|||1||f||||f||||||||||2017-02-18 15:21:56.162287|2017-02-18 15:21:56.162287
NCT00515983|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2007-08-10|||October 2004||2004-10-01|August 2007|2007-08-01|December 2005|Actual|2005-12-01|||||Interventional|||Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells|Phase I Clinical Trial of a Therapeutic Vaccine Composed of Autologous Dendritic Cells Loaded With Allogeneic Apoptotic Tumor Cells in Patients With Melanoma Stages IIB, IIC, III and IV|Completed||Phase 1|16|Actual|José Mordoh, M.D., Ph.D.||1|||f||||||||||||||2017-02-18 15:21:56.254716|2017-02-18 15:21:56.254716
NCT00515970|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2010-06-14|||December 2007||2007-12-01|June 2010|2010-06-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas|Prospective Randomized Trial: Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas|Suspended||N/A|400|Anticipated|University Hospital Tuebingen||4||Problems with the electronic data collection program|f||||t||||||||||2017-02-18 15:21:56.337346|2017-02-18 15:21:56.337346
NCT00515957|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2012-04-13|||August 2007||2007-08-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|DELLA||Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)|Administration of LMP1- and LMP2-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody Administration to Patients With EBV-Positive Nasopharyngeal Carcinoma|Withdrawn||Phase 1|0|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 15:21:56.625016|2017-02-18 15:21:56.625016
NCT00515944|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2009-03-31|||August 2007||2007-08-01|March 2009|2009-03-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products||Completed||Phase 1|30|Anticipated|Merz Pharmaceuticals GmbH|||||f||||||||||||||2017-02-18 15:21:56.72197|2017-02-18 15:21:56.72197
NCT00515931|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2014-10-06|||August 2007||2007-08-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|February 2014|Actual|2014-02-01||Interventional|GIST-RT||Radiation Therapy as Palliative Treatment of GIST|Radiation Therapy as Palliative Treatment of GIST Progressing During or After Tyrosine Kinase Inhibitor Therapy: A Prospective Study|Completed||Phase 1/Phase 2|25|Actual|Helsinki University||1|||f||||f||||||||||2017-02-18 15:21:56.816999|2017-02-18 15:21:56.816999
NCT00515918|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-08-13|||September 2007||2007-09-01|August 2007|2007-08-01|September 2010|Anticipated|2010-09-01|||||Observational|IDBB||The Effect of Early Iron Deficiency on Developmental Brain and Behavior in Infants||Unknown status|Not yet recruiting|N/A|||Zhejiang University|||2||f||||t||||||||||2017-02-18 15:21:56.925001|2017-02-18 15:21:56.925001
NCT00515905|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2010-09-14|||October 2004||2004-10-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||One-lung Ventilation: Expression of Pulmonary Inflammatory Mediators|Lung: One-lung Ventilation: Expression of Pulmonary Inflammatory Mediators After Deflation and Re-expansion of the Lung During Thoracic Surgery|Completed||N/A|76|Anticipated|University of Zurich||1|||f||||f||||||||||2017-02-18 15:21:57.034455|2017-02-18 15:21:57.034455
NCT00515892|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2007-08-10|||August 2007||2007-08-01|August 2007|2007-08-01||||||||Interventional|NHL||Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease|A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Relapsed or Refractory Non-Hodgkin'd Lymphoma (NHL)|Unknown status|Recruiting|Phase 1|50|Anticipated|Cambridge Antibody Technology|||||f||||f||||||||||2017-02-18 15:21:57.117821|2017-02-18 15:21:57.117821
NCT00515879|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2015-07-20|2013-08-02||December 2007||2007-12-01|July 2015|2015-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia|D-cycloserine Enhancement of Exposure in Social Phobia|Completed||Phase 3|169|Actual|Boston University||2|||f||||t||||||||||2017-02-18 15:21:57.209932|2017-02-18 15:21:57.209932
NCT00515866|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2013-12-19|||August 2007||2007-08-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|October 2011|Actual|2011-10-01||Interventional|||Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer|A Phase I, Open Label, Study of the Safety and Tolerability of KU-0059436 in Combination With Gemcitabine in the Treatment of Patients With Advanced Solid Tumours|Completed||Phase 1|68|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 15:21:57.630075|2017-02-18 15:21:57.630075
NCT00515853|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2008-06-03|||November 2006||2006-11-01|June 2008|2008-06-01||||||||Interventional|||The Role of Biofeedback in Improving Continence After Anterior Resection||Unknown status|Recruiting|N/A|110||University of Southampton||2|||f||||t||||||||||2017-02-18 15:21:57.742744|2017-02-18 15:21:57.742744
NCT00515840|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2015-11-04|||October 2003||2003-10-01|November 2015|2015-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|GLAD||GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled Study|GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled Study|Completed||Phase 3|182|Actual|University of Aberdeen||1|||f||||t||||||||||2017-02-18 15:21:57.83119|2017-02-18 15:21:57.83119
NCT00515827|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2014-11-19|2011-01-25||November 2007||2007-11-01|November 2013|2013-11-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load|A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification With a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia Below 50 Copies/ml in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens|Completed||Phase 2|53|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 15:21:57.919586|2017-02-18 15:21:57.919586
NCT00515814|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2011-06-08|||September 2005||2005-09-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors|A Prospective Open Pilot Study With Functional Placebo-control to Evaluate the Efficacy and Tolerability/Safety of a Subretinal Implant in Blind Patients in Accordance With ICH/GCP Guidelines|Completed||N/A|15|Anticipated|Retina Implant AG||1|||f||||t||||||||||2017-02-18 15:21:58.488416|2017-02-18 15:21:58.488416
NCT00040092|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-19|2008-01-04|||July 2002||2002-07-01|January 2008|2008-01-01||||July 2005|Actual|2005-07-01||Interventional|||A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer||Completed||Phase 3|400||Aptose Biosciences Inc.|||||||||||||||||||2017-02-18 18:05:18.640924|2017-02-18 18:05:18.640924
NCT00515788|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2012-03-08|||February 2006||2006-02-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis|Phase I Study of Temozolomide and Intrathecal DepoCyt in Patients With Neoplastic Meningitis|Terminated||Phase 1|11|Actual|M.D. Anderson Cancer Center||1||Study terminated due to slow accrual with no expansion to additional phase.|f||||f||||||||||2017-02-18 15:21:58.70815|2017-02-18 15:21:58.70815
NCT00515775|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2009-02-12|||September 2005||2005-09-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Observational|||Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children||Completed||N/A|27|Anticipated|Technische Universität Dresden|||2||f||||||||||||||2017-02-18 15:21:58.820715|2017-02-18 15:21:58.820715
NCT00515762|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2011-08-08|||May 2007||2007-05-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling|Pilot Trial of Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling (ELASTO-GEL CAPS)in Breast Cancer Patients|Completed||Phase 2|150|Actual|Hospital San Carlos, Madrid||1|||f||||t||||||||||2017-02-18 15:21:58.886237|2017-02-18 15:21:58.886237
NCT00515736|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2010-07-29|||January 2003||2003-01-01|April 2008|2008-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|Etude-AOX||Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome|Influence Of Early Antioxidant Supplements On Clinical Evolution And Organ Function In Critically Ill Cardiac Surgery, Major Trauma And Subarachnoid Hemorrhage Patients|Terminated||Phase 3|200|Actual|Centre Hospitalier Universitaire Vaudois||2||enrollment was completed|f||||t||||||||||2017-02-18 15:21:58.991218|2017-02-18 15:21:58.991218
NCT00515723|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2011-02-25|||September 2001||2001-09-01|February 2011|2011-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|Glulipid||Glucose and Lipid Metabolism on Antipsychotic Medication|Glucose and Lipid Metabolism on Antipsychotic Medication|Completed||Phase 4|216|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 15:21:59.127793|2017-02-18 15:21:59.127793
NCT00515710|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2016-10-19|||August 2007||2007-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||LTFU for Gene Transfer Subjects With Hemophilia B|A Long-Term Follow-Up Study in Subjects With Sever Hemophilia B Who Received Adeno-Associated Viral Vectors Expressing Human Factor IX|Active, not recruiting||Phase 1|9|Anticipated|Spark Therapeutics|||1||f||||t||||||||||2017-02-18 15:21:59.239496|2017-02-18 15:21:59.239496
NCT00515697|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2014-05-16|2014-05-16||November 2007||2007-11-01|May 2014|2014-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||Intent-to-treat population: participants who received any quantity of ramucirumab.|A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma|Phase II Single Arm Study of IMC-1121B in Patients With Metastatic Renal Cell Carcinoma With Disease Progression on or Intolerance to Tyrosine Kinase Inhibitor Therapy|Completed||Phase 2|39|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:21:59.434562|2017-02-18 15:21:59.434562
NCT00515684|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2015-04-29|||May 2007||2007-05-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Corneal Thinning During Topical Bevacizumab Therapy||Withdrawn||N/A|0|Actual|Yonsei University||||Side effect can increase the risk of the research|f||||t||||||||||2017-02-18 15:21:59.870102|2017-02-18 15:21:59.870102
NCT00515671|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2015-04-06|2014-10-03||January 2008||2008-01-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|April 2012|Actual|2012-04-01||Interventional|||Illness Management and Recovery for Veterans With Severe Mental Illness|Illness Management and Recovery for Veterans With Severe Mental Illness|Completed||N/A|118|Actual|VA Office of Research and Development|"Low attendance in both groups, may not have had enough exposure Study embedded in a treatment-rich environment, cannot sort out other impacts on outcomes."|2|||f||||f||||||||||2017-02-18 15:21:59.954199|2017-02-18 15:21:59.954199
NCT00515658|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-08-13|||March 2007||2007-03-01|August 2007|2007-08-01||||||||Interventional|||Antidepressant Effect of Theta-Burst rTMS|Antidepressant Effect of Theta-Burst rTMS|Unknown status|Recruiting|Phase 2|||Rambam Health Care Campus|||||f||||t||||||||||2017-02-18 15:22:00.405845|2017-02-18 15:22:00.405845
NCT00515645|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2011-07-18|||April 2008||2008-04-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|IMMERSION||Cardiac Autonomic Functions During Head-out Immersion and During Head Down Tilt|Cardiac Autonomic Functions During Head-out Immersion and During Head Down Tilt|Completed||N/A|15|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-02-18 15:22:00.494706|2017-02-18 15:22:00.494706
NCT00515632|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2010-07-22|||July 2007||2007-07-01|July 2010|2010-07-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|BALLET||Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy|A Randomized, Double-blind, Parallel-group, Placebo and Active Comparator (Pioglitazone)-Controlled Clinical Study to Determine the Efficacy and Safety of Balaglitazone in Patients With Type 2 Diabetes on Stable Insulin Therapy|Completed||Phase 3|409|Actual|Rheoscience A/S||4|||f||||f||||||||||2017-02-18 15:22:00.72133|2017-02-18 15:22:00.72133
NCT00515619|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2015-06-16|2011-08-05||December 2004||2004-12-01|June 2015|2015-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures|An International Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral Lacosamide (SPM 927) in Patients With Partial Seizures|Completed||Phase 3|376|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:22:00.838687|2017-02-18 15:22:00.838687
NCT00515606|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2007-08-13|||February 2007||2007-02-01|February 2007|2007-02-01|June 2007||2007-06-01|||||Interventional|||Noninvasive Positive Pressure Ventilation Using Helium:Oxygen Versus Air:Oxygen in Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients Exposed to Sulfur Mustard||Completed||Phase 3|||Baqiyatallah Medical Sciences University|||||f||||||||||||||2017-02-18 15:22:01.595384|2017-02-18 15:22:01.595384
NCT00515593|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-13|2012-05-04|||September 2006||2006-09-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|||||Observational|||PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)|Non-interventional Open Single Arm, Multicentre Study to Observe the Use of Preotact in Patients With Severe Postmenopausal Osteoporosis|Completed||N/A|110|Actual|Nycomed|||1||f||||t||||||||||2017-02-18 15:22:01.677081|2017-02-18 15:22:01.677081
NCT00515021|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2009-01-27|||April 2007||2007-04-01|January 2009|2009-01-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Diurnal Variation of Plasminogen Activator Inhibitor-1|The Effects of Night-Time Versus Morning Administration of Eplerenone on the Diurnal Variation of Plasminogen Activator Inhibitor-1|Unknown status|Active, not recruiting|Phase 4|40|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 15:22:19.761289|2017-02-18 15:22:19.761289
NCT00515580|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-12|2012-12-18|||August 2007||2007-08-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|||Minimally Invasive Tongue Suture For Obstructive Sleep Apnea|Minimally Invasive Genioglossus And Hyoid Advancement For Obstructive Sleep Apnea Using Silhouette Sutures: A Pilot Study|Terminated||N/A|5|Actual|West Side ENT||1||"Results from first few subjects was not significantly improved over standard, traditional~   procedures."|f||||f||||||||||2017-02-18 15:22:01.780524|2017-02-18 15:22:01.780524
NCT00515567|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-09-19|||February 2006||2006-02-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Explanted Lung Tissues With Pulmonary Fibrosis|Utilization of Explanted Lungs for Isolation of Tissue Samples and Primary Cell Lines to Study Pulmonary Fibrosis|Recruiting||N/A|90|Anticipated|University of Chicago|||1||f||||f||||||Samples With DNA|"~     explanted lung tissue~   "|||2017-02-18 15:22:01.900172|2017-02-18 15:22:01.900172
NCT00515554|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2016-11-07|||May 2008||2008-05-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||HD18 for Advanced Stages in Hodgkins Lymphoma||Active, not recruiting||Phase 3|1500|Anticipated|University of Cologne||4|||f||||t||||||||||2017-02-18 15:22:02.01504|2017-02-18 15:22:02.01504
NCT00515541|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2013-06-27|2013-06-27||September 2007||2007-09-01|June 2013|2013-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|LEAP|The number of subjects for baseline does not represent the number of subjects that completed the 24 week study.|Lovaza's Effect on the Activation of Platelets|Effect of the Omega n3 Fatty on Human Platelet Function|Completed||Phase 2|43|Actual|Invitrox|Major limitation for this pilot study was the small number of patients analyzed per group. Despite the small numbers we were able to show the statistical significance for a change in the platelet surface charge with Lovaza.|4|||f||||t||||||||||2017-02-18 15:22:02.15132|2017-02-18 15:22:02.15132
NCT00515528|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-08-25|||April 2007||2007-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccination Plus Ontak in Patients With Metastatic Melanoma|Randomized Phase II Study of Multipeptide Vaccination With or Without Regulatory T Cell Depletion Using Ontak in Patients With Metastatic Melanoma|Active, not recruiting||Phase 2|24|Anticipated|University of Chicago||2|||f||||t||||||||||2017-02-18 15:22:02.926475|2017-02-18 15:22:02.926475
NCT00515502|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-03-27|2013-12-19||June 2007||2007-06-01|February 2014|2014-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease|See Detailed Description|Completed||Phase 2|24|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:22:03.079316|2017-02-18 15:22:03.079316
NCT00515489|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2011-05-18|||November 2001||2001-11-01|March 2011|2011-03-01|August 2002|Actual|2002-08-01|||||Observational|||Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients|Aggressiveness and Agitation of Acute Psychotic Patients: Influence in Safety and Effectiveness of Risperidone Treatment|Terminated||N/A|1882|Actual|Janssen-Cilag, S.A.|||1|Due to the achievement of minimum required sample size and new changes in local regulations.|f||||f||||||||||2017-02-18 15:22:05.608613|2017-02-18 15:22:05.608613
NCT00515476|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2010-06-22|||June 2007||2007-06-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|HERMET||Effect of Exercise Training on the Function of the High Density Lipoprotein (HDL)-Cholesterol, Endothelial Function and Endothelial Progenitor Cells in Patients With Metabolic Syndrome(HERMET-Study)|Randomized, Clinical Trial to Study the Effect of Exercise Training on the Function of HDL-Cholesterol, Endothelial Function, Oxidative Stress and Regenerative Capacity of Endothelial Progenitor Cells in Patients With Metabolic Syndrome|Completed||N/A|24|Anticipated|Hannover Medical School||1|||f||||||||||||||2017-02-18 15:22:05.713248|2017-02-18 15:22:05.713248
NCT00515463|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2013-08-27|2010-06-18||May 2007||2007-05-01|August 2013|2013-08-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density|A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density|Completed||Phase 3|311|Actual|Amgen||2|||f||||||||||||||2017-02-18 15:22:08.429885|2017-02-18 15:22:08.429885
NCT00515450|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2010-07-29|||July 2007||2007-07-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis|A Randomized, Controlled Clinical Study of GB-0998 for Treatment of Generalized Myasthenia Gravis|Completed||Phase 3|46|Anticipated|Benesis Corporation||2|||f||||f||||||||||2017-02-18 15:22:10.455516|2017-02-18 15:22:10.455516
NCT00515437|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2009-06-30|2009-05-12||July 2007||2007-07-01|June 2009|2009-06-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled,Sequential Dose Escalation, Safety, Tolerability, and Preliminary Efficacy Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients|Completed||Phase 2|54|Actual|Solstice Neurosciences||4|||f||||t||||||||||2017-02-18 15:22:10.567033|2017-02-18 15:22:10.567033
NCT00515424|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2007-12-19|||July 2007||2007-07-01|December 2007|2007-12-01||||||||Interventional|||Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension|A Multicenter, Randomized, Placebo-Controlled, Latanoprost-Controlled, Parallel Group Study to Assess the Tolerability, Safety and Efficacy of RKI983 Ophthalmic Solution Given Twice a Day Over One Week in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 1|90||Novartis|||||||||||||||||||2017-02-18 15:22:11.304645|2017-02-18 15:22:11.304645
NCT00515411|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2016-11-09|||October 2006||2006-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma|A Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Patients With Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 2|111|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||t||||||||||2017-02-18 15:22:11.40428|2017-02-18 15:22:11.40428
NCT00515398|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2008-06-04|||August 2007||2007-08-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease|A Multicenter Study to Evaluate and Characterize the Effects of Pharmacological Chaperones in Cell Lines Derived From Blood and Skin Samples From Patients With Pompe Disease|Completed||N/A|30|Actual|Amicus Therapeutics|||1||f||||f||||||Samples With DNA|"~     White blood cells~   "|||2017-02-18 15:22:11.533309|2017-02-18 15:22:11.533309
NCT00515385|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2009-07-14|||August 2007||2007-08-01|July 2009|2009-07-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults|A Phase 1, Randomized, Double-Blind, Dose-Escalation Cohort Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Single Intravenous Infusion of MGAWN1, a Neutralizing, Humanized, Monoclonal Antibody (IgG1k) to West Nile Virus, in Healthy Adults|Completed||Phase 1|40|Anticipated|MacroGenics||10|||f||||t||||||||||2017-02-18 15:22:11.638628|2017-02-18 15:22:11.638628
NCT00515372|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2016-11-28|||December 2002||2002-12-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Depression Treatment and Screening in Ovarian Cancer Patients|Depression Treatment and Screening in Ovarian Cancer Patients|Active, not recruiting||Phase 1|588|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:22:11.741467|2017-02-18 15:22:11.741467
NCT00515359|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2010-01-26|||June 2007||2007-06-01|December 2009|2009-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies|RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies|Completed||N/A|500|Anticipated|Spectrum Health Hospitals||1|||f||||f||||||||||2017-02-18 15:22:12.083714|2017-02-18 15:22:12.083714
NCT00515346|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2013-12-16|||July 2006||2006-07-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|December 2009|Actual|2009-12-01||Interventional|XCELL||Study to Evaluate the Safety & Performance of the Xpert(TM) Stent in Treating Below-the-knee Lesions in Patients Undergoing Percutaneous Intervention for Chronic CLI.|Phase 1 Study of Xpert(TM) Nitinol Stenting for Critically Ischemic Lower Limbs|Completed||Phase 1|120|Actual|VIVA Physicians||1|||f||||t||||||||||2017-02-18 15:22:12.218577|2017-02-18 15:22:12.218577
NCT00515333|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2008-02-19|||August 2004||2004-08-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||TRx0014 in Patients With Mild or Moderate Alzheimer's Disease|An Exploratory Placebo-Controlled, Dose-Ranging Study of the Effects of TRx0014 30 MG TID, 60 MG TID AND 100 MG TID in Patients With Mild or Moderate Dementia of the Alzheimer Type|Completed||Phase 2|323|Actual|TauRx Therapeutics Ltd||4|||f||||f||||||||||2017-02-18 15:22:12.322159|2017-02-18 15:22:12.322159
NCT00515320|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2012-04-26|||August 2007||2007-08-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|SOFIA||Study of Fluoxetine in Autism|Study Of Fluoxetine In Autism: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group 14-Week Study To Investigate The Effect Of Fluoxetine Orally Dissolving Tablet (ODT) On Repetitive Behaviors In Childhood And Adolescent Autistic Disorder.|Completed||Phase 3|158|Actual|Neuropharm||2|||f||||t||||||||||2017-02-18 15:22:12.419478|2017-02-18 15:22:12.419478
NCT00515307|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2008-08-28|||June 2007||2007-06-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia|In-Vitro Transdifferentiation of Mesenchymal Stem Cells to Hepatocytes and Allogenic Transplantation of Hepatocytes to the Patients With Homozygous Familial Hypercholesterolemia|Completed||Phase 1|1|Actual|University of Tehran||1|||f||||t||||||||||2017-02-18 15:22:12.547283|2017-02-18 15:22:12.547283
NCT00515294|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-07-20|||October 2006||2006-10-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Acute and Residual Effects of Caffeinated Beer|Acute and Residual Effects of Beer VS. Caffeinated Beer On Simulated Driving|Completed||Phase 2|144|Actual|Boston University||4|||f||||t||||||||||2017-02-18 15:22:12.65326|2017-02-18 15:22:12.65326
NCT00515281|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-05-10|||May 2008||2008-05-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|NOVA2||Inhaled Nitric Oxide and Neuroprotection in Premature Infants|Inhaled Nitric Oxide and Neuroprotection in Premature Infants|Active, not recruiting||Phase 2/Phase 3|484|Anticipated|University of Chicago||2|||f||||t||||||||||2017-02-18 15:22:12.766064|2017-02-18 15:22:12.766064
NCT00515268|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2012-03-15|||September 2007||2007-09-01|February 2011|2011-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Endotoxin Challenge Study For Healthy Men and Women|A Double Blind, Placebo Controlled, Repeat Dose Study to Compare the Effectiveness of Two Doses of GSK256066 With Placebo in Reducing Lung Inflammation Following Segmental LPS Challenge in Healthy Volunteers|Completed||Phase 1|36|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:22:12.888218|2017-02-18 15:22:12.888218
NCT00515255|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2012-04-26|||July 2007||2007-07-01|April 2012|2012-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)|Open-Label Exploratory Investigation Of NPL-2003 In Adolescents With Obsessive Compulsive Disorder|Terminated||Phase 2|6|Actual|Neuropharm||1||Recruitment Goal of 20 Not Met|f||||||||||||||2017-02-18 15:22:12.979917|2017-02-18 15:22:12.979917
NCT00515242|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-03-20|||September 2007||2007-09-01|March 2014|2014-03-01|August 2009|Actual|2009-08-01|October 2008|Actual|2008-10-01||Interventional|CALM||Therapeutic Massage for Generalized Anxiety Disorder|Therapeutic Massage for Generalized Anxiety Disorder|Completed||Phase 1/Phase 2|68|Actual|Group Health Cooperative||3|||f||||t||||||||||2017-02-18 15:22:13.081234|2017-02-18 15:22:13.081234
NCT00515229|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2007-08-10|||October 2006||2006-10-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo|Protocol for a Phase II-Study Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo - Randomised, Double-Blinded, Placebo-Controlled, Cross Over - Study -|Completed||Phase 2|18|Actual|University Hospital Tuebingen||4|||f||||t||||||||||2017-02-18 15:22:13.193334|2017-02-18 15:22:13.193334
NCT00515216|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2015-12-08|2015-02-11||August 2007||2007-08-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|August 2011|Actual|2011-08-01||Interventional|||Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors|Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study|Completed||Phase 2|26|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 15:22:13.31269|2017-02-18 15:22:13.31269
NCT00515203|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-07-18|2010-10-28||July 2007||2007-07-01|July 2014|2014-07-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects|A Randomized, Double-Blind, Placebo-controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Pediatric Subjects With Chronic Immune (Idiopathic) Thrombocytopenic Purpura|Completed||Phase 1/Phase 2|22|Actual|Amgen||2|||f||||||||||||||2017-02-18 15:22:13.869664|2017-02-18 15:22:13.869664
NCT00515190|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2007-12-21|||July 2007||2007-07-01|December 2007|2007-12-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma|A Randomized Phase II Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma|Unknown status|Recruiting|Phase 2|198|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 15:22:14.50188|2017-02-18 15:22:14.50188
NCT00515177|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2013-02-20|2012-12-18||August 2007||2007-08-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|MVP#1||Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study|Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study|Completed||Phase 2/Phase 3|30|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 15:22:14.600523|2017-02-18 15:22:14.600523
NCT00515164|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2011-10-21|||August 2007||2007-08-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|April 2008|Actual|2008-04-01||Interventional|||US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study|Phase 2 Study of the 20 mL Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema|Completed||Phase 2|22|Actual|Aeris Therapeutics||2|||f||||t||||||||||2017-02-18 15:22:15.242633|2017-02-18 15:22:15.242633
NCT00515151|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2007-08-10|||May 2002||2002-05-01|August 2007|2007-08-01|April 2005|Actual|2005-04-01|||||Interventional|||Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride|Skin Disinfection With Octenidine Dihydrochloride for the Prevention of Catheter-Associated Infections - A Double-Blind, Randomized, Controlled Trial|Completed||Phase 4|400|Actual|University Hospital Freiburg||2|||f||||t||||||||||2017-02-18 15:22:15.365639|2017-02-18 15:22:15.365639
NCT00515138|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2012-04-11|||May 2007||2007-05-01|April 2012|2012-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant|A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant|Terminated||Early Phase 1|7|Actual|University of California, San Francisco||1||Investigator left institution. 7 patients accrued and there is insufficient data to analyze.|f||||t||||||||||2017-02-18 15:22:15.486785|2017-02-18 15:22:15.486785
NCT00515125|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2015-09-10|||August 2007||2007-08-01|June 2015|2015-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Community Oral Nutrition Support Trial|A Randomised Trial of Oral Nutritional Supplements Versus Dietary Advice on Clinical Nutrition in the Community.|Completed||N/A|104|Actual|University of Southampton||2|||f||||f||||||||||2017-02-18 15:22:15.585417|2017-02-18 15:22:15.585417
NCT00515112|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-05-12|2014-05-12||July 2007||2007-07-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|November 2010|Actual|2010-11-01||Interventional|||Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer|A Randomized, Double Blind, Placebo-Controlled Phase II Study of Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer|Terminated||Phase 2|6|Actual|University of Chicago||2||This study has been terminated due to poor accrual|f||||t||||||||||2017-02-18 15:22:15.693206|2017-02-18 15:22:15.693206
NCT00515099|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2016-10-24|2014-02-10||August 2007||2007-08-01|October 2016|2016-10-01|July 2013|Actual|2013-07-01|June 2012|Actual|2012-06-01||Interventional|START|Intent-to-treat|Study of Antithymocyte Globulin for Treatment of New-onset T1DM|Effect of Antithymocyte Globulin on Preserving Beta Cell Function in New Onset Type 1 Diabetes Mellitus|Terminated||Phase 2|58|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Enrollment for this trial was closed at 58 participants and did not meet the planned sample size of 66 participants due to slow accrual.|2||Slow accrual|f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal. ITN TrialShare makes data from the consortium's clinical trials publicly available.|2017-02-18 15:22:16.069031|2017-02-18 15:22:16.069031
NCT00515086|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2011-09-20|2010-12-15||August 2007||2007-08-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)|A Phase II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme|Terminated||Phase 2|41|Actual|Novartis|Due to the early termination of this study, the analysis of some of the planned objectives is not included in this clinical study report.|4||Early termination due to slow enrollment and protocol-defined stopping rule.|f||||||||||||||2017-02-18 15:22:16.968376|2017-02-18 15:22:16.968376
NCT00515073|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-05-30|2014-05-30||April 2001||2001-04-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Papillary Serous Carcinoma of the Endometrium|A Phase II Study: Paclitaxel and Pelvic Radiation for Stage I-IIIA Papillary Serous Carcinoma of the Endometrium|Completed||Phase 2|30|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:22:18.164842|2017-02-18 15:22:18.164842
NCT00515060|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-11-02|||January 2001||2001-01-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Observational|||Psychophysical Studies of Cancer Therapy-Induced Pain|Psychophysical Studies of Cancer Therapy-Induced Pain: A Feasibility Study|Recruiting||N/A|450|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:22:18.618521|2017-02-18 15:22:18.618521
NCT00515047|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2014-04-01|||May 2006||2006-05-01|April 2014|2014-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|Genetics||Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis|Genetics of Atopic Dermatitis - Eczema Herpeticum|Completed||N/A|900|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||t||||||Samples With DNA|"~     Skin scrapings and blood collection may occur~   "|||2017-02-18 15:22:18.731727|2017-02-18 15:22:18.731727
NCT00515034|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-10|2011-05-09|2009-11-13||October 2007||2007-10-01|May 2011|2011-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia|A Randomized, Open-Label, Multicenter Study to Assess the Safety and Tolerability of Doripenem Compared With Imipenem in the Treatment of Subjects With Complicated Intra-Abdominal Infections or Ventilator Associated Pneumonia|Completed||Phase 2|146|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|open-label study design and limited number of subjects in the comparator group|4|||f||||||||||||||2017-02-18 15:22:18.855858|2017-02-18 15:22:18.855858
NCT00514982|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2017-01-24|||August 7, 2007||2007-08-07|March 8, 2011|2011-03-08|March 8, 2011|Actual|2011-03-08|March 8, 2011|Actual|2011-03-08||Interventional|||Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome|An Observational Study of the Immunopathogenesis of and Response to Step-Up Inflammatory Bowel Disease Therapy for Hermansky-Pudlak Syndrome-Associated Colitis|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||6|||f||||||||||||||2017-02-18 15:22:20.780152|2017-02-18 15:22:20.780152
NCT00514969|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2007-08-09|||August 2000||2000-08-01|July 2007|2007-07-01||||||||Interventional|CML003||Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase|Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase. A Phase II Study|Completed||Phase 2|||University of Bologna|||||f||||||||||||||2017-02-18 15:22:20.902017|2017-02-18 15:22:20.902017
NCT00514956|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2009-09-21|||September 2007||2007-09-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effect of Emotional Freedom Technique and Diaphragmatic Breathing on Post Traumatic Stress Disorder (PTSD)|Effect of Emotional Freedom Technique and Diaphragmatic Breathing on PTSD|Completed||Phase 1|12|Anticipated|Soul Medicine Institute||1|||f||||t||||||||||2017-02-18 15:22:21.003082|2017-02-18 15:22:21.003082
NCT00514943|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-06-24|2013-08-08||August 2007||2007-08-01|June 2016|2016-06-01|July 2013|Actual|2013-07-01|March 2010|Actual|2010-03-01||Interventional|||BIBW 2992 (Afatinib) in Head & Neck Cancer|A Randomized, Open-label Phase II Study of BIBW 2992 Versus Cetuximab (Erbitux) in Patients With Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of Platinum-containing Therapy With a Cross-over Period for Progressing Patients|Completed||Phase 2|124|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:22:21.130166|2017-02-18 15:22:21.130166
NCT00514930|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2007-08-09|||February 2007||2007-02-01|August 2007|2007-08-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver|A Multicentre Prospective Clinical Trial of a New Bipolar Radiofrequency Ablation/Aspirator Device (Hexablate) in the Management of Primary and Secondary Liver Cancers|Unknown status|Recruiting|Phase 1/Phase 2|||University of Thessaly|||||f||||||||||||||2017-02-18 15:22:23.014538|2017-02-18 15:22:23.014538
NCT00514917|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2013-08-30|2013-08-30||July 2007||2007-07-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|Rising PSA|Safety population included all randomized participants who received at least part of one dose of any of the study drugs.|A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)|A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA Following Definitive Local Therapy|Terminated||Phase 3|413|Actual|Sanofi||2||Company decision to discontinue the study, not due to any safety or efficacy concerns|f||||t||||||||||2017-02-18 15:22:23.113739|2017-02-18 15:22:23.113739
NCT00514904|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-10-18||2009-09-03|September 2007||2007-09-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects|Non-inferiority of GSK Biologicals' Meningococcal Vaccine GSK134612 Versus Mencevax™ in Healthy Subjects Aged 2 Through 10 Years of Age|Completed||Phase 3|1505|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:22:24.048092|2017-02-18 15:22:24.048092
NCT00514891|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2011-02-26|||August 2007||2007-08-01|January 2011|2011-01-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Impact of the WHO Recommended Vitamin A Supplementation at Immunisation Contacts|Evaluation of the Impact on Mortality and Morbidity of the WHO Recommended Vitamin A Supplementation at First Immunisation Contact After 6 Months of Age|Terminated||Phase 4|9500|Anticipated|Bandim Health Project||2||Reccomended by DSMB after review of planned interim analyses.|f||||t||||||||||2017-02-18 15:22:24.191032|2017-02-18 15:22:24.191032
NCT00514878|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2009-10-30|||August 2007||2007-08-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Observational|Apfel-PDNV||Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)|Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)|Completed||N/A|2000|Anticipated|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 15:22:24.300807|2017-02-18 15:22:24.300807
NCT00514865|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2013-11-30||2013-11-30|June 2007||2007-06-01|November 2013|2013-11-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder|Completed||Phase 2|278|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||||||||||||2017-02-18 15:22:24.393456|2017-02-18 15:22:24.393456
NCT00514852|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2009-11-10|2009-05-19||October 2007||2007-10-01|November 2009|2009-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye||Completed||N/A|316|Actual|Allergan||2|||f||||f||||||||||2017-02-18 15:22:24.502429|2017-02-18 15:22:24.502429
NCT00514839|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-04-01|||November 2005||2005-11-01|April 2014|2014-04-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|MIMIK||Brief Intervention for Prescription Drug Misuse in General Hospital|Brief Intervention for Regular Prescription Drug Use and Prescription Drug Use Disorders in General Hospital|Completed||Phase 2|126|Actual|University of Luebeck||2|||f||||t||||||||||2017-02-18 15:22:25.020583|2017-02-18 15:22:25.020583
NCT00514826|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2010-05-25|||August 2007||2007-08-01|May 2010|2010-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study to Investigate Sleep Apnea Patients at Altitude|Study to Investigate Sleep Apnea Patients at Altitude|Completed||N/A|40|Anticipated|University of Zurich||1|||f||||f||||||||||2017-02-18 15:22:25.112947|2017-02-18 15:22:25.112947
NCT00514618|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2011-04-04|||March 2006||2006-03-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics|Outpatient Cervical Ripening and Labor Induction With Orally Administered Misoprostol for Term Pregnancies Complicated by Diabetes Mellitus|Terminated||N/A|5|Actual|University of California, Irvine||2||Poor enrollment|f||||f||||||||||2017-02-18 15:22:32.674853|2017-02-18 15:22:32.674853
NCT00514813|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-06-06|2009-08-18||June 2007||2007-06-01|November 2009|2009-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Dynepo Long-Term Safety Study|An Open-Label, Phase IV, Multi-Centre Study to Investigate the Long-Term Safety and Efficacy of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease|Terminated||Phase 4|152|Actual|Shire|This study terminated early due to a decision by Shire Pharmaceuticals to permanently cease marketing Dynepo due to commercial reasons, it was not the result of any safety signal. Not enough subjects completed the study to do any efficacy analyses.|1||"The termination of the study is not linked to a product recall or result of any safety signal.~   Rather it was sponsor's commercial decision to withdraw the MA"|f||||f||||||||||2017-02-18 15:22:25.203457|2017-02-18 15:22:25.203457
NCT00514800|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2015-06-05|||March 2007||2007-03-01|August 2007|2007-08-01|April 2009|Actual|2009-04-01|||||Interventional|||Home Blood Pressure Monitoring Trial|Community Based Trial of Home Blood Pressure Monitoring With Nurse Led Support in Patients With Stroke or TIA Recently Discharged From Hospital|Completed||Phase 3|360|Anticipated|St George's, University of London||2|||f||||f||||||||||2017-02-18 15:22:26.269644|2017-02-18 15:22:26.269644
NCT00514787|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2009-03-26||||||March 2009|2009-03-01||||||||Observational|||Be SMART NIS, Moderate to Servere Asthma Patient Observation|Be SMART NIS, Moderate to Servere Asthma Patient Observation|Completed||N/A|900|Anticipated|AstraZeneca|||1||f||||f||||||||||2017-02-18 15:22:26.374645|2017-02-18 15:22:26.374645
NCT00514774|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2009-02-04|||August 2007||2007-08-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|UDCA-HD||Ursodiol in Huntington's Disease|Ursodiol in Huntington's Disease|Unknown status|Active, not recruiting|Phase 1|21|Anticipated|Oregon Health and Science University||3|||f||||t||||||||||2017-02-18 15:22:26.449073|2017-02-18 15:22:26.449073
NCT00514761|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-08-12|||September 2006||2006-09-01|August 2014|2014-08-01|July 2008|Actual|2008-07-01|June 2007|Actual|2007-06-01||Interventional|||Phase II Efficacy Study of AZD6244 in Colorectal Cancer|A Phase II, Open, Randomized Study to Assess the Efficacy and Safety of AZD6244 vs Capecitabine (Xeloda) in Patients With Colorectal Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens.|Completed||Phase 2|64|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:22:26.565996|2017-02-18 15:22:26.565996
NCT00514748|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2009-06-23|||January 2007||2007-01-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|August 2008|Actual|2008-08-01||Interventional|||A Bilateral Interconnected DIEP Flap Based on One Vessel Pedicle for Breast Reconstruction||Completed||N/A|||Chinese Academy of Sciences||2|||f||||f||||||||||2017-02-18 15:22:26.855318|2017-02-18 15:22:26.855318
NCT00514735|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2012-04-11|2012-01-25||May 2007||2007-05-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|TTOP-AF||Tailored Treatment of Permanent Atrial Fibrillation|Tailored Treatment of Permanent Atrial Fibrillation - TTOP-AF|Completed||Phase 3|210|Actual|Medtronic Atrial Fibrillation Solutions|- The study population was mostly Caucasian men.|2|||f||||t||||||||||2017-02-18 15:22:26.97099|2017-02-18 15:22:26.97099
NCT00514722|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2013-08-13|||October 2002||2002-10-01|August 2013|2013-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies|Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies|Terminated||N/A|4|Actual|University of California, San Francisco||1||low accrual|f||||t||||||||||2017-02-18 15:22:27.738725|2017-02-18 15:22:27.738725
NCT00514709|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-07-05|2013-09-09||September 2007||2007-09-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants|Immunogenicity Study of the Antibody Persistence and Booster Effect of DTaP-Hep B-PRP-T Combined Vaccine at 12 to 18 Months of Age Following a Primary Series at 6, 10 and 14 Weeks of Age in Healthy Filipino Infants Having Received Hepatitis B Vaccine at Birth|Completed||Phase 3|1843|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:22:27.845935|2017-02-18 15:22:27.845935
NCT00514696|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2013-06-14|||February 2007||2007-02-01|June 2013|2013-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|PR-CS008||Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia|Open Label Phase 2 Study of the Safety and Biological Activity of GCS-100 in Subjects With Chronic Lymphocytic Leukemia|Completed||Phase 2|12|Actual|La Jolla Pharmaceutical Company||1|||f||||t||||||||||2017-02-18 15:22:28.368146|2017-02-18 15:22:28.368146
NCT00514683|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2015-01-05|2014-11-14||August 2007||2007-08-01|January 2015|2015-01-01||||June 2010|Actual|2010-06-01||Interventional||Treated Set: This patient set includes all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis|A 12 Month, Double Blind, Randomized, Placebo-controlled Trial Evaluating the Effect of BIBF 1120 Administered at Oral Doses of 50 mg qd, 50 mg Bid, 100 mg Bid and 150 mg Bid on Forced Vital Capacity Decline During One Year, in Patients With Idiopathic Pulmonary Fibrosis, With Optional Active Treatment Extension Until Last Patient Out.|Completed||Phase 2|432|Actual|Boehringer Ingelheim|There were numerous additional pre-specified endpoints. Full results are available under the BI Transparency web page ( http://trials.boehringer-ingelheim.com/trial_results.html )|5|||f||||||||||||||2017-02-18 15:22:28.710868|2017-02-18 15:22:28.710868
NCT00514670|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2007-08-09|||March 2006||2006-03-01|August 2007|2007-08-01|May 2006|Actual|2006-05-01|||||Interventional|||A Randomized Controlled Trial of a School Disinfection and Hand Hygiene Program|A Randomized Controlled Trial of a School Disinfection and Hand Hygiene Program|Completed||N/A|285|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-02-18 15:22:32.22023|2017-02-18 15:22:32.22023
NCT00514657|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2007-08-09|||December 2001||2001-12-01|August 2007|2007-08-01|February 2004|Actual|2004-02-01|||||Interventional|||Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2|Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 (Randomised Controlled Phase II Clinical Trial)|Completed||Phase 2|91|Actual|Kaken Pharmaceutical||4|||f||||f||||||||||2017-02-18 15:22:32.318244|2017-02-18 15:22:32.318244
NCT00514644|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2012-01-09|||August 2007||2007-08-01|January 2012|2012-01-01|February 2010|Actual|2010-02-01|November 2009|Actual|2009-11-01||Interventional|SPACE||Stroke and Panorama - Analyzing Carotid Endocalcifications (SPACE)|Stroke and Panorama - Analyzing Carotid Endocalcifications|Completed||N/A|266|Actual|Umeå University||2|||f||||f||||||||||2017-02-18 15:22:32.569449|2017-02-18 15:22:32.569449
NCT00514410|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2011-10-11|||July 2007||2007-07-01|February 2009|2009-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|FolATED||Folate Augmentation of Treatment - Evaluation for Depression: a Randomised Controlled Trial|Folate Augmentation of Treatment - Evaluation for Depression: a Randomised Controlled Trial|Completed||Phase 4|730|Anticipated|Bangor University||2|||f||||t||||||||||2017-02-18 15:22:36.186427|2017-02-18 15:22:36.186427
NCT00514605|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2007-12-10|||July 2007||2007-07-01|December 2007|2007-12-01||||||||Interventional|||Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection|A Study to Evaluate the Point-of-Care Use and Laboratory Investigational Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection|Completed||Phase 2/Phase 3|2500|Anticipated|bioLytical Laboratories||1|||f||||f||||||||||2017-02-18 15:22:32.784433|2017-02-18 15:22:32.784433
NCT00514592|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2013-09-16|2013-07-08||August 2007||2007-08-01|September 2013|2013-09-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Observational|ANSYSCAP||Additional Neurological Symptoms Before Surgery of the Carotid Arteries - A Prospective Study (ANSYSCAP)|Additional Neurological Symptoms Before Surgery of the Carotid Arteries - A Prospective Study|Completed||N/A|230|Actual|Umeå University|||1||f||||f||||||||||2017-02-18 15:22:32.896|2017-02-18 15:22:32.896
NCT00514579|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-03-07|||August 2007||2007-08-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Adult Double Cord Blood Transplant Study|A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults With Hematologic Malignancy|Completed||Phase 2|56|Actual|Center for International Blood and Marrow Transplant Research||1|||f||||t||||||||||2017-02-18 15:22:33.107167|2017-02-18 15:22:33.107167
NCT00514566|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2007-08-08|||October 2004||2004-10-01|August 2007|2007-08-01|April 2006|Actual|2006-04-01|||||Interventional|PPMAC||PDS vs Polyamide for Midline Abdominal Closure|Is Polydioxanone 'THE' Suture of Choice for Midline Abdominal Closure? Results of a Prospective Randomized Clinical Trial|Terminated||N/A|64|Actual|Christian Medical College and Hospital, Ludhiana, India||1||Unacceptable incidence of wound dehiscence in the PDS group|f||||t||||||||||2017-02-18 15:22:33.253391|2017-02-18 15:22:33.253391
NCT00514553|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2017-01-24|||August 7, 2007||2007-08-07|May 31, 2011|2011-05-31|May 31, 2011||2011-05-31|||||Observational|||Informed Choice Regarding Invasive Prenatal Testing|Deliberation With and Without Attention: Can We Enhance Informed Choices About Invasive Prenatal Testing? A Proof of Principle Study|Completed||N/A|37|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:22:33.351361|2017-02-18 15:22:33.351361
NCT00514540|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-01-16|||May 2006||2006-05-01|January 2014|2014-01-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer|Phase II Study of Carboplatin Plus Docetaxel (Taxotere) in Patients With Anaplastic Prostate Carcinoma|Completed||Phase 2|121|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:22:33.429124|2017-02-18 15:22:33.429124
NCT00514527|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2008-08-13|||August 2007||2007-08-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|SIMPLIFI||A Study for Patients With Complicated Skin and Skin Structure Infections|Nuvocid® (Oritavancin) at Single or Infrequent Doses for the Treatment of Complicated Skin and Skin Structure Infections (SIMPLIFI)|Completed||Phase 2|294|Anticipated|Targanta Therapeutics Corporation||3|||f||||f||||||||||2017-02-18 15:22:33.548591|2017-02-18 15:22:33.548591
NCT00514514|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2016-11-21|2016-06-03||July 2007||2007-07-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen|Multi-center, Open-label, Prospective, Randomized, Parallel Group, Long-term Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a CNI-free Regimen and a CNI-low Dose Regimen|Completed||Phase 3|802|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:22:33.72717|2017-02-18 15:22:33.72717
NCT00514501|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2016-02-29|2015-12-15||May 2007||2007-05-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|Zeus-ACS||Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome|Open-label, Phase 2 Study of the Safety and Efficacy of B-methyl-P-(123I)- Iodophenyl-pentadecanoic Acid (Iodofiltic Acid I 123) For Identification of Ischemic Myocardium Using Single Photon Emission Computed Tomography (Spect) in Adults With Symptoms Consistent With Acute Coronary Syndrome (ACS).|Completed||Phase 2|510|Actual|Molecular Insight Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-02-18 15:22:35.231263|2017-02-18 15:22:35.231263
NCT00514488|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2007-08-09|||June 2004||2004-06-01|July 2007|2007-07-01||||||||Interventional|CML022||Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)|A Phase III Study Comparing Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day) in the Treatment of Newly Diagnosed High Risk Chronic Myeloid Leukemia in Chronic Phase|Completed||Phase 3|||University of Bologna||2|||f||||f||||||||||2017-02-18 15:22:35.617776|2017-02-18 15:22:35.617776
NCT00514475|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2012-05-03|||November 2005||2005-11-01|May 2008|2008-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma|High-dose Therapy With Autologous Stem Cell Support in First Line Treatment of Mantle Cell Lymphoma- 90Y-Ibritumomab Tiuxetan in Combination With BEAM or BEAC to Improve Outcome for Patients Not in CR After Induction Treatment|Completed||Phase 2|160|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-02-18 15:22:35.704206|2017-02-18 15:22:35.704206
NCT00514462|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2007-08-09|||July 2007||2007-07-01|August 2007|2007-08-01|August 2007|Anticipated|2007-08-01|||||Interventional|CTS||Carpal Tunnel Syndrome Treated With 830nm Diode Laser|Instiutional Review Board of Chung Shan Medical University Hospital|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Chung Shan Medical University||1|||f||||t||||||||||2017-02-18 15:22:35.81436|2017-02-18 15:22:35.81436
NCT00514449|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2011-02-17|||June 2007||2007-06-01|February 2011|2011-02-01|February 2010|Anticipated|2010-02-01|January 2010|Anticipated|2010-01-01||Interventional|SEAMS||Systematic Evaluation of Antiviral Medication in Schizophrenia|A Randomized Double-blind Controlled Trial of Valacyclovir Add-on Treatment of HSV Positive Early Course Schizophrenia Patients|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 15:22:35.905291|2017-02-18 15:22:35.905291
NCT00514436|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2015-12-08|||January 1997||1997-01-01|December 2015|2015-12-01|January 2001|Actual|2001-01-01|||||Interventional|||Case Management and Environmental Control in Asthma||Completed||Phase 3|189|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 15:22:36.008753|2017-02-18 15:22:36.008753
NCT00514423|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-09|2014-08-28|||September 2006||2006-09-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs|How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs|Completed||N/A|896|Anticipated|Technische Universität München||4|||f||||||||||||||2017-02-18 15:22:36.094676|2017-02-18 15:22:36.094676
NCT00514397|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2013-08-09|||January 2008||2008-01-01|June 2009|2009-06-01||||||||Interventional|||Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma|A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide With Radiotherapy in Diffuse Pontine Gliomas|Unknown status|Recruiting|Phase 2|43|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:22:36.49342|2017-02-18 15:22:36.49342
NCT00514384|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-12-02|||February 2007||2007-02-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2012|Actual|2012-12-01||Observational|||Serial Measurements of Biomarker in Patients With Acute Decompensated Heart Failure|Prognostic Value of Serial Biomarker Measurements in Patients With ADHF|Completed||N/A|350|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 15:22:36.630643|2017-02-18 15:22:36.630643
NCT00514371|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2015-11-06||2010-09-10|August 2007||2007-08-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|TIME-2||A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma|Phase 2/3 Randomized, Open-Label Clinical Trial of Tanespimycin (KOS-953) Plus Bortezomib Comparing Three Doses of Tanespimycin in Patients With Relapsed-Refractory Multiple Myeloma|Completed||Phase 2/Phase 3|22|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 15:22:36.728239|2017-02-18 15:22:36.728239
NCT00514358|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2011-07-06|||November 2005||2005-11-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Fluconazole Pharmacokinetics in Infants|A Multicenter, Open Label Pharmacokinetic Study of Fluconazole in Infants|Completed||Phase 1|55|Actual|Children's Hospital of Philadelphia|||1||f||||t||||||||||2017-02-18 15:22:36.8752|2017-02-18 15:22:36.8752
NCT00514345|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2013-08-09|||July 2007||2007-07-01|June 2009|2009-06-01||||||||Observational|||CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide|CYP3A5 Genotype as a Potential Risk Factor for the Development of Ifosamide Nephrotoxicity in Children|Unknown status|Recruiting|N/A|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:22:36.998639|2017-02-18 15:22:36.998639
NCT00514332|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2007-08-08|||December 2002||2002-12-01|August 2007|2007-08-01|October 2006|Actual|2006-10-01|||||Interventional|||Comparison Between Colorectal Stents and Primary Surgery in Obstructive Colonic Cancer. A Randomized, Controlled Study|Etude Prospective Multicentrique randomisée Comparant Deux stratégies thérapeutiques Pour Les Cancers Coliques en Occlusion : stratégie Chirurgicale Exclusive Versus stratégie thérapeutique Avec Stent Colique Initial|Terminated||N/A|70|Actual|University Hospital, Montpellier||1||enrolling participants stopped|f||||f||||||||||2017-02-18 15:22:37.116724|2017-02-18 15:22:37.116724
NCT00514306|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2011-09-12|||June 2007||2007-06-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study of Intermittent OSI-906 Dosing|A Phase I Dose Escalation Study of Intermittent Oral OSI-906 Dosing in Patients With Advanced Solid Tumors|Completed||Phase 1|79|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 15:22:37.216514|2017-02-18 15:22:37.216514
NCT00514293|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-01-09|||January 2007||2007-01-01|August 2008|2008-08-01||||December 2011|Anticipated|2011-12-01||Interventional|||Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Trial of Bexarotene (Targretin) Capsules With Tretinoin and Chemotherapy in Patients With Advanced Non-small-cell Lung Cancer|Unknown status|Recruiting|Phase 2|39|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:22:37.32724|2017-02-18 15:22:37.32724
NCT00514280|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2017-01-24|||August 2, 2007||2007-08-02|May 11, 2011|2011-05-11|May 11, 2011||2011-05-11|||||Observational|||Tobacco Smoke and Lead Exposure During Pregnancy|Tobacco Smoke and Lead Exposure During Pregnancy: Intervention to Reduce Effects on Birth-Weight and Gestational Age|Completed||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:22:37.434545|2017-02-18 15:22:37.434545
NCT00514267|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2015-07-23||2015-07-23|May 2007||2007-05-01|July 2015|2015-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors|A Phase I/II Multicenter, Open-Label Study of YM155 Plus Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors|Completed||Phase 1/Phase 2|32|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 15:22:37.51879|2017-02-18 15:22:37.51879
NCT00514254|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2016-03-28|||July 2007||2007-07-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Risk Factors for Endometrial Cancer in Black Women|Endometrial Cancer in Black Women|Active, not recruiting||N/A|59|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     saliva/buccal specimens~   "|||2017-02-18 15:22:37.632039|2017-02-18 15:22:37.632039
NCT00514241|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2011-12-05|||January 2006||2006-01-01|December 2011|2011-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Evaluate Use of Gravitational Platelet Separation System on Leg Wound Healing in Coronary Bypass Surgery|A Clinical Study to Evaluate the Use of Gravitational Platelet Separation System on Leg Wound Healing in Coronary Bypass Surgery|Completed||Phase 1|140|Actual|Zimmer Biomet||2|||f||||||||||||||2017-02-18 15:22:37.748964|2017-02-18 15:22:37.748964
NCT00514228|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2012-06-25|||July 2007||2007-07-01|June 2012|2012-06-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|Continuous Sunitinib Treatment in Patients With Unresectable Hepatocellular Carcinoma A Multicenter Phase II Trial|Completed||Phase 2|45|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||||2017-02-18 15:22:37.848254|2017-02-18 15:22:37.848254
NCT00514215|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2015-02-09|2015-02-09||January 2006||2006-01-01|February 2015|2015-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer|Percutaneous Cryotherapy and Aerosolized GM-CSF for Pulmonary Metastases and Primary Lung Cancer|Completed||Phase 2|8|Actual|Barbara Ann Karmanos Cancer Institute|Small sample size.|1|||f||||t||||||||||2017-02-18 15:22:37.970176|2017-02-18 15:22:37.970176
NCT00514202|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-02-21|||August 2007||2007-08-01|February 2012|2012-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)|Dextroamphetamine Treatment for Comorbid Cocaine Dependence and ADHD|Terminated||Phase 2|5|Actual|The University of Texas Health Science Center, Houston||2||Investigator left UTHSC-Houston|f||||t||||||||||2017-02-18 15:22:38.21165|2017-02-18 15:22:38.21165
NCT00033813|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-10|2014-03-07|||January 2002||2002-01-01|March 2014|2014-03-01||||December 2006|Actual|2006-12-01||Interventional|||KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy||Completed||Phase 2|15||Cooperative International Neuromuscular Research Group|||||f||||||||||||||2017-02-18 18:06:58.232693|2017-02-18 18:06:58.232693
NCT00514189|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2012-07-27|||July 2007||2007-07-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines|Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines|Terminated||Phase 1|2|Actual|M.D. Anderson Cancer Center||1||Terminated early due to slow accrual.|f||||f||||||||||2017-02-18 15:22:38.329522|2017-02-18 15:22:38.329522
NCT00514163|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2011-06-27|||June 2007||2007-06-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|August 2010|Actual|2010-08-01||Interventional|||GEM vs GEM+TS-1 for Advanced Pancreatic Cancer|Randomized Phase II Study of Gemcitabine (GEM) Versus GEM+TS-1 for Advanced Pancreatic Cancer|Completed||Phase 2|110|Anticipated|Japan Clinical Cancer Research Organization||2|||f||||t||||||||||2017-02-18 15:22:38.447763|2017-02-18 15:22:38.447763
NCT00514150|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2008-09-04|||August 2007||2007-08-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)|Comparing Sodium Bicarbonate Plus Isotonic Normal Saline Versus Isotonic Normal Saline Alone to Prevent Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Controlled Trial|Completed||Phase 3|265|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:22:38.567516|2017-02-18 15:22:38.567516
NCT00514137|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-05-12|2013-01-30||September 2007||2007-09-01|March 2013|2013-03-01|August 2010|Actual|2010-08-01|March 2009|Actual|2009-03-01||Interventional|||Sunitinib in Treating Patients With Relapsed Multiple Myeloma|A Phase II Trial of Sunitinib (SU11248) in Multiple Myeloma|Completed||Phase 2|13|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:22:38.670657|2017-02-18 15:22:38.670657
NCT00514111|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2009-03-19|||August 2007||2007-08-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Observational|||Factors Associated to Success of Hepatitis C Therapy|Factors Associated to Success of Hepatitis C Therapy|Completed||Phase 4|100|Actual|UPECLIN HC FM Botucatu Unesp|||1||f||||t||||||||||2017-02-18 15:22:38.944342|2017-02-18 15:22:38.944342
NCT00514098|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-09-17|||August 2008||2008-08-01|September 2014|2014-09-01|November 2020|Anticipated|2020-11-01|November 2020|Anticipated|2020-11-01||Observational|||Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials|An Observational Cohort Study of Women Following HIV-1 Seroconversion in Microbicide Trials|Recruiting||N/A|500|Anticipated|Microbicide Trials Network|||1||f||||f||||||Samples With DNA|"~     Blood and urine collection, pelvic, vaginal, and cervicovaginal sampling~   "|||2017-02-18 15:22:39.043441|2017-02-18 15:22:39.043441
NCT00514085|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2016-11-25|||July 2007||2007-07-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|September 2010|Actual|2010-09-01||Interventional|||Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma|A Phase II Study of Interleukin-21 (IL-21) in Patients With Metastatic or Recurrent Malignant Melanoma|Completed||Phase 2|40|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 15:22:39.182296|2017-02-18 15:22:39.182296
NCT00514072|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2012-08-08|||March 2007||2007-03-01|August 2012|2012-08-01||||September 2012|Anticipated|2012-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer|A Double-Blind Randomized Phase 2.5 Trial of ONY-P1 Vaccine Versus Placebo in Men With D0 Prostate Cancer Following Limited Androgen Ablation|Unknown status|Active, not recruiting|Phase 2|54|Anticipated|Kael-GemVax Co., Ltd.||2|||f||||||||||||||2017-02-18 15:22:39.395849|2017-02-18 15:22:39.395849
NCT00514059|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2007-08-08|||April 2007||2007-04-01|April 2007|2007-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine|Open Clinical Study to Assess the Immune Response and Safety of a Booster Dose (5th Dose) of a Combination Vaccine Against Diphteria-Tetanus-Pertussis-Polio Given to Healthy Adolescents 15-16 Years of Age.|Completed||Phase 4|83|Actual|Norwegian Institute of Public Health||1|||f||||f||||||||||2017-02-18 15:22:39.505924|2017-02-18 15:22:39.505924
NCT00514046|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2017-01-24|||July 9, 2007||2007-07-09|September 26, 2016|2016-09-26|July 27, 2020|Anticipated|2020-07-27|April 1, 2018|Anticipated|2018-04-01||Interventional|||Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer|Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents With Hereditary Medullary Thyroid Carcinoma|Active, not recruiting||Phase 1/Phase 2|17|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:22:39.596619|2017-02-18 15:22:39.596619
NCT00514033|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2012-03-15|||July 2007||2007-07-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children|Open, Multicentric, PMS Study to Monitor Safety and Reactogenicity of GlaxoSmithKline Biologicals' Poliomyelitis Vaccine (Inactivated)-Poliorix, Administered in Korean Children as a Primary Vaccination in Healthy Subjects Aged 2 to 6 Months or as a Booster Vaccination in Subjects Aged 4 to 6 Years|Completed||N/A|349|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 15:22:39.708387|2017-02-18 15:22:39.708387
NCT00514020|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2012-10-30|2012-09-18||August 2007||2007-08-01|October 2012|2012-10-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer|Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors: A Phase II Study|Completed||Phase 2|33|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:22:39.809846|2017-02-18 15:22:39.809846
NCT00514007|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-04-16|||December 2006||2006-12-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Study of Continuous OSI-906 Dosing|A Phase I Dose Escalation Study of Continuous Oral OSI-906 Dosing in Patients With Advanced Solid Tumors|Completed||Phase 1|95|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 15:22:40.110344|2017-02-18 15:22:40.110344
NCT00513994|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2008-04-08|||August 2007||2007-08-01|April 2008|2008-04-01|October 2007|Actual|2007-10-01|||||Interventional|||MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects|MQX-503 Applied to the Fingers vs. Nitroglycerin Ointment 2%, USP, Applied to the Chest: A Pharmacokinetic Comparison in Normal Subjects|Completed||Phase 1|6|Anticipated|MediQuest Therapeutics||1|||f||||f||||||||||2017-02-18 15:22:40.223527|2017-02-18 15:22:40.223527
NCT00513981|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2013-06-25|||March 2007||2007-03-01|June 2009|2009-06-01|August 2009|Actual|2009-08-01|March 2008|Actual|2008-03-01||Interventional|||High-Dose Methotrexate in Treating Young Patients With Solid Tumors|Study to Determine the Maximum Tolerated Time of Infusion for High-Dose Methotrexate, Administered as a Continuous Intravenous Infusion at a Dose of 6g/m² Per 24 Hours of Infusion Time|Completed||Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:22:40.319113|2017-02-18 15:22:40.319113
NCT00513968|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2012-08-03|||July 2007||2007-07-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine|A Single Center, Randomized, Open-label, Dose Escalating Phase I Study to Evaluate the Safety of Intramuscularly Administered DNA Vaccine (HB-110) Combined With Oral Antiviral (Adefovir) in Subjects With Chronic Hepatitis B Over a 48-week Period|Completed||Phase 1|27|Actual|Genexine, Inc.||2|||f||||f||||||||||2017-02-18 15:22:40.443634|2017-02-18 15:22:40.443634
NCT00513955|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-11-04|||June 2006||2006-06-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma|A Parallel Randomised Phase II Trial of CHOP Chemotherapy With or Without Bortezomib in Relapsed Mantle Cell Lymphoma|Completed||Phase 2|50|Actual|Plymouth Hospitals NHS Trust||1|||f||||t||||||||||2017-02-18 15:22:40.540807|2017-02-18 15:22:40.540807
NCT00513942|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-10-17|||August 2007||2007-08-01|October 2014|2014-10-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||Effects of Fetal Movement Counting in Third Trimester of Pregnancy|Effects of Fetal Movement Counting - a Randomized Controlled Trial of an Unselected Population|Completed||N/A|1200|Actual|Norwegian Institute of Public Health||2|||f||||f||||||||||2017-02-18 15:22:40.680356|2017-02-18 15:22:40.680356
NCT00513929|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2009-01-27|||August 2007||2007-08-01|January 2009|2009-01-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|EcuaPAZ||Zinc as Adjunct to Treatment of Pneumonia|Effects of Zinc as an Adjunct to Treatment of Pneumonia in Young Children|Unknown status|Recruiting|N/A|450|Anticipated|Corporacion Ecuatoriana de Biotecnologia||1|||f||||t||||||||||2017-02-18 15:22:40.776731|2017-02-18 15:22:40.776731
NCT00513916|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2013-12-18|||July 2006||2006-07-01|April 2009|2009-04-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Interventional|||Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women|Effects of Soy on Estrogens in Breast Fluid and Urine|Completed||Phase 3|100|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:22:40.888868|2017-02-18 15:22:40.888868
NCT00513903|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2014-08-18|||March 2008||2008-03-01|August 2014|2014-08-01|October 2012|Actual|2012-10-01|July 2012|Actual|2012-07-01||Interventional|IowaCOC||Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases|Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases|Completed||Phase 3|954|Actual|University of Iowa||3|||f||||f||||||||||2017-02-18 15:22:43.453466|2017-02-18 15:22:43.453466
NCT00513890|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2013-10-23|||October 2006||2006-10-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Interest of Non Invasive Ventilation Versus Oxygen During the Intial Managment of Infant With Bronchiolitis|Interest of Non Invasive Ventilation Versus Oxygen During the Intial Managment of Infant With Bronchiolitis Who Didn't Require Mechanical Ventilation|Completed||N/A|19|Actual|University Hospital, Montpellier|||||f||||t||||||||||2017-02-18 15:22:43.585731|2017-02-18 15:22:43.585731
NCT00513877|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-12-30|||May 2006||2006-05-01|January 2013|2013-01-01||||December 2009|Actual|2009-12-01||Interventional|||Bortezomib in Treating Patients With Malignant Pleural Mesothelioma|An Open Label Phase II Multicentre Clinical Trial of Single Agent Bortezomib in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|33|Actual|Cancer Trials Ireland||1|||f||||||||||||||2017-02-18 15:22:43.684046|2017-02-18 15:22:43.684046
NCT00513864|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2014-12-19|||November 2006||2006-11-01|December 2014|2014-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Assessment of Opioid Analgesia in Sickle Cell|Non-Invasive Assessment of Opioid Analgesia in Children With Sickle Cell Disease|Withdrawn||Phase 4|0|Actual|Children's Research Institute||2||lack of funding|f||||t||||||||||2017-02-18 15:22:43.799068|2017-02-18 15:22:43.799068
NCT00513851|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2011-09-26|||April 2006||2006-04-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Phase 1 Study of OSI-930 in Cancer Patients|A Phase I Dose Escalation Study of Daily Oral OSI-930 in Patients With Advanced Solid Tumors|Completed||Phase 1|60|Anticipated|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 15:22:43.909649|2017-02-18 15:22:43.909649
NCT00513825|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2008-11-23|||August 2007||2007-08-01|November 2008|2008-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN|The Evaluation of the Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN) in Patients With Pulmonary Edema,Severe Heart Failure or Uncontrolled Hypertension|Completed||Phase 2|72|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:22:44.018428|2017-02-18 15:22:44.018428
NCT00513799|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2015-07-07|2011-03-02||March 2007||2007-03-01|July 2015|2015-07-01|December 2010|Actual|2010-12-01|June 2009|Actual|2009-06-01||Interventional|StLStaRS||The Natural History of Community-Associated MRSA Infections and Decolonization Strategies|The Natural History of Community-Associated Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections and an Evaluation of Decolonization Strategies|Completed||N/A|300|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-02-18 15:22:44.132266|2017-02-18 15:22:44.132266
NCT00513786|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2015-07-25|||August 2007||2007-08-01|July 2015|2015-07-01||||November 2016|Anticipated|2016-11-01||Interventional|||Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma|A Phase II Study of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma|Active, not recruiting||Phase 2|38|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:22:47.038638|2017-02-18 15:22:47.038638
NCT00513773|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2011-07-25|||July 2008||2008-07-01|July 2011|2011-07-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Observational|||Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm|Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm|Unknown status|Recruiting|Phase 2|30|Anticipated|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     Serum/plasma for biomarker analysis~   "|||2017-02-18 15:22:47.161165|2017-02-18 15:22:47.161165
NCT00513760|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2014-01-23|||June 2007||2007-06-01|January 2014|2014-01-01|September 2014|Anticipated|2014-09-01|September 2014|Anticipated|2014-09-01||Interventional|TPORT||Transporter Mediated Uptake of Montelukast|Characterization of Transporter Mediated Uptake of Montelukast in Humans|Unknown status|Recruiting|N/A|27|Anticipated|Nemours Children's Clinic||3|||f||||f||||||||||2017-02-18 15:22:47.246327|2017-02-18 15:22:47.246327
NCT00513019|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2013-08-06|2012-03-01||August 2007||2007-08-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation|A Double-Blind Study of Lamictal in Neurotic Excoriation|Completed||Phase 2|35|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 15:23:02.902567|2017-02-18 15:23:02.902567
NCT00513747|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2016-07-01|||January 2008||2008-01-01|July 2016|2016-07-01|December 2033|Anticipated|2033-12-01|October 2020|Anticipated|2020-10-01||Interventional|||Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia|A Phase III Intergroup CLL Study of Asymptomatic Patients With Untreated Chronic Lymphocytic Leukemia Randomized to Early Intervention Versus Observation With Later Treatment in the High Risk Genetic Subset With IGVH Unmutated Disease|Active, not recruiting||Phase 3|84|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 15:22:47.393213|2017-02-18 15:22:47.393213
NCT00513734|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2007-08-08|||September 2004||2004-09-01|August 2007|2007-08-01|February 2005|Actual|2005-02-01|||||Interventional|||A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill|Randomised Trial Comparing the Efficacy of Ocular Lubricant (Lacrilube) and Polyacrylamide Hydrogel Dressing (Geliperm) for the Prevention of Exposure Keratopathy in the Critically Ill|Completed||N/A|40|Actual|Barts & The London NHS Trust||2|||f||||t||||||||||2017-02-18 15:22:48.352669|2017-02-18 15:22:48.352669
NCT00513721|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2009-05-04|||July 2007||2007-07-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy|Do Positive Lateral Biopsy Cores on TRUS Directed Biopsies Predict Capsular Penetration and Positive Surgical Margins?|Completed||N/A|400|Anticipated|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 15:22:48.444271|2017-02-18 15:22:48.444271
NCT00513708|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2011-04-15|2011-02-14||July 2007||2007-07-01|April 2011|2011-04-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Facilitating Aftercare for Alcohol Detox Patients|Helping Alcoholics Link to Substance Abuse Treatment Programs After Being in the Hospital for Detoxification|Completed||N/A|150|Actual|State University of New York at Buffalo||3|||f||||f||||||||||2017-02-18 15:22:48.528342|2017-02-18 15:22:48.528342
NCT00513695|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2017-01-04|||June 2007||2007-06-01|January 2017|2017-01-01||||August 2012|Actual|2012-08-01||Interventional|||Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer|A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Maleate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer|Active, not recruiting||Phase 2|67|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 15:22:49.028772|2017-02-18 15:22:49.028772
NCT00513682|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2014-03-05|2010-11-03||July 2007||2007-07-01|March 2014|2014-03-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional||Analysis population included all the participants who were enrolled in the study.|Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)|Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA%) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)|Completed||Phase 3|9|Actual|Forest Laboratories|No limitations|1|||f||||t||||||||||2017-02-18 15:22:49.166017|2017-02-18 15:22:49.166017
NCT00513669|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2013-03-14|||January 2008||2008-01-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|PMAL03||Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania|A Phase Ib Double-blind Randomized Placebo Controlled Age-deescalating Trial of Two Virosome Formulated Anti-malaria Vaccine Components (PEV 301 and PEV 302) Administered in Combination to Healthy Semi-immune Tanzanian Volunteers|Completed||Phase 1|50|Actual|Swiss Tropical & Public Health Institute||2|||f||||t||||||||||2017-02-18 15:22:49.468961|2017-02-18 15:22:49.468961
NCT00513656|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2012-08-09|||September 2007||2007-09-01|August 2012|2012-08-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain|A Randomised, Double-blind, Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Cancer Pain|Completed||Phase 2|230|Anticipated|Mundipharma Research GmbH & Co KG||2|||f||||f||||||||||2017-02-18 15:22:49.578823|2017-02-18 15:22:49.578823
NCT00513643|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-08|2007-08-08|||April 2002||2002-04-01|August 2007|2007-08-01|June 2002|Actual|2002-06-01|||||Interventional|||Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses|Pharmacodynamic and Pharmacokinetic Properties of Insulin Aspart: Dose - Ranging vs. Human Soluble Insulin|Completed||Phase 1|16|Actual|Profil Institut für Stoffwechselforschung GmbH||6|||f||||f||||||||||2017-02-18 15:22:49.692824|2017-02-18 15:22:49.692824
NCT00513630|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2011-04-25|||June 2004||2004-06-01|December 2010|2010-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SPREADDIMCAD||Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease|Phase 4 Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease|Completed||Phase 4|304|Actual|Shanghai Jiao Tong University School of Medicine||2|||f||||t||||||||||2017-02-18 15:22:49.81276|2017-02-18 15:22:49.81276
NCT00513617|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-11-04|2009-02-23||June 2004||2004-06-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Interventional|Arginine||Effectiveness of Arginine as a Treatment for Sickle Cell Anemia|Arginine Supplementation in Sickle Cell Anemia: Physiological and Prophylactic Effects|Completed||Phase 2|128|Actual|National Heart, Lung, and Blood Institute (NHLBI)|Adult enrollment was slower than expected. Adult subjects were more likely than peds to drop-out due to SCD pain crisis. Higher doses of arginine (such as used in animal studies) were limited by number of daily pills required.|3|||f||||t||||||||||2017-02-18 15:22:49.912697|2017-02-18 15:22:49.912697
NCT00513604|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-05-29|2013-02-19||June 2007||2007-06-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma|A Phase II Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Melanoma|Completed||Phase 2|158|Actual|National Institutes of Health Clinical Center (CC)||5|||f||||t||||||||||2017-02-18 15:22:50.486212|2017-02-18 15:22:50.486212
NCT00513591|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-06-14|||August 2007||2007-08-01|June 2016|2016-06-01||||December 2017|Anticipated|2017-12-01||Observational|DAP Registry||Duke Autoimmunity in Pregnancy Registry|Duke Autoimmunity in Pregnancy Registry|Recruiting||N/A|500|Anticipated|Duke University|||3||f||||f||||||Samples With DNA|"~     Blood samples will be collected and stored for future analysis.~   "|||2017-02-18 15:22:52.42297|2017-02-18 15:22:52.42297
NCT00513578|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2014-01-03|||January 2007||2007-01-01|February 2009|2009-02-01||||January 2009|Anticipated|2009-01-01||Interventional|||Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome|Phase 2 Study of Proteinase 3 PR1 Peptide Mixed With Montanide ISA 51 VG Adjuvant and Administered With GM-CSF in Low Risk and Intermediate-1 MDS|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 15:22:52.533126|2017-02-18 15:22:52.533126
NCT00513565|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2012-03-15|||September 2007||2007-09-01|February 2011|2011-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers|A Randomised, Placebo-controlled, Double-dummy, Crossover Design Study to Investigate the Changes of fMRI BOLD Activation Induced by Emotional Activation Paradigms Following Single Doses of GSK561679 and Lorazepam (Comparator) in Healthy Subjects|Completed||Phase 1|22|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 15:22:52.629598|2017-02-18 15:22:52.629598
NCT00513552|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2007-08-07|||January 2007||2007-01-01|August 2007|2007-08-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis|Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis|Unknown status|Recruiting|Phase 4|20|Anticipated|Medstar Health Research Institute|||||f||||f||||||||||2017-02-18 15:22:52.733826|2017-02-18 15:22:52.733826
NCT00513539|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-02-18|||July 2007||2007-07-01|February 2013|2013-02-01||||December 2009|Actual|2009-12-01||Interventional|Photostent-02||Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery|Porfimer Sodium Photodynamic Therapy Plus Stenting Versus Stenting Alone in Patients With Advanced or Metastatic Cholangiocarcinomas and Other Biliary Tract Tumours: a Multicentre, Randomised, Phase Lll Study|Completed||Phase 3|92|Actual|University College, London||2|||f||||t||||||||||2017-02-18 15:22:52.829559|2017-02-18 15:22:52.829559
NCT00513526|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2015-08-27|2011-06-28||November 2007||2007-11-01|August 2015|2015-08-01|October 2011|Actual|2011-10-01|May 2010|Actual|2010-05-01||Interventional|||Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection|A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men|Completed||Phase 2|112|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-02-18 15:22:52.964554|2017-02-18 15:22:52.964554
NCT00513513|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2010-04-22|||September 2006||2006-09-01|April 2010|2010-04-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously|A Phase II, Open Label Trial in Treatment na�ve, HIV 1 Infected Subjects Who Will Receive TMC114/Rtv as a Monotherapy|Terminated||Phase 2|7|Actual|Tibotec Pharmaceuticals, Ireland||||Poor recruitment.|f||||f||||||||||2017-02-18 15:22:53.385492|2017-02-18 15:22:53.385492
NCT00513500|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2010-07-13|2010-04-27||June 2007||2007-06-01|July 2010|2010-07-01|September 2009|Actual|2009-09-01|February 2009|Actual|2009-02-01||Interventional|ZIMMAPS||Zambia Integrated Management of Malaria and Pneumonia Study|Zambia Integrated Management of Malaria and Pneumonia Study|Completed||N/A|3125|Actual|Boston University|Imbalance in enrollment. More patients enrolled in the control arm possibly due to many control community health workers working full time and available to see patients all day.|2|||f||||t||||||||||2017-02-18 15:22:53.477112|2017-02-18 15:22:53.477112
NCT00513487|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2008-07-14|||July 2007||2007-07-01|July 2008|2008-07-01|November 2007|Actual|2007-11-01|||||Interventional|||Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity|Assessment of the Effects of Multiple Nasal Antigen Challenges With Dust Mite Allergen on Local and Systemic Allergic Inflammation and Bronchoreactivity in Subjects With Allergic Rhinitis Sensitive to House Dust Mite - a Feasibility and Site Evaluation Study|Completed||N/A|18|Anticipated|Novartis||1|||f||||f||||||||||2017-02-18 15:22:53.897754|2017-02-18 15:22:53.897754
NCT00513474|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2015-05-08|||January 2008||2008-01-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant|Rasburicase to Prevent Graft -Versus-Host Disease|Completed||N/A|25|Anticipated|Massachusetts General Hospital|||||f||||t||||||||||2017-02-18 15:22:53.997314|2017-02-18 15:22:53.997314
NCT00513461|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-02-15|||October 2007||2007-10-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|August 2012|Actual|2012-08-01||Interventional|||S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate in Preventing Liver Cancer in Patients With Chronic Hepatitis C Infection|A Phase II, Randomized, Controlled Trial of The Safety and Efficacy of S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) in Reducing Serum Alpha-Fetoprotein (AFP) in Patients With Hepatitis C and Moderately Elevated AFP|Unknown status|Active, not recruiting|Phase 2|110|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 15:22:54.106505|2017-02-18 15:22:54.106505
NCT00513448|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2007-08-07|||April 2005||2005-04-01|August 2007|2007-08-01|November 2005|Actual|2005-11-01|||||Interventional|||Promoting Physical Activity for Persons With Multiple Sclerosis|Comparing Individualized Rehabilitation to a Group Wellness Intervention for Persons With Multiple Sclerosis|Completed||N/A|50|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 15:22:54.219697|2017-02-18 15:22:54.219697
NCT00513435|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2014-04-02|2013-08-13||July 2007||2007-07-01|August 2013|2013-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Study of AZD0530 for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)|Completed||Phase 2|9|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:22:54.313995|2017-02-18 15:22:54.313995
NCT00513422|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2010-06-29|||October 2007||2007-10-01|June 2010|2010-06-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|LEGS||The Long-term Evaluation of Glucosamine Sulphate Study|The Effect of Glucosamine Sulphate on Structural Disease Progression in Knee Osteoarthritis and the Cost-effectiveness of Glucosamine Sulphate for Knee Arthritis.|Unknown status|Active, not recruiting|Phase 4|600|Anticipated|University of Sydney||4|||f||||f||||||||||2017-02-18 15:22:54.820248|2017-02-18 15:22:54.820248
NCT00033189|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-08|2010-11-15|||September 2001||2001-09-01|November 2010|2010-11-01|January 2005||2005-01-01|||||Interventional|||An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy||Completed||Phase 2|15||Cooperative International Neuromuscular Research Group|||||||||||||||||||2017-02-18 18:07:11.649247|2017-02-18 18:07:11.649247
NCT00513409|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2016-10-26|2009-03-11||August 2007||2007-08-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|February 2008|Actual|2008-02-01||Interventional|||Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule|Phase II, Observer-blind Follow-up Study to Assess reacto-and Immunogenicity of GSK Biologicals' Pneumococcal Conjugate Vaccine (GSK1024850A), When Given as Booster in Primed Children or as 2-dose Catch-up in Unprimed Children.|Completed||Phase 2|163|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:22:54.943524|2017-02-18 15:22:54.943524
NCT00513396|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2007-08-06|||January 2004||2004-01-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis|A Randomized Control Trial Of High-Dose Isoniazid Adjuvant Therapy For Multidrug Resistant Tuberculosis|Completed||Phase 2/Phase 3|134|Actual|GSVM Medical College||3|||f||||f||||||||||2017-02-18 15:22:55.562848|2017-02-18 15:22:55.562848
NCT00513383|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-03-06|||April 2006||2006-04-01|March 2012|2012-03-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck|Phase I Study Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck|Unknown status|Active, not recruiting|Phase 1|44|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 15:22:55.658202|2017-02-18 15:22:55.658202
NCT00513370|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2011-04-07|2009-08-21||September 2007||2007-09-01|April 2011|2011-04-01||||September 2008|Actual|2008-09-01||Interventional|PRIDE||A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis|A Canadian Open-Label Access Program to Evaluate the Safety and the Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis|Completed||Phase 3|203|Actual|Abbott||1|||f||||f||||||||||2017-02-18 15:22:55.791697|2017-02-18 15:22:55.791697
NCT00513357|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2012-12-07|2012-06-06||June 2006||2006-06-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients|A Randomized Clinical Trial of Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients|Completed||Phase 3|82|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:22:56.488717|2017-02-18 15:22:56.488717
NCT00513344|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-07-12|2013-03-28||June 2008||2008-06-01|July 2013|2013-07-01|April 2012|Actual|2012-04-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of Polyphenols From Milk and Dark Chocolate|Efficacy of Polyphenols From Milk and Dark Chocolate|Completed||N/A|6|Actual|Nestlé||3|||f||||f||||||||||2017-02-18 15:22:56.830492|2017-02-18 15:22:56.830492
NCT00513331|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-12-31|||July 2007||2007-07-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Barrett's Esophagus & Gastroesophageal Reflux Disease|The Valley Hospital Center for Barrett's Esophagus and Gastroesophageal Reflux Disease (GERD)|Completed||Phase 2/Phase 3|125|Actual|Valley Health System|||3||f||||f||||||Samples With DNA|"~     Tissue and blood for future analysis~   "|||2017-02-18 15:22:57.118101|2017-02-18 15:22:57.118101
NCT00513318|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2013-08-01|||August 2004||2004-08-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies|Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies|Terminated||N/A|15|Anticipated|University of California, San Francisco|||1|Insufficient enrollment to justify keeping open.|f||||t||||||||||2017-02-18 15:22:57.394652|2017-02-18 15:22:57.394652
NCT00513305|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2012-07-24|2010-07-29||October 2007||2007-10-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia|An Open-Label, Randomized Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide Compared With Low-Dose Cytarabine Alone for the Treatment of Elderly Patients With Acute Myeloid Leukemia|Terminated||Phase 3|67|Actual|Teva Pharmaceutical Industries|In September 2009, the sponsor decided to stop the study due to difficulty in enrollment. The study was stopped prior to the first planned interim analysis. Most of the analysis planned in the protocol was not performed.|2||Study has been stopped by sponsor decision|f||||||||||||||2017-02-18 15:22:57.501549|2017-02-18 15:22:57.501549
NCT00513292|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-11-14|2015-07-14||July 2007||2007-07-01|November 2016|2016-11-01||||June 2012|Actual|2012-06-01||Interventional||Total enrolled: 282, 2 withdrew consent before start of treatment|Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery|A Randomized Phase III Trial Comparing a Neoadjuvant Regimen of FEC-75 Followed by Paclitaxel Plus Trastuzumab With a Neoadjuvant Regimen of Paclitaxel Plus Trastuzumab Followed by FEC-75 Plus Trastuzumab in Patients With HER-2 Positive Operable Breast Cancer|Active, not recruiting||Phase 3|280|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:22:58.379519|2017-02-18 15:22:58.379519
NCT00513279|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2010-10-13||2010-10-13|June 2007||2007-06-01|October 2010|2010-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334|A First Time in Human, Blinded, Randomised, Placebo-Controlled, Two-cohort Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single Oral Escalating Doses of GSK618334 in Healthy Male Volunteers|Completed||Phase 1|20|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:22:59.901427|2017-02-18 15:22:59.901427
NCT00513266|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2009-08-06|||June 2007||2007-06-01|June 2009|2009-06-01||||||||Interventional|||Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery|Oxaliplatin-CPT-11-5-FU-Leucovarin + Bevacizumab and Cetuximab (OCFL-BC) as a Combination Regimen for Systemic Treatment of Advanced Colorectal Carcinoma With Potentially Resectable Liver and/or Lung Metastases. A Phase II Study|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:22:59.995803|2017-02-18 15:22:59.995803
NCT00513253|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2015-02-12|||April 2008||2008-04-01|February 2015|2015-02-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|||A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib|Relative Bioavailability of Four Alternative Oral Formulations Versus the Current Tablet Formulation of Lapatinib|Withdrawn||Phase 1|0|Actual|GlaxoSmithKline||||It was determined not to be needed based on the clinical development plan of Tykerb.|||||f||||||||||2017-02-18 15:23:00.115462|2017-02-18 15:23:00.115462
NCT00513240|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2016-11-09|2014-01-24||September 2006||2006-09-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|September 2012|Actual|2012-09-01||Interventional||These were the number of subjects followed for the intention-to-treat analysis because they received at least one dose of study drug/placebo.|Erythropoetin Neuroprotection for Neonatal Cardiac Surgery|Erythropoetin Neuroprotection for Neonatal Cardiac Surgery|Active, not recruiting||Phase 1/Phase 2|62|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 15:23:00.226979|2017-02-18 15:23:00.226979
NCT00513214|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2011-09-30|||July 2007||2007-07-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus|A Phase 1/2a, Double-blind, Placebo-controlled Study of the Safety and Pharmacokinetics of XOMA 052 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|68|Actual|XOMA (US) LLC||2|||f||||t||||||||||2017-02-18 15:23:00.726826|2017-02-18 15:23:00.726826
NCT00513201|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2007-08-07||||||August 2007|2007-08-01||||||||Interventional|||Lyspro Insulin vs Regular Insulin in Cirrhotic Patients||Completed||Phase 4|||Second University of Naples|||||f||||f||||||||||2017-02-18 15:23:00.843433|2017-02-18 15:23:00.843433
NCT00513188|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-12-14|||February 2007||2007-02-01|December 2016|2016-12-01||||June 2008|Actual|2008-06-01||Interventional|||Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma|A Pilot Study of the Efficacy of the Chop-Montak Regimen in Patients With Newly Diagnosed Peripheral T Cell Lymphoma|Withdrawn||N/A|0|Actual|University of Miami|||||f||||t||||||||||2017-02-18 15:23:00.947904|2017-02-18 15:23:00.947904
NCT00513175|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-11-07|||October 2001||2001-10-01|November 2012|2012-11-01|November 2007|Actual|2007-11-01|||||Observational|||Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia|Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia|Completed||N/A|44||University of California, San Francisco|||1||f||||t||||||||||2017-02-18 15:23:01.059224|2017-02-18 15:23:01.059224
NCT00513162|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-09-18|||July 2007||2007-07-01|September 2012|2012-09-01||||September 2012|Actual|2012-09-01||Interventional|||Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases|Valproate (Valproic Acid) and Etoposide for Patients With Progressive, Relapsed or Refractory Neuronal Tumors and Brain Metastases|Completed||Phase 1|8|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:23:01.143044|2017-02-18 15:23:01.143044
NCT00513149|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2011-01-20|||July 2006||2006-07-01|January 2011|2011-01-01|July 2011|Anticipated|2011-07-01|June 2011|Anticipated|2011-06-01||Interventional|||Platelet Function Assessment for Atherothrombotic Patients|Validation of the Clinical Applicability of Various Platelet Function Assessments in High-Risk Atherothrombotic Patients Undergoing Percutaneous Coronary Angioplasty: Phase 4 Study|Unknown status|Recruiting|Phase 4|150|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 15:23:01.279741|2017-02-18 15:23:01.279741
NCT00513136|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-04-18|||May 2007||2007-05-01|April 2012|2012-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Fatigue Intervention Trial for Breast Cancer Survivors|A Randomized Trial to Evaluate a Family-focused Mind Body Medicine Intervention to Reduce Fatigue Among Breast Cancer Survivors|Completed||Phase 3|40|Anticipated|Mercy Medical Center||2|||f||||f||||||||||2017-02-18 15:23:01.39574|2017-02-18 15:23:01.39574
NCT00513123|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-07-31|||September 2002||2002-09-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia|A Pilot Study: Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia|Completed||N/A|100|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:23:01.507187|2017-02-18 15:23:01.507187
NCT00513110|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2009-09-30|||August 2007||2007-08-01|August 2007|2007-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Possible Therapeutic Role for Adenosine During Inflammation|A Possible Therapeutic Role for Adenosine During Inflammation|Completed||Phase 1|33|Anticipated|Radboud University||3|||f||||f||||||||||2017-02-18 15:23:01.619949|2017-02-18 15:23:01.619949
NCT00513097|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2017-02-06|||July 2006|Actual|2006-07-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Curbing Tobacco Use in Suburban and Rural Schools|Curbing Tobacco Use in Suburban and Rural Schools|Active, not recruiting||Phase 1|2384|Anticipated|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:23:01.733996|2017-02-18 15:23:01.733996
NCT00513084|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2007-08-07|||July 2004||2004-07-01|July 2007|2007-07-01|July 2009|Anticipated|2009-07-01|||||Interventional|PESO||Promotion of Exercise and Health in Obesity|Moderators and Mediators of Physical Activity, Body Weight, and Body Composition Change During Obesity Treatment in Women|Unknown status|Active, not recruiting|N/A|259|Actual|Technical University of Lisbon||2|||f||||f||||||||||2017-02-18 15:23:01.857974|2017-02-18 15:23:01.857974
NCT00513071|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2014-10-01|2014-07-30||August 2007||2007-08-01|December 2012|2012-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Trial of AZD0530 in Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 2|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:23:01.970673|2017-02-18 15:23:01.970673
NCT00513058|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2014-01-13|||June 2007||2007-06-01|January 2014|2014-01-01|April 2012|Actual|2012-04-01|May 2010|Actual|2010-05-01||Interventional|||Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer|Phase I Study Evaluating the Combination of Lapatinib + Vinorelbine in Patients With Locally Advanced or Metastatic Breast Cancer Overexpressing HER2|Completed||Phase 1|33|Actual|UNICANCER||1|||f||||t||||||||||2017-02-18 15:23:02.386636|2017-02-18 15:23:02.386636
NCT00513045|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2008-11-18|||April 2007||2007-04-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|Nightmares||A Self-Help Method for Nightmares|A Self-Help Method for Nightmares|Completed||N/A|399|Actual|Utrecht University||4|||f||||t||||||||||2017-02-18 15:23:02.704489|2017-02-18 15:23:02.704489
NCT00513032|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2007-08-07|||January 2005||2005-01-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Observational|||Interaction Between Anaesthetics and Methylene Blue|Effects of Methylene Blue on Propofol Requirement During Anaesthesia Induction and Surgery|Completed||N/A|22|Actual|University Hospital, Geneva|||2||f||||f||||||||||2017-02-18 15:23:02.808268|2017-02-18 15:23:02.808268
NCT00512993|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2015-03-04|||December 2004||2004-12-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|NATAN||Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy|A Randomized, Multicenter, Open Phase III Study Comparing the Postoperative Use of Zoledronic Acid Versus no Treatment in Patients With Histological Tumor Residuals After Preoperative Anthracycline and Taxane Containing Chemotherapy for Primary Breast Cancer|Completed||Phase 3|654|Anticipated|German Breast Group||2|||f||||t||||||||||2017-02-18 15:23:03.28403|2017-02-18 15:23:03.28403
NCT00512980|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2015-12-01|||August 2008||2008-08-01|December 2015|2015-12-01||||November 2013|Actual|2013-11-01||Interventional|||PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma|A Randomized Phase II Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Patients With Intermediate Stage Hodgkin's Lymphoma|Terminated||Phase 2|||University of Cologne||2||lower recruitment rates as expected|f||||f||||||||||2017-02-18 15:23:03.684624|2017-02-18 15:23:03.684624
NCT00512967|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2008-02-25|||September 2005||2005-09-01|February 2008|2008-02-01|June 2006|Actual|2006-06-01|||||Observational|||The Occurence of Inflammation and Oxidative Stress in Lung Diseases|The Inflammatory and Antioxidant Status in Pulmonary Sarcoidosis, Idiopathic Pulmonary Fibrosis and COPD: a Potential Role for Antioxidants|Completed||N/A|76|Actual|Maastricht University Medical Center|||4||f||||f||||||Samples With DNA|"~     blood samples were collected~   "|||2017-02-18 15:23:03.794685|2017-02-18 15:23:03.794685
NCT00512954|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2011-01-18|||April 2007||2007-04-01|July 2009|2009-07-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Observational|||Causes, Characteristics and Mechanisms of Infective Exacerbations in Subjects With Asthma and Chronic Obstructive Pulmonary Disease (COPD)|A Prospective One Year Study of the Causes, Characteristics, Mechanisms and Kinetics of Exacerbations in Subjects With Asthma|Completed||N/A|100|Anticipated|McMaster University|||1||f||||f||||||||||2017-02-18 15:23:03.90638|2017-02-18 15:23:03.90638
NCT00512941|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2008-09-04|||June 2007||2007-06-01|September 2008|2008-09-01|August 2007|Actual|2007-08-01|||||Observational|||Laboratory Profile of Hepatitis B and C in Users of a Reference Service|Laboratory Profile of Hepatitis B and C in Users of a Reference Service|Completed||N/A|531|Actual|UPECLIN HC FM Botucatu Unesp|||7||f||||t||||||||||2017-02-18 15:23:04.017779|2017-02-18 15:23:04.017779
NCT00512928|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2008-03-25|||September 2007||2007-09-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety Study of Vitamin K2 During Anticoagulation in Human Volunteers|Safety Study of Vitamin K2 During Anticoagulation in Human Volunteers|Completed||N/A|20|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 15:23:04.129496|2017-02-18 15:23:04.129496
NCT00512915|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2009-03-04|||December 2006||2006-12-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional|Avoid FFS||Avoid FFS - Use of the Atrial Pacemaker Lead 1699 With Very Short Tip Ring Spacing to Avoid Far Field Sensing|Atriale Vorhofsonde 1699 Mit Sehr Kurzem Bipolabstand Zur Vermeidung Von Far Field Sensing|Completed||Phase 4|204|Actual|St. Jude Medical||2|||f||||f||||||||||2017-02-18 15:23:04.241745|2017-02-18 15:23:04.241745
NCT00512902|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2014-10-24|2012-04-20||August 2007||2007-08-01|October 2014|2014-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis|Pilot Study to Examine The Use of Imatinib (Gleevec) For The Treatment of Active Alveolitis in Systemic Sclerosis|Completed||Phase 1/Phase 2|20|Actual|University of California, Los Angeles|Open label, small.|1|||f||||f||||||||||2017-02-18 15:23:04.354591|2017-02-18 15:23:04.354591
NCT00512889|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2013-02-28|||August 2007||2007-08-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|February 2011|Actual|2011-02-01||Interventional|||Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma|A Pilot Study of the Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma|Completed||Phase 1|9|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||||2017-02-18 15:23:04.646505|2017-02-18 15:23:04.646505
NCT00512876|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-07-03|2013-05-15||August 2007||2007-08-01|July 2013|2013-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization|Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization|Completed||N/A|24|Actual|Walter Reed Army Medical Center||1|||f||||||||||||||2017-02-18 15:23:04.976736|2017-02-18 15:23:04.976736
NCT00512863|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2007-11-05|||August 2007||2007-08-01|November 2007|2007-11-01||||||||Interventional|||A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma|A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel, Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma|Withdrawn||Phase 2|272|Anticipated|Abbott||4|||f||||f||||||||||2017-02-18 15:23:05.206184|2017-02-18 15:23:05.206184
NCT00512850|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2015-07-21|||May 1996||1996-05-01|July 2015|2015-07-01|January 2020|Anticipated|2020-01-01|March 2004|Actual|2004-03-01||Interventional|||Folic Acid in Preventing Colorectal Polyps in Patients With Previous Colorectal Polyps|The Nurses' Health Study (NHS) and Health Professionals Follow-Up Study (HPFS) Folic Acid Prevention Trial|Active, not recruiting||N/A|672|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 15:23:05.28803|2017-02-18 15:23:05.28803
NCT00512837|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2016-01-20|||November 2007||2007-11-01|June 2008|2008-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Mobile Phone Based Structured Intervention|A Mobile Phone Based Structured Intervention to Achieve Asthma Control in Patients With Uncontrolled Persistent Asthma: Pragmatic Randomised Controlled Trial|Completed||N/A|312|Anticipated|University of Aberdeen||1|||f||||t||||||||||2017-02-18 15:23:05.391629|2017-02-18 15:23:05.391629
NCT00512824|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2011-01-07|||August 2007||2007-08-01|January 2011|2011-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Calcium, Probiotics and Acute Diarrheal Disease Among Indonesian Children|Calcium, Probiotics and Acute Diarrheal Disease Among Indonesian Children Aged 1-6 Years in Low Socio-economic Urban Area of East Jakarta|Completed||N/A|494|Actual|Wageningen University||4|||f||||t||||||||||2017-02-18 15:23:05.495494|2017-02-18 15:23:05.495494
NCT00512811|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2007-08-07||||||August 2007|2007-08-01||||||||Interventional|||Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients|Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study|Completed||Phase 3|||Baqiyatallah Medical Sciences University||2|||f||||t||||||||||2017-02-18 15:23:05.601368|2017-02-18 15:23:05.601368
NCT00512603|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-05|2013-01-15|||January 2007||2007-01-01|May 2007|2007-05-01|July 2008|Actual|2008-07-01|January 2008|Actual|2008-01-01||Observational|||Association Between Levels of D-Dimer, Fibrinogen and PAI-1 in Elderly Patients With Infection and Occurrence of Cardio- and Cerebro-vascular Disease After Discharge||Completed||N/A|52|Actual|Wolfson Medical Center|||1||f||||f||||||||||2017-02-18 15:23:07.966682|2017-02-18 15:23:07.966682
NCT00512798|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2012-09-19|2012-06-27||June 2003||2003-06-01|September 2012|2012-09-01|March 2008|Actual|2008-03-01|July 2006|Actual|2006-07-01||Interventional|||Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma|(Inhibition of NF-kB Signaling in Melanoma Therapy) A Phase I/II Clinical Trial of PS-341, a Proteasome Inhibitor, in Combination With an Extended Continuous Oral Schedule of Temozolomide in Patients With Advanced Refractory Solid Tumors With the Phase II Component Only in Patients With Melanoma|Terminated||Phase 1/Phase 2|47|Actual|Vanderbilt-Ingram Cancer Center||2||This study was terminated due to lack of efficacy|f||||t||||||||||2017-02-18 15:23:05.703267|2017-02-18 15:23:05.703267
NCT00512785|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-06-12|||August 2007||2007-08-01|June 2012|2012-06-01||||May 2009|Actual|2009-05-01||Interventional|||Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder|An Open-label Study to Evaluate the Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder|Completed||Phase 3|435|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||||||||||||2017-02-18 15:23:06.495528|2017-02-18 15:23:06.495528
NCT00512772|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2010-12-17|||October 2007||2007-10-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Improved Use of Antibiotic Guidelines in Hospital Environment|Improved Use of Antibiotic Guidelines in in Hospital Environment: Research on an Implementation Model and the Role of the Hospital Pharmacist.|Completed||N/A|823|Actual|Katholieke Universiteit Leuven|||1||f||||f||||||||||2017-02-18 15:23:06.597386|2017-02-18 15:23:06.597386
NCT00512759|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-11-29|||September 2007||2007-09-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|December 2017|Anticipated|2017-12-01||Interventional|GALACTIC||Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study|Goal-Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study (GALACTIC)|Recruiting||N/A|770|Anticipated|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 15:23:06.679512|2017-02-18 15:23:06.679512
NCT00512746|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2011-12-20|||August 2007||2007-08-01|December 2011|2011-12-01||||March 2011|Actual|2011-03-01||Interventional|||Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease|A Randomised Controlled Trial of Surveillance for the Early Detection of Lung Cancer in an at Risk Group [Lung-SEARCH Trial]|Completed||N/A|1569|Actual|University College, London||2|||f||||t||||||||||2017-02-18 15:23:06.832151|2017-02-18 15:23:06.832151
NCT00512733|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2014-08-08|||March 2006||2006-03-01|August 2014|2014-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Validation of Dietary Calcium Questionnaires Using Diet Records|Validation of Dietary Calcium Questionnaires Using Diet Records|Completed||N/A|160|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 15:23:06.944708|2017-02-18 15:23:06.944708
NCT00512720|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2013-02-20|||August 2007||2007-08-01|February 2013|2013-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|FIX-IT Retro||Clinical Outcomes of Three Different Percutaneous Revascularization Strategies for the Treatment of Lifestyle Limiting Claudication: A Retrospective Analysis|Clinical Outcomes of Three Different Percutaneous Revascularization Strategies for the Treatment of Lifestyle Limiting Claudication: A Retrospective Analysis|Completed||N/A|355|Actual|Spectrum Health Hospitals|||1||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 15:23:07.038325|2017-02-18 15:23:07.038325
NCT00512707|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2012-03-06|||November 2006||2006-11-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|TED||Effect of Testosterone in Men With Erectile Dysfunction|Androgen Modulation of Response to Selective Phosphodiesterase Inhibitors in Erectile Dysfunction|Completed||Phase 4|152|Actual|Boston University||2|||f||||t||||||||||2017-02-18 15:23:07.126595|2017-02-18 15:23:07.126595
NCT00512694|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-11-21|||July 2007||2007-07-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Observational|||Duke Lupus Registry|Duke Lupus Registry|Recruiting||N/A|1000|Anticipated|Duke University|||1||f||||f||||||Samples Without DNA|"~     Blood samples will be collected for future research.~   "|||2017-02-18 15:23:07.244158|2017-02-18 15:23:07.244158
NCT00512681|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2009-09-17|||July 2007||2007-07-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|TIROX2||A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer|A Phase II Study of S-1 Combined With Irinotecan and Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma|Completed||Phase 2|44|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:23:07.352315|2017-02-18 15:23:07.352315
NCT00512668|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-01-04|||September 2007||2007-09-01|January 2013|2013-01-01||||January 2008|Actual|2008-01-01||Interventional|||Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer|Phase Ib Study of Limited Androgen Ablation and Two Dose Levels of Temsirolimus (NSC#683864) in Patients With Prostate Cancer Who Have a Biochemical Relapse After Prostatectomy and/or Radiotherapy|Terminated||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:23:07.445471|2017-02-18 15:23:07.445471
NCT00512655|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2010-07-06|||January 2008||2008-01-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|CP||Trial to Reduce Falls Incidence Rate in Frail Elderly|Randomized Controlled Trial to Reduce Falls Incidence Rate in Frail Elderly|Terminated||N/A|320|Anticipated|Radboud University||2||Extremely difficult recruitment. Preliminary analysis showed no effect of the intervention.|f||||f||||||||||2017-02-18 15:23:07.564635|2017-02-18 15:23:07.564635
NCT00512642|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-07|2017-01-24|||July 29, 1999||1999-07-29|February 19, 2016|2016-02-19||||||||Observational|||Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients|Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients|Completed||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:23:07.667014|2017-02-18 15:23:07.667014
NCT00512629|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2011-12-14|||July 2007||2007-07-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Cholestasis Prevention: Efficacy of IV Fish Oil|Cholestasis Prevention: Efficacy of IV Fish Oil|Completed||Phase 1|19|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 15:23:07.756705|2017-02-18 15:23:07.756705
NCT00512616|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-04|2017-01-24|||August 1, 2007||2007-08-01|September 15, 2009|2009-09-15|September 15, 2009|Anticipated|2009-09-15|September 15, 2009|Actual|2009-09-15||Interventional|||A Glutamate Transporter GLT1, in the Treatment of Bipolar Disorder|An Investigation of the Efficacy of the Glutamate Transporter GLT 1 in the Treatment of Bipolar Depression|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:23:07.86551|2017-02-18 15:23:07.86551
NCT00512590|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2007-08-03|||April 2005||2005-04-01|August 2007|2007-08-01|June 2006|Actual|2006-06-01|||||Interventional|||Pilot Study: Relaxation and Guided Imagery in Hispanic Persons Diagnosed With Fibromyalgia|Effects of Guided Imagery on Pain, Distress, Functional Status and Self-Efficacy in Hispanics Diagnosed With Fibromyalgia|Completed||N/A|14|Actual|Florida International University||1|||f||||f||||||||||2017-02-18 15:23:08.164718|2017-02-18 15:23:08.164718
NCT00512577|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2007-08-13|||July 2007||2007-07-01|August 2007|2007-08-01||||||||Interventional|TAPS||Transfusion Alternatives Pre-Operatively in Sickle Cell Disease (TAPS)|Transfusion Alternatives Pre-Operatively in Sickle Cell Disease|Unknown status|Recruiting|Phase 3|400|Anticipated|NHS Blood and Transplant||2|||f||||t||||||||||2017-02-18 15:23:08.266472|2017-02-18 15:23:08.266472
NCT00512564|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-05|2011-08-25|||September 2008||2008-09-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia|Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia - An Observational and Laboratory Study|Completed||N/A|50|Anticipated|HaEmek Medical Center, Israel|||1||f||||||||||||||2017-02-18 15:23:08.366207|2017-02-18 15:23:08.366207
NCT00512551|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2016-10-03|||June 2000||2000-06-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Observational|||DNA Array Analysis of Patients With Cervical Cancer|A Pilot Study of Early Changes in DNA Array Expression Following Chemo-Radiation Treatment of Cervical Cancer|Active, not recruiting||N/A|18|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Two biopsies of the cervix will be performed to obtain tumor cells.~   "|||2017-02-18 15:23:08.455314|2017-02-18 15:23:08.455314
NCT00512538|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2007-08-03|||October 2000||2000-10-01|August 2007|2007-08-01|September 2002|Actual|2002-09-01|||||Interventional|||Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers|A Randomized, Open-Label, Multi-Center Study to Compare the Safety and Efficacy of Apligraf Versus Standard Therapy (i.e., Saline Moistened Dressing Regimen) in the Treatment of Diabetic (Primarily Neuropathic) Foot Ulcers|Terminated||Phase 3|82|Actual|Organogenesis||2||Interruption of business relations between Study Sponsor and Device Manufacturer|f||||f||||||||||2017-02-18 15:23:08.553701|2017-02-18 15:23:08.553701
NCT00512525|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2009-09-08|||January 2003||2003-01-01|September 2009|2009-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Ghrelin Decreases Insulin Sensitivity|Intravenous Ghrelin Infusion Decreases Insulin Sensitivity in Healthy Young Men|Completed||Phase 1|8|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 15:23:08.638615|2017-02-18 15:23:08.638615
NCT00512512|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2010-06-30|||June 2007||2007-06-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|January 2008|Actual|2008-01-01||Observational|||Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass|Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass|Completed||N/A|4|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 15:23:08.73375|2017-02-18 15:23:08.73375
NCT00512499|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2016-07-11|||February 2007||2007-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2013|Actual|2013-07-01||Interventional|OPTIMUS||Strategies to Treat Osteoporosis Following a Fragility Fracture|Osteoporosis and Peripheral Fractures: Treatment and Investigation Multidisciplinary at the chUS|Completed||N/A|1410|Actual|Université de Sherbrooke||3|||f||||t||||||||Undecided||2017-02-18 15:23:08.824987|2017-02-18 15:23:08.824987
NCT00512486|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2008-11-26|||November 2006||2006-11-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||A Sequential Dose-Escalation Study in Subjects With Mild Asthma|A Multi-Center, Open-Label, Single Administration, Sequential Dose Escalation of BIW-8405/MEDI-563 in Subjects With Mild Asthma|Completed||Phase 1|42|Anticipated|MedImmune LLC||1|||f||||t||||||||||2017-02-18 15:23:08.940809|2017-02-18 15:23:08.940809
NCT00512473|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2007-08-06|||September 2005||2005-09-01|August 2007|2007-08-01|April 2006|Actual|2006-04-01|||||Interventional|||Growth Hormone Signaling in Vivo in Humans|Growth Hormone (GH) Signaling in Vivo in Human Muscle and Adipose Tissue: Impact of Insulin, Substrate Background and gh Receptor Blockade|Completed||N/A|8|Actual|University of Aarhus||3|||f||||f||||||||||2017-02-18 15:23:09.047546|2017-02-18 15:23:09.047546
NCT00512460|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2016-05-12|||September 2006||2006-09-01|May 2016|2016-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||RTA 744 Injection in Patients With Leptomeningeal Disease|A Phase I Safety and Pharmacokinetic Study of Intravenous RTA 744 Injection in Patients With Recurrent, Progressive or Refractory Neoplastic Meningitis|Terminated||Phase 1|7|Actual|M.D. Anderson Cancer Center||1||Study was closed due to loss of industry sponsorship|f||||f||||||||||2017-02-18 15:23:09.157926|2017-02-18 15:23:09.157926
NCT00512447|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2010-09-13|||July 2007||2007-07-01|September 2010|2010-09-01||||||||Observational|||Normal Values of Brain Oxygenation|Normal Values of Cerebral Oxygenation|Completed||N/A|171|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 15:23:09.430746|2017-02-18 15:23:09.430746
NCT00512434|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-05-25|||September 2007||2007-09-01|May 2016|2016-05-01|September 2013|Actual|2013-09-01|September 2012|Actual|2012-09-01||Interventional|IMOCA||Percutaneous Autologous Bone-marrow Grafting for Open Tibial Shaft Fracture|Injection of Concentrated Autologous Bone-marrow (IMOCA) and Bone Union of Open Tibial Shaft Fracture: Randomized Study to Assess Efficiency of IMOCA in Addition to Standard of Care.|Completed||N/A|85|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-02-18 15:23:09.506551|2017-02-18 15:23:09.506551
NCT00512421|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-05|2011-09-15||||||August 2011|2011-08-01||||||||Observational|||Navigated EM Total Knee Replacement: Accuracy Study|Phase 2 Study of Computer Assisted Surgery vs Conservative Surgery- Accuracy Study.|Terminated||N/A|200|Anticipated|Hadassah Medical Organization|||3||f||||||||||||||2017-02-18 15:23:09.632864|2017-02-18 15:23:09.632864
NCT00512408|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2008-10-16|||July 2006||2006-07-01|August 2007|2007-08-01|March 2007|Actual|2007-03-01|||||Observational|||Testosterone Improves Exercise Oxygen Uptake, Insulin Resistance and Muscle Strength in Elderly Patients With Chronic Heart Failure|Long-Acting Testosterone Improves Exercise Oxygen Uptake, Insulin Resistance and Muscle Strength in Elderly Patients With Chronic Heart Failure|Terminated||N/A|||IRCCS San Raffaele|||2||f||||||||||||||2017-02-18 15:23:09.715568|2017-02-18 15:23:09.715568
NCT00512395|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2015-03-09|||November 2004||2004-11-01|March 2015|2015-03-01|January 2007|Actual|2007-01-01|||||Interventional|||Influence of Epidural Analgesia in Elective Laparoscopic Colorectal Resections|Influence of Epidural Analgesia in Elective Laparoscopic Colorectal Resections|Completed||Phase 4|75|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 15:23:09.805276|2017-02-18 15:23:09.805276
NCT00033176|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-08|2006-08-17|||February 2002||2002-02-01|July 2006|2006-07-01|August 2004||2004-08-01|||||Interventional|||Immune Restoration by Lipoic Acid in AIDS|Immune Restoration by Lipoic Acid in AIDS|Completed||Phase 2|33||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:11.732007|2017-02-18 18:07:11.732007
NCT00512382|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2011-09-04|||March 2007||2007-03-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Observational|||The Nature of Reflux-respiratory Symptoms Association in Difficult to Treat Wheezing\Coughing Babies|The Nature of Reflux-respiratory Symptoms Association in Difficult to Treat Asthmatic/Wheezing Babies Using Impedance and Wheezy Monitoring|Completed||N/A|15|Actual|Wolfson Medical Center|||2||f||||t||||||||||2017-02-18 15:23:09.896333|2017-02-18 15:23:09.896333
NCT00512369|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2011-07-14|||March 2006||2006-03-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|||||Observational|||Effects of PA-1 Transcriptional Regulation on Monocyte Function|Angiotensin, the Vascular Endothelium, and Fibrinolysis - The Effects of PAI-1 Transcriptional Regulation on Human Monocyte Function|Terminated||N/A|125|Anticipated|Vanderbilt University|||1|Investigator left institution|f||||f||||||||||2017-02-18 15:23:09.994545|2017-02-18 15:23:09.994545
NCT00512356|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2007-08-13|||December 2000||2000-12-01|August 2007|2007-08-01|April 2003|Actual|2003-04-01|||||Interventional|||Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions|Study to Evaluate the Efficacy and Safety of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions|Completed||Phase 2|46|Actual|Baxter Healthcare Corporation||2|||f||||t||||||||||2017-02-18 15:23:10.080498|2017-02-18 15:23:10.080498
NCT00512343|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2016-07-11|||June 2002||2002-06-01|July 2016|2016-07-01|September 2029|Anticipated|2029-09-01|December 2019|Anticipated|2019-12-01||Observational|||Synovial Fluid Bank From Arthritic Patients|Establishment of a Bank of Synovial Fluids and Paired Sera From Arthritic Patients for the Evaluation of New Methods Facilitating the Diagnosis and the Monitoring of Progression and Therapy of Arthritis.|Recruiting||N/A|500|Anticipated|Université de Sherbrooke|||1||f||||t||||||Samples Without DNA|"~     Synovial fluids from joints with effusion Sereum samples drawn on the same day~   "|No||2017-02-18 15:23:10.178043|2017-02-18 15:23:10.178043
NCT00512330|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2008-08-05|||August 2007||2007-08-01|August 2008|2008-08-01|August 2008|Anticipated|2008-08-01|||||Observational|||Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)|Evaluation of Urine Lipoarabinomannan ELISA In Diagnostics of Childhood Tuberculosis|Unknown status|Recruiting|N/A|250|Anticipated|University Hospital, Bonn|||||f||||f||||||||||2017-02-18 15:23:10.282657|2017-02-18 15:23:10.282657
NCT00512317|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2013-10-14||2012-04-18|June 2007||2007-06-01|October 2013|2013-10-01|September 2013|Actual|2013-09-01|December 2009|Actual|2009-12-01||Interventional|||Open-label Extension to Protocol 1042-0600|An Open-label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Patients With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.|Completed||Phase 2|125|Actual|Marinus Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:23:10.365858|2017-02-18 15:23:10.365858
NCT00512304|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-03-04|||August 2007||2007-08-01|March 2013|2013-03-01||||December 2012|Actual|2012-12-01||Interventional|TRACE||Adjuvant Treatment of Gastric Cancer With Chemotherapy and Chemoradiotherapy (TRACE)|Feasibility Study of 2 Parallel Phases II Pre or Postgastrectomy in Patients With Gastric Cancer (FOLFIRI-radiotherapy Plus 5 Fluorouracil-surgery or Surgery-FOLFIRI-radiotherapy Plus 5 Fluorouracil)|Completed||Phase 2|63|Actual|University Hospital, Rouen||2|||f||||f||||||||||2017-02-18 15:23:10.500747|2017-02-18 15:23:10.500747
NCT00512291|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2011-09-26|||June 2005||2005-06-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|August 2007|Actual|2007-08-01||Interventional|||Subcutaneous Olanzapine for Hyperactive or Mixed Delirium|Study of Subcutaneous Olanzapine for Hyperactive or Mixed Delirium|Completed||N/A|25|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:23:10.611745|2017-02-18 15:23:10.611745
NCT00512278|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2012-11-14|||July 2007||2007-07-01|November 2012|2012-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PARTNER||Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C|Infliximab (Remicade®) as an Adjunct to Pegylated- Interferon α-2b and Ribavirin in the Treatment of Hepatitis C Virus Infection|Completed||Phase 2|149|Actual|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 15:23:10.731002|2017-02-18 15:23:10.731002
NCT00512265|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-08-27|||January 2006||2006-01-01|August 2013|2013-08-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|||Influence of N-Acetylcysteine on Morbidity, Oxygenation and Cytokine Levels in Partial or Total Esophagectomy for Cancer|Influence of N-Acetylcysteine on Morbidity, Oxygenation and Cytokine Levels in Partial or Total Esophagectomy for Cancer. A Multicenter, Prospective, Randomised Double Blind, Placebo-controlled Study|Completed||Phase 4|29|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 15:23:10.847186|2017-02-18 15:23:10.847186
NCT00512252|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-10-27|2014-07-28||July 2007||2007-07-01|October 2016|2016-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|AMD3100+MEC|The 6 participants that were enrolled in Dose Level 3 in the Phase I portion of the study were carried over to the Phase II analysis. 40 additional patients were enrolled in the Phase II portion of the study using the Dose Level 3 dose.|AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia|A Phase I/II Study of AMD3100 With Mitoxantrone, Etoposide and Cytarabine (AMD3100+MEC) in Relapsed or Refractory AML|Completed||Phase 1/Phase 2|52|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 15:23:10.963625|2017-02-18 15:23:10.963625
NCT00512239|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2016-05-15|||November 1999||1999-11-01|May 2016|2016-05-01|September 2025|Anticipated|2025-09-01|June 2020|Anticipated|2020-06-01|10 Years|Observational [Patient Registry]|EUPA||Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset|Early Prediction of Patient-related and Radiological Outcomes in Patients With Recent-onset Inflammatory Polyarthritis (EPA) Using Established and Novel Independent Predictors|Recruiting||N/A|1000|Anticipated|Université de Sherbrooke|||1||f||||t||||||Samples With DNA|"~     Serum, genomic DNA and RNA from peripheral blood, PBMC used for in vitro osteoclastogenesis~   "|No|Anonymized data to be shared following individual agreements|2017-02-18 15:23:12.459564|2017-02-18 15:23:12.459564
NCT00512226|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-05|2011-08-25|||September 2007||2007-09-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia|Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia Using T2* Cardiac MRI.|Completed||N/A|50|Anticipated|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-02-18 15:23:12.57763|2017-02-18 15:23:12.57763
NCT00512213|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2012-04-21|||September 2007||2007-09-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery|Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery: A Single-center Double-blinded Controlled Randomized Superiority Trial|Completed||N/A|154|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-02-18 15:23:12.663224|2017-02-18 15:23:12.663224
NCT00512200|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2015-10-14|||July 2007||2007-07-01|October 2015|2015-10-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Postoperative Cognitive Dysfunction in Geriatric Patients|Postoperative Cognitive Dysfunction in Geriatric Patients: the Role of Intraoperative Cerebral Perfusion and Perioperative Anticholinergic Medication|Completed||N/A|280|Actual|University Hospital, Basel, Switzerland|||3||f||||f||||||||||2017-02-18 15:23:12.768276|2017-02-18 15:23:12.768276
NCT00512187|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2007-08-06|||November 2005||2005-11-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial|Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial|Completed||Phase 4|||Universita di Verona||1|||f||||f||||||||||2017-02-18 15:23:12.85703|2017-02-18 15:23:12.85703
NCT00512174|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2007-08-06|||August 2007||2007-08-01|August 2007|2007-08-01||||||||Interventional|||Prospective Trial to Evaluate Efficacy and Accuracy of a Portable Ultrasound Scanner for Non-Invasive Bladder Volume Measurement (BladderScan BVI3000) in Patients After Radical Cystectomy and Bladder Reconstruction|Prospective Trial to Evaluate Efficacy and Accuracy of a Portable Ultrasound Scanner for Non-Invasive Bladder Volume Measurement (BladderScan BVI3000) in Patients After Radical Cystectomy and Bladder Reconstruction|Unknown status|Recruiting|N/A|||Sheba Medical Center|||||f||||f||||||||||2017-02-18 15:23:12.955101|2017-02-18 15:23:12.955101
NCT00512161|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2017-01-17|||June 2007||2007-06-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Placement of Permanent Pacemaker Study|A Retrospective Study to Determine the Frequency of Indications That Lead to the Placement of Permanent Pacemakers After Cardiac Surgery|Completed||N/A|500|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-02-18 15:23:13.038345|2017-02-18 15:23:13.038345
NCT00512148|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2015-05-11|2010-12-20||July 2007||2007-07-01|May 2015|2015-05-01|April 2011|Actual|2011-04-01|January 2010|Actual|2010-01-01||Interventional|||Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury|An Open Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury|Terminated||Phase 2|7|Actual|Tengion||1||24 months follow up completed without substantial change to the profile.|f||||t||||||||||2017-02-18 15:23:13.12322|2017-02-18 15:23:13.12322
NCT00512135|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2013-02-21|||June 2007||2007-06-01|February 2013|2013-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Efficacy of IncobotulinumtoxinA (Xeomin) in the Treatment of Glabellar Frown Lines|A Prospective, Open-label, Multicenter, Repeat-dose Trial to Investigate the Safety and Efficacy of IncobotulinumtoxinA (Xeomin), Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines|Completed||Phase 3|796|Actual|Merz Pharmaceuticals GmbH||1|||f||||f||||||||||2017-02-18 15:23:13.57348|2017-02-18 15:23:13.57348
NCT00512122|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2015-07-29|||August 2007||2007-08-01|July 2015|2015-07-01|December 2021|Anticipated|2021-12-01|February 2011|Actual|2011-02-01||Interventional|EPaNIC||Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients|Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients|Active, not recruiting||Phase 4|4640|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-02-18 15:23:13.719703|2017-02-18 15:23:13.719703
NCT00512109|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2016-03-15|||August 2007||2007-08-01|March 2016|2016-03-01|July 2016|Anticipated|2016-07-01|December 2014|Actual|2014-12-01||Observational|VISION||Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)|Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study|Active, not recruiting||N/A|40060|Actual|McMaster University|||1||f||||f||||||||||2017-02-18 15:23:13.858566|2017-02-18 15:23:13.858566
NCT00512096|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2012-07-27|2010-11-03||August 1999||1999-08-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis|A Phase II Study of (Neoadjuvant Chemotherapy Trial Prior to Extirpative Surgery) for Clinical Stage TanyN2-3M0 Squamous Cell Carcinoma of the Penis|Completed||Phase 2|30|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:23:13.963427|2017-02-18 15:23:13.963427
NCT00512083|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2009-09-24|||July 2007||2007-07-01|September 2009|2009-09-01||||April 2009|Actual|2009-04-01||Interventional|||Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia|An Open Label Randomized Controlled Dose Escalating Phase II Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia|Completed||Phase 2|70|Anticipated|Antisoma Research||3|||||||||||||||||2017-02-18 15:23:14.201846|2017-02-18 15:23:14.201846
NCT00512070|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2015-11-19|||July 2007||2007-07-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine|Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality|Active, not recruiting||N/A|20|Anticipated|Seattle Institute for Biomedical and Clinical Research||2|||f||||t||||||||||2017-02-18 15:23:14.296108|2017-02-18 15:23:14.296108
NCT00512057|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2010-06-25|||June 2008||2008-06-01|February 2009|2009-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|APEX||APEX Study: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients With Cardiac Syndrome X|APEX Study: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients With Cardiac Syndrome X|Completed||Phase 4|40|Anticipated|University of Dundee||2|||f||||t||||||||||2017-02-18 15:23:14.413216|2017-02-18 15:23:14.413216
NCT00512044|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2015-06-23|||October 2007||2007-10-01|June 2015|2015-06-01|May 2008|Anticipated|2008-05-01|November 2007|Actual|2007-11-01||Interventional|||Local Versus General Anaesthesia in Stapled Hemorrhoidectomy|Local vs General Anaesthesia in Stapled Hemorrhoidectomy: A Multicentric Controlled Randomized Trial|Withdrawn||Phase 4|0|Actual|University of Lausanne Hospitals||2||slow recruitment, internal problems with the study protocol|f||||f||||||||||2017-02-18 15:23:14.518997|2017-02-18 15:23:14.518997
NCT00512031|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2011-07-15|||January 2007||2007-01-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Characterizing PAI-1 Modulation on Monocyte Adhesion|Characterizing the Effects of PAI-1 Modulation on Human Monocyte Function - The Effect of PAI-1 Post-transcriptional Regulation on Human Monocyte Adhesion|Terminated||N/A|50|Anticipated|Vanderbilt University|||1|Investigator left institution|f||||f||||||||||2017-02-18 15:23:14.630277|2017-02-18 15:23:14.630277
NCT00512018|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2013-04-17|||January 2005||2005-01-01|April 2013|2013-04-01|July 2007|Actual|2007-07-01|December 2006|Actual|2006-12-01||Interventional|||Neuromuscular Electrical Stimulation and Isokinetic Training|Neuromuscular Electrical Stimulation and Isokinetic Training: Effects on Strength and Neuromuscular Properties|Completed||N/A|20|Actual|Universidade Federal de Sao Carlos||2|||f||||f||||||||||2017-02-18 15:23:14.716986|2017-02-18 15:23:14.716986
NCT00512005|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-06|2009-06-23|||January 2008||2008-01-01|May 2008|2008-05-01|December 2013|Anticipated|2013-12-01|December 2009|Anticipated|2009-12-01||Interventional|VIVID||VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study|Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study|Unknown status|Recruiting|Phase 1|30|Anticipated|Myocor||1|||f||||t||||||||||2017-02-18 15:23:14.817717|2017-02-18 15:23:14.817717
NCT00511992|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2015-05-29|||July 2007||2007-07-01|May 2015|2015-05-01|May 2016|Anticipated|2016-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer|PHASE II STUDY OF PACLITAXEL (TAXOL), INTRAPERITONEAL CISPLATIN AND IV AVASTIN FOLLOWED BY AVASTIN CONSOLIDATION FOR ADVANCED OVARIAN AND PERITONEAL CARCINOMA OR FALLOPIAN TUBE CANCER|Active, not recruiting||Phase 2|22|Actual|University of Oklahoma||1|||f||||t||||||||||2017-02-18 15:23:14.921239|2017-02-18 15:23:14.921239
NCT00511979|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2012-06-25|||August 1999||1999-08-01|June 2012|2012-06-01|June 2000|Actual|2000-06-01|February 2000|Actual|2000-02-01||Interventional|||Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin|Effect of Different Doses of Inhaled Technosphere Insulin on Glucose Infusion Rates During Euglycemic Clamps in Comparison to a Subcutaneous Injection of Regular Human Insulin|Completed||Phase 1|12|Actual|Mannkind Corporation||4|||f||||||||||||||2017-02-18 15:23:15.035258|2017-02-18 15:23:15.035258
NCT00511966|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2011-05-18||||||April 2010|2010-04-01|November 2002|Actual|2002-11-01|||||Observational|||Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol|Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol|Terminated||N/A|1049|Actual|Janssen-Cilag, S.A.|||2|Due to the achievement of minimum required sample size and new changes in local regulations.|f||||f||||||||||2017-02-18 15:23:15.117246|2017-02-18 15:23:15.117246
NCT00511953|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2011-06-06|||June 2007||2007-06-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women|A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study of the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 2|108|Anticipated|Depomed||2|||f||||f||||||||||2017-02-18 15:23:15.224739|2017-02-18 15:23:15.224739
NCT00511940|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2011-06-21|||April 2007||2007-04-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Acamprosate in the Treatment of Binge-Eating Disorder||Completed||Phase 2/Phase 3|40|Anticipated|Lindner Center of HOPE||2|||f||||||||||||||2017-02-18 15:23:15.335477|2017-02-18 15:23:15.335477
NCT00511927|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2014-02-18|||July 2010||2010-07-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||Growth Hormone Deficiency in Chronic Heart Failure: an Observational Study|Observational Study on Prevalence and Prognostic Value of Growth Hormone Deficiency in Patients With Chronic Heart Failure|Completed||N/A|250|Actual|Federico II University|||2||f||||f||||||Samples Without DNA|"~     Sera of the patients at time-points upon recruitment and after 12 months~   "|||2017-02-18 15:23:15.446462|2017-02-18 15:23:15.446462
NCT00511914|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2013-01-18|2012-12-10||July 2007||2007-07-01|January 2013|2013-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008|A Phase III, Multicenter, Uncontrolled, Open-label Study to Evaluate Safety and Immunogenicity of a Single Intramuscular Dose of a Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture, Using the Strain Composition 2007/2008, When Administered to Adult and Elderly Subjects|Completed||Phase 3|135|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:23:15.544653|2017-02-18 15:23:15.544653
NCT00511901|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2013-12-27|2013-08-27||November 2005||2005-11-01|November 2011|2011-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Intention to treat|Prevalence and Treatment of Anemia in Rehabilitation Patients|Prevalence and Treatment of Anemia in Patients Admitted to Subacute Rehabilitation Hospital|Terminated||Phase 4|22|Actual|Rutgers, The State University of New Jersey|Limited number of eligible subjects, burdensome protocol requirements impeded recruitment, controversy concerning safety of epoetin alpha which led to early termination of study|2||"Study enrollment was suspended in response to an FDA alert regarding the study drug. The study~   was subsequently terminated"|f||||t||||||||||2017-02-18 15:23:15.97483|2017-02-18 15:23:15.97483
NCT00511888|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2008-10-16|||January 2004||2004-01-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Observational|||Nebivolol Versus Carvedilol in Patients With Heart Failure|Effects of Nebivolol Versus Carvedilol in Hypertensive Patients With Chronic Heart Failure|Terminated||N/A|160|Actual|IRCCS San Raffaele||||is finish|f||||t||||||||||2017-02-18 15:23:16.640132|2017-02-18 15:23:16.640132
NCT00511875|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2012-10-04|||July 2008||2008-07-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|POC1||Evaluation of Doxycyline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy|Evaluation of Effect of Doxycyline Verses Placebo on Diabetic Retinopathy Progression and Retinal Function in Patients With Severe Non-proliferative or Mild or Moderate (Non-high-risk) Proliferative Diabetic Retinopathy|Completed||Phase 2|28|Actual|Penn State University||2|||f||||t||||||||||2017-02-18 15:23:16.718954|2017-02-18 15:23:16.718954
NCT00511862|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2014-06-05|2013-10-17||January 2007||2007-01-01|February 2014|2014-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional||Subjects treated with TheraSphere were enrolled and assigned to groups based on their primary cancer type. The total population and each subgroup population was analyzed for safety, progression and survival endpoints. In the neuroendocrine group, a median overall survival was not achieved so a post-hoc analysis of 2 year survival was performed.|TheraSphere for the Treatment of Liver Metastases|TheraSphere for the Treatment of Liver Metastases: An Open Label Trial of TheraSphere in Patients With Liver Metastases From Primary Colorectal Cancer, Neuroendocrine Cancer or Non-colorectal/Non-neuroendocrine Cancer|Completed||Phase 2|151|Actual|BTG International Inc.||1|||f||||f||||||||||2017-02-18 15:23:16.947506|2017-02-18 15:23:16.947506
NCT00511849|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2010-02-16|||November 2005||2005-11-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors|Phase I Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Malignancies|Completed||Phase 1|43|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:23:17.44317|2017-02-18 15:23:17.44317
NCT00511836|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2010-12-09|2010-06-10||July 2007||2007-07-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults|The Effects of VIVITROL® on Alcohol-Related Cue-Induced Craving and BOLD [Blood Oxygen-level-dependent] Functional Magnetic Resolution Imaging (fMRI) Signal Activation Patterns|Completed||Phase 4|31|Actual|Alkermes, Inc.|The study was powered to detect whether VIVITROL blocks the fMRI BOLD signal increase in response to alcohol-related cues as compared to placebo. Results of the secondary endpoints should be interpreted with caution.|2|||f||||f||||||||||2017-02-18 15:23:17.556343|2017-02-18 15:23:17.556343
NCT00511823|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2016-11-03|||July 2007||2007-07-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects|An Open-Label, Three-Part, Two Period, Single Sequence Study to Assess the Pharmacokinetic Interaction Between Repeat Doses of Oral Casopitant and Repeat Oral Doses of Dolasetron, Granisetron or Rosiglitazone When Co-Administered in Healthy Adult Subjects|Completed||Phase 1|16|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:23:18.096574|2017-02-18 15:23:18.096574
NCT00511810|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2016-04-29|2013-03-21||August 2007||2007-08-01|April 2016|2016-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder|Evaluation of Omega-3 Fatty Acids as a Treatment-adjunct in Adolescent Patients With Major Depressive Disorder Exhibiting Partial Response to SSRI Medications: An Open-label Neuroimaging Trial|Completed||Phase 2/Phase 3|20|Actual|University of Cincinnati||2|||f||||t||||||||No||2017-02-18 15:23:18.373989|2017-02-18 15:23:18.373989
NCT00511797|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2016-11-30|2010-04-15||July 2007||2007-07-01|November 2016|2016-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study|A Multicenter, Double-blind, Randomized, Placebo-controlled Comparative Study to Investigate the Optimal Dose of Drospirenone for Dysmenorrhea With SH T04740A [Drospirenone 1 mg/Ethinylestradiol 20 µg (as ß-cyclodextrin Clathrate)], SH T 04740E [Drospirenone 2 mg/Ethinylestradiol 20 µg (as ß-cyclodextrin Clathrate)] and SH T00186D [Drospirenone 3 mg/ Ethinylestradiol 20 µg (as ß-cyclodextrin Clathrate)] Administered Orally for 16 Weeks (4 Cycles), and to Confirm the Efficacy of SH T00186D for Dysmenorrhea.|Completed||Phase 2/Phase 3|249|Actual|Bayer||4|||f||||f||||||||||2017-02-18 15:23:18.804649|2017-02-18 15:23:18.804649
NCT00511784|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2016-07-15|||November 2006||2006-11-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.|Postmarketing Study of ORTHO EVRA and Levonorgestrel Oral Contraceptives in Relation to Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction.|Completed||N/A|440|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||2||f||||||||||||||2017-02-18 15:23:20.501982|2017-02-18 15:23:20.501982
NCT00511771|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2010-11-16||||||November 2010|2010-11-01||||||||Expanded Access|||A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation|A Treatment Investigational New Drug (tIND) Program of Tegaserod 6 mg Bid Given Orally in Women Adult Patients With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation|No longer available||N/A|||Novartis|||||||||||||||||||2017-02-18 15:23:20.590069|2017-02-18 15:23:20.590069
NCT00511758|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-07-31|||June 2007||2007-06-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Digital Imaging Aid for Assessment of Cervical Dysplasia|Pilot Study of a Digital Imaging Aid for Assessment of Cervical Dysplasia|Terminated||N/A|3|Actual|M.D. Anderson Cancer Center|||1|Low accrual rate.|f||||f||||||||||2017-02-18 15:23:20.669739|2017-02-18 15:23:20.669739
NCT00511745|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2011-05-18||||||April 2010|2010-04-01|November 2002|Actual|2002-11-01|||||Observational|||Safety of Rabeprazole in Patients Under Multiple Treatments|Safety of Rabeprazole in Patients Under Multiple Treatments|Terminated||N/A|2157|Actual|Janssen-Cilag, S.A.|||1|Due to the achievement of minimum required sample size and new changes in local regulations.|f||||f||||||||||2017-02-18 15:23:20.767133|2017-02-18 15:23:20.767133
NCT00511732|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2012-04-27|||June 2004||2004-06-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2005|Actual|2005-08-01||Interventional|||18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes|A Randomized, Double-blind, Controlled, Stepwise Titration Study to Evaluate Dose Response to Prandial Administration of Inhaled Technosphere/Insulin or Technosphere in Patients With Type 2 Diabetes Mellitus Who Are Sub-optimally Treated|Completed||Phase 2|227|Actual|Mannkind Corporation||2|||f||||||||||||||2017-02-18 15:23:20.863237|2017-02-18 15:23:20.863237
NCT00511719|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2011-06-28|||February 2004||2004-02-01|June 2011|2011-06-01|March 2005|Actual|2005-03-01|April 2004|Actual|2004-04-01||Interventional|||Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes|A Prospective, Controlled, Single-Center, Open-Label,Randomized, Replicated, Crossover Isoglycemic Glucose Clamp Study Evaluating Intrapatient Variability in Bioavailability of Technosphere® Insulin Compared With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes|Completed||Phase 2|13|Actual|Mannkind Corporation||2|||f||||f||||||||||2017-02-18 15:23:20.947027|2017-02-18 15:23:20.947027
NCT00511706|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-08-01|2012-08-01||November 2007||2007-11-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)||Completed||Phase 2|243|Actual|Allergan||2|||f||||f||||||||||2017-02-18 15:23:21.147035|2017-02-18 15:23:21.147035
NCT00511693|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2007-08-06|||June 2007||2007-06-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|ROCKET||Osteoporosis Coordinator for Low Volume Community Hospitals|Regional Osteoporosis Coordinator Knowledge Exchange Trial|Unknown status|Recruiting|N/A|300|Anticipated|Ontario Ministry of Health and Long Term Care||2|||f||||f||||||||||2017-02-18 15:23:21.575509|2017-02-18 15:23:21.575509
NCT00511680|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-08-07|||September 2008||2008-09-01|August 2012|2012-08-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Beat the Blues: Treating Depression in African American Elders|Treating Depression in African American Elders: A Community-Academic Partnership|Completed||Phase 3|192|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 15:23:21.684378|2017-02-18 15:23:21.684378
NCT00511667|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2016-08-23|2012-04-04||May 2007||2007-05-01|August 2016|2016-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Sequential Panel Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK0941 After Multiple Daily Administration of MK0941 Before Each Meal (q.a.c.) in Subjects With Type 2 Diabetes|Completed||Phase 1|70|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:23:21.780523|2017-02-18 15:23:21.780523
NCT00511654|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2010-10-13||2010-10-13|June 2007||2007-06-01|October 2010|2010-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296)|A Parallel Group, Single-Blind, Randomised, Placebo Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GW823296 and Its Effect on the Pharmacokinetics of Midazolam After Once-Daily Repeated Oral Doses in Healthy Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:23:22.298856|2017-02-18 15:23:22.298856
NCT00511641|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2016-11-14|||February 2002||2002-02-01|November 2016|2016-11-01||||February 2018|Anticipated|2018-02-01||Observational|||Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer|Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer|Recruiting||N/A|2400|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:23:22.380353|2017-02-18 15:23:22.380353
NCT00511628|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2011-05-18|||July 2001||2001-07-01|March 2011|2011-03-01|January 2003|Actual|2003-01-01|||||Observational|||Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia|BMI-2002 Study: Evaluation of Functionality and Evolution of Body Weight of Psychotic Patients With a High Body Mass Index|Terminated||N/A|1717|Actual|Janssen-Cilag, S.A.|||1|Due to the achievement of minimum required sample size and new changes in local regulations.|f||||f||||||||||2017-02-18 15:23:22.494324|2017-02-18 15:23:22.494324
NCT00511615|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-07-31|||March 2005||2005-03-01|July 2012|2012-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia|A Feasibility Study of Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia|Completed||N/A|30|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Tissue sample removal from the cervix using LEEP during the scheduled colposcopy.~   "|||2017-02-18 15:23:22.589424|2017-02-18 15:23:22.589424
NCT00511602|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2012-04-27|||December 2003||2003-12-01|April 2012|2012-04-01|December 2005|Actual|2005-12-01|November 2004|Actual|2004-11-01||Interventional|||Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes|Efficacy and Safety of Inhaled Technosphere Insulin Compared to Technosphere Placebo in Patients With Type 2 Diabetes Mellitus Following Diabetes Education|Completed||Phase 2|123|Actual|Mannkind Corporation||2|||f||||||||||||||2017-02-18 15:23:22.703798|2017-02-18 15:23:22.703798
NCT00511589|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2011-03-23||||||August 2007|2007-08-01||||||||Interventional|||Chagas Disease Diagnostic - Inconclusive Serology|PCR in Blood Cultures of Individuals With Positive and Inconclusive Serology for Chagas' Disease|Completed||N/A|||UPECLIN HC FM Botucatu Unesp|||||f||||||||||||||2017-02-18 15:23:22.795289|2017-02-18 15:23:22.795289
NCT00511576|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2015-01-06|||August 2007||2007-08-01|January 2015|2015-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors|A Phase 1, Open-Label, Dose-Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of MGCD0103 (MG-0103) in Combination With Docetaxel (Taxotere®) in Subjects With Advanced Solid Malignancies|Terminated||Phase 1|54|Anticipated|Mirati Therapeutics Inc.||2||"Celgene terminated its collaboration agreement with MethylGene for the development of~   MGCD0103. All Celgene-sponsored trials with MGCD0103 will be closed."|f||||f||||||||||2017-02-18 15:23:22.873899|2017-02-18 15:23:22.873899
NCT00511563|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2015-02-26|||August 2007||2007-08-01|February 2015|2015-02-01||||November 2012|Actual|2012-11-01||Interventional|||A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679|A Double-blind, Randomised, Placebo-controlled, Three-period Crossover Study to Investigate the Pharmacodynamic Effect of Two CRF-1 Antagonists GSK561679 and GW876008 on Meal Induced Cortisol Responses in Patients With IBS.|Withdrawn||Phase 2|0|Actual|GlaxoSmithKline||1||Cancelled before active due to the results of emerging scientific data|f||||f||||||||||2017-02-18 15:23:22.983866|2017-02-18 15:23:22.983866
NCT00511550|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2008-03-03|||August 2005||2005-08-01|July 2007|2007-07-01|November 2007||2007-11-01|||||Observational|||Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors|Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors|Completed||N/A|15||University of California, San Francisco|||||f||||t||||||||||2017-02-18 15:23:23.068107|2017-02-18 15:23:23.068107
NCT00511537|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2013-08-01|||January 1999||1999-01-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders|Standard of Care Trial: Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders|Completed||N/A|30|Anticipated|University of California, San Francisco|||1||f||||t||||||||||2017-02-18 15:23:23.177232|2017-02-18 15:23:23.177232
NCT00511524|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-03-15|||June 2007||2007-06-01|February 2011|2011-02-01||||||||Interventional|||An Imaging Study to Investigate the Distribution of GW842166X in the Brain.|An Open Label Positron Emission Tomography (PET) Study to Investigate Brain Penetration by [11C]GW842166 in Healthy Subjects|Completed||Phase 1|6|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:23:25.840449|2017-02-18 15:23:25.840449
NCT00511511|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2010-01-04|||August 2007||2007-08-01|July 2009|2009-07-01|December 2009|Actual|2009-12-01|||||Observational|||Angiogenesis Inhibitors and Hypertension: Clinical Aspects|Angiogenesis Inhibitors and Hypertension: Clinical Aspects|Completed||N/A|80|Anticipated|Erasmus Medical Center|||1||f||||f||||||Samples Without DNA|"~     Blood and urine samples~   "|||2017-02-18 15:23:25.937571|2017-02-18 15:23:25.937571
NCT00511498|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-03|2008-11-28|||March 2006||2006-03-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical Prostatectomy|Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Nerve-Sparing Laparoscopic Radical Prostatectomy|Completed||N/A|100|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 15:23:26.025263|2017-02-18 15:23:26.025263
NCT00511485|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2015-02-09||2012-03-05|August 2007||2007-08-01|February 2015|2015-02-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03)|Protocol EC-FV-03: A Phase II Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung|Completed||Phase 2|43|Actual|Endocyte||1|||f||||f||||||||||2017-02-18 15:23:26.132401|2017-02-18 15:23:26.132401
NCT00511472|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2015-06-19|2012-04-10||July 2007||2007-07-01|June 2015|2015-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)|A Multicenter, 2-Part, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-0941 on Postprandial Plasma Glucose Concentrations After Daily Administration MK-0941 Before Each Meal (q.a.c) in Subjects With Type 2 Diabetes Being Treated With Basal Insulin|Completed||Phase 1|70|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:23:26.248785|2017-02-18 15:23:26.248785
NCT00511459|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2015-10-07||2014-03-27|July 2007||2007-07-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|August 2010|Actual|2010-08-01||Interventional|||Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients|A Randomized, 4-Arm, Placebo-Controlled Phase 2 Trial of AMG 386 in Combination With Bevacizumab and Paclitaxel or AMG 386 Plus Paclitaxel as First-Line Therapy in Subjects With Her2-Negative, Metastatic or Locally Recurrent Breast Cancer|Completed||Phase 2|228|Actual|Amgen||4|||f||||f||||||||||2017-02-18 15:23:26.807414|2017-02-18 15:23:26.807414
NCT00511446|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2013-06-25|||August 2007||2007-08-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|May 2010|Actual|2010-05-01||Interventional|||Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer|Phase II Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer|Completed||Phase 2|56|Actual|Martin-Luther-Universität Halle-Wittenberg||1|||f||||t||||||||||2017-02-18 15:23:27.233617|2017-02-18 15:23:27.233617
NCT00511433|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2014-11-14|2011-07-28||October 2006||2006-10-01|November 2014|2014-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)|A Randomized, Open-Label, Comparative Trial to Evaluate the Effects on Ovarian Function of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2), Compared to a Monophasic COC Containing 3 mg Drospirenone (DRSP) and 30 ug Ethinyl Estradiol (EE)|Completed||Phase 3|48|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:23:27.375448|2017-02-18 15:23:27.375448
NCT00511420|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2007-08-02|||April 2005||2005-04-01|August 2007|2007-08-01|December 2005|Actual|2005-12-01|||||Interventional|CoCD||Effects of Cocoa Products on Cardiovascular Disease Risk Factors|Effects of Cocoa Products on Cardiovascular Disease Risk Factors|Completed||Phase 3|113|Actual|University Rovira i Virgili||4|||f||||f||||||||||2017-02-18 15:23:28.230142|2017-02-18 15:23:28.230142
NCT00511407|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-11-29|||March 2004||2004-03-01|November 2012|2012-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure|A Multi-Center, Randomized, Phase II Study To Assess Safety and Efficacy With the Renal Assist Device (RAD) In Patients With Acute Renal Failure|Completed||Phase 2|58|Actual|RenaMed Biologics||2|||||||t||||||||||2017-02-18 15:23:28.557132|2017-02-18 15:23:28.557132
NCT00511394|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2008-10-14|||May 2007||2007-05-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis|Acute Hemodynamic Effects of Albumin Versus Normal Saline in Patients With Cirrhosis With Ascites: A Randomized Controlled Trial|Suspended||N/A|16|Anticipated|Govind Ballabh Pant Hospital||2|||f||||f||||||||||2017-02-18 15:23:28.666416|2017-02-18 15:23:28.666416
NCT00511381|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-02-28|||October 2007||2007-10-01|February 2012|2012-02-01|September 2011|Actual|2011-09-01|September 2009|Actual|2009-09-01||Observational|SoundGene||Genetic Testing in Detection of Late-Onset Hearing Loss|Utility of Genetic Testing in Detection of Late-Onset Hearing Loss|Completed||N/A|3681|Actual|Mednax Center for Research, Education and Quality|||1||f||||t||||||||||2017-02-18 15:23:28.768242|2017-02-18 15:23:28.768242
NCT00511368|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2010-01-15|||April 2006||2006-04-01|January 2010|2010-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*|Phase 2 Dose-escalating, P-C, D-B, Parallel Group Study in HIV Treatment-experienced Patients to Evaluate the Safety, Tolerability and Efficacy of PA103001-04 Administered as Functional Monotherapy for 14 Days *(PART B)|Completed||Phase 2|92|Actual|Myrexis Inc.||2|||f||||t||||||||||2017-02-18 15:23:28.863852|2017-02-18 15:23:28.863852
NCT00511355|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2014-11-14|2011-07-28||September 2006||2006-09-01|November 2014|2014-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)|A Randomized, Open-Label, Comparative, Multi -Center Trial to Evaluate the Effects on Hemostasis, Lipids and Carbohydrate Metabolism, and on Adrenal and Thyroid Function of a Monophasic COC Containing 2.5 mg NOMAC and 1.5 mg E2 Compared to a Monophasic COC Containing 150 ug LNG and 30 ug EE|Completed||Phase 3|121|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:23:29.021787|2017-02-18 15:23:29.021787
NCT00511342|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2015-02-12|2011-07-28||September 2006||2006-09-01|February 2015|2015-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)|An Open-Label, Randomized, Single Center Trial in Healthy Young Women, to Evaluate the Effects of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg NOMAC and 1.5 mg E2 on Bone Mineral Density (BMD) Compared to a Monophasic COC Containing 0.150 mg Levonorgestrel and 0.030 mg Ethinyl Estradiol|Completed||Phase 3|110|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:23:30.455894|2017-02-18 15:23:30.455894
NCT00511329|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2015-05-14|||August 2007||2007-08-01|May 2015|2015-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease|Growth and the Effect of Genotropin in Chronically Ill Children With Juvenile Rheumatoid Arthritis and With Crohn's Disease|Terminated||Phase 2/Phase 3|11|Actual|Nationwide Children's Hospital||1||PI left the institution|f||||f||||||||||2017-02-18 15:23:31.679354|2017-02-18 15:23:31.679354
NCT00511316|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2015-11-02|||August 2007||2007-08-01|November 2015|2015-11-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Trial of Montelukast in Eosinophilic Esophagitis|A Randomized Placebo-Controlled Trial of Montelukast in Maintenance Therapy of Asymptomatic Eosinophilic Esophagitis|Completed||Phase 1|41|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 15:23:31.799005|2017-02-18 15:23:31.799005
NCT00511303|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2007-08-02|||August 2000||2000-08-01|August 2007|2007-08-01||||||||Interventional|||Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia|Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia Who Are Resistant to or Intolerant of *-Interferon. A Phase II Study|Completed||Phase 2|200||University of Bologna|||||f||||t||||||||||2017-02-18 15:23:31.912141|2017-02-18 15:23:31.912141
NCT00511290|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2007-08-02||||||August 2007|2007-08-01||||||||Observational|||Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung||Completed||N/A|||Tel-Aviv Sourasky Medical Center|||||f||||f||||||||||2017-02-18 15:23:31.999124|2017-02-18 15:23:31.999124
NCT00511277|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2011-06-20|||August 2007||2007-08-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study|Single-arm, Open-label and Multicenter Phase IV Study: Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode Psychosis - a Pilot Study|Completed||Phase 4|60|Anticipated|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||1|||f||||f||||||||||2017-02-18 15:23:32.082686|2017-02-18 15:23:32.082686
NCT00511264|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2008-05-27|||May 2007||2007-05-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract|Prospective Evaluation of the Impact of Laparoscopic Ultrasound (LUS) Guided Fine-Needle Aspiration or Tru-Cut Biopsy in Patients With Upper GI Tract Cancer|Completed||N/A|250|Anticipated|Odense University Hospital|||||f||||f||||||||||2017-02-18 15:23:32.185242|2017-02-18 15:23:32.185242
NCT00511251|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2007-08-02|||January 2005||2005-01-01|August 2007|2007-08-01|April 2006|Actual|2006-04-01|||||Observational|||Analysis of Induced Sputum and Lung Biopsies by SEM: a Tool to Identify Source of Exposure of Workers to Hazardous Dust||Completed||N/A|||Tel-Aviv Sourasky Medical Center|||||f||||f||||||||||2017-02-18 15:23:32.2699|2017-02-18 15:23:32.2699
NCT00511238|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2013-10-11|2013-09-27||August 2007||2007-08-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|November 2010|Actual|2010-11-01||Interventional||Safety population: The safety population consists of all enrolled patients who received at least 1 dose of carfilzomib.|Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma|An Open-label, Single-arm, Phase 2 Study of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma|Completed||Phase 2|302|Actual|Onyx Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:23:32.34885|2017-02-18 15:23:32.34885
NCT00511225|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2012-06-29|||September 2007||2007-09-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|June 2010|Actual|2010-06-01||Interventional|Neph||Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney Disease|Effects of Oral Cholecalciferol (Vitamin D3) on Bone Health, Neuromuscular Function, and Quality of Life in Adults With Chronic Kidney Disease|Completed||N/A|47|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 15:23:33.454147|2017-02-18 15:23:33.454147
NCT00511212|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2011-07-20|||August 2007||2007-08-01|August 2007|2007-08-01|June 2009|Anticipated|2009-06-01|||||Interventional|||Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract|Clinical Study of Intravenous Immunoglobulin (IVIG) in Combination Therapy With Antibacterial Agents for Surgical Site Infection of the Lower Digestive Tract|Withdrawn||N/A|60|Anticipated|Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group||1||No eligible patient.|f||||t||||||||||2017-02-18 15:23:33.571241|2017-02-18 15:23:33.571241
NCT00511199|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2014-11-14|2011-07-28||May 2006||2006-05-01|November 2014|2014-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)|A Randomized, Open-Label, Comparative, Multi -Center Trial to Evaluate Contraceptive Efficacy, Cycle Control, Safety and Acceptability of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2), Compared to a Monophasic COC Containing 3 mg Drospirenone (DRSP) and 30 µg Ethinyl Estradiol (EE)|Completed||Phase 3|2152|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:23:33.666721|2017-02-18 15:23:33.666721
NCT00511186|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-03-30|||May 2008||2008-05-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study in Sepsis Patients With Renal Failure|A Phase-IIa, Double-blind, Randomized, Placebo-controlled Study on the Safety and Early Efficacy of Alkaline Phosphatase in Sepsis Patients With Renal Failure|Terminated||Phase 2|36|Actual|AM-Pharma||2||sufficient POC to switch development from bovine AP to recombinant AP|f||||t||||||||||2017-02-18 15:23:34.500089|2017-02-18 15:23:34.500089
NCT00511173|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2012-12-07|2012-04-17||August 2006||2006-08-01|December 2012|2012-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm|Warfarin Dosing: Pharmacogenetic Algorithm Compared to Pharmacist's Dosing|Completed||Phase 4|102|Actual|Creighton University||1|||f||||f||||||||||2017-02-18 15:23:34.623027|2017-02-18 15:23:34.623027
NCT00511160|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2016-10-04|||August 2007||2007-08-01|October 2016|2016-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Cardiotropic Viruses in Cardiac Surgery Patients Without Clinical Evidence of Myocarditis or Myocarditic Sequelae|Prevalence of Cardiotropic Viruses in Cardiac Surgery Patients Without Clinical Evidence of Myocarditis or Myocarditic Sequelae|Terminated||N/A|120|Actual|Robert Bosch Gesellschaft für Medizinische Forschung mbH||2||Study suspended due to logistical/personnel difficulties|f||||t||||||||No||2017-02-18 15:23:34.880373|2017-02-18 15:23:34.880373
NCT00511147|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2016-02-17|||February 2008||2008-02-01|February 2016|2016-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||IGIV Study for Chronic ITP Patients Ages 3-70|A Multi-center, Prospective, Open-label, Clinical Trial to Assess the Safety and the Efficacy of a New Intravenous Immune Globulin (IGIV3I Grifols 10%) in Patients With Idiopathic (Immune) Thrombocytopenic Purpura|Completed||Phase 3|58|Actual|Grifols Biologicals Inc.||1|||f||||f||||||||||2017-02-18 15:23:34.991648|2017-02-18 15:23:34.991648
NCT00511134|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2012-03-09|2009-09-28||April 2007||2007-04-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban|A Placebo-Controlled, Randomized Trial of Eszopiclone for the Treatment of Bupropion- and Abstinence-Related Insomnia During Smoking Cessation|Terminated||Phase 4|4|Actual|Yale University||2||Study has been terminated due low recruitment of participant population.|f||||f||||||||||2017-02-18 15:23:35.127959|2017-02-18 15:23:35.127959
NCT00511121|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2007-08-02|||April 2001||2001-04-01|August 2007|2007-08-01||||||||Interventional|||Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)|An Exploratory Phase II Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON) in the Treatment of Chronic Myeloid Leukemia in Chronic Phase|Terminated||Phase 2|5||University of Bologna|||||f||||t||||||||||2017-02-18 15:23:35.513749|2017-02-18 15:23:35.513749
NCT00511108|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2015-06-08|2010-01-08||July 2007||2007-07-01|June 2015|2015-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)|A Phase I Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Study the Safety, Efficacy, and Mechanism of Action of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet and Exercise|Completed||Phase 1|211|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 15:23:35.620678|2017-02-18 15:23:35.620678
NCT00511095|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2016-11-08||2010-06-17|June 2007||2007-06-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine|An Open-Label Study of Safety and Immunogenicity in Subjects Following Injection With Two Doses of HEPLISAV™|Completed||Phase 2|207|Actual|Dynavax Technologies Corporation||1|||f||||t||||||||Yes|There is a BLA un progress at this time. Data to be shared post approval.|2017-02-18 15:23:36.325399|2017-02-18 15:23:36.325399
NCT00511082|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2008-07-01|||December 2007||2007-12-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma|Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma|Unknown status|Recruiting|Phase 1|42|Anticipated|Otsuka Beijing Research Institute||1|||f||||t||||||||||2017-02-18 15:23:36.44138|2017-02-18 15:23:36.44138
NCT00511069|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2008-11-21|||July 2006||2006-07-01|November 2008|2008-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia|A Phase II Study of Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia|Completed||Phase 2|3|Actual|University of Bologna|||||f||||||||||||||2017-02-18 15:23:36.535406|2017-02-18 15:23:36.535406
NCT00511056|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2011-07-07|||September 2007||2007-09-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Observational|ARB||Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy|Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy|Completed||N/A|700|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||f||||||Samples With DNA|"~     Blood samples required to provide Viral Load data and CD4 cell count~   "|||2017-02-18 15:23:36.619816|2017-02-18 15:23:36.619816
NCT00511043|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2014-11-19||2012-09-07|November 2005||2005-11-01|November 2014|2014-11-01|June 2010|Actual|2010-06-01|August 2009|Actual|2009-08-01||Interventional|||PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma|Phase II Open Label Study of PTK787/ZK222584 in Adults Patients With Refractory or Relapsed Diffuse Large Cell Lymphoma|Terminated||Phase 2|20|Actual|Duke University||1||Manufacturer stopped drug development|f||||t||||||||||2017-02-18 15:23:36.727778|2017-02-18 15:23:36.727778
NCT00511030|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2008-01-21|||July 2007||2007-07-01|July 2007|2007-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit|Assessment of Stability and Ease of Use of a Mail-in Capillary Blood Hemoglobin A!c Sample Kit|Completed||N/A|23|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||None Retained|"~     Capillary blood~   "|||2017-02-18 15:23:36.839204|2017-02-18 15:23:36.839204
NCT00511017|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2012-07-27|||August 2007||2007-08-01|July 2012|2012-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Doxercalciferol in Recurrent Pediatric Solid Tumors|A Phase I Study of Doxercalciferol in Recurrent Pediatric Solid Tumors|Terminated||Phase 1|1|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 15:23:37.153223|2017-02-18 15:23:37.153223
NCT00511004|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2015-07-30|2015-07-02||July 2007||2007-07-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Effect of Albendazole Dose on Treatment of Lymphatic Filariasis|Effect of Albendazole Dose and Interval on Brugia Malayi Microfilarial Clearance in India: A Randomized, Open Label Study|Completed||Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)|Study never fully enrolled so sample size was smaller than hoped for.|3|||f||||f||||||||||2017-02-18 15:23:37.270148|2017-02-18 15:23:37.270148
NCT00510991|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2008-02-26|||July 2006||2006-07-01|February 2008|2008-02-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Non Invasive Ventilation in Acute Asthma|Non Invasive Ventilation in Acute Asthma|Unknown status|Recruiting|Phase 3|100|Anticipated|Postgraduate Institute of Medical Education and Research||1|||f||||t||||||||||2017-02-18 15:23:37.867|2017-02-18 15:23:37.867
NCT00510978|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2011-06-13|||January 2002||2002-01-01|August 2007|2007-08-01|November 2007||2007-11-01|||||Interventional|PROGID||Probiotics in GastroIntestinal Disorders|One Year, Randomised, Double Blind, Placebo Controlled Trial of Probiotics, Bifidobacterium Infantis 35624 or Lactobacillus Salivarius UCC118, as Food Supplements for Maintenance of Remission in Crohn's Disease and Ulcerative Colitis|Unknown status|Active, not recruiting|Phase 2/Phase 3|360|Actual|University College Cork||3|||f||||t||||||||||2017-02-18 15:23:37.965934|2017-02-18 15:23:37.965934
NCT00510965|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2012-06-14|||August 2007||2007-08-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)|Ranibizumab in Choroidal Neovascularization (CNV) Due to Pseudoxanthoma Elasticum (PXE, Groenblad-Strandberg-Syndrome)|Completed||Phase 2|10|Actual|University Hospital, Bonn||1|||f||||f||||||||||2017-02-18 15:23:38.077296|2017-02-18 15:23:38.077296
NCT00510757|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2008-10-16|||June 2007||2007-06-01|October 2008|2008-10-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Observational|||Multi Cervical Unit Measures of Cervical Isometric Strength and Range of Motion: A Pilot Study||Unknown status|Recruiting|N/A|200|Anticipated|Logan College of Chiropractic|||2||f||||||||||||||2017-02-18 15:23:44.238362|2017-02-18 15:23:44.238362
NCT00510952|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2010-10-12|2009-09-25||August 2007||2007-08-01|October 2010|2010-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|IOPE||Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)|The PERSISTENT Trial: A Prospective Randomized Trial Comparing Insulin Lispro Protamine Suspension to Insulin Glargine in Patients With Type 2 Diabetes on Anti-hyperglycemic Medications|Completed||Phase 3|471|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:23:38.203006|2017-02-18 15:23:38.203006
NCT00510939|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2009-08-13|||March 2007||2007-03-01|August 2009|2009-08-01||||||||Interventional|HEMOS AML 0106||Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia|Phase II, Open-Label, Multi-centre, 2-part Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Unfit for Conventional Chemotherapy ( >18 Years) or in Patients With Acute Myeloid Leukemia in First Relapse ( >60 Years)|Unknown status|Recruiting|Phase 2|72|Anticipated|University of Bologna||1|||f||||t||||||||||2017-02-18 15:23:39.382021|2017-02-18 15:23:39.382021
NCT00510926|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-02|2007-08-02|||January 2004||2004-01-01|August 2007|2007-08-01|November 2006||2006-11-01|||||Interventional|||Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase|"CML/021 A Phase II Exploratory Study of IMATINIB High Dose (800mg/gg) in the Treatment of Newly Diagnosed Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase"|Completed||Phase 2|80||University of Bologna|||||f||||||||||||||2017-02-18 15:23:39.474604|2017-02-18 15:23:39.474604
NCT00510913|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2007-07-31|||February 1999||1999-02-01|July 2007|2007-07-01|September 2000|Actual|2000-09-01|||||Interventional|CRAF||A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure|Prograf® (Tacrolimus) as Secondary Intervention vs. Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure|Completed||Phase 4|450|Anticipated|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 15:23:39.569685|2017-02-18 15:23:39.569685
NCT00510900|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2016-01-04|||August 2005||2005-08-01|January 2016|2016-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Effects of Left Atrial Appendage Occlusion|Effects of Left Atrial Appendage Occlusion|Withdrawn||N/A|0|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:23:39.681783|2017-02-18 15:23:39.681783
NCT00510887|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2014-04-29|2013-12-18||January 2007||2007-01-01|April 2014|2014-04-01|September 2013|Actual|2013-09-01|November 2012|Actual|2012-11-01||Interventional||All patients who were consented are included in the baseline analysis population.|Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma|A Phase II Study of Bortezomib in Combination With Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone (VR-FND) for Relapsed or Refractory Follicular Lymphoma|Terminated||Phase 2|14|Actual|Duke University||1||Low accrual.|f||||f||||||||||2017-02-18 15:23:39.775364|2017-02-18 15:23:39.775364
NCT00510874|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2016-10-18|2013-12-19||July 2007||2007-07-01|October 2016|2016-10-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults|A Phase I/II, Observer-Blind, Randomized, Active-Controlled Trial to Evaluate the Safety and Immunogenicity of a Two-Dose Series of GSK Biologicals' Candidate Influenza Vaccine GSK 1557484A Antigens With or Without Adjuvant|Completed||Phase 1|780|Actual|GlaxoSmithKline||7|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:23:40.151093|2017-02-18 15:23:40.151093
NCT00510861|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2007-08-01|||February 2007||2007-02-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Observational|MALE AGING||Influence of Paternal Age on Assisted Reproduction Outcome|Influence of Paternal Age on Assisted Reproduction Outcome|Completed||N/A|||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||f||||||||||2017-02-18 15:23:41.712328|2017-02-18 15:23:41.712328
NCT00510848|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2014-12-04|||August 2007||2007-08-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Hamstrings Autograft Versus Tibialis Allograft for Reconstruction of Anterior Cruciate Ligament|Hamstrings Autograft Versus Tibialis Allograft for Reconstruction of Anterior Cruciate Ligament: Randomized Clinical Trial With 2 Year Follow-up|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 15:23:42.023181|2017-02-18 15:23:42.023181
NCT00510835|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2016-12-01|2016-12-01||March 2008||2008-03-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|ProCESS||Protocolized Care for Early Septic Shock|Protocolized Care for Early Septic Shock|Completed||N/A|1351|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 15:23:42.144161|2017-02-18 15:23:42.144161
NCT00510822|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2013-11-12|||October 2007||2007-10-01|November 2013|2013-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Cimicoxib for the Treatment of Major Depression (SECIM)|Safety and Efficacy of Cimicoxib, a Selective COX-2 Inhibitor, in Combination With Sertraline Compared to Sertraline Combined With Placebo in Treatment of Major Depression|Completed||Phase 2|169|Actual|Affectis Pharmaceuticals AG||2|||f||||f||||||||||2017-02-18 15:23:42.704055|2017-02-18 15:23:42.704055
NCT00510809|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2015-09-22|2012-05-11||July 2007||2007-07-01|September 2015|2015-09-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy|Safety and Efficacy of Policosanol Monotherapy and When Added to Chronic Statin Therapy: A Pilot Study|Completed||N/A|54|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-02-18 15:23:42.868418|2017-02-18 15:23:42.868418
NCT00510796|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2016-02-15|||March 2002||2002-03-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Combined Colon and Endometrial Cancer Screening in Women With HNPCC|A Pilot Study for Combined Colon and Endometrial Cancer Screening in Women at High-Risk for Colon and Endometrial Cancer|Completed||N/A|50|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:23:43.577416|2017-02-18 15:23:43.577416
NCT00510783|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2013-11-18|2011-01-08||July 2007||2007-07-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures|IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures|Completed||Phase 4|158|Actual|Emory University|Several patients were lost to follow-up.|2|||f||||t||||||||||2017-02-18 15:23:43.713792|2017-02-18 15:23:43.713792
NCT00510770|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2009-02-17|||December 2004||2004-12-01|February 2009|2009-02-01||||||||Interventional|||CPAP in Liver Transplant|Continuous Positive Airway Pressure for Treatment of Postoperative Hypoxemia in Liver Transplant|Unknown status|Recruiting|Phase 4|80|Anticipated|University of Turin, Italy||2|||f||||t||||||||||2017-02-18 15:23:44.130317|2017-02-18 15:23:44.130317
NCT00510744|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2016-04-26|2016-04-26||August 2007||2007-08-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|July 2015|Actual|2015-07-01||Interventional|||Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients|Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients|Completed||N/A|5|Actual|University of Pittsburgh||1|||f||||t||||||||Yes|with publication|2017-02-18 15:23:44.326404|2017-02-18 15:23:44.326404
NCT00510731|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2015-12-07|||November 2006||2006-11-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|VITAL||The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events|Prospective, Multi-Center Study Of The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of VentrIcular TachyArrhythmic Events Such As, Sudden Cardiac Death, VentricuLar Fibrillation or Ventricular Tachycardia in High Risk Patients|Withdrawn||N/A|0|Actual|Vicor Technologies, Inc.|||1|Lack of funding|f||||t||||||||||2017-02-18 15:23:44.665995|2017-02-18 15:23:44.665995
NCT00510718|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2017-01-18|||July 2007||2007-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|September 2010|Actual|2010-09-01||Interventional|||A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer|A Phase 1, Open-Label, Dose-Escalation Safety and Pharmacokinetic Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer|Active, not recruiting||Phase 1|140|Actual|Medivation, Inc.||1|||f||||f||||||||||2017-02-18 15:23:44.770588|2017-02-18 15:23:44.770588
NCT00510705|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2014-12-02|||July 2007||2007-07-01|December 2014|2014-12-01||||July 2012|Actual|2012-07-01||Interventional|KFO||Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery Disease||Terminated||N/A|29|Actual|University of Leipzig||4|||f||||||||||||||2017-02-18 15:23:44.886985|2017-02-18 15:23:44.886985
NCT00510692|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2014-08-06|2014-07-07||November 2006||2006-11-01|August 2014|2014-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||The baseline characteristics are presented for the full analysis set which constitutes 55 of the 58 randomised subjects. The full analysis set includes all subjects who were randomised into the study, took at least one dose of study medication provided both at baseline and at least one treatment measurement for efficacy.|Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA|A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Patients Using the Purified Free Fatty Acid, Eicosapentaenoic Acid|Completed||Phase 2/Phase 3|58|Actual|S.L.A. Pharma AG||2|||f||||f||||||||||2017-02-18 15:23:44.996555|2017-02-18 15:23:44.996555
NCT00510679|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2007-08-01|||July 1999||1999-07-01|August 2007|2007-08-01|October 2004|Actual|2004-10-01|||||Interventional|||Study of Post-Training Supports for Health Workers in Benin|A Randomized Controlled Trial of Post-Training Supports for Health Workers Trained in the Use of Integrated Management of Childhood Illness Guidelines in Ouémé Department, Benin|Completed||N/A|1577|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 15:23:45.568902|2017-02-18 15:23:45.568902
NCT00510666|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2009-03-30|||January 2007||2007-01-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|BATPCAH||Comparison of Butorphanol and Tramadol Associated Patient-Controlled Analgesia (PCA) After Hysterectomy|Butorphanol and Tramadol for Morphine PCA Pain Management After Total Hysterectomy|Completed||Phase 4|841|Actual|Nanjing Medical University||4|||f||||t||||||||||2017-02-18 15:23:45.677575|2017-02-18 15:23:45.677575
NCT00510653|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2013-06-14|2013-06-14||March 2002||2002-03-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Gleevec Study for Patients With Ovarian Cancer|A Phase II Study of Gleevec in Patients With Recurrent Platinum-Resistant, Taxane-Resistant Epithelial Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|Completed||Phase 2|73|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:23:45.793636|2017-02-18 15:23:45.793636
NCT00510640|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2013-02-27|||August 2007||2007-08-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|THYSU||Thyroid Cancer and Sunitinib|Phase 2 of Sunitinib (Sutent) in Patients With Locally Advanced or Metastatic Anaplastic, Differentiated or Medullar Thyroid Cancer|Completed||Phase 2|71|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-02-18 15:23:46.107097|2017-02-18 15:23:46.107097
NCT00510627|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2007-12-20|||August 2007||2007-08-01|December 2007|2007-12-01|December 2010|Anticipated|2010-12-01|||||Interventional|Prometheus||Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases|A Prospective, Randomized, Active-Control, Multi-Center Study Assessing Overall Survival Using Chemotherapy With or Without Impedance-Based Radiofrequency Ablation for Subjects With Colorectal Cancer and Incurable Metastatic Liver Disease, Failing at Least First-Line Chemotherapy|Withdrawn||Phase 4|682|Anticipated|Boston Scientific Corporation||2||Boston Scientific has decided to close the Study.|f||||f||||||||||2017-02-18 15:23:46.237281|2017-02-18 15:23:46.237281
NCT00510614|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2011-02-16|||October 2007||2007-10-01|February 2011|2011-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study|Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study|Completed||Early Phase 1|37|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:23:46.362875|2017-02-18 15:23:46.362875
NCT00510601|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2016-01-12|||July 2007||2007-07-01|January 2016|2016-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Treating Congestive Heart Failure Using a Device to Remove Cholesterol|LDL Apheresis for the Treatment of Congestive Heart Failure|Completed||Early Phase 1|5|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 15:23:46.47822|2017-02-18 15:23:46.47822
NCT00510588|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2014-12-02|||July 2007||2007-07-01|December 2014|2014-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|KFO||Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease||Completed||N/A|120|Actual|University of Leipzig||4|||f||||||||||||||2017-02-18 15:23:46.591583|2017-02-18 15:23:46.591583
NCT00510575|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2013-01-15|||May 2007||2007-05-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Surgical Outcomes Using Variable Rod Diameters in the Treatment of Idiopathic Scoliosis|Surgical Outcomes Using Variable Rod Diameters in the Treatment of Idiopathic Scoliosis|Completed||Phase 4|300|Actual|Shriners Hospitals for Children||2|||f||||f||||||||||2017-02-18 15:23:46.696935|2017-02-18 15:23:46.696935
NCT00510562|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2013-04-02|||October 2001||2001-10-01|April 2013|2013-04-01|February 2002|Actual|2002-02-01|||||Interventional|||Effect of Cranial Osteopathy on Visual Function|Effect of Cranial Osteopathy on Visual Function|Completed||N/A|29|Actual|Nova Southeastern University||2|||f||||f||||||||||2017-02-18 15:23:46.803458|2017-02-18 15:23:46.803458
NCT00510549|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2008-09-25|||July 2007||2007-07-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of the Impact of Dialysis Treatment Type on Patient Survival|A Prospective, Randomized, Multicenter, Open Label, Interventional Pilot Study To Compare Mortality, Morbidity and QOL in Hemodialysis Versus Peritoneal Dialysis Subjects|Completed||Phase 4|50|Anticipated|Baxter Healthcare Corporation||2|||f||||f||||||||||2017-02-18 15:23:46.900893|2017-02-18 15:23:46.900893
NCT00510536|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2009-04-08|||July 2007||2007-07-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab|A Phase 4 Study to Assess the Practical Management of Mild to Moderate Arthritic or Arthralgic Events in Patients With Chronic Plaque Psoriasis Receiving Efalizumab|Completed||Phase 4|50|Anticipated|Probity Medical Research||1|||f||||f||||||||||2017-02-18 15:23:49.579227|2017-02-18 15:23:49.579227
NCT00510523|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2013-05-02|||October 2006||2006-10-01|May 2013|2013-05-01|November 2007||2007-11-01|||||Interventional|||Whole Body Vibration Therapy in Participants With MS Related Balance Deficits|Whole Body Vibration Therapy in Participants With MS Related Balance Deficits|Completed||N/A|80|Anticipated|Logan College of Chiropractic|||||f||||||||||||||2017-02-18 15:23:49.671451|2017-02-18 15:23:49.671451
NCT00510510|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2012-05-14|2010-12-23||August 2007||2007-08-01|May 2012|2012-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease|A Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Study, to Assess the Safety and Tolerability of 28 Days Treatment With NVA237 (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|281|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:23:49.781177|2017-02-18 15:23:49.781177
NCT00510497|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2016-05-12|2016-01-12||July 2007||2007-07-01|May 2016|2016-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||11 particpants were enrolled but one received no study vaccines and was withdrawn and not included in any analyses.|Autologous Dendritic Cell Vaccine in HIV1 Infection|Phase I/II Evaluation of Therapeutic Immunization With Autologous Dendritic Cells Pulsed With Autologous, Inactivated HIV-1 Infected, Apoptotic Cells|Completed||Phase 1/Phase 2|11|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 15:23:50.47046|2017-02-18 15:23:50.47046
NCT00510484|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2010-05-26|2009-05-29||November 2007||2007-11-01|August 2009|2009-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis|A Double-blind, Randomized, Multi-center, Placebo-controlled, Cross-over Study to Assess the Efficacy and Safety of Pancrelipase Delayed Release 24,000 Unit Capsules in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis|Completed||Phase 3|35|Actual|Solvay Pharmaceuticals|Only treatment emergent events have been presented. They are defined as events started at or after the 1st administration of study medication and include events started prior to the 1st administration but which worsened after the 1st intake.|2|||f||||f||||||||||2017-02-18 15:23:50.71791|2017-02-18 15:23:50.71791
NCT00510471|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2008-03-14|||May 2007||2007-05-01|March 2008|2008-03-01||||||||Interventional|||Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma|A Phase 2 Multi-Center, Open-Label Study to Evaluate the Efficacy and Safety of Patient-Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH (Id-KLH) and Administered With GM-CSF, in Patients With Follicular Non-Hodgkin's Lymphoma (fNHL) Following Primary Treatment With Rituximab and Chemotherapy (R-Chemo)|Terminated||Phase 2|||Genitope Corporation|||||f||||||||||||||2017-02-18 15:23:51.454863|2017-02-18 15:23:51.454863
NCT00510458|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2016-12-30|||April 2007||2007-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|LFIT||LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study|LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study - An Open Label, Prospective, Post-market, Multi-center Clinical Evaluation of the LFIT™ Anatomic CoCr Femoral Heads With X3® Inserts|Completed||N/A|96|Actual|Stryker Orthopaedics||1|||f||||f||||||||||2017-02-18 15:23:51.547893|2017-02-18 15:23:51.547893
NCT00510445|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2015-12-22|||July 2007||2007-07-01|December 2015|2015-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer|A Phase I Study of GRN163L in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1|27|Actual|Geron Corporation||1|||f||||f||||||||||2017-02-18 15:23:51.644831|2017-02-18 15:23:51.644831
NCT00510432|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2009-08-18|||April 2007||2007-04-01|August 2009|2009-08-01|January 2009|Anticipated|2009-01-01|||||Observational|||Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients|Inzidenz Und Art Heparin-induzierter Hautveränderungen|Unknown status|Recruiting|N/A|500|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||f||||||||||2017-02-18 15:23:51.752767|2017-02-18 15:23:51.752767
NCT00510419|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2012-06-06|||July 2007||2007-07-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack|A Phase 3 Open-Label Study to Assess Subcutaneous Self-Injection With Sumatriptan Succinate Using an Auto-injector During a Single Migraine Attack|Completed||Phase 3|73|Actual|Pfizer|||||f||||t||||||||||2017-02-18 15:23:51.845941|2017-02-18 15:23:51.845941
NCT00510406|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2014-08-19|||January 2007||2007-01-01|August 2014|2014-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|SATURN||A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH|A Randomized, Double-blind, Parallel Group, Placebo Controlled, Multi Center Dose Ranging Study of Solifenacin Succinate in Combination With Tamsulosin Hydrochloride Compared With Solifenacin Succinate Monotherapy and Tamsulosin Hydrochloride Monotherapy in Males With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)|Completed||Phase 2|919|Actual|Astellas Pharma Inc||8|||f||||f||||||||||2017-02-18 15:23:51.94357|2017-02-18 15:23:51.94357
NCT00510393|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2010-12-01|||March 2008||2008-03-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|DESTINY||Drug Eluting Stents In The Critically Ischemic Lower Leg|The DESTINY Trial: a Prospective Randomized Multicenter Trial Comparing the Implant of a Drug Eluting Stent (XIENCE V, Abbott Vascular) vs. a Bare Metal Stent (MULTILINK VISION, Abbott Vascular) in the Critically Ischemic Lower Leg|Completed||Phase 2|140|Actual|Flanders Medical Research Program||2|||f||||t||||||||||2017-02-18 15:23:52.390476|2017-02-18 15:23:52.390476
NCT00510380|ClinicalTrials.gov processed this data on February 17, 2017|2007-08-01|2009-09-18|||April 2007||2007-04-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|||||Observational|||Epigenetic Markers in Growth Restricted Human Pregnancies: a Case-controlled Study|Epigenetic Markets in Growth Restricted Human Pregnancies: A Case- Control Study|Completed||N/A|40|Anticipated|National University Hospital, Singapore|||2||f||||t||||||||||2017-02-18 15:23:52.501087|2017-02-18 15:23:52.501087
NCT00510367|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2016-10-18|||August 2001||2001-08-01|October 2016|2016-10-01||||August 2018|Anticipated|2018-08-01||Interventional|||Primary Breast Cancer Occurring Concomitant With Pregnancy|Multimodality Treatment of Primary Breast Cancer Occurring Concomitant With Pregnancy|Active, not recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:23:52.587735|2017-02-18 15:23:52.587735
NCT00510354|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2016-11-16|||October 2006||2006-10-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|Radix||Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate|Multicenter, Single-arm, Two Stage Phase II Trial of RAD001 (Everolimus) With Imatinib in Imatinib-resistant Patients With Progressive GIST|Completed||Phase 4|28|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:23:52.707942|2017-02-18 15:23:52.707942
NCT00510341|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2012-12-18|||April 2006||2006-04-01|December 2012|2012-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|CMP||Evaluating the Collaborative Management in Pediatrics (CMP) Training Program Among Pediatric Resident Doctors and Their Patients With Asthma or Obesity|Asthma Management Support Training in Pediatrics|Completed||N/A|18|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:23:52.824787|2017-02-18 15:23:52.824787
NCT00510328|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2007-08-01|||October 2006||2006-10-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Vibration Therapy Effects on Muscle Firing Patterns|Vibration Therapy Effects on Muscle Firing Patterns|Completed||Phase 1/Phase 2|60|Anticipated|Logan College of Chiropractic|||||f||||||||||||||2017-02-18 15:23:52.94236|2017-02-18 15:23:52.94236
NCT00510315|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2017-02-02|||July 2007||2007-07-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant|Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related IllnessFollowing Total Body Irradiation and Stem Cell Transplant|Active, not recruiting||N/A|11|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples Without DNA|"~     whole blood~   "|||2017-02-18 15:23:53.03549|2017-02-18 15:23:53.03549
NCT00510302|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2016-07-13|||November 2002||2002-11-01|July 2016|2016-07-01||||November 2018|Anticipated|2018-11-01||Observational|||Melanoma Risk-Reduction Among Patients and Family Members|Melanoma Risk-Reduction Practices Among Melanoma Patients and Their Family Members|Active, not recruiting||N/A|170|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:23:53.149538|2017-02-18 15:23:53.149538
NCT00510289|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-03-21|2013-10-30||July 2006||2006-07-01|March 2016|2016-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||All patients who signed consent|Sorafenib in Myelodysplastic Syndrome|Phase II Trial of Sorafenib in Patients With Myelodysplastic Syndrome|Terminated||Phase 2|19|Actual|Duke University|The limitations of our study include the small sample size, the poor toxicity profile and the lack of response.|1||Early closure of study due to poor response|f||||t||||||||||2017-02-18 15:23:53.262951|2017-02-18 15:23:53.262951
NCT00510276|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2010-04-07|2010-01-27||August 2007||2007-08-01|April 2010|2010-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes|A Double-Blind Study of Atomoxetine Hydrochloride Versus Placebo for the Treatment of ADHD in Young Adults With an Assessment of Associated Functional Outcomes|Completed||Phase 4|445|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:23:53.619319|2017-02-18 15:23:53.619319
NCT00510263|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2008-06-03|||May 2001||2001-05-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|SBPS||Scandinavian Bell's Palsy Study|A Multicentre Placebo-Controlled Evaluation of Prednisolone and/or Valaciclovir for the Treatment of Bell's Palsy|Completed||Phase 4|839|Actual|Uppsala University Hospital||4|||f||||t||||||||||2017-02-18 15:23:55.773891|2017-02-18 15:23:55.773891
NCT00510250|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2015-07-24|||June 2007||2007-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|September 2010|Actual|2010-09-01||Interventional|||A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer|A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer|Completed||Phase 1/Phase 2|13|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 15:23:55.884661|2017-02-18 15:23:55.884661
NCT00510237|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2016-08-30|||February 2007||2007-02-01|August 2016|2016-08-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||Intervention for Newly Diagnosed Youth With HIV|Intervention Development for Newly Diagnosed Youth With HIV|Completed||Phase 1|50|Actual|Westat||2|||f||||t||||||||||2017-02-18 15:23:55.996568|2017-02-18 15:23:55.996568
NCT00510224|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2013-10-17|2013-10-17||July 2007||2007-07-01|October 2013|2013-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Sandostatin for Patients With Androgen Independent Prostate Cancer|A Phase II Study of the Somatostatin Analog Sandostatin LAR in Patients With Androgen Independent Prostate Cancer|Terminated||Phase 2|13|Actual|University of California, San Francisco||1||Stopped at interim analyses phase due to lack of efficacy|f||||t||||||||||2017-02-18 15:23:56.114887|2017-02-18 15:23:56.114887
NCT00510211|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2009-07-31|||April 2007||2007-04-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|||||Observational|||An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.|An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.|Completed||N/A|1131|Actual|Eli Lilly and Company|||2||f||||f||||||||||2017-02-18 15:23:56.429347|2017-02-18 15:23:56.429347
NCT00510198|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2009-06-08|||October 2007||2007-10-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|PRECEDE-HF||Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure|PRECEDE-HF -Prospective, Randomized Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure|Terminated||N/A|120|Actual|Medtronic Cardiac Rhythm and Heart Failure||2||Study enrollment significantly below protocol expectation|f||||t||||||||||2017-02-18 15:23:56.539079|2017-02-18 15:23:56.539079
NCT00510185|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2012-02-22|||October 2007||2007-10-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Early Aggressive Versus Initially Conservative Therapy in Elderly Patients With Non-ST-Elevation Acute Coronary Syndrome|Italian Elderly ACS Study|Completed||N/A|313|Actual|Niguarda Hospital||2|||f||||t||||||||||2017-02-18 15:23:56.675212|2017-02-18 15:23:56.675212
NCT00510172|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2007-07-30|||December 2006||2006-12-01|July 2007|2007-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2|Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2|Unknown status|Recruiting|N/A|12|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-02-18 15:23:56.786047|2017-02-18 15:23:56.786047
NCT00510159|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2008-01-17|||August 2007||2007-08-01|July 2007|2007-07-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis|Randomized Double Blind Clinical Trial in Mali, Comparing the Effectiveness of Artesunate + Sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel in the Treatment of S. Haematobium in Children|Completed||Phase 2/Phase 3|800|Actual|Dafra Pharma||2|||f||||f||||||||||2017-02-18 15:23:56.885065|2017-02-18 15:23:56.885065
NCT00510146|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2011-04-26|2011-02-15||August 2007||2007-08-01|April 2011|2011-04-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||Olanzapine Treatment of Patients With Bipolar I Disorder|Efficacy and Safety of Olanzapine in the Treatment of Patients With Bipolar I Disorder, Depressed: A Randomized, Double-Blind Comparison With Placebo|Completed||Phase 3|514|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-02-18 15:23:57.005941|2017-02-18 15:23:57.005941
NCT00510133|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2014-08-11|||July 2007||2007-07-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|December 2011|Actual|2011-12-01||Interventional|||A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)|A Phase II Study of Active Immunotherapy With GRNVAC1, Autologous Mature Dendritic Cells Transfected With mRNA Encoding Human Telomerase Reverse Transcriptase, in Patients With Acute Myelogenous Leukemia in Complete Clinical Remission|Completed||Phase 2|21|Actual|Asterias Biotherapeutics, Inc.||1|||f||||f||||||||||2017-02-18 15:23:59.083244|2017-02-18 15:23:59.083244
NCT00510120|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2013-06-06|||June 2007||2007-06-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Comparison of Two Psychosocial Therapies for Treating Children With Oppositional-Defiant Disorder|Mediators, Moderators, and Treatment Outcomes With ODD Youth|Completed||N/A|150|Actual|Virginia Polytechnic Institute and State University||3|||f||||f||||||||||2017-02-18 15:23:59.193504|2017-02-18 15:23:59.193504
NCT00510107|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2007-07-31|||July 2007||2007-07-01|July 2007|2007-07-01|July 2009|Anticipated|2009-07-01|||||Interventional|||Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC|A Randomized Phase II Trial of Weekly Docetaxel/Cisplatin Versus Weekly Docetaxel/Oxaliplatin in Previously Untreated Patients With Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|90|Anticipated|Gachon University Gil Medical Center||2|||f||||f||||||||||2017-02-18 15:23:59.311898|2017-02-18 15:23:59.311898
NCT00510094|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2015-06-03|||October 2007||2007-10-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2014|Actual|2014-05-01||Interventional|||Effectiveness of Treatment for Relational Aggression in Urban African American Girls|Determining the Efficacy of a Relational Aggression Intervention for Urban African American Girls|Completed||Phase 3|144|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 15:23:59.414771|2017-02-18 15:23:59.414771
NCT00510081|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2014-12-05|||July 2007||2007-07-01|December 2014|2014-12-01|February 2009||2009-02-01|February 2009||2009-02-01||Interventional|||An Evaluation of an Injectable Material for Correction of Wrinkles|An Open Label Evaluation of the Safety and Efficacy of Calcium Hydroxylapatite (Radiesse®) Injection in the Correction of Jowl-Associated Chin Notches|Withdrawn||Phase 3|0|Actual|Northwestern University||1||The study was not executed. No subjects were enrolled.|f||||f||||||||||2017-02-18 15:23:59.546523|2017-02-18 15:23:59.546523
NCT00510068|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2015-06-04|2011-11-11||July 2007||2007-07-01|June 2015|2015-06-01|March 2014|Actual|2014-03-01|February 2010|Actual|2010-02-01||Interventional|RADIANT-3||Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors|A Randomized Double-blind Phase III Study of RAD001 10 mg/d Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Neuroendocrine Tumor (NET)|Completed||Phase 3|410|Actual|Novartis||2|||f||||t||||||||||2017-02-18 15:23:59.666605|2017-02-18 15:23:59.666605
NCT00510055|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2012-09-14|||June 2007||2007-06-01|September 2012|2012-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Treatment of Acne Scarring With a Novel Procedure Combination|The Effect of Subcision and Calcium Hydroxylapatite (Radiesse) Injection on Rolling Acne Scarring Appearance|Completed||N/A|30|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 15:24:01.872405|2017-02-18 15:24:01.872405
NCT00510042|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2010-04-23|||July 2007||2007-07-01|April 2010|2010-04-01|September 2009|Actual|2009-09-01|||||Observational|WiN||National Study of Moderate and Severe Von Willebrand Disease in the Netherlands|National Study of Moderate and Severe Von Willebrand Disease in the Netherlands|Completed||N/A|1100|Anticipated|Erasmus Medical Center|||1||f||||f||||||Samples With DNA|"~     plasma, DNA~   "|||2017-02-18 15:24:01.9844|2017-02-18 15:24:01.9844
NCT00510029|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2008-03-12|||September 2007||2007-09-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously|Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously as a 24-Hour Infusion to Healthy Subjects.|Completed||Phase 1|72|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:24:02.098643|2017-02-18 15:24:02.098643
NCT00510016|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2017-01-10|||July 2002||2002-07-01|July 2007|2007-07-01|December 2005|Actual|2005-12-01|||||Interventional|NAS||Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome|Efficacy of Clonidine in the Treatment of Neonatal Abstinence Syndrome: A Prospective, Double Blind, Randomized Controlled Trial|Completed||Phase 2|80|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-02-18 15:24:02.19285|2017-02-18 15:24:02.19285
NCT00510003|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2016-11-16|||December 2004||2004-12-01|November 2016|2016-11-01||||January 2006|Actual|2006-01-01||Interventional|||Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old|A Multicenter, 3-week, Randomized, Double-blind, Parallel-group, Vehicle-controlled Study to Evaluate the Efficacy and Safety of Pimecrolimus Cream 1% in Pediatric Patients With Mild to Moderate Atopic Dermatitis|Completed||Phase 4|117|Actual|Novartis|||||f||||||||||||||2017-02-18 15:24:02.30057|2017-02-18 15:24:02.30057
NCT00509990|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2011-11-01|||April 2005||2005-04-01|November 2011|2011-11-01||||September 2007|Actual|2007-09-01||Interventional|||Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting|Open Label Multicenter Study, 52 Weeks Duration, Using Pimecrolimus Cream 1% for the Long-term Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients Within a Usual Clinical Setting|Completed||Phase 4|200|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:24:02.405322|2017-02-18 15:24:02.405322
NCT00509977|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2012-09-14|||April 2007||2007-04-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of Light Treatment and Laser Treatment for Melasma|A Randomized, Rater-blinded, Split-face Comparison of the Efficacy of Intense Pulse Light vs. Q-switched Nd:Yag Laser for the Treatment of Melasma.|Completed||N/A|17|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 15:24:02.51631|2017-02-18 15:24:02.51631
NCT00509964|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2007-07-31|||May 2007||2007-05-01|July 2007|2007-07-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Second-Line Irinotecan vs. ILF for AGC|A Randomized Phase II Trial of Irinotecan Monotherapy Versus Irinotecan, Leucovorin and 5-FU (ILF) Combination Chemotherapy in Patients With Advanced Gastric Cancer Failing Prior Chemotherapy|Unknown status|Recruiting|Phase 2|50|Anticipated|Gachon University Gil Medical Center||2|||f||||f||||||||||2017-02-18 15:24:02.626541|2017-02-18 15:24:02.626541
NCT00509951|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2013-06-06|||July 2007||2007-07-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias|Augmented Treatment of Specific Phobias in Children|Completed||N/A|154|Actual|Virginia Polytechnic Institute and State University||2|||f||||f||||||||||2017-02-18 15:24:02.717206|2017-02-18 15:24:02.717206
NCT00509938|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2008-10-16|||March 2006||2006-03-01|October 2008|2008-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients|Safety and Efficacy of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients Part A: Clinical Study Protocol SC12: Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients|Completed||Phase 1/Phase 2|8|Actual|AM-Pharma||1|||f||||t||||||||||2017-02-18 15:24:02.828523|2017-02-18 15:24:02.828523
NCT00509925|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2012-06-26|2010-04-19||July 2007||2007-07-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes|Effect of Insulin Detemir Compared to Insulin NPH Combined With Insulin Aspart on Energy Expenditure in Subjects With Type 1 Diabetes|Terminated||Phase 4|23|Actual|Novo Nordisk A/S|This open-label study was terminated prematurely due to 2 unplanned interim analyses having been performed. At this point, only 23 out of the planned 30 patients had been randomised into the study.|2||See detailed description|f||||f||||||||||2017-02-18 15:24:02.949155|2017-02-18 15:24:02.949155
NCT00509899|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-09-16|2011-12-15||June 2007||2007-06-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2007|Actual|2007-12-01||Interventional|||Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis|A Phase 1/2, Open-Label Study of the JAK2 Inhibitor INCB018424 Administered Orally to Patients With Primary Myelofibrosis (PMF) and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (Post-PV/ET)|Active, not recruiting||Phase 1/Phase 2|154|Actual|Incyte Corporation||1|||f||||f||||||||||2017-02-18 15:24:03.718643|2017-02-18 15:24:03.718643
NCT00509886|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2014-11-07|||June 2007||2007-06-01|November 2014|2014-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating|Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating|Completed||N/A|24|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 15:24:08.907535|2017-02-18 15:24:08.907535
NCT00509873|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2011-10-24|2010-06-15||August 2007||2007-08-01|October 2011|2011-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis||Completed||Phase 3|578|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:24:09.006497|2017-02-18 15:24:09.006497
NCT00509860|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2012-12-28|||March 2003||2003-03-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|August 2007|Actual|2007-08-01||Interventional|||Irinotecan (Camptosar) in Patients With Advanced Sarcomas|A Phase II Study of Irinotecan (Camptosar) in Patients With Advanced Sarcomas|Completed||Phase 2|38|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:24:09.64381|2017-02-18 15:24:09.64381
NCT00509847|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2014-05-26|||February 2009||2009-02-01|January 2010|2010-01-01|October 2009|Anticipated|2009-10-01|July 2009|Anticipated|2009-07-01||Interventional|LIST||A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis|A Phase-IIa, Double-blind, Randomized, Controlled Study on the Tolerability and Early Efficacy of hLF1-11 in Hospitalized Patients With Bacteremia Due to Staphylococcus Epidermidis|Withdrawn||Phase 1/Phase 2|0|Actual|AM-Pharma||1||conduct (recruitment) not feasible within timeframe|f||||t||||||||||2017-02-18 15:24:09.757301|2017-02-18 15:24:09.757301
NCT00509834|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2015-06-29|||July 2008||2008-07-01|April 2008|2008-04-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|SLIC||A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia|A Phase-IIa, Double-blind, Randomized Study on the Tolerability and Early Efficacy of hLF1-11 in Hospitalized Patients With Proven Candidaemia. (SLIC: Study of Lactoferrin Peptide in Infections With Candida)|Withdrawn||Phase 1/Phase 2|0|Actual|AM-Pharma||2||Patient population not available|f||||t||||||||||2017-02-18 15:24:09.865412|2017-02-18 15:24:09.865412
NCT00509821|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-04-22||2010-12-09|October 2007||2007-10-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|February 2010|Actual|2010-02-01||Interventional|||Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Patients With Newly Diagnosed Glioblastoma|Enzastaurin Before and Concomitant With Radiation Therapy, Followed by Enzastaurin Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma Without Methylation of the Promoter Gene of MGMT Enzyme - a Phase II Study|Completed||Phase 2|60|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:24:09.979124|2017-02-18 15:24:09.979124
NCT00509808|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2010-04-05|||January 2007||2007-01-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2008|Actual|2008-04-01||Interventional|GenNarino||Evaluation of an Electro-stimulator for the Treatment of Xerostomia|Safety and Performance Evaluation of an Electro-stimulator Mounted on an Intra-oral Removable Appliance (Saliwell GenNarino) for the Treatment of Xerostomia|Completed||Phase 4|200|Anticipated|Saliwell Ltd.||1|||f||||f||||||||||2017-02-18 15:24:10.089826|2017-02-18 15:24:10.089826
NCT00509795|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2012-12-20|2011-12-16||August 2007||2007-08-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|September 2010|Actual|2010-09-01||Interventional|VIEW1||Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)|A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects With Neovascular Age-Related Macular Degeneration|Completed||Phase 3|1217|Actual|Regeneron Pharmaceuticals||4|||f||||t||||||||||2017-02-18 15:24:10.227706|2017-02-18 15:24:10.227706
NCT00509782|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2012-07-31|||May 2005||2005-05-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase I Trial of ZIO-101 in Patients With Solid Tumors|Phase I Trial of ZIO-101 in Patients With Solid Tumors|Completed||Phase 1|47|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:24:13.558152|2017-02-18 15:24:13.558152
NCT00509769|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2013-02-22|2013-02-22||July 2007||2007-07-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer|A Phase II, Single-arm, Open-label Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed While Receiving HER2-Directed Therapy|Completed||Phase 2|112|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 15:24:13.840574|2017-02-18 15:24:13.840574
NCT00509756|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2010-10-21|||November 2007||2007-11-01|October 2010|2010-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Evaluating FXR-450 in Healthy Japanese Men|Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of FXR-450 Administered Orally to Healthy Japanese Male Subjects|Terminated||Phase 1|56|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2||Please see termination statement in the detailed description.|f||||||||||||||2017-02-18 15:24:14.22927|2017-02-18 15:24:14.22927
NCT00509743|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2009-02-11|||September 2007||2007-09-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|DFC-PK-008||Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium|An Open-Label, Single-Dose Study to Assess the Effects of Age, Weight, and Body Composition on the Pharmacokinetic Profile, Safety, and Tolerability of Intravenous Diclofenac Sodium (DIC075V) in Adult Volunteers|Completed||Phase 1|89|Anticipated|Javelin Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:24:14.327089|2017-02-18 15:24:14.327089
NCT00509730|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2009-10-06|||March 2007||2007-03-01|June 2008|2008-06-01|March 2010|Anticipated|2010-03-01|||||Interventional|VUSIS||Value of Urodynamics Prior to Stress Incontinence Surgery|Multicentered Randomized Controlled Trail to Test the Cost Effectiveness of Urodynamics in Women With Symptoms of Stress Urinary Incontinence in Whom Surgical Treatment is Considered|Terminated||N/A|290|Anticipated|Radboud University|||||f||||t||||||||||2017-02-18 15:24:14.428701|2017-02-18 15:24:14.428701
NCT00509717|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2008-07-09|||October 2006||2006-10-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs|Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs. A Randomized Trial.|Completed||N/A|70|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:24:14.514764|2017-02-18 15:24:14.514764
NCT00509704|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2010-11-08|||October 2008||2008-10-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|||||Observational|||Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma|Pilot Study on the Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma|Completed||N/A|10|Anticipated|Radboud University|||1||f||||f||||||||||2017-02-18 15:24:14.621509|2017-02-18 15:24:14.621509
NCT00509691|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2013-06-10|||June 2007||2007-06-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy|A Phase I Trial to Examine the Safety, Clinical, Immunologic and Virologic Effects of CMV pp65 Specific Cytotoxic T Lymphocytes for Recipients of Allogeneic Stem Cell Transplants With Persistent or Therapy Refractory Infections|Completed||Phase 1|20|Actual|University of Louisville||1|||f||||t||||||||||2017-02-18 15:24:14.897899|2017-02-18 15:24:14.897899
NCT00509678|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2012-01-16|||December 2006||2006-12-01|January 2012|2012-01-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Rituxan With or Without Methotrexate in Psoriatic Arthritis|Phase IB, Investigator-Initiated, Open-Label, Multi-Center Trial of Rituximab With or Without Methotrexate In Subjects With Psoriatic Arthritis and Psoriasis|Completed||Phase 1|6|Actual|Swedish Medical Center||1|||f||||t||||||||||2017-02-18 15:24:15.039909|2017-02-18 15:24:15.039909
NCT00509665|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2012-04-26|||June 2005||2005-06-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer|A Phase II Study of Gemcitabine in Combination With Doxorubicin for Patients With Head and Neck Cancer|Completed||Phase 2|17|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-02-18 15:24:15.14518|2017-02-18 15:24:15.14518
NCT00509652|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2007-07-27|||January 2006||2006-01-01|July 2007|2007-07-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis|Therapeutic Effect of Erythrocyte Apheresis as Compared to Full Blood Phlebotomy in Patients With Hereditary Hemochromatosis|Unknown status|Recruiting|N/A|67|Anticipated|University of Bergen||2|||f||||f||||||||||2017-02-18 15:24:15.256646|2017-02-18 15:24:15.256646
NCT00509639|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2012-12-12|||May 2005||2005-05-01|December 2012|2012-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease|Phase III Study to Evaluate the Effect of 10% Metronidazole Ointment, Applied Topically Three Times a Day in and Around the Anus and the Change in Perianal Crohn's Disease Activity|Completed||Phase 3|74|Actual|S.L.A. Pharma AG||2|||f||||f||||||||||2017-02-18 15:24:15.366117|2017-02-18 15:24:15.366117
NCT00509626|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2010-02-11|||June 2007||2007-06-01|February 2010|2010-02-01||||July 2008|Actual|2008-07-01||Interventional|||Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy|A Physical Activity Intervention to Prevent Weight Gain in Breast Cancer Patients|Completed||Phase 1/Phase 2|380|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 15:24:15.475557|2017-02-18 15:24:15.475557
NCT00509600|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2012-08-01|2009-08-31||September 2004||2004-09-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia|Phase IIA Window Study of Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center|Early termination due to low accrual. Rare disease with less than 100 cases diagnosed per year.|1||Slow enrollment; study terminated.|f||||t||||||||||2017-02-18 15:24:15.653907|2017-02-18 15:24:15.653907
NCT00509587|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-10-20|2015-08-10||June 2007||2007-06-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|July 2009|Actual|2009-07-01||Interventional|||Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer|A Phase 2 Study of GW786034 (Pazopanib) in Patients With Recurrent and/or Metastatic Invasive Breast Carcinoma|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:24:16.026326|2017-02-18 15:24:16.026326
NCT00509574|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-29|2010-12-10|||March 2007||2007-03-01|November 2010|2010-11-01|February 2010|Anticipated|2010-02-01|||||Observational|||Association of Genetic Polymorphisms With Lipid Lowering Effects of Statin Therapy|Association of Genetic Polymorphisms With Lipid Lowering Effects of Statin Therapy|Unknown status|Recruiting|Phase 4|200|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     blood samples are obtained for genomic DNA extraction.~   "|||2017-02-18 15:24:16.333169|2017-02-18 15:24:16.333169
NCT00509561|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2012-12-17|||February 2008||2008-02-01|December 2012|2012-12-01||||September 2012|Actual|2012-09-01||Interventional|||Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer|A Randomised Phase II/III Multi-Centre Clinical Trial of Definitive Chemotherapy, With or Without Cetuximab, in Carcinoma of the Oesophagus|Unknown status|Active, not recruiting|Phase 2/Phase 3|259|Actual|Wales Cancer Trials Unit||2|||f||||t||||||||||2017-02-18 15:24:16.412616|2017-02-18 15:24:16.412616
NCT00509548|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2010-03-25|||July 2007||2007-07-01|March 2010|2010-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD|An Open-Label Randomized Pilot Study of Safety and Preliminary Efficacy of TG100801 in Patients With Choroidal Neovascularization Due to Age-Related Macular Degeneration|Terminated||Phase 2|7|Actual|TargeGen||2|||f||||f||||||||||2017-02-18 15:24:16.586833|2017-02-18 15:24:16.586833
NCT00509535|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2007-07-30|||January 2005||2005-01-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Prospective, Randomized, Double Blind Comparative Study on the Use of Two Creams in Xerosis Atopic Probands|Prospective, Randomized, Double Blind Comparative Study on the Use of Two Creams in Xerosis Atopic Probands Biomedical Findings With Vitreoscilla Filiformis|Completed||N/A|75|Actual|L'Oreal||2|||f||||t||||||||||2017-02-18 15:24:16.701386|2017-02-18 15:24:16.701386
NCT00509509|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-29|2012-05-22||||||May 2012|2012-05-01||||||||Observational|||High Risk Breast Cancer Screening Program|High Risk Breast Cancer Screening Program|Unknown status|Recruiting|N/A|||Organisation for Oncology and Translational Research|||1||f||||||||||||||2017-02-18 15:24:16.801974|2017-02-18 15:24:16.801974
NCT00509496|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2013-01-04|2012-10-31||June 2007||2007-06-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes|Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes|Terminated||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)||2||Low accrual|f||||t||||||||||2017-02-18 15:24:16.888543|2017-02-18 15:24:16.888543
NCT00509483|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2008-10-16|||January 2002||2002-01-01|October 2008|2008-10-01|December 2006||2006-12-01|||||Interventional|||Three-Year Follow-up of Radioiodine Therapy for Goitre|Long-Term Follow-up and Outcome of Administering Recombinant Human Thyrotropin as an Adjuvant of Therapy With Radioiodine in the Outpatient Treatment of Multinodular Goitres|Completed||N/A|40||University of Sao Paulo||1|||f||||f||||||||||2017-02-18 15:24:17.557761|2017-02-18 15:24:17.557761
NCT00509470|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-28|2016-10-17|||July 2007||2007-07-01|October 2016|2016-10-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|ONEAST||Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine|ONgoing Evaluation of Depressor Effect And Safety of Combination Therapy With Telmisartan and Low-dose Hydrochlorothiazide in Patients With Hypertension Uncontrolled on Amlodipine Treatment|Completed||Phase 4|75|Actual|Tokyo University||2|||f||||f||||||||||2017-02-18 15:24:17.628801|2017-02-18 15:24:17.628801
NCT00509457|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2011-06-30|||November 2006||2006-11-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|||||Interventional|||GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC)|Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC). A Phase II Study of GV 1001 Telomerase Peptide Vaccination in Patients With Locally Advanced NSCLC|Completed||N/A|20|Anticipated|Oslo University Hospital||1|||f||||||||||||||2017-02-18 15:24:17.728393|2017-02-18 15:24:17.728393
NCT00509444|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2012-06-18|||October 2006||2006-10-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2010|Actual|2010-12-01||Interventional|CPTD||Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial|Cancer Prevention and Treatment Among African American Older Adults|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-02-18 15:24:17.812401|2017-02-18 15:24:17.812401
NCT00509431|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-02-05|||August 2006||2006-08-01|February 2016|2016-02-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma|A Phase I/II, Dual-Center, Open-Label Trial of the Safety and Efficacy of Tarceva™ (Erlotinib Hydrochloride) Plus Sirolimus in Patients With Recurrent Malignant Glioma Not on P450-Inducing Anti-Epileptics|Completed||Phase 1|19|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:24:18.034343|2017-02-18 15:24:18.034343
NCT00509418|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2009-01-09|||February 2007||2007-02-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis|Efficacy and Safety of Viusid, a Nutritional Supplement, in Patients With Nonalcoholic Steatohepatitis. A Randomized, Controlled and Open Label Study|Completed||Phase 3|60|Actual|Catalysis SL||2|||f||||t||||||||||2017-02-18 15:24:18.145756|2017-02-18 15:24:18.145756
NCT00509405|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2012-04-23|||July 2007||2007-07-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural|Effect of Neutralization of Endogenous Acid Production on Bone Mineral Density and Microarchitectural Composition of Bone in Humans|Completed||Phase 3|202|Actual|Kantonsspital Baselland Bruderholz||1|||f||||f||||||||||2017-02-18 15:24:18.253525|2017-02-18 15:24:18.253525
NCT00509392|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2009-12-11|||March 2007||2007-03-01|December 2009|2009-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|RECOVERY||ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.|Radiofrequency Endovenous ClosureFAST vs. Laser Ablation for the Treatment of Great Saphenous Reflux: A Multicenter, Single-Blinded, Randomized Study (RECOVERY)|Completed||Phase 4|87|Actual|VNUS Medical Technologies, A Covidien Company||2|||f||||f||||||||||2017-02-18 15:24:18.369723|2017-02-18 15:24:18.369723
NCT00509379|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2011-01-27|||September 2006||2006-09-01|July 2009|2009-07-01|January 2011|Actual|2011-01-01|November 2007|Actual|2007-11-01||Interventional|LYM-2023||Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma|A Phase II Multicenter Non-randomized Study to Assess Safety, Toxicity and Clinical Activity of the Association of Bortezomib(VELCADE)With Rituximab in Relapsed/Refractory Indolent Non Follicular and Mantle-cell Non-Hodgkin Lymphoma|Completed||Phase 2|48|Actual|Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie||1|||f||||t||||||||||2017-02-18 15:24:18.48374|2017-02-18 15:24:18.48374
NCT00509366|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2014-08-15|2014-05-07||May 2007||2007-05-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|TOP0602|The number of participants in each group reflects the number of participants at the end of the study period (COMPLETED) in the Participant Flow Analysis, with the exception of 3 patients who were assigned treatment, but not treated, and were added to the number of screen failures.|Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer|Phase II Prospective Study Evaluating the Role of Personalized Chemotherapy Regimens for Chemo-Naive Select Stage IIIB and IV Non-Small Cell Lung Cancer (NSCLC) in Patients Using a Genomic Predictor of Platinum Resistance to Guide Therapy|Terminated||Phase 2|101|Actual|Duke University|The microarray-based prediction model of chemotherapy sensitivity, used to allocate patients into the cisplatin treatment arms, was irreproducible and inaccurate. Quality of life measurements were incomplete and could not be analyzed.|4||Study terminated due to reproducibility issues with genomics prediction model.|f||||t||||||||||2017-02-18 15:24:18.627101|2017-02-18 15:24:18.627101
NCT00509353|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2014-08-28|||January 2007||2007-01-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|October 2010|Actual|2010-10-01||Interventional|||N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma|Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma, A Phase I Study|Completed||Phase 1|26|Actual|Children's Hospital Los Angeles||1|||f||||t||||||||||2017-02-18 15:24:20.08929|2017-02-18 15:24:20.08929
NCT00509340|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2013-06-20|||June 2007||2007-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy|Cognitive Behavioral Adherence Intervention for Depressed HIV Patients|Terminated||Phase 1|7|Actual|RAND||2||Inability to recruit enough eligible participants at study site.|f||||t||||||||||2017-02-18 15:24:20.192281|2017-02-18 15:24:20.192281
NCT00509327|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2007-07-30|||November 2004||2004-11-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Randomized Clinical Trial of Bisacodyl Versus Placebo on Postoperative Bowel Motility in Elective Colorectal Surgery|Randomized Clinical Trial of Bisacodyl Versus Placebo on Postoperative Bowel Motility in Elective Colorectal Surgery|Completed||Phase 4|200|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 15:24:20.29634|2017-02-18 15:24:20.29634
NCT00509314|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-29|2007-07-29|||May 2006||2006-05-01|May 2006|2006-05-01|December 2016|Anticipated|2016-12-01|||||Observational|||The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis|The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis|Unknown status|Recruiting|N/A|400|Anticipated|National Taiwan University Hospital|||||f||||t||||||||||2017-02-18 15:24:20.391361|2017-02-18 15:24:20.391361
NCT00509301|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2011-08-03|||November 2006||2006-11-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme|Open-label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B MAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme|Completed||Phase 1|12|Anticipated|Peregrine Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:24:20.475606|2017-02-18 15:24:20.475606
NCT00509288|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2012-12-27|2012-11-14||June 2007||2007-06-01|December 2012|2012-12-01|July 2012|Actual|2012-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes|Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes|Completed||Phase 2|24|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 15:24:20.58936|2017-02-18 15:24:20.58936
NCT00509275|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2011-07-12|||July 2007||2007-07-01|October 2010|2010-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)|A Phase Ib, Randomized, Double Blind, Placebo Controlled Study to Investigate the Pharmacokinetics, Safety and Efficacy of 3 Different Doses of W0027 and Placebo Capsules in Subjects With Clinically and Mycologically Proven MTTP|Completed||Phase 1|120|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 15:24:21.429416|2017-02-18 15:24:21.429416
NCT00509262|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2015-04-27|2012-02-28||October 2007||2007-10-01|April 2015|2015-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency Who Have Inadequate Glycemic Control|Completed||Phase 3|426|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:24:21.541872|2017-02-18 15:24:21.541872
NCT00509249|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2015-01-07|2014-12-12||September 2007||2007-09-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Aflibercept in Treating Patients With Myelodysplastic Syndromes|A Phase II Study of VEGF Trap (NSC 724770) in Patients With MDS|Terminated||Phase 2|18|Actual|National Cancer Institute (NCI)|Study was terminiated after completion of the first stage due to a lack of activity (no hematological responses were observed).|1||Early termination for discouraging results|f||||t||||||||||2017-02-18 15:24:22.353425|2017-02-18 15:24:22.353425
NCT00368225|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2017-01-24|||June 22, 2006||2006-06-22|January 22, 2009|2009-01-22|January 22, 2009||2009-01-22|||||Observational|||Transplant-Related Accelerated Progression of Hepatitis C|Transplant-Related Accelerated Progression of Hepatitis C (TRAP-C)|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:27.250013|2017-02-18 16:18:27.250013
NCT00509236|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2015-03-23|2012-02-13||October 2007||2007-10-01|March 2015|2015-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)|A Multicenter, Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease Who Are on Dialysis and Who Have Inadequate Glycemic Control|Completed||Phase 3|129|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:24:22.759157|2017-02-18 15:24:22.759157
NCT00509223|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-29|2013-12-04|2013-08-08||July 2007||2007-07-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||118 subjects (of the 416 that started in the participant flow module) were not included in endpoint analysis due to reanalysis of OSA inclusion criteria. Thus, 298 of the 416 were included for final analysis.|GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes|Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes and Obstructive Sleep Apnea|Completed||N/A|416|Actual|ResMed||2|||f||||f||||||||||2017-02-18 15:24:23.310358|2017-02-18 15:24:23.310358
NCT00509210|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2008-10-28|||September 2007||2007-09-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Telaprevir in Subjects With Hepatic Impairment||Completed||Phase 1|||Vertex Pharmaceuticals Incorporated|||||f||||t||||||||||2017-02-18 15:24:23.757534|2017-02-18 15:24:23.757534
NCT00509197|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2016-07-05|2015-05-26||October 2007||2007-10-01|July 2016|2016-07-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?|Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?|Terminated||N/A|12|Actual|Université de Montréal|Very small sample size. Impossible to recruit the anticipated number of subjects.|2||Inability to complete the recruitment.|f||||f||||||||No||2017-02-18 15:24:23.842061|2017-02-18 15:24:23.842061
NCT00509184|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2013-07-21|||March 2008||2008-03-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|MIR||Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma|Therapy of Nodal Follicular Lymphoma (Grade I/II) Clinical Stage I or II Using Involved Field Radiotherapy in Combination With Rituximab|Completed||Phase 2|85|Actual|Heidelberg University||1|||f||||t||||||||||2017-02-18 15:24:24.426083|2017-02-18 15:24:24.426083
NCT00509171|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-12-06|||January 2005||2005-01-01|December 2016|2016-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|RIA||Effect of a Novel Reamer-Irrigator-Aspirator on the Incidence of Fat Embolism|A Prospective Randomized Trial Investigating the Effect of a Novel Reamer-Irrigator-Aspirator on the Incidence of Fat Embolism and Respiratory Function During Intramedullary Nailing of Femoral Shaft Fractures|Completed||N/A|22|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||No||2017-02-18 15:24:24.56414|2017-02-18 15:24:24.56414
NCT00509158|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2010-02-22|||October 2007||2007-10-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|LSA-3-rec||Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine|Phase I and IIa Trial for Assessment of Safety, Immunogenicity and Efficacy Against Sporozoite Challenge of the Candidate Malaria Vaccine PfLSA-3-rec|Completed||Phase 1/Phase 2|36|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 15:24:24.670147|2017-02-18 15:24:24.670147
NCT00509145|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2012-02-16||2012-02-16|December 2007||2007-12-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|ALLEGRO||Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)|A Multinational, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study, to Evaluate the Safety, Tolerability and Efficacy of Daily Oral Administration of Laquinimod 0.6 mg in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)|Completed||Phase 3|1106|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-02-18 15:24:24.769633|2017-02-18 15:24:24.769633
NCT00509132|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2008-01-08|||May 2007||2007-05-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Tolerance and Pharmacokinetic Study of Trodusquemine in Healthy Volunteers|A Phase I, Double-Blind, Randomized, Placebo-Controlled Ascending IV Single-Dose Tolerance and Pharmacokinetic Study of Trodusquemine in Healthy Volunteers|Completed||Phase 1|42|Anticipated|Genaera Corporation||6|||f||||||||||||||2017-02-18 15:24:24.87997|2017-02-18 15:24:24.87997
NCT00509119|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2015-04-24|||December 2006||2006-12-01|October 2010|2010-10-01|December 2008|Anticipated|2008-12-01|||||Observational|||ICP Waveform Analysis in Stroke Patients|Retrospective ICP Waveform Analysis in Stroke Patients Followed Prospectively|Withdrawn||N/A|0|Actual|Oslo University Hospital|||1|Change of workplace for leading investigator, not replaced|f||||f||||||||||2017-02-18 15:24:24.958115|2017-02-18 15:24:24.958115
NCT00509106|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2010-11-09|2010-10-12||July 2007||2007-07-01|November 2010|2010-11-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|CAP||Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia|A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Ceftriaxone in the Treatment of Adult Subjects With Community-Acquired Pneumonia|Completed||Phase 3|622|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 15:24:25.051766|2017-02-18 15:24:25.051766
NCT00509093|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-10-31|||December 2008||2008-12-01|October 2016|2016-10-01||||April 2013|Actual|2013-04-01||Interventional|||Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy|A Phase 2 Study of Imatinib Mesylate (Gleevec) as Maintenance Therapy After Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed C-kit Positive Acute Myeloid Leukemia|Active, not recruiting||Phase 2|32|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:24:25.903247|2017-02-18 15:24:25.903247
NCT00509080|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-07-11|||April 2006||2006-04-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Observational|||Prognosis in Asymptomatic Mitral Regurgitation (PAMIR) Study|Prognosis in Asymptomatic Mitral Regurgitation (PAMIR) Study|Active, not recruiting||N/A|200|Anticipated|University Hospital, Basel, Switzerland|||1||f||||t||||||Samples Without DNA|"~     Blood samples~   "|No||2017-02-18 15:24:26.035197|2017-02-18 15:24:26.035197
NCT00509067|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2014-02-10|2013-07-01||November 2007||2007-11-01|February 2014|2014-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|STAR-1||Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia|Interventions to Test the Alpha7 Nicotinic Receptor Model in Schizophrenia|Completed||Phase 2|43|Actual|Georgetown University||2|||f||||f||||||||||2017-02-18 15:24:26.147137|2017-02-18 15:24:26.147137
NCT00509054|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2008-04-15|||January 2001||2001-01-01|January 2001|2001-01-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Prevention of Parastomal Hernia With a Mesh|Randomised Clinical Trial of the Use of a Prosthetic Mesh to Prevent Parastomal Hernia|Completed||Phase 4|54|Anticipated|Sundsvall Hospital||2|||f||||t||||||||||2017-02-18 15:24:26.59247|2017-02-18 15:24:26.59247
NCT00509041|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2016-07-11|2012-12-11||August 2007||2007-08-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|February 2010|Actual|2010-02-01||Interventional|||Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma|A Phase II Study of Dasatinib (NSC #732517) in Patients With Previously Treated Malignant Mesothelioma|Completed||Phase 2|46|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:24:26.704852|2017-02-18 15:24:26.704852
NCT00509028|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-07-24|2009-10-06||December 2006||2006-12-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma|An Open-label, Multi-center, Long Term Study to Investigate the Safety and Efficacy of Budesonide Turbuhaler® Treatment for 48 Weeks (Following 6 Weeks Phase III Study) in Japanese Children With Bronchial Asthma Aged 5 Years to 15 Years Old|Completed||Phase 3|241|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:24:27.352524|2017-02-18 15:24:27.352524
NCT00509015|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-30|2008-08-12|||February 2008||2008-02-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|MDATRANS||Mass-Drug Administration to Reduce Malaria Transmission|Mass-Drug Administration With a Gametocytocidal Drug Combination, a Model for a Transmission Blocking Vaccine|Completed||N/A|6000|Anticipated|Radboud University||2|||f||||t||||||||||2017-02-18 15:24:27.926063|2017-02-18 15:24:27.926063
NCT00509002|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-09-22|||May 2004||2004-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Iressa Study in Patients With Salivary Gland Cancer|Phase II Study of ZD1839 (Iressa®), Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor in Patients With Advanced, Recurrent or Metastatic Salivary Gland Cancer (IRUSIRES0198)|Completed||Phase 2|37|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:24:28.041057|2017-02-18 15:24:28.041057
NCT00508989|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2017-01-24|||July 24, 2007||2007-07-24|December 24, 2015|2015-12-24|December 24, 2015|Actual|2015-12-24|December 31, 2010|Actual|2010-12-31||Interventional|||Niacin to Improve Blood Flow in People With Sickle Cell Disease|Niacin Therapy to Improve Endothelial Function in Sickle Cell Disease|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 15:24:28.157197|2017-02-18 15:24:28.157197
NCT00508976|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2012-05-09|||June 2007||2007-06-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic|Evaluation of Aerosolized Bupivacaine Versus Pre-incision Lidocaine Versus Instilled Liquid Bupivacaine Versus Post-operative Bupivacaine Injection for Optimization of Post-operative Pain Control in Laparoscopic Bariatric Surgical Patients|Completed||Phase 2|100|Actual|Pinnacle Health System||4|||f||||t||||||||||2017-02-18 15:24:28.433435|2017-02-18 15:24:28.433435
NCT00508963|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2014-12-12||||||December 2014|2014-12-01||||||||Expanded Access|||Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis|Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis|Available||N/A|||University of California, San Francisco|||||||||||||||||||2017-02-18 15:24:28.569208|2017-02-18 15:24:28.569208
NCT00508950|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2016-08-16|||August 2007||2007-08-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay|Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Pneumococcal Opsonophagocytic Assay Development.|Completed||N/A|152|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:24:28.657517|2017-02-18 15:24:28.657517
NCT00508937|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2011-10-04|||February 2007||2007-02-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Dietary Protein and Insulin Sensitivity Study|The Effects of Increased Dietary Protein Intake on Insulin Sensitivity in Stable Weight Individuals, Independent of Dietary Content of Carbohydrate and Saturated Fat|Completed||N/A|250|Anticipated|Children's Hospital & Research Center Oakland||5|||f||||f||||||||||2017-02-18 15:24:28.756892|2017-02-18 15:24:28.756892
NCT00508924|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2012-11-06|2012-11-06||August 2005||2005-08-01|November 2012|2012-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)|A Randomised, Open, Parallel-group, Multicentre Study to Examine the Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Combination With Clopidogrel and Aspirin in Patients Undergoing Elective Percutaneous Coronary Intervention in Comparison With Unfractionated Heparin, Clopidogrel and Aspirin|Completed||Phase 2|140|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||||||||||||2017-02-18 15:24:28.878745|2017-02-18 15:24:28.878745
NCT00508911|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2010-10-13||2010-10-13|June 2007||2007-06-01|October 2010|2010-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills.|An Open-label, Repeat-dose, Single-sequence Study to Investigate the Effects of Once-daily Repeat Oral Administration of GW876008 125mg on the Pharmacokinetics of the Combined Oral Contraceptive in Female Volunteers|Terminated||Phase 1|4|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:24:29.535028|2017-02-18 15:24:29.535028
NCT00508898|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2015-07-31|||May 2008||2008-05-01|January 2009|2009-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria|The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria|Withdrawn||Phase 4|0|Actual|Chinese University of Hong Kong||2||Funding problem; trial abandoned.|f||||f||||||||||2017-02-18 15:24:29.626555|2017-02-18 15:24:29.626555
NCT00508885|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2007-07-26|||October 2006||2006-10-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients|The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients|Completed||Phase 1/Phase 2|17|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 15:24:29.726935|2017-02-18 15:24:29.726935
NCT00508508|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2013-06-17|||April 2007||2007-04-01|July 2011|2011-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Effectiveness of Peer Support in Improving Heart Failure Self-Management and Care|Mobilizing Peer Support for Effective Heart Failure Self-Management|Completed||N/A|266|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 15:24:41.300339|2017-02-18 15:24:41.300339
NCT00508872|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2012-07-27|2010-10-08||November 2005||2005-11-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Folfox-B Study for Patients With Colorectal Liver Metastases|Single-Institution Phase II Trial of Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab (Folfox-B) for Initially Unresectable Colorectal Liver Metastases: Downstaging Followed By Hepatic Resection|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Slow accrual, study terminated.|f||||f||||||||||2017-02-18 15:24:29.847327|2017-02-18 15:24:29.847327
NCT00508859|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2007-07-27|||July 1997||1997-07-01|July 2007|2007-07-01||||||||Interventional|MTAD||Maintenance Study for Adolescent Depression||Completed||Phase 4|93|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 15:24:30.090181|2017-02-18 15:24:30.090181
NCT00508846|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-03-10|||May 2003||2003-05-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients|Screening for Gynecologic Cancers Among Women With Hereditary Non-Polyposis Colon Cancer (HNPCC)|Completed||N/A|93|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:24:30.198734|2017-02-18 15:24:30.198734
NCT00508833|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2007-07-27|||March 2000||2000-03-01|July 2007|2007-07-01||||||||Interventional|||Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)|Safety and the Efficacy of GSK Biologicals' Candidate Adjuvanted Vaccines (287615) Containing HBsAg With Various Adjuvants to Induce Cytotoxic T Lymphocytes (CTL) in Healthy Adult Volunteers|Completed||Phase 1/Phase 2|200|Anticipated|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:24:30.310955|2017-02-18 15:24:30.310955
NCT00508820|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2017-02-07|2012-01-11||February 2005||2005-02-01|February 2017|2017-02-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP|An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|Completed||Phase 3|407|Actual|Amgen||1|||f||||||||||||||2017-02-18 15:24:30.406408|2017-02-18 15:24:30.406408
NCT00508807|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2012-07-27|||April 2006||2006-04-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies|Clinical Study Protocol RTA 402-C-0501: A Phase I Dose-finding and Pharmacokinetic Study of RTA 402 (CDDO-Me) Administered Orally for 21 Days of a 28-day Cycle in Patients With Advanced Solid Tumors or Lymphoid Malignancies|Completed||Phase 1|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:24:31.276765|2017-02-18 15:24:31.276765
NCT00508794|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2016-11-28|||March 2006||2006-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||Effects of Yoga in Breast Cancer Patients|Biobehavioral Effects of Yoga During Breast Cancer Treatment|Active, not recruiting||N/A|180|Anticipated|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-02-18 15:24:31.387806|2017-02-18 15:24:31.387806
NCT00508781|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2007-07-26|||November 2002||2002-11-01|November 2002|2002-11-01|December 2012|Anticipated|2012-12-01|||||Observational|||Multiphoton Laser Scanning Microscopy in Cutaneous Optical Pathology|Multiphoton Laser Scanning Microscopy in Cutaneous Optical Pathology|Unknown status|Recruiting|N/A|400|Anticipated|National Taiwan University Hospital|||||f||||t||||||||||2017-02-18 15:24:31.500056|2017-02-18 15:24:31.500056
NCT00508768|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2011-05-18||||||April 2010|2010-04-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis|A Randomized, Double-Blind, Parallel-Group, Pharmacokinetic Study of Oral SCIO-469 (90 mg qd and 30 mg Tid) in Female Subjects With Active Rheumatoid Arthritis|Completed||Phase 1|16|Actual|Scios, Inc.|||||||||||||||||||2017-02-18 15:24:31.582069|2017-02-18 15:24:31.582069
NCT00508755|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2014-04-08|2013-10-18||August 2005||2005-08-01|April 2014|2014-04-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional||This was a feasibility study of six subjects. Sample size was constrained by funding limit.|Feasibility and Practice Characteristics of FNS and Gait Robot|Feasibility and Practice Characteristics of FNS and Gait Robot|Completed||N/A|6|Actual|VA Office of Research and Development|This was a feasibility study to determine the possibility of combining two technologies. Further study of the combined treatment is needed to determine whether the feasible combined treatment is more effective than other methods.|1|||f||||f||||||||||2017-02-18 15:24:31.670352|2017-02-18 15:24:31.670352
NCT00508742|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2013-05-06|2012-06-12||December 2007||2007-12-01|May 2013|2013-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization|A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization With Vaccine Serotypes of Streptococcus Pneumoniae in Healthy Infants in Israel.|Completed||Phase 3|1866|Actual|Pfizer|Study designated analysis of effect of 13vPnC on serotypes 6A+19A, changed prior to unblinding, to effect on 6A’+19A. Serotype 6A found to include serotype 6A isolates and isolates of newly identified serotype 6C. Serotype 6A assessed as 6A+6C (6A’).|2|||f||||f||||||||||2017-02-18 15:24:32.055175|2017-02-18 15:24:32.055175
NCT00508729|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2007-07-29|||October 2007||2007-10-01|July 2007|2007-07-01|October 2010|Anticipated|2010-10-01|||||Interventional|||Effect of Traditional Chinese Medicine on GI Function Recovery and Nutrition Support in SAP|Effect of Traditional Chinese Medicine on Gastrointestinal Function Recovery and Nutrition Support in Severe Acute Pancreatitis|Unknown status|Not yet recruiting|Phase 2/Phase 3|300|Anticipated|Tianjin Nankai Hospital|||||f||||f||||||||||2017-02-18 15:24:34.589581|2017-02-18 15:24:34.589581
NCT00508716|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2015-03-25|2015-03-15||March 2007||2007-03-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2010|Actual|2010-12-01||Interventional|||Health Literacy in Patients With Congestive Heart Failure|A Randomized-Controlled Trial of a Health Literacy Tailored Educational Intervention for Hospitalized Congestive Heart Failure Patients|Completed||N/A|124|Actual|Griffin Hospital||2|||f||||f||||||||||2017-02-18 15:24:34.67543|2017-02-18 15:24:34.67543
NCT00508703|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-10-03|||March 2003||2003-03-01|October 2016|2016-10-01||||September 2018|Anticipated|2018-09-01||Observational|||Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy|Pilot Study of Intensity Modulated Radiotherapy (IMRT) to Pelvis Post-Hysterectomy With Analysis of Clinical Target Volume Motion and Relation to Position and Volume of Bladder and Rectum During Course of Radiotherapy for Use in Optimization of Margin Size|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:24:35.110403|2017-02-18 15:24:35.110403
NCT00508690|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2012-09-18|||September 2007||2007-09-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics|Randomized Controlled Trial of Antibiotic Prophylaxis in Elective Laparoscopic Colorectal Surgery: Oral and Systemic Versus Systemic Antibiotics|Completed||Phase 3|584|Actual|Japan Multinational Trial Organization||2|||f||||t||||||||||2017-02-18 15:24:35.229187|2017-02-18 15:24:35.229187
NCT00508677|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2009-09-30|||March 2008||2008-03-01|July 2007|2007-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|MAZDAH||Mazindol in Children With ADHD : Open-label, Efficacy, Safety and Pharmacokinetic Pilot Trial|Mazindol in Children With Attention Deficit Hyperactivity Disorder Design Study to Explore the Effectiveness, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Orally Administered Doses of Mazindol.|Completed||N/A|24|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||||||2017-02-18 15:24:35.347295|2017-02-18 15:24:35.347295
NCT00508664|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2015-06-01|||July 2007||2007-07-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|DeLOS II||Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)|Randomised Phase II Screening Study to be Used in an TP/TPF-chemotherapy (Short Induction) Before TP/TPF-induction, Radiotherapy With or Without Cetuximab in the Primary Therapy of the Only by Laryngectomy Operable Carcinoma of the Larynx/Hypopharynx|Completed||Phase 2|180|Actual|University of Leipzig||2|||f||||f||||||||||2017-02-18 15:24:35.444058|2017-02-18 15:24:35.444058
NCT00508651|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2011-11-28|2011-09-08||October 2007||2007-10-01|November 2011|2011-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age|An Expanded Phase1/2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-560, A Live, Attenuated Recombinant Parainfluenza Virus Type 3 (PIV3) Vaccine, Administered Intranasally to Healthy Infants 1 to <12 Mos. of Age|Terminated||Phase 1/Phase 2|30|Actual|MedImmune LLC|Cohort 2 was not enrolled due to a sponsor decision.|2||"The study was closed prior to enrollment of Cohort 2 due to a non-safety related sponsor~   decision."|f||||f||||||||||2017-02-18 15:24:35.594589|2017-02-18 15:24:35.594589
NCT00508638|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2015-06-01|||May 2007||2007-05-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2014|Actual|2014-12-01||Observational|Stratify||Identifying High- and Low-Risk Heart Failure Patients in the Emergency Department (The Stratify Study)|Improving Heart Failure Risk Stratification in the ED|Active, not recruiting||N/A|1200|Anticipated|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 15:24:39.338275|2017-02-18 15:24:39.338275
NCT00508625|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-06-10||2016-03-02|June 2006||2006-06-01|June 2016|2016-06-01|November 2011|Actual|2011-11-01|March 2009|Actual|2009-03-01||Interventional|||A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab|A Multicenter, Open Label, Randomized Study of AMG 951 in Subjects With Previously Untreated Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy With or Without Bevacizumab|Completed||Phase 2|213|Actual|Amgen||5|||f||||||||||||||2017-02-18 15:24:39.432214|2017-02-18 15:24:39.432214
NCT00508612|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2016-07-11|||April 2007||2007-04-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|May 2009|Actual|2009-05-01||Interventional|||Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth|Impact of LifeSkills Training on Blood Pressure in Youth|Completed||Phase 2|259|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||f||||||||||2017-02-18 15:24:39.548072|2017-02-18 15:24:39.548072
NCT00508599|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2008-04-22|||May 2003||2003-05-01|April 2008|2008-04-01|February 2006|Actual|2006-02-01|October 2004|Actual|2004-10-01||Interventional|||The Effects of Two Days of Bedrest on Insulin Resistance in Type 2 Diabetics|Effect of a 2-Day Bed Rest on Metabolic and Cardiovascular Risk Factors in Type 2 Diabetic Patients|Completed||N/A|16|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 15:24:39.659027|2017-02-18 15:24:39.659027
NCT00508586|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-03-01|||November 2007||2007-11-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer|A Phase 1b Study to Assess the Safety, Feasibility, Pharmacokinetics, and Activity of PTC299 Monotherapy or Combination Therapy With Hormonal Agents in Patients With Metastatic Breast Cancer|Completed||Phase 1|33|Actual|PTC Therapeutics||1|||f||||f||||||||||2017-02-18 15:24:39.768547|2017-02-18 15:24:39.768547
NCT00508573|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-11-15|||May 2007||2007-05-01|November 2016|2016-11-01||||May 2018|Anticipated|2018-05-01||Observational|||Registry for Women Who Are At Risk Or May Have Lynch Syndrome|Registry for Women Who Are At Risk Or May Have Lynch Syndrome|Recruiting||N/A|1000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Leftover tissue samples will be collected from surgery performed. These samples will be~     stored and used to perform molecular studies to characterize Lynch syndrome tumors.~   "|||2017-02-18 15:24:39.878867|2017-02-18 15:24:39.878867
NCT00508560|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2015-06-25|||July 2007||2007-07-01|June 2015|2015-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders|Contingency Management for Smoking Cessation Among Veterans With Schizophrenia or Other Psychoses|Terminated||N/A|23|Actual|VA Office of Research and Development||2||Stopped due to low recruitment.|f||||f||||||||||2017-02-18 15:24:39.992523|2017-02-18 15:24:39.992523
NCT00508547|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2017-01-26|||December 2009||2009-12-01|January 2017|2017-01-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|||Psoriasis Longitudinal Assessment and Registry (PSOLAR)|A Multicenter, Open Registry of Patients With Plaque Psoriasis Who Are Candidates for Systemic Therapy Including Biologics|Active, not recruiting||N/A|1013|Actual|Janssen Scientific Affairs, LLC|||4||f||||f||||||||||2017-02-18 15:24:40.116001|2017-02-18 15:24:40.116001
NCT00508534|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2009-05-15|||July 2007||2007-07-01|May 2009|2009-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People|An Open-Label Study to Evaluate the Effects of Repeat Dosing of Esomeprazole on the Pharmacokinetics of SB-751689 in Healthy Adult Subjects|Completed||Phase 1|13|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:24:40.729028|2017-02-18 15:24:40.729028
NCT00508521|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2013-12-19|2013-10-30||January 2007||2007-01-01|December 2013|2013-12-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Treatment of Hand Dysfunction After Stroke|Treatment of Hand Dysfunction After Stroke|Completed||N/A|4|Actual|VA Office of Research and Development|This was a small pilot feasibility study providing data for future work.|2|||f||||f||||||||||2017-02-18 15:24:40.833283|2017-02-18 15:24:40.833283
NCT00508495|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2011-08-10|||August 2007||2007-08-01|August 2011|2011-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain|Single-Dose Comparison of the Analgesic Efficacy, Safety and Tolerability of Two Paracetamol 1%-Containing Solutions and Placebo in a Post-Surgical Total Hip Replacement Model|Completed||Phase 3|148|Actual|Baxter Healthcare Corporation||3|||f||||f||||||||||2017-02-18 15:24:41.415088|2017-02-18 15:24:41.415088
NCT00508482|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2014-05-22|2012-11-28||April 2008||2008-04-01|May 2014|2014-05-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation|A Clinical Standardization Study of the Preferred Acupuncture Treatment Protocol to Treat Functional Constipation|Completed||Phase 2|475|Actual|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Spontaneous bowel movements were used as the primary outcome in our trial rather than complete, spontaneous bowel movements. Outcomes of follow-up were not the mean value of weekly data.|3|||f||||t||||||||||2017-02-18 15:24:41.532796|2017-02-18 15:24:41.532796
NCT00508469|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2012-06-08|2012-06-08||October 2007||2007-10-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Adherence Assessment With Travalert Dosing Aid|Adherence of Patients Using Travalert® for Instillation of a Fixed Combination of Travoprost 0.004%/Timolol 0.5% Compared to a Concomitant Regimen of Travoprost 0.004% and Timolol 0.5%|Completed||Phase 4|102|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 15:24:42.577497|2017-02-18 15:24:42.577497
NCT00508456|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2012-01-12|||August 2004||2004-08-01|January 2012|2012-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM|A Phase I Study of Dietary Methionine Restriction and Temodar® (Temozolomide) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme|Terminated||Phase 1|18|Actual|M.D. Anderson Cancer Center||1||Low Accrual|f||||f||||||||||2017-02-18 15:24:42.888349|2017-02-18 15:24:42.888349
NCT00508443|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2017-02-06|||October 2002||2002-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)|Phase I/II Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) for the Treatment of Metastatic Spine Disease|Active, not recruiting||Phase 1/Phase 2|150|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:24:43.009498|2017-02-18 15:24:43.009498
NCT00508430|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2008-12-04|||July 2007||2007-07-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||ASP 8825 - Study in Patients With Painful Diabetic Polyneuropathy|ASP 8825 Phase II Study—A Double- Blind, Placebo- Controlled Study in Patients With Painful Diabetic Polyneuropathy|Terminated||Phase 2|199|Actual|Astellas Pharma Inc||4||"An independent DMC determined continuation was unlikely to demonstrate a statistically~   significant advantage of ASP8825 over placebo on the primary endpoint"|f||||t||||||||||2017-02-18 15:24:43.122371|2017-02-18 15:24:43.122371
NCT00508417|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2017-01-24|||July 24, 2007||2007-07-24|February 11, 2011|2011-02-11|February 11, 2011||2011-02-11|||||Observational|||Malaria Incidence in Infants in Bancoumana, Mali|Malaria Incidence in Infants in Bancoumana, Mali|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:24:43.239792|2017-02-18 15:24:43.239792
NCT00508404|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-12-15|2015-12-18||May 2007||2007-05-01|December 2016|2016-12-01|June 2012|Actual|2012-06-01|June 2009|Actual|2009-06-01||Interventional|||Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer|A Single Arm Multicentre Phase II Study of Panitumumab in Combination With Irinotecan/5-fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|154|Actual|Amgen||1|||f||||f||||||||||2017-02-18 15:24:43.344058|2017-02-18 15:24:43.344058
NCT00508391|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2010-01-21|2009-10-27||July 2007||2007-07-01|January 2010|2010-01-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||Interventricular Delay of Lumax HF-T for Heart Failure|Clinical Investigation to Study Safety and Efficacy of the Interventricular Delay Feature of the Lumax HF-T Device for Heart Failure.|Completed||Phase 2|122|Actual|Biotronik, Inc.||2|||f||||f||||||||||2017-02-18 15:24:44.216839|2017-02-18 15:24:44.216839
NCT00508378|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-27|2016-09-30|||January 2001||2001-01-01|September 2016|2016-09-01||||January 2018|Anticipated|2018-01-01||Observational|||Chemotherapy-Related Toxicities In Ovarian Cancer Patients|Chemotherapy-Related Toxicities In Ovarian Cancer Patients: Preference Assessments of Patients, Family Members, Ancillary Staff and Gynecologic Oncologists, and Patients' Quality of Life|Active, not recruiting||N/A|288|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:24:44.736495|2017-02-18 15:24:44.736495
NCT00508365|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-11-03|||September 2007||2007-09-01|November 2016|2016-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives|A Study to Evaluate the Potential Incidence of Orthostatic Hypotension in Elderly Hypertensive Patients Following Administration of a Combination of Carvedilol CR and Lisinopril|Completed||Phase 1|40|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:24:44.848498|2017-02-18 15:24:44.848498
NCT00508352|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2013-05-31|||January 2007||2007-01-01|May 2013|2013-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Post-operative Radiation With IMRT in the Management of Stage IIB-III Breast Cancer|Post-operative Locoregional Irradiation Using Helical Tomotherapy IMRT in the Management of Stage IIb-III Breast Cancer: a Feasibility Study|Completed||Phase 1/Phase 2|30|Actual|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-02-18 15:24:44.974204|2017-02-18 15:24:44.974204
NCT00508339|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2012-07-31|||September 2006||2006-09-01|July 2012|2012-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients|Functional Outcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma and Pre-Operative Radiotherapy|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:24:45.096627|2017-02-18 15:24:45.096627
NCT00508326|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-07-27|||October 2005||2005-10-01|July 2012|2012-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement|Phase I Study of Paclitaxel Administered by Hepatic Artery Infusion to Patients With Advanced Cancer and Dominant Liver Involvement|Completed||Phase 1|27|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:24:45.204773|2017-02-18 15:24:45.204773
NCT00508313|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-04-06|||July 2007||2007-07-01|September 2009|2009-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Thermal Signature of Patients Undergoing Radiation Therapy|Phase I Assessment of Thermal Signature of Patients Undergoing Radiation Therapy|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||2|Study closed early without enrollment.|f||||f||||||||||2017-02-18 15:24:45.318837|2017-02-18 15:24:45.318837
NCT00508300|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2014-02-21|||January 2010||2010-01-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|EVA||Epidural Analgesia (EDA) Versus Patient Controlled Analgesia (PCA) in Laparoscopic Colon Surgery|Epidural Analgesia (EDA) Versus Patient Controlled Analgesia (PCA) in Laparoscopic Colon Surgery: A Monocentric Controlled Non-blinded Randomized Superiority Trial|Completed||N/A|128|Actual|University of Lausanne Hospitals||2|||f||||f||||||||||2017-02-18 15:24:45.425983|2017-02-18 15:24:45.425983
NCT00508287|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2009-03-13|||August 2007||2007-08-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes|Randomized, Placebo-Controlled, Single-Dose, Crossover Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes|Completed||Phase 1|36|Anticipated|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 15:24:45.527328|2017-02-18 15:24:45.527328
NCT00508274|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-03-28|2009-07-24||July 2007||2007-07-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China|An Open-Label Multicenter Study Administering Lapatinib and Capecitabine in Women With Advanced or MEtastatic Breast Cancer|Active, not recruiting||Phase 3|52|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:24:45.635141|2017-02-18 15:24:45.635141
NCT00508261|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-10-18||2009-09-03|August 2007||2007-08-01|October 2016|2016-10-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine|Co-Administration of GSK Biologicals' Meningococcal Vaccine GSK134612 With Infanrix Hexa™, Compared to Individual Administration of Each Vaccine, in Healthy 12- Through 23-Month-Old Children|Completed||Phase 3|793|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:24:46.062035|2017-02-18 15:24:46.062035
NCT00508248|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2016-10-24|||January 2005||2005-01-01|October 2016|2016-10-01|November 2008|Anticipated|2008-11-01|January 2005||2005-01-01||Interventional|||Omega 3 Fatty Acids and Atrial Fibrillation|Use of Omega 3 Polyunsaturated Fatty Acids Supplements to Maintain Sinus Rhythm in Persistent Atrial Fibrillation|Withdrawn||N/A|0|Actual|University of Dundee||2||Funding|f||||t||||||||||2017-02-18 15:24:46.271147|2017-02-18 15:24:46.271147
NCT00508235|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2012-07-31|||December 2004||2004-12-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Quality of Friendships in Children With Neurofibromatosis|Quality of Friendships in Children With Neurofibromatosis: Relationship to Disease Severity|Completed||N/A|61|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:24:46.375119|2017-02-18 15:24:46.375119
NCT00508222|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-05-28|||June 2007||2007-06-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Kaletra Monotherapy in HIV/HCV Co-infected Subjects|A Pilot, Prospective, Open-label Study to Evaluate the Safety and Efficacy of Kaletra® Monotherapy in HIV/HCV Co-infected Subjects.|Completed||Phase 3|22|Actual|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-02-18 15:24:46.479433|2017-02-18 15:24:46.479433
NCT00508209|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2010-06-17|||July 2007||2007-07-01|June 2010|2010-06-01|September 2010|Anticipated|2010-09-01|June 2009|Actual|2009-06-01||Interventional|||Bortezomib and High-dose Melphalan at Myeloma Relapse|Phase II Study of Bortezomib Dexamethasone and High-dose Melphalan in Patients With Relapse After High-dose Melphalan With Autologous Stem Cell Support|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Nordic Myeloma Study Group||1|||f||||t||||||||||2017-02-18 15:24:46.810995|2017-02-18 15:24:46.810995
NCT00508196|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2007-07-26|||November 2006||2006-11-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Endothelial Function and Cardiac Output in RV Pacing|Endothelial Function and Cardiac Output in Right Ventricular Pacing|Completed||N/A|22|Actual|University of Dundee||3|||f||||t||||||||||2017-02-18 15:24:46.924631|2017-02-18 15:24:46.924631
NCT00508183|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2011-10-24|||April 2007||2007-04-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Types of Fixation in Arthroscopic Rotator Cuff Repair|Single Row Versus Double Row Fixation in Arthroscopic Cuff Repair; a Randomized Controlled Sutdy.|Completed||N/A|80|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 15:24:47.032005|2017-02-18 15:24:47.032005
NCT00508170|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-07-27|||March 2006||2006-03-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection|Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection|Completed||N/A|252|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 15:24:47.138115|2017-02-18 15:24:47.138115
NCT00508157|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2013-11-20|2010-06-22||November 2007||2007-11-01|November 2013|2013-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome|A 16-Week, Multicenter, Randomized, Open-label Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome|Terminated||Phase 4|125|Actual|Bristol-Myers Squibb|Following a review of all studies in development, a strategic decision was made to terminate this study due to slow accrual. Patients randomized and treated at the time of study termination could continue the study as per protocol until completion.|2||Slow Accrual|f||||f||||||||||2017-02-18 15:24:47.258167|2017-02-18 15:24:47.258167
NCT00508144|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-12-20|2016-12-20||September 2005||2005-09-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer|Single Agent Alimta in Poor Performance Status in Patients With Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|64|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:24:47.989183|2017-02-18 15:24:47.989183
NCT00508131|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2007-07-26|||May 2003||2003-05-01|July 2007|2007-07-01|July 2004|Actual|2004-07-01|||||Interventional|||Effectiveness of Iron-Fortified Milk on Iron Status and Anemia in Young Children in Mexico||Completed||Phase 3|798|Actual|Instituto Nacional de Salud Publica, Mexico||2|||f||||f||||||||||2017-02-18 15:24:48.296121|2017-02-18 15:24:48.296121
NCT00508118|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2014-07-29|2011-09-21||January 2008||2008-01-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|NICNACS||NICardipine Neuroprotection in AortiC Surgery (NICNACS)|NICardipine Neuroprotection in AortiC Surgery (NICNACS)|Terminated||Phase 2|7|Actual|Duke University|This study was terminated early because of safety concerns in the active treatment group. In 3 patients randomized, the blind was broken in 3 because of refractory hypotension and acidosis requiring vasopressor therapy. All 3 were on active drug.|2||3/7 subjects experienced hypotension. Study was terminated.|f||||f||||||||||2017-02-18 15:24:48.40781|2017-02-18 15:24:48.40781
NCT00508105|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-04-11|||November 2006||2006-11-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparing Two Surgical Methods of Fixation of Subscapularis During Shoulder Arthroplasty|Comparison of Two Methods of Fixation of Subscapularis During Shoulder Arthroplasty|Completed||N/A|87|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 15:24:48.934852|2017-02-18 15:24:48.934852
NCT00508092|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2008-04-22|||January 2007||2007-01-01|April 2008|2008-04-01||||||||Interventional|||Combined Nerve Blockade and Local Infiltration Anesthesia in Appendectomy - A Blinded Randomized Study|Combined Nerve Blockade and Local Infiltration Anesthesia in Appendectomy - A Blinded Randomized Study|Completed||N/A|75|Anticipated|Royal Berkshire NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 15:24:49.041661|2017-02-18 15:24:49.041661
NCT00508079|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2013-07-10|||July 2007||2007-07-01|July 2013|2013-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Evaluating the Occurence of New and Progression of Existing Peripheral Venous Disease in Leg Veins|Incidence and Progression of Peripheral Venous Disease|Completed||N/A|1103|Actual|University of California, San Diego|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, plasma~   "|||2017-02-18 15:24:49.150641|2017-02-18 15:24:49.150641
NCT00508066|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2013-01-15||2013-01-15|May 2007||2007-05-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Continuous Local Infusion of Anesthetic at the Incisional Site for Scoliosis Surgery|Continuous Local Infusion of Anesthetic at the Incisional Site for Scoliosis Surgery|Completed||Phase 4|60|Actual|Shriners Hospitals for Children||2|||f||||f||||||||||2017-02-18 15:24:49.249476|2017-02-18 15:24:49.249476
NCT00508053|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2007-07-27|||January 2001||2001-01-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||When Closing Midline Incisions, do Small Stitches Reduce the Risk for Incisional Hernia, Wound Infection or Dehiscence?||Completed||N/A|737|Actual|Sundsvall Hospital||2|||f||||f||||||||||2017-02-18 15:24:49.374567|2017-02-18 15:24:49.374567
NCT00508040|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2013-01-22|||September 2007||2007-09-01|October 2008|2008-10-01|January 2013|Actual|2013-01-01|October 2011|Actual|2011-10-01||Interventional|BIRDFERON||Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a|Evaluation of Birdshot RETINE CHOROIDOPATHY Treatment by Either Steroid or Interferon alpha2a|Completed||Phase 2|58|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:24:49.487184|2017-02-18 15:24:49.487184
NCT00508027|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2013-08-20|2013-02-11||June 2007||2007-06-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||42 subjects started the study; of these,12 were withdrawn from the study and 30 completed the study: dose level 1 (n=16); dose level 2 (n=12), dose level 3 (n=2). Only those participants who completed the study were included in the final analyses (n=30).|Simvastatin (Zocor) Therapy in Sickle Cell Disease|Phase I/II Study of Simvastatin (Zocor) Therapy in Sickle Cell Disease|Completed||Phase 1/Phase 2|42|Actual|Children's Hospital & Research Center Oakland||1|||f||||t||||||||||2017-02-18 15:24:49.610752|2017-02-18 15:24:49.610752
NCT00508014|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2013-10-10|||December 2006||2006-12-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes|Concurrent Peer Review Visits to Reduce Cardiovascular Risk Factors|Completed||N/A|727|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 15:24:50.174328|2017-02-18 15:24:50.174328
NCT00508001|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2016-08-29|2011-05-09||July 2007||2007-07-01|August 2016|2016-08-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)|A Randomised, Double-blind, Parallel Group, Multi-centre, Phase II Study to Assess the Efficacy and Safety of Best Support Care (BSC) Plus ZD6474(Vandetanib) 300 mg, BSC Plus ZD6474(Vandetanib) 100 mg, and BSC Plus Placebo in Patients With Inoperable Hepatocellular Carcinoma (HCC)|Completed||Phase 2|67|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 15:24:50.286534|2017-02-18 15:24:50.286534
NCT00507988|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2009-05-14|||August 2007||2007-08-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Complex Problem Solving Training in Schizophrenic Patients|Complex Problem Solving Training in Schizophrenic Patients|Completed||N/A|91|Actual|Heidelberg University||2|||f||||t||||||||||2017-02-18 15:24:51.306327|2017-02-18 15:24:51.306327
NCT00507975|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-12-12|||November 2007||2007-11-01|July 2007|2007-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|SNIPP||Study of Nicotine Patch in Pregnancy (SNIPP)|Assessment of the Effectiveness of Nicotine Replacement Therapies (Nicotine Patches Delivering Nicotine 16 h/24 h) in 400 Pregnant Smokers. Randomized, Placebo-controlled, Multicenter, National Study. The SNIPP.|Completed||Phase 3|404|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:24:51.419436|2017-02-18 15:24:51.419436
NCT00507962|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-08-01|||March 2005||2005-03-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement|A Phase I Study Dose Escalation Clinical Study Of Hepatic Intraarterial Cisplatin, In Combination With Systemic Intravenous Liposomal Doxorubicin Administered Every Four Weeks to Patients With Advanced Cancer And Dominant Liver Involvement|Completed||Phase 1|51|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:24:51.533784|2017-02-18 15:24:51.533784
NCT00507949|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2011-06-07|||October 2006||2006-10-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight|Randomized Trial,Comparative With Placebo, Double Blind, to Evaluate the Effect of the Treatment With 320 mg/d of Megestrol Acetate in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) and Loss of Body Weight. Pilot Study|Completed||Phase 2|40|Anticipated|Rottapharm Spain||2|||f||||f||||||||||2017-02-18 15:24:51.649154|2017-02-18 15:24:51.649154
NCT00506220|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2009-07-14|||June 2007||2007-06-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 15:25:34.288623|2017-02-18 15:25:34.288623
NCT00507936|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2013-01-15||2011-09-21|August 2007||2007-08-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain|A Global, Multicenter, Randomized, Double-Blind Placebo Controlled Study Comparing the Safety and Efficacy of ABT-894, Duloxetine and Placebo in Subjects With Diabetic Neuropathic Pain|Completed||Phase 2|280|Actual|AbbVie||5|||f||||f||||||||||2017-02-18 15:24:51.761406|2017-02-18 15:24:51.761406
NCT00507923|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2016-05-19|||November 2006||2006-11-01|September 2015|2015-09-01||||November 2017|Anticipated|2017-11-01||Interventional|||Effects of Tibetan Yoga on Fatigue and Sleep in Cancer|Effects of Tibetan Yoga on Fatigue and Sleep in Cancer|Active, not recruiting||N/A|480|Anticipated|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-02-18 15:24:51.921034|2017-02-18 15:24:51.921034
NCT00507910|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2011-07-19|||December 2006||2006-12-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||The Development of Flat Foot After Ankle Fractures|Pes Planus After Weber B and C Ankle Fractures|Completed||N/A|25|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 15:24:52.038864|2017-02-18 15:24:52.038864
NCT00507897|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2008-02-06||||||February 2008|2008-02-01|December 2007|Actual|2007-12-01|||||Observational|||Hemodynamic Parameters in Euthyroid Patients With Thyroid Nodules||Terminated||N/A|100|Anticipated|Yaroslavl State Medical Academy|||4|The received reliability with increase in quantity of participants of research did not vary|f||||f||||||||||2017-02-18 15:24:52.131605|2017-02-18 15:24:52.131605
NCT00507884|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2016-09-12|||March 2005||2005-03-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Observational|||Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors|Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors|Active, not recruiting||N/A|45|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:24:52.22069|2017-02-18 15:24:52.22069
NCT00507871|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2009-12-02|||October 2007||2007-10-01|September 2007|2007-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Transmission and the Respiratory Tract in Cryptosporidiosis|Prevalence and Clinical Presentation of Respiratory Cryptosporidiosis Among Children With Diarrhea in Mulago Hospital, Uganda|Completed||N/A|480||Tufts University|||1||f||||||||||||||2017-02-18 15:24:52.327723|2017-02-18 15:24:52.327723
NCT00507858|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2011-09-22|||September 2005||2005-09-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer|A Phase I Dose Escalation Study of Pemetrexed in Patients With Advanced Head and Neck Squamous Cell Cancer|Completed||Phase 1|36|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 15:24:52.413557|2017-02-18 15:24:52.413557
NCT00507845|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2009-04-16|||June 2007||2007-06-01|April 2009|2009-04-01||||April 2008|Actual|2008-04-01||Interventional|RAFEHELP||Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina|Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina|Completed||Phase 4|271|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:24:52.531374|2017-02-18 15:24:52.531374
NCT00507832|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2010-07-06|||April 2007||2007-04-01|February 2009|2009-02-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|CASM981CDE21||Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease|Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease|Completed||Phase 2|30|Actual|University Hospital Muenster||2|||f||||t||||||||||2017-02-18 15:24:52.626456|2017-02-18 15:24:52.626456
NCT00507819|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2015-05-04|2011-02-09||December 2007||2007-12-01|May 2015|2015-05-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|SAFO|All subjects who consented to participate and were randomized, completed at least the first six-week study period.|Sildenafil After the Fontan Operation|The Sildenafil After Fontan Operation Study|Completed||Phase 2|28|Actual|Children's Hospital of Philadelphia|Characteristics of screened but not enrolled subjects was not evaluated, so enrolled subjects may not be a representative sample from the group at large. Safety of Sildenafil over a prolonged (>6week) period of continuous use was not evaluated.|2|||f||||f||||||||||2017-02-18 15:24:52.749348|2017-02-18 15:24:52.749348
NCT00507806|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2007-07-25|||March 2005||2005-03-01|July 2007|2007-07-01|May 2006|Actual|2006-05-01|||||Interventional|||Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke|Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke|Terminated||Phase 1/Phase 2|||ImaRx Therapeutics||2||for administrative reasons|f||||t||||||||||2017-02-18 15:24:53.086152|2017-02-18 15:24:53.086152
NCT00507793|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2007-07-26|||April 2000||2000-04-01|July 2007|2007-07-01|June 2002|Actual|2002-06-01|||||Interventional|||Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus|An Open-Label Study to Evaluate the Efficacy and Safety of Cyclosporine Reduction in de Novo Renal Allograft Recipients Receiving Sirolimus: a Dose Comparative Study|Completed||Phase 4|385|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:24:53.173147|2017-02-18 15:24:53.173147
NCT00507780|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2017-01-24|||July 18, 2007||2007-07-18|July 22, 2010|2010-07-22|July 22, 2010|Actual|2010-07-22|July 22, 2010|Actual|2010-07-22||Interventional|||Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy|Use of the GnRH Agonist Leuprolide Acetate (Lupron(Registered Trademark)) to Preserve Ovarian Function in Women Undergoing Chemotherapy|Withdrawn||Phase 4|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:24:53.252652|2017-02-18 15:24:53.252652
NCT00507767|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-26|2014-09-17|2012-04-18||July 2007||2007-07-01|April 2013|2013-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase 2 Study of Dasatinib in Head and Neck Squamous Cell Carcinoma|Completed||Phase 2|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:24:53.342363|2017-02-18 15:24:53.342363
NCT00507754|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2011-09-22|||June 2007||2007-06-01|September 2011|2011-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Latent Tuberculosis Infection in Cancer Patients|Latent Mycobacterium Tuberculosis Infection Among Cancer Patients|Completed||N/A|24|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     A blood sample will be collected and used to perform the T-SPOT. TB test.~   "|||2017-02-18 15:24:53.669559|2017-02-18 15:24:53.669559
NCT00507741|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2014-12-18||2011-03-21|August 2007||2007-08-01|December 2014|2014-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)|Protocol EC-FV-02: A Phase II Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers|Completed||Phase 2|49|Actual|Endocyte||1|||f||||f||||||||||2017-02-18 15:24:53.77584|2017-02-18 15:24:53.77584
NCT00507728|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2017-01-30|||December 5, 2005|Actual|2005-12-05|January 2017|2017-01-01|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Pharmacogenetics, Emotional Reactivity and Smoking|Pharmacogenetics, Emotional Reactivity and Smoking|Active, not recruiting||Phase 2/Phase 3|646|Actual|M.D. Anderson Cancer Center||3|||f||||t|t|f||||||||2017-02-18 15:24:53.886794|2017-02-18 15:24:53.886794
NCT00507715|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2007-07-25|||September 2006||2006-09-01|July 2007|2007-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk|Clinical Trial to Study the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk|Completed||Phase 1|18|Actual|Rottapharm Spain||2|||f||||f||||||||||2017-02-18 15:24:54.015386|2017-02-18 15:24:54.015386
NCT00507702|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-07-05|||July 2006||2006-07-01|July 2012|2012-07-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|||Identification of Key Blood Molecular Markers for Immunotherapy|Identification of Key Blood Molecular Markers for Immunotherapy|Suspended||N/A|300|Anticipated|Stanford University|||1|Improving assay methods|f||||t||||||||||2017-02-18 15:24:54.114511|2017-02-18 15:24:54.114511
NCT00507689|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2014-02-12|2013-07-15||September 2007||2007-09-01|February 2014|2014-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||Three groups are reported for baseline characteristics: the 2 treatment groups in the randomized period, and non-randomized participants who discontinued prior to the randomized period.|Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant|A Phase 2, Open-Label Randomized Study to Evaluate the Efficacy and Safety of the Combination Product, Emtricitabine/Tenofovir Disoproxil Fumarate in the Presence or Absence of Hepatitis B Immunoglobulin (HBIg) in Preventing Recurrence of Chronic Hepatitis B (CHB) Post-Orthotopic Liver Transplant (OLT)|Completed||Phase 2|40|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 15:24:54.208785|2017-02-18 15:24:54.208785
NCT00507676|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-03-29|||October 2000||2000-10-01|January 2011|2011-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing|Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing|Completed||N/A|220|Actual|Indiana University|||3||f||||t||||||Samples Without DNA|"~     We collect hair samples to analyzed for nicotine and cotinine.~   "|||2017-02-18 15:24:55.101538|2017-02-18 15:24:55.101538
NCT00507663|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2016-03-14|||September 2002||2002-09-01|March 2016|2016-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Elder Surgery - Functional Recovery Following Beta Blockade|Elder Surgery - Functional Recovery Following Beta Blockade|Completed||Phase 4|359|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 15:24:55.192493|2017-02-18 15:24:55.192493
NCT00507650|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2015-03-05|||September 2003||2003-09-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Increasing Fluids in Older Adults to Prevent & Treat Pressure Ulcers|Supplement Fluid & Collagen Deposition|Completed||N/A|63|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 15:24:55.30904|2017-02-18 15:24:55.30904
NCT00507637|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-02-03|||August 2007||2007-08-01|February 2012|2012-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Blepharospasm Short Interval|Prospective, Open-label, Single-arm, Single-center Trial to Investigate the Tolerability of NT 201 and Quality of Life of Patients in the Treatment of Blepharospasm With Shortened Injection Intervals|Terminated||Phase 2|8|Actual|Merz Pharmaceuticals GmbH||1||primary efficacy endpoint not attainable.|f||||f||||||||||2017-02-18 15:24:55.407681|2017-02-18 15:24:55.407681
NCT00507611|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-09-23|||October 2006||2006-10-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients|Sentinel Lymph Node Mapping and Biopsy For Predicting the Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients Who Had Biopsy-Proven Axillary Lymph Node Involvement at Initial Presentation|Completed||N/A|11|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:24:55.519359|2017-02-18 15:24:55.519359
NCT00507598|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2014-09-10|||July 2007||2007-07-01|September 2014|2014-09-01|November 2012|Actual|2012-11-01|March 2009|Actual|2009-03-01||Observational|metabolomics||Metabolomics-Based Detection of Colorectal Cancer|Metabolomics-Based Detection of Colorectal Cancer|Completed||Phase 1|69|Actual|Indiana University|||1||f||||t||||||Samples With DNA|"~     serum, urine~   "|||2017-02-18 15:24:55.631351|2017-02-18 15:24:55.631351
NCT00507585|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-07-26|||June 2006||2006-06-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin|A Phase I Study of Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic Fluorouracil, Leucovorin and Avastin for Patients With Advanced Solid Tumors Metastatic to the Liver|Completed||Phase 1|63|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:24:55.725289|2017-02-18 15:24:55.725289
NCT00507572|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2016-12-08|||December 2005||2005-12-01|December 2016|2016-12-01||||December 2019|Anticipated|2019-12-01||Observational|||Collection of Outcomes Data for Pregnant Patients With Cancer|Collection of Outcomes Data for Pregnant Patients With Cancer|Recruiting||N/A|500|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:24:55.853809|2017-02-18 15:24:55.853809
NCT00507559|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2016-10-07|2016-04-21||September 2007||2007-09-01|April 2016|2016-04-01|May 2014|Actual|2014-05-01|March 2010|Actual|2010-03-01||Interventional|STAPLE-2||The Pivotal Study of the Aptus Endovascular AAA Repair System|The Pivotal Study of the Aptus Endovascular AAA Repair System|Completed||N/A|155|Actual|Medtronic Endovascular||1|||f||||t||||||||||2017-02-18 15:24:55.970162|2017-02-18 15:24:55.970162
NCT00507546|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2014-04-25|2013-09-13||July 2007||2007-07-01|April 2014|2014-04-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia|Melatonin Replacement for Treatment of Sleep Disruption|Completed||Phase 4|12|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:24:56.790451|2017-02-18 15:24:56.790451
NCT00507533|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2009-02-17|||October 2005||2005-10-01|February 2009|2009-02-01||||November 2007|Actual|2007-11-01||Interventional|HEMOCPAP||Early Application of CPAP in Hematologic|Early Application of CPAP in Hematologic Neutropenic Patients Avoid Acute Respiratory Failure|Completed||Phase 4|40|Anticipated|University of Turin, Italy|||||f||||t||||||||||2017-02-18 15:24:57.229963|2017-02-18 15:24:57.229963
NCT00507520|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2007-07-25|||December 1999||1999-12-01|July 2007|2007-07-01|September 2001|Actual|2001-09-01|||||Interventional|||Almond Dose Response Study.|The Effect of Almonds on Coronary Heart Disease Risk Factors: Dose Response Study.|Completed||Phase 2|27|Actual|University of Toronto||3|||f||||||||||||||2017-02-18 15:24:57.325|2017-02-18 15:24:57.325
NCT00507507|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2015-07-07|2013-05-23||September 2007||2007-09-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional||Participants who were randomized and treated were analyzed for baseline characteristics.|A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)|A Randomized, Double-Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus the Combination of Emtricitabine and Tenofovir DF for the Treatment of Chronic Hepatitis B|Completed||Phase 2|126|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 15:24:57.438917|2017-02-18 15:24:57.438917
NCT00507494|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2011-10-27|||July 2007||2007-07-01|October 2011|2011-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Influence of Pioglitazone for Renal Transplant Function in Diabetics|Influence of Pioglitazone for Renal Transplant Function in Diabetics - a Double Blind Randomised Placebo Controlled Cross Over Study|Completed||Phase 3|||Technische Universität Dresden|||||f||||t||||||||||2017-02-18 15:24:58.773336|2017-02-18 15:24:58.773336
NCT00507481|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2008-06-03|||January 2006||2006-01-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|||||Observational|||Evaluation of Risk Factors of Sleep Quality in Intensive Care Unit|Evaluation of Risk Factors of Sleep Quality in Critically Ill Patients|Completed||N/A|||University of Turin, Italy|||||f||||f||||||||||2017-02-18 15:24:58.868775|2017-02-18 15:24:58.868775
NCT00507468|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-22|2009-11-02|||December 2005||2005-12-01|November 2009|2009-11-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|TABMMI||Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone|Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone|Completed||Phase 1|20|Actual|BioCardia, Inc.||1|||f||||t||||||||||2017-02-18 15:24:58.953007|2017-02-18 15:24:58.953007
NCT00507455|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2014-07-14|2014-07-14||June 2007||2007-06-01|July 2014|2014-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction|A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multi-Center Study to Evaluate the Safety of the Co-administration of Solifenacin Succinate With 0.4 mg Tamsulosin Hydrochloride OCAS (TOCAS) Using Urodynamics in Male Subjects With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)|Completed||Phase 2|222|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|3|||f||||f||||||||||2017-02-18 15:24:59.144397|2017-02-18 15:24:59.144397
NCT00507442|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2013-07-18|2011-11-28||August 2007||2007-08-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|EVOLUTION||Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients|Phase 1/2 Study of VELCADE® (Bortezomib), Dexamethasone, and Revlimid® (Lenalidomide) Versus VELCADE, Dexamethasone, Cyclophosphamide, and Revlimid Versus VELCADE, Dexamethasone and Cyclophosphamide in Subjects With Previously Untreated Multiple Myeloma|Completed||Phase 1/Phase 2|158|Actual|Millennium Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 15:25:02.98392|2017-02-18 15:25:02.98392
NCT00507429|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2014-05-12|2013-08-16||August 2007||2007-08-01|February 2014|2014-02-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|FACT||Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer|A Phase II/III Study to Evaluate the Safety and Efficacy of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin in Comparison With Paclitaxel and Carboplatin Against Anaplastic Thyroid Carcinoma [FACT]|Terminated||Phase 2/Phase 3|80|Actual|Mateon Therapeutics|The study was to enroll 180 subjects. Enrollment was terminated early due to low accrual rate. Eighty subjects were enrolled.|2||Low rate of subject accrual|f||||t||||||||||2017-02-18 15:25:04.58356|2017-02-18 15:25:04.58356
NCT00507416|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2014-03-28|2014-03-28||June 2007||2007-06-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|UPFRONT|Intention to treat population, defined as all participants randomized|Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone|Randomized Phase 3b Study of Three Treatment Regimens in Subjects With Previously Untreated Multiple Myeloma Who Are Not Considered Candidates for High-Dose Chemotherapy and Autologous Stem Cell Transplantation: VELCADE, Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone|Completed||Phase 3|502|Actual|Millennium Pharmaceuticals, Inc.||3|||f||||||||||||||2017-02-18 15:25:05.472751|2017-02-18 15:25:05.472751
NCT00507403|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2017-01-13|||October 2007||2007-10-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|SPAXIM||Infliximab and Methotrexate in Ankylosing Spondylitis|Effect of Methotrexate on the Relation Dose-effect of Infliximab in Ankylosing Spondylitis|Completed||Phase 4|30|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-02-18 15:25:08.283148|2017-02-18 15:25:08.283148
NCT00507390|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2016-10-24|||January 2007||2007-01-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia|The Effect of Omega-3 Polyunsaturated Fatty Acid Supplements on Microvolt T Wave Alternans in Patients With Ventricular Arrhythmia|Withdrawn||Phase 4|0|Actual|University of Dundee||2||funding not secured|f||||t||||||||No||2017-02-18 15:25:08.395925|2017-02-18 15:25:08.395925
NCT00507377|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2007-07-25|||September 2005||2005-09-01|July 2007|2007-07-01|July 2007|Anticipated|2007-07-01|||||Observational|GERDSurgery||Foreshortened Esophagus and Its Surgical Therapy|Frequency, Predictors, Intraoperative Assessment and Outcome of Foreshortened Esophagus and Its Surgical Therapy in Patients Treated for Gastro-Esophageal Reflux Disease (GERD)|Unknown status|Active, not recruiting|N/A|180|Actual|University of Bologna|||||f||||t||||||||||2017-02-18 15:25:08.524602|2017-02-18 15:25:08.524602
NCT00507364|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2007-07-25||||||July 2007|2007-07-01||||||||Interventional|||Treatment of Anal Fissure by Activated Human Macrophages|Treatment of Anal Fissure by Activated Human Macrophages|Unknown status|Not yet recruiting|Phase 3|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:25:08.635086|2017-02-18 15:25:08.635086
NCT00507351|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-07-31|||July 2006||2006-07-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Ambulatory Cancer Pain Management: A Feasibility Study|Ambulatory Cancer Pain Management: A Feasibility Study|Completed||N/A|30|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:25:08.730087|2017-02-18 15:25:08.730087
NCT00505817|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2009-01-09||||||January 2009|2009-01-01||||||||Interventional|||GnRH Agonist and Antagonists in an Oocyte Donation Program||Completed||Phase 4|||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||||||||||||2017-02-18 15:25:39.647898|2017-02-18 15:25:39.647898
NCT00507338|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2009-01-08|||October 2007||2007-10-01|January 2009|2009-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|vITAL-1||Study of ARC1779 in Patients With Acute Myocardial Infarction Undergoing PCI|A Phase 2 Study of an Aptameric Von Willebrand Factor Antagonist, ARC1779, in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention|Terminated||Phase 2|300|Anticipated|Archemix Corp.||4|||f||||t||||||||||2017-02-18 15:25:08.85805|2017-02-18 15:25:08.85805
NCT00507325|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2016-09-12|||June 2006||2006-06-01|September 2016|2016-09-01||||June 2018|Anticipated|2018-06-01||Observational|||Sample Collection From Melanoma Patients|Blood and Tumor Sample Collection From Patients With Malignant Melanoma for Long Term Storage|Active, not recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Patients will provide blood and tumor samples to help researchers learn about melanoma and~     other cancers.~   "|||2017-02-18 15:25:08.972704|2017-02-18 15:25:08.972704
NCT00507312|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2015-06-02|||October 2007||2007-10-01|June 2015|2015-06-01|December 2010|Actual|2010-12-01|January 2009|Actual|2009-01-01||Interventional|||Assessment of Myocardial Disease in Man Using Novel Non-invasive Diagnostic Tools|Assessment of Myocardial Disease in Man Using Novel Non-invasive Diagnostic Tools|Terminated||Phase 1|41|Actual|Monash University||3||Suspended while we determine if usable data can be collected from this device.|f||||f||||||||||2017-02-18 15:25:09.087665|2017-02-18 15:25:09.087665
NCT00507299|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2007-07-25|||June 2002||2002-06-01|July 2007|2007-07-01|December 2005|Actual|2005-12-01|||||Interventional|SEEK2||A Safe Environment for Every Kid (SEEK) II|A Safe Environment for Every Kid II: Preventing Child Maltreatment - A Role for Pediatrics|Completed||Phase 2|2004|Actual|University of Maryland||2|||f||||f||||||||||2017-02-18 15:25:09.197386|2017-02-18 15:25:09.197386
NCT00507286|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2009-01-27|||May 2007||2007-05-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|September 2008|Anticipated|2008-09-01||Interventional|||Efficacy and Safety Study of Combined Oral and Injection Therapy for Erectile Dysfunction|Efficacy and Safety Study of Using Oral Sildenafil and Intracavernosal Alprostadil Injection as a Combined Pharmacotherapy for Men With Difficult to Treat Erectile Dysfunction.|Unknown status|Active, not recruiting|N/A|20|Anticipated|Keogh Institute for Medical Research|||||f||||t||||||||||2017-02-18 15:25:09.301481|2017-02-18 15:25:09.301481
NCT00507273|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2012-08-01|||August 2005||2005-08-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Gastrointestinal Stromal Tumors (GIST) Registry|Gastrointestinal Stromal Tumors (GIST) Registry Protocol: reGISTry|Completed||N/A|1800|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:25:09.398423|2017-02-18 15:25:09.398423
NCT00507260|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2014-12-23|||September 2006||2006-09-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Nutritional Assessment Intervention to Improve Cancer-Related Fatigue|A Pilot Study to Evaluate a Nutritional Assessment Intervention to Improve Cancer-Related Fatigue Among Post-Allogeneic Blood and Marrow Transplantation Recipients|Completed||N/A|10|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:25:09.50933|2017-02-18 15:25:09.50933
NCT00507247|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2016-07-18|||May 2006||2006-05-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|October 2007|Actual|2007-10-01||Interventional|||Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus|Phase II, Open-Label Study to Evaluate the Safety and Efficacy of Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus Bloodstream Infections|Completed||Phase 2|11|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:25:09.632489|2017-02-18 15:25:09.632489
NCT00507234|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2010-11-10|||March 2007||2007-03-01|July 2009|2009-07-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01||Interventional|||Study in Subjects Greater Than 40 Years of Age With COPD|A 6-Week Trial to Compare the Efficacy and Safety of Concomitant Treatment With Formoterol Fumarate Inhalation Solution 20 Mcg Twice Daily and Tiotropium 18 Mcg Once Daily to Tiotropium 18 Mcg Once Daily Alone in the Treatment of Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|128|Actual|Dey|||||f||||t||||||||||2017-02-18 15:25:09.752021|2017-02-18 15:25:09.752021
NCT00507221|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2014-11-18|||February 2008||2008-02-01|November 2014|2014-11-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|THE or PHE||Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression|Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression|Completed||N/A|948|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:25:09.873481|2017-02-18 15:25:09.873481
NCT00507208|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2016-08-01|2016-06-14||July 2007||2007-07-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Dynasplint Therapy for Trismus in Head and Neck Cancer|Dynasplint Therapy for Trismus in Head and Neck Cancer|Completed||N/A|53|Actual|University of Alabama at Birmingham||2|||f||||f||||||||No||2017-02-18 15:25:10.000473|2017-02-18 15:25:10.000473
NCT00507195|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-24|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Observational|||Postanesthesia Cognitive Recovery and Neuropsychologic Complications|Post Operative Cognitive Recovery and Neuropsychological Complications After General Anesthesia. A Comparison Between Different Techniques of Anesthesia: A Multi-Center Observational Study|Unknown status|Recruiting|N/A|1200|Anticipated|University of Roma La Sapienza|||||f||||t||||||||||2017-02-18 15:25:10.493886|2017-02-18 15:25:10.493886
NCT00507182|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2017-01-06|||July 1999||1999-07-01|January 2017|2017-01-01||||July 2018|Anticipated|2018-07-01||Interventional|||Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions|Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions|Recruiting||N/A|395|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:25:10.599913|2017-02-18 15:25:10.599913
NCT00505154|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-01-24|||July 2007||2007-07-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of Rosuvastatin on Left Ventricular Remodeling|A Phase III Study of the Effect of Rosuvastatin on Left Ventricular Remodeling and Inflammatory Markers in Heart Failure|Completed||Phase 3|75|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 15:25:10.711592|2017-02-18 15:25:10.711592
NCT00505141|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2007-07-20|||September 2004||2004-09-01|July 2007|2007-07-01|February 2006|Actual|2006-02-01|||||Observational|||Urban Environmental Exposures and Childhood Cancer|Case-Control Study of Urban Environmental Effects on Childhood Leukemia and Brain Cancer|Completed||N/A|||Georgetown University|||||f||||||||||||||2017-02-18 15:25:10.885274|2017-02-18 15:25:10.885274
NCT00505128|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2011-05-06|||July 2007||2007-07-01|May 2007|2007-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|EEPAB||Impact on Outcome of Early Endoscopic Extraction of Bile Duct Stones in Biliary Pancreatitis|Impact on Outcome of Early Endoscopic Extraction of Bile Duct Stones in Biliary Pancreatitis: a Prospective Multicenter Randomized Controlled Study|Completed||N/A|900|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 15:25:10.961108|2017-02-18 15:25:10.961108
NCT00504023|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-03-28|||April 2007||2007-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva|A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease|Active, not recruiting||N/A|8|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:25:11.238108|2017-02-18 15:25:11.238108
NCT00504010|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2009-01-06|||August 2007||2007-08-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|Arnica||The Role of Arnica on Muscle Pain Following Eccentric Exercise|The Role of Arnica on Muscle Pain Following Eccentric Exercise|Completed||Phase 1|55|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 15:25:11.379894|2017-02-18 15:25:11.379894
NCT00503997|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-05-07|2012-02-07||December 2006||2006-12-01|May 2012|2012-05-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer|Phase II Trial: Efficacy and Toxicity of Induction Pemetrexed (ALIMTA) and Oxaliplatin (ELOXATIN) in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma|Completed||Phase 2|42|Actual|Vanderbilt-Ingram Cancer Center|The two cohorts of pemetrexed and oxaliplatin patients represented similar populations, thus the response data were combined.|1|||f||||t||||||||||2017-02-18 15:25:11.480814|2017-02-18 15:25:11.480814
NCT00503984|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-05-03|2015-12-09||May 2007||2007-05-01|May 2016|2016-05-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients|A Phase I/II Study of Azacitidine (Vidaza), Docetaxel and Prednisone for Patients With Hormone Refractory Metastatic Prostate Cancer Previously Treated With a Taxotere Containing Regimen.|Terminated||Phase 1/Phase 2|22|Actual|University of Miami||2||Withdrawal of Funding|f||||t||||||||||2017-02-18 15:25:11.775166|2017-02-18 15:25:11.775166
NCT00503971|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2012-10-19|||December 2007||2007-12-01|April 2008|2008-04-01|December 2011|Actual|2011-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.|Sequential Phase I/II Trial of Oral Vorinostat in Combination With Erlotinib in Non-small-cell Lung Cancer Patients With Mutations at Epidermal Growth Factor Receptor With Disease Progression After Erlotinib Treatment|Terminated||Phase 1/Phase 2|50|Actual|Spanish Lung Cancer Group||1|||f||||f||||||||||2017-02-18 15:25:12.81022|2017-02-18 15:25:12.81022
NCT00503958|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2013-05-14|||August 1998||1998-08-01|November 2007|2007-11-01||||||||Observational|||Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer|Liverpool Lung Project|Unknown status|Recruiting|N/A|8300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:25:12.939492|2017-02-18 15:25:12.939492
NCT00503945|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2007-07-18|||November 2004||2004-11-01|July 2007|2007-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Cardiac Dysfunction in Obstructive Sleep Apnea Patients: Prevalence of and Effect of nCPAP|The Clinical Significance of an Index of Cardiac Function, Tei-Index, in Obstructive Sleep Apnea Syndrome Patients.|Completed||N/A|27|Actual|Nagasaki University||1|||f||||f||||||||||2017-02-18 15:25:13.051618|2017-02-18 15:25:13.051618
NCT00503932|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-03-21|||July 2007||2007-07-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Proton Therapy With Capecitabine for Rectal Cancer|A Phase I/II Trial of Proton Therapy With Concurrent Capecitabine for Locally Advanced and Recurrent Rectal Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||1||No participant enrollment.|f||||f||||||||||2017-02-18 15:25:13.145097|2017-02-18 15:25:13.145097
NCT00503919|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-04-06|||May 2007||2007-05-01|September 2009|2009-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device|A Pilot Study: Measurement of Digital Colposcopy for Fluorescence Spectroscopy of the Normal Cervix for Screening, Using a Second Generation Device|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1||Study closed early with no enrollment.|f||||f||||||||||2017-02-18 15:25:13.258837|2017-02-18 15:25:13.258837
NCT00503906|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-12-14|2013-01-22||June 2007||2007-06-01|December 2016|2016-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Bevacizumab, and Gemcitabine as First-Line Therapy in Treating Patients With Metastatic Breast Cancer|A Phase II Study of Abraxane, Bevacizumab and Gemcitabine for First Line Metastatic Breast Cancer|Completed||Phase 2|30|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:25:13.371841|2017-02-18 15:25:13.371841
NCT00503893|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-08-10|||December 1980||1980-12-01|August 2016|2016-08-01||||December 2017|Anticipated|2017-12-01||Observational|||Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies|Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies|Recruiting||N/A|1500|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood sample(s) for genetic testing. Also, tissue samples, and/or bodily fluids (whether~     healthy or cancerous) left over from surgeries or procedures performed as part of standard~     care. The purpose of this clinical research study is to find out why some people develop~     cancers and tumors, why some families have more cancers than others, and whether certain~     genes or regions of DNA affect a person's risk of getting cancer.~   "|||2017-02-18 15:25:13.781235|2017-02-18 15:25:13.781235
NCT00503880|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2011-02-03|||May 2007||2007-05-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes|A Dose Escalation Phase I/II Study of Clofarabine Plus Cytarabine With Growth Factor Priming in Patients Who Are Not Felt to be Candidates for More Aggressive Treatment, With Int-2 and High-Risk MDS|Terminated||Phase 1/Phase 2|33|Anticipated|University of Nebraska||1||Funding|f||||||||||||||2017-02-18 15:25:13.905189|2017-02-18 15:25:13.905189
NCT00507169|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-25|2011-06-07|||September 2006||2006-09-01|June 2011|2011-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||SVT-40776 in Patients Suffering From Overactive Bladder Syndrome||Completed||Phase 2|||Salvat|||||f||||||||||||||2017-02-18 15:25:14.004955|2017-02-18 15:25:14.004955
NCT00507156|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2016-10-05|||July 2007||2007-07-01|October 2016|2016-10-01||||November 2008|Actual|2008-11-01||Interventional|POSTCON||Postconditioning in the Treatment of Acute ST-segment Elevation Myocardial Infarction|Postconditioning Used to Limit Final Infarct Size in Patients With Acute ST-segment Elevation Myocardial Infarction|Completed||Phase 4|200|Anticipated|Rigshospitalet, Denmark||2|||f||||||||||||||2017-02-18 15:25:14.08089|2017-02-18 15:25:14.08089
NCT00507143|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||August 2006||2006-08-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan|A Clinical Study for the Evaluation of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on the Pharmacokinetics and Treatment Effects of Irinotecan in Patients With Colorectal and Gastric Cancer|Unknown status|Recruiting|N/A|100|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:25:14.18287|2017-02-18 15:25:14.18287
NCT00507130|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2013-10-17|2013-10-17||July 2007||2007-07-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma|A Phase 2A, Randomized, Double-Blind, Placebo-Controlled,Dose-Escalation Study to Evaluate the Safety and Tolerability of Multiple-Dose Subcutaneous Administration of MEDI-528, A Humanized Anti-Interleukin-9 Monoclonal Antibody,When Administered to Adults With Mild Persistent Asthma|Completed||Phase 2|36|Actual|MedImmune LLC||4|||f||||f||||||||||2017-02-18 15:25:14.29056|2017-02-18 15:25:14.29056
NCT00507117|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-11-29|||March 2007||2007-03-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Ezopiclone Improves the Quality of Overnight Polysomnography|Prospective, Randomized, Placebo Controlled Trial Assessing the Effects of Ezopiclone on the Quality of Overnight Polysomnography and CPAP Titration|Completed||Phase 4|300|Anticipated|Walter Reed Army Medical Center||1|||f||||t||||||||||2017-02-18 15:25:15.433771|2017-02-18 15:25:15.433771
NCT00507104|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2007-09-27|||September 2006||2006-09-01|July 2007|2007-07-01||||||||Observational|||Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)|Prospective Longitudinal Study on Pituitary Functions After TBI and/or SAH|Unknown status|Recruiting|N/A|100|Anticipated|University of Erlangen-Nürnberg Medical School|||||f||||f||||||||||2017-02-18 15:25:15.544272|2017-02-18 15:25:15.544272
NCT00507091|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-08-24|||August 2005||2005-08-01|August 2016|2016-08-01|June 2008|Actual|2008-06-01|May 2006|Actual|2006-05-01||Interventional|||Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination|A Phase I Open Label Study to Asses the Safety and Tolerability of ZD6474 (Vandetanib)in Combination With Irinotecan, 5-Fluorouracil and Leucovorin (FOLFIRI) as First or Second Line Therapy in Patients With Metastatic Colorectal Adenocarcinoma.|Completed||Phase 1|24|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:25:15.636011|2017-02-18 15:25:15.636011
NCT00507078|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2012-05-18|||June 2005||2005-06-01|May 2012|2012-05-01|June 2007|Actual|2007-06-01|||||Interventional|||Biomarkers in Obstructive Sleep Apnea Surgery|Biomarkers in Obstructive Sleep Apnea Surgery|Completed||N/A|60|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 15:25:15.762334|2017-02-18 15:25:15.762334
NCT00507065|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2015-03-04|||May 2003||2003-05-01|November 2007|2007-11-01|April 2004|Actual|2004-04-01|||||Interventional|||Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)|A Phase III, Randomized, Multicenter, Double-blind, Parallel-Group, Placebo-Controlled Safety and Efficacy Study of ADDERALL XR With an Open Label Extension, in the Treatment of Adolescents Aged 13-17 With ADHD|Completed||Phase 3|329|Actual|Shire||5|||f||||f||||||||||2017-02-18 15:25:15.865747|2017-02-18 15:25:15.865747
NCT00507052|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2007-07-24||||||July 2007|2007-07-01||||||||Interventional|||Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients||Unknown status|Not yet recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:25:15.973586|2017-02-18 15:25:15.973586
NCT00507039|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2011-10-07|||February 2007||2007-02-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Observational|||Safety and Repeatability of Bronchial Challenge With Grass-pollen|Repeatability of a Single Concentration and Single-step Bronchial Allergen Challenge With Grass Pollen|Completed||N/A|47|Actual|Johann Wolfgang Goethe University Hospital|||1||f||||t||||||||||2017-02-18 15:25:16.071647|2017-02-18 15:25:16.071647
NCT00507026|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2009-02-11|||July 2007||2007-07-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery|Randomized, Double-Blind, Active-and Placebo-Controlled Study of the Analgesic Efficacy and Safety of Repeated Dosing of DIC075V Versus Parenteral Ketorolac and Placebo in Acute Post-Operative Pain After Elective Orthopedic Surgery|Completed||Phase 3|277|Actual|Javelin Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:25:16.179924|2017-02-18 15:25:16.179924
NCT00507013|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2008-04-22|||July 2007||2007-07-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|||||Interventional|||Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose|The QuickClose Study: Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose: a Prospective, Non-Randomized Clinical Study|Completed||Phase 1/Phase 2|8|Actual|CardioDex||1|||f||||f||||||||||2017-02-18 15:25:16.28933|2017-02-18 15:25:16.28933
NCT00507000|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2011-01-26|||May 2008||2008-05-01|July 2009|2009-07-01|September 2012|Anticipated|2012-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Pulmonary Tuberculosis and Vitamin D|Role of Oral Vitamin D as an Adjunct Therapy in Category I Pulmonary Tuberculosis Along With Assessment of Immunological Parameters. (Double-blind, Randomized, Placebo-Controlled, Clinical Trial)|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|Indian Council of Medical Research||2|||f||||t||||||||||2017-02-18 15:25:16.386541|2017-02-18 15:25:16.386541
NCT00506987|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2015-08-13|||January 2007||2007-01-01|August 2015|2015-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)|Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Idiopathic Cough|Completed||Phase 2|31|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:25:16.500031|2017-02-18 15:25:16.500031
NCT00506974|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2008-09-25|||May 2007||2007-05-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Enhancing Slow Wave Sleep With Sodium Oxybate|Enhancing Slow Wave Sleep With Sodium Oxybate to Reduce the Behavioral and Physiological Impact of Sleep Loss|Completed||Phase 4|60|Actual|St. Luke's Hospital, Chesterfield, Missouri||1|||f||||f||||||||||2017-02-18 15:25:16.583621|2017-02-18 15:25:16.583621
NCT00506961|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2011-12-05|||June 2006||2006-06-01|December 2011|2011-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia|A Phase IV, Randomized, Open-label, Parallel-arm, Comparative and Forced- Titration Study to Compare the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Patients With Type 2 DM and Dyslipidemia|Completed||Phase 4|90|Actual|Taipei Veterans General Hospital, Taiwan||2|||f||||f||||||||||2017-02-18 15:25:16.683641|2017-02-18 15:25:16.683641
NCT00506948|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-01-07|2014-01-07||September 2006||2006-09-01|January 2014|2014-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)|Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute GVHD Following Allogeneic Hematopoietic Stem Cell Transplantation|Terminated||Phase 2|13|Actual|M.D. Anderson Cancer Center|A decision to terminate this trial was made due to the high incidence of veno-occlusive disease of the liver in participants receiving this graft-versus-host disease (GVHD) prophylaxis regimen.|1||Halted due to high incidence of veno-oclusive disease of the liver.|f||||f||||||||||2017-02-18 15:25:16.797989|2017-02-18 15:25:16.797989
NCT00506935|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2008-08-06|||July 2006||2006-07-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Assessment of GVG for the Treatment of Methamphetamine Dependence|Phase 1 Study of Vigabatrin (GVG) for Methamphetamine Dependence|Completed||Phase 1|17|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-02-18 15:25:17.052066|2017-02-18 15:25:17.052066
NCT00506922|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2015-04-06|2011-03-01||September 2000||2000-09-01|August 2012|2012-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT|Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After Matched-Unrelated Donor Blood and Marrow Transplantation|Completed||Phase 1/Phase 2|150|Actual|M.D. Anderson Cancer Center||5|||f||||f||||||||||2017-02-18 15:25:17.166329|2017-02-18 15:25:17.166329
NCT00506909|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2017-01-11|||March 2008||2008-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|Oxytocin||Oxytocin Add on Study for Stable Schizophrenic Patients|Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study of Intranasal Oxytocin Augmentation of Antipsychotic Medication in Schizophrenia Patients|Suspended||N/A|40|Anticipated|University of California, San Diego||2||Break in funding|f||||f||||||||||2017-02-18 15:25:17.790027|2017-02-18 15:25:17.790027
NCT00506896|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2007-07-20|||July 2004||2004-07-01|July 2007|2007-07-01|January 2006|Actual|2006-01-01|||||Interventional|||Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients|Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients: A Randomized Double-Blind Controlled Study|Completed||Phase 2|60|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 15:25:17.899305|2017-02-18 15:25:17.899305
NCT00506883|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2012-10-30|2009-08-12||April 2007||2007-04-01|October 2012|2012-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|AGREE||MPC-004 for the Treatment of an Acute Gout Flare|A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, 1 Week, Dose Comparison Study to Evaluate the Efficacy, Safety, and Tolerability of MPC-004 in Patients With an Acute Gout Flare|Completed||Phase 3|185|Actual|Takeda||3|||f||||f||||||||||2017-02-18 15:25:18.205136|2017-02-18 15:25:18.205136
NCT00506870|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2010-12-13|||June 2007||2007-06-01|December 2010|2010-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|4A||Benefit of Self-monitoring of Anticoagulation Instrument|Economic and Medical Evaluation of Self-monitoring of Anticoagulation in a Population of Patients Recently Fitted With a Mechanical Heart Valve Compared to Conventional Anticoagulation Follow-up|Completed||N/A|919|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 15:25:18.824417|2017-02-18 15:25:18.824417
NCT00506857|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2012-01-24|2012-01-24||November 2003||2003-11-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support|Phase I/II Trial of Fludarabine in Combination With Intravenous Busulfan and Allogeneic Progenitor Cell Support for Patients With Hematologic Malignancies|Completed||Phase 1/Phase 2|82|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:25:19.102598|2017-02-18 15:25:19.102598
NCT00506844|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||May 2006||2006-05-01|July 2007|2007-07-01|May 2010|Anticipated|2010-05-01|||||Interventional|ERBIRIX||Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer|A Phase II Study of Pre-Operative Concurrent Chemoradiotherapy With Cetuximab, Irinotecan, and Capecitabine in Resectable Rectal Cancer|Unknown status|Active, not recruiting|Phase 2|40|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:25:19.378923|2017-02-18 15:25:19.378923
NCT00506831|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-07-10|2012-06-06||July 2007||2007-07-01|July 2012|2012-07-01||||September 2010|Actual|2010-09-01||Interventional|||Imatinib in Systemic Sclerosis|A Pilot Study of Imatinib in the Treatment of Refractory Systemic Sclerosis|Completed||Phase 1/Phase 2|9|Actual|Stanford University|Open label, uncontrolled study. Small study population at a single center.|1|||f||||||||||||||2017-02-18 15:25:19.492096|2017-02-18 15:25:19.492096
NCT00506818|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2009-09-18|||February 2007||2007-02-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Cognitive and Emotional Impairment After Stroke|Cognitive and Emotional Impairment After Stroke|Completed||N/A|250|Anticipated|Sykehuset Asker og Baerum||1|||f||||f||||||||||2017-02-18 15:25:19.759536|2017-02-18 15:25:19.759536
NCT00506805|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-05-25|||June 2007||2007-06-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies|A Phase 1, Open-label, Dose-escalation Study Of The Safety And Pharmacokinetics Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies Or Non-Hodgkin's Lymphoma|Completed||Phase 1|44|Actual|Esanex Inc.||1|||f||||f||||||||||2017-02-18 15:25:19.856273|2017-02-18 15:25:19.856273
NCT00506792|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-22|2012-05-02||2012-05-02|July 2007||2007-07-01|May 2012|2012-05-01|November 2009|Actual|2009-11-01|December 2008|Actual|2008-12-01||Interventional|||Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis|A Two-part, Randomized, Double-blind, Placebo-controlled, Ascending Single-dose, Adaptive Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAU145 Administered Via a Nasal Spray Pump to Patients With Cystic Fibrosis|Completed||Phase 2|9|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:25:19.95279|2017-02-18 15:25:19.95279
NCT00506779|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2015-04-13|||December 2003||2003-12-01|April 2015|2015-04-01||||April 2015|Actual|2015-04-01||Interventional|||Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma|A Phase I/II Study of Gleevec/Taxol in Patients With Newly Diagnosed Stage IIIC or IV or Recurrent (Any Stage) Uterine Papillary Serous Carcinoma (UPSC)|Completed||Phase 1/Phase 2|17|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:25:20.045337|2017-02-18 15:25:20.045337
NCT00506766|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||September 2000||2000-09-01|July 2007|2007-07-01|August 2006|Actual|2006-08-01|||||Interventional|||Promoting Self Care to Prevent Urinary Incontinence (UI): A Four-Year Follow-up|Promoting Self Care to Prevent Urinary Incontinence (UI): A Four-Year Follow-up|Completed||Phase 3|360|Actual|University of Michigan|||||f||||f||||||||||2017-02-18 15:25:20.163037|2017-02-18 15:25:20.163037
NCT00506753|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2016-12-28|||September 2004||2004-09-01|December 2016|2016-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|SMART||Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail|Prison Study: Motivation and Skills for THC/ETOH+ Teens in Jail|Completed||Phase 1/Phase 2|205|Actual|University of Rhode Island||1|||f||||t||||||||||2017-02-18 15:25:20.265156|2017-02-18 15:25:20.265156
NCT00506740|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2015-08-03|||October 2006||2006-10-01|August 2015|2015-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Harmonic™ vs. Electrocautery in Abdominoplasties|A Randomized, Prospective, Parallel Group Study Comparing the Harmonic™ to Electrocautery in Abdominoplasties|Completed||N/A|70|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-02-18 15:25:20.379619|2017-02-18 15:25:20.379619
NCT00506727|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2015-03-04|||August 2003||2003-08-01|November 2007|2007-11-01|August 2004|Actual|2004-08-01|||||Interventional|||Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD|A Randomized, Double-Blind, Parallel-Group, Analog Classroom Study, Evaluating ADDERALL XR Versus STRATTERA, Dosed Once Daily, in Children Aged 6-12 With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 4|215|Actual|Shire||2|||f||||||||||||||2017-02-18 15:25:20.476152|2017-02-18 15:25:20.476152
NCT00506714|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2012-09-28|2012-02-06||July 2007||2007-07-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Walking Aids in the Management of Hip Osteoarthritis|Walking Aids in the Management of Hip Osteoarthritis|Completed||N/A|26|Actual|Arthritis Foundation||2|||f||||f||||||||||2017-02-18 15:25:20.581726|2017-02-18 15:25:20.581726
NCT00506701|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2015-03-17|||February 2008||2008-02-01|July 2007|2007-07-01|February 2010|Anticipated|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension|Pilot Study to Investigate the Effect of Tadalafil on Secondary Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease|Withdrawn||N/A|0|Actual|Herlev Hospital||1||due to lack of finance|f||||t||||||||||2017-02-18 15:25:20.959657|2017-02-18 15:25:20.959657
NCT00506688|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-07-06|||July 2007||2007-07-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients|Randomized, Placebo-controlled, Double-blinded Study to Investigate the Efficacy and Safety of a 24-week Inhalation Treatment With Glutathione in Cystic Fibrosis Patients|Completed||Phase 2|153|Actual|Mukoviszidose Institut gGmbH||1|||f||||t||||||||||2017-02-18 15:25:21.062144|2017-02-18 15:25:21.062144
NCT00506675|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2016-07-06|2010-09-14||October 2007||2007-10-01|July 2016|2016-07-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|ATS11||Combined Patching-Atropine for Residual Amblyopia|A Randomized Trial to Evaluate Combined Patching-Atropine for Residual Amblyopia|Terminated||Phase 3|55|Actual|Jaeb Center for Health Research|This trial was stopped after 18 months due to inadequate recruitment.|2||Poor enrollment and infeasibility of ever reaching the necessary sample size|f||||t||||||||||2017-02-18 15:25:21.164567|2017-02-18 15:25:21.164567
NCT00506662|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2016-05-11|2010-10-19||July 2007||2007-07-01|May 2016|2016-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|3L||Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes|The Effect of Insulin Detemir on Glucose Control in Ageing Subjects With Type 2 Diabetes.|Terminated||Phase 4|86|Actual|Novo Nordisk A/S|Trial terminated prematurely due to low recruitment, and thus it was not possible to assess efficacy in this trial due to the small number of patients in each treatment group.|2||See termination reason in detailed description|f||||f||||||||||2017-02-18 15:25:22.340021|2017-02-18 15:25:22.340021
NCT00506649|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||August 2003||2003-08-01|July 2007|2007-07-01|November 2005|Actual|2005-11-01|||||Observational|||Improved ICU Outcomes With Protocolized Management of Analgesia, Sedation and Delirium|Comparison of no Protocol vs Protocolized Approach to Pain, Sedation and Delirium Management in the ICU|Completed||N/A|1214|Actual|Maisonneuve-Rosemont Hospital|||||f||||f||||||||||2017-02-18 15:25:23.129351|2017-02-18 15:25:23.129351
NCT00506636|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||May 2006||2006-05-01|May 2006|2006-05-01|December 2016|Anticipated|2016-12-01|||||Observational|||Tissue Engineering for Hair Follicle Regeneration|Study of Tissue Engineering for Hair Follicle Regeneration|Unknown status|Recruiting|N/A|400|Anticipated|National Taiwan University Hospital|||||f||||t||||||||||2017-02-18 15:25:23.204038|2017-02-18 15:25:23.204038
NCT00506623|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||July 2004||2004-07-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer|A Phase Ⅱ Study of Pre-Operative Concurrent Chemoradiotherapy With Capecitabine Plus Irinotecan in Resectable Rectal Cancer.|Unknown status|Active, not recruiting|Phase 2|48|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:25:23.27691|2017-02-18 15:25:23.27691
NCT00506610|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-06-06||||||June 2012|2012-06-01||||||||Interventional|||A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Flexible Escalating -Dose, Pilot Analgesic Efficacy Study of T-62 in Subjects With Postherpetic Neuralgia|Withdrawn||Phase 2|0|Actual|Pfizer|||||f||||f||||||||||2017-02-18 15:25:23.372858|2017-02-18 15:25:23.372858
NCT00506597|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-09-04|2013-10-17||May 2007||2007-05-01|September 2014|2014-09-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Erwinase Study in Patients With Acute Lymphoblastic Leukemia|Erwinia L-Asparaginase (Erwinase) Study in Patients With Acute Lymphoblastic Leukemia|Completed||N/A|33|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:25:23.465558|2017-02-18 15:25:23.465558
NCT00506584|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2010-02-16|||July 2007||2007-07-01|February 2010|2010-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants|A Randomized Study of Human Milk-Based Versus Bovine-based Nutrition for Very Low Birth Weight Pre-Term Infants|Completed||N/A|260|Actual|Prolacta Bioscience||5|||f||||t||||||||||2017-02-18 15:25:23.688117|2017-02-18 15:25:23.688117
NCT00506571|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||July 2007||2007-07-01|April 2007|2007-04-01|June 2010|Anticipated|2010-06-01|||||Interventional|TIROX2||Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer|Phase II Study of S-1 Combined With Irinotecan and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer|Unknown status|Recruiting|Phase 2|42|Anticipated|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:25:23.815927|2017-02-18 15:25:23.815927
NCT00506558|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-08-28|||November 2006||2006-11-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|CSM||The CSM Trial: A Multicenter Study Comparing Ventral to Dorsal Surgery for Cervical Spondylotic Myelopathy|The CSM Trial: A Multicenter Study Comparing Ventral to Dorsal Surgery for Cervical Spondylotic Myelopathy|Completed||Phase 3|103|Actual|Greenwich Hospital||2|||f||||t||||||||||2017-02-18 15:25:24.079375|2017-02-18 15:25:24.079375
NCT00506545|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2013-11-26|||January 2007||2007-01-01|November 2013|2013-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888)|Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Idiopathic Cough|Completed||Phase 2|35|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:25:24.223754|2017-02-18 15:25:24.223754
NCT00506532|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-15|2007-07-23|||January 2005||2005-01-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study|The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study|Unknown status|Recruiting|Phase 2/Phase 3|42|Anticipated|Rabin Medical Center|||||f||||||||||||||2017-02-18 15:25:24.409171|2017-02-18 15:25:24.409171
NCT00506519|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2010-08-23|||July 2007||2007-07-01|August 2010|2010-08-01|March 2009|Actual|2009-03-01|||||Interventional|||Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis|Exploratory Efficacy and Safety, Pharmacokinetics and Dose Finding Study of ATryn® (Antithrombin Alfa) in Patients With Disseminated Intravascular Coagulation Associated With Severe Sepsis|Terminated||Phase 2|200|Anticipated|LEO Pharma|||||f||||t||||||||||2017-02-18 15:25:24.505433|2017-02-18 15:25:24.505433
NCT00506506|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2009-04-14|||October 2007||2007-10-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease|Randomized Controlled Trial Examining the Effect of N-Acetylcysteine on Serum Creatinine in Patients With Stage 3 Chronic Kidney Disease|Completed||Phase 3|60|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 15:25:24.596204|2017-02-18 15:25:24.596204
NCT00506493|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-22|2013-12-11|2013-08-09||September 2007||2007-09-01|December 2013|2013-12-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|CURE-AF/Perst||Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/Persistent|Medtronic Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF)/Persistent Study|Completed||Phase 3|75|Actual|Medtronic Cardiovascular|"Slow/delayed enrollment~Medical management of subjects by non-investigators leading to medication washout protocol deviations~Missing endpoint data (attrition) due to cohort demographics (old age, dementia, relocation, etc.)"|1|||f||||t||||||||||2017-02-18 15:25:24.712127|2017-02-18 15:25:24.712127
NCT00506480|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-22|2010-02-04|||August 2007||2007-08-01|July 2007|2007-07-01||||||||Interventional|ERPOD||Assessment of Endometrial Receptivity in Recipients of Donated Oocytes|Phase 1 Study of Endometrial Markers of Endometrial Receptivity in Oocyte Donation|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 15:25:25.084689|2017-02-18 15:25:25.084689
NCT00506467|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2012-07-31|||November 2006||2006-11-01|July 2012|2012-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Vibration Response Imaging (VRI) in Lung Cancer Patients|Vibration Response Imaging (VRI) in Patients Who Are Candidates for Undergoing Surgical Resection Due to Lung Cancer or Other Intrathoracic Malignancy|Completed||N/A|100|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:25:25.186758|2017-02-18 15:25:25.186758
NCT00506454|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2011-09-16|2011-06-10||August 2007||2007-08-01|September 2011|2011-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|LIPIDOSE||Lipid Infusion in Dialysis Patients With Endotoxemia|A Phase II, Double-Blind, Placebo-Controlled, Randomized Study of the Effects of a Lipid Emulsion (Lipidose) on Endotoxin Levels in Patients on Chronic Hemodialysis|Completed||Phase 2|22|Actual|Sepsicure|There was no significant difference between endotoxin activity assay values in the active versus placebo recipients in this study.|2|||f||||t||||||||||2017-02-18 15:25:25.307261|2017-02-18 15:25:25.307261
NCT00506441|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2014-09-05|2014-04-10||September 2007||2007-09-01|September 2014|2014-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-center, Withdrawal Study Comparing MCI-196 v.s Placebo Following A 12-Week Dose Titration Period With MCI-196 in Stage V Subjects on Dialysis With Hyperphosphatemia|Completed||Phase 3|245|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 15:25:25.624295|2017-02-18 15:25:25.624295
NCT00506428|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2009-04-28|||December 2006||2006-12-01|April 2009|2009-04-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|||Effects of Chronic Sleep Restriction in Young and Older People|Sleep, Aging, and Circadian Rhythm Disorders|Unknown status|Recruiting|N/A|25|Anticipated|National Institute on Aging (NIA)||1|||f||||f||||||||||2017-02-18 15:25:26.700043|2017-02-18 15:25:26.700043
NCT00506415|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2012-09-17|2012-05-01||June 2007||2007-06-01|September 2012|2012-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline|A 48-Week, Multicenter, Randomized, Double-Blind, Parallel-Group Evaluation of the Comparative Efficacy, Safety, and Tolerability of Exelon® 10 and 15 cm^2 Patch in Patients With Mild to Moderate Alzheimer's Disease (AD) Showing Functional and Cognitive Decline|Completed||Phase 3|1584|Actual|Novartis||4|||f||||||||||||||2017-02-18 15:25:26.836487|2017-02-18 15:25:26.836487
NCT00506402|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2009-05-04|||November 2006||2006-11-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies|A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies|Completed||Phase 1|30|Anticipated|CASI Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 15:25:31.564446|2017-02-18 15:25:31.564446
NCT00506389|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2015-08-04|2014-07-14||June 2007||2007-06-01|August 2015|2015-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)|A Six-Week Double-Blind Randomized, Placebo-Controlled, Parallel Group, Efficacy and Safety, Sleep Lab Trial With Org 50081 in Patients With Chronic Primary Insomnia|Completed||Phase 3|419|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 15:25:31.679016|2017-02-18 15:25:31.679016
NCT00506376|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2016-02-25|||January 2003||2003-01-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Observational|||Simple Versus Radical Hysterectomy for Stage I Cervical Cancer|Simple Versus Radical Hysterectomy for Stage I Cervical Cancer: Preferences of Women at High-Risk for Developing Cervix Cancer vs. Women Diagnosed With Cervix Cancer|Completed||N/A|85|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:25:32.124297|2017-02-18 15:25:32.124297
NCT00506363|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2009-10-04|||January 2008||2008-01-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Different Onset Times of Treatment With Pulsed Dye Laser on Improvement of Surgical Scars|The Effect of Different Onset Times of Treatment With 595-nm Pulsed Dye Laser on Improvement of Surgical Scars: A Double Blind Randomised Clinical Trial|Terminated||N/A|15|Anticipated|Tehran University of Medical Sciences||3||"The trial was terminated on May 2008 after inclusion of 10 patients due to low recruitment and~   patient compliance."|f||||f||||||||||2017-02-18 15:25:32.239005|2017-02-18 15:25:32.239005
NCT00506350|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2016-10-06||2011-02-04|August 2007||2007-08-01|October 2016|2016-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults|Evaluate the Reactogenicity & Immunogenicity of 1 or 2 Booster Administrations of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults Aged Between 19 & 61 Years|Completed||Phase 2|350|Actual|GlaxoSmithKline||9|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:25:32.335974|2017-02-18 15:25:32.335974
NCT00506337|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-29|||October 2006||2006-10-01|July 2007|2007-07-01|October 2009|Anticipated|2009-10-01|||||Interventional|||Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis|Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis|Unknown status|Recruiting|Phase 2/Phase 3|300|Anticipated|Tianjin Nankai Hospital||2|||f||||t||||||||||2017-02-18 15:25:32.460924|2017-02-18 15:25:32.460924
NCT00506324|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2015-07-10|||June 2006||2006-06-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Oropharyngeal Function After Radiotherapy With IMRT|Oropharyngeal Function After Radiotherapy With IMRT|Terminated||N/A|125|Anticipated|Northwestern University|||1|Physician deceased|f||||t||||||||||2017-02-18 15:25:32.542815|2017-02-18 15:25:32.542815
NCT00506311|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2012-08-01|||February 2003||2003-02-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients|A Randomized Trial Evaluating the Use of Fibrin Tissue Adhesive Following Superficial Groin Dissection in Patients With Melanoma|Completed||N/A|53|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:25:32.639811|2017-02-18 15:25:32.639811
NCT00506298|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2009-05-12|||July 2007||2007-07-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes|A Randomized, Multi-Center Study to Compare the Effects of CRx-401 to Bezafibrate Plus Placebo on Plasma Glucose Levels When Given to Subjects With Type II Diabetes on Metformin.|Completed||Phase 2|150|Anticipated|Zalicus||2|||f||||f||||||||||2017-02-18 15:25:32.752977|2017-02-18 15:25:32.752977
NCT00506285|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2015-01-15|2012-10-19||June 2007||2007-06-01|January 2015|2015-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD|Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD|Completed||Phase 3|92|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 15:25:32.872748|2017-02-18 15:25:32.872748
NCT00506272|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2015-12-11|||December 2007||2007-12-01|December 2015|2015-12-01||||December 2016|Anticipated|2016-12-01||Interventional|ISMAS||Inpatient Self Monitoring and Administration Study (ISMAS)|Inpatient Self Monitoring and Administration Study (ISMAS)|Active, not recruiting||N/A|1|Actual|Atlanta VA Medical Center||2|||f||||t||||||||||2017-02-18 15:25:33.539866|2017-02-18 15:25:33.539866
NCT00506259|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-21|2017-01-24|||July 17, 2007||2007-07-17|September 26, 2016|2016-09-26|June 1, 2017|Anticipated|2017-06-01|June 1, 2017|Anticipated|2017-06-01||Interventional|||Treatment Strategies for Children With Smith-Magenis Syndrome|A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)|Recruiting||Phase 1|75|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:25:33.653505|2017-02-18 15:25:33.653505
NCT00506246|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2008-02-22|||June 2007||2007-06-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety Study of Two Propofol Formulations|A Multi-Center, Randomized, Double-Blind, Positive Controlled Study to Evaluate the Efficacy and Safety of Propofol(Propofol®-Lipuro) in Total Intravenous Anaesthesia|Completed||Phase 3|220|Anticipated|B. Braun Melsungen AG||2|||f||||f||||||||||2017-02-18 15:25:33.774311|2017-02-18 15:25:33.774311
NCT00506233|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2012-07-30|||August 2006||2006-08-01|July 2012|2012-07-01||||September 2007|Actual|2007-09-01||Observational|||Feasibility Study of Collecting Multicenter Chronic GVHD Data|Feasibility Study of Collecting Multicenter Chronic GVHD Data|Completed||N/A|13|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:25:33.881446|2017-02-18 15:25:33.881446
NCT00504062|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2011-08-23|||October 2006||2006-10-01|August 2011|2011-08-01|October 2007|Actual|2007-10-01|||||Interventional|||Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma|A Randomized, Open-label, Parallel-group, 6 Week Treatment, Multi-center, Phase III Study to Investigate the Efficacy and Safety of 100ug and 200ug Twice Daily of Budesonide Turbuhaler® and 50ug and 100umg Twice Daily of Fluticasone Diskus® in Japanese Children With Bronchial Asthma Aged 5-15|Completed||Phase 3|240|Actual|AstraZeneca|||||f||||f||||||||||2017-02-18 15:25:33.99012|2017-02-18 15:25:33.99012
NCT00504049|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2010-07-21|||March 2007||2007-03-01|January 2009|2009-01-01|March 2009|Actual|2009-03-01|||||Observational|||Wavelet Analysis of Electromyography (EMG) in Cerebral Palsy|Wavelet Analysis of Surface EMG in Cerebral Palsy|Completed||N/A|32|Actual|Shriners Hospitals for Children|||1||f||||f||||||||||2017-02-18 15:25:34.097135|2017-02-18 15:25:34.097135
NCT00504036|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2011-10-31|||October 2007||2007-10-01|October 2008|2008-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|BIGPOM||Efficacy of Preoperative Intra Gastric Balloon in Morbidly Obese Patients Selected for Gastric By-pass|Medico Economic Evaluation of a Temporary (6 Months) Intra-gastric Balloon in Morbidly Obese Patients Before a Gastric By-pass. A Randomised Multicenter Study Comparing the Usual Strategy to Two Types of Gastric Balloon|Completed||N/A|314|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:25:34.180492|2017-02-18 15:25:34.180492
NCT00506207|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||September 2006||2006-09-01|July 2007|2007-07-01|December 2009|Anticipated|2009-12-01|||||Interventional|TIROX||A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy|A Phase I and Pharmacokinetic Study of S-1 Combined With Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy|Unknown status|Active, not recruiting|Phase 1|23|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:25:34.361033|2017-02-18 15:25:34.361033
NCT00506194|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2013-09-30|||October 2005||2005-10-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|August 2007|Actual|2007-08-01||Interventional|||Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control|Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control Is Associated With Improvement of ß-Cell Function in Newly Diagnosed Type 2 Diabetic Patients|Completed||N/A|60|Anticipated|Taipei Veterans General Hospital, Taiwan||2|||f||||t||||||||||2017-02-18 15:25:34.460866|2017-02-18 15:25:34.460866
NCT00506181|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-22|2007-07-23|||July 2007||2007-07-01|July 2007|2007-07-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Probiotics: is it Really That Good? Cost-Effectiveness of Treating the in-Patient|Phase 3 Study of Probiotics, to Provide a Legitimate Reason for the Administration of Probiotic Therapy in the Hospitalized Patient, Particularly in Patients on Antibiotic Therapy|Unknown status|Not yet recruiting|Phase 3|120|Anticipated|Hadassah Medical Organization||3|||f||||f||||||||||2017-02-18 15:25:34.586321|2017-02-18 15:25:34.586321
NCT00506168|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||November 2001||2001-11-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer|Phase II Study of Irinotecan in Combination With Capecitabine in Previously Untreated Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|37|Actual|National Cancer Center, Korea||1||The study drugs are not covered anymore by insurance.|f||||f||||||||||2017-02-18 15:25:34.681436|2017-02-18 15:25:34.681436
NCT00506155|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2016-03-01|2016-03-01||June 2007||2007-06-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer|A Phase II Clinical Trial of Neoadjuvant Chemotherapy With M-VAC Plus Avastin in Patients With Locally Advanced Urothelial Cancer|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:25:34.776175|2017-02-18 15:25:34.776175
NCT00506142|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2015-06-02|||November 2007||2007-11-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma|A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma|Completed||Phase 2|54|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||t||||||||||2017-02-18 15:25:35.12755|2017-02-18 15:25:35.12755
NCT00506129|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2015-06-19|||September 2003||2003-09-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma|Study of Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma (CTCL)|Completed||Phase 2|33|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:25:35.235603|2017-02-18 15:25:35.235603
NCT00506116|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-30|||July 1996||1996-07-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|PERL||Promoting Effective Recovery From Labor Urinary Incontinence (PERL)|Promoting Effective Recovery From Labor Urinary Incontinence: Prevention Reducing Birthing Risk|Completed||Phase 3|140|Actual|University of Michigan|||||f||||f||||||||||2017-02-18 15:25:35.364788|2017-02-18 15:25:35.364788
NCT00506103|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-21|2007-07-25|||October 2006||2006-10-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Observational|||The No-Tie Technique Using the Harmonic Scalpel in Total Thyroidectomy With Central Neck Dissection: A Prospective Randomized Study||Completed||N/A|||Soonchunhyang University Hospital|||||f||||t||||||||||2017-02-18 15:25:35.476193|2017-02-18 15:25:35.476193
NCT00506090|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2009-10-04|||July 2007||2007-07-01|October 2009|2009-10-01||||||||Interventional|||Safety and Efficacy of Different Intervals of Pulsed Dye Laser Sessions on Improvement of Surgical Scars|The Effect of Different Intervals of 595-nm Pulsed Dye Laser Sessions on Improvement of Surgical Scars: A Double Blind Randomised Clinical Trial|Withdrawn||N/A|0|Actual|Tehran University of Medical Sciences||3||"Because of unsatisfactory results of previous trial which assessed the effect of different~   onset times of PDL on surgical scars."|f||||f||||||||||2017-02-18 15:25:35.567731|2017-02-18 15:25:35.567731
NCT00506077|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2015-07-31|2010-10-13||December 2007||2007-12-01|July 2015|2015-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, 2-Period, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia|Completed||Phase 2|55|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:25:35.671534|2017-02-18 15:25:35.671534
NCT00506064|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2012-12-03|2010-03-29||February 2004||2004-02-01|December 2012|2012-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Melatonin Postoperative Sleep Study in Breast Cancer Patients|Melatonin Postoperative Sleep Study in Breast Cancer Patients|Terminated||Phase 1|4|Actual|M.D. Anderson Cancer Center|Study terminated early due to low recruitment, no analysis done.|2||Terminated due to low accrual.|f||||f||||||||||2017-02-18 15:25:36.13229|2017-02-18 15:25:36.13229
NCT00506051|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-08-24|||July 2005||2005-07-01|August 2016|2016-08-01|October 2011|Actual|2011-10-01|May 2006|Actual|2006-05-01||Interventional|||ZD6474(Vandetanib) + Alimta Combo Study|A Phase I, Open-Label Study to Assess the Safety and Tolerability of ZD6474 in Combination With Pemetrexed (Alimta) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Prior Chemotherapy.|Completed||Phase 1|21|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:25:36.670396|2017-02-18 15:25:36.670396
NCT00506038|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2009-06-21||||||November 2008|2008-11-01||||||||Interventional|||Efficacy Study of Fine Needle Technique on Calcific Tendinitis|Phase 2 Study of the Fine Needle Technique on Calcific Tendinitis|Terminated||Phase 2|40|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 15:25:36.786092|2017-02-18 15:25:36.786092
NCT00506025|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2010-09-28|2009-12-03||August 2006||2006-08-01|September 2010|2010-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effectiveness of Cranberry Ingestion on Bacterial Adhesion: An Adjunct Study|Effectiveness of Cranberry Ingestion on Bacterial Adhesion: Adjunct to Pilot Study of Daily Cranberry Ingestion of Cranberry Juice for the Prevention of Asymptomatic Bacteriuria in Pregnancy|Completed||N/A|51|Actual|University of California, Irvine|Our study methodology could have been improved with a series of timed urine collections such as collections at pre-treatment, 2, 4 and 6 hours after ingestion of the cranberry juice cocktail and placebo to determine time of maximal effect.|3|||f||||f||||||||||2017-02-18 15:25:36.855892|2017-02-18 15:25:36.855892
NCT00506012|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2013-12-19|||August 2007||2007-08-01|November 2013|2013-11-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||Pilot Efficacy Study of T2000 in Myoclonus Dystonia|Phase II Efficacy and Safety of Taro Pharmaceuticals' Pro-Drug T2000 (1,3-Dimethoxymethyl-5,5-Diphenyl-Barbituric Acid) In Patients With Myoclonus Dystonia: An Open Label Sequential Dose Escalation Study|Terminated||Phase 2|5|Anticipated|Taro Pharmaceuticals USA||1||Slow Recruitment of eligible patients|f||||||||||||||2017-02-18 15:25:37.304872|2017-02-18 15:25:37.304872
NCT00505999|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2016-11-09|||July 2006||2006-07-01|November 2016|2016-11-01||||July 2018|Anticipated|2018-07-01||Observational|||Etiology of Multiple Myeloma: A Case-Control Study|Etiology of Multiple Myeloma: A Case-Control Study|Active, not recruiting||N/A|500|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood and saliva samples that will be used for special tests to look for any biological~     factors associated with Multiple Myemloma (MM).~   "|||2017-02-18 15:25:37.403924|2017-02-18 15:25:37.403924
NCT00505986|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2012-03-30|||June 2007||2007-06-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Genomic Endometrial Expression in Obesity||Completed||N/A|||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||||||||||||2017-02-18 15:25:37.511579|2017-02-18 15:25:37.511579
NCT00505973|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2007-12-03|||July 2007||2007-07-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects|An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SCA-136 Administered Orally to Healthy Japanese Male Subjects|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:25:37.601174|2017-02-18 15:25:37.601174
NCT00505960|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2010-12-20|||September 2007||2007-09-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Culturally Tailored Behavioral Diabetes Care Intervention for Korean Americans|Diabetes Care for Korean Americans|Completed||Phase 1|80|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 15:25:37.673722|2017-02-18 15:25:37.673722
NCT00505947|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2009-02-19|||July 2007||2007-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Treatment of Refractory Diabetic Macular Edema With Infliximab|Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation: a Randomized, Double-Masked, Placebo-Controlled, Cross-Over, 32 Weeks Study|Terminated||Phase 3|12|Actual|University of Athens||2||The number of the anticipated participants was not achieved|f||||t||||||||||2017-02-18 15:25:37.772154|2017-02-18 15:25:37.772154
NCT00505934|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2015-06-22|2011-01-28||May 2008||2008-05-01|June 2015|2015-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy|Open-label, Single-arm, Multi-center, Pharmacokinetic, Safety and Tolerability Study of Levetiracetam Intravenous Infusion in Children (1 Month- 4 Years Old) With Epilepsy|Completed||Phase 2|19|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:25:37.897029|2017-02-18 15:25:37.897029
NCT00505921|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2011-11-08|2011-09-30||March 2003||2003-03-01|November 2011|2011-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma|Autologous and Allogeneic Transplantation for T-Cell Lymphoma: Impact of Campath -1H and Soluble CD52|Terminated||Phase 2|27|Actual|M.D. Anderson Cancer Center|Early termination due to slow accrual.|1||Slow Accrual.|f||||f||||||||||2017-02-18 15:25:38.250612|2017-02-18 15:25:38.250612
NCT00505908|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2011-02-17|||July 2007||2007-07-01|February 2011|2011-02-01|December 2013|Anticipated|2013-12-01|||||Observational|NIFTI||Non-Interventional F-Two Isoprostane Trial (NIFTI)|Non-Interventional F-Two Isoprostane Trial|Unknown status|Recruiting|N/A|50|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-02-18 15:25:38.558881|2017-02-18 15:25:38.558881
NCT00505895|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-10-03|2014-10-03||January 2002||2002-01-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||FM 140 vs FM100 Study in Patients With Multiple Myeloma|A Randomized Phase II Trial of Fludarabine/Melphalan 140 VS. Fludarabine/Melphalan 100 Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation for Patients With Multiple Myeloma|Completed||Phase 2|52|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:25:38.634704|2017-02-18 15:25:38.634704
NCT00505882|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2009-05-08|||July 2007||2007-07-01|May 2009|2009-05-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes|The Pilot Study:Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes|Withdrawn||Phase 4|24|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 15:25:39.021529|2017-02-18 15:25:39.021529
NCT00505869|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2012-08-01|||August 2004||2004-08-01|August 2012|2012-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||A Mood Management Intervention for Pregnant Smokers|A Mood Management Intervention for Pregnant Smokers|Completed||Phase 3|338|Actual|M.D. Anderson Cancer Center|||2||f||||t||||||Samples Without DNA|"~     Saliva sample for cotinine.~   "|||2017-02-18 15:25:39.130456|2017-02-18 15:25:39.130456
NCT00505856|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2008-12-11|||July 2007||2007-07-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Observational|||Dermabond Skin Adhesives vs Skin Staples for Closure of Repeat Cesarean Section Skin Incisions|Dermabond Skin Adhesives vs Skin Staples for Closure of Repeat Cesarean Section Skin Incisions|Terminated||N/A|50|Anticipated|Texas Tech University Health Sciences Center||||Resident project--resident left institution and was not picked up by anyone else|f||||f||||||||||2017-02-18 15:25:39.24161|2017-02-18 15:25:39.24161
NCT00505843|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-24|2015-01-28|||May 2007||2007-05-01|January 2015|2015-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study of MK0657 in Parkinson's Disease Patients (0657-006)|A Randomized, Double-Blind, Placebo-Controlled, 2-Period Crossover Study to Evaluate Effectiveness of Single-Dose MK0657 in Combination With Levodopa on Motor Symptoms and Dyskinesias in Patients With Parkinson's Disease|Completed||Phase 1|18|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:25:39.428591|2017-02-18 15:25:39.428591
NCT00505830|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2007-07-23|||July 2007||2007-07-01|July 2007|2007-07-01|July 2009|Anticipated|2009-07-01|||||Observational|||Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome: AQ, EQ and SQ|Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome : Autism Spectrum Quotient (AQ) Empathy Quotient (EQ) and Systemizing Quotient (SQ)|Unknown status|Recruiting|N/A|450|Anticipated|Groupe Francais d'Epidemiologie Psychiatrique|||4||f||||f||||||||||2017-02-18 15:25:39.545708|2017-02-18 15:25:39.545708
NCT00505804|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-23|2013-01-22|||January 2005||2005-01-01|January 2013|2013-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|Dex||A Comparison of Dexmedetomidine and Haloperidol in Patients With Intensive Care Unit (ICU)-Associated Agitation and Delirium|A Randomised Open Label Pilot Study of the Efficacy of Dexmedetomidine and Haloperidol in Ventilated Patients With ICU-associated Agitation and Delirium|Completed||Phase 2|20|Actual|Austin Health||2|||f||||f||||||||||2017-02-18 15:25:39.725479|2017-02-18 15:25:39.725479
NCT00505791|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2015-11-09|||August 2007||2007-08-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF|Double Blind Randomized Placebo Controlled Trial of Natrecor in Patients Hospitalized for Decompensated Heart Failure in the Presence of a Normal Left Ventricular Ejection Fraction|Withdrawn||Phase 4|0|Actual|Rutgers, The State University of New Jersey||2||Unable to enroll patients|f||||f||||||||||2017-02-18 15:25:39.834843|2017-02-18 15:25:39.834843
NCT00505778|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2013-04-15|2011-04-18||July 2007||2007-07-01|April 2013|2013-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Comparison of Once a Day Dose Compared to 2 Doses/Day|A Multi-center, Investigator-blinded, Randomized, 12-month, Parallel-group, Non-inferiority Study to Compare the Efficacy of 1.6 to 2.4 g Asacol® Therapy QD Versus Divided Dose (BID) in the Maintenance of Remission of Ulcerative Colitis|Completed||Phase 3|1027|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 15:25:39.968697|2017-02-18 15:25:39.968697
NCT00505765|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2016-12-02|2014-12-03||July 2007||2007-07-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|AL-108|Of 69 randomized participants, 6 were excluded prior to starting double-blind medication; 63 participants exposed to drug or placebo were included in analyses.|A Multicenter Study of NAP (AL-108) in Schizophrenia|A Multicenter Ascending Dose, Double Blind, Placebo-controlled Study of NAP (AL-108) in Chronic Schizophrenia|Completed||Phase 2|63|Actual|University of California, Los Angeles||4|||f||||t||||||||||2017-02-18 15:25:40.975177|2017-02-18 15:25:40.975177
NCT00505752|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-01-20|2013-05-29||January 2007||2007-01-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)|A Phase II, Multicenter, Randomized, Assessor-blinded, Active-comparator, Dose-finding Study to Evaluate AS900672 Enriched Versus Follitropin Alfa (Gonal-f®) in Stimulating Multiple Follicular Development in Infertile Women Undergoing Assisted Reproductive Technology (ART)|Completed||Phase 2|520|Actual|Merck KGaA||4|||f||||||||||||||2017-02-18 15:25:41.530356|2017-02-18 15:25:41.530356
NCT00505739|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2012-07-26|||September 2001||2001-09-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Mifepristone for Patients With Endometrial Cancer and LGESS|Phase II Study of Mifepristone (RU-486) in the Treatment of PR Positive Advanced/Recurrent Endometrioid Adenocarcinoma and Low Grade Endometrial Stromal Sarcoma (LGESS)|Completed||Phase 2|13|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:25:42.080173|2017-02-18 15:25:42.080173
NCT00505726|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2012-07-31|||November 2001||2001-11-01|July 2012|2012-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Reflectance Confocal Imaging in Cervical Cancer Patients|Reflectance Confocal Imaging of Cervical Intraepithelial Neoplasia (CIN)|Completed||Phase 1|39|Actual|M.D. Anderson Cancer Center|||1||f||||t||||||||||2017-02-18 15:25:42.184152|2017-02-18 15:25:42.184152
NCT00505713|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2011-06-09|||July 2007||2007-07-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy Study Using Rexin-G for Sarcoma|Evaluation of Safety and Efficacy of Rexin-G as Intervention for Recurrent or Metastatic Sarcoma|Completed||Phase 1/Phase 2|36|Actual|Epeius Biotechnologies||5|||f||||t||||||||||2017-02-18 15:25:42.287013|2017-02-18 15:25:42.287013
NCT00505700|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2010-09-23|||July 2003||2003-07-01|September 2010|2010-09-01||||September 2005|Actual|2005-09-01||Interventional|||VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia|Phase I Dose Escalating Trial of VELCADE (PS-341) in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia|Completed||Phase 1|36|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:25:42.398493|2017-02-18 15:25:42.398493
NCT00505687|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-09-24|2009-12-08||February 2005||2005-02-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease|A Multicenter, Multinational, Phase 3b, Open-Label Extension Trial to Assess the Safety and Tolerability of Long-Term Treatment of Rotigotine Patch in Subjects With Idiopathic Parkinson's Disease|Completed||Phase 3|186|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:25:42.492483|2017-02-18 15:25:42.492483
NCT00505661|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2012-04-16|2010-09-28||September 2003||2003-09-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Letrozole in Patients With Ovarian Tumors|Phase II Study of Letrozole in Patients With Recurrent Advanced Borderline Tumors or Low Grade Epithelial Cancers of the Ovary, Fallopian Tube and Primary Peritoneum|Terminated||Phase 2|16|Actual|M.D. Anderson Cancer Center||1||Terminated due to slow patient accrual.|f||||f||||||||||2017-02-18 15:25:43.02104|2017-02-18 15:25:43.02104
NCT00505648|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2015-03-23|||January 2008||2008-01-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|DRESS2||Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)|Treatment of DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) With Tegeline®|Terminated||Phase 3|6|Actual|University Hospital, Rouen||1||Side effects valuation|f||||f||||||||||2017-02-18 15:25:43.234816|2017-02-18 15:25:43.234816
NCT00505635|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2016-05-16|2012-03-26||March 2007||2007-03-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Biochemotherapy With Temozolomide for Metastatic Melanoma|Biochemotherapy With Temozolomide, Velban, Cisplatin, Interleukin-2, Interferon-alpha and Thalidomide for Metastatic Melanoma With Optional Intrathecal Interleukin-2 Treatment|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center||1||Slow accrual|f||||f||||||||||2017-02-18 15:25:43.49112|2017-02-18 15:25:43.49112
NCT00505427|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2013-06-28|||March 2006||2006-03-01|June 2013|2013-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Alpha Lipoic Acid and Polycystic Ovary Syndrome|Alpha Lipoic Acid and Polycystic Ovary Syndrome|Completed||Phase 1|22|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:25:46.089305|2017-02-18 15:25:46.089305
NCT00505622|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2015-12-17|2012-10-23||July 2007||2007-07-01|November 2015|2015-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations|A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations|Terminated||Phase 3|328|Actual|Eisai Inc.|Due to early termination, no subjects completed this open-label extension study.|1||Study stopped due to lack of efficacy.|f||||||||||||||2017-02-18 15:25:43.76049|2017-02-18 15:25:43.76049
NCT00505609|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2007-07-20|||November 1999||1999-11-01|July 2007|2007-07-01|October 2001|Actual|2001-10-01|||||Interventional|||Efficacy of the Standard Days Method of Family Planning|Efficacy of the Standard Days Method of Family Planning|Completed||N/A|478|Actual|Georgetown University||1|||f||||f||||||||||2017-02-18 15:25:44.350652|2017-02-18 15:25:44.350652
NCT00505596|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-10-17|||December 2007||2007-12-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|EPIC||Expanded Prenatal Testing Options and Informed Choice|Expanded Prenatal Testing Options and Informed Choice|Completed||N/A|744|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:25:44.456978|2017-02-18 15:25:44.456978
NCT00505583|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2011-07-22|||July 2007||2007-07-01|July 2011|2011-07-01|December 2007|Anticipated|2007-12-01|December 2007|Anticipated|2007-12-01||Interventional|||Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy|A Randomized, Double-Blind, Triple-Dummy, 3-Period Crossover Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a New Formulation of MOA-728 in Subjects on Stable Methadone Maintenance|Withdrawn||Phase 1|||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 15:25:44.558869|2017-02-18 15:25:44.558869
NCT00505570|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2015-04-06|||May 2006||2006-05-01|April 2015|2015-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|PRIMA||PRIMA PFO Migraine Trial|Percutaneous Closure of Patent Foramen Ovale In Migraine With Aura - A Randomized Prospective Study (Prima Trial)|Terminated||Phase 2|107|Actual|St. Jude Medical||2|||f||||t||||||||||2017-02-18 15:25:44.647083|2017-02-18 15:25:44.647083
NCT00505557|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2009-06-23|||May 2006||2006-05-01|June 2009|2009-06-01|April 2008|Actual|2008-04-01|April 2007|Actual|2007-04-01||Interventional|||Dual-Plane Breast Augmentation: Axillary Approach With Assistant of Endoscope||Completed||Phase 1|||Chinese Academy of Sciences||1|||f||||t||||||||||2017-02-18 15:25:44.776207|2017-02-18 15:25:44.776207
NCT00505544|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-11-02|||August 2005||2005-08-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Observational|||Measuring Sleep Disturbance Among Cancer Patients|The Brief Sleep Disturbance Scale: Measuring Sleep Disturbance Among Cancer Patients|Active, not recruiting||N/A|570|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 15:25:44.870203|2017-02-18 15:25:44.870203
NCT00505531|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2014-07-02|||June 2007||2007-06-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|December 2007|Actual|2007-12-01||Observational|||Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics|Pain Study to See if Ultram ER Will Provide Relief to Subjects Whose Pain is Not Well Controlled by Narcotics|Unknown status|Active, not recruiting|N/A|93|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-02-18 15:25:44.984132|2017-02-18 15:25:44.984132
NCT00505518|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2013-07-09|2012-02-24||September 2006||2006-09-01|July 2013|2013-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home|Feasibility and Effectiveness of Telepsychiatry for Collaborative Management of Chinese Americans With Psychiatric Disorders in a Nursing Home|Completed||N/A|9|Actual|Massachusetts General Hospital|Many subjects in the study suffered from dementia and psychotic symptoms, thus their responses may not be reliable.|1|||f||||t||||||||||2017-02-18 15:25:45.08591|2017-02-18 15:25:45.08591
NCT00505505|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2008-08-06|||January 2002||2002-01-01|July 2007|2007-07-01||||||||Interventional|||Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy|Effects of Intensive Insulin Therapy on Mortality, Morbidity and Long Term Neurologic Outcome in Neurosurgical Intensive Care Patients|Unknown status|Recruiting|Phase 4|800|Anticipated|University of Roma La Sapienza||2|||f||||t||||||||||2017-02-18 15:25:45.362542|2017-02-18 15:25:45.362542
NCT00505492|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2011-09-13|||February 2002||2002-02-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|February 2006|Actual|2006-02-01||Interventional|||Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy|A Phase II Study of Adjuvant Postoperative Radiation With Cisplatin Followed by Carboplatin/Paclitaxel Chemotherapy Following Total Abdominal Hysterectomy/Bilateral Salpino-Oophorectomy (TAH/BSO) for Patients With Stage I, II and IIIa Malignant Mixed Mesodermal Tumor (MMMT) of the Uterus.|Terminated||Phase 2|4|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 15:25:45.47027|2017-02-18 15:25:45.47027
NCT00505479|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2007-07-20|||May 2007||2007-05-01|July 2007|2007-07-01|May 2010|Anticipated|2010-05-01|||||Observational|||Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy?||Unknown status|Recruiting|N/A|||Zhejiang University|||||f||||t||||||||||2017-02-18 15:25:45.588608|2017-02-18 15:25:45.588608
NCT00505466|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-08-10|||May 1999||1999-05-01|August 2016|2016-08-01||||May 2018|Anticipated|2018-05-01||Observational|||Transition From Research to Disclosure in Human Genetics|Transition From Research to Disclosure in Human Genetics|Recruiting||N/A|800|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Optional small sample of blood (about 6 tablespoons) for genetic testing for p53 following~     pre-test genetic counseling.~   "|||2017-02-18 15:25:45.675826|2017-02-18 15:25:45.675826
NCT00505453|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2016-11-03|||July 2007||2007-07-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|||||Interventional|||A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine|A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2007 - 2008 Season) in Adults Ranging in Age From 18 to 60 Years and 61 Years and Over|Completed||Phase 3|110|Anticipated|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:25:45.783176|2017-02-18 15:25:45.783176
NCT00505440|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2013-04-22|||June 2005||2005-06-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|TARAA||Trial of Automated Risk Appraisal for Adolescents|Trial of Automated Risk Appraisal for Adolescents|Completed||N/A|1185|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-02-18 15:25:45.882177|2017-02-18 15:25:45.882177
NCT00505414|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-06-14|2010-05-27||June 2007||2007-06-01|June 2016|2016-06-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional||"Safety Analysis Set. The information is correct for each treatment arm. The demographic details for the total population is for the 93 participants that started treatment in the titration phase of the trial.~The tapentadol titration population was subject to a randomized withdrawal-trial design."|A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine|"A Randomized Withdrawal, Active- and Placebo-controlled, Double-blind, Multi-center Phase III Trial Assessing Safety and Efficacy of Oral CG5503 (Tapentadol) Prolonged Release (PR*) in Subjects With Moderate to Severe Chronic Malignant Tumor-related Pain. *Prolonged Release and is the Recommended Nomenclature for Use in the European Union (EU). ER Means Extended Release and is the Recommended Nomenclature for Use in the United States of America (USA). PR is Synonymous With ER and is Interchangeable."|Terminated||Phase 3|136|Actual|Grünenthal GmbH|Early termination, due to a recall of the morphine rescue medication and issues regarding supply of an alternative, lead to only 93 participants out of the 573 planned (16%) being available for analysis. The data should be interpreted with caution.|3||Recall of rescue medication, alternative rescue medication availability issues.|f||||f||||||||||2017-02-18 15:25:46.211395|2017-02-18 15:25:46.211395
NCT00505401|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2011-02-28|||December 2003||2003-12-01|July 2007|2007-07-01|November 2007|Actual|2007-11-01|||||Interventional|ISST-001||Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS|A Phase I Safety and Immunogenicity Trial of Recombinant HIV-1 Tat in HIV-1 Infected Adult Volunteers|Completed||Phase 1|27|Actual|Istituto Superiore di Sanità||2|||f||||t||||||||||2017-02-18 15:25:47.358281|2017-02-18 15:25:47.358281
NCT00505388|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2010-04-23|||July 2007||2007-07-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice|A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice|Completed||N/A|5137|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 15:25:47.481244|2017-02-18 15:25:47.481244
NCT00505375|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2016-07-07|2016-05-12||February 2008||2008-02-01|July 2016|2016-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus|Effects of CTLA-4 Ig (Abatacept) On The Progression of Type 1 Diabetes In New Onset Subjects|Completed||Phase 2|112|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 15:25:51.343259|2017-02-18 15:25:51.343259
NCT00505362|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2014-11-18|||June 2006||2006-06-01|November 2014|2014-11-01|September 2015|Anticipated|2015-09-01|August 2014|Actual|2014-08-01||Interventional|||Pain Study of Rectus Muscle Closure at Cesarean Delivery|Rectus Muscle Closure vs. Non-Closure at Primary Cesarean Delivery and Post-Operative Pain|Unknown status|Active, not recruiting|Phase 2/Phase 3|112|Anticipated|Stanford University||2|||f||||f||||||||||2017-02-18 15:25:51.765677|2017-02-18 15:25:51.765677
NCT00505349|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-02-04|||June 2007||2007-06-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Blood Neurotrophic Factors in Adults|Blood Neurotrophic Factors in Adults|Withdrawn||N/A|0|Actual|Posit Science Corporation||2|||f||||f||||||||||2017-02-18 15:25:51.853384|2017-02-18 15:25:51.853384
NCT00505336|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2009-02-10|||April 2006||2006-04-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure|The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure|Completed||N/A|43|Actual|St Vincent's University Hospital, Ireland||3|||f||||f||||||||||2017-02-18 15:25:51.952215|2017-02-18 15:25:51.952215
NCT00505323|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-07-04|||September 2007||2007-09-01|July 2014|2014-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|CORDYS||Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness|Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Pallidal Lesion : Evaluation of Safety and Effectiveness|Completed||Phase 1|5|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:25:52.063118|2017-02-18 15:25:52.063118
NCT00505310|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-04-25|||August 2002||2002-08-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Interventional|||Biobehavioral Effects of Emotional Expression in Cancer|Biobehavioral Effects of Emotional Expression in Cancer|Active, not recruiting||N/A|710|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:25:52.14261|2017-02-18 15:25:52.14261
NCT00505297|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2007-07-20|||August 2004||2004-08-01|October 2006|2006-10-01|July 2007|Actual|2007-07-01|||||Observational|||A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography|A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography|Completed||N/A|18|Actual|University of California, San Francisco|||2||f||||t||||||||||2017-02-18 15:25:52.24765|2017-02-18 15:25:52.24765
NCT00505284|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2014-06-26|2012-10-23||June 2007||2007-06-01|February 2013|2013-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy|Completed||Phase 2/Phase 3|352|Actual|Eisai Inc.||5|||f||||f||||||||||2017-02-18 15:25:52.353015|2017-02-18 15:25:52.353015
NCT00505271|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2011-06-09|||July 2007||2007-07-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy Study Using Rexin-G for Breast Cancer|Phase I/II Evaluation of Safety and Efficacy of Pathotropic Nanoparticles Bearing a Dominant Negative Cyclin G1 Construct (Rexin-G) as Intervention for Recurrent or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|20|Actual|Epeius Biotechnologies||1|||f||||t||||||||||2017-02-18 15:25:54.127477|2017-02-18 15:25:54.127477
NCT00505258|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2013-02-19||||||February 2013|2013-02-01|April 2009|Anticipated|2009-04-01|||||Interventional|||Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia|Randomized, Open-Label Study Evaluating the Safety and Rate of Bacterial Clearance of Ceftobiprole 500 Milligram Every 8 Hours Compared to Conventional Therapy in the Treatment of Hospitalized Subjects With Staphylococcus Aureus Bacteremia|Withdrawn||Phase 2|0|Actual|Basilea Pharmaceutica||||The study was withdrawn due to lack of an appropriate patient population.|||||f||||||||||2017-02-18 15:25:54.237203|2017-02-18 15:25:54.237203
NCT00365443|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-06-18|||October 2006||2006-10-01|June 2015|2015-06-01||||||||Interventional|||Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)|Proprietary Information - Exploratory (Non-Confirmatory) Trial|Withdrawn||Phase 2|0|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:19:28.342914|2017-02-18 16:19:28.342914
NCT00505245|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-11-28|||April 1999||1999-04-01|November 2016|2016-11-01||||April 2018|Anticipated|2018-04-01||Observational|||M.D. Anderson Symptom Inventory (MDASI) Validation Study in Cancer Patients|Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System|Recruiting||N/A|4500|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:25:54.327726|2017-02-18 15:25:54.327726
NCT00505232|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2011-12-30|||January 2006||2006-01-01|December 2011|2011-12-01|May 2011|Actual|2011-05-01|March 2010|Actual|2010-03-01||Interventional|LCM-04-02||Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)|Induction Treatment With Anti-CD20 Plus Hyper-CVAD and Methotrexate/Cytarabine Followed by Consolidation Treatment With Y90 Ibritumomab-Tiuxetan in Patients With Mantle Cell Lymphoma|Completed||Phase 2|30|Actual|CABYC||1|||f||||f||||||||||2017-02-18 15:25:54.440644|2017-02-18 15:25:54.440644
NCT00505219|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2016-11-02||2016-06-27|September 2007||2007-09-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|ON-CORE||Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head|Multi-center Clinical Trial of the Application of Ixmyelocel-T in the Treatment of Osteonecrosis of the Femoral Head|Completed||Phase 2|11|Actual|Vericel Corporation||2|||f||||f||||||||||2017-02-18 15:25:54.571336|2017-02-18 15:25:54.571336
NCT00505180|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2007-07-19|||June 2004||2004-06-01|July 2007|2007-07-01|June 2006|Actual|2006-06-01|||||Observational|ArMORR||Accelerated Mortality on Renal Replacement|Accelerated Mortality on Renal Replacement|Completed||N/A|10018|Actual|Massachusetts General Hospital|||||f||||f||||||||||2017-02-18 15:25:54.685039|2017-02-18 15:25:54.685039
NCT00505167|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2008-12-26|||July 2007||2007-07-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Memantine Versus Donepezil in Early Stages of Alzheimer's Disease|Memantine Versus Donepezil in Mild to Moderate Alzheimer's Disease. A Randomized Trial With Magnetic Resonance Spectroscopy.|Completed||Phase 4|64|Actual|Hospital Miguel Servet||2|||f||||f||||||||||2017-02-18 15:25:54.756614|2017-02-18 15:25:54.756614
NCT00505115|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-20|2007-07-20||||||July 2007|2007-07-01||||||||Observational|||The Human Blastocyst Secretome and Implantome||Completed||N/A|||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||f||||||||||2017-02-18 15:25:54.878205|2017-02-18 15:25:54.878205
NCT00505102|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2008-02-12|||January 2007||2007-01-01|February 2008|2008-02-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|SAREFU||Safe Renal Function In Long Term Heart Transplanted Patients|Efficacy and Safety of Everolimus to SAve REnal Function (SAREFU) in Long Term Heart Transplanted Patients|Unknown status|Active, not recruiting|Phase 4|200|Anticipated|A.O. Ospedale Papa Giovanni XXIII||1|||f||||t||||||||||2017-02-18 15:25:54.94498|2017-02-18 15:25:54.94498
NCT00505089|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2009-08-24|||August 2007||2007-08-01|August 2009|2009-08-01||||May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis|An Exploratory, Open Label Pharmacokinetic - Pharmacodynamic Study to Compare Subcutaneous Versus Intravenous Administration of ACZ885 in Adult Patients With Established Rheumatoid Arthritis|Terminated||Phase 1/Phase 2|11|Actual|Novartis||4|||f||||f||||||||||2017-02-18 15:25:55.044369|2017-02-18 15:25:55.044369
NCT00505076|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2014-10-30|2011-04-27||July 2007||2007-07-01|October 2014|2014-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|TURNS||Treatment Study for Cognitive Deficits in Schizophrenia|MK-0777 for the Treatment of Cognitive Impairments in Patients With Schizophrenia|Completed||Phase 2|63|Actual|University of California, Los Angeles||3|||f||||t||||||||||2017-02-18 15:25:55.152258|2017-02-18 15:25:55.152258
NCT00505063|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2017-01-03|||July 2007||2007-07-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Prospective Trial of Vaccine Responses in Childhood Cancer Survivors|Phase II Prospective Trial of Vaccine Responses in Childhood Cancer Survivors|Active, not recruiting||Phase 2|75|Anticipated|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 15:25:55.725997|2017-02-18 15:25:55.725997
NCT00505050|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2007-07-18|||October 1999||1999-10-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|REMADHE||A Long-Term Prospective Randomized Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients – The REMADHE Study||Completed||Phase 3|||University of Sao Paulo||1|||f||||f||||||||||2017-02-18 15:25:55.829496|2017-02-18 15:25:55.829496
NCT00505037|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2011-03-21|||October 2007||2007-10-01|March 2011|2011-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis|A Phase 2, Randomized, Double-blind-placebo-controlled and Open-label-Sevelamer Hydrochloride-controlled, Dose-ranging Study for ASP1585 in Patients With Chronic Kidney Disease(CKD) and Hyperphosphatemia on Hemodialysis|Completed||Phase 2|156|Actual|Astellas Pharma Inc||5|||f||||t||||||||||2017-02-18 15:25:55.91683|2017-02-18 15:25:55.91683
NCT00505024|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2012-07-27|||July 2006||2006-07-01|July 2012|2012-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic Surgery|A Randomized Clinical Trial of the Efficacy of an Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic Surgery|Completed||N/A|100|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:25:56.027358|2017-02-18 15:25:56.027358
NCT00505011|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2007-07-19|||February 1998||1998-02-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|||||Observational|||Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease|Study of the Influence of the GST, CYP and TP53 Gene Polymorphisms in the Risk of Graves' Disease and Its Outcome.|Completed||N/A|1998|Actual|University of Campinas, Brazil|||||f||||f||||||||||2017-02-18 15:25:56.138801|2017-02-18 15:25:56.138801
NCT00504998|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2011-06-09|||July 2007||2007-07-01|February 2010|2010-02-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|||Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer|Phase I/II Evaluation of Safety and Efficacy of Rexin-G for Recurrent or Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|20|Actual|Epeius Biotechnologies||5|||f||||t||||||||||2017-02-18 15:25:56.207244|2017-02-18 15:25:56.207244
NCT00504985|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2012-07-26|2010-03-26||August 2005||2005-08-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Fatigue in Emergency Center Patients|Fatigue and Its Symptom Cluster Related to Inflammatory Cytokine Profiles in Cancer Patients Seeking Emergency Care|Terminated||N/A|14|Actual|M.D. Anderson Cancer Center|Early termination led to small numbers of subjects, too little data to analyze.||1|Low Accrual|f||||f||||||Samples Without DNA|"~     About 1 tablespoon of blood drawn for cytokine testing.~   "|||2017-02-18 15:25:56.543369|2017-02-18 15:25:56.543369
NCT00504972|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2017-02-07|||June 2007||2007-06-01|February 2017|2017-02-01|October 7, 2015|Actual|2015-10-07|April 1, 2011|Actual|2011-04-01||Interventional|||Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies|Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies|Completed||Phase 1|23|Actual|Weill Medical College of Cornell University||1|||f||||t|t|f||||||Undecided||2017-02-18 15:25:56.748891|2017-02-18 15:25:56.748891
NCT00504959|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-03-02|||July 2007||2007-07-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration|A Phase IV, Long-term, Open-label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)|Completed||Phase 4|234|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:25:56.846669|2017-02-18 15:25:56.846669
NCT00504946|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2008-04-08|||September 2005||2005-09-01|April 2008|2008-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Pharmacological Modulations of Allergen-Specific Immunotherapy|The Effect of Glucocorticosteroid and Vitamin D3 Administration and Montelukast Treatment on Early Clinical and Immunological Effect of Allergen-Specific Immunotherapy in Asthmatic Children, Double-Blind, Placebo-Controlled Study|Completed||Phase 3|85|Actual|Medical Universtity of Lodz||5|||f||||t||||||||||2017-02-18 15:25:56.97996|2017-02-18 15:25:56.97996
NCT00504933|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2012-04-04|||May 2005||2005-05-01|April 2012|2012-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis|Double-blind, Randomised, Placebo-controlled, Phase III Study Comparing the Efficacy and Safety of Bilastine 20 mg Once Daily and Cetirizine 10 mg for the Treatment of Seasonal Allergic Rhinitis.|Completed||Phase 3|683|Actual|Faes Farma, S.A.||3|||f||||f||||||||||2017-02-18 15:25:57.092037|2017-02-18 15:25:57.092037
NCT00504920|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2012-07-31|||May 2004||2004-05-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients|Feasibility Study of the Assessment of Symptom-Related Cytokines in AML/MDS Patients Undergoing Allogeneic Blood or Marrow Transplantation|Completed||N/A|30|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     At admission, blood sample drawn (around 2½ tablespoons) to measure levels of cytokines~     before transplant procedure, then another three days postadmission, on day of transplant, 1~     day after transplant, 3 days, 8 days, 15 days, 22 days, 29 days postransplant, then between~     50 - 60 days postransplant and again 80 - 100 days after transplant.~   "|||2017-02-18 15:25:57.200669|2017-02-18 15:25:57.200669
NCT00504907|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2015-03-31|||July 2007||2007-07-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety Study of Oral BTA9881 to Treat RSV Infection|A Phase I, Single-Centre, Double-Blind, Placebo-Controlled, Escalating Single Oral Dose, Safety and Tolerability Clinical Trial With BTA9881 in Healthy Subjects|Completed||Phase 1|63|Actual|Aviragen Therapeutics||7|||f||||t||||||||||2017-02-18 15:25:57.29796|2017-02-18 15:25:57.29796
NCT00504894|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2015-01-28|||March 2007||2007-03-01|April 2013|2013-04-01||||December 2015|Anticipated|2015-12-01||Interventional|Amygdala||Neuroimaging the Effects of Intravenous Anesthetic on Amygdala Dependent Memory Processes|Neuroimaging the Effects of Intravenous Anesthetic on Amygdala Dependent Memory Processes|Unknown status|Active, not recruiting|Phase 4|90|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 15:25:57.398846|2017-02-18 15:25:57.398846
NCT00504881|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2015-04-29||2010-02-01|October 2007||2007-10-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy|An International, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible Dose Study: Evaluation of the Safety and Efficacy of Brivaracetam in Subjects (≥ 16 to 70 Years Old) Suffering From Localization-related or Generalized Epilepsy.|Completed||Phase 3|480|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 15:25:57.495327|2017-02-18 15:25:57.495327
NCT00504855|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2013-04-05|||July 2007||2007-07-01|April 2013|2013-04-01|March 2014|Anticipated|2014-03-01|February 2012|Actual|2012-02-01||Interventional|||Cast Sores With Waterproof Vs. Standard Cast Padding|Cast Sores With Waterproof Vs. Standard Cast Padding in a Pediatric Population|Terminated||N/A|84|Actual|Shriners Hospitals for Children||2||"Staffing changes resulted in the expiration of IRB approval (2/15/12), and recruitment halted~   (n=84). IRB approval is now current for retrospective analysis."|f||||f||||||||||2017-02-18 15:25:57.841363|2017-02-18 15:25:57.841363
NCT00504842|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2008-04-11|||December 2006||2006-12-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|||||Interventional|TUCSON||Transcranial Ultrasound in Clinical SONothrombolysis|A Phase 1-2, Randomized, Placebo-Controlled, Single-Blind, Dose Escalation Study to Evaluate the Safety, Tolerability, and Activity of Ascending Single Doses of MRX-801 With Continuous Ultrasound Administration in Subjects With Acute Ischemic Stroke Receiving Treatment With Intravenous Tissue Plasminogen Activator|Terminated||Phase 1/Phase 2|72|Anticipated|ImaRx Therapeutics||2||Sponsor decision|f||||t||||||||||2017-02-18 15:25:57.952001|2017-02-18 15:25:57.952001
NCT00504829|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2008-04-11|||July 2007||2007-07-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia|A 12-Week, Multi-Center, Double-Blind, Randomized, Parallel-Group Study, Followed by a 12 Month Extension Study, of the Efficacy and Safety of LCP-AtorFen in Subjects With Dyslipidemia|Completed||Phase 2|220|Actual|Veloxis Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:25:58.047571|2017-02-18 15:25:58.047571
NCT00504816|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-05-31|||April 2007||2007-04-01|February 2011|2011-02-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers|An Open Label, Single-sequence, Repeat-dose Study to Investigate the Effects of GSK189075 on the Pharmacokinetics of an Oral Contraceptive Pill When Coadministered to Healthy Female Volunteers|Completed||Phase 1|22|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:25:58.159571|2017-02-18 15:25:58.159571
NCT00504803|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2011-09-01|||December 2006||2006-12-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease|Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning: a Pilot Study|Completed||Phase 2|30|Anticipated|University Hospital of Liege||1|||f||||f||||||||||2017-02-18 15:25:58.271814|2017-02-18 15:25:58.271814
NCT00504790|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2015-06-04|||June 2007||2007-06-01|June 2015|2015-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer|A Phase I, Open-Label, Dose-Escalation, First Time in Human Study to Evaluate the Safety Profile, Pharmacokinetics, and Pharmacodynamics of GSK923295 in Subjects With Refractory Cancers|Completed||Phase 1|39|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:25:58.384097|2017-02-18 15:25:58.384097
NCT00504777|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2014-07-09|2014-07-09||July 2007||2007-07-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||Intent-to-Treat (ITT) Population: all participants who recieved any part of an infusion.|A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Agents.|An Open Label Study to Evaluate the Safety, and Effect on Treatment Response, of MabThera in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response or Intolerance to One or More Anti-TNF Agents.|Completed||Phase 4|36|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:25:58.663723|2017-02-18 15:25:58.663723
NCT00504764|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2014-10-27|||July 2007||2007-07-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)|APL-R2007: Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)|Completed||Phase 4|60|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:25:58.984857|2017-02-18 15:25:58.984857
NCT00504751|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2017-02-07|||May 2007|Actual|2007-05-01|February 2017|2017-02-01|February 17, 2012|Actual|2012-02-17|December 2010|Actual|2010-12-01||Interventional|||"Phase II Study of VIPER Chemotherapy in Rel/Ref DLBCL"|"Phase II Trial of VIPER Chemotherapy in Relapsed and Refractory Diffuse Large B-cell Lymphoma (NHL)"|Completed||Phase 2|15|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 15:25:59.171025|2017-02-18 15:25:59.171025
NCT00504738|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2015-04-20|||April 2006||2006-04-01|April 2015|2015-04-01|April 2007|Actual|2007-04-01|||||Observational|Q-LD||Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease|Evaluation of the Lungs of Individuals With Lung Disease With Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing, and Bronchial Wall Biopsy (Qatar)|Completed||N/A|75|Actual|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"~     The purpose of this protocol is to obtain biologic samples from the blood and lungs from~     patients with lung diseases in order to study the causes and indications of these disorders,~     learn how these lung disease manifest and progress, and how the lung disease can be treated.~   "|||2017-02-18 15:25:59.281712|2017-02-18 15:25:59.281712
NCT00504725|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2014-07-18|2011-09-29||July 2007||2007-07-01|November 2012|2012-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|KITS||Ketamine In Thoracic Surgery (KITS) Trial|Ketamine In Thoracic Surgery (KITS) Trial|Completed||Phase 2|40|Actual|Duke University||2|||f||||f||||||||||2017-02-18 15:25:59.367364|2017-02-18 15:25:59.367364
NCT00504712|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2007-07-19|||February 2006||2006-02-01|July 2007|2007-07-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Testosterone for Peripheral Vascular Disease|A Randomised, Double Blind, Placebo Controlled, Parallel Pilot Study to Test the Effect of Testosterone Treatment on Peripheral Vascular Disease in Hypogonadal Men With Type 2 Diabetes Mellitus|Unknown status|Recruiting|Phase 4|30|Anticipated|Barnsley Hospital||2|||f||||f||||||||||2017-02-18 15:25:59.735799|2017-02-18 15:25:59.735799
NCT00504699|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2016-09-24|||January 2002||2002-01-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients|Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients Undergoing Embryo or Oocyte Cryopreservation: A Prospective Controlled Follow up Study|Active, not recruiting||N/A|100|Anticipated|New York Medical College||2|||f||||f||||||||No||2017-02-18 15:25:59.943412|2017-02-18 15:25:59.943412
NCT00504686|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2009-02-02|||January 2007||2007-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Patients With Neck Pain Likely to Benefit From Thoracic Spine Thrust Mobilization|Validation of a Clinical Prediction Rule to Identify Patients With Neck Pain Likely to Benefit From Thoracic Spine Thrust Mobilization: A Randomized Clinical Trial|Completed||Phase 1|140|Anticipated|Franklin Pierce University||2|||f||||f||||||||||2017-02-18 15:26:00.058814|2017-02-18 15:26:00.058814
NCT00504673|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2014-11-20|||April 2005||2005-04-01|November 2014|2014-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|PREDICTIVE™||Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes|Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes|Completed||Phase 3|277|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:26:00.171509|2017-02-18 15:26:00.171509
NCT00504660|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2011-12-06|2011-12-06||September 2003||2003-09-01|December 2011|2011-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients|Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme|Completed||Phase 2|75|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 15:26:00.31257|2017-02-18 15:26:00.31257
NCT00504647|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2007-07-18|||June 2006||2006-06-01|July 2007|2007-07-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Biventricular Pacing in Hypertrophic Cardiomyopathy|Diastolic Ventricular Interaction and the Effects Of Biventricular Pacing in Hypertrophic Cardiomyopathy|Unknown status|Recruiting|Phase 1|30|Anticipated|University Hospital Birmingham||2|||f||||f||||||||||2017-02-18 15:26:00.808613|2017-02-18 15:26:00.808613
NCT00504634|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2011-09-14|||January 2004||2004-01-01|September 2011|2011-09-01|May 2010|Actual|2010-05-01|August 2007|Actual|2007-08-01||Interventional|||Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma|A Phase II Trial of Bortezomib (Velcade) After Allogenic Peripheral Blood Stem Cell or Bone Marrow Transplantation for Patients With Multiple Myeloma|Completed||Phase 2|8|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:26:00.908441|2017-02-18 15:26:00.908441
NCT00504621|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2014-03-25|||August 2007||2007-08-01|March 2014|2014-03-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Observational|||The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis|The Influence of Personality on Quality of Life, Fatigue, Prognosis, and Health Care Consumption in Pulmonary Fibrosis and Sarcoidosis|Completed||N/A|450|Actual|Maastricht University Medical Center|||2||f||||f||||||||||2017-02-18 15:26:01.029532|2017-02-18 15:26:01.029532
NCT00504608|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2017-01-03|||April 2003||2003-04-01|January 2017|2017-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure|A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure|Completed||Phase 1/Phase 2|150|Actual|Merck KGaA|||||f||||||||||||||2017-02-18 15:26:01.115528|2017-02-18 15:26:01.115528
NCT00504595|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2012-08-02|2011-01-20||May 2007||2007-05-01|August 2012|2012-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis|A 12-week, Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Response to Treatment (ACR20) and to Determine a Biomarker Profile in Adult Patients With Established Rheumatoid Arthritis Responding to ACZ885 (Anti-interleukin-1beta Monoclonal Antibody) as Compared to Healthy Subjects Exposed to ACZ885|Completed||Phase 2|80|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:26:01.360233|2017-02-18 15:26:01.360233
NCT00504582|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-09-27|||May 2002||2002-05-01|September 2016|2016-09-01||||May 2018|Anticipated|2018-05-01||Interventional|||Fibrin Melanoma Axillary Node Study in Patients With Melanoma|A Randomized Trial Evaluating the Use of Fibrin Tissue Adhesive Following Axillary Node Dissection in Patients With Melanoma|Active, not recruiting||N/A|115|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:26:01.875657|2017-02-18 15:26:01.875657
NCT00504556|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2015-03-12|2015-02-05||June 2007||2007-06-01|March 2015|2015-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation|A Phase 2, Randomized, Parallel Group, Multi Center, Multi National Study for the Evaluation of Safety of Four Fixed Dose Regimens of DU-176b in Subjects With Non- Valvular Atrial Fibrillation|Completed||Phase 2|1146|Actual|Daiichi Sankyo Inc.||5|||f||||t||||||||||2017-02-18 15:26:02.011033|2017-02-18 15:26:02.011033
NCT00504543|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-11-16|||July 2007||2007-07-01|November 2016|2016-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|AEB071||Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients|A 12 Month Open-label, Randomized, Multicenter, Sequential Cohort-group, Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of Oral AEB071 Versus Cyclosporine in Combination With Everolimus, Basiliximab and Corticosteroids in de Novo Adult Renal Transplant Recipients.|Completed||Phase 2|311|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:26:04.328506|2017-02-18 15:26:04.328506
NCT00504530|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2017-01-03|||September 2001||2001-09-01|December 2016|2016-12-01|April 2002|Actual|2002-04-01|||||Interventional|||r-hLIF for Improving Embryo Implantation in IVF|A Randomised, Double-blind, Placebo Controlled, Proof of Concept Study to Assess the Efficacy, Safety and Acceptability of r-hLIF for Improving Embryo Implantation Following in Vitro Fertilisation (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure.|Completed||Phase 1/Phase 2|50|Actual|Merck KGaA|||||f||||||||||||||2017-02-18 15:26:04.459302|2017-02-18 15:26:04.459302
NCT00504517|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2012-08-15|||July 2007||2007-07-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|P4||Preparing the Personal Physician for Practice (P4)|Preparing the Personal Physician for Practice (P4)|Completed||N/A|35|Actual|Christiana Care Health Services|||1||f||||f||||||||||2017-02-18 15:26:04.533264|2017-02-18 15:26:04.533264
NCT00504504|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2013-05-20|2013-05-20||March 2001||2001-03-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Rituximab and ABVD for Hodgkin's Patients|A Phase II Study of Rituximab + ABVD for Patients With Hodgkin's Disease|Completed||Phase 2|85|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:26:04.617466|2017-02-18 15:26:04.617466
NCT00504491|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2011-12-28|||July 2007||2007-07-01|December 2011|2011-12-01|June 2012|Anticipated|2012-06-01|January 2012|Anticipated|2012-01-01||Interventional|R-CHOP||R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia|Rescue Treatment With Rituximab-CHOP Therapy and Alemtuzumab (R-CHOP-A) in Refractory or Recidivant Patients With Chronic Lymphocytic Leukemia After Purine-analogous Treatment|Withdrawn||Phase 2|0|Actual|CABYC||1||IMP new owner decision|f||||t||||||||||2017-02-18 15:26:05.034619|2017-02-18 15:26:05.034619
NCT00504478|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2007-07-19|||January 2008||2008-01-01|April 2007|2007-04-01|December 2009|Anticipated|2009-12-01|||||Interventional|HCCD||Effect of HCCD Supplemented With Omega-3 Fatty-Acids on Inflammation in Healthy, Overweight Subjects||Unknown status|Not yet recruiting|N/A|150|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-02-18 15:26:05.181724|2017-02-18 15:26:05.181724
NCT00504465|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2007-07-19|||May 2002||2002-05-01|July 2007|2007-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Combined Agent Randomized Trial of Induction of Labor|Cervical Ripening and Induction of Labor: a Randomized Controlled Trial of Combined Versus Sequential Use of Dinoprostone and Oxytocin.|Completed||N/A|210||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 15:26:05.280959|2017-02-18 15:26:05.280959
NCT00504452|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2011-11-03|||July 2007||2007-07-01|November 2008|2008-11-01|June 2009|Actual|2009-06-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients|An Open-Label, Multicenter, Mechanism Validation Study to Evaluate the Safety, Efficacy and Tolerability of KP-1461 as Monotherapy for 124 Days in Antiretroviral-experienced, HIV-1-infected Subjects|Terminated||Phase 2|27|Actual|Koronis Pharmaceuticals.||1||"Corroboration of supporting in vitro data~    - Data successfully corroborated 2009"|f||||t||||||||||2017-02-18 15:26:05.381672|2017-02-18 15:26:05.381672
NCT00504439|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2017-01-18|||June 2007||2007-06-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects.|A Randomised, Double-blind, Placebo Controlled, Dose Ascending, Parallel Group Study to Evaluate the Safety, Tolerability, Steady State Pharmacokinetics and Pharmacodynamics of SB-656933-AAA Following Repeated Doses in Healthy Adult Subjects. The Pharmacokinetic Interaction Between Repeated Doses of SB-656933-AAA and Single Dose of Simvastatin Will Also be Assessed|Completed||Phase 1|36|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:26:05.517142|2017-02-18 15:26:05.517142
NCT00365040|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2006-08-15|||December 2004||2004-12-01|July 2006|2006-07-01|October 2006||2006-10-01|||||Interventional|||Customized PRK With Mitomycin Versus Customized Lasik for Myopic Astigmatism|Customized PRK With Mitomycin Versus Customized Lasik for Myopic Astigmatism|Completed||N/A|40||Federal University of São Paulo|||||f||||||||||||||2017-02-18 16:19:40.953417|2017-02-18 16:19:40.953417
NCT00504426|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2013-12-24|2013-07-01||July 2007||2007-07-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|July 2008|Actual|2008-07-01||Interventional|||Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis|Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis|Completed||Phase 2|101|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-02-18 15:26:05.607171|2017-02-18 15:26:05.607171
NCT00504413|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2010-10-11|||July 2007||2007-07-01|October 2010|2010-10-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|||Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone|Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone in Human Subjects|Unknown status|Recruiting|Phase 1|20|Anticipated|University of Washington||1|||f||||t||||||||||2017-02-18 15:26:06.192704|2017-02-18 15:26:06.192704
NCT00504400|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2009-09-21|||August 2007||2007-08-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)|Ranibizumab in Idiopathic Macular Telangiectasia, Type 2. A Prospective Interventional Non-randomized Study Comparing the Efficacy and Safety of Intravitreal Ranibizumab in Type 2 Idiopathic Macular Telangiectasia.|Completed||Phase 2|10|Actual|University Hospital, Bonn||1|||f||||f||||||||||2017-02-18 15:26:06.322084|2017-02-18 15:26:06.322084
NCT00504387|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2012-12-20|||April 2007||2007-04-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder|Burning Mouth Disorder (BMD) - a Neuropathic Pain Disorder? An Investigation Using Qualitative and Quantitative Sensory Testing (QST)|Unknown status|Recruiting|N/A|12|Anticipated|Charite University, Berlin, Germany|||2||f||||f||||||||||2017-02-18 15:26:06.439477|2017-02-18 15:26:06.439477
NCT00504374|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2017-02-02|||June 2006||2006-06-01|February 2017|2017-02-01||||June 2018|Anticipated|2018-06-01||Observational|||Gene Polymorphisms and Symptoms in Lung Cancer Patients|Gene Polymorphisms and Symptoms in Lung Cancer Patients|Active, not recruiting||N/A|320|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Leftover blood sample to look at certain genes in your blood that may affect your symptoms.~     If you did not have blood collected in the previous lung cancer study, you will have a blood~     sample (one tablespoon) drawn when you first agree to participate in this study.~   "|||2017-02-18 15:26:06.566757|2017-02-18 15:26:06.566757
NCT00504361|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-04-29|||May 2006||2006-05-01|April 2016|2016-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|Q-BC||Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)|Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases (Qatar)|Completed||N/A|600|Actual|Weill Medical College of Cornell University|||2||f||||f||||||Samples With DNA|"~     This protocol is designed to collect a small amount of blood for extraction of DNA (genetic~     material) for the study of the genetic basis of lung disease. Genomic DNA will be extracted,~     and genome wide SNP analysis and promoter sequences for genes will be obtained. The goal is~     to find single nucleotide polymorphims (SNP), small changes in single genes that affect~     disease risk, to see if they correlate with lung disease.~   "|Undecided||2017-02-18 15:26:06.674091|2017-02-18 15:26:06.674091
NCT00504348|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2010-07-28|||July 2007||2007-07-01|July 2010|2010-07-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|IMPPACT||Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus|An Open-label Clinical Trial of the Combination Treatment of Tacrolimus and Corticosteroid in Polymyositis/Dermatomyositis Patients With Interstitial Pneumonitis, With Comparison Against Corticosteroid-treated Historical Controls|Unknown status|Active, not recruiting|Phase 2/Phase 3|20|Anticipated|Tokyo Medical and Dental University||1|||f||||f||||||||||2017-02-18 15:26:06.768473|2017-02-18 15:26:06.768473
NCT00504335|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2015-03-16|||June 2007||2007-06-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Pharmacokinetic Study of BIO 300 Capsules|A Dose Escalation Trial Evaluating the Safety and Pharmacokinetic Profiles of BIO 300 Capsules in Healthy Male and Female Volunteers|Completed||Phase 1|24|Actual|Humanetics Corporation||4|||f||||f||||||||||2017-02-18 15:26:06.879405|2017-02-18 15:26:06.879405
NCT00504322|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2016-05-03|||July 2011||2011-07-01|May 2016|2016-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|cd40||Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma|Phase II, Randomized, Double-blinded, Placebo-Control, Toxicity/Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Stage I, II or III Esophageal Carcinoma|Withdrawn||Phase 1/Phase 2|0|Actual|Weill Medical College of Cornell University||2||No funding available.|f||||t||||||||Undecided||2017-02-18 15:26:06.974035|2017-02-18 15:26:06.974035
NCT00504309|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-19|2010-07-14|||July 2007||2007-07-01|June 2008|2008-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|OMEGA||Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides|Omacor: Measures of Endothelial Function and triGleride Alteration|Completed||N/A|28|Actual|Penn State University||3|||f||||f||||||||||2017-02-18 15:26:07.074552|2017-02-18 15:26:07.074552
NCT00504296|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-05-31|||June 2007||2007-06-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional|||SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Clinical and Pharmacokinetic Study of SB939 in Patients With Advanced Cancer|Completed||Phase 1|39|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 15:26:07.173478|2017-02-18 15:26:07.173478
NCT00504283|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-10-17|||February 2007||2007-02-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||An Analgesia Protocol for Acute Renal Colic in the Emergency Department|An Analgesia Protocol for Acute Renal Colic in the DHMC Emergency Department|Completed||N/A|45|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 15:26:07.276824|2017-02-18 15:26:07.276824
NCT00504270|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2016-11-01||2016-07-06|July 2007||2007-07-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.|A Randomized, Placebo-controlled Dose-ranging Pilot Study to Assess the Effect on Clinical Response, and the Safety and Tolerability of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|66|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 15:26:07.373857|2017-02-18 15:26:07.373857
NCT00503503|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2007-12-20|||March 2005||2005-03-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan|Safety and Efficacy From Large Scale All Cases Surveillance for Etanercept in Japan|Completed||Phase 4|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:26:20.244962|2017-02-18 15:26:20.244962
NCT00504257|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2014-01-07|2013-05-28||March 2007||2007-03-01|May 2013|2013-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Participants who were evaluable for the outcome measures.|Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma|A Phase II Trial of Avastin in Combination With Docetaxel in Patients With Recurrence of Epithelial Carcinoma of the Ovary/Fallopian Tube/Peritoneum Within 12 Months of Platinum Therapy|Completed||Phase 2|45|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 15:26:07.487872|2017-02-18 15:26:07.487872
NCT00504244|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2010-11-15|||July 2007||2007-07-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Myfortic Versus Azathioprine in Systemic Lupus Erythematosus|A Randomized, Multicenter Study to Assess the Efficacy on Diseases Activity of Enteric-coated Mycophenolate Sodium Versus Continuation of Azathioprine in Patients With Systemic Lupus Erythematosus on Azathioprine Maintenance Therapy.|Terminated||Phase 3|12|Actual|Erasmus Medical Center||1||Insufficient recruitment|f||||f||||||||||2017-02-18 15:26:07.950985|2017-02-18 15:26:07.950985
NCT00504231|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2012-06-08|2012-01-11||September 2007||2007-09-01|July 2011|2011-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Intradermal Influenza Vaccine Study in Elders|Intradermal vs. Intramuscular Delivery of Influenza Vaccine in Immunocompetent Elders|Completed||Phase 2|257|Actual|PATH||4|||f||||t||||||||||2017-02-18 15:26:08.064219|2017-02-18 15:26:08.064219
NCT00504218|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2017-01-24|||July 13, 2007||2007-07-13|October 31, 2016|2016-10-31||||||||Observational|||Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients|Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoitic Stem Cell Transplant Recipients|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:26:09.042567|2017-02-18 15:26:09.042567
NCT00504205|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2013-08-01|||May 2007||2007-05-01|April 2008|2008-04-01|March 2010|Actual|2010-03-01|December 2008|Actual|2008-12-01||Interventional|||MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma|Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multi-Targeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies|Terminated||N/A|30|Anticipated|National Cancer Institute (NCI)||||Withdrawn as trial was never activated by SuperGen|||||||||||||||2017-02-18 15:26:09.14622|2017-02-18 15:26:09.14622
NCT00504192|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2014-05-19|||September 2006||2006-09-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer|A Phase II Study of Gemcitabine in Combination With Oxaliplatin as First Line Chemotherapy in Patients With Inoperable Biliary Tract Adenocarcinoma|Completed||Phase 2|40|Actual|Soonchunhyang University Hospital||1|||f||||t||||||||||2017-02-18 15:26:09.418561|2017-02-18 15:26:09.418561
NCT00504179|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-07-17|||April 2001||2001-04-01|July 2007|2007-07-01|October 2005|Actual|2005-10-01|||||Interventional|CABGOMT||The Effect of Osteopathic Manipulative Treatment on Recovery of Coronary Bypass Patients|The Effect of Osteopathic Manipulative Treatment on Post-Operative Medical and Functional Recovery of Coronary Artery Bypass Graft Patients|Completed||N/A|53|Actual|Michigan State University||3|||f||||t||||||||||2017-02-18 15:26:09.510753|2017-02-18 15:26:09.510753
NCT00504166|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2013-07-31|2011-07-13||February 2006||2006-02-01|July 2013|2013-07-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women|Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal|Completed||Phase 4|53|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:26:09.605322|2017-02-18 15:26:09.605322
NCT00504153|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2014-04-30|2013-07-01||July 2007||2007-07-01|October 2011|2011-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer|A Phase II Study of Dasatinib (NSC 732517) in Previously-Treated Patients With Metastatic Colorectal Cancer|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:26:10.085424|2017-02-18 15:26:10.085424
NCT00504140|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-08-01|||November 1996||1996-11-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|November 2007|Actual|2007-11-01||Interventional|||Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma|Phase II Study of Recombinant Interferon Alpha and Etoposide in Patients With Relapsed Osteosarcoma|Completed||Phase 2|30|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:26:10.391658|2017-02-18 15:26:10.391658
NCT00504127|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2011-06-16|||April 2007||2007-04-01|June 2011|2011-06-01||||December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee|A Phase 3, 53 Weeks Study on Analgesic Efficacy and Safety of Naproxcinod (HCT 3012): 26-Week, Randomized, Parallel-Group, Double-Blind, Placebo (13 Weeks)- and Naproxen (26 Weeks)-Controlled, Multicenter Study of Naproxcinod (375 mg Bid and 750 mg Bid) With a 26-Week Naproxen-Controlled Safety Follow-up in Subjects With Osteoarthritis of the Knee, and a 1-week Post-treatment Safety Follow-up|Completed||Phase 3|1020|Actual|NicOx||4|||f||||t||||||||||2017-02-18 15:26:10.518179|2017-02-18 15:26:10.518179
NCT00504114|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2013-12-11|||August 2006||2006-08-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Observational|||MR Imaging of Knee Osteoarthritis and Acute Knee Injuries|MR Imaging of Knee Osteoarthritis and Acute Knee Injuries|Completed||N/A|139|Actual|University of California, San Francisco|||5||f||||f||||||Samples Without DNA|"~     Bone/cartilage tissue will be collected after the total knee replacement surgery. The tissue~     will further studied using advanced MR imaging techniques.~   "|||2017-02-18 15:26:10.688048|2017-02-18 15:26:10.688048
NCT00504101|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-12-14|||June 2007||2007-06-01|December 2016|2016-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma|Phase I Clinical Trial of Dose Escalated Bortezomib + ATO (Arsenic Trioxide) + Melphalan as a Conditioning Regimen for Multiple Myeloma|Withdrawn||Phase 1|0|Actual|University of Miami||1||Temporarily closed to accrual pending availablity of drug.|f||||t||||||||||2017-02-18 15:26:10.791696|2017-02-18 15:26:10.791696
NCT00504088|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2008-08-19|||October 2006||2006-10-01|August 2007|2007-08-01||||||||Interventional|PROOF||Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia|Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia|Terminated||Phase 4|||FoxHollow Technologies||2||Company decision to halt study|f||||||||||||||2017-02-18 15:26:10.904457|2017-02-18 15:26:10.904457
NCT00504075|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2013-02-26|2012-05-04||September 2007||2007-09-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)|A Phase III, Multicenter, Open-Label Study To Evaluate the Efficacy and Safety of GAMMAPLEX® in Chronic Idiopathic Thrombocytopenic Purpura|Completed||Phase 3|35|Actual|Bio Products Laboratory||1|||f||||f||||||||||2017-02-18 15:26:11.028439|2017-02-18 15:26:11.028439
NCT00503867|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2012-05-04|||May 2008||2008-05-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma|A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma|Terminated||Phase 2|10|Actual|Sirtex Medical||1||low patient recruitment|f||||t||||||||||2017-02-18 15:26:11.502434|2017-02-18 15:26:11.502434
NCT00503854|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-02-18|||May 2007||2007-05-01|February 2016|2016-02-01||||May 2017|Anticipated|2017-05-01||Observational|||Fatigue and Symptom Burden in Febrile Neutropenia|Fatigue and Symptom Burden in Febrile Neutropenia|Active, not recruiting||N/A|70|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:26:11.592466|2017-02-18 15:26:11.592466
NCT00503841|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2013-03-27|2013-01-09||December 2007||2007-12-01|March 2013|2013-03-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer|A Pilot Study of the Effect of Erlotinib (Tarceva®) on Biomarkers in Estrogen Receptor Negative Breast Cancer Expressing the Epidermal Growth Factor Receptor and Interleukin 1α|Terminated||N/A|44|Actual|Barbara Ann Karmanos Cancer Institute||1||All enrolled participants were screen failures, no data were collected for outcome measures.|f||||t||||||||||2017-02-18 15:26:11.7004|2017-02-18 15:26:11.7004
NCT00503828|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2010-01-11|||July 2007||2007-07-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Derris Scandens Benth Extract VS Naproxen in Knee OA|The Efficacy and Safety of Derris Scandens Benth Extract and Naproxen for Therapy of Patients With Knee Osteoarthritis|Completed||Phase 3|120|Actual|Mahidol University||2|||f||||t||||||||||2017-02-18 15:26:11.93064|2017-02-18 15:26:11.93064
NCT00503815|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-12-20|||July 2007||2007-07-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy|A Safety and Efficacy Evaluation of BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy|Completed||Phase 3|360|Anticipated|Braintree Laboratories|||||f||||f||||||||||2017-02-18 15:26:12.039363|2017-02-18 15:26:12.039363
NCT00503802|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2013-06-17|||July 2007||2007-07-01|June 2013|2013-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|TURBO||Randomized Clinical Trial of Nasal Turbinate Reduction to Improve Continuous Positive Airway Pressure (CPAP) Outcomes for Sleep Apnea|Turbinate Reduction & CPAP Use: A Randomized Blinded OSA (TURBO) Trial|Completed||Phase 2|242|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:26:12.143847|2017-02-18 15:26:12.143847
NCT00503789|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2008-09-04|||August 2007||2007-08-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||The Effect of Infant Feeding on Stool Characteristics|The Effect of Infant Feeding on Stool Characteristics|Completed||N/A|280|Anticipated|Mead Johnson Nutrition||3|||f||||f||||||||||2017-02-18 15:26:12.262808|2017-02-18 15:26:12.262808
NCT00503776|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-10-23|2011-11-03||January 2006||2006-01-01|October 2012|2012-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia|Randomized Pilot Trial of Chemoradiation Plus or Minus Amifostine to Assess Potential Nutritional, Inflammatory and Physical Outcomes Related to Xerostomia, Mucositis and Dysphagia|Terminated||Phase 2|42|Actual|Vanderbilt-Ingram Cancer Center||4||funding became unavailable|f||||t||||||||||2017-02-18 15:26:12.379011|2017-02-18 15:26:12.379011
NCT00503763|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2015-04-15|||September 2007||2007-09-01|July 2007|2007-07-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|PSMMSS||Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma|Open -Label Phase IIa Trial of the Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma|Withdrawn||Phase 2|0|Actual|Meir Medical Center||1||We found out that there is another study on the same issue|f||||f||||||||||2017-02-18 15:26:15.708013|2017-02-18 15:26:15.708013
NCT00503750|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-06-16|2012-03-26||April 2008||2008-04-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)|Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™) Followed by Vinorelbine for HER2 Overexpressing Early Stage Breast Cancer|Completed||Phase 2|27|Actual|Emory University||1|||f||||t||||||||||2017-02-18 15:26:15.803657|2017-02-18 15:26:15.803657
NCT00503737|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-11-02|||September 2007||2007-09-01|July 2007|2007-07-01|September 2010|Anticipated|2010-09-01|||||Interventional|||Pilot Study of the National Colorectal Cancer Roundtable Toolbox (NCCRT) to Increase Colorectal Cancer Screening Rates||Unknown status|Not yet recruiting|N/A|15|Anticipated|Penn State University||3|||f||||t||||||||||2017-02-18 15:26:16.072317|2017-02-18 15:26:16.072317
NCT00503724|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-03-02|||June 2007||2007-06-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors|Phase I and Pharmacokinetic Study of Enzastaurin (LY317615) in Children and Adolescents With Refractory Primary CNS Tumors|Completed||Phase 1|32|Actual|Pediatric Brain Tumor Consortium||1|||f||||t||||||||||2017-02-18 15:26:16.16135|2017-02-18 15:26:16.16135
NCT00503711|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2016-08-29|||September 2006||2006-09-01|August 2016|2016-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Phase I Chinese PK|An Open Label, Phase I, Rising Multiple Dose, Single Centre Study to Determine the PK and Tolerability of ZD6474 at Different Dose Levels in Chinese Patients With Solid Malignancy Tumor|Completed||Phase 1|36|Actual|Sanofi||3|||f||||||||||||||2017-02-18 15:26:16.272031|2017-02-18 15:26:16.272031
NCT00503698|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2014-10-28|2009-12-15||July 2007||2007-07-01|October 2014|2014-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|OPPORTUNITY||The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis|Efficacy and Safety of Somatropin in Adult Patients on Chronic Haemodialysis|Terminated||Phase 3|712|Actual|Novo Nordisk A/S|Trial terminated early due to slow recruitment, which largely reduced the power of showing differences. The end of trial visit was used to describe week 104.|2||See termination reason in detailed description|f||||t||||||||||2017-02-18 15:26:16.406758|2017-02-18 15:26:16.406758
NCT00503685|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2011-10-12||2010-10-12|June 2007||2007-06-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Patients With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFr Therapy|A Randomized Phase 2 Clinical Trial of IMC-A12, as a Single Agent or in Combination With Cetuximab, in Patients With Metastatic Colorectal Cancer With Disease Progression on Prior Anti-EGFR Therapy|Completed||Phase 2|65|Actual|ImClone LLC||3|||f||||f||||||||||2017-02-18 15:26:18.46362|2017-02-18 15:26:18.46362
NCT00503672|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2012-10-18|||January 2007||2007-01-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Assessment of Activity in Pregnancy Using an Actigraph|Assessment of Activity in Pregnancy Using an Actigraph|Completed||N/A|76|Actual|University of California, Irvine|||1||f||||f||||||||||2017-02-18 15:26:18.583832|2017-02-18 15:26:18.583832
NCT00503659|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2011-10-07|||February 2007||2007-02-01|October 2011|2011-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Two Methods of Bronchial Methacholine Provocation|Comparison of Two Methods of Bronchial Methacholine Provocation: PC 20 FEV1 Versus PD 20 FEV1|Completed||N/A|48|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||t||||||||||2017-02-18 15:26:18.669642|2017-02-18 15:26:18.669642
NCT00503646|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2013-09-16|||May 2007||2007-05-01|July 2009|2009-07-01||||May 2010|Anticipated|2010-05-01||Interventional|||Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners|Communication and Intimacy-Enhancing Intervention for Men Diagnosed With Early Stage Prostate Cancer and Their Partners: A Pilot and Feasibility Trial|Unknown status|Recruiting|N/A|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:26:18.796252|2017-02-18 15:26:18.796252
NCT00503633|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2010-06-22|||March 2005||2005-03-01|June 2010|2010-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|SAG||Biomarkers of Insomnia and Fatigue in HIV/AIDS (Symptoms and Genetics Study)|Biomarkers of Insomnia and Fatigue in HIV/AIDS|Completed||N/A|350|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 15:26:18.90503|2017-02-18 15:26:18.90503
NCT00503620|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2010-07-21|||January 2007||2007-01-01|January 2009|2009-01-01|June 2009|Actual|2009-06-01|||||Observational|||The Effect of Botox on Children With Cerebral Palsy|The Effect of Botulinum Toxin on Neuromuscular Function in the Child With Cerebral Palsy|Completed||Phase 1/Phase 2|11|Actual|Shriners Hospitals for Children|||1||f||||f||||||||||2017-02-18 15:26:18.99161|2017-02-18 15:26:18.99161
NCT00503607|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-12-20|||July 2007||2007-07-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy|A Safety and Efficacy Evaluation of BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy|Completed||Phase 3|400|Anticipated|Braintree Laboratories|||||f||||f||||||||||2017-02-18 15:26:19.084214|2017-02-18 15:26:19.084214
NCT00503594|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-18|2012-07-27|||July 2007||2007-07-01|July 2007|2007-07-01|July 2012|Anticipated|2012-07-01|July 2010|Actual|2010-07-01||Interventional|CNSLymphoma||Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine|Multicenter Randomized Phase II Study of Methotrexate (MTX) and Temozolomide Versus MTX, Procarbazine, Vincristine and Cytarabine for Primary CNS Lymphoma (PCNSL) in the Elderly|Unknown status|Recruiting|Phase 2|92|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:26:19.187246|2017-02-18 15:26:19.187246
NCT00503581|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2015-05-27|||July 2007||2007-07-01|May 2015|2015-05-01||||July 2012|Actual|2012-07-01||Interventional|||Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia|A Randomized Phase II Evaluation of Continuous Progestin Therapy vs. Sequential Progestin Therapy in the Treatment of Endometrial Intraepithelial Neoplasia (EIN) From a Referred Cohort of Atypical Endometrial Hyperplasia (AEH) or EIN Patients That Desire Uterine Preservation|Terminated||Phase 2|9|Actual|Gynecologic Oncology Group||3|||f||||||||||||||2017-02-18 15:26:19.308091|2017-02-18 15:26:19.308091
NCT00503568|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-12-14|||May 2007||2007-05-01|December 2016|2016-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy|Novel Tumor Vaccine gp96-Ig Fusion Protein in Advanced (Stage IIIB), Relapsed or Metastatic (Stage IV) Non-Small Cell Lung Cancer (NSCLC) Patients Who Have Failed First Line Chemotherapy|Completed||Phase 1|19|Actual|University of Miami||3|||f||||t||||||||||2017-02-18 15:26:19.483889|2017-02-18 15:26:19.483889
NCT00503555|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-08-29|||June 2006||2006-06-01|October 2006|2006-10-01|October 2006|Anticipated|2006-10-01|||||Observational|||Creation of a PBRN to Study Healthcare Delivery to a Transitioning Community|Creation of a PBRN to Study Healthcare Delivery to a Transitioning Community|Unknown status|Recruiting|N/A|||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 15:26:19.597085|2017-02-18 15:26:19.597085
NCT00503542|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2014-01-07|||February 2007||2007-02-01|September 2007|2007-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|VCAT||Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network|Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network|Completed||Early Phase 1|46|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-02-18 15:26:19.682446|2017-02-18 15:26:19.682446
NCT00503529|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2015-05-20|||July 2007||2007-07-01|May 2015|2015-05-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)|Open-label Phase IV Study to Investigate the Seropersistence of Tick Borne Encephalitis (TBE) Virus Antibodies After the First Booster and the Response to a Second Booster Vaccination With FSME-IMMUN 0.5ml in Adults (Follow Up to Study 223)|Completed||Phase 4|314|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 15:26:19.80104|2017-02-18 15:26:19.80104
NCT00503516|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2011-06-07|||June 2007||2007-06-01|June 2011|2011-06-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients|Multicenter, Double Blind, Randomized, Clinical Trial, Controlled With Placebo, to Evaluate the Effect of the Treatment With 320 mg/Day of Megestrol Acetate During 24 Weeks in the Weight Loss in Mixed Dementia Patients.|Terminated||Phase 2/Phase 3|39|Actual|Rottapharm Spain||2||Difficulties to recruit the patients following the inclusion criteria|f||||f||||||||||2017-02-18 15:26:19.90551|2017-02-18 15:26:19.90551
NCT00365027|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2015-09-03||||||September 2015|2015-09-01||||||||Interventional|||Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation.||Withdrawn||N/A|0|Actual|HaEmek Medical Center, Israel||||Enrollment difficulties|f||||||||||||||2017-02-18 16:19:41.045266|2017-02-18 16:19:41.045266
NCT00503490|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2008-04-22|||June 2007||2007-06-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis|Phase I, Single and Multi-Dose, Placebo Controlled, Randomized, Dose-Escalation Study to Evaluate the Safety, Tolerability and PK Profile of MP-376 Using the PARI eFlow Nebulizer for 14 Days to CF Patients|Completed||Phase 1|40|Actual|Forest Laboratories||2|||f||||t||||||||||2017-02-18 15:26:20.328667|2017-02-18 15:26:20.328667
NCT00503477|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2009-06-11|||October 2005||2005-10-01|June 2009|2009-06-01|January 2009|Actual|2009-01-01|July 2007|Actual|2007-07-01||Interventional|||A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan|A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 Following Single and Multiple Oral Doses in Patients in Japan With Advanced Solid Malignancies|Completed||Phase 1|40|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 15:26:20.461009|2017-02-18 15:26:20.461009
NCT00503464|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-07-18|||September 2006||2006-09-01|July 2012|2012-07-01||||||||Observational|||"Assessing Barriers to ADA Guideline Adherence"|"Assessing Barriers to American Diabetes Association Guideline Adherence"|Unknown status|Recruiting|N/A|||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 15:26:20.557949|2017-02-18 15:26:20.557949
NCT00503451|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-11-26|||September 2007||2007-09-01|November 2012|2012-11-01||||April 2010|Actual|2010-04-01||Interventional|||A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors|A Phase IB, Study to Investigate the Effect of Ketoconazole, a CYP3A4 Inhibitor, on Oral LBH589 and to Assess the Efficacy and Safety of Oral LBH589 in Patients With Advanced Solid Tumors.|Completed||Phase 1|14|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:26:20.636241|2017-02-18 15:26:20.636241
NCT00503438|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-10-13|||July 2007||2007-07-01|October 2016|2016-10-01|December 2023|Anticipated|2023-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Ankle Joint Replacement Outcomes Study|Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study|Active, not recruiting||Phase 4|75|Anticipated|Integra LifeSciences Corporation||1|||f||||f||||||||||2017-02-18 15:26:20.745421|2017-02-18 15:26:20.745421
NCT00503425|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-05-16|2016-03-16||June 2005||2005-06-01|May 2016|2016-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||Intent to treat (ITT) population: All participants who had received any part of infusion of study medication. Participants who prematurely withdrew from study for any reason and for whom assessment is not performed for whatever reason were also included in ITT analysis. Due to incomplete database only 209 participants were considered for analysis.|A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.|An Open Label Study to Assess the Safety and Effect on Disease Activity of MabThera in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Prior Treatment With DMARDs and/or One Anti-TNF Alpha Agent|Completed||Phase 3|215|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:26:20.868509|2017-02-18 15:26:20.868509
NCT00503412|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2009-01-15|||November 2005||2005-11-01|January 2009|2009-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors|A Phase 1, Open Label, Non-Randomised, Single Centre Pharmacokinetic and Mass Balance Study of Orally Administered 14-C-AZD2171 in Patients With Solid Metastatic Tumours|Completed||Phase 1|6|Actual|AstraZeneca||1|||f||||t||||||||||2017-02-18 15:26:21.304907|2017-02-18 15:26:21.304907
NCT00503399|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2012-03-12|2011-10-04||July 2007||2007-07-01|October 2011|2011-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|EuroGIOPS||Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis|Comparison of the Effects of Teriparatide With Those of Risedronate on Lumbar Spine vBMD in Glucocorticoid-Induced Osteoporosis in Men|Completed||Phase 3|92|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:26:21.400923|2017-02-18 15:26:21.400923
NCT00503386|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2010-09-16|||April 2006||2006-04-01|September 2010|2010-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting|A Phase II,Multicenter,Randomized,Double-blind,Cross-over Study of Palonosetron Compared With Granisetron in Prevention of Chemotherapy-induced Nausea and Vomiting in Asian Population|Completed||Phase 2|144|Actual|Hangzhou Jiuyuan Gene Engineering Co. Ltd.,||2|||f||||t||||||||||2017-02-18 15:26:22.253115|2017-02-18 15:26:22.253115
NCT00503360|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2008-04-23|||April 2007||2007-04-01|April 2008|2008-04-01||||||||Interventional|||Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension|A Multicenter, Randomized, Placebo-Controlled, Double-Masked, 4-Arm Parallel Group Study to Assess the Tolerability, Safety and Efficacy of Two Doses of SAD448 in Subjects With Ocular Hypertension|Completed||Phase 1|80|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:26:22.351117|2017-02-18 15:26:22.351117
NCT00503347|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2011-06-07|||July 2007||2007-07-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus|A Phase Ib Open-Label, Escalating Repeat-Dose Trial of Bavituximab (Chimeric Anti-Phosphatidylserine Monoclonal Antibody) in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus|Completed||Phase 1|24|Anticipated|Peregrine Pharmaceuticals||4|||f||||||||||||||2017-02-18 15:26:22.429396|2017-02-18 15:26:22.429396
NCT00503334|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2008-12-05|||July 2007||2007-07-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral Surgery|Efficacy and Tolerability of a Preoperative Oral Nutritional Supplement (preOP Booster) Versus Placebo in Visceral Surgery|Completed||N/A|36|Actual|Fresenius Kabi||2|||f||||f||||||||||2017-02-18 15:26:22.539478|2017-02-18 15:26:22.539478
NCT00503321|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2009-01-22|||October 2006||2006-10-01|January 2009|2009-01-01|August 2011|Anticipated|2011-08-01|August 2009|Anticipated|2009-08-01||Interventional|eNCIT-Japan||Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma|Randomized Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Unresectable Advanced Gastric Carcinoma and Recurrent Gastric Carcinoma|Terminated||Phase 2/Phase 3|13|Actual|Eastern Network of Cancer Immunological Therapy, Japan||2||Patients' enrollment was not sufficient.|f||||t||||||||||2017-02-18 15:26:22.620627|2017-02-18 15:26:22.620627
NCT00503308|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2015-05-06|2009-09-24||October 2006||2006-10-01|May 2015|2015-05-01|February 2008|Actual|2008-02-01|September 2007|Actual|2007-09-01||Interventional|||HIV Testing Strategies in the Perinatal Setting|Patient Perspectives and Testing Uptake With Abbreviated Versus Standard HIV Consenting in the Prenatal Setting: A Randomized-Controlled, Non-Inferiority Trial|Completed||N/A|281|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:26:22.735767|2017-02-18 15:26:22.735767
NCT00503295|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2014-09-30|||June 2007||2007-06-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung|A Phase 2 Study of Intravenous REOLYSIN® (Wild-Type Reovirus) in the Treatment of Patients With Bone and Soft Tissue Sarcomas Metastatic to the Lung|Completed||Phase 2|53|Actual|Oncolytics Biotech||1|||f||||f||||||||||2017-02-18 15:26:23.0945|2017-02-18 15:26:23.0945
NCT00503282|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-07-17|||October 2007||2007-10-01|July 2007|2007-07-01|October 2007|Anticipated|2007-10-01|||||Observational|||Urinary Catheter Exchange on Admission of Septic Elderly With Permanent Catheter Before Initiation of Antibiotics||Unknown status|Not yet recruiting|N/A|||Shaare Zedek Medical Center|||||f||||f||||||||||2017-02-18 15:26:23.428097|2017-02-18 15:26:23.428097
NCT00503269|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2008-10-16|||July 2005||2005-07-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Local Anaesthetic Day-Care Haemorrhoidectomy Challenges Traditional Concepts - a Randomised Controlled Trial|Cost Effectiveness of Local Anaesthetic Day Surgical Haemorrhoidectomy|Completed||N/A|42|Actual|East Kent Hospitals University NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 15:26:23.489228|2017-02-18 15:26:23.489228
NCT00503256|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2017-01-03|||September 2003||2003-09-01|January 2017|2017-01-01||||September 2018|Anticipated|2018-09-01||Observational|||Genetic Study of Chronic Lymphocytic Leukemia Families|Genetic Study of Chronic Lymphocytic Leukemia Families|Active, not recruiting||N/A|4000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood and cheek cell sample collection that will be used for special tests to look for genes~     that may play a role in the development of CLL.~   "|||2017-02-18 15:26:23.592738|2017-02-18 15:26:23.592738
NCT00503243|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2014-06-06|||September 2003||2003-09-01|November 2007|2007-11-01|August 2005|Actual|2005-08-01|||||Interventional|||Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis|A Phase III, Randomized, Multi-Centre, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) Versus SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis|Completed||Phase 3|280|Actual|Shire|||||f||||||||||||||2017-02-18 15:26:23.716587|2017-02-18 15:26:23.716587
NCT00503230|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2013-05-02|||October 2005||2005-10-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|AURORA||Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking|Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking|Completed||Phase 3|400|Actual|Butler Hospital||2|||f||||t||||||||||2017-02-18 15:26:23.805458|2017-02-18 15:26:23.805458
NCT00503217|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-09-05|||February 2005||2005-02-01|September 2016|2016-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||GnRH Agonist and Intrauterine Insemination|Effect of GnRH Agonist Administration at the Time of Implantation in Intrauterine Insemination Cycles: A Randomized Controlled Trial|Completed||Phase 4|||Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 15:26:23.913441|2017-02-18 15:26:23.913441
NCT00503204|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2009-11-24|||September 2007||2007-09-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour|A Phase I, Open Label, Multi-Centre Study to Assess the Safety and Tolerability of Cediranib (RECENTIN™, AZD2171) in Combination With Lomustine Chemotherapy for Patients With Primary Recurrent Malignant Brain Tumours for Whom Lomustine Would be a Standard Therapy|Completed||Phase 1|20|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 15:26:23.993696|2017-02-18 15:26:23.993696
NCT00503191|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2014-01-19|||July 2007||2007-07-01|January 2014|2014-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|NMT||NeuroModulation Technique Treatment of Autism|Intention-based Therapy for Autism Spectrum Disorder: Promising Results of a Wait-List Control Study in Children|Completed||Phase 1|18|Actual|NeuroModulation Technique Research Institute||1|||f||||||||||||||2017-02-18 15:26:24.09587|2017-02-18 15:26:24.09587
NCT00503178|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2014-12-04|||April 2006||2006-04-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)|Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)|Unknown status|Recruiting|Phase 2|20|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 15:26:24.207609|2017-02-18 15:26:24.207609
NCT00503165|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2008-04-30|||July 2007||2007-07-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|||||Interventional|||A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix|A Phase IV, Single Group Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of a Licensed Hib and Meningococcal C Conjugate Combined Vaccine (Menitorix)|Completed||Phase 4|30|Anticipated|Public Health England||1|||f||||f||||||||||2017-02-18 15:26:24.301787|2017-02-18 15:26:24.301787
NCT00503152|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-09-15|||May 2007||2007-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|VARIETY||Preventing Microalbuminuria in Type 2 Diabetes|A Prospective, Randomized, Probe Trial to Evaluate Whether, at Comparable Blood Pressure Control, Combined Therapy With the ACEI Benazepril and the ARB Valsartan, Reduces the Incidence of Microalbuminuria More Effectively Than BEN or VAL Alone in Hypertensive Patients With Type 2 Diabetes and High-normal Albuminuria|Completed||Phase 3|613|Actual|Mario Negri Institute for Pharmacological Research||3|||f||||f||||||||||2017-02-18 15:26:24.383336|2017-02-18 15:26:24.383336
NCT00503139|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2014-02-14|||June 2007||2007-06-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan|Long Term Safety and Efficacy From Special Surveillance for Etanercept in Japan|Completed||N/A|684|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:26:24.496726|2017-02-18 15:26:24.496726
NCT00503126|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2011-11-08|||August 2007||2007-08-01|November 2011|2011-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Bivalirudin as a Procedural Anticoagulant in Pediatrics|Bivalirudin (Angiomax®) As A Procedural Anticoagulant In The Pediatric Population Undergoing Intravascular Procedures For Congenital Heart Disease|Completed||Phase 2|110|Actual|The Medicines Company||1|||f||||t||||||||||2017-02-18 15:26:24.578657|2017-02-18 15:26:24.578657
NCT00502918|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2009-12-27|||February 2008||2008-02-01|July 2007|2007-07-01|August 2008|Actual|2008-08-01|July 2008|Anticipated|2008-07-01||Observational|||Clinical Feasibility of Computerized Labor Monitor (CLM) -Heart Application (HA)|Feasibility Study -Clinical Feasibility of Computerized Labor Monitor (CLM) -Heart Application|Terminated||N/A|3|Actual|Barnev Ltd|||1|The study was terimnated - low rate of cases|f||||f||||||||||2017-02-18 15:26:28.754269|2017-02-18 15:26:28.754269
NCT00503113|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2011-05-17|2011-03-31||July 2007||2007-07-01|May 2011|2011-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.|A Randomized, Open Label Study Evaluating the Effect on Renal Function of Intravenous Bonviva Given by Injection or Infusion, Compared With Oral Alendronate, in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.|Completed||Phase 4|801|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 15:26:24.667926|2017-02-18 15:26:24.667926
NCT00503100|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2015-05-20|||August 2007||2007-08-01|May 2015|2015-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Somatosensory Evoked Potentials and Pain Thresholds in Term and Preterm-Born Adolescents After Early Exposure to Pain; a Quantitative Study||Terminated||N/A|10|Actual|Soroka University Medical Center|||4|Difficulties in recruiting|f||||t||||||||||2017-02-18 15:26:25.546469|2017-02-18 15:26:25.546469
NCT00503087|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-08-07|||August 2007||2007-08-01|August 2007|2007-08-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Evaluation of Pain Reduction in the Administration of Saline Injections by the Usage of Pneumatic Skin Flattening|Evaluation of Pain Reduction in the Administration of Saline Injections by the Usage of Pneumatic Skin Flattening (PSF)|Unknown status|Recruiting|Phase 1|20|Anticipated|PalJect Ltd.||1|||f||||t||||||||||2017-02-18 15:26:25.658952|2017-02-18 15:26:25.658952
NCT00503074|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2009-11-18|||July 2007||2007-07-01|November 2009|2009-11-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|||Starting Healthy Staying Healthy Pilot Trial|Starting Healthy Staying Healthy Pilot Trial|Completed||N/A|70|Anticipated|University of Washington||2|||f||||t||||||||||2017-02-18 15:26:25.744044|2017-02-18 15:26:25.744044
NCT00503061|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2010-11-30|||June 2007||2007-06-01|November 2010|2010-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART|A Pharmaceopidemiological Study in Patients Who Use Symbicort Turbuhaler as Maintenance and Reliever Therapy (Symbicort SMART) Capturing Over Use and Under Use Via the General Practice Research Database|Completed||N/A|1000|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 15:26:25.850594|2017-02-18 15:26:25.850594
NCT00503048|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2008-12-23|||December 2003||2003-12-01|December 2008|2008-12-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Observational|||Markers of Atopy in Children With Presumed Early Exposure to Allergens, Unhygienic Conditions, and Infections|Markers of Atopy in Children With Presumed Early Exposure to Allergens, Unhygienic Conditions, and Infections|Completed||N/A|915|Actual|Medical Universtity of Lodz|||2||f||||t||||||Samples With DNA|"~     whole blood samples~   "|||2017-02-18 15:26:25.938189|2017-02-18 15:26:25.938189
NCT00503035|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2016-11-28|||August 2003||2003-08-01|November 2016|2016-11-01||||August 2018|Anticipated|2018-08-01||Interventional|||Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers|Molecular Targeting of 15-LOX-1 for Apoptosis Induction in Human Colorectal Cancers|Active, not recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:26:26.028886|2017-02-18 15:26:26.028886
NCT00503022|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2007-12-19|||July 2006||2006-07-01|December 2007|2007-12-01||||||||Interventional|||Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration|A Randomized, Double-Masked, Multi-Center Phase I Study of 6 Months Duration to Assess the Safety and Tolerability of Intravenous ACZ885 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|Completed||Phase 1|20||Novartis|||||f||||||||||||||2017-02-18 15:26:26.148104|2017-02-18 15:26:26.148104
NCT00503009|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-11-04|2009-07-06||October 2007||2007-10-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Of RV-39 In Patients Who Also Have Asthma|An Exploratory Study to Evaluate the Response of Salmeterol Plus Fluticasone vs Fluticasone Alone to Experimental Nasal Inoculation With Rhinovirus|Terminated||Phase 4|16|Actual|GlaxoSmithKline|Due to the small sample size, efficacy measures were not analyzed.|3||lack of data|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:26:26.237815|2017-02-18 15:26:26.237815
NCT00502996|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-08-22|2016-06-29||February 2006||2006-02-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||The safety population included all eligible participants who received one treatment dose of rituximab and have completed the follow up period (Week 48) regardless of whether withdrawn or not from the study.|A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.|Multicenter Non-Comparative Expanded Access Program of to Assess Safety of Rituximab (Mab Anti Cd-20) in Patients With Rheumatoid Arthritis (Ser)|Completed||Phase 3|246|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:26:26.785712|2017-02-18 15:26:26.785712
NCT00502983|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2016-10-03|||September 2003||2003-09-01|October 2016|2016-10-01||||September 2018|Anticipated|2018-09-01||Observational|||Molecular Epidemiology of Acute Myelogenous Leukemia|Molecular Epidemiology of Acute Myelogenous Leukemia|Active, not recruiting||N/A|1200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood sample collection to look for any biologic factors associated with AML.~   "|||2017-02-18 15:26:27.646716|2017-02-18 15:26:27.646716
NCT00502970|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2008-01-09|||May 2004||2004-05-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|STAR||Short Course of Interferon Treatment in Patients With HCV Infection|A Randomized Trial Comparing a Short Course Versus Standard Treatment in Patients With Chronic Hepatitis C Virus Infection|Completed||Phase 4|150|Actual|Aga Khan University||2|||f||||t||||||||||2017-02-18 15:26:27.757785|2017-02-18 15:26:27.757785
NCT00502957|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2010-06-24|||March 2005||2005-03-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|||||Interventional|||Biofeedback Treatment for Functional Constipation|Biofeedback for Functional Constipation: Efficacy and Predictive Factors of Success|Completed||N/A|15|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 15:26:27.873093|2017-02-18 15:26:27.873093
NCT00502944|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2012-07-16|2012-05-03||February 2007||2007-02-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Two Approaches to Routine HIV Testing in a Hospital Emergency Department|Optimizing Strategies for Universal HIV Testing (The USHER Trial)|Completed||N/A|4855|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 15:26:27.958285|2017-02-18 15:26:27.958285
NCT00502931|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2007-07-16|||November 2006||2006-11-01|July 2007|2007-07-01||||||||Observational|||A Systematic Review on the Accuracy and Reliability the BodyGem/MedGem Metabolic Devices|A Systematic Review on the Accuracy and Reliability of a Hand-Held Indirect Calorimeter for Assessing Energy Needs in Adults & Children|Completed||N/A|||Microlife|||||f||||f||||||||||2017-02-18 15:26:28.683701|2017-02-18 15:26:28.683701
NCT00502905|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2012-05-23|2012-04-17||October 2003||2003-10-01|May 2012|2012-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Busulfan and Fludarabine in Patients With AML and MDS|A Phase II Study of High-Dose Intravenous Busulfan and Fludarabine With Allogeneic Marrow and Peripheral Blood Progenitor Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes|Completed||Phase 2|200|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:26:28.868033|2017-02-18 15:26:28.868033
NCT00502892|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2012-07-31|||August 2004||2004-08-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors|A Phase I Study of a Novel Chemotherapeutic Regimen: Topotecan, Ifosfamide and Carboplatin (TIC) in Children and Young Adults With Solid Tumors-- A Limited Multi-Institution Study|Completed||Phase 1|2|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:26:29.159668|2017-02-18 15:26:29.159668
NCT00502879|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2007-12-04|||July 2007||2007-07-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects|A Randomized, Open-Label, Single-Dose Administration, Parallel-Group Study of the Pharmacokinetics of Etanercept, 25mg or 50 mg, Administered Subcutaneously to Healthy Chinese Male Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:26:29.277089|2017-02-18 15:26:29.277089
NCT00502866|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2014-01-07|||June 2006||2006-06-01|October 2006|2006-10-01|June 2008|Actual|2008-06-01|||||Observational|||Study to Assess the Use of a Simple Lab Test to Screen for Rickets in Children|The Feasibility of Assessing the Prevalence of Rickets in Children|Completed||N/A|246|Actual|Agency for Healthcare Research and Quality (AHRQ)|||1||f||||f||||||||||2017-02-18 15:26:29.363774|2017-02-18 15:26:29.363774
NCT00502853|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2015-03-10|2014-07-16||October 2007||2007-10-01|March 2015|2015-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional||Safety population: all participants who received any part of an infusion of study drug.|A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.|Pilot Study to Evaluate the Effect of Mabthera in Combination With MTX in the Inhibition of Progression of Synovitis, Bone Marrow Edema, and Erosions Evaluated by Magnetic Resonance Imaging (MRI) in the Hand of Patients With Rheumatoid Arthritis.|Completed||Phase 4|10|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:26:29.470798|2017-02-18 15:26:29.470798
NCT00502840|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2014-09-03|2014-06-04||July 2007||2007-07-01|September 2014|2014-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||Safety Population: all participants who received at least 1 dose of the trial medication and had at least 1 safety follow-up, whether withdrawn prematurely or not. A safety follow-up was assumed if the participant had at least 1 documented study visit after baseline or if at least 1 adverse event had been documented with start date after baseline.|A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.|An Open Label Study to Evaluate the Safety of Re-treatment With MabThera, and Its Effect on Treatment Response, in Patients With Rheumatoid Arthritis Following Inadequate Response to a Single Anti-TNF Agent (Extension Study to ML19070).|Completed||Phase 3|193|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:26:30.234159|2017-02-18 15:26:30.234159
NCT00502827|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2016-02-25|||January 2004||2004-01-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Smoking Cessation for HIV/AIDS Patients|An Innovative Telephone Intervention for HIV-Positive Smokers|Completed||N/A|706|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:26:34.262078|2017-02-18 15:26:34.262078
NCT00502814|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2012-02-20|||January 2003||2003-01-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||3-Dimensional Form and Soft Tissue Biomechanics of the Breast|3-Dimensional Form and Soft Tissue Biomechanics of the Breast|Terminated||N/A|45|Actual|M.D. Anderson Cancer Center|||1|Sample size too small for data analysis.|f||||f||||||||||2017-02-18 15:26:34.387155|2017-02-18 15:26:34.387155
NCT00502801|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2013-09-19|2013-02-13||August 2007||2007-08-01|September 2013|2013-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia|A Phase 2 Study of Doripenem In The Treatment of Nosocomial and Ventilator-Associated Pneumonia In Hospitals|Completed||Phase 2|185|Actual|PriCara, Unit of Ortho-McNeil, Inc.||1|||f||||f||||||||||2017-02-18 15:26:34.497727|2017-02-18 15:26:34.497727
NCT00502788|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2014-03-03|||May 2003||2003-05-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|HepC||Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)|Thalassemia Clinical Research Network - Hepatitis C Clinical Trial|Completed||Phase 2|21|Actual|New England Research Institutes||1|||t||||t||||||||||2017-02-18 15:26:35.200384|2017-02-18 15:26:35.200384
NCT00502775|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-10-27|2008-11-17||August 2007||2007-08-01|October 2016|2016-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine|A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis|Completed||Phase 4|680|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:26:35.324977|2017-02-18 15:26:35.324977
NCT00502762|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2008-03-10|||September 2004||2004-09-01|March 2008|2008-03-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Topotecan for Irinotecan-Refractory SCLC|Salvage Treatment With Topotecan in Patients With Irinotecan-Refractory Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||Gachon University Gil Medical Center|||||f||||f||||||||||2017-02-18 15:26:36.27378|2017-02-18 15:26:36.27378
NCT00502749|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2011-10-14|||February 2003||2003-02-01|October 2011|2011-10-01|October 2010|Actual|2010-10-01|November 2007|Actual|2007-11-01||Interventional|||Exercise Program for Adolescents and Young Adults With Cancer|Feasibility, Safety, and Effect of an Exercise Program for Adolescents and Young Adults With Cancer|Completed||N/A|37|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:26:36.372612|2017-02-18 15:26:36.372612
NCT00502736|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2014-01-20|||January 2008||2008-01-01|January 2014|2014-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.|An Open Label Study to Assess the Effect of Intravenous Loading Doses of Bondronat on Bone Pain in Patients With Breast Cancer and Skeletal Metastases|Completed||Phase 2|13|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:26:36.483464|2017-02-18 15:26:36.483464
NCT00502723|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2012-07-27|||December 2007||2007-12-01|January 2008|2008-01-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|PROPENLAP||Multicentric Study Comparing Carcinological and Functional Results of Surgery|Prostate Cancer: Multicentric Study Comparing Carcinological and Functional Results of Surgery|Unknown status|Recruiting|Phase 3|1440|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:26:36.590088|2017-02-18 15:26:36.590088
NCT00502710|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2016-08-03||2016-07-28|July 2007||2007-07-01|August 2016|2016-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.|A Randomized, Double-blind Dose-ranging Study of the Effect of DPP-IV on HbA1c, Other Efficacy Parameters, Pharmacokinetics and Safety in Patients With Type 2 Diabetes (BC20779)|Completed||Phase 2|289|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-02-18 15:26:36.696421|2017-02-18 15:26:36.696421
NCT00502697|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2016-03-07|2015-04-13||November 2006||2006-11-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|BBO|We analyzed data for participants who remained in the study for at least four weeks following enrollment. The final sample totaled 211 women: 109 intervention and 102 controls.|Tennessee Connections for Better Birth Outcomes|Tennessee Connections for Better Birth Outcomes|Completed||N/A|236|Actual|Vanderbilt University||2|||f||||f||||||||Undecided||2017-02-18 15:26:36.860522|2017-02-18 15:26:36.860522
NCT00502684|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2014-06-29|||June 2014||2014-06-01|June 2014|2014-06-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Interventional|||Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery|Perioperative Administration of COX 2 Inhibitors and Beta Blockers in Women Undergoing Breast Cancer Surgery: an Intervention to Decrease Immune Suppression, Metastatic Potential and Cancer Recurrence|Unknown status|Recruiting|N/A|32|Anticipated|Kaplan Medical Center||2|||f||||f||||||||||2017-02-18 15:26:37.81394|2017-02-18 15:26:37.81394
NCT00502671|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-17|2015-08-06|2015-08-06||July 2007||2007-07-01|August 2015|2015-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||Safety Population: All enrolled participants who received a dose of study medication.|A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.|An Open Label Study to Evaluate the Safety of Xeloda as Adjuvant Monotherapy in Patients Who Have Undergone Surgery for Colon Cancer, Dukes Stage C.|Completed||Phase 4|228|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:26:37.935465|2017-02-18 15:26:37.935465
NCT00502658|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2008-03-26|||July 2007||2007-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dietary Supplements and Personal Energy Tracking Device to Promote and Maintain Healthy Weight|Evaluation of Dietary Supplements (Shakes and Supplements) and Personal Energy Tracking Device to Promote and Maintain Healthy Weight|Completed||N/A|120|Anticipated|Pharmanex||3|||f||||f||||||||||2017-02-18 15:26:38.21492|2017-02-18 15:26:38.21492
NCT00502645|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-15|2007-07-15|||April 2007||2007-04-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Clinical Risk Assesment of CS-1 Decision Support System|SINGLE-CENTER,OPEN,NON-CONTROLLED FEASIBILITY STUDY ON THE PERFORMANCE OF THE CS-1 DECISION SUPPORT SYSTEM WITH INCORPORATED SOFTWARE-ALGORITHM eMPC USED FOR BLOOD GLUCOSE CONTROL OVER 72 HOURS IN CRITICALLY ILL PATIENTS AT THE INTENSIVE CARE UNIT|Completed||N/A|10|Actual|Medical University of Graz||1|||f||||f||||||||||2017-02-18 15:26:38.303359|2017-02-18 15:26:38.303359
NCT00502632|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2008-05-09|||October 2007||2007-10-01|May 2008|2008-05-01|October 2009|Anticipated|2009-10-01|||||Interventional|DUKE||Dornase Alfa and Urokinase for Kids With Pleural Empyema|Multicentre Randomized Double-Blinded Trial of Intrapleural Dornase Alfa and Urokinase vs Urokinase Alone for Complicated Parapneumonic Effusions in Children|Unknown status|Recruiting|Phase 2/Phase 3|94|Anticipated|Azienda Ospedaliera di Padova||2|||f||||f||||||||||2017-02-18 15:26:38.409293|2017-02-18 15:26:38.409293
NCT00502619|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2011-08-02|||September 2007||2007-09-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Assessment of Acupuncture to Improve Function, Exercise Capacity, and Pain|Pilot Study to Determine the Efficacy and Feasibility of a Structured Acupuncture and Treadmill Program to Treat Chronic Low Back Pain Patients to Improve Function, Exercise Capacity, and Pain Control.|Terminated||Phase 1|10|Actual|VA Maryland Health Care System||1||Inadequate recruitment of study subjects and inadequate retention.|f||||t||||||||||2017-02-18 15:26:38.509486|2017-02-18 15:26:38.509486
NCT00502606|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2010-01-05|||February 2007||2007-02-01|October 2009|2009-10-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Observational|IABN||a Clinical Study.the Effect of Addition of Insoluble Antibacterial Nanoparticles(IABN) in Resin Base Provisional Cement|Clinical Study :The Effect of Antibacterial Nanoparticles, Incorporated in Provisional Resin Based Cement, on S.Mutans in the Margins of Provisional Restorations|Unknown status|Active, not recruiting|N/A|10|Actual|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 15:26:38.632342|2017-02-18 15:26:38.632342
NCT00502593|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2016-10-06|2012-12-20||July 2007||2007-07-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children|A Phase II, Randomized, Open, Controlled Study to Evaluate the Safety and Immunogenicity of Different Formulations of a Pandemic Influenza Vaccine Candidate (Split Virus Formulation Adjuvanted With AS03) Given Following a Two-administration Schedule (21 Days Apart) in Children Between 3 and 9 Years of Age.|Completed||Phase 2|138|Actual|GlaxoSmithKline||12|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:26:39.012041|2017-02-18 15:26:39.012041
NCT00502580|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-07-26|||July 2005||2005-07-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions|Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions|Completed||N/A|45|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Pictures of suspicious and normal oral cavity lesions along with small sample of oral lesion~     (2-4 mm each, the size of a small eraser) will be removed or biopsied from the areas imaged.~   "|||2017-02-18 15:26:51.165074|2017-02-18 15:26:51.165074
NCT00502567|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2011-07-26|||January 2005||2005-01-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors|A Phase 1, Open Label Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2171 and Selected Chemotherapy Regimens When Given in Combination to Patients With Advanced Solid Tumors|Completed||Phase 1|104|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:26:51.265796|2017-02-18 15:26:51.265796
NCT00502554|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2011-07-25|||August 2007||2007-08-01|May 2008|2008-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation|Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation|Terminated||N/A|12|Actual|Hannover Medical School||2||insufficient patient recruitment and ECP capacity|f||||t||||||||||2017-02-18 15:26:51.362622|2017-02-18 15:26:51.362622
NCT00502541|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2013-11-27|||September 2001||2001-09-01|November 2013|2013-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema|A Multicenter, Randomized, Masked, Controlled Study to Evaluate Retisert, and Intravitreal Fluocinolone Acetonide Implant, in the Treatment of Patients With Diabetic Macular Edema|Completed||Phase 2/Phase 3|196|Actual|Bausch & Lomb Incorporated||2|||f||||t||||||||||2017-02-18 15:26:51.466462|2017-02-18 15:26:51.466462
NCT00502528|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2013-04-27|||May 2007||2007-05-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2009|Actual|2009-08-01||Interventional|||Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction|Endothelin Receptor Blockade in Acute ST-elevation Myocardial Infarction|Completed||Phase 2|57|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:26:51.567527|2017-02-18 15:26:51.567527
NCT00502515|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2010-01-19|||July 2007||2007-07-01|January 2010|2010-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Dose-effect of SSR180575 in Diabetic Neuropathy|A Multi-center, Randomized, Double-blind, Placebo Controlled Study of the Effect of SSR180575 at Two Doses for 24 Weeks Treatment on the Rate of Regeneration of Epidermal Nerve Fibers in Patients With Mild Diabetic Peripheral Neuropathy|Completed||Phase 2|309|Actual|Sanofi||3|||f||||||||||||||2017-02-18 15:26:51.683543|2017-02-18 15:26:51.683543
NCT00502502|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2012-07-18|||November 2002||2002-11-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients|Feasibility Study of the Assessment of Symptom-Related Cytokines in Lung and GI Cancer Patients Undergoing Chemoradiation Therapy|Completed||N/A|205|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood samples will be collected to study the levels of cytokines in your blood.~   "|||2017-02-18 15:26:51.790223|2017-02-18 15:26:51.790223
NCT00502489|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-15|2007-07-16|||October 2007||2007-10-01|May 2007|2007-05-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Computer Driven Management of Weaning Following Prolonged Mechanical Ventilation|Computer Driven Management of Weaning Following Prolonged Mechanical Ventilation: a Pilot Study|Unknown status|Not yet recruiting|N/A|50|Anticipated|Rabin Medical Center|||||f||||f||||||||||2017-02-18 15:26:51.90215|2017-02-18 15:26:51.90215
NCT00502476|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2007-08-06|||August 2007||2007-08-01|August 2007|2007-08-01|September 2009|Anticipated|2009-09-01|||||Observational|CBET||Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections|Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE|Unknown status|Recruiting|N/A|14000|Anticipated|Hunter Holmes Mcguire Veteran Affairs Medical Center|||||f||||f||||||||||2017-02-18 15:26:51.974372|2017-02-18 15:26:51.974372
NCT00502463|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-15|2009-07-30|||June 2007||2007-06-01|July 2009|2009-07-01|December 2013|Anticipated|2013-12-01|February 2009|Actual|2009-02-01||Interventional|ASOG-HNO1||Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial|Induction by Docetaxel/Cisplatin/5-Fluorouracil (TCF) Prior to Radiotherapy With Concomintant Cetuximab in Locally Advanced Inoperable Head and Neck Tumours - a Methodical Trial|Unknown status|Active, not recruiting|N/A|50|Actual|Austrian South Oncology Group||1|||f||||f||||||||||2017-02-18 15:26:54.767421|2017-02-18 15:26:54.767421
NCT00502450|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-15|2013-07-18|||September 2007||2007-09-01|July 2007|2007-07-01||||||||Observational|||Is There Hearing Loss After Acute Mastoiditis||Withdrawn||N/A|0|Actual|Rabin Medical Center|||1||f||||||||||||||2017-02-18 15:26:54.851353|2017-02-18 15:26:54.851353
NCT00502437|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2010-11-28||||||June 2007|2007-06-01||||||||Interventional|||The Antigagging Effect of Granisetron (Kytril), an Antiemetic Drug, in Dental Situations||Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:26:54.927301|2017-02-18 15:26:54.927301
NCT00502424|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2007-07-16|||July 2004||2004-07-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Interventional|||The Effectiveness of a Nighttime Positioning Hand Splint in Patients With Rheumatoid Arthritis|Study of the Effectiveness of a Positioning Hand Splint for Wrist, Fingers and Thumb in Patients With Arthritis Rheumatoid|Completed||Phase 2|50|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 15:26:55.004966|2017-02-18 15:26:55.004966
NCT00502411|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2015-11-17|||January 2003||2003-01-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma|A Phase I Study of Post-Operative Concurrent Chemoradiation for Extremity and Trunk Soft Tissue Sarcoma|Completed||Phase 1|4|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:26:55.09124|2017-02-18 15:26:55.09124
NCT00502398|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-15|2007-10-14|||September 2007||2007-09-01|October 2007|2007-10-01||||||||Observational|||Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?||Unknown status|Recruiting|N/A|||Rabin Medical Center|||||f||||f||||||||||2017-02-18 15:26:55.206132|2017-02-18 15:26:55.206132
NCT00502385|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2011-01-20|||April 2004||2004-04-01|January 2011|2011-01-01||||||||Interventional|||Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML||Completed||Phase 1|54|Anticipated|AstraZeneca|||||f||||t||||||||||2017-02-18 15:26:55.27411|2017-02-18 15:26:55.27411
NCT00502372|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2015-12-14|||December 2008||2008-12-01|December 2015|2015-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)|Nutritional Effect of an Oral Supplement Enriched in Arginine, Glutamine and Leucine Metabolite B-Hydroxy B-Methylbutyrate|Terminated||Phase 1|9|Actual|Central Arkansas Veterans Healthcare System||2||VA never granted approval following suspension of enrollment.|f||||t||||||||||2017-02-18 15:26:55.347544|2017-02-18 15:26:55.347544
NCT00502359|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2007-07-19|||April 2005||2005-04-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Observational|||Testing Ascensia Contour Glucometer for the Measurement of Blood Glucose|Testing Ascensia Contour Glucometer for the Measurement of Blood Glucose Values in Pregnancy|Completed||Phase 4|2005|Actual|University of Zurich|||||f||||f||||||||||2017-02-18 15:26:55.476403|2017-02-18 15:26:55.476403
NCT00501553|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2011-06-23|||June 2005||2005-06-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Observational|KarViD||Vitamin D in Patients With Heart Failure||Completed||N/A|148|Actual|Hvidovre University Hospital|||1||f||||t||||||||||2017-02-18 15:27:10.779277|2017-02-18 15:27:10.779277
NCT00502346|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2008-08-22||||||August 2008|2008-08-01||||||||Interventional|||A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers|A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers|Completed||Phase 1|342|Anticipated|Prism Pharmaceuticals||4|||f||||f||||||||||2017-02-18 15:26:55.55745|2017-02-18 15:26:55.55745
NCT00502333|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2014-03-11|||November 2006||2006-11-01|March 2014|2014-03-01|April 2012|Actual|2012-04-01|January 2012|Actual|2012-01-01||Observational|||The Influence of Coping Strategies and Catastrophizing on Patients With Back and Neck Pain|The Influence of Coping Strategies and Catastrophizing on Patients With Back and Neck Pain Treated Within the Spanish National Health Service|Completed||N/A|1400|Actual|Kovacs Foundation|||1||f||||t||||||||||2017-02-18 15:26:55.627959|2017-02-18 15:26:55.627959
NCT00502320|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2009-10-02|2009-07-21||September 2006||2006-09-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|SAM-SAD||Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder|Randomized Placebo-Controlled Trial of Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder|Completed||Phase 4|50|Actual|Lehigh Valley Hospital||2|||f||||f||||||||||2017-02-18 15:26:55.797324|2017-02-18 15:26:55.797324
NCT00502307|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2012-10-02||2012-06-01|October 2007||2007-10-01|October 2012|2012-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma|A Phase 2, Placebo-Controlled, Randomized, Discontinuation Trial of Tivozanib (AV-951) in Patients With Renal Cell Carcinoma|Completed||Phase 2|272|Actual|AVEO Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 15:26:56.431487|2017-02-18 15:26:56.431487
NCT00502294|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2009-06-23||||||July 2008|2008-07-01||||||||Interventional|||A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis|Withdrawn||Phase 3|150|Anticipated|Facet Biotech||2|||f||||t||||||||||2017-02-18 15:26:56.570204|2017-02-18 15:26:56.570204
NCT00502281|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2013-04-05|||January 2007||2007-01-01|April 2013|2013-04-01||||March 2013|Actual|2013-03-01||Interventional|||Controlled Ovarian Stimulation Followed by Timed Intercourse or Intrauterine Insemination in Infertile PCOS Patients|Timed Intercourse Versus Intrauterine Insemination in Infertile Patients Undergoing Gonadotropin Ovarian Stimulation|Suspended||Phase 4|100|Anticipated|University Magna Graecia||2|||f||||||||||||||2017-02-18 15:26:56.640211|2017-02-18 15:26:56.640211
NCT00502268|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2016-03-25|||February 2008||2008-02-01|March 2016|2016-03-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Vitamin D and Carboxy PTH Fragments in Coronary Calcification|A Prospective, Randomized, Open-Label Trial Investigating the Effect of 1 Alpha Hydroxy Vitamin D2 on the Development of Coronary Calcification in New ESRD Patients Using the 1-84/7-84 PTH Ratio to Determine Dosing|Withdrawn||Phase 4|0|Actual|Southeast Renal Research Institute||2||study never initiated|f||||f||||||||||2017-02-18 15:26:56.748122|2017-02-18 15:26:56.748122
NCT00502255|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2015-04-07|||October 2007||2007-10-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|TEHAF2||Telemonitoring in Patients With Heart Failure|Telemonitoring in Patients With Heart Failure|Completed||N/A|382|Actual|Maastricht University Medical Center||2|||f||||t||||||||||2017-02-18 15:26:56.852124|2017-02-18 15:26:56.852124
NCT00502242|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2014-08-13|2014-08-13||December 2007||2007-12-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus|A Randomized, Placebo Controlled, Double-Blind Comparative Study Evaluating The Effect of Ramipril On Urinary Protein Excretion In Maintenance Renal Transplant Patients Converted To Sirolimus|Completed||Phase 4|229|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:26:56.979612|2017-02-18 15:26:56.979612
NCT00502229|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2013-04-05|||January 2010||2010-01-01|April 2013|2013-04-01||||January 2011|Actual|2011-01-01||Interventional|||Therapy for Infertile PCOS Patients Ovulating Under Clomiphene Citrate or Metformin|What is the Following Step to Improve Fertility in Infertile PCOS Patients Ovulating Under Clomiphene Citrate or Metformin? A Randomized Controlled Clinical Study.|Withdrawn||Phase 4|0|Actual|University Magna Graecia||2|||f||||||||||||||2017-02-18 15:26:58.681949|2017-02-18 15:26:58.681949
NCT00502216|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2010-08-30|2010-06-03||July 2007||2007-07-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers|Naltrexone and Varenicline: Weight Gain and Tolerability in Smokers|Completed||Phase 1/Phase 2|40|Actual|Yale University||2|||f||||t||||||||||2017-02-18 15:26:58.795457|2017-02-18 15:26:58.795457
NCT00502203|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2016-04-05|2011-12-05||August 2001||2001-08-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus|A Phase II Multicenter Trial of Paclitaxel and Carboplatin in Women With Advanced (IIIb, IIIc, IVa and IVb) or Recurrent (All Stages) Malignant Mixed Mullerian Tumors (MMMT) of the Uterus|Completed||Phase 2|23|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:26:59.145304|2017-02-18 15:26:59.145304
NCT00502190|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2011-11-09|||June 2007||2007-06-01|April 2007|2007-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|EPEGE||Evaluation Of Pessaries In Twin Pregnancies With A Short Cervix (25 mm) Between 20-28 WG (EPEGE)|Evaluation Of Pessaries In Twin Pregnancies With A Short Cervix (25 mm) Between 20-28 WG|Completed||Phase 3|220|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:26:59.664105|2017-02-18 15:26:59.664105
NCT00502177|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2017-01-17|||June 2007||2007-06-01|January 2017|2017-01-01||||December 2018|Anticipated|2018-12-01||Observational|||Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin|Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin|Active, not recruiting||N/A|48|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:26:59.773958|2017-02-18 15:26:59.773958
NCT00502164|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2011-01-20|||March 2004||2004-03-01|January 2009|2009-01-01||||||||Interventional|AZD2171IL/0003||Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer|A Phase I Open-label Dose Escalation Study to Assess the Safety and Tolerability of AZD2171 Following Multiple Oral Doses in Subjects With Advanced Prostate Cancer.|Completed||Phase 1|40|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 15:26:59.89001|2017-02-18 15:26:59.89001
NCT00502138|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2013-01-15|||July 2007||2007-07-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes|A Pilot Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of Pramlintide Acetate When Administered by Subcutaneous Infusion in a Basal-Bolus Manner as an Adjunct to Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes|Completed||Phase 4|12|Actual|University Diabetes & Endocrine Consultants||1|||f||||t||||||||||2017-02-18 15:26:59.975652|2017-02-18 15:26:59.975652
NCT00502125|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-07-31|||January 2003||2003-01-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||In Vivo Confocal Imaging of Oral Mucosa|A Pilot Study: In Vivo Reflectance Confocal Imaging for Detection of Neoplasia of Oral Mucosa|Completed||N/A|12|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Tissue samples will be removed.~   "|||2017-02-18 15:27:00.091644|2017-02-18 15:27:00.091644
NCT00502112|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2011-10-07|||March 2008||2008-03-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)|A Phase I Combination Trial of SGN-33 (Anti-huCD33 mAb; HuM195; Lintuzumab) and Lenalidomide (Revlimid®) in Patients With Myelodysplastic Syndromes (MDS)|Completed||Phase 1|13|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-02-18 15:27:00.195585|2017-02-18 15:27:00.195585
NCT00502099|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-15|2012-10-21|||January 2006||2006-01-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4|Phase 4 Comparative Study of Pegasys vs Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4|Completed||Phase 4|217|Actual|Ain Shams University||2|||f||||t||||||||||2017-02-18 15:27:00.334221|2017-02-18 15:27:00.334221
NCT00502086|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2011-02-10|||May 2005||2005-05-01|February 2010|2010-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.|Efficacy and Safety of Viusid, a Nutritional Supplement, in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection. A Randomized, Controlled and Double Blind Study.|Completed||Phase 3|100|Actual|Catalysis SL||2|||f||||t||||||||||2017-02-18 15:27:00.478608|2017-02-18 15:27:00.478608
NCT00501384|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2009-01-09|||April 2004||2004-04-01|January 2009|2009-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|SPA||Satavaptan Dose-Ranging Study in the Prevention of Ascites|Study for the Prevention of Ascites (SPA): Comparison of Fixed Doses of SR121463B Versus Placebo in the Reduction of Recurrence of Cirrhotic Ascites|Completed||Phase 2|151|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 15:27:00.594924|2017-02-18 15:27:00.594924
NCT00501371|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2011-12-13|||July 2007||2007-07-01|December 2011|2011-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia|Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of MCS in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia|Terminated||Phase 3|85|Actual|Health Ever Bio-Tech Co., Ltd.||2||"Study terminated for re-design. A new IND study (US FDA, July 2009) will be conducted in US~   and Taiwan. Termination not related to safety concerns."|f||||f||||||||||2017-02-18 15:27:00.725884|2017-02-18 15:27:00.725884
NCT00501358|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2007-07-13||||||July 2007|2007-07-01||||||||Observational|||Sleep Apnea and Tromboembolic Disease|Assessment of Sleep Apnea Syndrome as a Risk Factor for Venous Thromboembolism|Unknown status|Recruiting|N/A|||Sociedad Española de Neumología y Cirugía Torácica|||||f||||t||||||||||2017-02-18 15:27:00.855665|2017-02-18 15:27:00.855665
NCT00501345|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-07-27|2009-09-24||February 2002||2002-02-01|July 2012|2012-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Aspirin in Patients With Myocardial Infarction and Thrombocytopenia|Effects of Aspirin on Platelet Function and Clinical Outcome in Patients With Thrombocytopenia, Neoplasm, and Myocardial Infarction|Terminated||Phase 3|5|Actual|M.D. Anderson Cancer Center|A change in hospital practice where patients with thrombocytopenia now routinely receive aspirin for acute coronary syndromes makes it difficult to obtain a baseline thromboelastogram.|1||Low accrual, study terminated.|f||||f||||||||||2017-02-18 15:27:00.958098|2017-02-18 15:27:00.958098
NCT00501332|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2007-12-19|||July 2007||2007-07-01|December 2007|2007-12-01||||||||Interventional|||Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy|A Phase IIa, Open Label, Controlled, Dose Ranging Study of Maxy-G34 as an Adjunct to TAC Chemotherapy in High-Risk Patients With Stage I, II, or IIIa Breast Cancer.|Unknown status|Recruiting|Phase 2|30|Anticipated|Maxygen Holdings Ltd.||1|||f||||t||||||||||2017-02-18 15:27:01.172204|2017-02-18 15:27:01.172204
NCT00501319|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2011-11-07|||April 2003||2003-04-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery|Longitudinal Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery|Completed||N/A|127|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:27:01.293915|2017-02-18 15:27:01.293915
NCT00501306|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2011-06-21|||June 2007||2007-06-01|June 2011|2011-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men|Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men|Completed||N/A|195|Actual|Laser Surgery Care|||1||f||||f||||||||||2017-02-18 15:27:01.416579|2017-02-18 15:27:01.416579
NCT00501293|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2015-06-23|2009-10-05||August 2007||2007-08-01|June 2015|2015-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD|A Phase IIIb, Long-Term, Open-Label, Multi-Center, Extension Study Designed to Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|163|Actual|Noven Therapeutics||1|||f||||f||||||||||2017-02-18 15:27:01.519424|2017-02-18 15:27:01.519424
NCT00501280|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2013-04-01|||June 2004||2004-06-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Genetic Susceptibility in Migrant Farmworker Children|Biomarkers of Genetic Susceptibility in Environmentally-Exposed Migrant/Seasonal Farmworker Women and Their Children|Completed||N/A|768|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||Samples With DNA|"~     10 teaspoons of blood drawn and a urine sample from each mother/child.~   "|||2017-02-18 15:27:02.290016|2017-02-18 15:27:02.290016
NCT00501267|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2015-04-14|||June 2007||2007-06-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder|A Randomized, Repeat Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Solabegron (GW427353) in Combination With Oxybutynin in Healthy Adult Subjects.|Completed||Phase 1|24|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:27:02.413596|2017-02-18 15:27:02.413596
NCT00501254|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2007-07-17|||February 2005||2005-02-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|||||Interventional|||Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period|Randomised Clinical Trial, Parallel, Double Blind, to Evaluate the Influence of the ASA-SR (Slow-Release) in the Platelet Parameters and the Oxidative Status, in Patients With Coronary Disease of Chronic Evolution During 12 Months|Completed||Phase 2/Phase 3|100|Actual|Rottapharm Spain||2|||f||||||||||||||2017-02-18 15:27:02.512404|2017-02-18 15:27:02.512404
NCT00501241|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2009-06-16|||July 2007||2007-07-01|February 2008|2008-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation|A Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation|Terminated||Phase 2|214|Anticipated|Procter and Gamble||5|||f||||f||||||||||2017-02-18 15:27:02.624071|2017-02-18 15:27:02.624071
NCT00501228|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2012-07-31|2009-03-03||February 2003||2003-02-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Tissue Repair in Stem Cell Transplant Recipients|RhG-CSF (Filgrastim) Treatment of Severe Epithelial/Endothelial or Solid Organ-Specific Tissue Damage In Stem Cell Transplant Recipients|Terminated||N/A|2|Actual|M.D. Anderson Cancer Center|Study was closed because of the very limited number of patients enrolled. Patients eligible for enrollment were not willing to undergo 4 weekly cycles of G-CSF treatment because of the well known side effect of bone pain.|1|||f||||f||||||||||2017-02-18 15:27:02.827061|2017-02-18 15:27:02.827061
NCT00502073|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2011-06-29||||||June 2011|2011-06-01||||||||Interventional|||Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)||Completed||Phase 3|||Sirion Therapeutics, Inc.|||||||||||||||||||2017-02-18 15:27:03.247749|2017-02-18 15:27:03.247749
NCT00502060|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2009-05-13|||August 2004||2004-08-01|May 2009|2009-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer|A Phase I Open-Label Study to Assess the Safety, Tolerability and PK of Ascending Multiple Oral Doses of AZD2171 When co-Administered With Fixed Multiple Oral Doses of ZD1839 (250mg or 500mg Once Daily) in Patients With Advanced Cancer|Completed||Phase 1|65|Anticipated|AstraZeneca|||||f||||t||||||||||2017-02-18 15:27:03.333678|2017-02-18 15:27:03.333678
NCT00502047|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2007-07-16|||September 2005||2005-09-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia|Multicentre, Comparative, Double-Blind, Two-Arm Parallel Clinical Trial of the Effects of Treatment With Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia|Completed||Phase 2/Phase 3|255|Actual|Rottapharm Spain||2|||f||||f||||||||||2017-02-18 15:27:03.432613|2017-02-18 15:27:03.432613
NCT00502034|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2013-07-09|||July 1994||1994-07-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|April 2007|Actual|2007-04-01||Interventional|||Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.|Adjuvant Low-dose Interleukin-2 (IL2) Plus Interferone-alpha (IFN) in Operable Renal Cell Cancer (RCC). Phase III, Randomized, Multicenter Trial of the Italian Oncology Group for Clinical Research (GOIRC).|Completed||Phase 3|310|Actual|Gruppo Oncologico Italiano di Ricerca Clinica||2|||f||||t||||||||||2017-02-18 15:27:03.527215|2017-02-18 15:27:03.527215
NCT00502021|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2012-09-27|||August 2007||2007-08-01|September 2012|2012-09-01|October 2013|Anticipated|2013-10-01|August 2013|Anticipated|2013-08-01||Interventional|||Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation|Inflammatory Indicators and Arterial Stiffness in Patients With Severe Obesity. Response to Supplementation of Alpha Linolenic Acid|Unknown status|Recruiting|Phase 2|90|Anticipated|University of Sao Paulo||4|||f||||f||||||||||2017-02-18 15:27:03.652934|2017-02-18 15:27:03.652934
NCT00502008|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2007-07-16|||November 2005||2005-11-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Effect of Coccinia Cordifolia Extract on Blood Sugar of Newly Diagnosed Diabetics|Efficacy of Coccinia Cordifolia Extract in Improving Blood Glucose Levels of Newly Diagnosed Diabetic Patients|Completed||N/A|60|Actual|St. John's Research Institute||2|||f||||f||||||||||2017-02-18 15:27:03.772479|2017-02-18 15:27:03.772479
NCT00501995|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2016-08-29|2014-03-25||February 2001||2001-02-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|July 2008|Actual|2008-07-01||Interventional||Patients with scleroderma were considered eligible for this open-label trial if they had a diagnosis of diffuse cutaneous scleroderma and evidence of clinically active disease.|High Dose Cyclophosphamide for Treatment of Scleroderma|High Dose Cyclophosphamide for Treatment of Systemic Sclerosis (Scleroderma)|Completed||Phase 3|6|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 15:27:03.864306|2017-02-18 15:27:03.864306
NCT00501982|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2015-03-18|||March 2007||2007-03-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|Curpap||Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study|An International, Open, Randomized, Controlled Study to Evaluate the Efficacy of Combining Prophylactic Curosurf® With Early Nasal CPAP Versus Early Nasal CPAP Alone in Very Preterm Infants at Risk of Respiratory Distress Syndrome|Completed||Phase 4|208|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||||||||||||2017-02-18 15:27:04.116414|2017-02-18 15:27:04.116414
NCT00501969|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2014-09-24|2009-12-08||August 2004||2004-08-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease|An Open-Label Extension to the Double-Blind SP515 (NCT00244387) Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Subjects With Advanced-Stage Idiopathic Parkinson's Disease Who Are Not Well Controlled on L-Dopa|Completed||Phase 3|395|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:27:04.232893|2017-02-18 15:27:04.232893
NCT00501956|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-16|2016-03-01|||July 2004||2004-07-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|IDPNHD||Intradialytic Parenteral Nutrition in Hemodialysis Patients|Randomized Study on the Effect of Intradialytic Parenteral Nutrition in Malnourished Hemodialysis Patients|Completed||Phase 4|140|Actual|Fresenius Kabi||2|||f||||f||||||||No||2017-02-18 15:27:04.952268|2017-02-18 15:27:04.952268
NCT00501943|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2014-03-11|2013-11-19||July 2006||2006-07-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Neuroprotection With Riluzole Patients With Early Multiple Sclerosis|Neuroprotection With Riluzole in Patients With Early Multiple Sclerosis|Completed||Phase 2|43|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 15:27:05.08464|2017-02-18 15:27:05.08464
NCT00501930|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-05-31|||April 2007||2007-04-01|February 2011|2011-02-01||||||||Interventional|||A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers|A Randomized, Placebo-Controlled, Double-Blind, Repeat Dose, Dose Escalation Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Supratherapeutic Doses of GSK189075 Administered for 3 Days in Healthy Volunteers|Completed||Phase 1|12|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:27:05.527483|2017-02-18 15:27:05.527483
NCT00501917|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2007-07-13|||March 2007||2007-03-01|July 2007|2007-07-01|February 2010|Anticipated|2010-02-01|||||Interventional|MAGIC Cell-5||MAGIC Cell-5-Combicytokine Trial|Single Center, Prospective, Randomized, Partly-Double Blinded, Controlled Trial to Assess the Safety and Feasibility of Intracoronary Cell Infusion Mobilized With G-CSF and Darbepoetin and Their Effects on Improvement of Cardiac Function in Patients With Myocardial Infarction: Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Erythropoietin Mobilization and Intra-Coronary Cell Infusion –5-Combination Cytokine Therapy Trial|Unknown status|Recruiting|Phase 2/Phase 3|116|Anticipated|Seoul National University Hospital||3|||f||||t||||||||||2017-02-18 15:27:05.619354|2017-02-18 15:27:05.619354
NCT00501904|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2015-12-01|||April 2012||2012-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Metformin in Infertile PCOS Patients|Efficacy of Long- Versus Short-term Metformin Protocol in Infertile Anovulatory PCOS Patients|Recruiting||Phase 4|20|Anticipated|University Magna Graecia||2|||f||||t||||||||||2017-02-18 15:27:05.709745|2017-02-18 15:27:05.709745
NCT00501891|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2013-05-17|2013-02-06||July 2007||2007-07-01|March 2013|2013-03-01|November 2009|Actual|2009-11-01|December 2007|Actual|2007-12-01||Interventional|||Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma|A Phase II Study of Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma|Completed||Phase 2|32|Actual|Duke University||1|||f||||t||||||||||2017-02-18 15:27:05.834507|2017-02-18 15:27:05.834507
NCT00501878|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-03-07|||May 2007||2007-05-01|March 2012|2012-03-01|July 2007|Actual|2007-07-01|||||Interventional|||2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides|2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides|Completed||Phase 4|100|Actual|Khon Kaen University||1|||f||||t||||||||||2017-02-18 15:27:06.113674|2017-02-18 15:27:06.113674
NCT00501865|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-05-31|||August 2007||2007-08-01|February 2011|2011-02-01||||||||Interventional|||Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers|An Open, Randomised, Two-period Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of GW273225 Administered Immediately After Food and Administered in the Fasted State to Healthy Male and Female Volunteers.|Completed||Phase 1|14|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:27:06.215684|2017-02-18 15:27:06.215684
NCT00501852|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-05-03|2010-12-22||July 2007||2007-07-01|December 2010|2010-12-01||||December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator Tiotropium|A Randomized, Double-blind, Placebo-controlled, 4 Period Incomplete Block Cross-over, Multi-center, Multiple Dose (7 Days) Dose-ranging Study to Assess the Efficacy and Safety of 4 Doses of NVA237 in Patients With Stable COPD, Compared to Seven Days Treatment With Tiotropium (18μg Once Daily, Open Label) as an Active Control|Completed||Phase 2|83|Actual|Novartis||6|||f||||||||||||||2017-02-18 15:27:06.308689|2017-02-18 15:27:06.308689
NCT00501839|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2013-04-05|||August 2008||2008-08-01|April 2013|2013-04-01||||September 2010|Actual|2010-09-01||Interventional|||Clomiphene Citrate in Infertile PCOS Patients|How Long Should First-line Treatment be Continued in Infertile PCOS Patients Who Ovulate Under Clomiphene Citrate? A Randomized Controlled Clinical Study.|Withdrawn||Phase 4|0|Actual|University Magna Graecia||3|||f||||||||||||||2017-02-18 15:27:06.791751|2017-02-18 15:27:06.791751
NCT00501826|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2017-02-16|||July 2007|Actual|2007-07-01|February 2017|2017-02-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma|Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated T-ALL and Lymphoblastic Lymphoma|Recruiting||Phase 2|100|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-02-18 15:27:06.902972|2017-02-18 15:27:06.902972
NCT00501813|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2010-07-29|||October 2006||2006-10-01|January 2010|2010-01-01|July 2010|Anticipated|2010-07-01|December 2009|Anticipated|2009-12-01||Interventional|MDTforHCC||Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion|A Randomized Controlled Trial of Multimodality Therapy in the Treatment of Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion|Unknown status|Recruiting|Phase 3|160|Anticipated|Sun Yat-sen University||2|||f||||t||||||||||2017-02-18 15:27:07.101705|2017-02-18 15:27:07.101705
NCT00501800|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2013-09-27|||November 2006||2006-11-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Genetic Epidemiology of Ovarian Aging|Genetic Epidemiology of Ovarian Aging|Unknown status|Active, not recruiting|N/A|1250|Anticipated|University of California, San Francisco|||5||f||||f||||||Samples With DNA|"~     Blood, urine~   "|||2017-02-18 15:27:07.384593|2017-02-18 15:27:07.384593
NCT00501787|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2013-04-05|||January 2008||2008-01-01|April 2013|2013-04-01||||October 2012|Actual|2012-10-01||Interventional|||Metformin Administration in Infertile Anovulatory PCOS Patients|Tailored Versus Non-tailored Metformin Protocol for Ovulation Induction in Infertile Anovulatory PCOS Patients. A Randomized Controlled Clinical Study|Withdrawn||Phase 4|0|Actual|University Magna Graecia||2|||f||||||||||||||2017-02-18 15:27:07.490957|2017-02-18 15:27:07.490957
NCT00501774|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2007-07-13|||May 2004||2004-05-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Observational|||A Search for Helicobacter Pylori in Localized Vulvodynia|A Laboratory and Clinical Search for the Presence of H. Pylori and Treatment Against it in Localized Vulvodynia (Vestibulitis, Vestibulodynia).|Completed||N/A|27|Actual|Western Galilee Hospital-Nahariya|||||f||||f||||||||||2017-02-18 15:27:07.60705|2017-02-18 15:27:07.60705
NCT00497692|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2008-05-19|||May 2007||2007-05-01|May 2008|2008-05-01||||||||Interventional|||Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)|Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability and Dermical Sensitivity) for Dermacyd Femina Delicata|Completed||Phase 4|30|Anticipated|Sanofi||1|||f||||f||||||||||2017-02-18 15:28:28.828388|2017-02-18 15:28:28.828388
NCT00501761|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2016-11-28|||May 2005||2005-05-01|November 2016|2016-11-01||||May 2018|Anticipated|2018-05-01||Observational|||Physical Activity After Endometrial Cancer|Social Cognitive Theory and Physical Activity After Endometrial Cancer|Active, not recruiting||N/A|326|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||Samples With DNA|"~     Saliva samples 5 times per day for 2 consecutive days.~   "|||2017-02-18 15:27:07.701711|2017-02-18 15:27:07.701711
NCT00501748|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2011-09-23|||January 2004||2004-01-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Tolerability of Rituximab in Neuromyelitis Optica|Open Label Study of Safety and Tolerability of Rituximab in Neuromyelitis Optica, Recurrent Transverse Myelitis and Recurrent Bilateral Simultaneous Optic Neuritis|Completed||Phase 1|20|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:27:07.826164|2017-02-18 15:27:07.826164
NCT00501735|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2012-01-18||2012-01-18|July 2007||2007-07-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|July 2010|Actual|2010-07-01||Interventional|||Forodesine in the Treatment of Cutaneous T-Cell Lymphoma|Single Agent Phase II Study of Forodesine (BCX1777) in the Treatment of Cutaneous T-Cell Lymphoma|Completed||Phase 2|144|Actual|BioCryst Pharmaceuticals||1|||f||||t||||||||||2017-02-18 15:27:07.948686|2017-02-18 15:27:07.948686
NCT00501722|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2009-01-09|||April 2004||2004-04-01|January 2009|2009-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|Hypo~CAT||Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites|SR121463B in Cirrhotic Ascites Treatment With Hyponatraemia: A Placebo-Controlled, Dose-Comparison Study|Completed||Phase 2|110|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 15:27:08.100828|2017-02-18 15:27:08.100828
NCT00501709|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2016-12-22|||February 2004||2004-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus||Completed||Phase 1/Phase 2|30|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:27:08.217758|2017-02-18 15:27:08.217758
NCT00501696|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2008-05-15|||February 2007||2007-02-01|February 2007|2007-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone|A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone on Quality of Life as Measured by the Multiple Sclerosis Quality of Life Inventory (MSQLI54)|Completed||Phase 3|80|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 15:27:08.318594|2017-02-18 15:27:08.318594
NCT00501683|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-05-31|||November 2006||2006-11-01|February 2011|2011-02-01||||||||Interventional|||A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers|A Mass Balance Study to Investigate the Metabolic Disposition of a 400 mg Single, Oral Dose of GSK189075 in Healthy Male Subjects|Completed||Phase 1|8|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:27:08.428452|2017-02-18 15:27:08.428452
NCT00501670|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2014-01-09|||August 2007||2007-08-01|January 2014|2014-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||VZV PCR Sampling Validation Study|A Non-therapeutic Study to Validate the Sampling Method to Confirm Presence of Varicella-zoster Virus (VZV) DNA by PCR in Clinical Samples From Lesions Collected From Adults (≥50 Years) With Clinically Diagnosed Herpes Zoster|Completed||N/A|41|Actual|GlaxoSmithKline|||1||f||||||||||Samples With DNA|"~     lesion samples~   "|||2017-02-18 15:27:08.525078|2017-02-18 15:27:08.525078
NCT00501657|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2015-10-27|||July 2007||2007-07-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|June 2008|Actual|2008-06-01||Interventional|||Effects of Sitagliptin on Gastric Emptying in Healthy Subjects|Effects of Sitagliptin on Gastric Emptying in Healthy Subjects|Completed||Phase 1|15|Actual|Royal Adelaide Hospital||2|||f||||f||||||||||2017-02-18 15:27:08.650957|2017-02-18 15:27:08.650957
NCT00501644|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2012-08-01|2010-12-23||January 2003||2003-01-01|August 2012|2012-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer|A Phase II Study of Chemoimmunotherapy for Patients With Potentially Platinum Sensitive Müllerian (Epithelial Ovarian, Peritoneal, or Fallopian Tube) Carcinomas|Completed||Phase 2|59|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:27:08.787649|2017-02-18 15:27:08.787649
NCT00501631|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2011-09-20|2011-03-23||July 2007||2007-07-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence|Efficacy and Safety of VIVITROL® in Adults Completing Inpatient Treatment for Alcohol Dependence|Completed||Phase 3|300|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-02-18 15:27:09.050641|2017-02-18 15:27:09.050641
NCT00501618|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2015-04-14|||November 2006||2006-11-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder|An Open-Label Study Changing Generic Clozapine Formulation to FazaClo® (Clozapine, USP) Orally Disintegrating Tablets in Stable Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|20|Actual|Manhattan Psychiatric Center||1|||f||||t||||||||||2017-02-18 15:27:09.80303|2017-02-18 15:27:09.80303
NCT00501605|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2011-01-20|||February 2003||2003-02-01|January 2009|2009-01-01|February 2006|Actual|2006-02-01|April 2005|Actual|2005-04-01||Interventional|||Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases|A Phase I Single Centre 2-part Open Study to Assess the Safety and Tolerability of AZD2171 Following Single and Multiple Oral Doses in Patients With Advanced Solid Malignant Tumors and Liver Metastases|Completed||Phase 1|80|Anticipated|AstraZeneca|||||f||||t||||||||||2017-02-18 15:27:09.919225|2017-02-18 15:27:09.919225
NCT00501592|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-04-17|2011-06-07||July 2007||2007-07-01|April 2012|2012-04-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Study of INT-747 in Patients With Diabetes and Presumed NAFLD|An Exploratory Study of INT-747 in Patients With Type 2 Diabetes Mellitus and Presumed Nonalcoholic Fatty Liver Disease|Completed||Phase 2|64|Actual|Intercept Pharmaceuticals||3|||f||||t||||||||||2017-02-18 15:27:10.015776|2017-02-18 15:27:10.015776
NCT00501579|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2008-08-27||||||August 2008|2008-08-01||||||||Interventional|||Study of Difluprednate in the Treatment of Uveitis||Completed||Phase 3|||Sirion Therapeutics, Inc.||2|||f||||||||||||||2017-02-18 15:27:10.566507|2017-02-18 15:27:10.566507
NCT00501566|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2007-07-13|||April 2004||2004-04-01|July 2007|2007-07-01|January 2005|Actual|2005-01-01|||||Interventional|Normo~CAT||Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites|SR121463B in Cirrhotic Ascites Treatment With Normonatraemia: A Placebo-Controlled, Dose-Comparison Study|Completed||Phase 2|148|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 15:27:10.670531|2017-02-18 15:27:10.670531
NCT00501540|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-01-19|||July 2007||2007-07-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Lithium for Low-Grade Neuroendocrine Tumors|A Phase II Clinical and Biological Study of Lithium Carbonate in Patients With Low-Grade Neuroendocrine Tumors|Completed||Phase 2|15|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 15:27:10.865184|2017-02-18 15:27:10.865184
NCT00501527|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2010-12-16|||September 2007||2007-09-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense|Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense in Patients Suffering From Allergic Rhinoconjunctivitis and/or Asthma|Completed||Phase 2|80|Actual|Laboratorios Leti, S.L.||3|||f||||f||||||||||2017-02-18 15:27:11.043085|2017-02-18 15:27:11.043085
NCT00501514|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2009-01-28|||November 1997||1997-11-01|January 2009|2009-01-01|November 2005|Actual|2005-11-01|||||Interventional|||Effects of Growth Hormone on Exercise Capacity|Effects of Growth Hormone on Exercise Capacity and Cardiopulmonary Performance in Patients With Chronic Heart Failure|Completed||Phase 3|22|Actual|Federico II University||2|||f||||t||||||||||2017-02-18 15:27:11.16355|2017-02-18 15:27:11.16355
NCT00501501|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2007-07-13|||January 1999||1999-01-01|July 2007|2007-07-01|December 2000|Actual|2000-12-01|||||Observational|||The Association Between Delivery Method and Maternal Rehospitalization|The Association Between Delivery Method and Maternal Rehospitalization|Completed||N/A|92|Actual|Western Galilee Hospital-Nahariya|||||f||||f||||||||||2017-02-18 15:27:11.268667|2017-02-18 15:27:11.268667
NCT00501488|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2007-07-19|||March 2006||2006-03-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|||||Observational|||Effect of Adiponectin Genetic Polymorphism on Rosiglitazone Response||Completed||N/A|42|Actual|Central South University|||||f||||t||||||||||2017-02-18 15:27:11.357142|2017-02-18 15:27:11.357142
NCT00501475|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2010-07-23|||March 2007||2007-03-01|July 2010|2010-07-01|October 2010|Anticipated|2010-10-01|||||Interventional|||NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED||Unknown status|Recruiting|Phase 4|||Seoul National University Hospital||3|||f||||f||||||||||2017-02-18 15:27:11.470356|2017-02-18 15:27:11.470356
NCT00501462|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-03-15|||July 2007||2007-07-01|June 2011|2011-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function|An Evaluation of the Pharmacokinetics of a Single Oral Dose of GSK189075 in Patients With Varying Degrees of Renal Insufficiency Compared to Volunteers With Normal Renal Function|Completed||Phase 1|29|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 15:27:11.562727|2017-02-18 15:27:11.562727
NCT00501449|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2016-11-02|||May 2007||2007-05-01|November 2016|2016-11-01||||May 2018|Anticipated|2018-05-01||Observational|||Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes|Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes|Active, not recruiting||N/A|581|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:27:11.673572|2017-02-18 15:27:11.673572
NCT00501423|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2014-01-30|||June 2006||2006-06-01|January 2014|2014-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|ADRIE||Antiplatelet Drug Resistances and Ischemic Events|Antiplatelet Drug Resistances and Ischemic Events|Completed||N/A|771|Actual|University Hospital, Geneva|||1||f||||t||||||||||2017-02-18 15:27:11.80341|2017-02-18 15:27:11.80341
NCT00501410|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2017-01-10|||April 2007||2007-04-01|January 2017|2017-01-01||||April 2018|Anticipated|2018-04-01||Interventional|||FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer|Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined With FOLFOX Chemotherapy in Metastatic Colorectal Cancer (CA180048)|Active, not recruiting||Phase 1|83|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:27:11.915982|2017-02-18 15:27:11.915982
NCT00501397|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-13|2012-05-31|||February 2007||2007-02-01|February 2011|2011-02-01||||||||Interventional|||A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers|An Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole on the Pharmacokinetics of GSK189075|Completed||Phase 1|22|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:27:12.042021|2017-02-18 15:27:12.042021
NCT00501215|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2017-02-02|||May 2007||2007-05-01|February 2017|2017-02-01||||May 2018|Anticipated|2018-05-01||Interventional|||Effect of Parathyroidectomy on Sleep|Pilot Study on the Effect of Parathyroidectomy on Sleep|Active, not recruiting||N/A|12|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:27:12.153403|2017-02-18 15:27:12.153403
NCT00501202|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2013-01-15||2013-01-15|March 2007||2007-03-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of RWJ 333369 for the Treatment of Neuropathic Pain in Diabetic Peripheral Neuropathy.|Completed||Phase 2|132|Actual|SK Life Science||2|||f||||||||||||||2017-02-18 15:27:12.278191|2017-02-18 15:27:12.278191
NCT00501189|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2008-08-01|||August 2007||2007-08-01|July 2008|2008-07-01|July 2009|Anticipated|2009-07-01|||||Observational|||Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities|Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities|Unknown status|Enrolling by invitation|N/A|300|Anticipated|Eisenhower Army Medical Center|||2||f||||f||||||||||2017-02-18 15:27:15.096195|2017-02-18 15:27:15.096195
NCT00501176|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2014-06-11|||December 2006||2006-12-01|June 2014|2014-06-01|December 2014|Anticipated|2014-12-01|November 2014|Anticipated|2014-11-01||Interventional|||Preoperative Stent Study|Randomized Study Comparing the Effect of Plastic Stents to That of Expandable Metal Stents Prior to Pancreaticoduodenectomy|Unknown status|Recruiting|N/A|50|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 15:27:15.220289|2017-02-18 15:27:15.220289
NCT00501163|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2010-03-16|||August 2007||2007-08-01|March 2010|2010-03-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|||Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients|Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients|Unknown status|Recruiting|N/A|90|Anticipated|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 15:27:15.329672|2017-02-18 15:27:15.329672
NCT00501150|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2015-05-27|||September 2005||2005-09-01|November 2005|2005-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections|A Prospective Implementation of an IV-oral Switch Policy to Treat Proven or Suspected Infections Due to Resistant Gram Positive Bacteria in a London Hospital Trust|Completed||N/A|100|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 15:27:15.409502|2017-02-18 15:27:15.409502
NCT00501137|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2015-04-08|||July 2007||2007-07-01|April 2015|2015-04-01|December 2010|Actual|2010-12-01|February 2008|Actual|2008-02-01||Interventional|BCGov-01||A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine|A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine|Completed||Phase 3|830|Actual|University of British Columbia||3|||f||||t||||||||||2017-02-18 15:27:15.506675|2017-02-18 15:27:15.506675
NCT00501124|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2010-12-21|||May 2007||2007-05-01|August 2009|2009-08-01||||July 2010|Actual|2010-07-01||Interventional|||Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV|Phase IV Study to Evaluate the Safety and Efficacy of Clevudine Compared With Clevudine and Vaccine in Patients Chronically Infected With HBV, HBeAg(+)|Completed||Phase 4|70|Anticipated|Bukwang Pharmaceutical|||||f||||f||||||||||2017-02-18 15:27:15.634149|2017-02-18 15:27:15.634149
NCT00501111|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2014-07-22|||July 2007||2007-07-01|July 2014|2014-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|Sirocco||Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease|A Multi-centre, Double-blind, Double-dummy, Placebo Controlled Parallel Group Randomized Phase IIb Proof of Concept Study With 3 Oral Dose Groups of AZD3480 or Donepezil During 12 Weeks Treatment in Patients With Alzheimer's Disease|Completed||Phase 2|659|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:27:15.735524|2017-02-18 15:27:15.735524
NCT00501098|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2009-09-21|||January 2007||2007-01-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PROFIL-C||Prophylaxis of Fungal Invasive Infections in Leukemia|A Multicenter Phase II Study to Evaluate the Safety, Tolerability and Efficacy of Caspofungin as Prophylactic Treatment of Invasive Fungal Infections in Patients With Acute Leukemia Undergoing Induction Chemotherapy|Completed||Phase 2|100|Anticipated|Northern Italy Leukemia Group||1|||f||||t||||||||||2017-02-18 15:27:16.140992|2017-02-18 15:27:16.140992
NCT00501085|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2015-01-15|2015-01-08||June 2007||2007-06-01|January 2015|2015-01-01|November 2013|Actual|2013-11-01|August 2013|Actual|2013-08-01||Observational||The analysis population is defined as the number of subjects who underwent treatment with the LAP-BAND System.|LAP-BAND AP Early Experience Trial (APEX)||Completed||N/A|521|Actual|Apollo Endosurgery, Inc.|||1||f||||||||||||||2017-02-18 15:27:16.262711|2017-02-18 15:27:16.262711
NCT00501072|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2008-04-08|||November 2007||2007-11-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|IP_RT-CGMS||Safety and Efficacy of RT-CGMS in Patients With Type 1 Diabetes Mellitus Treated With an Implantable Pump|Use of a Real Time Continuous Glucose Monitoring System (RT-CGMS) in Type 1 Diabetes Patients on Continuous Intraperitoneal Insulin Infusion (CIPII. A Feasibility Study|Completed||N/A|12|Actual|Medical Research Foundation, The Netherlands||2|||f||||f||||||||||2017-02-18 15:27:16.639946|2017-02-18 15:27:16.639946
NCT00501059|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2017-02-06|||July 2007||2007-07-01|February 2017|2017-02-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|ARRIVE||A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group Study to Assess the Efficacy (Reduction of Cardiovascular Disease Events) and Safety of 100 mg Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease|Completed||Phase 3|12551|Actual|Bayer||2|||f||||t||||||||||2017-02-18 15:27:16.767621|2017-02-18 15:27:16.767621
NCT00501046|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2015-03-02|2015-02-15||July 2007||2007-07-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients With Moderate to Severe Chronic Kidney Disease Including Assessment of Quality of Life|Completed||Phase 3|1015|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||t||||||||||2017-02-18 15:27:18.048028|2017-02-18 15:27:18.048028
NCT00501033|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2008-05-02|||January 2006||2006-01-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||A Prospective Comparative Study of Induction of Labor With a Cervical Ripening Double Balloon vs Foley Catheter|A Prospective Comparative Study of Induction of Labor With a Cervical Ripening Double Balloon vs Foley Catheter|Completed||N/A|200|Anticipated|Western Galilee Hospital-Nahariya||2|||f||||f||||||||||2017-02-18 15:27:19.433007|2017-02-18 15:27:19.433007
NCT00501020|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2016-09-22|||April 2001||2001-04-01|September 2016|2016-09-01||||||||Interventional|||Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin|A 24-Week Randomized, Double-blind, Double-Dummy, Multicenter Study to Compare the Efficacy of AVANDIA When Added to Submaximal Doses of Metformin and to Compare the Tolerability of the Combination to Metformin Monotherapy When Administered to Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|750||GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:27:19.539494|2017-02-18 15:27:19.539494
NCT00501007|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2013-12-06|2013-01-07||February 2005||2005-02-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Observational|||Predictors of Treatment Outcome for Smokers With and Without Schizophrenia|Predictors of Treatment Outcome for Smokers With and Without Schizophrenia|Completed||Phase 1|203|Actual|Rutgers, The State University of New Jersey|||2||f||||f||||||||||2017-02-18 15:27:19.652158|2017-02-18 15:27:19.652158
NCT00500994|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2017-02-01|||July 11, 2007||2007-07-11|January 17, 2017|2017-01-17||||||||Observational|||Neurobiology of Psychogenic Movement Disorder and Non-Epileptic Seizures|Neurobiological Studies of Psychogenic Movement Disorders and Non-Epileptic Seizures|Recruiting||N/A|320|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:27:19.902461|2017-02-18 15:27:19.902461
NCT00500981|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2012-07-25|||June 2007||2007-06-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|October 2007|Actual|2007-10-01||Interventional|||Internal Jugular Vein Ultrasound Measures and Fluid Responsiveness in Post-Operative Cardiac Surgical Patients|Do Internal Jugular Vein Measurements Made By Ultrasound Correlate With Fluid Responsiveness in Ventilated Post-Operative Cardiac Surgical Patients?|Completed||Phase 1|40|Actual|University of Calgary||1|||f||||f||||||||||2017-02-18 15:27:20.01518|2017-02-18 15:27:20.01518
NCT00500968|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2011-04-06|||November 2006||2006-11-01|September 2007|2007-09-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail|Randomized Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail|Completed||N/A|50|Actual|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 15:27:20.118566|2017-02-18 15:27:20.118566
NCT00500955|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2016-09-13|||April 2000||2000-04-01|September 2016|2016-09-01|June 2004|Actual|2004-06-01|||||Interventional|||Rosiglitazone on Microalbuminuria in Type 2 Diabetics|A Study to Evaluate the Efficacy of Rosiglitazone (BRL-049653) on Reduction of Microalbuminuria in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|336||GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:27:20.238173|2017-02-18 15:27:20.238173
NCT00500942|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2012-08-01|||January 2003||2003-01-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Pain Quantification and Pain Management in Interventional Radiology (IR)|Pain Quantification and Management for Standard Interventional Radiology (IR) Procedures With Subsequent Patient Satisfaction Analysis|Completed||N/A|374|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:27:20.453738|2017-02-18 15:27:20.453738
NCT00500929|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2009-03-23|||July 2007||2007-07-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|MiniMetrxics||A Clinical Trial in Higher Risk Geriatric Patients Undergoing OHSP|Mini-Metrxics: A Single-Centre, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Clinical Trial of CMI X-11S in Higher Risk Geriatric Patients Undergoing Open-Heart Surgical Procedures (OHSP)|Completed||Phase 2|80|Anticipated|Cardiometabolics||2|||f||||t||||||||||2017-02-18 15:27:20.563307|2017-02-18 15:27:20.563307
NCT00500916|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2007-12-03|||March 2007||2007-03-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Different Techniques for Insertion of the ProSeal Laryngeal Mask Airway in Patients With Difficult Airway|Different Techniques for Insertion of the ProSeal Laryngeal Mask Airway in Patients With Difficult Airway|Completed||N/A|0|Anticipated|Medical University Innsbruck||1|||f||||f||||||||||2017-02-18 15:27:20.650312|2017-02-18 15:27:20.650312
NCT00500903|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2013-11-15|||May 2007||2007-05-01|November 2013|2013-11-01|November 2010|Actual|2010-11-01|August 2010|Actual|2010-08-01||Interventional|||A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors|An Open-Label, Dose Escalation Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors|Completed||Phase 1|87|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:27:20.732058|2017-02-18 15:27:20.732058
NCT00500890|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2016-10-18|||September 2005||2005-09-01|October 2016|2016-10-01||||September 2018|Anticipated|2018-09-01||Interventional|||Treatment of Tumors of the Choroid Plexus Epithelium|A Pilot Study Evaluating the Feasibility of an Intercontinental Phase III Chemotherapy Study for Patients With Choroid Plexus Tumors|Active, not recruiting||Phase 3|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:27:20.831892|2017-02-18 15:27:20.831892
NCT00500877|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2016-07-19|||February 2007||2007-02-01|July 2016|2016-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Mood Management Phone Counseling in Smoking Cessation|Mood Management Phone Counseling in Smoking Cessation|Completed||Phase 2|53|Actual|Butler Hospital||2|||f||||f||||||||||2017-02-18 15:27:20.963291|2017-02-18 15:27:20.963291
NCT00500864|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2008-06-27|||August 2004||2004-08-01|June 2008|2008-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Magnesium Loading in Chronic Obstructive Pulmonary Disease|Effects of Acute Intravenous Magnesium Loading on Pulmonary Function Parameters and Maximal Exercise Capacity of Patients With Chronic Obstructive Pulmonary Disease in Stable Clinical Conditions.|Completed||Phase 1/Phase 2|24|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 15:27:21.066512|2017-02-18 15:27:21.066512
NCT00500851|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2010-11-29|||May 2007||2007-05-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Jejunal Placement of Enteral Feeding Tubes|Evaluation of Two Methods of Jejunal Placement of Enteral Feeding Tubes in Critically Ill Patients: Endoscopic Versus Electromagnetic Method (CORTRAK™)|Completed||N/A|66|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:27:21.16123|2017-02-18 15:27:21.16123
NCT00500838|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2016-05-18|||July 2007||2007-07-01|May 2016|2016-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study|CRT-D Based Impedance Monitoring Feasibility Study|Completed||Phase 2|75|Actual|St. Jude Medical||1|||f||||f||||||||||2017-02-18 15:27:21.270316|2017-02-18 15:27:21.270316
NCT00500825|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2008-05-15|||July 2005||2005-07-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Observational|||Influence of Therapeutic Hypothermia on Resting Energy Expenditure|Influence of Therapeutic Hypothermia on Resting Energy Expenditure in Patients After Cardiopulmonary Resuscitation|Completed||N/A|25|Actual|Medical University of Vienna|||1||f||||t||||||||||2017-02-18 15:27:21.381439|2017-02-18 15:27:21.381439
NCT00500812|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2016-03-15||2015-03-09|February 2005||2005-02-01|May 2012|2012-05-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries|A Phase I/IIa Dose-Ranging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BA-210 and the Neurological Status of Patients Following Administration of a Single Extradural Application of Cethrin During Surgery for Acute Thoracic and Cervical Spinal Cord Injury|Completed||Phase 1/Phase 2|48|Actual|Vertex Pharmaceuticals Incorporated||5|||f||||t||||||||||2017-02-18 15:27:21.487035|2017-02-18 15:27:21.487035
NCT00500799|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2017-01-24|||July 9, 2007||2007-07-09|April 14, 2009|2009-04-14|April 14, 2009||2009-04-14|||||Observational|||Brain Changes in Blepharospasm|Role of the Cortical Medial Frontal Areas in Blepharospasm|Completed||N/A|72||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:27:21.605322|2017-02-18 15:27:21.605322
NCT00500786|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2012-08-20|||November 2004||2004-11-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|September 2006|Actual|2006-09-01||Interventional|||Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb||Completed||Phase 1/Phase 2|88|Actual|Cytos Biotechnology AG||5|||f||||t||||||||||2017-02-18 15:27:21.91817|2017-02-18 15:27:21.91817
NCT00500773|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2014-04-30|||July 2007||2007-07-01|April 2014|2014-04-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Observational|MMS||Investigation of Cardiac Function and Cardiovascular Risk Factors in Marathon Runners- The Munich Marathon Study|Investigation of Myocardial Injury, Ventricular Dysfunction and Cardiovascular Risk Factors in Different Groups of Marathon Runners|Completed||N/A|60|Actual|Technische Universität München|||1||f||||t||||||||||2017-02-18 15:27:22.01853|2017-02-18 15:27:22.01853
NCT00497484|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-07-05||||||June 2007|2007-06-01||||||||Interventional|||Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)|Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)|Unknown status|Active, not recruiting|N/A|||University of Milan||1|||f||||||||||||||2017-02-18 15:28:30.45274|2017-02-18 15:28:30.45274
NCT00500760|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2014-07-10|2014-02-13||October 2007||2007-10-01|July 2014|2014-07-01|November 2011|Actual|2011-11-01|April 2011|Actual|2011-04-01||Interventional|||Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer|A Phase 2, Randomized Trial of Chemoradiation With or Without Panitumumab in Subjects With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|153|Actual|Amgen||2|||f||||||||||||||2017-02-18 15:27:22.115643|2017-02-18 15:27:22.115643
NCT00500747|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2011-06-09|||August 2003||2003-08-01|April 2010|2010-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Chiron Corp HCV E1/E2 Vaccine|A Phase I Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of Chiron Corporation's HCV E1E2/MF59 Vaccine Administered to Healthy HCV-Negative Adults|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 15:27:23.146011|2017-02-18 15:27:23.146011
NCT00500734|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2016-08-25|||December 2002||2002-12-01|August 2016|2016-08-01||||December 2018|Anticipated|2018-12-01||Observational|||Cardiomyopathy Tissue Bank in a Cancer Population|Cardiomyopathy Tissue Bank in a Cancer Population|Recruiting||N/A|1000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood and tissue collection. This blood may be studied in the future to try to find possible~     genetic or biochemical markers that may be the cause of CHF.~   "|||2017-02-18 15:27:23.255467|2017-02-18 15:27:23.255467
NCT00500721|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2008-04-10|||June 2007||2007-06-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Desipramine|An Open-Label, Single-Dose Desipramine, Multiple-Dose HCV-796, Sequential 3-Period Study to Determine the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Desipramine|Completed||Phase 1|22|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:27:23.384641|2017-02-18 15:27:23.384641
NCT00500708|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2017-02-15|||July 2007||2007-07-01|February 2017|2017-02-01|August 1, 2011|Actual|2011-08-01|August 1, 2011|Actual|2011-08-01||Observational|DISCERN||Diagnostic Investigation of Sudden Cardiac Event Risk|Identifying Markers That Predict Ventricular Arrhythmia Risk|Completed||N/A|1564|Actual|CardioDx|||1||f||||t||||||Samples With DNA|"~     whole blood, buffy coat, spun plasma, saliva~   "|||2017-02-18 15:27:23.478527|2017-02-18 15:27:23.478527
NCT00500695|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2014-11-03|||May 2006||2006-05-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness|Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness|Completed||Phase 1|98|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 15:27:23.571003|2017-02-18 15:27:23.571003
NCT00500682|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2015-03-02|2015-02-15||July 2007||2007-07-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients With Moderate to Severe Chronic Kidney Disease|Completed||Phase 3|1020|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||t||||||||||2017-02-18 15:27:23.690933|2017-02-18 15:27:23.690933
NCT00500669|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2010-03-15|||June 2004||2004-06-01|March 2010|2010-03-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery|A Randomised, Blinded Study to Assess the Effect of Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery|Unknown status|Recruiting|Phase 3|60|Anticipated|Royal Hobart Hospital||1|||f||||f||||||||||2017-02-18 15:27:24.789704|2017-02-18 15:27:24.789704
NCT00500656|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2015-01-29|2013-10-30||March 2005||2005-03-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|FAST2||Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)|Randomised Double Blind, Controlled, Parallel Group, Multicentre Study of a Subcutaneous Formulation of Icatibant Versus Oral Tranexamic Acid for the Treatment of Hereditary Angioedema (HAE)|Completed||Phase 3|85|Actual|Shire||4|||f||||t||||||||||2017-02-18 15:27:24.891007|2017-02-18 15:27:24.891007
NCT00500630|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-12|2007-07-12||||||July 2007|2007-07-01||||||||Interventional|||Objective Evaluation of Shoulder Pathology and Surgery||Completed||N/A|||University of Lausanne Hospitals|||||f||||||||||||||2017-02-18 15:27:26.149155|2017-02-18 15:27:26.149155
NCT00500617|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2014-11-25|||July 2007||2007-07-01|November 2014|2014-11-01|September 2011|Actual|2011-09-01|January 2010|Actual|2010-01-01||Observational|PREDICT||Personalized Risk Evaluation and Diagnosis In the Coronary Tree|Identification of Gene Expression Patterns in Circulating Cells That Predict the Presence of Coronary Artery Disease|Terminated||N/A|4350|Actual|CardioDx|||4|Primary endpoint reached. Discovery, development and validationcohorts completed and analyzed|f||||f||||||Samples With DNA|"~     whole blood, buffy coat, spun plasma, rna~   "|||2017-02-18 15:27:26.227727|2017-02-18 15:27:26.227727
NCT00500604|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2010-07-16|||July 2007||2007-07-01|July 2010|2010-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|COSIMA2||Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension|A Comparative Study of the Efficacy of Irbesartan/Hydrochlorothiazide 300/25 mg Versus Valsartan/Hydrochlorothiazide 160/25 mg Using Home Blood Pressure Monitoring in the Treatment of Mild to Moderate Hypertension|Completed||Phase 4|1617|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:27:26.358362|2017-02-18 15:27:26.358362
NCT00500591|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-07-13|||June 2004||2004-06-01|July 2016|2016-07-01||||June 2018|Anticipated|2018-06-01||Observational|||Prevalence of Endometrial Abnormalities In Obese Women|Prevalence of Endometrial Abnormalities In Obese Women|Active, not recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood samples used to look at different hormone levels related to risk of endometrial~     abnormalities. An endometrial biopsy will be performed to collect a tissue sample.~   "|||2017-02-18 15:27:26.483698|2017-02-18 15:27:26.483698
NCT00500578|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-07-27|2010-06-01||February 2003||2003-02-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Intermittent Use of Aerosolized Ribavirin for Treatment of RSV|A Randomized Study Evaluating Two Different Schedules of Aerosolized Ribavirin For Treatment of RSV Upper Respiratory Infections in Patients With Hematological Malignancies|Completed||Phase 4|51|Actual|M.D. Anderson Cancer Center|The interpretation of our data is limited by our study’s open-label design, which may bias assessments of tolerability or toxicity but would be less likely to bias assessments of therapeutic endpoints.|2|||f||||f||||||||||2017-02-18 15:27:26.599454|2017-02-18 15:27:26.599454
NCT00500565|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2013-10-10|||December 2003||2003-12-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|||Pain Management Following TRAM Flap for Breast Reconstruction|Randomized, Double Blind, Controlled Trial of Two Methods of Postoperative Pain Management Following Free Transverse Rectus Abdominous Musculocutaneous (TRAM) Flap for Breast Reconstruction|Completed||N/A|61|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:27:27.024645|2017-02-18 15:27:27.024645
NCT00500552|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2010-11-03|||December 2006||2006-12-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|METAL-HCM||Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy|Metabolic Alteration With Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy (METAL-HCM Study)|Completed||Phase 2|44|Anticipated|University Hospital Birmingham||2|||f||||t||||||||||2017-02-18 15:27:27.130347|2017-02-18 15:27:27.130347
NCT00500539|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2011-05-31|2010-11-17||July 2007||2007-07-01|May 2011|2011-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.|An Open Label, Single Arm Study to Assess the Safety and Immunogenicity of Omalizumab Liquid Administered Subcutaneously to Male and Female Adolescents and Adults With Persistent Allergic Asthma|Completed||Phase 3|155|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:27:27.232453|2017-02-18 15:27:27.232453
NCT00500526|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2008-06-27|||January 2005||2005-01-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Singing in Chronic Obstructive Pulmonary Disease|Effects of Singing on Dyspnea, Quality of Life and Pulmonary Function Parameters of COPD Patients in Stable Conditions.|Completed||Phase 1/Phase 2|43|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 15:27:27.576462|2017-02-18 15:27:27.576462
NCT00500513|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2013-01-30|||April 2004||2004-04-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|June 2007|Actual|2007-06-01||Interventional|||Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials|Assessment of the Reliability of Implanted Fiducials for Tracking of Respiratory-Induced Tumor Motion|Completed||N/A|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:27:27.668905|2017-02-18 15:27:27.668905
NCT00500500|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2013-10-10|||July 2005||2005-07-01|October 2013|2013-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease|Effect of EGb 761® on the Ratio of the Isoforms of the Protein Precursor of Beta Amyloid Platelets on Patients With Mild to Moderate Alzheimer's Disease. A Phase II, Randomised, Double-blind Trial, on Parallel Groups Versus Placebo.|Terminated||Phase 2|40|Actual|Ipsen||2||Inability to recruit sufficient number of patients|f||||||||||||||2017-02-18 15:27:27.768868|2017-02-18 15:27:27.768868
NCT00500487|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2015-01-09|||April 2003||2003-04-01|October 2009|2009-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Therapeutic Schools: Affect Management and HIV Prevention|Therapeutic Schools: Affect Management and HIV Prevention|Completed||Phase 1|420|Anticipated|Rhode Island Hospital||3|||f||||t||||||||||2017-02-18 15:27:27.857432|2017-02-18 15:27:27.857432
NCT00500474|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2007-07-23|||April 1996||1996-04-01|July 2007|2007-07-01|March 2005|Actual|2005-03-01|||||Interventional|EDSS||Effects of Endolymphatic Sac Drainage With Steroids for Meniere’s Disease|Clinical Study of Endolymphatic Sac Drainage With or Without Steroids for Intractable Meniere's Disease|Completed||N/A|197|Actual|Osaka University||3|||f||||t||||||||||2017-02-18 15:27:27.960838|2017-02-18 15:27:27.960838
NCT00500461|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-10-27|||June 2007||2007-06-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705|A Single-centre, Open-label, Sequential Ascending Cross Over Study to Examine Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Ascending Single Doses, Nominally 10, 30, 70 and 110µg Intravenous Doses and a Single 250µg Oral Dose of GSK233705 in Healthy Volunteers.|Completed||Phase 1|9|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:27:28.05088|2017-02-18 15:27:28.05088
NCT00500448|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-07-18|2015-04-26||July 2007||2007-07-01|July 2016|2016-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||An Intervention of Electrical Stimulation in Osteoarthritis|The Efficacy of Neuromuscular Electrical Stimulation for Improving Quadriceps Activation in Women With Medial Tibiofemoral Osteoarthritis|Completed||N/A|30|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 15:27:28.212252|2017-02-18 15:27:28.212252
NCT00500435|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-03-22|||October 2003||2003-10-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer|A Pilot Study of Laparoscopic Extraperitoneal Lymph Node Dissection in Patients With Locally Advanced Cervical Cancer|Completed||N/A|65|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:27:28.745013|2017-02-18 15:27:28.745013
NCT00500422|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2013-02-11|||January 2005||2005-01-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients|Phase I Study of a Combination of Doxil, Velcade, and Gemcitabine in Advanced Cancer|Completed||Phase 1|134|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:27:28.856356|2017-02-18 15:27:28.856356
NCT00500409|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2014-12-15|||December 2005||2005-12-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis|Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis. A Randomized Controlled Open-label Multicentre Study in India|Completed||Phase 3|82|Actual|Virchow Group||2|||f||||f||||||||||2017-02-18 15:27:28.971851|2017-02-18 15:27:28.971851
NCT00500396|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2007-11-21|||March 2007||2007-03-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Vascular Endothelial Growth Factor in Stage V ROP|Vascular Endothelial Growth Factor Levels in Aqueous, Vitreous and Subretinal Fluid in Patients With Retinopathy of Prematurity Stage V.|Completed||Phase 4|15|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||f||||||||||2017-02-18 15:27:29.086991|2017-02-18 15:27:29.086991
NCT00500383|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-03-22|||October 2009||2009-10-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|March 2015|Actual|2015-03-01||Observational|||Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)|Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)|Completed||N/A|372|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 15:27:29.200449|2017-02-18 15:27:29.200449
NCT00500370|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-03-19|2009-02-26||June 2007||2007-06-01|March 2015|2015-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients|A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients|Completed||Phase 2|163|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:27:29.306024|2017-02-18 15:27:29.306024
NCT00500357|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2011-04-15|2011-01-21||November 2007||2007-11-01|April 2011|2011-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects|A Phase 3, Open-Label, Single-Arm Trial Evaluating the Safety, Tolerability, and Immunogenicity of a Subsequent Dose of 13-valent Pneumococcal Conjugate Vaccine Administered to One Group of Individuals Who Participated in Study 6115A1-500|Completed||Phase 3|105|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:27:32.594307|2017-02-18 15:27:32.594307
NCT00500344|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2009-02-03|||July 2007||2007-07-01|February 2009|2009-02-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|CAPTAIN||CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography|CAPTAIN: Choroidal Neovascularization Assessment by Pattern Electroretinography After Ranibizumab in Naive Age-Related Macular Degeneration Patients|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 15:27:34.542793|2017-02-18 15:27:34.542793
NCT00500331|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2013-11-07||2009-07-22|January 2007||2007-01-01|November 2013|2013-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)|A Dose-Ranging Study of GSK189075 Versus Placebo In The Treatment of Type 2 Diabetes Mellitus in Treatment Naïve Subjects.|Completed||Phase 2|336|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 15:27:34.67151|2017-02-18 15:27:34.67151
NCT00500318|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-11-16|2012-08-14||July 2007||2007-07-01|November 2016|2016-11-01|September 2010|Actual|2010-09-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 6-Week Clinical Study to Assess the Effect of Inhaled Aclidinium Bromide (LAS34273) 200 ug on Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe COPD|Completed||Phase 3|181|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:27:34.918541|2017-02-18 15:27:34.918541
NCT00500305|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2007-07-10|||April 2004||2004-04-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||The Use of B-Type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants||Completed||N/A|60|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 15:27:35.38324|2017-02-18 15:27:35.38324
NCT00500292|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-08-25|2011-04-27||March 2007||2007-03-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|March 2008|Actual|2008-03-01||Interventional|||A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer|A Phase II, Double-blind, Placebo Controlled, Randomized Study to Assess the Efficacy and Safety of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer in Patients Who Have Failed Therapy With an Irinotecan and Fluoropyrimidine Regimen|Active, not recruiting||Phase 2|109|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 15:27:35.471177|2017-02-18 15:27:35.471177
NCT00500279|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2007-07-10|||November 2006||2006-11-01|July 2007|2007-07-01|October 2009|Anticipated|2009-10-01|||||Interventional|mini-COREA||Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial||Unknown status|Recruiting|Phase 4|900|Anticipated|Seoul National University Hospital||2|||f||||f||||||||||2017-02-18 15:27:36.282684|2017-02-18 15:27:36.282684
NCT00500266|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2011-08-11|2011-08-11||May 2008||2008-05-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects|A Phase 3, Open-Label, Single-Arm Trial Evaluating the Safety, Tolerability, & Reactogenicity of a 13vPnC Vaccine in Ambulatory Elderly Adults Aged 68 Years & Older Who Received 1 or More Doses of 23vPS Vaccine at Least 3 Years Before Study Enrollment|Completed||Phase 3|1053|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:27:36.403436|2017-02-18 15:27:36.403436
NCT00500253|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2013-02-06|||February 2007||2007-02-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma|Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma|Unknown status|Recruiting|Phase 4|120|Anticipated|Medical Universtity of Lodz||2|||f||||t||||||||||2017-02-18 15:27:37.241132|2017-02-18 15:27:37.241132
NCT00500240|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-06-02|2013-06-05||April 2004||2004-04-01|June 2015|2015-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)|Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia|Terminated||Phase 3|52|Actual|M.D. Anderson Cancer Center|Study terminated early due to futility at the pre-determined interim analysis point.|2||Terminated early due to futility.|f||||f||||||||||2017-02-18 15:27:37.355513|2017-02-18 15:27:37.355513
NCT00500227|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2012-07-30|||September 2007||2007-09-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|ESPORA||Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery|Observational Study to Evaluate, in Acromegalic Patients With Disease Persistence After Surgery, Those Histopathologic, Clinical, Morphologic and Biochemical Factors Predictors of Hormonal Control Under Somatostatin Analogue Treatment|Completed||Phase 4|55|Actual|Ipsen|||1||f||||||||||||||2017-02-18 15:27:37.93663|2017-02-18 15:27:37.93663
NCT00500214|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2007-07-11|||April 2005||2005-04-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Ilioinguinal Nerve Excision in Open Mesh Repair of Inguinal Hernia,a Randomized Clinical Trial||Completed||Phase 2|||Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:27:38.039693|2017-02-18 15:27:38.039693
NCT00500201|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-05-31|||May 2007||2007-05-01|February 2011|2011-02-01||||||||Interventional|||A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.|A Single Blind, Double Dummy, Placebo Controlled, Randomized, 2 Period Crossover Study to Assess the Relative Bioavailability of a 120mg Tablet Compared to Two 60 mg SB-773812 Tablets in Healthy Volunteers|Completed||Phase 1|18|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:27:38.117224|2017-02-18 15:27:38.117224
NCT00500188|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2011-08-04|||July 2003||2003-07-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST|A Prospective, Randomized, Phase II Study of Preoperative Plus Postoperative Imatinib Mesylate (Gleevec, Formerly STI-571) in Patients With Primary, Recurrent, or Metastatic Resectable, Kit-Expressing, Gastrointestinal Stromal Tumor (GIST)|Completed||Phase 2|28|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-02-18 15:27:38.20278|2017-02-18 15:27:38.20278
NCT00500175|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2007-07-11|||January 2007||2007-01-01|July 2007|2007-07-01|June 2008|Anticipated|2008-06-01|||||Interventional|TempTouchRM||Novel Home Care Device for High-Risk Diabetic Patients|Novel Home Care Device for High-Risk Diabetic Patients|Unknown status|Recruiting|N/A|110|Anticipated|Diabetica Solutions Inc.||2|||f||||t||||||||||2017-02-18 15:27:38.338854|2017-02-18 15:27:38.338854
NCT00500162|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2009-03-05|||November 2006||2006-11-01|March 2009|2009-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|CLARA||Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma|Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma|Completed||Phase 4|340|Actual|Galderma||2|||f||||f||||||||||2017-02-18 15:27:38.498713|2017-02-18 15:27:38.498713
NCT00500149|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-03-03|2008-12-02||June 2007||2007-06-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)|A Phase IIIb, Randomized, Double-Blind, Multi-Center, Placebo- Controlled, Dose-Optimization, Cross-Over, Analog Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|129|Actual|Shire||2|||f||||||||||||||2017-02-18 15:27:38.759888|2017-02-18 15:27:38.759888
NCT00500136|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-10-03|||January 2007||2007-01-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Psychosocial Effect of Thoughts of Personal Mortality on Cardiac Risk Assessment by Medical Students|The Effects of Religion and Motivation on Medical Decision Making: A Terror Management Approach|Completed||N/A|49|Actual|University of Missouri-Columbia||4|||f||||t||||||||Undecided||2017-02-18 15:27:39.120831|2017-02-18 15:27:39.120831
NCT00500123|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2016-03-14|||January 2001||2001-01-01|March 2016|2016-03-01|January 2050|Anticipated|2050-01-01|January 2050|Anticipated|2050-01-01|50 Years|Observational [Patient Registry]|ACT||Alpha-1 Coded Testing(ACT) Study|Alpha-1 Coded Testing(ACT) Study|Recruiting||N/A|50000|Anticipated|Medical University of South Carolina|||1||f||||t||||||Samples With DNA|"~     A blood card is mailed to the participants home. The provide lancet is used for fingerstick~     collection of sufficient bloodspots to genotype for alpha-1 antitrypsin (AAT) deficiency~     alleles and to estimate an AAT level.~   "|Yes|Data sharing is encouraged by MUSC coordinator contact|2017-02-18 15:27:39.214808|2017-02-18 15:27:39.214808
NCT00500110|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-04-06|2011-07-11||June 2003||2003-06-01|August 2012|2012-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer|Neoadjuvant Hormonal Ablation, Imatinib Mesylate and Docetaxel Followed by Radical Prostatectomy for High-Risk Localized Prostate Cancer|Completed||Phase 2|39|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:27:39.330945|2017-02-18 15:27:39.330945
NCT00500097|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2007-07-27|||May 2005||2005-05-01|July 2007|2007-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training||Completed||N/A|840|Actual|Ministry of Health, Thailand|||||f||||t||||||||||2017-02-18 15:27:39.642593|2017-02-18 15:27:39.642593
NCT00500084|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-10-15||2010-12-13|December 2007||2007-12-01|October 2014|2014-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|DIGEST CP||Phase III ALTU-135 CP Safety Trial|An Open-Label Clinical Study Evaluating the Long Term Safety of ALTU-135 in the Treatment of Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis or Pancreatectomy|Terminated||Phase 3|39|Actual|Anthera Pharmaceuticals||1||Sponsor decision.|f||||t||||||||||2017-02-18 15:27:39.733277|2017-02-18 15:27:39.733277
NCT00500071|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2011-01-14|2009-05-26||July 2007||2007-07-01|January 2011|2011-01-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD|A Prospective, Open-Label, Multi-Center, Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) 20-70mg in Children Aged 6-12 Diagnosed With ADHD|Completed||Phase 4|318|Actual|Shire||1|||f||||||||||||||2017-02-18 15:27:39.850073|2017-02-18 15:27:39.850073
NCT00500058|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-12-01|||July 2007||2007-07-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18|"A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 (SB-485232) Administered by Intravenous Infusion in Combinationwith Rituximab in Adult Patients With B Cell Non-Hodgkin'sLymphoma"|Completed||Phase 1|24|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:27:40.236948|2017-02-18 15:27:40.236948
NCT00500045|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-10-21|||February 2007||2007-02-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions|"Retrospective Study of Niacin (as a Vasodilator), Combined With a Topical Steroid (for Macular Edema), For CRVO, HRVO, BRVO."|Active, not recruiting||Phase 2/Phase 3|45|Anticipated|Palo Alto Medical Foundation||1|||f||||f||||||||||2017-02-18 15:27:40.349522|2017-02-18 15:27:40.349522
NCT00500032|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2009-09-15|||March 2007||2007-03-01|September 2009|2009-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Blood Collection for Use in Serological Assay Development From Healthy Adult Volunteers|Blood Collection for Use in Serological Assay Development From Healthy Adult Volunteers Who Completed Study 6108A1-500|Completed||N/A|87|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:27:40.460962|2017-02-18 15:27:40.460962
NCT00500019|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2009-03-30|||January 2005||2005-01-01|March 2009|2009-03-01|September 2008|Actual|2008-09-01|||||Observational|||Uterine Flora During Elective and Urgent Cesarean Sections|Uterine Flora During Elective and Urgent Cesarean Sections and Its Relationship to Postpartum Complications.|Completed||N/A|600|Anticipated|Western Galilee Hospital-Nahariya|||2||f||||t||||||Samples Without DNA|"~     Uterine bacteriological cultures~   "|||2017-02-18 15:27:40.554858|2017-02-18 15:27:40.554858
NCT00500006|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-01-29|||October 2007||2007-10-01|January 2015|2015-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)|A Phase I Dose Escalation of MK0457 in Combination With Dasatinib in Patients With Chronic Myelogenous Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia|Terminated||Phase 1|3|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:27:40.643444|2017-02-18 15:27:40.643444
NCT00499993|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2009-12-21|||January 2001||2001-01-01|December 2009|2009-12-01|May 2003|Actual|2003-05-01|||||Interventional|||Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly|Phase III, Multicentre, Open Clinical Study on the Efficacy and Tolerability of a New Slow-release Formulation of Lanreotide (Autogel 120 mg) in Patients With Active Acromegaly|Completed||Phase 3|63|Actual|Ipsen||1|||f||||||||||||||2017-02-18 15:27:40.748953|2017-02-18 15:27:40.748953
NCT00499980|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2007-07-11|||March 2005||2005-03-01|July 2007|2007-07-01|August 2005|Actual|2005-08-01|||||Observational|NIR||Near Infrared/ Ultrasound Dual Modal Imaging for Breast Cancer Diagnosis|A Prospective Pilot Clinical Trial Evaluating the Utility of a Dynamic Near Infrared Imaging Device for Characterizing Suspicious Breast Lesions|Completed||N/A|50|Actual|Ohio State University|||||f||||t||||||||||2017-02-18 15:27:40.864896|2017-02-18 15:27:40.864896
NCT00499967|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2009-04-07|||August 2007||2007-08-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts|A Phase 1, Randomized, Double-Blind, Placebo-Controlled Assessment of the Safety, Tolerability, and Activity of GS-9191 Ointment for the Treatment of External Genital and Perianal Warts Caused by Human Papilloma Virus Infection|Completed||Phase 1|202|Actual|Gilead Sciences||6|||f||||f||||||||||2017-02-18 15:27:40.939718|2017-02-18 15:27:40.939718
NCT00499954|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2007-07-11|||February 2006||2006-02-01|April 2006|2006-04-01||||||||Observational|||Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics|An Open, Mono-Centre Trial to Investigate the Correlation Between Concentrations of Glucose in Arterialized Venous Blood and Subcutaneous Interstitial Fluid Applying Different Extracorporeal Sensor Techniques in Type 1 Diabetics|Completed||N/A|16|Actual|Medical University of Graz|||||f||||f||||||||||2017-02-18 15:27:41.169884|2017-02-18 15:27:41.169884
NCT00499941|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2016-03-14|||April 2000||2000-04-01|March 2016|2016-03-01|June 2050|Anticipated|2050-06-01|June 2050|Anticipated|2050-06-01|50 Years|Observational [Patient Registry]|||Alpha-1 Foundation Research Registry|Alpha-1 Foundation Research Registry|Recruiting||N/A|10000|Anticipated|Medical University of South Carolina|||1||f||||t||||||||Yes|Data sharing is encouraged by coordinator contact at MUSC|2017-02-18 15:27:41.251329|2017-02-18 15:27:41.251329
NCT00499928|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2009-05-15|||April 2007||2007-04-01|May 2009|2009-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women|An Open-Label Study to Investigate the Excretion and Metabolic Disposition of a Single, Oral Dose of [14C]-SB-751689 (a Calcium-Sensing Receptor Antagonist) in Healthy Male Subjects and Healthy Postmenopausal Female Subjects|Completed||Phase 1|6|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:27:41.3614|2017-02-18 15:27:41.3614
NCT00499915|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-10-20|2015-09-15||February 2007||2007-02-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||NICU Asthma Education and Secondhand Smoke Reduction Study|Preventing Respiratory Illness Among Premature Infants: An Asthma Education and Secondhand Smoke Reduction Study|Completed||N/A|165|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 15:27:41.449531|2017-02-18 15:27:41.449531
NCT00499902|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2008-04-22|||June 2007||2007-06-01|April 2008|2008-04-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke|Phase 2, Multicenter, Open-Label, Two-Stage Study to Evaluate the Safety and Efficacy of Intra-Arterial Catheter-Directed Alfimeprase for Restoration of Neurologic Function and Rapid Opening of Arteries in Stroke (CARNEROS-1)|Terminated||Phase 2|7|Actual|ARCA Biopharma, Inc.||1||"CO Phase 2 data did not show sufficient improvement in cath opening at higher~   dose/concentration evaluated. Nuvelo ended further clinical dev of alfimeprase."|f||||t||||||||||2017-02-18 15:27:41.746531|2017-02-18 15:27:41.746531
NCT00499889|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-04-19|2011-09-30||February 2003||2003-02-01|April 2012|2012-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients|Imatinib Mesylate, Busulfan, Fludarabine, Antithymocyte Globulin and Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia|Terminated||Phase 2|42|Actual|M.D. Anderson Cancer Center|Study completed early due to support issues.|1||Support issue.|f||||f||||||||||2017-02-18 15:27:41.874194|2017-02-18 15:27:41.874194
NCT00499876|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2017-01-25|||October 2007||2007-10-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of Malaria on Disease Progression of HIV/AIDS|The Effect of Malaria on Disease Progression of HIV/AIDS in Kumasi, Ghana|Completed||N/A|197|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 15:27:42.367905|2017-02-18 15:27:42.367905
NCT00499863|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-06-23|2009-04-24||July 2007||2007-07-01|June 2015|2015-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD|A Phase IIIb, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled, Dose Optimization Study, Designed to Evaluate the Efficacy and Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|217|Actual|Noven Therapeutics||2|||f||||f||||||||||2017-02-18 15:27:42.490805|2017-02-18 15:27:42.490805
NCT00499850|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-08-24|||August 2005||2005-08-01|August 2016|2016-08-01|April 2008|Actual|2008-04-01|June 2006|Actual|2006-06-01||Interventional|||Phase I FOLFOX Combination|A Phase I,Open Label Study to Assess the Safety and Tolerability of ZD6474 in Combination With 5-Fluorouracil, Leucovorin and Oxaliplatin (mFOLFOX6) as First and Second Line Therapy in Patients With Advanced Colorectal Adenocarcinoma.|Completed||Phase 1|18|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:27:43.198608|2017-02-18 15:27:43.198608
NCT00498290|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2009-03-24|||September 2006||2006-09-01|March 2009|2009-03-01|March 2010|Anticipated|2010-03-01|February 2009|Actual|2009-02-01||Interventional|ERAS||The Protocol of Enhanced Recovery After Surgery in Colorectal Surgery|The Protocol of Enhanced Recovery After Surgery in Colorectal Surgery|Unknown status|Recruiting|N/A|500|Anticipated|Fudan University||2|||f||||t||||||||||2017-02-18 15:28:15.41699|2017-02-18 15:28:15.41699
NCT00499837|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-11|2016-06-08|||September 2007||2007-09-01|April 2016|2016-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients|Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients|Completed||Phase 2|21|Actual|Kamada, Ltd.||2|||f||||f||||||||No||2017-02-18 15:27:43.304199|2017-02-18 15:27:43.304199
NCT00499824|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2010-05-03|||January 2007||2007-01-01|May 2010|2010-05-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|GIANT||GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets|GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets|Completed||N/A|386|Actual|International Diabetes Institute, Australia||2|||f||||f||||||||||2017-02-18 15:27:43.409245|2017-02-18 15:27:43.409245
NCT00499811|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-02-21|||June 2007||2007-06-01|October 2011|2011-10-01||||August 2011|Actual|2011-08-01||Interventional|||Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction|Phase I and Pharmacokinetic Study of Vorinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:27:43.536423|2017-02-18 15:27:43.536423
NCT00499798|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2017-01-17|||August 2004||2004-08-01|July 2013|2013-07-01|September 2014|Actual|2014-09-01|June 2009|Actual|2009-06-01||Observational|||Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors|Temozolomide Induced Changes in Semen/Sperm Analysis in Men With Newly Diagnosed, Progressive or Recurrent Primary Malignant Brain Tumors|Completed||N/A|16|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 15:27:43.665419|2017-02-18 15:27:43.665419
NCT00499785|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2017-01-17|||June 2007||2007-06-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|January 2009|Actual|2009-01-01||Observational|||Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia|Inpatient Functional and Cognitive Assessment in Older Adults With Acute Myelogenous Leukemia|Completed||N/A|11|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 15:27:43.765825|2017-02-18 15:27:43.765825
NCT00499759|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-03-05|||February 2006||2006-02-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|January 2007|Actual|2007-01-01||Interventional|||Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia|In-Hospital Individualized Prescriptive Exercise Intervention for Acute Leukemia Patients Undergoing Chemotherapy|Completed||N/A|10|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 15:27:43.858019|2017-02-18 15:27:43.858019
NCT00499746|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2012-04-21|||November 2007||2007-11-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|April 2010|Actual|2010-04-01||Interventional|||The Discriminative Effects of Tramadol in Humans|Medications Development for Drug Abuse Disorders|Completed||Phase 1/Phase 2|12|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 15:27:43.954977|2017-02-18 15:27:43.954977
NCT00499733|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2011-02-24|||June 2007||2007-06-01|July 2009|2009-07-01||||July 2010|Anticipated|2010-07-01||Interventional|||Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer|Sequential Administration of Cryoablation and Cyclophosphamide for Advanced Solid Epithelial Cancer|Unknown status|Recruiting|N/A|23|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:27:44.065732|2017-02-18 15:27:44.065732
NCT00499720|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2011-07-29||||||July 2011|2011-07-01||||||||Expanded Access|||Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection|Expanded Access Program for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection Who Have Limited Treatment Options and Are at Risk for Disease Progression|Approved for marketing||N/A|||Gilead Sciences|||||||||||||||||||2017-02-18 15:27:44.167586|2017-02-18 15:27:44.167586
NCT00499707|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2017-01-16|||October 2003||2003-10-01|January 2017|2017-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects|A Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Fixed Dose Rosiglitazone/Metformin Combination Therapy Compared to Both Rosiglitazone and Metformin Monotherapies in Drug Naive Type 2 Diabetes Mellitus Subjects|Completed||Phase 3|453|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:27:44.418854|2017-02-18 15:27:44.418854
NCT00499694|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-08-09|2014-08-09||October 2007||2007-10-01|August 2014|2014-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel|Phase II Trial of Bevacizumab and Satraplatin in Docetaxel Treated Metastatic Androgen Independent Prostate Cancer|Completed||N/A|31|Actual|Barbara Ann Karmanos Cancer Institute|Small sample size, correlative ERCC testing conducted in only a subset of patients (14 of 30 pts) and the findings of this study are hypothesis generating however validation in larger sample size would be needed.|1|||f||||t||||||||||2017-02-18 15:27:44.623168|2017-02-18 15:27:44.623168
NCT00499681|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-08-07|2011-10-17||July 2007||2007-07-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|October 2009|Actual|2009-10-01||Interventional|||PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE|A Phase II Neo-Adjuvant Study of Letrozole in Combination With Lapatinib in Post -Menopausal Patients With HER2-Positive and Hormone Receptor-Positive Operable Breast Cancer|Terminated||Phase 2|6|Actual|Vanderbilt-Ingram Cancer Center|Due to the restrictive nature of the eligibility criteria, only a total of 6 out of the planned 36 patients were accrued in 2 years, leading to early termination of the study. Hence, both clinical and correlative data were deemed uninterpretable.|2||slow accrual|f||||t||||||||||2017-02-18 15:27:44.896776|2017-02-18 15:27:44.896776
NCT00499668|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2013-03-29|||August 2007||2007-08-01|March 2013|2013-03-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer|A Pilot Study of Aprepitant Versus Ondansetron for the Treatment of Opioid Induced Nausea and Vomiting|Withdrawn||N/A|0|Actual|Vanderbilt-Ingram Cancer Center||2||slow accrual|f||||t||||||||||2017-02-18 15:27:45.337368|2017-02-18 15:27:45.337368
NCT00499655|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-12-19|||November 2007||2007-11-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer|A Randomized, Placebo-Controlled Phase II Clinical Trial of Combination Erlotinib (Tarceva) and Celecoxib (Celebrex) Versus Erlotinib (Tarceva)/Placebo in Advanced Non-Small Cell Lung Cancer Patients|Completed||Phase 2|107|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 15:27:48.022481|2017-02-18 15:27:48.022481
NCT00499642|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2007-12-19|||June 2007||2007-06-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating the Effect of Lecozotan SR on the QTc Interval|A Single-Dose, Double-Blind, Crossover, Placebo- and Moxifloxacin (Open-Label)-Controlled Study of the Effects of Lecozotan SR on Cardiac Repolarization in Healthy Adult Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||||||||||||2017-02-18 15:27:48.175302|2017-02-18 15:27:48.175302
NCT00499629|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2008-03-12|||October 2007||2007-10-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Evaluating the Safety of FXR-450 in Healthy Subjects|Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of FXR-450 Administered Orally to Healthy Subjects|Completed||Phase 1|64|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 15:27:48.262405|2017-02-18 15:27:48.262405
NCT00499616|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-07-18|||October 2007||2007-10-01|July 2014|2014-07-01||||June 2014|Actual|2014-06-01||Interventional|||Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma|Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma|Unknown status|Active, not recruiting|Phase 3|464|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 15:27:48.363112|2017-02-18 15:27:48.363112
NCT00499603|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2016-09-12|2013-04-01||July 2007||2007-07-01|September 2016|2016-09-01|April 2017|Anticipated|2017-04-01|April 2012|Actual|2012-04-01||Interventional|||Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer|Open Label Randomized Clinical Trial of Standard Neoadjuvant Chemotherapy (Paclitaxel Followed by FEC) Versus the Combination of Paclitaxel and RAD001 Followed by FEC in Women With Triple Receptor-Negative Breast Cancer (CRAD001C24101)|Active, not recruiting||Phase 2|62|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:27:48.939747|2017-02-18 15:27:48.939747
NCT00499590|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-09-29|2014-09-25||August 2007||2007-08-01|September 2014|2014-09-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|COBALT||Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD|A Phase 3, Randomized, Double-masked, Parallel-assignment Study of Intravitreal Bevasiranib Sodium, Administered Every 8 or 12 Weeks as Maintenance Therapy Following Three Injections of Lucentis® Compared With Lucentis® Monotherapy Every 4 Weeks in Patients With Exudative Age-Related Macular Degeneration (AMD).|Terminated||Phase 3|338|Actual|OPKO Health, Inc.|Study was terminated early.|3|||f||||t||||||||||2017-02-18 15:27:49.870904|2017-02-18 15:27:49.870904
NCT00499577|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-01-09|||December 2006||2006-12-01|August 2009|2009-08-01||||February 2009|Actual|2009-02-01||Interventional|||Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma|Phase I/II Combination Immunotherapy After ASCT for Advanced Myeloma to Study HTERT Vaccination Followed by Adoptive Transfer of Vaccine-Primed Autologous T Cells|Completed||Phase 1/Phase 2|56|Anticipated|National Cancer Institute (NCI)||4|||||||||||||||||2017-02-18 15:27:50.973708|2017-02-18 15:27:50.973708
NCT00499551|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2008-07-08|||September 2007||2007-09-01|July 2008|2008-07-01|September 2009|Anticipated|2009-09-01|||||Interventional|||A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis|A Phase I/IIa Study of the Treatment of None-Infectious Anterior, Intermediate, Posterior and Panuveitis, With the Use of Dexamethasone Delivered by a Iontophoresis Device|Withdrawn||Phase 1/Phase 2|30|Anticipated|Asociación para Evitar la Ceguera en México||3||The drug needed for the study is not available in Mexico anymore.|f||||t||||||||||2017-02-18 15:27:51.123728|2017-02-18 15:27:51.123728
NCT00499538|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2007-12-18|||July 2007||2007-07-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects|A Single Dose Bioavailability Study of 3 New Formulations of SKI-606 (500 mg) Compared With a Reference Capsule and an Oral Solution in Healthy Adult Subjects|Completed||Phase 1|40|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:27:51.232817|2017-02-18 15:27:51.232817
NCT00499525|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-11-01|||June 2007||2007-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer|A Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo When Administered in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Breast Cancer|Active, not recruiting||Phase 2|180|Anticipated|Northwestern University||2|||f||||t||||||||||2017-02-18 15:27:51.316155|2017-02-18 15:27:51.316155
NCT00499512|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-04-01|||August 2005||2005-08-01|April 2016|2016-04-01||||August 2017|Anticipated|2017-08-01||Observational|||Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer|Evaluation of the Role of Spirituality in Coping With and Surviving Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Active, not recruiting||N/A|115|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:27:51.47216|2017-02-18 15:27:51.47216
NCT00499499|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2009-02-03|||July 2007||2007-07-01|February 2009|2009-02-01|August 2010|Anticipated|2010-08-01|June 2009|Anticipated|2009-06-01||Interventional|||A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors|A Phase I Open-Label, Single-Arm, Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid Tumors|Suspended||Phase 1|40|Anticipated|Eisai Inc.||1|||f||||||||||||||2017-02-18 15:27:51.589375|2017-02-18 15:27:51.589375
NCT00499486|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-10-18|2013-03-18||January 2005||2005-01-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|September 2008|Actual|2008-09-01||Interventional||All patients had previously progressed to a gemcitabine-containing regimen, including 22 patients who had received previous chemotherapy for metastatic disease.|Sirolimus in Treating Patients With Advanced Pancreatic Cancer|Phase II Clinical, Biological and Pharmacological Study of Rapamycin (Rapamune®, Sirolimus) in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|47|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||Undecided||2017-02-18 15:27:51.686175|2017-02-18 15:27:51.686175
NCT00499473|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-01-29|2015-08-25||June 2007||2007-06-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|June 2009|Actual|2009-06-01||Interventional|||Sunitinib in Treating Patients With Recurrent Malignant Gliomas|A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas|Completed||Phase 2|31|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:27:51.989056|2017-02-18 15:27:51.989056
NCT00499460|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-04-30|||November 2006||2006-11-01|April 2012|2012-04-01|September 2008|Actual|2008-09-01|||||Interventional|||Effect of Garlic Supplements on Opioids in Healthy Volunteers|Modulation of Opioid Effects by Garlic Supplements|Completed||Phase 4|18|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-02-18 15:27:52.504381|2017-02-18 15:27:52.504381
NCT00499447|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-09-22|2013-01-25||May 2007||2007-05-01|September 2015|2015-09-01||||March 2010|Actual|2010-03-01||Interventional|||Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|A Phase II Study of Radiofrequency Ablation Combined With External Beam Radiation Therapy for Patients With Medically Inoperable Non-Small Cell Lung Cancer (Stage Ia and Select Ib) and the Predictive Value of Positron Emission Tomography|Active, not recruiting||Phase 2|13|Actual|Wake Forest University Health Sciences|adverse events were tracked in two cycles, one during treatment and one longer term|1|||f||||t||||||||||2017-02-18 15:27:52.625679|2017-02-18 15:27:52.625679
NCT00499434|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2009-12-03|||August 2007||2007-08-01|December 2009|2009-12-01|February 2010|Anticipated|2010-02-01|January 2009|Anticipated|2009-01-01||Observational|||Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus|Correlation Between Values of Serum Cytokines and of Those Dosed by mRNA Expression Through the Use of Real-time PCR and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus|Unknown status|Active, not recruiting|N/A|110|Anticipated|UPECLIN HC FM Botucatu Unesp|||1||f||||t||||||||||2017-02-18 15:27:52.921854|2017-02-18 15:27:52.921854
NCT00499421|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-04-19|||September 2005||2005-09-01|April 2016|2016-04-01||||September 2017|Anticipated|2017-09-01||Observational|||Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy|Evaluation of Intraprostatic Fiducial Markers For Targeting of External Beam Radiation Therapy|Active, not recruiting||N/A|20|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:27:53.247153|2017-02-18 15:27:53.247153
NCT00499408|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-09-29|2013-11-15||April 2007||2007-04-01|January 2014|2014-01-01||||December 2012|Actual|2012-12-01||Interventional|||Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer|Phase II Trial of Vitamin D and Soy Supplementation for Biochemically Recurrent Prostate Cancer Following Definitive Local Therapy|Completed||Phase 2|26|Actual|Wake Forest University Health Sciences|only the most severe of each type of adverse event during treatment was recorded.|1|||f||||t||||||||||2017-02-18 15:27:53.360913|2017-02-18 15:27:53.360913
NCT00499395|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-04-02|||July 2005||2005-07-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer|Detection of Residual Colorectal Liver Metastases Within 24 Hours After RFA With 18-F FDG PET|Completed||N/A|4|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:27:53.63833|2017-02-18 15:27:53.63833
NCT00499382|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-07-31|||September 2004||2004-09-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging|Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging|Terminated||N/A|5|Actual|M.D. Anderson Cancer Center|||1|Slow accrual; study terminated.|f||||f||||||||||2017-02-18 15:27:53.732724|2017-02-18 15:27:53.732724
NCT00499369|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-07-25|2013-10-22||June 2007||2007-06-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||All eligible patients are included in this analysis.|Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy|Phase III Trial of Irinotecan-Based Chemotherapy Plus Cetuximab (NSC-714692) or Bevacizumab (NSC-704865) as Second-Line Therapy for Patients With Metastatic Colorectal Cancer Who Have Progressed on Bevacizumab With Either FOLFOX, OPTIMOX or XELOX|Terminated||Phase 3|72|Actual|National Cancer Institute (NCI)|Due to inadequate accrual, study was terminated and limited outcome data was reported.|3||Due to inadequate accrual, study was terminated and limited outcome data was reported.|f||||||||||||||2017-02-18 15:27:53.860591|2017-02-18 15:27:53.860591
NCT00499356|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2007-07-10|||May 2002||2002-05-01|July 2007|2007-07-01|January 2005|Actual|2005-01-01|||||Interventional|GlideSoft||Shear and Pressure Reducing Insoles for the Diabetic Foot|Shear and Pressure Reducing Insoles for the Diabetic Foot|Completed||N/A|299|Actual|Diabetica Solutions Inc.||2|||f||||t||||||||||2017-02-18 15:27:56.682467|2017-02-18 15:27:56.682467
NCT00499343|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2013-06-03|2009-03-03||January 2004||2004-01-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients|A Randomized Study Comparing Chemotherapy Followed by G-CSF Alone Versus G-CSF Plus GM-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas|Completed||Phase 2|84|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:27:56.781806|2017-02-18 15:27:56.781806
NCT00499330|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2017-01-24|||June 2007||2007-06-01|January 2017|2017-01-01||||March 2021|Anticipated|2021-03-01||Interventional|||Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer|A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (≤ 2 cm) Peripheral Non-Small Cell Lung Cancer|Recruiting||Phase 3|1258|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 15:27:57.144782|2017-02-18 15:27:57.144782
NCT00499317|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2011-07-21|||January 2007||2007-01-01|July 2011|2011-07-01|June 2012|Anticipated|2012-06-01|||||Observational|CP/CPPS||Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)||Unknown status|Recruiting|N/A|500|Anticipated|Boston Children’s Hospital|||1||f||||t||||||Samples With DNA|"~     DNA sample via saliva and urine samples will be collected and stored.~   "|||2017-02-18 15:27:57.840673|2017-02-18 15:27:57.840673
NCT00499304|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2008-06-05|||November 2006||2006-11-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Forced Oscillation Technique (FOT) and Expiratory Flow Limitation (EFL)|Diagnosing Expiratory Flow Limitation in COPD Patients With the Forced Oscillation Technique Using Linear Regression in the Time Frequency Domain|Completed||N/A|60|Anticipated|Medical Center Alkmaar|||1||f||||f||||||||||2017-02-18 15:27:57.934225|2017-02-18 15:27:57.934225
NCT00499291|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-10-06|||September 2006||2006-09-01|October 2015|2015-10-01||||October 2007|Anticipated|2007-10-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors|Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Study of Nab-Paclitaxel (Nanoparticle Albumin Bound-Paclitaxel) in Patients With Advanced Solid Tumors|Withdrawn||N/A|0|Actual|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 15:27:58.017323|2017-02-18 15:27:58.017323
NCT00499278|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2007-07-09|||November 2005||2005-11-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|||||Observational|JOINTS||JOINTS Study - Joint Replacement Outcome in Inpatient Rehabilitation Facilities and Nursing Treatment Sites|Joint Replacement Outcome in Inpatient Rehabilitation Facilities and Nursing Treatment Sites|Completed||N/A|2384|Actual|MedStar National Rehabilitation Network|||||f||||f||||||||||2017-02-18 15:27:58.113572|2017-02-18 15:27:58.113572
NCT00499265|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-03-28|||April 2007||2007-04-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery|A Randomized, Open Label, Phase II Proof of Concept Study of WX-671 in Combination With Gemcitabine vs.Gemcitabine Alone in Patients With Locally Advanced, Non Resectable Pancreatic Cancer in Order to Evaluate the Anti-Tumor Activity of the Combination Therapy|Completed||Phase 2|95|Actual|Wilex||3|||f||||f||||||||||2017-02-18 15:27:58.219392|2017-02-18 15:27:58.219392
NCT00499252|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-03-19|2013-10-23||June 2007||2007-06-01|March 2015|2015-03-01||||July 2011|Actual|2011-07-01||Interventional||Eligible and treated patients|Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase II Evaluation of Abraxane® in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Completed||Phase 2|51|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 15:27:58.541882|2017-02-18 15:27:58.541882
NCT00499239|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2014-01-03||2014-01-03|July 2007||2007-07-01|January 2014|2014-01-01|October 2010|Actual|2010-10-01|July 2010|Actual|2010-07-01||Interventional|||A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)|Multi-center, Open-label, Dose-escalating Phase I/II Trial of GS-9219 Administered Once Every Three Weeks Intravenously to Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma or Multiple Myeloma|Terminated||Phase 1/Phase 2|32|Actual|Gilead Sciences||1||Unacceptable safety profile|f||||t||||||||||2017-02-18 15:27:58.937817|2017-02-18 15:27:58.937817
NCT00499213|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2009-02-06|||July 2007||2007-07-01|July 2007|2007-07-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Observational|||Rates of Hospitalization in Home Care Assisted Peritoneal Dialysis|Home Care Assisted Peritoneal Dialysis: The Impact of Expanding Eligibility for Peritoneal Dialysis on Rates of Hospitalization|Unknown status|Active, not recruiting|N/A|||Sunnybrook Health Sciences Centre|||||f||||f||||||||||2017-02-18 15:27:59.05776|2017-02-18 15:27:59.05776
NCT00499200|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2008-07-07|||October 2007||2007-10-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy|A Positron Emission Tomography Study to Assess the Level and Duration of Occupancy of Serotonin-1A Receptors Produced by Single Oral Doses of SRA-444 in Healthy Elderly Subjects and in Subjects With Alzheimer Disease|Completed||Phase 1|42|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:27:59.132646|2017-02-18 15:27:59.132646
NCT00499187|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2014-03-14|||September 2007||2007-09-01|March 2014|2014-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Fanconi Syndrome Due to ARVs in HIV-Infected Persons|A Preliminary Evaluation of Fanconi Syndrome Due to Antiretroviral Therapies in HIV-Infected Persons|Completed||Phase 4|56|Actual|Gilead Sciences|||2||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 15:27:59.392328|2017-02-18 15:27:59.392328
NCT00499174|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-10-05|||June 2007||2007-06-01|July 2012|2012-07-01|January 2013|Actual|2013-01-01|December 2011|Actual|2011-12-01||Interventional|||Observation or Radical Treatment in Patients With Prostate Cancer|A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed With Favourable Risk Prostate Cancer [START]|Terminated||Phase 3|180|Actual|Canadian Cancer Trials Group||2||Not meeting accrual target.|f||||t||||||||||2017-02-18 15:27:59.507715|2017-02-18 15:27:59.507715
NCT00499161|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2008-02-15|||April 2007||2007-04-01|February 2008|2008-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|PCC||Effect of Patient-Centered Care (PCC) on Patient Satisfaction at Hospital Discharge|Effect of Patient-Centered Care (PCC) on Patient Satisfaction at Hospital Discharge|Completed||N/A|80|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:27:59.637686|2017-02-18 15:27:59.637686
NCT00499148|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2010-07-29|||August 2006||2006-08-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes|Effect of Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes|Completed||Phase 2/Phase 3|59|Actual|Abbott Nutrition|||||f||||f||||||||||2017-02-18 15:27:59.74238|2017-02-18 15:27:59.74238
NCT00499135|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2017-01-31|||May 2007||2007-05-01|October 2016|2016-10-01||||July 2013|Actual|2013-07-01||Interventional|||Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors|Pharmacodynamic Study of Sunitinib Malate in Patients With Renal Cell Cancer and Other Advanced Solid Malignancies|Active, not recruiting||Phase 1|25|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:27:59.82972|2017-02-18 15:27:59.82972
NCT00499122|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-12-14|2013-01-18||May 2007||2007-05-01|December 2016|2016-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Oxidized Glutathione (NOV-002), Doxorubicin, Cyclophosphamide, and Docetaxel in Treating Women With Newly Diagnosed Stage IIB, or Stage IIIC Breast Cancer|Phase II Study of Neoadjuvant Treatment With NOV-002 in Combination With Doxorubicin and Cyclophosphamide Followed by Docetaxel in Patients With Stages IIB-IIIC Breast Cancer|Completed||Phase 2|41|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:27:59.964055|2017-02-18 15:27:59.964055
NCT00499109|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-06-25|2013-09-12||May 2007||2007-05-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional||All Participants|Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC|Randomized Phase III Multicenter Trial of RRM1 & ERCC1 Directed Customized Chemotherapy Versus Standard of Care for 1st Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer|Completed||Phase 3|275|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-02-18 15:28:00.305319|2017-02-18 15:28:00.305319
NCT00499096|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2014-11-12|2014-10-17||May 2008||2008-05-01|November 2014|2014-11-01|November 2012|Actual|2012-11-01|May 2012|Actual|2012-05-01||Interventional|SMAHRT||Self-Management Addressing Heart Disease Risk Trial|Cardiovascular Risk Factors in Veterans With Bipolar Disorder|Completed||Phase 3|118|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:28:01.414225|2017-02-18 15:28:01.414225
NCT00499083|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2011-07-06|||May 2006||2006-05-01|July 2011|2011-07-01||||December 2011|Anticipated|2011-12-01||Interventional|||Paclitaxel, Cyclophosphamide, and Doxorubicin Followed by Autologous Dendritic Cells and Surgery With or Without Radiation Therapy and/or Hormone Therapy in Treating Women With Stage II or Stage III Breast Cancer|Neoadjuvant Intratumoral Injection of Dendritic Cells in Breast Cancer Translation of Biotechnology Into the Clinic|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 15:28:01.962379|2017-02-18 15:28:01.962379
NCT00499070|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-01-15|||January 2007||2007-01-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment|TCR Vbeta Repertoire and PNH Clones in Children With Refractory Cytopenia (RC). An Open Nonrandomised Multi-Center Prospective Study|Completed||N/A|119|Actual|University Hospital Freiburg|||1||f||||f||||||Samples With DNA|"~     Bone Marrow Peripheral blood cells~   "|||2017-02-18 15:28:02.08247|2017-02-18 15:28:02.08247
NCT00499057|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2014-12-19|||August 2003||2003-08-01|June 2010|2010-06-01|August 2016|Anticipated|2016-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Partial Breast Irradiation With Interstitial High Dose Rate Brachytherapy|Interstitial High Dose-Rate Brachytherapy for Partial Breast Irradiation in Early Breast Cancer: Results of Phase II Prospective Study|Unknown status|Recruiting|Phase 2|150|Anticipated|University Of Perugia||1|||f||||f||||||||||2017-02-18 15:28:02.190237|2017-02-18 15:28:02.190237
NCT00499044|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2009-11-25|||December 2007||2007-12-01|November 2009|2009-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Comparison of Two Cognitive Batteries in People With Schizophrenia|CDR Versus MATRICS Cognitive Batteries in Patients With Schizophrenia|Completed||N/A|32|Actual|North Suffolk Mental Health Association||2|||f||||f||||||||||2017-02-18 15:28:02.292494|2017-02-18 15:28:02.292494
NCT00499031|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2014-12-29|2014-05-22||June 2007||2007-06-01|December 2014|2014-12-01||||January 2012|Actual|2012-01-01||Interventional||Total number eligible and evaluable participants|Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation of Cetuximab (Erbitux®, C225, NSC# 714692) in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix|Completed||Phase 2|38|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 15:28:02.411998|2017-02-18 15:28:02.411998
NCT00499018|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2011-02-14|||January 2006||2006-01-01|February 2011|2011-02-01|September 2013|Anticipated|2013-09-01|June 2011|Anticipated|2011-06-01||Interventional|DLCL04||Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma|A Randomised Multicentric Phase III Study for the Treatment of Young Patients With High Risk (IPI 2-3) Diffuse Large B-Cell Lymphoma. Dose Dense Chemotherapy + Rituximab +/- Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cells.|Unknown status|Active, not recruiting|Phase 3|399|Anticipated|Fondazione Italiana Linfomi ONLUS||4|||f||||f||||||||||2017-02-18 15:28:03.018666|2017-02-18 15:28:03.018666
NCT00499005|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2009-09-18|||November 2006||2006-11-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Carbetocin Versus Syntometrine for the Third Stage of Labour|Carbetocin Versus Syntometrine for the Third Stage of Labour Following Vaginal Delivery - A Double-blind Randomised Trial|Completed||Phase 4|720|Anticipated|National University Hospital, Singapore||2|||f||||t||||||||||2017-02-18 15:28:03.231412|2017-02-18 15:28:03.231412
NCT00498992|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2013-09-19|||July 2006||2006-07-01|July 2009|2009-07-01||||||||Interventional|||Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer|Regenecare® in the Treatment of Skin Rash Associated With Cetuximab (Erbitux®) or Other EGFR Treated Cancer Patients|Unknown status|Recruiting|N/A|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:28:03.350586|2017-02-18 15:28:03.350586
NCT00498979|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-09-29|||May 2007||2007-05-01|September 2015|2015-09-01|January 2012|Actual|2012-01-01|May 2010|Actual|2010-05-01||Interventional|||Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers|Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon α-2b Followed by Cisplatin, Vinblastine and Dacarbazine for Patients With Melanoma or Malignancies Potentially Responsive to SSG and/or Interferons|Completed||Phase 1|22|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:28:03.441613|2017-02-18 15:28:03.441613
NCT00498966|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2014-02-14|||July 2007||2007-07-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Ph II Study of Perifosine for Patients With Carcinoma of the Kidney|Phase II Study of Perifosine for Patients With Metastatic Carcinoma of the Kidney Who Have Progressed on a VEGF Receptor Inhibitor|Completed||Phase 2|50|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 15:28:03.564281|2017-02-18 15:28:03.564281
NCT00498953|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2013-01-07|||May 2007||2007-05-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx|Phase I/II Study on Induction Chemotherapy Followed by Chemoradiation With or Without Lapatinib, a Dual EGFR/ErbB2 Kinase Inhibitor, in Patients With Locally Advanced Larynx and Hypopharynx Squamous Cell Carcinoma|Completed||Phase 1/Phase 2|7|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 15:28:03.675528|2017-02-18 15:28:03.675528
NCT00498940|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2014-04-01|2014-02-03||October 2006||2006-10-01|April 2014|2014-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|BIPACS||Biventricular Pacing After Cardiopulmonary Bypass|Biventricular Pacing After Cardiopulmonary Bypass|Terminated||Phase 1/Phase 2|111|Actual|Columbia University||2||Accrual too slow; grant renewal unlikely; AAI as effective as BiV in Phase III|f||||t||||||||||2017-02-18 15:28:03.800739|2017-02-18 15:28:03.800739
NCT00498927|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2016-02-01|2015-10-05||June 2007||2007-06-01|February 2016|2016-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma|A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma|Completed||Phase 2|47|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:28:04.14341|2017-02-18 15:28:04.14341
NCT00498914|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2015-08-20||2015-08-20|June 2007||2007-06-01|August 2015|2015-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects|A Phase II Multicenter, Open-Label Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects|Terminated||Phase 2|41|Actual|Astellas Pharma Inc||1||Futility boundary at interim analysis not met|f||||t||||||||||2017-02-18 15:28:04.398447|2017-02-18 15:28:04.398447
NCT00498901|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2013-05-07|||February 2007||2007-02-01|May 2013|2013-05-01|November 2008|Actual|2008-11-01|December 2007|Actual|2007-12-01||Interventional|||Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer|Phase II Pilot of Aromatase Inhibitor Therapy With Femara® (Letrozole) and Ovarian Suppression in Premenopausal Estrogen Receptor Positive Women With Stage IV Carcinoma of the Breast|Terminated||Phase 2|1|Actual|University of Washington||1|||f||||||||||||||2017-02-18 15:28:04.536071|2017-02-18 15:28:04.536071
NCT00498888|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-10|2012-11-28|||June 2007||2007-06-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|January 2012|Actual|2012-01-01||Interventional|UUI||The Long Term Outcomes of Rehabilitation and Drug Treatment for in Urgency Urinary Incontinence|Is the a Difference Between Rehabilitation Treatment, Pelvic Floor Muscle Training, Bladder Training and Anticholinergic Drug Treatment in UUI in the Long Term: A Study of Impairment, Quality of Life, and Cost Effectiveness|Completed||N/A|164|Actual|Assuta Hospital Systems||4|||f||||t||||||||||2017-02-18 15:28:04.651715|2017-02-18 15:28:04.651715
NCT00498875|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2016-09-27|||March 2005||2005-03-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Observational|||Depression and Adherence in Head and Neck Cancer|Depression and Adherence in Head and Neck Cancer|Active, not recruiting||Phase 1|350|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:28:04.769855|2017-02-18 15:28:04.769855
NCT00498862|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2007-07-09|||September 2006||2006-09-01|September 2006|2006-09-01||||||||Observational|||Catecholamines Can Attenuate Intermittent Hypoxia-Induced Expression of TNF in Human Monocytes||Unknown status|Recruiting|N/A|15|Anticipated|National Taiwan University Hospital|||||f||||t||||||||||2017-02-18 15:28:04.8784|2017-02-18 15:28:04.8784
NCT00498849|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2007-07-08|||February 2005||2005-02-01|January 2005|2005-01-01|December 2007|Anticipated|2007-12-01|||||Interventional|||The Changes of Patterns of Microarray in Patients With Obstructive Sleep Apnea|The Changes of Patterns of Microarray in Patients With Obstructive Sleep Apnea|Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 15:28:04.958175|2017-02-18 15:28:04.958175
NCT00498836|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2013-08-28||2013-08-28|March 2007||2007-03-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma|A Multicentre, Dose Finding, Phase II Study of CP-4055 in Combination With Sorafenib in Patients With Metastatic Malignant Melanoma|Completed||Phase 2|18|Actual|Clavis Pharma||1|||f||||f||||||||||2017-02-18 15:28:05.047841|2017-02-18 15:28:05.047841
NCT00498810|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2011-01-27|||September 2007||2007-09-01|January 2011|2011-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|COMPAC||COMplete Versus PArtial Open inCisional Hernia Repair (COMPAC-TRIAL)|COMplete Versus PArtial Open inCisional Hernia Repair (COMPAC-TRIAL)|Terminated||N/A|160|Anticipated|University Hospital, Ghent||||patients had to be converted to the other study arm|f||||f||||||||||2017-02-18 15:28:05.291423|2017-02-18 15:28:05.291423
NCT00498797|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2016-08-25|2011-04-27||December 2005||2005-12-01|August 2016|2016-08-01|September 2008|Actual|2008-09-01|July 2007|Actual|2007-07-01||Interventional|||E3-Hormone Refractory Prostrate Cancer Taxotere Combination|A Phase II, Double-blind, Placebo-controlled, Randomised Study to Assess the Efficacy and Safety of Docetaxel (Taxotere)/Prednisolone/ZD6474 vs Docetaxel/Prednisolone/Placebo in Patients With Hormone Refractory Prostrate Cancer (HRPC)|Completed||Phase 2|86|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:28:05.38452|2017-02-18 15:28:05.38452
NCT00498784|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2013-01-21|||November 2005||2005-11-01|January 2013|2013-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||HR-QoL and Sexuality in Mirena Inserted Contraception Users|A Multicenter, Open Labelled, Uncontrolled, Phase IV Clinical Study to Evaluate the Health-related Quality of Life and Sexual Well-being in Young (18-35) Healthy Mirena Users Switching From OC, Over the First Year Post-insertion.|Completed||Phase 4|141|Actual|Bayer||1|||f||||f||||||||||2017-02-18 15:28:05.863921|2017-02-18 15:28:05.863921
NCT00498771|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2013-06-17|||July 2006||2006-07-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|December 2009|Actual|2009-12-01||Interventional|||Aquatic Exercise Study for Breast Cancer Patients With Lymphedema|Aquatic Exercise Study for Breast Cancer Patients With Lymphedema|Completed||N/A|35|Actual|Baylor Research Institute||2|||f||||f||||||||||2017-02-18 15:28:05.964016|2017-02-18 15:28:05.964016
NCT00498758|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2007-07-09|||August 2007||2007-08-01|July 2007|2007-07-01|August 2008|Anticipated|2008-08-01|||||Interventional|||The APOS System: Effects on Gait, Mobility and QOL in Patients With Parkinson's Disease||Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Tel-Aviv Sourasky Medical Center||2|||f||||f||||||||||2017-02-18 15:28:06.075865|2017-02-18 15:28:06.075865
NCT00498745|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2012-05-10|||July 2007||2007-07-01|May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects|A Single Dose Bioavailability Study of 2 New Formulations of HKI-272 (240 mg) Compared With a Reference Capsule and an Oral Solution in Healthy Adult Subjects|Completed||Phase 1|36||Puma Biotechnology, Inc.|||||||||||||||||||2017-02-18 15:28:06.328155|2017-02-18 15:28:06.328155
NCT00498732|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2010-11-30|||June 2007||2007-06-01|November 2010|2010-11-01|July 2008|Actual|2008-07-01|March 2008|Actual|2008-03-01||Observational|||Dissection of Differentially Expressed Genes and Pathways in Patients With OSAS Before and After CPAP Treatment|Dissection of Differentially Expressed Genes and Pathways in Patients With Obstructive Sleep Apnea Syndrome Before and After CPAP Treatment|Completed||N/A|50|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:28:06.415622|2017-02-18 15:28:06.415622
NCT00498719|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2016-09-27|||April 2004||2004-04-01|September 2016|2016-09-01||||April 2018|Anticipated|2018-04-01||Observational|||Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer|A Pilot Study of the Effectiveness of Cognitive Training in Preventing Attention Deficits Among Children in Treatment for Cancer|Active, not recruiting||N/A|30|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 15:28:06.510613|2017-02-18 15:28:06.510613
NCT00498706|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2013-07-15|2012-08-20||December 2007||2007-12-01|July 2013|2013-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effectiveness of Telephone Versus Face-to-Face CBT in Treating People With Depression|Telephone Versus Face-to-Face Administration of CBT for Depression|Completed||Phase 3|325|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 15:28:06.635839|2017-02-18 15:28:06.635839
NCT00498693|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2009-01-12|||March 2006||2006-03-01|January 2009|2009-01-01||||||||Observational|||Hypoxia Inducible factor1-Alpha Genetic Polymorphism of Obstructive Sleep Apnea||Unknown status|Recruiting|N/A|1000|Anticipated|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:28:07.145009|2017-02-18 15:28:07.145009
NCT00498680|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2010-10-21|||March 2007||2007-03-01|January 2007|2007-01-01|June 2011|Anticipated|2011-06-01|January 2011|Anticipated|2011-01-01||Interventional|||Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i|A Prospective, Randomized, 3-arm Parallel Trial to Evaluate the Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Treatment|Unknown status|Recruiting|Phase 4|46|Anticipated|Rambam Health Care Campus||3|||f||||f||||||||||2017-02-18 15:28:07.22976|2017-02-18 15:28:07.22976
NCT00498667|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2015-05-05|||December 2006||2006-12-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2009|Actual|2009-12-01||Observational|||The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma|Evaluation of the Prognostic Value of Early Interim PET/CT for Prediction of Progression Free Survival of Patients With Aggressive B Cells Non Hodgkin Lymphoma|Withdrawn||N/A|0|Actual|Rambam Health Care Campus|||1||f||||f||||||None Retained|"~     no biopsies are to be retained~   "|||2017-02-18 15:28:07.355386|2017-02-18 15:28:07.355386
NCT00498654|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2008-06-27|||July 2007||2007-07-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|October 2007|Actual|2007-10-01||Interventional|||Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects|A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of a Single Oral Dose Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects|Completed||Phase 2|180|Anticipated|Avant Immunotherapeutics||3|||f||||t||||||||||2017-02-18 15:28:07.445451|2017-02-18 15:28:07.445451
NCT00498641|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2007-07-09|||January 2005||2005-01-01|July 2007|2007-07-01|January 2007|Actual|2007-01-01|||||Interventional|||Anisometropia Amblyopia Improved by Perceptual Learning and Patching||Completed||Phase 3|||Tri-Service General Hospital|||||f||||t||||||||||2017-02-18 15:28:07.536802|2017-02-18 15:28:07.536802
NCT00498628|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2015-06-17|2012-04-25||December 2007||2007-12-01|June 2015|2015-06-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency|A Phase 2, Double-Blind, Placebo Controlled Trial to Assess the Efficacy of Quetiapine Fumarate Extended Release for the Treatment of Alcohol Dependence in Very Heavy Drinkers.|Completed||Phase 2|224|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||2|||f||||t||||||||||2017-02-18 15:28:07.615759|2017-02-18 15:28:07.615759
NCT00498615|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2014-11-03|2014-03-25||April 2007||2007-04-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||Men and women between ages 18–80 years with a clinical diagnosis of Raynauds Phenomenon secondary to Scleroderma were eligible for the study.|A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon|Efficacy, Tolerability and Biology of a Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon|Completed||Phase 3|17|Actual|Johns Hopkins University||3|||f||||f||||||||||2017-02-18 15:28:08.112688|2017-02-18 15:28:08.112688
NCT00498602|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2015-11-30|2014-04-23||November 2007||2007-11-01|November 2015|2015-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||245 participants were randomized in both studies (86 participants in NCT00479557 and 159 participants in NCT00498602) are included in the analysis below. One participant of the randomized participants did not receive treatment.|Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease|Phase Iia, Multicenter, Randomized, Third-party Unblinded, Adjuvant And Placebo-controlled, Multiple Ascending Dose, Safety, Tolerability, And Immunogenicity Trial Of Acc-001 And Qs-21 Adjuvant In Subjects With Mild To Moderate Alzheimers Disease|Completed||Phase 2|160|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 15:28:08.507389|2017-02-18 15:28:08.507389
NCT00498589|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2015-02-04|||September 2007||2007-09-01|February 2015|2015-02-01|June 2014|Actual|2014-06-01|February 2014|Actual|2014-02-01||Interventional|METEOR||Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis|A Controlled, Randomized, Double-blind, Multicenter Study, Comparing Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis|Completed||Phase 2|110|Actual|Centre Hospitalier Universitaire de Besancon||2|||f||||t||||||||||2017-02-18 15:28:10.971919|2017-02-18 15:28:10.971919
NCT00498576|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2009-06-29|||September 2007||2007-09-01|June 2009|2009-06-01||||||||Observational|||Melatonin and Adiponectin in Hypertensive Kidney Transplant||Completed||N/A|60|Anticipated|Sheba Medical Center|||3||f||||f||||||||||2017-02-18 15:28:11.095924|2017-02-18 15:28:11.095924
NCT00498563|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2015-04-22|||October 2006||2006-10-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Mild Hypobaric Hypoxia on Sleep and Post-sleep Performance|Investigation to Determine the Effects of Mild Hypobaric Hypoxia on Sleep and Post-Sleep Neurobehavioral Performance|Completed||N/A|34|Actual|Oklahoma State University Center for Health Sciences||1|||f||||f||||||||||2017-02-18 15:28:11.348736|2017-02-18 15:28:11.348736
NCT00498550|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2011-12-15|2011-09-28||October 2000||2000-10-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual|Cannabis and Schizophrenia: Effects of Clozapine|Completed||Phase 4|31|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 15:28:11.439528|2017-02-18 15:28:11.439528
NCT00498537|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2008-10-16|||January 2003||2003-01-01|May 2008|2008-05-01|June 2006|Actual|2006-06-01|December 2005|Actual|2005-12-01||Interventional|||Spironolactone for Reducing Proteinuria in Diabetic Nephropathy|Spironolactone for Reducing Proteinuria in Diabetic Nephropathy|Completed||N/A|30|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:28:11.891187|2017-02-18 15:28:11.891187
NCT00498524|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2012-12-06|||July 2007||2007-07-01|December 2012|2012-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|SIBFIB||Risk of Life-threatening Heart Rhythm Disturbances in Siblings|The Sibling Concordance for Implantable Cardioverter-defibrillator Therapies in Ischemic Cardiomyopathy Study|Completed||N/A|2047|Actual|Duke University|||2||f||||f||||||||||2017-02-18 15:28:12.009294|2017-02-18 15:28:12.009294
NCT00498511|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2007-07-12|||August 2007||2007-08-01|June 2007|2007-06-01||||||||Observational|||Gastrointestinal Evaluation in Young Men With Iron Deficiency Anemia|Prospective Evaluation of the Gastrointestinal Tract in Young Men With Iron Deficiency Anemia|Unknown status|Not yet recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:28:12.116065|2017-02-18 15:28:12.116065
NCT00498498|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2011-11-15|||July 2007||2007-07-01|November 2011|2011-11-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|Endothelin||Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury|A Multicenter Observational Study to Evaluate Dynamics of Endothelin and Markers of Cellular Apoptosis in Cerebrospinal Fluid and Plasma in Moderate and Severe Human Head Injury|Completed||N/A|51|Actual|Virginia Commonwealth University|||1||f||||f||||||Samples Without DNA|"~     CSF, plasma~   "|||2017-02-18 15:28:12.21282|2017-02-18 15:28:12.21282
NCT00498277|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2012-07-31|||August 2004||2004-08-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Quantitative Diffusion and Fat Imaging of the Spine|Quantitative Diffusion and Fat Imaging of Vertebral Fractures|Completed||N/A|21|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:28:15.509345|2017-02-18 15:28:15.509345
NCT00498485|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-05-18|2015-05-15||May 2007||2007-05-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||No info available|Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome|Phase IV - A Trial of Xyrem in the Treatment of Chronic Fatigue Syndrome.|Terminated||Phase 4|17|Actual|Rutgers, The State University of New Jersey|Too few subjects to get any definitive data. Based on the preliminary data analysis done with available subjects, we infer that had we completed the study, we might have found a significant effect for drug treated over placebo treated subjects.|2||Withdrawal of support.|f||||f||||||||No||2017-02-18 15:28:12.31893|2017-02-18 15:28:12.31893
NCT00498472|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2010-06-14|||July 2006||2006-07-01|July 2007|2007-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|BOT_AcuteHF||NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial|NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure (BOT-AcuteHF) Trial|Completed||Phase 4|330|Anticipated|Università degli Studi di Brescia||2|||f||||f||||||||||2017-02-18 15:28:12.739713|2017-02-18 15:28:12.739713
NCT00498459|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2016-03-01|||September 2002||2002-09-01|March 2016|2016-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|ICAPS||Intervention Centered on Adolescents' Physical Activity and Sedentary Behavior (ICAPS)|Intervention Centered on Adolescents' Physical Activity and Sedentary Behavior (ICAPS)|Completed||N/A|954|Actual|Louis Pasteur University, Strasbourg||2|||f||||t||||||||No||2017-02-18 15:28:12.870659|2017-02-18 15:28:12.870659
NCT00498446|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2013-06-18|||July 2002||2002-07-01|July 2007|2007-07-01|July 2004|Actual|2004-07-01|||||Observational|||Magnetic Resonance Imaging of Atrial Septal Defects|Imaging of Atrial Septal Defects by Velocity Encoded Cardiovascular Magnetic Resonance|Completed||N/A|44|Actual|Duke University|||||f||||f||||||||||2017-02-18 15:28:12.984147|2017-02-18 15:28:12.984147
NCT00498433|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2014-09-09|2013-03-21||June 2007||2007-06-01|September 2014|2014-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||"Part 1 : Baseline measures are on all patients.~Part 2: Randomized population of double-blind period used for Baseline/Demographic measurements."|Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension|Part 1: An Open Label Pilot Study to Determine Interstitial and Tissue Concentrations of Aliskiren and Effects on the Renin- Angiotensin System (RAS) in Fat and Skeletal Muscle of Hypertensive Patients With Abdominal Obesity. Part 2: A Randomized, Double Blind, 12-weeks Parallel Group Study to Compare Effects of Aliskiren 300 mg and Amlodipine 5 mg on the RAS and Lipid/Carbohydrate Metabolism in Fat and Skeletal Muscle of Hypertensive Patients With Abdominal Obesity|Terminated||Phase 2|46|Actual|Novartis||2||Early termination resulted from interim analysis of the ALTITUDE trial|f||||t||||||||||2017-02-18 15:28:13.077468|2017-02-18 15:28:13.077468
NCT00498420|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2016-09-01|||May 2007||2007-05-01|September 2016|2016-09-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Observational|HUE-MAN||The Natural History of Alpha-Mannosidosis|A Multicenter, Multinational Study That Will Evaluate Clinical and Surrogate Parameters Known to be Affected in Alpha-Mannosidosis Patients|Completed||N/A|45|Actual|Chiesi Farmaceutici S.p.A.|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 15:28:13.8681|2017-02-18 15:28:13.8681
NCT00498407|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2009-06-03|||May 2007||2007-05-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer|A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer|Completed||Phase 2|16|Actual|Clavis Pharma||1|||f||||f||||||||||2017-02-18 15:28:13.961493|2017-02-18 15:28:13.961493
NCT00498394|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2007-07-06|||June 2000||2000-06-01|July 2007|2007-07-01|October 2002|Actual|2002-10-01|||||Interventional|||Effects of a Ketogenic Diet on Body Weight and Cardiovascular Risk Factors|Effects of a Ketogenic Diet on Body Weight and Cardiovascular Risk Factors|Completed||Phase 1|103|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 15:28:14.073417|2017-02-18 15:28:14.073417
NCT00498381|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-08|2007-07-08|||August 2005||2005-08-01|February 2005|2005-02-01|August 2006|Actual|2006-08-01|||||Interventional|OSA||The Induction of IL-6 by NF-kB in PBMC in OSA||Completed||N/A|20|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 15:28:14.167386|2017-02-18 15:28:14.167386
NCT00498368|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2016-12-06|2016-09-28||February 2009||2009-02-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy|A Multicenter, Randomized, Prospective, Open-Label Trial of Rituximab in the Treatment of Progressive IgA Nephropathy|Completed||Phase 4|34|Actual|Mayo Clinic||2|||f||||t||||||||Undecided||2017-02-18 15:28:14.244915|2017-02-18 15:28:14.244915
NCT00498355|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2012-09-19|2012-06-20||July 2007||2007-07-01|September 2012|2012-09-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|LIME||Lucentis for Inflammatory Macular Edema Trial|Effect of Ranibizumab on Refractory Macular Edema in Uveitis|Completed||Phase 1/Phase 2|7|Actual|University of California, San Francisco|Limitations of the study include a small sample size and lack of a control group.|1|||f||||t||||||||||2017-02-18 15:28:14.644134|2017-02-18 15:28:14.644134
NCT00498342|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2008-02-11|||June 2007||2007-06-01|July 2007|2007-07-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease|The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease|Completed||N/A|||University of Vermont|||||f||||f||||||||||2017-02-18 15:28:14.999416|2017-02-18 15:28:14.999416
NCT00498329|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-07|2017-01-24|||July 3, 2007||2007-07-03|November 18, 2011|2011-11-18|November 18, 2011||2011-11-18|||||Observational|||Brain Function in Performance of Motor Tasks|Brain Connectivity and Sensorimotor Integration During Dual/Single Motor Tasks|Completed||N/A|144|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:28:15.101209|2017-02-18 15:28:15.101209
NCT00498316|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2016-10-27|||July 2007||2007-07-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Cord Blood Expansion on Mesenchymal Stem Cells|Cord Blood Expansion on Mesenchymal Stem Cells|Completed||Phase 1|98|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:28:15.197405|2017-02-18 15:28:15.197405
NCT00498303|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2008-04-21|||June 2007||2007-06-01|April 2008|2008-04-01||||||||Interventional|||Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008|A Phase III, Multicenter, Uncontrolled, Open-Label Study to Evaluate Safety and Immunogenicity of Preservative Free, Inactivated Split Influenza Vaccine, Using the Strain Composition 2007/2008 When Administered to Adult and Elderly Subjects|Completed||Phase 3|120||Novartis|||||f||||f||||||||||2017-02-18 15:28:15.32874|2017-02-18 15:28:15.32874
NCT00498264|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-09|2007-07-09|||January 2005||2005-01-01|June 2007|2007-06-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Effectiveness of Physical Exercise in Women With Fibromyalgia|Effectiveness of Physical Exercise on Decrease of Pain in Patients With Fibromyalgia:Randomized Clinical Trial|Unknown status|Recruiting|Phase 2|90|Anticipated|Federal University of São Paulo||3|||f||||t||||||||||2017-02-18 15:28:15.618127|2017-02-18 15:28:15.618127
NCT00498251|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2007-07-09|||September 2004||2004-09-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Prevention of Lung Edema After Thoracic Surgery|Does Inhaled Salbutamol Prevent Lung Edema After Thoracic Surgery? A Randomized Controlled Study|Completed||N/A|30|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 15:28:15.71171|2017-02-18 15:28:15.71171
NCT00498238|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2007-07-06|||July 2003||2003-07-01|July 2007|2007-07-01|September 2005|Actual|2005-09-01|||||Interventional|||The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism|The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients|Completed||N/A|34|Actual|Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:28:15.806524|2017-02-18 15:28:15.806524
NCT00498225|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2012-11-01|||July 2007||2007-07-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|July 2011|Actual|2011-07-01||Interventional|GEST||Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer|Randomized Phase III Study of Gemcitabine Versus TS-1 Versus Gemcitabine Plus TS-1 in Unresectable Advanced Pancreatic Cancer (With Local Progression or Metastasis)|Completed||Phase 3|834|Actual|Taiho Pharmaceutical Co., Ltd.||3|||f||||t||||||||||2017-02-18 15:28:15.879894|2017-02-18 15:28:15.879894
NCT00498212|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2016-11-08||2014-06-16|July 2007||2007-07-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease|A Phase 2, Single-Blind, Randomized Study of Safety and Immunogenicity Following Vaccination With Single or Double Doses of HEPLISAV™ in Adults With End-Stage Renal Disease|Terminated||Phase 2|41|Actual|Dynavax Technologies Corporation||2||"Voluntary halt of further dosing due to an FDA Clinical Hold issued in relation to Dynavax~   study DV2-HBV-10"|f||||t||||||||Undecided|a/o August 2016, decision pending.|2017-02-18 15:28:16.004941|2017-02-18 15:28:16.004941
NCT00498199|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2010-09-29|||April 2007||2007-04-01|July 2007|2007-07-01||||||||Observational|||Visual Impairment, Oscillopsia and Multiple Sclerosis|Visual Impairment, Oscillopsia and Multiple Sclerosis|Terminated||N/A|100|Anticipated|Hospices Civils de Lyon|||1||f||||||||||||||2017-02-18 15:28:16.123498|2017-02-18 15:28:16.123498
NCT00498186|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2014-09-24|2010-03-23||July 2003||2003-07-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)|An Open-label Extension Trial to Determine Safety and Tolerability of Long-term Transdermal Application of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|Completed||Phase 2|295|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:28:16.214017|2017-02-18 15:28:16.214017
NCT00498173|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2016-06-07|||July 2007||2007-07-01|June 2016|2016-06-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism|Targeted Pharmacologic Interventions for Autism: A Double-Blind, Placebo-Controlled Trial of Atomoxetine in Children and Adolescents With Autism|Completed||Phase 3|60|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 15:28:16.624615|2017-02-18 15:28:16.624615
NCT00498160|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2016-09-12|||January 2005||2005-01-01|September 2016|2016-09-01|December 2024|Anticipated|2024-12-01|June 2021|Anticipated|2021-06-01||Interventional|||Induction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusion|1) Induction of Donor Specific Tolerance in Recipients of Kidney Allografts by Donor Bone Marrow Cell Infusion (Deceased Donors) and 2) Induction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusion|Active, not recruiting||Phase 1/Phase 2|38|Actual|University of Louisville||1|||t||||t||||||||||2017-02-18 15:28:19.217001|2017-02-18 15:28:19.217001
NCT00498147|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2009-10-05|||July 2007||2007-07-01|October 2009|2009-10-01|July 2010|Anticipated|2010-07-01|March 2010|Anticipated|2010-03-01||Observational|DECIDE||Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program|Does Managed Diabetes Care Decrease Cardiovascular Complications of Diabetes?|Unknown status|Active, not recruiting|N/A|1213|Actual|Group Health Centre|||2||f||||f||||||||||2017-02-18 15:28:19.324029|2017-02-18 15:28:19.324029
NCT00498134|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2010-07-06|||March 2004||2004-03-01|July 2010|2010-07-01|April 2013|Anticipated|2013-04-01|||||Interventional|||Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway|Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway|Unknown status|Active, not recruiting|N/A|1200|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:28:19.438362|2017-02-18 15:28:19.438362
NCT00498121|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2009-12-17|||July 2007||2007-07-01|December 2009|2009-12-01|May 2009|Actual|2009-05-01|||||Observational|||The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP)|The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP)|Terminated||N/A|50|Anticipated|McGill University Health Center|||1|One of the principal investigators has moved to a different institution|f||||t||||||||||2017-02-18 15:28:19.529036|2017-02-18 15:28:19.529036
NCT00498108|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2014-09-24|||January 2006||2006-01-01|September 2009|2009-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects|An Open-label Extension Trial to Investigate the Safety and Tolerability of Long-term Treatment With Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|Completed||Phase 3|341|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 15:28:19.64171|2017-02-18 15:28:19.64171
NCT00498095|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2011-06-14|||July 2006||2006-07-01|June 2011|2011-06-01|December 2006|Actual|2006-12-01|||||Observational|||A Study on a New Staining Method (C4d Staining) of Transplanted Kidney Biopsies|Experience of C4d Staining in Renal Allograft Biopsies|Completed||N/A|52|Actual|Hospital Authority, Hong Kong|||1||f||||||||||||||2017-02-18 15:28:19.728621|2017-02-18 15:28:19.728621
NCT00498082|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2007-09-05|||September 2007||2007-09-01|September 2007|2007-09-01|September 2008|Anticipated|2008-09-01|||||Observational|||Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease|Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease|Unknown status|Recruiting|N/A|||Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||||f||||f||||||||||2017-02-18 15:28:19.808111|2017-02-18 15:28:19.808111
NCT00498069|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2015-03-17|||November 2007||2007-11-01|June 2014|2014-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Study of Autologous Bone Marrow Concentrate for the Treatment of Critical Limb Ischemia (CLI)|Feasibility Study of the Safety and Activity of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the Treatment of Critical Limb Ischemia Due to Peripheral Arterial Occlusive Disease|Completed||N/A|48|Actual|Harvest Technologies||2|||f||||f||||||||||2017-02-18 15:28:19.883891|2017-02-18 15:28:19.883891
NCT00498056|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2012-03-23||||||March 2012|2012-03-01||||||||Interventional|||Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa|A Phase IIB Test-of-Concept, Randomized, Double-Blind, Placebo-Controlled, International Clinical Trial to Evaluate the Efficacy, Safety, and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in HIV Uninfected Persons|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 15:28:19.995612|2017-02-18 15:28:19.995612
NCT00498043|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2014-08-12|||July 2007||2007-07-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|LNH2007-3B||A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma|Randomized Phase II Study of Two Associations of Rituximab and Chemotherapy, With a PET -Driven Strategy, in Patients From 18 to 59 With DLBCL CD20+ Lymphoma and 2 or 3 Adverse Prognostic Factors of the Age-adjusted IPI|Completed||Phase 2|222|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 15:28:20.107866|2017-02-18 15:28:20.107866
NCT00498030|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2010-04-14|||December 2005||2005-12-01|April 2010|2010-04-01|November 2009|Actual|2009-11-01|||||Observational|||Predicting Insulin Resistance in American Indian Youth|Predicting Insulin Resistance in American Indian Youth|Completed||N/A|202|Actual|University of Nebraska|||1||f||||t||||||Samples Without DNA|"~     Samples are only retained until specific tests are completed. Some tests are done in the~     clinical lab and some tests are done in the research lab.~   "|||2017-02-18 15:28:22.701133|2017-02-18 15:28:22.701133
NCT00498017|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2011-06-14|||July 2006||2006-07-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|||||Observational|||Infections After Renal Transplantation: Diseases Pattern in Hong Kong|Infections After Renal Transplantation: Diseases Pattern in Hong Kong|Completed||N/A|58|Anticipated|Hospital Authority, Hong Kong|||1||f||||||||||||||2017-02-18 15:28:22.78875|2017-02-18 15:28:22.78875
NCT00498004|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2008-11-03|||August 2007||2007-08-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Quality of Life (QOL) in Female Patient With Schizophrenia|Randomized, Open Label, 8-Week Study of Quetiapine and Risperidone on Quality of Life in Female With Schizophrenia|Terminated||Phase 4|100|Anticipated|Inje University||1||difficult to recruit subject|f||||t||||||||||2017-02-18 15:28:22.862345|2017-02-18 15:28:22.862345
NCT00497991|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2010-12-07|||May 2006||2006-05-01|December 2010|2010-12-01|April 2010|Actual|2010-04-01|October 2009|Actual|2009-10-01||Interventional|||Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia|A Phase I/II, Open Label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1152 in Patients With Acute Myeloid Leukaemia.|Completed||Phase 1|65|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 15:28:22.961702|2017-02-18 15:28:22.961702
NCT00497978|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2011-12-27|||March 2008||2008-03-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|TAUP||The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient|The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient|Completed||N/A|236|Actual|Medical Center Alkmaar||2|||f||||f||||||||||2017-02-18 15:28:23.054002|2017-02-18 15:28:23.054002
NCT00497965|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2010-04-16|||April 2007||2007-04-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pilot Study: Does Chiropractic Care Decrease Fall Risk in Older Adults|Pilot Study: Does Chiropractic Care Decrease Fall Risk in Older Adults?|Completed||N/A|30|Anticipated|Cleveland Chiropractic College||3|||f||||f||||||||||2017-02-18 15:28:23.169213|2017-02-18 15:28:23.169213
NCT00497952|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2016-11-30|||July 2007||2007-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis|Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis|Active, not recruiting||Phase 1/Phase 2|3|Actual|University of Louisville||1|||t||||t||||||||Undecided||2017-02-18 15:28:23.254641|2017-02-18 15:28:23.254641
NCT00497939|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2010-07-06|||January 2006||2006-01-01|July 2010|2010-07-01|March 2008|Anticipated|2008-03-01|||||Interventional|||The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients|The Effectiveness of Saw Palmetto and Sanmiaoshan on International Prostate Symptom Score and Peak Urinary Flow Rate of Chinese Patients With Benign Prostatic Hyperplasia|Unknown status|Recruiting|N/A|40|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:28:23.351456|2017-02-18 15:28:23.351456
NCT00497926|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2016-08-17|||March 2008||2008-03-01|August 2016|2016-08-01|March 2031|Anticipated|2031-03-01|March 2026|Anticipated|2026-03-01||Interventional|||Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion|Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion|Recruiting||Phase 2|60|Anticipated|University of Louisville||1|||f||||t||||||||||2017-02-18 15:28:23.440597|2017-02-18 15:28:23.440597
NCT00497913|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2008-04-22|||August 2007||2007-08-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|DCLE||Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis||Completed||Phase 3|52|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:28:23.545251|2017-02-18 15:28:23.545251
NCT00497900|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2015-06-02|||August 2007||2007-08-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|KarViDII||The Effect of Calcium and Vitamin D in Patients With Heart Failure||Completed||Phase 4|45|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-02-18 15:28:23.881376|2017-02-18 15:28:23.881376
NCT00497887|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2010-10-18|||December 2006||2006-12-01|January 2010|2010-01-01||||||||Observational|LE-Heart||Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study|Observational Study for Identification of Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study (LE-Heart)|Unknown status|Recruiting|N/A|4000|Anticipated|University of Leipzig|||1||f||||f||||||Samples With DNA|"~     serum, plasma, whole blood (DNA), blood cells~   "|||2017-02-18 15:28:23.998671|2017-02-18 15:28:23.998671
NCT00497874|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2015-07-10|2011-06-22||July 2003||2003-07-01|July 2015|2015-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||An Expert System to Reduce Depression in Primary Care|An Expert System to Reduce Depression in Primary Care|Completed||Phase 2|902|Actual|Pro-Change Behavior Systems|"There was only a single follow up assessment administered at 9 months post-baseline.~The study attrition rate was > 30%."|2|||f||||f||||||||||2017-02-18 15:28:24.085287|2017-02-18 15:28:24.085287
NCT00497861|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-07-06|||December 2004||2004-12-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Comparison of Activator Manipulation Versus Manual Side Posture Manipulation in Patients With Low Back Pain|Comparison of Mechanical Force, Manually Assisted Activator Manipulation Versus Manual Side Posture Manipulation in Patients With Low Back Pain: a Randomized Pilot Study|Completed||N/A|40|Actual|Cleveland Chiropractic College||2|||f||||f||||||||||2017-02-18 15:28:24.5774|2017-02-18 15:28:24.5774
NCT00497848|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2011-06-23|||May 2007||2007-05-01|July 2007|2007-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Compliance Project Concerning People With Schizophrenia|Individual Versus System Orientated Interventions in Handling Drug Related Problems in People With Schizophrenia|Completed||N/A|70|Actual|Ministry of the Interior and Health, Denmark||2|||f||||t||||||||||2017-02-18 15:28:24.668839|2017-02-18 15:28:24.668839
NCT00497835|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2011-06-14|||October 2007||2007-10-01|July 2007|2007-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Study of Algorithm for Epilepsy Alert Device|Epilepsy Alert Device - Epilert Performance|Completed||N/A|15|Actual|Biolert|||1||f||||t|||||||"~     no Biospecimen~   "|||2017-02-18 15:28:24.771646|2017-02-18 15:28:24.771646
NCT00497822|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2010-07-06|||January 2006||2006-01-01|July 2010|2010-07-01|October 2007|Anticipated|2007-10-01|||||Interventional|||A Randomized Controlled Trial on the Effect of Exercise on Physical, Cognitive and Affective Function in Dementia Subjects|To Study the Effect of Exercise Training in Term of Aerobic Exercise for 3 Months, on the Physical, Cognitive and Affective Function in Dementia Subjects|Unknown status|Recruiting|N/A|64|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:28:24.851104|2017-02-18 15:28:24.851104
NCT00497809|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2011-05-02|||August 2007||2007-08-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia|An Open-Label, Dose Finding, Prospective, Multi Center, Randomized, Parallel Group Study to Assess the Efficacy and Safety of Three Different Dose Levels of AVI 014 (G-CSF) Compared With a Standard Dose of Neupogen® in Breast Cancer Patients at High (>20%) Risk for Chemotherapy Induced Severe Neutropenia|Completed||Phase 2|189|Actual|AviGenics||4|||f||||t||||||||||2017-02-18 15:28:24.955505|2017-02-18 15:28:24.955505
NCT00497796|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2015-05-20|2015-05-04||July 2007||2007-07-01|March 2014|2014-03-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional||The Intent-to-Treat Safety (ITT-S) population, defined as all randomized subjects who received at least one dose of study drug, regardless of whether they had any post-baseline evaluations.|Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients|A Randomized, Double-blind Study To Assess The Efficacy And Safety Of Prophylactic Use Of Maribavir Versus Oral Ganciclovir For The Prevention Of Cytomegalovirus Disease In Recipients Of Orthotopic Liver Transplants|Completed||Phase 3|307|Actual|Shire||2|||f||||t||||||||||2017-02-18 15:28:25.113367|2017-02-18 15:28:25.113367
NCT00497783|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2008-05-19|||May 2007||2007-05-01|May 2008|2008-05-01||||||||Interventional|||Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)|Safety Dermatological Evaluation of the Acceptability With Gynecological Follow up for Dermacyd Femina Delicata|Completed||Phase 4|30|Anticipated|Sanofi||1|||f||||f||||||||||2017-02-18 15:28:26.414719|2017-02-18 15:28:26.414719
NCT00497770|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2012-04-27|2012-03-15||February 2007||2007-02-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed|Non-small Cell Lung Cancer: The Impact of Ethnic Origin on Patients Being Treated Second Line With Pemetrexed - An Observational Study|Completed||N/A|434|Actual|Eli Lilly and Company|This is an observational study, as such, the investigators followed the label recommendations and any changes to the label which occurred during the study.||4||f||||f||||||||||2017-02-18 15:28:26.503412|2017-02-18 15:28:26.503412
NCT00497757|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2016-11-23||2013-02-22|July 2003||2003-07-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|October 2011|Actual|2011-10-01||Interventional|||Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion|1) Induction of Donor-Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion 2) Induction of Donor-Specific Tolerance by Donor Facilitating Cell (FC): Stem Cell Infusion in Recipients of Hepatic Allografts|Completed||Phase 1/Phase 2|62|Actual|University of Louisville||2|||f||||t||||||||Undecided||2017-02-18 15:28:28.392359|2017-02-18 15:28:28.392359
NCT00497744|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2011-06-14|||November 2005||2005-11-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|||||Observational|||A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis|Research Study on the Pharmacokinetic Profile of Intraperitoneal Cefepime in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis|Completed||N/A|6|Anticipated|Hospital Authority, Hong Kong|||1||f||||||||||||||2017-02-18 15:28:28.487963|2017-02-18 15:28:28.487963
NCT00497731|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2009-06-19|||May 2005||2005-05-01|June 2009|2009-06-01|April 2009|Anticipated|2009-04-01|June 2008|Actual|2008-06-01||Interventional|||AZD1152 in Patients With Advanced Solid Malignancies-Study 1|A Phase I, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1152 Given as a 2 Hour Intravenous Infusion on Two Dose Schedules in Patients With Advanced Solid Malignancies|Terminated||Phase 1|70|Anticipated|AstraZeneca||1||"Efficacy seen in the solid tumour patient population was not sufficient to continue research~   with AZD1152 monotherapy in solid tumors at that time."|f||||f||||||||||2017-02-18 15:28:28.573777|2017-02-18 15:28:28.573777
NCT00497718|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2010-04-16|||February 2007||2007-02-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of Chiropractic Manipulation on Spine-related Pain and Balance in Older Adults|The Effect of Chiropractic Manipulation on Spine-related Pain and Balance in Older Adults|Completed||N/A|75|Anticipated|Cleveland Chiropractic College||1|||f||||f||||||||||2017-02-18 15:28:28.651735|2017-02-18 15:28:28.651735
NCT00497705|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2017-01-24|||July 3, 2007||2007-07-03|July 7, 2009|2009-07-07||||July 7, 2009|Actual|2009-07-07||Observational|||Genes Causing Ebstein's Anomaly|Genes Causing Congenital Ebstein's Anomaly|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:28:28.738956|2017-02-18 15:28:28.738956
NCT00497679|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2009-05-13|||August 2006||2006-08-01|May 2009|2009-05-01|July 2007|Actual|2007-07-01|||||Interventional|||AZD1152 in Patients With Advanced Solid Malignancies-Study 3|A Phase I, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1152 Given as a Continuous 7-Day Intravenous Infusion in Patients With Advanced Solid Malignancies|Terminated||Phase 1|45|Anticipated|AstraZeneca||1||"Study is now terminated due to technical difficulties with administration of study drug in~   this patient population with this schedule"|f||||f||||||||||2017-02-18 15:28:28.899913|2017-02-18 15:28:28.899913
NCT00497666|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-06|2007-07-06|||August 2007||2007-08-01|July 2007|2007-07-01|December 2007|Anticipated|2007-12-01|||||Observational|||Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study|Retrospective Study Evaluating the Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study|Unknown status|Not yet recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:28:28.97455|2017-02-18 15:28:28.97455
NCT00497653|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2011-11-15|||February 2001||2001-02-01|November 2011|2011-11-01|July 2009|Actual|2009-07-01|July 2007|Actual|2007-07-01||Interventional|PCOS||Oral Administration of DCI to Women With PCOS|Determination if Oral DCI Administration to Women With PCOS Increases Total DCI Content in Urine and Blood...|Terminated||Phase 2/Phase 3|13|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 15:28:29.06334|2017-02-18 15:28:29.06334
NCT00497640|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2016-01-14|||May 2007||2007-05-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|July 2008|Actual|2008-07-01||Interventional|||CPAP Titration Using an Artificial Neural Network: A Randomized Controlled Study|CPAP Titration Using an Artificial Neural Network: A Randomized Controlled Study|Withdrawn||N/A|0|Actual|State University of New York at Buffalo||1|||f||||t||||||||||2017-02-18 15:28:29.162691|2017-02-18 15:28:29.162691
NCT00497627|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2016-05-11|||January 2007||2007-01-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|January 2015|Actual|2015-01-01||Observational|||Quality of Life and Cardiometabolic Risk Factors in Patients After Debanding|Quality of Life and Cardiometabolic Risk Factors in Patients After Debanding|Completed||N/A|12|Actual|University of Zurich|||1||f||||f||||||||||2017-02-18 15:28:29.270718|2017-02-18 15:28:29.270718
NCT00497614|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2008-12-04|||May 2006||2006-05-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|PETRA||Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)|18F-FDG Positron Emission Tomography to Study the Response to Adalimumab in Rheumatoid Arthritis. A Monocentric Pilot Study|Completed||N/A|8|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-02-18 15:28:29.366341|2017-02-18 15:28:29.366341
NCT00497601|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2008-09-11|||February 2007||2007-02-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar|A Prospective, Single Center, Open-Label, Dose-Escalation Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Treatment Naïve Or Resistant Cases Of Visceral Leishmaniasis (Kala-Azar).|Completed||Phase 2|60|Actual|Banaras Hindu University||4|||f||||f||||||||||2017-02-18 15:28:29.478637|2017-02-18 15:28:29.478637
NCT00497588|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2013-07-10|||March 2007||2007-03-01|July 2013|2013-07-01|April 2014|Anticipated|2014-04-01|April 2014|Anticipated|2014-04-01||Interventional|||the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy||Unknown status|Recruiting|Phase 3|33|Anticipated|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:28:29.603447|2017-02-18 15:28:29.603447
NCT00497575|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-07-05|||October 1999||1999-10-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Observational|CHRO1||Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism||Completed||N/A|||Zhejiang University|||||f||||t||||||||||2017-02-18 15:28:29.719231|2017-02-18 15:28:29.719231
NCT00497562|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-07-05|||May 2004||2004-05-01|July 2007|2007-07-01|November 2005|Actual|2005-11-01|||||Interventional|||Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)|Exploratory Study to Investigate the Efficacy and Safety of Recombinant Growth Hormone as Add-on Treatment in Patients With Severe Fibromialgia|Completed||Phase 2|||Centro Medico Teknon||2|||f||||t||||||||||2017-02-18 15:28:29.794416|2017-02-18 15:28:29.794416
NCT00497549|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2011-05-09|||July 2004||2004-07-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|||Trial Comparing Side-to-Side Stapled and Hand-sewn Esophagogastric Anastomosis in Neck|Prospective Randomized Controlled Trial Comparing Side to Side Stapled and Hand Sewn Esophagogastric Anastomosis in the Neck|Completed||N/A|174|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||||||||||||2017-02-18 15:28:29.890016|2017-02-18 15:28:29.890016
NCT00497536|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2009-02-04|||July 2007||2007-07-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Pharmacokinetics of IAsp Following CSII in Patients With T1DM|Pharmacokinetics of Insulin Aspart (IAsp) Following Continuous Subcutaneous Insulin Infusion (CSII) in Patients With Type 1 Diabetes Mellitus (T1DM)- Basal Rate Resolution.|Completed||Phase 4|12|Anticipated|University of Aarhus||3|||f||||t||||||||||2017-02-18 15:28:30.002671|2017-02-18 15:28:30.002671
NCT00497523|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2015-03-18|||March 2006||2006-03-01|March 2015|2015-03-01|January 2007|Actual|2007-01-01|||||Interventional|||Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms|Double Blind, Multinational, Multicentre, Parallel-group, Placebo-controlled Design Trial of the Efficacy and Safety of Nebulised Beclometahsone Dipropionate (400 μg b.i.d.) Plus as Needed Salbutamol Versus as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination, in the 12-week Treatment of Young Children With Asthma Symptoms|Completed||Phase 3|283|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||||2017-02-18 15:28:30.117054|2017-02-18 15:28:30.117054
NCT00497510|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-07-05|||October 2006||2006-10-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Feasibility Study of Short-Term Effects of Chiropractic Manipulation on Older Adults With Impaired Balance|Feasibility Study of Short-Term Effects of Chiropractic Manipulation on Older Adults With Impaired Balance|Completed||N/A|11|Actual|Cleveland Chiropractic College||2|||f||||f||||||||||2017-02-18 15:28:30.252905|2017-02-18 15:28:30.252905
NCT00497497|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2011-02-15|||October 2007||2007-10-01|February 2011|2011-02-01||||||||Interventional|||A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)|A Phase Ib, Dose-Escalation Study of the Safety and Pharmacokinetics of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer|Completed||Phase 1|20|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:28:30.342322|2017-02-18 15:28:30.342322
NCT00497471|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-07-05|||February 1995||1995-02-01|July 2007|2007-07-01|July 1999|Actual|1999-07-01|||||Interventional|||RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants|The Prevention of Anaemia and Malaria in Infants in an Area of Intense and Perennial Malaria Transmission|Terminated||N/A|832|Actual|Hospital Clinic of Barcelona||4||Follow-up end in 1999|f||||t||||||||||2017-02-18 15:28:30.543512|2017-02-18 15:28:30.543512
NCT00497458|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2009-04-07|||July 2007||2007-07-01|April 2009|2009-04-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Interventional|ART2||Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects|Phase II Study of Testosterone Replacement in Women Experiencing Aromatase Inhibitor Side-Effects in Adjuvant Therapy for Breast Cancer|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|Chavah Pty Ltd||3|||f||||f||||||||||2017-02-18 15:28:30.647282|2017-02-18 15:28:30.647282
NCT00497445|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2009-11-05|||December 2005||2005-12-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|NETP-extra||The Value of Supervised Exercise Therapy After Invasive Treatment of Peripheral Arterial Disease|Additional Exercise Therapy in Patients With Peripheral Arterial Disease: The Value of Supervised Exercise Therapy After Invasive Treatment of Peripheral Arterial Disease.|Completed||N/A|86|Actual|Atrium Medical Center||2|||f||||f||||||||||2017-02-18 15:28:30.990287|2017-02-18 15:28:30.990287
NCT00497432|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2013-05-30|||July 2007||2007-07-01|May 2013|2013-05-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Observational|||Hyperbaric Oxygen Treatment in Patients With White Matter Hyperintensities|Hyperbaric Oxygen Treatment In Patients With White Matter Hyperintensities On Magnetic Resonance Imaging and Neurologic Deficits|Completed||Phase 2/Phase 3|20|Actual|St. Luke's Hospital, Chesterfield, Missouri|||1||f||||f||||||||||2017-02-18 15:28:31.09761|2017-02-18 15:28:31.09761
NCT00497419|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2008-08-19|||January 2007||2007-01-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Reperfusion Time in ST Segment Elevation Myocardial Infarction (STEMI)|Evaluation of a Fast Track for Patients With STEMI|Completed||N/A|150|Anticipated|University Hospital, Geneva||1|||f||||t||||||||||2017-02-18 15:28:31.188757|2017-02-18 15:28:31.188757
NCT00497406|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-03-14|||December 2005||2005-12-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia|A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Transfer Procedure and Intensity Modulated Radiation Therapy (Helical Tomotherapy) to Reduce Dryness of Mouth (Xerostomia) in Head and Neck Cancer Patients After Surgery|Active, not recruiting||N/A|46|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 15:28:31.280746|2017-02-18 15:28:31.280746
NCT00497393|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2008-09-11|||July 2007||2007-07-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Clinical Decision Unit (CDU) - Evaluation of a Novel Approach to Address Emergency Department Overcrowding|Clinical Decision Unit (CDU) - Evaluation of a Novel Approach to Address Emergency Department Overcrowding|Completed||Phase 4|6217|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 15:28:31.385526|2017-02-18 15:28:31.385526
NCT00497380|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2016-02-01|||April 2009||2009-04-01|February 2016|2016-02-01|February 2018|Anticipated|2018-02-01|July 2012|Actual|2012-07-01||Interventional|||Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery|Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery|Active, not recruiting||N/A|32|Anticipated|Texas A&M University||2|||f||||f||||||||||2017-02-18 15:28:31.496866|2017-02-18 15:28:31.496866
NCT00497367|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2015-03-25|||July 2007||2007-07-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|July 2008|Actual|2008-07-01||Interventional|||Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System|A Prospective, Single-arm, Multicenter 2-phase Feasibility Study to Assess the TAXUS Petal Paclitaxel-Eluting Bifurcation Coronary Stent System (TAXUS Petal)for the Treatment of de Novo Atherosclerotic Bifurcation Lesions|Completed||Phase 1|28|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 15:28:31.595934|2017-02-18 15:28:31.595934
NCT00497354|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2010-06-14|||July 2007||2007-07-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Does a Low Volume Ultrasound-Guided Technique Reduce Common Complications of Interscalene Brachial Plexus Block?|Does a Low Volume Ultrasound-Guided Technique Reduce Common Complications of Interscalene Brachial Plexus Block?|Completed||Phase 3|38|Anticipated|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 15:28:31.719086|2017-02-18 15:28:31.719086
NCT00497341|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2016-02-17|||January 2008||2008-01-01|February 2016|2016-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Antibiotic Prophylaxis in Total Knee Prosthesis|Randomised And Double Blind Study To Evaluate The Best Moment To Infuse The Prophylactic Antibiotic In Knee Arthroplasty Performed Under Ischemia|Completed||Phase 4|1332|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 15:28:31.806958|2017-02-18 15:28:31.806958
NCT00497328|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2014-01-13|||August 2007||2007-08-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|CONTRAST||COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT|An Open Labelled Randomized Multi-center Study of COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Incidence of Contrast Induced Nephropathy|Completed||Phase 2/Phase 3|477|Actual|National University Hospital, Singapore||3|||f||||t||||||||||2017-02-18 15:28:31.918184|2017-02-18 15:28:31.918184
NCT00497315|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2009-04-09|||February 2006||2006-02-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|PACCORA||Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|A Randomized Multicenter Phase II Study Of Induction Therapy With Pemetrexed And Cisplatin Followed By Chemoradiation With Pemetrexed Versus Chemoradiation With Pemetrexed Followed By Consolidation Therapy With Pemetrexed And Cisplatin In Patients With Stage III Non-Small Cell Lung Cancer: Paccora Trial|Completed||Phase 2|30|Actual|University Hospital, Antwerp||2|||f||||f||||||||||2017-02-18 15:28:32.032215|2017-02-18 15:28:32.032215
NCT00497302|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2013-03-01|||November 2004||2004-11-01|March 2013|2013-03-01|August 2009|Actual|2009-08-01|June 2008|Actual|2008-06-01||Interventional|HOME||Recovery Housing For Drug Dependent Pregnant Women|Recovery Housing For Drug Dependent Pregnant Women|Completed||Phase 2/Phase 3|128|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 15:28:32.14491|2017-02-18 15:28:32.14491
NCT00497289|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2011-06-08|||January 2006||2006-01-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants|Double-blind, Prospective, Randomized Comparison of a MCT/LCT/FO Containing 20% Lipid Emulsion With a MCT/LCT Emulsion (20%) for Parenteral Nutrition in Preterm Infants|Completed||Phase 2|34|Anticipated|B. Braun Melsungen AG||2|||f||||f||||||||||2017-02-18 15:28:32.252337|2017-02-18 15:28:32.252337
NCT00497276|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2009-12-18|||August 2007||2007-08-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Comparison of Ultrasound and Nerve Stimulation Technique for Continuous Sciatic Nerve Block|A Prospective, Randomized Comparison of Ultrasound Versus Nerve Stimulation Guidance of Popliteal, Sciatic Catheter Placement After Major Foot and Ankle Surgery: Clinical Outcome and Cost Analysis|Completed||N/A|100|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:28:32.36299|2017-02-18 15:28:32.36299
NCT00497263|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2011-06-28||||||June 2011|2011-06-01||||||||Interventional|||End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study||Completed||Phase 2|||Niti Medical Technologies Ltd.|||||f||||t||||||||||2017-02-18 15:28:32.474663|2017-02-18 15:28:32.474663
NCT00497250|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2008-10-20|||July 2007||2007-07-01|October 2008|2008-10-01|October 2009|Anticipated|2009-10-01|March 2009|Anticipated|2009-03-01||Interventional|||Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy|Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy|Unknown status|Recruiting|Phase 1|32|Anticipated|Fudan University||1|||f||||t||||||||||2017-02-18 15:28:32.55385|2017-02-18 15:28:32.55385
NCT00497237|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2010-04-21|||April 2007||2007-04-01|April 2010|2010-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|FORTE||Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma|Prospective, Randomised, Open-label, Multicentre, Active Drug Controlled, Parallel Group Design Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate 400 Mcg + Formoterol 24 Mcg pMDI Via HFA-134a (Foster™) vs. Fluticasone Propionate 500 Mcg + Salmeterol Xinafoate 100 Mcg DPI (Seretide Diskus®) in the 6 Months Stepdown Treatment of Adult Patients With Controlled Asthma|Completed||Phase 3|382|Anticipated|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-02-18 15:28:32.667696|2017-02-18 15:28:32.667696
NCT00497224|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2013-07-08|||November 2006||2006-11-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|December 2008|Actual|2008-12-01||Interventional|||Phase II Trial of Erlotinib in Advanced Pancreatic Cancer|Phase II Trial of Erlotinib in Advanced Pancreatic Cancer|Completed||Phase 2|51|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 15:28:32.808829|2017-02-18 15:28:32.808829
NCT00497211|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2007-07-05||||||July 2007|2007-07-01||||||||Interventional|||Intracoronary Infusion of BM-Derived Mononuclear Cells in Patients With Large Acute Myocardial Infarction||Unknown status|Recruiting|Phase 2/Phase 3|||University Hospital, Antwerp||2|||f||||f||||||||||2017-02-18 15:28:32.924252|2017-02-18 15:28:32.924252
NCT00497198|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2012-06-03|2011-07-14||October 2005||2005-10-01|June 2012|2012-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes|An Exploratory Study of MCI-196 for Treatment of Type 2 Diabetes in Randomized, Double-Blind, Parallel-Assignment, Placebo-Controlled Manner|Completed||Phase 2|183|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 15:28:33.004202|2017-02-18 15:28:33.004202
NCT00497185|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2011-11-11|||June 2007||2007-06-01|November 2011|2011-11-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Mindfulness-based Cognitive Therapy for Patients With Functional Disorders|Mindfulness-based Cognitive Therapy for Patients With Functional Disorders. A Randomized Controlled Trial|Completed||N/A|150|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:28:33.508457|2017-02-18 15:28:33.508457
NCT00497172|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2010-02-03|||January 2004||2004-01-01|February 2010|2010-02-01|April 2009|Actual|2009-04-01|March 2006|Actual|2006-03-01||Interventional|DESSERT||Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial|An Italian Multicenter, Randomized, Single Blind Study of the Sirolimus Eluting Stent in the Treatment Of Diabetic Patients With De Novo Coronary Artery Lesions|Completed||Phase 4|150|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 15:28:33.818014|2017-02-18 15:28:33.818014
NCT00497159|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-05-16||2015-05-16|July 2007||2007-07-01|May 2015|2015-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|DIMOND||A Study of the Novel Drug Dimebon in Patients With Huntington's Disease|A Multi-Center, Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study of Dimebon in Subjects With Huntington's Disease|Completed||Phase 2|91|Actual|Medivation, Inc.||2|||f||||t||||||||||2017-02-18 15:28:33.921038|2017-02-18 15:28:33.921038
NCT00497146|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-03-08|2011-09-22||February 2008||2008-02-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|September 2010|Actual|2010-09-01||Interventional|PRIMO||The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4|The PRIMO Study: Paricalcitol Capsules Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4|Completed||Phase 3|227|Actual|AbbVie||2|||f||||t||||||||||2017-02-18 15:28:34.044074|2017-02-18 15:28:34.044074
NCT00497133|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2008-06-03|||July 2007||2007-07-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes||Completed||N/A|20|Anticipated|University of Copenhagen|||2||f||||f||||||Samples With DNA|"~     Blood for further analyzes and buffy coat~   "|||2017-02-18 15:28:35.897196|2017-02-18 15:28:35.897196
NCT00497120|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2007-07-05||||||July 2007|2007-07-01||||||||Interventional|||A Combined Surgical and Medical Approach in Mild Sleep Apnea||Unknown status|Recruiting|N/A|||University Hospital, Antwerp|||||f||||||||||||||2017-02-18 15:28:35.981557|2017-02-18 15:28:35.981557
NCT00497107|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2008-07-30|||July 2007||2007-07-01|July 2008|2008-07-01|May 2013|Anticipated|2013-05-01|||||Interventional|ICOG||Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer|Phase III Randomized Controlled Clinical Study of UFT/LV Therapy Versus UFT/LV + PSK Therapy as Postoperative Adjuvant Therapy for Histological Stage IIIa and IIIb Colorectal Cancer|Unknown status|Recruiting|Phase 3|300|Anticipated|Iwate Medical University||2|||f||||t||||||||||2017-02-18 15:28:36.073059|2017-02-18 15:28:36.073059
NCT00497094|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2013-02-27|||March 2004||2004-03-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|June 2010|Actual|2010-06-01||Interventional|||Stenting Versus Best Medical Treatment of Asymptomatic High Grade Carotid Artery Stenosis|Stenting vs. Best Medical Treatment of Asymptomatic High Grade Carotid Artery Stenosis - a Randomized Controlled Trial|Completed||N/A|148|Actual|Vienna General Hospital||2|||f||||f||||||||||2017-02-18 15:28:36.185068|2017-02-18 15:28:36.185068
NCT00497081|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2014-12-12|2014-10-07||May 2007||2007-05-01|December 2014|2014-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors|Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors|Completed||Phase 2|60|Actual|San Francisco Department of Public Health||2|||f||||t||||||||||2017-02-18 15:28:36.298649|2017-02-18 15:28:36.298649
NCT00497068|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2013-03-01|||January 2005||2005-01-01|March 2013|2013-03-01|June 2010|Actual|2010-06-01|September 2009|Actual|2009-09-01||Interventional|ROSE||Tobacco Use in Opioid Agonist Treated Pregnant Women|Tobacco Use in Opioid Agonist Treated Pregnant Women|Completed||Phase 2/Phase 3|210|Anticipated|Johns Hopkins University||3|||f||||f||||||||||2017-02-18 15:28:36.722566|2017-02-18 15:28:36.722566
NCT00497055|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2014-02-05|2012-12-12||March 2009||2009-03-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals|Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals|Completed||Phase 2|90|Actual|San Francisco Department of Public Health||2|||f||||t||||||||||2017-02-18 15:28:36.825174|2017-02-18 15:28:36.825174
NCT00497042|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2007-07-10||||||July 2007|2007-07-01||||||||Interventional|||Safety and Efficacy of Using the Endodontic Self Adjusting File - SAF for Root Canal Treatment|Safety and Efficacy of Using the Endodontic Self Adjusting File - SAF for Root Canal Treatment|Unknown status|Not yet recruiting|N/A|100|Anticipated|ReDent Nova||1|||f||||t||||||||||2017-02-18 15:28:37.284507|2017-02-18 15:28:37.284507
NCT00497029|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-07-05|||June 2004||2004-06-01|July 2007|2007-07-01|August 2006|Actual|2006-08-01|||||Interventional|||Early Childhood Caries Prevention at a Pediatric Clinic||Completed||N/A|219|Actual|University of Maryland Baltimore Dental School||1|||f||||f||||||||||2017-02-18 15:28:37.434437|2017-02-18 15:28:37.434437
NCT00497016|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2008-09-29|||May 2007||2007-05-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|||||Interventional|||Does Statin Therapy Reduce Sympathoexcitation in Hypertension?|Does Statin Therapy Reduce Sympathoexcitation in Hypertension?|Completed||N/A|13|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 15:28:37.532291|2017-02-18 15:28:37.532291
NCT00497003|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-10-12|||February 2004||2004-02-01|July 2007|2007-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Effect of Beta Blocker Treatment on Endothelial Function in Patients With Type 2 Diabetes or Chronic Heart Failure||Completed||Phase 4|50|Actual|Bispebjerg Hospital||3|||f||||f||||||||||2017-02-18 15:28:37.616865|2017-02-18 15:28:37.616865
NCT00496990|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2013-03-01|||October 2005||2005-10-01|March 2013|2013-03-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|HOPE||Treating the Partners of Drug Using Pregnant Women: Stage II|Treating the Partners of Drug Using Pregnant Women: Stage II|Completed||Phase 2/Phase 3|158|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 15:28:37.711436|2017-02-18 15:28:37.711436
NCT00496977|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2007-07-05|||October 2004||2004-10-01|June 2007|2007-06-01|January 2010|Anticipated|2010-01-01|||||Interventional|DLCST||Danish Lung Cancer Screening Trial (DLCST)|Screening for Lung Cancer. A Randomised Controlled Trial of Low-Dose CT-Scanning.|Unknown status|Active, not recruiting|N/A|4104|Actual|Danish Lung Cancer Group||2|||f||||t||||||||||2017-02-18 15:28:37.849039|2017-02-18 15:28:37.849039
NCT00496964|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2011-04-22|2011-03-14||May 2005||2005-05-01|April 2011|2011-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Botox for Non-surgical Lateral Release in Patellofemoral Pain|Botox for Non-surgical Lateral Release in Patellofemoral Pain|Terminated||Phase 3|5|Actual|Virginia Commonwealth University|Early termination due to small number of subjects. No statistical analysis of data due to small number of subjects.|2||Insufficient recruitment in a reasonable time + expiration of study medication|f||||f||||||||||2017-02-18 15:28:37.933431|2017-02-18 15:28:37.933431
NCT00496951|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2013-02-20|||September 2006||2006-09-01|February 2013|2013-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|NAS||Vagal Tone and Neonatal Abstinence Syndrome|Vagal Tone and Neonatal Abstinence Syndrome|Completed||N/A|65|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 15:28:38.346528|2017-02-18 15:28:38.346528
NCT00496938|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-05-12|||July 2007||2007-07-01|May 2015|2015-05-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|||XIENCE V: SPIRIT WOMEN|A Clinical Evaluation of the XIENCE Everolimus Eluting Coronary Stent System in the Treatment of Women With de Novo Coronary Artery Lesions|Completed||Phase 4|1600|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 15:28:38.439811|2017-02-18 15:28:38.439811
NCT00496925|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2010-01-31|||November 2007||2007-11-01|January 2010|2010-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Examining the Usage of Dopamine Blockers in OCD Patients|Examining the Usage of Dopamine Blockers in OCD Patients|Completed||N/A|63|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:28:41.222613|2017-02-18 15:28:41.222613
NCT00496899|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-04|2008-05-08|||June 2007||2007-06-01|July 2007|2007-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|CLM||Clinical Evaluation of New Computerized Labor Monitoring System|Clinical Evaluation of New Computerized Labor Monitoring System.|Terminated||N/A|3|Actual|Barnev Ltd|||1|The study was stopped prematurally due to low recruiting|f||||f||||||||||2017-02-18 15:28:41.302865|2017-02-18 15:28:41.302865
NCT00496886|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-05|2015-10-01|||April 2006||2006-04-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Observational|||Determining How the Nervous System Processes Pain in Adults With Fibromyalgia|Imaging the Cognitive Modulation of Pain|Completed||N/A|137|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 15:28:41.395874|2017-02-18 15:28:41.395874
NCT00496873|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-07-13|2016-07-13||June 2005||2005-06-01|July 2016|2016-07-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan|"A Single-Center, Open-Label Study to Evaluate the Safety and Efficacy of Nipent, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated and Treated, Stage III or IV, Low-Grade B-Cell Non-Hodgkin's Lymphoma or Bulky Lymphoma"|Completed||Phase 2|100|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:28:41.490189|2017-02-18 15:28:41.490189
NCT00496860|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-07-17|2013-04-02||May 2007||2007-05-01|July 2013|2013-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies|Phase I Study of ALT-801 in Patients With Progressive Metastatic Malignancies|Completed||Phase 1|26|Actual|Altor Bioscience Corporation||1|||f||||t||||||||||2017-02-18 15:28:42.011924|2017-02-18 15:28:42.011924
NCT00493701|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-01-22|||October 2010||2010-10-01|January 2016|2016-01-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Interventional|||"ADAPT The Adaptation to High Fat Diets Extention"|ADAPT-The Adaptation to High Fat Diets|Active, not recruiting||N/A|65|Anticipated|Pennington Biomedical Research Center||2|||f||||t||||||||||2017-02-18 15:29:44.750262|2017-02-18 15:29:44.750262
NCT00496847|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2014-12-15|||August 2007||2007-08-01|November 2009|2009-11-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect|Study on the Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect - A Double-blind, Controlled, Randomised,Parallel,Multi-centre Study|Completed||Phase 3|60|Actual|Virchow Group||2|||f||||f||||||||||2017-02-18 15:28:42.858214|2017-02-18 15:28:42.858214
NCT00496834|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-10-19|2010-08-26||February 2008||2008-02-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)|A Randomized, Open-label, Comparative, Non-inferiority, Multicenter Study to Compare Efficacy of Losartan Potassium Group and Carvedilol Group on Arterial Stiffness in Essential Hypertension Patients|Completed||Phase 4|201|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:28:42.961047|2017-02-18 15:28:42.961047
NCT00496821|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2007-11-29|||July 2007||2007-07-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus|A Study to Investigate the Safety and Efficacy of Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus|Completed||Phase 2|88|Anticipated|Alnylam Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:28:43.587626|2017-02-18 15:28:43.587626
NCT00496808|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2012-04-19|2011-06-27||March 2005||2005-03-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast|Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast|Completed||N/A|69|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:28:43.66673|2017-02-18 15:28:43.66673
NCT00496795|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-05-18|||September 2007||2007-09-01|May 2016|2016-05-01|May 2026|Anticipated|2026-05-01|May 2016|Actual|2016-05-01||Interventional|MEDOBREC||Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer|Molecular Markers Predictive Response to Dose Dense Chemotherapy With Epirubicin and Docetaxel in Sequences for Locally Advanced Breast Cancer.|Active, not recruiting||Phase 2|100|Anticipated|University of Bergen||1|||f||||f||||||||||2017-02-18 15:28:44.123628|2017-02-18 15:28:44.123628
NCT00496782|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2010-11-10|2009-06-23||July 2007||2007-07-01|March 2010|2010-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay|Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study|Terminated||Phase 1|16|Actual|ViiV Healthcare|Study terminated prematurely due to slow enrollment. Premature termination of study was not due to any safety concerns. Efficacy data not summarized due to low sample size; only safety was summarized.|1||See Detailed Description|f||||f||||||||||2017-02-18 15:28:44.245166|2017-02-18 15:28:44.245166
NCT00496769|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-03-01|2013-08-01||August 2007||2007-08-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|November 2010|Actual|2010-11-01||Interventional|AVERROES||A Phase III Study of Apixaban in Patients With Atrial Fibrillation|Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial|Active, not recruiting||Phase 3|6421|Actual|Bristol-Myers Squibb|On May 28, 2010, after a planned interim analysis for efficacy, the Data Monitoring Committee recommended early termination due to apixaban's superior efficacy over ASA, with an acceptable safety profile. The open-label phase is ongoing.|2|||f||||t||||||||||2017-02-18 15:28:44.856261|2017-02-18 15:28:44.856261
NCT00496756|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-05-10|||March 2007||2007-03-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|October 2009|Actual|2009-10-01||Interventional|||Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Phase II Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|14|Actual|University of Nebraska||1||Low accrual rate.|f||||t||||||||||2017-02-18 15:28:48.197142|2017-02-18 15:28:48.197142
NCT00496743|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2007-07-02|||January 2002||2002-01-01|July 2007|2007-07-01|January 2006|Actual|2006-01-01|||||Interventional|||Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides|A Prospective, Open-Label Study on Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides|Terminated||N/A|10|Actual|Bispebjerg Hospital||||The study was discontinued after the first 10 patients because of discouraging results.|f||||f||||||||||2017-02-18 15:28:48.30985|2017-02-18 15:28:48.30985
NCT00496730|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2015-11-19|2009-09-03||July 2007||2007-07-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)|A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea|Completed||Phase 3|256|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:28:48.392442|2017-02-18 15:28:48.392442
NCT00496717|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2011-07-27|||July 2007||2007-07-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Aorta Calcium Scoring|Measurement of an Abdominal Aorta Calcium Scoring and Its Correlation With Cardiovascular Risk Factors|Completed||N/A|60|Anticipated|University Hospital, Strasbourg, France|||1||f||||||||||||||2017-02-18 15:28:48.896951|2017-02-18 15:28:48.896951
NCT00496704|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2009-08-20|||January 2007||2007-01-01|August 2009|2009-08-01||||August 2009|Anticipated|2009-08-01||Interventional|||Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan|A Phase I/II Study to Determine the Safety and Efficacy of Second-Line Treatment With XELOX Plus Gemcitabine in Irinotecan Pre-Treated Advanced Colorectal Cancer Patients|Unknown status|Recruiting|Phase 1/Phase 2|56|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:28:48.990087|2017-02-18 15:28:48.990087
NCT00496691|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-05-19|||April 2002||2002-04-01|January 2015|2015-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||HIV Prevention for Youth With Severe Mental Illness|HIV Prevention for Youth With Severe Mental Illness|Completed||Phase 1|718|Actual|Rhode Island Hospital||3|||f||||t||||||||||2017-02-18 15:28:49.086323|2017-02-18 15:28:49.086323
NCT00496678|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-08-06|||April 2007||2007-04-01|December 2007|2007-12-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Trial of Patient Navigation-Activation|RCT of Primary Care-based Patient Navigation-Activation|Completed||Phase 4|900|Anticipated|University of Rochester||2|||f||||f||||||||||2017-02-18 15:28:49.177926|2017-02-18 15:28:49.177926
NCT00492414|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2007-08-07||||||March 2007|2007-03-01||||||||Interventional|||Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release||Unknown status|Recruiting|Phase 4|||Inje University|||||f||||||||||||||2017-02-18 15:30:14.272793|2017-02-18 15:30:14.272793
NCT00496665|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-11-14|||July 2007||2007-07-01|November 2013|2013-11-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Interventional|||ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer|A Phase I Study of ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer|Completed||Phase 1|25|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:28:49.28802|2017-02-18 15:28:49.28802
NCT00496652|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-11-22|||November 2007||2007-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|July 2012|Actual|2012-07-01||Interventional|||DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC|DAHANCA 19: A Randomized Study of the Importance of the EGFr-Inhibitor Zalutumumab for the Outcome After Primary Curative Radiotherapy for Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|619|Actual|Danish Head and Neck Cancer Group||2|||f||||t||||||||||2017-02-18 15:28:49.403364|2017-02-18 15:28:49.403364
NCT00496639|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2008-05-21|||October 2006||2006-10-01|May 2008|2008-05-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long-Term Outcomes|Stent vs. Angioplasty for Treatment of Thrombosed AV Grfats: Long-Term Outcomes|Unknown status|Recruiting|N/A|130|Anticipated|National Kidney Foundation||1|||f||||f||||||||||2017-02-18 15:28:49.508571|2017-02-18 15:28:49.508571
NCT00496626|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-09-11|2010-02-08||July 2008||2008-07-01|September 2015|2015-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)|An Immunogenicity and Safety Study of Quadrivalent HPV (Types 6, 11, 16, 18) Virus-Like Particle (VLP) Vaccine in Chinese Female Subjects Aged 9 to 45 Years and Male Subjects Aged 9 to 15 Years|Completed||Phase 3|600|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:28:49.614995|2017-02-18 15:28:49.614995
NCT00496613|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-07-25|||June 2007||2007-06-01|July 2016|2016-07-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors|Chemotherapy-Induced Cognitive Change and DNA Damage in Breast Cancer Survivors|Active, not recruiting||N/A|200|Anticipated|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 15:28:50.115726|2017-02-18 15:28:50.115726
NCT00496600|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2012-06-13|||July 2007||2007-07-01|June 2012|2012-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Phase I Study of Patupilone and RAD001|Phase I Study of Patupilone and RAD001 in Patients With Refractory Solid Tumor Malignancy|Completed||Phase 1|42|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 15:28:50.218285|2017-02-18 15:28:50.218285
NCT00496587|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-05-09|||July 2007||2007-07-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma|Phase II Safety and Efficacy Study of Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Metastatic or Unresectable Sarcomatoid Renal Cell Carcinoma|Completed||Phase 2|34|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:28:50.387937|2017-02-18 15:28:50.387937
NCT00496574|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-02-06|||May 2006||2006-05-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma|Evaluation of Long-term Clinical Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma|Unknown status|Recruiting|Phase 4|60|Anticipated|Medical Universtity of Lodz||2|||f||||t||||||||||2017-02-18 15:28:50.503938|2017-02-18 15:28:50.503938
NCT00496561|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-02-06|||August 2006||2006-08-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Effect of Specific Immunotherapy to Dust Mites in Children With Asthma|Evaluation of Early Clinical and Immunological Efficacy of Specific Immunotherapy to Dust Mites in Children With Asthma|Unknown status|Recruiting|Phase 4|80|Anticipated|Medical Universtity of Lodz||2|||f||||t||||||||||2017-02-18 15:28:50.609414|2017-02-18 15:28:50.609414
NCT00496548|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-05-06|||August 2007||2007-08-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity|Urinary PGE-M, A Metabolite of PGE2: A Novel Biomarker of Crohn's Disease Activity|Active, not recruiting||N/A|30|Anticipated|Vanderbilt University||1|||f||||t||||||||||2017-02-18 15:28:50.878023|2017-02-18 15:28:50.878023
NCT00496535|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2012-02-22||||||May 2011|2011-05-01||||||||Interventional|||A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer|"A Phase I/II Safety, Tolerability, and Proof of Concept Study of TNFerade™ Biologic in Combination With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) for Patients With Unresectable Recurrent Head and Neck Cancer"|Completed||Phase 1/Phase 2|||GenVec|||||||||||||||||||2017-02-18 15:28:50.977007|2017-02-18 15:28:50.977007
NCT00496522|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-07-27|||April 2006||2006-04-01|July 2016|2016-07-01||||April 2017|Anticipated|2017-04-01||Interventional|||Proton Beam Therapy for Chondrosarcoma|Phase II Evaluation of Proton Beam Therapy for Skull Base Chondrosarcoma|Active, not recruiting||Phase 2|15|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:28:51.068776|2017-02-18 15:28:51.068776
NCT00496509|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-08-25|||August 2006||2006-08-01|August 2016|2016-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer|A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients With Advanced Colorectal Cancer and Liver Metastases|Completed||Phase 1|24|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:28:51.176198|2017-02-18 15:28:51.176198
NCT00496483|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2015-06-25|2014-05-29||July 2007||2007-07-01|June 2015|2015-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients|A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Kidney Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf® Capsules Twice-A-Day|Completed||Phase 2|60|Actual|Veloxis Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:28:51.289462|2017-02-18 15:28:51.289462
NCT00496470|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2012-10-10|2009-06-15||May 2007||2007-05-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.|A 12-week, Double-blind, Randomised, Parallel Group, Multi-centre, Study to Evaluate Efficacy and Safety of Budesonide/Formoterol (Symbicort Turbuhaler®) 320/9 µg One Inhalation Twice Daily on Top of Tiotropium (Spiriva®) 18 µg One Inhalation Once Daily|Completed||Phase 4|660|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:28:51.707325|2017-02-18 15:28:51.707325
NCT00496457|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2016-11-21|||May 2007||2007-05-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy|A Double-Blind, Randomized, Multicenter Study With 500 mg QD of TRO19622 Versus Placebo in Patients With Painful Peripheral Diabetic Neuropathy|Completed||Phase 2|159|Actual|Hoffmann-La Roche||2|||f||||f||||||||||2017-02-18 15:28:52.960274|2017-02-18 15:28:52.960274
NCT00496444|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2012-07-31|||May 2005||2005-05-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Azacytidine and Valproic Acid in Patients With Advanced Cancers|Phase I Study of Low-Dose Hypomethylating Agent Azacitidine Combined With the Histone Deacetylase Inhibitor Valproic Acid in Patients With Advanced Cancers|Completed||Phase 1|69|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:28:53.293167|2017-02-18 15:28:53.293167
NCT00496431|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-05-23|||May 2007||2007-05-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients|Phase II Study of the Histone-deacetylase Inhibitor ITF2357 in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients|Terminated||Phase 1/Phase 2|19|Actual|Italfarmaco||1||"ITF2357 (Givinostat) was well tollerated but had limited activity against refractory/relapsed~   HL"|f||||t||||||||||2017-02-18 15:28:53.419533|2017-02-18 15:28:53.419533
NCT00496418|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-01-12|||July 2007||2007-07-01|January 2015|2015-01-01|November 2014|Actual|2014-11-01|September 2011|Actual|2011-09-01||Interventional|||Peristomal Mesh for Prophylaxis of Parastomal Hernia|Randomized Controlled Open Interventional Study for Evaluation of Use of Peristomal Mesh for Prophylaxis of Parastomal Hernia|Completed||Phase 3|60|Actual|Oslo University Hospital||2|||f||||||||||||||2017-02-18 15:28:53.543286|2017-02-18 15:28:53.543286
NCT00496405|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2007-10-11|||April 2007||2007-04-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Unilateral Bevacizumab for Bilateral Diabetic Macular Edema|The Role of Unilateral Intravitreal Bevacizumab (Avastin), for the Treatment of Bilateral Diabetic Macular Edema: a Pilot Study.|Completed||Phase 4|13|Anticipated|Asociación para Evitar la Ceguera en México||2|||f||||f||||||||||2017-02-18 15:28:53.641583|2017-02-18 15:28:53.641583
NCT00496392|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2012-05-04|||January 2007||2007-01-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)|An Open Label, Comparative, Randomised, Balanced Crossover Trial Comparing Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq®) in Breakthrough Pain in Patients With Cancer|Completed||Phase 3|115|Anticipated|Nycomed||1|||f||||t||||||||||2017-02-18 15:28:53.750829|2017-02-18 15:28:53.750829
NCT00496379|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-03-12|2012-11-30||July 2007||2007-07-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|October 2009|Actual|2009-10-01||Interventional|||ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases|A Phase 2 Study of ZK219477 (ZK-EPO) in Patients With Breast Cancer and Brain Metastases|Terminated||Phase 2|15|Actual|Dana-Farber Cancer Institute||1||This study has closed to accrual early due to slow accrual.|f||||f||||||||||2017-02-18 15:28:53.856337|2017-02-18 15:28:53.856337
NCT00496366|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2017-02-02|||July 2007||2007-07-01|February 2017|2017-02-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer|Phase II Trial of Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in Patients With HER2/Neu-Overexpressing Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 2|11|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 15:28:54.164239|2017-02-18 15:28:54.164239
NCT00496353|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2015-03-30|||June 2007||2007-06-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)|A Phase I/II Dose Escalation and Proof-of-Concept Study of MK2461 in Patients With Advanced Solid Tumors|Completed||Phase 1/Phase 2|26|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:28:54.272839|2017-02-18 15:28:54.272839
NCT00496340|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2014-05-30|2014-03-27||July 2007||2007-07-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|April 2013|Actual|2013-04-01||Interventional|Pento & tBU|All participants. Bone marrow chimerism data were available for only 38 patients at day +28 and for only 36 patients at day +100.|Phase II Trial of Pentostatin and Targeted Busulfan|Phase II Trial of Pentostatin and Targeted Busulfan as a Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation Using Laboratory-Guided (CD4-guided) Immunosuppression.|Completed||Phase 2|42|Actual|H. Lee Moffitt Cancer Center and Research Institute|Bone marrow chimerism data were available for only 38 patients at day +28 and for only 36 patients at day +100.|1|||f||||f||||||||||2017-02-18 15:28:54.369458|2017-02-18 15:28:54.369458
NCT00496327|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-04-15|||June 2005||2005-06-01|April 2015|2015-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)|Evaluation of Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX (V210)in Healthy Indian Children|Completed||Phase 3|100|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:28:54.803744|2017-02-18 15:28:54.803744
NCT00496314|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2008-06-13|||May 2007||2007-05-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|||||Observational|||Physician's Comfort Level and Satisfaction Study With The e2TM Collector Compared to the Spatula/CytoBrush Technique|Clinical Study Assessing Physician's Comfort Level and Satisfaction When Using The e2TM Cervical Cell Collector Compared to the Standard Spatula/CytoBrush Technique|Terminated||N/A|30|Anticipated|CytoCore, Inc.|||1|Terminated for lack of resources to complete.|f||||f||||||||||2017-02-18 15:28:54.889481|2017-02-18 15:28:54.889481
NCT00496301|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2009-01-13|||November 2006||2006-11-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|SOGUG-02-06||Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC|Phase II Clinical Trial, Non-Randomized, Multicentre, on the Combination of Gemcitabine, Capecitabine and Sorafenib (Bay 43-9006) in Treatment of Patients With Unresectable and/or Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 2|40|Anticipated|Spanish Oncology Genito-Urinary Group||1|||f||||t||||||||||2017-02-18 15:28:54.971743|2017-02-18 15:28:54.971743
NCT00496288|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2011-04-04|||March 2008||2008-03-01|June 2008|2008-06-01||||March 2023|Anticipated|2023-03-01||Interventional|||Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer|Phase II Multicenter Clinical Trial of Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer|Recruiting||Phase 2|240|Anticipated|Assaf-Harofeh Medical Center||2|||f||||t||||||||||2017-02-18 15:28:55.080851|2017-02-18 15:28:55.080851
NCT00496275|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-08-25|||August 2006||2006-08-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC|A Phase I, Open Label Study to Assess the Safety and Tolerability of ZD6474 (ZACTIMA) in Combination With Vinorelbine (Navelbine) or Gemcitabine (Gemzar) Plus Cisplatin as First Line Therapy in Patients With Locally Advanced or Metastatic (Stage IIIB-IV) Non Small Cell Lung Cancer.|Completed||Phase 1|17|Actual|Sanofi|||||f||||f||||||||||2017-02-18 15:28:55.202735|2017-02-18 15:28:55.202735
NCT00496262|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-07-27|2009-05-19||July 2007||2007-07-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Human Fibrinogen - Pharmacokinetics|Pharmacokinetics of Haemocomplettan® P in Subjects With Congenital Fibrinogen Deficiency|Completed||Phase 2|15|Actual|CSL Behring||1|||f||||f||||||||||2017-02-18 15:28:55.287382|2017-02-18 15:28:55.287382
NCT00496249|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-12-21|||July 2007||2007-07-01|December 2015|2015-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer|The Effect of Radiation on Semen Quality and Fertility in Men Treated With External Beam Radiation or Brachytherapy for Early Stage Prostate Cancer|Completed||N/A|19|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 15:28:55.736635|2017-02-18 15:28:55.736635
NCT00496236|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2012-02-22||||||May 2011|2011-05-01||||||||Interventional|||Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer|"A Phase I/II Safety, Tolerability and Proof of Concept Study of Radiotherapy, Cetuximab, and Intratumoral Injections of TNFerade™ Biologic (AdGVEGR.TNF.11D) for Elderly or Frail Patients or Intermediate Stage Patients With Head and Neck Cancer"|Completed||Phase 1/Phase 2|||GenVec|||||||||||||||||||2017-02-18 15:28:55.817757|2017-02-18 15:28:55.817757
NCT00496223|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2011-02-21|||September 2006||2006-09-01|February 2011|2011-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Phase I/II Study of Sunitinib and Dacarbazine|A Phase I/II Study of Sunitinib and Dacarbazine in Patients With Metastatic Melanoma|Terminated||Phase 1/Phase 2|11|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||toxicities required dose reduction compromising effectiveness and PI left Moffitt|f||||t||||||||||2017-02-18 15:28:55.912451|2017-02-18 15:28:55.912451
NCT00496210|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2017-01-24|||June 27, 2007||2007-06-27|December 7, 2015|2015-12-07|December 7, 2015||2015-12-07|||||Observational|||Predictors of Caregiver Adaptation to Pervasive Developmental Disorders|Understanding Caregiver Adaptation to Pervasive Developmental Disorders|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:28:56.027833|2017-02-18 15:28:56.027833
NCT00496197|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2011-08-29|2011-05-12||July 2007||2007-07-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis|Phase IV Open Label Non Comparative Trial Of IV Anidulafungin Followed By Oral Azole Therapy For The Treatment Of Candidemia And Invasive Candidiasis|Completed||Phase 4|282|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 15:28:56.151766|2017-02-18 15:28:56.151766
NCT00496184|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2008-05-02|||April 2006||2006-04-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis|Topical Application of Nifedipine Cream for the Treatment of Vulvar Vestibulitis Syndrome|Completed||Phase 3|30|Anticipated|Western Galilee Hospital-Nahariya||3|||f||||f||||||||||2017-02-18 15:28:57.159286|2017-02-18 15:28:57.159286
NCT00496171|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2009-01-15||||||January 2009|2009-01-01||||||||Observational|||Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers|A Phase I Hexaminolevulinate (HAL) Dose-Finding Study Applying Different Formulations to the Cervix in Healthy Volunteers|Terminated||N/A|||Photocure|||||f||||||||||||||2017-02-18 15:28:57.259619|2017-02-18 15:28:57.259619
NCT00496158|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2009-04-23|||August 2007||2007-08-01|April 2009|2009-04-01||||||||Interventional|QUASH2||Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus|A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus|Terminated||Phase 3|||Pharmasset||||The study was terminated in the interest of patient safety.|f||||||||||||||2017-02-18 15:28:57.327056|2017-02-18 15:28:57.327056
NCT00496145|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-04-18|||August 2002||2002-08-01|April 2016|2016-04-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|SDSMP||Spanish Diabetes Self-Management Program|Spanish Diabetes Self-Management Program|Completed||N/A|567|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 15:28:57.52944|2017-02-18 15:28:57.52944
NCT00496132|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2013-01-18||2013-01-18|September 2007||2007-09-01|January 2013|2013-01-01||||June 2009|Actual|2009-06-01||Interventional|||A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|An Open-Label, Multicenter, Phase I/II Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Who Have Been Treated With a Purine Nucleoside Analogue-Containing Regimen|Terminated||Phase 1/Phase 2|16|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 15:28:57.640354|2017-02-18 15:28:57.640354
NCT00496119|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-10-18|||September 2006||2006-09-01|October 2016|2016-10-01||||September 2018|Anticipated|2018-09-01||Interventional|||Proton Beam Therapy for Chordoma Patients|Phase II Evaluation of Proton Beam Therapy for Skull Base Chordoma|Active, not recruiting||Phase 2|15|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:28:57.733258|2017-02-18 15:28:57.733258
NCT00496106|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2010-12-15|||August 2007||2007-08-01|December 2010|2010-12-01|February 2011|Anticipated|2011-02-01|August 2010|Anticipated|2010-08-01||Interventional|CXR01||Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes|Stress, Immunity & Cervical Cancer: Biobehavioral Outcomes of a Randomized Trial|Unknown status|Recruiting|Phase 2|939|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-02-18 15:28:57.840305|2017-02-18 15:28:57.840305
NCT00496093|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-02-06|||October 2005||2005-10-01|February 2015|2015-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)|Safety, Tolerability and Immunogenicity of Pneumovax 23 (V110) in Healthy Adults in India|Completed||Phase 3|133|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 15:28:57.946579|2017-02-18 15:28:57.946579
NCT00495872|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2012-10-16|||June 2007||2007-06-01|October 2012|2012-10-01||||October 2012|Actual|2012-10-01||Interventional|||Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor|A Multi-Arm Complete Phase 1 Trial of Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor|Completed||Phase 1|204|Actual|M.D. Anderson Cancer Center||6|||f||||f||||||||||2017-02-18 15:29:00.717807|2017-02-18 15:29:00.717807
NCT00496080|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2012-09-06|2012-06-19||June 2007||2007-06-01|September 2012|2012-09-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|DUAO||Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding|A Pivotal Study of Doppler Guided Uterine Artery Occlusion as Treatment for the Reduction of Fibroid Associated Bleeding|Terminated||N/A|87|Actual|Ethicon, Inc.|Study was terminated early because 6 mo interim analysis of parallel European study showed that device was not meeting the primary endpoint. Target enrollment was 200 subjects, but results are based on 87 subjects who were treated with the device.|1||Trial terminated early due to results from a similar study.|f||||t||||||||||2017-02-18 15:28:58.051793|2017-02-18 15:28:58.051793
NCT00496067|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2011-03-08|||April 2007||2007-04-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Uterine Artery Occlusion for Fibroid Related Bleeding|An Evaluation of a Doppler-Guided Uterine Artery Occlusion Device as Treatment for the Reduction of Fibroid-Associated Bleeding|Terminated||N/A|91|Actual|Ethicon, Inc.||1||Data required further pilot work to be undertaken.|f||||t||||||||||2017-02-18 15:28:58.367874|2017-02-18 15:28:58.367874
NCT00496054|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2015-01-05|2009-11-12||May 2008||2008-05-01|January 2015|2015-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)|Evaluation of Safety,Tolerability and Immunogenicity of Vaccination With Rotateq (V260) in Healthy Infants in India|Completed||Phase 3|110|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:28:58.508904|2017-02-18 15:28:58.508904
NCT00496041|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2014-12-04|||July 2007||2007-07-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classification|Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classification|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 15:28:59.079561|2017-02-18 15:28:59.079561
NCT00496028|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2010-09-21|||March 2007||2007-03-01|September 2010|2010-09-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Phase I Study in Patients With Solid Tumours|A Phase I, Open-label Study to Assess the Safety and Tolerability of AZD0530 in Combination With Carboplatin and/or Paclitaxel Chemotherapy in Patients With Solid Tumours|Completed||Phase 1|148|Actual|AstraZeneca||3|||f||||t||||||||||2017-02-18 15:28:59.185534|2017-02-18 15:28:59.185534
NCT00496015|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2016-10-11||2009-05-20|July 2007||2007-07-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|March 2008|Actual|2008-03-01||Interventional|||Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A|Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Vaccine GSK1024850A and DTPa-HBV-IPV/Hib Vaccine (Infanrix Hexa) and Assessment of Impact of Pneumococcal Vaccination on Nasopharyngeal Carriage|Completed||Phase 3|750|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:28:59.304691|2017-02-18 15:28:59.304691
NCT00496002|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2009-04-23|||August 2007||2007-08-01|April 2009|2009-04-01||||||||Interventional|QUASH 1||Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus|A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus|Terminated||Phase 3|||Pharmasset||2||The study was terminated in the interest of patient safety.|f||||||||||||||2017-02-18 15:28:59.62635|2017-02-18 15:28:59.62635
NCT00495989|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-03|2009-04-09|||June 2007||2007-06-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Saliva and Dental Calculus in Handicapped People|The Relationship Between Saliva and Dental Calculus in a Population of Institutionalized Handicapped Persons|Completed||N/A|100|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 15:28:59.88049|2017-02-18 15:28:59.88049
NCT00495976|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2008-03-21|||September 2007||2007-09-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study to Investigate the Effects of Hot Drinks on Nasal Airway Resistance and Symptoms of Common Cold|A Pilot Study to Investigate the Effects of Hot Drinks on Nasal Airway Resistance and Symptoms of Common Cold|Completed||N/A|60|Actual|Cardiff University||2|||f||||f||||||||||2017-02-18 15:28:59.993313|2017-02-18 15:28:59.993313
NCT00495963|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2008-10-16|||January 2003||2003-01-01|July 2007|2007-07-01|September 2003|Actual|2003-09-01|||||Interventional|||Diagnosis of Ventilator- Associated Pneumonia in Children: A Comparative Study of Bronchoscopic and Non-Bronchoscopic Methods||Completed||Phase 3|||Sir Ganga Ram Hospital|||||f||||f||||||||||2017-02-18 15:29:00.11731|2017-02-18 15:29:00.11731
NCT00495950|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-11-23|||May 2006||2006-05-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Observational|||Prospective Measurement of Post-Treatment Lymphedema|Prospective Measurement of Post-Treatment Lymphedema in Patients With Melanoma|Completed||N/A|350|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:29:00.218109|2017-02-18 15:29:00.218109
NCT00495924|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2009-07-07|||October 2006||2006-10-01|July 2009|2009-07-01|October 2008|Actual|2008-10-01|||||Observational|||Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma|Prognostic Relevance of Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma|Completed||N/A|100|Anticipated|Katholieke Universiteit Leuven|||1||f||||t||||||Samples With DNA|"~     Tissue, serum, blood~   "|||2017-02-18 15:29:00.332058|2017-02-18 15:29:00.332058
NCT00495898|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2009-12-02|||November 2002||2002-11-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|May 2005|Actual|2005-05-01||Interventional|SCORPIUS||A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions|A German Multicenter, Randomized, Controlled, Open-Label Study of the Cypher Sirolimus-Eluting Stent in the Treatment of Diabetic Patients With De Novo Native Coronary Artery Lesions|Completed||Phase 4|200|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 15:29:00.441462|2017-02-18 15:29:00.441462
NCT00495885|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-04-26||2016-04-26|June 2007||2007-06-01|April 2016|2016-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|SAMS12||Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus|Efficacy and Safety of 2 mg/Day of M100907 on Sleep Maintenance Insomnia With a Sub-study of the Effect of M100907 on Stable Type II Diabetes Mellitus: a 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 3|848|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:29:00.573102|2017-02-18 15:29:00.573102
NCT00495859|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2008-04-02|||April 2008||2008-04-01|April 2008|2008-04-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|PROUD||Effects of Preoperative Long-Term Immunonutrition in Patients Listed for Liver Transplantation|Randomized Controlled Double Blind Multi-Center Clinical Trial to Assess the Effects of Preoperative Long-Term Immunonutrition in Patients Listed for Liver Transplantation|Unknown status|Recruiting|N/A|156|Anticipated|Heidelberg University||2|||f||||t||||||||||2017-02-18 15:29:00.850688|2017-02-18 15:29:00.850688
NCT00495846|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2009-08-14|||April 2007||2007-04-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|SS-HCC||GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma|Treatment of Advanced Hepatocellular Carcinoma With Depot Somatostatin Analogues: a Pilot Prospective Study Based on Somatostatin Receptors Tumors Expression|Completed||Phase 2/Phase 3|25|Actual|Federico II University||2|||f||||t||||||||||2017-02-18 15:29:00.958302|2017-02-18 15:29:00.958302
NCT00495833|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2010-06-25|||June 2007||2007-06-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||SPHERE Hypertension Intervention Study|SPHERE Hypertension Intervention Study|Completed||N/A|8000|Anticipated|University of Washington||7|||f||||t||||||||||2017-02-18 15:29:01.093568|2017-02-18 15:29:01.093568
NCT00495820|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2015-10-19|2014-01-21||August 2007||2007-08-01|October 2015|2015-10-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study|Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study|Completed||Phase 4|60|Actual|VA Office of Research and Development|Small sample size and short duration of the study are two important limitations of the study. All male subjects in the study also make it difficult to generalize the results.|2|||f||||t||||||||||2017-02-18 15:29:01.215966|2017-02-18 15:29:01.215966
NCT00495807|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2008-07-11|||June 2006||2006-06-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|NWPOP||Nurses' Negative Words and Postoperative Pain Management|Influence on Pain Management of Nurses' Negative Words After Total Hysterectomy|Completed||N/A|1500|Actual|Nanjing Medical University||4|||f||||t||||||||||2017-02-18 15:29:01.768078|2017-02-18 15:29:01.768078
NCT00495794|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2015-04-06|2014-09-03||August 2008||2008-08-01|July 2014|2014-07-01|July 2012|Actual|2012-07-01|March 2010|Actual|2010-03-01||Interventional|||Adherence and Intensification of Medications (AIM) Implementation Study|Adherence and Intensification of Medications: A Population-Based Clinical Pharmacists Implementation Study Among Hypertensive Diabetes Patients|Completed||N/A|4622|Actual|VA Office of Research and Development|In the intervention arm, only 53% of subjects had a pharmacist encounter. Higher rates of participation might have led to a more substantial initial improvement and a detectable longer term effect.|2|||f||||t||||||||||2017-02-18 15:29:01.90219|2017-02-18 15:29:01.90219
NCT00495781|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2007-07-02|||October 2004||2004-10-01|July 2007|2007-07-01|May 2006|Actual|2006-05-01|||||Interventional|SFIDS||Out Come Study To Define Laboratory Parameters That Are Best Suited to Diagnose Functional Iron Deficiency|Swiss Functional Iron Deficiency Study|Completed||N/A|77|Actual|Spital Zollikerberg||2|||f||||f||||||||||2017-02-18 15:29:02.399908|2017-02-18 15:29:02.399908
NCT00495768|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2007-12-13|||July 2004||2004-07-01|December 2007|2007-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Reducing Depressive Symptoms During HCV Therapy: A Randomized Study|Reducing Depressive Symptoms During HCV Therapy: A Randomized Study|Unknown status|Active, not recruiting|N/A|90|Anticipated|South Texas Veterans Health Care System||1|||f||||t||||||||||2017-02-18 15:29:02.504999|2017-02-18 15:29:02.504999
NCT00495755|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2013-08-07|2013-04-14||July 2007||2007-07-01|August 2013|2013-08-01|October 2012|Actual|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||Campath in Chronic GVHD|An Open Label Phase I Trial of Alemtuzumab (Campath 1-H) Therapy for Refractory Chronic Graft-vs-Host Disease|Completed||Phase 1|13|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-02-18 15:29:02.612111|2017-02-18 15:29:02.612111
NCT00495729|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2012-05-31|||April 2007||2007-04-01|February 2011|2011-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.|A Single-blind, Randomised, Placebo-controlled, 15 Day Repeated-dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SB-649868 and Its Interaction With the CYP3A4 Isoenzyme in Healthy Male Subjects.|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:29:02.859991|2017-02-18 15:29:02.859991
NCT00495716|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2016-10-26|||January 2008||2008-01-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Effect of HSV-2 Suppressive Therapy on Sexual Behavior|Effect of Suppressive Therapy on Behavioral Determinants of HSV-2 Transmission|Active, not recruiting||Phase 4|72|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 15:29:02.955842|2017-02-18 15:29:02.955842
NCT00495703|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2008-04-04|||February 2006||2006-02-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|TACTIC||The Activity Intervention for Chemobrain|Exercise Intervention for Chemotherapy-Related Cognitive Dysfunction|Completed||Phase 2|64|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 15:29:03.060107|2017-02-18 15:29:03.060107
NCT00495690|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-30|2011-09-14|||November 2004||2004-11-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional|||Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease|Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Mortality and Severe Disease Requiring Hospitalization|Completed||Phase 3|2012|Actual|Society for Applied Studies||1|||f||||f||||||||||2017-02-18 15:29:03.159113|2017-02-18 15:29:03.159113
NCT00495677|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2013-08-26|2013-08-26||June 2007||2007-06-01|August 2013|2013-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Phase 2 Study Of PF-00232798 In HIV Positive Patients|A Randomised, Double-Blind, Placebo-Controlled, Multicentre Study In Asymptomatic Hiv-Infected Patients To Investigate The Pharmacodynamics, Pharmacokinetics, Safety And Toleration Of PF-00232798|Completed||Phase 2|43|Actual|Pfizer||6|||f||||f||||||||||2017-02-18 15:29:03.274509|2017-02-18 15:29:03.274509
NCT00495664|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2012-09-05|||December 2005||2005-12-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|TITAX AMI||Titanium Nitride Oxide Coated Stents and Paclitaxel Eluting Stents for Acute Myocardial Infarction|Titanium Nitride Oxide Coated Stents Versus Paclitaxel Eluting Stents for Acute Myocardial Infarction|Completed||N/A|425|Actual|The Hospital District of Satakunta||2|||f||||t||||||||||2017-02-18 15:29:04.338625|2017-02-18 15:29:04.338625
NCT00357877|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2009-12-10|||July 2006||2006-07-01|November 2009|2009-11-01|June 2010|Anticipated|2010-06-01|August 2009|Actual|2009-08-01||Interventional|||Prevention of Adult Caries Study (PACS)|Prevention of Adult Caries Study|Unknown status|Active, not recruiting|Phase 3|983|Actual|Tufts University||1|||f||||t||||||||||2017-02-18 16:22:37.315295|2017-02-18 16:22:37.315295
NCT00495651|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2015-06-01|||March 2008||2008-03-01|June 2015|2015-06-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|TEMPRANO||Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)|Benefits and Risks of Early Antiretroviral Therapy in HIV-infected Adults in Abidjan, Côte d'Ivoire: Randomized Controlled Trial (ANRS 12136 TEMPRANO)|Completed||Phase 3|2073|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||4|||f||||t||||||||||2017-02-18 15:29:04.44922|2017-02-18 15:29:04.44922
NCT00495638|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-30|2017-01-24|||June 28, 2007||2007-06-28|December 2, 2014|2014-12-02|December 2, 2014||2014-12-02|||||Observational|||Pulmonary Hypertension, Hypoxia and Sickle Cell Disease|Pulmonary Hypertension and the Hypoxic Response in SCD|Completed||N/A|29|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:29:04.570939|2017-02-18 15:29:04.570939
NCT00495625|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2012-03-22|2012-01-12||October 2006||2006-10-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)|Phase II Open-Label Study of Sunitinib Malate (SUO11248) in Adult Subjects With Metastatic and/or Surgically Unresectable Hepatocellular Cancers (HCC)|Terminated||Phase 2|33|Actual|H. Lee Moffitt Cancer Center and Research Institute|The Principal Investigator who initiated the study left Moffitt before reaching the target enrollment required to perform the planned analysis.|1|||f||||t||||||||||2017-02-18 15:29:07.164062|2017-02-18 15:29:07.164062
NCT00495612|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2013-03-25|2012-12-10||September 2007||2007-09-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|AERO||A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma|A Phase IV, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma|Completed||Phase 4|69|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:29:07.573119|2017-02-18 15:29:07.573119
NCT00495599|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-11-17|||March 2006||2006-03-01|November 2016|2016-11-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Adipose Secretory Function in Patients Before & After Laparoscopic Surgery|Adipose Secretory Function in Patients Before & After Laparoscopic Surgery|Completed||Phase 3|107|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 15:29:07.976307|2017-02-18 15:29:07.976307
NCT00495586|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2012-03-11|2012-01-08||October 2007||2007-10-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Interventional|TRANCE||Effectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease|Situations That do Not Require Antibiotics for Acute Exacerbations of Mild-to-moderate Chronic Obstructive Pulmonary Disease|Completed||Phase 4|318|Actual|Catalan Society of Family Medicine|The required sample size could not be achieved. This clinical trial was only partially funded by an independent academic institution without any other source of funding. However, due differences obtained the sample size allowed for a power of 80%.|2|||f||||f||||||||||2017-02-18 15:29:10.532883|2017-02-18 15:29:10.532883
NCT00495573|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2012-03-21|||June 2007||2007-06-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|November 2009|Actual|2009-11-01||Observational|||HSV-2 Shedding Resolution After Acyclovir Treatment|Half-life and Pattern of Resolution of Herpes Simplex Virus Type 2 (HSV-2) Shedding After Beginning Acyclovir Treatment|Completed||N/A|36|Actual|University of Washington|||2||f||||f||||||Samples With DNA|"~     whole blood, genital swab specimens~   "|||2017-02-18 15:29:10.989206|2017-02-18 15:29:10.989206
NCT00495560|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2008-10-03|||January 2007||2007-01-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Pilot Study of Priming Before Induction Termination of Pregnancy|A Pilot Study of Priming Before Induction Termination of Pregnancy|Completed||N/A|25|Actual|Boston University||1|||f||||f||||||||||2017-02-18 15:29:11.099688|2017-02-18 15:29:11.099688
NCT00495547|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2014-04-04|||February 2009||2009-02-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|SIMIDIS||SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome|A Multicenter, Non-Randomized, Open-Label Study to Evaluate Efficacy and Safety of Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome Red Cell Transfusion Dependent With Low or Intermediate -1 Risk.|Terminated||Phase 2|16|Actual|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:29:11.193067|2017-02-18 15:29:11.193067
NCT00495521|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2011-10-19|||June 2007||2007-06-01|October 2011|2011-10-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children|A Prospective Randomized Double-Blind Study of PASER® in the Management of Patients Experiencing an Acute Flare of Crohn's Disease|Terminated||Phase 2|2|Actual|Jacobus Pharmaceutical||2||Efforts at recruitment have halted as recruitment was poor|f||||f||||||||||2017-02-18 15:29:11.310032|2017-02-18 15:29:11.310032
NCT00495508|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2010-05-12|||October 2006||2006-10-01|May 2010|2010-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy|A Randomised, Open-label Non-inferiority Trial of Artemether-lumefantrine Versus Quinine for the Treatment of Uncomplicated Falciparum Malaria During Pregnancy, Mbarara, Uganda (2006-2007)|Completed||Phase 4|300|Anticipated|Epicentre||2|||f||||t||||||||||2017-02-18 15:29:11.432318|2017-02-18 15:29:11.432318
NCT00495495|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-01|2015-02-02|2010-10-12||February 2007||2007-02-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Healozone Study to Evaluate the Safety and Efficacy of the Use of Ozone for Management of Dental Caries|A Multi-Center Study to Evaluate the Safety and Efficacy of the Use of Ozone for the Management of Fissure Caries|Completed||Phase 2/Phase 3|394|Actual|Indiana University|Study length may have been too brief to permit progression of early stage caries; Low caries increment in study population; Difficult to establish that lesions were truly active at baseline.|2|||f||||t||||||||||2017-02-18 15:29:11.758541|2017-02-18 15:29:11.758541
NCT00495482|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2012-11-12|||September 2006||2006-09-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|||||Observational|ESPIL||Incurable Ill Patients Attitudes Towards Euthanasia and Assisted Suicide|Incurable Ill Patients Attitudes to Euthanasia and Assisted Suicide: A Prospective, Multi-Centre Trial in Palliative Care Units in Saxony|Completed||N/A|200|Actual|Klinikum St. Georg gGmbH|||1||f||||f||||||||||2017-02-18 15:29:12.128034|2017-02-18 15:29:12.128034
NCT00495469|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2013-02-21||2009-07-22|August 2007||2007-08-01|February 2013|2013-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive|A Once-Daily Dose-Ranging Study of GSK189075 Versus Placebo In The Treatment of Type 2 Diabetes Mellitus in Treatment-Naïve Subjects|Completed||Phase 2|252|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:29:12.219244|2017-02-18 15:29:12.219244
NCT00495456|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-05-30|||August 2007||2007-08-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|CLEAR||Cardiovascular Longitudinal Evaluation & Assessment of Risk (CLEAR) Study|Cardiovascular Longitudinal Evaluation & Assessment of Risk Study|Recruiting||N/A|999999|Anticipated|Monash University|||1||f||||t||||||||||2017-02-18 15:29:12.343819|2017-02-18 15:29:12.343819
NCT00495443|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-01|2007-07-01|||September 2007||2007-09-01|July 2007|2007-07-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Enhanced Safety Aesthetic Laser System|Peterio™ – an Add-on Device for Enhanced Safety of Aesthetic Laser Treatments|Unknown status|Not yet recruiting|N/A|25|Anticipated|Scilex Ltd.|||||f||||f||||||||||2017-02-18 15:29:12.451307|2017-02-18 15:29:12.451307
NCT00495430|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-01|2009-06-15|||December 2004||2004-12-01|June 2009|2009-06-01|July 2009|Anticipated|2009-07-01|||||Observational|||Vibration Response Imaging in Healthy Subjects|Passive Acoustic Imaging With the Vibration Response Imaging Device in Healthy Subjects|Unknown status|Active, not recruiting|N/A|310|Anticipated|Deep Breeze|||1||f||||f||||||||||2017-02-18 15:29:12.540678|2017-02-18 15:29:12.540678
NCT00495417|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2010-10-18|||July 2007||2007-07-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease|Randomized, Controlled, Parallel Group, Patient-blinded, Single-center Phase I Pilot Study to Assess Tolerability and Safety of Repeated s.c. Administration of a Single-dose of Affitope AD01 Applied With or Without Adjuvant to Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|24|Actual|Affiris AG||2|||f||||t||||||||||2017-02-18 15:29:12.647836|2017-02-18 15:29:12.647836
NCT00495404|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2015-04-06|||August 2001||2001-08-01|June 2007|2007-06-01|March 2005|Actual|2005-03-01|||||Interventional|||Health Outcomes From Opioid Therapy for Chronic Pain|Health Outcomes From Opioid Therapy for Chronic Pain|Completed||N/A|135|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:29:12.762667|2017-02-18 15:29:12.762667
NCT00495391|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2014-04-08|2013-11-18||July 2007||2007-07-01|April 2014|2014-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|STEALTHC-2||Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C|Phase II, Randomized, Double-blind, Placebo-controlled Study of Nitazoxanide in Combination With Peginterferon Alfa-2a and Ribavirin in Patients With Hepatitis C Who Have Failed to Respond to a Prior Course of Peginterferon and Ribavirin|Completed||Phase 2|64|Actual|Romark Laboratories L.C.||2|||f||||t||||||||||2017-02-18 15:29:12.879583|2017-02-18 15:29:12.879583
NCT00495378|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2016-12-19|||November 2002||2002-11-01|June 2007|2007-06-01|March 2003|Actual|2003-03-01|||||Interventional|||RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia|Retrospective Review of Alternate PROCRIT Dosing In Patients With Chemotherapy Related Anemia|Terminated||Phase 4|25|Actual|Ortho Biotech Products, L.P.||||This study was stopped due to slow enrollment after enrolling 25 of 200 patients.|f||||f||||||||||2017-02-18 15:29:13.911098|2017-02-18 15:29:13.911098
NCT00495365|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2011-05-17|||June 2003||2003-06-01|April 2010|2010-04-01|September 2003|Actual|2003-09-01|||||Interventional|||A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.|Evaluation of Dose Conversion From Variable Dosing Intervals of Darbepoetin Alfa to Variable Dosing Intervals of Epoetin Alfa in Patients With the Anemia of Chronic Kidney Disease|Terminated||Phase 4|8|Actual|Ortho Biotech Products, L.P.||||This study was stopped due to slow enrollment|f||||f||||||||||2017-02-18 15:29:14.009388|2017-02-18 15:29:14.009388
NCT00495352|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-30|2010-04-13|||January 2006||2006-01-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|||||Interventional|PSIAARP||The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia|1. The Pharmacogenetic Study of Interaction Among Antipsychotics, Readiness to Change, and Pharmacological Intervention for Smoking Cessation Among Schizophrenic Patients 2. Stages of Change and Outcomes of Nicotine Replacement Therapy in Chronic Schizophrenic Patients|Completed||Phase 4|360|Actual|Yu-Li Hospital||1|||f||||t||||||||||2017-02-18 15:29:14.105369|2017-02-18 15:29:14.105369
NCT00495339|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2009-03-03|||June 2007||2007-06-01|June 2008|2008-06-01||||April 2008|Actual|2008-04-01||Interventional|||MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis|Multicenter Open Non-Comparative Clinical Study to Evaluate the Efficacy and Safety of Three Months TAVANIC Course (Levofloxacin) in Combine Treatment of Multi-Drug-Resistant Tuberculosis (MDR-TB)|Completed||Phase 4|100|Anticipated|Sanofi||1|||f||||||||||||||2017-02-18 15:29:14.220683|2017-02-18 15:29:14.220683
NCT00495326|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2012-02-14|||December 2007||2007-12-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|CARINEMO||Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)|Randomized Non-inferiority Trial Comparing the Nevirapine-based Antiretroviral Therapy Versus the Standard Efavirenz-based ART for the Treatment of HIV-TB Co-infected Patients on Rifampicin-based Therapy (ANRS 12146 CARINEMO)|Completed||Phase 2/Phase 3|570|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||t||||||||||2017-02-18 15:29:14.317332|2017-02-18 15:29:14.317332
NCT00495313|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2008-12-11|||March 2007||2007-03-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens|Determine the Effects of COL-101 Administered Once Daily With Metronidazole Topical Gel, 1% Versus Doxycycline Hyclate 100 mg Administered Once Daily With Metronidazole Topical Gel, 1% in Patients With Moderate to Severe Rosacea|Completed||Phase 4|91|Actual|CollaGenex Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:29:14.451293|2017-02-18 15:29:14.451293
NCT00495300|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-30|2017-01-24|||June 27, 2007||2007-06-27|November 7, 2016|2016-11-07||||||||Observational|||Collection of Samples and Data for the National Marrow Donor Program Repository|The Collection of Research Samples and/or Data for Repository From Related or Unrelated Hematopoietic Stem Cell Transplantation Recipients for the National Marrow Donor Program|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:29:14.571856|2017-02-18 15:29:14.571856
NCT00495287|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2016-03-29|||November 2006||2006-11-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|July 2015|Actual|2015-07-01||Interventional|||A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)|Phase III Trial in AML Comparing Standard-dose vs High-dose Remission Induction and, Within a Risk-oriented Postremission Strategy, Autologous Blood Stem Cell Transplantation vs Blood Stem Cell-supported Multicycle High-dose Program|Completed||Phase 3|573|Actual|Northern Italy Leukemia Group||2|||f||||t||||||||||2017-02-18 15:29:14.678758|2017-02-18 15:29:14.678758
NCT00495274|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2017-01-19|||July 2007||2007-07-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Bioequivalence and Food Effect Study in Healthy Volunteers|A Single-centre, Open-label, Randomized, Single-dose, 6-way Crossover Study to Investigate the Pharmacokinetics, Safety and Tolerability of 6 Different Formulations of SB-649868 30 mg (Part A) and the Effect of Food on the Selected Formulation of SB-649868 Pharmacokinetic (Part B) in Healthy Male Volunteers|Completed||Phase 1|16|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:29:14.832474|2017-02-18 15:29:14.832474
NCT00495261|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2008-01-14|||February 2007||2007-02-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Development and Validation of a Mindfulness Intervention for Problem Gambling: An Exploratory Study|Development and Validation of a Mindfulness Intervention for Problem Gambling: An Exploratory Study|Completed||N/A|24|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 15:29:14.93799|2017-02-18 15:29:14.93799
NCT00495248|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2011-08-08|||January 2007||2007-01-01|August 2011|2011-08-01|September 2011|Anticipated|2011-09-01|September 2009|Actual|2009-09-01||Interventional|||Thriving, Activity and Social Participation After Stroke|Well-being, Activity and Social Participation After Stroke/TIA. RCT-psycho Social Intervention Study.|Unknown status|Active, not recruiting|Phase 1/Phase 2|140|Anticipated|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 15:29:15.049105|2017-02-18 15:29:15.049105
NCT00495235|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-02|2014-05-20|||October 2005||2005-10-01|May 2014|2014-05-01||||May 2014|Actual|2014-05-01||Observational|||Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas|Case-Control Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas|Completed||N/A|147|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||Samples With DNA|"~     Blood sample and, if diagnosed with endometrial cancer and had surgical removal of uterus, a~     piece of leftover tumor and surrounding normal tissue will be tested for markers of insulin~     resistance and PCOS.~   "|||2017-02-18 15:29:15.177611|2017-02-18 15:29:15.177611
NCT00495222|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2009-09-08|2009-04-21||February 2007||2007-02-01|September 2009|2009-09-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Endoscopic Suturing System for Tissue Apposition|Evaluation of an Endoscopic Suturing System for Tissue Apposition|Completed||N/A|9|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-02-18 15:29:15.314589|2017-02-18 15:29:15.314589
NCT00495209|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2012-08-01|||July 2006||2006-07-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Pre-Surgical Qigong Therapy for Women With Breast Cancer|Pre-Surgical Qigong Therapy for Women With Breast Cancer|Completed||N/A|7|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:29:15.523606|2017-02-18 15:29:15.523606
NCT00495196|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2010-07-25|||June 2007||2007-06-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Cardiovascular Responses in Congestive Heart Failure With Cheyne- Stokes Respiration|Cardiovascular Response to Peripheral Chemoreceptor Stimulation in Congestive Heart Failure With Cheyne- Stokes Respiration|Completed||N/A|50|Actual|ResMed||2|||f||||f||||||||||2017-02-18 15:29:15.634307|2017-02-18 15:29:15.634307
NCT00495183|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2010-05-26|||January 2009||2009-01-01|May 2010|2010-05-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence|Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence|Unknown status|Recruiting|Phase 4|108|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||t||||||||||2017-02-18 15:29:15.730041|2017-02-18 15:29:15.730041
NCT00495170|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-11-22|||April 2006||2006-04-01|November 2016|2016-11-01||||April 2018|Anticipated|2018-04-01||Interventional|||Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)|Phase II Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|65|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:29:15.844297|2017-02-18 15:29:15.844297
NCT00495157|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2013-04-05|2012-04-30||June 2007||2007-06-01|April 2013|2013-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|BASALT||Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)|Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT)|Completed||Phase 3|342|Actual|Milton S. Hershey Medical Center||3|||f||||t||||||||||2017-02-18 15:29:15.967339|2017-02-18 15:29:15.967339
NCT00495144|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2012-07-25|||June 2007||2007-06-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors|A Phase I, Multi-Center, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors|Completed||Phase 1|129|Actual|Threshold Pharmaceuticals||1|||f||||t||||||||||2017-02-18 15:29:16.440861|2017-02-18 15:29:16.440861
NCT00495131|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2009-09-07|2008-12-21||June 2006||2006-06-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients|Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Genotype 1-infected Patients in Taiwan|Completed||Phase 4|308|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 15:29:16.542204|2017-02-18 15:29:16.542204
NCT00495118|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2011-05-16|||October 2001||2001-10-01|May 2010|2010-05-01|March 2005|Actual|2005-03-01|||||Interventional|||A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.|Risperidone Depot (Microspheres) in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder - an Open-label Follow-up Trial of RIS-INT-62 and RIS-INT-85.|Completed||Phase 3|314|Actual|Janssen, LP|||||f||||||||||||||2017-02-18 15:29:17.262067|2017-02-18 15:29:17.262067
NCT00495105|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2013-02-08|||August 2007||2007-08-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Dairy Foods and Blood Pressure in Multi-Ethnic Children|Dairy Foods and Blood Pressure in Multi-Ethnic Children|Completed||N/A|2115|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 15:29:17.35274|2017-02-18 15:29:17.35274
NCT00495092|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2012-02-29|||January 2005||2005-01-01|February 2012|2012-02-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients|Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients|Completed||Phase 2/Phase 3|85|Actual|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||t||||||||||2017-02-18 15:29:17.452009|2017-02-18 15:29:17.452009
NCT00495079|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2013-12-02|2012-03-15||May 2007||2007-05-01|December 2013|2013-12-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia|A Phase 2 Study to Evaluate the Safety and Efficacy of Weekly Doses of Marqibo® (Vincristine Sulfate Liposomes Injection) in Adult Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia (ALL) in Second Relapse or Adult Patients With Philadelphia Chromosome-negative ALL Who Failed Two Treatment Lines of Anti-leukemia Chemotherapy|Completed||Phase 2|65|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||||||||||||2017-02-18 15:29:17.569263|2017-02-18 15:29:17.569263
NCT00495066|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2013-05-30||||||May 2013|2013-05-01||||||||Expanded Access|||Compassionate Use Trial for Unresectable Melanoma With Ipilimumab|A Multicenter Treatment Protocol for Expanded Access Use of Ipilimumab (BMS-734016) Monotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma|No longer available||N/A|||Bristol-Myers Squibb|||||||||f||||||||||2017-02-18 15:29:18.091824|2017-02-18 15:29:18.091824
NCT00495053|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2012-03-21|||April 2007||2007-04-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|July 2008|Actual|2008-07-01||Interventional|||Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder Syndrome and Detrusor Overactivity|A Phase 1 Multicenter Study of Three Escalating Doses of hMaxi-K Gene Transfer in Female Participants With Overactive Bladder Syndrome and Detrusor Overactivity|Completed||Phase 1|21|Actual|Ion Channel Innovations||2|||f||||t||||||||||2017-02-18 15:29:18.194916|2017-02-18 15:29:18.194916
NCT00495040|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-12-05|||May 2006||2006-05-01|December 2016|2016-12-01||||May 2018|Anticipated|2018-05-01||Interventional|||Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)|Phase II Escalated/Accelerated Proton Radiotherapy for Inoperable Stage I (T1-T2, N0, M0) and Selected Stage II (T3N0M0) Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:29:18.305258|2017-02-18 15:29:18.305258
NCT00495027|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2007-06-28|||March 2002||2002-03-01|June 2007|2007-06-01|August 2005|Actual|2005-08-01|||||Interventional|||Brief Cognitive-Behavioral Treatment for Victims of Mass Violence|Brief Cognitive-Behavioral Treatment for Victims of Mass Violence|Completed||Phase 1|45|Actual|Boston University||2|||f||||f||||||||||2017-02-18 15:29:18.416804|2017-02-18 15:29:18.416804
NCT00495014|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2010-10-13||2010-10-13|June 2007||2007-06-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects|A Single-Blind, Randomized, Placebo-Controlled, Ascending Single Dose and Repeat Dose Study With Once Daily Dosing To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK376501 in Healthy Overweight and Obese Subjects|Completed||Phase 1|70|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:29:18.514124|2017-02-18 15:29:18.514124
NCT00494988|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2016-03-03|||December 2004||2004-12-01|March 2016|2016-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart|Self-control Trial to Evaluate the Remission Rate and Safety in Newly Diagnosed Type 2 Diabetes Patients After Short-term Intensive Insulin Aspart and Insulin NPH Treatment|Completed||Phase 4|33|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:29:18.610532|2017-02-18 15:29:18.610532
NCT00494975|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2011-01-26|2010-10-05||June 2007||2007-06-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Effect of Phototherapy on Pruritus of Patients With Chronic Kidney Disease|The Effect of Phototherapy on Pruritus of Patients With Chronic Kidney Disease|Completed||N/A|21|Actual|National Taiwan University Hospital|small numbers of subjects analyzed|2|||f||||f||||||||||2017-02-18 15:29:18.704409|2017-02-18 15:29:18.704409
NCT00494962|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2007-12-03|||June 2007||2007-06-01|December 2007|2007-12-01|June 2007||2007-06-01|||||Interventional|||Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects|An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study Between Two 5-mg Tablets and a New 10-mg Tablet Formulation of Lecozotan SR in Healthy Subjects.|Completed||Phase 1|40||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:29:19.082776|2017-02-18 15:29:19.082776
NCT00494949|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2013-08-15|||April 2003||2003-04-01|August 2013|2013-08-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients|A Clinical Safety (Phase Ib/II) Increasing Dose Study of MP4 (Hemospan) in Orthopedic Surgery Patients|Completed||Phase 1/Phase 2|30|Actual|Sangart||2|||f||||t||||||||||2017-02-18 15:29:19.159824|2017-02-18 15:29:19.159824
NCT00494936|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2015-05-21|||May 2006||2006-05-01|May 2015|2015-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Effects of HIV and Hepatitis C Virus on the Brain|HIV/HCV: Neuropsychiatric and Neurophysiological Features|Completed||N/A|78|Actual|Icahn School of Medicine at Mount Sinai|||4||f||||f||||||||||2017-02-18 15:29:19.285939|2017-02-18 15:29:19.285939
NCT00494923|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2013-12-11|||January 1999||1999-01-01|December 2013|2013-12-01|December 2020|Anticipated|2020-12-01|December 2015|Anticipated|2015-12-01||Observational|||Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma|Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)|Recruiting||N/A|2500|Anticipated|University of Erlangen-Nürnberg Medical School|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 15:29:19.381504|2017-02-18 15:29:19.381504
NCT00494910|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2016-08-02|||June 2007||2007-06-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Randomized Controlled Trial of Group Psychotherapy Interventions for Cancer Patients|A Randomized Controlled Trial of Group Psychotherapy Interventions for Cancer Patients|Active, not recruiting||Phase 3|253|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 15:29:19.487641|2017-02-18 15:29:19.487641
NCT00494897|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2009-05-15|||June 1996||1996-06-01|May 2009|2009-05-01|December 2007|Actual|2007-12-01|May 2007|Actual|2007-05-01||Interventional|||PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia|PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia|Completed||Phase 4|374|Actual|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:29:19.594651|2017-02-18 15:29:19.594651
NCT00494884|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2009-07-13|||June 2007||2007-06-01|July 2009|2009-07-01||||July 2008|Actual|2008-07-01||Interventional|||Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin|A Multicenter, Randomized, Double-blind, Parallel-group Study to Investigate the Glucose Lowering Effect, Safety and Tolerability of 24 Weeks Treatment With Vildagliptin 100 mg o.d. Versus Placebo Followed by a 12 Weeks Treatment Period With Open-label Vildagliptin 100 mg o.d. as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-02-18 15:29:20.024431|2017-02-18 15:29:20.024431
NCT00494871|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2015-04-01|2012-03-28||June 2007||2007-06-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation|Evaluation of the Efficacy and Safety of Rivaroxaban (BAY59-7939) for the Prevention of Stroke and Non-central Nervous System Systemic Embolism in Subjects With Non-valvular Atrial Fibrillation|Completed||Phase 3|1280|Actual|Bayer||2|||f||||t||||||||||2017-02-18 15:29:20.139647|2017-02-18 15:29:20.139647
NCT00494858|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-07-18|||July 2007||2007-07-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Focused Versus Enhanced Cognitive Behavioral Therapy for Treating Women With Bulimia Nervosa|Treatment of Bulimia Nervosa: Dysregulated Subtype|Completed||Phase 2|50|Actual|Boston University||2|||f||||f||||||||||2017-02-18 15:29:21.962971|2017-02-18 15:29:21.962971
NCT00494845|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-01-13|||July 2007||2007-07-01|January 2016|2016-01-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Mindfulness Meditation for Chronic Low Back Pain in Older Adults|Mindfulness Meditation for Chronic Low Back Pain in Older Adults|Completed||Phase 4|40|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:29:22.074115|2017-02-18 15:29:22.074115
NCT00494832|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2012-09-12|||February 2008||2008-02-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery|Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery|Completed||N/A|40|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:29:22.170398|2017-02-18 15:29:22.170398
NCT00494819|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2012-11-12|||September 2005||2005-09-01|August 2008|2008-08-01|August 2006|Actual|2006-08-01|||||Observational|||Validity of ADHD Subtypes Using Neuropsychological Measure|Discriminate Validity of ADHD Subtypes Using Neuropsychological Test|Completed||N/A|122|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:29:22.293951|2017-02-18 15:29:22.293951
NCT00494806|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2012-07-31|2009-08-31||July 2005||2005-07-01|July 2012|2012-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effects of Rocking on Postoperative Ileus Duration Study|The Effects of Rocking Chair Motion on Postoperative Ileus Duration, Subjective Pain and Time to Discharge Following Abdominal Surgery|Completed||Early Phase 1|66|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:29:22.607997|2017-02-18 15:29:22.607997
NCT00494793|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2010-09-24|||February 2006||2006-02-01|September 2010|2010-09-01|November 2014|Anticipated|2014-11-01|November 2009|Actual|2009-11-01||Interventional|||Vacuum Assisted Wound Closure (VAWC) and Mesh Mediated Fascial Traction - Prospective Study of a Novel Technique for Open Abdomen Closure|Clinical Multicenter Trial Evaluating a Combination of Mesh Mediated Fascial Traction and Vacuum for Closure of the Open Abdomen|Unknown status|Active, not recruiting|N/A|111|Actual|Skane University Hospital||1|||f||||f||||||||||2017-02-18 15:29:23.216383|2017-02-18 15:29:23.216383
NCT00494780|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2014-06-26|2011-07-28||June 2007||2007-06-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|April 2009|Actual|2009-04-01||Interventional|MUNIN||Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients|An Open-labeled, Randomized, Two-dose, Parallel Group Trial of Ofatumumab, a Fully Human Monoclonal Anti-CD20 Antibody, in Combination With CHOP, in Patients With Previously Untreated Follicular Lymphoma (FL).|Completed||Phase 2|59|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 15:29:23.333799|2017-02-18 15:29:23.333799
NCT00494767|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2015-04-14|||September 2006||2006-09-01|April 2015|2015-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs|An Exploratory Study to Evaluate Weight Loss, Body Composition Changes, Food Intake and Urine Glucose Excretion in Healthy Obese Subjects Over 8 Weeks of Dosing With GSK189075, GW869682 Versus Placebo|Completed||Phase 1|27|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:29:24.44591|2017-02-18 15:29:24.44591
NCT00494754|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2009-12-14|||May 2007||2007-05-01|December 2009|2009-12-01|January 2010|Anticipated|2010-01-01|||||Observational|||Clinical and Genetic Study of Autism Spectrum Disorder|Clinical and Genetic Study of Autism Spectrum Disorder|Unknown status|Recruiting|N/A|300|Anticipated|National Taiwan University Hospital|||1||f||||t||||||Samples With DNA|"~     The subjects will receive blood withdrawal. The blood sample will be used for establishing~     lymphoblastoid cell lines, which will be used for molecular genetic experiments.~   "|||2017-02-18 15:29:24.537072|2017-02-18 15:29:24.537072
NCT00494741|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2016-09-15|||May 2007||2007-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|July 2016|Actual|2016-07-01||Interventional|ATHENA||MMF vs. AZA for Kidney Transplantation|A Randomized, Prospective, Multicenter Trial to Compare the Effect on Chronic Allograft Nephropathy Prevention of Mycophenolate Mofetil Versus Azathioprine as the Sole Immunosuppressive Therapy for Kidney Transplant Recipients|Completed||Phase 4|233|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-02-18 15:29:24.624251|2017-02-18 15:29:24.624251
NCT00494728|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-04-28|||June 2007||2007-06-01|April 2016|2016-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Smoking Cessation for Depressed Smokers|Smoking Cessation Intervention for Depressed Smokers: Treatment Development|Active, not recruiting||Phase 1/Phase 2|202|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:29:24.733966|2017-02-18 15:29:24.733966
NCT00494715|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2016-05-31|||May 2007||2007-05-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|VALID||Preventing ESRD in Overt Nephropathy of Type 2 Diabetes|A Prospective, Randomized, Probe Trial to Evaluate Whether,at Comparable Blood Pressure Control,Combined Therapy With ACEI BEN and ARB VAL Reduces Progression to ESRD More Effectively Than BEN or VAL Alone in High Risk Patients With Type 2 Diabetes and Overt Nephropathy|Completed||Phase 3|102|Actual|Mario Negri Institute for Pharmacological Research||3|||f||||f||||||||||2017-02-18 15:29:24.855878|2017-02-18 15:29:24.855878
NCT00494702|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2008-10-14|||April 2005||2005-04-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|OXTOX||Oxygen Toxicity in the Resuscitation in Extremely Premature Infants|Achievement of a Targeted Saturation in Extremely Low Gestational Age Neonates Resuscitated With Low or High Oxygen Concentration: A Prospective Randomized Trial|Completed||Phase 3|88|Actual|Fundacion Para La Investigacion Hospital La Fe||2|||f||||t||||||||||2017-02-18 15:29:24.97095|2017-02-18 15:29:24.97095
NCT00494689|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2007-06-28|||January 2002||2002-01-01|June 2007|2007-06-01|June 2007|Anticipated|2007-06-01|||||Observational|||Transcranial and Rapid Magnetic Stimulation for Gait Apraxia Due to Normal Pressure Hydrocephalus and Cerebral Ischemia||Unknown status|Recruiting|N/A|30|Anticipated|Devathasan Neurology Practice Pte Ltd|||||f||||t||||||||||2017-02-18 15:29:25.081061|2017-02-18 15:29:25.081061
NCT00494676|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2015-10-28|2013-07-07||September 2007||2007-09-01|September 2013|2013-09-01|April 2010|Actual|2010-04-01|July 2009|Actual|2009-07-01||Interventional|||Clinical Trial of Peripheral Prism Glasses for Hemianopia|Community-based Multi-center Randomized Control Trial of Peripheral Prism Glasses for Hemianopia|Completed||N/A|73|Actual|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||||2017-02-18 15:29:25.178866|2017-02-18 15:29:25.178866
NCT00494663|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2008-11-11|||July 2007||2007-07-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|March 2008|Anticipated|2008-03-01||Interventional|||A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes|A Phase 2b, Randomized, Double-Blind, Parallel-Group, Study of Safety and Efficacy of 16 Weeks of Treatment With DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo in Subjects With Type 2 Diabetes Mellitus (Protocol No. DIO-502)|Terminated||Phase 2|200|Anticipated|DiObex||8||Program Terminated|f||||f||||||||||2017-02-18 15:29:25.501466|2017-02-18 15:29:25.501466
NCT00494650|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2012-08-07|||April 2008||2008-04-01|August 2012|2012-08-01||||July 2012|Actual|2012-07-01||Interventional|||Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental Illnesses|Cognitive Behavioral Treatment of Post-Traumatic Stress Disorder in Clients With Severe Mental Illness (in New Jersey)|Completed||N/A|200|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 15:29:25.643983|2017-02-18 15:29:25.643983
NCT00494637|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2009-01-27|||July 2007||2007-07-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy||Terminated||N/A|468|Anticipated|Lenox Hill Hospital||1||Not reaching recruitment and endpoint goals|f||||f||||||||||2017-02-18 15:29:25.75735|2017-02-18 15:29:25.75735
NCT00494624|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-29|2007-06-29|||September 2000||2000-09-01|June 2007|2007-06-01|May 2008|Anticipated|2008-05-01|||||Interventional|VINKU||Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children||Unknown status|Recruiting|Phase 4|300|Anticipated|University of Turku||1|||f||||f||||||||||2017-02-18 15:29:25.916795|2017-02-18 15:29:25.916795
NCT00494611|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2011-05-18|||September 2007||2007-09-01|June 2010|2010-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients|A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients|Terminated||Phase 1|25|Anticipated|St. Luke's-Roosevelt Hospital Center||1||Unable to recruit subjects in timely fashion for the study|f||||f||||||||||2017-02-18 15:29:26.025765|2017-02-18 15:29:26.025765
NCT00494598|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2013-07-31|||March 2007||2007-03-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|||||Observational|||The Pharmacokinetics of Opioids and Sedative/Hypnotics During Selective Cerebral Perfusion|The Pharmacokinetics of Opioids and Sedative/Hypnotics During Selective Cerebral Perfusion|Completed||Phase 4|6|Actual|Columbia University|||1||f||||f||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 15:29:26.120186|2017-02-18 15:29:26.120186
NCT00494585|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2012-06-19|2011-04-07||June 2007||2007-06-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||CEP-701 for PH-negative Myelofibrosis|Evaluation of CEP-701, an Orally Available JAK2 Tyrosine Kinase Inhibitor, as a Therapy for Patients With Myelofibrosis|Completed||Phase 2|27|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:29:26.220244|2017-02-18 15:29:26.220244
NCT00494572|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2008-12-15|||December 2006||2006-12-01|November 2008|2008-11-01|October 2010|Anticipated|2010-10-01|January 2010|Anticipated|2010-01-01||Interventional|||Montelukast With Status Asthmaticus, Ages 6-18|Pharmacokinetics and Pharmacodynamics of Montelukast in Children, Ages 6 Through 18 Years Old, With Status Asthmaticus Unresponsive to Conventional Treatment|Unknown status|Recruiting|Phase 2/Phase 3|52|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 15:29:26.452802|2017-02-18 15:29:26.452802
NCT00494559|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-02-24|||July 2007||2007-07-01|February 2016|2016-02-01|July 2015|Actual|2015-07-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers|Phase 4 Study of Pioglitazone on Neointima Volume and Inflammatory Markers in Diabetic Patients|Completed||Phase 4|240|Actual|Korea University Anam Hospital||2|||f||||t||||||||||2017-02-18 15:29:26.730362|2017-02-18 15:29:26.730362
NCT00494546|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2007-06-28|||January 1999||1999-01-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer|High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer|Completed||Phase 3|568|Actual|VA Puget Sound Health Care System||2|||f||||f||||||||||2017-02-18 15:29:27.06312|2017-02-18 15:29:27.06312
NCT00494533|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2014-01-28|||March 2005||2005-03-01|January 2014|2014-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|TRUST-1||Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension|Treprostinil for Untreated Symptomatic PAH Trial: A 12-Week Multicenter Randomized Double-Blind Placebo-Controlled Trial of the Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension|Terminated||Phase 4|45|Actual|United Therapeutics||1||Safety issues related to outpatient intravenous infusion in India|f||||t||||||||||2017-02-18 15:29:27.16099|2017-02-18 15:29:27.16099
NCT00494520|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2009-03-10|||July 2004||2004-07-01|November 2005|2005-11-01|June 2009|Anticipated|2009-06-01|||||Interventional|||Cognitive Therapy to Improve Word Finding|Learning Paradigms in Aphasia Rehabilitation|Unknown status|Recruiting|N/A|40|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:29:27.284266|2017-02-18 15:29:27.284266
NCT00494117|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2010-07-25|||June 2007||2007-06-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Investigation of Heart Failure Status Over Time Using Respiratory Parameters|Investigation of Heart Failure Status Over Time Using Respiratory Parameters|Completed||N/A|50|Actual|ResMed|||1||f||||f||||||||||2017-02-18 15:29:34.96755|2017-02-18 15:29:34.96755
NCT00494507|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2015-11-05|2014-04-30||June 2007||2007-06-01|November 2015|2015-11-01|May 2013|Actual|2013-05-01|April 2013|Actual|2013-04-01||Interventional|HYP-HOP||Hyper- and Hypokalemic Periodic Paralysis Study|Dichlorphenamide vs. Placebo for Periodic Paralysis|Completed||Phase 3|71|Actual|University of Rochester|Sample sizes in the trial were limited by slow recruitment and the trial was concluded before attainment of the target numbers of subjects. Statistical analyses were conducted using smaller group sizes than planned, particularly for HYP subjects.|4|||f||||t||||||||||2017-02-18 15:29:27.391922|2017-02-18 15:29:27.391922
NCT00494494|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2011-06-13|2011-04-11||June 2007||2007-06-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery|Effect of Nepafenac on Post-operative Cystoid Macular Edema Following Uncomplicated Cataract Surgery|Completed||Phase 4|82|Actual|University of North Carolina, Chapel Hill|Although the peak incidence of CME is said to be at 4–12 weeks after surgery, we may have missed the time course for detecting the maximum increased OCT measured macular thickness.|2|||f||||t||||||||||2017-02-18 15:29:28.293703|2017-02-18 15:29:28.293703
NCT00494481|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-08-24|2011-04-27||January 2006||2006-01-01|August 2016|2016-08-01|January 2009|Actual|2009-01-01|June 2007|Actual|2007-06-01||Interventional|||E3 Breast Cancer Taxotere Combination|A Phase II, Double-blind, Placebo Controlled, Randomized Study to Assess the Efficacy and Safety of ZD6474 in Combination With Docetaxel (Taxotere™) vs Docetaxel Alone as 2nd Line Treatment for Advanced Breast Cancer (ABC).|Completed||Phase 2|64|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:29:28.748393|2017-02-18 15:29:28.748393
NCT00494468|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2007-06-28|||October 2002||2002-10-01|November 2005|2005-11-01|March 2004||2004-03-01|||||Interventional|||Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children|Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Zolpidem Doses in Children Ages 2 to 18 Years of Age|Completed||Phase 1/Phase 2|63||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:29:29.284417|2017-02-18 15:29:29.284417
NCT00494455|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2008-02-19|||April 2005||2005-04-01|June 2007|2007-06-01|March 2007|Actual|2007-03-01|April 2006|Actual|2006-04-01||Interventional|||Continuous Glucose Monitoring in Critically Ill Patients|Accuracy and Reliability of Continuous Glucose Monitoring in Critically Ill Patients With Shock Requiring Norepinephrine Therapy|Completed||N/A|50|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:29:29.403484|2017-02-18 15:29:29.403484
NCT00494442|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-12-27|2015-01-15||June 2007||2007-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|March 2009|Actual|2009-03-01||Interventional|ICEBERG 2||Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer|A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Ovarian Cancer|Active, not recruiting||Phase 2|70|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 15:29:29.521352|2017-02-18 15:29:29.521352
NCT00494429|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-07-25|||May 2005||2005-05-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2014|Actual|2014-11-01||Interventional|||Optimizing the Use of Morphine in Pre-Term Neonates|Optimizing Pain Treatment in Pre-Term Neonates|Completed||Phase 2|33|Actual|Children's Research Institute||2|||f||||f||||||||||2017-02-18 15:29:30.077312|2017-02-18 15:29:30.077312
NCT00494416|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2017-01-25|||June 2007||2007-06-01|January 2017|2017-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Different Approaches for Delivery of IPT in Pregnancy in Burkina Faso|A Comparison of Different Approaches for Delivery of Intermittent Preventive Treatment (IPT)to Pregnant Women in Burkina Faso With Regard to Coverage and Compliance|Completed||N/A|11523|Actual|London School of Hygiene and Tropical Medicine||3|||f||||f||||||||||2017-02-18 15:29:30.185653|2017-02-18 15:29:30.185653
NCT00494403|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2013-05-01|||August 2009||2009-08-01|May 2013|2013-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Chronic Ankle Instability and Proprioception|Effects of Ankle Instability on Cervical Proprioception|Completed||N/A|60|Actual|Logan College of Chiropractic|||1||f||||f||||||||||2017-02-18 15:29:30.297013|2017-02-18 15:29:30.297013
NCT00494390|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2008-03-18|||July 2007||2007-07-01|July 2007|2007-07-01||||March 2008|Actual|2008-03-01||Observational|||Evaluation Study for a Non-Contact Biometer|Neuartige Kontaktlose Biometrische Messungen|Completed||N/A|95|Anticipated|University Hospital Inselspital, Berne|||||f||||t||||||||||2017-02-18 15:29:30.369651|2017-02-18 15:29:30.369651
NCT00494377|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2007-06-28|||February 2004||2004-02-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression|Duloxetine Versus Duloxetine Plus Non-Pharmacological Intervention in the Treatment of Depression|Completed||Phase 4|940||Eli Lilly and Company|||||f||||f||||||||||2017-02-18 15:29:30.449439|2017-02-18 15:29:30.449439
NCT00494364|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2011-11-07|||June 2007||2007-06-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3a Part ii|Gas Supply, Demand and Middle Ear Gas Balance: Sp Aim 3a Pt ii|Completed||N/A|28|Actual|Children's Hospital of Pittsburgh|||1||f||||f||||||||||2017-02-18 15:29:30.536612|2017-02-18 15:29:30.536612
NCT00494351|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2010-05-20|||June 2007||2007-06-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa|Prospective Controlled Study of the Efficacy of NdYag for Hidradenitis Suppurativa|Completed||N/A|20|Actual|Henry Ford Health System||1|||f||||f||||||||||2017-02-18 15:29:30.614079|2017-02-18 15:29:30.614079
NCT00494338|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2009-09-30|||November 2004||2004-11-01|September 2009|2009-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer|A Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer|Terminated||Phase 2|6|Actual|Sanofi||||due to celecoxib safety issues|f||||||||||||||2017-02-18 15:29:30.712367|2017-02-18 15:29:30.712367
NCT00494325|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-04-08|||October 2005||2005-10-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2010|Actual|2010-12-01||Observational|||The Role of Macular Pigment in Patients With Age-related Macular Degeneration|The Role of Macular Pigment in Patients With Age-related Macular Degeneration|Active, not recruiting||N/A|500|Anticipated|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-02-18 15:29:30.889388|2017-02-18 15:29:30.889388
NCT00493714|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2012-07-27|||July 2005||2005-07-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Delirium Recall in Advanced Cancer Patients|The Impact of Acute Delirium On the Level of Distress In Patients With Advanced Cancer and Their Caregivers|Completed||N/A|200|Actual|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 15:29:44.640103|2017-02-18 15:29:44.640103
NCT00494312|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2012-02-27|||October 2000||2000-10-01|February 2012|2012-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Safety Study of Pioglitazone Compared To Glyburide on Liver Function|A Randomized, Comparator Controlled, Double-Blind Study of the Liver Safety of Pioglitazone HCl vs Glyburide With Metformin and Insulin as Part of Step Therapy in Subjects With Type 2 (Non-Insulin Dependent) Diabetes|Completed||Phase 4|2120|Actual|Takeda||2|||f||||t||||||||||2017-02-18 15:29:30.971577|2017-02-18 15:29:30.971577
NCT00494299|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2013-11-26|2010-12-21||April 2006||2006-04-01|November 2013|2013-11-01|November 2010|Actual|2010-11-01|July 2009|Actual|2009-07-01||Interventional|||Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)|Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)|Completed||Phase 3|458|Actual|Bayer||2|||f||||t||||||||||2017-02-18 15:29:31.087942|2017-02-18 15:29:31.087942
NCT00494286|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2013-02-15|||September 2006||2006-09-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|PFF||Abuse-Focused Cognitive Behavioral Therapy for Children Who Have Been Physically Abused|Treatment of Child Physical Abuse: An Effectiveness Trial (PFF)|Completed||Phase 1|280|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:29:32.109195|2017-02-18 15:29:32.109195
NCT00494273|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2014-10-28|||December 2002||2002-12-01|September 2014|2014-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||HIV Prevention in Haitian American Adolescents|HIV Prevention in Haitian Youths (HAP)|Completed||Phase 1/Phase 2|320||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:29:32.209479|2017-02-18 15:29:32.209479
NCT00494260|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-03-30|||November 2003||2003-11-01|March 2016|2016-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Managing Recurrent Abdominal Pain|Intergenerational Transmission of Illness Behavior|Completed||Phase 2|200|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||||||||||||2017-02-18 15:29:32.314668|2017-02-18 15:29:32.314668
NCT00494247|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2010-06-18|||October 2007||2007-10-01|November 2009|2009-11-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|JACK-EPC||Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes|Comparison of Efficiency of High Dose Atorvastatin and Endothelial Progenitor-Capture Stents and Bare Metal Stents in Reduction of Neointimal Formation in Patients With Non ST-Segment Elevation Acute Coronary Syndromes|Completed||Phase 4|60|Anticipated|Silesian School of Medicine||1|||f||||t||||||||||2017-02-18 15:29:32.438586|2017-02-18 15:29:32.438586
NCT00494234|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-12-27|2015-01-16||June 2007||2007-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|February 2009|Actual|2009-02-01||Interventional|ICEBERG 1||Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer|A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer|Active, not recruiting||Phase 2|81|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 15:29:32.561902|2017-02-18 15:29:32.561902
NCT00494221|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2014-02-26|2012-03-28||June 2007||2007-06-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|October 2009|Actual|2009-10-01||Interventional|||A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX|A Two Part Study in Japanese Patients With mCRC, Consisting of an Open-label Phase I Part to Assess the Safety and Tolerability of Cediranib (AZD2171) in Combination With FOLFOX Followed by a Phase II, Randomised, Double-blind, Parallel Group Study to Assess the Efficacy of Cediranib (AZD2171) in Combination With FOLFOX|Completed||Phase 1/Phase 2|172|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:29:33.253487|2017-02-18 15:29:33.253487
NCT00494208|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2013-04-30|||January 2009||2009-01-01|January 2009|2009-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||TDSM- Testosterone Dose Response in Surgically Menopausal Women|Testosterone Dose Response in Surgically Menopausal Women|Completed||N/A|270|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||5|||f||||||||||||||2017-02-18 15:29:33.989392|2017-02-18 15:29:33.989392
NCT00494195|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2013-02-04|||March 2008||2008-03-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)|Phase I Gene Transfer of rAAV1.tMCK.Human-alpha-sarcoglycan for Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)|Completed||Phase 1|6|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-02-18 15:29:34.094378|2017-02-18 15:29:34.094378
NCT00494182|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2017-01-03|||April 2007||2007-04-01|January 2017|2017-01-01||||April 2019|Anticipated|2019-04-01||Interventional|||Sorafenib Plus Carboplatin and Paclitaxel in Head and Neck Squamous Cell Cancer|A Phase II Study of Sorafenib in Combination With Carboplatin and Paclitaxel in Metastatic or Recurrent Head and Neck Squamous Cell Cancer|Active, not recruiting||Phase 2|42|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:29:34.215422|2017-02-18 15:29:34.215422
NCT00494169|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2017-01-17|||January 1999||1999-01-01|January 2017|2017-01-01|May 2021|Anticipated|2021-05-01|May 2021|Anticipated|2021-05-01||Observational|||Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders|Molecular Basis of Inherited Reproductive Disorders|Recruiting||N/A|5000|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||Samples With DNA|"~     WBC are transformed into immortalized cell lines.~   "|||2017-02-18 15:29:34.335016|2017-02-18 15:29:34.335016
NCT00494156|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2015-10-20|||July 2003||2003-07-01|October 2015|2015-10-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||Anticoagulation in Blunt Cerebrovascular Injuries|Anticoagulation in the Management of Grade I-III Blunt Cerebrovascular Injuries|Withdrawn||N/A|0|Actual|Denver Health and Hospital Authority||||Study halted prematurely prior to enrollment of first participant.|f||||||||||||||2017-02-18 15:29:34.523929|2017-02-18 15:29:34.523929
NCT00494143|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2014-05-21|2013-08-30||July 2007||2007-07-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|May 2009|Actual|2009-05-01||Interventional|||Metabolic Cost Savings for Transtibial Amputees Wearing the Controlled Energy Storage and Return (CESR) Foot|Metabolic Cost Savings for Transtibial Amputees Walking With the CESR Foot|Completed||Phase 3|7|Actual|VA Office of Research and Development|Acclimatization to a prosthetic foot type can alter the measured performance. In this study, subjects were most experienced using their prescribed foot. The CESR foot was also only available in one foot size which can affect gait characteristics.|3|||f||||f||||||||||2017-02-18 15:29:34.614726|2017-02-18 15:29:34.614726
NCT00494104|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2012-12-14|||September 2006||2006-09-01|September 2006|2006-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Prevention of Vitamin D Deficiency|Prevention of Vitamin D Deficiency in Breastfed Infants|Completed||N/A|398|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||4|||f||||t||||||||||2017-02-18 15:29:35.041334|2017-02-18 15:29:35.041334
NCT00494091|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2013-03-15|2012-05-31||February 2007||2007-02-01|March 2013|2013-03-01|March 2012|Actual|2012-03-01|May 2011|Actual|2011-05-01||Interventional|||Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma|Phase 2, Non Randomized, Open Label Study Of Temsirolimus (CCI-779) In Subjects With Advanced Renal Cell Carcinoma (RCC)|Completed||Phase 2|82|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:29:35.164565|2017-02-18 15:29:35.164565
NCT00494078|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2010-11-29|||June 2006||2006-06-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficiency of Continuous Glucose Monitoring in Critically Ill Patients|Efficiency of Real Time Continuous Glucose Monitoring to Achieve Normoglycemia in Critically Ill Patients - a Prospective, Randomized Study|Completed||N/A|120|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:29:38.778998|2017-02-18 15:29:38.778998
NCT00494065|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2014-01-30|||June 2007||2007-06-01|January 2014|2014-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Chiropractic and Self-care for Back-Related Leg Pain|Chiropractic and Self-care for Back-Related Leg Pain|Completed||N/A|192|Actual|Northwestern Health Sciences University||2|||f||||||||||||||2017-02-18 15:29:38.89015|2017-02-18 15:29:38.89015
NCT00494052|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2013-01-25|||June 2007||2007-06-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluating a Web-Based Educational Program for Adults at Risk for Coronary Heart Disease (The Heart to Heart Feasibility Study)|An Intervention to Enhance CHD Risk Factor Modification: The Heart to Heart Feasibility Study|Completed||N/A|186|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 15:29:38.987124|2017-02-18 15:29:38.987124
NCT00494039|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2007-06-28|||January 1998||1998-01-01|June 2007|2007-06-01|January 2010|Anticipated|2010-01-01|||||Interventional|||I-125 Versus Pd-103 for Low Risk Prostate Cancer|I-125 Versus Pd-103 for Low Risk Prostate Cancer|Unknown status|Active, not recruiting|Phase 3|602|Actual|VA Puget Sound Health Care System||2|||f||||t||||||||||2017-02-18 15:29:39.113876|2017-02-18 15:29:39.113876
NCT00494026|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2009-11-17|2009-10-14||September 2007||2007-09-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)|Phase II Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage of Small Cell Lung Cancer|Terminated||Phase 2|4|Actual|Eli Lilly and Company||1||"Study stopped early based on interim results of another trial, showing inferior activity of~   pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC."|f||||t||||||||||2017-02-18 15:29:39.460938|2017-02-18 15:29:39.460938
NCT00494013|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2009-11-04|2009-09-25||August 2007||2007-08-01|November 2009|2009-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|IOOY||Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)|Treat-to-Target Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Comparator) in Basal Therapy for Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|442|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:29:39.777915|2017-02-18 15:29:39.777915
NCT00493987|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2010-05-12|||November 2002||2002-11-01|January 2009|2009-01-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|5aR||The Role of 5-alpha Reductase in Mediating Testosterone Actions|The Role of 5-alpha Reductase in Mediating Testosterone Actions|Completed||Phase 4|184|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||||||||||||2017-02-18 15:29:40.86491|2017-02-18 15:29:40.86491
NCT00493974|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-08-24|2009-12-18||March 2007||2007-03-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|LEUKO||Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)|Antileukotriene Therapy for COPD Exacerbations|Terminated||Phase 3|119|Actual|University of Minnesota - Clinical and Translational Science Institute|Early termination leading to small numbers of subjects recruited|2||Lack of feasibility due to low recruitment|f||||t||||||||No||2017-02-18 15:29:40.972919|2017-02-18 15:29:40.972919
NCT00493961|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-09-09|||January 1999||1999-01-01|September 2016|2016-09-01|May 2021|Anticipated|2021-05-01|May 2016|Actual|2016-05-01||Interventional|||Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism|The Effects of 7 Days of Exogenous Pulsatile GnRH Treatment on the Pituitary-Gonadal Axis in Hypogonadotropic Hypogonadal Subjects|Active, not recruiting||N/A|50|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||t||||||||||2017-02-18 15:29:41.906266|2017-02-18 15:29:41.906266
NCT00493948|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2009-11-09|||July 2007||2007-07-01|November 2009|2009-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure|Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure|Completed||N/A|35|Actual|ResMed|||1||f||||f||||||||||2017-02-18 15:29:42.03143|2017-02-18 15:29:42.03143
NCT00493935|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2016-09-02|||March 2006||2006-03-01|September 2016|2016-09-01|August 2007|Actual|2007-08-01|||||Observational|||Effect of the Fat Content of the Bedtime Snack on Overnight Hypoglycemia|Nocturnal Hypoglycemia Prevention Study: Effect of the Fat Content of the Bedtime Snack on Overnight Hypoglycemia|Completed||N/A|100|Anticipated|Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 15:29:42.129266|2017-02-18 15:29:42.129266
NCT00493922|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2017-01-11|||July 2007||2007-07-01|January 2017|2017-01-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|RDT||Trial of Rapid Diagnostic Tests in Rural Ghana|An Individually Randomised Trial of Rapid Diagnostic Tests in Rural Ghana|Completed||Phase 4|7263|Actual|London School of Hygiene and Tropical Medicine||3|||f||||f||||||||||2017-02-18 15:29:42.215007|2017-02-18 15:29:42.215007
NCT00493909|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-28|2009-02-12|||June 2007||2007-06-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Prospective, Randomised, Single-Blinded, Monocentric Clinical Study to Compare Postoperative Analgesia and Outcome After Combined Paravertebral and Intrathecal Versus Thoracic Epidural Analgesia for Thoracotomy|Prospective, Randomised, Single-Blinded, Monocentric Clinical Study to Compare Postoperative Analgesia and Outcome After Combined Paravertebral and Intrathecal Versus Thoracic Epidural Analgesia for Thoracotomy|Completed||Phase 4|200|Anticipated|University Hospital Freiburg||2|||f||||t||||||||||2017-02-18 15:29:42.328607|2017-02-18 15:29:42.328607
NCT00493896|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2014-01-13|||July 2007||2007-07-01|September 2012|2012-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients|Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients: An Investigator Initiated Protocol|Terminated||Phase 3|27|Actual|Eastern Virginia Medical School||2||low enrollment|f||||t||||||||||2017-02-18 15:29:42.441644|2017-02-18 15:29:42.441644
NCT00493883|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2015-05-12|||December 2006||2006-12-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors|Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors|Completed||Phase 1/Phase 2|81|Actual|Southwestern Regional Medical Center||1|||f||||f||||||||||2017-02-18 15:29:42.549076|2017-02-18 15:29:42.549076
NCT00493870|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-09-15|||May 2007||2007-05-01|September 2016|2016-09-01|May 2017|Anticipated|2017-05-01|May 2015|Actual|2015-05-01||Interventional|||TAC Versus TC for Adjuvant Breast Cancer|Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients|Active, not recruiting||Phase 3|1296|Actual|US Oncology Research||2|||f||||f||||||||||2017-02-18 15:29:42.673848|2017-02-18 15:29:42.673848
NCT00493857|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2008-11-14|||June 2007||2007-06-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer|A Phase II Open-Label, 2-Cohort Study of Nimotuzumab 400 mg Weekly Plus Irinotecan (Cohort 1) and Nimotuzumab 400 mg Every 2 Weeks Plus Irinotecan (Cohort 2) in Patients With Irinotecan-Refractory Metastatic Colorectal Cancer|Terminated||Phase 2|100|Anticipated|YM BioSciences||1||Cohort 2 not going forward. Manadate changes in Company|f||||t||||||||||2017-02-18 15:29:42.889587|2017-02-18 15:29:42.889587
NCT00493844|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-10-24|||January 2007||2007-01-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||N-terminal Pro B-type Natriuretic Peptide (Nt-proBNP) Versus Exercise Test for Evaluation of Acute Chest Pain|Clinical History and NT-proBNP Versus Exercise Testing for Evaluation of Patients With Acute Chest Pain Without Ischemic Changes in the Electrocardiogram or Troponin Elevation|Completed||N/A|320|Actual|University of Valencia||2|||f||||f||||||||No||2017-02-18 15:29:43.004426|2017-02-18 15:29:43.004426
NCT00493831|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2007-06-27|||May 2006||2006-05-01|June 2007|2007-06-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Analysis of Lipid Biomarkers of Exposure and Host Response||Unknown status|Active, not recruiting|N/A|20|Actual|University of Nebraska||1|||f||||f||||||||||2017-02-18 15:29:43.123508|2017-02-18 15:29:43.123508
NCT00493818|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2017-01-16|||April 2007||2007-04-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693|An Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the AKT Inhibitor GSK690693 Given on Various Schedules in Subjects With Solid Tumors or Lymphoma|Terminated||Phase 1|70|Anticipated|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:29:43.206224|2017-02-18 15:29:43.206224
NCT00493805|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2015-11-02|2010-10-27||April 2007||2007-04-01|November 2015|2015-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)|Study to Evaluate Response Rates in Chronic Hepatitis C (CHC) Patients Genotype 1 With Insulin Resistance and to Assess Prolonged Treatment Duration in Late Virological Responders|Terminated||Phase 4|59|Actual|Merck Sharp & Dohme Corp.||2||Slow Enrollment|f||||f||||||||||2017-02-18 15:29:43.299803|2017-02-18 15:29:43.299803
NCT00493792|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-09-12|||February 2007||2007-02-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||X-3 Polyethylene Survival Outcomes Study|A Prospective, Randomized Study Comparing the Survival for X-3 Polyethylene to N2Vac Polyethylene When Used With the Triathlon Posterior Stabilized (PS) Total Knee System.|Active, not recruiting||Phase 4|516|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 15:29:43.616777|2017-02-18 15:29:43.616777
NCT00493779|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2010-08-03|2009-06-05||October 2007||2007-10-01|June 2010|2010-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|DECADES||A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients|An Exploratory, Multi-Center, Open-Label, Single-Arm Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent (DECADES) on Inflammatory and Platelet Activation Markers in Subjects Who Are Receiving Low Dose Acetylsalicylic Acid (ASA)|Completed||Phase 4|103|Actual|Bristol-Myers Squibb|The open-label and exploratory nature of this small study and the absence of control group inherently limit the interpretability of the results.|1|||f||||||||||||||2017-02-18 15:29:43.949942|2017-02-18 15:29:43.949942
NCT00493766|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-11-26|||May 2006||2006-05-01|November 2012|2012-11-01||||July 2008|Actual|2008-07-01||Interventional|||Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone|A Phase IA/IB, Two Arm, Multi-center, Open-label, Dose Escalation Study of Oral LBH589 Alone and in Combination With IV Docetaxel and Oral Prednisone in Hormone Refractory Prostate Cancer (HRPC)|Terminated||Phase 1|16|Actual|Novartis||2||Because of a strategic decision by Novartis|f||||||||||||||2017-02-18 15:29:44.254331|2017-02-18 15:29:44.254331
NCT00493753|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2007-06-26|||November 2004||2004-11-01|June 2007|2007-06-01|April 2006|Actual|2006-04-01|||||Interventional|||Feasibility and Safety of Acupuncture for Systemic Lupus|Feasibility and Safety of Acupuncture for Systemic Lupus Erythematosus|Completed||N/A|24|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 15:29:44.364941|2017-02-18 15:29:44.364941
NCT00493740|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2007-07-05|||July 2007||2007-07-01|June 2007|2007-06-01|December 2007|Anticipated|2007-12-01|||||Interventional|Cephalic chemo||Cephalic Phase of Oncology Patients Before and After Chemotherapy as Compared to Healthy Controls|Cephalic Phase of Oncology Patients Before and After Chemotherapy as Compared to Healthy Controls|Unknown status|Recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center||4|||f||||t||||||||||2017-02-18 15:29:44.439747|2017-02-18 15:29:44.439747
NCT00493727|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2008-05-16|||September 2006||2006-09-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria|Use of Mucomyst (NAC) to Ameliorate Oxidant Stress in Diabetic Patients as Measurable by Surrogate Serum Markers|Completed||N/A|15|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 15:29:44.530832|2017-02-18 15:29:44.530832
NCT00493688|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-11-28|||October 2005||2005-10-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Observational|||A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes|A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes|Active, not recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:29:44.85165|2017-02-18 15:29:44.85165
NCT00493675|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2010-06-24|||June 2006||2006-06-01|February 2009|2009-02-01|June 2010|Anticipated|2010-06-01|||||Interventional|||Biodegradable Biliary Stent for Post Operative Cystic Duct Leakage|Biodegradable Biliary Stent for Post Operative Cystic Duct Leakage. Pilot Study|Withdrawn||Phase 1|||University of Tampere||1||Difficulties in getting suitable applicators for biodegradable stents.|f||||f||||||||||2017-02-18 15:29:44.95811|2017-02-18 15:29:44.95811
NCT00493662|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2008-01-11||||||January 2008|2008-01-01||||||||Interventional|||Cross-Over Evaluation of Two Lubricating Eye Drops||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 15:29:45.059572|2017-02-18 15:29:45.059572
NCT00493649|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-09-15|2016-01-12||June 2007||2007-06-01|September 2016|2016-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional||ITT population|Adj TC + Herceptin Early Stage Breast Cancer|Phase II Trial of Adjuvant TC (Docetaxel/Cyclophosphamide) Plus Trastuzumab in HER2-Positive Early Stage Breast Cancer Patients|Completed||Phase 2|493|Actual|US Oncology Research||1|||f||||f||||||||||2017-02-18 15:29:45.157551|2017-02-18 15:29:45.157551
NCT00493636|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-05-15|2014-04-17||June 2007||2007-06-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|September 2010|Actual|2010-09-01||Interventional||All randomized patients are included (i.e., the intent-to-treat population)|1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy|A Double-Blind, Randomized Phase 2b Study of Sorafenib Compared to Placebo When Administered in Combination With Chemotherapy for Patients With Locally Advanced or MBC That Has Progressed During or After Bevacizumab Therapy|Completed||Phase 2|160|Actual|Accelerated Community Oncology Research Network||2|||f||||t||||||||||2017-02-18 15:29:45.626663|2017-02-18 15:29:45.626663
NCT00493623|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-03-01|||June 2007||2007-06-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.|A Randomized, Double-blind Study of the Efficacy of Intravenous Bonviva in the Relief of Pain After Recent Vertebral Osteoporotic Fracture in Osteoporotic Patients.|Completed||Phase 3|68|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:29:46.193935|2017-02-18 15:29:46.193935
NCT00493610|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2010-01-07|||November 2006||2006-11-01|June 2008|2008-06-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Mucomyst for Hepatitis C|Use of Mucomyst (NAC) to Ameliorate Oxidant Stress as Measured by Surrogate Serum in Patients With Hepatitis C|Suspended||N/A|5|Anticipated|VA Office of Research and Development||1||Collaborator no longer interested, short of funds|f||||f||||||||||2017-02-18 15:29:46.313153|2017-02-18 15:29:46.313153
NCT00493597|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2009-01-30|||October 2007||2007-10-01|October 2007|2007-10-01||||||||Observational|||Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of in-Stent Restenosis|Blood Endothelium Progenitor Cells and Dendritic Cells as Novel Predictive Biomarkers of in-Stent Restenosis After Percutaneous Coronary Intervention.|Unknown status|Recruiting|N/A|250|Anticipated|University Hospital, Antwerp|||1||f||||f||||||||||2017-02-18 15:29:46.417951|2017-02-18 15:29:46.417951
NCT00493584|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2009-05-19|||March 2008||2008-03-01|May 2009|2009-05-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|DaNSTEMI2||Acute Balloon Angioplasty vs. Traditional Early Invasive Treatment of Non-ST-Elevation Myocardial Infarction|Acute Angioplasty (Primary PCI) Versus Traditional Early Invasive Treatment of Patients Presenting With NSTEMI (The Second Danish Non-ST-Elevation MI Trial - DaNSTEMI-2)|Terminated||N/A|14|Actual|University of Aarhus||2||Due to insufficient patient inclusion the study has been stopped prematurely.|f||||t||||||||||2017-02-18 15:29:46.500423|2017-02-18 15:29:46.500423
NCT00493571|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2015-05-11|||August 2007||2007-08-01|May 2015|2015-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes|Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes|Completed||Phase 1|16|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:29:46.616024|2017-02-18 15:29:46.616024
NCT00493558|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2013-02-18|||July 2007||2007-07-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|SpineRSA||Spine Research With Roentgen Stereophotogrammetric Analysis|A Consecutive Case Series of One-Level Lumbar Fusions With Pedicle Screw Instrumentation and the Trabecular Metal™ Intervertebral Cage Using Roentgen Stereophotogrammetric Analysis (RSA)|Completed||Phase 4|17|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-02-18 15:29:46.72511|2017-02-18 15:29:46.72511
NCT00493545|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2008-05-05|||May 2007||2007-05-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia|A Multicenter, Nonrandomized, Open-Label Phase 1 Safety Study of HspE7 and Poly-ICLC Administered Concomitantly in Cervical Intraepithelial Neoplasia (CIN) Subjects|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|Nventa Biopharmaceuticals Corporation||1|||f||||f||||||||||2017-02-18 15:29:46.828475|2017-02-18 15:29:46.828475
NCT00493532|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-11-01|||June 2007||2007-06-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Expanded Access|||A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.|An Open Label Study to Evaluate the Effect on Bone Mineral Density, and the Safety, of Quarterly Intravenous Bonviva in Patients With Post-menopausal Osteoporosis.|No longer available||Phase 4|||Hoffmann-La Roche|||||f||||||||||||||2017-02-18 15:29:46.936281|2017-02-18 15:29:46.936281
NCT00493519|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2007-07-04|||July 2007||2007-07-01|April 2007|2007-04-01|December 2007|Anticipated|2007-12-01|||||Interventional|Cephalic 1||Cephalic Phase in Anorexia Nervosa,Bulimia Nervosa and Obese Binge Eaters|Cephalic Phase in Anorexia Nervosa,Bulimia Nervosa and Obese Binge Eaters|Unknown status|Recruiting|N/A|75|Anticipated|Tel-Aviv Sourasky Medical Center||5|||f||||t||||||||||2017-02-18 15:29:47.255478|2017-02-18 15:29:47.255478
NCT00493506|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2007-06-27|||May 2006||2006-05-01|June 2007|2007-06-01|September 2006|Actual|2006-09-01|||||Interventional|||ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency|The Effects of ProAlgaZyme Novel Algae Infusion Alone or in Combination With HAART on Markers of Immune Status, Dyslipidemia, Inflammation and Oxidative Stress in HIV or HIV/HBV Patients|Completed||N/A|59|Actual|Health Enhancement Products, Inc.||8|||f||||f||||||||||2017-02-18 15:29:47.346635|2017-02-18 15:29:47.346635
NCT00493493|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2007-06-27|||January 2007||2007-01-01|June 2007|2007-06-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease|Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease|Unknown status|Recruiting|N/A|50|Anticipated|Matino, James, M.D.||1|||f||||f||||||||||2017-02-18 15:29:47.445876|2017-02-18 15:29:47.445876
NCT00493480|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2009-08-07|||September 2003||2003-09-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|DACAPO||Danish Carvedilol Study in Portal Hypertension|Danish Carvedilol Study in Portal Hypertension. Carvedilol in the Prevention of Bleeding in Portal Hypertension and Esophageal Varices|Completed||Phase 3|40|Anticipated|Hvidovre University Hospital||2|||f||||t||||||||||2017-02-18 15:29:47.535822|2017-02-18 15:29:47.535822
NCT00493467|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2015-11-17|||June 2006||2006-06-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas|Phase II Study of Zevalin for the Treatment of Early-Stage Indolent Lymphomas|Completed||Phase 2|31|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:29:47.635156|2017-02-18 15:29:47.635156
NCT00493454|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2013-05-30|2012-09-28||April 2006||2006-04-01|May 2013|2013-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas|Multicenter Phase II Study for Zevalin® in Patients With Relapsed/Refractory Indolent Lymphomas: Extranodal Marginal Lymphoma of MALT Type, Nodal Marginal Zone B-Cell Lymphoma, and Splenic Marginal B-Cell Lymphoma|Terminated||Phase 2|6|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 15:29:47.773956|2017-02-18 15:29:47.773956
NCT00493441|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-08-05|||June 2007||2007-06-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer|A Phase II Study of AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer|Terminated||Phase 2|28|Actual|Vertex Pharmaceuticals Incorporated||1|||f||||t||||||||||2017-02-18 15:29:47.991803|2017-02-18 15:29:47.991803
NCT00493428|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2014-05-15|||July 2007||2007-07-01|May 2014|2014-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study|Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study|Withdrawn||Phase 2|0|Actual|University of Manitoba||1||The study have been stoped because the protocol is going to be modify.|f||||f||||||||||2017-02-18 15:29:48.114442|2017-02-18 15:29:48.114442
NCT00493415|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2008-07-15|||June 2007||2007-06-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|NISMIS||The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis|The Evaluation of the Effect of Nitroglycerine Versus Placebo on the Microcirculation by Means of SDF Imaging in Septic Patients on the ICU|Completed||Phase 3|70|Actual|Medical Centre Leeuwarden||2|||f||||f||||||||||2017-02-18 15:29:48.209376|2017-02-18 15:29:48.209376
NCT00493402|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2012-12-12|||July 2007||2007-07-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|TACEforHCC||Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma|The Efficacy, Safety, and Patient Reported Outcomes of Different Regimens of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma|Completed||Phase 3|365|Actual|Sun Yat-sen University||3|||f||||t||||||||||2017-02-18 15:29:48.320407|2017-02-18 15:29:48.320407
NCT00493389|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2008-08-01|||July 2007||2007-07-01|July 2008|2008-07-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|CRAAS||Cortisol Response to Adrenocorticotrophin (ACTH) in Acute Stress|Improving The Assessment of Hypothalamic Pituitary Adrenal Function In Acute Stress|Unknown status|Recruiting|N/A|80|Anticipated|University of Ottawa||1|||f||||t||||||||||2017-02-18 15:29:48.445482|2017-02-18 15:29:48.445482
NCT00493376|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-02-01|||August 2007||2007-08-01|February 2012|2012-02-01||||||||Observational|||Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer|Prospective Study of Tirapazamine Targeting in Cervical Cancer|Terminated||N/A|1|Actual|British Columbia Cancer Agency|||1|"This study was a companion study to another one. The other study closed early so this one did~   as well."|f||||f||||||||||2017-02-18 15:29:48.544827|2017-02-18 15:29:48.544827
NCT00493363|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2010-01-21|||June 2007||2007-06-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia|Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia|Completed||N/A|40|Anticipated|University of Oxford||2|||f||||t||||||||||2017-02-18 15:29:48.639935|2017-02-18 15:29:48.639935
NCT00493350|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-07-27|||October 2005||2005-10-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer|International Stage IV Stratification Study (ISSS): Prospective Validation Trial of Circulating Tumor Cells (CTCs) as Prognostic and Predictive Markers in Women With Metastatic Breast Cancer About to Start First-Line Treatment|Completed||Phase 4|660|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood collected prior to the initiation of chemotherapy as follows: 1 x 4 ml (serum tube),~     2x10 ml (CellSave Tube), and 1x10 ml EDTA (selected centers); To perform global gene~     profiling on selected specimens and correlate the profiles with clinical outcomes.~   "|||2017-02-18 15:29:48.750026|2017-02-18 15:29:48.750026
NCT00493337|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2010-06-24|||May 2008||2008-05-01|June 2007|2007-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment|A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment|Completed||N/A|373|Actual|Utrecht Institute for Pharmaceutical Sciences||3|||f||||f||||||||||2017-02-18 15:29:48.864915|2017-02-18 15:29:48.864915
NCT00493324|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2012-02-01|||July 2007||2007-07-01|January 2012|2012-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis|An Open-Label Phase 4 Study in Adult Patients With Chronic Plaque Psoriasis to Evaluate the Immune Response to Pneumococcal Vaccine in Subjects Treated With Alefacept|Completed||Phase 4|43|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 15:29:48.985185|2017-02-18 15:29:48.985185
NCT00490087|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2011-09-01|||January 1999||1999-01-01|June 2007|2007-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women|Operational Hysteroscopy Versus Traditional Surgery: Costs and Health Benefits|Completed||Phase 3|21|Actual|IRCCS Burlo Garofolo||2|||f||||f||||||||||2017-02-18 15:31:11.489046|2017-02-18 15:31:11.489046
NCT00493311|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-10-18|2009-09-25||June 2007||2007-06-01|October 2016|2016-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study of the Efficacy and Safety of Intravenous Acetaminophen Versus Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males|Completed||Phase 3|60|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 15:29:49.121453|2017-02-18 15:29:49.121453
NCT00493298|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2017-02-09|||June 2007||2007-06-01|February 2017|2017-02-01|December 2027|Anticipated|2027-12-01|December 2027|Anticipated|2027-12-01||Observational|TOP||Tysabri Observational Program|TOP: Tysabri® Observational Program|Recruiting||N/A|6000|Anticipated|Biogen|||1||f||||t||||||||||2017-02-18 15:29:49.623713|2017-02-18 15:29:49.623713
NCT00493285|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-07-13|2012-03-12||July 2007||2007-07-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|November 2009|Actual|2009-11-01||Interventional|CP149||Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability,Immunogenicity, and Viral Shedding of MEDI-534, a Live, Attenuated Intranasal Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV), in Healthy Children 6 to <24 Months of Age|Completed||Phase 1|49|Actual|MedImmune LLC||3|||f||||t||||||||||2017-02-18 15:29:50.432074|2017-02-18 15:29:50.432074
NCT00493272|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2015-11-30|||June 2007||2007-06-01|November 2015|2015-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Dilutional Coagulopathy in Patients Undergoing Elective Surgery|Fibrinogen vs Placebo for Improvement of Clot Strength|Completed||Phase 1/Phase 2|20|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 15:29:53.052893|2017-02-18 15:29:53.052893
NCT00493259|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2008-01-21|||June 2007||2007-06-01|June 2007|2007-06-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Observational|||Health Related QOL, Depression and Lifestyle Changes in Insulin Resistant Adolescents|Health-Related Quality of Life, Depression and the Impact on Successful Incorporation of Lifestyle Changes in Insulin Resistant Adolescents as Evidenced by Changes in BMI, Waist Circumference and Metabolic Parameters|Unknown status|Recruiting|N/A|100|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-02-18 15:29:53.177669|2017-02-18 15:29:53.177669
NCT00493246|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-09-08|2009-09-25||June 2007||2007-06-01|September 2016|2016-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Pharmacokinetic (PK) Study of Intravenous (IV) Acetaminophen Administration in Pediatric Inpatients|A Prospective, Multi-Center, Randomized, Open-Label, Single and Repeated Dose, 48 Hour Study, of Intravenous Acetaminophen in Pediatric Inpatients to Determine Pharmacokinetics (PK) and Safety in Acute Pain and Fever|Completed||Phase 1|75|Actual|Mallinckrodt|"Median ranges were not calculated or not assessable for neonates at the following due to limited samples.:~12.5 mg/kg q6h- t1/2 (h)~15 mg/kg q8h -Cmax, Tmax, AUC0-t and t1/2."|2|||f||||f||||||||||2017-02-18 15:29:53.277362|2017-02-18 15:29:53.277362
NCT00493233|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2009-05-18|||November 2006||2006-11-01|May 2009|2009-05-01||||December 2008|Actual|2008-12-01||Interventional|||Antipsychotic Polypharmacy in Schizophrenia|Antipsychotic Polypharmacy in Schizophrenia|Completed||N/A|100|Anticipated|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 15:29:54.517588|2017-02-18 15:29:54.517588
NCT00493220|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2011-10-24|2011-09-12||June 2007||2007-06-01|October 2011|2011-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|INFUSE-Cftrx||Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration|INcreased Flow Utilizing Subcutaneously-Enabled Ceftriaxone (INFUSE-Ceftriaxone) Study: A Phase I Study Comparing the Safety and Pharmacokinetics of Ceftriaxone Administered Subcutaneously With and Without Human Recombinant Hyaluronidase (HYLENEX Recombinant) and Intravenously in Human Volunteers|Completed||Phase 1|30|Actual|Baxter Healthcare Corporation||6|||f||||f||||||||||2017-02-18 15:29:54.632589|2017-02-18 15:29:54.632589
NCT00493194|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2008-11-25|||May 2005||2005-05-01|October 2005|2005-10-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Fibrosis in Renal Allografts|Interstitial Fibrosis in Protocol Biopsies of Renal Allografts: A Prospective, Randomised Trial of Sirolimus Versus Cyclosporine.(Fibrasic)|Unknown status|Recruiting|Phase 4|100|Anticipated|University Hospital, Antwerp|||||f||||||||||||||2017-02-18 15:29:58.111512|2017-02-18 15:29:58.111512
NCT00493181|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-02-17|2011-04-01||October 2005||2005-10-01|February 2012|2012-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients|The Effect of Interleukin 11 on Thrombocytopenia Associated With Imatinib or Other Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myelogenous Leukemia|Completed||Phase 2|8|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:29:58.227858|2017-02-18 15:29:58.227858
NCT00493168|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2013-05-24|||January 1998||1998-01-01|June 2007|2007-06-01|November 2006|Actual|2006-11-01|||||Observational|||Determination of the Prevalence and Prognostic Importance of Unrecognized Non-Q-wave Myocardial Infarction by MRI|Unrecognized Non-Q-wave Myocardial Infarction: Prevalence, Angiographic Correlation, and Prognostic Significance in Patients With Suspected Coronary Disease|Completed||N/A|185|Actual|Duke University|||||f||||||||||||||2017-02-18 15:29:58.447955|2017-02-18 15:29:58.447955
NCT00493155|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-27|2016-11-01|||October 2005||2005-10-01|November 2016|2016-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.|"An Open-label, Multiple Ascending Dose Study to Determine the Maximum Tolerated Dose of R1530 in Patients With Advanced Solid Tumors."|Completed||Phase 1|48|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:29:58.535367|2017-02-18 15:29:58.535367
NCT00493142|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-09-14|||July 2008||2008-07-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|July 2013|Actual|2013-07-01||Interventional|PREP||Pre-operative Rehabilitation Exercise Program for Total Knee Arthroplasty|Impact of a Pre-operative Rehabilitation Exercise Program for Patients With Severe Dysfunction Awaiting Total Knee Arthroplasty|Active, not recruiting||N/A|240|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 15:29:58.625512|2017-02-18 15:29:58.625512
NCT00493129|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-02-07|||July 2004||2004-07-01|February 2012|2012-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)|ONTAK (Denileukin Diftitox) in Patients With Systemic Mastocytosis|Completed||Phase 2|8|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:29:58.723761|2017-02-18 15:29:58.723761
NCT00493116|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-09-12|||October 2003||2003-10-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|RENeu||Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta|A Multi-Centre, Open Label Study to Investigate the Recovery of IFN-beta Efficacy in Relapsing-Remitting Multiple Sclerosis Patients With Neutralising IFN-beta Antibodies and Reduced Bioavailability|Completed||Phase 4|20|Actual|Biogen||1|||f||||f||||||||||2017-02-18 15:29:58.832674|2017-02-18 15:29:58.832674
NCT00493103|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-06-25|||July 2003||2003-07-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Observational|||TG Gene Mutations and Congenital Hypothyroidism|Congenital Hypothyroidism Due to Thyroglobulin Mutations in an Inbred Brazilian Family: A Novel Compound Heterozygous Constellation and Intronic Mutation Related to Fetal Goiter.|Completed||N/A|||University of Sao Paulo|||||f||||f||||||||||2017-02-18 15:29:58.94712|2017-02-18 15:29:58.94712
NCT00493090|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-01-20|||October 2005||2005-10-01|November 2015|2015-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Evaluating the Impact of GP and Practice Nurse Training in Self Regulations Skills on Patient Outcomes|Effects of Patient-centred Asthma Education for GPs and Practice Nurses:Evaluating the Impact of Training in Self Regulation Skills on Patient Outcomes:a Randomised Controlled Trial|Completed||N/A|360|Actual|University of Aberdeen||1|||f||||t||||||||||2017-02-18 15:29:59.019506|2017-02-18 15:29:59.019506
NCT00493077|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2008-01-28|||May 2004||2004-05-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|SAFE||Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy|A Swedish Multi-Centre, Prospective, Open Label Study: Safety of Avonex Treatment in Multiple Sclerosis Patients Who Are NAB Positive on Previous s.c Interferon Beta Therapy|Completed||Phase 4|3|Actual|Biogen||1|||f||||t||||||||||2017-02-18 15:29:59.356791|2017-02-18 15:29:59.356791
NCT00493064|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2015-10-21|||October 2006||2006-10-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions|Niacin (as a Vasodilator), and a Topical Steroid (for Macular Edema), Non-Ischemic CRVO,HRVO,BRVO|Active, not recruiting||Phase 2/Phase 3|68|Anticipated|Palo Alto Medical Foundation||1|||f||||f||||||||||2017-02-18 15:29:59.482691|2017-02-18 15:29:59.482691
NCT00493051|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2010-02-08|||November 2007||2007-11-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|MATRIX||Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities|A Randomized, Double-Blind, Placebo-Controlled, Single- and Double-Dose, Comparator Arm (Standard of Care), Multicenter Phase 2b Study of Topical GAM501 (Ad5PDGF-B/Bovine Type I Collagen Gel) in the Treatment of Non-Healing Diabetic Ulcers of the Lower Extremities|Completed||Phase 2|124|Actual|Tissue Repair Company||5|||f||||t||||||||||2017-02-18 15:29:59.601805|2017-02-18 15:29:59.601805
NCT00493038|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-11-03|2009-01-20||February 2006||2006-02-01|November 2014|2014-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis|Prospective, Multicenter, Randomized, Double Blind, Parallel Arm Study to Evaluate the Efficacy and Safety of Moxifloxacin 400 mg OD for 7 Days Versus a Standard Antibiotic Therapy for 10 Days in the Treatment of Acute Bacterial Rhino Sinusitis|Terminated||Phase 4|293|Actual|Bayer|The study was prematurely terminated due to slow enrollment beyond the planned study timelines.|2||"The study was prematurely terminated due to slow enrollment beyond the planned study~   timelines."|f||||f||||||||||2017-02-18 15:29:59.751638|2017-02-18 15:29:59.751638
NCT00493025|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2011-08-15|||April 2005||2005-04-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery|Phase II Study in Operable Adenocarcinoma of the Esophagus to Measure Response Rate and Toxicity of Preoperative Combined Modality Paclitaxel (Taxol®, Bristol-Myers Squibb), Cisplatin (Platinol®, Abbott Laboratories), ZD1839 (IRESSA®) and Radiotherapy Followed by Postoperative ZD1839|Terminated||Phase 2|36|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1||Completed as planned|f||||||||||||||2017-02-18 15:30:00.278998|2017-02-18 15:30:00.278998
NCT00493012|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-02-07|2011-03-29||January 2006||2006-01-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|SMART||Vitamin D Effects in Overweight Patients|Effects of a Vitamin D (Cholecalciferol) Supplement on Body Composition, Blood Pressure, and Lipid and Diabetes Parameters in Overweight Patients Attending a Telemedically Guided Weight Loss Program|Completed||Phase 4|200|Actual|Heart and Diabetes Center North-Rhine Westfalia||2|||f||||f||||||||||2017-02-18 15:30:00.407895|2017-02-18 15:30:00.407895
NCT00492999|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2016-06-01|||May 2007||2007-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver|A Phase II Study of the Rate of Conversion to Complete Resection in Patients With Initially Inoperable Hepatic-Only Metastases From Colorectal Cancer After Treatment With Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Best Systemic Chemotherapy|Active, not recruiting||Phase 2|64|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 15:30:00.966473|2017-02-18 15:30:00.966473
NCT00492986|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-12-26|||October 2005||2005-10-01|December 2014|2014-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma|An Open Label, Non Comparative, Phase III Study of the Raf Kinase Inhibitor BAY 43-9006 as a Subsequent to First Line Therapy in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 3|1150|Actual|Bayer||1|||f||||f||||||||||2017-02-18 15:30:01.33664|2017-02-18 15:30:01.33664
NCT00492973|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-10-29|2012-10-18||March 2006||2006-03-01|April 2013|2013-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?|Peri-articular Injections Containing a Corticosteroid During Total Knee Arthroplasty|Completed||N/A|101|Actual|New Lexington Clinic|One patient died 25 days after the surgery as a result of complications associated with deep knee joint sepsis.|2|||f||||f||||||||||2017-02-18 15:30:01.488798|2017-02-18 15:30:01.488798
NCT00492960|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2010-01-18|||August 2007||2007-08-01|January 2010|2010-01-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|||Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease|A Phase IIb, Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Multicenter Study to Determine the Safety, Tolerance, and Efficacy of AT-1001 in Celiac Disease Subjects During a Gluten Challenge|Completed||Phase 2|184|Actual|Alba Therapeutics||4|||f||||f||||||||||2017-02-18 15:30:02.005906|2017-02-18 15:30:02.005906
NCT00492947|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2013-01-10|||June 2007||2007-06-01|May 2010|2010-05-01|June 2012|Anticipated|2012-06-01|June 2010|Anticipated|2010-06-01||Interventional|Dendritic||Dendritic Cell Vaccine for Head and Neck Cancer|0608 GCC:Phase I Study of Intra-tumoral Injection of Dendritic Cells for the Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Withdrawn||Phase 1|0|Actual|University of Maryland||1||major amendments in progress|f||||t||||||||||2017-02-18 15:30:02.151778|2017-02-18 15:30:02.151778
NCT00492934|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-09-09|||January 2004||2004-01-01|September 2014|2014-09-01|October 2014|Anticipated|2014-10-01|October 2013|Actual|2013-10-01||Interventional|||What is the Best Preparation for Embryo Transfer in Cryo Cycles: a Natural Cycle or Light Hormonal Stimulation?|Natural Cycle Versus Stimulation With Human Menopausal Gonadotropin in Cycles With Cryopreserved Embryos|Unknown status|Active, not recruiting|N/A|300|Anticipated|University Hospital, Gasthuisberg||2|||f||||f||||||||||2017-02-18 15:30:02.258606|2017-02-18 15:30:02.258606
NCT00492921|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-06-03|||May 2007||2007-05-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||High-Dose Cyclophosphamide in Treating Patients With Acute Graft-Versus-Host Disease That Did Not Respond to Steroid Therapy||Completed||Phase 2|12|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 15:30:02.369154|2017-02-18 15:30:02.369154
NCT00492908|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-04-30|||June 2007||2007-06-01|April 2014|2014-04-01|August 2013|Actual|2013-08-01|March 2009|Actual|2009-03-01||Interventional|||Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent|Randomized Clinical Trial Comparing A Titanium-Nitride-Oxide Coated Stent With A Zotarolimus-Eluting Stent in Patients With Coronary Artery Disease|Completed||Phase 4|303|Actual|University of Bern||2|||f||||f||||||||||2017-02-18 15:30:02.478973|2017-02-18 15:30:02.478973
NCT00492895|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2013-01-28|||June 2007||2007-06-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients|Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients|Completed||Phase 4|25|Actual|University of Zurich||1|||f||||f||||||||||2017-02-18 15:30:02.603572|2017-02-18 15:30:02.603572
NCT00492882|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2007-06-26|||November 2003||2003-11-01|September 2003|2003-09-01|January 2007|Actual|2007-01-01|||||Observational|SOPK||Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome|Dynamic Changes in the Serum Anti-Müllerian Hormone Level During Low-Dose recFSH Administration Further Support Its Role in the Anovulation of Polycystic Ovary Syndrome|Completed||Phase 4|30|Actual|University Hospital, Lille|||||f||||f||||||||||2017-02-18 15:30:02.709433|2017-02-18 15:30:02.709433
NCT00492869|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-09-22|||January 2007||2007-01-01|September 2016|2016-09-01||||May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation|A 12-month Open-label, Randomized, Multicenter, Sequential Cohort, Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of Oral AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Corticosteroids in de Novo Adult Renal Transplant Recipients|Completed||Phase 1/Phase 2|124|Actual|Novartis|||||f||||||||||||||2017-02-18 15:30:02.81214|2017-02-18 15:30:02.81214
NCT00492856|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2016-04-14|2014-04-22||June 2007||2007-06-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|December 2013|Actual|2013-12-01||Interventional|||S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia|S0521, A Randomized Trial of Maintenance Versus Observation for Patients With Previously Untreated Low and Intermediate Risk Acute Promyelocytic Leukemia (APL), Phase III|Completed||Phase 3|105|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 15:30:02.973166|2017-02-18 15:30:02.973166
NCT00492843|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2016-02-14|||July 2007||2007-07-01|February 2016|2016-02-01|July 2008|Actual|2008-07-01|January 2008|Actual|2008-01-01||Interventional|||Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis|A Randomized Study to Evaluate the Safety and Efficacy of Loading Dose of Bondronat Versus Standard Dose of Bondronat in Patients With Lung Cancer and Skeletal Metastasis Experiencing Moderate to Severe Pain|Terminated||Phase 4|20|Actual|Chinese Society of Lung Cancer||2||It is too difficult to recruit suitable patients.|f||||t||||||||||2017-02-18 15:30:04.676393|2017-02-18 15:30:04.676393
NCT00492830|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2010-02-03|||June 2007||2007-06-01|February 2010|2010-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors|A Phase 1, Open-label, Dose Escalation Study of the Humanized Monoclonal Antibody, TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors|Completed||Phase 1|19|Actual|Tracon Pharmaceuticals Inc.||1|||f||||f||||||||||2017-02-18 15:30:04.792634|2017-02-18 15:30:04.792634
NCT00492817|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2017-02-09|||October 2005|Actual|2005-10-01|February 2017|2017-02-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Evaluation of Single Session Stereotactic Body Radiotherapy|Phase I/II Evaluation of Single Session Stereotactic Body Radiotherapy for Spinal or Paraspinal Metastases|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:30:04.888739|2017-02-18 15:30:04.888739
NCT00492804|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2013-01-25|||July 2005||2005-07-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Interventional|||Elective Neurectomy During Inguinal Hernia Repair|Effect of Elective Intraoperative Neurectomy on Chronic Pain After Lichtenstein Hernia Repair. A Prospective, Single-blind, Randomized, Controlled Clinical Trial|Completed||Phase 2|200|Actual|Cantonal Hospital of St. Gallen||2|||f||||f||||||||||2017-02-18 15:30:04.994312|2017-02-18 15:30:04.994312
NCT00492791|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-04-16|||March 2007||2007-03-01|August 2011|2011-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|CAPSCDEIS||Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy|Development and Validation of an Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy|Completed||Phase 4|158|Actual|Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives|||1||f||||f||||||||||2017-02-18 15:30:05.320418|2017-02-18 15:30:05.320418
NCT00492778|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2016-10-26|||February 2008||2008-02-01|October 2016|2016-10-01||||January 2017|Anticipated|2017-01-01||Interventional|||Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer|A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus|Recruiting||Phase 2|164|Anticipated|Gynecologic Oncology Group||2|||f||||t||||||||||2017-02-18 15:30:05.459546|2017-02-18 15:30:05.459546
NCT00492765|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2010-10-14|||February 2006||2006-02-01|October 2010|2010-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|SIMCOMBIN||Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis|A Multi-centre, Double Blind, Randomised, Placebo Controlled, Parallel Group Study Investigating Simvastatin as an Add-on Treatment IM Administered Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis|Completed||Phase 4|380|Actual|Biogen||2|||f||||t||||||||||2017-02-18 15:30:06.66523|2017-02-18 15:30:06.66523
NCT00492752|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-03-26|2010-12-08||October 2005||2005-10-01|March 2014|2014-03-01|July 2009|Actual|2009-07-01|March 2007|Actual|2007-03-01||Interventional|||A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma|A Randomized, Double-blinded, Placebo-controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 3|226|Actual|Bayer|On review of unblinded data, up to 19 Mar. 2007, the independent Data Monitoring Committee concluded the efficacy results can be considered positive, recommended subjects under placebo to cross over to Sorafenib; study continued to extension phase.|2|||f||||t||||||||||2017-02-18 15:30:06.790673|2017-02-18 15:30:06.790673
NCT00492739|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2016-12-29|||June 2007||2007-06-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|April 2017|Anticipated|2017-04-01||Interventional|VZVinOLTx||Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients|Induction and Maintenance of Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients: a Retrospective and Prospective Nationwide Study in Switzerland|Recruiting||Phase 2/Phase 3|80|Anticipated|University Hospital, Geneva||1|||f||||t||||||||Undecided||2017-02-18 15:30:08.05618|2017-02-18 15:30:08.05618
NCT00492726|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-11-03|2010-02-11||July 2006||2006-07-01|November 2014|2014-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem|A Prospective, Randomized, Double-dummy, Double-blind, Multicenter Trial Comparing the Safety and Efficacy of Intravenous Moxifloxacin 400 mg IV QD 24 Hours to That of Ertapenem 1.0 g IV QD 24 Hours for 5 to 14 Days for the Treatment of Subjects With Complicated Intra-abdominal Infections (PROMISE Study)|Completed||Phase 3|804|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:30:08.183829|2017-02-18 15:30:08.183829
NCT00492713|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-03-27|||June 2007||2007-06-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|September 2008|Actual|2008-09-01||Interventional|||Polyphenol Bioavailability From Chocolate|Comparison of the Bioavailability of Polyphenols From Milk and Dark Chocolate|Completed||N/A|18|Actual|Nestlé||3|||f||||f||||||||||2017-02-18 15:30:09.178084|2017-02-18 15:30:09.178084
NCT00492700|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2007-06-26|||January 2003||2003-01-01|June 2007|2007-06-01||||||||Interventional|FLIRT||A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis|A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis|Completed||Phase 2|63|Actual|Association pour la Recherche sur les Maladies Hépatiques Virales||2|||f||||f||||||||||2017-02-18 15:30:09.284187|2017-02-18 15:30:09.284187
NCT00492687|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-01-09|||December 2006||2006-12-01|July 2009|2009-07-01||||July 2009|Anticipated|2009-07-01||Interventional|||Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas|A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas|Unknown status|Recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:30:09.377611|2017-02-18 15:30:09.377611
NCT00492674|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2007-06-26||||||April 2007|2007-04-01||||||||Interventional|||The Effect of Perioperative Neuromuscular Training on the Outcome of Total Knee Arthroplasty|The Effect of Perioperative Neuromuscular Training on the Outcome of Total Knee Arthroplasty: A Double Blind Randomized Prospective Study|Unknown status|Not yet recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:30:09.47564|2017-02-18 15:30:09.47564
NCT00492661|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-05-24|||July 2007||2007-07-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PRIDE||A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus|A Pilot Trial of the Effect of Dietary and Exercise Intervention on Insulin Resistance and Metabolic Parameters in De Novo Renal Transplant Recipients on Prograf (Tacrolimus)|Completed||Phase 4|55|Actual|Janssen-Cilag Pty Ltd||1|||f||||f||||||||||2017-02-18 15:30:09.551977|2017-02-18 15:30:09.551977
NCT00492648|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-04-04|||June 2007||2007-06-01|June 2012|2012-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Month 30 & 42 Extension Studies of CRD-004 Primary Study|An Extension Study to Evaluate the Persistence of the Immune Responses Induced by GSK Biologicals Zoster Vaccine, GSK324332A, Administered in Healthy Adult Subjects Aged 18-30 Years and 50-70 Years|Completed||Phase 2|34|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 15:30:09.682728|2017-02-18 15:30:09.682728
NCT00492635|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-10-27|||December 2004||2004-12-01|October 2014|2014-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED|A Randomized, Double-blind, Double-dummy, Multicenter Parallel Group Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil Versus Vardenafil PRN Versus Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving Erectile Function|Completed||Phase 3|628|Actual|Bayer||3|||f||||||||||||||2017-02-18 15:30:09.795752|2017-02-18 15:30:09.795752
NCT00492622|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2011-09-21|||June 2007||2007-06-01|August 2011|2011-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis|Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Patients With Heartburn Associated With Gastroparesis|Completed||Phase 4|15|Anticipated|University of Louisville||1|||f||||f||||||||||2017-02-18 15:30:09.980107|2017-02-18 15:30:09.980107
NCT00492609|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2009-11-10|||May 2006||2006-05-01|November 2009|2009-11-01|April 2008|Actual|2008-04-01|||||Observational|||Medical and Economical Evaluation of Computer-assisted Reconstruction of the Anterior Cruciate Ligament (ACL)|Medical and Economical Evaluation of Computer-assisted Reconstruction of the ACL|Completed||N/A|285|Actual|University Hospital, Grenoble|||2||f||||t||||||||||2017-02-18 15:30:10.083368|2017-02-18 15:30:10.083368
NCT00492596|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-08-07||2014-08-07|June 2006||2006-06-01|August 2014|2014-08-01|June 2011|Actual|2011-06-01|April 2011|Actual|2011-04-01||Interventional|||The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence|An Evaluation of the AttenueX IntraVesical System in the Management of Female Subjects With Stress Urinary Incontinence|Completed||Phase 3|166|Actual|Solace Therapeutics, Inc.||2|||f||||f||||||||||2017-02-18 15:30:10.184119|2017-02-18 15:30:10.184119
NCT00492583|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2011-07-21|2011-06-21||July 2007||2007-07-01|June 2011|2011-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|SIPPY||Study to Investigate the Potential of Probiotics in Yogurt|Study to Investigate the Potential of Probiotics in Yogurt|Completed||Phase 3|182|Actual|Georgetown University||2|||f||||t||||||||||2017-02-18 15:30:10.420854|2017-02-18 15:30:10.420854
NCT00492570|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2009-06-15|||April 2006||2006-04-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|October 2007|Actual|2007-10-01||Observational|FIT||GER-009-06-AVX Early Therapy in Multiple Sclerosis|GER-009-06-AVX Early Therapy in Multiple Sclerosis|Completed||N/A|230|Actual|Biogen|||1||f||||f||||||||||2017-02-18 15:30:10.788377|2017-02-18 15:30:10.788377
NCT00492557|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-01-17|2012-01-17||September 2007||2007-09-01|January 2012|2012-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults|A Phase 3, Randomized, Double-blind Trial to Evaluate Safety, Tolerability, and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine When Administered Concomitantly With Trivalent Inactivated Influenza Vaccine in Healthy Adults 65 Years of Age or Older, Who Are Naive to 23-Valent Pneumococcal Polysaccharide Vaccine|Completed||Phase 3|1185|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:30:10.882753|2017-02-18 15:30:10.882753
NCT00492544|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-11-03|2009-11-12||July 2007||2007-07-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age|Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 When Administered as a 3-dose Schedule in Healthy Japanese Pre-adolescent and Adolescent Female Subjects.|Completed||Phase 3|100|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:30:12.249153|2017-02-18 15:30:12.249153
NCT00492531|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2015-12-07|2011-04-28||June 2007||2007-06-01|December 2015|2015-12-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease|Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy|Terminated||Phase 2|74|Actual|National Heart, Lung, and Blood Institute (NHLBI)|As a result of early termination due to safety findings, the study was underpowered to assess the effects of sildenafil therapy on the predetermined efficacy endpoints.|2||Subjects on drug were more likely to have severe pain crises requiring hospitalization.|f||||t||||||||||2017-02-18 15:30:12.679139|2017-02-18 15:30:12.679139
NCT00492518|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2007-06-26|||February 2002||2002-02-01|June 2007|2007-06-01|October 2004|Actual|2004-10-01|||||Interventional|ATHENS||Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy|Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy: A Placebo Controlled Randomized Study|Completed||Phase 4|254|Actual|Technische Universität München||4|||f||||t||||||||||2017-02-18 15:30:13.337581|2017-02-18 15:30:13.337581
NCT00492505|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-01-09|||April 2007||2007-04-01|July 2009|2009-07-01||||December 2011|Anticipated|2011-12-01||Interventional|||Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma|A Phase II Pilot Trial of Sorafenib, Tamoxifen and Cisplatin as Adjuvant Therapy for Patients With Stage III Malignant Melanoma|Unknown status|Recruiting|Phase 2|200|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:30:13.428131|2017-02-18 15:30:13.428131
NCT00492492|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-09-06|||May 2007||2007-05-01|September 2016|2016-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|fradius||Treatement of Extension Fractures of the Distal Radius|Treatement of Extension Fractures of the Distal Radius : Prospective Randomized Postoperative Comparison Between Trans-styloid and Intrafical Pinning on the One Side and Volar Fixed-angle Plating on the Other Side.|Completed||N/A|110|Actual|University Hospital, Limoges||2|||f||||t||||||||||2017-02-18 15:30:13.526392|2017-02-18 15:30:13.526392
NCT00492479|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-12-18|||June 2007||2007-06-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging||Terminated||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 15:30:13.64013|2017-02-18 15:30:13.64013
NCT00492466|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2008-01-28|||March 2003||2003-03-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|RECOVER||Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies|A Multicentre, Open Label, Non-Comparative Trial Investigating the Recovering of INF-Beta Efficacy in Breakthrough Relapsing-Remitting Multiple Sclerosis Patients With Neutralizing Interferon-Beta Antibodies|Completed||Phase 4|14|Actual|Biogen||1|||f||||t||||||||||2017-02-18 15:30:13.821915|2017-02-18 15:30:13.821915
NCT00492453|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2010-01-13|||September 2004||2004-09-01|June 2008|2008-06-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|SALC||Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy|A Controlled Randomized Trial Comparing Spinal Versus General Anesthesia for Elective Laparoscopic Cholecystectomy in Fit Patients|Unknown status|Recruiting|N/A|300|Anticipated|University of Thessaly||2|||f||||t||||||||||2017-02-18 15:30:13.930966|2017-02-18 15:30:13.930966
NCT00492440|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2012-10-17|||May 2007||2007-05-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer|"A Phase I Study of Subcutaneous CYT 107 (Interleukin-7) in Refractory Metastatic Melanoma or Renal Cell Carcinoma"|Terminated||Phase 1|9|Actual|Cytheris SA||1|||f||||f||||||||||2017-02-18 15:30:14.042606|2017-02-18 15:30:14.042606
NCT00492427|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2009-01-06|||June 2007||2007-06-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|||Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)|Correction and Maintenance Study of Subcutaneous Injections of R744 to Predialysis Patients ( Phase III, Comparative Study in Comparison With Epoetin Beta)|Completed||Phase 3|187|Actual|Chugai Pharmaceutical||2|||f||||t||||||||||2017-02-18 15:30:14.159254|2017-02-18 15:30:14.159254
NCT00492401|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2016-05-18|2015-10-22||May 2007||2007-05-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|December 2010|Actual|2010-12-01||Interventional|||Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia|Phase II Study of Decitabine in Acute Myeloid Leukemia|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)|After completing the target accrual of 33 subjects, the study was expanded to include 22 additional patients. All patients who received decitabine are included in the analyses, except for two who had not completed therapy at the time of the analysis.|1|||f||||||||||||||2017-02-18 15:30:14.371146|2017-02-18 15:30:14.371146
NCT00492388|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-01-10|||June 2007||2007-06-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Comparing the Efficacy and Safety of PMI-150 (Intranasal Ketamine) to Placebo as an Analgesic for the Treatment of Breakthrough Pain in Cancer Patients|Terminated||Phase 3|2|Actual|Hospira, Inc.||2||Business decision not to continue development|f||||f||||||||||2017-02-18 15:30:14.934059|2017-02-18 15:30:14.934059
NCT00492362|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2008-06-02|||July 2007||2007-07-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Trial of Aerobic Exercise in Patients Undergoing Outpatient Hemodialysis|A Randomized Controlled Trial of Aerobic Exercise in Patients With End Stage Renal Disease During Outpatient Hemodialysis|Completed||N/A|60|Actual|University of Manitoba||2|||f||||t||||||||||2017-02-18 15:30:15.042195|2017-02-18 15:30:15.042195
NCT00492349|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-03-19|||May 2007||2007-05-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|May 2010|Actual|2010-05-01||Interventional|||Varenicline Adjunctive Treatment in Schizophrenia|Varenicline Adjunctive Treatment in Schizophrenia|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|University of Maryland||2|||f||||t||||||||||2017-02-18 15:30:15.151337|2017-02-18 15:30:15.151337
NCT00492336|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2013-06-17|2013-02-01||January 2007||2007-01-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia|Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia|Completed||Phase 4|84|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 15:30:15.267366|2017-02-18 15:30:15.267366
NCT00492323|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-01-15||2013-01-15|March 2007||2007-03-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group With a Crossover Confirmation Period Study of RWJ-333369 for the Treatment of Postherpetic Neuralgia.|Completed||Phase 2|91|Actual|SK Life Science||2|||f||||||||||||||2017-02-18 15:30:15.651911|2017-02-18 15:30:15.651911
NCT00492310|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2010-07-19|||August 2007||2007-08-01|July 2010|2010-07-01|March 2011|Anticipated|2011-03-01|February 2010|Actual|2010-02-01||Interventional|||Yoga for Women Attempting Smoking Cessation|Yoga for Women Attempting Smoking Cessation: an Initial Investigation|Unknown status|Active, not recruiting|Phase 3|60|Anticipated|The Miriam Hospital||2|||f||||f||||||||||2017-02-18 15:30:15.755957|2017-02-18 15:30:15.755957
NCT00492297|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-10-23|2009-10-28||April 2005||2005-04-01|October 2014|2014-10-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma|A Phase II, Multi-center, Open-label, Uncontrolled Study to Evaluate the Efficacy and Safety of BAY 43-9006 Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma.|Completed||Phase 2|83|Actual|Bayer|Due to the small number of patients, no conclusions can be drawn from these data in terms of BRAF mutations.|1|||f||||f||||||||||2017-02-18 15:30:15.872391|2017-02-18 15:30:15.872391
NCT00492284|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2011-05-31|2010-04-13||July 2007||2007-07-01|May 2011|2011-05-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|RADICAL||Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)|A Multicenter, Randomized, Single-masked Study Comparing Reduced-fluence Visudyne®-Lucentis® Combination Therapies and Lucentis® Monotherapy in Subjects With Choroidal Neovascularization (CNV) Secondary to AMD.|Completed||Phase 2|162|Actual|QLT Inc.|Retreatment and vision analysis limitations, sample size, lack of standard monotherapy regimen used in practice, no treatment regimen approved by regulatory authorities, potential for bias in FA assessment, no central reading center, single-masked|4|||f||||t||||||||||2017-02-18 15:30:16.448298|2017-02-18 15:30:16.448298
NCT00492271|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2008-07-22|||June 2007||2007-06-01|July 2008|2008-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||First Time in Man Trial for Friulimicin B|A Double-Blind, Placebo-Controlled, Randomized, Dose-Escalating Study of Single (Part A) and Multiple (Part B) Intravenous Doses of Friulimicin B in Healthy Subjects|Terminated||Phase 1|31|Actual|MerLion Pharmaceuticals GmbH||1||Unfavourable Pharmakokinetics|f||||f||||||||||2017-02-18 15:30:18.321977|2017-02-18 15:30:18.321977
NCT00492258|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-08-09|||June 2007||2007-06-01|April 2008|2008-04-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer|SORCE: A Phase III Randomised Double-Blind Study Comparing Sorafenib With Placebo in Patients With Resected Primary Renal Cell Carcinoma at High or Intermediate Risk of Relapse|Completed||Phase 3|1656|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:30:18.434264|2017-02-18 15:30:18.434264
NCT00492245|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2008-08-01|||April 2006||2006-04-01|July 2008|2008-07-01|December 2008|Anticipated|2008-12-01|May 2008||2008-05-01||Interventional|||Phototherapeutic Keratectomy (PTK) With Mitomycin in Adenoviral Opacities|Phototherapeutic Keratectomy With Mitomycin C in Adenoviral Infiltrates|Unknown status|Active, not recruiting|N/A|30|Anticipated|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 15:30:18.581956|2017-02-18 15:30:18.581956
NCT00492232|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2010-07-13|2009-05-28||April 2007||2007-04-01|July 2010|2010-07-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia|Randomized, Double Blind, Placebo-Controlled Study to Assess Whether the Administration of Ramelteon Could Facilitate the Discontinuation of Zolpidem (Ambien®) ≥10 mg Therapy in Subjects With Chronic Insomnia|Completed||Phase 4|135|Actual|Takeda||2|||f||||f||||||||||2017-02-18 15:30:18.694968|2017-02-18 15:30:18.694968
NCT00483626|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2007-06-06|||August 2003||2003-08-01|April 2007|2007-04-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Hemodynamic Response After Six Months of Sildenafil|Hemodynamic Evaluation of Patients With Pulmonary Arterial Hypertension. Response to Sildenafil Treatment|Unknown status|Recruiting|Phase 4|27|Anticipated|University of Chile||1|||f||||f||||||||||2017-02-18 15:33:53.835318|2017-02-18 15:33:53.835318
NCT00492219|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2012-10-18|||October 2006||2006-10-01|June 2007|2007-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Postoperative Function Following Partial and Total Knee Replacement|Postoperative Function Following Partial and Total Knee Replacement|Terminated||N/A|324|Anticipated|New Lexington Clinic||4||No longer have access to equipment used for functional data collection|f||||f||||||||||2017-02-18 15:30:19.702306|2017-02-18 15:30:19.702306
NCT00492206|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-12-07|2016-01-14||June 2006||2006-06-01|December 2016|2016-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Number of patients with surgically unresectable stage IIIA or IIIB NSCLC accrued|Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC|A Phase II Study of Cetuximab in Combination With External Beam Radiation Followed By Consolidation Chemotherapy for Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|40|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 15:30:19.941468|2017-02-18 15:30:19.941468
NCT00492193|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-12-12|||June 2007||2007-06-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Early Post-Op Recovery After Partial Large Bowel Resection|A Prospective, Observational, Multi-center Study Assessing Early Post-Operative Recovery Following Laparoscopic Partial Large Bowel Resection|Completed||N/A|139|Actual|University Hospitals Cleveland Medical Center|||1||f||||f||||||||||2017-02-18 15:30:20.336771|2017-02-18 15:30:20.336771
NCT00492167|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2016-03-07|||August 2005||2005-08-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma|Phase I Study of Oral Yeast β-Glucan and Intravenous Anti-GD2 Monoclonal Antibody 3F8 Among Patients With Metastatic Neuroblastoma|Active, not recruiting||Phase 1|45|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:30:20.43099|2017-02-18 15:30:20.43099
NCT00492154|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2009-07-20|||September 2008||2008-09-01|June 2009|2009-06-01||||||||Observational|||Fracture of Distal Radius and Ulna Healed With Shortening of One Bone. Clinical Significance at Skeletal Maturity|Fracture of Distal Radius and Ulna Healed With Shortening of One Bone. Clinical Significance at Skeletal Maturity|Terminated||N/A|20|Anticipated|Hadassah Medical Organization|||1|the study stopped because we could not recruit enough patients.|f||||f||||||||||2017-02-18 15:30:20.546131|2017-02-18 15:30:20.546131
NCT00492141|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2012-08-01|||June 2006||2006-06-01|August 2012|2012-08-01|September 2009|Actual|2009-09-01|May 2007|Actual|2007-05-01||Interventional|||Aerosol L9-NC and Temozolomide in Ewing's Sarcoma|Aerosol Liposomal 9-Nitro-20(S)-Camptothecin (L9-NC) and Temozolomide in Ewing's Sarcoma and Other Solid Tumors With Lung Involvement|Completed||Phase 1/Phase 2|10|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:30:20.811816|2017-02-18 15:30:20.811816
NCT00492128|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2015-01-28|||September 2007||2007-09-01|January 2015|2015-01-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Interventional|||Kanagawa Combination Anti-hypertensive Therapy (K-CAT)|Comparative Trial of Combination Therapy of ARB/Diuretic Versus ARB/CCB in Uncontrolled Hypertensive Patients With Monotherapy of ARB|Completed||Phase 4|196|Actual|Yokohama City University Medical Center||2|||f||||f||||||||||2017-02-18 15:30:20.942383|2017-02-18 15:30:20.942383
NCT00492115|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2013-06-17|||July 2007||2007-07-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|TAP||Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease|Cognitive Benefits of Treating Sleep Apnea in Dementia|Completed||N/A|96|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 15:30:21.069029|2017-02-18 15:30:21.069029
NCT00492102|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2012-08-01|||March 2007||2007-03-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Montelukast in Very Low Birthweight Infants|Pharmacokinetics of Montelukast in Very Low Birthweight (VLBW) Preterm Infants|Completed||Phase 1|9|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 15:30:21.179368|2017-02-18 15:30:21.179368
NCT00492089|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-04-21|2012-06-15||June 2007||2007-06-01|April 2013|2013-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer|A Randomized Phase II Trial of Bevacizumab to Control Brain Radiation Damage|Completed||Phase 2|11|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:30:21.318364|2017-02-18 15:30:21.318364
NCT00492076|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2008-10-15|||October 2006||2006-10-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma|A Randomised, Double-Blind Placebo-Controlled Study Assessing the Short-Term Effect of a Dermatophagoides Pteronyssinus Extract, Quantified in Mass Units, in Subjects With Perennial Mite Induced Asthma|Completed||Phase 4|45|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-02-18 15:30:21.674323|2017-02-18 15:30:21.674323
NCT00492063|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2015-12-03|2012-12-11||September 2004||2004-09-01|December 2015|2015-12-01|May 2005|Actual|2005-05-01|December 2004|Actual|2004-12-01||Interventional|||Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly|A Phase III, Observer-Blind, Randomized, Multi-Center Study to Evaluate Safety, Tolerability and Immunogenicity of a Single Intramuscular Dose of a Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture and of a Trivalent Subunit Influenza Vaccine Produced in Embryonated Hen Eggs, in Healthy Adult and Elderly Subjects|Completed||Phase 3|2654|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:30:21.789979|2017-02-18 15:30:21.789979
NCT00492050|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2016-11-16|||August 2006||2006-08-01|November 2016|2016-11-01||||February 2018|Anticipated|2018-02-01||Interventional|||Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia|Primary Treatment of Waldenstrom's Macroglobulinemia With Bortezomib (Velcade) and Rituximab (Rituxan) Followed by Autologous Stem Cell Collection|Active, not recruiting||Phase 2|38|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:30:22.674876|2017-02-18 15:30:22.674876
NCT00492037|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-04-30|||January 2000||2000-01-01|April 2014|2014-04-01|February 2002|Actual|2002-02-01|||||Interventional|||Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia|A 5-Day, Double-Blind, Placebo-Controlled Multicenter Study of Oral YM087 (CI-1025) to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia|Completed||Phase 3|83|Actual|Cumberland Pharmaceuticals|||||f||||f||||||||||2017-02-18 15:30:22.798574|2017-02-18 15:30:22.798574
NCT00491647|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2012-11-12|||May 2006||2006-05-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|||||Observational|||Time Perception Deficits and Attention-Deficit/Hyperactivity Disorder|Time Perception Deficits and Behaviors of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder|Completed||N/A|258|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:30:29.225457|2017-02-18 15:30:29.225457
NCT00492024|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2013-10-31|2009-03-19||January 2005||2005-01-01|November 2013|2013-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||BAY12-8039: 5 Days for Sinusitis vs Placebo|Prospective, Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Moxifloxacin 400 mg QD for 5 Days Versus Placebo in the Treatment of Acute Bacterial Sinusitis|Completed||Phase 3|374|Actual|Bayer|Confounding factors include concomitant medication for symptomatic relief not standardised, TOC visit occured earlier than for other sinusitis studies, response on placebo underestimated and short-term relief provided by the sinus tap.|2|||f||||f||||||||||2017-02-18 15:30:22.924633|2017-02-18 15:30:22.924633
NCT00492011|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2012-02-27|||February 2007||2007-02-01|February 2012|2012-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Ability of Ramelteon 1 mg, 4 mg, and 8 mg to Alleviate the Insomnia Symptoms Associated With Eastward Bound Jet Lag Across 5 Time Zones in Healthy Adult Volunteers|Completed||Phase 4|110|Actual|Takeda||4|||f||||f||||||||||2017-02-18 15:30:23.680595|2017-02-18 15:30:23.680595
NCT00491998|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2011-07-21|||November 2006||2006-11-01|July 2011|2011-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets|Randomised, Double-blind, Double-dummy, Two-period, Cross-over Study to Determine the PK, PD and Safety of Multiple Doses of V1512 Effervescent Tablets in Parkinson's Disease Patients Compared to Sinemet® Oral Tablets|Completed||Phase 1/Phase 2|27|Anticipated|Vernalis (R&D) Ltd||3|||f||||f||||||||||2017-02-18 15:30:23.926082|2017-02-18 15:30:23.926082
NCT00491985|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-26|2014-01-10|||June 2007||2007-06-01|January 2014|2014-01-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children||Completed||Phase 2|240|Actual|Sanofi||3|||f||||||||||||||2017-02-18 15:30:24.028937|2017-02-18 15:30:24.028937
NCT00491959|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2010-05-03|||September 2007||2007-09-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||The Application of Oral Mucosal Epithelial Cell Sheets Cultivated on Amino Membrane in Patients Suffering From Corneal Stem Cell Insufficiency or Symblepharon.|Phase 1 Study of Oral Mucosal Epithelial Cell Sheets in Patients Suffering From Corneal Stem Cell Insufficiency or Symblepharon|Terminated||Phase 1|0|Actual|National Taiwan University Hospital||1||Due to unstalbe cell sheet quality. We didn't use this tech on patients.|f||||t||||||||||2017-02-18 15:30:24.146848|2017-02-18 15:30:24.146848
NCT00491946|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-25|||June 2004||2004-06-01|June 2007|2007-06-01||||||||Interventional|||A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer|A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer|Unknown status|Recruiting|Phase 4|24|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:30:24.23544|2017-02-18 15:30:24.23544
NCT00491933|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-06-25|||June 2007||2007-06-01|June 2007|2007-06-01|October 2007|Anticipated|2007-10-01|||||Interventional|TNFTB||Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists|Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in the Assessment of Latent Mycobacterium Tuberculosis Infection in Patients Candidate to Treatment or Treated With TNFα Antagonists|Unknown status|Recruiting|N/A|100|Anticipated|Ospedale L. Sacco – Polo Universitario||1|||f||||f||||||||||2017-02-18 15:30:24.322283|2017-02-18 15:30:24.322283
NCT00491920|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2011-11-02|||February 2007||2007-02-01|November 2011|2011-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||High Dosage Vitamin D and Osteoporosis|High Dosage Vitamin D in the Treatment of Osteoporosis in Postmenopausal Women|Completed||Phase 4|297|Actual|University Hospital of North Norway||1|||f||||f||||||||||2017-02-18 15:30:24.431858|2017-02-18 15:30:24.431858
NCT00491907|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-10-01|||October 2004||2004-10-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Effect of Folic Acid on Endothelial and Baroreceptor Function in Patients With Heart Failure|Effect of Folic Acid on Endothelial and Baroreceptor Function in Patients With Heart Failure|Terminated||Phase 4|||University of Zurich||2||recruitment is finished|f||||f||||||||||2017-02-18 15:30:24.537285|2017-02-18 15:30:24.537285
NCT00491894|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2012-06-05|2010-08-02||March 2007||2007-03-01|April 2012|2012-04-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions|A Six-Month, Multi-Center, Open-Label Study to Assess the Safety and Efficacy of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions|Completed||Phase 3|137|Actual|Shionogi Inc.|There were no limitations of the trial|1|||f||||f||||||||||2017-02-18 15:30:24.625195|2017-02-18 15:30:24.625195
NCT00491881|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-08-02|||May 2005||2005-05-01|June 2007|2007-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Effect of no Added Salt Diet on Urinary Sodium and Blood Pressure|"Effect of no Added Salt Diet  on Blood Pressure Control & 24 Hour Urinary Sodium Excretion in Mild to Moderate Hypertension"|Completed||N/A|2005|Actual|Shiraz University of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:30:25.205574|2017-02-18 15:30:25.205574
NCT00491868|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2009-01-29|||June 2007||2007-06-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional|||Clinical Study of R744 to Hemodialysis Patients|Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients ( Phase III, Double Blind Study in Comparison With Epoetin Beta).|Completed||Phase 3|134|Actual|Chugai Pharmaceutical||4|||f||||t||||||||||2017-02-18 15:30:25.30402|2017-02-18 15:30:25.30402
NCT00491855|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2012-12-31|||June 2007||2007-06-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis|Phase I Trial of Intraperitoneal Oxaliplatin and Paclitaxel Plus Intravenous Paclitaxel and Bevacizumab in the Treatment of Advanced Peritoneal Carcinomatosis|Completed||Phase 1|3|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:30:25.430113|2017-02-18 15:30:25.430113
NCT00491842|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2017-01-24|||June 20, 2007||2007-06-20|December 29, 2016|2016-12-29||||||||Observational|||Individuals Patterns of Disclosure About Huntington s Disease (HD) and the Association With Adaptation to HD|Individuals' Patterns of Disclosure About Huntington's Disease and Association With Adaptation to HD|Completed||N/A|315|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:30:25.55245|2017-02-18 15:30:25.55245
NCT00491829|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-05-06|2014-04-02||June 2007||2007-06-01|May 2014|2014-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Flibanserin Versus Placebo in Premenopausal Women With HSDD|A Twenty-Four Week, Randomized, Double-Blind, Placebo Controlled, Safety and Efficacy Trial of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in Premenopausal European Women With Hypoactive Sexual Desire Disorder|Completed||Phase 3|945|Actual|Sprout Pharmaceuticals, Inc||3|||f||||t||||||||||2017-02-18 15:30:25.660032|2017-02-18 15:30:25.660032
NCT00491816|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2017-01-18|||July 2007||2007-07-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|||Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer|Phase II Trial of Neoadjuvant Erlotinib Plus Chemotherapy for Treatment of ER Negative, PgR Negative and HER-2 Negative Primary Breast Cancer|Active, not recruiting||Phase 2|32|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-02-18 15:30:26.741908|2017-02-18 15:30:26.741908
NCT00491803|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2009-11-09|||June 2007||2007-06-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|SIL-COPD-01||Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in Chronic Obstructive Pulmonary Disease (COPD)|Acute Effects of a Single Dose of Sildenafil (20mg/40mg) on Pulmonary Haemodynamics and Gas Exchange at Rest and During Exercise in COPD Patients With Pulmonary Hypertension|Completed||Phase 4|20|Anticipated|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 15:30:26.853164|2017-02-18 15:30:26.853164
NCT00491790|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2008-12-15|||December 2006||2006-12-01|November 2008|2008-11-01|October 2010|Anticipated|2010-10-01|January 2010|Anticipated|2010-01-01||Interventional|||Montelukast With Status Asthmaticus, Ages 2-5||Unknown status|Recruiting|Phase 2/Phase 3|52|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 15:30:26.962546|2017-02-18 15:30:26.962546
NCT00491777|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-22|||June 2007||2007-06-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|NMT-CT||Correlation Research Study: IQ2, NcIQ and IQ101|Correlation Study of NMT's IQ2, NcIQ and Its' Predicate Technology, IQ101.|Completed||Phase 1|25|Actual|Noninvasive Medical Technologies, Inc.|||||||||t||||||||||2017-02-18 15:30:27.073153|2017-02-18 15:30:27.073153
NCT00491764|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2015-09-11|2009-12-23||June 2007||2007-06-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)|An Investigator-Blinded Study Evaluating the Efficacy and Safety of Four Posaconazole Treatment Regimens With Placebo and Terbinafine in the Treatment of Onychomycosis of the Toenail|Completed||Phase 2|218|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 15:30:27.166828|2017-02-18 15:30:27.166828
NCT00491751|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2012-05-23|||May 2004||2004-05-01|May 2012|2012-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Clinical Utility of Endothelial Dysfunction in PAD|Clinical Utility of Endothelial Dysfunction in PAD|Unknown status|Active, not recruiting|N/A|400|Anticipated|Boston University||1|||f||||t||||||||||2017-02-18 15:30:28.109958|2017-02-18 15:30:28.109958
NCT00491738|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2009-04-09|2009-02-06||August 2007||2007-08-01|April 2009|2009-04-01||||January 2008|Actual|2008-01-01||Interventional|||A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R)|A Multicenter, Phase II, Randomized, Blinded, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Sutent With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer|Terminated||Phase 2|16|Actual|Genentech, Inc.|Based on the early safety results from this study, Genentech terminated further recruitment and discontinued treatment. Insufficient efficacy information was available to perform additional outcome analyses.|2||"Based on the data collected, the combination of bevacizumab and sunitinib appeared to be~   poorly tolerated."|f||||||||||||||2017-02-18 15:30:28.225052|2017-02-18 15:30:28.225052
NCT00491725|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2016-03-02|||September 2005||2005-09-01|March 2016|2016-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs|A Multi-centre, Single Armed, Open Labelled Trial to Study the Efficacy and Safety Profile of Repaglinide & Metformin Combination Therapy in Chinese Type 2 Diabetics|Completed||Phase 4|187|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:30:28.652656|2017-02-18 15:30:28.652656
NCT00491712|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-06-25|||September 2005||2005-09-01|March 2007|2007-03-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection|Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection|Unknown status|Active, not recruiting|N/A|49|Actual|Federal University of São Paulo||2|||f||||f||||||||||2017-02-18 15:30:28.746713|2017-02-18 15:30:28.746713
NCT00491699|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2010-02-18|||August 2007||2007-08-01|February 2010|2010-02-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer|A Phase 1 Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL999 Administered Intravenously to Subjects With Non-Small-Cell Lung Cancer (NSCLC)|Terminated||Phase 1|2|Actual|Symphony Evolution, Inc.||1||The study was stopped due to safety concerns|f||||t||||||||||2017-02-18 15:30:28.848475|2017-02-18 15:30:28.848475
NCT00491686|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2011-01-20|||July 2007||2007-07-01|January 2011|2011-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||AZD6765 for Treatment Resistant Depression|A Phase IIa, Multi-Center, Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Assess the Antidepressant Effect and Onset of Effect of AZD6765 in Treatment-Resistant Major Depressive Disorder Patients|Completed||Phase 2|34|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:30:28.939162|2017-02-18 15:30:28.939162
NCT00491673|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2010-09-23|||September 2004||2004-09-01|September 2010|2010-09-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|HEMI04||A Prospective Randomized Trial of Uncemented Versus Cemented Hemiarthroplasty for Displaced Femoral Neck Fractures|A Prospective Randomized Trial of Uncemented Versus Cemented Hemiarthroplasty for Displaced Femoral Neck Fractures|Unknown status|Active, not recruiting|N/A|230|Actual|Ullevaal University Hospital||2|||f||||f||||||||||2017-02-18 15:30:29.036518|2017-02-18 15:30:29.036518
NCT00491660|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-06-25|||January 2005||2005-01-01|June 2007|2007-06-01|July 2006|Actual|2006-07-01|||||Interventional|||Effect of Gravity on Tracheal Colonization During Mechanical Ventilation in Infants||Completed||N/A|60|Actual|Cairo University||2|||f||||||||||||||2017-02-18 15:30:29.147572|2017-02-18 15:30:29.147572
NCT00491634|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2015-11-30|||June 2007||2007-06-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Treosulfan-based Conditioning for Transplantation in AML/MDS|Phase II Trial of Fludarabine Combined With Intravenous Treosulfan and Allogeneic Hematopoietic Stem-cell Transplantation in Patients With Chemo-refractory or Previously Untreated Acute Myeloid Leukemia and Myelodysplastic Syndrome.|Completed||Phase 2|24|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 15:30:29.303645|2017-02-18 15:30:29.303645
NCT00491621|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2015-06-03|||April 2007||2007-04-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|CMM||Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer|Study Evaluating the Interest of Cytology-molecular Tumor Markers Association for the Diagnostic Strategy in Adult Kidney Tumors|Terminated||N/A|74|Actual|Centre Hospitalier Universitaire de Saint Etienne||1||No enough inclusion. The aim is no longer relevant. The sponsor decided to stop this study.|f||||f||||||||||2017-02-18 15:30:29.406042|2017-02-18 15:30:29.406042
NCT00491608|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2012-01-11|2011-11-03||June 2007||2007-06-01|January 2012|2012-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis|A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin (rThrombin) in Surgical Hemostasis|Completed||Phase 3|234|Actual|ZymoGenetics||1|||f||||f||||||||||2017-02-18 15:30:29.516737|2017-02-18 15:30:29.516737
NCT00491595|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-25|||March 2004||2004-03-01|June 2007|2007-06-01|July 2005|Actual|2005-07-01|||||Interventional|||Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women|Phase I Multiple-Dose Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women|Completed||Phase 1|36|Actual|University of North Carolina, Chapel Hill||2|||t||||t||||||||||2017-02-18 15:30:32.585563|2017-02-18 15:30:32.585563
NCT00491582|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-08-12|||July 2007||2007-07-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|July 2009|Actual|2009-07-01||Interventional|||The Effects of Growth Hormone (GH) on Lipid Depots|The Effect of Growth Hormone (GH) on Intramyocellular Lipids (IMCL), Intrahepatocellular Lipids (IHCL) and Visceral Fat Mass in Relation to Insulin Resistance|Completed||N/A|34|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 15:30:32.662765|2017-02-18 15:30:32.662765
NCT00491569|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-24|2007-06-24|||January 2005||2005-01-01|June 2007|2007-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia|NMDA Enhancers in the Treatment of Schizophrenia: Sarcosine vs. D-Serine|Completed||Phase 2|60|Actual|China Medical University Hospital||3|||f||||f||||||||||2017-02-18 15:30:32.768858|2017-02-18 15:30:32.768858
NCT00491556|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2016-05-16|2016-03-18||October 2007||2007-10-01|May 2016|2016-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||75 subjects were randomized to the experimental arm, however 2 subjects withdrew from the study at the pre-entry visit. Therefore, only 73 experimental arm subjects were available for the baseline analyses.|Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)|Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r) in Adolescents With CD4 + T Cells > 350 Cells/mm3 Initiating HAART|Completed||N/A|102|Actual|Westat||2|||f||||t||||||||||2017-02-18 15:30:32.884348|2017-02-18 15:30:32.884348
NCT00491543|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2008-07-01|||June 2007||2007-06-01|June 2007|2007-06-01|May 2008|Actual|2008-05-01|||||Interventional|||Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease|A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ALT 2074 in Subjects With Type 2 Diabetes Who Have a Haptoglobin Type 2-2 Genotype and Coronary Artery Disease|Completed||Phase 2|66|Anticipated|Synvista Therapeutics, Inc||4|||f||||f||||||||||2017-02-18 15:30:34.281768|2017-02-18 15:30:34.281768
NCT00491530|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2012-01-18|2009-11-03||June 2007||2007-06-01|January 2012|2012-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia|A Year 2, Long-Term, Open-Label, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia|Completed||Phase 3|310|Actual|Abbott|This was an open-label study designed to assess the long-term safety of the combination therapies. Evaluation of efficacy outcomes was a secondary objective.|3|||f||||f||||||||||2017-02-18 15:30:34.384632|2017-02-18 15:30:34.384632
NCT00491517|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2013-04-23|||March 2007||2007-03-01|April 2013|2013-04-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|SIRENA||Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety|Sirolimus Treatment in Patients With ADPKD|Completed||Phase 2|22|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||t||||||||||2017-02-18 15:30:35.480815|2017-02-18 15:30:35.480815
NCT00491504|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2015-02-24|2010-03-11||February 2007||2007-02-01|February 2015|2015-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)|A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study Using Subjective and Objective Measures to Evaluate the Clinical Efficacy of Mometasone Furoate Nasal Spray (MFNS) Following Initial and Maintenance Dosing in Subjects With Allergen-Induced Seasonal Allergic Rhinitis (SAR) in an Environmental Exposure Chamber (EEC)|Completed||Phase 4|310|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:30:35.591806|2017-02-18 15:30:35.591806
NCT00491491|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2015-12-01|||June 2007||2007-06-01|December 2015|2015-12-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Zevalin-beam for Aggressive Lymphoma|SPINOZA / שפינוזה. Study With Preparatory INduction Of Zevalin in Aggressive Lymphoma. A Randomized Phase 3 Study of BEAM Versus 90Yttrium Ibritumomab Tiuxetan (Zevalin) / BEAM in Patients Requiring Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed Diffuse Large B-cell Lymphoma|Completed||Phase 3|60|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 15:30:36.014371|2017-02-18 15:30:36.014371
NCT00491478|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-22|||September 1992||1992-09-01|May 2003|2003-05-01||||||||Interventional|||Repetitive Behavior Disorders in People With Severe Mental Retardation|Stereotypies and Mental Retardation: Neurobiological Basis|Unknown status|Recruiting|Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:30:36.12972|2017-02-18 15:30:36.12972
NCT00491062|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2010-11-15|||June 2007||2007-06-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|||||Interventional|ENTEROPARK||Enteric Nervous System in Parkinson's Disease|Analysis of Dopamine Neuronal Cell Loss Within the Enteric Nervous System in Parkinson's Disease|Completed||N/A|||Nantes University Hospital||4|||f||||f||||||||||2017-02-18 15:30:41.047483|2017-02-18 15:30:41.047483
NCT00491465|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-06-25|||July 2007||2007-07-01|June 2007|2007-06-01|July 2009|Anticipated|2009-07-01|||||Interventional|4301||The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.|Randomized,Controlled,Open,Cross-Over Intervention Study for Evaluating the Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.|Unknown status|Not yet recruiting|N/A|2007|Anticipated|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 15:30:36.234405|2017-02-18 15:30:36.234405
NCT00491452|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2011-05-26|||April 2007||2007-04-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|||||Observational|IMR2||Repair of Ischemic Mitral Regurgitation: Comparison Between Flexible and Rigid Annuloplasty Rings||Completed||N/A|||Shaare Zedek Medical Center|||1||f||||||||||||||2017-02-18 15:30:36.542037|2017-02-18 15:30:36.542037
NCT00491439|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2012-04-01|||April 2007||2007-04-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|||||Observational|||Using in Vivo Confocal Microscope to Evaluate the Corneal Wound Healing After Various Ocular Surgeries|Phase 1 Study of in Vivo Confocal Microscope to Evaluate the Corneal Wound Healing After Various Ocular Surgeries|Completed||N/A|120|Actual|National Taiwan University Hospital|||3||f||||f||||||||||2017-02-18 15:30:36.61814|2017-02-18 15:30:36.61814
NCT00491426|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2012-11-16|||January 2006||2006-01-01|November 2012|2012-11-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Observational|||Antimicrobial PK in Infants With Suspected or Confirmed Infection|Antimicrobial Pharmacokinetics in High Risk Infants (Urinary Proteomics in Antimicrobial/Antifungal-Treated Newborns - add-on Study)|Completed||Phase 1|450|Actual|Duke University|||3||f||||t||||||||||2017-02-18 15:30:36.723323|2017-02-18 15:30:36.723323
NCT00491413|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-22||||||August 2003|2003-08-01||||||||Interventional|||Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth|High Dose Erythropoietin for Neonates With Asphyxia|Unknown status|Not yet recruiting|Phase 1|15|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:30:36.846262|2017-02-18 15:30:36.846262
NCT00491400|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2012-09-24|2012-05-23||September 2005||2005-09-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of a Fibrate and a Statin on Endothelial Dysfunction|Effect of a Fibrate (Fenofibrate) and a Statin (Atorvastatin) and on Endothelial Dysfunction in Diabetes Mellitus and the Metabolic Syndrome|Terminated||N/A|28|Actual|Boston University|Early termination due to inadequate enrollment|2||Insufficient enrollment|f||||f||||||||||2017-02-18 15:30:36.945551|2017-02-18 15:30:36.945551
NCT00491387|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2012-07-16|2011-02-22||August 2007||2007-08-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Sympathetic Nervous System Modulation in Hypertension|Sympathetic Nervous System Modulation in Hypertension by Beta-adrenergic Blockade|Terminated||Phase 4|24|Actual|University of Cincinnati|Early termination due to a publication in the literature suggesting potential increased cardiac mortality in hypertensive patients treated primarily with beta blockers. Did not feel that continued treatment in volunteer subjects could be justified.|1||"Publications appeared suggesting increased mortality using beta-blockers as primary therapy~   for hypertension."|f||||f||||||||||2017-02-18 15:30:37.320102|2017-02-18 15:30:37.320102
NCT00491374|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2009-01-05|2008-11-26||September 2006||2006-09-01|January 2009|2009-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)|A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Single-Site Study Of Mometasone Furoate Nasal Spray (MFNS) In Subjects With Mild-Moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) Associated With Perennial Allergic Rhinitis (PAR) Using Polysomnographic Recordings of Sleep Parameters|Terminated||Phase 4|0|Actual|Schering-Plough|This study was difficult to enroll subjects, and after 5 months of screening, the screen failure rate was 100%. At that time the decision was made to terminate the study. No subject was treated and no data were collected.|2||Very poor enrollment|f||||f||||||||||2017-02-18 15:30:37.533269|2017-02-18 15:30:37.533269
NCT00491361|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2012-11-12|||January 2005||2005-01-01|August 2008|2008-08-01|July 2006|Actual|2006-07-01|||||Observational|||Chinese Versions of the Swanson, Nolan, and Pelham, Version IV (SNAP-IV) Scale and Strengths Difficulties Questionnaire.|Psychometric Study of the Chinese Versions of the Swanson, Nolan, and Pelham, Version IV (SNAP-IV) Scale and Strengths Difficulties Questionnaire.|Completed||N/A|3600|Actual|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 15:30:37.794003|2017-02-18 15:30:37.794003
NCT00491348|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2008-12-21|||April 2007||2007-04-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study|Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study|Terminated||N/A|23|Actual|National Taiwan University Hospital||1||Change of MRI mode|f||||t||||||||||2017-02-18 15:30:37.880431|2017-02-18 15:30:37.880431
NCT00491335|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2017-01-24|||June 18, 2007||2007-06-18|February 16, 2010|2010-02-16|February 16, 2010||2010-02-16|||||Observational|||HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers|HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:30:37.976934|2017-02-18 15:30:37.976934
NCT00491322|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2008-03-26|||May 2006||2006-05-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Vitamin D Deficiency, Insulin Resistance and FGF-23|Impact of Vitamin D Deficiency on Insulin Resistance and the Regulation of FGF-23|Completed||N/A|90|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 15:30:38.057412|2017-02-18 15:30:38.057412
NCT00491309|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-07-01|||July 2011||2011-07-01|July 2014|2014-07-01||||December 2015|Anticipated|2015-12-01||Interventional|||Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension|Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension|Unknown status|Recruiting|Phase 2|45|Anticipated|Heidelberg University||2|||f||||f||||||||||2017-02-18 15:30:38.1706|2017-02-18 15:30:38.1706
NCT00491296|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2008-11-05|||June 2007||2007-06-01|June 2007|2007-06-01|June 2007|Anticipated|2007-06-01|||||Observational|||Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia||Unknown status|Not yet recruiting|N/A|||HaEmek Medical Center, Israel|||||f||||t||||||||||2017-02-18 15:30:38.498104|2017-02-18 15:30:38.498104
NCT00491283|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2008-01-23|||July 2006||2006-07-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||QuickVue Influenza A+B Clinical Field Trial|Comparison of Swab Types for Specimen Collection|Completed||N/A|||Quidel Corporation|||||f||||f||||||||||2017-02-18 15:30:38.580775|2017-02-18 15:30:38.580775
NCT00491270|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-24|2011-05-24|||January 2011||2011-01-01|May 2011|2011-05-01|August 2013|Anticipated|2013-08-01|January 2012|Anticipated|2012-01-01||Interventional|||Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery|Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|Western Galilee Hospital-Nahariya||1|||f||||t||||||||||2017-02-18 15:30:38.661855|2017-02-18 15:30:38.661855
NCT00491257|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2014-01-16|||June 2007||2007-06-01|January 2014|2014-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine|Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route)|Completed||Phase 2|130|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:30:38.75703|2017-02-18 15:30:38.75703
NCT00491244|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2014-01-13|2013-09-29||June 2007||2007-06-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C|Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin Versus Pegylated Interferon Alfa-2a Alone for Treatment-naïve Hemodialysis Patients With Chronic Hepatitis C|Completed||Phase 4|377|Actual|National Taiwan University Hospital|"Open-label trial~Results may not be generalizable to peritoneal dialysis patients~Higher percentages of favorable IL28B genotypes~Secondary endpoint may not be powered to detect the differences"|2|||f||||t||||||||||2017-02-18 15:30:38.87203|2017-02-18 15:30:38.87203
NCT00491231|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-11-15|||July 2007||2007-07-01|November 2007|2007-11-01|December 2008|Anticipated|2008-12-01|||||Observational|||Is Orthostatic Hypotension Associated With Nondipping Hypertension||Unknown status|Recruiting|N/A|400|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:30:39.326379|2017-02-18 15:30:39.326379
NCT00491218|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-22|||June 2007||2007-06-01|June 2007|2007-06-01||||||||Observational|CT-EXTRA||The Addition of Cardiac CT to Exercise Treadmill Testing in the Evaluation of Angina|The Addition of Cardiac Computed Tomography to Exercise Treadmill Testing in the Evaluation of Angina|Unknown status|Recruiting|N/A|||Walter Reed Army Medical Center|||||f||||f||||||||||2017-02-18 15:30:39.403752|2017-02-18 15:30:39.403752
NCT00491192|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-25|2007-09-19|||June 2007||2007-06-01|June 2007|2007-06-01|June 2009||2009-06-01|||||Interventional|||Normothermia in Patients With Acute Cerebral Damage|Normothermia in Patients With Acute Cerebral Damage|Unknown status|Recruiting|Phase 4|||Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico||2|||f||||f||||||||||2017-02-18 15:30:39.495725|2017-02-18 15:30:39.495725
NCT00491179|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-23|2009-10-07|2008-12-21||June 2006||2006-06-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin|Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin Who Fail Interferon Alfa or Pegylated Interferon Alfa Monotherapy - a Pilot Study|Completed||Phase 4|35|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 15:30:39.606117|2017-02-18 15:30:39.606117
NCT00491166|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-22|||June 2007||2007-06-01|June 2007|2007-06-01||||||||Interventional|||Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser|A Single-Center, Investigator-Sponsored Pilot Study to Assess Safety and Biologic Activity of Bromfenac Ophthalmic Solution, 0.09%, in Subjects With Diffuse DME Refractory to Laser|Unknown status|Recruiting|Phase 1|10|Anticipated|Ophthalmic Consultants of Boston||1|||f||||f||||||||||2017-02-18 15:30:40.084901|2017-02-18 15:30:40.084901
NCT00491153|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2013-12-17|||September 2007||2007-09-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Sensitivity and Specificity of Aridol Challenge for a Diagnosis of Asthma by a Specialist Pulmonologist|Sensitivity and Specificity of Aridol Challenge for a Diagnosis of Asthma by a Specialist Pulmonologist|Terminated||N/A|35|Actual|St. Olavs Hospital|||1|due to low recruitment rate secondary to very stringent inclusion criteria|f||||f||||||||||2017-02-18 15:30:40.181299|2017-02-18 15:30:40.181299
NCT00491140|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2008-09-30|||December 2006||2006-12-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|May 2007|Actual|2007-05-01||Observational|||Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab|Retrospective Study Assessing Molecular Features Predicting Response or Resistance to Cetuximab Therapy in Metastatic Colorectal Cancer Patients|Completed||N/A|85|Actual|Istituto Clinico Humanitas|||1||f||||f||||||Samples With DNA|"~     Paraffine embedded tumor sections~   "|||2017-02-18 15:30:40.278383|2017-02-18 15:30:40.278383
NCT00491127|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||April 2003||2003-04-01|June 2007|2007-06-01|June 2004|Actual|2004-06-01|||||Interventional|||Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma|Phase II Study of Cisplatin With Gemcitabine in Fixed Dose Rate Infusion and Dexamethasone in Second-Line in Patients With Aggressive Non-Hodgkin’s Lymphoma|Completed||Phase 2|10|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 15:30:40.392049|2017-02-18 15:30:40.392049
NCT00491114|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||July 2003||2003-07-01|June 2007|2007-06-01|August 2004|Actual|2004-08-01|||||Interventional|||Intravesical Chemotherapy Treatment of Superficial Bladder Cancer|Intravesical Gemcitabine Therapy in Intermediate Risk Superficial Bladder Cancer: A Phase II Study With the Marker Lesion|Completed||Phase 2|8|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:30:40.478647|2017-02-18 15:30:40.478647
NCT00491101|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2010-09-10|||March 2007||2007-03-01|December 2008|2008-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Valuation of Quality of Life in Children With Asthma|Valuation of Quality of Life in Children With Asthma|Completed||N/A|110|Actual|Medical Universtity of Lodz|||1||f||||t||||||||||2017-02-18 15:30:40.580109|2017-02-18 15:30:40.580109
NCT00491088|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2010-02-25|||June 2007||2007-06-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||The CPAP Effect in Severe Obstructive- Sleep- Apnea Patients Without Daytime Sleepiness: A Control Randomized Trial|The CPAP Effect in Severe Obstructive- Sleep- Apnea Patients Without Daytime Sleepiness: A Control Randomized Trial|Completed||N/A|96|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 15:30:40.673887|2017-02-18 15:30:40.673887
NCT00491075|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2013-04-16|2012-04-06||December 2005||2005-12-01|April 2013|2013-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Pemetrexed Plus Gemcitabine in Renal Cell Cancer|Phase II Trial of Pemetrexed Plus Gemcitabine in Patients With Advanced Non-Clear Cell Renal Cell Cancer|Terminated||Phase 2|16|Actual|M.D. Anderson Cancer Center||1||Closed early for poor accrual.|f||||f||||||||||2017-02-18 15:30:40.787518|2017-02-18 15:30:40.787518
NCT00491049|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||September 2004||2004-09-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery|Phase 4 Study on Effectiveness of Topical 0.5% Levofloxacin on Reduction of Preoperative Conjunctival Flora in Patients Scheduled for Intraocular Surgery|Completed||Phase 4|140|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-02-18 15:30:41.131508|2017-02-18 15:30:41.131508
NCT00491036|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2016-04-26|||June 2009||2009-06-01|April 2016|2016-04-01|October 2016|Anticipated|2016-10-01|June 2012|Actual|2012-06-01||Interventional|IABP-SHOCK II||Intraaortic Balloon Pump in Cardiogenic Shock II|Randomized Clinical Study of Intraaortic Balloon Pump Use in Cardiogenic Shock Complicating Acute Myocardial Infarction|Active, not recruiting||Phase 4|600|Actual|University of Leipzig||2|||f||||t||||||||||2017-02-18 15:30:41.229248|2017-02-18 15:30:41.229248
NCT00491023|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2013-02-08|||February 2007||2007-02-01|February 2007|2007-02-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Observational|||Examining Macrophage Influx and Vascularization in Chronic Pancreatitis|Examining Macrophage Influx and Vascularization in Chronic Pancreatitis|Completed||N/A|||University of Colorado, Denver|||||f||||t||||||||||2017-02-18 15:30:41.356395|2017-02-18 15:30:41.356395
NCT00491010|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||July 2006||2006-07-01|June 2007|2007-06-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Maximum Targeted Ablation of Atrial Flutter|Maximum Targeted Ablation of Atrial Flutter|Unknown status|Recruiting|Phase 4|||Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 15:30:41.42657|2017-02-18 15:30:41.42657
NCT00490997|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2008-08-14|||June 2007||2007-06-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Ketamine/Propofol vs Ketamine Alone for Pediatric Fracture Reduction|A Prospective Randomized Double Blind Evaluation of Ketamine/Propofol vs Ketamine Alone for Pediatric Extremity Fracture Reduction|Completed||Phase 4|140|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-02-18 15:30:41.512597|2017-02-18 15:30:41.512597
NCT00490984|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2009-12-22|||February 2006||2006-02-01|April 2009|2009-04-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Tongue Advancement for Obstructive Sleep Apnea|Tongue Advancement for Obstructive Sleep Apnea. An Evaluation fo the Aspire Medical Advance System.|Completed||N/A|60|Anticipated|Aspire Medical||1|||f||||t||||||||||2017-02-18 15:30:41.626983|2017-02-18 15:30:41.626983
NCT00490971|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2015-03-25|2011-04-26||May 2006||2006-05-01|March 2015|2015-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder|A Randomized, Double-Blind, Active- and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Extended-Release Paliperidone as Maintenance Treatment After an Acute Manic or Mixed Episode Associated With Bipolar I Disorder|Completed||Phase 3|768|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|The study employed a randomized withdrawal design, and as such, was enriched for responders to the study drug. Thus, the long-term efficacy demonstrated cannot be extrapolated to a population of patients without prior exposure to paliperidone ER.|3|||f||||t||||||||||2017-02-18 15:30:41.745891|2017-02-18 15:30:41.745891
NCT00490958|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2008-10-16|||January 1999||1999-01-01|November 2007|2007-11-01|June 2005|Actual|2005-06-01|||||Interventional|||Telmisartan in Haemodialysis Patients With Chronic Heart Failure|Effects Of Telmisartan Added To Angiotensin Converting Enzyme Inhibitors On Mortality And Morbidity In Haemodialysed Patients With Chronic Heart Failure: A Double-Blind Placebo-Controlled Trial|Completed||Phase 4|351|Actual|Second University of Naples||2|||f||||f||||||||||2017-02-18 15:30:43.688685|2017-02-18 15:30:43.688685
NCT00490945|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2014-08-08|2014-02-28||July 2004||2004-07-01|August 2014|2014-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers|A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of VEC-162 on Circadian Rhythm in Healthy Subjects|Completed||Phase 2|45|Actual|Vanda Pharmaceuticals|||||f||||f||||||||||2017-02-18 15:30:43.786787|2017-02-18 15:30:43.786787
NCT00490932|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-22|||March 2005||2005-03-01|February 2007|2007-02-01|April 2007|Actual|2007-04-01|||||Interventional|||New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects|Introduction of New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Management of Diarrhoeal Diseases – A Phase IV Surveillance Study|Completed||Phase 4|27966|Actual|Society for Applied Studies|||||f||||f||||||||||2017-02-18 15:30:44.663777|2017-02-18 15:30:44.663777
NCT00490919|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2012-09-05|2010-07-15||June 2007||2007-06-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain|Multi-center, Randomized, Double-blind, Placebo-controlled With Open Label run-in Study Assessing Efficacy, Tolerability, Safety of BTDS 10 or 20 Compared to Placebo in Opioid-naïve Subjects With Moderate to Severe, Chronic Low Back Pain|Completed||Phase 3|539|Actual|Purdue Pharma LP||2|||f||||f||||||||||2017-02-18 15:30:44.760736|2017-02-18 15:30:44.760736
NCT00490906|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2014-01-17|||June 2007||2007-06-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|February 2009|Actual|2009-02-01||Observational|||Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis|Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis: A Pilot Study|Completed||N/A|60|Actual|University of Kansas Medical Center|||2||f||||t||||||||||2017-02-18 15:30:45.533374|2017-02-18 15:30:45.533374
NCT00490893|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-22|||March 2006||2006-03-01|June 2007|2007-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir|Effects of Insulin Detemir Versus Regular Insulin (Actrapid) on Hormonal Counterregulation, Cognitive Function and Symptom Perception During Hypoglycemia|Terminated||Phase 4|12|Actual|University Hospital Tuebingen||2|||f||||f||||||||||2017-02-18 15:30:45.646638|2017-02-18 15:30:45.646638
NCT00490880|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||November 2003||2003-11-01|June 2007|2007-06-01|August 2004|Actual|2004-08-01|||||Interventional|||Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer|The Evaluation of Efficacy and Toxicity of Combined Treatment: Neoadjuvant Chemotherapy (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer Stage T2b-T3 NO/Nx M0|Completed||Phase 2|2|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:30:45.736125|2017-02-18 15:30:45.736125
NCT00490295|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2013-11-25|||March 2008||2008-03-01|November 2013|2013-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Biomarkers for Detection of Brain Ischemia|Biomarkers for the Detection of Brain Ischemia in Neonates With Congenial Heart Disease Requiring Cardiac Surgery|Completed||N/A|10|Actual|Emory University|||1||f||||f||||||||||2017-02-18 15:30:57.460663|2017-02-18 15:30:57.460663
NCT00490867|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2007-06-22|||July 2004||2004-07-01|June 2007|2007-06-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes|Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 2|30|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 15:30:45.828063|2017-02-18 15:30:45.828063
NCT00490854|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2008-07-03|||July 2007||2007-07-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study for Patients With Type 2 Diabetes Mellitus|A Crossover Study to Evaluate the Efficacy and Safety of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Once-Daily NPH in Insulin-Naïve Patients With Type 2 Diabetes Mellitus on Oral Agents|Completed||Phase 2/Phase 3|129|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:30:45.919084|2017-02-18 15:30:45.919084
NCT00490841|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2012-12-13|2011-09-06||August 2007||2007-08-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|June 2010|Actual|2010-06-01||Interventional|HERCULES||The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis|A Clinical Trial to Assess the Safety and Efficacy of the RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Suboptimal Post-procedural Percutaneous Transluminal Angioplasty (PTA) in de Novo or Restenotic Renal Artery Stenoses in Patients With Uncontrolled Hypertension.|Completed||N/A|202|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 15:30:46.055775|2017-02-18 15:30:46.055775
NCT00490828|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2008-09-02|||June 2007||2007-06-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional|||Influence of Hydrocortisone on Immunologic Markers and Health Care Related Quality of Life in Patients After Cardiac Surgery|Influence of Hydrocortisone on Humoral and Cellular Immunologic Markers in High Risk Patients After Cardiac Surgery|Completed||Phase 4|120|Actual|Ludwig-Maximilians - University of Munich||2|||f||||f||||||||||2017-02-18 15:30:46.584152|2017-02-18 15:30:46.584152
NCT00490815|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2014-01-17|2013-09-27||August 2007||2007-08-01|January 2014|2014-01-01|April 2011|Actual|2011-04-01|September 2009|Actual|2009-09-01||Interventional|||Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema|An Open Label Pharmacokinetic and Efficacy Study of 0.5 μg/Day and 0.2 μg/Day Fluocinolone Acetonide Intravitreal Inserts in Subjects With Diabetic Macular Edema|Completed||Phase 3|37|Actual|Alimera Sciences||2|||f||||||||||||||2017-02-18 15:30:46.711407|2017-02-18 15:30:46.711407
NCT00490802|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2015-10-21|2013-04-26||June 2006||2006-06-01|October 2015|2015-10-01|April 2012|Actual|2012-04-01|September 2011|Actual|2011-09-01||Interventional|||Intranasal Oxytocin in the Treatment of Autism|Intranasal Oxytocin in the Treatment of Autism|Completed||Phase 2|19|Actual|Anagnostou, Evdokia, M.D.|Small sample size resulted in baseline differences; short duration of study; didn't examine impact of other characteristics; short-half life in the blood; inactive ingredients not identical in placebo; no participant follow-up after study|2|||f||||t||||||||||2017-02-18 15:30:47.441303|2017-02-18 15:30:47.441303
NCT00490789|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2008-04-29|||October 2005||2005-10-01|April 2008|2008-04-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|TESSTAL||Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM|A Trial of the Efficacy and Safety of Sirolimus(Rapamycin)Therapy for Renal Angiomyolipmoas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|Cardiff University||1|||f||||t||||||||||2017-02-18 15:30:47.895771|2017-02-18 15:30:47.895771
NCT00490776|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2012-11-26|||June 2007||2007-06-01|November 2012|2012-11-01||||September 2009|Actual|2009-09-01||Interventional|||Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma|A Phase II Study of Oral LBH589 in Adult Patients With Cutaneous T-Cell Lymphoma Who Are Intolerant to or Have Progressed on or After Prior HDAC Inhibitor|Completed||Phase 2/Phase 3|9|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:30:48.007217|2017-02-18 15:30:48.007217
NCT00490763|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2016-09-14|||February 2006||2006-02-01|September 2016|2016-09-01||||February 2020|Anticipated|2020-02-01||Observational|||Active Surveillance in Prostate Cancer|Active Surveillance in Prostate Cancer: A Prospective Cohort Study|Active, not recruiting||N/A|1139|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:30:48.226834|2017-02-18 15:30:48.226834
NCT00490750|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2015-12-07|||March 2003||2003-03-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Laparoscopic Dor Versus Toupet Fundoplication for the Treatment of Idiopathic Esophageal Achalasia|Randomized Prospective Trial of Laparoscopic Heller Myotomy and Partial Fundoplication for the Treatment of Idiopathic Esophageal Achalasia|Completed||N/A|60|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 15:30:48.334197|2017-02-18 15:30:48.334197
NCT00490737|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2008-06-12|||June 2007||2007-06-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety Study to Evaluate Daptomycin in Non-Infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis|An Evaluation of the Pharmacokinetic Profile and Safety and Tolerability of Multiple Doses of 6mg/kg Intravenous Daptomycin in Non-Infected Adult Subjects With End Stage Renal Disease on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis|Completed||Phase 1|12|Anticipated|Cubist Pharmaceuticals LLC||1|||f||||f||||||||||2017-02-18 15:30:48.443438|2017-02-18 15:30:48.443438
NCT00490724|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2013-12-31|2013-06-07||March 2007||2007-03-01|December 2013|2013-12-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional||The per protocol set (PPS) included all participants who met the principal criteria for eligibility, received at least 1 dose of study medication and had one efficacy assessment after randomization except those participants who had significant protocol deviations|An Exploratory Study of Nesiritide in Participants With Acute Heart Failure|An Exploratory Study of JNS004 (Nesiritide) in Patients With Acute Heart Failure (J2)|Completed||Phase 2|67|Actual|Janssen Pharmaceutical K.K.||3|||f||||f||||||||||2017-02-18 15:30:48.573249|2017-02-18 15:30:48.573249
NCT00490711|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||July 2003||2003-07-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer|Phase II Study of Sequential Therapy With Paclitaxel Plus Carboplatin Followed by Gemzar Plus Carboplatin in the Treatment of Patients With Epithelial Ovarian Cancer FIGO Stages III-IV|Completed||Phase 2|7|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:30:50.538917|2017-02-18 15:30:50.538917
NCT00490698|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2013-02-13|2013-02-13||October 2006||2006-10-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Zoledronate With Atorvastatin in Renal Cell Carcinoma|Bone-Targeted Therapy Combining Zoledronate With Atorvastatin in Renal Cell Carcinoma: A Phase II Study|Completed||Phase 2|11|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:30:50.633373|2017-02-18 15:30:50.633373
NCT00490685|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-22|2010-09-01|||April 2007||2007-04-01|August 2009|2009-08-01||||June 2008|Actual|2008-06-01||Interventional|||Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)|Randomized Continuation, Dose Escalation Trial of Sorafenib in Patients With Advanced HCC With Radiological Progression on Prior Sorafenib Treatment (Phase II Study)|Completed||Phase 2|142|Actual|Istituto Clinico Humanitas|||||f||||t||||||||||2017-02-18 15:30:50.859565|2017-02-18 15:30:50.859565
NCT00490672|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2015-04-06|||August 2007||2007-08-01|April 2010|2010-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|CORFIS||Community Based Multiple Risk Factors Intervention Strategy|Community Based Multiple Risk Factors Intervention Strategy to Prevent Cardiovascular and Chronic Kidney Diseases [CORFIS]|Completed||Phase 4|770|Actual|Ministry of Health, Malaysia||2|||f||||t||||||||||2017-02-18 15:30:50.949893|2017-02-18 15:30:50.949893
NCT00490659|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||September 2003||2003-09-01|June 2007|2007-06-01|December 2004|Actual|2004-12-01|||||Interventional|||Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes|A Phase II Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (-With Weekly Low-Dose Gemcitabine) in the Treatment of Nodes Positive NSCLC Patients|Completed||Phase 2|13|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:30:51.21218|2017-02-18 15:30:51.21218
NCT00490646|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2016-02-09|2012-06-14||February 2008||2008-02-01|February 2016|2016-02-01|November 2011|Actual|2011-11-01|June 2011|Actual|2011-06-01||Interventional|||A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer|Randomized Phase II Study of Ixabepilone Plus Trastuzumab vs. Docetaxel Plus Trastuzumab in Female Subjects With Her2+ Locally Advanced and/or Metastatic Breast Cancer|Completed||Phase 2|50|Actual|R-Pharm||2|||f||||f||||||||||2017-02-18 15:30:51.307559|2017-02-18 15:30:51.307559
NCT00490633|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2011-08-18|||October 2006||2006-10-01|June 2007|2007-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|M-FLU||Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission|Reducing the Transmission of Influenza by Face Masks|Completed||N/A|1420|Actual|University of Michigan||3|||f||||t||||||||||2017-02-18 15:30:52.365685|2017-02-18 15:30:52.365685
NCT00490620|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-10-31|||January 2004||2004-01-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Study of Combivir for Patients With Primary Biliary Cirrhosis|Randomized Controlled Pilot Study of Combivir for Patients With Primary Biliary Cirrhosis|Completed||Phase 2/Phase 3|59|Actual|University of Alberta||2|||f||||f||||||||||2017-02-18 15:30:52.487411|2017-02-18 15:30:52.487411
NCT00490607|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21||||||June 2007|2007-06-01||||||||Observational|||A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities||Unknown status|Recruiting|N/A|||Rady Children's Hospital, San Diego|||||f||||||||||||||2017-02-18 15:30:52.611228|2017-02-18 15:30:52.611228
NCT00490594|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2008-10-17|||June 2007||2007-06-01|October 2008|2008-10-01||||October 2008|Anticipated|2008-10-01||Interventional|||SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction|A Multi-Center Open Study to Evaluate the SeriACL™ Device for Primary Anterior Cruciate Ligament Repair|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|Serica Technologies, Inc.||1|||f||||f||||||||||2017-02-18 15:30:52.693623|2017-02-18 15:30:52.693623
NCT00490581|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2008-09-09|||September 2003||2003-09-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|CHHP||Evaluation of Housing First Initiative for Chicago Homeless With Chronic Medical Illness|Evaluation of the Housing First Initiative of Chicago Housing for Health Partnership|Completed||N/A|407|Actual|John H. Stroger Hospital||2|||f||||f||||||||||2017-02-18 15:30:52.789471|2017-02-18 15:30:52.789471
NCT00490568|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2016-09-28||2010-03-29|August 2007||2007-08-01|September 2016|2016-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers|An Open-label Extension Study of the Long-term Safety and Efficacy of Rosiglitazone Extended-release (RSG XR) as Adjunctive Therapy to Acetylcholinesterase Inhibitors in Subjects With Mild-to-moderate Alzheimer's Disease (REFLECT-4).|Terminated||Phase 3|1480|Actual|GlaxoSmithKline||1||Based on preliminary parent study results|f||||||||||||||2017-02-18 15:30:52.887977|2017-02-18 15:30:52.887977
NCT00490555|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2013-09-12|2013-06-19||January 2009||2009-01-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|PROS-1||PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue|The Effect of Male Hormonal Contraceptive Regimens on Prostate Tissue In Normal Men|Completed||Phase 2/Phase 3|32|Actual|University of Washington||4|||f||||f||||||||||2017-02-18 15:30:53.459874|2017-02-18 15:30:53.459874
NCT00490542|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-07-12|2011-08-03||December 2006||2006-12-01|July 2016|2016-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State|Double-blind, Placebo-controlled Trial of Ziprasidone (Geodon) for the Depressive Mixed State|Completed||Phase 2|73|Actual|Tufts Medical Center|One potential limitation in relation to secondary analyses would be sample size. The randomized study design should account for most potential confounding effects, but residual confounding cannot be completely eliminated without larger studies.|2|||f||||f||||||||||2017-02-18 15:30:54.566882|2017-02-18 15:30:54.566882
NCT00490529|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-11-29|||August 2009||2009-08-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL|"Phase 1-2 Study of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for Mantle Cell Lymphoma"|Active, not recruiting||Phase 2|57|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 15:30:54.970848|2017-02-18 15:30:54.970848
NCT00490516|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2008-02-22|||June 2007||2007-06-01|February 2008|2008-02-01||||February 2008|Anticipated|2008-02-01||Interventional|||ACP-104 in Acutely Psychotic Subjects With Schizophrenia|A Six-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase II Study of the Efficacy and Safety of ACP-104 in Acutely Psychotic Subjects With Schizophrenia|Completed||Phase 2|250|Anticipated|ACADIA Pharmaceuticals Inc.||3|||f||||||||||||||2017-02-18 15:30:55.085187|2017-02-18 15:30:55.085187
NCT00490282|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2016-02-25|||June 2007||2007-06-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer|A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer|Completed||N/A|25|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:30:57.554494|2017-02-18 15:30:57.554494
NCT00490503|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-04-19|||October 2006||2006-10-01|April 2016|2016-04-01||||October 2017|Anticipated|2017-10-01||Observational|||Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer|Non-Invasive MRI and MRS Techniques for Assessing Therapeutic Response to Pre-surgical Chemotherapy in Breast Cancer Patients|Active, not recruiting||N/A|28|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples Without DNA|"~     The tissues removed during surgery (mastectomy) will be collected as part of this study.~   "|||2017-02-18 15:30:55.216092|2017-02-18 15:30:55.216092
NCT00490490|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2014-06-19|||January 2007||2007-01-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma|Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma|Terminated||Phase 2|8|Actual|Stanford University||1||Low Accrual|f||||t||||||||||2017-02-18 15:30:55.340685|2017-02-18 15:30:55.340685
NCT00490477|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2010-06-04|2010-03-09||May 2006||2006-05-01|June 2007|2007-06-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial|Polymyxin-B Hemoperfusion Inactivates Circulating Proapoptotic Factors|Completed||Phase 3|16|Actual|University of Turin, Italy||2|||f||||t||||||||||2017-02-18 15:30:55.45629|2017-02-18 15:30:55.45629
NCT00490464|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-21|||June 2004||2004-06-01|June 2007|2007-06-01|February 2007|Actual|2007-02-01|||||Observational|||Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH||Completed||N/A|163|Actual|University of Illinois at Chicago|||||f||||f||||||||||2017-02-18 15:30:55.847047|2017-02-18 15:30:55.847047
NCT00490451|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2010-12-09||2010-12-09|August 2007||2007-08-01|December 2010|2010-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma|A Phase 2 Study of LY573636-Sodium Administered as Second-line or Third-line Treatment in Patients With Unresectable or Metastatic Soft Tissue Sarcoma|Completed||Phase 2|101|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:30:55.932939|2017-02-18 15:30:55.932939
NCT00490438|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||January 2007||2007-01-01|September 2006|2006-09-01|July 2007|Anticipated|2007-07-01|||||Observational|||Measurement of Vaginal Squeeze Pressure in Incontinent Patients||Unknown status|Recruiting|N/A|||Hospital de Clinicas de Porto Alegre|||||f||||t||||||||||2017-02-18 15:30:56.061341|2017-02-18 15:30:56.061341
NCT00490425|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||October 2002||2002-10-01|June 2007|2007-06-01|October 2006|Actual|2006-10-01|||||Interventional|FRALAC||Prevention of Asthma and Allergy by Probiotic Lactobacillus GG|Efficacy of Lactbacillus GG on Wheeze and Allergic Sensitization in Infants at Risk|Completed||Phase 4|131|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||t||||||||||2017-02-18 15:30:56.140126|2017-02-18 15:30:56.140126
NCT00490412|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2016-02-29|||December 2007||2007-12-01|February 2016|2016-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection|Randomized, Placebo-controlled Trial of the Safety and Effectiveness of Vitamin D Supplement to Improve Tubular Reabsorption of Phosphate and Decrease Bone Turnover in Adolescents and Young Adults With HIV Infection Being Treated With Antiretroviral Therapy Containing Tenofovir Compared to Those Being Treated With Antiretroviral Therapy Not Containing Tenofovir|Completed||N/A|207|Actual|Westat||4|||f||||t||||||||||2017-02-18 15:30:56.239051|2017-02-18 15:30:56.239051
NCT00490399|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||March 2003||2003-03-01|June 2007|2007-06-01|September 2004|Actual|2004-09-01|||||Interventional|||Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas|A Phase II Trial of GEMZAR Combined With Cisplatin in Patients With Inoperable Biliary Tract Carcinomas|Completed||Phase 2|39|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:30:56.377724|2017-02-18 15:30:56.377724
NCT00490386|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-21|||June 2006||2006-06-01|June 2007|2007-06-01||||||||Observational|||Helicobacter Pylori and Acute Alcohol Induced Pancreatitis|Alkoholihaimatulehduksen Uusiminen|Completed||N/A|100|Actual|University of Tampere|||||f||||f||||||||||2017-02-18 15:30:56.475057|2017-02-18 15:30:56.475057
NCT00490373|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||October 2003||2003-10-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic|A Phase 2 Trial of ALIMTA in Pretreated Patients With Unresectable or Metastatic Cancer of the Pancreas|Completed||Phase 2|52|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:30:56.567316|2017-02-18 15:30:56.567316
NCT00490360|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||October 2001||2001-10-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head|Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head|Completed||Phase 2|2007|Actual|University of Zurich||1|||f||||f||||||||||2017-02-18 15:30:56.655129|2017-02-18 15:30:56.655129
NCT00490347|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2008-01-15|||July 2005||2005-07-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|||||Interventional|||VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial|Evaluation of the VentrAssistTM Left Ventricular Assist Device as a Bridge to Cardiac Transplantation - Feasibility Trial|Completed||Phase 2|30|Anticipated|Ventracor||1|||f||||t||||||||||2017-02-18 15:30:56.744643|2017-02-18 15:30:56.744643
NCT00490334|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-05-19|||August 2007||2007-08-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer|Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer|Completed||N/A|72|Actual|Stanford University|||2||f||||t||||||||||2017-02-18 15:30:56.82997|2017-02-18 15:30:56.82997
NCT00490321|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2009-09-04|||June 2007||2007-06-01|September 2009|2009-09-01|June 2012|Anticipated|2012-06-01|||||Interventional|||VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy|Evaluation of the VentrAssistTM Left Ventricular Assist Device for the Treatment of Advanced Heart Failure - Destination Therapy|Unknown status|Active, not recruiting|Phase 3|225|Anticipated|Ventracor||3|||f||||t||||||||||2017-02-18 15:30:56.920457|2017-02-18 15:30:56.920457
NCT00490308|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-24|||August 2007||2007-08-01|June 2007|2007-06-01|August 2008|Anticipated|2008-08-01|||||Interventional|||The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment|Blinded Randomised Trial About the Influence of Estradiol Supplementation During the Luteal in Patients Undergoing in Vitro Fertilization (IVF) Treatment|Unknown status|Not yet recruiting|Phase 1|120|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 15:30:57.243314|2017-02-18 15:30:57.243314
NCT00490269|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2017-01-11|2012-12-19||October 2006||2006-10-01|August 2016|2016-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Ph1 Marinol Interaction Study - Part 2 - 1|Phase 1, Pilot Study to Examine the Cardiovascular Effects of Smoked Marijuana, Interactions With Oral Dronabinol, and Effects of Dronabinol on Withdrawal in Marijuana Dependent Volunteers|Completed||Phase 1|12|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-02-18 15:30:57.675631|2017-02-18 15:30:57.675631
NCT00490256|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2014-05-21|2011-07-08||June 2007||2007-06-01|May 2014|2014-05-01|June 2010|Actual|2010-06-01|April 2010|Actual|2010-04-01||Interventional|||Modified Perfusion for Neonatal Aortic Arch Reconstruction|Evaluation of a Modified Perfusion Strategy for Neonatal Aortic Arch Reconstruction: Does Perfusing the Lower Body During Arch Repair Help?|Completed||N/A|14|Actual|Emory University|Early termination leading to small numbers for analysis|2|||f||||f||||||||||2017-02-18 15:30:58.078299|2017-02-18 15:30:58.078299
NCT00490243|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-27|||July 2003||2003-07-01|June 2007|2007-06-01|October 2006|Actual|2006-10-01|||||Interventional|||Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma|A Randomized, Double-Blind Trial of the Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma|Completed||Phase 4|150|Actual|Medical Universtity of Lodz||5|||f||||t||||||||||2017-02-18 15:30:58.453347|2017-02-18 15:30:58.453347
NCT00490230|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-12-31|||April 2007||2007-04-01|December 2015|2015-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|SCAR||Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application|Assessment of Cutaneous Leishmaniasis Scar (Caused by Leishmania Major) for Cosmetic Outcome After Treatment With WR279396 (Paromomycin/Gentamicin Cream in Vehicle) Versus a No Treatment Control Group (Natural Healing)|Completed||N/A|108|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||f||||||||||2017-02-18 15:30:58.55187|2017-02-18 15:30:58.55187
NCT00490217|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||December 1993||1993-12-01|June 2007|2007-06-01|March 2007|Actual|2007-03-01|||||Observational|||Spontaneous Bacterial Peritonitis: Incidence, Risk Factors and Outcome|Spontaani Bakterielli Peritoniitti: Esiintyvyys, riskitekijät ja Vaikutus Ennusteeseen|Completed||N/A|240|Actual|University of Tampere|||||f||||f||||||||||2017-02-18 15:30:58.662999|2017-02-18 15:30:58.662999
NCT00490204|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2009-05-21|||July 2007||2007-07-01|May 2009|2009-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis|A Randomized, Double Blind, Placebo Controlled Study for Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup (CTZ DS) (2.5 mg or 5 mg Twice a Day) in Children (2 Years of Age or Older But Under 15 Years Old) Suffering From Perennial Allergic Rhinitis.|Completed||Phase 3|236||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:30:58.907945|2017-02-18 15:30:58.907945
NCT00490191|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||January 1999||1999-01-01|June 2007|2007-06-01|July 2001|Actual|2001-07-01|||||Interventional|||Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency|Comparison of an Incremental Weight-Based Dose Regimen With an Individualized Dosage Adjusted According to the IGF-I Response in Adults With Growth Hormone Deficiency|Completed||Phase 4|387|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:30:59.031455|2017-02-18 15:30:59.031455
NCT00490178|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-08-31|||March 2007||2007-03-01|August 2007|2007-08-01||||||||Interventional|||Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia|An Open Label, Multicenter Trial Assessing the Acceptability of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Patients With Type 2 Diabetes and Dyslipidemia|Completed||Phase 3|29|Actual|Solvay Pharmaceuticals|||||f||||f||||||||||2017-02-18 15:30:59.149863|2017-02-18 15:30:59.149863
NCT00490165|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2012-04-05|||March 2007||2007-03-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Periodontal and Periapical Inflammation and Pregnancy|Associations Between Periodontal and Periapical Inflammation and Pregnancy Outcomes|Completed||N/A|30|Actual|University of Mississippi Medical Center|||1||f||||f||||||||||2017-02-18 15:30:59.23614|2017-02-18 15:30:59.23614
NCT00490152|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2016-05-24|||August 2007||2007-08-01|May 2016|2016-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Microbicides Acceptability Among Sexually Active Young Women|"Microbicide-Use Adherence, Acceptability, and Attitudes Among Sexually Active Young Women Participating in a Phase I Microbicide Trial (MTN 004) Tell Juliana"|Completed||N/A|59|Actual|Westat|||3||f||||t||||||||||2017-02-18 15:30:59.315384|2017-02-18 15:30:59.315384
NCT00490139|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-04-03|2014-07-30||May 2007||2007-05-01|April 2016|2016-04-01|November 2022|Anticipated|2022-11-01|December 2013|Actual|2013-12-01||Interventional|ALTTO||ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D|A Randomised, Multi-centre, Open-label, Phase III Study of Adjuvant Lapatinib, Trastuzumab, Their Sequence and Their Combination in Patients With HER2/ErbB2 Positive Primary Breast Cancer|Active, not recruiting||Phase 3|8381|Actual|Novartis||4|||f||||t||||||||||2017-02-18 15:30:59.508788|2017-02-18 15:30:59.508788
NCT00490126|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-11-09|||June 2006||2006-06-01|November 2016|2016-11-01||||June 2027|Anticipated|2027-06-01||Observational|||Data Collection of Demographics and Perioperative Care of Patients Undergoing Laparoscopic Surgery|Data Collection of Demographics and Perioperative Care of Patients Undergoing Laparoscopic Surgery in the Department of Gynecologic Oncology|Recruiting||N/A|5000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:31:10.965969|2017-02-18 15:31:10.965969
NCT00490113|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2017-01-03|||January 2007||2007-01-01|January 2017|2017-01-01||||||||Interventional|||A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria|Effects of Pyridoxamine on Oxalate Excretion in Stone Disease and Hyperoxaluria|Withdrawn||Phase 2|0|Actual|University of Kansas Medical Center||1||Drug unavailable|f||||t||||||||||2017-02-18 15:31:11.076872|2017-02-18 15:31:11.076872
NCT00490100|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2015-07-02|2014-03-18||June 2007||2007-06-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1|Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency (XSCID): A Phase 2 Study Assessing Safety and Clinical Response to Treatment With Insulin-like Growth Factor-1 (IGF-1)|Terminated||Phase 1/Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|Due to limited subject participation, there is insufficient complete data to generate meaningful statistics for the outcome measures. Instead, this data will be reported as a case series.|1||Insufficient patient participation|f||||t||||||||||2017-02-18 15:31:11.180799|2017-02-18 15:31:11.180799
NCT00490074|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2009-11-25|||July 2007||2007-07-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|EV03/ANRSVAC20||Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers|A Phase I/II Trial to Compare the Immunogenicity and Safety of 3 DNA C Prime Followed by 1 NYVAC C Boost to 2 DNA C Prime Followed by 2 NYVAC C Boost|Completed||Phase 1/Phase 2|147|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||t||||||||||2017-02-18 15:31:11.597912|2017-02-18 15:31:11.597912
NCT00490061|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-05-20|||July 2007||2007-07-01|May 2015|2015-05-01|July 2025|Anticipated|2025-07-01|July 2025|Anticipated|2025-07-01||Interventional|||Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy|A Multi-Institutional Phase II Study of Radiation and GW572016 (Lapatinib) for Patients With Stage III-IV Head and Neck Cancer Who Cannot Tolerate Concurrent Chemoradiotherapy.|Active, not recruiting||Phase 2|60|Anticipated|Stanford University||1|||f||||t||||||||||2017-02-18 15:31:11.710017|2017-02-18 15:31:11.710017
NCT00490048|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2007-06-21|||June 2007||2007-06-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum||Completed||N/A|20|Anticipated|Hillel Yaffe Medical Center||1|||f||||||||||||||2017-02-18 15:31:11.824615|2017-02-18 15:31:11.824615
NCT00490035|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2016-03-14|2016-03-14||September 2007||2007-09-01|March 2016|2016-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional||Baseline Characteristics refer to the Randomized Set.|Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures|A Multi-center, Double-blind, Parallel-group, Placebo Controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (>= 16 to 70 Years Old) With Partial Onset Seizures.|Completed||Phase 3|399|Actual|UCB Pharma||4|||f||||f||||||||||2017-02-18 15:31:11.938187|2017-02-18 15:31:11.938187
NCT00490022|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2011-06-20|2011-01-10||June 2007||2007-06-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|DHT-3||Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]|The Effect of Dihydrotestosterone (DHT) on Prostate Tissue Androgen Concentrations and Inflammation in Normal Men|Completed||Phase 1/Phase 2|31|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 15:31:13.959741|2017-02-18 15:31:13.959741
NCT00490009|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2014-06-19|||September 2004||2004-09-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma|Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma (DLCL)|Completed||Phase 2|25|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 15:31:14.395118|2017-02-18 15:31:14.395118
NCT00489996|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||January 2003||2003-01-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer|A Multicenter, Randomized Trial Comparing a Combined Gemcitabine and Cisplatin 3-Week Regimen With a 4-Week Regimen in Non-Small Cell Lung Cancer Patients|Completed||Phase 2|100|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:31:14.507643|2017-02-18 15:31:14.507643
NCT00489983|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||July 2003||2003-07-01|June 2007|2007-06-01|March 2005|Actual|2005-03-01|||||Interventional|||Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy|A Multicenter Phase 2 Randomized Trial of Single-Agent ALIMTA or ALIMTA With Sequentially Administered GEMZAR as First-Line Chemotherapy in Elderly Patients or Patients Who Are Not Eligible for Platinum-Based Chemotherapy With Advanced NSCLC|Completed||Phase 2|91|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:31:14.606798|2017-02-18 15:31:14.606798
NCT00489970|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-21|2016-05-26|2010-07-15||June 2007||2007-06-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|September 2011|Actual|2011-09-01||Interventional|||Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9|Persistence Study of GSK Biologicals' Tdap Vaccine (776423), 1, 3, 5 and 9 Years Following Administration as a Single Dose in NCT00346073 Study and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9|Completed||Phase 3|1592|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 15:31:14.870865|2017-02-18 15:31:14.870865
NCT00489957|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2013-11-25|||March 2007||2007-03-01|November 2013|2013-11-01|December 2009|Actual|2009-12-01|May 2008|Actual|2008-05-01||Observational|||Speckle Tracking in Pediatric Patients|Speckle Tracking and Function Assessment in Pediatric Patients|Completed||N/A|70|Actual|Emory University|||2||f||||f||||||||||2017-02-18 15:31:15.430809|2017-02-18 15:31:15.430809
NCT00489944|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2014-01-09|||May 2007||2007-05-01|July 2009|2009-07-01||||December 2012|Anticipated|2012-12-01||Interventional|||Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma|A Phase II Pilot Trial of Sutent, Tamoxifen, and Cisplatin in Patients With High-Risk Ocular Melanoma|Unknown status|Recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:31:15.525399|2017-02-18 15:31:15.525399
NCT00489931|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2017-01-24|||June 18, 2007||2007-06-18|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Interventional|||Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally|A Phase I Open-Label Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for the Influenza Virus H5 Hemagglutinin Protein Administered Intradermally in Healthy Adults|Completed||Phase 1|44||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:31:15.805646|2017-02-18 15:31:15.805646
NCT00489918|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2009-05-07|||June 2007||2007-06-01|May 2009|2009-05-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Dose Ranging Study - Macroflux PTH in Postmenopausal Women With Osteoporosis|A Dose Ranging Study of the Effects of Macroflux® PTH Compared With Macroflux® Placebo and FORTEO® in Postmenopausal Women With Osteoporosis|Completed||Phase 2|165|Actual|Zosano Pharma Inc.||5|||f||||f||||||||||2017-02-18 15:31:15.91971|2017-02-18 15:31:15.91971
NCT00489905|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2013-10-22|||April 2005||2005-04-01|October 2013|2013-10-01|May 2008|Actual|2008-05-01|||||Interventional|||Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer|Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer|Completed||N/A|24|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:31:16.031818|2017-02-18 15:31:16.031818
NCT00489892|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-07-23|||August 2003||2003-08-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Efficacy of Pharmacological Treatment of Working Memory Impairment After Traumatic Brain Injury: Evaluation With fMRI|Efficacy of Pharmacological Treatment of Working Memory Impairment After Traumatic Brain Injury: Evaluation With fMRI|Unknown status|Recruiting|N/A|20|Anticipated|Kessler Foundation||2|||f||||f||||||||||2017-02-18 15:31:16.134404|2017-02-18 15:31:16.134404
NCT00489879|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2008-05-19|||July 2007||2007-07-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Management of Patients With Type 2 Diabetes and Hypertension Using Mobile Health Care System|Efficacy of Mobile Health Care System in Patients With Type 2 Diabets and Hypertension|Completed||N/A|140|Anticipated|Korea University||1|||f||||t||||||||||2017-02-18 15:31:16.242623|2017-02-18 15:31:16.242623
NCT00489866|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-03-12|2011-09-16||March 2007||2007-03-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|September 2008|Actual|2008-09-01||Interventional|||Aripiprazole Augmentation of Antidepressants in PTSD|Aripiprazole Augmentation of Antidepressants in PTSD|Completed||Phase 2|14|Actual|Durham VA Medical Center|One of the primary limitations of this pilot clinical trial is small sample size. Results of this study will clearly need to be replicated in a larger cohort.|2|||f||||||||||||||2017-02-18 15:31:16.352183|2017-02-18 15:31:16.352183
NCT00489853|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2012-07-27|2009-08-06||July 2007||2007-07-01|July 2012|2012-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|CODEX||Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD|A Multi-centre, Randomised, Double-blind, Cross-over Design Study to Evaluate Efficacy on Exercise Tolerance of Symbicort ®(Budesonide/Formoterol) 320/9μg One Inhalation Twice Daily Compared With Placebo and Oxis® 9μg One Inhalation Twice Daily in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 4|137|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 15:31:16.867639|2017-02-18 15:31:16.867639
NCT00489840|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2012-10-24|||May 2007||2007-05-01|October 2012|2012-10-01||||July 2010|Actual|2010-07-01||Interventional|CSC-AA||Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate|Treatment of Chronic Central Serous Chorioretinopathy With Open-label Anecortave Acetate|Completed||Phase 1/Phase 2|5|Actual|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-02-18 15:31:17.916453|2017-02-18 15:31:17.916453
NCT00489827|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2013-01-16|||October 2005||2005-10-01|January 2013|2013-01-01|December 2014|Anticipated|2014-12-01|December 2009|Actual|2009-12-01||Interventional|GLUTAMICS||Glutamate for Metabolic Intervention in Coronary Surgery|Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery Disease|Unknown status|Active, not recruiting|Phase 3|800|Anticipated|University Hospital, Linkoeping||2|||f||||t||||||||||2017-02-18 15:31:18.03012|2017-02-18 15:31:18.03012
NCT00489814|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2016-09-30|||May 2006||2006-05-01|September 2016|2016-09-01||||May 2018|Anticipated|2018-05-01||Observational|||Study of Quality of Life for Prostate Proton Therapy|Prospective Evaluation of Quality of Life After Proton Therapy for Prostate Cancer|Active, not recruiting||N/A|1084|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:31:18.158665|2017-02-18 15:31:18.158665
NCT00489801|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2009-11-09|||January 2007||2007-01-01|November 2009|2009-11-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|HOME-BASE||Trial Comparing Home-based Cardiac Rehabilitation With Comprehensive Centre-based Cardiac Rehabilitation in Patients Older Than 65 Years With Coronary Heart Disease. The HOMEBASE Trial|RCT Comparing Home-based Cardiac Rehabilitation With Comprehensive Centre-based Cardiac Rehabilitation and Usual Care in Patients Older Than 65 Years With Coronary Heart Disease. The HOMEBASE Trial.|Unknown status|Active, not recruiting|N/A|115|Actual|Bispebjerg Hospital||1|||f||||f||||||||||2017-02-18 15:31:18.269992|2017-02-18 15:31:18.269992
NCT00489788|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2013-12-10|||September 2008||2008-09-01|December 2013|2013-12-01|March 2009|Actual|2009-03-01|||||Observational|||Predictors for Pulmonary Valve Replacement - Anatomic and Hemodynamic Using MRI|MRI Assessment of Right and Left Ventricular Strain, Associated Function, Volume and ECG Parameters as Predictors of Optimal Timing for Pulmonary Valve Replacement in Patients Post Repair for Tetralogy of Fallot|Completed||N/A|101|Actual|Emory University|||1||f||||f||||||||||2017-02-18 15:31:18.380881|2017-02-18 15:31:18.380881
NCT00489775|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-19|||January 2004||2004-01-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Duloxetine Versus Paroxetine for Major Depression|Duloxetine Versus Paroxetine in the Acute Treatment of Major Depression|Completed||Phase 3|480||Eli Lilly and Company|||||f||||f||||||||||2017-02-18 15:31:18.461172|2017-02-18 15:31:18.461172
NCT00489762|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-19|||June 2005||2005-06-01|June 2007|2007-06-01|October 2006|Actual|2006-10-01|||||Interventional|||Does Improving Insulation and Heating Improve Health?|Housing, Heating and Health Study:a Randomised Community Trial|Completed||N/A|409|Actual|University of Otago||1|||f||||f||||||||||2017-02-18 15:31:18.649702|2017-02-18 15:31:18.649702
NCT00489749|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-19|||October 2003||2003-10-01|June 2007|2007-06-01|May 2006|Actual|2006-05-01|||||Interventional|||A Study Comparing Protected Early Weightbearing Versus Non-Weightbearing After Surgery for Achilles Tendon Rupture|The Influence of Protected Early Weightbearing Versus Nonweightbearing After Surgical Repair of the Achilles Tendon|Completed||N/A|110|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 15:31:18.772571|2017-02-18 15:31:18.772571
NCT00489736|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2010-02-15|2009-09-30||June 2007||2007-06-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|DIONYSOS||Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation|Randomized Double Blind Trial to Evaluate the Efficacy and Safety of Dronedarone (400mg BID) Versus Amiodarone (600mg Daily for 28 Days, Then 200mg Daily Thereafter) for at Least 6 Months for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation (AF)|Completed||Phase 3|504|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:31:18.869276|2017-02-18 15:31:18.869276
NCT00489723|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-20|||May 2007||2007-05-01|June 2007|2007-06-01||||||||Observational|||Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?||Unknown status|Recruiting|N/A|||HaEmek Medical Center, Israel|||||f||||t||||||||||2017-02-18 15:31:19.652281|2017-02-18 15:31:19.652281
NCT00489710|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2013-05-07|||December 2006||2006-12-01|May 2013|2013-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Talabostat in Treating Patients With Metastatic Kidney Cancer|A Phase II Study of Talabostat in Patients With Metastatic Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|University of Nebraska||1||Terminated for safety reasons|f||||t||||||||||2017-02-18 15:31:19.744685|2017-02-18 15:31:19.744685
NCT00489697|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2017-01-02|||January 2007||2007-01-01|January 2017|2017-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases|Medical and Economical Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases|Completed||N/A|200|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-02-18 15:31:19.857375|2017-02-18 15:31:19.857375
NCT00489684|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2008-06-13|||August 2007||2007-08-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|||||Observational|AEO-2007-01||Effect of Opioids on Experimental Hyperalgesia in Oesophagus, Skin and Muscles|Investigation of the Effect of Opioids on Experimental Hyperalgesia in Oesophagus and Skin, and in an Ischemic Model of Musclepain. Including an Explorative Study of the Effect of Morphine on the Pain Processing in the Brain|Completed||N/A|24|Actual|University of Aarhus|||1||f||||t||||||Samples With DNA|"~     Blood samples are collected to study the pharmacokinetic of the drugs~   "|||2017-02-18 15:31:19.983054|2017-02-18 15:31:19.983054
NCT00489671|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2017-01-17|||June 2003||2003-06-01|October 2015|2015-10-01|August 2007|Actual|2007-08-01|October 2006|Actual|2006-10-01||Observational|||Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis|Differential Diagnosis Between Pancreatic Cancer and Chronic Pancreatitis: Value of the Detection of Urinary Cadmium|Completed||N/A|32|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 15:31:20.062161|2017-02-18 15:31:20.062161
NCT00489658|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||October 2002||2002-10-01|June 2007|2007-06-01||||||||Interventional|NECS||Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda|Efficacy and Safety of an Eflornithine + Nifurtimox Combination for Treatment of Late-Stage Human African Trypanosomiasis (HAT) in West Nile, Uganda|Terminated||Phase 2/Phase 3|31|Actual|Epicentre||||"Because of unexpectedly reduced disease prevalence in the study area, a pragmatic decision was~   taken to terminate recruitment in March 2003."|f||||f||||||||||2017-02-18 15:31:20.15053|2017-02-18 15:31:20.15053
NCT00489645|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2008-01-15|||January 2005||2005-01-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide|The Influence of Ambient Glycemia on the Effect of Pramlintide on Gastric Emptying in Patients With Type 1 Diabetes and Healthy Subjects|Completed||N/A|27|Actual|Ludwig-Maximilians - University of Munich||4|||f||||t||||||||||2017-02-18 15:31:20.244572|2017-02-18 15:31:20.244572
NCT00489632|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2012-02-17|||April 2006||2006-04-01|February 2012|2012-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Children's Resiliency, Adjustment, and Coping|Children's Resiliency, Adjustment, and Coping: Cancer-Related, Family Context, and Within-Child Factors|Completed||N/A|66|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:31:20.348353|2017-02-18 15:31:20.348353
NCT00489619|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2014-07-29|||April 2004||2004-04-01|July 2014|2014-07-01|March 2005|Actual|2005-03-01|||||Observational|||Safe Pregnancy by Infectious Disease Control|Safe Pregnancy by Infectious Disease Control in the Democratic Republic of Congo - Pilot Study|Completed||N/A|2008|Actual|NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 15:31:20.469423|2017-02-18 15:31:20.469423
NCT00489606|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||April 2007||2007-04-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530|Clinical Trial to Investigate the Influence of Drug Interaction After Oral Administration of Tamsulosin and SK3530 in Healthy Male Volunteers|Completed||Phase 1|16|Actual|SK Chemicals Co.,Ltd.||2|||f||||t||||||||||2017-02-18 15:31:20.564296|2017-02-18 15:31:20.564296
NCT00489593|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-01-07|||October 2006||2006-10-01|January 2015|2015-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Olanzapine in Patients With Advanced Cancer and Weight Loss|Phase I Dose-Finding Pilot Study of the Safety and Tolerability of Olanzapine in Patients With Advanced Cancer and Weight Loss|Completed||Phase 1|57|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:31:20.658599|2017-02-18 15:31:20.658599
NCT00489580|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-07-23|||August 2005||2005-08-01|July 2007|2007-07-01|May 2006|Actual|2006-05-01|||||Interventional|||A Pilot Study Investigating the Feasibility of the Saebo Arm Training Program on an Inpatient Population|A Pilot Study Investigating the Feasibility of Using a Functional Tone Management (F.T.M.) Arm Training Program With the SaeboFlex Dynamic Hand Orthosis on an Inpatient Population|Completed||N/A|24|Actual|Kessler Foundation||2|||f||||f||||||||||2017-02-18 15:31:20.781487|2017-02-18 15:31:20.781487
NCT00489567|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2011-01-27|||October 2007||2007-10-01|January 2011|2011-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden|A Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE, Its Complications and Diversity of Co-circulating Rotavirus Strains in Children < 5 Years of Age in Sweden|Completed||N/A|642|Actual|GlaxoSmithKline|||1||f||||||||||Samples With DNA|"~     Stool sample, Blood sample~   "|||2017-02-18 15:31:20.887157|2017-02-18 15:31:20.887157
NCT00489554|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-11-03|2012-03-15||July 2007||2007-07-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age|Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Infanrix Hexa and Rotarix|Completed||Phase 3|230|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:31:20.987538|2017-02-18 15:31:20.987538
NCT00489541|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2014-04-24|2011-04-28||July 2007||2007-07-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|June 2009|Actual|2009-06-01||Interventional|PERSEUS SV||TAXUS PERSEUS Small Vessel|A Prospective Evaluation in a Non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions in Small Vessels|Completed||Phase 3|224|Actual|Boston Scientific Corporation|There were no commercially available dedicated small vessel paclitaxel-eluting stents at the time of study enrollment, thus, the PERSEUS Small Vessel comparator group does not represent the most recently available paclitaxel-eluting stents.|1|||f||||t||||||||||2017-02-18 15:31:21.465163|2017-02-18 15:31:21.465163
NCT00489528|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2013-10-21|||July 1997||1997-07-01|October 2013|2013-10-01|March 2002|Actual|2002-03-01|||||Interventional|||Growth Hormone in the Treatment of HIV-Associated Wasting|A Randomized, Parallel Group, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Recombinant Human Growth Hormone (Serostim) in the Treatment of HIV-Associated Catabolism/Wasting|Completed||Phase 3|||EMD Serono|||||f||||||||||||||2017-02-18 15:31:23.177992|2017-02-18 15:31:23.177992
NCT00489515|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-10-22|||February 1999||1999-02-01|October 2015|2015-10-01|August 2010|Actual|2010-08-01|June 2009|Actual|2009-06-01||Observational|||Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder|Visceral Lymphatic Mapping Project: A Pilot Study|Completed||N/A|115|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 15:31:23.253542|2017-02-18 15:31:23.253542
NCT00489502|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||June 2007||2007-06-01|June 2007|2007-06-01||||||||Observational|||Clinical Observation of Implementing the MedGem Into a Medical Specialty Practice|Phase I: Clinical Observation of Implementing the MedGem Into a Medical Specialty (i.e. Cardiology) Practice|Unknown status|Recruiting|N/A|30|Anticipated|Microlife|||||f||||f||||||||||2017-02-18 15:31:23.473053|2017-02-18 15:31:23.473053
NCT00489489|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2012-11-05|2012-10-03||May 2007||2007-05-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis|A Randomized, Multinational, Double-Blind, Placebo-Controlled, Parallel-Group Design Pilot Study to Estimate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamic Effects of Teriflunomide for 24 Weeks When Added to Treatment With Interferon-beta in Subjects With Multiple Sclerosis.|Completed||Phase 2|118|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 15:31:23.555823|2017-02-18 15:31:23.555823
NCT00489476|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2008-04-09|||June 2007||2007-06-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Staccato® Loxapine for Inhalation in Patients With Migraine Headache|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Efficacy and Safety Study of Staccato® Loxapine for Inhalation in Patients With Migraine Headache|Completed||Phase 2|160|Anticipated|Alexza Pharmaceuticals, Inc.||4|||f||||f||||||||||2017-02-18 15:31:24.513398|2017-02-18 15:31:24.513398
NCT00489463|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-20|||January 2004||2004-01-01|January 2006|2006-01-01|November 2006|Actual|2006-11-01|||||Interventional|||IUD Uterine Vascularization and Side Effects|The Effect of the Levonorgestrel-Releasing Intrauterine System and the Copper-Intrauterine Device (TCu 380A) on Subendometrial Microvascularization and Uterine Artery Blood Flow.|Completed||N/A|63|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-02-18 15:31:24.601402|2017-02-18 15:31:24.601402
NCT00489450|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||March 2007||2007-03-01|March 2007|2007-03-01|May 2007|Actual|2007-05-01|||||Interventional|||Phase I Study to Investigate the Alcohol Interaction of SK3530|Clinical Trial to Investigate the Influence of Alcohol on the Pharmacokinetics and Safety of SK3530 in Healthy Male Volunteers|Completed||Phase 1|18|Actual|SK Chemicals Co.,Ltd.||3|||f||||t||||||||||2017-02-18 15:31:24.857464|2017-02-18 15:31:24.857464
NCT00489437|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2013-09-09|||December 2007||2007-12-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Heparin-Induced Thrombocytopenia Score Card Study|Improving the Diagnosis of Heparin-Induced Thrombocytopenia: Utility of the 4T's Score and Evaluation of New Rapid Assays|Completed||Phase 1|536|Actual|McMaster University||1|||f||||t||||||||||2017-02-18 15:31:24.954152|2017-02-18 15:31:24.954152
NCT00489424|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2011-02-15|2009-08-06||June 2007||2007-06-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass|A Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group Study of Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an i.v. Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass|Completed||Phase 4|793|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:31:25.059212|2017-02-18 15:31:25.059212
NCT00489411|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-08-11|||April 2008||2008-04-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|January 2012|Actual|2012-01-01||Interventional|||Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer|A Phase III Double Blind Trial of Oral Duloxetine for Treatment of Pain Associated With Chemotherapy-Induced Peripheral Neuropathy|Completed||Phase 3|242|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 15:31:25.736017|2017-02-18 15:31:25.736017
NCT00489398|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2010-10-05|||July 2007||2007-07-01|October 2010|2010-10-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Comparison of CL Wear Between Two Allergy Drops|Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride|Withdrawn||Phase 4|25|Anticipated|Hom, Milton M., OD, FAAO||2||Protocol changes|f||||t||||||||||2017-02-18 15:31:26.478273|2017-02-18 15:31:26.478273
NCT00489385|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2017-01-24|||June 18, 2007||2007-06-18|January 25, 2012|2012-01-25|March 15, 2011|Actual|2011-03-15|March 15, 2011|Actual|2011-03-15||Interventional|||An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals|An Open Label Non-Randomized Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals|Completed||Phase 1|41|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:31:26.577317|2017-02-18 15:31:26.577317
NCT00489372|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2014-11-13|||July 2007||2007-07-01|September 2014|2014-09-01|July 2009|Actual|2009-07-01|March 2008|Actual|2008-03-01||Interventional|||Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients|Phase I Study of Single Oral Dose of Se-Methyl-Seleno-L-Cysteine (MSC) in Adult Men|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 15:31:26.687605|2017-02-18 15:31:26.687605
NCT00489359|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2011-05-17|2011-02-17||July 2005||2005-07-01|May 2011|2011-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer|A Phase 1 and 2 Clinical Trial of ALIMTA® (Pemetrexed) in Combination With Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer|Completed||Phase 1/Phase 2|86|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:31:26.822759|2017-02-18 15:31:26.822759
NCT00489346|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-06-22|||October 2001||2001-10-01|June 2015|2015-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)|A Double-Blind, Randomized, Double-Dummy, Multicenter Study to Evaluate and Compare Oral Montelukast and Inhaled Fluticasone in the Control of Asthma for 6- to 14-Year-Olds With Mild Persistent Asthma|Completed||Phase 3|994|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:31:30.682929|2017-02-18 15:31:30.682929
NCT00483613|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2007-06-06|||December 2003||2003-12-01|June 2007|2007-06-01|July 2005|Actual|2005-07-01|||||Interventional|||Effects of Treatment of Chronic Stress in Patients With Lupus||Completed||N/A|45|Actual|University Hospital Virgen de las Nieves||2|||f||||t||||||||||2017-02-18 15:33:53.933484|2017-02-18 15:33:53.933484
NCT00489333|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-19|||May 2006||2006-05-01|June 2007|2007-06-01|September 2006|Actual|2006-09-01|||||Interventional|||ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome|The Effects of ProAlgaZyme Novel Algae Infusion vs. Placebo on Metabolic Syndrome and Markers of Cardiovascular Health|Completed||N/A|52|Actual|Health Enhancement Products, Inc.||2|||f||||f||||||||||2017-02-18 15:31:30.7666|2017-02-18 15:31:30.7666
NCT00489320|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-08-01|||December 2004||2004-12-01|August 2007|2007-08-01|July 2006|Actual|2006-07-01|||||Observational|DESCOVER||An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).|An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).|Completed||N/A|7759|Actual|Cordis Corporation|||||f||||f||||||||||2017-02-18 15:31:30.859702|2017-02-18 15:31:30.859702
NCT00489307|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2016-03-07|||February 2006||2006-02-01|March 2016|2016-03-01||||February 2018|Anticipated|2018-02-01||Interventional|||Dexamethasone for Symptom Burden in Advanced Cancer Patients|The Effect of Dexamethasone on Symptoms in Patients With Advanced Cancer|Active, not recruiting||Phase 2|160|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:31:30.951086|2017-02-18 15:31:30.951086
NCT00489294|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2012-03-09|||August 2004||2004-08-01|March 2012|2012-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency|An Open-Label Study of the Pharmacokinetics and Pharmacodynamics of Syntropin (a Human Growth Hormone) in Growth Hormone-Suppressed Healthy Volunteers|Completed||Phase 1|20|Actual|Phage Pharmaceuticals, Inc.|||||f||||t||||||||||2017-02-18 15:31:31.059652|2017-02-18 15:31:31.059652
NCT00489281|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2017-01-26|||May 2007||2007-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|May 2018|Anticipated|2018-05-01||Interventional|||Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Sickle Cell Anemia and Other Blood Disorders|A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients With Sickle Cell Anemia and Other Hemoglobinopathies|Active, not recruiting||Phase 2|42|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 15:31:31.154533|2017-02-18 15:31:31.154533
NCT00489268|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2016-11-29|2011-03-07||November 2003||2003-11-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|February 2007|Actual|2007-02-01||Interventional|AIM||Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years|Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years|Completed||N/A|102|Actual|Medtronic - MITG|Study had no concurrent control arm, biopsy forceps were not standardized for all cases, the original patient group comprised 70 patients, whereas 69 and 61 patients were available at 1 and 2.5 years, respectively, 60 eligible patients at 5 years.|5|||f||||f||||||||||2017-02-18 15:31:31.265238|2017-02-18 15:31:31.265238
NCT00489255|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2014-05-22|2012-12-24||May 2007||2007-05-01|May 2014|2014-05-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Interventional|||Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment|"A Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Trimethobenzamide (Tigan®) in the Control of Nausea and Vomiting During Initiation and Continued Treatment With Subcutaneous Apomorphine (Apokyn®) in Apomorphine-naïve Subjects With Parkinson's Disease Suffering From Acute Intermittent Off Episodes, With Phased Withdrawal of Subjects From Tigan® to Placebo"|Completed||Phase 4|117|Actual|Ipsen||2|||f||||f||||||||||2017-02-18 15:31:34.44932|2017-02-18 15:31:34.44932
NCT00489242|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-20|||August 2003||2003-08-01|June 2007|2007-06-01|September 2005|Actual|2005-09-01|||||Interventional|PREDICT||Prediction of CK-MB Release During Otherwise Successful Stenting Procedure|PREDICT Trial: Prediction of CK-MB Release During Otherwise Successful Stenting Procedure Correlating With Indicators of Microvascular Obstruction|Completed||N/A|72|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||||||||||||2017-02-18 15:31:35.731363|2017-02-18 15:31:35.731363
NCT00489229|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2009-07-15|||October 2002||2002-10-01|March 2007|2007-03-01|December 2005|Actual|2005-12-01|||||Interventional|||To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients|Studies on Diabetic and Pre Diabetic Vascular Disease and the Effect of Selected Therapeutic Modalities on Associated Vasculopathy|Completed||Phase 3|66|Actual|University of Science Malaysia||3|||f||||t||||||||||2017-02-18 15:31:35.813579|2017-02-18 15:31:35.813579
NCT00489216|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-01-20|||December 2006||2006-12-01|January 2016|2016-01-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|NRR||Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids|Weekly Subcutaneous Efalizumab for the Treatment of Steroid Refractory Graft-Versus-Host Disease of the Skin and Liver|Terminated||N/A|2|Actual|UNC Lineberger Comprehensive Cancer Center||1||insufficient accrual|f||||t||||||||||2017-02-18 15:31:35.909528|2017-02-18 15:31:35.909528
NCT00489203|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-03-05||2011-09-21|April 2007||2007-04-01|March 2015|2015-03-01||||November 2010|Actual|2010-11-01||Interventional|||Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer|A Phase II Study to Evaluate the Efficacy of Oral Beclomethasone Dipropionate for Prevention of Acute GVHD After Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens|Completed||Phase 2|140|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-02-18 15:31:36.027585|2017-02-18 15:31:36.027585
NCT00489190|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2009-03-13|||August 2005||2005-08-01|March 2009|2009-03-01||||||||Interventional|||APIDRA Registration Study|Local, Open, Non-Randomized, Phase IV Clinical Study for the Collection of Data Regarding the Drug Portability Received During the Treatment With Subcutaneous Injection of Apidra Glulisine (HMR1964) to Patients With Diabetes Mellitus 1st Type|Completed||Phase 4|45|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:31:36.178766|2017-02-18 15:31:36.178766
NCT00489177|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-11-17|||June 2007||2007-06-01|November 2015|2015-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|OPTIMISE-CRT||Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Cardiac Resynchronization Therapy.|Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Cardiac Resynchronization Therapy.|Completed||Phase 4|461|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 15:31:36.26408|2017-02-18 15:31:36.26408
NCT00489164|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2008-11-10|||August 2002||2002-08-01|November 2008|2008-11-01|May 2004|Actual|2004-05-01|||||Interventional|DECODE||Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions|A Randomized Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)|Terminated||Phase 1/Phase 2|83|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 15:31:36.366165|2017-02-18 15:31:36.366165
NCT00489151|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2010-07-06|||June 2005||2005-06-01|July 2010|2010-07-01|December 2007|Anticipated|2007-12-01|||||Interventional|||A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy|A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy|Unknown status|Recruiting|N/A|70|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 15:31:36.46521|2017-02-18 15:31:36.46521
NCT00489138|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2014-02-24|||April 2007||2007-04-01|February 2014|2014-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Prospective, Open-label Study of Pharmacokinetics of Ertapenem in the Muscle Using Microdialysis in Mechanically Ventilated Intensive Care Unit Patients, Treated or Not by Norepinephrine||Terminated||Phase 4|9|Actual|Assistance Publique Hopitaux De Marseille||2|||f||||||||||||||2017-02-18 15:31:36.5509|2017-02-18 15:31:36.5509
NCT00489125|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-02-10|||March 2005||2005-03-01|February 2016|2016-02-01||||December 2016|Anticipated|2016-12-01||Observational|||Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer|Breast Clinic Strength and Range of Motion Study|Recruiting||N/A|275|Anticipated|Wake Forest University Health Sciences|||1||f||||t||||||||||2017-02-18 15:31:36.649151|2017-02-18 15:31:36.649151
NCT00489112|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-25||||||June 2007|2007-06-01||||||||Interventional|||The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study||Unknown status|Recruiting|Phase 4|||HaEmek Medical Center, Israel|||||f||||t||||||||||2017-02-18 15:31:36.779392|2017-02-18 15:31:36.779392
NCT00489099|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2015-10-29|||June 2005||2005-06-01|October 2015|2015-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)|A Study in Healthy Young Adults To Assess the Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured by a Process Upgrade|Completed||Phase 3|860|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:31:36.853316|2017-02-18 15:31:36.853316
NCT00489086|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-01-13|2013-07-31||July 2004||2004-07-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face|A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCC's With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome|Completed||Phase 2|36|Actual|Children's Hospital & Research Center Oakland|34 pts. were included in the analysis of the primary endpoint. 23 pts. completed 18 months (68%). Only 2 of 34 patients achieved complete resolution (CR = 5.9%). 13 pts. completed 36 month trial (first 18 months tazarotene, months 19-36 observation).|1|||f||||f||||||||||2017-02-18 15:31:37.028779|2017-02-18 15:31:37.028779
NCT00489073|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-19|||November 2002||2002-11-01|June 2007|2007-06-01|December 2003|Actual|2003-12-01|||||Interventional|||Duloxetine Versus Placebo for Fibromyalgia|Duloxetine Versus Placebo in the Treatment of Fibromyalgia Patients With or Without Major Depressive Disorder|Completed||Phase 3|345||Eli Lilly and Company|||||||||f||||||||||2017-02-18 15:31:37.448223|2017-02-18 15:31:37.448223
NCT00489060|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2008-07-16|||December 1997||1997-12-01|July 2008|2008-07-01|April 2007|Actual|2007-04-01|||||Interventional|||A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer|A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Clinically Localized Prostate Cancer|Completed||Phase 3|244|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 15:31:37.546927|2017-02-18 15:31:37.546927
NCT00489034|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2016-08-01|||July 2003||2003-07-01|August 2016|2016-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Engaging Care for HIV-infected Adolescent Females.|Drug Use and HIV-Infected Female Adolescents' Care Use|Completed||N/A|178|Actual|Westat|||2||f||||f||||||||No||2017-02-18 15:31:37.644566|2017-02-18 15:31:37.644566
NCT00489021|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2007-06-20|||July 2007||2007-07-01|June 2007|2007-06-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Feasibility and Outcomes of Older Patients Hospitalization||Unknown status|Not yet recruiting|N/A|300|Anticipated|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-02-18 15:31:37.767475|2017-02-18 15:31:37.767475
NCT00489008|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-20|2016-03-07|||November 2005||2005-11-01|March 2016|2016-03-01||||September 2017|Anticipated|2017-09-01||Interventional|||SRS Study in Patients With Non-Small Cell Lung Cancer|Phase II Stereotactic Body Radiotherapy for Stage I (T1-T2, N0, M0), Selective Stage II (Chest Wall T3, N0M0) or Isolated Peripheral Lung Recurrent Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|138|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 15:31:37.853795|2017-02-18 15:31:37.853795
NCT00488995|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2015-03-10|||July 2007||2007-07-01|March 2015|2015-03-01||||||||Interventional|||Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients|A Phase 2 Study To Evaluate The Safety, Tolerability, Virologic And Immunologic Effect Of Single-Dose CP-675,206 In Patients Infected With Human Immunodeficiency Virus|Withdrawn||Phase 2|0|Actual|Pfizer|||||||||||||||||||2017-02-18 15:31:37.974308|2017-02-18 15:31:37.974308
NCT00488982|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-10-26|||April 2007||2007-04-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|March 2014|Actual|2014-03-01||Interventional|||Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC|A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy With Maintenance GM-CSF in Patients With Previously Untreated Hormone Refractory Prostate Cancer|Completed||Phase 2|125|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 15:31:38.061356|2017-02-18 15:31:38.061356
NCT00488969|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2016-03-18|||July 2007||2007-07-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury|Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury|Completed||Phase 2|17|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 15:31:38.167313|2017-02-18 15:31:38.167313
NCT00488956|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2014-03-14|||June 2007||2007-06-01|March 2014|2014-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Foot and Ankle Edema Post-Cesarean Delivery|Foot and Ankle Edema Post-Cesarean Delivery|Completed||N/A|35|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 15:31:38.279906|2017-02-18 15:31:38.279906
NCT00488943|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2012-06-28|||January 2005||2005-01-01|June 2012|2012-06-01||||December 2009|Actual|2009-12-01||Observational|||Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm|Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm|Completed||N/A|300|Actual|University of California, San Francisco|||1||f||||t||||||||||2017-02-18 15:31:38.363277|2017-02-18 15:31:38.363277
NCT00488930|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2016-10-24|||June 2007||2007-06-01|October 2016|2016-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Characteristics of Dendritic Cells Before and After Gastric Banding|Characteristics of Dendritic Cells Before and After Gastric Banding|Terminated||N/A|7|Actual|University of California, San Diego|||1|Terminated due to a lack of recruitment and decision by the PI not to continue.|f||||f||||||||||2017-02-18 15:31:38.464031|2017-02-18 15:31:38.464031
NCT00488917|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2009-09-02|||June 2007||2007-06-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|SELLIFA||Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)|Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)|Completed||N/A|167|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||t||||||Samples Without DNA|"~     plasma, urine, ascites fluid.~   "|||2017-02-18 15:31:38.564176|2017-02-18 15:31:38.564176
NCT00488904|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2010-04-09|||June 2007||2007-06-01|April 2010|2010-04-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|omega3||Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery|Omega-3 Fatty Acids and Postoperative Complication After Colorectal Surgery|Completed||Phase 4|148|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-02-18 15:31:38.653569|2017-02-18 15:31:38.653569
NCT00488891|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2012-08-28|||April 2007||2007-04-01|August 2012|2012-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|POST||The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia|The Paliperidone ER Outcomes Study of Schizophrenia Patients in Typical Clinical Practice|Terminated||Phase 4|43|Actual|Ortho-McNeil Janssen Scientific Affairs, LLC|||2|The study was terminated because it was not enrolling at the expected rate|f||||f||||||Samples With DNA|"~     10 mL blood sample is collected from patients who consent to the pharmacogenomic component~     of the study.~   "|||2017-02-18 15:31:38.767261|2017-02-18 15:31:38.767261
NCT00488878|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-12-19|||May 2006||2006-05-01|December 2016|2016-12-01||||May 2034|Anticipated|2034-05-01||Observational|||Data Collection for Patients With Low Grade Ovarian Carcinoma|Data Collection for Patients With Low Grade Ovarian Carcinoma|Recruiting||N/A|2000|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     If patient gives consent, tumor tissue left over from earlier surgery or surgeries that is~     preserved in wax or on glass slides will be stored in a research tissue bank.~   "|||2017-02-18 15:31:38.883373|2017-02-18 15:31:38.883373
NCT00488865|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2010-08-04|2010-05-03||October 2006||2006-10-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||RexMedical- Option* Vena Cava Filter IDE Study|RexMedical- Option* Vena Cava Filter IDE Study|Completed||N/A|100|Actual|Rex Medical||1|||f||||t||||||||||2017-02-18 15:31:38.99784|2017-02-18 15:31:38.99784
NCT00488839|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2017-02-09||2013-09-27|June 2007||2007-06-01|February 2017|2017-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis|A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the PK and PD of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis|Completed||Phase 3|173|Actual|IMPAX Laboratories, Inc.||4|||f||||f||||||||No||2017-02-18 15:31:39.251403|2017-02-18 15:31:39.251403
NCT00488826|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2010-01-15|2009-03-31||October 2005||2005-10-01|January 2010|2010-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants|An Open-Label Controlled Phase I/III Study to Evaluate the Safety and Immunogenicity of Pneumococcal 7-Valent Conjugate Vaccine [DIPHTHERIA CRM197 PROTEIN] (PrevenarTM) in Healthy Infants|Completed||Phase 1|800|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:31:39.428803|2017-02-18 15:31:39.428803
NCT00488813|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2009-09-04|||July 2004||2004-07-01|September 2009|2009-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study of Antibiotic Utilization Measures and Control of ESBLs in China|Association of Antibiotic Utilization Measures and Control of Extended-spectrum β-lactamases (ESBLs) in MICU1 and MICU2 at Buddhist Tzu Chi General Hospital.|Completed||Phase 4|300||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:31:39.884026|2017-02-18 15:31:39.884026
NCT00488800|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2007-12-20|||July 2006||2006-07-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Safety and Local Tolerability of Prevenar in Indian Children|A Postmarketing Surveillance Study Evaluating the Safety and Local Tolerance of PREVENAR in Indian Children|Completed||Phase 4|1000||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:31:39.967889|2017-02-18 15:31:39.967889
NCT00488787|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2008-02-05|||March 2001||2001-03-01|February 2008|2008-02-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain|A Randomized, Double-Blind, Placebo-Controlled Pilot Study of the Safety and Efficacy of 10 mg, 30 mg, and 50 mg of Transnasal Ketamine Hydrochloride (PMI-100) for the Treatment of Postoperative Dental Pain|Completed||Phase 2|40|Actual|Javelin Pharmaceuticals||4|||f||||f||||||||||2017-02-18 15:31:40.277063|2017-02-18 15:31:40.277063
NCT00488774|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2013-04-29|2013-04-29||August 2007||2007-08-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis|A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis|Terminated||Phase 2/Phase 3|291|Actual|Janssen Research & Development, LLC|Data collection was not considered complete for primary outcome measure because study was terminated prematurely.|4||Protocol was cancelled by company based on overall efficacy, no safety concern|f||||t||||||||||2017-02-18 15:31:40.379355|2017-02-18 15:31:40.379355
NCT00488761|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2007-12-21|||July 2006||2006-07-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI|A Multicenter, Open Label Study to Evaluate the Safety and Efficacy of Tigecycline to Treat Complicated Skin and Skin Structure Infections (cSSSI) in Hospitalized Patients|Completed||Phase 4|50|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:31:41.057539|2017-02-18 15:31:41.057539
NCT00488748|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2015-01-16||2014-11-10|June 2007||2007-06-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Magnetic Seizure Therapy (MST) for Severe Mood Disorder|Magnetic Seizure Therapy (MST) for the Treatment of Severe Mood Disorder|Completed||Phase 3|75|Actual|Duke University||2|||f||||f||||||||||2017-02-18 15:31:41.152382|2017-02-18 15:31:41.152382
NCT00488735|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2010-05-06|||August 2000||2000-08-01|June 2007|2007-06-01|July 2005|Actual|2005-07-01|||||Interventional|||Subacute and Chronic, Non-specific Back and Neck Pain: Cognitive-behavioral Rehabilitation vs. Traditional Primary Care|Subacute and Chronic, Non-specific Back and Neck Pain: Cognitive-behavioral Rehabilitation Compared With Traditional Primary Care Concerning Sick-listing and Health-care Visits. A Randomized Controlled Trial, 18-month Follow-up|Completed||N/A|125|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 15:31:41.271738|2017-02-18 15:31:41.271738
NCT00488722|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2007-06-25|||April 2007||2007-04-01|April 2007|2007-04-01|March 2009||2009-03-01|||||Interventional|||A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer|A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer|Unknown status|Recruiting|N/A|||Tianjin Medical University||1|||f||||t||||||||||2017-02-18 15:31:41.3682|2017-02-18 15:31:41.3682
NCT00488709|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2008-11-17|||May 2003||2003-05-01|November 2008|2008-11-01|April 2007|Actual|2007-04-01|||||Interventional|FLAT||Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|FLAT: Fludarabine, Cytarabine and Topotecan in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia|Completed||Phase 4|47|Actual|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:31:41.46558|2017-02-18 15:31:41.46558
NCT00488696|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-10-31|||October 2006||2006-10-01|October 2016|2016-10-01||||December 2018|Anticipated|2018-12-01||Interventional|||Branched Aortic Arch Study|Branched Stent-Graft Repair for Endo Repair of Aneurysms Involving the Proximal Aortic Arch|Recruiting||Phase 1/Phase 2|25|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:31:41.600495|2017-02-18 15:31:41.600495
NCT00488683|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2014-09-18|2013-05-30||July 2007||2007-07-01|September 2014|2014-09-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional||Analysis was done on all enrolled subjects.|B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants|A Phase II, Single Center, Open-label, Randomized Study to Investigate Meningococcal Serogroup A, C, W-135 and Y Saccharide Specific B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants|Completed||Phase 2|216|Actual|Novartis||3|||f||||f||||||||||2017-02-18 15:31:41.756796|2017-02-18 15:31:41.756796
NCT00488670|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2011-06-02|||December 2010||2010-12-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Escitalopram and Depression in Elderly Alzheimer's Patients|An Open-label Study of Escitalopram in the Treatment of Major Depressive Disorder in Elderly Patients With Alzheimer's Disease|Terminated||Phase 3|50|Anticipated|University of British Columbia||1||"Dr. Rabheru left VCH last year and the study was cancelled according to his research~   coordinator."|f||||f||||||||||2017-02-18 15:31:44.233937|2017-02-18 15:31:44.233937
NCT00488657|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2013-01-17|||June 2006||2006-06-01|January 2013|2013-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|MJFFSpeech||Improve Speech Using an In-the-ear Device in Parkinson's Disease|Treating Speech Disorders in Patients With Parkinson's Disease Using Altered Auditory Feedback|Completed||Phase 1|40|Actual|Rush University Medical Center||1|||f||||f||||||||||2017-02-18 15:31:44.327477|2017-02-18 15:31:44.327477
NCT00488644|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2013-06-14|2012-03-22||February 2006||2006-02-01|June 2013|2013-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors|Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors|Terminated||N/A|12|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 15:31:44.427113|2017-02-18 15:31:44.427113
NCT00488631|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-03-24|2013-05-01||September 2007||2007-09-01|March 2016|2016-03-01|February 2015|Actual|2015-02-01|October 2011|Actual|2011-10-01||Interventional|||An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis|A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis|Completed||Phase 3|1228|Actual|Janssen Research & Development, LLC||6|||f||||t||||||||||2017-02-18 15:31:44.679415|2017-02-18 15:31:44.679415
NCT00488618|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2012-03-02||2012-03-02|April 2007||2007-04-01|March 2012|2012-03-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating RGH-188 in the Treatment of Patients With Acute Mania|A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of RGH-188 in Patients With Acute Mania Associated With Bipolar I Disorder|Completed||Phase 2|238|Actual|Forest Laboratories||2|||f||||||||||||||2017-02-18 15:31:53.887612|2017-02-18 15:31:53.887612
NCT00488605|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2016-05-10|||February 2004||2004-02-01|May 2016|2016-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis|H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis|Completed||Phase 3|476|Anticipated|University of New Mexico||2|||f||||t||||||||||2017-02-18 15:31:53.981533|2017-02-18 15:31:53.981533
NCT00488592|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2014-06-05|2013-04-30||June 2007||2007-06-01|June 2014|2014-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers|Efficacy of Peptide (WT1) and Peptide(PRI) Vaccination for Patients With Low Risk Myeloid Malignancies|Completed||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)|"Although not tested or described formally, no clinically meaningful hematological responses were seen.~Despite boosting, cellular immune responses were only transient."|1|||f||||t||||||||||2017-02-18 15:31:54.093274|2017-02-18 15:31:54.093274
NCT00488579|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2012-05-16|||May 2007||2007-05-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|December 2007|Actual|2007-12-01||Interventional|PROFEG||Routine Iron Prophylaxis During Pregnancy|Routine Iron Prophylaxis During Pregnancy - Effects on Maternal and Child Health in Maputo City and Province (Mozambique)|Unknown status|Active, not recruiting|Phase 4|4326|Anticipated|National Istitute For Health and Welfare, Finland||2|||f||||f||||||||||2017-02-18 15:31:54.367958|2017-02-18 15:31:54.367958
NCT00488566|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2012-03-15|||May 2007||2007-05-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||GSK Drug Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers|Double Blind, Randomised, Placebo Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Doses of GSK Drug and the Effect of Single Doses of GSK Drug or Lamotrigine on Resting Motor Threshold in Healthy Volunteers|Completed||Phase 1|50|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:31:54.477619|2017-02-18 15:31:54.477619
NCT00488553|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2012-02-23|||August 2006||2006-08-01|February 2012|2012-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Molecular Epidemiology of Lymphoma Patients|Molecular Epidemiology of Lymphoma Patients|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||2|No participants recruited, study discontinued.|f||||f||||||Samples With DNA|"~     Subjects will also provide 30 cc of blood. The blood will be genotyped, and the genotype and~     epidemiological data will be used to evaluate the role of genomic instability (baseline and~     induced) in the development of lymphomas.~   "|||2017-02-18 15:31:54.586956|2017-02-18 15:31:54.586956
NCT00488540|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2017-02-07|||June 2007||2007-06-01|February 2017|2017-02-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||Is Paracetamol an Effective Treatment for Chronic Moderate Pain in the Newborn After Operative Vaginal Delivery?|Is Paracetamol an Effective Treatment for Chronic Moderate Pain in the Newborn After Operative Vaginal Delivery?|Completed||Phase 4|280|Anticipated|Basel Women’s University Hospital||2|||f||||f||||||||||2017-02-18 15:31:54.701602|2017-02-18 15:31:54.701602
NCT00488527|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2010-09-10|||April 2007||2007-04-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|DOMME||DOMME Dose Optimization Multicentric Mexican Evaluation|Multicentric, Open Label Clinical Trial. Use of Optimal Method to Initiate and Maintain Lantus Therapy (Insulin Glargine) in Combination With Hypoglycemic Agents, Assessing the Resulting Metabolic Control and the Safety in T2 Diabetes Mellitus Patients.|Completed||Phase 4|371|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:31:55.081823|2017-02-18 15:31:55.081823
NCT00488514|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-10-11|2010-08-06||July 2007||2007-07-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents|Study TXA107977, a Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents|Completed||Phase 3|656|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:31:55.199889|2017-02-18 15:31:55.199889
NCT00488501|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2009-11-09|||July 2007||2007-07-01|November 2009|2009-11-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|||Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM)|Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM) in Medtronic(R) ICD's for Early Detection of Decompensated Heart Failure|Completed||N/A|29|Actual|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||||2017-02-18 15:31:56.703848|2017-02-18 15:31:56.703848
NCT00488488|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2011-07-20|2011-03-29||November 2006||2006-11-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting|A Non-Interventional Study To Evaluate The Safety And Effectiveness Of Tygacil In The Treatment Of Patients With Complicated Intra-Abdominal Infections Or Complicated Skin And Skin Structure Infections|Completed||N/A|1028|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:31:56.997638|2017-02-18 15:31:56.997638
NCT00488475|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2014-07-25|2014-04-16||September 2006||2006-09-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational||Safety population included all participants with available documentations.|Observational Trial With Enbrel|A 1 Year Observational Study of the Use of Etanercept in Routine German Clinical Practice to Treat Rheumatoid Arthritis Patients: a Health Economic, Safety and Effectiveness Evaluation|Completed||N/A|4945|Actual|Pfizer|Prioritization of endpoints as primary or secondary was not specified in protocol and was based on study team's inputs.||1||f||||f||||||||||2017-02-18 15:31:57.949188|2017-02-18 15:31:57.949188
NCT00488462|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2015-01-16|||October 2007||2007-10-01|January 2015|2015-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|NASG||Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage: Zambia and Zimbabwe|Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage: Zambia and Zimbabwe|Completed||N/A|887|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 15:32:00.179506|2017-02-18 15:32:00.179506
NCT00488449|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2012-05-31|||June 2007||2007-06-01|February 2011|2011-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers|A Two-Part Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Oral Doses of GSK256073A, in a Randomized, Single-Blind, Dose Escalation Study in Healthy Adult Subjects|Completed||Phase 1|56|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:32:00.451161|2017-02-18 15:32:00.451161
NCT00488436|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2008-11-17|||May 2002||2002-05-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome|SMD/ATG-CSA: Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome|Completed||Phase 4|25|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:32:00.550661|2017-02-18 15:32:00.550661
NCT00488423|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2011-06-21|||November 2006||2006-11-01|June 2011|2011-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|MIDAS||Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery|Glucose Metabolism in the Immediate and Short Term Follow up From Bariatric Surgery|Completed||Phase 1|21|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 15:32:00.681172|2017-02-18 15:32:00.681172
NCT00488410|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2010-09-06|||November 2006||2006-11-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||SYNCHRO. Evaluation of the Forecasts Parameters of Real Time-three-dimensional Doppler Echocardiography in Selecting Patients With Chronic Heart Failure for Cardiac Resynchronisation Therapy|Evaluation of the Forecasts Parameters of Real Time Three-dimensional Doppler Echocardiography in Selecting Patients With Chronic Heart Failure for Cardiac Resynchronisation Therapy|Completed||N/A|||University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:32:00.792007|2017-02-18 15:32:00.792007
NCT00488397|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2011-03-21|||August 2006||2006-08-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Tigecycline In-Vitro Surveillance Study In Taiwan|Tigecycline In-Vitro Surveillance Study In Taiwan|Completed||N/A|7902|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 15:32:00.888599|2017-02-18 15:32:00.888599
NCT00488384|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2015-06-10|||June 2007||2007-06-01|June 2015|2015-06-01|June 2018|Anticipated|2018-06-01|December 2014|Actual|2014-12-01||Interventional|||Acitretin Plasma Levels Under Hemodialysis|Acitretin Plasma Levels Under Hemodialysis|Suspended||Phase 4|2009|Anticipated|University of Zurich||1||lack of subjects|f||||f||||||||||2017-02-18 15:32:00.998298|2017-02-18 15:32:00.998298
NCT00488371|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2007-12-16|||November 2006||2006-11-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Observational|||Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®|Evaluation of Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Pneumococcal Conjugated Vaccine (Prevnar®) Under the Auspices of the Taipei City Government Vaccination Program|Completed||Phase 4|250||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||f||||||||||2017-02-18 15:32:01.109269|2017-02-18 15:32:01.109269
NCT00488358|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2013-10-08|||November 2005||2005-11-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|January 2010|Actual|2010-01-01||Observational|||Hemodynamic Changes After Aortic Aneurysm Treatment With Stent-Graft|Hemodynamic Changes After Aortic Aneurysm Treatment With Stent-Graft|Completed||N/A|10|Actual|University of California, San Francisco|||1||f||||t||||||||||2017-02-18 15:32:01.190706|2017-02-18 15:32:01.190706
NCT00488345|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2012-09-12|2010-09-01||December 2007||2007-12-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age|A Multicenter, Open-Label, Ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age With Selected Serious Infections|Completed||Phase 2|59|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 15:32:01.287488|2017-02-18 15:32:01.287488
NCT00488332|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2012-07-18|||March 2006||2006-03-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||An Exploratory Study on Optical Assessment of Oral Mucositis|An Exploratory Study on Optical Assessment of Oral Mucositis|Terminated||N/A|2|Actual|M.D. Anderson Cancer Center|||1|Terminated due to slow accrual.|f||||f||||||||||2017-02-18 15:32:02.326593|2017-02-18 15:32:02.326593
NCT00488319|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-12-19|2013-07-12||June 2007||2007-06-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.|A 6-Month, Open-Label, Single-Arm Safety Study of Flexibly Dosed Paliperidone Extended Release (1.5 - 12 mg/Day) in the Treatment of Adolescents (12 to 17 Years of Age) With Schizophrenia|Completed||Phase 3|400|Actual|Janssen Research & Development, LLC||1|||f||||f||||||||||2017-02-18 15:32:02.466592|2017-02-18 15:32:02.466592
NCT00488306|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2009-07-06|||August 2006||2006-08-01|July 2009|2009-07-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI|A Multicenter, Open Label Study to Evaluate the Efficacy and Safety of Tigecycline to Treat Complicated Intra-Abdominal Infections (cIAI) in Hospitalized Patients|Completed||Phase 4|50|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:32:04.302756|2017-02-18 15:32:04.302756
NCT00488293|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2015-05-11|2014-11-03||November 2008||2008-11-01|May 2015|2015-05-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional||One patient assigned to teledermatology was misrandomized and not included in the analysis.|Impact of Teledermatology on Health Services Outcomes in the Department of Veterans Affairs|Impact of Teledermatology on Health Services Outcomes in the VA|Completed||N/A|392|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:32:04.408099|2017-02-18 15:32:04.408099
NCT00488280|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2013-01-07|||February 2007||2007-02-01|January 2010|2010-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Restoring Walking in Non-ambulatory Children With Severe Chronic Spinal Cord Injury (SCI) (Kids STEP Study)|Restoring Walking in Non-ambulatory Children With Severe Chronic SCI (Kids STEP Study)|Completed||Phase 1|7|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 15:32:05.011988|2017-02-18 15:32:05.011988
NCT00488267|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2012-05-17||2012-03-14|June 2007||2007-06-01|May 2012|2012-05-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee|A Randomized, Double-Blind, 12-Week Study to Evaluate the Efficacy of ThermoProfen™ in the Treatment of Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee (ZMK-301)|Completed||Phase 3|679|Actual|ZARS Pharma Inc.||3|||f||||f||||||||||2017-02-18 15:32:05.127427|2017-02-18 15:32:05.127427
NCT00488254|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2011-04-12|||June 2007||2007-06-01|April 2011|2011-04-01|April 2008|Actual|2008-04-01|||||Observational|||The Long QT Syndrome in Pregnancy|The Long QT Syndrome in Pregnancy|Completed||N/A|12|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 15:32:05.278693|2017-02-18 15:32:05.278693
NCT00488241|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2014-02-25|||June 2007||2007-06-01|February 2014|2014-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema|A Multicenter, Open Uncontrolled Clinical Study to Examine the Efficacy and Safety of Zarzenda in the Management of Hand Eczema|Completed||Phase 4|40|Actual|Bayer||1|||f||||f||||||||||2017-02-18 15:32:05.376597|2017-02-18 15:32:05.376597
NCT00488228|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2012-04-12|||April 2007||2007-04-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Behavioral Self-Regulation|Behavioral Self-Regulation for Weight Loss in Young Adults|Completed||N/A|41|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-02-18 15:32:05.488705|2017-02-18 15:32:05.488705
NCT00488215|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2008-05-28|||January 2000||2000-01-01|June 2007|2007-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of Prucalopride|A Double-Blind, Placebo-Controlled, 2-Way Cross-Over Trial in Healthy Volunteers, to Evaluate the Pharmacokinetics, Tolerability and Cardiac Safety of Oral Prucalopride at Steady State, After up-Titration to a Maximum of 20 mg.|Completed||Phase 1|32|Actual|Movetis||2|||f||||f||||||||||2017-02-18 15:32:05.579626|2017-02-18 15:32:05.579626
NCT00488202|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2013-04-16|||May 2007||2007-05-01|April 2013|2013-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|ANOVA1||Advanced Ovarian Cancer and Sexuality Phase 1|Advanced Ovarian Cancer and Sexuality Phase 1|Completed||N/A|26|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 15:32:05.681267|2017-02-18 15:32:05.681267
NCT00488189|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2011-04-14|||May 2007||2007-05-01|June 2010|2010-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Evaluation Tazocin Intervention|Association of Antibiotic Utilization Measures and Control of Extended-Spectrum β-Lactamases (ESBLs) Producing Bacteria|Completed||Phase 4|134|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 15:32:05.770416|2017-02-18 15:32:05.770416
NCT00030030|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-30|2006-08-17|||July 2000||2000-07-01|July 2006|2006-07-01|June 2002||2002-06-01|||||Interventional|||Evaluating Silymarin for Chronic Hepatitis C|Evaluating Silymarin for Chronic Hepatitis C|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:53.12069|2017-02-18 18:07:53.12069
NCT00488176|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-19|2013-02-06|||April 2007||2007-04-01|February 2013|2013-02-01|December 2013|Anticipated|2013-12-01|November 2013|Anticipated|2013-11-01||Interventional|||Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis|Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation Measured by Exhaled Nitric Oxide Concentration in Children With Seasonal Allergic Rhinitis|Unknown status|Recruiting|Phase 4|116|Anticipated|Medical Universtity of Lodz||4|||f||||t||||||||||2017-02-18 15:32:05.869686|2017-02-18 15:32:05.869686
NCT00488163|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2007-06-18|||January 2005||2005-01-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia|Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia|Completed||Phase 4|20|Actual|Research Foundation for Mental Hygiene, Inc.||2|||f||||f||||||||||2017-02-18 15:32:05.989681|2017-02-18 15:32:05.989681
NCT00488137|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2013-09-25|||March 1998||1998-03-01|September 2013|2013-09-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Interventional|||Efficacy and Safety Study of Prucalopride to Treat Chronic Constipation|A Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Prucalopride (R108512) Tablets in Subjects With Chronic Constipation|Completed||Phase 3|716|Actual|Movetis||3|||f||||f||||||||||2017-02-18 15:32:06.090167|2017-02-18 15:32:06.090167
NCT00488124|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2011-03-29|||November 2005||2005-11-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|ISS||Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin|Evaluation of Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin: A Prospective, Longitudinal Non-randomised, Open, Phase II Study|Completed||Phase 2|120|Anticipated|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-02-18 15:32:06.201788|2017-02-18 15:32:06.201788
NCT00488111|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2008-08-12|||May 2007||2007-05-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|FMCS||Fluid Management for Cesarean Section|Fluid Management With Ringer's and 6% Starch for Cesarean Section After Epidural or Spinal Anesthesia|Completed||N/A|850|Actual|Nanjing Medical University||2|||f||||f||||||||||2017-02-18 15:32:09.044862|2017-02-18 15:32:09.044862
NCT00488098|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2012-05-31|||July 2007||2007-07-01|February 2011|2011-02-01||||||||Interventional|||GSK372475 Bioequivalence Study|An Open Label, Randomized, Parallel Groups, Bioequivalence Study to Compare a Single Oral Dose of GSK372475B or GSK372475C in Male and Female Healthy Volunteers.|Completed||Phase 1|66|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:32:09.147178|2017-02-18 15:32:09.147178
NCT00488085|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-17|2007-06-18|||June 2007||2007-06-01|March 2007|2007-03-01|December 2007|Anticipated|2007-12-01|||||Observational|CROHN_OBESE||Crohn’s Disease, Obesity and Disease Severity|Crohn’s Disease, Obesity and Disease Severity|Unknown status|Recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||||f||||t||||||||||2017-02-18 15:32:09.244498|2017-02-18 15:32:09.244498
NCT00488072|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-07-27|||January 2007||2007-01-01|July 2016|2016-07-01||||May 2017|Anticipated|2017-05-01||Interventional|||Effects of Mirtazapine on Appetite in Advanced Cancer Patients|Preliminary Study to Explore the Effects of Mirtazapine on Appetite in Advanced Cancer Patients|Active, not recruiting||N/A|98|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:32:09.317703|2017-02-18 15:32:09.317703
NCT00488059|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2011-07-18|2009-11-11||June 2007||2007-06-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|AMICI||A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients|A Multicenter, Open-label Study Evaluating the Antiviral Activity and Safety of Enfuvirtide (ENF) Once Daily (QD) or Twice Daily (BID) in Triple-class Experienced HIV-1 Infected Patients Changing Their Therapy to a Standard of Care (SOC) Regimen That Includes Initiating Raltegravir Plus an Optimized Background (OB) Antiviral Regimen|Terminated||Phase 4|29|Actual|Hoffmann-La Roche||2||This study was terminated early due to poor enrollment.|f||||||||||||||2017-02-18 15:32:09.429939|2017-02-18 15:32:09.429939
NCT00488046|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2007-11-19|||June 2007||2007-06-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults|Phase I Inpatient Study of the Safety and Immunogenicity of Live Influenza A Vaccine Modified H5N1 (6-2) AA ca Recombinant (A/Hong Kong/213/2003 x A/AnnArbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H5N1 Infection in the Event of a Pandemic|Completed||Phase 1|16|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 15:32:10.127582|2017-02-18 15:32:10.127582
NCT00488033|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2014-10-03|||June 2007||2007-06-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|faCTor-64||Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64|Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64: A Randomized Control Study (The faCTor-64 Study)|Completed||N/A|900|Actual|Intermountain Health Care, Inc.||2|||f||||t||||||||||2017-02-18 15:32:10.244006|2017-02-18 15:32:10.244006
NCT00488020|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2008-06-12|||April 2006||2006-04-01|June 2007|2007-06-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Stem Cells for Treating Critical Ischemia|the Use of Autogenous Adult Stem Cells in the Treatment of Critical Ischemia|Unknown status|Recruiting|Phase 1|10|Anticipated|Instituto de Molestias Cardiovasculares||1|||f||||t||||||||||2017-02-18 15:32:10.357744|2017-02-18 15:32:10.357744
NCT00488007|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-08-29|||May 2007||2007-05-01|December 2011|2011-12-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids|Clinical Trial on Cognitive, Behavioural, Quality of Life and Medico-economic Benefits of Hearing Aids in Alzheimer Disease Patients Suffering From Presbycusis|Completed||N/A|51|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-02-18 15:32:10.451427|2017-02-18 15:32:10.451427
NCT00487994|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2012-05-23|||November 2004||2004-11-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia|A Double-Blind, Randomized, Parallel Group Study to Evaluate the Safety, Tolerability and Efficacy of Lapaquistat Acetate Alone or Coadministered With Atorvastatin in Subjects With Primary Dyslipidemia|Completed||Phase 3|2130|Actual|Takeda||3|||f||||t||||||||||2017-02-18 15:32:10.55595|2017-02-18 15:32:10.55595
NCT00352287|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2006-07-12|||March 2003||2003-03-01|July 2006|2006-07-01|April 2005||2005-04-01|||||Interventional|||Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults|Effects of GH and Pioglitazone in Viscerally Obese Adults With IGT|Completed||Phase 4|60||Stanford University|||||||||||||||||||2017-02-18 16:24:26.95589|2017-02-18 16:24:26.95589
NCT00487981|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2012-02-21|2012-02-13||February 2007||2007-02-01|February 2012|2012-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|DPN||Spinal Cord Stimulation for Painful Diabetic Neuropathy|Precision Spinal Cord Stimulation for Painful Diabetic Neuropathy|Terminated||Phase 4|1|Actual|Boston Scientific Corporation|One subject enrolled.|1||Insufficient Data Collected|f||||f||||||||||2017-02-18 15:32:11.018754|2017-02-18 15:32:11.018754
NCT00487968|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2012-03-15|||May 2007||2007-05-01|February 2011|2011-02-01||||||||Interventional|||Eltrombopag Taste Testing in Healthy Adult Volunteers|Eltrombopag Pediatric Formulation Taste Testing in Healthy Adult Volunteers|Completed||Phase 1|12|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:32:11.26212|2017-02-18 15:32:11.26212
NCT00487955|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2007-06-18|||June 2007||2007-06-01|March 2007|2007-03-01|December 2007|Anticipated|2007-12-01|||||Observational|A-P-REE||The Metabolic Contribution of the Human Microbiota to Resting Energy Expenditure|The Metabolic Contribution of the Human Microbiota to Resting Energy Expenditure|Unknown status|Recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||||f||||t||||||||||2017-02-18 15:32:11.344445|2017-02-18 15:32:11.344445
NCT00487942|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2013-07-12|2010-04-30||July 2007||2007-07-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits|A 4-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Cognitive Deficits Associated With Schizophrenia|Completed||Phase 2|60|Actual|Teva Pharmaceutical Industries||4|||f||||||||||||||2017-02-18 15:32:11.479052|2017-02-18 15:32:11.479052
NCT00487929|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2013-04-01|||June 2007||2007-06-01|October 2008|2008-10-01|October 2012|Actual|2012-10-01|April 2012|Actual|2012-04-01||Interventional|OSCAMSA||Oxidative Stress and Cardiovascular Morbidity in Sleep Apnea-Hypopnea Syndrome (SAHS)|Phase 4 Study of the Relationship Between the Oxidative Stress and the Development of Cardiovascular Complications in the Sleep Apnea-hypopnea Syndrome (SAHS). Effect of the Treatment With CPAP|Completed||Phase 4|100|Actual|Hospital Universitario La Paz||2|||f||||f||||||||||2017-02-18 15:32:16.040195|2017-02-18 15:32:16.040195
NCT00487916|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-16|2017-01-24|||June 13, 2007||2007-06-13|September 22, 2009|2009-09-22|February 5, 2009|Actual|2009-02-05|February 5, 2009|Actual|2009-02-05||Interventional|||Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium Falciparum|Phase 1 Study of the Safety, Reactogenicity and Immunogenicity of AMA1-C1/ISA 720: A Blood Stage Vaccine for Plasmodium Falciparum|Completed||Phase 1|150||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:32:16.37132|2017-02-18 15:32:16.37132
NCT00487903|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2008-07-01|||September 2007||2007-09-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems|A Phase 2 Trial of PB127 Myocardial Perfusion Echocardiography to Evaluate and Optimize Additional Ultrasound Imaging Systems|Terminated||Phase 2|40|Anticipated|Point Biomedical||1||Discontinued PB127 development program for business reasons|f||||f||||||||||2017-02-18 15:32:16.475078|2017-02-18 15:32:16.475078
NCT00487890|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2008-12-31|||April 2004||2004-04-01|December 2008|2008-12-01|September 2009|Anticipated|2009-09-01|||||Observational|PERFORM||Performance Evaluation and Research for Older Adults Requiring Major Surgery|Performance Evaluation and Research for Older Adults Requiring Major Surgery|Unknown status|Active, not recruiting|N/A|400|Anticipated|University of Washington|||1||f||||f||||||||||2017-02-18 15:32:16.572451|2017-02-18 15:32:16.572451
NCT00487877|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2007-06-18|||June 2007||2007-06-01|December 2006|2006-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|TEMP||Measurements of Skin Physiological Parameters as Mean of Metabolic Assessment|Measurements of Skin Physiological Parameters as Mean of Metabolic Assessment|Unknown status|Recruiting|N/A|40|Anticipated|Tel-Aviv Sourasky Medical Center|||||f||||t||||||||||2017-02-18 15:32:16.670597|2017-02-18 15:32:16.670597
NCT00487864|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2007-06-18|||September 2006||2006-09-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Observational|CSLM-nevi||In Vivo Confocal Scanning Laser Microscopy of Benign Nevi|In Vivo Confocal Scanning Laser Microscopy of Benign Globular, Homogeneous and Reticular Nevi; Comparison With Dermoscopy and Histopathology|Completed||N/A|30|Actual|Medical University of Graz|||||f||||f||||||||||2017-02-18 15:32:16.783994|2017-02-18 15:32:16.783994
NCT00487851|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2013-04-11|||March 2007||2007-03-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|March 2012|Anticipated|2012-03-01||Interventional|||Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer|Endoscopic Strategy Versus Surgical by Pass in Nonresectable Periampullary Cancer|Withdrawn||Phase 2|0|Actual|Karolinska Institutet||2||Withdrawn|f||||t||||||||||2017-02-18 15:32:16.867171|2017-02-18 15:32:16.867171
NCT00487838|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-16|2017-01-24|||June 14, 2007||2007-06-14|May 4, 2012|2012-05-04|May 4, 2012||2012-05-04|||||Observational|||Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants|Noninvasive Optical Imaging of the Effects of External Spectral Filters on Macular Autofluorescence in Pseudophakic Eyes|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:32:16.978569|2017-02-18 15:32:16.978569
NCT00487825|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2012-07-24|2011-01-24||March 2007||2007-03-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis|A 26-week, Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Assess the Response to Treatment (ACR50) and to Determine a Biomarker Profile in Responders to ACZ885 (Anti-interleukin-1beta Monoclonal Antibody) Plus MTX as Compared to MTX Alone in Early Rheumatoid Arthritis Patients|Completed||Phase 2|78|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:32:17.069566|2017-02-18 15:32:17.069566
NCT00487812|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2008-10-06|||December 2004||2004-12-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|August 2006|Actual|2006-08-01||Interventional|||Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI|Prediction of Left Ventricular Remodelling in Patients Treated by Angioplasty in the Acute of Phase of a First Myocardial Infarction by Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT|Completed||N/A|50|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:32:17.529529|2017-02-18 15:32:17.529529
NCT00487799|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2009-07-17||||||July 2009|2009-07-01||||||||Interventional|||A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure|Withdrawn||Phase 1|32|Anticipated|Facet Biotech||2||Facet no longer has ownership of ularitide.|f||||t||||||||||2017-02-18 15:32:17.635012|2017-02-18 15:32:17.635012
NCT00487786|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2016-01-14|||June 2007||2007-06-01|April 2014|2014-04-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|||Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer|A Phase 1 Study Evaluating A Second Generation Antisense Oligonucleotide (OGX 427) That Inhibits Heat Shock Protein 27 (Hsp27|Completed||Phase 1|64|Actual|OncoGenex Technologies||1|||f||||t||||||||||2017-02-18 15:32:17.751393|2017-02-18 15:32:17.751393
NCT00487773|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2010-04-12|||September 2007||2007-09-01|April 2010|2010-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma|Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma - Randomized, Controlled Trial.|Completed||Phase 4|96|Actual|Medical Universtity of Lodz||4|||f||||t||||||||||2017-02-18 15:32:17.869818|2017-02-18 15:32:17.869818
NCT00487760|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-16|2017-01-24|||June 11, 2007||2007-06-11|August 2, 2011|2011-08-02|August 2, 2011||2011-08-02|||||Observational|||African American Families and Lung Cancer Study|African American Families and Lung Cancer Study|Completed||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:32:17.991036|2017-02-18 15:32:17.991036
NCT00487747|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2010-02-15||||||February 2010|2010-02-01|October 2009|Actual|2009-10-01|||||Interventional|||A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.|An Open Label Study of the Effect of PEGASYS on Treatment Response in Patients With HBeAg-positive or HBeAg-negative Chronic Hepatitis B|Completed||Phase 4|19|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:32:18.080181|2017-02-18 15:32:18.080181
NCT00487734|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2012-10-22|||August 2007||2007-08-01|October 2012|2012-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Effect of Testosterone Replacement on Insulin Resistance|Effect of Testosterone Replacement on Insulin Resistance in Hypogonadal, Non-obese Men With Metabolic Syndrome|Completed||Phase 4|19|Actual|McGuire Research Institute||2|||f||||f||||||||||2017-02-18 15:32:18.20886|2017-02-18 15:32:18.20886
NCT00487721|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-16|2014-03-03|2014-01-15||August 2006||2006-08-01|March 2014|2014-03-01|November 2010|Actual|2010-11-01|September 2007|Actual|2007-09-01||Interventional||Since this was a pilot study, the number of patients was selected based on the feasibility of accrual and support, rather than statistical calculations. The results of this study will be considered in the planning of future trials with silibinin.|The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer|A Pilot Biomarker Study of Oral Silybin-Phytosome Followed by Prostatectomy in Patients With Localized Prostate Cancer|Completed||Phase 2|12|Actual|University of Colorado, Denver|Some end of study blood samples were not obtained due to the timing of surgery, tissue was successfully obtained in all participants.|2|||f||||f||||||||||2017-02-18 15:32:18.333568|2017-02-18 15:32:18.333568
NCT00487708|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2009-02-16|||January 2005||2005-01-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms|An Open-Label, Phase II Dose Titration Study of ACZ885 (Human Anti-IL-1β Monoclonal Antibody) to Assess the Clinical Efficacy, Safety, Pharmacokinetics and Pharmacodynamics in Patients With NALP3 Mutations|Completed||Phase 2|34|Actual|Novartis||1|||f||||t||||||||||2017-02-18 15:32:18.94084|2017-02-18 15:32:18.94084
NCT00487695|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-18|2016-09-07|2011-06-21||April 2007||2007-04-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|CEBE||Confocal Endomicroscopy for Barrett's Esophagus|Confocal Laser Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Associated Neoplasia|Completed||Phase 3|46|Actual|Johns Hopkins University|Relatively small study (39 patients) and performed at a tertiary care, referral center, which can reduce generalizability.|2|||f||||t||||||||||2017-02-18 15:32:19.062621|2017-02-18 15:32:19.062621
NCT00487682|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2011-12-19|||August 2007||2007-08-01|December 2011|2011-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dose-finding Study of ASP2151 in Subjects With Herpes Zoster|Dose-finding Study of ASP2151 in Subjects With Herpes Zoster- A Multicenter, Randomized, Double-blind, Valacyclovir Hydrochloride-controlled, Parallel-group, Comparative Study|Completed||Phase 2|403|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-02-18 15:32:19.456903|2017-02-18 15:32:19.456903
NCT00487669|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2013-11-21|2013-11-21||October 2006||2006-10-01|November 2013|2013-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)|Phase II Study of the Combination of Paclitaxel Poliglumex (CT-2103, Xyotax) and Pemetrexed (Alimta) for the Treatment of Patients With Advanced Non-small Cell Lung Cancer.|Completed||Phase 2|14|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 15:32:19.563892|2017-02-18 15:32:19.563892
NCT00487656|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2011-05-13||2011-05-06|July 2007||2007-07-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation|A Randomized, Double-Blind, Placebo-Controlled, Phase-2B Study to Assess the Safety and Efficacy Effects of ART-123 on Subjects With Sepsis and Disseminated Intravascular Coagulation|Completed||Phase 2|750|Actual|Artisan Pharma, Inc.||2|||f||||t||||||||||2017-02-18 15:32:19.946559|2017-02-18 15:32:19.946559
NCT00487643|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2014-07-10|||May 2008||2008-05-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|October 2010|Actual|2010-10-01||Observational|||Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay|Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay|Completed||N/A|100|Anticipated|Walter Reed Army Medical Center|||1||f||||||||||||||2017-02-18 15:32:20.085066|2017-02-18 15:32:20.085066
NCT00487630|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2007-06-15|||June 2005||2005-06-01|June 2007|2007-06-01|June 2009|Anticipated|2009-06-01|||||Interventional|HEART||Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease|A Multicenter, Phase 4, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Recombinant Alpha-Galactosidase A (Agalsidase Beta, FABRAZYME) in Heterozygous Females for Fabry Disease|Unknown status|Recruiting|Phase 4|34|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:32:20.34556|2017-02-18 15:32:20.34556
NCT00487617|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2009-02-24|||July 2007||2007-07-01|February 2009|2009-02-01|April 2012|Anticipated|2012-04-01|October 2011|Anticipated|2011-10-01||Interventional|||Arteriopathy and Endothelial Function|Endothelial Dysfunction Reversibility in Patients With Peripheral Arterial Disease|Unknown status|Recruiting|N/A|50|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 15:32:20.440114|2017-02-18 15:32:20.440114
NCT00029978|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-29|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|January 2004||2004-01-01|||||Observational|||Transfer of Neural Energy Between Humans|Transfer of Neural Energy Between Human Subjects|Completed||N/A|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:53.373448|2017-02-18 18:07:53.373448
NCT00487604|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2007-08-01|||May 2007||2007-05-01|April 2007|2007-04-01|May 2008|Anticipated|2008-05-01|||||Observational|||Retrospective Study of the Impact of Drug Eluting Stents|Retrospective Study of the Impact of Drug Eluting Stents on Intermediate Term Survival, Cardiovascular Outcomes Including Revascularization, Bleeding Rates and Economic Costs|Unknown status|Recruiting|N/A|9800|Anticipated|Providence Health & Services|||||f||||f||||||||||2017-02-18 15:32:20.537977|2017-02-18 15:32:20.537977
NCT00487591|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2008-04-28|||November 2006||2006-11-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia|An Evaluation of Simvastatin 20 mg Plus Omacor 4 g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia|Completed||Phase 4|40|Actual|Provident Clinical Research|||2||f||||f||||||Samples Without DNA|"~     serum and plasma~   "|||2017-02-18 15:32:20.62493|2017-02-18 15:32:20.62493
NCT00487578|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2013-02-04|2009-11-16||October 2006||2006-10-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction|Evaluation of the Efficacy of Naratriptan for the Treatment and Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction|Terminated||Phase 4|12|Actual|Cady, Roger, M.D.|"Study terminated October 2009 (in 4th year) due to low enrollment and anticipated drug expiration November 2009 (study drug had previously been re-supplied at expiration of 1st batch November 2007).~No analysis performed."|2||"Terminated October 2009 (in 4th year) due to low enrollment and anticipated drug expiration~   November 2009."|f||||t||||||||||2017-02-18 15:32:20.742806|2017-02-18 15:32:20.742806
NCT00487565|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2013-08-06|2012-02-21||September 2006||2006-09-01|August 2013|2013-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System|LCS® PS: A Prospective, Multi-center Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System|Completed||N/A|210|Actual|DePuy Orthopaedics||1|||f||||f||||||||||2017-02-18 15:32:21.289656|2017-02-18 15:32:21.289656
NCT00487552|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2015-12-29|2012-01-16||January 2008||2008-01-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|January 2009|Actual|2009-01-01||Interventional|MAD||Magnetic Anastomosis Device Relief of Malignant Gastric Outlet Obstruction|Endoscopic Gastroenteric Anastomosis Formed by Magnetic Compression and Stent Placement for Palliation of Malignant Gastric Outlet Obstruction|Terminated||Phase 1|18|Actual|Cook|Enrollment was stopped in Feb 2009, due to the death of a patient after distal stent migration.|1||Failure to achieve one of the primary endpoints.|f||||f||||||||||2017-02-18 15:32:21.542306|2017-02-18 15:32:21.542306
NCT00487539|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2014-01-14|2013-04-29||August 2007||2007-08-01|January 2014|2014-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis|A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis|Completed||Phase 2/Phase 3|1065|Actual|Janssen Research & Development, LLC||4|||f||||t||||||||||2017-02-18 15:32:21.884937|2017-02-18 15:32:21.884937
NCT00487526|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-07-10|||June 2007||2007-06-01|July 2007|2007-07-01||||||||Interventional|DJBD||Duodenal Jejunal Bypass for Type 2 Diabetes (DJBD)|Clinical Evaluation of the Effect of Duodenal Jejunal Bypass on Type Two Diabetes in Non Obese Adults|Unknown status|Recruiting|Phase 1|50|Anticipated|Ferzli, George S., M.D. F.A.C.S.||1|||f||||t||||||||||2017-02-18 15:32:22.892394|2017-02-18 15:32:22.892394
NCT00487513|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2017-01-04|||June 2007||2007-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Observational|||Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials|Procurement of Follicular B Cell Lymphoma Cells From Blood, Tissue or Malignant Effusion for the Purpose of Possible Use in Future Clinical Trials: A Minimal Risk Protocol|Active, not recruiting||N/A|40|Anticipated|Dana-Farber Cancer Institute|||1||f||||f||||||Samples With DNA|"~     Whole Blood Lymph node biopsy Drainage of an effusion Bone marrow biopsy~   "|||2017-02-18 15:32:22.975455|2017-02-18 15:32:22.975455
NCT00487500|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2014-08-15|||December 1998||1998-12-01|June 2007|2007-06-01|May 2005|Actual|2005-05-01|December 2002|Actual|2002-12-01||Interventional|||Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression|Affective and Cognitive Consequences of ECT|Completed||Phase 4|180|Actual|New York State Psychiatric Institute||4|||f||||t||||||||||2017-02-18 15:32:23.063706|2017-02-18 15:32:23.063706
NCT00487487|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2007-06-15||||||March 2007|2007-03-01||||||||Observational|||Study of Mental Fatigue in Polio Survivors||Unknown status|Recruiting|N/A|||Uniformed Services University of the Health Sciences|||||f||||f||||||||||2017-02-18 15:32:23.173871|2017-02-18 15:32:23.173871
NCT00487474|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2009-03-12|||June 2007||2007-06-01|March 2009|2009-03-01|February 2008|Actual|2008-02-01|||||Interventional|||A Single-Center, Open-Label, Exploratory Study of the Volumizing Effect of SCULPTRA Measured by Three Dimensional Digital Surface Imaging|A Single-Center, Open-Label, Exploratory Study of the Volumizing Effect of Sculptra (Poly-L-Lactic Acid) Measured by Three Dimensional Digital Surface Imaging|Completed||Phase 4|20|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:32:23.239504|2017-02-18 15:32:23.239504
NCT00487461|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2015-10-22|2015-07-22||May 2007||2007-05-01|October 2015|2015-10-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage|Randomized Double Blind Study Using Simvastatin for the PRevention Aof Vasospasm in Aneurysmal Subarachnoid Hemorrhage|Terminated||N/A|25|Actual|University of Illinois at Chicago|Early termination leading to small numbers of subjects analyzed and Primary Physician leaving institution before study completion.|3||Study PI left the institution and study was stopped at that time.|f||||f||||||||||2017-02-18 15:32:23.342114|2017-02-18 15:32:23.342114
NCT00487448|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2008-11-17|||July 1998||1998-07-01|November 2008|2008-11-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|FLAG-IDA||SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia|FLAG-IDA Chemotherapy Induction Follow by Intensive Chemotherapy Postremission +/- Autologous Hemopoietic Stem Cell Transplantation or Bone Marrow Transplantation in Patients With High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia.|Completed||Phase 4|200|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:32:23.924892|2017-02-18 15:32:23.924892
NCT00487435|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2014-04-24|2010-06-24||June 2007||2007-06-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain|Open-Label Extension, Single-Arm, Flexible-Dosing, Phase 3 Trial With CG5503 Extended-Release (ER) in Patients With Moderate to Severe Chronic Pain|Completed||Phase 3|1166|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 15:32:26.700288|2017-02-18 15:32:26.700288
NCT00487422|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2008-05-28|||October 1998||1998-10-01|June 2007|2007-06-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation|A Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Quality-of-Life of R108512 Tablets in Elderly Subjects With Chronic Constipation|Completed||Phase 3|303|Actual|Movetis||3|||f||||f||||||||||2017-02-18 15:32:27.47528|2017-02-18 15:32:27.47528
NCT00487409|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2014-12-12|||December 2006||2006-12-01|December 2014|2014-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery|A Randomized Trial Comparing Outcomes for the LigaSure and Disposable Stapling Instruments for Laparoscopic Surgery|Completed||N/A|100|Actual|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-02-18 15:32:27.581533|2017-02-18 15:32:27.581533
NCT00487396|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2012-04-17|2012-03-20||September 2007||2007-09-01|March 2012|2012-03-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|MA-51||Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease|Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease|Completed||N/A|98|Actual|Given Imaging Ltd.||1|||f||||f||||||||||2017-02-18 15:32:27.699695|2017-02-18 15:32:27.699695
NCT00487383|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2017-01-24|||June 12, 2007||2007-06-12|June 29, 2012|2012-06-29|June 29, 2012||2012-06-29|||||Observational|||Brain Changes in Blepharospasm|Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients With Dystonia and Healthy Controls|Terminated||N/A|47|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:32:27.963131|2017-02-18 15:32:27.963131
NCT00487370|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2007-06-15|||March 1997||1997-03-01|June 2007|2007-06-01|December 1998|Actual|1998-12-01|||||Interventional|||Implantation of Gold Beads to Relieve Discomfort From Knee Osteoarthritis|Extraarticular Gold Implantation for Treatment of Knee Osteoarthritis.|Completed||N/A|43|Actual|Research Unit Of General Practice, Copenhagen||2|||f||||f||||||||||2017-02-18 15:32:28.053191|2017-02-18 15:32:28.053191
NCT00487357|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2016-02-17|||June 2006||2006-06-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||MATCh Parents' Supplemental Survey|MATCh Parents' Supplemental Survey: Predictors of Smoking in Mexican American Youth|Completed||N/A|1215|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:32:28.142649|2017-02-18 15:32:28.142649
NCT00487344|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2007-07-02|||June 2007||2007-06-01|May 2007|2007-05-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Research Study of Nutritional Methods to Reduce Body Fat Percentages in Overweight and Obese Populations|Comparison of Body Fat Reduction in Overweight and Obese Subjects Utilizing Personalized Low-Fat Meal Plans vs. Non-Personalized Low-Fat Meal Plans.|Unknown status|Recruiting|Phase 1|32|Anticipated|Central FITT, Inc||2|||f||||f||||||||||2017-02-18 15:32:28.242425|2017-02-18 15:32:28.242425
NCT00487331|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2015-01-07|||June 2007||2007-06-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study|Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study|Completed||N/A|52|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:32:28.330295|2017-02-18 15:32:28.330295
NCT00487318|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2012-08-20|||June 2007||2007-06-01|August 2012|2012-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin|A Randomized Controlled Trial of Adding Fluvastatin to Standard Medical Treatment (SMT) and a Pilot Trial of Rosuvastatin and Other Statins With SMT, for Patients Infected With Chronic Hepatitis C Who Are Naive to Therapy.|Completed||Phase 2|40|Actual|Bader, Ted, M.D.||2|||f||||f||||||||||2017-02-18 15:32:28.495308|2017-02-18 15:32:28.495308
NCT00487305|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2016-11-16|||June 2007||2007-06-01|November 2016|2016-11-01|October 2024|Anticipated|2024-10-01|May 2017|Anticipated|2017-05-01||Interventional|||Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma|A Phase I Trial of Vaccination With Lethally Irradiated Lymphoma Cells Admixed With Granulocyte-Macrophage Colony Stimulating Factor Secreting K562 Cells for the Treatment of Previously Untreated or Relapses Follicular Lymphoma|Active, not recruiting||Phase 1|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:32:28.764769|2017-02-18 15:32:28.764769
NCT00487292|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2007-06-18|||April 2003||2003-04-01|June 2007|2007-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Naps and Pulses of Bright Light in Shift Workers|The Effects of a Combination of Napping and Bright Light Pulses on Shift Workers Sleepiness at the Wheel A Pilot Study|Completed||N/A|9|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:32:28.872844|2017-02-18 15:32:28.872844
NCT00487279|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2012-03-25|2012-01-04||June 2007||2007-06-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|DETERMINE||DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation|DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation|Terminated||N/A|81|Actual|St. Jude Medical||2||Study terminated early due to inability to enroll.|f||||t||||||||||2017-02-18 15:32:28.965891|2017-02-18 15:32:28.965891
NCT00487266|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2013-11-04|||September 2006||2006-09-01|November 2013|2013-11-01|August 2010|Actual|2010-08-01|September 2009|Actual|2009-09-01||Interventional|||Soft Tissue Biomechanical Behavior During Acupuncture in Low Back Pain|Soft Tissue Biomechanical Behavior During Acupuncture in Low Back Pain|Completed||N/A|180|Actual|National Center for Complementary and Integrative Health (NCCIH)||1|||f||||t||||||||||2017-02-18 15:32:29.459493|2017-02-18 15:32:29.459493
NCT00487253|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2010-02-13|||July 2007||2007-07-01|February 2010|2010-02-01|December 2010|Anticipated|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia|Randomized Clinical Trial of the Efficacy and Tolerability of Oral Miltefosine Versus Parenteral Antimony for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|Centro Internacional de Entrenamiento e Investigaciones Médicas||2|||f||||t||||||||||2017-02-18 15:32:29.569665|2017-02-18 15:32:29.569665
NCT00487240|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2010-10-20|2009-08-17||June 2007||2007-06-01|October 2010|2010-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|IOOZ||Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes|Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Insulin Detemir) in Basal-Bolus Therapy for Patients With Type 1 Diabetes|Completed||Phase 3|387|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:32:29.692708|2017-02-18 15:32:29.692708
NCT00487227|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-15|2015-10-06|||June 2005||2005-06-01|October 2015|2015-10-01|November 2005|Actual|2005-11-01|||||Interventional|||Effects of Low Doses of Caffeine on Mood, Physiology and Mental Function|Levels of Caffeine Lower Than Those Found in Decaffeinated Beverages Exert Effects on Cognition, Mood, and Autonomic Activity|Completed||N/A|20|Actual|Northumbria University||4|||f||||f||||||||||2017-02-18 15:32:31.12556|2017-02-18 15:32:31.12556
NCT00487214|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2011-05-31|||June 2002||2002-06-01|May 2011|2011-05-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Observational|||Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma||Completed||N/A|361|Actual|Allergan|||1||f||||||||||||||2017-02-18 15:32:31.228283|2017-02-18 15:32:31.228283
NCT00487201|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2007-06-15|||April 2006||2006-04-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Endoscopic Treatment of Biliary Strictures After LTX: Balloon Dilatation Versus Stent Placement||Completed||N/A|22|Actual|University of Ulm||2|||f||||f||||||||||2017-02-18 15:32:31.293428|2017-02-18 15:32:31.293428
NCT00487188|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2015-07-22|2011-03-22||November 2005||2005-11-01|July 2015|2015-07-01|April 2008|Actual|2008-04-01|November 2007|Actual|2007-11-01||Interventional|INTENSE||A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience|Phase IIIb/IV Randomized, Controlled Study Evaluating an Intensification Treatment Strategy of Adding Enfuvirtide (ENF) to an Oral Highly Active AntiRetroviral Therapy (HAART) in Treatment Experienced Patients|Completed||Phase 4|47|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:32:31.400193|2017-02-18 15:32:31.400193
NCT00487175|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2009-03-16|||September 2007||2007-09-01|March 2009|2009-03-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|TRAMADOL||Tramadol and Pain Sensitization|Tramadol and Pain Sensitization|Completed||Phase 1|12|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:32:32.277179|2017-02-18 15:32:32.277179
NCT00487162|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2016-10-04|2010-12-03||June 2007||2007-06-01|September 2016|2016-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||males and females between the ages of 18 and 89.|The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality|The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality|Terminated||N/A|56|Actual|Rutgers, The State University of New Jersey|Study was terminated. No final conclusion drawn. A sentinel article was published in Feb 2009 issue of Anesthesiology which questioned the safety of intense insulin therapy/strict glycemic control.|2||potential harm of insulin infusion outweights the benefit.|f||||f||||||||No||2017-02-18 15:32:32.366907|2017-02-18 15:32:32.366907
NCT00487149|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2009-01-13|||October 2005||2005-10-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|||||Observational|||Respiratory Muscle Strength in Bronchiectasis: Repeatability and Reliability||Completed||N/A|40|Actual|University of Ulster|||2||f||||t||||||||||2017-02-18 15:32:32.722205|2017-02-18 15:32:32.722205
NCT00487136|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2012-09-27|||June 2007||2007-06-01|September 2012|2012-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Interaction Between ABT-335, Rosuvastatin and Warfarin|Multiple-Dose Pharmacokinetic and Pharmacodynamic Interaction Between ABT-335, Rosuvastatin and Warfarin|Completed||Phase 1|45|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:32:32.805264|2017-02-18 15:32:32.805264
NCT00487123|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2008-06-13||||||June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months|A Multi-Center, Randomized, Proof-of-Concept, Parallel Control Study With Remind Cap® in Patients With Essential Hypertension and Newly Treated With Valsartan+/-Hydrochlorothiazide (HCTZ)|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 15:32:32.907961|2017-02-18 15:32:32.907961
NCT00487110|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2010-03-26|||June 2008||2008-06-01|March 2010|2010-03-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|Tropisétron||Clinical Confirmation of a Pharmacodynamic Interaction Between Tropisetron and Paracetamol||Completed||Phase 4|40|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:32:32.996243|2017-02-18 15:32:32.996243
NCT00487097|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2013-02-15|||September 2007||2007-09-01|February 2013|2013-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients|Effect of EPA, GLA and Antioxidants on the Immune Response - Cellular and Molecular Mechanisms of Wound Healing in Critically Ill Patients.|Completed||N/A|40|Actual|Rabin Medical Center||2|||f||||f||||||||||2017-02-18 15:32:33.080287|2017-02-18 15:32:33.080287
NCT00487084|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2014-03-17|2011-02-09||August 2004||2004-08-01|March 2014|2014-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia|Interaction Between Epidural 2-chloroprocaine and Epidural Morphine: Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia|Completed||N/A|136|Actual|Northwestern University|We used a single 30-minute interval between morphine and 2-chloroprocaine administration and additional investigation is warranted to determine the optimum interval for administration.|3|||f||||f||||||||||2017-02-18 15:32:33.189433|2017-02-18 15:32:33.189433
NCT00487071|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2014-02-12|||August 2006||2006-08-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Anal Fistula Plug for High-type Anal Fistulae|Efficacy of Anal Fistula Plug in the Management of High-type Anal Fistulae: a Pilot Study|Terminated||N/A|10|Actual|Chinese University of Hong Kong||1||No financial support|f||||t||||||||||2017-02-18 15:32:33.730409|2017-02-18 15:32:33.730409
NCT00487058|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2009-11-18|||May 2007||2007-05-01|November 2009|2009-11-01||||June 2008|Actual|2008-06-01||Interventional|||A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors|A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors.|Completed||Phase 1|28|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:32:33.825656|2017-02-18 15:32:33.825656
NCT00487045|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2009-07-23|||December 2007||2007-12-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|HEM-AVERT||Prevention and/or Reduction of Hemorrhoids and/or Thrombosed External Hemorrhoids Using the HEM-AVERT Perianal Stabilizer Instrument|Prevention and/or Reduction of Hemorrhoids and/or Thrombosed External Hemorrhoids (TEH) Using the HEM-AVERT Perianal Stabilizer Instrument|Completed||Phase 1|176|Actual|Plexus Biomedical, Inc.||2|||f||||t||||||||||2017-02-18 15:32:33.909528|2017-02-18 15:32:33.909528
NCT00487032|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2016-10-24|||May 2008||2008-05-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation|A Proof of Concept Study to Evaluate Differential Tachyphylaxis of Alpha 1 and Alpha 2 Adrenoreceptor Mediated Decongestant Response to Oxymetazoline and Its Acute Reversal by Corticosteroid in Healthy Volunteers|Completed||Phase 4|19|Actual|University of Dundee||2|||f||||f||||||||||2017-02-18 15:32:34.250957|2017-02-18 15:32:34.250957
NCT00487019|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2008-05-27|||August 2006||2006-08-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Observational|||Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment|Comparative Study of Two Antibiotic Regimen - Penicillin G/Gentamicin Versus Ampicillin/Gentamicin in Empirical Treatment of Early Onset Neonatal Septicaemia|Completed||N/A|281|Actual|University of Tartu|||2||f||||f||||||||||2017-02-18 15:32:34.370976|2017-02-18 15:32:34.370976
NCT00487006|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2015-06-12|||October 2006||2006-10-01|June 2015|2015-06-01|February 2015|Actual|2015-02-01|July 2011|Actual|2011-07-01||Interventional|CIH||Study of High Blood Sugars and Insulin in Hospitalized, Critically Ill Children|Insulin Resistance Versus Absolute Insulin Deficiency: Evaluating the Mechanism of Hyperglycemia in Pediatric Critical Illness|Completed||N/A|209|Actual|Children's Healthcare of Atlanta||3|||f||||f||||||||||2017-02-18 15:32:34.460135|2017-02-18 15:32:34.460135
NCT00486993|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2016-11-05|||May 2006||2006-05-01|November 2016|2016-11-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|AsuRiesgo||Cardiovascular Risk Factors in an Ambulatory Urban Patient Population|Estimation of Prevalence and Assessment of the Effects of Modification of Cardiovascular Risk Factors in an Ambulatory Urban Patient Population|Completed||N/A|18287|Actual|Heidelberg University|||1||f||||t||||||||||2017-02-18 15:32:34.566119|2017-02-18 15:32:34.566119
NCT00486980|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2008-01-28||||||January 2008|2008-01-01||||||||Interventional|||Intramuscular Peramivir for the Treatment of Uncomplicated Influenza|A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAMUSCULAR PERAMIVIR IN SUBJECTS WITH UNCOMPLICATED ACUTE INFLUENZA|Withdrawn||Phase 3|||BioCryst Pharmaceuticals||||"This study was withdrawn for administrative reasons. The dose ranging plan for the program was~   revised."|||||||||||||||2017-02-18 15:32:34.678771|2017-02-18 15:32:34.678771
NCT00486967|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2007-06-13|||August 2006||2006-08-01|June 2007|2007-06-01||||||||Observational|||Insulin Resistance : Heart Failure|Insulin Resistance: A New Target in Heart Failure|Unknown status|Recruiting|N/A|||University of Dundee|||||f||||t||||||||||2017-02-18 15:32:34.749998|2017-02-18 15:32:34.749998
NCT00486954|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2013-06-12|2012-12-20||July 2007||2007-07-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|January 2012|Actual|2012-01-01||Interventional|||Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer|A Randomized, Multicenter, Open-label, Phase III Study of Lapatinib (GW572016) in Combination With Weekly Paclitaxel Versus Weekly Paclitaxel Alone in the Second Line Treatment of ErbB2 Amplified Advanced Gastric Cancer|Completed||Phase 3|273|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:32:34.857613|2017-02-18 15:32:34.857613
NCT00486941|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2007-07-18|||February 2003||2003-02-01|July 2007|2007-07-01|March 2006|Actual|2006-03-01|||||Interventional|||Lifestyle Intervention in Primary Health Care - the Björknäs Study|A Randomized Trial of Lifestyle Intervention in Primary Health Care for the Modification of Cardiovascular Risk Factors - the Björknäs Study|Completed||Phase 3|151|Actual|Umeå University||2|||f||||f||||||||||2017-02-18 15:32:36.797042|2017-02-18 15:32:36.797042
NCT00486928|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2011-07-22|||May 2004||2004-05-01|July 2011|2011-07-01|May 2005|Actual|2005-05-01|||||Observational|Hall-Kaster||Twenty-five-year Experience With the Medtronic-Hall Valve Prosthesis|Twenty-five-year Experience With the Medtronic-Hall Valve Prosthesis|Completed||N/A|816|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-02-18 15:32:36.888079|2017-02-18 15:32:36.888079
NCT00486915|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2011-06-22|||April 2007||2007-04-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|||||Interventional|||Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence|Concurrent Prophylactic Left Atrial Appendage Exclusion: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|150|Anticipated|London Health Sciences Centre||2|||f||||f||||||||||2017-02-18 15:32:36.979283|2017-02-18 15:32:36.979283
NCT00486902|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2014-03-17|2011-03-15||July 2006||2006-07-01|March 2014|2014-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?|Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?|Completed||N/A|188|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 15:32:37.077227|2017-02-18 15:32:37.077227
NCT00486889|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2017-01-18|||August 2008||2008-08-01|January 2017|2017-01-01|January 2026|Anticipated|2026-01-01|December 2025|Anticipated|2025-12-01||Interventional|||Growth and Development Study of Alglucosidase Alfa.|A Long-term Study to Evaluate Growth and Development Outcomes in Patients With Infantile-Onset Pompe Disease Who Are Receiving Alglucosidase Alfa.|Active, not recruiting||Phase 4|30|Anticipated|Sanofi||1|||f||||f||||||||||2017-02-18 15:32:38.035597|2017-02-18 15:32:38.035597
NCT00486876|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2011-08-01|||June 2007||2007-06-01|August 2011|2011-08-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome|A Double-Blind, Randomized, Placebo-Controlled Phase 2b Study of 100, 200, and 300 mg BID Dextofisopam in Female Outpatients With Irritable Bowel Syndrome|Completed||Phase 2|324|Actual|Pharmos||4|||f||||t||||||||||2017-02-18 15:32:38.145781|2017-02-18 15:32:38.145781
NCT00486863|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2015-12-17|2013-10-31||August 2007||2007-08-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||S. Japonicum and Pregnancy Outcomes|S. Japonicum and Pregnancy Outcomes: A Randomized, Double Blind, Placebo Controlled Trial (RCT)|Completed||Phase 2|370|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 15:32:38.34067|2017-02-18 15:32:38.34067
NCT00475241|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2014-11-03|2014-10-27||January 2008||2008-01-01|November 2014|2014-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms|Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms|Completed||Phase 2/Phase 3|36|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:36:37.884864|2017-02-18 15:36:37.884864
NCT00486850|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2009-07-09|||October 2006||2006-10-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Synchronized Intermittent Mandatory Ventilation (SIMV) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) In Preterm Infants With Respiratory Distress|Synchronized Intermittent Mandatory Ventilation (SIMV) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) In Preterm Infants With Respiratory Distress|Completed||Phase 4|110|Actual|University of Southern California||1|||f||||t||||||||||2017-02-18 15:32:39.218953|2017-02-18 15:32:39.218953
NCT00486837|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2014-08-05|2009-09-24||December 2003||2003-12-01|August 2014|2014-08-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|CF2||Deposition of Inhaled Prolastin in Cystic Fibrosis Patients|Multicenter, Randomized, Parallel Group Study to Investigate the Optimal Deposition Site for Inhaled Prolastin® in Patients With Cystic Fibrosis (CF)|Completed||Phase 2|72|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 15:32:39.320662|2017-02-18 15:32:39.320662
NCT00486824|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2016-11-28|||April 2007||2007-04-01|November 2016|2016-11-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Indomethacin Versus Nifedipine for Preterm Labor Tocolysis|Indocin Versus Nifedipine for Preterm Labor Tocolysis - A Randomized Double-Blinded Clinical Trial|Recruiting||N/A|110|Anticipated|Stanford University||2|||f||||f||||||||No||2017-02-18 15:32:39.873034|2017-02-18 15:32:39.873034
NCT00486811|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2012-04-16|2010-10-25||June 2007||2007-06-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee|A Randomized Double-blind, Placebo- and Active-control, Parallel-arm, Phase III Trial With Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee.|Completed||Phase 3|990|Actual|Grünenthal GmbH||3|||f||||f||||||||||2017-02-18 15:32:40.007895|2017-02-18 15:32:40.007895
NCT00486798|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2010-12-08|||May 2007||2007-05-01|April 2009|2009-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|FAST||FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis||Terminated||Phase 3|||AstraZeneca||1||study was not ethically acceptable to continue and therefore it was finally stopped|f||||||||||||||2017-02-18 15:32:41.303648|2017-02-18 15:32:41.303648
NCT00486785|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2009-09-29|||April 2006||2006-04-01|September 2009|2009-09-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin|Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin 10mg Once Daily (XATRAL OD 10mg), Open, 24-week Study|Completed||Phase 4|431|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:32:41.451361|2017-02-18 15:32:41.451361
NCT00486772|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2007-06-18||||||June 2007|2007-06-01||||||||Interventional|||Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD||Completed||Phase 4|||Gulhane School of Medicine|||||f||||f||||||||||2017-02-18 15:32:41.543092|2017-02-18 15:32:41.543092
NCT00486759|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2012-11-28|2012-11-28||July 2007||2007-07-01|November 2012|2012-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma|A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial Comparing the Efficacy of Bevacizumab in Combination With Rituximab and CHOP (R-CHOP + Bevacizumab) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With CD20-positive Diffuse Large B-cell Lymphoma (DLBCL)|Terminated||Phase 3|787|Actual|Hoffmann-La Roche|Due to premature termination of the study, the efficacy results should be interpreted with caution.|2||Due to an unfavorable benefit/risk ratio.|f||||||||||||||2017-02-18 15:32:41.706313|2017-02-18 15:32:41.706313
NCT00486746|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2016-08-30|||October 2004||2004-10-01|August 2016|2016-08-01|December 2016||2016-12-01|December 2007|Actual|2007-12-01||Interventional|||Lifestyle Intervention Treatment for Patients With Mild Obstructive Sleep Apnea|Lifestyle Intervention Treatment for Patients With Mild Obstructive Sleep Apnea|Active, not recruiting||N/A|81|Actual|Kuopio University Hospital||2|||f||||f||||||||||2017-02-18 15:32:43.186734|2017-02-18 15:32:43.186734
NCT00486733|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2012-12-18|||April 2007||2007-04-01|December 2012|2012-12-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|CWI||Study to Determine if Shock Wave Therapy Applied to Traumatic Wounds of the Extremity Improves Healing Time|Prospective Randomized Trial of Standard Wound Care Versus Standard Wound Care Plus Shock Wave Therapy for Traumatic Wounds of the Extremity|Unknown status|Recruiting|Phase 3|213|Anticipated|Walter Reed Army Medical Center||2|||f||||t||||||||||2017-02-18 15:32:43.297766|2017-02-18 15:32:43.297766
NCT00486720|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2015-06-08|2010-04-19||June 2007||2007-06-01|June 2015|2015-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)|A Randomized Phase IIa Study of Vorinostat in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome|Terminated||Phase 2|22|Actual|Merck Sharp & Dohme Corp.|This trial was terminated because the pre-specified futility criterion was met.|2|||f||||||||||||||2017-02-18 15:32:43.424181|2017-02-18 15:32:43.424181
NCT00486707|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2012-07-31|||June 2007||2007-06-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Ovarian Cancer Patient Questionnaire on Genetic Testing|Questionnaire for Ovarian Cancer Patients Regarding Acceptance and Willingness to Undergo Genetic Testing|Completed||N/A|237|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:32:44.096834|2017-02-18 15:32:44.096834
NCT00486694|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2007-06-13|||March 2004||2004-03-01|June 2007|2007-06-01|August 2004|Actual|2004-08-01|||||Interventional|||Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria|A Randomised Non-Inferiority Trial of Sulfadoxine-Pyrimethamine Plus Artesunate Compared to Chloroquine for the Treatment of Vivax Malaria in Eastern Afghanistan.|Completed||Phase 2|190|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-02-18 15:32:44.272449|2017-02-18 15:32:44.272449
NCT00486681|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-14|2008-02-26|||January 2007||2007-01-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|July 2007|Actual|2007-07-01||Observational|COBAS||Clinical Assessment of an in-Patient Glucose Monitoring System (Accu-Chek Inform Cobas IT 1000)|Evaluation of the Implementation of the Accu-Chek Inform Cobas IT 1000 System in Three Medical Hospital Departments: Impact on the Management of Diabetes|Completed||N/A|949|Actual|University Hospital, Grenoble|||2||f||||f||||||||||2017-02-18 15:32:44.362857|2017-02-18 15:32:44.362857
NCT00486668|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2016-06-03|||July 2007||2007-07-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|June 2012|Actual|2012-06-01||Interventional|||A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer|A Randomized Phase III Trial of Neoadjuvant Therapy for Patients With Palpable and Operable HER2-Positive Breast Cancer Comparing the Combination of Trastuzumab Plus Lapatinib to Trastuzumab and to Lapatinib Administered With Weekly Paclitaxel Following AC Accompanied by Correlative Science Studies to Identify Predictors of Pathologic Complete Response|Active, not recruiting||Phase 3|529|Actual|NSABP Foundation Inc||3|||f||||t||||||||||2017-02-18 15:32:44.478911|2017-02-18 15:32:44.478911
NCT00486655|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2012-08-07|||May 2007||2007-05-01|August 2012|2012-08-01|June 2007|Actual|2007-06-01|||||Interventional|||NOTES-Assisted Laparoscopic Cholecystectomy Surgery|Assisted Laparoscopic Cholecystectomy Surgery|Terminated||N/A|25|Anticipated|USGI Medical||1||Change of Focus for the company|f||||f||||||||||2017-02-18 15:32:44.701725|2017-02-18 15:32:44.701725
NCT00486642|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2015-08-03|||September 2007||2007-09-01|July 2015|2015-07-01||||August 2015|Actual|2015-08-01||Interventional|||Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase 2 Study of GW786034 (Pazopanib) With or Without Bicalutamide in Hormone Refractory Prostate Cancer|Active, not recruiting||Phase 2|23|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:32:44.785952|2017-02-18 15:32:44.785952
NCT00486629|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2016-02-18|||July 2004||2004-07-01|February 2016|2016-02-01|July 2020|Anticipated|2020-07-01|June 2019|Anticipated|2019-06-01||Interventional|IDEA||Impact of Diet and Exercise Activity on Pregnancy Outcomes|Impact of a Community-based Obesity and Diabetes Prevention Program on Pregnant Outcomes in Pregnant Women|Recruiting||Phase 2|1000|Anticipated|University of Manitoba||2|||f||||t||||||||Yes|"Hui A, Back L, Ludwig S, Gardiner P, Sevenhuysen G, Dean H, Sellers E, McGavock J, Morris M, Bruce S, Murray R, Shen GX. Lifestyle intervention on diet and exercise reduced excessive gestational weight gain in pregnant women under a randomized controlled trial. Br J Obstetr Gynecol 2012;119:70-77~Hui AL, Back L, Ludwig S, Gardiner P, Sevenhuysen G, Dean HJ, Sellers E, McGavock J, Morris M, Jiang D, Shen GX. Effects of lifestyle intervention on dietary intake, physical activity level, and gestational weight gain in pregnant women with different pre-pregnancy Body Mass Index in a randomized control trial. BMC Pregnancy Childbirth. 2014;14:331. PMID:25248797"|2017-02-18 15:32:47.479857|2017-02-18 15:32:47.479857
NCT00485641|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-12|||August 2005||2005-08-01|June 2007|2007-06-01|January 2007|Actual|2007-01-01|||||Observational|||Saeboflex Dynamic Hand Orthosis for Inpatient Rehabilitation Stroke Patients|Screening of Inpatient Rehabilitation Stroke Patients for Their Potential to Qualify to Use the Saeboflex Dynamic Hand Orthosis|Completed||N/A|222|Actual|Kessler Foundation|||||f||||f||||||||||2017-02-18 15:32:47.622471|2017-02-18 15:32:47.622471
NCT00485628|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||April 2003||2003-04-01|June 2007|2007-06-01|October 2003|Actual|2003-10-01|||||Interventional|||Safety Study in Outpatient Japanese Children With ADHD|An Open-Label, Dose Titration Safety Study of Atomoxetine Hydrochloride in Outpatient Japanese Children With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 2|37|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 15:32:47.726211|2017-02-18 15:32:47.726211
NCT00485615|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2013-10-29|||October 2008||2008-10-01|June 2010|2010-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|OMEGA3SP||An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia|An Open-label, Pilot Study Evaluating the Efficacy of Enteric-coated Eicosapentaenoic Acid (o3mega+Joy) in the Treatment of Social Phobia|Completed||Phase 2|8|Actual|START Clinic for Mood and Anxiety Disorders||1|||f||||f||||||||||2017-02-18 15:32:47.8137|2017-02-18 15:32:47.8137
NCT00485602|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2007-06-12|||December 2007||2007-12-01|June 2007|2007-06-01||||||||Interventional|||Orthodontic Treatment With a Part-Time Wearing Esthetic Removable Appliance||Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 15:32:47.911033|2017-02-18 15:32:47.911033
NCT00486616|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2008-02-11|||May 2007||2007-05-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Examination of Double-Lumen Tube Placement by Functional Electrical Impedance Tomography|Examination of Double-Lumen Tube Placement: Functional Electrical Impedance Tomography Versus Fibreoptic Bronchoscopy|Completed||N/A|||University Hospital Freiburg|||||f||||f||||||||||2017-02-18 15:32:47.997077|2017-02-18 15:32:47.997077
NCT00486603|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2012-05-01|||October 2007||2007-10-01|May 2012|2012-05-01||||January 2013|Anticipated|2013-01-01||Interventional|||Hydroxychloroquine, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I/II Trial of Hydroxychloroquine in Conjunction With Radiation Therapy and Concurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 1/Phase 2|94|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 15:32:48.067756|2017-02-18 15:32:48.067756
NCT00486590|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2008-02-27|||August 2006||2006-08-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Evaluation of Prolact-Plus Human Milk Fortifier|The Evaluation of Prolact-Plus, Human Milk Fortifier (Human, Pasteurized) for Pre-Term Infants Receiving Human Milk|Completed||N/A|105|Actual|Prolacta Bioscience||2|||f||||f||||||||||2017-02-18 15:32:48.182017|2017-02-18 15:32:48.182017
NCT00486577|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2011-01-27|||June 2007||2007-06-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|ACOUSCO||Chronic Electrical Stimulation of the Auditory Cortex for Intractable Tinnitus|Chronic Electrical Stimulation of the Auditory Cortex for Intractable Tinnitus|Completed||Phase 2/Phase 3|10|Anticipated|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 15:32:48.285281|2017-02-18 15:32:48.285281
NCT00486564|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2009-10-22|||November 2006||2006-11-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|November 2007|Actual|2007-11-01||Interventional|||Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma|A Phase I Trial of Nifurtimox for Relapsed or Refractory Neuroblastoma|Completed||Phase 1|20|Anticipated|University of Vermont||1|||f||||t||||||||||2017-02-18 15:32:48.38384|2017-02-18 15:32:48.38384
NCT00486551|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2007-06-13|||August 2001||2001-08-01|June 2007|2007-06-01|January 2006|Actual|2006-01-01|||||Interventional|||Anger Control Training for Youth With Tourette Syndrome|Anger Control Training for Youth With Tourette Syndrome|Completed||N/A|26|Actual|Yale University||2|||f||||t||||||||||2017-02-18 15:32:48.70662|2017-02-18 15:32:48.70662
NCT00473707|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2008-05-14|||August 2002||2002-08-01|May 2008|2008-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Active Versus Expectant Management of the Third Stage of Labor|A Randomized Trial of Active Versus Expectant Management of the Third Stage of Labor|Completed||N/A|218|Actual|Christiana Care Health Services||2|||f||||f||||||||||2017-02-18 15:37:27.387074|2017-02-18 15:37:27.387074
NCT00486538|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2013-01-02||2012-06-29|June 2007||2007-06-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib|An Open-Label, Phase 2 Study to Evaluate the Efficacy and Tolerability of ABT-869 in Subjects With Advanced Renal Cell Carcinoma (RCC) Who Have Previously Received Treatment With Sunitinib|Completed||Phase 2|53|Actual|AbbVie||1|||f||||f||||||||||2017-02-18 15:32:48.809591|2017-02-18 15:32:48.809591
NCT00486525|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2014-04-17|2013-11-14||August 2007||2007-08-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors|Breast Cancer Survivors: Physical Activity, Inflammation, Fatigue, and Distress|Completed||N/A|200|Actual|Ohio State University Comprehensive Cancer Center|We did not compare yoga to an active control group; Fatigue and depressive symptoms were not used as part of the inclusion criteria. Accordingly, our data may underestimate yoga's potential benefit.|2|||f||||t||||||||||2017-02-18 15:32:48.931335|2017-02-18 15:32:48.931335
NCT00486512|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2011-02-04|||June 2007||2007-06-01|February 2011|2011-02-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Chemoprevention of Colorectal Adenomas|A Clinical Trial Evaluating the Efficacy and Safety of a Combination Treatment Administered Over 3 Years in Patients at Risk of Experiencing Recurrence of Colorectal Adenomas|Terminated||Phase 3|1000|Anticipated|Colotech A/S||2||Planned Interim Analysis failed to show difference between the active and placebo groups|f||||f||||||||||2017-02-18 15:32:50.374215|2017-02-18 15:32:50.374215
NCT00486499|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2007-06-12|||March 2003||2003-03-01|June 2007|2007-06-01||||||||Interventional|||I-125 Versus Pd-103 for Medium Risk Prostate Cancer||Unknown status|Recruiting|Phase 3|660|Anticipated|VA Puget Sound Health Care System|||||f||||||||||||||2017-02-18 15:32:50.520805|2017-02-18 15:32:50.520805
NCT00486486|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2014-05-09|||March 2007||2007-03-01|May 2014|2014-05-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|BTFC||24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination|A 3-month, 4-centre, Crossover, Double-masked Study Investigating the 24-hour Intraocular Pressure Control With the Bimatoprost/Timolol Fixed Combination Dosed Morning, or Evening in Subjects With Exfoliative Glaucoma|Completed||Phase 4|60|Actual|Aristotle University Of Thessaloniki||2|||f||||t||||||||||2017-02-18 15:32:50.611219|2017-02-18 15:32:50.611219
NCT00486473|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2010-07-14|||July 2007||2007-07-01|July 2010|2010-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|DETECT||Multihance Versus Magnevist in Breast MRI|Phase III Multicenter Double-Blind, Randomized, Crossover Study to Compare MultiHance With Magnevist in Contrast-enhanced Magnetic Resonance Imaging (MRI) of the Breast|Completed||Phase 3|130|Anticipated|Bracco Diagnostics, Inc||1|||f||||f||||||||||2017-02-18 15:32:50.950605|2017-02-18 15:32:50.950605
NCT00486460|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2007-06-13|||June 2005||2005-06-01|June 2007|2007-06-01||||||||Interventional|||Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer||Unknown status|Recruiting|Phase 3|||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 15:32:51.028715|2017-02-18 15:32:51.028715
NCT00486447|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2010-03-25|||June 2007||2007-06-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|April 2008|Actual|2008-04-01||Interventional|PICTURE||Perfusion Imaging and CT -Understanding Relative Efficacy|A Prospective Multi-center Study Comparing Cardiac Computed Tomography (CT) Using a 64-detector Row Volumetric Computed Tomography (VCT) Scanner for the Detection of Coronary Artery Disease With Cardiac Radionuclide Imaging.|Completed||N/A|249|Actual|GE Healthcare||1|||f||||t||||||||||2017-02-18 15:32:51.108162|2017-02-18 15:32:51.108162
NCT00486434|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2012-10-22|2012-03-28||May 2007||2007-05-01|October 2012|2012-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis|A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis|Completed||Phase 3|1176|Actual|Nordic Bioscience A/S||2|||f||||||||||||||2017-02-18 15:32:51.20625|2017-02-18 15:32:51.20625
NCT00486421|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2014-10-15|||January 2007||2007-01-01|October 2014|2014-10-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura|A Pilot Study of Rituximab in Combination With Corticosteroids for the Initial Treatment of Immune Thrombocytopenic Purpura|Completed||Early Phase 1|22|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:32:52.119473|2017-02-18 15:32:52.119473
NCT00486408|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2015-06-02|||July 2007||2007-07-01|June 2015|2015-06-01|November 2012|Actual|2012-11-01|September 2008|Actual|2008-09-01||Interventional|||Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults|A Phase 1B Open-label Clinical Trial to Expand the Characterization of the Immune Responses to the Merck Adenovirus Serotype 5 HIV-1 Gag/Pol/Nef Vaccine in Healthy, HIV-1-uninfected Adult Participants|Completed||Phase 1|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 15:32:52.237049|2017-02-18 15:32:52.237049
NCT00486395|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2012-02-08|||September 2007||2007-09-01|February 2012|2012-02-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|OLIVIA||Will CPAP Reduce Length Of Respiratory Support In Premature Infants?|Offering Less Invasive Ventilation in Infants Born 28 to 32 Weeks Gestation: A Randomized Controlled Trial.|Terminated||Phase 3|126|Actual|Children's & Women's Health Centre of British Columbia||2||Decreasing recruitment|f||||t||||||||||2017-02-18 15:32:52.355418|2017-02-18 15:32:52.355418
NCT00486382|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2015-04-01|||April 2007||2007-04-01|April 2015|2015-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India|A Phase 1, Open-Label, Dose Escalating Study to Evaluate the Safety, Tolerability, and Immunogenicity of the LEISH-111F + MPL-SE Vaccine (Recombinant Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE) in Healthy Adults In India|Completed||Phase 1|36|Actual|IDRI||3|||f||||t||||||||||2017-02-18 15:32:52.464009|2017-02-18 15:32:52.464009
NCT00486369|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2007-06-13|||January 2007||2007-01-01|June 2007|2007-06-01||||||||Interventional|||SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study|SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study.|Completed||Phase 1|||Nordic Bioscience A/S|||||f||||||||||||||2017-02-18 15:32:52.566727|2017-02-18 15:32:52.566727
NCT00024999|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-10|2008-03-03|||October 2001||2001-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||EEG and EMG Analysis of Ideomotor Apraxia|EEG Analysis of Ideomotor Apraxia|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:57.007575|2017-02-18 18:08:57.007575
NCT00486356|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2013-05-16|||October 2004||2004-10-01|May 2013|2013-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer|A Phase I Trial of Epirubicin, Carboplatin and Capecitabine in Adult Cancer Patients|Completed||Phase 1|46|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 15:32:52.656203|2017-02-18 15:32:52.656203
NCT00486343|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2008-04-01|||July 2007||2007-07-01|April 2008|2008-04-01|June 2008|Anticipated|2008-06-01|May 2008|Anticipated|2008-05-01||Interventional|||Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS|A Randomized, Double-Blind, Placebo Controlled Study of Zileuton CR Tablets Versus Placebo in Adult Patients With Poorly Controlled Asthma Patients on Moderate Dose Inhaled Corticosteroids (ICS)|Terminated||Phase 4|400|Anticipated|Critical Therapeutics||2||Slower than anticipated enrollment|f||||f||||||||||2017-02-18 15:32:52.771939|2017-02-18 15:32:52.771939
NCT00486330|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2012-10-19|2010-02-25||May 2006||2006-05-01|October 2012|2012-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|BUTI||Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir|Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Tipranavir/Ritonavir in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone|Completed||N/A|12|Actual|Yale University|First, the sample size was small. Second, this study utilized a within-subject design with patients acting as their own controls and thereby resulting in less intra-patient variability in the analysis of BUP/NLX.|1|||f||||f||||||||||2017-02-18 15:32:52.879714|2017-02-18 15:32:52.879714
NCT00486317|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2007-06-13|||October 2005||2005-10-01|June 2007|2007-06-01||||||||Interventional|||Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With Osteoarthritis|SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study.|Completed||Phase 1|||Nordic Bioscience A/S|||||f||||||||||||||2017-02-18 15:32:53.097178|2017-02-18 15:32:53.097178
NCT00486304|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2012-04-16|||February 2006||2006-02-01|April 2012|2012-04-01|May 2008|Actual|2008-05-01|February 2007|Actual|2007-02-01||Interventional|||Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy|Phase I Randomized, Double-blind, Placebo-controlled Trial of the Effect of Temporary Dietary Antioxidant Depletion on Tumor Growth and Cachexia in Head and Neck Cancer Patients Receiving Chemoradiation Therapy|Completed||Phase 1|4|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 15:32:53.181933|2017-02-18 15:32:53.181933
NCT00486291|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2012-09-05|2012-07-31||June 2007||2007-06-01|September 2012|2012-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics|A Phase 2, Randomized, Double Blind, Parallel Design Study Comparing the Efficacy and Safety of VI-0521 to Placebo in the Glycemic Management of Obese Diabetic Adults|Completed||Phase 2|210|Actual|VIVUS, Inc.||2|||f||||f||||||||||2017-02-18 15:32:53.305153|2017-02-18 15:32:53.305153
NCT00486278|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2015-04-15|2013-09-27||June 2007||2007-06-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds|A Multi-centre, Randomised, Double-blinded, Controlled, Dose-escalation Trial on Safety and Efficacy of Activated Recombinant FVII Analogue (NN1731) in the Treatment of Joint Bleeds in Congenital Haemophilia Patients With Inhibitors|Completed||Phase 2|51|Actual|Novo Nordisk A/S||6|||f||||t||||||||||2017-02-18 15:32:53.946164|2017-02-18 15:32:53.946164
NCT00486265|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2010-12-07|2010-07-20||July 2007||2007-07-01|July 2010|2010-07-01|July 2009|Actual|2009-07-01|||||Interventional|||Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)|A Phase I/II, Open-Label, Multi-Center, Two-Part Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of AZD4877 Administered on Days 1, 2 and 3 in Adult Patients With Recurrent or Refractory Acute Myelogenous Leukemia (AML) Excluding Promyelocytic Leukemia|Terminated||Phase 1|47|Actual|AstraZeneca|On 16 June 2009, the study was terminated for a lack of efficacy. None of the 8 patients had experienced CR or CRi. The secondary efficacy outcome measures were not evaluated due to early termination and small number of participants.|1||"AML assess. of response in Part B patients find treatment failure in all 8 evaluable for~   marrow response following a maximum of 2 induction courses of therapy"|f||||||||||||||2017-02-18 15:32:55.530027|2017-02-18 15:32:55.530027
NCT00486252|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2009-11-04|2009-03-31||June 2007||2007-06-01|November 2009|2009-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®|Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® (Latanoprost) as First-Line Monotherapy and as Second-Line Monotherapy After Beta-Blockers Therapy Failure|Completed||Phase 4|996|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:32:55.811836|2017-02-18 15:32:55.811836
NCT00486239|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2007-06-13|||October 2006||2006-10-01|June 2007|2007-06-01||||||||Interventional|||Emotional Processing and Memory Evaluation in Epilepsy Patients|Emotional Processing and Memory Evaluation in Epilepsy Patients|Unknown status|Recruiting|Early Phase 1|36|Anticipated|University Hospitals Cleveland Medical Center||2|||f||||f||||||||||2017-02-18 15:32:56.119669|2017-02-18 15:32:56.119669
NCT00486226|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2014-03-19|2014-01-08||June 2007||2007-06-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|SUNRISE||The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System|The SUNRISE Registry - A Multicenter Post-Market Surveillance With the CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System|Completed||Phase 4|109|Actual|Codman & Shurtleff|This study was powered to have a total of 250 subjects, but was stopped early due to slow enrollment. Hence, this study ended up having only 105 total subjects, making it underpowered.|1|||f||||t||||||||||2017-02-18 15:32:56.217235|2017-02-18 15:32:56.217235
NCT00486213|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-13|2015-09-22|||June 2007||2007-06-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer|Randomized Double-Blind Placebo-Controlled Trial of Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome (HFS)|Terminated||Phase 3|210|Actual|National Cancer Centre, Singapore||2||Slow accrual|f||||t||||||||||2017-02-18 15:32:56.81488|2017-02-18 15:32:56.81488
NCT00486200|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2013-02-27||2010-01-04|June 2007||2007-06-01|February 2013|2013-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes|A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes|Completed||Phase 2|695|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-02-18 15:32:56.923737|2017-02-18 15:32:56.923737
NCT00486187|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2016-01-27|||April 2006||2006-04-01|January 2016|2016-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study|Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study|Completed||N/A|103|Actual|Canadian Cardiovascular Research Network||2|||f||||f||||||||||2017-02-18 15:32:57.05569|2017-02-18 15:32:57.05569
NCT00486174|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2008-05-26|||June 2007||2007-06-01|May 2008|2008-05-01||||||||Interventional|SMURF||Methylene Blue in Sepsis: A Randomized Controlled Trial|Intermittent Bolus Infusion of Methylene Blue to Reduce Norepinephrine Requirements in Sepsis: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|Queen's University||2||primary site withdrew due to competing study: never enrolled any subjects.|f||||t||||||||||2017-02-18 15:32:57.171091|2017-02-18 15:32:57.171091
NCT00486161|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-12|||March 2004||2004-03-01|June 2007|2007-06-01|December 2006|Actual|2006-12-01|||||Observational|aeroghre||Acylated Ghrelin Response to Acute Exercise in Obesity|Evaluation of Acylated Ghrelin Response Following Acute Exercise in Relation to Adiposity, Metabolic Homeostasis and Growth Hormone Secretion|Completed||N/A|16|Actual|Istituto Auxologico Italiano|||||f||||t||||||||||2017-02-18 15:32:57.281853|2017-02-18 15:32:57.281853
NCT00486148|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2015-03-17|||February 2006||2006-02-01|March 2015|2015-03-01|June 2013|Actual|2013-06-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS)|Randomized, Double Blind Study to Evaluate the Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS) in Healthy, Full Term Infants|Completed||N/A|360|Actual|Heinz Italia SpA||3|||f||||f||||||||||2017-02-18 15:32:57.37354|2017-02-18 15:32:57.37354
NCT00486135|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2013-01-31|||June 2007||2007-06-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL147 Administered Orally Daily to Subjects With Solid Tumors or Lymphoma|Completed||Phase 1|118|Actual|Sanofi||3|||f||||||||||||||2017-02-18 15:32:57.492517|2017-02-18 15:32:57.492517
NCT00486122|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||September 2003||2003-09-01|June 2007|2007-06-01|June 2004|Actual|2004-06-01|||||Interventional|||Evaluation of Continuous Symptom Treatment of ADHD|Evaluation of Continuous Symptom Treatment of ADHD: A Placebo-Controlled Double-Blind Assessment of Morning-Dosed or Evening-Dosed Strattera|Completed||Phase 4|282|Actual|Eli Lilly and Company||3|||||||||||||||||2017-02-18 15:32:57.598118|2017-02-18 15:32:57.598118
NCT00486109|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2008-03-10|||October 2006||2006-10-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|||||Interventional|||A Prospective, Randomized, Parallel Crossover Study Demonstrating Subject Wearability and Usability of the I-Port Injection Port|A Study Assessing an Injection Port for Administration of Insulin|Completed||N/A|74|Actual|Patton Medical Devices||4|||f||||f||||||||||2017-02-18 15:32:57.695833|2017-02-18 15:32:57.695833
NCT00486096|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2012-03-14|||February 2007||2007-02-01|June 2007|2007-06-01|August 2007|Actual|2007-08-01|||||Observational|||Femoral Arterial Cannulation|Femoral Arterial Cannulation in Infants Following Complicated Sternal Re-entry|Terminated||N/A|1|Actual|Children's Healthcare of Atlanta|||1|sufficient data collected.|f||||f||||||||||2017-02-18 15:32:57.797168|2017-02-18 15:32:57.797168
NCT00486083|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||December 2003||2003-12-01|June 2007|2007-06-01|October 2004|Actual|2004-10-01|||||Interventional|||Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD|A Randomized, Double-Blind Comparison, Safety and Efficacy Trial of Atomoxetine Hydrochloride and Methylphenidate Hydrochloride in Pediatric Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|330|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:32:57.871889|2017-02-18 15:32:57.871889
NCT00486070|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2012-03-14|||December 2006||2006-12-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Observational|||Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection|Proposal for Retrospective Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection|Terminated||N/A|40||Children's Healthcare of Atlanta|||1|conclusions drawn, manuscript written|f||||f||||||||||2017-02-18 15:32:57.96814|2017-02-18 15:32:57.96814
NCT00486057|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2011-11-18|||August 2004||2004-08-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||Daclizumab Experience in Pediatric Heart Transplant|A Retrospective Review of Daclizumab Experience in Pediatric Heart Transplant|Terminated||N/A|30|Actual|Children's Healthcare of Atlanta|||1|sufficient data collected for conclusion of retrospective study|f||||f||||||||||2017-02-18 15:32:58.049508|2017-02-18 15:32:58.049508
NCT00486044|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2015-10-01|2012-11-16||February 2005||2005-02-01|March 2014|2014-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|ESPRIT||Evaluating Simvastatin's Potential Role in Therapy|Effect of Statins on Pathobiology of Alzheimer's Disease|Completed||Phase 2|103|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 15:32:58.141878|2017-02-18 15:32:58.141878
NCT00486031|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2009-12-21|||October 2006||2006-10-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study|A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis|Completed||Phase 3|500|Anticipated|Valeant Pharmaceuticals International, Inc.||1|||f||||f||||||||||2017-02-18 15:32:58.725624|2017-02-18 15:32:58.725624
NCT00486018|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2016-11-25|2010-08-16||July 2007||2007-07-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|BRAVO||A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)|A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection Compared With Sham in Subjects With Macular Edema Secondary to Branch Retinal Vein Occlusion|Completed||Phase 3|397|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 15:32:59.033988|2017-02-18 15:32:59.033988
NCT00486005|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||February 2003||2003-02-01|June 2007|2007-06-01|October 2003|Actual|2003-10-01|||||Interventional|||Weight Gain Management in Patients With Schizophrenia|Weight Gain Management in Patients With Schizophrenia During Treatment With Olanzapine in Association With Nizatidine|Completed||Phase 4|74|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:33:00.032378|2017-02-18 15:33:00.032378
NCT00351455|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2010-12-02|||May 2006||2006-05-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Watchful Waiting of Incisional Hernias|Watchful Waiting of Incisional Hernias: A Prospective Trial|Completed||N/A|50|Anticipated|Baylor College of Medicine|||||f||||f||||||||||2017-02-18 16:24:34.108259|2017-02-18 16:24:34.108259
NCT00485992|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2011-11-18|||August 2006||2006-08-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Observational|||Chlorhexidine Swabs Effectiveness in Reducing Blood Stream Infections|Effectiveness of Utilizing Chlorhexidine Swabs for Accessing Lines and Results Impact on Catheter Related Blood Stream Infections in the Cardiac Intensive Care Unit|Terminated||N/A|352|Actual|Children's Healthcare of Atlanta|||1|sufficient data has been collected for significant conclusion|f||||t||||||||||2017-02-18 15:33:00.119283|2017-02-18 15:33:00.119283
NCT00485979|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2011-06-27|||June 2007||2007-06-01|June 2011|2011-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|SATIN||Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients|A Randomized, Open-label, Multi-center Study of Larotaxel at 90mg/m2 or Docetaxel Every 3 Weeks, Alone or in Combination With Trastuzumab According to Her2neu Status, Administered After a Combination of Anthracycline and Cyclophosphamide as Pre-operative Therapy in Patients With High Risk Localized Breast Cancer.|Completed||Phase 2|330|Actual|Sanofi||4|||f||||||||||||||2017-02-18 15:33:00.211844|2017-02-18 15:33:00.211844
NCT00485966|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2008-11-03|||June 2007||2007-06-01|November 2008|2008-11-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia|A Phase 2, Multi-Center, Open Label Study Evaluating Clinical Efficacy, Safety, and Pharmacodynamic Effects of Quarfloxacin (CX-3543) in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)|Withdrawn||Phase 2|25|Anticipated|Cylene Pharmaceuticals||1||This study was withdrawn prior to patient enrollment|f||||f||||||||||2017-02-18 15:33:00.332559|2017-02-18 15:33:00.332559
NCT00485953|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2014-07-08|2014-06-02||September 2007||2007-09-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|REBBeCA II||Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy|The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women With Breast Cancer Following Initiation of Aromatase Inhibitor Therapy|Completed||Phase 4|109|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:33:00.434443|2017-02-18 15:33:00.434443
NCT00485940|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2013-09-24|||March 1998||1998-03-01|September 2013|2013-09-01|May 1999|Actual|1999-05-01|May 1999|Actual|1999-05-01||Interventional|||Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic Constipation|A Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of R108512 Tablets in Subjects With Chronic Constipation|Completed||Phase 3|641|Actual|Movetis||3|||f||||f||||||||||2017-02-18 15:33:01.045803|2017-02-18 15:33:01.045803
NCT00485927|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||April 2007||2007-04-01|June 2007|2007-06-01||||||||Interventional|||The Effects of Stress on the Clinical Performance of Residents in Simulated Trauma Scenarios|The Effects of Stress on the Clinical Performance of Residents in Simulated Trauma Scenarios|Unknown status|Recruiting|N/A|20|Anticipated|University of Toronto|||||f||||f||||||||||2017-02-18 15:33:01.158536|2017-02-18 15:33:01.158536
NCT00485914|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2016-10-03|||October 2003||2003-10-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Work Interventions to Improve Employment Outcomes for Persons With Rheumatoid Arthritis and Osteoarthritis|Worksite Vocational Rehabilitation Intervention to Improve Employment Outcomes for Persons With Arthritis?|Completed||N/A|89|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-02-18 15:33:01.251616|2017-02-18 15:33:01.251616
NCT00485901|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||July 2004||2004-07-01|June 2007|2007-06-01|January 2005|Actual|2005-01-01|||||Interventional|||Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia|A Double-Blind Randomized Comparison of the Efficacy and Safety of Intramuscular Olanzapine and Intramuscular Haloperidol in Acutely Agitated Patients With Schizophrenia|Completed||Phase 3|50|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:33:01.360272|2017-02-18 15:33:01.360272
NCT00485888|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2013-10-29|||October 2008||2008-10-01|October 2008|2008-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Flushing in Social Anxiety Disorder on Cipralex|Changes in the Vasodilatory Response to Methyl-nicotinate in Response to S-citalopram Treatment in Social Phobia Patients|Completed||Phase 2|71|Actual|START Clinic for Mood and Anxiety Disorders||2|||f||||f||||||||||2017-02-18 15:33:01.46432|2017-02-18 15:33:01.46432
NCT00485875|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||June 2004||2004-06-01|June 2007|2007-06-01|January 2005|Actual|2005-01-01|||||Interventional|||Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD|An Open-Label, Multicenter, Pilot Study of the Safety and Efficacy of Transitioning From a Stimulant Medication to Atomoxetine in Pediatric and Adolescent Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 4|62|Actual|Eli Lilly and Company||1|||||||||||||||||2017-02-18 15:33:01.582752|2017-02-18 15:33:01.582752
NCT00485862|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||June 2003||2003-06-01|June 2007|2007-06-01|January 2005|Actual|2005-01-01|||||Interventional|||Combination Therapy in Patients With Depression|Noradrenergic Augmentation of SSRI Therapy in Patients With Depression Unresponsive or Incompletely Responsive to SSRI Monotherapy|Completed||Phase 4|214|Actual|Eli Lilly and Company||2|||||||||||||||||2017-02-18 15:33:01.685935|2017-02-18 15:33:01.685935
NCT00485849|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||February 2004||2004-02-01|June 2007|2007-06-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD|An Open Label Pilot Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behavior Problems in Children and Adolescents With Autistic Spectrum Disorders|Completed||Phase 4|12|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 15:33:01.784196|2017-02-18 15:33:01.784196
NCT00485836|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2011-02-01|2010-08-16||July 2007||2007-07-01|February 2011|2011-02-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|CRUISE||A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)|A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection Compared With Sham in Subjects With Macular Edema Secondary to Central Retinal Vein Occlusion|Completed||Phase 3|392|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 15:33:01.885501|2017-02-18 15:33:01.885501
NCT00485823|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||December 2002||2002-12-01|June 2007|2007-06-01|September 2003|Actual|2003-09-01|||||Interventional|||Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia|The Assessment of a Weight Management Program for Treatment-Emergent Weight Gain in Patients With Schizophrenia, Schizophreniform Disorder, and Schizoaffective Disorder During Olanzapine Therapy|Completed||Phase 4|48|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:33:02.955191|2017-02-18 15:33:02.955191
NCT00485810|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||June 2004||2004-06-01|June 2007|2007-06-01|November 2004|Actual|2004-11-01|||||Interventional|||Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia|A Study Examining Clinical Therapeutic Dose of Rapid Acting Intra-Muscular Olanzapine in Japanese Agitated Patients With Schizophrenia|Completed||Phase 1/Phase 2|31|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:33:03.037601|2017-02-18 15:33:03.037601
NCT00485797|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2011-02-17|||October 2007||2007-10-01|May 2007|2007-05-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Effects of Ritalin on Postural Stability of Hyper Active Children|Effects of Methylphenidate on Postural Stability of Children Suffer From Attention Deficit Hyperactivity Disorder (ADHD) Under Single and Dual Task Conditions.|Completed||N/A|30|Actual|Soroka University Medical Center||1|||f||||t||||||||||2017-02-18 15:33:03.130372|2017-02-18 15:33:03.130372
NCT00485784|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2014-08-27|||July 2007||2007-07-01|August 2014|2014-08-01||||July 2012|Actual|2012-07-01||Interventional|||Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications|Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications|Completed||N/A|280|Actual|Assistance Publique Hopitaux De Marseille||4|||f||||||||||||||2017-02-18 15:33:03.219108|2017-02-18 15:33:03.219108
NCT00485771|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||November 2003||2003-11-01|June 2007|2007-06-01|January 2005|Actual|2005-01-01|||||Interventional|||Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression|Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression|Completed||Phase 4|403|Actual|Eli Lilly and Company||2|||||||||||||||||2017-02-18 15:33:03.440908|2017-02-18 15:33:03.440908
NCT00485758|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2015-10-09|2009-08-04||July 2007||2007-07-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)|A Multicenter, Randomized, Double-Blind, Placebo Controlled 36 Week Study to Evaluate the Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant in Patients With Type 2 Diabetes|Completed||Phase 3|796|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:33:03.54024|2017-02-18 15:33:03.54024
NCT00485745|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2014-11-25|||January 2002||2002-01-01|November 2014|2014-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Repeat Sternotomy for Pediatrics|Repeat Sternotomy for Pediatric Cardiac Surgery: Indications, Risks and Results|Completed||N/A|1281|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 15:33:04.078479|2017-02-18 15:33:04.078479
NCT00485732|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2016-11-03|2009-11-12||June 2007||2007-06-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years|A Phase IIIb, Double-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV-16/18 L1 VLP AS04 Vaccine, Administered Intramuscularly in Healthy Female Subjects Aged 15 - 25 Years|Completed||Phase 3|225|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:33:04.155689|2017-02-18 15:33:04.155689
NCT00485719|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2013-05-29|||June 2007||2007-06-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL765 Administered Orally Daily to Subjects With Solid Tumors|Completed||Phase 1|83|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:33:04.807262|2017-02-18 15:33:04.807262
NCT00485706|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2010-01-15|||June 2007||2007-06-01|June 2007|2007-06-01||||||||Interventional|||Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients|Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients|Completed||N/A|||Universitaire Ziekenhuizen Leuven|||||f||||f||||||||||2017-02-18 15:33:04.921135|2017-02-18 15:33:04.921135
NCT00485693|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2013-07-03|2011-11-23||June 2007||2007-06-01|July 2013|2013-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|TKA||Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty|A Phase 2 Multicenter, Randomized, Double-blind, Parallel-group, Active-control, Dose-ranging Study to Evaluate the Safety, Efficacy, and Comparative Systemic Bioavailability of a Single Administration of SKY0402 Via Local Infiltration for Prolonged Postoperative Analgesia in Subjects Undergoing Total Knee Arthroplasty.|Completed||Phase 2|138|Actual|Pacira Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 15:33:05.022757|2017-02-18 15:33:05.022757
NCT00485680|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||December 2003||2003-12-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Olanzapine Versus Comparator in the Treatment of Bipolar Disorder|Olanzapine Versus Lithium Carbonate in the Treatment of Bipolar Disorder, Manic or Mixed Episodes|Completed||Phase 3|140|Actual|Eli Lilly and Company||2|||||||||||||||||2017-02-18 15:33:05.540954|2017-02-18 15:33:05.540954
NCT00485667|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2010-09-07||2010-08-30|June 2007||2007-06-01|September 2010|2010-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|TQT||Phase 1 Thorough QT Study in Young Healthy Volunteers|Evaluation of the Effects of Therapeutic and Supra-therapeutic Single Doses of SKY0402 Given as Subcutaneous Injection on the QT/QTc Interval in Young Healthy Volunteers. A Prospective, Randomized, Placebo- and Positive-controlled, Double Blind, Single-centre, Crossover Phase 1 Study.|Completed||Phase 1|48|Actual|Pacira Pharmaceuticals, Inc||5|||f||||f||||||||||2017-02-18 15:33:05.635839|2017-02-18 15:33:05.635839
NCT00485654|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2012-03-14|||January 1990||1990-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|January 2005|Actual|2005-01-01||Observational|||Racial Distribution of Heterotaxy Syndrome|Racial Distribution of Heterotaxy Syndrome and Effects on Clinical Outcomes Protocol|Terminated||N/A|65|Actual|Children's Healthcare of Atlanta|||1|study was terminated because study conclusions varied.|f||||f||||||||||2017-02-18 15:33:05.758159|2017-02-18 15:33:05.758159
NCT00485589|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2013-06-28||2013-06-28|June 2007||2007-06-01|June 2013|2013-06-01||||April 2011|Actual|2011-04-01||Interventional|FILM||A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)|A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab in Combination With Methotrexate (MTX) Compared to MTX Alone in Methotrexate- Naive Patients With Active Rheumatoid Arthritis|Terminated||Phase 3|613|Actual|Genentech, Inc.||2||"Based on analysis of results and consideration of available treatments, the overall benefit to~   risk profile of ocrelizumab was not favorable in RA."|f||||||||||||||2017-02-18 15:33:05.859011|2017-02-18 15:33:05.859011
NCT00485576|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2009-01-14|||September 2007||2007-09-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma|A Randomized, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Mild Allergic Asthma.|Completed||Phase 2|21|Actual|Alexion Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:33:05.990541|2017-02-18 15:33:05.990541
NCT00485563|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2012-03-05||2010-08-20|June 2007||2007-06-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Interventional|||A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma|A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma|Terminated||Phase 2|12|Actual|Endocyte||1||Changes in treatment paradigm resulted in a lower than expected rate of accrual.|f||||f||||||||||2017-02-18 15:33:06.083383|2017-02-18 15:33:06.083383
NCT00485550|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||January 2004||2004-01-01|June 2007|2007-06-01|March 2005|Actual|2005-03-01|||||Interventional|||Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy|A Randomized, Double-Blind Comparison of Atomoxetine Hydrochloride Augmented With Either Extended-Release Methylphenidate Hydrochloride (Concerta-TM) or Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Not Responded to Stimulant Mono Therapy|Completed||Phase 3|14|Actual|Eli Lilly and Company||3|||||||||||||||||2017-02-18 15:33:06.207605|2017-02-18 15:33:06.207605
NCT00485537|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||September 2005||2005-09-01|June 2007|2007-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles|Pregnancy Outcomes With a Gonadotropin-Releasing Hormone (GnRH) Antagonist (Cetrorelix) Protocol Versus GnRH-Agonist Protocol in Ovarian Stimulation for ICSI Cycles-a Prospective Study|Completed||N/A|2005|Actual|Clinic and Research Center in Human Reproduction Roger Abdelmassih||2|||f||||t||||||||||2017-02-18 15:33:06.305318|2017-02-18 15:33:06.305318
NCT00485524|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2012-03-14|||January 2002||2002-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Comparison of NIRS and Serum Lactate to Predict Poor Post-operative Outcomes|A Retrospective Evaluation of the Utility of NIRS Compared With Serum Lactate Levels in Predicting Poor Post-Operative Outcome After Repair of Complex Congenital Heart Disease|Completed||N/A|12|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 15:33:06.402518|2017-02-18 15:33:06.402518
NCT00485511|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2010-02-11|||June 2007||2007-06-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Trial of Hydroxyurea in Spinal Muscular Atrophy|A Randomized, Double-Blind, Placebo-Controlled Trial of Hydroxyurea in Spinal Muscular Atrophy|Completed||Phase 2/Phase 3|||Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||||||||||||2017-02-18 15:33:06.492922|2017-02-18 15:33:06.492922
NCT00485498|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||April 2003||2003-04-01|June 2007|2007-06-01|December 2003|Actual|2003-12-01|||||Interventional|||Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics|Managing Acute Schizophrenia, a Double Blind Comparison Between Two Atypical Antipsychotics - Olanzapine and Risperidone|Completed||Phase 4|122|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:33:06.5894|2017-02-18 15:33:06.5894
NCT00485485|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2012-08-01|2011-07-28||January 2007||2007-01-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer|Phase II Study of Imatinib Mesylate and Docetaxel in Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer|Completed||Phase 2|7|Actual|M.D. Anderson Cancer Center|Study was closed to enrollment early due to low enrollment. Study enrolled 7 participants over approximately 2 years with a planned enrollment of up to 58.|1|||f||||f||||||||||2017-02-18 15:33:06.678439|2017-02-18 15:33:06.678439
NCT00485472|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2014-09-19|2009-08-12||March 2007||2007-03-01|September 2011|2011-09-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Osteoarthritis of the Knee|Terminated||Phase 2|194|Actual|UCB Pharma||2||"Based on the outcome of the planned first interim analysis, it was decided not to continue the~   trial. No safety concerns were identified."|f||||f||||||||||2017-02-18 15:33:06.946182|2017-02-18 15:33:06.946182
NCT00485459|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||February 2004||2004-02-01|June 2007|2007-06-01|November 2004|Actual|2004-11-01|||||Interventional|||Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD|Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|106|Actual|Eli Lilly and Company||2|||||||||||||||||2017-02-18 15:33:07.646737|2017-02-18 15:33:07.646737
NCT00485446|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-12|2007-06-12||||||June 2007|2007-06-01||||||||Observational|||Thrombophilia and Thyroid Autoimmunity in Implantation Failure and Recurrent Miscarriage||Completed||N/A|||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||||||||||||2017-02-18 15:33:07.732137|2017-02-18 15:33:07.732137
NCT00485433|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2013-07-03|2011-11-23||June 2007||2007-06-01|July 2013|2013-07-01|August 2008|Actual|2008-08-01|December 2007|Actual|2007-12-01||Interventional|||Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair|A Phase 2 Multicenter, Randomized, Double-blind, Parallel-group, Active-control, Dose-ranging Study to Evaluate the Safety and Efficacy of a Single Administration of SKY0402 for Prolonged Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair.|Completed||Phase 2|98|Actual|Pacira Pharmaceuticals, Inc||4|||f||||f||||||||||2017-02-18 15:33:07.805073|2017-02-18 15:33:07.805073
NCT00485420|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2012-04-18|||September 2002||2002-09-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||eCare for Moods: An Internet-based Management Program|Using the Internet to Provide Disease Management and Improve Compliance Among Bipolar and Depressed Patients|Completed||N/A|404|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 15:33:08.327105|2017-02-18 15:33:08.327105
NCT00485407|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-10-31|||July 2003||2003-07-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine|Guiding Dose Increases In Patients Incompletely Responsive to Usual Doses of Atomoxetine by Determining Plasma Atomoxetine Concentrations: a Randomized, Double-Blind Study|Completed||Phase 3|377|Actual|Eli Lilly and Company||2|||||||||||||||||2017-02-18 15:33:08.438892|2017-02-18 15:33:08.438892
NCT00485394|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2008-03-31|||June 2007||2007-06-01|March 2008|2008-03-01||||February 2010|Anticipated|2010-02-01||Interventional|OMEGA||The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)|A Randomized, Double-Masked, Dose-Ranging, Multi-Center, Phase II Study Comparing the Safety and Efficacy of OT-551 With Placebo to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration|Unknown status|Active, not recruiting|Phase 2|198|Anticipated|Othera Pharmaceuticals||3|||f||||t||||||||||2017-02-18 15:33:08.524346|2017-02-18 15:33:08.524346
NCT00485368|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-12|||January 2004||2004-01-01|June 2007|2007-06-01|September 2006|Actual|2006-09-01|||||Interventional|||Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome|The Effect of an Angiotensin Converting Enzyme Inhibitor on Aortic Wall Properties in Patients With Marfan Syndrome.|Completed||Phase 3|17|Actual|Bayside Health||2|||f||||f||||||||||2017-02-18 15:33:08.639399|2017-02-18 15:33:08.639399
NCT00485355|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2014-02-18|||June 2007||2007-06-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy|A Prospective Randomized Trial Comparing Conventional vs. Robotic Assisted Laparoscopic Hysterectomy|Completed||N/A|27|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 15:33:08.807137|2017-02-18 15:33:08.807137
NCT00485342|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2012-01-06|||April 2006||2006-04-01|January 2012|2012-01-01|March 2013|Anticipated|2013-03-01|March 2013|Anticipated|2013-03-01||Interventional|RIBAJUSTE||RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin|Multicentric, Controlled and Randomised Open Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin Using Pharmacologic Measures of Ribavirin Exposition During Combination Peginterferon Alfa-2 and Ribavirin Treatment in Naive Patients With Chronic Hepatitis C of Genotype 1 on a First Combination Therapy|Unknown status|Recruiting|Phase 3|236|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 15:33:08.929352|2017-02-18 15:33:08.929352
NCT00485329|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-10|2010-05-24|||July 2007||2007-07-01|May 2010|2010-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|ENZ-DER-002-IL||Assessment of the Safety and Efficacy of DERMASTREAM™ - ENZYSTREAM™ System for the Treatment of Chronic Venous Ulcers|A Phase I/II Randomized, Double Blind, Placebo-Controlled Dose- Escalating Study, to Assess The Safety and Efficacy of Enzystream™ Debriding Solution (Papain) Applied by Dermastream™ Device for the Treatment of Lower Extremity Chronic Venous Ulcers|Completed||Phase 1/Phase 2|48|Actual|EnzySurge||3|||f||||t||||||||||2017-02-18 15:33:09.030476|2017-02-18 15:33:09.030476
NCT00485316|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2009-03-30|||September 1993||1993-09-01|March 2009|2009-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Laparoscopic Assisted Versus Open Resection for Colorectal Carcinoma|Prospective Randomized Trial Comparing Laparoscopic Assisted and Open Resection for Colonic and Rectal Carcinoma|Completed||Phase 3|||Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 15:33:09.146331|2017-02-18 15:33:09.146331
NCT00485303|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2013-06-25|2013-04-23||June 2007||2007-06-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy|A Phase II Open Label Study of CB7630 (Abiraterone Acetate) and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy|Completed||Phase 2|58|Actual|Cougar Biotechnology, Inc.||1|||f||||f||||||||||2017-02-18 15:33:09.249241|2017-02-18 15:33:09.249241
NCT00485290|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2008-08-06|||June 2007||2007-06-01|November 2007|2007-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|VIPE||Effect of Meal on Portal and Esophagus Variceal Pressure|Effect of Meal on Portal and Esophagus Variceal Pressure|Terminated||N/A|0|Actual|Hvidovre University Hospital||1||No eligible patients were found, the study stopped without including any patients|f||||f||||||||||2017-02-18 15:33:09.890347|2017-02-18 15:33:09.890347
NCT00485277|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2012-01-25|||June 2007||2007-06-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer|A Phase I Trial of a Fixed Dose of MVA-BN-HER2 Following 1st- or 2nd-Line Chemotherapy for HER-2-Positive Metastatic Breast Cancer|Completed||Phase 1|9|Actual|Bavarian Nordic, Inc.||1|||f||||t||||||||||2017-02-18 15:33:09.981341|2017-02-18 15:33:09.981341
NCT00485264|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2016-10-13|2014-02-28||September 2007||2007-09-01|October 2016|2016-10-01||||June 2013|Actual|2013-06-01||Interventional||All Treated Population: All patients exposed to raltegravir (at any dose); Cohorts IV and V were not included in this interim analysis.|Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents|A Phase I/II, Multicenter, Open-Label, Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Raltegravir (Isentress, MK-0518) in HIV-1 Infected Children and Adolescents|Active, not recruiting||Phase 1/Phase 2|153|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-02-18 15:33:10.1105|2017-02-18 15:33:10.1105
NCT00485251|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2009-11-23|||February 2007||2007-02-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Prospective Randomized Trial of Hand-assisted Laparoscopic Right Hemicolectomy vs Total Laparoscopic Right Hemicolectomy||Completed||Phase 4|60|Anticipated|Pamela Youde Nethersole Eastern Hospital||2|||f||||t||||||||||2017-02-18 15:33:13.350104|2017-02-18 15:33:13.350104
NCT00485238|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2008-05-13|||February 2007||2007-02-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|||||Interventional|Iridoplasty||ALPI vs Medical Therapy Effects on Optic Nerve Structure & Function|EFFECTS OF IMMEDIATE ARGON LASER PERIPHERAL IRIDOPLASTY Versus CONVENTIONAL SYSTEMIC MEDICAL THERAPY ON OPTIC NERVE HEAD STRUCTURE AND FUNCTION OF ACUTE PRIMARY ANGLE CLOSURE EYES|Unknown status|Recruiting|Phase 4|60|Anticipated|National University Hospital, Singapore||2|||f||||f||||||||||2017-02-18 15:33:13.460337|2017-02-18 15:33:13.460337
NCT00485225|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2012-02-21||2012-02-21|June 2007||2007-06-01|December 2011|2011-12-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain|An Open-Label, Two-Stage, Phase II Study to Explore the Titration Schedule for Transitioning Opioid-Experienced Patients With Non-Malignant Moderate to Severe Chronic Pain From Current Opioid Therapy to EN3270.|Completed||Phase 2|77|Actual|Durect||4|||f||||f||||||||||2017-02-18 15:33:13.566257|2017-02-18 15:33:13.566257
NCT00023556|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-07|2016-07-11|||September 2001||2001-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Genetic Architecture of Heart Disease in Rural Brazil||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:09:13.776944|2017-02-18 18:09:13.776944
NCT00485212|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||January 2007||2007-01-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Compression Bandage in Local Infiltration Analgesia Afte Total Knee Arthroplasty|The Effect of a Compression Bandage in Local Infiltration Analgesia After Total Knee Arthroplasty|Completed||Phase 4|48|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 15:33:13.654966|2017-02-18 15:33:13.654966
NCT00485199|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||January 2005||2005-01-01|June 2007|2007-06-01|December 2006|Actual|2006-12-01|||||Interventional|RDMH||Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole|Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole|Completed||N/A|231|Actual|Peking University||2|||f||||t||||||||||2017-02-18 15:33:13.74138|2017-02-18 15:33:13.74138
NCT00485186|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2013-09-04|||June 2007||2007-06-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Gene Polymorphisms Influencing Steroid Synthesis and Action|Investigation of Gene Polymorphisms Influencing Steroid Synthesis and Action in Patients With Deficient Steroid Biosynthesis and Disorders of Sex Development|Withdrawn||N/A|0|Actual|University of Schleswig-Holstein|||2||f||||f||||||||||2017-02-18 15:33:13.845743|2017-02-18 15:33:13.845743
NCT00485173|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2013-02-14|2012-12-14||June 2007||2007-06-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|ACDF||INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial|A Pivotal Clinical Investigation of INFUSE® Bone Graft With a PEEK Interbody Spacer and an Anterior Cervical Plate in Patients With Cervical Degenerative Disc Disease at a Single Level.|Completed||N/A|224|Actual|Medtronic Spinal and Biologics||1|||f||||t||||||||||2017-02-18 15:33:13.946849|2017-02-18 15:33:13.946849
NCT00485160|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2011-07-20|||February 2002||2002-02-01|June 2007|2007-06-01|September 2006|Actual|2006-09-01|||||Interventional|||Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA|Comparison of Intravenous Ibuprofen vs. Continuous Indomethacin in the Treatment of Patent Ductus Arteriosus|Completed||Phase 3|70|Anticipated|Shaare Zedek Medical Center||1|||f||||f||||||||||2017-02-18 15:33:19.297715|2017-02-18 15:33:19.297715
NCT00485147|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2012-06-28|||March 2006||2006-03-01|April 2010|2010-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Starter-GPS||Locomotion and Global Positioning System in Arterial Disease|Study of Human Locomotion With Global Positioning System. Application to Patients With Peripheral Arterial Disease|Completed||N/A|140|Actual|University Hospital, Angers||1|||f||||f||||||||||2017-02-18 15:33:19.408753|2017-02-18 15:33:19.408753
NCT00485134|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2010-12-01|||May 2007||2007-05-01|December 2010|2010-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection||Completed||Phase 1/Phase 2|||Walter Reed Army Institute of Research (WRAIR)|||||||||f||||||||||2017-02-18 15:33:19.505386|2017-02-18 15:33:19.505386
NCT00485121|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2010-11-24|||April 2007||2007-04-01|May 2008|2008-05-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis|Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis|Completed||N/A|50|Anticipated|Canadian Cardiovascular Research Network||1|||f||||f||||||||||2017-02-18 15:33:19.589884|2017-02-18 15:33:19.589884
NCT00485108|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-09|2015-09-21|||January 2007||2007-01-01|September 2015|2015-09-01|December 2014|Actual|2014-12-01|June 2009|Actual|2009-06-01||Interventional|||Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty|Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty (SLT): A Randomized, Masked, Placebo Controlled Study|Completed||N/A|120|Actual|Queen's University||3|||f||||f||||||||||2017-02-18 15:33:19.680972|2017-02-18 15:33:19.680972
NCT00485095|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2011-06-30|||January 2007||2007-01-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The Effect of Plant Sterol Supplement on Blood Cholesterol|A Single Centre, Randomized Crossover Double-Blind Placebo-Controlled Study to Measure the Effect of Plant Sterol Supplement on Blood Cholesterol|Completed||Phase 4|41|Actual|Oslo University Hospital||1|||f||||||||||||||2017-02-18 15:33:19.811974|2017-02-18 15:33:19.811974
NCT00485082|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-09|2017-01-24|||June 5, 2007||2007-06-05|August 25, 2009|2009-08-25||||March 21, 2008|Actual|2008-03-21||Observational|||Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner|Disclosure of a Cystic Fibrosis Diagnosis to a Dating Partner|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:33:19.887493|2017-02-18 15:33:19.887493
NCT00485069|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2010-11-18|2010-09-20||June 2007||2007-06-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study|Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients With Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -|Completed||Phase 4|123|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:33:19.971938|2017-02-18 15:33:19.971938
NCT00485056|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2016-08-08|||April 2008||2008-04-01|August 2009|2009-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|PICCOLA||Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study)|Pioglitazone on Cardiac Function and Large Arteries (PICCOLA)|Completed||Phase 4|24|Actual|Imperial College London||2|||f||||t||||||||No||2017-02-18 15:33:21.151842|2017-02-18 15:33:21.151842
NCT00485043|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||January 2006||2006-01-01|June 2007|2007-06-01|April 2006|Actual|2006-04-01|||||Interventional|||Effects of Modified T'ai Chi on Symptoms in Older Adults With Osteoarthritis|Effects of Modified T’ai Chi Exercise on Physical Function, Pain, and Stiffness in Older Adults With Lower Extremity Osteoarthritis|Completed||Phase 1|30|Actual|University of Kansas||1|||f||||f||||||||||2017-02-18 15:33:21.26262|2017-02-18 15:33:21.26262
NCT00485030|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2012-08-06|||March 2007||2007-03-01|August 2012|2012-08-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|DES-ISR||Diffuse Type In-Stent Restenosis After Drug-Eluting Stent|Comparison Between Drug-Eluting Stents for the Treatment of the Diffuse Type In-Stent Restenosis After Drug-Eluting Stents Implantation: Sirolimus-Eluting vs. Paclitaxel-Eluting Stents|Completed||Phase 4|60|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 15:33:21.34895|2017-02-18 15:33:21.34895
NCT00485017|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2008-06-30|||August 2007||2007-08-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy and Safety of THR-4109 in Obese Subjects|A Phase II Randomized, Double-Blind, Double-Dummy, Parallel Group, Placebo Controlled Study of THR-4109 in Obese Subjects|Completed||Phase 2|220|Anticipated|Theracos||4|||f||||f||||||||||2017-02-18 15:33:21.48894|2017-02-18 15:33:21.48894
NCT00485004|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2012-08-06|||March 2007||2007-03-01|August 2012|2012-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|FOCUS||Focal In-stent Restenosis After Drug-Eluting Stent|FOcal Type In-stent Restenosis After Drug-Eluting Stent Implantation Treated by CUtting Balloon Angioplasty Versus Sirolimus-Eluting Stent|Completed||Phase 4|100|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 15:33:21.605181|2017-02-18 15:33:21.605181
NCT00484991|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2008-04-11||||||April 2008|2008-04-01||||||||Expanded Access|||Sapropterin Expanded Access Program|Sapropterin Expanded Access Program|Approved for marketing||N/A|||BioMarin Pharmaceutical|||||||||||||||||||2017-02-18 15:33:21.741069|2017-02-18 15:33:21.741069
NCT00484978|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||February 2007||2007-02-01|June 2007|2007-06-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis|A Single Center Prospective Phase II Study: Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis|Unknown status|Recruiting|Phase 2|35|Anticipated|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 15:33:21.979292|2017-02-18 15:33:21.979292
NCT00484965|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-06-11|||July 2007||2007-07-01|June 2007|2007-06-01|January 2009|Anticipated|2009-01-01|||||Interventional|TROY||Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis|Erythrocyte-Mediated Drug Delivery for the Prevention of Restenosis After Coronary Artery Stent Implantation:TROY-Study|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|University of Rome Tor Vergata||2|||f||||t||||||||||2017-02-18 15:33:22.067175|2017-02-18 15:33:22.067175
NCT00484952|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2007-07-31|||September 2007||2007-09-01|June 2007|2007-06-01|September 2009|Anticipated|2009-09-01|||||Observational|||Surveillance of Hospitalizations Due to Rotavirus Infections Among Children From Israel|Multicenter Study for Surveillance of Hospitalizations Due to Rotavirus-Associated Diarrhea and Estimation of the Economic Burden of Rotavirus Hospitalizations|Unknown status|Not yet recruiting|N/A|2500|Anticipated|Hillel Yaffe Medical Center|||||f||||f||||||||||2017-02-18 15:33:22.160862|2017-02-18 15:33:22.160862
NCT00484939|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2015-01-07|2014-03-07||July 2007||2007-07-01|January 2015|2015-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Intent-to-treat population: All participants randomized into the study.|A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer|A Randomised, Open-label Phase III Study to Assess Efficacy and Safety of Bevacizumab in Combination With Capecitabine as First-line Treatment for Elderly Patients With Metastatic Colorectal Cancer|Completed||Phase 3|280|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:33:22.26508|2017-02-18 15:33:22.26508
NCT00484926|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-11|2012-08-09|||March 2007||2007-03-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|REAL-LATE||Association of Clopidogrel Therapy and Stent Thrombosis|Correlation of Clopidogrel Therapy Discontinuation in REAL-world Patients Treated With Drug-Eluting Stent Implantation and Late Coronary Arterial Thrombotic Events|Completed||Phase 4|2000|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 15:33:23.213458|2017-02-18 15:33:23.213458
NCT00484913|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2007-06-08|||September 2003||2003-09-01|June 2007|2007-06-01|December 2003|Actual|2003-12-01|||||Interventional|||Effects of Abdominal Hot Compresses on Indocyanine Green Elimination in Healthy Subjects|Effects of Abdominal Hot Compresses on Indocyanine Green Elimination – a Randomized Cross Over Study in Healthy Subjects|Completed||Phase 1|14|Actual|University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 15:33:23.336376|2017-02-18 15:33:23.336376
NCT00484900|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2008-03-25|||May 2006||2006-05-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria|Open Randomized Multi-Centre Trial, Comparing Artesunate-Sulfamethoxypyrazine-Pyrimethamine FDC Over 3 Days, Artesunate-Sulfamethoxypyrazine-Pyrimethamine FDC Over 48 Hours and Artemether-Lumefantrine FDC Over 3 Days on P. Falciparum Malaria|Completed||Phase 3|1390|Actual|Dafra Pharma||3|||f||||f||||||||||2017-02-18 15:33:23.43318|2017-02-18 15:33:23.43318
NCT00484887|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2016-08-05|||April 2007||2007-04-01|May 2016|2016-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Characterization of Explanted Hernia Meshes From Human Subjects: A Multi-Center, Prospective Study|Characterization of Explanted Hernia Meshes From Human Subjects: A Multi-Center, Prospective Study|Terminated||N/A|272|Actual|University of Missouri-Columbia|||1|PI left institution|f||||f||||||Samples Without DNA|"~     Explanted mesh from surgical procedures.~   "|No||2017-02-18 15:33:23.531073|2017-02-18 15:33:23.531073
NCT00484874|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2011-04-21|||June 2007||2007-06-01|April 2011|2011-04-01||||January 2014|Anticipated|2014-01-01||Interventional|||Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma|A Phase I/II Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:33:23.622296|2017-02-18 15:33:23.622296
NCT00484861|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2017-02-15|||June 7, 2007||2007-06-07|February 14, 2017|2017-02-14|February 14, 2017||2017-02-14|||||Observational|||Effect of Diet on Vascular Disease in Pre-Menopausal Women|The Effect of Diet on Vascular Disease: A Study of African American and Caucasian Women|Completed||N/A|47|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:33:23.733712|2017-02-18 15:33:23.733712
NCT00484848|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2009-01-23|||September 2004||2004-09-01|January 2009|2009-01-01|March 2005|Actual|2005-03-01|December 2004|Actual|2004-12-01||Interventional|||Functional Evaluation of Two Types of Totally Implanted Venous Ports|Functional Evaluation of Conventional Venous Access Port (Celsite®) Versus Venous Access Port With Tangential Outlet (Vortex®) : a Prospective Randomized Pilot Study|Completed||N/A|200|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-02-18 15:33:23.8292|2017-02-18 15:33:23.8292
NCT00484835|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2007-08-07|||September 2007||2007-09-01|June 2007|2007-06-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Are Sutures Required in Total Abdominal Hysterectomy? A Randomised Control Trial|Randomised Control Trial Comparing Hysterectomy Using Electrocoagulation Forceps With the Traditional Clamp & Suture Technique of Richardson Abdominal Hysterectomy|Unknown status|Not yet recruiting|Phase 1|60|Anticipated|Southern Health||2|||f||||t||||||||||2017-02-18 15:33:23.917666|2017-02-18 15:33:23.917666
NCT00484640|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2007-06-08|||June 2007||2007-06-01|June 2007|2007-06-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing|Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing|Unknown status|Not yet recruiting|N/A|260|Anticipated|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||t||||||||||2017-02-18 15:33:25.716126|2017-02-18 15:33:25.716126
NCT00484822|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2010-02-03|||February 2007||2007-02-01|February 2010|2010-02-01|May 2009|Anticipated|2009-05-01|||||Interventional|BERTA||Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)|Multicentric, Randomized, Controlled, Double-blind Clinical Trial to Assess Perioperative Bridging Therapy With Sodium Bemiparin vs Calcium Unfractionated Heparin in Invasive Procedures, Outpatient Surgery and Laparoscopy Surgery in Patients Receiving Long-term Oral Anticoagulant Therapy|Terminated||Phase 3|206|Actual|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2||The study has been halted prematurely due to a low recruitment.|f||||t||||||||||2017-02-18 15:33:24.008926|2017-02-18 15:33:24.008926
NCT00484809|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2007-12-11|||March 2004||2004-03-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Observational|||Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children|A Post-Marketing Surveillance Looking at Safety of Enbrel (Etanercept) in Adults With Active Rheumatoid Arthritis (RA) and Children With Juvenile Rheumatoid Arthritis (JRA).|Completed||Phase 4|100||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:33:24.132895|2017-02-18 15:33:24.132895
NCT00484796|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2012-10-26|||October 2006||2006-10-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Observational|TRISEP||Trigeminus-evoked Somatosensory Potentials in Patients Undergoing Carotid Surgery|Comparison of Trigeminus-evoked Somatosensory Potentials (TRI-SEP) and Medianus-evoked Somatosensory Potentials (MED-SEP) in Patients Undergoing Carotid Surgery|Completed||N/A|120|Actual|Klinikum St. Georg gGmbH|||1||f||||f||||||||||2017-02-18 15:33:24.207807|2017-02-18 15:33:24.207807
NCT00484783|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2014-12-12|||August 2006||2006-08-01|December 2014|2014-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|NOTES||Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery|Prospective Evaluation of the Intraoperative Use of Translumenal Flexible Endoscopes During Combined Flexible and Laparoscopic Foregut and Urologic Surgery|Completed||N/A|11|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-02-18 15:33:24.302771|2017-02-18 15:33:24.302771
NCT00484770|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2014-08-20|||February 2003||2003-02-01|June 2007|2007-06-01|August 2005|Actual|2005-08-01|||||Interventional|STARBRITE||STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure|Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: Brain Natriuretic Peptide Levels Versus the Clinical Congestion Score|Completed||Phase 2|135|Actual|Duke University||2|||f||||t||||||||||2017-02-18 15:33:24.408585|2017-02-18 15:33:24.408585
NCT00484757|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2009-04-02|||June 2007||2007-06-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|NARKOREX||Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition||Unknown status|Active, not recruiting|N/A|||Zentrum für Integrative Psychiatrie|||||f||||f||||||||||2017-02-18 15:33:24.508637|2017-02-18 15:33:24.508637
NCT00484744|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2013-04-24|||June 2007||2007-06-01|April 2013|2013-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Acetaminophen Versus Ibuprofen for the Control of Immediate and Delayed Pain Following Orthodontic Separator Placement|Acetaminophen Versus Ibuprofen for the Control of Immediate and Delayed Pain Following Orthodontic Separator Placement|Completed||Phase 4|35|Actual|University of Missouri, Kansas City||3|||f||||f||||||||||2017-02-18 15:33:24.599536|2017-02-18 15:33:24.599536
NCT00484731|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2011-06-21|||July 2006||2006-07-01|May 2008|2008-05-01|June 2012|Anticipated|2012-06-01|December 2011|Anticipated|2011-12-01||Interventional|||Effect of Intraoperative Infiltration With Bupivacain on the Development of Chronic Pain After Inguinal Hernia Repair|Investigating the Effect of Intra-operative Infiltration With Local Anaesthesia on the Development of Chronic Postoperative Pain After Inguinal Hernia Repair. A Randomized Placebo Controlled Triple Blinded and Group Sequential Study Design|Unknown status|Recruiting|Phase 4|404|Anticipated|Luzerner Kantonsspital||2|||f||||t||||||||||2017-02-18 15:33:24.698179|2017-02-18 15:33:24.698179
NCT00484718|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2012-01-26|||February 2008||2008-02-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.|Measures Of Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee: A Randomized, Single-Blind Washout, Double-Blind Treatment, Double Dummy Cross-Over Pilot Trial Using Placebo, Oxycodone And Celecoxib (A9011030)|Terminated||N/A|6|Actual|Pfizer||3||See termination reason in detailed description.|f||||f||||||||||2017-02-18 15:33:24.79755|2017-02-18 15:33:24.79755
NCT00484705|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2009-11-09|||October 2005||2005-10-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|PCOSNTS||Polycystic Ovary Syndrome (PCOS) - Effect Of Physical Exercise And Electroacupuncture|Polycystic Ovary Syndrome (PCOS) - The Female Metabolic Syndrome Genes And Processes In The Aetiology And Pathogenesis Of PCOS And Identification Of New Treatment Strategies|Completed||N/A|84|Actual|Göteborg University||3|||f||||t||||||||||2017-02-18 15:33:24.908419|2017-02-18 15:33:24.908419
NCT00484692|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2007-06-08|||July 2005||2005-07-01|June 2007|2007-06-01|January 2007|Actual|2007-01-01|||||Interventional|||Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation|Randomized Clinical Trial Comparing a Medication, i.e., Sustained-Release Bupropion (Zyban®) With an Ultrashort (1 1/2 d) Manual-Based Psychotherapeutic Intervention, Psychodynamic Model Training®|Completed||Phase 4|779|Actual|Medical University Innsbruck||2|||f||||t||||||||||2017-02-18 15:33:25.011217|2017-02-18 15:33:25.011217
NCT00484679|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2014-05-20|2013-02-27||May 2007||2007-05-01|May 2014|2014-05-01|March 2011|Actual|2011-03-01|June 2009|Actual|2009-06-01||Interventional||15 completed the study and were used for analysis.|Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata|Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata|Completed||Phase 2|18|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-02-18 15:33:25.221109|2017-02-18 15:33:25.221109
NCT00484666|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2013-02-05|||May 2008||2008-05-01|February 2013|2013-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|Topo Txt||A Phase II Study of Weekly Docetaxel and Topotecan in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer|A Phase II Study of Weekly Docetaxel and Topotecan in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|46|Actual|Carilion Clinic||1|||f||||t||||||||||2017-02-18 15:33:25.494525|2017-02-18 15:33:25.494525
NCT00484653|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2014-08-27|||July 2007||2007-07-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman|Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman|Completed||N/A|1000|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-02-18 15:33:25.620801|2017-02-18 15:33:25.620801
NCT00484627|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2007-06-08|||August 2001||2001-08-01|June 2007|2007-06-01|October 2003|Actual|2003-10-01|||||Interventional|||Effects of Creatine and Resistance Exercise Training in People With HIV Infection|Ergogenic Effects of Creatine Supplementation in HIV Infection|Completed||Phase 2|43|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||f||||||||||2017-02-18 15:33:25.813936|2017-02-18 15:33:25.813936
NCT00484614|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2009-09-02|||September 2006||2006-09-01|December 2008|2008-12-01|March 2009|Anticipated|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer|Prospective Multicenter Study of the Role of Positron Emission Mammography (PEM) in Pre-Surgical Planning for Breast Cancer|Unknown status|Active, not recruiting|Phase 4|472|Actual|Naviscan PET Systems||2|||f||||t||||||||||2017-02-18 15:33:25.904736|2017-02-18 15:33:25.904736
NCT00484601|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2008-12-16|||October 2004||2004-10-01|December 2008|2008-12-01|September 2010|Anticipated|2010-09-01|||||Interventional|||Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma|Phase II Study of Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma|Terminated||Phase 2|35|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||f||||||||||2017-02-18 15:33:26.019046|2017-02-18 15:33:26.019046
NCT00484588|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2007-06-08|||May 2005||2005-05-01|June 2007|2007-06-01|December 2006||2006-12-01|||||Observational|||A Multi-Center Observational Surveillance Study of VAP Causing Bacteria|A Multi-Center Observational Surveillance of VAP Causing Bacteria Study|Completed||Phase 4|500||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:33:26.273501|2017-02-18 15:33:26.273501
NCT00484575|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2010-05-19|||June 2007||2007-06-01|June 2007|2007-06-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting|Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting|Completed||Phase 1/Phase 2|100|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 15:33:26.347532|2017-02-18 15:33:26.347532
NCT00484562|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2016-10-03|||May 2006||2006-05-01|October 2016|2016-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Prospective Study Comparing Different Modalities of Oxygen Delivery During Assessment of Functional Exercise Capacity|A Randomized, Multi-arm Repeated Measures Prospective Study Comparing Different Modalities of Portable Oxygen Delivery During Assessment of Functional Exercise Capacity|Completed||N/A|39|Actual|University of Missouri-Columbia||4|||f||||f||||||||No||2017-02-18 15:33:26.47642|2017-02-18 15:33:26.47642
NCT00484549|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2009-12-18|||March 2007||2007-03-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|FIND||Fabry : National Initiative of Screening|National, Multicenter, Prospective Study of Screening of Fabry Disease in a Population of Men Over 28 Days Old and Less Than 55 Years, Hospitalized for an Ischemic Stroke.|Completed||N/A|889|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:33:26.583362|2017-02-18 15:33:26.583362
NCT00484536|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2011-09-02||2011-01-20|May 2007||2007-05-01|March 2011|2011-03-01|July 2010|Actual|2010-07-01|November 2009|Actual|2009-11-01||Interventional|||Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323|Double-blind, Placebo-controlled, Randomized, Parallel-group Phase II Study in Subjects With Relapsing Forms of Multiple Sclerosis (MS) to Evaluate the Safety, Tolerability, and Effects of CDP323.|Terminated||Phase 2|232|Actual|UCB Pharma||3||The study was discontinued due to unfavorable interim analysis|f||||t||||||||||2017-02-18 15:33:26.68998|2017-02-18 15:33:26.68998
NCT00484523|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2014-08-27|||July 2007||2007-07-01|August 2014|2014-08-01||||January 2010|Actual|2010-01-01||Interventional|||Constitution of a Standardized Neural Imaging Database in Healthy Subjects|Constitution of a Standardized Neural Imaging Database in Healthy Subjects|Completed||Early Phase 1|60|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||||||||||||2017-02-18 15:33:26.864786|2017-02-18 15:33:26.864786
NCT00484510|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2013-03-04|||April 2007||2007-04-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||High Dose Ascorbic Acid Treatment of CMT1A|"A Randomized, Placebo-controlled, Double Masked 120 Subject Futility Design Clinical Trial of Ascorbic Acid Treatment of Charcot Marie Tooth Disease Type 1A."|Completed||Phase 2/Phase 3|110|Actual|Wayne State University||2|||f||||t||||||||||2017-02-18 15:33:26.952601|2017-02-18 15:33:26.952601
NCT00484497|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2007-06-08|||September 2006||2006-09-01|June 2007|2007-06-01||||||||Interventional|Cyclamax||Evaluation of a Food Supplement on Sleep Quality|A Randomized, Double-Blind, Placebo-Controlled Trial for the Evaluation of a Food Supplement on Sleep Quality in Primary Insomnia Patient|Completed||N/A|105|Actual|Persee Medica||2|||f||||f||||||||||2017-02-18 15:33:27.074062|2017-02-18 15:33:27.074062
NCT00484484|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2011-05-03|||May 2007||2007-05-01|June 2007|2007-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|KETADOL||Ketamine Associated With Opioids in Refractory Cancer Pain Treatment|Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment|Completed||Phase 3|100|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:33:27.17046|2017-02-18 15:33:27.17046
NCT00484471|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2012-11-27|||October 2007||2007-10-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2011|Actual|2011-11-01||Interventional|ABLE||ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness|A Double Blind, Randomized, Placebo Controlled Trial of Aripiprazole Plus Valproate in the Short-Term and Long-Term Treatment of Bipolar Disorder|Completed||Phase 4|127|Actual|Korea Otsuka International Asia Arab||2|||f||||f||||||||||2017-02-18 15:33:27.282293|2017-02-18 15:33:27.282293
NCT00484458|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2011-10-03|||January 2007||2007-01-01|October 2011|2011-10-01|November 2014|Anticipated|2014-11-01|November 2013|Anticipated|2013-11-01||Interventional|||Wallis Stabilization System for Low Back Pain|A Prospective, Multi-center, Randomized, Active-Controlled Study of the Wallis System for the Treatment of Mild to Moderate Degenerative Disc Disease of the Lumbar Spine|Unknown status|Active, not recruiting|Phase 3|340|Anticipated|Zimmer Spine||2|||f||||t||||||||||2017-02-18 15:33:27.411452|2017-02-18 15:33:27.411452
NCT00484445|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-08|2013-09-04|||January 2003||2003-01-01|September 2013|2013-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|||Transfer to Another Health Care Facility Following Critical Illness|Transfer to Another Health Care Facility Following Critical Illness|Completed||N/A|548|Actual|University of Chicago|||1||f||||f||||||||||2017-02-18 15:33:27.520589|2017-02-18 15:33:27.520589
NCT00484250|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2007-06-08|||September 2005||2005-09-01|June 2007|2007-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Study of Metronidazole and Doxycycline to Treat Oral Lichen Planus and to Compare Their Efficacy With Each Other||Completed||Phase 2|20|Actual|Mashhad University of Medical Sciences|||||f||||t||||||||||2017-02-18 15:33:38.115263|2017-02-18 15:33:38.115263
NCT00484432|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2015-10-08|||November 2008||2008-11-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer|NGR012: A Phase II Study of NGR-hTNF Administered in Combination With Doxorubicin Every 3 Weeks in Patients Affected by Advanced or Metastatic Ovarian Cancer|Active, not recruiting||Phase 2|37|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 15:33:27.612995|2017-02-18 15:33:27.612995
NCT00484419|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2016-08-23|2009-04-29||May 2007||2007-05-01|August 2016|2016-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin|Effects of Colesevelam HCl, Avandia® (Rosiglitazone Maleate), or JanuviaTM (Sitagliptin) on Glycemic Parameters and Lipid Profiles in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Monotherapy|Completed||Phase 3|169|Actual|Daiichi Sankyo Inc.||3|||f||||||||||||||2017-02-18 15:33:27.733994|2017-02-18 15:33:27.733994
NCT00484406|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2007-06-07|||February 2005||2005-02-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Observational|||MMP Polymorphisms and Acute Coronary Syndromes|Matrix Metalloproteinase Genetic Polymorphisms and Outcome of Non-ST Elevated Acute Coronary Syndromes|Completed||N/A|||University of Trieste|||||f||||f||||||||||2017-02-18 15:33:28.857047|2017-02-18 15:33:28.857047
NCT00484393|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2015-05-22|2015-03-05||November 2007||2007-11-01|May 2015|2015-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Tetracaine Compared to Placebo for Reducing Pain With Palivizumab - A Pilot Study|Tetracaine (Ametop®) Compared to Placebo for Reducing Pain Associated With Intramuscular Injection of Palivizumab (Synagis®) - A Pilot Study|Completed||Phase 4|7|Actual|Fraser Health||2|||f||||f||||||||||2017-02-18 15:33:28.948879|2017-02-18 15:33:28.948879
NCT00484380|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2011-03-15|||August 2007||2007-08-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Scanner in the Coronary Evaluation|Contribution of the Scanner in the Coronary Evaluation Before Valvular Replacement|Completed||N/A|66|Actual|French Cardiology Society||1|||f||||t||||||||||2017-02-18 15:33:29.453643|2017-02-18 15:33:29.453643
NCT00484367|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2011-08-25|||July 1999||1999-07-01|November 2008|2008-11-01|August 2012|Anticipated|2012-08-01|August 2012|Anticipated|2012-08-01||Interventional|||A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers|Family and Group Therapies for Adolescent Alcohol Abuse|Unknown status|Active, not recruiting|Phase 2/Phase 3|120|Actual|The Morton Center, Inc.||2|||f||||f||||||||||2017-02-18 15:33:29.546115|2017-02-18 15:33:29.546115
NCT00484354|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2013-12-16|||May 2006||2006-05-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Interventional|||Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery|Reduction of Acute Renal Failure Associated With Cardiovascular Surgery: A Randomized Study Comparing Sodium Bicarbonate to Normal Saline|Completed||N/A|123|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 15:33:29.659956|2017-02-18 15:33:29.659956
NCT00484341|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2015-10-08|||October 2010||2010-10-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.|NGR016: Randomized Phase II Study Evaluating Two Doses of NGR-hTNF Administered Either as Single Agent or in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma (STS)|Active, not recruiting||Phase 2|96|Anticipated|MolMed S.p.A.||4|||f||||f||||||||||2017-02-18 15:33:29.762088|2017-02-18 15:33:29.762088
NCT00484328|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2011-07-19|||July 2007||2007-07-01|July 2011|2011-07-01|February 2012|Anticipated|2012-02-01|December 2011|Anticipated|2011-12-01||Interventional|Ribados||Ribavirin, Its Dosing Regime|Ribavirin, Its Dosing Regime|Unknown status|Recruiting|Phase 4|20|Anticipated|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 15:33:29.878534|2017-02-18 15:33:29.878534
NCT00484315|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2014-04-24|2011-04-28||July 2007||2007-07-01|April 2014|2014-04-01|October 2013|Actual|2013-10-01|September 2009|Actual|2009-09-01||Interventional|PERSEUS WH||TAXUS PERSEUS Workhorse|A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions|Completed||Phase 3|1264|Actual|Boston Scientific Corporation|The comparator control for PERSEUS Workhorse study was chosen based on commercially available stent (TAXUS Express) at the time of study enrollment. Thus, the comparator group does not represent the most recently available paclitaxel-eluting stent.|2|||f||||t||||||||||2017-02-18 15:33:30.110969|2017-02-18 15:33:30.110969
NCT00484302|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2011-01-24|||September 2007||2007-09-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|CapOpus||Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis|Cannabis and Psychosis. Randomized Clinical Trial: Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis|Completed||N/A|103|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-02-18 15:33:32.531486|2017-02-18 15:33:32.531486
NCT00484289|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2013-06-18|2012-05-25||December 2006||2006-12-01|June 2013|2013-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis|A Phase III, Multi-center, Open-label, Uncontrolled, Long-term Study to Evaluate the Safety of Abatacept (BMS-188667) in Japanese Subjects With Rheumatoid Arthritis Having Completed Clinical Studies IM101-071, IM101-034, and Also Special DMARD Failures|Completed||Phase 3|217|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 15:33:32.669141|2017-02-18 15:33:32.669141
NCT00484276|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2015-10-26|||May 2007||2007-05-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|September 2010|Actual|2010-09-01||Interventional|NGR010||Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma|NGR010: A Phase II Study of NGR-hTNF Administered as Single Agent Every 3 Weeks or Weekly in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma Previously Treated With no More Than One Systemic Therapeutic Regimen|Completed||Phase 2|57|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 15:33:37.886677|2017-02-18 15:33:37.886677
NCT00484263|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2011-06-22|||December 2007||2007-12-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis|The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non-cystic Fibrosis Bronchiectasis.|Completed||Phase 3|40|Actual|The Alfred||1|||f||||t||||||||||2017-02-18 15:33:38.008919|2017-02-18 15:33:38.008919
NCT00484237|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2007-12-03|||April 2007||2007-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis|A Randomized, Double-Blind, Multicenter, Parallel Study Evaluating the Safety and Efficacy of Etanercept 10 mg Twice Weekly and 25 mg Once Weekly in Japanese Subjects With Active Rheumatoid Arthritis|Completed||Phase 3|80|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:33:38.204581|2017-02-18 15:33:38.204581
NCT00484224|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2007-06-07||||||May 2007|2007-05-01||||||||Observational|||Audiological Disturbances in Vitiligo||Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:33:38.313926|2017-02-18 15:33:38.313926
NCT00484211|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2014-05-29|||December 2006||2006-12-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|November 2011|Actual|2011-11-01||Interventional|||Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)|NGR008: A Phase II Study of NGR-hTNF Administered as Single Agent Every 3 Weeks or Weekly in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC) Previously Treated With no More Than One Systemic Therapeutic Regimen|Completed||Phase 2|40|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 15:33:38.390619|2017-02-18 15:33:38.390619
NCT00484198|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2010-02-01||2010-02-01|April 2007||2007-04-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Randomized, Double-Blind Active Comparator-Controlled Study of Rivoglitazone in Type 2 Diabetes Mellitus|A Randomized, Double-blind, Placebo and Active Comparator-Controlled, Parallel-Group Study of the Efficacy and Safety of Rivoglitazone as Monotherapy Treatment of Type 2 Diabetes Mellitus|Completed||Phase 3|1820|Anticipated|Daiichi Sankyo Inc.||4|||f||||t||||||||||2017-02-18 15:33:38.530664|2017-02-18 15:33:38.530664
NCT00484185|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2013-05-15|2013-05-15||August 2007||2007-08-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B|Post Marketing Surveillance To Observe Safety And Efficacy Of BeneFIX In Patients With Hemophilia B|Completed||N/A|183|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:33:39.06387|2017-02-18 15:33:39.06387
NCT00484172|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2007-06-07|||June 2007||2007-06-01|May 2007|2007-05-01|June 2008|Anticipated|2008-06-01|||||Observational|||Genomic Search for Childhood Obesity Genes-A Pilot Study|Genomic Search for Childhood Obesity Genes-A Pilot Study|Unknown status|Not yet recruiting|N/A|500|Anticipated|Children's Mercy Hospital Kansas City|||||f||||f||||||||||2017-02-18 15:33:39.494277|2017-02-18 15:33:39.494277
NCT00484159|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2011-07-25|2011-06-22||February 2007||2007-02-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy and Cost: Benefit Ratio of 0, 1, and 2 Medial Branch Blocks for Lumbar Facet Joint Radiofrequency Denervation|Prospective Randomized Study Comparing 0, 1, and 2 Diagnostic Lumbar Medial Branch (Facet Joint) Blocks Before Radiofrequency Denervation in Patients With Chronic Low Back Pain: A Cost: Benefit Analysis.|Completed||N/A|151|Actual|Johns Hopkins University|This study only followed patients for 3 months, so we don't know if proceeding straight to radiofrequency is associated with the same duration of pain relief as when diagnostic facet blocks are performed.|3|||f||||t||||||||||2017-02-18 15:33:39.578501|2017-02-18 15:33:39.578501
NCT00484146|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2017-02-07|||June 2006||2006-06-01|February 2017|2017-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|LAVISS_01||Alterations of Immunologic Mediators During Severe Sepsis|Alterations of Immunologic Mediators During Severe Sepsis|Terminated||N/A|20|Actual|Klinikum St. Georg gGmbH|||1|anticipated number of patients could not be reached|f||||f||||||Samples Without DNA|"~     Whole Blood Samples, Plasma Samples~   "|||2017-02-18 15:33:40.262629|2017-02-18 15:33:40.262629
NCT00484133|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2008-01-17|||June 2007||2007-06-01|January 2008|2008-01-01||||December 2008|Anticipated|2008-12-01||Interventional|||"Microcirculation Guided Therapy Versus Standard Treatment of Severe Sepsis"||Unknown status|Recruiting|Phase 4|80|Anticipated|Onze Lieve Vrouwe Gasthuis||1|||f||||f||||||||||2017-02-18 15:33:40.362988|2017-02-18 15:33:40.362988
NCT00484120|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2011-08-01|||June 2007||2007-06-01|August 2011|2011-08-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Proof-of Concept Study of Topical 3%-Diclofenac-Nano-Emulsion Cream for Knee OA Pain|Proof-of Concept Study to Evaluate the Safety and Analgesic Efficacy of Topical 3%-Diclofenac-Nano-Emulsion Cream Versus Placebo for Knee Osteoarthritis|Completed||Phase 2|123|Actual|Pharmos||2|||f||||t||||||||||2017-02-18 15:33:40.476237|2017-02-18 15:33:40.476237
NCT00484107|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2007-12-20|||September 2005||2005-09-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Observational|||Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women|A Postmarketing Surveillance Study Evaluating the Tolerability and Safety of PREMARIN VAGINAL CREAM in Indian Postmenopausal Women|Completed||Phase 4|200||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:33:40.597038|2017-02-18 15:33:40.597038
NCT00484094|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2016-11-21|2016-06-02||July 2011||2011-07-01|November 2016|2016-11-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational||Safety Analysis Set: Participants who received Rapamune at least once and were evaluated on its related safety endpoints at least once.|Study Investigating Rapamune For Post-Marketing Surveillance|Post Marketing Surveillance Study To Observe Safety And Efficacy Of Rapamune|Completed||N/A|209|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:33:40.686075|2017-02-18 15:33:40.686075
NCT00484081|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2007-06-07|||June 2005||2005-06-01|June 2007|2007-06-01|October 2006|Actual|2006-10-01|||||Interventional|||Microdissection Testicular Sperm Extraction (MicroTESE) and IVF-ICSI Outcome in Non-Obstructive Azoospermia (NOA)|Prospective Evaluation of Microdissection Testicular Sperm Extraction in Non-Obstructive Azoospermic Men and Their IVF-ICSI Related Outcomes at ART Treatment.|Completed||N/A|53|Actual|Clinic and Research Center in Human Reproduction Roger Abdelmassih||1|||f||||t||||||||||2017-02-18 15:33:41.062766|2017-02-18 15:33:41.062766
NCT00484068|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2007-06-07|||January 2003||2003-01-01|June 2007|2007-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Chicken-Diet vs. Enalapril to Reduce Albuminuria|Effect of Chicken-Based Diet Versus Enalapril on Albuminuria in Patients With Type 2 Diabetes and Microalbuminuria: a One-Year Randomized Controlled Study|Completed||N/A|28|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||||2017-02-18 15:33:41.15429|2017-02-18 15:33:41.15429
NCT00484055|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2016-10-12|||January 2007||2007-01-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|LOGIX||Local Collagen-Gentamicin and Extra Fixation of the Sternum for Prevention of Sternal Wound Infection in Cardiac Surgery|Local Application of Collagen-Gentamicin in Addition to Fixation of the Sternum With Extra Sternal Wires for Prevention of Sternal Wound Infection in Cardiac Surgery|Completed||N/A|1358|Actual|Region Örebro County||1|||f||||f||||||||||2017-02-18 15:33:41.258592|2017-02-18 15:33:41.258592
NCT00484029|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2010-08-18||2010-08-17|February 2007||2007-02-01|August 2010|2010-08-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain|A Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Nasal CO2 in the Symptomatic Treatment of Temporomandibular Disorders|Completed||Phase 2|100|Actual|Capnia, Inc.||2|||f||||f||||||||||2017-02-18 15:33:41.456173|2017-02-18 15:33:41.456173
NCT00484016|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2013-08-09|||February 2006||2006-02-01|August 2013|2013-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC|Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected Non Small Cell Lung Cancer|Completed||N/A|45|Actual|Washington University School of Medicine|||1||f||||f||||||||||2017-02-18 15:33:41.569784|2017-02-18 15:33:41.569784
NCT00484003|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2008-02-13|||October 2004||2004-10-01|February 2008|2008-02-01|December 2004|Actual|2004-12-01|||||Interventional|||A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis|A 3-Month Open Label, National, Quality of Life , and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years ) With Atopic Dermatitis|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 15:33:41.654147|2017-02-18 15:33:41.654147
NCT00483990|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2010-07-14|||March 2007||2007-03-01|July 2010|2010-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers|A Phase I, Double-blind, Stratified, Parallel Group, Placeob-controlled Study of the Safety, Tolerability and Pharmacokinetics of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times Daily for 21 Days in Healthy Male Volunteers|Completed||Phase 1|16||Plethora Solutions Ltd|||||f||||f||||||||||2017-02-18 15:33:41.759487|2017-02-18 15:33:41.759487
NCT00483977|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2011-04-22||2009-04-06|June 2007||2007-06-01|April 2011|2011-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee|A 2 Week, Randomized, Double Blind, Placebo And Positive Controlled, Parallel Group, Multicentre Study To Assess The Efficacy And Tolerability Of PF-00592379 In Patients With Moderate To Severe Pain Due To Osteoarthritis|Terminated||Phase 2|113|Actual|Pfizer||3||Met criteria for study futility at interim analysis|f||||t||||||||||2017-02-18 15:33:41.858974|2017-02-18 15:33:41.858974
NCT00483964|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2007-10-09|||September 2005||2005-09-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia|A Randomized, Controlled ,Clinical Trial of a Herbal Combination of Aqueous Extracts of Bacopa Monnieri and Nardostachys Jatamansi in the Treatment of Schizophrenia, Compared to Standard Anti-Psychotic Drugs|Completed||Phase 2|200|Actual|Q.Mundewadi Ayurvedic Research & Charitable Trust||2|||f||||f||||||||||2017-02-18 15:33:41.987001|2017-02-18 15:33:41.987001
NCT00483951|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2017-01-24|||June 1, 2007||2007-06-01|September 27, 2016|2016-09-27||||||||Observational|||Cardiovascular Disease Screening|Suburban/NHLBI Cardiovascular Disease Screening Protocol|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:33:42.093975|2017-02-18 15:33:42.093975
NCT00483938|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2016-11-25|2016-11-25||June 2007||2007-06-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|IMPROVE|The safety (SAF) population included participants who received at least one dose of study medication and had at least one post-baseline safety assessment.|The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE)|The Individualized Management With Pegasys and Ribavirin Offering Viral Eradication (IMPROVE) Trial|Completed||Phase 3|236|Actual|Hoffmann-La Roche||7|||f||||||||||||||2017-02-18 15:33:42.213516|2017-02-18 15:33:42.213516
NCT00483925|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2007-06-07|||September 2005||2005-09-01|June 2007|2007-06-01||||||||Observational|||Cardiovascular Risk Factors and LCH in Adults|CARDIOVASCULAR RISK FACTORS IN ADULT PATIENTS WITH MULTISYSTEM LANGERHANS-CELL HISTIOCYTOSIS: EVIDENCE OF GLUCOSE METABOLISM ABNORMALITIES|Unknown status|Recruiting|N/A|||Laikon General District Hospital, Athens|||||f||||f||||||||||2017-02-18 15:33:43.575466|2017-02-18 15:33:43.575466
NCT00483912|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-07|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|pancreatitis||Albumindialysis in Acute Pancreatitis|Molecular Adsorbent Recirculating System (MARS) in Severe Acute Pancreatitis|Suspended||N/A|||University of Tampere|||||f||||f||||||||||2017-02-18 15:33:43.671733|2017-02-18 15:33:43.671733
NCT00483899|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2012-05-31|||October 2005||2005-10-01|February 2011|2011-02-01||||||||Interventional|||Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects|Double-blind, Placebo-controlled, 3-way Crossover Study to Investigate the Effect of 7-days Repeat Once Daily Inhaled Doses of GW870086X Administered Via DISKHALER on Airway Responsiveness to AMP in Mild Steroid-naive Male Asthmatics|Completed||Phase 1|20|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:33:43.759583|2017-02-18 15:33:43.759583
NCT00483886|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2013-04-10|||April 1998||1998-04-01|April 2013|2013-04-01|May 1999|Actual|1999-05-01|May 1999|Actual|1999-05-01||Interventional|||Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation|A Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Prucalopride (R108512) Tablets in Subjects With Chronic Constipation.|Completed||Phase 3|620|Actual|Movetis||3|||f||||f||||||||||2017-02-18 15:33:43.843655|2017-02-18 15:33:43.843655
NCT00483873|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2009-01-28|||August 2007||2007-08-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|||||Observational|CARES||Cardiac Arrest Recovery EEG Study|Phase IIB Study of Novel Quantitative Neurodiagnostic Technology in the Early Period After Cardiac Arrest|Unknown status|Recruiting|N/A|100|Anticipated|Infinite Biomedical Technologies|||1||f||||t||||||||||2017-02-18 15:33:43.943717|2017-02-18 15:33:43.943717
NCT00483860|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2012-10-25|||June 2007||2007-06-01|May 2012|2012-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function|A Phase I Study of Oral Topotecan in Subjects With Cancer and Impaired Renal Function|Completed||Phase 1|54|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:33:44.04746|2017-02-18 15:33:44.04746
NCT00483847|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2015-04-09|||September 2006||2006-09-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|TYGRIS - ROW||TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World|TYGRIS - ROW: TYSABRI® Global Observational Program in Safety - Rest of World|Completed||N/A|4296|Actual|Biogen|||1||f||||f||||||||||2017-02-18 15:33:44.159075|2017-02-18 15:33:44.159075
NCT00483834|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2012-03-19|||December 2006||2006-12-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer|A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer|Completed||Phase 2|50|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 15:33:44.252173|2017-02-18 15:33:44.252173
NCT00483821|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2012-09-07|||May 2004||2004-05-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC|A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC|Completed||N/A|165|Actual|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-02-18 15:33:44.361966|2017-02-18 15:33:44.361966
NCT00483808|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2013-11-01|||June 2007||2007-06-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Renal Denervation in Patients With Refractory Hypertension|Renal Denervation in Patients With Refractory Hypertension|Completed||Phase 1|73|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-02-18 15:33:44.462507|2017-02-18 15:33:44.462507
NCT00482820|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2013-02-06|||July 2007||2007-07-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Clinical Research Studying a Method of Intervention for Children Diagnosed With Anxiety Disorder: Attentional Bias Intervention||Completed||N/A|80|Actual|Rabin Medical Center||2|||f||||||||||||||2017-02-18 15:33:44.560305|2017-02-18 15:33:44.560305
NCT00482807|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2011-02-22|||August 2004||2004-08-01|February 2011|2011-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Intensity-Modulated Radiation Therapy, Docetaxel, and Hormone Therapy in Treating Patients With High-Risk Locally Advanced Prostate Cancer With Pelvic Lymph Node Metastasis|Phase I Study Evaluating Extended Field Intensity Modulated Radiation Therapy and Docetaxel in Patients With Prostate Cancer Associated With Pelvic Node Metastasis|Completed||Phase 1|9|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 15:33:44.646089|2017-02-18 15:33:44.646089
NCT00482794|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2016-11-30|||June 2006||2006-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Observational|APS||Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome|Genetics of Antiphospholipid Antibody Syndrome|Recruiting||N/A|2800|Anticipated|Duke University|||3||f||||f||||||Samples With DNA|"~     Serum, plasma, and DNA samples~   "|No||2017-02-18 15:33:44.744631|2017-02-18 15:33:44.744631
NCT00482781|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2007-06-04|||September 2000||2000-09-01|June 2007|2007-06-01|September 2004|Actual|2004-09-01|||||Interventional|PIA||DTaP and Apnea/Bradycardia in Preterm Infants|Prolonged Apnea and Prolonged Bradycardia Following DTaP Immunization in Preterm Infants: A Randomized Multicenter Study|Completed||N/A|191|Actual|American SIDS Institute||2|||f||||f||||||||||2017-02-18 15:33:44.855563|2017-02-18 15:33:44.855563
NCT00482768|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2011-03-15|||June 2007||2007-06-01|March 2011|2011-03-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Improving Risk Factors for Diabetes Complications in Primary Care|Improving Risk Factors for Diabetes Complications in Primary Care|Unknown status|Recruiting|N/A|2400|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 15:33:44.960959|2017-02-18 15:33:44.960959
NCT00482755|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2013-06-20|||March 2007||2007-03-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery|A Feasibility Study of Pre-Operative Sunitinib (SU11248) With Multiple Pharmacodynamic Endpoints in Patients With T1c-T3 Operable Carcinoma of the Breast|Completed||Phase 2|4|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 15:33:45.068845|2017-02-18 15:33:45.068845
NCT00482742|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-03|2013-07-06|||October 2006||2006-10-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Safety & Performance Randomized Study of the CiTop™ Guidewire for Peripheral CTO|A Feasibility, Multi Center Multinational Randomized Open Label Study, to Evaluate the Safety and Performance of the CiTop™ Guidewire for Crossing Total Occlusion in Peripheral Arteries.|Terminated||N/A|50|Actual|Ovalum||2||product development was cancelled|f||||t||||||||||2017-02-18 15:33:45.17729|2017-02-18 15:33:45.17729
NCT00482729|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-02-20|2009-12-09||June 2007||2007-06-01|February 2015|2015-02-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)|A Randomized, Double-Blind, Active-Comparator Controlled, Clinical Trial to Study the Efficacy and Safety of MK0431A for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 3|1246|Actual|Merck Sharp & Dohme Corp.|Site 079011301 was non-compliant with Good Clinical Practice (GCP). Data from the 4 patients at this site are included in the Participant Flow summary, but are excluded from all other summaries and analyses.|2|||f||||||||||||||2017-02-18 15:33:45.265597|2017-02-18 15:33:45.265597
NCT00482716|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2014-01-09|||January 2007||2007-01-01|August 2009|2009-08-01||||||||Interventional|||Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer|Randomized Controlled Study of Iron Supplementation to Support the Response to Recombinant Human Erythropoietin for the Treatment of Chemotherapy-Induced Anaemia|Unknown status|Active, not recruiting|Phase 3|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:33:46.14149|2017-02-18 15:33:46.14149
NCT00482703|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2010-11-30|2010-07-23||May 2007||2007-05-01|November 2010|2010-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia|A Randomized, Multicenter, Open-label Phase II Study of Dasatinib (BMS-354825) Administered Orally at a Dose of 50mg Twice Daily or 100mg Once Daily in Subjects With Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Imatinib|Completed||Phase 1/Phase 2|23|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 15:33:46.253077|2017-02-18 15:33:46.253077
NCT00482690|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2007-06-04|||March 2006||2006-03-01|June 2007|2007-06-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Analysis of Aldehyde Biomarkers of Exposure and Host Response||Unknown status|Active, not recruiting|N/A|||University of Nebraska|||||f||||f||||||||||2017-02-18 15:33:47.453767|2017-02-18 15:33:47.453767
NCT00483639|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2013-03-13|||November 2003||2003-11-01|March 2013|2013-03-01|January 2008|Actual|2008-01-01|March 2006|Actual|2006-03-01||Observational|||Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer|Social Anxiety and Avoidance in Head and Neck Cancer Patients|Completed||N/A|100|Actual|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-02-18 15:33:53.726591|2017-02-18 15:33:53.726591
NCT00482677|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2016-08-10|||May 2007||2007-05-01|April 2016|2016-04-01|August 2016|Actual|2016-08-01|March 2016|Actual|2016-03-01||Interventional|||Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme|A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients|Completed||Phase 3|562|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||Undecided||2017-02-18 15:33:47.548198|2017-02-18 15:33:47.548198
NCT00482664|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2010-10-27||2009-03-24|July 2007||2007-07-01|October 2010|2010-10-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.|A Phase 2a Multi-Centre, Double Blind, Placebo Controlled Cross-Over Trial To Investigate The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women Diagnosed With Female Sexual Arousal Disorder (FSAD).|Completed||Phase 2|84|Anticipated|Pfizer||4|||f||||||||||||||2017-02-18 15:33:47.693723|2017-02-18 15:33:47.693723
NCT00482651|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2012-01-20|||November 2007||2007-11-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Imaging of Vulnerable Plaques in Coronary Artery Disease by Multidetector Computed Tomography|Imaging of Vulnerable Plaques in Coronary Artery Disease by Multidetector Computed Tomography|Completed||N/A|60|Actual|University of Aarhus||1|||f||||t||||||||||2017-02-18 15:33:47.82236|2017-02-18 15:33:47.82236
NCT00483795|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2007-07-23||||||July 2007|2007-07-01||||||||Interventional|||Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 15:33:47.9261|2017-02-18 15:33:47.9261
NCT00483782|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2013-08-09|||April 2006||2006-04-01|April 2012|2012-04-01||||||||Interventional|||Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer|ICON7 - A Randomised, Two-Arm, Multi-Centre Gynaecologic Cancer InterGroup Trial of Adding Bevacizumab to Standard Chemotherapy (Carboplatin and Paclitaxel) in Patients With Epithelial Ovarian Cancer|Completed||Phase 3|1520|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:33:48.01147|2017-02-18 15:33:48.01147
NCT00483769|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2007-06-06|||February 2006||2006-02-01|February 2007|2007-02-01|January 2007|Actual|2007-01-01|||||Interventional|||One Year Glargine Treatment in CFRD Children and Adolescents|One-Year Glargine-Treatment Can Ameliorate Clinical Features in Cystic Fibrosis Children and Adolescents With Glucose Derangements|Completed||Phase 4|20|Actual|Federico II University||1|||f||||t||||||||||2017-02-18 15:33:48.251082|2017-02-18 15:33:48.251082
NCT00483756|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2013-02-08|2012-12-03||August 2007||2007-08-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|||Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients|A Phase 2 Randomized, Multicenter, Active Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Co-administration of CP-690,550 and Mycophenolate Mofetil / Mycophenolate Sodium in De Novo Renal Allograft Recipients|Completed||Phase 2|338|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 15:33:48.619186|2017-02-18 15:33:48.619186
NCT00483743|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2012-11-30|||November 2007||2007-11-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients|Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled, 6-week Study to Evaluate the Safety, Tolerability and Pharmacodynamic Activity of Inhaled TPI 1020 in COPD Patients.|Completed||Phase 2|62|Actual|Pharmaxis||3|||f||||f||||||||||2017-02-18 15:33:51.161583|2017-02-18 15:33:51.161583
NCT00483730|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2012-05-04|||December 2006||2006-12-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)|A Multi-centre, Double-blind, Placebo-controlled, Randomised, Parallel Group Clinical Trial to Evaluate Efficacy and Safety of Actovegin® in Diabetic Type 2 Patients With Symptomatic Diabetic Peripheral Polyneuropathy|Completed||Phase 3|569|Actual|Nycomed||1|||f||||t||||||||||2017-02-18 15:33:51.271118|2017-02-18 15:33:51.271118
NCT00483717|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2016-09-22|2012-08-31||July 2007||2007-07-01|September 2016|2016-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine|A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability, and Analgesic Efficacy of Ketorolac Tromethamine Administered Intranasally for the Acute Treatment of Migraine|Completed||Phase 2|173|Actual|Egalet Ltd||2|||f||||f||||||||||2017-02-18 15:33:51.356654|2017-02-18 15:33:51.356654
NCT00483704|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2015-06-23|2014-07-14||August 2008||2008-08-01|June 2015|2015-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)|A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Multiple Attacks Study to Compare the Efficacy and Safety of Oral MK-0974 With Placebo for the Acute Treatment of Migraine With or Without Aura|Completed||Phase 3|1935|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:33:52.121816|2017-02-18 15:33:52.121816
NCT00483691|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2008-09-17|||January 1989||1989-01-01|September 2008|2008-09-01|May 2010|Anticipated|2010-05-01|December 1995|Actual|1995-12-01||Interventional|FTT||Trial of Home Visitation Among Infants With Failure To Thrive|Growth and Development Longitudinal Follow-Up|Unknown status|Active, not recruiting|N/A|130|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 15:33:52.956556|2017-02-18 15:33:52.956556
NCT00483678|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2016-03-28|||April 2007||2007-04-01|March 2016|2016-03-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners|A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners|Active, not recruiting||N/A|64|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 15:33:53.054008|2017-02-18 15:33:53.054008
NCT00483665|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2008-11-17|||June 2006||2006-06-01|November 2008|2008-11-01||||||||Observational|||Vasovist Endoleak Study|Detection of Endoleak by Vasovist-Enhanced Magnetic Resonance Imaging|Completed||N/A|20|Anticipated|UMC Utrecht|||1||f||||f||||||||||2017-02-18 15:33:53.171315|2017-02-18 15:33:53.171315
NCT00483652|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2016-01-04|2010-11-22||May 2007||2007-05-01|January 2016|2016-01-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Study of Fampridine-SR Tablets in Multiple Sclerosis Patients|Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis|Completed||Phase 3|240|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-02-18 15:33:53.270573|2017-02-18 15:33:53.270573
NCT00483600|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2014-07-25|||August 2007||2007-08-01|February 2011|2011-02-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction|Studies of Fondaparinux in Patients With Renal Dysfunction: PK Study of Fondaparinux in Outpatients With Renal Dysfunction|Withdrawn||N/A|0|Actual|Duke University||1||unable to enroll|f||||f||||||||||2017-02-18 15:33:54.029965|2017-02-18 15:33:54.029965
NCT00483587|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2010-09-17|||July 2007||2007-07-01|September 2010|2010-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|HAEM||Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?|A Safety and Efficacy Study to Evaluate Intravenous Heme Arginate Infusion in Patients With an Acute Coronary Syndrome Without ST-elevation (NSTEMI)|Completed||Phase 1/Phase 2|15|Actual|University Medical Center Groningen||2|||f||||f||||||||||2017-02-18 15:33:54.134391|2017-02-18 15:33:54.134391
NCT00483574|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2016-04-12|2011-05-10||May 2007||2007-05-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers|Safety Study of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered With Other Pediatric Vaccines to Healthy Toddlers|Completed||Phase 3|1378|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:33:54.256323|2017-02-18 15:33:54.256323
NCT00483561|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2011-03-08|||January 2004||2004-01-01|March 2011|2011-03-01||||December 2014|Anticipated|2014-12-01||Interventional|||Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Study Evaluating the Efficacy of Iressa Plus Etoposide in Patients With Advanced Hormone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|21|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 15:33:55.054699|2017-02-18 15:33:55.054699
NCT00483548|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2010-02-04|2009-12-22||October 2007||2007-10-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Adjunctive Ziprasidone in the Treatment of Bipolar I Depression|A Six-Week, Double-Blind, Multicenter, Placebo Controlled Study Evaluating The Efficacy And Safety Of Flexible Doses Of Oral Ziprasidone As Add-On, Adjunctive Therapy With Lithium, Valproate Or Lamotrigine In Bipolar I Depression|Completed||Phase 3|298|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:33:55.330054|2017-02-18 15:33:55.330054
NCT00483535|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2012-05-31|||March 2007||2007-03-01|February 2011|2011-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Oral Contraceptive Interaction Study for GW273225|An Open, Repeat Dose Study to Investigate the Effect of Co-administration of the Combined Oral Contraceptive Pill (COC) and GW273225 on the Pharmacokinetics of the COC and to Investigate the Effects of the COC on the Pharmacokinetics of GW273225 in Healthy Female Subjects|Terminated||Phase 1|12|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:33:56.572941|2017-02-18 15:33:56.572941
NCT00483522|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2012-06-19|||December 2004||2004-12-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Telephone Intervention After Traumatic Brain Injury|The Effect of Scheduled Telephone Intervention on Outcomes After Traumatic Brain Injury|Completed||N/A|433|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 15:33:56.667098|2017-02-18 15:33:56.667098
NCT00483509|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2015-10-08|||December 2006||2006-12-01|October 2015|2015-10-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|NGR007||Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma|NGR007: A Phase II Study of NGR-hTNF Administered in Combination With Doxorubicin Every 3 Weeks in Patients Affected by Advanced or Metastatic Small Cell Lung Carcinoma (SCLC) Previously Treated With at Least One Therapeutic Regimen|Active, not recruiting||Phase 2|28|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 15:33:56.776278|2017-02-18 15:33:56.776278
NCT00483496|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2014-02-14|2013-12-19||September 2007||2007-09-01|February 2014|2014-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)|Evaluation of the Protection Activity of Microfine Ti02, Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With SU: Phase II Photoprovocation Test|Completed||Phase 2|16|Actual|Orfagen||1|||f||||||||||||||2017-02-18 15:33:56.887567|2017-02-18 15:33:56.887567
NCT00483483|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2012-06-18|||October 2007||2007-10-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|July 2011|Actual|2011-07-01||Interventional|||Project HERMITAGE: HIV Prevention in Hospitalized Russian Drinkers|Maximizing Opportunity: HIV Prevention in Hospitalized Russian Drinkers|Completed||Phase 3|700|Actual|Boston Medical Center||2|||f||||f||||||||||2017-02-18 15:33:57.169242|2017-02-18 15:33:57.169242
NCT00483470|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2014-01-17|||June 2007||2007-06-01|January 2014|2014-01-01|August 2008|Actual|2008-08-01|May 2008|Actual|2008-05-01||Interventional|||Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose||Completed||Phase 3|720|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:33:57.28172|2017-02-18 15:33:57.28172
NCT00483457|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2012-08-31|||February 2006||2006-02-01|August 2012|2012-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients|Pilot Study of the Effects of Epidermal Growth Factor Receptor (EGFR) Inhibitors on the EGFR in Skin Lesions|Completed||N/A|33|Actual|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-02-18 15:33:57.386429|2017-02-18 15:33:57.386429
NCT00483444|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2017-02-02|||October 2003||2003-10-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|||||Interventional|TBI||Telephone Follow-Up on Outcome After Mild Traumatic Brain Injury|The Effect of Telephone Follow-Up on Outcome After Mild TBI|Completed||N/A|366|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 15:33:57.596385|2017-02-18 15:33:57.596385
NCT00483431|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2009-03-09|||May 2007||2007-05-01|March 2009|2009-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Dose-Finding Study for Vitamin K2 in Human Volunteers|Dose-Finding Study for Vitamin K2 in Human Volunteers|Completed||N/A|42|Actual|Maastricht University Medical Center||7|||f||||f||||||||||2017-02-18 15:33:57.71777|2017-02-18 15:33:57.71777
NCT00483418|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2011-03-10|||June 2007||2007-06-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Survey of Testosterone Levels in Male Cancer Patients|Survey of Testosterone Levels in a Diverse Set of Male Patients With Hormone-Independent Cancers|Completed||N/A|425|Actual|Beth Israel Medical Center|||1||f||||f||||||||||2017-02-18 15:33:57.838594|2017-02-18 15:33:57.838594
NCT00013949|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-03|2006-09-01|||September 1998||1998-09-01|September 2006|2006-09-01|September 2004||2004-09-01|||||Observational|||Cardiovascular Vulnerability to Particulate Exposure|Active Elderly Study|Completed||N/A|200||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:00.118898|2017-02-18 18:11:00.118898
NCT00483405|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2016-01-20|||October 2006||2006-10-01|January 2016|2016-01-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|NRR||Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer|Phase II Study of Oxaliplatin, Capecitabine, and Cetuximab in Advanced Hepatocellular Carcinoma|Completed||Phase 2|33|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:33:57.930423|2017-02-18 15:33:57.930423
NCT00483392|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2007-06-05||||||June 2007|2007-06-01||||||||Interventional|||Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected Patients||Completed||N/A|||University Medical Centre Ljubljana||3|||f||||f||||||||||2017-02-18 15:33:58.042244|2017-02-18 15:33:58.042244
NCT00483379|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2014-02-04|2011-02-07||May 2007||2007-05-01|February 2014|2014-02-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|||High Dose or High Dose Frequency Study of Alglucosidase Alfa|An Exploratory, Open-Label Study of the Safety and Efficacy of High Dose or High Dosing Frequency Alglucosidase Alfa Treatment in Patients With Pompe Disease Who Do Not Have an Optimal Response to the Standard Dose Regimen|Completed||Phase 4|13|Actual|Sanofi|This small exploratory study lacked a parallel control arm at the standard dose for a longer period; decline in respiratory or motor function prior to study was not collected systematically, thus change from baseline observations are inconclusive.|2|||f||||t||||||||||2017-02-18 15:33:58.135187|2017-02-18 15:33:58.135187
NCT00483366|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2010-07-22|||August 2006||2006-08-01|July 2010|2010-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors (Closed to Accrual 12/11/2008)|Phase I Study of Imatinib, Gemcitabine and Capecitabine in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|56|Anticipated|University of Nebraska||1|||f||||||||||||||2017-02-18 15:33:59.388512|2017-02-18 15:33:59.388512
NCT00483353|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2008-06-12|||July 2007||2007-07-01|June 2008|2008-06-01||||||||Interventional|||Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers|A Pilot Study to Explore the Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers in Subjects With Seasonal Allergic Rhinitis|Completed||Phase 1|6||Pfizer|||||f||||||||||||||2017-02-18 15:33:59.499428|2017-02-18 15:33:59.499428
NCT00483327|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2016-12-08|2015-07-30||June 2007||2007-06-01|December 2016|2016-12-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional||All the patients enrolled to the study (including one who withdrew before the start of treatment)|Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate|Prospective Trial of Conservative Management of Atypical Endometrial Hyperplasia and Well to Moderately Differentiated Endometrial Carcinoma Using Megestrol Acetate|Completed||Phase 2|31|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 15:33:59.586567|2017-02-18 15:33:59.586567
NCT00483314|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2009-02-16|||November 2007||2007-11-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Homocystinuria: Treatment With N-Acetylcysteine|Homocystinuria: Treatment With N-Acetylcysteine|Completed||Phase 2|5|Actual|McGill University Health Center||1|||f||||f||||||||||2017-02-18 15:34:02.656661|2017-02-18 15:34:02.656661
NCT00483301|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2012-05-02|||May 2007||2007-05-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma|A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma|Completed||Phase 2|34|Actual|Mt. Sinai Medical Center, Miami||1|||f||||t||||||||||2017-02-18 15:34:02.763629|2017-02-18 15:34:02.763629
NCT00483288|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2017-01-17|||May 2005||2005-05-01|June 2013|2013-06-01||||September 2006|Actual|2006-09-01||Interventional|||Written Educational Information and Phone Calls in Increasing Follow-Up Care in Hispanic Women With Abnormal Pap Smears|Wake Forest University Cervical Screening and Follow Up System for Hispanic Women - A Pilot Study|Completed||N/A|238|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 15:34:02.877157|2017-02-18 15:34:02.877157
NCT00483275|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-06|2011-07-20|||June 2007||2007-06-01|July 2011|2011-07-01|September 2009|Anticipated|2009-09-01|||||Interventional|SPALT||Fall Prevention by Alfacalcidol and Training|Effects of a Multi-modal 12-month-intervention With Alfacalcidol Plus Calcium, Patient Education and a Mobility Program on the Number of Fallers Among Patients With an Impaired Kidney Function Aged 65 and Older.|Withdrawn||Phase 4|484|Anticipated|Ruhr University of Bochum||1||No final agreement with sponsor|f||||f||||||||||2017-02-18 15:34:02.973814|2017-02-18 15:34:02.973814
NCT00483262|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2013-10-16|2011-06-27||May 2007||2007-05-01|October 2013|2013-10-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Interventional|||Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma|Phase I/II Trial of Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|63|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:34:03.071111|2017-02-18 15:34:03.071111
NCT00483249|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2017-02-02|||May 2005||2005-05-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm|Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm|Recruiting||Phase 1/Phase 2|250|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:34:03.769624|2017-02-18 15:34:03.769624
NCT00483236|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2009-09-17|||December 2007||2007-12-01|September 2009|2009-09-01|June 2009|Anticipated|2009-06-01|||||Observational|||Prospective Study Looking at Quality of Life Measures in Non-ischaemic Cardiomyopathy After Mitral Valve Repair|Quality of Life Measures After Mitral Valve Repair in Non-Ischaemic Cardiomyopathy|Suspended||N/A|20|Anticipated|McGill University Health Center|||1|Lack of patient recruitment.|f||||f||||||||||2017-02-18 15:34:03.908857|2017-02-18 15:34:03.908857
NCT00483223|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2017-01-09|||June 2007||2007-06-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2014|Actual|2014-06-01||Interventional|||Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response|A Phase II Study of Cisplatin or Carboplatin for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response|Active, not recruiting||Phase 2|86|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-02-18 15:34:04.004299|2017-02-18 15:34:04.004299
NCT00483210|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2015-03-03||||||March 2015|2015-03-01||||||||Interventional|||Tissue Lipids and Insulin Resistance|Tissue Lipids and Insulin Resistance|Withdrawn||N/A|0|Actual|University of Arkansas||||The study goals were accomplished by a similar study at UAMS. (W.J. Evans)|f||||t||||||||||2017-02-18 15:34:04.13061|2017-02-18 15:34:04.13061
NCT00483197|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2009-09-04|||June 2007||2007-06-01|September 2009|2009-09-01|June 2010|Anticipated|2010-06-01|||||Interventional|||VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial|Evaluation of the VentrAssistTM Left Ventricular Assist Device as a Bridge to Cardiac Transplantation - Pivotal Trial|Unknown status|Active, not recruiting|Phase 3|140|Anticipated|Ventracor||1|||f||||t||||||||||2017-02-18 15:34:04.218786|2017-02-18 15:34:04.218786
NCT00483184|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2009-04-27|2009-04-27||April 2006||2006-04-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease|Phase II Study, Evaluation of Low Dose Natural Human Interferon Alpha Administered by the Oral Mucosal Route in the Treatment of Behçet's Disease|Completed||Phase 2|84|Actual|Nobel Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:34:04.344358|2017-02-18 15:34:04.344358
NCT00483171|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2012-11-05||2009-08-11|January 2008||2008-01-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients|A 14-Month, Randomized, Double-Blind,Placebo-Controlled Phase 3 Study To Evaluate The Long-Term Efficacy And Safety of CP-945,598 In Prevention Of Weight Regain In Obese Subjects|Terminated||Phase 3|699|Actual|Pfizer||3||See termination reason in detailed description.|f||||t||||||||||2017-02-18 15:34:04.832468|2017-02-18 15:34:04.832468
NCT00483158|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2008-07-25|||August 2007||2007-08-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||First Time in Man Study of Finafloxacin Hydrochloride|A Double-Blind, Placebo-Controlled, Randomized, Dose-Escalating Study of Single and Multiple Oral Doses of Finafloxacin Hydrochloride in Healthy Subjects and a Study of H. Pylori Treatment in Healthy Carriers|Completed||Phase 1|95|Actual|MerLion Pharmaceuticals GmbH||3|||f||||f||||||||||2017-02-18 15:34:04.965492|2017-02-18 15:34:04.965492
NCT00483145|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2008-06-02|||November 2006||2006-11-01|June 2008|2008-06-01|November 2007|Actual|2007-11-01|||||Interventional|||Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea|Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea|Completed||N/A|||Bispebjerg Hospital||2|||f||||||||||||||2017-02-18 15:34:05.081848|2017-02-18 15:34:05.081848
NCT00483132|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2007-06-05|||September 1994||1994-09-01|June 2007|2007-06-01|April 2002|Actual|2002-04-01|||||Interventional|||Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III|Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III|Completed||Phase 3|232|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||||2017-02-18 15:34:05.175899|2017-02-18 15:34:05.175899
NCT00483119|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2016-01-21|2015-10-05||April 2007||2007-04-01|January 2016|2016-01-01|February 2011|Actual|2011-02-01|February 2010|Actual|2010-02-01||Interventional||This number is based only on the number of patients who passed screening and then were enrolled. Please note that this study was not evaluable due to the untimely death of the study Principal Investigator as noted previously.|Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus|Phase 2 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus|Terminated||Phase 2|9|Actual|New York University School of Medicine|Sadly, the trial PI, Dr. Jean-Claude Bystryn, died on August 19, 2010. As a result the study could not be completed and an analysis of the data collected was not performed.|2||Study was terminated due to the death of the PI.|f||||t||||||||||2017-02-18 15:34:05.27629|2017-02-18 15:34:05.27629
NCT00483106|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2016-07-05|||November 1999||1999-11-01|July 2016|2016-07-01||||March 2018|Anticipated|2018-03-01||Interventional|||Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)||Recruiting||Phase 4|700|Anticipated|McGill University||2|||f||||f||||||||||2017-02-18 15:34:05.975979|2017-02-18 15:34:05.975979
NCT00483093|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2014-05-29|||July 2007||2007-07-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|June 2010|Actual|2010-06-01||Interventional|||Study of NGR-hTNF in Combination With Cisplatin in Solid Tumor|NGR004:A Phase IB Study of NGR-hTNF in Combination With Cisplatin in Patient Affected by Advanced or Metastatic Solid Tumor|Completed||Phase 1|22|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 15:34:06.110404|2017-02-18 15:34:06.110404
NCT00483080|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2014-05-29|||December 2006||2006-12-01|May 2014|2014-05-01|April 2013|Actual|2013-04-01|June 2009|Actual|2009-06-01||Interventional|||Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)|NGR006: A Phase II Study of NGR-hTNF Administered as Single Agent Every 3 Weeks or Weekly in Patients Affected by Colorectal Cancer (CRC), Previously Treated With Fluoropyrimidine, Oxaliplatin and Irinotecan Based Regimens|Completed||Phase 2|46|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 15:34:06.228271|2017-02-18 15:34:06.228271
NCT00483067|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2012-08-01|||March 1998||1998-03-01|August 2012|2012-08-01|July 2008|Actual|2008-07-01|March 2006|Actual|2006-03-01||Interventional|||2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)|Phase II Study: 2-Chlorodeoxyadenosine (2-CdA) and Cytarabine (Ara-C) in Idiopathic Hypereosinophilic Syndrome (HES)|Completed||Phase 2|13|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:34:06.356559|2017-02-18 15:34:06.356559
NCT00483054|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2011-11-21|||January 2007||2007-01-01|June 2009|2009-06-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|N2R||Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin|Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin|Completed||Phase 3|142|Actual|Bamrasnaradura Infectious Diseases Institute||2|||f||||t||||||||||2017-02-18 15:34:06.494468|2017-02-18 15:34:06.494468
NCT00483041|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2014-02-04|2013-10-22||July 2007||2007-07-01|February 2014|2014-02-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528|A Phase2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528, A Humanized Anti-Interleukin-9 Monoclonal Antibody, on Allergen-Induced Interleukin-9 Levels in Bronchoalveolar Lavage Fluid in Adults With Atopic Asthma|Terminated||Phase 2|11|Actual|MedImmune LLC||2||Study is replaced by MI-CP198 per CPM.|f||||||||||||||2017-02-18 15:34:06.630228|2017-02-18 15:34:06.630228
NCT00483028|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2008-02-01|||June 2004||2004-06-01|February 2008|2008-02-01|January 2007|Actual|2007-01-01|||||Interventional|||A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI|A Randomized Double-Blind, Parallel, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil (5 mg QD for 6 Weeks) After Single Dose and Steady State Therapy (2 Weeks and 6 Weeks) in Subjects With Mild Cognitive Impairment|Completed||N/A|38||Pfizer|||||f||||||||||||||2017-02-18 15:34:07.240621|2017-02-18 15:34:07.240621
NCT00483015|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2013-08-09|||March 2006||2006-03-01|August 2013|2013-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC|Differences in the Presentation, Outcome and Response to Treatment Between Never- Smokers and Smokers With Non- Small Cell Lung Cancer.|Completed||N/A|280|Actual|Washington University School of Medicine|||||f||||f||||||||||2017-02-18 15:34:07.337115|2017-02-18 15:34:07.337115
NCT00483002|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2012-04-11|2012-04-11||June 2007||2007-06-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets|Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets|Completed||N/A|3719|Actual|Pfizer|Planned observation time points at 4, 8 and 12 weeks were reported as from week 3 to less than week 7, from week 7 to less than week 11, at least week 11. As this is non-interventional study it is likely that adverse events had been under reported.||1||f||||t||||||||||2017-02-18 15:34:07.424643|2017-02-18 15:34:07.424643
NCT00482989|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2012-07-10|||June 2007||2007-06-01|July 2012|2012-07-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus|A Phase 1b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI-545, a Fully Human Anti-Interferon-Alpha Monoclonal Antibody, in Patients With Systemic Lupus Erythematosus|Completed||Phase 1|183|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 15:34:07.713625|2017-02-18 15:34:07.713625
NCT00482976|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2016-07-25|||December 2003||2003-12-01|July 2016|2016-07-01|March 2005|Actual|2005-03-01|||||Interventional|||Effect of LY333531 on Vascular and Neural Functions|The Effects of a Protein Kinase C Beta Inhibitor, LY333531, on Vascular and Neural Functions in Type 2 Diabetes Mellitus - Study B7A-MC-MBDM|Completed||Phase 2|30|Actual|Chromaderm, Inc.||2|||f||||f||||||||||2017-02-18 15:34:07.845179|2017-02-18 15:34:07.845179
NCT00482963|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-05|2013-07-11|||May 2007||2007-05-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication|A Pilot Study of the Pharmacokinetic Interactions Between the Hormonal Emergency Contraception, Plan B, and Efavirenz|Completed||Phase 1|24|Actual|University of Colorado, Denver||1|||f||||f||||||||||2017-02-18 15:34:07.941029|2017-02-18 15:34:07.941029
NCT00482950|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2009-06-04|||April 2007||2007-04-01|June 2009|2009-06-01|February 2008|Anticipated|2008-02-01|||||Interventional|||A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus|Unknown status|Active, not recruiting|Phase 2|400|Anticipated|Phenomix||3|||t||||f||||||||||2017-02-18 15:34:08.059344|2017-02-18 15:34:08.059344
NCT00482937|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2007-06-04|||January 2007||2007-01-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety and Pharmacodynamic Study of CD-NP|A Phase I, Single Ascending Dose Trial to Examine the Safety and Pharmacodynamic Effects of CD-NP|Completed||Phase 1|22|Actual|Nile Therapeutics||1|||f||||f||||||||||2017-02-18 15:34:08.162483|2017-02-18 15:34:08.162483
NCT00482924|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2016-04-08|||January 2003||2003-01-01|April 2016|2016-04-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Observational|STYJOBS||Observational Study of Early Metabolic and Vascular Changes in Obesity|Study for the Investigation of New Individual Risk Profiles and Therapeutic Strategies in Obesity Related Cardiovascular and Metabolic Disorders.|Recruiting||N/A|1500|Anticipated|Medical University of Graz|||2||f||||f||||||Samples With DNA|"~     Collection of fasted blood samples between 9 and 12 AM.~   "|||2017-02-18 15:34:08.255512|2017-02-18 15:34:08.255512
NCT00482911|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2015-09-29|2012-10-11||April 2007||2007-04-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma|A Phase II Study of Combination Oral CC-5013 Lenalidomide (Revlimid™), Oral Sunitinib (Sutent™) and Low Dose Oral Metronomic Cyclophosphamide for the Treatment of Stage IV Ocular Melanoma|Terminated||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||2||Investigator left the institute.|f||||f||||||||||2017-02-18 15:34:08.406349|2017-02-18 15:34:08.406349
NCT00482898|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-05-26|||September 2002||2002-09-01|May 2015|2015-05-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||A Study of MK0359 in Patients With Chronic Asthma (0359-013)|A Multicenter, Randomized, Double-Blind, Crossover Study Comparing the Effect of MK0359 and Placebo in Adult Patients With Chronic Asthma|Completed||Phase 2|56|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:09.315258|2017-02-18 15:34:09.315258
NCT00482885|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2011-06-24|||October 2007||2007-10-01|June 2011|2011-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Coordination Versus Pressure in Oesophageal Peristalsis|The Effect of Position on Oesophageal Peristalsis and LOS Pressures: a High Resolution Manometry Study|Completed||N/A|25|Actual|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||||||2017-02-18 15:34:09.403006|2017-02-18 15:34:09.403006
NCT00482872|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2010-02-26|||March 2004||2004-03-01|February 2010|2010-02-01||||December 2010|Anticipated|2010-12-01||Observational|||Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer|Familial HNSCC Syndrome and p16 Germline Mutations|Unknown status|Active, not recruiting|N/A|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:34:09.506768|2017-02-18 15:34:09.506768
NCT00482859|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-03|2009-01-21|||April 2007||2007-04-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Observational|||Sleep Disturbance and Sleep Quality in Women With Fibromyalgia Syndrome|Sleep Disturbance and Sleep Quality in Women With Fibromyalgia Syndrome|Completed||N/A|57|Actual|University of Kentucky|||1||f||||f||||||||||2017-02-18 15:34:09.619042|2017-02-18 15:34:09.619042
NCT00482846|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2014-04-14|||June 2007||2007-06-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Interventional|||Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma|Phase I Dose Escalation Trial of High Dose Melphalan Conditioning Regimen With Palifermin for Cytoprotection Followed by Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma|Completed||Phase 1|38|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 15:34:09.710957|2017-02-18 15:34:09.710957
NCT00472628|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2015-07-20|||May 2007||2007-05-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|||||Observational|MINDSET||Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)|Multi-marker Index for the Risk Assessment of Sepsis in the Emergency Department|Withdrawn||N/A|0|Actual|Biosite||||Change in company strategy|f||||f||||||||||2017-02-18 15:37:38.024676|2017-02-18 15:37:38.024676
NCT00482833|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2017-02-16|||August 2007||2007-08-01|February 2017|2017-02-01|October 2017|Anticipated|2017-10-01|September 2012|Actual|2012-09-01||Interventional|APL0406||Phase III Trial in Acute Promyelocytic Leukemia Patients|A Randomised Phase III Study to Compare Arsenic Trioxide (ATO) Combined to ATRA Versus Standard ATRA and Anthracycline-Based Chemotherapy (AIDA Regimen) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia|Active, not recruiting||Phase 3|276|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||2|||f||||f||||||||||2017-02-18 15:34:09.840601|2017-02-18 15:34:09.840601
NCT00482638|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-08-11|||May 2004||2004-05-01|August 2015|2015-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)||Completed||Phase 2|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:10.068039|2017-02-18 15:34:10.068039
NCT00482625|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2014-10-07|2014-04-18||June 2007||2007-06-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|February 2010|Actual|2010-02-01||Interventional|||Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery|Phase IIA Trial Testing Erlotinib as an Intervention Against Intraductal Pancreatic Mucinous Neoplasms|Terminated||Phase 2|6|Actual|National Cancer Institute (NCI)||1||"The protocol has been completed prematurely (e.g., due to poor accrual, insufficient drug~   supply, IND closure)."|f||||t||||||||||2017-02-18 15:34:10.140559|2017-02-18 15:34:10.140559
NCT00482612|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-05-11|2014-06-09||December 2006||2006-12-01|May 2015|2015-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|RUBY|Baseline characteristics were reported for the All-Subjects-Treated group. One participant who was randomized to receive MK-8265 4.5 mg did not receive double-blind study medication.|Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)|A Two-Week, Double Blind, Placebo-Controlled, Randomized, Parallel Group, Efficacy and Safety Out-Patient Trial With Org 50081 in Patients With Chronic Primary Insomnia|Completed||Phase 3|526|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:34:10.431508|2017-02-18 15:34:10.431508
NCT00482599|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2015-06-05|||June 2005||2005-06-01|June 2015|2015-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)|A Multicenter, Parallel Group, Comparative Trial Evaluating the Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function|Completed||Phase 3|30|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:34:11.085899|2017-02-18 15:34:11.085899
NCT00482586|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2015-06-03|||October 2003||2003-10-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Observational|||Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy|Outcomes Following Image-Guided Therapy for Hepatic Malignancies|Completed||N/A|137|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 15:34:11.173176|2017-02-18 15:34:11.173176
NCT00482573|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2008-06-04|||April 2004||2004-04-01|June 2008|2008-06-01|January 2006|Actual|2006-01-01|July 2005|Actual|2005-07-01||Interventional|||Dental Anesthesia in Pregnant Women With Rheumatic Heart Disease|Maternal-Fetal Monitoring of Patients With Rheumatic Heart Disease During Dental Procedure Under Local Anesthesia|Completed||Phase 1|31|Actual|University of Sao Paulo||2|||f||||t||||||||||2017-02-18 15:34:11.292246|2017-02-18 15:34:11.292246
NCT00482560|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2007-06-28|||January 2007||2007-01-01|June 2007|2007-06-01|April 2007|Actual|2007-04-01|||||Interventional|||Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening|Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening|Completed||Phase 3|100|Actual|University of Turin, Italy||2|||f||||f||||||||||2017-02-18 15:34:11.481807|2017-02-18 15:34:11.481807
NCT00482547|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2010-01-20|2009-04-06||June 2007||2007-06-01|January 2010|2010-01-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|SUCCESS||Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS)|Study of a Urethral Catheter Coated With Eluting Silver Salts|Terminated||Phase 4|1188|Actual|C. R. Bard|Sample size calculations required 1244 Efficacy Evaluable 48 subjects, only 854 Efficacy Evaluable 48 subjects were enrolled, which does not allow for a fully powered study and there is the threat of a type II error (false negative result).|2||Terminated for futility reasons.|f||||t||||||||||2017-02-18 15:34:11.577939|2017-02-18 15:34:11.577939
NCT00482521|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2012-08-27|||March 2007||2007-03-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|September 2010|Actual|2010-09-01||Interventional|||CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment|A Phase I, Open-Label Study to Determine the Maximum Tolerated Dose (MTD) and to Evaluate the Safety Profile of CC-4047 in Subjects With Advanced Solid Tumors|Completed||Phase 1|42|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:34:12.46151|2017-02-18 15:34:12.46151
NCT00482508|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2011-10-24|||May 2003||2003-05-01|October 2011|2011-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients|A One Year Open-label Extension Study to Assess Long Term Safety and Tolerability of Omalizumab Treatment in Poorly Controlled Moderate to Severe Allergic Asthma Patients Who Participated in the 52-week CIGE24IA04E1 Study|Completed||Phase 3|95|Actual|Novartis|||||f||||||||||||||2017-02-18 15:34:12.562386|2017-02-18 15:34:12.562386
NCT00482495|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2011-05-10|||April 2006||2006-04-01|May 2011|2011-05-01|November 2009|Actual|2009-11-01|December 2006|Actual|2006-12-01||Interventional|||Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Trial of Bevacizumab in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|42|Anticipated|Mayo Clinic||1|||f||||||||||||||2017-02-18 15:34:12.639153|2017-02-18 15:34:12.639153
NCT00482482|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2012-12-04|||September 2007||2007-09-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Yoga in Unipolar and Bipolar Disorders|The Safety and Effectiveness of Yoga as Augmentation in Improving Residual Depressive Symptoms in Unipolar and Bipolar Disorders.|Completed||N/A|90|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 15:34:12.745832|2017-02-18 15:34:12.745832
NCT00482469|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2009-01-06|||April 2007||2007-04-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|||||Observational|||The DIEP-Flap as a Model of Ischemia-Reperfusion|The DIEP-Flap as a Model of Ischemia-Reperfusion|Completed||N/A|45|Actual|Maastricht University Medical Center|||1||f||||t||||||Samples With DNA|"~     Frozen tissue.~   "|||2017-02-18 15:34:12.866946|2017-02-18 15:34:12.866946
NCT00482456|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2007-06-01|||January 2005||2005-01-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Homocysteine After Nitrous Oxide Anesthesia|Influence of the MTHFR 677C>T Mutation on Homocysteine Levels After Nitrous Oxide Anesthesia.|Completed||Phase 4|140|Actual|Medical University of Vienna|||||f||||f||||||||||2017-02-18 15:34:12.941986|2017-02-18 15:34:12.941986
NCT00482443|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2008-07-08|||March 2007||2007-03-01|July 2008|2008-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|DID||Assessing the Effectiveness of Diabetes Interactive Diary (DID) in Diabetes Management|A Multinational, Randomised Study of the Efficacy of the Diabetes Interactive Diary (DID), a Carbohydrates/Insulin Bolus Calculator and a Telemedicine System Based on the Communication Between Physician or Dietitian and Patient by SMS|Completed||N/A|20|Actual|The Royal Bournemouth Hospital||2|||f||||f||||||||||2017-02-18 15:34:13.032648|2017-02-18 15:34:13.032648
NCT00482430|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-08-20|||September 2007||2007-09-01|August 2015|2015-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, 2-Period, Cross-Over Clinical Trial to Study the Safety and Efficacy of MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia|Completed||Phase 2|50|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:34:13.139693|2017-02-18 15:34:13.139693
NCT00482417|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-11-19|||December 2002||2002-12-01|November 2015|2015-11-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)||Completed||Phase 2|11|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:13.236491|2017-02-18 15:34:13.236491
NCT00482404|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2007-06-04|||February 2007||2007-02-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Effects of Romantic Affection on Blood Chemistry and Immune Parameters|Study of the Effects of Romantic Affection on Blood Lipids, Blood Glucose, C-Reactive Protein, and Antibodies to Latent Epstein-Barr Virus|Completed||Early Phase 1|||Arizona State University||1|||f||||f||||||||||2017-02-18 15:34:13.311797|2017-02-18 15:34:13.311797
NCT00482391|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2013-03-06|||March 2007||2007-03-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer|Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Paclitaxel With Trastuzumab and Lapatinib in HER2/NEU-Overexpressed/Amplified Breast Cancer: Feasibility|Completed||Phase 2|95|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:34:13.38341|2017-02-18 15:34:13.38341
NCT00482378|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2016-10-10|||March 2005||2005-03-01|January 2016|2016-01-01||||May 2017|Anticipated|2017-05-01||Interventional|||Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain|An Open-Label, Pilot Study of Samarium - Sm 153 Lexidronam (Quadramet) in Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain|Active, not recruiting||Phase 1/Phase 2|39|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:34:13.510931|2017-02-18 15:34:13.510931
NCT00482365|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2013-08-16|||April 2002||2002-04-01|May 2013|2013-05-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Observational|||National Registry and Blood Bank of Patients With Liver Cancer|A National Registry of Patients With Hepatocellular Carcinoma|Completed||N/A|151|Actual|Vanderbilt-Ingram Cancer Center|||1||f||||t||||||||||2017-02-18 15:34:13.631927|2017-02-18 15:34:13.631927
NCT00482352|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2016-02-19|||December 2003||2003-12-01|February 2016|2016-02-01||||April 2012|Actual|2012-04-01||Observational|||Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|Classification Of Acute Lymphoblastic Leukemia|Completed||N/A|11196|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"~     marrow and blood samples~   "|||2017-02-18 15:34:13.743474|2017-02-18 15:34:13.743474
NCT00482339|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2007-06-04|||June 2007||2007-06-01|May 2007|2007-05-01|July 2009|Anticipated|2009-07-01|||||Observational|||PCR-Based Detection of Bacterial Agents in Platelet Concentrates and Whole Blood|PCR-Based Detection of Bacterial Agents in Platelet Concentrates and Whole Blood (First Study)|Unknown status|Not yet recruiting|N/A|2000|Anticipated|University of Jena|||||f||||f||||||||||2017-02-18 15:34:14.043848|2017-02-18 15:34:14.043848
NCT00482313|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2010-05-07|||May 2007||2007-05-01|August 2009|2009-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD)|A Single Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy of PR OROS Methylphenidate Followed by Open-Label Extension, in Swedish Male Prison Inmates With ADHD|Completed||Phase 3|30|Actual|Psychiatry Karolinska||2|||f||||t||||||||||2017-02-18 15:34:14.118852|2017-02-18 15:34:14.118852
NCT00482300|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2007-06-04||||||March 2007|2007-03-01||||||||Interventional|||Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer||Completed||N/A|||University of Roma La Sapienza|||||f||||t||||||||||2017-02-18 15:34:14.241593|2017-02-18 15:34:14.241593
NCT00482287|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-04-06|||January 2008||2008-01-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients|A Phase II, Randomized, Double Blind, Placebo-controlled, Dose-escalating Study to Assess the Pharmacokinetics and Pharmacodynamics of MTR105 in Cardiac Surgery Induced Hypotension Patients During Weaning Off Cardiopulmonary Bypass|Withdrawn||Phase 2|0|Actual|Meditor Pharmaceuticals Ltd.||4||Site did not recruit any patients|f||||f||||||||||2017-02-18 15:34:14.309871|2017-02-18 15:34:14.309871
NCT00482274|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2011-07-05|2010-07-27||May 2007||2007-05-01|July 2011|2011-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Docetaxel in Treating Patients With Relapsed Prostate Cancer|Phase II Study of the Early Use of Docetaxel in Patients With Biochemical Relapse After Primary Therapy for Prostate Cancer and an Incomplete Response to Androgen Deprivation Therapy.|Terminated||Phase 2|3|Actual|OHSU Knight Cancer Institute|Due to withdrawal of sponsor support, this study was terminated after only 3 subjects were enrolled (of the planned 36 subjects). Sufficient data were not obtained to make statistically significant conclusions.|1||Drug supplier stopped funding due to loss of study drug (docetaxel) patent.|f||||||||||||||2017-02-18 15:34:14.426884|2017-02-18 15:34:14.426884
NCT00482261|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-03|2013-01-08|||June 2007||2007-06-01|January 2013|2013-01-01|September 2013|Anticipated|2013-09-01|August 2010|Actual|2010-08-01||Interventional|||A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression|Phase II Trial of Low Dose Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma (Rev-Lite) in Patients at High Risk for Myelosuppression|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-02-18 15:34:14.699376|2017-02-18 15:34:14.699376
NCT00013936|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-03|2008-03-03|||March 2001||2001-03-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||A Novel Acuity Testing Method|A Novel Acuity Testing Method|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:00.222327|2017-02-18 18:11:00.222327
NCT00482248|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2016-11-16|||June 2003||2003-06-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma|An Open-label Extension Study to Assess Long Term Safety and Tolerability of Omalizumab Treatment in Adults and Adolescents With Severe Allergic Asthma Who Participated in the 52 Week CIGE250011E2 Study|Completed||Phase 3|132|Actual|Novartis|||||f||||||||||||||2017-02-18 15:34:14.808812|2017-02-18 15:34:14.808812
NCT00482235|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-11-30|||December 2002||2002-12-01|November 2015|2015-11-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)||Completed||Phase 2|45|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:14.889529|2017-02-18 15:34:14.889529
NCT00482222|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2013-01-22|||February 2007||2007-02-01|April 2008|2008-04-01||||December 2014|Anticipated|2014-12-01||Interventional|||Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer|A Prospective Randomised Open Label Trial of Oxaliplatin/Fluoropyrimidine Versus Oxaliplatin/Fluoropyrimidine Plus Cetuximab Pre and Post Operatively in Patients With Resectable Colorectal Liver Metastasis Requiring Chemotherapy|Unknown status|Recruiting|Phase 3|340|Anticipated|University of Southampton||2|||f||||t||||||||||2017-02-18 15:34:14.961769|2017-02-18 15:34:14.961769
NCT00482209|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2009-10-09|||May 2007||2007-05-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation||Completed||N/A|1220|Anticipated|Gynuity Health Projects||2|||f||||||||||||||2017-02-18 15:34:15.168482|2017-02-18 15:34:15.168482
NCT00482196|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-04-27|||July 2005||2005-07-01|April 2015|2015-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)||Completed||Phase 2|173|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:15.273714|2017-02-18 15:34:15.273714
NCT00482183|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-04|2007-06-04|||July 2003||2003-07-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Comparison Between Pioglitazone and SES With type2 DM|Comparison of Bare Metal Stent With Pioglitazone Versus Sirolimus-Eluting Stent for Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus.|Completed||Phase 2/Phase 3|38|Actual|Showa University|||||f||||f||||||||||2017-02-18 15:34:15.519288|2017-02-18 15:34:15.519288
NCT00482170|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2012-03-01|2012-03-01||September 2007||2007-09-01|March 2012|2012-03-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept|A 3 Month, Randomised, Open Label, Parallel Group, Descriptive Study to Explore and Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept (Etanercept Auto-injector and the Etanercept Prefilled Syringe) in Patients With Psoriasis.|Completed||Phase 3|421|Actual|Pfizer||2|||f||||||||||||||2017-02-18 15:34:15.646003|2017-02-18 15:34:15.646003
NCT00482157|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2009-06-23|||February 2007||2007-02-01|June 2009|2009-06-01|November 2008|Anticipated|2008-11-01|November 2007|Anticipated|2007-11-01||Interventional|||Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance|Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance|Unknown status|Active, not recruiting|N/A|24|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 15:34:21.624758|2017-02-18 15:34:21.624758
NCT00482144|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2016-06-26|||July 2003||2003-07-01|June 2016|2016-06-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Study of the Effects of the Pulsed-dye Laser at 585nm and 595nm to Treat Post-operative Scars on Suture-removal Day|Comparison of the Effectiveness of the Pulsed Dye Laser 585nm Versus 595nm in the Treatment of New Surgical Scars|Completed||N/A|20|Actual|University of Miami||3|||f||||f||||||||||2017-02-18 15:34:21.715011|2017-02-18 15:34:21.715011
NCT00482118|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2017-01-24|||February 6, 2006||2006-02-06|August 9, 2016|2016-08-09||||||||Observational|||Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China|A Hospital-Based Case-Control Study of Non-Smoking Women in Xuan Wei and Fu Yua, China: PAH Exposure, Genetic Susceptibility, and Lung Cancer|Completed||N/A|3750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:34:21.82048|2017-02-18 15:34:21.82048
NCT00482105|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-04-20|||March 2007||2007-03-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|DermTech||Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells|Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells|Terminated||N/A|7|Actual|University of California, Davis||1||Withdrawn per sponsor and Investigator|f||||f||||||||||2017-02-18 15:34:21.90606|2017-02-18 15:34:21.90606
NCT00482092|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2016-10-27|||May 2007||2007-05-01|October 2016|2016-10-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease|A Phase III, Multicenter, Placebo-controlled, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of PROCHYMAL® (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Induction of Remission in Subjects Experiencing Treatment-refractory Moderate-to-severe Crohn's Disease|Active, not recruiting||Phase 3|330|Anticipated|Mesoblast, Ltd.||3|||f||||t||||||||||2017-02-18 15:34:22.006773|2017-02-18 15:34:22.006773
NCT00482079|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-08-07|||May 2003||2003-05-01|August 2015|2015-08-01|June 2006|Actual|2006-06-01|August 2004|Actual|2004-08-01||Interventional|||A Study of MK0431 in Patients With Type 2 Diabetes (0431-010)|A Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled Dose-Range Finding Study of MK0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 2|743|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:22.402105|2017-02-18 15:34:22.402105
NCT00482066|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-05-28|||November 2007||2007-11-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|ABAVAS||Abatacept in ANCA Associated Vasculitis|A Pilot Study Examining the Effect of Abatacept in ANCA Associated Vasculitis|Terminated||Phase 2|7|Actual|Imperial College London||2||Funders withdrew funding due to slow recruitment|f||||t||||||||||2017-02-18 15:34:22.484081|2017-02-18 15:34:22.484081
NCT00481884|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2016-04-29|||May 2007||2007-05-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients|Phase III Trial to Compare RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients|Completed||Phase 3|80|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:34:25.549201|2017-02-18 15:34:25.549201
NCT00482053|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2010-09-10|||October 2006||2006-10-01|September 2010|2010-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Phase II Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)|A Phase II Study in Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as a Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)|Completed||Phase 2|30|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 15:34:22.590736|2017-02-18 15:34:22.590736
NCT00482040|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2007-08-23|||March 2004||2004-03-01|May 2007|2007-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Randomized Trial Investigating Four Nasal CPAP Systems in the Management of Apnea of Prematurity|Randomized Trial Investigating Four Nasal CPAP Systems in the Management of Apnea of Prematurity|Terminated||N/A|16|Actual|University Hospital Tuebingen||4||"Recruiting took longer than expected due to a lack of eligible patients (very strong inclusion~   and exclusion criterias)"|f||||f||||||||||2017-02-18 15:34:22.683205|2017-02-18 15:34:22.683205
NCT00482027|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2013-01-14|||December 2003||2003-12-01|May 2007|2007-05-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|A001||Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine|A Phase 1 Randomized, Placebo-controlled, Double-blind Dose-escalation Trial to Evaluate the Safety and Immunogenicity of tgAAC09, a Gag-PR-RT AAV HIV Vaccine|Completed||Phase 1|80|Actual|International AIDS Vaccine Initiative||2|||f||||t||||||||||2017-02-18 15:34:22.774229|2017-02-18 15:34:22.774229
NCT00482014|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2012-10-26|2012-10-26||May 2007||2007-05-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer|Phase 1/2 Study of Pemetrexed (Alimta) Plus Carboplatin, or Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Every-21-Day Pemetrexed Consolidation in Patients With Favorable-Prognosis Inoperable Stage IIIA/B Non-Small-Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|120|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:34:22.915391|2017-02-18 15:34:22.915391
NCT00482001|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2009-02-05|||June 2007||2007-06-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults|The Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults: A Pilot Study|Completed||Phase 4|22|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 15:34:24.252567|2017-02-18 15:34:24.252567
NCT00481988|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2013-05-17|2012-12-06||March 2007||2007-03-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|June 2009|Actual|2009-06-01||Interventional||One patient dropped out of study after 5 treatments due to One patient dropped out of study after 5 treatments to pursue other treatment options One patient dropped by investigator when patient had HDRS of 8 at baseline ratings One patient dropped out of study after 1 treatment to pursue other treatment options|Treating Depression With Transcranial Direct Current Stimulation (tDCS)|Randomized, Double Blind Crossover Study of the Treatment of Major Depressive Episode With Transcranial Direct Current Stimulation (tDCS)|Completed||Phase 1/Phase 2|20|Actual|New York State Psychiatric Institute|Data for the secondary outcome measure (Beck Depression Inventory) was incompletely collected and not analyzed.|2|||f||||t||||||||||2017-02-18 15:34:24.356829|2017-02-18 15:34:24.356829
NCT00481975|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2009-04-06|||August 2004||2004-08-01|April 2009|2009-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients|A Randomized, Double-Bind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study to Assess Efficacy and Safety of Rimonabant 20 mg Versus Placebo on Weight Loss and Frequency of Binge Episodes in Obese Patients With Food Craving|Completed||Phase 3|289|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:34:24.743969|2017-02-18 15:34:24.743969
NCT00481962|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2009-09-25|||February 2006||2006-02-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)|Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units|Completed||Phase 4|180|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 15:34:24.835241|2017-02-18 15:34:24.835241
NCT00481949|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2011-06-24|||September 2010||2010-09-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo|What is the Physiologic and Clinical Relevance of Oesophagogastric Junction Distensibility? Studies Using Endo-Flip and 96 Hour Wireless pH System|Completed||N/A|50|Actual|Guy's and St Thomas' NHS Foundation Trust|||1||f||||f||||||Samples Without DNA|"~     Biopsies taken at the gastro-oesophageal junction will be sent to histology lab and analysed~     as per routine histology specimens. These will be stored as all samples at our hospital are~     stored and only results reported by the appointed histologist will be used for analysis.~   "|||2017-02-18 15:34:25.146143|2017-02-18 15:34:25.146143
NCT00481936|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-12-22|||May 2007||2007-05-01|December 2015|2015-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin|A Phase I, Escalating Dose Study of VB6-845, a Recombinant Fusion Protein Targeting EpCAM, in Patients With Advanced Solid Tumours of Epithelial Origin|Terminated||Phase 1|15|Actual|Viventia Bio||1||Corporate reasons unrelated to safety and efficacy|f||||f||||||||||2017-02-18 15:34:25.243228|2017-02-18 15:34:25.243228
NCT00481923|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2009-04-17|||May 2004||2004-05-01|April 2009|2009-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|REBA||Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients|A Randomized, Double-Bind, Placebo-Controlled, Parallel-Group, Fixed-Dose (20 mg/Day), 3-Month, Multicenter Study of the Energy Intake Effects and Safety of SR141716 With or Without Hypocaloric Diet in Obese Patients|Completed||Phase 3|156|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:34:25.352863|2017-02-18 15:34:25.352863
NCT00481897|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2012-08-06|||May 2007||2007-05-01|August 2012|2012-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Worksite Nutrition Study|Worksite Nutrition Study|Completed||N/A|113|Actual|Physicians Committee for Responsible Medicine||1|||f||||t||||||||||2017-02-18 15:34:25.44083|2017-02-18 15:34:25.44083
NCT00480350|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2007-09-04|||September 2007||2007-09-01|March 2007|2007-03-01|January 2009|Anticipated|2009-01-01|||||Interventional|||RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients||Unknown status|Not yet recruiting|Phase 2|140|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 15:34:53.140214|2017-02-18 15:34:53.140214
NCT00481871|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2013-05-08|2012-08-20||May 2007||2007-05-01|May 2013|2013-05-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies|A Phase 1/2a Open-label Study of Pralatrexate and Gemcitabine With Vitamin B12 and Folic Acid Supplementation in Patients With Relapsed or Refractory Lymphoproliferative Malignancies|Completed||Phase 1/Phase 2|119|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||||||||||||2017-02-18 15:34:25.675924|2017-02-18 15:34:25.675924
NCT00481858|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2011-02-25|||July 2005||2005-07-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01||Observational|CRC011||Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis|A CLL Research Consortium (CRC) Phase II Study of Kinetic Biomarker for Chronic Lymphocytic Leukemia (CLL) Prognosis|Completed||N/A|150|Anticipated|KineMed|||1||f||||f||||||Samples With DNA|"~     CLL cells~   "|||2017-02-18 15:34:26.808651|2017-02-18 15:34:26.808651
NCT00481845|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2016-12-13|2016-12-13||January 2008||2008-01-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer|Randomized Phase 2 Trial of Anastrozole Combined With Novel Agent ZD6474 in the Neoadjuvant Treatment of Postmenopausal Patients With Hormone Receptor-Positive Breast Cancer|Terminated||Phase 2|1|Actual|Stanford University||2||Low accrual|f||||t||||||||||2017-02-18 15:34:26.908102|2017-02-18 15:34:26.908102
NCT00481832|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-08-04|||January 2007||2007-01-01|August 2015|2015-08-01|June 2019|Anticipated|2019-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma|Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 2|25|Anticipated|Stanford University||1|||f||||t||||||||||2017-02-18 15:34:27.450348|2017-02-18 15:34:27.450348
NCT00481819|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2016-02-23|||July 2007||2007-07-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation|A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Combination With MMF and Steroids in Patients Undergoing Kidney Transplantation and a Pharmacokinetics Study.|Completed||Phase 3|240|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-02-18 15:34:27.571361|2017-02-18 15:34:27.571361
NCT00481806|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2013-05-08|||February 2007||2007-02-01|May 2013|2013-05-01|December 2013|Anticipated|2013-12-01|May 2013|Anticipated|2013-05-01||Observational|||Evaluating the Role of Thrombin in Saphenous Vein Graft Failure After Heart Bypass Surgery|Thrombin Dysregulation Leads to Early Saphenous Vein Graft Failure|Unknown status|Recruiting|N/A|450|Anticipated|University of Arizona|||1||f||||||||||Samples With DNA|"~     Whole blood and vein samples~   "|||2017-02-18 15:34:27.682903|2017-02-18 15:34:27.682903
NCT00481793|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2017-01-24|||June 9, 2004||2004-06-09|September 17, 2014|2014-09-17|September 17, 2014||2014-09-17|||||Observational|||Relationship of Genetic Differences to the Development of Chromosome Abnormalities|Germline Genetic Variation and Risk of Chromosome Aberrations Among Mayak Nuclear Workers|Terminated||N/A|380|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:34:27.77893|2017-02-18 15:34:27.77893
NCT00481780|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2007-09-10|||November 2004||2004-11-01|May 2007|2007-05-01|April 2007||2007-04-01|||||Interventional|||PTA vs. CB-PTA for Treatment of Femoropopliteal Artery In-Stent Restenosis|Conventional Balloon Angioplasty vs. Cutting Balloon Angioplasty for Treatment of Femoropopliteal Artery In-Stent Restenosis - A Randomized Controlled Pilot Trial|Completed||N/A|40|Actual|Vienna General Hospital||2|||f||||f||||||||||2017-02-18 15:34:27.874012|2017-02-18 15:34:27.874012
NCT00481767|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2016-09-26|2011-02-24||October 2007||2007-10-01|September 2016|2016-09-01|July 2010|Actual|2010-07-01|February 2010|Actual|2010-02-01||Interventional|||Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.|Study to Assess the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine GSK580299 in Healthy Female Subjects Aged 10-25 Years|Completed||Phase 3|676|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:34:27.975954|2017-02-18 15:34:27.975954
NCT00481754|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2017-01-24|||February 28, 2006||2006-02-28|July 15, 2016|2016-07-15||||||||Observational|||Benign Reproductive Tissue Analysis for Endometrial Cancer Markers|Benign Reproductive Tissue Evaluation (BRTE) Study|Active, not recruiting||N/A|295|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:34:29.517746|2017-02-18 15:34:29.517746
NCT00481741|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2009-07-30|||May 2007||2007-05-01|July 2009|2009-07-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions|A Prospective Randomized Controlled Efficacy and Safety Trial of the SafeSeal Hemostasis Patch Compared to Manual Compression for Achieving Vascular Hemostasis Following Percutaneous Coronary and Peripheral Intervention.|Completed||Phase 4|150|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 15:34:29.621956|2017-02-18 15:34:29.621956
NCT00481728|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2009-05-27|||June 2007||2007-06-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.|Evaluation of Sympathetic Skin Responses and Heart Rate Variability as Objective Measures of Bladder Sensation - a Double Blind Third Party Open Placebo Controlled Randomised Study Using a Single Dose of Tolterodine in Patients With Idiopathic Overactive Bladder and Healthy Volunteers|Completed||Phase 1|28|Anticipated|Pfizer||1|||f||||||||||||||2017-02-18 15:34:29.719676|2017-02-18 15:34:29.719676
NCT00481715|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2011-01-26|||September 2008||2008-09-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Comparison of Two Workplace-Sponsored Obesity Prevention Programs|Interventions to Control Obesity in Colleges|Completed||N/A|1020|Actual|University of North Carolina, Chapel Hill||4|||f||||t||||||||||2017-02-18 15:34:29.831453|2017-02-18 15:34:29.831453
NCT00481702|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2015-10-19|||December 2001||2001-12-01|October 2015|2015-10-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)|A Prospective, Multicenter, Open-Label, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-Abdominal Infections in Adults|Completed||Phase 3|300||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:29.921345|2017-02-18 15:34:29.921345
NCT00481689|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2009-06-25|||May 2004||2004-05-01|June 2009|2009-06-01|September 2005|Actual|2005-09-01|||||Interventional|||Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens|Prospective, Open-Label, Noncomparative, Multicenter Study to Evaluate the Efficacy and Safety of Ciprofloxacin Extended Release (Cipro XR) 1000 mg Tablets Given Once Daily for 7 to 14 Days in the Treatment of Patients 18 Years or Older With Complicated Urinary Tract Infections Caused by Pseudomonas Aeruginosa and Other Common Uropathogens|Completed||Phase 4|500|Actual|Bayer|||||||||||||||||||2017-02-18 15:34:30.004058|2017-02-18 15:34:30.004058
NCT00481676|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2011-09-14|2010-12-17||May 2007||2007-05-01|September 2011|2011-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria|A Randomized, 24 Weeks, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of Omalizumab in Adult Patients With Chronic Urticaria Who Exhibit IgE Against Thyroperoxidase|Completed||Phase 2|49|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:34:30.143998|2017-02-18 15:34:30.143998
NCT00481663|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2014-12-30|||August 2003||2003-08-01|December 2014|2014-12-01|May 2006|Actual|2006-05-01|July 2004|Actual|2004-07-01||Interventional|||A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Finding Study of Once-Daily Dosing of Sitaglipin (MK-0431) in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 2|555|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 15:34:30.764213|2017-02-18 15:34:30.764213
NCT00480649|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2012-11-08|||January 2004||2004-01-01|November 2012|2012-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)|SUccessful Control and Clinical Effectiveness of SERETIDE Study in aSthma, a Randomised Controlled Study to Investigate the Clinical Effectiveness and Health Outcome of SERETIDE in Patients With Moderate and Severe Persistent Asthma in Korea|Completed||Phase 4|424|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:34:30.865379|2017-02-18 15:34:30.865379
NCT00480636|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2010-07-14|2010-05-25||June 2007||2007-06-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients|Fragmin Safety And Efficacy In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism And Extended Thromboprophylaxis In Cancer Patients In Slovakia (An Open, Prospective, Non-Comparative Study)|Completed||N/A|102|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:34:30.97812|2017-02-18 15:34:30.97812
NCT00480623|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2012-03-21|||May 2007||2007-05-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence|A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence Following Radical Prostatectomy|Terminated||Phase 1|||Agennix||1||Sponsor decided to discontinue study drug development|f||||f||||||||||2017-02-18 15:34:31.262136|2017-02-18 15:34:31.262136
NCT00480610|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2014-09-17|||April 2004||2004-04-01|September 2014|2014-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment|"Clinical Study on Tacrolimus Ointment Over the Long-term. CONTROL Study - Adults"|Completed||Phase 3|226|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 15:34:31.588949|2017-02-18 15:34:31.588949
NCT00481650|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2007-12-07|||May 2005||2005-05-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Observational|||Observational Trial With Leios/Alesse|A Prospective Observation Study (Anwendungsbeobachtung [AWB]) of the Prescribing and Administration Practices of German Gynecologists With Leios® Dragées/Alesse|Completed||Phase 4|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:34:31.73496|2017-02-18 15:34:31.73496
NCT00481637|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2017-01-03|||March 1998||1998-03-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients|Tumor Immunity in Neurologically Normal Patients|Recruiting||N/A|10|Anticipated|Rockefeller University|||2||f||||f||||||||||2017-02-18 15:34:31.799698|2017-02-18 15:34:31.799698
NCT00481624|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2013-05-14|||May 2007||2007-05-01|May 2013|2013-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|Procrit||Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia|A Phase II Trial Using Intravenous Iron in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia Treated With 120,000 Units Epoetin Alfa Every Three Weeks|Withdrawn||Phase 2|0|Actual|James Graham Brown Cancer Center||1||The study was stopped because of lack of funding.|f||||t||||||||||2017-02-18 15:34:31.907554|2017-02-18 15:34:31.907554
NCT00481611|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2017-01-24|||June 2, 2006||2006-06-02|October 25, 2016|2016-10-25||||||||Observational|||Cancer Markers Associated With Occupational Exposure to Trichloroethylene|A Cross-Sectional Study of Occupational Exposure to Trichloroethylene, Chromosomal Aberrations, and Related Biomarkers in Guangdong, China|Completed||N/A|125|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:34:32.027429|2017-02-18 15:34:32.027429
NCT00481598|ClinicalTrials.gov processed this data on February 17, 2017|2007-06-01|2008-09-11|||January 2006||2006-01-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Non Invasive Assessment of Liver Glycogen Kinetics and ATP Synthesis in Type1 Diabetics|Non Invasive Assessment of Liver Glycogen Kinetics and ATP Synthesis in Type1 Diabetics|Completed||N/A|28|Anticipated|Landsteiner Institut||1|||f||||t||||||||||2017-02-18 15:34:32.120332|2017-02-18 15:34:32.120332
NCT00481585|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2014-02-01|||May 2007||2007-05-01|February 2014|2014-02-01||||July 2009|Actual|2009-07-01||Observational|||The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture|The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture|Terminated||N/A|13|Actual|Hackensack University Medical Center|||1|study team failed to complete timely reviews, study suspended|f||||t||||||||||2017-02-18 15:34:32.213562|2017-02-18 15:34:32.213562
NCT00481572|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2008-02-26|||January 2007||2007-01-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Continuous Infusion of Terlipressin in Septic Shock|"Continuous Terlipressin Versus Vasopressin Infusion in Septic Shock. A Randomized, Controlled, Pilot Trial. THE TERLIVAP STUDY"|Completed||Phase 2|45|Actual|University of Roma La Sapienza||3|||f||||f||||||||||2017-02-18 15:34:32.306165|2017-02-18 15:34:32.306165
NCT00481559|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2014-01-16||||||January 2014|2014-01-01||||||||Expanded Access|||Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity|An Open-Label Treatment Protocol for the Use of Voraxaze as Adjunctive Treatment for Patients Experiencing or at Risk of Methotrexate Toxicity|Approved for marketing||N/A|||BTG International Inc.|||||||||||||||||||2017-02-18 15:34:32.423099|2017-02-18 15:34:32.423099
NCT00481546|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2016-08-18|||July 2007||2007-07-01|August 2016|2016-08-01|June 2026|Anticipated|2026-06-01|June 2026|Anticipated|2026-06-01||Interventional|LCA||Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations|Phase I Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-CBSB-hRPE65) Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations (Clinical Trials of Gene Therapy for Leber Congenital Amaurosis)|Active, not recruiting||Phase 1|15|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 15:34:32.520999|2017-02-18 15:34:32.520999
NCT00481533|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||June 2005||2005-06-01|May 2007|2007-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in Labour|Prophylactic Ergonovine-Oxytocin Versus Oxytocin During Cesarean Delivery Following Failure to Progress in Labour|Completed||N/A|47|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-02-18 15:34:32.637238|2017-02-18 15:34:32.637238
NCT00481520|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2009-09-28||2009-09-28|June 2007||2007-06-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease|A Randomized, Double-blind, Placebo-controlled, Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) Trial of Multiple Ascending Fixed Doses of SAM-531 in Subjects With Mild to Moderate Alzheimer's Disease.|Completed||Phase 2|72|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 15:34:32.728252|2017-02-18 15:34:32.728252
NCT00481507|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2012-02-21|2011-05-09||July 2007||2007-07-01|February 2012|2012-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|MILK||Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)|Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)|Completed||Phase 3|125|Actual|Georgetown University||2|||f||||t||||||||||2017-02-18 15:34:32.833655|2017-02-18 15:34:32.833655
NCT00481494|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2007-05-31|||May 2007||2007-05-01|May 2007|2007-05-01|October 2007|Anticipated|2007-10-01|||||Observational|GDC||Personality Characteristics and Compliance With Antiglaucoma Medication|Personality Characteristics and Compliance With Antiglaucoma Medication|Unknown status|Recruiting|N/A|150|Anticipated|Yonsei University|||||f||||f||||||||||2017-02-18 15:34:33.226033|2017-02-18 15:34:33.226033
NCT00481481|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2014-07-17|||April 2007||2007-04-01|July 2014|2014-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|CONCERTO||Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects|A Multicenter, Single-arm, Open, Conversion Study From a Cyclosporine (CyA) Based Immunosuppressive Regimen to a Tacrolimus Modified Release, FK506E (MR4), Based Immunosuppressive Regimen in Kidney Transplant Subjects (CONCERTO: Converting Cyclosporine to FK506E (MR4) in Renal Transplantation)|Completed||Phase 3|346|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 15:34:33.314064|2017-02-18 15:34:33.314064
NCT00481468|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2012-09-26|||June 2006||2006-06-01|September 2012|2012-09-01|March 2010|Actual|2010-03-01|June 2007|Actual|2007-06-01||Observational|SOMARIS||Validation of the Siemens System Somatom Definition and Operating Software for Cardiac CT Studies|Validation of the Siemens System Somatom Definition and Operating Software SYNGO CT2007 (Software Version SOMARIS/7 SYNGO® Software) for Cardiac CT Studies|Completed||N/A|385|Actual|William Beaumont Hospitals|||1||f||||t||||||||||2017-02-18 15:34:33.487023|2017-02-18 15:34:33.487023
NCT00481455|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2008-11-24|||April 2007||2007-04-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)|A Single-Center, Open-Label, Phase II, Safety and Efficacy Study of Panzem Nanocrystal Colloidal Dispersion Administered Orally in Combination With Protracted Oral Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|15|Actual|CASI Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:34:33.57645|2017-02-18 15:34:33.57645
NCT00481442|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||January 2007||2007-01-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Phenylephrine Versus Norepinephrine in Septic Shock|Effects of Phenylephrine on Systemic and Regional Hemodynamics in Patients With Septic Shock: a Crossover Pilot Study|Completed||Phase 2|15|Actual|University of Roma La Sapienza|||||f||||f||||||||||2017-02-18 15:34:33.685225|2017-02-18 15:34:33.685225
NCT00481429|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2009-01-28|||May 2007||2007-05-01|May 2007|2007-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study|Evaluation of Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study|Completed||N/A|12|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 15:34:33.782231|2017-02-18 15:34:33.782231
NCT00481416|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||December 2004||2004-12-01|June 2006|2006-06-01|January 2005|Actual|2005-01-01|||||Observational|MA-37||“Evaluation of the PillCam™ESO Capsule in the Detection of Esophageal Varices|Evaluation of the PillCam™ Eso Capsule in the Detection of Esophageal Varices|Completed||N/A|318|Actual|Given Imaging Ltd.|||||f||||f||||||||||2017-02-18 15:34:33.900758|2017-02-18 15:34:33.900758
NCT00481403|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-03-09|||May 2006||2006-05-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Study of Sperm Molecular Factors Implicated in Male Fertility|Microarray Analysis in Sperm From Fertile and Infertile Males Without Basic Sperm Analysis Abnormalities|Active, not recruiting||N/A|100|Anticipated|Instituto Valenciano de Infertilidad, IVI VALENCIA|||1||f||||f||||||Samples Without DNA|"~     After sperm washing, sperm pellet was suspended in trizol and immediately frozen by direct~     immersion in liquid nitrogen and stored in a nitrogen tank until mRNA extraction.~   "|||2017-02-18 15:34:33.993419|2017-02-18 15:34:33.993419
NCT00481390|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2011-06-07|||June 2007||2007-06-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients|Prospective Epidemiological Study of the Prevalence of HLA-B*5701 in HIV-1 Infected Patients|Completed||N/A|1110|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 15:34:34.099097|2017-02-18 15:34:34.099097
NCT00480337|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2008-12-16||||||December 2008|2008-12-01||||||||Interventional|||In Vitro Maturation of Immature Oocytes||Completed||N/A|||Sheba Medical Center|||||f||||f||||||||||2017-02-18 15:34:53.226549|2017-02-18 15:34:53.226549
NCT00481377|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2008-07-18|||May 2007||2007-05-01|July 2008|2008-07-01|May 2010|Anticipated|2010-05-01|||||Interventional|ABLATION 4 ICD||Ablation for ICD Intervention Reduction in Patients With CAD|Ablation for ICD Intervention Reduction in Patients With CAD - a Prospective Randomized Trial|Terminated||N/A|200|Anticipated|Institute of Cardiology, Warsaw, Poland||1|||f||||f||||||||||2017-02-18 15:34:34.211873|2017-02-18 15:34:34.211873
NCT00481364|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2013-09-06|||November 2006||2006-11-01|September 2013|2013-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients|Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease: Prospective, Randomized, Controlled Study|Completed||Phase 3|446|Actual|Ege University||2|||f||||t||||||||||2017-02-18 15:34:34.298532|2017-02-18 15:34:34.298532
NCT00481351|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2011-01-07|2011-01-07||June 2007||2007-06-01|January 2007|2007-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons|Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons in Men With Stable Coronary Heart Disease.|Completed||Phase 4|25|Actual|University of Sao Paulo||2|||f||||f||||||||||2017-02-18 15:34:34.411283|2017-02-18 15:34:34.411283
NCT00481338|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-07-31|||April 2007||2007-04-01|July 2015|2015-07-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|KHOALA||Prevalence,Natural History,Prognosis Factor,QualityofLife,Health Care Consumption and Social Consequences of Symptomatic Knee and Hip Osteoarthritis in France|Knee and Hip OsteoArthritis Long Term Assessment. Prevalence, Natural History, Prognosis Factor, Quality of Life, Health Care Consumption and Social Consequences of Symptomatic Knee and Hip Osteoarthritis in France|Active, not recruiting||N/A|878|Actual|Central Hospital, Nancy, France||1|||f||||t||||||||||2017-02-18 15:34:35.047541|2017-02-18 15:34:35.047541
NCT00481325|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-09-23||2010-09-10|July 2007||2007-07-01|September 2015|2015-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder|A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder|Completed||Phase 2/Phase 3|260|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 15:34:35.150214|2017-02-18 15:34:35.150214
NCT00481312|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2012-05-04|||June 2007||2007-06-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|MIDEX||Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)|A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Midazolam for Continuous Sedation of Ventilated Patients in Intensive Care Unit|Completed||Phase 3|501|Actual|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-02-18 15:34:35.361066|2017-02-18 15:34:35.361066
NCT00481299|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||October 2004||2004-10-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Observational|||Insulin Resistance in Women With Prolactinoma|Insulin Resistance and Lipid Profile in Non-Obese Women With Prolactinoma Treated With Dopamine Agonists|Completed||N/A|2004|Actual|Universidade Federal do Rio de Janeiro|||||f||||t||||||||||2017-02-18 15:34:35.499178|2017-02-18 15:34:35.499178
NCT00481286|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2009-10-20|||April 2007||2007-04-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|April 2008|Actual|2008-04-01||Interventional|EPIC||Improving Outcomes Using Collaborative Group Clinics to Empower Older Patients|Improving Outcomes for Multiple Morbidities Using Collaborative Group Clinics to Empower Older Patients|Completed||Phase 2|129|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 15:34:35.584769|2017-02-18 15:34:35.584769
NCT00481273|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2013-12-31|||October 2006||2006-10-01|December 2013|2013-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|AVIDA||AVIDA The Vidaza® (Azacitidine) Patient Registry|AVIDA The Vidaza® (Azacitidine) Patient Registry|Completed||N/A|479|Actual|Celgene|||1||f||||f||||||||||2017-02-18 15:34:35.686694|2017-02-18 15:34:35.686694
NCT00481260|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2009-09-03|||May 2007||2007-05-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous|Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous|Completed||N/A|100|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-02-18 15:34:38.436943|2017-02-18 15:34:38.436943
NCT00481247|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2016-12-22|2010-11-23||September 2007||2007-09-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|December 2009|Actual|2009-12-01||Interventional|DASISION||A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia|An Open-Label, Randomized, Multicenter Phase III Trial of Dasatinib (SPRYCEL®) vs. Standard Dose Imatinib (400 mg) in the Treatment of Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia|Completed||Phase 3|547|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 15:34:38.555325|2017-02-18 15:34:38.555325
NCT00481234|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2007-05-31|||June 2002||2002-06-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Observational|||Heart Rate Variability for Prediction of Perioperative Events|Heart Rate Variability for Prediction of Incidence of Cardiac Ischemia and Cardiovascular Events After General Anesthesia in High Risk Patients|Completed||N/A|2002|Actual|University of Schleswig-Holstein|||||f||||f||||||||||2017-02-18 15:34:40.150428|2017-02-18 15:34:40.150428
NCT00481221|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2015-08-30|||March 2007||2007-03-01|August 2015|2015-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter|Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter. A Clinical Retrospective Study.|Recruiting||N/A|300|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-02-18 15:34:40.235272|2017-02-18 15:34:40.235272
NCT00481208|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2007-05-31|||March 2006||2006-03-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Observational|IOPMG||Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma|Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma|Completed||N/A|70|Actual|Yonsei University|||||f||||f||||||||||2017-02-18 15:34:40.343033|2017-02-18 15:34:40.343033
NCT00481195|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2013-07-12|2010-04-30||June 2007||2007-06-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder|An 8 Week Double Blind, Placebo-Controlled, Parallel Group, Fixed Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder|Completed||Phase 2|257|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 15:34:40.666074|2017-02-18 15:34:40.666074
NCT00481182|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2009-02-19|||February 2005||2005-02-01|February 2009|2009-02-01||||||||Interventional|||Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.|A Phase I, Open-Label, 2-Period, Single-Sequence, Drug Interaction Study to Assess Steady-State Plasma Methadone Enantiomer Pharmacokinetics Following Co-Administration of Methadone QD With Fosamprenavir 700mg BID + RTV 100mg BID in Opiate-Dependent, HIV Seronegative, Adult Subjects|Completed||Phase 1|20||GlaxoSmithKline|||||||||||||||||||2017-02-18 15:34:42.03516|2017-02-18 15:34:42.03516
NCT00481169|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2009-08-20|||July 2001||2001-07-01|August 2009|2009-08-01|September 2004|Actual|2004-09-01|July 2004|Actual|2004-07-01||Interventional|||Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women|A Multicenter, Double Blind, Randomized, Placebo and Raloxifene Controlled Study to Assess Safety and Efficacy of TSE-424 (Bazedoxifene Acetate) in the Prevention of Postmenopausal Osteoporosis|Completed||Phase 3|1742|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:34:42.122018|2017-02-18 15:34:42.122018
NCT00481156|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||September 2005||2005-09-01|May 2007|2007-05-01||||||||Interventional|||Functional Neuroimaging Effects of Cognitive Remediation Training||Completed||N/A|18||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 15:34:42.201947|2017-02-18 15:34:42.201947
NCT00481143|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2016-11-16|||May 2007||2007-05-01|November 2016|2016-11-01||||November 2010|Actual|2010-11-01||Interventional|||Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload|A One-year, Open-label, Single Arm, Multi-center Trial Evaluating the Efficacy and Safety of Oral ICL670 in Patients Diagnosed With Low and INT-1 Risk Myelodysplastic Syndrome (MDS) and Transfusion-dependent Iron Overload|Completed||Phase 4|63|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:34:42.281822|2017-02-18 15:34:42.281822
NCT00481130|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2017-01-24|||September 2007||2007-09-01|January 2017|2017-01-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01|15 Years|Observational [Patient Registry]|ASTOR||Alport Syndrome Treatments and Outcomes Registry|Alport Syndrome Treatments and Outcomes Registry|Recruiting||N/A|1000|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-02-18 15:34:42.389298|2017-02-18 15:34:42.389298
NCT00481117|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2010-09-10|||August 2008||2008-08-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|||||Interventional|||Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes|Safety, Tolerability, PK and PD of LY2405319 After Multiple Subcutaneous Injections in Subjects With Type 2 Diabetes|Completed||Phase 1|37|Actual|Eli Lilly and Company||5|||f||||t||||||||||2017-02-18 15:34:42.481824|2017-02-18 15:34:42.481824
NCT00481104|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2011-07-01|||May 2007||2007-05-01|March 2008|2008-03-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of Long Term Safety of Tesofensine in Patients With Obesity|Evaluation of Long Term Safety of Tesofensine in Patients With Obesity|Completed||Phase 2|140|Actual|NeuroSearch A/S||1|||f||||f||||||||||2017-02-18 15:34:42.816424|2017-02-18 15:34:42.816424
NCT00481091|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2017-01-04|||July 2007||2007-07-01|January 2017|2017-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia|A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 2|72|Anticipated|AbbVie||1|||f||||f||||||||||2017-02-18 15:34:42.893466|2017-02-18 15:34:42.893466
NCT00481078|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2014-10-24|2014-10-24||May 2007||2007-05-01|December 2012|2012-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Randomized Phase II Study of Vorinostat or Placebo in Combination With Carboplatin and Paclitaxel for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|94|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:34:43.004604|2017-02-18 15:34:43.004604
NCT00481065|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2013-12-31|2011-08-26||April 2007||2007-04-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||The demographic characteristics of the randomized population are summarized in this section.|Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects|A Phase II, Randomized, Controlled, Open Label, Single-Center Study to Evaluate the Immunogenicity, Safety and Tolerability of an H5N1-vaccine and a Seasonal Influenza Vaccine in Adult Subjects|Completed||Phase 2|405|Actual|Novartis||8|||f||||||||||||||2017-02-18 15:34:43.798395|2017-02-18 15:34:43.798395
NCT00481052|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2016-10-24|||June 2007||2007-06-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CML0307||Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase|The Protein Tyrosine Kinase Inhibitor Nilotinib as First-line Treatment of Ph+ Chronic Myeloid Leucemia (CML) in Early Chronic Phase: a Phase II Exploratory, Multicenter Study. GIMEMA Protocol CML 0307. EUDRACT 2007-000597-22.|Active, not recruiting||Phase 2|70|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||t||||||||||2017-02-18 15:34:45.839607|2017-02-18 15:34:45.839607
NCT00481039|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2009-09-03|||May 2007||2007-05-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel|Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel- An Observational Study|Completed||N/A|300|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-02-18 15:34:45.966873|2017-02-18 15:34:45.966873
NCT00481026|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2008-05-05|||July 2007||2007-07-01|May 2007|2007-05-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression|A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression|Unknown status|Recruiting|N/A|100|Anticipated|Bayside Health||2|||f||||f||||||||||2017-02-18 15:34:46.064579|2017-02-18 15:34:46.064579
NCT00481013|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2016-12-05|||July 2007||2007-07-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|December 2009|Actual|2009-12-01||Interventional|VALIANTSMA||Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy|Prospective Controlled Trial of Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy (VALIANTSMA) Study|Completed||Phase 2|33|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 15:34:46.172484|2017-02-18 15:34:46.172484
NCT00479960|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2007-05-29|||June 2007||2007-06-01|November 2006|2006-11-01|June 2007|Anticipated|2007-06-01|||||Interventional|||A Preliminary Study on Effect of Omega-3 on Human Sperm|Effect of Dietary Supplementation With Omega-3 Fatty Acids on Human Sperm Characteristics, a Preliminary Study|Unknown status|Not yet recruiting|Early Phase 1|20|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 15:35:00.651103|2017-02-18 15:35:00.651103
NCT00481000|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2010-04-20|||April 2007||2007-04-01|April 2010|2010-04-01|October 2010|Anticipated|2010-10-01|December 2008|Anticipated|2008-12-01||Interventional|PASA||Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe PTSD Following Sexual Abuse|Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe Posttraumatic Stress Disorder Following Sexual Abuse - A Randomised Controlled Trial|Unknown status|Active, not recruiting|Phase 2|64|Anticipated|Central Institute of Mental Health, Mannheim||1|||f||||f||||||||||2017-02-18 15:34:46.292438|2017-02-18 15:34:46.292438
NCT00480987|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2012-08-01|2011-06-06||July 2007||2007-07-01|August 2012|2012-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)|A Phase I-II Study of Oxaliplatin, Fludarabine, and Cytarabine in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes at First Relapse With Complete Remission Duration < 1 Year|Terminated||Phase 1/Phase 2|27|Actual|M.D. Anderson Cancer Center||1||Lack of support.|f||||f||||||||||2017-02-18 15:34:46.399595|2017-02-18 15:34:46.399595
NCT00480974|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2009-09-03|||May 2007||2007-05-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea|Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea.Observational Retrospective Study.|Completed||N/A|20|Anticipated|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-02-18 15:34:46.633377|2017-02-18 15:34:46.633377
NCT00480961|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-31|2007-05-31|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Interventional|||Congestive Heart Failure Surgical Treatmment With Autologous Stem Cell Therapy||Unknown status|Recruiting|Phase 2|||The Mediterranean Institute for Transplantation and Advanced Specialized Therapies||1|||f||||t||||||||||2017-02-18 15:34:46.733164|2017-02-18 15:34:46.733164
NCT00480948|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2011-06-06|||September 2008||2008-09-01|August 2008|2008-08-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Interventional|||Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants|Effects of InFat™ Product (High Sn-2 Palmitic Acid) on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants: a Triple-blind, Randomized, Placebo-controlled Trial|Terminated||Phase 4|80|Anticipated|Enzymotec||2||"Study design changes were needed due to change of protocol to a multisite trial and updated~   set up"|f||||||||||||||2017-02-18 15:34:46.8187|2017-02-18 15:34:46.8187
NCT00480935|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2015-12-07|||October 2007||2007-10-01|December 2015|2015-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma|A Phase II, Single Arm, Prospective Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma|Terminated||Phase 2|3|Actual|University Health Network, Toronto||1||poor recruitment|f||||t||||||||||2017-02-18 15:34:46.932967|2017-02-18 15:34:46.932967
NCT00480922|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2011-08-25|||May 2007||2007-05-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|DELIVER||Effects of a Low Glycemic Load Diet on Fatty Liver in Children|Randomized Controlled Trial Comparing the Effects of a Low Glycemic Load Diet With a Low Fat Diet on Hepatic Steatosis in Overweight Children and Adolescents|Completed||N/A|40|Anticipated|Boston Children’s Hospital||2|||f||||f||||||||||2017-02-18 15:34:47.051644|2017-02-18 15:34:47.051644
NCT00480896|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2014-09-17|||June 2004||2004-06-01|September 2014|2014-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment|"Clinical Study on Tacrolimus Ointment Over the Long-term. CONTROL Study - Children"|Completed||Phase 3|250|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 15:34:47.157068|2017-02-18 15:34:47.157068
NCT00480883|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2010-06-01|||January 2008||2008-01-01|May 2008|2008-05-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol|Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate 20 Mg/Kg/Day Versus Meglumine Antimoniate 10 Mg/Kg/Day And Tablet Allopurinol 20 Mg/Kg/Day|Completed||N/A|400|Anticipated|Combined Military Hospital, Pakistan||2|||f||||f||||||||||2017-02-18 15:34:47.29225|2017-02-18 15:34:47.29225
NCT00480870|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-12-03|||April 1999||1999-04-01|December 2007|2007-12-01|January 2005|Actual|2005-01-01|||||Interventional|ACHALZSLEEP||The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients|The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients|Completed||Phase 4|65|Actual|Associacao Fundo de Incentivo a Psicofarmcologia||2|||f||||f||||||||||2017-02-18 15:34:47.390443|2017-02-18 15:34:47.390443
NCT00480857|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2015-01-09|2015-01-09||March 2007||2007-03-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|August 2013|Actual|2013-08-01||Interventional|||Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy|Salvage Radiation Therapy and Docetaxel (Taxotere) for Biochemical Failure After Radical Prostatectomy|Terminated||Phase 2|19|Actual|University of Michigan Cancer Center||1||Lack of funding.|f||||t||||||||||2017-02-18 15:34:47.503175|2017-02-18 15:34:47.503175
NCT00480844|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2009-03-24|||October 2008||2008-10-01|March 2009|2009-03-01||||October 2011|Anticipated|2011-10-01||Interventional|||Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone|Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone|Unknown status|Recruiting|Phase 4|60|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 15:34:47.740506|2017-02-18 15:34:47.740506
NCT00480831|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2013-01-17||2013-01-17|June 2007||2007-06-01|January 2013|2013-01-01||||August 2010|Actual|2010-08-01||Interventional|||A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)|A Randomized, Double-Blind, Phase II Trial of Paclitaxel + Carboplatin + Bevacizumab With or Without PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer|Completed||Phase 2|128|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:34:47.852638|2017-02-18 15:34:47.852638
NCT00480818|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-12-09|||September 2006||2006-09-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects|An Ascending Multiple Dose Study of the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-531 Administered Orally to Healthy Young and Elderly Subjects|Completed||Phase 1|80||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:34:47.948773|2017-02-18 15:34:47.948773
NCT00480805|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2013-05-24|||October 2002||2002-10-01|May 2013|2013-05-01||||October 2002|Actual|2002-10-01||Interventional|||HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)|HYZAAR Versus Ramipril Diabetic Patients|Completed||Phase 3|280||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:48.023409|2017-02-18 15:34:48.023409
NCT00480792|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2013-07-22|||June 2007||2007-06-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|December 2008|Actual|2008-12-01||Interventional|VIHVAC-B||Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients|Open-label, Randomized, and Multicentric Phase III Clinical Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV-1-infected Patients With CD4-positive T-lymphocytes Counts Above 200 permm3 ANRS HB 03 VIHVAC-B|Completed||Phase 3|437|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||3|||f||||t||||||||||2017-02-18 15:34:48.098195|2017-02-18 15:34:48.098195
NCT00480779|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2016-05-19|2016-01-11||June 2007||2007-06-01|May 2016|2016-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|STEPUP||Evaluation of Group Lifestyle Balance DVD in Primary Care Practice|Screening, Training, Education and Prevention Service of the University of Pittsburgh, Phase 2|Completed||N/A|48|Actual|University of Pittsburgh|It should be noted that this was a small pilot study and should be tested in a larger sample.|2|||f||||f||||||||No||2017-02-18 15:34:48.336255|2017-02-18 15:34:48.336255
NCT00480766|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2016-02-03|||July 2001||2001-07-01|February 2016|2016-02-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 12-Month Study to Evaluate the Efficacy and Safety of Oral Alendronate Sodium Once Weekly for the Prevention and Treatment of Glucocorticoid-Induced Bone Loss|Completed||Phase 3|173|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:48.814044|2017-02-18 15:34:48.814044
NCT00480753|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-12-18|||May 2007||2007-05-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon|Phase II Dose Response Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, in the Treatment of Raynaud's Phenomenon|Completed||Phase 2|15|Anticipated|MediQuest Therapeutics||3|||f||||||||||||||2017-02-18 15:34:48.909828|2017-02-18 15:34:48.909828
NCT00480740|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2015-06-17|2014-08-19||December 2006||2006-12-01|June 2015|2015-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease|The Pharmacology of Dexmedetomidine in Children With Congenital Heart Disease|Completed||Phase 3|41|Actual|Children's Research Institute||3|||f||||f||||||||||2017-02-18 15:34:48.998365|2017-02-18 15:34:48.998365
NCT00480727|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2013-02-10|||April 2007||2007-04-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Determining Optimal Halo Pin Management Practises to Decrease Pin Complications|Determining Optimal Halo Pin Management Practises to Decrease Pin Complications|Completed||N/A|44|Actual|Bayside Health||2|||f||||f||||||||||2017-02-18 15:34:49.685476|2017-02-18 15:34:49.685476
NCT00480714|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||March 2003||2003-03-01|May 2007|2007-05-01|September 2003|Actual|2003-09-01|||||Interventional|||A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers|A Study of the Immunogenicity of M. Bovis BCG (SSI Strain), Delivered Intradermally in Healthy Volunteers|Completed||N/A|10|Actual|University of Oxford||1|||f||||t||||||||||2017-02-18 15:34:49.810071|2017-02-18 15:34:49.810071
NCT00480701|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2014-04-16||2014-03-21|February 2007||2007-02-01|April 2014|2014-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|IBVM001||Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease|Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT as a Marker of Acetylcholine Transporter Density in the Brain of Healthy Subjects and Patients With Alzheimer Disease|Completed||Phase 2|26|Actual|Institute for Neurodegenerative Disorders||1|||f||||t||||||||||2017-02-18 15:34:50.066619|2017-02-18 15:34:50.066619
NCT00480688|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||November 2001||2001-11-01|May 2007|2007-05-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers|A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers|Completed||Phase 1|11|Actual|University of Oxford||1|||f||||t||||||||||2017-02-18 15:34:50.161433|2017-02-18 15:34:50.161433
NCT00480675|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2009-01-27|||March 2007||2007-03-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Randomized Study Comparing Fluoroscopically-Guided Versus Blinded Trochanteric Bursa Injections||Completed||N/A|65|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 15:34:50.2513|2017-02-18 15:34:50.2513
NCT00480662|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2015-02-12|||October 2001||2001-10-01|February 2015|2015-02-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)|A 6-Month, Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Alendronate 280-mg Oral Buffered Solution Once Weekly in Patients With Paget's Disease of Bone|Completed||Phase 3|60|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:34:50.364659|2017-02-18 15:34:50.364659
NCT00480597|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2010-10-27|||October 2002||2002-10-01|May 2007|2007-05-01||||||||Interventional|||Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer|Randomised, Multicenter Phase II Study in Patients With Metastatic Breast Cancer With Gemcitabine Plus Vinorelbine Versus Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Capecitabine|Completed||Phase 2|141|Actual|Ludwig-Maximilians - University of Munich||3|||f||||t||||||||||2017-02-18 15:34:50.456408|2017-02-18 15:34:50.456408
NCT00480584|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2012-11-07|||April 2007||2007-04-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer|A Phase I Trial of GemCap-T, Capecitabine in Combination With Gemcitabine and Erlotinib (Tarceva®) in Patients With Advanced Pancreatic Adenocarcinoma|Completed||Phase 1|20|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 15:34:50.540905|2017-02-18 15:34:50.540905
NCT00480571|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2009-07-20|||June 2007||2007-06-01|August 2007|2007-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder|An Open-label, Multi-center, 6-week, Sequential Cohort Study Designed to Determine the Safety and Tolerability of Two Dose Ranges of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-affective Disorder|Completed||Phase 2|90|Anticipated|BioLineRx, Ltd.||2|||f||||t||||||||||2017-02-18 15:34:50.653177|2017-02-18 15:34:50.653177
NCT00013208|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|August 2002|Actual|2002-08-01|||||Interventional|||Proactive Diabetes Case Management|Proactive Diabetes Case Management|Completed||N/A|260|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:06.858187|2017-02-18 18:11:06.858187
NCT00480558|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2011-03-25|||July 2007||2007-07-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both|A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Asymptomatic Volunteers Who Are Infected With Either Mycobacterium Tuberculosis (M.tb.), Human Immunodeficiency Virus (HIV) or Both|Completed||Phase 1|48|Anticipated|University of Oxford||4|||f||||t||||||||||2017-02-18 15:34:50.762308|2017-02-18 15:34:50.762308
NCT00480545|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2014-12-03|||October 2005||2005-10-01|December 2014|2014-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Changes in Bleeding and Clotting During the Menstrual Cycle|Changes in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle|Withdrawn||N/A|0|Actual|The University of Texas Health Science Center, Houston|||1|IRB Approval lapsed|f||||f||||||Samples Without DNA|"~     Blood samples will be discarded when the study is completed.~   "|||2017-02-18 15:34:50.889031|2017-02-18 15:34:50.889031
NCT00480532|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2014-10-14|2012-05-21||May 2007||2007-05-01|October 2014|2014-10-01|May 2011|Actual|2011-05-01|January 2010|Actual|2010-01-01||Interventional|||A Study of Continuous Oral Contraceptives and Doxycycline|A Study of Continuous Oral Contraceptives and Doxycycline|Completed||N/A|131|Actual|Oregon Health and Science University|Treatment Arm: Subjects had difficulty understanding when to start and stop treatment.|4|||f||||f||||||||||2017-02-18 15:34:50.98935|2017-02-18 15:34:50.98935
NCT00480519|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||May 2007||2007-05-01|May 2007|2007-05-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Use of Sedation and Local Anesthesia in Meatotomy: A Prospective Comparison Study|Use of Sedation and Local Anesthesia in Meatotomy: A Prospective Comparison Study|Unknown status|Recruiting|Phase 3|75|Anticipated|Rabin Medical Center||3|||f||||f||||||||||2017-02-18 15:34:51.604948|2017-02-18 15:34:51.604948
NCT00480506|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2012-02-22|||April 2004||2004-04-01|February 2012|2012-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major|Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major|Completed||N/A|40|Anticipated|Dana-Farber Cancer Institute|||1||f||||f||||||||||2017-02-18 15:34:51.693432|2017-02-18 15:34:51.693432
NCT00480493|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2012-06-21|2011-11-03||June 2004||2004-06-01|June 2012|2012-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|STEP||STEP: Social Support To Empower Parents|STEP: Social Support To Empower Parents|Completed||Phase 3|60|Actual|University of Massachusetts, Worcester|We did not have enough parents recruited to look at structural equation modeling.|2|||f||||f||||||||||2017-02-18 15:34:51.780541|2017-02-18 15:34:51.780541
NCT00480480|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2007-05-30|||September 2000||2000-09-01|May 2007|2007-05-01|October 2001|Actual|2001-10-01|||||Interventional|||Randomized Controlled Trial of the Effectiveness of Group Treatment With War-Exposed Bosnian Adolescents|Long-Term Post- War Adjustment in Bosnian Adolescents, Their Parents and Teachers|Completed||N/A|144|Actual|Brigham Young University||2|||f||||f||||||||||2017-02-18 15:34:52.184795|2017-02-18 15:34:52.184795
NCT00480467|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-12-03|||September 2006||2006-09-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 Administered Orally to Healthy Japanese Male Subjects|Completed||Phase 1|32||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:34:52.278555|2017-02-18 15:34:52.278555
NCT00480454|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2010-02-08|||October 2006||2006-10-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines|An Open Randomized Dose Selection Study Evaluating the Safety, Immunogenicity, and Impact of a TB Vaccine, MVA85A, on the Immunogenicity of EPI Vaccines Administered Simultaneously to Healthy Infants Previously Vaccinated With BCG.|Completed||Phase 1|214|Actual|University of Oxford||2|||f||||t||||||||||2017-02-18 15:34:52.359054|2017-02-18 15:34:52.359054
NCT00480441|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2012-01-17|||August 2006||2006-08-01|January 2012|2012-01-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal|A Phase II Double-Blind Placebo-Controlled Trial of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal|Completed||Phase 2|61|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 15:34:52.46942|2017-02-18 15:34:52.46942
NCT00480428|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-30|2017-01-24|||May 17, 2007||2007-05-17|August 22, 2016|2016-08-22||||||||Observational|||Radiation Exposure and Thyroid Disease in Kazakhstan|Study to Improve Thyroid Doses From Fallout Exposure in Kazakhstan|Completed||N/A|128|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:34:52.599903|2017-02-18 15:34:52.599903
NCT00480402|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2013-04-03|||January 2006||2006-01-01|April 2013|2013-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Natural Progesterone and Preterm Birth in Twins|Eficacia de Los Suplementos de Progesterona Natural en la prevención Del Parto pretérmino Gemelar|Completed||Phase 3|290|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA||3|||f||||t||||||||||2017-02-18 15:34:52.693855|2017-02-18 15:34:52.693855
NCT00480389|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2015-12-07|||May 2007||2007-05-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal|Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy|Completed||Phase 2|19|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 15:34:52.793045|2017-02-18 15:34:52.793045
NCT00480376|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-05-29|||June 2007||2007-06-01|May 2007|2007-05-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate|Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate|Unknown status|Not yet recruiting|Phase 4|160|Anticipated|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-02-18 15:34:52.917408|2017-02-18 15:34:52.917408
NCT00480363|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2013-07-30|||May 2007||2007-05-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|December 2008|Actual|2008-12-01||Interventional|QUIREDEX||QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression|QUIREDEX: A National, Open-Label, Multicenter, Randomized, Phase III Study of Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression|Completed||Phase 3|120|Actual|PETHEMA Foundation||2|||f||||t||||||||||2017-02-18 15:34:53.008154|2017-02-18 15:34:53.008154
NCT00480324|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2016-10-06|2010-03-30||June 2007||2007-06-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants|Efficacy, Safety, Reactogenicity and Immunogenicity Study of the Lyophilised Formulation of Rotarix Vaccine in Healthy Japanese Infants|Completed||Phase 3|765|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:34:53.311393|2017-02-18 15:34:53.311393
NCT00480311|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2011-06-26|||April 2007||2007-04-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||World Health Organization Disability Assessment Schedule II (WHODAS-II) for Patients With Symptomatic Lumbar Spinal Stenosis|WHODAS-II for Patients With Symptomatic Lumbar Spinal Stenosis|Terminated||N/A|200|Anticipated|Kovacs Foundation|||1|"Recruitment was so slow, that it made the study impossible. Organizational changes made it~   impossible for recruiting centers to continue recruitment"|f||||t||||||||||2017-02-18 15:34:54.065933|2017-02-18 15:34:54.065933
NCT00480298|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-12-19|||November 2002||2002-11-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis|Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis|Completed||Phase 2|48||University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 15:34:54.163687|2017-02-18 15:34:54.163687
NCT00480285|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-05-29|||November 2006||2006-11-01|May 2007|2007-05-01|November 2011|Anticipated|2011-11-01|||||Interventional|||A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients|A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients|Unknown status|Recruiting|Phase 3|100|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 15:34:54.245646|2017-02-18 15:34:54.245646
NCT00480272|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2009-08-03|||May 2007||2007-05-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|CURE||Prospective Study on Intensive Early Rheumatoid Arthritis Treatment|A Phase IV Multicenter, Randomized, Double-blind Study. prospeCtive Study on Intensive Early Rheumatoid Arthritis Treatment With adalimUmab: Induction of REmission and Maintenance|Unknown status|Recruiting|Phase 4|240|Anticipated|IRCCS Policlinico S. Matteo||1|||f||||t||||||||||2017-02-18 15:34:54.340248|2017-02-18 15:34:54.340248
NCT00480259|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-05-29||||||May 2007|2007-05-01||||||||Interventional|||Hyperproteic Nutrition:Correlation of BUN to Nitrogen Balance|Hyperproteic Nutrition; Correlation of BUN to Nitrogen Balance and Associated Infection Rates With Bimodal Protein Administration|Unknown status|Not yet recruiting|N/A|||Penn State University||2|||f||||f||||||||||2017-02-18 15:34:54.451784|2017-02-18 15:34:54.451784
NCT00480246|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2009-07-20|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Interventional|||A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer||Completed||Phase 1|||BioLineRx, Ltd.|||||f||||||||||||||2017-02-18 15:34:54.689721|2017-02-18 15:34:54.689721
NCT00480233|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2008-02-04|||January 2008||2008-01-01|February 2008|2008-02-01||||||||Observational|||Screening Questionnaire for Depression|Validation of a Hebrew Version of a Brief Screening Questionnaire for Depression in General Medicine|Unknown status|Recruiting|N/A|200|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:34:54.771736|2017-02-18 15:34:54.771736
NCT00480220|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2015-08-18|||August 2003||2003-08-01|August 2015|2015-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|PLASA||Specific Care and Assistance Plan for Alzheimer's Disease|Specific Care and Assistance Plan for Alzheimer's Disease: Impact Study on Disease Progression and Management Modalities|Completed||N/A|1200|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 15:34:54.863217|2017-02-18 15:34:54.863217
NCT00480207|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2012-11-05|||May 2007||2007-05-01|November 2012|2012-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults|Randomized Double-blind Controlled Clinical Trial to Assess the Impact of Folic Acid and Omega-3 Fatty Acids Supplementation on the Severity of Depressive Symptoms in Older Adults With Identified Depression|Completed||Phase 2/Phase 3|15|Actual|Beersheva Mental Health Center||4|||f||||t||||||||||2017-02-18 15:34:55.030994|2017-02-18 15:34:55.030994
NCT00480194|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2012-05-04|||December 2006||2006-12-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)|A Non-interventional, Non-controlled, Post-marketing Study to Obtain Knowledge of the Safety of ZyComb® (Xylometazoline Hydrochloride 0.5 mg/mL and Ipratropium Bromide 0.6 mg/mL) for Symptoms of Common Cold in a Real-life OTC Setting|Completed||N/A|1000|Anticipated|Nycomed|||1||f||||t||||||||||2017-02-18 15:34:55.142306|2017-02-18 15:34:55.142306
NCT00480181|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2012-07-26|||June 2007||2007-06-01|March 2011|2011-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis|A Comparative, Single Center, Randomized, Double-blinded, Parallel, Placebo-controlled Study to Evaluate the Efficacy of Nabilone (Cesamet) as Adjunctive Therapy to Gabapentin (Neurontin) in the Management of Neuropathic Pain (NPP) Symptoms in Subjects With Multiple Sclerosis (MS)|Completed||Phase 4|50|Anticipated|University of Manitoba||2|||f||||f||||||||||2017-02-18 15:34:55.218291|2017-02-18 15:34:55.218291
NCT00480168|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2010-03-22|||May 2007||2007-05-01|March 2010|2010-03-01|August 2011|Anticipated|2011-08-01|||||Observational|||A Prospective Study to Assess Metabolic Changes in Children and Adolescents Treated With Atypical Antipsychotics|A Prospective Study to Assess Metabolic Changes in Children and Adolescents Aged 6-18 Treated With Atypical Antipsychotics|Unknown status|Recruiting|N/A|50|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-02-18 15:34:55.326718|2017-02-18 15:34:55.326718
NCT00480155|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2008-12-19|||May 2007||2007-05-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate the Safety of A Monovalent Vaccine in Healthy Adults|Completed||Phase 2|300|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 15:34:55.425723|2017-02-18 15:34:55.425723
NCT00480142|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2007-06-05|||July 2007||2007-07-01|May 2007|2007-05-01|July 2008||2008-07-01|||||Interventional|||Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy|Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy : Prospective Double Blind, Randomized, Placebo-Controlled Study|Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Kaplan Medical Center||4|||f||||t||||||||||2017-02-18 15:34:55.531389|2017-02-18 15:34:55.531389
NCT00480129|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2015-08-10|||May 2007||2007-05-01|August 2015|2015-08-01|October 2007|Actual|2007-10-01|||||Interventional|||The Anti-allergic Effects of Specific Probiotics|The Anti-allergic Effects of Specific Probiotics - a Double Blind Clinical Study|Completed||Phase 1|36|Actual|Lawson Health Research Institute||1|||f||||||||||||||2017-02-18 15:34:55.608871|2017-02-18 15:34:55.608871
NCT00480116|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2008-08-22|||January 2008||2008-01-01|August 2008|2008-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule|Phase III, Single Centre, Double Blind, Randomised Study Evaluating the Consistency of Three Lots of Henogen's New Adjuvanted Hepatitis B Vaccine, When Given at 0, 1 Month Schedule in Healthy Volunteers Aged 18 Years to 40 Years.|Completed||Phase 3|450|Actual|Henogen||3|||f||||f||||||||||2017-02-18 15:34:55.722723|2017-02-18 15:34:55.722723
NCT00480103|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2011-03-03|||August 2007||2007-08-01|March 2011|2011-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|ANECOVA||Intrauterine Embryo Development With ANECOVA Device|Multi-Center Evaluation Program NCVD1H Intrauterine Embryo'S Development Assisted by ANECOVA ACVd1 Device|Terminated||Phase 3|||Instituto Valenciano de Infertilidad, IVI VALENCIA||||INHERENT MODIFICATIONS NEEDED BEFORE PROCEEDING|f||||f||||||||||2017-02-18 15:34:55.843105|2017-02-18 15:34:55.843105
NCT00480090|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2013-01-10|||April 2007||2007-04-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|October 2010|Actual|2010-10-01||Interventional|SLAP||A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer|A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer|Completed||Phase 2|10|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 15:34:55.930656|2017-02-18 15:34:55.930656
NCT00480077|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2010-02-05|||March 2007||2007-03-01|February 2010|2010-02-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|DOT-HF||Diagnostic Outcome Trial in Heart Failure (DOT-HF Trial)|Diagnostic Outcome Trial in Heart Failure|Terminated||Phase 4|336|Actual|Medtronic Bakken Research Center||2||Low enrollment rates|f||||t||||||||||2017-02-18 15:34:56.04069|2017-02-18 15:34:56.04069
NCT00480064|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-05-29|||July 1995||1995-07-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Lomustine and Intermediate Dose Cytarabine in Older Patients With AML|Randomized Prospective Study of Adding Lomustine to Idarubicin and Cytarabine for Induction Chemotherapy and Adding Intermediate Dose Cytarabine to Consolidation in Older Patients With Acute Myeloid Leukaemia|Completed||Phase 3|360|Actual|French Innovative Leukemia Organisation||2|||f||||t||||||||||2017-02-18 15:34:56.155944|2017-02-18 15:34:56.155944
NCT00480051|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-07-09|||July 2007||2007-07-01|May 2007|2007-05-01|June 2010|Anticipated|2010-06-01|||||Interventional|BIPIDS||Birmingham Biventricular Pacing in Patients With Heart Failure Unselected for Dyssynchrony|Birmingham Biventricular Pacing in Patients With Heart Failure Unselected for Dyssynchrony (QRS < 120ms)- a Randomised Controlled Trial|Unknown status|Recruiting|Phase 3|60|Anticipated|Heart of England NHS Trust||2|||f||||t||||||||||2017-02-18 15:34:56.257761|2017-02-18 15:34:56.257761
NCT00480038|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2011-06-26|||April 2007||2007-04-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||World Health Organization Disability Assessment Schedule (WHODAS-II) for Patients With Symptomatic Lumbar Disc Herniation|WHODAS-II for Patients With Symptomatic Lumbar Disc Herniation|Terminated||N/A|200|Anticipated|Kovacs Foundation||1||"Recruitment was so slow, that it made the study impossible. Organizational changes made it~   impossible for recruiting centers to continue recruitment"|f||||t||||||||||2017-02-18 15:34:56.366725|2017-02-18 15:34:56.366725
NCT00480025|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2015-11-19||2013-08-22|October 2007||2007-10-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|December 2013|Actual|2013-12-01||Interventional|||GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer|GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Resectable MAGE-A3 Positive Non-Small Cell Lung Cancer|Terminated||Phase 3|2278|Actual|GlaxoSmithKline||2||"The study was terminated following assessment of the lack of efficacy of the study product by~   the Independent Data monitoring Committee for the study."|f||||||||||||||2017-02-18 15:34:56.504007|2017-02-18 15:34:56.504007
NCT00480012|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2011-08-28|||May 2005||2005-05-01|August 2011|2011-08-01||||June 2007|Anticipated|2007-06-01||Interventional|||The Effects of TMS on Memory-consolidation in Human Primary Visual Cortex|The Effects of Transcranial Magnetic Stimulation of the Brain on Memory-consolidation in Human Primary Visual Cortex|Withdrawn||N/A|0|Anticipated|Sheba Medical Center||1||Due to administrative issues, the study was withdrawn.|f||||||||||||||2017-02-18 15:35:00.224149|2017-02-18 15:35:00.224149
NCT00479999|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-26|2017-01-24|||May 24, 2007||2007-05-24|May 5, 2014|2014-05-05|May 5, 2014|Actual|2014-05-05|May 5, 2014|Actual|2014-05-05||Interventional|||Phase 1 Safety Study of Two Experimental HIV Vaccines|VRC 012: A Phase I Clinical Trial of the Safety and Immunogenicity of an HIV-1 Adenoviral Vector Serotype 35 Vaccine: Dose Escalation as a Single Agent and Prime-Boost Schedules With an HIV-1 Adenoviral Vector Serotype 5 Vaccine in Uninfected Adults|Completed||Phase 1|35|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:35:00.311932|2017-02-18 15:35:00.311932
NCT00479986|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2015-03-31|||June 2005||2005-06-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Interventional|PIOcard||Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease|Effects of Pioglitazone in Patients With Type 2 Diabetes Mellitus and Coronary Heart Disease at High Risk for Vascular Complications : A Placebo-Controlled Study|Completed||Phase 4|92|Actual|IKFE Institute for Clinical Research and Development||2|||f||||t||||||||||2017-02-18 15:35:00.426038|2017-02-18 15:35:00.426038
NCT00479973|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-28|2007-11-19|||September 2007||2007-09-01|November 2007|2007-11-01|May 2008|Anticipated|2008-05-01|||||Interventional|||The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark|The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark (Cinnamomum Verum and C. Aromaticum) (Cinnamonforce™) - Randomized Placebo-Controlled Clinical Trial|Unknown status|Recruiting|Phase 2|70|Anticipated|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 15:35:00.537195|2017-02-18 15:35:00.537195
NCT00479947|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-05-29|||May 2007||2007-05-01|May 2007|2007-05-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis|A Double-Blind,Randomized Placebo-Controlled Study Using Probiotic Lactobacillus GR-1 and RC-14 as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis|Unknown status|Recruiting|Phase 1|100|Anticipated|Faith Mediplex||2|||f||||f||||||||||2017-02-18 15:35:00.745392|2017-02-18 15:35:00.745392
NCT00479934|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2011-03-03|||December 2007||2007-12-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|SCLEROGLIVEC||Efficacy and Safety of Imatinib in Scleroderma|Phase II Randomized Double Blind Clinical Trial of'Imatinib Mesylate STI571 (Glivec®) Versus Placebo in Patients With Severe Cutaneous Scleroderma or Systemic Sclerosis With Severe Cutaneous Involvement.|Completed||Phase 2|28|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 15:35:00.853825|2017-02-18 15:35:00.853825
NCT00479921|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2009-01-29|||June 2007||2007-06-01|January 2009|2009-01-01||||||||Interventional|||Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe|Immunogenicity and Reactogenicity of Trivalent Influenza Subunit Vaccine Influvac® for the Season 2007/2008. An Open, Baseline-Controlled Multi-Center Study in Two Groups of Healthy Subjects: Adults and Elderly|Completed||Phase 3|120|Anticipated|Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 15:35:00.977428|2017-02-18 15:35:00.977428
NCT00479908|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-29|2007-05-29|||January 2004||2004-01-01|May 2007|2007-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With Angina|Investigation of the Time Course of the Interaction of the Hypotensive Effects of Sildenafil Citrate and Sublingual Glyceryl Trinitrate (GTN) in Men With Stable Angina Pectoris|Completed||Phase 4|20|Actual|University of Edinburgh||2|||f||||f||||||||||2017-02-18 15:35:01.071236|2017-02-18 15:35:01.071236
NCT00479895|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2008-05-29|||April 2007||2007-04-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Hemoglobin Based Oxygen Therapeutics in Elective Percutaneous Coronary Revascularization|Phase II, Open-Label Study in the Catheterization Laboratory Setting to Challenge the Concept That HBOC-201 Administration Might Improve Myocardial 'Oxygenation' and Myocardial Function at the Moment of (Brief) Coronary Occlusion|Completed||Phase 2|5|Actual|Biopure Corporation||2|||f||||f||||||||||2017-02-18 15:35:01.17931|2017-02-18 15:35:01.17931
NCT00479882|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-03-02|2015-12-16||June 2007||2007-06-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||MK-0524B Lipid Study (MK-0524B-063)|"A Multicenter, Randomized, Double-Blind, Crossover Design Study to Evaluate the Lipid-Altering Efficacy and Safety of MK-0524B Combination Tablet Compared to MK-0524A + Simvastatin Coadministration in Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia"|Completed||Phase 3|2414|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:35:01.545104|2017-02-18 15:35:01.545104
NCT00479856|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2012-05-31|2010-05-03||November 2007||2007-11-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|||Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer|An Open-label, Multi-centre Study of Lapatinib in Combinationwith Chemotherapy in Patients With ErbB2 Overexpressing Breastcancer After Trastuzumab Failure in the Neoadjuvant or Adjuvantsetting.|Terminated||Phase 2|9|Actual|GlaxoSmithKline||1||Study was terminated due to difficulty in identifying eligible subjects|f||||||||||||||2017-02-18 15:35:03.656073|2017-02-18 15:35:03.656073
NCT00479843|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2014-01-23|||July 2005||2005-07-01|January 2014|2014-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Nutritional Programme for Dementia Elderly Patient|Development of a Programme to Show the Positive Effect of a Nutritional Programme on Preventing Functional and Weight Losses in Patients With Dementia|Completed||N/A|946|Actual|Nestlé||1|||f||||f||||||||||2017-02-18 15:35:04.238308|2017-02-18 15:35:04.238308
NCT00479830|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2016-04-11|||April 2007||2007-04-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Health and Cancer Issues in the South Asian Community|Health and Cancer Issues in the South Asian Community|Completed||N/A|39|Actual|M.D. Anderson Cancer Center|||4||f||||f||||||||||2017-02-18 15:35:04.334564|2017-02-18 15:35:04.334564
NCT00479817|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2017-02-01||2015-10-29|July 2007||2007-07-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|August 2009|Actual|2009-08-01||Interventional|||Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer|A Randomized, Double-Blind, Placebo Controlled, Phase 2 Trial of Paclitaxel in Combination With AMG 386 in Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer|Active, not recruiting||Phase 2|161|Actual|Amgen||3|||f||||f||||||||||2017-02-18 15:35:04.445465|2017-02-18 15:35:04.445465
NCT00479804|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2008-06-04|||August 2006||2006-08-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|NICO||Non-Invasive Determination of Cardiac Output by Inertgas Rebreathing Method|Non-Invasive Determination of Cardiac Output by the Inertgas Rebreathing Method Compared With Magnetic Resonance Tomography|Completed||N/A|311|Actual|Universitätsmedizin Mannheim|||1||f||||||||||||||2017-02-18 15:35:04.573587|2017-02-18 15:35:04.573587
NCT00479791|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-05-25|||April 1997||1997-04-01|May 2007|2007-05-01|June 1999|Actual|1999-06-01|||||Interventional|||Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids|Lipid, Glycemic, and Insulin Responses to Meals Rich in Saturated, Cis-Monounsaturated, and Polyunsaturated Fatty (n-3 and n-6)Acids in Subjects With Type 2 Diabetes Mellitus|Completed||N/A|11|Actual|University of Texas Southwestern Medical Center||4|||f||||f||||||||||2017-02-18 15:35:04.661149|2017-02-18 15:35:04.661149
NCT00479778|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-12-19|||April 2007||2007-04-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms|An Open Label, Randomized, Multicenter Study To Compare Bazedoxifene Steady-State Exposures Obtained With 2 Bazedoxifene Acetate/Conjugated Estrogen Formulations In Postmenopausal Women|Completed||Phase 1|72||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:35:04.754584|2017-02-18 15:35:04.754584
NCT00479765|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2014-04-17|2014-04-17||March 2007||2007-03-01|April 2014|2014-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||Four subjects were dosed with 5% Oncogel prior to study termination.|A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma|A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma|Terminated||Phase 1/Phase 2|4|Actual|BTG International Inc.||1||Sponsor business decision, not based on safety or efficacy data|f||||t||||||||||2017-02-18 15:35:04.836977|2017-02-18 15:35:04.836977
NCT00479752|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2016-02-17|||January 2008||2008-01-01|February 2016|2016-02-01|November 2015|Actual|2015-11-01|June 2010|Actual|2010-06-01||Interventional|CORE 2||Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer|A Randomized, Open-label Phase II Study Evaluating the Efficacy and Safety of FOLFOX4 + Weekly Cetuximab Versus FOLFOX4+ Biweekly Cetuximab as First-line Therapy in Patients With Metastatic Colorectal Cancer.|Completed||Phase 2|151|Actual|Central European Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 15:35:05.047961|2017-02-18 15:35:05.047961
NCT00479739|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2016-09-13|||November 2002||2002-11-01|September 2016|2016-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.|Randomised, Double-blind, Double-dummy, 52-week, Parallel Group Study of a Standard Dosing Regimen With Salmeterol/Fluticasone propionate50/250 Twice Daily Diskus Versus a Symptom-driven, Variable Dosing Regimen With Formoterol/Budesonide Combination 4.5/160 in Adult Asthmatics|Completed||Phase 4|700|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:35:05.181848|2017-02-18 15:35:05.181848
NCT00479726|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-05-25|||August 2004||2004-08-01|May 2007|2007-05-01|January 2005|Actual|2005-01-01|||||Interventional|LEAPS||Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)|Lilly's Emotional and Physical Symptoms of Depression Study|Completed||Phase 4|8000||Eli Lilly and Company|||||f||||f||||||||||2017-02-18 15:35:05.403858|2017-02-18 15:35:05.403858
NCT00479713|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-09-01|2009-02-11||February 2007||2007-02-01|September 2015|2015-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)|A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Assess the LDL-C Lowering of Switching to a Combo Tab Ezetimibe/Simvastatin (10 mg/20 mg) Compared to Rosuvastatin 10 mg in Patients With Primary High Cholesterol and High Cardiovascular Risk Not Controlled With a Prior Statin Treatment|Completed||Phase 3|618|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:35:05.507144|2017-02-18 15:35:05.507144
NCT00479700|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-12-07|||May 2006||2006-05-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-531 Administered Orally to Healthy Subjects|Completed||Phase 1|80||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:35:06.458436|2017-02-18 15:35:06.458436
NCT00479687|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-03-17|||May 2007||2007-05-01|July 2013|2013-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder|A Multi-center, Randomized, Double-blind, Placebo Controlled Trial of SUPARTZ (Sodium Hyaluronate) for the Treatment of Chronic Shoulder Pain|Completed||Phase 3|256|Actual|Bioventus LLC||2|||f||||f||||||||||2017-02-18 15:35:06.544841|2017-02-18 15:35:06.544841
NCT00479674|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2015-01-29|2014-12-09||May 2007||2007-05-01|January 2015|2015-01-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|ABC||Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer|"A Phase II Study of Abraxane®, Carboplatin and Bevacizumab in Triple Negative (Demonstrating No Expression for Estrogen, Progesterone, or Her2 Receptors) Metastatic Breast Cancer"|Completed||Phase 2|41|Actual|Duke University||1|||f||||f||||||||||2017-02-18 15:35:06.828031|2017-02-18 15:35:06.828031
NCT00479661|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2010-08-12|||May 2007||2007-05-01|August 2010|2010-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|Prodex||Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)|A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Propofol for Continuous Sedation of Ventilated Patients in Intensive Care Unit|Completed||Phase 3|500|Actual|Orion Corporation, Orion Pharma||2|||f||||t||||||||||2017-02-18 15:35:07.306914|2017-02-18 15:35:07.306914
NCT00479648|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2016-07-17|||May 2007||2007-05-01|November 2008|2008-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants|A Phase II, Double-Blind, Randomised, Controlled, Multi-Centre Study to Evaluate the Immunogenicity, Safety and Tolerability of Three Formulations of CSL412 in Adults (≥ 18 to ≤ 45 Years) and Older Adults (≥ 60 Years)|Completed||Phase 2|612|Actual|Seqirus||4|||f||||||||||||||2017-02-18 15:35:07.470029|2017-02-18 15:35:07.470029
NCT00479635|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2014-01-09||2012-07-16|January 2007||2007-01-01|January 2014|2014-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer|A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Taxane Regimen|Terminated||Phase 2|26|Actual|Cortice Biosciences, Inc.||1||Sponsor could no longer support; enrollment stopped August 2008.|f||||f||||||||||2017-02-18 15:35:07.581069|2017-02-18 15:35:07.581069
NCT00479622|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2008-05-07|||August 2007||2007-08-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus|A Randomized, Two-Arm, Parallel Group Study of the Safety, Pharmacokinetics, and Pharmacodynamics of TRU-015 Added to Standard Therapy in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus|Terminated||Phase 1|20|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 15:35:07.69836|2017-02-18 15:35:07.69836
NCT00479609|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2008-05-06|||April 2007||2007-04-01|May 2008|2008-05-01|April 2009|Anticipated|2009-04-01|January 2009|Anticipated|2009-01-01||Interventional|||Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes|A Randomised Placebo Controlled Study of Transdermal Testosterone Therapy to Investigate the Efficacy and Safety in Men With Abdominal Obesity, Low Testosterone Levels and Early Stages of the Metabolic Cluster Syndrome.|Unknown status|Recruiting|Phase 3|176|Anticipated|Karolinska Institutet||2|||f||||t||||||||||2017-02-18 15:35:07.805237|2017-02-18 15:35:07.805237
NCT00479414|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-05-25|||August 2004||2004-08-01|May 2007|2007-05-01|January 2005|Actual|2005-01-01|||||Interventional|LEAPS||Lilly's Emotional and Physical Symptoms of Depression Study|Lilly's Emotional and Physical Symptoms of Depression Study|Completed||Phase 4|8000||Eli Lilly and Company|||||f||||f||||||||||2017-02-18 15:35:12.667527|2017-02-18 15:35:12.667527
NCT00479596|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-05-29|||January 2007||2007-01-01|January 2007|2007-01-01|May 2007|Anticipated|2007-05-01|||||Interventional|BTX0621||This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.|Safety and Efficacy Study of Intradetrusor Injections of Botox® for the Treatment of Urinary Incontinence Secondary to Benign Prostatic Obstruction (BTX0621)|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Urological Sciences Research Foundation||2|||f||||f||||||||||2017-02-18 15:35:07.919422|2017-02-18 15:35:07.919422
NCT00479583|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2011-11-29|||September 2007||2007-09-01|March 2011|2011-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX|A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-690514 in Combination With FOLFIRI and FOLFOX in Subjects With Advanced Metastatic Solid Tumors|Completed||Phase 1|25|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 15:35:08.021503|2017-02-18 15:35:08.021503
NCT00479570|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-04-07|||June 2007||2007-06-01|April 2009|2009-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.|Phase 2A Multi-Centre, Double Blind, Placebo Controlled 3-Way Cross-Over Study To Investigate The Effect Of Single Doses Of PF-00446687 On Sexual Arousal And Sexual Desire In Women Suffering From Female Sexual Dysfunction (FSD).|Completed||Phase 2|23|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:35:08.131634|2017-02-18 15:35:08.131634
NCT00479557|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-11-30|2014-05-06||May 2007||2007-05-01|November 2015|2015-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||245 participants were randomized in both studies (86 participants in 3134K1-200-EU [B2571004] and 159 participants in 3134K1-2201-US [B2571005]) and included in the analysis below. One participant of the randomized participants did not receive treatment.|Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease|A Phase Iia, Multicenter, Randomized, Third-party Unblinded, Adjuvant And Placebo-controlled, Multiple Ascending Dose, Safety, Tolerability And Immunogenicity Trial Of Acc-001 And Qs-21 Adjuvant In Subjects With Mild To Moderate Alzheimer's Disease|Completed||Phase 2|86|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 15:35:08.251795|2017-02-18 15:35:08.251795
NCT00479531|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-11-29|||September 2005||2005-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Sequential Compression Devices for Treatment of Restless Legs Syndrome|Sequential Compression Devices for Treatment of Restless Legs Syndrome - a Prospective, Randomized, Sham-Controlled Study|Completed||Phase 3|40|Anticipated|Walter Reed Army Medical Center||2|||f||||t||||||||||2017-02-18 15:35:11.046444|2017-02-18 15:35:11.046444
NCT00479518|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2009-04-09|||March 2007||2007-03-01|April 2009|2009-04-01|March 2012|Anticipated|2012-03-01|||||Observational|ABC-AVC||Prognostic Value of Cardiac and Renal Markers in Ischemic Stroke and Transient Ischemic Attack|Prognostic Value of Cardiac and Renal Markers in the Acute Phase of Ischemic Stroke or Transient Ischemic Attack :Albuminuria-Brain Natriuretic Peptide-Cystatine C in Stroke|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Tours|||1||f||||f||||||Samples Without DNA|"~     Blood Urine~   "|||2017-02-18 15:35:11.139525|2017-02-18 15:35:11.139525
NCT00479505|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2011-03-11||2009-03-24|June 2007||2007-06-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder|A Multi-Center, Randomised, Parallel Group, Double-Blind, Placebo Controlled Estimation Study To Assess The Efficacy And Safety Of Modified Release UK-369,003 In The Treatment Of Men With Storage Lower Urinary Tract Symptoms (LUTS) With And Without Erectile Dysfunction (ED).|Completed||Phase 2|275|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 15:35:11.234117|2017-02-18 15:35:11.234117
NCT00479492|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-09-29||2009-09-29|June 2007||2007-06-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers|A 12-Week, Randomized, Subject And Investigator Blind, Placebo-Controlled Trial To Evaluate The Effect Of CP-866,087 On Weight Loss In Obese, Otherwise Healthy Adult Subjects|Completed||Phase 2|94|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 15:35:11.396478|2017-02-18 15:35:11.396478
NCT00479479|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2015-07-20|||December 2004||2004-12-01|July 2015|2015-07-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development|Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development|Completed||N/A|107|Actual|Haukeland University Hospital||2|||f||||f||||||||||2017-02-18 15:35:11.514731|2017-02-18 15:35:11.514731
NCT00479466|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2015-09-08|2011-10-07||July 2007||2007-07-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Dose-Range Finding Study for MK0893 (0893-008)|A Multicenter, Double-Blind, Randomized, Placebo and Active Comparator Controlled Dose-Range Finding Study of MK0893 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Terminated||Phase 2|342|Actual|Merck Sharp & Dohme Corp.|Sufficient data regarding the dose-response to MK-0893 had been obtained from the first cohort of the study to assess the safety and efficacy, thus the study was discontinued.|6||"Sufficient data regarding the dose-response to MK-0893 had been obtained from the first cohort~   of the study to assess the safety and efficacy"|f||||||||||||||2017-02-18 15:35:11.636446|2017-02-18 15:35:11.636446
NCT00479453|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-05-25|||August 2004||2004-08-01|May 2007|2007-05-01|January 2005|Actual|2005-01-01|||||Interventional|LEAPS||Lilly's Emotional and Physical Symptoms of Depression|Lilly's Emotional and Physical Symptoms of Depression|Completed||Phase 4|8000||Eli Lilly and Company|||||f||||f||||||||||2017-02-18 15:35:12.410161|2017-02-18 15:35:12.410161
NCT00479440|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-12-03|||August 2006||2006-08-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 Administered Orally to Healthy Adult Subjects|Completed||Phase 1|56||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:35:12.502875|2017-02-18 15:35:12.502875
NCT00479427|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-07-22||2009-07-22|July 2007||2007-07-01|July 2009|2009-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis|A Double-blind, Placebo Controlled Cross-over Study of the Effects of the CB2 Compound of GW842166 in Patients With Osteoarthritis|Completed||Phase 2|45|Anticipated|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:35:12.571131|2017-02-18 15:35:12.571131
NCT00479401|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2014-06-20|2009-11-20||May 2007||2007-05-01|June 2014|2014-06-01||||November 2008|Actual|2008-11-01||Interventional|||Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients|A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing the Efficacy, Safety and Tolerability of Pramipexole ER Versus Placebo and Versus Pramipexole IR Administered Orally Over a 26-week Maintenance Phase in Patients With Early Parkinsons Disease (PD).|Completed||Phase 3|539|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 15:35:12.776072|2017-02-18 15:35:12.776072
NCT00479388|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-02-20|2009-06-09||July 2007||2007-07-01|February 2015|2015-02-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)|A Multicenter, Randomized, Double-Blind, Parallel Group, 12 Week Study to Evaluate the Efficacy and Safety of Extended-release (ER) Niacin/Laropiprant in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia.|Completed||Phase 3|1216|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:35:14.089312|2017-02-18 15:35:14.089312
NCT00479375|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-05-25|||May 1997||1997-05-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|SWEDESCREEN||Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening|Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Screening|Completed||N/A|12527|Actual|Skane University Hospital||2|||f||||t||||||||||2017-02-18 15:35:15.008226|2017-02-18 15:35:15.008226
NCT00479362|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2012-09-14|||September 2005||2005-09-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|FINPAC||Anticoagulant Therapy During Pacemaker Implantation|Randomized Trial of Uninterrupted Versus Interrupted Anticoagulant Therapy in Patients Undergoing Cardiac Pacing Device Implantation|Completed||Phase 4|447|Actual|University of Turku||4|||f||||f||||||||||2017-02-18 15:35:15.102097|2017-02-18 15:35:15.102097
NCT00479349|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-07-06|||May 2007||2007-05-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531|An Ascending Multiple Dose Study of the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-531 Administered Orally to Healthy Japanese Young Male and Elderly Subjects|Completed||Phase 1|32|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 15:35:15.222991|2017-02-18 15:35:15.222991
NCT00479336|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2014-01-30|2013-12-15||June 2007||2007-06-01|January 2014|2014-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||"2 subjects (1 of placebo and 1 of OPC-41061 30 mg) were excluded by GCP deviation.~1 subject (OPC-41061 7.5 mg) was excluded by receiving a dose 7 times higher than specified daily dose."|A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema|A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema|Completed||Phase 2|104|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-02-18 15:35:15.319378|2017-02-18 15:35:15.319378
NCT00479323|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-12-22|||June 2007||2007-06-01|April 2011|2011-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Pneumococcal Reference Standard|Stimulation of Donors for Pneumococcal Reference Serum|Completed||Phase 1|250|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 15:35:16.040615|2017-02-18 15:35:16.040615
NCT00479310|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-05-25|||January 2006||2006-01-01|May 2007|2007-05-01||||||||Interventional|||Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice|A Multi-Center, Randomized, Vehicle Controlled, Double Blind Clinical Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice.|Completed||Phase 3|120||Summers Laboratories|||||||||||||||||||2017-02-18 15:35:16.141684|2017-02-18 15:35:16.141684
NCT00479297|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-08-06|||May 2006||2006-05-01|August 2009|2009-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-531 Administered Orally to Healthy Japanese Male Subjects|Completed||Phase 1|72||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:35:16.212931|2017-02-18 15:35:16.212931
NCT00479284|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2007-05-25|||June 2006||2006-06-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Efficacy of Average Volume Assured Pressure Support With Bi-Level Pressure Support Nocturnal Ventilation|Contribution of Average Volume Assured Pressure Support (AVAPS) to Efficacy of bi-Level Pressure Support Nocturnal Ventilation and Impact on Sleep Structure|Completed||N/A|14|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 15:35:16.285252|2017-02-18 15:35:16.285252
NCT00479271|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2015-03-31|||October 2003||2003-10-01|May 2007|2007-05-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Evaluating the Effectiveness of a Community Based Intervention for Persons With Dementia and Their Caregivers in a Developing Country|The Dementia Home Care Project: a Randomised Controlled Trial to Evaluate the Effectiveness of a Home Care Program for Supporting Caregivers of Persons With Dementia in Developing Countries: a Randomised Controlled Trial From Goa, India|Completed||N/A|||London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 15:35:16.381012|2017-02-18 15:35:16.381012
NCT00479258|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2008-10-31|2008-10-29||October 2007||2007-10-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents|Safety And Efficacy Of Exubera® (Inhaled Insulin) Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents Ages 6-17 Years With Type 1 Diabetes Mellitus: A 12 Month, Outpatient, Randomized, Open Label, Parallel Group Comparative Trial.|Terminated||Phase 3|554|Anticipated|Pfizer|Pfizer announced Oct07 it would stop marketing Exubera; recruitment placed on hold. Nektar, from which Pfizer licensed Exubera, announced April 9, 2008 it had stopped its search for a new marketing partner. Study terminated; no further recruitment.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 15:35:16.489825|2017-02-18 15:35:16.489825
NCT00479245|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2011-06-26|||April 2007||2007-04-01|June 2011|2011-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||WHODAS-II for Patients With Nonspecific Low Back Pain|WHODAS-II for Patients With Nonspecific Low Back Pain|Terminated||N/A|200|Anticipated|Kovacs Foundation||1||"Recruitment rate, lower than expected. Organizational changes made it impossible for~   recruiting centers to continue"|f||||t||||||||||2017-02-18 15:35:16.784107|2017-02-18 15:35:16.784107
NCT00478855|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-12-07|||September 2006||2006-09-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Tazocin Intervention Study|Association of Antibiotic Utilization Measures and Control of ESBLs Producing Bacteria|Completed||Phase 4|500||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:35:22.871875|2017-02-18 15:35:22.871875
NCT00479232|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-09-04|2011-04-28||June 2007||2007-06-01|September 2015|2015-09-01|March 2012|Actual|2012-03-01|April 2010|Actual|2010-04-01||Interventional|||Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)|A Phase I Clinical Trial of Vorinostat in Combination With Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Completed||Phase 1|71|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:35:16.900052|2017-02-18 15:35:16.900052
NCT00479219|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2008-07-09|||May 2007||2007-05-01|July 2008|2008-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients|A Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSI-953 in Blood and Cerebrospinal Fluid, When Administered Orally to Healthy Young Subjects and Patients With Alzheimer Disease|Completed||Phase 1|17|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 15:35:18.476479|2017-02-18 15:35:18.476479
NCT00479206|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2008-04-29|||October 2006||2006-10-01|April 2008|2008-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Artemisinin Resistance in Cambodia|Artemisinin Resistance in Cambodia|Completed||N/A|||Medical University of Vienna||2|||f||||f||||||||||2017-02-18 15:35:18.5675|2017-02-18 15:35:18.5675
NCT00479193|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2008-01-24|||October 2006||2006-10-01|January 2008|2008-01-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Polymem vs. Bacitracin/Xeroform in Treating Burn Wounds|Prospective Randomized Trial of Polymem vs. Bacitracin/Xeroform for Superficial Second Degree Burns|Unknown status|Recruiting|Phase 1|100|Anticipated|MetroHealth Medical Center||1|||f||||f||||||||||2017-02-18 15:35:18.656293|2017-02-18 15:35:18.656293
NCT00479180|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2011-10-25|||July 2006||2006-07-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use|Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use|Completed||Phase 1/Phase 2|65|Actual|Pervasis Therapeutics, Inc||4|||f||||t||||||||||2017-02-18 15:35:18.770144|2017-02-18 15:35:18.770144
NCT00479167|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-02-04|||May 2007||2007-05-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma|A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodg|Completed||Phase 2|20|Anticipated|Rush University Medical Center||1|||f||||f||||||||||2017-02-18 15:35:19.027158|2017-02-18 15:35:19.027158
NCT00479154|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2012-04-25|2011-03-14||May 2007||2007-05-01|April 2012|2012-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Botulinum Toxin to Treat Restless Legs Syndrome|Pilot Study of Botulinum Toxin Type A for the Treatment of Restless Legs Syndrome|Completed||Phase 1/Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 15:35:19.136283|2017-02-18 15:35:19.136283
NCT00479141|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-25|2009-03-26|||March 2006||2006-03-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|July 2007|Actual|2007-07-01||Interventional|||A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China|A Cluster-Randomized Trail to Evaluate the Efficacy of a Combined Individual- and Community-Based Behavioral Intervention to Improve Quality of Life (QOL) For HIV-Positive Villagers in Rural China|Completed||N/A|3199|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 15:35:19.500242|2017-02-18 15:35:19.500242
NCT00479128|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-03-22|||September 2006||2006-09-01|March 2016|2016-03-01||||September 2017|Anticipated|2017-09-01||Interventional|||Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors|Phase I Two-Dimensional Dose-Finding Study of Bortezomib in Combination With Gemcitabine/Doxorubicin in Metastatic Surgically Unresectable Urothelial Cancer or Other Solid Tumors|Active, not recruiting||Phase 1|80|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:35:19.608832|2017-02-18 15:35:19.608832
NCT00479115|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2012-02-15|||May 2007||2007-05-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100|AMD3100 in Combination With G-CSF to Mobilize Peripheral Blood Stem Cells in Patients With Fanconi Anemia(FA): A Phase I/II Study|Completed||Phase 1/Phase 2|1|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 15:35:19.739496|2017-02-18 15:35:19.739496
NCT00479102|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-05-24|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Interventional|||Prevention of Iron Deficiency in 2nd Year of Life|Effectiveness of Iron Supplementation in the Second Year of Life for Prevention of Iron Deficiency|Unknown status|Not yet recruiting|Phase 4|||Soroka University Medical Center|||||f||||f||||||||||2017-02-18 15:35:19.833914|2017-02-18 15:35:19.833914
NCT00479089|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-10-08|2015-07-27||February 2004||2004-02-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer|Phase II Trial of Weekly Docetaxel (Taxotere) Vs. Weekly Docetaxel in Combination With ZD1839 (Iressa®) As Consolidation Therapy For Metastatic Urothelial Cancer Following Maximal Response To Multi-Agent Chemotherapy|Terminated||Phase 2|50|Actual|M.D. Anderson Cancer Center|Early termination leading to small numbers of subjects analyzed.|2||Study halted due to drug sponsor decision to not continue.|f||||t||||||||||2017-02-18 15:35:19.916243|2017-02-18 15:35:19.916243
NCT00479076|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2011-01-25|||March 2007||2007-03-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients|A Single Agent-combination Hybrid Phase I, Open-label, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous AVE0005 (VEGF Trap)Administered Every 2 Weeks in Combination With Oral S-1 in Patients With Advanced Solid Malignancies|Completed||Phase 1|22|Anticipated|Sanofi||1|||f||||||||||||||2017-02-18 15:35:20.321756|2017-02-18 15:35:20.321756
NCT00479063|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2011-06-26|||February 2010||2010-02-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Observational|MODIC 2||Association of Lumbar MODIC Changes With Chronic Low Back Pain in Southern European Subjects|Modic Changes Are Not Associated With a Higher Risk of Chronic Low Back Pain Among Southern European Subjects. A Case Control Study|Completed||N/A|304|Actual|Kovacs Foundation|||2||f||||t||||||||||2017-02-18 15:35:20.409952|2017-02-18 15:35:20.409952
NCT00472615|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2009-02-25|||August 2006||2006-08-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Menstrual Effects On Mood Symptoms in Bipolar Disorder|Menstrual Effects On Mood Symptoms in Bipolar Disorder|Completed||N/A|45|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"~     whole blood~   "|||2017-02-18 15:37:38.128744|2017-02-18 15:37:38.128744
NCT00479050|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-05-24|||January 2001||2001-01-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|TACE-RFA||Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm|Phase 1 Study of Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm|Completed||Phase 1|291|Actual|Shandong University||3|||f||||t||||||||||2017-02-18 15:35:20.501449|2017-02-18 15:35:20.501449
NCT00479037|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2012-05-04|2011-03-31||April 2007||2007-04-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)|A 24-week, International, Multi Centre, Randomised, Open Label, Parallel Group, Phase IV Clinical Trial Investigating Changes in Bone Formation Markers in Postmenopausal Women With Primary Osteoporosis Treated With Either PTH(1-84) or Strontium Ranelate|Completed||Phase 4|82|Actual|Nycomed|A limitation of the trial was the open label design, however this is not considered to affect the primary or secondary outcome of the trial.|2|||f||||t||||||||||2017-02-18 15:35:20.587621|2017-02-18 15:35:20.587621
NCT00479024|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2009-09-29|||June 2007||2007-06-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Observational|||Follow-up Study to Previous CARE Trial|CARE (Visipaque 320 and Isovue 370 in Cardiac Angiography in REnally Impaired Patients); FOLLOW-UP STUDY|Completed||N/A|294|Actual|Bracco Diagnostics, Inc|||1||f||||f||||||||||2017-02-18 15:35:20.958872|2017-02-18 15:35:20.958872
NCT00479011|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-05-24|||September 2005||2005-09-01|May 2007|2007-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Intraoperative Fluid Management Based on Arterial Pulse Pressure Variation During High-Risk Surgery|Intraoperative Fluid Management Based on Arterial Pulse Pressure Variation During High-Risk Surgery|Terminated||N/A|33|Actual|Santa Casa de Passos||2||significant reduction in length of hospital stay (primary endpoint)|f||||t||||||||||2017-02-18 15:35:21.055439|2017-02-18 15:35:21.055439
NCT00478998|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-05-24||||||May 2007|2007-05-01||||||||Interventional|||Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin|Phase II Study Comparing Two Groups of Patients Undergoing ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin|Unknown status|Not yet recruiting|Phase 2|||Hadassah Medical Organization||3|||f||||f||||||||||2017-02-18 15:35:21.137421|2017-02-18 15:35:21.137421
NCT00478985|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2013-07-01|||June 2007||2007-06-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|STIM||Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia|Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia (STIM)|Completed||N/A|100|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-02-18 15:35:21.236049|2017-02-18 15:35:21.236049
NCT00478972|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-06-06||2016-06-01|April 2007||2007-04-01|June 2016|2016-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|SOLO||Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Fixed Single-dose Regimen, Multicenter Study to Assess the Efficacy and Safety of SR141716 in Obese Type 2 Diabetic Patients Inadequately Controlled With Diet and Exercise Alone|Terminated||Phase 3|321|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 15:35:21.367981|2017-02-18 15:35:21.367981
NCT00478959|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-06-21|||December 2006||2006-12-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma|Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma|Completed||Phase 2|30|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 15:35:21.488223|2017-02-18 15:35:21.488223
NCT00478946|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2009-01-20|||April 2006||2006-04-01|January 2009|2009-01-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||A Study of Picoplatin in Colorectal Cancer|A Phase I Open-Label Study of Picoplatin in Combination With 5-Fluorouracil and Leucovorin as Initial Therapy in Subjects With Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|43|Anticipated|Poniard Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:35:21.601721|2017-02-18 15:35:21.601721
NCT00478933|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2013-03-04|||February 2007||2007-02-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|July 2012|Actual|2012-07-01||Interventional|DISCOVERY||DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.|Diagnostic Data Influence on Disease Management and Relation of Genetic Polymorphisms to Tachy-arrhythmia in ICD Patients.|Completed||Phase 4|1223|Actual|Medtronic Bakken Research Center||1|||f||||f||||||||||2017-02-18 15:35:21.73354|2017-02-18 15:35:21.73354
NCT00478907|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-05-24|||March 2004||2004-03-01|May 2007|2007-05-01|March 2006|Actual|2006-03-01|||||Interventional|ocr||Prevention of Complications of Eye Surgery|phase2 Study of Prevention of Complications of Strabismus Surgery|Completed||Phase 2|300|Actual|Isfahan University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:35:21.843282|2017-02-18 15:35:21.843282
NCT00478894|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-12-12|||August 2007||2007-08-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Observational|MOON-Onsite||Multicenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): Onsite Follow-up|Multicenter Orthopaedic Outcomes Network (MOON) Anterior Cruciate Ligament (ACL) Reconstruction (ACLR): Onsite Follow-up|Enrolling by invitation||N/A|432|Actual|Vanderbilt University Medical Center|||1||f||||t||||||||||2017-02-18 15:35:21.940572|2017-02-18 15:35:21.940572
NCT00478881|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2014-11-24|2009-11-16||August 2007||2007-08-01|November 2014|2014-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function|Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity)|Completed||Phase 2|397|Actual|Bayer|635 participants were screened; 238 were not randomized because they did not fulfill the inclusion/exclusion criteria. Cystometric bladder compliance not presented since only relevant to characterization of detrusor overactivity, not to efficacy.|2|||f||||f||||||||||2017-02-18 15:35:22.052005|2017-02-18 15:35:22.052005
NCT00478868|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2011-06-26|||May 2008||2008-05-01|June 2011|2011-06-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Observational|MODIC||Modic Changes and Associated Features in Southern European Chronic Low Back Pain Patients|Modic Changes and Associated Features in Southern European Chronic Low Back Pain Patients|Completed||N/A|487|Actual|Kovacs Foundation|||1||f||||t||||||||||2017-02-18 15:35:22.782557|2017-02-18 15:35:22.782557
NCT00478842|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-07-13|||November 2007||2007-11-01|July 2015|2015-07-01|December 2016|Anticipated|2016-12-01|December 2013|Actual|2013-12-01||Interventional|STIC||Pallidal Stimulation and Gilles de la Tourette Syndrome|Treatment of Gilles de la Tourette Syndrome by Bilateral Stimulation of the Internal Part of the Globus PALLIDUS|Active, not recruiting||Phase 3|20|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 15:35:22.956903|2017-02-18 15:35:22.956903
NCT00478829|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-12-04|||April 2007||2007-04-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Observational|||Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China|Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in 5 Large Cities in China|Completed||N/A|8000||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:35:23.061434|2017-02-18 15:35:23.061434
NCT00478816|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-11-30|||May 2007||2007-05-01|February 2012|2012-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines|A Phase II, Single Center, Exploratory Study to Evaluate Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With MF59-adjuvanted or Non-adjuvanted H5N3 Influenza Vaccines|Completed||Phase 2|58|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:35:23.154594|2017-02-18 15:35:23.154594
NCT00478803|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-03-06|||May 2007||2007-05-01|July 2012|2012-07-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|CAVIAAR||Conservative Aortic Valve Surgery for Aortic Insufficiency and Aneurysms of the Aortic Root. CAVIAAR|Conservative Aortic Valve Surgery for Aortic Insufficiency and Aneurysms of the Aortic Root|Completed||Phase 3|245|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:35:23.267235|2017-02-18 15:35:23.267235
NCT00478790|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2011-10-06|||February 2007||2007-02-01|June 2008|2008-06-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital|Study of the Safety and Effectiveness of the Ologen(OculusGen) Collagen Matrix Implant as an Aid in Glaucoma and Pterygium Surgery|Unknown status|Recruiting|Phase 3|60|Anticipated|Pro Top & Mediking Company Limited||1|||f||||t||||||||||2017-02-18 15:35:23.381275|2017-02-18 15:35:23.381275
NCT00478777|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2011-09-26|2011-09-26||March 2007||2007-03-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|November 2007|Actual|2007-11-01||Interventional|||A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma|A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma|Completed||Phase 3|150|Actual|Celgene||1|||f||||t||||||||||2017-02-18 15:35:23.5112|2017-02-18 15:35:23.5112
NCT00478764|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2007-05-24|||March 2006||2006-03-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Intraocular Steroid After Cataract Surgery Study|Intracameral Use of Triamcinolone and Gatifloxacin Versus Standard Postoperative Steroid and Antibiotic Eye Drops After Cataract Surgery|Completed||N/A|41|Actual|Dean Health System||1|||f||||f||||||||||2017-02-18 15:35:26.60234|2017-02-18 15:35:26.60234
NCT00478751|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-01-28|||May 2007||2007-05-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|||Impact of Long Wavelength Ultraviolet (UVA) and Visible Light on Melanocompetent Skin|Impact of Long Wavelength UVA and Visible Light on Melanocompetent Skin|Completed||N/A|22|Actual|Henry Ford Health System|||1||f||||f||||||||||2017-02-18 15:35:26.71248|2017-02-18 15:35:26.71248
NCT00478738|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2017-02-01||2009-07-22|June 2007||2007-06-01|January 2017|2017-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients|A Study to Assess the Pharmacokinetics of Single Escalating Doses of Inhaled GSK961081 DPI (a Dual Pharmacophore) in Healthy Subjects (Part 1) and a Randomised, Double-blind, Double Dummy, Crossover (Incomplete Block) Study to Assess the Safety, Tolerability, Pharmacodynamics (Pulmonary and Systemic) and Pharmacokinetics of 14 Days Dosing With Inhaled GSK961081 DPI Compared With Placebo and Tiotropium Plus Salmeterol in Patients With COPD (Part 2)|Completed||Phase 2|82|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:35:26.814285|2017-02-18 15:35:26.814285
NCT00478725|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2012-11-08|||July 2007||2007-07-01|November 2012|2012-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034|An Open-Label, Two-Part Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of Pazopanib (GW786034) and the Absorption, Distribution, Metabolism and Elimination of a Single Oral [14C] Labeled Dose of Pazopanib in Subjects With Solid Tumor Malignancies|Completed||Phase 1|10|Actual|GlaxoSmithKline||2|||||||f||||||||||2017-02-18 15:35:26.965757|2017-02-18 15:35:26.965757
NCT00478712|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-10-22|||January 2001||2001-01-01|October 2015|2015-10-01|March 2025|Anticipated|2025-03-01|March 2025|Anticipated|2025-03-01||Observational|||Hirschsprung Disease Genetic Study|Genetic Analysis of Hirschsprung Disease|Recruiting||N/A|3000|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"~     Study volunteers are asked to provide blood or cheek swab/saliva samples. DNA is extracted~     from the samples for use in the study.~   "|||2017-02-18 15:35:27.085508|2017-02-18 15:35:27.085508
NCT00478699|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2015-07-03|||June 2007||2007-06-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|June 2015|Actual|2015-06-01||Interventional|GECP-SCAT||Randomized Customized Adjuvant Chemotherapy (GECP-SCAT)|Phase III, Open, Multicenter and Randomized Study of Customized Adjuvant Chemotherapy Based on BRCA1 mRNA Levels in Completely Resected Stages II-IIIA Non-Small-Cell Lung Cancer Patients|Completed||Phase 3|500|Actual|Spanish Lung Cancer Group||2|||f||||t||||||||||2017-02-18 15:35:27.201411|2017-02-18 15:35:27.201411
NCT00478686|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-02-29|||May 2007||2007-05-01|February 2016|2016-02-01||||May 2017|Anticipated|2017-05-01||Observational|||Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine|A Retrospective Analysis of the Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine|Active, not recruiting||N/A|210|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||Samples With DNA|"~     5 to 7.5 milliliter (mL) sample of blood. Alternatively, DNA will be extracted from 10um~     slices of formalin-fixed paraffin-embedded tissue from previously collected tumor tissue~     (from the time of the breast cancer diagnosis).~   "|||2017-02-18 15:35:29.799566|2017-02-18 15:35:29.799566
NCT00478673|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2012-07-02|2010-12-20||May 2007||2007-05-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|SONOMA||Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA|The NexStent® Carotid Stent System: A Post Market Approval Evaluation Study In Conjunction With the FilterWire EZ™ Embolic Protection System|Terminated||Phase 4|298|Actual|Boston Scientific Corporation|Enrollment was terminated in June 2008 due to market withdrawal of the NexStent Carotid Stent System. The early termination of enrollment led to a smaller than expected number of analyzable subjects (298 actual vs. 1500 anticipated).|1||"Enrollment was terminated in June 2008 due to market withdrawal of the NexStent Carotid Stent~   System."|f||||f||||||||||2017-02-18 15:35:29.921154|2017-02-18 15:35:29.921154
NCT00478660|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2007-10-04|||February 2006||2006-02-01|October 2007|2007-10-01||||||||Interventional|RHAPSODY||An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)|Review of Safety and Efficacy With Adalimumab in Patients With Active Ankylosing Spondylitis - An Open-Label Study to Evaluate the Response to Adalimumab in Patients Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)|Completed||Phase 3|1250|Actual|Abbott|||||f||||||||||||||2017-02-18 15:35:31.176113|2017-02-18 15:35:31.176113
NCT00478647|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2015-03-19|2010-08-04||July 2007||2007-07-01|February 2014|2014-02-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase|A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase|Completed||Phase 2/Phase 3|40|Actual|Shire||1|||f||||f||||||||||2017-02-18 15:35:31.690742|2017-02-18 15:35:31.690742
NCT00478634|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2012-11-01|||May 2007||2007-05-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer|An Open-label, Multicenter Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab (if Given as Part of Local Standard Practice) in Patient With Metastatic Colorectal Adenocarcinoma|Completed||Phase 1|19|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:35:32.093832|2017-02-18 15:35:32.093832
NCT00478621|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-10-18|||May 2007||2007-05-01|October 2016|2016-10-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)|A Multicentre Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' HPV Vaccine (GSK1674330A) in Healthy Female Subjects Aged 18-25 Years.|Completed||Phase 1|540|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:35:32.226596|2017-02-18 15:35:32.226596
NCT00478608|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2010-04-22|2009-11-30||March 2007||2007-03-01|April 2010|2010-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study Evaluating Rapamune® Maintenance Regimen|A Clinical Study to Evaluate the Efficacy and Safety of Cyclosporine (CsA) and Sirolimus (SRL) Induction Followed by Cyclosporine Withdrawal in Korean Renal Allograft Recipients|Completed||Phase 3|79|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 15:35:32.352905|2017-02-18 15:35:32.352905
NCT00478595|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2016-06-01||2016-06-01|April 2007||2007-04-01|June 2016|2016-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|SYMPHONY||Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of SR141716 in Obese Type 2 Diabetic Patients on Monotherapy Inadequately Controlled With Oral Anti-diabetic Drug|Terminated||Phase 3|458|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||||||||||||2017-02-18 15:35:32.77758|2017-02-18 15:35:32.77758
NCT00478582|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2011-01-12|||May 2007||2007-05-01|January 2011|2011-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients|Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients|Completed||N/A|||University Hospital Inselspital, Berne|||||f||||f||||||||||2017-02-18 15:35:32.886332|2017-02-18 15:35:32.886332
NCT00478569|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2014-04-29|2014-04-29||April 2007||2007-04-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Adherence to PTH(1-84) Treatment (FP-002-IM)|Adherence to PTH(1-84) Treatment in Europe. A Non-interventional Cohort Study Collecting Safety Information and Examining Reasons and Predictors for Adherence to PTH(1-84) Treatment in Usual Clinical Settings|Completed||N/A|1179|Actual|Takeda|||1||f||||t||||||||||2017-02-18 15:35:33.217755|2017-02-18 15:35:33.217755
NCT00478556|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2010-05-19|2010-02-09||August 2007||2007-08-01|May 2010|2010-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT|Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT|Completed||Phase 4|300|Actual|University of Alabama at Birmingham|Study was completed.|2|||f||||f||||||||||2017-02-18 15:35:33.997616|2017-02-18 15:35:33.997616
NCT00478543|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-02-03|||September 2005||2005-09-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Loop Diuretics in Chronic Kidney Disease|Effect of Loop Diuretics Treatment on Blood Pressure Control in Phase 3-4 of Chronic Kidney Disease|Completed||Phase 4|40|Actual|Second University of Naples||1|||f||||f||||||||||2017-02-18 15:35:34.408153|2017-02-18 15:35:34.408153
NCT00478530|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-24|2009-02-04|||May 2007||2007-05-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram|The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram|Completed||N/A|20|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 15:35:34.527752|2017-02-18 15:35:34.527752
NCT00478517|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2009-03-10|||May 2007||2007-05-01|March 2009|2009-03-01||||||||Interventional|TETRAM2||TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study|Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study. TETRAM2|Withdrawn||Phase 1|20||Hospices Civils de Lyon|||||f||||t||||||||||2017-02-18 15:35:34.630046|2017-02-18 15:35:34.630046
NCT00478504|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-10-26|||May 2007||2007-05-01|October 2016|2016-10-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Letrozole Versus Clomifene Citrate for Ovulation Induction|Double Blind Cross-over Randomized Controlled Trial Comparing Letrozole Versus Clomifene Citrate for Ovulation Induction in Women With Polycystic Ovarian Syndrome|Completed||Phase 4|159|Actual|University of Nottingham||2|||f||||t||||||||||2017-02-18 15:35:34.720726|2017-02-18 15:35:34.720726
NCT00478491|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2016-10-25|||January 2003||2003-01-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Observational|ALZ||fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease|fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease|Completed||N/A|390|Actual|University of Wisconsin, Madison|||4||f||||t||||||Samples Without DNA|"~     plasma and serum~   "|||2017-02-18 15:35:34.8341|2017-02-18 15:35:34.8341
NCT00478478|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-11-06|||June 2007||2007-06-01|November 2014|2014-11-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Observational|||Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke|Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke|Completed||Phase 4|1000|Actual|Stryker Neurovascular|||1||f||||f||||||||||2017-02-18 15:35:34.92322|2017-02-18 15:35:34.92322
NCT00478465|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2007-08-29|||May 2007||2007-05-01|August 2007|2007-08-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)|A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Valganciclovir (Valcyte) in Patients Experiencing Chronic Fatigue Syndrome With Elevated Antibody Titers Against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV)|Unknown status|Active, not recruiting|Phase 1/Phase 2|0|Anticipated|Stanford University||2|||f||||||||||||||2017-02-18 15:35:35.036296|2017-02-18 15:35:35.036296
NCT00478452|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2017-01-04|||August 2005||2005-08-01|January 2017|2017-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|DC-Ova||Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients|Randomized Phase I/II Pilot Study of the Immunogenicity of Cyclophosphamide With Peptide Pulsed Mature Dendritic Cells for Patients With Previously Treated Ovarian Epithelial or Primary Peritoneal Carcinoma|Completed||Phase 1/Phase 2|14|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 15:35:35.135024|2017-02-18 15:35:35.135024
NCT00478439|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2010-10-26|||December 2007||2007-12-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|September 2009|Actual|2009-09-01||Interventional|||Investigation of Macular Pigment Augmentation on Dark Adaptation|Investigation of Macular Pigment Augmentation on Dark Adaptation|Terminated||Phase 4|13|Actual|University of Alabama at Birmingham||1||Study terminated: Recruitment delay due to equipment malfunction|f||||f||||||||||2017-02-18 15:35:35.23957|2017-02-18 15:35:35.23957
NCT00478426|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2017-01-31|||April 2007||2007-04-01|January 2017|2017-01-01||||January 2017|Anticipated|2017-01-01||Interventional|||Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer|A Phase 2 Study of Sunitinib Malate in Recurrent or Metastatic Endometrial Carcinoma|Active, not recruiting||Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 15:35:35.354167|2017-02-18 15:35:35.354167
NCT00478400|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2015-10-06|||October 2007||2007-10-01|September 2010|2010-09-01|October 2016|Anticipated|2016-10-01|||||Observational|||Awareness of Deficit After Combat-related Brain Injury|Awareness of Deficit After Combat-related Brain Injury|Unknown status|Recruiting|N/A|100|Anticipated|University of Wisconsin, Madison|||4||f||||t||||||||||2017-02-18 15:35:35.488236|2017-02-18 15:35:35.488236
NCT00478387|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2016-10-03|||October 2006||2006-10-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Ovarian Cancer and Immune Response to Flu Vaccine|Study of the Immunogenicity of Killed Influenza Vaccine in Patients With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Remission|Completed||N/A|37|Actual|University of Pennsylvania|||1||f||||t||||||||||2017-02-18 15:35:35.590144|2017-02-18 15:35:35.590144
NCT00478374|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2010-11-01|||May 2007||2007-05-01|November 2010|2010-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|S-TACE||Sorafenib With TACE to Treat Hepatocellular Carcinoma|Transarterial Chemoembolisation With Doxorubicin in Combination With Systemic Administration of Sorafenib for Patients With Hepatocellular Carcinoma|Completed||Phase 1|21|Actual|University of Bern||1|||f||||f||||||||||2017-02-18 15:35:35.676018|2017-02-18 15:35:35.676018
NCT00478361|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2015-06-19|||April 2007||2007-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function|A Phase II Study of Gemcitabine, Paclitaxel, and Doxorubicin, With Pegfilgrastim for the Treatment of Patients With Metastatic Transitional Cell Carcinoma and Renal Insufficiency|Completed||Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:35:35.777967|2017-02-18 15:35:35.777967
NCT00478348|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-12-03|||May 2007||2007-05-01|December 2014|2014-12-01|January 2016|Anticipated|2016-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Should Prosthetic Repair of Incisional Abdominal Hernias be Drain or Not?|Adequacy of Drainage During Prosthetic Repair of Incisional Abdominal Hernias: a Randomized Controlled Trial.|Unknown status|Recruiting|N/A|380|Anticipated|University of Lausanne Hospitals||2|||f||||t||||||||||2017-02-18 15:35:35.908452|2017-02-18 15:35:35.908452
NCT00478335|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2012-12-19|||May 2007||2007-05-01|October 2008|2008-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus|Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus|Completed||N/A|4|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 15:35:36.017694|2017-02-18 15:35:36.017694
NCT00478322|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2016-12-02|||April 2007||2007-04-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|||Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects||Completed||Phase 2|24|Actual|Incyte Corporation||2|||f||||f||||||||||2017-02-18 15:35:36.14354|2017-02-18 15:35:36.14354
NCT00478309|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-03-01|||March 2007||2007-03-01|March 2016|2016-03-01||||March 2014|Actual|2014-03-01||Interventional|||Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants|Gene Environment Risk Assessment and CRC Screening|Completed||N/A|697|Actual|Fox Chase Cancer Center||2|||f||||||||||||||2017-02-18 15:35:36.2422|2017-02-18 15:35:36.2422
NCT00477854|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-02-11|||April 2005||2005-04-01|February 2016|2016-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effects of Chromium Picolinate on Food Intake|Effects of Chromium Picolinate on Food Intake, Satiety, and Eating Attitudes in Overweight Women With Food Cravings|Completed||N/A|42|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-02-18 15:35:53.198793|2017-02-18 15:35:53.198793
NCT00478296|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2012-03-14|||October 2004||2004-10-01|January 2008|2008-01-01|March 2008|Actual|2008-03-01|February 2007|Actual|2007-02-01||Observational|||Pulmonary Hypertension in Trisomy 21 Patients|Case Report: Resolution of Pulmonary Hypertension With Sildenafil and Bosentan in Patients With Trisomy 21 and Atrial Septal Defect|Completed||N/A|1|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 15:35:36.352012|2017-02-18 15:35:36.352012
NCT00478283|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2010-02-05|||December 2006||2006-12-01|February 2010|2010-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer|Perspectives and Attitudes on the Use of Adjuvant Chemotherapy and Hormonal Therapy in Older and/or Frail Women: A Survey of Oncologists and Geriatricians|Completed||N/A|300|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-02-18 15:35:36.672841|2017-02-18 15:35:36.672841
NCT00478270|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-08-23|||June 2007||2007-06-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.|An Open Label Study to Assess the Effect of Intravenous Loading Doses of Bondronat on Metastatic Bone Pain in Patients With Breast Cancer and Skeletal Metastases.|Withdrawn||Phase 2|0|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:35:36.760678|2017-02-18 15:35:36.760678
NCT00478257|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2016-05-10|2012-06-18||November 2005||2005-11-01|May 2016|2016-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effect of Increased Light Exposure on Fatigue in Breast Cancer|Effect of Increased Light Exposure on Fatigue in Breast Cancer|Completed||N/A|39|Actual|University of California, San Diego|Small sample size; only partial compliance data; light only administered in morning; only tested effect in patients with breast cancer.|2|||f||||f||||||||||2017-02-18 15:35:36.871058|2017-02-18 15:35:36.871058
NCT00478244|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2013-01-04|2012-07-17||April 2007||2007-04-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa|Allogeneic Hematopoietic Cell Transplantation to Correct the Biochemical Defect and Create Tolerance to Donor Tissue in Subjects With Epidermolysis Bullosa|Terminated||N/A|7|Actual|Masonic Cancer Center, University of Minnesota||1||Competing studies|f||||t||||||||||2017-02-18 15:35:37.257283|2017-02-18 15:35:37.257283
NCT00478231|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2011-09-01|2011-07-08||July 2007||2007-07-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Multicenter, Safety Study Of Maraviroc|A Multicenter, Open Label, Non-Comparative Safety Study Of Maraviroc|Completed||Phase 3|209|Actual|ViiV Healthcare||1|||f||||f||||||||||2017-02-18 15:35:37.634359|2017-02-18 15:35:37.634359
NCT00478218|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2011-08-29|2011-06-30||July 2006||2006-07-01|August 2011|2011-08-01|April 2011|Actual|2011-04-01|September 2008|Actual|2008-09-01||Interventional|||Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma|A Phase II Trial of Revlimid, Cyclophosphamide, and Dexamethasone in Patients With > Newly Diagnosed Active Multiple Myeloma|Completed||Phase 2|53|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:35:38.574348|2017-02-18 15:35:38.574348
NCT00478205|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-06-26|2012-11-12||June 2007||2007-06-01|January 2013|2013-01-01||||June 2009|Actual|2009-06-01||Interventional|||Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease|Double-Blind, Parallel-Group Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease|Completed||Phase 3|1467|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 15:35:39.27931|2017-02-18 15:35:39.27931
NCT00478192|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-04-30|2010-03-31||April 2007||2007-04-01|April 2014|2014-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia|A Phase IIIb, Randomized, Double-Blind, Parallel Group, Multi-Center, Study to Assess the Efficacy and Safety of Multiple 30 Minute Infusions of YM087 (Conivaptan) in Subjects With Euvolemic or Hypervolemic Hyponatremia|Completed||Phase 3|50|Actual|Cumberland Pharmaceuticals|Company makes no warranties or representations of any kind as to the currency or completeness of the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose and shall not be liable for any damages.|3|||f||||f||||||||||2017-02-18 15:35:40.269933|2017-02-18 15:35:40.269933
NCT00478179|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2009-09-09||2009-09-09|September 2006||2006-09-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia|A Randomized, Double-Blind, Placebo Controlled, Two-Way Cross-Over Study of Analgesic Efficacy of Bupivacaine Transdermal Therapeutic System in Patients With Post-Herpetic Neuralgia|Completed||Phase 2|60|Actual|Durect|||||f||||||||||||||2017-02-18 15:35:41.203583|2017-02-18 15:35:41.203583
NCT00478166|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2015-10-01|||July 2005||2005-07-01|April 2011|2011-04-01|October 2007|Actual|2007-10-01|||||Observational|PC||Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease|Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease|Completed||N/A|206|Anticipated|University of Wisconsin, Madison|||1||f||||t||||||||||2017-02-18 15:35:41.29964|2017-02-18 15:35:41.29964
NCT00478140|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2014-05-15|2013-09-17||May 2007||2007-05-01|September 2013|2013-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery|A Phase II Study Trastuzumab (NSC 688097) in Her2/Neu Positive Cancer of the Gallbladder or Biliary Tract (NCI 7756)|Completed||Phase 2|4|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:35:41.387905|2017-02-18 15:35:41.387905
NCT00477334|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2011-03-24|2010-12-15||June 2007||2007-06-01|March 2011|2011-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients|A Randomized, Multicenter, Double-blind Study to Compare the Efficacy of Single-day Treatment (1000 mg b.i.d.) With Famciclovir Compared to That of Placebo in Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Immunocompetent Black Patients|Completed||Phase 4|463|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:35:41.670314|2017-02-18 15:35:41.670314
NCT00477321|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2012-10-17|||May 2007||2007-05-01|October 2012|2012-10-01|July 2010|Actual|2010-07-01|October 2009|Actual|2009-10-01||Interventional|||Safety Study of IL-7 in HIV-infected Patients (Inspire)|A Ph I/IIa Rand Placebo Ctrl, S-Blind Multictr Dose-Esc Study of SC Intermittent Interleukin-7 CYT107 in Chronically HIV-Infected Pts With CD4 T Lymphocyte Counts 101-400 Cells-/mm(3) and Plasma HIV RNA Less Than 50 Copies/mL After at Least 12 M of HAART|Completed||Phase 1|30|Actual|Cytheris SA||1|||f||||t||||||||||2017-02-18 15:35:42.320143|2017-02-18 15:35:42.320143
NCT00477308|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2010-06-04|||January 2006||2006-01-01|June 2010|2010-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs|Clinical, Immunologic and Virological Outcomes of Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs|Completed||Phase 4|95|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||t||||||||||2017-02-18 15:35:42.44546|2017-02-18 15:35:42.44546
NCT00477295|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2015-12-21|2012-11-12||May 2007||2007-05-01|November 2015|2015-11-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy|A Randomized, Multi-centre, Double-blind Study, to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy|Completed||Phase 3|583|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 15:35:42.564393|2017-02-18 15:35:42.564393
NCT00477282|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2017-01-09|||August 2007||2007-08-01|January 2017|2017-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer|A Phase 3 Study of Safety and Efficacy of Karenitecin Versus Topotecan Administered for 5 Consecutive Days Every 3 Weeks in Patients With Advanced Epithelial Ovarian Cancer|Completed||Phase 3|509|Actual|BioNumerik Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 15:35:43.490559|2017-02-18 15:35:43.490559
NCT00477269|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2015-03-10|2015-01-26||April 2006||2006-04-01|March 2015|2015-03-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension|A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of the Six Months Treatment With the Tyrosine Kinase Inhibitor STI571 for the Treatment of Pulmonary Arterial Hypertension (PAH)|Completed||Phase 2/Phase 3|59|Actual|Novartis||3|||f||||t||||||||||2017-02-18 15:35:43.674532|2017-02-18 15:35:43.674532
NCT00477256|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2012-07-27|||May 2007||2007-05-01|July 2012|2012-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||School Reintegration Outcomes in Pediatric Cancer Patients|Psychosocial Predictors of Child Adjustment and School Reintegration Outcome in a Pediatric Cancer Population|Completed||N/A|91|Actual|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-02-18 15:35:45.237208|2017-02-18 15:35:45.237208
NCT00477243|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2016-09-19|||June 2004||2004-06-01|September 2016|2016-09-01||||October 2018|Anticipated|2018-10-01||Observational|||Locus of Control and Spirituality in Palliative Care Patients|Locus of Control and Spirituality in Palliative Care Patients|Active, not recruiting||N/A|167|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:35:45.349107|2017-02-18 15:35:45.349107
NCT00477230|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2012-06-26|2012-06-26||March 2007||2007-03-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|ENABLE||Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs|Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic Atrial Fibrillation (AF)|Terminated||Phase 3|64|Actual|CardioFocus|This study was terminated early due to Sponsor decision. Therefore, full patient assignement to treatments post-randomziation did not occur. Results and other measures cannot be determined because most patients exited the study before completion.|2||Study terminated based on decision of Sponsor.|f||||t||||||||||2017-02-18 15:35:45.452504|2017-02-18 15:35:45.452504
NCT00477217|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2016-09-22|||January 2008||2008-01-01|September 2016|2016-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee|A Randomized, Double-blind, Placebo-controlled, Proof of Concept Study of Zoledronic Acid in Spontaneous Osteonecrosis of the Knee (SONK)|Withdrawn||Phase 2|0|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:35:45.862391|2017-02-18 15:35:45.862391
NCT00478127|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2007-05-23||||||May 2007|2007-05-01||||||||Observational|||Hepatocyte Growth Factor and Cardiovascular Autonomic Function||Completed||N/A|||Oita Red Cross Hospital|||||f||||||||||||||2017-02-18 15:35:45.961791|2017-02-18 15:35:45.961791
NCT00478114|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2011-08-25|||May 2007||2007-05-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)|An Open-label, Non-comparative, Treatment Protocol for the Use of BAY 43-9006 (Sorafenib) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 3|15|Actual|Mahidol University||1|||f||||f||||||||||2017-02-18 15:35:46.024762|2017-02-18 15:35:46.024762
NCT00478101|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2008-03-12|||February 2006||2006-02-01|March 2008|2008-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain||Completed||Phase 2|2006|Actual|Gachon University Gil Medical Center||2|||f||||f||||||||||2017-02-18 15:35:46.134726|2017-02-18 15:35:46.134726
NCT00478088|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2012-05-30||2011-08-29|September 2006||2006-09-01|May 2012|2012-05-01|March 2012|Actual|2012-03-01|August 2010|Actual|2010-08-01||Interventional|NeoDisc™||Evaluating The Safety and Effectiveness of The NeoDisc™ Versus ACDF in Subjects With Single-Level Cervical Disc Disease|A Pivotal, Multi-Center, Randomized, Controlled Trial Evaluating The Safety and Effectiveness of The NeoDisc™ Versus Instrumented Anterior Cervical Discectomy and Fusion (ACDF) in Subjects With Single-Level Cervical Disc Disease|Completed||N/A|488|Actual|NuVasive||2|||f||||t||||||||||2017-02-18 15:35:46.209679|2017-02-18 15:35:46.209679
NCT00478075|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2011-05-10|||September 2005||2005-09-01|May 2011|2011-05-01|June 2009|Actual|2009-06-01|November 2007|Actual|2007-11-01||Interventional|||Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase I/II Study of 153 Sm EDTMP (Quadramet™) and PS-341 (Velcade®) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|50|Anticipated|Mayo Clinic||1|||f||||||||||||||2017-02-18 15:35:46.336327|2017-02-18 15:35:46.336327
NCT00478062|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-10-14|||April 2007||2007-04-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma|KGEL Vaccine After Initial Therapy of Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|1|Actual|Sidney Kimmel Comprehensive Cancer Center||1||Poor accrual|f||||f||||||||||2017-02-18 15:35:46.447159|2017-02-18 15:35:46.447159
NCT00478049|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2012-06-05|||September 2005||2005-09-01|June 2012|2012-06-01|February 2009|Actual|2009-02-01|May 2007|Actual|2007-05-01||Interventional|ISTANA||Iressa as Second Line Therapy in Advanced NSCLC-Asia|A Randomized, Open Label, Parallel Group, Regional, Multicenter, Phase III Study of Oral Gefitinib (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non Small Cell Lung Cancer Who Have Previously Received Platinum Based Chemotherapy (ISTANA)|Completed||Phase 3|163|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:35:49.139978|2017-02-18 15:35:49.139978
NCT00478036|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-08-15|2016-03-17||May 2007||2007-05-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells|A Randomized Prospective Double Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells.|Terminated||N/A|31|Actual|University of Colorado, Denver||3||insufficient enrollment|f||||f||||||||No||2017-02-18 15:35:49.263888|2017-02-18 15:35:49.263888
NCT00478023|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2013-12-20|2009-12-16||May 2007||2007-05-01|December 2013|2013-12-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy|A Randomized, Double-blind, Parallel-arm, Placebo- and Comparator- Controlled Trial of the Efficacy and Safety of Multiple Doses of Immediate-release (IR) CG5503 for Postoperative Pain Following Abdominal Hysterectomy|Completed||Phase 3|854|Actual|Grünenthal GmbH|Approval to conduct the trial was obtained in Slovenia. No Slovenian subjects were exposed to study drug.|5|||f||||f||||||||||2017-02-18 15:35:49.677276|2017-02-18 15:35:49.677276
NCT00478010|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2010-08-05|||January 2007||2007-01-01|August 2010|2010-08-01||||December 2008|Anticipated|2008-12-01||Interventional|||Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer|Research Participation: Decision Making and Outcomes in Cancer Clinical Trials|Unknown status|Active, not recruiting|N/A|200|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 15:35:50.956901|2017-02-18 15:35:50.956901
NCT00477997|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2009-04-20|||May 2007||2007-05-01|April 2009|2009-04-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Growth Hormone on Insulin Signaling in Muscle Tissue|The Effect of a Physiological Bolus of Growth Hormone (GH) on Insulin Signaling Pathways in Muscle Tissue From Healthy Adults|Completed||N/A|8|Anticipated|University of Aarhus||3|||f||||f||||||||||2017-02-18 15:35:51.04991|2017-02-18 15:35:51.04991
NCT00477984|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2008-04-11|||May 2007||2007-05-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effects of Alcohol on Simulated Driving|The Effects of Five Dosages of Ethanol on Simulated Driving Performance and Event-Related Potentials|Completed||N/A|32|Actual|Utrecht Institute for Pharmaceutical Sciences||1|||f||||f||||||||||2017-02-18 15:35:51.163286|2017-02-18 15:35:51.163286
NCT00477971|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-04-13|2015-06-23||October 2005||2005-10-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|July 2012|Actual|2012-07-01||Interventional|||Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis|Phase III Trial of Stem Cell Transplantation Compared to Parenteral Melphalan and Oral Dexamethasone in the Treatment of Primary Systemic Amyloidosis (AL)|Completed||Phase 3|89|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 15:35:51.269313|2017-02-18 15:35:51.269313
NCT00477958|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-07-27|||December 2006||2006-12-01|July 2016|2016-07-01||||July 2017|Anticipated|2017-07-01||Interventional|||Assessment Tool for Older Patients With Cancer|Determining the Utility of an Assessment Tool for Older Patients With Cancer|Active, not recruiting||N/A|750|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 15:35:52.091261|2017-02-18 15:35:52.091261
NCT00477945|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-09-10|||May 2007||2007-05-01|September 2014|2014-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL|A Phase I Trial of Clofarabine in Combination With High-Dose Etoposide and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation for Patients With High-Risk or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 1|18|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 15:35:52.20199|2017-02-18 15:35:52.20199
NCT00477932|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-12-16|||March 2006||2006-03-01|December 2014|2014-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Genes Mutation Pentalogy of Cantrell|Human Disease With Mutation of Nonmuscle Myosin Heavy Chain Genes|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta|||1|Physician's chose to not follow through with the study.|f||||f||||||||||2017-02-18 15:35:52.313075|2017-02-18 15:35:52.313075
NCT00477919|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2015-10-08|||February 2007||2007-02-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||E-MOSAIC Electronic Tool to Monitor Symptoms|E-MOSAIC: A Multicenter Randomized Controlled Phase III Study of Longitudinal Electronic Monitoring of Symptoms and Syndromes Associated With Advanced Cancer in Patients Receiving Anticancer Treatment in Palliative Intention|Completed||Phase 3|264|Actual|Swiss Group for Clinical Cancer Research|||2||f||||t||||||||||2017-02-18 15:35:52.409563|2017-02-18 15:35:52.409563
NCT00477906|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2015-12-02|||July 2016||2016-07-01|December 2015|2015-12-01|January 2021|Anticipated|2021-01-01|January 2019|Anticipated|2019-01-01||Interventional|||M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma|Comparison of M-Vax Plus Low Dose Interleukin-2 Versus Placebo Vaccine Plus Low Dose Interleukin-2 in Patients With Stage IV Melanoma|Not yet recruiting||Phase 3|387|Anticipated|AVAX Technologies||2|||f||||f||||||||||2017-02-18 15:35:52.513762|2017-02-18 15:35:52.513762
NCT00477893|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2012-03-27|||February 2006||2006-02-01|March 2012|2012-03-01|January 2013|Anticipated|2013-01-01|January 2009|Actual|2009-01-01||Interventional|DANISH||Danish Multicenter Study of Adalimumab in Spondyloarthritis|Can New Imaging- and Bio-markers Improve the Assessment of Disease Activity and Progression and Predict Therapeutic Outcome in Spondyloarthritis Patients Receiving Adalimumab|Unknown status|Active, not recruiting|Phase 4|52|Actual|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-02-18 15:35:52.867526|2017-02-18 15:35:52.867526
NCT00477880|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2017-01-06|||April 2001||2001-04-01|January 2017|2017-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer|Treatment of Ménétrier's Disease With EGF Receptor Blockade|Completed||Phase 1|9|Actual|Vanderbilt University Medical Center||1|||f||||t||||||||||2017-02-18 15:35:52.982176|2017-02-18 15:35:52.982176
NCT00477867|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2013-06-07||||||October 2007|2007-10-01||||||||Interventional|||Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172|Assessing Economic Outcomes in Women With Stage III Ovarian Cancer Treated With Intravenous Paclitaxel and Cisplatin v. Intravenous Paclitaxel, Intraperitoneal Cisplatin and Intraperitoneal Paclitaxel on GOG #172: A Feasibility Study of Assessing Costs and Medical Resource Use|Withdrawn||N/A|0|Actual|Gynecologic Oncology Group||||Trial was never activated|f||||||||||||||2017-02-18 15:35:53.102135|2017-02-18 15:35:53.102135
NCT00477815|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-10-10|||May 2005||2005-05-01|January 2016|2016-01-01||||May 2017|Anticipated|2017-05-01||Interventional|||Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma|A Phase I Trial of Zevalin Radioimmunotherapy With High-Dose Melphalan and Stem Cell Transplant for Multiple Myeloma|Active, not recruiting||Phase 1|42|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:35:53.495082|2017-02-18 15:35:53.495082
NCT00477802|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2009-02-13|||May 2007||2007-05-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease|Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease: A Double-Blind, Randomized, Placebo Controlled, Cross-Over Design Study|Terminated||Phase 4|8|Actual|University of Cincinnati||2||Intervention did not appear to be effective in most enrolled patients.|f||||t||||||||||2017-02-18 15:35:53.62061|2017-02-18 15:35:53.62061
NCT00477789|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2007-05-23||||||May 2007|2007-05-01||||||||Interventional|||Effects of Allopurinol on Diastolic Function in Chronic Heart Failure Patients|Effects of Allopurinol on Diastolic Function in Chronic Heart Failure Patients|Completed||Phase 4|||Universita di Verona||2|||f||||f||||||||||2017-02-18 15:35:53.735189|2017-02-18 15:35:53.735189
NCT00477776|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2009-09-18|||April 2006||2006-04-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|Maxalon||Maxolon to Improve Breastmilk Supply in Diabetic Women: a Randomised Controlled Trial|Metoclopramide to Improve Lactogenesis II in Diabetic Women: a Randomized Controlled Trial|Completed||Phase 3|160|Anticipated|National University Hospital, Singapore||4|||f||||t||||||||||2017-02-18 15:35:53.841601|2017-02-18 15:35:53.841601
NCT00477763|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2008-02-13|||May 2007||2007-05-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Oasys vs. Extreme H20 Xtra 59|Oasys vs. Extreme H20 Xtra 59|Completed||Phase 4|52|Actual|Innovative Medical||2|||f||||||||||||||2017-02-18 15:35:53.978037|2017-02-18 15:35:53.978037
NCT00477750|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2016-04-19|2010-11-08||June 2005||2005-06-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|April 2008|Actual|2008-04-01||Interventional|||Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma|Phase I/II Trial of Melphalan, Prednisone Plus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Stem Cell Transplant|Active, not recruiting||Phase 1/Phase 2|33|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 15:35:54.073317|2017-02-18 15:35:54.073317
NCT00477737|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2007-05-23|||August 2006||2006-08-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Early Cardioprotective Effect of Sevoflurane|Early Cardioprotective Effect of Sevoflurane on Left Ventricular Performance During Coronary Artery Bypass Grafting on a Beating Heart|Completed||Phase 4|32|Actual|University Hospital Dubrava|||||f||||f||||||||||2017-02-18 15:35:54.432498|2017-02-18 15:35:54.432498
NCT00477724|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-07-01|||June 2007||2007-06-01|July 2014|2014-07-01||||June 2015|Anticipated|2015-06-01||Interventional|||Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory Therapy|Incidence of Latent Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension After Endarterectomy and Influence of Exercise and Respiratory Therapy|Unknown status|Recruiting|N/A|35|Anticipated|Heidelberg University||2|||f||||||||||||||2017-02-18 15:35:54.525972|2017-02-18 15:35:54.525972
NCT00477711|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2015-05-17|||March 2007||2007-03-01|May 2015|2015-05-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|EXTRA||A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer||Completed||Phase 2|41|Actual|Peking University||1|||f||||t||||||||||2017-02-18 15:35:54.63642|2017-02-18 15:35:54.63642
NCT00477685|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2014-02-24|2011-10-24||May 2007||2007-05-01|February 2014|2014-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India|Study of the Safety and Effectiveness of the OculusGenTM Collagen Matrix Implant as an Aid in Phacotrabeculectomy Surgery|Completed||Phase 3|10|Actual|Pro Top & Mediking Company Limited|Limited sample size.|1|||f||||||||||||||2017-02-18 15:35:54.74843|2017-02-18 15:35:54.74843
NCT00477672|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-02-06|2014-02-06||June 2007||2007-06-01|February 2014|2014-02-01||||June 2009|Actual|2009-06-01||Interventional||Safety Analysis Set|A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis|A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson's Disease|Completed||Phase 3|298|Actual|ACADIA Pharmaceuticals Inc.||3|||f||||||||||||||2017-02-18 15:35:54.98554|2017-02-18 15:35:54.98554
NCT00477659|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2009-05-06|||July 2007||2007-07-01|May 2009|2009-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Neural Correlates In Mild Alzheimer's Disease|A Single Center Study To Examine Neural Correlates Of Cognition In Subjects With Mild Alzheimer's Disease After Three Months Of Open Label Donepezil HCl (Aricept® ) Treatment|Completed||Phase 4|14|Actual|Eisai Inc.||1|||f||||f||||||||||2017-02-18 15:35:55.912493|2017-02-18 15:35:55.912493
NCT00477646|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2011-08-04|||July 2007||2007-07-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Helping Women Stay Up-To-Date With Cancer Screening By Using a Prevention Care Manager or Usual Care|New York Prevention Care Manager Project / Medicaid Managed Care Organization Version|Completed||N/A|2241|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-02-18 15:35:56.020626|2017-02-18 15:35:56.020626
NCT00477633|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2013-04-15|2010-10-13||June 2007||2007-06-01|April 2013|2013-04-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Study of Safety and Efficacy of an Oral Contraceptive|An Open Label Study of the Contraceptive Efficacy of Norethindrone and Ethinyl Estradiol.|Completed||Phase 3|1700|Actual|Warner Chilcott||1|||f||||f||||||||||2017-02-18 15:35:56.129563|2017-02-18 15:35:56.129563
NCT00477620|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2009-02-19|||April 2004||2004-04-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|SMART||Study of Myopia Acquisition and Prevention|Study of Myopia Acquisition and Prevention in a Randomised Trial|Completed||N/A|||University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 15:35:56.486334|2017-02-18 15:35:56.486334
NCT00477607|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-23|2014-02-03|2013-10-04||October 2007||2007-10-01|February 2014|2014-02-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin|Prevention of Cisplatin Ototoxicity With the Antioxidant Alpha-Lipoic Acid|Completed||Phase 2/Phase 3|39|Actual|VA Office of Research and Development|Missing data constraints have the number of subjects in the study being different for different outcomes.|2|||f||||t||||||||||2017-02-18 15:35:56.562522|2017-02-18 15:35:56.562522
NCT00477594|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2016-08-01|2013-02-25||May 2007||2007-05-01|August 2016|2016-08-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Interventional|||Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia|An Open-Label Extension Study to Assess the Long-term Safety and Efficacy of Mipomersen in Subjects With Familial Hypercholesterolemia|Completed||Phase 2|21|Actual|Kastle Therapeutics, LLC||2|||f||||f||||||||||2017-02-18 15:35:57.03567|2017-02-18 15:35:57.03567
NCT00477581|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2015-08-25|||May 2007||2007-05-01|August 2015|2015-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus|A Randomized, Double-Blind, Crossover Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|102|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:35:58.377176|2017-02-18 15:35:58.377176
NCT00477568|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2015-03-31|||November 2007||2007-11-01|March 2015|2015-03-01|September 2015|Anticipated|2015-09-01|June 2015|Anticipated|2015-06-01||Observational|||Back Pain Prevalence in Wheelchair Users and Associated Risk Factors|Back Pain Prevalence in Wheelchair Users and Associated Risk Factors|Recruiting||N/A|350|Anticipated|Kovacs Foundation|||1||f||||t||||||||||2017-02-18 15:35:58.493404|2017-02-18 15:35:58.493404
NCT00477555|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2015-10-28|||April 2006||2006-04-01|October 2015|2015-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Hemodynamic Assessment of Mosaic Ultra Stented Heart Valve in the Aortic Position|Mosaic Ultra Porcine Bioprosthesis - Hemodynamic Study|Completed||N/A|43|Actual|Medtronic Cardiovascular|||1||f||||f||||||||||2017-02-18 15:35:58.580083|2017-02-18 15:35:58.580083
NCT00477542|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2014-09-17|||May 2007||2007-05-01|September 2014|2014-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT|A Phase I Trial of Myeloablative Conditioning Using Clofarabine and High-Dose Busulfan for Patients With Refractory Hematological Malignancies Undergoing Allogeneic HSCT|Completed||Phase 1|18|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 15:35:58.897704|2017-02-18 15:35:58.897704
NCT00477529|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2015-09-09|||April 2007||2007-04-01|September 2015|2015-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer|A Phase I/II Trial of ABI-008 (Nab-docetaxel) in Patients With Hormone-refractory Prostate Cancer|Completed||Phase 1/Phase 2|102|Anticipated|Celgene||1|||f||||f||||||||||2017-02-18 15:35:58.999583|2017-02-18 15:35:58.999583
NCT00477516|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2012-06-13|||January 2007||2007-01-01|June 2012|2012-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients|Determination of FDF-23 Levels in Non-suppressible PTH Secretion and the Influence of Inflammation on Fetuin A Levels During Hemodialysis Treatment|Completed||N/A|18|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 15:35:59.106616|2017-02-18 15:35:59.106616
NCT00477503|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2012-07-31|||May 2007||2007-05-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA|Phase 1 Study Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA|Terminated||Phase 1|1|Actual|M.D. Anderson Cancer Center||3||One participant enrolled, study terminated .|f||||f||||||||||2017-02-18 15:35:59.207947|2017-02-18 15:35:59.207947
NCT00477490|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2015-09-29|2015-06-16||May 2007||2007-05-01|September 2015|2015-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||Demographic data offered from the Intent-to-Treat population|Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia|"A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-Center Study With a Double Blind Extension Investigating the Efficacy and Safety of a Fast- Dissolving (Melt) Formulation of Desmopressin for the Treatment of Nocturia in Adults"|Completed||Phase 3|799|Actual|Ferring Pharmaceuticals||5|||f||||t||||||||||2017-02-18 15:35:59.340078|2017-02-18 15:35:59.340078
NCT00477477|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2014-10-24|||May 2007||2007-05-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|||Nutritional Treatment of Overweight Adolescents With Cardiovascular Risk Factors (PowerUp)|Nutritional Treatment of Overweight Adolescents With Cardiovascular Risk Factors|Terminated||N/A|27|Actual|Boston Children’s Hospital||2||Inadequate enrollment and lack of funds.|f||||f||||||||||2017-02-18 15:36:01.446221|2017-02-18 15:36:01.446221
NCT00477464|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2011-09-15|2011-08-04||June 2007||2007-06-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer|Clinical Evaluation of Lapatinib Administered With Capecitabine in Japanese Patients With ErbB2 Overexpressing Advanced or Metastatic Breast Cancer|Completed||Phase 2|51|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-02-18 15:36:01.567751|2017-02-18 15:36:01.567751
NCT00477451|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2017-01-30|||May 2007||2007-05-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Staccato Alprazolam in Panic Attack|Investigation of a Single Dose of Staccato™ Alprazolam for Inhalation on Doxapram-Induced Panic Attack in Patients With Panic Disorder|Completed||Phase 2|40|Actual|Alexza Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 15:36:02.05918|2017-02-18 15:36:02.05918
NCT00477425|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2010-12-01|||June 2007||2007-06-01|December 2010|2010-12-01||||||||Observational|||A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab|Evaluation of Corrected QT Interval From Clinical Studies Conducted With Bevacizumab|Withdrawn||Phase 4|150||Genentech, Inc.|||||f||||||||||||||2017-02-18 15:36:02.174423|2017-02-18 15:36:02.174423
NCT00477412|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2016-08-17|||April 2007||2007-04-01|August 2016|2016-08-01||||April 2017|Anticipated|2017-04-01||Interventional|||Bortezomib (Velcade) Plus Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma|Phase I Study of Bortezomib (Velcade) Plus Rituximab-HyperCVAD Alternating With Bortezomib Plus Rituximab-High Dose Methotrexate/Cytarabine in Patients With Untreated Aggressive Mantle Cell Lymphoma|Active, not recruiting||Phase 1|110|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:36:02.241244|2017-02-18 15:36:02.241244
NCT00477399|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2007-05-22|||May 2007||2007-05-01|May 2007|2007-05-01|May 2012|Anticipated|2012-05-01|||||Interventional|||Long Term Follow up After 1 Year Initial Lifestyle Intervention|Effect of Four Years Intensive- Versus Regular Follow up, After a One Year Weight Loss Period, in Patients With Morbid Obesity.|Unknown status|Recruiting|N/A|100|Anticipated|Evjeklinikken||2|||f||||t||||||||||2017-02-18 15:36:02.600553|2017-02-18 15:36:02.600553
NCT00473369|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2007-05-14|||January 2001||2001-01-01|May 2007|2007-05-01|May 2007|Anticipated|2007-05-01|||||Observational|||Prognosis of Atypical Pituitary Adenomas||Unknown status|Active, not recruiting|N/A|||Tohoku University|||||f||||t||||||||||2017-02-18 15:37:38.217072|2017-02-18 15:37:38.217072
NCT00477386|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2014-09-19|2014-09-19||July 2007||2007-07-01|September 2014|2014-09-01|September 2013|Actual|2013-09-01|May 2011|Actual|2011-05-01||Interventional|||Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer|Phase I/II Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer|Completed||Phase 1/Phase 2|28|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 15:36:02.710149|2017-02-18 15:36:02.710149
NCT00477373|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2008-12-18|||December 2006||2006-12-01|December 2008|2008-12-01||||December 2007|Actual|2007-12-01||Interventional|GEVANS||Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study|Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study|Completed||Phase 4|70|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:36:03.494607|2017-02-18 15:36:03.494607
NCT00477360|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-22|2011-08-10|||January 2007||2007-01-01|August 2011|2011-08-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|CAP||Humeral Resurfacing Hemiarthroplasty|Humeral Resurfacing Hemiarthroplasty. Phase 2: Prospective Cohort Study|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Calgary||1|||f||||f||||||||||2017-02-18 15:36:03.599386|2017-02-18 15:36:03.599386
NCT00477347|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2016-09-22|||May 2007||2007-05-01|September 2016|2016-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|Drone-TH||Closed-loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation|Comparison of Manual Propofol and Remifentanil Administration and Dual Closed-loop, Using Bispectral Index as the Control Variable, During Liver Transplantation|Terminated||Phase 4|5|Actual|Hopital Foch||2||lack of recrutment|f||||f||||||||||2017-02-18 15:36:03.703509|2017-02-18 15:36:03.703509
NCT00477204|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2013-08-19|2013-01-23||May 2007||2007-05-01|August 2013|2013-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes|Clinical Trial of Zocor and Vytorin in Adolescents With Type 1 Diabetes|Completed||Phase 2|9|Actual|University of Colorado, Denver|Recruitment for this study failed to meet target and therefore it is difficult to make conclusions on the data obtained in these 9 subjects.|2|||f||||t||||||||||2017-02-18 15:36:03.81745|2017-02-18 15:36:03.81745
NCT00477191|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2016-04-12|2015-09-16||May 2007||2007-05-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional||Psoriasis patients with MetS|Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis|Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis|Terminated||N/A|18|Actual|Massachusetts General Hospital|It was likely underpowered to detect small changes in laboratory and exam measures. Patients were only evaluated after a 6 month course of etanercept therapy.|1||Difficulty in recruitment.|f||||f||||||||||2017-02-18 15:36:04.19912|2017-02-18 15:36:04.19912
NCT00477178|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2011-08-09|||August 2004||2004-08-01|May 2007|2007-05-01|December 2005|Actual|2005-12-01|May 2005|Actual|2005-05-01||Observational|||The Effect of Codeine on Driving Abilities|The Effect of Codeine on Driving Abilities|Completed||Phase 3|60|Actual|Norwegian University of Science and Technology|||3||f||||f||||||||||2017-02-18 15:36:04.482347|2017-02-18 15:36:04.482347
NCT00477165|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-09-12|||April 2001||2001-04-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Citalopram in Irritable Bowel Syndrome|Effect of Citalopram on Clinical Symptoms and Visceral Sensitivity in Patients With Irritable Bowel Syndrome|Completed||Phase 2|54|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 15:36:04.562403|2017-02-18 15:36:04.562403
NCT00477152|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2011-11-22|2011-09-12||August 2007||2007-08-01|November 2011|2011-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|INFUSE-PR||Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children|INcreased Flow Utilizing Subcutaneously-Enabled Pediatric Rehydration (INFUSE-Pediatric Rehydration Study): Phase IV Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase (HYLENEX) for Infants and Children|Completed||Phase 4|52|Actual|Baxter Healthcare Corporation||1|||f||||f||||||||||2017-02-18 15:36:04.659811|2017-02-18 15:36:04.659811
NCT00477139|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2011-04-11|||January 2009||2009-01-01|April 2011|2011-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer|A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer|Completed||N/A|4|Actual|Stanford University|||1||f||||t||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 15:36:05.044135|2017-02-18 15:36:05.044135
NCT00477126|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2012-04-03|||January 2007||2007-01-01|April 2012|2012-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Bioequivalence Study of Generic GPO Ritonavir Versus Norvir®|Bioequivalence Study of Generic GPO Ritonavir Versus Norvir® in Thai Healthy Volunteers|Completed||Phase 1|16|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||t||||||||||2017-02-18 15:36:05.126488|2017-02-18 15:36:05.126488
NCT00477113|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2015-06-18|||January 2007||2007-01-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|TYGRIS||TYSABRI Global Observational Program in Safety|TYGRIS: TYSABRI® Global Observational Program in Safety|Completed||N/A|2207|Actual|Biogen|||1||f||||f||||||Samples With DNA|"~     whole blood, serum~   "|||2017-02-18 15:36:05.232568|2017-02-18 15:36:05.232568
NCT00477100|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2017-01-03|||April 2007||2007-04-01|January 2017|2017-01-01||||April 2018|Anticipated|2018-04-01||Observational|||Inflammatory Breast Cancer (IBC) Registry|Inflammatory Breast Cancer (IBC) Registry|Recruiting||N/A|1200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples Without DNA|"~     The collection of serum and plasma from patients with inflammatory breast cancer.~   "|||2017-02-18 15:36:05.346436|2017-02-18 15:36:05.346436
NCT00477087|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-07-03|||July 2006||2006-07-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|January 2009|Actual|2009-01-01||Interventional|||Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer|Phase II Study of Granulocyte-Macrophage Colony Stimulating Factor Plus Mitoxantrone for the Treatment of Hormone Refractory Prostate Cancer|Completed||Phase 2|10|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 15:36:05.482604|2017-02-18 15:36:05.482604
NCT00477074|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2007-05-18|||January 2004||2004-01-01|May 2007|2007-05-01|December 2005|Actual|2005-12-01|||||Observational|||Pulmonary and Systemic Hepatocyte Growth Factors in Patients With COPD|Pulmonary and Systemic Hepatocyte Anb Keratinocyte Growth Factors in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|44|Actual|Hospital Universitari Son Dureta|||||f||||f||||||||||2017-02-18 15:36:05.586515|2017-02-18 15:36:05.586515
NCT00477061|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2007-05-20|||January 2004||2004-01-01|May 2007|2007-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Morphine Analgesia in Patients With Acute Appendicitis|Double Blind Randomized Study of Morphine Analgesia in Patients With Acute Appendicitis|Completed||Phase 4|71|Actual|Tehran University of Medical Sciences||2|||f||||f||||||||||2017-02-18 15:36:05.833516|2017-02-18 15:36:05.833516
NCT00477048|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2016-02-18|||May 2004||2004-05-01|February 2016|2016-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity|Efficacy and Safety of a Saquinavir Based Regimen in HIV-1 Infected Thai Patients Who Have Chronic IDV Associated Nephrotoxicity.|Completed||Phase 2|30|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||t||||||||||2017-02-18 15:36:05.923294|2017-02-18 15:36:05.923294
NCT00477035|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2017-01-09|||May 2006||2006-05-01|January 2017|2017-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies|A Phase I Study of Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for the Treatment of High-risk Hematologic Malignancies|Completed||Phase 1|22|Actual|Stanford University||1|||f||||t||||||||No||2017-02-18 15:36:06.062974|2017-02-18 15:36:06.062974
NCT00477022|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2007-05-22|||February 2006||2006-02-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Interventional|VCT||The Effects of Vacuum-Compression Therapy on the Healing of Diabetic Foot Ulcers||Completed||N/A|20|Actual|Zahedan University of Medical Sciences||1|||f||||f||||||||||2017-02-18 15:36:06.183523|2017-02-18 15:36:06.183523
NCT00477009|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2013-01-17|||May 2007||2007-05-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects From a Mandibular Repositioning Appliance in Patients With Obstructive Sleep Apnea and Snoring|A Randomized Controlled Trial of Effects From a Mandibular Advancement Device in Patients With Obstructive Sleep Apnea and Snoring|Completed||N/A|96|Actual|Umeå University||2|||f||||f||||||||||2017-02-18 15:36:06.283587|2017-02-18 15:36:06.283587
NCT00476996|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2016-03-17||2013-08-20|May 2007||2007-05-01|March 2016|2016-03-01|June 2016|Anticipated|2016-06-01|August 2011|Actual|2011-08-01||Interventional|SCRIPT||A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)|A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to at Least One Anti-TNF-α Therapy|Active, not recruiting||Phase 3|840|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 15:36:06.402146|2017-02-18 15:36:06.402146
NCT00476983|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2015-03-27||||||March 2015|2015-03-01||||||||Interventional|||Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg|Pharmacokinetic and Efficacy of Saquinavir Mesylate Film Coated Tablet / Ritonavir 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg Once Daily in HIV Pretreated Patients|Withdrawn||Phase 2/Phase 3|0|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1||No funding|f||||t||||||||||2017-02-18 15:36:06.509285|2017-02-18 15:36:06.509285
NCT00476970|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2016-09-20|||September 2007||2007-09-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations|Improving Colorectal Cancer Screening Rates by Lowering Barriers in Low Income and Non-English Speaking Populations: The Chelsea Colorectal Cancer Screening Project|Completed||N/A|1223|Actual|Massachusetts General Hospital||2|||f||||f||||||||No||2017-02-18 15:36:06.608798|2017-02-18 15:36:06.608798
NCT00476957|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2014-11-03|2013-09-17||June 2007||2007-06-01|November 2014|2014-11-01|July 2014|Actual|2014-07-01|May 2012|Actual|2012-05-01||Interventional|PROTECT|Intention to treat analysis has been used.|Randomized Study Comparing Endeavor With Cypher Stents (PROTECT)|PROTECT Trial: Patient Related OuTcomes With Endeavor Versus Cypher Stenting Trial|Completed||Phase 4|8709|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-02-18 15:36:06.712696|2017-02-18 15:36:06.712696
NCT00476944|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2007-05-18|||September 2006||2006-09-01|May 2007|2007-05-01||||||||Interventional|||Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI|Minimizing Post-Procedural Vascular Complications: Comparing Bivalirudin Versus Heparin/GP IIB/IIA in Patients Undergoing Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 4|||Gold, Herman K., MD||2|||||||||||||||||2017-02-18 15:36:07.394609|2017-02-18 15:36:07.394609
NCT00476931|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-10-30||2012-10-30|May 2007||2007-05-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy|A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderate to Severe Diabetic Neuropathy and Unmeasurable Nerve Conduction Velocity|Completed||Phase 2|91|Actual|Sangamo Therapeutics||2|||f||||f||||||||||2017-02-18 15:36:07.489419|2017-02-18 15:36:07.489419
NCT00476918|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2007-05-21|||July 2006||2006-07-01|May 2007|2007-05-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema|Dosage Dependency of Intravitreal Triamcinolone Acetonide for Treatment of Diabetic Macular Edema|Unknown status|Recruiting|Phase 1|60|Anticipated|Heidelberg University||2|||f||||t||||||||||2017-02-18 15:36:07.607935|2017-02-18 15:36:07.607935
NCT00476905|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2016-05-25|||April 2007||2007-04-01|May 2016|2016-05-01||||April 2018|Anticipated|2018-04-01||Observational|||Spectral Diagnosis of Cutaneous Malignancy|Spectral Diagnosis of Cutaneous Malignancy|Active, not recruiting||N/A|350|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:36:07.702908|2017-02-18 15:36:07.702908
NCT00476892|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2011-03-22|||June 2007||2007-06-01|February 2010|2010-02-01|March 2011|Actual|2011-03-01|July 2010|Actual|2010-07-01||Interventional|POPPY||Multi-centre Randomised Controlled Trial of Pelvic Floor Muscle Training for Prolapse|A Multi-centre Randomised Controlled Trial of a Pelvic Floor Muscle Training Intervention for Women With Pelvic Organ Prolapse|Completed||N/A|448|Actual|Glasgow Caledonian University||2|||f||||t||||||||||2017-02-18 15:36:07.813514|2017-02-18 15:36:07.813514
NCT00476879|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2008-08-11|||August 2006||2006-08-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content|Growth Hormone During Fasting. Signaltransduktion in Muscle and Adipose Tissue, Consequence of Growth Hormone Receptor Antagonist, Quantification of Intrahepatic Lipid Content Based on MR Scanning|Completed||N/A|10|Actual|University of Aarhus||4|||f||||f||||||||||2017-02-18 15:36:07.94529|2017-02-18 15:36:07.94529
NCT00476866|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2007-05-21|||December 2002||2002-12-01|May 2007|2007-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Intermittent Positive-Pressure Breathing Effects in Patients With High Spinal Cord Injury|Intermittent Positive-Pressure Breathing Effects in Patients With High Spinal Cord Injury|Terminated||N/A|14|Actual|University of Versailles||2||The number of patients desired has been reached|f||||f||||||||||2017-02-18 15:36:08.051273|2017-02-18 15:36:08.051273
NCT00476853|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2010-06-04|||October 2005||2005-10-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy|A 48 Week, Randomized, Open-label, 2 Arm Study to Compare the Efficacy, Safety and Tolerability of HAART Containing Nevirapine 400mg/Day Versus Nevirapine 600 mg/Day in HIV-1 Infected Patients Started at 2-6 Weeks After Initiating Rifampin Containing Antituberculous Therapy|Completed||Phase 2|42|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||t||||||||||2017-02-18 15:36:08.137754|2017-02-18 15:36:08.137754
NCT00476827|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2013-07-15|2012-12-10||May 2007||2007-05-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain|A Phase II Safety and Tolerability Study of Avastin When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain|Terminated||Phase 2|16|Actual|Duke University||6||Slow accrual|f||||f||||||||||2017-02-18 15:36:08.263251|2017-02-18 15:36:08.263251
NCT00476814|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2007-10-30||||||October 2007|2007-10-01||||||||Observational|||NPD Measurements in PSC Patients|Cystic Fibrosis Transmembrane Conductance Regulator Function as Measured by Nasal Potential Difference Measurements in Patients With Primary Sclerosing Cholangitis|Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||||f||||f||||||||||2017-02-18 15:36:09.194123|2017-02-18 15:36:09.194123
NCT00476801|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2015-07-08|||July 2001||2001-07-01|July 2015|2015-07-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||UVA1 Light for Treatment of Scleroderma and Similar Conditions|The Effectiveness Of UVA1 Irradiation In The Treatment Of Skin Conditions With Altered Dermal Matrix: A Controlled, Cross-Over Study|Completed||N/A|27|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 15:36:09.27204|2017-02-18 15:36:09.27204
NCT00476788|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2010-12-20|2010-10-12||April 2007||2007-04-01|December 2010|2010-12-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM|Fast Track Continuous Subcutaneous Insulin Infusion (CSII) in Children With Newly Diagnosed Type 1 Diabetes Mellitus: An Evaluation of a Novel CSII Device in the Immediate Period Following Diagnosis of Type 1 Diabetes (T1DM)|Completed||N/A|14|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-02-18 15:36:09.376916|2017-02-18 15:36:09.376916
NCT00476775|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-12-12|||May 2007||2007-05-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|March 2011|Actual|2011-03-01||Interventional|ECHALE||Ethnic Dance and Screen Time Reduction to Prevent Weight Gain in Latina Girls|Ethnic Dance and Screen Time Reduction to Prevent Weight Gain in Latina Girls|Completed||N/A|233|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 15:36:09.614591|2017-02-18 15:36:09.614591
NCT00476736|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2007-05-21|||May 2007||2007-05-01|May 2007|2007-05-01|May 2007|Anticipated|2007-05-01|||||Interventional|NAC||The Effect of N-Acetylcystein on Quality of Life and Air Trapping During Rest and After Exercise|Reassessment Study of The Effect of N-Acetylcystein on Quality of Life and Air Trapping During Rest and After Exercise|Unknown status|Recruiting|Phase 4|30|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 15:36:09.727725|2017-02-18 15:36:09.727725
NCT00476723|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2010-06-04|||April 2005||2005-04-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection|Generation of HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection Receiving HBV-active Antiretroviral Therapy|Completed||Phase 3|36|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||t||||||Samples With DNA|"~     PBMC~   "|||2017-02-18 15:36:09.811515|2017-02-18 15:36:09.811515
NCT00476710|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2015-03-30|||May 2007||2007-05-01|March 2015|2015-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Effects of Colesevelam HCl On Bile Acid Kinetics|Effects of Colesevelam HCl On Bile Acid Pools And Kinetic Parameters in Normal Subjects, Subjects With Impaired Glucose Tolerance, And Subjects With Type 2 Diabetes Mellitus|Completed||N/A|36|Actual|KineMed|||3||f||||f||||||||||2017-02-18 15:36:09.905975|2017-02-18 15:36:09.905975
NCT00476697|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2015-07-24|||January 1997||1997-01-01|July 2015|2015-07-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||UVA1 Light for Scleroderma and Similar Conditions|The Effectiveness of UVA1 Irradiation in the Treatment of Skin Conditions With Altered Dermal Matrix: An Open Pilot Study|Terminated||N/A|23|Actual|University of Michigan||1||inactivity|f||||f||||||||||2017-02-18 15:36:10.033288|2017-02-18 15:36:10.033288
NCT00476684|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2012-03-06|||August 2004||2004-08-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||The Effect of Radiofrequency-treatment on Patients With Facet-joint Pain in Cervical- and Lumbar-columna|The Effect of Radiofrequency-treatment on Patients With Facet-joint Pain in Cervical- and Lumbar-columna|Completed||N/A|28|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 15:36:10.130626|2017-02-18 15:36:10.130626
NCT00476671|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2008-10-19|||March 2007||2007-03-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Observational|||Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1|Prevalence and Risk Factors of HIV-Associated Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 Infected Thai Individuals With Undetectable Viral Load in the HAART Era.|Completed||N/A|100|Anticipated|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||t||||||Samples Without DNA|"~     PBMC and plasma~   "|||2017-02-18 15:36:10.230146|2017-02-18 15:36:10.230146
NCT00476658|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2011-12-06|||January 2007||2007-01-01|May 2007|2007-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Macrophage Infiltration in Human Adipose Tissue|Characterisation of Macrophage Infiltration in Obesity and Its Complications|Completed||N/A|200|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||f||||||Samples With DNA|"~     adipose tissue, visceral adipose tissue, muscle, liver, bowel and stomach~   "|||2017-02-18 15:36:10.369568|2017-02-18 15:36:10.369568
NCT00476645|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2014-08-04|2014-06-30||September 2006||2006-09-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional||All participants were included in the analysis|Fulvestrant in Hormone Refractory Prostate Cancer|Fulvestrant in Hormone-refractory Prostate Cancer|Completed||Phase 2|10|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 15:36:10.453129|2017-02-18 15:36:10.453129
NCT00476632|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2016-09-30|||June 2004||2004-06-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Observational|||Epidemiology Controls Using Healthy Participants|Epidemiology Controls Using Healthy Participants|Active, not recruiting||N/A|1500|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     2 ½ tablespoons of blood drawn.~   "|||2017-02-18 15:36:10.743984|2017-02-18 15:36:10.743984
NCT00476619|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2009-04-02|||September 2004||2004-09-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|ERIN||Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial|Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial|Terminated||Phase 4|17|Actual|Brigham and Women's Hospital||1||The exclusion criteria were stringent and enrollment was slow.|f||||t||||||||||2017-02-18 15:36:10.84727|2017-02-18 15:36:10.84727
NCT00476606|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2016-02-19|||March 2003||2003-03-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||A Prospective Cohort of Children With HIV Infection|Treatment Outcome of Children With HIV Infection|Recruiting||Phase 4|1000|Anticipated|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||t||||||Samples With DNA|"~     PBMC~   "|||2017-02-18 15:36:11.063679|2017-02-18 15:36:11.063679
NCT00476593|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2011-08-09|2011-05-24||September 2005||2005-09-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications|Retinal Optical Coherence Tomography and Multifocal Electroretinogram; Establishing Normal Ranges Related to Age and Reproductive Factors; With the Use of Anti-inflammatory Medications;In Uncomplicated Anterior Uveitis; Anatomy and Function.|Completed||N/A|218|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 15:36:11.202676|2017-02-18 15:36:11.202676
NCT00476580|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2015-08-27|||April 2007||2007-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans|Health Habits and Cancer Risk Among a US Migrant Sri Lankan Population and a Comparison With Siblings Living in Sri Lanka|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||2|Study terminated.|f||||f||||||||||2017-02-18 15:36:11.743037|2017-02-18 15:36:11.743037
NCT00476567|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2015-08-18|||May 2007||2007-05-01|August 2015|2015-08-01|June 2015|Actual|2015-06-01|June 2011|Actual|2011-06-01||Interventional|||Effects of Regular Exercise During Pregnancy|Training During Pregnancy - Effects of Regular Exercise During Pregnancy in Prevention of Pregnancy-related Diseases and Complications During Labour. A Randomised Clinical Trial|Completed||N/A|855|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 15:36:11.855108|2017-02-18 15:36:11.855108
NCT00476554|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-19|2011-11-07|||April 2007||2007-04-01|November 2011|2011-11-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma||Terminated||Phase 2|32|Anticipated|Cyclacel Pharmaceuticals, Inc.||2||slow accrual and financial resource limitation|f||||||||||||||2017-02-18 15:36:11.969888|2017-02-18 15:36:11.969888
NCT00476541|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2016-05-12|||January 2004||2004-01-01|May 2015|2015-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia|NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia|Completed||Phase 3|250|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-02-18 15:36:12.066426|2017-02-18 15:36:12.066426
NCT00476528|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2010-08-09|||September 2007||2007-09-01|August 2010|2010-08-01|September 2010|Anticipated|2010-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Early Rehabilitation of Patients With Posttraumatic Amnesia|Early Rehabilitation of Patients With Posttraumatic Amnesia. A Clinical Controlled Investigation of the Effect of a Nursing Programme in Patients With Traumatic Brain Injury in the Acute Care|Unknown status|Active, not recruiting|N/A|62|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-02-18 15:36:12.178135|2017-02-18 15:36:12.178135
NCT00476515|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2008-02-15|||March 2007||2007-03-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor|Multicenter Trial Using Multi-Dose Rituximab as Induction and Desensitization Therapy for Patients on the Waiting List for Kidney Transplant With a Positive Donor Specific Crossmatch to a Living Donor|Completed||Phase 1|0|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:36:12.268248|2017-02-18 15:36:12.268248
NCT00476502|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2012-04-03|||February 2006||2006-02-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r|Study of Genetic Polymorphisms of CYP 3A and MDR-1 Genes in Thai HIV-1 Infected Patients on Saquinavir/Ritonavir|Completed||N/A|250|Actual|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||t||||||Samples With DNA|"~     PBMC~   "|||2017-02-18 15:36:12.549367|2017-02-18 15:36:12.549367
NCT00476489|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2007-05-21|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Observational|||Does Topical Steroid Treatment Impair the Adrenal Function?|Low Dose (1mcg) ACTH Stimulation Test for Assessment of the Hypothalamo-Pituitary- Adrenal Axis in Patients Treated With Topical Corticosteroids|Unknown status|Recruiting|N/A|50|Anticipated|HaEmek Medical Center, Israel|||||f||||f||||||||||2017-02-18 15:36:12.658892|2017-02-18 15:36:12.658892
NCT00476476|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2015-04-13|2015-03-08||December 2006||2006-12-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||The analysis population is comprised of all enrolled patients.|Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar|A Phase II Trial of Tarceva (Erlotinib) in Women With Squamous Cell Carcinoma of the Vulvar|Completed||Phase 2|41|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:36:12.758956|2017-02-18 15:36:12.758956
NCT00476463|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2016-02-18|||April 2005||2005-04-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection|Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Antiretroviral Naive Patients With HIV/HBV Co-infection|Completed||Phase 2|24|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||t||||||||||2017-02-18 15:36:13.225577|2017-02-18 15:36:13.225577
NCT00476450|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-19|2017-01-24|||May 16, 2007||2007-05-16|March 7, 2016|2016-03-07|March 7, 2016||2016-03-07|||||Observational|||Effects of Stem Cell Transplantation on Bacteria in the Mouth|Effects of Peripheral Blood Stem Cell Transplantation on the Microbial Flora of the Oral Cavity|Completed||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:36:13.544417|2017-02-18 15:36:13.544417
NCT00476437|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2014-11-03|||April 2007||2007-04-01|November 2014|2014-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.|Safety and Effect of Biphasic Insulin Aspart 50 Compared to Biphasic Human Insulin 50 in Patients With Type 2 Diabetes Mellitus.|Completed||Phase 3|81|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:36:13.633139|2017-02-18 15:36:13.633139
NCT00476424|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2010-06-04|||June 2007||2007-06-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects|A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects|Completed||Phase 2|28|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||t||||||||||2017-02-18 15:36:13.730954|2017-02-18 15:36:13.730954
NCT00476411|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2010-06-04|||December 2006||2006-12-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection|The Efficacy of HBV Vaccine Response and Prevalence of Occult HBV Infection in Isolated Anti HBc Between HIV Infected and HIV Un-infected Thai Patients|Completed||N/A|200|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||t||||||||||2017-02-18 15:36:13.842784|2017-02-18 15:36:13.842784
NCT00476398|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2009-09-08|||January 2006||2006-01-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of Patients With Non-cardiac Chest Pain|Evaluation of Patients With Non-cardiac Chest Pain Using PillCam Eso - a Wireless Imaging Capsule of the Esophagus.|Completed||Phase 4|40|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-02-18 15:36:13.959421|2017-02-18 15:36:13.959421
NCT00476385|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2009-02-11|||June 2003||2003-06-01|February 2009|2009-02-01||||December 2005|Actual|2005-12-01||Interventional|||Practicability and Acceptability of Stylomax® in Children|Usability and Acceptability of Stylomax® in Growth Hormone Deficient Children.|Completed||Phase 3|12|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:36:14.059797|2017-02-18 15:36:14.059797
NCT00476372|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2013-01-11|||August 2007||2007-08-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Cognitive Impairment in Parkinson's Disease Categorised in Accordance to Motor Symptoms|Cognitive Impairment in Parkinson's Disease Categorised in Accordance to Motor Symptoms -the Relation Between Cognitive Deficits and Comorbid Psychiatric Disorders, Medication, and Age at Disease Onset|Completed||N/A|107|Actual|University of Aarhus|||1||f||||f||||||||||2017-02-18 15:36:14.161525|2017-02-18 15:36:14.161525
NCT00476359|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-20|2015-03-26|||October 2003||2003-10-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A PK and Salvage Study for Children With HIV-infection|Lopinavir/r Plus Saquinavir Salvage Therapy in HIV-infected Children With NRTI and/or NNRTI Failure: PK and Two-year Treatment Follow up|Completed||Phase 4|50|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||t||||||||||2017-02-18 15:36:14.252755|2017-02-18 15:36:14.252755
NCT00476346|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2015-03-24|||May 2002||2002-05-01|August 2008|2008-08-01|March 2006|Actual|2006-03-01|||||Interventional|||Calcium and Vitamin D Supplementation Decreases Incidence of Stress Fractures in Female Navy Recruits|Calcium and Vitamin D Supplementation Decreases Incidence of Stress Fractures in Female Navy Recruits|Completed||N/A|5201|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 15:36:14.385175|2017-02-18 15:36:14.385175
NCT00476333|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-19|2007-05-21||||||April 2007|2007-04-01||||||||Interventional|||The Effect of Custom-Made Biomechanical Perturbation Platform on Kinetics, Kinematics and Electromyography in Healthy Subjects||Unknown status|Recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:36:14.497219|2017-02-18 15:36:14.497219
NCT00476320|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2007-05-21|||August 2004||2004-08-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Observational|||The Use of Myocardial Deformation Imaging|The Use of Myocardial Deformation Imaging Based on Ultrasonic Pixel Tracking to Identify Reversible Myocardial Dysfunction|Completed||N/A|||RWTH Aachen University|||||f||||f||||||||||2017-02-18 15:36:14.575431|2017-02-18 15:36:14.575431
NCT00476307|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-21|2016-11-02|||June 2007||2007-06-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above|A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People Aged 18 Years or Above|Completed||Phase 3|120|Anticipated|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:36:14.673163|2017-02-18 15:36:14.673163
NCT00476294|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2012-07-10|||October 2006||2006-10-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Long-Term Follow Up Study for AMD3100 Patients|Long-Term Observational Follow-Up Study of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 (240 MCG/KG) Plus G-CSF (10 MCG/KG) Versus G-CSF (10 MCG/KG) Plus Placebo to Mobilize and Collect >/= 6 x 10^6 CD34+ Cells/KG in Multiple Myeloma Patients for Autologous Transplantation|Completed||N/A|7|Actual|M.D. Anderson Cancer Center|||2||f||||t||||||||||2017-02-18 15:36:14.781248|2017-02-18 15:36:14.781248
NCT00476281|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2016-04-08|||April 2008||2008-04-01|March 2016|2016-03-01|October 2023|Anticipated|2023-10-01|October 2023|Anticipated|2023-10-01||Interventional|||Nutritional, Metabolic and Respiratory Status in Cystic Fibrosis|Multicenter Prospective Study of Abnormalies Tolerance Glucose by the Continuous Measurement of Glucose of Nutritional Status and Breathing in the Patient With Cystic Fibrosis|Recruiting||N/A|100|Anticipated|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-02-18 15:36:14.906493|2017-02-18 15:36:14.906493
NCT00476268|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-04-02|||February 2004||2004-02-01|April 2012|2012-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma|A 24-week Phase III Study to Evaluate the Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler HFA 134a-pMDI in Adult Patients With Moderate to Severe Persistent Asthma|Completed||Phase 3|824|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||f||||||||||2017-02-18 15:36:15.039488|2017-02-18 15:36:15.039488
NCT00476255|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2014-11-05|||December 2011||2011-12-01|April 2010|2010-04-01||||November 2014|Actual|2014-11-01||Interventional|||Evaluating Models for Dissemination of Injury Prevention Information in the Pediatric Emergency Department Setting|Evaluating Models for Dissemination of Injury Prevention Information in the PED|Withdrawn||N/A|0|Actual|Rhode Island Hospital||2||Unfunded|f||||t||||||||||2017-02-18 15:36:15.149941|2017-02-18 15:36:15.149941
NCT00476242|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2014-06-04|2014-04-09||June 2008||2008-06-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|NAMHS||Memantine as a Supplement to Naltrexone in Treating Heroin Dependence|Placebo Controlled Study of Memantine as an Adjunct to Naltrexone in the Treatment of Opioid Dependence|Completed||Phase 2/Phase 3|82|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 15:36:15.251592|2017-02-18 15:36:15.251592
NCT00476229|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2012-08-01|2011-07-13||June 2006||2006-06-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies|Total Lymphoid Irradiation, Thymoglobulin, and Rituximab for Allogeneic Transplantation in Lymphoid Malignancies|Completed||N/A|20|Actual|M.D. Anderson Cancer Center|Early termination due to financial support.|1|||f||||f||||||||||2017-02-18 15:36:15.623514|2017-02-18 15:36:15.623514
NCT00476216|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2014-03-03|||September 2007||2007-09-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional|||Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer|Phase I Feasibility Study of the Combination of Fondaparinux (Arixtra) With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|23|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 15:36:16.005281|2017-02-18 15:36:16.005281
NCT00476203|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2012-11-27|||May 2007||2007-05-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|Yoga||Yoga Study in Breast Cancer Patients|Effect of Yoga on Weight and Fatigue in Breast Cancer Patients Study|Completed||N/A|63|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-02-18 15:36:16.1277|2017-02-18 15:36:16.1277
NCT00476190|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2016-02-11|||April 2007||2007-04-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||ALL Adult Consortium Trial: Adult ALL Trial|ALL Adult Consortium Trial: Adult ALL Trial|Active, not recruiting||Phase 2|112|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 15:36:16.243615|2017-02-18 15:36:16.243615
NCT00476177|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-03-28|||July 2003||2003-07-01|March 2012|2012-03-01|July 2009|Actual|2009-07-01|August 2007|Actual|2007-08-01||Interventional|||Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant|Infusion of Donor Dendritic Cells and Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogenic Transplant|Completed||Phase 1|25|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:36:16.391525|2017-02-18 15:36:16.391525
NCT00476164|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2017-01-09|||January 2007||2007-01-01|January 2017|2017-01-01|April 2017|Anticipated|2017-04-01|May 2015|Actual|2015-05-01||Interventional|RituxiCAN-C4||Study of Rituximab to Treat Chronic Renal Transplant Rejection|Randomised Trial of Anti-Cd20 in C4d+ Chronic Allograft Nephropathy|Active, not recruiting||Phase 4|62|Actual|King's College London||2|||f||||t||||||||||2017-02-18 15:36:16.490149|2017-02-18 15:36:16.490149
NCT00476151|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2011-04-19|2010-09-28||July 2007||2007-07-01|April 2011|2011-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of EpiCept™ NP-1 Topical Cream in Patients With Pain From Diabetic Peripheral Neuropathy (DPN)|Completed||Phase 2|226|Actual|EpiCept Corporation||2|||f||||f||||||||||2017-02-18 15:36:16.616039|2017-02-18 15:36:16.616039
NCT00476138|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2007-05-18|||November 2006||2006-11-01|May 2007|2007-05-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma|Functional Effects of Epigallocatechingallate on Retinal Function in Glaucoma|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Catholic University of the Sacred Heart||2|||f||||t||||||||||2017-02-18 15:36:17.035011|2017-02-18 15:36:17.035011
NCT00476125|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2015-11-13|||March 2008||2008-03-01|February 2015|2015-02-01|February 2016|Anticipated|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Effects of Dietary Manipulation on Metabolism in Healthy Adults|Effects of Dietary Manipulation on Metabolism in Healthy Adults|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|Beth Israel Deaconess Medical Center||3|||f||||f||||||||||2017-02-18 15:36:17.124779|2017-02-18 15:36:17.124779
NCT00476112|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2008-03-31|||August 2003||2003-08-01|March 2008|2008-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|Scene 2||A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter|A Phase II/III Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Centred Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter|Completed||Phase 2/Phase 3|60|Actual|Cardiome Pharma||1|||f||||t||||||||||2017-02-18 15:36:17.223084|2017-02-18 15:36:17.223084
NCT00476099|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2013-01-29|||December 2006||2006-12-01|April 2008|2008-04-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD|"A 48-week, Double Blind, Double Dummy, Randomised, Multinational, Multicentre, 3-arm Parallel Group Clinical Study of Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Administered Via pMDI With HFA-134a Propellant Versus Fixed Combination Budesonide Plus Formoterol DPI Versus Formoterol DPI in Patients With Stable Severe Chronic Obstructive Pulmonary Disease (COPD)"|Completed||Phase 3|828|Actual|Chiesi Farmaceutici S.p.A.||3|||f||||t||||||||||2017-02-18 15:36:17.349381|2017-02-18 15:36:17.349381
NCT00476086|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-05-05|2016-03-10||August 2006||2006-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|March 2012|Actual|2012-03-01||Interventional||The baseline population is comprised of all enrolled patients.|Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus|A Phase II Study of Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus|Completed||Phase 2|20|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 15:36:17.454653|2017-02-18 15:36:17.454653
NCT00476073|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-02-08|||April 2007||2007-04-01|February 2016|2016-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma||Completed||Phase 3|228|Actual|Mundipharma Research Limited|||||f||||f||||||||||2017-02-18 15:36:17.797163|2017-02-18 15:36:17.797163
NCT00476060|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2011-01-10|||January 2007||2007-01-01|February 2009|2009-02-01|August 2011|Anticipated|2011-08-01|August 2011|Anticipated|2011-08-01||Interventional|||Mesenchymal Stem Cell Transplantation in Decompensated Cirrhosis|Autologous Mesenchymal Stem Cell Transplantation in Patients With Decompensated Cirrhosis: A Randomized Placebo-controlled Trial|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|University of Tehran||2|||f||||t||||||||||2017-02-18 15:36:20.589715|2017-02-18 15:36:20.589715
NCT00476047|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2015-08-04|||February 2007||2007-02-01|August 2015|2015-08-01||||February 2015|Actual|2015-02-01||Interventional|||Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission|A Study of 131I-Tositumomab (Bexxar®) Consolidation in Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission|Completed||Phase 2|24|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 15:36:20.694004|2017-02-18 15:36:20.694004
NCT00476034|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-05-18|||December 2003||2003-12-01|May 2012|2012-05-01||||November 2004|Actual|2004-11-01||Interventional|||Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)|A 39-week, Double-blind, Active-controlled Extension to CCOX189A2361, a 13-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Trial of 2 Different Dose Regimens of Lumiracoxib (100 mg od and 200 mg od Initial Dose for Two Weeks Followed by 100 mg od) in Patients With Primary Knee Osteoarthritis, Using Celecoxib (200 mg od) as a Comparator|Completed||Phase 3|1312|Actual|Novartis|||||f||||||||||||||2017-02-18 15:36:20.803437|2017-02-18 15:36:20.803437
NCT00476021|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-05-17|2014-12-01||May 2007||2007-05-01|May 2016|2016-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|POPI||Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery|Randomized Trial of Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device After Vaginal Delivery|Completed||N/A|168|Actual|University of Pittsburgh||2|||f||||f||||||||Undecided||2017-02-18 15:36:20.90598|2017-02-18 15:36:20.90598
NCT00476008|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2014-08-07|2013-09-20||July 2007||2007-07-01|August 2014|2014-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease|Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease|Completed||Phase 4|60|Actual|Florida Atlantic University||2|||f||||f||||||||||2017-02-18 15:36:21.394483|2017-02-18 15:36:21.394483
NCT00475982|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-03-22|||January 2009||2009-01-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Effect of Weight Loss on Prostate Cancer Pathology|Effect of Weight Loss on Prostate Cancer Pathology|Completed||N/A|44|Actual|VA Office of Research and Development||2|||f||||||||||||||2017-02-18 15:36:22.27304|2017-02-18 15:36:22.27304
NCT00475969|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-17|||August 2004||2004-08-01|May 2007|2007-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Duloxetine vs Placebo in the Treatment of General Anxiety|Duloxetine Hydrochloride Once Daily Compared With Placebo in the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|327||Eli Lilly and Company|||||f||||f||||||||||2017-02-18 15:36:22.372032|2017-02-18 15:36:22.372032
NCT00475956|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2010-04-14|||May 2007||2007-05-01|April 2010|2010-04-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours|Phase I, Open-Label Study To Assess the Safety, Tolerability and Pharmacokinetics of Daily Oral Doses of Cediranib (RECENTIN™;AZD2171) (20, 30 or 45mg) When Co-Administered With Daily Oral Doses of AZD0530 (125mg or 175mg) in Patients With Advanced Solid Tumours|Completed||Phase 1|40|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:36:22.467003|2017-02-18 15:36:22.467003
NCT00475943|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2017-01-24|||May 16, 2007||2007-05-16|September 1, 2009|2009-09-01||||September 1, 2009|Actual|2009-09-01||Observational|||Movement of Epiglottis During Swallowing|Biomechanics of Human Epiglottal Movement and Inversion|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:36:22.573385|2017-02-18 15:36:22.573385
NCT00475930|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2009-09-01|||May 2007||2007-05-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates|Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates: A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||N/A|1563|Actual|Uniformed Services University of the Health Sciences||2|||f||||t||||||||||2017-02-18 15:36:22.658068|2017-02-18 15:36:22.658068
NCT00475917|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2015-08-19|||May 2007||2007-05-01|August 2015|2015-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Subjects With Advanced Malignancies|Terminated||Phase 1|28|Actual|Exelixis||1|||f||||||||||||||2017-02-18 15:36:22.765934|2017-02-18 15:36:22.765934
NCT00475904|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2011-07-25|2011-04-20||July 2007||2007-07-01|July 2011|2011-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)|A Phase II, Double-Blind, Randomized, Placebo-Controlled Non-inferiority Trial of EpiCept™ NP-1 Topical Cream (2% Ketamine / 4% Amitriptyline) vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)|Completed||Phase 2|360|Actual|EpiCept Corporation||3|||f||||f||||||||||2017-02-18 15:36:22.861169|2017-02-18 15:36:22.861169
NCT00475891|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2014-12-05|||April 2007||2007-04-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2010|Actual|2010-12-01||Observational|||Determination of Genetic Relatedness of Linezolid-resistant Vancomycin-resistant Enterococci (VRE) Surveillance Cultures|Determination of Genetic Relatedness of Linezolid-resistant Vancomycin-resistant Enterococci (VRE) Surveillance Cultures|Completed||N/A|20|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:36:23.344263|2017-02-18 15:36:23.344263
NCT00475878|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-03-05|2011-06-28||December 2006||2006-12-01|March 2012|2012-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||SSRI and Buprenorphine|Antidepressants During Office-Based Buprenorphine|Completed||Phase 3|147|Actual|Butler Hospital||2|||f||||t||||||||||2017-02-18 15:36:23.433343|2017-02-18 15:36:23.433343
NCT00475865|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-11-05|2012-10-03||April 2007||2007-04-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis|A Randomized, Multinational, Double-blind, Placebo-controlled, Parallel-group Design Pilot Study to Estimate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamic Effects of Teriflunomide for 24 Weeks When Added to Treatment With Glatiramer Acetate in Subjects With Multiple Sclerosis|Completed||Phase 2|123|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 15:36:23.820785|2017-02-18 15:36:23.820785
NCT00475852|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2013-03-01|2011-09-27||May 2007||2007-05-01|March 2013|2013-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure|Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)|Completed||Phase 3|7141|Actual|Scios, Inc.|Only summary counts of deaths by group are provided for other pre-specified endpoints “All-cause mortality through Day 30” and “All-cause mortality through Day 180.” Formal statistical comparisons were not planned.|2|||f||||f||||||||||2017-02-18 15:36:24.976356|2017-02-18 15:36:24.976356
NCT00475839|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2013-01-09|||December 2004||2004-12-01|January 2013|2013-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Comparing Tension-free Vaginal Tape With the Monarc Procedure for Stress Urinary Incontinence|A Randomized Trial Comparing the Monarc Subfascial Hammock Procedure With Tension-free Vaginal Tape Procedure for the Surgical Treatment of Stress Urinary Incontinence|Completed||Phase 3|180|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 15:36:27.244277|2017-02-18 15:36:27.244277
NCT00475826|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2008-03-20|||April 2007||2007-04-01|May 2007|2007-05-01||||||||Interventional|||Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe|Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe|Unknown status|Recruiting|N/A|||University of Sao Paulo||2|||f||||t||||||||||2017-02-18 15:36:27.371482|2017-02-18 15:36:27.371482
NCT00475813|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2016-03-15|||March 2007||2007-03-01|March 2016|2016-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma||Completed||Phase 3|211|Actual|Mundipharma Research Limited|||||f||||f||||||||||2017-02-18 15:36:27.455393|2017-02-18 15:36:27.455393
NCT00475800|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2012-05-18|||January 2004||2004-01-01|May 2012|2012-05-01||||December 2004|Actual|2004-12-01||Interventional|||Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)|A 39-week, Open-label Extension to CCOX189A2360, a 13-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Trial of 2 Different Dose Regimens of Lumiracoxib (100 mg od and 200 mg od Initial Dose for Two Weeks Followed by 100 mg od) in Patients With Primary Knee Osteoarthritis, Using Celecoxib (200 mg od) as a Comparator|Completed||Phase 3|833|Actual|Novartis|||||f||||||||||||||2017-02-18 15:36:27.552983|2017-02-18 15:36:27.552983
NCT00475787|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2014-12-16|2014-10-21||April 2008||2008-04-01|December 2014|2014-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Chiropractic Management of Chronic Lower Back Pain in Older Adults|Chiropractic Management of Chronic Lower Back Pain in Older Adults|Completed||N/A|136|Actual|VA Office of Research and Development|"Sham intervention was that it did involve some tactile stimulation~Only VA sites/predominantly male~Clinicians not blinded to invention delivered~All received educational booklet~Consideration of non-specific therapeutic effects"|2|||f||||t||||||||||2017-02-18 15:36:27.648729|2017-02-18 15:36:27.648729
NCT00475774|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2008-04-04|||May 2007||2007-05-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|||||Interventional|||Body Fat Distribution and Fat Metabolism|The Effect of Body Fat Distribution on the Physiological Response to a Dietary Fat Intervention|Completed||N/A|12|Anticipated|TNO||2|||f||||f||||||||||2017-02-18 15:36:28.0098|2017-02-18 15:36:28.0098
NCT00475761|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-18|2017-01-24|||May 10, 2007||2007-05-10|July 8, 2016|2016-07-08||||||||Observational|||Breast Mammogram and Tissue Study|Breast Radiology Evaluation and Study of Tissues (Breast) Stamp Project|Active, not recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:36:28.106672|2017-02-18 15:36:28.106672
NCT00475748|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2009-06-23|||May 2007||2007-05-01|June 2009|2009-06-01|May 2010|Anticipated|2010-05-01|May 2009|Actual|2009-05-01||Interventional|CCSS||Surgical Management of Spinal Cord Injuries In Neck|ASIA Motor, Functional and Health Related Quality of Life Outcome in Traumatic Central Cord Syndrome, a Prospective Randomized Study|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Maryland Department of Health and Mental Hygiene||1|||f||||f||||||||||2017-02-18 15:36:28.188718|2017-02-18 15:36:28.188718
NCT00475735|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2015-07-21|2010-10-13||July 2007||2007-07-01|July 2015|2015-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled, Incomplete Block, Two-period, Crossover Clinical Trial to Study the Safety and Efficacy of MK0249, 10 mg, for Adult Patients, Ages 18 to 55, With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2|72|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 15:36:28.516634|2017-02-18 15:36:28.516634
NCT00475722|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-08-18|2015-05-26||May 2007||2007-05-01|August 2016|2016-08-01|December 2011|Actual|2011-12-01|November 2010|Actual|2010-11-01||Interventional|||Healthy Eating for Colon Cancer Prevention|A Mediterranean Diet in Colon Cancer Prevention|Completed||N/A|120|Actual|University of Michigan||2|||f||||t||||||||Undecided||2017-02-18 15:36:29.276605|2017-02-18 15:36:29.276605
NCT00475709|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2014-01-24|2012-09-19||June 2007||2007-06-01|January 2014|2014-01-01|January 2012|Actual|2012-01-01|July 2010|Actual|2010-07-01||Interventional|||Aortic Valve Replacement With Trifecta(TM)|An Observational, Prospective Evaluation of the Trifecta Valve|Completed||N/A|1022|Actual|St. Jude Medical|The SAEs reported are based on the Edmunds criteria noted in Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller CM, Weisel RD. Guidelines for reporting Morbidity and Mortality after Cardiac Valvular Operations. Ann Thorac Surg 1996;62:932-5.|1|||f||||t||||||||||2017-02-18 15:36:29.806512|2017-02-18 15:36:29.806512
NCT00475696|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-16|||November 2002||2002-11-01|May 2007|2007-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Urge Incontinence Bladder Overactivity Study|Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Bladder Overactivity|Completed||Phase 2|300||Eli Lilly and Company|||||||||||||||||||2017-02-18 15:36:30.079446|2017-02-18 15:36:30.079446
NCT00475683|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2015-08-17|||January 2009||2009-01-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Curcumin for Prevention of Oral Mucositis in Children Chemotherapy|Randomized Cross-over Study of Curcumin for Prevention of Oral Mucositis in Children Receiving Doxorubicin Based Chemotherapy.|Completed||Phase 3|8|Actual|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 15:36:30.167464|2017-02-18 15:36:30.167464
NCT00475670|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2014-09-09|2014-07-15||October 2005||2005-10-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Full analysis set (FAS) included all enrolled participants who received at least one dose of either trastuzumab or taxane.|A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer|An Open-label Study of the Effect of First-line Herceptin Alone or in Combination With a Taxane on Tumor Response and Disease Progression in Patients With Metastatic Breast Cancer Who Relapsed After Receiving Adjuvant Herceptin for HER2-positive Early Breast Cancer|Completed||Phase 2|44|Actual|Hoffmann-La Roche|Cohort A (trastuzumab monotherapy) was closed prematurely due to enrollment difficulties. Therefore, Cohort A included only 3 participants.|2|||f||||||||||||||2017-02-18 15:36:30.287692|2017-02-18 15:36:30.287692
NCT00351429|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2009-02-10|||October 2005||2005-10-01|February 2009|2009-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study of PGA Suture in Ophthalmology|Evaluating the Safety and Efficacy of Polyglycolic Acid Suture in Ophthalmic Surgical Procedures|Completed||Phase 4|50|Actual|Aurolab||1|||f||||f||||||||||2017-02-18 16:24:34.296243|2017-02-18 16:24:34.296243
NCT00475657|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2009-05-22|2009-03-31||October 2007||2007-10-01|May 2009|2009-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer|Phase II Study of Pemetrexed Plus Cisplatin in the Treatment of Patients With Extensive Small Cell Lung Cancer|Terminated||Phase 2|5|Actual|Eli Lilly and Company|On the advice of an independent monitoring board, this trial was stopped early due to lack of efficacy of the combination pemetrexed/carboplatin for small cell lung cancer.|1||Terminated due to lack of efficacy|f||||f||||||||||2017-02-18 15:36:30.860222|2017-02-18 15:36:30.860222
NCT00475644|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2015-03-17||2011-05-09|May 2007||2007-05-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|April 2012|Actual|2012-04-01||Interventional|||A Study of Enzastaurin in Patients With Follicular Lymphoma|A Phase 2 Study of Enzastaurin in Patients With Follicular Lymphoma|Completed||Phase 2|66|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:36:31.143656|2017-02-18 15:36:31.143656
NCT00475631|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-03-08|||October 2003||2003-10-01|March 2012|2012-03-01||||||||Observational|||Economic Evaluation of Clubfoot Treatment: One Centre's Experience|Economic Evaluation of Clubfoot Treatment: One Centre's Experience|Withdrawn||N/A|0|Actual|University of British Columbia|||1|The person who started the study joined medical school|f||||f||||||||||2017-02-18 15:36:31.266272|2017-02-18 15:36:31.266272
NCT00475618|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-05-29|||May 2007||2007-05-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effect of Therapeutic Measures in Dental Caries Reduction in Children With Primary Dentition From Medellín City|Effect of Therapeutic Measures in Dental Caries Reduction in Children With Primary Dentition From Metropolitan Area Sorrounded Medellín City. A Clinical Trial|Completed||Phase 3|180|Actual|CES University||3|||f||||f||||||||||2017-02-18 15:36:31.356039|2017-02-18 15:36:31.356039
NCT00475605|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-07-07|||May 2005||2005-05-01|July 2016|2016-07-01|August 2022|Anticipated|2022-08-01|August 2022|Anticipated|2022-08-01||Observational|APPLES||A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis|APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis|Active, not recruiting||N/A|8037|Actual|LEO Pharma|||1||f||||t||||||||||2017-02-18 15:36:31.702826|2017-02-18 15:36:31.702826
NCT00475592|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2010-12-15|||January 2007||2007-01-01|May 2007|2007-05-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy|Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy|Unknown status|Recruiting|N/A|100|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 15:36:32.300489|2017-02-18 15:36:32.300489
NCT00475579|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2007-05-17|||March 2006||2006-03-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Interventional|A/N||Endotracheal Tube With Polyurethane Cuff and Subglottic Secretion Drainage|Influence of an Endotracheal Tube With Polyurethane Cuff and Subglottic Secretion Drainage on Ventilator-Associated Pneumonia|Completed||Phase 4|280|Actual|Hospital Universitario de Canarias||2|||f||||t||||||||||2017-02-18 15:36:32.391957|2017-02-18 15:36:32.391957
NCT00475566|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2011-03-09|||May 2007||2007-05-01|March 2011|2011-03-01|February 2010|Actual|2010-02-01|July 2008|Actual|2008-07-01||Interventional|STRIDES||A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System|A Study to Evaluate the Safety and Performance of the Dynalink®-E, Everolimus Eluting Peripheral Stent System for Treating Atherosclerotic de Novo or Restenotic Native Superficial Femoral and Proximal Popliteal Artery Lesions|Completed||N/A|104|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 15:36:32.477871|2017-02-18 15:36:32.477871
NCT00475553|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2009-12-17|||May 2006||2006-05-01|December 2009|2009-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®|The Frequency and Management of Breakthrough Bleeding During Extended Therapy With the Transvaginal Contraceptive Ring|Completed||N/A|75|Actual|Scott and White Hospital & Clinic||2|||f||||f||||||||||2017-02-18 15:36:32.582735|2017-02-18 15:36:32.582735
NCT00475540|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2015-09-21|||January 2007||2007-01-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|July 2009|Actual|2009-07-01||Interventional|VAMP||Efficacy Study of Vaginal Mesh for Prolapse|A Randomized Clinical Trial of Vaginal Mesh for Prolapse|Completed||Phase 4|65|Actual|Medstar Health Research Institute||2|||f||||t||||||||||2017-02-18 15:36:32.877786|2017-02-18 15:36:32.877786
NCT00475527|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2015-08-19||||||January 2009|2009-01-01||||||||Interventional|||Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of Therapy||Withdrawn||Phase 4|0|Actual|Hadassah Medical Organization||2||problem of accrual|f||||f||||||||||2017-02-18 15:36:32.994734|2017-02-18 15:36:32.994734
NCT00475514|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2014-02-14|||October 2004||2004-10-01|February 2014|2014-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine|A Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy, and Safety of Oral Frovatriptan in the Prevention on Menstrually-related Migraine (MRM) Headaches in a 'Difficult to Treat' Population|Completed||Phase 3|500|Actual|Endo Pharmaceuticals|||||||||f||||||||||2017-02-18 15:36:33.099287|2017-02-18 15:36:33.099287
NCT00475501|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2014-12-04|2013-11-20||January 2007||2007-01-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|March 2012|Actual|2012-03-01||Interventional||Men aged over 60 with serum testosterone 300 ng/dL or biotestosterone 70 ng/dL or less were recruited|5-Alpha Reductase and Anabolic Effects of Testosterone|5-Alpha Reductase and Anabolic Effects of Testosterone|Completed||Phase 2|60|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 15:36:33.199431|2017-02-18 15:36:33.199431
NCT00475488|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-05-10|||June 1996||1996-06-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|April 2015|Actual|2015-04-01||Interventional|RAPCO||Radial Artery Patency and Clinical Outcomes Trial|Randomised Trial of Graft Patency and Clinical Outcomes, Comparing Radial Artery With Either the Right Internal Thoracic Artery or Saphenous Vein|Active, not recruiting||N/A|605|Anticipated|Austin Health||2|||f||||t||||||||No||2017-02-18 15:36:34.176079|2017-02-18 15:36:34.176079
NCT00475475|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-04-30|||May 2007||2007-05-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Sweetened Beverages and Food Intake|Sweetened Beverages and Food Intake|Completed||N/A|10|Actual|University of Washington||3|||f||||f||||||||||2017-02-18 15:36:34.278635|2017-02-18 15:36:34.278635
NCT00475462|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2007-05-18|||July 2001||2001-07-01|May 2007|2007-05-01|December 2003|Actual|2003-12-01|||||Interventional|||The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents||Completed||N/A|28|Actual|Peking University First Hospital||2|||f||||t||||||||||2017-02-18 15:36:34.382134|2017-02-18 15:36:34.382134
NCT00475449|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2007-05-17|||November 1996||1996-11-01|May 2007|2007-05-01|February 2006|Actual|2006-02-01|||||Interventional|||The Stent or Surgery (SoS) Trial|A Randomised Controlled Trial to Compare Coronary Artery Bypass Grafting With Percutaneous Transluminal Coronary Angioplasty and Primary Stent Implantation in Patients With Multi-Vessel Coronary Artery Disease|Completed||N/A|988|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 15:36:34.464715|2017-02-18 15:36:34.464715
NCT00475436|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2016-10-27|||May 2007||2007-05-01|October 2016|2016-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers|A Single-centre, Randomised, Double-blind, Placebo-controlled, Dose-ascending, 3-cohort Parallel-group Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK573719 Administered as Singledoses (750 μg and 1000 μg) and Repeat Doses Over 14 Days (250 μg-1000 μg Once-daily) of GSK573719 in Healthy Male and Female Subjects.|Completed||Phase 1|36|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:36:34.539498|2017-02-18 15:36:34.539498
NCT00475423|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2015-02-04|2014-10-06||May 2007||2007-05-01|February 2015|2015-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||Safety population: all participants who received at least one dose of study medication and for whom follow-up safety information was available.|A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.|An Open Label Study of a Fixed Dose Regimen of MabThera on Overall Response Rate in Patients With Refractory, Relapsing or Chronic Idiopathic Thrombocytopenic Purpura.|Completed||Phase 2|122|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:36:34.793571|2017-02-18 15:36:34.793571
NCT00475410|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2011-06-13|||February 2007||2007-02-01|June 2011|2011-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|FATT1||Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease|A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel Disease|Completed||Phase 3|214|Actual|Cellerix||3|||f||||f||||||||||2017-02-18 15:36:35.274931|2017-02-18 15:36:35.274931
NCT00475397|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-16|||December 2003||2003-12-01|May 2007|2007-05-01|October 2004|Actual|2004-10-01|||||Interventional|||Duloxetine Stress Urinary Incontinence Efficacy and Safety Study|Efficacy and Safety of Duloxetine Compared With Placebo in Subjects With Stress Urinary Incontinence|Completed||Phase 3|120||Eli Lilly and Company|||||||||||||||||||2017-02-18 15:36:35.57401|2017-02-18 15:36:35.57401
NCT00475384|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2014-11-07|||June 2006||2006-06-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Haploidentical Transplantation in Patients With Acute Leukemia and Myelodysplasia|Delayed Infusion of Ex Vivo Anergized Peripheral Blood Mononuclear Cells Following CD34 Selected Peripheral Blood Stem Cell Transplant From A Haploidentical Donor For Patients With Acute Leukemia and Myelodysplasia|Completed||Phase 1|10|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:36:35.675761|2017-02-18 15:36:35.675761
NCT00475371|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-06-12|||April 2007||2007-04-01|June 2012|2012-06-01||||June 2007|Actual|2007-06-01||Interventional|||A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males|A Phase 1a, Single-Dose, Open-Label, Parallel, Ascending Dose, Controlled Safety and Tolerability Trial of Inhaled MKC253 in Healthy Adult Male Subjects|Completed||Phase 1|26|Actual|Mannkind Corporation||1|||f||||||||||||||2017-02-18 15:36:35.81345|2017-02-18 15:36:35.81345
NCT00475358|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-16|||April 2003||2003-04-01|May 2007|2007-05-01|February 2005|Actual|2005-02-01|||||Interventional|||Efficacy and Safety Stress Urinary Incontinence Study|Efficacy and Safety of Duloxetine Compared With Placebo in Subjects With Stress Urinary Incontinence|Completed||Phase 3|120||Eli Lilly and Company|||||f||||||||||||||2017-02-18 15:36:35.914689|2017-02-18 15:36:35.914689
NCT00475345|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-17|||August 2000||2000-08-01|May 2007|2007-05-01|September 2001|Actual|2001-09-01|||||Interventional|||Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia|Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia in Adults With Type 1 Diabetes Undergoing Intensive Management|Completed||N/A|29|Actual|McGill University||3|||f||||f||||||||||2017-02-18 15:36:36.002715|2017-02-18 15:36:36.002715
NCT00475332|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-01-09|2011-11-28||September 2007||2007-09-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar|Feasibility Study of External Beam Radiotherapy and Iodine-131 Tositumomab (Bexxar) for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma|Terminated||Phase 2|2|Actual|University of Florida|The PI left our institution and the study was closed. There were only 2 patients enrolled on the study so no conclusions can be drawn regarding the objectives of the study.|1||PI left our institution|f||||f||||||||||2017-02-18 15:36:36.102387|2017-02-18 15:36:36.102387
NCT00475319|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2013-06-04|2013-01-31||May 2007||2007-05-01|May 2013|2013-05-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Late Phase 2 Study of OPC-12759 Ophthalmic Suspension|Late Phase 2 Study of OPC-12759 Ophthalmic Suspension|Completed||Phase 2|308|Actual|Otsuka Pharmaceutical Co., Ltd.||3|||f||||f||||||||||2017-02-18 15:36:36.351707|2017-02-18 15:36:36.351707
NCT00475306|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-11-28|2011-07-11||May 2007||2007-05-01|November 2012|2012-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The Montefiore Metoclopramide Study|A Randomized, Facorial Design Study to Optimize the Dose of Parenteral Metoclopramide|Completed||Phase 4|289|Actual|Montefiore Medical Center||4|||f||||f||||||||||2017-02-18 15:36:36.954158|2017-02-18 15:36:36.954158
NCT00475293|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2013-09-12|||May 2007||2007-05-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC|A Phase 2 Clinical Trial of Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With Metastatic Colorectal Cancer|Completed||Phase 2|85|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||1|||f||||f||||||||||2017-02-18 15:36:37.405504|2017-02-18 15:36:37.405504
NCT00475280|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-07-13|||November 2007||2007-11-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|LAL1104||"Geriatric Assessment Adapted Therapy for Ph- ALL Elderly Patients"|"Geriatric Assessment Adapted Therapy for Ph- ALL Elderly Patients. GIMEMA Protocol LAL1104. EudraCT Code 2005-002156-17"|Recruiting||Phase 2|102|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||No||2017-02-18 15:36:37.520844|2017-02-18 15:36:37.520844
NCT00475228|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2011-02-25|||March 2007||2007-03-01|February 2011|2011-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|ILIAD||IUD Insertion After D&E Procedure|Immediate Versus Delayed Insertion of the Levonorgestrel-Releasing Intrauterine Device Following Dilation and Evacuation: A Randomized Controlled Trial|Completed||Phase 4|93|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 15:36:38.213062|2017-02-18 15:36:38.213062
NCT00475215|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2016-05-05|||October 2005||2005-10-01|May 2016|2016-05-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Evaluation of Safety and Efficacy of Org 25969 in Subjects With or Having a Past History of Pulmonary Disease (19.4.308)(P05932)|A Multicenter, Randomized, Parallel Group, Comparative, Safety-Assessor Blinded, Phase IIIa Trial in Adult Surgical Subjects Under General Anesthesia at Increased Risk for Pulmonary Complications|Completed||Phase 3|86|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:36:38.445638|2017-02-18 15:36:38.445638
NCT00475202|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-17||||||May 2007|2007-05-01||||||||Observational|||Hyperbaric Oxygen Therapy and Angiogenesis in Diabetic Patients With Foot Ulcers||Unknown status|Recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:36:38.529689|2017-02-18 15:36:38.529689
NCT00475189|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2011-07-22|||June 2007||2007-06-01|July 2011|2011-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||"Study of Loestrin 24(24 Days of Real Pills) Fe Versus Loestrin 1/20 (21 Real Pills)"|Prospective Comparison of Hormone Withdrawal Symptoms of a 24/4 Regimen With a 21/7 Regimen of OC|Completed||N/A|51|Actual|Scott and White Hospital & Clinic||2|||f||||f||||||||||2017-02-18 15:36:38.595158|2017-02-18 15:36:38.595158
NCT00475176|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2013-05-31|2012-05-01||May 2007||2007-05-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C|Effects of S-Adenosyl Methionine (SAMe) on Viral and Cell Signaling Response to Combination Therapy for Chronic Hepatitis C|Completed||Phase 2|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 15:36:38.710002|2017-02-18 15:36:38.710002
NCT00475163|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-17|2009-03-03|||November 2004||2004-11-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|MIM||Mentors in Motion: A Physical Activity Intervention for Obese Adolescents|Mentors in Motion: A Physical Activity Intervention for Obese Adolescents|Completed||N/A|34|Actual|McGill University Health Center||2|||f||||f||||||||||2017-02-18 15:36:38.995465|2017-02-18 15:36:38.995465
NCT00475150|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2016-12-28|2013-03-22||May 2008||2008-05-01|December 2016|2016-12-01|March 2012|Actual|2012-03-01|July 2011|Actual|2011-07-01||Interventional|||Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome|A Phase II Study of AZD2171 in the Treatment of Patients With Acute Leukemia and Myelodysplastic Syndrome.|Completed||Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:36:39.086171|2017-02-18 15:36:39.086171
NCT00475137|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2015-06-02|||December 2007||2007-12-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for the Treatment of Bipolar II Depression|A Randomized, Single-Blind Comparison of Lamotrigine Add-on Versus Switch to Lamotrigine Monotherapy in the Treatment of Bipolar II Depression Unresponsive to Antidepressant Treatment|Completed||Phase 2|15|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 15:36:39.738272|2017-02-18 15:36:39.738272
NCT00475124|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2014-10-30|||May 2007||2007-05-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|VIRTUE||Virtual Clinic Pacemaker Follow-up|VIRTUE: Virtual Clinic Pacemaker Follow-up|Terminated||Phase 4|123|Actual|Biotronik SE & Co. KG||2||"Redundant in-clinic visits increased the workload in virtual follow-up group. An interim~   analysis showed that the study would not support the primary hypothesis"|f||||f||||||||||2017-02-18 15:36:39.860004|2017-02-18 15:36:39.860004
NCT00475111|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2013-05-16|||March 2001||2001-03-01|May 2013|2013-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)|Stress and Adaptation in Rheumatoid Arthritis (SARA)|Completed||N/A|136|Actual|Arizona State University||3|||f||||f||||||||||2017-02-18 15:36:39.981317|2017-02-18 15:36:39.981317
NCT00475098|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2016-09-01|||June 2007||2007-06-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|TILT||Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)|Effect of Low Molecular Weight Heparin on Survival of Stage I,II or IIIA Non Small Cell Lung Cancer. A Multicenter, Open, Randomized Controlled Trial.|Completed||Phase 3|553|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:36:40.104695|2017-02-18 15:36:40.104695
NCT00475085|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2015-10-13|2013-07-12||December 2006||2006-12-01|October 2015|2015-10-01||||December 2012|Actual|2012-12-01||Interventional|||Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial|Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial|Completed||Phase 3|1021|Actual|University of Rochester||4|||f||||t||||||||||2017-02-18 15:36:40.222381|2017-02-18 15:36:40.222381
NCT00475072|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2016-10-29|||June 2003||2003-06-01|October 2016|2016-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.|An Open Label Study to Evaluate the Safety and Effect on Sustained Virological Response of PEGASYS Plus Ribavirin in Patients With Hemophilia A and Chronic Hepatitis C|Completed||Phase 4|14|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:36:41.089393|2017-02-18 15:36:41.089393
NCT00475059|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2010-01-05|||March 2007||2007-03-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Performance of Cimetidine-corrected MDRD Equation in Renal Transplant Patients|Performance of Cimetidine-corrected MDRD Equation in Renal Transplant Patients|Completed||N/A|59|Actual|Centre Hospitalier Universitaire de Saint Etienne||1|||f||||f||||||||||2017-02-18 15:36:41.182319|2017-02-18 15:36:41.182319
NCT00475046|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-18|||October 2001||2001-10-01|May 2007|2007-05-01|May 2005|Actual|2005-05-01|||||Interventional|EARLINT-EP3||Smoking Cessation and Relapse Prevention in Women Postpartum|Smoking Cessation and Relapse Prevention in Women Postpartum|Completed||Phase 1|2790|Actual|University Medicine Greifswald||2|||f||||f||||||||||2017-02-18 15:36:41.284867|2017-02-18 15:36:41.284867
NCT00474864|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2012-05-31||2009-07-22|July 2007||2007-07-01|February 2011|2011-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.|A Double-Blind, Placebo-Controlled, Parallel Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.|Completed||Phase 2|66|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:36:47.640765|2017-02-18 15:36:47.640765
NCT00475033|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2011-04-18|2010-05-04||June 2007||2007-06-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants|A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Canada|Completed||Phase 3|603|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 15:36:41.400538|2017-02-18 15:36:41.400538
NCT00475020|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2016-09-12|||January 2006||2006-01-01|September 2016|2016-09-01||||January 2018|Anticipated|2018-01-01||Interventional|||Allogeneic Stem Cell Transplantation for Myelofibrosis|Allogeneic Stem Cell Transplantation for Myelofibrosis Using Reduced Intensity Busulfan and Fludarabine Conditioning|Active, not recruiting||Phase 2|110|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:36:44.206197|2017-02-18 15:36:44.206197
NCT00475007|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2016-04-12|||September 2007||2007-09-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|IBV®Valve||Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema|A Prospective, Randomized, Controlled Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema|Completed||Phase 3|300|Anticipated|Spiration, Inc.||2|||f||||t||||||||||2017-02-18 15:36:44.331484|2017-02-18 15:36:44.331484
NCT00474994|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2015-12-15|2015-12-15||April 2007||2007-04-01|December 2015|2015-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas|A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas|Completed||Phase 2|53|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 15:36:44.474737|2017-02-18 15:36:44.474737
NCT00474981|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-04-02|||June 2006||2006-06-01|April 2012|2012-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|IMNCI-India||Impact of the Integrated Management of Neonatal and Childhood Illness Strategy on Neonatal and Infant Mortality|Impact of the Integrated Management of Neonatal and Childhood Illness Strategy on Neonatal and Infant Mortality in Haryana, India|Completed||N/A|66600|Actual|Society for Applied Studies||2|||f||||f||||||||||2017-02-18 15:36:44.735197|2017-02-18 15:36:44.735197
NCT00474968|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2009-11-16|2009-05-04||April 2007||2007-04-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique.|Clinical Study Validating the Adequacy, Efficacy, and Safety of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique In Patients With Recent History of Abnormal Pap Test Returning for Colposcopy/Biopsy.|Completed||N/A|737|Actual|CytoCore, Inc.|||2||f||||t||||||None Retained|"~     Cervical cells~   "|||2017-02-18 15:36:44.847573|2017-02-18 15:36:44.847573
NCT00474955|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2016-06-14|2016-04-22||July 2007||2007-07-01|June 2016|2016-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||Intent-to-treat (ITT) population included all enrolled participants who received at least one dose of study medication.|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.|Multicenter Open-label Observation Program in Patients With Chronic Hepatitis C and With Chronic Renal Failure (CRF) Receiving Peginterferon Alpha-2a (40 kDa) Pegasys|Completed||Phase 4|27|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:36:45.293094|2017-02-18 15:36:45.293094
NCT00474942|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2015-12-10|||April 2007||2007-04-01|December 2015|2015-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Natural History of Apparent Mineralocorticoid Excess Syndrome|Apparent Mineralocorticoid Excess Syndrome Natural History Clinical Protocol|Completed||N/A|130|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||t||||||Samples With DNA|"~     Peripheral blood~   "|||2017-02-18 15:36:45.642413|2017-02-18 15:36:45.642413
NCT00474929|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2016-12-20|2015-03-23||August 2007||2007-08-01|March 2016|2016-03-01|October 2017|Anticipated|2017-10-01|November 2011|Actual|2011-11-01||Interventional|||Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma|A Phase I/II Study of the Raf Kinase/VEGFR Inhibitor Sorafenib in Combination With the mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|103|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 15:36:45.742476|2017-02-18 15:36:45.742476
NCT00474916|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2010-08-13|||June 2006||2006-06-01|August 2010|2010-08-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Neuropathic Pain in Patients With Cancer|A Phase 2 Double-Blind Dose Escalation Study of KRN5500 for Neuropathic Pain in Patients With Cancer|Completed||Phase 2|19|Actual|DARA Therapeutics||2|||f||||t||||||||||2017-02-18 15:36:46.852877|2017-02-18 15:36:46.852877
NCT00474903|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2014-06-02|2014-01-08||April 2007||2007-04-01|January 2014|2014-01-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional||Two patients from ARM II withdrew due to an inadequate number of biopsies and were not included in baseline measures.|Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus|Randomized, Double-Blinded Phase II Trial of Esomeprazole Versus Esomeprazole + Two Doses of Aspirin in Barrett's Esophagus Patients|Completed||Phase 2|122|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 15:36:46.994292|2017-02-18 15:36:46.994292
NCT00474890|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2008-02-12|||June 2007||2007-06-01|February 2008|2008-02-01|February 2008||2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of Season|A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Assess the Efficacy's Reproducibility of a Combination of Pseudoephedrine and Cetirizine on Symptom Scores and Rhinomanometry in Patients With Allergic Rhinitis Following Pollen Exposure in the Fraunhofer Environmental Challenge Chamber (ECC) in- and Outside the Grass Pollen Season|Completed||N/A|70|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine||1|||f||||t||||||||||2017-02-18 15:36:47.458491|2017-02-18 15:36:47.458491
NCT00474877|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-16|||October 2001||2001-10-01|May 2007|2007-05-01|April 2004|Actual|2004-04-01|||||Interventional|||The Clinical Effectiveness of Static Resting Splints in Early Rheumatoid Arthritis|The Clinical Effectiveness of Static Resting Splints in Early Rheumatoid Arthritis: a Randomized Controlled Trial|Completed||N/A|120|Actual|University of Southampton||2|||f||||f||||||||||2017-02-18 15:36:47.546578|2017-02-18 15:36:47.546578
NCT00349882|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2006-07-05|||June 2005||2005-06-01|July 2006|2006-07-01||||||||Interventional|||Effects of Contact Lens Care Regimens on the Corneal Epithelium|Effects of Contact Lens Care Regimens on the Corneal Epithelium|Completed||Phase 4|30||University of Waterloo|||||f||||||||||||||2017-02-18 16:25:10.66168|2017-02-18 16:25:10.66168
NCT00474851|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2015-03-17|2015-03-04||August 2007||2007-08-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|October 2013|Actual|2013-10-01||Interventional|||The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial|The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial|Completed||Phase 2|53|Actual|Boston Children’s Hospital|Sample of skeletally mature young women; Measurements of aBMD are two-dimensional and do not yield information regarding skeletal strength or microarchitecture|2|||f||||t||||||||||2017-02-18 15:36:47.730131|2017-02-18 15:36:47.730131
NCT00474838|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2013-09-25|||April 2007||2007-04-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|KIIT||Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy|The Effect of Intensive and Short-term Insulin Treatment on Long-term Pancreatic β-cell Function in Newly Diagnosed People With Type 2 Diabetes in Korea|Completed||Phase 4|112|Actual|Kyunghee University Medical Center||2|||f||||t||||||||||2017-02-18 15:36:48.270371|2017-02-18 15:36:48.270371
NCT00474825|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-02-03|||July 2007||2007-07-01|February 2012|2012-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|HBO-XRT||Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck|Phase I Clinical Trial of Hyperbaric Oxygen Combined With Radiation and Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|12|Actual|Baromedical Research Foundation||3|||f||||t||||||||||2017-02-18 15:36:51.062164|2017-02-18 15:36:51.062164
NCT00474812|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2015-04-14|2013-07-31||May 2007||2007-05-01|November 2013|2013-11-01|February 2014|Actual|2014-02-01|January 2013|Actual|2013-01-01||Interventional|||Dasatinib in Treating Patients With Metastatic Pancreatic Cancer|Phase II Study of Dasatinib (BMS-354825) in Patients With Metastatic Adenocarcinoma of the Pancreas|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:36:51.173614|2017-02-18 15:36:51.173614
NCT00474799|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2008-01-11|||January 2007||2007-01-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)|An Open Label, Randomized, Single Center, Repeat Dose Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine) in Opioid naïve, Healthy Adult Volunteers|Completed||Phase 1|32|Actual|Javelin Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:36:51.567946|2017-02-18 15:36:51.567946
NCT00474786|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2013-10-28|2013-01-31||September 2007||2007-09-01|October 2013|2013-10-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Interventional|INTORSECT||Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib|A Randomized Trial Of Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced Renal Cell Carcinoma Who Have Failed First-Line Sunitinib Therapy|Completed||Phase 3|512|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:36:51.691711|2017-02-18 15:36:51.691711
NCT00474773|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2016-04-26|||June 2007||2007-06-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery|Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery: A Randomized Controlled Study|Completed||Phase 4|107|Actual|St. Louis Joint Replacement Institute|||1||f||||f||||||||||2017-02-18 15:36:53.038523|2017-02-18 15:36:53.038523
NCT00474760|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2013-10-25|2013-10-25||August 2005||2005-08-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|January 2011|Actual|2011-01-01||Interventional||All enrolled participants|Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors|Phase 1, Open Label, Multiple Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of CP 751,871 In Patients With Advanced Solid Tumors|Completed||Phase 1|65|Actual|Pfizer|The study was completed and 2 participants in figitumumab 20 mg/kg RP2D ESFT group were transitioned to compassionate figitumumab treatment as investigators judged they were receiving benefit from the protocol therapy.|1|||f||||f||||||||||2017-02-18 15:36:53.30974|2017-02-18 15:36:53.30974
NCT00474747|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2017-01-10|||February 2006||2006-02-01|January 2017|2017-01-01||||February 2019|Anticipated|2019-02-01||Interventional|||Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia|Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From HLA-Compatible Unrelated Donors in Severe Aplastic Anemia|Active, not recruiting||Phase 1/Phase 2|94|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:36:56.158093|2017-02-18 15:36:56.158093
NCT00474734|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2007-05-16|||May 2007||2007-05-01|May 2007|2007-05-01|September 2007|Anticipated|2007-09-01|||||Observational|||Intravascular Ultrasound for Hepatocellular Carcinoma Staging|Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study|Unknown status|Recruiting|N/A|||University Hospital, Geneva|||||f||||t||||||||||2017-02-18 15:36:56.287868|2017-02-18 15:36:56.287868
NCT00474721|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-16|||November 2002||2002-11-01|May 2007|2007-05-01|February 2004|Actual|2004-02-01|||||Interventional|||Comparison of Acetaminophen With Codeine and Ibuprofen for Children With Injuries|A Randomized Blinded Comparison of Acetaminophen With Codeine and Ibuprofen for Treatment of Acute Pain in Children With Extremity Injuries|Completed||N/A|68|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 15:36:56.372178|2017-02-18 15:36:56.372178
NCT00474708|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2012-03-02|2009-03-31||April 2007||2007-04-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients|The Efficacy of Venlafaxine XR (Efexor XR®) Versus SSRIs & Conventional Antidepressants in Depressed Patients Switched From Prior Antidepressants in Psychiatric Outpatient Care Settings in China|Completed||Phase 4|1151|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|365 participants were assessed for safety. Certain demographic data (gender and age) is missing for one participant. Thereby resulting in the participant flow reflecting 364 participants.|2|||f||||t||||||||||2017-02-18 15:36:56.483216|2017-02-18 15:36:56.483216
NCT00474695|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2015-02-10|||May 2007||2007-05-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|SEAGUL||Study Evaluating Genotypes Using Lucentis|VEGF and HTRA1 DNA Polymorphisms in Neovascular AMD Pathogenesis and Response to Lucentis|Terminated||N/A|65|Actual|University of Utah|||1|IND holder relocated from the University of Utah|f||||f||||||||||2017-02-18 15:36:56.936456|2017-02-18 15:36:56.936456
NCT00474682|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2008-12-02||||||May 2007|2007-05-01||||||||Interventional|||Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink|Relative Bioavailability of Ferric Pyrophosphate From an Apple Juice Drink|Completed||N/A|16|Anticipated|Institute of Food Research|||||f||||t||||||||||2017-02-18 15:36:57.043657|2017-02-18 15:36:57.043657
NCT00474669|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2013-04-22|||June 2007||2007-06-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|IP||A Phase I Study of Intraperitoneal Hyperthermic Docetaxel|A Phase I Study of Intraperitoneal Hyperthermic Docetaxel at the Time of Second Look Surgery Following Front-Line Normothermic Intraperitoneal and Intravenous Cisplatin/Paclitaxel for Patients With Stage II and III Ovarian Carcinoma|Completed||Phase 1|30|Anticipated|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-02-18 15:36:57.128134|2017-02-18 15:36:57.128134
NCT00474656|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2009-01-29|||June 2007||2007-06-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|OSCILLATE||The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study|The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study|Completed||N/A|94|Actual|Canadian Critical Care Trials Group||2|||f||||t||||||||||2017-02-18 15:36:57.230888|2017-02-18 15:36:57.230888
NCT00474643|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-05-15|||August 2006||2006-08-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Observational|||Correlation of Hyperghrelinemia With Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome||Completed||N/A|51|Actual|Samsung Medical Center|||||f||||t||||||||||2017-02-18 15:36:57.322847|2017-02-18 15:36:57.322847
NCT00474630|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2014-11-18|2014-10-10||May 2007||2007-05-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||All randomized subjects|A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes|A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Naltrexone 32 mg Sustained Release (SR)/Bupropion 360 mg Sustained Release (SR) and Placebo in Obese Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|505|Actual|Orexigen Therapeutics, Inc||2|||f||||t||||||||||2017-02-18 15:36:57.411221|2017-02-18 15:36:57.411221
NCT00474617|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2016-05-10|||December 2005||2005-12-01|May 2016|2016-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Comparison of Org 25969 in Elderly Subjects With Adult Subjects (19.4.305)(P05950)|A Multicenter, Parallel Group, Comparative, Phase IIIa Trial to Compare the Efficacy, Safety, and Pharmacokinetics of Org 25969 in Elderly Subjects With Adult Subjects|Completed||Phase 3|162|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 15:36:58.636492|2017-02-18 15:36:58.636492
NCT00474604|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2016-08-18|||March 2006||2006-03-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|January 2019|Anticipated|2019-01-01||Interventional|||Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants|MRI Evaluation of Breast Tumor Growth and Treatment Response|Recruiting||N/A|250|Anticipated|Vanderbilt-Ingram Cancer Center||2|||f||||f||||||||||2017-02-18 15:36:58.726288|2017-02-18 15:36:58.726288
NCT00474591|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-25||||||May 2007|2007-05-01||||||||Interventional|Fonda CABG||Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study|Fondaparinux Compared With Heparin to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery|Unknown status|Not yet recruiting|Phase 3|100|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 15:36:58.84682|2017-02-18 15:36:58.84682
NCT00474565|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2012-09-19|||February 2007||2007-02-01|September 2012|2012-09-01|December 2008|Anticipated|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Coronary Artery and Coronary Artery Bypass Graft Imaging Using a Specialized Catheter and Computed Tomography|Contrast-Enhanced Coronary Artery and Coronary Artery Bypass Graft Imaging Using Aortic Root Catheter Injection With Computed Tomographic Angiography (CTA)|Withdrawn||Phase 1|0|Actual|William Beaumont Hospitals||1||Suspended failure to follow Conflict of Interest Management Plan|f||||t||||||||||2017-02-18 15:36:59.091696|2017-02-18 15:36:59.091696
NCT00474552|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2008-02-13|||June 2007||2007-06-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315|An Ascending Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 Administered Orally to Healthy Young Adult and Elderly Subjects|Terminated||Phase 1|56|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 15:36:59.19066|2017-02-18 15:36:59.19066
NCT00474539|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2013-01-22|2010-03-26||July 2007||2007-07-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants|A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With a Meningococcal C-Tetanus Toxoid Conjugate Vaccine and Other Routine Pediatric Vaccinations in Spain|Completed||Phase 3|449|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 15:36:59.306731|2017-02-18 15:36:59.306731
NCT00474526|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2014-02-24|2013-05-27||March 2007||2007-03-01|February 2014|2014-02-01|November 2009|Actual|2009-11-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants|A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants|Completed||Phase 3|4545|Actual|Novartis||17|||f||||||||||||||2017-02-18 15:37:01.404776|2017-02-18 15:37:01.404776
NCT00474513|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2012-05-31|||March 2007||2007-03-01|February 2011|2011-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.|A PET Study Using [11C] GSK189254 to Establish the Dose, Plasma Concentration and Brain Receptor Occupancy Relationship of GSK239512, a Histamine H3 Antagonist, in Healthy Subjects|Completed||Phase 1|5|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:37:08.002456|2017-02-18 15:37:08.002456
NCT00474500|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2011-03-16|||May 2007||2007-05-01|March 2011|2011-03-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Coca-Cola on Iron Absorption|Effect of Coca-Cola on Iron Absorption|Completed||N/A|16|Actual|Institute of Food Research|||||f||||t||||||||||2017-02-18 15:37:08.090898|2017-02-18 15:37:08.090898
NCT00474487|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2014-04-01|2010-03-19||May 2007||2007-05-01|April 2014|2014-04-01|February 2008|Actual|2008-02-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults|A Phase 3, Multi-center Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adults and Compare to the Safety and Immune Response of a Licensed Conjugate Meningococcal ACWY Vaccine in Subjects Aged 19-55 Years of Age and to a Licensed Polysaccharide Vaccine in Subjects Aged 56-65 Years of Age.|Completed||Phase 3|2831|Actual|Novartis||4|||f||||t||||||||||2017-02-18 15:37:08.195195|2017-02-18 15:37:08.195195
NCT00474474|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2007-05-16|||February 2007||2007-02-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|VPtdl-rct1||Study of the Impact of Virtual Patient Designs on the Reasoning Pattern and Therapeutic Decision Making|Study of the Impact of How the Virtual Patient's Anamnesis is Designed on the Reasoning Pattern and Therapeutic Decision Making|Completed||N/A|58|Actual|Karolinska Institutet||1|||f||||f||||||||||2017-02-18 15:37:09.094256|2017-02-18 15:37:09.094256
NCT00474461|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2014-10-15|||February 2009||2009-02-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|SCIPIO||Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)|Myocardial Regeneration Using Cardiac Stem Cells Harvested From Right Atrial Appendages in Patients With Ischemic Cardiomyopathy.|Completed||Phase 1|33|Actual|University of Louisville||2|||f||||t||||||||||2017-02-18 15:37:09.186319|2017-02-18 15:37:09.186319
NCT00474448|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2015-07-30|||May 2007||2007-05-01|July 2015|2015-07-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Observational|||The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses|The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses|Completed||N/A|200|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 15:37:09.293949|2017-02-18 15:37:09.293949
NCT00474435|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-16|2010-12-16|||November 2008||2008-11-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|PETE||Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis|The Pharmacokinetics of Co-formulated Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Smear-positive Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania|Unknown status|Recruiting|Phase 2|30|Anticipated|African Poverty Related Infection Oriented Research Initiative||1|||f||||t||||||||||2017-02-18 15:37:09.380403|2017-02-18 15:37:09.380403
NCT00474422|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2007-05-14|||December 2003||2003-12-01|May 2007|2007-05-01|February 2005|Actual|2005-02-01|||||Interventional|||Hospital-Based Paraprofessional Lactation Clinic|Hospital-Based Paraprofessional Lactation Clinic|Completed||N/A|522|Actual|Baylor College of Medicine||1|||f||||f||||||||||2017-02-18 15:37:09.484518|2017-02-18 15:37:09.484518
NCT00474409|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2008-12-05|||May 2007||2007-05-01|December 2008|2008-12-01||||||||Interventional|||A Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation|A Multicenter, Placebo-Controlled, Double-Blind Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation|Terminated||Phase 4|360|Anticipated|Eisai Inc.||||Due to poor enrollment, this study was terminated.|f||||||||||||||2017-02-18 15:37:09.56969|2017-02-18 15:37:09.56969
NCT00474396|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2007-05-15|||April 2005||2005-04-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Interventional|dietUAT||Dietary Interventions Evaluating Transport of Uric Acid Across the Tubules|Dietary Interventions Evaluating Transport of Uric Acid Across the Tubules|Completed||N/A|59|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 15:37:09.67451|2017-02-18 15:37:09.67451
NCT00474383|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2014-04-10|2013-05-13||November 2006||2006-11-01|April 2014|2014-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy|A Phase II Open Label Study of CB7630 (Abiraterone Acetate) in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy|Completed||Phase 2|47|Actual|Cougar Biotechnology, Inc.||1|||f||||f||||||||||2017-02-18 15:37:09.774289|2017-02-18 15:37:09.774289
NCT00474370|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2015-12-18|||May 2007||2007-05-01|December 2015|2015-12-01|October 2010|Actual|2010-10-01|August 2009|Actual|2009-08-01||Interventional|||Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)|Vicriviroc in Combination Treatment With an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4)|Completed||Phase 3|400|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:37:10.307992|2017-02-18 15:37:10.307992
NCT00474357|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2010-12-16|||May 2007||2007-05-01|May 2008|2008-05-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|BAD||Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy|Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy|Unknown status|Recruiting|N/A|110|Anticipated|Lev-Hasharon Mental Healtlh Center||3|||f||||t||||||||||2017-02-18 15:37:10.409086|2017-02-18 15:37:10.409086
NCT00474344|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2014-03-27|||August 2004||2004-08-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|December 2010|Actual|2010-12-01||Observational|||Genetic Linkage Study of Idiopathic Talipes Equinovarus (ITEV) (Clubfoot)|Genetic Linkage Study of Idiopathic Talipes Equinovarus (ITEV) (Clubfoot)|Completed||N/A|370|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 15:37:10.515044|2017-02-18 15:37:10.515044
NCT00474331|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2014-12-12|||June 2004||2004-06-01|December 2014|2014-12-01|June 2023|Anticipated|2023-06-01|June 2023|Anticipated|2023-06-01||Observational|||Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project|Genotype-Phenotype Correlation of Multiple Hereditary Exostoses: Multicentre Project|Suspended||N/A|2000|Anticipated|University of British Columbia|||1|Due to unavailability of testing for gene mutation|f||||f||||||||||2017-02-18 15:37:10.5994|2017-02-18 15:37:10.5994
NCT00474318|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2017-02-06|||March 2007||2007-03-01|February 2017|2017-02-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Observational|Teen-LABS||Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Adolescent Bariatrics: Assessing Health Benefits and Risk|Adolescent Bariatrics: Assessing Health Benefits and Risks|Enrolling by invitation||N/A|200|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||Samples With DNA|"~     Serum, plasma and urine, as well as liver samples (if agreed upon as part of the study; may~     participate in the study without giving samples per Informed Consent)~   "|Yes|Data uploaded to NIH repository and available from publications|2017-02-18 15:37:10.690379|2017-02-18 15:37:10.690379
NCT00474305|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2010-12-15|||December 2007||2007-12-01|May 2010|2010-05-01|December 2011|Anticipated|2011-12-01|August 2011|Anticipated|2011-08-01||Interventional|||Virtual Reality Prolonged Exposure (PE) for Bus Bomb Survivors|Effectiveness of Virtual Reality for Persons With PTSD Following a Bus Bombing|Unknown status|Recruiting|N/A|5|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-02-18 15:37:10.802676|2017-02-18 15:37:10.802676
NCT00474292|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2017-01-24|||May 14, 2007||2007-05-14|April 8, 2011|2011-04-08|April 8, 2011||2011-04-08|||||Observational|||Influence of Area of Brain Damage on Brain Reorganization After Chronic Stroke|Influence of Lesion Location on Cortical Reorganization After Chronic Stroke|Completed||N/A|4|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:37:10.90395|2017-02-18 15:37:10.90395
NCT00474279|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2007-05-15|||July 1998||1998-07-01|May 2007|2007-05-01|June 2004|Actual|2004-06-01|||||Interventional|MOT089||Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults|Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults|Completed||Phase 1/Phase 2|72||University of Virginia|||||f||||t||||||||||2017-02-18 15:37:10.987047|2017-02-18 15:37:10.987047
NCT00474266|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2016-11-03||2009-09-03|June 2007||2007-06-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children|Immunogenicity & Safety Study of GSK Biologicals' Meningococcal Vaccine GSK134612 When Co-Administered With GSK Biologicals' MMRV Vaccine (Priorix-Tetra™) in Healthy 12 to 23-Month-Old Children|Completed||Phase 3|1000|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:37:11.265406|2017-02-18 15:37:11.265406
NCT00474253|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2016-05-10|||February 2006||2006-02-01|May 2016|2016-05-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Comparison of Recovery From Rocuronium 1.2 mg/kg Followed By Org 25969 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)|A Multicenter, Randomized, Parallel Group, Comparative, Active-Controlled, Safety-Assessor Blinded, Phase IIIa, Trial, in Adult Subjects Comparing Recovery From 1.2 mg.Kg-1 Rocuronium Followed by 16 mg.Kg-1 Org 25969 at 3 Minutes With Recovery From 1.0 mg.Kg-1 Succinylcholine|Completed||Phase 3|115|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:37:11.397759|2017-02-18 15:37:11.397759
NCT00474240|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2014-01-15|2013-01-18||April 2007||2007-04-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of the Combination of AEGR-733 (Formerly BMS201038) and Atorvastatin 20 mg vs. Monotherapy in Subjects With Moderate Hypercholesterolemia|Completed||Phase 2|157|Actual|Aegerion Pharmaceuticals, Inc.|Study AEGR-733-003, initiated in May 2007, was halted, and restarted under an amended Protocol in November 2007.|6|||f||||f||||||||||2017-02-18 15:37:11.500994|2017-02-18 15:37:11.500994
NCT00474227|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2008-05-01|||April 2007||2007-04-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness|Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness|Completed||N/A|50|Anticipated|Lev-Hasharon Mental Healtlh Center||2|||f||||t||||||||||2017-02-18 15:37:12.760214|2017-02-18 15:37:12.760214
NCT00474214|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2010-02-22|||January 2007||2007-01-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|SAFE-DEPART||Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary Percutaneous Coronary Intervention (PCI) Patients|Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary PCI Patients (The SAFE-DEPART Trial)|Completed||N/A|54|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 15:37:12.882312|2017-02-18 15:37:12.882312
NCT00474201|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2016-09-23|2010-03-23||May 2007||2007-05-01|March 2012|2012-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|GEM-PK||Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil|The Influence of Lopinavir/Ritonavir on Gemfibrozil Pharmacokinetics in Healthy Volunteers|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 15:37:12.992084|2017-02-18 15:37:12.992084
NCT00474188|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2009-08-27|2009-06-30||May 2007||2007-05-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma|A Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Lenalidomide (Revlimid ®) in Combination With Dexamethasone in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Terminated||Phase 2|26|Actual|Celgene|Study terminated prematurely as a business decision. Analyses of efficacy not conducted.|1||Business decision|f||||t||||||||||2017-02-18 15:37:13.261807|2017-02-18 15:37:13.261807
NCT00474175|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2013-02-22|2011-12-09||May 2007||2007-05-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Benzocaine Gel Toothache Dose-Response Study|Benzocaine Gel Toothache Dose-Response Study|Completed||Phase 4|577|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 15:37:13.588974|2017-02-18 15:37:13.588974
NCT00474162|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2008-02-20|||May 2007||2007-05-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The Clotting Effects of Pentastarch and Normal Saline in Obstetric Patients|Observational Pilot Study of the Effect of Intravenous Saline or Pentastarch on Coagulation in Women Having an Elective Cesarean Section|Completed||N/A|30|Anticipated|University of British Columbia|||||f||||f||||||||||2017-02-18 15:37:14.618742|2017-02-18 15:37:14.618742
NCT00474136|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2007-12-27|||March 2007||2007-03-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium|Open-Label, Randomized, Single Center Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses) Versus Oral Diclofenac Potassium in Healthy Adult Volunteers Following Single- and Multiple-Dose Administration|Completed||Phase 1|36|Actual|Javelin Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:37:14.71508|2017-02-18 15:37:14.71508
NCT00474123|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2010-06-18|2010-01-08||January 2006||2006-01-01|February 2010|2010-02-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Interventional|||Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Moderate Dose Statin Plus Ezetimibe|Completed||N/A|78|Actual|University of Sao Paulo|Adverse Events were assessed, but none were observed.|2|||f||||f||||||||||2017-02-18 15:37:14.828519|2017-02-18 15:37:14.828519
NCT00474110|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-10-29|||August 2009||2009-08-01|October 2010|2010-10-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Ketamine and Hydromorphone for Patient Controlled Pain Relief in Children's Mucositis|Ketamine and Hydromorphone PCA Analgesia for Antineoplastic-Induced Pediatric Mucositis|Withdrawn||Phase 3|0|Actual|University of British Columbia||1||"Clinical practice had changed between time of initial protocol development and subject~   recruitment. We were not able to find eligible patients."|f||||f||||||||||2017-02-18 15:37:15.571504|2017-02-18 15:37:15.571504
NCT00474097|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2014-12-12|||February 2006||2006-02-01|December 2014|2014-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Follow-Up Phone Calls After Colorectal Surgery|Follow-Up Phone Calls After Colorectal Surgery to Assess Patient Satisfaction and Post-Operative Outcomes|Completed||N/A|100|Actual|University Hospitals Cleveland Medical Center|||1||f||||f||||||||||2017-02-18 15:37:15.686097|2017-02-18 15:37:15.686097
NCT00474084|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2007-05-15|||July 2007||2007-07-01|May 2007|2007-05-01||||||||Interventional|HApFIM||Hydroxyapatite Active Pro Healing Clinical Trial Program|First In Man Evaluation of the Vesta™ & VestaCOR™ (Hydroxy-Apetite Coated genX™) Stent for Treatment of de Novo Native Coronary Artery Lesion(s)|Unknown status|Not yet recruiting|N/A|70|Anticipated|BioSync Scientific Pvt. Ltd.||2|||f||||t||||||||||2017-02-18 15:37:15.778202|2017-02-18 15:37:15.778202
NCT00474071|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2008-09-24|||March 2007||2007-03-01|May 2007|2007-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Optimum Dose of Remifentanil for Intubation in Small Children|Investigation to Determine the Optimum Dose of Remifentanil for Tracheal Intubation in Children Using the Up/Down Method|Completed||Phase 3|60|Anticipated|University of British Columbia|||||f||||f||||||||||2017-02-18 15:37:15.860964|2017-02-18 15:37:15.860964
NCT00474058|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2015-05-26|2010-02-25||May 2007||2007-05-01|May 2015|2015-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|RECOVER||Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine|Phase 3B, Multicenter, Multinational, Double-Blind, Placebo Controlled, 2-Arm Trial to Evaluate the Effect of the 24-Hour Transdermal Delivery of Rotigotine on the Control of Early Morning Motor Function, Sleep Quality, Nocturnal Symptoms, and Non-Motor Symptoms in Subjects With Idiopathic Parkinson's Disease|Completed||Phase 3|287|Actual|UCB Pharma|During the course of the trial, the manufacturing process for rotigotine was changed. At that time, the expiry date for trial medication was Apr 2009, recruitment for SP889 had to be stopped effective on 17 Nov 2008.|2|||f||||f||||||||||2017-02-18 15:37:15.962703|2017-02-18 15:37:15.962703
NCT00474045|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2014-08-12|2011-08-05||May 2007||2007-05-01|August 2014|2014-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes|A Randomised, Parallel-group, Open-labelled, Multinational Trial Comparing the Efficacy and Safety of Insulin Detemir (Levemir®) Versus Human Insulin (NPH Insulin), Used in Combination With Insulin Aspart as Bolus Insulin, in the Treatment of Pregnant Women With Type 1 Diabetes|Completed||Phase 3|470|Actual|Novo Nordisk A/S||2|||f||||t||||||||||2017-02-18 15:37:16.729122|2017-02-18 15:37:16.729122
NCT00474032|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2016-05-30|||March 2003||2003-03-01|May 2016|2016-05-01|March 2023|Anticipated|2023-03-01|March 2023|Anticipated|2023-03-01||Interventional|||Using Botox to Treat Patients With Idiopathic Clubfoot|Efficacy of Botox in Patients With Idiopathic Clubfoot|Recruiting||N/A|2000|Anticipated|University of British Columbia||1|||f||||t||||||||||2017-02-18 15:37:18.772699|2017-02-18 15:37:18.772699
NCT00474019|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-12-02|||October 2007||2007-10-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|||||Interventional|||Phase 1 Pharmacokinetics of Intravenous Nexium in Children|A Phase I, Randomised, Open-label, Multi-National Study to Evaluate the Pharmacokinetics of Repeated Once-Daily Intravenous Doses of Esomeprazole in Paediatric Patients 0 to 17 Years Old, Inclusive.|Completed||Phase 1|42|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 15:37:18.90183|2017-02-18 15:37:18.90183
NCT00474006|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2011-06-08|||August 2001||2001-08-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|August 2008|Actual|2008-08-01||Interventional|ADcomparison||High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML|A RANDOMIZED COMPARISON OF TWO DIFFERENT DOSAGES OF DAUNORUBICIN IN INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA|Completed||Phase 3|398|Actual|Cooperative Study Group A for Hematology||1|||f||||f||||||||||2017-02-18 15:37:19.009317|2017-02-18 15:37:19.009317
NCT00473993|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2009-02-13|||July 2007||2007-07-01|May 2007|2007-05-01|December 2007|Actual|2007-12-01|||||Observational|HepCOP||Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland|Hepatitis C Bei Opioidabhängigen in Der Praxis, Eine Querschnittsuntersuchung|Completed||N/A|||Seidenberg, Arztpraxis A., M.D.|||||f||||t||||||||||2017-02-18 15:37:19.122805|2017-02-18 15:37:19.122805
NCT00473980|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2012-03-30|||December 1998||1998-12-01|March 2012|2012-03-01|May 2007|Actual|2007-05-01|||||Interventional|||Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients|Preoperative Treatment With NSAID in Colorectal Cancer Patients in Relationship to Tumor Host Reactions|Completed||Phase 4|28|Actual|Göteborg University||2|||f||||f||||||||||2017-02-18 15:37:19.199292|2017-02-18 15:37:19.199292
NCT00473967|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2012-07-06|||May 2007||2007-05-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults|Double-blind, Randomized, Controlled Phase 1 Study of the Safety and Immunogenicity of Na-ASP-2 Hookworm Vaccine in Previously-Infected Brazilian Adults|Terminated||Phase 1|9|Actual|Albert B. Sabin Vaccine Institute||2||Occurrence of unacceptable adverse events.|f||||t||||||||||2017-02-18 15:37:19.307284|2017-02-18 15:37:19.307284
NCT00473954|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2013-03-25|||April 2007||2007-04-01|March 2013|2013-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer|A Phase 1, Open-Label, Dose Escalation Study of the Safety and Preliminary Efficacy of EGEN-001 in Combination With Carboplatin and Docetaxel in Women With Recurrent, Platinum-Sensitive, Epithelial Ovarian Cancer|Completed||Phase 1|13|Actual|EGEN, Inc.||1|||f||||t||||||||||2017-02-18 15:37:19.419113|2017-02-18 15:37:19.419113
NCT00473941|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2011-08-24|||September 2005||2005-09-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Life After Cancer Treatment Study|Expressive Writing and Adjustment to Colorectal Cancer|Completed||N/A|150|Anticipated|Temple University||2|||f||||t||||||||||2017-02-18 15:37:19.698164|2017-02-18 15:37:19.698164
NCT00473928|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-03-16|||May 2007||2007-05-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|ASaP||Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)|Assessment of Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)|Completed||Phase 1|27|Actual|Potentia Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-02-18 15:37:19.811499|2017-02-18 15:37:19.811499
NCT00473915|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2013-05-30|||April 2007||2007-04-01|May 2013|2013-05-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Intranasal Steroids and the Nasal Ocular Response|Intranasal Steroids Prevent Antigen-Induced Hyperresponsiveness of the Nasal Ocular Response|Completed||Phase 4|20|Anticipated|University of Chicago||1|||f||||f||||||||||2017-02-18 15:37:19.918003|2017-02-18 15:37:19.918003
NCT00473902|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2007-05-15|||August 2003||2003-08-01|May 2007|2007-05-01|September 2004|Actual|2004-09-01|||||Interventional|OTR||Older Adult Training Study With Creatine and CLA|Creatine Monohydrate and Conjugated Linoleic Acid Improve Strength and Body Composition Following Resistance Exercise in Older Adults|Completed||N/A|39|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 15:37:20.017044|2017-02-18 15:37:20.017044
NCT00473889|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2015-06-08|2009-09-03||May 2007||2007-05-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)|A Phase II/III Randomized, Double-Blind Study of Paclitaxel Plus Carboplatin in Combination With Vorinostat or Placebo in Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small-Cell Lung Cancer (NSCLC)|Terminated||Phase 2/Phase 3|253|Actual|Merck Sharp & Dohme Corp.|The study was stopped following a pre-planned interim analysis because the goal for this study to continue was not met, based on 100 events, a reduction in the hazard ratio for progression-free survival by > 23% with a one-sided p-value < 0.1|2||"The study was terminated based on the recommendation by the DSMB following a pre-planned~   protocol interim analysis because the endpoint was not achieved."|f||||f||||||||||2017-02-18 15:37:20.112301|2017-02-18 15:37:20.112301
NCT00473876|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2013-05-28|2013-01-14||August 2007||2007-08-01|May 2013|2013-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|TAYSIDE||Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial)|Metformin in Insulin Resistant LV Dysfunction, a Double-blind, Placebo-controlled Trial (TAYSIDE Trial)|Completed||Phase 4|62|Actual|University of Dundee||2|||f||||t||||||||||2017-02-18 15:37:21.100797|2017-02-18 15:37:21.100797
NCT00473863|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2007-11-19|||November 2007||2007-11-01|November 2007|2007-11-01|July 2008|Anticipated|2008-07-01|||||Interventional|CCTA||Coronary Computed Tomographic Angiography in Emergency Department Chest Pain Patients at Intermediate Risk of Acute Coronary Syndrome|Coronary Computed Tomographic Angiography in Emergency Department Chest Pain Patients at Intermediate Risk of Acute Coronary Syndrome|Unknown status|Recruiting|Phase 3|150|Anticipated|Vancouver General Hospital||2|||f||||f||||||||||2017-02-18 15:37:21.484518|2017-02-18 15:37:21.484518
NCT00473850|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2011-04-13|||December 1998||1998-12-01|April 2011|2011-04-01|March 2023|Anticipated|2023-03-01|||||Observational|||Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC|Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC|Terminated||N/A|2000|Anticipated|University of British Columbia|||1|"This study is recruiting under a different title - Genotype-Phenotype Correlation of Multiple~   Hereditary Exostoses: Multicentre Project NCT00474331"|f||||||||||||||2017-02-18 15:37:21.58693|2017-02-18 15:37:21.58693
NCT00473837|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-15|2014-10-09|2014-10-09||July 2007||2007-07-01|October 2014|2014-10-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|CQ-PMA||Chloroquine and Post Malaria Anaemia Study|Chloroquine as a Therapeutic Option for Mild Post Malaria Anaemia|Completed||N/A|96|Actual|Medical Research Council Unit, The Gambia||2|||f||||f||||||||||2017-02-18 15:37:21.686071|2017-02-18 15:37:21.686071
NCT00473824|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2012-05-07|2012-01-05||May 2007||2007-05-01|May 2012|2012-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation|A Randomized, Open-Label Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplant Recipients|Terminated||Phase 2|7|Actual|Biotest Pharmaceuticals Corporation|Early termination by sponsor due to data from the initial 7 patients of 36 planned for this study. Therefore, statistical analysis was not performed and no conclusion were reached regarding efficacy or drug safety.|2||New sponsor's decision to pursue a redesigned clinical study|f||||f||||||||||2017-02-18 15:37:22.046583|2017-02-18 15:37:22.046583
NCT00473811|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2012-08-28|||August 2005||2005-08-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|DEEP||Diabetic Educational Eating Plan|Applicability of a Low Glycemic Index Diet in Diabetes|Completed||Phase 1/Phase 2|40|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-02-18 15:37:22.460572|2017-02-18 15:37:22.460572
NCT00473798|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2016-03-07|||July 1999||1999-07-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Observational|||Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer|Patient Satisfaction and Psychological Distress Related to Emerging Technologies for Cervical Cancer Screening and Diagnosis|Active, not recruiting||N/A|5885|Anticipated|M.D. Anderson Cancer Center|||5||f||||t||||||||||2017-02-18 15:37:22.572237|2017-02-18 15:37:22.572237
NCT00473785|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2007-05-14|||January 2002||2002-01-01|May 2007|2007-05-01|December 2005|Actual|2005-12-01|||||Interventional|COHRT||CVD Risk Reduction Trial|Community Outreach Heart Health and Risk Reduction Trial|Completed||N/A|827|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 15:37:22.809061|2017-02-18 15:37:22.809061
NCT00473772|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2014-05-05|||July 2007||2007-07-01|May 2014|2014-05-01|January 2011|Actual|2011-01-01|October 2008|Actual|2008-10-01||Interventional|PEPCADIII||DEBlue Stent vs Cypher Stent in the Treatment of Advanced Coronary Artery Disease|Paclitaxel-Eluting PTCA-Balloon in Combination With the CoroflexTM Blue Stent vs the Sirolimus Coated CypherTM Stent in the Treatment of Advanced Coronary Artery Disease|Completed||Phase 1/Phase 2|643|Actual|University Hospital, Saarland||2|||f||||t||||||||||2017-02-18 15:37:22.910027|2017-02-18 15:37:22.910027
NCT00473746|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2014-03-27|2013-12-20||June 2006||2006-06-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer|Phase I/II Open Label Dose Escalation Study of the 17α-Hydroxylase/ C17,20-Lyase Inhibitor, Abiraterone Acetate in Hormone Refractory Prostate Cancer|Completed||Phase 1/Phase 2|66|Actual|Janssen Research & Development, LLC||2|||f||||f||||||||||2017-02-18 15:37:23.056983|2017-02-18 15:37:23.056983
NCT00473733|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-13|2007-05-14||||||April 2007|2007-04-01||||||||Interventional|GLP||Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2||Unknown status|Not yet recruiting|Phase 4|||Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-02-18 15:37:24.52411|2017-02-18 15:37:24.52411
NCT00473720|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2013-01-21|||May 2007||2007-05-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers|Phase I Dose Finding Study of the Orally Bioavailable Platinum Analog Satraplatin in Combination With Abraxane (Paclitaxel Protein-bound Particles) in Advanced Cancers|Completed||Phase 1|15|Actual|Yale University||1|||f||||f||||||||||2017-02-18 15:37:24.604423|2017-02-18 15:37:24.604423
NCT00473694|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2016-05-13|||November 2005||2005-11-01|May 2016|2016-05-01|January 2007|Actual|2007-01-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of Sugammadex With Neostigmine Administered at 1-2 PTCs After Administration of Rocuronium or Vecuronium (19.4.302)(P05945)|A Multicenter Randomized Parallel Group Comparative Active-Controlled Safety-Assessor Blinded Phase 3a, Pivotal Trial in Adult Subjects Comparing Org 25969 With Neostigmine as Reversal Agent of a NMB Induced by Maintenance Dosing of Rocuronium or Vecuronium at 1-2 PTCs|Completed||Phase 3|182|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:37:27.536098|2017-02-18 15:37:27.536098
NCT00473681|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2008-05-05|||September 2003||2003-09-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|HBP||Intervention Study to Control High Blood Pressure for Korean American|High Blood Pressure Care for Korean Americans|Completed||N/A|445|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 15:37:27.635623|2017-02-18 15:37:27.635623
NCT00473668|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2016-11-03||2009-05-20|June 2007||2007-06-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib|Non-inferiority of One Formulation of GSK Biologicals' DTPw-HBV/Hib to 2 Formulations of GSK Biologicals' DTPw-HBV/Hib With Respect to the Immune Response to the PRP Antigen, When Administered to Healthy Infants at 6, 10, 14 Weeks of Age|Completed||Phase 3|300|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:37:27.732408|2017-02-18 15:37:27.732408
NCT00473655|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-11-30|2010-05-10||January 2007||2007-01-01|November 2010|2010-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients|A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients|Completed||Phase 4|334|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:37:27.84959|2017-02-18 15:37:27.84959
NCT00473642|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2012-10-09|2011-09-20||May 2007||2007-05-01|October 2012|2012-10-01|April 2010|Actual|2010-04-01|May 2009|Actual|2009-05-01||Interventional|||Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration|A Prospective Pilot Study of Reduced Fluence Photodynamic Therapy With Visudyne® (Verteporfin) in Combination With Lucentis™ (Ranibizumab) for the Treatment of Age-Related Macular Degeneration|Completed||Phase 4|31|Actual|Oklahoma State University Center for Health Sciences|This study was limited by a small number of subjects. Additionally, several subjects did not meet the 12 month study endpoint. These subjects were included in the final analysis if their last visit was within 2 months of the final endpoint.|3|||f||||f||||||||||2017-02-18 15:37:28.556051|2017-02-18 15:37:28.556051
NCT00473616|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2011-02-10|||May 2007||2007-05-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan|A Phase I Open-label, Multi-center, Dose-escalation and Safety Expansion Study to Assess Safety, Tolerability, and Pharmacokinectics of AZD7762 Administered as a Single Intravenous Agent and in Combination With Weekly Standard Dose of Irinotecan in Patients With Advanced Solid Malignancies.|Terminated||Phase 1|60|Anticipated|AstraZeneca||1||"Termination of the study was made after a full review of program data and assessment of the~   current risk-benefit profile."|f||||f||||||||||2017-02-18 15:37:29.268035|2017-02-18 15:37:29.268035
NCT00473603|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2008-07-23|||December 2006||2006-12-01|May 2007|2007-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Free Fatty Acids (FFA) on Androgen Precursors in Women|Effect of Free Fatty Acids on Androgen Precursors in Vivo in Healthy Young Women|Completed||N/A|13|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 15:37:29.384458|2017-02-18 15:37:29.384458
NCT00473590|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2011-12-13|2011-03-31||May 2007||2007-05-01|December 2011|2011-12-01||||November 2009|Actual|2009-11-01||Interventional|AMBER||A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER)|A Randomized, Blinded, Placebo-Controlled, Multicenter, Phase II Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|102|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:37:29.491272|2017-02-18 15:37:29.491272
NCT00473577|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2010-08-24|||August 2005||2005-08-01|August 2010|2010-08-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients|Two Phase, Open-Label, Sequential, Ascending Dose Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients|Completed||Phase 1|40|Anticipated|Pharmacyclics LLC.||1|||f||||t||||||||||2017-02-18 15:37:30.064054|2017-02-18 15:37:30.064054
NCT00473564|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2016-02-05|2015-04-14||February 2007||2007-02-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2013|Actual|2013-12-01||Interventional|||Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery|Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery|Completed||N/A|170|Actual|University of Alabama at Birmingham||1|||f||||t||||||||No||2017-02-18 15:37:30.157302|2017-02-18 15:37:30.157302
NCT00473551|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2011-12-16|||May 2007||2007-05-01|December 2011|2011-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies|Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Treatment of Indolent Lymphoid Malignancies|Terminated||Phase 1|4|Actual|M.D. Anderson Cancer Center||1||Terminated due to slow accrual.|f||||f||||||||||2017-02-18 15:37:30.450874|2017-02-18 15:37:30.450874
NCT00473538|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2007-11-13|||January 2004||2004-01-01|November 2007|2007-11-01|August 2006||2006-08-01|||||Interventional|||Structured Exercise Training Program Versus Hypocaloric Hyperproteic Diet in Obese Anovulatory Infertile Patients With PCOS|Effects of Structured Exercise Program Versus Hypocaloric Hyperproteic Diet on the Reproductive Function in Obese Anovulatory Infertile Patients With Polycystic Ovary Syndrome: a 24-Week Prospective Study.|Completed||Phase 4|40|Actual|University Magna Graecia||2|||f||||f||||||||||2017-02-18 15:37:30.57939|2017-02-18 15:37:30.57939
NCT00473525|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-06-22||2009-03-20|July 2007||2007-07-01|June 2010|2010-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin|A Phase 2a, Randomized, Placebo-Controlled, Parallel Group, Multiple-Dose Study To Evaluate The Efficacy, Safety, And Tolerability Of 12-Week Oral Administration Of PF-00734200 Tablets To Subjects With Type 2 Diabetes Mellitus On Stable Treatment With Metformin|Completed||Phase 2|303|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 15:37:30.68086|2017-02-18 15:37:30.68086
NCT00473512|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2014-02-27|2013-06-07||November 2005||2005-11-01|February 2014|2014-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy|A Phase I/II Open Label Study of the 17α-Hydroxylase/ C17,20 Lyase Inhibitor, Abiraterone Acetate in Patients With Prostate Cancer Who Have Failed Hormone Therapy|Completed||Phase 1/Phase 2|54|Actual|Cougar Biotechnology, Inc.||1|||f||||t||||||||||2017-02-18 15:37:31.099821|2017-02-18 15:37:31.099821
NCT00473499|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-06-29|||July 2007||2007-07-01|June 2010|2010-06-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|PEPCADIIIsub||PEPCAD III Substudy: Stem Cell Mobilization|Paclitaxel-Eluting PTCA-Balloon in Combination With the Coroflex Blue Stent vs the Sirolimus Coated Cypher Stent in the Treatment of Advanced Coronary Artery Disease - Substudy Homburg/Saar|Completed||Phase 1/Phase 2|60|Anticipated|University Hospital, Saarland||3|||f||||t||||||||||2017-02-18 15:37:32.591717|2017-02-18 15:37:32.591717
NCT00473486|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-01-26|||May 2007||2007-05-01|June 2007|2007-06-01|January 2010|Actual|2010-01-01|August 2008|Actual|2008-08-01||Interventional|PECASO||Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib|A Randomized (PhaseII), Double-blind, Multicenter Phase I/II Trial of Pemetrexed, Carboplatin Plus or Minus Sorafenib in the First-line Treatment of Patients With Stage IIIb or IV Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|12|Actual|University Hospital Muenster||2||"Sorafenib administered in the combination with pemetrexed-carboplatin appears to enhance~   thrombocytopenia compared to historical data."|f||||t||||||||||2017-02-18 15:37:32.710106|2017-02-18 15:37:32.710106
NCT00473473|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2012-02-19|||July 2008||2008-07-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Effect of the Homeopathic Remedy Kalium Bichromicum (Potassium Dichromate) on Viscosity and Amount of Sputum and Time to Extubation in Mechanically Ventilated ICU Patients.|A Multicenter, Randomized, Double Blind, Placebo Controlled Trial to Investigate the Efficacy and Safety of the Homeopathic Remedy Kalium Bichromicum (Potassium Dichromate) to Decrease Viscosity and Amount of Sputum as Well as Time to Extubation, in Intubated Mechanically Ventilated ICU Patients.|Unknown status|Recruiting|Phase 3|56|Anticipated|Shaare Zedek Medical Center||2|||f||||f||||||||||2017-02-18 15:37:32.813384|2017-02-18 15:37:32.813384
NCT00473460|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2014-10-27|||October 2004||2004-10-01|October 2014|2014-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis|A Double-blind, Randomized, Placebo-controlled Study to Investigate Chronic Intermittent-pulse-therapy of Moxifloxacin as a Prevention of Acute in Exacerbation Out-patients With Chronic Bronchitis.|Completed||Phase 3|1404|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:37:32.911675|2017-02-18 15:37:32.911675
NCT00473447|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2007-05-14|||January 2004||2004-01-01|May 2007|2007-05-01|April 2006|Actual|2006-04-01|||||Interventional|mCIT||A Modified Constraint-Induced Movement Therapy Program in Rehabilitation of Arm Paresis in Children With Cerebral Palsy|Phase1 Effectiveness of a Modified Constraint-Induced Movement Therapy Program in Rehabilitation of Arm Paresis in Children With Cerebral Palsy: a Cross-Over Study|Completed||Phase 1|10|Actual|Universita di Verona|||||f||||f||||||||||2017-02-18 15:37:33.329967|2017-02-18 15:37:33.329967
NCT00473434|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2012-12-04|2012-06-26||April 2007||2007-04-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia|An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia|Completed||Phase 3|64|Actual|Janssen-Cilag Pty Ltd||1|||f||||f||||||||||2017-02-18 15:37:33.421284|2017-02-18 15:37:33.421284
NCT00473421|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2007-05-14|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Interventional|||"How do Contrast Medias in Bone Cement Affect DXA Measurements After THR"||Unknown status|Recruiting|Phase 1/Phase 2|||Ullevaal University Hospital||3|||f||||f||||||||||2017-02-18 15:37:34.198507|2017-02-18 15:37:34.198507
NCT00473408|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2016-12-05|||March 2007||2007-03-01|December 2016|2016-12-01|November 2011|Actual|2011-11-01|May 2007|Actual|2007-05-01||Observational|Gliomstudien||The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas|The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas|Terminated||N/A|1|Actual|Haukeland University Hospital|||1|Moved to another country, not possible to recruit from abroad.|f||||f||||||Samples With DNA|"~     Tumor samples and blood samples are collected and frozen for future analysis for tumor~     vascularization and tumor stem cells.~   "|No|Only one patient was included before the study was terminated.|2017-02-18 15:37:34.290115|2017-02-18 15:37:34.290115
NCT00473382|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-13|2014-08-25|2012-11-30||June 2007||2007-06-01|August 2014|2014-08-01|September 2012|Actual|2012-09-01|January 2011|Actual|2011-01-01||Interventional|RIDE|The Baseline Characteristics of the patients enrolled in the open-label extension phase (N=88, 83, 84 patients originally randomized to the ranibizumab 0.3 mg, ranibizumab 0.5 mg, and sham injection groups, respectively) were similar to the Baseline Characteristics of the patients enrolled in the core study.|A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)|A Phase III, Double-masked, Multicenter, Randomized, Sham Injection-controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus|Completed||Phase 3|382|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 15:37:34.415147|2017-02-18 15:37:34.415147
NCT00472667|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2008-11-24|||July 2007||2007-07-01|May 2007|2007-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|PRORATA||PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)|Impact of Procalcitonin to Reduce Antibiotics Use in ICU Adults Patients|Completed||N/A|630|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 15:37:37.705701|2017-02-18 15:37:37.705701
NCT00472654|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2014-10-11|||March 2007||2007-03-01|July 2012|2012-07-01|March 2011|Actual|2011-03-01|May 2010|Actual|2010-05-01||Interventional|||The Effect of Vitamin D Supplementation During Caloric Restriction on Intestinal Calcium Absorption|Nutritional Regulation of Bone - Aim 3|Completed||N/A|83|Actual|Rutgers University||4|||f||||t||||||||||2017-02-18 15:37:37.811442|2017-02-18 15:37:37.811442
NCT00472641|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2012-12-11|||January 2007||2007-01-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Geodon in Weight Loss Study for Bipolar Disorders|Adjunctive Ziprasidone in Overweight and Obese Patients With Bipolar Disorder|Completed||Phase 4|25|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 15:37:37.926029|2017-02-18 15:37:37.926029
NCT00473356|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2013-11-17|||June 2007||2007-06-01|November 2013|2013-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bariatric Surgery Patients|Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bariatric Surgery Patients|Completed||N/A|30|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 15:37:38.287091|2017-02-18 15:37:38.287091
NCT00473343|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-09-01|||September 2000||2000-09-01|September 2010|2010-09-01|June 2006|Actual|2006-06-01|||||Interventional|||"Metvix PDT in Patients With High Risk Basal Cell Carcinoma"|"An Open Multicenter, Phase III Study of Photodynamic Therapy With Metvix Cream 160 mg/g in Patients With High Risk Basal Cell Carcinoma"|Completed||Phase 3|102|Actual|Galderma||1|||f||||f||||||||||2017-02-18 15:37:38.384289|2017-02-18 15:37:38.384289
NCT00473330|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-13|2014-08-25|2012-12-10||June 2007||2007-06-01|August 2014|2014-08-01|November 2012|Actual|2012-11-01|November 2010|Actual|2010-11-01||Interventional|RISE|The Baseline Characteristics of the patients enrolled in the open-label extension phase (N=88, 83, 84 patients originally randomized to the ranibizumab 0.3 mg, ranibizumab 0.5 mg, and sham injection groups, respectively) were similar to the Baseline Characteristics of the patients enrolled in the core study.|A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)|A Phase III, Double-masked, Multicenter, Randomized, Sham Injection-controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus|Completed||Phase 3|377|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 15:37:38.521291|2017-02-18 15:37:38.521291
NCT00473317|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2008-03-30|||July 2007||2007-07-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Sunlight Exposures Effect on Serum Vitamin D Levels|Sunlight Exposures Effect on Serum Vitamin D Levels|Completed||N/A|6|Actual|Creighton University||1|||f||||f||||||||||2017-02-18 15:37:41.955987|2017-02-18 15:37:41.955987
NCT00473304|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2010-05-10|||December 2006||2006-12-01|May 2010|2010-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|CLIP||Contact Lens in Pediatrics (CLIP) in an Asian Population Study||Completed||N/A|60|Anticipated|Singapore National Eye Centre||1|||f||||f||||||||||2017-02-18 15:37:42.06399|2017-02-18 15:37:42.06399
NCT00473291|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2009-06-15|||November 2006||2006-11-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|||||Observational|||Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion|Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion|Completed||N/A|80|Anticipated|Deep Breeze|||1||f||||f||||||||||2017-02-18 15:37:42.147815|2017-02-18 15:37:42.147815
NCT00473278|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2013-01-29|||January 2007||2007-01-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Analysis of Human Tear Proteins in Children|Analysis of Human Tear Proteins in Children: A Pilot Study to Describe the Tear Film Proteome of Pediatric Patients Undergoing Ophthalmic Examination.|Completed||N/A|2|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-02-18 15:37:42.232642|2017-02-18 15:37:42.232642
NCT00473265|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2015-07-14|2013-10-23||May 2004||2004-05-01|July 2015|2015-07-01|June 2014|Actual|2014-06-01|January 2011|Actual|2011-01-01||Interventional||hypoparathyroidism patients who signed Consent to participate in the study|Bone Properties in Hypoparathyroidism: Effects of PTH|Bone Properties in Hypoparathyroidism: Effects of PTH|Completed||Phase 2/Phase 3|68|Actual|Columbia University|Only 16 subjects received a bone biopsy, which is why many of the measurements were only analyzed in 16 subjects. In total, data was only analyzed for the first 30 subjects analyzed for data.|1|||f||||f||||||||||2017-02-18 15:37:42.315803|2017-02-18 15:37:42.315803
NCT00473252|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-14|2011-05-19|||May 2006||2006-05-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Surveillance of Fungal Infections During Construction Activity||Completed||N/A|340|Actual|University Hospital Inselspital, Berne|||2||f||||f||||||||||2017-02-18 15:37:42.92668|2017-02-18 15:37:42.92668
NCT00473239|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2015-04-30|||October 2006||2006-10-01|April 2015|2015-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|Stoss||The Pharmacokinetics of a Single Large Dose of Vitamin D3|The Pharmacokinetics of a Single Large Dose of Vitamin D3|Completed||N/A|40|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 15:37:43.010903|2017-02-18 15:37:43.010903
NCT00473213|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2007-05-11|||September 1999||1999-09-01|May 2007|2007-05-01|February 2004|Actual|2004-02-01|||||Interventional|Optims||Optimizing IFN Beta - 1B Dose|Optimizing IFN Beta - 1B Dose|Completed||Phase 3|217|Actual|University of Turin, Italy||2|||f||||t||||||||||2017-02-18 15:37:43.117144|2017-02-18 15:37:43.117144
NCT00473200|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2013-09-23|||August 2009||2009-08-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine|Effect of Oral S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine in Human Subjects|Completed||Phase 1|27|Actual|Baylor Research Institute||2|||f||||t||||||||||2017-02-18 15:37:43.212794|2017-02-18 15:37:43.212794
NCT00473187|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2007-05-11|||August 2004||2004-08-01|May 2007|2007-05-01|August 2009|Anticipated|2009-08-01|||||Interventional|||Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets|Effects of Growth Hormone Treatment on Body Proportions and Final Height Among Small Children With X-Linked Hypophosphatemic Rickets|Unknown status|Active, not recruiting|Phase 1|||University of Rostock||2|||f||||||||||||||2017-02-18 15:37:43.307731|2017-02-18 15:37:43.307731
NCT00473174|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2009-09-01|||March 2007||2007-03-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|HYCCRA||Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension|A Prospective, Randomized, Open Label, Blinded-endpoint Study to Compare Awakening Versus Bedtime Administration of 5-10 mg Ramipril in Terms of Systolic Blood Pressure Lowering Determined by ABPM in Subjects With Mild-to-moderate Essential|Completed||Phase 4|120|Actual|University of Vigo||2|||f||||t||||||||||2017-02-18 15:37:43.39523|2017-02-18 15:37:43.39523
NCT00473161|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2014-05-21|||May 2007||2007-05-01|May 2014|2014-05-01||||January 2009|Actual|2009-01-01||Observational|||Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy||Completed||Phase 1/Phase 2|20|Anticipated|University of Southern California|||1||f||||f||||||||||2017-02-18 15:37:43.507688|2017-02-18 15:37:43.507688
NCT00473148|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2010-04-29|||June 2007||2007-06-01|November 2008|2008-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|BMW||B-type Natriuretic Peptide for the Management of Weaning|Weaning of Mechanical Ventilation Guided by the Natriuretic Peptide of Type B|Completed||Phase 3|265|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:37:43.594728|2017-02-18 15:37:43.594728
NCT00473135|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2010-01-11|||May 2007||2007-05-01|January 2008|2008-01-01||||January 2010|Actual|2010-01-01||Interventional|||Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine|Safety and Immunogenicity of a 2-Dose Regimen of rDEN1delta30 Dengue Serotype 1 Vaccine With Boosting at 4 Versus 6 Months|Completed||Phase 1|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 15:37:43.710172|2017-02-18 15:37:43.710172
NCT00473122|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2016-07-14|||April 2005||2005-04-01|July 2016|2016-07-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Delayed-Immediate Breast Reconstruction|Delayed-Immediate Breast Reconstruction|Completed||Phase 2|200|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:37:43.839624|2017-02-18 15:37:43.839624
NCT00473109|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2009-05-22|||May 2007||2007-05-01|May 2007|2007-05-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|HDSH||Chronic Hemodialysis Without Systemic Heparinization : a Randomized Study|Chronic Hemodialysis Without Systemic Heparinization : a Randomized Study|Completed||Phase 3|75|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 15:37:43.968977|2017-02-18 15:37:43.968977
NCT00473096|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2015-09-18|||October 2000||2000-10-01|September 2015|2015-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|H-6019||Efficacy Study of an Educational Program for Decision Support for Breast Cancer|Assessing the Efficacy of a CDSS for Breast Cancer|Completed||N/A|100|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 15:37:44.075218|2017-02-18 15:37:44.075218
NCT00473083|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2013-12-19|||January 2009||2009-01-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|December 2012|Actual|2012-12-01||Interventional|LUTRAERL||Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer|A Randomized Controlled Trial of Systemic and Topical Treatments for Rash Secondary to Erlotinib in Advanced Stage IIIB or IV Non-Small Cell Lung Cancer|Completed||Phase 2|150|Actual|British Columbia Cancer Agency||3|||f||||f||||||||||2017-02-18 15:37:44.177932|2017-02-18 15:37:44.177932
NCT00473070|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2008-07-28|||November 2006||2006-11-01|July 2008|2008-07-01||||February 2007|Actual|2007-02-01||Interventional|||A Clinical Study of Tobradex AF|A Clinical Study of Tobradex AF|Completed||Phase 3|900|Anticipated|Alcon Research|||||||||||||||||||2017-02-18 15:37:44.298632|2017-02-18 15:37:44.298632
NCT00473057|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2011-05-18|||December 2005||2005-12-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke|Phase I Study of Autologous Bone Marrow Cell Transplantation in Patient With Ischemic Stroke|Completed||Phase 1|12|Actual|Universidade Federal do Rio de Janeiro||1|||f||||t||||||||||2017-02-18 15:37:44.381833|2017-02-18 15:37:44.381833
NCT00473044|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2008-12-29|||April 2006||2006-04-01|December 2008|2008-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||An Intervention to Increase Physical Activity Among African American Women|An Intervention to Increase Physical Activity Among African American Women|Completed||N/A|104|Anticipated|National Institute on Aging (NIA)||2|||f||||f||||||||||2017-02-18 15:37:44.478121|2017-02-18 15:37:44.478121
NCT00473031|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2012-07-02|||March 2007||2007-03-01|July 2012|2012-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||The Effect of Weight Loss and Dietary Protein Intake on Bone|Nutritional Regulation of Bone - Aim 1|Completed||N/A|48|Actual|Rutgers University||2|||f||||t||||||||||2017-02-18 15:37:44.788764|2017-02-18 15:37:44.788764
NCT00473018|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2015-06-01||||||May 2007|2007-05-01||||||||Interventional|PEP-2||"Behavioral, Clinical and Basic Science Studies of Non-occupational Post-exposure Prophylaxis (PEP-2)"||Completed||N/A|||University of California, San Francisco|||||f||||f||||||||||2017-02-18 15:37:44.915561|2017-02-18 15:37:44.915561
NCT00473005|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2012-05-24|||August 2007||2007-08-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast|A Phase I Pilot Study of the Oral mTOR Inhibitor RAD001 in Combination With Capecitabine for Metastatic Breast Cancer|Terminated||Phase 1|18|Actual|Stanford University||1||Principal Investigator (Dr. Guardino) left Stanford|f||||t||||||||||2017-02-18 15:37:44.988144|2017-02-18 15:37:44.988144
NCT00472992|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2014-08-07|||January 2007||2007-01-01|August 2014|2014-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01|52 Weeks|Observational [Patient Registry]|||Pregnancy Exposure Registry for Tysabri®|TYSABRI® Pregnancy Exposure Registry|Completed||N/A|376|Actual|Biogen|||1||f||||f||||||||||2017-02-18 15:37:45.088081|2017-02-18 15:37:45.088081
NCT00472966|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2008-03-27|||November 2006||2006-11-01|March 2008|2008-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma|Open Label Study to Evaluate the Efficacy and Safety of Sequential Therapy With Fluocinolone Acetonide 0.01%, Hydroquinone (HQ) 4% and Tretinoin 0.05% (TriLuma® Cream) and a Series of Glycolic Acid Peels for the Treatment of Melasma|Completed||Phase 4|20|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-02-18 15:37:45.178491|2017-02-18 15:37:45.178491
NCT00472953|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2012-05-22||2009-11-09|May 2007||2007-05-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|iINHALE 8||Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)|Inhaled Pre-prandial Human Insulin Versus Subcutaneous Injected Insulin Aspart in Subjects With Diabetes and Chronic Obstructive Pulmonary Disease: A 52-week Open Label, Multicentre, Randomized, Parallel Trial to Investigate Long-term Safety|Terminated||Phase 3|38|Actual|Novo Nordisk A/S||2||See termination reason in detailed description|f||||f||||||||||2017-02-18 15:37:45.282441|2017-02-18 15:37:45.282441
NCT00472940|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2011-06-23|||November 2006||2006-11-01|June 2011|2011-06-01||||||||Observational|||Prevalence of Hypogonadism in Male Cancer Patients|Prevalence of Hypogonadism in Male Cancer Patients|Completed||N/A|135|Anticipated|Baylor College of Medicine|||1||f||||t||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 15:37:45.394354|2017-02-18 15:37:45.394354
NCT00472927|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-12-04|||May 2007||2007-05-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)|An Open-Label, Single-Dose, Randomized, 4-Period, Crossover, Bioequivalence Study of Three New Formulations of Premarin 0.45mg/Medroxyprogesterone Acetate (MPA) 1.5mg Compared With a Reference Formulation of Premarin/MPA (PremproTM) 0.45mg/1.5mg in Healthy Postmenopausal Women|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:37:45.472242|2017-02-18 15:37:45.472242
NCT00472914|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2014-05-21|||January 2007||2007-01-01|May 2014|2014-05-01|March 2007|Actual|2007-03-01|||||Observational|||Use of EMG to Assess Clinical Hypertonia|Initial Assessment of the Use of Surface Electromyography as a Tool for Clinical Evaluation of Hypertonia in Children|Completed||Phase 1/Phase 2|14||University of Southern California|||||f||||f||||||||||2017-02-18 15:37:45.549027|2017-02-18 15:37:45.549027
NCT00472901|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2011-10-04|||May 2007||2007-05-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Observational|||Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)|A Phase III, Randomised, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of CUV1647 in Patients Suffering From Polymorphic Light Eruption (PLE).|Completed||Phase 3|18|Actual|Clinuvel Pharmaceuticals Limited|||1||f||||f||||||||||2017-02-18 15:37:45.635686|2017-02-18 15:37:45.635686
NCT00472888|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-05-10|||November 2005||2005-11-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Observational|||Clinical Factors Associated Floppy Iris|Clinical Factors Associated With Floppy Iris Signs: a Prospective Study From Two Centers|Completed||N/A|500|Actual|Baskent University|||||f||||t||||||||||2017-02-18 15:37:45.738821|2017-02-18 15:37:45.738821
NCT00472875|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-05-10|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Interventional|||Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia?||Unknown status|Recruiting|Phase 4|10|Anticipated|King's College Hospital NHS Trust||2|||f||||f||||||||||2017-02-18 15:37:46.005841|2017-02-18 15:37:46.005841
NCT00472862|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2015-04-14|||January 2007||2007-01-01|April 2015|2015-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|NEUROCOM||Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual|NEUROCOM: Cognitive Training for Patients With First Episode Schizophrenia|Completed||Phase 3|117|Actual|Neurocom||2|||f||||f||||||||||2017-02-18 15:37:46.102377|2017-02-18 15:37:46.102377
NCT00472849|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2013-11-01|2013-08-09||May 2007||2007-05-01|November 2013|2013-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias|A Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation, Prolymphocytic Leukemia, Aggressive, Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|92|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:37:46.206736|2017-02-18 15:37:46.206736
NCT00472836|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2009-08-11||2009-08-11|June 2007||2007-06-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug|A Phase 1, Open-Label, Parallel Group, Multiple-Dose Study To Evaluate The Pharmacokinetics, Safety And Toleration Of CP-945,598 Administered To Subjects With Severely Impaired And Normal Renal Function|Completed||Phase 1|17|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:37:46.621088|2017-02-18 15:37:46.621088
NCT00472823|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2016-03-11|||April 2007||2007-04-01|March 2016|2016-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|VIDOS||Vitamin D Supplementation in Older Women|Determination of RDA for Vitamin D in Caucasian and African American Women|Completed||N/A|273|Actual|Creighton University||8|||f||||t||||||||No||2017-02-18 15:37:46.718851|2017-02-18 15:37:46.718851
NCT00472810|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2011-10-06|||March 2007||2007-03-01|October 2011|2011-10-01||||May 2008|Actual|2008-05-01||Interventional|||Ologen (OculusGen)-Glaucoma MMC Control in Pakistan|Comparative Study of the Safety and Effectiveness Between Ologen (OculusGen) Collagen Matrix Implant and Mitomycin-C in Glaucoma Filtering Surgery|Completed||Phase 3|40|Actual|Pro Top & Mediking Company Limited||2|||f||||f||||||||||2017-02-18 15:37:46.851853|2017-02-18 15:37:46.851853
NCT00472797|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2013-08-02|2009-02-18||April 2007||2007-04-01|August 2013|2013-08-01|November 2009|Actual|2009-11-01|February 2009|Actual|2009-02-01||Interventional|RebiQoL||Rebif New Formulation (RNF) Quality of Life (QOL) Study|A Randomized, Multicenter, Two-arm, 12 Week Phase IIIb Study to Evaluate Quality of Life (QOL) Measures in Subjects With Relapsing Forms of Multiple Sclerosis (MS) Who Are Transitioning From Rebif® (Interferon Beta-1a) to Rebif New Formulation (RNF)|Completed||Phase 3|232|Actual|EMD Serono||2|||f||||||||||||||2017-02-18 15:37:46.973791|2017-02-18 15:37:46.973791
NCT00472784|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2016-05-09|||October 1998||1998-10-01|May 2016|2016-05-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Quantitative and Qualitative Changes in Neural Efferent Receptors|Quantitative and Qualitative Changes in Neural Efferent Receptors, Collagen and Smooth Muscle Content in the Bladder, Following Spinal Cord Injury (SCI) in Humans|Withdrawn||Early Phase 1|0|Actual|Baylor College of Medicine|||1|Study no longer being conducted.|f||||t||||||||||2017-02-18 15:37:47.66268|2017-02-18 15:37:47.66268
NCT00472771|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2012-02-08|||May 2008||2008-05-01|February 2012|2012-02-01|November 2008|Actual|2008-11-01|||||Interventional|||INNO-206 in Patients With Small Cell Lung Cancer (SCLC)|A Phase II, Open-label Study of INNO-206 in Patients With Recurrent Extensive Small Cell Lung Cancer After First-line Platinum-based Therapy|Withdrawn||Phase 2|0|Actual|CytRx||1||Terminated due to clinical trial material production delays|f||||f||||||||||2017-02-18 15:37:47.746069|2017-02-18 15:37:47.746069
NCT00472758|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2011-11-16|||February 2007||2007-02-01|November 2011|2011-11-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|CP145||A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545|A Phase 1, Randomized, Double-blind, Placebo-controlled, Dose-escalation, Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose, Intravenously Administered MEDI-545, a Fully Human Anti-Interferon-Alpha Monoclonal Antibody, in Patients With Chronic Plaque Psoriasis|Completed||Phase 1|40|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 15:37:47.852996|2017-02-18 15:37:47.852996
NCT00472745|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2014-07-12|||March 2007||2007-03-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||The Effect of Weight Loss on Bone in Men|Nutritional Regulation of Bone - Pilot Study|Completed||N/A|39|Actual|Rutgers University||2|||f||||t||||||||||2017-02-18 15:37:47.965328|2017-02-18 15:37:47.965328
NCT00472732|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2015-05-28|2015-04-22||March 2007||2007-03-01|May 2015|2015-05-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Observational||Half of the subjects were affected and half were normal controls age 18-60|Neurologic Injuries in Adults With Urea Cycle Disorders|Assessing Neural Mechanisms of Injury in Inborn Errors of Urea Metabolism Using Structural MRI, Functional MRI, and Magnetic Resonance Spectroscopy|Completed||N/A|46|Actual|Children's Research Institute|This study examined the neurobiological differences between OTCD patients and controls. This was, however, not a clinical trial, since participants received no form of drug therapy or treatment as part of this study.||2||f||||t||||||||||2017-02-18 15:37:48.080377|2017-02-18 15:37:48.080377
NCT00472446|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2016-07-27|2015-11-24||January 2006||2006-01-01|July 2016|2016-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial|Impact and Cost Efficiency of Bilateral, Superficial Cervical Block in Thyroid Surgery Under General Anesthesia|Completed||Phase 2/Phase 3|183|Actual|Cantonal Hospital of St. Gallen||4|||f||||f||||||||No||2017-02-18 15:37:50.744072|2017-02-18 15:37:50.744072
NCT00472719|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2014-10-15|||August 2007||2007-08-01|October 2014|2014-10-01|January 2013|Actual|2013-01-01|July 2008|Actual|2008-07-01||Interventional|||Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults|A Phase 1B Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Adenoviral Serotype 35 (rAd35) and Serotype 5 (rAd5) HIV-1 Vaccines When Given in Heterologous Prime-Boost Regimens or as a Boost to a Recombinant DNA Vaccine in Healthy, HIV-1-Uninfected Adult Participants With Pre-Existing Immunity to Adenovirus Serotype 5 Infection|Completed||Phase 1|17|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 15:37:48.761167|2017-02-18 15:37:48.761167
NCT00472706|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2010-05-12|||May 2007||2007-05-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease|A Randomized Clinical Trial of Excision Versus Photodynamic Therapy in Bowen's Disease|Terminated||Phase 4|65|Actual|Catharina Ziekenhuis Eindhoven||2||Study stopped because of disappointing inclusion rates|f||||t||||||||||2017-02-18 15:37:48.892004|2017-02-18 15:37:48.892004
NCT00472693|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-11|2016-09-23|||May 2007||2007-05-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer|A Phase II Trial of Bevacizumab and ABI-007 (Abraxane) as Second-line Therapy in Her-2 Negative, Hormone Receptor Negative Metastatic Breast Cancer|Completed||Phase 2|5|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 15:37:48.995113|2017-02-18 15:37:48.995113
NCT00472680|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2014-07-12|||March 2008||2008-03-01|July 2012|2012-07-01|December 2015|Anticipated|2015-12-01|May 2015|Anticipated|2015-05-01||Interventional|||The Effect of Severe Weight Loss and Protein Intake on Bone|Nutritional Regulation of Bone - Aim 2|Unknown status|Recruiting|N/A|38|Anticipated|Rutgers University||2|||f||||t||||||||||2017-02-18 15:37:49.091412|2017-02-18 15:37:49.091412
NCT00472602|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2010-08-26|||August 2007||2007-08-01|May 2007|2007-05-01||||||||Observational|||Pathogenesis of Liver Fluke Induced Cancer in Thailand|Pathogenesis of Liver Fluke Induced Cancer in Thailand|Unknown status|Recruiting|N/A|6000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 15:37:49.200441|2017-02-18 15:37:49.200441
NCT00472589|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2016-08-22|||May 2007||2007-05-01|August 2016|2016-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||A Biological Sample Collection Protocol of Women With and Without Breast Cancer|A Biological Sample Collection Protocol of Women With and Without Breast Cancer: Hoosier Oncology Group Study BRE06-120 for the Analytical Proteomics Team|Completed||N/A|400|Actual|Hoosier Cancer Research Network|||2||f||||t||||||Samples With DNA|"~     plasma, serum, whole blood and tissue samples~   "|||2017-02-18 15:37:49.267984|2017-02-18 15:37:49.267984
NCT00472576|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2012-07-19|2011-03-14||May 2007||2007-05-01|July 2012|2012-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Antidepressant Effects of NR2B in Major Depression|An Investigation of the Antidepressant Effects of the Selective NR2B Antagonist MK-0657 in Major Depression|Completed||Phase 1|5|Actual|National Institutes of Health Clinical Center (CC)|The study was ended early due to recruitment problems.|2|||f||||f||||||||||2017-02-18 15:37:49.366597|2017-02-18 15:37:49.366597
NCT00472563|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2008-05-05|||May 2007||2007-05-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|PROMEC||Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate|Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate|Completed||Phase 2/Phase 3|212|Actual|Universidad de Antioquia|||||f||||t||||||||||2017-02-18 15:37:49.958484|2017-02-18 15:37:49.958484
NCT00472550|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-05-10|||January 2006||2006-01-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Interventional|||Esomeprazole and Gastric Emptying of Beer|Effects of Esomeprazole on Gastric Emptying of Alcoholic Beverages, Blood Alcohol Concentrations, Gastroesophageal Reflux and Release of Some Gastrointestinal Hormones in Healthy Volunteers|Completed||Phase 4|16|Actual|Heidelberg University||2|||f||||t||||||||||2017-02-18 15:37:50.049628|2017-02-18 15:37:50.049628
NCT00472537|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2013-04-22|||November 2005||2005-11-01|April 2013|2013-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|ProLOVE||ProLOVE - Prospective Randomized Study of Midline Incisional Hernia Treatment|Prospective Randomized Evaluation of Open vs. Laparoscopic Operation of Ventral Incisional Eventrations. A Swedish Multicenter Study|Completed||N/A|157|Actual|Skane University Hospital|||1||f||||f||||||||||2017-02-18 15:37:50.140459|2017-02-18 15:37:50.140459
NCT00472524|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2008-07-01||||||July 2008|2008-07-01||||||||Interventional|||Cycloplegic Delivery Investigation||Completed||N/A|50||Ohio State University|||||f||||||||||||||2017-02-18 15:37:50.245758|2017-02-18 15:37:50.245758
NCT00472511|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2008-07-01||||||July 2008|2008-07-01||||||||Observational|||Study of Eyes and Attention Deficit (SEAD)||Completed||N/A|75||Ohio State University|||||f||||||||||||||2017-02-18 15:37:50.304943|2017-02-18 15:37:50.304943
NCT00472498|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2013-09-26|||June 2005||2005-06-01|September 2013|2013-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|AED||Comparison on the Efficacy of a Monophasic|Comparison on the Efficacy of a Monophasic, Manually Operated Defibrillator to That of a Biphasic Automatic External Defibrillator in the Hospital Setting.|Terminated||N/A|95|Actual|Emory University|||2|Terminated: No longer recruiting.|f||||f||||||||||2017-02-18 15:37:50.368756|2017-02-18 15:37:50.368756
NCT00472485|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2008-07-01||||||July 2008|2008-07-01||||||||Interventional|||Study of Eye Movement Testing and Therapy||Completed||N/A|40||Ohio State University|||||f||||||||||||||2017-02-18 15:37:50.452863|2017-02-18 15:37:50.452863
NCT00472472|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2010-06-29|||April 2004||2004-04-01|May 2007|2007-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|PACCOCATH_F||Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal Arteries|Paclitaxel Coated Balloon Catheter for Inhibition of Restenosis in Femoropopliteal Arteries (PACCOCATH - FEM I)|Completed||Phase 1/Phase 2|87|Actual|University Hospital, Saarland||2|||f||||t||||||||||2017-02-18 15:37:50.520414|2017-02-18 15:37:50.520414
NCT00472459|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2010-09-01|||July 2003||2003-07-01|September 2010|2010-09-01|July 2006|Actual|2006-07-01|||||Interventional|||PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer|A Multicentre, Randomised Study of Photodynamic Therapy(PDT) With Metvix® 160 mg/g Cream in Immuno-compromised Patients With Non-melanoma Skin Cancer|Completed||Phase 3|81|Actual|Galderma||2|||f||||f||||||||||2017-02-18 15:37:50.630062|2017-02-18 15:37:50.630062
NCT00349869|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2014-09-08|||August 2006||2006-08-01|September 2014|2014-09-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Yoga for Rheumatoid Arthritis|Yoga for Persons With Rheumatoid Arthritis|Completed||Phase 1|75|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:25:10.754655|2017-02-18 16:25:10.754655
NCT00472433|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2009-06-18|||March 2007||2007-03-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias|A Phase II Study of Alemtuzumab in Autoimmune Cytopenias|Terminated||Phase 2|30|Anticipated|Phramongkutklao College of Medicine and Hospital||||no eligible patient|f||||f||||||||||2017-02-18 15:37:51.531985|2017-02-18 15:37:51.531985
NCT00472420|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2014-11-21|2014-11-21||June 2007||2007-06-01|November 2014|2014-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||Intent-to-treat (ITT) population: all randomized participants who received at least 1 dose of study treatment.|A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.|An Open-label Study of the Effect of the Addition of MabThera to Standard Chemotherapy on Clinical Response in Patients With Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|48|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:37:51.622324|2017-02-18 15:37:51.622324
NCT00470418|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2017-01-05|2014-01-16||January 2007||2007-01-01|January 2017|2017-01-01|March 2010|Actual|2010-03-01|August 2008|Actual|2008-08-01||Interventional|||Development of NIC5-15 in the Treatment of Alzheimer's Disease|Development of NIC5-15 in the Treatment of Alzheimer's Disease|Completed||Phase 2|15|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:37:51.94441|2017-02-18 15:37:51.94441
NCT00470405|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2011-04-14|||May 2004||2004-05-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|May 2007|Actual|2007-05-01||Interventional|||Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma|A Phase I Study of ALIMTA Plus Oxaliplatin Administered Every Other Week in the Treatment of Patients With Metastatic Cancer|Completed||Phase 1|25|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:37:52.294301|2017-02-18 15:37:52.294301
NCT00470392|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2016-10-03|2013-09-26||May 2007||2007-05-01|October 2016|2016-10-01|July 2012|Actual|2012-07-01|July 2010|Actual|2010-07-01||Interventional|||Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis|Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis|Terminated||N/A|9|Actual|VA Office of Research and Development|No synchronized T cell reactivation was observed upon immunohistochemical analysis, nor upon analysis of T cell death associated gene (TDAG) mRNA by PCR, with Clobetasol treatment, so this arm was terminated.|2||Recruiting complete and administrative termination|f||||t||||||||||2017-02-18 15:37:52.419737|2017-02-18 15:37:52.419737
NCT00470379|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-10-30|||April 2006||2006-04-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery|Transcutaneous (Topical) Peptide Immunization With NY-ESO-1b (SLLMWITQC) Peptide Using Resiquimod as an Immune Adjuvant: A Pilot Study|Completed||Early Phase 1|30|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:37:52.793579|2017-02-18 15:37:52.793579
NCT00470366|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-06-16|||March 2007||2007-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors|Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Previously Untreated Intermediate and Poor Risk Germ Cell Tumor Patients|Completed||Phase 2|60|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 15:37:52.905423|2017-02-18 15:37:52.905423
NCT00470353|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2013-01-31|||September 2006||2006-09-01|January 2013|2013-01-01|September 2009|Actual|2009-09-01|July 2008|Actual|2008-07-01||Interventional|||Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery|A Pilot Study of Low and High Dose Vitamin Cholecalciferol (D3) With Pharmacokinetic and Pharmacodynamic Correlates in Patients With Resected Colon Cancer|Terminated||N/A|8|Actual|Roswell Park Cancer Institute||||Withdrawn due to poor accrual/lack of funding|f||||||||||||||2017-02-18 15:37:53.017557|2017-02-18 15:37:53.017557
NCT00470340|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2011-05-04|||June 2007||2007-06-01|May 2007|2007-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|GEMOXIAL||Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients|Arterial LIPIODOLISED Chemotherapy Versus Systemic Chemotherapy With Gemcitabine Plus Oxaliplatin (GEMOX) Versus no Treatment Following Surgical Resection or Local Ablation of Hepatocellular Carcinoma in Cirrhotic Patients|Terminated||Phase 3|263|Actual|Assistance Publique - Hôpitaux de Paris||2||during the study|f||||t||||||||||2017-02-18 15:37:53.127983|2017-02-18 15:37:53.127983
NCT00470327|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-10-13|||September 2005||2005-09-01|October 2016|2016-10-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Observational|||A Study of the Natural Progression of Interstitial Lung Disease (ILD)|A Study of the Natural Progression of Interstitial Lung Disease (ILD)|Recruiting||N/A|4000|Anticipated|University of Chicago|||1||f||||f||||||Samples With DNA|"~     blood~   "|Yes|We will share coded data with no PHI|2017-02-18 15:37:53.24085|2017-02-18 15:37:53.24085
NCT00470314|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2008-01-04|||January 2005||2005-01-01|April 2007|2007-04-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure|Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure: A Double- Blind, Randomized, Placebo- Controlled Study|Unknown status|Active, not recruiting|Phase 2|150|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 15:37:53.347122|2017-02-18 15:37:53.347122
NCT00470301|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2015-05-06|2015-05-06||April 2007||2007-04-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer|A Phase I-II Study of R115777 (Tipifarnib, Zarnestra®) Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients With Stage IIB-IIIC Breast Cancer|Completed||Phase 1/Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:37:53.468587|2017-02-18 15:37:53.468587
NCT00470288|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2007-05-04|||October 2005||2005-10-01|April 2007|2007-04-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Randomized Controlled Trial of Bladder Flap vs.None|Randomized Controlled Trial of Bladder Flap vs.None|Unknown status|Recruiting|N/A|123|Anticipated|Mountain Area Health Organization Center||2|||f||||f||||||||||2017-02-18 15:37:53.812718|2017-02-18 15:37:53.812718
NCT00470275|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-10-09|2013-08-29||May 2007||2007-05-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|August 2008|Actual|2008-08-01||Interventional|||Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma|Phase II Trial of Intermediate-Dose Cytarabine to Modulate EWS/FLI for Children and Young Adults With Recurrent or Refractory Ewing Sarcoma|Completed||Phase 2|10|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 15:37:53.9213|2017-02-18 15:37:53.9213
NCT00470262|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2016-06-09|2014-06-27||January 2007||2007-01-01|June 2016|2016-06-01|June 2014|Actual|2014-06-01|December 2012|Actual|2012-12-01||Interventional|||Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation|Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation in Subjects With Impaired Glucose Tolerance|Completed||N/A|27|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:37:54.335693|2017-02-18 15:37:54.335693
NCT00470249|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2009-08-01|||February 2007||2007-02-01|July 2009|2009-07-01||||April 2008|Anticipated|2008-04-01||Interventional|||Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Phase II Study of Carboplatin in Combination With Gemcitabine as a Dose Dense Schedule in Patients With Locally Advanced or Metastatic Breast Cancer That Are Resistant to Anthracyclines & Taxanes|Unknown status|Recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:37:54.889058|2017-02-18 15:37:54.889058
NCT00470236|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2017-02-15|||June 2007||2007-06-01|February 2017|2017-02-01|June 2024|Anticipated|2024-06-01|June 2024|Anticipated|2024-06-01||Interventional|DCIS||Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast|A Randomised Phase III Study of Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast|Active, not recruiting||Phase 3|1608|Actual|Trans-Tasman Radiation Oncology Group (TROG)||4|||f||||t||||||||||2017-02-18 15:37:55.003395|2017-02-18 15:37:55.003395
NCT00470223|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-06-21|||March 2007||2007-03-01|June 2016|2016-06-01|April 2025|Anticipated|2025-04-01|December 2015|Actual|2015-12-01||Interventional|OS2006||Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma|OS2006 : Protocole de Traitement Des ostéosarcomes de l'Enfant, de l'Adolescent et de l'Adulte Comportant|Terminated||Phase 3|318|Actual|UNICANCER||2||IDMC decision upon interim efficacy analysis|f||||t||||||||No|IPD will not be shared at an individual level, they will be part of the study database including all enrolled patients.|2017-02-18 15:37:55.267142|2017-02-18 15:37:55.267142
NCT00470210|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2010-04-15|||May 2007||2007-05-01|April 2010|2010-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens|Efficacy and Safety of High-dose Ribavirin (1600 mg/d) Boosted With Epoetin β (450 IU/kg/wk) in HIV/HCV Coinfected Patients Not Responding to Previous Treatment Regimens|Completed||Phase 4|10|Actual|Germans Trias i Pujol Hospital||1|||f||||f||||||||||2017-02-18 15:37:55.442642|2017-02-18 15:37:55.442642
NCT00470197|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2013-09-27|||April 2007||2007-04-01|September 2013|2013-09-01||||January 2011|Actual|2011-01-01||Interventional|||Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia|Phase I Study of a Pharmacologically Derived Hybrid Bolus-Infusion Schedule of Flavopiridol (NSC 649890, IND 46,211) Given in Timed Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:37:55.56641|2017-02-18 15:37:55.56641
NCT00470184|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2013-09-19|2013-09-19||November 2006||2006-11-01|September 2013|2013-09-01||||October 2012|Actual|2012-10-01||Interventional||treated patients|Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer|Phase II Study of Capecitabine in Combination With Oxaliplatin and Radiotherapy for Esophageal and Gastroesophageal Junction Cancer|Completed||Phase 2|41|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 15:37:55.709235|2017-02-18 15:37:55.709235
NCT00472407|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2008-07-01||||||July 2008|2008-07-01||||||||Interventional|||Eye Teaming Evaluation Study||Completed||N/A|72|Anticipated|Ohio State University|||||f||||||||||||||2017-02-18 15:37:56.199109|2017-02-18 15:37:56.199109
NCT00472394|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-08-17|||October 2006||2006-10-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Observational|||Determining Women's Preferences for Medical Abortion Using Willingness to Pay||Completed||N/A|||University of Pittsburgh|||||f||||f||||||||||2017-02-18 15:37:56.277296|2017-02-18 15:37:56.277296
NCT00472381|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2014-06-04|||May 2007||2007-05-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|INSULINFARCT||Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke|Assessment of Continuous Intravenous Insulin Protocol Versus Subcutaneous Insulin in Acute Ischemic Stroke|Completed||Phase 2/Phase 3|180|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 15:37:56.348602|2017-02-18 15:37:56.348602
NCT00472368|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2012-04-27|||May 2007||2007-05-01|April 2012|2012-04-01||||June 2008|Actual|2008-06-01||Interventional|||A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589|An Open-label, Single Center, Study to Determine the Absorption, Distribution, Metabolism, and Excretion (ADME) of LBH589 After a Single Oral Administration of 20 mg (14C) LBH589 in Advanced Cancer Patients|Completed||Phase 1|4|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:37:56.459446|2017-02-18 15:37:56.459446
NCT00472355|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2009-09-03|||October 2005||2005-10-01|September 2009|2009-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Low Dose Apomorphine and Parkinsonism|Does Presynaptic Dopamine Receptor Stimulation Transiently Worsen Parkinsonism?|Completed||Phase 2|14|Anticipated|Oregon Health and Science University|||||f||||||||||||||2017-02-18 15:37:56.559972|2017-02-18 15:37:56.559972
NCT00472342|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-05-10|||March 2007||2007-03-01|May 2007|2007-05-01|December 2007|Anticipated|2007-12-01|||||Interventional|||The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients|The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients|Unknown status|Recruiting|N/A|182|Anticipated|Yonsei University||1|||f||||t||||||||||2017-02-18 15:37:56.655817|2017-02-18 15:37:56.655817
NCT00472329|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2014-06-26|||March 2007||2007-03-01|June 2014|2014-06-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant|Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant|Recruiting||Phase 2|20|Anticipated|Colorado Blood Cancer Institute||1|||f||||f||||||||||2017-02-18 15:37:56.741439|2017-02-18 15:37:56.741439
NCT00472316|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2009-08-07|||May 2007||2007-05-01|August 2009|2009-08-01|May 2011|Anticipated|2011-05-01|October 2009|Anticipated|2009-10-01||Observational|||Innovative Approaches to Tuberculosis Control|A Cluster Randomized Trial of DOTS vs DOTS Plus Active Case Finding|Unknown status|Active, not recruiting|Phase 4|1000|Anticipated|Johns Hopkins University|||1||f||||t||||||||||2017-02-18 15:37:56.964622|2017-02-18 15:37:56.964622
NCT00472303|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2016-06-10|2013-09-30||July 2007||2007-07-01|June 2016|2016-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||"Titration Phase:~Safety Analysis Set (N = 496) Full Analysis Set (N = 492)~Maintenance Phase:~Safety Analysis Set (N = 327) Full Analysis Set (N = 325)~Note:~One site was excluded from all analysis sets (efficacy and safety) due to GCP non-compliance. Thus 8 participants who were randomized and treated are not reported in the tables below."|A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine|A Randomized Withdrawal, Active- and Placebo-controlled, Double-blind, Multi-center Phase III Trial Assessing Safety and Efficacy of Oral CG5503 (Tapentadol) PR* in Subjects With Moderate to Severe Chronic Malignant Tumor-related Pain|Completed||Phase 3|622|Actual|Grünenthal GmbH||3|||f||||f||||||||||2017-02-18 15:37:57.078573|2017-02-18 15:37:57.078573
NCT00472290|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2013-09-18|2012-12-05||April 2007||2007-04-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|||Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)|An Open Label Extension Study Evaluating the Safety of Long Term Dosing of Romiplostim in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)|Completed||N/A|72|Actual|Amgen|Early termination leading to small number of subjects analyzed;|1|||f||||||||||||||2017-02-18 15:38:01.222533|2017-02-18 15:38:01.222533
NCT00472264|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2009-07-01|||May 2007||2007-05-01|July 2009|2009-07-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Observational|||A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients|An Exploratory Study To Investigate The Reproducibility Of Lung 18Fluoro-Deoxyglucose Positron Emission Tomography In Patients With Chronic Obstructive Airways Disease (COPD) In The Absence Of Anti-Inflammatory Treatments|Terminated||Early Phase 1|20|Actual|Pfizer|||1|"Study terminated on Nov 7, 2008 as a result of poor recruitment and changes in business~   priorities. The decision was not based on safety concerns."|f||||f||||||||||2017-02-18 15:38:01.717653|2017-02-18 15:38:01.717653
NCT00472251|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2011-07-20|||May 2006||2006-05-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Observational|||One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients|One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients|Completed||N/A|120|Actual|Seoul National University Hospital|||1||f||||t||||||||||2017-02-18 15:38:01.835698|2017-02-18 15:38:01.835698
NCT00472238|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2008-11-19|||August 2007||2007-08-01|May 2007|2007-05-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Effects of Endurance Training on Patients With Reduced Left Ventricular Ejection Fraction (LVEF) and Cardiac Resynchronisation Therapy Especially for Cardiac Arrhythmias|Effects of Endurance Training on Patients With Reduced LVEF and Cardiac Resynchronisation Therapy Especially for Cardiac Arrhythmias|Unknown status|Recruiting|N/A|30|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 15:38:04.408949|2017-02-18 15:38:04.408949
NCT00472225|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2009-02-20|||May 2007||2007-05-01|February 2009|2009-02-01|May 2009|Anticipated|2009-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease|Open-Labelled, Multicenter Phase II Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease|Unknown status|Active, not recruiting|Phase 2|42|Anticipated|The Korean Society of Hematopoietic Stem Cell Transplantation||1|||f||||t||||||||||2017-02-18 15:38:04.501435|2017-02-18 15:38:04.501435
NCT00472212|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2014-10-14|||November 2003||2003-11-01|October 2014|2014-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|CHICS||Correction of Farsightedness in Children Study|Correction of Hyperopia in Children Study|Completed||N/A|48|Actual|Ohio State University||2|||f||||f||||||||||2017-02-18 15:38:04.620839|2017-02-18 15:38:04.620839
NCT00472199|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2014-06-17|2009-07-02||May 2007||2007-05-01|May 2012|2012-05-01||||July 2008|Actual|2008-07-01||Interventional|||Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)|A Phase IV Randomised, Double-blind, Placebo-controlled, Dose Titration Trial With Pramipexole (Sifrol, Mirapexin) 0.125-0.75 mg/Day Per os to Investigate the Long-term Efficacy, Safety and Tolerability in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome for 26 Weeks Followed by a 26 Week Open-label Extension Treatment Period|Completed||Phase 4|331|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 15:38:04.733741|2017-02-18 15:38:04.733741
NCT00472186|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-12-26|||December 2007||2007-12-01|December 2007|2007-12-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||The Effects of Reducing Stomach Acid on Post-Tonsillectomy Pain|The Effects of Gastro-Esophageal Acid Suppression on Post-Tonsillectomy Pain|Unknown status|Recruiting|Phase 4|150|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 15:38:06.00849|2017-02-18 15:38:06.00849
NCT00472173|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2011-11-09|||May 2007||2007-05-01|November 2011|2011-11-01|May 2011|Actual|2011-05-01|November 2010|Actual|2010-11-01||Interventional|APEXMTA||Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth|Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth|Completed||Phase 3|34|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:38:06.11907|2017-02-18 15:38:06.11907
NCT00472160|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2011-03-25|||June 2007||2007-06-01|May 2007|2007-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|PREOXY||Preoxygenation Using NIV in Hypoxemic Patients|Preoxygenation Using Noninvasive Ventilation Prior Intubation in Hypoxemic Patients|Completed||Phase 4|200|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 15:38:06.227263|2017-02-18 15:38:06.227263
NCT00472147|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2007-05-10||||||May 2007|2007-05-01||||||||Interventional|||Selection of Shock Energy in Out-Of-Hospital Cardiac Arrest||Unknown status|Not yet recruiting|N/A|||Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 15:38:06.330851|2017-02-18 15:38:06.330851
NCT00472134|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2015-06-04|||December 2005||2005-12-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Laparoscopic Ventral Hernia Repair With Elastomeric Pain Pump|Prospective, Randomized, Double-blind Trial of Continuous Infusion of 0.5% Bupivacaine be Elastomeric Pump for Prospective Pain Management After Laparoscopic Ventral Hernia Repair.|Completed||N/A|100|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-02-18 15:38:06.408121|2017-02-18 15:38:06.408121
NCT00471172|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2008-09-12|||August 2004||2004-08-01|September 2008|2008-09-01|May 2005|Actual|2005-05-01|||||Interventional|||Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss|A 6-Month, Randomized Study To Evaluate The Efficacy Of Various Non-Pharmacologic, Disease Management Programs For The Treatment Of Obesity|Completed||N/A|350||Pfizer|||||f||||||||||||||2017-02-18 15:38:24.971161|2017-02-18 15:38:24.971161
NCT00472121|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2008-04-17|||May 2007||2007-05-01|April 2008|2008-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||The Precision and Arm-to-Arm Variation of Mechanomyography and Acceleromyography for Monitoring of Neuromuscular Block|The Precision and Arm-to-Arm Variation og Mechanomyography and Acceleromyography for Monitoring the Neuromuscular Block During Anesthesia, A Randomized Controlled Study|Completed||Phase 4|||Rigshospitalet, Denmark|||2||f||||t||||||||||2017-02-18 15:38:06.517195|2017-02-18 15:38:06.517195
NCT00472108|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2010-09-01|||December 2000||2000-12-01|September 2010|2010-09-01|April 2002|Actual|2002-04-01|||||Interventional|||Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma|A Multicenter, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix 160 mg/g Cream in Comparison to PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma|Completed||Phase 3|65|Actual|Galderma||2|||f||||f||||||||||2017-02-18 15:38:06.604166|2017-02-18 15:38:06.604166
NCT00472095|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2014-01-21|||June 2007||2007-06-01|January 2014|2014-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Fotonovela for Type 2 Diabetes Mellitus|Utility of a Diabetes Themed Fotonovela to Encourage Glycemic Control: a Culturally Appropriate Tool for Education in Latinos|Recruiting||N/A|260|Anticipated|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:38:06.710081|2017-02-18 15:38:06.710081
NCT00472082|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2013-12-19|2012-11-09||May 2007||2007-05-01|December 2013|2013-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients|An Open Label, Single-Center Pilot Study of Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Primary Renal Transplant Recipients|Terminated||Phase 1/Phase 2|5|Actual|Emory University||1||This study was terminated at the request of the drug manufacturer.|f||||t||||||||||2017-02-18 15:38:07.064106|2017-02-18 15:38:07.064106
NCT00472069|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2011-05-04|||April 2007||2007-04-01|September 2007|2007-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A New Therapeutic Strategy for Urethral Sphincter Insufficiency|EVALUATION Of A NEW THERAPEUTIC STRATEGY FOR URETHRAL SPHINCTER INSUFFICIENCY BASED ON THE INTRA-URETHRAL IMPLANTATION OF AUTOLOGOUS MYOFIBERS WITH THEIR SATELLITE CELLS|Completed||Phase 1|10|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 15:38:07.320325|2017-02-18 15:38:07.320325
NCT00472056|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2016-02-17|2012-01-09||March 2005||2005-03-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies|Randomized Trial Using Standard Dose Versus High Dose Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Diffuse Large B Cell Lymphomas|Completed||Phase 2|93|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:38:07.4291|2017-02-18 15:38:07.4291
NCT00472043|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-10|2010-09-01|||October 2000||2000-10-01|September 2010|2010-09-01|September 2002|Actual|2002-09-01|||||Interventional|||PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma|A Multicentre, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix® 160 mg/g Cream in Comparison to PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma.|Completed||Phase 3|66|Actual|Galderma||2|||f||||f||||||||||2017-02-18 15:38:08.038188|2017-02-18 15:38:08.038188
NCT00472030|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2012-09-17|2012-06-26||August 2007||2007-08-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Efficacy and Safety of Omalizumab in Bullous Pemphigoid|An Open Label Case Series on the Effects of Xolair (Omalizumab) in Bullous Pemphigoid|Completed||Phase 4|2|Actual|University of Iowa|Limitations of this trial include low enrollment of research subjects and the need to withdraw a subject from the trial.|2|||f||||f||||||||||2017-02-18 15:38:08.143136|2017-02-18 15:38:08.143136
NCT00472017|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2012-10-11|||April 2007||2007-04-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma|Phase I Trial of Vandetanib (ZD6474, ZACTIMA) With Concurrent Radiation in Treatment of Newly Diagnosed Brainstem Glioma|Completed||Phase 1|35|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 15:38:08.591642|2017-02-18 15:38:08.591642
NCT00472004|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2010-10-28|||February 2006||2006-02-01|October 2010|2010-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women|A Prospective, Randomized, Open Label Study To Compare The Efficacy, Safety And Tolerability Of 17-B Estradiol/Trimegestone CC 1 Mg (Totelle) And Tibolone (Livial) In Postmenopausal Women.|Completed||Phase 4|204|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 15:38:08.708823|2017-02-18 15:38:08.708823
NCT00471991|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2013-01-23|||April 2007||2007-04-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition|Monocenter, Open-label, Randomized Study to Determine the Ovulation Inhibitory Effect of the Combined Oral Contraceptive SH T04769G and SH D00659AF (0.03 mg Ethinylestradiol and 2.0 mg Dienogest), Applied for Two Treatment Cycles to 60 Healthy Female Volunteers|Completed||Phase 2|60|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:38:08.812552|2017-02-18 15:38:08.812552
NCT00471978|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2017-01-13|||September 2005||2005-09-01|January 2017|2017-01-01|September 2017|Anticipated|2017-09-01|June 2017|Anticipated|2017-06-01||Observational|||DNA Analysis of Blood and Tissue From Patients With Lung Cancer|Molecular and Genetic Analysis of Lung Cancer|Recruiting||N/A|6800|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"~     blood or tissue samples may be collected~   "|No||2017-02-18 15:38:08.920126|2017-02-18 15:38:08.920126
NCT00471965|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2010-09-17|||March 2007||2007-03-01|September 2010|2010-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|EACH||Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients|Oxaliplatin(Eloxatin®) + 5-FU/LV (FOLFOX4) Compared With Single Agent Doxorubicin (Adriamycin®) as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients Ineligible for Curative Resection or Local Treatment|Completed||Phase 3|371|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:38:09.032985|2017-02-18 15:38:09.032985
NCT00471952|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2012-04-24|||April 2007||2007-04-01|April 2012|2012-04-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache|Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache|Completed||Phase 3|50|Actual|Diamond Headache Clinic||3|||f||||f||||||||||2017-02-18 15:38:09.129821|2017-02-18 15:38:09.129821
NCT00471939|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2009-03-02|||April 2007||2007-04-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy of I-020502 in Meshed Skin Autografting|A Phase II, Multi-Centre, Controlled Study of the Safety and Efficacy of Wound Healing Gel I-020502 (KUR-212) in Patients Undergoing Autologous Meshed Skin Grafting.|Completed||Phase 2|10|Actual|Kuros Biosurgery AG||1|||f||||f||||||||||2017-02-18 15:38:09.235404|2017-02-18 15:38:09.235404
NCT00471926|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2007-05-09|||April 2007||2007-04-01|May 2007|2007-05-01|April 2008|Anticipated|2008-04-01|||||Observational|DQIP-DCMP||Diabetes Quality Improvement Program on Diabetes Case Management Program 2001|Diabetes Quality Improvement Program on Diabetes Case Management Program 2001|Unknown status|Recruiting|N/A|20000|Anticipated|China Medical University Hospital|||||f||||t||||||||||2017-02-18 15:38:09.31953|2017-02-18 15:38:09.31953
NCT00471913|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2011-04-13|||April 2007||2007-04-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Functional Outcome and MRI of Muscle Damage Following Nailing Procedure in Femur (Thigh) Fractures Using Different Entry Points|Functional Outcome and MR Imaging of Abductor Damage Following Antegrade Femoral Nailing With Different Entry Points: A Prospective Randomized Trial|Completed||N/A|60|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 15:38:09.400815|2017-02-18 15:38:09.400815
NCT00471900|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2007-05-09|||October 2001||2001-10-01|May 2007|2007-05-01|February 2003|Actual|2003-02-01|||||Interventional|||Six Months DHEA Treatment in Female Adrenal Failure|Physiolocal Effects of 6 Months DHEA Substitutional Therapy in Female Adrenal Failure in a Randomised, Placebo Controlled and Overcrossed Study.|Completed||N/A|10|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:38:09.490103|2017-02-18 15:38:09.490103
NCT00471887|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2016-01-28|||January 2007||2007-01-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|July 2011|Actual|2011-07-01||Interventional|||Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma|A Phase II, Open-Label, Single Arm Clinical Trial to Study the Mechanism of Action of CP-675,206 in Patients With In-Transit and Metastatic Melanoma Amenable to Repeated Outpatient Tumor Biopsies|Completed||Phase 2|34|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:38:09.559838|2017-02-18 15:38:09.559838
NCT00471874|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2007-12-11|||April 2007||2007-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Observational|||Study Evaluating Health Related Utility in Rheumatoid Arthritis|An Observational Study to Examine the Relationship Between Rheumatoid Arthritis Disease Severity and Health Related Utility|Completed||N/A|250|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||f||||||||||2017-02-18 15:38:09.665011|2017-02-18 15:38:09.665011
NCT00471861|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2011-08-05|||May 2007||2007-05-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|||||Observational|||Inflammatory Markers in Patients With Active Migraine Headaches|Does Migraine As A Partly Inflammatory Disease Increase The Inflammatory Markers Of The Patient When Actively Having a Migraine?|Completed||N/A|30|Actual|Westside Family Medical Center, P.C.|||1||f||||f||||||||||2017-02-18 15:38:09.737297|2017-02-18 15:38:09.737297
NCT00471848|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2012-08-23|||August 2008||2008-08-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|September 2010|Actual|2010-09-01||Interventional|RATGAA07||Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia|Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia and Comparison With Matched Historical Patients Treated With Horse ATG and Ciclosporin|Unknown status|Active, not recruiting|Phase 2|35|Actual|European Group for Blood and Marrow Transplantation||1|||f||||t||||||||||2017-02-18 15:38:09.818165|2017-02-18 15:38:09.818165
NCT00471835|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2017-01-17|||January 2007||2007-01-01|June 2013|2013-06-01||||||||Interventional|||Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer|A Phase I/II Study of Hypofractionated Stereotactic Body Radiotherapy for Stage I/II Non-small Cell Lung Cancer Within the Central Lung Region and the Prognostic Impact of FDG Positron Emission Tomography|Withdrawn||Phase 1/Phase 2|0|Actual|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 15:38:10.17942|2017-02-18 15:38:10.17942
NCT00471822|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2013-09-18|2012-10-03||July 2005||2005-07-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Nasopharyngeal Streptococcus Pneumoniae Carriage|An Evaluation of Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Taiwanese Children Attending Pediatric Clinics in Hospitals, Day Care Centers, or Kindergartens|Completed||N/A|9707|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:38:10.280316|2017-02-18 15:38:10.280316
NCT00471809|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2016-07-28|||March 2006||2006-03-01|April 2012|2012-04-01|March 2007|Actual|2007-03-01|||||Interventional|MARS||Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)|Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)|Terminated||Phase 4|210||National Heart, Lung, and Blood Institute (NHLBI)||||"The CARE Network DSMB recommended to the NHLBI that the MARS trial be terminated, based on a~   futility analysis with 55 randomized children."|f||||t||||||||||2017-02-18 15:38:10.583804|2017-02-18 15:38:10.583804
NCT00471796|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2007-05-09||||||April 2007|2007-04-01||||||||Interventional|||A Comparison of Factors of Symptoms Generation and Evaluation of Role of Biofeedback in Patients With Different Types of Functional Esophageal Disorders (Functional Heartburn and Functional Chest Pain)||Unknown status|Not yet recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:38:10.688708|2017-02-18 15:38:10.688708
NCT00471783|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2008-08-13|||April 2006||2006-04-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Flossing With Chlorhexidine|The Effects of Flossing With a Chlorhexidine Solution on Interproximal Gingivitis: a Randomized Controlled Trial|Completed||Phase 3|66|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 15:38:10.765273|2017-02-18 15:38:10.765273
NCT00471770|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2008-03-12|||February 2007||2007-02-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Pneumoniae Epidemiology Study in China|Epidemiological Study of Hospitalized Pediatric Pneumonia in China|Completed||N/A|1000|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||3||f||||t||||||Samples Without DNA|"~     deep respiratory aspirate,pleural fluid,cerebrospinal fluid,serum~   "|||2017-02-18 15:38:10.859324|2017-02-18 15:38:10.859324
NCT00471757|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2015-12-16|||May 2007||2007-05-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|CAP||Etiology of Community Acquired Pneumonia|Etiology of Community Acquired Pneumonia|Active, not recruiting||N/A|200|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:38:10.948286|2017-02-18 15:38:10.948286
NCT00471744|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2009-01-28|||June 2006||2006-06-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|||||Interventional|HEAD||HEAD-Study Optimizing the Treatment of Children With BECTS|HEAD-TO-HEAD Evaluation of the Antiepileptic Drugs Levetiracetam (LEV) vs. Sulthiame (STM) in a German Multi-Centre, Doubleblind Controlled Trial in Children With Benign Epilepsy With Centro-Temporal Spikes|Terminated||Phase 3|44|Actual|Ludwig-Maximilians - University of Munich||2||low patient number after 2 years recruiting|f||||t||||||||||2017-02-18 15:38:11.039724|2017-02-18 15:38:11.039724
NCT00471731|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2017-01-24|||May 7, 2007||2007-05-07|November 13, 2014|2014-11-13|November 13, 2014||2014-11-13|||||Observational|||Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure|Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome|Completed||N/A|72|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:38:11.128557|2017-02-18 15:38:11.128557
NCT00471718|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2012-06-27|2011-10-26||January 2004||2004-01-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase1/2 Trial of ABT-751 in Patients With Advanced, Androgen-Independent Prostate Cancer|Terminated||Phase 1/Phase 2|27|Actual|Vanderbilt-Ingram Cancer Center||1||pharmaceutical company closed study because the treatment was not effective|f||||t||||||||||2017-02-18 15:38:11.221199|2017-02-18 15:38:11.221199
NCT00471705|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2010-07-15|2010-06-14||June 2006||2006-06-01|June 2009|2009-06-01|December 2009|Actual|2009-12-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.|Phase 3 Open-label Study of Efficacy and Safety of Miltefosine or Thermotherapy vs Glucantime for Cutaneous Leishmaniasis in Colombia.|Completed||Phase 3|437|Actual|Universidad de Antioquia||3|||f||||f||||||||||2017-02-18 15:38:11.560839|2017-02-18 15:38:11.560839
NCT00471692|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2015-10-26|||October 2006||2006-10-01|October 2015|2015-10-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Local Anaesthetic Following Hernia Repair|A Randomised, Double Blind, Placebo Controlled Study to Compare Ilio Inguinal Nerve Block and Local Wound Irrigation|Terminated||Phase 1|12|Actual|Royal Hobart Hospital||2||Due to high incidence of neurological complication in those with ilioinguinal block|f||||f||||||||||2017-02-18 15:38:12.087672|2017-02-18 15:38:12.087672
NCT00471679|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2013-03-04|||April 2007||2007-04-01|March 2013|2013-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma|Phase I Study of an Ethanol-Lock Strategy to Prevent Central Venous Catheter Infections Among Patients With High-Risk Neuroblastoma|Completed||Phase 1|12|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:38:12.197633|2017-02-18 15:38:12.197633
NCT00471666|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2017-01-24|||May 7, 2007||2007-05-07|January 31, 2012|2012-01-31|January 31, 2012||2012-01-31|||||Observational|||Medical Implications of Coinfection With Malaria and Filariasis Parasites|Coinfection With Plasmodium Falciparum and Wuchereria Bancrofti: Clinical, Epidemiologic and Immunologic Implications|Completed||N/A|1039|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:38:12.30772|2017-02-18 15:38:12.30772
NCT00471653|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2009-11-06|||November 2006||2006-11-01|July 2009|2009-07-01||||December 2008|Anticipated|2008-12-01||Interventional|||Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy|A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide|Unknown status|Active, not recruiting|N/A|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:38:12.388961|2017-02-18 15:38:12.388961
NCT00471640|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2010-09-24|||November 2007||2007-11-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|Ovidius||Dexamethasone Infusion in Community-acquired Pneumonia|Dexamethasone Infusion in Community-acquired Pneumonia|Completed||N/A|300|Anticipated|St. Antonius Hospital||2|||f||||t||||||||||2017-02-18 15:38:12.485907|2017-02-18 15:38:12.485907
NCT00471627|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2008-06-09|||December 2006||2006-12-01|June 2008|2008-06-01||||December 2008|Anticipated|2008-12-01||Interventional|||New Type of a Pancreaticojejunostomy|New Type of a Pancreaticojejunostomy - a Pilot Study|Unknown status|Recruiting|Phase 1|30|Anticipated|University of Tampere||1|||f||||f||||||||||2017-02-18 15:38:12.58742|2017-02-18 15:38:12.58742
NCT00471614|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2012-05-15|||April 2007||2007-04-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine|Uridine Supplementation, Mitochondrial Function, and Glucose Metabolism in HIV|Completed||Phase 2|3|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 15:38:12.66509|2017-02-18 15:38:12.66509
NCT00471601|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2016-03-07|||March 2007||2007-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions|Measuring Patient Expectations for Breast Reconstruction: Development and Validation of a Patient-Reported Outcomes Instrument|Active, not recruiting||N/A|357|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:38:12.778694|2017-02-18 15:38:12.778694
NCT00471588|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2014-09-11|||August 2006||2006-08-01|September 2014|2014-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors|Dopamine D2/D3 Receptor Agonist and Antagonist Drug Effects on Fronto-striatal Systems Related to Compulsive Behaviour in Healthy Volunteers and Patients With Addictive and Compulsive Disorders|Completed||Phase 1|52|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:38:12.883501|2017-02-18 15:38:12.883501
NCT00471575|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2007-05-13|||June 2007||2007-06-01|April 2007|2007-04-01|December 2007|Anticipated|2007-12-01|||||Observational|||Fatty Liver in Pregnancy|Prospective Observational Study|Unknown status|Not yet recruiting|N/A|||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:38:12.981593|2017-02-18 15:38:12.981593
NCT00471562|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2013-02-27|||March 2007||2007-03-01|June 2012|2012-06-01||||October 2009|Actual|2009-10-01||Interventional|||Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors|Phase I Clinical Trial of Angiotensin 1-7 for Advanced Solid Tumors|Completed||Phase 1|18|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 15:38:13.073538|2017-02-18 15:38:13.073538
NCT00471549|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2007-05-09|||June 1991||1991-06-01|May 2007|2007-05-01|December 1993|Actual|1993-12-01|||||Interventional|||Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes|Simvastatin Reduces Plasma Osteoprotegerin in Type 2 Diabetic Patients With Microalbuminuria|Completed||Phase 4|18|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 15:38:13.160699|2017-02-18 15:38:13.160699
NCT00471536|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2014-05-22|2013-02-13||August 2008||2008-08-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|July 2010|Actual|2010-07-01||Interventional|||Pazopanib in Treating Patients With Metastatic Urothelial Cancer|A Phase II Safety and Efficacy Study With the VEGF Receptor Tyrosine Kinase Inhibitor GW786034 in Patients With Metastatic Urothelial Cancer|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:38:13.251356|2017-02-18 15:38:13.251356
NCT00471523|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2007-05-08|||May 2006||2006-05-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Treatment of Anovulatory Infertility in PCOS Patients|Clomiphene Citrate Versus Metformin as First-Line Approach for the Treatment of Anovulation in Infertile Patients With Polycystic Ovary Syndrome|Completed||Phase 4|80|Actual|University Magna Graecia||2|||f||||f||||||||||2017-02-18 15:38:13.820787|2017-02-18 15:38:13.820787
NCT00471510|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2008-05-16|||May 2007||2007-05-01|May 2008|2008-05-01||||February 2008|Actual|2008-02-01||Interventional|||Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss|A Phase 2 Multicenter, Randomized, Placebo-Controlled, Parallel Group Dose-Ranging Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopecia in Men|Unknown status|Active, not recruiting|Phase 2|140|Actual|Neosil, Inc.||4|||f||||f||||||||||2017-02-18 15:38:13.922972|2017-02-18 15:38:13.922972
NCT00471497|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2016-11-27|2013-04-10||July 2007||2007-07-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|September 2009|Actual|2009-09-01||Interventional|ENESTnd|Patients in the Full Analysis Set (FAS) were analyzed according to the treatment they were randomized to regardless of actual treatment received.|A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|A Phase III Multi-center, Open-label, Randomized Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|Active, not recruiting||Phase 3|852|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:38:14.062407|2017-02-18 15:38:14.062407
NCT00471484|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2011-06-21|||March 2007||2007-03-01|November 2008|2008-11-01||||||||Interventional|||Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery|A Phase II Trial of Oxaliplatin/Adriamycin/5 Fluorouracil in Continuous Infusion / Interferon α-2b (OXAFI) Combination as Neoadjuvant Therapy in Unresectable Non-Metastatic Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|54|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:38:15.889706|2017-02-18 15:38:15.889706
NCT00471471|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2015-05-29|||October 2008||2008-10-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery|Safety and Immunogenicity of Vaccination With Multi-Epitope Peptide Vaccine Containing MART-1, gp100, and Tyrosinase Peptides Given With the Combination of GMCSF and CpG Oligonucleotide (CpG 7909) in ISA-Oil Adjuvant for Patients With Recurrent Inoperable Stage III or Stage IV Melanoma|Completed||Phase 1|22|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 15:38:16.005258|2017-02-18 15:38:16.005258
NCT00471458|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-09|2007-05-09|||January 1969||1969-01-01|May 2007|2007-05-01|December 2003|Actual|2003-12-01|||||Observational|||Follow-up Study of the RAI-Treated Hyperthyroid Patients|Follow-up Study of Hyperthyroid Patients Treated With RAI in 1965-2002: Morbidity in Long-Term Follow-up|Completed||N/A|5222|Actual|University of Tampere|||||f||||f||||||||||2017-02-18 15:38:16.12636|2017-02-18 15:38:16.12636
NCT00471445|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2015-10-13|2014-08-20||October 2007||2007-10-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|September 2013|Actual|2013-09-01||Interventional||The number of 458 does not include 2 subjects from the Placebo cream and 2 subjects from the Amitriptyline and ketamine hydrochloride topical analgesic cream group who did not provide baseline data.|Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients|Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)|Completed||Phase 3|462|Actual|University of Rochester|Since ketamine and amitriptyline are both analgesics, it is possible that the effects of the ketamine plus amitriptyline-containing creams may have been diluted when all three neuropathy symptoms were assessed together.|2|||f||||t||||||||||2017-02-18 15:38:16.230379|2017-02-18 15:38:16.230379
NCT00471432|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2010-11-07|||March 2003||2003-03-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors|A Phase I Study of a Second Generation Clusterin Antisense Oligonucleotide (OGX-011) in Combination With Docetaxel|Completed||Phase 1|30|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 15:38:17.776503|2017-02-18 15:38:17.776503
NCT00470171|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2009-02-02|||October 2005||2005-10-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|URSONASH||Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis|Efficacy and Safety of Ursodesoxycholic Acid in the Management of Non-Alcoholic Steatohepatitis|Completed||Phase 2|98|Anticipated|Axcan Pharma||2|||f||||f||||||||||2017-02-18 15:38:17.876567|2017-02-18 15:38:17.876567
NCT00471419|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2012-06-03|||July 2006||2006-07-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye|Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye|Completed||Phase 3|750|Anticipated|Alcon Research|||||||||||||||||||2017-02-18 15:38:17.960269|2017-02-18 15:38:17.960269
NCT00471406|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2008-10-16||||||October 2008|2008-10-01||||||||Interventional|||Photodynamic Therapy With Verteporfin for Corneal Neovascularization||Completed||N/A|||Chonnam National University Hospital|||||f||||||||||||||2017-02-18 15:38:18.049677|2017-02-18 15:38:18.049677
NCT00471393|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2007-05-07|||May 2006||2006-05-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease|Double-Blind Randomized Clinical Study on Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease in Women.|Completed||N/A|28|Actual|University of Alberta, Graduate Orthodontic Program||2|||f||||t||||||||||2017-02-18 15:38:18.130667|2017-02-18 15:38:18.130667
NCT00471380|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2010-03-10|2009-11-04||March 2007||2007-03-01|March 2010|2010-03-01||||October 2008|Actual|2008-10-01||Interventional|||A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension|A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension|Completed||Phase 4|46|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 15:38:18.248936|2017-02-18 15:38:18.248936
NCT00471367|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2009-09-23|||April 2007||2007-04-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|||||Interventional|||Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877|A Phase I, Open-Label, Multi-Center, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 Administered Twice a Week in Adult Patients With Advanced Solid Malignancies Including Lymphoma|Terminated||Phase 1|44|Anticipated|AstraZeneca||1||Part B of the study was terminated early due to a lack of enrollment.|f||||||||||||||2017-02-18 15:38:18.508167|2017-02-18 15:38:18.508167
NCT00471354|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2010-01-04|2009-11-19||April 2007||2007-04-01|January 2010|2010-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine|Evaluation of Academic Performance in Asian Children Aged 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine Hydrochloride|Completed||Phase 4|228|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:38:18.60648|2017-02-18 15:38:18.60648
NCT00471341|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2011-09-16|||July 2002||2002-07-01|May 2007|2007-05-01|December 2004|Actual|2004-12-01|||||Interventional|||Effect of Celecoxib on Markers of Vascular Inflammation|A Pilot Study to Determine the Effect of Celecoxib on Markers of Inflammation in Patients With Hypertension and Coronary Artery Disease|Completed||Phase 4|75||University of Florida|||||f||||f||||||||||2017-02-18 15:38:19.0601|2017-02-18 15:38:19.0601
NCT00471328|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2012-06-05|2011-01-12||March 2007||2007-03-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|August 2008|Actual|2008-08-01||Interventional|ENEST||Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib|A Randomized, Open-label, Multi-center Study to Evaluate the Efficacy of Nilotinib Versus Best Supportive Care With or Without a Tyrosine Kinase Inhibitor (Investigator's Choice) in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Both Imatinib and Sunitinib|Completed||Phase 3|248|Actual|Novartis||2|||f||||t||||||||||2017-02-18 15:38:19.174019|2017-02-18 15:38:19.174019
NCT00471315|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2013-12-18|2013-10-23||July 2006||2006-07-01|February 2009|2009-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|SOD||Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction)|Pilot Study of the Efficacy and Tolerability of Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction).|Completed||Phase 3|18|Actual|Medical University of South Carolina|Most frequently reported adverse events included fatigue, nausea, headaches, constipation, decreased appetite and insomnia at primarily mild to moderate severity.|1|||f||||f||||||||||2017-02-18 15:38:20.378212|2017-02-18 15:38:20.378212
NCT00471302|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2017-01-24|||May 3, 2007||2007-05-03|November 23, 2016|2016-11-23||||||||Observational|||Normal Immunological Parameters Among Healthy Volunteers in Kambila, Mali|Establishment of Normal Immunological Parameters Among Healthy Volunteers in Kambila, Tieneguebougou and Kalifabougou, Mali|Recruiting||N/A|280|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:38:20.621379|2017-02-18 15:38:20.621379
NCT00471289|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2014-05-23|||August 2007||2007-08-01|May 2014|2014-05-01|March 2023|Anticipated|2023-03-01|September 2013|Actual|2013-09-01||Interventional|PADI||PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia|Percutaneous Transluminal Balloon Angioplasty (PTA) and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia|Active, not recruiting||Phase 2/Phase 3|144|Actual|Netherlands Society for Interventional Radiology||2|||f||||f||||||||||2017-02-18 15:38:20.723497|2017-02-18 15:38:20.723497
NCT00471276|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2011-07-21|2011-06-23||August 2007||2007-08-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer|A Phase II Study Of Sunitinib Malate Single Agent For The Treatment Of Women With Advanced Breast Cancer|Completed||Phase 2|83|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 15:38:20.855375|2017-02-18 15:38:20.855375
NCT00471263|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2008-04-04|||May 2007||2007-05-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|||||Interventional|||The Effects of Milk Proteins on Blood Pressure|The Effects of Casigold and Casimax on Blood Pressure in Subjects With Highnormal Blood Pressure or Mild Hypertension|Completed||N/A|84|Anticipated|TNO||3|||f||||f||||||||||2017-02-18 15:38:24.278612|2017-02-18 15:38:24.278612
NCT00471250|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2017-01-24|||May 3, 2007||2007-05-03|December 13, 2016|2016-12-13||||||||Observational|||Collection of Lung Fluid and Tissue Samples for Research|Research Respiratory Tract Procedures|Recruiting||N/A|550|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:38:24.372291|2017-02-18 15:38:24.372291
NCT00471237|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2016-11-15||2010-10-13|May 2007||2007-05-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.|Study CR9108963: A 12-month, Randomized, Double-blind, Parallel-group, Placebo and Active-controlled Dose-range Finding Study of the Efficacy and Safety of SB-751689 in Post-menopausal Women With Osteoporosis|Terminated||Phase 2|569|Actual|GlaxoSmithKline||4||Terminated for futility by sponsor after a pre-planned interim review of data|f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:38:24.4842|2017-02-18 15:38:24.4842
NCT00471224|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2011-02-16|||June 2007||2007-06-01|February 2011|2011-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product|A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Formulated Drug Product (LOT 8716-098).|Completed||N/A|16|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:38:24.662011|2017-02-18 15:38:24.662011
NCT00471211|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2008-01-13|||December 2006||2006-12-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease|A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Three-Group Study to Assess the Safety, Tolerability and Efficacy of Two Dose Levels of PBT2 to Slow Progression of Disease in Patients With Early Alzheimer's Disease|Completed||Phase 2|80|Anticipated|Prana Biotechnology Limited||3|||f||||t||||||||||2017-02-18 15:38:24.762335|2017-02-18 15:38:24.762335
NCT00471185|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2010-12-02|||June 2007||2007-06-01|December 2010|2010-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|ACY-6||ACY-6 Oral Administration of Acyline|Oral Administration of the GnRH Antagonist Acyline in Normal Men|Completed||Phase 1|9|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 15:38:24.860811|2017-02-18 15:38:24.860811
NCT00471159|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2015-04-30|||August 2007||2007-08-01|April 2015|2015-04-01||||||||Interventional|||A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.|A Randomized Phase 2 Clinical Trial Of Docetaxel With Or Without PF-3512676 As First-Line Treatment Of Patients With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|Pfizer|||||f||||||||||||||2017-02-18 15:38:25.063846|2017-02-18 15:38:25.063846
NCT00471146|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2012-06-14|2012-02-25||July 2007||2007-07-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|January 2009|Actual|2009-01-01||Interventional|||Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.|A Randomized, Double-Blind Phase 3 Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For The First-Line Treatment Of Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer.|Completed||Phase 3|630|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:38:25.206558|2017-02-18 15:38:25.206558
NCT00471133|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2011-06-03|||April 2007||2007-04-01|June 2011|2011-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation|A Phase Ia/Ib Study of the Safety and Immunogenicity of a Xenogeneic Tyrosinase DNA Vaccine Melanoma|Completed||Phase 1|24|Actual|Ichor Medical Systems Incorporated||1|||f||||f||||||||||2017-02-18 15:38:29.111863|2017-02-18 15:38:29.111863
NCT00471120|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2015-08-03|||November 2006||2006-11-01|August 2015|2015-08-01|February 2008|Actual|2008-02-01|April 2007|Actual|2007-04-01||Interventional|||Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer|Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women|Terminated||N/A|20|Actual|CytoCore, Inc.||1||Study terminated due to protocol deficiencies.|f||||t||||||||||2017-02-18 15:38:29.519558|2017-02-18 15:38:29.519558
NCT00471107|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2016-03-23|2012-01-17||May 2007||2007-05-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Effect of Electrical Stimulation (DC Polarization) to the Brain on Memory|Effect of Direct Current Brain Polarization on Verbal Memory|Completed||Phase 1/Phase 2|45|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-02-18 15:38:29.624292|2017-02-18 15:38:29.624292
NCT00471094|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2012-01-31|||May 2007||2007-05-01|January 2012|2012-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis|A Phase 2 Study to Evaluate the Safety and Efficacy of Ilaprazole (5 mg QD, 20 mg QD and 40 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis.|Completed||Phase 2|831|Actual|Takeda||4|||f||||f||||||||||2017-02-18 15:38:29.977738|2017-02-18 15:38:29.977738
NCT00471081|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2016-10-18||2009-09-03|July 2007||2007-07-01|October 2016|2016-10-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.|Study to Assess Immunogenicity, Reactogenicity and Safety of Primary Vaccination With GSK Biologicals' MenACWY Vaccine (GSK134612) Given as 1 or 2 Doses to Healthy Toddlers 9-12 Months of Age|Completed||Phase 2|385|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:38:30.184353|2017-02-18 15:38:30.184353
NCT00471068|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2012-04-07|2009-10-21||March 2007||2007-03-01|February 2010|2010-02-01||||August 2008|Actual|2008-08-01||Interventional|||Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension|Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension|Terminated||Phase 4|46|Actual|Alcon Research|Sample size smaller than the one defined by the protocol|2||Question raised by Ethics Committee|f||||f||||||||||2017-02-18 15:38:30.310679|2017-02-18 15:38:30.310679
NCT00471055|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2008-07-08|||June 2007||2007-06-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|OAknee||Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 0.0125% of Capsaicin to Placebo|Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 0.0125% of Capsaicin to Placebo|Completed||Phase 3|100|Actual|Khon Kaen University||2|||f||||t||||||||||2017-02-18 15:38:30.625131|2017-02-18 15:38:30.625131
NCT00471042|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2015-05-19|||June 2006||2006-06-01|May 2015|2015-05-01|August 2012|Actual|2012-08-01|August 2008|Actual|2008-08-01||Observational|||Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care|Buprenorphine for Treatment of Opioid Dependence in Primary Care|Completed||N/A|30|Actual|New York State Psychiatric Institute|||1||f||||f||||||||||2017-02-18 15:38:30.725453|2017-02-18 15:38:30.725453
NCT00471029|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-08|2007-05-08|||September 2005||2005-09-01|May 2007|2007-05-01|September 2007|Anticipated|2007-09-01|||||Interventional|NPH||Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer|Compare Gastric Acid Suppression of Esomeprazole by Oral or Intravenous Administration - A Randomized Trial|Unknown status|Recruiting|Phase 4|20|Anticipated|Pamela Youde Nethersole Eastern Hospital||2|||f||||t||||||||||2017-02-18 15:38:30.815404|2017-02-18 15:38:30.815404
NCT00471016|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2007-05-04|||June 2006||2006-06-01|May 2007|2007-05-01|September 2006|Actual|2006-09-01|||||Interventional|||An Intervention to Improve End of Life Decision Making Among Homeless Persons|An Intervention to Improve End of Life Decision Making Among Homeless Persons|Completed||N/A|59|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 15:38:30.970512|2017-02-18 15:38:30.970512
NCT00471003|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2010-01-19|||September 2006||2006-09-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|METABOLIC||The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension|A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients|Completed||N/A|5448|Actual|Bayer|||1||f||||f||||||||||2017-02-18 15:38:31.236105|2017-02-18 15:38:31.236105
NCT00470990|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2011-04-18|||October 2002||2002-10-01|April 2011|2011-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men|Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men|Completed||N/A|40|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 15:38:31.348519|2017-02-18 15:38:31.348519
NCT00470782|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2016-02-24|||October 2007||2007-10-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Aerobic Capacity and Body Composition in Colon Cancer Patients|Changes in Aerobic Capacity and Body Composition in Colon Cancer Patients Receiving Chemotherapy|Completed||N/A|40|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 15:38:34.27339|2017-02-18 15:38:34.27339
NCT00470977|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2012-10-24|||May 2007||2007-05-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|FVF4140S||Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy|Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy With Intravitreal Injection of Lucentis (Ranibizumab Injection)|Completed||Phase 1/Phase 2|18|Actual|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-02-18 15:38:31.460829|2017-02-18 15:38:31.460829
NCT00470964|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-06|2007-05-07||||||May 2007|2007-05-01||||||||Interventional|||Titanium-Sapphire Laser Trabeculoplasty in Glaucoma: A Randomized Study Comparing Titanium-Sapphire With Argon Laser Trabeculoplasty in Open-Angle Glaucoma Patients||Completed||N/A|||Goldschleger Eye Institute|||||t||||t||||||||||2017-02-18 15:38:31.571776|2017-02-18 15:38:31.571776
NCT00470951|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2012-08-16|||April 2006||2006-04-01|August 2012|2012-08-01|August 2014|Anticipated|2014-08-01|August 2012|Actual|2012-08-01||Interventional|CTS-179||Randomized Prospective Trial for Laparoscopic vs Open Resection for Rectal Cancer|A Comparison for Laparoscopically Assisted and Open Surgery for Advanced Rectal Cancer After Preoperative Chemoradiation- Randomized Prospective Trial|Unknown status|Active, not recruiting|Phase 3|340|Anticipated|National Cancer Center, Korea||2|||f||||t||||||||||2017-02-18 15:38:31.663393|2017-02-18 15:38:31.663393
NCT00470938|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2008-02-19|||March 2007||2007-03-01|February 2008|2008-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Randomized Controlled Trial of the Effects of Reactive Neuromuscular Training on Balance||Completed||Phase 1/Phase 2|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 15:38:31.773209|2017-02-18 15:38:31.773209
NCT00470925|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2010-12-28|||May 2007||2007-05-01|December 2010|2010-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|mZINT||Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects|Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects|Terminated||Phase 1|10|Anticipated|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 15:38:31.847163|2017-02-18 15:38:31.847163
NCT00470912|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2007-05-07|||May 2001||2001-05-01|May 2007|2007-05-01|February 2002|Actual|2002-02-01|||||Interventional|||Sunscreen RV 2457C in Photoinduced CLE|Photoprotective Effects of the RV 2457C Sunscreen Milk in Photoinduced Cutaneous Lupus Erythematosus|Completed||Phase 3|25|Actual|Heinrich-Heine University, Duesseldorf|||||f||||f||||||||||2017-02-18 15:38:31.957587|2017-02-18 15:38:31.957587
NCT00470899|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2015-04-06|||January 2005||2005-01-01|May 2007|2007-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Effect of Placental Drainage of Fetal Blood at Cesarean Section on the Incidence of Feto-Maternal Transfusion|Effect of Placental Drainage of Fetal Blood at Cesarean Section on the Incidence of Feto-Maternal Transfusion: A Randomized Controlled Trial|Completed||Phase 3|86|Actual|Lester E. Cox Medical Centers||2|||f||||t||||||||||2017-02-18 15:38:32.069232|2017-02-18 15:38:32.069232
NCT00470886|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2012-11-14|||April 2007||2007-04-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|COAST||Assessment of Compliance With Antihypertensive Telmisartan Therapy|A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy|Completed||N/A|3400|Actual|Bayer|||1||f||||f||||||||||2017-02-18 15:38:32.164575|2017-02-18 15:38:32.164575
NCT00470873|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2014-11-26|||January 2007||2007-01-01|November 2014|2014-11-01|February 2008|Actual|2008-02-01|||||Observational|||Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men|A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Obtain Data on Safety and Efficacy of Levitra® in Routine Treatment of Erectile Dysfunction in Depressive and Non-Depressive Men.|Completed||N/A|2471|Actual|Bayer|||1||f||||f||||||||||2017-02-18 15:38:32.258863|2017-02-18 15:38:32.258863
NCT00470860|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2007-05-07|||December 2004||2004-12-01|May 2007|2007-05-01|August 2005|Actual|2005-08-01|||||Interventional|||Educational Technology to Enhance Diabetes Care - Retention Study||Completed||N/A|105|Actual|University of California, Los Angeles||6|||f||||f||||||||||2017-02-18 15:38:32.355646|2017-02-18 15:38:32.355646
NCT00470847|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2014-04-28|2013-09-10||April 2007||2007-04-01|April 2014|2014-04-01|June 2012|Actual|2012-06-01|December 2009|Actual|2009-12-01||Interventional|||Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer|A Phase I Study of Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer|Completed||Phase 1|35|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:38:32.437896|2017-02-18 15:38:32.437896
NCT00470834|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2016-11-18|2013-08-29||May 2007||2007-05-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy|A Randomized Double-Blind Parallel Group Study Comparing Casodex (or Generic Equivalent) 50mg Plus Placebo to Casodex (or Generic Equivalent) 50mg Plus Dutasteride 3.5mg Administered for 18 Months to Men With Prostate Cancer Who Have Failed First-Line Androgen Deprivation Therapy (Assessed by Rising PSA) Followed by a Two-Year Extension Phase|Completed||Phase 4|127|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:38:32.853568|2017-02-18 15:38:32.853568
NCT00470821|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2010-07-26|||May 2007||2007-05-01|January 2010|2010-01-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Oral Melatonin in Critically Ill High-risk Patients|Randomized, Controlled, Double Blind Trial to Evaluate Sedation and Quality of Life in High-risk, Critically Ill Patients Treated With Oral Melatonin|Completed||Phase 4|96|Actual|University of Milan||2|||f||||f||||||||||2017-02-18 15:38:33.812817|2017-02-18 15:38:33.812817
NCT00470808|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2007-05-07|||May 2007||2007-05-01|April 2007|2007-04-01|August 2007|Anticipated|2007-08-01|||||Interventional|POMX||The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients||Unknown status|Not yet recruiting|Phase 4|||HaEmek Medical Center, Israel|||||f||||f||||||||||2017-02-18 15:38:34.090288|2017-02-18 15:38:34.090288
NCT00470795|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2008-12-14|||June 2009||2009-06-01|December 2008|2008-12-01|September 2010|Anticipated|2010-09-01|June 2010|Anticipated|2010-06-01||Interventional|||Acupuncture for Diabetic Gastroparesis|A Randomized, Placebo/Sham-Controlled, Double-Blind Crossover Study to Assess the Efficacy of Acupuncture in the Treatment of Diabetic Gastroparesis.|Suspended||Phase 3|40|Anticipated|Shaare Zedek Medical Center||2||Protocol to be re-designed (primary outome still GCSI)|f||||f||||||||||2017-02-18 15:38:34.171654|2017-02-18 15:38:34.171654
NCT00470769|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2007-05-07|||September 2006||2006-09-01|May 2007|2007-05-01|May 2007|Anticipated|2007-05-01|||||Observational|||The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR|Color-Doppler Ultrasonography vs 99mTc-DTPA Scintigraphy to Assess the Renal Blood Flow|Unknown status|Recruiting|N/A|2006|Anticipated|University of Roma La Sapienza|||||f||||f||||||||||2017-02-18 15:38:34.358631|2017-02-18 15:38:34.358631
NCT00470756|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-06|2011-05-11|||March 2008||2008-03-01|April 2011|2011-04-01||||March 2012|Anticipated|2012-03-01||Observational|||Forefoot Adduction (FFA) in Infants and Toddlers. Differences of Neuromuscular Activity.|Difference of Neuromuscular Activity in Infants and Toddlers With Foot Dorsiflexion Compare to Infants and Toddlers With Foot Plantarflexion|Suspended||Phase 2|20|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 15:38:34.451301|2017-02-18 15:38:34.451301
NCT00470743|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2015-09-01|||May 2007||2007-05-01|June 2009|2009-06-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies|A Randomised Controlled Trial Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus In Very Premature Infants|Withdrawn||Phase 4|0|Actual|KK Women's and Children's Hospital||2||Funding withdrawn|f||||f||||||||||2017-02-18 15:38:34.537342|2017-02-18 15:38:34.537342
NCT00470717|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2010-12-27|||November 2008||2008-11-01|December 2010|2010-12-01|January 2010|Actual|2010-01-01|February 2009|Actual|2009-02-01||Interventional|||Feeding and Wellness Among Late Preterm Infants|Early Feeding and Wellness Among Late Preterm Infants Born at MacDonald Women's Hospital: A Feasibility Study for a Breastfeeding Intervention|Completed||N/A|38|Actual|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-02-18 15:38:34.650681|2017-02-18 15:38:34.650681
NCT00470704|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2017-01-03|||May 2007||2007-05-01|November 2015|2015-11-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer|A Phase 2 Study of Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer|Active, not recruiting||Phase 2|116|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||Undecided||2017-02-18 15:38:34.738124|2017-02-18 15:38:34.738124
NCT00470691|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2015-04-07|||June 2004||2004-06-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||Dorsal Splint or Circular Cast for Colles' Fracture?|Comparison of Dorsal Plaster Splint and Circular Plaster Cast for Colles' Fractures|Completed||N/A|72|Actual|St. Olavs Hospital||2|||f||||f||||||||||2017-02-18 15:38:34.860277|2017-02-18 15:38:34.860277
NCT00470678|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2016-11-16|||June 2007||2007-06-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)|An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Ranibizumab (0.5 mg) in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration Over 12 Months|Completed||Phase 3|95|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:38:34.960137|2017-02-18 15:38:34.960137
NCT00470665|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2007-05-07|||August 2002||2002-08-01|May 2007|2007-05-01|July 2004||2004-07-01|||||Interventional|||Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients|An Open-Label, Concentration-Controlled, Randomized, 12-Month Study of Prograf + Rapamune + Corticosteroids Compared to Cyclosporine,USP (Modified) + Rapamune + Corticosteroids in High Risk Renal Allograft Recipients|Completed||Phase 3|460||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:38:35.078653|2017-02-18 15:38:35.078653
NCT00470652|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2009-01-26|||May 2007||2007-05-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|||||Observational|||Management of Acute Pain in the Emergency Department|Management of Acute Pain in the Emergency Department:Impact of a Computer-Assisted Support|Completed||N/A|631|Actual|Centre Hospitalier Universitaire Vaudois|||3||f||||f||||||||||2017-02-18 15:38:35.158139|2017-02-18 15:38:35.158139
NCT00470639|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2008-09-25|||April 2007||2007-04-01|September 2008|2008-09-01|April 2010|Anticipated|2010-04-01|||||Interventional|||Transcranial Magnetic Stimulation for Bipolar Depression|A Comparison of Left vs. Right Prefrontal Cortex Transcranial Magnetic Stimulation as a Treatment for Bipolar Depression|Suspended||Phase 1/Phase 2|100|Anticipated|The University of New South Wales||3||Poor recruitment|f||||f||||||||||2017-02-18 15:38:35.26964|2017-02-18 15:38:35.26964
NCT00470626|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-12-21|2010-02-03||November 2005||2005-11-01|December 2015|2015-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Celect Vena Cava Filter Clinical Trial|Prospective Study of the Cook Celect Filter, Including Permanent and Retrievable Use|Completed||N/A|129|Actual|Cook||1|||f||||t||||||||||2017-02-18 15:38:35.385943|2017-02-18 15:38:35.385943
NCT00470613|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2016-09-14|||February 2008||2008-02-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Safety Study of Infusion of SGT-53 to Treat Solid Tumors|A Phase I Open-Label Safety and Pharmacokinetic Study of Escalating Doses of SGT-53 for Infusion in Subjects With Advanced Solid Tumors|Active, not recruiting||Phase 1|12|Anticipated|SynerGene Therapeutics, Inc.||1|||f||||t||||||||||2017-02-18 15:38:35.835025|2017-02-18 15:38:35.835025
NCT00470600|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2015-08-03|2011-04-07||May 2007||2007-05-01|August 2015|2015-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orthopedic Patients|A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF IBUPROFEN INJECTION (IVIb) FOR TREATMENT OF PAIN IN POST-OPERATIVE ORTHOPEDIC ADULT PATIENTS|Completed||Phase 3|185|Actual|Cumberland Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:38:35.945635|2017-02-18 15:38:35.945635
NCT00470587|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-07|2016-09-12|||April 2006||2006-04-01|September 2016|2016-09-01|June 2019|Anticipated|2019-06-01|September 2018|Anticipated|2018-09-01||Observational|APACE||Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) Study|Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) Study|Recruiting||N/A|6000|Anticipated|University Hospital, Basel, Switzerland|||1||f||||t||||||Samples Without DNA|"~     EDTA plasma, Heparin, Serum, Citrate~   "|||2017-02-18 15:38:36.412561|2017-02-18 15:38:36.412561
NCT00470574|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-03-28|||March 2007||2007-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer|Pilot Study of Immunization of High Risk Breast Cancer Patients With a Sialyl Lewisª -Keyhole Limpet Hemocyanin Conjugate Plus the Immunological Adjuvant QS-21|Active, not recruiting||N/A|7|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:38:36.537897|2017-02-18 15:38:36.537897
NCT00470561|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2010-11-10|||November 2005||2005-11-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Aspirin on Mammogram Density in Healthy Postmenopausal Women With a Moderate or High Level of Breast Density|The Effect of Aspirin on Mammogram Density (TEAM)|Completed||N/A|144|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 15:38:36.645812|2017-02-18 15:38:36.645812
NCT00470548|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-11-13|||April 2007||2007-04-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|UCDCC#185||Abraxane and Alimta in Advanced Solid Tumors|Phase I/II Trial of Abraxane® (ABI-007) and Alimta® (Pemetrexed) in Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer (NSCLC) and Breast Cancer|Completed||Phase 1/Phase 2|49|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 15:38:36.752149|2017-02-18 15:38:36.752149
NCT00470535|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-12-03|2014-12-03||January 2007||2007-01-01|December 2014|2014-12-01|September 2010|Actual|2010-09-01|January 2009|Actual|2009-01-01||Interventional|||Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer|Phase II Study of Erlotinib (Tarceva®) in Patients With Advanced Pancreatic Adenocarcinoma|Terminated||Phase 2|18|Actual|Roswell Park Cancer Institute|This study was terminated earlier due to a phase III study that showed this drug was not better than sorafenib|1||"This study was terminated earlier due to a phase III study that showed this drug inferior to~   sorafenib"|f||||t||||||||||2017-02-18 15:38:36.864609|2017-02-18 15:38:36.864609
NCT00470522|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2007-05-04|||June 1995||1995-06-01|May 2007|2007-05-01|December 2001|Actual|2001-12-01|||||Interventional|SMILE||Study of Methotrexate in Lupus Erythematosus|A Canadian Multicenter, Randomized, Double-Blind Placebo-Controlled Study of Methotrexate and Folic Acid in Systemic Lupus Erythematosus: A Phase III Trial.|Completed||Phase 3|86|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 15:38:37.298567|2017-02-18 15:38:37.298567
NCT00470509|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2008-06-06|||May 2005||2005-05-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|ASAS||Adalimumab in Severe and Acute Sciatica|Adalimumab in Severe and Acute Sciatica|Completed||Phase 2|61|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 15:38:37.398915|2017-02-18 15:38:37.398915
NCT00470496|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-09-20|||October 2006||2006-10-01|September 2016|2016-09-01||||October 2011|Actual|2011-10-01||Interventional|||Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer|A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer|Active, not recruiting||Phase 1|15|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 15:38:37.488991|2017-02-18 15:38:37.488991
NCT00470483|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-03-15|||January 2007||2007-01-01|February 2011|2011-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder|A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, fMRI and PET Study Comparing Emotional Challenge-induced Regional Cerebral Blood Flow Changes Before and After 8 Weeks of Treatment With Placebo and Paroxetine in Subjects With Social Anxiety Disorder|Completed||Phase 1|56|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 15:38:37.612387|2017-02-18 15:38:37.612387
NCT00470470|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-12-15|2014-03-19||April 2007||2007-04-01|January 2014|2014-01-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|||Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery|A Phase II Study of Imatinib Mesylate (STI571;NSC#716051:IND 61135) in Patients With Inoperable AJCC Stage III or IV Melanoma Harboring Somatic Alterations of C-KIT|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:38:37.726195|2017-02-18 15:38:37.726195
NCT00470457|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2015-12-02|||June 2001||2001-06-01|December 2015|2015-12-01|March 2005|Actual|2005-03-01|||||Interventional|||A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy|A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy in Grass and/or Tree Pollen Allergic Subjects by Intralymphatic Allergen Administration|Completed||Phase 2|156|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 15:38:38.210086|2017-02-18 15:38:38.210086
NCT00470444|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2015-07-30|||December 2006||2006-12-01|November 2008|2008-11-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|TTRICS||Transfusion Triggers in Cardiac Surgery|Transfusion Triggers in Cardiac Surgery|Completed||N/A|50|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-02-18 15:38:38.332705|2017-02-18 15:38:38.332705
NCT00470158|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2011-08-10|2011-08-10||May 2007||2007-05-01|December 2009|2009-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes|Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes|Completed||Phase 4|1000|Actual|Johns Hopkins Bloomberg School of Public Health||5|||f||||t||||||||||2017-02-18 15:38:38.457483|2017-02-18 15:38:38.457483
NCT00470145|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-05-31|||April 2007||2007-04-01|February 2011|2011-02-01|July 2007|Actual|2007-07-01|||||Interventional|||Comparison Of Two Tablet Formulations Of SB-568859|A Randomised, Single Blind, 2 Period, Crossover Study to Compare the Single Dose Pharmacokinetics and Tolerability of Formulations Containing Unmilled and Micronised SB-568859 in Healthy Adults|Completed||Phase 1|28|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:38:39.154283|2017-02-18 15:38:39.154283
NCT00470132|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-08-23|||May 2007||2007-05-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Ventricular Shunt and Drain Infections - Timing of Reimplantation|Ventricular Shunt and Drain Infections - Timing of Reimplantation|Completed||N/A|400|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 15:38:39.245224|2017-02-18 15:38:39.245224
NCT00470119|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-09-07|||December 2004||2004-12-01|September 2012|2012-09-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Women|Exercise Diet and Sex Hormones in Postmenopausal Women (NEW)|Completed||N/A|439|Actual|Fred Hutchinson Cancer Research Center||4|||f||||t||||||||||2017-02-18 15:38:39.329852|2017-02-18 15:38:39.329852
NCT00470106|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2016-03-22|2015-10-14||September 2007||2007-09-01|March 2016|2016-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|IBASC||Improving Basic and Social Cognition in Veterans With Schizophrenia|Improving Basic and Social Cognition in Veterans With Schizophrenia|Completed||N/A|85|Actual|VA Office of Research and Development||4|||f||||t||||||||Undecided||2017-02-18 15:38:39.459916|2017-02-18 15:38:39.459916
NCT00470093|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-01-25|||August 2007||2007-08-01|January 2012|2012-01-01||||January 2010|Actual|2010-01-01||Interventional|||Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma|A Pilot Study of Differentiation Therapy in Multiple Myeloma Using Interleukin-6 and Interferon-a|Completed||N/A|4|Actual|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 15:38:40.021828|2017-02-18 15:38:40.021828
NCT00470080|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2011-05-03|||June 2007||2007-06-01|May 2007|2007-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|VIEP||Randomised Trial of Eutectic Mixture of Local Anaesthetics Cream and Oral Sucrose Solution for Venepuncture|Randomised Trial of Eutectic Mixture of Local Anaesthetics Cream and Oral Sucrose Solution for Venepuncture in Preterm Infants|Completed||Phase 4|80|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 15:38:40.136226|2017-02-18 15:38:40.136226
NCT00470067|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-08-08|2014-01-27||February 2007||2007-02-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|May 2008|Actual|2008-05-01||Interventional||All treated and eligible patients|Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer|A Multi-center Phase II Study of Doxil®/Carboplatin in Patients With Advanced or Recurrent Endometrial Carcinoma|Terminated||Phase 2|9|Actual|Roswell Park Cancer Institute|Due to the study’s early termination and inadequate number of patients, no patients were analyzed.|1||Due to low accrual|f||||t||||||||||2017-02-18 15:38:40.243937|2017-02-18 15:38:40.243937
NCT00470054|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2015-04-14|2013-01-02||April 2007||2007-04-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|February 2009|Actual|2009-02-01||Interventional||Only eligible participants (those who met the criteria for inclusion) were evaluated for baseline characteristics.|Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer|A Phase II Study of Dasatinib (NSC #732517) in Patients With Chemo-Sensitive Relapsed Small Cell Lung Cancer|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:38:40.514142|2017-02-18 15:38:40.514142
NCT00470041|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2010-06-15|||June 2007||2007-06-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers|Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers|Completed||Phase 1|12|Anticipated|University Ghent||1|||f||||f||||||||||2017-02-18 15:38:41.026211|2017-02-18 15:38:41.026211
NCT00470028|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2010-01-19|||April 2005||2005-04-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Transcranial Magnetic Stimulation: Treatment Trial for Depressed Adolescents|A Study of Transcranial Magnetic Stimulation (TMS) Treatment in Depressed Adolescents|Terminated||Phase 1/Phase 2|30|Anticipated|The University of New South Wales||||Low recruitment.|f||||f||||||||||2017-02-18 15:38:41.114053|2017-02-18 15:38:41.114053
NCT00470015|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-09-12|||March 2007||2007-03-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|April 2009|Actual|2009-04-01||Interventional|||Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma|Melanoma Peptide Vaccines (MART1 Analog, gp100 and Survivin) With GM-CSF and Low-Dose IL-2 as Immune Adjuvants, A Pilot Study|Active, not recruiting||Phase 1|20|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:38:41.209203|2017-02-18 15:38:41.209203
NCT00470002|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2007-05-04|||May 2004||2004-05-01|May 2007|2007-05-01|January 2005|Actual|2005-01-01|||||Interventional|||Effects of Growth Hormone on the Nitric Oxide Pathway|Effects of Growth Hormone (GH) on Parameters of the Nitric Oxide (NO) Pathway|Completed||Phase 1|16|Actual|Hannover Medical School||1|||f||||f||||||||||2017-02-18 15:38:41.329186|2017-02-18 15:38:41.329186
NCT00469989|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2008-01-02|||January 2007||2007-01-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Randomised Placebo Controlled Study of Effects of Therapeutic Hookworm Infection in Asthma|Randomised Placebo Controlled Study of Effects of Therapeutic Hookworm Infection in Asthma|Completed||N/A|30|Anticipated|University of Nottingham||1|||f||||t||||||||||2017-02-18 15:38:41.431238|2017-02-18 15:38:41.431238
NCT00469976|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2015-10-06|||June 2007||2007-06-01|October 2015|2015-10-01||||||||Interventional|||Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer|Phase II Trial of Enzastaurin Plus Carboplatin and Gemcitabine (ECoG) in Bevacizumab-Ineligible Patients and Enzastaurin Plus Carboplatin, Gemcitabine and Bevacizumab (B-ECoG) in Bevacizumab-Eligible Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 2|0|Actual|Eastern Cooperative Oncology Group||||ECOG will not proceed with activation|f||||f||||||||||2017-02-18 15:38:41.520579|2017-02-18 15:38:41.520579
NCT00469963|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-08-31|||December 2003||2003-12-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|October 2006|Actual|2006-10-01||Interventional|||Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery|Clinical Trial of Sir Spheres® in Patients With Primary Hepatocellular Carcinoma|Terminated||N/A|12|Actual|Vanderbilt-Ingram Cancer Center||1||slow accrual|f||||t||||||||||2017-02-18 15:38:41.60639|2017-02-18 15:38:41.60639
NCT00469950|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2015-04-13|||January 2006||2006-01-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|EFECTOR||The Effect of Training on Endothelial Function, Progression of Disease,Inflammation, Heart Rate Variability and Mental Health After Percutaneous Coronary Intervention|Effect of Exercise Training After Percutaneous Coronary Intervention|Completed||Phase 4|40|Anticipated|Helse Stavanger HF||1|||f||||f||||||||||2017-02-18 15:38:41.711355|2017-02-18 15:38:41.711355
NCT00469937|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-02-26|||February 2006||2006-02-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases|A Phase I Study of Lithium During Whole Brain Radiotherapy for Patients With Brain Metastases|Terminated||Phase 1|9|Actual|Vanderbilt-Ingram Cancer Center||1||low accrual|f||||t||||||||||2017-02-18 15:38:41.809085|2017-02-18 15:38:41.809085
NCT00469924|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-05-16|||February 2006||2006-02-01|May 2016|2016-05-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Effect of an Automated Paging System on Response to Critical Laboratory Values|Effect of an Automated Paging System on Response to Critical Laboratory Values|Completed||N/A|271|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 15:38:41.92303|2017-02-18 15:38:41.92303
NCT00469911|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2014-05-02|||August 2005||2005-08-01|May 2014|2014-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|MRS||Quantification of Intramyocardial Lipid by Proton Magnetic Resonance Spectroscopy|Quantification of Intramyocardial Lipid by Proton Magnetic Resonance Spectroscopy|Completed||N/A|25|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 15:38:42.021924|2017-02-18 15:38:42.021924
NCT00469898|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-07-20|2010-10-11||December 2003||2003-12-01|July 2012|2012-07-01|July 2010|Actual|2010-07-01|July 2008|Actual|2008-07-01||Interventional|||Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase II Trial of Carboplatin and Irinotecan (CPT-11) as First-Line Therapy for Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|50|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:38:42.121717|2017-02-18 15:38:42.121717
NCT00469885|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2017-01-09|||January 2001||2001-01-01|June 2008|2008-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Reduction of Smoking in Cardiac Disease Patients|Harm Reduction Treatment for Smokers With Cardiovascular Disease {Reduction of Smoking in Cardiovascular Disease Patients (ROSCAP)}|Completed||Phase 2|152|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 15:38:42.451145|2017-02-18 15:38:42.451145
NCT00469872|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-09-23|||June 2006||2006-06-01|September 2014|2014-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Focus on Function Study for Children With Cerebral Palsy|Family Centred Functional Therapy for Children With Cerebral Palsy|Completed||N/A|128|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 15:38:42.559628|2017-02-18 15:38:42.559628
NCT00469859|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2017-01-12|2013-08-29||June 2007||2007-06-01|September 2016|2016-09-01||||March 2010|Actual|2010-03-01||Interventional|||Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Pilot Study of Lestaurtinib (CEP-701) in Combination With Chemotherapy in Young Patients With Relapsed or Refractory FLT3-mutant Acute Myeloid Leukemia|Active, not recruiting||Phase 1/Phase 2|14|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 15:38:45.283268|2017-02-18 15:38:45.283268
NCT00469846|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2007-05-07|||January 2001||2001-01-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|L-Arg||L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia|Supplementation With L-Arginine and Antioxidant Vitamins During Pregnancy in a Medical Food to Reduce the Risk of Preeclampsia in a High Risk Population|Terminated||Phase 2|585|Actual|Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes||3||Recruitment and follow-up has been completed.|f||||t||||||||||2017-02-18 15:38:46.025192|2017-02-18 15:38:46.025192
NCT00469833|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2015-01-06|2013-10-17||April 2008||2008-04-01|January 2015|2015-01-01|September 2012|Actual|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Insulin Secretion in Diabetes Before and After Glycemic Control|Pathogenesis of the Impaired Incretin Effect in Type 2 Diabetes|Completed||N/A|17|Actual|VA Office of Research and Development|Two subjects could not complete the initial assessment due to poor IV access. All 15 subjects who completed the initial assessment and were started on insulin completed the study. There were no significant adverse events.|1|||f||||f||||||||||2017-02-18 15:38:46.12929|2017-02-18 15:38:46.12929
NCT00469820|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-03-20|||April 2007||2007-04-01|March 2014|2014-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant|Posttransplant Immunotherapy With Donor Lymphocyte Infusions and Autologous Tumor Vaccines After HLA-Matched Transplant|Terminated||Phase 1|1|Actual|Sidney Kimmel Comprehensive Cancer Center||||low accrual|f||||||||||||||2017-02-18 15:38:46.694753|2017-02-18 15:38:46.694753
NCT00469807|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2007-05-04|||June 2004||2004-06-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Observational|||Ghrelin Levels in Early IVF Pregnancies|Maternal Serum Ghrelin Levels in Early IVF Pregnancies: Lack of Prognostic Value for Gestational Outcome and Altered Post-Prandial Responses|Completed||N/A|||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||f||||||||||2017-02-18 15:38:46.798965|2017-02-18 15:38:46.798965
NCT00469794|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2007-05-04|||May 2006||2006-05-01|May 2007|2007-05-01|May 2008|Anticipated|2008-05-01|||||Observational|Athlete||The Significance of Arrhythmias in Athletes|The Long Term Significance of Exercise Induced Ventricular Arrhythmias in Trained Athletes|Unknown status|Recruiting|N/A|300|Anticipated|Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:38:46.879136|2017-02-18 15:38:46.879136
NCT00469781|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-04|2008-09-23|||May 2007||2007-05-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening||Completed||Phase 4|95|Actual|Center For Excellence In Eye Care||2|||f||||||||||||||2017-02-18 15:38:47.055001|2017-02-18 15:38:47.055001
NCT00469768|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2009-08-31|||May 2007||2007-05-01|August 2009|2009-08-01|August 2007|Actual|2007-08-01|||||Interventional|||A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium|A Double-blind, Randomized, Placebo-controlled Safety and Pharmacokinetic Study in Healthy HIV-negative Women to Assess the Delivery of Dapivirine From Matrix and Reservoir Intravaginal Rings Each Containing 25 mg of Dapivirine|Completed||Phase 1|24|Actual|International Partnership for Microbicides, Inc.||3|||f||||f||||||||||2017-02-18 15:38:47.161296|2017-02-18 15:38:47.161296
NCT00469755|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-03-28|||February 2006||2006-02-01|March 2008|2008-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne|A Comparison of Differin® Gel, 0.1% vs. Tazorac® Cream, 0.1% vs. Differin® Gel, 0.1% 6-Week Treatment Switched to Tazorac® Cream, 0.1% 6-Week Treatment in Patients With Acne Vulgaris|Completed||Phase 4|302|Actual|Galderma Laboratories, L.P.||3|||f||||f||||||||||2017-02-18 15:38:47.269433|2017-02-18 15:38:47.269433
NCT00469742|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2012-03-14|||April 2007||2007-04-01|May 2010|2010-05-01|December 2008|Actual|2008-12-01|||||Observational|||Aprotinin in Neonates Undergoing Cardiopulmonary Bypass|Safety Profile of Aprotinin in Neonates Undergoing Cardiopulmonary Bypass: A Retrospective Chart Review|Completed||N/A|290|Anticipated|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 15:38:47.596187|2017-02-18 15:38:47.596187
NCT00469729|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2015-07-09|||October 2007||2007-10-01|March 2013|2013-03-01|June 2015|Actual|2015-06-01|February 2013|Actual|2013-02-01||Interventional|ExCell||Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy|A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy|Completed||Phase 2/Phase 3|101|Actual|Gamida Cell -Teva Joint Venture Ltd.||1|||f||||t||||||||||2017-02-18 15:38:47.700202|2017-02-18 15:38:47.700202
NCT00469703|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2008-01-10|||August 2005||2005-08-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis|A Phase II, Open-Label, Single Center Pilot Study to Determine the Safety and Efficacy of THALOMID (Thalidomide) in Patients With Chronic Pancreatitis.|Terminated||Phase 2|10|Anticipated|Winthrop University Hospital||||Terminated|f||||||||||||||2017-02-18 15:38:47.969775|2017-02-18 15:38:47.969775
NCT00469690|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-05-19|||May 2007||2007-05-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects|Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects|Completed||Phase 4|58|Actual|Innovative Medical||2|||f||||||||||||||2017-02-18 15:38:48.062942|2017-02-18 15:38:48.062942
NCT00469664|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-05-20|||February 2000||2000-02-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|August 2008|Anticipated|2008-08-01||Interventional|Guanfacine||Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia|A Double Blind Placebo Controlled Study of Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Research Foundation for Mental Hygiene, Inc.||2|||f||||f||||||||||2017-02-18 15:38:48.172481|2017-02-18 15:38:48.172481
NCT00469651|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2007-12-13|||October 2007||2007-10-01|December 2007|2007-12-01|August 2008|Anticipated|2008-08-01|||||Interventional|MSP3TN||Phase Ib Trial of MSP3 LSP in Children in Tanzania|A Double Blind, Randomized, Controlled Phase Ib Field Trial in 12 to 24 Month Old Children in Tanzania to Evaluate the Safety and Immunogenicity of Candidate Malaria Vaccine MSP 3 Versus Hepatitis B Vaccine|Unknown status|Recruiting|Phase 1|45|Anticipated|African Malaria Network Trust||4|||f||||t||||||||||2017-02-18 15:38:48.273943|2017-02-18 15:38:48.273943
NCT00469638|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2010-04-21|||May 2007||2007-05-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|AGILIS||Efficacy and Safety Study on Agilis NxT Introducer in AF Patients|Ablation Success With the Use of Steerable AGILIS NxT Introducer Compared With Conventionally Used Swartz SL0.|Completed||N/A|130|Anticipated|St. Jude Medical||2|||f||||f||||||||||2017-02-18 15:38:48.383369|2017-02-18 15:38:48.383369
NCT00469625|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2015-12-24|||July 2006||2006-07-01|December 2015|2015-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease|A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease|Withdrawn||N/A|0|Actual|Winthrop University Hospital||1||Investigator left the Institution.|f||||f||||||||||2017-02-18 15:38:48.494456|2017-02-18 15:38:48.494456
NCT00469612|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2010-04-09|||June 2007||2007-06-01|July 2008|2008-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment|Evaluating the Efficacy of NeuroVisions's NVC Treatment for Low Myopia|Completed||N/A|50|Anticipated|Ohio State University||2|||f||||f||||||||||2017-02-18 15:38:48.58764|2017-02-18 15:38:48.58764
NCT00469599|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2011-04-01|||July 2007||2007-07-01|April 2011|2011-04-01|October 2010|Actual|2010-10-01|September 2010|Anticipated|2010-09-01||Interventional|||Treatment of Secondary Hyperparathyroidism in the Uremic Patient|Treatment of Secondary Hyperparathyroidism in the Uremic Patient. A Study Comparing Alfacalcidol and Paricalcitol|Terminated||N/A|86|Actual|Zealand University Hospital||2||Terminated after 86 pt included, because of recruitment problems|f||||t||||||||||2017-02-18 15:38:48.699833|2017-02-18 15:38:48.699833
NCT00469586|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-07-09||2009-11-09|April 2007||2007-04-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|iINHALE 7||Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes|Efficacy and Safety of Inhaled Prandial Insulin Compared to Metformin Plus Glimepiride in Type 2 Diabetes|Terminated||Phase 3|174|Actual|Novo Nordisk A/S||3||See termination reason in detailed description|f||||f||||||||||2017-02-18 15:38:49.064036|2017-02-18 15:38:49.064036
NCT00469573|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-03-31|||May 2007||2007-05-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes|Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes|Completed||Phase 4|36|Actual|Innovative Medical||1|||f||||||||||||||2017-02-18 15:38:49.194172|2017-02-18 15:38:49.194172
NCT00469560|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-11-21|||June 2007||2007-06-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|March 2010|Actual|2010-03-01||Interventional|||Safety, Tolerability, and Efficacy of Deferasirox in MDS|Open Label, Multicenter Study to Evaluate Safety/Tolerability and Efficacy of Deferasirox (ICL670) in Myelodysplastic Syndrome Patients With Chronic Transfusional Hemosiderosis.|Completed||Phase 3|158|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||No||2017-02-18 15:38:49.293457|2017-02-18 15:38:49.293457
NCT00469547|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2009-04-28|||November 2007||2007-11-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides|Safety & Acceptance of 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides|Completed||Phase 1|30|Anticipated|University of Washington||2|||f||||t||||||||||2017-02-18 15:38:49.426597|2017-02-18 15:38:49.426597
NCT00469534|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2011-09-21||||||September 2011|2011-09-01||||||||Interventional|||Minimized Time to Beam in Patients With High Grade Gliomas|A Pilot Study Evaluating Minimized Time to Beam Hypofractionated IMRT With PET-Assisted Target Definition in Patients With High Grade Gliomas|Withdrawn||N/A|0|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 15:38:49.546813|2017-02-18 15:38:49.546813
NCT00469521|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2007-09-05||||||September 2007|2007-09-01||||||||Interventional|||Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 15:38:49.633599|2017-02-18 15:38:49.633599
NCT00469508|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2013-02-13|2012-12-07||April 2007||2007-04-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|Modafinil||Modafinil vs Placebo for the Treatment of Methamphetamine Dependence|A Randomized, Double-Blind, Placebo-Controlled Evaluation of Modafinil vs Placebo for the Treatment of Methamphetamine Dependence|Completed||Phase 2|71|Actual|University of California, Los Angeles|study is powered to detect at least a moderate effect for modafinil (d = 0.50) in the overall sample; subgroups may be more meaningful|2|||f||||t||||||||||2017-02-18 15:38:49.716391|2017-02-18 15:38:49.716391
NCT00468338|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2016-10-28|||December 2006||2006-12-01|April 2015|2015-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Correlation BIS Scores Mentally Retarded Patients|Correlation Between the Severity of Mental Retardation and BIS in Mentally Retarded Patients Undergoing Dental Rehabilitation|Completed||N/A|90|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||No||2017-02-18 15:38:52.678873|2017-02-18 15:38:52.678873
NCT00469495|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2009-08-25|||February 2007||2007-02-01|August 2009|2009-08-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis|Empiric Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Trial in Subjects Co-Infected With Helminths and Leishmania Brasiliensis|Completed||N/A|90|Anticipated|Hospital Universitário Professor Edgard Santos||2|||f||||t||||||||||2017-02-18 15:38:50.315025|2017-02-18 15:38:50.315025
NCT00469482|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2015-11-04|||June 2007||2007-06-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|October 2008|Actual|2008-10-01||Interventional|SOMNUS||The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status|A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients|Active, not recruiting||Phase 3|200|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-02-18 15:38:50.409578|2017-02-18 15:38:50.409578
NCT00469469|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2015-04-21|||May 2007||2007-05-01|May 2008|2008-05-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma|A Phase II Study of Bevacizumab in Patients With Nonresectable Cancer of the Adrenal Cortex.|Withdrawn||Phase 2|0|Actual|Dartmouth-Hitchcock Medical Center||1||unable to enroll subjects into the study|f||||t||||||||||2017-02-18 15:38:50.536786|2017-02-18 15:38:50.536786
NCT00469456|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2009-12-21|2009-11-03||April 2007||2007-04-01|December 2009|2009-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy of Memantine on Functional Communication in Patients With Alzheimer's Disease (AD)|Completed||Phase 4|265|Actual|Forest Laboratories||2|||f||||||||||||||2017-02-18 15:38:50.639741|2017-02-18 15:38:50.639741
NCT00469443|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2010-08-18|||December 2006||2006-12-01|August 2010|2010-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC|A Randomized Phase III Study of Irinotecan Plus 5-fluorouracil Plus Leucovorin and Bevacizumab (FOLFIRI+Avastin) Versus Irinotecan Plus Capecitabine and Bevacizumab (XELIRI+Avastin) as 1st Line Treatment of Locally Advanced or Metastatic Colorectal Cancer|Completed||Phase 3|330|Anticipated|Hellenic Oncology Research Group||2|||f||||f||||||||||2017-02-18 15:38:51.126058|2017-02-18 15:38:51.126058
NCT00469430|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2009-04-20|||May 2006||2006-05-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||Study of Conservative Versus Surgical Treatment of Appendicitis|Randomized Study of Conservative Versus Surgical Treatment of Appendicitis; Analyses of Result and Economics|Completed||Phase 2|360|Actual|Göteborg University||2|||f||||f||||||||||2017-02-18 15:38:51.274165|2017-02-18 15:38:51.274165
NCT00469417|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2010-09-01|||October 1999||1999-10-01|September 2010|2010-09-01|May 2005|Actual|2005-05-01|||||Interventional|||Metvix PDT Versus Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma|A Multicenter, Phase III, Randomised Study of Photodynamic Therapy With Metvix Cream 160 mg/g in Comparison With Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma|Completed||Phase 3|120|Actual|Galderma||2|||f||||||||||||||2017-02-18 15:38:51.386394|2017-02-18 15:38:51.386394
NCT00469404|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-11-15|||May 2007||2007-05-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)|Single Dose Bioequivalence Trial Comparing a Down-Scaled New Analgesic Transdermal Patch Formulation to an Analgesic Reference Patch.|Terminated||Phase 1|24|Anticipated|Grünenthal GmbH||||The trial end was achieved according to the definition in the trial protocol|f||||||||||||||2017-02-18 15:38:51.71317|2017-02-18 15:38:51.71317
NCT00469391|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-12-29|2016-11-01||June 2007||2007-06-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||ITT population: All subjects who did not withdraw before the procedure and device subjects who had a successful implant procedure|Multi-Center Pre-Bariatric Weight Loss Study|A Multi-Center, Pilot Efficacy Study of the GI Sleeve for Pre-Surgical Weight Loss|Completed||Phase 2|56|Actual|GI Dynamics||2|||f||||f||||||||Undecided|De-identified individual patient data is on file at the Sponsor|2017-02-18 15:38:51.806092|2017-02-18 15:38:51.806092
NCT00469378|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2014-07-03|||July 2007||2007-07-01|June 2014|2014-06-01|February 2010|Actual|2010-02-01|May 2009|Actual|2009-05-01||Interventional|||Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis|An Open-label Study of Leukocyte Counts in the Cerebrospinal Fluid and Blood of Subjects With Relapsing Forms of Multiple Sclerosis Following Treatment With Firategrast|Completed||Phase 2|46|Actual|GlaxoSmithKline||1|||f||||t||||||||||2017-02-18 15:38:52.152821|2017-02-18 15:38:52.152821
NCT00469365|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2008-11-25|||January 2006||2006-01-01|May 2007|2007-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Pharmacy Interventions to Improve Chronic Disease Medication Refill|A Randomized Controlled Trial of Two Pharmacy Interventions to Improve Refill Adherence for Chronic Disease Medications|Completed||Phase 3|3048|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-02-18 15:38:52.275544|2017-02-18 15:38:52.275544
NCT00469352|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2011-07-20|||May 2007||2007-05-01|July 2011|2011-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD|The Effect of Genotype and Environmental Risk Factors on Treatment Response to Intravitreal Lucentis (Ranibizumab) for Neovascular AMD|Completed||Phase 3|150|Anticipated|Oregon Health and Science University||1|||f||||f||||||||||2017-02-18 15:38:52.368323|2017-02-18 15:38:52.368323
NCT00469339|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2017-01-24|||April 27, 2007||2007-04-27|August 9, 2016|2016-08-09|December 13, 2010|Actual|2010-12-13|December 13, 2010|Actual|2010-12-13||Interventional|||Risk Communication Within Mexican-American Families|The Role of Family History and Culture in Communal Coping Within Mexican-American Families|Completed||N/A|560|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:38:52.465441|2017-02-18 15:38:52.465441
NCT00469326|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2009-01-26|||April 2005||2005-04-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|TIPS||Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study|Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study|Completed||Phase 3|200|Actual|University Hospital, Motol||2|||f||||f||||||||||2017-02-18 15:38:52.562634|2017-02-18 15:38:52.562634
NCT00468325|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2009-11-13|||May 2007||2007-05-01|November 2009|2009-11-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|CTSTAT||Coronary Computed Tomography for Systematic Triage of Acute Chest Pain Patients to Treatment (CT-STAT)|Coronary Computed Tomography for Systematic Triage of Acute Chest Pain Patients to Treatment (CT-STAT)|Completed||N/A|750|Actual|William Beaumont Hospitals||2|||f||||t||||||||||2017-02-18 15:38:52.786572|2017-02-18 15:38:52.786572
NCT00468312|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2015-02-24|2010-05-21||March 2007||2007-03-01|February 2015|2015-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)|Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis|Completed||Phase 3|429|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:38:52.915692|2017-02-18 15:38:52.915692
NCT00468299|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2011-06-23|2011-04-12||April 2007||2007-04-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|MiMi||MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure|Treatment of Early Pregnancy Failure|Terminated||N/A|16|Actual|Boston University|The study was terminated because of poor enrollment. Few eligible women were referred.|2||poor enrollment|f||||t||||||||||2017-02-18 15:38:53.370069|2017-02-18 15:38:53.370069
NCT00468286|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2011-03-21|2011-02-08||May 2007||2007-05-01|March 2011|2011-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy|An Open-Label, Multi-Centre, Randomised Parallel-Group Dose-Finding Study, Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy|Completed||Phase 2|133|Actual|Ferring Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:38:53.785097|2017-02-18 15:38:53.785097
NCT00468273|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2014-08-07||2014-02-26|November 2006||2006-11-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|IGIV||A Clinical Study of Intravenous Immunoglobulin|A Clinical Study of Immune Globulin Intravenous (Human) Omr-IgG-am IGIV in Subjects With Primary Immune Deficiency Diseases|Completed||Phase 3|57|Actual|FFF Enterprises||1|||f||||t||||||||||2017-02-18 15:38:54.885071|2017-02-18 15:38:54.885071
NCT00468260|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2009-11-18|||May 2007||2007-05-01|November 2009|2009-11-01||||||||Interventional|||The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies|An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies-extension Study|Terminated||Phase 1|12|Anticipated|Novartis||||pts. will be captured in core|f||||||||||||||2017-02-18 15:38:55.019198|2017-02-18 15:38:55.019198
NCT00468247|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2008-04-24|||March 2007||2007-03-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|NAV-1||Registration Enabling Study of the Safety and Efficacy of the Use of the Navigator Circulatory Management System|A Prospective,Open,Multicentre,RCT to Assess the Safety & Efficacy of Navigator v Conventional Care in Post-op Cardiac Surgery Patients Undergoing CABG &/or Heart Valve Repair/Replacement Utilising Heart Lung Perfusion Pump(The NAV-1 Study)|Completed||Phase 2|112|Actual|Applied Physiology Pty Ltd||2|||f||||f||||||||||2017-02-18 15:38:55.120359|2017-02-18 15:38:55.120359
NCT00468234|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2009-12-31|||December 2005||2005-12-01|December 2009|2009-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Validation of Biomarkers of Exposure and Host Response|Validation of Biomarkers of Exposure and Host Response|Completed||N/A|60||University of Nebraska|||||f||||f||||||||||2017-02-18 15:38:55.234109|2017-02-18 15:38:55.234109
NCT00468221|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2015-05-27|||June 2009||2009-06-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|Lowoz||The Effect of Low Level Ozone Exposure on Healthy Volunteers|The Effect of Low Level Ozone Exposure on Healthy Volunteers|Withdrawn||Phase 1|0|Actual|University of North Carolina, Chapel Hill||1||Lack of funding|f||||f||||||||||2017-02-18 15:38:55.323289|2017-02-18 15:38:55.323289
NCT00468208|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2015-12-15|2013-09-20||February 2008||2008-02-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis|A Multi-Center, Open-label Pilot Study of Abatacept (CTLA4-Ig) in the Treatment of Mild Relapsing Wegener's Granulomatosis|Completed||Phase 1/Phase 2|20|Actual|University of Pennsylvania|The main limitation of this trial is the small sample size and the open-label, uncontrolled design.|1|||f||||t||||||||||2017-02-18 15:38:55.645723|2017-02-18 15:38:55.645723
NCT00468195|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2012-03-20|||May 2007||2007-05-01|March 2012|2012-03-01|September 2010|Actual|2010-09-01|||||Observational|BMI40||Optimizing Image Quality in Obese Patients Undergoing Coronary Computed Tomography (CT) Angiography|Optimizing Image Quality in Obese Patients Undergoing Coronary CT Angiography|Completed||N/A|175|Actual|William Beaumont Hospitals|||1||f||||t||||||||||2017-02-18 15:38:56.050268|2017-02-18 15:38:56.050268
NCT00469313|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-05-21|||May 2007||2007-05-01|May 2008|2008-05-01||||||||Observational|||Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients With COPD|Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients|Unknown status|Enrolling by invitation|N/A|||Hospital Hietzing|||||f||||f||||||||||2017-02-18 15:38:56.136563|2017-02-18 15:38:56.136563
NCT00469300|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-01-31|||April 2007||2007-04-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Iontophoretic Application of Acyclovir Gel to Treat Cold Sores|A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of the Electrokinetic Transdermal System (ETS) With Acyclovir Gel for the Episodic Treatment of Herpes Labialis|Completed||Phase 2|810|Anticipated|Transport Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:38:56.221466|2017-02-18 15:38:56.221466
NCT00469287|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-04-04|||June 2007||2007-06-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|||||Observational|7348||Early Diagnosis of Diabetes Mellitus Type 2 (DM2)|Exploration of Early Diagnosis of Diabetes Mellitus Type 2 Based on Traditional Chinese Medicine by MERID Diagnostics, Biophoton Measurements, Heart Rate Variability and Systems Biology|Completed||N/A|50|Anticipated|TNO|||||f||||f||||||||||2017-02-18 15:38:56.340391|2017-02-18 15:38:56.340391
NCT00469274|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-12-18|2011-08-04||May 2007||2007-05-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|VPES||Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure|A Randomized Open-Label Non-Inferiority Study to Examine the Impact of Pertussis Vaccination of Healthcare Workers on Post-exposure Prophylaxis|Completed||N/A|1102|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 15:38:56.426458|2017-02-18 15:38:56.426458
NCT00469261|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-09-24|||May 2007||2007-05-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|TIPTOP||Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling|Tetracycline (Doxycycline) In Patients With Large Acute Myocardial Infarction TO Prevent Left Ventricular Remodeling. TIPTOP Study|Completed||Phase 2|110|Actual|Careggi Hospital||2|||f||||t||||||||||2017-02-18 15:38:56.799201|2017-02-18 15:38:56.799201
NCT00469248|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2007-05-03|||March 2003||2003-03-01|April 2007|2007-04-01|June 2004|Actual|2004-06-01|||||Interventional|IABPSHOCK||Aortic Balloon Counterpulastion in Myocardial Infarction Related Shock|Intra-Aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock - The Prospective, Randomised IABP SHOCK Trial for Attenuation of Multi-Organ Dysfunction Syndrome|Completed||N/A|45|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||f||||||||||2017-02-18 15:38:56.919148|2017-02-18 15:38:56.919148
NCT00469235|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2009-09-15|||June 2007||2007-06-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars|A Single-centre, Double Blind, Randomised, Rising Dose Tolerance Study to Investigate the Safety of Juvista When Administered Following Excision of Ear Lobe Keloids.|Completed||Phase 1/Phase 2|20|Actual|Renovo||2|||f||||f||||||||||2017-02-18 15:38:57.020944|2017-02-18 15:38:57.020944
NCT00469222|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2016-02-24|||March 2007||2007-03-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Hypofractionated Radiotherapy for Small Cell Lung Cancer|Phase I Dose Escalation Trial of Hypofractionated Limited-field External Beam Thoracic Radiotherapy for Limited Stage Small Cell Carcinoma of the Lung|Completed||Phase 1|24|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 15:38:57.114771|2017-02-18 15:38:57.114771
NCT00469209|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2012-08-01|2010-03-23||June 2006||2006-06-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients|Phase I/II Study of the Combination of Bortezomib With Arsenic Trioxide, Ascorbic Acid and High-Dose Melphalan for Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|60|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-02-18 15:38:57.207995|2017-02-18 15:38:57.207995
NCT00469196|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2016-04-05|||October 2006||2006-10-01|March 2016|2016-03-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Tomotherapy Treatment for Mesothelioma|Tomotherapy Treatment for Mesothelioma|Completed||Phase 2|18|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 15:38:57.623975|2017-02-18 15:38:57.623975
NCT00469183|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-03-28|||May 2006||2006-05-01|March 2008|2008-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma|An Assessment of the Atrophogenic Potential of Triple Combination Cream Using Histology Measures in the Treatment of Moderate to Severe Melasma|Completed||Phase 4|70|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-02-18 15:38:57.714007|2017-02-18 15:38:57.714007
NCT00469170|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2010-11-10|||March 2007||2007-03-01|November 2010|2010-11-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method|A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method for the Prevention of HIV Infection in Women|Completed||Early Phase 1|220|Actual|International Partnership for Microbicides, Inc.||2|||f||||t||||||||||2017-02-18 15:38:57.816235|2017-02-18 15:38:57.816235
NCT00469157|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-04-16|||May 2007||2007-05-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Refractive Surgery and Optive Compatibility Study|Refractive Surgery and Optive Compatibility Study|Completed||Phase 4|92|Actual|Innovative Medical||1|||f||||||||||||||2017-02-18 15:38:57.933982|2017-02-18 15:38:57.933982
NCT00469144|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2015-11-23|||June 2005||2005-06-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome|A Randomized Study of Once Daily IV Busulfan With Fludarabine With Hemopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Completed||Phase 3|233|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:38:58.031495|2017-02-18 15:38:58.031495
NCT00469131|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2011-09-13|||September 2003||2003-09-01|September 2011|2011-09-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid|Randomized Comparative Study on Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparison Between Tacrolimus + MMF and Tacrolimus + Steroid|Completed||Phase 3|79|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t||||||||||2017-02-18 15:38:58.144028|2017-02-18 15:38:58.144028
NCT00469118|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2015-10-07|||February 2009||2009-02-01|October 2015|2015-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Clinical Efficacy and Safety of Axiom Worldwide DRX9000 Axial Decompression System for Treatment of Low Back Pain|Clinical Efficacy and Safety of Axiom Worldwide DRX9000 Axial Decompression|Withdrawn||Phase 2|0|Actual|NEMA Research, Inc.||2||Financial concerns with device manufacturer.|f||||f||||||||||2017-02-18 15:38:58.251746|2017-02-18 15:38:58.251746
NCT00469105|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2010-04-22|||December 2006||2006-12-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills|Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills|Completed||Phase 4|110|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 15:38:58.35764|2017-02-18 15:38:58.35764
NCT00469092|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-10-03|2009-11-30||May 2007||2007-05-01|October 2014|2014-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes|A Multi-national, Open-labelled, Randomised, Parallel Group, 4 Week run-in and 26 Weeks Treat-to-target Comparison of Biphasic Insulin Aspart 30 Once Daily Versus Insulin Glargine Once Daily Both in Combination With Metformin and Glimepiride in Insulin naïve Subjects With Type 2 Diabetes|Completed||Phase 4|480|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 15:38:58.476234|2017-02-18 15:38:58.476234
NCT00468897|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2008-10-15|||March 2007||2007-03-01|October 2008|2008-10-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.|An Open-Label, Randomized, Two-Period Crossover Study to Demonstrate the Bioequivalence of a Tablet Formulation of Rosiglitazone XR (BRL-049653) 8mg Manufactured at Two Different Sites in Healthy Volunteers in Fasting Conditions|Completed||Phase 1|50||GlaxoSmithKline|||||||||||||||||||2017-02-18 15:39:01.541045|2017-02-18 15:39:01.541045
NCT00469079|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2014-10-03|2013-10-29||January 2007||2007-01-01|October 2014|2014-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|ANTS3||Health Effects of SLT, Cigarette Smoking, and New Tobacco Products|Comparing the Health Effects of Smokeless Tobacco, Cigarette Smoking, and New Tobacco Products Advertised as Safer Alternatives Part of Tobacco Exposure Reduction|Completed||Phase 2|130|Actual|University of Minnesota - Clinical and Translational Science Institute|Smokeless tobacco products commercially available have been introduced, withdrawn, or changed at a relatively rapid rate resulting in products that are no longer available and changes that occurred during the time period that the study occurred.|3|||f||||t||||||||||2017-02-18 15:38:59.306933|2017-02-18 15:38:59.306933
NCT00469066|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2016-02-23|||May 2007||2007-05-01|December 2011|2011-12-01|April 2010|Actual|2010-04-01|August 2009|Actual|2009-08-01||Observational|||Cone Beam CT Scanning in Lung and Bladder Cancer.|Improving the Accuracy of Radiotherapy Planning and Delivery Using Kilovoltage Cone Beam CT Imaging|Completed||N/A|22|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 15:38:59.937295|2017-02-18 15:38:59.937295
NCT00469053|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-11-15|||May 2007||2007-05-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)|Multiple Dose Bioequivalence Trial Comparing a Down-Scaled New Analgesic Transdermal Patch Formulation to an Analgesic Reference Patch (Protocol ID: 855509)|Terminated||Phase 1|36|Anticipated|Grünenthal GmbH||||The trail end was achived according to the definition in the trial protocol|f||||||||||||||2017-02-18 15:39:00.023294|2017-02-18 15:39:00.023294
NCT00469040|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2016-10-26|||February 2007||2007-02-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Safety, Blood Levels and Effects of GW642444|A Randomised, Double-blind, Placebo-controlled, Parallel-group, 14 Day Repeat Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Extra-pulmonary Pharmacodynamics of Inhaled Doses of GW642444M Formulated With Magnesium Stearate in Healthy Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:39:00.11854|2017-02-18 15:39:00.11854
NCT00469027|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2016-10-13|||May 2006||2006-05-01|October 2016|2016-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|PHACeT||Pulmonary Hypertension: Assessment of Cell Therapy|Phase I Trial to Establish Safety of Autologous Progenitor Cell-based Gene Therapy Delivery of heNOS in Patients With Severe Pulmonary Arterial Hypertension(PAH)Refractory to Conventional Treatment|Completed||Phase 1|7|Actual|Northern Therapeutics||1|||f||||t||||||||||2017-02-18 15:39:00.246713|2017-02-18 15:39:00.246713
NCT00469014|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-03|2013-04-01|||September 2006||2006-09-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia|Busulfan-Fludarabine-Clofarabine With Allogeneic Stem Cell Transplantation for Advanced Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Advanced, Gleevec Refractory Chronic Myeloid Leukemia. A Randomized Phase II Study.|Completed||Phase 2|72|Actual|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 15:39:00.359631|2017-02-18 15:39:00.359631
NCT00469001|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2010-09-12|||June 2007||2007-06-01|September 2010|2010-09-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Observational|||Evaluation of NT PRO BNP Guided Therapy on Hospitalization Rate and Mortality in Patients With Chronic HF NYHA II-IY|Phase 1 Study of Using BNP as Guided Parameter in Treatment HF|Completed||Phase 1|108|Actual|Hillel Yaffe Medical Center|||2||f||||f||||||||||2017-02-18 15:39:00.487883|2017-02-18 15:39:00.487883
NCT00468988|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2012-05-23|||May 2007||2007-05-01|May 2012|2012-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers|Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers|Completed||Phase 4|30|Anticipated|Alcon Research|||||f||||||||||||||2017-02-18 15:39:00.809594|2017-02-18 15:39:00.809594
NCT00468975|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2010-10-27||2009-03-24|May 2007||2007-05-01|October 2010|2010-10-01||||||||Interventional|||A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.|A Phase IIA Randomised, Double-blind, Double Dummy, Placebo and Active Controlled 5-Way Cross-over Trial to Examine the Bronchodilator Effects of PF-610,355 and to Test for Superiority Versus Placebo in Reversible Asthmatic Patients|Completed||Phase 2|42||Pfizer|||||f||||||||||||||2017-02-18 15:39:00.903242|2017-02-18 15:39:00.903242
NCT00468962|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2007-05-02||||||May 2007|2007-05-01||||||||Interventional|||The Effct of Chitooligosaccharide on Immune Function in Healthy Adults||Completed||Phase 4|||Eulji University Hospital|||||f||||||||||||||2017-02-18 15:39:01.00412|2017-02-18 15:39:01.00412
NCT00468949|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2011-07-27|||May 2007||2007-05-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Health-Related Quality of Life in Patients With Dupuytren's Disease|Health-Related Quality of Life in Patients With Dupuytren's Disease: A Prospective Cohort Study.|Completed||Phase 1|51|Actual|McMaster University|||2||f||||f||||||||||2017-02-18 15:39:01.078261|2017-02-18 15:39:01.078261
NCT00468936|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2008-10-16|||May 2007||2007-05-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms|Open-Label, Randomized Study Comparing the Patient Reported Severity of GI Side Effects of MMF Versus EC-MPS in Maintenance Heart Transplant Patients.|Unknown status|Recruiting|Phase 3|100|Anticipated|McGill University Health Center||2|||f||||f||||||||||2017-02-18 15:39:01.175286|2017-02-18 15:39:01.175286
NCT00468923|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2017-02-08|||May 2007||2007-05-01|February 2017|2017-02-01|January 2016|Actual|2016-01-01|December 2015|Actual|2015-12-01||Interventional|HOPE-3||Heart Outcomes Prevention Evaluation-3|Heart Outcomes Prevention Evaluation-3|Completed||Phase 4|12705|Actual|Population Health Research Institute||2|||f||||t||||||||Yes|Data will be shared with participants in the study April/May 2016|2017-02-18 15:39:01.277675|2017-02-18 15:39:01.277675
NCT00468910|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2013-12-06|||March 2007||2007-03-01|December 2013|2013-12-01||||December 2009|Actual|2009-12-01||Interventional|||Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer|Spectral Markers in Aspirin Chemoprevention of Colonic Neoplasia|Unknown status|Active, not recruiting|Phase 2|115|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:39:01.41011|2017-02-18 15:39:01.41011
NCT00349856|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2009-02-17|||January 2005||2005-01-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Dispensing Overnight Study in Lenses|Dispensing Overnight Study in Lenses|Completed||Phase 3|40|Actual|University of Waterloo||1|||f||||f||||||||||2017-02-18 16:25:10.877505|2017-02-18 16:25:10.877505
NCT00468884|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2008-10-16|||October 2006||2006-10-01|October 2008|2008-10-01|February 2007|Actual|2007-02-01|||||Interventional|||Oral Administration of Peptides; Absorption From Gastrointestinal Tract|Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: a Proof of Concept Study in Healthy Subjects|Completed||Phase 1|12||University Hospital, Basel, Switzerland|||||f||||f||||||||||2017-02-18 15:39:01.648667|2017-02-18 15:39:01.648667
NCT00468871|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2011-12-07|||April 2002||2002-04-01|December 2011|2011-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy|A Multicenter, Randomized, Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide (0.5mg) Implant Compared to Standardized Therapy in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye|Completed||Phase 2/Phase 3|140|Actual|Bausch & Lomb Incorporated||2|||f||||t||||||||||2017-02-18 15:39:01.748411|2017-02-18 15:39:01.748411
NCT00468858|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2016-02-01||2015-12-28|July 2007||2007-07-01|February 2016|2016-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children|Phase II, Randomized, Double-blind, Placebo-controlled Study of Two Doses of WRAIR Live Attenuated Tetravalent Dengue Vaccine Formulations, Administered Six Months Apart, to Healthy Adults and Children|Completed||Phase 2|636|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||f||||||||||2017-02-18 15:39:01.860565|2017-02-18 15:39:01.860565
NCT00468845|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2011-06-07|2011-04-29||June 2007||2007-06-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|May 2010|Actual|2010-05-01||Interventional|||Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy|A Multiple Dose, Randomized, Double-Blind Multicenter Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo In The Treatment Of Patients With Post-Surgical Pain From Hysterectomy|Completed||Phase 3|501|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 15:39:02.050936|2017-02-18 15:39:02.050936
NCT00468832|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2016-04-19|||December 2005||2005-12-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)|Longitudinal Study of the Relationship Between Impairment, Activity Limitation, Participation and Quality of Life in Persons With Confirmed Duchenne Muscular Dystrophy (DMD)|Active, not recruiting||N/A|551|Actual|Cooperative International Neuromuscular Research Group|||3||f||||t||||||Samples With DNA|"~     Blood samples are being collected for single-nucleotide polymorphism, Genome-wide~     Association Study, and biomarker analyses.~   "|||2017-02-18 15:39:08.052965|2017-02-18 15:39:08.052965
NCT00468819|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2015-06-29|2011-06-10||May 2007||2007-05-01|June 2015|2015-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children|Open-label Multi-center Study of Magnetic Resonance Imaging (MRI) With 0.1 mmol/kg Body Weight (BW) Gadavist (1.0 M) to Assess Pharmacokinetics, Safety and Tolerability in Children.|Completed||Phase 1|140|Actual|Bayer|Originally, urine was collected up to 6 hours post injection in patients > 9 years. This was amended to patients of all age groups. As a result, urine was collected in 102 of 138 patients with gadobutrol injection (lowest rate in patients 2-6 years).|4|||f||||f||||||||||2017-02-18 15:39:08.417265|2017-02-18 15:39:08.417265
NCT00468806|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2010-10-14||2010-10-14|April 2007||2007-04-01|October 2010|2010-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.|An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain Dopamine D3 Occupancy Kinetics, Pharmacokinetics and Safety of Single Oral Doses of GSK598809, Using [11C]-(+)-PHNO as PET Ligand.|Completed||Phase 1|25|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:39:09.684269|2017-02-18 15:39:09.684269
NCT00468793|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2009-06-05|||April 2007||2007-04-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Traditional Versus ScvO2 Guided Perioperative Fluid Therapy|Randomized Clinical Study of Traditional Versus ScvO2 Guided Perioperative Fluid Therapy|Completed||Phase 4|240|Anticipated|Haukeland University Hospital||2|||f||||f||||||||||2017-02-18 15:39:09.777086|2017-02-18 15:39:09.777086
NCT00468780|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2014-05-23|||February 2003||2003-02-01|May 2014|2014-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Standardized Comparison of Triage in EMS|Study to Evaluate the Safety and Efficacy of Redirecting Ambulance Patients to Destinations Based on Acuity|Completed||N/A|928|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-02-18 15:39:09.869741|2017-02-18 15:39:09.869741
NCT00468767|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2008-03-31|||August 2003||2003-08-01|March 2008|2008-03-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|ACT I||Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation|A Phase III Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Centred Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation|Completed||Phase 3|356|Actual|Cardiome Pharma||2|||f||||t||||||||||2017-02-18 15:39:09.963181|2017-02-18 15:39:09.963181
NCT00468754|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2016-03-01|||July 2003||2003-07-01|June 2010|2010-06-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine|A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine|Completed||N/A|50|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:39:10.123967|2017-02-18 15:39:10.123967
NCT00468741|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2016-04-21|||September 2003||2003-09-01|April 2016|2016-04-01|June 2014|Actual|2014-06-01|December 2008|Actual|2008-12-01||Interventional|||Component and Couple Analysis of Cancer Communications|Component and Couple Analysis of Cancer Communications|Completed||N/A|338|Actual|University of Wisconsin, Madison||4|||f||||f||||||||||2017-02-18 15:39:10.336587|2017-02-18 15:39:10.336587
NCT00468728|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2016-07-07|2011-07-01||October 2006||2006-10-01|July 2016|2016-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)|A Double-Blind Study to Compare the Safety and Efficacy of PAR-101 to Vancomycin in Subjects With Clostridium Difficile-Associated Diarrhea (CDAD)|Completed||Phase 3|535|Actual|Optimer Pharmaceuticals LLC||2|||f||||f||||||||||2017-02-18 15:39:10.45443|2017-02-18 15:39:10.45443
NCT00468715|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2016-04-28|||March 2007||2007-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Bicalutamide in Treating Patients With Metastatic Breast Cancer|Bicalutamide for the Treatment of Androgen Receptor Positive (AR(+)), Estrogen Receptor Negative, Progesterone Receptor Negative (ER(-)/PR(-)) Metastatic Breast Cancer Patients: A Phase II Feasibility Study|Active, not recruiting||Phase 2|28|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:39:11.608827|2017-02-18 15:39:11.608827
NCT00468689|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2008-10-09|||April 2007||2007-04-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects.|A Two-Part Dose-Rising Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SB-751689 When Administered as an Oral Formulation at Supratherapeutic Dose Levels in Healthy Adult Subjects.|Completed||Phase 1|15|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:39:11.819044|2017-02-18 15:39:11.819044
NCT00468676|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2014-05-01|2013-12-13||May 2007||2007-05-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|October 2010|Actual|2010-10-01||Interventional|||Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression|Randomized Trial of Liaison Psychiatry in Primary Care|Completed||N/A|214|Actual|University of Washington|"Limitations include the study being completed in one health care system in one geographic area, inadequate power to determine cardiovascular events or rates of hospitalization, potential spill-over of intervention to usual care patients."|2|||f||||t||||||||||2017-02-18 15:39:11.934971|2017-02-18 15:39:11.934971
NCT00468663|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2015-04-13|||July 2006||2006-07-01|April 2015|2015-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Ambient Air Pollution, Preeclampsia, and Preterm Delivery|Ambient Air Pollution, Preeclampsia, and Preterm Delivery|Completed||N/A|4200|Actual|National Institute of Environmental Health Sciences (NIEHS)|||||f||||f||||||||||2017-02-18 15:39:12.494142|2017-02-18 15:39:12.494142
NCT00468650|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2015-04-21|2009-02-12||June 2007||2007-06-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction.|A Multicenter, Open Label, High Dose (100mg) Rapid Titration Study, To Evaluate The Efficacy And Satisfaction Of Patrex® (Sildenafil Citrate) In Men With Erectile Dysfunction In Mexico.|Completed||Phase 4|117|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:39:12.590603|2017-02-18 15:39:12.590603
NCT00468637|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2009-02-13|||May 2007||2007-05-01|February 2009|2009-02-01|September 2011|Anticipated|2011-09-01|||||Observational|AMORE-Eur||Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe|Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe|Unknown status|Recruiting|N/A|1200|Anticipated|University Hospital, Saarland|||1||f||||f||||||||||2017-02-18 15:39:14.074839|2017-02-18 15:39:14.074839
NCT00468624|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2007-05-02|||December 2004||2004-12-01|May 2007|2007-05-01|July 2005|Actual|2005-07-01|||||Interventional|||Effect of Pegvisomant on GH/IGF-I Relationship in GHD|A Study of the Relationship Between Serum Growth Hormone (GH) and Insulin-Like Growth Factor One (IGF-I) in Patients With Severe Adult Growth Hormone Deficiency (AGHD)|Terminated||N/A|||The Christie NHS Foundation Trust||2||recruitment completed|f||||f||||||||||2017-02-18 15:39:14.162278|2017-02-18 15:39:14.162278
NCT00468611|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2009-08-12|||June 2007||2007-06-01|August 2009|2009-08-01|September 2009|Anticipated|2009-09-01|July 2009|Actual|2009-07-01||Interventional|MAESTRO-03||Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis|A Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis|Terminated||Phase 3|510|Actual|BioMS Technology Corp.||2||Negative efficacy results of the MAESTRO-01 study|f||||t||||||||||2017-02-18 15:39:14.267372|2017-02-18 15:39:14.267372
NCT00468598|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2015-03-09|||January 2007||2007-01-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Observational|||The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery|The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery|Completed||N/A|3000|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 15:39:14.363613|2017-02-18 15:39:14.363613
NCT00468585|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-02|2015-12-17|2015-12-17||June 2005||2005-06-01|December 2015|2015-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model|A Multicenter, Phase I/II Study of Every Other Week Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model|Completed||Phase 1/Phase 2|62|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 15:39:14.455354|2017-02-18 15:39:14.455354
NCT00468572|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2012-01-06|||February 2007||2007-02-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Using Affectionate Communication as a Response to Acute Stress|Affectionate Communication as a Mechanism for Responding to Acute Stress|Completed||N/A|120|Anticipated|Arizona State University||2|||f||||f||||||||||2017-02-18 15:39:15.092284|2017-02-18 15:39:15.092284
NCT00468559|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2014-05-06|2009-06-03||April 2007||2007-04-01|April 2014|2014-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Phase 3/Safety & Efficacy of Esomeprazole in Infants|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Treatment-withdrawal Study to Evaluate the Efficacy and Safety of Esomeprazole for the Treatment of Gastroesophageal Reflux (GERD) in Infants Aged 1 to 11 Months, Inclusive|Completed||Phase 3|98|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 15:39:15.21336|2017-02-18 15:39:15.21336
NCT00468546|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2016-08-30|2016-08-30||May 2003||2003-05-01|August 2016|2016-08-01|July 2012|Actual|2012-07-01|January 2005|Actual|2005-01-01||Interventional||Safety population included participants who were randomized and received any part of an infusion of the study drug.|A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy|A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Alpha Therapies|Completed||Phase 3|520|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:39:16.166823|2017-02-18 15:39:16.166823
NCT00468533|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2007-04-30|||May 2006||2006-05-01|April 2007|2007-04-01|July 2007|Anticipated|2007-07-01|||||Interventional|||The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial|The Monitor of Serum Prolactin Level and Related Clinical Observations Among Individuals With Schizophrenia Spectrum Illnesses in a 3 Months Aripiprazole Trial|Unknown status|Recruiting|Phase 4|50|Anticipated|Yu-Li Hospital||3|||f||||t||||||||||2017-02-18 15:39:17.183102|2017-02-18 15:39:17.183102
NCT00468520|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2011-02-28|||November 2003||2003-11-01|February 2011|2011-02-01|October 2005|Actual|2005-10-01|||||Interventional|||Adjuvant Oxytocin for Preinduction Ripening With a Foley catheter--a Clinical Trial|A Prospective, Randomized Trial of Transcervical Foley Catheter With or Without Oxytocin for Preinduction Cervical Ripening|Completed||N/A|200|Actual|Columbia University||1|||f||||f||||||||||2017-02-18 15:39:17.288073|2017-02-18 15:39:17.288073
NCT00468507|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2010-03-30|||March 2007||2007-03-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||The Anti-inflammatory Effects of High-fat Nutrition; Towards a Clinical Application|The Anti-inflammatory Effects of High-fat Nutrition; Towards a Clinical Application|Completed||Early Phase 1|18|Actual|Maastricht University Medical Center||1|||f||||t||||||||||2017-02-18 15:39:17.387669|2017-02-18 15:39:17.387669
NCT00468494|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2013-01-24|||September 2006||2006-09-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?|Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia|Completed||N/A|308|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-02-18 15:39:17.494135|2017-02-18 15:39:17.494135
NCT00468481|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2014-04-04|2011-01-04||April 2007||2007-04-01|April 2014|2014-04-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety Study for an Oral Contraceptive Containing Folate|Multi-Center, Randomized, Double-Blind Active-Controlled, Parallel Group Study to Investigate Plasma Folate, Red Blood Cell Folate and Homocysteine Levels During a 24 Week Oral Administration of an OC Containing Folate Compared to OC Alone|Completed||Phase 3|385|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:39:17.600213|2017-02-18 15:39:17.600213
NCT00468468|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2016-02-03|||September 2003||2003-09-01|February 2016|2016-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Mentor Integration Study|Mentor Integration Study|Completed||N/A|126|Actual|University of Wisconsin, Madison||4|||f||||||||||||||2017-02-18 15:39:18.95388|2017-02-18 15:39:18.95388
NCT00468455|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2014-12-12|||October 2005||2005-10-01|December 2014|2014-12-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Observational|||Post-Op Quality of Life After Colorectal Surgery|Postoperative Quality of Life: Development and Assessment of a Novel Tool to Assess Quality of Life Following Colorectal Surgery|Completed||N/A|100|Actual|University Hospitals Cleveland Medical Center|||1||f||||f||||||||||2017-02-18 15:39:19.050158|2017-02-18 15:39:19.050158
NCT00468442|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2016-02-21||2011-11-28|November 2006||2006-11-01|February 2016|2016-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||B-Lymphocyte Immunotherapy in Islet Transplantation|B-Lymphocyte Immunotherapy in Islet Transplantation: Toward Calcineurin-Inhibitor Free Immunosuppression (CIT-05)|Terminated||Phase 2|2|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Lack of efficacy|f||||||||||||||2017-02-18 15:39:19.148273|2017-02-18 15:39:19.148273
NCT00468429|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2007-06-01|||May 2007||2007-05-01|June 2007|2007-06-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery|Comparative Study of the Safety and Effectiveness Between Off-Label Subconjunctival Bevacizumab and Mitomycin C in Glaucoma Filtering Surgery.|Unknown status|Recruiting|Phase 4|40|Anticipated|Grewal Eye Institute||2|||f||||f||||||||||2017-02-18 15:39:19.273652|2017-02-18 15:39:19.273652
NCT00468416|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2007-05-03|||February 2007||2007-02-01|May 2007|2007-05-01|February 2008||2008-02-01|||||Interventional|||Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior Resection|Evaluation of NiTi Shape Memory End-to-End Compression Anastomosis Ring (CAR) for Compression Anastomosis in Anterior Resection|Unknown status|Recruiting|Phase 2|60||Tel-Aviv Sourasky Medical Center|||||f||||t||||||||||2017-02-18 15:39:22.046781|2017-02-18 15:39:22.046781
NCT00468403|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2016-03-09||2012-12-27|October 2008||2008-10-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Interventional|LEEP||LEA29Y (Belatacept) Emory Edmonton Protocol|Islet Transplantation in Type I Diabetes With LEA29Y (Belatacept) Maintenance Therapy (CIT-04)|Completed||Phase 2|10|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 15:39:22.147733|2017-02-18 15:39:22.147733
NCT00468390|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2008-10-10|||April 2007||2007-04-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|||||Observational|||Capsaicin-Evoked Pain in Patients With CRPS|Capsaicin-Evoked Pain in Patients With Complex Regional Pain Syndrome|Completed||N/A|40|Actual|Danish Pain Research Center|||1||f||||f||||||||||2017-02-18 15:39:22.30936|2017-02-18 15:39:22.30936
NCT00468377|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2011-11-23|||March 2004||2004-03-01|November 2011|2011-11-01|October 2014|Anticipated|2014-10-01|December 2011|Anticipated|2011-12-01||Interventional|||Safety and Efficacy Study of Re-treatment With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNFα Therapies|An Open Label Study of the Efficacy and Safety of Re-treatments With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNFα Therapies|Unknown status|Active, not recruiting|Phase 3|341|Actual|Hoffmann-La Roche||1|||f||||f||||||||||2017-02-18 15:39:22.386535|2017-02-18 15:39:22.386535
NCT00468364|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2007-08-29|||July 2003||2003-07-01|August 2007|2007-08-01|March 2006|Actual|2006-03-01|||||Observational|ClampHOE901||Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes|Comparison of Carbohydrate Metabolism During the Night and at Hypoglycemia in Type-2 Diabetic Patients Either on Glargine or NPH Insulin|Completed||N/A|12|Actual|University of Giessen|||||f||||f||||||||||2017-02-18 15:39:22.464842|2017-02-18 15:39:22.464842
NCT00468351|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2007-05-01|||April 2006||2006-04-01|April 2007|2007-04-01|April 2007||2007-04-01|||||Interventional|IBEME||Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study)|Intravitreal Bevacizumab Versus Intravitreal Triamcinolone Acetonide for Refractory Diabetic Macular Edema|Unknown status|Active, not recruiting|Phase 1|||University of Sao Paulo||2|||f||||t||||||||||2017-02-18 15:39:22.553267|2017-02-18 15:39:22.553267
NCT00468182|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2015-05-05|||April 2007||2007-04-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis|Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis|Completed||Phase 4|24|Actual|Rutgers, The State University of New Jersey|||2||f||||f||||||||||2017-02-18 15:39:22.671158|2017-02-18 15:39:22.671158
NCT00468169|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2012-10-05|||July 2006||2006-07-01|October 2012|2012-10-01|November 2012|Anticipated|2012-11-01|August 2012|Actual|2012-08-01||Interventional|EPIC||Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer|A Randomized Phase II Trial of Concurrent Chemoradiation With Cetuximab (ERBITUX®), 5 Fluorouracil, Hydroxyurea, and Twice-daily Radiation (CetuxFHX) Versus Cetuximab (ERBITUX®), Cisplatin, and Accelerated Radiation With Concomitant Boost (CetuxPX) After Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 2|110|Anticipated|University of Chicago||2|||f||||t||||||||||2017-02-18 15:39:22.773223|2017-02-18 15:39:22.773223
NCT00468143|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2016-04-26|2013-04-17||August 2007||2007-08-01|April 2016|2016-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall|A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall|Completed||Phase 4|62|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-02-18 15:39:23.001229|2017-02-18 15:39:23.001229
NCT00468130|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2014-09-23||2013-09-03|May 2006||2006-05-01|September 2014|2014-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|Abilify||Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children|Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children|Completed||N/A|15|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 15:39:23.633412|2017-02-18 15:39:23.633412
NCT00468117|ClinicalTrials.gov processed this data on February 17, 2017|2007-05-01|2016-10-07||2016-10-07|January 2007||2007-01-01|October 2016|2016-10-01|September 2017|Anticipated|2017-09-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy of Islet After Kidney Transplantation|Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients: Efficacy of Islet After Kidney Transplantation (CIT-06)|Active, not recruiting||Phase 3|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 15:39:23.755245|2017-02-18 15:39:23.755245
NCT00468104|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-29|2012-04-25|2011-12-18||April 2004||2004-04-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|October 2008|Actual|2008-10-01||Interventional|CPE||Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas|Response to Instillation of Activase in the Pleural Cavity vs Placebo in the Management of Complicated Pleural Effusion/Empyema|Completed||N/A|100|Actual|Midwest Pulmonary and Critical Care|The sample size for secondary outcomes in the Placebo group is small|2|||f||||t||||||||||2017-02-18 15:39:23.90173|2017-02-18 15:39:23.90173
NCT00468091|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2015-03-31|||February 1999||1999-02-01|April 2007|2007-04-01|September 2000|Actual|2000-09-01|||||Interventional|||Effects of Exendin(9-39) on Gastroduodenal Motility|Regulation of Antro-pyloro-duodenal and Proximal Gastric Motility by GLP-1: Involvement of Cholinergic Pathways|Completed||Phase 1|10|Actual|Ludwig-Maximilians - University of Munich||4|||f||||||||||||||2017-02-18 15:39:24.309872|2017-02-18 15:39:24.309872
NCT00468078|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2016-01-11|||November 2006||2006-11-01|January 2016|2016-01-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|FPCIT||Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients|The Single Center, Phase III Clinical Trial to Evaluate the Efficacy and the Safety of [18F]FPCIT Positron Emission Tomography in Parkinson's Disease and Essential Tremor Patients|Completed||Phase 3|78|Actual|Asan Medical Center||2|||f||||t||||||||||2017-02-18 15:39:24.423273|2017-02-18 15:39:24.423273
NCT00468065|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2008-05-05|||April 2007||2007-04-01|April 2007|2007-04-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||VeinViewer Assisted Intravenous Catheter Placement in the Pediatric Emergency Department|VeinViewer Assisted Intravenous Catheter Placement in the Pediatric Emergency Department|Unknown status|Recruiting|Phase 4|200|Anticipated|Lifespan||2|||f||||t||||||||||2017-02-18 15:39:24.546067|2017-02-18 15:39:24.546067
NCT00468052|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2016-10-11|2013-09-13||March 2007||2007-03-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Decrease Emergence Agitation and Provide Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy|Use of Dexmedetomidine Infusion for Analgesia and Emergence Agitation for Children Undergoing Tonsillectomy and Adenotonsillectomy|Completed||Phase 3|122|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 15:39:24.656715|2017-02-18 15:39:24.656715
NCT00468039|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2013-01-02|||March 2007||2007-03-01|January 2013|2013-01-01||||June 2008|Actual|2008-06-01||Interventional|||A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin|A Multicenter, Open-label Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin 100mg qd Plus Metformin 1000mg Bid in Drug Naive Patients With Type 2 Diabetes With Very Poor Glycemic Control|Completed||Phase 3|94|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:39:25.208672|2017-02-18 15:39:25.208672
NCT00468026|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2007-04-30||||||March 2007|2007-03-01||||||||Interventional|||Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate||Unknown status|Not yet recruiting|Phase 1|||ProstaPlant Urology System Ltd.||1|||f||||||||||||||2017-02-18 15:39:25.322551|2017-02-18 15:39:25.322551
NCT00468013|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2015-02-06|||March 2007||2007-03-01|February 2015|2015-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Computer-Based Intervention for Medically Unexplained Physical Symptoms||Completed||N/A|60|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 15:39:25.406489|2017-02-18 15:39:25.406489
NCT00468000|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2016-06-29||2016-06-24|April 2007||2007-04-01|June 2016|2016-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|RESTORE-CLI||Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia|Use of Ixmyelocel-T (Formerly TRC Autologous Bone Marrow Cells) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia|Completed||Phase 2|86|Actual|Vericel Corporation||2|||f||||t||||||||||2017-02-18 15:39:25.757007|2017-02-18 15:39:25.757007
NCT00467987|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2016-11-15|||June 2007||2007-06-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism|Effect of Androgel on Atherogenesis, Inflammation, Cardiovascular Risk Factors And Adiposity in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism.: a Prospective, Randomized and Controlled-Study|Recruiting||N/A|80|Anticipated|University at Buffalo||3|||f||||f||||||||||2017-02-18 15:39:25.909687|2017-02-18 15:39:25.909687
NCT00467974|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2015-01-21|||June 2007||2007-06-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma|A Randomized Controlled Trial of Transarterial Ethanol Ablation (TEA) With Lipiodol-Ethanol Mixture (LEM) Versus Transcatheter Arterial Chemoembolisation (TACE) for Unresectable Hepatocellular Carcinoma|Completed||Phase 3|98|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 15:39:26.048552|2017-02-18 15:39:26.048552
NCT00467961|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-28|2014-12-22|2014-12-22||April 2007||2007-04-01|December 2014|2014-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Stem Cell Transplantation for Patients With Cancers of the Blood|Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD After HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects With Hematologic Malignancies|Completed||Phase 2|61|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 15:39:26.159743|2017-02-18 15:39:26.159743
NCT00467948|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-29|2007-04-30|||June 2004||2004-06-01|June 2003|2003-06-01|March 2006|Actual|2006-03-01|||||Interventional|||Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients|Double Blind Randomised Study of 2 Days and 5 Days Cefazolin Prophylactic Method in Laryngeal Oncologic Surgery|Completed||Phase 3|90|Actual|Tehran University of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:39:26.460479|2017-02-18 15:39:26.460479
NCT00467935|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-29|2011-07-28|||March 2007||2007-03-01|July 2011|2011-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|SALVAGE||Scotoma Reduction in AMD Patients Treated With Ranibizumab|A Phase I/II Study to Evaluate Scotoma Reduction in And Limited Visual Acuity in aGe Related Macular Degeneration Patients Treated With Intravitreal Lucentis|Completed||Phase 1/Phase 2|20|Anticipated|Retina Research Foundation||1|||f||||t||||||||||2017-02-18 15:39:26.556682|2017-02-18 15:39:26.556682
NCT00467922|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2009-10-20|||May 2007||2007-05-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy|A Randomized Prospective Double Blind Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy: Standard Care Versus Either Colloid and Crystalloid|Completed||Phase 3|69|Anticipated|Spectrum Health Hospitals||1|||f||||f||||||||||2017-02-18 15:39:26.668953|2017-02-18 15:39:26.668953
NCT00467909|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2007-04-30|||November 2005||2005-11-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|CHAMPION||Nutrition and Cognition in Indian Children|Efficacy of Fortified Products on Improving Long Term Cognitive Performance in School Children in India|Completed||N/A|600|Actual|St. John's Research Institute||4|||f||||f||||||||||2017-02-18 15:39:26.778177|2017-02-18 15:39:26.778177
NCT00467896|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2013-03-27|2012-09-27||September 2006||2006-09-01|March 2013|2013-03-01|June 2011|Actual|2011-06-01|November 2010|Actual|2010-11-01||Interventional|||"The Power 15 Study: Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting"|"A Comparison of Safety and Inhalation Times of Ventavis (Iloprost) Inhalation Solution Delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 Power 15 Study"|Terminated||Phase 2|62|Actual|Actelion|Study was terminated early due to the discontinuation of the I-neb Power Disc-15 development program.|1||Sponsor's decision|f||||||||||||||2017-02-18 15:39:26.881959|2017-02-18 15:39:26.881959
NCT00467883|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2014-07-17|||June 2007||2007-06-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|June 2011|Actual|2011-06-01||Interventional|AMBIZYGO||Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment|AMBIZYGO: Efficacy of High Dose [10 mg/kg/j] Liposomal Amphotericin B (Ambisome)Efficacy in Initial Zygomycosis Treatment:Phase II Trial|Completed||Phase 2|40|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 15:39:27.465955|2017-02-18 15:39:27.465955
NCT00467870|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2012-09-13||2012-08-31|March 2006||2006-03-01|September 2012|2012-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|TU||Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men|A Two-Arm, Open-Label, Randomized, Multi-Center Pharmacokinetic and Long-Term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men|Completed||Phase 3|500|Actual|Endo Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:39:27.588152|2017-02-18 15:39:27.588152
NCT00467857|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2012-09-13|2010-11-03||April 2007||2007-04-01|January 2011|2011-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study of the Combination of a Cyanoacrylate and Surgical Solutions in Reducing Skin Flora Contamination|A Randomized, Controlled, Parallel Group, Multi-center, Open Label Study Comparing Common Surgical Skin Preparation Solutions in Combination With InteguSeal Versus Common Surgical Skin Preparation Solutions to Reduce Skin Flora Contamination.|Completed||Phase 4|293|Actual|Kimberly-Clark Corporation||2|||f||||f||||||||||2017-02-18 15:39:27.712515|2017-02-18 15:39:27.712515
NCT00467844|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2014-06-26|2013-01-18||May 2007||2007-05-01|June 2014|2014-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.|Double-Blind, Placebo-Controlled, Dose-Finding Study of the Effect of GTx-024 on Muscle Wasting (Cachexia) in Patients With Cancer|Completed||Phase 2|159|Actual|GTx||3|||f||||f||||||||||2017-02-18 15:39:28.888522|2017-02-18 15:39:28.888522
NCT00467831|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-28|2013-06-03|2013-06-03||April 2007||2007-04-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome|Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome|Terminated||Phase 1/Phase 2|3|Actual|National Institutes of Health Clinical Center (CC)|The study was terminated because enrollment was too low. The results shown are not statistically significant.|1||insufficient enrollment|f||||f||||||||||2017-02-18 15:39:29.639311|2017-02-18 15:39:29.639311
NCT00467818|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2010-11-23|||January 2007||2007-01-01|November 2010|2010-11-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders|Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders|Unknown status|Recruiting|N/A|60|Anticipated|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-02-18 15:39:29.901122|2017-02-18 15:39:29.901122
NCT00467805|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2010-04-08|||March 2009||2009-03-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|May 2009|Actual|2009-05-01||Interventional|||Immediate Effect of Light on Reproductive Hormones in Women: a Role of the Spectrum||Completed||N/A|16|Actual|Russian Academy of Medical Sciences||1|||f||||f||||||||||2017-02-18 15:39:30.034966|2017-02-18 15:39:30.034966
NCT00467792|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2008-12-05|||January 2006||2006-01-01|December 2008|2008-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|UP||Natural History of Urticaria Pigmentosa in Children|Natural History of Urticaria Pigmentosa in Children|Completed||N/A|47|Actual|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 15:39:30.125215|2017-02-18 15:39:30.125215
NCT00467779|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2016-07-25|2016-06-10||May 2007||2007-05-01|July 2016|2016-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional||Safety population consisted of all participants who received at least 1 dose of study drug.|Study of Cobimetinib in Participants With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of GDC-0973/XL518 Administered Orally Daily to Subjects With Solid Tumors|Completed||Phase 1|119|Actual|Genentech, Inc.||5|||f||||||||||||||2017-02-18 15:39:30.270236|2017-02-18 15:39:30.270236
NCT00467766|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2007-05-03|||July 1999||1999-07-01|May 2007|2007-05-01|June 2003|Actual|2003-06-01|||||Interventional|||Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer’s Disease|Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer’s Disease|Completed||N/A|300|Actual|National Institute on Aging (NIA)|||||f||||t||||||||||2017-02-18 15:39:36.544661|2017-02-18 15:39:36.544661
NCT00467753|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2013-10-25|2013-10-25||April 2006||2006-04-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||5 patients started in the study, 2 dropped out after 1-2 weeks , 3 were lost to follow up.|Oxcarbazepine Versus Placebo in Childhood Autism|Oxcarbazepine Versus Placebo in Childhood Autism|Completed||N/A|5|Actual|Rutgers, The State University of New Jersey|Patients became more irritable coming off of previous medication and were unable to tolerate monotherapy with the medication.|2|||f||||t||||||||||2017-02-18 15:39:36.657504|2017-02-18 15:39:36.657504
NCT00467740|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2014-06-17|2014-03-28||May 2007||2007-05-01|June 2014|2014-06-01||||October 2008|Actual|2008-10-01||Interventional|||Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma|Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy (Bronchodilation) and Safety of 4 Weeks of Treatment of Orally Inhaled BI 1744 CL (4 Doses) Delivered by the Respimat® Inhaler in Patients With Asthma|Completed||Phase 2|296|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:39:37.368467|2017-02-18 15:39:37.368467
NCT00467727|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-29|2012-04-27|||April 2007||2007-04-01|April 2012|2012-04-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||Visibility of Lesion Characteristics With Phase Contrast Mammography|Lesion Characteristics' Visibility With Phase Contrast Mammography in Comparison to X-Ray Mammography for Women Undergoing X-Ray Diagnostic Mammography|Completed||N/A|53|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:39:39.879223|2017-02-18 15:39:39.879223
NCT00467714|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-29|2008-11-17|||February 2007||2007-02-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation Of Cloumella Strut Effect In Tip Rotation|Evaluation of Cloumella Strut in Maintenance of Tip Rotation|Completed||Phase 4|92|Actual|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-02-18 15:39:40.183365|2017-02-18 15:39:40.183365
NCT00467701|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2009-01-16|||May 2007||2007-05-01|January 2009|2009-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|CAPITO||Community Acquired Pneumonia in Telemark and Ostfold|Prevalence of Legionella Infections, Bacterial Etiology in Pneumonia Among Patients Admitted to Hospital,- and Risk Factors/Characteristics for These Patients.(Translated From Norwegian)|Completed||N/A|380|Actual|Sykehuset Telemark|||1||f||||f||||||Samples Without DNA|"~     sputum~   "|||2017-02-18 15:39:40.316724|2017-02-18 15:39:40.316724
NCT00467688|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2007-10-30|||February 2007||2007-02-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes|The Effect of Continuous Glucose Monitoring With and Without Real Time Access to Glucose Values and Glucose Alerts on Course of Glucose and Satisfaction With CGMS in Type 1 Diabetic Patients|Completed||N/A|50|Actual|Forschungsinstitut der Diabetes Akademie Mergentheim||2|||f||||t||||||||||2017-02-18 15:39:40.401715|2017-02-18 15:39:40.401715
NCT00467675|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-30|2015-12-02|||April 2006||2006-04-01|September 2007|2007-09-01|January 2007|Actual|2007-01-01|||||Observational|||Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM Data|Observational Study of Interstitial Glucose Monitoring With the FreeStyle Navigator CGM System to Develop Novel Methods for Displaying, Reporting and Analyzing CGM Data for Clinical Decision-Making: Phase 2-Establishing Ambulatory Glucose Profiles for Individuals Without Diabetes|Completed||Phase 2|35|Actual|HealthPartners Institute|||||f||||f||||||||||2017-02-18 15:39:40.514755|2017-02-18 15:39:40.514755
NCT00467662|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2007-04-30||||||April 2007|2007-04-01||||||||Interventional|||Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)|"The Safety, Efficacy and Convenience of Use of the Natural Agent Superlysin Gel as Treatment for Herpes Labialis in Comparison to Acyclovir 5% and Docozanole 10%."|Unknown status|Not yet recruiting|Phase 4|75|Anticipated|Hadassah Medical Organization|||||f||||t||||||||||2017-02-18 15:39:40.59786|2017-02-18 15:39:40.59786
NCT00467649|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2015-03-26|2009-04-10||May 2007||2007-05-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes|A Phase 4, Randomized, Open Label, Parallel Group, Multicenter Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes|Completed||Phase 4|112|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:39:40.701511|2017-02-18 15:39:40.701511
NCT00467636|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2009-10-01|||July 2007||2007-07-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations|Influence of Insulin Therapy in Patients Admitted to Hospital With Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Terminated||N/A|51|Actual|The Royal Bournemouth Hospital||2||Difficulty recruiting (early discharge scheme initiated)|f||||t||||||||||2017-02-18 15:39:42.039727|2017-02-18 15:39:42.039727
NCT00467623|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2008-10-16|||January 1995||1995-01-01|April 2007|2007-04-01|December 1997|Actual|1997-12-01|||||Observational|||Holotranscobalamin Remains Unchanged During Pregnancy|Holotranscobalamin Remains Unchanged During Pregnancy. Longitudinal Changes of Cobalamins and Its Binding Proteins During Pregnancy and Postpartum|Completed||N/A|150||University of Aarhus|||||f||||f||||||||||2017-02-18 15:39:42.162802|2017-02-18 15:39:42.162802
NCT00467610|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2014-10-23|2012-08-21||May 2007||2007-05-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS|A Phase 2, Open-Label, Multiple-Dose Study Investigating the Efficacy and Safety of Panhematin in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome|Terminated||Phase 2|6|Actual|Rush University Medical Center||1||lack of efficacy.|f||||t||||||||||2017-02-18 15:39:42.253285|2017-02-18 15:39:42.253285
NCT00467597|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2014-11-19|2014-10-30||April 2006||2006-04-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|August 2008|Actual|2008-08-01||Observational|||Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)|Quantification of Levodopa Induced Dyskinesia in Parkinson Disease: Developing Objective Measures of Levodopa Induced Dyskinesia (Study One)|Completed||N/A|36|Actual|VA Office of Research and Development|||1||f||||t||||||||||2017-02-18 15:39:42.539389|2017-02-18 15:39:42.539389
NCT00467584|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2014-05-15|2014-04-17||July 2007||2007-07-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Aspirin for Treatment of Multiple Sclerosis-Related Fatigue|Aspirin for Treatment of Multiple Sclerosis-Related Fatigue|Terminated||Phase 3|62|Actual|Mayo Clinic|Early termination leading to smaller number of subjects analyzed.|3||Interim analysis indicated treatment unlikely effective;slow recruitment|f||||f||||||||||2017-02-18 15:39:43.062048|2017-02-18 15:39:43.062048
NCT00467571|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2013-05-01|||March 2006||2006-03-01|September 2008|2008-09-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura|Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura|Completed||Phase 4|26|Actual|Mahidol University||1|||f||||t||||||||||2017-02-18 15:39:43.464368|2017-02-18 15:39:43.464368
NCT00467558|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2012-04-18|2012-02-03||May 2007||2007-05-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Double-Blind Naltrexone in Compulsive Sexual Behavior|A Double-Blind, Placebo-Controlled Study of Naltrexone in Compulsive Sexual Behavior|Completed||Phase 2|7|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 15:39:43.597738|2017-02-18 15:39:43.597738
NCT00467545|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2012-05-07|||April 2007||2007-04-01|May 2012|2012-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B|An Extension to A Randomized, Open-label, Controlled, Multicenter, Exploratory Trial to Characterize the Results of Daily Oral Administration of Telbivudine (LDT600) 600 mg or Entecavir (ETV) 0.5 mg Given Over 12 Weeks on the Kinetics of Hepatitis B Virus (HBV) DNA in Adults With HBeAg-positive, Compensated Chronic Hepatitis B (CHB) (An Open-label Multicenter, follow-on Trial of the Safety of Oral Administration of Telbivudine (LDT600) 600 mg Over 21 Months in Adults With HBeAg-positive Ompensated Chronic Hepatitis B (CHB))|Completed||Phase 4|44|Actual|Novartis|||||f||||||||||||||2017-02-18 15:39:43.998248|2017-02-18 15:39:43.998248
NCT00467532|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2013-01-16|||March 2007||2007-03-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients|A Prospective Longitudinal Study of the Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Patients Sustaining Significant Burn Injury|Completed||N/A|60|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 15:39:44.210383|2017-02-18 15:39:44.210383
NCT00467519|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2014-01-10|2010-11-04||April 2007||2007-04-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age|Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine as Fifth Dose Booster in Children 4 to 6 Years of Age|Completed||Phase 3|1045|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:39:44.315546|2017-02-18 15:39:44.315546
NCT00467506|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2011-11-10|||May 2004||2004-05-01|November 2011|2011-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|RIT in MTC||Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma|Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma|Completed||Phase 2|||Nantes University Hospital|||||f||||t||||||||||2017-02-18 15:39:44.953688|2017-02-18 15:39:44.953688
NCT00467493|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2009-06-02|||March 2007||2007-03-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers|A Partial Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Anastrozole, an Aromatase Inhibitor, on Endometrial Thickness in Healthy Premenopausal Women When Dosed at Various Times During the Menstrual Cycle (Protocol M-001)|Completed||Phase 2|64|Actual|Meditrina Pharmaceuticals||6|||f||||f||||||||||2017-02-18 15:39:45.222609|2017-02-18 15:39:45.222609
NCT00467467|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2013-05-28|||June 2006||2006-06-01|May 2013|2013-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort|Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort|Completed||Phase 3|60|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||||f||||t||||||||||2017-02-18 15:39:45.313809|2017-02-18 15:39:45.313809
NCT00467454|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2011-12-13|||June 2007||2007-06-01|December 2011|2011-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Naltrexone in the Treatment of Pyromania|A Double-Blind, Placebo-Controlled Study of Naltrexone in Pyromania|Withdrawn||Phase 2|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Funding allocation to different clinical trials.|f||||t||||||||||2017-02-18 15:39:45.39089|2017-02-18 15:39:45.39089
NCT00467441|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2007-10-31||||||October 2007|2007-10-01||||||||Interventional|||VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness|A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Efficacy and Safety of VSF-173 and Matching Placebo in Healthy Male and Female Subjects With Induced Excessive Sleepiness|Completed||Phase 2|60|Anticipated|Vanda Pharmaceuticals|||||f||||||||||||||2017-02-18 15:39:45.504488|2017-02-18 15:39:45.504488
NCT00467428|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2007-04-27|||August 2003||2003-08-01|April 2007|2007-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder|Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder. A Randomised, Double-Blind, Placebo-Controlled Study|Completed||Phase 2|126|Actual|NeuroSearch A/S||2|||f||||||||||||||2017-02-18 15:39:45.583191|2017-02-18 15:39:45.583191
NCT00467415|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2009-06-26|||May 2007||2007-05-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|October 2009|Anticipated|2009-10-01||Interventional|SSTTEP||Supported Speed Treadmill Training Exercise Program (SSTTEP) for Marginally Ambulatory Children With Cerebral Palsy|Multi-Center Project: Supported Speed Treadmill Training Exercise Program (SSTTEP) for Marginally Ambulatory Children With Cerebral Palsy|Unknown status|Active, not recruiting|N/A|66|Anticipated|Shriners Hospitals for Children||1|||f||||f||||||||||2017-02-18 15:39:45.663374|2017-02-18 15:39:45.663374
NCT00467402|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2012-05-02||2012-05-02|April 2007||2007-04-01|May 2012|2012-05-01||||September 2009|Actual|2009-09-01||Interventional|||Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder|A 52-week, Randomized, Double-blind, Placebo-controlled, Multi-center, Parallel-group Study of the Long-term Efficacy, Tolerability and Safety of Agomelatine 25 and 50 mg in the Prevention of Relapse of Major Depressive Disorder (MDD) Following Open-label Treatment of 16-24 Weeks|Completed||Phase 3|644|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:39:45.76362|2017-02-18 15:39:45.76362
NCT00467389|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2014-05-21|2013-12-18||February 2007||2007-02-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||All participating subjects|Use of Donepezil for Treatment of Cocaine Dependence|Donepezil Effects on Cocaine Craving and Pharmacokinetics|Completed||Phase 2|12|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:39:45.953238|2017-02-18 15:39:45.953238
NCT00467376|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2009-09-14|||January 2007||2007-01-01|September 2009|2009-09-01||||June 2008|Actual|2008-06-01||Interventional|||Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus|12-week, Multicenter, Controlled, Open, 3:1 Randomized, Parallel Clinical Trial Comparing Insulin Glulisine With Regular Human Insulin (Insulin Lispro) Injected Subcutaneously in Subjects With Type 1 or 2 Diabetes Mellitus Also Using Lantus (Insulin Glargine)|Completed||Phase 3|485|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:39:46.249997|2017-02-18 15:39:46.249997
NCT00467363|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2016-12-09|2014-04-10||June 2007||2007-06-01|December 2016|2016-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|EAGeR|All women who consented and underwent randomization were included in baseline analyses.|The Effects of Aspirin in Gestation and Reproduction|The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.|Completed||N/A|1228|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 15:39:46.355949|2017-02-18 15:39:46.355949
NCT00467350|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2013-02-13|||December 2006||2006-12-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Comparison Trial of Enema vs. PEG 3350 for Constipation|Randomized Clinical Trial of Milk and Molasses Enema vs. PEG 3350 for Fecal Impaction in Childhood Constipation|Terminated||N/A|80|Actual|Children's Mercy Hospital Kansas City||2||concern patients in oral cleaout arm had worse outcome|f||||f||||||||||2017-02-18 15:39:46.977743|2017-02-18 15:39:46.977743
NCT00467337|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2007-04-27|||June 2004||2004-06-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Medial-Wedge Insole is Highly Effective in the Treatment of Valgus Knee Osteoarthritis|Medial-Wedge Insole is Highly Effective in the Treatment of Valgus Knee Osteoarthritis|Terminated||Phase 3|||University of Sao Paulo||2||Terminated|f||||t||||||||||2017-02-18 15:39:47.078599|2017-02-18 15:39:47.078599
NCT00467324|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2008-10-13|||April 2007||2007-04-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|October 2007|Actual|2007-10-01||Interventional|||The Advance Trial. Tongue Advancement for Obstructive Sleep Apnea: An Evaluation of the Aspire Medical Advance System|The Advance Trial. Tongue Advancement for Obstructive Sleep Apnea: An Evaluation of the Aspire Medical Advance System|Unknown status|Active, not recruiting|N/A|42|Actual|Aspire Medical||1|||f||||t||||||||||2017-02-18 15:39:47.172393|2017-02-18 15:39:47.172393
NCT00467311|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2008-05-06|||December 2006||2006-12-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Observational|||Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients|Diagnostic, Transversal, Comparative, Not Randomized Trial for the Evaluation of Cystatin C as an Early Marker of Contrast-Medium Nephropathy in High-and-Intermedium-Risk Patients Undergoing to Cardiac Catheterization|Completed||N/A|66|Actual|National Heart Institute, Mexico|||1||f||||f||||||||||2017-02-18 15:39:47.270346|2017-02-18 15:39:47.270346
NCT00467298|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2014-12-01|||December 2007||2007-12-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||An Intervention to Improve Function in Severe Cardiopulmonary Illness|An Intervention to Enhance Function in Severe Cardiopulmonary Illness|Completed||N/A|100|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:39:47.361763|2017-02-18 15:39:47.361763
NCT00467285|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2015-01-13|2014-12-02||October 2006||2006-10-01|January 2015|2015-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Effect of Diabetic Medications on Bone Metabolism|Effect of Thiazolidinediones on Skeletal Health|Completed||N/A|96|Actual|VA Office of Research and Development|||2||f||||f||||||Samples Without DNA|"~     Urine and serum samples collected for the study will be spin and stored at -70 degree C and~     assays run intermittently~   "|||2017-02-18 15:39:47.604212|2017-02-18 15:39:47.604212
NCT00467272|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2012-09-18|||March 2007||2007-03-01|September 2012|2012-09-01||||September 2012|Actual|2012-09-01||Interventional|||Catheter Related - Gram Positive Bloodstream Infections|Phase II, Open-Label Study to Evaluate the Safety and Efficacy of Daptomycin in the Treatment of Catheter-Related Gram Positive Bloodstream Infections|Completed||Phase 2|30|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:39:48.071802|2017-02-18 15:39:48.071802
NCT00467259|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2011-11-10|2011-08-03||April 2007||2007-04-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women|A Randomized, Double-Blind, Placebo-controlled, Multicenter, 52-week Study to Evaluate the Endometrial Safety of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women With Hypoactive Sexual Desire Disorder.|Completed||Phase 3|1271|Actual|Warner Chilcott||2|||f||||t||||||||||2017-02-18 15:39:48.192018|2017-02-18 15:39:48.192018
NCT00467246|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2007-04-27||||||April 2007|2007-04-01||||||||Interventional|||Sub-Cutaneous Insulin in Hyperglycaemic Emergencies|The Use of a Long-Acting Sub-Cutaneous Insulin Analogue in the Management of Hyperglycaemic Emergencies|Withdrawn||N/A|||The Royal Bournemouth Hospital||2||Ethics approval denied|f||||t||||||||||2017-02-18 15:39:49.378393|2017-02-18 15:39:49.378393
NCT00467233|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2012-09-14|||May 2007||2007-05-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of Acid Peel and Laser for the Treatment of Melasma|A Randomized, Rater-blinded, Split-face Comparison of the Efficacy of 30 % Salicylic Acid Peel vs. Q-switched Nd:Yag Laser for the Treatment of Melasma.|Completed||N/A|15|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 15:39:49.465044|2017-02-18 15:39:49.465044
NCT00467220|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2015-12-01|||April 2007||2007-04-01|December 2015|2015-12-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|1072||Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and Cancer|Effect of Daily Calorie Restriction or Alternate-day Reductions in Calorie Intake on Risk for Cardiovascular Disease and Cancer|Active, not recruiting||N/A|40|Anticipated|University of California, San Francisco||3|||f||||t||||||||||2017-02-18 15:39:49.576091|2017-02-18 15:39:49.576091
NCT00467207|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-27|2016-04-15|||September 2006||2006-09-01|April 2016|2016-04-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Intensive Strength Training in Children With Cerebral Palsy - Effect on Hand Function|Intensive Strength Training in Children With Cerebral Palsy - Effect on Hand Function|Completed||Phase 2|10|Actual|St. Olavs Hospital||2|||f||||f||||||||Undecided||2017-02-18 15:39:49.686649|2017-02-18 15:39:49.686649
NCT00467194|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-06-14|||December 2006||2006-12-01|June 2013|2013-06-01||||May 2011|Actual|2011-05-01||Interventional|||Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|A Phase I Study of Rapamycin in Combination With Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 1|27|Actual|National Cancer Centre, Singapore||1|||f||||||||||||||2017-02-18 15:39:49.796149|2017-02-18 15:39:49.796149
NCT00467181|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2008-01-28|||January 2005||2005-01-01|April 2007|2007-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery||Completed||Phase 2|30|Anticipated|Summa Health System|||||f||||t||||||||||2017-02-18 15:39:49.907527|2017-02-18 15:39:49.907527
NCT00467168|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2007-04-26|||January 1998||1998-01-01|April 2007|2007-04-01|May 1998|Actual|1998-05-01|||||Interventional|||Optimal Dietary Fat Pattern to Prevent Cardiovascular Disease Among Type 2 Diabetes|Effects of Fatty Acid Composition Ratios of Oral Fatty Loads on the Dynamic Metabolism of Postprandial Lipid and Triglyceride-Rich Lipoproteins in Chinese NIDDM Out-Patients|Completed||Phase 1/Phase 2|30||Sun Yat-sen University|||||f||||t||||||||||2017-02-18 15:39:49.995964|2017-02-18 15:39:49.995964
NCT00467155|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2015-09-23|||June 2007||2007-06-01|April 2015|2015-04-01||||||||Observational|||Helicobacter in The Gambia (Part 2)|Genotypes of Helicobacter Pylori in West African Children and Adults: Part 2: The Application of a Minimally Invasive Technique for H. Pylori Isolation in a Population Study|Withdrawn||N/A|0|Actual|Medical Research Council Unit, The Gambia|||1||f||||f||||||||||2017-02-18 15:39:50.104157|2017-02-18 15:39:50.104157
NCT00467142|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2011-05-13|||January 2007||2007-01-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery|Phase II Study Evaluating the Efficacy and Tolerance to Chemotherapy With 5-fluorouracil, Folinic Acid, Irinotecan and Bevacizumab as First-line Treatment in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|61|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:39:50.178588|2017-02-18 15:39:50.178588
NCT00467129|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-12-17|||July 2002||2002-07-01|May 2007|2007-05-01||||||||Observational|||Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer|The Role of Genetic Factors in Clinical Outcome for Colorectal Cancer|Unknown status|Active, not recruiting|N/A|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:39:50.274181|2017-02-18 15:39:50.274181
NCT00467116|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2012-05-16|||October 2005||2005-10-01|May 2012|2012-05-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca|A Phase I Study of Erbitux and Gemcitabine With Radiation Therapy for Locally Advanced Pancreas Cancer|Completed||Phase 1|9|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:39:50.351228|2017-02-18 15:39:50.351228
NCT00467103|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2016-09-20|||October 1999||1999-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Observational|||Neural Networks and Language Recovery in Aphasia From Stroke: fMRI Studies|Neural Networks and Language Recovery in Aphasia From Stroke: fMRI Studies|Active, not recruiting||N/A|80|Anticipated|VA Office of Research and Development|||1||f||||f||||||||No||2017-02-18 15:39:50.466915|2017-02-18 15:39:50.466915
NCT00467090|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2017-01-24|||April 23, 2007||2007-04-23|February 3, 2014|2014-02-03|February 3, 2014||2014-02-03|||||Observational|||Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene Mutation|Expanding the Phenotype of the LRRK-2 Mutation in Individuals With History of Parkinson s Disease and Their Relatives: a Prospective Study|Terminated||N/A|34|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:39:50.574023|2017-02-18 15:39:50.574023
NCT00467077|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-09-10|||September 2004||2004-09-01|September 2013|2013-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer|Phase II Trial of ZD1839 (IRESSA®) and Pegylated Interferon Alfa 2b (PEG-Intron™) in Unresectable or Metastatic Renal Cell Carcinoma|Completed||Phase 2|21|Actual|California Cancer Consortium||1|||f||||||||||||||2017-02-18 15:39:50.663426|2017-02-18 15:39:50.663426
NCT00467064|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2010-01-27|||October 2006||2006-10-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Arthritis Self-Management Education Program|Arthritis Self-Management Education -- Dose Response|Completed||N/A|690|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 15:39:50.877211|2017-02-18 15:39:50.877211
NCT00467051|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2016-04-12|2015-03-11||November 2007||2007-11-01|April 2016|2016-04-01||||March 2012|Actual|2012-03-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors|Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin|Active, not recruiting||Phase 2|20|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 15:39:50.98815|2017-02-18 15:39:50.98815
NCT00467038|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-08-20|2014-11-24||November 2006||2006-11-01|August 2015|2015-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Treatment of Aggression, Anger and Emotional Dysregulation in Borderline Personality Disorder|Treatment of Aggression, Anger and Emotional Dysregulation in Borderline Personality Disorder|Completed||N/A|22|Actual|VA Office of Research and Development|Small community sample. Additionally, our emotional task was a “passive viewing task” which means that we did not examine “active” emotion regulation, per se which might be considered a study limitation by some. No comparison treatment group.|2|||f||||f||||||||||2017-02-18 15:39:51.406094|2017-02-18 15:39:51.406094
NCT00467025|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2016-02-23||2015-04-06|May 2007||2007-05-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|April 2010|Actual|2010-04-01||Interventional|||AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib|A Randomized, Double Blinded, Multi-Center Phase 2 Study to Estimate the Efficacy and Evaluate the Safety and Tolerability of Sorafenib in Combination With AMG 386 or Placebo In Subjects With Metastatic Clear Cell Carcinoma of the Kidney|Completed||Phase 2|152|Actual|Amgen||3|||f||||f||||||||||2017-02-18 15:39:51.808968|2017-02-18 15:39:51.808968
NCT00467012|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2012-04-25|||April 2007||2007-04-01|April 2012|2012-04-01|September 2011|Actual|2011-09-01|June 2009|Actual|2009-06-01||Interventional|||Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer|Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer|Completed||Phase 2|122|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 15:39:51.92729|2017-02-18 15:39:51.92729
NCT00466999|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2012-03-28|||February 2007||2007-02-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion|Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion|Completed||N/A|1000|Actual|Gynuity Health Projects||2|||f||||f||||||||||2017-02-18 15:39:52.036873|2017-02-18 15:39:52.036873
NCT00466986|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2011-10-07|||November 2005||2005-11-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer|A Phase II, Non-Randomized Study of Abraxane Plus Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|40|Anticipated|Southeastern Gynecologic Oncology||1|||f||||f||||||||||2017-02-18 15:39:52.153937|2017-02-18 15:39:52.153937
NCT00466973|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-04-26|||April 2007||2007-04-01|April 2007|2007-04-01|May 2009|Anticipated|2009-05-01|||||Interventional|||Atrial Fibrillation Ablation Device Comparison Study|Randomized Comparison of Ablation Devices Used During Surgery for the Treatment of Atrial Fibrillation|Unknown status|Recruiting|Early Phase 1|100|Anticipated|Maimonides Medical Center|||||f||||t||||||||||2017-02-18 15:39:52.254918|2017-02-18 15:39:52.254918
NCT00466960|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2014-01-15|||May 2006||2006-05-01|January 2014|2014-01-01||||July 2011|Actual|2011-07-01||Interventional|||Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy|A Phase II Trial of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) With Weekly Protein Bound Paclitaxel (Abraxane™) as Chemoimmunotherapy for Platinum-Refractory/Resistant Epithelial Ovarian, Primary Peritoneal and Fallopian Tube Cancer|Completed||Phase 2|21|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 15:39:52.353967|2017-02-18 15:39:52.353967
NCT00466947|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2016-11-25|2011-08-25||June 2007||2007-06-01|September 2016|2016-09-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|||COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine|COMPAS: A Phase III Study to Demonstrate Efficacy of GSK Biologicals' 10-valent Pneumococcal Vaccine (GSK1024850A) Against Community Acquired Pneumonia and Acute Otitis Media|Completed||Phase 3|23802|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:39:52.505917|2017-02-18 15:39:52.505917
NCT00466934|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2017-01-24|||April 24, 2007||2007-04-24|December 29, 2011|2011-12-29|December 29, 2011||2011-12-29|||||Observational|||Measuring Blood Flow in the Brain|Cross-Validating NIRS With fMRI|Completed||N/A|31|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:39:58.735017|2017-02-18 15:39:58.735017
NCT00466921|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2016-05-05|||February 2005||2005-02-01|May 2016|2016-05-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome|Phase II Trial of CC-5013 (Lenalidomide, Revlimid®) in Patients With Cutaneous T-Cell Lymphoma|Active, not recruiting||Phase 2|35|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 15:39:58.821482|2017-02-18 15:39:58.821482
NCT00466908|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2010-10-01|||March 2007||2007-03-01|October 2010|2010-10-01|August 2007|Actual|2007-08-01|||||Observational|||Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery|Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery|Completed||Phase 4|0|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 15:39:58.930746|2017-02-18 15:39:58.930746
NCT00466895|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2016-05-15|||April 2007||2007-04-01|May 2016|2016-05-01||||December 2014|Actual|2014-12-01||Interventional|||Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.|Phase I Study of Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.|Active, not recruiting||Phase 1|37|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 15:39:59.010152|2017-02-18 15:39:59.010152
NCT00466882|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2015-05-29|2013-05-30||October 2005||2005-10-01|May 2015|2015-05-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Interventional|||Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients|Issues Related to the Use of the INAMED LAPBAND SYSTEM to Reduce BMI's in Obese Renal Failure Patients Needing Renal Transplantation: A Pilot Study|Completed||N/A|3|Actual|Summa Health System|There were no SAEs, the study had a small sample size and was not able to enroll enough participants to get quality data.|1|||f||||t||||||||||2017-02-18 15:39:59.128562|2017-02-18 15:39:59.128562
NCT00466869|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-09-24|||May 2007||2007-05-01|August 2007|2007-08-01|September 2007|Actual|2007-09-01|||||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin|A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin|Terminated||Phase 2|30|Anticipated|OBEcure Ltd.||||Sponsor decision|f||||f||||||||||2017-02-18 15:39:59.347378|2017-02-18 15:39:59.347378
NCT00466856|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2012-05-17|||December 2003||2003-12-01|May 2012|2012-05-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors|Clinical Trial of Sir-Spheres® in Patients With Symptomatic or Progressive Hepatic Metastases From Neuroendocrine Tumors|Terminated||Phase 2|10|Actual|Vanderbilt-Ingram Cancer Center||1||due to slow accrual|f||||t||||||||||2017-02-18 15:39:59.437053|2017-02-18 15:39:59.437053
NCT00466843|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2009-06-01|||April 2007||2007-04-01|June 2009|2009-06-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome|Mechanism and Response of Thymoglobulin in Patients With Myelodysplastic Syndrome (MDS)|Unknown status|Recruiting|Phase 2|54|Anticipated|Office of Rare Diseases (ORD)||1|||f||||t||||||||||2017-02-18 15:39:59.559558|2017-02-18 15:39:59.559558
NCT00466830|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2011-05-12|||September 2005||2005-09-01|May 2011|2011-05-01||||May 2011|Actual|2011-05-01||Observational|||Psychological and Social Factors That May Increase the Risk of Developing Chronic Pain After Surgery in Women With Breast Cancer|Study of Psychological and Sociological Predisposing the Development of Chronic Pain After Surgery in Women With Resectable Breast Cancer|Completed||N/A|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:39:59.907952|2017-02-18 15:39:59.907952
NCT00466817|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2015-08-13|2013-08-29||June 2008||2008-06-01|July 2015|2015-07-01|June 2013|Actual|2013-06-01|December 2011|Actual|2011-12-01||Interventional|||Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections|A Phase III, Randomized, Placebo-Controlled Blinded Investigation of Six Weeks vs. Six Months of Oral Valganciclovir Therapy in Infants With Symptomatic Congenital Cytomegalovirus Infection (CASG 112)|Completed||Phase 3|109|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 15:40:00.017319|2017-02-18 15:40:00.017319
NCT00466804|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-12-31|||June 2007||2007-06-01|December 2015|2015-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients|Observational Study of Alloimmunity in Cardiac Transplant Recipients|Completed||N/A|263|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"~     Blood samples may be retained~   "|||2017-02-18 15:40:01.30328|2017-02-18 15:40:01.30328
NCT00466791|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-06-23|||August 2004||2004-08-01|June 2015|2015-06-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD|A Phase II, Randomized, Double-blind, Multi-center, Placebo-controlled, Dose Optimization, Analog Classroom, Crossover Study Designed to Assess the Time Course of Treatment Effect, Tolerability and Safety of Methylphenidate Transdermal System (MTS) in Pediatric Patients Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|93|Actual|Noven Therapeutics||2|||f||||f||||||||||2017-02-18 15:40:01.432772|2017-02-18 15:40:01.432772
NCT00466778|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-09-20|||April 2007||2007-04-01|September 2007|2007-09-01||||||||Observational|||Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled Study|Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled Study|Completed||Phase 4|40|Anticipated|Weintraub, Michael I., MD, FACP, FAAN|||||f||||f||||||||||2017-02-18 15:40:01.591908|2017-02-18 15:40:01.591908
NCT00466765|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-05-01||2015-04-13|January 2010||2010-01-01|May 2015|2015-05-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Breast Reconstruction and Augmentation With Brava Enhanced Autologous Fat Micro Grafting|Breast Reconstruction and Augmentation With Brava Enhanced Autologous Fat Micro Grafting|Completed||N/A|589|Actual|Brava||1|||f||||f||||||||||2017-02-18 15:40:01.69153|2017-02-18 15:40:01.69153
NCT00466752|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-05-07|||December 2006||2006-12-01|May 2013|2013-05-01||||April 2010|Actual|2010-04-01||Interventional|||Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer|A Phase II Study of Sorafenib (Nexavar®) Prior to Radical Prostatectomy in Patients With High-Risk Localized Prostate Cancer|Completed||Phase 2|5|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 15:40:01.814622|2017-02-18 15:40:01.814622
NCT00466739|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2008-05-22|||January 2006||2006-01-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|||||Observational|||European Compliance Study in Parkinson's Disease|European Study of Therapeutic Compliance in Parkinson's Disease|Completed||Phase 3|144|Anticipated|South Glasgow University Hospitals NHS Trust|||||f||||||||||||||2017-02-18 15:40:01.939731|2017-02-18 15:40:01.939731
NCT00466726|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-02-17|||March 2007||2007-03-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|CML 0206||Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia|Phase II Multicenter Study of P210-B3A2 Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Response With Persistent Molecular Residual Disease During Imatinib Treatment|Completed||Phase 2|44|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto|||||f||||f||||||||||2017-02-18 15:40:02.031982|2017-02-18 15:40:02.031982
NCT00466713|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2014-05-12|||March 2007||2007-03-01|May 2014|2014-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy|Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy|Terminated||N/A|||Stanford University||||concern over safety of rosiglitazone in heart failure|f||||f||||||||||2017-02-18 15:40:02.160345|2017-02-18 15:40:02.160345
NCT00466700|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2015-05-07|||July 2007||2007-07-01|May 2015|2015-05-01|March 2009|Actual|2009-03-01|June 2008|Actual|2008-06-01||Observational|||Helicobacter in The Gambia (Part 1)|Genotypes of Helicobacter Pylori in West African Children and Adults: Part 1: The Development and Evaluation of Minimally Invasive Techniques for Obtaining H. Pylori Isolates From Adults and Children in The Gambia|Completed||N/A|75|Actual|Medical Research Council Unit, The Gambia|||1||f||||f||||||||||2017-02-18 15:40:02.264925|2017-02-18 15:40:02.264925
NCT00466687|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-07-15|2011-06-02||September 2004||2004-09-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma|A Phase II Trial of Tarceva (Erlotinib) and Avastin (Bevacizumab) in the Treatment of Patients With Metastatic Melanoma|Completed||Phase 2|34|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:40:02.367306|2017-02-18 15:40:02.367306
NCT00466674|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2014-01-14|||January 2007||2007-01-01|January 2014|2014-01-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|IFM 2005-03||Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning|Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning (IFM 2005-03)|Completed||Phase 2|13|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-02-18 15:40:02.758142|2017-02-18 15:40:02.758142
NCT00466661|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2010-03-25|||April 2007||2007-04-01|March 2010|2010-03-01|March 2010|Anticipated|2010-03-01|February 2010|Anticipated|2010-02-01||Interventional|||Acamprosate vs. Placebo in Bipolar Alcoholics|A Double-Blind, Randomized, Placebo-Controlled Trial of Acamprosate in Alcohol-Dependent Individuals With Comorbid Bipolar Disorder|Unknown status|Active, not recruiting|Phase 4|40|Anticipated|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 15:40:02.870286|2017-02-18 15:40:02.870286
NCT00466648|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-04-25|||March 2007||2007-03-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Randomized Controlled Trial Comparing Different Closure Methods for Laparoscopic Port Sites|Randomized Controlled Trial Comparing Two Different Methods of Laparoscopy Port Closure|Completed||N/A|20||New York Presbyterian Hospital|||||f||||t||||||||||2017-02-18 15:40:02.980856|2017-02-18 15:40:02.980856
NCT00466635|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-03-17|||April 2007||2007-04-01|March 2015|2015-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea|An Open-label Study to Assess the Safety, Efficacy and Absorption of Exodif™ (Tolevamer Potassium Sodium) Tablets in Patients With Clostridium Difficile-Associated Diarrhea|Terminated||Phase 3|65|Anticipated|Sanofi|||||||||||||||||||2017-02-18 15:40:03.276716|2017-02-18 15:40:03.276716
NCT00466011|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2012-07-11|||April 2007||2007-04-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Observational|Stardust||Validation of the Stardust Cardio-Respiratory Recorder|Validation of the Stardust Cardio-Respiratory Recorder|Completed||N/A|80|Actual|Associação Fundo de Incentivo à Pesquisa|||1||f||||t||||||||||2017-02-18 15:40:11.779904|2017-02-18 15:40:11.779904
NCT00466622|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2016-07-19|||April 2007||2007-04-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|FlowMet||Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin|Uterine Artery Blood Flow in Pregnant Women With Polycystic Ovary Syndrome(PCOS)Treated With Metformin - a Substudy to The PregMet Study|Completed||Phase 3|48|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 15:40:03.383308|2017-02-18 15:40:03.383308
NCT00466609|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2010-05-12|||May 2007||2007-05-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|EPMTOC||Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment|Pharmacological Augmentation Strategies for Obsessive Compulsive Disorder Patients Non-respondent to First Line Medication Treatment: a Double Blind Placebo Controlled Study|Completed||Phase 4|54|Actual|University of Sao Paulo||3|||f||||t||||||||||2017-02-18 15:40:03.499221|2017-02-18 15:40:03.499221
NCT00466596|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2014-01-08|||March 2007||2007-03-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|November 2013|Actual|2013-11-01||Interventional|MiteE||Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements|Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements|Completed||Phase 1|8|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 15:40:03.621614|2017-02-18 15:40:03.621614
NCT00466583|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2011-07-05|||March 2007||2007-03-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma|A Phase 1, Open-Label, Dose Escalation Study Evaluating the Safety and Tolerability of EZN-2968, a Locked Nucleic Acid Antisense Oligonucleotide Against Hypoxia-Inducible Factor-1α, Administered as a Weekly 2-Hour Intravenous Infusion in Adult Patients With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|52|Actual|Enzon Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:40:03.728827|2017-02-18 15:40:03.728827
NCT00466570|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-06-12|||April 2007||2007-04-01|June 2013|2013-06-01||||||||Interventional|||Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application|Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour|Withdrawn||N/A|0|Actual|Stanford University|||||f||||f||||||||||2017-02-18 15:40:03.828777|2017-02-18 15:40:03.828777
NCT00466557|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2010-08-26|||June 2007||2007-06-01|April 2008|2008-04-01||||||||Observational|||Plasmodium Resistance in A. Gambiae|Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae|Unknown status|Recruiting|N/A|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 15:40:03.912927|2017-02-18 15:40:03.912927
NCT00466544|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2007-04-26|||May 2007||2007-05-01|March 2007|2007-03-01||||||||Interventional|jPK||Randomized Controlled Study of Plasmaknife Tonsillectomy Versus Monopolar Tonsillectomy||Unknown status|Not yet recruiting|Phase 4|100|Anticipated|Children's Hospital of Michigan|||||f||||t||||||||||2017-02-18 15:40:03.991035|2017-02-18 15:40:03.991035
NCT00466531|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2016-08-19|||March 2007||2007-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19|A Phase I/IIa Trial For The Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19|Recruiting||Phase 1/Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:40:04.082818|2017-02-18 15:40:04.082818
NCT00466518|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2010-01-11|||April 2007||2007-04-01|January 2010|2010-01-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant|Sitagliptin Treatment in Patients With Type 2 Diabetes Mellitus After Kidney Transplant|Unknown status|Active, not recruiting|N/A|20|Anticipated|University of Nebraska||1|||f||||f||||||||||2017-02-18 15:40:04.214395|2017-02-18 15:40:04.214395
NCT00466505|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2012-12-14|2011-08-15||May 2005||2005-05-01|December 2012|2012-12-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|||Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery|A Phase 2 Study of Cetuximab in Combination With Celecoxib in Colorectal Cancer|Completed||Phase 2|17|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:40:04.336057|2017-02-18 15:40:04.336057
NCT00466492|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2010-03-18|||April 2007||2007-04-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Advantages and Disadvantages of Long Term Sedation in Intensive Care Unit Patients|Advantages and Disadvantages of Long Term Sedation in ICU Patients|Completed||N/A|140|Actual|Odense University Hospital||1|||f||||f||||||||||2017-02-18 15:40:04.748826|2017-02-18 15:40:04.748826
NCT00466479|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2007-04-26|||August 1999||1999-08-01|April 2007|2007-04-01|October 2002|Actual|2002-10-01|||||Interventional|||Brimonidine vs ALTP in Progressing Human Glaucoma|Topical Brimonidine vs Argon Laser Trabeculoplasty in Progressing Human Glaucoma. A Prospective Randomized Clinical Trial.|Completed||Phase 4|50||University of Parma|||||f||||f||||||||||2017-02-18 15:40:04.879569|2017-02-18 15:40:04.879569
NCT00466466|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-26|2011-11-21|||April 2007||2007-04-01|November 2011|2011-11-01||||November 2010|Actual|2010-11-01||Interventional|||Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients|A Phase Ib Study Investigating the Combination of RAD001 With Cisplatin and Etoposide in Patients With Extensive-stage Small-cell Lung Cancer Not Previously Treated With Chemotherapy|Completed||Phase 1|20|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:40:04.99913|2017-02-18 15:40:04.99913
NCT00466453|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2010-01-14|||November 2005||2005-11-01|January 2010|2010-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Adapting Web-based Instruction to Baseline Knowledge of Physicians-in-training|Adapting Web-based Instruction to Learner Baseline Knowledge: A Randomized Controlled Trial|Completed||Phase 2/Phase 3|144||Mayo Clinic|||||f||||||||||||||2017-02-18 15:40:05.110666|2017-02-18 15:40:05.110666
NCT00466440|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2010-11-23||2010-08-06|June 2007||2007-06-01|November 2010|2010-11-01|June 2010|Actual|2010-06-01|August 2009|Actual|2009-08-01||Interventional|||A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients|A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study With and Without Enzastaurin in Combination With Docetaxel and Prednisone, Followed By Enzastaurin Maintenance as First-Line Treatment in Hormone Refractory Metastatic Prostate Cancer Patients|Completed||Phase 2|101|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:40:05.196097|2017-02-18 15:40:05.196097
NCT00466414|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2008-05-14|||March 2007||2007-03-01|May 2008|2008-05-01|April 2007|Anticipated|2007-04-01|||||Interventional|||Alveolar Ridge Preservation With Polycaprolactone Scaffold for Implant Site Development|Alveolar Ridge Preservation With Polycaprolactone Scaffold for Implant Site Development|Unknown status|Recruiting|Phase 2|20|Anticipated|National University Hospital, Singapore|||||f||||t||||||||||2017-02-18 15:40:05.333746|2017-02-18 15:40:05.333746
NCT00466401|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-02-19|||February 2005||2005-02-01|February 2013|2013-02-01|August 2007|Actual|2007-08-01|||||Interventional|||Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation|Phase 4 Study on Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation In Hypercholesterolemic Patients on Simvastatin|Completed||Phase 4|20||Ziv Hospital|||||f||||||||||||||2017-02-18 15:40:05.417898|2017-02-18 15:40:05.417898
NCT00466388|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2014-05-21|||May 2007||2007-05-01|May 2014|2014-05-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|SMILE||Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia|An Investigator-Initiated,Multicenter,Randomized,Double-Blind Placebo-Controlled Design Study to Assess the Effectiveness of CeviMeline to Improve OraL Health in Patients With XErostomia Secondary to Radiation Therapy for Treatment of Head and Neck Squamous Cell Carcinoma|Completed||Phase 4|54|Actual|American Academy of Otolaryngology-Head and Neck Surgery Foundation||2|||f||||f||||||||||2017-02-18 15:40:05.505329|2017-02-18 15:40:05.505329
NCT00466375|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2016-03-16|||April 2007||2007-04-01|March 2016|2016-03-01|May 2017|Anticipated|2017-05-01|November 2014|Actual|2014-11-01||Observational|||Genetic Basis of Hemangiomas|Genetic Basis of Hemangiomas|Active, not recruiting||N/A|3000|Anticipated|Medical College of Wisconsin|||2||f||||f||||||Samples With DNA|"~     Buccal smear (cheek cells)or small blood sample (4 mL or one teaspoon)~   "|||2017-02-18 15:40:05.770091|2017-02-18 15:40:05.770091
NCT00466362|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-05-22|||April 2007||2007-04-01|May 2007|2007-05-01|December 2008|Anticipated|2008-12-01|||||Observational|||Lifestyle Intervention in Obesity, Effect on Diabetes|One Year Observational Study on Effects of Lifestyle Intervention in Morbidly Obese Persons With Type 2 Diabetes.|Unknown status|Recruiting|N/A|50|Anticipated|Evjeklinikken|||||f||||t||||||||||2017-02-18 15:40:05.874682|2017-02-18 15:40:05.874682
NCT00466349|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2016-11-04|||May 1986||1986-05-01|November 2016|2016-11-01||||December 2020|Anticipated|2020-12-01|50 Years|Observational [Patient Registry]|||International SMA Patient Registry|International Spinal Muscular Atrophy Patient Registry|Recruiting||N/A|5000|Anticipated|Indiana University|||1||f||||t||||||||||2017-02-18 15:40:05.962073|2017-02-18 15:40:05.962073
NCT00466336|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2008-03-05|||January 2003||2003-01-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Observational|||Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices|Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices|Completed||N/A|503|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:40:06.064468|2017-02-18 15:40:06.064468
NCT00466323|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2015-04-06|2014-10-09||September 2007||2007-09-01|August 2014|2014-08-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.|The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness|Completed||N/A|238|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:40:06.176909|2017-02-18 15:40:06.176909
NCT00466310|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2014-07-11|2011-04-05||February 2007||2007-02-01|March 2013|2013-03-01|January 2011|Actual|2011-01-01|January 2009|Actual|2009-01-01||Interventional|||Metabolic Signatures and Biomarkers in Schizophrenia|Metabolic Signatures and Biomarkers in First Episode and Recurrent Patients With Schizophrenia in Comparison to Healthy Controls|Completed||Phase 1|71|Actual|Duke University|Limited to patients admitted to Psychiatric facility|3|||f||||f||||||||||2017-02-18 15:40:06.598717|2017-02-18 15:40:06.598717
NCT00466297|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2009-02-06|||April 2007||2007-04-01|April 2007|2007-04-01|December 2008|Actual|2008-12-01|||||Interventional|SCRIPT||Interprofessional Collaborative Communication in Acute Care Hospital Teams|The SCRIPT Programme (GIM): Structuring Communication Relationships for Interprofessional Teamwork to Achieve Interprofessional Education for Collaborative Patient-Centered Practice (IECPCP)|Completed||N/A|1000|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-02-18 15:40:07.214882|2017-02-18 15:40:07.214882
NCT00466284|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-04-25|||January 2006||2006-01-01|April 2007|2007-04-01||||||||Interventional|||Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer|Phase II Trial of Tarceva Following Concurrent Chemo-Radiotherapy as First Line Therapy in Patients With Unresectable Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|46||Grupo Gallego de Cancer de Pulmon|||||f||||t||||||||||2017-02-18 15:40:07.314367|2017-02-18 15:40:07.314367
NCT00466271|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2008-12-21|||April 2007||2007-04-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Observational|||Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study|Prediction of Significant Hepatic Fibrosis in HCV Carriers With Persistently Normal Alanine Aminotransferase Levels by Splenic Arterial Pulsatility Index- A Validation Study|Completed||N/A|102|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:40:07.405596|2017-02-18 15:40:07.405596
NCT00466258|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2009-11-23|||October 2006||2006-10-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|LINFOTARGAM||LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)|LINFOTARGAM: First-line Treatment With Dose-dense Chemotherapy Plus Rituximab (R-CHOP/14) and Highly Active Antiretroviral Therapy (HAART) in Patients With Diffuse Large B Cell Lymphoma (DLBCL) and Infection With the Human Immunodeficiency Virus (HIV)|Completed||Phase 4|50|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 15:40:07.513078|2017-02-18 15:40:07.513078
NCT00466245|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2014-01-17|||July 2005||2005-07-01|January 2014|2014-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine|Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Study Assessing Safety, Tolerability, Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara Smallpox Vaccine in Adults With and Without Previous Smallpox Vaccination|Completed||Phase 2|590|Actual|Sanofi||8|||f||||t||||||||||2017-02-18 15:40:07.663431|2017-02-18 15:40:07.663431
NCT00466232|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2015-12-15|||April 2007||2007-04-01|April 2007|2007-04-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer|Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer|Completed||Phase 1|16|Actual|HealthPartners Institute||1|||f||||f||||||||||2017-02-18 15:40:07.77114|2017-02-18 15:40:07.77114
NCT00466206|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2015-12-02|2012-05-11||April 2007||2007-04-01|December 2015|2015-12-01|April 2011|Actual|2011-04-01|May 2010|Actual|2010-05-01||Interventional|3MP||Magnetic Mini-Mover Procedure to Treat Pectus Excavatum|Phase II Magnetic Alteration of Pectus Excavatum|Completed||Phase 1/Phase 2|10|Actual|University of California, San Francisco|Technical problems with measurement of PSI. PSI is uninformative in assessing efficacy of treatment as it is a dynamic measure that varies with patient position and respiration at any given measurement.|1|||f||||t||||||||||2017-02-18 15:40:08.002685|2017-02-18 15:40:08.002685
NCT00466193|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2012-02-10|2011-12-15||May 2007||2007-05-01|February 2012|2012-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy and Safety of the Zolpidem Tartrate Sublingual Tablet in Adult Subjects With Insomnia Characterized by Difficulty Returning to Sleep After Awakening in the Middle-of-the-Night (MOTN)|Completed||Phase 3|295|Actual|Transcept Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:40:08.318428|2017-02-18 15:40:08.318428
NCT00466180|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2010-10-27|||June 2004||2004-06-01|October 2010|2010-10-01|November 2006|Actual|2006-11-01|||||Interventional|POSOVIR||Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients||Completed||Phase 4|62|Actual|University Hospital, Caen||2|||f||||f||||||||||2017-02-18 15:40:09.146162|2017-02-18 15:40:09.146162
NCT00466167|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2014-06-24|2009-11-17||April 2007||2007-04-01|May 2014|2014-05-01||||November 2008|Actual|2008-11-01||Interventional|||Pivotal Study in Advanced Parkinsons Disease Patients|A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing the Efficacy, Safety and Tolerability of Pramipexole Extended Release (ER) Versus Placebo and Versus Pramipexole Immediate Release (IR) Administered Orally Over a 26-week Maintenance Phase in L-Dopa+ Treated Patients With Advanced Parkinsons Disease (PD).|Completed||Phase 3|517|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 15:40:09.248369|2017-02-18 15:40:09.248369
NCT00466154|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-02-19|||July 2005||2005-07-01|February 2013|2013-02-01|January 2007|Actual|2007-01-01|||||Interventional|||The Effect of Serum LDL Lowering on Aspirin Resistance|The Effect of Serum LDL Lowering on Aspirin Resistance|Completed||N/A|40||Ziv Hospital|||||f||||t||||||||||2017-02-18 15:40:10.463012|2017-02-18 15:40:10.463012
NCT00466141|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2008-01-21|||June 2007||2007-06-01|April 2007|2007-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|STOPRegain||Weight Maintenance Study for 2007 Shape UP RI Participants|Evaluation of the 2007 Shape Up RI Campaign: Study 3 Maintenance|Completed||N/A|180|Anticipated|The Miriam Hospital|||||f||||t||||||||||2017-02-18 15:40:10.56791|2017-02-18 15:40:10.56791
NCT00466128|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-03-17|||April 2007||2007-04-01|March 2015|2015-03-01|April 2016|Anticipated|2016-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)|A Double-blinded Randomized Controlled Trial With Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) Between 24 and 32 Weeks Gestation|Recruiting||Phase 2|116|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 15:40:10.655029|2017-02-18 15:40:10.655029
NCT00466115|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-04-25|||April 2007||2007-04-01|April 2007|2007-04-01|April 2007|Anticipated|2007-04-01|||||Interventional|||A Phase II Study of MS-275, in Combination With GM-CSF Treating Relapsed and Refractory Myeloid Malignancies|A Phase II Study of an Oral Histone Deacetylase Inhibitor, MS-275 (NSC 706995), in Combination With Sargramostim (GM-CSF, Berlex, Inc.) Treating Relapsed and Refractory Myeloid Malignancies|Unknown status|Not yet recruiting|Phase 2|18||Johns Hopkins University|||||f||||t||||||||||2017-02-18 15:40:10.776856|2017-02-18 15:40:10.776856
NCT00466102|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2012-08-29|||December 2006||2006-12-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2010|Actual|2010-12-01||Interventional|RADAR||Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases|RADAR: A Randomized Discontinuation Phase II Study to Determine the Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases|Unknown status|Active, not recruiting|Phase 2|130|Anticipated|German Breast Group||2|||f||||t||||||||||2017-02-18 15:40:10.873295|2017-02-18 15:40:10.873295
NCT00466089|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2008-01-09|||March 2006||2006-03-01|November 2007|2007-11-01||||||||Interventional|||Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer|Phase II Randomized Trial of 3D Radiotherapy Versus the Combination of 3D Radiotherapy and Erlotinib (Tarceva®) in Patients With Localized-Unresectable Non-Small Cell Lung Cancer Non Susceptible for Chemotherapy Treatment.|Unknown status|Recruiting|Phase 2|90|Anticipated|Hospital of Navarra||2|||f||||f||||||||||2017-02-18 15:40:10.983686|2017-02-18 15:40:10.983686
NCT00466076|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2007-04-25|||August 2006||2006-08-01|April 2007|2007-04-01|April 2007|Anticipated|2007-04-01|||||Interventional|||Copaxone in Age Related Macular Degeneration|Subcutaneous Copaxone as Treatment for Dry Age Related Macular Degeneration|Unknown status|Recruiting|Phase 2/Phase 3|30||Kaplan Medical Center|||||f||||f||||||||||2017-02-18 15:40:11.085714|2017-02-18 15:40:11.085714
NCT00466063|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-12-26|||May 2007||2007-05-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Observational|||ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox|A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox|Completed||Phase 4|108|Actual|Novartis|||1||f||||t||||||||||2017-02-18 15:40:11.173745|2017-02-18 15:40:11.173745
NCT00466050|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2009-08-23|||April 2007||2007-04-01|April 2007|2007-04-01|May 2009|Actual|2009-05-01|April 2008|Actual|2008-04-01||Observational|IVUS||Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS|Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS|Completed||N/A|30|Anticipated|Ziv Hospital|||1||f||||t||||||||||2017-02-18 15:40:11.298939|2017-02-18 15:40:11.298939
NCT00466037|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2007-04-25|||September 2005||2005-09-01|April 2007|2007-04-01|February 2006||2006-02-01|||||Interventional|||The Effect of Rituximab on the Humoral Response to Influenza Vaccine|Vaccination Against Influenza in Rheumatoid Arthritis Patients: The Effect of Rituximab on the Humoral Response|Terminated||N/A|64||Tel-Aviv Sourasky Medical Center|||||f||||f||||||||||2017-02-18 15:40:11.575445|2017-02-18 15:40:11.575445
NCT00466024|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2015-08-31|||October 2006||2006-10-01|March 2009|2009-03-01|June 2010|Actual|2010-06-01|February 2009|Actual|2009-02-01||Interventional|PREACH||Particulate Reduction Education in City Homes|Particulate Reduction Education in City Homes (PREACH)|Completed||Phase 3|125|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 15:40:11.668208|2017-02-18 15:40:11.668208
NCT00465998|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2016-06-07|2016-04-28||January 2006||2006-01-01|June 2016|2016-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Study of Ultrasound Imaging to Predict Time and Outcome in Pregnancies With Induced Labor|Prediction of Labor and Delivery With the Use of Ultrasound in Pregnancies With Induced Labor|Completed||N/A|250|Actual|Helse Stavanger HF|||1||f||||f||||||||||2017-02-18 15:40:11.863753|2017-02-18 15:40:11.863753
NCT00465985|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2012-07-31|2010-11-16||April 2007||2007-04-01|July 2012|2012-07-01||||October 2008|Actual|2008-10-01||Interventional|REMITTER||Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome|A Three-part,Multicenter Study,With a Randomized,Double-blind,Placebo Controlled,Withdrawal Design in Part II to Assess Efficacy,Safety,and Tolerability of ACZ885(Anti-interleukin-1beta Monoclonal Antibody)in Patients With Muckle-Wells Syndrome|Completed||Phase 3|35|Actual|Novartis|The outcomes for this study were reported in separate tables for each period. The SAE and AEs were reported in all in one table.|2|||f||||||||||||||2017-02-18 15:40:12.138615|2017-02-18 15:40:12.138615
NCT00465972|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2013-07-26|2012-12-12||March 2007||2007-03-01|May 2013|2013-05-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||The Treatment of Insomnia in Patients With HIV Disease|A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Doxepin and Temazepam in HIV Seropositive Patients With Insomnia.|Completed||Phase 4|44|Actual|Duke University||3|||f||||t||||||||||2017-02-18 15:40:12.902176|2017-02-18 15:40:12.902176
NCT00465959|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2013-12-03||2013-12-03|April 2007||2007-04-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease|Safety, Tolerability, Pharmacokinetics, and Efficacy of Single Inhaled Administrations of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 1/Phase 2|24|Actual|Endo Pharmaceuticals||3|||f||||||||||||||2017-02-18 15:40:13.402606|2017-02-18 15:40:13.402606
NCT00465946|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2007-04-25|||June 2004||2004-06-01|April 2007|2007-04-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Effect of Dietary Salt Supplemantation in Vasovagal Syncope Prophylaxis: A Clinical Trial|Effect of Dietary Salt Supplemantation in Vasovagal Syncope Prophylaxis: A Clinical Trial|Unknown status|Active, not recruiting|N/A|20||Hospital de Clinicas de Porto Alegre|||||f||||f||||||||||2017-02-18 15:40:13.499785|2017-02-18 15:40:13.499785
NCT00465933|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2008-03-27|||March 1999||1999-03-01|March 2008|2008-03-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA)|Treatment of Acute Promyelocytic Leukemia: Remission Induction With ATRA + Idarubicin (AIDA) Risk Adapted Intensity of Consolidation and Addition of ATRA Maintenance With ATRA + Methotrexate + Mercaptopurine Salvage Therapy for Molecular and Haematological Relapses|Completed||Phase 4|||PETHEMA Foundation|||||f||||||||||||||2017-02-18 15:40:13.597362|2017-02-18 15:40:13.597362
NCT00465920|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-25|2009-02-19|||May 2007||2007-05-01|February 2009|2009-02-01|April 2010|Anticipated|2010-04-01|||||Interventional|mCBT||Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis|Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis|Unknown status|Recruiting|Phase 2|42|Anticipated|University of Cologne|||||f||||t||||||||||2017-02-18 15:40:13.706932|2017-02-18 15:40:13.706932
NCT00465907|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2008-12-16|||May 2003||2003-05-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|November 2008|Anticipated|2008-11-01||Interventional|||Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer|Phase II Study of Weekly Paclitaxel, Carboplatin and Irinotecan in Patients With Advanced Non-Small Cell Lung Cancer Nad Malignant Plerual Effusion|Unknown status|Active, not recruiting|Phase 2|48|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 15:40:13.791481|2017-02-18 15:40:13.791481
NCT00465894|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-06-25|2012-06-01||April 2007||2007-04-01|July 2015|2015-07-01|December 2011|Actual|2011-12-01|July 2010|Actual|2010-07-01||Interventional|DRIVE||Detrol LA vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms|Randomized Controlled Trial of Tolterodine in Combination With or Without Low-Dose Intra-Vaginal Estradiol Cream for the Treatment of Overactive Bladder in Post-Menopausal Women|Completed||N/A|58|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 15:40:13.890289|2017-02-18 15:40:13.890289
NCT00465881|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2015-12-02|||January 2006||2006-01-01|September 2007|2007-09-01|April 2006|Actual|2006-04-01|||||Observational|||Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes|Observational Study of Interstitial Glucose Monitoring With the FreeStyle Navigator Continuous Glucose Monitoring (CGM) System to Develop Novel Methods for Displaying, Reporting and Analyzing CGM Data for Clinical Decision-Making|Completed||Phase 1|30||HealthPartners Institute|||||f||||f||||||||||2017-02-18 15:40:14.28518|2017-02-18 15:40:14.28518
NCT00465868|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2015-07-27|||December 2004||2004-12-01|June 2008|2008-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|KoMPiS||MR, Myocardial Infarct and Heart Failure|Magnetic Resonance Imaging, Myocardial Infarction and Development of Heart Failure.|Completed||N/A|44|Actual|Helse Stavanger HF|||1||f||||f||||||Samples Without DNA|"~     collagen markers, inflammatory markers and heart failure markers~   "|||2017-02-18 15:40:14.366824|2017-02-18 15:40:14.366824
NCT00465855|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-10-04|||April 2007||2007-04-01|October 2016|2016-10-01|May 2018|Anticipated|2018-05-01|April 2017|Anticipated|2017-04-01||Interventional|1V3CORCT||One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning|Randomized Trial of One Versus Three Hyperbaric Oxygen Treatments for Acute CO Poisoning|Active, not recruiting||Phase 4|75|Actual|Intermountain Health Care, Inc.||2|||f||||t||||||||||2017-02-18 15:40:14.454811|2017-02-18 15:40:14.454811
NCT00465842|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2008-05-19|||June 2006||2006-06-01|May 2008|2008-05-01|December 2010|Anticipated|2010-12-01|||||Observational|||Protein Biomarker in Hepatocellular Carcinoma|Protein Biomarkers for Early Detection and Prognostication in Hepatocellular Carcinoma (HCC)|Suspended||N/A|1050|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 15:40:14.571036|2017-02-18 15:40:14.571036
NCT00465829|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2016-09-20|||March 2006||2006-03-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|January 2015|Actual|2015-01-01||Observational|LABS-2||Long-term Effects of Bariatric Surgery|Longitudinal Assessment of Bariatric Surgery (LABS-2)|Completed||N/A|2458|Actual|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     Whole blood, serum, plasma, urine.~   "|Yes|Data deposited in NIDDK funded data repository|2017-02-18 15:40:14.658788|2017-02-18 15:40:14.658788
NCT00464464|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2014-11-04|2014-03-10||April 2007||2007-04-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Coping With Depression in Parkinson's Disease|Treating Depression in Parkinson's Disease: A New Method|Completed||N/A|80|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 15:40:40.245107|2017-02-18 15:40:40.245107
NCT00465816|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2016-11-02|2012-04-23||April 2007||2007-04-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612|Non-inferiority of GSK Biologicals' Meningococcal Vaccine 134612 Given Concomitantly With GSK Biologicals' Twinrix™ Versus 134612 Alone and Twinrix™ Alone in Healthy Subjects Aged 11 Through 17 Years.|Completed||Phase 3|611|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:40:14.76504|2017-02-18 15:40:14.76504
NCT00465803|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2014-07-22||2014-07-22|March 2007||2007-03-01|May 2012|2012-05-01||||January 2009|Actual|2009-01-01||Interventional|||A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension|Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol Using the Dosing Aid|Completed||Phase 3|81|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 15:40:15.916817|2017-02-18 15:40:15.916817
NCT00465790|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-09-26|||October 2007||2007-10-01|December 2011|2011-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|Genepark||Research of Biomarkers in Parkinson Disease|GENomic Biomarkers for PARKinson's Disease|Completed||Early Phase 1|219|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-02-18 15:40:16.02533|2017-02-18 15:40:16.02533
NCT00465777|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-04-23|||December 2004||2004-12-01|April 2007|2007-04-01|February 2006|Actual|2006-02-01|||||Interventional|MTV||Improved Management and in-Hospital Mortality|Reduced in-Hospital Mortality After Improved Management of Patients Hospitalised With Malaria. A Randomised Trial|Completed||N/A|950||Bandim Health Project|||||f||||f||||||||||2017-02-18 15:40:16.118786|2017-02-18 15:40:16.118786
NCT00465764|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2009-04-24|||April 2007||2007-04-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Tolerance and Development of Healthy, Term Infants|Pilot Tolerance and Bone Status of Healthy, Term Infants Fed Infant Formulas|Completed||Phase 2|115|Actual|Abbott Nutrition||2|||f||||t||||||||||2017-02-18 15:40:16.209282|2017-02-18 15:40:16.209282
NCT00465751|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2012-03-08|||October 2004||2004-10-01|March 2012|2012-03-01||||||||Interventional|||Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism|Effects of Activation of the Farnesoid X Receptor (FXR) on Hepatic Lipid and Glucose Metabolism in Patients With the Metabolic Syndrome and Familial Forms of Hypertriglyceridemia|Completed||Early Phase 1|30|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 15:40:18.952496|2017-02-18 15:40:18.952496
NCT00465738|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2010-12-21|2010-08-31||February 2007||2007-02-01|December 2010|2010-12-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|NT-Spin||IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity|Prospective, Randomized, Observer-blind, Parallel-group, Multi-center Trial to Assess Efficacy and Safety of Two Different Dilutions of incobotulinumtoxinA (Xeomin) in Patients With Upper Limb Spasticity|Completed||Phase 3|216|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-02-18 15:40:19.065864|2017-02-18 15:40:19.065864
NCT00465725|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2009-09-23|||April 2007||2007-04-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors|A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies|Completed||Phase 1|18|Anticipated|Poniard Pharmaceuticals||1|||f||||t||||||||||2017-02-18 15:40:20.589211|2017-02-18 15:40:20.589211
NCT00465712|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2011-05-31|||July 2006||2006-07-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|AMNIO||Effect of Amnioinfusion on External Cephalic Version Successful Rate|Effect of Amnioinfusion on External Cephalic Version After Initial Failure a Prospective Multicentric Randomized Study|Terminated||N/A|240|Anticipated|University Hospital, Tours||2|||f||||t||||||||||2017-02-18 15:40:20.712107|2017-02-18 15:40:20.712107
NCT00465699|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-04-23|||April 2007||2007-04-01|April 2007|2007-04-01|April 2007|Anticipated|2007-04-01|||||Interventional|||Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis|Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis|Unknown status|Recruiting|N/A|50||Spartanburg Regional Family Medicine|||||f||||t||||||||||2017-02-18 15:40:20.823898|2017-02-18 15:40:20.823898
NCT00465686|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2008-05-05|||February 2007||2007-02-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Ergonomic Classroom Furniture on the Printing Legibility of Elementary Students With Cerebral Palsy|Ergonomic Classroom Furniture and the Printing Legibility of Elementary School Students With CP|Completed||Phase 1|30|Actual|Holland Bloorview Kids Rehabilitation Hospital||1|||f||||f||||||||||2017-02-18 15:40:20.91242|2017-02-18 15:40:20.91242
NCT00465673|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2009-08-04|||September 2005||2005-09-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer|A Phase II Study of Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer|Terminated||Phase 2|2|Actual|Sidney Kimmel Comprehensive Cancer Center||1||Low recruitment|f||||t||||||||||2017-02-18 15:40:21.024331|2017-02-18 15:40:21.024331
NCT00465660|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2007-04-24|||April 2005||2005-04-01|December 2006|2006-12-01|July 2009||2009-07-01|||||Interventional|||Resistive Exercise for Arthritic Cartilage Health (REACH)|The Effect of 6 Month High Intensity Progressive Resistance Training on Knee Articular Cartilage Morphology in Female Osteoarthritic Patients|Unknown status|Active, not recruiting|Phase 2|60||University of Sydney|||||f||||||||||||||2017-02-18 15:40:21.13643|2017-02-18 15:40:21.13643
NCT00465647|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2015-10-19|2010-12-22||April 2007||2007-04-01|October 2015|2015-10-01|April 2010|Actual|2010-04-01|May 2009|Actual|2009-05-01||Interventional|Palladone||An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain|A Multi-center, Open-label, Dose Titration Study Pharmacokinetics/Pharmacodynamics, Safety, and Efficacy of Hydromorphone Oral Solution in Subjects From 28 Days to 16 Years of Age, Who Require Opioid Analgesics for Postoperative Pain|Completed||Phase 4|116|Actual|Purdue Pharma LP||4|||f||||t||||||||||2017-02-18 15:40:21.231702|2017-02-18 15:40:21.231702
NCT00465634|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2013-08-06|||May 2003||2003-05-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|ARTULEP||Doppler and Biological Second Trimester Placental Insufficiency Screening|Screening for Placental Insufficiency by a Combination of Second Trimester Uterine Artery Doppler and Maternal Serum Leptin and Lipids|Completed||N/A|235|Actual|University Hospital, Tours|||1||f||||f||||||||||2017-02-18 15:40:22.498188|2017-02-18 15:40:22.498188
NCT00465621|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2008-07-28|||March 2007||2007-03-01|July 2008|2008-07-01||||July 2007|Actual|2007-07-01||Interventional|||Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension|Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|150|Anticipated|Alcon Research|||||||||||||||||||2017-02-18 15:40:22.596617|2017-02-18 15:40:22.596617
NCT00465608|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2009-01-06|||April 2007||2007-04-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|Reductrauma||Propranolol in Post Traumatic Stress Disorder|Reduction of the Traumatic Memory by Reconsolidation Blockade: A Pilot Study|Completed||Phase 2|20|Anticipated|University Hospital, Toulouse||1|||f||||f||||||||||2017-02-18 15:40:22.684465|2017-02-18 15:40:22.684465
NCT00465595|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-10-10|||April 2007||2007-04-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Psychopharmacology of Psilocybin in Cancer Patients|Psychopharmacology of Psilocybin in Cancer Patients|Active, not recruiting||N/A|44|Anticipated|Sidney Kimmel Comprehensive Cancer Center||4|||f||||t||||||||||2017-02-18 15:40:22.797288|2017-02-18 15:40:22.797288
NCT00465582|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2012-03-26|||January 2008||2008-01-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|||||Observational|||B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors|B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors|Terminated||N/A|3296|Actual|University Hospital, Rouen|||1||f||||t||||||Samples Without DNA|"~     pharynx ecouvillonnage~   "|||2017-02-18 15:40:22.931372|2017-02-18 15:40:22.931372
NCT00465569|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-04-27|||August 2006||2006-08-01|April 2012|2012-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy|A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy|Completed||Phase 1/Phase 2|20|Actual|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 15:40:23.008894|2017-02-18 15:40:23.008894
NCT00465556|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2015-03-31|||February 2006||2006-02-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|||Domestic Violence Enhanced Home Visitation Program (DOVE)|Domestic Violence Enhanced Home Visitation Program - DOVE|Completed||Phase 2|239|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 15:40:23.110862|2017-02-18 15:40:23.110862
NCT00465543|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2011-12-08|||May 2007||2007-05-01|December 2011|2011-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Mint Tea for the Treatment of Nasal Polyps|A Double-blind,Placebo-controlled, Randomized, Crossover Trial of Mint Tea High in Rosmarinic Acid in Adults With Nasal Polyposis|Completed||Phase 2|22|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 15:40:23.211916|2017-02-18 15:40:23.211916
NCT00465530|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2013-04-22|2012-12-11||March 2007||2007-03-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparing the Use of Saline or Saline Plus Gentamycin in Nasal Irrigation to Treat Chronic Sinusitis in Children|Safety and Efficacy of Once Daily Intranasal Gentamycin Irrigation Versus Saline in the Treatment of Pediatric Chronic Sinusitis|Completed||N/A|40|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 15:40:23.32452|2017-02-18 15:40:23.32452
NCT00465517|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2009-10-28||2009-10-28|February 2007||2007-02-01|October 2009|2009-10-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures|A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Subjects With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.|Completed||Phase 2|147|Actual|Marinus Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:40:23.900775|2017-02-18 15:40:23.900775
NCT00465504|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2011-05-13|||July 2006||2006-07-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Two Different Methods of Delivering Local Analgesia During Intra-articular Corticosteroid Injections in Children With Juvenile Idiopathic Arthritis|Comparison of Iontophoresis of Lidocaine and Eutectic Mixture of Local Anesthetics (EMLA®) Cream Versus Subcutaneous Injections of Lidocaine and EMLA® for Pain Relief in Intra-articular Corticosteroid Injections in Children With Juvenile Idiopathic Arthritis: A Randomized Clinical Trial|Completed||Phase 3|5|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 15:40:24.031954|2017-02-18 15:40:24.031954
NCT00465491|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2009-04-13|||April 2007||2007-04-01|April 2009|2009-04-01||||May 2009|Anticipated|2009-05-01||Interventional|SPEAR||Study of Picoplatin Efficacy After Relapse|A Randomized, Controlled Phase III Trial of Picoplatin and BSC Versus BSC Alone in Patients With Small Cell Lung Cancer (SCLC), Refractory or Progressive Within Six Months of Completing First-Line, Platinum-Containing Chemotherapy.|Unknown status|Active, not recruiting|Phase 3|399|Anticipated|Poniard Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:40:24.131115|2017-02-18 15:40:24.131115
NCT00465478|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2007-04-24|||March 2006||2006-03-01|April 2007|2007-04-01|March 2014|Anticipated|2014-03-01|||||Interventional|||Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients|Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Patients With Type 1 or 2 Diabetes Mellitus－a Phase 1/2 Study|Unknown status|Recruiting|Phase 1/Phase 2|200||Shandong University|||||f||||t||||||||||2017-02-18 15:40:24.613492|2017-02-18 15:40:24.613492
NCT00465465|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2008-04-02|||October 2005||2005-10-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG|A Dose Selection Study Evaluating the Safety and Immunogenicity of 2 Different Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Have Previously Been Vaccinated With BCG|Completed||Phase 1|24|Actual|University of Oxford||2|||f||||f||||||||||2017-02-18 15:40:24.704745|2017-02-18 15:40:24.704745
NCT00465452|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2009-03-18|||January 2007||2007-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Impact of Switching to Continuous Release Dopamine Agonists|The Impact of Switching to Continuous Release Dopamine Agonists on Non-Motor Side Effects|Completed||Phase 3|15|Anticipated|University of Toledo Health Science Campus||1|||f||||f||||||||||2017-02-18 15:40:24.814359|2017-02-18 15:40:24.814359
NCT00465439|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2008-08-21|||May 2007||2007-05-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety/Efficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal|Randomized Controlled Trial Examining the Effect of Subcutaneous Xylocaine 2% on the Incidence of Vasovagal Reactions and Pain Intensity During Femoral Artery Sheath Removal.|Completed||N/A|78|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 15:40:24.91877|2017-02-18 15:40:24.91877
NCT00465426|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2012-10-30|||April 2007||2007-04-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||HIV and Cardiovascular Risk|Assessment of Cardiovascular Risk in HIV Patients|Completed||N/A|129|Actual|Massachusetts General Hospital|||2||f||||f||||||Samples Without DNA|"~     blood will be frozen for end of study analysis for insulin, CRP, adiponectin, TNF-α, sTNFR2,~     IL-6, PAI-1, MCP-1~   "|||2017-02-18 15:40:25.015177|2017-02-18 15:40:25.015177
NCT00465413|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2007-11-13|||September 2004||2004-09-01|September 2007|2007-09-01||||||||Interventional|MDI||Bronchodilatation Effects of a Small Volume Spacer Used With a Metered-Dose Inhaler||Completed||Phase 2|300|Anticipated|Mackay Memorial Hospital|||||f||||t||||||||||2017-02-18 15:40:25.139621|2017-02-18 15:40:25.139621
NCT00465400|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2008-12-08|||November 2006||2006-11-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Oxidative Stress in Patients With Age-Related Macular Degeneration|Quantification of Oxidative Stress in Patients With Age-Related Macular Degeneration Prior to and After Photodynamic Therapy: a Comet Assay Analysis|Completed||N/A|12|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||None Retained|"~     plasma~   "|||2017-02-18 15:40:25.23702|2017-02-18 15:40:25.23702
NCT00465387|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2007-04-24|||March 2003||2003-03-01|April 2007|2007-04-01|January 2006|Actual|2006-01-01|||||Interventional|||FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study|Falls, Fracture, and Osteoporosis Risk Control Evaluation (FORCE) Study: A Randomized Controlled Trial With Community Partnerships in Northern Ontario|Completed||N/A|400||Group Health Centre|||||f||||f||||||||||2017-02-18 15:40:25.322388|2017-02-18 15:40:25.322388
NCT00465374|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2007-04-24|||October 2002||2002-10-01|April 2007|2007-04-01||||||||Interventional|||A Validation/Interventional Study on Stress Index in Predicting Mechanical Stress in ARDS Patients||Unknown status|Recruiting|Phase 3|||University of Turin, Italy|||||f||||||||||||||2017-02-18 15:40:25.406141|2017-02-18 15:40:25.406141
NCT00465361|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-02-06|2011-02-08||May 2007||2007-05-01|December 2011|2011-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Resident Surveillance of Pediatric Patient Developmental Status at the Two Month Preventive Care Visit|Evaluation of Resident Surveillance of Pediatric Patient Developmental Status at the Two Month Preventive Care Visit|Completed||N/A|7|Actual|Children's Mercy Hospital Kansas City|Long-term effects of intervention are unknown.|2|||f||||f||||||||||2017-02-18 15:40:25.509686|2017-02-18 15:40:25.509686
NCT00465348|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2012-10-24|||June 2009||2009-06-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||The Antioxidant Effect of Routine Vascular Therapy for Normal Tension Glaucoma Patients|The Antioxidant Effect of Routine Vascular Therapy for Normal Tension Glaucoma Patients|Withdrawn||N/A|0|Actual|University Hospital, Basel, Switzerland|||1|investigator withdrew|f||||f||||||None Retained|"~     plasma~   "|||2017-02-18 15:40:25.769031|2017-02-18 15:40:25.769031
NCT00465335|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2012-09-19|||March 2006||2006-03-01|September 2012|2012-09-01|February 2007|Actual|2007-02-01|||||Observational|IMPACCT||Usefulness of Coronary CT Angiography in Patients With Inconclusive Stress Test Results|Multi-Detector Computer Tomography(MDCT)in Patients With Equivocal/Intermediate Post Test Probability of Coronary Artery Disease|Completed||N/A|200|Actual|William Beaumont Hospitals|||1||f||||t||||||||||2017-02-18 15:40:25.858058|2017-02-18 15:40:25.858058
NCT00465322|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-04-23||||||April 2007|2007-04-01||||||||Observational|EFA-1||Effect of Fluvastatin on Top of Clopidogrel and Aspirin in Patients After DES Implantation on Platelet Aggregation|Effect of Fluvastatin on Top of Clopidogrel and Aspirin in Patients After DES Implantation on Platelet Aggregation|Completed||Phase 4|100||University Hospital Inselspital, Berne|||||f||||f||||||||||2017-02-18 15:40:25.935728|2017-02-18 15:40:25.935728
NCT00465309|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-24|2009-01-09|||April 2007||2007-04-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|||||Interventional|||Protective Ventilation With Carbon Dioxide (CO2) -Removal Technique in Patients With Adult Respiratory Distress Syndrome (ARDS)||Completed||Phase 3|200|Anticipated|University of Turin, Italy||1|||f||||||||||||||2017-02-18 15:40:26.026741|2017-02-18 15:40:26.026741
NCT00465296|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2008-05-21|||January 2006||2006-01-01|April 2007|2007-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS|Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS|Terminated||Phase 3|200|Anticipated|Medstar Health Research Institute||||Funding Discontinued|f||||t||||||||||2017-02-18 15:40:26.13887|2017-02-18 15:40:26.13887
NCT00465283|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-22|2009-01-26|||May 2007||2007-05-01|January 2009|2009-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Donepezil Double Blind Trial for ECT Memory Disfunction|Donepezil Double Blind Trial for ECT Memory Disfunction|Unknown status|Recruiting|Phase 4|40|Anticipated|BeerYaakov Mental Health Center||2|||f||||||||||||||2017-02-18 15:40:26.234829|2017-02-18 15:40:26.234829
NCT00465270|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-07-20|||August 2003||2003-08-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2011|Actual|2011-12-01||Interventional|||RESPECT PFO Clinical Trial|Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment|Active, not recruiting||Phase 2|980|Actual|St. Jude Medical||2|||t||||t||||||||||2017-02-18 15:40:26.344906|2017-02-18 15:40:26.344906
NCT00465257|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2008-05-16|||May 2007||2007-05-01|May 2008|2008-05-01||||||||Interventional|||Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in Zanzibar|Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction as New Treatment Policy for Uncomplicated Plasmodium Falciparum Malaria in Zanzibar|Suspended||Phase 4|110|Anticipated|Karolinska University Hospital||||Due to lack of malaria patients in Zanzibar the study has been suspended.|f||||||||||||||2017-02-18 15:40:26.630167|2017-02-18 15:40:26.630167
NCT00465244|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-10-30|||January 2008||2008-01-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|STILL||Seizure Therapy With Intravenous Levetiracetam and Lorazepam|Seizure Therapy With Intravenous Levetiracetam and Lorazepam|Withdrawn||Phase 2/Phase 3|0|Actual|Massachusetts General Hospital||2||Inability to recruit subjects|f||||t||||||||||2017-02-18 15:40:26.711892|2017-02-18 15:40:26.711892
NCT00465231|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-12-12|||January 2007||2007-01-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Preventive Analgesia in Multiparas Undergoing Induction of Labour|Preventive Analgesia in Labour:A Randomised, Placebo-Controlled Study in Multiparas Undergoing Induction of Labour|Completed||N/A|16|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-02-18 15:40:26.812633|2017-02-18 15:40:26.812633
NCT00463489|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2016-11-21|||August 2007||2007-08-01|May 2016|2016-05-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Interventional|LISA||Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer|Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer|Active, not recruiting||Phase 3|2150|Anticipated|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-02-18 15:41:10.684758|2017-02-18 15:41:10.684758
NCT00465218|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2012-06-20|||March 2007||2007-03-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|December 2007|Actual|2007-12-01||Observational|Tissue-Valve||Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement|"Transcranial Doppler Assessment of Cerebral Embolization During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement: Comparison of High-dose Aspirin Versus Warfarin Plus Low-dose Aspirin"|Completed||Phase 1|56|Actual|Ottawa Heart Institute Research Corporation|||2||f||||f||||||||||2017-02-18 15:40:26.914428|2017-02-18 15:40:26.914428
NCT00465205|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2013-08-21|||January 2005||2005-01-01|August 2013|2013-08-01|December 2007|Actual|2007-12-01|December 2005|Actual|2005-12-01||Interventional|||HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons|A Randomized,Double-Blind , Placebo-Controlled Crossover Trial of Antivirals for Suppression of HSV and HIV Shedding in HIV-1, HSV-2 Co-infected Persons|Completed||Phase 3|20|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 15:40:27.191907|2017-02-18 15:40:27.191907
NCT00465192|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-03-19|||August 1994||1994-08-01|March 2012|2012-03-01|November 1995|Actual|1995-11-01|November 1995|Actual|1995-11-01||Interventional|||Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Comparing the Efficacy and Safety of 17-Beta Estradiol 10 Micrograms and 25 Micrograms (Vagifem) Doses in Treatment of Estrogen Deficiency-Derived Atrophic Vaginitis|Completed||Phase 3|230|Anticipated|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:40:27.302247|2017-02-18 15:40:27.302247
NCT00465179|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2016-05-04|2016-03-31||March 2007||2007-03-01|May 2016|2016-05-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer|Phase II Trial of Sunitinib Malate (Sutent) Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma|Completed||Phase 2|61|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:40:27.395965|2017-02-18 15:40:27.395965
NCT00465166|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-12-12|||February 2007||2007-02-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Observational|||Lumbar Spine Ultrasound of Patients With Previous Accidental Dural Puncture During Labour Epidural|Lumbar Spine Ultrasound of Patients With Previous Accidental Dural Puncture During Labour Epidural|Completed||N/A|56|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||1||f||||f||||||||||2017-02-18 15:40:27.814575|2017-02-18 15:40:27.814575
NCT00465153|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2007-11-01|||April 2007||2007-04-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||The Combined Effects of Resistance Training and Flax Oil Supplementation Upon Inflammation in Older Adults|The Combined Effects of Resistance Training and Flax Oil Supplementation Upon Inflammation in Older Adults|Completed||Phase 3|60|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-02-18 15:40:27.911973|2017-02-18 15:40:27.911973
NCT00465140|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-04-23|||January 2004||2004-01-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Effects of Creatine Supplementation on Renal Function|Effects of Creatine Supplementation on Renal Function in Sedentary Healthy Males Urdergoing Aerobic Training: a Randomized, Double-Blind, Placebo-Controlled Trial|Completed||N/A|18||University of Sao Paulo|||||f||||t||||||||||2017-02-18 15:40:28.021577|2017-02-18 15:40:28.021577
NCT00465114|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2009-10-01|||April 2007||2007-04-01|October 2009|2009-10-01|December 2007|Anticipated|2007-12-01|||||Observational|||Minimally-invasive Assessment of Cardiac Output in Severe Preeclampsia|Minimally-invasive Assessment of Cardiac Output in Severe Preeclampsia: Radial Artery Wave Form Analysis Versus Trans-thoracic Echocardiogram|Withdrawn||N/A|12|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||1|Feasibility issues, only 1 patient recruited.|f||||f||||||||||2017-02-18 15:40:28.102664|2017-02-18 15:40:28.102664
NCT00465101|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2015-09-24|2015-07-21||May 2007||2007-05-01|June 2012|2012-06-01|January 2013|Actual|2013-01-01|August 2012|Actual|2012-08-01||Interventional|PVP||A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization|A Prospective Clinical Study for GreenLight HPS in the Treatment of Obstructive Benign Prostatic Hyperplasia (BPH)|Completed||Phase 4|150|Actual|American Medical Systems|Follow-up of subjects was discontinued in August 2012 prior to most participants completing the assessment planned at 5 years. At the time of the discontinuation, all but five of the participants remaining on study had completed 3 years of follow-up.|1|||f||||f||||||||||2017-02-18 15:40:28.202464|2017-02-18 15:40:28.202464
NCT00465088|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2011-06-09|2009-02-10||April 2007||2007-04-01|June 2011|2011-06-01||||February 2008|Actual|2008-02-01||Interventional|SUPREME||An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)|SUPREME: A 12-Week, Open-Label, Multicenter Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia|Completed||Phase 3|199|Actual|Abbott||2|||f||||||||||||||2017-02-18 15:40:28.853606|2017-02-18 15:40:28.853606
NCT00465075|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-12-19|||March 2007||2007-03-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women|An Open-Label, Single-Dose, 3-Period, Crossover Study To Determine The Effect Of A High-Fat Meal On The Relative Bioavailability And Pharmacokinetics Of A Single Dose Of Bazedoxifene Acetate/Conjugated Estrogens (Premarin© New Process) Administered Orally To Healthy, Postmenopausal Women|Completed||Phase 1|24|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:40:29.621944|2017-02-18 15:40:29.621944
NCT00465062|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-21|2017-01-24|||April 19, 2007||2007-04-19|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease|A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:40:29.710782|2017-02-18 15:40:29.710782
NCT00465049|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-10-19|||January 2007||2007-01-01|October 2012|2012-10-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|||Comparison of Suturing and Packing of Drained Abscesses|Primary vs. Secondary Closure of Cutaneous Abscesses After I&D: A RCT|Completed||Phase 2|100|Anticipated|Stony Brook University||2|||f||||f||||||||||2017-02-18 15:40:29.79267|2017-02-18 15:40:29.79267
NCT00465036|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2009-03-25|||October 2006||2006-10-01|March 2009|2009-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Effect of Flaxseed on Lipid Uptake and Appetite|Effect of Whole Flaxseeds and Flaxseed Mucilage on Lipid Absorption, Glucose and Insulin Metabolism and Appetite Regulation|Completed||N/A|18||University of Copenhagen||4|||f||||f||||||||||2017-02-18 15:40:29.900678|2017-02-18 15:40:29.900678
NCT00465023|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2017-01-19|||June 2003||2003-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|September 2013|Actual|2013-09-01||Interventional|||Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases|Phase I Study of Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases|Completed||N/A|16|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:40:29.996257|2017-02-18 15:40:29.996257
NCT00465010|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2011-10-14|||April 2002||2002-04-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effects of a Worksite Parenting Program|Talking Parents, Healthy Teens: A Worksite-Based Parenting Program for Parents of Adolescents|Completed||N/A|1252|Actual|RAND||1|||f||||f||||||||||2017-02-18 15:40:30.108038|2017-02-18 15:40:30.108038
NCT00464997|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-04-23|||June 2007||2007-06-01|April 2007|2007-04-01||||||||Observational|||The Effect of Low Dose Aspirin on the Pharmacokinetics of Methotrexate|The Effect of Low Dose Aspirin on the Pharmacokinetics of Methotrexate|Unknown status|Not yet recruiting|N/A|30||Tel-Aviv Sourasky Medical Center|||||f||||f||||||||||2017-02-18 15:40:30.300946|2017-02-18 15:40:30.300946
NCT00464984|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-05-25|||August 2006||2006-08-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Lifestyle Intervention in Morbidly Obese Patients|Lifestyle Intervention in Morbidly Obese Patients|Active, not recruiting||N/A|100|Anticipated|The Hospital of Vestfold||2|||f||||f||||||||||2017-02-18 15:40:30.375677|2017-02-18 15:40:30.375677
NCT00464971|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-03-19|||January 1995||1995-01-01|March 2012|2012-03-01|November 1996|Actual|1996-11-01|November 1996|Actual|1996-11-01||Interventional|||Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial|Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Estrogen Deficiency-Derived Atrophic Vaginitis|Completed||Phase 3|102|Anticipated|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:40:30.481262|2017-02-18 15:40:30.481262
NCT00464958|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-22|2009-02-17|||January 2008||2008-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||One Year Extension Study To Protocol C2/5/TZ:MS-05|Long Term Clinical Efficacy and Safety of Novel Sublingual Tizanidine HCl (12 mg) for the Treatment of Spasticity in Patients With Multiple Sclerosis - Open Label Extension Study|Terminated||Phase 1/Phase 2|10|Actual|Teva GTC||1||Study was stopped as the sponsor is no longer funding this project|f||||f||||||||||2017-02-18 15:40:30.568552|2017-02-18 15:40:30.568552
NCT00464945|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-07-06|2010-03-26||June 2007||2007-06-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants|A Phase 3, Randomised,Active-Controlled ,Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of Manufacturing Scale 13-valent Pneumococcal Conjugate Vaccine|Completed||Phase 3|269|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 15:40:30.855895|2017-02-18 15:40:30.855895
NCT00464932|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-04-23|||June 2003||2003-06-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Observational|VIPCOPD||Vasoactive Intestinal Peptide in COPD||Completed||Phase 2|34||Medical University of Vienna|||||f||||t||||||||||2017-02-18 15:40:32.236569|2017-02-18 15:40:32.236569
NCT00464919|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2009-07-06|||April 2007||2007-04-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|||||Interventional|||Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)|A Phase II Study of Sorafenib Plus Tegafur/Uracil for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|50|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 15:40:32.322599|2017-02-18 15:40:32.322599
NCT00464893|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2013-12-03|||April 2007||2007-04-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|April 2009|Actual|2009-04-01||Interventional|||Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection|Multicenter, Open-label Phase II Study to Evaluate the Safety and Efficacy of the Trifunctional Bispecific Antibody Catumaxomab (Anti-EpCAM x Anti-CD3) in Patients With Gastric Adenocarcinoma After Neoadjuvant Chemotherapy and Intended Curative Resection|Completed||Phase 2|70|Actual|Neovii Biotech||1|||f||||t||||||||||2017-02-18 15:40:32.448472|2017-02-18 15:40:32.448472
NCT00464880|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-21|2007-11-28|||September 2005||2005-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy|A Randomized, Double-Blind, Parallel-Group, Cross-Over, 4-Period, 4 Treatment, Within-Subject Placebo-Controlled Study to Assess the Reno-Protective Effect of Renin Inhibition With Aliskiren as an Alternative to Irbesartan in Type 2 Patients With Incipient/Overt Diabetic Nephropathy|Completed||Phase 1/Phase 2|24||Novartis|||||f||||f||||||||||2017-02-18 15:40:32.570058|2017-02-18 15:40:32.570058
NCT00464867|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2012-06-09|||January 2006||2006-01-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|January 2006|Actual|2006-01-01||Interventional|||Effect of Probiotic on Immunogenicity of Oral Cholera Vaccine||Completed||N/A|128|Actual|International Centre for Diarrhoeal Disease Research, Bangladesh||1|||f||||f||||||||||2017-02-18 15:40:32.673124|2017-02-18 15:40:32.673124
NCT00464854|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-22|2007-04-23|||July 2005||2005-07-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward|Feasiblity, Safety And Efficacy Of Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward|Terminated||N/A|100||Assaf-Harofeh Medical Center||||The study was started before the official request for protocol registration|f||||f||||||||||2017-02-18 15:40:32.767228|2017-02-18 15:40:32.767228
NCT00464841|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2011-09-02|||February 2007||2007-02-01|September 2011|2011-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Usefulness of the Tsui Test in Combined Spinal-Epidural Analgesia in Labour|Can the Tsui Test be Used to Test the Placement of Epidural Catheters Following the Intrathecal Component of a Combined Spinal-epidural Technique Used for Labor Analgesia?|Completed||N/A|14|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||f||||||||||2017-02-18 15:40:32.860024|2017-02-18 15:40:32.860024
NCT00464828|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-11-13|||November 2006||2006-11-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Observational|||Ultrasound Imaging of Neck Blood Vessels in Pregnant and Non-Pregnant Women|Internal Jugular Vein and Carotid Artery Anatomic Relation as Determined by Ultrasonography in Obstetric Patients|Completed||N/A|156|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||||f||||f||||||||||2017-02-18 15:40:32.961461|2017-02-18 15:40:32.961461
NCT00348244|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-01-15||||||January 2007|2007-01-01||||||||Interventional|||Ketorolac vs. Steroid in the Prevention of CME|A Masked Comparison of Acular LS Plus Steroid Versus Steroid Alone for the Prevention of Macular Leakage in Cataract Patients|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:25:35.389482|2017-02-18 16:25:35.389482
NCT00464815|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-10-26||2009-09-03|May 2007||2007-05-01|October 2016|2016-10-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|||Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects|Primary Vaccination Study in Subjects Aged 11-17 Years to Demonstrate the Non-inferiority of GSK Biologicals' Meningococcal Vaccine GSK134612 Vaccine Versus Mencevax™ ACWY|Completed||Phase 3|1024|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:40:33.04012|2017-02-18 15:40:33.04012
NCT00464802|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2011-07-22|||April 2007||2007-04-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Study Evaluating the Safety and Tolerability of a New Intravenous Formulation of MOA-728 in Healthy Subjects|A Double-Blind, Placebo-Controlled, Multiple-Dose, 2-Period Crossover Study to Evaluate the Safety and Tolerability of a New Intravenous Formulation of MOA-728 in Comparison With the Current Formulation in Healthy Subjects|Completed||Phase 1|36|Anticipated|Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 15:40:33.160123|2017-02-18 15:40:33.160123
NCT00464789|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2007-12-19|||March 2007||2007-03-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women|An Open-Label, Single-Dose, Randomized, 3-Period, Crossover, Bioequivalence Study Between Bazedoxifene/Conjugated Estrogens (Premarin Current Process) And Bazedoxifene/Conjugated Estrogens (Premarin New Process) In Healthy Postmenopausal Women|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:40:33.333806|2017-02-18 15:40:33.333806
NCT00464776|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-21|2011-02-03|||October 2005||2005-10-01|February 2011|2011-02-01||||April 2008|Actual|2008-04-01||Interventional|||Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy|A Randomized, Double-blind, Cross-over, 4-period, 4 Treatment, Within-subject Placebo-controlled Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Type 2 Diabetic Patients With Incipient or Overt Nephropathy|Completed||Phase 1/Phase 2|26|Actual|Novartis||4|||f||||t||||||||||2017-02-18 15:40:33.410846|2017-02-18 15:40:33.410846
NCT00464763|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2015-11-02|||April 2007||2007-04-01|November 2015|2015-11-01|September 2007|Actual|2007-09-01|||||Interventional|||A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Heart Surgery With Cardiopulmonary Bypass|Withdrawn||Phase 3|0|Actual|Hospira, Inc.||2||"The incidence of post-operative delirium observed from interim blinded data in DEX-06-09 was~   significantly lower than the current literature in this population."|f||||f||||||||||2017-02-18 15:40:33.51591|2017-02-18 15:40:33.51591
NCT00464750|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-07-15|||November 2006||2006-11-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|||||Observational|||Study on the Repeatability of Cardiac Output Measurements Dependence of Temperature of Injectate|The Impact of Temperature of the Injectate on the Precision (Repeatability) of Cardiac Output Measurements Synchronized With the Respiration (the Temperature Study)|Completed||Early Phase 1|40|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 15:40:33.628261|2017-02-18 15:40:33.628261
NCT00464737|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2015-05-26|2009-11-23||March 2007||2007-03-01|September 2010|2010-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|SP888||The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.|A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 2 Different Doses of Rotigotine in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome|Completed||Phase 2|230|Actual|UCB Pharma||3|||f||||f||||||||||2017-02-18 15:40:33.739349|2017-02-18 15:40:33.739349
NCT00464724|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-11-10|||March 2007||2007-03-01|November 2016|2016-11-01||||March 2018|Anticipated|2018-03-01||Interventional|||3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate|3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate|Recruiting||N/A|80|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:40:34.867681|2017-02-18 15:40:34.867681
NCT00464711|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2016-11-04|2014-09-15||September 2006||2006-09-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Brain GABA Levels and Treatment Response in Major Depressive Disorder|Brain GABA Levels and Treatment Response in Major Depressive Disorder|Completed||Phase 4|40|Actual|Massachusetts General Hospital||1|||f||||f||||||||No||2017-02-18 15:40:34.992284|2017-02-18 15:40:34.992284
NCT00464698|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2014-09-15|||December 2005||2005-12-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|FIJ-MC-1003||Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)|Duloxetine for the Treatment of Obsessive Compulsive Disorder|Completed||Phase 4|20|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:40:35.249964|2017-02-18 15:40:35.249964
NCT00464685|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2014-07-10|2014-07-10||May 2007||2007-05-01|July 2014|2014-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema||Completed||Phase 2|253|Actual|Allergan||2|||f||||f||||||||||2017-02-18 15:40:35.363852|2017-02-18 15:40:35.363852
NCT00464672|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-23|2015-09-16|2010-01-25||April 2007||2007-04-01|September 2015|2015-09-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old|A Phase III, Observer-Blind, Randomized, Controlled, Multicenter Study to Evaluate Safety, Tolerability, and Immunogenicity of Two Trivalent Subunit Inactivated Influenza Vaccines in Healthy Children Aged 3 to 8 Years, in Healthy Children/Adolescents Aged 9 to 17 Years,and in Healthy Adults Aged 18 to 64 Years|Completed||Phase 3|1893|Actual|Novartis||2|||f||||t||||||||||2017-02-18 15:40:35.956881|2017-02-18 15:40:35.956881
NCT00464659|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2015-12-29|||April 2007||2007-04-01|December 2015|2015-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Protocol Memory Deficit in Patients With Obstructive Sleep Apnea Syndrome|"Comparison of the Evolution of Memory Deficit in Patients With Sleep Apnea Obstructive Syndrome (SAOS) Before and After Effective Versus Sham Treatment by Positive Pression Continues (PPC)"|Completed||N/A|40|Actual|University Hospital, Grenoble||2|||f||||t||||||||Yes|All individual patient data are anonymized|2017-02-18 15:40:37.168471|2017-02-18 15:40:37.168471
NCT00348231|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-08-31|||November 2004||2004-11-01|June 2006|2006-06-01|August 2006||2006-08-01|||||Interventional|||Jikei Optimal Insulin Therapy in Type 2 Diabetes||Unknown status|Recruiting|N/A|60||Jikei University School of Medicine|||||f||||||||||||||2017-02-18 16:25:35.469609|2017-02-18 16:25:35.469609
NCT00464646|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2014-07-17|2012-08-24||May 2007||2007-05-01|July 2014|2014-07-01|May 2014|Actual|2014-05-01|December 2009|Actual|2009-12-01||Interventional|||Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer|A Phase II Clinical Trial of Epirubicin Plus Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and Bevacizumab Given as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or Given as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer|Completed||Phase 2|105|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-02-18 15:40:37.278578|2017-02-18 15:40:37.278578
NCT00464633|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2013-02-08||2013-02-08|March 2007||2007-03-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)|A Multicenter, Open-label, Single Arm Study of Weekly Alvocidib in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia (CLL) or Prolymphocytic Leukemia (PLL) Arising From CLL|Completed||Phase 2|165|Actual|Sanofi||1|||f||||t||||||||||2017-02-18 15:40:38.176971|2017-02-18 15:40:38.176971
NCT00464620|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2016-10-12|||May 2007||2007-05-01|October 2016|2016-10-01|January 2017|Anticipated|2017-01-01|December 2016|Anticipated|2016-12-01||Interventional|||Trial of Dasatinib in Advanced Sarcomas|A Phase II Trial of Dasatinib in Advanced Sarcomas|Active, not recruiting||Phase 2|386|Actual|Sarcoma Alliance for Research through Collaboration||1|||f||||t||||||||||2017-02-18 15:40:38.32684|2017-02-18 15:40:38.32684
NCT00464607|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2007-04-20|||December 2001||2001-12-01|April 2007|2007-04-01|April 2005|Actual|2005-04-01|||||Interventional|||Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA|A Prospective, Randomized, Controlled Clinical Study on the Assessment of Tolerability and of Clinical Efficacy of MERIONAL® (hMG-IBSA) Administered Subcutaneously Versus MERIONALâ Administered Intramuscularly in Women Undergoing Controlled Ovarian Hyperstimulation (COH) in an ART Programme (IVF)|Completed||Phase 3|160||IBSA Institut Biochimique SA|||||f||||f||||||||||2017-02-18 15:40:38.457558|2017-02-18 15:40:38.457558
NCT00464594|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-22|||April 2007||2007-04-01|April 2007|2007-04-01||||||||Interventional|JEDIS||Japan Early Diabetes Intervention Study|A Randomized Comparative Clinical Study on Suppression of Progression From Early Diabetes, Diet/Exercise Standard Intervention vs. Concurrent Pharmacological Standard Intervention|Unknown status|Recruiting|N/A|2560||Japan Early Diabetes Intervention Study Group|||||f||||||||||||||2017-02-18 15:40:38.712903|2017-02-18 15:40:38.712903
NCT00464581|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2012-05-24|||May 2007||2007-05-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|FVF4153s||Lucentis for Treatment of Macular Edema|A Single-center Phase 2 Trial of Intravitreous Injections of Lucentis (Ranibizumab) in Subjects With Cystoid Macular Edema Secondary to Non-ischemic Retinopathy|Completed||N/A|30|Actual|Retina Institute of Hawaii|||1||f||||f||||||||||2017-02-18 15:40:38.825889|2017-02-18 15:40:38.825889
NCT00464568|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2012-05-31|||March 2007||2007-03-01|February 2011|2011-02-01|May 2007|Actual|2007-05-01|||||Interventional|||A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis|A Randomised, Open, Placebo-controlled 5-way Crossover Trial of Single Doses of Intranasal GSK256066 in Subjects With Seasonal Allergic Rhinitis (SAR).|Completed||Phase 2|32|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:40:38.947543|2017-02-18 15:40:38.947543
NCT00464555|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2016-03-24||2014-03-27|December 2006||2006-12-01|March 2016|2016-03-01|February 2014|Actual|2014-02-01|November 2011|Actual|2011-11-01||Interventional|||Strategies to Improve Islet Survival|Strategies to Improve Long Term Islet Graft Survival|Completed||Phase 2|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 15:40:39.050301|2017-02-18 15:40:39.050301
NCT00464542|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2011-08-31|2011-03-22||December 2007||2007-12-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|MASH||Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study|Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 Shedding|Completed||Phase 4|12|Actual|University of Pittsburgh|Inadequate controls (study would have been improved by inclusion of women without herpes simplex virus type 2 infection) to better determine the strength of the association between recalcitrance of BV and HSV-2 infection.|1|||f||||f||||||||||2017-02-18 15:40:39.182172|2017-02-18 15:40:39.182172
NCT00464529|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2007-11-06|||May 2007||2007-05-01|May 2007|2007-05-01|October 2007|Actual|2007-10-01|||||Observational|GluContinu||Accuracy and Safety of Real Time Continuous Glucose Monitoring Before, During and After Surgery|Peri-Operative Accuracy and Safety of Real Time Continuous Glucose Monitoring System in Cardiac Surgical Patients. A Pilot Study|Completed||N/A|30|Actual|Medical Research Foundation, The Netherlands|||||f||||f||||||||||2017-02-18 15:40:39.428169|2017-02-18 15:40:39.428169
NCT00464516|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2012-06-28|||April 2007||2007-04-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|February 2009|Actual|2009-02-01||Interventional|||Preoperative Estetrol in Breast Cancer|Preoperative Hormone Therapy for Pre- and Postmenopausal Women With ER Positive Breast Cancer: A Double Blind Randomized Parallel Group Phase II Trial, Comparing the Effect of 2 Weeks of Preoperative Estetrol With Placebo|Completed||Phase 2|30|Actual|Pantarhei Bioscience||2|||f||||f||||||||||2017-02-18 15:40:39.517732|2017-02-18 15:40:39.517732
NCT00464503|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2008-04-03|||September 2007||2007-09-01|April 2008|2008-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Statins and the Urinary Proteome|The Effect of Statins on the Urinary Proteome|Completed||N/A|7|Actual|Universiteit Antwerpen||2|||f||||t||||||||||2017-02-18 15:40:39.625714|2017-02-18 15:40:39.625714
NCT00464490|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2014-10-29|2014-10-25||November 2007||2007-11-01|October 2014|2014-10-01|December 2012|Actual|2012-12-01|May 2012|Actual|2012-05-01||Interventional|||Use of Dexmedetomidine to Facilitate Extubation in Surgical ICU Patients Who Failed Previous Weaning Attempts|A Prospective, Randomized, Controlled Study on the Use of Dexmedetomidine to Facilitate Extubation in Surgical Intensive-Care-Unit Patients Who Failed Previous Weaning Attempts|Terminated||N/A|42|Actual|University of California, San Francisco|Lower than anticipated enrollment due to unwillingness of providers to assign patients to the control group led to smaller-than-planned samples for analysis|2||Lack of eligible participants|f||||f||||||||||2017-02-18 15:40:39.731424|2017-02-18 15:40:39.731424
NCT00464477|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2007-11-06|||June 2007||2007-06-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Observational|||Advanced Grandparental Age as a Risk Factor for Autism|Advanced Grandparental Age as a Risk Factor for Autism and Other Pervasive Developmental Disorders|Completed||N/A|100|Actual|University of Mississippi Medical Center|||1||f||||f||||||||||2017-02-18 15:40:40.15369|2017-02-18 15:40:40.15369
NCT00464451|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2016-11-01|||August 2009||2009-08-01|November 2016|2016-11-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|||Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG|Prospective, Double Blinded,Randomized Controlled Trial of Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG|Withdrawn||Phase 2|0|Actual|Wesley Medical Center||2||Unable to obtain approval from FDA for use of chloral hydrate|f||||t||||||||||2017-02-18 15:40:40.772102|2017-02-18 15:40:40.772102
NCT00464438|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2011-08-17|2010-06-15||June 2007||2007-06-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis||Completed||Phase 4|171|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:40:40.880778|2017-02-18 15:40:40.880778
NCT00464425|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2011-04-20|||October 2008||2008-10-01|April 2011|2011-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Electroacupuncture for Postoperative Ileus After Laparoscopic Colorectal Surgery|Electroacupuncture for Postoperative Ileus After Laparoscopic Colorectal Surgery: a Randomised Sham-controlled Pilot Study|Completed||Phase 3|165|Anticipated|Chinese University of Hong Kong||3|||f||||t||||||||||2017-02-18 15:40:41.246021|2017-02-18 15:40:41.246021
NCT00464412|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-05-08|||January 2006||2006-01-01|May 2007|2007-05-01|February 2006|Actual|2006-02-01|||||Interventional|||The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis|The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis|Completed||Phase 1|135|Actual|Valdosta State University||2|||f||||f||||||||||2017-02-18 15:40:41.357122|2017-02-18 15:40:41.357122
NCT00464399|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2016-11-15|||September 2006||2006-09-01|November 2016|2016-11-01||||December 2012|Actual|2012-12-01||Interventional|||Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients|A Pilot Study to Evaluate Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant|Completed||Phase 3|20||Novartis|||||f||||||||||||||2017-02-18 15:40:41.437009|2017-02-18 15:40:41.437009
NCT00464386|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2016-04-28|||September 2006||2006-09-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|February 2009|Actual|2009-02-01||Interventional|POC||Continuous Glucose Monitoring (POC) in the ICU|Continuous Glucose Monitors (CGM) Versus Point-of-Care (POC) Glucometers in the Intensive Care Unit (ICU)|Terminated||N/A|23|Actual|United States Army Institute of Surgical Research||2||Study device required infeasible modifications. No patients received device.|f||||f||||||||No||2017-02-18 15:40:41.530225|2017-02-18 15:40:41.530225
NCT00464373|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2014-01-31|||April 2007||2007-04-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|BTX-URO-01||Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome|Injection of Botulinum Toxin Type A Into the External Urethral Sphincter for Male Patients Suffering From Chronic Prostatitis/Chronic Pelvic Pain Syndrome (NIH Cat. III): a Prospective, Double-blind and Placebo-controlled Clinical Trial|Terminated||Phase 3|11|Actual|Cantonal Hospital of St. Gallen||2||Slow accrual.|f||||t||||||||||2017-02-18 15:40:41.638124|2017-02-18 15:40:41.638124
NCT00464347|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2010-03-23|||January 2007||2007-01-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|VERTACL||TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration|Multi-Center, Randomized, Phase II Clinical Trial to Study the Effects of Preservative-Free Triamcinolone Acetonide and Avastin® in Combination With Photodynamic Therapy in Participants With Neovascular Age Related Macular Degeneration|Terminated||Phase 2|100|Anticipated|National Eye Institute (NEI)||2||Study was terminated because of poor enrollment.|f||||t||||||||||2017-02-18 15:40:41.750889|2017-02-18 15:40:41.750889
NCT00464334|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2015-09-24|2012-11-19||March 2007||2007-03-01|September 2015|2015-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study of V950 in People With Alzheimer Disease (V950-001 AM7)|A Double-Blind, Randomized, Placebo-Controlled, Dose Escalating Study to Evaluate the Safety, Tolerability, and Immunogenicity of V950 Formulated on Aluminum-Containing Adjuvant With or Without ISCOMATRIX™ in Patients With Alzheimer Disease|Completed||Phase 1|86|Actual|Merck Sharp & Dohme Corp.||11|||f||||f||||||||||2017-02-18 15:40:41.879889|2017-02-18 15:40:41.879889
NCT00464321|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2014-03-17|||May 2007||2007-05-01|March 2014|2014-03-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS|A Phase I, Multicentre, Open-label, Dose-escalating Study of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS)|Completed||Phase 1|16|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 15:40:44.583627|2017-02-18 15:40:44.583627
NCT00464308|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2014-04-02|2009-06-09||November 2006||2006-11-01|April 2014|2014-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg|The Rabeprazole and Esomeprazole Reflux Assessment Trial (TREAT)|Completed||Phase 4|1392|Actual|Janssen-Cilag Pty Ltd|The MCID of 7.5% was amended to 9% to maintain power with smaller sample size.The proportion of patients without heartburn symptoms at baseline was not evenly distributed between treatment arms. This was a significant predictor of symptom resolution.|3|||f||||f||||||||||2017-02-18 15:40:44.697489|2017-02-18 15:40:44.697489
NCT00464295|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2007-12-13|||August 2006||2006-08-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|HCC-CAP||Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)|Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)|Completed||Phase 2|15|Actual|Aga Khan University||1|||f||||f||||||||||2017-02-18 15:40:47.919067|2017-02-18 15:40:47.919067
NCT00464282|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2007-04-20||||||April 2007|2007-04-01||||||||Observational|||Fluorine-18-α–Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer||Completed||N/A|||Gunma University|||||f||||||||||||||2017-02-18 15:40:48.017734|2017-02-18 15:40:48.017734
NCT00464269|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2016-03-14|2016-03-14||September 2007||2007-09-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional||Baseline Characteristics refer to Randomized Set.|Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures|An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (>= 16 to 70 Years Old) With Partial Onset Seizures|Completed||Phase 3|400|Actual|UCB Pharma||4|||f||||f||||||||||2017-02-18 15:40:48.093375|2017-02-18 15:40:48.093375
NCT00464256|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2010-12-09|||April 2004||2004-04-01|December 2010|2010-12-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|STRATUS-META||Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation|Comparison of the Efficacy and Safety of a 20 mg/Day Oral Dose of Rimonabant Versus Placebo as an Aid to Smoking Cessation - a US, Randomized, Double-blind, 2 Arm, Placebo-controlled, Parallel-group, Fixed Dose, 12-week Study|Completed||Phase 3|533|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:40:52.210919|2017-02-18 15:40:52.210919
NCT00464243|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2009-02-16|||April 2007||2007-04-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|NOCTURNE907||Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study|Efficacy and Safety of 2 mg/Day M100907 on Sleep Maintenance Insomnia: a 6-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Polysomnographic Study|Completed||Phase 3|604|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:40:52.298469|2017-02-18 15:40:52.298469
NCT00464230|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2011-06-30|||September 2002||2002-09-01|April 2007|2007-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Hemiarthroplasty or Internal Fixation for Displaced Femoral Neck Fractures|The Management of Intracapsular Fractures of the Proximal Femur. A Prospective, Randomized Trial of Two Parallel Screws and Hemiarthroplasty|Completed||Phase 4|220||Oslo University Hospital|||||f||||f||||||||||2017-02-18 15:40:52.406604|2017-02-18 15:40:52.406604
NCT00464217|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2010-01-03|||October 1998||1998-10-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years|PETHEMA-LAM99:Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years|Completed||Phase 4|100||PETHEMA Foundation|||||f||||t||||||||||2017-02-18 15:40:52.497953|2017-02-18 15:40:52.497953
NCT00464204|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2012-01-09|2011-05-30||July 2007||2007-07-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|CRYSTMAS||Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis|Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis|Completed||Phase 3|196|Actual|Fresenius Kabi||2|||f||||t||||||||||2017-02-18 15:40:52.630231|2017-02-18 15:40:52.630231
NCT00464191|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2009-09-19|||April 2006||2006-04-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment|Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment|Terminated||Phase 4|150|Anticipated|Nordfjord Psychiatric Centre||2||The study has been terminated because too few patients have been recruited|f||||||||||||||2017-02-18 15:40:54.011247|2017-02-18 15:40:54.011247
NCT00464178|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2013-09-04|||April 2007||2007-04-01|September 2013|2013-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma|A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed Refractory Multiple Myeloma|Completed||Phase 2|7|Actual|Hackensack University Medical Center||1|||f||||f||||||||||2017-02-18 15:40:54.10845|2017-02-18 15:40:54.10845
NCT00464165|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-20|2010-12-09|||November 2002||2002-11-01|December 2010|2010-12-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|STRATUS-EU||Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation|Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5mg/Day or 20mg/Day, Versus Placebo, as an Aid to Smoking Cessation; Multiple Country, Randomized, Double-blind, 3-arm, 10-week Treatment, 40-week Follow-up|Completed||Phase 3|789|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:40:54.220425|2017-02-18 15:40:54.220425
NCT00464139|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2009-02-19|||January 2007||2007-01-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Prevalence of Endometriosis in a Well Defined Group of Infertile Women|High Prevalence of Endometriosis in Infertile Women With Normal Ovulation and Normospermic Partners|Completed||N/A|221|Actual|University Hospital, Gasthuisberg|||1||f||||f||||||Samples Without DNA|"~     The diagnosis of endometriosis was always confirmed by histological examination of the~     lesions excised.~   "|||2017-02-18 15:40:54.320003|2017-02-18 15:40:54.320003
NCT00464126|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2011-03-02|||August 2006||2006-08-01|March 2011|2011-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Use of Colloid Versus Crystalloid in Post-operative Pediatric Cardiac Patients for Fluid Resuscitation|The Use of Colloid Versus Crystalloid in Post-operative Pediatric Cardiac Patients for Fluid Resuscitation|Completed||N/A|32|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 15:40:54.430325|2017-02-18 15:40:54.430325
NCT00464113|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-08-19|||May 2007||2007-05-01|August 2015|2015-08-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL228 Administered Intravenously to Subjects With Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia (Ph+ ALL)|Terminated||Phase 1|49|Actual|Exelixis||2||Sponsor decision|f||||t||||||||||2017-02-18 15:40:54.539891|2017-02-18 15:40:54.539891
NCT00464100|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-09-21|||August 2006||2006-08-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Observational|NIRS ND||Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes|Neurodevelopmental Outcomes and Postoperative Hemodynamics in Children With Hypoplastic Left Heart Syndrome|Active, not recruiting||N/A|48|Anticipated|Medical College of Wisconsin|||1||f||||f||||||||||2017-02-18 15:40:54.640058|2017-02-18 15:40:54.640058
NCT00464087|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2013-07-30|2013-04-16||June 2007||2007-06-01|July 2013|2013-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|SWITCHIII||Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI|Switching From Arixtra (Fondaparinux) to Angiomax (Bivalirudin) or Unfractionated Heparin in Patients With Acute Coronary Syndromes (ACS) Without ST-segment Elevation Undergoing Percutaneous Coronary Intervention (PCI): SWITCH III|Completed||Phase 3|100|Actual|Medstar Health Research Institute|This trial included only small number of patients and is not powered to detect intergroup differences|2|||f||||t||||||||||2017-02-18 15:40:54.730594|2017-02-18 15:40:54.730594
NCT00464074|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2011-07-07|||September 2007||2007-09-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|ENER-G||Evaluation of Natalizumab for thE Relief of MS Associated FatiGue|Multi-center, Open-Label Study to Evaluate the Effects of Natalizumab Treatment on Fatigue and Cognition in Subjects With Relapsing Forms of MS|Completed||N/A|200|Actual|Biogen|||1||f||||f||||||||||2017-02-18 15:40:55.29643|2017-02-18 15:40:55.29643
NCT00464061|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2016-04-26||2016-04-26|April 2007||2007-04-01|April 2016|2016-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|SAMS||Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus|Efficacy and Safety of 2mg/Day of M100907 on Sleep Maintenance Insomnia With a Sub-study of the Effect of M100907 on Stable Type II Diabetes Mellitus: a One Year, Multi-center, Randomized, Double-blind, Placebo-controlled Study|Terminated||Phase 3|1847|Actual|Sanofi||2||"Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary~   insomnia with predominant sleep maintenance problems"|f||||||||||||||2017-02-18 15:40:55.411438|2017-02-18 15:40:55.411438
NCT00464048|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19|||May 2007||2007-05-01|April 2007|2007-04-01|May 2009|Anticipated|2009-05-01|||||Interventional|||A Controlled Study to Assess the Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients With Major Depressive Disorder|A Controlled Study to Assess the Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients With Major Depressive Disorder|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hadassah Medical Organization|||||f||||f||||||||||2017-02-18 15:40:55.538804|2017-02-18 15:40:55.538804
NCT00464035|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2009-01-20|||February 2005||2005-02-01|December 2004|2004-12-01|October 2005||2005-10-01|||||Interventional|||The Effect of Calcium on Postprandial Lipid Profile and Appetite||Completed||N/A|18||University of Copenhagen|||||f||||||||||||||2017-02-18 15:40:55.625409|2017-02-18 15:40:55.625409
NCT00464022|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-10-16|||November 2006||2006-11-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||CO2 Insufflation During Double Balloon Enteroscopy|Carbon Dioxide Versus Air Insufflation in Double-Balloon Endoscopy -a Randomised Controlled Multicentre Trial|Completed||Phase 4|100|Anticipated|Rikshospitalet University Hospital|||||f||||f||||||||||2017-02-18 15:40:55.71403|2017-02-18 15:40:55.71403
NCT00464009|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2010-01-28|||February 2001||2001-02-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|April 2002|Actual|2002-04-01||Interventional|IMB-RCT||Development and Evaluation of a Medical Intervention for Early Childhood Caries|Development and Evaluation of a Medical Intervention for Early Childhood Caries|Completed||N/A|120|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-02-18 15:40:55.795599|2017-02-18 15:40:55.795599
NCT00463996|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-04-18|||April 2007||2007-04-01|April 2007|2007-04-01|April 2008|Anticipated|2008-04-01|||||Observational|||MRI in Staging Ovarian Cancer Using MRI Contrast Agent|Værdien af MRI Til Staging af c.Ovarii-et Prospektivt Studie|Unknown status|Not yet recruiting|N/A|50||University of Aarhus|||||f||||f||||||||||2017-02-18 15:40:56.128545|2017-02-18 15:40:56.128545
NCT00463983|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2012-09-20|||October 2006||2006-10-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2010|Actual|2010-01-01||Interventional|FIBROSAND||Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide|Phase 2 Study of Long Acting Octreotide in Idiopathic Pulmonary Fibrosis|Completed||Phase 1/Phase 2|25|Actual|Institut National de la Santé Et de la Recherche Médicale, France||1|||f||||t||||||||||2017-02-18 15:40:56.195977|2017-02-18 15:40:56.195977
NCT00463970|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-06-25|||February 2008||2008-02-01|June 2015|2015-06-01|August 2012|Actual|2012-08-01|August 2010|Actual|2010-08-01||Interventional|CINS||Cognitive Interventions and Nutritional Supplementation for Patients With Long-lasting Back Pain|A Randomized Controlled Multicentre Trial of a Brief Intervention (BI) Versus a BI Plus Cognitive Behavioural Treatment (CBT) Versus Nutritional Supplementation for Patients With Long-lasting Back Pain.|Completed||Phase 1|414|Actual|Uni Research||4|||f||||t||||||||||2017-02-18 15:40:56.290995|2017-02-18 15:40:56.290995
NCT00463957|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2010-01-11|||August 2006||2006-08-01|April 2007|2007-04-01||||||||Interventional|||The Pharmacological Basis for the Increase in Visual Time Constants Induced by Single Oral Doses of Sildenafil|The Pharmacological Basis for the Increase in Visual Time Constants Induced by Single Oral Doses of Sildenafil|Unknown status|Active, not recruiting|N/A|12||University of Cambridge|||||f||||f||||||||||2017-02-18 15:40:56.420088|2017-02-18 15:40:56.420088
NCT00463944|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-04-19|||January 2001||2001-01-01|June 2005|2005-06-01|December 2001||2001-12-01|||||Observational|||Assessment of an Electronic Voting System Within the Tutorial Setting. A Randomised Controlled Trial|Assessment of an Electronic Voting System Within the Tutorial Setting. A Randomised Controlled Trial|Completed||N/A|130||University of Adelaide|||||f||||||||||||||2017-02-18 15:40:56.509879|2017-02-18 15:40:56.509879
NCT00463931|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19|||September 2006||2006-09-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Observational|||Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana|Using Community-Based Volunteers to Reach Non-Enrolled School-Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana|Completed||N/A|916||DBL -Institute for Health Research and Development|||||f||||f||||||||||2017-02-18 15:40:56.587577|2017-02-18 15:40:56.587577
NCT00463918|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2008-11-18|||May 2007||2007-05-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|||||Interventional|||A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers|Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Multiple-Dose Pharmacokinetics, Safety and Tolerability of Varenicline in Healthy Adolescent Smokers|Completed||Phase 1|73|Actual|Pfizer|||||f||||||||||||||2017-02-18 15:40:56.67003|2017-02-18 15:40:56.67003
NCT00463905|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2014-12-03|||October 2007||2007-10-01|December 2014|2014-12-01|August 2011|Actual|2011-08-01|June 2009|Actual|2009-06-01||Interventional|COSHIBA||Evaluation of the Impact of a Case-finding Strategy for Vertebral Fractures|Evaluation of the Impact of a Case-finding Strategy for Vertebral Fractures on Bisphosphonate and Other Drug Prescribing in Primary Care, Using the Cohort for Skeletal Health in Bristol and Avon (COSHIBA)|Completed||N/A|3200|Actual|University of Bristol||2|||f||||t||||||||||2017-02-18 15:40:56.770331|2017-02-18 15:40:56.770331
NCT00463892|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2014-11-08|||June 2007||2007-06-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|November 2011|Actual|2011-11-01||Interventional|||High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes|A Phase II Study of High-resolution Contrast-enhanced MRI of Regional Lymph Nodes in Patients With Clinically Localized Invasive Melanoma|Completed||Phase 2|200|Anticipated|Redwood Regional Medical Group||1|||f||||f||||||||||2017-02-18 15:40:56.883891|2017-02-18 15:40:56.883891
NCT00463879|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-12-11|||September 2005||2005-09-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Galantamine for Cognitive Deficits in Schizophrenia|Galantamine for Cognitive Deficits in Schizophrenia|Completed||Phase 2/Phase 3|21|Actual|Yale University|||||f||||f||||||||||2017-02-18 15:40:56.981109|2017-02-18 15:40:56.981109
NCT00463866|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2010-03-08|2009-12-22||March 2007||2007-03-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|||||Interventional|||Local Phase 4 Pan-European SMART Study||Completed||Phase 4|8424|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:40:57.119285|2017-02-18 15:40:57.119285
NCT00463853|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2014-06-10|||August 2007||2007-08-01|June 2014|2014-06-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|STAR||Stem Cell Therapy as Adjunct to Revascularization|Stem Cell Therapy as Adjunct to Revascularization: STAR|Withdrawn||Phase 1|0|Actual|VA Office of Research and Development||1||inability to recruit due to administrative difficulties at the site|f||||t||||||||||2017-02-18 15:40:59.276885|2017-02-18 15:40:59.276885
NCT00463840|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-11-06|2012-03-05||June 2004||2004-06-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|July 2010|Actual|2010-07-01||Interventional|||Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer|A Phase I/II Study of Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer|Terminated||Phase 1/Phase 2|24|Actual|New York University School of Medicine|This study did not reach its target accrual due to slow accrual. Small number of patients were analyzed.|1||Due to slow accrual|f||||t||||||||||2017-02-18 15:40:59.399341|2017-02-18 15:40:59.399341
NCT00463827|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2010-01-15|||August 2007||2007-08-01|October 2007|2007-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Statins on Asthma Control in Smokers With Asthma|Effect of Statins on Asthma Control and Airway Inflammation in Smokers With Asthma: a Randomised Controlled Double-blind Parallel Group Study|Completed||Phase 2|80|Anticipated|NHS Greater Clyde and Glasgow||2|||f||||t||||||||||2017-02-18 15:40:59.760048|2017-02-18 15:40:59.760048
NCT00463814|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2017-01-19|||March 2007||2007-03-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|June 2008|Actual|2008-06-01||Interventional|||AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Patients With Advanced Solid Malignancies|A Phase I, Open Label, Multi-centre Study to Assess the Safety, Tolerability and Pharmacokinetics of a Solid Oral Dosage Formulation (Capsule) of AZD6244 in Patients With Advanced Solid Malignancies|Active, not recruiting||Phase 1|64|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 15:40:59.895436|2017-02-18 15:40:59.895436
NCT00463801|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2011-03-22|2010-12-09||January 2007||2007-01-01|March 2011|2011-03-01||||November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections|A Multicentre, Open Label, Uncontrolled Clinical Trial to Evaluate Efficacy and Safety of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections (cSSTI) Caused by Methicillin-resistant Staphylococcus Aureus (MRSA)|Terminated||Phase 4|52|Actual|Novartis|Inadequate accrual caused the premature study termination and the insufficient sample size, therefore none of the planned study analyses were performed; nor were any tabulations with descriptive statistics were provided.|1||Because of inadequate accrual.|f||||||||||||||2017-02-18 15:41:00.005248|2017-02-18 15:41:00.005248
NCT00463788|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2014-01-20|2012-06-05||June 2007||2007-06-01|January 2014|2014-01-01|February 2011|Actual|2011-02-01|July 2009|Actual|2009-07-01||Interventional|BALI-1||"Cetuximab and Cisplatin in the Treatment of Triple Negative (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer"|"Randomized Phase II Trial With Cetuximab and Cisplatin in the Treatment of ER-negative, PgR-negative, HER2-negative Metastatic Breast Carcinoma (Basal Like)"|Completed||Phase 2|181|Actual|Merck KGaA|Participants were randomized to 2 groups in a 2:1 ratio.|2|||f||||f||||||||||2017-02-18 15:41:00.246119|2017-02-18 15:41:00.246119
NCT00463775|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2012-01-26|||March 2007||2007-03-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence|Topiramate for Treatment of Patients With Borderline Personality Disorder and Alcohol Dependence|Withdrawn||Phase 3|0|Actual|Yale University||1||Recruitment not progressing as planned.|f||||f||||||||||2017-02-18 15:41:01.405512|2017-02-18 15:41:01.405512
NCT00463762|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2011-04-21|||May 2007||2007-05-01|April 2011|2011-04-01||||||||Observational|||Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.|Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections In Slovakia. An Open, Prospective, Non-Comparative Study.|Withdrawn||Phase 4|0|Actual|Pfizer|||||||||||||||||||2017-02-18 15:41:01.508616|2017-02-18 15:41:01.508616
NCT00463749|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2008-07-07|||December 2006||2006-12-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|LIPSIA-N-ACC||Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein|Trial to Compare Infarct Size and Occurrence of Contrast Dye Induced Nephropathy in Patients With Primary Percutaneous PCI in STEMI|Completed||Phase 3|251|Actual|University of Leipzig||2|||f||||t||||||||||2017-02-18 15:41:01.595733|2017-02-18 15:41:01.595733
NCT00463736|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2016-08-17|||April 2007||2007-04-01|August 2016|2016-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Magnesium Sulfate Versus Placebo for Tocolysis in PPROM|Magnesium Sulfate Versus Placebo for Tocolysis in Preterm Premature Rupture of Membranes|Terminated||N/A|4|Actual|Regional Obstetrical Consultants||2||enrollment proceeding too slowly|f||||t||||||||Undecided||2017-02-18 15:41:01.713551|2017-02-18 15:41:01.713551
NCT00463723|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-04-18||||||August 1999|1999-08-01||||||||Interventional|||Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty||Terminated||Phase 2/Phase 3|||University Hospital Freiburg|||||f||||f||||||||||2017-02-18 15:41:01.826272|2017-02-18 15:41:01.826272
NCT00463710|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19|||June 2005||2005-06-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Observational|||Effect of Interferon Beta-1a (Avonex®) on Changes of Non-Conventional MRI Measures in Patients With MS|Effect of Interferon Beta-1a (Avonex®) on Changes of Non-Conventional MRI Measures in Patients With Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis|Completed||Phase 4|150||State University of New York at Buffalo|||||f||||f||||||||||2017-02-18 15:41:01.903862|2017-02-18 15:41:01.903862
NCT00463697|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2016-10-27|||April 2007||2007-04-01|October 2016|2016-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients|A Randomized, Single-dose, Dose-ascending, Double Blind, Placebo-controlled, 5-way Crossover Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled Doses of GW642444M With Magnesium Stearate in Asthmatic Patients|Completed||Phase 1|20|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:41:01.996791|2017-02-18 15:41:01.996791
NCT00463684|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2009-05-04|||July 2007||2007-07-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|October 2008|Actual|2008-10-01||Interventional|JEV03||Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age|Assessment of the Immunogenicity and Safety of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine in Children in Sri Lanka|Completed||Phase 3|277|Anticipated|PATH|||||f||||f||||||||||2017-02-18 15:41:02.117895|2017-02-18 15:41:02.117895
NCT00463671|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2008-10-16|||December 2003||2003-12-01|May 2007|2007-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Hyperbaric Oxygen, Oxidative Stress, NO Bioavailability and Tissue Oxygenation|The Relation Between Hyperbaric Oxygen, Oxidative Stress, NO Bioavailability and Tissue Oxygenation in Diabetic Patients Suffering From Foot Ulcers|Completed||N/A|50||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:41:02.219999|2017-02-18 15:41:02.219999
NCT00463658|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2008-05-05|||May 2006||2006-05-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Interdisciplinary Falls Prevention for Seniors|The Comparative Effects and Expenses of a Proactive Nurse-Led, Multifactorial and Interdisciplinary Team Approach to Falls Prevention for Older At-Risk Home Care Clients|Completed||Phase 1|109|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 15:41:02.301701|2017-02-18 15:41:02.301701
NCT00463645|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-06-05|||September 2005||2005-09-01|April 2007|2007-04-01|January 2006|Actual|2006-01-01|||||Observational|||Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients|An Open, Mono-Centre Trial to Investigate the Correlation Between the Interstitial and Arterial Blood Concentrations of Glucose During Subcutaneous Glucose Monitoring in Patients With Severe Sepsis at the Medical Intensive Care Unit|Completed||N/A|10||Medical University of Graz|||||f||||f||||||||||2017-02-18 15:41:02.41036|2017-02-18 15:41:02.41036
NCT00463632|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2010-01-11|||January 2007||2007-01-01|January 2010|2010-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control|Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control|Completed||N/A|200|Anticipated|DBL -Institute for Health Research and Development|||1||f||||f||||||None Retained|"~     urine faeces blood~   "|||2017-02-18 15:41:02.484948|2017-02-18 15:41:02.484948
NCT00463619|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2011-08-15|||April 2000||2000-04-01|April 2010|2010-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis||Completed||N/A|132|Actual|Heidelberg University|||1||f||||f||||||||||2017-02-18 15:41:02.565934|2017-02-18 15:41:02.565934
NCT00463606|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2012-09-27|2012-04-25||April 2007||2007-04-01|September 2012|2012-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia|A 12-week, Multicenter, Randomized, Double-Blind, Parallel-Group Study of the Combination of ABT-335 and Rosuvastatin Compared to ABT-335 and Rosuvastatin Monotherapy in Subjects With Type IIa and IIb Dyslipidemia|Completed||Phase 3|760|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 15:41:02.650286|2017-02-18 15:41:02.650286
NCT00463593|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2008-01-23|||December 2006||2006-12-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|||||Observational|||Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes|Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control|Completed||N/A|1293|Actual|DBL -Institute for Health Research and Development|||1||f||||f||||||None Retained|"~     faeces blood~   "|||2017-02-18 15:41:06.419706|2017-02-18 15:41:06.419706
NCT00463580|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2014-10-02|2013-08-13||November 2008||2008-11-01|October 2014|2014-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Infliximab||A Study of Infliximab for Treatment Resistant Major Depression|An Evaluation of the Efficacy of the Tumor Necrosis Factor-alpha Antagonist Infliximab in Treatment Resistant Major Depression: Mechanisms and Mediators|Completed||Phase 4|60|Actual|Emory University|Our study was underpowered to adequately test placebo response typically reported for TRD. Also, no direct measures of the effect of either infliximab or placebo on the CNS were obtained.|2|||f||||t||||||||||2017-02-18 15:41:06.532186|2017-02-18 15:41:06.532186
NCT00463567|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2011-07-22|2011-07-22||April 2007||2007-04-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A 26-week Treatment, Multicenter, Randomized, Double Blind, Double Dummy, Placebo-controlled, Adaptive, Seamless, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Two Doses of Indacaterol (Selected From 75, 150, 300 & 600 µg o.d.) in Patients With Chronic Obstructive Pulmonary Disease Using Blinded Formoterol (12 µg b.i.d.) and Open Label Tiotropium (18 µg o.d.) as Active Controls|Completed||Phase 2/Phase 3|2059|Actual|Novartis||7|||f||||||||||||||2017-02-18 15:41:07.01126|2017-02-18 15:41:07.01126
NCT00463554|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2009-01-26|||April 2006||2006-04-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|January 2007|Actual|2007-01-01||Observational|||TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence|An Evaluation of the GYNECARE TVT-SECUR* System (Tension-Free Support for Incontinence) for the Treatment of Stress Urinary Incontinence *Trademark|Completed||N/A|72|Actual|Ethicon, Inc.|||1||f||||f||||||||||2017-02-18 15:41:09.742195|2017-02-18 15:41:09.742195
NCT00463541|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2014-09-17|||June 2004||2004-06-01|September 2014|2014-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|VOLT||Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms|An Open-label Study of the Efficacy and Safety of 5 and 10mg VESIcare® (Solifenacin Succinate) in Patients With Overactive Bladder Symptoms VOLT: VESIcare® Open-Label Trial|Completed||Phase 3|2225|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 15:41:09.857157|2017-02-18 15:41:09.857157
NCT00463528|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-07-02|||December 2006||2006-12-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|||||Observational|||Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso|Women and Childres at the Focal Point for the Schistosomiasis Control and Sustainability and Effectiveness in the Hydro Agricultural Zone of Sourou, Burkina Faso|Completed||N/A|360|Actual|DBL -Institute for Health Research and Development|||||f||||||||||||||2017-02-18 15:41:10.433837|2017-02-18 15:41:10.433837
NCT00463515|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-07-11|||January 2003||2003-01-01|July 2013|2013-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|CHER@NOS||Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC|A Multicenter Phase II Study of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation in Patients With Non-resectable Stage III Non-Small-Cell-Lung Cancer|Completed||Phase 2|77||University Hospital, Antwerp|||||f||||||||||||||2017-02-18 15:41:10.516753|2017-02-18 15:41:10.516753
NCT00463502|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19||||||March 2007|2007-03-01||||||||Interventional|||The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus||Completed||Phase 4|||Haydarpasa Numune State Hospital|||||f||||f||||||||||2017-02-18 15:41:10.609536|2017-02-18 15:41:10.609536
NCT00463476|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2009-05-04|||July 2007||2007-07-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|October 2008|Actual|2008-10-01||Interventional|||Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine|Assessment of the Immunogenicity and Safety of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine in Children in Sri Lanka|Completed||Phase 3|306|Anticipated|PATH|||||f||||f||||||||||2017-02-18 15:41:10.817358|2017-02-18 15:41:10.817358
NCT00463463|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2012-07-11|||April 2007||2007-04-01|February 2007|2007-02-01||||||||Interventional|Zevalin||Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's Lymphoma|Phase III Stidy of Zevalin And BEAM Compared With BEAM Alone Prior to Autologous Hematopoietic Steem Cell Transpl. in Pts Relapse of Non-Hodgkins Lymphoma|Unknown status|Recruiting|Phase 3|||Soroka University Medical Center||1|||f||||f||||||||||2017-02-18 15:41:10.902377|2017-02-18 15:41:10.902377
NCT00463450|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2014-12-28|||May 2002||2002-05-01|December 2014|2014-12-01|April 2004|Actual|2004-04-01|||||Interventional|||Efficacy of Gynodian® Depot in Women With Impaired Well-being|A Multicenter, Double-blind, Randomized, Cross-over Study to Investigate the Efficacy of Gynodian® Depot i.m. Compared to 4 mg Estradiol Valerate i.m. Both Given Every Four Weeks for Five Months Combined With 5 mg Medroxyprogesterone Acetate Orally in Postmeno-pausal Women With Impaired Well-being, Mood and Sexuality|Completed||Phase 3|140|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:41:10.984141|2017-02-18 15:41:10.984141
NCT00463437|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2016-10-27|2009-06-11||April 2007||2007-04-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines|Booster Vaccination With Pneumococcal Vaccine GSK1024850A, a DTPa-Combined and MenC or Hib-MenC Vaccines|Completed||Phase 3|1437|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:41:11.242213|2017-02-18 15:41:11.242213
NCT00463424|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19|||October 2000||2000-10-01|April 2007|2007-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Comparison of NeuFlex and Swanson Metacarpophalangeal Implants for Rheumatoid Arthritis|NeuFlex and Swanson Metacarpophalangeal Implants for Rheumatoid Arthritis: a Prospective Randomized Controlled Clinical Trial|Completed||Phase 2|40||St. Michael's Hospital, Toronto|||||f||||f||||||||||2017-02-18 15:41:12.734534|2017-02-18 15:41:12.734534
NCT00463411|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-04-19|||December 2006||2006-12-01|December 2006|2006-12-01|December 2017|Anticipated|2017-12-01|||||Observational|||Study of Male Osteoporosis and Aging|Study on Male Osteoporosis and Aging|Recruiting||N/A|30000||Odense University Hospital|||||f||||||||||||||2017-02-18 15:41:12.833835|2017-02-18 15:41:12.833835
NCT00463398|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2010-08-31|||September 2006||2006-09-01|August 2010|2010-08-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Observational|||Fertility Surgery, Prospective Analysis|Quality Control in Surgical Diagnosis and Treatment of Endometriosis.|Unknown status|Recruiting|N/A|600|Anticipated|University Hospital, Gasthuisberg|||1||f||||f||||||Samples Without DNA|"~     Endometriosis is confirmed by histologic examination of excised lesions~   "|||2017-02-18 15:41:12.922391|2017-02-18 15:41:12.922391
NCT00463385|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2015-06-04|2013-03-07||April 2007||2007-04-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|May 2009|Actual|2009-05-01||Interventional|||A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia|A Phase 2, Prospective, Randomized, Multicenter, Double-blind, Active-control, Parallel-group Study to Determine the Safety of and to Select a Treatment Regimen of CC-4047 (Pomalidomide) Either as Single-agent or in Combination With Prednisone to Study Further in Subjects With Myelofibrosis With Myeloid Metaplasia|Completed||Phase 2|88|Actual|Celgene||4|||f||||t||||||||||2017-02-18 15:41:13.039156|2017-02-18 15:41:13.039156
NCT00463372|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-09-17|||October 2006||2006-10-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia|A Phase I, Investigator And Subject-Blind (Sponsor Unblinded), Placebo-Controlled Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-02545920 After Multiple Oral Dose Administration In Subjects With Stable Schizophrenia|Completed||Phase 1|40||Pfizer|||||f||||||||||||||2017-02-18 15:41:15.0948|2017-02-18 15:41:15.0948
NCT00463359|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19||||||April 2007|2007-04-01||||||||Interventional|||A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base|A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base|Unknown status|Not yet recruiting|N/A|50||University of Glasgow|||||f||||t||||||||||2017-02-18 15:41:15.344036|2017-02-18 15:41:15.344036
NCT00463346|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-12-11|2015-10-19||September 2006||2006-09-01|December 2015|2015-12-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional||Individuals with schizophrenia, schizoaffective or psychotic disorder not otherwise specified and current alcohol dependence|Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism|Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism|Completed||Phase 3|23|Actual|Yale University||2|||f||||t||||||||||2017-02-18 15:41:15.442602|2017-02-18 15:41:15.442602
NCT00463333|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2007-04-19|||May 2005||2005-05-01|April 2007|2007-04-01||||||||Observational|||Postoperative Delirium at Heidelberg's Intensive Care Unit -New Diagnostic Markers||Completed||N/A|||Heidelberg University|||||f||||f||||||||||2017-02-18 15:41:15.823599|2017-02-18 15:41:15.823599
NCT00463320|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2012-03-15|||March 2007||2007-03-01|February 2011|2011-02-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.|A Placebo-controlled, Randomized, Dose Rising Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Ocular Doses of Pazopanib in Healthy Adult and Elderly Subjects.|Completed||Phase 1|29|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:41:15.894599|2017-02-18 15:41:15.894599
NCT00463307|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-10-30|||April 2006||2006-04-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Observational|||Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya|Evaluation of Applicability of Urine Based Schistosomiasis Test Strip in the Epidemiologic Mapping and Sampling of Schistosoma Mansoni Infection in Low Endemic Areas of Kenya|Completed||N/A|1100|Actual|DBL -Institute for Health Research and Development|||||f||||f||||||||||2017-02-18 15:41:16.231281|2017-02-18 15:41:16.231281
NCT00463294|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2016-09-15|||October 2007||2007-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|March 2012|Actual|2012-03-01||Interventional|CORONARY||Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study|CABG Off or On Pump Revascularization Study (CORONARY)|Completed||Phase 3|4752|Actual|Population Health Research Institute||2|||f||||t||||||||||2017-02-18 15:41:16.318301|2017-02-18 15:41:16.318301
NCT00463281|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2009-05-13|||January 2007||2007-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Observational|CT-DEFINE||CT Based Definition of a Tissue Window for Acute Stroke Thrombolysis|Observational Study of Multimodal CT in Acute Ischemic Stroke to Define a Tissue Window for Thrombolysis|Completed||N/A|100|Anticipated|Technische Universität Dresden|||1||f||||f||||||||||2017-02-18 15:41:16.492455|2017-02-18 15:41:16.492455
NCT00463268|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2013-05-28|||September 2007||2007-09-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Osteoporosis Prevention With Low Dose Alendronate|Prevention of Postmenopausal Bone Loss in Osteopenic Women With Alendronate Given on a 70 mg Once-every Two Week Regimen: a 2-year, Double-blind, Placebo-controlled Clinical Trial.|Completed||Phase 3|83|Actual|University Hospital of Mont-Godinne||2|||f||||f||||||||||2017-02-18 15:41:16.579222|2017-02-18 15:41:16.579222
NCT00463255|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2011-11-07|||August 2006||2006-08-01|November 2011|2011-11-01|October 2008|Actual|2008-10-01|||||Interventional|||Diet and the Aging Brain|Phase IV Interventional Study: Effect of Diet on Brain Function in Elderly Healthy People|Completed||Phase 3|120|Anticipated|University Hospital Muenster|||||f||||t||||||||||2017-02-18 15:41:16.681533|2017-02-18 15:41:16.681533
NCT00463242|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2012-05-02||2012-05-02|March 2007||2007-03-01|May 2012|2012-05-01||||June 2008|Actual|2008-06-01||Interventional|||A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)|An 8-week, Multicenter, Randomized, Double-blind, Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine 25 or 50 mg Given Once Daily in the Treatment of Major Depressive Disorder (MDD) Followed by a 52-week Open-label Treatment With Agomelatine 25 or 50 mg|Completed||Phase 3|501|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:41:16.785472|2017-02-18 15:41:16.785472
NCT00463229|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2010-09-28|2010-07-22||February 2006||2006-02-01|August 2010|2010-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Interdisciplinary Team Approach to Stroke Rehabilitation in Home Care|The Comparative Acceptability, Safety, Effects and Expense of Specialized, Integrated, and Interdisciplinary Community Rehabilitation for Stroke Survivors and Their Caregivers|Completed||Phase 1|101|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 15:41:16.947698|2017-02-18 15:41:16.947698
NCT00463216|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2010-02-05|||April 2004||2004-04-01|March 2007|2007-03-01|April 2006||2006-04-01|||||Interventional|||A Coordinated Return to Work Program|A Coordinated Return to Work Program for Workers on Long-term Sickness Absence Due to Musculoskeletal Disorders: a Prospective Controlled Intervention Study|Completed||N/A|120||Vejle Hospital|||||f||||f||||||||||2017-02-18 15:41:17.321274|2017-02-18 15:41:17.321274
NCT00463203|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2011-06-27|||March 2007||2007-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy||Completed||Phase 2|54|Anticipated|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-02-18 15:41:17.551234|2017-02-18 15:41:17.551234
NCT00463190|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2008-09-18|||February 2006||2006-02-01|April 2007|2007-04-01|November 2007|Actual|2007-11-01|||||Interventional|||Effect of Probiotics (Bio-Three) in Children's Enterocolitis|Postmarketing Study of Probiotics Medication in Childhood Diarrhea|Completed||Phase 4|300|Anticipated|Chang Gung Memorial Hospital|||||f||||t||||||||||2017-02-18 15:41:17.64239|2017-02-18 15:41:17.64239
NCT00463177|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2008-09-03|||March 2007||2007-03-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Augmented Cerebral Pain Processing in Chronic, Unexplained Pain: a fMRI Study|Augmented Cerebral Pain Processing in Chronic, Unexplained Pain: a 3T Event-Related Functional MRI Study|Completed||N/A|24|Actual|UMC Utrecht|||1||f||||f||||||||||2017-02-18 15:41:17.73538|2017-02-18 15:41:17.73538
NCT00463164|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19|||December 2007||2007-12-01|April 2007|2007-04-01||||||||Observational|||Functional MRI of Cognitive Control in Autism|Functional MRI of Cognitive Control in Autism|Unknown status|Not yet recruiting|N/A|90||UMC Utrecht|||||f||||f||||||||||2017-02-18 15:41:17.820994|2017-02-18 15:41:17.820994
NCT00463151|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2011-02-09|||June 2007||2007-06-01|February 2011|2011-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis|An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis|Completed||Phase 2|120|Anticipated|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-02-18 15:41:17.896968|2017-02-18 15:41:17.896968
NCT00463138|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2013-09-03|||April 2007||2007-04-01|September 2013|2013-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma|Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma|Completed||Early Phase 1|100|Actual|Herzog Hospital|||1||f||||t||||||||||2017-02-18 15:41:18.002606|2017-02-18 15:41:18.002606
NCT00463125|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19|||March 2007||2007-03-01|April 2007|2007-04-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Platelet Gel in Systemic Sclerosis|Platelet Gel for Digital Ulcers in Patients With SSc: a Randomized Controlled Trial|Unknown status|Recruiting|Phase 2/Phase 3|40||Università Politecnica delle Marche|||||f||||f||||||||||2017-02-18 15:41:18.082532|2017-02-18 15:41:18.082532
NCT00463112|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2007-04-19|||March 2004||2004-03-01|December 2003|2003-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS|Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS: a Randomized, 24-Week Study|Completed||Phase 4|80||Hippocration General Hospital|||||f||||f||||||||||2017-02-18 15:41:18.176712|2017-02-18 15:41:18.176712
NCT00463099|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2016-11-01|||January 2002||2002-01-01|November 2016|2016-11-01|December 2024|Anticipated|2024-12-01|December 2023|Anticipated|2023-12-01||Observational|||Multicenter Orthopaedics Outcomes Network for ACL Reconstructions|Prognosis and Predictors of ACL Reconstruction - A Multicenter Cohort Study|Active, not recruiting||N/A|5000|Anticipated|Vanderbilt University|||1||f||||f||||||||No||2017-02-18 15:41:18.27457|2017-02-18 15:41:18.27457
NCT00462891|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-05-18|||March 2007||2007-03-01|May 2013|2013-05-01||||March 2008|Actual|2008-03-01||Interventional|||A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening|Breast Cancer Screening and Follow-Up in a PBRN: The Mammography FastTrack Trial|Completed||N/A|6730|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 15:41:23.926753|2017-02-18 15:41:23.926753
NCT00463086|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2012-07-16|||November 2007||2007-11-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|HAART-IPT||Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons|A Randomized-controlled Trial of Isoniazid Plus Highly Active Antiretroviral Therapy Against Placebo to Prevent Tuberculosis in HIV-infected Persons|Completed||N/A|1368|Actual|University of Cape Town||2|||f||||t||||||||||2017-02-18 15:41:18.383583|2017-02-18 15:41:18.383583
NCT00463073|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-19|2008-12-10|||August 2006||2006-08-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas|A Phase II Trial With Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas and Progression After Radiation Therapy and Temozolamide|Completed||Phase 2|32|Actual|Rigshospitalet, Denmark|||||f||||f||||||||||2017-02-18 15:41:18.668651|2017-02-18 15:41:18.668651
NCT00463060|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2008-06-17|||January 2007||2007-01-01|June 2008|2008-06-01||||||||Interventional|||Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer|Phase I/II Study of Stereotactic Radiation Therapy and Concurrent and Adjuvant Sutent (SU11248) as Treatment for Oligometastatic Disease|Unknown status|Recruiting|Phase 1/Phase 2|65|Anticipated|Icahn School of Medicine at Mount Sinai|||||f||||t||||||||||2017-02-18 15:41:18.751803|2017-02-18 15:41:18.751803
NCT00463047|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2012-05-22|2010-02-26||July 2007||2007-07-01|May 2012|2012-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain|A Randomized, Double-Blind, Active-Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Compared With Immediate-release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patient With Chronic Pain|Completed||Phase 3|323|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 15:41:18.854034|2017-02-18 15:41:18.854034
NCT00463034|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-12-17|||April 2005||2005-04-01|November 2008|2008-11-01||||March 2008|Anticipated|2008-03-01||Observational|||Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer|Genetic Factors Affecting Breast Cancer Progression|Unknown status|Active, not recruiting|N/A|1800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:41:20.117244|2017-02-18 15:41:20.117244
NCT00463021|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-05-04|||April 2007||2007-04-01|May 2015|2015-05-01|December 2007|Actual|2007-12-01|||||Interventional|||A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection|A Phase 4, Multi Center, Open-Label, Randomized Study to Determine Clinically Appropriate Doses of Hectorol® (Doxercalciferol Capsules) When Converting From Zemplar® (Paricalcitol Injection) for the Treatment of Secondary Hyperparathyroidism in Stage 5 Chronic Kidney Disease (CKD) Subjects on Hemodialysis.|Completed||Phase 4|36|Anticipated|Sanofi||3|||||||||||||||||2017-02-18 15:41:20.212215|2017-02-18 15:41:20.212215
NCT00463008|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-06-21|||May 2004||2004-05-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma|A Pharmacokinetic Study of Methotrexate Using an Intratumoral Microdialysis Catheter|Completed||N/A|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:41:20.309887|2017-02-18 15:41:20.309887
NCT00462995|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-05-26|||May 2006||2006-05-01|May 2015|2015-05-01|February 2012|Actual|2012-02-01|January 2012|Actual|2012-01-01||Interventional|SELECT||Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)|Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial|Completed||Phase 2|25|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 15:41:20.396207|2017-02-18 15:41:20.396207
NCT00462982|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-11-24|2015-10-21||March 2007||2007-03-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma|A Phase II Study of SU11248 (Sunitinib) in Patients With Renal Cell Carcinoma and Melanoma Metastatic to the Brain|Completed||Phase 2|8|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:41:20.519499|2017-02-18 15:41:20.519499
NCT00462969|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-01-30|||April 2007||2007-04-01|January 2015|2015-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer|Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer|Completed||N/A|40|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 15:41:20.767441|2017-02-18 15:41:20.767441
NCT00462956|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2017-01-16|||June 2004||2004-06-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GW572016 In Patients With Advanced Or Metastatic Breast Cancer|Phase II Clinical Study of GW572016 in Patients With Advanced or Metastatic Breast Cancer|Completed||Phase 1|67|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:41:20.876946|2017-02-18 15:41:20.876946
NCT00462943|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2014-06-27|2014-05-05||March 2007||2007-03-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|December 2010|Actual|2010-12-01||Interventional||Intent to Treat Population: all participants who provided written informed consent and received at least 1 dose of study drug constitute the ITT population.|Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML|A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (Omacetaxine Mepesuccinate) in the Treatment of Patients With Chronic Myeloid Leukemia (CML) Who Have Failed or Are Intolerant to Tyrosine Kinase Inhibitor Therapy|Completed||Phase 2|100|Actual|Teva Pharmaceutical Industries||1|||f||||t||||||||||2017-02-18 15:41:21.116741|2017-02-18 15:41:21.116741
NCT00462917|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2014-09-09|2014-08-21||March 2007||2007-03-01|September 2014|2014-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|REVEAL|Baseline population includes all participants who received genetic risk information, regardless of whether they completed follow-up time surveys.|REVEAL III: Risk Evaluation and Education for Alzheimer's Disease|Risk Evaluation and Education for Alzheimer's Disease|Completed||N/A|290|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-02-18 15:41:22.96194|2017-02-18 15:41:22.96194
NCT00462904|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2008-06-02|||April 2006||2006-04-01|April 2007|2007-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Pharmacokinetic Response to BPI in Burns|Phase IIa Trial to Evaluate the Pharmacokinetic Response to Bactericidal/Permeability-Increasing Protein (rBPI21) for the Treatment of Patients With Burn Injury.|Completed||Phase 2|6|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 15:41:23.820817|2017-02-18 15:41:23.820817
NCT00462878|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2009-05-11|||November 2002||2002-11-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|||||Observational|MERONEM||Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation|MERONEM: Observational Study About Efficacy of Meropenem in Comparison of Meropenem and Glycopeptide in Treatment of Neutropenia Febrile in Allogenic Blood Stem Cell Transplantation Patients|Completed||N/A|392|Anticipated|PETHEMA Foundation|||1||f||||t||||||||||2017-02-18 15:41:24.03624|2017-02-18 15:41:24.03624
NCT00462865|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-04-07|2013-11-14||November 2007||2007-11-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|March 2012|Actual|2012-03-01||Interventional|||Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse|A Phase II Study of Adjuvant Gemcitabine/Capecitabine and Bevacizumab for Patients Treated Neoadjuvantly Chemotherapy for Early Stage Breast Cancer With High Risk for Relapse|Terminated||Phase 2|18|Actual|Brown University||1||DSMB determined toxicity of regimen more than originally thought. Slow accrual.|f||||t||||||||||2017-02-18 15:41:24.204196|2017-02-18 15:41:24.204196
NCT00462852|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-08-09|||April 2003||2003-04-01|April 2007|2007-04-01|November 2011|Actual|2011-11-01|||||Interventional|||Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase II Randomized Study of Chemo-Anticoagulation (Gemcitabine-Dalteparin) Versus Chemotherapy Alone (Gemcitabine) for Locally Advanced and Metastatic Pancreatic Adenocarcinoma [FRAGEM]|Completed||Phase 2|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:41:24.622373|2017-02-18 15:41:24.622373
NCT00462839|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2014-03-17|2011-06-22||July 2006||2006-07-01|March 2014|2014-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Accuracy of Blood Loss Estimation After Vaginal Delivery|The Accuracy of Blood Loss Estimation After Simulated Vaginal Delivery|Completed||N/A|106|Actual|Northwestern University|A limitation to our study is that we asked participants to estimate blood loss based on inspection of the conical drape only. We did not ask them to estimate blood loss in hidden places. In addition, this was not an actual delivery but a simulation.|2|||f||||f||||||||||2017-02-18 15:41:24.733281|2017-02-18 15:41:24.733281
NCT00462826|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2014-06-18|2013-07-09||November 2007||2007-11-01|June 2014|2014-06-01||||January 2013|Actual|2013-01-01||Interventional||Number of Eligible and Evaluable Participants|VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of VEGF-Trap (AFLIBERCEPT, NSC #724770, NCI-Supplied Agent) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|49|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:41:25.194128|2017-02-18 15:41:25.194128
NCT00462813|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-08-06|||October 2004||2004-10-01|September 2008|2008-09-01|January 2010|Actual|2010-01-01|June 2008|Actual|2008-06-01||Interventional|||Diindolylmethane in Treating Patients With Abnormal Cervical Cells|An Investigation Into the Effects of Diidolylmethane (BioResponse DIM®) Supplementation in Women With Low-Grade Cervical Cytological Abnormalities [CRISP-1]|Completed||Phase 3|3000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:41:25.707138|2017-02-18 15:41:25.707138
NCT00462787|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-11-13|||April 2007||2007-04-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia|A Phase I Dose Escalation Trial of Clofarabine in Addition to Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients With Relapsed or Refractory Acute Leukemia|Completed||Phase 1|23|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:41:25.819267|2017-02-18 15:41:25.819267
NCT00462774|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-01-15|||April 2007||2007-04-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Cardio133||Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure|Evaluierung Eines Therapiemodells Der Autologen Knochenmark-Transplantation Bei Herzerkrankungen Mit Besonderem Schwerpunkt Der Prüfung Verschiedener Progenitorzellen|Completed||Phase 2/Phase 3|60|Actual|German Heart Institute|||||f||||t||||||||||2017-02-18 15:41:25.93573|2017-02-18 15:41:25.93573
NCT00462761|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-10-29|||January 2007||2007-01-01|October 2015|2015-10-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|||A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status|Phase I Open-Label, Sequential Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AC220 When Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia|Completed||Phase 1|76|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 15:41:28.647449|2017-02-18 15:41:28.647449
NCT00462748|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-10-09|2009-05-07||March 2007||2007-03-01|October 2015|2015-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)|A MC, DB, Rand, Study to Evaluate Efficacy, Safety and Tolerability of Eze/Simva 10/40 mg, Atorva 40 mg, Rosuva 10 mg in Achieving LDL-C <2 mmol/l in Pts With CVD...on Simva 40 mg With LDL-C ³2 mmol/l|Completed||Phase 3|786|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 15:41:28.769873|2017-02-18 15:41:28.769873
NCT00462735|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2010-10-12|||February 2007||2007-02-01|June 2008|2008-06-01||||October 2010|Actual|2010-10-01||Interventional|||Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer|Phase II Study of Concomitant Fluorouracil, Hydroxyurea, Cetuximab and Hyperfractionated Intensity Modulated Radiation Therapy for Locally Advanced Head and Neck Cancer|Completed||Phase 2|30|Anticipated|Icahn School of Medicine at Mount Sinai|||||f||||t||||||||||2017-02-18 15:41:29.314951|2017-02-18 15:41:29.314951
NCT00462722|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-10-07|2015-06-11||July 2007||2007-07-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|MOXI||Myogenic and Osteogenic Responses to eXercise and Ibuprofen|COX Inhibition & Musculoskeletal Responses to Exercise|Completed||N/A|159|Actual|University of Colorado, Denver|"The study did not include a no-exercise control group. The variability in the BMD responses was greater than expected.~The results may be specific to ibuprofen and not to other NSAIDs."|3|||f||||t||||||||||2017-02-18 15:41:29.414369|2017-02-18 15:41:29.414369
NCT00462709|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2014-03-19|2010-03-31||June 2006||2006-06-01|March 2014|2014-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|CHANGE 3||Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks|LEVP2006-4 CHANGE 3 Trial (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation Evaluating Efficacy): Open-Label Use of C1INH-nf (Human) for the Prophylactic Treatment to Prevent HAE Attacks and as Treatment in Acute HAE Attacks|Completed||Phase 3|146|Actual|Shire||1|||f||||||||||||||2017-02-18 15:41:30.461072|2017-02-18 15:41:30.461072
NCT00462696|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2011-05-12|||February 2006||2006-02-01|December 2008|2008-12-01||||May 2011|Actual|2011-05-01||Interventional|||MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer|Study Evaluating the Contribution of MRI for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Patients With Infiltrative Breast Cancer|Completed||N/A|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:41:30.772883|2017-02-18 15:41:30.772883
NCT00462683|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2012-01-04|||July 2007||2007-07-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Bone Loss, Fractures, and Management of Bone Health in People With Stroke in Managed Rehabilitation Settings|Bone Loss, Fractures, and Management of Bone Health in People With Stroke in Managed Rehabilitation Settings|Completed||N/A|87|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"~     Two 10ml tubes of blood will be obtained from each participant. Serum will be separated and~     frozen to be saved for possible measurement of vitamin D levels and/or bone markers.~   "|||2017-02-18 15:41:30.872513|2017-02-18 15:41:30.872513
NCT00462670|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2013-12-24|2013-10-31||April 2007||2007-04-01|December 2013|2013-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)|A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)|Completed||Phase 3|110|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||f||||||||||2017-02-18 15:41:30.974928|2017-02-18 15:41:30.974928
NCT00462657|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-08-23|||July 2005||2005-07-01|September 2007|2007-09-01||||||||Interventional|||Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease|Early Diagnosis of Invasive Aspergillosis in a High Risk Group of Patients Using Serum and Bronchoalveolar Lavage Fluid Real Time PCR and Galactomannan ELISA|Unknown status|Recruiting|N/A|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:41:31.45404|2017-02-18 15:41:31.45404
NCT00462644|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2010-02-17|2009-03-04||February 2006||2006-02-01|February 2010|2010-02-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Evaluation of Etomidate on Adrenal Function in Trauma Patients|A Single Dose of Etomidate During Rapid Sequence Induction in Trauma Patients Causes Significant Adrenocortical Insufficiency: A Prospective Randomized Study|Completed||N/A|30|Actual|University of Tennessee|Small trial most likely underpowered; large number of exclusions; other limitations discussed in published paper (PMID: 18784570).|2|||f||||f||||||||||2017-02-18 15:41:31.557726|2017-02-18 15:41:31.557726
NCT00462631|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2016-02-18|||May 2007||2007-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|September 2011|Actual|2011-09-01||Interventional|PEPCAD IV||Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients|Paclitaxel-Eluting Balloon Angioplasty and Cobalt-Chromium Stents Versus Conventional Angioplasty and Paclitaxel-Eluting Stents in the Treatment of Native Coronary Artery Stenoses of Diabetic Patients|Completed||Phase 2/Phase 3|84|Actual|Heart Centre Rotenburg||2|||f||||t||||||||||2017-02-18 15:41:32.056656|2017-02-18 15:41:32.056656
NCT00462618|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-04-22|||April 2007||2007-04-01|April 2013|2013-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders||Completed||Phase 2/Phase 3|32|Actual|Michael Debakey Veterans Affairs Medical Center||1|||f||||f||||||||||2017-02-18 15:41:32.169788|2017-02-18 15:41:32.169788
NCT00462605|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2016-09-20|||April 2007||2007-04-01|September 2016|2016-09-01||||March 2011|Actual|2011-03-01||Interventional|||MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia|A Phase II Study of and Oral Histone Deacytylase Inhibitor, MS-275 (NSC 706995), in Combination With Sargramostim (GM-CSF, Berlex, Inc.) Treating Relapsed and Refractory Myeloid Malignancies|Completed||Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:41:32.491444|2017-02-18 15:41:32.491444
NCT00462592|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2009-10-20|||March 2007||2007-03-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction|A Randomised Double Blind, Placebo Controlled 4-way Cross Over Study Comparing Montelukast, Inhaled Budesonide and Their Combination on Exercise-induced Bronchoconstriction|Completed||Phase 3|18|Actual|McMaster University||4|||f||||f||||||||||2017-02-18 15:41:32.610665|2017-02-18 15:41:32.610665
NCT00462579|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-12-16|||April 2007||2007-04-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Risk Factors for Carbapenem-resistant Acinetobacter Baumannii|Risk Factors for Carbapenem-resistant Acinetobacter Baumannii|Active, not recruiting||N/A|100|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:41:32.723362|2017-02-18 15:41:32.723362
NCT00462566|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2016-10-17|||October 2005||2005-10-01|June 2016|2016-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||The Efficacy of Motor Cortex Stimulation for Pain Control|The Efficacy of Motor Cortex Stimulation for Pain Control|Completed||N/A|12|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-02-18 15:41:32.818766|2017-02-18 15:41:32.818766
NCT00462553|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2014-02-21|||March 2007||2007-03-01|April 2013|2013-04-01||||June 2010|Actual|2010-06-01||Interventional|||Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors|A Phase I Study of Sunitinib Malate and Standard Infusion Gemcitabine in Solid Tumors|Completed||Phase 1|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:41:32.918964|2017-02-18 15:41:32.918964
NCT00462540|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2009-03-03|||May 2007||2007-05-01|March 2009|2009-03-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||A Crossover Study in the Treatment of Patients With COPD||Completed||Phase 3|100|Anticipated|Dey|||||f||||||||||||||2017-02-18 15:41:33.032068|2017-02-18 15:41:33.032068
NCT00462527|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2011-06-27|||May 2007||2007-05-01|September 2007|2007-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|CARING||Cystatin C as a Marker for Detecting Early Renal Dysfunction in a Pediatric Emergency Department|Cystatin C as a Marker for Detecting Early Renal Dysfunction in a Pediatric Emergency Department|Completed||Phase 1|464|Anticipated|Children's Hospital of Eastern Ontario|||1||f||||f||||||||||2017-02-18 15:41:33.141092|2017-02-18 15:41:33.141092
NCT00462501|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2015-12-15|2015-12-15||March 2007||2007-03-01|December 2015|2015-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer|A Pilot Study of Neoadjuvant Chemotherapy With Selective Use of Radiation for Locally Advanced Rectal Cancer|Completed||N/A|35|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:41:33.230013|2017-02-18 15:41:33.230013
NCT00462488|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-05-12|||March 2007||2007-03-01|May 2015|2015-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ|Phase II Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Patients With Non-Invasive Urothelial Carcinoma in Situ (CIS) Previously Treated With Bacille Calmette-Guérin (BCG)|Completed||Phase 2|46|Actual|Viventia Bio||2|||f||||f||||||||||2017-02-18 15:41:33.517615|2017-02-18 15:41:33.517615
NCT00462475|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-10-15|||January 1996||1996-01-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Observational|5yrGH||Effect of 5 Years of GH Replacement on Atherosclerosis|Phase 4 Study of Recombinant GH on Intima-Media Thickness at Common Carotids and on Cardiovascular Risk Factors in Hypopituitary Patients|Completed||Phase 4|20|Actual|Federico II University|||3||f||||f||||||||||2017-02-18 15:41:33.646343|2017-02-18 15:41:33.646343
NCT00462462|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-01-06|2014-12-05||May 2007||2007-05-01|January 2015|2015-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||Baseline characteristics of the patients who received the study product (L0122 gel or Absolute Ethanol), whichever the amount of product was infused . 32 patients were enrolled in the study, but 31 received the study product (1 patient not treated; inclusion mistake).|Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.|Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.|Completed||Phase 2|32|Actual|Orfagen||2|||f||||f||||||||||2017-02-18 15:41:33.75538|2017-02-18 15:41:33.75538
NCT00462449|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2014-06-19|2011-08-11||November 2007||2007-11-01|June 2014|2014-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|Botox + FES||Efficacy of Functional Electrical Stimulation (FES) in Persons Receiving Botulinum Neurotoxin for Upper Extremity Spasticity|Single Blind, Randomized Study to Determine the Safety and the Efficacy of Using Functional Electrical Stimulation (FES) and Repetitive Task Practice vs. Repetitive Task Practice Alone in Persons Receiving Botulinum Neurotoxin Type A Injections for Upper Extremity Spasticity|Completed||N/A|23|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:41:34.224166|2017-02-18 15:41:34.224166
NCT00462436|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2010-07-21|||February 2007||2007-02-01|February 2009|2009-02-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Innovative Strategies For Risk Reduction Following CABG|Do Innovative Strategies Complement Medical Management to Reduce Cardiovascular Risk Factors Following Coronary Artery Bypass Graft Surgery?|Completed||Phase 2|35|Anticipated|St. Michael's Hospital, Toronto||1|||f||||f||||||||||2017-02-18 15:41:34.641426|2017-02-18 15:41:34.641426
NCT00462423|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2014-01-07|2013-07-06||April 2007||2007-04-01|January 2014|2014-01-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional|AbraxAvast||Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study|Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study|Completed||Phase 2|50|Actual|Northern California Melanoma Center|This was a single arm study. Follow-up trials to further explore this regimen are warranted.|1|||f||||t||||||||||2017-02-18 15:41:34.764842|2017-02-18 15:41:34.764842
NCT00462410|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2012-01-20|||March 2006||2006-03-01|May 2011|2011-05-01||||May 2011|Actual|2011-05-01||Interventional|||Effect of Advertisements on Treatment Compliance in Women With Breast Cancer|Socio-anthropological Study Evaluating the Impact of Observance or Treatment in Patients With Breast Cancer|Completed||N/A|65|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:41:35.057896|2017-02-18 15:41:35.057896
NCT00462397|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-08-23|||June 2005||2005-06-01|April 2007|2007-04-01||||||||Interventional|||Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer|Phase II Study of Weekly Neoadjuvant Chemotherapy Followed by Radical Chemoradiation for Locally Advanced Cervical Cancer|Unknown status|Recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:41:35.139274|2017-02-18 15:41:35.139274
NCT00462384|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2016-03-02|2016-03-02||February 2008||2008-02-01|March 2016|2016-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional||Safety population: included all participants who were treated with at least one dose of the study medication.|A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.|An Open-label, Multi-center Study to Demonstrate Correction of Anemia and to Assess the Maintenance of Hemoglobin Levels Using Subcutaneous Once Monthly Injections of Mircera in Pre-dialysis Patients With Chronic Kidney Disease|Terminated||Phase 3|39|Actual|Hoffmann-La Roche|This study was terminated early due to strategic decision unrelated to safety or efficacy.|1||Strategic decision unrelated to safety or efficacy|f||||||||||||||2017-02-18 15:41:35.238052|2017-02-18 15:41:35.238052
NCT00462371|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-04-18|||January 2002||2002-01-01|April 2007|2007-04-01|February 2004|Actual|2004-02-01|||||Interventional|||Comparison Between Insulin Pump Treatment and Multiple Daily Insulin Injections in Diabetic Type 1 Children|Open-Label, Randomised Trial Comparing Efficacy of Continuous Subcutaneous Insulin Infusion(CSII) and Multiple Daily Insulin Injections (MDII) in Improving Glycemic Control and Quality of Life in Poorly Regulated Type 1 Diabetic Children.|Completed||Phase 4|38||Erasmus Medical Center|||||f||||t||||||||||2017-02-18 15:41:35.759622|2017-02-18 15:41:35.759622
NCT00462358|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2011-09-29|||April 2007||2007-04-01|September 2011|2011-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of ARRY-520 in Patients With Advanced Cancer||Completed||Phase 1|41|Actual|Array BioPharma||2|||f||||||||||||||2017-02-18 15:41:35.858116|2017-02-18 15:41:35.858116
NCT00462345|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2014-10-30|2014-05-08||June 2007||2007-06-01|October 2014|2014-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||Intent to treat (ITT) population included all enrolled participants who received the investigational treatment.|A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.|An Open-label Study to Evaluate the Effect of MabThera in Combination With Methotrexate on Treatment Response in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies|Completed||Phase 4|40|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:41:35.970846|2017-02-18 15:41:35.970846
NCT00461916|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2007-04-17|||May 2005||2005-05-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin|Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin in a Long Protocol of Controlled Ovarian Stimulation for ICSI/ET|Completed||Phase 4|182||Tehran University of Medical Sciences|||||f||||f||||||||||2017-02-18 15:41:44.650323|2017-02-18 15:41:44.650323
NCT00462332|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2013-08-20|2012-08-20||May 2007||2007-05-01|August 2013|2013-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|LLC0405||Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia|Phase II Pilot Trial to Evaluate the Efficacy of a Combined Therapy Approach for Young CLL Patients With Advanced and Progressive Disease Stratified According to the Biological Prognostic Features|Completed||Phase 2|86|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||2|||f||||f||||||||||2017-02-18 15:41:36.504743|2017-02-18 15:41:36.504743
NCT00462319|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2007-04-18|||May 2005||2005-05-01|April 2007|2007-04-01||||||||Interventional|ARTIST||ARTIST: ARThrose Intervention STandardisée|Evaluation of Standardized Management of Knee Arthritis Patients|Completed||Phase 4|||Almirall, SAS|||||f||||f||||||||||2017-02-18 15:41:36.95384|2017-02-18 15:41:36.95384
NCT00462306|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2014-03-17|2011-03-28||September 2005||2005-09-01|March 2014|2014-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|OSA||Incidence of Obstructive Sleep Apnea in Pregnancy|Incidence of Obstructive Sleep Apnea in Pregnancy|Completed||N/A|4577|Actual|Northwestern University|The Berlin questionnaire has not been validated as a screening tool in pregnancy.||2||f||||f||||||||||2017-02-18 15:41:37.047192|2017-02-18 15:41:37.047192
NCT00462280|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-18|2014-10-24|2014-04-23||May 2007||2007-05-01|February 2014|2014-02-01|February 2012|Actual|2012-02-01|April 2011|Actual|2011-04-01||Interventional|||Lovastatin in Treating Patients At High Risk of Melanoma|A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||4|||f||||t||||||||||2017-02-18 15:41:37.460428|2017-02-18 15:41:37.460428
NCT00462267|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-04-02|||January 2005||2005-01-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|SHINE-Garfield||Examining the Feasibility of Collaborative Care Treatment for Overweight Adolescents|Examining the Feasibility of Collaborative Care Treatment for Overweight Adolescents|Completed||Phase 2|215|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-02-18 15:41:38.758115|2017-02-18 15:41:38.758115
NCT00462254|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2010-11-10|||June 2007||2007-06-01|November 2010|2010-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease|Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease|Terminated||Phase 4|4|Actual|Southern California Institute for Research and Education||2||Study discontinued.|f||||f||||||||||2017-02-18 15:41:38.863942|2017-02-18 15:41:38.863942
NCT00462241|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2013-02-19|||August 2006||2006-08-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|CARPA||Treatment Study Comparing Manual Treatment or Advice in Acute, Musculoskeletal Chest Pain|Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 2: Treatment Study|Completed||N/A|115|Actual|Clinical Locomotion Science||2|||f||||t||||||||||2017-02-18 15:41:39.035409|2017-02-18 15:41:39.035409
NCT00462228|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2016-11-22|2012-05-18||April 2007||2007-04-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury|Double-blind Cross-over Study of the Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury, Protocol NAM-MD-44|Terminated||Phase 4|11|Actual|University of Missouri-Columbia|The enrollment goal for the study was 20 subjects. The study included 11 subjects but was terminated due to a lack of additional subjects.|2||The study was stopped due to a lack of additional subjects.|f||||f||||||||No||2017-02-18 15:41:39.326493|2017-02-18 15:41:39.326493
NCT00462215|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-10-07|||April 2007||2007-04-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|June 2007|Actual|2007-06-01||Interventional|||Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)|An Open Label Phase III Study of a Vero Cell-Derived Whole Virus H5N1 Influenza Vaccine to Assess the Immunogenicity and Safety and to Investigate the Need for and Timing of a Booster Vaccination|Completed||Phase 3|550|Anticipated|Nanotherapeutics, Inc.||6|||f||||t||||||||||2017-02-18 15:41:39.934438|2017-02-18 15:41:39.934438
NCT00462202|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-04-13||2015-04-13|April 2007||2007-04-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong|An Open Label Tolerability and Safety Study of KRX-101 (Sulodexide Gelcaps) for the Treatment of Type 2 Diabetic Nephropathic Patients With Persistent Microalbuminuria in Australia, New Zealand, and Hong Kong|Terminated||Phase 3|200|Actual|Keryx Biopharmaceuticals||1||Interim analysis of efficacy trial showed no drug efficacy.|f||||t||||||||||2017-02-18 15:41:40.042704|2017-02-18 15:41:40.042704
NCT00462189|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||April 2007||2007-04-01|April 2007|2007-04-01||||||||Interventional|||Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease|A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patient With Relapsed or Refractory Hairy Cell Leukemia (HCL)|Unknown status|Recruiting|Phase 1|40||Cambridge Antibody Technology|||||f||||f||||||||||2017-02-18 15:41:40.155406|2017-02-18 15:41:40.155406
NCT00462176|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2009-02-19|||September 2004||2004-09-01|February 2009|2009-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Laparoscopic Segmental Bowel Resection for Deep Infiltrating Colorectal Endometriosis|A Retrospective Follow-up of Patients After Laparoscopic Segmental Bowel Resection for Deep Infiltrating Colorectal Endometriosis|Completed||N/A|45|Actual|University Hospital, Gasthuisberg|||1||f||||f||||||Samples Without DNA|"~     The diagnosis of endometriosis was confirmed by histologic examination of resected lesions.~   "|||2017-02-18 15:41:40.265602|2017-02-18 15:41:40.265602
NCT00462150|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||September 2002||2002-09-01|April 2007|2007-04-01|June 2003|Actual|2003-06-01|||||Interventional|||Effects of Home-Based Emotional Disclosure in Rheumatoid Arthritis|Psychological, Physiological, and Clinical Consequences of Emotional Disclosure in Rheumatoid Arthritis (RA)|Completed||Phase 2|80||UMC Utrecht|||||f||||f||||||||||2017-02-18 15:41:40.376834|2017-02-18 15:41:40.376834
NCT00462137|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2008-10-08|||March 2006||2006-03-01|October 2008|2008-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux|The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux|Completed||N/A|8|Actual|Thomas Jefferson University|||2||f||||f||||||||||2017-02-18 15:41:40.474597|2017-02-18 15:41:40.474597
NCT00461019|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2011-03-04|||February 2007||2007-02-01|March 2011|2011-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||CardioFit™ for the Treatment of Heart Failure|CardioFiT™ for Heart Failure - Safety and Efficacy Study Protocol|Completed||Phase 2|32|Actual|BioControl Medical||1|||f||||f||||||||||2017-02-18 15:41:49.746766|2017-02-18 15:41:49.746766
NCT00462124|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2009-06-09|||June 2007||2007-06-01|June 2009|2009-06-01|February 2010|Anticipated|2010-02-01|December 2009|Anticipated|2009-12-01||Interventional|||Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy|One-Arm, Multi-Center, Prospective Study to Assess the Safety and Efficacy of BioProtect Biodegradable Implantable Balloon in Prostate Cancer Subjects Undergoing Radiotherapy|Unknown status|Recruiting|Phase 1|15|Anticipated|BioProtect||1|||f||||f||||||||||2017-02-18 15:41:40.580555|2017-02-18 15:41:40.580555
NCT00462111|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2012-02-13|||April 2007||2007-04-01|February 2012|2012-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Indomethacin and Mechanisms Underlying Risk of Falling|Effect of Indomethacin on Reaction Time, Postural Balance and the Ability to Avoid Suddenly Appearing Obstacles During Gait in Healthy Middle-aged Individuals.|Completed||Phase 4|20|Anticipated|Sint Maartenskliniek|||||f||||||||||||||2017-02-18 15:41:40.679379|2017-02-18 15:41:40.679379
NCT00462098|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2013-02-19|||August 2006||2006-08-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken Bisphosphonates|Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken Bisphosphonates|Completed||Phase 1|54|Actual|Duke University||2|||f||||t||||||||||2017-02-18 15:41:40.767968|2017-02-18 15:41:40.767968
NCT00462085|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2007-04-17|||September 2004||2004-09-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Observational|||Muscle Activity With the Use of Ankle Foot Orthoses in Cerebral Palsy|Muscle Activity With the Use of Ankle Foot Orthoses in Cerebral Palsy|Completed||N/A|24||University Children's Hospital Basel|||||f||||t||||||||||2017-02-18 15:41:40.873083|2017-02-18 15:41:40.873083
NCT00462072|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-04-07|2011-08-02||March 2007||2007-03-01|April 2015|2015-04-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Centocor Microarray Study of Patients|Microarray Analysis of Peripheral Blood and Tissues of Patients With Immune Mediated Inflammatory Diseases|Completed||Phase 4|31|Actual|University of Rochester||1|||f||||f||||||||||2017-02-18 15:41:40.952949|2017-02-18 15:41:40.952949
NCT00462059|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||June 2005||2005-06-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Assessment of a Medication Reconciliation Program on Transitional Care|Impact of a Medication Reconciliation Program on Patients Transitioning From an Inpatient Hospitalization to Primary Care|Completed||N/A|200||Kaiser Permanente|||||f||||f||||||||||2017-02-18 15:41:41.435625|2017-02-18 15:41:41.435625
NCT00462046|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||April 2005||2005-04-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia|The Efficacy and Safety of Berberine in the Treatment of Type 2 Diabetes With Dyslipidemia|Completed||Phase 3|120||Shanghai Jiao Tong University School of Medicine|||||f||||t||||||||||2017-02-18 15:41:41.532069|2017-02-18 15:41:41.532069
NCT00462020|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2011-12-12|2011-12-12||March 2007||2007-03-01|December 2011|2011-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis|Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis|Completed||N/A|150|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-02-18 15:41:41.623582|2017-02-18 15:41:41.623582
NCT00462007|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-04-20|||September 2006||2006-09-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|SENSE||Study to Evaluate Initiation of Stalevo in Early Wearing-off|Efficacy and Safety of Stalevo® in Subjects With Early Wearing-off Identified Using a Screening Tool WOQ-9; an Open, Non-randomised, Multinational, Multicentre 6-week Direct Switch Study in Levodopa-treated Parkinson's Disease Patients|Completed||Phase 4|115|Actual|Orion Corporation, Orion Pharma||1|||f||||f||||||||||2017-02-18 15:41:42.011222|2017-02-18 15:41:42.011222
NCT00461994|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2007-04-17|||April 2004||2004-04-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||The Role of Exercise and Diet in Weight Loss in Obese Children|The Role of Exercise and/or Diet in Weight Loss, and Weight Maintenance in Obese Preadolescent Children|Completed||N/A|160||Rabin Medical Center|||||f||||f||||||||||2017-02-18 15:41:42.130173|2017-02-18 15:41:42.130173
NCT00461981|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2010-01-12|2009-05-29||May 2007||2007-05-01|January 2010|2010-01-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||A Phase 2 Study to Evaluate Immune Responses of FluMist®|A Phase 2, Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of FluMist® Compared With Trivalent Inactivated Vaccine (TIV) in Children 12 to <36 Months of Age|Completed||Phase 2|101|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 15:41:42.240065|2017-02-18 15:41:42.240065
NCT00461968|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2007-04-17|||February 2005||2005-02-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both|Genetic Determinanats of Cardiovascular Risk Factors: Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both|Completed||N/A|240||University of Texas Southwestern Medical Center|||||f||||t||||||||||2017-02-18 15:41:44.230819|2017-02-18 15:41:44.230819
NCT00461955|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2010-11-03|||August 2007||2007-08-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|September 2008|Actual|2008-09-01||Interventional|Expansion||Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation|Pilot Clinical Trial of Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation in Adult Patients With Multiple Myeloma in First Response|Completed||Phase 2|13|Anticipated|University Hospital, Bordeaux||1|||f||||f||||||||||2017-02-18 15:41:44.330261|2017-02-18 15:41:44.330261
NCT00461942|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2011-08-15|||April 2006||2006-04-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|||||Interventional|||Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients|A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Neuroprotection Effect of Green Tea Polyphenol in De Novo Parkinson's Disease Patients|Completed||Phase 2|480|Anticipated|Xuanwu Hospital, Beijing|||||f||||t||||||||||2017-02-18 15:41:44.44427|2017-02-18 15:41:44.44427
NCT00461929|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2009-02-12|||February 2005||2005-02-01|April 2007|2007-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|GIST||Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib|Are the Secondary Chromosome Abnormalities Seen in Chronic Myeloid Leukemia (CML) Cells Induced to Ph-Chromosome Negativity by Imatinib a Result of Chromosome Instability or a Side Effect of the Therapy - a Study in GIST (Gastrointestinal Stromal Cell Tumors) Patients Treated With Imatinib.|Terminated||Phase 4|68|Anticipated|University Health Network, Toronto||||study terminated 12Feb09 due to low recruitment|f||||f||||||||||2017-02-18 15:41:44.54214|2017-02-18 15:41:44.54214
NCT00461903|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-12-11|||December 2007||2007-12-01|December 2015|2015-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|CTAF-2||Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension|A Prospective, Randomized, Double-blind Placebo-controlled Study to Determine the Efficacy of 8 mg/Day Oral Perindopril to Prevent the Recurrence of Atrial Fibrillation in Patients With Essential Hypertension|Completed||Phase 3|316|Actual|Montreal Heart Institute||2|||f||||t||||||||||2017-02-18 15:41:44.779107|2017-02-18 15:41:44.779107
NCT00461890|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2011-10-21|||October 2006||2006-10-01|October 2011|2011-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial|Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial|Terminated||Phase 4|20|Anticipated|State University of New York - Upstate Medical University|||||f||||||||||||||2017-02-18 15:41:44.899932|2017-02-18 15:41:44.899932
NCT00461877|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2013-11-15|||March 2007||2007-03-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||High-Risk HPV Infections in Women Aged 25 to 65|High-Risk HPV Infections in Women Aged 25 to 65|Completed||N/A|303|Actual|University of Washington|||1||f||||f||||||Samples With DNA|"~     Vaginal swab samples for HPV DNA testing~   "|||2017-02-18 15:41:44.994359|2017-02-18 15:41:44.994359
NCT00461864|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-17|||April 2007||2007-04-01|March 2007|2007-03-01||||||||Observational|||Diagnosis of Occult Hip Fractures With Ultrasound||Unknown status|Not yet recruiting|N/A|40||Rabin Medical Center|||||f||||f||||||||||2017-02-18 15:41:45.097405|2017-02-18 15:41:45.097405
NCT00461851|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2016-09-12|2016-09-12||March 2007||2007-03-01|September 2016|2016-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma|A Phase II, Multicenter Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma|Completed||Phase 2|17|Actual|Yale University||1|||f||||f||||||||||2017-02-18 15:41:45.183945|2017-02-18 15:41:45.183945
NCT00461838|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2009-02-19|||September 1996||1996-09-01|February 2009|2009-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Observational|||Outcome After Multidisciplinary CO2 Laser Laparoscopic Excision of Deep Infiltrating Colorectal Endometriosis|Outcome After Multidisciplinary CO2 Laser Laparoscopic Excision of Deep Infiltrating Colorectal Endometriosis|Completed||N/A|56|Actual|University Hospital, Gasthuisberg|||1||f||||f||||||Samples Without DNA|"~     Endometriosis was proven by histologic examination of excised lesions.~   "|||2017-02-18 15:41:45.480712|2017-02-18 15:41:45.480712
NCT00461825|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2007-04-17|||July 1998||1998-07-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation|Efficacy and Safety of Maintenance Neoral Compared to Bitherapy Neoral-Imurel or Neoral-CellCept in Renal Transplantation|Completed||Phase 3|207||Poitiers University Hospital|||||f||||f||||||||||2017-02-18 15:41:45.590607|2017-02-18 15:41:45.590607
NCT00461812|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||April 2007||2007-04-01|April 2007|2007-04-01||||||||Interventional|||A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma|A Single-Blind, Randomized, Positive-Controlled Study to Compare Monotherapy With an Inhaled Corticosteroid (Mometasone) to Combination Therapy With an Inhaled Corticosteroid + a Long-Acting Bronchodilator (Advair) in Patients With Milder Persistent Asthma|Unknown status|Recruiting|Phase 4|45||Johns Hopkins University|||||f||||t||||||||||2017-02-18 15:41:45.698564|2017-02-18 15:41:45.698564
NCT00461799|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||September 2003||2003-09-01|April 2007|2007-04-01|January 2004|Actual|2004-01-01|||||Interventional|||Orlistat Treatment of Crigler-Najjar Disease|Orlistat Treatment of Unconjugated Hyperbilirubinemia in Crigler-Najjar Disease; A Randomized Controlled Trial|Completed||N/A|16||University Medical Center Groningen|||||f||||f||||||||||2017-02-18 15:41:45.771076|2017-02-18 15:41:45.771076
NCT00461786|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2009-12-01|2008-10-13||September 2004||2004-09-01|December 2009|2009-12-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer|A Phase II Evaluation of Pemetrexed (Alimta, LY231514l, IND # 40061) in the Treatment of Recurrent or Persistent Platinum Resistant Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|51|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 15:41:45.877501|2017-02-18 15:41:45.877501
NCT00461773|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2009-06-05|||March 2007||2007-03-01|June 2009|2009-06-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer|Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer|Unknown status|Recruiting|Phase 2|40|Anticipated|Yale University||2|||f||||f||||||||||2017-02-18 15:41:46.563072|2017-02-18 15:41:46.563072
NCT00461760|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2016-06-05|||March 2007||2007-03-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|HPVFOCAL||HPV Testing for Cervical Cancer Screening Study|A Randomized Controlled Evaluation of HPV Testing for Cervical Cancer Screening|Active, not recruiting||N/A|28000|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 15:41:46.679382|2017-02-18 15:41:46.679382
NCT00461747|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2009-09-17|||March 2006||2006-03-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|GEM05MENOS65||GEM05 for Patients With Multiple Myeloma Under 65 Years|A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With VBMCP-VBAD/Velcade Versus Thalidomide / Dexamethasone Versus Velcade / Thalidomide / Dexamethasone Followed by High Dose Intensive Therapy With Autologous Hemopoietic Stem Cell Support and Maintenance Treatment With Interferon-a Versus Thalidomide Versus Thalidomide / Velcade in Untreated Patients With Multiple Myeloma Less Than 65 Yrs Old|Completed||Phase 3|390|Anticipated|PETHEMA Foundation||3|||f||||t||||||||||2017-02-18 15:41:46.791057|2017-02-18 15:41:46.791057
NCT00461734|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2012-05-14|||May 2007||2007-05-01|May 2012|2012-05-01|August 2015|Anticipated|2015-08-01|August 2012|Anticipated|2012-08-01||Interventional|PROTECT-PACE||PROTECT-PACE STUDY - The Protection of Left Ventricular Function During Right Ventricular Pacing|PROTECT-PACE STUDY - The Protection of Left Ventricular Function During Right Ventricular Pacing. Does Right Ventricular High-septal Pacing Improve Outcome Compared With Right Ventricular Apical Pacing?|Unknown status|Active, not recruiting|N/A|248|Anticipated|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f||||||||||2017-02-18 15:41:46.998572|2017-02-18 15:41:46.998572
NCT00461006|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2016-07-28||2016-07-28|June 2007||2007-06-01|July 2016|2016-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.|A Randomized, Double Blind Study to Compare the Effects of Aleglitazar and Actos on Glomerular Filtration Rate and Other Parameters of Renal Function in Patients With Type 2 Diabetes.|Completed||Phase 2|176|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:41:49.85419|2017-02-18 15:41:49.85419
NCT00460993|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2014-06-16|2013-11-06||June 2005||2005-06-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|June 2008|Actual|2008-06-01||Interventional||71 subjects were in baseline. But only 31 subjects enrolled into the study intervention portion used for analysis.|Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients|Efficacy and Safety of Eszopiclone (Lunesta) in Nursing Home Patients|Completed||Phase 4|71|Actual|Emory University|Low power to detect statistically significant effects of the interventions on outcomes; Inability to examine predictors of responsiveness because of the small sample size and the large number of predictors of response.|2|||f||||t||||||||||2017-02-18 15:41:49.993384|2017-02-18 15:41:49.993384
NCT00460980|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2015-04-02|||May 2006||2006-05-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Virtual Reality Training by Novices on Laparoscopic Cholecystectomy in a Porcine Model|Effect of Virtual Reality Training by Novices on Laparoscopic Cholecystectomy in a Porcine Model|Withdrawn||N/A|0|Actual|Columbia University||1||Principal investigator left institution.|f||||f||||||||||2017-02-18 15:41:50.355201|2017-02-18 15:41:50.355201
NCT00460967|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-11-06|||January 2007||2007-01-01|April 2007|2007-04-01|December 2009|Anticipated|2009-12-01|||||Interventional|RHEO-AMD||Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis|Safety and Effectiveness, in a Multi-Center, Randomized, Sham Controlled Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD)Using Rheopheresis|Suspended||Phase 3|325|Anticipated|OccuLogix||2||"In light of the company's current financial position we have indefinately suspended the~   Rheo-AMD trial."|f||||f||||||||||2017-02-18 15:41:50.462507|2017-02-18 15:41:50.462507
NCT00460954|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2008-08-13|||June 2007||2007-06-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|||||Observational|||A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects|An Open Label, Multiple-Dose Study ot Determine the Plasma Levodopa Profiles of Sinemet® CR (Carbidopa/Levodopa) at 4 Daily Dose Levels in Healthy Subjects|Completed||N/A|20|Anticipated|Bristol-Myers Squibb|||||||||||||||||||2017-02-18 15:41:50.825535|2017-02-18 15:41:50.825535
NCT00460941|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2016-11-01||2016-06-28|April 2007||2007-04-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.|A Double-blind, Placebo-controlled Titration Study to Investigate the Tolerability, Safety and Pharmacodynamic Profile of a GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin.|Completed||Phase 2|133|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 15:41:50.914401|2017-02-18 15:41:50.914401
NCT00460928|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2016-04-06|||April 2007||2007-04-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|PITCH||Preventive IVIG Therapy for Congenital Heart Block|Preventive IVIG Therapy for Congenital Heart Block (The PITCH Study)|Completed||Phase 2/Phase 3|54|Actual|New York University School of Medicine||1|||f||||f||||||||||2017-02-18 15:41:51.045189|2017-02-18 15:41:51.045189
NCT00460915|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2010-03-01|||January 2007||2007-01-01|November 2009|2009-11-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|ELDER||Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 Years|Korea University Guro Hospital|Completed||Phase 4|204|Anticipated|Korea University Guro Hospital|||||f||||||||||||||2017-02-18 15:41:51.154951|2017-02-18 15:41:51.154951
NCT00460902|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-15|2015-03-18|||April 2007||2007-04-01|March 2015|2015-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Evaluation of the Deep TMS H-Coil in the Treatment of Major Depression- Augmentation of Antidepressant Medication|Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression|Completed||Phase 1/Phase 2|57|Actual|Hadassah Medical Organization||3|||f||||f||||||||||2017-02-18 15:41:51.246073|2017-02-18 15:41:51.246073
NCT00461721|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-12-02|||December 2006||2006-12-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|January 2007|Actual|2007-01-01||Observational|||Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis|Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis Due to Grass Pollen During Immunotherapy|Completed||Phase 1|20|Anticipated|University of Zurich|||2||f||||f||||||||||2017-02-18 15:41:51.356633|2017-02-18 15:41:51.356633
NCT00461708|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-09-14|2014-11-10||May 2007||2007-05-01|September 2015|2015-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional||Intent-to-treat (ITT) population: all participants included in the study.|A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival|An Open Label Study of Tarceva in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas : Relationship Between Skin Rash and Survival|Completed||Phase 2|153|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:41:51.44063|2017-02-18 15:41:51.44063
NCT00461695|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2013-08-26|||May 2007||2007-05-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|August 2008|Actual|2008-08-01||Interventional|||Influence of Persistent CMV-infection on Immune Senescence|Influence of Persistent CMV-infection on Immune Senescence Evaluated With a Prospective Vaccination Trial Against Tick-borne Encephalitis Virus in Healthy Elderly Individuals (CYTEL-Study)|Completed||Phase 4|183|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 15:41:52.522046|2017-02-18 15:41:52.522046
NCT00461682|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2012-05-31|||January 2007||2007-01-01|February 2011|2011-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Sb-705498 Rectal Pain Study|A Double-blind, Randomised, Placebo Controlled, Single Dose, Two-period Crossover Study to Investigate the Therapeutic Potential of the TRPV1 Antagonist SB-705498 in Treatment of Subjects With Rectal Hypersensitivity Including Irritable Bowel Syndrome.|Terminated||Phase 2|1|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:41:52.634617|2017-02-18 15:41:52.634617
NCT00461669|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||April 2007||2007-04-01|March 2007|2007-03-01||||||||Observational|||Hip Fracture Characterization With Ultrasound Exam||Unknown status|Not yet recruiting|N/A|100||Rabin Medical Center|||||f||||f||||||||||2017-02-18 15:41:52.726907|2017-02-18 15:41:52.726907
NCT00461656|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2013-03-04|||September 2009||2009-09-01|July 2011|2011-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PASS||Povidone-iodine Antisepsis for Strabismus Surgery|Prospective, Randomized, Double-blind Comparison of 5 % Against 1.25 % Povidone-iodine Solution as Preoperative Antisepsis for Strabismus Surgery in Young Children|Completed||Phase 4|70|Actual|Erasmus Medical Center||1|||f||||f||||||||||2017-02-18 15:41:52.813968|2017-02-18 15:41:52.813968
NCT00461643|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2013-04-05|||January 2007||2007-01-01|April 2013|2013-04-01||||December 2015|Anticipated|2015-12-01||Interventional|||Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOS|Comparison of Three Different Strategies for Treating Infertility in Anovulatory Women With Polycystic Ovary Syndrome: a Multicentre Randomized Controlled Clinical Trial|Unknown status|Recruiting|Phase 4|552|Anticipated|University Magna Graecia||3|||f||||f||||||||||2017-02-18 15:41:52.937166|2017-02-18 15:41:52.937166
NCT00461630|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2014-01-27|2013-07-12||January 2007||2007-01-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|HPS2-THRIVE||Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE|A Randomized Trial of the Long-term Clinical Effects of Raising HDL Cholesterol With Extended Release Niacin/Laropiprant|Completed||Phase 3|25673|Actual|University of Oxford|Participants may have SAEs reported in >1 category hence total participants affected across reported categories is less than total given.|2|||f||||t||||||||||2017-02-18 15:41:53.061063|2017-02-18 15:41:53.061063
NCT00461617|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2008-10-20|||August 2006||2006-08-01|April 2007|2007-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients|Multicentre, Double-Dummy, Randomized, Double-Blind Comparison Between Mitiglinide and Nateglinide in the Patients With Type 2 Diabetes|Completed||Phase 3|291|Actual|Kissei Pharmaceutical Co., Ltd.||1|||f||||f||||||||||2017-02-18 15:41:53.615408|2017-02-18 15:41:53.615408
NCT00461604|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2008-05-19|||October 2006||2006-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|NEXBAC||High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease||Completed||N/A|40|Anticipated|Technische Universität München|||||f||||t||||||||||2017-02-18 15:41:53.712015|2017-02-18 15:41:53.712015
NCT00461591|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-05-26||2013-12-18|April 2007||2007-04-01|May 2015|2015-05-01|April 2012|Actual|2012-04-01|December 2009|Actual|2009-12-01||Interventional|||Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant Instilled in the Early Postoperative Period in Patients Undergoing TUR-BT|A Multicenter,Randomized,Placebo-Controlled,Double-Blind,Phase3 Trial of Single Dose Intravesical EOquin® as a Surgical Adjuvant Instilled in Early Post Operative Period in Patients Undergoing Transurethral Resection for Noninvasive Bladder Cancer|Completed||Phase 3|802|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||f||||||||||2017-02-18 15:41:53.793339|2017-02-18 15:41:53.793339
NCT00461578|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||April 2005||2005-04-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children|Open Study on the Tolerability and Efficacy of the Combination Chlorproguanil-Dapsone+Artesunate Compared to Amodiaquine+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria in Rwandan Children|Completed||N/A|800||London School of Hygiene and Tropical Medicine|||||f||||f||||||||||2017-02-18 15:41:53.95912|2017-02-18 15:41:53.95912
NCT00461565|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-03-18|||February 2005||2005-02-01|March 2015|2015-03-01|October 2006|Actual|2006-10-01|||||Interventional|||FDA Phase IV - Commitment - Retinal Function Study|A Double Blind, Randomized, Placebo Controlled, Two Part, Two Session Balanced, Crossover Study to Evaluate Visual Changes in Healthy Male Subjects Aged 18 - 55 Years After Receiving: 1. at Least 15 Doses of 20 mg Vardenafil, Compared to Placebo and 2. Two Doses of Sildenafil, 200 mg Compared to Placebo|Completed||Phase 4|63|Actual|Bayer||4|||f||||f||||||||||2017-02-18 15:41:54.286954|2017-02-18 15:41:54.286954
NCT00461552|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-06-22|||January 2003||2003-01-01|June 2015|2015-06-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Therapeutic Approaches to HAART-Induced Lipodystrophy|Therapeutic Approaches to HAART-Induced Lipodystrophy|Completed||Phase 2|23|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 15:41:54.394993|2017-02-18 15:41:54.394993
NCT00461539|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2013-06-05|||October 2007||2007-10-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Reducing Health Risk Behavior and Improving Health in Adolescents With Depression|Reducing Health Risk Behavior and Improving Health in Adolescent Depression|Completed||Phase 1/Phase 2|217|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 15:41:54.507199|2017-02-18 15:41:54.507199
NCT00461526|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2010-11-19|||October 2006||2006-10-01|November 2010|2010-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Diarrhea Predominant Irritable Bowel Syndrome in Females|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRN-002 (Crofelemer) for the Symptomatic Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS) in Females|Completed||Phase 2|240|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||t||||||||||2017-02-18 15:41:54.624879|2017-02-18 15:41:54.624879
NCT00461513|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2015-04-06|2014-11-19||May 2009||2009-05-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|PCDM||Patient-Centered Heart Failure Trial|Patient-Centered Disease Management for Heart Failure Trial|Completed||N/A|392|Actual|VA Office of Research and Development|||2||f||||t||||||||||2017-02-18 15:41:54.776512|2017-02-18 15:41:54.776512
NCT00461500|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2012-03-22|2008-12-19||March 2007||2007-03-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults|See Detailed Description|Completed||Phase 4|81|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:41:55.133902|2017-02-18 15:41:55.133902
NCT00461487|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2013-07-09|||April 2007||2007-04-01|July 2013|2013-07-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|||A Parent-Based Intervention to Reduce Sexual Risk Behavior in Adolescents|Reducing Teen Sexual Behavior: A Clinic-Based Approach|Completed||N/A|530|Actual|Columbia University||3|||f||||f||||||||||2017-02-18 15:41:55.722463|2017-02-18 15:41:55.722463
NCT00461474|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-18|||March 2004||2004-03-01|April 2007|2007-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Study of Strengthening Exercises and Improving Movement for Painful Shoulders in Adults With Spinal Cord Injury|Strengthening and Optimal Movements for Painful Shoulders in Chronic Spinal Cord Injury (STOMPS)|Completed||Phase 1|80||University of Southern California|||||f||||t||||||||||2017-02-18 15:41:55.833166|2017-02-18 15:41:55.833166
NCT00461461|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2009-06-24|||January 2007||2007-01-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||a Multifaceted Program for Improving Quality of Care in ICU|IATROREF III: a Multifaceted Program for Improving Quality of Care in Critically Ill Patients|Completed||N/A|2117|Actual|Groupe Hospitalier Paris Saint Joseph|||||f||||t||||||||||2017-02-18 15:41:55.924427|2017-02-18 15:41:55.924427
NCT00461448|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2009-02-04|||February 2007||2007-02-01|February 2009|2009-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Pilot Study of Potassium Supplementation for Adult Patients With Rheumatoid Arthritis|Pilot Study of Potassium Supplementation in the Treatment of Rheumatoid Arthritis: a 4-Week, Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 1|36|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 15:41:56.017297|2017-02-18 15:41:56.017297
NCT00461435|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2007-04-17||||||April 2007|2007-04-01||||||||Interventional|||Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa|Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa|Completed||N/A|||Azienda Policlinico Umberto I|||||f||||||||||||||2017-02-18 15:41:56.139952|2017-02-18 15:41:56.139952
NCT00461422|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2008-06-26|||January 2004||2004-01-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Early Follicular Supplementation of Ganirelix in IVF 2004|Early Follicular GnRH Antagonist Supplementation Improves Fertilization and Embryo Cleavage Rates in IVF-ET GnRH Antagonist Cycles|Completed||Phase 4|50|Actual|The Baruch Padeh Medical Center, Poriya||2|||f||||f||||||||||2017-02-18 15:41:56.218755|2017-02-18 15:41:56.218755
NCT00461409|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-10-07|||April 2007||2007-04-01|October 2015|2015-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||IV Levetiracetam for the Treatment of Neonatal Seizures: a Pharmacokinetic and Preliminary Efficacy and Safety Study|Phase I/II Study of IV Levetiracetam as an add-on Drug for Seizures in Term Neonates Assessing Pharmacokinetics, Safety and Efficacy.|Completed||Phase 1/Phase 2|18|Actual|University of California, San Diego||1|||f||||t||||||||||2017-02-18 15:41:56.329612|2017-02-18 15:41:56.329612
NCT00461396|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2011-04-07|||May 2007||2007-05-01|April 2011|2011-04-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Observational|START||Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron|Open-Label, Multicenter, Observational, Phase IV Study to Evaluate the Adherence to Treatment With 250mcg (8MIU) IFNB-1b (Betaseron®) Given Subcutaneous Every Other Day Over a Period of up to 12 Months in Patients With a First Clinical Demyelinating Event Suggestive of Multiple Sclerosis and Patients With Onset of Relapsing-Remitting Multiple Sclerosis (RRMS) Within the Past 12 Months|Completed||N/A|104|Actual|Bayer|||1||f||||f||||||||||2017-02-18 15:41:56.448261|2017-02-18 15:41:56.448261
NCT00461370|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2008-03-11|||April 2007||2007-04-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|AVN001||Safety Study of SRX251 Capsules in Healthy Female Volunteers|Phase I, Double-Blind, Placebo-Controlled, Ascending, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of SRX251 Capsules in Healthy Female Volunteers|Completed||Phase 1|77|Actual|Azevan Pharmaceuticals||1|||f||||t||||||||||2017-02-18 15:41:56.577436|2017-02-18 15:41:56.577436
NCT00461357|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2007-04-17|||January 2003||2003-01-01|April 2007|2007-04-01|December 2007|Anticipated|2007-12-01|||||Observational|ESP||Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program|Outcome After Renal Transplantation of a Randomized Prospective Trial in the Eurotransplant Senior Program|Unknown status|Active, not recruiting|Phase 4|48||Medical University of Vienna|||||f||||f||||||||||2017-02-18 15:41:56.663848|2017-02-18 15:41:56.663848
NCT00461344|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2008-04-01|||July 2004||2004-07-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|June 2005|Actual|2005-06-01||Interventional|||Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer|A Multicenter, Open Label, Phase II Trial Evaluating Docetaxel + Anthracycline x 4 Cycles Followed by Docetaxel Single Agent x 4 Cycles as First-Line Therapy in Patients With Her2 Negative Locally Advanced or Metastatic Breast Cancer Who Have Relapsed ≥ 12 Months From Completion of Neoadjuvant/Adjuvant Taxotere®- Based Chemotherapy|Terminated||Phase 2|20|Actual|Sanofi||||due to slow recruitment of patients|f||||f||||||||||2017-02-18 15:41:56.723646|2017-02-18 15:41:56.723646
NCT00461331|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2016-12-01|2009-05-12||October 2004||2004-10-01|December 2016|2016-12-01|August 2008|Actual|2008-08-01|June 2007|Actual|2007-06-01||Interventional|||Comparison of Insulins Aspart and Lispro in Insulin Pumps|A Comparison of the Efficacy Beyond 48 Hours of Insulin Aspart (Novolog) and Lispro (Humalog) in Insulin Pumps|Completed||Phase 4|20|Actual|Tulane University||2|||f||||t||||||||||2017-02-18 15:41:56.807492|2017-02-18 15:41:56.807492
NCT00461318|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||April 2003||2003-04-01|April 2007|2007-04-01|November 2005|Actual|2005-11-01|||||Interventional|EQOLISE||The Effectiveness of Supported Employment for People With Severe Mental Illness: an RCT in Six European Countries|Enhancing the Quality of Life and Independence of Persons Disabled by Severe Mental Illness Through Supported Employment|Completed||N/A|300||University of Oxford|||||f||||f||||||||||2017-02-18 15:41:57.103316|2017-02-18 15:41:57.103316
NCT00461305|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-17|2013-01-22|2010-09-10||February 2007||2007-02-01|January 2013|2013-01-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Interventional|||Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea|A Multicenter, Single-blind, Randomized Study, to Investigate Efficacy of Ethinylestradiol for Intracyclic Bleeding Profile During 24 Weeks (6 Cycles) by Oral Administration of Drospirenone 3 mg/Ethinylestradiol 20 µg and Drospirenone 3 mg/ Ethinylestradiol 30 µg in Patients With Dysmenorrheal and to Investigate the Long Term Safety Oral Administration of Drospirenone 3 mg/Ethinylestradiol 20 µg Administered for 52 Weeks (13 Cycles)|Completed||Phase 2/Phase 3|420|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:41:57.206864|2017-02-18 15:41:57.206864
NCT00461292|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2015-09-17|2011-09-09||May 2007||2007-05-01|September 2015|2015-09-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder||Completed||Phase 3|275|Actual|Allergan||4|||f||||||||||||||2017-02-18 15:41:58.854616|2017-02-18 15:41:58.854616
NCT00461279|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2011-12-02|||August 2006||2006-08-01|December 2011|2011-12-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Attachment Security as Mediator and Moderator of Outcome in Major Depression|Attachment Security as Mediator and Moderator of Outcome in Major Depression Following Interpersonal Therapy and Cognitive Behavior Therapy|Completed||N/A|134|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 15:41:59.592913|2017-02-18 15:41:59.592913
NCT00461266|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2016-08-23|||April 2007||2007-04-01|August 2016|2016-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.|A Randomized, Open Label Study to Determine the Immunological Benefits of Adding Fuzeon to an Antiretroviral Regimen in HIV-infected Fuzeon-naïve Patients With Sustained HIV Viral Suppression|Withdrawn||Phase 4|0|Actual|Hoffmann-La Roche||2||Slow recruitment|f||||||||||||||2017-02-18 15:41:59.704681|2017-02-18 15:41:59.704681
NCT00461253|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-12-17|2015-12-17||October 2006||2006-10-01|December 2015|2015-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Observational||Definitions: cases were defined as women who were diagnised with breast cancer (invasive carcinoma or carcinoma in situ) between 1/2000 and 12/2007 and aged <50 years at diagnosis. Controls were selected randomly from the national population registry (Finland) or via neighborhood controls by a controlled random route method (Germany).|Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs|Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs|Completed||Phase 4|25565|Actual|Center for Epidemiology and Health Research, Germany|Limitations include information-bias, which cannot be entirely eliminated in retrospective studies. However, in this study recall is likely not to be differential between cases and controls.||2||f||||t||||||||||2017-02-18 15:41:59.81608|2017-02-18 15:41:59.81608
NCT00461240|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2012-07-24|||June 2007||2007-06-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|||||Observational|||Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States|Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States|Completed||N/A|25|Actual|Barts & The London NHS Trust|||2||f||||f||||||Samples With DNA|"~     blood samples will be retained~   "|||2017-02-18 15:42:00.197891|2017-02-18 15:42:00.197891
NCT00461227|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2012-12-18|||August 2006||2006-08-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Effect of Heredity and Environment on Asthma Development and Severity in Puerto Rican Children|Genes, Home Allergens, and Asthma in Puerto Rican Children|Completed||N/A|1127|Actual|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"~     Serum~   "|||2017-02-18 15:42:00.299021|2017-02-18 15:42:00.299021
NCT00461214|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2012-11-19|||October 2006||2006-10-01|November 2012|2012-11-01||||August 2008|Actual|2008-08-01||Observational|||General Surgery Training Outcomes Project|General Surgery Training Outcomes Project: Evaluating the Impact of the Curriculum on General Surgery Resident Training and Evaluation|Terminated||N/A|35|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 15:42:00.396274|2017-02-18 15:42:00.396274
NCT00461201|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2007-04-16|||January 2009||2009-01-01|April 2007|2007-04-01||||||||Interventional|||Nurse vs General Practitioner Care for Patients Requesting Same Day Consultations in Primary Care|Effectiveness of an Intervention in Primary Care: Randomized Controlled Trial Comparing Care for Patients Requesting Same Day Consultations by Nurse Practitioner vs General Practitioners|Unknown status|Not yet recruiting|N/A|1640||Catalan Institute of Health|||||f||||f||||||||||2017-02-18 15:42:00.483605|2017-02-18 15:42:00.483605
NCT00461188|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-07-15|||March 2007||2007-03-01|July 2015|2015-07-01|April 2099|Anticipated|2099-04-01|April 2099|Anticipated|2099-04-01||Observational|||Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA|Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA|Recruiting||N/A|150|Anticipated|Barts & The London NHS Trust|||1||f||||f||||||Samples With DNA|"~     DNA sample, tissue sample~   "|||2017-02-18 15:42:00.583878|2017-02-18 15:42:00.583878
NCT00461175|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2015-06-24|2014-10-16||November 2006||2006-11-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|May 2012|Actual|2012-05-01||Observational|EURAS-IUD||European Active Surveillance Study for Intrauterine Devices|European Active Surveillance Study for Intrauterine Devices|Completed||Phase 4|63194|Actual|Center for Epidemiology and Health Research, Germany|In observational studies like EURAS-IUD, the possibility of bias and residual confounding can never be entirely eliminated. Thus, for risk estimates smaller than 2-fold, causality cannot be inferred confidently in view of alternative explanations.||2||f||||t||||||||||2017-02-18 15:42:00.694957|2017-02-18 15:42:00.694957
NCT00461162|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2014-08-14|||January 2007||2007-01-01|August 2014|2014-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Dyspnea Self-Management: Internet or Face-to-Face|Dyspnea Self-Management: Internet or Face-to-Face|Completed||Phase 1/Phase 2|125|Actual|University of California, San Francisco||3|||f||||||||||||||2017-02-18 15:42:01.483082|2017-02-18 15:42:01.483082
NCT00461149|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2007-04-13|||January 1995||1995-01-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|HDacro||Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly|Beneficial Effect of Dose Escalation of Octreotide-LAR as First-Line Therapy in Patients With Resistant Acromegaly|Completed||Phase 4|50||Federico II University|||||f||||f||||||||||2017-02-18 15:42:01.602006|2017-02-18 15:42:01.602006
NCT00461136|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2016-09-22|||August 2005||2005-08-01|September 2016|2016-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes|An Open-label, One-period, One-treatment Study to Evaluate the Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes Suffering From Incipient and/or Established Nephropathy|Completed||Phase 1/Phase 2|18||Novartis|||||f||||f||||||||||2017-02-18 15:42:01.715365|2017-02-18 15:42:01.715365
NCT00461123|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2014-12-04|2009-09-29||March 2007||2007-03-01|December 2014|2014-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy|A Randomized, Double-blind, Parallel Group Prospective Pilot Study to Assess the Effect of Vardenafil on Clinical Outcome and on Procedure Duration After Green Light Laser-ablation of the Prostate Gland for Therapy of Benign Prostate Hypertrophy (BPH)|Completed||Phase 2|50|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:42:01.806003|2017-02-18 15:42:01.806003
NCT00461110|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2009-09-03|||January 2008||2008-01-01|September 2009|2009-09-01|April 2009|Anticipated|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)|A Phase 1 Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)|Terminated||Phase 1|35|Anticipated|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 15:42:02.252395|2017-02-18 15:42:02.252395
NCT00460785|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-07-05|||February 2007||2007-02-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Bioequivalence Trial of a New Opioid Combination Compared to Reference|Phase 1 Single Center Trial to Demonstrate the Bioequivalence of a New Combination Analgesic Formulation as Compared to an Equimolar Marketed Formulation|Completed||Phase 1|32||Grünenthal GmbH|||||f||||||||||||||2017-02-18 15:42:07.276495|2017-02-18 15:42:07.276495
NCT00461097|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2016-09-15|2011-12-29||May 2007||2007-05-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|December 2010|Actual|2010-12-01||Interventional|||Oral Immunotherapy for Childhood Egg Allergy|Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)|Completed||Phase 2|55|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 15:42:02.363874|2017-02-18 15:42:02.363874
NCT00461084|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2014-09-17|||April 2007||2007-04-01|September 2014|2014-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma|Biaxin(Clarithromycin)Based Antibiotic Therapy In Previously Untreated, Advanced Stage Indolent Lymphoma|Completed||Phase 2|36|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||t||||||Samples Without DNA|"~     tissue and whole blood~   "|||2017-02-18 15:42:03.501218|2017-02-18 15:42:03.501218
NCT00461071|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2009-09-17|||April 2007||2007-04-01|September 2009|2009-09-01|April 2010|Anticipated|2010-04-01|February 2008|Actual|2008-02-01||Interventional|||Randomised Controlled Study on the Use of Psychoeducation for Bulimia Nervosa in Young Women|RCT on the Use of Psychoeducation for Bulimia Nervosa in Young Women|Unknown status|Active, not recruiting|N/A|150|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 15:42:03.630744|2017-02-18 15:42:03.630744
NCT00461058|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2016-08-03|||May 2007||2007-05-01|August 2016|2016-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.|A Randomized, Double Blind Study to Compare the Safety and Tolerability of Aleglitazar and Actos in Patients With Type 2 Diabetes and NYHA Class II Heart Failure.|Completed||Phase 2|14|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:42:03.748131|2017-02-18 15:42:03.748131
NCT00461045|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2014-12-20|||March 2007||2007-03-01|August 2014|2014-08-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Phase 1/2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma|Phase 1/2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma|Unknown status|Active, not recruiting|Phase 1/Phase 2|100|Anticipated|Triphase Research and Development I Corporation||1|||f||||f||||||||||2017-02-18 15:42:03.892211|2017-02-18 15:42:03.892211
NCT00461032|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2015-06-23|2010-01-12||June 2006||2006-06-01|June 2015|2015-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Montelukast Back to School Asthma Study (0476-340)|A Multicenter, Randomized, Double-blind, Placebo-Controlled Parallel Group 8-week Study to Evaluate the Efficacy and Safety of Chewable Montelukast When Initiated at the Start of the School Year in Pediatric Patients With Chronic Asthma|Completed||Phase 3|1162|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:42:04.023111|2017-02-18 15:42:04.023111
NCT00460889|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2015-04-02|||October 2006||2006-10-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Renal Donor Comparison of Outcomes: Hand Assist Versus Laparoscopic Nephrectomy|Renal Donor Comparison of Outcomes: Hand Assist Versus Laparoscopic Nephrectomy|Withdrawn||N/A|0|Actual|Columbia University|||1|Principal Investigator left institution|f||||f||||||||||2017-02-18 15:42:04.615839|2017-02-18 15:42:04.615839
NCT00460876|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2008-04-30|||March 2007||2007-03-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Phase I Trial of Periocular Topotecan in Retinoblastoma|Toxicity and Activity of Periocular Topotecan in Children With Retinoblastoma|Completed||Phase 1|5|Actual|Hospital JP Garrahan||1|||f||||t||||||||||2017-02-18 15:42:04.703931|2017-02-18 15:42:04.703931
NCT00460863|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2014-04-22|||April 2003||2003-04-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Hemodialysis on the Sleep/Wake Cycle|Effects of Hemodialysis on the Slee/Wake Cycle of Patients on Chronic Hemodialysis|Completed||Phase 1|58|Actual|Emory University||1|||f||||t||||||||||2017-02-18 15:42:04.797528|2017-02-18 15:42:04.797528
NCT00460850|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2008-06-27|||September 2007||2007-09-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|||||Interventional|||A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.|An Open Label Study to Evaluate the Effect of PEGASYS on ALT and HBV DNA Levels in Patients With Lamivudine-Resistant HbeAg-Negative Chronic Hepatitis B|Terminated||Phase 4|60|Anticipated|Hoffmann-La Roche||1||Low recruitment rate due to treatment regimen change|f||||||||||||||2017-02-18 15:42:04.901473|2017-02-18 15:42:04.901473
NCT00460837|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2010-07-23|||November 2007||2007-11-01|July 2010|2010-07-01|March 2009|Anticipated|2009-03-01|||||Interventional|||Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient Experience|Virtual Colonoscopy: Comparison of Reduced Laxative Virtual Colonoscopy Regimens With Standard Preparation on Patient Experience and Compliance - a Questionnaire Based Study|Withdrawn||Phase 4|150|Anticipated|London North West Healthcare NHS Trust||2||Supply of adequate label was not provided to the MHRA|f||||t||||||||||2017-02-18 15:42:05.002474|2017-02-18 15:42:05.002474
NCT00460824|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-16|2013-12-29|||July 1988||1988-07-01|December 2013|2013-12-01||||||||Observational|||A Retrospective Review - Anti-HLA Antibodies|A Retrospective Review of Anti-HLA Antibodies and Donor Crossmatch Results as a Predictor of Pediatric Heart Transplant Outcomes|Withdrawn||N/A|0|Actual|Emory University|||1|Not a Clinical trial. Retrospective Data review only.|f||||f||||||||||2017-02-18 15:42:05.115466|2017-02-18 15:42:05.115466
NCT00460811|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2013-01-29|2012-09-28||April 2007||2007-04-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)|A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-design, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Irritable Bowel Syndrome With Constipation|Completed||Phase 2|420|Actual|Ironwood Pharmaceuticals, Inc.||5|||f||||||||||||||2017-02-18 15:42:05.200729|2017-02-18 15:42:05.200729
NCT00460798|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2010-11-03|2010-09-30||February 2007||2007-02-01|November 2010|2010-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|SUNIKA||SUTENT® In The First Line Treatment Of Renal Cell Carcinoma|A Non-Interventional Study With SUTENT® In The First Line Treatment Of Renal Cell Cancer|Completed||Phase 4|356|Actual|Pfizer|Owing to extent of missing data, the planned TTP analyses derived from standardized lesion measurement was not reported. An additional TTP analysis using Investigator Disease Status and Overall Objective Tumor Assessments at 12 months was reported.||1||f||||f||||||||||2017-02-18 15:42:06.509443|2017-02-18 15:42:06.509443
NCT00460746|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2013-07-24|2009-10-02||May 2007||2007-05-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.|Open Label Phase 3b, 48 wk Pilot Study of the Antiviral Efficacy and Tolerability of Combination of PREZISTA/r and TMC125 When Substituted for Enfuvirtide, Current Protease Inhibitor(s) and NNRTI(s) in Antiretroviral Resistant Patients With Viral Suppression But Who Are Intolerant of Enfuvirtide.|Completed||Phase 3|10|Actual|Tibotec, Inc|Conclusions on efficacy and safety are limited as the target enrollment of 40 subjects was not reached due to a shortage of eligible subjects.|1|||f||||f||||||||||2017-02-18 15:42:07.454813|2017-02-18 15:42:07.454813
NCT00460733|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2011-10-03|||March 2007||2007-03-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|SOLID||SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.|Local (Brazil) Study, Multicenter, Opened, Comparative, Randomized, With Parallel Groups, Phase IV, in Post Menopausal Woman With Colles' Fracture of the Risedronate Sodium Usage in the Consolidation and in the Callus of the Colles'Fracture.|Completed||Phase 4|141|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:42:07.842314|2017-02-18 15:42:07.842314
NCT00460720|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2010-04-26||||||April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Observational|||Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)|Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)|Completed||N/A|591|Actual|Johnson & Johnson Taiwan Ltd|||1||f||||||||||||||2017-02-18 15:42:07.953708|2017-02-18 15:42:07.953708
NCT00460707|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2016-10-27|||April 2007||2007-04-01|October 2016|2016-10-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults|A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant [GW679769] in Healthy Subjects|Completed||Phase 1|72|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:42:08.065883|2017-02-18 15:42:08.065883
NCT00460694|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2017-02-09|||August 2006||2006-08-01|February 2017|2017-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|alloCIK||Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies|A Phase II Trial on Allogeneic Cytokine-induced Killer Cell Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies|Completed||Phase 1/Phase 2|24|Actual|Singapore General Hospital||1|||f||||t||||||||||2017-02-18 15:42:08.180276|2017-02-18 15:42:08.180276
NCT00460681|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2007-10-30|||February 2007||2007-02-01|October 2007|2007-10-01|February 2012|Anticipated|2012-02-01|||||Interventional|||Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma|Phase III Study of Thymopentin in Patients After Curative Resection of Small|Unknown status|Recruiting|Phase 3|220|Anticipated|Fudan University||1|||f||||t||||||||||2017-02-18 15:42:08.346402|2017-02-18 15:42:08.346402
NCT00460668|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2013-04-05|||April 2007||2007-04-01|April 2013|2013-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The Effect of Post-thoracotomy Pulmonary Rehabilitation on Quality of Life|A Prospective Single Centre Open Randomized Trial on the Effect of Post-thoracotomy Pulmonary Rehabilitation on Quality of Life|Completed||N/A|57|Actual|Isala||2|||f||||t||||||||||2017-02-18 15:42:08.444554|2017-02-18 15:42:08.444554
NCT00460655|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2010-08-30|2009-09-02||May 2007||2007-05-01|August 2010|2010-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity|A Multicenter Study to Evaluate the Efficacy and Safety in Patients With Post-Stroke Lower Limb Spasticity Receiving a Double-Blind, Placebo-Controlled GSK1358820 Treatment Followed by an Open-Label GSK1358820 Treatment|Completed||Phase 3|120|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:42:08.553238|2017-02-18 15:42:08.553238
NCT00460642|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2010-05-24|||January 2007||2007-01-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||GnRH Antagonist to Prepare Recipients for Embryo Transfer|Use of GnRH Antagonist (Cetrotide) Protocol, Instead of Agonist, to Prepare Recipients for Embryo Transfer|Completed||N/A|130|Anticipated|Institute for Human Reproduction (IHR)|||||f||||t||||||||||2017-02-18 15:42:12.018822|2017-02-18 15:42:12.018822
NCT00460629|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2013-06-19|||March 2005||2005-03-01|June 2013|2013-06-01||||December 2011|Actual|2011-12-01||Interventional|||Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation|Specific Cellular Immunotherapy in Patients With Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation|Completed||Phase 1/Phase 2|20|Anticipated|University Hospital Carl Gustav Carus||1|||f||||f||||||||||2017-02-18 15:42:12.114631|2017-02-18 15:42:12.114631
NCT00460616|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2008-04-14|||January 2007||2007-01-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Observational|ValveCab||Cardiac Valve Complications in Prolactinomas Treated With Cabergoline|Observational Study to Investigate the Prevalence of Cardiac Abnormalities and Valvular Regurgitation in Patients With Prolactinomas Treated Chronically With Cabergoline|Completed||Phase 4|50|Actual|Federico II University|||2||f||||f||||||||||2017-02-18 15:42:12.217464|2017-02-18 15:42:12.217464
NCT00460603|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2013-11-07|2013-03-28||January 2006||2006-01-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|April 2012|Actual|2012-04-01||Interventional|||Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer|A Randomized Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Combinations With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer Preceded By A Phase 1 Portion|Completed||Phase 1/Phase 2|187|Actual|Pfizer|Time to Treatment Failure (TTF) was included as a secondary endpoint of the study after change in analysis plan.|3|||f||||f||||||||||2017-02-18 15:42:12.646433|2017-02-18 15:42:12.646433
NCT00460590|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2008-08-06|||October 2005||2005-10-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town|A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine MVA85A, in Healthy Volunteers With no Evidence of Infection With Mycobacterium Tuberculosis, in Cape Town|Completed||Phase 1|36|Actual|University of Oxford||3|||f||||t||||||||||2017-02-18 15:42:19.116131|2017-02-18 15:42:19.116131
NCT00460057|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2014-08-02|||March 2006||2006-03-01|August 2014|2014-08-01|February 2007|Actual|2007-02-01|December 2006|Actual|2006-12-01||Interventional|||The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women With Bone Loss|The Change of Bone Markers After Low Dose Alendronate in Postmenopausal Women|Completed||Phase 4|63|Actual|Eulji University Hospital||1|||f||||f||||||||||2017-02-18 15:42:32.076077|2017-02-18 15:42:32.076077
NCT00460577|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2011-03-23|2010-12-13||March 2007||2007-03-01|March 2011|2011-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction|Randomized, Double Blind, Double Dummy, Placebo Controlled Trial to Compare the Effectiveness of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Asthmatic Children (5-<12 Years) With Acute Bronchial Obstruction Attending Emergency Services|Completed||Phase 4|60|Actual|Novartis|Secondary Outcome Measure 2: Safety Assessed by Pulse Oxymetry, Clinical Assessments, Adverse Events has not been posted. Analysis of Pulse Oxymetry and Clinical Assessment was not performed. Adverse events are reported in the Adverse Event section.|2|||f||||||||||||||2017-02-18 15:42:19.227503|2017-02-18 15:42:19.227503
NCT00460564|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2011-03-17|2009-09-02||May 2007||2007-05-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity|A Multicenter Study to Evaluate the Efficacy and Safety in Patients With Post-Stroke Upper Limb Spasticity Receiving a Double-Blind, Placebo-Controlled GSK1358820 Treatment Followed by an Open-Label GSK1358820 Treatment|Completed||Phase 3|109|Actual|GlaxoSmithKline|The frequency threshold (5%) for reporting other adverse events is based on the result of the double-blind phase for the first four arms listed in the table and on the open-label phase for the last four arms listed in the table.|4|||f||||f||||||||||2017-02-18 15:42:19.976299|2017-02-18 15:42:19.976299
NCT00460551|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2011-12-05|2011-09-12||April 2007||2007-04-01|December 2011|2011-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer|A Randomized, Open-label, Multi-center Trial Investigating Zalutumumab, a Human Monoclonal Anti-EGF Receptor Antibody, in Combination With Chemo-Radiation in Stage IIIA-IIIB Non Small Cell Lung Cancer Patients|Terminated||Phase 2|13|Actual|Genmab|The trial was prematurely closed. The original protocol contained Part 1A, followed by Part 1B and Part 2. The trial was terminated when 13 patients were enrolled in Part 1A. Scans for efficacy were planned for Part 1B and Part 2.|1||Due to considerations regarding the appropriate therapeutic regimen for these patients.|f||||t||||||||||2017-02-18 15:42:22.332568|2017-02-18 15:42:22.332568
NCT00460538|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2010-04-02|||April 2007||2007-04-01|March 2010|2010-03-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms|Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms|Completed||Phase 4|48|Actual|Milsing d.o.o.||2|||f||||t||||||||||2017-02-18 15:42:22.720794|2017-02-18 15:42:22.720794
NCT00460525|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2015-05-18|2010-07-02||May 2007||2007-05-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali|Randomized, Controlled Phase II Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the AMA-1 Malaria Vaccine FMP2.1/AS02A Versus Rabies Vaccine in 1-6 Year Old Children in Bandiagara, Mali|Completed||Phase 2|400|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-02-18 15:42:22.839425|2017-02-18 15:42:22.839425
NCT00460512|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2017-01-27|||April 2007||2007-04-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|January 2009|Actual|2009-01-01||Interventional|PERFlexS||An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia|An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia|Active, not recruiting||Phase 3|1812|Actual|Janssen-Cilag International NV||1|||f||||f||||||||||2017-02-18 15:42:23.989354|2017-02-18 15:42:23.989354
NCT00460499|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2015-06-22|||July 2004||2004-07-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control||Completed||Phase 1|250|Actual|American Heart Association||3|||f||||t||||||||||2017-02-18 15:42:24.340155|2017-02-18 15:42:24.340155
NCT00460486|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2015-05-20|||September 2006||2006-09-01|May 2015|2015-05-01||||November 2007|Actual|2007-11-01||Interventional|||Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule|Open-Label Phase 3b Clinical Study to Evaluate the Immunogenicity and Safety of FSME-IMMUN 0.5 ml With the First and Second Vaccination Being Administered According to a Rapid Immunization Schedule in Healthy Adults Aged 16 Years or Older|Completed||Phase 3|330||Pfizer|||||f||||t||||||||||2017-02-18 15:42:24.44581|2017-02-18 15:42:24.44581
NCT00460473|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2015-07-23|||April 2007||2007-04-01|July 2015|2015-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery|A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia|Terminated||Phase 3|52|Actual|Hospira, Inc.||2||"The incidence of post-operative delirium observed from interim blinded data was significantly~   lower than the current literature in this population."|f||||f||||||||||2017-02-18 15:42:24.721237|2017-02-18 15:42:24.721237
NCT00460460|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2011-01-24|||March 2007||2007-03-01|January 2011|2011-01-01|August 2007|Actual|2007-08-01|||||Interventional|||Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies|A Phase I, Open-label, Dose Escalation Study to Assess the Safety, Tolerability & Pharmacokinetics of AZD4877 Administered Once Weekly in Adult Patients With Recurrent or Refractory AML, PH Negative ALL, NHL or MN|Terminated||Phase 1|75|Anticipated|AstraZeneca||||Study was terminated due to low enrollment|f||||||||||||||2017-02-18 15:42:24.865282|2017-02-18 15:42:24.865282
NCT00460447|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2007-04-12|||October 2004||2004-10-01|April 2007|2007-04-01||||||||Interventional|||Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation|Gentuzumab Ozogamicin Berfore Allogeneic Stem Cell Transplantation in Patients With Relapsed CD33+ Acute Myeloid Leukemia|Unknown status|Recruiting|Phase 1/Phase 2|30||University Hospital Carl Gustav Carus|||||f||||f||||||||||2017-02-18 15:42:24.9424|2017-02-18 15:42:24.9424
NCT00460434|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2013-09-27|||May 2007||2007-05-01|September 2013|2013-09-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|OPUS||Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial|Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling (OPUS) Trial|Completed||Phase 3|517|Actual|NICHD Pelvic Floor Disorders Network||2|||f||||t||||||||||2017-02-18 15:42:25.039714|2017-02-18 15:42:25.039714
NCT00460044|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2007-04-12|||January 2002||2002-01-01|April 2007|2007-04-01|July 2003|Actual|2003-07-01|||||Observational|||ADMA and Mechanical Ventilation in Preterm Infants|Plasma ADMA Concentrations at Birth and Mechanical Ventilation in Preterm Infants|Completed||N/A|35||VU University Medical Center|||||f||||f||||||||||2017-02-18 15:42:32.167214|2017-02-18 15:42:32.167214
NCT00460421|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2014-11-04|2012-05-30||August 2006||2006-08-01|November 2014|2014-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT|A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Pediatric Subjects With Acute Leukemias Undergoing Myeloablative Therapy and Allogeneic Hematopoietic Stem Cell Transplant (HSCT)|Completed||Phase 1|27|Actual|Swedish Orphan Biovitrum|The original protocol included a long term follow-up (LTFU) phase up to 10 years. This was reduced in a protocol amendment to up to the time when the last enrolled subject had completed the day +100 follow-up.|1|||f||||t||||||||||2017-02-18 15:42:25.173576|2017-02-18 15:42:25.173576
NCT00460408|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-13|2012-11-14|2012-09-24||August 2006||2006-08-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration|European Epidemiologic COHORT Study: A Prospective Epidemiologic COHORT Study Of Ocular Safety In Patients Receiving Macugen Injections For Neovascular Age-Related Macular Degeneration (AMD) In Europe|Completed||N/A|501|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:42:26.252547|2017-02-18 15:42:26.252547
NCT00460395|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2012-02-22|||January 1998||1998-01-01|February 2012|2012-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial|Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial|Completed||Phase 3|64|Actual|M.D. Anderson Cancer Center|||||f||||t||||||||||2017-02-18 15:42:27.501709|2017-02-18 15:42:27.501709
NCT00460382|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2010-09-16|||May 2007||2007-05-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|March 2008|Actual|2008-03-01||Interventional|ANRS139 TRIO||Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses|Prospective Clinical Trial to Assess Safety and Efficacy of DRV/r(TMC 114/r), ETV(TMC 125) and MK-0518 in Addition to OBT in HIV-1 Infected Patients With Limited to No Treatment Options ANRS 139 TRIO|Completed||Phase 2|103|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-02-18 15:42:27.607199|2017-02-18 15:42:27.607199
NCT00460369|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2008-04-11|||April 2007||2007-04-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Treatment of Uncomplicated Malaria in Benin|Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine Versus Amodiaquine-Artesunate Coformulation in Uncomplicated Plasmodium Falciparum Malaria : an Open Randomized Study|Completed||N/A|240|Actual|Institut de Recherche pour le Developpement||3|||f||||t||||||||||2017-02-18 15:42:27.71942|2017-02-18 15:42:27.71942
NCT00460356|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2016-10-26|||April 2007||2007-04-01|October 2016|2016-10-01||||January 2100|Anticipated|2100-01-01||Observational|||Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes|Glycoprotein and Glycan Profiling in Patients With Locally Advanced Cervical Cancer (Stage IB2, IIA &gt; 4 CM, IIB to IVA) Undergoing Pelvic and Para-aortic (Abdominal) Lymphadenectomy|Active, not recruiting||N/A|286|Anticipated|Gynecologic Oncology Group|||1||f||||||||||Samples Without DNA|"~     Tissue and Blood Samples~   "|||2017-02-18 15:42:27.833064|2017-02-18 15:42:27.833064
NCT00460343|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2008-07-09|||April 2007||2007-04-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Pharmacy Implementation Trial: Adherence to Antihypertensive Therapy|Implementation of a Pharmacy-Intervention to Establish and if Necessary Improve Adherence to Antihypertensive Therapy. A Cluster Randomized Trial.|Completed||N/A|57|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:42:27.952749|2017-02-18 15:42:27.952749
NCT00460330|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2007-04-12|||April 2007||2007-04-01|April 2007|2007-04-01|December 2008|Anticipated|2008-12-01|||||Observational|||Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT|The Value of Real-Time Polymerase Chain Reaction (RT-PCR) Assay, Galactomannan and β-D-Glucan Detection (GM/G-Test) for Diagnosis of Invasive Fungal Infection (IFI) in Chinese Patients After Hematopoietic Stem Cell Transplantation (HSCT)|Unknown status|Recruiting|N/A|120||Peking University|||||f||||t||||||||||2017-02-18 15:42:28.173132|2017-02-18 15:42:28.173132
NCT00460317|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2015-08-24||2015-07-13|July 2007||2007-07-01|August 2015|2015-08-01|August 2013|Actual|2013-08-01|March 2011|Actual|2011-03-01||Interventional|||MONET1-MOtesanib NSCLC Efficacy and Tolerability Study|A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial of AMG 706 in Combination With Paclitaxel and Carboplatin for Advanced Non-small Cell Lung Cancer.|Terminated||Phase 3|1450|Actual|Amgen||2||"Amgen discontinued the development of AMG706 because 20050201 did not meet its primary~   objective."|f||||t||||||||||2017-02-18 15:42:28.281184|2017-02-18 15:42:28.281184
NCT00460304|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2009-04-02|||September 2007||2007-09-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||The Effect of Pramlintide on Meal Time Insulin Bolus|The Effect of Pramlintide on Meal Time Insulin Bolus|Completed||N/A|12|Anticipated|Diabetes Care Center||1|||f||||f||||||||||2017-02-18 15:42:28.407111|2017-02-18 15:42:28.407111
NCT00460291|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2007-10-02|||June 2005||2005-06-01|October 2007|2007-10-01|December 2008|Anticipated|2008-12-01|||||Interventional|PROVENA||Pilot Study to Asses the Function and Patency of Polyester-Coated Composite Bypasses From Autologous Varicose Veins|Pilot Study to Asses the Function and Patency of Polyester-Coated Composite Bypasses From Autologous Varicose Veins|Unknown status|Recruiting|N/A|50|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||f||||||||||2017-02-18 15:42:28.502534|2017-02-18 15:42:28.502534
NCT00460278|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2008-06-02|||April 2007||2007-04-01|June 2008|2008-06-01||||||||Interventional|||Study of XL418 in Adults With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL418 Administered Orally Daily to Subjects With Solid Tumors|Suspended||Phase 1|63|Anticipated|Exelixis||||Enrollment suspended due to low drug exposure.|||||t||||||||||2017-02-18 15:42:28.613831|2017-02-18 15:42:28.613831
NCT00460265|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2014-02-03|2011-05-13||May 2007||2007-05-01|February 2014|2014-02-01|May 2012|Actual|2012-05-01|May 2010|Actual|2010-05-01||Interventional|SPECTRUM||Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer|A Phase 3 Randomized Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 3|658|Actual|Amgen||2|||f||||t||||||||||2017-02-18 15:42:28.697789|2017-02-18 15:42:28.697789
NCT00459251|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2007-04-10|||December 2006||2006-12-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Observational|||Pharmacogenetics Study in Taiwan's Ethnic Groups|The Pharmacogenetics Study of Drug-Metabolising Enzyme Genetic Polymorphisms in Aboriginal and Minnan/Hakka Ethnic Groups in Taiwan|Completed||Phase 4|350||Mackay Memorial Hospital|||||f||||f||||||||||2017-02-18 15:42:51.565144|2017-02-18 15:42:51.565144
NCT00460252|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2007-04-12|||May 2006||2006-05-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Tight Glycemic Control by eMPC Algorithm in Medical ICU Patients.|An Open, Mono-Centre Randomised Controlled Trial to Investigate the Feasibility of Blood Glucose Control With the Software-Algorithm eMPC (Enhanced Model Predictive Control) Via the Arterial-Intravenous Route in Patients at the Medical Intensive Care Unit.|Completed||N/A|50||Medical University of Graz|||||f||||f||||||||||2017-02-18 15:42:30.26441|2017-02-18 15:42:30.26441
NCT00460239|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2012-04-21|||January 2007||2007-01-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|July 2009|Actual|2009-07-01||Interventional|||Buprenorphine's Dose Response Curve|Evaluation of Opioid Antagonist Activity in Humans|Unknown status|Active, not recruiting|Phase 2|12|Anticipated|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 15:42:30.372871|2017-02-18 15:42:30.372871
NCT00460226|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2012-03-15|||March 2007||2007-03-01|January 2011|2011-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Lamictal Bipolar Observational Study|A Multi-centre, Observational Study to Evaluate the Incidence of Non-serious Rash in Korean Bipolar I Patients With Lamotrigine Therapy in Real World Setting|Completed||N/A|238|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 15:42:30.485106|2017-02-18 15:42:30.485106
NCT00460213|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2013-12-05|||July 2006||2006-07-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|December 2008|Actual|2008-12-01||Interventional|||Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study|Study on Optimal Anti-hypertensive Therapy With Valsartan by Using Home Blood Pressure Measurement|Completed||Phase 4|103|Actual|Kitakyushu-Tsuyazaki Hospital||1|||f||||t||||||||||2017-02-18 15:42:30.596091|2017-02-18 15:42:30.596091
NCT00460200|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2012-10-03|||December 2003||2003-12-01|October 2012|2012-10-01||||||||Observational|||Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer|Depression and IL-6 in Epithelial Ovarian Cancer: Genetic Diathesis and Psychological Stress|Withdrawn||N/A|0|Actual|Jonsson Comprehensive Cancer Center|||1|no patient accrual|f||||f||||||||||2017-02-18 15:42:30.706119|2017-02-18 15:42:30.706119
NCT00460187|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2008-10-20|||March 2007||2007-03-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|||||Interventional|EPIC||EPIC US Pivotal Study|Evaluating the Use of the FiberNet Embolic Protection System in Carotid Artery Stenting: The EPIC US Pivotal Study.|Completed||N/A|237|Actual|Lumen Biomedical|||||f||||t||||||||||2017-02-18 15:42:30.794876|2017-02-18 15:42:30.794876
NCT00460174|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2016-10-21|||October 2005||2005-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer|A Phase II Trial of Weekly Gemcitabine Hydrochloride and Bevacizumab in Combination With Abdominal Radiation Therapy in Patients With Localized Pancreatic Cancer|Active, not recruiting||Phase 2|31|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 15:42:30.884753|2017-02-18 15:42:30.884753
NCT00460161|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2009-02-17|||February 2009||2009-02-01|August 2008|2008-08-01||||August 2009|Anticipated|2009-08-01||Interventional|||Acupuncture for Phantom Limb Pain|Acupuncture for Phantom Limb Pain: A Randomized, Double-Blind, Placebo/Sham - Controlled Study|Suspended||Phase 3|40|Anticipated|Shaare Zedek Medical Center||2||Lack of patients|f||||f||||||||||2017-02-18 15:42:30.999505|2017-02-18 15:42:30.999505
NCT00460148|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2016-10-27|||April 2007||2007-04-01|October 2016|2016-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole|An Open Label, Repeat Dose, Dose Escalation Study Conducted in Parkinson's Disease Patients to Characterize the Pharmacokinetics and Effect of Food on Ropinirole Prolonged Release (PR/CR) 12mg Tablets.|Completed||Phase 2|28|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:42:31.098439|2017-02-18 15:42:31.098439
NCT00460135|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2009-03-03|||April 2006||2006-04-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||The Impact of Resistance Exercise Training On Metabolic Dysregulation in Obese Children.|The Impact of Resistance Exercise Training On Metabolic Dysregulation in Obese Children.|Completed||N/A|20|Actual|McGill University Health Center||2|||f||||f||||||||||2017-02-18 15:42:31.196229|2017-02-18 15:42:31.196229
NCT00460122|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2017-01-24|||April 10, 2007||2007-04-10|August 10, 2012|2012-08-10|August 10, 2012||2012-08-10|||||Observational|||Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients|Pilot Study of the Incidence of HLA Class I and Class II Antibodies in Platelet Donors and Their Effects on the Transfusion Recipient|Completed||N/A|135|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:42:31.297867|2017-02-18 15:42:31.297867
NCT00460109|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2016-08-12|||April 2008||2008-04-01|August 2016|2016-08-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|||Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma|A Phase II Clinical Trial of Denileukin Diftitox in Combination With Rituximab in Previously Untreated Follicular B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|24|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 15:42:31.389384|2017-02-18 15:42:31.389384
NCT00460096|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2007-10-16|||March 2007||2007-03-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|Kamada API||Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency|Randomized Double-Blind Comparison of an Alpha-1 Proteinase Inhibitor (Kamada API) With a Currently Marketed API Product in Individuals With Alpha-1 Antitrypsin Deficiency|Completed||Phase 2/Phase 3|50|Anticipated|Kamada, Ltd.|||||f||||t||||||||||2017-02-18 15:42:31.764813|2017-02-18 15:42:31.764813
NCT00460083|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2008-02-05|||April 2007||2007-04-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis|A Randomized, Double-Blinded Study of Epiceram Versus Elidel in Pediatric Subjects With Mild to Moderate Atopic Dermatitis|Completed||Phase 4|35|Actual|Ceragenix Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:42:31.857399|2017-02-18 15:42:31.857399
NCT00460070|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2011-07-26|||January 2007||2007-01-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|||||Observational|||Study of Hormonal Sideeffects in Patients Taking Levetiracetam, Carbamazepine or Lamotrigine for Epilepsy|Levetiracetam, Carbamazepine and Lamotrigine and Hormonal Side Effects in Adult Males and Females.|Completed||N/A|240|Actual|Rikshospitalet University Hospital|||1||f||||f||||||||||2017-02-18 15:42:31.969801|2017-02-18 15:42:31.969801
NCT00460031|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2016-10-19|2014-07-14||September 2006||2006-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|August 2010|Actual|2010-08-01||Interventional|||Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy|Phase II Trial to Assess the Activity of Ketoconazole Plus Lenalidomide in Patients With Prostate Cancer Progressive After Androgen Deprivation|Active, not recruiting||Phase 2|34|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:42:32.244667|2017-02-18 15:42:32.244667
NCT00460018|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2009-06-18|||September 2005||2005-09-01|January 2009|2009-01-01||||||||Interventional|DEBI||Diet, Exercise, and Breastfeeding Intervention Program for Women With Gestational Diabetes (DEBI Trial)|Diet, Exercise and Breastfeeding Intervention (DEBI) Program for Women With Gestational Diabetes|Completed||Phase 2|180|Anticipated|Kaiser Permanente||2|||f||||f||||||||||2017-02-18 15:42:32.89417|2017-02-18 15:42:32.89417
NCT00460005|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2008-04-14|||January 2006||2006-01-01|April 2008|2008-04-01||||||||Observational|||Clinical Study Of Migraine Evolution|A Multicenter Study to Determine the Clinical Characteristics of the Temporal Aspects of Migraine in a Canadian Population: Clinical Study Of Migraine Evolution (C-SOME)|Completed||Phase 4|250||GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:42:33.018175|2017-02-18 15:42:33.018175
NCT00459992|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2017-01-24|||April 10, 2007||2007-04-10|December 11, 2014|2014-12-11|February 14, 2011|Actual|2011-02-14|February 14, 2011|Actual|2011-02-14||Interventional|||Effects of Betahistine Hydrochloride in Overweight Women|Pilot Study of the Metabolic Effects of Betahistine Hydrochloride in Overweight Women|Completed||Phase 1|150|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:42:33.106712|2017-02-18 15:42:33.106712
NCT00459979|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2014-02-04|2013-11-19||March 2007||2007-03-01|February 2014|2014-02-01|September 2013|Actual|2013-09-01|March 2011|Actual|2011-03-01||Interventional|||Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery|A Phase II Study of Sunitinib Malate in Patients With Renal Cell Carcinoma and Unresectable Primary Tumors|Completed||Phase 2|30|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:42:33.206822|2017-02-18 15:42:33.206822
NCT00459966|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2007-04-12|||February 2005||2005-02-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Preoperative Prevention and Early Rehabilitation for Patients Undergoing Elective Spine Surgery||Completed||N/A|60||Rigshospitalet, Denmark|||||f||||f||||||||||2017-02-18 15:42:33.671862|2017-02-18 15:42:33.671862
NCT00459953|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2016-05-22|2016-03-02||September 2006||2006-09-01|May 2016|2016-05-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|Nicoteens|Adolescent smokers were recruited from 10 continuation high schools in the San Francisco Bay Area over a period of 3 years. Recruitment was conducted on a nonrolling basis, with a new cohort participating each academic school year|Extended Cessation Treatment for Teen Smokers|Extended Cessation Treatment for Teen Smokers|Completed||Phase 2/Phase 3|141|Actual|Stanford University||2|||f||||t||||||||No||2017-02-18 15:42:33.758793|2017-02-18 15:42:33.758793
NCT00459940|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2007-04-12|||September 2004||2004-09-01|April 2007|2007-04-01|March 2006|Actual|2006-03-01|||||Interventional|||The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients|"Can Growth Hormone's Lipolytic and Insulin-Antagonistic Effects be Modified by Peroxisome Proliferator-Activated Gamma Agonists?"|Completed||N/A|20||University of Aarhus|||||f||||t||||||||||2017-02-18 15:42:34.174245|2017-02-18 15:42:34.174245
NCT00459927|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2014-03-18|||July 2009||2009-07-01|March 2014|2014-03-01||||||||Interventional|||Comparison of Floseal Hemostasis Tonsillectomy With Coblation Tonsillectomy and Cautery Hemostasis Tonsillectomy|Prospective, Controlled Clinical Trial of a Novel Hemostatic Sealant Versus Electrocautery Hemostasis and Coblation Dissection in Patients Undergoing Tonsillectomy|Withdrawn||Phase 2/Phase 3|0|Actual|Kaiser Permanente|||||f||||f||||||||||2017-02-18 15:42:34.26885|2017-02-18 15:42:34.26885
NCT00459914|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2009-01-27|||January 2005||2005-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment|Sleep Apnea in Patients With Refractory Hypertension: Study of the Prevalence and the Effect of CPAP Treatment on Blood Pressure Control, Endothelial Dysfunction and Angiogenesis.|Completed||Phase 2|130|Actual|Fundacio Catalana de Pneumologia||2|||f||||f||||||||||2017-02-18 15:42:34.370206|2017-02-18 15:42:34.370206
NCT00459901|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2015-04-28|||June 2004||2004-06-01|April 2015|2015-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer|Phase II Trial of OSI-774 (Erlotinib, Tarceva™,) and Capecitabine for Patients With Previously Untreated Metastatic Colorectal Cancer|Terminated||Phase 2|13|Actual|Beth Israel Medical Center||1||Study halted by drug manufacturer|f||||||||||||||2017-02-18 15:42:34.479014|2017-02-18 15:42:34.479014
NCT00459888|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2010-07-02|||May 2007||2007-05-01|July 2010|2010-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|CLIMB||Cryoplasty CLIMB-registry|CLIMB Prospective Multicenter Registry Evaluating the Use of the PolarCath Peripheral Dilatation System (Boston Scientific) in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia (Rutherford 4 and 5).|Completed||Phase 4|100|Anticipated|Flanders Medical Research Program||1|||f||||f||||||||||2017-02-18 15:42:34.590572|2017-02-18 15:42:34.590572
NCT00459875|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2015-10-26|2015-09-24||March 2007||2007-03-01|October 2015|2015-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer|Phase II Study of Sunitinib in Patients With Metastatic Papillary Renal Cell Carcinoma|Completed||Phase 2|24|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:42:34.686541|2017-02-18 15:42:34.686541
NCT00459862|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2015-01-28|2013-10-07||March 2007||2007-03-01|October 2013|2013-10-01|May 2013|Actual|2013-05-01|April 2009|Actual|2009-04-01||Interventional|||Pazopanib in Treating Patients With Malignant Pleural Mesothelioma|Phase II Study of GW786034 in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|34|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:42:34.957115|2017-02-18 15:42:34.957115
NCT00459849|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2008-05-06|||July 2000||2000-07-01|May 2008|2008-05-01|July 2007|Anticipated|2007-07-01|July 2007|Anticipated|2007-07-01||Interventional|||Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma|Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma|Unknown status|Active, not recruiting|N/A|175|Anticipated|Barnes Retina Institute||1|||f||||f||||||||||2017-02-18 15:42:35.441872|2017-02-18 15:42:35.441872
NCT00458224|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-07|2015-06-02|||February 2007||2007-02-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Prevention of Permanent Obesity in Children|Prevention of Permanent Obesity in Children|Completed||N/A|48|Actual|Sykehuset Innlandet HF||1|||f||||f||||||||||2017-02-18 15:43:07.787163|2017-02-18 15:43:07.787163
NCT00459836|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2011-02-28|||February 2007||2007-02-01|February 2011|2011-02-01||||October 2009|Actual|2009-10-01||Interventional|||PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors|A Phase Ib, Multi-Center, Open-Label, Dose Escalation Trial of Intravenous PR-104 Given in Combination With Docetaxel or Gemcitabine in Subjects With Solid Tumors|Completed||Phase 1|42|Actual|Proacta, Incorporated||1|||f||||||||||||||2017-02-18 15:42:35.54552|2017-02-18 15:42:35.54552
NCT00459823|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2009-03-23|||May 2007||2007-05-01|March 2009|2009-03-01||||June 2009|Anticipated|2009-06-01||Interventional|||A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours|A Phase I Open-Label, Single-Arm, Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours|Suspended||Phase 1|40|Anticipated|Eisai Inc.||1|||f||||||||||||||2017-02-18 15:42:35.646773|2017-02-18 15:42:35.646773
NCT00459810|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2012-03-28|2010-05-25||February 2007||2007-02-01|March 2012|2012-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer|A Phase II Study of Paclitaxel Poliglumex (PPX) in Combination With Transdermal Estradiol for the Treatment of Androgen Independent Prostate Cancer After Docetaxel Chemotherapy|Terminated||Phase 2|21|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 15:42:35.74139|2017-02-18 15:42:35.74139
NCT00459797|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2009-04-20|||April 2007||2007-04-01|April 2009|2009-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Conventional GlideScope to Single-Use GlideScope Cobalt for Orotracheal Intubation|Comparison of Conventional GlideScope to Single-Use GlideScope Cobalt for Orotracheal Intubation|Completed||N/A|100|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 15:42:36.044782|2017-02-18 15:42:36.044782
NCT00459784|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-12|2007-04-12|||November 2006||2006-11-01|April 2007|2007-04-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Implementation Study of Dementia Guidelines in Primary Care|How to Reach Evidence Based Practice in Diagnostic Assessment and Management of Dementia by General Practitioners and Primary Care Nurses? The Effectiveness of an EASYcare Based Educational Program.|Unknown status|Recruiting|N/A|200||Radboud University|||||f||||f||||||||||2017-02-18 15:42:36.145477|2017-02-18 15:42:36.145477
NCT00459771|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2014-12-01|||June 2007||2007-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity|Prospective, Randomized, Pharmacological Intervention Study; Evaluating Effect of the Angiotensin II-receptor (AT1) Blocker Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity in Patients Treated With Trastuzumab|Completed||Phase 3|210|Actual|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-02-18 15:42:36.240565|2017-02-18 15:42:36.240565
NCT00459758|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2007-07-31|||January 2007||2007-01-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Effect of Electrical Stimulation at Acupoints on Blood Pressure|Pilot Study Using Electrical Stimulation on Hypertension|Completed||Phase 1|40|Anticipated|Logan College of Chiropractic|||||f||||t||||||||||2017-02-18 15:42:36.369888|2017-02-18 15:42:36.369888
NCT00459745|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2009-07-02|||April 2007||2007-04-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia|A Multi-Center, Prospective, Longitudinal, Randomized, Double-Blind, Phase III Study to Evaluate the Efficacy and Safety of Daily Administration of Pravastatin 40 mg or Fenofibrate 160 mg or Pravafen (the Combination of Pravastatin and Fenofibrate 40/160 mg) for 12 Weeks Followed by a 52-Week Open-Label Safety Phase of the Pravafen Alone in the Treatment of Combined Hyperlipidemia.|Completed||Phase 3|481|Actual|Shionogi Inc.||3|||||||||||||||||2017-02-18 15:42:36.457391|2017-02-18 15:42:36.457391
NCT00459732|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2011-10-04|2010-11-04||April 2006||2006-04-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|October 2009|Actual|2009-10-01||Interventional|ThinkZn||Zinc & Bone Health in Thalassemia: The Think Zinc Study|Zinc and Bone Metabolism in Thalassemia|Completed||Phase 2|45|Actual|Children's Hospital & Research Center Oakland||2|||f||||t||||||||||2017-02-18 15:42:39.25961|2017-02-18 15:42:39.25961
NCT00459719|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2016-02-23|||March 2007||2007-03-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation|A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Combination With Steroids in Patients Undergoing Liver Transplantation and a Pharmacokinetics Study.|Completed||Phase 3|42|Actual|Astellas Pharma Inc||2|||f||||f||||||||Undecided||2017-02-18 15:42:39.747936|2017-02-18 15:42:39.747936
NCT00459706|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2013-02-20|2011-09-07||September 2007||2007-09-01|February 2013|2013-02-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept|A 3-Month, Randomised, Open-Label, Parallel-Group, Descriptive Study To Explore And Compare Perceptions and Satisfaction For Two Different Delivery Mechanisms For Etanercept (Etanercept Autoinjector And The Etanercept Prefilled Syringe) In Patients With Rheumatoid Arthritis|Completed||Phase 3|640|Actual|Pfizer||2|||f||||||||||||||2017-02-18 15:42:39.903264|2017-02-18 15:42:39.903264
NCT00459693|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2017-01-24|||April 9, 2007||2007-04-09|August 28, 2014|2014-08-28|April 6, 2014|Actual|2014-04-06|April 6, 2014|Actual|2014-04-06||Interventional|||PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)|PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients With (MCMD)|Terminated||N/A|40|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:42:42.778544|2017-02-18 15:42:42.778544
NCT00459680|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2010-01-20|||February 2008||2008-02-01|October 2008|2008-10-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Acupuncture and Laser Acupoint Treatment on Hypertension|Acupuncture and Laser Acupoint Treatment on Hypertension|Unknown status|Recruiting|Phase 1|30|Anticipated|Logan College of Chiropractic||2|||f||||f||||||||||2017-02-18 15:42:42.875268|2017-02-18 15:42:42.875268
NCT00459667|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2015-04-03|2009-03-16||May 2007||2007-05-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Beyond||BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose|International, Multicenter, Phase IIIb Study of Subcutaneous Every-other-day Treatment of Patients With Relapsing Multiple Sclerosis With (Phase A): Double-blind Betaseron/Betaferon 250µg or 500µg or Open-label Betaseron/Betaferon 250µg and (Phase B): Open-label Betaseron/Betaferon 500µg|Completed||Phase 3|1420|Actual|Bayer|Due to the termination of the study before start of Phase B according to protocol defined stopping rules, functional assessments of multiple sclerosis (FAMS) and EuroQoL (EQ-5D) were not performed.|3|||f||||f||||||||||2017-02-18 15:42:42.994659|2017-02-18 15:42:42.994659
NCT00459654|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2014-06-24|||February 2004||2004-02-01|June 2014|2014-06-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer|A Phase II Randomised, Placebo-controlled, Multicentre Study in Prostate Cancer Patients With Painful Bone Metastases to Evaluate the Efficacy of Repeated Radium-223 Injections|Completed||Phase 2|64|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:42:44.295441|2017-02-18 15:42:44.295441
NCT00459641|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2012-07-16|||December 2012||2012-12-01|July 2012|2012-07-01|July 2019|Anticipated|2019-07-01|June 2014|Anticipated|2014-06-01||Interventional|||Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts|A Phase 2 Randomised, Open-label, Multi-centre Ascending Dose Study of the Efficacy, Safety and Tolerability of I-040302 Versus Control Injection (Bone Marrow Aspirate or Steroids) in Children and Young Adults With Solitary Bone Cysts|Withdrawn||Phase 2|0|Actual|Kuros Biosurgery AG||2||"Stopped before any site initiation or any recruitment due to change in overall product~   development plan"|f||||t||||||||||2017-02-18 15:42:44.406808|2017-02-18 15:42:44.406808
NCT00459628|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2014-09-08|||May 2007||2007-05-01|September 2014|2014-09-01|December 2016|Anticipated|2016-12-01|August 2011|Actual|2011-08-01||Interventional|TomoBreast||Trial of Tomotherapy in Breast Cancer|Randomized Trial Comparing Conventional vs Short-course Reduced Volume Conformal Post-surgery Radiation Treatment in Women With Stage I or II Breast Cancer|Unknown status|Active, not recruiting|Phase 3|118|Anticipated|Vrije Universiteit Brussel||2|||f||||t||||||||||2017-02-18 15:42:44.498187|2017-02-18 15:42:44.498187
NCT00459615|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2008-09-23|||April 2007||2007-04-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Phase II Dose Ranging Study of Artesunate|A Phase II, Randomized, Open-Label, Dose-Ranging Study of Intravenous Artesunate Therapy for the Treatment of Acute, Uncomplicated Plasmodium Falciparum Malaria.|Completed||Phase 2|120|Anticipated|Walter Reed Army Institute of Research (WRAIR)|||||||||||||||||||2017-02-18 15:42:44.60545|2017-02-18 15:42:44.60545
NCT00459602|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2015-03-25|||August 2004||2004-08-01|March 2015|2015-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Incisional Hernia Outcomes Study Using Parietex Composite Mesh|A Multi-Center, Laparoscopic Abdominal-Wall Hernia Repair Outcomes Study Using Parietex Composite Mesh|Terminated||Phase 4|22|Actual|Columbia University|||1|Principal Investigator left institution.|f||||f||||||||||2017-02-18 15:42:44.697903|2017-02-18 15:42:44.697903
NCT00459589|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2012-06-19|||April 2007||2007-04-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|INOGAD||Nutritional Intervention in Geriatric Oncology|Nutritional Intervention in Geriatric Oncology in Patients at Risk of Undernutrition|Completed||N/A|341|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 15:42:44.795778|2017-02-18 15:42:44.795778
NCT00459576|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2013-04-16|||May 2005||2005-05-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Observational|||Risk of Asthma in Infants With Atopic Dermatitis|Risk of Asthma in Infants With Atopic Dermatitis|Completed||N/A|120|Actual|Indiana University|||1||f||||t||||||Samples With DNA|"~     We have retained nasal cell samples, whole blood cells, and serum.~   "|||2017-02-18 15:42:44.921628|2017-02-18 15:42:44.921628
NCT00459563|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2014-01-07|||March 2007||2007-03-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Vitamin D and Blood Pressure|A Randomized Placebo-controlled Double Blinded Trial to Evaluate Cholecalciferol (Vitamin D3) and Calcitriol Treatment on Reducing Blood Pressure in Middle Aged Adults With Stage I Hypertension and Vitamin D Deficiency|Withdrawn||N/A|0|Actual|Atlanta VA Medical Center||3||Inadequate enrollment|f||||f||||||||||2017-02-18 15:42:45.01135|2017-02-18 15:42:45.01135
NCT00459550|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2017-01-27|||March 2007||2007-03-01|January 2017|2017-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease|A Randomised, Single-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Intravenous Infusion of GSK933776 in Patients With Alzheimer's Disease.|Completed||Phase 1|50|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:42:45.147112|2017-02-18 15:42:45.147112
NCT00459537|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2011-05-03|2011-01-19||March 2007||2007-03-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis|A Randomized, Open-label, Active-controlled, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride (HCl) Formulation Versus 5% Amorolfine Nail Lacquer for 48 Weeks of Treatment in Patients With Mild to Moderate Toenail Onychomycosis|Completed||Phase 3|1029|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:42:45.262955|2017-02-18 15:42:45.262955
NCT00459524|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2012-07-31|||April 2004||2004-04-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)|Longitudinal Assessment of Neurocognitive Function and Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Treatment|Completed||N/A|104|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:42:45.999495|2017-02-18 15:42:45.999495
NCT00459511|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2007-04-11|||January 2006||2006-01-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Observational|AM||The Importance of Adrenomedullin (AM) on ACTH-Cortisol-Glucose Axis|The Importance of Adrenomedullin (AM) on Pituitary-Adrenal Axis and Glucose Kinetics in Pediatric Patients With Systemic Inflammatory Response Syndrome|Completed||Phase 2|20||University of Sao Paulo|||||f||||t||||||||||2017-02-18 15:42:46.127497|2017-02-18 15:42:46.127497
NCT00459498|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2007-04-10|||April 2002||2002-04-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Observational|||Expression of NIS Protein and mRNA in Thyroid Tumors|Significant Intracellular NIS Protein Associated With Low Levels of NIS Messenger RNA in Malignant Thyroid Tumors|Completed||N/A|30||University of Sao Paulo|||||f||||f||||||||||2017-02-18 15:42:46.224723|2017-02-18 15:42:46.224723
NCT00459485|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2010-02-18|||April 2007||2007-04-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Initiation and Discontinuation of Short Term Zinc Supplementation on Plasma Zinc Concentration|Effects of Initiation and Discontinuation of Short Term Zinc Supplementation on the Magnitude and Velocity of Change in Plasma Zinc Concentration|Completed||Phase 4|58|Actual|University of California, Davis||3|||f||||f||||||||||2017-02-18 15:42:46.305282|2017-02-18 15:42:46.305282
NCT00459472|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2015-04-03|||January 2006||2006-01-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Operating Room Outcomes After Resident Training on a Virtual Reality Simulator|Operating Room Outcomes After Resident Training on a Virtual Reality Simulator|Terminated||N/A|100|Actual|Columbia University||1||Principal investigator left institution.|f||||f||||||||||2017-02-18 15:42:46.412699|2017-02-18 15:42:46.412699
NCT00459459|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2007-04-11|||January 2006||2006-01-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Observational|||Prognostic Significance of Fine-Needle Aspiration Cytology Features in Papillary Thyroid Carcinoma||Completed||N/A|100||National Taiwan University Hospital|||||f||||t||||||||||2017-02-18 15:42:46.52009|2017-02-18 15:42:46.52009
NCT00459446|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2017-01-24|||April 5, 2007||2007-04-05|November 25, 2008|2008-11-25||||November 25, 2008|Actual|2008-11-25||Interventional|||Imaging of Totally Blocked Arteries|Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:42:46.602381|2017-02-18 15:42:46.602381
NCT00459433|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2009-05-28|||October 2006||2006-10-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Right Intervention for the Right Patient|The Right Intervention for the Right Patient|Completed||N/A|300|Anticipated|The Back Research Center, Denmark||2|||f||||f||||||||||2017-02-18 15:42:46.693013|2017-02-18 15:42:46.693013
NCT00459420|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-11|2015-04-15|||April 2007||2007-04-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Caffeine for Excessive Daytime Somnolence in Parkinson's Disease|Caffeine for Excessive Daytime Somnolence in Parkinson's Disease|Completed||Phase 2/Phase 3|58|Actual|McGill University Health Center||2|||f||||t||||||||||2017-02-18 15:42:46.798915|2017-02-18 15:42:46.798915
NCT00459407|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2014-10-07|||March 2007||2007-03-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate|Phase Ib Study of Polyphenon E in a Pre-prostatectomy Prostate Cancer Cohort|Completed||Phase 1|50|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:42:46.913051|2017-02-18 15:42:46.913051
NCT00459381|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2013-02-01|||May 2007||2007-05-01|January 2013|2013-01-01||||December 2008|Actual|2008-12-01||Interventional|||Pazopanib in Treating Patients With Recurrent Glioblastoma|A Phase II Trial of GW786034 (Pazopanib) in Patients With Recurrent Glioblastoma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:42:47.031957|2017-02-18 15:42:47.031957
NCT00459368|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2010-08-10|2010-06-17||May 2007||2007-05-01|June 2010|2010-06-01|November 2009|Actual|2009-11-01|August 2008|Actual|2008-08-01||Interventional|AFFIRM||Using Information Technology to Improve Asthma Adherence|Adherence Feedback for Improving Respiratory Medication Use|Completed||N/A|2698|Actual|Henry Ford Health System||2|||f||||f||||||||||2017-02-18 15:42:47.14124|2017-02-18 15:42:47.14124
NCT00459355|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2015-04-06|2014-08-21||July 2007||2007-07-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|May 2010|Actual|2010-05-01||Interventional||Sample size calculations indicated that 216 total participants was sufficient for all calculations|Home Safety Clinical Trial for Alzheimer's Disease|Clinical Trial of a Home Safety Intervention for Alzheimer's Disease|Completed||Phase 1|254|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:42:47.540979|2017-02-18 15:42:47.540979
NCT00459342|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2014-04-29|2013-11-01||March 2007||2007-03-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|Phase II Study of Dasatinib in Non Small Cell Lung Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:42:48.055978|2017-02-18 15:42:48.055978
NCT00459329|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2008-06-02|||March 2007||2007-03-01|June 2008|2008-06-01|March 2009|Anticipated|2009-03-01|March 2009|Anticipated|2009-03-01||Interventional|PEARL||PEARL Intervention to Reduce Depression Among Adults With Epilepsy|PEARL Intervention to Reduce Depression Among Adults With Epilepsy|Unknown status|Active, not recruiting|N/A|80|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 15:42:48.453366|2017-02-18 15:42:48.453366
NCT00459316|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2016-01-12|2014-03-03||June 2007||2007-06-01|January 2016|2016-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||All participants who started study treatment.|Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth|Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth|Completed||Phase 1/Phase 2|384|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 15:42:48.561168|2017-02-18 15:42:48.561168
NCT00459303|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2013-12-29|2009-10-05||October 2005||2005-10-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of Functional Vision Provided by AMO Tecnis Z9000 and Alcon SA60AT Acrysof|Intraidivisual Comparison of Functional Vision Provided by AMO Tecnis Z9000 and ALcon SA60AT Acrysof Posterior Chamber Intraocular Lenses|Completed||Phase 4|20|Actual|National Taiwan University Hospital|small sample size|1|||f||||t||||||||||2017-02-18 15:42:50.605788|2017-02-18 15:42:50.605788
NCT00459290|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2014-06-16|2014-01-31||May 2007||2007-05-01|June 2014|2014-06-01||||July 2010|Actual|2010-07-01||Interventional||Eligible and treated participants|Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase II Evaluation of Mifepristone in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|24|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 15:42:50.916578|2017-02-18 15:42:50.916578
NCT00459277|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2012-01-20||2010-01-20|December 2006||2006-12-01|January 2010|2010-01-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids|A Multicenter, Placebo-Controlled, Double-Blind, Two-Phase Crossover Study of Nasalfent (Fentanyl Citrate Nasal Spray) in the Treatment of Breakthrough Cancer Pain (BTCP) in Subjects Taking Regular Opioid Therapy|Completed||Phase 3|73|Actual|Archimedes Development Ltd||2|||f||||f||||||||||2017-02-18 15:42:51.345599|2017-02-18 15:42:51.345599
NCT00459264|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2016-11-21|||December 2005||2005-12-01|November 2016|2016-11-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|PRE-EMPT||Prevention of Mood Disorders by Folic Acid Supplementation|Prevention of Mood Disorders by Folic Acid Supplementation|Completed||N/A|112|Actual|University of Oxford||2|||f||||t||||||||||2017-02-18 15:42:51.450376|2017-02-18 15:42:51.450376
NCT00459238|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-09-22|||October 2006||2006-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants|A Telephone-Based Education and Prevention Intervention for Teens and Young Adults|Active, not recruiting||N/A|300|Anticipated|Georgetown University||1|||f||||f||||||||||2017-02-18 15:42:51.642092|2017-02-18 15:42:51.642092
NCT00459225|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2014-12-08|||April 2007||2007-04-01|December 2014|2014-12-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease|Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease: An Open Label Trial|Withdrawn||N/A|0|Actual|Emory University||2||Difficulty recruiting subjects|f||||f||||||||||2017-02-18 15:42:51.741011|2017-02-18 15:42:51.741011
NCT00459212|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2015-12-03|||March 2007||2007-03-01|April 2013|2013-04-01||||December 2010|Actual|2010-12-01||Interventional|||GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia|Phase I and Pharmacodynamic Study of GTI-2040 (NSC 722929, IND 67368) in Acute Leukemias|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:42:51.853573|2017-02-18 15:42:51.853573
NCT00459186|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2016-04-13|2013-12-13||November 2005||2005-11-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Number of baseline participants represents the number who received at least one dose of investigational agent (did not withdraw before treatment).|The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer|A Phase I/II Study of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer|Completed||Phase 1/Phase 2|19|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-02-18 15:42:51.981866|2017-02-18 15:42:51.981866
NCT00459173|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2009-04-06|||November 2002||2002-11-01|April 2009|2009-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|STRATUS-WW||Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation|Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Maintenance of Smoking Cessation (1-Year Treatment, 1-Year Follow-up)|Completed||Phase 3|4850|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:42:52.256862|2017-02-18 15:42:52.256862
NCT00459160|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2010-11-30|||July 2007||2007-07-01|November 2010|2010-11-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||A Comparison of Two Target Mean Arterial Pressures in the Resuscitation of Hypotensive Trauma Patients|A Comparison of Two Target Mean Arterial Pressures in the Resuscitation of Hypotensive Trauma Patients Undergoing Laparotomy or Thoracotomy for Trauma: A Prospective Randomized Controlled Clinical Trial|Unknown status|Recruiting|N/A|271|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 15:42:52.346291|2017-02-18 15:42:52.346291
NCT00459134|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-12-20|2015-01-12||May 2007||2007-05-01|July 2015|2015-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||All randomized participants|L-Arginine Supplements in Treating Women Who Are Cancer Survivors|A Randomized Study to Determine Whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors|Completed||N/A|186|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||Undecided||2017-02-18 15:42:52.464839|2017-02-18 15:42:52.464839
NCT00459121|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2013-04-03|2012-11-12||July 2007||2007-07-01|February 2013|2013-02-01|October 2008|Actual|2008-10-01|January 2008|Actual|2008-01-01||Interventional|||Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery|Assessment of Feasibility and Safety of the Addition of ZD6474 (Zactima) to Carboplatin and Paclitaxel Administered Neo-Adjuvantly in Stage IB, II and T3, N1 Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|2|Actual|Barbara Ann Karmanos Cancer Institute|This was a single center study. We did not accrue enough particpants in a timely fashion and a joint decision was made with AstraZeneca to terminate the study.|1|||f||||t||||||||||2017-02-18 15:42:53.345998|2017-02-18 15:42:53.345998
NCT00459108|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2015-03-19|2014-06-19||April 2007||2007-04-01|June 2014|2014-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery|A Phase II Trial of Dasatinib (BMS-354825) in Advanced Hepatocellular Carcinoma|Terminated||Phase 2|25|Actual|National Cancer Institute (NCI)|Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results.|1||Halted early for futility.|f||||||||||||||2017-02-18 15:42:53.596199|2017-02-18 15:42:53.596199
NCT00459082|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2007-04-10|||May 2004||2004-05-01|April 2007|2007-04-01|November 2006||2006-11-01|||||Interventional|||A Pharmacokinetic Study of Dexmedetomine in Infants|A Pharmacokinetic Study of Dexmedetomine in Infants|Completed||Phase 1|36||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:42:53.932726|2017-02-18 15:42:53.932726
NCT00459069|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2010-01-11|||July 2004||2004-07-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|June 2008|Actual|2008-06-01||Interventional|||The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma|The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma|Completed||Phase 1|18|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:42:54.022398|2017-02-18 15:42:54.022398
NCT00459056|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2013-11-13|2012-04-23||April 2007||2007-04-01|November 2013|2013-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients|The Vascular Effects of Carvedilol Controlle Release (CR) + Lisinopril Versus Lisinopril + Hydrochlorothiazide (HCTZ) in Abdominally Obese Hypertensive Patients|Completed||Phase 3|25|Actual|St. Paul Heart Clinic|crossover study design|2|||f||||f||||||||||2017-02-18 15:42:54.122673|2017-02-18 15:42:54.122673
NCT00459043|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2013-07-01|2013-02-28||March 2007||2007-03-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|March 2010|Actual|2010-03-01||Interventional||One patient withdrew consent after being randomized to docetaxel alone arm and did not receive any treatment, therefore, 29 patients were analyzable.|Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck|Randomized Phase II Study of Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 15:42:54.493535|2017-02-18 15:42:54.493535
NCT00345709|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2015-10-05|||September 2003||2003-09-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Elizabeth Registry for Low Grade Ovarian Cancer|The Elizabeth Registry for Low Grade Ovarian Cancer|Completed||N/A|60|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 16:25:42.597376|2017-02-18 16:25:42.597376
NCT00459030|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2013-08-16|||October 2005||2005-10-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Traditional Print Communication Methods, Simple Electronic Communication Methods, or Usual Care in Increasing How Often Older Women Undergo Colorectal Cancer Screening|Two Delivery Channels to Improve CRC Screening|Completed||N/A|904|Actual|Fox Chase Cancer Center||3|||f||||f||||||||||2017-02-18 15:42:55.170165|2017-02-18 15:42:55.170165
NCT00459017|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2007-04-10|||December 2002||2002-12-01|April 2007|2007-04-01|June 2005|Actual|2005-06-01|||||Interventional|||The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension|The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension|Completed||Phase 3|150||Sheba Medical Center|||||f||||f||||||||||2017-02-18 15:42:55.279285|2017-02-18 15:42:55.279285
NCT00459004|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2009-04-06|||October 2004||2004-10-01|April 2009|2009-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Japanese Dose-Response Study of Rimonabant in Obese Patients|A Dose-Response Relationship Study of SR141716 in Obese Patients|Completed||Phase 2|527|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:42:55.368031|2017-02-18 15:42:55.368031
NCT00458991|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2011-08-04|||June 2001||2001-06-01|April 2007|2007-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||rhGH Therapy on Hepatic Drug Metabolism|Recombinant Human Growth Hormone Therapy and Drug Metabolism|Completed||N/A|9|Actual|University of Louisville|||1||f||||f||||||||||2017-02-18 15:42:55.455503|2017-02-18 15:42:55.455503
NCT00458978|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2015-04-14||2013-09-04|February 2007||2007-02-01|April 2014|2014-04-01|July 2014|Actual|2014-07-01|May 2013|Actual|2013-05-01||Interventional|||Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer|Phase II Clinical Trial of AZD2171 Monotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Patients|Completed||Phase 2|6|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:42:55.566968|2017-02-18 15:42:55.566968
NCT00458952|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-06-13|2015-12-15||April 2007||2007-04-01|June 2016|2016-06-01|June 2011|Actual|2011-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma|A Phase I Study Evaluating the Maximum Tolerated Dose, Dosimetry, Safety, and Efficacy of Ultratrace Iobenguane I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma|Completed||Phase 1/Phase 2|24|Actual|Molecular Insight Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:42:55.693061|2017-02-18 15:42:55.693061
NCT00458926|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2012-05-30|||November 2003||2003-11-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|||||Observational|||Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care|Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care|Unknown status|Active, not recruiting|N/A|800|Anticipated|Tufts Medical Center|||1||f||||f||||||||||2017-02-18 15:42:56.120357|2017-02-18 15:42:56.120357
NCT00458913|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2013-04-19|||February 2007||2007-02-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|April 2010|Actual|2010-04-01||Interventional|||Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma|Phase II Study of Bortezomib (VELCADE) With Cisplatin as First Line Treatment of Malignant Mesothelioma|Completed||Phase 2|82|Actual|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||||||||||||2017-02-18 15:42:56.220309|2017-02-18 15:42:56.220309
NCT00458900|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2012-12-07|||July 2007||2007-07-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients|Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients|Completed||Phase 2|4|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 15:42:56.330721|2017-02-18 15:42:56.330721
NCT00458887|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-04-27|||May 2007||2007-05-01|April 2016|2016-04-01||||January 2015|Actual|2015-01-01||Observational|||Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin|A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy|Completed||N/A|301|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-02-18 15:42:56.449114|2017-02-18 15:42:56.449114
NCT00458874|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-05-17|||November 2007||2007-11-01|May 2016|2016-05-01|April 2011|Actual|2011-04-01|July 2010|Actual|2010-07-01||Interventional|BATTLE||Better Adherence to Therapeutic Lifestyle Change Efforts Trial|Better Adherence to Therapeutic Lifestyle Change Efforts (BATTLE) Trial|Completed||N/A|166|Actual|Walter Reed National Military Medical Center||2|||f||||f||||||||No||2017-02-18 15:42:56.664552|2017-02-18 15:42:56.664552
NCT00458861|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2015-12-17||2015-12-17|March 2007||2007-03-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis|A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, PK, and PD of BG9924 When Given in Combo With MTX to Subjects With Active RA Who Have Had an Inadequate Response to Anti-TNF|Terminated||Phase 2|115|Actual|Biogen||2||Interim analysis of data failed to meet primary endpoint.|f||||t||||||||||2017-02-18 15:42:56.780182|2017-02-18 15:42:56.780182
NCT00458848|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2015-05-26|||October 2004||2004-10-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|LAL0904||Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia|Phase II Study of Adult Acute Lymphoblastic Leukaemia (ALL): Imatinib in Combination With Chemotherapy in Ph+ Patients, and Post-remissional Treatment Intensification in High-risk Ph- Patients, With Minimal Residual Disease Monitoring.|Completed||Phase 2|470|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||f||||||||||2017-02-18 15:42:56.889371|2017-02-18 15:42:56.889371
NCT00458835|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2016-12-01|||April 2007||2007-04-01|September 2016|2016-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)|A Randomized, Open-label, Single-dose, 3-period Crossover, Pharmacokinetic Study Designed to Compare the Systemic Des-ciclesonide Exposure of OMNARIS™ (Ciclesonide) Nasal Spray, Ciclesonide HFA Nasal Aerosol, and Orally Inhaled Ciclesonide|Completed||Phase 4|30|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 15:42:57.100759|2017-02-18 15:42:57.100759
NCT00458822|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-06-29|2016-01-04||February 2007||2007-02-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis|Risk-Adapted Intravenous Melphalan With Stem Cell Transplant and Adjuvant Bortezomib and Dexamethasone for Recently Diagnosed Untreated Patients With Systemic Light-Chain (AL) Amyloidosis|Completed||Phase 2|40|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:42:57.196487|2017-02-18 15:42:57.196487
NCT00458809|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2012-04-26|||March 2007||2007-03-01|April 2012|2012-04-01||||November 2007|Actual|2007-11-01||Interventional|||Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer|A Phase I Evaluation of Intraperitoneal Hyperthermic Chemoperfusion With Oxaliplatin for Peritoneal Surface Disemmination of Appendiceal and Colorectal Cancer|Completed||Phase 1|16|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 15:42:57.452888|2017-02-18 15:42:57.452888
NCT00458796|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2013-08-23|||March 2006||2006-03-01|November 2007|2007-11-01||||||||Interventional|||Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone|Cost-Effective Use of Bisphosphonates in Metastatic Bone Disease - A Comparison of Bone Marker Directed Zoledronic Acid Therapy to a Standard Schedule|Unknown status|Recruiting|N/A|1500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:42:57.573405|2017-02-18 15:42:57.573405
NCT00458783|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2017-01-19|||April 2007||2007-04-01|January 2017|2017-01-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Red Cell Storage Duration and Outcomes in Cardiac Surgery|Red Cell Storage Duration and Outcomes in Cardiac Surgery|Recruiting||N/A|2800|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No||2017-02-18 15:42:57.700708|2017-02-18 15:42:57.700708
NCT00458770|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2014-02-24|||May 2009||2009-05-01|February 2014|2014-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks|Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks|Terminated||N/A|1|Actual|Assistance Publique Hopitaux De Marseille||1|||f||||f||||||||||2017-02-18 15:42:57.805085|2017-02-18 15:42:57.805085
NCT00458757|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2008-05-12|||November 2007||2007-11-01|March 2007|2007-03-01||||||||Observational|||The Effect of Amputation on Spatial Visual Representation in Peripersonal Space|The Effect of Upper Arm Amputation and the Use of Prosthetics on Spatial Visual Representation in Peripersonal Space - a Behavioural Study|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:42:57.88635|2017-02-18 15:42:57.88635
NCT00458744|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2014-08-07|||February 2007||2007-02-01|August 2014|2014-08-01||||July 2008|Anticipated|2008-07-01||Interventional|||Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment|A Phase I Study Of Talotrexin (PT-523) In Children And Adolescents With Recurrent Solid Tumors Or Recurrent/Refractory Leukemias|Withdrawn||Phase 1|0|Actual|Children's Oncology Group||||Study withdrawn because of toxicity reported on the adult phase 1 trial.|||||f||||||||||2017-02-18 15:42:58.036147|2017-02-18 15:42:58.036147
NCT00458731|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2014-02-14|||May 2007||2007-05-01|December 2013|2013-12-01||||December 2013|Actual|2013-12-01||Interventional|||Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma|Phase I Clinical Trial Evaluating the Toxicity, Pharmacokinetics and Biological Effect of Intravenous Bevacizumab (Avastin TM) in Combination With Escalating Doses of Oral AZD2171 for Patients With Advanced Malignancies|Completed||Phase 1|57|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:42:58.137423|2017-02-18 15:42:58.137423
NCT00458718|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2009-04-17|||September 2004||2004-09-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|CIRRUS||Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch|Single Country, Double-Blind, Randomized, 2-Arm, Parallel-Group Study, Evaluating Efficacy and Safety of Rimonabant 20 mg OD, With/Without Association of Nicotine Patch, as Aid to Smoking Cessation During 9-Week Period|Completed||Phase 3|755|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:42:58.261516|2017-02-18 15:42:58.261516
NCT00458705|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2015-12-16|2015-12-16||November 2006||2006-11-01|December 2015|2015-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma|Bortezomib + Pegylated Liposomal Doxorubicin (Doxil) + Dexamethasone Followed by Thalidomide + Dexamethasone or Bortezomib + Thalidomide + Dexamethasone for Patients With Symptomatic Untreated High-Risk or Primary Resistant Multiple Myeloma|Completed||Phase 2|45|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:42:58.354742|2017-02-18 15:42:58.354742
NCT00458679|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2014-01-30|||December 2006||2006-12-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|October 2008|Actual|2008-10-01||Interventional|PRIMAL||Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells|Prolonged Immunization With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells for Treatment of B-Chronic Lymphocytic Leukemia (B-CLL)|Completed||Phase 1|6|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 15:42:58.642586|2017-02-18 15:42:58.642586
NCT00458666|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2007-04-10|||June 2006||2006-06-01|March 2007|2007-03-01||||||||Observational|||Coagulation Parameters During Pregnancy in Amniotic Fluid|Coagulation Parameters During Pregnancy in Amniotic Fluid|Unknown status|Recruiting|N/A|170||Rambam Health Care Campus|||||f||||t||||||||||2017-02-18 15:42:58.747511|2017-02-18 15:42:58.747511
NCT00458653|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2016-12-06|||April 2005||2005-04-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|April 2012|Actual|2012-04-01||Interventional|||Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma|Vaccination With Dendritic Cell/Tumor Fusions in Conjunction With Autologous Stem Cell Transplant in Patients With Multiple Myeloma|Active, not recruiting||Phase 1|45|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 15:42:58.817511|2017-02-18 15:42:58.817511
NCT00458627|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2007-04-10|||February 2006||2006-02-01|April 2007|2007-04-01|September 2006||2006-09-01|||||Observational|||Body Plethysmograph Measurements Before and After Methacholine Challenge in Early Childhood|Body Plethysmograph Measurements Before and After Methacholine Challenge in Early Childhood|Completed||N/A|50||Rambam Health Care Campus|||||f||||t||||||||||2017-02-18 15:42:58.927089|2017-02-18 15:42:58.927089
NCT00458614|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2011-01-10|||June 2006||2006-06-01|January 2011|2011-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis|Lansoprazole Disposition in Young Children With Cystic Fibrosis|Completed||Phase 1|18||Arkansas Children's Hospital Research Institute|||||f||||||||||||||2017-02-18 15:43:01.624481|2017-02-18 15:43:01.624481
NCT00458601|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2016-08-09||2010-06-24|August 2007||2007-08-01|August 2016|2016-08-01|May 2016|Actual|2016-05-01|November 2010|Actual|2010-11-01||Interventional|ACT III||Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme|A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|82|Actual|Celldex Therapeutics||1|||f||||f||||||||||2017-02-18 15:43:01.75887|2017-02-18 15:43:01.75887
NCT00458588|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-03-01|||September 2005||2005-09-01|March 2016|2016-03-01||||October 2013|Actual|2013-10-01||Observational|||Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children|Adolescent Diet, Hormones and Breast Cancer Susceptibility|Active, not recruiting||N/A|301|Anticipated|Fox Chase Cancer Center|||1||f||||||||||||||2017-02-18 15:43:01.909596|2017-02-18 15:43:01.909596
NCT00458575|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2014-06-25|||April 2007||2007-04-01|June 2014|2014-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa|A Phase I Open Label Non-comparative Study Evaluating the Safety of a Single, Unilateral, Subretinal Administration of CNTO 2476 in Advanced Retinitis Pigmentosa|Terminated||Phase 1|7|Actual|Centocor, Inc.||1||Internal Business Decision|f||||t||||||||||2017-02-18 15:43:02.03084|2017-02-18 15:43:02.03084
NCT00458562|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2013-11-15|||January 2006||2006-01-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer|HIV-Associated DNA Hypermethylation in Cervical Cancer|Completed||N/A|1680|Actual|University of Washington|||3||f||||f||||||Samples With DNA|"~     Cervical brush in PreservCyt, cervical swab in STM, cervical swab in Roche media, whole~     blood, void urine, cervical tissue biopsy.~   "|||2017-02-18 15:43:02.135499|2017-02-18 15:43:02.135499
NCT00458549|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2009-02-06|||July 2006||2006-07-01|July 2008|2008-07-01||||||||Interventional|||Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery|Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids|Unknown status|Recruiting|N/A|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:43:02.244605|2017-02-18 15:43:02.244605
NCT00458536|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2016-09-22|2016-01-20||October 2004||2004-10-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF|Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF|Active, not recruiting||Phase 1/Phase 2|38|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:43:02.341062|2017-02-18 15:43:02.341062
NCT00458523|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2013-08-09|||December 2006||2006-12-01|April 2007|2007-04-01|February 2008|Actual|2008-02-01|||||Interventional|||Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission|Eradication of Minimal Residual Disease (MRD) in Patients With Chronic Lymphocytic Leukaemia (CLL) With Alemtuzumab: A Phase II Study|Completed||Phase 2|54|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:43:02.786971|2017-02-18 15:43:02.786971
NCT00458510|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-10|2013-07-10|||January 2007||2007-01-01|July 2013|2013-07-01|July 2012|Actual|2012-07-01|October 2011|Actual|2011-10-01||Interventional|||Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain|An Open-Label Study Investigating Long-Term Safety and Tolerability of Fentanyl Citrate Nasal Spray in the Treatment of BTCP in Subjects Taking Regular Opioid Therapy|Completed||Phase 3|403|Actual|Archimedes Development Ltd||1|||f||||f||||||||||2017-02-18 15:43:02.892272|2017-02-18 15:43:02.892272
NCT00458497|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2010-06-02|||April 2007||2007-04-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Holofiber Socks and Bedding on Pain and Quality of Sleep in Subjects With Chronic Foot Pain|Effect of Holofiber Socks and Bedding on Pain and Quality of Sleep in Subjects With Chronic Foot Pain|Terminated||N/A|60|Actual|Southern California Institute for Research and Education||2||Low enrollment|f||||f||||||||||2017-02-18 15:43:02.998193|2017-02-18 15:43:02.998193
NCT00458484|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-09-28|||February 2007||2007-02-01|September 2016|2016-09-01||||April 2017|Anticipated|2017-04-01||Interventional|||Radiosurgery in Treating Patients With Kidney Tumors|Evaluation of a Radio-Surgical Approach for the Treatment of Kidney Tumors in Poor Surgical Candidates|Recruiting||Phase 1/Phase 2|32|Anticipated|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:43:03.113426|2017-02-18 15:43:03.113426
NCT00458471|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2007-04-09|||November 2003||2003-11-01|April 2007|2007-04-01|July 2005||2005-07-01|||||Interventional|||E. Coli for Prevention of Catheter UTI in SCI Patients|Evaluate the Safety in Human Subjects of Using Bladder Catheters That Are Pre-Coated With a Biofilm That Contains Living Bacteria Escherichia Coli 83972.|Completed||Phase 1|12||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:43:03.233718|2017-02-18 15:43:03.233718
NCT00458458|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2012-10-24|||August 2004||2004-08-01|October 2012|2012-10-01||||December 2012|Anticipated|2012-12-01||Interventional|||Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)|Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)|Unknown status|Active, not recruiting|Phase 3|112|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 15:43:03.339247|2017-02-18 15:43:03.339247
NCT00458445|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2015-03-03|||April 2007||2007-04-01|April 2008|2008-04-01||||||||Interventional|||A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators|A Phase IIIb Study to Evaluate the Efficacy and Time Course of Treatment With SPD465 Compared to Placebo on Simulated Driving Safety and Performance in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|Withdrawn||Phase 3|0|Actual|Shire||||"This study was stopped by the sponsor before enrollment based on a non-safety related~   corporate decision."|f||||||||||||||2017-02-18 15:43:03.484135|2017-02-18 15:43:03.484135
NCT00458432|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-07|2017-01-24|||April 5, 2007||2007-04-05|June 8, 2009|2009-06-08|August 31, 2009|Actual|2009-08-31|August 31, 2009|Actual|2009-08-31||Observational|||Functional Neuroanatomy of Emotion Perception, Recognition, Learning, and Memory|Functional Neuroanatomy of Emotion Perception, Recognition, Learning, and Memory|Completed||N/A|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:43:03.571708|2017-02-18 15:43:03.571708
NCT00458419|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-08|2007-10-31|||September 2005||2005-09-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease|Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|17|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-02-18 15:43:03.653331|2017-02-18 15:43:03.653331
NCT00457639|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2011-08-02|||April 2006||2006-04-01|August 2011|2011-08-01|October 2013|Anticipated|2013-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Cholic Acid for Hepatic Steatosis in Lipodystrophy|Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 15:43:19.131621|2017-02-18 15:43:19.131621
NCT00458406|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2014-03-31|2013-01-10||May 2007||2007-05-01|March 2014|2014-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Evaluation of Adherence and Therapeutic Effectiveness of Bi-Flex Versus CPAP in Children With OSA|Evaluation of Adherence and Therapeutic Effectiveness of BiPAP With Bi-Flex Versus CPAP in Children With Obstructive Sleep Apnea|Completed||N/A|60|Actual|Children's Hospital of Philadelphia|Limitations of the study include the relatively small sample size in the CPAP arm.|2|||f||||f||||||||||2017-02-18 15:43:03.751793|2017-02-18 15:43:03.751793
NCT00458393|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2016-02-08|||June 2007||2007-06-01|February 2016|2016-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men|Chemoprophylaxis for HIV Prevention in Men|Completed||Phase 3|2653|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 15:43:04.303154|2017-02-18 15:43:04.303154
NCT00458380|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2007-04-09|||September 2004||2004-09-01|April 2007|2007-04-01|February 2005||2005-02-01|||||Interventional|||Perifollicular Vascularity Assessment in in-Vitro Fertilization|Clinical Use of the Perifollicular Vascularity Assessment in in-Vitro Fertilization Cycles: a Pilot Study|Completed||Phase 4|116||University Magna Graecia|||||f||||f||||||||||2017-02-18 15:43:04.429438|2017-02-18 15:43:04.429438
NCT00458367|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2010-10-15|||June 2002||2002-06-01|October 2010|2010-10-01|October 2006|Actual|2006-10-01|||||Observational|||RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice|Risperdal Safety Protocol Evaluation Consta Treatment; A Post Authorization Safety Survey With RISPERDAL CONSTA TM|Completed||N/A|5296|Actual|Janssen Pharmaceutica N.V., Belgium|||1||f||||||||||||||2017-02-18 15:43:04.524612|2017-02-18 15:43:04.524612
NCT00458354|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2011-10-10|||January 2006||2006-01-01|October 2011|2011-10-01|December 2008|Actual|2008-12-01|November 2007|Actual|2007-11-01||Interventional|||Use of Spinal Sealant System During Spinal Surgery|A Prospective, Multi-Center, Randomized Controlled Study to Compare the Spinal Sealant System as an Adjunct to Sutured Dural Repair With Standard of Care Methods During Spinal Surgery|Completed||Phase 3|3|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:43:04.866655|2017-02-18 15:43:04.866655
NCT00458341|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2009-04-01|||March 2007||2007-03-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||PTC124 for Pediatric Patients With Cystic Fibrosis|A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis|Completed||Phase 2|30|Anticipated|PTC Therapeutics|||||f||||f||||||||||2017-02-18 15:43:04.991473|2017-02-18 15:43:04.991473
NCT00458328|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2010-11-21|||April 2007||2007-04-01|November 2010|2010-11-01|July 2010|Actual|2010-07-01|September 2009|Actual|2009-09-01||Interventional|||The Effect of Z-338 in Subjects With Functional Dyspepsia|The Effect of Z-338 in Subjects With Functional Dyspepsia, Evaluate the Function of Gastro-duodenum by Ultrasound|Completed||Phase 2|40|Anticipated|Zeria Pharmaceutical|||||f||||t||||||||||2017-02-18 15:43:05.091506|2017-02-18 15:43:05.091506
NCT00458315|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2015-05-06|||May 2007||2007-05-01|September 2009|2009-09-01|May 2012|Anticipated|2012-05-01|August 2007|Actual|2007-08-01||Interventional|||Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor|Randomized Fase II Trial: Comparing Cisplatin, Paclitaxel and Gemcitabine Versus Cisplatin, Paclitaxel, Gemcitabine and Avastin in Patients With Unknown Primary Tumors|Withdrawn||Phase 2|0|Actual|Rigshospitalet, Denmark||||never been started|f||||t||||||||||2017-02-18 15:43:05.174797|2017-02-18 15:43:05.174797
NCT00458302|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2012-12-14|2010-02-04||June 2007||2007-06-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|February 2009|Actual|2009-02-01||Interventional|MONET||Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir|A Randomised, Controlled, Open-label Trial to Compare the Efficacy, Safety and Tolerability of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg O.D. vs a Triple Combination Therapy With DRV/r in HIV-1 Infected Patients With Undetectable Plasma HIV-RNA on Their Current Treatments.|Completed||Phase 3|256|Actual|Janssen-Cilag International NV|This study was not blinded and not designed to demonstrate a safety benefit to stopping nucleoside analogues.|2|||f||||t||||||||||2017-02-18 15:43:05.283185|2017-02-18 15:43:05.283185
NCT00458289|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2009-03-11|||January 2007||2007-01-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate||Completed||Phase 1|12|Actual|University of Illinois at Chicago||3|||f||||f||||||||||2017-02-18 15:43:06.494647|2017-02-18 15:43:06.494647
NCT00458276|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2010-02-11||2010-02-11|April 2007||2007-04-01|February 2010|2010-02-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery|Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery|Terminated||Phase 3|274|Actual|Actelion||2||"6 month vital status report not collected after 28 day follow up analysis indicated no~   difference between placebo & tezosentan"|f||||t||||||||||2017-02-18 15:43:06.586759|2017-02-18 15:43:06.586759
NCT00458263|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-08|2013-01-01|||April 2006||2006-04-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|ISS||Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature|One Arm, Open Study to Assess Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature|Completed||Phase 4|21|Actual|Rabin Medical Center||1|||f||||f||||||||||2017-02-18 15:43:06.742274|2017-02-18 15:43:06.742274
NCT00458250|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-07|2008-11-15|||September 2006||2006-09-01|November 2008|2008-11-01|February 2008|Actual|2008-02-01|||||Interventional|||Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H|Haploidentical Hematopoietic Stem Cell Transplantation in the Treatment of Hematological Malignancies Using CAMPATH-1H|Completed||Phase 1|10|Anticipated|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-02-18 15:43:06.854559|2017-02-18 15:43:06.854559
NCT00458237|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-09|2016-10-18|2015-12-04||April 2007||2007-04-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer|A Brief Dose Escalation Followed by a Phase 2 Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer|Completed||Phase 1/Phase 2|11|Actual|Dana-Farber Cancer Institute||3|||f||||t||||||||No||2017-02-18 15:43:06.954935|2017-02-18 15:43:06.954935
NCT00458211|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2015-07-20|2012-04-25||May 2005||2005-05-01|July 2015|2015-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||The four Rochester subjects were dropped. The 17 Buffalo subjects were all out patients and 20 years older than the 19 Bronx subjects who were all in-patients. Buffalo subjects were 88% white (Bronx 5%), 12% African American (Bronx 39%), 0% Hispanic (Bronx 50%), 24% with Substance abuse (Bronx 68%)|Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics|Evaluation of Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotic Medications|Completed||Phase 4|40|Actual|Bronx Psychiatric Center||1|||f||||f||||||||||2017-02-18 15:43:07.895875|2017-02-18 15:43:07.895875
NCT00458198|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2016-11-23|||January 2006||2006-01-01|November 2016|2016-11-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||Integrated Behavioral Therapy for Treating Children With Selective Mutism|Integrated Behavioral Treatment for Selective Mutism|Completed||N/A|21|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-02-18 15:43:08.25264|2017-02-18 15:43:08.25264
NCT00458185|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2008-03-11|||August 2006||2006-08-01|March 2008|2008-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Study Evaluating Etanercept in Patients With Ankylosing Spondylitis|Multicentre, Open-Labeled Study Of Etanercept In The Treatment Of Patients With Ankylosing Spondylitis|Completed||Phase 4|40|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:43:08.360197|2017-02-18 15:43:08.360197
NCT00458172|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2016-07-28|||April 2007||2007-04-01|July 2016|2016-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Lay Theories of Health in Young and Middle Aged American Adults|Study 1 of Lay Theories of Health: Conceptualizations of Physical, Mental, and Social Health in Young and Middle-Aged Adults|Completed||Phase 2|302|Actual|University of Michigan|||||f||||f||||||||No||2017-02-18 15:43:08.437044|2017-02-18 15:43:08.437044
NCT00458159|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2009-08-28|||May 2007||2007-05-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes|A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes|Terminated||Phase 1|34|Actual|Celgene||1||"The compound has a benign safety profile with short-term use, clinically sig efficacy~   responses have not been demonstrated, or if so, have not been sustained."|f||||f||||||||||2017-02-18 15:43:08.528861|2017-02-18 15:43:08.528861
NCT00458146|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2008-03-24|||February 2007||2007-02-01|March 2008|2008-03-01||||||||Interventional|||A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis|A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 60mg of MM-093 Versus Placebo in Patients With Active Rheumatoid Arthritis on Stable Doses of Methotrexate|Completed||Phase 2|100|Anticipated|Merrimack Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:43:08.635287|2017-02-18 15:43:08.635287
NCT00458133|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2012-11-02|||April 2007||2007-04-01|November 2012|2012-11-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|HART-D||Health Benefits of Aerobic and Resistance Training in Individuals With Type 2 Diabetes|Health Benefits of Aerobic and Resistance Training in Individuals With Type 2 Diabetes|Completed||N/A|262|Actual|Pennington Biomedical Research Center||4|||f||||t||||||||||2017-02-18 15:43:08.7497|2017-02-18 15:43:08.7497
NCT00458120|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2010-12-13|||March 2007||2007-03-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus|Evaluation of the Safety and Immunogenicity of Heterologous Dengue Vaccine Administration in Dengue Immune Individuals|Completed||Phase 1|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-02-18 15:43:08.881469|2017-02-18 15:43:08.881469
NCT00458107|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-12-03|||April 2007||2007-04-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects|An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SCA-136 Administered Orally to Healthy Japanese and Non-Japanese Female Subjects|Completed||Phase 1|64|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:43:09.012956|2017-02-18 15:43:09.012956
NCT00458094|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2014-04-23|||March 2007||2007-03-01|April 2014|2014-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses|Activating Consumers to Exercise in Community Psychiatry Through Peer Support|Completed||Phase 2|100|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 15:43:09.099398|2017-02-18 15:43:09.099398
NCT00458081|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2010-12-09|||March 2007||2007-03-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|RIALTO||Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors|A 12-month Multicentre, Randomised, Double-blind, Placebo-controlled Study With Two Parallel Groups to Assess the Effects of Rimonabant 20 mg in Patients With Abdominal Obesity and Microalbuminuria, With Type 2 Diabetes Mellitus or Dyslipidaemia With or Without Other Cardiometabolic Risk Factors.|Terminated||Phase 3|174|Actual|Sanofi||2||"Company decision has been taken in light of recent demands by certain national health~   authorities"|f||||f||||||||||2017-02-18 15:43:09.214237|2017-02-18 15:43:09.214237
NCT00458068|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2007-04-06|||June 1996||1996-06-01|April 2007|2007-04-01|September 1999|Actual|1999-09-01|||||Interventional|||Early Versus Late Enteral Iron in Infants Less Than 1301 Grams|Prospective Randomized Trial of Early Versus Late Enteral Iron Supplementation in Infants With a Birth Weight of Less Than 1301 Grams|Completed||N/A|126||University of Ulm|||||f||||f||||||||||2017-02-18 15:43:09.326425|2017-02-18 15:43:09.326425
NCT00458055|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2008-06-02|||November 2006||2006-11-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||High-Density Lipoprotein (HDL) Treatment Study|Treatment Study for Severe High-Density Lipoprotein Deficiency|Completed||N/A|19|Actual|McGill University Health Center||1|||f||||t||||||||||2017-02-18 15:43:09.427718|2017-02-18 15:43:09.427718
NCT00458042|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-11-09|||March 2007||2007-03-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction|Transitioning To Intravenous Remodulin® (Treprostinil Sodium) From Inhaled Iloprost (Ventavis®) in Patients With Pulmonary Arterial Hypertension: Safety, Efficacy and Treatment Satisfaction|Terminated||Phase 4|10|Anticipated|United Therapeutics||||Low Enrollment|f||||f||||||||||2017-02-18 15:43:09.540906|2017-02-18 15:43:09.540906
NCT00458029|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2011-05-31|||August 2006||2006-08-01|May 2011|2011-05-01|February 2011|Actual|2011-02-01|June 2009|Actual|2009-06-01||Interventional|HEALTHY||Middle-School Based Primary Prevention Trial of Type 2 Diabetes|Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Middle-School Based Primary Prevention Trial (HEALTHY)|Completed||Phase 3|4603|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 15:43:09.638202|2017-02-18 15:43:09.638202
NCT00458016|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2011-09-29|||March 2007||2007-03-01|September 2011|2011-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus|A Phase 2, 28-day, Multicenter, Double-Blind,Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of MB07803 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|105|Actual|Ligand Pharmaceuticals||5|||f||||f||||||||||2017-02-18 15:43:09.772999|2017-02-18 15:43:09.772999
NCT00458003|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2017-01-31|||July 2006||2006-07-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Phenylephrine in Spinal Anesthesia in Preeclamptic Patients|Phenylephrine Versus Ephedrine to Treat Spinal Anesthesia-Induced Hypotension in Preeclamptic Patients During Cesarean Delivery|Completed||N/A|110|Actual|Northwestern University||2|||f||||f||||||||No||2017-02-18 15:43:09.886105|2017-02-18 15:43:09.886105
NCT00457990|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2007-04-06|||April 2002||2002-04-01|April 2007|2007-04-01|December 2005|Actual|2005-12-01|||||Interventional|||Neurodevelopment After Early Iron Supplementation|Early Versus Late Enteral Iron Supplementation in Infants With a Birth Weight of Less Than 1301g – Neurocognitive Development at 5.3 Years Corrected Age|Completed||N/A|204||University of Ulm|||||f||||f||||||||||2017-02-18 15:43:10.007568|2017-02-18 15:43:10.007568
NCT00457977|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2015-04-22|2014-03-27||March 2007||2007-03-01|April 2015|2015-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|PNEUMO||Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease|Pneumococcal Vaccine Response in COPD|Completed||Phase 3|181|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 15:43:10.106124|2017-02-18 15:43:10.106124
NCT00457964|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2013-09-23|||August 2005||2005-08-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM|RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis|Completed||Phase 1/Phase 2|36|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 15:43:11.214253|2017-02-18 15:43:11.214253
NCT00457951|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2016-10-25|2016-01-26||April 2007||2007-04-01|October 2016|2016-10-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|COPD|Open-Label followed by multi-center, randomized, double-blind, placebo-controlled trial in hospitalized subjects with exacerbations of COPD. In the double-blind phase, 145 subjects consented and 138 met criteria and were randomized.|A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD|An Open-Label Phase Followed by a Randomized, Double-Blind, Placebo-Controlled Phase in a Study Designed to Evaluate Intravenous 2-O, 3-O Desulfated Heparin (ODSH) in Subjects With Exacerbations of Chronic Obstructive Pulmonary Disease|Terminated||Phase 2|158|Actual|Cantex Pharmaceuticals|PGX-ODSH-2006, Ph II in patients with exacerbation of COPD. There were no safety issues. An interim analysis demonstrated lack of efficacy for the primary and secondary endpoints; therefore, Cantex terminated the study on August 11, 2009.|3||Interim analysis: safety without efficacy ODSH in patients with acute COPD.|f||||t||||||||||2017-02-18 15:43:11.322985|2017-02-18 15:43:11.322985
NCT00457938|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2013-06-19|||April 2006||2006-04-01|June 2013|2013-06-01|December 2016|Anticipated|2016-12-01|August 2016|Anticipated|2016-08-01||Interventional|||Novel Therapies for Metabolic Complications of Lipodystrophies|Novel Therapies for Metabolic Complications in Patients With Lipodystrophies|Unknown status|Recruiting|Phase 2/Phase 3|72|Anticipated|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-02-18 15:43:11.763809|2017-02-18 15:43:11.763809
NCT00457925|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2012-03-15|||October 2006||2006-10-01|February 2011|2011-02-01||||||||Interventional|||Absorption, Distribution, Metabolism And Excretion Study For GSK221149A|An Open-label, Two Period Study to Determine the Excretion Balance and Pharmacokinetics of [14C]-GSK221149A, Administered as Single Doses of an Oral Solution and an Intravenous Infusion to Healthy Female Volunteers|Completed||Phase 1|6||GlaxoSmithKline|||||||||||||||||||2017-02-18 15:43:11.875503|2017-02-18 15:43:11.875503
NCT00457912|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2016-07-25|||June 2005||2005-06-01|July 2016|2016-07-01||||||||Observational|||Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy|Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy|Active, not recruiting||N/A|500|Anticipated|Nationwide Children's Hospital|||1||f||||f||||||Samples With DNA|"~     whole blood, muscle tissue~   "|||2017-02-18 15:43:11.971913|2017-02-18 15:43:11.971913
NCT00457899|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-11-26|||July 2007||2007-07-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|RAPID||Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder|RAPID-An Open-Label Randomized, Multicenter Phase IIIb Study to Evaluate the Efficacy and Tolerability of Quetiapine IR (Immediate Release), Over 14 Days, in Acute Schizophrenia/Schizoaffective Disorder (Rapid Versus Conventional Titration)|Terminated||Phase 3|234|Anticipated|AstraZeneca||||Study terminated due to poor recruitment|f||||||||||||||2017-02-18 15:43:12.063057|2017-02-18 15:43:12.063057
NCT00457886|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2009-06-30|||July 2005||2005-07-01|April 2007|2007-04-01|June 2007||2007-06-01|||||Observational|||Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery|Serum Levels of Hormones Known to Affect Parturition in Patients Receiving 17 Alpha-Hydroxyprogesterone Caproate (17-P) for the Prevention of Preterm Delivery|Completed||Phase 4|20||Georgetown University|||1||f||||||||||||||2017-02-18 15:43:12.181921|2017-02-18 15:43:12.181921
NCT00457873|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2008-05-20|||January 2007||2007-01-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Isotonic Versus Hypotonic Fluid for Maintenance IV Therapy|Isotonic Versus Hypotonic Saline for Maintenance Intravenous Fluid Therapy: A Pilot Randomized Trial|Completed||Phase 3|38|Actual|McGill University Health Center||2|||f||||||||||||||2017-02-18 15:43:12.268405|2017-02-18 15:43:12.268405
NCT00457860|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-04-16|||March 2007||2007-03-01|April 2007|2007-04-01||||||||Interventional|||Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease|A Phase 1, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia (CLL), Prolymphocytic Leukemia (PLL), or Small Lymphocytic Lymphoma (SLL)|Unknown status|Recruiting|Phase 1|50||Cambridge Antibody Technology|||||f||||f||||||||||2017-02-18 15:43:12.372433|2017-02-18 15:43:12.372433
NCT00457847|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2016-09-09|||February 2007||2007-02-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|||Identifying Genetic Characteristics That Increase the Risk of Developing Primary Graft Dysfunction Following Lung Transplantation|Genetics of Primary Graft Dysfunction|Recruiting||N/A|1150|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 15:43:12.473665|2017-02-18 15:43:12.473665
NCT00457834|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2008-01-08|||November 2003||2003-11-01|January 2008|2008-01-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|BIFF||Bi-Ventricular Pacing in Patients With Atrial Fibrillation and Heart Failure (BIFF-Study)|Study on the Efficacy of bi-Ventricular Pacing of Patients With Severe Heart Failure and Chronic Atrial Fibrillation|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|Umeå University||1|||f||||||||||||||2017-02-18 15:43:12.579907|2017-02-18 15:43:12.579907
NCT00457821|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2012-10-03|2012-02-27||May 2007||2007-05-01|October 2012|2012-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety Study of Ivacaftor in Subjects With Cystic Fibrosis|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of VX-770 to Evaluate Safety, Pharmacokinetics, and Biomarkers of CFTR Activity in Cystic Fibrosis (CF) Subjects With Genotype G551D|Completed||Phase 2|39|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||t||||||||||2017-02-18 15:43:12.769482|2017-02-18 15:43:12.769482
NCT00457808|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2007-04-06|||December 2002||2002-12-01|April 2007|2007-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM|Rapamycin Therapy of Angiomyolipomas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis|Completed||Phase 2|25||Children's Hospital Medical Center, Cincinnati|||||f||||t||||||||||2017-02-18 15:43:14.561829|2017-02-18 15:43:14.561829
NCT00457795|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-06|2011-10-18|2011-10-18||December 2006||2006-12-01|October 2011|2011-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||24-hour IOP-lowering Effect of Brimonidine 0.1%||Completed||Phase 4|15|Actual|Allergan||1|||f||||||||||||||2017-02-18 15:43:14.657161|2017-02-18 15:43:14.657161
NCT00457782|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2011-01-31|||April 2007||2007-04-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|August 2010|Actual|2010-08-01||Interventional|||A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma|A Phase I, Open-Label, Dose-escalation, Multicentre Study of KW-2478 Administered as a Single Agent Intravenously in a Consecutive Dosing Schedule in Patients With Relapsed/Refractory Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma|Completed||Phase 1|27|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1|||f||||t||||||||||2017-02-18 15:43:15.133531|2017-02-18 15:43:15.133531
NCT00457769|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2016-02-22|||May 2007||2007-05-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Aricept to Improve Functional Tasks in Vascular Dementia|Phase 1 Study of Aricept Plus a Behavioral Strategy to Improve Functional Tasks in Vascular Dementia|Active, not recruiting||Phase 1|18|Anticipated|Kessler Foundation||2|||f||||t||||||||||2017-02-18 15:43:15.249264|2017-02-18 15:43:15.249264
NCT00457756|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2008-05-05|||January 2007||2007-01-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The Effect of BiosLife on Serum Lipids|The Effect of an Integrative Dietary Supplement on the Lipid Profile of Subjects With Hypercholesterolemia|Completed||N/A|100|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 15:43:15.371691|2017-02-18 15:43:15.371691
NCT00457743|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2009-10-02|2009-07-16||January 2005||2005-01-01|October 2009|2009-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)|A Phase I/II Study of Sunitinib Malate (SU011248) In The Treatment of Patients With Malignant Gastrointestinal Stromal Tumor (GIST) Previously Treated by Imatinib Mesylate.|Completed||Phase 1/Phase 2|36|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 15:43:15.482667|2017-02-18 15:43:15.482667
NCT00457730|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-04-08|2014-08-27||January 2007||2007-01-01|April 2015|2015-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||A Study to Test the Use of Duloxetine for Pain in MS|A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis|Completed||Phase 2/Phase 3|38|Actual|Brown, Theodore R., M.D., MPH||2|||f||||f||||||||||2017-02-18 15:43:16.840282|2017-02-18 15:43:16.840282
NCT00457717|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-04-05|||July 2005||2005-07-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Interventional|||Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops||Completed||Phase 1|60||China Medical University, China|||||f||||t||||||||||2017-02-18 15:43:17.202542|2017-02-18 15:43:17.202542
NCT00457704|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04||||||April 2007|2007-04-01||||||||Observational|||Carriage and Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Patients Admitted to Home Care.||Terminated||N/A|||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 15:43:17.29562|2017-02-18 15:43:17.29562
NCT00457691|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-03-10|2011-03-09||June 2007||2007-06-01|March 2015|2015-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer|A Multicenter, Randomised, Double-Blind, Phase 3 Study Of Sunitinib In Metastatic Colorectal Cancer Patients Receiving Irinotecan, 5-Fluorouracil And Leucovorin (FOLFIRI) As First Line Treatment|Completed||Phase 3|768|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:43:17.381604|2017-02-18 15:43:17.381604
NCT00457678|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-12-30||||||December 2015|2015-12-01||||||||Expanded Access|||Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself|A Multicenter, Randomized, Single-Masked Comparison of Lucentis™ Monotherapy With Triple Therapy of Reduced Fluence Visudyne-Lucentis-Dexamethasone (V-L-D) in Patients With CNV Secondary to AMD as Second Line Therapy After Lucentis Monotherapy|Available||N/A|||Vitreous -Retina- Macula Consultants of New York|||||||||||||||||||2017-02-18 15:43:18.817037|2017-02-18 15:43:18.817037
NCT00457665|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-05-29|||February 2002||2002-02-01|August 2014|2014-08-01|October 2014|Actual|2014-10-01|October 2007|Actual|2007-10-01||Interventional|||Mechanisms of Lipodystrophy in HIV-Infected Pateints|Mecahnisms of Lipodystrophy in HIV-Infected Patients|Completed||Phase 4|200||University of Texas Southwestern Medical Center|||||f||||t||||||||||2017-02-18 15:43:18.912592|2017-02-18 15:43:18.912592
NCT00457652|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2008-04-14|||June 2007||2007-06-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?|Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?|Completed||Phase 4|24|Actual|Radboud University||2|||f||||t||||||||||2017-02-18 15:43:19.01607|2017-02-18 15:43:19.01607
NCT00457626|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2016-11-16|||April 2007||2007-04-01|November 2016|2016-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||An Open Label Extension Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension|An Open Label Extension Study to Evaluate Safety, Tolerability, and Efficacy of 18 Weeks of Valsartan Treatment in Children 6 Months-5 Years Old With Hypertension|Completed||Phase 3|66|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:43:19.249045|2017-02-18 15:43:19.249045
NCT00457613|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-05|||November 2004||2004-11-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Effects of Alkaline Phosphatase on Renal Function in Septic Patients|Effects of Alkaline Phosphatase on Renal Function in Patients With Severe Sepsis or Septic Shock.|Completed||Phase 2|15||Radboud University|||||f||||||||||||||2017-02-18 15:43:19.407632|2017-02-18 15:43:19.407632
NCT00457600|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-05|||June 2005||2005-06-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Observational|||ParentLink: Better and Safer Emergency Care for Children|ParentLink: Better and Safer Emergency Care for Children|Completed||Phase 2/Phase 3|3000||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 15:43:19.500591|2017-02-18 15:43:19.500591
NCT00457587|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2016-10-28|||September 2005||2005-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|December 2011|Actual|2011-12-01|2 Years|Observational [Patient Registry]|||Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma|Präklinische Studie Zur Etablierung Einer Immuntherapie für Das Nebennierenrindenkarzinom - Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma|Active, not recruiting||Early Phase 1|70|Actual|University of Wuerzburg|||1||f||||f||||||Samples With DNA|"~     whole blood for monocytes isolation serum urine~   "|||2017-02-18 15:43:19.593923|2017-02-18 15:43:19.593923
NCT00457574|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2013-08-27|||March 2007||2007-03-01|August 2013|2013-08-01|August 2010|Actual|2010-08-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas|A Single-Center, Open-Label, Phase I Study of Single-Agent GMX1777 Administered as a 24-Hour Infusion Every 3 Weeks to Patients With Refractory Solid Tumors or Lymphomas|Withdrawn||Phase 1|0|Actual|Teva Pharmaceutical Industries||1||Study terminated prematurely due to financial constraints.|f||||f||||||||||2017-02-18 15:43:19.687167|2017-02-18 15:43:19.687167
NCT00456586|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2016-07-12|||April 2002||2002-04-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|May 2003|Actual|2003-05-01||Interventional|||12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa|A 12-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study of the Efficacy of 40 mg/Day KW-6002 as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy|Completed||Phase 2|180||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-02-18 15:43:19.778755|2017-02-18 15:43:19.778755
NCT00456573|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2008-06-02|||April 2006||2006-04-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|September 2008|Anticipated|2008-09-01||Interventional|||Cytokine Profiles in Children With Obstructive Sleep Apnea|Local and Systemic Cytokine Profiles in Children With Obstructive Sleep Apnea and Controls|Unknown status|Recruiting|N/A|40|Anticipated|University of Chicago||1|||f||||f||||||||||2017-02-18 15:43:19.868809|2017-02-18 15:43:19.868809
NCT00456560|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-09-13|||April 2007||2007-04-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||AV650 Drug-Drug Interaction Study|A Phase I, Randomized, Two-Period, Single-Center Study to Assess the Effect of CYP2D6 and CYP2C19 Inhibitors on a Single Oral Dose of AV650 (300 mg) in Healthy Subjects|Completed||Phase 1|30|Anticipated|Avigen|||||f||||f||||||||||2017-02-18 15:43:19.958096|2017-02-18 15:43:19.958096
NCT00456547|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2014-03-17|2011-11-06||December 2003||2003-12-01|March 2014|2014-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Coagulation Factor Changes Associated With Postpartum Hysterectomies|Coagulation Factor Changes Associated With Postpartum Hysterectomies|Completed||N/A|24|Actual|Northwestern University|||2||f||||f||||||||||2017-02-18 15:43:20.032823|2017-02-18 15:43:20.032823
NCT00456534|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03|||November 2006||2006-11-01|April 2007|2007-04-01|June 2007|Anticipated|2007-06-01|||||Observational|||The Effect of Smoking on Perception||Unknown status|Recruiting|N/A|130||American University|||||f||||f||||||||||2017-02-18 15:43:20.469025|2017-02-18 15:43:20.469025
NCT00456521|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2014-12-02|2014-10-08||March 2007||2007-03-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||All randomized subjects|A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Naltrexone Sustained Release (SR)/Bupropion SR and Placebo in Subjects With Obesity Participating in a Behavior Modification Program|Completed||Phase 3|793|Actual|Orexigen Therapeutics, Inc||2|||f||||t||||||||||2017-02-18 15:43:20.55988|2017-02-18 15:43:20.55988
NCT00456508|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2016-06-28|2011-06-29||April 2007||2007-04-01|June 2016|2016-06-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)|Open-label Patient Continuation of DX-88 (Ecallantide) for Acute Hereditary Angioedema Attacks|Completed||Phase 3|147|Actual|Shire||1|||f||||f||||||||||2017-02-18 15:43:21.586815|2017-02-18 15:43:21.586815
NCT00456495|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2013-05-03|2011-04-12||March 2007||2007-03-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Effect of Ranibizumab on Malignant Conjunctival Neoplasia|Effect of Ranibizumab on Malignant Conjunctival Neoplasia|Completed||Phase 1|5|Actual|The New York Eye Cancer Center|This was a small case series involving a small number of subjects. Further investigations for dose, drug delivery and case selection are warranted.|1|||f||||f||||||||||2017-02-18 15:43:24.549519|2017-02-18 15:43:24.549519
NCT00456482|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2011-12-07|||May 2002||2002-05-01|December 2011|2011-12-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant|A Multicenter, Randomized, Double-Masked, Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide Implant in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye|Terminated||Phase 2/Phase 3|239|Actual|Bausch & Lomb Incorporated||3||SARS epidemic in Asia and Canada|f||||t||||||||||2017-02-18 15:43:24.784027|2017-02-18 15:43:24.784027
NCT00456469|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04|||May 2007||2007-05-01|April 2007|2007-04-01|October 2009|Anticipated|2009-10-01|||||Observational|ALTAC||Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children|Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children|Unknown status|Not yet recruiting|N/A|500||Liverpool School of Tropical Medicine|||||f||||t||||||||||2017-02-18 15:43:24.871361|2017-02-18 15:43:24.871361
NCT00456430|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-11-11|||July 2003||2003-07-01|January 2010|2010-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response|Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response|Completed||Phase 4|80|Anticipated|Indiana University||1|||f||||f||||||||||2017-02-18 15:43:25.098606|2017-02-18 15:43:25.098606
NCT00456417|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2008-01-17|||April 2007||2007-04-01|January 2008|2008-01-01||||December 2007|Actual|2007-12-01||Interventional|||Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects|Evaluation of [123I] MNI-187 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Completed||Phase 1|30|Anticipated|Institute for Neurodegenerative Disorders|||||t||||f||||||||||2017-02-18 15:43:25.187707|2017-02-18 15:43:25.187707
NCT00456404|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04|||February 2005||2005-02-01|March 2004|2004-03-01|June 2005|Actual|2005-06-01|||||Interventional|||Effect of Peppermint Water on Breast Crack|Effect of Peppermint Water on Prevention of Nipple Crack in Lactating Primiparous Women: a Randomized Controlled Trial|Completed||N/A|196||Tabriz University|||||f||||t||||||||||2017-02-18 15:43:25.272011|2017-02-18 15:43:25.272011
NCT00456391|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04|||October 2006||2006-10-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Observational|||The Utility of Performing Brain CT Scan in Non Trauma Patients at the Pediatric Emergency Unit|The Utility of Performing Brain CT Scan in Non Trauma Patients at the Pediatric Emergency Unit. A Retrospective Observational Study.|Completed||N/A|||HaEmek Medical Center, Israel|||||f||||f||||||||||2017-02-18 15:43:25.349284|2017-02-18 15:43:25.349284
NCT00456378|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2016-12-16|||December 2006||2006-12-01|December 2016|2016-12-01|March 2018|Anticipated|2018-03-01|December 2017|Anticipated|2017-12-01||Interventional|||Study of the Safety and Effectiveness of DIAM™ Spinal Stabilization System Versus Conservative Care|A Prospective, Randomized, Controlled Pivotal Clinical Investigation of DIAM™ Spinal Stabilization System in Patients With Lumbar Degenerative Disc Disease.|Active, not recruiting||Phase 3|311|Anticipated|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-02-18 15:43:25.424181|2017-02-18 15:43:25.424181
NCT00456365|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2012-12-12|||November 2006||2006-11-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 3|112|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 15:43:25.780584|2017-02-18 15:43:25.780584
NCT00456352|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2014-08-21|||April 2007||2007-04-01|August 2014|2014-08-01|October 2010|Actual|2010-10-01|April 2009|Actual|2009-04-01||Interventional|||Duodenal Exclusion for the Treatment of T2DM|Phase IV Study of Duodenal Exclusion for the Treatment of Type 2 Diabetes Mellitus (T2DM)|Completed||Phase 4|37|Actual|Medtronic - MITG||1|||f||||||||||||||2017-02-18 15:43:25.89983|2017-02-18 15:43:25.89983
NCT00456339|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2013-09-04|||July 2006||2006-07-01|September 2013|2013-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Systemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in Children|The Effect of a Combination of Systemic Steroids and Antibiotics on Obstructive Sleep Apnea Syndrome in Children|Terminated||Phase 4|4|Actual|University of Chicago||1||Problems recruiting; patient relapse following treatment|f||||f||||||||||2017-02-18 15:43:25.984825|2017-02-18 15:43:25.984825
NCT00456326|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2008-02-12|||October 2005||2005-10-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|||||Observational|HIT||Heparin-Induced Thrombocytopenia Registry|A 3 Year Retrospective Heparin Induced Thrombocytopenia Registry (HIT) at Brigham and Women's Hospital.|Completed||N/A|242|Actual|Brigham and Women's Hospital|||1||f||||t||||||||||2017-02-18 15:43:26.081883|2017-02-18 15:43:26.081883
NCT00456313|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2015-04-15|||December 2007||2007-12-01|April 2015|2015-04-01|December 2007|Anticipated|2007-12-01|December 2007|Anticipated|2007-12-01||Interventional|||No Resistance After Long Term Treatment SERETIDE|Rationale for Therapy With Low Dose Steroids Combined With Long-acting beta2-agonists in Patients With Allergic Asthma: Redirecting Innate Immune Responses by Long-term Treatment With High Doses of Inhaled Steroids|Withdrawn||Phase 4|0|Actual|GlaxoSmithKline||1||lack of data|f||||||||||||||2017-02-18 15:43:26.187944|2017-02-18 15:43:26.187944
NCT00457561|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-04-05||||||April 2007|2007-04-01||||||||Observational|||Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis||Completed||N/A|||Hamamatsu University|||||f||||||||||||||2017-02-18 15:43:26.289081|2017-02-18 15:43:26.289081
NCT00457548|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2011-03-29||||||February 2009|2009-02-01||||||||Expanded Access|DIAL||Phone Intervention for Alcohol (ETOH) Use in Emergency Department Motor Vehicle Crash (ED MVC) Patients|Study of Effectiveness of BI Given to Injured MVC ED Patients Who Use Alcohol Harmfully and Hazardously|Available||N/A|||Rhode Island Hospital|||||f||||||||||||||2017-02-18 15:43:26.365189|2017-02-18 15:43:26.365189
NCT00457535|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-04-05|||August 2000||2000-08-01|April 2007|2007-04-01|July 2004||2004-07-01|||||Observational|||Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning HD|Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis|Terminated||N/A|||Hamamatsu University|||||f||||||||||||||2017-02-18 15:43:26.451902|2017-02-18 15:43:26.451902
NCT00457522|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-04-05|||April 2006||2006-04-01|September 2006|2006-09-01|December 2006|Actual|2006-12-01|||||Interventional|||Telephone Intervention to Increase Safety in Abused Women|Phone Intervention to Increase Safety in Abused Women: Pilot|Completed||N/A|40||Johns Hopkins University|||||f||||||||||||||2017-02-18 15:43:26.533171|2017-02-18 15:43:26.533171
NCT00457509|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2014-01-10|||January 2007||2007-01-01|January 2014|2014-01-01|September 2010|Actual|2010-09-01|November 2009|Actual|2009-11-01||Interventional|||Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults||Completed||Phase 1|251|Actual|Sanofi||5|||f||||f||||||||||2017-02-18 15:43:26.632335|2017-02-18 15:43:26.632335
NCT00457496|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2008-07-11|||March 2005||2005-03-01|July 2008|2008-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in Working Communities|Effectiveness of a Cognitive and Physical Program in Reducing Headache, Neck and Shoulder Pain: a Workplace Controlled Trial|Completed||Phase 3|300|Actual|University of Turin, Italy||1|||f||||f||||||||||2017-02-18 15:43:26.745472|2017-02-18 15:43:26.745472
NCT00457483|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2012-02-13|||August 2007||2007-08-01|April 2011|2011-04-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|NAMIS||Nijmegen Antihypertensive Management Improvement Study|A Cross-over Trial to Identify Patient Characteristics That Predict Blood Pressure Response to Antihypertensive Therapy in General Practice|Completed||Phase 4|120|Actual|Radboud University||1|||f||||f||||||||||2017-02-18 15:43:26.844054|2017-02-18 15:43:26.844054
NCT00457470|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-04-30|||June 2007||2007-06-01|April 2015|2015-04-01||||||||Interventional|||A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)|A Phase 2, Multi-Stage, Multi-Center Trial Exploring The Safety And Efficacy Of AG-014699 In Subjects With Diffuse Diabetic Macular Edema (DME) Involving The Center Of The Retina|Withdrawn||Phase 2|0|Actual|Pfizer||||Cancelled before first patient enrolled|f||||||||||||||2017-02-18 15:43:26.944804|2017-02-18 15:43:26.944804
NCT00457457|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2010-10-27||2009-03-24|May 2007||2007-05-01|October 2010|2010-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.|A Multi-center, Randomized, Parallel Group, Double-blind, Placebo Controlled Proof of Concept and Dose Ranging Study With an Active Control to Assess the Efficacy and Safety/Tolerability of UK-369,003 Immediate Release (IR) and Modified Release (MR) in the Treatment of Men With Lower Urinary Tract Symptoms (LUTS) With and Without Erectile Dysfunction (ED)|Completed||Phase 2|609|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:43:27.03148|2017-02-18 15:43:27.03148
NCT00457444|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-04-05|||December 2005||2005-12-01|April 2007|2007-04-01|November 2006||2006-11-01|||||Interventional|||Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration|ZU-SkinSIT-001 Single Center Phase I/IIa, Placebo Controlled, Randomized, Double Blind Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration|Completed||Phase 1|35||University of Zurich|||||f||||f||||||||||2017-02-18 15:43:27.192426|2017-02-18 15:43:27.192426
NCT00457431|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-06-12|||April 2007||2007-04-01|June 2015|2015-06-01||||April 2016|Anticipated|2016-04-01||Interventional|HACAinhospital||Hypothermia After In-hospital Cardiac Arrest|Hypothermia After In-hospital Cardiac Arrest|Recruiting||N/A|440|Anticipated|University of Schleswig-Holstein||2|||f||||t||||||||||2017-02-18 15:43:27.262678|2017-02-18 15:43:27.262678
NCT00457418|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2015-02-12|2013-05-28||February 2007||2007-02-01|February 2015|2015-02-01|July 2012|Actual|2012-07-01|May 2008|Actual|2008-05-01||Interventional|||High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)|A Pharmacokinetic Study of PEG-Intron, Administered Weekly in Subjects With High-Risk Melanoma|Completed||Phase 1|32|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:43:27.395706|2017-02-18 15:43:27.395706
NCT00457405|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2008-04-14|||June 2007||2007-06-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?|Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?|Completed||Phase 4|10|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:43:27.976458|2017-02-18 15:43:27.976458
NCT00457392|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2013-09-24|2011-07-06||July 2007||2007-07-01|September 2013|2013-09-01|December 2012|Actual|2012-12-01|July 2010|Actual|2010-07-01||Interventional|||A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone|A Multicenter, Randomized, Double-Blind, Controlled Phase 3, Efficacy And Safety Study Of Sunitinib (SU011248) In Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Treated With Erlotinib|Completed||Phase 3|960|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:43:28.1414|2017-02-18 15:43:28.1414
NCT00457379|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-08-14|||April 2007||2007-04-01|April 2007|2007-04-01|April 2008|Anticipated|2008-04-01|||||Interventional|HERCET||Effect of Exercise Training on the Function of HDL-Cholesterol, Endothelial Function and Endothelial Progenitor Cells in Patients With Coronary Artery Disease (HERCET-Study)|Randomized, Clinical Trial to Study the Effect of Exercise Training on the Function of HDL-Cholesterol, Endothelial Function, Oxidative Stress and Regenerative Capacity of Endothelial Progenitor Cells in Patients With Coronary Artery Disease|Unknown status|Recruiting|N/A|30|Anticipated|Hannover Medical School|||||f||||||||||||||2017-02-18 15:43:30.462164|2017-02-18 15:43:30.462164
NCT00457366|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2014-01-29|||May 2006||2006-05-01|January 2014|2014-01-01|May 2009|Actual|2009-05-01|August 2008|Actual|2008-08-01||Interventional|||A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room|A Comparison Study of the Efficacy of a Rapid Titration of Quetiapine and Haloperidol in Agitated Adults in an Emergency Setting.|Completed||Phase 4|72|Actual|University of Southern California||2|||f||||t||||||||||2017-02-18 15:43:30.553065|2017-02-18 15:43:30.553065
NCT00457353|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2009-01-20|||March 2007||2007-03-01|January 2009|2009-01-01||||December 2007|Actual|2007-12-01||Interventional|ENIGMA||ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children|Phase III Comparative Study to Assess the Efficacy and Safety of Oral Rehydration Therapy (ORT) in Combination With Spores of Bacillus Clausii (Enterogermina)Versus ORT Alone, Administered for 5 Days With the Treatment of Acute Diarrhea in Children.|Completed||Phase 3|264|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:43:30.64649|2017-02-18 15:43:30.64649
NCT00457340|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2009-06-17|||February 2000||2000-02-01|June 2009|2009-06-01|September 2004|Actual|2004-09-01|||||Interventional|CLARIDI||Atorvastatin For The Reduction Of Ventricular Arrhythmias|Cholesterol Lowering and Arrhythmia Recurrences After Internal Defibrillator Implantation (CLARIDI)|Completed||Phase 4|220||Pfizer|||||f||||||||||||||2017-02-18 15:43:30.745374|2017-02-18 15:43:30.745374
NCT00457327|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2008-06-04|||July 2006||2006-07-01|June 2008|2008-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Pilot Study for Evaluation of the Need for Protective Ileostomy After Low Anterior Resection Due to Rectal Cancer|Pilot Study for Evaluation of the Need for Protective Ileostomy After Low Anterior Resection Due to Rectal Cancer|Terminated||Phase 2|40|Anticipated|Heidelberg University||||"RCT with same hypothesis ended and showed a superiority for protective ileostomy after lower~   anterior rectum resection."|f||||f||||||||||2017-02-18 15:43:30.842914|2017-02-18 15:43:30.842914
NCT00457314|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2009-05-18|||June 2007||2007-06-01|May 2009|2009-05-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease|Exercise Training and Deconditions: Implications for Therapy in Mitochondrial Myopathy|Unknown status|Recruiting|Phase 2|50|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||2|||f||||t||||||||||2017-02-18 15:43:30.940183|2017-02-18 15:43:30.940183
NCT00457301|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2009-09-21|2009-04-15||July 2005||2005-07-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|April 2007|Actual|2007-04-01||Interventional|||Using Health-related Quality of Life (HRQL) in Routine Clinical Care|An Assessment of the Effects of the Use of Measures of Health-related Quality of Life in Routine Clinical Care:an Application to Lung Transplantation.|Completed||N/A|213|Actual|University of Alberta|Randomizing patients instead of clinicians lead to sensitizing effects. EQ-5D is a generic preference-based measure, a specific measure should have been used to maximize responsiveness.|1|||f||||t||||||||||2017-02-18 15:43:31.041803|2017-02-18 15:43:31.041803
NCT00457275|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2015-05-07|||April 2005||2005-04-01|May 2015|2015-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)|A Multicentre, Open-Label, Observational Local Study to Evaluate the LDL-C Lowering Effect of Ezetimibe as Prescribed in Daily Routine Practice in the South African Population|Completed||Phase 3|440||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:43:31.751803|2017-02-18 15:43:31.751803
NCT00457262|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04|||January 2006||2006-01-01|March 2007|2007-03-01|August 2006|Actual|2006-08-01|||||Interventional|||Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women|Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women|Completed||N/A|42||Iran University of Medical Sciences|||||f||||t||||||||||2017-02-18 15:43:31.834968|2017-02-18 15:43:31.834968
NCT00457249|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2012-09-17|2012-09-17||March 2007||2007-03-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older|Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (ADACEL®) in Persons ≥65 Years of Age|Completed||Phase 4|1564|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:43:31.926221|2017-02-18 15:43:31.926221
NCT00457236|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-05|||March 2003||2003-03-01|April 2007|2007-04-01|December 2007|Anticipated|2007-12-01|||||Observational|EXCELSIOR||Effect of Clopidogrel Loading and Risk of PCI|Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement|Unknown status|Active, not recruiting|N/A|800||Heart Center Bad Krozingen|||||f||||||||||||||2017-02-18 15:43:32.66243|2017-02-18 15:43:32.66243
NCT00457223|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2008-02-12|||April 2007||2007-04-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||To Compare Fibrin Glue and Suture in Primary Pterygium Excision With Amniotic Membrane Transplantation|Randomized Controlled Trial to Compare Fibrin Glue and Suture in Primary Pterygium Excision With Amniotic Membrane Transplantation|Completed||Phase 2/Phase 3|32|Actual|Chulalongkorn University||2|||f||||t||||||||||2017-02-18 15:43:32.760497|2017-02-18 15:43:32.760497
NCT00457210|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-05|2007-04-05|||April 2007||2007-04-01|April 2007|2007-04-01||||||||Observational|||The Influence of Radiotherapy on Cognitive Function|The Influence of the Radiotherapy or Stereotactic Radiosurgery on the Cognitive Function of the Patients With the Neurotrax Assessment System and a Cognitive Questionnaire.|Unknown status|Not yet recruiting|N/A|150||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 15:43:32.878279|2017-02-18 15:43:32.878279
NCT00457197|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2016-04-01|2015-10-23||March 2007||2007-03-01|April 2016|2016-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Quetiapine for Bipolar Disorder and Alcohol Dependence|Quetiapine for Bipolar Disorder and Alcohol Dependence|Completed||Phase 4|90|Actual|University of Texas Southwestern Medical Center|Larger sample size possibly needed for between-group differences in outcome measures. Pill counts not an optimum measure of medication adherence.|2|||f||||t||||||||||2017-02-18 15:43:32.975775|2017-02-18 15:43:32.975775
NCT00457184|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-08-27|||January 2004||2004-01-01|January 2004|2004-01-01|June 2007|Actual|2007-06-01|||||Observational|||Thrombophilia and Migraine, Are They Related?|Thrombophilia and Migraine, Are They Related? - A Clinical Study|Completed||N/A|50|Actual|HaEmek Medical Center, Israel|||||f||||f||||||||||2017-02-18 15:43:34.039326|2017-02-18 15:43:34.039326
NCT00457171|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2009-05-15|||December 2004||2004-12-01|May 2009|2009-05-01||||||||Interventional|||GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis|A Double-Blind, Placebo-Controlled Phase I/II Study in Patients With Mild to Moderate Ulcerative Colitis Treated With GI-270384X, an Oral ICAM-1 and E-Selectin Inhibitor|Terminated||Phase 1|16||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:43:34.124507|2017-02-18 15:43:34.124507
NCT00457158|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2012-11-22|||July 2006||2006-07-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|PREPIC2||PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption|PREPIC 2 : Interruption of Inferior Vena Cava by a Retrievable Filter for the Prevention of Recurrent Pulmonary Embolism : a Randomised, Open Label Study|Completed||Phase 4|399|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t||||||||||2017-02-18 15:43:34.209045|2017-02-18 15:43:34.209045
NCT00457145|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2017-01-24|||March 27, 2007||2007-03-27|October 24, 2007|2007-10-24|October 24, 2007||2007-10-24|||||Interventional|||Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation|Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia Without Neovascularization|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:43:34.335313|2017-02-18 15:43:34.335313
NCT00457132|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-06-26|||September 2005||2005-09-01|April 2007|2007-04-01|February 2006|Actual|2006-02-01|||||Interventional|||The Effect of Neuromuscular Training on Osteoarthritis: A Comparative Prospective Randomized Study|Dynamic Wedging: A Novel Treatment for Knee Osteoarthritis|Completed||N/A|60||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:43:34.429376|2017-02-18 15:43:34.429376
NCT00457119|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2013-02-09|||February 2007||2007-02-01|February 2013|2013-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients|A Two-step Phase 1 Study Investigating the Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients Not Treated Previously With Systemic Therapy|Completed||Phase 1|69|Actual|Novartis||4|||f||||t||||||||||2017-02-18 15:43:34.633422|2017-02-18 15:43:34.633422
NCT00457106|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2010-11-30|||June 2002||2002-06-01|November 2010|2010-11-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks|A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks|Completed||N/A|90|Anticipated|Beth Israel Medical Center|||||f||||||||||||||2017-02-18 15:43:34.765615|2017-02-18 15:43:34.765615
NCT00457093|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2010-11-17|||October 2006||2006-10-01|April 2007|2007-04-01|May 2007|Actual|2007-05-01|||||Interventional|||A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes|A Double Blind, Randomized, Parallel, Cross-Over Comparision of Glycemic Control Achieved With Once a Day Insulin Glargine Versus Detemir in Type 2 Diabetes|Completed||N/A|35|Anticipated|Diabetes Care Center|||||f||||f||||||||||2017-02-18 15:43:34.876761|2017-02-18 15:43:34.876761
NCT00457080|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2008-07-08|||October 2006||2006-10-01|July 2008|2008-07-01|February 2007|Actual|2007-02-01|||||Interventional|ETCO2||Application of Capnography Monitoring on the General Care Nursing Unit|Application of Capnography Monitoring on the General Care Nursing Unit|Completed||N/A|60||Texas Health Resources|||||f||||t||||||||||2017-02-18 15:43:34.988444|2017-02-18 15:43:34.988444
NCT00457067|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2017-01-24|||March 27, 2007||2007-03-27|October 24, 2007|2007-10-24|October 24, 2007||2007-10-24|||||Interventional|||Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation|Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia With Neovascularization|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:43:35.084526|2017-02-18 15:43:35.084526
NCT00457054|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-09-27|||July 2003||2003-07-01|September 2011|2011-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania|Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania Before and After Lithium Treatment: An Brain fMRI Study|Completed||Phase 4|60|Anticipated|Indiana University||1|||f||||f||||||||||2017-02-18 15:43:35.171963|2017-02-18 15:43:35.171963
NCT00457041|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2017-01-24|||January 17, 2007||2007-01-17|September 8, 2010|2010-09-08|September 8, 2010||2010-09-08|||||Observational|||Research Participants' Views on the Ethics of Clinical Research|Pilot Study Investigating Research Participants' Views on the Ethics of Clinical Research|Completed||N/A|11|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:43:35.272175|2017-02-18 15:43:35.272175
NCT00457028|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2011-06-07|||May 2003||2003-05-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|||||Observational|||Efficacy of Treatment for Obsessive Compulsive Disorder|Efficacy of Treatment for Obsessive Compulsive Disorder|Completed||N/A|250|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 15:43:35.352955|2017-02-18 15:43:35.352955
NCT00457015|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2016-06-28|2009-12-30||April 2007||2007-04-01|June 2016|2016-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)|EDEMA4: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of DX-88 (Ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema|Completed||Phase 3|96|Actual|Shire||2|||f||||t||||||||||2017-02-18 15:43:35.444764|2017-02-18 15:43:35.444764
NCT00457002|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-12-07|2014-04-14||June 2007||2007-06-01|May 2014|2014-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|ADOPT|Randomized Participants|Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness|A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.|Completed||Phase 3|6758|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 15:43:36.227088|2017-02-18 15:43:36.227088
NCT00456989|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2014-10-06|2014-10-06||January 2004||2004-01-01|October 2014|2014-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer|Phase I/II Study of Docetaxel (Taxotere) in Combination With Doxorubicin HCI Liposome Injection (Doxil) in Advanced Androgen-Independent Prostate Cancer (AIPC)|Completed||Phase 1/Phase 2|39|Actual|James Graham Brown Cancer Center||1|||f||||f||||||||||2017-02-18 15:43:39.769667|2017-02-18 15:43:39.769667
NCT00456976|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2008-07-22|||April 2007||2007-04-01|July 2008|2008-07-01|September 2007||2007-09-01|||||Interventional|||Efficacy of Selegiline in Negative Symptoms of Schizophrenia|Efficacy of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Inpatients With Chronic Schizophrenia|Completed||Early Phase 1|70||Tabriz University|||||f||||t||||||||||2017-02-18 15:43:40.069531|2017-02-18 15:43:40.069531
NCT00456963|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2011-07-04|||September 2007||2007-09-01|July 2011|2011-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|PHIDIAS||Prevention of Diabetes and Hypertension|Prevention of Hypertension Incidence and Diabetes Italian Assessment Study. Therapeutic Strategies of Prevention of Diabetes and Hypertension in Subjects With Metabolic Syndrome and High-Normal Blood Pressure.|Terminated||Phase 4|3000|Anticipated|Istituto Auxologico Italiano||3||"Because of delay in approval of the protocol by a number of Ethics Commitees the trial was~   terminated on March 4, 2010. No patient had received any study drug."|f||||t||||||||||2017-02-18 15:43:40.156061|2017-02-18 15:43:40.156061
NCT00456950|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2009-09-23|||October 2005||2005-10-01|September 2009|2009-09-01||||June 2008|Actual|2008-06-01||Observational|||Magnetic Resonance Imaging of the Coronary Vessel Wall|Detection of Vulnerable Plaque With Coronary Vessel Wall Magnetic Resonance Imaging|Completed||N/A|75|Actual|Maastricht University Medical Center|||2||f||||f||||||||||2017-02-18 15:43:40.286169|2017-02-18 15:43:40.286169
NCT00456937|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-03|2009-01-26|||July 2006||2006-07-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Escitalopram in Schizophrenia in OCD- Open Label Study|Escitalopram in the Treatment of Patient Suffering From Scizophrenia and Obsessive Compulsive Disorder- an Open Label Study|Completed||Phase 4|15|Anticipated|BeerYaakov Mental Health Center|||||f||||f||||||||||2017-02-18 15:43:40.361922|2017-02-18 15:43:40.361922
NCT00456924|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2010-06-16|||January 2004||2004-01-01|June 2010|2010-06-01|December 2004|Actual|2004-12-01|||||Interventional|||Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914|Prospective Randomized Multicenter Phase II Study of the Dose-Response Effects of Continuous Administration of Low-Dose VA2914 on Parameters of the Hypothalamic-Pituitary-Gonadal Axis and the Endometrium|Completed||Phase 2|48||HRA Pharma|||||f||||f||||||||||2017-02-18 15:43:40.446982|2017-02-18 15:43:40.446982
NCT00456911|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2008-02-12|||March 2005||2005-03-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Interventional|ELPAS||Family Dietary Coaching to Improve Nutritional Intakes and Body Weight Control|Prospective Longitudinal Study on Health and Diet (Etude Longitudinale Prospective Alimentation et Santé)|Completed||N/A|2020||Centre d'Etudes et de Documentation du Sucre|||||f||||t||||||||||2017-02-18 15:43:40.544703|2017-02-18 15:43:40.544703
NCT00456898|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-12-19|||January 2007||2007-01-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway|A Randomized, Open-Label, 3-Period Crossover Study to Evaluate the Effect of Multiple Doses of DVS SR and Paroxetine on the CYP2D6 Biotransformation of Codeine to Morphine in Healthy Subjects.|Completed||Phase 1|40||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:43:40.655077|2017-02-18 15:43:40.655077
NCT00456885|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2012-02-24|||April 2007||2007-04-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women|The Effect of Exenatide on Body Weight, Energy Expenditure and Hunger in Obese Women Without Diabetes Mellitus|Completed||Phase 4|42|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 15:43:40.737235|2017-02-18 15:43:40.737235
NCT00347711|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-07-03||||||June 2006|2006-06-01||||||||Interventional|||Bevacizumab and Retinal Vascular Occlusions||Unknown status|Recruiting|Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:25:42.703286|2017-02-18 16:25:42.703286
NCT00456872|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2012-04-13|||December 2004||2004-12-01|April 2012|2012-04-01|May 2007|Actual|2007-05-01|June 2006|Actual|2006-06-01||Observational|||Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies|A Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies|Completed||N/A|49|Actual|Ohio State University Comprehensive Cancer Center|||1||f||||t||||||||||2017-02-18 15:43:40.839935|2017-02-18 15:43:40.839935
NCT00456859|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-10-17|||April 2004||2004-04-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|CAP-KD||Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease|Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease (CAP-KD)|Completed||Phase 4|450||Institute for Health Outcomes and Process Evaluation Reseach|||||f||||t||||||||||2017-02-18 15:43:41.090194|2017-02-18 15:43:41.090194
NCT00456846|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2016-04-27|2014-06-19||February 2008||2008-02-01|April 2016|2016-04-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional||Treated Population|First Line Therapy for Patients With Metastatic Breast Cancer|An Open-Label, Phase II Study of Weekly ABI-007 as First Line Therapy for Patients With Metastatic Breast Cancer|Terminated||Phase 2|123|Actual|Celgene Corporation||1|||f||||f||||||||||2017-02-18 15:43:41.19838|2017-02-18 15:43:41.19838
NCT00456833|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2012-04-12|||June 2005||2005-06-01|April 2012|2012-04-01||||March 2011|Actual|2011-03-01||Interventional|||Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy|A Combined Phase 1 and 2 Study Investigating the Combination of RAD001 and Erlotinib in Patients With Advanced NSCLC Previously Treated Only With Chemotherapy|Completed||Phase 1|248|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:43:42.331669|2017-02-18 15:43:42.331669
NCT00456820|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-10-15|||July 2004||2004-07-01|April 2007|2007-04-01|November 2007||2007-11-01|||||Interventional|||Wellbutrin XL Effects on SSRIs Induced Changes|Wellbutrin XL Effects on SSRIs Induced Changes in the Reactivity of the Frontal Cortex and Limbic System to Emotional Stimuli: An fMRI Study|Completed||Phase 4|15||Indiana University|||||f||||||||||||||2017-02-18 15:43:42.448057|2017-02-18 15:43:42.448057
NCT00456807|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2016-11-03|2009-11-12||April 2007||2007-04-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years|Complementary Testing to Further Evaluate the Immunogenicity of a GSK Biologicals' HPV Vaccine (580299) in Healthy Female Subjects Aged Over 26 Years Enrolled in Study 104820.|Completed||Phase 3|100|Actual|GlaxoSmithKline|No safety data were collected in the framework of this ancillary study.|2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:43:42.544417|2017-02-18 15:43:42.544417
NCT00456794|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2016-07-13|||March 2002||2002-03-01|July 2016|2016-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa|A 12-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study of the Efficacy of Doses of 20 and 60 mg/Day Istradefylline as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa|Completed||Phase 2|325||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-02-18 15:43:42.984301|2017-02-18 15:43:42.984301
NCT00456781|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2014-07-02|||April 2007||2007-04-01|July 2014|2014-07-01|March 2011|Actual|2011-03-01|April 2009|Actual|2009-04-01||Interventional|||Use of Graft Jacket for Rotator Cuff Repair|GraftJacket® Rotator Cuff Tendon Reinforcement Scaffold: A Randomized Prospective Clinical Evaluation|Completed||N/A|79|Actual|Wright Medical Technology||2|||f||||f||||||||||2017-02-18 15:43:43.07637|2017-02-18 15:43:43.07637
NCT00456768|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2011-04-28|||May 2003||2003-05-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Efficacy of Treatment for Panic Disorder|Efficacy of Treatment for Panic Disorder|Completed||N/A|250|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 15:43:43.190295|2017-02-18 15:43:43.190295
NCT00456755|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2009-11-23|2009-11-23||March 2004||2004-03-01|November 2009|2009-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Herbal Treatment for Perennial Allergic Rhinitis|A Herbal Formula (SBL) for the Treatment of Perennial Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 2|126|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 15:43:43.279532|2017-02-18 15:43:43.279532
NCT00456742|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2012-04-30|||June 2006||2006-06-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|||||Observational|||Efficacy of Treatment for Generalized Anxiety Disorder|Efficacy of Treatment for Generalized Anxiety Disorder|Completed||N/A|250|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 15:43:43.650003|2017-02-18 15:43:43.650003
NCT00456729|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04|||May 2006||2006-05-01|January 2007|2007-01-01|July 2006|Actual|2006-07-01|||||Interventional|||Malabsorption as a Cause of Iron Treatment Failure in Infants|Malabsorption as a Cause of Iron Treatment Failure in Infants - A Clinical Observational Study|Completed||N/A|100||HaEmek Medical Center, Israel|||||f||||f||||||||||2017-02-18 15:43:43.736875|2017-02-18 15:43:43.736875
NCT00456716|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2010-03-02|||March 2007||2007-03-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma|A Phase II Trial of Sorafenib in BAC or Never-Smokers With Any Lung Adenocarcinoma|Completed||Phase 2|5|Actual|Swedish Medical Center||1|||f||||f||||||||||2017-02-18 15:43:43.823965|2017-02-18 15:43:43.823965
NCT00456703|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2016-01-15|||July 2008||2008-07-01|January 2016|2016-01-01|December 2009|Anticipated|2009-12-01|July 2009|Anticipated|2009-07-01||Interventional|||Restricted Fluid Regimen in Open Abdominal Bowel Surgery|Safety and Efficacy of Restricted Fluid Regimen in Open Abdominal Bowel Surgery|Withdrawn||N/A|0|Actual|Beth Israel Deaconess Medical Center||1||Lack of funding|f||||f||||||||||2017-02-18 15:43:43.937468|2017-02-18 15:43:43.937468
NCT00456690|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-08-30|||May 2007||2007-05-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Endocrine and Nutritional Assessment in B Thalassemia Major|Endocrine and Nutritional Assessment in B Thalassemia Major - A Clinical Trial|Completed||N/A|133|Actual|HaEmek Medical Center, Israel||1|||f||||f||||||||||2017-02-18 15:43:44.057413|2017-02-18 15:43:44.057413
NCT00456677|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04|||June 1996||1996-06-01|April 2007|2007-04-01|October 2007|Anticipated|2007-10-01|||||Interventional|Mino||Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma|Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma|Unknown status|Active, not recruiting|Phase 2|20||State University of New York - Downstate Medical Center|||||f||||f||||||||||2017-02-18 15:43:44.165193|2017-02-18 15:43:44.165193
NCT00456664|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2009-02-01|||November 2006||2006-11-01|May 2008|2008-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||CMV Disease and IRIS in HIV-1 Infected Persons|Molecular Diagnostics for CMV Disease and IRIS in HIV-1 Infected Persons, and the Mechanism Study for CMV Alternative Gene Splicing in Immediate Early Protein|Completed||N/A|200|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||||||||||||2017-02-18 15:43:44.266937|2017-02-18 15:43:44.266937
NCT00456651|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2007-04-04|||February 2007||2007-02-01|April 2007|2007-04-01||||||||Interventional|||Sleep Apnea-Hypopnea Syndrome and the Pathogenesis of Obesity|Sleep Apnea-Hypopnea Syndrome and the Pathogenesis of Obesity|Unknown status|Recruiting|N/A|40||Sociedad Española de Neumología y Cirugía Torácica|||||f||||t||||||||||2017-02-18 15:43:44.351969|2017-02-18 15:43:44.351969
NCT00456638|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2014-08-13|||April 2008||2008-04-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Clinical Study of Depodur Efficacy in Decreasing Post Operative Pain After Off Pump Coronary Artery Bypass Grafting (OP-CABG)|Clinical Study of Depodur Efficacy in Decreasing Post Operative Pain After Off Pump Coronary Artery Bypass Grafting (OP-CABG)|Withdrawn||N/A|0|Actual|Drexel University||2||Difficulty aquiring investigational drug|f||||f||||||||||2017-02-18 15:43:44.573082|2017-02-18 15:43:44.573082
NCT00456625|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2016-11-03|2009-01-15||April 2007||2007-04-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.|To Evaluate Immune Response to a Hepatitis B Vaccine (Engerix™-B ) Challenge Dose in Healthy Subjects Who Received GSK Biologicals' Hepatitis B Vaccine (Engerix™-B ) Approximately 20 Years Ago as Primary Vaccination at 0, 1, 2 and 12 Months.|Completed||Phase 4|76|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:43:44.684337|2017-02-18 15:43:44.684337
NCT00456612|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-12-18|2011-06-22||February 2007||2007-02-01|December 2015|2015-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Radiosurgery for Glioblastoma Multiforme|Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status|Terminated||Phase 1/Phase 2|4|Actual|Beth Israel Deaconess Medical Center|Early termination due to difficulty in recruitment and retaining due to extremely bad prognosis of disease|1||Poor accrual|f||||f||||||||||2017-02-18 15:43:44.923542|2017-02-18 15:43:44.923542
NCT00456599|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-04|2015-11-04|2014-03-04||April 2007||2007-04-01|November 2015|2015-11-01|January 2013|Actual|2013-01-01|May 2012|Actual|2012-05-01||Interventional||68 patients were evaluable. 71 patients were enrolled however 1 was removed from study during cycle 1 due to non-compliance and 2 additional patients withdrew for reasons not related to toxicity or progression.|Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer|A Multi-Institutional Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer|Completed||Phase 2|71|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 15:43:45.165439|2017-02-18 15:43:45.165439
NCT00456300|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2010-11-30|||March 2007||2007-03-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Role of Exenatide in Type 1 Diabetes|The Role of Exenatide in Type 1 Mellitus|Completed||Phase 4|17|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 15:43:45.494624|2017-02-18 15:43:45.494624
NCT00456287|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2007-04-02|||February 2007||2007-02-01|April 2007|2007-04-01||||||||Interventional|||Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome|Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome. Implications in the Precipitation of Cardiovascular Events|Unknown status|Recruiting|N/A|40||Sociedad Española de Neumología y Cirugía Torácica|||||f||||t||||||||||2017-02-18 15:43:45.775|2017-02-18 15:43:45.775
NCT00456274|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2014-07-31|||September 1999||1999-09-01|July 2014|2014-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Baselines in Reproductive Disorders|Baselines in Reproductive Disorders|Recruiting||N/A|180|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:43:45.870353|2017-02-18 15:43:45.870353
NCT00456261|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2013-01-23|2013-01-23||March 2007||2007-03-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|February 2010|Actual|2010-02-01||Interventional|||First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC|A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|110|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 15:43:45.998955|2017-02-18 15:43:45.998955
NCT00456248|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2012-10-11|||February 2007||2007-02-01|October 2012|2012-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|ENHANCE||Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin|Phase 4 Study Using Infergen and Ribavirin in Patients With Chronic Hepatitis C Virus Who Achieved Partial Response to Peginterferon-alfa and Ribavirin Therapy|Terminated||Phase 4|5|Actual|Kadmon Pharmaceuticals||3||slow enrollment|f||||t||||||||||2017-02-18 15:43:46.675409|2017-02-18 15:43:46.675409
NCT00456235|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2013-04-16|||September 2006||2006-09-01|April 2007|2007-04-01|September 2011|Actual|2011-09-01|September 2009|Actual|2009-09-01||Interventional|MONOCEPT||Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors|Interruption of the Calcineurine Inhibitors (ICN) and Introduction of Mycophenolate Mofetil (MMF) in Liver Transplant Patients With Side Effects Due to ICN: Study of the Reduction of the Risks of Rejection by Mycophenolate Mofetil Therapeutic Drug Monitoring|Completed||Phase 4|92|Actual|University Hospital, Limoges||2|||f||||||||||||||2017-02-18 15:43:46.783985|2017-02-18 15:43:46.783985
NCT00456222|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2009-08-20|||June 2003||2003-06-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|July 2007|Actual|2007-07-01||Observational|||Impact of Sleep Disruption on the Menstrual Cycle|Impact of Sleep Disruption on the Menstrual Cycle|Completed||N/A|18|Actual|Brigham and Women's Hospital|||2||f||||f||||||Samples Without DNA|"~     Blood/plasma~   "|||2017-02-18 15:43:46.907181|2017-02-18 15:43:46.907181
NCT00456209|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2014-02-01|||December 2006||2006-12-01|February 2014|2014-02-01|June 2011|Actual|2011-06-01|December 2008|Actual|2008-12-01||Observational|||Lived Experiences of Adolescents in the Treatment Process of Cancer and the Impact on Occupations|Lived Experiences of Adolescents in the Treatment Process of Cancer and the Impact of Occupations|Completed||N/A|4|Actual|Hackensack University Medical Center|||1||f||||f||||||||||2017-02-18 15:43:47.006727|2017-02-18 15:43:47.006727
NCT00456196|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2009-07-09|||April 2006||2006-04-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Epidemiology of Venous Thromboembolism|Epidemiology of Venous Thromboembolism: Analyses and Publications From the DVT FREE Database|Completed||N/A|5451|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 15:43:47.094816|2017-02-18 15:43:47.094816
NCT00456183|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-05-30|||August 2005||2005-08-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.|A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Are Latently Infected With Mycobacterium Tuberculosis.|Completed||Phase 1|12|Actual|University of Oxford||1|||f||||t||||||||||2017-02-18 15:43:47.197452|2017-02-18 15:43:47.197452
NCT00456170|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03|||April 2007||2007-04-01|April 2007|2007-04-01||||||||Interventional|HAVE||Are Sutures Required for Vaginal Hysterectomy: A Randomized Controlled Trial|Randomized Controlled Trial Comparing Traditional Vaginal Hysterectomy to Harmonic Scalpel Hysterectomy|Unknown status|Not yet recruiting|Phase 1|60||Southern Health|||||f||||t||||||||||2017-02-18 15:43:47.300735|2017-02-18 15:43:47.300735
NCT00456157|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2010-06-16|||March 2007||2007-03-01|June 2010|2010-06-01|November 2008|Actual|2008-11-01|||||Interventional|Knee OA||A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee|A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular Osteogenic Protein-1 OP-1 in Subjects With Osteoarthritis of the Knee|Completed||Phase 1|33|Anticipated|Stryker Biotech|||||f||||f||||||||||2017-02-18 15:43:47.394686|2017-02-18 15:43:47.394686
NCT00456144|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-07-09|||August 2006||2006-08-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer|Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone (GnRH) Agonist Therapy for Prostate Cancer|Completed||N/A|36|Actual|Massachusetts General Hospital|||2||f||||||||||Samples With DNA|"~     Whole blood Urine~   "|||2017-02-18 15:43:47.490961|2017-02-18 15:43:47.490961
NCT00456131|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2012-08-16|||September 2006||2006-09-01|August 2012|2012-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|Healthy Start||Prevention of Obesity at Universities: A Randomized Trial||Completed||N/A|330|Actual|Drexel University||1|||f||||t||||||||||2017-02-18 15:43:47.59684|2017-02-18 15:43:47.59684
NCT00456118|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03|||September 2006||2006-09-01|April 2007|2007-04-01||||||||Observational|||Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies|Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies|Unknown status|Recruiting|N/A|150||University Hospital, Limoges|||||f||||||||||||||2017-02-18 15:43:47.694474|2017-02-18 15:43:47.694474
NCT00456105|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2014-03-14|||July 2006||2006-07-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes|Early Post-Operative Dysglycemia in Patients With and Without Diabetes Post-Infrainguinal Bypass Surgery and the Effectiveness of a Diabetes Action Team in the Management of Diabetes Post Infrainguinal Bypass Surgery on Glycemic Control, Length of Stay, and Infection Rates: A Pilot Study|Terminated||N/A|10|Actual|University of British Columbia||3||The study was stopped due to lack of resources of the study coordinator's time|f||||f||||||||||2017-02-18 15:43:47.768357|2017-02-18 15:43:47.768357
NCT00456092|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-11-22||2013-03-28|January 2009||2009-01-01|November 2013|2013-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Phase II Study With CC-10004 in Psoriatic Arthritis|A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of CC-10004 in Subjects With Active Psoriatic Arthritis|Completed||Phase 2|204|Actual|Celgene||3|||f||||t||||||||||2017-02-18 15:43:47.876268|2017-02-18 15:43:47.876268
NCT00456066|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2008-10-07|||June 2006||2006-06-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Coronary Thromboaspiration and Infarct Size|Assessment of Efficacity of Coronary Thromboaspiration (Export System) Performed Before Angioplasty on Infarct Size in Patients Treated by Coronary Percutaneous Interventions During Acute Phase.|Terminated||N/A|50|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:43:48.174727|2017-02-18 15:43:48.174727
NCT00456053|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2007-11-02|||December 2005||2005-12-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|||A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin|A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin|Completed||Phase 2|145|Actual|FibroGen|||||f||||f||||||||||2017-02-18 15:43:48.272339|2017-02-18 15:43:48.272339
NCT00456040|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2007-04-03|||March 2007||2007-03-01|April 2007|2007-04-01|March 2007||2007-03-01|||||Observational|||Characteristics of Patients With Amyloidosis & Heart Failure Being Evaluated for a Heart Transplant|Characteristics of Patients With Systemic Amyloidosis and Severe Heart Failure Being Evaluated for a Sequential Cardiac and Autologous Stem Cell Transplantation|Completed||N/A|25||Massachusetts General Hospital|||||f||||f||||||||||2017-02-18 15:43:48.381758|2017-02-18 15:43:48.381758
NCT00456027|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2011-06-09|||December 2004||2004-12-01|April 2007|2007-04-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)|A Placebo-Controlled Study to Investigate the Impact of Diamyd® on the Diabetes Status of Patients With LADA (Latent Autoimmune Diabetes in Adult)|Completed||Phase 2|160|Actual|Diamyd Therapeutics AB||1|||f||||t||||||||||2017-02-18 15:43:48.453175|2017-02-18 15:43:48.453175
NCT00456014|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-05-10|||September 2006||2006-09-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment|Biological Predictors of Response to Antidepressants|Completed||N/A|75|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 15:43:48.55554|2017-02-18 15:43:48.55554
NCT00456001|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2009-02-26|||July 2006||2006-07-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Observational|||Heparin Induced Thrombocytopenia: Pharmacoeconomics|Study to Compare the Heparin Induced Thrombocytopenia Rates Associated With Heparin and Low Molecular Weight Heparin Usage as Well as Evaluate the Economic and Long-Term Clinical Burden of Heparin Induced Thrombocytopenia.|Completed||N/A|200|Actual|Brigham and Women's Hospital|||1||f||||t||||||||||2017-02-18 15:43:48.67131|2017-02-18 15:43:48.67131
NCT00455975|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2014-12-12|2014-12-12||February 2007||2007-02-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|July 2013|Actual|2013-07-01||Interventional|||High-dose Bevacizumab in Advanced Renal Carcinoma Patients|Phase II Trial of High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma|Completed||Phase 2|119|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 15:43:48.876808|2017-02-18 15:43:48.876808
NCT00455962|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-11-05|||January 2005||2005-01-01|November 2013|2013-11-01|December 2018|Anticipated|2018-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Race on Gonadotropin Responses|Effect of Race on Gonadotropin Responses to Short Term Negative and Positive Feedback Effects of Gonadal Steroids|Active, not recruiting||N/A|60|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-02-18 15:43:49.489518|2017-02-18 15:43:49.489518
NCT00455949|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03||||||April 2007|2007-04-01||||||||Observational|||Effect of Premature Luteinization on the Oocyte Quality in Oocyte Donation Program.||Completed||N/A|||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||f||||||||||2017-02-18 15:43:49.598805|2017-02-18 15:43:49.598805
NCT00455936|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2010-10-22|||October 2005||2005-10-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|||First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker|A Randomized Phase III Study of Gefitinib (IRESSATM) Versus Standard Chemotherapy (Gemcitabine Plus Cisplatin) as First-line Treatment for in Never Smokers Advance or Metastatic Adenocarcinoma of Lung|Completed||Phase 3|315|Actual|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 15:43:49.668582|2017-02-18 15:43:49.668582
NCT00455923|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2012-05-31|||May 2005||2005-05-01|January 2012|2012-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)|SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII)|Completed||Phase 4|100||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:43:52.410716|2017-02-18 15:43:52.410716
NCT00455910|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03|||January 2003||2003-01-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200|Thalidomide for the Treatment of Cytopenias of Patients With Low Risk Myelodysplastic Syndromes|Completed||Phase 2|112||Groupe Francophone des Myelodysplasies|||||f||||t||||||||||2017-02-18 15:43:52.53209|2017-02-18 15:43:52.53209
NCT00455897|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2012-10-23|||December 2006||2006-12-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma|Phase II Trial of CHOP-Rituximab Augmented With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma|Terminated||Phase 2|5|Actual|Massachusetts General Hospital||1||Accrual was too slow. Trial terminated|f||||||||||||||2017-02-18 15:43:52.65188|2017-02-18 15:43:52.65188
NCT00455884|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2012-04-03|||June 2006||2006-06-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|||||Observational|||A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency|International Cooperative Metabolic Study (iNCMS) of NutropinAq® [Somatropin (rDNA Origin) Injection] Replacement Therapy in Adults With Growth Hormone Deficiency|Completed||Phase 4|546|Actual|Ipsen|||1||f||||f||||||||||2017-02-18 15:43:52.765168|2017-02-18 15:43:52.765168
NCT00455871|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2008-05-06|||April 2007||2007-04-01|May 2008|2008-05-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|||Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD|An Open-Label, Single-Site, Comparative, Pilot Study of the Treatment Effects of Combination Therapy of Lucentis (Ranibizumab) Plus Reduced Fluence Photodynamic Therapy With Visudyne in Patients With Exudative Age-Related Macular Degeneration (AMD)|Unknown status|Recruiting|N/A|30|Anticipated|Barnes Retina Institute||2|||f||||t||||||||||2017-02-18 15:43:52.846429|2017-02-18 15:43:52.846429
NCT00455858|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2014-11-25|2009-12-16||November 2007||2007-11-01|November 2014|2014-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea|A 20-week, Multi-centre, Open-labelled, Non-comparative Evaluation of the Safety and Efficacy of Insulin Detemir in Combination With Oral Anti-diabetic Drug(s), in Subjects With Type 2 Diabetes Mellitus Who Were Inadequately Controlled on Current Therapy in Korea|Completed||Phase 4|87|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 15:43:52.959666|2017-02-18 15:43:52.959666
NCT00455845|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2011-03-01|||April 2007||2007-04-01|April 2007|2007-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Effectiveness of Lng IUD for Treatment of the Patient Undergone Conservative Surgery for Pelvic Endometriosis|A Double Blind Randomized Controlled Trial to Study the Effectiveness of a Levonorgestrel Releasing Intrauterine Device for the Treatment of Pelvic Pain or Dysmenorrhea in the Patients Undergone Conservative Surgery for Pelvic Endometriosis|Completed||Phase 3|54|Anticipated|Mahidol University||2|||f||||f||||||||||2017-02-18 15:43:53.495716|2017-02-18 15:43:53.495716
NCT00455832|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2012-02-28|||November 2006||2006-11-01|February 2012|2012-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|IRIS||Influence of Ribavirin and Interferon on Semen Quality, IRIS Study|Influence of Ribavirin and Interferon on Semen Quality, IRIS Study|Completed||N/A|23|Actual|Foundation for Liver Research|||1||f||||f||||||||||2017-02-18 15:43:53.623964|2017-02-18 15:43:53.623964
NCT00455819|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2009-03-30|||December 2006||2006-12-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Home Treatment of Patients With Pulmonary Embolism Based on Pro-Brain Natriuretic Peptide (BNP) Levels|Home Treatment of Patients With Pulmonary Embolism Based on Pro-BNP Levels|Completed||N/A|150|Actual|St. Antonius Hospital|||||f||||t||||||||||2017-02-18 15:43:53.734265|2017-02-18 15:43:53.734265
NCT00455806|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03|||January 2007||2007-01-01|March 2007|2007-03-01|February 2008|Anticipated|2008-02-01|||||Interventional|ESAMOX||Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection|Randomized, Controlled, Multicenter Phase III Study for the Efficacy and Tolerability of Triple Therapy With Esomeprazole, Moxifloxacin and Amoxicillin for Rescue Therapy of Helicobacter Pylori Infection|Unknown status|Recruiting|Phase 3|132||Technische Universität Dresden|||||f||||t||||||||||2017-02-18 15:43:53.832398|2017-02-18 15:43:53.832398
NCT00455793|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-11-27|||June 2006||2006-06-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Subclinical Atherosclerosis in HIV-infected Patients|Subclinical Atherosclerosis in HIV-infected Patients|Completed||N/A|263|Actual|Massachusetts General Hospital|||2||f||||f||||||Samples With DNA|"~     DNA~   "|||2017-02-18 15:43:53.956512|2017-02-18 15:43:53.956512
NCT00455767|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2008-06-23|||July 2006||2006-07-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients|Phase IIA Multicenter 1 Week Treatment, Randomised, Double-Blind, Placebo Controlled Study of Depelestat in Patients Suffering From Acute Respiratory Distress Syndrome|Completed||Phase 2|84|Actual|Debiopharm International SA||2|||f||||t||||||||||2017-02-18 15:43:54.182545|2017-02-18 15:43:54.182545
NCT00455754|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2007-04-03|||February 2007||2007-02-01|February 2007|2007-02-01|December 2009|Anticipated|2009-12-01|||||Interventional|LYNEX||Esomeprazole Treatment for Patients With Lymphocytic Gastritis|Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on the Efficacy of Esomeprazole Treatment for Patients With Lymphocytic Gastritis|Unknown status|Recruiting|Phase 3|40||Technische Universität Dresden|||||f||||t||||||||||2017-02-18 15:43:54.321642|2017-02-18 15:43:54.321642
NCT00455741|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-10-31|||November 2000||2000-11-01|October 2013|2013-10-01|January 2018|Anticipated|2018-01-01|February 2007|Actual|2007-02-01||Interventional|||Postmenopausal Women Estrogen and Progesterone Infusion|Effect of Age on Gonadotropin Responses to Short-Term Negative and Positive Feedback Effects of Gonadal Steroids Using PET Scanning|Active, not recruiting||N/A|40|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:43:54.413967|2017-02-18 15:43:54.413967
NCT00455728|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2017-01-30|||June 2006|Actual|2006-06-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|iNCGS||A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders|International Cooperative Growth Study (iNCGS) Post Marketing Surveillance Program for NutropinAq® [Somatropin (rDNA Origin) Injection]|Completed||N/A|3690|Actual|Ipsen|||1||f||||f||||||||||2017-02-18 15:43:54.521004|2017-02-18 15:43:54.521004
NCT00455715|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2011-06-27|||February 2006||2006-02-01|June 2011|2011-06-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Interventional|||A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia|A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia|Completed||Phase 4|18|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 15:43:54.599616|2017-02-18 15:43:54.599616
NCT00455702|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2014-07-14|2014-06-11||July 2004||2004-07-01|July 2014|2014-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia|Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals|Completed||Phase 4|38|Actual|Massachusetts General Hospital|As the first study of once-weekly dosing in Schizophrenia, this study was exploratory and so results must be considered preliminary. Additional studies are needed to replicate these findings.|2|||f||||f||||||||||2017-02-18 15:43:54.704486|2017-02-18 15:43:54.704486
NCT00455689|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2012-04-25|||November 2005||2005-11-01|April 2012|2012-04-01|October 2012|Anticipated|2012-10-01|September 2007|Actual|2007-09-01||Interventional|||Understanding Experimentally Induced Hot Flushes|Understanding Experimentally Induced Hot Flushes|Unknown status|Active, not recruiting|Phase 2/Phase 3|33|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 15:43:55.126003|2017-02-18 15:43:55.126003
NCT00455676|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2008-12-29|||June 2006||2006-06-01|December 2008|2008-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Chevron Osteotomy Versus SCARF Osteotomy in the Treatment of Hallux Valgus|Chevron Osteotomy Versus SCARF Osteotomy in the Treatment of Hallux Valgus|Completed||N/A|74||University Hospital, Limoges|||||f||||f||||||||||2017-02-18 15:43:55.23586|2017-02-18 15:43:55.23586
NCT00455663|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2015-05-29|2013-08-08||November 2000||2000-11-01|May 2015|2015-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia|Medication Adherence and Outcomes in Schizophrenia|Completed||N/A|105|Actual|The University of Texas Health Science Center at San Antonio|Subjects were ill for a long-period of time|3|||f||||t||||||||||2017-02-18 15:43:55.330177|2017-02-18 15:43:55.330177
NCT00455650|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-11-06|||March 2007||2007-03-01|November 2013|2013-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Study of the Effects of Mecamylamine and Varenicline in Schizophrenia|Cognitive Effects of Mecamylamine and Varenicline in Schizophrenia|Completed||N/A|71|Actual|Massachusetts General Hospital||3|||f||||f||||||||||2017-02-18 15:43:55.977819|2017-02-18 15:43:55.977819
NCT00455637|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-03|2008-06-18|||March 2007||2007-03-01|June 2008|2008-06-01||||||||Interventional|||Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?|A Phase II, Randomised, Double-Blind, Dose-Ranging Study in Children and Young People to Determine the Optimal Dose of Botulinum Toxin Type-A (Dysport®) in Managing the Symptoms of Hip Muscle Spasticity Due to Cerebral Palsy|Terminated||Phase 2|40|Anticipated|Ipsen||||Low levels of recruitment|f||||f||||||||||2017-02-18 15:43:56.10633|2017-02-18 15:43:56.10633
NCT00455624|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-07-09|||November 2002||2002-11-01|July 2013|2013-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer|Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer|Completed||N/A|60|Actual|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 15:43:56.19466|2017-02-18 15:43:56.19466
NCT00455611|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-03-07|||May 2006||2006-05-01|April 2007|2007-04-01||||December 2012|Anticipated|2012-12-01||Interventional|||Effects of CPAP on Ventricular Function Modifications|Evaluation of the Effects of Intra-thoracic Positive Pressure Applicated With CPAP (Continuous Positive Airway Pressure) on Ventricular Function in Patients With Chronic Heart Failure: Modification Induced on Baroreflex Sensitivity|Withdrawn||N/A|0|Actual|Ospedale S. Giovanni Bosco||||No patients enrolled in the study|f||||t||||||||||2017-02-18 15:43:56.297813|2017-02-18 15:43:56.297813
NCT00455598|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2009-08-26|||February 2007||2007-02-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea|A Phase 2, Multi Center, Randomized, Double Blind, Placebo Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, PK, & Activity of ISIS 113715 Administered Weekly in Subjects With Type 2 DM Treated w/ Sulfonylurea|Completed||Phase 2|88|Actual|Ionis Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 15:43:56.396283|2017-02-18 15:43:56.396283
NCT00455585|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2008-02-07|||January 2007||2007-01-01|February 2008|2008-02-01|November 2007|Actual|2007-11-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products|Comparison of the Steady State Pharmacokinetics of Nevirapine, Stavudine Plus Lamivudine in HIV Positive Ugandan Patients Taking Triomune 40 With the Pharmacokinetics of the Originator Products.|Completed||Phase 4|18||Makerere University|||||f||||f||||||||||2017-02-18 15:43:56.554089|2017-02-18 15:43:56.554089
NCT00455572|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2017-01-09|||May 2007||2007-05-01|January 2017|2017-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer|Cancer Immunotherapeutic GSK1572932A as Adjuvant Therapy for Patients With MAGE-A3-positive Non-Small Cell Lung Cancer|Terminated||Phase 1|71|Actual|GlaxoSmithKline||4||"Study early termination was due to slow recruitment and difficulties at achieving the required~   enrolment for the study."|f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:43:56.666939|2017-02-18 15:43:56.666939
NCT00455559|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2014-02-14|||August 2006||2006-08-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|November 2010|Actual|2010-11-01||Interventional|||Ph II Study of Perifosine Plus Gleevec for Patients With GIST|A Phase II Study of Perifosine Plus Imatinib Mesylate for Patients With Resistant Gastrointestinal Stromal Tumor|Completed||Phase 2|40|Actual|AEterna Zentaris||2|||f||||f||||||||||2017-02-18 15:43:56.814711|2017-02-18 15:43:56.814711
NCT00455546|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2010-02-01|||April 2007||2007-04-01|January 2008|2008-01-01|September 2007||2007-09-01|||||Interventional|PLASMA||PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease|PLASMA Trial: Phospholipase Levels And Serological Markers of Atherosclerosis: A Dose-Response Clinical Pharmacology Study of A-002 In Subjects With Stable Coronary Artery Disease|Completed||Phase 2|400|Actual|Anthera Pharmaceuticals|||||f||||f||||||||||2017-02-18 15:43:56.927442|2017-02-18 15:43:56.927442
NCT00455533|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2016-01-25|2011-03-04||October 2007||2007-10-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer|A Randomized Phase II Biomarker Neoadjuvant Study of Sequential AC Followed by Ixabepilone Compared to Sequential AC Followed by Paclitaxel in Women With Early Stage Breast Cancer|Completed||Phase 2|384|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 15:43:57.094923|2017-02-18 15:43:57.094923
NCT00455520|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-01|2013-07-12|2009-08-19||April 2007||2007-04-01|July 2013|2013-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy|A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of CG5503 Extended Release (ER) in Subjects With Painful Diabetic Peripheral Neuropathy|Completed||Phase 3|395|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-02-18 15:43:59.664286|2017-02-18 15:43:59.664286
NCT00455507|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2012-08-28|||March 2007||2007-03-01|August 2012|2012-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa|Placebo-controlled, Double-blind, Parallel Group, Fixed Dose Study of KW-6002 (Istradefylline) in the Treatment of Parkinson's Disease (Phase 2 Study)|Completed||Phase 2|363|Actual|Kyowa Hakko Kirin Co., Ltd||3|||f||||f||||||||||2017-02-18 15:44:00.490631|2017-02-18 15:44:00.490631
NCT00455494|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2007-04-02|||March 2007||2007-03-01|April 2007|2007-04-01||||||||Interventional|||Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial|Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial|Unknown status|Recruiting|Phase 1|14||Tulane University Health Sciences Center|||||f||||t||||||||||2017-02-18 15:44:00.609884|2017-02-18 15:44:00.609884
NCT00455468|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-01|2011-07-11|||December 2005||2005-12-01|March 2007|2007-03-01|April 2009|Actual|2009-04-01|December 2007|Actual|2007-12-01||Interventional|||Randomized Controlled Trial (RCT) in Children With Severe Pneumonia||Completed||N/A|368|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||t||||||||||2017-02-18 15:44:00.717342|2017-02-18 15:44:00.717342
NCT00455455|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2010-06-09|2010-01-05||March 2007||2007-03-01|June 2010|2010-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Corneal and Conjunctival Sensitivity and Staining Study|Corneal and Conjunctival Sensitivity and Staining Study|Completed||Phase 4|50|Actual|University of Waterloo|Sample size completed as anticipated.|2|||f||||f||||||||||2017-02-18 15:44:00.825316|2017-02-18 15:44:00.825316
NCT00455442|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2008-09-18|||March 2007||2007-03-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|||||Interventional|||A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain|A Two-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain in Healthy Male Volunteers|Completed||Phase 2|57|Actual|Corcept Therapeutics|||||f||||t||||||||||2017-02-18 15:44:01.225119|2017-02-18 15:44:01.225119
NCT00455429|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-01|2014-02-11|2013-02-28||April 2007||2007-04-01|February 2014|2014-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis|A Double-Blind, Randomized, Placebo-Controlled, Sequential Cohort Exploratory Study of the Safety and Efficacy of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis That is Moderate in Severity|Terminated||Phase 2|84|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Participants were not enrolled into JNJ-26113100(250 mg) twice daily dose because the study was stopped during 100mg twice daily dose due to preclinical finding of retinal atrophy in high dose group(150 mg/kg) of 6-month, albino rat toxicology study.|5||The study was stopped due to a non-clinical safety finding.|f||||t||||||||||2017-02-18 15:44:01.33868|2017-02-18 15:44:01.33868
NCT00455416|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2008-05-20|||April 2007||2007-04-01|April 2007|2007-04-01|December 2009|Anticipated|2009-12-01|April 2009|Anticipated|2009-04-01||Interventional|KLYMF||Dietary Intervention in Follicular Lymphoma|Dietary Intervention in Stage III/IV Follicular Lymphoma. Impact on Markers of Cell Proliferation, Apoptosis, Host Immune Cell Infiltrate and Oxidative Stress.|Unknown status|Recruiting|Phase 2|45|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-02-18 15:44:02.592246|2017-02-18 15:44:02.592246
NCT00455403|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2016-10-31|||April 2006||2006-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|ARCH-MS||Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)|Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3|Active, not recruiting||N/A|150|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 15:44:02.704796|2017-02-18 15:44:02.704796
NCT00455390|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2007-04-02|||January 2007||2007-01-01|April 2007|2007-04-01|April 2009|Anticipated|2009-04-01|||||Interventional|IPPI A||Evaluation of the Effects of Post-Immediate Psychotherapeutic Interventions in Secondary Prevention of Psychotraumatic Disorders|Evaluation of the Effects of Post-Immediate Psychotherapeutic Interventions in Secondary Prevention of Psychotraumatic Disorders|Unknown status|Recruiting|Phase 3|330||Groupe Francais d'Epidemiologie Psychiatrique|||||f||||f||||||||||2017-02-18 15:44:02.831451|2017-02-18 15:44:02.831451
NCT00455377|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2013-06-12|||March 2007||2007-03-01|June 2013|2013-06-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Observational|SPUTUM||Lung Function and Airway Inflammation in Portland Cement Workers|Airway Inflammation in Cement Dust Exposed Workers|Completed||N/A|72|Actual|Sykehuset Telemark|||1||f||||f||||||Samples Without DNA|"~     Induced sputum samples and blood samples~   "|||2017-02-18 15:44:02.933105|2017-02-18 15:44:02.933105
NCT00455364|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-02-05|||April 2007||2007-04-01|February 2013|2013-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|VORI||Voriconazole as Prophylactic Therapy in Lung Transplant Recipients|Assessment of Safety and Efficacy of Voriconazole as Prophylactic Antifungal Therapy for Lung Transplant Recipients|Terminated||Phase 4|20|Anticipated|University of Chicago||||Protocol never received funding.|f||||f||||||||||2017-02-18 15:44:03.035197|2017-02-18 15:44:03.035197
NCT00455351|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2011-07-21|||February 2007||2007-02-01|July 2011|2011-07-01|August 2009|Actual|2009-08-01|||||Interventional|PRAVO||Vorinostat and Palliative Radiotherapy|Phase I Study on Suberoylanilide Hydroxyamic Acid (Vorinostat) a Histone Deacetylase Inhibitor, in Palliative Radiotherapy for Advanced Tumors.|Completed||Phase 1|20|Anticipated|Oslo University Hospital||1|||f||||f||||||||||2017-02-18 15:44:03.144855|2017-02-18 15:44:03.144855
NCT00455338|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2007-04-02|||May 2005||2005-05-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Effect of Meal Composition on Postprandial Testosterone Concentration in Women With Polycystic Ovary Syndrome|The Effect of Meals of Varying Fat and Fiber Content on Postprandial Testosterone Concentration in Women With Polycystic Ovary Syndrome|Completed||N/A|16||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||f||||||||||2017-02-18 15:44:03.255071|2017-02-18 15:44:03.255071
NCT00455325|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2016-10-31|||March 2007||2007-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|ARCH-MS||Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)|Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome-AIM 2|Active, not recruiting||Phase 2|35|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-02-18 15:44:03.347194|2017-02-18 15:44:03.347194
NCT00455312|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2016-01-21|||August 2007||2007-08-01|January 2016|2016-01-01|November 2016|Anticipated|2016-11-01|March 2015|Actual|2015-03-01||Interventional|||SCT for Dyskeratosis Congenita or SAA|Hematopoietic Stem Cell Transplant For Patients With Dyskeratosis Congenita and Severe Aplastic Anemia|Active, not recruiting||Phase 2/Phase 3|33|Actual|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-02-18 15:44:03.476658|2017-02-18 15:44:03.476658
NCT00455299|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2014-10-14|||March 2007||2007-03-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|October 2013|Actual|2013-10-01||Interventional|||LVHR Multicenter Study|Randomized Controlled National Multicenter Study for Evaluation of Two Different Ways of Fixation of Mesh-implants and Differences With or Without Approximation of Herniadefects at Laparoscopic Operation for Incisional and Ventral Hernia|Completed||Phase 3|156|Actual|Oslo University Hospital||4|||f||||f||||||||||2017-02-18 15:44:03.596934|2017-02-18 15:44:03.596934
NCT00455286|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2007-04-03|||November 2006||2006-11-01|April 2007|2007-04-01|November 2011|Anticipated|2011-11-01|||||Interventional|||a Phase II Study in Primary Central Nervous System Lymphoma|High-Dose Methotrexate Plus Steroid Followed by Concurrent Whole Brain Chemoradiation With Temozolomide for Immunocompetent Patients With Primary Central Nervous System Lymphoma – a Phase II Study|Unknown status|Recruiting|Phase 2|25||National Health Research Institutes, Taiwan|||||f||||t||||||||||2017-02-18 15:44:03.933831|2017-02-18 15:44:03.933831
NCT00455273|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2016-04-12|||November 2006||2006-11-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer|Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer|Recruiting||N/A|5|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||t||||||||||2017-02-18 15:44:04.046329|2017-02-18 15:44:04.046329
NCT00455260|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-08-30|||April 2007||2007-04-01|April 2009|2009-04-01||||October 2007|Actual|2007-10-01||Interventional|||A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study, to Assess Tolerability, Safety, Pharmacokinetic and Pharmacodynamic Profiles of hGH-ViaDerm™ System in Adult Subjects With Growth Hormone Deficiency|Completed||Phase 1|60|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 15:44:04.146275|2017-02-18 15:44:04.146275
NCT00455247|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2013-06-04|||October 2007||2007-10-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects||Completed||Phase 3|||Nestlé|||||f||||||||||||||2017-02-18 15:44:04.224923|2017-02-18 15:44:04.224923
NCT00455234|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2007-04-02|||September 2005||2005-09-01|March 2007|2007-03-01|July 2006|Actual|2006-07-01|||||Interventional|TRECIndia-II||Rapid Tranquillization Trial: TREC-India II|Rapid Tranquilization of Violent or Agitated People in Psychiatric Emergency Settings- A Pragmatic Randomized Controlled Trial of Intramuscular Olanzepine Vs. Intramuscular Haloperidol + Promethazine.|Completed||Phase 3|300||Christian Medical College, Vellore, India|||||f||||f||||||||||2017-02-18 15:44:04.304145|2017-02-18 15:44:04.304145
NCT00455221|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-31|2012-05-31|||February 2008||2008-02-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|December 2010|Actual|2010-12-01||Interventional|||Safety Assessment of a Multipeptide-gene Vaccine in CML|Safety Assessment of a Peptide Vaccine Derived From Bcr-abl Along With Cytokine Genes in CML Patients Undergoing Imatinib Treatment|Completed||Phase 1|12|Actual|Tehran University of Medical Sciences||1|||f||||t||||||||||2017-02-18 15:44:04.415655|2017-02-18 15:44:04.415655
NCT00455208|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2009-02-18|||May 2007||2007-05-01|March 2007|2007-03-01|December 2008|Anticipated|2008-12-01|||||Interventional|||A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis|Study Evaluating Cura-100 in Rheumatoid Arthritis and Osteoarthritis|Unknown status|Not yet recruiting|Phase 1/Phase 2|20|Anticipated|Cura Biotech LLC|||||f||||t||||||||||2017-02-18 15:44:04.526024|2017-02-18 15:44:04.526024
NCT00455195|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2014-02-04|2011-11-23||March 2007||2007-03-01|February 2014|2014-02-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Late-Onset Treatment Study Extension Protocol|An Open-Label Extension Study of Patients With Late-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU02704|Completed||Phase 4|81|Actual|Sanofi||2|||t||||t||||||||||2017-02-18 15:44:04.627512|2017-02-18 15:44:04.627512
NCT00455182|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2015-03-17|||March 2007||2007-03-01|March 2015|2015-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Acupuncture for Pain Management After Hip or Knee Arthroplasty|Acupuncture for Pain Management After Hip or Knee Arthroplasty|Withdrawn||N/A|0|Actual|HealthEast Care System||3||Inability to enroll subjects who were willing to be randomized to control group|f||||f||||||||||2017-02-18 15:44:06.06231|2017-02-18 15:44:06.06231
NCT00455169|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2015-09-15|||October 2007||2007-10-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Influenza Vaccine in Premature Infants|Influenza Vaccine Immunogenicity in Extremely Premature Infants|Completed||Phase 4|66|Actual|University of Rochester|||2||f||||f||||||None Retained|"~     No retention~   "|||2017-02-18 15:44:06.17597|2017-02-18 15:44:06.17597
NCT00455156|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2012-10-26|||December 2006||2006-12-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|January 2009|Actual|2009-01-01||Interventional|||Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring|A Multicenter, Open-label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150µg of Nestorone® and 15µg of Ethinyl Estradiol (150/15 NES/EE CVR)|Completed||Phase 3|1143|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||t||||||||||2017-02-18 15:44:06.290099|2017-02-18 15:44:06.290099
NCT00455143|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2016-03-16|||September 2006||2006-09-01|March 2016|2016-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Cognitive Protection - Dexmedetomidine and Cognitive Reserve|Cognitive Protection - Dexmedetomidine and Cognitive Reserve|Terminated||Phase 4|27|Actual|Icahn School of Medicine at Mount Sinai||2||"Pilot study initiated to provide support data for main grant GCO 06-0217 funded before this~   pilot collected significant data. no results for this study."|f||||f||||||||||2017-02-18 15:44:06.401993|2017-02-18 15:44:06.401993
NCT00455130|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2010-01-31|||March 2004||2004-03-01|January 2010|2010-01-01|August 2005|Actual|2005-08-01|||||Interventional|||A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis||Completed||Phase 2|||Pharmaxis|||||f||||||||||||||2017-02-18 15:44:06.509825|2017-02-18 15:44:06.509825
NCT00455117|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-01|2013-05-28|||September 2006||2006-09-01|May 2013|2013-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Parecoxib on Post-craniotomy Pain|Phase Four Study of Intravenous Parecoxib on Post-craniotomy Pain|Completed||Phase 4|130|Actual|Melbourne Health||2|||f||||f||||||||||2017-02-18 15:44:06.605693|2017-02-18 15:44:06.605693
NCT00455104|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2016-02-02|||January 2007||2007-01-01|February 2016|2016-02-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|CFDI||Canadian Fabry Disease Initiative (CFDI) Enzyme Replacement Therapy (ERT) Study|Enzyme Replacement Therapy for Fabry Disease: A Model for the Integration of Rare Disease Therapeutics Into the Canadian Health Care System|Recruiting||Phase 4|600|Anticipated|Canadian Fabry Research Consortium||3|||f||||t||||||||||2017-02-18 15:44:06.717051|2017-02-18 15:44:06.717051
NCT00455091|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2009-06-29|||May 2007||2007-05-01|June 2009|2009-06-01|April 2018|Anticipated|2018-04-01|April 2012|Anticipated|2012-04-01||Observational|||A Phase III Study in Post-Operative HBV-Related Hepatocellular Carcinoma|A Randomization Trial of Adjuvant Lamivudine/ Adefovir Dipivoxil Against Recurrence in Post-Operative HBV-Related Hepatocellular Carcinoma|Active, not recruiting||Phase 3|309|Anticipated|National Health Research Institutes, Taiwan|||1||f||||t||||||Samples With DNA|"~     HBVDNA~   "|||2017-02-18 15:44:06.864786|2017-02-18 15:44:06.864786
NCT00455078|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-02|2013-09-04|||June 2007||2007-06-01|September 2013|2013-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|LTXGERD||GI Reflux in Lung Transplant and Its Relationship to Chronic Rejection|The Role of Reflux in Innate Immunity Activation After Lung Transplantation.|Completed||N/A|20|Actual|University of Chicago|||1||f||||f||||||||||2017-02-18 15:44:06.970956|2017-02-18 15:44:06.970956
NCT00455065|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2007-03-30|||August 2005||2005-08-01|March 2007|2007-03-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Weight Loss and Cardiovascular Disease (CVD) Prevention Via a Whole Grain Diet in Men and Women With Metabolic Syndrome|Weight Loss and Cardiovascular Disease (CVD) Prevention Via a Whole Grain Diet in Men and Women With Metabolic Syndrome|Unknown status|Active, not recruiting|N/A|50||Penn State University|||||f||||f||||||||||2017-02-18 15:44:07.061175|2017-02-18 15:44:07.061175
NCT00455052|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-01|2017-01-19|||March 2011||2011-03-01|January 2017|2017-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors|A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous XMT-1001 in Patients With Advanced Solid Tumors|Completed||Phase 1|30|Actual|Mersana Therapeutics||1|||f||||f||||||||No||2017-02-18 15:44:07.14363|2017-02-18 15:44:07.14363
NCT00455039|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2016-05-10|||July 2005||2005-07-01|May 2016|2016-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||INST 0514C- Biologic Correlative Study: Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients|INST 0514C- A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study|Completed||Phase 1/Phase 2|55|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 15:44:07.504247|2017-02-18 15:44:07.504247
NCT00455026|ClinicalTrials.gov processed this data on February 17, 2017|2007-04-01|2013-05-28|||March 2006||2006-03-01|March 2007|2007-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia|Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia|Completed||Phase 1|45|Actual|Melbourne Health||3|||f||||f||||||||||2017-02-18 15:44:07.610729|2017-02-18 15:44:07.610729
NCT00455013|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2014-05-27|2013-07-16||July 2007||2007-07-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|October 2008|Actual|2008-10-01||Interventional||All participants who received transplant and were treated with drug were analyzed up to Month 12 post transplant.|A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation|A Randomized, Open-Label, Multicenter, Parallel-Group Study of Belatacept (BMS-224818)-Based Corticosteroid-Free Regimens in Renal Transplant|Completed||Phase 2|93|Actual|Bristol-Myers Squibb|Main limitations of this study include: small size (small number of participants in each treatment arm), the open-label nature of the trial, its exploratory nature, and the high rate of switches from sirolimus to MMF in one of the belatacept groups.|3|||f||||t||||||||||2017-02-18 15:44:07.740755|2017-02-18 15:44:07.740755
NCT00455000|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2009-10-12|||March 2007||2007-03-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease|A Phase I, Randomized, Placebo Controlled, Double Blind Dose Escalation Study Of The Safety, Tolerability, Pharmacokinetics,Pharmacodynamics, And Immunogenicity Of A Single Intravenous Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease|Completed||Phase 1|37|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:44:09.852085|2017-02-18 15:44:09.852085
NCT00454610|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2007-03-30|||January 2005||2005-01-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|FLOW||Family Lifestyle Overweight Prevention Program|Family Lifestyle Overweight Prevention Program: Evaluation of a Weight Management Program for Mexican American Youth|Unknown status|Active, not recruiting|Phase 3|100||Baylor College of Medicine|||||f||||f||||||||||2017-02-18 15:44:28.386628|2017-02-18 15:44:28.386628
NCT00454987|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2015-11-12|2015-11-12||May 2007||2007-05-01|October 2015|2015-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine|Assessment of Long-term Antibody Persistence After a Booster Dose of GSK Biologicals' Hib & Meningococcal C Vaccine (Menitorix™) 811936 Given at 12-15 Months of Age to Subjects Primed With 3 Doses of Menitorix™ at 2, 3, 4 Months of Age|Completed||Phase 4|288|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 15:44:10.036387|2017-02-18 15:44:10.036387
NCT00454974|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2007-03-30|||March 2007||2007-03-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|WAK||Pilot Study of Wearable Artificial Kidney|Preliminary Study to Assess the Safety and Efficacy of a Wearable Artificial Kidney Device for the Treatment of Patients With Endstage Renal Failure|Completed||Phase 1|8||Royal Free Hampstead NHS Trust|||||f||||t||||||||||2017-02-18 15:44:14.018037|2017-02-18 15:44:14.018037
NCT00454961|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2007-10-24|||April 2007||2007-04-01|October 2007|2007-10-01||||||||Interventional|C3||Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in Tanzania|Effectiveness of Artemether-Lumefantrine Treatment Provided by Community Health Worker Against Uncomplicated Malaria in Children Under 5 Years of Age in Tanzania|Completed||Phase 4|200|Anticipated|Karolinska University Hospital|||||f||||||||||||||2017-02-18 15:44:14.191131|2017-02-18 15:44:14.191131
NCT00454948|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2007-03-30|||March 2007||2007-03-01|March 2007|2007-03-01|August 2009|Anticipated|2009-08-01|||||Interventional|CHICOS||Nutrition Intervention and Play Group Exercise for Low-Income Latinas|Home Based Nutrition Intervention Nad Play Group Exercise for Low-Income Latinas|Unknown status|Recruiting|Phase 1|250||Stanford University|||||f||||t||||||||||2017-02-18 15:44:14.463221|2017-02-18 15:44:14.463221
NCT00454935|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2008-06-06|||April 2007||2007-04-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|||||Observational|||Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy|Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy|Unknown status|Recruiting|Phase 4|40|Anticipated|VU University Medical Center|||1||f||||f||||||Samples Without DNA|"~     Blood Tumor tissue~   "|||2017-02-18 15:44:14.556234|2017-02-18 15:44:14.556234
NCT00454922|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2012-12-04|||October 2007||2007-10-01|October 2008|2008-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients|Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients|Completed||N/A|44|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 15:44:14.65762|2017-02-18 15:44:14.65762
NCT00454909|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2016-11-03||2009-09-03|April 2007||2007-04-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.|Study to Assess Immunogenicity, Reactogenicity and Safety of 1 Dose of GSK Biologicals' Meningococcal Vaccine GSK134612 vs. 1 Dose of Sanofi-Pasteur's Menactra® in Healthy Subjects 10-25 Years.|Completed||Phase 2|873|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:44:14.765122|2017-02-18 15:44:14.765122
NCT00454896|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2014-09-17|||May 2004||2004-05-01|September 2014|2014-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|VENUS||A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of Daily Oral Administration of 5mg and 10mg VESIcare® for the Treatment of Urgency Associated With Overactive Bladder|Completed||Phase 3|739|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 15:44:14.899464|2017-02-18 15:44:14.899464
NCT00454883|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2015-06-30|||April 2007||2007-04-01|June 2015|2015-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.|Treatment Of Manic Or Mixed Episodes Of Up To Moderate Severity In Patients With Bipolar Disorder And Schizoaffective Disorder|Completed||N/A|379|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:44:15.089478|2017-02-18 15:44:15.089478
NCT00454870|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2008-05-05|||February 2007||2007-02-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of the Pharmacodynamics/Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Fixed Dosages of MEM 3454 (5 mg, 15 mg, and 50 mg) in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|80|Anticipated|Memory Pharmaceuticals|||||f||||f||||||||||2017-02-18 15:44:15.208983|2017-02-18 15:44:15.208983
NCT00454857|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2013-10-23|2009-10-16||May 2006||2006-05-01|October 2013|2013-10-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Observational|||Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|A Prospective Observational Descriptive Study and Retrospective Chart Review of Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|Completed||N/A|326|Actual|Amgen|||1||f||||||||||None Retained|"~     None retained.~   "|||2017-02-18 15:44:15.303097|2017-02-18 15:44:15.303097
NCT00454831|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2007-11-14|||February 2006||2006-02-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|HEP-40||Efficacy and Safety of HEP-40 Chitosan for Mild to Moderately Elevated Cholesterol|A 16 Week With 12 Week Active Treatment Multi-Center, Placebo-Controlled, Randomized Study Evaluating the Efficacy of HEP-40 Chitosan in Managing Moderate Hypercholesterolemia|Completed||Phase 2|207|Actual|DNP Canada||5|||f||||f||||||||||2017-02-18 15:44:15.76141|2017-02-18 15:44:15.76141
NCT00454818|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2014-08-19|2014-06-25||March 2007||2007-03-01|August 2014|2014-08-01|August 2012|Actual|2012-08-01|August 2010|Actual|2010-08-01||Interventional|CUPID|Baseline data are provided for subjects enrolled in the Phase 1 or Phase 2 trials.|Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure|A Phase 1/2 Trial of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure in Two Stages (Open-Label, Sequential Dose-Escalation Cohorts and Randomized, Double-Blind, Placebo-Controlled, Parallel Cohorts)|Completed||Phase 1/Phase 2|51|Actual|Celladon Corporation|Limitations of this study include its small sample size and the inability to conclusively prove that the delivered gene was responsible for the observed clinical effects. Larger confirmatory trials are needed.|5|||f||||t||||||||||2017-02-18 15:44:16.126221|2017-02-18 15:44:16.126221
NCT00454805|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2016-07-06|2012-04-25||March 2007||2007-03-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|December 2008|Actual|2008-12-01||Interventional|||AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.|A Phase II, Double-Blind, Placebo Controlled, Randomized Study to Assess the Efficacy and Safety of AZD2171 in Combination With Fulvestrant vs Fulvestrant Alone in Hormone Sensitive (ER+ve or PgR+ve) Post Menopausal Metastatic Breast Cancer Patients|Completed||Phase 2|75|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:44:18.57021|2017-02-18 15:44:18.57021
NCT00454792|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2011-09-23|||March 2007||2007-03-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Rehabilitation of Patients With Modic Changes in the Lumbar Spine|Rehabilitation of Patients With Modic Changes in the Lumbar Spine - a Randomized Controlled Trial|Completed||N/A|100|Actual|The Back Research Center, Denmark||2|||f||||f||||||||||2017-02-18 15:44:19.339209|2017-02-18 15:44:19.339209
NCT00454779|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2016-12-15|2013-10-11||January 2007||2007-01-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|August 2012|Actual|2012-08-01||Interventional|||PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response|A Randomized, Open-Label, Controlled, Phase II Trial of Combination Chemotherapy With or Without Panitumumab as First-line Treatment of Subjects With Metastatic or Recurrent Head and Neck Cancer, and Cross-over Second-line Panitumumab Monotherapy of Subjects Who Fail the Combination Chemotherapy…|Completed||Phase 2|113|Actual|Amgen||2|||f||||t||||||||||2017-02-18 15:44:19.462997|2017-02-18 15:44:19.462997
NCT00454766|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2016-09-12|||February 2007||2007-02-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Observational|||Evaluating Materials to Educate Patients About Cervical Dysplasia|Evaluating Materials to Educate Patients About Cervical Dysplasia|Active, not recruiting||N/A|80|Anticipated|M.D. Anderson Cancer Center|||1||f||||t||||||||||2017-02-18 15:44:20.566897|2017-02-18 15:44:20.566897
NCT00454753|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2010-05-07|||May 2007||2007-05-01|May 2010|2010-05-01||||||||Expanded Access|||Korean Early Access Program|Study of Dasatinib (BMS-354825) in Subjects With Chronic Phase or Advanced Chronic Myelogenous Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Who Are Resistant to or Intolerant of Imatinib Mesylate|Approved for marketing||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 15:44:20.678793|2017-02-18 15:44:20.678793
NCT00454740|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2014-09-17|||June 2004||2004-06-01|September 2014|2014-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|VERSUS||Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder|An Open-Label Multicenter Study to Assess the Efficacy and Safety of Daily Oral Administration of 5 and 10mg VESIcare® (Solifenacin Succinate) in Patients Who Wish to Switch From Detrol LA® (Tolterodine Tartrate Extended Release) for the Treatment of Overactive Bladder Symptoms Versus: VESIcare® Efficacy and Research Study US|Completed||Phase 3|441|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 15:44:20.972287|2017-02-18 15:44:20.972287
NCT00454714|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2015-10-27|||March 2007||2007-03-01|October 2015|2015-10-01||||December 2009|Actual|2009-12-01||Interventional|||Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm|Application of Sildenafil in Patients With Documented Coronary Vasospasm to Explore the Pathophysiology of Coronary Vasospasm and the Therapeutic Effect of Sildenafil in Patients Suffering From Coronary Vasospasm|Suspended||Phase 3|26|Anticipated|Robert Bosch Gesellschaft für Medizinische Forschung mbH||2||Patient study insurance expired|f||||f||||||||||2017-02-18 15:44:21.198389|2017-02-18 15:44:21.198389
NCT00454701|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2013-12-10|||June 2003||2003-06-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|ATLAS||Assessment and Tracking of Long-term Alefacept Safety|Assessment and Tracking of Long-term Alefacept (LFA-3/IgG1 Fusion Protein) Safety (ATLAS)|Terminated||Phase 4|1897|Actual|Astellas Pharma Inc|||1|"The Sponsor has made a decision, driven by business needs, to cease promotion, manufacturing,~   distribution and sales of Amevive"|f||||t||||||||||2017-02-18 15:44:21.323083|2017-02-18 15:44:21.323083
NCT00454688|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2011-10-17|||August 2006||2006-08-01|October 2011|2011-10-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome|A 12-Week, Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Study of Asimadoline in Subjects With Irritable Bowel Syndrome|Completed||Phase 2|596|Actual|Tioga Pharmaceuticals||4|||f||||f||||||||||2017-02-18 15:44:21.866773|2017-02-18 15:44:21.866773
NCT00454675|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2008-08-13|||March 2007||2007-03-01|June 2008|2008-06-01|August 2008|Actual|2008-08-01|||||Observational|||Pulmonary Function Changes in 10 Pack Year Smokers With Chronic Bronchitis|Pulmonary Function Changes in 10 Pack Year Smokers With Chronic Bronchitis|Completed||N/A|100|Anticipated|Westside Family Medical Center, P.C.|||1||f||||||||||||||2017-02-18 15:44:22.248367|2017-02-18 15:44:22.248367
NCT00454662|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2013-01-22|||April 2007||2007-04-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)|Combination of OLMesartan and Calcium Channel Blocker or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)|Completed||Phase 4|5141|Actual|COLM Study Research Organization||2|||f||||t||||||||||2017-02-18 15:44:22.333617|2017-02-18 15:44:22.333617
NCT00454649|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2012-03-30|2012-02-25||December 2005||2005-12-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|August 2009|Actual|2009-08-01||Interventional|||Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor|A Phase 1 Dose-Finding Study Of The Anti-Angiogenesis Agent, AG-013736, In Combinations Of Paclitaxel/Carboplatin, Weekly Paclitaxel, Docetaxel, Capecitabine, Gemcitabine/Cisplatin and Pemetrexed/Cisplatin In Patients With Advanced Solid Tumors|Completed||Phase 1|102|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:44:22.490269|2017-02-18 15:44:22.490269
NCT00454636|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-30|2016-08-23|2016-07-12||March 2007||2007-03-01|August 2016|2016-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.|Open Label, Phase II Study of Capecitabine (Xeloda®) as Fluoropyrimidine of Choice in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer Suitable for Treatment With a Fluoropyrimidine-Based Regimen|Completed||Phase 2|158|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 15:44:27.241619|2017-02-18 15:44:27.241619
NCT00454623|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2007-03-30|||March 2006||2006-03-01|March 2007|2007-03-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Normal Serum Adiponectin Levels in Females|Normal Serum Adiponectin Levels in Females During the Childbearing Ages and Normal Serum Adiponectin Levels in Pregnancy|Unknown status|Active, not recruiting|N/A|300||The Cooper Health System|||||f||||f||||||||||2017-02-18 15:44:28.297527|2017-02-18 15:44:28.297527
NCT00454597|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2008-05-30|||February 2007||2007-02-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|omentectomy||Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity|PHASE 1 The Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity|Completed||Early Phase 1|21|Actual|Universidad de Guanajuato||1|||f||||t||||||||||2017-02-18 15:44:28.477756|2017-02-18 15:44:28.477756
NCT00454584|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2012-10-19|2009-10-23||March 2007||2007-03-01|October 2012|2012-10-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|||An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis|A Phase 3, Multicenter, Randomized Study Comparing CNTO 1275 and Etanercept for the Treatment of Moderate to Severe Plaque Psoriasis|Completed||Phase 3|903|Actual|Centocor, Inc.||3|||f||||t||||||||||2017-02-18 15:44:28.583345|2017-02-18 15:44:28.583345
NCT00454571|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-01-08|2015-05-29||June 2006||2006-06-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||Baseline demographics data for this multi-center trial are only available for participants at The University of Chicago with known study arm assignment.|Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer|A Randomized, Phase II Study of GW786034 (Pazopanib) in Stage D0 Relapsed Androgen Sensitive Prostate Cancer Following Limited GnRH Agonist Therapy|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 15:44:29.951078|2017-02-18 15:44:29.951078
NCT00454558|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2015-10-14|||January 2007||2007-01-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|July 2014|Actual|2014-07-01||Interventional|||An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension|A Multicenter, Non-randomized, Non-blinded, Noncontrolled Study to Investigate the Impact of Multiple Doses of BAY 63-2521 on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Pulmonary Hypertension in a 12-week 3 Times a Day Individual Dose Titration Scheme|Completed||Phase 2|75|Actual|Bayer||1|||f||||f||||||||||2017-02-18 15:44:30.376632|2017-02-18 15:44:30.376632
NCT00454545|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2007-10-18|||October 2006||2006-10-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Atorvastatin in Moderate Active Crohns Disease||Completed||Phase 2|12|Anticipated|Skane University Hospital|||||f||||t||||||||||2017-02-18 15:44:30.713699|2017-02-18 15:44:30.713699
NCT00454532|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2012-02-27|2012-02-27||March 2007||2007-03-01|February 2012|2012-02-01||||December 2009|Actual|2009-12-01||Interventional|||A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer|A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 For Metastatic Breast Cancer.|Completed||Phase 1/Phase 2|27|Actual|Bionovo||1|||f||||t||||||||||2017-02-18 15:44:30.805662|2017-02-18 15:44:30.805662
NCT00454519|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2009-02-12|||March 2007||2007-03-01|February 2009|2009-02-01||||December 2009|Anticipated|2009-12-01||Interventional|IPHC||Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis|Cytoreductive Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy for the Treatment of Peritoneal Carcinomatosis From Gastrointestinal Cancer: an Open Label, Randomized, Prospective, Phase 2 Clinical Trial|Unknown status|Recruiting|Phase 2|60|Anticipated|Wuhan University||2|||f||||t||||||||||2017-02-18 15:44:31.742029|2017-02-18 15:44:31.742029
NCT00454506|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2015-08-17|||April 2007||2007-04-01|August 2015|2015-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Hospital for Special Surgery Hip Arthroplasty Cohort|Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: HSS Hip Arthroplasty Cohort|Active, not recruiting||N/A|3000|Anticipated|Hospital for Special Surgery, New York|||1||f||||t||||||||||2017-02-18 15:44:31.865768|2017-02-18 15:44:31.865768
NCT00454493|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2007-03-29|||August 2006||2006-08-01|March 2007|2007-03-01|July 2008|Anticipated|2008-07-01|||||Interventional|||The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease|The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease|Unknown status|Recruiting|N/A|100||University of California, Los Angeles|||||f||||||||||||||2017-02-18 15:44:31.942177|2017-02-18 15:44:31.942177
NCT00454480|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2013-08-23|||August 2006||2006-08-01|August 2008|2008-08-01||||August 2012|Actual|2012-08-01||Interventional|||Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes|A Programme of Treatment Development for Older Patients With Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome|Completed||Phase 2/Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:44:32.036511|2017-02-18 15:44:32.036511
NCT00454467|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2015-08-17|||April 2007||2007-04-01|August 2015|2015-08-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Observational|||Hospital for Special Surgery Knee Arthroplasty Cohort|Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: The HSS Knee Arthroplasty Cohort|Active, not recruiting||N/A|3000|Anticipated|Hospital for Special Surgery, New York|||1||f||||t||||||||||2017-02-18 15:44:32.428983|2017-02-18 15:44:32.428983
NCT00454454|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2013-07-27|||March 2007||2007-03-01|July 2013|2013-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|DETECT||Virtual Reality Helmet to Test for Problems With Memory|Display Enhanced TEsting for Cognitive Impairment and Traumatic Brain Injury|Completed||N/A|425|Actual|Emory University|||1||f||||f||||||||||2017-02-18 15:44:32.525153|2017-02-18 15:44:32.525153
NCT00454441|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-03-29|||February 2006||2006-02-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Sleep Quality in CHIMES (MF101)|Sleep Quality in CHIMES (MF101)|Completed||Phase 2|180||Bionovo|||||f||||||||||||||2017-02-18 15:44:32.624661|2017-02-18 15:44:32.624661
NCT00454428|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2007-03-29||||||March 2006|2006-03-01||||||||Interventional|||Randomized Trial of Pulsatile vs Non Pulsatile Perfusion on Short Term Changes in Kidney Function Using an Intra-Aortic Ballooon Pump During Cardioplegic Arrest in Patients Undergoing Myocardial Reperfusion||Completed||Phase 4|||University of Cantanzaro|||||f||||f||||||||||2017-02-18 15:44:32.712402|2017-02-18 15:44:32.712402
NCT00454415|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2012-12-24|||January 2007||2007-01-01|December 2012|2012-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Prospective Study of Dietary Factors, BMI, and Risk of Asthma in Children|Prospective Study of Dietary Factors, BMI, and Risk of Asthma in Children|Completed||N/A|16000|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 15:44:32.802105|2017-02-18 15:44:32.802105
NCT00454402|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2007-09-21|||August 2006||2006-08-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||ALF-STONE: Alfuzosin in Uretheric Stones|Alfuzosin in Uretheric Stones|Terminated||Phase 3|220|Anticipated|Sanofi||2||Discontinued due to incomplete recruitment|f||||f||||||||||2017-02-18 15:44:32.897226|2017-02-18 15:44:32.897226
NCT00454389|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2011-07-26|||April 2007||2007-04-01|July 2011|2011-07-01|August 2012|Anticipated|2012-08-01|September 2011|Anticipated|2011-09-01||Interventional|CABERNET||A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration|A Randomized, Prospective, Active Controlled, Study of the Epi-Rad90™ Ophthalmic System for the Treatment of Subfoveal Choroidal Neovascularization Associated With Wet Age-Related Macular Degeneration|Unknown status|Active, not recruiting|Phase 3|494|Actual|NeoVista||2|||f||||t||||||||||2017-02-18 15:44:32.981423|2017-02-18 15:44:32.981423
NCT00454376|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2013-10-28|||October 2006||2006-10-01|November 2008|2008-11-01||||||||Observational|||Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors|Clinical and Psychometric Validation of a Disease-Specific Questionnaire Module in Assessing the Quality of Life of Patients With G.I.-Related Neuroendocrine Tumours|Unknown status|Active, not recruiting|Phase 4|408|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:44:33.138905|2017-02-18 15:44:33.138905
NCT00454363|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-10-15|2015-01-22||March 2007||2007-03-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|March 2014|Actual|2014-03-01||Interventional|||Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer|A Phase 2 Study of GW786034 (Pazopanib) in Advanced Low-Grade or Intermediate-Grade Neuroendocrine Carcinoma|Completed||Phase 2|52|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 15:44:33.448656|2017-02-18 15:44:33.448656
NCT00454350|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2015-05-04|||February 2007||2007-02-01|May 2015|2015-05-01|July 2007|Actual|2007-07-01|||||Interventional|||A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis|A Randomized , Open-Label, Cross-over, Pharmacokinetic Study of Doxercalciferol and Paricalcitol Following Multiple Intravenous Injections in Chronic Kidney Disease Subjects on Hemodialysis|Completed||Phase 4|12|Anticipated|Sanofi||2|||||||||||||||||2017-02-18 15:44:34.155106|2017-02-18 15:44:34.155106
NCT00454337|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2012-11-06|||May 2007||2007-05-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|EASIER||Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load|Randomized Non-inferiority Study Comparing a Strategy Maintaining Current Enfuvirtide-based Antiretroviral Therapy to a Strategy Replacing Enfuvirtide by an Integrase Inhibitor (Raltegravir) in HIV-1 Infected Subjects With Plasma Hiv-1 RNA Levels Below 400 Copies Per ml.ANRS 138 EASIER|Completed||Phase 3|170|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 15:44:34.257472|2017-02-18 15:44:34.257472
NCT00454324|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2016-01-20|||April 2006||2006-04-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|July 2010|Actual|2010-07-01||Interventional|NRR||Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer|Phase II Clinical Trial of Carboplatin and Abraxane in Patients With Extensive Stage Small Cell Lung Cancer|Terminated||Phase 2|30|Actual|UNC Lineberger Comprehensive Cancer Center||2||slow accrual|f||||t||||||||||2017-02-18 15:44:34.380099|2017-02-18 15:44:34.380099
NCT00454311|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2011-03-03|||November 2007||2007-11-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Impact of the Biopsy of 1-2 Cells in a PGD Program for Anueploidy Screening|Prospective and Randomized Study of the Impact of the Biopsy of 1-2 Cells in a PGD Program for Aneuploidy Screening|Completed||N/A|||Instituto Valenciano de Infertilidad, IVI VALENCIA||2|||f||||f||||||||||2017-02-18 15:44:34.691432|2017-02-18 15:44:34.691432
NCT00454298|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2009-07-28|||May 2007||2007-05-01|July 2009|2009-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Regimen, Parallel-Group Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AGG-523 Administered Orally to Subjects With Severe Osteoarthritis|Completed||Phase 1|2|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||||||||||||2017-02-18 15:44:34.803496|2017-02-18 15:44:34.803496
NCT00454285|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2009-12-02|||January 2003||2003-01-01|December 2009|2009-12-01|June 2006|Actual|2006-06-01|November 2005|Actual|2005-11-01||Interventional|||Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing|Bacteremia From Dental Extractions vs. Oral Hygiene|Completed||Phase 2|290|Actual|Carolinas Healthcare System|||||f||||t||||||||||2017-02-18 15:44:34.925935|2017-02-18 15:44:34.925935
NCT00454272|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2009-03-05|||January 2005||2005-01-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients|Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients|Completed||Phase 4|197|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:44:35.033801|2017-02-18 15:44:35.033801
NCT00454259|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2015-06-02|||March 2007||2007-03-01|March 2007|2007-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|FENTANULD||Fentanyl Ultra Low Doses Effects on the Nociceptive Threshold|Fentanyl Ultra Low Doses Effects on Human Volunteer's Nociceptive Threshold. Towards a Simple Pharmacological Test Able to Predict Pain Vulnerability, Post Operative Hyperalgesia Development Risk?|Completed||Phase 4|48|Actual|University Hospital, Bordeaux||4|||f||||t||||||||||2017-02-18 15:44:35.146671|2017-02-18 15:44:35.146671
NCT00454246|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2011-11-14|2011-03-29||April 2007||2007-04-01|November 2011|2011-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.|A Randomized, Open Label Study of the Effect of Intravenous Mircera on Hemoglobin Control in Patients Transitioning From Chronic Kidney Disease Stage 4 Through Dialysis|Terminated||Phase 3|111|Actual|Hoffmann-La Roche||3||Strategic decision unrelated to safety or efficacy|f||||||||||||||2017-02-18 15:44:35.279084|2017-02-18 15:44:35.279084
NCT00454233|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2008-10-14|||February 2007||2007-02-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects|A Randomized, Double Blind, Placebo and Active Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Potential Efficacy of a 12-Week Treatment With YM543 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|97|Actual|Astellas Pharma Inc||6|||f||||t||||||||||2017-02-18 15:44:35.892562|2017-02-18 15:44:35.892562
NCT00453817|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2014-12-01|||June 2005||2005-06-01|December 2014|2014-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging|Suivi Par résonance magnétique après Transplantation d'îlots de Langerhans|Terminated||Phase 1|5|Actual|University Hospital, Geneva||1||Feasibility issues|f||||f||||||||||2017-02-18 15:44:52.669655|2017-02-18 15:44:52.669655
NCT00454220|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2014-10-27||2011-12-16|July 2007||2007-07-01|October 2014|2014-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter|Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction With Radioiodine for the Treatment of Multinodular Goiter.|Completed||Phase 2|96|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 15:44:36.002405|2017-02-18 15:44:36.002405
NCT00454207|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2013-08-19|2010-02-18||April 2007||2007-04-01|August 2010|2010-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension|A Phase 3, Multi-Center, Open-Label Study to Assess Safety and Efficacy of Sildenafil Citrate 20 mg TID in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 3|44|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:44:36.118196|2017-02-18 15:44:36.118196
NCT00454194|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-12-07|2016-12-07||September 2007||2007-09-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|July 2010|Actual|2010-07-01||Interventional||All participants who met the eligibility criteria and started the treatment.|Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|110|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 15:44:37.04448|2017-02-18 15:44:37.04448
NCT00454181|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2011-09-12|2010-11-09||February 2007||2007-02-01|September 2011|2011-09-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Treatment of Oral Warts in HIV+ Patients|Evaluation of Natural Human Interferon Alpha Administered Oromucosally in the Treatment of Oral Warts in HIV-seropositive Subjects Receiving Combination Anti-retroviral Therapy: A Phase 2 Clinical Trial|Completed||Phase 2|59|Actual|Amarillo Biosciences, Inc.|Only 59 of 80 planned subjects were randomized, so statistical power of the study was limited.|2|||f||||f||||||||||2017-02-18 15:44:38.324274|2017-02-18 15:44:38.324274
NCT00454168|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2014-01-03|||May 2005||2005-05-01|February 2009|2009-02-01||||April 2009|Anticipated|2009-04-01||Interventional|||Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission|A Phase 3, Randomized, Double-Blind, Multicenter Study of Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF in Elderly Patients With AML in First Complete Remission or Adults in Second Complete Remission: A Pivotal Study|Unknown status|Active, not recruiting|Phase 3|244|Anticipated|National Cancer Institute (NCI)||2|||||||||||||||||2017-02-18 15:44:38.8627|2017-02-18 15:44:38.8627
NCT00454155|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2012-07-27|||February 2007||2007-02-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|HSCT||Study of Opebacan in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|A Phase I/II Study of the Safety and Pharmacokinetics of Opebacan (rBPI21) in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)|Terminated||Phase 1/Phase 2|6|Actual|XOMA (US) LLC||1||Lack of enrollment|f||||t||||||||||2017-02-18 15:44:39.001419|2017-02-18 15:44:39.001419
NCT00454142|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-11-16|2014-12-12||August 2007||2007-08-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|April 2010|Actual|2010-04-01||Interventional|||Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer|A Phase 2 Study of GW786034 (Pazopanib) in Asian Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 15:44:39.120275|2017-02-18 15:44:39.120275
NCT00453401|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2008-05-28|||February 2007||2007-02-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis|The Safety, Pharmacokinetics, and Efficacy of NB-001 (0.1%, 0.3%, 0.5%) in Subjects With Recurrent Herpes Labialis|Completed||Phase 2|1000|Anticipated|NanoBio Corporation||4|||f||||f||||||||||2017-02-18 15:44:39.491769|2017-02-18 15:44:39.491769
NCT00453388|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-08-22|||February 2007||2007-02-01|August 2016|2016-08-01||||June 2013|Actual|2013-06-01||Interventional|||Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia|Nonmyeloablative Hematopoietic Cell Transplantation for Patients With Fanconi Anemia Using Alternative Marrow Donors: A Phase II Dose-Finding Study|Active, not recruiting||Phase 2|1|Actual|Fred Hutchinson Cancer Research Center||4|||f||||t||||||||||2017-02-18 15:44:39.734164|2017-02-18 15:44:39.734164
NCT00453375|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2011-06-27|||October 2006||2006-10-01|January 2011|2011-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus|A Randomized, Blinded, Placebo Controlled, Safety and Pharmacodynamic Study of BHT-3021 With Open Label Cross-Over in Subjects With Type I Diabetes Mellitus|Completed||Phase 1|80|Actual|Bayhill Therapeutics||2|||f||||t||||||||||2017-02-18 15:44:39.880598|2017-02-18 15:44:39.880598
NCT00453362|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2011-10-26|2011-03-31||December 2006||2006-12-01|October 2011|2011-10-01||||April 2010|Actual|2010-04-01||Interventional|||A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib|Pilot Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib|Completed||Phase 1/Phase 2|88|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 15:44:40.007235|2017-02-18 15:44:40.007235
NCT00453349|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2014-09-02|2009-09-01||January 2007||2007-01-01|September 2014|2014-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease|A Prospective, Randomized, Double Dummy, Double Blind, Multi-center Multinational Trial Comparing the Efficacy and Safety of Moxifloxacin 400 mg PO QD 24 Hours for 14 Days to That of Levofloxacin 500 mg PO QD 24 Hours Plus Metronidazole 500 mg BID for 14 Days in Subjects With an Uncomplicated Pelvic Inflammatory Disease (PID). Moxifloxacin, Metronidazole, and Levofloxacin in Asia (MONALISA Study)|Completed||Phase 3|460|Actual|Bayer|Out of the 460 randomized subjects, 5 subjects (3 moxifloxacin subjects, 2 placebo subjects) did not receive any study medication. Only one of these patients had an adverse event (stomachache, randomized to Moxifloxacin).|2|||f||||f||||||||||2017-02-18 15:44:40.745639|2017-02-18 15:44:40.745639
NCT00453804|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2008-03-17|||July 2006||2006-07-01|March 2008|2008-03-01|June 2007|Actual|2007-06-01|||||Interventional|vivitrol||Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)|Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI): A Pilot Study|Completed||Phase 4|15||State University of New York - Upstate Medical University|||||f||||t||||||||||2017-02-18 15:44:52.781015|2017-02-18 15:44:52.781015
NCT00453336|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-12-14|2013-08-14||June 2003||2003-06-01|December 2016|2016-12-01|May 2010|Actual|2010-05-01|August 2009|Actual|2009-08-01||Interventional|||Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract|A Phase II Clinical Trial on the Efficacy of Photodynamic Therapy With Porfimer Sodium (Photofrin®) for Malignant and Pre-Malignant Lesions and Condemned Mucosa Syndrome in the Upper Aerodigestive Tract|Completed||Phase 2|45|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:44:41.415329|2017-02-18 15:44:41.415329
NCT00453323|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-07-09|||June 2006||2006-06-01|July 2010|2010-07-01|December 2010|Anticipated|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer|A Phase II Study of Weekly Paclitaxel and Capecitabine in Patients With Metastatic or Recurrent Esophageal Cancer|Unknown status|Active, not recruiting|Phase 2|33|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:44:41.750499|2017-02-18 15:44:41.750499
NCT00453310|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-09-24|2015-09-24||March 2007||2007-03-01|September 2015|2015-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment|A Phase II Study of Sunitinib in Patients With Refractory or Relapsed Germ Cell Tumors|Completed||Phase 2|10|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:44:41.864479|2017-02-18 15:44:41.864479
NCT00453297|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2008-08-27|||October 2006||2006-10-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components|A Randomized, Double-Blind, Placebo-Controlled, Single Dose, Oral, Dose Escalation Phase 1 Study to Evaluate the Safety and Tolerance of MF 101 as Well as the Pharmacokinetics of Its Key Active Components in Healthy Post-Menopausal Women.|Terminated||Phase 1|32|Anticipated|Bionovo|||||t||||||||||||||2017-02-18 15:44:42.099252|2017-02-18 15:44:42.099252
NCT00453271|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2013-05-15||2013-05-15|January 2007||2007-01-01|May 2013|2013-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail|A Randomized, Double-Blind, Parallel-Group,Multicenter, Dose-Response, Vehicle-Controlled Study of the Safety and Efficacy of NB-002 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail|Completed||Phase 2|443|Actual|NanoBio Corporation||4|||f||||f||||||||||2017-02-18 15:44:42.187266|2017-02-18 15:44:42.187266
NCT00454129|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-29|2013-01-25|||March 2007||2007-03-01|March 2007|2007-03-01||||||||Interventional|DBE ERC||ERC Via Double-Balloon-Enteroscopy in Patients With Biliodigestive Anastomosis|ERC Via Double-Balloon-Enteroscopy in Patients With Biliodigestive Anastomosis|Unknown status|Recruiting|N/A|||Heidelberg University|||||f||||f||||||||||2017-02-18 15:44:42.32271|2017-02-18 15:44:42.32271
NCT00454116|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2016-08-25|2011-04-27||March 2007||2007-03-01|August 2016|2016-08-01|November 2009|Actual|2009-11-01|March 2008|Actual|2008-03-01||Interventional|||A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients|A Phase II, Double Blind, Placebo Controlled, Randomised Study to Assess the Efficacy and Safety of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients Who Have Failed Therapy With an Oxaliplatin and Fluoropyrimidine Containing Regimen|Completed||Phase 2|106|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 15:44:42.409127|2017-02-18 15:44:42.409127
NCT00454103|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2010-08-17|||March 2007||2007-03-01|October 2007|2007-10-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy||Completed||Phase 1/Phase 2|||University of Wuerzburg|||||f||||t||||||||||2017-02-18 15:44:43.13366|2017-02-18 15:44:43.13366
NCT00454090|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2011-08-23|||March 2007||2007-03-01|August 2011|2011-08-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|||AZD8330 First Time in Man in Patients With Advanced Malignancies|A Phase I, Open-Label, Multi-centre Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of AZD8330 in Patients With Advanced Malignancies|Completed||Phase 1|83|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 15:44:43.21216|2017-02-18 15:44:43.21216
NCT00454077|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-03-28|||December 2004||2004-12-01|October 2006|2006-10-01|September 2006|Actual|2006-09-01|||||Observational|||rhTSH-Thyroid Ablation With 1850 MBq of 131I|Recombinant Human TSH (rhTSH)-Aided Radioiodine (131) Therapy for Thyroid Remnant Ablation in Differentiated Thyroid Cancer Patients: a Comparison Between 1850 MBq and 3700 MBq Activities|Completed||Phase 3|72||University of Siena|||||f||||f||||||||||2017-02-18 15:44:43.301677|2017-02-18 15:44:43.301677
NCT00454064|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2008-05-27|||September 2004||2004-09-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|September 2007|Actual|2007-09-01||Interventional|||Cognitive-Behavioural Treatment of Chronic Back Pain|Study to Compare a Cognitive-Behavioral Treatment With a Cognitive-Behavioral Treatment With Biofeedback Elements to Patients With Chronic (Low) Back Pain|Completed||Phase 3|128|Actual|Philipps University Marburg Medical Center||2|||f||||t||||||||||2017-02-18 15:44:43.382496|2017-02-18 15:44:43.382496
NCT00454051|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2011-08-02|2010-12-03||December 2006||2006-12-01|August 2011|2011-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma|Double Blind Placebo Controlled Study to Assess the Expression of IgE on Basophils and Dendritic Cells During Omalizumab Treatment.|Completed||Phase 4|31|Actual|Novartis||2|||f||||t||||||||||2017-02-18 15:44:43.489284|2017-02-18 15:44:43.489284
NCT00454038|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2009-07-09|||June 2007||2007-06-01|January 2009|2009-01-01|May 2009|Anticipated|2009-05-01|January 2008|Anticipated|2008-01-01||Interventional|GBR||Study of Collagen Membrane in Guided Bone Regeneration|Preliminary Study of Hypro-Sorb® F Bilayer Bioabsorbable Membrane for Guided Tissue and Bone Regeneration|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|The Baruch Padeh Medical Center, Poriya||1|||f||||||||||||||2017-02-18 15:44:44.099973|2017-02-18 15:44:44.099973
NCT00454025|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2013-01-29|||January 2007||2007-01-01|January 2013|2013-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Intraocular Pressure (IOP) Changes Associated With Muslim Prayer Postural Changes|Intraocular Pressure Changes Associated With Muslim Prayer Postural Changes|Terminated||N/A|5|Actual|University of Colorado, Denver|||2|Stopped due to low enrollment|f||||f||||||||||2017-02-18 15:44:44.187334|2017-02-18 15:44:44.187334
NCT00454012|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2009-11-07|||April 2005||2005-04-01|March 2009|2009-03-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Use of Intrapartum Biophysical Profile When Fetal Heart Rate Monitoring is Non-reassuring in Labor|Use of Intrapartum Biophysical Profile When Fetal Heart Rate Monitoring is Non-reassuring in Labor|Terminated||N/A|100|Anticipated|The Cooper Health System||1||poor enrolment|f||||f||||||||||2017-02-18 15:44:44.266365|2017-02-18 15:44:44.266365
NCT00453999|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-01-28|2015-01-16||July 2007||2007-07-01|January 2015|2015-01-01|August 2009|Actual|2009-08-01|September 2008|Actual|2008-09-01||Interventional||ITT Population|Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza|Phase II, Multicenter, Randomized, Double-Mask, Double-Dummy Study Comparing Efficacy and Safety of Intravenous Peramivir Once Daily Versus Oral Oseltamivir Twice Daily in Adults With Acute Serious or Potentially Life-Threatening Influenza|Completed||Phase 2|137|Actual|BioCryst Pharmaceuticals||3|||f||||t||||||||||2017-02-18 15:44:44.363066|2017-02-18 15:44:44.363066
NCT00453986|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2016-11-02|2012-04-23||April 2007||2007-04-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional|||Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults|Lot-to-Lot Consistency, Non-Inferiority Versus Mencevax™ and Evaluation of the Co-Administration With Fluarix™ of GSK Biologicals' Meningococcal Vaccine GSK134612, in Healthy Subjects Aged 18 Through 55 Years of Age|Completed||Phase 3|1352|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:44:48.841883|2017-02-18 15:44:48.841883
NCT00453973|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2012-06-22|2012-04-26||November 2006||2006-11-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)|An Open-Label, Multi-Center, Extension Study to Evaluate the Safety and Tolerability of Peginesatide for the Long-Term Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease|Terminated||Phase 2|114|Actual|Affymax|Early termination of study due to generation of controlled long-term data in Phase 3 studies. Amended dosing guidelines during the trial to reflect label changes for ESAs; the primary outcome was assessed after the dosing guideline change.|2||Due to more robust long-term data generated in other active-controlled studies|f||||f||||||||||2017-02-18 15:44:50.780065|2017-02-18 15:44:50.780065
NCT00453960|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2008-12-18|||January 2007||2007-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Genistein and Endometrial Hyperplasia|Effect of Genistein on Endometrial Hyperplasia|Completed||Phase 2|59|Actual|University of Messina||3|||f||||t||||||||||2017-02-18 15:44:51.384648|2017-02-18 15:44:51.384648
NCT00453947|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-03-28|||July 2002||2002-07-01|March 2007|2007-03-01|May 2005|Actual|2005-05-01|||||Interventional|||Non-Invasive Ventilation in Pulmonary Edema|Non Invasive Positive Airway Pressure And Risk Of Myocardial Infarction In Acute Cardiogenic Pulmonary Edema: Continuous Positive Airway Pressure Vs Non Invasive Positive Pressure Ventilation|Completed||Phase 4|60||Ospedale S. Giovanni Bosco|||||f||||t||||||||||2017-02-18 15:44:51.496008|2017-02-18 15:44:51.496008
NCT00453934|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2007-12-05|||May 2007||2007-05-01|March 2007|2007-03-01|September 2007|Actual|2007-09-01|||||Interventional|||Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device|h-Patch vs. Pen or Needle and Syringe as Insulin Administration Device in Type 1 or 2 Diabetes Patients Using MDI: Patient Preference and Glycemic Control After Switch in an Open-Label, Randomized Cross-Over Study|Terminated||Phase 4|11|Actual|Valeritas, Inc.||2||Endpoint no longer deemed meaningful|f||||f||||||||||2017-02-18 15:44:51.581832|2017-02-18 15:44:51.581832
NCT00453921|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2013-06-19|||February 2007||2007-02-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)|Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)|Completed||N/A|160|Actual|Dartmouth-Hitchcock Medical Center||4|||f||||t||||||||||2017-02-18 15:44:51.676005|2017-02-18 15:44:51.676005
NCT00453908|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-08-17|||May 2004||2004-05-01|August 2007|2007-08-01||||||||Interventional|ALF-RIK||Alfuzosin Versus Placebo in Acute Urinary Retention|Does Alfuzosin OD vs. Placebo in Male Patients Facilitate Spontaneous Voiding During Clean Intermittent Self-Catheterization Following Acute Urinary Retention?|Terminated||Phase 3|160||Sanofi||||The study was early terminated due to slow and difficult recruitment|f||||f||||||||||2017-02-18 15:44:51.793873|2017-02-18 15:44:51.793873
NCT00453895|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2010-07-06|||July 2007||2007-07-01|July 2010|2010-07-01|June 2011|Anticipated|2011-06-01|October 2010|Anticipated|2010-10-01||Interventional|SIRAC||Sunitinib in Refractory Adrenocortical Carcinoma|Sunitinib in Refractory Adrenocortical-Carcinoma Patients Progressing After Cytotoxic Chemotherapy|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|University of Wuerzburg||1|||f||||f||||||||||2017-02-18 15:44:51.871665|2017-02-18 15:44:51.871665
NCT00453882|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2012-01-26|||November 2006||2006-11-01|January 2012|2012-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Uretal Flow Assessment During Gynecological Procedures|An Evaluation of Ureteral Flow After Temporary Bilateral Uterine Artery Occlusion During Conservative Gynecological Procedures|Completed||N/A|7|Actual|Ethicon, Inc.||1|||f||||f||||||||||2017-02-18 15:44:51.9581|2017-02-18 15:44:51.9581
NCT00453869|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2014-12-11|||April 2007||2007-04-01|December 2014|2014-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|SNIFF11||Screening of Fibrosing and/or Viral Chronic Hepatopathies in Jail|Screening of Fibrosing and/or Viral Chronic Hepatopathies in Jail|Terminated||N/A|240|Actual|University Hospital, Angers|||1|Few prevalence of liver fibrosis in subjects|f||||f||||||||||2017-02-18 15:44:52.262763|2017-02-18 15:44:52.262763
NCT00453856|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-08-08|||March 2007||2007-03-01|August 2007|2007-08-01||||||||Interventional|||Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children|Efficacy of Sulfadoxine-Pyrimethamine in the Treatment of Symptomatic, Uncomplicated Plasmodium Falciparum Malaria Among 6-59 Month Old Children in Lambaréné|Terminated||Phase 4|139|Anticipated|Albert Schweitzer Hospital||||"The study was terminated because of Early Treatment Failure in child.The justification for~   this decision are concerns about safety of children."|f||||||||||||||2017-02-18 15:44:52.352243|2017-02-18 15:44:52.352243
NCT00453843|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2012-10-28|||June 2004||2004-06-01|March 2007|2007-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Shoulder, or Elbow, or Wrist: What Should we Train First After a Stroke?|The Effect of Proximal and Distal Training on Stroke Recovery|Completed||Phase 2|190|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||4|||f||||f||||||||||2017-02-18 15:44:52.449474|2017-02-18 15:44:52.449474
NCT00453830|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2009-02-17|||January 2005||2005-01-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Laparoscopic Versus Open Sigmoid Colectomy for Diverticular Disease|Laparoscopic Versus Open Sigmoid Colectomy for Diverticular Disease: A Prospective Randomized Single-Blind Trial|Completed||Phase 4|100|Anticipated|University Hospital, Geneva||1|||f||||f||||||||||2017-02-18 15:44:52.56757|2017-02-18 15:44:52.56757
NCT00453791|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2012-05-31|||February 2006||2006-02-01|February 2011|2011-02-01||||||||Interventional|||The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics|A Randomised, Single and Repeat Dose, Double-blind, Placebo Controlled Study to Assess the Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics|Terminated||Phase 1|54||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:44:52.884201|2017-02-18 15:44:52.884201
NCT00453778|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2013-02-11|||November 2002||2002-11-01|February 2013|2013-02-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients|A Study to Investigate the Effect of Inhaled Fluticasone Propionate on the Bronchial Responsiveness to Leukotriene D4 in Asthmatics Patients|Completed||Phase 4|14||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:44:52.970913|2017-02-18 15:44:52.970913
NCT00453765|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2013-04-05|||December 2007||2007-12-01|April 2013|2013-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|montelukast||The Effect of Montelukast in Patients With Chronic Cough and Bronchial Hyperreactivity|Prospective Single-centre, Double Blind Randomised Trial of Montelukast in Patients With Chronic Cough and Bronchial Hyperreactivity|Completed||Phase 4|89|Actual|Isala||2|||f||||t||||||||||2017-02-18 15:44:53.067585|2017-02-18 15:44:53.067585
NCT00453752|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-03-28|||April 2006||2006-04-01|March 2006|2006-03-01|April 2010|Anticipated|2010-04-01|||||Observational|||Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis||Unknown status|Recruiting|N/A|100||Medical University of Warsaw|||||f||||t||||||||||2017-02-18 15:44:53.190221|2017-02-18 15:44:53.190221
NCT00453739|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2014-05-05|||February 2007||2007-02-01|May 2014|2014-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||TVT Worldwide Registry|TVT-World Wide Observational Registry for Long-Term Data|Completed||N/A|1407|Actual|Ethicon, Inc.|||1||f||||f||||||||||2017-02-18 15:44:53.292505|2017-02-18 15:44:53.292505
NCT00453726|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2009-10-02|||May 2006||2006-05-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|||||Observational|||Brain Natriuretic Peptide (BNP) Levels in Patients in Non Invasive Mechanical Ventilation|Evaluation of BNP in Patients With Severe Acute Respiratory Failure Requiring Non Invasive Mechanical Ventilation|Completed||Phase 4|40|Anticipated|Ospedale S. Giovanni Bosco|||1||f||||t||||||||||2017-02-18 15:44:53.414375|2017-02-18 15:44:53.414375
NCT00453713|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-04-20|||July 2006||2006-07-01|April 2015|2015-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Race, Ethnicity, and Diffuse Parenchymal Lung Disease|Determinants of Outcome in Diffuse Parenchymal Lung Disease|Completed||N/A|565|Actual|Columbia University|||1||f||||f||||||Samples With DNA|"~     Plasma/serum, DNA, and circulating cells and endothelial microparticles will be collected~     and processed.~   "|||2017-02-18 15:44:53.512398|2017-02-18 15:44:53.512398
NCT00453700|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-03-28|||February 2007||2007-02-01|March 2007|2007-03-01||||||||Interventional|||Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram|Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram|Unknown status|Recruiting|N/A|300||University of California, Los Angeles|||||f||||f||||||||||2017-02-18 15:44:53.596105|2017-02-18 15:44:53.596105
NCT00453687|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-10-27|||March 2007||2007-03-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.|A Single-centre, Randomized, Double-blind Placebo-controlled, Dose-ascending, Cross-over Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of GSK233705, Formulated With the Excipient Magnesium Stearate, in Healthy Volunteers|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:44:53.679482|2017-02-18 15:44:53.679482
NCT00453674|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2016-10-28|||January 2003||2003-01-01|October 2016|2016-10-01|December 2025|Anticipated|2025-12-01|December 2023|Anticipated|2023-12-01||Observational|||German Adrenocortical Carcinoma Registry|Deutsches Nebennieren-Karzinom-Register - German Adrenocortical Carcinoma Registry|Recruiting||N/A|1000|Anticipated|University of Wuerzburg|||1||f||||f||||||||||2017-02-18 15:44:53.779576|2017-02-18 15:44:53.779576
NCT00453661|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-09-30|||March 2007||2007-03-01|September 2016|2016-09-01||||March 2018|Anticipated|2018-03-01||Observational|||Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities|Cancer Prevention and Treatment Demonstration for Hispanic Medicare Eligible Beneficiaries - CMS|Active, not recruiting||N/A|2812|Anticipated|M.D. Anderson Cancer Center|||2||f||||t||||||||||2017-02-18 15:44:53.875493|2017-02-18 15:44:53.875493
NCT00453648|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-01-19|||March 2006||2006-03-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Impact of Consumption of Orange-fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age|Efficacy of Daily Consumption of Sweet Potatoes for Increasing Total Body Vitamin A Pool Size, and the Effect of Consumption of Sweet Potatoes on Iron and Zinc Absorption in Bangladeshi Women of Reproductive Age|Completed||N/A|130|Actual|University of California, Davis||1|||f||||f||||||||||2017-02-18 15:44:53.985846|2017-02-18 15:44:53.985846
NCT00453635|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2012-03-12|||December 2003||2003-12-01|March 2012|2012-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients|A Multicenter Randomized Phase II Study of First Line Treatment With Sequential Administration of Docetaxel, Carboplatin and Herceptin Versus the Administration of Vinorelbine and Herceptin Combination in HER-2 Positive Patients With Metastatic Breast Cancer|Terminated||Phase 2|88|Actual|Hellenic Oncology Research Group||2||Due to poor accrual|f||||f||||||||||2017-02-18 15:44:54.084101|2017-02-18 15:44:54.084101
NCT00453622|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2013-07-17|||November 2005||2005-11-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|RISK||RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D|RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D|Completed||Phase 4|222|Actual|St. Jude Medical|||1||f||||t||||||Samples Without DNA|"~     Blood samples will be collected~   "|||2017-02-18 15:44:54.210333|2017-02-18 15:44:54.210333
NCT00453609|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2008-12-10|||April 2007||2007-04-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|vivitrol||Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)|Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI): An Open Prospective Pilot Trial|Completed||Phase 4|15|Actual|State University of New York - Upstate Medical University|||||f||||t||||||||||2017-02-18 15:44:54.314418|2017-02-18 15:44:54.314418
NCT00453583|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2013-12-13|||March 2007||2007-03-01|May 2012|2012-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine|Evaluation of the Treatment Satisfaction in Children Suffering From an Allergy and Who Received an Antihistamine Treatment|Completed||N/A|4581|Actual|UCB Pharma|||1||f||||||||||||||2017-02-18 15:44:54.617281|2017-02-18 15:44:54.617281
NCT00453570|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2012-04-13|||March 2007||2007-03-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months||Completed||Phase 3|792|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 15:44:54.726555|2017-02-18 15:44:54.726555
NCT00453557|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-12-06|||April 1999||1999-04-01|December 2016|2016-12-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|GH||Mechanism of Growth Hormone Effects on Adipose Tissue||Completed||Phase 4|30||Pennington Biomedical Research Center|||||f||||t||||||||||2017-02-18 15:44:54.844789|2017-02-18 15:44:54.844789
NCT00453544|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2016-10-26|||April 2006||2006-04-01|October 2016|2016-10-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|BWP-AD||Enhancing Consent for Alzheimer's Research|Enhancing Consent for Alzheimer's Research|Completed||N/A|252|Actual|University of California, San Diego||4|||f||||t||||||||||2017-02-18 15:44:54.929152|2017-02-18 15:44:54.929152
NCT00453531|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2017-01-24|||March 26, 2007||2007-03-26|February 11, 2009|2009-02-11||||February 11, 2009|Actual|2009-02-11||Interventional|||Model System for Transient Forearm Blood Vessel Dysfunction|Pilot Study for the Development of Transient Forearm Endothelial Dysfunction|Completed||N/A|20||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:44:55.043885|2017-02-18 15:44:55.043885
NCT00453518|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2009-08-17|||March 2007||2007-03-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|RETRIEVE||The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts|Evaluating the Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts: The RETRIEVE Study|Completed||N/A|29|Actual|Lumen Biomedical||1|||f||||t||||||||||2017-02-18 15:44:55.137273|2017-02-18 15:44:55.137273
NCT00453505|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2017-01-24|||March 23, 2007||2007-03-23|October 6, 2016|2016-10-06||||||||Observational|||Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System|Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:44:55.244392|2017-02-18 15:44:55.244392
NCT00453492|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2008-03-10|||January 2004||2004-01-01|March 2008|2008-03-01||||||||Interventional|||Risedronate Sodium in Post Menopausal Osteoporosis|A Multicenter, Prospective, Randomized, 2-Way Crossover, Open-Label Study pn Postmenopausal Women With Osteoporosis Examining Subject Satisfaction and Compliance When Risedronate Sodium (Actonel) in Administered 35mg Once a Week or 5mg Once Daily|Completed||Phase 4|246||Sanofi|||||f||||||||||||||2017-02-18 15:44:55.344441|2017-02-18 15:44:55.344441
NCT00453479|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2009-07-22||2009-07-22|March 2007||2007-03-01|July 2009|2009-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B.|A Randomised, Double-blind, Placebo-controlled, Dose Ascending,2-cohort, Parallel Group Study to Examine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Twice-daily Inhaled Doses of GSK233705B Formulated With the Excipient Magnesium Stearate in COPD Subjects for 7-days.|Completed||Phase 2|24|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:44:55.433297|2017-02-18 15:44:55.433297
NCT00453466|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2007-03-28|||December 2001||2001-12-01|March 2007|2007-03-01|December 2004|Actual|2004-12-01|||||Interventional|EBW||Group Empowerment of Battered Women as a Tool for Violence Prevention||Completed||N/A|||Ben-Gurion University of the Negev|||||f||||t||||||||||2017-02-18 15:44:55.529851|2017-02-18 15:44:55.529851
NCT00453453|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2015-02-06|||March 2007||2007-03-01|February 2015|2015-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|BOOST||BNP Therapy Observation Unit Outcomes STudy (BOOST)|BNP Therapy Observation Unit Outcomes STudy|Terminated||Phase 4|17|Actual|Emory University||2|||f||||t||||||||||2017-02-18 15:44:55.780664|2017-02-18 15:44:55.780664
NCT00453440|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-28|2010-08-31|||March 2007||2007-03-01|August 2010|2010-08-01||||||||Interventional|||Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701|Prospective Epidemiological Study of the Prevalence of HLA-B*5701 in HIV-1 Infected UK Patients|Completed||Phase 4|1569|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:44:55.893431|2017-02-18 15:44:55.893431
NCT00453427|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-06-01|||September 2006||2006-09-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|June 2013|Actual|2013-06-01||Interventional|ACCAPELA||Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas|Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas: A Multi-centre Phase I and II Study|Completed||Phase 1/Phase 2|20|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-02-18 15:44:55.978886|2017-02-18 15:44:55.978886
NCT00453414|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-02-12|||July 2006||2006-07-01|February 2010|2010-02-01|October 2006|Anticipated|2006-10-01|October 2006|Anticipated|2006-10-01||Interventional|||Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension|Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension|Withdrawn||Phase 2|0|Actual|Actelion||||Withdrawn due to lack of enrollment|f||||||||||||||2017-02-18 15:44:56.077998|2017-02-18 15:44:56.077998
NCT00453258|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2013-01-15|||February 2007||2007-02-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Pilot Study of Human Tear Proteins|Analysis of Human Tear Proteins: A Pilot Study to Describe the Tear Film Proteome of Patients Undergoing Ophthalmic Examination.|Terminated||N/A|63|Actual|University of Colorado, Denver|||1|Stopped due to low enrollment|f||||f||||||||||2017-02-18 15:44:56.168841|2017-02-18 15:44:56.168841
NCT00453245|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2007-03-27|||January 2004||2004-01-01|January 2004|2004-01-01|January 2006|Actual|2006-01-01|||||Observational|||Molecular Basis of the Growth Axis in Short Stature|Study of the Molecular Basis of the Growth Axis Among Short Stature Children|Completed||N/A|||HaEmek Medical Center, Israel|||||f||||t||||||||||2017-02-18 15:44:56.26734|2017-02-18 15:44:56.26734
NCT00453232|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2013-08-06|||August 2004||2004-08-01|August 2007|2007-08-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors|Accelerated BEP Chemotherapy for Intermediate and High Risk Metastatic Germ Cell Tumor|Completed||Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:44:56.345711|2017-02-18 15:44:56.345711
NCT00453219|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2013-10-29|||July 2011||2011-07-01|October 2013|2013-10-01||||||||Observational|||FHA: Characterization of Metabolic Status, Brain Circuitry, and Stress-Reactivity|Functional Hypothalamic Amenorrhea: Characterization of Metabolic Status, Brain Circuitry, and Stress-reactivity|Withdrawn||N/A|0|Actual|Emory University|||3|prior to participant recruitment, PI left Emory, study stopped|f||||t||||||Samples With DNA|"~     Blood samples will be collected, processed, and stored for the evaluation of genetic markers~     assocaited with stress vulnerability. Serum and plasma specimens will be collected and~     stored for the evaluation of factors associated with the regulation of reproduction.~   "|||2017-02-18 15:44:56.454202|2017-02-18 15:44:56.454202
NCT00453206|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2014-09-11|2014-05-28||February 2007||2007-02-01|September 2014|2014-09-01|August 2014|Actual|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases|Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients With Hematological Diseases|Completed||Phase 2|66|Actual|Wake Forest University Health Sciences|By the time the primary objective of this trial was completed, the treatment approach of the trial had become standard of care. Analysis was therefore limited.|1|||f||||t||||||||||2017-02-18 15:44:56.566208|2017-02-18 15:44:56.566208
NCT00453193|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2012-08-01|2011-03-01||September 2004||2004-09-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Alemtuzumab and Pentostatin In T-cell Neoplasms|A Phase II Study of Alemtuzumab and Pentostatin In T-Cell Neoplasms|Terminated||Phase 2|26|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 15:44:56.892243|2017-02-18 15:44:56.892243
NCT00453180|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2014-06-03||2013-04-23|March 2007||2007-03-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders|A Pilot Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders|Completed||Phase 2|32|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 15:44:57.150615|2017-02-18 15:44:57.150615
NCT00453167|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-07-09|||December 2005||2005-12-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer|A Phase II Study of Weekly Paclitaxel and Gemcitabine as Second-line Therapy in Patients With Metastatic or Recurrence Small Cell Lung Cancer|Completed||Phase 2|35|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:44:57.266509|2017-02-18 15:44:57.266509
NCT00453154|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-11-01|2015-03-24||March 2007||2007-03-01|November 2016|2016-11-01||||June 2013|Actual|2013-06-01||Interventional||Per protocol, participants who were randomized and received treatment were analyzed.|Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Combination Chemotherapy With or Without Maintenance Sunitinib Malate (NSC 736511) For Untreated Extensive Stage Small Cell Lung Cancer: A Phase IB/Randomized Phase II Study|Active, not recruiting||Phase 1/Phase 2|156|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:44:57.388166|2017-02-18 15:44:57.388166
NCT00453141|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2009-11-07|||April 2006||2006-04-01|March 2009|2009-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Betamethasone Dosing Interval - 12 or 24 Hours?|Betamethasone Dosing Interval - 12 or 24 Hours?|Completed||N/A|200|Anticipated|The Cooper Health System||1|||f||||f||||||||||2017-02-18 15:44:58.775559|2017-02-18 15:44:58.775559
NCT00453128|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2007-03-27|||January 1997||1997-01-01|March 2007|2007-03-01|December 2006|Actual|2006-12-01|||||Observational|||Diagnostic Rentability of Screening for Associated Conditions in Calcium Pyrophosphate Deposition Disease Patients|Appraisal of the Diagnostic Rentability of Thorough Analytical Screening Searching Associated Conditions in Patients Newly Diagnosed With Calcium Pyrophosphate Dihydrate Deposition Disease|Completed||N/A|240||Sociedade Galega de Reumatoloxía|||||f||||f||||||||||2017-02-18 15:44:58.875255|2017-02-18 15:44:58.875255
NCT00453115|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-10-22|||January 2006||2006-01-01|July 2010|2010-07-01|May 2011|Anticipated|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)|A Phase II Study of Gemcitabine Plus Oxaliplatin for Patients With Advanced Stage IIIB or IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|43|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:44:58.952517|2017-02-18 15:44:58.952517
NCT00453102|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-11-30|2015-10-23||February 2006||2006-02-01|November 2015|2015-11-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional||Data reported for only 16 of 18 participants due to 2 participants withdrawing consent.|Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma|Phase II Study of Ibritumomab Tiuxetan (Zevalin®) in Patients With Previously Untreated Marginal Zone Lymphoma|Completed||Phase 2|18|Actual|University of Miami|Data reported for only 16 of 18 enrolled participants due to 2 participants withdrawing consent.|1|||f||||t||||||||||2017-02-18 15:44:59.064512|2017-02-18 15:44:59.064512
NCT00453089|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2012-02-06|||June 2012||2012-06-01|February 2012|2012-02-01|August 2013|Anticipated|2013-08-01|June 2013|Anticipated|2013-06-01||Interventional|||VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women|A Phase I/II Dose Escalation Clinical Trial to Assess Safety and Efficacy of VG101 to Treat the Symptoms of Vulvar and Vaginal Atrophy in Post-Menopausal Women|Unknown status|Not yet recruiting|Phase 1/Phase 2|40|Anticipated|Bionovo|||||f||||||||||||||2017-02-18 15:44:59.719311|2017-02-18 15:44:59.719311
NCT00453076|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-06-10|||November 2006||2006-11-01|November 2006|2006-11-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||Paclitaxel Eluting Covered Metallic Stent for Unresectable Malignant Bile Duct Obstruction|Randomized Trial of Conventional Covered Self Expandable Metallic Stent Versus Paclitaxel Eluting Covered Self Expandable Metallic Stent in Unresectable Malignant Bile Duct Obstruction|Completed||Phase 3|52|Actual|Asan Medical Center||2|||f||||t||||||||||2017-02-18 15:44:59.820159|2017-02-18 15:44:59.820159
NCT00453063|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2015-03-17|2010-02-03||March 2007||2007-03-01|March 2015|2015-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)|Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis|Completed||Phase 3|426|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:44:59.937997|2017-02-18 15:44:59.937997
NCT00453050|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-05-05|||March 2006||2006-03-01|November 2008|2008-11-01||||March 2009|Actual|2009-03-01||Interventional|||Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin|Laser and TLR-Agonist Immunotherapy: A Novel Autologous Melanoma Vaccine Study|Completed||Phase 1|11|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:45:00.426235|2017-02-18 15:45:00.426235
NCT00453037|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2011-01-14|||March 2007||2007-03-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|herzleben||Effects of a Structured Education Program on Blood Pressure in Essential Hypertensive Patients|Effects of a Structured Education Program on Blood Pressure in Essential Hypertensive Patients and Effects of a Reminder Program for Physicians to Guide Optimal Therapy|Completed||N/A|256|Actual|Medical University of Graz||2|||f||||f||||||||||2017-02-18 15:45:00.535927|2017-02-18 15:45:00.535927
NCT00453024|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2008-05-12|||February 2007||2007-02-01|May 2008|2008-05-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Imaging Ahmed Glaucoma Tubes With a Pericardial Graft and Tissue Glue or Partial-Thickness Scleral Flap and Sutures|Anterior Segment Optical Coherence Tomography Findings in Patients With Ahmed Glaucoma Drainage Implants With Either a Pericardial Patch Graft and Fibrin Tissue Glue or a Partial-Thickness Scleral Flap and Conventional Sutures|Unknown status|Recruiting|Phase 2|40|Anticipated|National University Hospital, Singapore|||||f||||t||||||||||2017-02-18 15:45:00.652987|2017-02-18 15:45:00.652987
NCT00453011|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2015-10-19|||February 1992||1992-02-01|October 2015|2015-10-01|February 1998||1998-02-01|||||Interventional|||Comparison of AC and PC Lenses After Vitreous Loss During ECCE|CSP #338 - Comparison of Anterior and Posterior Chamber Lens Implants After Vitreous Loss in Attempted Extracapsular Cataract Extraction|Completed||Phase 3|1202||VA Office of Research and Development|||||f||||||||||||||2017-02-18 15:45:00.759028|2017-02-18 15:45:00.759028
NCT00452998|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2008-05-12|||November 2006||2006-11-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study|Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study|Completed||N/A|10|Anticipated|National University Hospital, Singapore|||||f||||t||||||||||2017-02-18 15:45:00.833635|2017-02-18 15:45:00.833635
NCT00452985|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2012-08-13|||February 2002||2002-02-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|OCSTUD||Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer|Randomised Study With Docetaxel, Cisplatin and Cyclophosphamide vs Docetaxel and Carboplatin as First Line Chemotherapy With Advanced or Metastatic Ovarian Cancer|Completed||N/A|30|Actual|Sanofi|||1||f||||||||||||||2017-02-18 15:45:00.946352|2017-02-18 15:45:00.946352
NCT00452972|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-03-26|||April 2004||2004-04-01|March 2007|2007-03-01|December 2004|Actual|2004-12-01|||||Interventional|||Exteriorized Versus In Situ Uterine Repair at Cesarean Delivery|Complications of Exteriorized Versus In Situ Uterine Repair at Cesarean Delivery Under Spinal Anesthesia|Completed||N/A|80||Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||||f||||f||||||||||2017-02-18 15:45:01.054233|2017-02-18 15:45:01.054233
NCT00452920|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-12-14|||September 2003||2003-09-01|December 2016|2016-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer|A Phase I/II Study of Docetaxel as a Radiosensitizer for Locally Advanced Cervical Cancer (GIA 13026)|Withdrawn||Phase 1/Phase 2|0|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:45:01.15671|2017-02-18 15:45:01.15671
NCT00452907|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-02-16|||July 2005||2005-07-01|February 2010|2010-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||ACT MALI: Treatment of Malaria Based on Combination Therapies|Assessment of the Public Health Benefit of Artemisinine Based Combination Therapies for Uncomplicated Malaria Treatment in Mali|Completed||Phase 4|780|Actual|Sanofi||3|||f||||||||||||||2017-02-18 15:45:01.26392|2017-02-18 15:45:01.26392
NCT00452894|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2008-03-28|||March 2007||2007-03-01|March 2008|2008-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers|A Pharmacokinetic, Toleration And Safety Study Of Single And Multiple Oral Doses Of Varenicline In Chinese Healthy Volunteers|Completed||Phase 1|14||Pfizer|||||f||||||||||||||2017-02-18 15:45:01.369661|2017-02-18 15:45:01.369661
NCT00452881|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-10-22|||May 2006||2006-05-01|July 2010|2010-07-01|December 2014|Anticipated|2014-12-01|October 2009|Actual|2009-10-01||Interventional|||Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC|A Randomized Phase II Study Adjuvant Gemcitabine And Oxaliplatin Versus Gemcitabine and Cisplatin for Completely Resected Stage IB, II or IIIA Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|151|Actual|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 15:45:01.459051|2017-02-18 15:45:01.459051
NCT00452868|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2016-07-26|2012-08-31||June 2006||2006-06-01|July 2016|2016-07-01||||February 2010|Actual|2010-02-01||Interventional|||Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain|A Pilot Study of Donepezil Hydrochloride in Pediatric Brain Tumor Survivors After Cranial Irradiation|Active, not recruiting||N/A|14|Actual|Wake Forest University Health Sciences|small number (11) analyzed|1|||f||||t||||||||||2017-02-18 15:45:01.588221|2017-02-18 15:45:01.588221
NCT00452855|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2007-03-28|||January 2002||2002-01-01|March 2007|2007-03-01|May 2005|Actual|2005-05-01|||||Interventional|||Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea|Postoperative Nausea and Vomiting Are Similar When Propofol or Sevoflurane Are Used as Adjuvant to Remifentanil During Anaesthesia for Gynaecological Surgery|Completed||N/A|160||Central Jutland Regional Hospital|||||f||||f||||||||||2017-02-18 15:45:01.888903|2017-02-18 15:45:01.888903
NCT00452842|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2008-02-21|||October 2007||2007-10-01|December 2007|2007-12-01||||||||Observational|||Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies|An Observational Safety Follow Up Trial Of The Occurrence Of Major Cardiovascular Events And All Cause Mortality In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Clinical Trials.|Terminated||N/A|26784||Pfizer||||See termination reason in detailed description.|f||||||||||||||2017-02-18 15:45:01.98805|2017-02-18 15:45:01.98805
NCT00452829|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2015-06-23|||September 2009||2009-09-01|June 2015|2015-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)|Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)|Completed||Phase 1|100|Actual|Institute of Child Health||2|||f||||f||||||||||2017-02-18 15:45:02.082604|2017-02-18 15:45:02.082604
NCT00452816|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2009-11-18|||April 2007||2007-04-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Marketing Workplace Chronic Disease Prevention|Marketing Workplace Chronic Disease Prevention|Completed||N/A|48|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:45:02.196802|2017-02-18 15:45:02.196802
NCT00452803|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-27|2010-07-09|||April 2006||2006-04-01|July 2010|2010-07-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)|A Randomized Phase II Study Preoperative Chemotherapy Versus Preoperative Concurrent Chemoradiotherapy for Patients With Biopsy-Proven N2 Stage IIIA Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|102|Anticipated|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 15:45:02.331113|2017-02-18 15:45:02.331113
NCT00452790|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2011-03-22|2010-10-13||June 2007||2007-06-01|March 2011|2011-03-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India|A Phase 3, Randomised, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Paediatric Vaccinations in India|Completed||Phase 3|708|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|Geometric Mean Concentration Outcome Measures were identified as secondary analysis in the study protocol, but are included to maintain consistency with other postings for this program.|2|||f||||||||||||||2017-02-18 15:45:02.471299|2017-02-18 15:45:02.471299
NCT00452777|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2014-10-31|||May 2007||2007-05-01|October 2014|2014-10-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain|A Double-blind, Placebo-controlled, Randomized, Parallel-group Study Evaluating the Efficacy and Tolerability of Oral BVT.115959, a Novel A2A Agonist, Versus Placebo in the Treatment of Diabetic Neuropathic Pain|Completed||Phase 2|193|Actual|Swedish Orphan Biovitrum||2|||f||||t||||||||||2017-02-18 15:45:04.6529|2017-02-18 15:45:04.6529
NCT00452764|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2007-11-07|||January 2007||2007-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||Regulatory T Cells in COPD|Phenotype and Number of Regulatory T Cells Present in Peripheral Blood of COPD Patients Versus Healthy Controls|Completed||N/A|50|Anticipated|Groningen Research Institute for Asthma and COPD|||||f||||t||||||||||2017-02-18 15:45:04.778094|2017-02-18 15:45:04.778094
NCT00452751|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2010-09-20|||February 2006||2006-02-01|September 2010|2010-09-01|May 2014|Anticipated|2014-05-01|||||Interventional|KLASS||Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized Trial|Multi-institutional Prospective Randomized Trial on the Assessment of Laparoscopic Surgery for Gastric Cancer|Unknown status|Recruiting|Phase 3|1400|Anticipated|National Cancer Center, Korea|||||f||||t||||||||||2017-02-18 15:45:04.855636|2017-02-18 15:45:04.855636
NCT00452738|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2015-04-20|||April 2007||2007-04-01|January 2008|2008-01-01|February 2008|Anticipated|2008-02-01|||||Interventional|Dog||The Effect of Pre Surgery Dog Visits on Post Surgery Consumption of Pain Medication|The Effect of Pre Surgery Dog Visits on Post Surgery Consumption of Pain Medication|Withdrawn||N/A|0|Actual|Oklahoma State University Center for Health Sciences||||PI left university. Did not start study|f||||f||||||||||2017-02-18 15:45:04.95784|2017-02-18 15:45:04.95784
NCT00452725|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2010-10-04|||October 1997||1997-10-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome|Effect of the Growth Hormone MAXOMAT ® on the Growth of Small Children and Adolescents (<-2 SD) Due to NOONAN's Syndrome|Completed||Phase 3|36|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 15:45:05.063893|2017-02-18 15:45:05.063893
NCT00452712|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2007-05-02|||November 2006||2006-11-01|May 2007|2007-05-01||||||||Observational|||Orthostatic Hypotension in Children With Acute Febrile Illness||Unknown status|Recruiting|Phase 2|100|Anticipated|Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:45:05.255695|2017-02-18 15:45:05.255695
NCT00452699|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2016-10-26|2010-01-14||May 2007||2007-05-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma|A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Treatment of Subjects With Asthma|Completed||Phase 4|621|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:45:05.353371|2017-02-18 15:45:05.353371
NCT00452686|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2016-10-27|||March 2007||2007-03-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine|Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix (dTpa) Vaccine and the Chinese DT Vaccine, When Administered as Booster Vaccination in Healthy Children Aged 6-8 Years|Completed||Phase 3|660||GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:45:05.962922|2017-02-18 15:45:05.962922
NCT00452673|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2015-03-04|2013-10-09||June 2007||2007-06-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer|Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Advanced Breast Cancer|Completed||Phase 1|52|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 15:45:06.079733|2017-02-18 15:45:06.079733
NCT00452660|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2014-06-13|||May 2007||2007-05-01|June 2014|2014-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load|A Phase IV , Multicenter ,Open Label ,Non Comparative ,Investigator Initiated Study , Evaluating the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load|Completed||Phase 4|21|Actual|Wolfson Medical Center||1|||f||||t||||||||||2017-02-18 15:45:09.980132|2017-02-18 15:45:09.980132
NCT00452647|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2013-09-05|||February 2007||2007-02-01|September 2013|2013-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Comparison of Blood Pressure Throughout Pregnancy|Comparison of Blood Pressure Throughout Pregnancy|Terminated||N/A|200|Actual|Drexel University|||1|data did not indicate any meaningful information|f||||||||||||||2017-02-18 15:45:10.081521|2017-02-18 15:45:10.081521
NCT00452634|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2013-06-17|||April 2006||2006-04-01|June 2013|2013-06-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional|||Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)|A Phase II Study of Irinotecan/Cisplatin Plus Simvastatin in Chemo-naive Patients With Extensive Disease-Small Cell Lung Cancer|Completed||Phase 2|62|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:45:10.159209|2017-02-18 15:45:10.159209
NCT00452621|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2008-04-22|||February 2007||2007-02-01|April 2008|2008-04-01||||||||Interventional|||Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years|A Phase IV, Uncontrolled, Open-Label, Multi-Center Study in Children and Adolescents: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a New Pediatric TBE Vaccine (Free of Protein-Derived Stabilizer) in Study V48P4E1, Five Years After First Booster Immunization|Completed||Phase 4|235|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:45:10.263698|2017-02-18 15:45:10.263698
NCT00452608|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2009-06-25|||December 2006||2006-12-01|June 2009|2009-06-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Statin for Immunomudulation in Sepsis|Use of Statins in Modulation of Inflammatory Answer in Septic Patients|Unknown status|Recruiting|Phase 2|80|Anticipated|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-02-18 15:45:10.360848|2017-02-18 15:45:10.360848
NCT00452595|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2007-03-23|||January 2004||2004-01-01|March 2007|2007-03-01|May 2005||2005-05-01|||||Interventional|||Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder|A 12-Month Open-Label Evaluation of the Long-Term Safety of DVS-233 SR in Outpatients With Major Depressive Disorder|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:45:10.455827|2017-02-18 15:45:10.455827
NCT00452582|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2011-03-15|||April 2005||2005-04-01|March 2011|2011-03-01||||||||Interventional|||Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke|Phase 1 Study of Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke|Terminated||Phase 1|20|Actual|Henry Ford Health System||2||Failure to recruit in expected time period.|f||||t||||||||||2017-02-18 15:45:10.538911|2017-02-18 15:45:10.538911
NCT00452569|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2016-11-22|||February 2006||2006-02-01|November 2016|2016-11-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|OPTIMUM||Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma|Randomised, Controlled, Open-labelled, Multi-centre Comparison of Thalidomide Versus High-dose Dexamethasone for the Treatment of Relapsed Refractory Multiple Myeloma|Completed||Phase 3|499|Actual|Celgene Corporation||4|||f||||t||||||||||2017-02-18 15:45:10.890429|2017-02-18 15:45:10.890429
NCT00452556|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2014-03-18|||May 2007||2007-05-01|March 2014|2014-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study|The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study: A Phase II Study of Chemo - Hormonal Therapy and Radiation in High Risk Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|86|Anticipated|Nova Scotia Cancer Centre||2|||f||||t||||||||||2017-02-18 15:45:11.09688|2017-02-18 15:45:11.09688
NCT00452543|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2012-06-04|2011-05-24||March 2007||2007-03-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism|A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) With Comorbid Alcohol Abuse/Dependence|Completed||Phase 4|23|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 15:45:11.216825|2017-02-18 15:45:11.216825
NCT00452530|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2014-07-08|2014-04-14||June 2007||2007-06-01|July 2014|2014-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|ADVANCE-2|All participants randomized to treatment|Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery|A Phase 3, Randomized, Double-blind, Active-controlled (Enoxaparin 40 mg QD), Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Apixaban in Subjects Undergoing Elective Total Knee Replacement Surgery (The ADVANCE - 2 Study)|Completed||Phase 3|3221|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 15:45:11.718622|2017-02-18 15:45:11.718622
NCT00452517|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2007-03-26|||March 2004||2004-03-01|March 2007|2007-03-01|November 2004|Actual|2004-11-01|||||Interventional|||Comparison of Stent Graft, Sirolimus Stent, and Bare Metal Stent Implanted in Patients With Acute Coronary Syndrome|Comparison of Stent Graft, Sirolimus Stent, and Bare Metal Stent Implanted in Patients With Acute Coronary Syndrome: Clinical and Angiographic Follow-up|Completed||Phase 4|100||University of Zagreb|||||f||||f||||||||||2017-02-18 15:45:13.735629|2017-02-18 15:45:13.735629
NCT00452504|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2007-12-03|||February 2007||2007-02-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Single Ascending Dose Study of SRA-444 in Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRA-444 Administered Orally to Healthy Adult Subjects|Completed||Phase 1|64|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:45:13.833586|2017-02-18 15:45:13.833586
NCT00452491|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2010-10-04|||May 1993||1993-05-01|October 2010|2010-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children|A Cohort of Pre-pubertal Children for the Study of Optimization of Methods of Administration of the Biosynthetic Growth Hormone MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation|Completed||Phase 3|306|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:45:13.911074|2017-02-18 15:45:13.911074
NCT00452478|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2014-06-06|||May 2007||2007-05-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5|A Phase IV, Open-Label, Multi-Centre Trial Evaluating the Conversion From Standard Phosphate Binder Therapy to Fosrenol® in Chronic Kidney Disease Stage 5 Patients on Haemodialysis|Terminated||Phase 4|68|Actual|Shire||1||This study was stopped by the sponsor based on a non-safety related corporate decision|f||||||||||||||2017-02-18 15:45:14.007292|2017-02-18 15:45:14.007292
NCT00452465|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2016-03-14|||February 2007||2007-02-01|March 2016|2016-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Primary Healthcare for Community Living Old Elderly|The ElderCare Project: Primary Healthcare for Community Living Old Elderly|Completed||N/A|236|Actual|Memorial University of Newfoundland||2|||f||||f||||||||||2017-02-18 15:45:14.130902|2017-02-18 15:45:14.130902
NCT00452452|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2012-07-06|2010-03-26||July 2007||2007-07-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children|A Phase 3 Open-label Trial Evaluating the Safety, Tolerability and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Older Infants and Children Who Are Naive to Previous Vaccination With Pneumococcal Conjugate Vaccine.|Completed||Phase 3|355|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 15:45:14.241361|2017-02-18 15:45:14.241361
NCT00452439|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2014-08-19|||February 2004||2004-02-01|August 2014|2014-08-01||||August 2014|Actual|2014-08-01||Interventional|||A Study of Actonel for the Prevention of Bone Loss|A Randomized, Double Blinded Study of Actonel for the Prevention of Bone Loss in Patients Receiving High Dose Corticosteroids for the Treatment of Acute Lymphocytic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)|Completed||Phase 3|95|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:45:15.364073|2017-02-18 15:45:15.364073
NCT00452426|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2010-12-30|2010-10-06||March 2007||2007-03-01|December 2010|2010-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy|Multi-center Pivotal Clinical Trial to Compare the Safety and Effectiveness of Procedural Sedation in GI Endoscopy: A Computer-Assisted Personalized Sedation (CAPS) Device Versus Current Standard of Care|Completed||Phase 3|1000|Actual|Ethicon Endo-Surgery||2|||f||||t||||||||||2017-02-18 15:45:15.495247|2017-02-18 15:45:15.495247
NCT00452413|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2016-11-30||2010-05-27|May 2007||2007-05-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|July 2009|Actual|2009-07-01||Interventional|||A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer|A Phase 1/2 Trial of Enzastaurin and Erlotinib in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy|Completed||Phase 1/Phase 2|65|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:45:15.891411|2017-02-18 15:45:15.891411
NCT00452400|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2014-06-17|2014-03-28||March 2007||2007-03-01|May 2014|2014-05-01||||January 2008|Actual|2008-01-01||Interventional||Treated set includes all patients who were dispensed study medication and were documented to have taken at least one dose of investigational treatment.|Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.|Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of 4 Weeks of Treatment of Orally Inhaled BI 1744 CL (3 - 4 Doses) Delivered by the Respimat® Inhaler in Patients With COPD|Completed||Phase 2|409|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:45:16.031031|2017-02-18 15:45:16.031031
NCT00452387|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2011-09-13|2009-08-17||May 2007||2007-05-01|September 2011|2011-09-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|||Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)|Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)|Terminated||Phase 2|22|Actual|Accelerated Community Oncology Research Network|Early termination, according to the stopping rule included in the protocol, leading to a small number of subjects analyzed|1||Early stopping rule|f||||f||||||||||2017-02-18 15:45:18.502284|2017-02-18 15:45:18.502284
NCT00452374|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2011-10-25|2011-07-28||November 2004||2004-11-01|October 2011|2011-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL|A Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Patients With Richter's Transformation, Prolymphocytic Leukemia or Refractory/Relapsed B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|48|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:45:18.987079|2017-02-18 15:45:18.987079
NCT00452361|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2012-07-27|2009-09-24||April 2007||2007-04-01|July 2012|2012-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient|A Randomized, Open-label, Comparative Evaluation of Conversion From Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipient|Terminated||Phase 4|31|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|Study terminated early due to difficulties in enrolling qualified patients. No patients completed 104 weeks (primary outcome); a few completed 60 weeks. Insufficient data were available for efficacy analyses.|2|||f||||f||||||||||2017-02-18 15:45:19.266624|2017-02-18 15:45:19.266624
NCT00452348|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2016-10-27|2010-01-20||May 2007||2007-05-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma|A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Treatment of Subjects With Asthma|Completed||Phase 4|628|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:45:19.878498|2017-02-18 15:45:19.878498
NCT00452335|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2016-07-12|2016-02-16||January 2007||2007-01-01|July 2016|2016-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation|A Multi-center, Open-labeled Study of the Safety, Efficacy, and Pharmacokinetics of Lubiprostone in Pediatric Patients With Constipation|Completed||Phase 4|127|Actual|Sucampo Pharma Americas, LLC||3|||f||||f||||||||||2017-02-18 15:45:20.505932|2017-02-18 15:45:20.505932
NCT00452322|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2007-03-26|||April 1997||1997-04-01|March 2007|2007-03-01|January 2007|Actual|2007-01-01|||||Interventional|||Safety of Testosterone Undecanoate i.m. in Hypogonadal Men|Long-Term Intervention Phase 2 Study of Safety Aspects of Testosterone Undecanoate i.m. in Hypogonadal Men|Completed||Phase 2|60||University Hospital Muenster|||||f||||t||||||||||2017-02-18 15:45:21.295959|2017-02-18 15:45:21.295959
NCT00452309|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-25|2007-09-25|||March 2007||2007-03-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Observational|||Validation of a Correction Factor for Measurement of an Accurate Ankle-Brachial Index in the Seated Position|Validation of a Correction Factor for Measurement of an Accurate Ankle-Brachial Index in the Seated Position|Completed||N/A|50|Anticipated|The Cleveland Clinic|||||f||||||||||||||2017-02-18 15:45:21.399563|2017-02-18 15:45:21.399563
NCT00452296|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-25|2012-06-25|||April 2007||2007-04-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|May 2010|Actual|2010-05-01||Interventional|||Tight Glycemic Control in Acute Exacerbations of COPD|Tight Glycemic Control in Acute Exacerbations of COPD|Unknown status|Active, not recruiting|N/A|84|Anticipated|Soroka University Medical Center||1|||f||||f||||||||||2017-02-18 15:45:21.477735|2017-02-18 15:45:21.477735
NCT00452283|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2013-01-29|||March 2007||2007-03-01|January 2013|2013-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy|The Effect of a Systemic Non-selective Endothelin Antagonist on Intraocular Pressure and Anterior Depth in Pulmonary Hypertension Patients.|Completed||N/A|23|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-02-18 15:45:21.554144|2017-02-18 15:45:21.554144
NCT00452270|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2007-05-02|||March 2007||2007-03-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold|A Double-Blind, Randomized, Parallel Group, Placebo Controlled Study, Evaluating the Decongestant Effect, Time to Onset, Duration of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold|Completed||Phase 3|60||Novartis|||||f||||f||||||||||2017-02-18 15:45:21.644493|2017-02-18 15:45:21.644493
NCT00452257|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2009-03-18|||May 2007||2007-05-01|March 2009|2009-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of Enzastaurin in Patients With Leukemia|A Phase 1b Pharmacokinetic-Pharmacodynamic-Pharmacogenomic Study of Enzastaurin in Patients With B-Cell Chronic Lymphocytic Leukemia (B-CLL)|Completed||Phase 1|18|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:45:21.734175|2017-02-18 15:45:21.734175
NCT00452244|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2011-09-15|||May 2006||2006-05-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)|Randomized Phase II Trail Comparing Gefitinib Plus Simvastatin and Gefitinib Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|110|Actual|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 15:45:21.837191|2017-02-18 15:45:21.837191
NCT00452231|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2007-03-26|||February 2007||2007-02-01|March 2007|2007-03-01|July 2008|Anticipated|2008-07-01|||||Interventional|||RCT of CBT Combined With D-Cycloserine for Treating PTSD|Comparative Study of the Efficacy of a Cognitive-Behavioral Therapy for Post-Traumatic Stress Disorder With or Without D-Cycloserine|Unknown status|Recruiting|Phase 2/Phase 3|20||Université de Montréal|||||f||||t||||||||||2017-02-18 15:45:21.946888|2017-02-18 15:45:21.946888
NCT00452218|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2016-08-23|||March 2007||2007-03-01|August 2016|2016-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)|Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 1|12|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 15:45:22.044062|2017-02-18 15:45:22.044062
NCT00452205|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2009-08-03|||April 2007||2007-04-01|August 2009|2009-08-01|March 2017|Anticipated|2017-03-01|||||Observational|||Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation|Bone Marrow-derived Cells' Contribution to Tumor Formation and Epithelial Cells Regeneration in the Gastrointestinal Tract|Recruiting||N/A|300|Anticipated|Komagome Hospital|||1||f||||f||||||Samples With DNA|"~     tissue~   "|||2017-02-18 15:45:22.153904|2017-02-18 15:45:22.153904
NCT00452192|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2012-07-06|||November 2006||2006-11-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome|Detailed Analysis of the Effects of Telmisartan on Renal Perfusion in Patients With Metabolic Syndrome|Completed||Phase 3|30|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-02-18 15:45:22.256509|2017-02-18 15:45:22.256509
NCT00452179|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2007-09-06|||February 2007||2007-02-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Safety and Efficacy Study of APD125 in Patient With Insomnia|A Randomized, Double-Blind, Placebo-Controlled, 3-Way Cross-Over Study to Evaluate the Effects of APD125 in Patients With Chronic Primary Insomnia|Completed||Phase 2|173|Actual|Arena Pharmaceuticals|||||||||||||||||||2017-02-18 15:45:22.595287|2017-02-18 15:45:22.595287
NCT00452166|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2008-09-30|||April 2007||2007-04-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Rosiglitazone and Insulin Resistance in Renally Impaired Patients|Rosiglitazone and Insulin Resistance in Renally Impaired Patients|Terminated||Phase 3|30|Anticipated|Leiden University Medical Center||2||it was not possible to recruit new patients anymore|f||||t||||||||||2017-02-18 15:45:22.685321|2017-02-18 15:45:22.685321
NCT00452153|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2015-07-28|||March 2007||2007-03-01|July 2015|2015-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Evaluation of Legionella PCR Techniques for the Routine Diagnosis of Legionellosis|Evaluation of Legionella PCR Techniques for the Routine Diagnosis of Legionellosis|Terminated||N/A|200|Actual|Centre Hospitalier Universitaire de Saint Etienne||1||Too much difficulties to includ patient|f||||f||||||||||2017-02-18 15:45:22.790336|2017-02-18 15:45:22.790336
NCT00452140|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-26|2009-05-18|||March 2007||2007-03-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|||||Interventional|||Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment|Phase II Study for Repeated Dosing of the Trifunctional Bispecific Anti-HER-2/Neu x Anti-CD3 Antibody Ertumaxomab in Patients With HER-2/Neu 1+ or 2+/FISH Negative Expressing Advanced or Metastatic Breast Cancer (Stage IIIb/IV) Progressing After Endocrine Treatment|Terminated||Phase 2|40|Anticipated|Neovii Biotech||1||company focus on other projects|f||||t||||||||||2017-02-18 15:45:22.908799|2017-02-18 15:45:22.908799
NCT00452127|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2013-01-18||2013-01-18|May 2007||2007-05-01|January 2013|2013-01-01||||May 2009|Actual|2009-05-01||Interventional|||A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|An Open-Label, Multicenter, Phase I/II Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Have Been Treated With a Prior Rituximab-Containing Regimen|Terminated||Phase 1/Phase 2|26|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 15:45:23.022665|2017-02-18 15:45:23.022665
NCT00452114|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2013-01-30|2013-01-30||April 2004||2004-04-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||In-exsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis|A Randomized, Controlled Study Evaluating the Effectiveness of the Inexsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis|Terminated||N/A|28|Actual|University of Massachusetts, Worcester||2||interim analysis indicates statistical futility for primary outcomes|f||||f||||||||||2017-02-18 15:45:23.124334|2017-02-18 15:45:23.124334
NCT00452101|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22|||January 2006||2006-01-01|March 2007|2007-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Effects of Aquamin F on Osteoarthritis of the Knee|Randomized, Placebo Controlled Trial: Effects of Aquamin F Alone or in Combination With Glucosamine Sulfate on Joint Mobility and Pain in Osteoarthritis of the Knee|Completed||Phase 1/Phase 2|70||Marigot Ltd.|||||f||||f||||||||||2017-02-18 15:45:23.486089|2017-02-18 15:45:23.486089
NCT00452088|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2008-05-06|||April 2007||2007-04-01|November 2007|2007-11-01|May 2008|Anticipated|2008-05-01|May 2008|Anticipated|2008-05-01||Interventional|MSP3LSP||A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso|Randomized, Controlled, Dose Escalation Phase Ib Trial of MSP 3 LSP Adjuvanted in Aluminium Hydroxide Versus Hepatitis Bin 12 to 24 Month Old Children in Burkina Faso.|Unknown status|Recruiting|Phase 1|45|Anticipated|African Malaria Network Trust||4|||f||||t||||||||||2017-02-18 15:45:23.573287|2017-02-18 15:45:23.573287
NCT00452075|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2014-12-10|||March 2007||2007-03-01|December 2014|2014-12-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Interventional|||Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy|A Phase II Study of Erlotinib and Predictive Markers as First-line Treatment of Advanced Non-small Cell Lung Cancer for Patients Unfit for Chemotherapy|Terminated||Phase 2|24|Actual|Rigshospitalet, Denmark||1||Poor recruitment|f||||t||||||||||2017-02-18 15:45:23.685228|2017-02-18 15:45:23.685228
NCT00452062|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2007-03-23|||October 2004||2004-10-01|March 2007|2007-03-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Dexamethasone and the Prevention of Post-Extubation Airway Obstruction in Adults|Mackay Memorial Hospital|Unknown status|Recruiting|Phase 2|70||Mackay Memorial Hospital|||||f||||t||||||||||2017-02-18 15:45:23.800334|2017-02-18 15:45:23.800334
NCT00452049|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2012-05-28|||April 2005||2005-04-01|May 2012|2012-05-01||||||||Observational|||The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood Pressure|Observational Study to Evaluate the Effect of Parathyroidectomy on Renal Function, Endothelial Function and Blood Pressure|Unknown status|Recruiting|N/A|20|Anticipated|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||||||2017-02-18 15:45:23.904136|2017-02-18 15:45:23.904136
NCT00452036|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2010-07-26|||December 2004||2004-12-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|||||Observational|||Diagnostic Algorithm in Patients With Minor Head Injury|Prospective Study to Find a Diagnostic Algorithm for Diagnosis of Minor Head Injury|Completed||N/A|12500|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-02-18 15:45:23.989921|2017-02-18 15:45:23.989921
NCT00452023|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2016-03-10|||April 2005||2005-04-01|March 2016|2016-03-01||||December 2017|Anticipated|2017-12-01||Interventional|||Pegasys® in Patients With Myeloproliferative Diseases|PEG IFN-alpha2a (Pegasys®) Therapy in Patients With Chronic Myeloproliferative Diseases (Excluding Philadelphia Chromosome Positive Chronic Myeloid Leukemia)|Active, not recruiting||Phase 2|280|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:45:24.168988|2017-02-18 15:45:24.168988
NCT00452010|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2012-07-03|||September 2006||2006-09-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|LOBOTENS||Pain Reducing Effect of Transcutaneous Electrical Nerve Stimulation in Patients With Chronic Low Back Pain or Lumbo-radiculalgia|Pain Reducing Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Patients With Chronic Low Back Pain or Chronic Lumbo-radiculalgia and Followed in Pain Treatment Centers|Completed||Phase 4|236|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-02-18 15:45:24.292858|2017-02-18 15:45:24.292858
NCT00451997|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2012-07-31|||March 2004||2004-03-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|August 2005|Actual|2005-08-01||Interventional|||Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes|Phase II Trial of Gleevec and Low-Dose Ara-C for Elderly Patients With C-Kit Positive Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes|Completed||Phase 2|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:45:24.405134|2017-02-18 15:45:24.405134
NCT00451984|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2007-10-31|||March 2007||2007-03-01|October 2007|2007-10-01||||||||Interventional|HEPVACHIV||Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2||Unknown status|Recruiting|Phase 3|80|Anticipated|Aalborg Universitetshospital||2|||f||||f||||||||||2017-02-18 15:45:24.526909|2017-02-18 15:45:24.526909
NCT00451971|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2008-09-04|||March 2002||2002-03-01|September 2008|2008-09-01||||||||Interventional|OSRA||Objective Study in Rheumatoid Arthritis|Objective Study in Rheumatoid Arthritis|Completed||Phase 4|249|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:45:24.615384|2017-02-18 15:45:24.615384
NCT00451958|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2013-03-20|2012-10-10||March 2007||2007-03-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional||CS21A intention-to-treat (ITT) population.|A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy|An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Patients With Prostate Cancer Requiring Androgen Ablation Therapy|Completed||Phase 3|386|Actual|Ferring Pharmaceuticals||4|||f||||t||||||||||2017-02-18 15:45:24.726047|2017-02-18 15:45:24.726047
NCT00451945|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2008-06-17|||March 2007||2007-03-01|June 2008|2008-06-01|March 2008||2008-03-01|||||Interventional|||New Indications for Ultrasound in the Staging of Cervical Cancer|New Indications for Ultrasound in the Staging of Cervical Cancer|Withdrawn||N/A|||Rigshospitalet, Denmark|||||f||||f||||||||||2017-02-18 15:45:27.123671|2017-02-18 15:45:27.123671
NCT00451932|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2008-04-15|||October 2002||2002-10-01|April 2008|2008-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients|A Multicentre, Randomised, Double-Blind, Tacrolimus Dual Therapy-Controlled, Parallel Group, Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of FK778 in Liver Transplant Patients Receiving Standard Tacrolimus (FK506) and Steroids Therapy|Completed||Phase 2|303|Actual|Astellas Pharma Inc|||||f||||t||||||||||2017-02-18 15:45:29.898831|2017-02-18 15:45:29.898831
NCT00451919|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2016-08-18|||July 2006||2006-07-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell Disease|Sickle-Cell Disease: Neuroimaging and Cognitive Decline|Completed||N/A|120|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 15:45:30.012645|2017-02-18 15:45:30.012645
NCT00451906|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2016-04-25|2016-03-23||August 2006||2006-08-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||Baseline characteristics were described for the intent-to-treat (ITT) population, which included all participants with at least one valid post-baseline (Day -28 to -1) assessment.|A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.|Open-label Study of Bevacizumab (AVASTIN®) in Combination With Platinum-containing Chemotherapy as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer|Completed||Phase 4|2252|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:45:30.129207|2017-02-18 15:45:30.129207
NCT00451893|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2016-05-31|||December 2006||2006-12-01|May 2016|2016-05-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Interventional|LJUNO||The Significance of the Mesh Thickness in the Operation of Inguinal Hernia|An Expertise-based Multicentre Randomized Controlled Trial Comparing a Heavy-weight and a Light-weight Mesh in the Operation of Inguinal Hernia|Active, not recruiting||Phase 2/Phase 3|400|Anticipated|Umeå University||2|||f||||f||||||||||2017-02-18 15:45:31.740413|2017-02-18 15:45:31.740413
NCT00451880|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2011-10-11|||February 2007||2007-02-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study of XL281 in Adults With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL281 Administered Orally to Subjects With Solid Tumors|Completed||Phase 1|180|Anticipated|Exelixis||3|||f||||||||||||||2017-02-18 15:45:31.851939|2017-02-18 15:45:31.851939
NCT00451867|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2010-01-12|||March 2007||2007-03-01|January 2010|2010-01-01|April 2008|Anticipated|2008-04-01|February 2008|Actual|2008-02-01||Interventional|ICCRN RCT2||A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . .|A Randomized Multicenter Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Mycophenolate Mofetil (CellCept) for the Treatment of Refractory Interstitial Cystitis (IC)|Terminated||Phase 3|210|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2||"The major and primary reason for the study termination is the observed reduced efficacy of~   CellCept compared to placebo."|f||||t||||||||||2017-02-18 15:45:31.968869|2017-02-18 15:45:31.968869
NCT00451854|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2017-01-10|||September 1999||1999-09-01|March 2007|2007-03-01|October 2002|Actual|2002-10-01|||||Interventional|SATURN||Student Athlete Testing Using Random Notification|Student Athlete Drug Surveillance Trail|Completed||N/A|14000||National Institute on Drug Abuse (NIDA)|||||f||||f||||||||||2017-02-18 15:45:32.113173|2017-02-18 15:45:32.113173
NCT00451841|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2017-01-19|||March 2007||2007-03-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|June 2013|Actual|2013-06-01||Observational|||Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux|Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux|Suspended||N/A|30|Anticipated|University of Massachusetts, Worcester|||2|insufficient enrollment; study suspended pending analysis|f||||f||||||Samples Without DNA|"~     frozen sputum supernatant and exhaled breath condensate fixed sputum cell preparations~   "|||2017-02-18 15:45:32.204434|2017-02-18 15:45:32.204434
NCT00451828|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2011-10-04|||March 2002||2002-03-01|October 2011|2011-10-01||||October 2004|Actual|2004-10-01||Interventional|CAP||Cholesterol and Pharmacogenetic Study|Cholesterol and Pharmacogenetic Study|Completed||Phase 4|1000|Anticipated|Children's Hospital & Research Center Oakland||1|||f||||t||||||||||2017-02-18 15:45:32.30624|2017-02-18 15:45:32.30624
NCT00451815|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2007-03-23||||||March 2007|2007-03-01||||||||Interventional|||BIIB014 Phase 2a Monotherapy|A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Multiple Oral Dose Administration of BIIB014 in Subjects With Early Parkinson’s Disease|Withdrawn||Phase 2|||Biogen|||||f||||||||||||||2017-02-18 15:45:32.408483|2017-02-18 15:45:32.408483
NCT00451802|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-23|||January 2003||2003-01-01|January 2005|2005-01-01|December 2005||2005-12-01|||||Observational|||A Pilot Scheme - Specimen Collection of Health Management Center|A Pilot Scheme - Specimen Collection of Health Management Center|Completed||N/A|7000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 15:45:32.479927|2017-02-18 15:45:32.479927
NCT00451789|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-23|2007-03-23|||December 2004||2004-12-01|March 2007|2007-03-01|April 2006|Actual|2006-04-01|||||Observational|||Risk Factors of Minor Head Injury|Risk Factors of Minor Head Injury in Traumatological Patients|Completed||N/A|12500||Medical University of Vienna|||||f||||f||||||||||2017-02-18 15:45:32.55714|2017-02-18 15:45:32.55714
NCT00451776|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2008-10-29|||June 2007||2007-06-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Post Operative Hemodynamic Function After Anesthetic Induction With Etomidate for Cardiac Surgery With ECC|Post Operative Hemodynamic Function After Anesthetic Induction With Etomidate for Cardiac Surgery With ECC. A Prospective, Monocentric, Randomised Double Blind Study|Completed||Phase 4|100|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t||||||||||2017-02-18 15:45:32.634605|2017-02-18 15:45:32.634605
NCT00451763|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2008-07-21|||January 2006||2006-01-01|March 2007|2007-03-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia|Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia|Completed||Phase 3|31|Actual|University of Sao Paulo|||||f||||t||||||||||2017-02-18 15:45:32.810118|2017-02-18 15:45:32.810118
NCT00451750|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2010-01-11|||May 2007||2007-05-01|January 2010|2010-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Cortisol in the Treatment of Phobias|The Efficacy of Cortisol in Combination With Behavioral Therapy in the Treatment of Phobias|Completed||N/A|40|Anticipated|University of Zurich||1|||f||||||||||||||2017-02-18 15:45:33.080432|2017-02-18 15:45:33.080432
NCT00451737|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22|||November 2006||2006-11-01|January 2006|2006-01-01|March 2007|Anticipated|2007-03-01|||||Interventional|||Correlation of 6-Minute Walk Test and Neuromuscular Parameters in the Elderly|Correlation of 6-Minute Walk Test and Neuromuscular Parameters in the Elderly: Knee Proprioception, Standing Balance, Quadriceps Muscle Strength, Endurance, and Torque Acceleration Energy|Unknown status|Recruiting|Phase 1|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 15:45:33.176741|2017-02-18 15:45:33.176741
NCT00451724|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2010-07-21|||May 2007||2007-05-01|July 2010|2010-07-01|February 2010|Actual|2010-02-01|||||Interventional|||Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair|Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair|Completed||Phase 2|45|Anticipated|Rhode Island Hospital||3|||f||||t||||||||||2017-02-18 15:45:33.25575|2017-02-18 15:45:33.25575
NCT00451711|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2013-12-12|||May 2007||2007-05-01|March 2007|2007-03-01|October 2014|Anticipated|2014-10-01|||||Interventional|||Intermittent Liposomal Amphotericin B Primary Prophylaxis|A Randomised, Stratified, Open Label, Phase II Pilot Study on the Safety of a Daily, Intermittent, or Weekly Administration of 1, 3 or 10mg/kg of AmBisome® in Antifungal Primary Prophylaxis of High-Risk Patients With Acute Myeloid Leukaemia|Unknown status|Recruiting|Phase 2|60|Anticipated|Bayside Health|||||f||||t||||||||||2017-02-18 15:45:33.35115|2017-02-18 15:45:33.35115
NCT00451698|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2013-07-25|2013-03-21||October 2007||2007-10-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|EPO||Erythropoietin and Pediatric Cardiac Surgery|Erythropoietin and Pediatric Cardiac Surgery|Terminated||N/A|9|Actual|Medical College of Wisconsin|Data for all recruited patients was included with available results. The number of participants fell far short of study goals and the study was terminated prematurely due to inadequate enrollment.|2||Inadequate patient enrollment|f||||t||||||||||2017-02-18 15:45:33.455575|2017-02-18 15:45:33.455575
NCT00451672|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22|||January 2007||2007-01-01|December 2006|2006-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|||The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism||Unknown status|Recruiting|Phase 4|25||National Taiwan University Hospital|||||t||||f||||||||||2017-02-18 15:45:33.871936|2017-02-18 15:45:33.871936
NCT00451646|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2010-08-26|||October 2007||2007-10-01|October 2008|2008-10-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition|A Double-blind, Randomised Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition|Completed||Phase 3|75|Actual|Fresenius Kabi||2|||f||||||||||||||2017-02-18 15:45:34.062421|2017-02-18 15:45:34.062421
NCT00451633|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2013-10-30|||March 2007||2007-03-01|October 2013|2013-10-01||||||||Interventional|||The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations|A Randomized, Double Blind, Placebo-Controlled Study To Investigate The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations|Withdrawn||Phase 2|0|Actual|Eisai Inc.||||"The study group changed from patients to a healthy volunteers. A healthy-volunteer study is~   being planned to replace 213."|f||||||||||||||2017-02-18 15:45:34.176018|2017-02-18 15:45:34.176018
NCT00451620|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2014-02-17|||November 2003||2003-11-01|February 2014|2014-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes|Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes|Completed||Phase 2|30|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 15:45:34.269032|2017-02-18 15:45:34.269032
NCT00451607|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2009-06-10|||March 2007||2007-03-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Observational|||Environmental Stress and Individualized Sensorimotor Care on Autonomic Nervous System Activity in Premature Population|Evaluation of Environmental Stress and Individualized Sensorimotor Care on Autonomic Nervous System Activity in a Premature Population : a Prospective Study|Completed||N/A|39|Actual|Centre Hospitalier Universitaire de Saint Etienne|||1||f||||f||||||||||2017-02-18 15:45:34.376728|2017-02-18 15:45:34.376728
NCT00451594|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2011-01-12|||September 2005||2005-09-01|January 2011|2011-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP|A Randomized Controlled Multicentre Trial of High Dose Dexamethasone Versus Conventional Dose Prednisolone for Adults With Untreated Idiopathic Thrombocytopenic Purpura|Completed||Phase 3|157|Actual|Cooperative Study Group A for Hematology||1|||f||||t||||||||||2017-02-18 15:45:34.457073|2017-02-18 15:45:34.457073
NCT00451581|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22|||January 2007||2007-01-01|October 2006|2006-10-01|January 2008|Anticipated|2008-01-01|||||Interventional|||A Prospective Randomized Study Comparing Different Dilation Durations for Endoscopic Papillary Balloon Dilatation|A Prospective Randomized Multicenter Study Comparing Different Dilation Durations During Endoscopic Papillary Balloon Dilatation for Bile Duct Stones.|Unknown status|Recruiting|N/A|160||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 15:45:34.56605|2017-02-18 15:45:34.56605
NCT00451568|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2015-04-10|||March 2007||2007-03-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|January 2012|Actual|2012-01-01||Interventional|||Metformin and Oral Contraceptives in PCOS|Metformin and Oral Contraceptives in PCOS|Completed||Phase 4|90|Actual|Odense University Hospital||3|||f||||t||||||||||2017-02-18 15:45:34.659047|2017-02-18 15:45:34.659047
NCT00451555|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2016-11-30||2011-04-05|March 2007||2007-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2010|Actual|2010-12-01||Interventional|||Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer|A Randomized, Double-Blind, Phase II Trial of Fulvestrant Plus Enzastaurin Versus Fulvestrant Plus Placebo in Aromatase Inhibitor-Resistant Metastatic Breast Cancer|Active, not recruiting||Phase 2|160|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:45:34.768595|2017-02-18 15:45:34.768595
NCT00451542|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-08-30|||February 2006||2006-02-01|August 2012|2012-08-01|February 2008|Actual|2008-02-01|May 2007|Actual|2007-05-01||Observational|||Divalproex vs. Lamotrigine for Bipolar Disorder|Time to Relapse During Treatment With Divalproex vs. Lamotrigine for Bipolar Disorder|Completed||Phase 3|1000|Actual|Tuscaloosa Research & Education Advancement Corporation|||1||f||||f||||||||||2017-02-18 15:45:34.905643|2017-02-18 15:45:34.905643
NCT00451529|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2011-04-18|||August 2007||2007-08-01|April 2011|2011-04-01|September 2011|Anticipated|2011-09-01|||||Observational|||Predictive Value for Stroke|Predictive Value of Magnetic Resonance Imaging (MRI), 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET), and Microemboli Detection for Stroke|Unknown status|Recruiting|N/A|200|Anticipated|Dutch Heart Foundation|||1||f||||t||||||||||2017-02-18 15:45:35.013707|2017-02-18 15:45:35.013707
NCT00451516|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2008-05-16|||March 2007||2007-03-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety|St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety|Completed||Phase 2|50|Anticipated|The University of Queensland|||||f||||f||||||||||2017-02-18 15:45:35.090814|2017-02-18 15:45:35.090814
NCT00451503|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-07-06|||March 2007||2007-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|January 2011|Actual|2011-01-01||Interventional|||Evaluation of Middle Ear Implantation|Evaluation of Middle Ear Implants in the Therapeutic Strategy of Auditory Rehabilitation in Case of Failure of Conventional Hearing Aid|Completed||N/A|69|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 15:45:35.182031|2017-02-18 15:45:35.182031
NCT00451490|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-12-24|||October 2006||2006-10-01|January 2007|2007-01-01|December 2007|Anticipated|2007-12-01|||||Interventional|||The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder|The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder|Withdrawn||N/A|24|Anticipated|National Taiwan University Hospital||||This study not get the approval by the drug company|f||||t||||||||||2017-02-18 15:45:35.285838|2017-02-18 15:45:35.285838
NCT00451464|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22|||January 2002||2002-01-01|July 2005|2005-07-01|January 2005||2005-01-01|||||Observational|||Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients|Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients|Completed||N/A|600||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 15:45:35.389493|2017-02-18 15:45:35.389493
NCT00451451|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2015-01-13|2014-05-05||June 2007||2007-06-01|January 2015|2015-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|CONFIRM||Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis|A Randomized, Multicenter, Placebo-Controlled and Active Reference (Glatiramer Acetate) Comparison Study to Evaluate the Efficacy and Safety of BG00012 in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|1417|Actual|Biogen||4|||f||||t||||||||||2017-02-18 15:45:35.486531|2017-02-18 15:45:35.486531
NCT00451425|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2009-05-28|||May 2007||2007-05-01|May 2009|2009-05-01|October 2010|Anticipated|2010-10-01|December 2009|Anticipated|2009-12-01||Interventional|VIGA||Weight Gain During Pregnancy - a Randomized Controlled Trial of Intervention to Prevent Excessive Gestational Weight Gain|Weight Gain During Pregnancy - a Randomized Controlled Trial of Intervention to Prevent Excessive Gestational Weight Gain.|Unknown status|Recruiting|N/A|430|Anticipated|Region Örebro County||1|||f||||f||||||||||2017-02-18 15:45:37.543823|2017-02-18 15:45:37.543823
NCT00451412|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-07-24|||January 2007||2007-01-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients|A Randomized, Double-blind, Multi-center Comparison of the Efficacy and Safety of Certoparin (3000 U Anti-Xa o.d.) With Unfractionated Heparin (5000 IU t.i.d.) in the Prophylaxis of Thromboembolic Events in Acutely Ill Medical Patients|Completed||Phase 3|3254|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:45:37.640233|2017-02-18 15:45:37.640233
NCT00451399|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-10-30|||October 2004||2004-10-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain|Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain: a Randomized Double-Blind Placebo- Controlled Comparison|Completed||Phase 4|128||Central South University|||||t||||t||||||||||2017-02-18 15:45:37.745439|2017-02-18 15:45:37.745439
NCT00451386|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2017-02-16|||January 2002||2002-01-01|February 2017|2017-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)|A Prospective, Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Local Tolerability, and Clinical Outcome of Ertapenem Versus Ceftriaxone in Pediatric Patients With Complicated Urinary Tract Infection, Skin and Soft Tissue Infection, or Community-Acquired Pneumonia|Completed||Phase 2|400||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:45:37.838487|2017-02-18 15:45:37.838487
NCT00451373|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22|||July 2006||2006-07-01|January 2007|2007-01-01|December 2012|Anticipated|2012-12-01|||||Interventional|||Acute Renal Failure in the Surgical Intense Care Units - NTUH-SICU-ARF (NSARF) Study||Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||t||||||||||2017-02-18 15:45:37.918861|2017-02-18 15:45:37.918861
NCT00451360|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2008-07-24|||March 1993||1993-03-01|March 2007|2007-03-01|April 1997|Actual|1997-04-01|||||Interventional|ECHODIAH||Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip|Evaluation of the CHOndromodulating Effect of DIAcerein in Osteoarthritis of the Hip. ECHODIAH.|Completed||Phase 3|500||Laboratoires NEGMA|||||f||||f||||||||||2017-02-18 15:45:38.02668|2017-02-18 15:45:38.02668
NCT00451347|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-03-21|||November 2006||2006-11-01|November 2006|2006-11-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Comparison of The Clinical Effects Between Different Physical Therapy Tools in Patellofemoral Pain Patients||Unknown status|Recruiting|Phase 1/Phase 2|90||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 15:45:38.138187|2017-02-18 15:45:38.138187
NCT00451334|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22||||||November 2006|2006-11-01||||||||Observational|GS||Safety and Efficacy of Using GlucoSat Technology For Non-Invasive Glucose Measurement|Safety and Efficacy of Using GlucoSat Technology For Non-Invasive Glucose Measurement|Unknown status|Not yet recruiting|Phase 2/Phase 3|40||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:45:38.217999|2017-02-18 15:45:38.217999
NCT00451321|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-11-15||2012-11-15|July 2006||2006-07-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|TTEDD||TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)|TRX4 Therapeutic Evaluation of Different Multi-Dose Regimens in Type 1 Diabetes Mellitus (TTEDD)|Completed||Phase 2|100|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:45:38.377789|2017-02-18 15:45:38.377789
NCT00451308|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2013-07-31|||November 2006||2006-11-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Induction of Labor With a Foley Balloon Catheter: Inflation With 30ml Compared to 60ml|Induction of Labor With a Foley Catheter Balloon: A Randomized Trial Comparing Inflation With 30ml and 60ml|Completed||Phase 4|192|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 15:45:38.668085|2017-02-18 15:45:38.668085
NCT00451295|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2011-11-13|||May 2007||2007-05-01|November 2011|2011-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia|A Phase III, Double-Blind, Multi-Centre, Randomised, Parallel Group Design, Placebo-Controlled, Flexible Dose Study of MCI-196 in Combination With a Ca-Based Phosphate Binder in CKD Stage V Subjects on Dialysis With Hyperphosphatemia.|Terminated||Phase 3|6|Actual|Mitsubishi Tanabe Pharma Corporation||2||This study was stopped because of insufficient enrollment.|f||||f||||||||||2017-02-18 15:45:38.771639|2017-02-18 15:45:38.771639
NCT00451282|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2015-04-02|2010-12-23||April 2007||2007-04-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Stepped Preventive Care to Reduce the Impact of Acute Pediatric Injury|Stepped Preventive Care to Reduce the Impact of Acute Pediatric Injury|Completed||Phase 3|290|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-02-18 15:45:38.903475|2017-02-18 15:45:38.903475
NCT00451269|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2011-02-18|||April 2007||2007-04-01|March 2007|2007-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|TDR-PALU||Evaluation of Rapid Diagnosis Tests in Imported Malaria|Multicentric Evaluation of Rapid Diagnosis Tests for the Diagnosis of Imported Malaria.|Completed||N/A|1297|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-02-18 15:45:39.343377|2017-02-18 15:45:39.343377
NCT00451256|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2009-07-06|||March 2007||2007-03-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)|Clinical Study to Assess the Safety and Efficacy of ex-Vivo Vein Graft Exposure to AVI-5126 in Coronary Artery By-Pass Grafting to Reduce Clinical Graft Failure|Terminated||Phase 2|600|Anticipated|Sarepta Therapeutics||||Protocol-defined outcome in terms of efficacy would not be achieved.|f||||t||||||||||2017-02-18 15:45:39.435816|2017-02-18 15:45:39.435816
NCT00451243|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22|||January 2005||2005-01-01|December 2004|2004-12-01|June 2005||2005-06-01|||||Observational|||Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment|Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatmen|Completed||N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 15:45:39.516033|2017-02-18 15:45:39.516033
NCT00451230|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2017-01-17|||June 2005||2005-06-01|October 2002|2002-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Metabolic Effects of Cocaine|Elucidating the Role of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Mechanisms Underlying Cocaine Dependence|Completed||N/A|15||National Institute on Drug Abuse (NIDA)|||||f||||f||||||||||2017-02-18 15:45:39.589193|2017-02-18 15:45:39.589193
NCT00451217|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2016-05-13|||November 2005||2005-11-01|May 2016|2016-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Comparison of Org 25969 With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (19.4.301)(P05960)|A Multi -Center Randomized Parallel Group Comparative Active Controlled Safety Assessor Blinded Phase 3a Pivotal Trial in Adult Subjects Comparing Org 25969 With Neostigmine as Reversal Agents of a Neuromuscular Block Induced by Rocuronium or Vecuronium at Reappearance of T2|Completed||Phase 3|198|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:45:39.67423|2017-02-18 15:45:39.67423
NCT00451204|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2016-05-10|2016-01-20||March 2007||2007-03-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|Estriol-MS|Relapsing remitting multiple sclerosis women aged 18 to 50 years.|A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)|A Combination Trial of Copaxone Plus Estriol in RRMS|Completed||Phase 2|158|Actual|University of California, Los Angeles||2|||f||||t||||||||Yes|Investigators interested in further research using the data should contact Dr. Voskuhl with proposed plans and request.|2017-02-18 15:45:39.777754|2017-02-18 15:45:39.777754
NCT00451191|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2013-06-20|2013-06-20||October 2006||2006-10-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|MIST2||Botulinum Toxin Injection for the Management of BPH|Intraprostatic Injection of Botulinum Toxin for the Management of Benign Prostatic Hyperplasia: A Randomized Phase II Trial|Completed||Phase 2|134|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|First, this study was not designed to compare the effect of onabotulinum toxin A to placebo. Second, we assessed our primary outcome, treatment efficacy, at 3 months post-injection. The long-term safety of this product should also be evaluated.|2|||f||||t||||||||||2017-02-18 15:45:40.372913|2017-02-18 15:45:40.372913
NCT00451178|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2013-03-26||2012-05-24|May 2007||2007-05-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|February 2012|Actual|2012-02-01||Interventional|||An Study of Patients With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Patients Who Take R-CHOP Only|An Open-label, Randomized, Phase 2 Study of R-CHOP Plus Enzastaurin Versus R-CHOP in the First-Line Treatment of Patients With Intermediate and High-Risk Diffuse Large B-Cell Lymphoma|Completed||Phase 2|100|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:45:40.743259|2017-02-18 15:45:40.743259
NCT00451165|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2010-04-14|||May 2007||2007-05-01|January 2009|2009-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Bowel, Urinary and Sexual Function After Laparoscopic Colorectal Surgery|Outcome Study of Bowel, Urinary and Sexual Function After Laparoscopic Colorectal Surgery, Using Questionnaire and Function Tests|Completed||N/A|36|Actual|Kyoto University|||2||f||||f||||||||||2017-02-18 15:45:41.002014|2017-02-18 15:45:41.002014
NCT00451152|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-11-27||2012-11-27|March 2007||2007-03-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma|A Study of the Safety and IOP-Lowering Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma|Completed||Phase 2|89|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 15:45:41.099662|2017-02-18 15:45:41.099662
NCT00451139|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-03-22||||||March 2007|2007-03-01||||||||Interventional|||Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials||Completed||Phase 4|||Jimma University|||||f||||||||||||||2017-02-18 15:45:41.194908|2017-02-18 15:45:41.194908
NCT00451126|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2007-03-22|||October 2005||2005-10-01|March 2007|2007-03-01|January 2006|Actual|2006-01-01|||||Observational|cortpersonal||Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol Response to a TSST|Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol|Completed||N/A|58||Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||||f||||t||||||||||2017-02-18 15:45:41.277383|2017-02-18 15:45:41.277383
NCT00451113|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2014-03-14|||November 2006||2006-11-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Sitagliptin in the Elderly|Sitagliptin in the Elderly|Completed||Phase 2|12|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 15:45:41.362726|2017-02-18 15:45:41.362726
NCT00451100|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2016-05-13|||November 2005||2005-11-01|May 2016|2016-05-01|August 2006|Actual|2006-08-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)|Comparison of Rocuronium and Org25969 With Cisatracurium and Neostigmine When Neuromuscular Block is Reversed at Reappearance of T2|Completed||Phase 3|84|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:45:41.459|2017-02-18 15:45:41.459
NCT00451087|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-22|2008-01-28|||December 2006||2006-12-01|December 2006|2006-12-01|September 2009|Anticipated|2009-09-01|March 2007|Actual|2007-03-01||Interventional|||Comparisons of Mechanical Properties of Tendon Structures|Phase 1 Study: Comparison of Electromechanical Delay Phase 2 Study: Research in Viscoelasticity of Tendon Structures Phase 3 Study: Effects of Exercise Training in the Mechanical Properties|Unknown status|Recruiting|Phase 1|120|Anticipated|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 15:45:41.554|2017-02-18 15:45:41.554
NCT00451074|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-03-22|||March 2007||2007-03-01|March 2012|2012-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons|A Six Month Randomized, Clinical Trial of Gentamicin in Duchenne Muscular Dystrophy Subjects With Stop Codon Mutations|Completed||Phase 1|12|Actual|Nationwide Children's Hospital||1|||f||||t||||||||||2017-02-18 15:45:41.658525|2017-02-18 15:45:41.658525
NCT00451061|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-07-11|||April 2007||2007-04-01|February 2007|2007-02-01||||||||Interventional|||The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones||Unknown status|Not yet recruiting|Phase 4|120|Anticipated|Soroka University Medical Center|||||f||||f||||||||||2017-02-18 15:45:41.760096|2017-02-18 15:45:41.760096
NCT00451048|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-12-03|2014-08-20||February 2007||2007-02-01|May 2013|2013-05-01|October 2012|Actual|2012-10-01|September 2011|Actual|2011-09-01||Interventional|||Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia|A Phase II Study of Sunitinib Malate (Sutent®; SU11248) in Patients With Intermediate-2 or High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia|Completed||Phase 2|10|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:45:41.866925|2017-02-18 15:45:41.866925
NCT00451035|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-11-16|||January 2007||2007-01-01|November 2016|2016-11-01||||September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase|A Phase II, Multicentre Study of Oral LBH589 in Patients With Chronic Phase Chronic Myeloid Leukemia With Resistant Disease Following Treatment With at Least Two BCR-ABL Tyrosine Kinase Inhibitors|Completed||Phase 2/Phase 3|29|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:45:42.293343|2017-02-18 15:45:42.293343
NCT00451022|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2017-01-24|||September 1, 2004||2004-09-01|November 16, 2016|2016-11-16||||||||Observational|||Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies|Follow-Up of Study Subjects Previously Enrolled in Immunotherapy Studies Utilizing Gene Transfer or Other Immunotherapeutic Agents|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:45:42.410296|2017-02-18 15:45:42.410296
NCT00451009|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2014-05-28|||March 2007||2007-03-01|May 2014|2014-05-01|April 2009|Anticipated|2009-04-01|||||Interventional|||Safety and Efficacy of Freezing and Thawing of Human Eggs in Assisted Reproductive Technology|Safety and Effectiveness of Freeze and Thaw Media Kits for the Manufacturing of Oocytes for Future Use in Assisted Reproductive Technology|Withdrawn||N/A|0|Actual|ViaCell|||||f||||t||||||||||2017-02-18 15:45:42.504125|2017-02-18 15:45:42.504125
NCT00450996|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-06-03|||January 1999||1999-01-01|June 2015|2015-06-01|March 2007|Actual|2007-03-01|||||Interventional|||Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty|Phase 3: Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty|Completed||N/A|400||University of Erlangen-Nürnberg Medical School|||||f||||f||||||||||2017-02-18 15:45:42.586358|2017-02-18 15:45:42.586358
NCT00450983|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2010-08-24|||December 2006||2006-12-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases|Transplantation of Haploidentical CD34+ Purified Peripheral Blood Stem Cells With NK-Cell Add-Back Following Conditioning With Total Body Irradiation, Thiotepa, Fludarabine and OKT3|Completed||Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 15:45:42.660168|2017-02-18 15:45:42.660168
NCT00450970|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2012-08-09||2012-08-09|February 2007||2007-02-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|SPERA||Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)|Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) Previously Treated With Unlimited Cytotoxic Chemotherapy Regimen (SPERA)|Terminated||Phase 3|344|Actual|Agennix||2||Sponsor decided to discontinue study drug development.|f||||f||||||||||2017-02-18 15:45:42.794221|2017-02-18 15:45:42.794221
NCT00450957|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-04-14|||October 2006||2006-10-01|April 2013|2013-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Lycopene in Healthy Male Participants|Phase I Multiple Dose Pharmacokinetic Study of the Dietary Supplement Lycopene Delivered in Capsule Form to Healthy Male Volunteers Between 18 and 55 Years of Age|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:45:43.036299|2017-02-18 15:45:43.036299
NCT00450944|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2009-02-06|||November 2005||2005-11-01|June 2007|2007-06-01||||||||Interventional|||Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia|A Phase I Study of Combination Therapy With Anti-CD19 and Anti-CD22 Immunotoxins (Combotox) in Adults With Refractory/Relapse Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:45:43.144139|2017-02-18 15:45:43.144139
NCT00450931|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2014-01-03||||||September 2008|2008-09-01||||||||Interventional|||Drug Facts Page or a Short Drug Summary in Helping Patients and Doctors Understand Medical Information|Helping Patients and Physicians Make Sense of Medical Data|Unknown status|Active, not recruiting|N/A|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:45:43.244543|2017-02-18 15:45:43.244543
NCT00450918|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-09-07|||August 2006||2006-08-01|September 2016|2016-09-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents|Longitudinal Study of Primary Ciliary Dyskinesia: Participants 5-18 Years of Age|Active, not recruiting||N/A|150|Anticipated|University of North Carolina, Chapel Hill|||1||f||||t||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 15:45:43.320815|2017-02-18 15:45:43.320815
NCT00450905|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2008-10-03|||March 2007||2007-03-01|February 2008|2008-02-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population|Randomized Evaluation of a Low-Frequency Investigational Device Employing Neuromodulation Therapy in Patients With Fibromyalgia|Terminated||Phase 3|200|Anticipated|Fralex Therapeutics|||||f||||t||||||||||2017-02-18 15:45:43.434112|2017-02-18 15:45:43.434112
NCT00450892|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-07-06|||February 2007||2007-02-01|July 2016|2016-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer|A Phase I-II Study of Lapatinib and Docetaxel as Neoadjuvant Treatment for HER-2 Positive Locally Advanced/Inflammatory or Large Operable Breast Cancer|Completed||Phase 1/Phase 2|129|Actual|European Organisation for Research and Treatment of Cancer - EORTC||3|||f||||t||||||||||2017-02-18 15:45:43.533847|2017-02-18 15:45:43.533847
NCT00450879|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-03-24|||January 2007||2007-01-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|November 2010|Actual|2010-11-01||Interventional|||Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery|Pilot Study of GW786034 (Pazopanib), a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Operable Breast Cancer|Terminated||Phase 1|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:45:43.669632|2017-02-18 15:45:43.669632
NCT00450866|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2014-01-28|2013-07-26||January 2007||2007-01-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|June 2011|Actual|2011-06-01||Interventional|||Epothilone B in Treating Patients With CNS Metastases From Breast Cancer|Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer|Completed||Phase 2|55|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:45:43.801684|2017-02-18 15:45:43.801684
NCT00450268|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-03-21|||January 2005||2005-01-01|March 2007|2007-03-01|January 2010|Anticipated|2010-01-01|||||Observational|DCalloTX||Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation|Analysis of Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|N/A|50||Technische Universität Dresden|||||f||||t||||||||||2017-02-18 15:45:59.39638|2017-02-18 15:45:59.39638
NCT00450853|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2015-01-26|||April 2005||2005-04-01|January 2015|2015-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients|Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients Treated With Platinum Based Chemotherapy|Completed||Phase 2|31|Actual|Clinica Universidad de Navarra, Universidad de Navarra||1|||f||||f||||||||||2017-02-18 15:45:44.24675|2017-02-18 15:45:44.24675
NCT00450840|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-09-14||||||September 2007|2007-09-01||||||||Interventional|||Simvastatin in Patients With Septic Shock||Unknown status|Recruiting|Phase 4|||Medical University of Vienna|||||f||||||||||||||2017-02-18 15:45:44.35226|2017-02-18 15:45:44.35226
NCT00450827|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-09-25|||August 2006||2006-08-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma|Combination of Targeted I -3F8-Mediated Radioimmunotherapy and Bevacizumab in Patients With Relapsed or Refractory Neuroblastoma: A Phase I Study|Completed||Phase 1|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:45:44.537351|2017-02-18 15:45:44.537351
NCT00450814|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2017-01-26|||January 2007||2007-01-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma|Phase I/II Trial of Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With or Without Cyclophosphamide, in Patients With Recurrent or Refractory Multiple Myeloma|Recruiting||Phase 1/Phase 2|85|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-02-18 15:45:44.651737|2017-02-18 15:45:44.651737
NCT00450801|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-10-12|2015-08-07||April 2004||2004-04-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma|Phase II Study of Rituximab in Combination With Methotrexate, Doxorubicin, Cyclophosphamide, Leucovorin, Vincristine, Ifosfamide, Etoposide, Cytarabine and Mesna (MACLO/IVAM) in Patients With Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|22|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:45:44.90779|2017-02-18 15:45:44.90779
NCT00450788|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-17|2017-01-24|||March 13, 2007||2007-03-13|March 4, 2016|2016-03-04||||||||Observational|||Esophageal Cancer in Northeastern Iran|The Golestan Cohort Study of Esophageal Cancer|Active, not recruiting||N/A|50000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:45:45.356354|2017-02-18 15:45:45.356354
NCT00450775|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2008-09-23|||March 2007||2007-03-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars|Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars|Completed||Phase 4|12|Anticipated|Innovative Medical||1|||f||||||||||||||2017-02-18 15:45:45.454733|2017-02-18 15:45:45.454733
NCT00450762|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2007-03-21|||March 2004||2004-03-01|March 2007|2007-03-01|October 2006||2006-10-01|||||Interventional|||Gemcitabine + Carboplatin in Breast Cancer|Gemcitabine Plus Carboplatin in Patients With Pretreated Metastatic Breast Cancer|Completed||Phase 2|||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 15:45:45.545172|2017-02-18 15:45:45.545172
NCT00450749|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2014-04-23|2012-03-30||February 2008||2008-02-01|April 2013|2013-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer|Phase II Placebo Controlled Trial of Preoperative Lycopene Supplementation in Prostate Cancer Patients|Completed||Phase 2|10|Actual|National Cancer Institute (NCI)||3|||f||||f||||||||||2017-02-18 15:45:45.633848|2017-02-18 15:45:45.633848
NCT00450736|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-12-14|||March 2004||2004-03-01|December 2016|2016-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery|A Phase I Trial of Postoperative Radiation With Dose-Escalation of A Cox-2 Inhibitor, Celebrex™ (CELECOXIB) in Patients With Soft Tissue Sarcoma of the Extremity|Completed||Phase 1|3|Actual|University of Miami||1|||f||||||||||||||2017-02-18 15:45:46.234392|2017-02-18 15:45:46.234392
NCT00450723|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-12-14|2013-01-22||May 2004||2004-05-01|December 2016|2016-12-01|March 2011|Actual|2011-03-01|January 2011|Actual|2011-01-01||Interventional|||Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer|Thoracoscopic Internal Mammary Sentinel Node Biopsy|Completed||N/A|39|Actual|University of Miami|A total of 39 subjects were enrolled however; only 34 of the subjects had identifiable internal mammary sentinel lymph nodes. As a result, the data of 34 subjects were analyzed.|1|||f||||t||||||||||2017-02-18 15:45:46.361084|2017-02-18 15:45:46.361084
NCT00450710|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2014-08-21|||March 2006||2006-03-01|August 2014|2014-08-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Neuroendocrine Brake for Type 2 Diabetes Mellitus|Phase IV Study of Neuroendocrine Brake Surgical Procedure for Type 2 Diabetes Mellitus|Completed||Phase 4|40||Medtronic - MITG|||||f||||||||||||||2017-02-18 15:45:46.673676|2017-02-18 15:45:46.673676
NCT00450697|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2010-11-04|||February 2007||2007-02-01|November 2010|2010-11-01|November 2008|Anticipated|2008-11-01|||||Observational|||Feeding Tolerance in Preterm Infants|Feeding Tolerance in Preterm Infants: Randomized Trial of Bolus Feeding Every 4 Hours Versus Every 3 Hours|Unknown status|Recruiting|N/A|160|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 15:45:46.759695|2017-02-18 15:45:46.759695
NCT00450684|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2014-10-09|||May 2007||2007-05-01|October 2014|2014-10-01|September 2013|Actual|2013-09-01|February 2012|Actual|2012-02-01||Interventional|CARE-CHD||Cardiac Resynchronization Therapy in Congenital Heart Defects|Cardiac Resynchronization Therapy in Heart Failure Patients With Congenital Heart Defects|Completed||Phase 2/Phase 3|55|Actual|Competence Network for Congenital Heart Defects||2|||f||||||||||||||2017-02-18 15:45:46.851883|2017-02-18 15:45:46.851883
NCT00450671|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2008-11-25|||February 2007||2007-02-01|March 2007|2007-03-01|February 2012|Anticipated|2012-02-01|||||Interventional|||Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug|Seton Placement vs. Surgisis Anal Fistula Plug Insertion for Perirectal Fistula: A Prospective Randomized Study|Unknown status|Recruiting|Phase 3|300|Anticipated|University of Southern California|||||f||||t||||||||||2017-02-18 15:45:46.984617|2017-02-18 15:45:46.984617
NCT00450658|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2013-04-22|2011-05-17||March 2007||2007-03-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers|A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 in Subjects Requiring NSAID Treatment|Completed||Phase 3|627|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||2|||f||||t||||||||||2017-02-18 15:45:47.093162|2017-02-18 15:45:47.093162
NCT00450645|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2009-03-03|||March 2005||2005-03-01|March 2009|2009-03-01|March 2011|Anticipated|2011-03-01|March 2009|Anticipated|2009-03-01||Interventional|Cancer-DACUS||Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis|Residual Vein Thrombosis Establishes the Optimal Duration of Low Molecular Weight Heparins in Cancer Patients With Deep Vein Thrombosis of the Lower Limbs|Unknown status|Recruiting|Phase 4|300|Anticipated|Azienda Ospedaliera Universitaria Policlinico||1|||f||||t||||||||||2017-02-18 15:45:47.667943|2017-02-18 15:45:47.667943
NCT00450632|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-03-26|||September 2005||2005-09-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection|CONSTITUTION D'UNE BIOTHEQUE DE PATIENTS DE SEINE-MARITIME AUX ANTECEDENTS D'INFECTION INVASIVE A MENINGOCOQUES|Completed||N/A|101|Actual|University Hospital, Rouen|||1||f||||t||||||||||2017-02-18 15:45:47.778688|2017-02-18 15:45:47.778688
NCT00450619|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-11-08|2013-05-10||February 2007||2007-02-01|November 2016|2016-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer|A Randomized Phase 2.5 Study of (153)Sm-EDTMP (Quadramet) With or Without a PSA/TRICOM Vaccine in Men With Androgen-Insensitive Metastatic Prostate Cancer|Completed||Phase 2|44|Actual|National Institutes of Health Clinical Center (CC)|This study was stopped before full accrual(after about two-thirds of the subjects were enrolled) due to a significant decrease in enrollment despite making this a multicenter study.|2|||f||||t||||||||No||2017-02-18 15:45:47.86835|2017-02-18 15:45:47.86835
NCT00450606|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2008-05-20|||March 2007||2007-03-01|May 2008|2008-05-01||||December 2007|Actual|2007-12-01||Interventional|||The Effects of Ambulatory Treatment at the Dead Sea on Osteoarthritis of the Knees||Completed||N/A|50|Anticipated|Soroka University Medical Center|||||f||||f||||||||||2017-02-18 15:45:49.230677|2017-02-18 15:45:49.230677
NCT00450593|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2013-08-09|||January 1989||1989-01-01|April 2008|2008-04-01||||December 2020|Anticipated|2020-12-01||Observational|||Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma|Studies of Familial Melanoma|Recruiting||N/A|5000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:45:49.301251|2017-02-18 15:45:49.301251
NCT00450580|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-05-31|2009-07-24||March 2007||2007-03-01|April 2012|2012-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults|Study of Once-Daily Versus Twice-Daily Fosamprenavir Plus Ritonavir, Administered With Abacavir/Lamivudine Once-Daily in Antiretroviral-Naive HIV-1 Infected Adult Subjects.|Completed||Phase 3|212|Actual|ViiV Healthcare||2|||f||||||||||||||2017-02-18 15:45:49.405639|2017-02-18 15:45:49.405639
NCT00450567|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-10-28|||December 2004||2004-12-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy|Monitoring Targeted Lung Cancer Treatments With FDG-PET/CT|Completed||N/A|36|Actual|Jonsson Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 15:45:50.104385|2017-02-18 15:45:50.104385
NCT00450554|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2012-03-26|||February 2007||2007-02-01|March 2012|2012-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac|EVALUATION DE LA REPONSE IMMUNITAIRE CONTRE LA SOUCHE DE NEISSERIA MENINGITIDIS B:14,P1.7,16|Completed||Phase 3|236|Actual|University Hospital, Rouen|||1||f||||t||||||||||2017-02-18 15:45:52.864991|2017-02-18 15:45:52.864991
NCT00450541|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2012-07-26|||March 2007||2007-03-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Fatigue Experience in Cancer Patients|The Experience of Fatigue for Patients With Cancer|Completed||N/A|73|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:45:52.939152|2017-02-18 15:45:52.939152
NCT00450528|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-10-23|||February 2007||2007-02-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Observational|||Kinetics of D-Dimers After Abdominal Surgery|The Kinetics of D-Dimers After Abdominal Surgery as a Function of the Invasiveness of Surgery|Completed||N/A|90|Anticipated|University of Zurich|||||f||||f||||||||||2017-02-18 15:45:53.052888|2017-02-18 15:45:53.052888
NCT00450515|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-12-02|||March 2007||2007-03-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer|Phase II Trial of Vinfluinine and Capecitabine in Previously Treated Metastatic Breast Cancer|Withdrawn||Phase 2|0|Actual|Alliance for Clinical Trials in Oncology||1||Study was dropped prior to opening.|f||||f||||||||||2017-02-18 15:45:53.126988|2017-02-18 15:45:53.126988
NCT00450502|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2017-01-24|||February 24, 2007||2007-02-24|August 14, 2013|2013-08-14|April 24, 2011|Actual|2011-04-24|April 24, 2011|Actual|2011-04-24||Interventional|||Safety of Batracylin in Patients With Solid Tumors and Lymphomas|A Phase I Study of Batracylin (NSC320846) in Subjects With Solid Tumors and Lymphomas|Completed||Phase 1|33|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:45:53.234327|2017-02-18 15:45:53.234327
NCT00450489|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2010-03-03|||June 2008||2008-06-01|March 2010|2010-03-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Assessment of Quality of Life and Satisfaction With Medical Care of Pediatric Type 1 Diabetes Mellitus Patients|Assessment of Quality of Life and Satisfaction With Medical Care of Pediatric Type 1 Diabetes Mellitus Patients|Withdrawn||N/A|120|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-02-18 15:45:53.3253|2017-02-18 15:45:53.3253
NCT00450476|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2007-03-21|||January 2007||2007-01-01|March 2007|2007-03-01||||||||Observational|||Aspiration of Subglottic Secretions Using Hi-Lo Evac Endotracheal Tube: Tube Size and Incidence of Suction Lumen Dysfunction|Aspiration of Subglottic Secretions in Intubated Critically Ill Patients Using Hi-Lo Evac Endotracheal Tube: Correlation Between Tube Size and Incidence of Suction Lumen Dysfunction|Unknown status|Recruiting|Phase 4|60||University Hospital, Alexandroupolis|||||f||||f||||||||||2017-02-18 15:45:53.419329|2017-02-18 15:45:53.419329
NCT00450463|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2017-01-24|||February 19, 2007||2007-02-19|September 26, 2016|2016-09-26|January 1, 2018|Anticipated|2018-01-01|October 1, 2017|Anticipated|2017-10-01||Interventional|||Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer|A Randomized Phase II Trial Combining Vaccine Therapy With PROSTVAC/TRICOM and Flutamide vs. Flutamide Alone in Men With Androgen Insensitive, Non-Metastatic (D0.5) Prostate Cancer|Active, not recruiting||Phase 2|53|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 15:45:53.495865|2017-02-18 15:45:53.495865
NCT00450450|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-03-30|||December 2007||2007-12-01|March 2016|2016-03-01||||June 2013|Actual|2013-06-01||Interventional|||Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases|A Phase III Randomized Trial of G-CSF Stimulated Bone Marrow vs. Conventional Bone Marrow as a Stem Cell Source In Matched Sibling Donor Transplantation|Active, not recruiting||Phase 3|27|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 15:45:53.618128|2017-02-18 15:45:53.618128
NCT00450437|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2015-01-15|2010-03-19||March 2007||2007-03-01|January 2015|2015-01-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults|A Phase 3, Multi-center Study to Evaluate Lot to Lot Consistency, Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults and Compare to the Safety and Immune Response to a Licensed Conjugate Meningococcal ACWY Vaccine|Completed||Phase 3|3539|Actual|Novartis||2|||f||||t||||||||||2017-02-18 15:45:53.999252|2017-02-18 15:45:53.999252
NCT00450424|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2014-09-04|2014-08-05||June 2007||2007-06-01|September 2014|2014-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer|Facilitating Informed Decisions for MSI Testing|Completed||N/A|239|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-02-18 15:45:55.38011|2017-02-18 15:45:55.38011
NCT00450411|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-10-11|||May 2007||2007-05-01|October 2016|2016-10-01||||June 2016|Actual|2016-06-01||Interventional|||Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy|A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy|Active, not recruiting||Phase 2|100|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 15:45:55.873172|2017-02-18 15:45:55.873172
NCT00450398|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2008-01-24|||March 2007||2007-03-01|January 2008|2008-01-01|February 2008|Anticipated|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation|A Controlled, Prospective, Blinded, Randomized, Single-Center, Study of YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation|Unknown status|Active, not recruiting|Phase 2|12|Anticipated|Y's Therapeutics, Inc.||2|||f||||t||||||||||2017-02-18 15:45:56.017311|2017-02-18 15:45:56.017311
NCT00450385|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-06-01|||February 2007||2007-02-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|R-CHOP||Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP)|Phase II Study to Establish Gene Expression Models Predicting Survival of Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP|Terminated||Phase 2|59|Actual|University of Miami||1||Investigator Decision due to insufficient accrual.|f||||t||||||||||2017-02-18 15:45:56.12953|2017-02-18 15:45:56.12953
NCT00450372|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-12-14|2013-02-01||June 2004||2004-06-01|December 2016|2016-12-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Interventional|||Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery|Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma|Completed||Phase 2|38|Actual|University of Miami|Of the 38 subjects enrolled, only 10 were ASS-positive and 17 were ASS-negative. The remaining 11 subjects, who declined pre-treatment biopsies, were not assessed.|1|||f||||t||||||||||2017-02-18 15:45:56.256917|2017-02-18 15:45:56.256917
NCT00450359|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2013-08-01|||September 2006||2006-09-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|||||Interventional|||Computer-Aided Breast Cancer Detection in Women Undergoing Screening Mammography|A Prospective Evaluation of Computer Aided Detection (CAD) in the NHS Breast Screening Programme [CADET II]|Completed||N/A|30000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:45:56.54797|2017-02-18 15:45:56.54797
NCT00450333|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2014-06-06|2009-08-18||October 2006||2006-10-01|November 2009|2009-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Dynepo Infrequent Dosing Study|An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease Who Are Pre-Dialysis or Require Peritoneal Dialysis or Haemodialysis|Terminated||Phase 3|407|Actual|Shire|This study terminated early due to a decision by Shire Pharmaceuticals to permanently cease marketing Dynepo due to commercial reasons, it was not the result of any safety signal. Not enough subjects completed the study to do any efficacy analyses.|4||"The termination of the study is not linked to a product recall or result of any safety signal.~   Rather it was sponsor's commercial decision to withdraw the MA"|f||||f||||||||||2017-02-18 15:45:56.653425|2017-02-18 15:45:56.653425
NCT00450320|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2014-08-27|||October 2007||2007-10-01|August 2014|2014-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma|A Pilot Study of Rapamycin in Patients With HIV-Related Kaposi's Sarcoma|Completed||Phase 1|7|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-02-18 15:45:57.844484|2017-02-18 15:45:57.844484
NCT00450307|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2013-10-14|||June 2005||2005-06-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma|3F8 Antibody Dose Escalation Plus Granulocyte-Macrophage Colony-Stimulating Factor in High-Risk Neuroblastoma: A Phase I Trial|Completed||Phase 1|32|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:45:57.956292|2017-02-18 15:45:57.956292
NCT00450294|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2014-02-12|2009-08-26||March 2007||2007-03-01|February 2014|2014-02-01|August 2007|Actual|2007-08-01|||||Observational|||Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair|The Effect of Aortic Infrarenal Clamping and Unclamping On Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair|Completed||N/A|10|Actual|University of Manitoba|There were no limitations to trial during course of study.||1||f||||t||||||||||2017-02-18 15:45:58.067661|2017-02-18 15:45:58.067661
NCT00450281|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-10-23|||October 2005||2005-10-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men|Completed||N/A|981|Actual|Southwest Oncology Group|||4||f||||t||||||||||2017-02-18 15:45:58.73289|2017-02-18 15:45:58.73289
NCT00450255|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-02-02|2014-04-22||June 2007||2007-06-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery|A Phase 2 Study Evaluating the Efficacy of VEGF Trap in Patients With Recurrent Inoperable Stage III or Stage IV Melanoma|Completed||Phase 2|41|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:45:59.477536|2017-02-18 15:45:59.477536
NCT00450242|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2012-06-12|2012-02-27||December 2006||2006-12-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis|Use of 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis|Terminated||Phase 2|14|Actual|University of North Carolina, Chapel Hill|The study terminated due to lack of funding and difficulties with recruitment. More extensive data analysis to include secondary outcome measures was not performed due to inability to fund statistical programming and analysis efforts.|2||lack of funding|f||||f||||||||||2017-02-18 15:46:00.063585|2017-02-18 15:46:00.063585
NCT00450229|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-12-03|||February 2007||2007-02-01|May 2013|2013-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer|Phase Ib Placebo-Controlled Trial of Diindolylmethane (BR-DIM) in the Study of the Modulation of Intermediate Endpoint Markers in Patients With Prostate Cancer Who Are Undergoing Prostatectomy|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 15:46:00.512199|2017-02-18 15:46:00.512199
NCT00450216|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2013-04-22|2011-05-17||March 2007||2007-03-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment|A Randomized, Double-Blind, Phase 3 Study of the Efficacy and Safety of HZT-501 in Subjects Requiring NSAID Treatment|Completed||Phase 3|906|Actual|Horizon Pharma Ireland, Ltd., Dublin Ireland||2|||f||||t||||||||||2017-02-18 15:46:00.649493|2017-02-18 15:46:00.649493
NCT00450203|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-11-30|||October 2007||2007-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ST03||Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer|A Randomised Phase II/III Trial of Peri-Operative Chemotherapy With or Without Bevacizumab in Operable Oesophagogastric Adenocarcinoma and A Feasibility Study Evaluating Lapatinib in HER-2 Positive Oesophagogastric Adenocarcinomas and (in Selected Centres) MRI and PET/CT Sub-studies|Recruiting||Phase 2/Phase 3|1103|Anticipated|Medical Research Council||3|||f||||t||||||||||2017-02-18 15:46:01.2347|2017-02-18 15:46:01.2347
NCT00450190|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-21|2014-02-17|||February 2006||2006-02-01|February 2014|2014-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Saizen® E-Device User Trial|User Trial on the Use in Common Practice of a New Electronic Auto-injector of Saizen®, the E-Device (Electronic Device), in Children Treated by Recombinant Human Growth Hormone Over a Period of 2 Months|Completed||Phase 3|20|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 15:46:01.440042|2017-02-18 15:46:01.440042
NCT00450177|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2008-03-31|||January 2006||2006-01-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy of Enteral Iron Supplementation in Critical Illness|A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Enteral Iron Supplementation on Anemia and Risk of Infection in Critical Illness|Completed||Phase 2|200|Anticipated|Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 15:46:01.654919|2017-02-18 15:46:01.654919
NCT00450164|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2007-03-20|||November 2000||2000-11-01|March 2007|2007-03-01|June 2004|Actual|2004-06-01|||||Interventional|KT-2000||Secondary Prophylaxis After Variceal Bleeding in Non-Responders|Secondary Prophylaxis After Variceal Bleeding: Combined Treatment With Endoscopic Ligation and Nadolol Against Nadolol Associated With Mononitrate of Isosorbide or Prazosin According to Hemodynamic Response.|Completed||Phase 4|50||Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||||f||||t||||||||||2017-02-18 15:46:01.751156|2017-02-18 15:46:01.751156
NCT00450151|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2012-02-29|||February 2007||2007-02-01|February 2012|2012-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Platelet Activation Markers in Pediatric Cardiac Surgery|Effect of Cardiopulmonary Bypass on Platelet Activation Markers Such as Platelet Factor 4 and Transforming Growth Factor B, in Pediatric Cardiac Surgery|Completed||N/A|10|Actual|Weill Medical College of Cornell University|||1||f||||f||||||Samples Without DNA|"~     For all patients, after obtaining written consent, 3.15ml of blood will be collected in CTAD~     tubes, from arterial line pre cardiopulmonary bypass and post cardiopulmonary bypass. Blood~     sample will be cooled in ice bath, centrifuged at 2500 rpm for 30 minutes, and supernatant~     plasma sample will be collected. This plasma will be stored at -20 degrees celcius or below.~     Enzyme-linked immunosorbent assay (ELISA) will be performed using the plasma to make~     quantitative assessment of platelet factor 4 and transforming growth factor beta.~   "|||2017-02-18 15:46:01.855185|2017-02-18 15:46:01.855185
NCT00450138|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-08-26|||December 2006||2006-12-01|August 2016|2016-08-01|November 2011|Actual|2011-11-01|November 2009|Actual|2009-11-01||Interventional|||Open Label, Phase I ZD6474 Head and Neck Cancer Study|An Open Label Phase 1 Study to Assess the Maximum Tolerated Dose of ZACTIMA™ Given Concomitantly With Weekly Cisplatin Chemotherapy and Radiation Therapy in Patients With Previously Untreated, Unresected Stage III-IV Head and Neck Squamous Cell Carcinoma|Completed||Phase 1|48|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:46:01.959765|2017-02-18 15:46:01.959765
NCT00450125|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2016-04-14|||February 2007||2007-02-01|April 2016|2016-04-01||||December 2017|Anticipated|2017-12-01||Observational|||Six-Minute Walk Test in Patients at High Risk for Complications From Lung Resection|Six-Minute Walk Test in the Evaluation of Patients at High Risk for Complications From Lung Resection|Active, not recruiting||Phase 2|101|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:46:02.079993|2017-02-18 15:46:02.079993
NCT00450112|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2011-07-25|2011-04-15||March 2007||2007-03-01|July 2011|2011-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee|A Multi-Center Extension and Open-Label Study of a Single or Repeat Intra-Articular Injection of Gel-200 in Osteoarthritis of the Knee.|Completed||Phase 3|202|Actual|Seikagaku Corporation||1|||f||||f||||||||||2017-02-18 15:46:02.195936|2017-02-18 15:46:02.195936
NCT00450099|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-12-12|||October 2005||2005-10-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Minimum Local Anesthetic Volume of Bupivacaine in Labour Epidurals|Determination of the Minimum Local Anesthetic Volume of 0.125% Bupivacaine in Labour Epidurals|Completed||N/A|50|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||1|||f||||f||||||||||2017-02-18 15:46:03.030117|2017-02-18 15:46:03.030117
NCT00450086|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2014-05-16|||March 2007||2007-03-01|May 2014|2014-05-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis|Double-blind, Double-dummy, Randomised, Placebo-controlled, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Budesonide Capsules vs. Mesalazine Granules vs. Placebo for Patients With Collagenous Colitis.|Completed||Phase 3|92|Actual|Dr. Falk Pharma GmbH||3|||f||||t||||||||||2017-02-18 15:46:03.157874|2017-02-18 15:46:03.157874
NCT00450073|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2014-01-07|2013-01-28||November 2006||2006-11-01|January 2014|2014-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Improving Vitamin D Status In Cystic Fibrosis|Desktop Tanning Unit to Improve Vitamin D Status in Patients With Cystic Fibrosis and Short Bowel Syndrome: A Pilot Study|Completed||N/A|30|Actual|Atlanta VA Medical Center||3|||f||||f||||||||||2017-02-18 15:46:03.283743|2017-02-18 15:46:03.283743
NCT00450060|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-03-19|||January 2007||2007-01-01|March 2007|2007-03-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Juvenile Postlumbar Puncture Headache After Puncture With Needles With Quincke Tip or With Sprotte Tip|Postlumbar Puncture Complaints After Lumbar Punctures in Children and Adolescents: Frequency and Impact by Compariosn of Two Needle Designs|Unknown status|Recruiting|N/A|150||Heidelberg University|||||f||||f||||||||||2017-02-18 15:46:03.766518|2017-02-18 15:46:03.766518
NCT00450047|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2007-03-20|||September 2005||2005-09-01|March 2007|2007-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia|Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia: a Randomized Controlled Trial|Completed||Phase 4|120||Hiroshima University|||||f||||f||||||||||2017-02-18 15:46:03.867961|2017-02-18 15:46:03.867961
NCT00450034|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2011-11-30|||April 2007||2007-04-01|March 2007|2007-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|OMAGE||Optimization of Drug Treatment in Hospitalized Elderly (OMAGE)|Impact of Optimization of Drug Treatment of Elderly Admitted in 4 Acute Geriatric Wards : Randomized Trial|Completed||N/A|665|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 15:46:03.952726|2017-02-18 15:46:03.952726
NCT00450021|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2017-01-24|||March 19, 2007||2007-03-19|February 6, 2008|2008-02-06||||February 6, 2008|Actual|2008-02-06||Interventional|||Imaging of Cannabinoid Receptors Using New Radioactive Tracer|Imaging of Cannabinoid CB(1) Receptors Using [11C] MePPEP|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:46:04.053647|2017-02-18 15:46:04.053647
NCT00450008|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2016-03-15|||December 2006||2006-12-01|March 2016|2016-03-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer|Phase II Study of Patients With Hormone-Naïve Prostate Cancer With a Rising Prostate Specific Antigen: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Thalidomide Plus Docetaxel|Terminated||Phase 2|9|Actual|The Methodist Hospital System||1||PI decision|f||||f||||||||No||2017-02-18 15:46:04.154305|2017-02-18 15:46:04.154305
NCT00449995|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2008-12-23|||March 2007||2007-03-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|||Confocal Laserscanning Microscopy for Detection of Barretts Esophagus|Confocal Laserscanning Microscopy for Detection of Barretts Esophagus. A Blinded Multi-Center Study.|Completed||N/A|73|Anticipated|Technische Universität München|||||f||||||||||||||2017-02-18 15:46:04.269592|2017-02-18 15:46:04.269592
NCT00449982|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2007-03-20|||July 2003||2003-07-01|March 2007|2007-03-01|August 2004||2004-08-01|||||Interventional|||Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts|A Randomized, Double-Blind, Three-Arm Parallel-Group, Placebo-Controlled Phase 3 Trial to Investigate the Clinical Efficacy and Safety of Polyphenon E in the Treatment of External Genital Warts|Completed||Phase 3|480||MediGene|||||f||||f||||||||||2017-02-18 15:46:04.34991|2017-02-18 15:46:04.34991
NCT00449969|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2011-04-21|||April 2007||2007-04-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|April 2009|Actual|2009-04-01||Interventional|||Out-of-hospital Cardiopulmonary Resuscitation and AED Feedback|Quality of Out-of-hospital Cardiopulmonary Resuscitation (CPR) With Real Time Automated Feedback: a Prospective Randomized Study|Completed||N/A|312|Actual|University Hospital Muenster||2|||f||||f||||||||||2017-02-18 15:46:04.461693|2017-02-18 15:46:04.461693
NCT00449956|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2015-04-07|2009-01-23||March 2007||2007-03-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)|Multicenter, Double-Blind, Active Comparator-controlled Study to Evaluate the Safety and Efficacy of MK0507A in Patients With Glaucoma and Ocular Hypertension Who Are Inadequately Controlled on Beta-Blockers|Completed||Phase 3|474|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 15:46:04.588935|2017-02-18 15:46:04.588935
NCT00449943|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2012-01-25|||September 2006||2006-09-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Cardiac Computed Tomographic Angiography (CTA) to Tc-99m Single Photon Emission Computed Tomography (SPECT)|Comparison of Cardiac Computed Tomographic Angiography (CTA) to Tc-99m Single Photon Emission Computed Tomography (SPECT)|Completed||N/A|107|Actual|Ottawa Heart Institute Research Corporation||1|||f||||||||||||||2017-02-18 15:46:05.447135|2017-02-18 15:46:05.447135
NCT00449930|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2015-04-27|2009-06-23||March 2007||2007-03-01|April 2015|2015-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)|A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of Sitagliptin Compared With Metformin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control|Completed||Phase 3|1050|Actual|Merck Sharp & Dohme Corp.|Site 0490125 was non-compliant with Good Clinical Practice (GCP). Data from the 8 patients at this site were removed from all analyses.|2|||f||||f||||||||||2017-02-18 15:46:05.559362|2017-02-18 15:46:05.559362
NCT00449917|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2011-10-05|||September 2006||2006-09-01|October 2011|2011-10-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||"Visiobiane Anti-age Effects on Vision Parameters"|"Study of the Effects of Visiobiane Anti-age Dietary Supplement on Macular Pigment Optical Density, Contrast Sensibility and Visual Acuity"|Completed||Phase 4|30||Pileje|||||f||||f||||||||||2017-02-18 15:46:06.183628|2017-02-18 15:46:06.183628
NCT00449904|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2014-10-15||2010-12-13|June 2007||2007-06-01|October 2014|2014-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|DIGEST||Open-Label Phase III Long-Term Safety Trial of Liprotamase|An Open-Label Clinical Study Evaluating the Long-Term Safety of ALTU-135 for the Treatment of Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency|Completed||Phase 3|214|Actual|Anthera Pharmaceuticals||1|||f||||t||||||||||2017-02-18 15:46:06.280366|2017-02-18 15:46:06.280366
NCT00449891|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2016-04-13|||January 2007||2007-01-01|April 2016|2016-04-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Observational|||Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus|Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus|Completed||N/A|30|Anticipated|Stanford University|||1||f||||t||||||||||2017-02-18 15:46:06.412257|2017-02-18 15:46:06.412257
NCT00449878|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2014-10-15||2010-12-13|May 2007||2007-05-01|October 2014|2014-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|DIGEST||Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency|A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Study Evaluating the Efficacy and Safety of ALTU-135 Treatment in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency|Completed||Phase 3|163|Actual|Anthera Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:46:06.50162|2017-02-18 15:46:06.50162
NCT00449865|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2015-03-23|2015-02-19||March 2007||2007-03-01|March 2015|2015-03-01|May 2014|Actual|2014-05-01|September 2013|Actual|2013-09-01||Interventional|||NET-PD LS-1 Creatine in Parkinson's Disease|A Multicenter, Double-Blind, Parallel Group, Placebo Controlled Study of Creatine in Subjects With Treated Parkinson's Disease (PD) Long Term Study (LS-1)|Terminated||Phase 3|1741|Actual|University of Rochester||2||Futility|f||||t||||||||||2017-02-18 15:46:06.783016|2017-02-18 15:46:06.783016
NCT00449852|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2011-04-27|||July 2006||2006-07-01|April 2011|2011-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|IVR||Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease|An Interactive, Voice Response-Mediated, Follow-up and Triage System for Smoking Cessation in Smokers With Coronary Heart Disease|Completed||Phase 2|442|Actual|Ottawa Heart Institute Research Corporation||2|||f||||f||||||||||2017-02-18 15:46:08.328356|2017-02-18 15:46:08.328356
NCT00449839|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2009-06-30|||April 2007||2007-04-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Changes of the Infusion Rate in Insulin Pump Treatment|Changes of the Infusion Rate in Insulin Pump Treatment. A Randomized, Unblinded Cross-Over Study.|Completed||Phase 4|10|Actual|University of Aarhus||3|||f||||t||||||||||2017-02-18 15:46:08.42804|2017-02-18 15:46:08.42804
NCT00449826|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2012-01-25|||September 2006||2006-09-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)|Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)|Completed||N/A|107|Actual|Ottawa Heart Institute Research Corporation||1|||f||||||||||||||2017-02-18 15:46:08.531482|2017-02-18 15:46:08.531482
NCT00449813|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2012-05-04|||March 2007||2007-03-01|May 2008|2008-05-01|November 2008|Actual|2008-11-01|October 2007|Actual|2007-10-01||Interventional|||The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)|The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms|Terminated||Phase 4|40|Actual|Takeda||1||"Inclusion-rate does not seem feasible anymore to obtain te required number of patients before~   the end of the trial."|f||||f||||||||||2017-02-18 15:46:08.622696|2017-02-18 15:46:08.622696
NCT00449800|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-03-20|||July 2006||2006-07-01|March 2007|2007-03-01|March 2007|Anticipated|2007-03-01|||||Interventional|PORTHOS||Pharmacokinetic of Ceftriaxone in Septic ICU Patients|Pharmacokinetics Variability of Ceftriaxone in Septic ICU Patients|Unknown status|Recruiting|Phase 4|70||Association Pour La Promotion A Tours De La Reanimation Medicale|||||f||||f||||||||||2017-02-18 15:46:08.73597|2017-02-18 15:46:08.73597
NCT00449787|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2012-10-29|2011-07-13||March 2007||2007-03-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|HEDNet2||Comparing Naproxen to Sumatriptan for Emergency Headache Patients|A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)|Completed||Phase 4|401|Actual|Montefiore Medical Center||2|||f||||f||||||||||2017-02-18 15:46:08.842847|2017-02-18 15:46:08.842847
NCT00449774|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2016-10-26|||May 2007||2007-05-01|October 2016|2016-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers|An Open-label, Randomised, Single-dose, Parallel-group Study to Demonstrate Bioequivalence of Two Formulations and the Effect of Food and Water on One Formulation of Lamotrigine in Healthy Male and Female Volunteers|Completed||Phase 1|220|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:46:09.301087|2017-02-18 15:46:09.301087
NCT00449761|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-11-16|||February 2007||2007-02-01|November 2016|2016-11-01||||August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis)|A Phase II, Multicentre Study of Oral LBH589 in Patients With Accelerated Phase or Blast Phase (Blast Crisis) Chronic Myeloid Leukemia With Resistant Disease Following Treatment With at Least Two BCR-ABL Tyrosine Kinase Inhibitors|Completed||Phase 2/Phase 3|27|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:46:09.404293|2017-02-18 15:46:09.404293
NCT00449748|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2012-08-01|2011-04-04||April 2007||2007-04-01|August 2012|2012-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis|Evaluation of RAD001 as Therapy for Patients With Systemic Mastocytosis|Completed||Phase 2|10|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 15:46:09.542552|2017-02-18 15:46:09.542552
NCT00449735|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2015-12-16|||March 2007||2007-03-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Quinolone Resistance in Bloodstream Isolates of Escherichia Coli|Quinolone Resistance in Bloodstream Isolates of Escherichia Coli|Recruiting||N/A|500|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:46:09.765345|2017-02-18 15:46:09.765345
NCT00449722|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2016-01-20|||July 2005||2005-07-01|January 2016|2016-01-01|June 2006|Actual|2006-06-01|||||Interventional|||OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis|Double-blind, Double-dummy, Randomised, Multicentre, Comparative Study of the Efficacy and Tolerability of Once Daily 3.0 g Mesalazine Granules Versus Three Times Daily 1.0 g Mesalazine Granules in Patients With Active Ulcerative Colitis|Completed||Phase 3|380||Dr. Falk Pharma GmbH|||||f||||t||||||||||2017-02-18 15:46:09.864667|2017-02-18 15:46:09.864667
NCT00447785|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-03-14|||September 2004||2004-09-01|March 2007|2007-03-01||||||||Observational|||Endocrine Regulation of Energy and Fluid Supplies in Alcoholic Patients|Etude Des déterminants Endocrinologiques Des Apports énergétiques et Fluides Des Patients Alcooliques en Cours de Sevrage|Unknown status|Recruiting|N/A|300||Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||||f||||f||||||||||2017-02-18 15:46:29.018611|2017-02-18 15:46:29.018611
NCT00449709|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2012-03-15|||March 2007||2007-03-01|February 2011|2011-02-01||||||||Interventional|||A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects|A Two-part, Open-label, Cross-over Study to Assess the Pharmacokinetics of GSK221149 Following Single Oral Doses of Various Modified Release Formulations and a Solution in Healthy Adult Subjects|Terminated||Phase 1|36|Anticipated|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:46:09.953876|2017-02-18 15:46:09.953876
NCT00449696|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-20|2011-10-03|2011-04-15||September 2006||2006-09-01|October 2011|2011-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Gel-200 Versus Placebo in Osteoarthritis of the Knee|A Multi-Center, Randomized, Double-Blind, Controlled, Parallel-Group Study of a Single Intra-Articular Injection of Gel-200 With a Single Intra-Articular Injection of Phosphate Buffered Saline (PBS) in Osteoarthritis of the Knee.|Completed||Phase 3|379|Actual|Seikagaku Corporation||2|||f||||f||||||||||2017-02-18 15:46:10.056565|2017-02-18 15:46:10.056565
NCT00449683|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2016-08-24|||March 2007||2007-03-01|August 2016|2016-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|ADIES||Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin|Antidepressant Induced Excessive Sweating: Measurement and Treatment With Terazosin|Completed||Phase 4|23|Actual|Thomas Jefferson University||1|||f||||f||||||||Undecided||2017-02-18 15:46:10.704893|2017-02-18 15:46:10.704893
NCT00449670|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2016-10-26|||March 2007||2007-03-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|July 2007|Actual|2007-07-01||Interventional|||Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults|Assess the Consistency of the Immunogenicity of a GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults Aged Between 18 and 60 Years|Completed||Phase 3|1206|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:46:10.809393|2017-02-18 15:46:10.809393
NCT00449657|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2014-10-23|||February 2007||2007-02-01|October 2014|2014-10-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC|Phase II Trial of Pulsed Paclitaxel With Concurrent Radiotherapy,and Adjuvant Chemotherapy in Stage III Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Leo W. Jenkins Cancer Center||1|||f||||f||||||||||2017-02-18 15:46:10.93393|2017-02-18 15:46:10.93393
NCT00449644|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2014-04-10|2013-01-29||June 2007||2007-06-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|March 2010|Actual|2010-03-01||Interventional|||TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).|A Phase II, Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Subjects With Newly Diagnosed Sputum Smear-positive Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).|Completed||Phase 2|208|Actual|Janssen Infectious Diseases BVBA|In Participant Flow, deaths occurring during the trial are reported. In addition, 1 TMC207 and 2 placebo subjects in stage 1 and 4 TMC207 and 1 placebo subject in stage 2 died after discontinuation during long-term survival follow-up.|4|||f||||t||||||||||2017-02-18 15:46:13.694534|2017-02-18 15:46:13.694534
NCT00449631|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-03-23||||||March 2007|2007-03-01||||||||Observational|||Multidrug Resistance After Trabeculectomy With Mitomycin C|Multidrug Resistance After Trabeculectomy With Mitomycin C|Completed||N/A|30||University of Cologne|||||f||||f||||||||||2017-02-18 15:46:14.52401|2017-02-18 15:46:14.52401
NCT00449618|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2008-12-31|||January 2007||2007-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension|A Prospective, Randomized, Multi-Center, Double-Blind Crossover Study to Compare Awakening Versus Bedtime Administration of 100 mg Aspirin or Placebo in Subjects With High-Normal Blood Pressure or Mild Essential Hypertension|Terminated||Phase 4|23|Actual|University of Vigo||4||Not enough recruitment during the proposed period.|f||||t||||||||||2017-02-18 15:46:14.693528|2017-02-18 15:46:14.693528
NCT00449605|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2016-04-13||2016-04-13|March 2007||2007-03-01|April 2016|2016-04-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|ALLEGRO||A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes|A Randomized, Double-Blind, Parallel-Group, Multicenter, Multinational Study to Assess Glycemic Control With Rimonabant in Comparison With Glimepiride Over 1 Year in Overweight/Obese Type2 Diabetic Patients Not Adequately Controlled With Metformin|Terminated||Phase 3|508|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 15:46:14.983809|2017-02-18 15:46:14.983809
NCT00449592|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-18|2008-10-02|||April 2007||2007-04-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Oral Zinc Therapy for the Prevention of Mucositis|A Ramdomized Double Blined Placebo Controlled Oral Zinc Therapy for the Prevention of Mucositis in Patients Undergoing High Dose Chemotherapy With Stem Cell Support|Completed||Phase 4|40|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 15:46:15.122382|2017-02-18 15:46:15.122382
NCT00449579|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2015-04-16|||August 2006||2006-08-01|October 2006|2006-10-01|October 2007||2007-10-01|||||Interventional|||The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing|The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing|Unknown status|Recruiting|Phase 3|1200|Anticipated|Assuta Hospital Systems|||||f||||||||||||||2017-02-18 15:46:15.230848|2017-02-18 15:46:15.230848
NCT00449566|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-18|2007-03-18|||January 2006||2006-01-01|March 2007|2007-03-01||||||||Observational|||Magnetic Resonance Imaging of Brain Development in Autism|Magnetic Resonance Imaging of Brain Development in Autism|Unknown status|Recruiting|N/A|300||UMC Utrecht|||||f||||f||||||||||2017-02-18 15:46:15.342862|2017-02-18 15:46:15.342862
NCT00449553|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-02-27|||June 2001||2001-06-01|February 2012|2012-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Observational|||Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.|A Prospective Study of Associations of Changes in HbA1C and Fasting Blood Lipids Due to Treatment With Pioglitazone for 6 Months and Genetic Polymorphism's in PPAR-gamma|Completed||Phase 4|326|Actual|Takeda|||4||f||||f||||||Samples With DNA|"~     Whole blood for DNA-analyses~   "|||2017-02-18 15:46:15.424983|2017-02-18 15:46:15.424983
NCT00448149|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-03-15|||December 2006||2006-12-01|March 2016|2016-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer|Phase I/II Trial of RAD001 Plus Nexavar® For Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|55|Actual|The Methodist Hospital System||1|||f||||f||||||||No||2017-02-18 15:46:45.449972|2017-02-18 15:46:45.449972
NCT00449540|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-18|2011-08-09|2009-01-07||August 2006||2006-08-01|July 2011|2011-07-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura|Phase III Randomized Double-Blind Parallel Group Sham-Controlled Study Evaluating the Efficacy and Safety of Non-invasive Non-repetitive Transcranial Magnetic Stimulation (TMS) for the Acute Preemptive Treatment of the Aura Phase of Migraine Headache|Completed||Phase 3|201|Actual|Neuralieve||2|||f||||f||||||||||2017-02-18 15:46:15.559333|2017-02-18 15:46:15.559333
NCT00449527|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2011-01-21|||March 2007||2007-03-01|January 2011|2011-01-01|August 2007|Actual|2007-08-01|||||Interventional|||A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects|A Two-week, Randomised, Double-blind Study Assessing the Onset of Effect Questionnaire Administered Daily Versus Weekly in Adult Subjects (≥ 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT® pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Actuations Twice Daily|Completed||Phase 3|123|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 15:46:16.109422|2017-02-18 15:46:16.109422
NCT00449514|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-18|2007-09-19|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle|Prospective Randomized Study of Ovulation Induction Using Either Tamoxifen or Clomiphene Citrate for Women Who Had Thin Endometrium During Previous Treatment With Clomiphene Citrate|Unknown status|Recruiting|N/A|100|Anticipated|Shaare Zedek Medical Center|||||f||||f||||||||||2017-02-18 15:46:16.25082|2017-02-18 15:46:16.25082
NCT00449501|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2011-01-21|||March 2007||2007-03-01|January 2011|2011-01-01|November 2007|Actual|2007-11-01|||||Interventional|||A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects|A Two-week, Randomised, Double-blind Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects (≥ 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT® pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Act. Twice Daily|Completed||Phase 3|134|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:46:16.339688|2017-02-18 15:46:16.339688
NCT00449488|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-18|2009-12-14|||January 2007||2007-01-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|HEBEIII||Clinical Study to Examine the Effects of Erythropoietin on Left Ventricular Function After Acute Myocardial Infarction|A Prospective, Randomised, Clinical Study to Examine the Effects of a Single Bolus Erythropoietin on Left Ventricular Function in Patients With an Acute Myocardial Infarction|Completed||Phase 2|529|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-02-18 15:46:16.716701|2017-02-18 15:46:16.716701
NCT00449462|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-07-05|||March 2007||2007-03-01|March 2007|2007-03-01|June 2007|Actual|2007-06-01|||||Interventional|||Effect of Conjugated Linoleic Acid Intake on Liver and Kidney Function|The Effect of Conjugated Linoleic Acid Intake on Liver and Kidney Function in Healthy Volunteers (CLAxon-Study)|Completed||N/A|20|Anticipated|Wageningen University|||||f||||f||||||||||2017-02-18 15:46:16.843957|2017-02-18 15:46:16.843957
NCT00449449|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-17|2007-03-19|||September 2003||2003-09-01|March 2007|2007-03-01|September 2006|Actual|2006-09-01|||||Interventional|||A Phase II Clinical Study of Lidocain Pertubation as Treatment for Couples With Unexplained Infertility|A Randomised, Open, Controlled, Parallel Group, Multi-Centre Phase II Clinical Study of Lidocain Pertubation as Treatment for Couples With Unexplained Infertility|Completed||Phase 2|330||Isifer AB|||||f||||t||||||||||2017-02-18 15:46:16.955561|2017-02-18 15:46:16.955561
NCT00449436|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2008-02-26|||October 2004||2004-10-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults|A Randomized, Open Label Study to Compare the Safety and Efficacy of a Long Term Maintenance With TRIZIVIR After a Switch From a Boosted PI or a NNRTI as First Line Therapy for 96 Weeks.|Completed||Phase 1|152|Anticipated|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:46:17.07121|2017-02-18 15:46:17.07121
NCT00449423|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-10-24|||March 2007||2007-03-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|MEMO||Metabolic Modulation as Treatment in Acute Heart Failure|Metabolic Modulation as Treatment in Acute Heart Failure|Terminated||Phase 2|32|Anticipated|University of Aarhus||||due to slow recruitment|f||||f||||||||||2017-02-18 15:46:17.194151|2017-02-18 15:46:17.194151
NCT00449410|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-03-19|||May 2005||2005-05-01|March 2007|2007-03-01|October 2006||2006-10-01|||||Interventional|SPACE||Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients|Silent Cerebrovascular Lesion and Cognitive Decline Prevention in Atrial Fibrillation by Intensive Cholesterol Lowering in Elderly Patients|Completed||Phase 4|35||Radboud University|||||f||||f||||||||||2017-02-18 15:46:17.291961|2017-02-18 15:46:17.291961
NCT00449397|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2011-01-25|||July 2003||2003-07-01|January 2011|2011-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis|A Naturalistic, Prospective, Single Centre, Double Blinded, Fixed Dose, Randomised, Four Week Comparison Study Investigating Efficacy, Tolerability and Safety of 200 mg Per Day Versus 400 mg Per Day Quetiapine Fumarate in 200 Drug naïve First Episode Psychosis Patients Aged 15 to 25 Years.|Completed||Phase 3|150||AstraZeneca|||||f||||f||||||||||2017-02-18 15:46:17.405822|2017-02-18 15:46:17.405822
NCT00449384|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-07-02|||February 2007||2007-02-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Observational|||SIB-Norwegian Version, Validation and Reliability Study|Severe Impairment Study - Norwegian Version. A Validation and Reliability Study.|Completed||N/A|59|Actual|Sykehuset Innlandet HF|||||f||||f||||||||||2017-02-18 15:46:17.495763|2017-02-18 15:46:17.495763
NCT00449358|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2013-04-14|||February 2006||2006-02-01|January 2006|2006-01-01|April 2013|Anticipated|2013-04-01|||||Interventional|||Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors|Correlation Between Mohs Surgery and Microscopic Fluorescence Photometry in Determination of Histological Borders in Basal Cell Carcinoma .|Unknown status|Active, not recruiting|N/A|32||Assuta Hospital Systems|||||f||||||||||||||2017-02-18 15:46:17.581946|2017-02-18 15:46:17.581946
NCT00449345|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-05-28|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Observational|||Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis||Unknown status|Recruiting|N/A|150|Anticipated|Assuta Hospital Systems|||||f||||f||||||||||2017-02-18 15:46:17.674807|2017-02-18 15:46:17.674807
NCT00447083|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2009-02-12|||May 2005||2005-05-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Benefits of Tanning in Fibromyalgia Patients|A Pilot Study of the Effect of Ultraviolet Light on Pain in Persons With Fibromyalgia Syndrome|Completed||N/A|19|Actual|Wake Forest University Health Sciences|||||f||||f||||||||||2017-02-18 15:47:04.156249|2017-02-18 15:47:04.156249
NCT00449332|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2016-09-19|||March 2006||2006-03-01|September 2016|2016-09-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|BOS||Early Indicators of Chronic Rejection in Lung Transplant|Role of Inflammatory and Fibroproliferative Cytokines in the Pathogenesis of Bronchiolitis Obliterans Syndrome-OP in Lung Transplant Recipients.|Terminated||N/A|120|Actual|University of Chicago|||1|PI left University|f||||f||||||Samples With DNA|"~     lung tissues, bal, blood~   "|||2017-02-18 15:46:17.764143|2017-02-18 15:46:17.764143
NCT00449319|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-03-22|||November 1998||1998-11-01|March 2007|2007-03-01|December 2002|Actual|2002-12-01|||||Interventional|LAM99P||AML Treatment in Untreated Adult Patients|AML Treatment in Untreated Adult Patients According to EORTC-GIMEMA Protocols AML8 and AML10|Completed||N/A|||Gruppo Italiano Malattie EMatologiche dell'Adulto|||||f||||f||||||||||2017-02-18 15:46:17.86408|2017-02-18 15:46:17.86408
NCT00449306|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2016-10-23|||March 2001||2001-03-01|October 2016|2016-10-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||Physical,Histological,and Genetic Analyses of Lipid-rich Atherosclerotic Plaques|Physical,Histological,and Genetic Analyses of Lipid-rich Atherosclerotic Plaques|Active, not recruiting||N/A|120|Anticipated|Sheba Medical Center|||1||f||||f||||||Samples Without DNA|"~     Tissue for RNA extraction (frozen); Tissue for histological analysis (formalin fixation);~     Plasma for CV biomarkers (frozen)~   "|||2017-02-18 15:46:17.985478|2017-02-18 15:46:17.985478
NCT00449293|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2008-01-04|||October 2006||2006-10-01|January 2008|2008-01-01|June 2009|Anticipated|2009-06-01|June 2007|Actual|2007-06-01||Interventional|||Behavioral Therapy for Reduction in Smoking Craving|Behavioral Therapy for Reduction in Smoking Craving|Unknown status|Active, not recruiting|N/A|40|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 15:46:18.095929|2017-02-18 15:46:18.095929
NCT00449280|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2013-06-11|||November 2006||2006-11-01|June 2013|2013-06-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies|A Drug Interaction Study of Sorafenib (BAY 43-9006 Tosylate) and Rapamycin in Patients With Advanced Malignancies|Completed||Phase 1|34|Actual|University of Chicago||4|||f||||t||||||||||2017-02-18 15:46:18.221297|2017-02-18 15:46:18.221297
NCT00449267|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-17|2009-02-10|||March 2007||2007-03-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Aurolab Hydrophobic Foldable Intraocular Lens Study|Clinical Evaluation of Hydrophobic Foldable Intraocular Lenses|Completed||Phase 4|120|Actual|Aurolab||1|||f||||t||||||||||2017-02-18 15:46:18.337489|2017-02-18 15:46:18.337489
NCT00449254|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2007-06-04|||October 2006||2006-10-01|June 2007|2007-06-01||||||||Interventional|||Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults|A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Oleoyl-Estrone (MP-101) in Male Obese Adults.|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|Manhattan Pharmaceuticals|||||t||||f||||||||||2017-02-18 15:46:18.45681|2017-02-18 15:46:18.45681
NCT00449241|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-19|2007-03-19|||November 2006||2006-11-01|March 2007|2007-03-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Acupuncture Treatment in Adults Undergoing Diagnostic OGD : A Double-Blind Placebo Controlled Randomized Trial|Acupuncture Treatment in Adults Undergoing Diagnostic Upper Gastrintestinal Endoscopy: A Double-Blind Placebo Controlled Randomized Trial|Unknown status|Recruiting|N/A|210||Chinese University of Hong Kong|||||f||||t||||||||||2017-02-18 15:46:18.538667|2017-02-18 15:46:18.538667
NCT00449228|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-18|2012-06-04|||April 2007||2007-04-01|March 2007|2007-03-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|ANRACT||Efficacy of Preoperative Education and Mini-invasive Surgery for Total Hip Replacement|Evaluation of Preoperative Education and Mini-invasive Total Hip Replacement in Regard to the Attainment of Functional Independency and Reduction of Hospital Stay|Unknown status|Recruiting|Phase 3|215|Anticipated|Assistance Publique - Hôpitaux de Paris|||||f||||t||||||||||2017-02-18 15:46:18.631201|2017-02-18 15:46:18.631201
NCT00449215|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-18|2007-03-18|||October 2004||2004-10-01|March 2007|2007-03-01|December 2006|Actual|2006-12-01|||||Observational|||The Genetic and Life Style Determinants of Bone Mass of Young Greek Males||Completed||N/A|301||University of Athens|||||f||||f||||||||||2017-02-18 15:46:18.735839|2017-02-18 15:46:18.735839
NCT00449202|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2007-03-16|||June 2006||2006-06-01|March 2007|2007-03-01||||||||Interventional|||Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)|A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Two 14 Day Cycles of Oral Doses of Oleoyl-Estrone (MP-101) in Obese Adult Subjects|Unknown status|Active, not recruiting|Phase 2|100||Manhattan Pharmaceuticals|||||t||||f||||||||||2017-02-18 15:46:18.82579|2017-02-18 15:46:18.82579
NCT00449189|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2012-08-30|||October 2006||2006-10-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|Mirtazapine||A Placebo-Controlled Study of Mirtazapine for PTSD|A Placebo-Controlled Study of Mirtazapine for PTSD in OIF/OEF Veterans and Veterans From All Other Southwest Asia Conditions|Completed||Phase 4|90|Actual|Tuscaloosa Research & Education Advancement Corporation||2|||f||||t||||||||||2017-02-18 15:46:18.908099|2017-02-18 15:46:18.908099
NCT00449176|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2012-04-26|2009-04-17||February 2007||2007-02-01|April 2012|2012-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain|A Randomized Double-Blind, Placebo- and Active-Control, Parallel-arm, Phase III Trial With Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Extended-Release (ER) in Subjects With Moderate to Severe Chronic Low Back Pain|Completed||Phase 3|981|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 15:46:19.018962|2017-02-18 15:46:19.018962
NCT00449163|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-12-14|2013-01-23||March 2006||2006-03-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer|Phase II Study of Avastin, Irinotecan, High Dose 24 Hour Continuous Intravenous Infusion of Floxuridine and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer|Terminated||Phase 2|25|Actual|University of Miami|A total of 25 subjects were enrolled however; data were analyzed for 22 subjects only. Study was terminated early by the University of Miami Institutional Review Board.|1||Study terminated by University of Miami Institutional Review Board|f||||t||||||||||2017-02-18 15:46:19.899475|2017-02-18 15:46:19.899475
NCT00447772|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2009-07-23|||October 2004||2004-10-01|July 2009|2009-07-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia|Open Multicentre Study to Demonstrate the Efficacy and Safety of Botulinum Toxin A (500 Units Dysport®) in the Treatment of Heterogeneous Forms of Cervical Dystonia|Completed||Phase 3|516|Actual|Ipsen||1|||f||||f||||||||||2017-02-18 15:46:29.101261|2017-02-18 15:46:29.101261
NCT00449150|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-06-06|2010-10-05||March 2007||2007-03-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Cetrorelix Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)|Cetrorelix Pamoate Intermittent IM Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment|Terminated||Phase 3|667|Actual|AEterna Zentaris||3||Trial did not meet primary efficacy endpoint for double blind phase.|f||||f||||||||||2017-02-18 15:46:20.181819|2017-02-18 15:46:20.181819
NCT00449137|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-12-14|||June 2005||2005-06-01|December 2016|2016-12-01|December 2010|Actual|2010-12-01|February 2010|Actual|2010-02-01||Interventional|||Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment|A Phase I Study of 5-FU (Plus Leucovorin) and Arsenic Trioxide for Patients With Refractory/Relapsed Metastatic Colorectal Carcinoma|Completed||Phase 1|13|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:46:21.088646|2017-02-18 15:46:21.088646
NCT00449124|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2010-08-26||||||June 2008|2008-06-01|September 2007|Anticipated|2007-09-01|September 2007|Anticipated|2007-09-01||Interventional|||TG4040 in Patients With Chronic HCV|A Phase I, Randomized, Double-Blind, Dose-Ranging, Crossover Trial of HCV Vaccine (TG4040) in Patients With Chronic Hepatitis C to be Conducted in Two Parts|Withdrawn||Phase 1|85|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-02-18 15:46:21.208829|2017-02-18 15:46:21.208829
NCT00449111|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2016-05-13|||March 2006||2006-03-01|May 2016|2016-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)|An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension|Terminated||Phase 3|11|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:46:21.316025|2017-02-18 15:46:21.316025
NCT00449098|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-10-06|||January 2007||2007-01-01|October 2011|2011-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Ologen (OculusGen)-Glaucoma MMC Control Trial in India|Comparative Study of the Safety and Effectiveness Between Ologen (OculusGen) Collagen Matrix Implant and Mitomycin-C in Glaucoma Filtering Surgery|Unknown status|Recruiting|Phase 4|40|Anticipated|Pro Top & Mediking Company Limited||2|||f||||||||||||||2017-02-18 15:46:21.398727|2017-02-18 15:46:21.398727
NCT00449085|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2015-01-05|||April 2007||2007-04-01|January 2015|2015-01-01||||July 2012|Anticipated|2012-07-01||Interventional|||Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study|Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study|Withdrawn||Phase 2|0|Actual|Biosense Webster, Inc.||1|||f||||f||||||||||2017-02-18 15:46:21.509863|2017-02-18 15:46:21.509863
NCT00449072|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2012-08-07|2012-06-29||March 2007||2007-03-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)|A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel Group Study of the 12 Month Effect of Treatment With Once Daily Triamcinolone Acetonide (NASACORT® AQ Nasal Spray 110 μg) on the Growth Velocity of Children, 3 to 9 Years of Age, With Perennial Allergic Rhinitis (PAR)|Completed||Phase 4|299|Actual|Sanofi|Two study sites with significant GCP noncompliance were reported to the U.S. Food and Drug Administration (FDA) by the Sponsor. A total of 5 treated participants (1 placebo and 4 TAA-AQ) from these 2 study sites were excluded from the analysis.|2|||f||||||||||||||2017-02-18 15:46:21.599325|2017-02-18 15:46:21.599325
NCT00449059|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2007-03-15|||January 2003||2003-01-01|March 2007|2007-03-01|December 2004|Actual|2004-12-01|||||Interventional|||Nitrate and Hypertension in Heart Transplanted Patients|Acute Effect of Nitroglycerin on Cyclosporine-Induced Hypertension After Cardiac Transplantation|Completed||Phase 4|20||University of Zurich|||||f||||f||||||||||2017-02-18 15:46:22.431474|2017-02-18 15:46:22.431474
NCT00449046|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2015-04-16|2008-11-21||March 2007||2007-03-01|April 2015|2015-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study-|Clinical Assessment of GW815SF Salmeterol/Fluticasone Propionate (HFA MDI) in Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study-|Completed||Phase 3|40|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:46:22.52173|2017-02-18 15:46:22.52173
NCT00449033|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2015-04-03|2011-04-20||February 2007||2007-02-01|April 2015|2015-04-01|June 2011|Actual|2011-06-01|April 2010|Actual|2010-04-01||Interventional|NEXUS||A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)|A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|904|Actual|Bayer|Inclusion of squamous patients stopped in FEB 2008, as 11961 (NCT00558636) trial reported higher mortality for this subgroup. Squamous patients in 12006 (NCT00449033) trial discontinued drug as a precaution endorsed by Data Monitoring Committee.|2|||f||||t||||||||||2017-02-18 15:46:23.066177|2017-02-18 15:46:23.066177
NCT00449020|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-12-14|||January 2004||2004-01-01|December 2016|2016-12-01|January 2008|Actual|2008-01-01|May 2007|Actual|2007-05-01||Interventional|||Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer|Carboplatin and Irinotecan Concomitantly With Radiation Therapy Followed by Consolidation Chemotherapy With Docetaxel for Locally Advanced Non-Small Cell Lung Cancer (GIA 12177).|Completed||Phase 2|32|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:46:24.526316|2017-02-18 15:46:24.526316
NCT00449007|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2008-09-26|||February 2006||2006-02-01|September 2008|2008-09-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism|A Randomized Controlled Study Comparing Fluoxetine With Bupropion for Impulsivity and Suicidality in Patients With Major Depressive Disorder and Comorbid Alcoholism (Abuse or Dependence)|Unknown status|Active, not recruiting|Phase 4|42|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||2|||f||||t||||||||||2017-02-18 15:46:24.629414|2017-02-18 15:46:24.629414
NCT00448994|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2014-12-08|||March 2007||2007-03-01|December 2014|2014-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients|Serial Monitoring of Adenovirus and Fungal Load by Real-Time, Quantitative Polymerase Chain Reaction (PCR) Assay and Correlation With Outcomes in Pediatric Hematopoietic Stem Cell Transplant Patients|Withdrawn||N/A|0|Actual|ViraCor Laboratories|||1|Method development/validation|f||||f||||||||||2017-02-18 15:46:24.737395|2017-02-18 15:46:24.737395
NCT00448981|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2012-10-01|||November 2006||2006-11-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|STUFFY||Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial|Stopping URIs and Flu in the Family: The Stuffy Trial|Completed||N/A|2788|Actual|Centers for Disease Control and Prevention|||||f||||t||||||||||2017-02-18 15:46:24.822547|2017-02-18 15:46:24.822547
NCT00448968|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2007-09-26|||March 2007||2007-03-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Observational|||The Utility of Ischemia Modified Albumin (IMA) in Sepsis|The Utility of Ischemia Modified Albumin (IMA) in Sepsis|Completed||N/A|150|Actual|Inverness Medical Innovations|||||f||||f||||||||||2017-02-18 15:46:24.924539|2017-02-18 15:46:24.924539
NCT00448955|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2008-04-17|||May 2007||2007-05-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Open-Label Study of ARD-0403 in Testosterone Deficient Men|A Phase III Open-Label Study of the Efficacy and Safety of ARD-0403, a Testosterone Cream, in Testosterone Deficient Men|Completed||Phase 3|150|Anticipated|Ardana Bioscience Ltd|||||f||||||||||||||2017-02-18 15:46:25.004258|2017-02-18 15:46:25.004258
NCT00448942|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2007-03-15|||November 2004||2004-11-01|March 2007|2007-03-01|January 2006|Actual|2006-01-01|||||Observational|||The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections|The Impact of the Use of Chlorhexidine-Based Bathing System in the Hospital to Reduce the Incidence of MRSA/VRE Infection or Colonization and Nosocomial Bloodstream Infections (BSI)|Completed||N/A|5300||Hunter Holmes Mcguire Veteran Affairs Medical Center|||||f||||f||||||||||2017-02-18 15:46:25.10818|2017-02-18 15:46:25.10818
NCT00448929|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-10-06|||January 2007||2007-01-01|October 2011|2011-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|||Ologen (OculusGen)-Glaucoma Case Control Trial in India|Comparative Study of the Safety and Effectiveness Between Trabeculectomy and Trabeculectomy With Ologen (OculusGen) Collagen Matrix Implant|Unknown status|Recruiting|Phase 3|40|Anticipated|Pro Top & Mediking Company Limited||2|||f||||||||||||||2017-02-18 15:46:25.203994|2017-02-18 15:46:25.203994
NCT00448916|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2014-11-24|2014-10-06||May 2007||2007-05-01|November 2014|2014-11-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures|A 12-month Open-label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Pregabalin In Pediatric Patients With Partial Onset Seizures|Completed||Phase 3|54|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:46:25.334021|2017-02-18 15:46:25.334021
NCT00448903|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-03-16|||March 2007||2007-03-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers|Multicentric, Randomized, Double-blind, Controlled Clinical Trial to Assess the Efficacy and Safety of Bemiparin Sodium as Treatment of Diabetic Foot Ulcers|Completed||Phase 3|329|Actual|Rovi Pharmaceuticals Laboratories||2|||f||||t||||||||||2017-02-18 15:46:27.311121|2017-02-18 15:46:27.311121
NCT00448890|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2010-10-14||2010-10-14|November 2006||2006-11-01|October 2010|2010-10-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers|Single-Blind, Randomised, Placebo-Controlled Two-Part Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Escalating Doses and Repeat Doses of GSK729327 in Healthy Volunteers|Completed||Phase 1|79|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 15:46:27.424309|2017-02-18 15:46:27.424309
NCT00448877|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2009-04-06|||December 2006||2006-12-01|April 2008|2008-04-01||||July 2007|Actual|2007-07-01||Interventional|||Deployment of Functional Optical Brain Monitor [fNIR] in Clinical Anesthesia|Deployment of Functional Optical Brain Monitor [fNIR] in Clinical Anesthesia|Completed||N/A|50|Actual|Drexel University||1|||f||||||||||||||2017-02-18 15:46:27.519495|2017-02-18 15:46:27.519495
NCT00448864|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2016-01-05|2015-04-22||May 2007||2007-05-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional||Randomized participants who received at least 1 dose of study drug.|Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement|KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass|Terminated||Phase 2|75|Actual|Cubist Pharmaceuticals LLC||3||Experience gained from this study is sufficient to design and facilitate the follow-on study.|f||||t||||||||||2017-02-18 15:46:27.619162|2017-02-18 15:46:27.619162
NCT00448851|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2013-12-09|||February 2007||2007-02-01|December 2013|2013-12-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Study of Dust Mite Inhalation in Humans|Phase 1 Study of Dermatophagoides Farinae Inhalation in Humans|Completed||Phase 1|13|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 15:46:28.597846|2017-02-18 15:46:28.597846
NCT00448838|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-12-14|||May 2006||2006-05-01|December 2016|2016-12-01|March 2011|Actual|2011-03-01|August 2007|Actual|2007-08-01||Interventional|||Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|Pilot Study of Gemcitabine, Oxaliplatin, and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer|Completed||N/A|42|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:46:28.709453|2017-02-18 15:46:28.709453
NCT00448825|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2013-03-14|||March 2007||2007-03-01|March 2013|2013-03-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Novel Pharmacotherapy for Dual Dependence|Novel Pharmacotherapy for Dual Dependence|Unknown status|Recruiting|Phase 3|180|Anticipated|University of Virginia||2|||f||||t||||||||||2017-02-18 15:46:28.808676|2017-02-18 15:46:28.808676
NCT00447798|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2015-03-31|||June 2005||2005-06-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|March 2011|Actual|2011-03-01||Interventional|||Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users|Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users|Completed||N/A|413|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 15:46:28.919299|2017-02-18 15:46:28.919299
NCT00347490|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-01-22|||May 2006||2006-05-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||HENOX: Enoxaparine in Hemodialysis|Efficacy and Safety in Hemodialysis With Enoxaparine|Completed||Phase 4|100|Anticipated|Sanofi|||||f||||||||||||||2017-02-18 16:25:44.46602|2017-02-18 16:25:44.46602
NCT00447759|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2016-01-07|||June 2007||2007-06-01|January 2016|2016-01-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|SCOTLSSS||The Standard Care Versus Celecoxib Outcome Trial|Phase 4 Study A Large Streamline Safety Study Designed to Compare the Cardiovascular Safety od Celecoxib Versus Traditional Non-selective NSAID's|Completed||Phase 4|7300|Actual|University of Dundee||2|||f||||t||||||||||2017-02-18 15:46:31.889944|2017-02-18 15:46:31.889944
NCT00447746|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-03-14|||March 2007||2007-03-01|March 2007|2007-03-01|March 2014||2014-03-01|||||Interventional|||A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial|A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|600||Tata Memorial Hospital|||||f||||t||||||||||2017-02-18 15:46:32.025|2017-02-18 15:46:32.025
NCT00447733|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2012-03-23|||March 2007||2007-03-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|ROP||Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders|Effects of Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders|Completed||N/A|76|Actual|University of Oslo||2|||f||||t||||||||||2017-02-18 15:46:32.110156|2017-02-18 15:46:32.110156
NCT00447720|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2015-12-01|||June 2004||2004-06-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||HIV Prevention Among Substance Abusing SMI|Translation of CDC and NIDA Programs to Prevent HIV/AIDS Among Persons With Serious Mental Illness|Completed||Phase 3|238|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 15:46:32.213816|2017-02-18 15:46:32.213816
NCT00447707|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2017-01-11|||December 2003||2003-12-01|March 2007|2007-03-01|September 2006||2006-09-01|||||Interventional|||Positive Choice: Prevention for Positive Health|Positive Choice: Prevention for Positive Health|Completed||N/A|497||National Institute on Drug Abuse (NIDA)|||||f||||f||||||||||2017-02-18 15:46:32.316767|2017-02-18 15:46:32.316767
NCT00447694|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2016-09-22|||February 2006||2006-02-01|September 2016|2016-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment|An Open Label Trial Evaluating Cardiac T2* in Beta-thalassemia Patients on Deferasirox (ICL670) Treatment for 18 Months|Completed||Phase 2|30|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:46:32.672742|2017-02-18 15:46:32.672742
NCT00447681|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-12-11|||December 2006||2006-12-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetiks, and Pharmacodynamics of ILV-094 Administered Intravenously and One Dose of ILV-094 Administered Subcutaneously to Healthy Subjects|Completed||Phase 1|56|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:46:32.783754|2017-02-18 15:46:32.783754
NCT00448812|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2010-02-11|||March 2005||2005-03-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 15:46:32.861264|2017-02-18 15:46:32.861264
NCT00448799|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2008-05-09|||March 2007||2007-03-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls|Evaluation of [123I] AV83 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Completed||Phase 1|30|Anticipated|Molecular NeuroImaging||1|||f||||f||||||||||2017-02-18 15:46:32.914146|2017-02-18 15:46:32.914146
NCT00448786|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-01-20|||February 2007||2007-02-01|January 2011|2011-01-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors|An Open-Label, Randomized, Phase 1b Study Evaluating the Effect of Different Doses of AMG 706 on the Gallbladder in Subjects With Advanced Solid Tumors|Completed||Phase 1|49|Actual|Amgen||3|||f||||||||||||||2017-02-18 15:46:33.002649|2017-02-18 15:46:33.002649
NCT00448773|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2010-01-06|||February 2007||2007-02-01|January 2010|2010-01-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|REDI-US||REDucing Influenza Among University Students, University of California at Berkeley|Effectiveness of Selected Non-pharmaceutical Interventions in Reducing Influenza-like Illness Among University Students|Completed||Phase 4|3000|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 15:46:33.109769|2017-02-18 15:46:33.109769
NCT00448760|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-12-14|2013-01-16||October 2004||2004-10-01|December 2016|2016-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery|A Nonrandomized Phase II Study: Feasibility and Outcome of Neo Adjuvant Chemotherapy With Oxaliplatin, Fluorodeoxyuridine (FUdR), Taxotere and Leucovorin in the Treatment of Previously Untreated Advanced Esophago-Gastric Carcinoma|Completed||Phase 2|29|Actual|University of Miami||1|||f||||||||||||||2017-02-18 15:46:33.196911|2017-02-18 15:46:33.196911
NCT00448747|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2014-02-19|||June 2007||2007-06-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Investigation of a New, Oral Growth Hormone Secretagogue, Macimorelin (AEZS-130) as a Growth Hormone Stimulation Test.|A Multi-center, Study Investigating a New, Oral Growth Hormone Secretagogue (GHS)(AEZS 130, Formerly ARD-07) as a Growth Hormone (GH) Stimulation Test in Terms of Safety and Efficacy|Completed||Phase 3|98|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 15:46:33.548165|2017-02-18 15:46:33.548165
NCT00448734|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2009-01-20|||June 2006||2006-06-01|January 2009|2009-01-01|July 2010|Anticipated|2010-07-01|December 2009|Anticipated|2009-12-01||Interventional|||A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer|A Phase 1/2 Study of Picoplatin and Docetaxel (With Prednisone) in Subjects With Chemotherapy-Naive Metastatic Hormone-Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|95|Anticipated|Poniard Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:46:33.672757|2017-02-18 15:46:33.672757
NCT00448721|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2014-02-11|||March 2007||2007-03-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer|A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|24|Actual|AEterna Zentaris||1|||f||||t||||||||||2017-02-18 15:46:33.789779|2017-02-18 15:46:33.789779
NCT00448188|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2013-01-25|||November 2005||2005-11-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Bleeding Risk in CVCs|Thrombocytes and International Normalized Ratio Are no Predictors for Bleeding in Application of Central Veneous Catheters|Completed||N/A|200|Anticipated|Heidelberg University|||||f||||t||||||||||2017-02-18 15:46:44.815865|2017-02-18 15:46:44.815865
NCT00448708|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-10-13|2011-06-08||March 2007||2007-03-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access|Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular Wrap Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan® ePTFE Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access|Terminated||N/A|222|Actual|Angiotech Pharmaceuticals|Due to an observed imbalance in the number of graft infections, enrollment in the 1-year study 012-VWAV06 was suspended at the recommendation of the DSMC. Many of the planned efficacy analyses did not occur as a result of this suspension.|2||Due to an imbalance in graft infections between groups.|f||||t||||||||||2017-02-18 15:46:33.901951|2017-02-18 15:46:33.901951
NCT00448695|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2012-06-14|||March 2007||2007-03-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer|Phase 1 Study of MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer|Completed||Phase 1|12|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 15:46:34.708255|2017-02-18 15:46:34.708255
NCT00448682|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-12-14|2013-02-21||June 2005||2005-06-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery|A Phase II Study of Weekly 24-hour Infusion 5-fluoro-deoxyuridine (FUdR)/Leucovorin With Oxaliplatin and Docetaxel (Taxotere) as First-line Treatment in Patients With Metastatic Gastric Adenocarcinoma (IIT# 14065)|Terminated||Phase 2|25|Actual|University of Miami|The study was terminated prematurely by the University of Miami Institutional Review Board. The results have not been analyzed.|1|||f||||t||||||||||2017-02-18 15:46:34.82026|2017-02-18 15:46:34.82026
NCT00448669|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2012-10-01|||March 2007||2007-03-01|October 2012|2012-10-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|TDF2||Botswana TDF/FTC Oral HIV Prophylaxis Trial|Study of the Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana|Completed||Phase 2/Phase 3|1219|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 15:46:35.067643|2017-02-18 15:46:35.067643
NCT00448656|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2012-06-18|||June 2006||2006-06-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ABOLISH-AF||Treatment of Atrial Fibrillation by Minimal Invasive Surgery|Treatment of Atrial Fibrillation by Minimal Invasive Epicardial Pulmonary Vein Isolation: The ABOLISH-AF Study|Completed||Phase 2|15|Actual|University Medical Center Groningen||1|||f||||t||||||||||2017-02-18 15:46:35.201278|2017-02-18 15:46:35.201278
NCT00448643|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-12-14|||May 2002||2002-05-01|December 2016|2016-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery|A Phase I Study Using Abdominal Radiotherapy as a Cisplatin Chemosensitizer for Optimally Debulked Stage III/IV Carcinoma of the Endometrium|Completed||Phase 1|12|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 15:46:35.314682|2017-02-18 15:46:35.314682
NCT00448630|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2010-06-04|2009-07-27||October 2007||2007-10-01|June 2010|2010-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|MESSAGE||An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics|A Multi-Center, Non-Interventional, Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics|Completed||Phase 4|328|Actual|Pfizer|||1||f||||f||||||Samples With DNA|"~     Whole blood (fasting blood glucose, total cholesterol, LDL cholesterol, HDL cholesterol,~     triglyceride levels)~   "|||2017-02-18 15:46:35.438291|2017-02-18 15:46:35.438291
NCT00448617|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2015-05-28|||July 2006||2006-07-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Cigarette Smoke and Susceptibility to Influenza Infection|Cigarette Smoke and Susceptibility to Influenza Infection|Completed||N/A|138|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"~     nasal lavage fluid, urine, blood, nasal epithelial tissue from subjects who consent to have~     excess samples stored in our repository~   "|||2017-02-18 15:46:36.666321|2017-02-18 15:46:36.666321
NCT00448604|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2010-11-03|||May 2007||2007-05-01|February 2009|2009-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|VICE||Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations|Impact of Viral Infections in Patients With Chronic Obstructive Pulmonary Diseases: Virological Work-up During Exacerbations and 1-year Follow-up|Completed||N/A|86|Actual|University Hospital, Geneva|||1||f||||f||||||Samples Without DNA|"~     Naso-pharyngeal swaps~   "|||2017-02-18 15:46:36.763767|2017-02-18 15:46:36.763767
NCT00448591|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2015-05-21|2014-12-22||September 2006||2006-09-01|May 2015|2015-05-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||The safety/intent-to-treat (ITT) population was defined as all participants who had signed informed consent, with at least one valid post-baseline assessment and who received at least one dose of bevacizumab.|A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.|An Open-label Study to Evaluate the Safety and Effect on Disease Progression and Overall Survival of Avastin Plus Taxane-based Chemotherapy in Patients With Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 3|2296|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:46:36.873952|2017-02-18 15:46:36.873952
NCT00448578|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2010-12-07|||August 2005||2005-08-01|December 2010|2010-12-01|June 2006|Actual|2006-06-01|||||Interventional|STAR||Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients|A Double Dummy & Double Blind, Multicenter, Randomized Study of the Efficacy and Safety of Seroquel (Quetiapine Fumarate) and Lithium as Monotherapy in the Treatment of Acute Mania in Patients With Bipolar Disorder|Completed||Phase 3|150||AstraZeneca|||||f||||||||||||||2017-02-18 15:46:38.334936|2017-02-18 15:46:38.334936
NCT00448565|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2009-01-30|||January 2007||2007-01-01|January 2009|2009-01-01||||||||Observational|||Prediction of Extubation Success by the Patient||Completed||N/A|200|Actual|Ospedale Regionale Bellinzona e Valli|||1||f||||||||||||||2017-02-18 15:46:38.42295|2017-02-18 15:46:38.42295
NCT00448552|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2016-12-14|||February 2004||2004-02-01|December 2016|2016-12-01|June 2008|Actual|2008-06-01|April 2007|Actual|2007-04-01||Interventional|||Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer|Treatment of Relapsed or Metastatic Head and Neck Carcinomas With Oxaliplatin and Capecitabine|Completed||Phase 2|30|Anticipated|University of Miami|||||f||||t||||||||||2017-02-18 15:46:38.499637|2017-02-18 15:46:38.499637
NCT00448539|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2012-11-12|2012-04-16||March 2007||2007-03-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures|An Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures|Completed||Phase 3|286|Actual|Eisai Inc.|This study was terminated early by the sponsor due to the discontinuation of clinical development for rufinamide.|2|||f||||f||||||||||2017-02-18 15:46:38.611928|2017-02-18 15:46:38.611928
NCT00448526|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2007-03-16|||December 1997||1997-12-01|March 2007|2007-03-01|August 2006||2006-08-01|||||Interventional|LPD||Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy||Terminated||N/A|||Kanazawa Medical University||||"Terminated: recruiting or enrolling participants has halted and will not resume because low~   protein diet is not feasible nor efficious."|f||||t||||||||||2017-02-18 15:46:39.334915|2017-02-18 15:46:39.334915
NCT00448513|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-16|2013-07-14|||June 2007||2007-06-01|April 2009|2009-04-01|April 2012|Actual|2012-04-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Tea Catechin Extracts on Oxidative Damage|Effects of Tea Catechin Extracts on the Frequency Changes of Micronuclei in Peripheral Lymphocytes in Late Middle Aged Healthy Volunteers|Completed||N/A|40|Actual|University of Shizuoka||1|||f||||f||||||||||2017-02-18 15:46:39.412777|2017-02-18 15:46:39.412777
NCT00448500|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2008-05-06|||February 2006||2006-02-01|May 2008|2008-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Exhaled Breath Condensate (EBC) Assessment in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)|Measurement of Biomarkers in the Exhaled Breath Condensate in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease|Completed||N/A|80|Actual|Chinese University of Hong Kong|||1||f||||f||||||None Retained|"~     Exhaled breath condensate~   "|||2017-02-18 15:46:39.516337|2017-02-18 15:46:39.516337
NCT00448487|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2015-06-10|||April 2005||2005-04-01|June 2015|2015-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|ICARER||Haptoglobin Phenotype and Cardiovascular Complications in Diabetic Patients|Prospective Observational Study to Asses the Incidence of CVD Complications in Diabetic Patients Pre-stratified by Haptoglobin Phenotype From the I CARE Registry|Completed||N/A|3054|Actual|Technion, Israel Institute of Technology|||1||f||||f||||||||||2017-02-18 15:46:39.598116|2017-02-18 15:46:39.598116
NCT00448474|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-03-15|||November 2005||2005-11-01|March 2007|2007-03-01|July 2006||2006-07-01|||||Interventional|||Development and Evaluation of A Mailed Arthritis Self-Management Program|Mail-Delivered Arthritis Self-Management Education -- Years 1, 2, Carryover|Completed||N/A|900||University of North Carolina, Chapel Hill|||||f||||t||||||||||2017-02-18 15:46:39.682323|2017-02-18 15:46:39.682323
NCT00448461|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2009-02-09|||March 2007||2007-03-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|ARNO||Antithrombotic Regimens and Outcome|Comparison of Bivalirudin and Unfractioned Heparin in Elective Percutaneous Coronary Interventions|Completed||Phase 4|850|Actual|Careggi Hospital||2|||f||||t||||||||||2017-02-18 15:46:39.767653|2017-02-18 15:46:39.767653
NCT00448448|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2014-06-23|2014-05-19||February 2007||2007-02-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|BrAIST|Age, gender, race, height, Scoliosis Research Society curve classification, Cobb angle, Risser grade|Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)|Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)|Completed||Phase 3|383|Actual|University of Iowa|Study was terminated early due to efficacy. 119 subjects were still on protocol.|2|||f||||t||||||||||2017-02-18 15:46:39.879499|2017-02-18 15:46:39.879499
NCT00448435|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2010-06-03|2009-01-19||April 2007||2007-04-01|June 2010|2010-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma|A Study to Compare GW815SF HFA MDI With Concomitant Treatment With Salmeterol Xinafoate DPI Plus Fluticasone Propionate DPI and to Assess Long-term Safety of GW815SF HFA MDI|Completed||Phase 3|51|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 15:46:40.847577|2017-02-18 15:46:40.847577
NCT00448422|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2010-09-22||2010-08-27|December 2006||2006-12-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers|A Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Prulifloxacin Versus Placebo in the Treatment of Acute Gastroenteritis in Adult Travelers|Completed||Phase 3|268|Actual|Optimer Pharmaceuticals LLC||2|||f||||f||||||||||2017-02-18 15:46:41.348864|2017-02-18 15:46:41.348864
NCT00448409|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2016-03-15|||May 2006||2006-05-01|March 2016|2016-03-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer|A Phase II Trial to Assess the Activity of TroVax® Alone vs. TroVax® Plus Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) in Patients With Progressive Hormone Refractory Prostate Cancer|Completed||Phase 2|27|Actual|The Methodist Hospital System||2|||f||||f||||||||No||2017-02-18 15:46:41.460339|2017-02-18 15:46:41.460339
NCT00448396|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2009-11-18|||March 2007||2007-03-01|November 2009|2009-11-01||||February 2008|Actual|2008-02-01||Interventional|||Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies|An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies|Completed||Phase 1|17|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:46:41.572215|2017-02-18 15:46:41.572215
NCT00448383|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2008-07-31|||September 2002||2002-09-01|July 2008|2008-07-01||||November 2004|Actual|2004-11-01||Interventional|ReAct||A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis|An Open-Label, Multi-Center Study to Assess the Safety and Efficacy of the Fully Human Anti-TNF-α Monoclonal Antibody Adalimumab (D2E7) When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis|Completed||Phase 3|6610|Actual|Abbott||1|||f||||||||||||||2017-02-18 15:46:41.68329|2017-02-18 15:46:41.68329
NCT00448370|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2016-11-10|||March 2007||2007-03-01|November 2016|2016-11-01||||December 2012|Actual|2012-12-01||Observational|||Role of Placenta Growth Factor in Sickle Acute Chest Syndrome|Role of Placenta Growth Factor in Sickle Acute Chest Syndrome|Completed||N/A|136|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-02-18 15:46:41.776757|2017-02-18 15:46:41.776757
NCT00448175|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2013-04-04|2013-01-24||June 2006||2006-06-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|OrBIT||Overactive Bladder Innovative Therapy Trial (OrBIT)|Overactive Bladder Innovative Therapy Trial|Completed||Phase 4|100|Actual|Uroplasty, Inc||1|||f||||||||||||||2017-02-18 15:46:44.907872|2017-02-18 15:46:44.907872
NCT00448357|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2015-11-23|||October 2005||2005-10-01|November 2015|2015-11-01|August 2017|Anticipated|2017-08-01|November 2016|Anticipated|2016-11-01||Interventional|LCCC 0510||Fludarabine and PK-Directed Busulfan With or Without ATG Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases|Allogeneic Hematopoietic Cell Transplantation for Patients With Hematologic Disorders Who Are Undergoing Dose-Adjusted Treatment With A Maximally Intensive Busulfex-Based Therapeutic Regimen|Active, not recruiting||Phase 1/Phase 2|60|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 15:46:41.871128|2017-02-18 15:46:41.871128
NCT00448344|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2015-04-06|2014-08-13||February 2008||2008-02-01|August 2014|2014-08-01|July 2012|Actual|2012-07-01|September 2010|Actual|2010-09-01||Interventional|||Family-supported Smoking Cessation for Chronically Ill Veterans|Family-Supported Smoking Cessation for Chronically Ill Veterans|Completed||N/A|471|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:46:42.0073|2017-02-18 15:46:42.0073
NCT00448331|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-10-31|||June 2004||2004-06-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Observational|MI||Facilitated Referral for Children Screening Positive for Mental Illness|Facilitated Referral for Children Screening Positive for Mental Illness in the Pediatric Emergency Department and Readiness to Seek Care|Completed||Early Phase 1|551|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-02-18 15:46:42.488423|2017-02-18 15:46:42.488423
NCT00448318|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-03-14|||March 2007||2007-03-01|February 2007|2007-02-01|October 2008||2008-10-01|||||Interventional|||Evaluating the Effects of Music Interventions on Hospitalised People With Dementia|Evaluating the Effects of Music Interventions on Hospitalised People With Dementia|Unknown status|Not yet recruiting|Phase 2/Phase 3|180||National Ageing Research Institute, Australia|||||f||||f||||||||||2017-02-18 15:46:42.580906|2017-02-18 15:46:42.580906
NCT00448305|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2012-01-03|||January 2007||2007-01-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|February 2010|Actual|2010-02-01||Interventional|||EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients|An Open-label, Randomized, Controlled Phase-II Trial Evaluating the Efficacy and Safety of EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients|Completed||Phase 2|143|Actual|MediGene||3|||f||||t||||||||||2017-02-18 15:46:42.676437|2017-02-18 15:46:42.676437
NCT00448292|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-11-09|||March 2007||2007-03-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of PRX-00023 in Patients With Major Depressive Disorder.|Completed||Phase 2|330|Anticipated|Epix Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 15:46:42.819364|2017-02-18 15:46:42.819364
NCT00448279|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2014-10-21|2014-10-21||April 2007||2007-04-01|October 2014|2014-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||Intent-to-treat (ITT) population: all randomized participants.|THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.|A Randomized, Open-label Study to Compare Progression-free Survival in Patients With HER2 Positive Metastatic Breast Cancer Who Continue or Discontinue Herceptin in Combination With 2nd Line Chemotherapy, Having Progressed on 1st Line Chemotherapy in Combination With Herceptin|Completed||Phase 3|58|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:46:42.939738|2017-02-18 15:46:42.939738
NCT00448266|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2010-10-25|||May 2007||2007-05-01|October 2010|2010-10-01||||February 2010|Actual|2010-02-01||Interventional|||Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD|Randomized Phase II/III Study of Intensified Alkylating Agent Chemotherapy With Peripheral Blood Progenitor Cell Support in the Preoperative Chemotherapy of Breast Tumors That Are Deficient for Homologous Recombination.|Terminated||Phase 2/Phase 3|237|Anticipated|The Netherlands Cancer Institute||2||Activation of a similar multicenter study for same population|f||||f||||||||||2017-02-18 15:46:43.439146|2017-02-18 15:46:43.439146
NCT00448253|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2011-03-25|||July 2007||2007-07-01|March 2011|2011-03-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum|Safety and Pharmacokinetics of Anthrax Immune Globulin Intravenous (Human), NP-015, in Healthy Volunteers.|Completed||Phase 1|92|Actual|Cangene Corporation||2|||f||||t||||||||||2017-02-18 15:46:43.666791|2017-02-18 15:46:43.666791
NCT00448240|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2010-02-01|||February 2007||2007-02-01|January 2009|2009-01-01|January 2015|Anticipated|2015-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer|Erlotinib (Tarceva) Given Intermittently During First Line Standard Platinum Containing Chemotherapy for Advanced Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 2/Phase 3|6|Actual|Henry Ford Health System||1||Low Accrual, Funding|f||||f||||||||||2017-02-18 15:46:43.781667|2017-02-18 15:46:43.781667
NCT00448227|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-02-09|2010-11-12||October 2007||2007-10-01|February 2011|2011-02-01||||November 2008|Actual|2008-11-01||Interventional|||Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection|A Multicenter, Open-label, Single-arm Study to Evaluate the Single-dose Pharmacokinetics, Acceptability and Safety of Famciclovir Oral Pediatric Formulation in Infants 1 Month to Less Than 1 Year of Age With Herpes Simplex Virus Infections|Completed||Phase 2|18|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:46:43.883957|2017-02-18 15:46:43.883957
NCT00448214|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2011-12-15|||March 2007||2007-03-01|December 2011|2011-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation|Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation - A Double Blind, Parallel, Dose-finding Study in Comparison With Open Label Warfarin|Completed||Phase 2|448|Actual|Astellas Pharma Inc||4|||f||||t||||||||||2017-02-18 15:46:44.36774|2017-02-18 15:46:44.36774
NCT00448201|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2015-11-23|||November 2003||2003-11-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|December 2016|Anticipated|2016-12-01||Interventional|LCCC 0306||Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease|Allogeneic Hematopoietic Cell Transplantation for Patients With Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment With a More Intensive Therapeutic Regimen|Active, not recruiting||Phase 2|70|Anticipated|UNC Lineberger Comprehensive Cancer Center||4|||f||||t||||||||||2017-02-18 15:46:44.487967|2017-02-18 15:46:44.487967
NCT00012688|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||Periodontal Care and Glycemic Control in Diabetes|Periodontal Care and Glycemic Control in Diabetes|Completed||N/A|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:11.093916|2017-02-18 18:11:11.093916
NCT00448136|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-15|2015-01-20|2014-10-31||July 2007||2007-07-01|January 2015|2015-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional||Intent-to-treat (ITT) population: all participants who received at least 1 dose of treatment.|A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.|An Open Label Study to Evaluate the Effect of Avastin in Association With Chemotherapy on Progression-free Survival in Patients With Progressive Advanced/Metastatic Well-differentiated Digestive Endocrine Tumors of the Gastrointestinal Tract|Completed||Phase 2|83|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:46:45.58937|2017-02-18 15:46:45.58937
NCT00448123|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2016-10-11|2013-12-24||February 2007||2007-02-01|October 2016|2016-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients|The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients|Completed||N/A|127|Actual|William Beaumont Hospitals|Limitations of this study include non-consecutive enrollment and small sample size.|2|||f||||f||||||||No||2017-02-18 15:46:46.938123|2017-02-18 15:46:46.938123
NCT00448110|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2009-05-21|||May 2006||2006-05-01|May 2009|2009-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety of IV Diclofenac (DIC075V) for Pain After Abdominal or Pelvic Surgery|Randomized, Double-Blind, Active- and Placebo-Controlled Study of the Efficacy and Safety of Repeated Dosing of DIC075V Relative To Parenteral Ketorolac and Placebo in Patients With Acute Post-Op Pain After Abdominal or Pelvic Surgery|Completed||Phase 3|331|Actual|Javelin Pharmaceuticals||4|||f||||f||||||||||2017-02-18 15:46:47.32486|2017-02-18 15:46:47.32486
NCT00448097|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2016-03-15|||February 2007||2007-02-01|March 2016|2016-03-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy|A Randomized Study of Cetuximab or Cetuximab Plus Docetaxel Followed by Radical Prostatectomy for Patients With Adenocarcinoma of the Prostate|Terminated||Phase 2|7|Actual|The Methodist Hospital System||1||lack of patient population - slow accrual|f||||f||||||||No||2017-02-18 15:46:47.436006|2017-02-18 15:46:47.436006
NCT00448084|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2017-01-24|||March 8, 2007||2007-03-08|August 5, 2008|2008-08-05|August 5, 2008||2008-08-05|||||Observational|||Brain Activity in People With Functional Movement Disorders|BOLD-fMRI of the Perception of Volition in Functional Movement Disorders|Completed||N/A|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:46:47.550184|2017-02-18 15:46:47.550184
NCT00448071|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-03-14|||May 2006||2006-05-01|December 2006|2006-12-01|March 2007||2007-03-01|||||Interventional|||Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients|A Phase II, Randomized Double Blind Placebo-Controlled, Dose Escalating Study to Determine Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients|Unknown status|Recruiting|Phase 2|12||Wolfson Medical Center|||||f||||t||||||||||2017-02-18 15:46:47.638887|2017-02-18 15:46:47.638887
NCT00448058|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2014-10-02||2009-11-30|April 2007||2007-04-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study Of New Medicine (GSK 372475) For The Treatment Of Depression|A Ten-Week, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Flexible-Dose Study Evaluating the Efficacy, Safety, and Tolerability of GSK372475 (1.5 mg/Day to 2.0 mg/Day) or Extended Release Venlafaxine XR (150 mg/Day to 225 mg/Day) Compared to Placebo in Adult s|Completed||Phase 2|396|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 15:46:47.726365|2017-02-18 15:46:47.726365
NCT00448045|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2013-01-14|||June 2007||2007-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Preventing Pneumonia and Other Respiratory Problems in Persons With Spinal Cord Injury|Prevention of Long-Term Respiratory Complications of Spinal Cord Injury: a Randomized Controlled Trial|Completed||Phase 2|120|Actual|Kessler Foundation||2|||f||||t||||||||||2017-02-18 15:46:47.874799|2017-02-18 15:46:47.874799
NCT00448032|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-12-03|||November 2006||2006-11-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects|A Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Ppm-204 Administered Orally to Healthy Male Japanese Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:46:47.974068|2017-02-18 15:46:47.974068
NCT00448019|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2015-10-05|2015-07-13||February 2007||2007-02-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional||Two participants included in the study demographics were registered but withdrew prior to receiving treatment.|FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)|Fludarabine, Cyclophosphamide, Rituximab and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia|Completed||Phase 2|64|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:46:48.060567|2017-02-18 15:46:48.060567
NCT00448006|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-03-14|||April 2007||2007-04-01|March 2007|2007-03-01|December 2008||2008-12-01|||||Interventional|||Clinical Feasibility Study of Allium's Biliary Stent|A Clinical Feasibility Study to Evaluate the New Allium Biliary Stent, in Patients Suffering From “Malignant Biliary Duct Obstruction” (Endoscopic Insertion)|Unknown status|Not yet recruiting|N/A|30||Allium, Ltd.|||||f||||f||||||||||2017-02-18 15:46:48.331739|2017-02-18 15:46:48.331739
NCT00447993|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2016-11-15||2016-11-15|January 2007||2007-01-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa|A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants With Retinitis Pigmentosa Using Visual Acuity as the Primary Outcome|Completed||Phase 2|65|Actual|Neurotech Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:46:48.417562|2017-02-18 15:46:48.417562
NCT00447980|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2016-11-15||2016-11-15|January 2007||2007-01-01|November 2016|2016-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa|A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants With Retinitis Pigmentosa Using Visual Field Sensitivity as the Primary Outcome|Completed||Phase 2|68|Actual|Neurotech Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:46:48.534115|2017-02-18 15:46:48.534115
NCT00447109|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2007-03-13|||September 2003||2003-09-01|March 2007|2007-03-01|April 2004||2004-04-01|||||Interventional|||Time Interval for Changing Closed System Suction Catheters, Effect on Ventilator Associated Pneumonia|Endotracheal Suction With or Without Daily Changes of Closed System Suction. Effect on Ventilator Associated Pneumonia and Cost|Completed||N/A|344||Bayside Health|||||f||||f||||||||||2017-02-18 15:47:03.950569|2017-02-18 15:47:03.950569
NCT00447967|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2009-09-25|||July 2004||2004-07-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients|A Randomized Phase II Study of Irinotecan and Oxaliplatin Versus the Combination of 5-FU/LV and Oxaliplatin, as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer|Completed||Phase 2|110|Anticipated|Hellenic Oncology Research Group||2|||f||||f||||||||||2017-02-18 15:46:51.327607|2017-02-18 15:46:51.327607
NCT00447954|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2016-11-15||2016-11-15|January 2007||2007-01-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration|A Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Participants With Visual Acuity Impairment Associated With Atrophic Macular Degeneration|Completed||Phase 2|51|Actual|Neurotech Pharmaceuticals||3|||f||||t||||||||||2017-02-18 15:46:51.453224|2017-02-18 15:46:51.453224
NCT00447941|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2009-08-06|||June 2006||2006-06-01|August 2009|2009-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety, PK and PD Study in Healthy Male Japanese Subjects|Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Sca-136 Administered Orally to Healthy Male Japanese Subjects|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:46:51.567336|2017-02-18 15:46:51.567336
NCT00447928|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-03-13|||April 2007||2007-04-01|March 2007|2007-03-01|November 2007||2007-11-01|||||Interventional|||Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow|A Randomized, Double-Blind, Placebo-Controlled Phase II Dose-Ranging Study of the OrthoDerm Transdermal Nitroglycerin Patch for Patients With Chronic Lateral Epicondylitis|Unknown status|Not yet recruiting|Phase 2|164||Cure Therapeutics|||||f||||f||||||||||2017-02-18 15:46:51.635822|2017-02-18 15:46:51.635822
NCT00447915|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2012-07-31|||March 2007||2007-03-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis|Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis - Comparative Study With Sodium Risedronate Hydrate(RIS) With Vertebral Fracture as an Index -|Completed||Phase 3|1265|Actual|Chugai Pharmaceutical||3|||f||||f||||||||||2017-02-18 15:46:51.721999|2017-02-18 15:46:51.721999
NCT00447902|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2014-04-25|2009-09-25||March 2007||2007-03-01|April 2014|2014-04-01||||October 2008|Actual|2008-10-01||Interventional|||Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation|Safety and Antiviral Activity of TPV in Hepatitis C or Hepatitis B HIV Coinfected Patients - TDM Randomised Pilot Evaluation|Terminated||Phase 3|11|Actual|Boehringer Ingelheim|Due to an early termination of the trial no analysis has been performed for primary and secondary endpoints||||f||||||||||||||2017-02-18 15:46:51.834674|2017-02-18 15:46:51.834674
NCT00447889|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2008-11-25|||March 2006||2006-03-01|November 2008|2008-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography|A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR)|Completed||Phase 4|||Guerbet|||||f||||f||||||||||2017-02-18 15:46:52.744219|2017-02-18 15:46:52.744219
NCT00447876|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2009-10-20|||July 2005||2005-07-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis|Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport®) in the Treatment of Chronic Plantar Fasciitis|Completed||Phase 2/Phase 3|40|Actual|Ipsen||2|||f||||f||||||||||2017-02-18 15:46:52.823406|2017-02-18 15:46:52.823406
NCT00447863|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2010-08-21|||August 2007||2007-08-01|August 2010|2010-08-01|August 2007||2007-08-01|||||Interventional|||Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women|An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study to Compare Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg in 2 Dosage Forms With Different Dissolution Characteristics in Healthy, Cycling Women|Withdrawn||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:46:52.941944|2017-02-18 15:46:52.941944
NCT00447850|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2009-09-18|||April 2007||2007-04-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization|Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization|Completed||N/A|||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||||||||||||2017-02-18 15:46:53.017572|2017-02-18 15:46:53.017572
NCT00447837|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2008-03-13|||October 2006||2006-10-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis|A Phase 2, Double-Blind, Placebo-Controlled, Multi-Center, Randomized Study Evaluating the Safety and Efficacy of SPRC-AB01, Tobramycin Solution for Nasal Inhalation, in Post-Surgical Subjects With Chronic Sinusitis|Completed||Phase 2|180|Actual|Naryx Pharma||3|||f||||f||||||||||2017-02-18 15:46:53.107142|2017-02-18 15:46:53.107142
NCT00447824|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-03-13|||March 2007||2007-03-01|March 2007|2007-03-01|November 2009||2009-11-01|||||Interventional|||Pain Detection and Interception in Neonates|Pain Detection and Interception in Neonates During Blood Sampling|Unknown status|Recruiting|N/A|160||Sorlandet Hospital HF|||||f||||t||||||||||2017-02-18 15:46:53.23811|2017-02-18 15:46:53.23811
NCT00447811|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2011-07-22|||March 2007||2007-03-01|July 2011|2011-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance|Two Ascending Single Doses Crossover, Placebo Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MOA-728 Administered Orally to Subjects on Stable Methadone Maintenance|Completed||Phase 1|||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 15:46:53.32985|2017-02-18 15:46:53.32985
NCT00447668|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2011-11-07|||March 2007||2007-03-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2009|Actual|2009-08-01||Interventional|YES||Effect of Yoga Vs. Stretching on Chronic Back Pain|Effect of Yoga Vs. Stretching on Chronic Back Pain|Completed||Phase 2|210|Anticipated|Group Health Cooperative||3|||f||||t||||||||||2017-02-18 15:46:53.415653|2017-02-18 15:46:53.415653
NCT00447655|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2009-02-03|||March 2007||2007-03-01|February 2009|2009-02-01|August 2009|Anticipated|2009-08-01|||||Interventional|PALS-PLUS||Improving Outcomes Following Limb Loss: PALS Plus|Improving Outcomes Following Limb Loss: PALS Plus|Unknown status|Not yet recruiting|Phase 1/Phase 2|400|Anticipated|Johns Hopkins University|||||f||||t||||||||||2017-02-18 15:46:53.554196|2017-02-18 15:46:53.554196
NCT00447642|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2012-10-09|||April 2007||2007-04-01|October 2012|2012-10-01|January 2010|Actual|2010-01-01|August 2008|Actual|2008-08-01||Interventional|||Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty|A Multi-center, Placebo-Controlled, Randomized, Parallel-Group, Dose-Ranging Study to Assess the Efficacy and Safety of LX201 Implantation for the Prevention of Corneal Allograft Rejection Episodes or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty|Terminated||Phase 3|122|Actual|Lux Biosciences, Inc.||3||The primary efficacy endpoint was not met|f||||t||||||||||2017-02-18 15:46:53.644258|2017-02-18 15:46:53.644258
NCT00447629|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2007-12-03|||January 2007||2007-01-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart|A Randomized, Double-Blind, Placebo- and Moxifloxacin (Open-Label)- Controlled, 4-Period Crossover Study of the Effects of Single Oral Doses of PPM 204 on Cardiac Repolarization in Healthy Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:46:54.02177|2017-02-18 15:46:54.02177
NCT00447616|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2017-02-05|||October 2003||2003-10-01|February 2017|2017-02-01|October 2029|Anticipated|2029-10-01|October 2029|Anticipated|2029-10-01||Observational|||Prostatectomy Prospective Database|Prostatectomy Database|Terminated||N/A|896|Actual|William Beaumont Hospitals|||1|Lack of funding|f||||f||||||||No||2017-02-18 15:46:54.110119|2017-02-18 15:46:54.110119
NCT00447603|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2015-03-25|2014-01-23||May 2007||2007-05-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional||All enrolled population which included all participants who provided consent and entered screening period of study.|A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)|A Randomized, Double-Blind, Active Comparator Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan/HCTZ Combination as Compared to Losartan Monotherapy in Pediatric Patients With Essential Hypertension|Terminated||Phase 3|40|Actual|Merck Sharp & Dohme Corp.|The study was discontinued early (during screening) due to limited availability of sites and readiness of sites to enroll participants within the predefined time.|4||Achieving site readiness and enrolling the trial within a reasonable time|f||||f||||||||||2017-02-18 15:46:54.202216|2017-02-18 15:46:54.202216
NCT00447590|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-14|2014-09-22|2014-09-16||March 2007||2007-03-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|January 2009|Actual|2009-01-01||Interventional||The baseline population consisted of all subjects who were implanted with the LAP-BAND System.|Effectiveness and Safety Study of LAP-BAND Treatment for Obese Adolescents||Completed||N/A|153|Actual|Apollo Endosurgery, Inc.||1|||f||||||||||||||2017-02-18 15:46:54.566067|2017-02-18 15:46:54.566067
NCT00447577|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2011-12-07|||January 2007||2007-01-01|December 2011|2011-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Zylet vs TobraDex in Blepharokeratoconjunctivitis|A Clinical Safety and Efficacy Evaluation of Zylet (Loteprednol Etabonate and Tobramycin Ophthalmic Suspension) vs. Tobradex (Tobramycin and Dexamethasone Ophthalmic Suspension) in the Treatment of Blepharokeratoconjunctivitis|Completed||Phase 4|276|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 15:46:54.97243|2017-02-18 15:46:54.97243
NCT00447564|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2012-10-18||2011-01-05|October 2006||2006-10-01|October 2012|2012-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Probuphine in Patients With Opioid Dependence|Completed||Phase 3|163|Actual|Titan Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:46:55.082616|2017-02-18 15:46:55.082616
NCT00447551|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2009-11-12|||January 2007||2007-01-01|November 2009|2009-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Canadian Aesthetic Experience With Sculptra Therapy|Canadian Study of the Use of Injectable POLY-L-LACTIC Acid (Sculptra Therapy) in Aesthetic Medicine|Completed||Phase 4|76|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:46:55.227909|2017-02-18 15:46:55.227909
NCT00447538|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2013-04-29|||November 2005||2005-11-01|April 2013|2013-04-01|January 2007||2007-01-01|||||Observational|||Posttraumatic Symptoms Among Toddlers and Their Parents Following Exposure to Terrorism|Identifying Distress, Developmental and Behavioral Problems Among Toddlers, and Posttraumatic Distress Among Their Parents Following Continuous Exposure to Terrorism|Completed||Phase 4|300||Herzog Hospital|||||f||||t||||||||||2017-02-18 15:46:55.326993|2017-02-18 15:46:55.326993
NCT00447525|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2009-04-03|||February 2007||2007-02-01|April 2009|2009-04-01|January 2008|Actual|2008-01-01|||||Interventional|||REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children|Comparison of the Immunogenicity and Safety of a Combined Adsorbed Low Dose Diphtheria, Tetanus and Inactivated Poliomyelitis Vaccine (REVAXIS®) With a Combined Diphtheria, Tetanus and Inactivated Poliomyelitis Vaccine (DT Polio®) When Given as a Booster Dose at 6 Years of Age|Completed||Phase 3|734|Anticipated|MCM Vaccines B.V.||2|||f||||||||||||||2017-02-18 15:46:55.413929|2017-02-18 15:46:55.413929
NCT00447512|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-10-29|||March 2004||2004-03-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of Hormones|Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of Hormones|Completed||N/A|80|Anticipated|Max-Planck-Institute of Psychiatry||1|||f||||f||||||||||2017-02-18 15:46:55.582898|2017-02-18 15:46:55.582898
NCT00447499|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2012-06-18|2010-03-23||April 2007||2007-04-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|SALSA||Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel|A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel|Completed||Phase 3|59|Actual|Ipsen||1|||f||||||||||||||2017-02-18 15:46:55.678653|2017-02-18 15:46:55.678653
NCT00447486|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2009-05-15|||April 2007||2007-04-01|May 2009|2009-05-01||||||||Interventional|||A Study of GW842166 in Adults With Osteoarthritis Pain|A Multicentre, Randomised, Double-Blind, Placebo and Naproxen (500mg) BID Controlled, Phase II Proof of Concept, Parallel Group Study to Assess the Efficacy and Safety of Oral GW842166 at Two Dose Levels Administered for 4 Weeks in Adults With Osteoarthritis of the Knee|Completed||Phase 2|308|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:46:56.426088|2017-02-18 15:46:56.426088
NCT00447473|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2016-03-15|||July 2006||2006-07-01|March 2016|2016-03-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer|Phase II Trial to Assess the Activity of Ketoconazole and Mitoxantrone Plus GM-CSF in Patients With Progressive Hormone Refractory Prostate Cancer|Terminated||Phase 2|31|Actual|The Methodist Hospital System||1||PI decision|f||||f||||||||No||2017-02-18 15:46:56.538023|2017-02-18 15:46:56.538023
NCT00447460|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-03-20|||January 2007||2007-01-01|March 2007|2007-03-01|August 2009|Anticipated|2009-08-01|||||Interventional|||Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell|A Phase I/II Trial in Treating Patients With Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell|Unknown status|Recruiting|Phase 1/Phase 2|15||University of Salamanca|||||f||||t||||||||||2017-02-18 15:46:56.664507|2017-02-18 15:46:56.664507
NCT00447434|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-03-13|||June 2005||2005-06-01|March 2007|2007-03-01|October 2005||2005-10-01|||||Interventional|||Efficacy and Safety of Natto Extract|An Open-Label, Parallel Comparison Study to Evaluate the Effect of Oral Administration of Nattokinase Taken by Normal Subjects, Patients Under Dialysis, and Patients of Cardiovascular High Risk Groups|Completed||Phase 4|45||Changhua Christian Hospital|||||f||||f||||||||||2017-02-18 15:46:56.767608|2017-02-18 15:46:56.767608
NCT00447421|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2009-10-24|2009-05-28||February 2007||2007-02-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy|Phase I/II Study of Concurrent Cisplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|9|Actual|Eli Lilly and Company|The Study Phase 1 was stopped early based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in extensive small cell lung cancer. The Study did not progress to Phase 2.|1||Interim results of another trial showed inferior activity of treatment|f||||f||||||||||2017-02-18 15:46:56.871403|2017-02-18 15:46:56.871403
NCT00447408|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2010-06-24|||January 2007||2007-01-01|June 2010|2010-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|BalanceWise-HD||Impact of a Personal Digital Assistant (PDA) - Based Dietary Adherence Intervention on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients|Impact of a PDA-Based Dietary Adherence Intervention on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients|Completed||N/A|22|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:46:57.270079|2017-02-18 15:46:57.270079
NCT00447395|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2015-10-21|||February 2007||2007-02-01|October 2015|2015-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Genetic Abnormalities and Oxidative Stress in Sperm as Cause of Recurrent Miscarriage.|Genetic Abnormalities and Oxidative Stress in Sperm as Cause of Recurrent Miscarriage.|Completed||N/A|90|Actual|Instituto Valenciano de Infertilidad, IVI VALENCIA|||4||f||||f||||||||||2017-02-18 15:46:57.378033|2017-02-18 15:46:57.378033
NCT00447382|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2014-10-08|2010-11-24||March 2007||2007-03-01|October 2014|2014-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes|A 12-months Multi-national, Multi-centre, Double Blind, Randomised, Parallel Safety and Efficacy Comparison of Insulin Detemir Produced by the Current Process and Insulin Detemir Produced by the NN729 Process in Subjects With Type 1 Diabetes on a Basal-bolus Regimen With Insulin Aspart as the Bolus Insulin|Completed||Phase 3|330|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 15:46:57.483237|2017-02-18 15:46:57.483237
NCT00447369|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2008-05-06|||May 2007||2007-05-01|May 2008|2008-05-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Efficacy of Pregabalin in Migraine Prevention||Withdrawn||Phase 3|70|Anticipated|Hospital Militar del General Luis Felipe Brieba Aran||||Because we did not find funds to do it|f||||t||||||||||2017-02-18 15:46:58.701995|2017-02-18 15:46:58.701995
NCT00447356|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2013-05-09|||January 2000||2000-01-01|May 2013|2013-05-01||||||||Interventional|||High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma|Phase III Randomized Study of Four Weeks High Dose IFN-2b in StageT3-T4 or N1 (Microscopic) Melanoma|Withdrawn||Phase 3|0|Actual|Hackensack University Medical Center||||There were no patient enrolled in this study at this site|f||||t||||||||||2017-02-18 15:46:58.812406|2017-02-18 15:46:58.812406
NCT00447343|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2010-06-02|||September 2008||2008-09-01|June 2010|2010-06-01|August 2012|Anticipated|2012-08-01|January 2011|Anticipated|2011-01-01||Observational|||Reorganization of Brain Functions in Patients With Cervical Myelopathy Using fMRI and MRS|Mapping of the Sensorimotor Cortex in Cervical Myelopathy Using Functional Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy|Unknown status|Recruiting|N/A|35|Anticipated|Lawson Health Research Institute|||2||f||||f||||||||||2017-02-18 15:46:58.898778|2017-02-18 15:46:58.898778
NCT00447330|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2015-01-28|2015-01-20||February 2007||2007-02-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|XAGastric|Number of subjects receiving study drug|Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma|A Phase ll Study of Oxaliplatin, Capecitabine, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas|Completed||Phase 2|60|Actual|Duke University||1|||f||||t||||||||||2017-02-18 15:46:59.011167|2017-02-18 15:46:59.011167
NCT00447317|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2010-05-14|||November 2007||2007-11-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|BalanceWise-PD||Dietary Adherence Enhancement in Peritoneal Dialysis: BalanceWise-PD|Dietary Adherence Enhancement in Peritoneal Dialysis|Completed||N/A|60|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:46:59.637529|2017-02-18 15:46:59.637529
NCT00447304|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2012-07-20|||October 2006||2006-10-01|March 2007|2007-03-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|ACDC||Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy|Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy = ACDC-study|Completed||Phase 3|644|Anticipated|Heidelberg University|||||f||||t||||||||||2017-02-18 15:46:59.736825|2017-02-18 15:46:59.736825
NCT00447291|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2011-01-26|||December 2006||2006-12-01|September 2006|2006-09-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||Safety & Efficacy of Omega-3 Fish Oil in Overweight Children & Adolescents|Evaluation of the Safety and Efficacy of Omega-3 Fish Oil Dietary Supplementation in Biometric Measurement, Lipid Profile, Serum Markers for Inflammation, and Insulin Resistance in Overweight Children and Adolescents|Terminated||Phase 3|60|Actual|Children's Heart Center||1||Zone Labs, Inc discontinue utilizing their fish oil supplement and frozen foods|f||||f||||||||||2017-02-18 15:46:59.833538|2017-02-18 15:46:59.833538
NCT00447096|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2016-06-08|||February 2007||2007-02-01|June 2016|2016-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|rTMS||rTMS for Treatment of Depressed Phase of Bipolar Disorder Type II|rTMS (Repetitive Transcranial Magnetic Stimulation) for Acute Treatment of Depressed Phase of Bipolar Disorder Type II|Withdrawn||Phase 2|0|Actual|University of Texas Southwestern Medical Center||2||No results, funding terminated and PI no longer at institution|f||||f||||||||||2017-02-18 15:47:04.041982|2017-02-18 15:47:04.041982
NCT00447278|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2010-04-22|2010-02-24||March 2007||2007-03-01|April 2010|2010-04-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|ADHD LIFE||A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents|A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning Using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactivity Disorder in Treatment-Naïve Children and Adolescents|Completed||Phase 3|399|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:46:59.941157|2017-02-18 15:46:59.941157
NCT00447265|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2013-02-06|2011-10-07||February 2008||2008-02-01|February 2013|2013-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Etanercept for the Treatment of Lupus Nephritis|A Randomized, Double-Blind, Placebo-Controlled, Phase II, Multi-Center Study for Treatment of Lupus Nephritis by Inhibition of Tumor Necrosis Factor-alpha Using Etanercept|Terminated||Phase 2|1|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The study terminated early with 1 subject enrolled. Based on safety info from other trials, the protocol chairs decided possible risks to patients outweighed the potential benefits. Analysis of groups is not possible. Study objectives cannot be met.|2||The perceived risk-benefit ratio for individuals with early active RA|f||||||||||||||2017-02-18 15:47:01.798958|2017-02-18 15:47:01.798958
NCT00447252|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-03-13|||January 2007||2007-01-01|March 2007|2007-03-01||||||||Observational|NABF||Needs Assessment for Bereaved Families|Needs Assessment for Bereaved Families|Unknown status|Recruiting|Phase 1|100||Herzog Hospital|||||f||||t||||||||||2017-02-18 15:47:02.176644|2017-02-18 15:47:02.176644
NCT00447239|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2008-10-23|||September 2004||2004-09-01|March 2007|2007-03-01|July 2006||2006-07-01|||||Interventional|||The Effect of Intensive Insulin Therapy|The Effect of Intensive Insulin Therapy on the Incidence of Ventilator-Associated Pneumonia in Surgical Critically Ill Patients|Completed||N/A|117||University Medical Centre Ljubljana|||||t||||t||||||||||2017-02-18 15:47:02.253403|2017-02-18 15:47:02.253403
NCT00447226|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2012-06-07|2010-01-11||May 2007||2007-05-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|||Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists|A Phase II, Placebo Controlled, Double-Blind, Randomized, Discontinuation Study of Lapatinib Administered Orally to Subjects With ErbB2 Positive Ovarian, Gastric/Esophageal Adenocarcinoma, Uterine Serous Papillary, or Bladder Cancer|Terminated||Phase 2|32|Actual|GlaxoSmithKline|Study terminated prematurely: preliminary assessment (prompted by low screening/enrollment rates) showed primary objective of tumor response rate not met. Also unable to test primary treatment comparison after randomization following SD at 12 wks.|2||"The study had failed to meet the primary objective of tumor response rate at 12 weeks from~   first dose."|f||||f||||||||||2017-02-18 15:47:02.350029|2017-02-18 15:47:02.350029
NCT00447213|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2010-10-12|||April 2007||2007-04-01|October 2010|2010-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study for Patients With Type 1 Diabetes Mellitus|A Crossover Study to Evaluate the Efficacy and Safety of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus|Completed||Phase 2/Phase 3|70|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:47:02.989316|2017-02-18 15:47:02.989316
NCT00447200|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-10-12|||March 2007||2007-03-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Observational|||Study of the Natural Variation in Strokevolume|Study of the Natural Variation in Strokevolume, and Investigation in the Number of Cycles Necessary to Find a 10% Strokevolume Variation Using Esophageal Doppler|Completed||N/A|20|Actual|Rigshospitalet, Denmark|||||f||||f||||||||||2017-02-18 15:47:03.106183|2017-02-18 15:47:03.106183
NCT00447187|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2012-10-09|||April 2007||2007-04-01|October 2012|2012-10-01|November 2010|Actual|2010-11-01|March 2009|Actual|2009-03-01||Interventional|||Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk|A Multi-center, Placebo-Controlled, Randomized, Parallel Group, Dose-Ranging Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure Following Penetrating Keratoplasty With LX201 Implantation in Subjects Who Are at Increased Immunological Risk|Terminated||Phase 3|368|Actual|Lux Biosciences, Inc.||3||The primary efficacy endpoint was not met|f||||t||||||||||2017-02-18 15:47:03.194833|2017-02-18 15:47:03.194833
NCT00447174|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2016-11-02|||January 2007||2007-01-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Interventional|PBS||Parental Bereavement Study Among Couples Coping Traumatic Loss of a Child|Dyadic Therapy Assessment Among Couples Coping With Traumatic Loss of a Child|Completed||N/A|64|Actual|Herzog Hospital||2|||f||||t||||||||||2017-02-18 15:47:03.33289|2017-02-18 15:47:03.33289
NCT00447161|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2008-09-04|||July 2006||2006-07-01|September 2008|2008-09-01||||October 2007|Actual|2007-10-01||Interventional|PADRE||Preventing Antibiotic-Associated DiarRhea Using Erceflora|Bacillus Clausii in Preventing Antibiotic-Associated Diarrhea Among Filipino Infant and Children: A Multi-Center, Randomized, Open-Label Controlled (Treatment vs No Treatment) Clinical Trial of Efficacy and Safety|Completed||Phase 4|323|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:47:03.434228|2017-02-18 15:47:03.434228
NCT00447148|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-13|2007-10-29|||October 2006||2006-10-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|3-DCA||Standard vs. 3-Dimensional Coronary Angiography: a Paired Comparison|"Standard vs. 3-Dimensional Coronary Angiography: a Paired Comparison Using Intra-Coronary Marker Wires as Matched-Comparison Gold Standard"|Completed||Phase 4|36|Actual|Antwerp Cardiovascular Institute Middelheim||1|||f||||f||||||||||2017-02-18 15:47:03.532737|2017-02-18 15:47:03.532737
NCT00447135|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2008-01-28|||March 2005||2005-03-01|January 2008|2008-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Immunologic Function in the Elderly After Injury|Immunologic Function in the Elderly After Injury: the Polymorphonuclear Leukocyte (PMN) and Innate Immunity|Completed||N/A|55|Actual|Summa Health System|||1||f||||f||||||||||2017-02-18 15:47:03.631624|2017-02-18 15:47:03.631624
NCT00447122|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2014-04-17|2013-05-21||March 2007||2007-03-01|April 2014|2014-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer|BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer: A Phase II Study #108181|Terminated||Phase 2|31|Actual|Brown University||1|||f||||t||||||||||2017-02-18 15:47:03.714039|2017-02-18 15:47:03.714039
NCT00345007|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2006-06-26|||June 2005||2005-06-01|May 2005|2005-05-01|October 2006||2006-10-01|||||Observational|||Macular Function After Scleral Buckle|Assessment of Recovery of Macula Function After Successful Scleral Buckling Surgery for Rhegmatogenous Retinal Detachment|Completed||N/A|27||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:26:35.237812|2017-02-18 16:26:35.237812
NCT00447070|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2009-05-26|||August 2004||2004-08-01|March 2007|2007-03-01|May 2006||2006-05-01|||||Interventional|ENDOPACT||Effect of Atazanavir on Endothelial Function in HIV-Infected Patients|Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy|Completed||Phase 4|50||Foundation for Cardiovascular Research, Zurich|||||f||||f||||||||||2017-02-18 15:47:04.247786|2017-02-18 15:47:04.247786
NCT00447057|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2011-09-12|2011-06-17||March 2007||2007-03-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|||Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC)|A Phase 2 Study of Pemetrexed Versus Pemetrexed Plus Erlotinib in Second-Line Treatment in Patients With Nonsquamous NSCLC|Completed||Phase 2|204|Actual|Eli Lilly and Company|Baseline Characteristics are presented by histology (nonsquamous/squamous) for each arm. Per the protocol amendment of August 2008, study entry criteria were changed to exclude participants with predominantly squamous cell histology.|4|||f||||f||||||||||2017-02-18 15:47:04.357065|2017-02-18 15:47:04.357065
NCT00447044|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2009-06-17|||January 2007||2007-01-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Combined Effects of Nutritional and Exercise Countermeasures|Combined Effects of Nutritional and Exercise Countermeasures|Completed||N/A|31|Actual|University of Arkansas||3|||f||||||||||||||2017-02-18 15:47:06.284739|2017-02-18 15:47:06.284739
NCT00447031|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2010-02-05|||March 2007||2007-03-01|March 2009|2009-03-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Combination Therapy for Neovascular Age Related Macular Degeneration|Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone Acetonide Injection Versus Intravitreal Bevacizumab for Age Related Macular Degeneration|Withdrawn||N/A|0|Actual|Yonsei University||1||Insufficient patients who met inclusion criteria|f||||f||||||||||2017-02-18 15:47:06.396288|2017-02-18 15:47:06.396288
NCT00447018|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2007-03-12|||October 2002||2002-10-01|March 2007|2007-03-01|June 2005||2005-06-01|||||Interventional|||Mannitol Versus Hypertonic Saline Solution in the Treatment of Elevated Intracranial Pressure|Equimolar Doses of Mannitol and Hypertonic Saline in the Treatment of Elevated Intracranial Pressure|Completed||Phase 4|20||University Hospital, Grenoble|||||f||||f||||||||||2017-02-18 15:47:06.495938|2017-02-18 15:47:06.495938
NCT00447005|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2012-05-17|2012-02-25||February 2007||2007-02-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors|A Phase 1 Study Of AG-013736 (Axitinib) In Japanese Patients With Advanced Solid Tumors|Completed||Phase 1|12|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 15:47:06.610214|2017-02-18 15:47:06.610214
NCT00446992|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2014-11-06|2014-10-22||April 2006||2006-04-01|November 2014|2014-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Diabetes in Neuropsychiatric Disorders|Metabolic Effects of Olanzapine in Patients With Newly Diagnosed Psychosis|Completed||Phase 1/Phase 2|30|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|The most important limitations in our study were sample size and duration. With a larger sample, some of these measures may have a significant change within this time frame.|1|||f||||t||||||||||2017-02-18 15:47:07.029349|2017-02-18 15:47:07.029349
NCT00446979|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2013-04-18|||June 2007||2007-06-01|April 2013|2013-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety Study of UC-781 Vaginal Microbicide|Phase I Study of the Safety and Acceptability of UC-781 Topical Vaginal Microbicide in Women and Acceptability in Their Male Partners,Chiang Rai, Thailand|Completed||Phase 1|90|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-02-18 15:47:07.832425|2017-02-18 15:47:07.832425
NCT00446966|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2010-05-10|||February 2007||2007-02-01|February 2007|2007-02-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|FISH||Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery|Fish Oil to Inhibit Supraventricular Arrhythmias After Cardiac Surgery: The Fish Trial|Completed||Phase 4|260|Actual|University of Iowa||1|||f||||t||||||||||2017-02-18 15:47:07.954566|2017-02-18 15:47:07.954566
NCT00446953|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2015-10-13|||February 2007||2007-02-01|September 2013|2013-09-01|November 2013|Actual|2013-11-01|October 2013|Actual|2013-10-01||Interventional|||Caesarean and Corticotherapy|Interest in Programming Caesarean Section at 38 Weeks of Pregnancy With Antenatal Betamethasone to Prevent Neonatal Respiratory Distress and to Avoid Emergency Caesarean Section Before Planned Date.|Completed||Phase 4|200|Actual|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 15:47:08.068221|2017-02-18 15:47:08.068221
NCT00446940|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-11|2008-09-08|||December 2006||2006-12-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C|Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C|Completed||Phase 2|16|Anticipated|Bader, Ted, M.D.|||||f||||f||||||||||2017-02-18 15:47:08.183803|2017-02-18 15:47:08.183803
NCT00446927|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2012-05-22|||April 2007||2007-04-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||SPY Imaging System: Its Role in Pediatric Cardiac Surgery|SPY Imaging System: Its Role in Pediatric Cardiac Surgery|Completed||N/A|40|Actual|Emory University|||1||f||||f||||||||||2017-02-18 15:47:08.282221|2017-02-18 15:47:08.282221
NCT00446914|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2008-08-18|||January 2007||2007-01-01|August 2008|2008-08-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||High Blood Pressure Strategy (HBPS)|High Blood Pressure Strategy: Hypertension Management Initiative Study|Unknown status|Recruiting|N/A|5000|Anticipated|Heart and Stroke Foundation of Ontario|||||f||||||||||||||2017-02-18 15:47:08.390191|2017-02-18 15:47:08.390191
NCT00446901|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2011-03-11|||June 2007||2007-06-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|SePros||Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression|Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression|Completed||N/A|60|Anticipated|Wageningen University||2|||f||||f||||||||||2017-02-18 15:47:08.498328|2017-02-18 15:47:08.498328
NCT00446888|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2009-06-17|||January 2007||2007-01-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients|Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients|Completed||N/A|35|Actual|University of Arkansas||2|||f||||||||||||||2017-02-18 15:47:08.638082|2017-02-18 15:47:08.638082
NCT00446875|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2007-03-09|||January 2007||2007-01-01|March 2007|2007-03-01||||||||Interventional|||Analgesic Properties of Oral Sucrose During Immunizations|Efficacy of Oral Sucrose and Maternal Contact During Routine Immunizations in Postnatal Infants|Unknown status|Recruiting|N/A|141||Penn State University|||||f||||t||||||||||2017-02-18 15:47:08.763614|2017-02-18 15:47:08.763614
NCT00446862|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-11|2013-11-17|||March 2007||2007-03-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Observational|FAACET||The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study|Multi-center, Open-label Study of the Safety and Efficacy of Control of Proteinuria With ACE Inhibitors and ARBS in Patients With Fabry Disease Who Are Receiving Fabrazyme®: The FAACET Study|Completed||N/A|36|Actual|University of Alabama at Birmingham|||1||f||||t||||||||||2017-02-18 15:47:08.857922|2017-02-18 15:47:08.857922
NCT00446849|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2011-10-19|2010-04-09||May 2007||2007-05-01|October 2011|2011-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)|A Phase IV, Multi-center, Open-label Study to Assess Clinical Recurrence Related to Compliance With Treatment With MMX Mesalamine 2.4g/Day Given Once Daily for the Maintenance of Quiescent Ulcerative Colitis (UC)|Completed||Phase 4|290|Actual|Shire||1|||f||||||||||||||2017-02-18 15:47:08.993707|2017-02-18 15:47:08.993707
NCT00446836|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2016-03-15|||March 2005||2005-03-01|March 2016|2016-03-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety Study of Xyotax to Treat Prostate Cancer|Phase II Study of Xyotax in Advanced Hormone Refractory Prostate Cancer|Completed||Phase 2|29|Actual|The Methodist Hospital System||1|||f||||f||||||||No||2017-02-18 15:47:09.462567|2017-02-18 15:47:09.462567
NCT00446823|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2007-03-12|||June 2002||2002-06-01|March 2007|2007-03-01|December 2003||2003-12-01|||||Interventional|XCell||Effectiveness of XCell on Autolytic Debridement of Venous Ulcers|A Prospective, Randomized, Controlled Clinical Study to Evaluate the Effectiveness of a Cellulose Matrix Wound Dressing for Autolytic Debridement and Healing of Chronic Venous Ulcers|Completed||N/A|50||Xylos Corporation|||||f||||f||||||||||2017-02-18 15:47:09.584035|2017-02-18 15:47:09.584035
NCT00446810|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2007-09-25|||September 2007||2007-09-01|September 2007|2007-09-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus|Effects of a Chronical Treatment With Benfotiamine in People With Type 2 Diabetes Mellitus on Pre- and Postprandial Endothelial Function, as Well as on the Function of the Autonomic Nervous System|Unknown status|Recruiting|Phase 4|30|Anticipated|Ruhr University of Bochum||2|||f||||t||||||||||2017-02-18 15:47:09.691046|2017-02-18 15:47:09.691046
NCT00446797|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2009-06-12|2009-04-21||May 2007||2007-05-01|June 2009|2009-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain|An Open Label Randomized Multicenter Comparative Study On Celecoxib Efficacy And Safety Versus Non-Selective NSAID In Acute Pain Due To Ankle Sprain|Completed||Phase 4|278|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:47:09.836805|2017-02-18 15:47:09.836805
NCT00446784|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2011-05-19|||April 2007||2007-04-01|May 2011|2011-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis|A Phase 1, Double Blind Study Of The Safety And Pharmacokinetics Of Multiple Doses Of CE 224,535 In Subjects With Rheumatoid Arthritis Receiving Methotrexate|Completed||Phase 1|20||Pfizer|||||f||||||||||||||2017-02-18 15:47:10.934288|2017-02-18 15:47:10.934288
NCT00446771|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2007-03-12|||October 2006||2006-10-01|March 2007|2007-03-01|November 2006||2006-11-01|||||Interventional|||A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects||Completed||Phase 1|18||Pharmaxis|||||f||||||||||||||2017-02-18 15:47:11.03201|2017-02-18 15:47:11.03201
NCT00446758|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2012-09-13|||March 2008||2008-03-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Trial of Zinc and HIV Progression in Children|Trial of Zinc and HIV Progression in Children|Completed||Phase 3|440|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-02-18 15:47:11.109242|2017-02-18 15:47:11.109242
NCT00446745|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2012-09-18|||April 2006||2006-04-01|September 2012|2012-09-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Observational|Mithycal||Abdominal Adiposity and Muscle Mitochondrial Functions|Study of Interaction Between Adipose and Muscle Tissues in the Control of Muscle Mitochondrial Functions|Completed||N/A|60|Actual|Institut National de la Recherche Agronomique|||1||f||||f||||||||||2017-02-18 15:47:11.229971|2017-02-18 15:47:11.229971
NCT00446732|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-11|2009-03-24|||March 2007||2007-03-01|March 2009|2009-03-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Interventional|CAUTI||The Use of the UroShield Device in Patients With Indwelling Urinary Catheters|Catheter Associated Urinary Tract Infections|Unknown status|Recruiting|Phase 2/Phase 3|200|Anticipated|Nanovibronix||2|||f||||t||||||||||2017-02-18 15:47:11.352861|2017-02-18 15:47:11.352861
NCT00446719|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2011-01-04|||August 2007||2007-08-01|January 2011|2011-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder|An Open-Label Pilot Study Evaluating the Safety and Antidepressant Effects of Rellidep (BI= Biological Isolate) in Major Depressive Disorder|Completed||Phase 2/Phase 3|23|Actual|Mount Sinai Hospital, Canada||1|||f||||f||||||||||2017-02-18 15:47:11.462442|2017-02-18 15:47:11.462442
NCT00446706|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2015-11-10|||January 2004||2004-01-01|November 2015|2015-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Estimation of Intrinsic Positive End-Expiratory Pressure (PEEP) in Acute Respiratory Distress Syndrome (ARDS)|Estimation of Intrinsic Positive End-Expiratory Pressure (PEEP) in Acute Respiratory Distress Syndrome (ARDS)|Completed||N/A|6|Actual|Texas Tech University Health Sciences Center, El Paso|||1||f||||f||||||||||2017-02-18 15:47:11.565628|2017-02-18 15:47:11.565628
NCT00446693|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2009-11-18|||February 2007||2007-02-01|November 2009|2009-11-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||Clinical Investigation to Evaluate Safety and Performance of the EndoFast Reliant™ System in Vaginal Wall Reinforcement|A Single Arm, Multi-center, Prospective Clinical Investigation to Evaluate Safety and Performance of the EndoFast Reliant™ System in Vaginal Wall Reinforcement|Completed||N/A|20|Actual|Endogun Medical Systems Ltd.||1|||f||||t||||||||||2017-02-18 15:47:11.661113|2017-02-18 15:47:11.661113
NCT00446680|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2010-06-23|||March 2007||2007-03-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study|Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study|Completed||Phase 3|340|Anticipated|Pharmaxis||2|||f||||t||||||||||2017-02-18 15:47:11.772932|2017-02-18 15:47:11.772932
NCT00344799|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2017-01-05|||April 2005||2005-04-01|January 2017|2017-01-01||||August 2017|Anticipated|2017-08-01||Observational|||Cytogenetic Study of Ocular Melanoma|Molecular and Cytogenetic Studies of Ocular Melanoma|Recruiting||N/A|200|Anticipated|Jonsson Comprehensive Cancer Center|||1||f||||||||||||||2017-02-18 16:26:41.870171|2017-02-18 16:26:41.870171
NCT00446667|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2016-09-26|||October 2006||2006-10-01|September 2016|2016-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD|A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD|Withdrawn||Phase 1/Phase 2|0|Actual|Pharmaxis||1||Failed to recruit|f||||f||||||||||2017-02-18 15:47:14.582479|2017-02-18 15:47:14.582479
NCT00446654|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2012-06-28|2012-05-29||April 2007||2007-04-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD|A Phase Ib Randomized Open Label Study Between Once-every-two-weeks and Once-every-four-weeks Treatment of CGC-11047 in Patients With CNV Due to Age Related Macular Degeneration|Completed||Phase 1|43|Actual|Progen Pharmaceuticals|Early termination leading to small numbers of subjects analyzed: 100 patients were planned; 43 patients were recruited.|2|||f||||f||||||||||2017-02-18 15:47:14.67942|2017-02-18 15:47:14.67942
NCT00446641|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2009-12-10|2009-01-22||March 2007||2007-03-01|November 2009|2009-11-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|ARCC||Overcome Biochemical Aspirin Resistance Through Cilostazol Combination|Phase 4 Study of Additional Cilostazol for Overcoming Biochemical Aspirin Resistance in the Chronic Stroke Patients|Completed||Phase 4|244|Actual|Asan Medical Center||2|||f||||f||||||||||2017-02-18 15:47:15.092431|2017-02-18 15:47:15.092431
NCT00446628|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2016-01-26|||January 2007||2007-01-01|January 2016|2016-01-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|PIPP||Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children|Pittsburgh Influenza Prevention Project|Completed||N/A|3360|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||No||2017-02-18 15:47:15.621516|2017-02-18 15:47:15.621516
NCT00446615|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2007-03-09|||March 2007||2007-03-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||Multifaceted Intervention to Improve Prescribing in Patients With Chronic Kidney Disease|Multifaceted Intervention to Improve Prescribing of Medications Requiring Dose Adjustment in Patients With Chronic Kidney Disease|Unknown status|Not yet recruiting|N/A|||McMaster University|||||f||||f||||||||||2017-02-18 15:47:15.795075|2017-02-18 15:47:15.795075
NCT00446602|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2016-09-19||||||June 2011|2011-06-01|August 2009|Anticipated|2009-08-01|||||Interventional|||A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)|A Phase 2, Randomized, Open-Label Study To Assess The Safety And Efficacy Of Weekly (QW) Or Once Every Two Week (Q2W) Dosing Of Epoetin Alfa (PROCRIT) in Anemic Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)|Withdrawn||Phase 2|0|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1||"Due to company decision to focus resources on a larger, controlled study in this patient~   population."|||||t||||||||||2017-02-18 15:47:16.060126|2017-02-18 15:47:16.060126
NCT00446589|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2014-10-28|||July 2006||2006-07-01|October 2014|2014-10-01||||||||Interventional|||The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density||Terminated||Phase 4|19|Actual|Papageorgiou General Hospital||2||due to financial problems|f||||||||||||||2017-02-18 15:47:16.152908|2017-02-18 15:47:16.152908
NCT00446576|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2011-01-31|||November 1999||1999-11-01|January 2011|2011-01-01|April 2003|Actual|2003-04-01|||||Interventional|||The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease|"A Study in Early Renal Insufficiency Patients to Assess the Effect of Maintaining Three Different Hemoglobin Levels With the Use of Erythropoetin Alpha on Left Ventricular Hypertrophy and Dilation and Quality if Life; The Cardiac Results of Early Treatment of Anaemia (CRETA) Study"|Completed||Phase 3|176|Actual|Janssen-Cilag B.V.|||||f||||||||||||||2017-02-18 15:47:16.251481|2017-02-18 15:47:16.251481
NCT00446563|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2011-05-06|2011-03-31||March 2007||2007-03-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy|An Open-label, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Amlodipine in Combination With Valsartan Compared to Losartan in Combination With Hydrochlorothiazide Given for 52 Weeks on the Regression of Left Ventricular Hypertrophy in Patients With Mild to Moderate Hypertension|Completed||Phase 3|90|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:47:16.348192|2017-02-18 15:47:16.348192
NCT00446550|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2011-05-12||2011-05-12|December 2007||2007-12-01|May 2011|2011-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study of Oral AT2101 in Treatment-naive Patients With Gaucher Disease|A Randomized, Open-label Study To Assess the Safety and Tolerability of AT2101 in Treatment-naive Adult Patients With Type I Gaucher Disease|Completed||Phase 2|19|Actual|Amicus Therapeutics||2|||f||||t||||||||||2017-02-18 15:47:16.969302|2017-02-18 15:47:16.969302
NCT00446537|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-11|2007-03-12||||||January 2007|2007-01-01||||||||Interventional|||Procedural Learning in Participants With ADHD||Unknown status|Not yet recruiting|Early Phase 1|||Shaare Zedek Medical Center|||||f||||t||||||||||2017-02-18 15:47:17.086881|2017-02-18 15:47:17.086881
NCT00446524|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2012-05-06|||February 2007||2007-02-01|May 2012|2012-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)|A 54-week Extension to the Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled, Factorial Study to Evaluate the Efficacy and Safety of VAA489 (Valsartan and Amlodipine Combined) and Alone in Essential Hypertensive Patients - Long Term Study of VAA489 in Patients With Essential Hypertension (Extension From A1301 Study)|Completed||Phase 3|403|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:47:17.180091|2017-02-18 15:47:17.180091
NCT00446511|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2011-06-30|2011-01-11||June 2007||2007-06-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension|An Extension to Study Protocol CVAL489K2302 to Evaluate the Long Term Safety, Tolerability and Efficacy of Valsartan in Children 6 to 17 Years of Age With Hypertension, Versus Enalapril Treatment for 14 Weeks, or Combined With Enalapril Versus Enalapril for 66 Weeks in Chronic Kidney Disease Patients.|Completed||Phase 3|250|Actual|Novartis|Study was prolonged from 14 to 66 wks for CKD patients only. Most CKD patients completed the initial 14 wk extension period prior to amendment approval and the study was terminated prematurely with 3 CKD patients progressing to a maximum of Visit 13.|4|||f||||f||||||||||2017-02-18 15:47:17.292285|2017-02-18 15:47:17.292285
NCT00446498|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2007-04-02|||July 2002||2002-07-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Interventional|||CPAP Versus NPPV in ACPE|Continuous Positive Airway Pressure Versus Non-Invasive Positive Pressure Support Ventilation in Acute Cardiogenic Pulmonary Oedema: a Prospective Randomised Multicentre Trial.|Completed||Phase 4|80||Ospedale S. Giovanni Bosco|||||f||||||||||||||2017-02-18 15:47:17.923943|2017-02-18 15:47:17.923943
NCT00446485|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-12|2015-09-24|||May 2007||2007-05-01|September 2015|2015-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency|Efficacy and Safety of Ginkgo Biloba Standardized Extract (24% Ginkoflavonoglicozides and 6% Terpenes) in Treatment of Mild Cognitive and Concentration Impairment|Completed||Phase 4|90|Actual|Milsing d.o.o.||2|||f||||t||||||||||2017-02-18 15:47:18.011526|2017-02-18 15:47:18.011526
NCT00446472|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2010-06-02|||April 2007||2007-04-01|June 2010|2010-06-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers|Evaluation of Windowed Casts With and Without Regranex® Gel for Healing|Unknown status|Recruiting|N/A|60|Anticipated|Southern California Institute for Research and Education||2|||f||||f||||||||||2017-02-18 15:47:18.351721|2017-02-18 15:47:18.351721
NCT00446459|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2010-04-05|2009-12-29||April 2006||2006-04-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.|The Highly Sensitized Patients: Effects of Mycophenolate Mofetil (MMF) On Anti-Human Leukocyte Antigen (HLA) Antibody Levels In Patients Awaiting Cadaveric Renal Transplant|Completed||Phase 2|45|Actual|University of Washington|The treatment of highly sensitized patients on dialysis with single agent therapy of mycophenolate was hampered by gastrointestinal side effects that reduced anticipated maximum tolerated doses and duration of treatment.|1|||f||||t||||||||||2017-02-18 15:47:18.488208|2017-02-18 15:47:18.488208
NCT00446446|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2016-12-14|2016-02-01||October 2007||2007-10-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|December 2010|Actual|2010-12-01||Interventional|||PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)|Phase 2, Single-Arm, Open-Label, Multi-Center Trial of Second-Line Panitumumab Monotherapy in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 2|52|Actual|Amgen||1|||f||||f||||||||||2017-02-18 15:47:18.784376|2017-02-18 15:47:18.784376
NCT00446433|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-11-30|||March 2002||2002-03-01|November 2016|2016-11-01|December 2003||2003-12-01|||||Interventional|||A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Parallel-Group Study to Evaluate the Safety and Efficacy of CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease|Completed||Phase 2|90||Celgene Corporation|||||f||||||||||||||2017-02-18 15:47:19.270125|2017-02-18 15:47:19.270125
NCT00446420|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2013-05-28|||February 2007||2007-02-01|May 2013|2013-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations|Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations|Completed||Phase 4|200|Actual|Melbourne Health||2|||f||||f||||||||||2017-02-18 15:47:19.380931|2017-02-18 15:47:19.380931
NCT00446407|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2015-03-31|||April 2007||2007-04-01|July 2009|2009-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|MANAS||Evaluating the Benefits and Affordability of a Program to Improve the Care of Common Mental Disorders in Primary Care|The Effectiveness and Cost-effectiveness of a Collaborative Stepped Care Intervention for the Treatment of Common Mental Disorders in Primary Care Settings in Goa, India|Completed||N/A|2796|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 15:47:19.491787|2017-02-18 15:47:19.491787
NCT00446394|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2012-10-18|||June 2007||2007-06-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)|Exercise & Health Promotion for MCI: A Controlled Trial|Completed||N/A|181|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:47:19.610557|2017-02-18 15:47:19.610557
NCT00446381|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2012-04-17|||October 2006||2006-10-01|April 2012|2012-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|PEGAP001||Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)|Effect of Macugen (Pegaptanib) on Surgical Outcomes and Growth Factors Including Vascular Endothelial Growth Factor (VEGF) Levels in Patients With Proliferative Diabetic Retinopathy (PDR) and Clinically Significant Diabetic Macular Edema (CSDME)|Completed||N/A|28|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 15:47:19.718677|2017-02-18 15:47:19.718677
NCT00446368|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2016-03-15|||May 2005||2005-05-01|March 2016|2016-03-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|RAD001||Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer|Phase II Study of RAD001 (Everolimus) in Patient's With Metastatic Renal Cell Cancer|Completed||Phase 2|66|Actual|The Methodist Hospital System||1|||f||||f||||||||No||2017-02-18 15:47:19.828839|2017-02-18 15:47:19.828839
NCT00446355|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2009-04-12|||February 2007||2007-02-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes|Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes|Completed||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:47:19.940678|2017-02-18 15:47:19.940678
NCT00446342|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2012-06-05|||February 2007||2007-02-01|June 2012|2012-06-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies|Phase 1 Multicenter, Dose-Escalation Clinical Study of the Safety and Tolerability of Intravenously Administered SNS-032 Injection, a Novel Cyclin-Dependent Kinase Inhibitor, Administered to Patients With Advanced B-Lymphoid Malignancies|Completed||Phase 1|21|Actual|Sunesis Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:47:20.036994|2017-02-18 15:47:20.036994
NCT00446329|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2014-10-28|||July 2006||2006-07-01|October 2014|2014-10-01||||||||Interventional|||Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis||Terminated||Phase 4|15|Actual|Papageorgiou General Hospital||1||due to financial problems|f||||||||||||||2017-02-18 15:47:20.14938|2017-02-18 15:47:20.14938
NCT00446316|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2016-06-21|||April 2007||2007-04-01|June 2016|2016-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effect of Antacids on Gleevec® in Healthy Volunteers|Effect of Antacids (Mg-Al-based) on Imatinib Mesylate (Gleevec®) Pharmacokinetics in Healthy Volunteers (CSTI571BUS257)|Completed||Phase 1|12|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:47:20.234939|2017-02-18 15:47:20.234939
NCT00446303|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2012-01-18|||July 2006||2006-07-01|June 2010|2010-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Phase II Study of Maintenance With Azacitidine in MDS Patients|A Phase II Study of Maintenance With Azacitidine in MDS Patients Achieving Complete or Partial Remission (CR or PR) After Intensive Chemotherapy|Terminated||Phase 2|39|Actual|Groupe Francophone des Myelodysplasies||1|||f||||t||||||||||2017-02-18 15:47:20.343513|2017-02-18 15:47:20.343513
NCT00446290|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2015-09-02|2013-12-15||March 2006||2006-03-01|September 2015|2015-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|DXO||Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer|A Phase I Study of Docetaxel, Capecitabine and Oxaliplatin (DXO) in Patients With Advanced Stomach Cancer|Completed||Phase 1|21|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 15:47:20.466572|2017-02-18 15:47:20.466572
NCT00446277|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2008-05-09|||January 2007||2007-01-01|May 2008|2008-05-01|June 2007|Anticipated|2007-06-01|June 2007|Anticipated|2007-06-01||Observational|||Corneal Endothelial Cell Loss in Diabetes Type II During Cataract Surgery|Corneal Endothelial Cell Loss in Diabetes Type II During Cataract Surgery|Suspended||Phase 4|30|Anticipated|Frederiksberg University Hospital|||1|The present study was joining 2005-41-4933 into one study|f||||t||||||||||2017-02-18 15:47:20.727681|2017-02-18 15:47:20.727681
NCT00446264|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2012-04-23|2009-05-18||May 2003||2003-05-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|October 2007|Actual|2007-10-01||Interventional|||Islet Allotransplantation With Steroid Free Immunosuppression|Sequential Islet Transplantation With Steroid Free Immunosuppression for Type 1 Diabetes|Completed||Phase 2|14|Actual|University Hospital, Lille||1|||f||||t||||||||||2017-02-18 15:47:20.812455|2017-02-18 15:47:20.812455
NCT00446251|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2010-03-30|2009-12-29||December 2006||2006-12-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant|The Highly Sensitized Patients: Effects of Rituximab and Mycophenolate Mofetil (MMF) On Anti-Human Leukocyte Antigen (HLA) Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.|Completed||Phase 2|14|Actual|University of Washington||1|||t||||t||||||||||2017-02-18 15:47:21.34723|2017-02-18 15:47:21.34723
NCT00446238|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2014-05-19|||September 2002||2002-09-01|May 2014|2014-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Treatment of Depressed Adolescents With Physical Illness|Treatment of Depressed Adolescents With Physical Illness|Completed||N/A|41|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:47:21.622874|2017-02-18 15:47:21.622874
NCT00446225|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2013-03-08|||February 2007||2007-02-01|October 2008|2008-10-01|December 2012|Actual|2012-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients With Mutations in the TK Domain of EGFR|Phase III, Multicenter, Open-label, Randomized Trial of Tarceva® vs Chemotherapy in Patients With Advanced NSCLC With Mutations in the TK Domain of the EGFR|Completed||Phase 3|174|Actual|Spanish Lung Cancer Group||2|||f||||t||||||||||2017-02-18 15:47:21.742852|2017-02-18 15:47:21.742852
NCT00446212|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2013-05-28|||August 2006||2006-08-01|May 2013|2013-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Dreaming and EEG Changes During Anaesthesia Maintained With Propofol or Desflurane|Dreaming and EEG Changes During Anaesthesia Maintained With Propofol or Desflurane|Completed||Phase 4|300|Actual|Melbourne Health||2|||f||||f||||||||||2017-02-18 15:47:21.934013|2017-02-18 15:47:21.934013
NCT00446199|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2015-04-16|2012-03-23||March 2007||2007-03-01|April 2015|2015-04-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Low-dose Hormone Therapy for Relief of Vasomotor Symptoms|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Determine the Lowest Effective Dose of Combinations of Oral Drospirenone and 17 Beta-Estradiol for the Relief of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women Over a Treatment Period of 12 Weeks|Completed||Phase 3|735|Actual|Bayer||4|||f||||f||||||||||2017-02-18 15:47:22.05316|2017-02-18 15:47:22.05316
NCT00446186|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2015-06-23|||February 2004||2004-02-01|June 2015|2015-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)|Mk0476 Phase II Dose Finding Study -Allergic Rhinitis-|Completed||Phase 2|945|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:47:23.566587|2017-02-18 15:47:23.566587
NCT00446173|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2015-08-21|||March 2007||2007-03-01|August 2015|2015-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia|Autologous Purged Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia (CML)|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Terminated due to low accrual.|f||||t||||||||||2017-02-18 15:47:23.645565|2017-02-18 15:47:23.645565
NCT00446160|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2017-01-31|||January 2000||2000-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Adult Congenital Heart Disease Surgery|Proposal for Retrospective Review of an Adult Congenital Heart Surgery Program|Active, not recruiting||N/A|350|Anticipated|Emory University|||1||f||||f||||||||||2017-02-18 15:47:23.760455|2017-02-18 15:47:23.760455
NCT00446147|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2014-01-13|2014-01-13||June 2004||2004-06-01|January 2014|2014-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Pyridoxine for Hand-Foot Syndrome|Double-Blind Phase III Study of Pyridoxine vs Placebo for the Prevention of Capecitabine-induced Hand-Foot Syndrome|Completed||Phase 3|389|Actual|Asan Medical Center||2|||f||||f||||||||||2017-02-18 15:47:23.845124|2017-02-18 15:47:23.845124
NCT00446134|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2012-06-20|2011-09-20||March 2007||2007-03-01|June 2012|2012-06-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)|Phase 2 Comparison of Weight-based Doses of Taribavirin Combined With Peginterferon Alfa-2b Versus Ribavirin Combined With Peginterferon Alfa-2b in Therapy-naïve Patients With Chronic Hepatitis C Virus Genotype 1 Infection|Completed||Phase 2|278|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||t||||||||||2017-02-18 15:47:24.238826|2017-02-18 15:47:24.238826
NCT00446121|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2007-03-09||||||March 2007|2007-03-01||||||||Observational|||Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients|The Effect of Inhaled Mannitol on Ciliary Beat Frequency in COPD Patients|Unknown status|Recruiting|N/A|||Imperial College London|||||f||||||||||||||2017-02-18 15:47:25.738653|2017-02-18 15:47:25.738653
NCT00446108|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2013-11-25|||February 2007||2007-02-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Retrospective Pulmonary Valve Replacement Imaging|Proposal for Retrospective Review of Imaging Pre- and Post - Pulmonary Valve Replacement|Completed||N/A|153|Actual|Emory University|||1||f||||f||||||||||2017-02-18 15:47:25.821004|2017-02-18 15:47:25.821004
NCT00446095|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2016-08-09|2014-05-14||April 2007||2007-04-01|August 2016|2016-08-01|October 2010|Actual|2010-10-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma|A Phase I/II Multi-Center, Open Label Trial of the Safety and Efficacy of Fostamatinib in Patients With Relapsed/Refractory B-Cell Lymphoma|Completed||Phase 1/Phase 2|81|Actual|Rigel Pharmaceuticals|This is a small, non-randomized study. Comparisons between the 3 groups cannot be reliably made and should be interpreted with caution.|1|||f||||t||||||||No||2017-02-18 15:47:26.137855|2017-02-18 15:47:26.137855
NCT00446082|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2016-11-07|||June 2006||2006-06-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease|A Phase I, Multicenter, Open-label, Randomized Study Assessing the Pharmacokinetics, Safety, and Tolerability of Monthly Doses of Pasireotide i.m. LAR Injection in Patients With Acromegaly and Patients With Carcinoid Disease|Completed||Phase 1|85|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:47:27.589773|2017-02-18 15:47:27.589773
NCT00446069|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2016-08-26|||August 2007||2007-08-01|August 2016|2016-08-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients|A Double-blind, Randomized, 2-way Cross-over, Phase II, Efficacy Trial in Cancer Patients to Assess the Overall Efficacy, Patient Preference, Morphine Related Side Effect Profile and Safety of the Egalet® Controlled Release Morphine Formulation 30-240 mg Once Daily Compared to MST Continus® 15-120 mg Twice Daily After 2 Weeks of Treatment|Completed||Phase 2|36|Actual|Egalet Ltd||2|||f||||f||||||||||2017-02-18 15:47:27.716774|2017-02-18 15:47:27.716774
NCT00446056|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2015-12-16|||September 2003||2003-09-01|December 2015|2015-12-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)|Montelukast, on Pediatric Bronchial Asthma in Multicenter Comparative Double-Blind Clinical Study (Phase IV) With Ketotifen Fumarate|Completed||Phase 4|188|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:47:27.825298|2017-02-18 15:47:27.825298
NCT00446043|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2007-03-08|||February 2004||2004-02-01|March 2007|2007-03-01|May 2004||2004-05-01|||||Interventional|||A Long-Term Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris|A Long-Term Safety and Efficacy Study of a Fixed Combination of Adapalene 0.1% and Benzoyl Peroxide 2.5% (Adapalene and Benzoyl Peroxide Topical Gel) Gel in Subjects With Acne Vulgaris|Completed||Phase 3|452||Galderma|||||f||||||||||||||2017-02-18 15:47:27.904399|2017-02-18 15:47:27.904399
NCT00446030|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2012-06-21|2011-08-18||March 2007||2007-03-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer|A Phase II, Open-Label, Multicenter, Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast Cancer|Completed||Phase 2|127|Actual|Sanofi|The number of participants enrolled into the TCH with bevacizumab arm was reduced to half of the originally intended number. Therefore, all conclusions related to the safety of TCH with bevacizumab must be interpreted with caution.|2|||f||||t||||||||||2017-02-18 15:47:27.989065|2017-02-18 15:47:27.989065
NCT00446017|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-09|2015-06-02|||June 2003||2003-06-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|August 2004|Actual|2004-08-01||Interventional|AMORI||The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG|Phase 3 Study of Adrenaline and Milrinone in Patients With Myocardial Dysfunction|Completed||Phase 3|60||University of Luebeck|||||f||||f||||||||||2017-02-18 15:47:28.970765|2017-02-18 15:47:28.970765
NCT00446004|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2016-06-21|||April 2007||2007-04-01|June 2016|2016-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers|Effect of a Proton Pump Inhibitor (Omeprazole, Prilosec®) on Imatinib Mesylate (Gleevec®) Pharmacokinetics in Healthy Volunteers (CSTI571BUS258)|Completed||Phase 1|15|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:47:29.054898|2017-02-18 15:47:29.054898
NCT00445978|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2014-09-04|||April 2007||2007-04-01|September 2014|2014-09-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease|A Phase 2a, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, and Efficacy of 6R-BH4 in Subjects With Sickle Cell Disease|Completed||Phase 2|40|Anticipated|BioMarin Pharmaceutical||1|||f||||f||||||||||2017-02-18 15:47:29.170097|2017-02-18 15:47:29.170097
NCT00445965|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-08-08|||January 2006||2006-01-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer|Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms|Recruiting||Phase 2|131|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:47:29.284285|2017-02-18 15:47:29.284285
NCT00445952|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2011-05-14|||February 2005||2005-02-01|July 2009|2009-07-01||||||||Observational|||Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant|Fungemia Survey in Cancer Patients|Unknown status|Active, not recruiting|N/A|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:47:29.423986|2017-02-18 15:47:29.423986
NCT00445939|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2011-06-20|2008-12-23||February 2007||2007-02-01|June 2011|2011-06-01||||December 2007|Actual|2007-12-01||Interventional|||A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease|A Multi-Center, Randomized, Double-blind, Placebo-controlled Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease|Completed||Phase 2/Phase 3|90|Actual|Abbott|Small population, therefore no statistical tests were performed|3|||f||||||||||||||2017-02-18 15:47:29.54845|2017-02-18 15:47:29.54845
NCT00445809|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2009-08-03|||February 2007||2007-02-01|August 2009|2009-08-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Observational|EVOLVE||Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury|EValuation Of NGAL in Early and eVolving Acute kidnEy Injury|Completed||N/A|355|Actual|Biosite|||2||f||||t||||||Samples Without DNA|"~     Blood Samples (3 10ml, 7 5ml) at ten timepoints over 5 days.~   "|||2017-02-18 15:47:39.469841|2017-02-18 15:47:39.469841
NCT00443950|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-12-11|||June 2006||2006-06-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Etanercept in Chinese Subjects With Active Rheumatoid Arthritis Receiving Methotrexate|Completed||Phase 3|150|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:47:30.283823|2017-02-18 15:47:30.283823
NCT00443937|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-10-31|||January 2004||2004-01-01|October 2007|2007-10-01|March 2006|Actual|2006-03-01|||||Interventional|||Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients|Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Stable Renal Transplant Patients|Completed||Phase 4|15|Anticipated|Charite University, Berlin, Germany||1|||f||||||||||||||2017-02-18 15:47:30.37661|2017-02-18 15:47:30.37661
NCT00443924|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2015-01-19|||March 2007||2007-03-01|January 2015|2015-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Ascending Dose Study of INS115644 Ophthalmic Solution in Subjects With Bilateral Ocular Hypertension or Early Primary Open Angle Glaucoma|Completed||Phase 1|56|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 15:47:30.468937|2017-02-18 15:47:30.468937
NCT00443911|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2011-06-23|||March 2007||2007-03-01|June 2011|2011-06-01|May 2012|Anticipated|2012-05-01|||||Observational|ReLux-AMD||Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration|Rheohemapheresis and Lutein Supplementation (Xantophyll Carotenoid) in the Non-Exsudative Form of Age-Related Macular Degeneration|Unknown status|Active, not recruiting|Phase 3|20|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 15:47:30.580514|2017-02-18 15:47:30.580514
NCT00443898|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2012-05-01|2011-01-19||December 2006||2006-12-01|May 2012|2012-05-01||||June 2008|Actual|2008-06-01||Interventional|||Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail|A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Topical Terbinafine Hydrogen Chloride (HCl) Formulation for 24 or 48 Weeks of Treatment in Patients With Mild to Moderate Toenail Onychomycosis|Completed||Phase 3|518|Actual|Novartis||4|||f||||f||||||||||2017-02-18 15:47:30.67085|2017-02-18 15:47:30.67085
NCT00443885|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2015-12-16|||February 2007||2007-02-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC|Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC to Problematic Gram-negative Organisms|Active, not recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:47:31.340197|2017-02-18 15:47:31.340197
NCT00443872|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-03|2014-10-30|2012-05-23||March 2007||2007-03-01|October 2014|2014-10-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|AtoZ||Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists|Adding Orally Disintegrating Selegiline (Zelapar) to Patients Taking Dopamine Agonists and Experiencing Complications|Completed||Phase 4|77|Actual|Parkinson's Disease and Movement Disorder Center of Boca Raton||1|||f||||f||||||||||2017-02-18 15:47:31.436453|2017-02-18 15:47:31.436453
NCT00443859|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2016-07-07|||February 2007||2007-02-01|May 2009|2009-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension|Clinical Significance of N-Terminal Pro-Brain Natriuretic Peptide Levels in Persistent Pulmonary Hypertension|Terminated||N/A|10|Actual|Christiana Care Health Services|||1|Interim analysis showed greater variablility in NT-proBNP findings than anticipated.|f||||f||||||Samples Without DNA|"~     Whole blood~   "|||2017-02-18 15:47:31.943053|2017-02-18 15:47:31.943053
NCT00443846|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2015-11-27|||February 2007||2007-02-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||RotaTeq® and Meningococcus C Vaccine in Healthy Infants|An Open-label, Randomised, Comparative, Multi-centre Study of the Immunogenicity and Safety of the Concomitant Use of a Live Pentavalent Rotavirus Vaccine (RotaTeq®) and a Meningococcal Group C Conjugate (MCC) Vaccine in Healthy Infants|Completed||Phase 3|246|Actual|MCM Vaccines B.V.||2|||f||||||||||||||2017-02-18 15:47:32.039033|2017-02-18 15:47:32.039033
NCT00443833|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-03-05|||January 2004||2004-01-01|March 2007|2007-03-01|December 2005||2005-12-01|||||Observational|||Genetic Analysis of Thyrotoxic Periodic Paralysis|Genetic Analysis of Thai Patients With Thyrotoxic Periodic Paralysis|Completed||N/A|80||Ramathibodi Hospital|||||f||||f||||||||||2017-02-18 15:47:32.147252|2017-02-18 15:47:32.147252
NCT00443820|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2011-03-22|2011-01-19||December 2006||2006-12-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail|A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel Group Study to Assess the Efficacy, Safety, and Tolerability of Topical Terbinafine Hydrogen Chloride (HCl) Formulation for 24 or 48 Weeks of Treatment in Patients With Mild to Moderate Toenail Onychomycosis|Completed||Phase 3|526|Actual|Novartis||4|||f||||f||||||||||2017-02-18 15:47:32.219618|2017-02-18 15:47:32.219618
NCT00443807|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2008-04-15|||August 2007||2007-08-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||EEG Monitoring to Assess Emergence From Neuroanesthesia|A Comparison of the EEGo and BIS Monitors to Assess Emergence From Neuroanesthesia|Completed||N/A|21|Actual|University of Manitoba||1|||f||||f||||||||||2017-02-18 15:47:33.185441|2017-02-18 15:47:33.185441
NCT00443794|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2010-09-22|||March 2007||2007-03-01|September 2010|2010-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||The Indian POLYCAP Study (TIPS)|A Randomized Double Blind Controlled Trial of the Efficacy and Safety of POLYCAP (Quintapill)Versus Its Components in Subjects With at Least One Additional Cardiovascular Risk Factor|Completed||N/A|2050|Actual|St. John's Research Institute||9|||f||||t||||||||||2017-02-18 15:47:33.303292|2017-02-18 15:47:33.303292
NCT00445822|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2012-02-28|||March 2007||2007-03-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|July 2012|Anticipated|2012-07-01||Observational|CML-paed II||Registration of Children With CML and Treatment With Imatinib|Protocol for Standardized Diagnostic Procedures, Registration, and Treatment Recommendations in Children and Adolescents With Philadelphia Chromosome-positive Chronic Myeloid Leukemia (CML)|Unknown status|Recruiting|N/A|150|Anticipated|Technische Universität Dresden|||1||f||||t||||||Samples With DNA|"~     Bone Marrow and blood smears~   "|||2017-02-18 15:47:39.372391|2017-02-18 15:47:39.372391
NCT00443781|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2012-03-19|2010-06-23||March 2007||2007-03-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|SODA||Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain|Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain|Completed||Phase 4|62|Actual|Medtronic Spine LLC|There were 12 subjects which did not undergo both PD (Provocative Discography) and F.A.D. (Functional Anesthetic Discography) and therefore could not be included in the primary endpoint analysis (analyzable population for primary endpoint = 50/62).|1|||f||||f||||||||||2017-02-18 15:47:33.529933|2017-02-18 15:47:33.529933
NCT00443768|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-02-01|||October 2006||2006-10-01|February 2013|2013-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|PDCom||Medication Review in Patients on Anti-parkinson Therapy|Medication Review in Patients on Anti-parkinson Therapy|Completed||N/A|120|Anticipated|South Glasgow University Hospitals NHS Trust|||2||f||||f||||||||||2017-02-18 15:47:33.839856|2017-02-18 15:47:33.839856
NCT00443755|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2013-10-07|2013-04-22||August 2005||2005-08-01|October 2013|2013-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional||The baseline characteristics are reported for the subjects who completed the study.|Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance|Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance|Completed||Phase 2|28|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 15:47:33.949331|2017-02-18 15:47:33.949331
NCT00442754|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-03-19|||December 2006||2006-12-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Dendritic Cells in Lung Cancer|Vaccination With Autologous Dendritic Cells Pulsed With Allogeneic Tumour Lysate (MelCancerVac) for the Treatment of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. A Phase II Study|Completed||Phase 2|50|Anticipated|Herlev Hospital||1|||f||||f||||||||||2017-02-18 15:47:34.946695|2017-02-18 15:47:34.946695
NCT00442741|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-04-23|||July 2007||2007-07-01|April 2012|2012-04-01||||July 2007|Actual|2007-07-01||Interventional|||Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)|An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)|Withdrawn||Phase 1|0|Actual|Novartis||2||pts. will be captured in core|f||||||||||||||2017-02-18 15:47:35.037551|2017-02-18 15:47:35.037551
NCT00442728|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-11|2007-03-01|||January 2003||2003-01-01|March 2007|2007-03-01|June 2003||2003-06-01|||||Interventional|||The Effect of Neuromuscular Electrical Stimulation|on Muscle Wasting in Artificially Ventilated and Sedated Patients at the Intensive Care Unit: a Pilot Study|Completed||N/A|21||Provinciale Hogeschool Limburg|||||f||||||||||||||2017-02-18 15:47:35.125124|2017-02-18 15:47:35.125124
NCT00445926|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2010-05-05|||July 2006||2006-07-01|May 2010|2010-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia|Deep TMS With the H Coils as a Novel Strategy for the Treatment of Negative Symptoms of Schizophrenia|Completed||Phase 1|||Shalvata Mental Health Center|||||f||||t||||||||||2017-02-18 15:47:35.223979|2017-02-18 15:47:35.223979
NCT00445913|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-02-12|||March 2007||2007-03-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|January 2012|Actual|2012-01-01||Interventional|||Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study|Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study|Completed||Phase 1|10|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 15:47:35.308249|2017-02-18 15:47:35.308249
NCT00445900|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2011-03-16|||October 2004||2004-10-01|March 2011|2011-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia|"Phase II Study of the Combination of Low-Dose Thalidomide, Prednisone, and Oral Cyclophosphamide (TPC) in the Therapy of Myelofibrosis With Myeloid Metaplasia (MMM)"|Completed||Phase 2|22|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 15:47:35.423873|2017-02-18 15:47:35.423873
NCT00445887|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2013-09-19|||March 2008||2008-03-01|September 2013|2013-09-01||||December 2013|Anticipated|2013-12-01||Interventional|||Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer|Phase II Double Blind Randomized Trial Evaluating the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer (IND# 79,610)|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Gynecologic Oncology Group||2|||f||||||||||||||2017-02-18 15:47:35.52055|2017-02-18 15:47:35.52055
NCT00445874|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-04-08|||February 2007||2007-02-01|April 2009|2009-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis|A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers|Completed||Phase 3|120|Anticipated|Vistakon Pharmaceuticals|||||f||||f||||||||||2017-02-18 15:47:35.757729|2017-02-18 15:47:35.757729
NCT00445861|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-06-08|||January 2007||2007-01-01|June 2012|2012-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery|Cetuximab in Combination With Radiation Therapy and Chemotherapy Prior to Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma. A Multicenter Phase IB-II Trial|Completed||Phase 1/Phase 2|27|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 15:47:35.850357|2017-02-18 15:47:35.850357
NCT00445848|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-07-21|2016-05-06||July 2007||2007-07-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|August 2013|Actual|2013-08-01||Interventional||85 patients were eligible and analyzable.|S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer|A Phase II Trial of the Combination of OSI-774 (Erlotinib; NSC-718781) and Bevacizumab (RHUMAB VEGF; NSC 704865) in Never-Smokers With Stage IIIB and IV Primary NSCLC Adenocarcinomas|Completed||Phase 2|89|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 15:47:35.97174|2017-02-18 15:47:35.97174
NCT00445835|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2010-09-30|||September 2007||2007-09-01|September 2010|2010-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|AMERICA||Active Detection of the Extension of Atherothrombosis in High Risk Coronary Patients|Active Detection and Management of the Extension of Atherothrombosis in High Risk Coronary Patients In Comparison With Standard of Care for Coronary Atherosclerosis: The AMERICA Study|Unknown status|Active, not recruiting|N/A|526|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:47:39.269663|2017-02-18 15:47:39.269663
NCT00445796|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2008-04-08|||June 2005||2005-06-01|April 2008|2008-04-01||||||||Interventional|ATOL||Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance|Randomised, Comparative Study of the Efficacy and Safety of Arsucam® Administered as a Single Daily Intake Versus Two Daily Intakes in the Treatment of Plasmodium Falciparum Malaria Attack|Completed||Phase 4|300||Sanofi|||||f||||||||||||||2017-02-18 15:47:39.572833|2017-02-18 15:47:39.572833
NCT00445783|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2013-08-09|||July 2000||2000-07-01|April 2008|2008-04-01||||December 2020|Anticipated|2020-12-01||Observational|||Study of Families With Melanoma|Melanoma Family Case-Control Study Protocol|Recruiting||N/A|3700|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:47:39.667697|2017-02-18 15:47:39.667697
NCT00445770|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2011-08-10|2011-07-12||July 2006||2006-07-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis|A Randomized, Double-Blind, Multicenter, Comparative Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Active Rheumatoid Arthritis|Completed||Phase 3|550|Actual|Pfizer|Total Sharp Score and modified total Sharp Score were used interchangeably in the protocol and meant the same thing. In the statistical analysis plan and study results, mTSS was used consistently.|3|||f||||f||||||||||2017-02-18 15:47:39.823188|2017-02-18 15:47:39.823188
NCT00445757|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-03-16|||January 2007||2007-01-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors|Evaluation of a Radio-Surgical Approach for the Treatment of Kidney Tumors|Withdrawn||Phase 1|0|Actual|Case Comprehensive Cancer Center||1||slow accrual|f||||t||||||||||2017-02-18 15:47:43.567807|2017-02-18 15:47:43.567807
NCT00445744|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2014-04-03|||December 2006||2006-12-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|June 2011|Actual|2011-06-01||Interventional|||Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome|Cyclophosphamide Followed by Intravenous Busulfan as Conditioning for Hematopoietic Cell Transplantation in Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome.|Completed||N/A|52|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 15:47:43.698211|2017-02-18 15:47:43.698211
NCT00445731|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2014-09-05|||May 2002||2002-05-01|September 2014|2014-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant|A Randomized Trial of the Effect of a Walking Regimen on the Functional Status of Adult Allogeneic Donor Bone Marrow Transplant Patients|Completed||N/A|115|Actual|University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-02-18 15:47:44.063236|2017-02-18 15:47:44.063236
NCT00445718|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2017-02-07|||July 2001||2001-07-01|February 2017|2017-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging|Perinatal Neuroblastoma: Expectant Observation A Children's Oncology Group Pilot Study|Completed||N/A|97|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"~     Urine, Tumor tissue~   "|||2017-02-18 15:47:44.170316|2017-02-18 15:47:44.170316
NCT00445705|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2015-08-25|2011-12-16||March 2007||2007-03-01|August 2015|2015-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome||Terminated||Phase 2|211|Actual|Allergan|This study was terminated early due to company decision. Only Part A results are presented; Part B was never conducted.|4||This study was terminated early due to company decision. Part B was never conducted.|f||||||||||||||2017-02-18 15:47:44.32593|2017-02-18 15:47:44.32593
NCT00445692|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-03-04|||January 2007||2007-01-01|March 2016|2016-03-01||||January 2018|Anticipated|2018-01-01||Interventional|||Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma|Maintenance Therapy With Lenalidomide, Dexamethasone and Clarithromycin (Biaxin) Following Autologous/Syngeneic Transplant for Multiple Myeloma|Active, not recruiting||Phase 2|32|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 15:47:44.90269|2017-02-18 15:47:44.90269
NCT00445679|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2013-10-08|2010-02-26||July 2007||2007-07-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD|A Multicenter, Randomized, Double-blind, Paroxetine-referenced, Parallel-group Study to Evaluate the Safety, Efficacy, and Tolerability of 3 Fixed Doses (50mg, 100mg, AND 200mg) of Desvenlafaxine Succinate Sustained-release Tablets in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|807|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||||||||||||2017-02-18 15:47:45.056034|2017-02-18 15:47:45.056034
NCT00445653|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2017-01-13|||August 2005||2005-08-01|January 2017|2017-01-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding|Molecular Epidemiology of Barrett's Esophagus|Completed||N/A|170|Actual|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"~     Blood samples only were collected~   "|No||2017-02-18 15:47:45.856581|2017-02-18 15:47:45.856581
NCT00445627|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2017-01-24|||March 2, 2007||2007-03-02|July 27, 2016|2016-07-27||||||||Observational|||Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus|Natural History of Type 2 Diabetes Mellitus in Children and Young Adults|Recruiting||N/A|430|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:47:45.944162|2017-02-18 15:47:45.944162
NCT00445614|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2008-08-12|||March 2007||2007-03-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effects of Trout Fed With a Vegetable Based Feed on Cardiovascular Risk Markers and Plasma Proteome|Healthy, Nutritious and Tasty Fish for the Future|Completed||N/A|72|Anticipated|University of Copenhagen||3|||f||||f||||||||||2017-02-18 15:47:46.053168|2017-02-18 15:47:46.053168
NCT00445601|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-10-04|||September 2007||2007-09-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer|A Phase III Blinded Study of Immediate Post TURBT Instillation of Gemcitabine Versus Saline in Patients With Newly Diagnosed or Occasionally Recurring Grade I/II Superficial Bladder Cancer|Completed||Phase 3|371|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 15:47:46.157863|2017-02-18 15:47:46.157863
NCT00445588|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-03-25|2016-03-25||January 2007||2007-01-01|March 2016|2016-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||histologically confirmed GBM, progressed or recurred following RT and 0-2 prior chemotherapy regimens|Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme|A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 15:47:46.429993|2017-02-18 15:47:46.429993
NCT00445575|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2011-12-29|||July 2007||2007-07-01|March 2010|2010-03-01|July 2014|Anticipated|2014-07-01|July 2013|Anticipated|2013-07-01||Interventional|PROFIDYS||Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone|Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone|Unknown status|Recruiting|Phase 2/Phase 3|156|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France||4|||f||||t||||||||||2017-02-18 15:47:46.702805|2017-02-18 15:47:46.702805
NCT00445562|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2013-07-09|||January 2001||2001-01-01|July 2009|2009-07-01||||December 2004|Actual|2004-12-01||Observational|||Blood Sample Collection and Health Information Collection From Patients With Invasive Breast Cancer and Their Brothers and Sisters|Breast Cancer Siblings Database|Unknown status|Recruiting|N/A|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:47:46.82187|2017-02-18 15:47:46.82187
NCT00445549|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-05-22|2011-06-30||January 2007||2007-01-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Phase II Study of Clinical Activity and Proteomic Pathway Profiling of the Vascular Endothelial Growth Factor 2 (VEGFR2) Inhibitor, ZD6474 (Vandetanib) in Women With Relapsed or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Terminated||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)|The study closed after the first stage of accrual because of inadequate early activity with 32 cycles of administered treatment.|1||The study closed because of inadequate early activity.|f||||f||||||||||2017-02-18 15:47:47.091298|2017-02-18 15:47:47.091298
NCT00445523|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2016-03-15|||May 2006||2006-05-01|March 2016|2016-03-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer|A Phase II Trial to Assess the Activity of TroVax® Alone vs. TroVax® Plus Interferon Alfa (IFN-α) on Patients With Advanced or Metastatic Renal Cell Cancer|Completed||Phase 2|28|Actual|The Methodist Hospital System||2|||f||||f||||||||No||2017-02-18 15:47:47.406718|2017-02-18 15:47:47.406718
NCT00445510|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-05-31|||June 2006||2006-06-01|February 2011|2011-02-01||||||||Interventional|||This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge|A Double Blind, Placebo Controlled, Repeat Dose Study to Determine the Effect of GSK256066 87.5 Mcg to Protect Against AMP Challenge in the Lung in Mild Steroid-naive Asthmatics.|Completed||Phase 2|24||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:47:47.519817|2017-02-18 15:47:47.519817
NCT00445497|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2013-08-09|||July 2007||2007-07-01|May 2007|2007-05-01||||July 2010|Anticipated|2010-07-01||Interventional|||Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia|A Prospective Randomised Phase III Trial of Early Hospital Discharge Versus Standard Inpatient Management of Cancer Patients With Low-Risk Febrile Neutropenia Receiving Oral Antibiotics. Oral Antibiotics for Neutropenic Sepsis Giving Early Hospital Discharge [ORANGE]|Unknown status|Recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:47:47.619243|2017-02-18 15:47:47.619243
NCT00445484|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2015-08-05|2015-06-26||January 2007||2007-01-01|August 2015|2015-08-01|September 2010|Actual|2010-09-01|April 2009|Actual|2009-04-01||Interventional||A total of 22 patients were enrolled, 11 in each cohort. Patients who showed evidence of disease progression while on study were not included in subsequent analysis.|Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma|Revlimid to Augment Efficacy of Prevnar Vaccines in Patients With Relapsed or Refractory Myeloma|Completed||Phase 2|22|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||||2017-02-18 15:47:47.740356|2017-02-18 15:47:47.740356
NCT00445471|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2014-12-24|||April 2007||2007-04-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment||Terminated||N/A|45|Actual|Rabin Medical Center||2||"Mifne began treating younger patients who could not be diagnosed with the ADOS used in the~   study"|f||||f||||||||||2017-02-18 15:47:48.173431|2017-02-18 15:47:48.173431
NCT00445458|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2016-06-22||2013-01-29|September 2007||2007-09-01|June 2016|2016-06-01|December 2017|Anticipated|2017-12-01|May 2011|Actual|2011-05-01||Interventional|||A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer|A Phase 1/2 Study of HKI-272 in Combination With Paclitaxel in Subjects With Solid Tumors and Breast Cancer|Active, not recruiting||Phase 1/Phase 2|115|Actual|Puma Biotechnology, Inc.||4|||f||||f||||||||||2017-02-18 15:47:48.2699|2017-02-18 15:47:48.2699
NCT00445445|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-09-29|||January 2007||2007-01-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women|Longitudinal Changes in Mammographic Density and Risk of Breast Cancer|Recruiting||N/A|3000|Anticipated|Case Comprehensive Cancer Center|||2||f||||t||||||Samples With DNA|"~     Time perspective: Prospective and retrospective. Blood and urine samples will be processed~     in our lab and stored in a -80 degree freezer until needed. Urine samples will be assessed~     for levels of bisphenol-A and remaining samples of urine and blood will be stored for future~     projects.~   "|||2017-02-18 15:47:48.422027|2017-02-18 15:47:48.422027
NCT00445432|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-02-01|2010-03-31||March 2007||2007-03-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease|A Multi-Center, Randomized, Double-blind, Placebo-controlled Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease|Completed||Phase 2/Phase 3|82|Actual|Abbott||3|||f||||||||||||||2017-02-18 15:47:48.562915|2017-02-18 15:47:48.562915
NCT00445419|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2010-02-05|||December 2006||2006-12-01|February 2010|2010-02-01|June 2008|Actual|2008-06-01|||||Interventional|||Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides|A Phase I Single-blind Randomised Placebo Controlled Dose Escalating Study of One Virosome Formulated CD4 and Two Virosomes Formulated CD8 Hepatitis C Virus (HCV) Vaccine Components (PEV2A and PEV2B) Administered to Healthy Adult Volunteers|Completed||Phase 1|30|Anticipated|Pevion Biotech Ltd|||||f||||t||||||||||2017-02-18 15:47:49.628609|2017-02-18 15:47:49.628609
NCT00445406|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-06-26|||December 2006||2006-12-01|June 2012|2012-06-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|||Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer|Bevacizumab and Pegylated Liposomal Doxorubicin as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer. A Multicenter, Single-Arm Phase II Trial|Completed||Phase 2|43|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 15:47:49.718669|2017-02-18 15:47:49.718669
NCT00445393|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-01-05|||October 2006||2006-10-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|||||Observational|||Adolescent Idiopathic Scoliosis and Mental Health|Prevalence of Psychiatric Disorders in Adolescents With Idiopathic Scoliosis: A Pilot Study of a Validated Screening Tool|Completed||N/A|100|Anticipated|University of British Columbia|||1||f||||t||||||||||2017-02-18 15:47:49.819089|2017-02-18 15:47:49.819089
NCT00445367|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-08|2016-07-13|||May 2006||2006-05-01|July 2016|2016-07-01||||October 2026|Anticipated|2026-10-01||Observational|||Biobank For MS And Other Demyelinating Diseases|Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases|Active, not recruiting||N/A|3226|Actual|Accelerated Cure Project for Multiple Sclerosis|||2||f||||f||||||||||2017-02-18 15:47:49.907802|2017-02-18 15:47:49.907802
NCT00445354|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2007-03-07|||March 2007||2007-03-01|March 2007|2007-03-01|August 2007||2007-08-01|||||Interventional|||Randomized Controlled Clinical Trial of Cinnamon to Lower Hemoglobin A1c|A Randomized Controlled Clinical Trial Comparing the Effect of 1g of Daily Cinnamon Plus Usual Care to Usual Cre on the Hemoglobin A1c of Uncontrolled Type 2 Diabetics|Unknown status|Recruiting|Phase 3|140||Eglin AFB Regional Hospital|||||f||||t||||||||||2017-02-18 15:47:50.005784|2017-02-18 15:47:50.005784
NCT00445341|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-10-18|2012-09-05||January 2007||2007-01-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|November 2011|Actual|2011-11-01||Interventional|||Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma|A Phase I/II Study of Flavopiridol in Relapsed or Refractory Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (DLBCL)|Completed||Phase 1/Phase 2|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 15:47:50.097743|2017-02-18 15:47:50.097743
NCT00445328|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-10-05|2009-07-20||June 2007||2007-06-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients|Prospective Randomized Phase IV Open Label Comparative Study Of Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients.|Terminated||Phase 4|84|Actual|Pfizer|Study terminated prematurely due to delay in overall study start-up and inability to meet predefined protocol recruitment milestones; sample size too small to permit meaningful statistical analyses. No statistical analyses for all but 2 endpoints.|2||See Detailed Description|f||||f||||||||||2017-02-18 15:47:50.61829|2017-02-18 15:47:50.61829
NCT00445315|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2014-01-02|2013-12-09||January 2007||2007-01-01|January 2014|2014-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients|A Phase 1, Randomized, Double Blind (3rd Party Open), Placebo-controlled, Sequential Group, Multicentre Study To Evaluate The Multiple Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics, of PF-00868554 in Hepatitis C Virus (HCV) Positive Otherwise Healthy Patient Volunteers|Completed||Phase 1|32|Actual|Pfizer|Designation of outcomes as primary, secondary based on team’s input. Results for relationship analyses of baseline susceptibility to PF-00868554 and/or non-structural 5B genotype and change in HCV RNA was not done, as per change in planned analysis.|5|||f||||f||||||||||2017-02-18 15:47:51.276582|2017-02-18 15:47:51.276582
NCT00445302|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2014-02-10|2010-12-12||January 2006||2006-01-01|February 2014|2014-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal Impairment|A Phase I Study Of The Safety, Pharmacokinetics, And Hematological Activity Of AMD3100 (240 µg/kg) In Subjects With Renal Impairment|Completed||Phase 1|23|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 15:47:52.65119|2017-02-18 15:47:52.65119
NCT00445289|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2008-08-15|||March 2007||2007-03-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|ASOPI||Automatic Control of Pressure Support Ventilation in Surgical Intensive Care Units|Automatic Control of Pressure Support Ventilation in Surgical Intensive Care Units - a Bicentric, Prospective, Randomized, Controlled Trial|Completed||N/A|300|Anticipated|University of Schleswig-Holstein|||||f||||t||||||||||2017-02-18 15:47:53.423957|2017-02-18 15:47:53.423957
NCT00445276|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2010-03-03|||November 2005||2005-11-01|March 2010|2010-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Symptomatic Efficacy of Diacerein in Knee Osteoarthritis|Efficacy Study of Diacerein in the Symptomatic Treatment of Knee Osteoarthritis|Completed||Phase 4|500||Laboratoires NEGMA|||||f||||f||||||||||2017-02-18 15:47:53.511896|2017-02-18 15:47:53.511896
NCT00445263|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2015-02-09|2015-01-26||March 2007||2007-03-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|December 2010|Actual|2010-12-01||Interventional|SISCA||Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation|Treatment by Anti GP IIb/IIIa in the Setting of a Strategy of Early Coronarography to Patients With an Acute Coronary Syndrome Without ST Elevation|Terminated||Phase 4|170|Actual|Hospital Avicenne||2||Because of inclusion delay|f||||t||||||||||2017-02-18 15:47:53.604846|2017-02-18 15:47:53.604846
NCT00445250|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2007-03-07||||||January 2007|2007-01-01||||||||Interventional|||The Role of Calcipotriol as Radioprotector of Skin|Phase 2 Study of the Role of Calcipotriol as Radioprotector of Skin in Women Receiving Radiotherapy Treatment to the Breast.|Unknown status|Not yet recruiting|Phase 2|50||Rabin Medical Center|||||f||||t||||||||||2017-02-18 15:47:54.256678|2017-02-18 15:47:54.256678
NCT00445237|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-02-04|||May 2006||2006-05-01|March 2007|2007-03-01|March 2008|Actual|2008-03-01|||||Interventional|||Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression|Evaluation of the H1 Coil and H2 Coil TMS Device - Safety and Feasibility in Major Depression Episode|Completed||Phase 1|||Shalvata Mental Health Center|||||f||||f||||||||||2017-02-18 15:47:54.444546|2017-02-18 15:47:54.444546
NCT00445224|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2015-07-30|2010-01-28||January 2008||2008-01-01|July 2015|2015-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Comparing Rehabilitation Programs for Patellofemoral Pain Syndrome|Comparison of Early Hip Strengthening to Early Quadriceps Strengthening in the Treatment of Females With Patellofemoral Pain|Completed||Phase 2|33|Actual|University of Kentucky|Early termination leading to small number of subjects analyzed. Intention to treat analysis, last score carried forward, was used to analyze all outcome data.|2|||f||||f||||||||||2017-02-18 15:47:54.536507|2017-02-18 15:47:54.536507
NCT00445198|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2013-01-17||2011-12-22|April 2007||2007-04-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies|A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects With Small Cell Lung Cancer or Other Non-Hematological Malignancies|Completed||Phase 1/Phase 2|86|Actual|AbbVie||1|||f||||||||||||||2017-02-18 15:47:55.054081|2017-02-18 15:47:55.054081
NCT00445185|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-11-18|||March 2007||2007-03-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™|A Study to Evaluate the Persistence of Anti-HBs Antibodies at Months 12, 24 and 36 in Pre-dialysis or Dialysis Patients Who Have Received a Primary Vaccination Course of Either Henogen's HBV Vaccine, HB-AS02V or GSK Biological's Fendrix™|Completed||Phase 3|102|Anticipated|Henogen||2|||f||||f||||||||||2017-02-18 15:47:55.164638|2017-02-18 15:47:55.164638
NCT00445172|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2016-02-26|||February 2008||2008-02-01|February 2016|2016-02-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)|Active, not recruiting||Phase 2/Phase 3|300|Anticipated|Eisai Inc.||1|||f||||||||||||||2017-02-18 15:47:55.290373|2017-02-18 15:47:55.290373
NCT00445159|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2007-03-07|||November 2006||2006-11-01|March 2007|2007-03-01||||||||Interventional|||UT-15C SR in the Treatment of Critical Limb Ischemia|An Investigator Initiated Eight Week Two Center Open-Label Pilot Study of the Tolerability and Safety of Oral UT-15C (Treprostinil Diethanolamine)SR Tablets in Patients With Critical Limb Ischemia (CLI) and Ischemic Rest Pain|Unknown status|Recruiting|Phase 2|20||Southern Arizona Vascular Institute|||||f||||t||||||||||2017-02-18 15:47:55.415941|2017-02-18 15:47:55.415941
NCT00445146|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2016-03-23|2016-03-23||February 2007||2007-02-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional||Safety Analysis Set: enrolled participants who received at least 1 dose of EVG|Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection|A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects|Completed||Phase 2|192|Actual|Gilead Sciences||1|||f||||f||||||||||2017-02-18 15:47:55.516472|2017-02-18 15:47:55.516472
NCT00445133|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-09-26|||February 2007||2007-02-01|September 2007|2007-09-01|December 2007||2007-12-01|||||Interventional|SLEEP/MAG||Study on Magnetic Field Therapy to Improve Quality of Sleep and Reduction of Chronic Spine Pain|A Double-Blind, Randomized, Placebo-Controlled Study on Magnetic Field Therapy to Improve Quality of Sleep and Reduction of Chronic Spine Pain (Sleep/Mag)|Unknown status|Recruiting|Phase 4|80|Anticipated|Weintraub, Michael I., MD, FACP, FAAN|||||f||||f||||||||||2017-02-18 15:47:59.141392|2017-02-18 15:47:59.141392
NCT00445120|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-01-28|||March 2007||2007-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment|Multicenter, Randomised, Double Masked, Controlled Studies on the Efficacy of Lactobacillus Rhamnosus GG Treatment in Preventing Vernal Keratoconjunctivitis VKC) Relapses.|Completed||Phase 2/Phase 3|48|Anticipated|Campus Bio-Medico University||2|||f||||f||||||||||2017-02-18 15:47:59.239878|2017-02-18 15:47:59.239878
NCT00445107|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2016-05-13|||November 2005||2005-11-01|May 2016|2016-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|STAR||SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)|An Open Label, Observational Study to Assess The Efficacy, Safety and Tolerability of Added Singulair in Persistent Asthma Patients With or Without Allergic Rhinitis and Long Acting B-Agonist|Completed||Phase 3|198|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:47:59.352044|2017-02-18 15:47:59.352044
NCT00445094|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2017-02-15|||November 2006||2006-11-01|February 2017|2017-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)|A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit|Completed||Phase 4|120|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:47:59.432734|2017-02-18 15:47:59.432734
NCT00445081|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2010-10-28|||March 2007||2007-03-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|PROVE||Prednisolone vs. Ciclosporine in Severe Atopic Eczema|Prednisolone vs. Ciclosporine in Severe Atopic Eczema|Completed||Phase 4|66|Anticipated|Technische Universität Dresden||2|||f||||t||||||||||2017-02-18 15:47:59.516888|2017-02-18 15:47:59.516888
NCT00445068|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2013-05-08|||April 2007||2007-04-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma|A Phase II Study Of Oral LBH589 In Adult Patients With Multiple Myeloma Who Have Received At Least Two Prior Lines Of Therapy And Whose Disease Is Refractory To The Most Recent Line Of Therapy|Terminated||Phase 2|38|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:47:59.631904|2017-02-18 15:47:59.631904
NCT00445055|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2011-12-12|||April 2007||2007-04-01|December 2011|2011-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|DIPAVO||Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative Nausea|Study of Evaluation of the Profile of Efficiency / Tolerance of 2 Doses of Intravenous Droperidol in the Prevention of the Postoperative Nausea and Vomits Related to the Surgery of the Thyroid|Terminated||Phase 4|71|Actual|University Hospital, Bordeaux||3|||f||||f||||||||||2017-02-18 15:47:59.767236|2017-02-18 15:47:59.767236
NCT00445042|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-03-15|||November 2005||2005-11-01|March 2016|2016-03-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer|A Phase II Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|71|Actual|The Methodist Hospital System||1|||f||||f||||||||No||2017-02-18 15:47:59.88769|2017-02-18 15:47:59.88769
NCT00445029|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2007-10-03|||March 2007||2007-03-01|October 2007|2007-10-01||||||||Observational|||Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation|Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation|Unknown status|Recruiting|N/A|36|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 15:47:59.996812|2017-02-18 15:47:59.996812
NCT00445016|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2008-05-05|||May 2008||2008-05-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|||||Observational|||Neurologic Complications in Peripheral Regional Anesthesia - An Evaluation Based on a Standardized Protocol|Neurologic Complications in Peripheral Regional Anesthesia - A Clinical Follow Up Study to Evaluate the Incidence of Neurologic Complications Defined According to a Standardized Protocol Considering Motoric and Sensory Function and Pain|Unknown status|Active, not recruiting|N/A|1000|Anticipated|BG Unfallklinik|||1||f||||||||||||||2017-02-18 15:48:00.070302|2017-02-18 15:48:00.070302
NCT00445003|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2016-08-25|2011-04-14||March 2007||2007-03-01|August 2016|2016-08-01|July 2010|Actual|2010-07-01|October 2009|Actual|2009-10-01||Interventional|LRTforDME+PRP||Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy|Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy|Completed||Phase 3|333|Actual|Jaeb Center for Health Research||3|||f||||t||||||||||2017-02-18 15:48:00.184518|2017-02-18 15:48:00.184518
NCT00444990|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-09-20|||February 2007||2007-02-01|September 2007|2007-09-01|December 2007||2007-12-01|||||Interventional|LBP||Study on Magnetic Field Therapy to Improve Chronic Lumbar Pain|A Double-Blind, Randomized, Placebo-Controlled Study on Magnetic Field Therapy to Improve Chronic Lumbar Pain (Lbp)|Unknown status|Recruiting|Phase 4|60|Anticipated|Weintraub, Michael I., MD, FACP, FAAN|||||f||||||||||||||2017-02-18 15:48:02.736629|2017-02-18 15:48:02.736629
NCT00444977|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2013-07-03|||April 2005||2005-04-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Enhancing Oral Health Care Use by HIV Positive Individuals|Enhancing Oral Health Care Use by HIV-Positives|Completed||N/A|600|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 15:48:02.828714|2017-02-18 15:48:02.828714
NCT00444964|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-03-07|||April 2005||2005-04-01|March 2007|2007-03-01|February 2007||2007-02-01|||||Interventional|||Growth Hormone Use in Adults With Prader-Willi Syndrome|Growth Hormone Use in Adults With Prader-Willi Syndrome|Unknown status|Recruiting|Phase 3|10||Children's Mercy Hospital Kansas City|||||f||||t||||||||||2017-02-18 15:48:02.929934|2017-02-18 15:48:02.929934
NCT00444951|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2015-06-16|2011-02-09||February 2007||2007-02-01|June 2015|2015-06-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia|Evaluation of the Response to a Single Dose of Menactra® in Adolescents Aged 16 to 19 Years Who Previously Received One Dose of Quadrivalent (A, C, Y, W 135) and at Least One Dose of Bivalent (A, C) Meningococcal Polysaccharide Vaccine in Saudi Arabia.|Completed||Phase 3|450|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 15:48:03.024827|2017-02-18 15:48:03.024827
NCT00442780|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2009-01-08|||August 2007||2007-08-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|MOBILE||Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Multiple Doses of BIIB014 Administered Orally in Subjects With Early Parkinson's Disease|Completed||Phase 2|36|Actual|Biogen||4|||f||||t||||||||||2017-02-18 15:48:03.849861|2017-02-18 15:48:03.849861
NCT00442767|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2010-11-30|||February 2007||2007-02-01|November 2010|2010-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus|Reducing Postprandial Hyperglycemia With Adjuvant Premeal Pramlintide and Postmeal Insulin in Children With Type 1 Diabetes Mellitus.|Completed||Phase 4|8|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 15:48:03.96911|2017-02-18 15:48:03.96911
NCT00444938|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-02-04|||June 2006||2006-06-01|March 2007|2007-03-01|March 2008|Actual|2008-03-01|||||Interventional|||Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device in the Treatment of Bipolar Depression|Evaluation of the H-Coil (TMS) Device - Safety and Feasibility in Bipolar Depression|Completed||Phase 1|||Shalvata Mental Health Center|||||f||||t||||||||||2017-02-18 15:48:04.063367|2017-02-18 15:48:04.063367
NCT00444925|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2015-03-04|2009-07-14||April 2007||2007-04-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)|12-Week, Randomized, Double-Blind, Double-Dummy,Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Comparison To Tolterodine ER In Patients With Overactive Bladder (OAB)|Completed||Phase 3|1712|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 15:48:04.16543|2017-02-18 15:48:04.16543
NCT00444912|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2014-02-10|2010-06-25||February 2006||2006-02-01|February 2014|2014-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)|A Pilot Cohort Study of AMD3100 in Combination With G-CSF and Rituximab Compared With AMD3100 in Combination With G-CSF Alone for Mobilization of BPCs in Patients With Relapsed or Refractory NHL or HD Prior to Autologous HPC Transplant|Completed||Phase 2|30|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:48:06.189794|2017-02-18 15:48:06.189794
NCT00444899|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-12-22|||March 2007||2007-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|December 2013|Actual|2013-12-01||Interventional|GRC||Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Type 2 Diabetes Patients|Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Diabetic Patients|Active, not recruiting||N/A|80|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-02-18 15:48:07.035972|2017-02-18 15:48:07.035972
NCT00444886|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2011-02-09|||May 2007||2007-05-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Treatment of Thoracic Outlet Syndrome (TOS) With Botox|Treatment of Thoracic Outlet Syndrome With Botulinum Toxin Injection: A Double-Blind, Randomized Controlled Trial|Completed||Phase 2|40|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 15:48:07.135513|2017-02-18 15:48:07.135513
NCT00444873|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-06-18|||January 2005||2005-01-01|June 2012|2012-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly|A Phase III, Multicentre, Open Label, Comparative, Dose-interval Titration Study Evaluating the Efficacy and Safety of Six Repeated Deep Subcutaneous Administrations of Lanreotide Autogel 120mg, in Acromegalic Patients Previously Treated With Octreotide LAR|Completed||Phase 3|38|Actual|Ipsen||3|||f||||f||||||||||2017-02-18 15:48:07.251862|2017-02-18 15:48:07.251862
NCT00444860|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2015-06-03|||March 2007||2007-03-01|June 2015|2015-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||ZOSTAVAX(R) Local Registration Trial (V211-019)|A Phase III Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of ZOSTAVAX(R) in Healthy Adults in Taiwan|Completed||Phase 3|150|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:48:07.364434|2017-02-18 15:48:07.364434
NCT00444847|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2007-04-02|||July 2005||2005-07-01|March 2007|2007-03-01||||||||Interventional|DANET1||Effect of Repeated Exposures to Compressed Air on Patients With AIDS|Effect of Repeated Exposure to Compressed Air on Patients With AIDS (Acquired Immunodeficiency Syndrome)|Suspended||Phase 2|||Designed Altobaric Technology, Incorporated||||Change in institutional headquarters for the US study.|f||||t||||||||||2017-02-18 15:48:07.457953|2017-02-18 15:48:07.457953
NCT00444834|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-08-26|||April 2007||2007-04-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension|A Phase II, Multi-center, Multiple-dose, Double-blind, Randomized, Crossover Study Comparing the Pharmacodynamic Effects of a Once-daily Controlled-Release Carvedilol (CRC; Egalet® Formulation) and an Immediate-Release Carvedilol (IRC) Formulation in Patients With Primary Hypertension|Terminated||Phase 2|14|Actual|Egalet Ltd||2||IMP supply|f||||f||||||||||2017-02-18 15:48:07.543486|2017-02-18 15:48:07.543486
NCT00444821|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2010-02-04|||March 2005||2005-03-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|December 2008|Actual|2008-12-01||Interventional|||The (PIVOTAL) Study|Positive Impact of Endovascular Options for Treating Aneurysms Early (PIVOTAL)|Terminated||Phase 4|728|Actual|Medtronic Vascular||1||Interim analysis of Primary Endpoint completed|f||||||||||||||2017-02-18 15:48:07.641715|2017-02-18 15:48:07.641715
NCT00444808|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2008-06-02|||February 2007||2007-02-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|||||Interventional|||Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs|Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs|Terminated||Phase 4|19|Actual|Université de Montréal||1||Medication expired|f||||f||||||||||2017-02-18 15:48:07.969694|2017-02-18 15:48:07.969694
NCT00444795|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-12-06|2016-02-19||May 2007||2007-05-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Observational||Safety Analysis Set: Participants who administered Sutene at least once and were evaluated upon its related safety endpoints at least once.|Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene|Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene|Completed||N/A|520|Actual|Pfizer|||3||f||||f||||||||||2017-02-18 15:48:08.069279|2017-02-18 15:48:08.069279
NCT00444782|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2008-12-17|||November 2006||2006-11-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.|"Heptovax - A Phase II, Open-Label Trial Evaluating the Safety and Efficacy of GV1001 in Advanced Hepatocellular Carcinoma."|Completed||Phase 2|41|Anticipated|Pharmexa A/S||1|||f||||||||||||||2017-02-18 15:48:08.523436|2017-02-18 15:48:08.523436
NCT00444769|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2009-05-15|||October 2006||2006-10-01|May 2009|2009-05-01||||||||Interventional|||Dental Pain 3rd Molar Tooth Extraction GW842166|A Multi-Centre, Randomised, Single-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy of Single Pre-Emptive Doses of GW842166X, a Non-Cannabinoid CB2 Receptor Agonist, on Pain Following Third Molar Tooth Extraction.|Completed||Phase 2|112|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:48:08.617985|2017-02-18 15:48:08.617985
NCT00444756|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2007-03-07|||April 2005||2005-04-01|March 2007|2007-03-01|April 2006||2006-04-01|||||Interventional|||Jet Injection of 1% Buffered Lidocaine Versus Topical ELA-Max for Anesthesia Prior to Intravenous (IV) Catheterization in Children|Jet Injection of 1% Buffered Lidocaine Versus Topical ELA-Max for Anesthesia Prior to Peripheral Intravenous Catheterization in Children|Completed||Phase 4|70||Norton Healthcare|||||f||||t||||||||||2017-02-18 15:48:08.70475|2017-02-18 15:48:08.70475
NCT00444743|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2008-12-16|||February 2007||2007-02-01|December 2008|2008-12-01||||November 2008|Actual|2008-11-01||Interventional|||Phase 2 Study of MM-093 to Treat Patients With Uveitis|A Phase 2, Double - Blind, Placebo - Controlled, Randomized Study to Evaluate the Tolerability, Pharmacokinetics, Pharmacodynamics, and Biologic Activity of MM-093 in Patients With Moderate to Severe Uveitis|Completed||Phase 2|20|Anticipated|Merrimack Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:48:08.82075|2017-02-18 15:48:08.82075
NCT00444730|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2014-08-26|||January 2007||2007-01-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Urology Database for Outcomes Research|Urology Database for Outcomes Research|Completed||N/A|860|Actual|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 15:48:08.922461|2017-02-18 15:48:08.922461
NCT00444717|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2011-07-12|||April 2007||2007-04-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome|Multicenter Study for Anti-oxidative and Anti-inflammatory Effects of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome|Completed||Phase 4|100|Actual|Aichi Gakuin University||1|||f||||t||||||||||2017-02-18 15:48:09.018204|2017-02-18 15:48:09.018204
NCT00444704|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-07-08|||March 2007||2007-03-01|July 2009|2009-07-01|December 2007|Actual|2007-12-01|||||Interventional|||Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRA-027 Administered Orally to Healthy Japanese Females|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:48:09.129644|2017-02-18 15:48:09.129644
NCT00444691|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-08-25|||March 2007||2007-03-01|August 2009|2009-08-01|April 2010|Anticipated|2010-04-01|August 2008|Actual|2008-08-01||Interventional|SEA||Sensitivity of Echography in Arthritis|Sensitivity of Echography in Arthritis|Unknown status|Active, not recruiting|N/A|120|Anticipated|Association de Recherche Clinique en Rhumatologie||1|||f||||f||||||||||2017-02-18 15:48:09.209248|2017-02-18 15:48:09.209248
NCT00444678|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-01-25|||June 2004||2004-06-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|August 2012|Actual|2012-08-01||Interventional|||Cetuximab, Capecitabine and Oxaliplatin in Patients With Epidermal Growth Factor Receptor (EGFr) Expressing Metastatic Colorectal Cancer|A Phase II Study of Cetuximab Plus Biweekly Capecitabine and Oxaliplatin (C-CO2) in the Treatment of Patients With EGFR-Expressing Metastatic Colorectal Cancer|Completed||Phase 2|38|Actual|New York University School of Medicine||1|||f||||t||||||||||2017-02-18 15:48:09.318772|2017-02-18 15:48:09.318772
NCT00444665|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-11-18|||May 2007||2007-05-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy|Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy|Completed||Phase 4|750|Anticipated|Alcon Research|||||f||||f||||||||||2017-02-18 15:48:09.444252|2017-02-18 15:48:09.444252
NCT00444652|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2012-06-28|||November 2006||2006-11-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Thromboprophylaxis and Bariatric Surgery|Thromboprophylaxis During Bariatric Surgery|Unknown status|Recruiting|Phase 4|300|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-02-18 15:48:09.543623|2017-02-18 15:48:09.543623
NCT00444639|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2009-12-10|||February 2007||2007-02-01|December 2009|2009-12-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)|Phase II Multi-Centric, Randomised, Open-label, Parallel-Group Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer|Terminated||Phase 2|25|Actual|Ipsen||2||Low recruitment|f||||||||||||||2017-02-18 15:48:09.64737|2017-02-18 15:48:09.64737
NCT00444626|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2015-04-07|2015-04-07||May 2007||2007-05-01|April 2015|2015-04-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|||A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)|A Subject- and Evaluator-Blinded, Randomized, Multi-Center Study to Evaluate the Safety and Effectiveness of Injection With DGE Injectable Gel as Compared to an FDA-Approved Dermal Filler in Subjects Undergoing Cutaneous Correction of Nasolabial Folds|Completed||Phase 3|140|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:48:09.898795|2017-02-18 15:48:09.898795
NCT00444613|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2014-12-04|||April 2007||2007-04-01|December 2014|2014-12-01|July 2014|Actual|2014-07-01|March 2014|Actual|2014-03-01||Interventional|||A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Phase II/III Study in Patients With Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2/Phase 3|373|Actual|Eisai Inc.||3|||f||||||||||||||2017-02-18 15:48:10.833184|2017-02-18 15:48:10.833184
NCT00444600|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2016-08-25|2011-01-14||March 2007||2007-03-01|August 2016|2016-08-01|February 2014|Actual|2014-02-01|December 2009|Actual|2009-12-01||Interventional|LRT for DME||Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema|Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination With Laser Photocoagulation for Diabetic Macular Edema|Completed||Phase 3|691|Actual|Jaeb Center for Health Research||4|||f||||t||||||||||2017-02-18 15:48:11.174157|2017-02-18 15:48:11.174157
NCT00444587|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-07|2016-05-12|2016-03-16||March 2007||2007-03-01|May 2016|2016-05-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional||The Safety Population included all participants who entered the trial and received at least one dose of trial medication.|A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.|A Multicenter Phase II Trial of Trastuzumab (Herceptin) Continuation in Combination With 2nd-line Chemotherapies After Progression on a 1st-line Chemotherapy Combined With Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer (Treatment Beyond Progression, TBP)|Completed||Phase 2|114|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:48:15.689253|2017-02-18 15:48:15.689253
NCT00444574|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2015-06-23|||September 2004||2004-09-01|June 2015|2015-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD|A Phase III, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled, Dose Optimization Study, Designed to Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) vs. CONCERTA® in Pediatric Patients Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|282|Actual|Noven Therapeutics||3|||f||||f||||||||||2017-02-18 15:48:16.409058|2017-02-18 15:48:16.409058
NCT00444561|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2015-06-10|||August 2004||2004-08-01|May 2015|2015-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects|A Phase 2, Randomized, Double‑Blind, Placebo‑Controlled, Multicenter Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects|Completed||Phase 2|184|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 15:48:16.523547|2017-02-18 15:48:16.523547
NCT00444548|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2011-05-31|||May 2007||2007-05-01|May 2011|2011-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Evaluation of A Novel Methodology in the Assessment of Urethral Function Using [S,S]-Reboxetine in Healthy Volunteers|Measurement Of Urethral Function In Healthy Female Volunteers - Evaluation Of The Sensitivity of Urethral Reflectometry Compared To Urethral Pressure Profilometry, Using [S,S]-Reboxetine.|Completed||N/A|12|Actual|Pfizer|||||f||||||||||||||2017-02-18 15:48:16.632651|2017-02-18 15:48:16.632651
NCT00444535|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2016-04-19|2009-07-09||February 2007||2007-02-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|July 2008|Actual|2008-07-01||Interventional|||Lapatinib and Bevacizumab for Metastatic Breast Cancer|A Phase II, Open-Label Study of the Clinical Activity, Safety, and Tolerability of Lapatinib in Combination With Bevacizumab in Subjects With Advanced or Metastatic ErbB2-Overexpressing Breast Cancer|Active, not recruiting||Phase 2|52|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:48:16.720999|2017-02-18 15:48:16.720999
NCT00444522|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-03-07|||June 2005||2005-06-01|March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||Staccato® Alprazolam for Inhalation in Panic Disorder|Safety, Tolerability, and Pharmacokinetics of a Single Dose of StaccatoTM Alprazolam for Inhalation in Normal, Healthy Volunteers|Completed||Phase 1|50||Alexza Pharmaceuticals, Inc.|||||f||||f||||||||||2017-02-18 15:48:17.281111|2017-02-18 15:48:17.281111
NCT00444509|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2016-10-26|||February 2007||2007-02-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.|A Randomised, Double Blind, Two-way Crossover Study, to Examine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Inhaled Administration of GW685698X (800 mcg) With and Without Magnesium Stearate, in Mild/Moderate Asthmatic Patients.|Completed||Phase 1|20|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:48:17.362|2017-02-18 15:48:17.362
NCT00444496|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2008-02-12|||February 2007||2007-02-01|February 2008|2008-02-01|July 2007|Actual|2007-07-01|||||Observational|||SPHERE Hypertension Baseline Data Study|SPHERE Hypertension Baseline Data Study|Completed||N/A|470|Actual|University of Washington|||1||f||||t||||||||||2017-02-18 15:48:17.473039|2017-02-18 15:48:17.473039
NCT00444483|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-03-06||||||March 2007|2007-03-01||||||||Interventional|||Structured Patient Education and Quality of Life of Elderly Patients With Diabetes Mellitus- a Prospective Study|Structured Treatment and Teaching of Elderly Patients With Type 2 Diabetes Mellitus|Completed||N/A|50||Heidelberg University|||||f||||f||||||||||2017-02-18 15:48:17.552811|2017-02-18 15:48:17.552811
NCT00444470|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-11-29|||February 2003||2003-02-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety of Tranexamic Acid in Reducing Bleeding in Adults Undergoing Spinal Surgery|Efficacy of Tranexamic Acid in Reducing Blood Loss in Adult Patients Having Major Spine Surgery|Completed||Phase 3|151|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 15:48:17.630353|2017-02-18 15:48:17.630353
NCT00444457|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2012-10-10|2010-06-11||May 2007||2007-05-01|October 2012|2012-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study Evaluating 13-valent Pneumococcal Conjugate Vaccine In Healthy Infants|A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of Three Lots of 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in the United States|Completed||Phase 3|1712|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|Commercially available Measles, Mumps, and Rubella-varicella vaccine (MMR-varicella) was not available as planned; the alternate of a commercially available MMR and a commercially available varicella vaccine was administered in separate injections.|4|||f||||||||||||||2017-02-18 15:48:17.991681|2017-02-18 15:48:17.991681
NCT00444444|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-06-25|||February 2002||2002-02-01|March 2007|2007-03-01|June 2007|Actual|2007-06-01|||||Observational|||Genetic Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP)|Clinical Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP) in Korean Population Based on the HLA Analysis by Using a High Resolution (Sequence Based) Techniques|Completed||N/A|40|Actual|Asan Medical Center|||||f||||f||||||||||2017-02-18 15:48:24.34503|2017-02-18 15:48:24.34503
NCT00444431|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-03-05|||March 2007||2007-03-01|March 2007|2007-03-01||||||||Interventional|TOKU||Ureteropelvic Junction Obstruction in Early Childhood: Comparison of Surgical Therapy and Surveillance. A Prospective, Randomized, Controlled Multi-Center Study|Ureteropelvic Junction Obstruction in Early Childhood: Comparison of Surgical Therapy and Surveillance in Children With Scintigraphically Prooved Obstruction. A Prospective, Randomized, Controlled Multi-Center Study|Unknown status|Not yet recruiting|N/A|240||University Hospital, Essen|||||f||||t||||||||||2017-02-18 15:48:24.430216|2017-02-18 15:48:24.430216
NCT00444418|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2013-04-30|||April 2006||2006-04-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||Medication and Counseling for Controlled Drinking (Project SMART)|Naltrexone and CBT for Problem-drinking MSM|Completed||Phase 3|200|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||4|||f||||t||||||||||2017-02-18 15:48:24.519608|2017-02-18 15:48:24.519608
NCT00444405|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2011-10-12|||March 2007||2007-03-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|||||Observational|||Surgical Treatment Comparison for Recurrent Lumbar Disc Herniation|Surgical Treatment Comparison for Recurrent Lumbar Disc Herniation|Withdrawn||Phase 4|4|Actual|St. John's Health System, Missouri|||1||f||||t||||||||||2017-02-18 15:48:24.635483|2017-02-18 15:48:24.635483
NCT00444392|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2016-11-17|||March 2007||2007-03-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus|Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus|Completed||Phase 3|9|Actual|Vanderbilt University||1|||f||||t||||||||||2017-02-18 15:48:24.927048|2017-02-18 15:48:24.927048
NCT00444379|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2014-08-19|||April 2007||2007-04-01|August 2014|2014-08-01|July 2012|Actual|2012-07-01|February 2012|Actual|2012-02-01||Interventional|ARKS||Anti-Retrovirals for Kaposi's Sarcoma|A Randomized Comparison of Protease Inhibitor-based Versus Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy for Initial Treatment of Individuals With AIDS-related Kaposi's Sarcoma in Sub-Saharan Africa|Completed||Phase 4|224|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 15:48:25.024522|2017-02-18 15:48:25.024522
NCT00444353|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2008-04-22|||August 2004||2004-08-01|April 2008|2008-04-01|January 2007|Actual|2007-01-01|||||Interventional|||DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up|A Randomized Study of the Safety and Effectiveness of DL6049 (Injectable Poly-l-Lactic Acid) Versus Cosmoplast Collagen Implant in the Treatment of Nasolabial Fold Wrinkles (Long Term Follow-up)|Completed||Phase 3|240||Sanofi|||||f||||f||||||||||2017-02-18 15:48:25.144234|2017-02-18 15:48:25.144234
NCT00444340|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-12-05|||April 2004||2004-04-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis|An Open-Label Multicentre Long-Term Extension Study of Etanercept in Ankylosing Spondylitis|Completed||Phase 4|70||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:48:25.212196|2017-02-18 15:48:25.212196
NCT00444327|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2009-05-13|||March 2007||2007-03-01|May 2009|2009-05-01||||||||Observational|||Use Cord Blood Single Nucleotide Polymorphism to Predict the Later Development of Atopy and Allergy|Observational Study of Cord Blood Single Nucleotide Polymorphisms of Genes Related to Atopy and Allergic Diseases|Unknown status|Recruiting|N/A|900|Anticipated|Min-Sheng General Hospital|||1||f||||t||||||||||2017-02-18 15:48:25.28679|2017-02-18 15:48:25.28679
NCT00444314|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2011-08-03|||February 2007||2007-02-01|August 2011|2011-08-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma|Phase II Study of 2-Methoxyestradiol Nanocrystal Colloidal Dispersion Alone and in Combination With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma Progressing on Sunitinib Malate|Completed||Phase 2|82|Anticipated|CASI Pharmaceuticals, Inc.||2|||f||||||||||||||2017-02-18 15:48:25.359558|2017-02-18 15:48:25.359558
NCT00444301|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2008-06-08|||June 2006||2006-06-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|PAIN-HF||Pain Assessment, Incidence & Nature in Heart Failure|Investigating Pain in Heart Failure Patients|Completed||Early Phase 1|349|Actual|PC-HEART|||1||f||||f||||||||||2017-02-18 15:48:28.123408|2017-02-18 15:48:28.123408
NCT00444288|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2017-01-24|||February 27, 2007||2007-02-27|March 1, 2010|2010-03-01|March 1, 2010||2010-03-01|||||Observational|||PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2|PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:48:28.238173|2017-02-18 15:48:28.238173
NCT00443352|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2014-04-25|2014-02-19||August 2007||2007-08-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache|A Single-Center, Open Label Pilot Study Examining The Use Of Duloxetine In The Prevention Of Episodic Migraine|Completed||Phase 4|27|Actual|Thomas Jefferson University|This trial was uncontrolled. Five of the 27 subjects did not complete.|1|||f||||t||||||||||2017-02-18 15:48:42.098777|2017-02-18 15:48:42.098777
NCT00444275|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2012-11-14|2010-03-29||March 2007||2007-03-01|November 2012|2012-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|MAESTRO||Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients|A Randomized, Open, Parallel-group Study to Evaluate the Efficacy of Three Different Patient Management Strategies During a 12 Weeks Maintenance Phase Following an Initial 4-weeks Acute Treatment Phase in Subjects With Symptoms Thought to be GERD Related|Completed||Phase 4|3029|Actual|AstraZeneca|"Planned number of patients not reached: statistical analysis plan revised,comparisons between treatment arms performed globally (No stratified analysis).~Safety pop=3032-3 incorrect enrolments (withdrawals at V2) with no information on ttmt received"|5|||f||||f||||||||||2017-02-18 15:48:28.330841|2017-02-18 15:48:28.330841
NCT00444262|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2011-10-06|||April 2007||2007-04-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|November 2010|Actual|2010-11-01||Interventional|FRACTALE||Stroke Volume Optimisation in Patients With Hip Fracture|"Study Multicentric, Randomised, in Duplicate Blind Person of the Impact of a Per Operatory Strategy of Optimization of the Cardiac Output on the Forecast of the Old Subjects Operated for Fracture of the Upper End of the Femur  FRACTALE "|Terminated||Phase 3|215|Actual|Assistance Publique - Hôpitaux de Paris||2||termination of the study due to difficulties to include patients|f||||t||||||||||2017-02-18 15:48:29.218576|2017-02-18 15:48:29.218576
NCT00444249|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2009-04-20|||March 2007||2007-03-01|April 2009|2009-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|BluMel||Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of Melatonin|Influence of Blue Light Filtering Intra Ocular Lenses on Daytime Levels of Melatonin in Patients With Non-Exudative Age-Related Macular Degeneration|Terminated||N/A|136|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||4||Because only a few patients follow the inclusion and exclusion criteria.|f||||f||||||||||2017-02-18 15:48:29.410221|2017-02-18 15:48:29.410221
NCT00444236|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2016-01-19|||April 2007||2007-04-01|January 2016|2016-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression|Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression|Terminated||Phase 1|31|Actual|University of Utah||2||The sponsor decided to terminate the study due to slow enrollment.|f||||t||||||||||2017-02-18 15:48:29.526241|2017-02-18 15:48:29.526241
NCT00444223|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2017-02-15|||May 4, 2004|Actual|2004-05-04|February 2016|2016-02-01|May 15, 2008|Actual|2008-05-15|May 15, 2008|Actual|2008-05-15||Interventional|||Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants|The Biodistribution of N-{4-[3'-[F-18] Fluoroethylphenyl)Amino]-6-quinazolinyl}-Acrylamide ([F-F18]FEQA) in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) and in Healthy Subjects: A Pilot Study|Terminated||N/A|30|Anticipated|Jonsson Comprehensive Cancer Center||1||poor recruitment|f||||f||||||||||2017-02-18 15:48:29.645933|2017-02-18 15:48:29.645933
NCT00444210|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2008-04-08|||June 2004||2004-06-01|April 2008|2008-04-01|April 2006||2006-04-01|||||Interventional|||DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles|A Randomized Study of the Safety and Effectiveness of DL6049 (Injectable Poly-L-Lactic Acid) Versus CosmoPlast Collagen Implant in the Treatment of Nasolabial Fold Wrinkles|Completed||Phase 3|240||Sanofi|||||f||||f||||||||||2017-02-18 15:48:30.135011|2017-02-18 15:48:30.135011
NCT00444197|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-03-05|||August 2001||2001-08-01|March 2007|2007-03-01|January 2006||2006-01-01|||||Interventional|||Community-Based Violence Prevention for High-Risk Youth||Completed||Phase 2|198||Johns Hopkins University|||||f||||f||||||||||2017-02-18 15:48:30.211975|2017-02-18 15:48:30.211975
NCT00444184|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2014-05-09|||March 2007||2007-03-01|May 2014|2014-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost|A Crossover, Double-Masked Comparison Investigating the 24-Hour Intraocular Pressure Control With the Travoprost/Timolol Fixed Combination Versus Travoprost, When Both Are Given in the Evening, in Subjects With Primary Open-Angle Glaucoma|Completed||Phase 4|32|Actual|Aristotle University Of Thessaloniki||2|||f||||f||||||||||2017-02-18 15:48:30.30231|2017-02-18 15:48:30.30231
NCT00444171|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-03-05|||September 2006||2006-09-01|March 2007|2007-03-01|February 2007||2007-02-01|||||Interventional|||Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients|Randomized Controlled Trial to Evaluate Blood Glucose Control by the Model Predictive Control Algorithm With Variable Sampling Rate (eMPC) vs. Routine Glucose Management Protocol in Peri- and Postoperative Period in Cardiac Surgery Patients|Completed||N/A|60||Charles University, Czech Republic|||||f||||f||||||||||2017-02-18 15:48:30.406811|2017-02-18 15:48:30.406811
NCT00444158|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2011-07-22|||March 2007||2007-03-01|July 2011|2011-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects|A Randomized, Double-Blind, Double-Dummy, 2-Period Crossover Study to Characterize the PK/PD Relationship of a 20-Minute Versus a 4-hour Intravenous Infusion of MOA-728 in Subjects on Stable Methadone Maintenance|Completed||Phase 1|24|Anticipated|Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 15:48:30.506517|2017-02-18 15:48:30.506517
NCT00444145|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2010-11-12|||March 2007||2007-03-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|biopsy II||Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?|Do Laryngeal Biopsy Findings Predict Treatment Response in Suspected Laryngopharyngeal Reflux|Completed||Phase 4|30|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 15:48:30.600646|2017-02-18 15:48:30.600646
NCT00444132|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-09-19|||March 2005||2005-03-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS|Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS|Completed||Phase 3|50|Anticipated|Sheba Medical Center|||||f||||||||||||||2017-02-18 15:48:30.707648|2017-02-18 15:48:30.707648
NCT00444119|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-03-05|||May 2004||2004-05-01|March 2007|2007-03-01|April 2005||2005-04-01|||||Observational|||Survey in Patients With Chronic Adrenal Insufficiency in Germany||Completed||N/A|||University of Wuerzburg|||||f||||||||||||||2017-02-18 15:48:30.804173|2017-02-18 15:48:30.804173
NCT00444106|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2011-04-01|2010-12-08||May 2007||2007-05-01|April 2011|2011-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function|An Open-label, Randomized, Single-center, Parallel Group Study of the Effects of Artemether-lumefantrine (Coartem®) Atovaquone-proguanil (Malarone®) and Artesunate-mefloquine on Auditory Function Following the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Patients 12 Years of Age or Older|Completed||Phase 4|265|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:48:30.900873|2017-02-18 15:48:30.900873
NCT00444093|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-08-31|||September 2007||2007-09-01|August 2007|2007-08-01||||||||Interventional|Loop||Prospective Randomized Open Label Study of the Treatment of Therapy-Associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium -|Prospective Randomized Open Label Study of the Treatment of Therapy-Associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium|Unknown status|Not yet recruiting|Phase 3|200|Anticipated|Philipps University Marburg Medical Center|||||f||||t||||||||||2017-02-18 15:48:31.486223|2017-02-18 15:48:31.486223
NCT00444080|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2013-02-01|||October 2006||2006-10-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma|A Multi Center Study Comparing the Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma|Completed||Phase 4|120|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 15:48:31.566692|2017-02-18 15:48:31.566692
NCT00444067|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2014-09-04|2012-07-17||May 2007||2007-05-01|September 2014|2014-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study to Evaluate Safety & Effectiveness of Spinal Sealant|A Prospective, Multi-Center, Randomized Controlled Study to Compare the Spinal Sealant System as an Adjunct to Sutured Dural Repair With Standard of Care Methods During Spinal Surgery|Completed||N/A|98|Actual|Integra LifeSciences Corporation||2|||f||||t||||||||||2017-02-18 15:48:31.681388|2017-02-18 15:48:31.681388
NCT00444054|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2012-09-24|||February 2006||2006-02-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2010|Actual|2010-05-01||Interventional|RECHARGE||The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer|Pilot Feasibility Study Of A Low Carbohydrate Diet In Patients With Advanced Cancer|Completed||N/A|10|Actual|Albert Einstein College of Medicine, Inc.||1|||f||||t||||||||||2017-02-18 15:48:32.152857|2017-02-18 15:48:32.152857
NCT00444041|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2013-01-29|||January 2007||2007-01-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ASSO-LM1||Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer|Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer (mCRC). A Multicenter, Single Arm Phase I/II Academic Trial|Completed||Phase 1/Phase 2|43|Actual|Austrian Society Of Surgical Oncology||1|||f||||t||||||||||2017-02-18 15:48:32.290129|2017-02-18 15:48:32.290129
NCT00444028|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2007-03-05|||October 2005||2005-10-01|March 2007|2007-03-01|November 2005||2005-11-01|||||Interventional|||Staccato® Loxapine for Inhalation in Schizophrenia|Safety, Tolerability, and Pharmacokinetics of a Single Dose of Staccato™ Loxapine for Inhalation in Normal, Healthy Volunteers|Completed||Phase 1|50||Alexza Pharmaceuticals, Inc.|||||f||||f||||||||||2017-02-18 15:48:32.490931|2017-02-18 15:48:32.490931
NCT00444015|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2013-11-21|||March 2007||2007-03-01|June 2011|2011-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)|Phase I Trial Evaluating the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Combination With the SRC Kinase Inhibitor Dasatinib for Patients With Recurrent Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1|34|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 15:48:32.582405|2017-02-18 15:48:32.582405
NCT00444002|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2014-01-09|||July 2005||2005-07-01|January 2014|2014-01-01|July 2010|Actual|2010-07-01|July 2008|Actual|2008-07-01||Observational|||Oxidative Stress and Fatty Acids in Hepatitis C|Hepatitis C Infection With Liver Steatosis Compared to Hepatitis C Infection Without Liver Steatosis: Is There a Difference in Lipid Peroxidation and Indicators of Inflammation?|Completed||N/A|105|Actual|University Health Network, Toronto|||2||f||||f||||||||||2017-02-18 15:48:32.702153|2017-02-18 15:48:32.702153
NCT00443989|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2008-05-27|||March 2007||2007-03-01|March 2007|2007-03-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Observational|VISION-pilot||Troponin-T for Detection of Perioperative Cardiovascular Events|"A Pilot for the:Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study"|Completed||N/A|100|Actual|Rigshospitalet, Denmark|||1||f||||f||||||Samples Without DNA|"~     Troponin-T~   "|||2017-02-18 15:48:32.81149|2017-02-18 15:48:32.81149
NCT00443976|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2016-11-25|||January 2007||2007-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma|A Phase I Study of AT9283 Given As a 24 Hour Infusion on Days 1 and 8 Every Three Weeks in Patients With Advanced Incurable Malignancy|Completed||Phase 1|35|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 15:48:32.910758|2017-02-18 15:48:32.910758
NCT00443963|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-06|2007-12-17|||December 2006||2006-12-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-Steroidal Anti-Inflammatory Drugs|Effects of Esomeprazole Magnesium on Gastric Free Radical Production and Total Antioxidant Capacity in Dyspeptic Patients Receiving Non-Steroidal Anti-Inflammatory Drugs|Terminated||Phase 4|20|Anticipated|Medstar Health Research Institute||||The Principal Investigator is no longer affiliated with the Study Site.|||||f||||||||||2017-02-18 15:48:33.203478|2017-02-18 15:48:33.203478
NCT00443742|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-03|2009-02-17||||||February 2009|2009-02-01||||||||Observational|||Diagnosis of Depression Among Adolescents|Diagnosis of Depression Among Adolescents - a Clinical Validation Study of Key Questions and Questionnaire|Completed||N/A|323|Anticipated|University of Oslo|||||f||||f||||||||||2017-02-18 15:48:33.311667|2017-02-18 15:48:33.311667
NCT00443729|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2015-09-01|2009-10-12||May 2007||2007-05-01|September 2015|2015-09-01|April 2009|Actual|2009-04-01|October 2008|Actual|2008-10-01||Interventional|||MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)|A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK0518 Versus KALETRA in HIV-Infected Patients Switched From a Stable KALETRA-Based Regimen - Study B|Terminated||Phase 3|355|Actual|Merck Sharp & Dohme Corp.|Study was terminated after the primary efficacy analysis at Week 24 did not demonstrate non-inferiority of MK0518 versus KALETRA™.|2||"Primary efficacy analysis at Week 24 did not demonstrate non-inferiority of raltegravir versus~   lopinavir (+) ritonavir"|f||||||||||||||2017-02-18 15:48:33.394887|2017-02-18 15:48:33.394887
NCT00443716|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2010-01-14|||April 1985||1985-04-01|January 2010|2010-01-01|April 1989|Actual|1989-04-01|April 1989|Actual|1989-04-01||Interventional|||Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women|Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women|Completed||N/A|60||Mayo Clinic|||||f||||t||||||||||2017-02-18 15:48:34.623868|2017-02-18 15:48:34.623868
NCT00443703|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2015-10-01|2009-10-16||May 2007||2007-05-01|October 2015|2015-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)|A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK0518 Versus KALETRA in HIV-Infected Patients Switched From a Stable KALETRA-Based Regimen - Study A|Terminated||Phase 3|352|Actual|Merck Sharp & Dohme Corp.|The reason for early termination: Study was terminated after the primary efficacy analysis at Week 24 did not demonstrate non-inferiority of MK0518 versus KALETRA™.|2||"primary efficacy analysis at Week 24 did not demonstrate non-inferiority of raltegravir versus~   lopinavir (+) ritonavir"|f||||||||||||||2017-02-18 15:48:34.715821|2017-02-18 15:48:34.715821
NCT00443690|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2009-02-19|||August 2007||2007-08-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|REACH UP||Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of KW-3902 Injectable Emulsion on Heart Failure Signs and Symptoms, Diuresis, Renal Function, and Clinical Outcomes in Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring Intravenous Therapy|Completed||Phase 3|480|Anticipated|NovaCardia, Inc.||2|||f||||t||||||||||2017-02-18 15:48:35.83109|2017-02-18 15:48:35.83109
NCT00443677|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2009-03-19|||April 2000||2000-04-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|||||Interventional|HD2000||Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)|Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)|Completed||Phase 3|307|Actual|Gruppo Italiano Studio Linfomi||3|||f||||f||||||||||2017-02-18 15:48:36.132177|2017-02-18 15:48:36.132177
NCT00443664|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2008-05-13|||June 2006||2006-06-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|||||Interventional|EMDLT||External Micropulse Diode Laser Transscleral Trabeculoplasty (EMDLT) for Severe Open Angle Glaucoma|External Micropulse Diode Laser Transscleral Trabeculoplasty(EMDLT) For Severe Open Angle Glaucoma|Unknown status|Recruiting|Early Phase 1|30|Anticipated|National University Hospital, Singapore|||||f||||f||||||||||2017-02-18 15:48:36.225815|2017-02-18 15:48:36.225815
NCT00443651|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-05-20|2012-04-18||January 2007||2007-01-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|May 2011|Actual|2011-05-01||Interventional|SUNDIAL||A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis|An Open-Label, Prospective Study of the Safety of Rituximab in Combination With Other Disease-Modifying Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis|Completed||Phase 3|578|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:48:36.32061|2017-02-18 15:48:36.32061
NCT00443638|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-01-29|||May 1998||1998-05-01|January 2013|2013-01-01|April 2000|Actual|2000-04-01|||||Interventional|ElmiraY19||Longitudinal Follow Up of Subjects Enrolled in Randomized Trial of Prenatal and Infancy Home Visitation|Longitudinal Follow Up of Subjects Enrolled in Randomized Trials of Prenatal and Infancy Home Visitation|Completed||N/A|320|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-02-18 15:48:37.325958|2017-02-18 15:48:37.325958
NCT00443625|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2013-04-16|||December 2006||2006-12-01|April 2013|2013-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Phase 1 Study of SK3530 to Investigate of the Effect of Food|Clinical Trials to Investigate the Influence of Food on Pharmacokinetics of SK3530 in Healthy Male Volunteers.|Completed||Phase 1|15||SK Chemicals Co.,Ltd.|||||f||||||||||||||2017-02-18 15:48:37.419199|2017-02-18 15:48:37.419199
NCT00443612|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2009-09-30|||September 2006||2006-09-01|September 2009|2009-09-01||||October 2008|Actual|2008-10-01||Interventional|||Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing|A Randomized, Open Label, Cross-over Comparative Study of Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension|Completed||Phase 4|60|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:48:37.499646|2017-02-18 15:48:37.499646
NCT00443599|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2016-08-19|2014-01-28||November 2006||2006-11-01|August 2016|2016-08-01|January 2014|Actual|2014-01-01|June 2012|Actual|2012-06-01||Interventional|SPECS||SPECS: Safe Pediatric Euglycemia in Cardiac Surgery|Maintaining Normal Blood Sugar Levels in Children Undergoing Heart Surgery to Reduce the Risk of Infections and Improve Recovery (The SPECS Study)|Completed||N/A|989|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 15:48:37.608047|2017-02-18 15:48:37.608047
NCT00443586|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2017-01-23|||September 2004|Actual|2004-09-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|||Follow-up Evaluation of Home Nurse Visitation Program for Socially Disadvantaged Women and Their Children|Age-27 Follow-up of Early Preventive Intervention|Active, not recruiting||N/A|345|Anticipated|University of Colorado, Denver||4|||f||||t|f|f||||||Yes|We plan to share individual participant data once the primary reports on this phase of the trial are published. This includes baseline data on maternal characteristics at registration during pregnancy and outcome data on primary outcomes for offspring participants at the 27-year follow-up. Data will be made available through the University of Michigan Inter-University Consortium for Political and Social Research (ICPSR). We anticipate archiving the data from this study with ICPSR by March 2018|2017-02-18 15:48:38.007912|2017-02-18 15:48:38.007912
NCT00443573|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2008-05-05|||December 2006||2006-12-01|May 2008|2008-05-01||||August 2007|Anticipated|2007-08-01||Interventional|||Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer|Multicenter, Two-Stage Study to Evaluate the Safety and Efficacy of Second-Line Metastatic Colorectal Carcinoma Treatment With Recombinant NAPc2|Suspended||Phase 1/Phase 2|100|Anticipated|ARCA Biopharma, Inc.||1||Company suspended development of product.|f||||t||||||||||2017-02-18 15:48:38.127172|2017-02-18 15:48:38.127172
NCT00443560|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2014-03-17|2011-05-09||January 2006||2006-01-01|March 2014|2014-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||The Association Between Decreasing Labor Analgesia Epidural Infusion and Forceps Delivery|A Retrospective Case-controlled Study of the Association Between Request to Discontinue Second Stage Labor Epidural Analgesia and Risk of Instrumental Vaginal Delivery|Completed||N/A|2162|Actual|Northwestern University|The retrospective design incurs the risk of unrecorded or unobserved data. The sample selected included all patients with neuraxial analgesia who underwent IVD, but a limited sample of SVD.||2||f||||f||||||||||2017-02-18 15:48:38.235978|2017-02-18 15:48:38.235978
NCT00443547|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2011-07-01|||March 2006||2006-03-01|July 2011|2011-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Outcome Study of Patients Treated With Translational Cervical Plate Used to Treat Degenerative Disc Disease|Prospective Multi-Center Clinical Study of Patients With Degenerative Disc Disease Treated With Anterior Cervical Decompression and Fusion Using the Vectra-T Translational Cervical Plate.|Completed||N/A|231|Actual|Synthes USA HQ, Inc.||4|||f||||f||||||||||2017-02-18 15:48:38.680651|2017-02-18 15:48:38.680651
NCT00443534|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-04-02|2012-12-15||May 2006||2006-05-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.|A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.|Completed||N/A|123|Actual|Pfizer|The reason for not completed ‘Study Terminated by Sponsor’ in participant flow table indicates the termination of study at few sites as captured in case report forms at those sites and does not reflect overall status of study.|1|||f||||f||||||||||2017-02-18 15:48:38.808231|2017-02-18 15:48:38.808231
NCT00443521|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2007-03-02|||March 2005||2005-03-01|March 2007|2007-03-01|July 2006||2006-07-01|||||Interventional|||Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy|Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy|Completed||Phase 2/Phase 3|30||University of Sao Paulo|||||f||||t||||||||||2017-02-18 15:48:39.194959|2017-02-18 15:48:39.194959
NCT00443508|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-04|2007-03-05|||February 2007||2007-02-01|September 2005|2005-09-01|February 2010||2010-02-01|||||Interventional|||Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion|Reduction or Discontinuation of Calcineurine Inhibitors With Conversion to Everolimus-Based Immunosuppresion to Alleviate Chronic Allograft Nephropathy (CAN) in Kidney Transplant Recipients: A Prospective Randomized Study|Unknown status|Recruiting|Phase 4|60||Rabin Medical Center|||||f||||f||||||||||2017-02-18 15:48:39.287213|2017-02-18 15:48:39.287213
NCT00443495|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2007-03-02|||October 2006||2006-10-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis|First Into Man Administration of Chitin Microparticles: a Randomised,Double Blind,Placebo Controlled Parallel Group Upward Titration Evaluation of 3 Dose Levels Given Intr-Nasally Over 24 Hours,Followed by a Placebo Controlled,Randomised Parallel Group Evaluation of Safety and Biological Activity Over 7 Days in Subjects Suffering From Allergic Rhinitis|Completed||Phase 1/Phase 2|24||CMP Therapeutics Ltd|||||f||||f||||||||||2017-02-18 15:48:39.394258|2017-02-18 15:48:39.394258
NCT00443482|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2011-10-24|||February 2007||2007-02-01|October 2011|2011-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)|A Randomized, Multi-centre, Double-blind, Double Dummy Placebo Controlled Single-dose Cross-over Study to Demonstrate That 12 and 24 µg of Formoterol Delivered by Concept1 Has a Bronchodilator Efficacy Which is Equivalent to the Same Dose of Formoterol Delivered by Aerolizer in Adult Patients With Persistent Asthma|Completed||Phase 2|50|Actual|Novartis|||||f||||||||||||||2017-02-18 15:48:39.466453|2017-02-18 15:48:39.466453
NCT00443469|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-04|2010-03-30|||August 2006||2006-08-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Spinal Magnetic Stimulation in Neuropathic Pain|A Randomized Placebo-controlled Trial on the Use of Repetitive Spinal Magnetic Stimulation as a Therapeutic Option in Patients With Intractable Neuropathic Pain of the Lower Limbs|Completed||Phase 3|20|Actual|Singapore General Hospital||2|||f||||t||||||||||2017-02-18 15:48:39.561544|2017-02-18 15:48:39.561544
NCT00443456|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2009-10-19|2009-06-10||May 2007||2007-05-01|October 2009|2009-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient|Long-Term Study For Amlodipine 10mg In Patients With Essential Hypertension For Whom Amlodipine 5mg Is Insufficiently Effective|Completed||Phase 3|134|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:48:39.669493|2017-02-18 15:48:39.669493
NCT00443443|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2015-03-26|||January 2007||2007-01-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Observational|SUNSTONE||A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)|A Long-Term Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)|Completed||Phase 4|1026|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 15:48:40.790113|2017-02-18 15:48:40.790113
NCT00443430|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-05-30|2013-03-13||May 2007||2007-05-01|May 2013|2013-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional||2 patients were ineligible|Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis|Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis (TREAT in JIA)|Completed||Phase 4|85|Actual|Seattle Children's Hospital|small number of participants with recent onset poly JIA|2|||f||||t||||||||||2017-02-18 15:48:41.07378|2017-02-18 15:48:41.07378
NCT00443417|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2009-12-08|||April 2007||2007-04-01|January 2008|2008-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease|Dose Finding Study to Assess the Efficacy and Safety of SK-PC-B70M in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|188|Anticipated|SK Chemicals Co.,Ltd.||4|||f||||||||||||||2017-02-18 15:48:41.552817|2017-02-18 15:48:41.552817
NCT00443404|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2011-11-04|||December 2003||2003-12-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Optimized Perioperative Analgesia Reduces the Prevalence and the Intensity of Phantom Pain in Lower Limb Amputation|Double Blind, Placebo Controlled Study for the Study of the Effectiveness of Perioperative Analgesia in Phantom and Stump Pain|Completed||Phase 2/Phase 3|60|Actual|University of Patras||5|||f||||t||||||||||2017-02-18 15:48:41.658908|2017-02-18 15:48:41.658908
NCT00443391|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-01-10||2011-08-18|February 2007||2007-02-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)|The Long-Term Safety and Tolerability of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD): An Open-Label Extension Study|Completed||Phase 2|141|Actual|AbbVie||1|||f||||||||||||||2017-02-18 15:48:41.779|2017-02-18 15:48:41.779
NCT00443378|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-05|2008-01-22|||March 2006||2006-03-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|CARE+||Computer Assisted Rx Education for HIV-Positives: CARE+|Computer Assisted Rx Education for HIV-Positives: CARE+|Completed||N/A|240|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 15:48:41.901813|2017-02-18 15:48:41.901813
NCT00443365|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2008-05-27|||March 2007||2007-03-01|May 2008|2008-05-01||||||||Interventional|||Should we Repair Ischemic Mitral Regurgitation?||Unknown status|Recruiting|N/A|100|Anticipated|Medical University of Silesia||2|||f||||||||||||||2017-02-18 15:48:42.012857|2017-02-18 15:48:42.012857
NCT00443339|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-04|2007-05-15|||December 2006||2006-12-01|March 2007|2007-03-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)|A Phase II Study of Darbepoetin Alpha in Myelodysplastic Syndromes (MSD)|Unknown status|Recruiting|Phase 2|99|Anticipated|Groupe Francophone des Myelodysplasies|||||f||||t||||||||||2017-02-18 15:48:42.357251|2017-02-18 15:48:42.357251
NCT00443326|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2015-12-16||2015-12-16|March 2007||2007-03-01|December 2015|2015-12-01|May 2010|Actual|2010-05-01|December 2008|Actual|2008-12-01||Interventional|||AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects|A Randomized, Double-blind, Placebo-controlled, Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of AMG 714 After Multiple Dose Administration in Subjects With Moderate to Severe Psoriasis|Completed||Phase 2|22|Actual|Amgen||1|||f||||||||||||||2017-02-18 15:48:42.478628|2017-02-18 15:48:42.478628
NCT00443313|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2017-01-24|||January 24, 2007||2007-01-24|June 25, 2015|2015-06-25|June 25, 2015||2015-06-25|||||Observational|||Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta|HPV Testing to Improve Cervical Cancer Screening in the Mississippi Delta (Mississippi Delta Project)|Completed||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:48:42.573916|2017-02-18 15:48:42.573916
NCT00443300|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-08-01|||January 2007||2007-01-01|August 2012|2012-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Effectiveness of Protected Environment Rooms for AML and MDS|"Effectiveness of HEPA-filtered Rooms (Protected Environment) to Prevent Morbidity and Mortality in Patients Age >/ = 60 Receiving Lower Intensity (Targeted) Therapy for Untreated AML and High-risk Myelodysplasia (MDS)"|Terminated||N/A|3|Actual|M.D. Anderson Cancer Center|||2|Terminated due to low accrual.|f||||t||||||||||2017-02-18 15:48:42.668894|2017-02-18 15:48:42.668894
NCT00443287|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2011-03-31|||February 2007||2007-02-01|March 2011|2011-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|ACCELA||Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease|A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial of HMR1766 Assessing the Efficacy and Safety of 3 Doses of HMR1766 Versus Placebo With Cilostazol as a Calibrator, Administered for 26 Weeks in Patients With Peripheral Arterial Disease (PAD) Fontaine Stage II|Completed||Phase 2|553|Actual|Sanofi||5|||f||||||||||||||2017-02-18 15:48:42.767143|2017-02-18 15:48:42.767143
NCT00443274|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2016-10-07|||November 2006||2006-11-01|October 2016|2016-10-01|October 2026|Anticipated|2026-10-01|October 2026|Anticipated|2026-10-01||Observational|BIFS||Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms||Recruiting||N/A|57000|Anticipated|Allergan|||3||f||||||||||||||2017-02-18 15:48:42.937649|2017-02-18 15:48:42.937649
NCT00443261|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2011-10-06|||February 2007||2007-02-01|October 2011|2011-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Phase I Study of Azacitidine in Combination With Cisplatin Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 1|27|Actual|University of Kansas Medical Center||1||Accrual problems|f||||t||||||||||2017-02-18 15:48:50.569972|2017-02-18 15:48:50.569972
NCT00443248|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2009-02-06|||March 2007||2007-03-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|FSAD HWO VBF||Vaginal Heat Wash-Out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)).|A 2-Way Repeatability Study To Investigate Vaginal Blood Flow Before, During And After Visual Sexual Stimulation In Pre- And Post-Menopausal Women With And Without Female Sexual Arousal Disorder, Using The Heat Wash-Out Technique.|Completed||Phase 1|64|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 15:48:50.676169|2017-02-18 15:48:50.676169
NCT00443235|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2011-09-16|||March 2005||2005-03-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|March 2007|Actual|2007-03-01||Interventional|||GEM05 for Patients With Multiple Myeloma More Than 65 Years Old|A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With Melphalan/Prednisone/Velcade Versus Thalidomide / Prednisone / Velcade and Maintenance Treatment With Thalidomide / Velcade Versus Prednisone / Velcade in Untreated Patients With Multiple Myeloma More Than 65 Years Old.|Completed||Phase 3|260|Anticipated|PETHEMA Foundation||2|||f||||t||||||||||2017-02-18 15:48:50.791514|2017-02-18 15:48:50.791514
NCT00443222|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2007-03-02||||||March 2007|2007-03-01||||||||Interventional|||Treatment With TNF Blockade, Infliximab, in Patients With Myositis|An Open Trial With TNF Blockade With Infliximab (Remicade®), in Patients With Chronic Inflammatory Myopathies|Completed||Phase 2/Phase 3|||Karolinska Institutet|||||f||||f||||||||||2017-02-18 15:48:51.216044|2017-02-18 15:48:51.216044
NCT00443209|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-07-13|2014-07-29||February 2007||2007-02-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||Baseline Analyis Population consisted of All Treated Participants.|Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)|A Multicenter, Double-Blind, Active-Controlled, Parallel Group Study to Examine the Safety, Tolerability and Efficacy of Oral MK-0974 for the Long Term Treatment of Acute Migraine With or Without Aura|Completed||Phase 3|1068|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 15:48:51.300979|2017-02-18 15:48:51.300979
NCT00443196|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2011-03-23|||March 2006||2006-03-01|March 2011|2011-03-01|September 2010|Actual|2010-09-01|||||Interventional|||Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas|Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas|Completed||Phase 2/Phase 3|150|Anticipated|DiaTech Oncology||1|||f||||||||||||||2017-02-18 15:48:51.795767|2017-02-18 15:48:51.795767
NCT00443183|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2016-08-04|||May 2002||2002-05-01|August 2016|2016-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Emergency Physician Brief Interventions for Alcohol|Emergency Physician Brief Interventions for Alcohol|Completed||N/A|500|Actual|Yale University||2|||f||||||||||||||2017-02-18 15:48:51.915881|2017-02-18 15:48:51.915881
NCT00443170|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-03-15|||November 2006||2006-11-01|February 2011|2011-02-01||||||||Interventional|||A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects|A Randomized, Blinded, Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Single and Repeat Dose Escalation of the Oral YAK3/DYRK3 Inhibitor GSK626616AC in Healthy Subjects|Completed||Phase 1|90|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:48:52.02608|2017-02-18 15:48:52.02608
NCT00443157|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2008-12-04|||February 2006||2006-02-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|MNB3||Meningococcal B Vaccination in University Students|A Phase II, Open Label, Randomised, Single Centre Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Three or Four Doses of Meningococcal Serogroup B Outer Membrane Vesicle (OMV) Vaccine MENZBTM When Administered to Healthy Adults (University Students)|Completed||Phase 2|50||Public Health England|||||f||||||||||||||2017-02-18 15:48:52.135957|2017-02-18 15:48:52.135957
NCT00443144|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2015-12-02|||May 2005||2005-05-01|December 2015|2015-12-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Observational|||D3-GHR Polymorphism and Turner Syndrome|D3-Growth Hormone Receptor Polymorphism and Total Effect of Recombinant Human Growth Hormone on Growth in Girls With Turner Syndrome|Completed||N/A|||University Hospital Tuebingen|||||f||||f||||||||||2017-02-18 15:48:52.22367|2017-02-18 15:48:52.22367
NCT00443131|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2011-09-29|||March 2007||2007-03-01|September 2011|2011-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines|Adjuvant Justification Study of Candidate Malaria Vaccines (257049), Administered According to a 0, 1, 2 Months Schedule .|Completed||Phase 2|36|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 15:48:52.313337|2017-02-18 15:48:52.313337
NCT00443118|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2015-03-30|2014-02-22||December 2009||2009-12-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Newborn Ventilation in the Delivery Room: Could it be Improved With a T-piece Resuscitator?|NEWBORN VENTILATION IN THE DELIVERY ROOM: CAN IT BE IMPROVED WITH A T-PIECE RESUSCITATOR? Multicenter Cross-over Cluster Randomized Controlled Trial|Completed||Phase 3|1032|Actual|Fundacion para la Salud Materno Infantil||3|||f||||t||||||||||2017-02-18 15:48:52.420246|2017-02-18 15:48:52.420246
NCT00443105|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2007-03-02||||||December 2006|2006-12-01||||||||Interventional|||Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study||Unknown status|Active, not recruiting|Phase 2|||Assaf-Harofeh Medical Center|||||f||||f||||||||||2017-02-18 15:48:53.323669|2017-02-18 15:48:53.323669
NCT00443092|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2012-08-01|||March 2007||2007-03-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy of Proprietary Cherry Juice Blend in Osteoarthritis of the Knee|A Double Blind Cross-over Study of the Efficacy of a Proprietary Cherry Juice Blend in Osteoarthritis of the Knee.|Completed||Phase 4|59|Actual|CherryPharm||2|||f||||f||||||||||2017-02-18 15:48:53.404592|2017-02-18 15:48:53.404592
NCT00443079|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2010-06-24|||March 2007||2007-03-01|June 2008|2008-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)|A Single-center, Single-blinded, Placebo-controlled Pilot Study of IdB 1016 (Siliphos) in Adult Patients With Non-alcoholic Steatohepatitis (NASH)|Completed||Phase 2|10|Anticipated|University of California, San Diego||1|||f||||||||||||||2017-02-18 15:48:53.514509|2017-02-18 15:48:53.514509
NCT00443066|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2017-02-06|||May 2005||2005-05-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|October 2020|Anticipated|2020-10-01||Observational|||Clinical Study of Spinal Muscular Atrophy|Clinical Study of Spinal Muscular Atrophy|Active, not recruiting||N/A|120|Actual|Columbia University|||1||f||||f||||||Samples With DNA|"~     blood and skin tissue~   "|No||2017-02-18 15:48:53.613028|2017-02-18 15:48:53.613028
NCT00443053|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2016-02-18|2010-07-02||March 2007||2007-03-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)|See Detailed Description|Completed||Phase 3|3002|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 15:48:53.716021|2017-02-18 15:48:53.716021
NCT00443040|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2011-11-30|2011-10-14||January 2007||2007-01-01|November 2011|2011-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Asimadoline for the Treatment of Post-Operative Ileus|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Asimadoline on the Duration of POI in Subjects Undergoing Laparoscopic/Hand-Assisted Lap Segmental Colonic Resection Secondary to Colon Cancer, Polypectomy or Diverticulitis|Terminated||Phase 2|35|Actual|Tioga Pharmaceuticals|Early termination leading to small numbers of subjects analyzed; no efficacy analysis was completed.|3||poor enrollment (31 of a planned 114 subjects were randomized and evaluable)|f||||f||||||||||2017-02-18 15:48:54.799616|2017-02-18 15:48:54.799616
NCT00443027|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2009-02-06|||March 2007||2007-03-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|HWO VBF||Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women.|Effect Of Menstrual Cycle On Vaginal Blood Flow (As Determined By The Heat Wash-Out Technique) Before, During And After Visual Sexual Stimulation In Pre-Menopausal Healthy Women.|Completed||Phase 1|12|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 15:48:55.409004|2017-02-18 15:48:55.409004
NCT00443014|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2011-11-09|||June 2003||2003-06-01|November 2011|2011-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Dementia Study in Northern Norway|Phase 4 Study of Cognitive Therapy and Donepezil in Alzheimers Disease.|Completed||Phase 4|187|Actual|University Hospital of North Norway||2|||f||||t||||||||||2017-02-18 15:48:55.50988|2017-02-18 15:48:55.50988
NCT00443001|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2008-07-23|||November 2001||2001-11-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias|Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias|Unknown status|Recruiting|N/A|40|Anticipated|GE Healthcare||1|||f||||t||||||||||2017-02-18 15:48:55.618766|2017-02-18 15:48:55.618766
NCT00442988|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2007-03-02|||October 2000||2000-10-01|March 2007|2007-03-01|October 2005||2005-10-01|||||Observational|||Prediction of NODAT After Renal Transplantation|Early Prediction of New Onset Diabetes Mellitus After Transplantation (NODAT) in Renal Transplantation: Use of Oral Glucose Tolerance Test (OGTT) and Fasting Plasma Glucose (FPG).|Completed||Phase 4|360||Katholieke Universiteit Leuven|||||f||||f||||||||||2017-02-18 15:48:55.699992|2017-02-18 15:48:55.699992
NCT00442975|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2008-07-09|||March 2007||2007-03-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|||||Interventional|CMVflu||Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status|A Phase IV, Single Group Study to Evaluate the Immune Response to Licensed Seasonal Influenza Vaccine and Relationship of This to Cytomegalovirus-Associated Immunosenescence in UK Older Adults Aged 50-80 Years|Completed||Phase 4|100|Actual|Public Health England|||||f||||f||||||||||2017-02-18 15:48:55.87092|2017-02-18 15:48:55.87092
NCT00442962|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2015-06-01|2011-07-13||May 2007||2007-05-01|June 2015|2015-06-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|Nearly Naive||HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV|"The Effect of Prior Short Course Combination Antiretroviral Therapy Administered for the Prevention of Mother-to-Child Transmission (pMTCT) of HIV-1 on Subsequent Treatment Efficacy in Treatment-Nearly Naive Participants"|Completed||Phase 4|54|Actual|AIDS Clinical Trials Group||1|||f||||t||||||||||2017-02-18 15:48:55.964088|2017-02-18 15:48:55.964088
NCT00442949|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2009-02-11|||August 2006||2006-08-01|April 2008|2008-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|ABOARD||Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndrome (ACS)|Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndromes Randomized for an Immediate or Delayed Intervention (The ABOARD Study)|Completed||N/A|400|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:48:56.654527|2017-02-18 15:48:56.654527
NCT00442936|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-06-11|2014-06-17||February 2007||2007-02-01|June 2015|2015-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)|A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Compare the Response to a Single Treatment With Oral MK0974 With Placebo and Comparator in Subjects With Moderate to Severe Acute Migraine With or Without Aura|Completed||Phase 3|1380|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 15:48:56.765584|2017-02-18 15:48:56.765584
NCT00442923|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-05-24||||||May 2013|2013-05-01||||||||Interventional|MARC||"The Evaluation of Stimulant Withdrawal"|Scientific Component IV: Pharmacotherapy to Prevent Methamphetamine Relapse|Withdrawn||Phase 2|0|Actual|Oregon Health and Science University||||This study was withdrawn for lack of progress. No subjects were recruited.|f||||t||||||||||2017-02-18 15:48:57.559564|2017-02-18 15:48:57.559564
NCT00442910|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2010-06-22|||July 2007||2007-07-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Acceptability of SPL7013 Gel (VivaGel™) in Sexually Active Women|Phase 1 Study of the Safety and Acceptability of 3% w/w SPL7013 Gel (VivaGel™) Applied Vaginally in Sexually Active Young Women|Completed||Phase 1|61|Actual|Starpharma Pty Ltd||3|||f||||t||||||||||2017-02-18 15:48:57.650655|2017-02-18 15:48:57.650655
NCT00442897|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-11-18|2009-10-01||September 2006||2006-09-01|November 2015|2015-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)|Evaluate The Lipid-Lowering Efficacy and Safety of Vytorin in Comparison With Atorvastatin in Hypercholesterolaemic Patients With Coronary Artery Disease|Completed||Phase 4|229|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:48:57.784558|2017-02-18 15:48:57.784558
NCT00442884|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2007-03-02|||February 2006||2006-02-01|March 2007|2007-03-01|August 2006||2006-08-01|||||Interventional|||Effect of Acute Psychological Stress on Glucose Concentrations in Patients With Type 2 Diabetes|Effect of Acute Psychological Stress on Glucose Concentrations in Patients With Type 2 Diabetes|Completed||N/A|30||University of Zurich|||||f||||f||||||||||2017-02-18 15:48:58.480428|2017-02-18 15:48:58.480428
NCT00442871|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-05-31|||September 2006||2006-09-01|August 2011|2011-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment|An Open-Label, Non-Randomized Pharmacokinetic and Safety Study of a Single Oral Dose of 50 mg [SB-497115] in Healthy Subjects and in Subjects With Mild, Moderate, or Severe Renal Impairment|Completed||Phase 1|32|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:48:58.568991|2017-02-18 15:48:58.568991
NCT00442858|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2007-03-01|||January 1999||1999-01-01|March 2007|2007-03-01|December 2002||2002-12-01|||||Observational|||Incidence of Cardiovascular Diseases in Patients With Hypopituitarims||Completed||N/A|800||Lund University Hospital|||||f||||f||||||||||2017-02-18 15:48:58.667762|2017-02-18 15:48:58.667762
NCT00442845|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-04-21|||January 2003||2003-01-01|April 2015|2015-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|ACTFAST||Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)|ACTFAST: Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration. A Multicenter, Twelve-Week Treatment, Single Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic High-Risk Patients Achieving Low Density Lipoprotein Cholesterol (LDL-C) Target With Atorvastatin Starting Doses Of 10 Mg, 20 Mg, 40 Mg, And 80 Mg|Completed||Phase 4|2080||Pfizer|||||f||||||||||||||2017-02-18 15:48:58.736242|2017-02-18 15:48:58.736242
NCT00442832|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2009-08-15|||December 2006||2006-12-01|August 2009|2009-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection|A Phase 2, Randomized, Double Blind, Study of Intravenous TD 1792 Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections|Completed||Phase 2|203|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-02-18 15:48:58.939306|2017-02-18 15:48:58.939306
NCT00442819|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2007-03-01|||July 2006||2006-07-01|March 2007|2007-03-01|September 2006||2006-09-01|||||Interventional|||Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial Kidney||Completed||Phase 4|30||China Medical University Hospital|||||f||||t||||||||||2017-02-18 15:48:59.041052|2017-02-18 15:48:59.041052
NCT00442806|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2013-11-25|||November 2007||2007-11-01|November 2013|2013-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction|A Randomized Clinical Trial of AdiPOse-derived Stem ceLLs in the Treatment of Patients With ST-elevation myOcardial Infarction - The APOLLO Trial|Completed||Phase 1|14|Actual|Cytori Therapeutics||2|||f||||t||||||||||2017-02-18 15:48:59.129702|2017-02-18 15:48:59.129702
NCT00442793|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2016-11-01|||May 2007||2007-05-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.|A Randomized, Open Label Study Comparing the Effect of Mircera and Epoetin Beta on Hemoglobin Response in Patients With Chronic Kidney Disease Who Are on Dialysis|Completed||Phase 3|265|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:48:59.235905|2017-02-18 15:48:59.235905
NCT00442715|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2007-03-05|||October 2006||2006-10-01|March 2007|2007-03-01|December 2006||2006-12-01|||||Observational|||Exercise Challenge Test in 3-6 Years Old Asthmatic Children|Exercise Challenge Test in 3-6 Years Old Asthmatic Children|Completed||N/A|100||Sheba Medical Center|||||f||||f||||||||||2017-02-18 15:48:59.443853|2017-02-18 15:48:59.443853
NCT00442702|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2011-12-13|2011-08-29||September 2007||2007-09-01|December 2011|2011-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.|An Open-label, Randomized, Multi-center, Parallel Group Non-inferiority Study of Subcutaneous Injections of RO0503821 Given Once Monthly vs. Darbepoetin Alfa Given According to Local Label in Patients With Chronic Kidney Disease Who Are Not on Dialysis.|Completed||Phase 3|228|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:48:59.546434|2017-02-18 15:48:59.546434
NCT00442689|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2014-05-09|2014-04-09||July 2006||2006-07-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Metabolic Syndrome in PCOS: Precursors and Interventions|Metabolic Syndrome in PCOS: Precursors and Interventions|Completed||N/A|97|Actual|Northwestern University|Please note there were 2 additional arms at the start of the study: Metformin alone (n=8) and Metformin+Flutamide (n=6), which were discontinued. These arms are therefore not included in these results data.|3|||f||||t||||||||||2017-02-18 15:49:00.413794|2017-02-18 15:49:00.413794
NCT00442676|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-03-12|||June 2009||2009-06-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia|Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia|Withdrawn||Phase 2|0|Actual|Virginia Commonwealth University||2||No patients were recruited. Treatment drug expired.|f||||t||||||||||2017-02-18 15:49:01.000074|2017-02-18 15:49:01.000074
NCT00442663|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-04-23|||June 2003||2003-06-01|April 2007|2007-04-01|December 2005|Actual|2005-12-01|||||Interventional|FOLEYEASI||Trial of Foley Catheter With and Without Extra-Amniotic Saline Infusion for Labor Induction|Randomized Trial of Transcervical Foley Catheter With and Without Extra-Amniotic Saline Infusion for Labor Induction|Completed||N/A|170||University of Alabama at Birmingham|||||f||||f||||||||||2017-02-18 15:49:01.122885|2017-02-18 15:49:01.122885
NCT00442650|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2016-11-18|||January 2004||2004-01-01|March 2009|2009-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis||Completed||Phase 3|||Merck KGaA|||||f||||||||||||||2017-02-18 15:49:01.219217|2017-02-18 15:49:01.219217
NCT00442637|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2013-12-11|||January 2007||2007-01-01|December 2013|2013-12-01|December 2013|Anticipated|2013-12-01|September 2013|Actual|2013-09-01||Interventional|CAIRO3||Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma|Maintenance Treatment With Capecitabine and Bevacizumab Versus Observation After Induction Treatment With Chemotherapy and Bevacizumab as First-line Treatment in Patients With Advanced Colorectal Carcinoma|Unknown status|Active, not recruiting|Phase 3|635|Anticipated|Dutch Colorectal Cancer Group||2|||f||||t||||||||||2017-02-18 15:49:01.30496|2017-02-18 15:49:01.30496
NCT00442624|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-03-08|||January 2007||2007-01-01|March 2012|2012-03-01|December 2008||2008-12-01|||||Observational|||Effects of Chronic Insomnia on the Neuroendocrine Regulation of Glucose and Lipid Metabolism|Effects of Chronic Insomnia on the Neuroendocrine Regulation of Glucose and Lipid Metabolism|Completed||Early Phase 1|25|Actual|University Hospital, Basel, Switzerland|||2||f||||t||||||Samples Without DNA|"~     plasma and serum samples~   "|||2017-02-18 15:49:01.422602|2017-02-18 15:49:01.422602
NCT00442611|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2015-04-23|2015-01-26||November 2008||2008-11-01|April 2015|2015-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)|A Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Systemic Sclerosis|Completed||Phase 1/Phase 2|10|Actual|Stanford University||2|||f||||||||||||||2017-02-18 15:49:01.516005|2017-02-18 15:49:01.516005
NCT00442598|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-03-06|2015-02-20||January 2007||2007-01-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy Study of Glufosfamide in Ovarian Cancer|An Open-Label Phase 2 Study of the Safety and Efficacy of Glufosfamide in Ovarian Cancer|Terminated||Phase 2|17|Actual|Eleison Pharmaceuticals LLC.||3|||f||||f||||||||||2017-02-18 15:49:01.897334|2017-02-18 15:49:01.897334
NCT00442585|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-03-12|||September 2006||2006-09-01|March 2012|2012-03-01|October 2007|Actual|2007-10-01|||||Interventional|||S(+)-Ibuprofen Effects on Asprin Treated Volunteers|Double Blind, Randomised, Parallel Group, Placebo Controlled Clinical Trial of S(+)-Ibuprofen Effects on TxB2 Concentrations and Platelet Aggregation in Aspirin-treated Healthy Adult Volunteers|Completed||Phase 1|72||Gebro Pharma GmbH|||||f||||f||||||||||2017-02-18 15:49:02.790077|2017-02-18 15:49:02.790077
NCT00442572|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-03-10|2015-12-08||July 2006||2006-07-01|March 2016|2016-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||Safety population included all the randomized participants who passed during at least one treatment period, and had at least one efficacy and safety evaluation.|SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).|Stop Progression of Fibrosis by Administration of Intermittent Continuous Treatment With Peginterferon Alfa-2a. Open-label, Randomized Efficacy and Safety Clinical Trial of Intermittent Continuous Treatment With Peginterferon Alfa-2a (PEGASYS) in Patients With HBeAg Negative Hepatitis B Responding to Prior Treatment With Interferon Alfa (SOFIA -LTT)|Completed||Phase 2|21|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:49:02.890383|2017-02-18 15:49:02.890383
NCT00442559|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2016-10-11|2008-10-12||January 2005||2005-01-01|October 2016|2016-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)|"Korean Study of Real-World Montelukast Use in Mild Asthmatic Children With Concomitant Allergic Rhinitis"|Completed||Phase 4|191|Actual|Merck Sharp & Dohme Corp.|This was an open-label study. Only 53 patients had diary information with daytime asthma symptom score - thus, 138 cases were dropped from analysis due to lack of daytime asthma symptom score.|2|||f||||||||||||||2017-02-18 15:49:03.525052|2017-02-18 15:49:03.525052
NCT00442546|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2011-02-15|2009-12-15||May 2007||2007-05-01|February 2011|2011-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement|A Multicenter, Double-Blind Randomized, Placebo-Controlled Study Of The Efficacy And Safety Of Pregabalin In The Treatment Of Subjects With Post-Operative Pain Following Total Knee Arthroplasty (TKA)|Completed||Phase 3|307|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 15:49:04.201501|2017-02-18 15:49:04.201501
NCT00442533|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2014-04-02|||August 2005||2005-08-01|April 2014|2014-04-01||||August 2014|Anticipated|2014-08-01||Interventional|||Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors|High Dose Indium-111 Pentetreotide Therapy in Somatostatin Receptor Expressing Neuroendocrine Neoplasms.|Unknown status|Active, not recruiting|Phase 2/Phase 3|200|Anticipated|Radio Isotope Therapy of America||1|||f||||t||||||||||2017-02-18 15:49:12.829833|2017-02-18 15:49:12.829833
NCT00442520|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2016-11-23|||February 2006||2006-02-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy|Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy|Completed||N/A|70|Actual|University of Kansas Medical Center|||3||f||||t||||||||||2017-02-18 15:49:12.928614|2017-02-18 15:49:12.928614
NCT00442507|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2015-07-02|2015-06-10||March 2007||2007-03-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|OSI3650||Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Trial of Erlotinib and Avastin in Previously Treated Patients With Cancer of the Esophagus or Gastroesophageal Junction|Terminated||Phase 2|6|Actual|Washington University School of Medicine||1||Slow accrual|f||||f||||||||||2017-02-18 15:49:13.018395|2017-02-18 15:49:13.018395
NCT00442494|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-11-15|||October 2012||2012-10-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Corticosteroids for the Prevention of Atrial Fibrillation After Cardiac Surgery|Feasibility of Corticosteroid in the Prevention of Atrial Fibrillation After Cardiac Surgery: A Prospective, Double-Blind Randomized Multicenter Trial|Terminated||N/A|1|Actual|Kuopio University Hospital||1||Study has been completed as planned|f||||f||||||||||2017-02-18 15:49:13.59086|2017-02-18 15:49:13.59086
NCT00442481|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2007-03-01|||February 2007||2007-02-01|March 2007|2007-03-01||||||||Interventional|||Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder|Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder|Unknown status|Recruiting|Phase 4|25||Sheba Medical Center|||||f||||f||||||||||2017-02-18 15:49:13.673589|2017-02-18 15:49:13.673589
NCT00442468|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2013-01-04|2009-12-02||April 2007||2007-04-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of Breath|An Evaluation of the Prevalence of Airway Obstruction Consistent With Chronic Obstructive Pulmonary Disease (COPD) in Subjects With a History of Cigarette Smoking and Symptoms of Chronic Bronchitis in a Primary Care Setting|Completed||N/A|1283|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 15:49:13.785993|2017-02-18 15:49:13.785993
NCT00442455|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2016-09-23|||January 2006||2006-01-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck|Phase I/II Trial of Erlotinib, Radiation Therapy, and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|53|Actual|Grupo de Investigación Clínica en Oncología Radioterapia||1|||f||||t||||||||||2017-02-18 15:49:14.580724|2017-02-18 15:49:14.580724
NCT00442442|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2007-10-30|||April 2007||2007-04-01|October 2007|2007-10-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Clinical Evaluation of Mosquito Coils to Control Malaria in China|Clinical Evaluation of Mosquito Coils to Control Malaria in China|Unknown status|Active, not recruiting|Phase 3|8000|Anticipated|London School of Hygiene and Tropical Medicine||4|||f||||f||||||||||2017-02-18 15:49:14.875858|2017-02-18 15:49:14.875858
NCT00442429|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2007-03-01|||July 2004||2004-07-01|March 2007|2007-03-01|June 2010||2010-06-01|||||Observational|||Morbidity and Mortality Among Dialysis Patients After Treatment for Depression|Morbidity and Mortality Among Dialysis Patients After Treatment for Depression|Unknown status|Recruiting|Phase 4|350||Portland VA Medical Center|||||f||||||||||||||2017-02-18 15:49:14.9764|2017-02-18 15:49:14.9764
NCT00442416|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2016-07-05|2016-07-05||February 2007||2007-02-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||Safety population included all participants who received at least one dose of the study drug and had at least one post-baseline safety assessment.|A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.|A Two-arm, Randomized, Open-label, Multicenter Study of Safety and Efficacy of Monthly Injections of RO0503821 Versus Epoetin Alfa in Peritoneal Dialysis Patients Who Self Inject or Receive In-center Injections.|Terminated||Phase 3|80|Actual|Hoffmann-La Roche|The study was prematurely terminated during enrollment period due to legal reasons. Therefore, the planned statistical analysis of the primary endpoint was not performed.|2||Strategic decision unrelated to safety or efficacy|f||||||||||||||2017-02-18 15:49:15.077926|2017-02-18 15:49:15.077926
NCT00442403|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-02-28|||April 2002||2002-04-01|February 2007|2007-02-01|September 2002||2002-09-01|||||Interventional|||Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria|Etude de l’Activite (Efficacite et Tolerance) de l’Association de la Chloroquine Avec la Dehydroepiandrosterone-Sulfate (Dheas) Dans le Traitement de l’Acces Palustre Simple A Plasmodium Falciparum|Suspended||Phase 3|200||Université Victor Segalen Bordeaux 2||||"At the end of the year 2002, Cameroon switched from chloroquine to amodiaquine as first-line~   therapy for of uncomplicated malaria."|f||||f||||||||||2017-02-18 15:49:15.882726|2017-02-18 15:49:15.882726
NCT00442390|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-02-28|||January 2002||2002-01-01|February 2007|2007-02-01|January 2003||2003-01-01|||||Interventional|||Metabolic Effects of Acute Cortisol Withdrawal in Adrenal Failure|Effects of Cortisol on Carbohydrate, Lipid, and Protein Metabolism; Studies of Acute Cortisol Withdrawal in Adrenocortical Failure.|Completed||N/A|10||University of Aarhus|||||f||||f||||||||||2017-02-18 15:49:15.976637|2017-02-18 15:49:15.976637
NCT00442377|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-08-15|||January 2007||2007-01-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Study to Investigate the Induction of an Protective Immune Response to Malaria|Exposure of Human Volunteers to Live Malaria Sporozoites Under Chloroquine Prophylaxis|Completed||N/A|15|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 15:49:16.061735|2017-02-18 15:49:16.061735
NCT00442364|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2015-02-19|2014-01-07||March 2007||2007-03-01|February 2015|2015-02-01|August 2009|Actual|2009-08-01|June 2008|Actual|2008-06-01||Interventional|MRI|Patients with bubbles detected on MRI|Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt|An Open Label Multicenter Safety Study of the Varisolve® Procedure for the Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt|Completed||Phase 2|60|Actual|BTG International Inc.||1|||f||||t||||||||||2017-02-18 15:49:16.161522|2017-02-18 15:49:16.161522
NCT00442351|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-09-28|2010-03-26||September 2006||2006-09-01|September 2015|2015-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)|"A Comparative Study of The Efficacy and Tolerability of Maintenance Treatment of Patients With Mild/Moderate Persistent Asthma With Asmanex Twisthaler 220 mcg QD PM Versus Asmanex Placebo QD PM"|Terminated||Phase 4|26|Actual|Merck Sharp & Dohme Corp.|This study was terminated early due to a high screening failure rate and poor enrollment that resulted from stringent inclusion and exclusion criteria. Efficacy data were not evaluated.|2||Slow Enrollment|f||||f||||||||||2017-02-18 15:49:16.408767|2017-02-18 15:49:16.408767
NCT00442338|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-09-07|2009-05-22||March 2007||2007-03-01|September 2016|2016-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)|MK-476 IV Formulation Phase III Open Label Exploratory Comparative Study - Acute Exacerbations of Asthma -|Completed||Phase 3|91|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 15:49:16.85062|2017-02-18 15:49:16.85062
NCT00442325|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-10-24|||January 2003||2003-01-01|April 2007|2007-04-01|February 2004||2004-02-01|||||Interventional|ACTFAST 2||Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets|ACTFAST (2): Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration: A Multicenter, Twelve-Week Treatment, Single-Step Titration, Open-Label Study Assessing The Percentage Of Dyslipidemic High-Risk Patients Achieving Low Density Lipoprotein Cholesterol (LDL-C) Target With Atorvastatin Starting Doses Of 10 mg, 20 mg, 40 mg, And 80 mg.|Completed||Phase 4|595||Pfizer|||||f||||||||||||||2017-02-18 15:49:17.437769|2017-02-18 15:49:17.437769
NCT00442312|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-02-28|||May 2006||2006-05-01|February 2007|2007-02-01|November 2006||2006-11-01|||||Interventional|||Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy|An Open Label,Switch Study of the Safety and Efficacy of Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy in Patient With Glaucoma or Ocular Hypertension.|Unknown status|Active, not recruiting|Phase 4|43||Genovate Biotechnology Co., Ltd.,|||||f||||f||||||||||2017-02-18 15:49:17.741738|2017-02-18 15:49:17.741738
NCT00442299|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-02-28|||April 2005||2005-04-01|February 2007|2007-02-01|December 2009||2009-12-01|||||Interventional|||Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function|Phase 1 Study of Albumin Dialysis Using Prometheus in End Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function|Suspended||Phase 1/Phase 2|10||Universitaire Ziekenhuizen Leuven||||Major side-effects|f||||t||||||||||2017-02-18 15:49:17.857979|2017-02-18 15:49:17.857979
NCT00442286|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-07-22|||October 2006||2006-10-01|July 2016|2016-07-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Interventional|||Rheos® Pivotal Trial|Rheos® Pivotal Trial: Rheos™ Baroreflex Hypertension Therapy System|Completed||N/A|591|Actual|CVRx, Inc.||2|||f||||t||||||||||2017-02-18 15:49:17.950934|2017-02-18 15:49:17.950934
NCT00442273|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-02-28||||||February 2007|2007-02-01||||||||Interventional|||Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome|Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome|Completed||N/A|||Chonnam National University Hospital|||||f||||||||||||||2017-02-18 15:49:18.09244|2017-02-18 15:49:18.09244
NCT00442260|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2009-01-15|||February 2007||2007-02-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|||||Interventional|||Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer|Dose Finding and Efficacy Evaluation of DOXIL (Doxorubicin HCL Liposome Injection) in Combination With Abraxane (Abraxane) in Patients With Metastatic Breast Cancer (MBC) [Phase I and II]|Completed||Phase 1/Phase 2|64|Anticipated|West Virginia University|||||f||||t||||||||||2017-02-18 15:49:18.175113|2017-02-18 15:49:18.175113
NCT00442247|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-02-28|||September 2004||2004-09-01|February 2007|2007-02-01|December 2008||2008-12-01|||||Interventional|||A Randomised, Controlled Study of Bimesh, Pelvicol for Vaginal Wall Prolapse|A Randomised, Controlled Study of Bimesh, Pelvicol for Vaginal Wall Prolapse|Unknown status|Active, not recruiting|N/A|60||Zealand University Hospital|||||f||||t||||||||||2017-02-18 15:49:18.274303|2017-02-18 15:49:18.274303
NCT00442234|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2010-01-27|||May 2007||2007-05-01|January 2010|2010-01-01||||April 2008|Actual|2008-04-01||Interventional|||"Post-marketing Study of Monteplase (Cleactor) in Patients With Acute Pulmonary Embolism"|"Pharmacokinetic/Pharmacodynamic Study of Monteplase (Cleactor) in Acute Pulmonary Embolism"|Completed||Phase 4|4||Eisai Inc.|||||f||||||||||||||2017-02-18 15:49:18.370455|2017-02-18 15:49:18.370455
NCT00442221|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-02-28|||May 2004||2004-05-01|February 2007|2007-02-01|August 2004||2004-08-01|||||Interventional|||The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months|An Open-Label, Repeat Dose Study Of The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months|Completed||Phase 3|500||POZEN|||||t||||t||||||||||2017-02-18 15:49:18.460979|2017-02-18 15:49:18.460979
NCT00442208|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2008-04-21|||January 2007||2007-01-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers||Completed||Phase 1|24||POZEN|||||t||||t||||||||||2017-02-18 15:49:18.556364|2017-02-18 15:49:18.556364
NCT00442195|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2017-02-01|||February 24, 2007||2007-02-24|January 13, 2017|2017-01-13||||||||Observational|||Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers|Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:49:18.642502|2017-02-18 15:49:18.642502
NCT00442182|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-02-28|||September 2006||2006-09-01|February 2007|2007-02-01||||||||Interventional|||The Efficacy and Safety of ITF2357 in AIS|The Effects and Side Effects of ITS2357 in Autoinflammatory Syndromes|Unknown status|Recruiting|Phase 2|20||Radboud University|||||f||||||||||||||2017-02-18 15:49:18.734605|2017-02-18 15:49:18.734605
NCT00442169|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-04-12|2011-01-21||December 2005||2005-12-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults|Randomized, Double-blind, Placebo Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Lyophilized ChimeriVax-WN02 West Nile Vaccine in Healthy Adults|Completed||Phase 2|208|Actual|Sanofi||6|||f||||t||||||||||2017-02-18 15:49:18.837167|2017-02-18 15:49:18.837167
NCT00442156|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-08-25|||January 2007||2007-01-01|August 2016|2016-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|Laser Resp||The Course of Response to Focal Photocoagulation for DME|The Course of Response to Focal Photocoagulation for Diabetic Macular Edema|Completed||N/A|122|Actual|Jaeb Center for Health Research|||1||f||||f||||||||||2017-02-18 15:49:19.971232|2017-02-18 15:49:19.971232
NCT00442143|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2010-07-22|||January 2007||2007-01-01|March 2007|2007-03-01|December 2007|Anticipated|2007-12-01|||||Interventional|DANCELL-CLI||Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells|Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells|Unknown status|Recruiting|Phase 1|10|Anticipated|Odense University Hospital|||||f||||f||||||||||2017-02-18 15:49:20.105223|2017-02-18 15:49:20.105223
NCT00442130|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-02-02|||February 2007||2007-02-01|February 2016|2016-02-01|July 2021|Anticipated|2021-07-01|February 2014|Actual|2014-02-01||Interventional|||Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination|Reduced Intensity Stem Cell Transplantation for Advanced Chronic Lymphocytic Leukemia Followed by Vaccination With Lethally Irradiated Autologous Tumor Cells Admixed With Granulocyte Macrophage-colony Stimulating Factor Secreting K562 Cells|Active, not recruiting||Phase 1|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:49:20.197894|2017-02-18 15:49:20.197894
NCT00442117|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2016-02-19|2011-01-12||June 2007||2007-06-01|February 2016|2016-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)|A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Mild Persistent and Moderate Persistent Asthmatic Patients|Completed||Phase 3|180|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:49:20.302286|2017-02-18 15:49:20.302286
NCT00442104|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2009-10-28||2009-10-28|January 2007||2007-01-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Open-label Extension to Protocol 1042-0500|An Open-label Clinical Study to Evaluate the Safety and Antiepileptic Activity of Ganaxolone in Treatment of Patients Diagnosed With Infantile Spasms.|Terminated||Phase 2|54|Actual|Marinus Pharmaceuticals||1||ganaxolone did not significantly reduce spasms after an 8-day placebo control period|f||||f||||||||||2017-02-18 15:49:20.729858|2017-02-18 15:49:20.729858
NCT00442091|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2016-09-26|||December 2010||2010-12-01|September 2016|2016-09-01|December 2019|Anticipated|2019-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema|Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema|Recruiting||N/A|4|Anticipated|Odense University Hospital||1|||f||||f||||||||No||2017-02-18 15:49:20.853301|2017-02-18 15:49:20.853301
NCT00442078|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2012-09-08|||May 2006||2006-05-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|May 2007|Actual|2007-05-01||Interventional|||I-STOP TOMS - Trans Obturator Male Sling|Evaluation of the Efficacy on Urinary Continence and Quality of Life of the Sub-urethral Tape I-STOP® Using the Transobturator and Perineal Route on Male Incontinent After Radical Prostatectomy.|Completed||Phase 4|50|Actual|CL Medical||1|||f||||f||||||||||2017-02-18 15:49:20.96636|2017-02-18 15:49:20.96636
NCT00442065|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-10-15|||October 2006||2006-10-01|October 2012|2012-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ARBITER-II||ARBITER-II: Aorfix™ Bifurcated Safety and Performance Trial: Phase II, Angulated Vessels|A Study to Assess the Acute Technical Success of Aorfix™ Stent Grafts in the Treatment of Abdominal Aortic and Aorto-Iliac Aneurysm Where a Significant Degree of Vessel Angulation Exists at the Neck of the Aneurysm|Completed||Phase 2/Phase 3|30|Actual|Lombard Medical||1|||f||||f||||||||||2017-02-18 15:49:21.058162|2017-02-18 15:49:21.058162
NCT00442052|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-02-28|||November 2006||2006-11-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Interventional|||To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin|An Open-Label, Investigator-Blinded, Randomized, Parellel Group Study to Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA 325 Versus Enteric-Coated Aspirin.|Completed||Phase 1|80||POZEN|||||f||||t||||||||||2017-02-18 15:49:21.353245|2017-02-18 15:49:21.353245
NCT00442039|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2012-02-24||2011-02-13|December 2006||2006-12-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||Lithium for the Treatment of Pediatric Mania|Pediatric Pharmacokinetic and Tolerability Study of Lithium for the Treatment of Pediatric Mania Followed by an Open Label Long Term Safety Period, Discontinuation Phase, and Restabilization Period.|Completed||Phase 2|61|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||4|||f||||t||||||||||2017-02-18 15:49:21.445825|2017-02-18 15:49:21.445825
NCT00442026|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-06-26|||December 2006||2006-12-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC|A Multicenter Randomized Phase III Study of the Docetaxel and Gemcitabine Combination Versus Monotherapy With Gemcitabine as First-line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)|Terminated||Phase 3|106|Actual|Hellenic Oncology Research Group||2||Due to poor accrual|f||||f||||||||||2017-02-18 15:49:21.565206|2017-02-18 15:49:21.565206
NCT00442013|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-12-05|2012-07-23||March 2007||2007-03-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|April 2011|Actual|2011-04-01||Interventional|SARCA||Lansoprazole to Treat Children With Asthma|Phase III: The Study of Acid Reflux in Children With Asthma|Completed||Phase 4|306|Actual|Johns Hopkins University|Results limited to patients without overt Gastroesophageal reflux disease(GERD). Did not conduct on-treatment potential hydrogen(pH) probe studies to confirm treatment effect. Protein-pump inhibitors(PPI) dose may not induce maximal acid suppression.|2|||f||||t||||||||||2017-02-18 15:49:21.72648|2017-02-18 15:49:21.72648
NCT00442000|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-03-19|||January 2005||2005-01-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy|Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy|Completed||N/A|700|Actual|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 15:49:22.265672|2017-02-18 15:49:22.265672
NCT00441987|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2010-06-17|||February 2007||2007-02-01|June 2010|2010-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953|A Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSI-953 Administered Orally to Healthy Japanese Male Subjects and Healthy Elderly Male Japanese Subjects.|Completed||Phase 1|96|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 15:49:22.35315|2017-02-18 15:49:22.35315
NCT00441974|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2009-10-15|2009-08-26||December 2006||2006-12-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients|A 48-week Multi-centre, Open-label, Local Phase IV Study to Demonstrate the Efficacy and Safety of Adefovir Dipivoxil Tablets (10mg) in Chinese Subjects With Compensated Chronic Hepatitis B|Completed||Phase 4|1470|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:49:22.443247|2017-02-18 15:49:22.443247
NCT00441961|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2011-08-10|||October 2006||2006-10-01|July 2010|2010-07-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis|Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis|Completed||N/A|6|Actual|Radboud University||1|||f||||f||||||||||2017-02-18 15:49:22.812478|2017-02-18 15:49:22.812478
NCT00441935|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2017-02-13|||April 2004||2004-04-01|February 2017|2017-02-01|April 2029|Anticipated|2029-04-01|April 2029|Anticipated|2029-04-01||Observational|||InterStim Prospective Database|InterStim Prospective Database for Outcomes Research|Terminated||N/A|736|Actual|William Beaumont Hospitals|||1|Shift in department's research interest|f||||f||||||||||2017-02-18 15:49:23.016594|2017-02-18 15:49:23.016594
NCT00441922|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2008-10-28|||January 2003||2003-01-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)|A Multicenter Randomized Phase II Study of Docetaxel Versus Vinorelbine as First-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)|Completed||Phase 3|166|Anticipated|Hellenic Oncology Research Group||2|||f||||f||||||||||2017-02-18 15:49:23.114354|2017-02-18 15:49:23.114354
NCT00441909|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2009-03-03|||April 2006||2006-04-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide|Phase I Study of the Safety and Persistence of 0.1% UC-781 Vaginal Gel in HIV-1 Seronegative Women|Completed||Phase 1|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||||||||||||2017-02-18 15:49:23.234706|2017-02-18 15:49:23.234706
NCT00441896|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2009-10-29||2009-10-28|January 2007||2007-01-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms|A Double-blind, Placebo-controlled, Dose-ranging Clinical Study to Evaluate the Safety, Tolerability, and Antiepileptic Activity of Ganaxolone in Treatment of Patients With Infantile Spasms|Completed||Phase 2|56|Actual|Marinus Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:49:23.366659|2017-02-18 15:49:23.366659
NCT00441883|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2013-11-20||2013-11-20|March 2007||2007-03-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|||Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma|A Phase 2, 28 Day Parallel-Group, Double-Masked, Dose-Finding Study Comparing the Safety and Efficacy of PF-03187207 to Latanoprost|Completed||Phase 2|242|Actual|Bausch & Lomb Incorporated||2|||f||||t||||||||||2017-02-18 15:49:23.484494|2017-02-18 15:49:23.484494
NCT00441870|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2012-03-08|||February 2007||2007-02-01|March 2012|2012-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of EC0225 for the Treatment of Refractory or Metastatic Tumors|Protocol EC-0225-01: A Phase 1 Study of EC0225 Administered Weeks 1 and 3 of a 4-Week Cycle|Completed||Phase 1|77|Actual|Endocyte||1|||f||||f||||||||||2017-02-18 15:49:23.604348|2017-02-18 15:49:23.604348
NCT00441857|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-07-04|||March 2007||2007-03-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Interventional|DOSE||Effect of Plant Stanols on Cholesterol Absorption|The Effect of Three Different Stanol Ester Doses in Margarines on Cholesterol Absorption Efficiency|Completed||Phase 4|60||Oy Foodfiles Ltd||3|||f||||f||||||||||2017-02-18 15:49:23.703325|2017-02-18 15:49:23.703325
NCT00441844|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-02-28|||October 2002||2002-10-01|February 2007|2007-02-01|July 2005||2005-07-01|||||Interventional|||Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation|Phase 2 Study Examining the Effect of Simvastatin vs Placebo on Monocyte Function and Inflammation in Patients With Type 1 Diabetes|Completed||Phase 2|50||University of California, Davis|||||f||||t||||||||||2017-02-18 15:49:23.905649|2017-02-18 15:49:23.905649
NCT00441831|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2009-02-04|||February 2007||2007-02-01|February 2009|2009-02-01|February 2008|Anticipated|2008-02-01|||||Observational|||The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy||Unknown status|Recruiting|N/A|65|Anticipated|Mackay Memorial Hospital|||1||f||||t||||||||||2017-02-18 15:49:24.007049|2017-02-18 15:49:24.007049
NCT00441818|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2008-05-08|||May 2006||2006-05-01|February 2007|2007-02-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma|A Phase I/II, Non-Randomized,Multiple-Dose,Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of TNX-650 in Patients With Refractory Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 1/Phase 2|59|Anticipated|Tanox|||||f||||f||||||||||2017-02-18 15:49:24.104728|2017-02-18 15:49:24.104728
NCT00441805|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-07-11|||November 2006||2006-11-01|September 2007|2007-09-01|September 2007||2007-09-01|||||Interventional|||The Treatment of Acne Vulgaris With Radiofrequency Device|The Treatment of Acne Vulgaris With Radiofrequency Device|Withdrawn||N/A|0|Actual|Alma Lasers|||||f||||f||||||||||2017-02-18 15:49:24.205084|2017-02-18 15:49:24.205084
NCT00441792|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2012-04-08|2012-02-07||October 2007||2007-10-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Effect of Etomidate on Patient Outcomes After Single Bolus Doses|A Randomized Trial of Etomidate Versus Midazolam for Intubation of Patients With Sepsis.|Completed||N/A|122|Actual|Advocate Hospital System|Because of limitations in the availability of study investigators and pharmacists, we were unable to enroll all potentially eligible patients, raising the possibility that our study sample was not representative of our entire patient population.|2|||f||||f||||||||||2017-02-18 15:49:24.288066|2017-02-18 15:49:24.288066
NCT00441779|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2016-07-11|||August 2008||2008-08-01|October 2014|2014-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Transfusion-Associated Microchimerism in Previously Injured Individuals Who Received a Blood Transfusion|Retrospective Study of the Prevalence of Transfusion-Associated Microchimerism Following Traumatic Injury, Burns, and Elective Orthopedic Procedures|Terminated||N/A|59|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||3|"A separate study (similar subjects) identified transfusion-associated microchimerism only~   rarely, making this observational study impractical to conduct."|f||||f||||||Samples With DNA|"~     Whole blood, plasma, peripheral blood mononuclear cells~   "|||2017-02-18 15:49:24.598795|2017-02-18 15:49:24.598795
NCT00441766|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2011-12-16|2011-12-16||March 2007||2007-03-01|December 2011|2011-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain||Terminated||Phase 2|213|Actual|Allergan|Only Part A results are presented; Due to termination of the study, Part B was never conducted.|4||Study was terminated due to company decision after Part A. Part B was never conducted|f||||||||||||||2017-02-18 15:49:24.698846|2017-02-18 15:49:24.698846
NCT00441753|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2009-02-05|||September 2006||2006-09-01|February 2009|2009-02-01||||||||Observational|||Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest|Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest|Unknown status|Recruiting|N/A|10|Anticipated|Radboud University|||1||f||||||||||||||2017-02-18 15:49:25.50639|2017-02-18 15:49:25.50639
NCT00441740|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2008-10-29|||April 2004||2004-04-01|October 2008|2008-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer|Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine as First Line Treatment in Patients With Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC). A Prospective , Multicenter, Randomized, Phase III Trial|Completed||Phase 3|419|Actual|Hellenic Oncology Research Group||2|||f||||f||||||||||2017-02-18 15:49:25.58518|2017-02-18 15:49:25.58518
NCT00441727|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2012-07-12|2009-08-28||February 2007||2007-02-01|July 2012|2012-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|Oberon||Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)|A Randomized, Double-blind, Parallel-group, Multicentre, Phase III Study to Assess the Effect of Esomeprazole 20 or 40 mg od Versus Placebo on the Occurrence of Peptic Ulcers During 26 Weeks in Subjects on Continuous Low Dose Acetylsalicylic Acid (ASA)|Completed||Phase 3|2426|Actual|AstraZeneca|Not enough patients had peptic ulcer, gastric ulcer, or duodenal ulcer to report the intended primary endpoint of time to peptic ulcer and two secondary endpoints, time to gastric ulcer and time to duodenal ulcer. Percentage used instead.|3|||f||||||||||||||2017-02-18 15:49:25.735956|2017-02-18 15:49:25.735956
NCT00441714|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-11-09|||October 2007||2007-10-01|November 2015|2015-11-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise|Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise|Withdrawn||N/A|0|Actual|Radboud University||||"new insights have let us to expect marginal annexin targeting with a 10 minutes delay between~   reperfusion and administration of Annexin A5"|f||||f||||||||||2017-02-18 15:49:26.817197|2017-02-18 15:49:26.817197
NCT00441701|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-07-29|2014-08-11||December 2006||2006-12-01|July 2015|2015-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study to Evaluate the Safety and Dose-Range of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (MK-7123-012)|Safety and Dose-Ranging Study of the Effects of SCH 527123 in Subjects With Moderate to Severe COPD|Terminated||Phase 2|99|Actual|Merck Sharp & Dohme Corp.||10|||f||||t||||||||||2017-02-18 15:49:26.923846|2017-02-18 15:49:26.923846
NCT00441688|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2008-10-13|||March 2007||2007-03-01|October 2008|2008-10-01||||||||Observational|||Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients|Prospective Epidemiological Study of the Prevalence of HLAB*5701 in HIV-1 Infected Patients|Completed||N/A|2469||GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:49:28.093758|2017-02-18 15:49:28.093758
NCT00441675|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-03-15|||January 2007||2007-01-01|June 2011|2011-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)|A Long Term Follow up Study for a Comparison of Stepwise Treatment of Asthmatic Children With Salmeterol/Fluticasone Propionate Combination Product (SERETIDE®) and/or Fluticasone Propionate (FLIXOTIDE (TM)) Based on PD20 Methacholine and Symptoms or Based on Symptoms Only.|Completed||N/A|137|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-02-18 15:49:28.16365|2017-02-18 15:49:28.16365
NCT00441662|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2007-02-28|||November 2004||2004-11-01|February 2007|2007-02-01|May 2007||2007-05-01|||||Interventional|||Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema|Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema Following Plaque Radiotherapy for Uveal Melanoma|Completed||N/A|170||Wills Eye|||||f||||||||||||||2017-02-18 15:49:28.390971|2017-02-18 15:49:28.390971
NCT00441649|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2013-10-29|||February 2000||2000-02-01|October 2013|2013-10-01|January 2007|Actual|2007-01-01|June 2004|Actual|2004-06-01||Interventional|||Methylphenidate for Treating Children With ADHD and Tourette Syndrome|Methylphenidate Treatment of ADHD in Children With Tourette Syndrome|Completed||N/A|71||Stony Brook University|||||f||||||||||||||2017-02-18 15:49:28.495112|2017-02-18 15:49:28.495112
NCT00441636|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2015-11-13|||March 2007||2007-03-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Treatment Resistant Depression and Obstructive Sleep Apnea, Effect of Continuous Positive Airway Pressure (CPAP)|Treatment Resistant Depression and Obstructive Sleep Apnea: Effect of Treatment With CPAP on Mood, Anxiety and Quality of Life|Recruiting||N/A|120|Anticipated|Queen's University||3|||f||||t||||||||||2017-02-18 15:49:28.585058|2017-02-18 15:49:28.585058
NCT00441623|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2016-05-12|||October 2005||2005-10-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||The Role of P-cresol and Related Protein Fermentation Metabolites in Chronic Kidney Disease Patients|A Single Centre Observational Cohort Study on the Prognostic Relevance of P-cresol and Related Uremic Retention Solutes in the Development and/or Progression of Renal Failure and Cardiovascular Disease in Chronic Kidney Disease Patients|Completed||N/A|499|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||f||||||Samples Without DNA|"~     Serum, plasma Urine (if provided by patient)~   "|No||2017-02-18 15:49:28.710988|2017-02-18 15:49:28.710988
NCT00441610|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-04-27|||January 2007||2007-01-01|April 2012|2012-04-01||||September 2009|Actual|2009-09-01||Interventional|||An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor|An Extension Trial to a Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor|Completed||Phase 1|4|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:49:28.798926|2017-02-18 15:49:28.798926
NCT00441597|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2009-03-16|||February 2007||2007-02-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?|Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?|Completed||Phase 4|30|Anticipated|Radboud University||3|||f||||f||||||||||2017-02-18 15:49:28.897452|2017-02-18 15:49:28.897452
NCT00441584|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2015-10-07|2009-06-18||July 2005||2005-07-01|October 2015|2015-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)|Efficacy and Safety of PEG-Intron Plus Rebetol in Subjects With Chronic Hepatitis C Genotype 1 Non Responder to Pegasys|Terminated||Phase 3|117|Actual|Merck Sharp & Dohme Corp.|Due to slow enrollment, an unplanned interim analysis was conducted: 75 of 93 (80.6%) subjects who had reached treatment Week 12 did not achieve early virologic response. Given the low likelihood of response, a decision was made to stop enrollment.|1||Subject accrual was prematurely terminated due slow enrollment.|f||||f||||||||||2017-02-18 15:49:29.012705|2017-02-18 15:49:29.012705
NCT00441571|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-09-06|||February 2007||2007-02-01|September 2007|2007-09-01||||||||Interventional|CYT-500||Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer|A Phase 1 Study of Radiolabeled Monoclonal Antibody 7E11-C5.3(177Lu-meO-DOTA-7E11;CYT-500) in Patients With Progressive Androgen-Independent Prostate Cancer|Unknown status|Recruiting|Phase 1|30|Anticipated|Cytogen Corporation|||||f||||f||||||||||2017-02-18 15:49:29.4046|2017-02-18 15:49:29.4046
NCT00441558|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2014-05-14|2014-05-14||February 2007||2007-02-01|May 2014|2014-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).|Worldwide One-year Open-label Safety Study of Flibanserin in Women With HSDD|Terminated||Phase 3|1723|Actual|Sprout Pharmaceuticals, Inc||1||terminated for administrative reasons|f||||t||||||||||2017-02-18 15:49:29.506355|2017-02-18 15:49:29.506355
NCT00441545|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2014-06-06|2009-06-29||February 2007||2007-02-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Head to Head Study Against Sevelamer Hydrochloride|A Prospective, Multicenter, Open-label, Randomized, Cross-over Study to Compare the Efficacy and Safety of Fosrenol® and Sevelamer Hydrochloride in Patients Receiving Hemodialysis for End Stage Renal Disease|Completed||Phase 3|182|Actual|Shire||2|||f||||||||||||||2017-02-18 15:49:30.029866|2017-02-18 15:49:30.029866
NCT00441532|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2011-11-22|||August 2005||2005-08-01|October 2010|2010-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy|A Double-Blind Randomized Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy|Completed||N/A|50||William Beaumont Hospitals|||||f||||f||||||||||2017-02-18 15:49:30.52861|2017-02-18 15:49:30.52861
NCT00441519|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2009-01-09|||February 2007||2007-02-01|January 2009|2009-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin|An Open-Label, Investigator-Blinded, Stratified, Randomized, Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin|Completed||Phase 1|80|Anticipated|POZEN|||||f||||t||||||||||2017-02-18 15:49:30.62537|2017-02-18 15:49:30.62537
NCT00441506|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2010-08-23|||November 2004||2004-11-01|February 2007|2007-02-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Effects of Daily Interruption of Sedatives in Critically Ill Children|Effects of Daily Interruption of Sedatives in Critically Ill Children|Completed||N/A|30|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:49:30.715493|2017-02-18 15:49:30.715493
NCT00441493|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2012-07-26|||September 2006||2006-09-01|September 2006|2006-09-01|September 2007|Actual|2007-09-01|March 2007|Actual|2007-03-01||Interventional|||Fluvastatin Versus Hepatitis C Virus|A Dose Finding Study of Fluvastatin for in Vivo Demonstration of Inhibiting Hepatitis C Replication in Patients Infected With Chronic Hepatitis C With Special Attention to the African-American Population.|Completed||N/A|32||Bader, Ted, M.D.|||||||||||||||||||2017-02-18 15:49:30.805005|2017-02-18 15:49:30.805005
NCT00441480|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-01-12|2009-07-01||March 2007||2007-03-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels|Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels in Healthy, Hyperlipidemic Subjects|Completed||Phase 4|91|Actual|Enzymotec||2|||f||||t||||||||||2017-02-18 15:49:30.903694|2017-02-18 15:49:30.903694
NCT00441467|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2015-03-03|2015-02-16||March 2007||2007-03-01|March 2015|2015-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma|An Open-Label Phase 2 Study of the Efficacy and Safety of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma|Completed||Phase 2|22|Actual|Eleison Pharmaceuticals LLC.||1|||f||||||||||||||2017-02-18 15:49:31.505608|2017-02-18 15:49:31.505608
NCT00441454|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2012-12-09|||September 2004||2004-09-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|June 2012|Actual|2012-06-01||Interventional|||Retropubic vs. Transobturator Tension-free Vaginal Tape|Retropubic vs. Transobturator Tension-free Vaginal Tape (TVT vs. TVT-O): A Randomized Trial|Completed||N/A|564|Actual|Austrian Urogynecology Working Group (AUWG)||2|||f||||||||||||||2017-02-18 15:49:31.925918|2017-02-18 15:49:31.925918
NCT00441441|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-28|2016-11-02|2009-01-23||February 2007||2007-02-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma|A Randomized, Double-blind, Parallel Group Study Evaluating the Safety of Fluticasone Propionate/Salmeterol 100/50mcg HFA (2 Inhalations of 50/25mcg) Twice Daily Compared With Fluticasone Propionate 100mcg HFA (2 Inhalations of 50mcg) Twice Daily in Subjects 4-11 Years of Age With Persistent Asthma|Completed||Phase 3|351|Actual|GlaxoSmithKline|A post-hoc evaluation confirmed that no clinically relevant ECG abnormalities were present. Differences in the primary and post-hoc analyses were associated with variation in the method of ECG interpretation and are not fully interpretable.|2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:49:32.058295|2017-02-18 15:49:32.058295
NCT00441428|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2008-06-02|||February 2006||2006-02-01|June 2008|2008-06-01||||January 2007||2007-01-01||Observational|||Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity||Completed||Phase 2|||University of L'Aquila|||||f||||t||||||||||2017-02-18 15:49:33.263355|2017-02-18 15:49:33.263355
NCT00441415|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2008-08-05|||February 2007||2007-02-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris|Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Compared to Clindamycin 0.1% / Benzoyl Peroxide 5% Gel in the Treatment of Acne Vulgaris|Completed||Phase 3|272|Actual|Galderma||2|||||||||||||||||2017-02-18 15:49:33.343622|2017-02-18 15:49:33.343622
NCT00441402|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2010-03-01||||||March 2010|2010-03-01||||||||Observational|||Exercise Amenorrhea Stress and Bone Health in Adolescents||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 15:49:35.949415|2017-02-18 15:49:35.949415
NCT00441389|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-02-27|||May 2004||2004-05-01|February 2007|2007-02-01|December 2007||2007-12-01|||||Observational|||Infectious Etiology of Acute Exacerbations of COPD|Infectious Etiology of Acute Exacerbations of COPD in Hong Kong|Completed||N/A|500||Chinese University of Hong Kong|||||f||||f||||||||||2017-02-18 15:49:36.03792|2017-02-18 15:49:36.03792
NCT00441376|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2016-03-04|||February 2007||2007-02-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver|A Phase I Dose Escalation Tolerability Study of ThermoDox™ (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) of Primary and Metastatic Tumors of the Liver|Completed||Phase 1|30|Actual|Celsion||1|||f||||f||||||||||2017-02-18 15:49:36.109012|2017-02-18 15:49:36.109012
NCT00441363|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-04-26|2010-11-08||February 2005||2005-02-01|April 2016|2016-04-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin|A Randomized, Double-Blind, Parallel-Group Trial to Assess the Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin in Patients With Type 2 Diabetes Mellitus|Terminated||Phase 3|66|Actual|VeroScience||2||Failure to Recruit in a Timely manner|f||||f||||||||||2017-02-18 15:49:36.209419|2017-02-18 15:49:36.209419
NCT00441350|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2009-06-03|||July 2007||2007-07-01|June 2009|2009-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension|Phase III Study Evaluating the Efficacy and Safety of Olmesartan Medoxomil/Hydrochlorothiazide 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Patients With Essential Hypertension|Completed||Phase 3|1004|Actual|Menarini Group||2|||f||||f||||||||||2017-02-18 15:49:36.544115|2017-02-18 15:49:36.544115
NCT00441337|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2015-02-05|2015-01-21||August 2006||2006-08-01|February 2015|2015-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|MDX1106-01|All participants who received at least 1 dose or any partial dose of study drug.|A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies|A Phase 1, Open Label, Dose-escalation, Safety and Pharmacokinetic Study of MDX-1106 in Patients With Selected or Relapsed Malignancies|Completed||Phase 1|39|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 15:49:36.663327|2017-02-18 15:49:36.663327
NCT00441324|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-02-27|||March 2003||2003-03-01|February 2007|2007-02-01|February 2006||2006-02-01|||||Interventional|||Efficacy and Safety of R-hLH (Luveris ®) Priming Prior to R-HFSH Treatment in Infertile Women Undergoing IVF-ET|Efficacy and Safety of R-hLH (Luveris ®) Priming Prior to R-HFSH Treatment in Infertile Women Undergoing IVF-ET|Completed||Phase 4|160||NHS Greater Clyde and Glasgow|||||f||||f||||||||||2017-02-18 15:49:41.844604|2017-02-18 15:49:41.844604
NCT00441311|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2011-01-28|||May 2003||2003-05-01|January 2011|2011-01-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Dissemination of Colorectal Cancer Screening to Primary Care Physicians|Dissemination of Colorectal Cancer Screening to Primary Care Physicians|Completed||Phase 4|264|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 15:49:41.936554|2017-02-18 15:49:41.936554
NCT00441298|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-01-29|||May 2007||2007-05-01|January 2016|2016-01-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV|Phase IIb Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel for the Prevention of HIV Infection in Women in South Africa|Completed||Phase 2|889|Actual|Centre for the AIDS Programme of Research in South Africa||2|||f||||t||||||||||2017-02-18 15:49:42.04097|2017-02-18 15:49:42.04097
NCT00441285|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2015-05-15|2010-01-28||January 2010||2010-01-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|December 2012|Actual|2012-12-01||Interventional||The population involves 32 patients in the Phase II substudy and 124 patients in the Phase III main study|Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)|Antiparasitic Therapy for Neurocysticercosis: Phase II/III Study on Safety and Efficacy of Combined Treatment With Praziquantel and Albendazole|Completed||Phase 2/Phase 3|156|Actual|Universidad Peruana Cayetano Heredia||3|||f||||t||||||||||2017-02-18 15:49:42.179051|2017-02-18 15:49:42.179051
NCT00441272|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2010-01-29|2009-04-08||February 2007||2007-02-01|October 2008|2008-10-01||||October 2008|Actual|2008-10-01||Interventional|||Pioglitazone to Treat Fatty Liver in People With HIV Infection|Pioglitazone for Hepatic Steatosis in HIV|Completed||Phase 2|100|Actual|National Institutes of Health Clinical Center (CC)|Early termination prior to enrollment leading to no analysis of enrolled participants receiving Pioglitazone or placebo.|1|||f||||||||||||||2017-02-18 15:49:43.223087|2017-02-18 15:49:43.223087
NCT00441259|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2012-07-24|2012-06-06||January 2007||2007-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age|Randomised, Double Blind, Controlled, Safety, Tolerability and Immunogenicity Phase II Trial of ChimeriVax™-JE and Japanese Encephalitis Inactivated Mouse Brain Vaccine in Children of Descending Age.|Completed||Phase 2|96|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:49:43.598139|2017-02-18 15:49:43.598139
NCT00441246|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2008-02-05|||February 2007||2007-02-01|February 2008|2008-02-01|July 2007|Actual|2007-07-01|May 2007|Actual|2007-05-01||Interventional|||Phase 4 Study - Mucinex D as Adjunct Therapy|A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Mucinex D as Adjunct Therapy to Antibiotic Treatment of Acute Respiratory Infection|Completed||Phase 4|600|Anticipated|Adams Respiratory Therapeutics||2|||f||||t||||||||||2017-02-18 15:49:44.37917|2017-02-18 15:49:44.37917
NCT00441233|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-12-27|||March 2007||2007-03-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Clinical Performance of Extended Wear Silicone Hydrogel Lenses||Completed||N/A|||University of Melbourne|||||f||||||||||||||2017-02-18 15:49:44.495879|2017-02-18 15:49:44.495879
NCT00441220|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2009-03-04|||October 2006||2006-10-01|February 2009|2009-02-01|October 2010|Anticipated|2010-10-01|||||Observational|||Cyclophosphamide in Lupus Nephritis|Failure of Cyclophosphamide Therapy in Lupus Nephritis Patients: the Role of Bioactivation Phenotype and Genotype|Unknown status|Recruiting|N/A|60|Anticipated|University of Auckland, New Zealand|||2||f||||f||||||||||2017-02-18 15:49:44.568271|2017-02-18 15:49:44.568271
NCT00441207|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2013-04-22|||August 2006||2006-08-01|April 2013|2013-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors|A Phase I Study of High-Dose IV Vitamin C Treatment in Patients With Solid Tumors|Completed||Phase 1|18|Actual|Midwestern Regional Medical Center||1|||f||||t||||||||||2017-02-18 15:49:44.660094|2017-02-18 15:49:44.660094
NCT00440843|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-25|2013-12-19|||February 2007||2007-02-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Zyprexa and Task Engagement in Schizophrenia|Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia|Withdrawn||Phase 3|0|Actual|VA Connecticut Healthcare System||2|||f||||f||||||||||2017-02-18 15:49:54.901569|2017-02-18 15:49:54.901569
NCT00441194|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2012-03-02|||November 2006||2006-11-01|March 2012|2012-03-01|May 2007|Actual|2007-05-01|||||Observational|||To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series|To Compare the Octopus 311 and the Humphrey Field Analyzer 700 Series With Respect to Reliability, Reproducibility, Test Duration, Patient Preference, Technician Preference.|Terminated||Phase 4|80|Anticipated|Haag Streit USA|||1|Study terminated due to resources|f||||t||||||||||2017-02-18 15:49:44.753994|2017-02-18 15:49:44.753994
NCT00441181|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2011-06-21|||January 2008||2008-01-01|February 2007|2007-02-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Effects of Travoprost on Neovascular Glaucoma|Effects of Travoprost on Neovascular Glaucoma|Withdrawn||N/A|40|Anticipated|Federal University of São Paulo|||||f||||f||||||||||2017-02-18 15:49:44.852431|2017-02-18 15:49:44.852431
NCT00441168|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2014-02-20|2009-12-03||December 2006||2006-12-01|February 2014|2014-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma|A Phase 2, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Safety and Efficacy of Velcade When Added to Adriamycin-Dexamethasone Treatment Versus Vincristine-Adriamycin-Dexamethasone Standard Treatment in Subjects With Multiple Myeloma Who Are Refractory to or Have Relapsed After Primary Therapy for Multiple Myeloma|Terminated||Phase 2|30|Actual|Janssen-Cilag International NV|Due to a substantial decline in the use of the VAD regimen as standard of care, recruitment of the study was halted at 30 subjects. It was not possible to statistically evaluate any long term efficacy parameter.|2||"TRIAL STOPPED due to a change in standard of care and the required patient numbers could no~   longer be achieved"|f||||f||||||||||2017-02-18 15:49:45.067657|2017-02-18 15:49:45.067657
NCT00441155|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2013-05-09|||November 2006||2006-11-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib|An Extension to a Phase I Multicenter, Dose Escalation Study of Nilotinib in Combination With Imatinib on a Continuous Daily Dosing Schedule in Adult Patients With Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 1|14|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:49:46.052104|2017-02-18 15:49:46.052104
NCT00441142|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2016-09-21|2015-02-05||May 2007||2007-05-01|September 2016|2016-09-01|March 2017|Anticipated|2017-03-01|August 2013|Actual|2013-08-01||Interventional|Zactima||Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors|Phase I/II Study of ZD6474 (Vandetanib) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma|Active, not recruiting||Phase 1/Phase 2|119|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 15:49:46.173634|2017-02-18 15:49:46.173634
NCT00441129|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-03-05|||June 2006||2006-06-01|December 2006|2006-12-01|October 2007||2007-10-01|||||Interventional|RTD||Obtain a Good Blood Glucose Control With the Paradigm Real Time System|To Assess Whether Type 1 Diabetic Patients Treated With M D I and in Poor Metabolic Control Can Improve Using the Paradigm® Real Time System Compared to Self-Monitoring Blood Glucose and Continuous Subcutaneous Insulin Infusion|Unknown status|Recruiting|Phase 4|120||Medtronic|||||f||||f||||||||||2017-02-18 15:49:47.476761|2017-02-18 15:49:47.476761
NCT00441116|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2011-08-11|2009-01-20||December 2006||2006-12-01|August 2011|2011-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia|An Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Dutasteride 0.5mg Once Daily for 6 Months in the Treatment of Male Subjects With Androgenetic Alopecia (Norwood-Hamilton Classification Type IIIv, IV and V)|Completed||Phase 3|150|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:49:47.609018|2017-02-18 15:49:47.609018
NCT00441103|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2014-06-06|2010-05-20||December 2006||2006-12-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|IMPROVE|Intent to treat (ITT) population included all randomized participants who received at least one dose of study drug.|A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis|A Two-arm, Randomized, Double-blind, Control Group-compared, Multicenter, Phase IIIb Study With Monthly MRI and Biomarker Assessments to Evaluate the Efficacy, Safety, and Tolerability of Rebif® New Formulation (IFN Beta-1a) in Subjects With Relapsing Remitting Multiple Sclerosis|Completed||Phase 3|180|Actual|Merck KGaA||2|||f||||||||||||||2017-02-18 15:49:49.594609|2017-02-18 15:49:49.594609
NCT00441090|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2013-10-30||2013-05-21|February 2007||2007-02-01|October 2013|2013-10-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)|A Phase 2 Double-Blind, Randomized, Dose-Ranging, Placebo-Controlled, Parallel Group Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP).|Completed||Phase 2|64|Actual|Eisai Inc.||2|||f||||f||||||||||2017-02-18 15:49:50.306159|2017-02-18 15:49:50.306159
NCT00441077|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2017-01-24|||February 19, 2007||2007-02-19|August 25, 2009|2009-08-25|December 12, 2007|Actual|2007-12-12|December 12, 2007|Actual|2007-12-12||Interventional|||Interventions to Educate An Underserved Population About Inherited Disease Risks|Using a Communication Intervention to Provide Information About Inherited Risk to Underserved Latino Communities|Completed||N/A|550||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:49:50.442478|2017-02-18 15:49:50.442478
NCT00441064|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2011-02-28|2010-12-15||January 2007||2007-01-01|February 2011|2011-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren|A Randomized, Open-label, Blinded Endpoint, Multi-center, Cross-over Study to Evaluate the Effect of High and Low Sodium Diets on Reduction in Mean 24-hour Ambulatory Blood Pressure in Systolic Hypertensive Patients Treated With Aliskiren (300 mg)|Completed||Phase 4|132|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:49:50.549989|2017-02-18 15:49:50.549989
NCT00441051|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-27|2007-02-27|||November 2006||2006-11-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn|A Randomized, Double-Blind, Vehicle-Controlled, Single Center, Intra-Individual Comparative Study of the Efficacy and Safety of Diclofenac Sodium 1 mg/g (0.1%) Gel in Subjects With Painful UV-Induced Erythema|Completed||Phase 3|45||Novartis|||||f||||f||||||||||2017-02-18 15:49:51.005235|2017-02-18 15:49:51.005235
NCT00441038|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2011-08-23|||December 2006||2006-12-01|August 2011|2011-08-01|September 2008|Anticipated|2008-09-01|July 2008|Anticipated|2008-07-01||Interventional|||A Trial on the Effect on Low Back Pain Related Disability of Different Health Education Programs for Retired Persons|Controlled Randomized Clinical Trial on the Effect on Low Back Pain Related Disability of Different Health Education Programs for Retired Persons|Withdrawn||Phase 2|1100|Actual|Kovacs Foundation||3||"Pilot study showed recruitment rates were lower than expected,and number of losses to~   follow-up, much higher."|f||||t||||||||||2017-02-18 15:49:51.104733|2017-02-18 15:49:51.104733
NCT00441025|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2009-06-24|||September 2006||2006-09-01|February 2007|2007-02-01|August 2009|Anticipated|2009-08-01|||||Interventional|||The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL|A Phase II Study of Alemtuzumab in Combination With CHOP as First-Line Treatment in Peripheral T-Cell Lymphoma|Terminated||Phase 2|4|Actual|Mahidol University||1||a lack of a potential patient.|f||||||||||||||2017-02-18 15:49:51.221807|2017-02-18 15:49:51.221807
NCT00441012|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2015-03-02|2009-05-11||December 2006||2006-12-01|March 2015|2015-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)|A Study in Healthy Infants of the Safety, Tolerability, and Immunogenicity of Haemophilus Influenzae, Type b/Hepatitis B Vaccine Manufactured With a Modified Process|Completed||Phase 3|546|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:49:51.335015|2017-02-18 15:49:51.335015
NCT00440999|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2009-01-21|||March 2007||2007-03-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|||Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria|A Phase III Multi-Centre, Randomised, Double-Blind, Double-Dummy, Comparative Clinical Study to Assess the Safety and Efficacy of a Fixed-Dose Formulation of Oral Pyronaridine Artesunate (180:60 mg Tablet) Versus Chloroquine (155 mg Tablet), in Children and Adult Patients With Acute Plasmodium Vivax Malaria|Completed||Phase 3|456|Anticipated|Medicines for Malaria Venture||2|||f||||t||||||||||2017-02-18 15:49:51.824988|2017-02-18 15:49:51.824988
NCT00440986|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2007-02-28|||April 2003||2003-04-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis|Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis|Completed||Phase 2/Phase 3|25||San Filippo Neri General Hospital|||||f||||f||||||||||2017-02-18 15:49:51.935717|2017-02-18 15:49:51.935717
NCT00440973|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2016-03-15|||October 2006||2006-10-01|March 2016|2016-03-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer|Phase II Study of Interleukin- 2 and Bevacizumab in Patients With Progressive Metastatic Renal Cell Carcinoma|Terminated||Phase 2|6|Actual|The Methodist Hospital System||1||contract issues|f||||f||||||||No||2017-02-18 15:49:52.020828|2017-02-18 15:49:52.020828
NCT00440960|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2007-02-26||||||February 2007|2007-02-01||||||||Interventional|||Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic||Completed||Phase 4|||Hospital Pompeia|||||f||||f||||||||||2017-02-18 15:49:52.12694|2017-02-18 15:49:52.12694
NCT00440947|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2012-03-15|2011-05-19||March 2007||2007-03-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection|See Detailed Description|Completed||Phase 3|515|Actual|ViiV Healthcare||2|||f||||f||||||||||2017-02-18 15:49:52.236633|2017-02-18 15:49:52.236633
NCT00440934|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-24|2008-05-02|||February 2007||2007-02-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Anticipated|2007-12-01||Interventional|THBC002||A Study of Electromagnetic Waves in the Treatment of the Advanced Hepatocarcinoma|Étude de Phase II Pour déterminer l'efficacité Des Ondes électromagnétiques de Basse intensité administrées Par Voie Buccale Dans le Traitement du Cancer du Foie avancé|Terminated||Phase 2|0|Actual|Pasche, Boris, M.D.||1||Poor patient accrual|f||||f||||||||||2017-02-18 15:49:54.191823|2017-02-18 15:49:54.191823
NCT00440921|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2015-06-01|||December 2008||2008-12-01|June 2015|2015-06-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|||Clinical Trial for Fibrin Sealant in Knee Surgery|Randomized Clinical Trial for Fibrin Sealant in Knee Surgery|Withdrawn||N/A|0|Actual|Sanquin Research & Blood Bank Divisions||||No agreement between investigator and sponsor|f||||t||||||||||2017-02-18 15:49:54.290285|2017-02-18 15:49:54.290285
NCT00440908|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2008-05-06|||March 2007||2007-03-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Inflammation and Nutritional Parameters in Hemodialysis Patients Using Reprocessed Dialyzers|A Prospective Observational Cohort Study Tracking Laboratory Markers for Changes Over Time, After Converting Dialyzer Practice From Reuse to Single Use in Outpatient Dialysis Units|Completed||N/A|2500|Actual|Fresenius Medical Care North America|||1||f||||f||||||||||2017-02-18 15:49:54.381432|2017-02-18 15:49:54.381432
NCT00440895|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2013-05-07|||February 2007||2007-02-01|May 2013|2013-05-01|May 2013|Actual|2013-05-01|October 2012|Actual|2012-10-01||Interventional|EASY-RESCUE||A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI|A Randomized Trial of Early Discharge After Trans-Radial Stenting of Coronary Arteries in Acute Myocardial Infarction and RESCUE-PCI: The EASY-RESCUE Pilot Study|Completed||Phase 4|74|Actual|Laval University||3|||f||||t||||||||||2017-02-18 15:49:54.465515|2017-02-18 15:49:54.465515
NCT00440882|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2008-10-08|||September 2004||2004-09-01|October 2008|2008-10-01||||||||Observational|||Changes of Transforming Growth Factor b1 and Procollagen III in Patients With Acute Respiratory Distress Syndrome|Changes of Transforming Growth Factor b1 and Procollagen III in Patients With Acute Respiratory Distress Syndrome|Completed||N/A|80|Anticipated|Assistance Publique Hopitaux De Marseille|||1||f||||t||||||||||2017-02-18 15:49:54.594653|2017-02-18 15:49:54.594653
NCT00440869|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2010-03-02|||March 2007||2007-03-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|NAC||Effects of N-acetylcysteine on Muscle Fatigue in Hemodialysis|Effects of N-acetylcysteine on Muscle Fatigue in ESRD|Completed||Phase 1|30|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 15:49:54.675643|2017-02-18 15:49:54.675643
NCT00440856|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2015-06-08|||February 2007||2007-02-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|POLDAROS||Presentation of Lumbar Disc and Reduction of Symptoms|Reduction in Leg and Back Pain Following Lumbar Microdiscetomy in Those Shown the Removed Disc Fragments After the Operation: a Double Blind Randomized Control Trial.|Completed||N/A|100|Actual|St George's, University of London||2|||f||||f||||||||||2017-02-18 15:49:54.7874|2017-02-18 15:49:54.7874
NCT00440830|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2010-10-29|2010-10-01||December 2005||2005-12-01|October 2010|2010-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Nicotine Patch as an Analgesic Adjuvant After Surgery|Study to Determine Whether the Use of a Nicotine Patch During the Day of Surgery Improves Postoperative Pain and Reduces Opioid Requirement.|Completed||Phase 4|68|Actual|Columbia University||4|||f||||f||||||||||2017-02-18 15:49:55.017887|2017-02-18 15:49:55.017887
NCT00440817|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2014-04-09|||February 2006||2006-02-01|April 2014|2014-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.|A Review of Reports of Lymphoma Occurring in Patients With Rheumatoid Arthritis or Crohn's Disease in Centocor-Sponsored and Centocor-Supported Disease Registries|Completed||Phase 4|120|Actual|Centocor Ortho Biotech Services, L.L.C.|||1||f||||f||||||||||2017-02-18 15:49:55.703291|2017-02-18 15:49:55.703291
NCT00440804|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-02-23|||December 2002||2002-12-01|February 2007|2007-02-01|August 2005||2005-08-01|||||Interventional|||Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA|Randomized, Double-Blind Study of Ibuprofen L-Lysine Intravenous Solution in Premature Infants for the Early Treatment of Patent Ductus Arteriosus|Completed||Phase 3|||Farmacon|||||f||||t||||||||||2017-02-18 15:49:55.816852|2017-02-18 15:49:55.816852
NCT00440791|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2007-08-01|||June 2006||2006-06-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Observational|||Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon|Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon|Terminated||N/A|40|Actual|Given Imaging Ltd.||||Interim analysis|f||||f||||||||||2017-02-18 15:49:55.908714|2017-02-18 15:49:55.908714
NCT00440778|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2011-11-23|||February 2007||2007-02-01|November 2011|2011-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|EASY-MI||A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI|A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute Myocardial Infarction: The EASY-MI Pilot Study.|Completed||Phase 4|105|Actual|Laval University||4|||f||||t||||||||||2017-02-18 15:49:55.998661|2017-02-18 15:49:55.998661
NCT00440765|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2014-01-13|||November 2004||2004-11-01|January 2014|2014-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands|A Post Authorization Study, Designed to Learn More About the Safety and Efficacy of the Use of VELCADE (Bortezomib) in the Netherlands|Completed||Phase 4|331|Actual|Janssen-Cilag B.V.|||1||f||||f||||||||||2017-02-18 15:49:56.124995|2017-02-18 15:49:56.124995
NCT00440752|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2008-03-25|||October 2006||2006-10-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Observational|||The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance|The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance in an Area of Seasonal Transmission|Completed||N/A|100|Actual|Tropical Medicine Research Institute|||1||f||||f||||||Samples With DNA|"~     Blood spots on glass fibre membranes. 0.5ml of whole blood preserved in TRI reagent.~   "|||2017-02-18 15:49:56.288193|2017-02-18 15:49:56.288193
NCT00440739|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2009-02-04|||September 2005||2005-09-01|February 2007|2007-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)|Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy: A Factorial Randomized Controlled Trial|Completed||Phase 4|128|Actual|Mahidol University||4|||f||||f||||||||||2017-02-18 15:49:56.383764|2017-02-18 15:49:56.383764
NCT00440726|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2012-06-29|||June 2006||2006-06-01|June 2012|2012-06-01||||February 2011|Actual|2011-02-01||Interventional|||Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)|A Study of Bortezomib With Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|31|Actual|Therapeutic Advances in Childhood Leukemia Consortium||1|||f||||t||||||||||2017-02-18 15:49:56.493588|2017-02-18 15:49:56.493588
NCT00440713|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-02-23|||January 2004||2004-01-01|February 2007|2007-02-01|March 2006||2006-03-01|||||Interventional|AripipPTSD||Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms|Phase 3 Study of Aripriprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms|Completed||Phase 3|40||Federal University of São Paulo|||||f||||t||||||||||2017-02-18 15:49:56.620683|2017-02-18 15:49:56.620683
NCT00440700|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2013-04-24|2012-05-23||July 2006||2006-07-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Anxiety Self-Management for ICU Patients Receiving Mechanical Ventilation|Reducing Sedative Exposure in Ventilated ICU Patients|Completed||Phase 2|364|Actual|University of Minnesota - Clinical and Translational Science Institute|Overall limitations of the trial include the challenges of obtaining informed consent from patients' themselves. Many times patients were too sedated or not alert enough to participate in the consent process.|3|||f||||t||||||||||2017-02-18 15:49:56.707178|2017-02-18 15:49:56.707178
NCT00440687|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2007-02-26|||January 2001||2001-01-01|February 2007|2007-02-01|March 2004||2004-03-01|||||Interventional|||Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care|Phase 4 Withdrawal of Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease in Primary Care: a Randomised Controlled Trial|Completed||Phase 4|256||Queen Mary University of London|||||f||||t||||||||||2017-02-18 15:49:59.945444|2017-02-18 15:49:59.945444
NCT00440674|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2009-10-29|||February 2007||2007-02-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|June 2007|Actual|2007-06-01||Interventional|DECIDE||Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)|The DECIDE Trial: Prospective, Multi-center, Randomized Study to Evaluate the CoStar Paclitaxel-Eluting Coronary Stent System Using a Direct Stenting Technique Compared to Conventional Stenting With Pre-dilatation Strategy|Terminated||Phase 4|18|Actual|Conor Medsystems||2|||f||||f||||||||||2017-02-18 15:50:00.090876|2017-02-18 15:50:00.090876
NCT00440661|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2010-03-03|||March 2007||2007-03-01|October 2007|2007-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Exploration of the Synovial Fluid Inflammation Mediators Under Diacerhein in Knee Osteoarthritis|Exploratory Study of Some Synovial Fluid Inflammation Mediatorsunder Diacerhein in Knee Osteoarthritis Patients. Phase IV Study.|Completed||Phase 4|96|Anticipated|Laboratoires NEGMA|||||f||||f||||||||||2017-02-18 15:50:00.194925|2017-02-18 15:50:00.194925
NCT00440648|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-24|2014-03-17|||March 2005||2005-03-01|March 2014|2014-03-01|July 2006|Actual|2006-07-01|March 2006|Actual|2006-03-01||Interventional|||Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate|A Double-Blind, Cross-Over Design Study of Sevelamer Hydrochloride (Renagel®) and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis|Completed||Phase 2|80|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:50:00.290401|2017-02-18 15:50:00.290401
NCT00440635|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2013-04-15|||January 2004||2004-01-01|April 2013|2013-04-01|October 2006|Actual|2006-10-01|||||Observational|||Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma|International Single-Arm Protocol to Provide Expanded Access to Bortezomib for Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma|Completed||N/A|641|Actual|Janssen-Cilag International NV|||||f||||||||||||||2017-02-18 15:50:00.409241|2017-02-18 15:50:00.409241
NCT00440622|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2013-02-12|||April 2003||2003-04-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients|A Multicenter Randomized Phase III Study of Gemcitabine Plus Herceptin Combination Versus the Capecitabine Plus Herceptin Combination in Pretreated Patients With HER-2 Positive Metastatic Breast Cancer|Terminated||Phase 3|90|Actual|Hellenic Oncology Research Group||2||Due to poor accrual|f||||f||||||||||2017-02-18 15:50:00.497913|2017-02-18 15:50:00.497913
NCT00440609|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2013-08-01|||March 2007||2007-03-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|November 2012|Actual|2012-11-01||Interventional|||Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema|A Phase I/II Study Comparing the Treatment of Clinically Significant Diabetic Macular Edema (CSDME) With 0.5mg Ranibizumab, 1.0mg Ranibizumab and 2.0mg Ranibizumab|Completed||Phase 1/Phase 2|50|Actual|Long Island Vitreoretinal Consultants||2|||f||||t||||||||||2017-02-18 15:50:00.619328|2017-02-18 15:50:00.619328
NCT00440596|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2009-05-18|||September 2006||2006-09-01|May 2009|2009-05-01||||May 2010|Anticipated|2010-05-01||Interventional|||Mindfulness Based Stress Reduction for High Blood Pressure|Mindfulness Based Stress Reduction for High Blood Pressure|Unknown status|Recruiting|N/A|84|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 15:50:00.714225|2017-02-18 15:50:00.714225
NCT00440583|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2015-01-28|||September 2006||2006-09-01|January 2015|2015-01-01|May 2012|Actual|2012-05-01|September 2011|Actual|2011-09-01||Interventional|||The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP|Yt90 Zevalin & Combination Chemotherapy in Treating Patients With Stage II,Stage III,or Stage IV Diffuse Large B-cell Lymphoma|Completed||Phase 2|15|Actual|Mahidol University||1|||f||||f||||||||||2017-02-18 15:50:00.82|2017-02-18 15:50:00.82
NCT00440570|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-24|2011-06-28|||October 2004||2004-10-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|September 2006|Actual|2006-09-01||Interventional|THBC001||A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors|Treatment of Advanced Cancer With Amplitude-modulated Electromagnetic Fields of Low Intensity by Means of an Intrabuccal Probe|Completed||Early Phase 1|2||Pasche, Boris, M.D.||1|||f||||f||||||||||2017-02-18 15:50:01.162119|2017-02-18 15:50:01.162119
NCT00440557|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2014-04-22|2009-02-23||September 2006||2006-09-01|April 2014|2014-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease|A Randomized, Open Label, Multicenter Study of Epoetin Alfa Comparing Two Extended-Dosing Regimens, Once-Weekly and Every-Two-Weeks, With the Three-Times-Weekly Dosing Regimen for Initiation and Maintenance Treatment in Anemic Subjects With Chronic Kidney Disease|Completed||Phase 3|375|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||t||||||||||2017-02-18 15:50:01.284299|2017-02-18 15:50:01.284299
NCT00440544|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2008-10-31|||January 2007||2007-01-01|October 2008|2008-10-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|TMUVA-01||A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)|A Phase I Trial of the Safety and Immunogenicity of an Adjuvated TB Subunit Vaccine (Ag85B-ESAT6 + LTK63) Administered at 0 and 2 Months|Terminated||Phase 1|9|Actual|St George's, University of London||6||Safety Issues|f||||t||||||||||2017-02-18 15:50:02.493415|2017-02-18 15:50:02.493415
NCT00440531|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2015-12-30|2008-11-11||November 2006||2006-11-01|December 2015|2015-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)|A Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process|Completed||Phase 3|540|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 15:50:02.618001|2017-02-18 15:50:02.618001
NCT00440518|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2014-09-19|2009-08-03||February 2007||2007-02-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|SP906||A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.|Completed||Phase 2|218|Actual|UCB Pharma||3|||f||||f||||||||||2017-02-18 15:50:03.281379|2017-02-18 15:50:03.281379
NCT00440505|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2011-01-12|2010-10-01||February 2004||2004-02-01|January 2011|2011-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Nicotine on Chronic Pelvic Pain|Effect of Nicotine on Chronic Pelvic Pain|Completed||Phase 4|20|Actual|Columbia University||3|||f||||f||||||||||2017-02-18 15:50:03.947549|2017-02-18 15:50:03.947549
NCT00440492|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-12-11|||December 2006||2006-12-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis|An Open-Label Study To Evaluate The Potential Pharmacokinetic Interaction Between PLA-695 And Methotrexate When Coadministered Orally To Adult Subjects With Rheumatoid Arthritis|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:50:04.347444|2017-02-18 15:50:04.347444
NCT00440479|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2015-04-15|||September 2006||2006-09-01|April 2015|2015-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.|An Observational Study To Determine Velcade (Bortezomib) Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies (ADVANCE)|Completed||Phase 4|11|Actual|Janssen-Cilag B.V.|||1||f||||f||||||||||2017-02-18 15:50:04.445052|2017-02-18 15:50:04.445052
NCT00440089|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2010-05-24|||October 2005||2005-10-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors|Effects of Hands-on-Healing vs. Touch for Fatigue and Inflammation in Breast Cancer Survivors|Completed||Phase 2/Phase 3|76|Actual|University of California, San Diego||3|||f||||||||||||||2017-02-18 15:50:14.390605|2017-02-18 15:50:14.390605
NCT00440466|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2014-04-02|2010-05-13||July 2007||2007-07-01|April 2014|2014-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients|A Randomized, Open-label, Multicenter Study of Epoetin Alfa Comparing Two Extended Dosing Regimens, Once-every-two-weeks and Once-every-four-weeks, With the Once-weekly Dosing Regimen for Maintenance Treatment in Anemic Subjects With Chronic Kidney Disease|Completed||Phase 3|430|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||t||||||||||2017-02-18 15:50:04.574889|2017-02-18 15:50:04.574889
NCT00440453|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2011-09-22|||February 2007||2007-02-01|September 2011|2011-09-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|EMS||Feeding the Patient at Nutritional Risk: Does the Clinical Outcome Improve?|Feeding the Patient at Nutritional Risk: Does the Clinical Outcome Improve?|Completed||Phase 4|200|Actual|University Hospital Inselspital, Berne||2|||f||||f||||||||||2017-02-18 15:50:06.027693|2017-02-18 15:50:06.027693
NCT00440440|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2015-08-06|||August 2009||2009-08-01|August 2015|2015-08-01|July 2012|Anticipated|2012-07-01|November 2011|Anticipated|2011-11-01||Interventional|||Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes|Effect of Androgel on Total and Regional Adipose Tissue and Lean Body Mass in Type 2 Diabetic Patients With Hypogonadism|Withdrawn||Phase 4|0|Actual|Diabetes Center of the Southwest||2||study merged with another study|f||||f||||||||||2017-02-18 15:50:06.132277|2017-02-18 15:50:06.132277
NCT00440427|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-12-03|||February 2007||2007-02-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)|A Randomized, Open-Label, Single-Dose Parallel Group Study of the Pharmacokinetic Profile, Safety, and Tolerability of 25- and 50-mg Desvenlafaxine Sustained Release (DVS SR) in Healthy Subjects|Completed||Phase 1|12||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:50:06.253276|2017-02-18 15:50:06.253276
NCT00440414|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2010-08-18|||April 2006||2006-04-01|August 2010|2010-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)|A Multicenter Randomized Phase III Study of Pemetrexed Versus Erlotinib in Patients With Pretreated Advanced Non-Small-Cell Lung Cancer (NSCLC)|Completed||Phase 3|320|Anticipated|Hellenic Oncology Research Group||2|||f||||f||||||||||2017-02-18 15:50:06.356129|2017-02-18 15:50:06.356129
NCT00440401|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2012-05-04|2010-05-07||February 2007||2007-02-01|July 2010|2010-07-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)|A Randomised, Open Label, Parallel-group, Multi-centre Trial to Compare the Efficacy and Safety of TachoSil® Versus Standard Haemostatic Treatment in Cardiovascular Surgery|Completed||Phase 4|120|Actual|Nycomed||2|||f||||t||||||||||2017-02-18 15:50:06.484102|2017-02-18 15:50:06.484102
NCT00440388|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2010-08-24||2010-08-12|October 2006||2006-10-01|August 2010|2010-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma|An Open-label, Multicenter, Phase II Study of AT-101 in Combination With Rituximab in Patients With Untreated, Grade I-II, Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|23|Actual|Ascenta Therapeutics||1|||f||||||||||||||2017-02-18 15:50:07.406511|2017-02-18 15:50:07.406511
NCT00440375|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2007-02-26|||June 2005||2005-06-01|February 2007|2007-02-01|March 2006||2006-03-01|||||Interventional|||Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women||Completed||Phase 4|82||Baskent University|||||f||||t||||||||||2017-02-18 15:50:07.540976|2017-02-18 15:50:07.540976
NCT00440362|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2008-11-07|||April 2007||2007-04-01|November 2008|2008-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza|A Single-Site, Phase 1/2, Double-Blind, Safety and Immunogenicity Trial of an Alphavirus Replicon Vaccine Expressing Influenza A/Wyoming/03/2003 Hemagglutinin (AVX502) in Healthy Volunteers|Completed||Phase 1/Phase 2|216|Actual|AlphaVax, Inc.||12|||f||||t||||||||||2017-02-18 15:50:07.628756|2017-02-18 15:50:07.628756
NCT00440349|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-02-23|||October 2000||2000-10-01|February 2007|2007-02-01|April 2007||2007-04-01|||||Interventional|||Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis|A Randomised Trial of Prednisone and Tamoxifen in Patients With Idiopathic Retroperitoneal Fibrosis|Unknown status|Active, not recruiting|Phase 2|38||University of Parma|||||f||||f||||||||||2017-02-18 15:50:07.761994|2017-02-18 15:50:07.761994
NCT00440336|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-24|2007-02-28|||October 2006||2006-10-01|February 2007|2007-02-01||||||||Interventional|||Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.|Comparison of Efficacy of Prostaglandin Analogues (Xalatan) and Aqueous Suppressants (Cosopt) in Reducing Intraocular Pressure Following Selective Laser Trabeculoplasty in the Management of Open-Angle Glaucoma.|Unknown status|Recruiting|N/A|30||Advanced Glaucoma Specialists|||||f||||f||||||||||2017-02-18 15:50:07.880561|2017-02-18 15:50:07.880561
NCT00440323|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2012-05-31|||January 2007||2007-01-01|February 2011|2011-02-01||||||||Interventional|||Disturbed Sleep Model Study.|A Double-blind, Double-dummy, Randomised, Placebo-controlled,Four-way Crossover Study to Investigate the Effect of Single Oral Doses of SB-649868 and of Zolpidem in a Model of Noise Induced Situational Insomnia in Healthy Male Volunteers.|Completed||Phase 1|52|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:50:07.981949|2017-02-18 15:50:07.981949
NCT00440310|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2015-07-28|2015-07-28||February 2007||2007-02-01|July 2015|2015-07-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Interventional||All patients randomized/enrolled|Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases|A Multicenter Multinational Phase 3 Randomized Study to Evaluate the Safety and Efficacy of Treating Colorectal Cancer Patients With Recurrent Liver Metastases Using the Litx™ System Plus Chemotherapy as Compared to Chemotherapy Only|Completed||Phase 3|483|Actual|Light Sciences Oncology||2|||f||||t||||||||||2017-02-18 15:50:08.083953|2017-02-18 15:50:08.083953
NCT00440297|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2015-10-29|2009-03-24||December 2006||2006-12-01|October 2015|2015-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||All vaccinated participants|Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)|A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process|Completed||Phase 3|277|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:50:08.932281|2017-02-18 15:50:08.932281
NCT00440284|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2007-02-23|||January 2004||2004-01-01|February 2007|2007-02-01|December 2004||2004-12-01|||||Interventional|||Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes|Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes - a Non-Blinded, Randomized Controlled Cross-Over Clinical Trial of Metabolic Control and Patient Preference|Unknown status|Active, not recruiting|Phase 3|38||University of Jena|||||f||||f||||||||||2017-02-18 15:50:09.441267|2017-02-18 15:50:09.441267
NCT00440271|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-26|2014-06-17|2009-10-20||February 2007||2007-02-01|January 2014|2014-01-01||||October 2008|Actual|2008-10-01||Interventional|||SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC|SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavi/r IN Race/Gender HIV+ Patients Randomized to Therapeutic Drug Monitoring or Standard of Care|Terminated||Phase 3|33|Actual|Boehringer Ingelheim|The study was terminated early due to low patient enrollment, and, therefore, no analysis was performed on the primary and secondary endpoints|2|||f||||||||||||||2017-02-18 15:50:09.545994|2017-02-18 15:50:09.545994
NCT00440258|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-02-26|||April 2004||2004-04-01|February 2007|2007-02-01|July 2006||2006-07-01|||||Interventional|||Cabergoline Reduces OHSS|Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted Reproduction.|Completed||Phase 3|60||Instituto Valenciano de Infertilidad, IVI VALENCIA|||||f||||f||||||||||2017-02-18 15:50:10.215237|2017-02-18 15:50:10.215237
NCT00440245|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2016-10-26|||February 2007||2007-02-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease|Bronchoprotection of Salbutamol in Asthma and COPD|Recruiting||Phase 4|20|Anticipated|University of Saskatchewan||1|||f||||f||||||||No||2017-02-18 15:50:10.310925|2017-02-18 15:50:10.310925
NCT00440232|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2011-05-23|2010-10-26||July 2007||2007-07-01|May 2011|2011-05-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting|A Pilot Trial Examining the Safety and Efficacy of Frovatriptan as a Preemptive Treatment for Fasting-Induced Migraine Headache|Completed||N/A|74|Actual|Thomas Jefferson University||2|||f||||||||||||||2017-02-18 15:50:10.456005|2017-02-18 15:50:10.456005
NCT00440219|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2014-01-08|||November 2010||2010-11-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy.|The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy.|Completed||Phase 3|34|Anticipated|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||2|||f||||t||||||||||2017-02-18 15:50:10.890029|2017-02-18 15:50:10.890029
NCT00440206|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-02-26|||September 2001||2001-09-01|February 2007|2007-02-01|December 2001||2001-12-01|||||Observational|||Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes|Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes|Completed||N/A|50||Ottawa Hospital Research Institute|||||f||||||||||||||2017-02-18 15:50:11.020367|2017-02-18 15:50:11.020367
NCT00440193|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2014-01-26|2012-11-22||March 2007||2007-03-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study|Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism|Completed||Phase 3|3449|Actual|Bayer||2|||f||||t||||||||||2017-02-18 15:50:11.137714|2017-02-18 15:50:11.137714
NCT00440180|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2016-03-08|2016-02-05||March 2007||2007-03-01|March 2016|2016-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Aromatase Inhibitors in the Treatment of Male Infertility|The Role of Aromatase Inhibitors in the Treatment of Infertility in Obese Male|Terminated||Phase 3|20|Actual|University of Utah||2||Not able meet target enrollment.|f||||t||||||||||2017-02-18 15:50:13.416939|2017-02-18 15:50:13.416939
NCT00440167|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2012-07-05|||June 2006||2006-06-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine|Randomized Phase III Trial With Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine in Patients With Advanced Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 3|280|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||||||||||||2017-02-18 15:50:13.75617|2017-02-18 15:50:13.75617
NCT00440154|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2008-12-15|||February 2007||2007-02-01|December 2008|2008-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled,Ezetimibe-Calibrated, Multicenter Study Evaluating the Safety and Efficacy of Four Doses and Two Dose-Regimens of AVE5530 Over 4 Weeks in Patients With Mild to Moderate Primary Hypercholesterolemia|Completed||Phase 2|206|Actual|Sanofi||7|||f||||||||||||||2017-02-18 15:50:13.864011|2017-02-18 15:50:13.864011
NCT00440141|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-12-26|||July 2006||2006-07-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%||Completed||Phase 4|40|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:50:13.972273|2017-02-18 15:50:13.972273
NCT00440128|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2016-11-02|||May 2007||2007-05-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer|A Phase I, Open-Label, Randomized, Two Period Crossover Study to Investigate the Effects of GW679769 on the Pharmacokinetics of Docetaxel in Subjects With Cancer|Completed||Phase 1|12|Actual|GlaxoSmithKline||2|||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:50:14.073823|2017-02-18 15:50:14.073823
NCT00440115|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2016-11-23|||June 2009||2009-06-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Disease Management for Smoking Cessation|Disease Management for Smokers in Rural Primary Care|Completed||Phase 3|750|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-02-18 15:50:14.194611|2017-02-18 15:50:14.194611
NCT00440102|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2011-09-21|||April 2007||2007-04-01|May 2007|2007-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|KETASED||Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity|Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity|Completed||Phase 4|655|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:50:14.290281|2017-02-18 15:50:14.290281
NCT00440076|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2015-04-21|||August 2006||2006-08-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|||||Interventional|||Velcade in Myelodysplastic Syndrome - Pilot Study|Phase II Study of PS341 (VELCADE) in Myelodysplastic Syndromes (MDS). EudraCT Number 2004-002935-23|Terminated||Phase 2|28|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||||Low accrual|f||||||||||||||2017-02-18 15:50:14.715463|2017-02-18 15:50:14.715463
NCT00440063|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-12-18||||||December 2007|2007-12-01||||||||Interventional|||A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.|A Randomized Study to Compare the Safety and Effectiveness of Two Monitoring Schedules to Maintain Hemoglobin Levels and Iron Parameters in Patients With Renal Anemia Receiving NeoRecormon|Terminated||Phase 4|||Hoffmann-La Roche|||||f||||||||||||||2017-02-18 15:50:14.829259|2017-02-18 15:50:14.829259
NCT00440050|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2014-09-15|2010-05-28||February 2007||2007-02-01|September 2014|2014-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|DHA||DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease|A Randomized Double-Blind Placebo-Controlled Trial Of The Effects Of Docosahexaenoic Acid (DHA) In Slowing The Progression Of Alzheimer's Disease|Completed||Phase 3|402|Actual|Alzheimer's Disease Cooperative Study (ADCS)||2|||f||||t||||||||||2017-02-18 15:50:14.935681|2017-02-18 15:50:14.935681
NCT00440037|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2014-09-11|||November 2006||2006-11-01|September 2014|2014-09-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Open Label Extension Study of AMG 531 in Japanese Subjects With ITP|An Open Label Extension Study Evaluating the Safety and Efficacy of Long Term Dosing of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura|Completed||Phase 2/Phase 3|44|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-02-18 15:50:15.393192|2017-02-18 15:50:15.393192
NCT00440024|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2011-01-07|||February 2007||2007-02-01|January 2011|2011-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance|A Single-Blind Study to Assess Benefits of a Controlled Daily Skin Care Regimen on Retinoid Intolerant Patients (Derm 570)|Completed||N/A|40|Actual|University of Michigan||1|||f||||||||||||||2017-02-18 15:50:15.520491|2017-02-18 15:50:15.520491
NCT00440011|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2013-07-16|2008-09-25||August 2006||2006-08-01|July 2013|2013-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%||Completed||Phase 4|266|Actual|Allergan||2|||f||||||||||||||2017-02-18 15:50:15.620318|2017-02-18 15:50:15.620318
NCT00439998|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2009-07-29|||October 2006||2006-10-01|July 2009|2009-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Ultrasound Imaging For Facilitating Labour Epidurals in Obese Parturients|Ultrasound Imaging For Facilitating Labour Epidurals in Obese Parturients|Completed||N/A|54|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||1|||f||||f||||||||||2017-02-18 15:50:16.019255|2017-02-18 15:50:16.019255
NCT00439985|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2011-06-06|||September 2006||2006-09-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Improving Metabolic Control in Diabetic Young Children|Improving Metabolic Control in Diabetic Young Children|Terminated||N/A|23|Actual|Icahn School of Medicine at Mount Sinai||1||decreased enrollment. (there are no data results for this study)|f||||f||||||||||2017-02-18 15:50:16.111172|2017-02-18 15:50:16.111172
NCT00439972|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2011-02-10|||February 2007||2007-02-01|February 2011|2011-02-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity|Comparison of Oral and Patch Forms of Hormonal Contraception on Plasma Lipoproteins, Glycemia, Clotting Factors, Indices of Inflammation and Vascular Reactivity|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|University of Washington||6|||f||||t||||||||||2017-02-18 15:50:16.215527|2017-02-18 15:50:16.215527
NCT00439959|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2012-05-31|||October 2006||2006-10-01|March 2011|2011-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults|A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single and Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK625433 in Healthy Subjects and in Subjects Who Are Chronically Infected With Hepatitis C.|Terminated||Phase 1|48|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:50:16.328973|2017-02-18 15:50:16.328973
NCT00439946|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2013-06-12|2013-03-26||February 2007||2007-02-01|June 2013|2013-06-01|March 2011|Actual|2011-03-01|September 2009|Actual|2009-09-01||Interventional|||Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH|Rapid Switch From Intravenous Epoprostenol to Intravenous Remodulin® (Treprostinil Sodium) Using the Crono Five Ambulatory Infusion Pump in Patients With Stable Pulmonary Arterial Hypertension (PAH): Safety, Efficacy and Treatment Satisfaction|Terminated||Phase 4|8|Actual|United Therapeutics|The main limitations of this study are the modest sample size and relatively short duration of follow-up.|1||"Study closed due to limited availability of eligible subjects and competition by for~   enrollment by other studies"|f||||f||||||||||2017-02-18 15:50:16.422943|2017-02-18 15:50:16.422943
NCT00439933|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-05-08|||April 2007||2007-04-01|March 2007|2007-03-01||||||||Interventional|||Weight Loss in Obese Children and Adolescents and Its Effect on Improvement of Destructive Changes in Blood Vessels|Weight Loss in Obese Children and Adolescents and Its Effect on Improvement of Endothelial Dysfunction|Unknown status|Recruiting|N/A|180|Anticipated|Heidelberg University|||||f||||||||||||||2017-02-18 15:50:17.005279|2017-02-18 15:50:17.005279
NCT00439920|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-02-23|||October 1996||1996-10-01|September 2000|2000-09-01|May 2006||2006-05-01|||||Interventional|||GIMEMA LAL 0496: High-Dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.|GIMEMA LAL 0496: High-Dose Anthracycline in the Induction Regimen for the Treatment of Adult Acute Lymphoblastic Leukemia. A Prospective Multicentric GIMEMA Trial.|Completed||Phase 2|||Gruppo Italiano Malattie EMatologiche dell'Adulto|||||f||||||||||||||2017-02-18 15:50:17.096275|2017-02-18 15:50:17.096275
NCT00439907|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2015-07-27|||February 2005||2005-02-01|August 2010|2010-08-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Overlap and End-to-end Repair in Anal Sphincter Rupture During Delivery|A Prospective, Randomized Study Comparing the Outcome of Overlap and End-to-end Repair in Anal Sphincter Rupture During Delivery|Completed||N/A|160|Actual|Helse Stavanger HF||2|||f||||f||||||||||2017-02-18 15:50:17.170919|2017-02-18 15:50:17.170919
NCT00439699|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2012-06-20|||February 2007||2007-02-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||A Pilot Clinical Trial Of Memantine for Essential Tremor|A Pilot Clinical Trial of Memantine for Essential Tremor|Completed||Phase 4|16|Actual|VA Greater Los Angeles Healthcare System||1|||f||||||||||||||2017-02-18 15:50:28.850099|2017-02-18 15:50:28.850099
NCT00439894|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2008-03-20|||December 2006||2006-12-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Observational|||Ancillary Study to Protocol 20060104|Protein Phosphorylation Ancillary Study to Amgen Protocol 20060104: Open Label Study to Assess the Safety and Immunogenicity of Etanercept SFP When Administered to Subjects Diagnosed With Rheumatoid Arthritis|Completed||N/A|50|Actual|Amgen|||1||f||||||||||None Retained|"~     no biospecimens will be retained.~   "|||2017-02-18 15:50:17.607911|2017-02-18 15:50:17.607911
NCT00439881|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2012-05-31|||October 2006||2006-10-01|February 2011|2011-02-01||||||||Interventional|||A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose|A Study to Assess the Safety and Tolerability of SB-681323 Administered Via the Intravenous Route|Completed||Phase 1|16||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:50:17.718434|2017-02-18 15:50:17.718434
NCT00439868|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2012-05-31|||February 2007||2007-02-01|March 2011|2011-03-01||||||||Interventional|||A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure|A Cross-over Study to Evaluate the Effect of WELLBUTRIN XL on Intraocular Pressure in Healthy Volunteers|Completed||Phase 1|33|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:50:17.806206|2017-02-18 15:50:17.806206
NCT00439855|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-02-23|||September 2003||2003-09-01|February 2007|2007-02-01|February 2006||2006-02-01|||||Interventional|||Enoxaparin Versus Unfractionated Heparin in PCI|Enoxaparin Versus Unfractionated Heparin in PCI|Completed||Phase 4|2100||Triemli Hospital|||||f||||||||||||||2017-02-18 15:50:17.902857|2017-02-18 15:50:17.902857
NCT00439842|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2015-04-16|||March 2007||2007-03-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|May 2013|Actual|2013-05-01||Interventional|||Self-Management and Care of Heart Failure With Group Clinics (SMAC-HF)|HF Group Clinic Appointments: Rehospitalization Prevention|Completed||N/A|198|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 15:50:17.988406|2017-02-18 15:50:17.988406
NCT00439829|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2010-05-21|||February 2007||2007-02-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Synchronization of Follicle Wave Emergence and Ovarian Stimulation|Synchronization of Follicle Wave Emergence and Ovarian Stimulation in Women With a History of Poor Ovarian Response to Treatment|Completed||Phase 4|80|Anticipated|University of Saskatchewan||2|||f||||||||||||||2017-02-18 15:50:18.086527|2017-02-18 15:50:18.086527
NCT00439816|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2015-04-06|||February 2005||2005-02-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes|Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes|Completed||N/A|160|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 15:50:18.205376|2017-02-18 15:50:18.205376
NCT00439803|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2008-11-07|||April 2007||2007-04-01|November 2008|2008-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|CMV||A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)|A Single-Site, Phase 1, Double-Blind, Safety and Immunogenicity Trial of an Alphavirus Replicon Vaccine Expressing Cytomegalovirus Genes (AVX601) in Healthy Volunteers|Completed||Phase 1|40|Actual|AlphaVax, Inc.||8|||f||||t||||||||||2017-02-18 15:50:18.309804|2017-02-18 15:50:18.309804
NCT00439790|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2012-06-12|||January 2007||2007-01-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|||||Observational|||Sympathetic Nerve Activity and an Implantable Cardioverter Defibrillator in Heart Failure Patients|Validation of a Prognostic Score to Identify Heart Failure Patients Who Might Need an Implantable Cardioverter Defibrillator Using Muscle Sympathetic Nerve Activity and Autonomic Testing|Completed||N/A|109|Actual|University Hospital, Toulouse|||1||f||||f||||||||||2017-02-18 15:50:18.418576|2017-02-18 15:50:18.418576
NCT00439777|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2014-01-25|2012-11-22||March 2007||2007-03-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study|Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism|Completed||Phase 3|4833|Actual|Bayer||2|||f||||t||||||||||2017-02-18 15:50:18.701616|2017-02-18 15:50:18.701616
NCT00439764|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2009-05-27|||March 2007||2007-03-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Health Education vs. Health Education Plus Physical Therapy for Low Back Pain Patients|Health Education vs. Health Education Plus Physical Therapy for Low Back Pain Patients|Completed||Phase 2|680|Anticipated|Kovacs Foundation||3|||f||||t||||||||||2017-02-18 15:50:21.193419|2017-02-18 15:50:21.193419
NCT00439751|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2016-07-08|||April 2007||2007-04-01|June 2015|2015-06-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|ELAAT||Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy|A Randomized Comparison of Immediate Versus Deferred Androgen Deprivation Therapy Using Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy.|Completed||Phase 3|79|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-02-18 15:50:23.773252|2017-02-18 15:50:23.773252
NCT00439738|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2009-02-09|2008-11-05||December 2006||2006-12-01|January 2009|2009-01-01||||November 2007|Actual|2007-11-01||Interventional|||Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults|A 16-Week Double-Blind, Randomized, Multicenter, Force-Titration Study to Evaluate the Antihypertensive Efficacy of Valsartan/Hydrochlorothiazide (HCTZ) Therapy Compared to HCTZ Based Therapy in Obese, Hypertensive Patients|Completed||Phase 4|412|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:50:23.950672|2017-02-18 15:50:23.950672
NCT00439725|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2014-10-28|2012-01-31||February 2007||2007-02-01|October 2014|2014-10-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study|Once-daily Oral Direct Factor Xa Inhibitor Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis or Pulmonary Embolism. The Einstein-Extension Study|Completed||Phase 3|1197|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:50:24.439195|2017-02-18 15:50:24.439195
NCT00439712|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2008-01-12|||February 2007||2007-02-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis|Efficacy of Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Rhinitis|Completed||Phase 4|60|Actual|Institut für Atemwegsforschung GmbH||2|||f||||f||||||||||2017-02-18 15:50:28.740303|2017-02-18 15:50:28.740303
NCT00439686|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2014-01-29|||February 2006||2006-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|June 2008|Actual|2008-06-01||Interventional|||Study of ZIO-201 in Advanced Sarcoma|A Phase IB/IIA Study of the Saftey and Activity of Intravenous Isophosporamide Mustard (ZIO-201) in Patients With Advanced Sarcoma|Completed||Phase 1/Phase 2|53|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 15:50:28.959816|2017-02-18 15:50:28.959816
NCT00439673|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2010-11-24|||May 2007||2007-05-01|November 2010|2010-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS|A Open Label, Phase II, Non Randomized, Clinical Trial of Chemotherapy Treatment With 5-Azacytidine Plus Valproic Acid and Eventually Atra for Patients Diagnosed With Intermediate II and High Risk Myelodysplastic Syndrome (MDS). EudraCT Number 2005-004811-31. GIMEMA Protocol MDS0205|Completed||Phase 2|56|Anticipated|Gruppo Italiano Malattie EMatologiche dell'Adulto|||||f||||||||||||||2017-02-18 15:50:29.054055|2017-02-18 15:50:29.054055
NCT00439660|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-23|2007-03-21|||December 2006||2006-12-01|February 2007|2007-02-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old|Double-Blind Randomized Placebo-Controlled Dose Escalating Phase Ib/IIa Study to Evaluate the Safety and Immunogenicity of Live Attenuated Oral Rotavirus Vaccine 116E in Healthy Non-Malnourished Infants 8 to 20 Weeks of Age|Unknown status|Active, not recruiting|Phase 1/Phase 2|540||Bharat Biotech International Limited|||||f||||||||||||||2017-02-18 15:50:29.161271|2017-02-18 15:50:29.161271
NCT00439647|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2011-10-10|2011-10-10||December 2006||2006-12-01|October 2011|2011-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis|A Two Year Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Fracture Efficacy and Safety of Intravenous Zoledronic Acid 5 mg Annually for the Treatment of Osteoporosis in Men|Completed||Phase 3|1199|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:50:29.286893|2017-02-18 15:50:29.286893
NCT00439634|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2016-04-18||2016-04-18|February 2007||2007-02-01|April 2016|2016-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|CONNECT||Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia|A 24-Week, Multicenter, Double-Blind, Randomized, Parallel-Group, Dose Ranging Study of the Efficacy and Safety of 3 Oral Doses of AVE1625 and Placebo on Top of Either Olanzapine, Risperidone/Paliperidone, Quetiapine or Aripiprazole in the Treatment of Cognitive Impairment in Schizophrenia.|Terminated||Phase 2|873|Actual|Sanofi||4||"Following a pre-specified interim analysis and Data Monitoring Committee recommendation due to~   insufficient level of efficacy"|f||||||||||||||2017-02-18 15:50:30.858808|2017-02-18 15:50:30.858808
NCT00439621|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2008-08-13|||February 2007||2007-02-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|March 2008|Actual|2008-03-01||Interventional|||Safety Study of Anti-IgE Immunotherapy in Allergic Patients|A Randomized, Double-Blind, Placebo-Controlled Safety and Tolerability Study of Repeated Doses of Anti-IgE Immunotherapy in Allergic Patients|Completed||Phase 2|42|Actual|Resistentia Pharmaceuticals AB||4|||f||||t||||||||||2017-02-18 15:50:30.971158|2017-02-18 15:50:30.971158
NCT00439608|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2013-07-01|2013-05-09||October 2004||2004-10-01|July 2013|2013-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||Patients received cetuximab, 400 mg/mg2 over 2 h on Day 1 then 250 mg/m2/week over 1 h, for 5 additional weeks. Patients also received paclitaxel, 50 mg/m2/week, over 1 h and carboplatin AUC (area under the curve) = 2/week, over 30 min, for 6 weeks. Cetuximab was administered first.|BrUOG-EG-203 Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer|BrUOG-EG-203 Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal, Gastroesophageal Junction and Gastric Cancer BMS#CA225091|Completed||Phase 2|60|Actual|Brown University||1|||f||||t||||||||||2017-02-18 15:50:31.064324|2017-02-18 15:50:31.064324
NCT00439595|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2010-05-26|||February 2007||2007-02-01|May 2010|2010-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|EARS||A Trial of 2 'Point of Care' Diagnostic Methods to Improve Detection and Treatment of Anaemia in African Children|A Cluster Randomised Trial of Different Methods of Haemoglobin Measurement to Improve Recognition and Treatment of Childhood and Pregnancy-related Anaemia in a Malaria Endemic Area of North East Tanzania.|Completed||N/A|450|Anticipated|London School of Hygiene and Tropical Medicine||3|||f||||f||||||||||2017-02-18 15:50:31.304989|2017-02-18 15:50:31.304989
NCT00439582|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2009-03-13|||August 2005||2005-08-01|March 2009|2009-03-01|December 2005||2005-12-01|||||Interventional|TRANSFACT1||Trans Fatty Acids and Cardiovascular Risk Factors|Comparative Effect of 2 Different Sources of Trans Fatty Acid (Milk Fat vs Hydrogenated Oil)on Cardiovascular Risk Factors in Healthy Humans|Completed||N/A|46||Institut National de la Recherche Agronomique||2|||f||||||||||||||2017-02-18 15:50:31.402211|2017-02-18 15:50:31.402211
NCT00439569|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2010-08-30|2010-01-19||January 2008||2008-01-01|August 2009|2009-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|NPTUNE01||Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III|Phase I/IIa Clinical Trial of Sodium Phenylbutyrate in Pediatric Subjects With Type II/III Spinal Muscular Atrophy|Terminated||Phase 1/Phase 2|9|Actual|Westat|The study was closed early due to poor study drug compliance. The sample size is therefore extremely limited.|1||Due to poor compliance with study drug administration.|f||||t||||||||||2017-02-18 15:50:31.509211|2017-02-18 15:50:31.509211
NCT00439556|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2016-08-01|||February 2007||2007-02-01|August 2016|2016-08-01||||February 2018|Anticipated|2018-02-01||Interventional|||Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies|Bortezomib (Velcade) and Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoid Malignancies|Active, not recruiting||Phase 2|52|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:50:32.047926|2017-02-18 15:50:32.047926
NCT00439543|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-02-22|||March 2007||2007-03-01|February 2007|2007-02-01|August 2007||2007-08-01|||||Interventional|||Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis|Inhaled Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis|Unknown status|Not yet recruiting|Phase 2/Phase 3|15||Interstitial Lung Disease Study Group, Korea|||||f||||||||||||||2017-02-18 15:50:32.173199|2017-02-18 15:50:32.173199
NCT00439530|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2009-07-24|||November 2006||2006-11-01|November 2006|2006-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|SEA002||Pharmacologic Study of Oseltamivir in Healthy Volunteers|Pharmacologic Study of Oseltamivir in Healthy Volunteers|Completed||Phase 1|21|Actual|Mahidol University||1|||f||||t||||||||||2017-02-18 15:50:32.279163|2017-02-18 15:50:32.279163
NCT00439517|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2014-06-18|2011-03-31||February 2007||2007-02-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|June 2009|Actual|2009-06-01||Interventional|FUTURE||Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.|A Randomized, Open-label Phase II Study Evaluating the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab as First-line Therapy in Subjects With Metastatic Colorectal Cancer.|Completed||Phase 2|302|Actual|Merck KGaA|Dosing of UFT/ folinic acid in the experimental arm were not directly recorded, so dosing data is not fully available in the UFOX plus cetuximab arm (36/151). Comparative conclusions on drug exposure might be impacted by a bias due to missing data.|2|||f||||t||||||||||2017-02-18 15:50:32.389342|2017-02-18 15:50:32.389342
NCT00439504|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2017-01-10||||||February 2007|2007-02-01||||||||Interventional|||Ph1 Lobeline Interaction Study - 1|Double-Blind, Placebo-Controlled, Cross-Over Assessment of Intravenous Methamphetamine and Sublingual Lobeline Interactions|Unknown status|Recruiting|Phase 1|10||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 15:50:33.541439|2017-02-18 15:50:33.541439
NCT00439491|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2007-02-21|||January 2004||2004-01-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||Role of Adipose Tissue in Pathogenesis of Insulin Resistance|Role of Adipose Tissue in Pathogenesis of Insulin Resistance|Completed||N/A|35||Charles University, Czech Republic|||||f||||||||||||||2017-02-18 15:50:33.62198|2017-02-18 15:50:33.62198
NCT00439478|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-11-13|||September 2004||2004-09-01|October 2007|2007-10-01|September 2006|Actual|2006-09-01|||||Observational|||Dental Safety Profile of High-Dose Radioiodine Therapy|The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer|Completed||Phase 4|202||University Hospital, Basel, Switzerland|||||f||||||||||||||2017-02-18 15:50:33.718663|2017-02-18 15:50:33.718663
NCT00439465|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2016-05-23|||January 2007||2007-01-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|February 2018|Anticipated|2018-02-01||Interventional|||Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma|Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma|Active, not recruiting||Phase 2|20|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 15:50:33.805391|2017-02-18 15:50:33.805391
NCT00439452|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2011-08-31|||May 2007||2007-05-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Telemedicine-Based Collaborative Care to Reduce Rural Disparities|Telemedicine-Based Collaborative Care to Reduce Rural Disparities|Completed||N/A|500|Anticipated|University of Arkansas||2|||f||||f||||||||||2017-02-18 15:50:33.902197|2017-02-18 15:50:33.902197
NCT00439439|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2008-05-19|||October 2006||2006-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||ACHAT-STUDY, Alternative Treatment of Chronic Globus Sensations|"ACHAT-STUDY: Argon-Beamer-Ablation of Cervical Heterotopic Gastral Mucosa, an Alternative Treatment of Chronic Globus Sensations - Sham-Controlled Multicenter Study"|Completed||N/A|40|Anticipated|Technische Universität München||2|||f||||||||||||||2017-02-18 15:50:34.005492|2017-02-18 15:50:34.005492
NCT00439426|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2016-11-01|||April 2007||2007-04-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.|An Open Label Study of First Line Chemotherapy With Xeloda in Combination With Cisplatin on Treatment Response in Patients With Metastatic Nasopharyngeal Cancer|Completed||Phase 2|25|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:50:34.112274|2017-02-18 15:50:34.112274
NCT00439413|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2016-12-07|2016-08-17||June 2007||2007-06-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||Selegiline for Smoking Cessation - 1|Phase 2, Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System (STS) as an Aid for Smoking Cessation.|Completed||Phase 2|246|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 15:50:34.215854|2017-02-18 15:50:34.215854
NCT00439400|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-10-01|||February 2007||2007-02-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period|A Double-Masked, Randomized, Placebo-Controlled Study of ALTY-0501 (Doxycycline 0.025% Ophthalmic Solution) for the Treatment of Dry Eye Administered QID for a 56 Day Period Utilizing the Controlled Adverse Environment Model|Completed||Phase 2|160|Actual|Alacrity Biosciences, Inc.||2|||||||||||||||||2017-02-18 15:50:34.713062|2017-02-18 15:50:34.713062
NCT00439387|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2017-01-24|||February 20, 2007||2007-02-20|June 5, 2015|2015-06-05|June 5, 2015||2015-06-05|||||Observational|||The Role of Serotonin in Seizures|Imaging Serotoninergic Neurotransmission in Epilepsy|Terminated||N/A|46|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:50:34.806557|2017-02-18 15:50:34.806557
NCT00439374|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2012-10-26|||April 2007||2007-04-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|SCAN||RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix|A Randomized Trial of 17 Alpha-Hydroxyprogesterone Caproate for Prevention of Preterm Birth in Nulliparous Women With a Short Cervix|Terminated||Phase 3|657|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1||Halted by NICHD after recommendation by DSMC to stop for futility|f||||t||||||||||2017-02-18 15:50:34.892868|2017-02-18 15:50:34.892868
NCT00439361|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2012-07-05|||February 2007||2007-02-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma|Phase-I Study of Bortezomib (VELCADE) Plus ICE (Ifosfamide, Carboplatin, Etoposide) for Patients With Relapsed Classical Hodgkin Lymphoma|Completed||Phase 1|14|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:50:35.25279|2017-02-18 15:50:35.25279
NCT00439348|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2009-11-20|||February 2007||2007-02-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Over-the-Counter Medication Usage|Improving Over-the-counter Medication Compliance.|Completed||N/A|246|Actual|Florida Hospital||2|||f||||||||||||||2017-02-18 15:50:35.383493|2017-02-18 15:50:35.383493
NCT00439335|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2013-03-28|2009-03-24||March 2007||2007-03-01|August 2009|2009-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Higher Dose Intradermal H5 Vaccine|A Phase I/II Randomized, Double-Blinded Placebo-Controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Immunization With Inactivated Subvirion Influenza A/H5N1 Vaccine Administered by the Intradermal or the Intramuscular Route Among Healthy Adults|Completed||Phase 1/Phase 2|227|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 15:50:35.49494|2017-02-18 15:50:35.49494
NCT00439309|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2014-09-04|2013-11-07||April 2007||2007-04-01|September 2014|2014-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study to Evaluate Safety & Effectiveness of Vascular Sealant System|Randomized Study to Evaluate Safety & Effectiveness of Vascular Sealant to Control Suture Line Bleeding|Terminated||N/A|69|Actual|Integra LifeSciences Corporation||2||Business Decision|f||||t||||||||||2017-02-18 15:50:36.328931|2017-02-18 15:50:36.328931
NCT00439296|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2012-11-28|||May 2006||2006-05-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||ABT-751 With Chemotherapy for Relapsed Pediatric ALL|A Phase I/II Trial of ABT-751 Combined With Dexamethasone, PEG-asparaginase, and Doxorubicin in Relapsed Acute Lymphoblastic Leukemia (ALL)|Terminated||Phase 1|9|Actual|Therapeutic Advances in Childhood Leukemia Consortium||1||The study was stopped due to poor accrual and lack of funding.|f||||t||||||||||2017-02-18 15:50:36.951462|2017-02-18 15:50:36.951462
NCT00439283|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-02-26|||April 2003||2003-04-01|February 2007|2007-02-01|December 2004||2004-12-01|||||Interventional|||Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis|Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis: Comparison of Infusion Every 6 Weeks Versus Infusion on Demand|Completed||Phase 3|240||Association de Recherche Clinique en Rhumatologie|||||f||||f||||||||||2017-02-18 15:50:37.079264|2017-02-18 15:50:37.079264
NCT00439270|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2014-02-28|2013-06-25||July 2007||2007-07-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|February 2012|Actual|2012-02-01||Interventional||All patients who received at least 1 dose of dasatinib|Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer|Phase I/II Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 1/Phase 2|49|Actual|Bristol-Myers Squibb||5|||f||||f||||||||||2017-02-18 15:50:37.23117|2017-02-18 15:50:37.23117
NCT00439257|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2015-04-06||||||February 2007|2007-02-01|June 2000|Actual|2000-06-01|||||Observational|||Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)|Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)|Completed||N/A|124|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 15:50:38.8858|2017-02-18 15:50:38.8858
NCT00439244|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2011-03-23|2011-01-05||December 2006||2006-12-01|March 2011|2011-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis|A One-year Partial Double-blinded, Randomized, Multi-center, Multi-national Study to Assess the Effects of Combination Therapy of Annual Zoledronic Acid (5 mg) and Daily Subcutaneous Teriparatide (2mcrg) on Postmenopausal Women With Severe Osteoporosis|Completed||Phase 3|412|Actual|Novartis|No teriparatide placebo available, Short study duration, Only bone mineral data, No bone strength or bone stucture assessment, No bone turnover markers data between 8 and 26 weeks, Study not powered for fracture outcomes.|3|||f||||||||||||||2017-02-18 15:50:38.979715|2017-02-18 15:50:38.979715
NCT00439231|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2013-11-14|2011-09-19||February 2007||2007-02-01|November 2013|2013-11-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|A Phase II Study of Lenalidomide Revlimid(Registered Trademark) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Completed||Phase 2|33|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 15:50:40.110825|2017-02-18 15:50:40.110825
NCT00439218|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2010-10-27|2010-04-16||January 2008||2008-01-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|NPTUNE 02||Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I|Phase I/IIa Clinical Trial of Sodium Phenylbutyrate in Pediatric Subjects With Type I Spinal Muscular Atrophy|Terminated||Phase 1/Phase 2|5|Actual|Westat|This study was closed early due to slow accrual. The sample size is therefore extremely limited.|1||Extremely slow enrollment|f||||t||||||||||2017-02-18 15:50:40.518844|2017-02-18 15:50:40.518844
NCT00439205|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2016-03-15|||February 2007||2007-02-01|March 2016|2016-03-01||||February 2018|Anticipated|2018-02-01||Observational|||Oral Margin Spectroscopy Detection Using Optical Spectroscopy|Oral Tumor Margin Detection Using Optical Spectroscopy|Active, not recruiting||N/A|60|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Tissue removal and study biopsies to be done so that researchers can better compare the~     appearance and diagnosis at these sites to the images that were taken.~   "|||2017-02-18 15:50:40.847768|2017-02-18 15:50:40.847768
NCT00439192|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-08-07|||February 2007||2007-02-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)|A Multicenter, Randomized, Double-Blind, Parallel Group, Phase II, Forced Dose Titration Study to Investigate the Efficacy and Safety of 400mg and 600mg ELB245 Given Once Daily for 12 Weeks (8 + 4 Weeks) Versus Placebo and Versus 4mg Tolterodine Given Once Daily in Patients With Incontinent Overactive Bladder (OAB)|Terminated||Phase 2|275|Anticipated|elbion AG||||side effect profile did not match expectations|f||||||||||||||2017-02-18 15:50:40.958433|2017-02-18 15:50:40.958433
NCT00439179|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2014-07-15|2013-05-13||July 2006||2006-07-01|July 2014|2014-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|BrUOG-PA205|participant number correlates to all enrolled patients treated on this study as a whole which is the way in which the abstract was written and therefore how these results are entered|A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema|BrUOG-PA-205 A Phase I Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema GSK Study ProtocolGSK #103556|Completed||Phase 1|27|Actual|Brown University||4|||f||||t||||||||||2017-02-18 15:50:41.080756|2017-02-18 15:50:41.080756
NCT00439166|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2010-07-27|||February 2007||2007-02-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|April 2010|Anticipated|2010-04-01||Interventional|||Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid|Effects of Treatment With Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|McMaster University||4|||f||||f||||||||||2017-02-18 15:50:41.667345|2017-02-18 15:50:41.667345
NCT00439153|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2011-10-12|||September 2006||2006-09-01|October 2011|2011-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Minimizing Tourniquet Pressures in Paediatric Orthopaedic Knee Surgery|Quality of Surgical Field in Reconstructive Anterior Cruciate Ligament Surgery: Comparison of Tourniquet Cuff Pressure Determined by an Automated Limb Occlusion Pressure Measurement to a Standard Pressure of 300 mm Hg.|Completed||N/A|41|Anticipated|University of British Columbia||1|||f||||||||||||||2017-02-18 15:50:41.790656|2017-02-18 15:50:41.790656
NCT00439140|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2013-12-09|2013-12-09||June 2007||2007-06-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder||Terminated||Phase 3|41|Actual|Allergan||4||In agreement with FDA the study was terminated based on data available.|f||||t||||||||||2017-02-18 15:50:41.883512|2017-02-18 15:50:41.883512
NCT00439127|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-02-27|||January 2005||2005-01-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Observational|||OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation|Is the Thyroglobulin Measurement Under Thyroxine of Prognostic Value Before rhTSH-Aided Radioiodine Ablation in Differentiated Thyroid Carcinoma?|Completed||N/A|28||Oncology Institute of Southern Switzerland|||||f||||||||||||||2017-02-18 15:50:42.820049|2017-02-18 15:50:42.820049
NCT00439114|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2007-02-21|||July 2005||2005-07-01|February 2007|2007-02-01|June 2006||2006-06-01|||||Observational|||Comparison of Ultrasonic Pachymetry With Orbscan in Corneal Haze|Comparison of Ultrasonic Pachymetry With Orbscan in Corneal Haze|Completed||N/A|40||Baskent University|||||f||||||||||||||2017-02-18 15:50:42.888907|2017-02-18 15:50:42.888907
NCT00439101|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2012-07-11|||April 2007||2007-04-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Randomized Clinical Trial of Megestrol Acetate as an Appetite Stimulant in Malnourished Children With Cancer|A Randomized, Double Blind, Placebo-Controlled Trial of Megestrol Acetate as an Appetite Stimulant in Malnourished Children With Cancer|Completed||N/A|26|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 15:50:42.968382|2017-02-18 15:50:42.968382
NCT00439088|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-03-07|||July 2005||2005-07-01|March 2007|2007-03-01|August 2005||2005-08-01|||||Observational|PamPed||Try Walking a Mile in These Shoes: Activity Level of Lower Extremity Amputees|Comparison of the Patient Activity Monitor to a Pedometer During Ambulation Monitoring of Transtibial Amputees|Completed||Phase 1|20||University of Ottawa|||||f||||||||||||||2017-02-18 15:50:43.073538|2017-02-18 15:50:43.073538
NCT00439075|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-22|2007-07-25|||October 2006||2006-10-01|July 2007|2007-07-01|April 2007|Actual|2007-04-01|||||Interventional|||OUT-OF-HOSPITAL CPAP STUDY|Randomised Controlled Comparison of Continuous Positive Airway Pressure (CPAP) With Standard Treatment in Out-of-Hospital Patients With Acute Cardiogenic Pulmonary Edema.|Completed||Phase 4|124|Actual|University Hospital, Toulouse|||||f||||f||||||||||2017-02-18 15:50:43.146977|2017-02-18 15:50:43.146977
NCT00439062|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-20|||June 2006||2006-06-01|February 2007|2007-02-01|June 2006||2006-06-01|||||Interventional|||Treatment of Rheumatoid Arthritis With Roxithromycin|Treatment of Rheumatoid Arthritis With Roxithromycin|Completed||Phase 4|100||Nazilli State Hospital|||||f||||||||||||||2017-02-18 15:50:43.244723|2017-02-18 15:50:43.244723
NCT00439049|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2015-12-28|||October 2005||2005-10-01|December 2015|2015-12-01|September 2016|Anticipated|2016-09-01|June 2016|Anticipated|2016-06-01||Observational|||Substance Abuse Pre-Treatment Screening Study|General Evaluation of Eligibility for Substance Abuse/Dependence Research|Recruiting||N/A|7500|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||t||||||Samples With DNA|"~     whole blood, serum, white cells~   "|||2017-02-18 15:50:43.335709|2017-02-18 15:50:43.335709
NCT00439036|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2013-05-03|||July 2006||2006-07-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|August 2010|Actual|2010-08-01||Interventional|||Acceptance Therapy During Methadone Detoxification|Acceptance Therapy During Methadone Detoxification|Completed||Phase 1|56|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-02-18 15:50:43.46451|2017-02-18 15:50:43.46451
NCT00439023|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2015-09-14|||May 2006||2006-05-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Glucose in Dialysis Water in Non-diabetics|Effect of Glucose in Dialysis Water on Blood Pressure and Vasoactive Hormones in Dialysis Patients|Completed||Phase 4|18|Actual|Regional Hospital Holstebro||2|||f||||f||||||||||2017-02-18 15:50:46.236109|2017-02-18 15:50:46.236109
NCT00439010|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2008-04-22|||February 2007||2007-02-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects|Evaluation of [123I] AV39 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects|Completed||Phase 1|30|Anticipated|Molecular NeuroImaging|||||f||||f||||||||||2017-02-18 15:50:46.321958|2017-02-18 15:50:46.321958
NCT00438984|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2012-03-14|||December 2006||2006-12-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|January 2011|Actual|2011-01-01||Interventional|||Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma|Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following Cyclophosphamide Conditioning For Patients With Metastatic Melanoma|Completed||Phase 1|11|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 15:50:46.414191|2017-02-18 15:50:46.414191
NCT00438971|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-03-24|2013-07-19||August 2006||2006-08-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder|The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder|Completed||Phase 4|15|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 15:50:46.535976|2017-02-18 15:50:46.535976
NCT00438958|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2014-03-04|||March 2007||2007-03-01|July 2009|2009-07-01||||||||Interventional|||Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases|A Randomized Multicentre Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation for Hematologic Malignancies|Completed||Phase 3|230|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:50:46.861548|2017-02-18 15:50:46.861548
NCT00438945|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2008-05-05|||January 2007||2007-01-01|May 2008|2008-05-01|January 2008|Actual|2008-01-01|||||Interventional|||The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension|The Effect of Eprosartan in Patients With Essential Hypertension on Renal Tubular Function and Vasoactive Hormones During Baseline Conditions and After Activation of the Sympathetic Nervous System.|Completed||Phase 4|18|Anticipated|Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 15:50:47.055758|2017-02-18 15:50:47.055758
NCT00438932|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2011-09-23|2011-07-25||January 2007||2007-01-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease|"Reduced Phosphate Intake in Normo-Phosphatemic Chronic Kidney Disease Patients"|Completed||N/A|16|Actual|Massachusetts General Hospital|In addition to limited power, the small sample size led to imbalances in baseline laboratory tests, which added further variability to the analyses. .|4|||f||||t||||||||||2017-02-18 15:50:47.310943|2017-02-18 15:50:47.310943
NCT00438906|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-09-07|||December 2006||2006-12-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|CAPS 3||Cancer of the Pancreas Screening Study (CAPS 3)|Screening for Early Pancreatic Neoplasia|Completed||N/A|200|Actual|Johns Hopkins University|||1||f||||t||||||Samples With DNA|"~     approx 40 ml of blood, approx 10 ml pancreatic juice, pancreatic cells if fine needle~     aspirate is clinically recommended~   "|||2017-02-18 15:50:48.031647|2017-02-18 15:50:48.031647
NCT00438893|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2013-07-22|||January 2004||2004-01-01|July 2013|2013-07-01||||April 2010|Actual|2010-04-01||Interventional|||Effects of a Long Term Dietary Portfolio and of Sequential Removal of Food Components From the Diet|The Long-Term Effect of Viscous Fibers, Soy Protein, and Plant Sterol Foods in Combination on Serum Cholesterol and Other Risk Factors for Cardiovascular Disease|Unknown status|Active, not recruiting|Phase 2|66|Anticipated|University of Toronto||1|||f||||f||||||||||2017-02-18 15:50:48.137878|2017-02-18 15:50:48.137878
NCT00438880|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-01-04|2014-05-20||October 2004||2004-10-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|October 2010|Actual|2010-10-01||Interventional||All participants accrued to this study were analyzed for baseline characteristics|Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma|A Phase I/II Trial of CpG 7909, Rituximab Immunotherapy, and Y-90 Zevalin Radioimmunotherapy for Patients With Previously Treated CD20+ Non-Hodgkin Lymphoma|Completed||Phase 1/Phase 2|38|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 15:50:48.255989|2017-02-18 15:50:48.255989
NCT00438867|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2013-02-11|||May 2007||2007-05-01|November 2008|2008-11-01||||November 2009|Actual|2009-11-01||Interventional|AWARE||Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization|A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Female Patients With Stable Angina Pectoris Who Are Not Candidates for Revascularization|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|Cardium Therapeutics||3|||f||||t||||||||||2017-02-18 15:50:48.698324|2017-02-18 15:50:48.698324
NCT00438854|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2013-04-23|2012-04-25||December 2006||2006-12-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|October 2010|Actual|2010-10-01||Interventional|||Dasatinib in Relapsed Chronic Lymphocytic Leukemia|Phase II Study of Dasatinib (BMS-354825) in Relapsed Chronic Lymphocytic Leukemia|Completed||Phase 2|15|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-02-18 15:50:48.845334|2017-02-18 15:50:48.845334
NCT00438841|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2009-03-12|||August 2006||2006-08-01|March 2009|2009-03-01||||December 2008|Anticipated|2008-12-01||Interventional|||Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma|A Phase II Trial With VELCADE® (PS-341), Cytoxan (Cyclophosphamide), Dexamethasone and Thalomid® (VEL-CTD) in Previously Untreated Multiple Myeloma Patients|Unknown status|Active, not recruiting|Phase 2|43|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:50:49.323497|2017-02-18 15:50:49.323497
NCT00438828|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2014-11-17|||February 2007||2007-02-01|November 2014|2014-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Dexamethasone for the Prophylaxis of Pain Flare Study|Dexamethasone for the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases|Completed||Phase 1|61|Actual|Sunnybrook Health Sciences Centre||1|||f||||t||||||||||2017-02-18 15:50:49.449156|2017-02-18 15:50:49.449156
NCT00438815|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2014-03-19|2010-03-31||September 2006||2006-09-01|March 2014|2014-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|CHANGE 2||Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks|LEVP2006-1 CHANGE 2 Trial (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation Evaluating Efficacy): Open-Label Safety/Efficacy Repeat Exposure Study of C1INH-nf (Human) in the Treatment of Acute HAE Attacks|Completed||Phase 3|113|Actual|Shire||1|||f||||||||||||||2017-02-18 15:50:49.571699|2017-02-18 15:50:49.571699
NCT00438802|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2015-06-23|||March 2006||2006-03-01|June 2015|2015-06-01|May 2018|Anticipated|2018-05-01|July 2010|Actual|2010-07-01||Interventional|||Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma|A Phase I Study of Alefacept (AmeviveTM) in the Treatment of Cutaneous T-cell Lymphoma and Peripheral T-cell NHL|Active, not recruiting||Phase 1|24|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:50:49.901669|2017-02-18 15:50:49.901669
NCT00438789|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2014-05-05||||||September 2011|2011-09-01||||||||Expanded Access|EMBRACE||The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol||Approved for marketing||Phase 3|||Alexion Pharmaceuticals|||||||||||||||||||2017-02-18 15:50:50.018112|2017-02-18 15:50:50.018112
NCT00438776|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2011-12-12|||February 2007||2007-02-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling||Completed||Phase 3|42|Actual|Lindner Center of HOPE||2|||f||||||||||||||2017-02-18 15:50:50.100088|2017-02-18 15:50:50.100088
NCT00438763|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2013-09-25|||December 2005||2005-12-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01||Observational|||CMC Arthritis - Neoprene Vs. Thermoplast Short Opponens Splinting|Prospective Randomized Comparison: Neoprene Vs. Thermoplast Short Opponens Splinting. Outcomes After a Five-week to Sixteen-week Treatment Trial.|Completed||N/A|120|Actual|Massachusetts General Hospital|||2||f||||||||||||||2017-02-18 15:50:50.224949|2017-02-18 15:50:50.224949
NCT00438750|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2012-06-01|2012-03-27||January 2007||2007-01-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Comparison of Occupational Therapy and Home Exercises for Adults With Operatively Treated Distal Radius Fractures|Prospective Randomized Comparison of Occupational Therapy vs Home Exercises After Volar Plate Fixation of a Fracture of the Distal Radius|Completed||N/A|94|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 15:50:50.323973|2017-02-18 15:50:50.323973
NCT00438737|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2011-09-01|||January 2007||2007-01-01|September 2007|2007-09-01||||||||Interventional|||Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer|Randomized Phase II Trial Evaluating the Feasibility and Tolerance of the Combination of FOLFOX With Cetuximab and the Combination of FOLFOX With Cetuximab and Bevacizumab as Perioperative Treatment in Patients With Resectable Liver Metastases From Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:50:50.8278|2017-02-18 15:50:50.8278
NCT00438724|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2007-09-19|||November 2004||2004-11-01|September 2007|2007-09-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Couples Coping With Alzheimer's Disease|A Randomized Control Trial of an Intervention for Couples Coping With Alzheimer's Disease|Unknown status|Recruiting|N/A|200|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 15:50:50.932873|2017-02-18 15:50:50.932873
NCT00438711|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2011-07-19|||September 2005||2005-09-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Surgical Decision Making Among People With Inflammatory Bowel Disease|Surgical Decision Making Among People With Inflammatory Bowel Disease|Completed||N/A|91|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 15:50:51.051783|2017-02-18 15:50:51.051783
NCT00438698|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2015-12-15|||September 2004||2004-09-01|December 2015|2015-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Low Glycemic Index Diets vs. High Cereal Fibre Diets in Type 2 Diabetes|Effect of Low Glycemic Index Diets on Glucose Control in Non-Insulin Dependent Diabetics|Completed||N/A|210|Actual|University of Toronto||2|||f||||f||||||||||2017-02-18 15:50:51.128935|2017-02-18 15:50:51.128935
NCT00438685|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2015-04-10|||October 2004||2004-10-01|July 2010|2010-07-01|September 2010|Actual|2010-09-01|August 2007|Actual|2007-08-01||Interventional|||Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders|Development of Outpatient MST for Dually Diagnosed Youth|Completed||Phase 1|40|Anticipated|Medical University of South Carolina|||||f||||||||||||||2017-02-18 15:50:51.23524|2017-02-18 15:50:51.23524
NCT00438672|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2012-04-25|2012-03-22||April 2003||2003-04-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Corticosteroid Injection for Common Upper Extremity Problems|Corticosteroid Injection for Common Upper Extremity Problems|Completed||N/A|64|Actual|Massachusetts General Hospital||3|||f||||||||||||||2017-02-18 15:50:51.346892|2017-02-18 15:50:51.346892
NCT00438659|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-07-01|2014-06-12||August 2007||2007-08-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|January 2010|Actual|2010-01-01||Interventional||All (169) eligible patients are included in the baseline analysis. There were 5 cancels in Arm I and 2 in Arm II.|Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ|Phase III Randomized Double-Blind Study of Mometasone Furoate Versus Placebo in the Prevention of Radiation Dermatitis in Breast Cancer Patients Receiving Radiation Therapy|Completed||Phase 3|176|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 15:50:51.73421|2017-02-18 15:50:51.73421
NCT00438646|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2009-08-24|||February 2007||2007-02-01|November 2008|2008-11-01||||December 2008|Actual|2008-12-01||Observational|||Oral Bacteria and Allergic Disease in Children|Oral Bacteria and History of Allergic Disease in Children: A Pilot Study|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:50:52.737731|2017-02-18 15:50:52.737731
NCT00438633|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2017-02-08|||February 2005||2005-02-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Comparison of Early and Late Therapy for Adults With Non-Operatively Treated Proximal Humerus Fractures|Early vs Delayed Physical Therapy (Exercises) for Non-Operatively-Treated Proximal Humerus Fractures: A Prospective Randomized Trial|Active, not recruiting||N/A|60|Anticipated|Massachusetts General Hospital|||2||f||||||||||||||2017-02-18 15:50:52.823952|2017-02-18 15:50:52.823952
NCT00438620|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-02-24|||October 2006||2006-10-01|January 2012|2012-01-01||||November 2011|Actual|2011-11-01||Observational|||The Feasibility of Physical Activity in Advanced Cancer Patients|A Pilot Study to Explore the Role of Physical Activity as a Quality of Life Intervention in Advanced Cancer Patients|Completed||N/A|30|Actual|AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 15:50:52.915503|2017-02-18 15:50:52.915503
NCT00438607|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2009-07-10|||April 2007||2007-04-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Single and Multiple Oral Dose Administration of BIIB014 in Subjects With Moderate to Late Stage Parkinson's Disease Who Are Also Receiving Treatment With Levodopa|Completed||Phase 2|83|Actual|Biogen||3|||f||||t||||||||||2017-02-18 15:50:53.002656|2017-02-18 15:50:53.002656
NCT00438594|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2013-01-29|||February 2004||2004-02-01|January 2013|2013-01-01|April 2006|Actual|2006-04-01|||||Interventional|DenverY09||Age 9 Follow-up of Preventive Intervention (Denver)|Age 9 Follow-up of Preventive Intervention|Completed||N/A|584|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-02-18 15:50:53.130196|2017-02-18 15:50:53.130196
NCT00438581|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-26|||March 2007||2007-03-01|February 2007|2007-02-01||||||||Interventional|Zevalin||Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma|Phase II Non-Randomized Study Combining Yttrium 90 Ibritumomab Tiuxetan (Zevalin) With High-Dose Chemotherapy Prior to Autologous Stem Cell Transplantation in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma|Unknown status|Not yet recruiting|Phase 2|40||McGill University|||||f||||||||||||||2017-02-18 15:50:53.242485|2017-02-18 15:50:53.242485
NCT00438568|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2012-09-12|||June 2006||2006-06-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|SNIFF 120||SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)|Therapeutic Effects of Intranasal Insulin Administration in AD|Completed||Phase 2|173|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 15:50:53.338648|2017-02-18 15:50:53.338648
NCT00438555|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2015-03-18|||October 2006||2006-10-01|July 2014|2014-07-01|December 2014|Actual|2014-12-01|October 2014|Actual|2014-10-01||Interventional|4055obesityprv||Randomized, Controlled, Open, Comparative Intervention Study for Obesity Prevention in Children|Randomized, Controlled, Open, Comparative Intervention Study for Obesity Prevention in Children|Completed||N/A|248|Actual|Rabin Medical Center||3|||f||||||||||||||2017-02-18 15:50:53.463917|2017-02-18 15:50:53.463917
NCT00436761|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2013-12-17|||May 2004||2004-05-01|June 2007|2007-06-01||||||||Interventional|||Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors|A Phase I Study to Examine the Toxicity of Killer IG-Like Receptor (KIR) Mismatched Umbilical Cord Blood for Pediatric Patients With Malignant Solid Tumors|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:50:53.576022|2017-02-18 15:50:53.576022
NCT00436748|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2015-03-26|2015-03-04||September 2008||2008-09-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||Efficacy analysis set, including all participants who received ≥ 1 dose of investigational product.|Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease|A Multi-Center, Double-Blind, Randomized Study Evaluating De Novo Weekly and Once Every Two Week Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease Receiving and Not Receiving Dialysis|Terminated||Phase 3|116|Actual|Amgen||2||Study Terminated; Commitment met per Regulatory Authorities.|f||||f||||||||||2017-02-18 15:50:53.692882|2017-02-18 15:50:53.692882
NCT00436722|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2009-05-19|||June 2006||2006-06-01|May 2009|2009-05-01||||July 2009|Anticipated|2009-07-01||Interventional|ATEGE-LIVER||Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial|Study of ATEGE-Fresenius Induction in Liver Transplantation Followed by Tacrolimus Weaning.|Terminated||Phase 2|72|Anticipated|Hospital Clinic of Barcelona||1||Experimental arm (induction + low dose tacrolimus) not effective.|f||||f||||||||||2017-02-18 15:50:55.332804|2017-02-18 15:50:55.332804
NCT00436709|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2014-01-03|||July 2006||2006-07-01|June 2007|2007-06-01||||||||Interventional|||Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer|A Pilot Study of Bevacizumab With Dose Dense Doxorubicin and Cyclophosphamide (AC) Followed by Dose Dense Nanoparticle Albumin Bound Paclitaxel for the Treatment of Early Stage Breast Cancer|Unknown status|Active, not recruiting|N/A|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:50:55.444567|2017-02-18 15:50:55.444567
NCT00438542|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2007-02-21|||July 2003||2003-07-01|February 2007|2007-02-01|July 2006||2006-07-01|||||Observational|||HMW-Adiponectin is Raised in Newborns||Completed||N/A|||University of Oslo|||||f||||||||||||||2017-02-18 15:50:55.553102|2017-02-18 15:50:55.553102
NCT00438516|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2008-01-09|||June 2000||2000-06-01|December 2007|2007-12-01|March 2003|Actual|2003-03-01|||||Interventional|MemphisYear9||Follow-up of Families in Early Preventive Intervention|Follow-up of Families in Early Preventive Intervention|Completed||N/A|627|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 15:50:55.620301|2017-02-18 15:50:55.620301
NCT00438503|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2015-09-14|||May 2006||2006-05-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Glucose in Dialysis Water in Diabetics With Chronic Renal Failure|Effect of Glucose in Dialysis Water in Diabetics With Chronic Renal Failure on Blood Pressure, Pulse Rate, Plasma Glucose, Plasma Concentrations of Insulin, Growth Hormone, Renin, Angiotensin II, Endothelin and Body Temperature|Completed||Phase 4|18|Actual|Regional Hospital Holstebro||2|||f||||f||||||||||2017-02-18 15:50:55.738359|2017-02-18 15:50:55.738359
NCT00438490|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2013-04-17|2013-02-05||April 2002||2002-04-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||The Safety and Efficacy of Recombinant Human Prolactin|Phase 2 Study of Recombinant Human Prolactin Efficacy and Safety|Completed||Phase 2|21|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 15:50:55.837065|2017-02-18 15:50:55.837065
NCT00438477|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2012-07-27|||June 2005||2005-06-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|August 2006|Actual|2006-08-01||Interventional|||Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer|A Preliminary Study To Explore Subareolar Injection As The Site For Lymphatic Mapping And Sentinel Lymph Node Biopsy In Patients With Breast Cancer|Completed||N/A|74|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:50:56.228946|2017-02-18 15:50:56.228946
NCT00438464|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-02-10|2015-10-20||February 2007||2007-02-01|June 2015|2015-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||Baseline includes participants who were randomized to arms and received assigned treatment.|Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery|A Randomized Controlled Trial Evaluating the Tissue Effects of Preoperative Finasteride Versus Placebo for Patients With Clinically Organ-Confined Prostate Cancer|Completed||Phase 2|204|Actual|National Cancer Institute (NCI)|Predefined molecular signature could not easily distinguish GG 4 from GG 3 tumor areas in the placebo arm.|2|||f||||f||||||||||2017-02-18 15:50:56.374156|2017-02-18 15:50:56.374156
NCT00438451|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2013-01-24|2012-09-24||January 2007||2007-01-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|July 2010|Actual|2010-07-01||Interventional|STEP-ONE||Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs|A Multicentre, Double-blind, Randomized, Phase IV Clinical Trial Comparing the Safety, Tolerability and Efficacy of Levetiracetam Versus Lamotrigine and Carbamazepine in the Oral Antiepileptic Therapy of Newly Diagnosed Elderly Patients With Focal Epilepsy.|Completed||Phase 4|361|Actual|Johannes Gutenberg University Mainz||3|||f||||f||||||||||2017-02-18 15:50:57.446549|2017-02-18 15:50:57.446549
NCT00438438|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2011-08-31|||April 2006||2006-04-01|August 2011|2011-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Interaction of Chronic Sleep Restriction and Circadian Misalignment on Sleep and Neuro-cognitive Performance|"Interaction of Chronic Sleep Restriction and Circadian Misalignment on Sleep and Neuro-cognitive Performance"|Completed||N/A|9|Anticipated|Brigham and Women's Hospital||1|||f||||f||||||||||2017-02-18 15:50:59.655742|2017-02-18 15:50:59.655742
NCT00438425|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2015-12-03|||January 2007||2007-01-01|December 2015|2015-12-01|January 2016|Anticipated|2016-01-01|January 2011|Actual|2011-01-01||Interventional|||Portfolio 5 - Multicentre Dietary Advice on Serum Lipids in Hyperlipidemia|Assessment of the Practical Application, Acceptability and Effectiveness of a Portfolio Diet in Reducing Serum Cholesterol|Active, not recruiting||Phase 2|351|Actual|University of Toronto||3|||f||||f||||||||||2017-02-18 15:50:59.752099|2017-02-18 15:50:59.752099
NCT00438412|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2008-04-17|||October 2006||2006-10-01|April 2008|2008-04-01||||||||Observational|||Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea||Suspended||Phase 4|40|Anticipated|Regional Hospital Holstebro|||2|It was not possible to recruit enough patients with obstructive sleep apnea.|f||||||||||||||2017-02-18 15:50:59.879203|2017-02-18 15:50:59.879203
NCT00438399|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2011-11-21|2011-06-22||February 2007||2007-02-01|November 2011|2011-11-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Subject Preference for Scalp Psoriasis Treatment|Subject Preference Comparison Between Clobetasol Propionate Shampoo, 0.05% and Three Other Topical Corticosteroids in the Treatment of Moderate to Severe Scalp Psoriasis|Completed||Phase 3|219|Actual|Galderma||6|||f||||f||||||||||2017-02-18 15:50:59.969216|2017-02-18 15:50:59.969216
NCT00438386|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2009-08-07|||April 2005||2005-04-01|August 2009|2009-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Aripiprazole for the Treatment of Refractory Anxiety|Aripiprazole for the Treatment of Refractory Anxiety: Impact on Clinical Outcomes, Resilience and Neuroendocrinologic Parameters|Completed||Phase 4|||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 15:51:00.750903|2017-02-18 15:51:00.750903
NCT00438373|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2015-02-25|||January 2007||2007-01-01|February 2015|2015-02-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||LH/HCG Receptor Expression and Retrieval Rates|Association of LH/HCG Receptor Expression and Retrieval Rates at Oocyte Pick up.|Suspended||N/A|100|Anticipated|Aristotle University Of Thessaloniki|||1||f||||||||||||||2017-02-18 15:51:00.856198|2017-02-18 15:51:00.856198
NCT00438360|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2011-07-13|2010-12-15||May 2006||2006-05-01|July 2011|2011-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis|A 24-week, Double-blind, Randomized, Placebo-controlled, Multicenter Study, to Evaluate the Effectiveness of Cyclosporine 2,5 mg/kg/Day Bid Twice a Week on Reducing Relapse Rate, in Maintenance Patients With Chronic Plaque Psoriasis|Completed||Phase 3|243|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:51:00.948733|2017-02-18 15:51:00.948733
NCT00438347|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2016-11-04|||April 2006||2006-04-01|November 2016|2016-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Influence of Fitness on Brain and Cognition|Influence of Fitness on Brain and Cognition|Completed||N/A|179|Actual|University of Illinois at Urbana-Champaign|||2||f||||t||||||||No||2017-02-18 15:51:01.373126|2017-02-18 15:51:01.373126
NCT00438334|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2016-11-18|||April 2001||2001-04-01|November 2016|2016-11-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Real-World Benefit From Directional Hearing Aids|Real-World Benefit From Directional Microphone Hearing Aids|Completed||N/A|105|Actual|Vanderbilt University|||||f||||||||||||||2017-02-18 15:51:01.485141|2017-02-18 15:51:01.485141
NCT00438321|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2010-05-03|||September 2006||2006-09-01|May 2010|2010-05-01|September 2010|Anticipated|2010-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome|Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome|Unknown status|Recruiting|N/A|72|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 15:51:01.580093|2017-02-18 15:51:01.580093
NCT00438308|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2010-08-11|||December 2004||2004-12-01|August 2010|2010-08-01|May 2007|Actual|2007-05-01|||||Observational|||Comparison of Early and Late Therapy for Adults With Operatively Treated Distal Radius Fractures|Prospective Randomized Comparison of Early and Late Wrist Mobilization After Volar Plate Fixation of a Fracture of the Distal Radius|Completed||N/A|60|Actual|Massachusetts General Hospital|||2||f||||||||||||||2017-02-18 15:51:01.706263|2017-02-18 15:51:01.706263
NCT00438295|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2015-09-14|||August 2006||2006-08-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Temperature Control During Dialysis Treatment|Effect of Temperature Control During Dialysis Treatment With Glucose in Dialysis Water in Patients With Chronic Renal Failure|Completed||Phase 4|18|Actual|Regional Hospital Holstebro||2|||f||||f||||||||||2017-02-18 15:51:01.817964|2017-02-18 15:51:01.817964
NCT00438282|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2013-04-30|||March 2001||2001-03-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|July 2005|Actual|2005-07-01||Interventional|DenverY06||Age 6 Test of Home Visits by Nurses vs Paraprofessionals|Age 6 Test of Home Visits by Nurses vs Paraprofessionals|Completed||N/A|604|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-02-18 15:51:01.911839|2017-02-18 15:51:01.911839
NCT00438269|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-17|2007-02-21|||February 2003||2003-02-01|February 2007|2007-02-01|March 2005||2005-03-01|||||Interventional|||Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection|Appropriate Antimicrobial Therapy in Critical Care: A Pilot Randomized Controlled Trial|Completed||Phase 2|80||Canadian Critical Care Trials Group|||||f||||||||||||||2017-02-18 15:51:02.026875|2017-02-18 15:51:02.026875
NCT00438256|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2017-01-18|||December 2007||2007-12-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer|Phase I/II of Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer|Active, not recruiting||Phase 1/Phase 2|49|Anticipated|Massachusetts General Hospital||4|||f||||t||||||||||2017-02-18 15:51:02.140916|2017-02-18 15:51:02.140916
NCT00438243|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2016-07-01|||May 2008||2008-05-01|July 2016|2016-07-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.|Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.|Withdrawn||Phase 2|0|Actual|Johns Hopkins University||2||Principal Investigator left institution|f||||||||||||||2017-02-18 15:51:02.266752|2017-02-18 15:51:02.266752
NCT00438230|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-21|||November 2003||2003-11-01|February 2007|2007-02-01|September 2006||2006-09-01|||||Interventional|DACUS||Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants|Residual Vein Thrombosis (RVT) Establishes the Optimal Duration of Oral Anticoagulants After a First Episode of Deep Vein Thrombosis of the Lower Limbs|Completed||Phase 4|250||Azienda Ospedaliera Universitaria Policlinico|||||f||||||||||||||2017-02-18 15:51:02.376655|2017-02-18 15:51:02.376655
NCT00438217|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2007-02-21||||||February 2007|2007-02-01||||||||Interventional|CPP-EDG 01||Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children|Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children|Unknown status|Recruiting|Phase 4|100||University of Pisa|||||f||||||||||||||2017-02-18 15:51:02.471966|2017-02-18 15:51:02.471966
NCT00438204|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-07-15|2014-06-04||May 2006||2006-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|March 2013|Actual|2013-03-01||Interventional|||Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Trial of Pemetrexed, Gemcitabine, and Bevacizumab Every Two Weeks in Chemotherapy-Naive Patients With Stages IIIB/IV Non- Squamous, Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|39|Actual|Barbara Ann Karmanos Cancer Institute|There were no significant limitations of the trial.|1||All data collection has completed.|f||||t||||||||||2017-02-18 15:51:02.563565|2017-02-18 15:51:02.563565
NCT00438191|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2015-04-06|||December 2005||2005-12-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||A Clinical Trial of Splinting for DeQuervain's Tenosynovitis|A Clinical Trial of Full Time vs. As Needed Splint Wear for DeQuervain's Tenosynovitis|Active, not recruiting||N/A|80|Anticipated|Massachusetts General Hospital|||2||f||||||||||||||2017-02-18 15:51:02.876895|2017-02-18 15:51:02.876895
NCT00438178|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-21|2014-05-09|||October 2005||2005-10-01|May 2014|2014-05-01||||October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies|A Phase I Study of Obatoclax Mesylate (GX15-070MS) in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myeloid Leukemia (CML)in Myeloid Blast Phase, Myelofibrosis, Previously-Treated Chronic Lymphocytic Leukemia (CLL), or Aplastic Anemia|Completed||Phase 1|44|Actual|Teva Pharmaceutical Industries|||||f||||f||||||||||2017-02-18 15:51:03.201881|2017-02-18 15:51:03.201881
NCT00438152|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2011-07-15|||September 2006||2006-09-01|February 2007|2007-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|LoCKIT||Lopinavir Capsules to Kaletra or Invirase Tablets|A 24-week, Randomized, Open-label, 2-arm Study to Compare the Safety, Efficacy and Tolerability of Invirase® Tablets With Ritonavir Versus Kaletra® Tablets in HIV 1 Infected Adults on a Kaletra® Based Regimen With 2 Nucleosides/Nucleotides|Completed||Phase 4|53|Actual|Royal Free Hampstead NHS Trust||2|||f||||t||||||||||2017-02-18 15:51:03.412679|2017-02-18 15:51:03.412679
NCT00438139|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2017-01-13|||March 2007||2007-03-01|February 2007|2007-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Ph1 Marinol Interaction Study - Part 1 - 1|Phase 1, Pilot Study to Examine the Cardiovascular Effects of Smoked Marijuana, Interactions With Oral Dronabinol, and Effects of Dronabinol on Withdrawal in Marijuana Dependent Volunteers|Terminated||Phase 1|6||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 15:51:03.527258|2017-02-18 15:51:03.527258
NCT00438126|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2010-03-01|||January 2002||2002-01-01|March 2010|2010-03-01|May 2006||2006-05-01|||||Interventional|||Family-Centered Diabetes Project - Sharing Wisdom||Completed||N/A|200||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||t||||||||||2017-02-18 15:51:03.621054|2017-02-18 15:51:03.621054
NCT00438113|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2017-01-30|||December 2009||2009-12-01|January 2017|2017-01-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|SMAC AF||Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF|Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF|Completed||Phase 4|184|Actual|Nova Scotia Health Authority||2|||f||||f||||||||No||2017-02-18 15:51:03.71829|2017-02-18 15:51:03.71829
NCT00438100|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-18|2015-05-14|2015-05-14||April 2008||2008-04-01|May 2015|2015-05-01|May 2013|Actual|2013-05-01|July 2012|Actual|2012-07-01||Interventional|||Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer|Randomized Control Study of Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer Patients|Completed||Phase 2|142|Actual|Japan Breast Cancer Research Network||2|||f||||t||||||||||2017-02-18 15:51:03.848111|2017-02-18 15:51:03.848111
NCT00438087|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2012-07-06|||March 2007||2007-03-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|March 2010|Actual|2010-03-01||Interventional|||Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery|Assessment of Corticosteroid Effect in the Prevention of Facial Palsy After Cerebella-pontine Angle Surgery|Completed||Phase 3|313|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 15:51:04.174427|2017-02-18 15:51:04.174427
NCT00438074|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-04-12|||February 2007||2007-02-01|April 2016|2016-04-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Observational|||A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast Cancer|A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast Cancer|Recruiting||N/A|40|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||||||||||||2017-02-18 15:51:04.286419|2017-02-18 15:51:04.286419
NCT00438061|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-23|||January 1995||1995-01-01|February 2007|2007-02-01|December 1998||1998-12-01|||||Interventional|||Effect of Abdominal Obesity on Lipoprotein Metabolism|Effect of Weight Loss on Lipoprotein Metabolism in Abdominal Obesity|Completed||Phase 3|40||The University of Western Australia|||||f||||||||||||||2017-02-18 15:51:04.387408|2017-02-18 15:51:04.387408
NCT00438048|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2008-05-21|||November 2006||2006-11-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment|Xerostomy Treatment in Patients With Sjogren's Syndrome in Chile :A Double Blind Control Trial Comparing Orally Pilocarpine Drops and Artificial Saliva|Completed||Phase 4|76|Actual|Pontificia Universidad Catolica de Chile||1|||f||||t||||||||||2017-02-18 15:51:04.49236|2017-02-18 15:51:04.49236
NCT00438035|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2008-08-11|||February 2007||2007-02-01|February 2007|2007-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|ECG-Spectral||Heart Rate Variability and Postoperative Pain|Evaluation of Postoperative Pain by Spectral Analysis of ECG R-R Intervals|Completed||N/A|106|Actual|University Hospital, Bordeaux||1|||f||||f||||||||||2017-02-18 15:51:04.611082|2017-02-18 15:51:04.611082
NCT00438022|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-10-04|||March 2006||2006-03-01|October 2016|2016-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis|Risk Factors in Atopic Dermatitis for the Development of Eczema Herpeticum|Completed||N/A|240|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||t||||||Samples With DNA|"~     Blood and skin samples will be retained~   "|Yes|Participant level data access is available to the public in the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 15:51:04.714436|2017-02-18 15:51:04.714436
NCT00438009|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2009-09-22|||February 2007||2007-02-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients|A Phase I, Open Label, Cohort Study of Two Doses of Cavatak (Coxsackievirus Type A21) Given Intratumourally in Stage IV Melanoma Patients.|Completed||Phase 1|9|Anticipated|Viralytics||1|||f||||t||||||||||2017-02-18 15:51:04.826732|2017-02-18 15:51:04.826732
NCT00437996|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2009-06-26|||February 2007||2007-02-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|||||Interventional|||Comparative Affect of a Continuous Epidural Infusion of Clonidine During Labour. Prospective Double Blind Randomized Trial|Epidural Analgesia During Labour. Impact of Clonidine Addition to Levobupivacaine and Sufentanil|Completed||Phase 3|85|Actual|Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 15:51:04.937955|2017-02-18 15:51:04.937955
NCT00437983|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2010-01-03|2009-06-30||April 2007||2007-04-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment|A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment|Completed||Phase 4|157|Actual|Enzymotec||2|||f||||||||||||||2017-02-18 15:51:05.026426|2017-02-18 15:51:05.026426
NCT00437970|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-18|2016-05-26|||April 2008||2008-04-01|April 2009|2009-04-01|February 2009|Anticipated|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Medication in Early Diabetes (MED) Study|Drug naïve Indigenous Australians With Type 2 Diabetes, Enrolled in a Randomised Controlled Trial of Rosiglitazone Versus Metformin Monotherapy to Assess the Effects on Metabolic and Cardiovascular Parameters|Withdrawn||Phase 4|0|Actual|Menzies School of Health Research||2||Unable to secure supply of the study medication|f||||t||||||||||2017-02-18 15:51:05.407273|2017-02-18 15:51:05.407273
NCT00437957|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2013-11-21|||December 2006||2006-12-01|June 2011|2011-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases|Phase I Trial Of Temozolomide Combined With The Histone Deacetylase Inhibitor Valproic Acid (VPA) And Whole Brain Radiation Therapy (WBR) For Brain Metastases From Solid Tumors In Adults|Terminated||Phase 1|10|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||Lack of enrollment|f||||f||||||||||2017-02-18 15:51:05.521508|2017-02-18 15:51:05.521508
NCT00437944|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2007-02-19|||May 2006||2006-05-01|February 2007|2007-02-01|July 2006||2006-07-01|||||Observational|||Relation Between Polymorphism in Genes Related to Kidney Disease and Renal Manifistations in Fabry Disease||Completed||N/A|||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 15:51:05.651226|2017-02-18 15:51:05.651226
NCT00437931|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2016-09-07|||February 2007||2007-02-01|September 2016|2016-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction||Completed||N/A|60|Actual|HaEmek Medical Center, Israel|||3||f||||||||||||||2017-02-18 15:51:05.721483|2017-02-18 15:51:05.721483
NCT00437918|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2008-03-21|||January 2007||2007-01-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients|Phase IV Study on Predictive Markers for the Effectiveness of Nateglinide or Acarbose for Controlling Post-Prandial Glucose in Type 2 Diabetics Already on Optimized Insulin Glargine Therapy|Completed||Phase 4|85|Actual|Inje University||1|||f||||t||||||||||2017-02-18 15:51:05.820962|2017-02-18 15:51:05.820962
NCT00437905|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-20|||June 2003||2003-06-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Interventional|||Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial|Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial|Terminated||Phase 4|40||Medical University of Vienna|||||f||||||||||||||2017-02-18 15:51:05.915254|2017-02-18 15:51:05.915254
NCT00437892|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2011-08-18|||May 2007||2007-05-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis|The Effect of Statins on D-dimer Levels in Patients With a Previous Venous Thromboembolic Event|Terminated||Phase 2|10|Actual|Università degli Studi dell'Insubria||2||Competitive trials and slow recruitment rate|f||||f||||||||||2017-02-18 15:51:06.00644|2017-02-18 15:51:06.00644
NCT00437879|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-04-12|||January 2007||2007-01-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Observational|||Pilot Investigation of Ultrasound Imaging and Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Locally-Advanced Breast Cancer Response to Neoadjuvant Treatment|Pilot Investigation of Ultrasound Imaging and Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Locally-Advanced Breast Cancer Response to Neoadjuvant Treatment|Recruiting||N/A|100|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||t||||||||||2017-02-18 15:51:06.121393|2017-02-18 15:51:06.121393
NCT00437866|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2012-12-05|||January 2007||2007-01-01|December 2012|2012-12-01|July 2010|Actual|2010-07-01|February 2008|Actual|2008-02-01||Observational|||Hepcidin in Anemic Chronic Heart Failure (CHF) Patients|Hepcidin in the Pathogenesis of Anemia in Patients With Chronic Heart Failure|Completed||N/A|100|Actual|Medical University of Vienna|||1||f||||||||||||||2017-02-18 15:51:06.209685|2017-02-18 15:51:06.209685
NCT00437853|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-20|||June 2003||2003-06-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer||Completed||N/A|30||Instituto Nacional de Cancerologia de Mexico|||||f||||||||||||||2017-02-18 15:51:06.289152|2017-02-18 15:51:06.289152
NCT00437840|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2008-10-09|||March 2007||2007-03-01|October 2008|2008-10-01||||||||Interventional|||A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809|A Placebo-Controlled, Single-Blind, Randomised, Human Volunteer Study Investigating the Tolerability and Pharmacokinetics of Escalating Single Oral Doses of GSK598809 in Smokers|Completed||Phase 1|12|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:51:06.374979|2017-02-18 15:51:06.374979
NCT00437827|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2009-10-23|||August 2006||2006-08-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure|A Multicenter, Randomized, Blinded, Controlled, Parallel Group Trial to Demonstrate the Efficacy of rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure|Completed||N/A|120|Anticipated|CNS Response||2|||f||||f||||||||||2017-02-18 15:51:06.467428|2017-02-18 15:51:06.467428
NCT00437814|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2007-02-20|||September 2005||2005-09-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Effect of Ketamine (Ketalar) on Intracranial Pressure|Effect of Ketamine (Ketalar) on Intracranial Pressure|Unknown status|Recruiting|N/A|30||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 15:51:06.579388|2017-02-18 15:51:06.579388
NCT00436696|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-10-04|||December 2006||2006-12-01|October 2016|2016-10-01||||January 2100|Anticipated|2100-01-01||Observational|||Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions|Genetic Basis of Neuroblastoma Tumorigenesis|Active, not recruiting||N/A|9350|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"~     Blood, Bone Marrow~   "|||2017-02-18 15:51:06.674304|2017-02-18 15:51:06.674304
NCT00436683|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2009-07-21||2009-07-21|February 2007||2007-02-01|July 2009|2009-07-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|ACT3||Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia|An Open Label, Dose-Ranging Study to Establish the Tolerability of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia.|Completed||Phase 2|64|Actual|Ineos Healthcare Limited||2|||f||||t||||||||||2017-02-18 15:51:06.766102|2017-02-18 15:51:06.766102
NCT00437788|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2007-02-20||||||January 2007|2007-01-01||||||||Observational|||The Effect of a Digital Photograph of the Patient in a CT Scan Examination on the Quality of Diagnosis by the Radiologist||Unknown status|Not yet recruiting|Early Phase 1|10000||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 15:51:06.887154|2017-02-18 15:51:06.887154
NCT00437775|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2007-02-20|||January 2007||2007-01-01|January 2007|2007-01-01|March 2007||2007-03-01|||||Observational|||ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects|Angiotensin Converting Enzyme Inhibitors & Angiotensin Receptor Blocker in the Treatment of Type 2 Diabetic Patients Adverse Drug Effects and Drug Interactions- a Survey in an Internal Medicine Department.|Unknown status|Recruiting|Phase 4|300||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:51:06.95984|2017-02-18 15:51:06.95984
NCT00437762|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2013-02-27|||April 2007||2007-04-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|TBA||Effectiveness of Botulinum Toxin Injection in the Tennis Elbow Treatment|Effectiveness of Botulinum Toxin A Injection for the Treatment of Lateral Epicondylitis Unrelieved by Usual Medical Cares : A Double Blind Randomized Controlled Trial Versus Placebo|Completed||Phase 3|61|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 15:51:07.128715|2017-02-18 15:51:07.128715
NCT00437749|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2011-09-08|||August 2001||2001-08-01|September 2011|2011-09-01|November 2010|Actual|2010-11-01|July 2010|Actual|2010-07-01||Interventional|||A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer|Phase 3, Randomized, Double-Blind, Placebo-controlled Study of CBT-1 and Paclitaxel/Carboplatin in Patients With Inoperable Non-Small Cell Lung Cancer|Terminated||Phase 3|214|Actual|CBA Research||2||slow accrual rate; interim accrual objective met|f||||||||||||||2017-02-18 15:51:07.240576|2017-02-18 15:51:07.240576
NCT00437736|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2015-09-16|||February 2007||2007-02-01|September 2015|2015-09-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|AP1001||A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors|Phase I Dose Finding and Pharmacokinetic Study of Intravenous APO010, a Recombinant Form of Human Fas Ligand, in Patients With Solid Tumors|Completed||Phase 1|26|Actual|Onxeo||1|||f||||t||||||||||2017-02-18 15:51:07.347051|2017-02-18 15:51:07.347051
NCT00437723|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2009-05-13||||||May 2009|2009-05-01|April 2008|Actual|2008-04-01|||||Interventional|||A Study of NeoRecormon in Patients With Chronic Kidney Disease.|An Open-Label Study to Investigate the Effect of NeoRecormon on Hemoglobin Level and Renal Function in Patients With Chronic Kidney Disease, Stage 2-4|Completed||Phase 4|90|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:51:07.446477|2017-02-18 15:51:07.446477
NCT00437710|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2010-03-23|||July 2005||2005-07-01|February 2007|2007-02-01|February 2007|Anticipated|2007-02-01|||||Interventional|CARDIAC||Safety and Efficacy of Bone Marrow Cell Transplantation in Humans Myocardial Infarction|Cardiac Study. Cellular Cardiomyoplasty of Infarcted Failed Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Azienda Unità Sanitaria Locale di Piacenza|||||f||||||||||||||2017-02-18 15:51:07.544642|2017-02-18 15:51:07.544642
NCT00437697|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-20|||April 2003||2003-04-01|February 2007|2007-02-01|April 2005||2005-04-01|||||Interventional|||Thromboprophylaxis in Critically Ill Patients|Thromboprophylaxis in Critically Ill Patients: a Prospective, Randomized Study Comparing Anti-Xa Activities Following Subcutaneous Administration of 5000 IU and 7500 IU Dalteparin|Terminated||Phase 4|90||Medical University of Vienna|||||f||||||||||||||2017-02-18 15:51:07.641524|2017-02-18 15:51:07.641524
NCT00437684|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2009-02-05|||February 2007||2007-02-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|||Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy|A Pilot, Open Label, Multicenter, Randomized Clinical Trial on Lopinavir/Ritonavir-Monotherapy vs Lopinavir/Ritonavir Plus Selected Nucs, in HIV/HCV Coinfected Patients With Chronic Hepatitis C or Compensated Cirrhosis, Starting Treatment With Ribavirin and Pegylated Interferon|Unknown status|Recruiting|Phase 3|50|Anticipated|IRCCS San Raffaele||2|||f||||||||||||||2017-02-18 15:51:07.74593|2017-02-18 15:51:07.74593
NCT00437671|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-01-18|||March 2007||2007-03-01|January 2016|2016-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels|Pharmacokinetics Of Active And Passive Tetanus Immunization Given Concurrently In Subjects With No Known Primary Immunization History Or In Subjects With Tetanus Antibody Levels Below Protective Levels|Terminated||Phase 4|6|Actual|Grifols Therapeutics Inc.||1||Study terminated for cGCP non-compliance. Analyses could not be performed.|f||||f||||||||||2017-02-18 15:51:07.85789|2017-02-18 15:51:07.85789
NCT00437658|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2013-01-02||2012-02-24|November 2006||2006-11-01|January 2013|2013-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy Study of NBI-56418 in Endometriosis|A Phase II, Randomized, Double Blind, Active-controlled Study to Access the Safety and Efficacy of NBI-56418 in Subjects With Endometriosis|Completed||Phase 2|252|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 15:51:07.97251|2017-02-18 15:51:07.97251
NCT00437645|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2014-11-03|2009-08-17||January 2007||2007-01-01|November 2014|2014-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension|A Double-blind, Randomized, Multicenter, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of Treatment With the Combination of Valsartan/Amlodipine 160/5 mg Compared to Amlodipine 10 mg in Patients With Essential Hypertension Not Adequately Controlled With Amlodipine 5 mg Alone|Completed||Phase 3|1183|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:51:10.798712|2017-02-18 15:51:10.798712
NCT00437632|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2012-03-15|||March 2007||2007-03-01|February 2011|2011-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809|A Placebo Controlled, Single Blind, Randomised Study Investigating the Safety, Tolerability and Pharmacokinetics of Repeated Oral Doses of GSK598809 in Healthy Male and Female Volunteers for 28 Days.|Completed||Phase 1|104|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:51:11.506836|2017-02-18 15:51:11.506836
NCT00437619|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2015-12-01|||February 2007||2007-02-01|December 2015|2015-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.|An Open Label Study to Evaluate the Clinical Response to Sequential Treatment With Daivobet and Daivonex in Patients With Mild to Moderate Psoriasis|Completed||Phase 4|200|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:51:11.601347|2017-02-18 15:51:11.601347
NCT00437606|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2016-08-23|||March 2007||2007-03-01|August 2016|2016-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.|A Nonrandomized, Open Label Study to Examine the Effect of Hepatic Impairment on the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.'|Terminated||Phase 1|2|Actual|Hoffmann-La Roche||3||poor recruitment|f||||||||||||||2017-02-18 15:51:11.706971|2017-02-18 15:51:11.706971
NCT00437593|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2008-09-21|||September 2005||2005-09-01|December 2007|2007-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue|UHR-OCT and HD-OCT for Preretinal Membranes: Is There a Difference Between ICG and Membrane Blue? A Randomized Clinical Trial|Completed||N/A|20|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||1|||f||||f||||||||||2017-02-18 15:51:11.809328|2017-02-18 15:51:11.809328
NCT00437580|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2011-01-18|||February 2007||2007-02-01|January 2011|2011-01-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage|Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus (VRE) Intestinal Carriage : a Double Blind Randomized Pilot Study|Unknown status|Recruiting|Phase 4|24|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 15:51:11.906987|2017-02-18 15:51:11.906987
NCT00437567|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2014-01-02|||July 2009||2009-07-01|January 2014|2014-01-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Interventional|||Prebiotics in the Prevention of Necrotizing Enterocolitis|Prebiotics vs. Placebo in the Prevention of Necrotizing Enterocolitis in Premature Neonates|Unknown status|Recruiting|Phase 2|260|Anticipated|Shaare Zedek Medical Center||2|||f||||t||||||||||2017-02-18 15:51:12.002292|2017-02-18 15:51:12.002292
NCT00437554|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-11-28|||August 2006||2006-08-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)|A 16-Week Controlled, Double Blind, Double Dummy, Randomized, Two Arm Parallel-Group Study to Compare the Efficacy and Safety of Amaryl M 1/250 mg b.i.d vs. Amaryl M SR 2/500 mg od. in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|188|Anticipated|Handok Pharmaceuticals Co., Ltd.|||||f||||f||||||||||2017-02-18 15:51:12.127311|2017-02-18 15:51:12.127311
NCT00437541|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-20|||July 2001||2001-07-01|February 2007|2007-02-01|December 2002||2002-12-01|||||Interventional|HIHS||Housing, Insulation and Health Study|The Impact of Insulating Domestic Houses on the Health of Occupants: an Intervention Study|Completed||N/A|4000||University of Otago|||||f||||||||||||||2017-02-18 15:51:12.21602|2017-02-18 15:51:12.21602
NCT00437528|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2007-05-16|||November 2006||2006-11-01|February 2007|2007-02-01|December 2007||2007-12-01|||||Observational|||Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity|Phase I Study for Evaluating the Safety and Applicability of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity|Unknown status|Recruiting|Phase 1|10|Anticipated|Rambam Health Care Campus|||||f||||f||||||||||2017-02-18 15:51:12.326105|2017-02-18 15:51:12.326105
NCT00437502|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2012-11-15|||March 2007||2007-03-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer|A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant (Montanide ISA-51) as Consolidation Following Optimal Debulking and Systemic Chemotherapy for Women With Advanced Stage Ovarian, Tubal, or Peritoneal Cancer|Completed||Phase 1|8|Actual|Duke University||1|||f||||t||||||||||2017-02-18 15:51:12.410108|2017-02-18 15:51:12.410108
NCT00437489|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2009-04-13|2008-12-11||June 2007||2007-06-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.|A 16 Week Open-Label Outpatient, Randomized, Parallel Study Assessing The Impact Of Two Different Initial Dose Prescriptions For Dry Powder Inhaled Insulin (Exubera®) On Glycemic Control In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Or More Oral Agents.|Terminated||Phase 4|49|Actual|Pfizer|As a result of Pfizer's decision (18Oct2007) to return the worldwide rights for Exubera (insulin human [rDNA origin]) Inhalation Powder) to Nektar, from which Pfizer licensed inhaled insulin technology, it was decided to terminate this study.|2||"This protocol was terminated not for safety reasons, but because Pfizer decided to return the~   worldwide rights for Exubera to Nektar, on 18 October 2007."|f||||f||||||||||2017-02-18 15:51:12.521932|2017-02-18 15:51:12.521932
NCT00437476|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2009-02-05|||February 2007||2007-02-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|||Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy|Pilot, Multicenter, Randomized Study on Lopinavir/Ritonavir-Monotherapy vs Lopinavir/Ritonavir Plus Selected Nucs, in HIV/HCV ARV-Naive Coinfected Patients With Chronic Hepatitis C or Compensated Cirrhosis, Starting Treatment With Ribavirin and Pegylated Interferon|Unknown status|Recruiting|Phase 3|60|Anticipated|IRCCS San Raffaele||2|||f||||||||||||||2017-02-18 15:51:12.950309|2017-02-18 15:51:12.950309
NCT00437463|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2010-11-17|||July 2004||2004-07-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor|Treatment of Early Immunoglobulin A Nephropathy by ACE Inhibitor - a Randomized Controlled Trial|Completed||Phase 3|60|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:51:13.058343|2017-02-18 15:51:13.058343
NCT00437450|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2009-11-17|||October 2004||2004-10-01|February 2007|2007-02-01|September 2005||2005-09-01|||||Interventional|||Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid|Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid|Unknown status|Active, not recruiting|Phase 2|99||Groupe Francophone des Myelodysplasies|||||f||||t||||||||||2017-02-18 15:51:13.380739|2017-02-18 15:51:13.380739
NCT00437437|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2013-06-20|||May 2000||2000-05-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|May 2008|Actual|2008-05-01||Interventional|||A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)|Phase I Study to Determine the Effect of a High Fat Meal on the Pharmacokinetics of BMS-540215, the Active Metabolite of Brivanib Alaninate in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|29|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:51:13.487297|2017-02-18 15:51:13.487297
NCT00437424|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2011-05-03|||July 2007||2007-07-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction|A Pharmacokinetic Study of Brivanib (BMS-582664) in Subjects With Advanced Solid Tumor Malignancies and Normal Hepatic Function or Hepatocellular Carcinoma With Impaired Hepatic Function|Completed||Phase 1|24|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:51:13.595587|2017-02-18 15:51:13.595587
NCT00437411|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-10-20|||April 2007||2007-04-01|October 2016|2016-10-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Healing Through Affective Self-Awareness in Fibromyalgia: a Randomized Controlled Trial|Healing Through Affective Self-Awareness in Fibromyalgia: a Randomized Controlled Trial|Completed||N/A|66|Actual|University of Michigan||2|||f||||f||||||||No||2017-02-18 15:51:13.71308|2017-02-18 15:51:13.71308
NCT00437398|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2013-04-18|2013-03-05||July 2006||2006-07-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Islet Transplantation for Type 1 Diabetes Mellitus|Islet Transplantation for Type 1 Diabetes Mellitus|Terminated||Phase 1/Phase 2|2|Actual|Mayo Clinic|The study was terminated early due to difficulty in recruiting subjects, and ran short of funds. The sample size (n=2) was too small to perform a meaningful analysis.|1||"The study was terminated early due to difficulty in recruiting subjects, and ran short of~   funds."|f||||t||||||||||2017-02-18 15:51:13.823415|2017-02-18 15:51:13.823415
NCT00437385|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2011-11-08|||March 2005||2005-03-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|EffECT||Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed Patients|Phase 1 Study: Evaluation of Three Continuation Therapies After Acute Electroconvusive Therapy (ECT) Concerning Efficacy and Cognition in Severly Depressed Patients|Completed||Phase 1|90|Actual|Charite University, Berlin, Germany||3|||f||||t||||||||||2017-02-18 15:51:14.044898|2017-02-18 15:51:14.044898
NCT00437372|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2016-10-19|||March 2007||2007-03-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients|A Phase IB, Open-Label, Safety Study of the Combination of Sunitinib and Radiation for the Treatment of Patients With Cancer|Completed||Phase 1|39|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 15:51:14.168729|2017-02-18 15:51:14.168729
NCT00437359|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-18|2012-03-28|||May 2007||2007-05-01|March 2012|2012-03-01|May 2020|Anticipated|2020-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer|Antiestrogen vs Aromatase Inhibitor After Chemotherapy for Adjuvant Setting: Efficacy of Endocrine Therapy After Chemotherapy in Postoperative Adjuvant Therapy for Breast Cancer|Terminated||Phase 2|240|Anticipated|Japan Breast Cancer Research Network||2|||f||||t||||||||||2017-02-18 15:51:14.28335|2017-02-18 15:51:14.28335
NCT00437346|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2015-01-22|||January 2007||2007-01-01|January 2015|2015-01-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Functional Dyspepsia - Effect of Acid-Reducing Treatment and Information.|Study of Gastroscopy Negative Dyspepsia - Effect of Acid-reducing Treatment and Information on Various Types of Dysmotility.|Unknown status|Active, not recruiting|N/A|200|Anticipated|Helse Fonna||2|||f||||||||||||||2017-02-18 15:51:14.402948|2017-02-18 15:51:14.402948
NCT00437333|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-20|2007-02-20|||December 2003||2003-12-01|February 2007|2007-02-01|April 2006||2006-04-01|||||Interventional|||Metformin Suspension and Insulin Sensitivity|Insulin Sensitivity After Metformin Suspension in Normal-Weight Women With Polycystic Ovary Syndrome|Completed||Phase 4|30||University Magna Graecia|||||f||||||||||||||2017-02-18 15:51:14.51485|2017-02-18 15:51:14.51485
NCT00437320|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2009-01-06|||March 2007||2007-03-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin|Comparison of Metvix PDT With Its Vehicle in the Treatment of Photoaged Skin|Completed||Phase 2|45|Anticipated|Galderma||2|||f||||f||||||||||2017-02-18 15:51:14.606517|2017-02-18 15:51:14.606517
NCT00437307|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-19|2016-09-21|||March 2007||2007-03-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|July 2013|Actual|2013-07-01||Interventional|HECTOR||Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse|Topotecan Plus Carboplatin im Vergleich Zur Standardtherapie (Paclitaxel Plus Carboplatin Oder Gemcitabin Plus Carboplatin) in Der Therapie Von Patientinnen Mit Platin-sensitivem Rezidivierten Epithelialen Ovarialkarzinom, Peritonealkarzinom Oder Tubenkarzinom|Completed||Phase 3|550|Actual|North Eastern Germany Society of Gynaecologic Oncology||2|||f||||||||||||No||2017-02-18 15:51:14.708271|2017-02-18 15:51:14.708271
NCT00437294|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2010-02-16||2010-02-16|March 2007||2007-03-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Enzastaurin in Combination of Capecitabine to Treat Breast Cancer|A Double-Blind, Randomized, Phase 2 Trial of Capecitabine Plus Enzastaurin Versus Capecitabine Plus Placebo in Patients With Metastatic or Recurrent Breast Cancer Previously Treated With an Anthracycline and a Taxane|Terminated||Phase 2|86|Actual|Eli Lilly and Company||2||Lack of efficacy|f||||t||||||||||2017-02-18 15:51:14.81627|2017-02-18 15:51:14.81627
NCT00437281|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2014-01-29|2013-09-16||April 2007||2007-04-01|January 2014|2014-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures|A Placebo-Controlled, Escalating Dose, Multiple Dose Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Pregabalin In Pediatric Patients With Partial Onset Seizures|Completed||Phase 1/Phase 2|65|Actual|Pfizer|Results are reported for AUCtau for multiple-dose PK analysis and AUC (0-∞) for single-dose PK analysis, instead of AUC (0-24), as per change in planned analysis.|2|||f||||f||||||||||2017-02-18 15:51:14.963612|2017-02-18 15:51:14.963612
NCT00437268|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2010-04-16||2010-04-16|March 2007||2007-03-01|April 2010|2010-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer|A Randomized Phase 2 Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Recurrent Colorectal Cancer|Completed||Phase 2|26|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:51:19.218486|2017-02-18 15:51:19.218486
NCT00437255|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-04-03|||August 2006||2006-08-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis|An Evaluation of the Efficacy, Safety, Preference and Duration of Response of Clobex® (Clobetasol Propionate) Spray and Taclonex® (Calcipotriene 0.05%/Betamethasone Dipropionate 0.064%) Ointment in Subjects With Stable Plaque Psoriasis|Completed||Phase 4|122|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||||2017-02-18 15:51:19.347218|2017-02-18 15:51:19.347218
NCT00437242|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2012-05-31|||October 2006||2006-10-01|March 2011|2011-03-01||||||||Interventional|||Odiparcil QT Definitive Study|A Study to Evaluate the Effect of Repeat Oral Doses of Odiparcil on Cardiac Conduction as Assessed by 12-lead Electrocardiogram Compared to Placebo and a Single Oral Dose of Moxifloxacin.|Terminated||Phase 1|54||GlaxoSmithKline|||||||||||||||||||2017-02-18 15:51:19.472712|2017-02-18 15:51:19.472712
NCT00437229|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2012-05-31|||February 2007||2007-02-01|February 2011|2011-02-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults|An Open-Label, Phase I Study to Assess the Pharmacokinetic Interaction Between Repeat Doses of Oral Casopitant [GW679769] and Intravenous and Oral Doses of Dexamethasone and Intravenous and Oral Doses of Ondansetron When Administered in Healthy Adult Subjects|Completed||Phase 1|37|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 15:51:19.561006|2017-02-18 15:51:19.561006
NCT00437216|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-03-27|||February 2006||2006-02-01|March 2008|2008-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis|Phase 4 Open-Label Multicenter Community-Based 4-Wk Trial to Assess Efficacy, Tolerance to Tx & Patient Satisfaction w/ CLOBEX® Spray When Used as Mono- or Add-on Therapy to Existing Systemic/Topical Agents for Tx of Plaque Psoriasis|Completed||Phase 4|2488|Actual|Galderma Laboratories, L.P.|||2||f||||f||||||||||2017-02-18 15:51:19.666548|2017-02-18 15:51:19.666548
NCT00437203|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2012-03-06|2012-03-06||December 2006||2006-12-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine|Phase I Study of PF-00477736 With Gemcitabine In Patients With Advanced Solid Malignancies|Terminated||Phase 1|43|Actual|Pfizer|The study was prematurely terminated due to business reasons.|1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 15:51:19.784167|2017-02-18 15:51:19.784167
NCT00437190|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2016-05-11|||June 2003||2003-06-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|December 2006|Actual|2006-12-01||Interventional|||Pivotal IDE Study of the BRYAN(R) Cervical Disc Prosthesis in the Treatment of DDD Versus ACDF|Pivotal IDE Study of the BRYAN(R) Cervical Disc Prosthesis in the Treatment of Degenerative Disc Disease|Completed||N/A|494|Actual|Medtronic Spinal and Biologics||2|||f||||t||||||||||2017-02-18 15:51:22.876733|2017-02-18 15:51:22.876733
NCT00437177|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2009-04-28|||January 2007||2007-01-01|April 2009|2009-04-01|June 2010|Anticipated|2010-06-01|December 2009|Anticipated|2009-12-01||Interventional|ALC-DRD2-APO||Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO)|Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence: Predictive Value for Relapse|Unknown status|Recruiting|Phase 2|50|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||1|||f||||||||||||||2017-02-18 15:51:23.027756|2017-02-18 15:51:23.027756
NCT00437164|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2012-05-31|||September 2006||2006-09-01|May 2011|2011-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus|A Randomized, Double-blind, Parallel, Placebo-Controlled, Study to Evaluate the Safety and Tolerability of Oral GW677954 Capsules (15 mg) in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 2|1|Actual|GlaxoSmithKline||||Company decision not related to safety.|||||f||||||||||2017-02-18 15:51:23.114206|2017-02-18 15:51:23.114206
NCT00437151|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-03-27|||June 2006||2006-06-01|March 2008|2008-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%|An Analysis of Adherence and Associated Factors in Subjects Undergoing Differin® Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris.|Completed||Phase 4|61|Actual|Galderma Laboratories, L.P.||4|||f||||f||||||||||2017-02-18 15:51:23.216133|2017-02-18 15:51:23.216133
NCT00437138|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2007-02-16|||April 2006||2006-04-01|February 2007|2007-02-01|June 2006||2006-06-01|||||Interventional|||Controlled Exposures to Air Pollution in Patients With Coronary Heart Disease|The Effects of Air Pollution on Vascular and Endogenous Fibrinolytic Function in Patients With Coronary Heart Disease|Completed||Early Phase 1|20||University of Edinburgh|||||f||||||||||||||2017-02-18 15:51:23.320588|2017-02-18 15:51:23.320588
NCT00437125|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2010-09-01|2010-07-16||March 2007||2007-03-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease|An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease|Completed||Phase 4|151|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 15:51:23.427704|2017-02-18 15:51:23.427704
NCT00437112|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-07-15|||February 2007||2007-02-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes|A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared With Once-Daily Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes Mellitus on Oral Agents|Completed||Phase 3|142|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:51:24.378969|2017-02-18 15:51:24.378969
NCT00437099|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2010-05-26|||February 2009||2009-02-01|May 2010|2010-05-01|September 2011|Anticipated|2011-09-01|February 2011|Anticipated|2011-02-01||Interventional|||Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder|Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder: a Randomized, Double Blind Clinical Trial.|Unknown status|Recruiting|Phase 4|102|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||||||||||||2017-02-18 15:51:24.511528|2017-02-18 15:51:24.511528
NCT00437086|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2014-10-15|||September 2005||2005-09-01|October 2014|2014-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders|A Prospective Open-Label Pilot Trial of PS-341 (Bortezomib; VELCADE) for the Therapy of Symptomatic Advanced Myeloproliferative Disorders|Completed||Early Phase 1|30|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:51:24.615705|2017-02-18 15:51:24.615705
NCT00437073|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2015-09-24|2012-09-13||May 2007||2007-05-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|January 2009|Actual|2009-01-01||Interventional|||Brain Metastases In ErbB2-Positive Breast Cancer|Study EGF107671 - a Phase II Study of Lapatinib Plus Topotecan or Lapatinib Plus Capecitabine in the Treatment of Recurrent Brain Metastases From ErbB2-Positive Breast Cancer Following Cranial Radiotherapy|Terminated||Phase 2|22|Actual|GlaxoSmithKline||2||"Lapatinib-topotecan arm enrollment closed early per protocol amendment 2. Then enrollment into~   remaining arm terminated due to operational issues."|f||||||||||||||2017-02-18 15:51:24.737949|2017-02-18 15:51:24.737949
NCT00437060|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-04-08|||January 2007||2007-01-01|April 2016|2016-04-01||||September 2015|Actual|2015-09-01||Observational|||Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia|A Study of Neurocognitive Function in Children Treated for ALL|Active, not recruiting||N/A|233|Actual|Children's Oncology Group|||1||f||||||||||Samples Without DNA|"~     blood and cerebrospinal fluid~   "|||2017-02-18 15:51:25.668947|2017-02-18 15:51:25.668947
NCT00437034|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2015-07-28|2015-05-07||January 2007||2007-01-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|October 2010|Actual|2010-10-01||Interventional|||Aflibercept for Relapsed Multiple Myeloma|A Phase 2 Study of Aflibercept for the Treatment of Relapsed or Refractory Multiple Myeloma|Terminated||Phase 2|6|Actual|National Cancer Institute (NCI)||1||Poor accrual|f||||t||||||||||2017-02-18 15:51:26.061335|2017-02-18 15:51:26.061335
NCT00437021|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2013-10-24||2011-07-20|April 2007||2007-04-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||MVA Post-Event: Administration Timing and Boost Study|Evaluation of IMVAMUNE® Smallpox Vaccine With Respect to Safety and Optimization of Immune Responses by Different Vaccination Regimens in Vaccinia-Naïve Adults|Completed||Phase 1/Phase 2|206|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-02-18 15:51:26.326629|2017-02-18 15:51:26.326629
NCT00437008|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2007-02-15|||November 2004||2004-11-01|February 2007|2007-02-01|January 2006||2006-01-01|||||Interventional|AGE-Benfo||Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes|Acute Effects of a Low-AGE vs. High-AGE Meal on Postprandial Endothelial Function in People With Type 2 Diabetes Mellitus. Protective Effects of Benfotiamine|Completed||Phase 4|21||Ruhr University of Bochum|||||f||||||||||||||2017-02-18 15:51:26.455767|2017-02-18 15:51:26.455767
NCT00436995|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2011-01-20|||April 2006||2006-04-01|January 2011|2011-01-01|December 2008|Actual|2008-12-01|January 2007|Actual|2007-01-01||Interventional|||Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis|A Multicentre, Single Arm Study Evaluating The Extension From Weekly To Once Every Other Week Darbepoetin Alfa Administration In Subjects With Chronic Kidney Disease Receiving Dialysis.|Completed||Phase 3|114|Actual|Amgen||1|||f||||||||||||||2017-02-18 15:51:26.554324|2017-02-18 15:51:26.554324
NCT00436982|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2016-12-05|2015-09-29||February 2006||2006-02-01|April 2016|2016-04-01|January 2017|Anticipated|2017-01-01|November 2008|Actual|2008-11-01||Interventional||With an alpha of 0.05 and a beta of 0.20 the required sample size in each group is 25 patients to detect a difference of 0.3 mm. Patients with inadequate marking will be excluded from the study. Taking the latter into account and to compensate for possible lost to follow up, 30 patients will be recruited per study group.|Evaluation of Triathlon - a New Total Knee Prosthesis System - Triathlon vs. Duracon|Evaluation of Triathlon - a New Total Knee Prosthesis System. Prospective, Comparative, Randomised, Roentgen Stereophotogrammetric Analysis (RSA) Series|Active, not recruiting||N/A|60|Actual|Stryker European Operations BV||2|||f||||f||||||||||2017-02-18 15:51:26.664406|2017-02-18 15:51:26.664406
NCT00436969|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2016-11-15|2013-08-13||December 2006||2006-12-01|November 2016|2016-11-01|August 2011|Actual|2011-08-01|February 2010|Actual|2010-02-01||Interventional||The number of partipants analyzed were all 270 subjects that received treatment (87 control, 183 investigational).|ORTHOVISC Shoulder Osteoarthritis Study|A Comparison of Orthovisc® to Corticosteroid Injection in Shoulder Osteoarthritis: Orthovisc Randomized Clinical Trial|Completed||Phase 3|275|Actual|DePuy Mitek||2|||f||||t||||||||No|We will not submit the data to FDA, and as such will not be making IPD available.|2017-02-18 15:51:27.010708|2017-02-18 15:51:27.010708
NCT00436956|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2014-07-07|2014-03-07||January 2007||2007-01-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|October 2010|Actual|2010-10-01||Interventional||The cohorts are grouped together because the second cohort added prednisone to minimize toxicity/side effects.|AZD2171 to Treat Prostate Cancer|A Phase II Study of AZD2171 in Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|59|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 15:51:27.914067|2017-02-18 15:51:27.914067
NCT00436943|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2010-07-09|||January 2007||2007-01-01|July 2010|2010-07-01|January 2008|Anticipated|2008-01-01|||||Observational|||Smoking Cessation Program: A Quality Improvement Trial in a Resident-Based Outpatient Clinic|Smoking Cessation Program: A Quality Improvement Trial in a Resident Based Outpatient Clinic|Terminated||N/A|900|Anticipated|Atlantic Health System|||1||f||||||||||||||2017-02-18 15:51:28.600303|2017-02-18 15:51:28.600303
NCT00436930|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2014-01-09|||December 2006||2006-12-01|June 2009|2009-06-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma|Randomized Phase II Trial of Autologous Vaccines Consisting of Adjuvant GM-CSF Plus Proliferating Tumor Cells Versus GM-CSF Plus Dendritic Cells Loaded With Proliferating Tumor Cells in Patients With Metastatic Melanoma (MAC-VAC)|Completed||Phase 2|200|Anticipated|National Cancer Institute (NCI)||2|||||||||||||||||2017-02-18 15:51:28.696279|2017-02-18 15:51:28.696279
NCT00436917|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-04-19|2011-07-19||April 2006||2006-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|June 2008|Actual|2008-06-01||Interventional|||Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer|Zoledronic Acid for Treatment of Osteopenia and Osteoporosis in Women With Primary Breast Cancer Undergoing Adjuvant Aromatase Inhibitor (Letrozole) Therapy|Active, not recruiting||N/A|60|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:51:28.989849|2017-02-18 15:51:28.989849
NCT00436904|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2011-11-21|2011-09-16||December 2004||2004-12-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|July 2008|Actual|2008-07-01||Interventional|||Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia|Antibody Therapy With Alemtuzumab and Rituximab for Initial Treatment of High Risk Chronic Lymphocytic Leukemia|Completed||Phase 2|30|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:51:29.398608|2017-02-18 15:51:29.398608
NCT00436891|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-05-01|||February 2007||2007-02-01|October 2007|2007-10-01|April 2007||2007-04-01|||||Observational|||Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji|The Epidemiology of Group A Streptococcal Infections in Fiji (Fiji GrASP) - Part 4 -The Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji|Completed||N/A|550||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 15:51:29.717393|2017-02-18 15:51:29.717393
NCT00436878|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2011-02-04|||October 2005||2005-10-01|June 2010|2010-06-01||||July 2010|Anticipated|2010-07-01||Interventional|||Intake Promoting Effects of Large Portions in Children||Unknown status|Recruiting|N/A|160|Anticipated|Temple University||1|||f||||||||||||||2017-02-18 15:51:29.799208|2017-02-18 15:51:29.799208
NCT00436865|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2015-12-10|||February 2007||2007-02-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study|Insulin and the Polycystic Ovary Syndrome|Active, not recruiting||N/A|79|Actual|Virginia Commonwealth University||2|||f||||||||||||||2017-02-18 15:51:29.892706|2017-02-18 15:51:29.892706
NCT00436852|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-01-29|2013-11-19||January 2007||2007-01-01|January 2016|2016-01-01||||September 2010|Actual|2010-09-01||Interventional||The protocol-specified definition of evaluability was applied. This was not an intention-to-treat analysis because patients who did not receive study drug were excluded (inevaluable).|ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment|A Phase II Study of ABT-751, an Orally Bioavailable Tubulin Binding Agent, in Children With Relapsed or Refractory Neuroblastoma|Active, not recruiting||Phase 2|92|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 15:51:30.009197|2017-02-18 15:51:30.009197
NCT00436839|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2012-07-05|||January 2007||2007-01-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Taxotere Prostate Cancer New Indication Registration Trial in China|An Multicenter, Randomized Study of Comparison of Docetaxel Plus Prednisone With Mitoxantrone Plus Prednisone in the Patients With Hormone-refractory (Androgen-independent) Metastatic Prostate Cancer|Completed||Phase 3|228|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:51:30.807419|2017-02-18 15:51:30.807419
NCT00436826|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2013-08-04|2013-03-28||November 2006||2006-11-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|ONWARD||A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)|A Phase II, Multicenter, Randomized, Double Blind, Placebo Controlled, Safety, Tolerability and Efficacy Study of Add-on Cladribine Tablet Therapy With Interferon-beta (IFN-β) Treatment in Multiple Sclerosis Subjects With Active Disease|Completed||Phase 2|214|Actual|EMD Serono|The 96-week DB treatment period of study was completed as planned, and safety and exploratory efficacy results are presented here. The duration of OL Ext. period was reduced for some participants, following termination of the development program.|2|||f||||||||||||||2017-02-18 15:51:30.912271|2017-02-18 15:51:30.912271
NCT00436800|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2009-09-17|||March 2005||2005-03-01|August 2009|2009-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma|Gemcitabine and Oxaliplatin in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma (NPC)|Completed||Phase 2|41|Actual|Sanofi||1|||f||||||||||||||2017-02-18 15:51:31.903339|2017-02-18 15:51:31.903339
NCT00436787|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-05-15|||February 2007||2007-02-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers|Pharmacokinetic Properties of Fondaparinux Sodium in Morbidly Obese Volunteers|Completed||Phase 2|21|Anticipated|University of Pittsburgh|||||t||||||||||||||2017-02-18 15:51:32.004509|2017-02-18 15:51:32.004509
NCT00436774|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2013-08-09|||June 2006||2006-06-01|June 2009|2009-06-01||||September 2010|Anticipated|2010-09-01||Observational|||Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01|Cross-Sectional Evaluation of Outcome Following Extra-Cranial Germ Cell Tumors Treated According to UKCCSG GC 7901 (GC I) and GC 8901 (GC II) Protocols|Unknown status|Recruiting|N/A|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:51:32.114327|2017-02-18 15:51:32.114327
NCT00436670|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-02-23||2016-02-23|March 2007||2007-03-01|February 2016|2016-02-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||Phase II Study to Evaluate the Efficacy of AMG 317|A Randomized, Double-blind, Placebo-controlled, Multiple Dose Phase 2 Study to Determine the Safety and Efficacy of AMG 317 in Subjects With Moderate to Severe Asthma|Completed||Phase 2|294|Actual|Amgen||4|||f||||||||||||||2017-02-18 15:51:32.225186|2017-02-18 15:51:32.225186
NCT00436657|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2012-03-29|||February 2007||2007-02-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer|A Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Doses of Cisplatin for Children With Peritoneal Carcinomatosis or Advanced Peritoneal and Retroperitoneal Disease|Completed||Phase 1|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:51:32.337426|2017-02-18 15:51:32.337426
NCT00436644|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2014-03-20|2012-02-17||March 2007||2007-03-01|March 2014|2014-03-01|November 2012|Actual|2012-11-01|March 2009|Actual|2009-03-01||Interventional|||Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin|A Phase II Trial of Lapatinib in Combination With Weekly Topotecan in Patients With Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma|Completed||Phase 2|18|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:51:32.459049|2017-02-18 15:51:32.459049
NCT00436631|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2015-08-31|||February 2007||2007-02-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|February 2011|Actual|2011-02-01||Interventional|||Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy|Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy|Completed||Phase 3|30|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 15:51:32.763876|2017-02-18 15:51:32.763876
NCT00436618|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2013-07-24|2013-05-01||August 2005||2005-08-01|July 2013|2013-07-01||||December 2010|Actual|2010-12-01||Interventional|||Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment|Phase II Trial of Everolimus (RAD001) in Relapsed/Refractory Lymphoma|Completed||Phase 2|277|Actual|Mayo Clinic||3|||f||||t||||||||||2017-02-18 15:51:32.879769|2017-02-18 15:51:32.879769
NCT00436605|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2014-04-29|2013-12-05||December 2006||2006-12-01|October 2011|2011-10-01|November 2010|Actual|2010-11-01|March 2010|Actual|2010-03-01||Interventional|||Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma|A Phase 2 Study of Dasatinib in Advanced Melanoma|Completed||Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:51:36.545279|2017-02-18 15:51:36.545279
NCT00436592|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2009-02-03|||February 2007||2007-02-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|Flo 24||Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients|Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients|Completed||Phase 1|26|Actual|CoAxia||1|||f||||t||||||||||2017-02-18 15:51:37.051884|2017-02-18 15:51:37.051884
NCT00436579|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2014-02-21|||January 2007||2007-01-01|October 2011|2011-10-01||||September 2011|Actual|2011-09-01||Interventional|||Sorafenib in Treating Patients With Advanced Solid Tumors|A Dose Escalation Study of Sorafenib (BAY 43-9006, NSC 724772) in Nomotensive Patients With Advanced Malignancies|Terminated||Phase 1|110|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 15:51:37.174405|2017-02-18 15:51:37.174405
NCT00436566|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2012-11-20|2012-10-22||March 2007||2007-03-01|November 2012|2012-11-01||||April 2009|Actual|2009-04-01||Interventional|||Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery|Phase II Study of Cardiac Safety and Tolerability of an Adjuvant Chemotherapy Plus Trastuzumab With Lapatinib in Patients With Resected HER2 + Breast Cancer|Completed||Phase 2|122|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 15:51:37.29883|2017-02-18 15:51:37.29883
NCT00436553|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2011-03-23|2011-01-06||February 2007||2007-02-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization|A 24-month Randomized, Double-masked, Controlled, Multicenter, Phase IIIB Study Assessing Safety and Efficacy of Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab Versus Ranibizumab Monotherapy in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration|Completed||Phase 3|321|Actual|Novartis|Shorten the study duration from 24 months to 12 months based on results of the European combination study MONT BLANC (CBPD952A2309).|3|||f||||||||||||||2017-02-18 15:51:37.962363|2017-02-18 15:51:37.962363
NCT00436540|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-03-27|||March 2006||2006-03-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam|A Comparison Between Clobetasol Propionate (Clobex®) Spray and Clobetasol Propionate (Olux®) Foam With Regard to Efficacy, Safety, Preference and Duration of Response in Stable Plaque Psoriasis|Completed||Phase 4|78|Actual|Galderma Laboratories, L.P.||2|||f||||f||||||||||2017-02-18 15:51:39.240485|2017-02-18 15:51:39.240485
NCT00436527|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-04-11|||August 2006||2006-08-01|April 2008|2008-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application|MetroGel 1% Hydration Study: A Kinetic Regression Study|Completed||Phase 4|26|Actual|Galderma Laboratories, L.P.||1|||f||||f||||||||||2017-02-18 15:51:39.350012|2017-02-18 15:51:39.350012
NCT00436514|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2009-07-21|||April 2007||2007-04-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.|Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.|Completed||N/A|550|Actual|Nantes University Hospital||1|||f||||||||||||||2017-02-18 15:51:39.456461|2017-02-18 15:51:39.456461
NCT00436501|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2015-03-11|2015-01-29||January 2007||2007-01-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|March 2011|Actual|2011-03-01||Interventional|||VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|Phase I/II and Pharmacokinetic Study of Docetaxel Plus VEGF Trap (AVE0005, NSC# 724770) in Patients With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|Completed||Phase 1/Phase 2|58|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 15:51:39.552745|2017-02-18 15:51:39.552745
NCT00436488|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2007-02-16|||January 2005||2005-01-01|February 2007|2007-02-01|July 2006||2006-07-01|||||Observational|||Frequency of ICAM-1 Polymorphisms in Obese Subjects|Study of the Association Between ICAM-1 Polymorphisms and Severe Obesity|Completed||N/A|200||Istituto Auxologico Italiano|||||f||||||||||||||2017-02-18 15:51:40.37029|2017-02-18 15:51:40.37029
NCT00436475|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2011-03-15|||September 2007||2007-09-01|March 2011|2011-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|CaDDM||Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes|Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes|Completed||Phase 1/Phase 2|112|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||t||||||||||2017-02-18 15:51:40.441129|2017-02-18 15:51:40.441129
NCT00436462|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2009-11-06|||December 2005||2005-12-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Expression of Steroid Receptors in Endometrium|Expression of Steroid Receptors in Endometrium During the Early Follicular Phase in Stimulated Cycles|Completed||N/A|30|Anticipated|Aristotle University Of Thessaloniki|||1||f||||f||||||Samples Without DNA|"~     endometrial tissue~   "|||2017-02-18 15:51:40.560402|2017-02-18 15:51:40.560402
NCT00436449|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2008-08-13|||December 2004||2004-12-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||RN1001(Avotermin) in Scar Improvement Following Breast Augmentation|A Double Blind, Within Subject, Placebo Controlled Randomised Trial to Investigate the Scar Improvement Efficacy of a Single Intradermal Application of RN1001 (Avotermin) in Female Subjects Undergoing Bilateral Breast Augmentation|Completed||Phase 2|63|Actual|Renovo|||||f||||f||||||||||2017-02-18 15:51:40.649502|2017-02-18 15:51:40.649502
NCT00436436|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-09-22|||December 2006||2006-12-01|September 2016|2016-09-01|May 2010|Actual|2010-05-01|July 2009|Actual|2009-07-01||Interventional|||O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy|A Phase 2 Study of O-Benzylguanine (O-BG) and Temozolomide in Patients With Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment With Radiation Therapy and Temozolomide|Completed||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:51:40.738852|2017-02-18 15:51:40.738852
NCT00436423|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2007-10-31|||March 2006||2006-03-01|October 2007|2007-10-01||||||||Interventional|||A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer||Completed||Phase 2|38|Actual|Korea University Anam Hospital||1|||f||||||||||||||2017-02-18 15:51:40.836123|2017-02-18 15:51:40.836123
NCT00436410|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2012-05-01|||December 2006||2006-12-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|||||Interventional|||Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer|An Evaluation of the Tissue Distribution and the Selective Tumor Trafficking of TNF-Bound Colloidal Gold (CYT-6091) Following Intravenous Administration in Subjects With Primary and Metastatic Cancer Undergoing Surgical Resection|Completed||Early Phase 1|108|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:51:40.948193|2017-02-18 15:51:40.948193
NCT00436397|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2010-02-11|||June 2002||2002-06-01|February 2010|2010-02-01|August 2005|Actual|2005-08-01|||||Interventional|||A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer|Evaluation of the Radionics Body Localizer System and XPLAN/IMRT for Extra-Cranial Sites: A Pilot Study|Completed||N/A|60|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 15:51:41.057775|2017-02-18 15:51:41.057775
NCT00436384|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2008-04-15|||November 2005||2005-11-01|February 2007|2007-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients|Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients|Completed||Phase 4|150||University Health Network, Toronto|||||f||||||||||||||2017-02-18 15:51:41.134815|2017-02-18 15:51:41.134815
NCT00436371|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2008-09-04|||May 2005||2005-05-01|September 2008|2008-09-01||||November 2006|Actual|2006-11-01||Interventional|ASAP||Amisulpride in Schizophrenic Acute Phase Patients|The Use of Amisulpride in Schizophrenic Acute Phase Patients.|Completed||Phase 4|50||Sanofi||1|||f||||||||||||||2017-02-18 15:51:41.44446|2017-02-18 15:51:41.44446
NCT00436358|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2011-01-27|||April 2007||2007-04-01|January 2011|2011-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Implementing Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in Mexico|Implementation of Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals With Pediatric Medical Care in Mexico|Completed||N/A|134|Actual|GlaxoSmithKline|||5||f||||||||||||||2017-02-18 15:51:41.554512|2017-02-18 15:51:41.554512
NCT00436345|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2011-03-17|2009-08-07||November 2007||2007-11-01|March 2011|2011-03-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU)|A Randomized, Open Label, Multicentre Study to Compare the Pharmaco-economic Implications of an Analgesia Based Regimen With Remifentanil and a Conventional Sedation Based Regimen Using Propofol in Medical and Post-surgical ICU Subjects Requiring Mechanical Ventilation for at Least 2 Days.|Terminated||Phase 3|39|Actual|GlaxoSmithKline||2||recruitment issues|f||||||||||||||2017-02-18 15:51:41.684758|2017-02-18 15:51:41.684758
NCT00436332|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-10-28|2016-10-28||July 2007||2007-07-01|October 2016|2016-10-01||||August 2016|Actual|2016-08-01||Interventional|||S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma|A Phase II Trial of the Combination of OSI-774 (ERLOTINIB; NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features (ADENOBAC)|Active, not recruiting||Phase 2|84|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 15:51:42.613665|2017-02-18 15:51:42.613665
NCT00436319|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2016-02-11|||May 2006||2006-05-01|February 2016|2016-02-01||||June 2015|Actual|2015-06-01||Interventional|||Duration of GnRH-analogue Downregulation and Pregnancy Rates|Effect of the Duration of GnRH-analogue Downregulation on Pregnancy Rates in IVF|Terminated||Phase 4|300|Actual|Aristotle University Of Thessaloniki||2|||f||||||||||||||2017-02-18 15:51:43.349579|2017-02-18 15:51:43.349579
NCT00436306|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2015-10-06|||October 1999||1999-10-01|October 2015|2015-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|PROTECT||Stage Matched Intervention to Increase Dual Method Use|Stage Matched Intervention to Increase Dual Method Use|Completed||Phase 4|550|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 15:51:43.457142|2017-02-18 15:51:43.457142
NCT00436293|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2010-11-16|||December 2002||2002-12-01|November 2010|2010-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Taxotere + Cisplatin in Nasopharyngeal Carcinoma|A Randomized Phase II Study of Concurrent Cisplatin-radiotherapy With or Without Neoadjuvant Chemotherapy Using Taxotere and Cisplatin in Advanced Nasopharyngeal Carcinoma (NPC)|Completed||Phase 2|61|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:51:43.575995|2017-02-18 15:51:43.575995
NCT00436280|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2012-11-28||2010-10-25|February 2007||2007-02-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2009|Actual|2009-11-01||Interventional|||Chemotherapy for Patients With Lymphoma|An Open-label, Single Arm, Phase 2 Study of Rituximab, Gemcitabine and Oxaliplatin Plus Enzastaurin as Treatment for Patients With Relapsed Diffuse Large B-Cell Lymphoma|Completed||Phase 2|61|Anticipated|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 15:51:43.674763|2017-02-18 15:51:43.674763
NCT00436267|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2013-12-18|||November 2006||2006-11-01|November 2009|2009-11-01||||October 2009|Anticipated|2009-10-01||Interventional|||Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery|Phase II Study of SIRT and SERT With Chemotherapy in Patients With Recurrent /Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:51:43.96277|2017-02-18 15:51:43.96277
NCT00436254|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-05-02|||October 2001||2001-10-01|May 2016|2016-05-01||||March 2010|Actual|2010-03-01||Interventional|||Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer|A Phase I Study of a DNA Plasmid Based Vaccine Encoding the HER-2/Neu Intracellular Domain in Subjects With HER-2/Neu (HER2) Overexpressing Tumors|Active, not recruiting||Phase 1|66|Anticipated|University of Washington||1|||f||||t||||||||||2017-02-18 15:51:44.058014|2017-02-18 15:51:44.058014
NCT00436241|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-16|2016-11-01|||March 2007||2007-03-01|November 2016|2016-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.|A Open Label Study of the Effect of First-line Therapy With Xeloda in Combination With Oxaliplatin on Overall Response Rate in Patients With Locally Advanced and/or Metastatic Gastric Cancer|Completed||Phase 2|45|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:51:44.182332|2017-02-18 15:51:44.182332
NCT00436228|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2008-10-09|||November 2006||2006-11-01|October 2008|2008-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug|An Open-Label, Randomized, Crossover Study to Estimate the Formulation Effect on the Relative Bioavailability of Single Dose Oral SB-742510 in Healthy Subjects|Completed||N/A|32|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:51:44.289172|2017-02-18 15:51:44.289172
NCT00436215|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2015-10-07|2015-03-16||December 2006||2006-12-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|June 2014|Actual|2014-06-01||Interventional|||Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer|A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer|Completed||Phase 2|55|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 15:51:44.376083|2017-02-18 15:51:44.376083
NCT00436202|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2010-09-12||||||September 2010|2010-09-01||||||||Interventional|||Evaluation of an Intervention Program for the Prevention of Anemia||Unknown status|Active, not recruiting|N/A|||Wolfson Medical Center|||||f||||||||||||||2017-02-18 15:51:44.875911|2017-02-18 15:51:44.875911
NCT00436189|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2008-04-25|||February 2007||2007-02-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008||2008-04-01||Interventional|||Assess Cancer in Ovarian Tumors With Biomarkers.|Whole Blood Collection Protocol For Ovarian Assay Clinical Trial In Women With Ovarian Tumors|Completed||N/A|1000|Anticipated|Ciphergen Biosystems|||||f||||||||||||||2017-02-18 15:51:44.96208|2017-02-18 15:51:44.96208
NCT00436176|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2009-03-20|||June 2007||2007-06-01|March 2009|2009-03-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|||Improving Diabetes Care for African Americans|The Expanded Chronic Care Model: Targeting Disparities in Diabetes Care|Completed||Phase 3|6000|Anticipated|Harvard Vanguard Medical Associates||2|||f||||f||||||||||2017-02-18 15:51:45.090589|2017-02-18 15:51:45.090589
NCT00436163|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-08-31|2016-08-31||March 2007||2007-03-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||All enrolled participants who received at least 1 dose of peginterferon alfa-2a.|A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B|Baltic Post-marketing Program of PEGASYS (Peg Interferon Alpha-2a 40KD) in Patients With HBeAg-positive and HBeAg-negative Chronic Hepatitis B|Completed||Phase 4|39|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:51:45.207782|2017-02-18 15:51:45.207782
NCT00436150|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2013-03-08|||February 2007||2007-02-01|March 2013|2013-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers|Preventing Postpartum Depression in Adolescent Mothers|Completed||N/A|106|Actual|Women and Infants Hospital of Rhode Island||2|||f||||t||||||||||2017-02-18 15:51:45.511171|2017-02-18 15:51:45.511171
NCT00436137|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2008-11-05|||June 2007||2007-06-01|November 2008|2008-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Improving Followup of Abnormal Colon Cancer Screening Tests|Improving Followup of Positive Fecal Occult Blood Tests|Completed||N/A|70|Actual|Harvard Vanguard Medical Associates||1|||f||||f||||||||||2017-02-18 15:51:45.612004|2017-02-18 15:51:45.612004
NCT00436124|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2017-02-16|||January 2007|Actual|2007-01-01|February 2017|2017-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.|A Randomized, Open Label Study to Evaluate the Effect of Tamiflu on Viral Shedding and on Serum and Cytoplasmic Inflammatory Cytokine Concentrations in Patients With Laboratory-confirmed Influenza|Terminated||Phase 4|||Hoffmann-La Roche||||poor recruitment, no patients were enrolled|f||||||||||||||2017-02-18 15:51:45.706297|2017-02-18 15:51:45.706297
NCT00436111|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2007-02-15|||January 2005||2005-01-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Observational|||Characterization of Macroprolactinemia||Completed||N/A|||Kansai Medical University|||||f||||||||||||||2017-02-18 15:51:45.790152|2017-02-18 15:51:45.790152
NCT00436098|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2008-08-26|||February 2007||2007-02-01|August 2008|2008-08-01|May 2010|Anticipated|2010-05-01|November 2009|Anticipated|2009-11-01||Interventional|||Pediatric Exercise With Congenital Heart Defects (Kinderturnen Mit Angeborenem Herzfehler)|Pediatric Exercise With Congenital Heart Defects (Kinderturnen Mit Angeborenem Herzfehler)|Unknown status|Recruiting|N/A|60|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 15:51:45.872949|2017-02-18 15:51:45.872949
NCT00436085|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2007-02-15|||December 2003||2003-12-01|February 2007|2007-02-01|December 2005||2005-12-01|||||Interventional|SWISSIT||Randomized Controlled Trial of Stress Management Training in HIV|Randomized Controlled Trial of Stress Management Training in Individuals With HIV Infection|Completed||Phase 3|100||University of Zurich|||||f||||||||||||||2017-02-18 15:51:45.983984|2017-02-18 15:51:45.983984
NCT00436072|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2012-10-03|||February 2007||2007-02-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|February 2012|Actual|2012-02-01||Interventional|||ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer|Phase I Study of ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer|Completed||Phase 1|46|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 15:51:46.071538|2017-02-18 15:51:46.071538
NCT00436059|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2009-07-07|||February 2007||2007-02-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)|The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)|Completed||Phase 2|20|Anticipated|Vejle Hospital|||||f||||||||||||||2017-02-18 15:51:46.176216|2017-02-18 15:51:46.176216
NCT00436046|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2011-06-09|2008-10-09||March 2007||2007-03-01|October 2009|2009-10-01|October 2007|Actual|2007-10-01|April 2007|Actual|2007-04-01||Interventional|||Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally|Type 1 Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally|Completed||Phase 1|95|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 15:51:46.262586|2017-02-18 15:51:46.262586
NCT00436033|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2013-07-10|||February 2006||2006-02-01|July 2013|2013-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome|A European Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia Syndrome|Completed||Phase 3|1429|Actual|Pierre Fabre Medicament||2|||f||||||||||||||2017-02-18 15:51:47.213552|2017-02-18 15:51:47.213552
NCT00436020|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2008-05-05|||April 2007||2007-04-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|November 2008|Anticipated|2008-11-01||Interventional|||rTMS in the Treatment of Bipolar Depression|A Double-Blind Sham Controlled Trial of rTMS in the Treatment of Bipolar Depression|Unknown status|Recruiting|Phase 2|120|Anticipated|Bayside Health||2|||f||||||||||||||2017-02-18 15:51:47.325394|2017-02-18 15:51:47.325394
NCT00436007|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2013-05-23|2012-12-19||April 2007||2007-04-01|May 2013|2013-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen|Safety and Immunogenicity Study of GSK Biologicals' Investigational Vaccination Regimen Malaria Vaccine 257049, When Incorporated Into an Expanded Program on Immunization (EPI) Regimen That Includes Tritanrix HepB/Hib, OPV, Measles and Yellow Fever Vaccination in Infants|Completed||Phase 2|511|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 15:51:47.445267|2017-02-18 15:51:47.445267
NCT00435994|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-05-23|2015-11-12||December 2003||2003-12-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|March 2009|Actual|2009-03-01||Interventional|||Assessment of Airway Obstruction in Infants With Lower Respiratory Infections|Assessment of Airway Obstruction in Infants With Lower Respiratory Infections|Completed||N/A|59|Actual|Indiana University|More than half of our infants woke up before completion of the protocol therefore limiting our analysis.|3|||f||||t||||||||||2017-02-18 15:51:48.824487|2017-02-18 15:51:48.824487
NCT00435981|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2008-01-29|||January 2005||2005-01-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes|A Phase II, Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Impact of Diamyd® on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus|Completed||Phase 2|70||Diamyd Therapeutics AB|||||f||||||||||||||2017-02-18 15:51:49.23497|2017-02-18 15:51:49.23497
NCT00435968|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2007-07-16|||March 2007||2007-03-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults|Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults|Completed||Phase 2|50|Anticipated|Afexa Life Sciences Inc|||||f||||||||||||||2017-02-18 15:51:49.333766|2017-02-18 15:51:49.333766
NCT00435955|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2007-02-15|||March 2000||2000-03-01|February 2007|2007-02-01||||||||Interventional|||Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma|MULTICENTER RANDOMIZED PROGRAM COMPARING HIGH-DOSE CHEMOTHERAPY + RITUXIMAB AND PERIPHERAL BLOOD PROGENITOR CELL (PBPC) AUTOGRAFT vs. CHOP + RITUXIMAB AS FIRST-LINE TREATMENT FOR PATIENTS WITH HIGH-RISK FOLLICULAR LYMPHOMA|Unknown status|Active, not recruiting|Phase 3|240||Azienda Ospedaliera San Giovanni Battista|||||f||||||||||||||2017-02-18 15:51:49.414325|2017-02-18 15:51:49.414325
NCT00435942|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2012-11-16|||January 2007||2007-01-01|November 2012|2012-11-01|May 2015|Anticipated|2015-05-01|April 2011|Actual|2011-04-01||Interventional|||Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft|Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|Bolton Medical||2|||t||||t||||||||||2017-02-18 15:51:49.508159|2017-02-18 15:51:49.508159
NCT00435929|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2016-11-01|2015-12-02||September 2006||2006-09-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.|Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients|Completed||Phase 1|16|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:51:49.626508|2017-02-18 15:51:49.626508
NCT00435916|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2014-12-17||2011-05-24|December 2006||2006-12-01|December 2014|2014-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma|A Phase II Study of SGN-40 (Anti-huCD40 mAb) in Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)|Completed||Phase 2|46|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-02-18 15:51:50.419293|2017-02-18 15:51:50.419293
NCT00435903|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2009-05-14|||June 2005||2005-06-01|February 2007|2007-02-01|October 2005||2005-10-01|||||Interventional|||Pilot Study of the Feasibility of Palm Pilots in Monitoring Smoking Behavior in Individuals With Chronic Mental Illness|Pilot Study of the Feasibility of Palm Pilots in Monitoring Smoking Behavior in Individuals With Chronic Mental Illness|Unknown status|Active, not recruiting|Early Phase 1|11||North Suffolk Mental Health Association|||||f||||||||||||||2017-02-18 15:51:50.536129|2017-02-18 15:51:50.536129
NCT00435890|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2008-09-11|||December 2005||2005-12-01|September 2008|2008-09-01|June 2006|Actual|2006-06-01|February 2006|Actual|2006-02-01||Interventional|||Triage Liaison Physician - Evaluation of a Novel Approach to Address Emergency Department Overcrowding|Randomized Controlled Trial of a Liaison Physician at the Triage Desk to Reduce Emergency Department Overcrowding and Improve Patient Flow.|Completed||Phase 4|5718|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 15:51:50.624218|2017-02-18 15:51:50.624218
NCT00435877|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2017-01-24|||January 29, 2007||2007-01-29|November 5, 2012|2012-11-05|November 5, 2012||2012-11-05|||||Observational|||Procurement of Tissue Samples for Cell Cultures and Analyses|Procurement of Normal Bone, Dermis, Spleen, Thymus and Adipose Tissue for Establishment of Cell Cultures and Tissue Analyses|Terminated||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:51:50.729675|2017-02-18 15:51:50.729675
NCT00435864|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2014-04-29|||April 2007||2007-04-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Natural Killer Index From Hematopoietic Stem Cell Graft|Pilot, Multicenter and Prospective Study of the Natural Killer Index From Hematopoietic Stem Cell Graft at a Genotypic, Phenotypic and Functional Level|Completed||N/A|92|Actual|Nantes University Hospital||3|||f||||f||||||||||2017-02-18 15:51:50.807382|2017-02-18 15:51:50.807382
NCT00435851|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2007-02-16|||February 2007||2007-02-01|February 2007|2007-02-01||||||||Interventional|Estimabl||Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients|Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients - Estimabl|Unknown status|Not yet recruiting|Phase 3|950||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 15:51:50.901589|2017-02-18 15:51:50.901589
NCT00435838|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2008-10-13|||March 2007||2007-03-01|October 2008|2008-10-01||||||||Observational|||A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701|A Retrospective, Multi-Centre Observational Study to Evaluate Disease Management and Adverse Events in Adult Subjects With HIV-1 Infection Who Were Withdrawn From CNA106030 Due to a Positive HLA-B*5701 Test Result|Completed||N/A|35||GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:51:50.996944|2017-02-18 15:51:50.996944
NCT00435825|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-15|2013-06-19|2013-03-20||March 2007||2007-03-01|June 2013|2013-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||Baseline Measures are based on participants from the Intent-to-treat population who received study drug.|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB).|A Randomized, Double-blind Study of the Effect of Treatment Duration and Dose of PEGASYS on HBeAg Seroconversion and Safety in Patients With HBeAg Positive Chronic Hepatitis B.|Completed||Phase 4|551|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 15:51:51.109007|2017-02-18 15:51:51.109007
NCT00435812|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2016-11-08||2014-06-16|December 2006||2006-12-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine|A Phase III Safety and Efficacy Study to Compare Immune Responses Following Injection With Either Two Doses of HEPLISAV™ or Three Doses of Engerix-B®|Completed||Phase 3|2428|Actual|Dynavax Technologies Corporation||2|||f||||t||||||||Yes|There is a BLA in progress at this time. Data to be shared post approval|2017-02-18 15:51:54.734162|2017-02-18 15:51:54.734162
NCT00342784|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 2, 2004||2004-11-02|May 23, 2016|2016-05-23||||||||Observational|||Identification of Prostate Cancer Genes|Genetic Analysis of Cases, Controls, and Families With Prostate Cancer|Completed||N/A|5118|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:16.888728|2017-02-18 16:27:16.888728
NCT00435799|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2008-06-09|||February 2007||2007-02-01|January 2007|2007-01-01|January 2010|Anticipated|2010-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Evaluating Collagen Cross-Linking (CCL) Treatment in Norway|Treatment of Keratectasia With Collagen Cross-Linking (CCL) at the Eye Departments of the University Hospital, North Norway in Tromsø and Ullevål University Hospital in Oslo|Unknown status|Recruiting|Phase 2/Phase 3|40|Anticipated|Ullevaal University Hospital||1|||f||||||||||||||2017-02-18 15:51:55.097716|2017-02-18 15:51:55.097716
NCT00435786|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2007-02-14||||||February 2007|2007-02-01||||||||Observational|||Diabetic Patients With End-Stage Renal Disease||Completed||N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 15:51:55.215612|2017-02-18 15:51:55.215612
NCT00435773|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2007-04-06|||February 2004||2004-02-01|April 2007|2007-04-01|December 2004||2004-12-01|||||Interventional|||Leeches for the Treatment of Knee Osteoarthritis|Single and Repeated Leech Therapy for the Treatment of Late Stage Knee Osteoarthritis. A Randomized, Placebo Controlled Comparative Trial|Completed||Phase 2|118||RWTH Aachen University|||||f||||||||||||||2017-02-18 15:51:55.281468|2017-02-18 15:51:55.281468
NCT00435760|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2016-11-16|||February 2007||2007-02-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients|Single Dose, Double-blind, Double-dummy, 3 Period Cross-over, Placebo Controlled Clinical Trial to Assess the Reate of Onset of Action of Inhaled Aclidinium Bromide 200µg Compared to Placebo and Tiotropium 18µg in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|115|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 15:51:55.387741|2017-02-18 15:51:55.387741
NCT00435747|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2012-03-13||||||March 2012|2012-03-01||||||||Interventional|||Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation|A Double-Blind Comparative Multicenter Study Of The Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo On Reducing Opioids Consumption Following Sub Muscular Breast Augmentation Surgery|Withdrawn||Phase 4|0|Actual|Pfizer|||||f||||||||||||||2017-02-18 15:51:55.505396|2017-02-18 15:51:55.505396
NCT00435734|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2016-10-24|||July 1999||1999-07-01|October 2016|2016-10-01|December 2035|Anticipated|2035-12-01|December 2034|Anticipated|2034-12-01||Observational|Obeldicks||"Obesity Intervention Obeldicks for Obese Children, Adolescents and Their Parents"|"Evaluation of the Intervention Program Obeldicks for Obese Children and Adolescents"|Recruiting||N/A|6000|Anticipated|University of Witten/Herdecke|||1||f||||||||||||||2017-02-18 15:51:55.59751|2017-02-18 15:51:55.59751
NCT00435721|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2007-02-14|||June 2002||2002-06-01|January 2007|2007-01-01|August 2005||2005-08-01|||||Interventional|||Families Coping With Mental Illness Program|The Families Coping With Mental Illness Program|Unknown status|Active, not recruiting|Phase 1|50||North Suffolk Mental Health Association|||||f||||||||||||||2017-02-18 15:51:55.708944|2017-02-18 15:51:55.708944
NCT00435708|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2015-09-28|||February 2007||2007-02-01|September 2015|2015-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|DISCO||Effect of Increased Fruit and Vegetable Intake on Chronic Obstructive Pulmonary Disease (COPD)|Effect of Increased Fruit and Vegetable Intake on Airway Inflammation and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|81|Actual|Queen's University, Belfast||2|||f||||f||||||||||2017-02-18 15:51:55.806833|2017-02-18 15:51:55.806833
NCT00435695|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2012-05-31|||November 2006||2006-11-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males|An Open Label, Non-randomized Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain 5-HT1A Receptor Occupancy, Pharmacokinetics and Safety of Single Oral Doses of GSK163090, Using the Ligand [11C]-WAY100635.|Completed||Phase 1|13|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:51:55.90701|2017-02-18 15:51:55.90701
NCT00435682|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2008-02-05|||March 2007||2007-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||To Study the Peripheral Effect of Botulinum Toxin-A (Botox-A) on Experimentally Induced Cutaneous Pain in Healthy Subjects||Completed||N/A|||Aalborg University|||||f||||||||||||||2017-02-18 15:51:56.018182|2017-02-18 15:51:56.018182
NCT00435669|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2009-01-21|||September 2007||2007-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)|Mass Balance, Pharmacokinetics and Metabolism of [14C]BMS-582664 Prodrug of BMS-540215, in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|4|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:51:56.110279|2017-02-18 15:51:56.110279
NCT00435656|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2011-08-24|||September 2007||2007-09-01|August 2011|2011-08-01||||||||Observational|||Pharmacogenetics of Antiretroviral Drugs||Completed||Phase 4|200|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||||||||||||2017-02-18 15:51:56.216654|2017-02-18 15:51:56.216654
NCT00435643|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2007-11-19|||October 2004||2004-10-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Influence of nCPAP on Metabolic Consequences Associated With OSAS|Improvement in Hypothalamic-Pituitary-Adrenal Axis Function After Continuous Positive Airway Pressure Therapy in Obstructive Sleep Apnea Syndrome|Completed||N/A|45|Actual|Federal University of São Paulo||1|||f||||t||||||||||2017-02-18 15:51:56.305962|2017-02-18 15:51:56.305962
NCT00435630|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2012-11-19|||July 2004||2004-07-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|January 2005|Actual|2005-01-01||Interventional|||Documenting a Learning Curve and Test-retest Reliability of a Virtual Reality Training Simulator in Laparoscopic Surgery|Documenting a Learning Curve and Test-retest Reliability of a Virtual Reality Training Simulator in Laparoscopic Surgery|Completed||N/A|29|Actual|Columbia University||1|||f||||f||||||||||2017-02-18 15:51:56.429283|2017-02-18 15:51:56.429283
NCT00435617|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2012-07-18|||May 2005||2005-05-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of Hand Therapy 3 to 24 Months After Stroke|Clinical Assessment of a Massed Practice Therapy Device|Completed||N/A|78|Actual|Kinetic Muscles||1|||f||||f||||||||||2017-02-18 15:51:56.536853|2017-02-18 15:51:56.536853
NCT00435604|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2011-10-13|||February 2007||2007-02-01|February 2007|2007-02-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase|Phase I Dose-Ranging Randomized Double-Blinded Controlled Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase|Completed||Phase 1|15|Anticipated|Halozyme Therapeutics|||||f||||||||||||||2017-02-18 15:51:56.664323|2017-02-18 15:51:56.664323
NCT00435591|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2014-04-30|2010-04-28||January 2007||2007-01-01|April 2014|2014-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia|A Phase 4, Randomized, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia|Completed||Phase 4|121|Actual|Cumberland Pharmaceuticals|Company makes no warranties or representations of any kind as to the currency or completeness of the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose and shall not be liable for any damages.|4|||f||||f||||||||||2017-02-18 15:51:56.767922|2017-02-18 15:51:56.767922
NCT00435578|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2009-04-28|||February 2007||2007-02-01|April 2009|2009-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma|An Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of Glufosfamide in the Treatment of Patients With Recurrent Sensitive Small Cell Lung Carcinoma|Terminated||Phase 2|50|Anticipated|Threshold Pharmaceuticals|||||||||||||||||||2017-02-18 15:51:58.231485|2017-02-18 15:51:58.231485
NCT00435565|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2007-02-14||||||February 2007|2007-02-01||||||||Observational|||Severe Hypoglycemia in Pregnant Women With Type 1 Diabetes|Severe Hypoglycemia in Pregnant Women With Type 1 Diabetes. Incidence, Risk Markers and Possibilities for Prevention|Completed||N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 15:51:58.3228|2017-02-18 15:51:58.3228
NCT00435552|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2007-02-14|||February 2007||2007-02-01|January 2007|2007-01-01||||||||Interventional|||Ease-it Spray for the Treatment of Fire Ant Stings||Completed||Phase 1|||C.R.Darnall Army Medical Center|||||f||||||||||||||2017-02-18 15:51:58.393234|2017-02-18 15:51:58.393234
NCT00435539|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2014-12-02|2013-07-04||February 2007||2007-02-01|April 2014|2014-04-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)|A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding Trial of Microplasmin Intravitreal Injection for Non-Surgical Posterior Vitreous Detachment (PVD) Induction for Treatment of Vitreomacular Traction (VMT).|Completed||Phase 2|60|Actual|ThromboGenics||5|||f||||t||||||||||2017-02-18 15:51:58.460209|2017-02-18 15:51:58.460209
NCT00435526|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2007-02-14|||March 2006||2006-03-01|February 2007|2007-02-01|October 2006||2006-10-01|||||Interventional|BIgGI||Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I|Protective Efficacy of Orally Delivered Bovine Milk Immunoglobulin (BIgG) Specific for the Minor CFA/I Fimbrial Adhesin CfaE Against Challenge With H10407 Enterotoxigenic E. Coli (ETEC) Strain Expressing CFA/I|Completed||Phase 1|30||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 15:51:59.19791|2017-02-18 15:51:59.19791
NCT00435513|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2015-05-03|||March 2007||2007-03-01|May 2015|2015-05-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Observational|||A Common Polymorphism of the SRD5A2 Gene is Not Associated With Male-to-Female and Female-to-Male Transsexualism|Association Study of a SRD5A2 SNP and Transsexualism.|Completed||Early Phase 1|1770|Actual|Medical University of Vienna|||2||f||||f||||||||||2017-02-18 15:51:59.287568|2017-02-18 15:51:59.287568
NCT00435500|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2009-08-21|||June 2003||2003-06-01|August 2009|2009-08-01|January 2006||2006-01-01|||||Interventional|||Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children|Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children|Unknown status|Active, not recruiting|Phase 3|1320||University of Toronto|||||f||||||||||||||2017-02-18 15:51:59.372462|2017-02-18 15:51:59.372462
NCT00435487|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2011-10-07|2009-12-22||June 2007||2007-06-01|October 2011|2011-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome|Prospective Randomized Phase IV Open Label Comparative Study Of Dalteparin vs Unfractionated Heparin In High Risk Patients Of Non-ST Elevation Acute Coronary Syndromes Intended For Early Invasive Strategy|Terminated||Phase 4|173|Actual|Pfizer|This study was terminated due to insufficient recruitment of subjects.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 15:51:59.470968|2017-02-18 15:51:59.470968
NCT00435474|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2009-06-08|||April 2007||2007-04-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Malignant Wounds, Wound Treatment, Psycho-Social Support and Relaxation Therapy|Malignant Wounds: A Randomized Clinical Trial Investigating a Complementary Multidimensional Intervention|Completed||Phase 3|70|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 15:52:00.349543|2017-02-18 15:52:00.349543
NCT00435461|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2016-10-27|||December 2006||2006-12-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine|A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis|Completed||Phase 4|1000|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:52:00.455376|2017-02-18 15:52:00.455376
NCT00435448|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2009-04-28|||June 2005||2005-06-01|April 2009|2009-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia|A Randomized Phase 3, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia|Terminated||Phase 3|480||Threshold Pharmaceuticals|||||f||||||||||||||2017-02-18 15:52:00.573034|2017-02-18 15:52:00.573034
NCT00435435|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2007-02-15|||September 2000||2000-09-01|February 2000|2000-02-01|April 2005||2005-04-01|||||Interventional|DNA||Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence|Phase Four Randomized, Multicentre, Open-Label, Comparative Trial Of Disulfiram, Nalterexone And Acamprosate In The Treatment Of Alcohol Dependence|Completed||Phase 4|243||National Institute for Health and Welfare, Finland|||||f||||||||||||||2017-02-18 15:52:00.728305|2017-02-18 15:52:00.728305
NCT00435422|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2010-03-24|||January 2010||2010-01-01|February 2009|2009-02-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Neuroaxial Blokade and Blood Pressure|Neuroaxial Blokade and the Effect of Fluid Optimization|Unknown status|Recruiting|N/A|16|Anticipated|Rigshospitalet, Denmark||1|||f||||||||||||||2017-02-18 15:52:00.836304|2017-02-18 15:52:00.836304
NCT00342498|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 12, 1994||1994-01-12|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Observational|||Estrogen Receptor Gene Mutations|Estrogen Receptor Gene Mutations|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.344331|2017-02-18 16:27:19.344331
NCT00435409|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2012-06-15|2010-12-14||February 2007||2007-02-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional|||A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer|A Randomized, Phase 3 Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Previously Treated Breast Cancer|Completed||Phase 3|442|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 15:52:00.9606|2017-02-18 15:52:00.9606
NCT00435396|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-14|2012-06-14|||February 2007||2007-02-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|August 2008|Actual|2008-08-01||Interventional|||Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects|A Phase I, Open-label, Vaccination Study to Evaluate the Safety and Immunogenicity of the GSK Biologicals Recombinant CMV gB Sub-unit Vaccine GSK1492903A in CMV-seronegative Healthy Male Adult Subjects|Completed||Phase 1|40|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:52:03.086849|2017-02-18 15:52:03.086849
NCT00435383|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2015-12-11|||March 2003||2003-03-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|February 2007|Actual|2007-02-01||Observational|||Comparing Oxygen Saturation in Post Anesthesia Care Unit After Different Methods of Pain Relief|Oxygen Saturation During Transfer From Operating Room to Post Anesthesia Care Unit After Current Anesthesia Care|Completed||Phase 2|42|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||||||||||||2017-02-18 15:52:03.195472|2017-02-18 15:52:03.195472
NCT00435370|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2014-08-12|2013-08-01||November 2006||2006-11-01|August 2014|2014-08-01|August 2011|Actual|2011-08-01|February 2011|Actual|2011-02-01||Interventional|||Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia|Tropisetron With Risperidone for Schizophrenia|Completed||Phase 3|179|Actual|Baylor College of Medicine|Since all participants were the first episode and drug naive patients, some participants quit before the completion of the entire clinical trial|2|||f||||f||||||||||2017-02-18 15:52:03.282143|2017-02-18 15:52:03.282143
NCT00435357|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2013-06-20|||February 2007||2007-02-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Comparison Between Fixed- Versus Mobile-bearing TKA|Comparison Between Fixed- Versus Mobile-bearing TKA : a Randomized Prospective Study|Completed||N/A|160|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-02-18 15:52:03.671712|2017-02-18 15:52:03.671712
NCT00435344|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2007-02-12|||February 1999||1999-02-01|February 2007|2007-02-01|January 2004||2004-01-01|||||Interventional|||Provider and Peer Delivered Youth Smoking Intervention|Provider and Peer Delivered Youth Smoking Intervention|Completed||Phase 2|2711||University of Massachusetts, Worcester|||||f||||||||||||||2017-02-18 15:52:03.772384|2017-02-18 15:52:03.772384
NCT00435331|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2013-06-17|||March 2008||2008-03-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||6R-BH4 Pulmonary Arterial Hypertension Study|A Phase 1, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety and Efficacy of 6R-BH4 in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 1|14|Actual|Vanderbilt University||1|||f||||t||||||||||2017-02-18 15:52:03.983874|2017-02-18 15:52:03.983874
NCT00435318|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2015-12-07|||February 2007||2007-02-01|December 2015|2015-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Lateral Epicondylitis Iontophoresis Randomized Control Trial (LERCT)|Lateral Epicondylitis Iontophoresis Randomized Control Trial (LERCT)|Withdrawn||N/A|0|Actual|Vanderbilt University||||Study approval deferred by the IRB.|f||||||||||||||2017-02-18 15:52:04.09368|2017-02-18 15:52:04.09368
NCT00435305|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2008-06-06|||November 2006||2006-11-01|June 2008|2008-06-01|November 2007|Anticipated|2007-11-01|||||Observational|||Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion|Antibiotic Concentrations in Serum and Epithelial Lining Fluid Under Continous Infusion|Terminated||Phase 4|40|Anticipated|University Hospital Tuebingen||||"difficulties by enrolling patients fundings consumed, no staff could be recruited and payed to~   continue enrolling patients,"|f||||t||||||||||2017-02-18 15:52:04.175192|2017-02-18 15:52:04.175192
NCT00435292|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2015-10-19|||April 2006||2006-04-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee|A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi Center Study of Flavocoxid ( Limbrel) vs Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee|Completed||N/A|350|Actual|Primus Pharmaceuticals||3|||f||||f||||||||||2017-02-18 15:52:04.276523|2017-02-18 15:52:04.276523
NCT00435279|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2012-02-21|||June 2007||2007-06-01|February 2012|2012-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia|A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered With Venlafaxine in Subjects With Major Depressive Disorder (MDD) and Co-existing Insomnia|Completed||Phase 3|678|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 15:52:04.391278|2017-02-18 15:52:04.391278
NCT00435266|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2009-02-16|||February 2007||2007-02-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Remote Ischemic Preconditioning in Primary PCI|The Effect of Remote Preconditioning in Primary Percutaneous Intervention of Acute ST Elevation Myocardial Infarction|Completed||Phase 2/Phase 3|250|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:52:04.593064|2017-02-18 15:52:04.593064
NCT00435253|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2011-10-21|||February 2007||2007-02-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study|Phase 2 Study of the Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema|Completed||Phase 2|20|Actual|Aeris Therapeutics||1|||f||||t||||||||||2017-02-18 15:52:04.897393|2017-02-18 15:52:04.897393
NCT00435240|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2008-05-13|||January 2005||2005-01-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Paleolithic Diet in the Treatment of Diabetes Type 2 in Primary Health Care||Completed||Phase 2|13|Actual|Lund University Hospital||1|||f||||||||||||||2017-02-18 15:52:05.015983|2017-02-18 15:52:05.015983
NCT00435227|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2012-07-02||2012-07-02|March 2007||2007-03-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Evaluate a Single IM Dose of Motavizumab Treatment of Children With RSV (Respiratory Syncytial Virus) Illness|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intramuscular Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Outpatient Treatment of Children With RSV Illness|Completed||Phase 2|12|Actual|MedImmune LLC||2|||f||||||||||||||2017-02-18 15:52:05.115308|2017-02-18 15:52:05.115308
NCT00435214|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2017-01-24|||January 24, 2007||2007-01-24|August 18, 2016|2016-08-18||||||||Observational|||Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer|The HPV Persistence and Progression (PaP) Cohort at Kaiser Permanente Northern California|Completed||N/A|135600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:52:05.252426|2017-02-18 15:52:05.252426
NCT00435201|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2013-08-06|||January 2007||2007-01-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Characterization of Clonal B Cell Populations in HCV Infection|Characterization of Clonal B Cell Populations in HCV Infection|Completed||N/A|14|Actual|Rockefeller University|||1||f||||t||||||Samples With DNA|"~     white blood cells~   "|||2017-02-18 15:52:05.347693|2017-02-18 15:52:05.347693
NCT00435188|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2015-01-08|2014-10-07||November 2004||2004-11-01|January 2015|2015-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|Project LIFE||Life 2: Improving Fitness and Function in Elders|Life 2: Improving Fitness and Function in Elders|Completed||N/A|400|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:52:05.445291|2017-02-18 15:52:05.445291
NCT00435175|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2007-02-13|||June 2005||2005-06-01|February 2007|2007-02-01|July 2006||2006-07-01|||||Interventional|||Acute Metabolic Effects of Estradiol|Acute Effects of Estradiol on Lipolysis in Subcutaneous Adipose Tissue and Muscle Assessed by Microdialysis and Tissue Biopsies|Completed||N/A|8||University of Aarhus|||||f||||||||||||||2017-02-18 15:52:06.473931|2017-02-18 15:52:06.473931
NCT00435162|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2011-04-15|2010-12-17||March 2007||2007-03-01|April 2011|2011-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure|A Randomized, Multicenter, Double-blind, 6 Week Study to Evaluate the Dose Response of Valsartan on Blood Pressure Reduction in Children 6 Months - 5 Years Old With Hypertension, Followed by a 2 Week Placebo Withdrawal Period.|Completed||Phase 3|74|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:52:06.574839|2017-02-18 15:52:06.574839
NCT00435149|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2011-02-17|||December 2006||2006-12-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Post-operative Mobilization for Carpal Tunnel Syndrome|Post-operative Mobilization for Carpal Tunnel|Completed||N/A|100|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 15:52:07.263191|2017-02-18 15:52:07.263191
NCT00435123|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2008-02-12|||July 2007||2007-07-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||ProStat Supplementation in Dialysis Patients|A Randomized, Placebo Controlled, Double Blind Study of the Use of a Nutritional Supplement, ProStat-64, in Chronic Hemodialysis Patients With Poor Nutritional Status.|Terminated||N/A|16|Actual|Fresenius Medical Care North America||2||Increased use of commercial product; less eligible patients & poor enrollment.|f||||f||||||||||2017-02-18 15:52:07.352082|2017-02-18 15:52:07.352082
NCT00435110|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2007-02-13|||May 2004||2004-05-01|February 2006|2006-02-01|October 2005||2005-10-01|||||Observational|HELP||Effects of PEEP and FIO2 in ALI and ARDS|Effects of PEEP and FiO2 in the Evaluation of Severity of ALI and ARDS|Completed||N/A|170||Instituto Canario de Investigacion Biomedica|||||f||||||||||||||2017-02-18 15:52:07.465314|2017-02-18 15:52:07.465314
NCT00435097|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2007-02-13||||||February 2007|2007-02-01||||||||Observational|||Computer Assisted Early Detection of Liver Metastases From fMRI Maps|Computer Assisted Early Detection of Liver Metastases From fMRI Maps|Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:52:07.561991|2017-02-18 15:52:07.561991
NCT00435084|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2015-09-22|||February 2007||2007-02-01|November 2013|2013-11-01|April 2009|Actual|2009-04-01|February 2008|Actual|2008-02-01||Interventional|||A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL|An Open Phase I/II Clinical Study Assessing the Safety and Tolerability of APO866 in Patients With Refractory B-cell Lymphocytic Leukaemia Not Amenable to Allogeneic Hemopoietic Stem Cell Transplantation|Completed||Phase 1/Phase 2|10|Actual|Onxeo||1|||f||||f||||||||||2017-02-18 15:52:07.653459|2017-02-18 15:52:07.653459
NCT00435071|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2011-02-17|||December 2006||2006-12-01|February 2011|2011-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Effect of Surgical Incision Size on Carpal Tunnel Surgery|The Effect of Surgical Incision Size on Carpal Tunnel Surgery|Terminated||N/A|100|Anticipated|Vanderbilt University||2||Investigator initiated suspension to focus on other studies.|f||||f||||||||||2017-02-18 15:52:07.763193|2017-02-18 15:52:07.763193
NCT00435058|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2007-02-16|||September 2005||2005-09-01|February 2007|2007-02-01|April 2006||2006-04-01|||||Interventional|||Visual Function Changes After Intraocular Pressure Reduction|Visual Function Changes After Intraocular Pressure Reduction Using Antiglaucoma Medications: A Randomized Clinical Trial|Completed||N/A|54||University of Sao Paulo|||||f||||||||||||||2017-02-18 15:52:07.857278|2017-02-18 15:52:07.857278
NCT00435045|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2016-12-02|2008-10-22||February 2007||2007-02-01|December 2016|2016-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia|A Randomized, Double-Blind, Placebo-Controlled, Forced Titration Study to Assess the Efficacy and Safety of Omacor, Co-Administered With Open-Label Atorvastatin Therapy, in Hypertriglyceridemic Subjects|Completed||Phase 3|245|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:52:08.074912|2017-02-18 15:52:08.074912
NCT00435032|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2010-01-11|||October 2006||2006-10-01|January 2010|2010-01-01||||September 2009|Actual|2009-09-01||Interventional|RAPTOR||Early Versus Interval Appendectomy for Ruptured Appendicitis in Children|Early Versus Interval Appendectomy for Ruptured Appendicitis in Children. Ruptured Appendicitis Pilot Trial (RAPTOR)|Completed||Phase 3|128|Anticipated|University of Tennessee||2|||f||||||||||||||2017-02-18 15:52:08.943941|2017-02-18 15:52:08.943941
NCT00435019|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2014-11-20|2009-11-03||February 2007||2007-02-01|November 2014|2014-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes|An Efficacy and Safety Comparison of Insulin Detemir vs. NPH Insulin in Children and Adolescents Diagnosed With Type 1 Diabetes|Completed||Phase 3|348|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 15:52:09.051315|2017-02-18 15:52:09.051315
NCT00435006|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2007-02-13|||August 2003||2003-08-01|February 2007|2007-02-01|June 2006||2006-06-01|||||Observational|||Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages||Completed||N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 15:52:09.735602|2017-02-18 15:52:09.735602
NCT00434993|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-12-21|2012-12-04||August 2007||2007-08-01|December 2016|2016-12-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|ALTA|All randomized patients were analyzed.|Drug Study of Albuterol to Treat Acute Lung Injury|Prospective, Randomized, Multicenter Trial of Aerosolized Albuterol Versus Placebo in Acute Lung Injury|Terminated||Phase 2/Phase 3|282|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2||Stopped for futility by DSMB|f||||t||||||||Yes|a deidentified database of the ALVEOLI study is available through BioLINCC|2017-02-18 15:52:09.817836|2017-02-18 15:52:09.817836
NCT00434980|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2016-01-21|||February 2005||2005-02-01|January 2016|2016-01-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia|Pilot Study of the Feasibility of a Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia|Completed||Phase 1|11|Actual|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-02-18 15:52:10.481709|2017-02-18 15:52:10.481709
NCT00434967|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2010-11-30|2009-01-09||January 2007||2007-01-01|November 2010|2010-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo|A Double-blind, Randomised, 4-arm Parallel Group, Multicentre, 8-week, Phase III Study to Assess the Antihypertensive Efficacy and Safety of the Combination of Candesartan Cilexetil (CC) 32 mg and Hydrochlorothiazide (HCT) 25 mg Compared With CC 32 mg, HCT 25 mg and Placebo in Hypertensive Adults|Completed||Phase 3|2207|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 15:52:10.603164|2017-02-18 15:52:10.603164
NCT00434954|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2015-03-19|2010-06-25||February 2007||2007-02-01|March 2015|2015-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes|Effect of Exenatide Plus Metformin vs. Premixed Human Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Inadequate Control of Type 2 Diabetes on Oral Antidiabetic Treatment|Completed||Phase 3|494|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:52:11.168983|2017-02-18 15:52:11.168983
NCT00434941|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2009-06-25|||September 2007||2007-09-01|June 2009|2009-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Administration of Capecitabine Simultaneous to Radiotherapy for Local Relapse Breast Cancer Patients With Negative Her2 Tumours|Multicenter Phase IV.II Trial, for the Administration of Capecitabine Simultaneous to Radiotherapy for Local Relapse Breast Cancer Patients With Negative Her2 Tumours|Terminated||Phase 2|46|Anticipated|Spanish Breast Cancer Research Group||1||Due to the slow rate of recruitment the study was stopped.|f||||||||||||||2017-02-18 15:52:12.085292|2017-02-18 15:52:12.085292
NCT00434928|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2007-02-13|||January 2006||2006-01-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Observational|||Dietary Intake and Nutrient Status of Children With ADHD|Dietary Intake and Nutrient Status of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||N/A|60||University of British Columbia|||||f||||||||||||||2017-02-18 15:52:12.192782|2017-02-18 15:52:12.192782
NCT00434915|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2011-03-22|||April 2003||2003-04-01|March 2011|2011-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Does DHEA Enhance the Effects of Exercise in Postmenopausal Women?|Does DHEA Enhance the Effects of Exercise in Postmenopausal Women?|Completed||N/A|32||Mayo Clinic|||||f||||||||||||||2017-02-18 15:52:12.274911|2017-02-18 15:52:12.274911
NCT00434902|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2012-12-18|||February 2007||2007-02-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|March 2009|Actual|2009-03-01||Observational|ETENDARD||Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease|Evaluation of the Characteristics, Prevalence and Prognosis of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease: Study ETENDARD.|Unknown status|Active, not recruiting|N/A|700|Anticipated|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-02-18 15:52:12.36574|2017-02-18 15:52:12.36574
NCT00434889|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-13|2010-01-08|||August 2007||2007-08-01|January 2010|2010-01-01|December 2009|Anticipated|2009-12-01|||||Observational|||A Study of Why People With Early Memory Problems Fall or Almost Fall|Factors Associated With Falls and Near-Falls in Community Dwelling Older Adults With Early-Stage Dementia|Unknown status|Recruiting|N/A|200|Anticipated|University of Saskatchewan|||2||f||||f||||||||||2017-02-18 15:52:12.461684|2017-02-18 15:52:12.461684
NCT00434876|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2013-07-09|2013-05-16||August 2007||2007-08-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence|The Effects of Quetiapine on Sleep During Alcohol Abstinence|Completed||Phase 3|22|Actual|Corporal Michael J. Crescenz VA Medical Center|The limitations of this study include the small sample size, and assessment of PSQI, PHQ-9, BAI, and SF-12 at week 9 (immediately after washout from the study drug). The corruption of stored online actigraphic sleep data prevented its interpretation.|2|||f||||t||||||||||2017-02-18 15:52:12.556001|2017-02-18 15:52:12.556001
NCT00434863|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2007-02-12|||October 2005||2005-10-01|February 2007|2007-02-01|March 2006||2006-03-01|||||Interventional|||Comparative Study of the Effect of Dysport and Botox|A Comparative Randomized Double-Blinded Study of the Effect of Dysport and Botox on Forehead Wrinkles and EMG Activity|Completed||Phase 4|24||Laserklinik Karlsruhe|||||f||||||||||||||2017-02-18 15:52:13.017932|2017-02-18 15:52:13.017932
NCT00434850|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2016-02-17||2011-11-28|October 2006||2006-10-01|February 2016|2016-02-01|November 2013|Actual|2013-11-01|September 2011|Actual|2011-09-01||Interventional|||Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes|Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes (CIT-03)|Completed||Phase 2|14|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 15:52:13.102426|2017-02-18 15:52:13.102426
NCT00434837|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2016-04-05|||February 2004||2004-02-01|April 2016|2016-04-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Interventional|||Initial Graft Tension and ACL Surgery|Effects of Initial Graft Tension on Anterior Cruciate Ligament Reconstruction|Active, not recruiting||N/A|168|Actual|Rhode Island Hospital||2|||f||||t||||||||||2017-02-18 15:52:13.231739|2017-02-18 15:52:13.231739
NCT00434824|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2015-04-15|||November 2001||2001-11-01|April 2015|2015-04-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)|A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Oral Administration of Different Doses of Org 538 in Symptomatic Aging Men With Androgen Deficiency|Completed||Phase 2|322|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:52:13.351465|2017-02-18 15:52:13.351465
NCT00434798|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2008-06-04|||February 2007||2007-02-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Campylobacter Jejuni Challenge Model Development: Dose Ranging Study|Campylobacter Jejuni Challenge Model Development: Dose Ranging Study|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|University of Vermont||1|||f||||||||||||||2017-02-18 15:52:16.245147|2017-02-18 15:52:16.245147
NCT00434785|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2007-12-03|||February 2007||2007-02-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males|An Ascending, Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 Administered Orally to Healthy Male Japanese Subjects.|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:52:16.32201|2017-02-18 15:52:16.32201
NCT00434772|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-11|2009-05-27|||December 2007||2007-12-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers|Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers|Completed||Phase 2|||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 15:52:16.394379|2017-02-18 15:52:16.394379
NCT00434759|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2012-10-28|2011-11-29||September 2006||2006-09-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|May 2009|Actual|2009-05-01||Interventional|||Social Phobia Intervention Study of Mannheim|Evaluation of the Efficacy, Mechanisms of Change and Efficiency of a Stepped-care Program With a Computer-based Self-help Module and Minimal Therapist Contact in Comparison to a Standard Cognitive Therapy for Patients With Social Phobia|Completed||N/A|89|Actual|Central Institute of Mental Health, Mannheim||2|||f||||t||||||||||2017-02-18 15:52:16.4941|2017-02-18 15:52:16.4941
NCT00434746|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-07-08|||January 2007||2007-01-01|July 2009|2009-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of the Safety, Tolerability, PK, and PD of ILV-094 Administered IV or SC to Healthy Subjects|Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ILV-094 Administered IV and One Dose of SC Administered to Healthy Subjects|Completed||Phase 1|56|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 15:52:16.974165|2017-02-18 15:52:16.974165
NCT00434733|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2008-04-23|||January 2007||2007-01-01|April 2008|2008-04-01||||||||Interventional|||Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects|A Phase III, Randomized, Controlled, Observer-Blind, Multicenter Study to Evaluate the Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects|Completed||Phase 3|4400|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:52:17.0612|2017-02-18 15:52:17.0612
NCT00434720|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2008-10-15|||January 2007||2007-01-01|October 2008|2008-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of GlideScope Specific Stylet to Malleable Stylet for GlideScope Intubation|Comparison of GlideScope Specific Stylet to Malleable Stylet for GlideScope Intubation|Completed||N/A|70|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 15:52:17.159917|2017-02-18 15:52:17.159917
NCT00434707|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-10|2007-02-12|||March 2007||2007-03-01|February 2007|2007-02-01|December 2007||2007-12-01|||||Observational|||Outcome of Small Pupil Phacotrabeculectomy in Persons With Glaucoma and Cataract||Unknown status|Not yet recruiting|N/A|70||Aravind Medical Research Foundation|||||f||||||||||||||2017-02-18 15:52:17.246264|2017-02-18 15:52:17.246264
NCT00434694|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2015-11-24|||July 2003||2003-07-01|November 2015|2015-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation|Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation: Efficacy of Isolating All Veins Vs Arrhythmogenic Veins Only Using Standard 4-mm or 8-mm Ablation Catheter Vs Saline Irrigated Cooled Tip Catheter|Completed||N/A|300|Actual|University of Pennsylvania|||||f||||t||||||||||2017-02-18 15:52:17.55517|2017-02-18 15:52:17.55517
NCT00434681|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2008-07-18|||October 2006||2006-10-01|July 2008|2008-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.|Multicentre, Open, Non-Comparative Study of the Acceptability and Safety of Paracetamol Oral Paediatric Suspension at 4.8%.|Completed||Phase 3|48||Sanofi|||||f||||f||||||||||2017-02-18 15:52:17.651441|2017-02-18 15:52:17.651441
NCT00434668|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2010-11-29|||December 2005||2005-12-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|TOLEDO||Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer|Randomized Phase II Study Evaluating The Tolerability Of Adjuvant Docetaxel-based Chemotherapy For Completely Resected Stage IB-II Non-Small Cell Lung Cancer (NSCLC): Toledo Trial|Completed||Phase 2|99|Anticipated|University Hospital, Antwerp|||||f||||||||||||||2017-02-18 15:52:17.739717|2017-02-18 15:52:17.739717
NCT00434655|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-12-14|||January 2008||2008-01-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Laparoscopic Adjustable Gastric Banding Versus Laparoscopic Sleeve Gastrectomy|Laparoscopic Adjustable Gastric Banding Versus Laparoscopic Sleeve Gastrectomy: A Prospective Trial|Completed||Phase 3|40|Anticipated|North Texas Veterans Healthcare System||2|||f||||||||||||||2017-02-18 15:52:17.833284|2017-02-18 15:52:17.833284
NCT00434642|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2014-09-26|2011-09-26||April 2007||2007-04-01|September 2014|2014-09-01|July 2013|Actual|2013-07-01|September 2010|Actual|2010-09-01||Interventional|OCEANS||A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma|A Phase III, Multicenter, Randomized, Blinded, Placebo-controlled Trial of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Platinum-sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma|Completed||Phase 3|484|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:52:17.952653|2017-02-18 15:52:17.952653
NCT00434629|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2016-08-15|||February 2007||2007-02-01|August 2016|2016-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant|A Phase I Study of Bexxar® (Tositumomab and 131I-Tositumomab) Radioimmunotherapy in Patients With Relapsed or Residual CD20 Antigen-Expressing B-Cell Lymphomas Following Autologous Hematopoietic Stem Cell Transplantation|Completed||Phase 1|16|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 15:52:18.74566|2017-02-18 15:52:18.74566
NCT00433394|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2013-06-26|||May 2001||2001-05-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|January 2007|Actual|2007-01-01||Interventional|||Registration and Informed Consent Study for the Childhood Cancer Research Network|Protocol for Registration and Consent to the Childhood Cancer Research Network - A Limited Institution Pilot|Completed||N/A|2242|Actual|Children's Oncology Group||3|||f||||f||||||||||2017-02-18 15:52:48.559927|2017-02-18 15:52:48.559927
NCT00434616|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2011-04-05|||April 2007||2007-04-01|April 2011|2011-04-01|July 2011|Anticipated|2011-07-01|April 2011|Actual|2011-04-01||Interventional|BONMOT||Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia|Security and Effectiveness of Autologous Bone Marrow Stem Cell Transplantation to Avoid Amputations in Patients With Limb-threatening Ischemia: A Multicentric Randomized Placebo-controlled Double-blind Study|Unknown status|Active, not recruiting|Phase 2/Phase 3|90|Anticipated|Franziskus-Krankenhaus||2|||f||||f||||||||||2017-02-18 15:52:18.849492|2017-02-18 15:52:18.849492
NCT00434603|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2009-02-26|||July 2007||2007-07-01|February 2009|2009-02-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Observational|||Expressive Arts as a Social and Community Integration Tool for Youth Recovering From Brain Injury|"Expressive Arts as a Social and Community Integration Tool for Adolescents With Acquired Brain Injury: I Want to Thrive, Not Just Survive!"|Unknown status|Active, not recruiting|Phase 1/Phase 2|8|Actual|University of Toronto|||1||f||||f||||||||||2017-02-18 15:52:18.969266|2017-02-18 15:52:18.969266
NCT00434590|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2011-03-08|2010-12-13||March 2007||2007-03-01|March 2011|2011-03-01|May 2008||2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients|Controlled, Randomized, Parallel Group Study to Assess Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients|Terminated||Phase 4|10|Actual|Novartis||2||The study has been stopped because of the lack of enrollment|f||||||||||||||2017-02-18 15:52:19.050225|2017-02-18 15:52:19.050225
NCT00434577|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2012-03-22||2012-03-09|February 2007||2007-02-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects|A Vaccination Study to Evaluate the Safety and Immune Response of the GSK Biologicals Zoster Vaccine, GSK1437173A, and to Compare 3 Dosages of GSK1437173A in Healthy Elderly Subjects, Aged 60 Years and Above|Completed||Phase 2|715|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-02-18 15:52:19.589192|2017-02-18 15:52:19.589192
NCT00434564|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2017-02-09|||August 2000||2000-08-01|February 2017|2017-02-01|May 2002||2002-05-01|||||Interventional|||Acute Chest Pain Treatment and Evaluation (ACTION) Study|A Randomised Trial on Early Stress Nuclear Scan for Patients Presented to the Emergency Department (ED) With Chest Pain But Non-diagnostic Electrocardiography-Acute Chest Pain Treatment and Evaluation (ACTION) Study|Completed||Phase 4|1690||Singapore General Hospital|||||f||||||||||||||2017-02-18 15:52:19.730987|2017-02-18 15:52:19.730987
NCT00434551|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-11|2009-03-25|||February 2005||2005-02-01|February 2007|2007-02-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Observational|MACCS||MACCS: Multicenter Australian CE in Patients With Suspected Crohn's Disease Study|Evaluation of Capsule Endoscopy in Patients With Suspected Small Bowel Crohn's Disease|Completed||N/A|119|Actual|Given Imaging Ltd.|||1||f||||f||||||||||2017-02-18 15:52:19.85613|2017-02-18 15:52:19.85613
NCT00434538|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-02-03|||February 2007||2007-02-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers|A Multicenter, Prospective, Randomized Comparison Study of BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers|Terminated||Phase 3|40|Actual|BioSyntech Canada Inc.||||Due to Sponsor's financial reasons|f||||f||||||||||2017-02-18 15:52:19.966378|2017-02-18 15:52:19.966378
NCT00434525|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-12-14|||January 2008||2008-01-01|August 2009|2009-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Laparoscopic Sleeve Gastrectomy With and Without Omentectomy|Metabolic Effects of Laparoscopic Sleeve Gastrectomy With or Without Omentectomy: Prospective Randomized Trial|Completed||Phase 3|30|Anticipated|North Texas Veterans Healthcare System||2|||f||||f||||||||||2017-02-18 15:52:20.089605|2017-02-18 15:52:20.089605
NCT00434512|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2011-10-27||2009-06-08|February 2007||2007-02-01|October 2011|2011-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers|A Dose-ranging Study to Compare the Safety and Immunogenicity of a Candidate HIV Vaccine 732461, Adjuvanted or Not, Administered According to a 0, 1 Month Schedule to Healthy Adult HIV Seronegative Volunteers.|Completed||Phase 2|180|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:52:20.20734|2017-02-18 15:52:20.20734
NCT00434499|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-10|2016-01-28|||February 2007||2007-02-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effect of EGCG on the Body's Response to Insulin|An Exploratory Study to Evaluate the Ability of Epigallocatechin Gallate to Simultaneously Improve Metabolic and Cardiovascular Actions of Insulin in Healthy and Obese Subjects|Withdrawn||Phase 2|0|Actual|University of Maryland||2||Not funded|f||||t||||||||||2017-02-18 15:52:20.316123|2017-02-18 15:52:20.316123
NCT00434486|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2007-09-10|||March 2007||2007-03-01|September 2007|2007-09-01|March 2007||2007-03-01|||||Interventional|||Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606|An Open-Label, Randomized, 2-Period Crossover Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606 Administered Orally to Healthy Subjects|Completed||Phase 1|24|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:52:20.431376|2017-02-18 15:52:20.431376
NCT00434473|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2014-01-30||2012-01-31|December 2006||2006-12-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome|IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome (Dose Escalation Study: Varespladib Infusion [A-001] for the Prevention of Acute Chest Syndrome in At-Risk Patients With Sickle Cell Disease and Vaso-occlusive Crisis)|Completed||Phase 2|30|Actual|Anthera Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:52:20.511786|2017-02-18 15:52:20.511786
NCT00434460|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2010-08-31|||April 2007||2007-04-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|||||Observational|ABATEVAP||Study of Knowledge Translation of Clinical Practice Guidelines for Ventilator Associated Pneumonia|Active Observational Study of the Adoption and Transfer of Clinical Practice Guidelines Through Education, for Ventilator Associated Pneumonia (ABATE VAP Study)|Completed||N/A|1320|Actual|Canadian Critical Care Trials Group|||1||f||||f||||||||||2017-02-18 15:52:20.623985|2017-02-18 15:52:20.623985
NCT00433277|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-02-08||||||February 2007|2007-02-01||||||||Interventional|||Autoimmunity in Retinitis Pigmentosa||Unknown status|Active, not recruiting|N/A|||Semmelweis University|||||f||||||||||||||2017-02-18 15:52:56.954517|2017-02-18 15:52:56.954517
NCT00434447|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2010-10-21|||December 2006||2006-12-01|October 2010|2010-10-01||||September 2009|Actual|2009-09-01||Interventional|||Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases|A Phase IV Study of Zoledronic Acid Therapy in Patients With Bone Metastases From Breast Cancer or Hormone Resistant Prostate Cancer, or Bone Involvement From Multiple Myeloma, Assessing Long-term Efficacy and Safety|Completed||Phase 4|73|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:52:20.744934|2017-02-18 15:52:20.744934
NCT00434434|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-11|2010-04-30|2010-02-17||October 2007||2007-10-01|April 2010|2010-04-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|AQUA||A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma|A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lyophilized and Aged Liquid Omalizumab in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma|Completed||Phase 2|61|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 15:52:20.863464|2017-02-18 15:52:20.863464
NCT00434421|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2015-06-05|2015-04-27||February 2007||2007-02-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|SCSS|All study participants who were initiated onto the initial placebo study treatment during the Preliminary Dosing Visit.|Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma|A Safety and Pilot Dosing Study for Sublingual-Oral Administration of Glycerinated German Cockroach Allergenic Extract in Pediatric and Adult Subjects With Cockroach Allergy and Perennial Allergic Rhinitis With or Without Asthma|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 15:52:21.36083|2017-02-18 15:52:21.36083
NCT00434408|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2011-08-09|||May 2007||2007-05-01|July 2007|2007-07-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Interventional|CHX||Impact of Umbilical Cord Cleansing With 4.0% Chlorhexidine on Neonatal Mortality|Impact of Umbilical Cord Cleansing With Chlorhexidine on Neonatal Mortality and Omphalitis in Rural Sylhet District of Bangladesh|Completed||Phase 3|28797|Anticipated|Johns Hopkins Bloomberg School of Public Health||3|||f||||f||||||||||2017-02-18 15:52:21.780109|2017-02-18 15:52:21.780109
NCT00434395|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2011-07-22|||March 2007||2007-03-01|July 2011|2011-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects|A Randomized, Double-Blind, Placebo- and Moxifloxacin (Open-Label)-Controlled, 4-Period Crossover Study of the Effects of a Single Dose of MOA-728 Infused Intravenously on Cardiac Repolarization in Healthy Subjects|Completed||Phase 1|||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 15:52:21.905433|2017-02-18 15:52:21.905433
NCT00434382|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2010-07-29|||October 2002||2002-10-01|February 2007|2007-02-01|December 2003||2003-12-01|||||Interventional|BEO||Neuronal Mechanisms of Sensory Processing During General Anesthesia|Neuronale Mechanismen Der Sensorischen Reizverarbeitung in Der Narkose|Unknown status|Active, not recruiting|N/A|768||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 15:52:21.988918|2017-02-18 15:52:21.988918
NCT00434369|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2008-04-18|||February 2006||2006-02-01|April 2008|2008-04-01||||||||Interventional|||5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients|A Multi-Center, Open-Label, Single-Arm Phase II Trial Assessing the Efficacy and Safety of Weekly Bolus Infusions of 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Advanced Breast Cancer Patients Who Failed Anthracycline and Taxane Chemotherapy Regimens|Unknown status|Active, not recruiting|Phase 2|31|Anticipated|Mast Therapeutics, Inc.|||||f||||||||||||||2017-02-18 15:52:22.093696|2017-02-18 15:52:22.093696
NCT00434356|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-11-17|2009-09-01||March 2007||2007-03-01|November 2009|2009-11-01||||May 2008|Actual|2008-05-01||Interventional|||A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)|A Multicenter, Phase II, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer|Terminated||Phase 2|46|Actual|Genentech, Inc.|Based on the early safety results from this study, further recruitment and treatment was halted. Insufficient efficacy data were available to perform all protocol-specified analyses and limited the interpretation of the analyses performed.|2||Based on data collected, the combination appeared to be poorly tolearated.|f||||||||||||||2017-02-18 15:52:22.196296|2017-02-18 15:52:22.196296
NCT00434343|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2010-03-02|||November 2006||2006-11-01|March 2010|2010-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|UPPCRN-RCT#1||Physical Therapy Trial for Pelvic Pain|A Pilot Feasibility Study of Physical Therapy for the Treatment of Urologic Pelvic Pain Syndromes|Completed||N/A|48|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 15:52:23.267555|2017-02-18 15:52:23.267555
NCT00434330|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2012-06-22|2012-04-26||December 2006||2006-12-01|June 2012|2012-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis|A Phase 2, Open-Label, Multi-Center, Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Peginesatide for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated With Epoetin|Completed||Phase 2|91|Actual|Affymax|Notable issues with some documentation occurred at some of the study sites. In general, overall results excluding the sites with issues were comparable to results based on the full population.|6|||f||||f||||||||||2017-02-18 15:52:23.375428|2017-02-18 15:52:23.375428
NCT00434317|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2012-08-06|||August 2005||2005-08-01|August 2012|2012-08-01||||April 2008|Actual|2008-04-01||Interventional|||Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases|A Multicenter, Open-label Study to Determine the Effect of iv. Zoledronic Acid on Pain and Quality of Life in Patients With Bone Metastases With or Without Skeletal Related Events (SRE) Resulting From Breast Cancer and Prostate Cancer|Completed||Phase 4|80|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:52:24.418854|2017-02-18 15:52:24.418854
NCT00434304|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2013-04-11|2009-11-16||April 2007||2007-04-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)|Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease - an Open-Label, Uncontrolled Study -|Completed||Phase 2|62|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:52:24.555396|2017-02-18 15:52:24.555396
NCT00429234|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2013-04-01|||January 2007||2007-01-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Gemcitabine and Dasatinib in Advanced Solid Tumors|Phase I Open-Labeled Trial of Gemcitabine and Dasatinib in Advanced Solid Tumors|Completed||Phase 1|54|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:54:31.924055|2017-02-18 15:54:31.924055
NCT00434291|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2009-11-23|||December 2006||2006-12-01|November 2009|2009-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia|A Randomized, Double-Blind, Comparative, Multi-Center Study of the Safety and Efficacy of TG-873870(Nemonoxacin) Versus Levofloxacin in Adult Patients With Community-Acquired Pneumonia (CAP)|Completed||Phase 2|264|Anticipated|TaiGen Biotechnology Co., Ltd.|||||f||||||||||||||2017-02-18 15:52:25.989964|2017-02-18 15:52:25.989964
NCT00434278|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-11|2010-10-18|2010-10-18||March 2007||2007-03-01|October 2010|2010-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease|Terminated||Phase 4|27|Actual|Genentech, Inc.|Because the study was terminated (for administrative reasons and infeasibility of enrollment), no conclusions can be made about the effect of Pulmozyme on exercise tolerance in this population.|2||This study was terminated for administrative reasons. There were no safety concerns.|f||||||||||||||2017-02-18 15:52:26.122005|2017-02-18 15:52:26.122005
NCT00434265|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2011-08-29|||March 2007||2007-03-01|January 2009|2009-01-01|August 2011|Actual|2011-08-01|||||Interventional|||Obesity, Physical Inactivity or Dietary Fat ?|OBESITY, PHYSICAL INACTIVITY OR DIETARY FAT ? Role of Physical Activity in the Trafficking of Dietary Fatty Acids Varying in Length and Saturation Degree.|Completed||N/A|12|Actual|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-02-18 15:52:26.485973|2017-02-18 15:52:26.485973
NCT00434252|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-11|2016-11-25|2011-03-29||February 2007||2007-02-01|November 2016|2016-11-01||||April 2009|Actual|2009-04-01||Interventional|BEAM||A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma|Completed||Phase 2|214|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 15:52:26.578197|2017-02-18 15:52:26.578197
NCT00434239|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-11|2013-01-08|||February 2007||2007-02-01|January 2013|2013-01-01|May 2014|Anticipated|2014-05-01|May 2011|Actual|2011-05-01||Interventional|||Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia|A Pilot Study of the Combination of Lenalidomide (Revlimid®) With Two Different Dose Levels of Short Term Administration of Recombinant Human Stem Cell Factor (rhSCF; Ancestim) for Myelodysplasia.|Unknown status|Active, not recruiting|Early Phase 1|25|Actual|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-02-18 15:52:27.588489|2017-02-18 15:52:27.588489
NCT00434226|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-11|2009-07-09|2009-07-09||March 2007||2007-03-01|July 2009|2009-07-01||||April 2008|Actual|2008-04-01||Interventional|||A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)|A Randomized, Controlled, Open-Label, Multicenter, Phase II Study of the Safety and Efficacy of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|56|Actual|Genentech, Inc.|Based on the early safety results from this study, Genentech halted further recruitment and discontinued treatment. Insufficient efficacy data was available to perform additional analyses and limited the interpretation of the analyses performed.|2||Based on data collected, the combination appeared to be poorly tolearated.|f||||||||||||||2017-02-18 15:52:27.718905|2017-02-18 15:52:27.718905
NCT00434213|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-12|2015-06-23|2009-02-04||January 2007||2007-01-01|June 2015|2015-06-01|July 2008|Actual|2008-07-01|August 2007|Actual|2007-08-01||Interventional|||Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA|A Phase IV, Multi-center, Open-label Study of DAYTRANA (Methylphenidate Transdermal System [MTS]) to Characterize the Dermal Reactions in Pediatric Patients Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD).|Completed||Phase 4|309|Actual|Noven Therapeutics||1|||f||||f||||||||||2017-02-18 15:52:28.451382|2017-02-18 15:52:28.451382
NCT00434200|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2007-02-09|||January 1998||1998-01-01|February 2007|2007-02-01|June 2000||2000-06-01|||||Interventional|RAPIT||Rheumatoid Arthritis Patients in Training|Interventional Study on the Effectiveness and Safety of Intensive Exercise in Patients With RA|Unknown status|Active, not recruiting|Phase 4|300||Leiden University Medical Center|||||f||||||||||||||2017-02-18 15:52:28.746813|2017-02-18 15:52:28.746813
NCT00434187|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-07-08|||August 2006||2006-08-01|July 2009|2009-07-01|October 2006||2006-10-01|||||Interventional|||Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects|An Ascending Multiple Dose Study of the Safety, Tolerability and Pharmacokinetics of ERB-041 Administered Orally to Healthy, Female Japanese Subjects|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:52:28.836492|2017-02-18 15:52:28.836492
NCT00434174|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2012-12-18|||December 2006||2006-12-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety of Everolimus and Pemetrexed in Lung Cancer Patients|A Phase I Study Investigating the Combination of Everolimus With Pemetrexed in Patients With Advanced Non Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy|Completed||Phase 1|48|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:52:28.912945|2017-02-18 15:52:28.912945
NCT00434161|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2015-03-10|2010-03-02||December 2006||2006-12-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma|A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin for Reduction in Severity of Oral Mucositis in Subjects With Multiple Myeloma Receiving Melphalan Followed by Autologous Blood Stem Cell Transplantation|Completed||Phase 3|281|Actual|Swedish Orphan Biovitrum||3|||f||||f||||||||||2017-02-18 15:52:29.03302|2017-02-18 15:52:29.03302
NCT00434148|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2016-02-05|2013-01-03||December 2006||2006-12-01|February 2016|2016-02-01|May 2014|Actual|2014-05-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease|A Randomized, Double-blind Study to Assess the Safety and Efficacy of Different Dose Levels of Pasireotide (SOM230) Subcutaneous (sc) Over a 6 Month Treatment Period in Patients With de Novo, Persistent or Recurrent Cushing's Disease|Completed||Phase 3|162|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:52:30.585219|2017-02-18 15:52:30.585219
NCT00432484|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2008-05-06|||May 2005||2005-05-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis|Lingzhi (Ganoderma Lucidum) and Sen Miao San Supplementation in Rheumatoid Arthritis(RA): An Animal Model and A Phase I Study|Completed||Phase 2|70|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-02-18 15:53:18.071473|2017-02-18 15:53:18.071473
NCT00434135|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-02-04|||May 2006||2006-05-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2007|Actual|2007-10-01||Interventional|ANGEL||Alimta and Gemcitabine in Non-Small Cell Lung Cancer|A Phase II Randomized Trial Assessing the Combination of Gemcitabine and Pemetrexed in the First Line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|180|Anticipated|Southern Italy Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 15:52:32.115971|2017-02-18 15:52:32.115971
NCT00434122|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2011-05-18|2009-01-19||March 2007||2007-03-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix|A Randomised, Assessor-blind, Parallel Groups, Multi-centre, Exploratory Study Assessing the Impact of Subcutaneous Administration of Degarelix 2.5 mg on Synchronisation of Follicle Cohort Compared to Placebo and Evaluating the Effects of Degarelix 2.5 mg Started in the Mid-luteal or Early Follicular Phase on Endometrial Receptivity Compared to a Fixed Gonadotrophin Releasing Hormone Antagonist Protocol in Oocyte Donors Undergoing Controlled Ovarian Hyperstimulation for Assisted Reproductive Technologies|Completed||Phase 2|85|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:52:32.246428|2017-02-18 15:52:32.246428
NCT00434109|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2012-09-07|2012-08-08||November 2006||2006-11-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization|Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization for Metastatic Gastrointestinal Neuroendocrine Tumors|Completed||Phase 2|39|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 15:52:32.782301|2017-02-18 15:52:32.782301
NCT00434096|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-07-17|||February 2007||2007-02-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)|A Randomized Double-blind, Placebo-controlled, Parallel-group, Fixed Single-dose Regimen (SR141716 20 mg), Multicenter Study to Assess the Efficacy and Safety of SR141716 in Obese Patients With Dyslipidemia.|Terminated||Phase 3|915|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||||||||||||2017-02-18 15:52:33.132832|2017-02-18 15:52:33.132832
NCT00434083|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2007-02-09|||July 2004||2004-07-01|February 2007|2007-02-01|January 2005||2005-01-01|||||Interventional|||To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches|A Double-Blind Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches|Completed||Phase 3|1200||POZEN|||||f||||||||||||||2017-02-18 15:52:33.243976|2017-02-18 15:52:33.243976
NCT00434070|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2017-01-24|||February 7, 2007||2007-02-07|February 7, 2013|2013-02-07|February 7, 2013||2013-02-07|||||Observational|||Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring|Comparison of the Development of Thymidine Analogue Mutations With CD4 Monitoring Alone Versus CD4 Monitoring Plus Viral Load Monitoring in Naive HIV-1 Individuals on First-Line Antiretroviral Therapy in Africa|Completed||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:52:33.337421|2017-02-18 15:52:33.337421
NCT00434057|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2012-02-10|2009-05-26||January 2007||2007-01-01|February 2012|2012-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Pigmented Skin Lesions With MelaFind(R) System|Evaluation of Pigmented Skin Lesions With MelaFind(R) System|Completed||Phase 3|1383|Actual|MELA Sciences, Inc.||1|||f||||f||||||||||2017-02-18 15:52:33.442027|2017-02-18 15:52:33.442027
NCT00434044|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2007-12-11|||February 2007||2007-02-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis|Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase III Study of Etanercept in the Treatment of Subjects With Ankylosing Spondylitis|Completed||Phase 3|150||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:52:33.781149|2017-02-18 15:52:33.781149
NCT00434031|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2012-07-27|||September 2007||2007-09-01|July 2012|2012-07-01||||||||Interventional|CETRA||CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer|Neoadjuvant Therapy With Trastuzumab and Docetaxel Followed by Trastuzumab, Caelyx (Liposomal Doxorubicin) and Cyclophosphamide in Operable or Locally Advanced Her-2 Positive Breast Cancer|Withdrawn||Phase 2|0|Actual|National Cancer Institute, Naples||||lack of enrollment|f||||||||||||||2017-02-18 15:52:33.884256|2017-02-18 15:52:33.884256
NCT00434018|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2015-04-24|2014-09-16||April 2008||2008-04-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional||One hundred thirty-eight veterans were recruited and randomly selected for group assignments.|Enhancing Indoor, Community, and Advanced Wheelchair Skills in Spinal Cord Injury (SCI)|Enhancing Indoor, Community, and Advanced Wheelchair Skills in SCI|Completed||Phase 2/Phase 3|138|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:52:33.985273|2017-02-18 15:52:33.985273
NCT00434005|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2013-01-14|||July 2008||2008-07-01|January 2013|2013-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effect of Diesel Exhaust Particulate Exposures on Endothelial Function in Humans|Effect of Diesel Exhaust Particulate Exposures on Endothelial Function in Humans - the Role of Oxidative Stress|Completed||N/A|24|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 15:52:34.548378|2017-02-18 15:52:34.548378
NCT00433992|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2010-02-22|||April 2006||2006-04-01|August 2007|2007-08-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Observational|||Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications|Effects of Thymidine Sparing Regimens on Mitochondrial Metabolism and Adipocyte Apoptosis|Completed||Phase 2|60|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood collection~   "|||2017-02-18 15:52:34.666045|2017-02-18 15:52:34.666045
NCT00433979|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2012-07-27|||February 2007||2007-02-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Study of Pharmacokinetics in HIV-infected Women|Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression on Combination Antiretroviral Therapy|Completed||N/A|88|Actual|Women's College Hospital|||1||f||||f||||||Samples Without DNA|"~     Blood samples will be drawn before and after antiretroviral drugs are taken for visits 1-3.~   "|||2017-02-18 15:52:34.75621|2017-02-18 15:52:34.75621
NCT00433784|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2012-08-20|||September 2004||2004-09-01|June 2008|2008-06-01|April 2006||2006-04-01|||||Interventional|||H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel|Evaluation of the Effect of the H2 Haplotype and CYP3As Polymorphisms on the Antiplatelet Response to Clopidogrel Given Before Elective Percutaneous Coronary Intervention|Completed||Phase 4|120||Hopital du Sacre-Coeur de Montreal|||||f||||||||||||||2017-02-18 15:52:40.380795|2017-02-18 15:52:40.380795
NCT00433966|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2016-01-12|||March 2005||2005-03-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|June 2008|Actual|2008-06-01||Interventional|||Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction|Dual Arm Factorial Randomized Trial in Patients w/ST Segment Elevation AMI to Compare the Results of Using Anticoagulation With Either Unfractionated Heparin + Routine GP IIb/IIIa Inhibition or Bivalirudin + Bail-out GP IIb/IIIa Inhibition; and Primary Angioplasty With Stent Implantation With Either a Slow Rate-release Paclitaxel-eluting Stent (TAXUS™) or Uncoated Bare Metal Stent (EXPRESS2™)|Completed||Phase 3|3604|Actual|Cardiovascular Research Foundation, New York||2|||f||||t||||||||||2017-02-18 15:52:37.521329|2017-02-18 15:52:37.521329
NCT00433953|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2013-02-18|||February 2007||2007-02-01|February 2013|2013-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients|Pharmacogenetics of Mycophenolic Acid in Kidney Transplant Patients|Terminated||Phase 1|44|Actual|Children's Hospital Medical Center, Cincinnati||1||No longer following patient and no plans to publish.|f||||||||||||||2017-02-18 15:52:37.654715|2017-02-18 15:52:37.654715
NCT00433940|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2013-01-23|||October 2006||2006-10-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|April 2008|Actual|2008-04-01||Observational|||Immune Suppression Of Infants Treated With Steroids|Immune Suppression of Infants Treated With Oral Corticosteroids for Infantile Hemangiomas: A Pilot Study|Completed||N/A|16|Actual|Medical College of Wisconsin|||1||f||||f||||||None Retained|"~     Collection of blood samples at each visit. Following laboratory testing, no samples were~     retained.~   "|||2017-02-18 15:52:37.750134|2017-02-18 15:52:37.750134
NCT00433927|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2014-03-13|||January 2007||2007-01-01|March 2014|2014-03-01|December 2016|Anticipated|2016-12-01|April 2014|Anticipated|2014-04-01||Interventional|||5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)|Multicenter Randomized Trial Evaluating FOLFIRI Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment of Metastatic Colorectal Cancer.|Unknown status|Active, not recruiting|Phase 3|568|Anticipated|Ludwig-Maximilians - University of Munich||2|||f||||||||||||||2017-02-18 15:52:37.856193|2017-02-18 15:52:37.856193
NCT00433914|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2015-03-05|2015-02-18||February 2007||2007-02-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional||Analysis was performed on all enrolled subjects.|Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants|A Phase 2, Single Blind, Single Center, Randomized Study of the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine +/- OMV, When Administered to Healthy Infants 6-8 Months Old|Completed||Phase 2|60|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:52:37.971324|2017-02-18 15:52:37.971324
NCT00433901|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2010-07-16|||November 2004||2004-11-01|July 2010|2010-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Family Connections Weight Management|Managing Weight in Overweight and At-Risk Children|Completed||N/A|220||Kaiser Permanente|||||f||||||||||||||2017-02-18 15:52:38.945341|2017-02-18 15:52:38.945341
NCT00433888|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-01-29|||January 2007||2007-01-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)|Clinical Study of Switching From rHuEPO to R744 and Maintenance Treatment With R744 in Renal Anemia Patients on Hemodialysis (Phase Ⅲ Study)|Completed||Phase 3|179|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 15:52:39.06377|2017-02-18 15:52:39.06377
NCT00433875|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2007-12-20|||December 2002||2002-12-01|December 2007|2007-12-01||||||||Interventional|||Phase 2 AMG 714 in Rheumatoid Arthritis|A Double-Blind, Placebo Controlled, Randomized, Parallel-Group Clinical Trial With Multiple Dose Treatment of Anti-IL 15 Human Monoclonal Antibody (AMG 714) in Patients With Active Rheumatoid Arthritis Who Have Previously Failed One or More Disease Modifying Anti-Rheumatic Drugs|Completed||Phase 2|180||Amgen|||||||||||||||||||2017-02-18 15:52:39.179207|2017-02-18 15:52:39.179207
NCT00433862|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2017-01-24|||February 6, 2007||2007-02-06|May 19, 2010|2010-05-19|May 19, 2010||2010-05-19|||||Observational|||Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders|Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders|Completed||N/A|8|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:52:39.256505|2017-02-18 15:52:39.256505
NCT00433849|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2009-01-29|||February 2007||2007-02-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Study of R744 to Peritoneal Dialysis Patients|Switch and Maintenance Study of Subcutaneous or Intravenous Injections of R744 to Peritoneal Dialysis Patients (Phase Ⅲ Study)|Completed||Phase 3|72|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 15:52:39.338696|2017-02-18 15:52:39.338696
NCT00433836|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2011-04-19|2010-12-08||January 2007||2007-01-01|April 2011|2011-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure|A Multicenter, Randomized, Double-blind, Parallel-group, Evaluation of 12 Weeks of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children 6 to 17 Years of Age With Hypertension|Completed||Phase 3|300|Actual|Novartis||6|||f||||||||||||||2017-02-18 15:52:39.437919|2017-02-18 15:52:39.437919
NCT00433823|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2007-02-09|||January 2007||2007-01-01|February 2007|2007-02-01|January 2008||2008-01-01|||||Interventional|||A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis|A Multicenter, Open Labeled, Cross-Over Designed Prospective Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis|Unknown status|Recruiting|Phase 4|||Abant Izzet Baysal University|||||f||||||||||||||2017-02-18 15:52:39.837475|2017-02-18 15:52:39.837475
NCT00433810|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2010-12-23|||March 2005||2005-03-01|December 2010|2010-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|LABS-1||Longitudinal Assessment of Bariatric Surgery|Longitudinal Assessment of Bariatric Surgery (LABS-1)|Completed||N/A|5102|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 15:52:39.928996|2017-02-18 15:52:39.928996
NCT00433797|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2013-12-18|||June 2007||2007-06-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|March 2012|Actual|2012-03-01||Interventional|||Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients|Prostate Phytochemical & PUFA Intervention - a Phase I/II Study|Completed||Phase 1/Phase 2|86|Actual|University of Oslo||3|||f||||f||||||||||2017-02-18 15:52:40.263244|2017-02-18 15:52:40.263244
NCT00342251|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 20, 2003||2003-06-20|April 4, 2012|2012-04-04|April 4, 2012||2012-04-04|||||Observational|||Investigating Age-Related Macular Degeneration|Age-Related Macular Degeneration: A Genetic Epidemiology Study in the Amish|Completed||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.489951|2017-02-18 16:27:21.489951
NCT00433771|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2010-06-21|2009-09-25||March 2007||2007-03-01|June 2010|2010-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction|A Multi-Center, Single Arm, Prospective Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction|Completed||Phase 3|74|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 15:52:40.487772|2017-02-18 15:52:40.487772
NCT00433758|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2008-03-17|||December 2006||2006-12-01|September 2007|2007-09-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Evaluation of the GlucoTrack, Non-Invasive Glucose Monitoring Device|Evaluation of the Performance and Use of the GlucoTrack(TM), Non-Invasive Glucose Monitoring Device|Unknown status|Active, not recruiting|N/A|142|Anticipated|Integrity Applications Ltd.||1|||f||||t||||||||||2017-02-18 15:52:40.913152|2017-02-18 15:52:40.913152
NCT00433745|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2014-06-05|2013-04-30||February 2007||2007-02-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy|Wilm's Tumor 1 (WT1) Peptide Vaccination for Patients With High Risk Hematological Malignancies|Completed||Phase 2|4|Actual|National Institutes of Health Clinical Center (CC)|"Although there was one partial response at 7 weeks, this patient went on to relapse as well.~Consequently, all 4 patients had rapid relapses despite vaccination. Accrual was stopped at 4."|1|||f||||t||||||||||2017-02-18 15:52:41.010411|2017-02-18 15:52:41.010411
NCT00433732|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2007-02-09|||August 2004||2004-08-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches|A Double-Blind, Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy Opf Trexima in the Acute Treatment of Migraine Headaches|Completed||Phase 3|1400||POZEN|||||f||||||||||||||2017-02-18 15:52:41.261935|2017-02-18 15:52:41.261935
NCT00433719|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-08-06|||September 2005||2005-09-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis|Randomised Controlled Trial of Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis|Unknown status|Active, not recruiting|N/A|253|Actual|University of Oxford||2|||f||||t||||||||||2017-02-18 15:52:41.35565|2017-02-18 15:52:41.35565
NCT00433706|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2016-12-12|||June 2007||2007-06-01|December 2016|2016-12-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||Image Guided Radiation Therapy For Prostate Cancer|Economic Evaluation of Image Guided Radiation Therapy For Prostate Cancer|Completed||Phase 3|470|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||||||||||||2017-02-18 15:52:41.468321|2017-02-18 15:52:41.468321
NCT00433693|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-01-29|||February 2007||2007-02-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|March 2008|Actual|2008-03-01||Interventional|||Correction Study of R744 in Renal Anemia Patients on Hemodialysis|Correction Study of Intravenous Injections of R744 to Hemodialysis Patients ( Phase Ⅲ Study ).|Completed||Phase 3|50|Actual|Chugai Pharmaceutical||1|||f||||f||||||||||2017-02-18 15:52:41.566692|2017-02-18 15:52:41.566692
NCT00433680|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2014-04-07|||March 2007||2007-03-01|April 2014|2014-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Targeted Obesity Prevention Program for Adolescent Females|Targeted Obesity Prevention Program for Adolescent Females|Completed||N/A|405|Anticipated|Oregon Research Institute||1|||f||||t||||||||||2017-02-18 15:52:41.67617|2017-02-18 15:52:41.67617
NCT00433667|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2012-06-15|||November 2006||2006-11-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.|Epilepsy Phase III Trial|Completed||Phase 3|563|Actual|SK Life Science|||||||||||||||||||2017-02-18 15:52:41.782728|2017-02-18 15:52:41.782728
NCT00433654|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2011-10-17|2011-01-11||February 2007||2007-02-01|July 2011|2011-07-01|August 2010|Actual|2010-08-01|November 2008|Actual|2008-11-01||Interventional|||EMRI SureScan™ Clinical Study|EnRhythm MRI™ SureScan™ Pacing System Clinical Investigation|Completed||N/A|484|Actual|Medtronic Cardiac Rhythm and Heart Failure|Comparisons with a historical control (5076 Lead) were performed for secondary objectives #11-#16, however the results database is currently only designed to allow for reporting of participants specifically enrolled as part of this protocol.|2|||f||||t||||||||||2017-02-18 15:52:41.888879|2017-02-18 15:52:41.888879
NCT00433641|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2011-03-10|||July 2006||2006-07-01|March 2011|2011-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes|Pharmacogenomics of Weight Loss With Sibutramine in Obese and Overweight Patients|Completed||Phase 4|181|Actual|Mayo Clinic||3|||f||||f||||||||||2017-02-18 15:52:43.392621|2017-02-18 15:52:43.392621
NCT00433628|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2017-01-24|||February 7, 2007||2007-02-07|August 25, 2009|2009-08-25||||November 12, 2008|Actual|2008-11-12||Observational|||Accuracy of Hemoglobin A1C to Predict Glycemia in HIV|Accuracy of Hemoglobin A1C to Predict Glycemia in HIV|Completed||N/A|175||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:52:43.512229|2017-02-18 15:52:43.512229
NCT00433615|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-09|2009-01-29|||February 2007||2007-02-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Clinical Study of R744 to Predialysis Patients|Switch and Maintenance Study of Subcutaneous or Intravenous Injections of R744 to Predialysis Patients ( Phase Ⅲ Study ).|Completed||Phase 3|124|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 15:52:43.587026|2017-02-18 15:52:43.587026
NCT00433602|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2013-06-11|||November 2006||2006-11-01|June 2013|2013-06-01||||March 2007|Actual|2007-03-01||Observational|||Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors|TEACH Survey (Thrombo-Embolism And Chemotherapy) A Prospective Survey on the Incidence of Venous Thromboembolic Events During Chemotherapy for Solid Tumors|Completed||N/A|64|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 15:52:43.701598|2017-02-18 15:52:43.701598
NCT00433589|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2016-07-06|||December 2006||2006-12-01|July 2016|2016-07-01||||March 2020|Anticipated|2020-03-01||Interventional|MINDACT||Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes|MINDACT (Microarray In Node-Negative and 1 to 3 Positive Lymph Node Disease May Avoid Chemotherapy): A Prospective, Randomized Study Comparing the 70-Gene Signature With the Common Clinical-Pathological Criteria in Selecting Patients for Adjuvant Chemotherapy in Breast Cancer With 0 to 3 Positive Nodes|Active, not recruiting||Phase 3|6600|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 15:52:43.810382|2017-02-18 15:52:43.810382
NCT00433576|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2014-09-12|||December 2006||2006-12-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery|Phase I Repeat-Dose Study of Resveratrol in Colorectal Cancer Patients: Tolerability, Target Tissue Levels and Pharmacodynamics|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:52:43.933684|2017-02-18 15:52:43.933684
NCT00433563|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2016-12-07|||April 2008||2008-04-01|December 2016|2016-12-01|February 2019|Anticipated|2019-02-01|February 2016|Actual|2016-02-01||Interventional|CONVERT||Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer|A 2-Arm Randomized Controlled Trial of Concurrent Chemo-Radiotherapy Comparing Twice-Daily and Once-Daily Radiotherapy Schedules in Patients With Limited Stage Small Cell Lung Cancer (SCLC) and Good Performance Status [CONVERT]|Active, not recruiting||Phase 3|547|Actual|The Christie NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 15:52:44.042273|2017-02-18 15:52:44.042273
NCT00433550|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2016-08-12|||May 2007||2007-05-01|August 2016|2016-08-01||||December 2014|Actual|2014-12-01||Interventional|||Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer|A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma|Active, not recruiting||Phase 2|33|Anticipated|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-02-18 15:52:44.148641|2017-02-18 15:52:44.148641
NCT00433537|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2014-10-24|2014-10-24||May 2007||2007-05-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional||All eligible patients who received VcR-CVAD induction.|Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma|A Phase II Study of VcR-CVAD With Rituximab Maintenance for Untreated Mantle Cell Lymphoma|Completed||Phase 2|77|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 15:52:44.599528|2017-02-18 15:52:44.599528
NCT00433524|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2010-02-11|||April 2003||2003-04-01|February 2010|2010-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest|Evaluation of Esophageal Motion by Computed Tomography (CT) During the Course of Thoracic Radiotherapy|Completed||N/A|30|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 15:52:45.130094|2017-02-18 15:52:45.130094
NCT00433511|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2016-09-30|||December 2009||2009-12-01|June 2016|2016-06-01||||September 2016|Anticipated|2016-09-01||Interventional|||Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer|A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer|Active, not recruiting||Phase 3|4950|Anticipated|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 15:52:45.252205|2017-02-18 15:52:45.252205
NCT00433498|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2014-12-01|||January 2007||2007-01-01|January 2013|2013-01-01|November 2013|Actual|2013-11-01|January 2012|Actual|2012-01-01||Interventional|||Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer|A Multicentre Phase III Randomized Double Blind Placebo Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Patients With Small Lung Cancer|Completed||Phase 3|846|Actual|University College, London||2|||f||||t||||||||||2017-02-18 15:52:46.868512|2017-02-18 15:52:46.868512
NCT00433485|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2016-09-21||||||September 2016|2016-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants|In Vivo and In Vitro Pharmacology of Sirolimus in Subjects With Basal Cell Nevus Syndrome|Completed||Phase 1|16|Anticipated|Yale University|||||f||||||||||||||2017-02-18 15:52:47.050518|2017-02-18 15:52:47.050518
NCT00433472|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2015-07-27||||||July 2015|2015-07-01||||||||Interventional|||MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806|Effect of RSR13 on T2 and T2* Cranial MRI Images: An Imaging Companion Study to NABTT 9806|Withdrawn||N/A|0|Actual|Sidney Kimmel Comprehensive Cancer Center||1||not enough interest|f||||||||||||||2017-02-18 15:52:47.143365|2017-02-18 15:52:47.143365
NCT00433459|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2015-11-17|||January 2007||2007-01-01|November 2015|2015-11-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma|First International Inter-Group Study for Classical Hodgkin's Lymphoma in Children and Adolescents|Completed||Phase 3|2134|Actual|Martin-Luther-Universität Halle-Wittenberg||2|||f||||t||||||||||2017-02-18 15:52:47.241532|2017-02-18 15:52:47.241532
NCT00433446|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2013-01-02|2012-11-09||April 2007||2007-04-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|May 2009|Actual|2009-05-01||Interventional|||S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Study of CNTO 328, A Monoclonal Antibody Against Interleukin-6 (IL-6), in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|62|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 15:52:47.481219|2017-02-18 15:52:47.481219
NCT00433433|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2014-06-13|||October 2006||2006-10-01|June 2014|2014-06-01||||December 2011|Actual|2011-12-01||Interventional|H10||Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma|The H10 EORTC/GELA/IIL Randomized Intergroup Trial on Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients With Supradiaphragmatic Stage I/II Hodgkin's Lymphoma|Completed||Phase 3|1952|Actual|European Organisation for Research and Treatment of Cancer - EORTC||6|||f||||t||||||||||2017-02-18 15:52:48.227579|2017-02-18 15:52:48.227579
NCT00433420|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2013-08-01|||April 2003||2003-04-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer|A Phase III Randomized Study of EC Followed by Paclitaxel Versus FEC Followed by Paclitaxel, All Given Either Every 3 Weeks or 2 Weeks Supported by Pegfilgrastim, for Node Positive Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:52:48.357406|2017-02-18 15:52:48.357406
NCT00433407|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2012-10-03|||August 2005||2005-08-01|October 2012|2012-10-01||||February 2006|Actual|2006-02-01||Interventional|||T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors|A Study to Assess HER2-Specific T Cell Responses in Patients Receiving Trastuzumab for Solid Tumor Treatment|Completed||N/A|12|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 15:52:48.448751|2017-02-18 15:52:48.448751
NCT00433381|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2014-05-07|2013-03-14||March 2007||2007-03-01|November 2012|2012-11-01|February 2011|Actual|2011-02-01|January 2010|Actual|2010-01-01||Interventional|||Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma|A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma|Completed||Phase 2|123|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 15:52:48.6878|2017-02-18 15:52:48.6878
NCT00433368|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2007-02-08|||October 2003||2003-10-01|February 2007|2007-02-01|September 2004||2004-09-01|||||Interventional|||Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy|Efficacy of a Three Days’ Infusion of L-Ornithine-L-Aspartate as an Adjuvant Therapy in Cirrhotic Patients With Overt Hepatic Encephalopathy: A Placebo Controlled Study|Completed||Phase 3|108||Aga Khan University|||||f||||||||||||||2017-02-18 15:52:49.543708|2017-02-18 15:52:49.543708
NCT00433355|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2009-03-18|||January 2007||2007-01-01|March 2009|2009-03-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Observational|||Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome|Studies on Epstein-Barr Virus as a Possible Etiological Agent for Chronic Fatigue Syndrome|Completed||N/A|15|Actual|University of Mississippi Medical Center|||1||f||||t||||||||||2017-02-18 15:52:49.748327|2017-02-18 15:52:49.748327
NCT00433342|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2011-09-14|||March 2006||2006-03-01|September 2011|2011-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients|Study on the Effect of Flucloxacillin on the Serum Level of P-cresol in Peritoneal Dialysis Patients|Suspended||Phase 1|10|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-02-18 15:52:49.830387|2017-02-18 15:52:49.830387
NCT00433329|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2013-05-30|2013-03-27||March 2007||2007-03-01|May 2013|2013-05-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|COMPASS 3||Combination Therapy in Pulmonary Arterial Hypertension|COMPASS 3: An Open-label, Multi-Center Study Employing a Targeted 6-Minute Walk Test (6-MWT) Distance Threshold Approach to Guide Bosentan-Based Therapy and to Assess the Utility of Magnetic Resonance Imaging (MRI) on Cardiac Remodeling|Completed||Phase 4|100|Actual|Actelion||1|||f||||||||||||||2017-02-18 15:52:49.936973|2017-02-18 15:52:49.936973
NCT00433316|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2008-06-19|||February 2007||2007-02-01|February 2007|2007-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy|Pain Relief by Continuous Intra-Peritoneal Nebulization of Ropivacaine During Gynecological Laparoscopic Surgery|Completed||Phase 3|40|Actual|Carmel Medical Center||2|||f||||f||||||||||2017-02-18 15:52:50.24183|2017-02-18 15:52:50.24183
NCT00433303|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2007-02-08||||||February 2007|2007-02-01||||||||Observational|||Correlation Between Coital Activity During Pregnancy and Premature Delivery Related to Prostanoid Receptor Polymorphisms|Correlation Between Coital Activity During Pregnancy and Premature Delivery Related to Prostanoid Receptor Polymorphisms|Unknown status|Not yet recruiting|N/A|||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 15:52:50.350532|2017-02-18 15:52:50.350532
NCT00433290|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2009-08-26|2009-04-30||February 2007||2007-02-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain|Protocol F1J-MC-HMFG Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain|Completed||Phase 3|256|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:52:50.612956|2017-02-18 15:52:50.612956
NCT00432250|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-02-06|||January 2002||2002-01-01|February 2007|2007-02-01|April 2005||2005-04-01|||||Interventional|||The Use of Cervical Length to Reduce Hospital Stay in Women Admitted Because of Preterm Labor.||Completed||Phase 4|150||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 15:52:52.262762|2017-02-18 15:52:52.262762
NCT00432237|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2015-06-08|2010-07-19||March 2007||2007-03-01|June 2015|2015-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)|A Phase III, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Oral MK0974 in the Acute Treatment of Migraine With or Without Aura|Completed||Phase 3|1703|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 15:52:52.356685|2017-02-18 15:52:52.356685
NCT00431223|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2015-04-14|||September 2006||2006-09-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|fMRI||Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training|Does Computerized Cognitive Skills Training Change Brain Activation Patterns in Schizophrenia?|Completed||N/A|11|Actual|Manhattan Psychiatric Center||2|||f||||t||||||||||2017-02-18 15:52:53.401227|2017-02-18 15:52:53.401227
NCT00431210|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2016-08-10|||February 2007||2007-02-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|June 2017|Anticipated|2017-06-01||Interventional|||Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma|A Pilot Feasibility Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma|Active, not recruiting||N/A|10|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||No|There are no plans to share IPD. Cumulative results will be posted and published.|2017-02-18 15:52:53.512768|2017-02-18 15:52:53.512768
NCT00431197|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2010-01-26|||February 2004||2004-02-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men|Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men|Completed||Phase 1|40|Anticipated|Mayo Clinic|||||||||||||||||||2017-02-18 15:52:53.611906|2017-02-18 15:52:53.611906
NCT00431184|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2014-08-05|2014-06-19||January 2007||2007-01-01|August 2014|2014-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effects of Pentazocine Versus Lorazepam on Manic Symptoms|Effects of Pentazocine Versus Lorazepam on Manic Symptoms|Completed||Phase 2|19|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 15:52:53.705472|2017-02-18 15:52:53.705472
NCT00431171|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2012-01-13|||September 2007||2007-09-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury|A Three Month, Open-label, Single-arm Trial Evaluating the Safety and Pharmacokinetics of Oral Lithium in Patients Diagnosed With Chronic Spinal Cord Injury|Completed||Phase 1|20|Anticipated|The University of Hong Kong|||||f||||||||||||||2017-02-18 15:52:54.167277|2017-02-18 15:52:54.167277
NCT00431158|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2014-09-17|||January 2007||2007-01-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||ARDSnet Protocol vs. Open Lung Approach in ARDS|ARDSnet Protocol vs. the Open Lung Approach for the Ventilatory Management of Severe, Established ARDS: A Global Randomized Controlled Trial|Completed||N/A|224|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 15:52:54.269003|2017-02-18 15:52:54.269003
NCT00431145|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-02-01|||October 2006||2006-10-01|February 2007|2007-02-01||||||||Interventional|||Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)|Influence of Combined Therapy of Niacin and Statins on Stem Cell Mobilization and Inflammatory Parameters in Patients Suffering From Coronary Artery Disease – Randomized Clinical Study -|Unknown status|Recruiting|Phase 2|80||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 15:52:54.379531|2017-02-18 15:52:54.379531
NCT00431132|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2016-05-13|2011-02-07||January 2007||2007-01-01|May 2016|2016-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis|A 12 Month, Open-label, Multi-center Trial to Investigate the Endometrial Safety of Vagifem Low Dose (10ug 17beta-estradiol Vaginal Tablet) in Postmenopausal Women With Atrophic Vaginitis Symptoms|Completed||Phase 3|336|Actual|Novo Nordisk A/S|This was a single-arm, 12-month, open label, multicentre trial; therefore there were no comparator results available.|1|||f||||f||||||||||2017-02-18 15:52:54.473392|2017-02-18 15:52:54.473392
NCT00431119|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2007-02-02|||October 1997||1997-10-01|February 2007|2007-02-01|October 2000||2000-10-01|||||Interventional|||Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid|A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Bullous Pemphigoid|Completed||Phase 2|70||University Hospital Muenster|||||f||||||||||||||2017-02-18 15:52:54.760359|2017-02-18 15:52:54.760359
NCT00431106|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2009-09-25|||April 2002||2002-04-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer|A Multicenter Randomized Phase III Study of Combination Treatment With Vinorelbine and Gemcitabine Versus Capecitabine Monotherapy in Metastatic Breast Cancer Patients Following Treatment Failure With the Combination of a Taxane and an Anthracycline|Completed||Phase 3|144|Anticipated|Hellenic Oncology Research Group||2|||f||||||||||||||2017-02-18 15:52:55.046941|2017-02-18 15:52:55.046941
NCT00431093|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2015-06-03|||November 2002||2002-11-01|June 2015|2015-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|TOTAL||Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)|A Multicenter, Randomized, Double-Blind, Double Dummy, Group-Comparative Trial to Compare the Effects of Livial® and Activelle ® on the Vaginal Bleeding Pattern, Vasomotor Complaints, Vaginal Atrophy, QoL and Sexual Function|Completed||Phase 4|570|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:52:55.18637|2017-02-18 15:52:55.18637
NCT00431080|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2008-01-18|||August 2004||2004-08-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer|A Multicenter Randomized Study Comparing the Dose Dense, G-CSF-Supported Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Women With Axillary Lymph Node Positive Breast Cancer|Completed||Phase 3|478|Actual|Hellenic Oncology Research Group||2|||f||||||||||||||2017-02-18 15:52:55.284246|2017-02-18 15:52:55.284246
NCT00431067|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2014-06-03|2013-08-08||September 2006||2006-09-01|November 2013|2013-11-01||||August 2009|Actual|2009-08-01||Interventional|||Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy|Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy|Completed||Phase 2|41|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-02-18 15:52:55.432243|2017-02-18 15:52:55.432243
NCT00431054|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2016-02-17|||February 2007||2007-02-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer|Pharmacodynamic Trial: Molecular Marker & Imaging Studies as Primary Endpoints to Determine Optimal Biological Dosage of Perifosine, Orally Avail AKT PH Domain Inhibitor Combined w/ Docetaxel in Patients w/Relapsed Epithelial Ovarian Cancer|Completed||Phase 1|22|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:52:55.75895|2017-02-18 15:52:55.75895
NCT00431041|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2010-06-01|2009-10-05||December 2006||2006-12-01|June 2010|2010-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|VECTOR||Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)|VECTOR: A Randomized Double-blind Study to Assess the Safety and Efficacy of Solifenacin (Vesicare®) in Comparison to Oxybutynin for Overactive Bladder Patients|Completed||Phase 4|132|Actual|Astellas Pharma Inc|The relatively high incidence of AEs, specifically dry mouth, in both groups may be a result of the direct questioning methodology used. Subjects were also informed the primary objectives were the relative frequency and severity of dry mouth.|2|||f||||f||||||||||2017-02-18 15:52:55.882813|2017-02-18 15:52:55.882813
NCT00431028|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2008-03-06|||September 2005||2005-09-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery|Phase I/II Comparative Study of a Single Intraoperative Sub-Tenon's Capsule Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System Versus 1% Prednisolone and 0.3% Ciprofloxacin Eyedrops for Cataract Surgery|Terminated||Phase 1/Phase 2|140|Actual|Federal University of São Paulo||1||Terminated|f||||t||||||||||2017-02-18 15:52:56.496477|2017-02-18 15:52:56.496477
NCT00431015|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2012-12-06||2012-12-06|January 2007||2007-01-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)|A Phase I/II Study to Investigate the Safety, Tolerability and Potential Activity of IPI-504 in Relapsed and / or Refractory Stage IIIb (With Malignant Pleural or Pericardial Effusion), or Stage IV NSCLC Patients|Completed||Phase 1/Phase 2|88|Actual|Infinity Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 15:52:56.620978|2017-02-18 15:52:56.620978
NCT00431002|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2013-03-26||||||March 2013|2013-03-01|September 2008||2008-09-01|||||Interventional|||Provincial Roll-Out Bone Health Strategy||Withdrawn||N/A|0|Actual|University of British Columbia||1||Withdrawn|f||||f||||||||||2017-02-18 15:52:56.727653|2017-02-18 15:52:56.727653
NCT00430989|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2013-09-24|||April 2007||2007-04-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial|Large, Randomised, Parallel-group, Controlled Trial, With Patients Randomly Allocated to Either N2O-containing (70% N2O in Oxygen [FiO2 0.3]) or N2O-free (70% Nitrogen in Oxygen [FiO2 0.3]).|Completed||Phase 4|7103|Actual|Bayside Health||2|||f||||t||||||||||2017-02-18 15:52:56.832706|2017-02-18 15:52:56.832706
NCT00433264|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2009-03-04|||February 2007||2007-02-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|INVEST-PD||The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis|The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis|Completed||Early Phase 1|62|Actual|Universitaire Ziekenhuizen Leuven|||1||f||||t||||||Samples With DNA|"~     serum, plasma, DNA~   "|||2017-02-18 15:52:57.041422|2017-02-18 15:52:57.041422
NCT00433238|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2007-02-07|||March 2007||2007-03-01|February 2007|2007-02-01||||||||Interventional|||Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors|Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors - a Feasibility Study|Unknown status|Not yet recruiting|Phase 1|100||Mount Sinai Hospital, Canada|||||f||||||||||||||2017-02-18 15:52:57.128862|2017-02-18 15:52:57.128862
NCT00433225|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2007-09-05||||||September 2007|2007-09-01||||||||Interventional|||Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 15:52:57.213946|2017-02-18 15:52:57.213946
NCT00433212|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2014-12-03|||April 2007||2007-04-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|NIPPV||Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV)|Efficacy and Safety of NIPPV to Increase Survival Without Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants|Completed||Phase 3|1011|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 15:52:57.301608|2017-02-18 15:52:57.301608
NCT00433199|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2015-01-15|2011-05-27||February 2007||2007-02-01|November 2011|2011-11-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01||Interventional|||Testosterone Treatment for Hypogonadal Men|A Multi-Center, Randomized, Double-Blind,Placebo-Controlled Efficacy and Safety Study of Testosterone Gel 1.62% for the Treatment of Hypogonadal Men|Completed||Phase 3|274|Actual|Abbott||2|||f||||||||||||||2017-02-18 15:52:57.450225|2017-02-18 15:52:57.450225
NCT00433186|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2011-03-29|||March 2006||2006-03-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Mycophenolate Mofetil in Systemic Sclerosis|Phase I, Open-label Study of Mycophenolate Mofetil In Systemic Sclerosis|Completed||Phase 1|30|Anticipated|Boston University||1|||f||||||||||||||2017-02-18 15:52:57.948951|2017-02-18 15:52:57.948951
NCT00433173|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2010-03-01|||May 2006||2006-05-01|March 2010|2010-03-01|March 2011|Anticipated|2011-03-01|February 2011|Anticipated|2011-02-01||Interventional|||Insulin Sensitivity in Men With the Metabolic Syndrome|Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome|Suspended||N/A|72|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3||Primary investigator is taking a leave of absence|f||||t||||||||||2017-02-18 15:52:58.174193|2017-02-18 15:52:58.174193
NCT00433160|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2010-09-14|2009-08-17||January 2007||2007-01-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Phase 3 Clinical Trial of Teriparatide in Japan|Efficacy and Safety of LY333334 in Japanese Patients With Osteoporosis|Completed||Phase 3|207|Actual|Eli Lilly and Company|Original data presented were for the 52-week double-blinded treatment phase; results of the open label phases at 76 weeks and 104 weeks have now been added|2|||f||||||||||||||2017-02-18 15:52:58.330165|2017-02-18 15:52:58.330165
NCT00433147|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2010-08-17||2010-08-17|February 2007||2007-02-01|August 2010|2010-08-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Safety Study of AT2101 in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy|A Randomized, Open-label Study to Assess the Safety and Tolerability of Multiple Dose Levels and Multiple Dosing Regimens of AT2101 in Adult Patients With Type 1 Gaucher Disease Currently Receiving ERT|Completed||Phase 2|32|Anticipated|Amicus Therapeutics||4|||f||||f||||||||||2017-02-18 15:52:59.811209|2017-02-18 15:52:59.811209
NCT00433134|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2009-04-23|||June 2006||2006-06-01|April 2009|2009-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients|Survey Investigation of Adherence to Immunosuppression and Other Medications Among Kidney Transplant Recipients at SUNY Downstate|Completed||N/A|100|Anticipated|State University of New York - Downstate Medical Center|||1||f||||f||||||||||2017-02-18 15:53:02.485922|2017-02-18 15:53:02.485922
NCT00433121|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-08-23|||September 2006||2006-09-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD|Discontinuation of Antipsychotics and Antidepressants Among Patients With Dementia and BPSD Living in Nursing Homes - an Open Study.|Completed||Phase 4|24|Actual|Sykehuset Innlandet HF||1|||f||||f||||||||||2017-02-18 15:53:02.590597|2017-02-18 15:53:02.590597
NCT00433108|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2008-08-12|||March 2007||2007-03-01|August 2008|2008-08-01|November 2007|Actual|2007-11-01|||||Interventional|||Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C|A Double-Blind, Parallel, Randomized Comparison of Two Doses of MitoQ and Placebo for the Treatment of Patients With Raised Liver Enzymes Due to Hepatitis C|Completed||Phase 2|30|Actual|Antipodean Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 15:53:02.710913|2017-02-18 15:53:02.710913
NCT00433095|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2011-03-11||||||February 2007|2007-02-01||||||||Interventional|||Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer||Completed||Phase 2|||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 15:53:02.811212|2017-02-18 15:53:02.811212
NCT00433082|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2007-02-08|||August 2006||2006-08-01|February 2007|2007-02-01|November 2006||2006-11-01|||||Interventional|||Metabolic Syndrome and Inflammatory Markers|Effect of Fasting With Two Meals on Inflammatory Markers of Metabolic Syndrome|Completed||N/A|||Free Islamic University of Medical Sciences|||||f||||||||||||||2017-02-18 15:53:02.917941|2017-02-18 15:53:02.917941
NCT00433069|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2015-05-27|||January 2007||2007-01-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone|A Pilot Study of Treatment With Pegylated Interferon-Alpha2a, Ribavirin and Insulin Sensitizer Pioglitazone of Insulin Resistance (With the Exception of Diabetes) in Hepatitis C Virus Infection (The INSPIRED HCV Study)|Completed||Phase 2|5|Actual|University Hospital, Geneva||1|||f||||f||||||||||2017-02-18 15:53:02.998301|2017-02-18 15:53:02.998301
NCT00433056|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2008-04-24|||January 2004||2004-01-01|April 2008|2008-04-01||||||||Interventional|||Long Term Treatment Interruptions|Strategic, Long Term, Immunologically Driven Treatment Interruptions in Patients on Effective HAART: A Controlled, Randomized Study|Completed||Phase 3|320|Anticipated|A.O. Ospedale Papa Giovanni XXIII||2|||f||||||||||||||2017-02-18 15:53:03.134423|2017-02-18 15:53:03.134423
NCT00433043|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2015-10-28|||January 2007||2007-01-01|January 2014|2014-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)|Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System|Terminated||Phase 4|2|Actual|St. Luke's-Roosevelt Hospital Center||2||Insufficient enrollment|f||||f||||||||||2017-02-18 15:53:03.245977|2017-02-18 15:53:03.245977
NCT00433030|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2015-12-22|||January 2007||2007-01-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand|Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand|Active, not recruiting||N/A|2816|Anticipated|Institut de Recherche pour le Developpement|||1||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 15:53:03.367055|2017-02-18 15:53:03.367055
NCT00433017|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2011-04-18|2011-01-12||May 2007||2007-05-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)|24-month Randomized, Double-masked, Controlled, Multicenter, Phase II Study Assessing Safety and Efficacy of Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab Versus Ranibizumab Monotherapy in Patients With Subfoveal Choroidal Neovascularization Secondary to AMD.|Terminated||Phase 2/Phase 3|255|Actual|Novartis||2||Study was terminated based on the results of analyses performed as planned at Month 12.|f||||||||||||||2017-02-18 15:53:05.984394|2017-02-18 15:53:05.984394
NCT00433004|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-08|2016-12-01|||February 2007||2007-02-01|December 2016|2016-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens|A Pilot Randomized Control Trial of Advanced Supply of Levonorgestrel Emergency Contraception vs. Routine Postpartum Contraceptive Care in the Teenage Population|Completed||Phase 4|50|Anticipated|University of Pennsylvania||2|||f||||||||||||||2017-02-18 15:53:06.555205|2017-02-18 15:53:06.555205
NCT00432991|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2013-06-13|||February 2007||2007-02-01|June 2013|2013-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section|A Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Intramuscular Ephedrine on the Incidence of Perioperative Nausea and Vomiting During Elective Cesarean Section|Completed||Phase 2|53|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 15:53:06.886242|2017-02-18 15:53:06.886242
NCT00432978|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-04-17|||July 2006||2006-07-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Effect of Bosentan on Exercise Capacity at High Altitude|Effect of Bosentan on Exercise Capacity at High Altitude|Completed||Phase 1|20||VA Loma Linda Health Care System|||||f||||f||||||||||2017-02-18 15:53:06.99784|2017-02-18 15:53:06.99784
NCT00432965|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2011-09-08|||May 2002||2002-05-01|September 2011|2011-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers|"KCI VAC Protocol VAC2001-08, A Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in the Treatment and Blinded Evaluation of Diabetic Foot Ulcers"|Completed||Phase 4|338|Actual|KCI USA, Inc.||1|||f||||||||||||||2017-02-18 15:53:07.093166|2017-02-18 15:53:07.093166
NCT00432952|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2008-08-12|||January 2007||2007-01-01|August 2008|2008-08-01|January 2009|Anticipated|2009-01-01|March 2007|Actual|2007-03-01||Interventional|||Acute Single Meal Effects of Trout on Cardiovascular Risk Markers and Plasma Proteome||Unknown status|Active, not recruiting|N/A|6||University of Copenhagen|||||f||||||||||||||2017-02-18 15:53:07.220674|2017-02-18 15:53:07.220674
NCT00432939|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2015-03-06|||October 2005||2005-10-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|November 2009|Actual|2009-11-01||Observational|||Primary Hyperparathyroidism: Non-classical Manifestations|Primary Hyperparathyroidism: Non-classical Manifestations|Completed||N/A|58|Actual|Columbia University|||1||f||||t||||||Samples Without DNA|"~     Specimens of frozen serum will be retained for possible future analyses.~   "|||2017-02-18 15:53:07.331121|2017-02-18 15:53:07.331121
NCT00432926|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2012-09-27|||February 2007||2007-02-01|September 2012|2012-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users|Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users|Completed||Phase 2|429|Actual|University of California, San Diego||3|||f||||t||||||||||2017-02-18 15:53:07.429763|2017-02-18 15:53:07.429763
NCT00432913|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2008-10-16|||October 2006||2006-10-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa|The Effect of Two Dose Levels of Eicosapentaenoic Acid (EPA) on Apoptosis and Cell Proliferation in the Colonic Mucosa of Patients With a History of Colonic Polyps.|Completed||Phase 2/Phase 3|120|Anticipated|S.L.A. Pharma AG||3|||f||||f||||||||||2017-02-18 15:53:07.556443|2017-02-18 15:53:07.556443
NCT00432900|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2017-01-24|||February 5, 2007||2007-02-05|April 22, 2014|2014-04-22|May 29, 2013|Actual|2013-05-29|May 23, 2013|Actual|2013-05-23||Interventional|||Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis|PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [(11)C]PBR28 in Patients With Multiple Sclerosis (MS)|Completed||Phase 1|21|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 15:53:07.679029|2017-02-18 15:53:07.679029
NCT00432887|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2010-03-01|||July 2004||2004-07-01|March 2010|2010-03-01|February 2007||2007-02-01|||||Interventional|||Experimental Studies of the Effects of Caffeine on Glucose Regulation|Caffeine and Glucose Regulation|Completed||Early Phase 1|150||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 15:53:07.787888|2017-02-18 15:53:07.787888
NCT00432874|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2010-10-15|||February 2007||2007-02-01|October 2010|2010-10-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Prospective Evaluation of Safety and Efficacy of Two Forms of Corneal Stromal Hydration|A Prospective Evaluation of the Safety and Efficacy of Two Forms of Corneal Stromal Hydration|Completed||N/A|60|Anticipated|University of Utah||2|||f||||f||||||||||2017-02-18 15:53:07.888723|2017-02-18 15:53:07.888723
NCT00432471|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2016-03-14|||January 2007||2007-01-01|March 2016|2016-03-01||||January 2018|Anticipated|2018-01-01||Interventional|||Optical Imaging of Skin Cancers for Margin Delineation of Non-melanoma Skin Cancers|Evaluation of Optical Imaging for Margin Delineation of Non-melanoma Skin Cancers|Active, not recruiting||N/A|55|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:53:18.182356|2017-02-18 15:53:18.182356
NCT00432861|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2012-02-21|||January 2007||2007-01-01|February 2012|2012-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Crossover Study to Evaluate the Effectiveness and Safety of PANCRECARB® MS-16 (Pancrelipase) in Reducing Steatorrhea in Children and Adults With Cystic Fibrosis|Completed||Phase 3|29|Actual|Digestive Care, Inc.||2|||f||||t||||||||||2017-02-18 15:53:07.975561|2017-02-18 15:53:07.975561
NCT00432835|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2012-11-01|2012-04-11||August 2005||2005-08-01|November 2012|2012-11-01|November 2007|Actual|2007-11-01|October 2006|Actual|2006-10-01||Interventional|||Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis|Double-Blind Placebo-Controlled Cross-Over Design With Wash-Out for Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis|Completed||Phase 3|58|Actual|University of Mississippi Medical Center|New lead implantation techniques now minimize dislodgment (only adverse effect); Parallel, non-crossover protocol will address any carry-over effect after tGES activation OFF; stratification for baseline mucosal EGG and medications may be useful.|2|||f||||t||||||||||2017-02-18 15:53:08.096902|2017-02-18 15:53:08.096902
NCT00432822|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2007-09-19||||||September 2007|2007-09-01||||||||Interventional|||Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years - Study on Phenylalanine Tolerance and Safety|Double-Blind, Placebo Controlled, Multicentre Study With an Open Label Extension to Evaluate the Efficacy and Safety of Tetrahydrobiopterin (BH4) in Children and Adolescents With Hyperphenylalaninemia Caused by Phenylalanine Hydroxylase Deficiency|Terminated||Phase 2/Phase 3|50|Anticipated|Orphanetics Pharma Entwicklungs GmbH|||||f||||||||||||||2017-02-18 15:53:08.527069|2017-02-18 15:53:08.527069
NCT00432809|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2016-11-17|2012-11-09||February 2007||2007-02-01|February 2016|2016-02-01|September 2016|Actual|2016-09-01|February 2016|Actual|2016-02-01||Interventional|||Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 Diabetes|STAMPEDE: Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently|Completed||Phase 4|150|Actual|The Cleveland Clinic|Important limitations in the primary endpoint and 1 year outcomes are the short duration of follow-up (12 months), the study occurred at a single-center and the open-label nature of the study (subjects were not blinded to treatment).|3|||f||||t||||||||||2017-02-18 15:53:08.617501|2017-02-18 15:53:08.617501
NCT00432796|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2016-03-02|||December 2006||2006-12-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin.|A Double Blind Randomized Control Trial of Post-Operative Low Molecular Weight Heparin Bridging Therapy Versus Placebo Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)|Active, not recruiting||Phase 3|1473|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-02-18 15:53:11.390683|2017-02-18 15:53:11.390683
NCT00432783|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2009-11-04|||June 2006||2006-06-01|November 2009|2009-11-01||||||||Observational|||A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor|A Comparison of Adherence Rates to Ritonavir (Soft-gel Capsules) and Its Accompanying Protease Inhibitor (PI) in Patients Receiving Ritonavir Boosted PI Regimens|Unknown status|Active, not recruiting|N/A|45|Anticipated|Montefiore Medical Center|||1||f||||||||||||||2017-02-18 15:53:11.526628|2017-02-18 15:53:11.526628
NCT00432770|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-04-19|||December 2006||2006-12-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers|A Phase 1, Single-Site, Double-Blind,Randomized, Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus or Intravenous Bolus Followed by Continuous Infusion Administration of ARC1779 Compared to Placebo in Healthy Volunteers|Completed||Phase 1|42||Archemix Corp.|||||f||||||||||||||2017-02-18 15:53:11.615735|2017-02-18 15:53:11.615735
NCT00432757|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-04|2009-04-08|||January 2007||2007-01-01|April 2009|2009-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis|A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers|Completed||Phase 3|120|Anticipated|Vistakon Pharmaceuticals|||||||||||||||||||2017-02-18 15:53:11.929368|2017-02-18 15:53:11.929368
NCT00432744|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2014-04-30|2014-04-11||January 2007||2007-01-01|April 2014|2014-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||This is the set of subjects that met all eligibility requirements|Phase III Trial of Coenzyme Q10 in Mitochondrial Disease|Phase 3 Trial of Coenzyme Q10 in Mitochondrial Disease|Completed||Phase 3|24|Actual|University of Florida|The trial intended to accrual 40 subjects, but accrual was below expectations and the granting agency turned down a request for extended accrual.|2|||f||||t||||||||||2017-02-18 15:53:12.036184|2017-02-18 15:53:12.036184
NCT00432731|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2009-04-03|||December 2004||2004-12-01|April 2009|2009-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety Study of a Refrigerator-Stable Formulation of VARIVAX®|A Double-Blind, Randomised, Controlled, Multi-Centre Safety Study of a Refrigerator-Stable Formulation of VARIVAX® in Healthy 12 to 15 Month-Old Infants.|Completed||Phase 4|500||MCM Vaccines B.V.|||||f||||||||||||||2017-02-18 15:53:12.555672|2017-02-18 15:53:12.555672
NCT00432718|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2007-02-07|||August 2001||2001-08-01|February 2007|2007-02-01||||||||Interventional|||Saline Instillation Before Tracheal Suctioning and the Incidence of Ventilator Associated Pneumonia||Completed||N/A|260||Hospital do Cancer, Sao Paulo|||||f||||||||||||||2017-02-18 15:53:12.658955|2017-02-18 15:53:12.658955
NCT00432705|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2009-07-21|||September 2006||2006-09-01|July 2009|2009-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Changes in Unstable Ankles After Balance Training|Modulation of Sensorimotor Measures in Chronically Unstable Ankles|Completed||Phase 1|70|Actual|University of North Carolina, Charlotte||1|||f||||f||||||||||2017-02-18 15:53:12.739777|2017-02-18 15:53:12.739777
NCT00432692|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2010-02-24|||December 2005||2005-12-01|April 2007|2007-04-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Falls Prevention in Osteoporosis|Falls Prevention for People With Increased Risk of Fractures as a Result of Osteoporosis: a Randomized Controlled Study on the Effects of a Modified Program|Completed||N/A|96|Actual|Sint Maartenskliniek|||||f||||||||||||||2017-02-18 15:53:12.833869|2017-02-18 15:53:12.833869
NCT00431288|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-02-01|||August 2003||2003-08-01|February 2007|2007-02-01|June 2006||2006-06-01|||||Interventional|||A Nutrition Intervention to Lower Blood Pressure in Adolescents|Efficacy of a Nutrition Intervention Emphasizing Fruits, Vegetables and Dairy to Lower Blood Pressure in Adolescents|Completed||N/A|54||University of Cincinnati|||||f||||||||||||||2017-02-18 15:53:41.402254|2017-02-18 15:53:41.402254
NCT00432679|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2017-01-16|||May 2006||2006-05-01|January 2017|2017-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study|Clinical Evaluation of Rosiglitazone Maleate (BRL49653C) in Patients With Type 2 Diabetes Mellitus (Combination Therapy With Sulfonyl Urea) - A Placebo-Controlled Double-Blind Study -|Completed||Phase 3|140|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:53:12.922377|2017-02-18 15:53:12.922377
NCT00432666|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2010-11-25|2010-08-31||June 2006||2006-06-01|November 2010|2010-11-01|May 2008|Actual|2008-05-01|November 2006|Actual|2006-11-01||Interventional|||IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb|Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Trial With an Open-label Extension Period to Investigate the Efficacy and Safety of incobotulinumtoxinA (Xeomin) in the Treatment of Post-stroke Spasticity of the Upper Limb|Completed||Phase 3|148|Actual|Merz Pharmaceuticals GmbH||2|||f||||||||||||||2017-02-18 15:53:13.067164|2017-02-18 15:53:13.067164
NCT00432653|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-02-07|||March 2007||2007-03-01|February 2007|2007-02-01|November 2009||2009-11-01|||||Interventional|||Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis|Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis|Unknown status|Not yet recruiting|Phase 2/Phase 3|20||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 15:53:15.88753|2017-02-18 15:53:15.88753
NCT00432640|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2010-12-15|||January 2007||2007-01-01|December 2010|2010-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study)|Complete Echo-Endoscopic Staging of Lung Cancer vs Surgical Staging: a Randomized Clinical Trial|Completed||N/A|240|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 15:53:15.996539|2017-02-18 15:53:15.996539
NCT00432627|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2016-04-20|||December 2006||2006-12-01|April 2016|2016-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.|An Open-label, Single-dose, Parallel-group Study to Assess the Pharmacokinetics of 20 mg/kg Oral Deferasirox in Patients With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function|Completed||Phase 1|24|Actual|Novartis||4|||f||||f||||||||||2017-02-18 15:53:16.10425|2017-02-18 15:53:16.10425
NCT00432614|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2009-03-24|||January 2007||2007-01-01|March 2009|2009-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|ALBERIO||Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder|A Multi-National, Multi-Center, DB, Placebo-Controlled, Parallel Group, Fixed Dose Efficacy & Safety Study of SR58611A 350 mg Twice Daily vs. Placebo in Adults With Major Depressive Disorder on Concomitant Treatment With Escitalopram 10mg/d|Completed||Phase 3|510|Actual|Sanofi||3|||f||||||||||||||2017-02-18 15:53:16.20992|2017-02-18 15:53:16.20992
NCT00432601|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2016-03-07|2015-03-19||August 2008||2008-08-01|March 2016|2016-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Testing the Helpfulness of 2 Decision Aids for Prostate Cancer|Impact of a Plain Language Prostate Cancer Decision Aid on Decision Making|Completed||N/A|1028|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:53:16.32848|2017-02-18 15:53:16.32848
NCT00432588|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-05-31||||||February 2007|2007-02-01||||||||Interventional|||Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies||Unknown status|Not yet recruiting|Phase 1/Phase 2|||Hormozgan University of Medical Sciences|||||||||||||||||||2017-02-18 15:53:16.634022|2017-02-18 15:53:16.634022
NCT00432575|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2009-04-14|||January 2007||2007-01-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed-Dose, 8-Week Treatment, Multi-Center Trial Evaluating the Efficacy and the Safety of 3 Oral Doses of Surinabant as an Aid to Smoking Cessation in Cigarette Smokers|Completed||Phase 2|810|Actual|Sanofi||4|||f||||||||||||||2017-02-18 15:53:16.985567|2017-02-18 15:53:16.985567
NCT00432562|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2012-01-19|2012-01-19||February 2007||2007-02-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.|A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion (ANX-530) in Patients With Advanced Cancer.|Completed||Phase 1|31|Actual|Mast Therapeutics, Inc.||1|||f||||f||||||||||2017-02-18 15:53:17.095616|2017-02-18 15:53:17.095616
NCT00432549|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-02-07|||January 2007||2007-01-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Detoxification and Treatment of Subjects With Medication Overuse Headache|Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache|Unknown status|Recruiting|Phase 4|60||The New England Center for Headache, P.C.|||||f||||||||||||||2017-02-18 15:53:17.678099|2017-02-18 15:53:17.678099
NCT00432536|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2013-05-14|||October 2002||2002-10-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|August 2011|Actual|2011-08-01||Observational|||Redesigning Cardiac Surgery to Reduce Neurologic Injury|Redesigning Cardiac Surgery to Reduce Neurologic Injury|Completed||N/A|469|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||f||||||Samples Without DNA|"~     Serum to study neurologic biomarker, Sb100.~   "|||2017-02-18 15:53:17.770696|2017-02-18 15:53:17.770696
NCT00432523|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2009-04-03|||January 2005||2005-01-01|April 2009|2009-04-01|July 2006||2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route|An Open, Randomised, Comparative, Multicentre Study of the Immunogenicity and Safety of M-M-R™II Manufactured With Recombinant Human Albumin (rHA) and VARIVAX® When Administered Concomitantly by Intramuscular (IM) Route or Subcutaneous (SC) Route at Two Separate Injection Sites in Healthy Subjects 12 to 18 Months of Age|Completed||Phase 3|752||MCM Vaccines B.V.|||||f||||||||||||||2017-02-18 15:53:17.874035|2017-02-18 15:53:17.874035
NCT00432510|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-07|2014-03-19|||October 2006||2006-10-01|March 2014|2014-03-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects|Protocol LEVP2006-5: Pharmacokinetics of C1INH-nf in Hereditary Angioedema Subjects|Completed||Phase 1|27|Actual|Shire||2|||f||||f||||||||||2017-02-18 15:53:17.959812|2017-02-18 15:53:17.959812
NCT00429221|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2013-04-22|||January 2006||2006-01-01|April 2013|2013-04-01||||||||Interventional|||Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder|ADHD Medication Adherence: A Parent-Provider Intervention Modeled From HIV|Withdrawn||N/A|0|Actual|New York State Psychiatric Institute|||||f||||||||||||||2017-02-18 15:54:32.046284|2017-02-18 15:54:32.046284
NCT00432458|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2012-06-04|2012-04-11||July 2003||2003-07-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|June 2011|Actual|2011-06-01||Interventional|||Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma|A Phase III Randomized Trial of Thalidomide Plus Zoledronic Acid Versus Zoledronic Acid Alone in Patients With Early Stage Multiple Myeloma|Completed||Phase 3|68|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 15:53:18.300607|2017-02-18 15:53:18.300607
NCT00432445|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2015-02-12|2015-02-12||January 2007||2007-01-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||No analysis performed as a result of small study population.|Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma|A Phase II Trial of Proton Beam Radiation Therapy for Intra- and Periocular Retinoblastoma|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Low accrual.|f||||f||||||||||2017-02-18 15:53:19.075513|2017-02-18 15:53:19.075513
NCT00432432|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2012-02-10|||February 2005||2005-02-01|February 2012|2012-02-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Combination Methotrexate and Infliximab|The Efficacy of Combination Methotrexate and Infliximab in Patients With Ankylosing Spondylitis:A Clinical and Magnetic Resonance Imaging Correlation|Completed||Phase 4|38|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-02-18 15:53:19.305173|2017-02-18 15:53:19.305173
NCT00432419|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2011-12-21|||February 2007||2007-02-01|December 2011|2011-12-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.|Therapeutic Intensification for HIV-associated Non-Hodgkin's Lymphoma by Autologous Transplantation of Either Unselected or CD34+-Selected Peripheral Blood Stem Cells, in Patients in First or Second Complete Remission. ANRS 131|Terminated||Phase 1/Phase 2|1|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1||only one patient enrolled|f||||t||||||||||2017-02-18 15:53:19.406539|2017-02-18 15:53:19.406539
NCT00432406|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2009-03-10|||May 2006||2006-05-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis|TNF-α Blockade for Psoriatic Arthritis - A Clinical and MRI Study, and the Effects on Cytokine and Cardiovascular Risk Profile|Completed||Phase 4|40|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 15:53:19.499492|2017-02-18 15:53:19.499492
NCT00432393|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2008-10-17|||June 2002||2002-06-01|February 2007|2007-02-01|April 2003||2003-04-01|||||Interventional|||Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy|Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy|Completed||Phase 4|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 15:53:19.613306|2017-02-18 15:53:19.613306
NCT00432380|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2016-11-03|||March 2007||2007-03-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.|Immunogenicity and Safety of Two Doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Liquid Vaccine (GSK 357941A) in Healthy Infants.|Completed||Phase 2|375|Anticipated|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:53:19.810486|2017-02-18 15:53:19.810486
NCT00432367|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2016-10-19|||February 2007||2007-02-01|February 2014|2014-02-01|September 2009|Actual|2009-09-01|February 2009|Actual|2009-02-01||Interventional|||Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancy|The Effectiveness, Cost and Cost Effectiveness of Intermittent Preventive Treatment or Screening and Treatment of Malaria in Pregnancy Among Women Using Long Lasting Insecticide Treated Bed Net: a Randomised Controlled Trial.|Completed||Phase 3|3333|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-02-18 15:53:19.908652|2017-02-18 15:53:19.908652
NCT00432354|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-03-19|||March 2007||2007-03-01|March 2007|2007-03-01|March 2009|Anticipated|2009-03-01|||||Interventional|||An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus||Unknown status|Recruiting|Phase 2/Phase 3|40||Buddhist Tzu Chi General Hospital|||||f||||||||||||||2017-02-18 15:53:20.033491|2017-02-18 15:53:20.033491
NCT00432341|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2011-11-14|2011-11-14||June 2007||2007-06-01|November 2011|2011-11-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia||Terminated||Phase 4|54|Actual|Allergan|The study was terminated early due to difficulties with patient recruitment.|2||Study was terminated early due to difficulties with patient recruitment|f||||||||||||||2017-02-18 15:53:20.151301|2017-02-18 15:53:20.151301
NCT00432328|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2009-01-12|||October 2006||2006-10-01|January 2009|2009-01-01||||||||Interventional|||Juvista (Avotermin) in Breast Reduction Surgery Scars|A Double Blind, Placebo Controlled, Randomised Trial to Investigate the Efficacy of Juvista (Avotermin) in the Improvement of Scar Appearance in Patients Undergoing Bilateral Reduction Mammaplasty.|Terminated||Phase 2|39|Anticipated|Renovo||||Futility analysis undertaken, determined that study was underpowered.|f||||||||||||||2017-02-18 15:53:20.662269|2017-02-18 15:53:20.662269
NCT00432315|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2010-09-13|||May 2001||2001-05-01|September 2010|2010-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Docetaxel in Non Small Cell Lung Cancer (NSCLC)|Multicenter Phase II Study Evaluating Docetaxel and CDDP as Induction Regimen Prior to Surgery or Radiochemotherapy With Docetaxel, Followed by Adjuvant Docetaxel Therapy in Chemonaive Patients With NSCLC Stage II, IIIa and IIIb|Completed||Phase 2|80|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:53:20.757868|2017-02-18 15:53:20.757868
NCT00432302|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2015-12-10|||January 2007||2007-01-01|December 2015|2015-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Investigation of Mass Balance of the Test Drug and Major Metabolites|Investigation of Mass Balance and Major Metabolites After Administration of 28 mg Radiolabeled ZK 219477 in Patients With Solid Tumor in an Open-label, Non Randomized Design|Completed||Phase 1|7|Actual|Bayer||1|||f||||f||||||||||2017-02-18 15:53:21.040233|2017-02-18 15:53:21.040233
NCT00432289|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2010-06-10|||November 2006||2006-11-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Acupuncture for Treatment of Acute Spinal Cord Injury: an Exploratory/Developmental Study|Acupuncture for Treatment of Acute Spinal Cord Injury|Completed||Phase 1/Phase 2|30|Anticipated|Craig Hospital||1|||f||||t||||||||||2017-02-18 15:53:21.152043|2017-02-18 15:53:21.152043
NCT00432276|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2013-04-01|2013-02-19||January 2007||2007-01-01|April 2013|2013-04-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus|A Multicenter, Randomized, Double-Blind Study to Determine the Efficacy and Safety of the Addition of SYR-322 25 mg Versus Dose Titration From 30 mg to 45 mg of Pioglitazone HCl (ACTOS®) in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Control on a Combination of Metformin and 30 mg of Pioglitazone HCl Therapy|Completed||Phase 3|803|Actual|Takeda||2|||f||||f||||||||||2017-02-18 15:53:21.261045|2017-02-18 15:53:21.261045
NCT00432263|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2015-04-21|||April 2007||2007-04-01|April 2015|2015-04-01||||||||Interventional|||Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.|Placebo-Controlled Trial On The Efficacy Of Growth Hormone Replacement Therapy In Patients With Growth Hormone Deficiency After Traumatic Brain Injury|Withdrawn||Phase 4|0|Actual|Pfizer|||||f||||||||||||||2017-02-18 15:53:23.331703|2017-02-18 15:53:23.331703
NCT00432224|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2007-02-06|||May 2006||2006-05-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light||Completed||N/A|28||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 15:53:23.520523|2017-02-18 15:53:23.520523
NCT00432211|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2009-02-03|||May 2006||2006-05-01|February 2009|2009-02-01|September 2012|Anticipated|2012-09-01|July 2008|Anticipated|2008-07-01||Interventional|||Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.|A Double Blind, Placebo Controlled, Randomised Trial to Investigate the Efficacy of Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Renovo||2|||f||||||||||||||2017-02-18 15:53:23.610017|2017-02-18 15:53:23.610017
NCT00432198|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2017-02-15|||February 2007||2007-02-01|February 2017|2017-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Zolpidem Postmarketing Study in Adolescent Patients With Insomnia|Zolpidem Postmarketing Clinical Study: A Double Blind, Placebo Controlled Group Comparative Trial in the Adolescent Patients With Insomnia|Completed||Phase 4|122|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 15:53:23.705136|2017-02-18 15:53:23.705136
NCT00432185|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2016-01-22||2016-01-22|February 2007||2007-02-01|January 2016|2016-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC|An Open-label, Multi-center, Dose-escalation, Cohort Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel Given as Either a Single Application (on Day 1) or as Two Applications (on Day 1 and Day 8) to a Superficial Basal Cell Carcinoma (sBCC) on the Trunk.|Completed||Phase 2|117|Actual|Peplin||2|||f||||f||||||||||2017-02-18 15:53:23.834619|2017-02-18 15:53:23.834619
NCT00432172|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2012-11-21|||September 2007||2007-09-01|November 2012|2012-11-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients|"A Randomized Multicenter Phase II Trial to Evaluate the Effectiveness of Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients"|Unknown status|Active, not recruiting|Phase 2|189|Actual|Spanish Breast Cancer Research Group||4|||f||||||||||||||2017-02-18 15:53:23.954782|2017-02-18 15:53:23.954782
NCT00432159|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2016-10-13|2014-05-27||July 2006||2006-07-01|October 2016|2016-10-01|May 2016|Actual|2016-05-01|May 2013|Actual|2013-05-01||Interventional||Intent-to-treat|Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)|A Multi-Center, Prospective, Randomized Controlled Trial Comparing Cervical Arthroplasty to Anterior Cervical Discectomy and Fusion for the Treatment of Cervical Degenerative Disc Disease|Completed||N/A|500|Actual|DePuy Spine|Enrollment terminated early, and beginning in March 2013, follow-up visits beyond 24 months were limited to Discover subjects only.|5|||f||||t||||||||||2017-02-18 15:53:24.09217|2017-02-18 15:53:24.09217
NCT00432146|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2008-10-17|||September 2005||2005-09-01|February 2007|2007-02-01|September 2006||2006-09-01|||||Observational|||Effect of Lugol's Solution in the Patients With Graves' Disease|Positive Effect of Lugol's Solution on the Blood Flow and Microvessel Density of Thyroid Gland in the Patients With Graves' Disease|Completed||N/A|36||Istanbul University|||||f||||||||||||||2017-02-18 15:53:27.970434|2017-02-18 15:53:27.970434
NCT00432133|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2012-04-26|||February 2006||2006-02-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Individual and Environmental Mechanisms of PA Change|Behavioral 2X2 Randomized Controlled Trial to Determine Individual and Environmental Mechanisms of Physical Activity Behavior Change|Completed||N/A|452|Actual|Kaiser Permanente||3|||f||||t||||||||||2017-02-18 15:53:28.054043|2017-02-18 15:53:28.054043
NCT00432120|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2008-01-28|||March 2006||2006-03-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?|Clopidogrel Loading Dose for ad-Hoc Percutaneous Coronary Intervention Immediately Following Elective Coronary Angiography: Randomized Multicenter Trial Comparing Pre-Treatment > 6 Hours Before Every Angiography vs. Cath-Lab Administration After Angiography (Just Before Intervention): the PRAGUE-8 Trial.|Completed||Phase 3|||Charles University, Czech Republic||2|||f||||||||||||||2017-02-18 15:53:28.161633|2017-02-18 15:53:28.161633
NCT00432107|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-06|2015-09-28|||July 2006||2006-07-01|November 2013|2013-11-01|March 2009|Actual|2009-03-01|February 2008|Actual|2008-02-01||Interventional|||A Study to Assess APO866 for the Treatment of Advanced Melanoma|A Multi-centre, Two-stage, Open Label Phase II Study to Assess the Efficacy and Safety of APO866 in the Treatment of Patients With Advanced Melanoma.|Completed||Phase 2|25|Actual|Onxeo||1|||f||||f||||||||||2017-02-18 15:53:28.266708|2017-02-18 15:53:28.266708
NCT00432094|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2016-08-15|||December 2006||2006-12-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors|Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors|Recruiting||Phase 2|25|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-02-18 15:53:28.379143|2017-02-18 15:53:28.379143
NCT00432081|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2007-02-05|||May 2000||2000-05-01|February 2007|2007-02-01|August 2005||2005-08-01|||||Interventional|||Effect of Indomethacin on the Progression of Alzheimer's Disease|Effect of Indomethacin on the Progression of Alzheimer's Disease|Completed||Phase 3|160||Radboud University|||||f||||||||||||||2017-02-18 15:53:28.523632|2017-02-18 15:53:28.523632
NCT00431275|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2012-06-05|||June 2006||2006-06-01|June 2012|2012-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody|An Open Label, Randomized Clinical Comparability Study Of The Current Liquid And Commercial Liquid Formulations|Completed||Phase 1|85|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:53:41.50672|2017-02-18 15:53:41.50672
NCT00432068|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2015-12-02|||January 2007||2007-01-01|December 2015|2015-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers|A Phase I , Open Label, Single Center, Dose Escalation Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of a New Extended Long-acting Formulation of Octreotide Pamoate Administered i.m. in Healthy Cholecystectomized Volunteers|Completed||Phase 1|48|Actual|Novartis||1|||f||||f||||||||No||2017-02-18 15:53:28.630132|2017-02-18 15:53:28.630132
NCT00432055|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2009-02-23|||January 2007||2007-01-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy|A Randomized Controlled Trial on Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy|Completed||Phase 4|66|Anticipated|Sunnaas Rehabilitation Hospital||2|||f||||f||||||||||2017-02-18 15:53:28.742546|2017-02-18 15:53:28.742546
NCT00432042|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2009-04-03|||January 2007||2007-01-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly|An Open, Randomised, Comparative, Multicentre Study of the Immunogenicity and Safety of Concomitant Versus Separate Administration of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad®) and a Booster Dose of Infanrix® Hexa in Healthy Children 12 to 23 Months of Age|Completed||Phase 3|960|Anticipated|MCM Vaccines B.V.|||||f||||||||||||||2017-02-18 15:53:28.857093|2017-02-18 15:53:28.857093
NCT00432029|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2008-07-01|||December 2006||2006-12-01|June 2008|2008-06-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Correlation of Flicker Induced and Flow Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers.|Correlation of Flicker Induced and Flow Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers|Completed||N/A|80|Actual|Medical University of Vienna||3|||f||||||||||||||2017-02-18 15:53:31.676127|2017-02-18 15:53:31.676127
NCT00432016|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2007-05-10|||February 2007||2007-02-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV|A Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerance, Pharmacokinetics and Antiviral Activity of Amdoxovir and Zidovudine in Untreated HIV-1 Infected Subjects Currently Untreated|Completed||Phase 1/Phase 2|24||RFS Pharma, LLC|||||f||||f||||||||||2017-02-18 15:53:31.772704|2017-02-18 15:53:31.772704
NCT00432003|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2014-04-16|||March 2005||2005-03-01|April 2014|2014-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Effects of Anti-HIV Therapy on Nervous System Function|Neurology: A Substudy of a Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (SMART) to Determine the Impact of the Strategies Upon Central and Peripheral Nervous System Function|Completed||N/A|297|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 15:53:31.880907|2017-02-18 15:53:31.880907
NCT00431990|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-04|2011-08-11|||November 2006||2006-11-01|August 2011|2011-08-01|January 2012|Anticipated|2012-01-01|December 2011|Anticipated|2011-12-01||Interventional|||A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma|A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma|Unknown status|Recruiting|Phase 1/Phase 2|40|Anticipated|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-02-18 15:53:32.037847|2017-02-18 15:53:32.037847
NCT00431977|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2011-06-20|||November 2006||2006-11-01|October 2006|2006-10-01|December 2012||2012-12-01|||||Interventional|||Validation Study of Coronary CT Angiography as a Screening Tool in Asymptomatic Diabetes|DEtection of Subclinical Coronary AtheRosclerosis in diabeTES Using Coronary CT Angiography (DESCARTES Trial)|Completed||N/A|1000|Anticipated|Seoul National University Bundang Hospital|||||f||||||||||||||2017-02-18 15:53:32.147739|2017-02-18 15:53:32.147739
NCT00431964|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2015-07-24|2015-07-24||February 2007||2007-02-01|July 2015|2015-07-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional||3 participants in the Placebo arm were randomized but did not receive drug due to withdrawal of consent and unstable health.|Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa|Multi-center, Multi-national, Randomized, Placebo-Controlled Trial of Azithromycin in Subjects With Cystic Fibrosis 6-18 Years Old, Culture Negative for Pseudomonas Aeruginosa|Completed||Phase 4|263|Actual|CF Therapeutics Development Network Coordinating Center||2|||f||||t||||||||||2017-02-18 15:53:32.487881|2017-02-18 15:53:32.487881
NCT00431951|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2010-09-15|2009-05-29||February 2007||2007-02-01|September 2010|2010-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|SIGA-246-002||Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers|Double-blind, Randomized, Placebo-controlled, Escalating, Multiple-dose, Phase I Trial to Assess Safety, Tolerability and Pharmacokinetics of ST-246 Administered as a Single Daily Dose for 21 Days in Healthy, Non-fasted Volunteers|Completed||Phase 1|30|Actual|SIGA Technologies||2|||f||||t||||||||||2017-02-18 15:53:33.015547|2017-02-18 15:53:33.015547
NCT00431925|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2007-08-09||||||February 2007|2007-02-01|May 2011|Anticipated|2011-05-01|||||Observational|||Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?|Can Cytokines Predict the Severity of Acute Mucositis and the Need for PEG During Chemo-Radiation Treatment to Head and Neck Cancer?|Unknown status|Not yet recruiting|N/A|35|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:53:34.221141|2017-02-18 15:53:34.221141
NCT00431912|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2015-07-07|||February 2007||2007-02-01|July 2015|2015-07-01|September 2011|Actual|2011-09-01|January 2011|Actual|2011-01-01||Interventional|||A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma|A Multicenter Open Label Phase II Study of to Assess the Efficacy and Safety of APO866 in the Treatment of Patients With Refractory or Relapsed Cutaneous T-cell Lymphoma|Completed||Phase 2|25|Actual|Onxeo||1|||f||||f||||||||||2017-02-18 15:53:34.305834|2017-02-18 15:53:34.305834
NCT00431899|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-03|2016-03-02|||May 2003||2003-05-01|February 2007|2007-02-01|November 2003||2003-11-01|||||Interventional|||Effects of Omega 3 in Hemodialysis Patients|Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis|Completed||N/A|8||Laboratoire Régional de Nutrition Humaine|||||f||||||||||||||2017-02-18 15:53:34.410536|2017-02-18 15:53:34.410536
NCT00431886|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2011-06-20|||April 2006||2006-04-01|February 2007|2007-02-01|December 2007|Actual|2007-12-01|||||Interventional|||Usefulness of 64 Slice Multi-Detector Computed Tomography as a First Diagnostic Approach in Acute Chest Pain Patients|Usefulness of 64 Slice Multi-Detector Computed Tomography as a First Diagnostic Approach in Acute Chest Pain Patients|Completed||N/A|400|Anticipated|Seoul National University Bundang Hospital|||||f||||f||||||||||2017-02-18 15:53:34.493942|2017-02-18 15:53:34.493942
NCT00431873|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2015-06-04||2015-06-04|January 2007||2007-01-01|June 2015|2015-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia|A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia|Completed||Phase 2|21|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 15:53:34.652803|2017-02-18 15:53:34.652803
NCT00431860|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2007-05-02|||December 2005||2005-12-01|May 2007|2007-05-01|November 2011|Anticipated|2011-11-01|||||Observational|||Subclinical COronary Atheroscleorosis Updated With Coronary cT Angiography (SCOUT Study)|Subclinical COronary Atheroscleorosis Updated With Coronary cT Angiography (SCOUT Study)|Unknown status|Recruiting|N/A|3000|Anticipated|Seoul National University Bundang Hospital|||||f||||t||||||||||2017-02-18 15:53:34.939942|2017-02-18 15:53:34.939942
NCT00431847|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2014-10-24|||October 2007||2007-10-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|September 2013|Actual|2013-09-01||Observational|RAMBPOS||Regional Anesthesia Military Battlefield Pain Outcomes Study|Regional Anesthesia in Combat Trauma Improves Pain Disability Outcomes|Unknown status|Active, not recruiting|N/A|670|Anticipated|VA Office of Research and Development|||2||f||||f||||||||||2017-02-18 15:53:35.034417|2017-02-18 15:53:35.034417
NCT00431834|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2013-11-03|2013-08-09||May 2007||2007-05-01|August 2013|2013-08-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study|Medtronic Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF)/Permanent Study|Completed||Phase 3|75|Actual|Medtronic Cardiovascular|"Slow/delayed enrollment~Medical management of subjects by non-investigators leading to medication washout protocol deviations~Missing endpoint data (attrition) due to cohort demographics (old age, dementia, relocation, etc.)"|1|||f||||t||||||||||2017-02-18 15:53:35.158352|2017-02-18 15:53:35.158352
NCT00431821|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2013-07-18|||October 2006||2006-10-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|February 2011|Actual|2011-02-01||Interventional|REHAB||Reshaping Exercise Habits and Beliefs (REHAB)|Reshaping Exercise Habits and Beliefs (REHAB): Pilot Testing of a Behavioral Intervention to Improve Mobility After Stroke|Completed||N/A|90|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:53:35.502076|2017-02-18 15:53:35.502076
NCT00431808|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2008-04-01|||May 2007||2007-05-01|April 2008|2008-04-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])|Randomized Controlled Trial to Evaluate the Safety and Immunogenicity of Recombinant Pichia Pastoris-Expressed P. Falciparum Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]) Versus Tetanus Toxoid, in Healthy Malian Adult in Bandiagara|Unknown status|Recruiting|Phase 1|40|Anticipated|African Malaria Network Trust||1|||f||||t||||||||||2017-02-18 15:53:35.603428|2017-02-18 15:53:35.603428
NCT00431795|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2013-02-12|||June 2003||2003-06-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer|A Multicenter Randomized Phase II Study of Second Line Chemotherapy With Epirubicin( Farmorubicin) Versus the Pegylated Liposomal Doxorubicin in Advanced Breast Cancer Patients|Terminated||Phase 2|100|Actual|Hellenic Oncology Research Group||2||Due to poor accrual|f||||||||||||||2017-02-18 15:53:35.712569|2017-02-18 15:53:35.712569
NCT00431782|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2007-11-07|||December 2006||2006-12-01|May 2007|2007-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation|An Open-Label Multi-Center Study of ATI-5923 for Anticoagulation in Patients With Atrial Fibrillation|Completed||Phase 2|60|Anticipated|ARYx Therapeutics|||||f||||||||||||||2017-02-18 15:53:35.844914|2017-02-18 15:53:35.844914
NCT00431769|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2014-05-09|||June 2006||2006-06-01|May 2014|2014-05-01|January 2010|Actual|2010-01-01|February 2009|Actual|2009-02-01||Interventional|||An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma|A Phase II, Open-Label Trial Using Velcade for ReTreatment of Multiple Myeloma Subjects Following an Initial Response to Velcade|Completed||Phase 2|130|Actual|Janssen-Cilag International NV||1|||f||||f||||||||||2017-02-18 15:53:35.941923|2017-02-18 15:53:35.941923
NCT00431756|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2016-09-07|||January 2002||2002-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Observational|BE||Predicting Risk of Cancer in Barrett's Esophagus|Methylation in Cancer Progression of Barrett's Esophagus|Recruiting||N/A|540|Anticipated|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"~     approx. 24 ml blood, 1-8 esophageal mucosal pinch specimens and or esophageal brushings~   "|||2017-02-18 15:53:36.092878|2017-02-18 15:53:36.092878
NCT00431743|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2009-02-27|||April 2009||2009-04-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Fluid Infusion During Breast Surgery|Phase 4 Study of Fluid Infusion During Breast Surgery.|Unknown status|Not yet recruiting|Phase 4|32|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 15:53:36.197498|2017-02-18 15:53:36.197498
NCT00431730|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2008-07-01|||December 2006||2006-12-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers?|Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers?|Completed||N/A|||Medical University of Vienna|||||f||||t||||||||||2017-02-18 15:53:36.2874|2017-02-18 15:53:36.2874
NCT00431717|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2008-08-22|||November 2006||2006-11-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Coronary Computed Tomography Angiography and SPECT in Asymptomatic Diabetes|Study Comparing Coronary Computed Tomography Angiography and SPECT to Detect Subclinical Coronary Atherosclerosis in Asymptomatic Diabetes|Completed||N/A|116|Actual|Seoul National University Bundang Hospital|||1||f||||t||||||||||2017-02-18 15:53:36.364175|2017-02-18 15:53:36.364175
NCT00431704|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2015-11-27|||October 2007||2007-10-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|July 2016|Anticipated|2016-07-01||Interventional|VinCaT||VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer|Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer, a Phase 2 Study|Active, not recruiting||Phase 2|39|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-02-18 15:53:36.455783|2017-02-18 15:53:36.455783
NCT00431691|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2008-07-01|||September 2006||2006-09-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.|Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.|Completed||Phase 4|22|Actual|Medical University of Vienna||2|||f||||||||||||||2017-02-18 15:53:36.569871|2017-02-18 15:53:36.569871
NCT00431678|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2014-12-16|||January 2004||2004-01-01|December 2014|2014-12-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia|A Multinational, Prospective, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Sequential Intravenous/Oral Moxifloxacin in Comparison to Intravenous Levofloxacin Plus Intravenous Ceftriaxone Followed by Oral Levofloxacin, in the Treatment of Patients With Severe Community-acquired Pneumonia|Completed||Phase 3|738|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:53:36.683364|2017-02-18 15:53:36.683364
NCT00431665|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2007-02-05|||July 1999||1999-07-01|February 2007|2007-02-01|June 2000||2000-06-01|||||Interventional|||Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters|Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters|Completed||N/A|9||Medical University of Vienna|||||f||||||||||||||2017-02-18 15:53:37.13053|2017-02-18 15:53:37.13053
NCT00431639|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-03|2017-01-24|||February 4, 2005||2005-02-04|July 27, 2016|2016-07-27|January 22, 2009|Actual|2009-01-22|January 22, 2009|Actual|2009-01-22||Interventional|||Effects of Pet Therapy on Pain in Cancer Patients|The Effect of Animal-Assisted Therapy on Distress in Oncology Patients Being Treated for Pain|Completed||Phase 2|36|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 15:53:37.230681|2017-02-18 15:53:37.230681
NCT00431626|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2015-10-06|2014-12-19||October 2006||2006-10-01|October 2015|2015-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Clinical Trial Comparing Laser TURP With and Without Dutasteride.|A Randomized, Placebo-Controlled, Double-Masked Clinical Trial Comparing Laser TURP With and Without Neo-Adjuvant Dutasteride|Terminated||Phase 3|4|Actual|Northwestern University|Difficulty in recruitment forced the closing of this trial.|2||Low enrollment|f||||t||||||||||2017-02-18 15:53:37.344798|2017-02-18 15:53:37.344798
NCT00431613|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2015-05-28|||March 2006||2006-03-01|May 2015|2015-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)|Sequential Administration of Docetaxel/Gemcitabine Followed by Concurrent Chemo-radiotherapy, With or Without Consolidation Chemotherapy, as First Line Treatment in Patients With Unresectable Stage IIIA/IIIB NSCLC. A Randomized Phase II Study|Terminated||Phase 2|38|Actual|Hellenic Oncology Research Group||2||Due to Poor Accrual|f||||||||||||||2017-02-18 15:53:37.638847|2017-02-18 15:53:37.638847
NCT00431600|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2012-09-20|||September 2010||2010-09-01|July 2008|2008-07-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||The Validity of Retinal Blood Flow Measurements During Hyperoxia in Humans Using Fourier Domain Color Doppler Optical Coherence Tomography (CDOCT)|The Validity of Retinal Blood Flow Measurements During Hyperoxia in Humans Using Fourier Domain CDOCT|Completed||N/A|12|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-02-18 15:53:37.789626|2017-02-18 15:53:37.789626
NCT00431587|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2008-04-16|||June 2007||2007-06-01|January 2007|2007-01-01||||||||Observational|||Changes in Different Fat Compartments and Their Effect on Particular Manifestations of Metabolic Syndrome After Bariatric Procedures.|Changes in Different Fat Compartments During Weight Loss and Their Effect on Particular Manifestations of Metabolic Syndrome After Bariatric Procedures.|Unknown status|Recruiting|N/A|1000|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:53:37.900743|2017-02-18 15:53:37.900743
NCT00431574|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2008-02-25|||August 2002||2002-08-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|June 2007|Actual|2007-06-01||Interventional|||Antipsychotic Medication Extended Dosing Study|Antipsychotic Medication Extended Dosing Study|Completed||N/A|40||Centre for Addiction and Mental Health|||||f||||||||||||||2017-02-18 15:53:37.981859|2017-02-18 15:53:37.981859
NCT00431561|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2013-12-02|||April 2003||2003-04-01|December 2013|2013-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma|Multi-national, Open-label, Active-controlled, Randomized Dose-finding Study to Evaluate Efficacy of 2 Doses of AP 12009 in Recurrent Glioma, Administered Intratumorally as Continuous High-flow Microperfusion Over 7 Days Every Other Week|Completed||Phase 2|141|Actual|Isarna Therapeutics GmbH||3|||f||||t||||||||||2017-02-18 15:53:38.098114|2017-02-18 15:53:38.098114
NCT00431548|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2007-02-05||||||February 2007|2007-02-01||||||||Interventional|||Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)|Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV).|Completed||N/A|30||Medical University of Vienna|||||f||||||||||||||2017-02-18 15:53:38.274662|2017-02-18 15:53:38.274662
NCT00431535|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-05|2013-06-14|||February 2007||2007-02-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Observational|||Study Concerning Relationship Between Mixed Venous Saturation (SvO2) and Balance|Descriptive Study Concerning the Connection Between SvO2 and Orthostatic Function Post Operatively|Completed||N/A|17|Actual|Rigshospitalet, Denmark|||1||f||||||||||||||2017-02-18 15:53:38.366531|2017-02-18 15:53:38.366531
NCT00431522|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2009-05-28|||December 2004||2004-12-01|May 2009|2009-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Valproic Acid Sodium Salt in Bipolar Disorder|Protective Effect of Valproate on Brain Cells:A Magnetic Resonance Imaging and Spectroscopy Study in Patients With Bipolar Disorder Diagnosis|Completed||Phase 4|58|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:53:38.459231|2017-02-18 15:53:38.459231
NCT00431509|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2007-04-23|||January 2007||2007-01-01|April 2007|2007-04-01|June 2009|Anticipated|2009-06-01|||||Interventional|||Trial Comparing Navigated and Conventional Implantation Techniques in Knee Replacement Surgery|A Randomized Trial Comparing Navigated and Conventional Implantation Techniques in Knee Replacement Surgery. Influence on Operative Result, Health-Related Quality of Life, and Coordinative Abilities.|Unknown status|Recruiting|Phase 4|477||University of Schleswig-Holstein|||||f||||||||||||||2017-02-18 15:53:38.549587|2017-02-18 15:53:38.549587
NCT00431496|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2013-04-18|2010-09-24||September 2006||2006-09-01|April 2013|2013-04-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)|A Study To Assess Achievement of NKF K/DOQI Targets Using Sensipar (Cinacalcet) in Australian Subjects With End Stage Renal Disease (ESRD) Who Are Being Treated With Aranesp for Anaemia Management|Completed||Phase 4|71|Actual|Amgen||1|||f||||||||||||||2017-02-18 15:53:38.653479|2017-02-18 15:53:38.653479
NCT00431262|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-03-02|||February 2007||2007-02-01|March 2007|2007-03-01|June 2009||2009-06-01|||||Interventional|||Antabuse in Severe Alcoholism: an Open Controlled Study|Antabuse in Severe Alcoholism: an Open Controlled Study|Unknown status|Recruiting|Phase 4|60||Psykiatrisk Center Gentofte|||||f||||||||||||||2017-02-18 15:53:41.640629|2017-02-18 15:53:41.640629
NCT00431483|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2013-09-25|||February 2007||2007-02-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards|Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards|Completed||N/A|779|Actual|Ludwig-Maximilians - University of Munich||1|||f||||f||||||||||2017-02-18 15:53:39.069935|2017-02-18 15:53:39.069935
NCT00431470|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2009-02-04|||February 2007||2007-02-01|October 2006|2006-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Are Character Building Lessons Effective in Decreasing Bullying Behaviors?|Is the Classroom Education Program Intervention Effective in Increasing Positive Self Esteem, Enhancing Leadership Behaviors, While Decreasing the Prevalence of Bullying Behaviors in Fifth Grade Elementary Students?|Completed||N/A|175|Anticipated|Maimonides Medical Center|||||f||||||||||||||2017-02-18 15:53:39.194689|2017-02-18 15:53:39.194689
NCT00431457|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2014-12-04|||June 2007||2007-06-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Controlled Randomized Stimulation Versus Resection (CoRaStiR)|Prospective Randomized Controlled Study of Neurostimulation in the Medial Temporal Lobe for Patients With Medically Refractory Medial Temporal Lobe Epilepsy; Controlled Randomized Stimulation Versus Resection (CoRaStiR)|Unknown status|Recruiting|N/A|45|Anticipated|University Hospital, Ghent||3|||f||||f||||||||||2017-02-18 15:53:39.301407|2017-02-18 15:53:39.301407
NCT00431444|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2011-03-25|2010-11-12||January 2007||2007-01-01|March 2011|2011-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density|A Multi-center, Randomized, Double-blind, Double-dummy Study in Postmenopausal Women With Low Bone Mineral Density to Compare the Effects of a Single Dose of i.v. Zoledronic Acid 5 mg, With Daily Oral Raloxifene 60 mg OD on Bone Turnover Markers|Completed||Phase 4|110|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:53:39.412141|2017-02-18 15:53:39.412141
NCT00431431|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2014-05-23|||October 2000||2000-10-01|May 2014|2014-05-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|STEP||Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)|A Multinational, Randomized, Double-Blind, Parallel Group Comparative Trial on the Effects of 2 Years Treatment With Tibolone (1.25 mg Org OD 14) and Raloxifene (60 mg) on Bone Mineral Density in Osteopenic Postmenopausal Women|Completed||Phase 4|324|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:53:40.247903|2017-02-18 15:53:40.247903
NCT00431418|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2015-09-21|||January 2007||2007-01-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|July 2010|Actual|2010-07-01||Interventional|||The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease|The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease (SPICE Trial): a Pilot Study|Completed||Phase 3|20|Actual|Mercy Hospital for Women, Australia||2|||f||||||||||||||2017-02-18 15:53:40.356569|2017-02-18 15:53:40.356569
NCT00431405|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-02-01|||August 2006||2006-08-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Observational|||Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population|Assessing Risk of Cardiovascular Events in RA Patients Using a Retrospective Cohort From the VARA Registry|Unknown status|Active, not recruiting|N/A|450||Dallas VA Medical Center|||||f||||||||||||||2017-02-18 15:53:40.47362|2017-02-18 15:53:40.47362
NCT00431392|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2007-02-02|||September 2001||2001-09-01|January 2007|2007-01-01||||||||Interventional|||Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions|Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions|Completed||Phase 2|42||Medical University of Vienna|||||f||||||||||||||2017-02-18 15:53:40.554934|2017-02-18 15:53:40.554934
NCT00431379|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2013-11-04|||February 2007||2007-02-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study|Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study: Phase I|Withdrawn||Phase 1|0|Actual|Medical Center of Central Georgia||1||drug has expired, no enrollments in study. Company pulled funding|f||||||||||||||2017-02-18 15:53:40.644082|2017-02-18 15:53:40.644082
NCT00431366|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2017-01-24|||February 1, 2007||2007-02-01|December 24, 2008|2008-12-24|December 24, 2008||2008-12-24|||||Observational|||Sequence Effect in Parkinson's Disease|The Characteristics of Sequence Effect in de Novo and Advanced Parkinson's Disease|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:53:40.742244|2017-02-18 15:53:40.742244
NCT00431353|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2016-11-01|||April 2004||2004-04-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients|A Randomized, Open-label Study of the Effect of Oral Valcyte Versus Intravenous Ganciclovir on CMV Viremia in Solid Organ Transplant Patients|Completed||Phase 4|325|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 15:53:40.845437|2017-02-18 15:53:40.845437
NCT00431340|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2015-07-07|||March 2007||2007-03-01|July 2015|2015-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma|A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma|Terminated||Phase 2|4|Actual|Onxeo||||Terminated due to dose limiting toxicity|||||||||||||||2017-02-18 15:53:41.006967|2017-02-18 15:53:41.006967
NCT00431327|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-02-02|||February 2005||2005-02-01|February 2007|2007-02-01|October 2006||2006-10-01|||||Interventional|||Facilitators to Keeping Colonoscopy Appointments|Peer Coach Intervention to Improve Attendance to Scheduled Colonoscopy|Completed||Early Phase 1|140||University of Pennsylvania|||||f||||||||||||||2017-02-18 15:53:41.104152|2017-02-18 15:53:41.104152
NCT00431314|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2008-07-08|||January 2007||2007-01-01|January 2007|2007-01-01|March 2007|Actual|2007-03-01|||||Observational|||Effect of Hemodialysis on Toe Pressure- and Finger Pressure and Skin Autofluorescence in Hemodialysis Patients|The Effect of Hemodialysis on Toe Pressure- and Finger Pressure Measurements and Measurement of Skin Autofluorescence; a Pilot Study in the Assessment of Critical Limb Ischemia in Hemodialysis Patients.|Completed||N/A|82|Actual|Isala|||1||f||||f||||||||||2017-02-18 15:53:41.190735|2017-02-18 15:53:41.190735
NCT00431301|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2013-07-03|||August 2006||2006-08-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|February 2013|Actual|2013-02-01||Observational|||Risk Factors for Progressive Supranuclear Palsy (PSP)|Genetic and Environmental Risk Factors for PSP|Completed||N/A|942|Actual|University of Louisville|||2||f||||||||||Samples With DNA|"~     DNA will be used for genotyping specific genes of interest related to the disease.~   "|||2017-02-18 15:53:41.281659|2017-02-18 15:53:41.281659
NCT00431249|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2015-05-11|||February 2007||2007-02-01|May 2015|2015-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease|Effects of Cilostazol on Vascular Endothelial Growth Factor , Inflammatory and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease.|Completed||Phase 4|40|Actual|Tungs’ Taichung Metroharbour Hospital||1|||f||||f||||||||||2017-02-18 15:53:41.74892|2017-02-18 15:53:41.74892
NCT00431236|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-02|2010-10-13||2010-10-13|November 2006||2006-11-01|October 2010|2010-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy|See Detailed Description|Completed||Phase 3|810||GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:53:41.851134|2017-02-18 15:53:41.851134
NCT00430976|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2009-12-10|||December 2006||2006-12-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Exercise, Executive Processes and the Aging Brain|Exercise, Executive Processes and the Aging Brain|Completed||Phase 3|100||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 15:53:42.07619|2017-02-18 15:53:42.07619
NCT00430963|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2011-10-25|||October 2006||2006-10-01|October 2011|2011-10-01|November 2007|Actual|2007-11-01|April 2007|Actual|2007-04-01||Interventional|||IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines|A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Trial With an Open-label Extension Period to Investigate the Efficacy and Safety of IncobotulinumtoxinA (Xeomin), Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines|Completed||Phase 3|256|Actual|Merz Pharmaceuticals GmbH||2|||f||||f||||||||||2017-02-18 15:53:42.177778|2017-02-18 15:53:42.177778
NCT00430950|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2009-04-29|2009-02-09||February 2007||2007-02-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension|Efficacy and Safety of Olmesartan Medoxomil/Hydrochlorothiazide Combination 20/25 mg Versus 40/25 mg in Moderately to Severely Hypertensive Patients Not Adequately Controlled by Olmesartan Medoxomil 40 mg Monotherapy|Completed||Phase 3|1011|Actual|Daiichi Sankyo Inc.||2|||f||||||||||||||2017-02-18 15:53:42.284218|2017-02-18 15:53:42.284218
NCT00430937|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2012-07-10|2010-12-07||April 2006||2006-04-01|July 2012|2012-07-01||||March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections|A Multicenter, Randomized, Assessor-Blind Study to Evaluate Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections (cSSTI)|Terminated||Phase 3|194|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:53:42.864436|2017-02-18 15:53:42.864436
NCT00430924|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2012-02-07|||March 2007||2007-03-01|February 2012|2012-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Inhibition of Aldosterone in Patients With Chronic Renal Disease|The Effect of Aldosterone Inhibition on Proteinuria in Patients With Progressive Renal Disease|Completed||Phase 4|42|Actual|Herlev Hospital||2|||f||||t||||||||||2017-02-18 15:53:43.321766|2017-02-18 15:53:43.321766
NCT00430911|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2007-01-31|||February 2001||2001-02-01|January 2007|2007-01-01||||||||Interventional|||Radiotherapy for Malignant Astrocytomas in the Elderly||Completed||Phase 3|||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 15:53:43.435376|2017-02-18 15:53:43.435376
NCT00430898|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2008-12-17|||January 2007||2007-01-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Basiliximab in Moderate to Severe Ulcerative Colitis|A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of Basiliximab, With Concomitant Corticosteroids, in Steroid-Refractory Ulcerative Colitis|Completed||Phase 2|181|Anticipated|Cerimon Pharmaceuticals||2|||f||||t||||||||||2017-02-18 15:53:43.546014|2017-02-18 15:53:43.546014
NCT00430885|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2014-01-24|||February 2007||2007-02-01|January 2014|2014-01-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction|Phase III Study of Intravenous Immunglobulin (IVIG) in Patients With Heart Failure After Myocardial Infarction|Completed||Phase 3|62|Actual|Oslo University Hospital||2|||f||||f||||||||||2017-02-18 15:53:43.954333|2017-02-18 15:53:43.954333
NCT00430872|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2012-07-31|||January 2007||2007-01-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Development of the MDASI-Spine Tumor Module|Validation of the M.D. Anderson Symptom Inventory-Spine Tumor Module|Completed||N/A|128|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:53:44.086376|2017-02-18 15:53:44.086376
NCT00430859|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2012-03-30|||September 2004||2004-09-01|March 2012|2012-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis|A Pilot, Double-blind, Randomised, Placebo-controlled, Exploratory Study to Investigate the Safety and Effect of Bovine Intestinal Alkaline Phosphatase in Patients With Sepsis|Completed||Phase 2|37|Actual|AM-Pharma||2|||f||||t||||||||||2017-02-18 15:53:44.20901|2017-02-18 15:53:44.20901
NCT00430846|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2014-12-17|||November 2006||2006-11-01|December 2014|2014-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies|A Phase I Dose Escalation Study of SGN-35 in Patients With Relapsed/Refractory CD30-Positive Hematologic Malignancies.|Completed||Phase 1|45|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-02-18 15:53:44.348926|2017-02-18 15:53:44.348926
NCT00430833|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2007-01-31||||||January 2007|2007-01-01||||||||Interventional|||CHANCE - Candesartan in Hypertrophic Cardiomyopathy|Candesartan Use in Hypertrophic and Non-Obstructive Cardiomyopathy Estate (The CHANCE): a Double-Blind, Placebo-Controlled, Randomized, Multicenter Study|Unknown status|Active, not recruiting|Phase 2|||Charles University, Czech Republic|||||f||||||||||||||2017-02-18 15:53:44.470107|2017-02-18 15:53:44.470107
NCT00430820|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2010-12-02|||March 2007||2007-03-01|April 2009|2009-04-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Observational|||Discovery of New Circulating Biomarkers of Coronary Atherosclerosis|Discovery of New Circulating Biomarkers of Coronary Atherosclerosis Using Differential Proteomics: the BIOmarkers of CORonary Events (BIOCORE) Study|Completed||N/A|124|Actual|Assistance Publique - Hôpitaux de Paris|||3||f||||f||||||Samples With DNA|"~     biomarqueurs~   "|||2017-02-18 15:53:44.572435|2017-02-18 15:53:44.572435
NCT00430807|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2015-10-04|||January 2002||2002-01-01|October 2015|2015-10-01|December 2006|Actual|2006-12-01|January 2005|Actual|2005-01-01||Interventional|||Hydroxychloroquine in Giant Cell Arteritis|Multicentric Double Blind Versus Placebo Randomised Study Evaluating the Corticosteroid Sparing Effect of Hydrocyschloroquine in Non Complicated Giant Cell Arteritis.|Completed||Phase 3|75|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 15:53:44.690897|2017-02-18 15:53:44.690897
NCT00430794|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2010-12-03|||March 2007||2007-03-01|February 2007|2007-02-01|December 2008|Actual|2008-12-01|||||Interventional|||The Efficacy of Spironolactone in Patients With Resistant Hypertension|A Randomised, Placebo Controlled Trial of the Efficacy of the Addition of Spironolactone to Modern Antihypertensive Treatment Regimens in Patients With Resistant Hypertension|Terminated||Phase 2|40|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust||||Difficulties with recruitment.|f||||||||||||||2017-02-18 15:53:44.840901|2017-02-18 15:53:44.840901
NCT00430781|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2015-04-15|2009-11-19||November 2006||2006-11-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2008|Actual|2008-07-01||Interventional|||Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer|A Phase II, Open-Label, Randomized, Multicenter Trial of Pazopanib (GW786034) in Combination With Lapatinib (GW572016) Compared to Pazopanib Monotherapy and Lapatinib Monotherapy in Subjects With FIGO Stage IVB or Recurrent or Persistent Cervical Cancer With Zero or One Prior Chemotherapy Regimen|Completed||Phase 2|228|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 15:53:44.966237|2017-02-18 15:53:44.966237
NCT00430768|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2016-12-13|2016-09-21||February 2006||2006-02-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|AAT||Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency|Preclinical & Phase I/II Trials of AAV-AAT Vectors: Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Alpha 1-Antitrypsin (rAAV1-CB-hAAT) Gene Vector to AAT-Deficient Adults|Completed||Phase 1|9|Actual|University of Massachusetts, Worcester|Study results based on small number of subjects No statistical analysis.|3|||f||||t||||||||Yes|Laboratory information shared as received; copy of manuscript given to patients; at 5 year follow up Principal investigator explained results to patients|2017-02-18 15:53:46.69501|2017-02-18 15:53:46.69501
NCT00430755|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2015-11-15|2010-09-24||August 2005||2005-08-01|November 2015|2015-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CLEOS||Improving the Quality of Patient Care by Using a Clinical Expert System.|Quality Assessment for History Taking With or Without an Knowledge Based Interview System.|Completed||N/A|98|Actual|Robert Bosch Gesellschaft für Medizinische Forschung mbH||1|||f||||f||||||||||2017-02-18 15:53:47.643142|2017-02-18 15:53:47.643142
NCT00430742|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2015-02-12|||November 2006||2006-11-01|February 2015|2015-02-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|||An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)|A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Taranabant (MK0364) in Overweight and Obese Patients With Type 2 Diabetes Mellitus (T2DM) Followed by a 1-Year Extension|Terminated||Phase 3|600|Actual|Merck Sharp & Dohme Corp.||4||The overall profile does not support development for obesity|f||||||||||||||2017-02-18 15:53:47.855191|2017-02-18 15:53:47.855191
NCT00430729|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2016-11-29|||January 2003||2003-01-01|September 2016|2016-09-01||||||||Interventional|||Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)|Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. A 52 Weeks Double Blind Study With 500mcg Roflumilast Once Daily Versus Placebo. Ratio-Study.|Completed||Phase 3|1100||AstraZeneca|||||f||||||||||||||2017-02-18 15:53:47.949046|2017-02-18 15:53:47.949046
NCT00430716|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2011-05-25|2011-04-22||April 2008||2008-04-01|May 2011|2011-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.|A Multinational, Multicentre, Randomized, Parallel Group, Double-Blind Study To Assess The Efficacy and Safety Of 1 mg, 5 mg and 20 mg TID of Oral Sildenafil in the Treatment of Subjects Aged 18 Years and Over With Pulmonary Arterial Hypertension (PAH)|Terminated||Phase 4|130|Actual|Pfizer|The trial was not designed to demonstrate the equivalence of doses and due to premature study termination, the resulting sample size was not adequately powered to show superiority.|4||"This study was terminated at the recommendation of an independent Data Monitoring Committee.~   The decision was not based on any safety concerns."|f||||t||||||||||2017-02-18 15:53:50.689201|2017-02-18 15:53:50.689201
NCT00430703|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2008-11-05|||August 2006||2006-08-01|November 2008|2008-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Passive Gait Training on the Cortical Activity in Patients With Severe Traumatic Brain Injury.|Effect of Massive Proprioceptive Stimulation With Passive Gait Training on the Cortical Activity in Patients With Impaired States of Consciousness After Severe Traumatic Brain Injury.|Completed||Early Phase 1|26|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:53:52.37894|2017-02-18 15:53:52.37894
NCT00430690|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2017-01-17|||September 2006||2006-09-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2012|Actual|2012-08-01||Observational|||Acoustic Startle Reduction In Cocaine Dependence|Acoustic Startle Reduction In Cocaine Dependence|Active, not recruiting||N/A|135|Anticipated|Emory University|||3||f||||f||||||Samples With DNA|"~     Blood and extracted DNA~   "|No||2017-02-18 15:53:52.483639|2017-02-18 15:53:52.483639
NCT00430677|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2015-03-03|2012-02-13||June 2007||2007-06-01|March 2015|2015-03-01|August 2011|Actual|2011-08-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis|A Phase II/III Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Versus Placebo on a Background of Mycophenolate Mofetil and Glucocorticosteroids in Subjects With Active Proliferative Glomerulonephritis Due to Systemic Lupus Erythematosus (SLE)|Terminated||Phase 2/Phase 3|423|Actual|Bristol-Myers Squibb||4||Terminated due to failure to meet the primary efficacy endpoint in the Short-term Period|f||||t||||||||||2017-02-18 15:53:52.616575|2017-02-18 15:53:52.616575
NCT00430664|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-02-01|||January 2006||2006-01-01|February 2007|2007-02-01|December 2007||2007-12-01|||||Interventional|||A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis|A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis|Unknown status|Recruiting|N/A|100||Postgraduate Institute of Medical Education and Research|||||f||||||||||||||2017-02-18 15:53:56.114089|2017-02-18 15:53:56.114089
NCT00430651|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2009-01-27|||July 2004||2004-07-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)|Multicenter Randomized Phase III Study Comparing Docetaxel With Carboplatin Versus Docetaxel Single Agent as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (NSCLC).|Completed||Phase 3|135|Actual|Hellenic Oncology Research Group||2|||f||||||||||||||2017-02-18 15:53:56.198587|2017-02-18 15:53:56.198587
NCT00430638|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2010-01-27|2008-10-03||December 2006||2006-12-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension|A Double-Blind, Randomized, Placebo Controlled, Parallel Group Study to Compare the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen to Placebo in Patients With Stage I and Stage II Hypertension|Completed||Phase 4|278|Actual|Daiichi Sankyo Inc.||2|||f||||||||||||||2017-02-18 15:53:56.319355|2017-02-18 15:53:56.319355
NCT00430625|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2014-02-19|2010-06-03||January 2007||2007-01-01|February 2014|2014-02-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease|A Multicenter, Randomized, Double-Blind, Parallel Group, Two-Dose Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease|Completed||Phase 3|25|Actual|Shire|Due to small sample sizes no conclusions could be drawn on Quality of life (QOL).|2|||f||||f||||||||||2017-02-18 15:53:56.905589|2017-02-18 15:53:56.905589
NCT00430612|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2015-04-30|||May 2009||2009-05-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|December 2013|Actual|2013-12-01|2 Years|Observational [Patient Registry]|OBTAIN||The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)|The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)|Active, not recruiting||N/A|6830|Anticipated|Northwestern University|||1||f||||t||||||||||2017-02-18 15:53:57.822226|2017-02-18 15:53:57.822226
NCT00430599|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2015-10-07|||February 2007||2007-02-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|||||Observational|||The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis||Completed||Phase 4|20|Actual|Newcastle-upon-Tyne Hospitals NHS Trust|||1||f||||||||||||||2017-02-18 15:53:57.957003|2017-02-18 15:53:57.957003
NCT00430586|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2011-08-02|||November 2006||2006-11-01|August 2011|2011-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines|A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Determine the Optimal Dose of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines|Completed||Phase 2|191|Actual|Merz Pharmaceuticals GmbH||4|||f||||||||||||||2017-02-18 15:53:58.041253|2017-02-18 15:53:58.041253
NCT00430573|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2013-05-23|||February 2007||2007-02-01|April 2013|2013-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use|Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use|Completed||Phase 2|36|Actual|Boston University||2|||f||||t||||||||||2017-02-18 15:53:58.136994|2017-02-18 15:53:58.136994
NCT00430560|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2016-12-19|||October 2000||2000-10-01|July 2015|2015-07-01|October 2015|Actual|2015-10-01|October 2005|Actual|2005-10-01||Interventional|||Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia|Work Activity Augmented by Cognitive Rehabilitation: Continuation and Follow-up|Completed||Phase 2/Phase 3|150|Anticipated|VA Connecticut Healthcare System||2|||f||||f||||||||||2017-02-18 15:53:58.278462|2017-02-18 15:53:58.278462
NCT00430547|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-02-01|||August 2003||2003-08-01|August 2003|2003-08-01|January 2006||2006-01-01|||||Interventional|||Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies|Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies|Completed||N/A|60||Barwon Health|||||f||||||||||||||2017-02-18 15:53:58.407529|2017-02-18 15:53:58.407529
NCT00430534|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2007-02-01||||||February 2007|2007-02-01||||||||Interventional|||Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).|To Evaluate the Safety, Immunogenicity and Efficacy of GSK Biologicals’ EBV Vaccine (268664) in Healthy Seronegative Adolescents/Adults When Injected Intramuscularly According to a 0-1-5 Month Schedule in Belgium.|Completed||Phase 2|200||Henogen|||||f||||||||||||||2017-02-18 15:53:58.49334|2017-02-18 15:53:58.49334
NCT00430521|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2016-10-18||2009-05-20|February 2007||2007-02-01|October 2016|2016-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)|Reactogenicity and Immunogenicity Study of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1119711A) Administered According to Different Vaccination Schedules|Completed||Phase 2|512|Actual|GlaxoSmithKline||8|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:53:58.582586|2017-02-18 15:53:58.582586
NCT00430508|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2009-06-17|2009-02-09||February 2007||2007-02-01|June 2009|2009-06-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension|Efficacy and Safety of Hydrochlorothiazide (HCTZ) Used as Add-on Therapy in Moderately to Severely Hypertensive Patients Not Adequately Controlled by Olmesartan Medoxomil (OM) 40 mg Monotherapy|Completed||Phase 3|972|Actual|Daiichi Sankyo Inc.||4|||f||||f||||||||||2017-02-18 15:53:58.723851|2017-02-18 15:53:58.723851
NCT00430495|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-01-19|2016-01-19||December 2006||2006-12-01|January 2016|2016-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|AUGUST I|Intention-to-treat (ITT) population included all randomized participants who received at least one treatment dose.|A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)|A Randomized, Double-blind, Placebo-controlled, Multicentre, Phase II Dose-finding Study of Atacicept Given Subcutaneously in Subjects With Rheumatoid Arthritis and Inadequate Response to TNFa Antagonist Therapy|Completed||Phase 2|256|Actual|EMD Serono||4|||f||||f||||||||||2017-02-18 15:53:59.76953|2017-02-18 15:53:59.76953
NCT00430482|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2013-05-23|||June 2005||2005-06-01|April 2013|2013-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Stress, Distress Intolerance, and Drug Dependence|Stress, Distress Intolerance, and Drug Dependence|Completed||Phase 2|133|Actual|Boston University||2|||f||||t||||||||||2017-02-18 15:54:00.808325|2017-02-18 15:54:00.808325
NCT00430469|ClinicalTrials.gov processed this data on February 17, 2017|2007-02-01|2015-06-29|||November 2008||2008-11-01|June 2015|2015-06-01|June 2009|Anticipated|2009-06-01|March 2009|Anticipated|2009-03-01||Interventional|||Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients|Safety of a 0.5mg Dose of hLF1-11 Given for 10 Consecutive Days to Autologous Haematopoietic Stem Cell Transplant Recipients|Withdrawn||Phase 1/Phase 2|0|Actual|AM-Pharma||1||Strategic company decision|f||||t||||||||||2017-02-18 15:54:00.927082|2017-02-18 15:54:00.927082
NCT00430456|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2012-06-11|||August 2006||2006-08-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|March 2011|Actual|2011-03-01||Interventional|STEPs||Treadmill Exercise Prescriptions to Improve Fitness Versus Ambulatory Function After Stroke.|Treadmill Exercise Prescriptions to Improve Fitness Versus Ambulatory Function After Stroke|Completed||Phase 1|120|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 15:54:01.035475|2017-02-18 15:54:01.035475
NCT00430443|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2011-08-30|||February 2007||2007-02-01|August 2011|2011-08-01|January 2009|Actual|2009-01-01|||||Interventional|||Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML|Phase I Study of Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed Acute Lymphocytic Leukemia and Acute Myelogeneous Leukemia|Terminated||Phase 1|3|Actual|Callisto Pharmaceuticals||1||Participants are no longer being examined or treated.|f||||f||||||||||2017-02-18 15:54:01.145238|2017-02-18 15:54:01.145238
NCT00430430|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-10-25|||April 2007||2007-04-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Lipoprotein Turnover on Low- and High-MUFA Portfolio Diets|Lipoprotein Turnover on Low- and High-MUFA Portfolio Diets|Completed||Phase 2|24|Actual|University of Toronto||2|||f||||||||||||||2017-02-18 15:54:01.25573|2017-02-18 15:54:01.25573
NCT00430417|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2013-10-30|||January 2007||2007-01-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Bone Metabolism and Parathyroid Hormone-related Protein (PTHrP) Lactation Study|A Prospective Cohort Pilot Study of Bone Metabolism in Lactating and Non-lactating Postpartum Women and Healthy Non-pregnant Women|Completed||N/A|49|Actual|University of Pittsburgh|||3||f||||t||||||Samples Without DNA|"~     archival blood serum and plasma~   "|||2017-02-18 15:54:01.36843|2017-02-18 15:54:01.36843
NCT00430404|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2014-01-02|||August 2004||2004-08-01|January 2014|2014-01-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||Screening and Treatment of Depression in the Community|Randomized Controlled Trial of a Community-based Early Psychiatric Intervention Strategy to Screen and Manage Depression in the Elderly|Completed||Phase 4|214|Actual|National University Hospital, Singapore||2|||f||||f||||||||||2017-02-18 15:54:01.485913|2017-02-18 15:54:01.485913
NCT00430391|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2013-06-18|||December 2003||2003-12-01|January 2011|2011-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Comparison of Video Consent Versus Routine Consent for Participation in Research Studies|Comparison of Video Consent and Routine Consent for Research|Completed||N/A|382|Actual|University of California, San Diego||8|||f||||t||||||||||2017-02-18 15:54:01.598259|2017-02-18 15:54:01.598259
NCT00430378|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-12-19|||January 2007||2007-01-01|December 2016|2016-12-01||||January 2018|Anticipated|2018-01-01||Interventional|||Acupuncture for Prevention of Radiation-Induced Xerostomia|Acupuncture for Prevention of Radiation-Induced Xerostomia|Active, not recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:54:01.70762|2017-02-18 15:54:01.70762
NCT00430365|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2015-11-25|||June 2006||2006-06-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|IFM2005-02||Maintenance Therapy Using Lenalidomide in Myeloma|Relevance of Maintenance Therapy Using Lenalidomide (Revimid®) After Autologous Stem Cell Transplantation Patients Under the Age Of 65. (Open, Randomised, Multi-centric Trial Versus Placebo).|Active, not recruiting||Phase 3|614|Anticipated|University Hospital, Toulouse||2|||f||||t||||||||||2017-02-18 15:54:01.820062|2017-02-18 15:54:01.820062
NCT00430352|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2015-06-03|2014-09-04||September 2006||2006-09-01|June 2015|2015-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||Intent-to-treat (ITT) population: all participants who completed a baseline visit and at least 1 further assessment.|MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.|A Study to Evaluate the Safety of MabThera (Rituximab) Maintenance Therapy in Patients With Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy.|Completed||Phase 4|545|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:54:02.000743|2017-02-18 15:54:02.000743
NCT00430326|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2010-03-08|||November 2006||2006-11-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Juvista (Avotermin) in Scars Following Varicose Vein Removal|A Dose Response Trial to Investigate the Efficacy of Juvista (Avotermin) in the Improvement of Scar Appearance When Applied to Approximated Wound Margins Following Bilateral Varicose Vein Removal.|Completed||Phase 2|156|Anticipated|Renovo||1|||f||||f||||||||||2017-02-18 15:54:02.937479|2017-02-18 15:54:02.937479
NCT00430313|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-09-12|||January 2007||2007-01-01|September 2016|2016-09-01||||January 2018|Anticipated|2018-01-01||Interventional|||Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin|Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin|Active, not recruiting||N/A|100|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:54:03.055648|2017-02-18 15:54:03.055648
NCT00430300|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2013-05-17|2013-05-17||January 2007||2007-01-01|May 2013|2013-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.|A Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group Study To Evaluate the Efficacy And Safety of UK-432,097 Dry Powder For Inhalation In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease.|Terminated||Phase 2|87|Actual|Pfizer|Study was terminated prematurely due to futility based on results of interim analysis.|2|||f||||t||||||||||2017-02-18 15:54:03.210807|2017-02-18 15:54:03.210807
NCT00430287|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-11-08|||March 2007||2007-03-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines?|Correlation of DDLS Grading to OCT, HRT, and HVF|Completed||N/A|101|Actual|Wills Eye|||2||f||||f||||||||Yes|A manuscript has been published.|2017-02-18 15:54:06.091642|2017-02-18 15:54:06.091642
NCT00430274|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2016-11-23|||January 2006||2006-01-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|August 2009|Actual|2009-08-01||Observational|||Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls|Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls|Active, not recruiting||N/A|120|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||No||2017-02-18 15:54:06.188035|2017-02-18 15:54:06.188035
NCT00430261|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2010-10-05|||January 2007||2007-01-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma|Phase II Trial of Sunitinib in Bronchoalveolar Carcinoma or Never-Smokers With Any Lung Adenocarcinoma|Completed||Phase 2|20|Anticipated|Swedish Medical Center||1|||f||||f||||||||||2017-02-18 15:54:06.268344|2017-02-18 15:54:06.268344
NCT00430248|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-01-31|2009-03-12||February 2007||2007-02-01|January 2012|2012-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|CONFIRMS||Efficacy and Safety of Oral Febuxostat in Participants With Gout|A Phase 3, Randomized, Multicenter, Double-Blind, Allopurinol-Controlled Study Assessing the Efficacy and Safety of Oral Febuxostat in Subjects With Gout.|Completed||Phase 3|2269|Actual|Takeda||3|||f||||t||||||||||2017-02-18 15:54:06.471506|2017-02-18 15:54:06.471506
NCT00430235|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2010-08-04|||March 2007||2007-03-01|August 2010|2010-08-01||||August 2010|Actual|2010-08-01||Interventional|||A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer|A Phase II Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer|Completed||Phase 2|39|Actual|British Columbia Cancer Agency||1|||f||||||||||||||2017-02-18 15:54:11.339733|2017-02-18 15:54:11.339733
NCT00430209|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2013-12-10|||December 2006||2006-12-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Neurovascular Coupling in Eyes of Glaucoma Patients|Neurovascular Coupling in Eyes of Glaucoma Patients|Completed||N/A|150|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 15:54:11.447262|2017-02-18 15:54:11.447262
NCT00430196|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2007-01-31|||December 2003||2003-12-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity|Placebo-Controlled Trial of BOTOX® Versus Zanaflex® for the Treatment of Subjects With Post Stroke Upper Limb Spasticity|Completed||Phase 4|135||Icahn School of Medicine at Mount Sinai|||||f||||||||||||||2017-02-18 15:54:11.531637|2017-02-18 15:54:11.531637
NCT00430183|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-04-13|||December 2006||2006-12-01|April 2016|2016-04-01||||June 2018|Anticipated|2018-06-01||Interventional|||Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer|A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer|Active, not recruiting||Phase 3|788|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 15:54:11.628382|2017-02-18 15:54:11.628382
NCT00430170|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2008-07-28|||January 2007||2007-01-01|July 2008|2008-07-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?|Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?|Completed||Phase 4|20|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 15:54:12.20744|2017-02-18 15:54:12.20744
NCT00430157|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-05-31|||January 2007||2007-01-01|February 2011|2011-02-01||||||||Interventional|||Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber|An 8 Day, Randomised, Double Blinded, Placebo-controlled 2-way Crossover Trial of Repeat Doses of Intranasal GSK256066 and Placebo in the Vienna Challenge Chamber in Subjects With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 2|45|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:54:12.328506|2017-02-18 15:54:12.328506
NCT00430144|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2012-04-25|||January 2007||2007-01-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|August 2009|Actual|2009-08-01||Interventional|||Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix|A Phase II Study of Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix|Completed||Phase 2|16|Actual|National Cancer Center, Korea||1|||f||||f||||||||||2017-02-18 15:54:12.421932|2017-02-18 15:54:12.421932
NCT00430131|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2009-08-12|||December 2006||2006-12-01|August 2009|2009-08-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Investigating Best Practices for Children With Cerebral Palsy: A Pilot Study of Two Approaches|Investigating Best Practices for Children With Cerebral Palsy: A Pilot Study of Two Approaches|Unknown status|Active, not recruiting|N/A|18|Actual|University of Toronto|||||f||||f||||||||||2017-02-18 15:54:12.534818|2017-02-18 15:54:12.534818
NCT00430118|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2013-05-28|||July 2000||2000-07-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia|ALL-BFM 2000 Multi-Center Study for the Treatment of Children and Adolescents With Acute Lymphoblastic Leukemia|Completed||Phase 3|4559|Actual|University of Schleswig-Holstein||10|||f||||||||||||||2017-02-18 15:54:12.620379|2017-02-18 15:54:12.620379
NCT00430105|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2007-01-31|||February 1998||1998-02-01|January 2007|2007-01-01|April 2004||2004-04-01|||||Interventional|||Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides|Randomized Trial of Intravenous Pulse Versus Oral Continuous Cyclophosphamide for Induction of Remission in Systemic ANCA-Associated Vasculitides|Completed||Phase 2/Phase 3|160||Cambridge University Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 15:54:12.902459|2017-02-18 15:54:12.902459
NCT00430092|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2009-05-12|2009-05-12|||||May 2009|2009-05-01||||||||Interventional|||Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)|A Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery|Completed||Phase 3|219|Actual|Sirion Therapeutics, Inc.||3|||f||||||||||||||2017-02-18 15:54:12.990133|2017-02-18 15:54:12.990133
NCT00430079|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2013-01-15|||July 2001||2001-07-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma|Assessment of Hypoxia in Malignant Gliomas Using EF5|Terminated||N/A|48|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 15:54:13.334556|2017-02-18 15:54:13.334556
NCT00430066|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2014-10-07|||February 2007||2007-02-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|November 2009|Actual|2009-11-01||Interventional|||Effects of Imatinib Mesylate in Polycythemia Vera|Glivec (Imatinib Mesylate) in the Treatment of Polycythemia Vera|Completed||Phase 2|9|Actual|Niguarda Hospital||1|||f||||t||||||||||2017-02-18 15:54:13.449128|2017-02-18 15:54:13.449128
NCT00430053|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-03-14|||January 2004||2004-01-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|||||Observational|||Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma|Pathogenesis And Course Of Cutaneous T-Cell Lymphoma|Completed||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:54:13.550432|2017-02-18 15:54:13.550432
NCT00430040|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-12-17|||February 2007||2007-02-01|December 2012|2012-12-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.|Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI:Effects on Oxidative Stress and Inflammation.|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Kaleida Health||2|||f||||f||||||||||2017-02-18 15:54:13.641232|2017-02-18 15:54:13.641232
NCT00429832|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2007-01-31|||October 2003||2003-10-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department|A Randomized Controlled Trial of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department|Completed||Phase 4|120||University of New Mexico|||||f||||||||||||||2017-02-18 15:54:19.184687|2017-02-18 15:54:19.184687
NCT00430027|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2013-10-22|2013-10-22||November 2006||2006-11-01|October 2013|2013-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma|Pilot Feasibility Trial of Preoperative Capecitabine, Oxaliplatin, Cetuximab and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma|Terminated||N/A|8|Actual|University of Colorado, Denver|This study was terminated due slow accrual.|1||This study was terminated due slow accrual.|f||||t||||||||||2017-02-18 15:54:13.75029|2017-02-18 15:54:13.75029
NCT00430014|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2012-02-14|||March 2005||2005-03-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study of Atiprimod Treatment for Patients With Advanced Cancer|An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer|Terminated||Phase 1|28|Actual|M.D. Anderson Cancer Center||1||Sponsor Withdrew|f||||f||||||||||2017-02-18 15:54:14.234002|2017-02-18 15:54:14.234002
NCT00430001|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2008-05-06|||May 2005||2005-05-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer|A Randomised Phase III Study of Trastuzumab-Docetaxel vs Trastuzumab-Vinorelbine as 1. Line Therapy for Patients With Metastatic HER2 Positive Breast Cancer|Unknown status|Recruiting|Phase 3|300|Anticipated|Danish Breast Cancer Cooperative Group||2|||f||||||||||||||2017-02-18 15:54:14.344645|2017-02-18 15:54:14.344645
NCT00429988|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-09-25|||August 2002||2002-08-01|September 2012|2012-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Observational|||Study of Ductal Lavage in Women at High Risk for Breast Cancer|Ductal Lavage to Monitor and Treat High Risk Women|Completed||N/A|30|Actual|University of California, San Francisco|||1||f||||||||||||||2017-02-18 15:54:14.443113|2017-02-18 15:54:14.443113
NCT00429975|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2007-01-31|||August 2004||2004-08-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia|Comparison Between Ceftriaxone and Levofloxacin on Cytokine Expression Over Time in Severe Pneumococcal Pneumonia|Terminated||Phase 4|45||Hospital Mutua de Terrassa|||||f||||||||||||||2017-02-18 15:54:14.539242|2017-02-18 15:54:14.539242
NCT00429962|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2009-04-06|||July 2006||2006-07-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV|Randomized, Phase IIIb Study Comparing Safety, Tolerability and Efficacy Between Lucentis® Administered in Conjunction With PDT With Visudyne® and Lucentis® in Patients With Subfoveal CNV Secondary to Age-Related Macular Degeneration|Completed||Phase 3|40|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 15:54:14.633526|2017-02-18 15:54:14.633526
NCT00429949|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2014-08-15|2014-07-28||January 2007||2007-01-01|August 2014|2014-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma|A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma|Completed||Phase 2|21|Actual|Washington University School of Medicine||1|||f||||||||||||||2017-02-18 15:54:14.763303|2017-02-18 15:54:14.763303
NCT00429936|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2010-06-21|||December 2006||2006-12-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration|A Phase II Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects With Age-Related Macular Degeneration|Completed||Phase 2|245|Actual|Sirion Therapeutics, Inc.||3|||f||||t||||||||||2017-02-18 15:54:15.344808|2017-02-18 15:54:15.344808
NCT00429923|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2009-05-12|2009-05-12|||||May 2009|2009-05-01||||||||Interventional|||Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)|A Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery|Completed||Phase 3|219|Actual|Sirion Therapeutics, Inc.||3|||f||||||||||||||2017-02-18 15:54:15.440637|2017-02-18 15:54:15.440637
NCT00429910|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-12-30|||February 2003||2003-02-01|December 2016|2016-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Natural History Study of Patients With Chronic Myelogenous Leukemia|Chronic Myeloid Leukemia (CML) Cohort|Completed||N/A|48|Actual|Dana-Farber Cancer Institute|||1||f||||f||||||||No||2017-02-18 15:54:15.753728|2017-02-18 15:54:15.753728
NCT00429897|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2007-01-31|||August 2006||2006-08-01|January 2007|2007-01-01|July 2007||2007-07-01|||||Interventional|||Double Blind Crossover Comparison of Diuretics in the Young|Double Blind Crossover Comparison od Diuretics in Young Patients With Low Renin Hypertension|Unknown status|Recruiting|N/A|30||University of Cambridge|||||f||||||||||||||2017-02-18 15:54:15.84636|2017-02-18 15:54:15.84636
NCT00428870|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2017-02-06|||February 2005||2005-02-01|February 2017|2017-02-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|||Operative or Conservative Treatment for Subacromial Impingement Syndrome?|Arthroscopic Decompression Versus Diagnostic Arthroscopy Without Subacromial Decompression Versus Supervised Exercise Therapy in Treatment of Subacromial Impingement Syndrome. A Blinded Randomized Controlled Trail.|Active, not recruiting||N/A|210|Actual|Helsinki University||3|||f||||||||||||||2017-02-18 15:54:15.944693|2017-02-18 15:54:15.944693
NCT00428857|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2011-02-23|||June 2008||2008-06-01|January 2007|2007-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|POPVNI||Noninvasive Ventilatory Support After Lung Surgery in COPD Patients|Noninvasive Ventilatory Support After Lung Surgery to Prevent Pulmonary Complications in COPD Patients|Completed||N/A|360|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||||||||||||2017-02-18 15:54:16.068382|2017-02-18 15:54:16.068382
NCT00428844|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2016-01-05|2011-03-16||January 2007||2007-01-01|January 2016|2016-01-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci|A Phase 2 Randomized Study Investigating the Safety, Efficacy and Pharmacokinetics of Daptomycin 6 mg/kg and 8 mg/kg Versus Comparator in the Treatment of Subjects Undergoing Surgical Standard of Care for Osteomyelitis Associated With an Infected Prosthetic Hip or Knee Joint Caused by Staphylococci|Completed||Phase 2|75|Actual|Cubist Pharmaceuticals LLC||3|||f||||t||||||||||2017-02-18 15:54:16.162255|2017-02-18 15:54:16.162255
NCT00428831|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2013-12-19|||February 2007||2007-02-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Clinical IGSP-CHOP Boston|Clinical Correlates to Influenza Genomic Data|Completed||N/A|500|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||||||2017-02-18 15:54:16.894234|2017-02-18 15:54:16.894234
NCT00428818|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-29|||August 2005||2005-08-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue Infections|Empiric Therapy With Trimethoprim-Sulfamethoxazole or Doxycycline for Outpatient Skin and Soft Tissue Infections in an Area of High MRSA Prevalence: A Prospective Randomized Trial|Completed||N/A|75||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 15:54:16.982916|2017-02-18 15:54:16.982916
NCT00428805|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2015-11-30|||March 2006||2006-03-01|July 2009|2009-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|CHILE||Child Health Initiative for Lifelong Eating and Exercise (CHILE)|Site Specific Approaches to Prevention or Management of Pediatric Obesity: Child Health Initiative for Lifelong Eating and Exercise--CHILE|Completed||N/A|980|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 15:54:17.067646|2017-02-18 15:54:17.067646
NCT00428792|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2011-04-11|2011-01-06||April 2007||2007-04-01|April 2011|2011-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)|An Open-label, Randomized, Rater-blinded, Cross-over, Multicenter Study Comparing the Clinical Efficacy of Methylphenidate (Immediate Release/Extended Release) Treatment (20 or 40 mg Orally od) in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Under Different Breakfast Conditions Over Two Weeks|Completed||Phase 3|150|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:54:17.17618|2017-02-18 15:54:17.17618
NCT00428779|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2009-06-10|||September 2007||2007-09-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Neuromuscular and Cognitive Fatigue During a 24 Hour Treadmill Running Exercise|Neuromuscular and Cognitive Fatigue During a 24h Treadmill Running Exercise.|Completed||N/A|30|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||f||||||||||2017-02-18 15:54:17.973889|2017-02-18 15:54:17.973889
NCT00428766|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-28|2013-11-05|||June 2005||2005-06-01|November 2013|2013-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer|A Study of the Safety, Tolerability, and Pharamcokinetics of MORAb-003, a Humanized Monoclonal Antibody, in Subjects With Advanced Ovarian Cancer|Completed||Phase 1|24|Anticipated|Morphotek|||||f||||||||||||||2017-02-18 15:54:18.079334|2017-02-18 15:54:18.079334
NCT00428753|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-05-29|||January 2007||2007-01-01|May 2008|2008-05-01|January 2008||2008-01-01|||||Observational|||China Case Control Avian Influenza|Matched Case-Control Study of Risk Factors for Human Infection With Avian Influenza A (H5N1) Virus, China|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 15:54:18.17119|2017-02-18 15:54:18.17119
NCT00428740|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-29|||October 2005||2005-10-01|January 2007|2007-01-01|December 2005||2005-12-01|||||Observational|||Long-Term IOP Fluctuation and VF Progression After Triple Procedure|Long-Term Intraocular Pressure Fluctuation and Visual Field Progression in Glaucoma Patients With Low Intraocular Pressure After Triple Procedure|Completed||N/A|300||Yonsei University|||||f||||||||||||||2017-02-18 15:54:18.253384|2017-02-18 15:54:18.253384
NCT00428727|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2012-11-02|||January 2005||2005-01-01|November 2012|2012-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON|Double Blind, Randomized, Placebo Controlled Clinical Trial for the Treatment of Diabetic Foot Ulcers, Using a Nitric Oxide Releasing Patch: PATHON|Completed||Phase 3|100|Actual|Fundación Cardiovascular de Colombia||2|||f||||t||||||||||2017-02-18 15:54:18.337402|2017-02-18 15:54:18.337402
NCT00428714|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2011-08-01||2010-05-27|January 2007||2007-01-01|August 2011|2011-08-01|January 2011|Actual|2011-01-01|June 2009|Actual|2009-06-01||Interventional|||Phase 2 Trial of Enzastaurin in Prostate Cancer in Patients Who Have Had Hormonal and Chemotherapy|Phase 2 Trial Oral Enzastaurin in Prostate Cancer Patients Who Have Rising PSA (1) During Hormonal Manipulation and (2) After First-Line Cytotoxic Chemotherapy|Completed||Phase 2|72|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:54:18.463602|2017-02-18 15:54:18.463602
NCT00428701|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2011-01-21|||October 2006||2006-10-01|January 2011|2011-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium|An Open-Label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium I.V. (Esomeprazole Sodium) 40mg BID for up to 72 Hours|Completed||Phase 4|40|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 15:54:18.584863|2017-02-18 15:54:18.584863
NCT00428688|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-28|2012-12-12|||July 2009||2009-07-01|December 2012|2012-12-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Endothelial Function and IMT in Survivors of Hodgkin's Lymphoma|Assessment of Endothelial Function and IMT in Survivors Hodgkin's Lymphoma Patients|Unknown status|Enrolling by invitation|N/A|40|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:54:18.68706|2017-02-18 15:54:18.68706
NCT00429884|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2008-07-01|||January 2007||2007-01-01|June 2008|2008-06-01||||||||Observational|||Studies of Disorders and Mechanisms Related to Atrial Fibrillation Before and After DC-Conversion.|Studies of Disorders and Mechanisms Related to Atrial Fibrillation Before and After DC-Conversion: Polysomnography, Heart Rate Variability and 24h Holter.|Unknown status|Recruiting|N/A|||Umeå University|||||f||||||||||||||2017-02-18 15:54:18.778254|2017-02-18 15:54:18.778254
NCT00429871|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2009-05-28|||May 2002||2002-05-01|May 2009|2009-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer|A Multicenter Randomized Comparative Study of Docetaxel Plus Epirubicin Versus Docetaxel Plus Capecitabine Combinations as First Line Treatment of Metastatic Breast Cancer|Completed||Phase 3|272|Actual|Hellenic Oncology Research Group||2|||f||||||||||||||2017-02-18 15:54:18.854592|2017-02-18 15:54:18.854592
NCT00429858|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2013-10-14|||January 2007||2007-01-01|October 2013|2013-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer|Individualized Management of Pancreatic Cancer With Targeted Therapeutics (IMPACTT): A Phase II Clinical Trial|Terminated||Phase 2|21|Actual|University of California, San Francisco||1||Study accrual rate is very slow, it was mandated by NCI to be terminated.|f||||t||||||||||2017-02-18 15:54:18.981936|2017-02-18 15:54:18.981936
NCT00429845|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2007-01-31|||March 2004||2004-03-01|January 2007|2007-01-01|February 2007||2007-02-01|||||Interventional|||Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial|Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start on Highly Active Antiretroviral Therapy: a Randomized Trial|Completed||N/A|80||Hospital de Clinicas de Porto Alegre|||||f||||||||||||||2017-02-18 15:54:19.096205|2017-02-18 15:54:19.096205
NCT00429806|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2016-03-19|||November 2006||2006-11-01|March 2016|2016-03-01|July 2007|Actual|2007-07-01|March 2007|Actual|2007-03-01||Interventional|||DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy|DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy-Phase I Randomized,Placebo-Controlled, Double-Blind Study.|Completed||Phase 1|40|Actual|Centre Hospitalier Universitaire de Québec, CHU de Québec||4|||f||||f||||||||No||2017-02-18 15:54:19.378993|2017-02-18 15:54:19.378993
NCT00429793|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2014-04-30|2013-07-09||February 2007||2007-02-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||Number of eligible and evaluable participants|Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Evaluation of CCI-779 (Temsirolimus, NCI-Supplied Agent, NSC #683864, IND #61010) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:54:19.517116|2017-02-18 15:54:19.517116
NCT00429780|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2009-11-17|||January 2007||2007-01-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)|A Randomized, Safety, Immunogenicity & Efficacy Study of Autoclaved Leishmania Major Plus BCG vs. BCG (Double Blind) or Placebo (Open), in Healthy High Risk Iranian Volunteers With Positive Response to Leishmanin (LST>0)|Completed||Phase 2/Phase 3|100|Anticipated|Tehran University of Medical Sciences||2|||f||||||||||||||2017-02-18 15:54:19.959347|2017-02-18 15:54:19.959347
NCT00429767|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-06-01|||January 2007||2007-01-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent Individuals|Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine: Study 1|Completed||Phase 1|16|Anticipated|Wayne State University|||1||f||||t||||||||||2017-02-18 15:54:20.070637|2017-02-18 15:54:20.070637
NCT00429754|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2016-01-25||||||January 2016|2016-01-01|September 2008||2008-09-01|||||Interventional|||Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP)|A Pharmacokinetic Evaluation of the Addition of Aprepitant to the Bleomycin -Etoposide - Cisplatin (BEP) Treatment of Patients With Testis Carcinoma (A-BEP)|Withdrawn||Phase 4|0|Actual|Radboud University||1||change of study population and chemotherapeutic regimen|f||||f||||||||||2017-02-18 15:54:20.163307|2017-02-18 15:54:20.163307
NCT00429728|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2009-05-15|||November 2006||2006-11-01|May 2009|2009-05-01||||||||Interventional|||A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers.|An Open-Label, Parallel Group, Single Session Study Comparing the Pharmacokinetics of a Single Oral Dose of GW876008 Administered to Healthy Volunteer Smokers and Healthy Volunteer Non-Smokers.|Completed||Phase 1|26|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:54:20.264783|2017-02-18 15:54:20.264783
NCT00429715|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2011-02-16|||January 2007||2007-01-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|May 2007|Actual|2007-05-01||Interventional|||Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin|A Randomized, Safety, Immunogenicity & Efficacy Study of Autoclaved Leishmania Major Plus BCG vs. BCG (Double Blind) or Placebo (Open), in Healthy High Risk Iranian Volunteers With no Response to Leishmanin|Completed||Phase 2/Phase 3|150|Anticipated|Tehran University of Medical Sciences||3|||f||||||||||||||2017-02-18 15:54:20.344427|2017-02-18 15:54:20.344427
NCT00429702|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2014-06-26|2014-03-24||October 2007||2007-10-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional||Baseline number of participants was determined by the number of participants that completed their Baseline Study visit.|Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy|Phase II Randomized, Double-Blinded Study of an Antiemetic Pump, Using Benadryl®, Avitan® and Decadron® (BAD), for Children Receiving Moderately or Highly Emetogenic Chemotherapy|Terminated||Phase 2|7|Actual|University of South Florida|The study was closed prior to completing enrollment based on the recommendation by the SunCoast CCOP Research Base Data Safety Monitoring Board for a lack of feasibility and poor enrollment.|2||Closed due to poor accrual and lack of feasibility to finish study per DSMB|f||||t||||||||||2017-02-18 15:54:20.464093|2017-02-18 15:54:20.464093
NCT00429689|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2011-08-28||||||August 2011|2011-08-01||||||||Observational|||Hormonal Levels in Men With Major Depressive Disorder|Hormonal Levels in Men With Major Depressive Disorder|Withdrawn||N/A|2000|Anticipated|Sheba Medical Center|||1||f||||||||||||||2017-02-18 15:54:20.837693|2017-02-18 15:54:20.837693
NCT00429676|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-11-13|||December 2005||2005-12-01|November 2009|2009-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Pilot Study of Haloperidol to Treat Critical Illness Delirium|A Randomized Prospective Pilot Study Of Haloperidol In Addition To Standard Sedation In Mechanically Ventilated Patients With Delirium|Completed||Phase 2|20|Anticipated|University of Colorado, Denver|||||f||||||||||||||2017-02-18 15:54:20.915935|2017-02-18 15:54:20.915935
NCT00429663|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-12-18|2016-12-18||February 2007||2007-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2014|Actual|2014-12-01||Interventional||156 Patients were randomized to locked plate (80) or IM nail (76). 126 patients were were followed, (71 men, 55 women) aged 16 – 90 (avg 51).|A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Distal Femur Fractures|Study of Locked Plates Versus Intramedullary Nails in Distal Femur Fractures: A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation (S.O.L.V.E.D)|Completed||N/A|160|Actual|Boston Medical Center||2|||f||||t||||||||No||2017-02-18 15:54:21.050295|2017-02-18 15:54:21.050295
NCT00429650|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2017-02-08|||July 2007||2007-07-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2013|Actual|2013-12-01||Interventional|Lose-It||Using the Energy Gap to Prevent Weight Regain|Using the Energy Gap to Prevent Weight Regain|Active, not recruiting||N/A|120|Anticipated|University of Colorado, Denver||3|||f||||t||||||||||2017-02-18 15:54:21.510726|2017-02-18 15:54:21.510726
NCT00429637|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2008-08-06|||December 2004||2004-12-01|August 2008|2008-08-01|January 2009|Anticipated|2009-01-01|||||Observational|||Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients|Phase 2 Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients|Unknown status|Recruiting|Phase 2|120|Anticipated|University of Virginia|||||f||||||||||||||2017-02-18 15:54:21.605206|2017-02-18 15:54:21.605206
NCT00428636|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2007-01-26|||May 2001||2001-05-01|January 2007|2007-01-01|July 2005||2005-07-01|||||Interventional|||Early Temporary Stoma Closure After Proctectomy|Study of Early Closure of Temporary Loop Ileostomy After Elective Rectal Resection With Low Pelvic Anastomoses|Completed||N/A|270||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 15:54:37.073551|2017-02-18 15:54:37.073551
NCT00429624|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2013-02-04|||September 1994||1994-09-01|January 2007|2007-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Randomized Controlled Trial of Chiropractic Manipulation Versus Medical Therapy for Chronic Neck Pain|Randomized Controlled Trial of Chiropractic Manipulation Versus Medical Therapy for Chronic Neck Pain|Completed||N/A|70||University of Colorado, Denver|||||f||||||||||||||2017-02-18 15:54:21.92194|2017-02-18 15:54:21.92194
NCT00429611|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-31|2009-06-30|||November 2004||2004-11-01|June 2009|2009-06-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||High Low Biphasic Energy Defibrillation (HiLoBED)|A Multicentre Prospective Randomised Study Comparing the Efficacy of High Versus Low Biphasic Energy Defibrillation in Patients With Cardiac Arrest|Unknown status|Active, not recruiting|Phase 3|600|Anticipated|Singapore General Hospital||1|||f||||t||||||||||2017-02-18 15:54:22.016547|2017-02-18 15:54:22.016547
NCT00429585|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-12-15|||February 2007||2007-02-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Proximal Tibial Fractures|Intramedullary Nail Versus Plate Fixation Re-Evaluation Study in Proximal Tibial Fractures: A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation (IMPRESS)|Recruiting||N/A|160|Anticipated|Boston Medical Center||2|||f||||t||||||||||2017-02-18 15:54:22.129013|2017-02-18 15:54:22.129013
NCT00429572|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2012-08-01|2009-09-25||January 1998||1998-01-01|August 2012|2012-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer|Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer|Completed||Phase 2|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:54:22.313932|2017-02-18 15:54:22.313932
NCT00429559|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2011-07-21|||June 2006||2006-06-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma|Weekly Administration of Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer|Completed||Phase 1/Phase 2|31|Actual|Hellenic Oncology Research Group||1|||f||||||||||||||2017-02-18 15:54:22.645573|2017-02-18 15:54:22.645573
NCT00429546|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2013-06-24|||September 2007||2007-09-01|June 2013|2013-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|TRACK||Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children|Maternal HIV: Intervention to Assist Disclosure to Children|Completed||Phase 1|160|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 15:54:22.760723|2017-02-18 15:54:22.760723
NCT00429533|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-02-01|||November 1996||1996-11-01|February 2007|2007-02-01|February 2004||2004-02-01|||||Interventional|||Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris|A Prospective Randomized Placebo-Controlled Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance Phase Pemphigus Vulgaris|Terminated||Phase 2|48||Jacobus Pharmaceutical|||||f||||||||||||||2017-02-18 15:54:22.870107|2017-02-18 15:54:22.870107
NCT00429520|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2008-02-05|||December 2005||2005-12-01|February 2008|2008-02-01|December 2006||2006-12-01|||||Interventional|||Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds|Prospective, Multicentre, Not Controlled Clinical Study to Investigate Efficacy and Tolerability of the Hyaluronic Acid Filler IMD1 Basic After Single Bilateral Injection for Correction of Nasolabial Folds (NLF)|Completed||Phase 4|114||Merz Pharmaceuticals GmbH|||||f||||||||||||||2017-02-18 15:54:22.979824|2017-02-18 15:54:22.979824
NCT00429507|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2015-10-22|2015-10-22||March 2007||2007-03-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases|Phase 2 Study of 153 Sm-EDTMP Followed by Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases|Completed||Phase 2|12|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:54:23.060783|2017-02-18 15:54:23.060783
NCT00429494|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2013-05-20|2013-05-20||November 2002||2002-11-01|May 2013|2013-05-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients|Phase II Study of GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:54:23.302408|2017-02-18 15:54:23.302408
NCT00429481|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2016-09-15|||January 2001||2001-01-01|September 2016|2016-09-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants|Study to Assess Efficacy, Immunogenicity, Reactogenicity and Safety of Two Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus Vaccine at Different Viral Concentrations in Healthy Infants Previously Uninfected With Human Rotavirus and Approximately 3 Months of Age.|Completed||Phase 2|2464|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:54:23.54561|2017-02-18 15:54:23.54561
NCT00429468|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-10-24|||January 2007||2007-01-01|October 2007|2007-10-01||||||||Interventional|||A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers|A Single-Centre, Double-Blind, Randomized, Placebo-Controlled, Phase 1 Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers|Completed||Phase 1|25||Abbott|||||||||||||||||||2017-02-18 15:54:23.650622|2017-02-18 15:54:23.650622
NCT00429455|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2012-07-31|||March 2007||2007-03-01|July 2012|2012-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Survey of the Need for Information on Fertility and Menopause-Related Treatment Effects Among HSCT Patients|Survey of the Need for Information on Fertility and Menopause-Related Treatment Effects Among Young Women Who Underwent Hematopoietic Stem Cell Transplantation|Completed||N/A|196|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:54:23.727011|2017-02-18 15:54:23.727011
NCT00429442|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2014-02-19|||March 2008||2008-03-01|February 2014|2014-02-01|March 2011|Anticipated|2011-03-01|||||Interventional|||Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis|A Double Blind, Randomised, Placebo Controlled Study Investigating Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis in Patients Treated With Copaxone for at Least 3 Months|Withdrawn||Phase 3|0|Actual|Glostrup University Hospital, Copenhagen||2|||f||||||||||||||2017-02-18 15:54:23.82646|2017-02-18 15:54:23.82646
NCT00429416|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-10-19|2013-07-19||March 2004||2004-03-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation|A Phase I/II Study of Llme Treated Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematological Malignancies|Completed||Phase 1/Phase 2|14|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 15:54:24.053223|2017-02-18 15:54:24.053223
NCT00429403|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-04-05|2011-06-27||August 2006||2006-08-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer|Phase III Randomized Study of a Goserelin Acetate for Preservation of Ovarian Function in Patients With Primary Breast Cancer (PBC)|Terminated||Phase 3|1|Actual|M.D. Anderson Cancer Center||2||Study stopped due to low accrual.|f||||t||||||||||2017-02-18 15:54:24.377817|2017-02-18 15:54:24.377817
NCT00429390|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-30|||August 2006||2006-08-01|January 2007|2007-01-01|November 2006||2006-11-01|||||Interventional|||Effect of Fasting With Two Meals on Insulin Resistance Indices of Metabolic Syndrome||Completed||N/A|55||Free Islamic University of Medical Sciences|||||f||||||||||||||2017-02-18 15:54:24.678902|2017-02-18 15:54:24.678902
NCT00429377|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-29|||June 2003||2003-06-01|January 2007|2007-01-01||||||||Interventional|||Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study|Phase 3 Study of Tacrolimus(FK506)for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study|Completed||Phase 3|64||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 15:54:24.763035|2017-02-18 15:54:24.763035
NCT00429364|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2015-03-17|2015-02-25||January 2007||2007-01-01|January 2014|2014-01-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome--Pediatric Heart Network|Trial of Beta Blocker Therapy (Atenolol) Versus Angiotensin II Receptor Blocker Therapy (Losartan) in Individuals With Marfan Syndrome (A Trial Conducted by the Pediatric Heart Network)|Completed||Phase 3|608|Actual|New England Research Institutes|"The effect of losartan on TGF-β was not assessed. The study results do not apply to Marfan subjects whose BSA–adj. aortic-root z score is ≤3.~Subjects may find their treatment based on the appearance of the drug."|2|||f||||t||||||||||2017-02-18 15:54:24.87244|2017-02-18 15:54:24.87244
NCT00429351|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2010-12-21|||September 2006||2006-09-01|December 2010|2010-12-01|June 2010|Actual|2010-06-01|||||Observational|||Aromatic Amino Acid Metabolism in the Pathogenesis of Kwashiorkor||Completed||Early Phase 1|82|Anticipated|Baylor College of Medicine|||1||f||||||||||Samples Without DNA|"~     plasma, expired breath~   "|||2017-02-18 15:54:29.914149|2017-02-18 15:54:29.914149
NCT00429338|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2015-01-07|||January 2007||2007-01-01|January 2015|2015-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate|Feasibility Study of 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate|Terminated||N/A|8|Actual|M.D. Anderson Cancer Center||2||Slow Accrual|f||||f||||||||||2017-02-18 15:54:29.98869|2017-02-18 15:54:29.98869
NCT00429325|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2007-07-16|||January 2004||2004-01-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Observational|||Fecal Calprotectin: Cheap Marker for Diagnosing Acute Infectious Diarrhea|Comparative Evaluation of Accuracy of Fecal Calprotectin, Lactoferrin and Occult Blood Testing (FOBT) in Predicting Microbiological Diagnosis for Acute Infectious Diarrhea: A Prospective Multicentre Double Blind Randomized Controlled Trial.|Completed||N/A|400||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 15:54:30.110838|2017-02-18 15:54:30.110838
NCT00429312|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2015-01-13|||March 2007||2007-03-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|February 2008|Actual|2008-02-01||Interventional|||A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma|A Phase I/II, Open-Label Study of JX-594 (Thymidine Kinase-deleted Vaccinia Virus Plus GM-CSF) Administered by Intratumoral Injection in Patients With Unresectable Stage 3 or Stage 4 Malignant Melanoma|Completed||Phase 1/Phase 2|10|Actual|Jennerex Biotherapeutics||1|||f||||t||||||||||2017-02-18 15:54:30.202591|2017-02-18 15:54:30.202591
NCT00429299|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-02-22|2014-07-21||August 2006||2006-08-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|CHERLOB||Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer|Chemotherapy Plus Lapatinib or Trastuzumab or Both in Her2+ Primary Breast Cancer. A Randomized Phase IIb Study With Biomarker Evaluation.|Completed||Phase 2|121|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 15:54:30.328763|2017-02-18 15:54:30.328763
NCT00429286|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2011-10-24|||May 2007||2007-05-01|October 2011|2011-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Preserving Function in Breast Cancer Patients|Preserving Function in Rural Breast Cancer Patients Undergoing Chemotherapy|Completed||N/A|30|Anticipated|Dartmouth-Hitchcock Medical Center|||1||f||||t||||||||||2017-02-18 15:54:31.281165|2017-02-18 15:54:31.281165
NCT00429273|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-01-11|||January 2007||2007-01-01|January 2016|2016-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|Project1||Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder|An Eight-Week, Randomized, Double-Blind Comparison of Guanfacine, Focalin XR, and the Combination, With a Twelve Month Open-Label Extension for the Treatment of ADHD in Pediatric Subjects Aged 7 to 14 Years|Completed||Phase 4|180|Actual|University of California, Los Angeles||3|||f||||t||||||||||2017-02-18 15:54:31.433199|2017-02-18 15:54:31.433199
NCT00429260|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-02-15|||January 2007||2007-01-01|February 2012|2012-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression|A 1-week, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Outpatients With Depression Who Completed 8 Weeks of Treatment With Saredutant 100 mg Once Daily|Completed||Phase 3|125|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:54:31.714086|2017-02-18 15:54:31.714086
NCT00429247|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2011-07-20|||February 2003||2003-02-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients|A Pilot Randomized Phase II Study of Adjuvant Administration of Trastuzumab (HERCEPTIN) Versus Observation After the Completion of Adjuvant Chemotherapy and Radiotherapy in Patients With Stage I-III Breast Cancer Who Have Detectable Disseminated and/or Circulating Tumor Cells (DTCs and/or CTCs) in the Bone Marrow or/and the Peripheral Blood Before or/and After the Completion of Adjuvant Treatment|Completed||Phase 2|75|Actual|University Hospital of Crete||2|||f||||f||||||||||2017-02-18 15:54:31.807596|2017-02-18 15:54:31.807596
NCT00429208|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2007-01-30|||February 2007||2007-02-01|January 2007|2007-01-01|April 2007|Anticipated|2007-04-01|||||Interventional|||Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers|Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers: A Double-Blind, Within-Subjects, Placebo-Controlled Study|Unknown status|Not yet recruiting|N/A|40|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:54:32.147416|2017-02-18 15:54:32.147416
NCT00429195|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2013-01-18|||February 2004||2004-02-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||The Effect of Dietary Fat Modification on Risk Factors Associated With the Metabolic Syndrome|LIPGENE Dietary Intervention Study|Completed||N/A|480||University College Dublin|||||f||||||||||||||2017-02-18 15:54:32.251423|2017-02-18 15:54:32.251423
NCT00429182|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2013-02-28|2013-02-28||June 2007||2007-06-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer|Phase II Study of Purging of Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer Patients|Completed||Phase 2|32|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:54:32.364602|2017-02-18 15:54:32.364602
NCT00429169|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2015-03-25|2012-12-11||June 2004||2004-06-01|December 2012|2012-12-01|January 2013|Actual|2013-01-01|January 2010|Actual|2010-01-01||Interventional|||Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression|Paroxetine Versus Bupropion for Suicide Ideators or Attempters With Major Depressive Disorder|Terminated||Phase 4|101|Actual|New York State Psychiatric Institute|"Significant dropout meant the number of subjects with analyzable data was smaller than the number enrolled.~An interim analysis of this pilot study showed differential treatment effects so a decision was made to stop enrollment early."|2||Interim analysis showed differential treatment effects.|f||||f||||||||||2017-02-18 15:54:32.619074|2017-02-18 15:54:32.619074
NCT00429156|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2009-10-22|||January 2007||2007-01-01|October 2009|2009-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Non-invasive Ventilation Versus Sham Ventilation in Chronic Obstructive Pulmonary Disease (COPD)|A Randomised Controlled Trial of Continuation of Home Non-invasive Ventilation vs Sham Ventilation in Survivors of Acute Hypercapnic Respiratory Failure in Chronic Obstructive Pulmonary Disease|Completed||Phase 3|46|Actual|United Christian Hospital||2|||f||||t||||||||||2017-02-18 15:54:33.071758|2017-02-18 15:54:33.071758
NCT00429143|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-10-19|2012-06-04||January 2006||2006-01-01|October 2016|2016-10-01|June 2010|Actual|2010-06-01|August 2009|Actual|2009-08-01||Interventional|||A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative|A Two Step Approach To Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies From HLA Partially-Matched Related Donors|Completed||Phase 1/Phase 2|27|Actual|Thomas Jefferson University|Limitations of the trial include small sample size and single institution|1|||f||||t||||||||||2017-02-18 15:54:33.19843|2017-02-18 15:54:33.19843
NCT00429117|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2011-11-17|||January 2007||2007-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Interest in Spirituality and Oncology: Is It An International Phenomenon?|Interest in Spirituality and Oncology: Is It An International Phenomenon?|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:54:33.514354|2017-02-18 15:54:33.514354
NCT00429104|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2012-12-04|2011-03-25||August 2002||2002-08-01|December 2012|2012-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Herceptin and GM-CSF for Metastatic Breast Cancer|Phase II Study of GM-CSF to Overcome Herceptin-Resistant HER-2/Neu-Overexpressing Metastatic Breast Cancer|Completed||Phase 2|18|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:54:33.61557|2017-02-18 15:54:33.61557
NCT00429091|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2010-11-01|||January 2007||2007-01-01|September 2010|2010-09-01||||August 2007|Actual|2007-08-01||Interventional|||A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose-Ranging Study of the Safety and Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|243|Actual|Abbott||3|||f||||||||||||||2017-02-18 15:54:33.854906|2017-02-18 15:54:33.854906
NCT00429078|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-03-01|||July 2007||2007-07-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer|Phase I Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer|Withdrawn||Phase 1|0|Actual|Roger Williams Medical Center||1||low accrual|f||||t||||||||||2017-02-18 15:54:33.979296|2017-02-18 15:54:33.979296
NCT00429065|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2007-01-30|||January 2007||2007-01-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Observational|||Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.|Selection of Young Patients (< 61 Years), With Good Prognosis Diffuse Large B Cell Lymphoma, According to the Immunophenotype (BCL-6 Negative) to be Treated With Chemoimmunotherapy, With R-CHOP. A Pilot Study.|Unknown status|Recruiting|Phase 4|30||Instituto Nacional de Cancerologia de Mexico|||||f||||||||||||||2017-02-18 15:54:34.061029|2017-02-18 15:54:34.061029
NCT00429052|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-30|2012-03-06|||November 2006||2006-11-01|January 2007|2007-01-01|September 2008|Actual|2008-09-01|||||Observational|||Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease|Insights Into the Mechanism of Percutaneous Revascularization of Coronary Bifurcation Disease in the Drug-eluting Stent Era. An Angiographic and Intravascular Ultrasound Study. The INSIGHT Trial|Terminated||N/A|24|Actual|University of Florida|||1|"PI left institution,inability to enroll and analyze data due to software/technical~   limitations, pt enrollment terminated early with no data generated"|f||||f||||||||||2017-02-18 15:54:34.152685|2017-02-18 15:54:34.152685
NCT00429039|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-10-19|||September 2000||2000-09-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation|LLME Treated Cellular Immunotherapy Following T-cell Depleted Allogeneic Heamtopoietic Stem Cell Transplantation for Acceleration of Immune Reconstitution|Terminated||Phase 2|21|Actual|Thomas Jefferson University||1||Low accrual.|f||||t||||||||||2017-02-18 15:54:34.239027|2017-02-18 15:54:34.239027
NCT00429026|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2013-02-26|2009-02-26||January 2004||2004-01-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation|Adaptive Randomization of Fludarabine-Melphalan Versus Fludarabine-Cyclophosphamide Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Related Donor for Metastatic Renal Cell Carcinoma|Terminated||Phase 2|40|Actual|M.D. Anderson Cancer Center|Primary outcome measure was not assessed due to early study termination, e.g. patients did not receive assigned treatment.|2||Slow accrual, study terminated.|f||||t||||||||||2017-02-18 15:54:34.330052|2017-02-18 15:54:34.330052
NCT00429013|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-09-14|||September 2006||2006-09-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Pressure Ulcer Formation Prevention in Paraplegics Using Computer and Sensory Substitution Via the Tongue.|A Prospective, Randomised, Controlled, Open Study. Phase II Treatment Equivalent.|Terminated||Phase 2|12|Actual|University Hospital, Grenoble||2||principal criteria was achieved with the intermediate statistical analysis|f||||t||||||||||2017-02-18 15:54:34.55257|2017-02-18 15:54:34.55257
NCT00429000|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2007-01-29|||January 2007||2007-01-01|January 2007|2007-01-01|October 2007||2007-10-01|||||Interventional|||Perinatal Hypothermia, Risk Factors and Long-Term Consequences in Guinea-Bissau, Westafrica|Reducing the Prevalence of Hypothermia Among Newborns by Means of Continuous Temperature Monitoring Using Thermospot.|Unknown status|Not yet recruiting|N/A|788||Bandim Health Project|||||f||||||||||||||2017-02-18 15:54:34.892316|2017-02-18 15:54:34.892316
NCT00428987|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-27|2017-01-24|||January 25, 2007||2007-01-25|December 27, 2016|2016-12-27||||||||Observational|||Physical and Behavioral Traits of Overweight and Obese Adults|Study of the Phenotype of Overweight and Obese Adults|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:54:34.983443|2017-02-18 15:54:34.983443
NCT00428974|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2015-02-25|2011-06-20||June 2007||2007-06-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety and Efficacy Study of CF101 to Treat Psoriasis|A Phase 2, Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Study of the Safety and Activity of Daily CF101 Administered Orally in Patients With Moderate-to-Severe Plaque Psoriasis|Completed||Phase 2|76|Actual|Can-Fite BioPharma||4|||f||||f||||||||||2017-02-18 15:54:35.093002|2017-02-18 15:54:35.093002
NCT00428961|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2013-01-08|||July 2002||2002-07-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|DGP||Diabetes Genome Project: A Prospective Registry to Identify Genetic Variation Among Diabetic Patients|Diabetic Genome Project: A Multi-Phase Prospective Registry to Identify Genetic Variation Among Diabetic Patients Undergoing Coronary Revascularization|Completed||N/A|1607|Actual|Saint Luke's Health System|||1||f||||t||||||Samples With DNA|"~     Whole blood separated into 12 x1000µL, 10x500µL EDTA plasma, 2x1,000 µL and 20x200 µL of~     buffy coat (baseline only) and 2x1,000 µL of RBCs (baseline only)~   "|||2017-02-18 15:54:35.718832|2017-02-18 15:54:35.718832
NCT00428948|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2013-02-01||2013-02-01|January 2007||2007-01-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|TEMPO3/4||Tolvaptan Phase 3 Efficacy and Safety Study in ADPKD|A Phase 3, Multi-center, Double-blind, Placebo-controlled, Parallel-arm Trial to Determine Long-term Safety and Efficacy of Oral Tolvaptan Tablets Regimens in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 3|1445|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-02-18 15:54:35.820566|2017-02-18 15:54:35.820566
NCT00428935|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2013-02-04|||March 2006||2006-03-01|February 2013|2013-02-01|July 2010|Actual|2010-07-01|March 2009|Actual|2009-03-01||Interventional|||Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy|Phase 1 Clinical Trial of rAAV2.5-CMV-mini-Dystrophin Gene Vector in Duchenne Muscular Dystrophy|Completed||Phase 1|6|Actual|Nationwide Children's Hospital||2|||f||||||||||||||2017-02-18 15:54:36.075381|2017-02-18 15:54:36.075381
NCT00428922|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-02-15|2015-11-10||June 2007||2007-06-01|February 2016|2016-02-01||||November 2012|Actual|2012-11-01||Interventional|||Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients|Phase II Trial of Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients|Active, not recruiting||Phase 2|26|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:54:36.196896|2017-02-18 15:54:36.196896
NCT00428909|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2016-04-20|||November 2006||2006-11-01|April 2016|2016-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)|A Non-randomized, Open-label Study to Investigate the Effects of Imatinib Mesylate on the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)|Completed||Phase 1|12|Actual|Novartis||1|||f||||f||||||||||2017-02-18 15:54:36.465387|2017-02-18 15:54:36.465387
NCT00428896|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2008-07-18|||April 2005||2005-04-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer|A Pilot Feasibility Study to Evaluate the Efficacy of ZD1839 (IRESSA) in Eliminating Chemo- and Hormone- Resistant Cytokeratin-Positive Tumour Cells Circulating in the Blood of Women With Breast Cancer|Completed||Phase 2|24|Actual|University Hospital of Crete||1|||f||||||||||||||2017-02-18 15:54:36.568798|2017-02-18 15:54:36.568798
NCT00428883|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-29|||January 2007||2007-01-01|January 2007|2007-01-01|February 2009||2009-02-01|||||Interventional|||High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis|Rare Disease With Microvascular Involvement: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis|Unknown status|Recruiting|Phase 2/Phase 3|45||Università Politecnica delle Marche|||||f||||||||||||||2017-02-18 15:54:36.675567|2017-02-18 15:54:36.675567
NCT00428675|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2011-11-29|||October 2005||2005-10-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|October 2007|Actual|2007-10-01||Observational|||A New Tool for Assessing Fatigue in Individuals With Advanced Cancer|Development of a Rapid Assessment Tool for Fatigue in Palliative Care|Completed||N/A|221|Actual|University of Alberta|||1||f||||f||||||||||2017-02-18 15:54:36.766436|2017-02-18 15:54:36.766436
NCT00428662|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-29|||January 2007||2007-01-01|January 2007|2007-01-01|October 2007||2007-10-01|||||Interventional|||Evaluation of a New Nanotechnology Based Drug-Eluting Stent for Opening of Narrowed Arteries of the Heart|Clinical and Angiographic Evaluation of Paclitaxel Eluting, Non-Polymeric, Nanoporous Carbon-Carbon Coated, Cobalt-Chromium Stent|Unknown status|Recruiting|N/A|200||All India Institute of Medical Sciences, New Delhi|||||f||||||||||||||2017-02-18 15:54:36.85814|2017-02-18 15:54:36.85814
NCT00428649|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-03-06|||March 2007||2007-03-01|March 2012|2012-03-01|October 2008|Actual|2008-10-01|December 2007|Actual|2007-12-01||Interventional|||Optimization of Selenoprotein P in Chinese Subjects|Optimization of Selenoprotein P in Chinese Subjects|Completed||N/A|98|Actual|Vanderbilt University||7|||f||||||||||||||2017-02-18 15:54:36.950328|2017-02-18 15:54:36.950328
NCT00428623|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-29|||January 2004||2004-01-01|January 2007|2007-01-01|January 2006||2006-01-01|||||Observational|||Aquacel Compared to Traditional Post Surgical Wound Dressing in Vascular Surgery Patients||Completed||Phase 3|160||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 15:54:37.16024|2017-02-18 15:54:37.16024
NCT00428610|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2012-01-31||2011-06-13|February 2007||2007-02-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|February 2011|Actual|2011-02-01||Interventional|||A Study of Chemotherapy Treatment for Patients With Ovarian Cancer|A Phase 2 Study of LY573636 as Treatment for Patients With Platinum-Resistant Ovarian Cancer|Completed||Phase 2|100|Anticipated|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 15:54:37.232273|2017-02-18 15:54:37.232273
NCT00428597|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2010-09-16|2010-04-15||June 2007||2007-06-01|September 2010|2010-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors|A Phase III Randomized, Double-Blind Study Of Sunitinib (SU011248, SUTENT) Versus Placebo In Patients With Progressive Advanced/Metastatic Well-Differentiated Pancreatic Islet Cell Tumors|Terminated||Phase 3|171|Actual|Pfizer||2||Refer to Detailed Description.|f||||t||||||||||2017-02-18 15:54:37.364013|2017-02-18 15:54:37.364013
NCT00428584|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2013-08-01|2008-11-26||December 2006||2006-12-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|November 2007|Actual|2007-11-01||Interventional|REFORMS||RNF and Betaseron® Tolerability Study|A Randomized, Multicenter, Two Arm, Open Label, Twelve Week Phase IIIb Study to Evaluate the Tolerability of Rebif (New Formulation) (IFN Beta-1a) and Betaseron (IFN Beta-1b) in IFN-naive Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) Followed by a Single Arm, Eighty-two Week Minimum, Rebif (New Formulation) Only Safety Extension|Completed||Phase 3|129|Actual|EMD Serono||2|||f||||||||||||||2017-02-18 15:54:38.953786|2017-02-18 15:54:38.953786
NCT00428571|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2016-04-13|||May 2007||2007-05-01|April 2016|2016-04-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Laparoscopic Bariatric Surgery to Treat Type 2 Diabetes in Obese Patients|Laparoscopic Bariatric Surgery for Treatment of Type 2 Diabetes in Obese Patients With End Organ Damage: A Prospective Randomized Controlled Pilot Study|Terminated||N/A|20|Actual|McMaster University||3|||f||||||||||||||2017-02-18 15:54:39.584136|2017-02-18 15:54:39.584136
NCT00428558|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2013-12-19|||July 2007||2007-07-01|July 2007|2007-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Timed-Sequential Induction in CBF-AML|A Phase 3 Trial of Systematic Versus Response-adapted Timed-Sequential Induction in Patients With Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)|Completed||Phase 3|200|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:54:39.680525|2017-02-18 15:54:39.680525
NCT00428545|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2013-02-11|||January 2007||2007-01-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Bevacizumab and Bortezomib in Patients With Advanced Malignancy|A Phase I Trial of Bevacizumab and Bortezomib in Patients With Advanced Malignancy|Completed||Phase 1|104|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:54:39.798538|2017-02-18 15:54:39.798538
NCT00428532|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-27|2007-05-07|||March 2007||2007-03-01|January 2007|2007-01-01|August 2007|Anticipated|2007-08-01|||||Interventional|||The Effect of Licorice Root Extract and Pomegranate Juice on Atherosclerotic Parameters in Diabetic Patients||Unknown status|Recruiting|N/A|10|Anticipated|HaEmek Medical Center, Israel|||||f||||||||||||||2017-02-18 15:54:39.913065|2017-02-18 15:54:39.913065
NCT00428519|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2016-06-02|||January 2007||2007-01-01|June 2016|2016-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals|A Phase Ib, Randomized, Placebo Controlled, Double Blind Study to Determine the Safety, Viral Suppression, Pharmacokinetics and Immune Modulatory Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals|Completed||Phase 1|30|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 15:54:39.984247|2017-02-18 15:54:39.984247
NCT00428506|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2008-04-09|||February 2007||2007-02-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction|Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction in Cirrhotic Patients With Ascites|Unknown status|Recruiting|Phase 2|70|Anticipated|University of Turin, Italy||1|||f||||t||||||||||2017-02-18 15:54:40.110526|2017-02-18 15:54:40.110526
NCT00428493|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-05-29|||January 2007||2007-01-01|May 2008|2008-05-01|January 2008||2008-01-01|||||Observational|||Prospective Study of AI H5N1 in China|Prospective Study of Individuals Exposed to Confirmed Cases of Human Influenza A (H5N1) Infection in China|Completed||N/A|4000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 15:54:40.201824|2017-02-18 15:54:40.201824
NCT00428480|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2011-11-10|||May 2007||2007-05-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|SIRROWS||Walking Study for Stroke Rehabilitation|Stroke Inpatient Rehabilitation Reinforcement of Walking Speed|Completed||Phase 1|216|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 15:54:40.27716|2017-02-18 15:54:40.27716
NCT00428467|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-29|||May 2004||2004-05-01|January 2007|2007-01-01|April 2007||2007-04-01|||||Interventional|||Apical Compression Stitch - a New Option for LV Remodelling|Pronounced Apical Dilatation in Failing Left Ventricles – a New Option for Surgical Remodelling Techniques|Unknown status|Active, not recruiting|N/A|||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 15:54:40.669069|2017-02-18 15:54:40.669069
NCT00428454|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2015-06-03|||January 2007||2007-01-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|December 2010|Actual|2010-12-01||Interventional|||Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions|A Randomized Comparison of Sirolimus-eluting Stent Implantation With Zotarolimus-eluting Stent Implantation for the Treatment of Chronic Total Coronary Occlusions. The PRISON III Trial.|Completed||Phase 3|301|Actual|R&D Cardiologie||2|||f||||||||||||||2017-02-18 15:54:40.751097|2017-02-18 15:54:40.751097
NCT00428441|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2011-08-18|2011-08-18||May 2007||2007-05-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|June 2010|Actual|2010-06-01||Interventional|||D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism|The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study|Terminated||N/A|73|Actual|Università degli Studi dell'Insubria||1||Enrolment was halted prematurely because of the observed excess in recurrences|f||||f||||||||||2017-02-18 15:54:40.875192|2017-02-18 15:54:40.875192
NCT00428428|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-11-15|||February 2007||2007-02-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract|Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract|Completed||Phase 2/Phase 3|12|Actual|Fredericia Hosptial||2|||f||||t||||||||||2017-02-18 15:54:41.106889|2017-02-18 15:54:41.106889
NCT00428415|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2008-03-03|||March 2007||2007-03-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Tesofensine on Energy Balance in Humans.|The Effect of Tesofensine on Energy Balance in Humans. A Randomised, Double-Blind, Placebo-Controlled, Parallel- Group, Single Centre Study.|Completed||Phase 1/Phase 2|32|Anticipated|NeuroSearch A/S|||||f||||||||||||||2017-02-18 15:54:41.201118|2017-02-18 15:54:41.201118
NCT00428402|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2012-02-27|||January 2007||2007-01-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Using Focus Groups to Assess the Impact of Environmental Health Science Programs for K-12 Educational Community|Using Focus Groups to Assess the Impact of Environmental Health Science Programs for K-12 Educational Community|Completed||N/A|6|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:54:41.284087|2017-02-18 15:54:41.284087
NCT00428389|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2014-06-05|2010-12-22||January 2007||2007-01-01|June 2014|2014-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease|A Prospective, 5-Week, Open-Label, Randomized, Multi-Center, Parallel-Group Study With a 20-Week, Open-Label Extension Evaluating the Tolerability and Safety of Switching From Donepezil to an Initial Dose of 5 cm2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease|Completed||Phase 3|262|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:54:41.393936|2017-02-18 15:54:41.393936
NCT00428376|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2008-09-25|||September 2005||2005-09-01|September 2008|2008-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Does Block Play Improve Language Acquisition: A Randomized Trial|Clinical Trial of Building Block Distribution in Children|Completed||N/A|200||University of Washington|||||f||||||||||||||2017-02-18 15:54:41.916274|2017-02-18 15:54:41.916274
NCT00428363|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-29|||June 2001||2001-06-01|January 2007|2007-01-01|March 2006||2006-03-01|||||Interventional|||Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification||Completed||Phase 4|52||Medical University of Vienna|||||f||||||||||||||2017-02-18 15:54:41.997714|2017-02-18 15:54:41.997714
NCT00428350|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2009-03-24|||December 2006||2006-12-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic|A 24-Week, Multi-Centre, Open-Label, Single-Arm, Phase IV Study of the Efficacy and Safety of Seroquel (Quetiapine Fumarate) With Daily Dose 600mg-750mg as Mono-Therapy in the Treatment of Acute Schizophrenic Patients|Completed||Phase 4|120|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 15:54:42.094949|2017-02-18 15:54:42.094949
NCT00428337|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2015-03-03|||April 2007||2007-04-01|March 2015|2015-03-01|August 2008|Actual|2008-08-01|||||Interventional|||Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of DNA Vaccine EP-1233 and Recombinant MVA-HIV Polytope Vaccine MVA-mBN32, Separately and in a Combined Prime-boost Regimen, When Given to Healthy, Vaccinia-naive, HIV-1-uninfected Adults|Completed||Phase 1|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 15:54:42.1909|2017-02-18 15:54:42.1909
NCT00428311|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2007-01-30|||April 2004||2004-04-01|January 2007|2007-01-01|October 2006||2006-10-01|||||Interventional|||Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS|The Cardiovascular Risk Profile Associated With The Polycystic Ovary Syndrome And With Ovulatory Hyperandrogenism, And Its Changes During Treatment With Metformin Or Oral Contraceptives|Completed||Phase 4|50||Hospital Universitario Ramon y Cajal|||||f||||||||||||||2017-02-18 15:54:42.317737|2017-02-18 15:54:42.317737
NCT00428298|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-29|2012-05-18|||March 2007||2007-03-01|January 2011|2011-01-01|October 2012|Anticipated|2012-10-01|August 2012|Anticipated|2012-08-01||Interventional|||Research Study of Bipolar Mood Symptoms and Cognitive Problems|A Double Blind Placebo Controlled Study of Valacyclovir in Cognitive Impairment and Mood Symptoms of Bipolar Disorder|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 15:54:42.410531|2017-02-18 15:54:42.410531
NCT00428285|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-07-29|||February 2007||2007-02-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|February 2010|Actual|2010-02-01||Interventional|||Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men|A Phase II, Prospective, Open-label, Pilot Study of the Tolerability, Safety, and Efficacy of Argon Plasma Coagulation for the Treatment of Anal Intraepithelial Neoplasia Grade 2 or 3 in HIV-positive Men Having Sex With Men|Completed||Phase 2|20|Actual|Centre hospitalier de l'Université de Montréal (CHUM)||1|||f||||t||||||||||2017-02-18 15:54:42.552785|2017-02-18 15:54:42.552785
NCT00428272|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2017-01-24|||December 4, 2006||2006-12-04|October 9, 2015|2015-10-09|October 9, 2015|Actual|2015-10-09|April 28, 2011|Actual|2011-04-28||Interventional|||HGS-ETR2 to Treat Children With Solid Tumors|A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) With or Without Interferon Gamma in Patients With Refractory Pediatric Solid Tumors|Terminated||Phase 1|19|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 15:54:42.664366|2017-02-18 15:54:42.664366
NCT00428246|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2009-04-06|2009-04-06||November 2006||2006-11-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation|Anti-Inflammatory and Endothelial Protectant Effects of Paricalcitol|Completed||N/A|24|Actual|Indiana University||3|||f||||f||||||||||2017-02-18 15:54:42.781199|2017-02-18 15:54:42.781199
NCT00428233|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-02-02|||November 2006||2006-11-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation|Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation|Completed||Phase 1|65|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:54:43.237008|2017-02-18 15:54:43.237008
NCT00428220|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2015-10-07|2015-07-26||July 2007||2007-07-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|August 2014|Actual|2014-08-01||Interventional||The safety population was defined as all participants enrolled in the study who received at least one dose of study drug in this study.|A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.|An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment|Completed||N/A|226|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:54:43.356344|2017-02-18 15:54:43.356344
NCT00011557|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2009-01-20|||January 1998||1998-01-01|January 2001|2001-01-01|December 2000|Actual|2000-12-01|||||Interventional|||Functional Magnetic Micturition in Patients w/SCI|Functional Magnetic Micturition in Patients w/SCI|Completed||Phase 2|36||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:13.117534|2017-02-18 18:11:13.117534
NCT00428207|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-12-27|||February 2007||2007-02-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy|Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy|Terminated||N/A|7|Actual|Joslin Diabetes Center||1||"The differences in treatment could be better observed and monitored by using a continuous~   glucose monitoring system instead of the 7 point fingerstick."|f||||f||||||||||2017-02-18 15:54:44.248256|2017-02-18 15:54:44.248256
NCT00428194|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-11-06|||January 2007||2007-01-01|November 2012|2012-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer|Erlotinib in Combination With Cisplatin as Radiosensitizing Agents in Women Receiving Radiation Therapy for Locally Advanced Squamous Cell Carcinoma of the Cervix; A Phase I Trial|Withdrawn||Phase 1|0|Actual|Masonic Cancer Center, University of Minnesota||3||Withdrawn due to lack of accrual|f||||t||||||||||2017-02-18 15:54:44.36633|2017-02-18 15:54:44.36633
NCT00428181|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-04-05|||September 2007||2007-09-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Multidisciplinary Approach to Reduce Injury and Alcohol|Multidisciplinary Approach to Reduce Injury and Alcohol|Completed||Phase 3|605|Actual|University of Texas at Austin||2|||f||||t||||||||||2017-02-18 15:54:44.491836|2017-02-18 15:54:44.491836
NCT00428168|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2015-10-13|||March 2007||2007-03-01|October 2008|2008-10-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment|Terminated||Phase 2|36|Actual|OBEcure Ltd.||2||"Interim Analysis result indicated the study will not show a significant benefit of the study~   medication on the primary endpoint."|f||||f||||||||||2017-02-18 15:54:44.610978|2017-02-18 15:54:44.610978
NCT00428155|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-01-26|||January 2007||2007-01-01|January 2007|2007-01-01||||||||Interventional|||Arterial Closure Device Comparison Trial II – ACDC Trial II|A Randomized Trial of Angioseal and Starclose for Hemostasis After PCI|Unknown status|Recruiting|N/A|448||St. Michael's Hospital, Toronto|||||f||||||||||||||2017-02-18 15:54:44.729057|2017-02-18 15:54:44.729057
NCT00428142|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-11-26|||December 2006||2006-12-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional|||Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma|A Multi-Centre Phase II Trial Investigating the Efficacy and Tolerability of Bortezomib Added to Cyclophosphamide, Vincristine, Prednisone, and Rituximab (BCVP-R) for Patients With Advanced Stage Follicular Non-Hodgkin's Lymphoma Requiring Systemic First-Line Treatment|Completed||Phase 2|95|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 15:54:44.824058|2017-02-18 15:54:44.824058
NCT00428129|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2014-04-04|||March 2007||2007-03-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|MAX-DVT||Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT|An Open Label Clinical Trial of Microplasmin Administered Via the Trellis-8 Infusion System for the Treatment of Acute Iliofemoral Deep Vein Thrombosis|Terminated||Phase 2|6|Actual|ThromboGenics||1||Sponsor's decision to not pursue uPLi for vascular conditions including DVT.|f||||t||||||||||2017-02-18 15:54:44.966387|2017-02-18 15:54:44.966387
NCT00428116|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2016-10-10|2015-06-08||September 2007||2007-09-01|October 2016|2016-10-01|December 2014|Actual|2014-12-01|July 2013|Actual|2013-07-01||Interventional||following 24 months of HAART|Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya|Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya (0-4.5 Month Randomized Controlled Trial)|Terminated||N/A|140|Actual|University of Washington||2||DSMB recommended termination because TI was safe but not durable.|f||||t||||||||||2017-02-18 15:54:45.097294|2017-02-18 15:54:45.097294
NCT00428103|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2013-02-26|||October 2006||2006-10-01|February 2013|2013-02-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy|Destiny Trial: Effects of Mitral Valve Annuloplasty With the Geoform Ring on Left Ventricular Geometry and Function in Patients With Cardiomyopathy|Withdrawn||N/A|0|Actual|Ohio State University||1|||f||||f||||||||||2017-02-18 15:54:45.612177|2017-02-18 15:54:45.612177
NCT00428090|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-11-15||2010-10-13|February 2007||2007-02-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease|A 24-week, Double-blind, Double-dummy, Randomized, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets), Donepezil, and Placebo as Monotherapy on Cognition and Overall Clinical Response in APOE ε4-stratified Subjects With Mild to Moderate Alzheimer's Disease. (REFLECT-1)|Completed||Phase 3|862|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:54:45.730737|2017-02-18 15:54:45.730737
NCT00428077|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2011-08-31|2011-05-26||October 2005||2005-10-01|August 2011|2011-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia|A Multi-Center Pilot Phase II Trial of a Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients With Chronic Myeloid Leukemia (CML) and Minimal Residual Disease|Terminated||Phase 2|4|Actual|OHSU Knight Cancer Institute||1||"Withdrawn because there were no dramatic changes in the main endpoint, as well as low~   enrollment numbers. The data are not interpretable in terms of efficacy."|f||||t||||||||||2017-02-18 15:54:46.095289|2017-02-18 15:54:46.095289
NCT00428064|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-01-26|||May 1998||1998-05-01|January 2007|2007-01-01|June 2004||2004-06-01|||||Interventional|||Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients|A Randomized, Open-Label Study of Continuous Therapy With Cyclosporine and Sirolimus Versus Induction With Cyclosporine and Sirolimus Followed by Continuous Therapy With Sirolimus in Renal Allograft Recipients|Completed||Phase 3|408||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:54:46.324583|2017-02-18 15:54:46.324583
NCT00428051|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2011-10-26|||September 2006||2006-09-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|February 2011|Actual|2011-02-01||Observational|LEAP II||Colombia Epidemiologic Surveillance Study|Multinational Latin American Epidemiologic Surveillance For Invasive Pneumococcal Disease|Terminated||N/A|32867|Actual|Pfizer|||1|See termination reason in detailed description.|f||||f||||||Samples With DNA|"~     Cerebral Spinal Fluid Pleural Fluid S. pneumoniae isolates~   "|||2017-02-18 15:54:46.397262|2017-02-18 15:54:46.397262
NCT00428038|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-03-29|||February 2004||2004-02-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|||||Observational|||Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease|Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease|Completed||N/A|68|Actual|Indiana University|||3||f||||t||||||||||2017-02-18 15:54:46.508897|2017-02-18 15:54:46.508897
NCT00428025|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2015-09-18|||October 2006||2006-10-01|September 2015|2015-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients|Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients: A Prospective, Randomized, Double Blind, Placebo Controlled Trial.|Terminated||Phase 4|23|Actual|Queen's University||2||slow recruitment|f||||f||||||||||2017-02-18 15:54:46.60057|2017-02-18 15:54:46.60057
NCT00428012|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-01-05|||January 2007||2007-01-01|January 2012|2012-01-01|April 2011|Actual|2011-04-01|July 2009|Actual|2009-07-01||Interventional|||Quality of Life Therapy for Adults With ESRD Awaiting Renal Transplantation|Quality of Life Therapy for Adults With ESRD Awaiting Renal Transplantation|Completed||Phase 2/Phase 3|65|Actual|Beth Israel Deaconess Medical Center||3|||f||||t||||||||||2017-02-18 15:54:46.703797|2017-02-18 15:54:46.703797
NCT00427999|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-10-06|2016-08-10||February 2007||2007-02-01|October 2016|2016-10-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|INV342||Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer|A Single Stage Phase II, Multi-centre, Open Label Study of Imatinib in Combination With Pioglitazone, Etoricoxib, Dexamethasone and Low-dose Treosulfane for Anti-inflammatory and Angiostatic Treatment in Patients With Hormone-refractory Prostate Cancer|Completed||Phase 2|67|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:54:46.811722|2017-02-18 15:54:46.811722
NCT00427986|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-06-25|||January 2007||2007-01-01|June 2007|2007-06-01|March 2007|Actual|2007-03-01|||||Interventional|||Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema|Diabetic Macular Oedema: Quantification of the Effect of Rising the Intracapillary Osmotic Pressure With Intravenous Galactose on the Retinal Thickness|Terminated||N/A|1|Actual|Glostrup University Hospital, Copenhagen||1||No sufficient increase in plasma osmolarity by galactose (one patient included)|f||||||||||||||2017-02-18 15:54:47.463514|2017-02-18 15:54:47.463514
NCT00427973|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-09-13|2015-07-01||May 2009||2009-05-01|September 2016|2016-09-01|March 2012|Actual|2012-03-01|April 2010|Actual|2010-04-01||Interventional|||AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer|A Phase II Study of AZD2171 in Hepatocellular Carcinoma|Terminated||Phase 2|17|Actual|National Cancer Institute (NCI)|Despite reaching the prespecified goal for the first stage of the trial, the study was stopped and did not proceed to the second stage after reviewing the development program of cediranib by AstraZeneca for reasons unrelated to this study.|1||The study was stopped prior to 2nd stage.|f||||t||||||||||2017-02-18 15:54:47.557492|2017-02-18 15:54:47.557492
NCT00427960|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2010-11-30|2009-03-25||December 2006||2006-12-01|November 2010|2010-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg|A Phase IV, 6-week, Randomised, Double-blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK Asian Subjects With Primary Hypercholesterolaemia|Terminated||Phase 4|55|Actual|AstraZeneca|The study achieved only 8% of the randomised target number of patients and for this reason alone was terminated early. Planned statistical analyses could not be performed. No scientifically valid conclusions can be drawn from the limited study data.|2||Due to inadequate recruitment|f||||||||||||||2017-02-18 15:54:50.52132|2017-02-18 15:54:50.52132
NCT00427947|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2009-12-28|||December 2006||2006-12-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|April 2009|Actual|2009-04-01||Interventional|CAPDAF||Leg Amputation and Continuous Sciatic Nerve Block|Continuous Popliteal Sciatic Nerve Block Interest in Postoperative Pain Management for Patients With Leg Amputation|Terminated||Phase 3|6|Actual|University Hospital, Bordeaux||2||lack of patients|f||||t||||||||||2017-02-18 15:54:51.073063|2017-02-18 15:54:51.073063
NCT00427934|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2014-10-30|2009-10-06||February 2007||2007-02-01|October 2014|2014-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Maraviroc in Rheumatoid Arthritis|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Maraviroc in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate|Terminated||Phase 2|128|Actual|Pfizer||2||See Detailed Description.|f||||f||||||||||2017-02-18 15:54:51.434352|2017-02-18 15:54:51.434352
NCT00427921|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2009-11-12|2009-01-09||January 2007||2007-01-01|November 2009|2009-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|ACCESS||Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)|A Multicentre, Open Label, Treatment Protocol of the Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)|Completed||Phase 3|304|Actual|Abbott|Subjects who failed prior infliximab therapy were eligible to enter study after minimum 8 week wash-out since last dose. Includes subjects who previously used infliximab & never responded or responded & developed intolerance/lost efficacy.|1|||f||||f||||||||||2017-02-18 15:54:53.330408|2017-02-18 15:54:53.330408
NCT00427908|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2016-10-18||2012-08-02|February 2007||2007-02-01|October 2016|2016-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612|Evaluate Non-Inferiority and Persistence of the Immune Response of GSK Biologicals' Meningococcal Vaccine 134612 Versus Meningitec™ or Mencevax™ ACWY in Healthy Subjects (1-10 Years of Age)|Completed||Phase 2|612|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:54:54.347357|2017-02-18 15:54:54.347357
NCT00427895|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-08-01|2012-08-01||March 2007||2007-03-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults|A Phase 3, Randomized, Active-Controlled, Modified Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine (13vPnC) Compared to a 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) in Adults 60 to 64 Years Old Who Are Naive to 23vPS and the Safety, Tolerability, and Immunogenicity of 13vPnC in Adults 18 to 59 Years Old Who Are Naïve to 23vPS|Completed||Phase 3|2141|Actual|Pfizer||7|||f||||f||||||||||2017-02-18 15:54:54.760807|2017-02-18 15:54:54.760807
NCT00427882|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-11-28|||September 2006||2006-09-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study|An Open, Non-Comparative, Multicenter Study on the Sexual Function Improvement Following Treatment With Alfuzosin in Patients With Benign Prostate Hyperplasia|Completed||Phase 4|125|Anticipated|Handok Pharmaceuticals Co., Ltd.|||||f||||||||||||||2017-02-18 15:55:00.60226|2017-02-18 15:55:00.60226
NCT00427856|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-07-20||2013-08-16|March 2007||2007-03-01|July 2016|2016-07-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)|A Multi-Center, Open-Label, Phase II Study of Sequential, Single-Agent Obatoclax Mesylate (GX15-070MS)Followed by a Combination With Rituximab to Patients With Previously-Untreated Follicular Lymphoma (FL)|Completed||Phase 2|7|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 15:55:00.690851|2017-02-18 15:55:00.690851
NCT00427843|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-10-14|||January 2007||2007-01-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||The Influence of Hip Strengthening Exercises on Walking Patterns and Muscle Strength in Persons With Knee Osteoarthritis|The Influence of a Home Program of Hip Abductor Exercises on Gait Parameters and Muscle Strength in Persons With Knee Osteoarthritis|Completed||N/A|80|Actual|Queen's University||1|||f||||t||||||||||2017-02-18 15:55:00.804808|2017-02-18 15:55:00.804808
NCT00427830|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-01-26|||May 2003||2003-05-01|December 2006|2006-12-01|January 2005||2005-01-01|||||Interventional|||A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG|A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG|Completed||Phase 1|16||University of Oxford|||||f||||||||||||||2017-02-18 15:55:00.916314|2017-02-18 15:55:00.916314
NCT00427817|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2011-10-05|||August 2006||2006-08-01|October 2011|2011-10-01|January 2011|Actual|2011-01-01|January 2009|Actual|2009-01-01||Observational|||PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma|PRO-STATE: Prognostic Interest of Serum Protein Profiles of Patients Undergoing a Prostate Biopsy: Search for a Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins.|Completed||N/A|300|Anticipated|University Hospital, Grenoble|||1||f||||||||||||||2017-02-18 15:55:01.021454|2017-02-18 15:55:01.021454
NCT00427804|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2013-01-30|2011-08-03||January 2007||2007-01-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption|Tumor Necrosis Factor-α Induces Vitamin D Resistance in Small Intestinal Calcium Absorption|Completed||N/A|9|Actual|Atlanta VA Medical Center||1|||f||||f||||||||||2017-02-18 15:55:01.140389|2017-02-18 15:55:01.140389
NCT00427791|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-04-05|2012-01-19||July 2005||2005-07-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia|Phase II Randomized Study Evaluating the Addition of Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia|Completed||Phase 2|23|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:55:01.582476|2017-02-18 15:55:01.582476
NCT00427778|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-05-30|||January 2007||2007-01-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Incontinence Ring on Stress Urinary Incontinence|Effect of the Incontinence Ring on Urodynamic Stress Urinary Incontinence: A Randomized Trial.|Terminated||Phase 4|29|Actual|Queen's University||2||Slow recruitment|f||||f||||||||||2017-02-18 15:55:02.299781|2017-02-18 15:55:02.299781
NCT00427765|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2011-12-15|2011-11-14||December 2004||2004-12-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma|A Phase II Study of High-Dose Intravenous Busulfan Plus Melphalan With Allogeneic or Autologous Marrow or Peripheral Blood Progenitor Cell Transplantation for Lymphoid Malignancies or Multiple Myeloma|Completed||Phase 2|168|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:55:02.424472|2017-02-18 15:55:02.424472
NCT00427752|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-05-03|||October 2006||2006-10-01|May 2012|2012-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Abdominal Exploration Without Incisions|Diagnostic Transluminal Endoscopic Peritoneoscopy|Completed||Early Phase 1|20|Actual|Ohio State University||1|||f||||f||||||||||2017-02-18 15:55:02.702613|2017-02-18 15:55:02.702613
NCT00427739|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2010-04-09|||June 2006||2006-06-01|April 2010|2010-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Data Collection During CT for Axial Flow VADs|Pilot Study of Data Collection During Computerized Tomography (CT) to Determine Accurate Flow Rates for Axial Flow Ventricular Assist Device (VAD) Patients|Completed||N/A|9|Actual|Ohio State University||1|||f||||f||||||||||2017-02-18 15:55:02.820708|2017-02-18 15:55:02.820708
NCT00427726|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2017-01-24|||March 6, 2003||2003-03-06|May 20, 2014|2014-05-20|May 20, 2014||2014-05-20|||||Observational|||Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies|Follow-Up Study of Breast Cancer and Multiple Myeloma Subjects Previously Enrolled in Retroviral Gene Transfer Studies|Completed||N/A|12|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:55:02.92588|2017-02-18 15:55:02.92588
NCT00427713|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2013-08-23|||November 2004||2004-11-01|June 2007|2007-06-01||||March 2008|Actual|2008-03-01||Interventional|||Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer|Chemotherapy or No Chemotherapy in Clear Margins After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. A Randomised Phase III Trial of Control Vs Capecitabine Plus Oxaliplatin [CHRONICLE]|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:55:03.014243|2017-02-18 15:55:03.014243
NCT00427505|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2009-11-18|||July 2006||2006-07-01|November 2009|2009-11-01||||||||Interventional|||Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam|An Open-label, One-sequence Cross-over Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam in Healthy Volunteers|Completed||Phase 1|22||Novartis|||||f||||||||||||||2017-02-18 15:55:06.03729|2017-02-18 15:55:06.03729
NCT00427700|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2016-08-15|2014-11-21||August 2008||2008-08-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||Age, body mass index (BMI), hormone levels, waist-hip ratio, degree os hirsutism by the Ferriman-Gallwey(FG) score, and fasting glycemia were compared between both groups. The FG represents hair growth in 11 parts in the body, ranging from 0 (no excessive terminal hair growth) to 4 (extensive terminal hair growth) adding up maximum count of 36.|Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome|Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome|Completed||Phase 3|82|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||f||||||||Undecided||2017-02-18 15:55:03.376139|2017-02-18 15:55:03.376139
NCT00427687|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-08-01|||February 2007||2007-02-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Study Evaluating AGG-523 in Subjects With Osteoarthritis|A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Parallel-Group Study of the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of AGG-523 Administered Orally to Subjects With Mild to Moderate Osteoarthritis|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:55:03.807284|2017-02-18 15:55:03.807284
NCT00427674|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2010-10-05|||January 2007||2007-01-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients|Phase I Evaluation of (123-I)MZINT as a Brain SPECT Tracer of Serotonin Transporters in Healthy Human Subjects|Terminated||Phase 1|28|Actual|Institute for Neurodegenerative Disorders||1||Scan results to date did not show reason to continue with study|f||||t||||||||||2017-02-18 15:55:03.889374|2017-02-18 15:55:03.889374
NCT00427661|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2016-07-08|2016-02-19||June 2002||2002-06-01|July 2016|2016-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen|A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With High Risk Hemoglobinopathy Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism|Completed||N/A|8|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 15:55:03.994393|2017-02-18 15:55:03.994393
NCT00427648|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2014-03-14|||March 2006||2006-03-01|March 2014|2014-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Local Anesthetic Treatments for Overactive Bladder|Intravesical Alkalized Lidocaine for the Treatment of Overactive Bladder (OAB), a Randomized, Double-blinded Controlled Trial|Terminated||Phase 3|22|Actual|NorthShore University HealthSystem Research Institute||2||Data collection complete; analysis to take place|f||||f||||||||||2017-02-18 15:55:04.243428|2017-02-18 15:55:04.243428
NCT00427635|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2010-12-02|2010-04-19||October 2006||2006-10-01|December 2010|2010-12-01|April 2009|Actual|2009-04-01|||||Interventional|||Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients|A Randomized, Double-blind, Placebo Controlled, Study to Evaluate the Efficacy and Safety of Esomeprazole Once Daily for the Treatment of Gastroesophageal Reflux Disease (GERD) in Neonatal Patients, Including Premature and up to 1 Month Corrected Age|Completed||Phase 3|32|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:55:04.367026|2017-02-18 15:55:04.367026
NCT00427622|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2014-04-07|||May 2006||2006-05-01|June 2007|2007-06-01||||June 2007|Actual|2007-06-01||Interventional|||Skin Conduction Device for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes|A Trial to Examine the Accuracy of an Ambulatory Sternal Skin Conductance Recording Tool to Measure Hot Flashes|Completed||N/A|25|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 15:55:05.044648|2017-02-18 15:55:05.044648
NCT00427609|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2015-04-20|||January 2007||2007-01-01|April 2015|2015-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications|Efficacy of Bicillin LA for the Treatment of Chronic, Plaque-type Psoriasis Unresponsive to Topical Medications.|Terminated||Phase 2|5|Actual|University of Tennessee||2||Not enough enrollees to obtain a valid conclusion|f||||f||||||||||2017-02-18 15:55:05.140834|2017-02-18 15:55:05.140834
NCT00427596|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-10-06|||January 2007||2007-01-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Two-Part Study to Determine: Best Medication Formulation and Food Effect|A Two-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Four MR Formulations and Food Effect of GW427353 (Solabegron) in Healthy Adult Subjects|Completed||Phase 1|18|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:55:05.253071|2017-02-18 15:55:05.253071
NCT00427583|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-08-06|||May 2006||2006-05-01|August 2012|2012-08-01||||April 2009|Actual|2009-04-01||Interventional|||Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors|An Open-label Multicenter Phase II Study of Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors|Terminated||Phase 2/Phase 3|11|Actual|Novartis||1||stopped due to slow recruitment and no effect|f||||||||||||||2017-02-18 15:55:05.354678|2017-02-18 15:55:05.354678
NCT00427570|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2013-06-21|||September 1977||1977-09-01|August 2010|2010-08-01|May 2006|Actual|2006-05-01|||||Interventional|||Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery|A Clinical Trial to Evaluate Postoperative Immunotherapy and Postoperative Systemic Chemotherapy in the Management of Resectable Colon Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:55:05.466279|2017-02-18 15:55:05.466279
NCT00427557|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-05-23|2012-04-19||October 2006||2006-10-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Cellular Therapy With Cord Blood Cells|Use of Umbilical Cord Blood Cell in the Preparative Regimen of Patients With Advanced Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|31|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:55:05.566813|2017-02-18 15:55:05.566813
NCT00427544|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-12-03|||February 2007||2007-02-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRA-027 Administered Orally to Healthy Women of Nonchildbearing Potential|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:55:05.845522|2017-02-18 15:55:05.845522
NCT00427531|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2011-03-16|||June 2006||2006-06-01|March 2011|2011-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Skin Conduction Device and Patient Diary for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes|An Exploratory Trial to Examine the Accuracy of Various Hot Flash Variables With an Ambulatory Sternal Skin Conductance Recording Tool|Completed||N/A|3|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 15:55:05.933694|2017-02-18 15:55:05.933694
NCT00427492|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2009-02-10|||January 2007||2007-01-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effect of Postoperative Laxative on Bowel Function After Colonic Surgery|Effect of Postoperative Laxative on Bowel Function After Colonic Surgery|Completed||Phase 4|56|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-02-18 15:55:06.113789|2017-02-18 15:55:06.113789
NCT00427479|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2007-01-26|||July 2002||2002-07-01|January 2007|2007-01-01|December 2003||2003-12-01|||||Observational|||Oral Allergy Syndrome (OAS): a Pilot Study to Evaluate a Clinical Questionnaire as a Diagnostic Tool|The Prevalence of Oral Allergy Syndrome and Types of Food Commonly Causing Reactions in Birch Pollen Sensitive Patients Who Have Springtime Hayfever|Completed||N/A|40||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-02-18 15:55:06.208101|2017-02-18 15:55:06.208101
NCT00427466|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2009-02-13|||January 2007||2007-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pemetrexed in Patients With Soft Tissue Sarcoma|Multicenter Phase II Study With Pemetrexed in Patients With Pre-Treated Metastatic Soft Tissue Sarcomas|Completed||Phase 2|54|Actual|University Hospital Tuebingen|||||f||||||||||||||2017-02-18 15:55:06.294128|2017-02-18 15:55:06.294128
NCT00427453|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-01-26|||June 2003||2003-06-01|December 2006|2006-12-01|March 2005||2005-03-01|||||Interventional|||A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously|A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously|Completed||Phase 1|12||University of Oxford|||||f||||||||||||||2017-02-18 15:55:06.396796|2017-02-18 15:55:06.396796
NCT00427440|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2015-04-06||2015-04-06|November 2006||2006-11-01|April 2015|2015-04-01|April 2013|Actual|2013-04-01|December 2008|Actual|2008-12-01||Interventional|||A Phase II Study to Treat Advanced Malignant Glioma|A Multicenter, Open-label, Single Agent, Two-stage Phase 2 Study to Evaluate the Efficacy and Safety of AMG 102 in Subjects With Advanced Malignant Glioma|Completed||Phase 2|61|Actual|Amgen||2|||f||||||||||||||2017-02-18 15:55:06.507362|2017-02-18 15:55:06.507362
NCT00427427|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-07-28|||January 2007||2007-01-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer|A Phase II Trial of Delayed Adjuvant Herceptin® in Patients With HER-2 Positive Breast Cancer|Terminated||Phase 2|75|Anticipated|Jonsson Comprehensive Cancer Center||||lack of accrual|f||||||||||||||2017-02-18 15:55:06.619182|2017-02-18 15:55:06.619182
NCT00427414|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2015-04-28|||September 2008||2008-09-01|April 2015|2015-04-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|||Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma|Pilot Study of Viral Load and Transcription in Kaposi's Sarcoma Patients Treated With Liposomal Anthracyclines|Terminated||Phase 1|14|Actual|AIDS Malignancy Consortium||1||Terminated due to slow accrual.|f||||f||||||||||2017-02-18 15:55:06.728759|2017-02-18 15:55:06.728759
NCT00427401|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-09-25|||February 2007||2007-02-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks|A Double Blind, Placebo Controlled, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-00915275 After Oral Administration To Subjects With Type 2 Diabetes Mellitus For 4-Weeks|Terminated||Phase 2|40||Pfizer||||"This study was terminated May 7, 2007. The study stopped due to tablet formulation issues. No~   safety issues were involved in the termination decision."|f||||||||||||||2017-02-18 15:55:06.855584|2017-02-18 15:55:06.855584
NCT00427388|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2014-07-31|||June 2007||2007-06-01|July 2014|2014-07-01|August 2014|Anticipated|2014-08-01|February 2014|Actual|2014-02-01||Interventional|||Steroids In caRdiac Surgery Trial (SIRS Trial)|Phase IV Study of Perioperative Steroid's Effects on Death or MI in High-Risk Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass|Unknown status|Active, not recruiting|Phase 4|7507|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 15:55:07.077285|2017-02-18 15:55:07.077285
NCT00427375|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2016-08-19|||March 2007||2007-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2014|Actual|2014-12-01||Interventional|GRECCAR 2||Local Excision in Downstaged Rectal Cancer|Phase III Randomized Trial of Local Excision Versus Total Mesorectal Excision in Downstaged T2T3 Low Rectal Cancer After Radiochemotherapy|Active, not recruiting||Phase 3|148|Actual|University Hospital, Bordeaux||2|||f||||t||||||||No||2017-02-18 15:55:07.200475|2017-02-18 15:55:07.200475
NCT00427362|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2008-04-30|||May 2006||2006-05-01|April 2008|2008-04-01||||May 2007|Actual|2007-05-01||Interventional|||A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)|A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)|Completed||Phase 3|127|Actual|Abbott||1|||f||||f||||||||||2017-02-18 15:55:07.335607|2017-02-18 15:55:07.335607
NCT00427349|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2016-07-12|2015-05-19||September 2008||2008-09-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|October 2014|Actual|2014-10-01||Interventional||Per protocol, the primary population for all efficacy analysis is all eligible and treated patients|AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors|A Phase II Clinical and Biologic Study of AMG 706 and Octreotide in Patients With Low-Grade Neuroendocrine Tumors|Completed||Phase 2|46|Actual|Eastern Cooperative Oncology Group||1|||f||||t||||||||||2017-02-18 15:55:07.425962|2017-02-18 15:55:07.425962
NCT00427336|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2011-09-20|2011-09-20||December 2000||2000-12-01|September 2011|2011-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia|Purine Analog-Based Conditioning for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia|Completed||N/A|9|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:55:08.062316|2017-02-18 15:55:08.062316
NCT00427323|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2009-12-10|||June 2006||2006-06-01|September 2007|2007-09-01|September 2007|Anticipated|2007-09-01|September 2007|Anticipated|2007-09-01||Interventional|||Light Exposure to Treat Sleep Disruption in Older People|Disrupted Sleep in the Elderly: Light Exposure Studies|Suspended||N/A|60|Anticipated|National Institute on Aging (NIA)||||recruitment has been put on hold until a future date|f||||||||||||||2017-02-18 15:55:08.314809|2017-02-18 15:55:08.314809
NCT00426725|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2008-07-30|||February 2007||2007-02-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Testing the Efficiency of a Device Meant to Relieve Labour Pain|Protocol for Testing the Efficiency of a Device Meant to Relieve Labour Pain|Completed||N/A|64|Actual|ACU Medical Technologies Ltd||2|||f||||f||||||||||2017-02-18 15:55:18.495793|2017-02-18 15:55:18.495793
NCT00427310|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2012-12-31|||March 1984||1984-03-01|December 2012|2012-12-01|February 2001|Actual|2001-02-01|September 1989|Actual|1989-09-01||Interventional|||Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery|A Clinical Trial to Evaluate the Postoperative Portal Vein Infusion of 5-Fluorouracil and Heparin in Patients With Resectable Adenocarcinoma of the Colon|Completed||Phase 3|1158|Actual|NSABP Foundation Inc||2|||f||||||||||||||2017-02-18 15:55:08.426607|2017-02-18 15:55:08.426607
NCT00427297|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2010-03-16|||September 2007||2007-09-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya|Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya (6-12 Month RCT)|Terminated||Phase 3|34|Actual|University of Washington||2||There is no longer equipoise.|f||||t||||||||||2017-02-18 15:55:08.541673|2017-02-18 15:55:08.541673
NCT00427284|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2011-12-22|||July 2004||2004-07-01|December 2011|2011-12-01||||||||Observational|||Effect of Eplerenone on Endothelial Function in Patients With Stable Coronary Heart Disease||Completed||Phase 2/Phase 3|42|Actual|University of Zurich|||1||f||||||||||||||2017-02-18 15:55:08.663927|2017-02-18 15:55:08.663927
NCT00427271|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-26|2007-01-26|||March 2003||2003-03-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients|Aspirin and the Antiproteinuric Effect of Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients: a Randomized, Double-Blind, Placebo-Controlled Study|Unknown status|Recruiting|Phase 4|20||Hospital de Clinicas de Porto Alegre|||||f||||||||||||||2017-02-18 15:55:08.747739|2017-02-18 15:55:08.747739
NCT00427258|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2011-07-22|||January 2010||2010-01-01|July 2011|2011-07-01||||||||Interventional|||Study Evaluating MOA-728 Administered in Healthy Men|An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]MOA-728 in Healthy Men|Withdrawn||Phase 1|6|Anticipated|Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 15:55:08.8425|2017-02-18 15:55:08.8425
NCT00427245|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2013-08-06|||August 2004||2004-08-01|May 2007|2007-05-01||||||||Interventional|||Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer|Ovarian Protection Trial In Premenopausal Breast Cancer Patients [OPTION]|Completed||Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:55:08.923023|2017-02-18 15:55:08.923023
NCT00427232|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-01-25|||May 2003||2003-05-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Endothelin-Receptor Blockade in Coronary Heart Disease|Selective and Non-Selective Endothelin-Receptor Blockade in Coronary Artey Disease|Completed||Phase 1|26||Medical University of Vienna|||||f||||||||||||||2017-02-18 15:55:09.082139|2017-02-18 15:55:09.082139
NCT00427219|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2012-06-06|||January 2007||2007-01-01|June 2012|2012-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate|A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Ozarelix, in Patients With Lower Urinary Tract Symptoms(LUTS)Due to Benign Prostatic Hypertrophy (BPH)|Completed||Phase 2/Phase 3|76|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||||||||||||2017-02-18 15:55:09.170376|2017-02-18 15:55:09.170376
NCT00427206|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2009-02-06|||November 2004||2004-11-01|February 2009|2009-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing|Hepatic Function Following Five Days of Therapeutic Dosing of Acetaminophen in Alcoholics|Completed||Phase 4|181|Actual|Denver Health and Hospital Authority||2|||f||||t||||||||||2017-02-18 15:55:09.287323|2017-02-18 15:55:09.287323
NCT00427193|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2015-03-25|||May 2007||2007-05-01|March 2015|2015-03-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy|Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy (CALERIE)|Completed||N/A|238|Actual|Duke University||2|||f||||t||||||||||2017-02-18 15:55:09.394214|2017-02-18 15:55:09.394214
NCT00427180|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2010-03-02|||December 2006||2006-12-01|March 2010|2010-03-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Interventional|||IRIS PILOT - Extended Pilot Study With a Retinal Implant System|Extended Pilot Study to Evaluate Pattern Recognition With a Chronic Retinal Implant System|Unknown status|Active, not recruiting|N/A|20|Anticipated|Intelligent Medical Implants GmbH||1|||f||||f||||||||||2017-02-18 15:55:09.506044|2017-02-18 15:55:09.506044
NCT00427167|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2017-01-24|||January 23, 2007||2007-01-23|August 3, 2009|2009-08-03|November 5, 2008|Actual|2008-11-05|November 5, 2008|Actual|2008-11-05||Interventional|||Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine|Phase I Study of the Safety and Immunogenicity of AMA1-C1/Alhydrogel + CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria|Completed||Phase 1|300||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:55:09.601895|2017-02-18 15:55:09.601895
NCT00427154|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2012-07-09||2009-11-09|January 2007||2007-01-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes|Effect of Inhaled Pre-Prandial Human Insulin Plus Metformin & Glimepiride Versus Rosiglitazone Plus Metformin & Glimepiride on HbA1c in Subjects With Type 2 Diabetes|Terminated||Phase 3|227|Actual|Novo Nordisk A/S||2||See termination reason in detailed description|f||||f||||||||||2017-02-18 15:55:09.702299|2017-02-18 15:55:09.702299
NCT00427141|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2012-05-31|||October 2006||2006-10-01|February 2011|2011-02-01||||||||Interventional|||A Three-Part Study Of GSK580416 In Healthy Subjects|A Three-part First Time in Human Study to Evaluate Safety, Tolerability, Pharmacokinetics and Food Effect of Single Oral Doses of GSK580416 in Healthy Adult Subjects|Completed||Phase 1|48|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:55:10.000709|2017-02-18 15:55:10.000709
NCT00427128|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2011-12-14|||November 1995||1995-11-01|December 2011|2011-12-01|March 2003|Actual|2003-03-01|||||Interventional|||Prozac Treatment of Major Depression: Discontinuation Study|Prozac Treatment of Major Depression: Discontinuation Study|Completed||Phase 4|627|Actual|New York State Psychiatric Institute|||||f||||||||||||||2017-02-18 15:55:10.08937|2017-02-18 15:55:10.08937
NCT00427115|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-05-20|||August 2005||2005-08-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Multimodal Intervention in Allogeneic Stem Cell Transplantation|Pilot Study of an Exercise an Psycho-Educational Intervention During Allogeneic Stem Cell Transplantation|Completed||Phase 3|42|Actual|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 15:55:10.198814|2017-02-18 15:55:10.198814
NCT00427102|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2012-11-13|||January 2007||2007-01-01|November 2012|2012-11-01|July 2007|Actual|2007-07-01|||||Interventional|||MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck|A Phase 1 Study of Oral MRX-1024 in Combination With Standard Fractionation Radiation Therapy and High-Dose Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck Following Surgical Resection|Terminated||Phase 1|||Sidney Kimmel Comprehensive Cancer Center||||No subjects enrolled and PI went to another facility|f||||||||||||||2017-02-18 15:55:10.281595|2017-02-18 15:55:10.281595
NCT00427089|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2008-04-15|||September 2004||2004-09-01|April 2008|2008-04-01|May 2005||2005-05-01|||||Interventional|||Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening|Parallel Group Comparison of the New 2 Liter Gut Cleansing Solution NRL 994 Versus Sodium Phosphate Preparation in Routine Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening.|Completed||Phase 3|360|Actual|Norgine||2|||f||||f||||||||||2017-02-18 15:55:10.372947|2017-02-18 15:55:10.372947
NCT00427076|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2015-09-23|||June 2007||2007-06-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections|Treatment With Cotrimoxazole vs. Vancomycin for Infections Caused by Methicillin-resistant Staphylococcus Aureus: Randomized Controlled Trial|Completed||Phase 3|252|Actual|Rabin Medical Center||2|||f||||t||||||||||2017-02-18 15:55:10.502599|2017-02-18 15:55:10.502599
NCT00427063|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-01-25|||January 1998||1998-01-01|January 2007|2007-01-01|December 1998||1998-12-01|||||Observational|||Heredity of Retinal Vessel Tortuosity|Heredity of Retinal Vessel Tortuosity - A Twin Study|Completed||N/A|218||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 15:55:10.615184|2017-02-18 15:55:10.615184
NCT00427050|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2015-09-11|||January 2007||2007-01-01|December 2008|2008-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel|An Open-label, Multi-centre, Dose-escalation, Cohort Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel When Applied to a 25 cm2 Contiguous Actinic Keratoses Treatment Area on the Face or Face and Scalp.|Completed||Phase 2|50|Anticipated|Peplin|||||f||||||||||||||2017-02-18 15:55:10.87044|2017-02-18 15:55:10.87044
NCT00427037|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2015-07-20|2009-01-14||December 2005||2005-12-01|July 2015|2015-07-01|March 2013|Actual|2013-03-01|July 2006|Actual|2006-07-01||Interventional|||Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects|Efficacy of Cholecalciferol (Vitamin D3) Therapy in Correcting Vitamin D Insufficiency and Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease: A Randomized, Placebo Controlled Pilot Study|Completed||N/A|34|Actual|Atlanta VA Medical Center||2|||f||||f||||||||||2017-02-18 15:55:10.98321|2017-02-18 15:55:10.98321
NCT00427024|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-25|2007-02-05|||February 2007||2007-02-01|February 2007|2007-02-01|February 2009||2009-02-01|||||Observational|||Renal Transporters After Renal Transplantation|Study of Renal Transporters and Their Regulators After Renal Transplantation|Unknown status|Not yet recruiting|N/A|200||University Hospital Muenster|||||f||||||||||||||2017-02-18 15:55:11.415329|2017-02-18 15:55:11.415329
NCT00427011|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2013-02-05|2012-11-20||February 2007||2007-02-01|February 2013|2013-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of E2007 In Patients With Parkinson's Disease|"A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of E2007 In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing-Off Motor Fluctuations"|Terminated||Phase 2|25|Actual|Eisai Inc.|Due to early termination, a limited number of subjects (n=26) were screened for inclusion in the study and only 25 subjects were analyzed. The majority of subjects did not reach the scheduled Week 56 assessment.|1||Study stopped due to lack of efficacy.|f||||||||||||||2017-02-18 15:55:11.509037|2017-02-18 15:55:11.509037
NCT00426998|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2007-01-25|||April 2006||2006-04-01|January 2007|2007-01-01||||||||Interventional|||Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD|A 24 Month Randomized, Double-Masked, Single Center, Phase II Study Comparing Photodynamic Therapy With Verteporfin (Visudyne)Plus Two Different Timing Regimens of Intravitreal Bevacizumab (Avastin) Given 1 Week Prior to or 1 Week Following Photodynamic Therapy in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.|Completed||Phase 2|30||Retinal Consultants Medical Group|||||f||||||||||||||2017-02-18 15:55:11.877141|2017-02-18 15:55:11.877141
NCT00426985|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2008-08-13|||January 2007||2007-01-01|August 2008|2008-08-01|October 2008|Anticipated|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study of the Efficacy, Tolerability and Safety of Ketoprofen Topical Patch, 20% (KTP) in the Treatment of Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee|Terminated||Phase 3|330|Anticipated|Endo Pharmaceuticals||||Sufficient number of subjects accrued to conduct analysis|f||||||||||||||2017-02-18 15:55:11.966506|2017-02-18 15:55:11.966506
NCT00426972|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2009-08-27|||January 2007||2007-01-01|August 2009|2009-08-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites|A Double Blind, Placebo Controlled Trial to Investigate the Efficacy of Zesteem (Estradiol) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites.|Completed||Phase 3|148|Anticipated|Renovo|||||f||||f||||||||||2017-02-18 15:55:12.062209|2017-02-18 15:55:12.062209
NCT00426959|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2012-11-13|||February 2005||2005-02-01|November 2012|2012-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Study of Image-guided Dosimetry for Interstitial Prostate Brachytherapy|Feasibility Study of Image-guided, Dynamic Dosimetry for Permanent Interstitial Prostate Brachytherapy|Completed||Phase 1|6|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 15:55:12.181246|2017-02-18 15:55:12.181246
NCT00426946|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2007-01-24|||January 2005||2005-01-01|September 2004|2004-09-01||||||||Interventional|||Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study|Phase 3 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study|Unknown status|Recruiting|Phase 4|60||Geha Mental Health Center|||||f||||||||||||||2017-02-18 15:55:12.278391|2017-02-18 15:55:12.278391
NCT00426933|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2010-09-13|||January 2007||2007-01-01|September 2010|2010-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections|Phase 2 Multicenter Randomized Semi-Single Blind Study to Compare Efficacy and Safety of High-dose Short Duration Daptomycin With Conventional Therapy in Complicated Skin and Skin Structure Infections Due to Gram-positive Bacteria|Completed||Phase 2|100|Actual|Cubist Pharmaceuticals LLC|||||f||||f||||||||||2017-02-18 15:55:12.364257|2017-02-18 15:55:12.364257
NCT00426920|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2007-01-24|||February 2007||2007-02-01|January 2007|2007-01-01||||||||Interventional|||Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler|Evaluation of the Pharmacokinetics and Pharmacodynamics of Spray-Dried Recombinant Human Insulin Powder for Inhalation Administered Via a Dry Powder Inhalation Device Relative to SC Recombinant Human Insulin in Healthy Male Volunteers|Unknown status|Not yet recruiting|Phase 1|14||QDose Limited|||||f||||||||||||||2017-02-18 15:55:12.456867|2017-02-18 15:55:12.456867
NCT00426907|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2015-04-09|||January 2007||2007-01-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Weightbearing After High Tibial Osteotomy|Weightbearing After Proximal Open-wedge Tibial Osteotomy - a Clinical, Randomized RSA-study.|Completed||Phase 4|20|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-02-18 15:55:12.551431|2017-02-18 15:55:12.551431
NCT00426894|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2007-01-24|||January 2007||2007-01-01|January 2007|2007-01-01||||||||Interventional|||Microbial Surveillance in Children Hospitalized for Cardiovascular Surgery|Longitudinal Microbial Surveillance in Children Hospitalized for Cardiac Surgery Before the Operation and During Hospitalization|Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:55:12.654511|2017-02-18 15:55:12.654511
NCT00426881|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2014-12-03|||January 2007||2007-01-01|December 2014|2014-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Brain Power: Resistance Training and Cognitive Function|The Effect of Resistance Training on Cognitive Performance, Cortical Plasticity, and Fall Risk in Women Aged 65-75 Years Old: A 12-Month RCT|Completed||N/A|155|Actual|University of British Columbia||3|||f||||f||||||||||2017-02-18 15:55:12.73803|2017-02-18 15:55:12.73803
NCT00426868|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2013-08-27|||January 2007||2007-01-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium|A Randomized Clinical Trial of adiPose-deRived stEm & Regenerative Cells In the Treatment of Patients With Non revaScularizable ischEmic Myocardium - The PRECISE Trial|Completed||Phase 1|27|Actual|Cytori Therapeutics||2|||f||||t||||||||||2017-02-18 15:55:12.839279|2017-02-18 15:55:12.839279
NCT00426855|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2015-04-02|2011-06-27||January 2007||2007-01-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)|Weekly Bendamustine and Bortezomib Combination Therapy in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or B-CLL: A Single-Center Phase 2 Study|Completed||Phase 1/Phase 2|12|Actual|Kantonsspital Aarau||1|||f||||f||||||||||2017-02-18 15:55:12.943969|2017-02-18 15:55:12.943969
NCT00426842|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2016-08-29|2013-09-17||January 2007||2007-01-01|August 2016|2016-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride|A Dose Response Trial Using 5 and 10 mg. of Midodrine Hydrochloride to Treat Orthostatic Hypotension in Persons With SCI|Completed||Phase 2|11|Actual|James J. Peters Veterans Affairs Medical Center|A matching placebo tablet was not used and the order of testing was not randomized. The total number of subjects recruited was relatively small and extrapolation to a broader group of individuals with chronic SCI may not be appropriate.|1|||f||||f||||||||||2017-02-18 15:55:13.278197|2017-02-18 15:55:13.278197
NCT00426829|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2012-07-31|||May 2007||2007-05-01|July 2012|2012-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Proton Therapy and Bevacizumab for Primary Liver Tumors|Phase I Study of Proton Radiotherapy and Bevacizumab for Primary Liver Tumors|Terminated||Phase 1|3|Actual|M.D. Anderson Cancer Center||1||Low Accural|f||||f||||||||||2017-02-18 15:55:13.531148|2017-02-18 15:55:13.531148
NCT00426816|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2012-08-09|||December 2006||2006-12-01|August 2012|2012-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia|A Multi-centre, Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of SB-649868 (10, 30 mg and 60 mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia|Completed||Phase 2|48|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:55:13.645271|2017-02-18 15:55:13.645271
NCT00426803|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2017-01-17|||August 2002||2002-08-01|January 2017|2017-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Recombinant Factor VIIa in Acute Intracerebral Haemorrhage|Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Parallel Groups, Study to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (NovoSeven®) in Acute Intracerebral Haemorrhage|Completed||Phase 2|400|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:55:13.750406|2017-02-18 15:55:13.750406
NCT00426790|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2007-01-24||||||January 2007|2007-01-01||||||||Interventional|||Open Lung Approach During General Anaesthesia to Prevent Post-Operative Pulmonary Complications||Unknown status|Recruiting|N/A|||Università degli Studi dell'Insubria|||||f||||||||||||||2017-02-18 15:55:13.860374|2017-02-18 15:55:13.860374
NCT00426777|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2012-02-02|||January 2007||2007-01-01|February 2012|2012-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer|A Randomized, Single-blind, Placebo-controlled, Multicentre Study to Evaluate the Effect of Risedronate and Placebo on Bone Mineral Density in Men Undergoing Androgen Deprivation Therapy With Leuprolide Acetate|Completed||Phase 3|160|Actual|CMX Research||2|||f||||f||||||||||2017-02-18 15:55:13.929847|2017-02-18 15:55:13.929847
NCT00426764|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2016-10-28|2012-07-05||June 2007||2007-06-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2010|Actual|2010-11-01||Interventional|||A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma|A Phase II, Multicenter, Open-Label Trial Evaluating The Activity And Tolerability Of Romidepsin (Depsipeptide, FK228) In Progressive Or Relapsed Peripheral T-Cell Lymphoma Following Prior Systemic Therapy (GPI-06-0002)|Active, not recruiting||Phase 2|131|Actual|Celgene Corporation||1|||f||||t||||||||||2017-02-18 15:55:14.066426|2017-02-18 15:55:14.066426
NCT00426751|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2012-11-21|2010-04-06||October 2006||2006-10-01|November 2012|2012-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)|Eptifibatide Versus Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction|Completed||Phase 3|429|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 15:55:17.411077|2017-02-18 15:55:17.411077
NCT00426075|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2008-06-09|||January 2006||2006-01-01|June 2008|2008-06-01||||November 2007|Actual|2007-11-01||Interventional|||Full-Leg vs Below-Knee Elastic Stockings for Prevention of the Post-Thrombotic Syndrome||Completed||Phase 3|||University of Padova|||||f||||||||||||||2017-02-18 15:55:33.658491|2017-02-18 15:55:33.658491
NCT00426712|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2016-08-23|||January 2006||2006-01-01|August 2016|2016-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients|A Phase 1, Randomized, Observer-blind, Dose-escalating Study in Adult End-stage Renal Failure Patients to Explore the Safety, Tolerability, Pharmacokinetics and Immune Response to Recombinant Hepatitis B Virus Surface Antigen (rHBsAg) Co-administered With Dynavax Immunostimulatory Phosphorothioate Oligodeoxyribonucleotide (1018 ISS)|Completed||Phase 1|42|Actual|Dynavax Technologies Corporation||4|||f||||t||||||||Undecided|Clinical decision still pending a/o August 2016|2017-02-18 15:55:18.608854|2017-02-18 15:55:18.608854
NCT00426699|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2011-05-18|||June 2006||2006-06-01|May 2011|2011-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Urinary Excretion of Enteroviruses From Children With a Presumed Enteroviral Infection||Completed||N/A|82|Actual|University Hospital Inselspital, Berne|||1||f||||||||||||||2017-02-18 15:55:18.733966|2017-02-18 15:55:18.733966
NCT00426686|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2012-12-11|||November 2006||2006-11-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|March 2009|Actual|2009-03-01||Observational|ADAMTS13||ADAMTS13 in Thrombotic Thrombocytopenic Purpura|ADAMTS13-related Prognostic Factors in Adult and Pediatric Thrombotic Thrombocytopenic Purpura|Completed||N/A|153|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"~     March 2010~   "|||2017-02-18 15:55:18.83229|2017-02-18 15:55:18.83229
NCT00426673|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2008-03-07|||April 2005||2005-04-01|March 2008|2008-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.|A Multi-Center, Open-Label, Unilateral Interaction Study of Ucb 34714 on Stable Phenytoin Monotherapy During a 45 Day b.i.d. Administration Period in 15 Adult Subjects Suffering From Epilepsy|Completed||Phase 1|15||UCB Pharma|||||f||||||||||||||2017-02-18 15:55:18.950139|2017-02-18 15:55:18.950139
NCT00426660|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2016-05-23|2011-06-02||February 2007||2007-02-01|May 2016|2016-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Expanded Access Program for Maraviroc At Multiple Centers|A Multicenter, Open Label, Expanded Access Trial Of Maraviroc|Completed||Phase 3|1047|Actual|ViiV Healthcare|Viral loads were not available for subjects uniformly as this expanded access study followed local country guidelines and practices that could vary significantly between countries, and testing frequency may have been affected by insurance status.|1|||f||||t||||||||||2017-02-18 15:55:19.091847|2017-02-18 15:55:19.091847
NCT00426647|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2010-01-29|||February 2007||2007-02-01|January 2010|2010-01-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine|A Randomised Double-blind Multicentre Equivalence Study With Active Parallel Comparator Group to Evaluate the Efficacy and Safety of Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip, Knee &/or Lumbar Spine.|Completed||Phase 4|120|Anticipated|Norpharma A/S||2|||f||||f||||||||||2017-02-18 15:55:21.631173|2017-02-18 15:55:21.631173
NCT00426634|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2017-01-24|||January 19, 2007||2007-01-19|August 30, 2016|2016-08-30|August 30, 2016||2016-08-30|||||Observational|||Children With Asthma in New Orleans After Hurricane Katrina|Head-Off Environmental Asthma in Louisiana|Completed||N/A|1950|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:55:21.749135|2017-02-18 15:55:21.749135
NCT00426621|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2007-12-13|||November 2006||2006-11-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis|A 12-Week, Randomized, Double-Blind, Multi-Center, Vehicle-Controlled, Parallel Group Study to Assess the Efficacy and Safety of the Diclofenac Sodium Gel 1% for the Relief of Signs and Symptoms in Patients With Osteoarthritis of the Knee.|Completed||Phase 3|420|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:55:22.014081|2017-02-18 15:55:22.014081
NCT00426608|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2009-06-04|||October 2006||2006-10-01|June 2009|2009-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.|Placebo-Controlled, Randomized, Blinded, Double-Dummy, Crossover Study to Investigate the Attenuation of ACTH Activation Induced by Metyrapone With a Single Dose of GSK561679 or Alprazolam in Healthy Volunteers|Completed||Phase 1|20|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 15:55:22.191468|2017-02-18 15:55:22.191468
NCT00426595|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2009-04-09|||April 2007||2007-04-01|April 2009|2009-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation|Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation|Completed||Phase 2|14|Anticipated|University Hospital, Ghent|||||f||||||||||||||2017-02-18 15:55:22.287332|2017-02-18 15:55:22.287332
NCT00426582|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-24|2011-03-24|||August 2006||2006-08-01|March 2011|2011-03-01||||August 2010|Actual|2010-08-01||Interventional|||Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors|A Phase Ib, Multicenter, Open-label, Dose-finding Study of Patupilone Administered Intravenously Every 3 Weeks in Combination With Carboplatin AUC 6 in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|48|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:55:22.376323|2017-02-18 15:55:22.376323
NCT00426569|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2015-05-22|||February 2007||2007-02-01|May 2015|2015-05-01|May 2015|Actual|2015-05-01|April 2015|Actual|2015-04-01||Observational|||Normal Paranasal Sinuses Microflora Study||Completed||N/A|18|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 15:55:22.478622|2017-02-18 15:55:22.478622
NCT00426556|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2015-11-24|2015-03-20||July 2007||2007-07-01|November 2015|2015-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional||The Full Analysis Set (FAS) consisted of all patients who received a least one dose of any one compound of the study treatment. Patients were analyzed according to the everolimus dose level to which they enrolled.|Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer|A Phase Ib/II Study Investigating the Combination of Everolimus With Trastuzumab and Paclitaxel in Patients With HER2-overexpressing Metastatic Breast Cancer|Completed||Phase 1|88|Actual|Novartis||4|||f||||||||||||||2017-02-18 15:55:22.570837|2017-02-18 15:55:22.570837
NCT00426543|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2011-01-13|||January 2007||2007-01-01|August 2010|2010-08-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome|Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjögren's Syndrome|Completed||Phase 2|21|Actual|University of Copenhagen||1|||f||||t||||||||||2017-02-18 15:55:24.140797|2017-02-18 15:55:24.140797
NCT00426530|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2016-04-20|||February 2007||2007-02-01|April 2016|2016-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer|A Phase Ib Study Investigating the Combination of Everolimus With Trastuzumab and Vinorelbine in Patients With HER2-overexpressing Metastatic Breast Cancer|Completed||Phase 1|50|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:55:24.261827|2017-02-18 15:55:24.261827
NCT00426517|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2017-01-24|||January 19, 2007||2007-01-19|December 1, 2016|2016-12-01|December 1, 2023|Anticipated|2023-12-01|December 1, 2020|Anticipated|2020-12-01||Interventional|||Donor Stem Cell Transplantation for Congenital Immunodeficiencies|Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies or Patients With Autoinflammatory/Immunodysregulatory Conditions: Busulfan-Based Conditioning With Campath- 1H or h-ATG, Radiation, and Sirolimus|Recruiting||Early Phase 1|100|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 15:55:24.495527|2017-02-18 15:55:24.495527
NCT00426504|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2013-06-04|||November 2006||2006-11-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Radiation Therapy Using Helical Tomotherapy IMRT for Head and Neck Cancer|Helical Tomotherapy Intensity Modulated Radiotherapy:A Phase I/II Pilot Study to Determine the Toxicity Profile, Pattern of Failures and Quality of Life of Patients With Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|89|Actual|Ottawa Hospital Research Institute||1|||f||||||||||||||2017-02-18 15:55:24.641857|2017-02-18 15:55:24.641857
NCT00426491|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2008-02-01|||March 1999||1999-03-01|February 2008|2008-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Misoprostol for Non-Viable Pregnancies|Misoprostol for the Medical Management of Non-Viable First Trimester Pregnancies|Completed||Phase 3|30|Actual|Madigan Army Medical Center||2|||f||||f||||||||||2017-02-18 15:55:24.747751|2017-02-18 15:55:24.747751
NCT00426478|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2008-08-20|||November 2006||2006-11-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients|The Comparison of the Antihypertensive Efficacy and Tolerability Between Valsartan Plus Hydrochlorothiazide 80mg/12.5mg and Amlodipine 5mg in the Essential Hypertensive Patients|Completed||Phase 4|80|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:55:24.867107|2017-02-18 15:55:24.867107
NCT00426465|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2017-01-24|||January 17, 2007||2007-01-17|December 16, 2013|2013-12-16|December 16, 2013||2013-12-16|||||Observational|||Spaced Versus Massed Skill Learning|Neural Substrates of Lasting Motor Skill Learning by Spacing Effect|Completed||N/A|213|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:55:24.959664|2017-02-18 15:55:24.959664
NCT00426452|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2009-11-18|||July 2006||2006-07-01|November 2009|2009-11-01||||||||Interventional|||A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers|A Phase IB, Open Label, Single Center, Drug-drug Interaction Study of Oral 1250 mg of PTK787/ZK 222584 Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor (Omeprazole) in Healthy Sterile or Postmenopausal Female Volunteers|Completed||Phase 1|24||Novartis|||||f||||||||||||||2017-02-18 15:55:25.043479|2017-02-18 15:55:25.043479
NCT00426439|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2011-01-02|||December 2006||2006-12-01|January 2011|2011-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau|Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau.|Completed||Phase 4|300|Anticipated|Bandim Health Project||2|||f||||t||||||||||2017-02-18 15:55:25.14018|2017-02-18 15:55:25.14018
NCT00426426|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2017-02-09|||January 2007|Actual|2007-01-01|February 2017|2017-02-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GAD|A Randomised Controlled Trial Comparing the Effectiveness of Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of Patients With Generalised Anxiety Disorder (GAD)|Completed||N/A|68|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-02-18 15:55:25.258991|2017-02-18 15:55:25.258991
NCT00426413|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2013-11-12|||May 2007||2007-05-01|November 2013|2013-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Ketosis Prone Diabetes in African-Americans|Ketosis Prone Diabetes Mellitus in African-Americans: Insulin Signaling, Proteomics, and Outcomes|Completed||N/A|44|Anticipated|Emory University|||3||f||||t||||||Samples With DNA|"~     The study has IRB approval for blood sample collection for future DNA analyses and HLA~     typing.~   "|||2017-02-18 15:55:25.361054|2017-02-18 15:55:25.361054
NCT00426400|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2007-01-23|||March 2006||2006-03-01|January 2007|2007-01-01||||||||Interventional|||Anti-Aggregative Therapy and Laser Iridectomy||Unknown status|Recruiting|Phase 4|||Sheba Medical Center|||||f||||||||||||||2017-02-18 15:55:25.472251|2017-02-18 15:55:25.472251
NCT00426374|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2007-01-31|||January 2007||2007-01-01|January 2007|2007-01-01||||||||Interventional|||Assessment of Asymptomatic Heart Disease in Children With HIV|Evaluation of the Cardiac Complications in Congenitally HIV-1 Infected Children in Israel by the Echocardiography and Measurement of N-Terminal Pro-B-Type Natriuretic Peptide (N-BNP).|Unknown status|Not yet recruiting|N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:55:25.708643|2017-02-18 15:55:25.708643
NCT00426361|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2016-10-26|2009-11-12||February 2007||2007-02-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|March 2008|Actual|2008-03-01||Interventional|||Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects|A Multicentre Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine (580299) Co-administered With Boostrix Polio (dTpa-IPV) in Healthy Female Subjects Aged 10-18 Years|Completed||Phase 3|751|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:55:25.803324|2017-02-18 15:55:25.803324
NCT00426348|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2013-08-27|||May 2007||2007-05-01|August 2013|2013-08-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy|A Prospective Randomized, Controlled, Double Blinded Trial of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy|Completed||Phase 4|75|Actual|Guangdong General Hospital||2|||f||||t||||||||||2017-02-18 15:55:26.76586|2017-02-18 15:55:26.76586
NCT00426062|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2007-02-18||||||February 2007|2007-02-01||||||||Observational|||Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva||Unknown status|Recruiting|Phase 1|||Sheba Medical Center|||||f||||||||||||||2017-02-18 15:55:33.742493|2017-02-18 15:55:33.742493
NCT00426335|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2010-01-12|||January 2007||2007-01-01|January 2010|2010-01-01||||||||Observational|||Evaluation of Group CBT Programme With Breast Cancer Patients|An Evaluation of a Group CBT Programme for Women With Primary Breast Cancer.|Unknown status|Recruiting|Early Phase 1|78|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||||||||||||2017-02-18 15:55:26.866592|2017-02-18 15:55:26.866592
NCT00426322|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2013-09-09|||March 2007||2007-03-01|September 2013|2013-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy of Sinus Floor Augmentation Using Large or Small Bovine Bone Mineral.|Efficacy of Sinus Floor Augmentation Using Large (1-2mm) or Small (0.25-1mm) Bovine Bone Mineral Particles (Bio-Oss®): A Comparative Histomorphometric Clinical Study|Completed||N/A|10|Actual|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 15:55:26.940901|2017-02-18 15:55:26.940901
NCT00426296|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2007-10-30|||August 2006||2006-08-01|October 2007|2007-10-01||||||||Interventional|||SHARE: Simple HAART With Abacavir, Reyataz, and Epivir|An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of a Fixed-Dose Combination of Abacavir 600 mg/Lamivudine 300 mg Once-Daily in Combination With Atazanavir 300 mg + Ritonavir 100 mg Once-Daily in Antiretroviral-Naïve HIV-1 Infected Subjects With Continuing Evaluation of Abacavir/Lamivudine Plus Atazanavir 400 mg for Maintenance Over an Additional 48 Weeks|Unknown status|Recruiting|Phase 4|||Clinical Alliance for Research & Education - Infectious Diseases, LLC.|||||f||||||||||||||2017-02-18 15:55:27.045306|2017-02-18 15:55:27.045306
NCT00426283|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2014-09-10|2013-12-16||January 2007||2007-01-01|September 2014|2014-09-01|October 2013|Actual|2013-10-01|January 2013|Actual|2013-01-01||Interventional|||A Study of Flovent in Patients With Eosinophilic Esophagitis|A Double Blinded, Randomized Trial of Swallowed 1760mcg Fluticasone Propionate Versus Placebo in the Treatment of Eosinophilic Esophagitis|Completed||Phase 2|42|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-02-18 15:55:27.138099|2017-02-18 15:55:27.138099
NCT00426270|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2014-07-28|2014-04-07||June 2006||2006-06-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Safety population: All participants who received at least 1 dose of study medication.|Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults|Clinical Study to Evaluate the Efficacy and Safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in Adults|Completed||Phase 3|116|Actual|Octapharma||1|||f||||t||||||||||2017-02-18 15:55:27.518408|2017-02-18 15:55:27.518408
NCT00426257|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2016-05-23|||February 2007||2007-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|March 2016|Actual|2016-03-01||Interventional|||Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer|Phase III Randomised Clinical Trial for Stage III Ovarian Carcinoma Randomising Between Secondary Debulking Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy|Active, not recruiting||Phase 3|242|Actual|The Netherlands Cancer Institute||2|||f||||t||||||||||2017-02-18 15:55:27.771051|2017-02-18 15:55:27.771051
NCT00426244|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2015-04-19|||April 2006||2006-04-01|April 2015|2015-04-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Osteopathic Manipulative Medicine in Pregnancy: Physiologic and Clinical Effects|Osteopathic Manipulative Medicine in Pregnancy: Physiologic and Clinical Effects|Completed||Phase 2|400|Actual|University of North Texas Health Science Center||3|||f||||t||||||||||2017-02-18 15:55:27.876911|2017-02-18 15:55:27.876911
NCT00426231|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2014-01-13|2014-01-13||March 2006||2006-03-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Culturally-Tailored Approach to Improve Medication Use in Patients With Heart Attacks|Culturally-Tailored Hospital-based Model to Improve Statin Use and Outcomes in Patients With Coronary Disease|Completed||N/A|140|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 15:55:28.030536|2017-02-18 15:55:28.030536
NCT00426218|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2011-08-08|||December 2006||2006-12-01|August 2011|2011-08-01||||March 2010|Actual|2010-03-01||Interventional|||Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)|Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)|Completed||Phase 1/Phase 2|26|Anticipated|Novartis||1|||f||||||||||||||2017-02-18 15:55:28.424288|2017-02-18 15:55:28.424288
NCT00426205|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2014-03-03|||June 2004||2004-06-01|March 2014|2014-03-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Interventional|||GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies|GM-CSF Secreting Leukemia Cell Vaccinations After Allogeneic Non-myeloablative Peripheral Blood Stem Cell Transplantation in Patients With Advanced Myelodysplastic Syndrome or Refractory Acute or Advanced Chronic Myeloid Leukemia|Completed||N/A|24|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:55:28.517543|2017-02-18 15:55:28.517543
NCT00426192|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-23|||October 2003||2003-10-01|January 2007|2007-01-01|November 2004||2004-11-01|||||Interventional|||Effects of Hemofiltration and Mannitol Treatment on Cardiopulmonary-Bypass Induced Immunosuppression|Mechanisms of Endotoxin-Tolerance of Human Monocytes After CABG-Sugery - Effects of Hemofiltration and Mannitol Treatment|Unknown status|Active, not recruiting|Phase 4|52||University Hospital, Saarland|||||f||||||||||||||2017-02-18 15:55:28.618712|2017-02-18 15:55:28.618712
NCT00426179|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2007-11-16|||December 2006||2006-12-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen|An Exploratory Study of the Effects of Imatinib on Allergic Inflammation Following Out of Allergy Season Repeated Nasal Allergen Challenge in Subjects With Seasonal Allergic Rhinitis Sensitive to Timothy Grass Pollen - an Exploratory Study of c-Kit Inhibition in Allergic Respiratory Diseases|Completed||Phase 1/Phase 2|30|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:55:28.717878|2017-02-18 15:55:28.717878
NCT00426166|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2011-05-09|||January 2007||2007-01-01|March 2010|2010-03-01|May 2011|Actual|2011-05-01|March 2009|Actual|2009-03-01||Interventional|||Assessment Of Infrared Photobiotherapy for Improved Wound Healing||Completed||N/A|50|Anticipated|University of Toledo Health Science Campus||2|||f||||||||||||||2017-02-18 15:55:28.80699|2017-02-18 15:55:28.80699
NCT00426153|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2012-10-22|2012-10-22||January 2007||2007-01-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Octreotide in Severe Polycystic Liver Disease|Pilot Study Of Long-Acting Octreotide (Octreotide LAR® Depot) In The Treatment Of Patients With Severe Polycystic Liver Disease|Completed||Phase 2/Phase 3|42|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 15:55:29.035946|2017-02-18 15:55:29.035946
NCT00424580|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2008-01-18|||January 2007||2007-01-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Airway Responses to Montelukast and Desloratadine.|Airway Responses to Montelukast and Desloratadine.|Completed||N/A|12||University of Saskatchewan|||||f||||||||||||||2017-02-18 15:56:03.570332|2017-02-18 15:56:03.570332
NCT00426140|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2010-04-22|||August 2006||2006-08-01|April 2010|2010-04-01||||November 2006|Actual|2006-11-01||Interventional|||Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.|An Open-label Single Center Study to Characterize the Absorption, Distribution, Metabolism, and Elimination (ADME) of Patupilone (EPO906) After a Single Intravenous Administration of 10 mg/m2 [14C] Patupilone in Patients With Advanced Solid Tumor Malignancies.|Completed||Phase 1|5|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:55:29.815233|2017-02-18 15:55:29.815233
NCT00426127|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2009-03-27|||November 2006||2006-11-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|||||Interventional|||Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer|Phase II Trial of Docetaxel and Liposomal Doxorubicin (Doxil) Chemotherapy Combined With Enoxaparin in Patients With Advanced Pancreatic Cancer|Terminated||Phase 2|27|Anticipated|University of Iowa||||Inadequate number of eligible patients|f||||||||||||||2017-02-18 15:55:29.91311|2017-02-18 15:55:29.91311
NCT00425399|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2014-05-21|||January 2007||2007-01-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|||||Interventional|||Shiatsu Adjuvant Therapy For Schizophrenia|Shiatsu Adjuvant Therapy for Hospitalized Psychiatric Patients: an Open Pilot Study|Completed||N/A|20|Anticipated|Herzog Hospital||1|||f||||||||||||||2017-02-18 15:55:30.017785|2017-02-18 15:55:30.017785
NCT00425386|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2015-03-19|2012-01-12||August 2006||2006-08-01|March 2015|2015-03-01|March 2014|Actual|2014-03-01|August 2010|Actual|2010-08-01||Interventional||The discrepancy between the number of participants enrolled (60) and the number of participants Started in the Participant Flow module (46) is due to screen failures and consent withdrawals.|Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer|A Dose Escalation Phase II Study of Sunitinib Plus Erlotinib in Advanced Renal Carcinoma|Completed||Phase 2|60|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 15:55:30.114034|2017-02-18 15:55:30.114034
NCT00425373|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2011-04-20|2011-01-12||November 2006||2006-11-01|April 2011|2011-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension|A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled, Factorial Study to Evaluate the Efficacy and Safety of 8-week Treatment With Valsartan (40 and 80 mg) and Amlodipine (2.5 and 5 mg) Combined and Alone in Essential Hypertensive Patients|Completed||Phase 2/Phase 3|1474|Actual|Novartis||9|||f||||||||||||||2017-02-18 15:55:30.662811|2017-02-18 15:55:30.662811
NCT00425360|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2013-08-23|||September 2006||2006-09-01|May 2009|2009-05-01|March 2013|Actual|2013-03-01|||||Interventional|||Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Prospective, Phase III, Controlled, Multicentre, Randomised Clinical Trial Comparing Combination Gemcitabine and Capecitabine Therapy With Concurrent and Sequential Chemoimmunotherapy Using a Telomerase Vaccine in Locally Advanced and Metastatic Pancreatic Cancer [TELOVAC]|Completed||Phase 3|1110|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:55:31.809222|2017-02-18 15:55:31.809222
NCT00425347|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2009-09-21|||December 2006||2006-12-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|August 2008|Actual|2008-08-01||Interventional|||Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma|Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Subjects With Advanced Multiple Myeloma|Completed||Phase 1|35|Actual|Facet Biotech||1|||f||||t||||||||||2017-02-18 15:55:31.95948|2017-02-18 15:55:31.95948
NCT00425334|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2013-08-15|||July 2005||2005-07-01|August 2013|2013-08-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Safety Study of Hemospan® in Prostatectomy Patients|A Clinical Safety (Phase II) Increasing Dose Study of MP4 (Hemospan®) in Total Prostatectomy Surgical Patients|Completed||Phase 2|20|Actual|Sangart||2|||f||||t||||||||||2017-02-18 15:55:32.069997|2017-02-18 15:55:32.069997
NCT00425321|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2014-05-06||2011-05-27|December 2006||2006-12-01|May 2014|2014-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy|A Phase IIa Multicenter, Randomized, Double-Blind, Placebo -Controlled, Parallel Group Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 2|259|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||t||||||||||2017-02-18 15:55:32.203928|2017-02-18 15:55:32.203928
NCT00425308|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2011-03-23|2011-01-06||October 2006||2006-10-01|March 2011|2011-03-01||||May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.|A Prospective Multicenter Open-label Randomized Study to Assess Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus Without Calcineurine Inhibitor in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.|Completed||Phase 3|30|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:55:32.367523|2017-02-18 15:55:32.367523
NCT00425295|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2014-12-02|||October 2006||2006-10-01|December 2014|2014-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effectiveness of Human Simulation Training for Medical Crisis Management Skills|Effectiveness of Human Simulation Training for Medical Crisis Management Skills|Withdrawn||Phase 1|0|Actual|University of Pittsburgh||2||too much cross over bias between small numbers of participants|f||||t||||||||||2017-02-18 15:55:33.24969|2017-02-18 15:55:33.24969
NCT00425282|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2012-06-19|||November 2006||2006-11-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects With Partial Onset Seizures Followed by an Open-Label Extension Study.|Completed||Phase 3|566|Actual|SK Life Science|||||f||||||||||||||2017-02-18 15:55:33.346348|2017-02-18 15:55:33.346348
NCT00426114|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2009-04-09||||||April 2009|2009-04-01||||||||Interventional|||Acute Haemodynamic Impact of an IV Glucose-Injection|Acute Haemodynamic Impact of an IV Glucose-Injection|Withdrawn||Phase 2|20|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 15:55:33.440356|2017-02-18 15:55:33.440356
NCT00426101|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2015-09-14|||January 2004||2004-01-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|December 2011|Actual|2011-12-01||Interventional|||Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004|HLH-2004 Treatment Protocol|Active, not recruiting||Phase 3|300|Anticipated|Karolinska University Hospital||1|||f||||t||||||||||2017-02-18 15:55:33.52631|2017-02-18 15:55:33.52631
NCT00426049|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2007-01-23|||October 2006||2006-10-01|January 2007|2007-01-01||||||||Interventional|||Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation|Monocenter, Double Blinded, Prospective, Randomized Placebo Controlled Study Investigating Prevention of Major Adverse Cardiac Events (MACEs) Within 6 Months by Systemic Treatment With Everolimus After Coronary Intervention With Bare Metal Stents in Patients With Significant Coronary Artery Disease|Unknown status|Recruiting|Phase 3|484||German Heart Institute|||||f||||||||||||||2017-02-18 15:55:33.814084|2017-02-18 15:55:33.814084
NCT00426036|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2007-06-21|||June 2006||2006-06-01|June 2007|2007-06-01||||||||Interventional|||Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine|An Open-Label Study in Healthy Subjects and in Patients With Stable Impaired Renal Function to Assess the Effect of Severe Renal Impairment on Licarbazepine Pharmacokinetics and Metabolism After the Single Administration of a 500 mg Licarbazepine Immediate Release (IR) Tablet|Completed||Phase 1|12||Novartis|||||f||||||||||||||2017-02-18 15:55:33.901444|2017-02-18 15:55:33.901444
NCT00426023|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2009-01-27|||February 2007||2007-02-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis|Multicenter, Randomised, Double Masked, Controlled Studies on the Efficacy of Cyclosporine Eye Drop Treatment in Preventing Vernal Keratoconjunctivitis (VKC) Relapses and in Treating the Acute Phase.|Completed||Phase 3|48|Anticipated|Campus Bio-Medico University||2|||f||||||||||||||2017-02-18 15:55:33.984909|2017-02-18 15:55:33.984909
NCT00426010|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2011-12-11|||January 2007||2007-01-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Measuring Placebo Effect by Elimination and Investigating Mechanism of Action|Measuring Placebo Effect by Elimination and Investigating Its Mechanism of Action|Completed||N/A|180|Anticipated|King Faisal Specialist Hospital & Research Center||4|||f||||||||||||||2017-02-18 15:55:34.109828|2017-02-18 15:55:34.109828
NCT00425997|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2011-06-07|||December 2006||2006-12-01|June 2011|2011-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension|A 10-week Multicenter,Forced-titration Study Using 24-hr ABPM to Evaluate the Efficacy of Valsartan/Hydrochlorothiazide (HCTZ) Treatment Regimen vs Conventional Treatment Regimen With Amlodipine and Hydrochlorothiazide (HCTZ) in Patients With Stage 2 Hypertension|Completed||Phase 4|480|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:55:34.216184|2017-02-18 15:55:34.216184
NCT00425984|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2007-08-23|||August 2002||2002-08-01|August 2007|2007-08-01|December 2006||2006-12-01|||||Interventional|||Male Circumcision for HIV Prevention in Rakai, Uganda|Randomized Trial of Male Circumcision for HIV Prevention, Rakai, Uganda|Completed||Phase 3|5000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 15:55:34.305546|2017-02-18 15:55:34.305546
NCT00425971|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2008-09-03|||July 2008||2008-07-01|September 2008|2008-09-01||||||||Interventional|||Safety Study of Anti-Asthma Agent BMEC-1217B|A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating Safety Study of BMEC-1217B, in Healthy Volunteers|Unknown status|Recruiting|Phase 1|32|Anticipated|Medigreen Biotechnology Corp.|||||f||||||||||||||2017-02-18 15:55:34.414595|2017-02-18 15:55:34.414595
NCT00425958|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2007-09-23|||April 2006||2006-04-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Observational|||Examination of Virtual Supermarket (Vmall) as an Assessment of Executive Functions in Children and Adolescents With Acquired Brain Injury||Completed||Phase 2|40|Anticipated|Sheba Medical Center|||||f||||f||||||||||2017-02-18 15:55:34.492223|2017-02-18 15:55:34.492223
NCT00425945|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-23|2014-02-19|2013-03-29||October 2006||2006-10-01|February 2014|2014-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study|Cardiovascular Effects of Pine Bark Extract|Completed||N/A|130|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 15:55:34.577665|2017-02-18 15:55:34.577665
NCT00425932|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2013-08-21|||February 2007||2007-02-01|August 2013|2013-08-01|November 2012|Actual|2012-11-01|November 2011|Actual|2011-11-01||Interventional|||Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis|Impact of Rituximab on Magnetic Resonance Imaging Evidence of Synovitis and Bone Lesions in Patients With Moderate or Severe Rheumatoid Arthritis|Completed||Phase 2|60|Actual|Gaylis, Norman B., M.D.||2|||f||||||||||||||2017-02-18 15:55:38.279479|2017-02-18 15:55:38.279479
NCT00425919|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2007-12-18|||January 2007||2007-01-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Evaluating PPM-204 In Subjects With Type 2 Diabetes|A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Safety And Efficacy Of PPM-204 In Subjects With Type 2 Diabetes|Terminated||Phase 2|500||Wyeth is now a wholly owned subsidiary of Pfizer||||Study terminated as a result of interim analysis not meeting predetermined criteria.|f||||||||||||||2017-02-18 15:55:38.40354|2017-02-18 15:55:38.40354
NCT00425906|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2016-01-11|||December 2003||2003-12-01|July 2011|2011-07-01||||||||Interventional|||"Nicotine in Treating Hunger Pain in Patients With Malignant Bowel Obstruction Caused By Cancer"|"A Pilot Study of Nicotine for Hunger Pain in Patients With Bowel Obstruction From Incurable Cancer"|Withdrawn||N/A|0|Actual|Mayo Clinic||2||No patient enrollment occurred.|f||||t||||||||||2017-02-18 15:55:38.832042|2017-02-18 15:55:38.832042
NCT00425893|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2012-04-12|||February 2007||2007-02-01|April 2012|2012-04-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households|A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households|Completed||N/A|6069|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-02-18 15:55:38.944126|2017-02-18 15:55:38.944126
NCT00425880|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2013-08-07|||January 2007||2007-01-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Monitoring and Outcome Measures in Asthmatics and Smokers During Pregnancy|GCRC: Monitoring and Outcome Measures in Asthmatics and Smokers (MOMAS) During Pregnancy|Withdrawn||Phase 3|0|Actual|University of Kentucky|||3||f||||||||||||||2017-02-18 15:55:39.061644|2017-02-18 15:55:39.061644
NCT00425867|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2007-01-25|||March 2007||2007-03-01|January 2007|2007-01-01|November 2007||2007-11-01|||||Observational|||PAR Family Polymorphisms and Placental Invasion Disorders||Unknown status|Not yet recruiting|N/A|100||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 15:55:39.161213|2017-02-18 15:55:39.161213
NCT00424567|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2007-01-18|||October 2003||2003-10-01|January 2007|2007-01-01|June 2007||2007-06-01|||||Interventional|||Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.|TRC Autologous Bone Marrow Cells for the Treatment of Appendicular Skeletal Fracture Non-Union|Completed||Phase 1/Phase 2|36||Vericel Corporation|||||t||||||||||||||2017-02-18 15:56:03.659098|2017-02-18 15:56:03.659098
NCT00425854|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2013-12-05|2013-08-08||November 2006||2006-11-01|August 2013|2013-08-01||||May 2009|Actual|2009-05-01||Interventional|||An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer|An Open Label Phase II Trial to Assess the Efficacy and Safety of a Once Daily Oral Dose of 50 mg BIBW 2992 in Two Cohorts of Patients With HER2-negative Metastatic Breast Cancer After Failure of no More Than Two Chemotherapy Regimen|Completed||Phase 2|50|Actual|Boehringer Ingelheim||1|||f||||||||||||||2017-02-18 15:55:39.253935|2017-02-18 15:55:39.253935
NCT00425841|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2012-12-11|||May 2006||2006-05-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|||||Interventional|||Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer|Lokal Fortgeschrittenes Pankreas-Karzinom: Stereotaktische Radiotherapie Gefolfgt Von Gemox-Chemotherapie|Completed||Phase 2|29|Anticipated|Technische Universität München|||||f||||||||||||||2017-02-18 15:55:39.860487|2017-02-18 15:55:39.860487
NCT00425815|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2016-02-05|||April 2009||2009-04-01|February 2016|2016-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia|A Placebo-Controlled Trial of Org 24448 (Ampakine) Added to Atypical Antipsychotics in Patients With Schizophrenia|Withdrawn||Phase 2|0|Actual|University of California, Los Angeles||3||Study terminated at Sponsor's request.|f||||f||||||||||2017-02-18 15:55:39.973715|2017-02-18 15:55:39.973715
NCT00425802|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2017-02-08|||November 28, 2006|Actual|2006-11-28|February 2017|2017-02-01|October 28, 2016|Actual|2016-10-28|October 28, 2016|Actual|2016-10-28||Interventional|||Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|A Non-Myeloablative Conditioning Regimen With Peri-Transplant Rituximab and the Transplantation of Hematopoietic Stem Cells From HLA-Compatible Related or Unrelated Donors in Patients With B Cell Lymphoid Malignancies|Completed||Phase 2|61|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:55:40.112661|2017-02-18 15:55:40.112661
NCT00425789|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2011-04-04|||January 2007||2007-01-01|December 2005|2005-12-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Hyperbaric Therapy and Deep Chemical Peeling|Hyperbaric Therapy and Healing From Deep Chemical Peel|Unknown status|Recruiting|Phase 1|40|Anticipated|Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:55:40.243837|2017-02-18 15:55:40.243837
NCT00425776|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2015-08-20|||February 2007||2007-02-01|August 2015|2015-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture||Completed||Phase 1|94|Actual|Vejle Hospital||3|||f||||f||||||||||2017-02-18 15:55:40.332913|2017-02-18 15:55:40.332913
NCT00425763|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2012-04-04|||May 2007||2007-05-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|IPTi DRWG||Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria|Efficacy of Amodiaquine-artesunate in the Treatment of Symptomatic, Uncomplicated Plasmodium Falciparum Malaria Among 6-59 Month Old Children at an IPTi Site in Rural Western Kenya|Completed||Phase 4|110|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-02-18 15:55:40.671667|2017-02-18 15:55:40.671667
NCT00425750|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2011-11-07|2011-03-07||August 2005||2005-08-01|November 2011|2011-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|Phase II Trial of Combination Weekly Bortezomib (VELCADE) and Docetaxel (TAXOTERE) in Patients With Recurrent and/ or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)|Completed||Phase 2|25|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:55:40.789197|2017-02-18 15:55:40.789197
NCT00425737|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2016-09-15|||August 2000||2000-08-01|September 2016|2016-09-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants|A Study to Assess the Efficacy, Immunogenicity and Safety of Two Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine (Rotarix) in Healthy Infants.|Completed||Phase 2|405|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:55:41.08444|2017-02-18 15:55:41.08444
NCT00425724|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2011-08-05|||January 2000||2000-01-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|February 2007|Actual|2007-02-01||Interventional|||HSP-glomerulonephritis Trial: MP vs CyA||Completed||Phase 4|20|Anticipated|Oulu University Hospital||1|||f||||||||||||||2017-02-18 15:55:41.178534|2017-02-18 15:55:41.178534
NCT00425711|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2012-07-26|||February 2007||2007-02-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of Acamprosate in Driving Under the Influence (DUI) Court Participants|An Open-Label Study of Acamprosate in DUI Court Participants|Terminated||N/A|4|Actual|University of Oklahoma||1||Recruitment barriers.|f||||f||||||||||2017-02-18 15:55:41.30895|2017-02-18 15:55:41.30895
NCT00425698|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2010-09-23|2010-08-04||February 2007||2007-02-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation|Effect of Erythropoietin on Renal Function After Kidney Transplantation|Completed||Phase 2/Phase 3|88|Actual|Hannover Medical School||2|||f||||t||||||||||2017-02-18 15:55:41.427637|2017-02-18 15:55:41.427637
NCT00425685|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2007-01-22|||January 2003||2003-01-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Observational|||Use of ECMO in Acute MI|Use of Extracorporeal Membrane Oxygenation in Treatment of Acute Myocardial Infarction Following Cardiac Surgery Procedures|Unknown status|Active, not recruiting|N/A|60||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 15:55:41.838989|2017-02-18 15:55:41.838989
NCT00425672|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2016-04-12|||September 2005||2005-09-01|April 2016|2016-04-01||||April 2010|Actual|2010-04-01||Interventional|||ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment|Phase I-II Study of Denileukin Diftitox (ONTAK®) in Patients With Advanced Refractory Breast Cancer|Active, not recruiting||Phase 1/Phase 2|15|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 15:55:41.904632|2017-02-18 15:55:41.904632
NCT00425659|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2009-07-09|||January 2007||2007-01-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||Evaluation of New Diagnostic and Treatment Algorithm for Obstructive Sleep Apnea|Evaluation of New Diagnostic and Treatment Algorithm for Obstructive Sleep Apnea in High Risk Population in Hong Kong|Completed||N/A|150|Anticipated|Chinese University of Hong Kong||3|||f||||f||||||||||2017-02-18 15:55:42.023389|2017-02-18 15:55:42.023389
NCT00425646|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2013-05-02|||November 2006||2006-11-01|May 2013|2013-05-01|July 2009|Actual|2009-07-01|October 2007|Actual|2007-10-01||Interventional|||Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Study Evaluating a Maintenance Strategy of Gleevce® (Imatinib Mesylate) and Bevacizumab in Patients With Advanced, Non-squamous, Non-small Cell Lung Cancer, Following Completion of First-line Chemotherapy With Bevacizumab|Completed||Phase 2|50|Anticipated|University of Washington||1|||f||||||||||||||2017-02-18 15:55:42.13629|2017-02-18 15:55:42.13629
NCT00425633|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2011-03-24|||January 2007||2007-01-01|March 2011|2011-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy Study of Homeopathic Potassium Dichromate to Treat Tracheal Secretions in Critically Ill Patients|A Study To Evaluate The Effect Of Homeopathic Concentrations Of Potassium Dichromate On Tracheal Secretions In Critically Ill Patients.|Terminated||Phase 2|16|Actual|Sunnybrook Health Sciences Centre||1||slow recruitment|f||||f||||||||||2017-02-18 15:55:42.234119|2017-02-18 15:55:42.234119
NCT00425620|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2007-11-29|||December 2006||2006-12-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Amphotericin B Suspension in Refractory Chronic Sinusitis|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of Intranasal Amphotericin B Suspension in Patients With Refractory, Postsurgical Chronic Sinusitis (CS)|Completed||Phase 3|300|Actual|Accentia Biopharmaceuticals||1|||f||||f||||||||||2017-02-18 15:55:42.340759|2017-02-18 15:55:42.340759
NCT00425607|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2007-12-24|||May 2007||2007-05-01|December 2007|2007-12-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria|An Open Label Dose Adjusted Phase II Trial of the Oral Farnesyltransferase Inhibitor (FTI) Lonafarnib (SCH66336) for Patients With Hutchinson-Gilford Progeria Syndrome (HGPS) and Progeroid Laminopathies|Unknown status|Active, not recruiting|Phase 2|29|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 15:55:42.528368|2017-02-18 15:55:42.528368
NCT00425594|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2007-12-20|||January 2007||2007-01-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population|A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population|Completed||Phase 4|150||Braintree Laboratories|||||f||||f||||||||||2017-02-18 15:55:42.643731|2017-02-18 15:55:42.643731
NCT00425581|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2008-01-22|||February 2007||2007-02-01|January 2008|2008-01-01||||||||Observational|||N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life|N-Terminal Pro-B-Type and Cardiac Troponin T Levels for Monitoring Effectiveness of Treatment in Very Low Birth Weight Infants With Hemodynamic Instability|Withdrawn||N/A|100|Anticipated|Sheba Medical Center||||Did not receive budget needed.|f||||f||||||||||2017-02-18 15:55:42.757326|2017-02-18 15:55:42.757326
NCT00425568|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-20|2007-01-22|||December 2005||2005-12-01|January 2007|2007-01-01||||||||Observational|||Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR|Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR)|Unknown status|Recruiting|Phase 1|30||Lamm, Steven, M.D.|||||f||||||||||||||2017-02-18 15:55:42.841833|2017-02-18 15:55:42.841833
NCT00425555|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2016-11-16|||January 2007||2007-01-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma|A Phase II Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma|Completed||Phase 2/Phase 3|139|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:55:42.933932|2017-02-18 15:55:42.933932
NCT00425542|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2010-06-10|||January 2007||2007-01-01|October 2009|2009-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|OTPE||Safety Study of Outpatient Treatment for Pulmonary Embolism|Outpatient Treatment of Low-risk Patients With Pulmonary Embolism: a Randomized-controlled Trial|Completed||Phase 3|343|Actual|University of Lausanne Hospitals||2|||f||||t||||||||||2017-02-18 15:55:43.335314|2017-02-18 15:55:43.335314
NCT00425529|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2007-01-22|||February 2002||2002-02-01|January 2007|2007-01-01|May 2003||2003-05-01|||||Interventional|||Tolerance and Practicality of Module AOX|Tolerance and Practicality of Module AOX - a Modular Device for Supplementation of Enteral Nutrition|Completed||Early Phase 1|20||VU University Medical Center|||||f||||||||||||||2017-02-18 15:55:43.468396|2017-02-18 15:55:43.468396
NCT00425516|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2014-09-30|||January 2007||2007-01-01|February 2007|2007-02-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Breast Cancer Treated by Neoadjuvant Chemotherapy|Clinical Trial of the Neoadjuvant Standard Chemotherapy 3 FEC 100 + 3 TAXOTERE Protocol Versus the Same Protocol Adapted as a Function of Clinical Response|Completed||Phase 2|264|Actual|Centre Jean Perrin||2|||f||||||||||||||2017-02-18 15:55:43.556951|2017-02-18 15:55:43.556951
NCT00425503|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2014-04-03|2014-02-15||December 2001||2001-12-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|November 2012|Actual|2012-11-01||Interventional|||PS-341 Followed by Removal of Prostate for Those With Prostate Cancer|H-11047: A Study of PS-341 Followed by Radical Prostatectomy for Patients With Adenocarcinoma of the Prostate (Spore #: 11-01-30-13)|Completed||Phase 2|40|Actual|Baylor College of Medicine||1|||f||||||||||||||2017-02-18 15:55:43.675013|2017-02-18 15:55:43.675013
NCT00425490|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2009-09-22|||January 2007||2007-01-01|September 2009|2009-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus|Phase III Study on the Effect of Sitagliptin on Maximal Beta Cell Stimulation|Completed||Phase 3|30|Anticipated|Sheba Medical Center|||||f||||f||||||||||2017-02-18 15:55:43.98295|2017-02-18 15:55:43.98295
NCT00425477|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2015-10-30|||November 2006||2006-11-01|October 2015|2015-10-01||||July 2016|Anticipated|2016-07-01||Interventional|||Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia|A Phase II Study of Bexarotene + Sargromastastin as Agents of Differentiation in MDS and AML|Active, not recruiting||Phase 2|26|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 15:55:44.080336|2017-02-18 15:55:44.080336
NCT00425464|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2013-09-16||2013-04-11|November 2005||2005-11-01|September 2013|2013-09-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Synchrony Dual Optic Intraocular Lens in Patients Undergoing Cataract Extraction|A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Synchrony Dual Optic Intraocular Lens in Patients Undergoing Cataract Extraction|Terminated||Phase 3|410|Actual|Abbott Medical Optics||2|||f||||||||||||||2017-02-18 15:55:44.202431|2017-02-18 15:55:44.202431
NCT00425451|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-21|2011-06-13|||August 2008||2008-08-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis|The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis|Completed||Phase 2|80|Actual|Dexcel Pharma Technologies Ltd.||4|||f||||||||||||||2017-02-18 15:55:44.330553|2017-02-18 15:55:44.330553
NCT00425438|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-22|2014-09-22|2014-08-14||March 2007||2007-03-01|September 2014|2014-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||Safety population: all participants who recieved at least one dose of study drug.|A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.|A Randomized, Open-label Study to Compare the Effect of CellCept Plus Corticosteroids, and Cyclophosphamide Plus Corticosteroids Followed by Azathioprine, on Remission Rate in Patients With Lupus Nephritis|Terminated||Phase 3|52|Actual|Hoffmann-La Roche|The study was terminated early due to administrative reasons.|2||Study was terminated early for administrative reasons.|f||||||||||||||2017-02-18 15:55:44.445139|2017-02-18 15:55:44.445139
NCT00425425|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2014-04-30|||July 2006||2006-07-01|April 2014|2014-04-01|May 2015|Anticipated|2015-05-01|May 2010|Actual|2010-05-01||Interventional|||Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer|Neoadjuvant Radiochemotherapy in Local Advanced Squamous Cell Carcinoma of the Esophagus With Weekly Cetuximab Plus Oxaliplatin Plus Continuous IV. 5-FU and Conventional Fractionated External Multi-Field Irradiation up to 45 Gray. A Phase I/II Study|Unknown status|Active, not recruiting|Phase 1/Phase 2|43|Anticipated|Technische Universität München|||||f||||f||||||||||2017-02-18 15:55:44.949042|2017-02-18 15:55:44.949042
NCT00425269|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2014-06-24|2014-04-11||April 2006||2006-04-01|April 2014|2014-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|InnvaDiab|Women, aged 18-65 years, more than 50 percent rated their command of the Norwegian language as poor, and mean number of years of education was 9.|Lifestyle Intervention for Pakistani Women in Oslo|Evaluation of a Lifestyle Intervention to Prevent Type 2 Diabetes/Metabolic Syndrome Among Pakistani Immigrants - Focusing on Changes in Diet and Physical Activity|Completed||N/A|198|Actual|University of Oslo||2|||f||||f||||||||||2017-02-18 15:55:45.070363|2017-02-18 15:55:45.070363
NCT00425256|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2011-02-22|||February 2006||2006-02-01|February 2011|2011-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)||Completed||Phase 2|||Palatin Technologies|||||f||||||||||||||2017-02-18 15:55:46.140788|2017-02-18 15:55:46.140788
NCT00425243|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2009-04-03|||August 2004||2004-08-01|April 2009|2009-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)|"Evaluation of the Long-Term Efficacy and Safety of Zolpidem-MR 12.5 mg Compared to Placebo, When Both Are Administered Over a Long-Term Period as Needed, in Patients With Chronic Primary Insomnia"|Completed||Phase 3|1025|Actual|Sanofi|||||f||||||||||||||2017-02-18 15:55:46.234918|2017-02-18 15:55:46.234918
NCT00425230|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2010-12-21|||January 2007||2007-01-01|December 2010|2010-12-01|June 2007||2007-06-01|||||Interventional|||Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain|Pilot Study of Use of Duloxetine for the Treatment of Phantom Limb Pain|Terminated||N/A|15|Anticipated|Baylor College of Medicine||||"No patients were enrolled in this study. The study onset was delayed due to problems with drug~   acquisition."|f||||||||||||||2017-02-18 15:55:46.330341|2017-02-18 15:55:46.330341
NCT00425217|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2011-02-23|||August 2004||2004-08-01|February 2011|2011-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Rituximab in Membranous Nephropathy|The Use of Rituximab in the Treatment of Idiopathic Membranous Nephropathy|Completed||Phase 2/Phase 3|15|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 15:55:46.6527|2017-02-18 15:55:46.6527
NCT00425204|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2008-09-11|||March 2004||2004-03-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|||Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment|A Multi-Center, Open-Label Clinical Trial To Determine The Safety of ABX-EGF As Continued Treatment For Patients Who Have Benefited From and Tolerated Prior ABX-EGF Treatment|Completed||Phase 2|31|Actual|Amgen||1|||f||||||||||||||2017-02-18 15:55:46.748639|2017-02-18 15:55:46.748639
NCT00425191|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2009-12-04|||July 2002||2002-07-01|December 2009|2009-12-01||||April 2005|Actual|2005-04-01||Interventional|||Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.|A Multicenter, Randomized Phase II Study Evaluating the Feasibility and Activity of Two Different Combinations of Docetaxel and Gemcitabine and of Cisplatin/Gemcitabine Followed by Docetaxel as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.|Completed||Phase 2|165|Actual|Sanofi||3|||f||||||||||||||2017-02-18 15:55:46.853459|2017-02-18 15:55:46.853459
NCT00425178|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2008-01-07|||September 2005||2005-09-01|November 2007|2007-11-01||||||||Interventional|||FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers|A Phase 1, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Patients With Diabetic or Venous Stasis Ulcers|Completed||Phase 1|8|Actual|CardioVascular BioTherapeutics, Inc.||1|||f||||||||||||||2017-02-18 15:55:46.965642|2017-02-18 15:55:46.965642
NCT00425165|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2015-03-17||2011-03-31|August 2007||2007-08-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease|A Randomized, Double-Blind, Two Way Crossover Evaluation of the Effects of a Single Dose of Denufosol Tetrasodium (INS37217) Inhalation Solution Versus Placebo (0.9% Sodium Chloride Solution) on Mucociliary Clearance in Patients With Mild to Moderate Cystic Fibrosis Lung Disease|Terminated||Phase 2|6|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 15:55:47.076798|2017-02-18 15:55:47.076798
NCT00425152|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2010-02-05|||July 1989||1989-07-01|February 2010|2010-02-01|April 2004|Actual|2004-04-01|June 1998|Actual|1998-06-01||Interventional|||Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer|A Clinical Trial to Assess the Relative Efficacy of 5-FU + Leucovorin, 5-FU + Levamisole, and 5-FU + Leucovorin + Levamisole in Patients With Dukes' B and C Carcinoma of the Colon|Completed||Phase 3|2151|Actual|NSABP Foundation Inc|||||f||||t||||||||||2017-02-18 15:55:47.165107|2017-02-18 15:55:47.165107
NCT00425139|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2015-03-19|||October 2004||2004-10-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Evaluation of a Video Game for Adolescents and Young Adults With Cancer|Multi-site Evaluation of a Video Game for Adolescents and Young Adults With Cancer|Completed||N/A|375||HopeLab Foundation|||||f||||||||||||||2017-02-18 15:55:47.268683|2017-02-18 15:55:47.268683
NCT00425126|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2010-05-25|||February 2007||2007-02-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation|Effect of Procrit(Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation|Completed||Phase 4|76|Actual|West Penn Allegheny Health System|||||f||||||||||||||2017-02-18 15:55:47.390024|2017-02-18 15:55:47.390024
NCT00425113|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2013-05-10|2013-02-07||December 2006||2006-12-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional||2 subjects excluded: 1 for uncontrolled diabetes mellitus and 1 for diagnosis of extrapulmonary TB. 2 additional subjects withdrew: 1 self- withdrew and the other was withdrawn for missing >14 days of study drug.|Metronidazole for Pulmonary Tuberculosis (South Korea)|A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Metronidazole Combined With Antituberculous Chemotherapy vs. Antituberculous Chemotherapy With Placebo in Subjects With Multi-Drug Resistant Pulmonary Tuberculosis|Completed||Phase 2|35|Actual|National Institutes of Health Clinical Center (CC)|Major limitation of our study was the small sample size. Planned enrollment was 80 subjects but DSMB recommended closing the study to new enrollment after 35 subjects due to increased peripheral neuropathy in the metronidazole arm.|2|||f||||t||||||||||2017-02-18 15:55:47.480965|2017-02-18 15:55:47.480965
NCT00425100|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2009-02-24|2008-10-10||January 2007||2007-01-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients|A 12-Week, Multicenter, Open-Label, Single-Arm Study To Evaluate The Effects Of Fesoterodine On Treatment Satisfaction And Symptom Relief In Overactive Bladder Patients.|Completed||Phase 3|516|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:55:47.877649|2017-02-18 15:55:47.877649
NCT00425074|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2011-06-07|||January 2007||2007-01-01|June 2011|2011-06-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.|Pharmacodynamic- Pharmacokinetic Trial, Comparative Double Blind, of the Chronic Administration of 150 mg of Slow Release ASA Versus 150 mg of Normal Release ASA, in the Platelet Functionalism.|Completed||Phase 1|50|Actual|Rottapharm Spain||2|||f||||||||||||||2017-02-18 15:55:48.539891|2017-02-18 15:55:48.539891
NCT00425061|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2015-01-12|2014-11-06||February 2007||2007-02-01|January 2015|2015-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional||Modified intent-to-treat (mITT) population included all randomized participants who received at least 1 dose administration of the test article.|Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma|Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study Conducted Sequentially With 3 Doses Of Ima-638 Administered Sc.|Completed||Phase 2|159|Actual|Pfizer|The study was stopped early due to futility of the interim efficacy analysis results. Hence, only safety results and key efficacy results were presented for this study.|3|||f||||f||||||||||2017-02-18 15:55:48.672234|2017-02-18 15:55:48.672234
NCT00425048|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2009-02-09|||January 2007||2007-01-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|||||Observational|||Does Gloved Medical Personnel Scratch Less Often?||Completed||N/A|40|Anticipated|Medical University Innsbruck|||||f||||||||||||||2017-02-18 15:55:51.446476|2017-02-18 15:55:51.446476
NCT00425035|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2013-05-10|||February 2003||2003-02-01|May 2013|2013-05-01||||||||Interventional|||Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2|A Two-part, Multiple Dose Clinical Trial Evaluating the Safety and Effectiveness of ABX-EGF in Patients With Renal Carcinoma|Completed||Phase 2|115||Amgen|||||||||||||||||||2017-02-18 15:55:51.517876|2017-02-18 15:55:51.517876
NCT00425022|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2007-01-29|||January 2007||2007-01-01|January 2007|2007-01-01||||||||Interventional|||VATS Lobectomy for Clinical Stage IB or II Lung Cancer|Feasibility of VATS(Video-Assisted Thoracoscopic Surgery) Lobectomy for Clinical Stage IB or II Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|40||National Cancer Center, Korea|||||f||||||||||||||2017-02-18 15:55:51.608296|2017-02-18 15:55:51.608296
NCT00425009|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2007-01-18|||January 2004||2004-01-01|January 2007|2007-01-01|December 2004||2004-12-01|||||Interventional|||Therapeutic Effects of Berberine in Patients With Type 2 Diabetes|Effects of Berberine on Improvement of Glucose and Lipid Metabolism in Patients With Type 2 Diabetes|Completed||Phase 1/Phase 2|70||Shanghai Jiao Tong University School of Medicine|||||f||||||||||||||2017-02-18 15:55:51.704943|2017-02-18 15:55:51.704943
NCT00424996|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2014-05-20|||August 2006||2006-08-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression|Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression|Completed||N/A|74|Actual|University Health Network, Toronto|||1||f||||||||||||||2017-02-18 15:55:51.797684|2017-02-18 15:55:51.797684
NCT00424983|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2014-09-08|||November 2006||2006-11-01|September 2014|2014-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year|A Stratified, Randomized, Open-label, Multi-center Comparative 2-arm Trial of PK, PD, and Safety of Zoledronic Acid Infusions Administered Monthly vs. Every 3-month, in Multiple Myeloma Patients With Malignant Bone Lesions, and Breast Cancer Patients With Bone Metastasis, Who Have Received 9-12* Doses of Zoledronic Acid Over the Prior Year. (*Amendment 1 Changed the Required Doses to 9-20 But Due to FDA Guidelines, the Title Has Not Been Changed)|Completed||Phase 1|18|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:55:51.892179|2017-02-18 15:55:51.892179
NCT00424970|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2013-01-23|||January 2007||2007-01-01|January 2013|2013-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Treatment of High Altitude Polycythemia by Acetazolamide|Hypoventilation and High Altitude Chronic Polycythemia: Acetazolamide as a Possible Treatment|Completed||Phase 4|55|Anticipated|Association pour la Recherche en Physiologie de l'Environnement||1|||f||||||||||||||2017-02-18 15:55:52.005106|2017-02-18 15:55:52.005106
NCT00424957|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2009-02-04|||November 2006||2006-11-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|April 2007|Actual|2007-04-01||Observational|||Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System|Brain Energy Metabolism in Patients With Acute Hepatic Encephalopathy Measured With PET|Completed||N/A|18|Anticipated|University of Aarhus|||1||f||||t||||||||||2017-02-18 15:55:52.115776|2017-02-18 15:55:52.115776
NCT00424216|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2017-01-24|||January 11, 2007||2007-01-11|December 23, 2008|2008-12-23|December 23, 2008||2008-12-23|||||Interventional|||Direct Current Brain Polarization of the Frontal Lobes|Direct Current Brain Polarization of Bilateral Prefrontal Cortex|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:56:21.831907|2017-02-18 15:56:21.831907
NCT00424944|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2008-04-01|||June 2007||2007-06-01|April 2008|2008-04-01|August 2008|Anticipated|2008-08-01|July 2008|Anticipated|2008-07-01||Interventional|||Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine|A Single Centre, Randomised Controlled Trial to Evaluate the Safety and Immunogenicity of Recombinant Lactococcus Lactis Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine Versus Rabies Vaccine in Healthy Gabonese Adult Volunteers|Unknown status|Recruiting|Phase 1|40|Anticipated|African Malaria Network Trust||2|||f||||t||||||||||2017-02-18 15:55:52.203437|2017-02-18 15:55:52.203437
NCT00424931|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2014-05-21|||January 2007||2007-01-01|May 2014|2014-05-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy|A Phase II Randomized, Double-blind, Double-dummy, Placebo and Comparator-controlled, Parallel Group, Multi-Center Study to Investigate the Safety and Efficacy of a Single Dose of JNJ-17216498 Administered to Subjects With Narcolepsy.|Completed||Phase 2|16|Actual|Alza Corporation, DE, USA||3|||f||||||||||||||2017-02-18 15:55:52.313575|2017-02-18 15:55:52.313575
NCT00424918|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2007-01-18|||September 2006||2006-09-01|January 2007|2007-01-01|September 2007||2007-09-01|||||Interventional|||"Generation Fit and Exerlearning With In the Groove"|"Generation-Fit, a Pilot Study of Youth in Maine Middle Schools Using an Exerlearning Dance Video Game to Promote Physical Activity During School"|Unknown status|Recruiting|N/A|85||Maine Medical Center|||||f||||||||||||||2017-02-18 15:55:52.517061|2017-02-18 15:55:52.517061
NCT00424905|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2008-11-28|||December 2006||2006-12-01|November 2008|2008-11-01||||December 2007|Actual|2007-12-01||Interventional|||DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect|Evaluation of the Effects of Enterogermina, 2 Billion Bacillus Clausii Spores, on the Intestinal Flora of Children Antibiotic Treated for Bacterial Upper Respiratory Tract Infections: Open, Pilot Study.|Completed||Phase 4|60|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:55:52.610188|2017-02-18 15:55:52.610188
NCT00424892|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2007-12-04||||||December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome|A 6-Month Open-Label Extension Study of the Long-Term Safety of DVS SR in Outpatients With Fibromyalgia Syndrome.|Completed||Phase 2/Phase 3|600||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:55:52.70972|2017-02-18 15:55:52.70972
NCT00424866|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2014-11-07|||December 2014||2014-12-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease|A Phase 1, Open Label, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Peripheral Arterial Disease Patients With Intermittent Claudication|Unknown status|Not yet recruiting|Phase 1|24|Anticipated|CardioVascular BioTherapeutics, Inc.||1|||f||||f||||||||||2017-02-18 15:55:52.857735|2017-02-18 15:55:52.857735
NCT00424853|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2009-12-04|||May 2005||2005-05-01|December 2009|2009-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)|Randomized Phase II Trial of Two Sequential Schedules of Docetaxel and Cisplatin Followed by Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer.|Completed||Phase 2|88|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:55:52.967104|2017-02-18 15:55:52.967104
NCT00424840|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2014-11-18|||June 2006||2006-06-01|November 2014|2014-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy|Phase I/II Study to Evaluate the Efficacy and Safety of Combination Chemotherapy With Carboplatin, Bortezomib and Bevacizumab as First Line Therapy in Patients With Advanced Non-small Cell Lung Cancer|Completed||Phase 1/Phase 2|19|Actual|University of Massachusetts, Worcester||1|||f||||f||||||||||2017-02-18 15:55:55.700762|2017-02-18 15:55:55.700762
NCT00424827|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2015-04-07|||June 2006||2006-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||A Trial of Chemo & Radiation Therapy for Pancreatic Cancer|A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil and Radiation Therapy in Locally Advanced Non-metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|8|Actual|University of Massachusetts, Worcester||1|||f||||f||||||||||2017-02-18 15:55:55.829752|2017-02-18 15:55:55.829752
NCT00424814|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2013-07-17|||March 2007||2007-03-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|September 2011|Actual|2011-09-01||Interventional|||Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva|Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. A Multicenter Randomised Phase II/III Open Label Study With a Group of 100 Pregnant Women Receiving Lopinavir/Ritonavir and a Group of 50 Receiving Lopinavir/Ritonavir Plus Zidovudine and Lamivudine. ANRS 135 Primeva|Completed||Phase 2/Phase 3|105|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 15:55:55.933812|2017-02-18 15:55:55.933812
NCT00424801|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2009-05-05|||January 2007||2007-01-01|May 2009|2009-05-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris|Intensive Non-Sympathetic Activating Vasodilatory Treatment in Hypertensive Patients With Microvascular Angina Pectoris|Terminated||N/A|10|Actual|University of Aarhus||1||Due to recent findings relating MRI contrast to nephrogenic systemic fibrosis|f||||t||||||||||2017-02-18 15:55:56.038903|2017-02-18 15:55:56.038903
NCT00424788|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2009-09-03|||January 2007||2007-01-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)|A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)|Completed||Early Phase 1|12|Anticipated|Biogen|||||f||||||||||||||2017-02-18 15:55:56.153927|2017-02-18 15:55:56.153927
NCT00424775|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2015-03-31|2009-04-03||January 2007||2007-01-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)|A Phase I Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|3|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:55:56.243975|2017-02-18 15:55:56.243975
NCT00424762|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2012-04-02|2011-08-10||February 2005||2005-02-01|April 2012|2012-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride|Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride|Completed||Phase 4|150|Actual|University of Texas Southwestern Medical Center|Larger than anticipated study discontinuation-72% with complete primary data analysis with lower numbers analyzed for imaging endpoints|2|||f||||f||||||||||2017-02-18 15:55:56.485448|2017-02-18 15:55:56.485448
NCT00424749|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-19|2011-11-03|2011-09-12||June 2007||2007-06-01|November 2011|2011-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Rituxan in Churg Strauss Syndrome With Renal Involvement|A Pilot Study on the Use of Rituximab in the Treatment of Churg- Strauss Syndrome With Renal Involvement|Terminated||Phase 2|4|Actual|Mayo Clinic|The limited number of individuals enrolled into the study makes it difficult to draw firm conclusions that are more than hypothesis generating. The company providing study drug terminated study due to lack of funds.|1||Company providing study drug terminated study due to lack of funds|f||||t||||||||||2017-02-18 15:55:57.175651|2017-02-18 15:55:57.175651
NCT00424736|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2007-01-18|||January 2007||2007-01-01|January 2007|2007-01-01|January 2008||2008-01-01|||||Observational|||the Role of Total Body Imaging in Asymptomatic Pediatric Trauma Patients|Role of Whole Body Imaging in Asymptomatic Pediatric Trauma Patients|Unknown status|Not yet recruiting|Early Phase 1|100||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:55:57.432682|2017-02-18 15:55:57.432682
NCT00424723|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2010-08-10|||December 2005||2005-12-01|August 2010|2010-08-01|March 2010|Actual|2010-03-01|January 2007|Actual|2007-01-01||Interventional|||Pemetrexed in Patients With Advanced Neuroendocrine Tumors|A Phase II Study of Pemetrexed in Patients With Advanced Neuroendocrine Tumors|Completed||Phase 2|32|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 15:55:57.50922|2017-02-18 15:55:57.50922
NCT00424710|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2014-11-03|||January 2007||2007-01-01|November 2014|2014-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|PEARL||Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)|Phase I Study of Ranibizumab Injection for Polypoidal Choroidal Vasculopathy (PEARL)|Completed||Phase 1|17|Actual|Hawaii Pacific Health||1|||f||||f||||||||||2017-02-18 15:55:57.61837|2017-02-18 15:55:57.61837
NCT00424697|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2010-10-13||2010-10-13|March 2007||2007-03-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.|A Randomized, Placebo-controlled, Double-dummy, Four-way Crossover Design Study to Investigate the Changes of fMRI BOLD Activation Induced by Emotional Activation Paradigms Following Single Doses of GW876008 and Lorazepam (Comparator) in Healthy Subjects.|Completed||Phase 1|26|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 15:55:57.733292|2017-02-18 15:55:57.733292
NCT00424684|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2015-12-16|||January 2007||2007-01-01|December 2015|2015-12-01||||||||Interventional|||Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation|Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation|Withdrawn||N/A|0|Actual|University of Pittsburgh||||unable to obtain contract with sponsor|f||||||||||||||2017-02-18 15:55:57.837463|2017-02-18 15:55:57.837463
NCT00424671|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2007-06-21|||November 2006||2006-11-01|June 2007|2007-06-01||||||||Interventional|||Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Metabolism of a Single Dose of Licarbazepine|An Open-Label Study in Healthy Subjects and in Subjects With Stable Impaired Hepatic Function to Assess the Effect of Moderate Hepatic Impairment on Licarbazepine Pharmacokinetics and Metabolism After a Single Dose of 1000 mg Licarbazepine IR Tablets|Completed||Phase 1|16||Novartis|||||f||||||||||||||2017-02-18 15:55:57.943951|2017-02-18 15:55:57.943951
NCT00424658|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-03-31|||January 2000||2000-01-01|January 2007|2007-01-01|April 2004||2004-04-01|||||Interventional|||Sleep Apnea. Concordance Between Non-reference and Reference Centres||Completed||Phase 4|90||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 15:55:58.032673|2017-02-18 15:55:58.032673
NCT00424645|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2012-12-04|2010-11-09||January 2007||2007-01-01|December 2012|2012-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Voraxaze for Delayed Methotrexate Clearance|Randomized, Double-Blind, Placebo Controlled Trial of Voraxaze™ in Patients With a Delayed MTX Clearance|Terminated||Phase 1/Phase 2|3|Actual|M.D. Anderson Cancer Center||2||Sponsor terminated due to low accrual.|f||||t||||||||||2017-02-18 15:55:58.130998|2017-02-18 15:55:58.130998
NCT00424632|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2012-06-14|2012-03-21||November 2006||2006-11-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors|A Phase 1, Open Label, Multi-Center, Accelerated Dose-Escalation, Pharmacokinetic And Pharmacodynamic Trial Of The Oral Single Agent Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors For Whom No Standard Therapy Is Available|Completed||Phase 1|57|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:55:58.468753|2017-02-18 15:55:58.468753
NCT00424619|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2012-05-11|2011-07-25||October 2007||2007-10-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients|A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients|Completed||Phase 4|64|Actual|McMaster University||3|||f||||f||||||||||2017-02-18 15:56:01.03667|2017-02-18 15:56:01.03667
NCT00424606|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2015-05-19|||June 2001||2001-06-01|May 2015|2015-05-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients|A Multicenter Randomized Phase III Study of Adjuvant Treatment With Epirubicin Followed by Docetaxel (E/T) Versus Epirubicin and Docetaxel Combination (ET) in High Risk Lymph Node Negative Breast Cancer Patients|Completed||Phase 3|658|Actual|Hellenic Oncology Research Group||2|||f||||||||||||||2017-02-18 15:56:01.674338|2017-02-18 15:56:01.674338
NCT00424593|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2009-11-18|2009-10-16||January 2007||2007-01-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|December 2007|Actual|2007-12-01||Interventional|||Duloxetine Versus Placebo in Chronic Low Back Pain|Effect of Duloxetine 60 mg to 120 mg Once Daily in Patients With Chronic Low Back Pain|Completed||Phase 3|236|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:56:01.809296|2017-02-18 15:56:01.809296
NCT00424554|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2015-06-11|2011-06-03||September 2006||2006-09-01|June 2015|2015-06-01|February 2011|Actual|2011-02-01|January 2010|Actual|2010-01-01||Interventional|||Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)|A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks on Brain Tumor O-6-methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas.|Completed||Phase 2|40|Actual|Merck Sharp & Dohme Corp.|"The assay developed to measure MGMT activity had high variability.~The TMZ assay was unable to detect the low levels of the drug due to the relatively low dose and short half life of TMZ."|2|||f||||f||||||||||2017-02-18 15:56:03.756711|2017-02-18 15:56:03.756711
NCT00424541|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2007-11-28|||January 2007||2007-01-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension|A Multiple Center, Randomized, Double Blind, Parallel Group, Multiple Oral Doses Study to Evaluate the Pharmacokinetic and Pharmacodynamic Profiles of 150 mg and 300 mg of SPP100 in Japanese Patients With Mild to Moderate Essential Hypertension|Completed||Phase 1|34|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:56:04.164857|2017-02-18 15:56:04.164857
NCT00424528|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2012-05-29|2008-10-24||December 2006||2006-12-01|May 2012|2012-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)|A Two-Week, Randomized, Modified-Blind, Double-Dummy, Parallel-Group Efficacy and Safety Study of Arformoterol Tartrate Inhalation Solution Twice-Daily, Tiotropium Once-Daily, and Arformoterol Tartrate Inhalation Solution Twice-Daily and Tiotropium Once Daily in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|235|Actual|Sunovion|As of October 24, 2008, Sepracor is unaware of any limitations or caveats associated with this study.|3|||f||||f||||||||||2017-02-18 15:56:04.268939|2017-02-18 15:56:04.268939
NCT00424515|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2016-10-16|2016-08-22||July 2006||2006-07-01|June 2016|2016-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|BUS255|The analysis dataset is comprised of enrolled and treated patients.|Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma|A Phase II Study of Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma and Melanomas That Arise on Chronically Sun Damaged Skin.|Completed||Phase 2|24|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 15:56:06.180477|2017-02-18 15:56:06.180477
NCT00424502|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2016-04-04|2014-06-12||January 2007||2007-01-01|April 2016|2016-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional||All enrolled participants|A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.|An Open-label Study to Evaluate the Effect of MabThera on Treatment Response in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Previous TNF Inhibition.|Completed||Phase 4|20|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 15:56:06.71287|2017-02-18 15:56:06.71287
NCT00424489|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2016-07-11|||February 2002||2002-02-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis|Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis|Terminated||Phase 1|9|Actual|Northwestern University||1||No participants enrolled for more than two years. No plan to continue study.|f||||f||||||||No||2017-02-18 15:56:06.998563|2017-02-18 15:56:06.998563
NCT00424476|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2016-10-28|2011-04-07||May 2007||2007-05-01|October 2016|2016-10-01|March 2010|Actual|2010-03-01|May 2009|Actual|2009-05-01||Interventional|BLISS-52||A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Wk Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 3|865|Actual|Human Genome Sciences Inc.||3|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:56:07.105072|2017-02-18 15:56:07.105072
NCT00424463|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2013-02-27|||January 2007||2007-01-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)|An Expanded Controlled Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis in Double-Blind, Parallel-Group, Placebo-Controlled Manner (Phase 3)|Completed||Phase 3|181|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 15:56:08.694165|2017-02-18 15:56:08.694165
NCT00424450|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2008-06-05|||October 2006||2006-10-01|June 2008|2008-06-01|July 2008|Anticipated|2008-07-01|January 2008|Actual|2008-01-01||Observational|||Assessment of Bypass Surgery and Balloon Angioplasty Effects in Peripheral Arterial Disease Using Contrast Ultrasound|Assessment of Revascularization Effects in Peripheral Arterial Disease Using Contrast Ultrasound Tissue Perfusion Imaging (REVASC-PI)|Unknown status|Active, not recruiting|N/A|30|Actual|University Hospital Freiburg|||1||f||||f||||||||||2017-02-18 15:56:08.806671|2017-02-18 15:56:08.806671
NCT00424437|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2007-02-09|||September 1999||1999-09-01|February 2007|2007-02-01|September 2000||2000-09-01|||||Interventional|||Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.|Efficacy and Safety of Inhaled Compared With Subcutaneous Human Insulin Therapy in Subjects With Type 1 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial|Completed||Phase 3|320||Pfizer|||||||||||||||||||2017-02-18 15:56:08.918278|2017-02-18 15:56:08.918278
NCT00424424|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2015-10-30|||August 2006||2006-08-01|October 2015|2015-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study to Evaluate the Efficacy of MK0719 in the Prevention of Postoperative Dental Pain (0719-002)|Proprietary Information - Exploratory (Non-Confirmatory) Trial|Terminated||Phase 2|81|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 15:56:09.053457|2017-02-18 15:56:09.053457
NCT00424411|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2007-02-09|||September 1999||1999-09-01|February 2007|2007-02-01|December 2000||2000-12-01|||||Interventional|||Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes|Efficacy and Safety of Inhaled Compared With Subcutaneous Human Insulin Therapy in Subjects With Type 2 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial|Completed||Phase 3|300||Pfizer|||||||||||||||||||2017-02-18 15:56:09.142719|2017-02-18 15:56:09.142719
NCT00424398|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2013-02-13|2009-10-08||February 2007||2007-02-01|February 2013|2013-02-01||||July 2007|Actual|2007-07-01||Interventional|||Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis|A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis|Completed||Phase 2/Phase 3|107|Actual|Bausch & Lomb Incorporated||3|||f||||||||||||||2017-02-18 15:56:09.293398|2017-02-18 15:56:09.293398
NCT00424385|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2014-06-19|2013-05-24||January 2007||2007-01-01|June 2014|2014-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)|Phase I Study Investigating the Safety and Feasibility of Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-Independent Chemotherapy-Failure Prostate Cancer.|Completed||Phase 1|17|Actual|Oncology Specialists, S.C.||1|||f||||f||||||||||2017-02-18 15:56:10.263146|2017-02-18 15:56:10.263146
NCT00424372|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2009-10-30|2009-08-19||January 2007||2007-01-01|October 2009|2009-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia|A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In The Treatment Of Postherpetic Neuralgia|Completed||Phase 3|126|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 15:56:10.689131|2017-02-18 15:56:10.689131
NCT00424359|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2011-05-12|||April 2005||2005-04-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|||||Observational|||Ambulation Study in Multiple Sclerosis|A Prospective Study of Clinical Indices as Predictors of Ambulatory Effectiveness in Multiple Sclerosis|Completed||N/A|40|Anticipated|Brown, Theodore R., M.D., MPH|||1||f||||f||||||||||2017-02-18 15:56:10.982304|2017-02-18 15:56:10.982304
NCT00424346|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2014-01-14|2013-04-02||November 2006||2006-11-01|June 2013|2013-06-01|October 2009|Actual|2009-10-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis|A 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose-finding Study to Evaluate the Efficacy, Safety and Tolerability of ACZ885 (Anti-interleukin-1beta Monoclonal Antibody) With Three Different Dose Regimens in Patients With Active Rheumatoid Arthritis Despite Stable Treatment With Methotrexate Including 76-week and 96-week Extensions|Completed||Phase 2|274|Actual|Novartis||4|||f||||||||||||||2017-02-18 15:56:11.251901|2017-02-18 15:56:11.251901
NCT00424333|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2007-02-09|||May 1999||1999-05-01|February 2007|2007-02-01|October 2000||2000-10-01|||||Interventional|||Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes|Efficacy and Safety of Inhaled Compared With Subcutaneous Human Insulin in an Intensive Insulin Regimen for Subjects With Type 1 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial|Completed||Phase 3|320||Pfizer|||||||||||||||||||2017-02-18 15:56:13.867306|2017-02-18 15:56:13.867306
NCT00424320|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2007-01-18|||October 2006||2006-10-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy|Clinical Controlled Trial to Determinate the Role of Sodium Bicarbonate in the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing to Diagnostic Coronariography and/or Percutaneous Coronary Intervention|Unknown status|Recruiting|Phase 3|100||Instituto Nacional de Cardiologia Ignacio Chavez|||||f||||||||||||||2017-02-18 15:56:13.9901|2017-02-18 15:56:13.9901
NCT00424307|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2011-06-24|||January 2007||2007-01-01|June 2011|2011-06-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||Bilateral Cochlear Implant Benefit in Young Children|Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Advanced Bionics||1|||f||||f||||||||||2017-02-18 15:56:14.093007|2017-02-18 15:56:14.093007
NCT00424294|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2014-09-10|2014-09-10||June 2006||2006-06-01|September 2014|2014-09-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional||Full analysis set (FAS) was an intent-to-treat analysis set including all participants randomized to treatment who had taken at least 1 dose of study drug.|A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of CP-195543 And Celecoxib Dual Therapy In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis In Subjects Who Are Inadequately Controlled On Methotrexate|Terminated||Phase 2|70|Actual|Pfizer|The study was terminated early because it was determined that the dual therapy with CP-195543 and celecoxib had poor tolerability and a high discontinuation rate.|3||See Detailed Description field|f||||t||||||||||2017-02-18 15:56:14.205263|2017-02-18 15:56:14.205263
NCT00424281|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2007-01-17|||February 2007||2007-02-01|January 2007|2007-01-01|January 2010||2010-01-01|||||Observational|||Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication|Pharmacokinetics of Fondaparinux (Arixtra) to Critically Ill Patients on Vasopressor Therapy|Unknown status|Not yet recruiting|Phase 4|40||Wayne State University|||||f||||||||||||||2017-02-18 15:56:18.036868|2017-02-18 15:56:18.036868
NCT00424268|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-18|2016-10-24|2011-03-17||January 2007||2007-01-01|September 2016|2016-09-01|July 2008|Actual|2008-07-01|January 2008|Actual|2008-01-01||Interventional|HELIOS||Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)|Effect of Roflumilast in COPD Patients Treated With Tiotropium. A 24-week, Double-blind Study With 500 µg Roflumilast Once Daily Versus Placebo. The HELIOS Study|Completed||Phase 3|743|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 15:56:18.12763|2017-02-18 15:56:18.12763
NCT00424255|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2014-07-10|2013-11-27||December 2006||2006-12-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|March 2013|Actual|2013-03-01||Interventional|||Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery|A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post-Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or Placebo Monotherapy in High-Risk Subjects With Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 3|688|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 15:56:19.022904|2017-02-18 15:56:19.022904
NCT00424242|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2015-04-09|||January 2007||2007-01-01|April 2015|2015-04-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases|A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases|Active, not recruiting||Early Phase 1|15|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 15:56:21.597537|2017-02-18 15:56:21.597537
NCT00424229|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2007-03-09|||October 2006||2006-10-01|January 2007|2007-01-01|October 2008||2008-10-01|||||Interventional|||Lenalidomide in Subjects With intermediate2 or High MDS Associated With a Deletion (DEL) 5q [31]|Phase II Study of the Efficacy and Safety of Lenalidomide in Adult Subjects With Intermediate-2-or Higt Risk Myelodysplastic Syndrome(MDS) Associated With a Deletion (DEL) 5q [31]|Unknown status|Recruiting|Phase 2|49||Groupe Francophone des Myelodysplasies|||||f||||f||||||||||2017-02-18 15:56:21.73278|2017-02-18 15:56:21.73278
NCT00011804|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-28|2008-03-03|||February 2001||2001-02-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Topiramate in the Treatment of Sciatica|Topiramate in the Treatment of Sciatica|Completed||Phase 2|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:26.013301|2017-02-18 18:11:26.013301
NCT00424203|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2013-09-02|||January 2006||2006-01-01|September 2013|2013-09-01|November 2011|Actual|2011-11-01|January 2008|Actual|2008-01-01||Interventional|||Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery|Multicenter Pilot Clinical Study of Adjuvant Chemotherapy for Subjects Over 70 Years: Impact on the Independence and Quality of Life of the Administration of Anthracycline-Based Chemotherapy in Adjuvant Setting for Patients Presenting With Immediately Operable Breast Cancer, Hormone Receptor Negative (RH-), and Lymph Node Positive (pN+) or pN0 But of Scarff-Bloom-Richardson* Grade III and ≥ 2cm [GERICO]|Completed||Phase 2|40|Actual|UNICANCER||1|||f||||f||||||||||2017-02-18 15:56:21.929669|2017-02-18 15:56:21.929669
NCT00424190|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2010-11-23|2010-10-12||February 2007||2007-02-01|November 2010|2010-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|cSSSI||Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections|A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin and Skin Structure Infection|Completed||Phase 3|698|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 15:56:22.068511|2017-02-18 15:56:22.068511
NCT00424177|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2013-07-25|2009-06-23||March 2007||2007-03-01|May 2012|2012-05-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)|An Open-label Repeat Dosing Study of Eltrombopag Olamine (SB-497115-GR) in Adult Subjects, With Chronic Idiopathic Thrombocytopenic Purpura (ITP)|Completed||Phase 2|66|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 15:56:22.630505|2017-02-18 15:56:22.630505
NCT00424164|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2013-06-18|||November 2006||2006-11-01|June 2013|2013-06-01||||June 2009|Actual|2009-06-01||Interventional|LAPATAM||Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer|Pharmacokinetics Study of Combined Treatment Lapatinib and Tamoxifen in Advanced/Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 15:56:24.015912|2017-02-18 15:56:24.015912
NCT00424151|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2010-10-04|||December 2006||2006-12-01|October 2010|2010-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy|Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy Phase I/II|Completed||Phase 1/Phase 2|12|Actual|Silkiss, Rona Z., M.D., FACS||1|||f||||||||||||||2017-02-18 15:56:24.12957|2017-02-18 15:56:24.12957
NCT00424138|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2013-02-04|||March 2007||2007-03-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|ACRIN 6678||FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy|[18F]FDG-PET/CT as a Predictive Marker of Tumor Response and Patient Outcome: Prospective Validation in Non-Small Cell Lung Cancer|Terminated||Phase 2|96|Actual|American College of Radiology Imaging Network||3||Recruitment obstacles; data to be combined with other resources for analysis|f||||t||||||||||2017-02-18 15:56:24.230683|2017-02-18 15:56:24.230683
NCT00424125|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-08-21|||July 2006||2006-07-01|August 2015|2015-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Involving Community Pharmacies in Improving Asthma Outcomes in an Urban Pediatric Population|Improving Pediatric Asthma Care in the District of Columbia (IMPACT DC)-Community Pharmacy Intervention|Completed||N/A|125|Actual|Children's Research Institute||1|||f||||||||||||||2017-02-18 15:56:24.351991|2017-02-18 15:56:24.351991
NCT00424112|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2007-01-17|||October 2004||2004-10-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Observational|||Motivation in Alcohol Treatment Facilities|Stages an Processes of Change in Help-Seeking and Drinking Behavior|Completed||Phase 1|450||University Medicine Greifswald|||||f||||||||||||||2017-02-18 15:56:24.461693|2017-02-18 15:56:24.461693
NCT00424099|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2011-12-06|||January 2007||2007-01-01|December 2011|2011-12-01||||December 2012|Anticipated|2012-12-01||Interventional|||Methylphenidate and a Nursing Telephone Intervention for Fatigue|A Randomized Controlled Trial of Methylphenidate and a Nursing Telephone Intervention (NTI) for Fatigue in Advanced Cancer Patients|Unknown status|Active, not recruiting|N/A|212|Anticipated|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 15:56:24.532774|2017-02-18 15:56:24.532774
NCT00424086|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-10-07|||January 2007||2007-01-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)|Single Blind, Randomized, Actively Controlled Phase 1/2 Study to Compare the Safety and Immunogenicity of a Split Virus, Vero Cell Derived, Seasonal Influenza Vaccine (VCIC) With a Licensed, Egg Derived, Split Virus, Seasonal Influenza Vaccine (EIV)|Completed||Phase 1/Phase 2|1000|Anticipated|Nanotherapeutics, Inc.|||||f||||t||||||||||2017-02-18 15:56:24.653665|2017-02-18 15:56:24.653665
NCT00424060|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2012-09-20|||December 2006||2006-12-01|September 2012|2012-09-01||||August 2007|Actual|2007-08-01||Interventional|||Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma|Phase II Study of ZK 219477 in Patients With Recurrent Glioblastoma|Completed||Phase 2|38|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 15:56:24.763231|2017-02-18 15:56:24.763231
NCT00424047|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-03-03|2015-02-13||September 2003||2003-09-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|August 2005|Actual|2005-08-01||Interventional||Intent to treat population included all participants who were randomized|A Study of Lenalidomide Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Patients With Multiple Myeloma|A Multi-center, Randomized, Parallel-group, Double-blind, Placebo Controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma.|Completed||Phase 3|351|Actual|Celgene||2|||f||||t||||||||||2017-02-18 15:56:24.88439|2017-02-18 15:56:24.88439
NCT00424034|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2017-01-18|||January 2007||2007-01-01|January 2017|2017-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study of GSK1325760A in Healthy Japanese Subjects|Phase I Study of Ambrisentan - Single Dose Study in Healthy Japanese Male Subjects|Completed||Phase 1|32|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:56:26.565338|2017-02-18 15:56:26.565338
NCT00424021|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2011-12-21|2011-07-12||April 2003||2003-04-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension|An Open-Label, Long-Term Study of Ambrisentan in Pulmonary Hypertension Subjects Having Completed Myogen Study AMB-220|Completed||Phase 2|54|Actual|Gilead Sciences|The small sample size, nonrandomized dose group assignments, and the potential for dose adjustments precluded meaningful comparisons between the dose groups. Therefore, efficacy results are only presented for the combined ambrisentan group.|1|||f||||||||||||||2017-02-18 15:56:26.684107|2017-02-18 15:56:26.684107
NCT00424008|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-03-27|2010-06-30||April 2007||2007-04-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)|A 52-Week Efficacy and Safety Non-Inferiority Study of Fluticasone Propionate/Salmeterol 250/50mcg BID Delivered by Dry Powder Inhaler (Diskus) Versus Mometasone Furoate/Formoterol Fumarate 200/10mcg BID Delivered by Pressurized Metered-Dose Inhaler in Persistent Asthmatics Previously Treated With Medium Doses of Inhaled Glucocorticosteroids|Completed||Phase 3|722|Actual|Merck Sharp & Dohme Corp.|The sponsor closed the study early, at 12 weeks treatment, for reasons that were not safety related. No efficacy analysis of data collected beyond 12 weeks of treatment was performed. All safety data were examined regardless of treatment duration.|2|||f||||f||||||||||2017-02-18 15:56:30.197241|2017-02-18 15:56:30.197241
NCT00423995|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-06-23|||November 2006||2006-11-01|June 2015|2015-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)|Study of the Decongestant Effect of the Combination of Loratadine and Montelukast Compared With Placebo in SAR Subjects Exposed to Pollen in an Environmental Exposure Unit|Completed||Phase 3|379|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:56:30.680435|2017-02-18 15:56:30.680435
NCT00423982|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2013-06-26|||April 2006||2006-04-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2012|Actual|2012-12-01||Interventional|||Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty|Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 15:56:30.763322|2017-02-18 15:56:30.763322
NCT00423969|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-01-17|||November 2003||2003-11-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Galantamine Augmentation of Escitalopram for Treatment of Depression|Galantamine Augmentation of Escitalopram for Treatment of Depression Associated Cognitive Impairment in Outpatients - A Randomized Single Blind Clinical Trial|Terminated||Phase 4|20||Indiana University|||||f||||||||||||||2017-02-18 15:56:30.878997|2017-02-18 15:56:30.878997
NCT00423956|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2013-01-20|||January 2007||2007-01-01|January 2013|2013-01-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Repair of Orthodontically-induced Tooth Root Resorption by Ultrasound|Repair of Orthodontically-induced Tooth Root Resorption by Ultrasound in Human Subjects|Unknown status|Recruiting|Phase 1/Phase 2|72|Anticipated|University of Alberta, Graduate Orthodontic Program||1|||f||||t||||||||||2017-02-18 15:56:30.973493|2017-02-18 15:56:30.973493
NCT00423943|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2012-12-13|||September 2005||2005-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia|Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia|Completed||Phase 4|38|Actual|University of California, Davis||1|||f||||||||||||||2017-02-18 15:56:31.082153|2017-02-18 15:56:31.082153
NCT00423930|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-08-02|||October 2006||2006-10-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer|A Phase II Study of Radiotherapy (IMRT) + Cisplatin + Bevacizumab for Patients With Stage III/IV Head and Neck Cancers|Completed||Phase 2|44|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:56:31.193166|2017-02-18 15:56:31.193166
NCT00423917|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-08-12|||August 2007||2007-08-01|August 2016|2016-08-01||||February 2009|Actual|2009-02-01||Interventional|||Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer|Phase II Trial of Fulvestrant and Bevacizumab in Patients With Metastatic Breast Cancer Previously Treated With an Aromatase Inhibitor|Active, not recruiting||Phase 2|51|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:56:31.319801|2017-02-18 15:56:31.319801
NCT00423904|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2007-01-17|||October 2001||2001-10-01|January 2007|2007-01-01|August 2005||2005-08-01|||||Interventional|||Brief Alcohol Intervention in General Hospitals|Implementing Early Intervention for Alcohol Use Disorders in the General Hospital|Completed||Phase 2|1035||University Medicine Greifswald|||||f||||||||||||||2017-02-18 15:56:31.744776|2017-02-18 15:56:31.744776
NCT00423891|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2015-10-07|2014-07-15||June 2007||2007-06-01|October 2015|2015-10-01|October 2017|Anticipated|2017-10-01|August 2013|Actual|2013-08-01||Interventional||All participants who received at least one dose of study drug.|A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection|Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive|Active, not recruiting||Phase 1/Phase 2|64|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:56:31.844831|2017-02-18 15:56:31.844831
NCT00423878|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-09-27|2012-11-16||January 2007||2007-01-01|November 2010|2010-11-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Interventional|CAMP||Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder|Clinical Management of Metabolic Problems in Patients With Schizophrenia|Completed||Phase 4|215|Actual|National Institute of Mental Health (NIMH)|Open-label treatment is a limitation of this study, particularly for outcomes not measured in the laboratory but instead subject to clinical judgment.|2|||f||||t||||||||||2017-02-18 15:56:33.905945|2017-02-18 15:56:33.905945
NCT00423865|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2015-05-22|||November 2006||2006-11-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors|A Phase I Study of Weekly Low-Dose Cisplatin Plus Escalating Doses of Oral RAD001(Everolimus) for Patients With Advanced Solid Tumors|Completed||Phase 1|30|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:56:34.416178|2017-02-18 15:56:34.416178
NCT00423852|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-04-12|2015-12-17||August 2006||2006-08-01|April 2016|2016-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin|Phase I/II Trial of Sequential Paclitaxel/Ifosfamide Followed by Dose-Escalated, Dose-Intensive Carboplatin, Paclitaxel and Ifosfamide With Stem Cell Support in Cisplatin-Resistant Germ Cell Tumor Patients|Completed||Phase 1/Phase 2|26|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:56:34.52829|2017-02-18 15:56:34.52829
NCT00010907|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-03-21||||||March 2013|2013-03-01||||||||Interventional|||Preliminary Human Trial of NPI-028||Withdrawn||Phase 2|0|Actual|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:31.201959|2017-02-18 18:11:31.201959
NCT00423839|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2007-01-17|||March 2003||2003-03-01|December 2006|2006-12-01|July 2005||2005-07-01|||||Interventional|||A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers|A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers|Completed||Phase 1|12||University of Oxford|||||f||||||||||||||2017-02-18 15:56:34.828382|2017-02-18 15:56:34.828382
NCT00423826|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-02-26|||January 2007||2007-01-01|February 2016|2016-02-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Expanded Access|||Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease|A Pilot Study of Double Cord Blood Stem Cell Transplantation in Patients With Hematologic Malignancies|No longer available||N/A|||Barbara Ann Karmanos Cancer Institute|||||f||||||||||||||2017-02-18 15:56:34.930863|2017-02-18 15:56:34.930863
NCT00423813|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2012-01-20|2011-09-08||December 2006||2006-12-01|December 2011|2011-12-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.|A Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.|Completed||Phase 3|573|Actual|Jazz Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:56:35.169|2017-02-18 15:56:35.169
NCT00423800|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-10-08|2011-01-27||December 2006||2006-12-01|October 2015|2015-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)|Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) Therapy (1.5 mcg/kg/Week + 800-1200 mg/Day) in Naïve Genotype 1 Hepatitis C Patients With High Baseline Viral Load Who Are HCV-RNA Negative at Week 4 and Week 12|Terminated||Phase 3|56|Actual|Merck Sharp & Dohme Corp.|Due to the small sample size (n=5), no conclusions should be drawn.|2||The study was terminated due to difficulty in recruiting participants.|f||||f||||||||||2017-02-18 15:56:36.305631|2017-02-18 15:56:36.305631
NCT00423787|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2010-06-16|||March 2007||2007-03-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety/Tolerability of Ragweed MATA MPL|Efficacy and Safety/Tolerability of Ragweed MATA MPL, a Randomized, Placebo-Controlled, Double-Blind Study|Completed||Phase 3|993|Actual|Allergy Therapeutics||2|||f||||t||||||||||2017-02-18 15:56:36.701909|2017-02-18 15:56:36.701909
NCT00423774|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2017-01-24|||January 11, 2007||2007-01-11|September 28, 2010|2010-09-28|December 1, 2008|Actual|2008-12-01|December 1, 2008|Actual|2008-12-01||Interventional|||Education Program to Manage Emotional Stress of Stem Cell Transplant Recipients and Their Caregivers|A Feasibility Study to Test an Individualized Dyadic Problem-Solving Education Intervention to Improve Problem-Solving Skills of Patients and Family Caregivers During Allogeneic HSCT|Completed||Phase 1|20|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 15:56:39.587117|2017-02-18 15:56:39.587117
NCT00423761|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2009-05-15|||December 2006||2006-12-01|May 2009|2009-05-01||||||||Interventional|||An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.|An Open-Label, Single-Sequence Study to Evaluate the Potential CYP 3A4 Pharmacokinetic Interaction of GW876008 in Healthy Subjects|Completed||Phase 1|25|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 15:56:39.676008|2017-02-18 15:56:39.676008
NCT00423748|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2009-04-15|||December 2003||2003-12-01|April 2009|2009-04-01|February 2006||2006-02-01|||||Interventional|||Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.|Ambrisentan in PAH - A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 3|186||Gilead Sciences|||||||||||||||||||2017-02-18 15:56:39.759943|2017-02-18 15:56:39.759943
NCT00423735|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-11-29|2014-06-19||January 2007||2007-01-01|November 2016|2016-11-01||||March 2011|Actual|2011-03-01||Interventional||Eligible patients who started protocol treatment.|Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma|Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme|Active, not recruiting||Phase 2|64|Actual|National Cancer Institute (NCI)|Designed as a 2-stage study. The protocol was amended after Stage 1 to add Stage 1B allowing intra-patient escalation. Per protocol criteria, the study did not continue to Stage 2.|1|||f||||f||||||||||2017-02-18 15:56:39.868102|2017-02-18 15:56:39.868102
NCT00423722|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2015-11-16|2012-07-05||January 2007||2007-01-01|November 2015|2015-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Parenteral Hydration in Advanced Cancer Patients|Parenteral Hydration in Advanced Cancer Patients - A Randomized Controlled Trial|Completed||N/A|262|Actual|M.D. Anderson Cancer Center|Study had a planned sample size of 150 participants but due to funding issues recruitment was halted after 129 patients; additionally, participants with delirium or severe dehydration were excluded for logistic purposes.|2|||f||||t||||||||||2017-02-18 15:56:40.880783|2017-02-18 15:56:40.880783
NCT00423709|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2012-01-20|||January 1998||1998-01-01|January 2012|2012-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Allogeneic Blood Stem Cell Transplantation|A Study of Allogeneic Blood Stem Cell Transplantation With Purine Analog-Based Conditioning For Patients With Advanced Hodgkin's Disease|Completed||N/A|46|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-02-18 15:56:41.506757|2017-02-18 15:56:41.506757
NCT00423696|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2011-09-28|||January 2006||2006-01-01|September 2011|2011-09-01||||||||Interventional|||Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Phase II Randomized Study of First-Line Therapy Comprising Bevacizumab and Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil (FOLFIRI) Versus Bevacizumab and Irinotecan Hydrochloride and Capecitabine (XELIRI) in Patients With Unresectable Metastatic Colorectal Cancer [ACCORD]|Unknown status|Active, not recruiting|Phase 2|144|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:56:41.841397|2017-02-18 15:56:41.841397
NCT00423683|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2016-05-06|2012-10-24||January 2007||2007-01-01|May 2016|2016-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism|A Randomized Control Trial of Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With A Venous Thromboembolism|Terminated||Phase 3|64|Actual|Northwell Health||2||Study accrual stopped due to poor accrual.|f||||t||||||||No||2017-02-18 15:56:41.963217|2017-02-18 15:56:41.963217
NCT00423670|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-02-16|2011-05-13||January 2007||2007-01-01|February 2015|2015-02-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)|A Safety and Efficacy Study of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1|Completed||Phase 2|765|Actual|Merck Sharp & Dohme Corp.||8|||f||||t||||||||||2017-02-18 15:56:42.623615|2017-02-18 15:56:42.623615
NCT00423657|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2010-11-23|2010-10-12||March 2007||2007-03-01|November 2010|2010-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections|A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroloine Versus Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin and Skin Structure Infection (cSSSI)|Completed||Phase 3|680|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 15:56:45.146156|2017-02-18 15:56:45.146156
NCT00423644|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2013-11-13|||January 2007||2007-01-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b|A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b|Unknown status|Active, not recruiting|Phase 2|17|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 15:56:45.805342|2017-02-18 15:56:45.805342
NCT00423631|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2011-10-06|||September 2006||2006-09-01|October 2011|2011-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Web-based Education to Enhance Fibromyalgia Management|Internet-Enhanced Management of Fibromyalgia|Completed||N/A|118|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 15:56:45.917683|2017-02-18 15:56:45.917683
NCT00423618|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2017-01-19|||March 2006||2006-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|VORTEX||Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma|Randomised Trial of Post-Operative Radiotherapy Given to Adult Patients With Extremity Soft Tissue Sarcoma [VORTEX]|Active, not recruiting||Phase 3|216|Actual|Sheffield Teaching Hospitals NHS Foundation Trust||2|||f||||t||||||||No||2017-02-18 15:56:46.053843|2017-02-18 15:56:46.053843
NCT00423605|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2012-03-28|2011-09-12||December 2006||2006-12-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.|A Long-Term, Open-Label, Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.|Completed||Phase 3|560|Actual|Jazz Pharmaceuticals||1|||f||||f||||||||||2017-02-18 15:56:46.175188|2017-02-18 15:56:46.175188
NCT00423592|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2013-06-07|2010-05-14||May 2005||2005-05-01|June 2013|2013-06-01|March 2009|Actual|2009-03-01|January 2006|Actual|2006-01-01||Interventional|||Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension|A Phase 2, Open-label, Multicenter Study Evaluating Ambrisentan in Subjects With Pulmonary Arterial Hypertension Who Have Previously Discontinued Endothelin Receptor Antagonist Therapy Due to Serum Aminotransferase Abnormalities|Completed||Phase 2|36|Actual|Gilead Sciences|Seven subjects were excluded from the change from baseline analysis of the SF-36 Health Survey because the incorrect version of the SF-36 questionnaire was used for evaluation at baseline, which made comparisons problematic.|1|||f||||||||||||||2017-02-18 15:56:46.793365|2017-02-18 15:56:46.793365
NCT00423579|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-04-01|2009-03-19||July 2006||2006-07-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)|A Multicenter, Randomized, Parallel-Groups, Double-Blind Placebo-Controlled Study Comparing the Efficacy, Safety, and Tolerability of Administration of Ezetimibe/Simvastatin Tablet 10/20 mg Versus Doubling the Dose of Simvastatin 20 mg [Simvastatin 40 mg] in Subjects With Primary Hypercholesterolemia and Coronary Heart Disease|Completed||Phase 4|120|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:56:47.711536|2017-02-18 15:56:47.711536
NCT00423566|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2007-01-17|||September 2002||2002-09-01|December 2006|2006-12-01|July 2003||2003-07-01|||||Interventional|||A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.|A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.|Completed||Phase 1|14||University of Oxford|||||f||||||||||||||2017-02-18 15:56:48.020089|2017-02-18 15:56:48.020089
NCT00423553|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2017-01-24|||January 11, 2007||2007-01-11|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Collection of Heart Tissue Sample During Open Heart Surgery|Modifying Tolerance to Ischemic Injury in Human Atrial Tissue|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:56:48.115691|2017-02-18 15:56:48.115691
NCT00423540|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2008-12-09|||January 2007||2007-01-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Exploring the Role of Magnesium in Rest Cramps|Magnesium Status & Effect of Magnesium Infusions on Rest Cramps|Completed||N/A|54|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 15:56:48.1953|2017-02-18 15:56:48.1953
NCT00423527|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2009-12-17|||January 2007||2007-01-01|January 2007|2007-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Levetiracetam in Central Pain in Multiple Sclerosis(MS)|Double-blind, Randomised,Placebo-controlled Trial of Levetiracetam in Central Pain in Multiple Sclerosis|Completed||Phase 4|30|Anticipated|Odense University Hospital||1|||f||||||||||||||2017-02-18 15:56:48.298653|2017-02-18 15:56:48.298653
NCT00423514|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-08-15|||November 2006||2006-11-01|August 2016|2016-08-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease|A Phase I/II Dose Escalation Trial of Clofarabine, in Addition to Melphalan and Thiotepa as Myeloablative Regimen Followed by an Allogeneic Unmodified Hematopoietic Stem Cell Transplant From HLA-Compatible Related or Unrelated Donors for the Treatment of High Risk and/or Advanced Hematologic Malignancies|Active, not recruiting||Phase 1/Phase 2|42|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:56:48.404643|2017-02-18 15:56:48.404643
NCT00423501|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2016-11-01|||February 2007||2007-02-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.|A Double Blind, Placebo-controlled, Dose-ranging Study to Investigate the Effect on Glycemic Control, Safety, Pharmacokinetics and Pharmacodynamics of GLP-1 in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin.|Completed||Phase 2|306|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-02-18 15:56:48.524678|2017-02-18 15:56:48.524678
NCT00341744|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2016-11-03|||July 2001||2001-07-01|October 2016|2016-10-01|December 2028|Anticipated|2028-12-01|December 2028|Anticipated|2028-12-01||Observational|||Providing Access to the Visual Environment|Providing Access to the Visual Environment|Recruiting||N/A|795|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-02-18 16:27:25.241495|2017-02-18 16:27:25.241495
NCT00423488|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-09-18|2010-02-17||July 2005||2005-07-01|September 2015|2015-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)|A Multicenter, Randomized, Parallel-Groups, Double-Blind Placebo Controlled Study Comparing the Efficacy, Safety, and Tolerability of Co-administration of Ezetimibe 10 mg With Ongoing Treatment With Simvastatin 20 mg Versus Doubling the Dose of Simvastatin in Subjects With Primary Hypercholesterolemia Diabetes Mellitus Type 2 and Coronary Heart Disease|Completed||Phase 3|93|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:56:48.679862|2017-02-18 15:56:48.679862
NCT00423475|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2015-02-02|||October 2006||2006-10-01|February 2015|2015-02-01||||January 2015|Actual|2015-01-01||Interventional|||Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer|Phase III Randomized Study of Adjuvant Radiotherapy With Versus Without Concurrent Goserelin in Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer|Completed||Phase 3|743|Actual|UNICANCER||2|||f||||t||||||||||2017-02-18 15:56:48.987939|2017-02-18 15:56:48.987939
NCT00423462|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2007-08-24|||January 1993||1993-01-01|August 2007|2007-08-01|December 2005||2005-12-01|||||Interventional|||First Experimental Study of Transference-Interpretations (FEST)|First Experimental Study of Transference Interpretations (FEST)|Completed||Phase 2/Phase 3|100||University of Oslo|||||f||||||||||||||2017-02-18 15:56:49.137146|2017-02-18 15:56:49.137146
NCT00423449|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2016-02-03|2011-07-06||March 2007||2007-03-01|February 2016|2016-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)|A Phase I Clinical Trial of Vorinostat in Combination With Gemcitabine Plus Platinum in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|61|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:56:49.24199|2017-02-18 15:56:49.24199
NCT00423436|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2011-11-14|2011-09-08||April 2003||2003-04-01|November 2011|2011-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients|Using an Interactive Voice Response Telephone System in the Assessment and Management of Symptoms in Advanced Lung Cancer Patients Receiving Chemotherapy|Completed||N/A|84|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 15:56:50.322312|2017-02-18 15:56:50.322312
NCT00423410|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2009-09-09|||December 2006||2006-12-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer|A First In Man Phase I Study Of EPC2407, A Microtubule Inhibitor Anti-Cancer Drug With Tumor Vascular Endothelial Disrupting Activity: Intravenous Administration Daily For Three Days In Patients With Advanced Solid Tumors And Lymphomas|Completed||Phase 1|30|Anticipated|EpiCept Corporation||1|||f||||f||||||||||2017-02-18 15:56:50.746074|2017-02-18 15:56:50.746074
NCT00423397|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2013-12-18|||September 2006||2006-09-01|March 2008|2008-03-01||||January 2008|Anticipated|2008-01-01||Interventional|||Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer|A Phase I/II Pilot Study of Bioimmunotherapy With IRESSA (Gefitinib) and Pegylated Interferon Alpha-2a for Patients With Unresectable/Metastatic Squamous Cell Carcinoma of the Skin|Unknown status|Active, not recruiting|Phase 1/Phase 2|16|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:56:50.850352|2017-02-18 15:56:50.850352
NCT00423384|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2010-03-22|||January 2007||2007-01-01|March 2010|2010-03-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.|Ibandronate Versus Placebo as add-on to Active Vitamin D and Calcium in the Prevention of Bone Loss After Renal Transplantation.|Unknown status|Active, not recruiting|Phase 2/Phase 3|130|Anticipated|Smerud Medical Research International AS||2|||f||||f||||||||||2017-02-18 15:56:50.954488|2017-02-18 15:56:50.954488
NCT00423371|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2011-05-18|||December 2006||2006-12-01|May 2011|2011-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Osteoarthritis (OA) of the First Carpometacarpal (CMC) Joint|Completed||Phase 2/Phase 3|79|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 15:56:51.068759|2017-02-18 15:56:51.068759
NCT00423358|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-07-27|2015-05-29||February 2005||2005-02-01|July 2015|2015-07-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Treatment of Hypovitaminosis D in Rheumatoid Arthritis|Treatment of Hypovitaminosis D in Rheumatoid Arthritis|Completed||N/A|22|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 15:56:51.181415|2017-02-18 15:56:51.181415
NCT00423345|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2012-08-24|||October 2006||2006-10-01|August 2012|2012-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Colon Investigation - Factors Determining Choice of Procedure|Colon Investigation With Barium Enema, CT Colonography and Colonoscopy: A Prospective Registration of Indications, Delay and Procedure Results.|Unknown status|Active, not recruiting|N/A|750|Actual|Sykehuset Telemark|||1||f||||t||||||||||2017-02-18 15:56:51.613913|2017-02-18 15:56:51.613913
NCT00423332|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-12-08|2012-04-03||January 2007||2007-01-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|March 2008|Actual|2008-03-01||Interventional|||Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma|A Phase II, Randomised, Double-blind, Parallel Group Study to Assess the Efficacy of Cediranib 45mg Versus Placebo Following 12 Weeks of Treatment in Patients With Metastatic or Recurrent Renal Cell Carcinoma Who Have Had no Previous Anti-VEGF Therapy.|Completed||Phase 2|105|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:56:51.879565|2017-02-18 15:56:51.879565
NCT00423319|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2014-04-14|2014-04-14||March 2007||2007-03-01|April 2014|2014-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)|A Phase 3 Randomized, Double-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Apixaban in Subjects Undergoing Elective Total Hip Replacement Surgery (The Advance-3 Study Apixaban Dosed Orally Versus Anticoagulation With Injectable Enoxaparin to Prevent Venous Thromboembolism)|Completed||Phase 3|5407|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 15:56:52.725456|2017-02-18 15:56:52.725456
NCT00010868|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||July 2000||2000-07-01|July 2006|2006-07-01|July 2004||2004-07-01|||||Interventional|||Omega-3 Fatty Acids in Bipolar Disorder|Omega-3 Fatty Acids in Bipolar Disorder Prophylaxis|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:31.351261|2017-02-18 18:11:31.351261
NCT00423306|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2013-11-13|||January 2007||2007-01-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma|A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 2|15|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 15:56:54.797887|2017-02-18 15:56:54.797887
NCT00423293|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-12-30|2013-04-11||December 2006||2006-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|February 2009|Actual|2009-02-01||Interventional||All eligible patients|Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer|A Phase II Evaluation of Dose-Painted Intensity-Modulated Radiation Therapy (IMRT) in Combination With 5-Fluorouracil (5-FU) and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal|Completed||Phase 2|63|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 15:56:54.907517|2017-02-18 15:56:54.907517
NCT00423280|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2008-08-06|||November 2006||2006-11-01|June 2008|2008-06-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)|A Randomised, Placebo-Controlled Study of Two Doses of Oral 6R-BH4 on Vascular Function in Subjects With Coronary Artery Disease|Unknown status|Recruiting|Phase 2|66|Anticipated|University of Oxford||3|||f||||t||||||||||2017-02-18 15:56:58.444642|2017-02-18 15:56:58.444642
NCT00423267|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-09-18|2010-05-27||May 2007||2007-05-01|September 2015|2015-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)|A Multicenter, Randomized, Controlled, Double-Blind, Double-Dummy, Two-Arm Study of Posaconazole vs Fluconazole in the Treatment of Coccidioidomycosis|Completed||Phase 3|16|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 15:56:58.561055|2017-02-18 15:56:58.561055
NCT00423254|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2010-08-02|||February 2007||2007-02-01|August 2010|2010-08-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.|A Phase I Multicenter, Open Label, Clinical Trial of Immune Response, Safety and Tolerability of DNA Vector pPRA-PSM With Synthetic Peptides E-PRA and E-PSM in Subjects With Advance Solid Malignancies|Completed||Phase 1|12|Actual|Mannkind Corporation||2|||f||||f||||||||||2017-02-18 15:56:59.168974|2017-02-18 15:56:59.168974
NCT00423241|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2010-08-20|||January 2007||2007-01-01|August 2010|2010-08-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||SEMPERFLO* Pain Management System in Inguinal Hernia Repair|A Prospective, Randomized, Exploratory Comparison of the SEMPERFLO* Pain Management System to a Commercially Available Pain Relief System in Subjects Undergoing Open Inguinal Hernia Repair|Terminated||N/A|7|Actual|Ethicon, Inc.||2||Market dynamics including other technologies made the project not viable.|f||||f||||||||||2017-02-18 15:56:59.299439|2017-02-18 15:56:59.299439
NCT00423228|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-01-13|||February 2007||2007-02-01|January 2015|2015-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|BRAINz||Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease|A Randomised, Double-blind, Double-dummy, Oral Donepezil Controlled Study on the Safety and Efficacy of Repeated Monthly Subcutaneous Injections of a Sustained-release Implant of ZT 1 in Patients With Moderate Alzheimer's Disease|Completed||N/A|228|Actual|Debiopharm International SA||2|||f||||t||||||||||2017-02-18 15:56:59.41318|2017-02-18 15:56:59.41318
NCT00423215|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2009-06-12|||March 2006||2006-03-01|June 2009|2009-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus|An Open Therapeutic Observational Evaluation of the Efficacy and Safety Profile of Lantus in Everyday Medical Practice in Type 2 Diabetes Mellitus Patients, Who Start Receiving Lantus - Treated With Any Other Insulin, With A1c>7%|Completed||Phase 4|1007|Actual|Sanofi|||1||f||||f||||||||||2017-02-18 15:56:59.818112|2017-02-18 15:56:59.818112
NCT00423202|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2009-04-15|||December 2003||2003-12-01|April 2009|2009-04-01|October 2005||2005-10-01|||||Interventional|||A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.|Ambrisentan in PAH - A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.|Completed||Phase 3|186||Gilead Sciences|||||||||||||||||||2017-02-18 15:56:59.919741|2017-02-18 15:56:59.919741
NCT00423189|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-02-05|2012-10-17||January 2007||2007-01-01|February 2016|2016-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration|Lucentis Utilizing Visudyne (LUV Trial)-- Reduced Fluence Photodynamic Therapy With Visudyne Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration|Terminated||Phase 4|7|Actual|Greater Houston Retina Research|The trial was discontinued due to a lack of efficacy.|3||Lack of efficacy|f||||t||||||||||2017-02-18 15:56:59.993773|2017-02-18 15:56:59.993773
NCT00423176|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-06-29|2009-07-29||December 2006||2006-12-01|June 2015|2015-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)|Efficacy and Safety of 200mcg BID Mometasone Furoate Nasal Spray (MFNS) Versus Placebo as Adjunctive Treatment to Antibiotics in Relief of Symptoms of Acute Bacterial Sinusitis|Terminated||Phase 3|237|Actual|Merck Sharp & Dohme Corp.|The study was terminated early due to a very high screening failure rate (mainly caused by the necessity to demonstrate CT changes at baseline indicative of acute sinusitis), which limits any conclusions.|2||"Based on business priorities. Not related to any safety or efficacy issue & took place before~   data were unblinded or analyzed"|f||||f||||||||||2017-02-18 15:57:00.524131|2017-02-18 15:57:00.524131
NCT00423163|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2015-08-31|||February 2007||2007-02-01|August 2015|2015-08-01||||||||Interventional|||A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis|A Double-Blind, Randomized Controlled Trial of Voriconazole (VFEND®) Plus Micafungin (MYCAMINE™) Versus Voriconazole Plus Placebo in the Treatment of Patients With Proven or Probable Invasive Aspergillosis|Withdrawn||Phase 4|0|Actual|Astellas Pharma Inc||||"An alternative joint industry effort will provide information on combination versus single~   agent therapy for treatment of aspergillosis"|f||||t||||||||||2017-02-18 15:57:00.933688|2017-02-18 15:57:00.933688
NCT00422812|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2008-06-02|||April 2006||2006-04-01|June 2008|2008-06-01||||||||Interventional|||Staccato® Prochlorperazine for Inhalation in Migraine|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose, Efficacy and Safety Outpatient Study of StaccatoTM Prochlorperazine for Inhalation in Patients With Migraine Headache|Completed||Phase 2|400||Alexza Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 15:57:08.892263|2017-02-18 15:57:08.892263
NCT00423150|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2014-10-30|2010-05-27||January 2007||2007-01-01|October 2014|2014-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)|A Phase 2 Study of Temozolomide (SCH 52365) in Subjects With Advanced Aerodigestive Tract Cancers Selected for Methylation of O6-Methyl-Guanine-DNA Methyltransferase (MGMT) Promoter|Terminated||Phase 2|86|Actual|Merck Sharp & Dohme Corp.|Due to low response rate for colorectal cancer in interim analyses, low enrollment in head & neck and non-small cell lung cancer groups due to low methylation rates, and low overall response rate in esophageal cancer group, the study was terminated.|1|||f||||f||||||||||2017-02-18 15:57:01.070708|2017-02-18 15:57:01.070708
NCT00423137|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-17|2014-04-30||2014-04-30|January 2007||2007-01-01|April 2014|2014-04-01||||July 2008|Actual|2008-07-01||Interventional|||Effect of BIBW 2948 BS in COPD|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Effects of a 4-week Treatment of 15 and 30 mg b.i.d BIBW2948 BS (Inhalation Powder, Hard Capsule for HandiHaler®) on Epithelial Mucin Stores and the Safety and Efficacy in COPD Patients With Symptoms Associated With Chronic Bronchitis|Completed||Phase 2|48|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 15:57:01.392893|2017-02-18 15:57:01.392893
NCT00423124|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2014-05-29|||July 2002||2002-07-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|December 2011|Actual|2011-12-01||Interventional|||Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies|A Phase I-II Study: Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK, After Transplantation of Allogeneic T-depleted Stem Cells From a Haploidentical Donor in Patients With Haematological Malignancies|Completed||Phase 1/Phase 2|57|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 15:57:01.490182|2017-02-18 15:57:01.490182
NCT00423111|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2007-09-20|||February 2007||2007-02-01|September 2007|2007-09-01|February 2009|Anticipated|2009-02-01|||||Observational|||Correlation Between Cognitive Functions and MRI in Multiple Sclerosis||Unknown status|Recruiting|N/A|100|Anticipated|Sheba Medical Center|||||f||||||||||||||2017-02-18 15:57:01.630927|2017-02-18 15:57:01.630927
NCT00423098|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2011-05-31|2010-12-14||February 2007||2007-02-01|May 2011|2011-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare|A Randomized, Multicenter, Open-label, 6-month Study to Explore the Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare|Completed||Phase 2|81|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:57:01.733567|2017-02-18 15:57:01.733567
NCT00423085|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2014-01-14|2011-04-27||January 2007||2007-01-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease|A 24-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-finding Evaluation of the Efficacy, Safety, and Tolerability of the Once-daily Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease (MMSE 10-20)|Completed||Phase 3|859|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:57:02.735492|2017-02-18 15:57:02.735492
NCT00423072|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2016-11-02|||August 2006||2006-08-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|June 2020|Anticipated|2020-06-01||Observational|||Middle Ear Pressure Disregulation in Cleft Palate Patients|Middle Ear Pressure Disregulation in Cleft Palate Patients: Form-Function Correlates|Active, not recruiting||N/A|220|Anticipated|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 15:57:03.862368|2017-02-18 15:57:03.862368
NCT00423059|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2007-03-12|||December 2006||2006-12-01|January 2007|2007-01-01|March 2007||2007-03-01|||||Interventional|||Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy|Histologic Changes of Fibrovascular Membrane Associated With Proliferative Diabetic Retinopathy After Intravitreal Bevacizumab (Avastin®)|Completed||N/A|20||Yonsei University|||||f||||||||||||||2017-02-18 15:57:03.960301|2017-02-18 15:57:03.960301
NCT00423046|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-08-29|2009-11-12||January 2007||2007-01-01|August 2016|2016-08-01|May 2012|Actual|2012-05-01|March 2008|Actual|2008-03-01||Interventional|||Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age|Phase IIIb, Observer-blind Study to Compare Immunogenicity of GSK Biologicals' HPV-16/18 L1/AS04 Vaccine Versus Gardasil® [Quadrivalent Human Papillomavirus (HPV-6,11,16,18 L1 VLP) Recombinant Vaccine Merck & Co., Inc.]|Completed||Phase 3|1106|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:57:04.085779|2017-02-18 15:57:04.085779
NCT00423033|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-14|2008-12-25|||March 2007||2007-03-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients||Completed||N/A|50|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 15:57:06.253343|2017-02-18 15:57:06.253343
NCT00423020|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2007-01-16||||||January 2007|2007-01-01||||||||Interventional|||Anti-Restenosis After AMI by Erythropoietin|Erythropoietin Prevention Trial of Coronary Restenosis and Cardiac Remodeling After Acute Myocardial Infarction (EPOC-AMI)|Unknown status|Recruiting|Phase 4|72||Kyoto Prefectural University of Medicine|||||f||||||||||||||2017-02-18 15:57:06.317592|2017-02-18 15:57:06.317592
NCT00423007|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2013-03-13|||November 2006||2006-11-01|March 2013|2013-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis|Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With a History of Allergic Conjunctivitis|Completed||Phase 3|90||Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 15:57:06.413516|2017-02-18 15:57:06.413516
NCT00422994|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2016-10-24|||April 2006||2006-04-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole|An Open-Label, Parallel-Group, Repeat-Dose Study to Investigate the Effects of End Stage Renal Disease and Haemodialysis on the Pharmacokinetics of Ropinirole (Study RRL103628)|Completed||Phase 1|48|Actual|GlaxoSmithKline|||||||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:57:06.520088|2017-02-18 15:57:06.520088
NCT00422435|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2008-10-23|||January 2007||2007-01-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2007|Actual|2007-05-01||Interventional|||CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation|The PreCiSE Trial: CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation|Completed||Phase 3|107|Actual|Conor Medsystems||1|||f||||f||||||||||2017-02-18 15:57:14.954703|2017-02-18 15:57:14.954703
NCT00422981|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2012-10-18||2012-07-11|January 2007||2007-01-01|October 2012|2012-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment|A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Effect on Cognitive Function of AL-108 After 12 Weeks of Intranasal Administration in Subjects With Mild Cognitive Impairment|Completed||Phase 2|144|Actual|Allon Therapeutics||3|||f||||f||||||||||2017-02-18 15:57:06.633029|2017-02-18 15:57:06.633029
NCT00422968|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2014-04-29|||March 2005||2005-03-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|November 2009|Actual|2009-11-01||Interventional|PRECOMBAT||Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease|PREmier of Randomized COMparison of Bypass Surgery Versus AngioplasTy Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease|Completed||Phase 3|1454|Actual|CardioVascular Research Foundation, Korea||2|||f||||t||||||||||2017-02-18 15:57:06.755758|2017-02-18 15:57:06.755758
NCT00422955|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2016-09-13|||November 2003||2003-11-01|September 2016|2016-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.|A 16-week, Randomised, Double-blind, Placebo-controlled, Single-centre Study to Investigate Fluid Retention in Insulin-treated Subjects With Type 2 Diabetes Mellitus and Varying Degrees of Autonomic Neuropathy When Administered Rosiglitazone 4mg Twice Daily|Completed||Phase 3|36|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:57:06.944556|2017-02-18 15:57:06.944556
NCT00422942|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2014-07-14|2014-05-07||January 2006||2006-01-01|July 2014|2014-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA)|An Open-label, Exploratory Study of the Pharmacokinetic and Pharmacodynamic Activity of MabThera in Combination With Methotrexate in Synovial Tissue and in Peripheral Blood of Patients With Active Rheumatoid Arthritis.|Terminated||Phase 2|3|Actual|Hoffmann-La Roche|Study terminated after enrollment of 3 participants due to recruitment difficulties and since the objectives and data under study had been published from other, independent sources it was not appropriate to expose further participants to study drug.|1||Study was terminated after enrollment of 3 participants due to recruitment difficulties.|f||||||||||||||2017-02-18 15:57:07.228429|2017-02-18 15:57:07.228429
NCT00422929|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2017-01-10|||August 2006||2006-08-01|January 2017|2017-01-01|June 2020|Anticipated|2020-06-01|July 2018|Anticipated|2018-07-01||Observational|||Eustachian Tube Growth and Development|Eustachian Tube Growth and Development: Anatomy/Function|Active, not recruiting||N/A|150|Anticipated|University of Pittsburgh|||3||f||||f||||||Samples With DNA|"~     cells obtained from buccal brushing~   "|||2017-02-18 15:57:07.528058|2017-02-18 15:57:07.528058
NCT00422916|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-10-24|||January 2007||2007-01-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Treatment of Overweight Children and Adolescents|"Evaluation of the Intervention Program Obeldicks Light for Overweight Children and Adolescents"|Completed||N/A|66|Actual|University of Witten/Herdecke||2|||f||||||||||||||2017-02-18 15:57:07.639183|2017-02-18 15:57:07.639183
NCT00422903|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2016-04-07|2012-04-06||April 2007||2007-04-01|March 2016|2016-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer|Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-sensitive, HER-2 Negative Operable Breast Cancer. A Double Blind Randomized Phase II Study With Biomarker Evaluation.|Completed||Phase 2|92|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:57:07.753553|2017-02-18 15:57:07.753553
NCT00422890|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2011-07-08|||January 2007||2007-01-01|July 2011|2011-07-01||||December 2009|Actual|2009-12-01||Interventional|||Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)||Completed||Phase 3|10|Anticipated|Technische Universität Dresden||1|||f||||||||||||||2017-02-18 15:57:08.3086|2017-02-18 15:57:08.3086
NCT00422877|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2010-01-08|||January 2007||2007-01-01|January 2010|2010-01-01|December 2008||2008-12-01|||||Interventional|||Taxoprexin® Treatment for Advanced Primary Cancers of the Liver|Phase II Open-Label Study of Weekly Taxoprexin® (DHA-paclitaxel) Injection as Second Line Therapy for Patients With Advanced Primary Cancers of the Liver, Including Hepatocellular Carcinoma and Carcinoma of the Gallbladder or Biliary Tract|Completed||Phase 2|60|Anticipated|Luitpold Pharmaceuticals|||||f||||||||||||||2017-02-18 15:57:08.398711|2017-02-18 15:57:08.398711
NCT00422864|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2011-12-14|||October 2006||2006-10-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|June 2009|Actual|2009-06-01||Interventional|||A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer|A Single-Arm Prospective Trial Evaluating The Local And Systemic Benefits Of Oxaliplatin And 5FU With Concurrent Radiation In Patients With Metastatic Rectal Cancer|Completed||Phase 2|26|Actual|Peter MacCallum Cancer Centre, Australia||1|||f||||||||||||||2017-02-18 15:57:08.500941|2017-02-18 15:57:08.500941
NCT00422851|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2010-09-08|||June 2007||2007-06-01|September 2010|2010-09-01|February 2009|Actual|2009-02-01|||||Observational|||Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3c|Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3c|Completed||N/A|45||Children's Hospital of Pittsburgh|||3||f||||f||||||||||2017-02-18 15:57:08.602023|2017-02-18 15:57:08.602023
NCT00422838|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2017-01-26|||January 2007||2007-01-01|January 2017|2017-01-01|November 2010|Actual|2010-11-01|June 2010|Actual|2010-06-01||Observational|CIRES||Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.|Impact of Immune Responses in Chronic Hepatitis C Genotype 1,2,3 Virus Infected Patients During Treatment With Pegylated Interferon-alpha-2b and Ribavirin (CIRES).|Completed||N/A|20|Actual|Foundation for Liver Research|||2||f||||f||||||Samples With DNA|"~     PBMC Serum RNA Liver infiltrating lymphocytes~   "|||2017-02-18 15:57:08.688472|2017-02-18 15:57:08.688472
NCT00422825|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2016-04-04|||June 2006||2006-06-01|April 2016|2016-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib|A Phase I, Open-label, Randomized, Crossover Study to Investigate the Effect of Food on the Bioavailability of a Single 800 mg Imatinib Dose in a Modified Release Formulation (MR2) and Compare the Bioavailability Between MR2 and Imatinib 400 mg Twice Daily Immediate Release Tablet (IR) in Healthy Subjects|Completed||Phase 1|16|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:57:08.798966|2017-02-18 15:57:08.798966
NCT00422799|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2017-01-18|||September 2006||2006-09-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|September 2016|Actual|2016-09-01||Interventional|||Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia|Phase II Study of Combination Bortezomib (Velcade PS-341) and Rituximab in Patients With Previously Untreated and Relapsed/Refractory Waldenstrom's Macroglobulinemia|Active, not recruiting||Phase 2|45|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:57:09.004454|2017-02-18 15:57:09.004454
NCT00422786|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2008-07-10|||March 2007||2007-03-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma|A Multi-Centre, Open Label, Phase II Study of the Safety, Efficacy and Pharmacokinetic (PK) Profile of CAP-232 Administered Through Continuous Intravenous Infusion in Patients With Metastatic Kidney Cancer|Completed||Phase 2|10|Actual|Thallion Pharmaceuticals||1|||f||||t||||||||||2017-02-18 15:57:09.119366|2017-02-18 15:57:09.119366
NCT00422773|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2009-02-26|||January 2007||2007-01-01|February 2009|2009-02-01||||June 2008|Actual|2008-06-01||Interventional|||Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer|Open Labeled, Multicenter Phase I/II Study Evaluating the Dose Escalation/Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan as First-Line Treatment of Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|21|Anticipated|Technische Universität Dresden||1|||f||||||||||||||2017-02-18 15:57:09.235247|2017-02-18 15:57:09.235247
NCT00422760|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-13|2007-01-13|||January 2007||2007-01-01|January 2007|2007-01-01|February 2007||2007-02-01|||||Observational|||A 75 Year Old With Dyspnea a Case Report.Observational Study||Completed||N/A|1||Stanley Medical College|||||f||||||||||||||2017-02-18 15:57:09.352577|2017-02-18 15:57:09.352577
NCT00422747|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2013-06-17|||April 2007||2007-04-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|June 2011|Actual|2011-06-01||Interventional|||Early Diagnosis of Asthma in Young Children|Early Diagnosis of Asthma in Young Children|Completed||N/A|202|Actual|Maastricht University Medical Center||1|||f||||f||||||||||2017-02-18 15:57:09.426949|2017-02-18 15:57:09.426949
NCT00422734|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2009-06-08|2008-12-23||November 2006||2006-11-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life|Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life|Completed||Phase 3|342|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:57:09.548163|2017-02-18 15:57:09.548163
NCT00422721|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2011-11-23|||April 2007||2007-04-01|November 2011|2011-11-01||||||||Interventional|||Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy|Genetical, Multi-center, Prospective Study of Phenotyping and Genotyping of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy in the Aim of the Realisation of a Clinical Trial of Gene Therapy|Completed||N/A|360|Anticipated|Nantes University Hospital||1|||f||||f||||||||||2017-02-18 15:57:11.016429|2017-02-18 15:57:11.016429
NCT00422708|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2010-01-19|||June 2006||2006-06-01|January 2010|2010-01-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|||Local Anesthesia for Prostate Biopsy|Local Anesthesia for Prostate Biopsy: Effects on Pain Control, Quality of Life, and Surgical Intervention|Completed||Phase 4|243|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 15:57:11.1074|2017-02-18 15:57:11.1074
NCT00422695|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2008-06-25|||January 2007||2007-01-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008||2008-05-01||Observational|||Pain and Sensory Changes Assessment in HIV+ Patients|Pain and Sensory Changes Assessment in HIV+ Patients, A Model for Pain and Sensory Changes Related Compromised Immune System.|Completed||N/A|160|Anticipated|Rutgers, The State University of New Jersey|||||f||||||||||||||2017-02-18 15:57:11.20318|2017-02-18 15:57:11.20318
NCT00422682|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2016-06-09|||January 2007||2007-01-01|June 2016|2016-06-01|October 2012|Actual|2012-10-01|January 2009|Actual|2009-01-01||Interventional|||A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors|A Phase 1B, Open-Label, Dose Escalation Study Evaluating the Safety of BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors|Completed||Phase 1|136|Actual|Sanofi||4|||t||||||||||||||2017-02-18 15:57:11.458283|2017-02-18 15:57:11.458283
NCT00422669|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2013-01-24|2011-06-09||January 2007||2007-01-01|January 2013|2013-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Optimize RV Selective Site Pacing Clinical Trial|Optimize RV Selective Site Pacing Clinical Trial|Terminated||N/A|205|Actual|Medtronic Cardiac Rhythm and Heart Failure|Early study termination due to enrollment rates significantly below protocol expectations.|2||Study enrollment significantly below protocol expectations|f||||f||||||||||2017-02-18 15:57:11.573849|2017-02-18 15:57:11.573849
NCT00422656|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2013-10-16|2011-06-29||September 2006||2006-09-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|June 2009|Actual|2009-06-01||Interventional|||Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia|A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia|Completed||Phase 2|37|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 15:57:12.292735|2017-02-18 15:57:12.292735
NCT00422643|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2007-01-17|||March 2007||2007-03-01|January 2007|2007-01-01|October 2007||2007-10-01|||||Interventional|||The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator|The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator|Unknown status|Not yet recruiting|Phase 4|60||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:57:12.574893|2017-02-18 15:57:12.574893
NCT00422630|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2011-10-12|||October 2007||2007-10-01|October 2011|2011-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Metabolic Effects of Different Weight Loss Diets|Dietary Interventions for Insulin Resistance and the Metabolic Syndrome|Completed||N/A|18|Anticipated|Rockefeller University||3|||f||||t||||||||||2017-02-18 15:57:12.672494|2017-02-18 15:57:12.672494
NCT00422617|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2007-01-16|||January 2005||2005-01-01|September 2004|2004-09-01|November 2005||2005-11-01|||||Interventional|||Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients||Completed||N/A|40||Uni-Pharma|||||f||||||||||||||2017-02-18 15:57:12.785726|2017-02-18 15:57:12.785726
NCT00422240|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-09-10|||June 2006||2006-06-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris|A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel Compared With Adapalene Topical Gel, 0.1%; Benzoyl Peroxide Topical Gel, 2.5% and Topical Gel Vehicle in Subjects With Acne Vulgaris|Completed||Phase 3|1656|Anticipated|Galderma|||||f||||||||||||||2017-02-18 15:57:24.253701|2017-02-18 15:57:24.253701
NCT00422604|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2016-10-27|||October 2006||2006-10-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Multicentre, Randomised, Partially Blinded, Placebo-controlled, Three-way Crossover, Incomplete Block Design Study to Investigate the Safety, Tolerability, Pharmacodynamics/ Efficacy and Pharmacokinetics of Dual Bronchodilator Therapy With Salmeterol 50µg Twice-daily Plus Two Different Doses of GSK233705B (20 and 50µg Twice-daily), Compared With Placebo, Salmeterol 50µg Twice-daily Alone, and Tiotropium 18µg Once-daily Alone, in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|60|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:57:12.868248|2017-02-18 15:57:12.868248
NCT00422591|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2017-01-17|||December 2006||2006-12-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)|Prospective Evaluation of Standard Chemotherapy Regimen of Idarubicin and Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)|Completed||Phase 2|175|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 15:57:13.003522|2017-02-18 15:57:13.003522
NCT00422578|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2007-10-23|||October 2004||2004-10-01|October 2007|2007-10-01|September 2005|Actual|2005-09-01|||||Interventional|||Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction|Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction (ED) Patients Previously Treated With Other Oral ED Therapy|Completed||Phase 4|200||Eli Lilly and Company|||||f||||||||||||||2017-02-18 15:57:13.117252|2017-02-18 15:57:13.117252
NCT00422565|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2009-01-30|||October 2006||2006-10-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|ZEST-AMI||Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients|Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients|Terminated||Phase 4|328|Actual|CardioVascular Research Foundation, Korea||3||The recruitment rate was much slower than expected.|f||||t||||||||||2017-02-18 15:57:13.212013|2017-02-18 15:57:13.212013
NCT00422552|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2007-06-21|||September 2006||2006-09-01|June 2007|2007-06-01||||||||Interventional|||Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol|An Exploratory, Double-Blind Comparison of Inspiratory Capacity (IC) and FEV1 in COPD Patients Following Single Dose Administration of Indacaterol and Placebo and Open Label b.i.d. Administration of Formoterol|Completed||Phase 1/Phase 2|30||Novartis|||||f||||||||||||||2017-02-18 15:57:13.339904|2017-02-18 15:57:13.339904
NCT00422539|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2007-01-16|||March 2006||2006-03-01|January 2007|2007-01-01||||||||Interventional|||Efficacy of TCA Effect on Varicella Atrophic Scars|Evaluation of Tri Chloro Acetic Acid (TCA) Effect on Atrophic Varicella Scars|Unknown status|Recruiting|Phase 2|100||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 15:57:13.419134|2017-02-18 15:57:13.419134
NCT00422526|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2007-01-16|||September 2003||2003-09-01|January 2007|2007-01-01|November 2006||2006-11-01|||||Interventional|||Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial|Randomised Study to Examine the Effectiveness of Progesterone in Preventing Severe Preterm Delivery|Completed||Phase 3|250||King's College Hospital NHS Trust|||||f||||||||||||||2017-02-18 15:57:13.50284|2017-02-18 15:57:13.50284
NCT00422513|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2011-11-09|2011-03-29||March 2007||2007-03-01|November 2011|2011-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.|A Randomized, Open-label Study Comparing the Pharmacoeconomic (Time and Motion) Benefit of Mircera and Epoetin Alfa in Patients With Chronic Kidney Disease (Stage V) on Dialysis.|Terminated||Phase 3|260|Actual|Hoffmann-La Roche||2||Strategic decision unrelated to safety or efficacy|f||||||||||||||2017-02-18 15:57:13.612163|2017-02-18 15:57:13.612163
NCT00422500|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2012-08-01|||November 2003||2003-11-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer|Longitudinal Study of the Prevalence, Severity, and Interference of Multiple Symptoms in Advanced Lung Cancer|Completed||N/A|204|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Study participants enrolled at M. D. Anderson will have additional serum drawn for cytokine~     analysis and DNA repair capacity. This blood will be drawn at the routine blood draws before~     treatment begins, and at the beginning of each treatment cycle.~   "|||2017-02-18 15:57:14.287034|2017-02-18 15:57:14.287034
NCT00422487|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2015-04-29|||October 2006||2006-10-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes|Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of MBX-2044 to Evaluate the Multiple-dose Pharmacokinetics, Safety and Tolerability When Administered Orally in Patients With Type 2 Diabetes|Completed||Phase 2|60|Actual|CymaBay Therapeutics, Inc.||7|||f||||||||||||||2017-02-18 15:57:14.399361|2017-02-18 15:57:14.399361
NCT00422474|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-14|2008-07-08|||January 2007||2007-01-01|July 2008|2008-07-01||||||||Observational|||Prognostic Significance of the Baroreflex Sensitivity Changes After Acute Ischemic Stroke|Noninvasive Study of the Time Course of Baroreflex Sensitivity 6-Month After Acute Ischemic Stroke and the Relation of Its Changes With Post Stroke Prognosis|Unknown status|Recruiting|N/A|100|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 15:57:14.506137|2017-02-18 15:57:14.506137
NCT00422461|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2009-10-07||2009-04-06|February 2007||2007-02-01|October 2009|2009-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure|A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study Of PF-00489791 In Subjects With Stage 1 And 2 Essential Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)|Completed||Phase 2|140|Anticipated|Pfizer||4|||f||||f||||||||||2017-02-18 15:57:14.579418|2017-02-18 15:57:14.579418
NCT00422448|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2010-12-14|2010-04-25||September 2006||2006-09-01|December 2010|2010-12-01|April 2010|Actual|2010-04-01|March 2009|Actual|2009-03-01||Interventional|||Study to Test Genetic Alterations Among Different Dermoscopic Types of Melanocytic Nevi.|BRAF and Nevi.Nevi Are Common Benign Pigmented Tumors of the Skin. Mutations in So-called BRAF and NRAS Genes Genes Appear to be Initiating Events Responsible for the Formation of Nevi.|Completed||N/A|43|Actual|Medical University of Graz|During first year of enrollment too few patients agreed to participate. Therefore a sample of 21 nevi were additionally retrospectively included.|1|||f||||t||||||||||2017-02-18 15:57:14.715184|2017-02-18 15:57:14.715184
NCT00422422|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2016-11-08|2016-03-14||July 2011||2011-07-01|November 2016|2016-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Baseline Characteristics consists of the Enrolled Subjects analysis set, which is comprised of all subjects enrolled into the study.|Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.|Open-Label, Single-Arm, Multicenter, Pharmacokinetic, Safety, and Efficacy Study of Adjunctive Administration of Brivaracetam in Subjects From ≥1 Month to <16 Years Old With Epilepsy|Completed||Phase 2|100|Actual|UCB Pharma||1|||f||||t||||||||||2017-02-18 15:57:15.067526|2017-02-18 15:57:15.067526
NCT00422409|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-16|2011-07-03|||October 2006||2006-10-01|April 2007|2007-04-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||Endoscopic Stenting of Gastrointestinal Cancer|Palliative Endoscopic Treatment of Malignant GI-strictures With Self Expanding Metal Stents(SEMS)-a Prospective Multicenter Study|Completed||N/A|270|Actual|Oslo University Hospital|||||f||||||||||||||2017-02-18 15:57:18.097974|2017-02-18 15:57:18.097974
NCT00422396|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2017-02-09|||January 2001|Actual|2001-01-01|February 2017|2017-02-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis|Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis|Completed||N/A|60||University of Michigan|||||f||||||||||||||2017-02-18 15:57:18.194481|2017-02-18 15:57:18.194481
NCT00422383|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-15|2015-04-16|2014-12-09||February 2006||2006-02-01|April 2015|2015-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||The intent-to-treat-modified 2 (ITT-M2) population included all randomized participants who received at least 1 infusion of study treatment. Due to a UK protocol amendment error, 6 participants incorrectly received placebo. Due to medication list error, 25 participants received an incorrect dose of treatment. Participants were analyzed as treated.|A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)|A Randomized, Double-blind Study to Evaluate the Effect of Various Re-treatment Regimens of MabThera in Combination With Methotrexate on Treatment Response in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.|Completed||Phase 3|378|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 15:57:18.334807|2017-02-18 15:57:18.334807
NCT00422370|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2007-01-16|||January 2007||2007-01-01|December 2006|2006-12-01||||||||Interventional|||Lipid Based Food Additives for Treating Patients With Dry Mouth|Lipid Based Food Additives for Treating Patients With Dry Mouth|Unknown status|Not yet recruiting|N/A|20|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:57:21.783246|2017-02-18 15:57:21.783246
NCT00422357|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2007-04-17|||January 2007||2007-01-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Effect of Urtica Dioica on Glycemic Control in Patients With Type 2 Diabetes Mellitus|Effect of Urtica Dioica on Glycemic Control in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|56||Shahid Beheshti University of Medical Sciences|||||f||||t||||||||||2017-02-18 15:57:21.854841|2017-02-18 15:57:21.854841
NCT00422344|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2010-02-25|||October 2006||2006-10-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma|A Phase I Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma Patients|Completed||Phase 1|20|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:57:22.178215|2017-02-18 15:57:22.178215
NCT00422331|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-08-13|||January 2007||2007-01-01|August 2007|2007-08-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Safety and Efficacy Study of Lithium in Bipolar Disorder|Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Lithium in Bipolar I Disorder|Unknown status|Active, not recruiting|Phase 3|206|Anticipated|JDS Pharmaceuticals|||||f||||||||||||||2017-02-18 15:57:22.283326|2017-02-18 15:57:22.283326
NCT00422318|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2007-01-12|||January 2004||2004-01-01|January 2007|2007-01-01|December 2005||2005-12-01|||||Interventional|||Treatment of Hyperuricemia in Patients With Heart Failure|Hyperuricemia and the Effects of the Uricosuric Agents Benzbromarone in Patients With Chronic Heart Failure|Completed||Phase 4|||Tottori University Hospital|||||f||||||||||||||2017-02-18 15:57:22.365071|2017-02-18 15:57:22.365071
NCT00422305|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2016-10-11|||January 2007||2007-01-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Assessment of Lung Structure and Function of Infants Born Prematurely|Assessment of Lung Structure and Function of Infants Born Prematurely|Recruiting||N/A|129|Anticipated|Indiana University|||3||f||||t||||||||||2017-02-18 15:57:22.460198|2017-02-18 15:57:22.460198
NCT00422292|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2016-04-12|2011-05-10||December 2006||2006-12-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers|An Immunogenicity, Safety, and Non-Interference Evaluation of Pediatric Vaccines Administered Concomitantly With Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) to Healthy Toddlers|Completed||Phase 3|1664|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 15:57:22.570488|2017-02-18 15:57:22.570488
NCT00422279|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2016-03-22|2012-01-17||November 2006||2006-11-01|March 2016|2016-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study of Dental Implants Coated With Bone Morphogenetic Protein|Evaluation of Implant Stability and Local Bone Formation at Endosseous Dental Implants With a Titanium Porous Oxide Surface Adsorbed With rhBMP-2|Completed||N/A|4|Actual|Nobel Biocare||2|||f||||t||||||||No||2017-02-18 15:57:23.704438|2017-02-18 15:57:23.704438
NCT00422266|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2007-09-24|||December 2006||2006-12-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults|Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Drink/Food on the Composite Risk Profile of Dyslipidemic Adults|Completed||Phase 3|178|Actual|Centre for Chronic Disease Control, India||4|||f||||t||||||||||2017-02-18 15:57:24.071023|2017-02-18 15:57:24.071023
NCT00422253|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2013-12-12|||November 2006||2006-11-01|January 2007|2007-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans|Will Reduction in Dietary Advanced Glycation End- Products Reduce Chronic Low Grade Inflammation and Improve Insulin Sensitivity in Overweight and Obese Humans|Completed||N/A|27|Actual|Bayside Health|||||f||||f||||||||||2017-02-18 15:57:24.15507|2017-02-18 15:57:24.15507
NCT00421850|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2011-05-20|||July 2001||2001-07-01|May 2011|2011-05-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Using Networks, Informatics, Technology, and Education in Care for People With Diabetes|UNITED Planned Care for People With Diabetes|Completed||N/A|3491||Mayo Clinic|||||f||||||||||||||2017-02-18 15:57:38.719819|2017-02-18 15:57:38.719819
NCT00422227|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2010-07-28|2010-03-31||June 2007||2007-06-01|July 2010|2010-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region|A Randomized, Open-Label Study in the Asia-Pacific Region Comparing the Safety and Efficacy of Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis|Completed||Phase 4|300|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 15:57:24.452832|2017-02-18 15:57:24.452832
NCT00422214|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2009-03-24|||December 2006||2006-12-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|||||Interventional|||Phase III/Seroquel SR Bipolar Depression Monotherapy - US|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel SR®) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Depression|Completed||Phase 3|400||AstraZeneca|||||f||||||||||||||2017-02-18 15:57:25.276861|2017-02-18 15:57:25.276861
NCT00422201|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2013-10-14|2013-08-08||December 2006||2006-12-01|August 2013|2013-08-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion|Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion|Terminated||Phase 2|18|Actual|HRA Pharma|As a consequence of the premature study end, analyses performed were primarily descriptive due to the reduced number of enrolled and completed patients.|1|||f||||||||||||||2017-02-18 15:57:25.43016|2017-02-18 15:57:25.43016
NCT00422188|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2015-12-08|||January 2007||2007-01-01|December 2015|2015-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Deoxycholic Acid Injection for the Treatment of Superficial Lipomas|Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Sequential Dose-Escalation Study of the Pharmacokinetics, Safety, and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Intralipomal Injections for the Treatment of Superficial Lipomas|Completed||Phase 1|16|Actual|Kythera Biopharmaceuticals||5|||f||||f||||||||||2017-02-18 15:57:25.80561|2017-02-18 15:57:25.80561
NCT00422175|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-11-28|||October 2006||2006-10-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Single Dose Study to Assess the Safety, Tolerability, Concentration in Body and Effect of BAF312|A First-in-Human Study for BAF312: A Two Parts, Single Center, Randomized, Double-Blind, Placebo-Controlled Ascending Single Dose Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral BAF312 in Healthy Volunteers|Completed||Phase 1|63||Novartis|||||f||||||||||||||2017-02-18 15:57:25.936672|2017-02-18 15:57:25.936672
NCT00422162|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2011-07-22|2009-08-25||February 2007||2007-02-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression|An Eight-Week, Randomized, Double Blind, Two Parallel Groups, Study to Assess Clinical Response of Duloxetine 60 mg and 120 Per Day in Patients Hospitalized for Severe Depression|Completed||Phase 4|339|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 15:57:26.037446|2017-02-18 15:57:26.037446
NCT00422149|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2012-02-06|||September 2006||2006-09-01|February 2012|2012-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Twin SUBLIVAC® Grasses Clinical Efficacy Study|Twin SUBLIVAC® Grasses Clinical Efficacy Study|Completed||Phase 3|350|Actual|HAL Allergy||2|||f||||t||||||||||2017-02-18 15:57:27.413161|2017-02-18 15:57:27.413161
NCT00422136|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2011-11-11|||July 2002||2002-07-01|November 2011|2011-11-01|July 2009|Actual|2009-07-01|July 2007|Actual|2007-07-01||Observational|||Genetics of Middle Ear Disease|Genetic Epidemiology of Otitis Media|Completed||N/A|2121|Actual|Children's Hospital of Pittsburgh|||1||f||||f||||||Samples With DNA|"~     Blood samples, DNA~   "|||2017-02-18 15:57:27.667944|2017-02-18 15:57:27.667944
NCT00422123|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2009-03-24|||January 2007||2007-01-01|March 2009|2009-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Phase 3 /Seroquel SR Acute Mania Monotherapy - US|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Mania|Completed||Phase 3|447|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:57:27.756523|2017-02-18 15:57:27.756523
NCT00422110|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2012-05-25|||May 2008||2008-05-01|May 2012|2012-05-01||||||||Interventional|||A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures|A Phase IIb/III, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Seletracetam as Adjunctive Treatment in Subjects (≥16 to 70 Years Old) With Refractory Partial Onset Seizures.|Withdrawn||Phase 2/Phase 3|0|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 15:57:28.06336|2017-02-18 15:57:28.06336
NCT00422097|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2016-02-09|2011-01-27||January 2007||2007-01-01|February 2016|2016-02-01|April 2011|Actual|2011-04-01|August 2009|Actual|2009-08-01||Interventional|||A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer|A Phase I Study of Ixabepilone Administered as a Daily Oral Dose on 5 Successive Days Every 21 Days in Subjects With Advanced Cancer|Completed||Phase 1|40|Actual|R-Pharm||8|||f||||||||||||||2017-02-18 15:57:28.152125|2017-02-18 15:57:28.152125
NCT00422084|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2008-05-19|||January 2007||2007-01-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients|A Phase III Comparative, (Double-Blind, Double-Dummy), Randomised, Multi-Centre, Clinical Study to Assess the Safety and Efficacy of Fixed Dose Formulation of Oral Pyronaridine Artesunate Tablet (180:60 mg) Versus Coartem® (Artemether Lumefantrine) in Children and Adult Patients With Acute Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 3|1269|Anticipated|Medicines for Malaria Venture||2|||f||||||||||||||2017-02-18 15:57:30.31273|2017-02-18 15:57:30.31273
NCT00422071|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2017-01-24|||January 8, 2007||2007-01-08|March 6, 2014|2014-03-06|March 6, 2014||2014-03-06|||||Observational|||Detecting a Reward Signal in the Motor Cortex|Detecting a Reward Signal in the Motor Cortex|Completed||N/A|168|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:57:30.44508|2017-02-18 15:57:30.44508
NCT00422058|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2015-04-22|2010-04-27||January 2007||2007-01-01|April 2015|2015-04-01|April 2009|Actual|2009-04-01|September 2007|Actual|2007-09-01||Interventional|||The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes|Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes: A 20-week Randomised, Double-blind, Placebo-controlled, Six Armed Parallel Group, Multi-centre, Multinational Trial With an Open Label Orlistat Comparator Arm and With an 84-week Extension Period|Completed||Phase 2|564|Actual|Novo Nordisk A/S||6|||f||||f||||||||||2017-02-18 15:57:30.537708|2017-02-18 15:57:30.537708
NCT00422045|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2014-12-09|||December 2006||2006-12-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Assessment of Low Level Laser Therapy for Late Postoperative Pain After Lumbar Fusion Surgery|Assessment of Low Level Laser Therapy for Late Postoperative Pain After Lumbar Fusion Surgery|Withdrawn||N/A|0|Actual|University of Toledo Health Science Campus||2|||f||||f||||||||||2017-02-18 15:57:33.293932|2017-02-18 15:57:33.293932
NCT00422032|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2012-06-22|2012-06-22||January 2006||2006-01-01|June 2012|2012-06-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||2 Arm Study of Clofarabine IV in MDS Patients|Phase II Randomized Study of Two Different Schedules of Intravenous Clofarabine in Myelodysplastic Syndrome (MDS)|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 15:57:33.402447|2017-02-18 15:57:33.402447
NCT00422019|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2015-03-23||2015-03-23|January 2007||2007-01-01|March 2015|2015-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma|A Global, Multicenter, Open-label, Single Agent, Two-stage Phase 2 Study to Evaluate the Efficacy and Safety of AMG 102 in Subjects With Advanced Renal Cell Carcinoma|Completed||Phase 2|61|Actual|Amgen||2|||f||||||||||||||2017-02-18 15:57:33.772861|2017-02-18 15:57:33.772861
NCT00422006|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2014-04-02|||February 2008||2008-02-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance|Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance|Completed||N/A|111|Actual|Nantes University Hospital||4|||f||||t||||||||||2017-02-18 15:57:33.878964|2017-02-18 15:57:33.878964
NCT00421993|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2009-10-19|2009-01-15||October 2006||2006-10-01|October 2009|2009-10-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris|A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel Compared With Adapalene Topical Gel, 0.1%; Benzoyl Peroxide Topical Gel, 2.5% and Topical Gel Vehicle in Subjects With Acne Vulgaris|Completed||Phase 3|1670|Actual|Galderma||4|||f||||||||||||||2017-02-18 15:57:33.993536|2017-02-18 15:57:33.993536
NCT00421980|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2007-01-12|||June 2002||2002-06-01|January 2007|2007-01-01|July 2004||2004-07-01|||||Interventional|||An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis|An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis|Completed||Phase 3|84||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:57:34.872582|2017-02-18 15:57:34.872582
NCT00421967|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2008-05-06|||January 2007||2007-01-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Postoperative Analgesia After Total Knee Arthroplasty|Postoperative Analgesia After Total Knee Arthroplasty. A Comparison of Continuous Epidural Infusion and Wound Infiltration With Continuous Intraarticular Infusion|Terminated||Phase 4|80|Actual|University of Aarhus||2||Interim analysis|f||||t||||||||||2017-02-18 15:57:34.958115|2017-02-18 15:57:34.958115
NCT00421954|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2017-01-12|2017-01-12||May 2006||2006-05-01|January 2017|2017-01-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional||P.I. has left the institution and NYSPI has no access to the data. Results will not be analyzed or presented.|Open-label Ziprasidone Study for Psychosis Treatment in Adolescents|Open-label Feasibility Study for the Treatment of Psychotic Adolescents With Ziprasidone in the Inpatient and Day Hospital Settings|Completed||Phase 3|8|Actual|New York State Psychiatric Institute||1|||f||||||||||||||2017-02-18 15:57:35.064419|2017-02-18 15:57:35.064419
NCT00421941|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2013-10-31|||January 2007||2007-01-01|October 2013|2013-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Enteral Feeding Study of Formula Containing Fish Oil in Critical Care Setting|Use of a High-protein Enteral Formula Containing Prebiotics and Fish Oil in Critical Care|Terminated||N/A|50|Anticipated|Nestlé||||Unable to meet enrollment goal|f||||||||||||||2017-02-18 15:57:35.232926|2017-02-18 15:57:35.232926
NCT00421928|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2012-04-16|2009-07-08||January 2007||2007-01-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Tapentadol (CG5503)|A Randomized Double-Blind, Placebo- and Active-Control, Parallel-arm, Phase III Trial With Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Extended-Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee|Completed||Phase 3|1030|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 15:57:35.32794|2017-02-18 15:57:35.32794
NCT00421915|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2007-01-12|||March 2002||2002-03-01|January 2007|2007-01-01|August 2002||2002-08-01|||||Interventional|||Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis|Multicenter, Double-Blind, Parallel, Placebo-Controlled, Randomised Phase 3 Study of Etanercept in the Treatment of Patients With Ankylosing Spondylitis: 12-Week Final Data|Completed||Phase 3|84||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:57:36.136607|2017-02-18 15:57:36.136607
NCT00421902|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2007-01-12|||January 2006||2006-01-01|November 2006|2006-11-01|July 2010||2010-07-01|||||Interventional|||Acupuncture Treatment for Hot Flashes Study|Acupuncture Treatment for Hot Flashes in Men With Prostate Cancer, A Phase I/II Study|Unknown status|Recruiting|Phase 1/Phase 2|50||New York Methodist Hospital|||||f||||||||||||||2017-02-18 15:57:36.204468|2017-02-18 15:57:36.204468
NCT00421889|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2015-07-07|2014-07-01||August 2005||2005-08-01|July 2015|2015-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment|A Phase I/II Safety, Pharmacodynamic, and Pharmacokinetic Study of Intravenously Administered PXD101 Plus Carboplatin or Paclitaxel or Both in Patients With Advanced Solid Tumours|Completed||Phase 1/Phase 2|80|Actual|Onxeo||1|||f||||f||||||||||2017-02-18 15:57:36.30522|2017-02-18 15:57:36.30522
NCT00421876|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2007-01-12|||December 2000||2000-12-01|January 2007|2007-01-01|December 2005||2005-12-01|||||Interventional|||GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study|GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study|Completed||N/A|3200||Heart Care Foundation|||||f||||||||||||||2017-02-18 15:57:38.352636|2017-02-18 15:57:38.352636
NCT00421863|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-12|2013-08-14|||February 2005||2005-02-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study|Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study|Completed||Phase 4|1111|Actual|Heart Care Foundation||2|||f||||f||||||||||2017-02-18 15:57:38.5372|2017-02-18 15:57:38.5372
NCT00421837|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2013-08-15|||May 2007||2007-05-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Pilot Study of Genotypic Analysis|Pilot Study of the Genotypic Analysis of Patients Infected With Influenza Virus Compared With Uninfected Spouse/Close Contact Controls|Completed||N/A|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     Sera and saliva~   "|||2017-02-18 15:57:38.81331|2017-02-18 15:57:38.81331
NCT00421824|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2011-01-03|||May 2006||2006-05-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer|Phase II Randomized Trial of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer|Completed||Phase 2|108|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:57:38.905749|2017-02-18 15:57:38.905749
NCT00421811|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2010-12-27|||April 2007||2007-04-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan|An Open-Label, Multicenter, Phase 1/2 Dose Escalation Study to Evaluate Safety, Tolerability and Anti-tumor Activity of Systemic ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan in Subjects With Locally Advanced In-Transit Malignant Melanoma (Adherex Protocol Number AHX-01-007).|Completed||Phase 1/Phase 2|56|Anticipated|Adherex Technologies, Inc.||1|||f||||||||||||||2017-02-18 15:57:39.009867|2017-02-18 15:57:39.009867
NCT00421798|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2009-07-08|||January 2007||2007-01-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Observational|||Rapid Characterization of Paucibacillary TB Along Tex/Mex Border|Rapid Characterization of Mycobacteria and Drug Resistance In Paucibacillary TB|Completed||N/A|780|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples With DNA|"~     Blood from participants will be collected, and DNA extracted from white blood cells. These~     are expected to also contain DNA from M. tuberculosis- that will be the research question~   "|||2017-02-18 15:57:39.110203|2017-02-18 15:57:39.110203
NCT00421785|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-07-06|||February 2007||2007-02-01|July 2007|2007-07-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients|Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients.|Unknown status|Recruiting|N/A|20|Anticipated|Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:57:39.20306|2017-02-18 15:57:39.20306
NCT00421772|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-01-11|||January 2007||2007-01-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Observational|||Prospective Follow-up of a Multicentric Cohort of Children With Prenatal Discovery of Mild Isolated Cerebral Ventriculomegaly. Evaluation at 2 and 5 Years.|Prospective Follow-up of a Multicentric Cohort of Children With Prenatal Discovery of Mild Isolated Cerebral Ventriculomegaly. Evaluation at 2 and 5 Years.|Unknown status|Recruiting|N/A|245||University Hospital, Angers|||||f||||||||||||||2017-02-18 15:57:39.331311|2017-02-18 15:57:39.331311
NCT00421759|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2009-12-10|||April 2006||2006-04-01|August 2008|2008-08-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Noise-Enhanced Sensory Function in Elders at Risk for Falls|Noise-Enhanced Sensory Function in Elders at Risk for Falls|Unknown status|Recruiting|N/A|170|Anticipated|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 15:57:39.527899|2017-02-18 15:57:39.527899
NCT00421746|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-08-02|||January 2006||2006-01-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart Failure|A Proof of Biological Efficacy Study Assessing the Potential of Piboserod, a Specific 5-HT4 Antagonist, for the Treatment of Symptomatic Congestive Heart Failure on Top of Usual Evidence Based Pharmacological Treatment|Completed||Phase 2|137|Actual|Bio-Medisinsk Innovasjon||2|||f||||t||||||||||2017-02-18 15:57:39.634948|2017-02-18 15:57:39.634948
NCT00421733|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2012-01-18|2010-06-09||December 2006||2006-12-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|VITAL||The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors|VITAL Study - Selective VITamin D Receptor Activator (Paricalcitol) for Albuminuria Lowering Study: A Phase 2, Prospective, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules on Reducing Albuminuria in Type 2 Diabetic Nephropathy Subjects Who Are Currently Being Treated With Renin-angiotensin System Inhibitors|Completed||Phase 2|281|Actual|Abbott||3|||f||||f||||||||||2017-02-18 15:57:39.774751|2017-02-18 15:57:39.774751
NCT00421720|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-07-24|||January 2007||2007-01-01|July 2007|2007-07-01||||||||Interventional|||A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.|A Randomized, Open-Label, Multicenter, Parallel-Group Study to Compare the Efficacy, Safety and Resource Utilization of a Remifentanil/Propofol Analgesia/Sedation Regimen Versus a Sufentanil/Propofol Analgesia/Sedation Regimen in Mechanically Ventilated Intensive Care Patients Requiring Analgesia and Sedation for up to 7 Days|Terminated||Phase 4|164||GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:57:41.086234|2017-02-18 15:57:41.086234
NCT00421707|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2015-09-17||2009-07-22|November 2006||2006-11-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome|A Randomised, Double-blind, Placebo-controlled, Crossover Study to Evaluate Efficacy and Safety of the CRF1 Receptor Antagonist GW876008 in Patients With Irritable Bowel Syndrome|Completed||Phase 2|133|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 15:57:41.182396|2017-02-18 15:57:41.182396
NCT00421694|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-10-05||||||October 2007|2007-10-01||||||||Interventional|||Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide||Completed||Phase 2/Phase 3|119||University of L'Aquila|||||f||||||||||||||2017-02-18 15:57:41.325051|2017-02-18 15:57:41.325051
NCT00421681|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2009-12-10|||October 2003||2003-10-01|January 2008|2008-01-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Exercise Adherence Among Older Adults With Osteoarthritis|Exercise Adherence Among Older Adults With Osteoarthritis|Unknown status|Active, not recruiting|N/A|600|Anticipated|National Institute on Aging (NIA)||2|||f||||f||||||||||2017-02-18 15:57:41.415725|2017-02-18 15:57:41.415725
NCT00421668|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2012-01-04|||September 2000||2000-09-01|January 2012|2012-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||A Trial of Zinc and Micronutrients in Tanzanian Children|A Trial of Zinc and Micronutrients in Tanzanian Children|Completed||Phase 3|2400|Anticipated|Harvard School of Public Health||4|||f||||t||||||||||2017-02-18 15:57:41.527206|2017-02-18 15:57:41.527206
NCT00421655|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2015-06-23|||December 2006||2006-12-01|June 2015|2015-06-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||A Trial of Grazax in Subjects With Hayfever|A Phase III Trial Assessing the Efficacy and Safety of Grazax in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma|Completed||Phase 3|329|Actual|ALK-Abelló A/S||2|||f||||t||||||||||2017-02-18 15:57:41.659828|2017-02-18 15:57:41.659828
NCT00421642|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2012-07-31|||October 2006||2006-10-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Open-Label Adalimumab for Ulcerative Colitis Patients|An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Ulcerative Colitis Patients|Completed||Phase 1|20|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 15:57:41.755293|2017-02-18 15:57:41.755293
NCT00421629|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-01-11|||October 2003||2003-10-01|January 2007|2007-01-01|April 2006||2006-04-01|||||Interventional|||Experimental Study to Assess Interventions Aimed at Improving the Equity Impact of Community-Based Health Insurance|Experimental Study to Assess Interventions Aimed at Improving the Equity Impact of Community-Based Health Insurance|Completed||N/A|688||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 15:57:41.882481|2017-02-18 15:57:41.882481
NCT00421616|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-02-16|||February 2007||2007-02-01|February 2007|2007-02-01||||||||Interventional|||Effectiveness of High Protein Diets in Promoting Weight Loss in Overweight and Obese Subjects.|A Diet Higher in Animal-Based Protein is More Effective in Promoting Weight Loss in Overweight and Obese Individuals Than Other Protein Based Diets.|Unknown status|Not yet recruiting|N/A|45||University of Wollongong|||||f||||||||||||||2017-02-18 15:57:41.994848|2017-02-18 15:57:41.994848
NCT00421603|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2016-04-06|2012-12-13||February 2007||2007-02-01|March 2016|2016-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|TACT||A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence|A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence|Completed||Phase 2|81|Actual|New York State Psychiatric Institute|The two-arm placebo controlled design does not allow us to address whether both medications are necessary for efficacy. Potential limited treatment masking that occurred when giving two medications with distinctive adverse effect profiles.|2|||f||||t||||||||||2017-02-18 15:57:42.103147|2017-02-18 15:57:42.103147
NCT00421590|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-06-21|||October 2006||2006-10-01|June 2007|2007-06-01||||||||Interventional|||Drug Interaction of SMC021 With Concomitant Antacid (Calcium Carbonate/Magnesium Hydroxide).|A Randomized, Partially Blind, Placebo Controlled, Crossover, Single Oral Dose Study to Assess the Effect of Concomitant Antacid (Calcium Carbonate / Magnesium Hydroxide) on the Pharmacokinetics and Pharmacodynamics of SMC021 (0.8 mg Salmon Calcitonin/200 mg 5-CNAC) in Healthy Postmenopausal Women|Completed||Phase 2|38||Novartis|||||f||||||||||||||2017-02-18 15:57:42.491597|2017-02-18 15:57:42.491597
NCT00421577|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-01-11||||||January 2007|2007-01-01||||||||Observational|||Technique for Localization of Caries Associated Bacteria on Tooth Surfaces.|Usage of Laboratory Technique for Localization of Caries Associated Bacteria on Tooth Surfaces as Clinical Measurement to Caries Diagnosis and Treatment Efficiency.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:57:42.573442|2017-02-18 15:57:42.573442
NCT00421564|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-01-11|||February 2003||2003-02-01|January 2007|2007-01-01|December 2004||2004-12-01|||||Interventional|||Study the Effect of Danggui Buxue Tang on Menopausal Symptoms|A Randomized, Double-Blind, Placebo Controlled Study of the Effect of Danggui Buxue Tang on Menopausal Symptoms and Quality of Life in Hong Kong Chinese Women|Completed||Phase 2|100||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 15:57:42.639191|2017-02-18 15:57:42.639191
NCT00421551|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2013-07-17|||March 2007||2007-03-01|July 2013|2013-07-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136|A Randomized Multicenter Study With Non-inferiority Hypothesis, Comparing the Availability to Maintain a Complete Viral Suppression by a Monotherapy of Darunavir/r to a NRTI Containing Regimen Including Darunavir/r, in HIV-1 Infected Patients With Previous Prolonged Complete Viral Suppression. ANRS 136 MONOI|Completed||Phase 3|225|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 15:57:42.717875|2017-02-18 15:57:42.717875
NCT00421538|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2015-05-27|||January 2008||2008-01-01|May 2015|2015-05-01|September 2015|Anticipated|2015-09-01|May 2015|Anticipated|2015-05-01||Interventional|CACTUS-PTS||Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)|Contention Alone Versus Anticoagulation for Symptomatic Calf Vein Thrombosis Diagnosed by Ultrasonography|Recruiting||Phase 3|600|Anticipated|University Hospital, Geneva||2|||f||||t||||||||||2017-02-18 15:57:42.830843|2017-02-18 15:57:42.830843
NCT00421525|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2012-10-03|||January 2007||2007-01-01|October 2012|2012-10-01||||August 2009|Actual|2009-08-01||Interventional|||Phase I/II Study of hLL1 in Multiple Myeloma|A Phase I/II Study of Immunotherapy With hLL1 Administered Twice Weekly for 4 Consecutive Weeks in Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|25|Actual|Immunomedics, Inc.||1|||f||||f||||||||||2017-02-18 15:57:42.963372|2017-02-18 15:57:42.963372
NCT00421512|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2008-11-10|||March 2006||2006-03-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients|A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients|Completed||Phase 1|28|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:57:43.186836|2017-02-18 15:57:43.186836
NCT00421499|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-01-11|||January 2005||2005-01-01|January 2007|2007-01-01|May 2005||2005-05-01|||||Interventional|||Effects of Cocoa Intake on Blood Pressure in Elderly Individuals With Mild Hypertension|Randomized Controlled, Parallel Group, Single Blinded, Phase 1 Study That Investigates the Effects of Regular Daily Intake of Small Amounts of Dark or White Chocolate on Blood Pressure in Elderly Individuals With Mild Hypertension|Completed||Phase 1|44||University of Cologne|||||f||||||||||||||2017-02-18 15:57:43.285731|2017-02-18 15:57:43.285731
NCT00421291|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2007-01-09|||April 2004||2004-04-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||Effect of Information on Service Delivery in Rural India||Completed||N/A|||Johns Hopkins University|||||f||||||||||||||2017-02-18 15:57:48.071846|2017-02-18 15:57:48.071846
NCT00421486|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2016-01-20|||March 2006||2006-03-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|||Oral Human Papillomavirus Infection in HIV-infected Men|Incidence, Prevalence, Spectrum of HPV-types, and Viral Load Determination of High-risk Human Papillomavirus Infection of the Oral Cavity in HIV-infected Men Who Have Sex With Men|Recruiting||N/A|500|Anticipated|Deutsche Luft und Raumfahrt|||1||f||||||||||||||2017-02-18 15:57:43.362244|2017-02-18 15:57:43.362244
NCT00421473|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2009-02-24|||March 2007||2007-03-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients|Drug Interactions Between ATOvaquone Used in MAlaria Prophylaxis and Antiretroviral Agents in HIV-1 Infected Patients (ATOMA)|Completed||Phase 4|79|Actual|Radboud University|||||f||||||||||||||2017-02-18 15:57:43.473928|2017-02-18 15:57:43.473928
NCT00421460|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2012-05-14|||January 2007||2007-01-01|May 2012|2012-05-01|May 2011|Actual|2011-05-01|January 2011|Actual|2011-01-01||Interventional|||The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction|Phase IV Study of The Therapy of Long-acting Testosterone Undecanoate,1000mg in 4 ml Oily Solution for i.m.Injection(Nebido) as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction|Completed||Phase 4|30|Actual|Chulalongkorn University||1|||f||||f||||||||||2017-02-18 15:57:43.563449|2017-02-18 15:57:43.563449
NCT00421447|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2015-09-22|||January 2007||2007-01-01|September 2015|2015-09-01|August 2009|Actual|2009-08-01|April 2009|Actual|2009-04-01||Observational|||Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole|Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole|Completed||N/A|58|Actual|McMaster University|||2||f||||t||||||||||2017-02-18 15:57:43.670435|2017-02-18 15:57:43.670435
NCT00421434|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2008-09-23|||June 2006||2006-06-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|STEALTHC-1||Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C|Randomized Study of Nitazoxanide-Peginterferon, Nitazoxanide-Peginterferon-Ribavirin and Peginterferon-Ribavirin in the Treatment of Chronic Hepatitis C|Completed||Phase 2/Phase 3|121|Actual|Romark Laboratories L.C.||3|||f||||f||||||||||2017-02-18 15:57:43.782965|2017-02-18 15:57:43.782965
NCT00421421|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2007-11-26|||March 2007||2007-03-01|November 2007|2007-11-01||||||||Interventional|||Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter|A Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase IV Study to Evaluate the Efficacy and Safety of Dutasteride 0.5mg Administered Orally Daily for 24 Weeks to Reduce The Risk of Acute Urinary Retention Relapse Following Successful Trial Without Catheter.|Terminated||Phase 4|276||GlaxoSmithKline||||Incomplete information|f||||||||||||||2017-02-18 15:57:43.896471|2017-02-18 15:57:43.896471
NCT00421408|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2013-08-26|2013-04-30||February 2007||2007-02-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional||Healthy older men and women with no known disorders that affect mineral metabolism and not taking drugs that alter skeletal metabolism.|The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women|Impact of a Protein Supplement on Bone Mass in Older Men and Women|Completed||Phase 1/Phase 2|208|Actual|Yale University|The limitations of this study include the large attrition rate due to the length of the intervention and the difficulty in adhering to 40 grams of protein or placebo powder as a daily supplement.|2|||f||||t||||||||||2017-02-18 15:57:44.013972|2017-02-18 15:57:44.013972
NCT00421395|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2008-01-16|||August 2002||2002-08-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety Study of NHL With 90Y-hLL2 IgG|Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized IMMU-LL2: Treatment With 90Y-hLL2 IgG|Completed||Phase 1/Phase 2|59|Actual|Immunomedics, Inc.||1|||f||||f||||||||||2017-02-18 15:57:44.508765|2017-02-18 15:57:44.508765
NCT00421369|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-11|2013-03-21|||September 2007||2007-09-01|January 2007|2007-01-01|August 2011|Actual|2011-08-01|||||Interventional|||Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.|Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.|Completed||N/A|35|Actual|Hadassah Medical Organization|||||f||||f||||||||||2017-02-18 15:57:44.627252|2017-02-18 15:57:44.627252
NCT00421356|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2010-08-05|||January 2007||2007-01-01|April 2007|2007-04-01|February 2009|Actual|2009-02-01|||||Observational|||Comparison of Prosthetic Knee Performance During Sitting and Standing|Kinetic and Kinematic Comparison of Power Assisted Versus Stance Control Artificial Knees During Sit To Stand|Completed||Early Phase 1|35|Anticipated|University of South Florida|||6||f||||||||||||||2017-02-18 15:57:44.730784|2017-02-18 15:57:44.730784
NCT00421343|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2011-05-11|2010-07-08||February 2007||2007-02-01|May 2011|2011-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Secondary Prevention of Osteoporosis|Secondary Prevention of Osteoporosis: A Window of Opportunity in the Acute Rehabilitation Setting|Completed||Phase 3|29|Actual|Hebrew Rehabilitation Center, Boston||1|||f||||f||||||||||2017-02-18 15:57:44.805162|2017-02-18 15:57:44.805162
NCT00421330|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2008-06-03|||November 2000||2000-11-01|June 2008|2008-06-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial|Endovascular Versus Transabdominal Treatment of the Abdominal Aortic Aneurysm: the Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial|Unknown status|Active, not recruiting|N/A|392|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 15:57:47.724962|2017-02-18 15:57:47.724962
NCT00421317|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2016-01-05|||December 2005||2005-12-01|January 2016|2016-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|O-Mel-Inib||Imatinib in Adult Patients With Metastatic Ocular Melanoma|A Phase II Multicentric Trial to Assess Efficacy and Toxicity of Imatinib in Adult Patients With Metastatic Ocular Melanoma|Terminated||Phase 2|13|Actual|Centre Oscar Lambret||1||Study stopped at the end of the first step|f||||f||||||||||2017-02-18 15:57:47.825933|2017-02-18 15:57:47.825933
NCT00421304|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-06-27||2012-06-27|January 2007||2007-01-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized With RSV Illness|Completed||Phase 2|118|Actual|MedImmune LLC||3|||f||||t||||||||||2017-02-18 15:57:47.936853|2017-02-18 15:57:47.936853
NCT00421278|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2016-01-21|||November 2006||2006-11-01|January 2016|2016-01-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)|A Clinical Study to Evaluate the Efficacy and Safety of MK0633 in Patients With Atherosclerosis|Completed||Phase 2|180|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 15:57:48.153277|2017-02-18 15:57:48.153277
NCT00421265|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-01-10||||||January 2007|2007-01-01||||||||Observational|||Active Surveillance for Prostate Cancer With Indolent Features|Prospective Cohort Study of Active Surveillance for Prostate Cancer With Indolent Linical Features|Unknown status|Not yet recruiting|Phase 1/Phase 2|150||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:57:48.233632|2017-02-18 15:57:48.233632
NCT00421252|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2008-03-10|||January 2007||2007-01-01|March 2008|2008-03-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.|Impact of Pre-Treatment With 600mg of Clopidogrel (Plavix) on the Incidence of Ischemic and Hemorrhagic Complications in Patients Undergoing Elective Percutaneous Coronary Revascularization.--Prospective Randomized Trial.|Unknown status|Not yet recruiting|Phase 1|600|Anticipated|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 15:57:48.317504|2017-02-18 15:57:48.317504
NCT00421239|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2008-12-08|||January 2007||2007-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|||||Observational|OSADA||Risk Factors of Hypertensive Urgencies|Retrospective Study of Hypertensive Urgencies in Patients With Arterial Hypertension|Completed||N/A|1200|Actual|Russian Cardiology Research and Production Center|||2||f||||f||||||||||2017-02-18 15:57:48.66365|2017-02-18 15:57:48.66365
NCT00421226|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2012-04-27|||December 2006||2006-12-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers|A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Demonstrate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 Administered as Intravenous Infusion and Subcutaneous Injection in Japanese Healthy Volunteers|Completed||Phase 1|48|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:57:48.746903|2017-02-18 15:57:48.746903
NCT00421213|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2012-07-18|||December 2006||2006-12-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers|Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers|Completed||Phase 2|50|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 15:57:48.834481|2017-02-18 15:57:48.834481
NCT00421200|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2013-08-15|||February 2007||2007-02-01|August 2013|2013-08-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty|A Randomized, Double-blind, Phase III Study of the Efficacy and Safety of an Oxygen-carrying Plasma Expander, Hemospan®, Compared With Voluven® to Prevent Hypotension in Patients Undergoing Primary Hip Arthroplasty With Spinal Anesthesia|Completed||Phase 3|375|Actual|Sangart||2|||f||||t||||||||||2017-02-18 15:57:48.944654|2017-02-18 15:57:48.944654
NCT00421187|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2011-03-09|||March 2007||2007-03-01|April 2008|2008-04-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics|Phase III Study of 3 Sequential Doses (10 mg/kg, 5 mg/kg, and 5 mg/kg) vs 3 mg/kg/Day of AmBisome® in the Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics|Terminated||Phase 4|20|Actual|Gilead Sciences||2||Unable to recruit subjects in the Turkey site.|f||||f||||||||||2017-02-18 15:57:49.103917|2017-02-18 15:57:49.103917
NCT00421174|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2016-10-25|2016-01-28||August 2007||2007-08-01|October 2016|2016-10-01|July 2013|Actual|2013-07-01|June 2010|Actual|2010-06-01||Interventional|||Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)|A Randomized Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Cell Transplantation (BMT CTN #0403)|Completed||Phase 3|37|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||Yes|Findings will be published in a manuscript|2017-02-18 15:57:49.230875|2017-02-18 15:57:49.230875
NCT00421161|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-01-10|||January 2007||2007-01-01|January 2007|2007-01-01|March 2007||2007-03-01|||||Interventional|||Olive Oil With Omega 3 to Treat Stasis Dermatitis|Phase 1 and 2 Study on the Efficacy and Side Effects of Olive Oil and Omega 3 Local Treatment in Stasis Dermatitis|Unknown status|Not yet recruiting|Phase 1/Phase 2|30||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 15:57:50.175716|2017-02-18 15:57:50.175716
NCT00421148|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2015-06-05|||May 2005||2005-05-01|June 2015|2015-06-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Dose-Finding Pediatric Trial With Sugammadex (19.4.306)(P05961)(COMPLETED)|A Multi -Center, Randomized, Parallel Dose-Finding, Safety Assessor-Blinded Trial to Explore the Efficacy, Safety and Pharmacokinetics of Four Doses of Sugammadex and Placebo in Pediatric and Adult Subjects.|Completed||Phase 3|120|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 15:57:50.280238|2017-02-18 15:57:50.280238
NCT00421135|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2009-09-16|||February 2006||2006-02-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer|A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer|Completed||Phase 1|30|Anticipated|Ziopharm||1|||f||||||||||||||2017-02-18 15:57:50.375024|2017-02-18 15:57:50.375024
NCT00421122|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2009-03-26|||September 2006||2006-09-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|||||Interventional|||Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD|A 6-Month, Phase IIIA, Multi-Center,Randomised,Double-Blind, Double-Dummy, Parallel-Group Study of the Efficacy and Safety of Symbicort® Turbuhaler®+ Bricasol® pMDI Compared With Pulmicort® Turbuhaler®+Bricasol® pMDI in Chinese Patients With COPD|Completed||Phase 3|315|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 15:57:50.470852|2017-02-18 15:57:50.470852
NCT00421109|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-04-04|||July 2006||2006-07-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria|Double-blind, Randomised, Placebo-controlled, Phase III Study Comparing the Efficacy and Safety of Bilastine 20 mg Once Daily and Levocetirizine 5 mg for the Treatment of Chronic Idiopathic Urticaria|Completed||Phase 3|522|Actual|Faes Farma, S.A.||3|||f||||f||||||||||2017-02-18 15:57:50.589919|2017-02-18 15:57:50.589919
NCT00010517|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-03-05|||September 1997||1997-09-01|March 2008|2008-03-01|April 2002||2002-04-01|||||Interventional|||Acupuncture in the Treatment of Depression|Acupuncture in the Treatment of Depression|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.70034|2017-02-18 18:11:33.70034
NCT00421096|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2012-07-23|||May 2005||2005-05-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|April 2008|Actual|2008-04-01||Interventional|GEMCOL||Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer|Stage IB2 to IVA Uterine Cervical Cancer: Phase 2 Study to Assess a New Therapeutic Sequence Associating a Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine|Terminated||Phase 2|19|Actual|Centre Oscar Lambret||1||Problems of recruitment|f||||f||||||||||2017-02-18 15:57:50.988658|2017-02-18 15:57:50.988658
NCT00421083|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2007-10-23|||September 2004||2004-09-01|October 2007|2007-10-01|June 2005|Actual|2005-06-01|||||Interventional|||Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury|A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess Efficacy and Safety of Tadalafil (LY450190) in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury|Completed||Phase 3|180||Eli Lilly and Company|||||f||||||||||||||2017-02-18 15:57:51.101182|2017-02-18 15:57:51.101182
NCT00421070|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2015-04-26|||May 2006||2006-05-01|April 2015|2015-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Effect of Massage Therapy on Aggression in a Psychiatric Inpatient Unit|The Evaluation of Relaxation Massage Therapy as an Intervention Treatment for Reducing the Level of Arousal and Aggression on a Young Adult Psychiatric Inpatient Unit|Completed||N/A|47|Actual|Melbourne Health||2|||f||||f||||||||||2017-02-18 15:57:51.20483|2017-02-18 15:57:51.20483
NCT00421057|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-07-27|||January 2007||2007-01-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Combined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical Performance|The Effects of Combined Strength Training and Functional Endurance Exercise Regimen on Cancer-Related Fatigue and Physical Performance|Completed||N/A|25|Actual|M.D. Anderson Cancer Center|||2||f||||t||||||||||2017-02-18 15:57:51.323318|2017-02-18 15:57:51.323318
NCT00421044|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-01-09|||May 2006||2006-05-01|January 2012|2012-01-01||||February 2008|Actual|2008-02-01||Interventional|||A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function|An Open-label, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function|Completed||Phase 1|14|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:57:51.441358|2017-02-18 15:57:51.441358
NCT00421031|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-01-10|||December 2003||2003-12-01|January 2007|2007-01-01|April 2004||2004-04-01|||||Interventional|||Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause|A Double-Blind, Randomized, Placebo-Controlled Efficacy and Safety Study of DVS-233 SR For Relief of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|540||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:57:51.540301|2017-02-18 15:57:51.540301
NCT00421018|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2012-08-14|||November 2006||2006-11-01|August 2012|2012-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)|Optimization of the Anti-Inflammatory Treatment of Asthma Patients Through Exhaled NO Measurements for Increased Asthma-Related Quality of Life in Primary Health Care (NOAK)|Completed||N/A|187|Actual|Karolinska Institutet||2|||f||||||||||||||2017-02-18 15:57:51.65483|2017-02-18 15:57:51.65483
NCT00421005|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2009-04-28|||November 2004||2004-11-01|April 2009|2009-04-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Fluvastatin After Heart Transplantation|Safety and Efficacy of Fluvastatin in Heart Transplant Recipients|Unknown status|Active, not recruiting|Phase 4|56|Actual|University of Bologna||2|||f||||||||||||||2017-02-18 15:57:51.760824|2017-02-18 15:57:51.760824
NCT00420992|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2013-09-13|2009-09-11||December 2006||2006-12-01|September 2013|2013-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Efficacy Study of Kadian NT (Morphine Sulfate Plus Naltrexone Hydrochloride Extended-Release) Capsules in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Hip or Knee|Completed||Phase 3|547|Actual|Pfizer||2|||f||||||||||||||2017-02-18 15:57:51.87002|2017-02-18 15:57:51.87002
NCT00420966|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2016-11-21|||October 2005||2005-10-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Observational|||Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy|Phase IV Study of Respiratory Syncytial Virus Monoclonal Antibody Therapy in High-risk Infants and Toddlers|Recruiting||Phase 4|1000|Anticipated|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 15:57:52.336717|2017-02-18 15:57:52.336717
NCT00420953|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2008-01-14|||December 2006||2006-12-01|January 2008|2008-01-01||||||||Interventional|||Relative Bioavailability of PM101 IV and Cordarone IV|A Randomized, Double-Blind, 2-Period Crossover Trial to Determine the Relative Bioavailability of PM101 I.V. (Amiodarone HCl) and Cordarone I.V. in Healthy Adult Volunteers|Completed||Phase 1|||Prism Pharmaceuticals|||||f||||||||||||||2017-02-18 15:57:52.45179|2017-02-18 15:57:52.45179
NCT00420940|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2010-04-07|||November 2006||2006-11-01|October 2008|2008-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause|The Effect of Daily Whole-Body Vibration on Tibial Trabecular Bone Mineral Density in Osteopenic Postmenopausal Women|Completed||Phase 3|202|Actual|University Health Network, Toronto||3|||f||||f||||||||||2017-02-18 15:57:52.529428|2017-02-18 15:57:52.529428
NCT00420927|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-04-16|2011-07-01||December 2006||2006-12-01|April 2012|2012-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|OPTIMA||Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis|A Multicenter, Randomized, Double-Period, Double − Blind Study to Determine the Optimal Protocol for Treatment Initiation With Methotrexate and Adalimumab Combination Therapy in Patients With Early Rheumatoid Arthritis (OPTIMA)|Completed||Phase 4|1032|Actual|Abbott||5|||f||||f||||||||||2017-02-18 15:57:52.672444|2017-02-18 15:57:52.672444
NCT00420914|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2008-05-27|||October 2003||2003-10-01|May 2008|2008-05-01||||||||Interventional|||Strategies for Transfusion of Platelets (SToP)|"Strategies for Transfusion of Platelets (SToP) [Formerly Titled Evaluation of the Hemostatic Efficacy and Platelet Utilization Rates of Low Versus Standard Dose Platelet Therapy]"|Terminated||Phase 3|130|Actual|McMaster University||||Stopped at the request of the Data Safety Monitoring Board for safety reasons.|f||||||||||||||2017-02-18 15:57:56.331834|2017-02-18 15:57:56.331834
NCT00341731|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2009-11-25|||December 2000||2000-12-01|October 2008|2008-10-01||||||||Observational|||Environmental Factors in the Development of Polycystic Ovary Syndrome|Environmental Factors in the Development of Polycystic Ovary Syndrome|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.348137|2017-02-18 16:27:25.348137
NCT00418834|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2015-10-30|2009-08-25||January 2007||2007-01-01|October 2015|2015-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)|A Multicenter, Randomized, Double-Blind, Parallel Arm, 12-Week Study to Evaluate the Efficacy and Safety of Ezetimibe 10 mg When Added to Atorvastatin 10 mg Versus Titration to Atorvastatin 20 mg and to 40 mg in Elderly Patients With Hypercholesterolemia at High Risk for CHD|Completed||Phase 3|1053|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:57:56.459003|2017-02-18 15:57:56.459003
NCT00418821|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2016-06-22|||October 2010||2010-10-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants|A Multicenter, Multinational, Open-Label Study of the Effects of Aldurazyme (Laronidase) Treatment on Lactation in Women With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants|Recruiting||Phase 4|10|Anticipated|Sanofi||1|||f||||f||||||||||2017-02-18 15:57:57.872614|2017-02-18 15:57:57.872614
NCT00418808|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2007-01-22|||August 2006||2006-08-01|January 2007|2007-01-01|August 2009||2009-08-01|||||Observational|||Early Movements as a Predictor of Future Developmental Delay|Analysis of Movements of Singletons and Infants of Multiple Fetus Pregnancy as a Predictor of Developmental Delay|Unknown status|Recruiting|Phase 1|50||Sheba Medical Center|||||f||||||||||||||2017-02-18 15:57:58.18358|2017-02-18 15:57:58.18358
NCT00418795|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2007-01-04|||February 2003||2003-02-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Porphozym in the Treatment of Acute Attacks in AIP|A Multi-Centre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial, Investigating the Efficacy and Safety of Porphozym(Recombinant Human Porphobilinogen Deaminase) in the Treatment of Acute Attacks in AIP|Completed||Phase 2|36||Zymenex A/S|||||t||||||||||||||2017-02-18 15:57:58.267137|2017-02-18 15:57:58.267137
NCT00418782|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2008-02-29|||January 2007||2007-01-01|February 2008|2008-02-01|August 2007|Anticipated|2007-08-01|||||Interventional|||A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) Pain|A 2 Week, Randomized, Double Blind, Placebo And Positive Controlled, Parallel Group, Multicenter Study Of CE-224,535 In Subjects With Osteoarthritic Pain Of The Knee|Terminated||Phase 2|212|Anticipated|Pfizer||3||Results of interim analysis indicate lack of efficacy when compared to placebo.|f||||t||||||||||2017-02-18 15:57:58.354209|2017-02-18 15:57:58.354209
NCT00418769|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2012-04-23|||June 2006||2006-06-01|April 2012|2012-04-01||||August 2006|Actual|2006-08-01||Interventional|||Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers|A Randomized, Open Label, Two-arm, Three Period Crossover Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers|Completed||Phase 1|24|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:57:58.505278|2017-02-18 15:57:58.505278
NCT00418756|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2010-03-18|||October 2006||2006-10-01|March 2010|2010-03-01||||November 2006|Actual|2006-11-01||Interventional|||Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects|A Phase I Open-label, Two Period, Single Center Study to Assess the Effect of 600 mg Daily Oral Dose of Rifampin (CYP3A4 Inducer) on the Pharmacokinetics of a Single 400 mg Oral Dose of Nilotinib in Healthy Subjects|Completed||Phase 1|12|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:57:58.590756|2017-02-18 15:57:58.590756
NCT00418743|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2010-03-08|||December 2005||2005-12-01|March 2010|2010-03-01|May 2010|Anticipated|2010-05-01|||||Observational|||Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)|A Phase II Randomised Trial of Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC), Comparing Oral Combination Chemotherapy (CCNU, Cyclophosphamide, Etoposide) With Intravenous Association Chemotherapy.|Unknown status|Recruiting|Phase 2|138|Anticipated|Groupe Francais De Pneumo-Cancerologie|||1||f||||t||||||||||2017-02-18 15:57:58.758491|2017-02-18 15:57:58.758491
NCT00418730|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2008-05-16|||January 2007||2007-01-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss|A Phase 2 Multicenter, Randomized, Placebo- and Comparator-Controlled, Double-Blind Parallel Group Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopecia in Men|Completed||Phase 2|180|Actual|Neosil, Inc.||3|||f||||||||||||||2017-02-18 15:57:59.036374|2017-02-18 15:57:59.036374
NCT00418717|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2012-03-01|2008-12-19||February 2007||2007-02-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA|An Open-label, Multicenter, Dose-regimen Study Evaluating the Efficacy and Safety of Etanercept 50 mg Once-weekly Dose in Japanese Subjects With Rheumatoid Arthritis|Completed||Phase 3|42|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 15:57:59.137133|2017-02-18 15:57:59.137133
NCT00418704|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2013-09-29|||May 2006||2006-05-01|September 2013|2013-09-01|June 2009|Actual|2009-06-01|June 2006|Actual|2006-06-01||Observational|||Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)|A Multicenter Randomized Phase II Trial in NSCLC Stage IV and IIIB (T4 With Pleural Effusion) in Elderly Independent Patients the Schedule Docetaxel / Gemcitabine First Line Following by Erlotinib When Progression Versus Erlotinib First Line Following by/ Gemcitabine When Progression.|Completed||Phase 2|100|Actual|Groupe Francais De Pneumo-Cancerologie|||1||f||||f||||||||||2017-02-18 15:57:59.383479|2017-02-18 15:57:59.383479
NCT00418691|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2012-08-01|2011-01-10||February 2004||2004-02-01|August 2012|2012-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning|Assessing the Efficacy of Immediate Release Methylphenidate, Sustained Release Methylphenidate and Modafinil for Patients With Brain Tumors|Terminated||Phase 3|34|Actual|M.D. Anderson Cancer Center|Early termination lead to limited analysis.|3||Closed early due to slow accrual.|f||||f||||||||||2017-02-18 15:57:59.499442|2017-02-18 15:57:59.499442
NCT00420901|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2007-01-09|||January 1999||1999-01-01|January 2007|2007-01-01|February 2000||2000-02-01|||||Interventional|||Effect of Chronic PDE5-Inhibition on Endothelial Function in Diabetics|Effect of Chronic Administration of Sildenafil on Endothelial Function in Men With Diabetes|Completed||Phase 3|30||IRCCS San Raffaele|||||f||||||||||||||2017-02-18 15:57:59.972626|2017-02-18 15:57:59.972626
NCT00420004|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2009-10-05||2009-03-26|December 2006||2006-12-01|October 2009|2009-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study for Patients With Major Depression|A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression|Completed||Phase 2|470|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 15:58:33.578381|2017-02-18 15:58:33.578381
NCT00420888|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2015-06-30||2014-06-02|January 2007||2007-01-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma|A Randomized, Open-label, Multi-center, Phase II/III Study on Treatment With ABR-217620/Naptumomab Estafenatox Combined With IFN-alpha vs. IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma.|Completed||Phase 2/Phase 3|526|Actual|Active Biotech AB||3|||f||||f||||||||||2017-02-18 15:58:00.086159|2017-02-18 15:58:00.086159
NCT00420875|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2015-08-25|||June 2007||2007-06-01|August 2015|2015-08-01||||||||Interventional|TOPAZ Registry||Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis|"Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis"|Withdrawn||Phase 4|0|Actual|ArthroCare Corporation||1||Did not meet enrollment goals|f||||||||||||||2017-02-18 15:58:00.483841|2017-02-18 15:58:00.483841
NCT00420862|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-01-10|||June 2001||2001-06-01|January 2007|2007-01-01|February 2010||2010-02-01|||||Interventional|||The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography||Terminated||Phase 3|2400||Istituto Clinico Humanitas|||||f||||||||||||||2017-02-18 15:58:00.593716|2017-02-18 15:58:00.593716
NCT00420849|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-05-15|2012-02-10||November 2006||2006-11-01|May 2012|2012-05-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma|A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma|Completed||Phase 3|587|Actual|Celgene|This study was defined primarily as an expanded access program in the selected countries. Treatment was to continue until disease progression, study drug was discontinued for any reason, or lenalidomide became commercially available for indication.|1|||f||||||||||||||2017-02-18 15:58:00.695657|2017-02-18 15:58:00.695657
NCT00420836|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-01-10|||April 2006||2006-04-01|January 2007|2007-01-01||||||||Interventional|||Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study|Crossover Pharmacokinetic Study of Tobramycin Administered for Inhalation by PARI eFlow® Rapid Electronic Nebulizer (no Compressor) vs. PARI LC PLUSTM Jet Nebulizer (With Compressor) in Cystic Fibrosis Subjects|Completed||Phase 1|20||Novartis|||||f||||||||||||||2017-02-18 15:58:02.103182|2017-02-18 15:58:02.103182
NCT00420823|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2015-11-18|||January 2007||2007-01-01|November 2015|2015-11-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment|A 12-week, Parallel, Double-blind, Randomised, Placebo-controlled Adjunctive Study of Taurine 4 Grams in 128 Patients With First-episode Psychosis Receiving Antipsychotic Treatment.|Completed||Phase 2/Phase 3|121|Actual|Melbourne Health||2|||f||||||||||||||2017-02-18 15:58:02.266812|2017-02-18 15:58:02.266812
NCT00420810|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2015-01-13|||September 2006||2006-09-01|January 2015|2015-01-01||||March 2007|Actual|2007-03-01||Interventional|||Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)|A Double-Blind, Placebo Controlled, Randomized, Cross-Over Polysomnographic Study of MK0928 15 mg in Adult Patients With Primary Insomnia|Terminated||Phase 3|138||H. Lundbeck A/S|||||f||||||||||||||2017-02-18 15:58:02.381383|2017-02-18 15:58:02.381383
NCT00420797|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2015-05-18|||February 2007||2007-02-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence|A Double-blind, Randomised, Placebo-controlled Study to Evaluate Topical 10% Phenylephrine Gel in the Management of Ileal Pouch Anal Anastomosis (IPAA)-Related Faecal Incontinence|Withdrawn||Phase 3|0|Actual|S.L.A. Pharma AG||2||Terminated, new protocol to be developed|f||||f||||||||||2017-02-18 15:58:02.45747|2017-02-18 15:58:02.45747
NCT00420784|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2014-07-09|2011-06-22||February 2007||2007-02-01|July 2014|2014-07-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional||Full Analysis Set = subjects who received at least 1 dose of study drug.|A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3)|A Phase 2 Study of Telaprevir (VX-950) in Combination With Peginterferon Alfa-2a (Pegasys®), and Ribavirin (Copegus®) in Subjects With Genotype 1 Hepatitis C Who Have Not Achieved Sustained Viral Response With a Prior Course of Interferon Based Therapy|Completed||Phase 2|465|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||t||||||||||2017-02-18 15:58:02.572135|2017-02-18 15:58:02.572135
NCT00420771|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2012-12-11|||January 2007||2007-01-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients|A Randomized Controlled Pilot Trial of Gabapentin for the Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients|Completed||Phase 2|19|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 15:58:04.001409|2017-02-18 15:58:04.001409
NCT00420758|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2015-12-03|||November 2007||2007-11-01|December 2015|2015-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effectiveness Trial on Alleviation of Infant Malnutrition With Fortified Spread or Maize-Soy Flour Food Supplements|LCNI-7. A Three-centre Intervention Trial in Rural Malawi, Testing the Effectiveness of Fortified Spread or Maize-Soy Flour Supplementation to Alleviate Moderate Malnutrition Among 6-18 Month Old Children|Completed||Phase 3|299|Actual|University of Tampere||3|||f||||t||||||||||2017-02-18 15:58:04.111679|2017-02-18 15:58:04.111679
NCT00420745|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2016-11-03|2009-03-13||January 2007||2007-01-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants|Phase IIIb, Double Blind, Randomised, Placebo-Controlled, Multi-Country/Centre, Study to Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Pre-Term Infants|Completed||Phase 3|1009|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:58:04.228891|2017-02-18 15:58:04.228891
NCT00420732|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2015-05-29||2014-05-28|January 2007||2007-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2012|Actual|2012-11-01||Interventional|||Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer|A Phase II Study of Tergenpumatucel-L (HyperAcute Lung) Cancer Vaccine in Subjects With Advanced Non-Small Cell Lung Cancer Who Responded to First Line Platinum-Doublet Treatment|Terminated||Phase 2|6|Actual|NewLink Genetics Corporation||1||Enrollment goals unable to be reached.|f||||t||||||||||2017-02-18 15:58:04.742972|2017-02-18 15:58:04.742972
NCT00420719|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2009-03-16|||October 2004||2004-10-01|March 2009|2009-03-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|||Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)|Multi-Center Pivotal Study of Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)|Unknown status|Active, not recruiting|N/A|100|Anticipated|Synapse Biomedical||1|||f||||||||||||||2017-02-18 15:58:04.854795|2017-02-18 15:58:04.854795
NCT00420706|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2007-12-06|||December 2006||2006-12-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating SCA-136 Tolerability With Dose Titration and Food|A Multi-Dose, Double-Blind, Parallel-Group Study of the Effects of Dose Titration and Administration With Food on the Tolerability of SCA-136 in Healthy Subjects|Terminated||Phase 1|120||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:58:04.964521|2017-02-18 15:58:04.964521
NCT00420693|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2009-01-14|||August 2006||2006-08-01|January 2009|2009-01-01||||May 2008|Actual|2008-05-01||Interventional|||Interest of Using the Sevoflurane in the Prevention of Newborns Pain|Interest of Using the Sevoflurane in the Prevention of Newborns Pain|Completed||Phase 2/Phase 3|60|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||||||||||||2017-02-18 15:58:05.042896|2017-02-18 15:58:05.042896
NCT00420680|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2016-05-13|||November 2005||2005-11-01|May 2016|2016-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Efficacy Evaluation of Sugammadex in Cardiac Patients (19.4.309)(P05934)|A Multi -Center, Randomized, Parallel-Group, Placebo-Controlled, Safety Assessor-Blinded Trial, Evaluating the Safety and Efficacy of Sugammadex in Cardiac Patients|Completed||Phase 3|120|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 15:58:05.121469|2017-02-18 15:58:05.121469
NCT00420667|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2007-01-08|||November 2004||2004-11-01|January 2007|2007-01-01|May 2005||2005-05-01|||||Interventional|||Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery|Effect of Low Molecular Weight Heparin vs Unfractionated Heparin on Bleeding After Cardiac Surgery|Completed||N/A|40||G. d'Annunzio University|||||f||||||||||||||2017-02-18 15:58:05.215283|2017-02-18 15:58:05.215283
NCT00420654|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2011-11-06|||August 2007||2007-08-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Growth Hormone Treatment of Women With Turner Syndrome|Growth Hormone Treatment of Women With Turner Syndrome: Body Composition and Heart Function.|Completed||N/A|24|Anticipated|University of Aarhus||3|||f||||t||||||||||2017-02-18 15:58:05.313898|2017-02-18 15:58:05.313898
NCT00420641|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2014-10-02|||December 2006||2006-12-01|June 2014|2014-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||MDD POC Study GSK372475 Subjects Depressive Disease|A Ten-week, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Paralleled-Group, Flexible-Dose Study Evaluating the Efficacy, Safety and Tolerability of GSK372475 or Paroxetine Compared to Placebo in Adult Subjects Diagnosed With Major Depressive Disorder|Completed||Phase 2|492|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 15:58:05.449216|2017-02-18 15:58:05.449216
NCT00420628|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2011-09-30|2010-03-19||November 2006||2006-11-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||Pediatric Zylet Safety and Efficacy Study|A Safety and Efficacy Study of Zylet® (Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension) Compared to Vehicle in the Management of Lid Inflammation (Chalazion/Hordeolum) in Pediatric Subjects|Completed||Phase 4|108|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 15:58:05.592884|2017-02-18 15:58:05.592884
NCT00420615|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2012-04-23|||December 2006||2006-12-01|April 2012|2012-04-01||||August 2008|Actual|2008-08-01||Interventional|||Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies|An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies|Completed||Phase 1|34|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:58:06.093834|2017-02-18 15:58:06.093834
NCT00420602|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2017-01-11|||August 2006||2006-08-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||DHA Supplementation in Patients With STGD3|Clinical Interventions Against Stargardt Macular Dystrophy: DHA Supplementation in Patients With STGD3|Active, not recruiting||N/A|11|Actual|University of Utah||1|||f||||f||||||||||2017-02-18 15:58:06.198774|2017-02-18 15:58:06.198774
NCT00420589|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2015-02-04|||October 2006||2006-10-01|February 2015|2015-02-01|November 2008|Actual|2008-11-01|February 2008|Actual|2008-02-01||Interventional|||A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)|A Study to Assess the Efficacy and Tolerability of Taranabant in Maintaining Weight Loss Induced by Diet in Obese Patients Followed by a 1-Year Extension|Terminated||Phase 3|1000|Actual|Merck Sharp & Dohme Corp.||4||The overall profile does not support development for obesity|f||||||||||||||2017-02-18 15:58:06.281993|2017-02-18 15:58:06.281993
NCT00420576|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2008-12-17|||June 2006||2006-06-01|January 2007|2007-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dose Finding Study of Danggui Buxue Tang (Herbal Formula)on the Treatment of Menopausal Symptoms|A Randomized, Double-Blind, Multiple-Dose Escalation Study of the Effect of Danggui Buxue Tang on Symptomatic Postmenopausal Hong Kong Chinese Women (Continuation of a Completed Study Using the Same Formula)|Completed||Phase 2|60|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-02-18 15:58:06.369487|2017-02-18 15:58:06.369487
NCT00420563|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-07-20|||September 2006||2006-09-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|PALANGI-0601||Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer|A Phase II Randomized Study to Assess the Benefit of a Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer|Completed||Phase 2|88|Actual|Centre Oscar Lambret||2|||f||||t||||||||||2017-02-18 15:58:06.472999|2017-02-18 15:58:06.472999
NCT00420550|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-03-19|||January 2007||2007-01-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC|Pilot Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With Interstitial Cystitis|Completed||Phase 2|10|Anticipated|William Beaumont Hospitals|||||f||||||||||||||2017-02-18 15:58:06.569097|2017-02-18 15:58:06.569097
NCT00420537|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2010-01-11|||September 2006||2006-09-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Shift to Everolimus (RAD) Kidney Sparing Study|Safety and Efficacy of Low-dose Cyclosporine in Association With Everolimus to Minimize Renal Dysfunction in Heart Transplant Recipients|Terminated||Phase 4|34|Actual|University of Bologna||2||A cluster of adverse events in everolimus arm was noted.|f||||||||||||||2017-02-18 15:58:06.660015|2017-02-18 15:58:06.660015
NCT00420524|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2011-12-22|||January 2006||2006-01-01|December 2011|2011-12-01||||July 2010|Actual|2010-07-01||Interventional|||A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function|An Open-label, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function|Completed||Phase 1|36|Actual|Novartis||3|||f||||||||||||||2017-02-18 15:58:06.880906|2017-02-18 15:58:06.880906
NCT00420511|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2011-12-28|2011-06-24||January 2007||2007-01-01|December 2011|2011-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|BEST||Beta-Cell Function and Sitagliptin Trial (BEST)|A Randomized Controlled Pilot Study Assessing the Effect of Sitagliptin on the Preservation of Beta-Cell Function in Patients With Type 2 Diabetes|Completed||Phase 2|21|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital|The modest sample size of this pilot study may have lacked sufficient statistical power to detect an effect on preservation of beta-cell function.|2|||f||||f||||||||||2017-02-18 15:58:06.981763|2017-02-18 15:58:06.981763
NCT00420498|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2007-12-11|||August 2005||2005-08-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Effects of Atomoxetine on Cognitive Function in Schizophrenia|Effects of Atomoxetine on Cognitive Function in Schizophrenia|Completed||Phase 2|12|Actual|Yale University|||||f||||f||||||||||2017-02-18 15:58:07.427303|2017-02-18 15:58:07.427303
NCT00420485|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2013-04-17|||March 2006||2006-03-01|April 2013|2013-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors|A Phase I Open-label, Multi-center Dose-escalation Study to Determine the Maximum Tolerated Dose (MTD) and Dose Limiting Toxicity of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|120|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:58:07.517272|2017-02-18 15:58:07.517272
NCT00420472|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-11-19|||March 2007||2007-03-01|November 2007|2007-11-01||||||||Interventional|||A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.|An Open-Label Study to Evaluate the Effect on Quality of Life of Switching Kidney Transplant Patients From Reduced Dose EC-MPS to a Higher Than the Equimolar Dose of CellCept|Terminated||Phase 4|||Hoffmann-La Roche|||||f||||||||||||||2017-02-18 15:58:07.628175|2017-02-18 15:58:07.628175
NCT00420459|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2012-04-25|||April 2007||2007-04-01|April 2012|2012-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Aripiprazole in Fragile X Syndrome|Aripiprazole in Fragile X Syndrome|Completed||Phase 2|12|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 15:58:07.711367|2017-02-18 15:58:07.711367
NCT00418678|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2010-11-30|||August 2006||2006-08-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting|A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting|Terminated||Phase 4|16|Actual|Veeda Oncology||1||Enrollment was too slow|f||||f||||||||||2017-02-18 15:58:07.797442|2017-02-18 15:58:07.797442
NCT00418665|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2011-01-20|2010-11-24||December 2006||2006-12-01|January 2011|2011-01-01|October 2010|Actual|2010-10-01|March 2009|Actual|2009-03-01||Interventional|||A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid|A Randomized, Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Receiving Lenalidomide.|Completed||Phase 2|39|Actual|Amgen||5|||f||||||||||||||2017-02-18 15:58:08.082539|2017-02-18 15:58:08.082539
NCT00418652|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2011-08-03|||January 2006||2006-01-01|August 2011|2011-08-01||||July 2010|Actual|2010-07-01||Interventional|||Interruption of Dorsal Visual Stream Using TMS|Interruption of Dorsal Visual Stream Using TMS in Normal Controls|Completed||N/A|12|Actual|Sheba Medical Center||3|||f||||||||||||||2017-02-18 15:58:09.167563|2017-02-18 15:58:09.167563
NCT00418639|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-03|||February 2005||2005-02-01|January 2007|2007-01-01||||||||Interventional|||Study of Nitazoxanide in the Treatment of Chronic Hepatitis C|Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide in the Treatment of Chronic Hepatitis C|Completed||Phase 2|50||Romark Laboratories L.C.|||||f||||||||||||||2017-02-18 15:58:09.266735|2017-02-18 15:58:09.266735
NCT00418626|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2012-03-07|||November 2006||2006-11-01|March 2012|2012-03-01||||September 2007|Actual|2007-09-01||Interventional|||Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function|A Phase I, Single Center, Open-label, Single Oral Dose, Study to Assess the Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function|Completed||Phase 1|27|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:58:09.364162|2017-02-18 15:58:09.364162
NCT00418613|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2015-09-02|||January 2008||2008-01-01|September 2015|2015-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions of MK0633 in Patients With COPD|Completed||Phase 2|266|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:58:09.455907|2017-02-18 15:58:09.455907
NCT00418600|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2015-03-17|||November 2006||2006-11-01|March 2015|2015-03-01|August 2007|Actual|2007-08-01|June 2007|Actual|2007-06-01||Interventional|||A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis|A Phase 4, Multi-Center, Open-Label, Randomized Study to Determine Clinically Appropriate Doses of Hectorol® Capsules When Converting From Hectorol® Injection for the Treatment of SHPT in Stage 5 CKD Subjects on Hemodialysis|Completed||Phase 4|36|Actual|Sanofi||3|||f||||||||||||||2017-02-18 15:58:09.547108|2017-02-18 15:58:09.547108
NCT00418587|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-08-14|||December 2006||2006-12-01|August 2016|2016-08-01|August 2014|Actual|2014-08-01|August 2008|Actual|2008-08-01||Interventional|||Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)|Phase 1 Study of Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)|Completed||Phase 1|18|Anticipated|Medical University of South Carolina||3|||f||||t||||||||||2017-02-18 15:58:09.659805|2017-02-18 15:58:09.659805
NCT00418574|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2011-11-17|2011-07-01||December 2006||2006-12-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|MIMOSA||Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients|A Randomised,Double Blind, Placebo Controlled, Multicentre Trial of Abagovomab Maintenance Therapy in Patients With Epithelial Ovarian Cancer After Complete Response to First Line Chemotherapy|Terminated||Phase 2/Phase 3|888|Actual|Menarini Group||2||No benefit on primary end point (RFS); no rationale to collect survival data|f||||t||||||||||2017-02-18 15:58:09.783983|2017-02-18 15:58:09.783983
NCT00418561|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-03-24|2015-07-16||January 2007||2007-01-01|March 2016|2016-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||Intent-to-treat (ITT) population included all participants who received at least 1 dose of study drug.|Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)|A Single Center, Open-label, Non-randomized, Uncontrolled, Multiple-dose, Dose Escalation Study of the Safety, Pharmacokinetics and Efficacy of Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)|Completed||Phase 1|13|Actual|Shire|ASA activity in leukocytes could not be included in basic results format as the results were presented graphically. Due to quick disappearance of rhASA from plasma, rhASA levels were not possible to report.|1|||f||||t||||||||||2017-02-18 15:58:11.330644|2017-02-18 15:58:11.330644
NCT00418548|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2007-01-04|||June 2004||2004-06-01|January 2007|2007-01-01|February 2005||2005-02-01|||||Interventional|||Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis|A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly Compared With 25 mg Twice Weekly in Subjects With Ankylosing Spondylitis|Completed||Phase 3|350||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 15:58:15.732891|2017-02-18 15:58:15.732891
NCT00418535|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2009-10-20|||April 2006||2006-04-01|January 2007|2007-01-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|||Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma|A Phase II Study of Concurrent Chemoradiation Followed by VIPD (Etoposide/Ifosfamide/Cisplatin/Dexamethasone) in Stage I, II Nasal NK/T-cell Lymphoma|Completed||Phase 2|||Samsung Medical Center|||||f||||||||||||||2017-02-18 15:58:15.807446|2017-02-18 15:58:15.807446
NCT00418522|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2009-09-08|2009-07-30||March 2007||2007-03-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus|A Six Month, Open Label, Randomized Parallel Group Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera) On Glycemic Control Compared To Insulin Glargine (Lantus) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Or More Oral Agents|Completed||Phase 4|413|Actual|Pfizer|Due to cancellation of the EXUBERA program, the collected Patient Reported Outcome (PRO) data were not summarized, and no statistical analyses were performed.|2|||f||||f||||||||||2017-02-18 15:58:15.913553|2017-02-18 15:58:15.913553
NCT00418509|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2007-06-21|||November 2006||2006-11-01|June 2007|2007-06-01||||||||Interventional|||Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers|A Randomized, Single Dose, 3-Period Crossover Study to Evaluate the Dosage Form Proportionality, Dose Proportionality and Pharmacokinetics of Mometasone Furoate and Formoterol Fumarate From Three Combination MDI Formulations|Completed||Phase 1|24||Novartis|||||f||||||||||||||2017-02-18 15:58:17.224925|2017-02-18 15:58:17.224925
NCT00418496|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2013-06-19|||December 2006||2006-12-01|June 2013|2013-06-01||||December 2013|Anticipated|2013-12-01||Interventional|||Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma|A Phase I Study of Bolus High Dose Interleukin-2 With Sorafenib (BAY 43-9006) in Patients With Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 15:58:17.306199|2017-02-18 15:58:17.306199
NCT00418483|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2016-10-28|||March 2007||2007-03-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|PRIORITY||A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion|A Sequential Phase I/II Dose Escalation and Dose Selection Safety Study of Regional Intra-thrombus Plasmin (Human) Infusion In Acute Lower Extremity Native Artery or Bypass Graft Occlusion|Completed||Phase 1|83|Actual|Grifols Therapeutics Inc.||7|||f||||t||||||||||2017-02-18 15:58:17.43362|2017-02-18 15:58:17.43362
NCT00420446|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2007-07-25|||January 2007||2007-01-01|February 2007|2007-02-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effect of Daily Intakes of Dairy Products on Blood Pressure in Human Beings||Completed||N/A|||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 15:58:17.558315|2017-02-18 15:58:17.558315
NCT00420433|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2016-02-17|||September 2004||2004-09-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|October 2008|Actual|2008-10-01||Observational|||Bone Response in Metastatic Breast Cancer Involving Bones|Prospective Study of Tumor Response Assessment in Metastatic Breast Cancer Involving Bones|Completed||N/A|37|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:58:17.634493|2017-02-18 15:58:17.634493
NCT00420420|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2015-01-28|2010-10-25||November 2006||2006-11-01|January 2015|2015-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of MK0249 for the Symptomatic Treatment of Alzheimer's Disease|Completed||Phase 2|144|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 15:58:17.760267|2017-02-18 15:58:17.760267
NCT00420407|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2013-04-16|2012-09-11||February 2007||2007-02-01|April 2013|2013-04-01|February 2011|Actual|2011-02-01|April 2009|Actual|2009-04-01||Interventional||Vasopressin enrolled 40 and two withdrawn and never received drug (38) Normal saline enrolled 41 and one withdrawn and never received drug (40)|Low Dose Vasopressin in Traumatic Shock|Prospective, Randomized, Double-Blind, Multi-Center Trial of Low Dose Vasopressin Versus Placebo in Traumatic Shock Resuscitation|Terminated||N/A|81|Actual|The University of Texas Health Science Center at San Antonio||2||accrual rate|f||||t||||||||||2017-02-18 15:58:18.178606|2017-02-18 15:58:18.178606
NCT00420394|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2007-06-19|||April 2007||2007-04-01|January 2007|2007-01-01||||||||Interventional|||Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer|Phase II Study of Preoperative Chemotherapy and Postoperative Chemo-Radiation for Newly Diagnosed, Potentially Resectable Gastric Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|Soroka University Medical Center|||||f||||t||||||||||2017-02-18 15:58:19.007181|2017-02-18 15:58:19.007181
NCT00420381|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2015-03-10||2009-12-11|January 2007||2007-01-01|March 2015|2015-03-01|December 2014|Actual|2014-12-01|May 2008|Actual|2008-05-01||Interventional|||Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer|A Phase II Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|28|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 15:58:19.092882|2017-02-18 15:58:19.092882
NCT00419575|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2008-06-04|||October 2006||2006-10-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|||||Observational|||Renal Transplantation With Immune Monitoring|Renal Transplantation With Immune Monitoring|Completed||N/A|60|Anticipated|Washington University School of Medicine|||1||f||||||||||||||2017-02-18 15:58:42.604409|2017-02-18 15:58:42.604409
NCT00420368|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2012-06-17|||February 2007||2007-02-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Efficacy Trial on Alleviation of Infant Malnutrition With Fortified Spread or Maize-soy Flour Food Supplements|LCNI-6. A Single-centre Intervention Trial in Rural Malawi, Testing the Efficacy of Fortified Spread or Maize-soy Flour Supplementation to Alleviate Moderate Malnutrition Among 6-18 Month Old Children|Completed||Phase 3|189||University of Tampere|||||f||||t||||||||||2017-02-18 15:58:19.200876|2017-02-18 15:58:19.200876
NCT00420355|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2009-02-05|||April 2007||2007-04-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|October 2007|Actual|2007-10-01||Interventional|||Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients|The Pharmacokinetics of Lopinavir/Ritonavir in Combination With Atazanavir in HIV-Infected Subjects|Terminated||Phase 4|19|Actual|University of Oklahoma||2||Unexpected adverse event|f||||f||||||||||2017-02-18 15:58:19.310586|2017-02-18 15:58:19.310586
NCT00420342|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2015-05-11|2009-10-28||January 2007||2007-01-01|May 2015|2015-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension|A Double Blind, Randomized, Active-control Study to Evaluate Effects of Drospirenone/Estradiol (Angeliq) and Medroxyprogesterone Acetate/Conjugated Equine Estrogen (Prempro) on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension|Completed||Phase 2|92|Actual|Bayer|Small sample size, as this was a pilot study.|3|||f||||f||||||||||2017-02-18 15:58:19.441362|2017-02-18 15:58:19.441362
NCT00420316|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2016-11-03|||February 2007||2007-02-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.|To Assess Long-term Efficacy & Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine (Rotarix) in the Primary Vaccination Study (102247).|Completed||Phase 3|2601||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:58:20.430733|2017-02-18 15:58:20.430733
NCT00420303|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2010-07-15|2009-09-30||January 2007||2007-01-01|July 2010|2010-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy|A Multicentre, Double-Blind, Placebo-Controlled, Randomized Study of Etanercept in the Treatment of Adults Patients With Refractory Heel Enthesitis in Spondylarthropathy|Completed||Phase 4|24|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 15:58:20.547202|2017-02-18 15:58:20.547202
NCT00420290|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2011-10-10|2011-07-11||January 2008||2008-01-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients|Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients|Completed||N/A|31|Actual|Vanderbilt University|The sample size is small and the intervention is of short duration. Also, the results cannot be generalized to all CHD patients because our inclusion criteria were stringent.|2|||f||||t||||||||||2017-02-18 15:58:20.97813|2017-02-18 15:58:20.97813
NCT00420277|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2013-08-15|||February 2007||2007-02-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty|A Randomized, Double-Blind, Phase III Study of the Efficacy and Safety of an Oxygen-Carrying Plasma Expander, Hemospan®, Compared With Voluven® toTreat Hypotension in Patients Undergoing Primary Hip Arthroplasty With Spinal Anesthesia|Completed||Phase 3|462|Actual|Sangart||2|||f||||t||||||||||2017-02-18 15:58:21.506588|2017-02-18 15:58:21.506588
NCT00420264|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-10|2013-08-13|||November 2005||2005-11-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|June 2008|Actual|2008-06-01||Interventional|||ThermaChoice III Under Local Sedation in the Office Setting|Feasibility of Using Gynecare Thermachoice III in the Office Setting Without Conscious Sedation|Completed||N/A|21|Actual|Female Pelvic Medicine & Urogynecology Institute of Michigan||1|||f||||||||||||||2017-02-18 15:58:21.649137|2017-02-18 15:58:21.649137
NCT00420251|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2007-01-09|||March 1996||1996-03-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis|Recombinant Human Growth Hormone Treatment in Juvenile Idiopathic Arthritis: Controlled Study on the Effect on Growth and Bone Development|Completed||Phase 3|50||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 15:58:21.734772|2017-02-18 15:58:21.734772
NCT00420238|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2010-06-24|2010-05-13||January 2007||2007-01-01|June 2010|2010-06-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis|A Multicentre, Double-Blind, Placebo-Controlled, Randomised Study of Etanercept in the Treatment of Adult Patients With Active, Severe, and Advanced Axial Ankylosing Spondylitis|Completed||Phase 4|82|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 15:58:21.860315|2017-02-18 15:58:21.860315
NCT00420225|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-09|2007-01-09|||April 2003||2003-04-01|January 2007|2007-01-01|May 2008||2008-05-01|||||Interventional|||Mesh Repair of Anterior Vaginal Wall Prolapse|Low-Weight Polypropylene Mesh for Anterior Vaginal Wall Prolapse: A Prospective Randomized Study|Completed||Phase 3|202||University of Tampere|||||f||||||||||||||2017-02-18 15:58:24.723954|2017-02-18 15:58:24.723954
NCT00420212|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2015-01-13|2014-05-05||January 2007||2007-01-01|January 2015|2015-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|DEFINE||Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Comparison Study to Determine the Efficacy and Safety of BG00012 in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|1234|Actual|Biogen||3|||f||||t||||||||||2017-02-18 15:58:25.063664|2017-02-18 15:58:25.063664
NCT00420199|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2012-01-13|2011-02-08||May 2007||2007-05-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|August 2009|Actual|2009-08-01||Interventional|||A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate|A Phase IIIB Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess Short-term Changes in Synovitis and Structural Damage Outcomes in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate, Treated With Abatacept Versus Placebo on a Background Therapy With Methotrexate|Completed||Phase 3|50|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 15:58:26.594711|2017-02-18 15:58:26.594711
NCT00010504|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-03-05|||August 2000||2000-08-01|March 2008|2008-03-01|July 2003||2003-07-01|||||Interventional|||Acupuncture in Fibromyalgia|Pilot Study of Acupuncture in Fibromyalgia|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.788523|2017-02-18 18:11:33.788523
NCT00420186|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2016-09-28|||October 2007||2007-10-01|May 2014|2014-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin|A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-690514 in Combination With Paclitaxel and Carboplatin for Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|37|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 15:58:27.908041|2017-02-18 15:58:27.908041
NCT00420173|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2013-12-11|||September 2004||2004-09-01|December 2013|2013-12-01|June 2008|Actual|2008-06-01|July 2005|Actual|2005-07-01||Observational|||Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)|Interdisciplinary Study Group of Lupus Erythematosus|Completed||N/A|45|Actual|European Society of Cutaneous Lupus Erythematosus e.V.|||1||f||||f||||||||||2017-02-18 15:58:28.006326|2017-02-18 15:58:28.006326
NCT00420160|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2015-04-10|||February 2007||2007-02-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?|Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?|Completed||Phase 2/Phase 3|59|Actual|The Miriam Hospital||2|||f||||||||||||||2017-02-18 15:58:28.096913|2017-02-18 15:58:28.096913
NCT00420147|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2009-01-26|||February 2002||2002-02-01|January 2009|2009-01-01||||||||Interventional|||Wedged Orthoses and Knee Osteoarthritis|Effect of in-Shoe Wedges on Knee Osteoarthritis|Completed||Phase 1/Phase 2|120|Anticipated|University of Delaware|||||f||||||||||||||2017-02-18 15:58:28.203542|2017-02-18 15:58:28.203542
NCT00420134|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2009-09-15|||February 2006||2006-02-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial|A Phase One/Two Clinical Trial on the Use of Autograft Mesenchymal Stem Cells Differentiated Into Progenitor of Hepatocytes for the Salvage Treatment of Patients With End-stage Liver Disease|Completed||Phase 1/Phase 2|30|Anticipated|Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 15:58:28.290593|2017-02-18 15:58:28.290593
NCT00420121|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2017-02-07|||January 2007||2007-01-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|July 2018|Anticipated|2018-07-01||Observational|||European Society of Cutaneous Lupus Erythematosus (EUSCLE)|European Society of Cutaneous Lupus Erythematosus|Enrolling by invitation||N/A|300|Anticipated|European Society of Cutaneous Lupus Erythematosus e.V.|||1||f||||f||||||||||2017-02-18 15:58:31.027751|2017-02-18 15:58:31.027751
NCT00420108|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2010-08-18|||December 2006||2006-12-01|August 2010|2010-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|3DHF||Optivol Diagnostic Data for Discharge in Heart Failure|Comparing ICD Device Diagnostics to Hospitalized Heart Failure Patient Symptoms and Physician Opinion on Discharge Readiness|Completed||N/A|23|Actual|Thomas Jefferson University|||1||f||||f||||||None Retained|"~     No biospecimens to be retained~   "|||2017-02-18 15:58:31.166815|2017-02-18 15:58:31.166815
NCT00420095|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2009-06-09|2009-01-07||January 2007||2007-01-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|IOPA||A Study for Patients With Diabetes Mellitus (IOPA)|Comparison of HbA1c in Type 1 or Type 2 Diabetic Patients Using Insulin Treated Twice Daily With Either Insulin Lispro Low Mixture or Human Insulin Mix 30/70|Completed||Phase 4|117|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:58:31.256237|2017-02-18 15:58:31.256237
NCT00420082|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2012-04-04|||October 2006||2006-10-01|April 2012|2012-04-01|December 2006|Actual|2006-12-01|||||Interventional|||A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber|A Randomized, Double-Blind, 4 Way Cross-over, Placebo Controlled Trial to Evaluate the Onset of Action of Bilastine 20 mg vs. Placebo, Cetirizine 10 mg, and Fexofenadine 120 mg in the Vienna Challenge Chamber|Completed||Phase 2|75|Actual|Faes Farma, S.A.||4|||f||||f||||||||||2017-02-18 15:58:31.951532|2017-02-18 15:58:31.951532
NCT00420069|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-07|2008-05-19|||July 2008||2008-07-01|January 2007|2007-01-01|December 2009|Anticipated|2009-12-01|||||Observational|||Biphasic Extrathoracic Cuirass Ventilation During Dental Treatment|Biphasic Extrathoracic Cuirass Ventilation During Dental Treatment Under Deep Sedation|Withdrawn||N/A|20|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:58:32.081295|2017-02-18 15:58:32.081295
NCT00420056|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2015-10-06|2015-03-04||May 2007||2007-05-01|October 2015|2015-10-01|March 2012|Actual|2012-03-01|March 2010|Actual|2010-03-01||Interventional||Full analysis set (FAS) included all participants enrolled in the study who received at least 1 dose of study medication.|An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.|A Pilot Study Of Pd 0332991 In Patients With Previously Treated Mantle Cell Lymphoma|Completed||Phase 1|17|Actual|Pfizer|Results are reported for change from baseline in maximum standard uptake value (SUVmax) instead of percent change from baseline in SUVmax.|1|||f||||f||||||||||2017-02-18 15:58:32.406139|2017-02-18 15:58:32.406139
NCT00420043|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2016-04-04|||September 2006||2006-09-01|February 2016|2016-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Effect of Food on Bioavailability of Modified Release Formulations of Imatinib|A Phase I, Two Arm, Open-label, Randomized, Study to Investigate the Effect of Food on the Bioavailability of a Single 800 mg Imatinib Dose in Modified Release Formulations (MR3 and MR4) and Compare the Bioavailability Between MR3, MR4 and Imatinib 400 mg Twice Daily Immediate Release Tablet (IR) in Healthy Subjects|Completed||Phase 1|32|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:58:32.934241|2017-02-18 15:58:32.934241
NCT00420030|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2009-06-22|||September 2006||2006-09-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock|Routine Upfront Abciximab Versus Standard Peri-Procedural Therapy in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock PRAGUE-7 Trial.|Completed||Phase 4|80|Anticipated|Charles University, Czech Republic||2|||f||||t||||||||||2017-02-18 15:58:33.027439|2017-02-18 15:58:33.027439
NCT00420017|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2013-09-06|2010-07-27||September 2005||2005-09-01|September 2013|2013-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Prevention of Atrial Fibrillation Following Esophagectomy|Prevention of Atrial Fibrillation Following Thoracoabdominal Esophagectomy Surgery|Completed||Phase 4|80|Actual|Indiana University|Design not double-blind placebo-control Atrial fibrillation was left to discretion of treating MD Larger study necessary to determine differences in length of hospital stay and cost and identify infrequently occurring amiodarone adverse effects|2|||f||||t||||||||||2017-02-18 15:58:33.140691|2017-02-18 15:58:33.140691
NCT00419991|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2011-06-21|||January 2007||2007-01-01|June 2011|2011-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection|An Open-Label Noncomparative, Multicenter, Clinical Trail Measuring Time Related Clinical Response Factors in Relation to Time to Bacterial Eradication With Tigecycline Treatment in Patients With Catheter Infection|Completed||Phase 4|10|Actual|CPL Associates||1|||f||||||||||||||2017-02-18 15:58:33.689094|2017-02-18 15:58:33.689094
NCT00419978|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2008-06-27|||June 2004||2004-06-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|||||Interventional|||The Significance of Sentinel Node Analysis in Colon Cancer|The Significance of Sentinel Node Analysis in Colon Cancer|Terminated||N/A|24|Actual|Legacy Health System||||Slow accrural to study.|f||||||||||||||2017-02-18 15:58:33.799855|2017-02-18 15:58:33.799855
NCT00419965|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2010-08-18|||October 2006||2006-10-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure|Measuring GRK2 in the Blood to Diagnose and Treat Patients With Heart Failure|Completed||N/A|582|Actual|Thomas Jefferson University|||1||f||||t||||||Samples With DNA|"~     Frozen serum/plasma - coded samples~   "|||2017-02-18 15:58:33.873716|2017-02-18 15:58:33.873716
NCT00419952|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2012-09-28|2010-11-30||February 2007||2007-02-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.|A 52-week, Randomised, Double-blind, Parallel-group, Multi-centre, Phase IIIB Study Comparing the Long Term Safety of SYMBICORT® pMDI 160/4.5 mg x 2 Actuations Twice Daily to Budesonide HFA pMDI 160 mg x 2 Actuations Twice Daily in Adult/Adolescent (≥12 Years) African American Subjects With Asthma|Completed||Phase 3|742|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:58:33.961974|2017-02-18 15:58:33.961974
NCT00419939|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2011-06-20|||February 2007||2007-02-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Intensive Rehabilitation of Patients With Severe Traumatic Brain Injury - Development of a Didactic Model|Improvement of the Interaction Between Motivation, Involvement and Re-learning of Daily Life Competences During the Intensive Neurorehabilitation of Patients With Severe TBI. Development of a Research-based Didactic Model.|Completed||Early Phase 1|11|Actual|University of Aarhus|||1||f||||f||||||||||2017-02-18 15:58:34.934871|2017-02-18 15:58:34.934871
NCT00419926|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2011-02-25|2010-12-14||December 2006||2006-12-01|February 2011|2011-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients|A Randomized, Multicenter, Parallel-group, Open-label Study to Evaluate the Therapeutic Benefit of an Initially Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Dosing Regimen, in Combination With Cyclosporine and Corticosteroids in de Novo Renal Transplant Patients|Completed||Phase 4|313|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:58:35.038311|2017-02-18 15:58:35.038311
NCT00419913|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-07|2008-03-31|||January 2007||2007-01-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|July 2007|Actual|2007-07-01||Interventional|||A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)|A Randomized Placebo-Controlled Trial of Dehydroepiandrosterone (DHEA) Treatment for Two Months Before Starting Ovulation Induction for in Vitro Fertilization (IVF)|Terminated||Phase 2/Phase 3|8|Actual|Center for Human Reproduction||2||Failure to recruit sufficient participants.|f||||||||||||||2017-02-18 15:58:35.820138|2017-02-18 15:58:35.820138
NCT00419900|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-07|2007-01-07|||December 2006||2006-12-01|January 2007|2007-01-01||||||||Interventional|||Use of Hair to Diagnose the Presence of Breast Cancer||Unknown status|Recruiting|Phase 1/Phase 2|2000||Fermiscan Ltd|||||f||||||||||||||2017-02-18 15:58:35.971333|2017-02-18 15:58:35.971333
NCT00419887|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2007-06-21|||September 2006||2006-09-01|June 2007|2007-06-01||||||||Interventional|||Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers|A Randomized, Double-Blind, Placebo-Controlled, Time-Lagged, Parallel-Group, Ascending Single and Multiple Oral Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LAF237 in Chinese Healthy Subjects|Completed||Phase 1|60||Novartis|||||f||||||||||||||2017-02-18 15:58:36.064203|2017-02-18 15:58:36.064203
NCT00419874|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-07|2007-01-07||||||November 2006|2006-11-01||||||||Observational|||Characteristics of Blood- Brain Barrier Permeability in Neurological Patients|Blood- Brain Barrier Permeability in Neurological Patients: Anatomical, Neurophysiological, and Clinical Characteristics|Unknown status|Recruiting|N/A|100||Soroka University Medical Center|||||f||||||||||||||2017-02-18 15:58:36.141132|2017-02-18 15:58:36.141132
NCT00419861|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2013-08-22|||November 2006||2006-11-01|January 2012|2012-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Inpatient Influenza Surveillance|Inpatient Surveillance for Influenza Infections in Adults|Completed||N/A|350|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Nasal and throat swabs will be obtained and combined for viral culture, rapid antigen~     testing, and PCR. Specimens obtained from hospitalized subjects will be tested for influenza~     A & B viruses by viral culture, rapid antigen testing and Real-Time Reverse-Transcriptase~     PCR (RTrtPCR) analysis.~   "|||2017-02-18 15:58:36.225246|2017-02-18 15:58:36.225246
NCT00419848|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2008-01-28|||August 2006||2006-08-01|January 2008|2008-01-01|February 2008|Anticipated|2008-02-01|January 2008|Anticipated|2008-01-01||Interventional|||the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris|the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris|Unknown status|Recruiting|Phase 2|100|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 15:58:36.55167|2017-02-18 15:58:36.55167
NCT00419835|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2011-08-03|||May 2005||2005-05-01|January 2007|2007-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus|Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus|Completed||Phase 4|80|Actual|University of Sao Paulo|||||f||||||||||||||2017-02-18 15:58:36.654898|2017-02-18 15:58:36.654898
NCT00419822|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2011-06-30|||September 2006||2006-09-01|May 2010|2010-05-01||||March 2011|Actual|2011-03-01||Interventional|||Acupuncture in the Management of Post Operative Symptoms in Breast Cancer Patients|A Randomized, Intent to Treat, Controlled Study of the Efficacy of Verum Acupuncture Compared to Sham Acupuncture in the Management of Post Operative Symptoms in Breast Cancer Subjects That Have Undergone Axillary Surgery|Completed||N/A|30|Anticipated|Legacy Health System||3|||f||||||||||||||2017-02-18 15:58:36.749855|2017-02-18 15:58:36.749855
NCT00419809|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2012-05-31|||May 2005||2005-05-01|January 2012|2012-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||SB-681323-Methotrexate Interaction Study|A Placebo Controlled Study to Evaluate the Safety and Tolerability of Repeat Doses of SB-681323 in Patients Receiving Methotrexate for Rheumatoid Arthritis.|Completed||Phase 1|18|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 15:58:36.863018|2017-02-18 15:58:36.863018
NCT00419796|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2007-11-28|||November 2006||2006-11-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension|A 4-Week, Multicentre, Randomized, Double-Blind, Placebo Controlled, Double Dummy, Parallel Group Study, to Assess the Effect of Lumiracoxib 100 mg o.d. and Ibuprofen 600 mg t.i.d on 24-Hour Blood Pressure Profile and on Urinary Excretions of Eicosanoids, in Osteoarthritis Patients With Controlled Hypertension|Completed||Phase 4|78|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:58:36.958894|2017-02-18 15:58:36.958894
NCT00419783|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2012-04-04|||August 2006||2006-08-01|April 2012|2012-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of Bilastine|A Phase 1, Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic Effects of Bilastine in Healthy Adult Subjects|Completed||Phase 1|30|Actual|Faes Farma, S.A.||5|||f||||f||||||||||2017-02-18 15:58:37.052369|2017-02-18 15:58:37.052369
NCT00419770|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2011-09-02|2011-06-29||October 2007||2007-10-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study|The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study|Completed||Phase 2|20|Actual|Los Angeles Biomedical Research Institute||2|||f||||t||||||||||2017-02-18 15:58:37.173189|2017-02-18 15:58:37.173189
NCT00419757|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2012-08-24|2009-05-20||January 2007||2007-01-01|August 2012|2012-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma|A 12-week, Randomised, Double Blind, Active-controlled, Multi-centre, Phase IIIB Study Comparing the Efficacy and Safety of SYMBICORT® pMDI 160/4.5 mg x 2 Actuations Twice Daily Versus Budesonide HFA pMDI 160 mg x 2 Actuations Twice Daily, in Adult/Adolescent (> 12 Yrs) Hispanic Subjects With Asthma|Completed||Phase 3|558|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 15:58:37.65551|2017-02-18 15:58:37.65551
NCT00419744|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2010-08-18|2010-08-18||January 2007||2007-01-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD|A Phase IIIB, 12-Month, Double-blind, Double-dummy,Randomised, Parallel-group, Multicentre Exacerbation Study of SYMBICORT® pMDI 160/4.5 μg x 2 Actuations Twice-daily and 80/4.5 μg x 2 Actuations Twice-daily Compared to Formoterol Turbuhaler® 4.5 μg x 2 Inhalations Twice-daily in COPD Subjects|Completed||Phase 3|1200|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 15:58:38.338913|2017-02-18 15:58:38.338913
NCT00419731|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2009-12-02|||November 2006||2006-11-01|December 2009|2009-12-01|July 2010|Anticipated|2010-07-01|February 2010|Anticipated|2010-02-01||Interventional|||Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation|Phase II Randomized, Double-Blind Trial of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation|Unknown status|Recruiting|Phase 2/Phase 3|120|Anticipated|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 15:58:39.681048|2017-02-18 15:58:39.681048
NCT00419718|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2017-01-23|||October 2005||2005-10-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes|Effect of Exercise on the Pharmacokinetics and Pharmacodynamics of Inhaled Human Insulin in Subjects With Type 1 Diabetes|Completed||Phase 1|23|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 15:58:39.818105|2017-02-18 15:58:39.818105
NCT00419705|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2011-06-07|||December 2006||2006-12-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)|NeuroThera® Effectiveness and Safety Trial - 2 (NEST-2) A Double Blind, Randomized, Controlled, Parallel Group, Multicenter, Pivotal Study to Assess the Safety and Effectiveness of the Treatment of Acute Ischemic Stroke With the NeuroThera® Laser System Within 24 Hours From Stroke Onset|Completed||Phase 3|660|Actual|PhotoThera, Inc||2|||f||||t||||||||||2017-02-18 15:58:39.931208|2017-02-18 15:58:39.931208
NCT00419692|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2012-03-15|||August 2006||2006-08-01|February 2011|2011-02-01||||||||Interventional|||Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food|An Open Label, Repeat Dose, Dose Escalation Study Conducted in RLS Patients to Characterize Pharmacokinetics and Food Effect of Ropinirole Controlled Release for RLS|Completed||Phase 1|32|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 15:58:40.105141|2017-02-18 15:58:40.105141
NCT00419679|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-07|2007-01-07|||December 2006||2006-12-01|January 2007|2007-01-01||||||||Interventional|||Use of Hair to Diagnose Breast Cancer|A Prospective Blinded Study to Evaluate and Characterise an Assay for the Diagnosis of Breast Cancer Using Synchrotron-Derived X-Ray Diffraction of Hair Fibres.|Unknown status|Recruiting|Phase 1/Phase 2|3600||Fermiscan Ltd|||||f||||||||||||||2017-02-18 15:58:40.197302|2017-02-18 15:58:40.197302
NCT00419666|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2012-03-08|||August 2006||2006-08-01|April 2011|2011-04-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis|PK and PD of Calcitriol Following Twice Daily Application of Calcitriol 3 µg/g Ointment Under Conditions of Maximal Use in Adolescents With Plaque Psoriasis|Completed||Phase 2|25|Actual|Galderma||1|||f||||||||||||||2017-02-18 15:58:40.293664|2017-02-18 15:58:40.293664
NCT00419653|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2008-09-15|||January 2003||2003-01-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy|Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy With Amisulpride, Olanzapine or Haloperidol. A Study With Functional Magnetic Resonance Imaging (fMRI) and Diffusion Tensor Imaging (DTI)|Terminated||Phase 4|19|Actual|University of Jena||3||Recruitment issues|f||||f||||||||||2017-02-18 15:58:40.404317|2017-02-18 15:58:40.404317
NCT00419640|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-08|2012-12-12|||May 2005||2005-05-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|February 2012|Actual|2012-02-01||Interventional|SAFE||SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation|Septal Pacing for Atrial Fibrillation Suppression Evaluation|Completed||N/A|385|Actual|St. Jude Medical||4|||f||||t||||||||||2017-02-18 15:58:40.513503|2017-02-18 15:58:40.513503
NCT00419627|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2007-01-05|||February 2007||2007-02-01|January 2007|2007-01-01||||||||Observational|||Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas|Proteomic Analysis of Serology and Peptides Presented on the HLA Complex of Breast, Ovarian, Colon, Rectal, Gastric and Pancreatic Adenocarcinoma.|Unknown status|Not yet recruiting|N/A|160||Hillel Yaffe Medical Center|||||f||||||||||||||2017-02-18 15:58:40.622034|2017-02-18 15:58:40.622034
NCT00418470|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2015-10-28|||March 2007||2007-03-01|October 2015|2015-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People|Prolonging the Duration on Site of Short Peripheral Venous Catheters Used to Administer Intravenous Antibiotics in Cystic Fibrosis Adults. Randomized Controlled Trial on the Effect of Different Concentrations of Antibiotic in Normal Saline|Terminated||Phase 4|60|Anticipated|University of Florence||2||impossibility to find volunteers|f||||f||||||||||2017-02-18 15:58:40.69899|2017-02-18 15:58:40.69899
NCT00418457|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2017-01-19|||January 2007||2007-01-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|March 2019|Anticipated|2019-03-01||Interventional|||Regional Anesthesia and Breast Cancer Recurrence|Regional Anesthesia and Breast Cancer Recurrence|Recruiting||Phase 3|1100|Anticipated|The Cleveland Clinic||2|||f||||t||||||||No||2017-02-18 15:58:40.824209|2017-02-18 15:58:40.824209
NCT00418444|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2015-06-30|||January 2007||2007-01-01|January 2007|2007-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Body Image and Psychosocial Functioning in Women With Breast Cancer: Can We Fix What We've Broken?|Randomized Control Trial of a Group Therapy Intervention Addressing Body Image and Psychosocial Functioning for Women With Breast Cancer|Completed||N/A|180|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 15:58:40.959897|2017-02-18 15:58:40.959897
NCT00418431|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-03|||April 2006||2006-04-01|June 2006|2006-06-01|August 2006||2006-08-01|||||Interventional|||Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy||Unknown status|Recruiting|Phase 2/Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 15:58:41.064318|2017-02-18 15:58:41.064318
NCT00418418|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2008-08-18|||October 2006||2006-10-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Combined CABG and Stem-Cell Transplantation for Heart Failure|Combined CABG and Stem-Cell Transplantation for Heart Failure|Unknown status|Recruiting|Phase 2|60|Anticipated|Helsinki University||2|||f||||t||||||||||2017-02-18 15:58:41.144806|2017-02-18 15:58:41.144806
NCT00418405|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-03|||January 2007||2007-01-01|January 2007|2007-01-01|January 2012||2012-01-01|||||Observational|||Hanyang University Medical Center Arthritis Network|Hanyang University Medical Center Arthritis Network|Unknown status|Not yet recruiting|Phase 4|1500||Hanyang University|||||f||||||||||||||2017-02-18 15:58:41.272054|2017-02-18 15:58:41.272054
NCT00418392|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-31|2012-12-13|||November 2006||2006-11-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Intrapleural Minocycline After Simple Aspiration for the Prevention of Primary Spontaneous Pneumothorax|Intrapleural Minocycline After Simple Aspiration for the Prevention of Primary Spontaneous Pneumothorax: A Randomized Trial|Unknown status|Recruiting|Phase 3|300|Anticipated|National Taiwan University Hospital||2|||f||||||||||||||2017-02-18 15:58:41.36574|2017-02-18 15:58:41.36574
NCT00418379|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2016-04-18|2016-01-25||December 2006||2006-12-01|April 2016|2016-04-01|September 2011|Actual|2011-09-01|August 2010|Actual|2010-08-01||Interventional||Full Analysis Set Year 1 (FASY1). FASY1 included all patients who received at least one dose of the investigational product and had at least one Adjusted Symptom Score (ASS) during the pollen period while on treatment during the Year 1.|Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets|A Randomised, Double-blind, Placebo-controlled, Multi-national, Multi-centre, Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of Two Dosing Regimens of 300 IR Sublingual Immunotherapy (SLIT) Administered as Allergen-based Tablets Once Daily to Patients Suffering From Grass Pollen Rhinoconjunctivitis|Completed||Phase 3|633|Actual|Stallergenes||3|||f||||t||||||||||2017-02-18 15:58:41.502438|2017-02-18 15:58:41.502438
NCT00418366|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2015-08-18|||January 2003||2003-01-01|August 2015|2015-08-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)|An Open- Label, 2 Part Study to Investigate the Pharmacokinetics, Safety, and Tolerability of MK0431(Sitagliptin Phosphate) in Patients With Varying Degrees of Renal Insufficiency|Completed||Phase 1|24|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 15:58:42.059286|2017-02-18 15:58:42.059286
NCT00418353|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2007-01-02|||August 2002||2002-08-01|January 2007|2007-01-01|April 2005||2005-04-01|||||Interventional|||"Antenatal Betamethasone Compared to Dexamethasone - BETACODE TRIAL"||Completed||N/A|||University of Oklahoma|||||f||||||||||||||2017-02-18 15:58:42.145505|2017-02-18 15:58:42.145505
NCT00418340|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2007-11-15|||December 2007||2007-12-01|November 2007|2007-11-01||||||||Interventional|||Manipulation of Visceral Sensitivity and Immune System in IBS|Bacteria and Cytokines as Factors Modulating Visceral Afferent Processing in Irritable Bowel Syndrome: Manipulation of Intestinal Bacteria and Mucosal Cytokines by Probiotic Therapy and the Effect on Visceral Hypersensitivity|Unknown status|Not yet recruiting|Phase 4|10|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 15:58:42.239403|2017-02-18 15:58:42.239403
NCT00419614|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2007-01-05||||||January 2007|2007-01-01||||||||Observational|||Outcome of Pancreatic Stump Closure Following Resection of Tumors of the Head of the Pancreas.|Retrospective Chart Review on the Association of Pancreaticoduodenectomy Without Pancreatic-Gastrointestinal Anastomosis to Perioperative Morbidity and Mortality|Unknown status|Not yet recruiting|N/A|||Hillel Yaffe Medical Center|||||f||||||||||||||2017-02-18 15:58:42.337305|2017-02-18 15:58:42.337305
NCT00419601|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2010-06-24|||November 2006||2006-11-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Rapip Study: Clinical Trial on Remifentanyl for Analgesia and Sedation of Ventilated Neonates and Infants|Prospective Randomized, Double-blinded Clinical Trial on Remifentanyl for Analgesia and Sedation of Ventilated Neonates and Infants|Completed||Phase 3|24|Actual|University of Cologne||2|||f||||f||||||||||2017-02-18 15:58:42.397885|2017-02-18 15:58:42.397885
NCT00419588|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2016-10-11|||September 2006||2006-09-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Growth of Airways and Lung Tissues in Premature and Healthy Infants|Growth of Airways and Lung Parenchyma|Recruiting||N/A|215|Anticipated|Indiana University|||3||f||||t||||||Samples With DNA|"~     Buccal Cells are being obtained.~   "|||2017-02-18 15:58:42.507819|2017-02-18 15:58:42.507819
NCT00419562|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-12-05|||February 2007||2007-02-01|December 2016|2016-12-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus|Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus|Active, not recruiting||Phase 3|400|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 15:58:42.686194|2017-02-18 15:58:42.686194
NCT00419549|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2009-01-28|||October 2003||2003-10-01|January 2009|2009-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)|Effect of Transdermal Glyceryl-Trinitrate and Parecoxib (Valdecoxib) for the Prevention of Post -ERCP Pancreatitis|Terminated||Phase 2/Phase 3|371|Actual|All India Institute of Medical Sciences, New Delhi||3||Because one of the drugs Valdecoxib was withdrawn due to safety concerns.|f||||f||||||||||2017-02-18 15:58:42.821614|2017-02-18 15:58:42.821614
NCT00419536|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2010-04-07|||May 2006||2006-05-01|April 2010|2010-04-01||||||||Interventional|||Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone|A Phase IA/IB, Two Arm, Multi-center, Open-label, Dose Escalation Study of Oral LBH589 Alone and in Combination With IV Docetaxel and Oral Prednisone in Hormone Refractory Prostate Cancer (HRPC)|Terminated||Phase 1|108||Novartis|||||f||||||||||||||2017-02-18 15:58:42.937443|2017-02-18 15:58:42.937443
NCT00419510|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-08-15|||February 2003||2003-02-01|August 2016|2016-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Genetic Counseling in African American Women|Genetic Counseling for Breast Cancer Susceptibility in African American Women|Completed||N/A|204|Actual|University of Pennsylvania||1|||f||||||||||||||2017-02-18 15:58:43.030098|2017-02-18 15:58:43.030098
NCT00419497|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-09-18|||January 2003||2003-01-01|September 2016|2016-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Paleolithic Diet in the Treatment of Glucose Intolerance|Paleolithic Diet in the Treatment of Glucose Intolerance|Completed||Phase 2/Phase 3|29|Actual|Lund University Hospital||1|||f||||f||||||||No||2017-02-18 15:58:43.1155|2017-02-18 15:58:43.1155
NCT00419484|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2007-01-05|||March 2004||2004-03-01|January 2007|2007-01-01|July 2008||2008-07-01|||||Observational|||Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes||Completed||Phase 4|1000||Dokkyo Medical University|||||f||||||||||||||2017-02-18 15:58:43.224854|2017-02-18 15:58:43.224854
NCT00419471|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2013-06-11|||May 2007||2007-05-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome|Efficacy and Safety of Escitalopram in the Treatment of Depressive Patients With Acute Coronary Artery Syndrome: A Double-blind Placebo-controlled Trial|Completed||Phase 4|300|Actual|Chonnam National University Hospital||2|||f||||t||||||||||2017-02-18 15:58:43.540614|2017-02-18 15:58:43.540614
NCT00419458|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2009-11-06|||February 2004||2004-02-01|November 2009|2009-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Inspiratory Muscle Training in Ventilator Dependent Patients|Respiratory Muscle Training in Ventilator Dependent Patients|Completed||Phase 1|150|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 15:58:43.671894|2017-02-18 15:58:43.671894
NCT00419445|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2010-08-16|2010-08-16||February 2007||2007-02-01|August 2010|2010-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder|A Double-Blind, Randomized, Proof-of-Concept Crossover Trial to Assess the Effects of GTS21 on Cognitive Function, Clinical Symptoms, and Adverse Events in Adults Diagnosed With Attention-Deficit Hyperactivity Disorder|Completed||Phase 1/Phase 2|37|Actual|CoMentis||3|||f||||f||||||||||2017-02-18 15:58:43.771616|2017-02-18 15:58:43.771616
NCT00419432|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2017-02-14|||January 2007||2007-01-01|February 2017|2017-02-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Outcomes of Orthopaedic Surgery Using Gait Laboratory Versus Observational Gait Analysis in Children With Cerebral Palsy|Functional Outcomes Following Orthopaedic Surgery Based on Gait Laboratory Versus Observational Gait Analysis in Ambulatory Children With Cerebral Palsy: A Multi-center Randomized Controlled Trial.|Active, not recruiting||Phase 1/Phase 2|60|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 15:58:44.291107|2017-02-18 15:58:44.291107
NCT00419419|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2007-05-29|||December 2006||2006-12-01|May 2007|2007-05-01||||||||Interventional|||Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon|"Phase III In-Life Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, and Matching Placebo Gel in the Treatment and Prevention of Raynaud's Phenomenon"|Completed||Phase 3|80||MediQuest Therapeutics|||||f||||||||||||||2017-02-18 15:58:44.41819|2017-02-18 15:58:44.41819
NCT00419406|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2009-01-21|||March 2005||2005-03-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic Dermatitis|Medium-Dose UVA1 Versus Narrow-Band UVB Phototherapy: A Randomized Double-Blind Controlled Cross-Over-Study|Completed||N/A|28|Actual|Ruhr University of Bochum||2|||f||||f||||||||||2017-02-18 15:58:44.529829|2017-02-18 15:58:44.529829
NCT00419393|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2014-08-26|2011-03-25||December 2007||2007-12-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures|An Open-label, Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Treatment of Partial-onset Seizures|Completed||Phase 3|190|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 15:58:44.651666|2017-02-18 15:58:44.651666
NCT00419380|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2015-03-11|2015-02-24||January 2007||2007-01-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)|Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)|Completed||Phase 4|40|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 15:58:45.070506|2017-02-18 15:58:45.070506
NCT00419367|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2016-12-30||||||December 2016|2016-12-01||||||||Expanded Access|||Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)|Compassionate Use of Vorinostat (MK0683) for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma|No longer available||Phase 3|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 15:58:45.728019|2017-02-18 15:58:45.728019
NCT00419354|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2009-04-20|||March 2007||2007-03-01|July 2006|2006-07-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Observational|||The Impact of Right Ventricular Pacing on Tricuspid Regurgitation||Unknown status|Recruiting|N/A|50|Anticipated|Rabin Medical Center|||1||f||||f||||||||||2017-02-18 15:58:45.808991|2017-02-18 15:58:45.808991
NCT00419341|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2012-12-16|2012-12-16||November 2006||2006-11-01|December 2012|2012-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy|A Phase III Open-Label, Prospective, Multicenter Study of the Efficacy, Tolerability, Safety, and Pharmacokinetics of Immune Globulin Subcutaneous (Human), IgPro20 in Subjects With Primary Immunodeficiency (PID)|Completed||Phase 3|49|Actual|CSL Behring||1|||f||||||||||||||2017-02-18 15:58:45.901006|2017-02-18 15:58:45.901006
NCT00419328|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2013-01-28|||March 2005||2005-03-01|January 2013|2013-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors|NGR002: A Modified Phase I Study of NGR-hTNF in Advanced Solid Tumors: Definition of an Optimal Biological Dose|Completed||Phase 1|16|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 15:58:46.438366|2017-02-18 15:58:46.438366
NCT00419315|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2015-04-24|2014-10-01||August 2007||2007-08-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|March 2011|Actual|2011-03-01||Interventional|||A Randomized Clinical Trial of Alcohol Care Management|Primary Care Based Disease Management for Alcohol Dependence|Completed||Phase 4|163|Actual|VA Office of Research and Development|The data presented in the results does not provide a true measure of the longitudinal effects done with GEE modeling.|2|||f||||t||||||||||2017-02-18 15:58:46.552938|2017-02-18 15:58:46.552938
NCT00419302|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2009-10-12|||October 2003||2003-10-01|October 2009|2009-10-01|April 2004||2004-04-01|||||Interventional|||To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.||Completed||Phase 2|16||Mannkind Corporation|||||f||||||||||||||2017-02-18 15:58:47.110969|2017-02-18 15:58:47.110969
NCT00419289|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2007-01-04|||January 2007||2007-01-01|January 2007|2007-01-01|June 2008||2008-06-01|||||Interventional|||Optimizing the Effect of COPD Rehabilitation|Rehabilitation of COPD Patients: Can the Effect be Prolonged by Follow-up and Continued Rehabilitation|Unknown status|Not yet recruiting|N/A|120||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 15:58:47.193964|2017-02-18 15:58:47.193964
NCT00419276|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-09-27|||April 2007||2007-04-01|September 2016|2016-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effect of Ambulatory Continuous Femoral Nerve Blocks on Readiness-for-Discharge Following Total Knee Replacement|Effect of Ambulatory Continuous Femoral Nerve Blocks on Readiness-for-Discharge Following Total Knee Arthroplasty: A Multicenter, Randomized, Triple-Masked, Placebo-Controlled Investigation|Completed||N/A|81|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 15:58:47.280274|2017-02-18 15:58:47.280274
NCT00419263|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2015-01-28|2015-01-16||January 2007||2007-01-01|January 2015|2015-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional||The safety population included all subjects who received any dose of study drug. Subjects were analyzed according to the treatment received.|Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.|A Phase II, Multicenter, Randomized, Double-Mask, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza.|Completed||Phase 2|344|Actual|BioCryst Pharmaceuticals||3|||f||||t||||||||||2017-02-18 15:58:47.391847|2017-02-18 15:58:47.391847
NCT00419250|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2016-10-27|||December 2006||2006-12-01|October 2016|2016-10-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia|A Phase 1, Multi-center, Open-label Study of the Safety and Efficacy of a Stepwise Dose-escalation Schedule of Lenalidomide Monotherapy in Subjects With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia|Completed||Phase 1|52|Actual|Celgene Corporation||5|||f||||t||||||||||2017-02-18 15:58:51.388041|2017-02-18 15:58:51.388041
NCT00419237|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2016-08-30|||January 2005||2005-01-01|August 2016|2016-08-01|April 2005|Actual|2005-04-01|||||Interventional|||Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function|A Study to Investigate the Pharmacokinetics of a Single Inhaled Dose (400mcg) of GW685698X and Its Effect on Serum Cortisol in Patients With Impaired Liver Function and Matched Control Subjects.|Completed||Phase 1|20||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 15:58:51.772817|2017-02-18 15:58:51.772817
NCT00419224|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2007-01-09|||October 2002||2002-10-01|January 2007|2007-01-01|April 2003||2003-04-01|||||Interventional|||Influenza Vaccination in Bone Marrow Transplantation|Immunogenicity of Influenza Vaccination (Flu Vac) in Patients Receiving Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NM Allo PBSCT) Compared to Healthy Controls|Completed||Phase 4|36||The Cleveland Clinic|||||f||||||||||||||2017-02-18 15:58:51.858637|2017-02-18 15:58:51.858637
NCT00419211|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2012-05-23|||January 2007||2007-01-01|May 2012|2012-05-01||||December 2011|Actual|2011-12-01||Interventional|||An Intervention Study to Increase Physical Activity and Maternal Well-being During Pregnancy|"Fit Pregnancy: A Transtheoretical-Model Based Intervention Designed To Increase Physical Activity and Maternal Well-Being During Pregnancy"|Completed||Early Phase 1|76|Actual|McGill University||2|||f||||||||||||||2017-02-18 15:58:51.947034|2017-02-18 15:58:51.947034
NCT00419198|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2010-03-08|||September 2005||2005-09-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Clinical Outcomes of Angioplasty Postconditioning|Postconditioning and Functional Recovery After Acute Myocardial Infarction|Completed||N/A|91|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-02-18 15:58:52.147925|2017-02-18 15:58:52.147925
NCT00419185|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2007-01-05|||April 2003||2003-04-01|January 2007|2007-01-01|January 2005||2005-01-01|||||Interventional|||Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery|Internal Limiting Membrane (ILM)- Peeling With Indocyanine Green or Trypan Blue in Macular Hole Surgery: A Prospective Randomized Trial|Completed||N/A|40||University of Luebeck|||||f||||||||||||||2017-02-18 15:58:52.248205|2017-02-18 15:58:52.248205
NCT00419172|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2009-11-18|||January 2007||2007-01-01|November 2009|2009-11-01||||||||Interventional|||Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers|A Phase I, Single Center, Open-label, One-sequence Cross-over Study to Investigate the Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers|Completed||Phase 1|22|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:58:52.354539|2017-02-18 15:58:52.354539
NCT00418288|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2008-06-09|||January 2007||2007-01-01|June 2008|2008-06-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia|The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Subjects During Hypoglycemia Assessed by Positron Emission Tomography|Completed||N/A|10|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 15:59:01.051772|2017-02-18 15:59:01.051772
NCT00419159|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2011-11-04|2010-12-17||December 2006||2006-12-01|November 2011|2011-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy|A Single Arm, Multicenter Phase II Study of Everolimus in Patients With Metastatic Colorectal Adenocarcinoma Whose Cancer Has Progressed Despite Prior Therapy With an Anti-EGFR Antibody (if Appropriate), Bevacizumab, Fluoropyrimidine, Oxaliplatin, and Irinotecan-based Regimens|Completed||Phase 2|199|Actual|Novartis||2|||f||||||||||||||2017-02-18 15:58:52.442974|2017-02-18 15:58:52.442974
NCT00419146|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2011-01-03|||September 2001||2001-09-01|August 2010|2010-08-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants|A Multicentre, Placebo-controlled Trial of Eicosapentaenoic Acid (EPA) and Antioxidant Supplementation in the Treatment of Schizophrenia and Related Disorders|Completed||Phase 2/Phase 3|99|Actual|Oslo University Hospital||4|||f||||f||||||||||2017-02-18 15:58:53.140329|2017-02-18 15:58:53.140329
NCT00419133|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2009-12-04|||June 2007||2007-06-01|December 2009|2009-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine|Immune Responses Following One Versus Two Doses of Killed Oral Cholera Vaccine in Eastern Kolkata, West Bengal, India|Completed||Phase 2|160|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-02-18 15:58:53.282397|2017-02-18 15:58:53.282397
NCT00419120|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2015-11-02|2009-12-08||December 2006||2006-12-01|November 2015|2015-11-01|April 2011|Actual|2011-04-01|October 2008|Actual|2008-10-01||Interventional|||Augmentation Cystoplasty Using an Autologous Neo-Bladder|An Open-Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Spina Bifida|Terminated||Phase 2|10|Actual|Tengion||1||36 months follow up without change to profile. No further studies planned.|f||||t||||||||||2017-02-18 15:58:53.397362|2017-02-18 15:58:53.397362
NCT00419107|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2011-11-07|||November 2004||2004-11-01|November 2011|2011-11-01|January 2007|Actual|2007-01-01|||||Observational|||Beta Cell Function in Women With Turner Syndrome|Beta Cell Function in Women With Turner Syndrome|Terminated||N/A|25|Actual|University of Aarhus|||1|Completed|f||||||||||Samples With DNA|"~     Blood samples.~   "|||2017-02-18 15:58:53.920271|2017-02-18 15:58:53.920271
NCT00419094|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2014-08-26|2010-09-13||August 2007||2007-08-01|January 2011|2011-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Conversion to Monotherapy Study With Keppra XR for Partial Seizures|A Multi-center, Double-blind, Historical Control, Randomized Conversion to Monotherapy Study With Keppra XR for Treatment of Partial Onset Seizures|Completed||Phase 3|228|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 15:58:54.002434|2017-02-18 15:58:54.002434
NCT00419081|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2012-01-18||2012-01-18|July 2006||2006-07-01|January 2012|2012-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens|A Phase IIb, Multicenter, Open-Label, Nonrandomized, Repeat-Dose Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens.|Terminated||Phase 2|100||BioCryst Pharmaceuticals||||Issues with Manufacturing|f||||||||||||||2017-02-18 15:58:54.589357|2017-02-18 15:58:54.589357
NCT00419068|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-05|2009-09-29|||January 2007||2007-01-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Trial of Adjunctive Vitamin D in Tuberculosis Treatment|Trial of Adjunctive Vitamin D in Tuberculosis Treatment|Completed||Phase 3|146|Anticipated|Barts & The London NHS Trust|||||f||||||||||||||2017-02-18 15:58:54.72592|2017-02-18 15:58:54.72592
NCT00419055|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2012-03-29|||August 2004||2004-08-01|March 2012|2012-03-01|August 2006|Actual|2006-08-01|||||Observational|||Outpatient Percutaneous Coronary Intervention|Outpatient Percutaneous Coronary Intervention in a Selected, Stable Patient Population|Terminated||Phase 2/Phase 3|100|Anticipated|University of Pennsylvania|||2|Stopped early due to inability to recruit full 100 subjects over 2 years|f||||t||||||||||2017-02-18 15:58:54.817735|2017-02-18 15:58:54.817735
NCT00419042|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2013-09-29|||July 2006||2006-07-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|September 2006|Actual|2006-09-01||Observational|||Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)|A Multicenter Randomized Phase II Trial in NSCLC Stage IV et IIIB in Elderly Dependent Patients With Evaluation of the Sequence Gemcitabine First Line Followed by Erlotinib When Progression Versus Erlotinib First Line Followed by Gemcitabine When Progression.|Completed||Phase 2|100|Actual|Groupe Francais De Pneumo-Cancerologie|||1||f||||t||||||||||2017-02-18 15:58:54.921608|2017-02-18 15:58:54.921608
NCT00419029|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2014-08-25|||September 2007||2007-09-01|August 2014|2014-08-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|||Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment|Motivational Interviewing to Engage OEF/OIF Veterans in Mental Health Treatment|Completed||N/A|400|Actual|San Francisco Veterans Affairs Medical Center||2|||f||||f||||||||||2017-02-18 15:58:55.051482|2017-02-18 15:58:55.051482
NCT00419016|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2007-01-04||||||January 2007|2007-01-01||||||||Observational|||Association Between Schizophrenia and Cancer||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 15:58:55.151642|2017-02-18 15:58:55.151642
NCT00419003|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-02-19|2013-09-05||December 2006||2006-12-01|February 2016|2016-02-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Research Study for Major Depressive Disorder: Investigation of Glutamate Medications|Continuation Riluzole in the Prevention of Relapse Following Ketamine in Major Depression|Completed||Phase 4|26|Actual|Baylor College of Medicine|The open-label administration of ketamine limits interpretation of phase 1 results. The sample size was too small to detect moderators and mediators of response. Third,lack of placebo-controlled efficacy data supporting riluzole's use in depression.|2|||f||||f||||||||No||2017-02-18 15:58:55.223118|2017-02-18 15:58:55.223118
NCT00418990|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-04|||August 2003||2003-08-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Effect of Vitamins on Academic Performance of School Children|Effect of a Randomized Trial of Multivitamin-Mineral Supplementation on Standardized Assessment of Academic Performance in Elementary School Children|Completed||N/A|1600||Rutgers, The State University of New Jersey|||||f||||||||||||||2017-02-18 15:58:55.59715|2017-02-18 15:58:55.59715
NCT00418275|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-03|||April 2001||2001-04-01|December 2006|2006-12-01|June 2004||2004-06-01|||||Interventional|||Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.|A Dose Finding, Pharmacokinetic and Safety Study of a Recombinant Human Plasminogen Activator (HTU-PA) in Patients With Acute Ischemic Stroke|Completed||Phase 1/Phase 2|30||Global Biotech|||||f||||||||||||||2017-02-18 15:59:01.157914|2017-02-18 15:59:01.157914
NCT00418977|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2015-11-19|2014-03-10||September 2005||2005-09-01|November 2015|2015-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents|Early Identification and Treatment of Anorexia Nervosa|Completed||N/A|59|Actual|Icahn School of Medicine at Mount Sinai|Limitations include a small sample size and attrition leading to missing end-of-intervention data. In addition, participation with follow-up evaluations was poor.|2|||f||||f||||||||||2017-02-18 15:58:55.692897|2017-02-18 15:58:55.692897
NCT00418964|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2012-03-22|2011-06-22||December 2006||2006-12-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Clinical Trial Comparing Three Anterior Cruciate Ligament Reconstructive Procedures|Functional, Clinical & Radiological Outcome of Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Control Clinical Trial Studies Comparing Bone Patella Bone, Single Bundle and Double Bundle Method.|Completed||N/A|62|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-02-18 15:58:56.04548|2017-02-18 15:58:56.04548
NCT00418951|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2012-08-01|2011-04-15||November 2006||2006-11-01|August 2012|2012-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections|Open, Randomized Comparative Trial of Two Different Schedules of Liposomal Amphotericin B Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections|Completed||Phase 2|120|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-02-18 15:58:56.770434|2017-02-18 15:58:56.770434
NCT00418938|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2014-02-13|2013-10-04||November 2006||2006-11-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|May 2012|Actual|2012-05-01||Interventional|||SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial|A Multi-center, Open-label, Randomized, Phase 2 Clinical Trial Evaluating Safety and Efficacy of FOLFIRI With Either Panitumumab or Bevacizumab as Second-Line Treatment in Subjects With Metastatic Colorectal Cancer With Wild-type KRAS Tumors|Completed||Phase 2|266|Actual|Amgen||2|||f||||t||||||||||2017-02-18 15:58:57.21739|2017-02-18 15:58:57.21739
NCT00418925|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2008-09-08|||September 2006||2006-09-01|August 2007|2007-08-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|||Efficacy of Dronabinol for the Treatment of Cervical Dystonia|Phase II, Double Blind, Randomized, Placebo Controlled Trial of Dronabinol for the Treatment of Cervical Dystonia|Unknown status|Recruiting|Phase 2|38|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 15:58:58.341532|2017-02-18 15:58:58.341532
NCT00418912|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2008-02-13|||March 2007||2007-03-01|February 2008|2008-02-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Observational|||Family Study in Schizophrenia||Unknown status|Recruiting|N/A|100|Anticipated|Sheba Medical Center|||1||f||||||||||||||2017-02-18 15:58:58.442886|2017-02-18 15:58:58.442886
NCT00418899|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2016-11-21|||February 2004||2004-02-01|November 2016|2016-11-01||||February 2018|Anticipated|2018-02-01||Observational|||Gliogene: Brain Tumor Linkage Study|Gliogene: Brain Tumor Linkage Study|Active, not recruiting||N/A|17080|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     About 3 tablespoons of blood will be drawn and if unable to donate blood, researchers will~     collect a saliva sample.~   "|||2017-02-18 15:58:58.51783|2017-02-18 15:58:58.51783
NCT00418886|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-08-24|2011-04-27||January 2007||2007-01-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|September 2008|Actual|2008-09-01||Interventional|ZEAL||Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients|A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to Assess the Efficacy and Safety of ZD6474 (ZACTIMA™) in Combination With Pemetrexed (Alimta®) Versus Pemetrexed Alone in Patients With Locally-Advanced or Metastatic NSCLC|Active, not recruiting||Phase 3|698|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:58:58.679348|2017-02-18 15:58:58.679348
NCT00418873|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2010-04-15|||March 2007||2007-03-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward|A Multi-centre Comparative Study to Evaluate the Anti-aggression Effect and Safety of Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward|Terminated||Phase 4|39|Actual|Astellas Pharma Inc||2||Study was stopped due to difficulty in patient enrollment|f||||f||||||||||2017-02-18 15:58:59.858256|2017-02-18 15:58:59.858256
NCT00418860|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2011-08-10|||September 2006||2006-09-01|August 2011|2011-08-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|DATE||The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent|The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent in the Patients With Coronary Artery Disease (DATE Registry)|Completed||N/A|1200|Anticipated|Samsung Medical Center||1|||f||||t||||||||||2017-02-18 15:58:59.969214|2017-02-18 15:58:59.969214
NCT00418847|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-04|2016-05-18|||July 2004||2004-07-01|May 2016|2016-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis|Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis: Single and Multiple Oral Doses|Completed||Phase 2|5|Actual|The Hospital for Sick Children||1|||f||||f||||||||||2017-02-18 15:59:00.0809|2017-02-18 15:59:00.0809
NCT00418327|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2009-08-06|||June 2005||2005-06-01|August 2009|2009-08-01||||||||Interventional|||Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma|Phase I Studies of TarcevaTM (Erlotinib Hydrochloride, OSI-774) as Single Agent in Children With Refractory and Relapsed Malignant Brain Tumors and in Combination With Irradiation in Newly Diagnosed Brain Stem Glioma|Completed||Phase 1|48|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||||||||||||2017-02-18 15:59:00.235065|2017-02-18 15:59:00.235065
NCT00418314|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2016-01-05|2014-05-14||October 2006||2006-10-01|January 2016|2016-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||Date of birth missing for 1 treatment patient and 1 control patient.|FREEDOM - A Frequent Optimization Study Using the QuickOpt Method|FREEDOM - A Frequent Optimization Study Using the QuickOpt Method|Completed||Phase 4|1647|Actual|St. Jude Medical||2|||f||||f||||||||No||2017-02-18 15:59:00.363547|2017-02-18 15:59:00.363547
NCT00418301|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2009-07-21|||January 2007||2007-01-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain|Changes in Regional Cerebral Blood Flow as an Indicator of Neuronal Activity in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain|Completed||Phase 4|15|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 15:59:00.961355|2017-02-18 15:59:00.961355
NCT00418262|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2010-12-06|||June 2006||2006-06-01|December 2010|2010-12-01|June 2011|Anticipated|2011-06-01|April 2011|Anticipated|2011-04-01||Interventional|||Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD|An Open-label Study of the Long Term Tolerability and Safety of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal-Alcohol Syndrome or Effects.|Unknown status|Recruiting|Phase 3|60|Anticipated|University of Oklahoma||1|||f||||t||||||||||2017-02-18 15:59:01.255107|2017-02-18 15:59:01.255107
NCT00418249|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2007-01-03||||||December 2006|2006-12-01||||||||Interventional|||Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women|Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women|Unknown status|Not yet recruiting|Phase 2|40||Rabin Medical Center|||||f||||||||||||||2017-02-18 15:59:01.369061|2017-02-18 15:59:01.369061
NCT00418236|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2010-08-17||2009-03-02|October 2006||2006-10-01|December 2007|2007-12-01|April 2010|Actual|2010-04-01|||||Observational|||Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density|Evaluation of Changes in Mammographic Breast Density Associated With Bazedoxifene, Raloxifene, and Placebo in Postmenopausal Women: An Ancillary Study of Protocol 3068A1-301-WW|Completed||Phase 4|400||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 15:59:01.470985|2017-02-18 15:59:01.470985
NCT00418223|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2011-04-18|||November 2005||2005-11-01|April 2011|2011-04-01|February 2007||2007-02-01|||||Observational|||Detecting Urinary Retention After Child Birth With a Ultrasound Scanner|Detecting Urinary Retention After Child Birth With a Ultrasound Scanner|Completed||Phase 4|100|Anticipated|Oslo University Hospital|||1||f||||||||||||||2017-02-18 15:59:01.599936|2017-02-18 15:59:01.599936
NCT00418210|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2017-02-15|||August 2007||2007-08-01|February 2017|2017-02-01|June 2019|Anticipated|2019-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Accelerated Partial Breast Irradiation for Early Breast Cancer|A Multicentre Feasibility Study of Accelerated Partial Breast Irradiation Using Three-dimensional Conformal Radiation Therapy for Early Breast Cancer.|Active, not recruiting||N/A|48|Anticipated|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||t||||||||||2017-02-18 15:59:01.694574|2017-02-18 15:59:01.694574
NCT00418197|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2009-02-04|||August 2005||2005-08-01|February 2009|2009-02-01||||||||Interventional|||Total Facet Arthroplasty System®(TFAS®) Clinical Trial|A Prospective and Randomized Controlled Trial to Evaluate the Safety and Effectiveness of Total Facet Arthroplasty in the Treatment of Degenerative Spinal Stenosis|Unknown status|Active, not recruiting|Phase 3|450|Anticipated|Archus Orthopedics, Inc.|||||f||||||||||||||2017-02-18 15:59:01.832509|2017-02-18 15:59:01.832509
NCT00418184|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-31|2014-02-12|2009-11-30||March 2007||2007-03-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|||The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder|A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder|Completed||Phase 2|200|Actual|Enzymotec||2|||f||||||||||||||2017-02-18 15:59:01.920975|2017-02-18 15:59:01.920975
NCT00418171|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2009-10-23|||February 2002||2002-02-01|October 2009|2009-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)|An International, Multicenter, Large Simple Trial (LST) To Compare The Cardiovascular Safety Of Ziprasidone And Olanzapine|Completed||Phase 4|18239|Actual|Pfizer|||||f||||||||||||||2017-02-18 15:59:02.315219|2017-02-18 15:59:02.315219
NCT00418158|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2009-11-09|||December 2005||2005-12-01|November 2009|2009-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Pulmonary Complications After Heart Surgery.|Pulmonary Complications After Heart Surgery|Completed||N/A|120|Anticipated|Catharina Ziekenhuis Eindhoven|||||f||||||||||||||2017-02-18 15:59:02.405876|2017-02-18 15:59:02.405876
NCT00418145|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2013-10-25|||September 2003||2003-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks|Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)|Terminated||Phase 3|17|Actual|Icahn School of Medicine at Mount Sinai||2||low enrollment|f||||f||||||||||2017-02-18 15:59:02.485623|2017-02-18 15:59:02.485623
NCT00418132|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2016-03-10|||August 2000||2000-08-01|March 2016|2016-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis|T Cell Immunity in Collagen Biosynthesis of Scleroderma|Terminated||Phase 1|30|Actual|New York University School of Medicine||2||Study terminated early due to difficulties in subject recruitment|f||||t||||||||||2017-02-18 15:59:02.603619|2017-02-18 15:59:02.603619
NCT00418119|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2007-01-03|||January 2007||2007-01-01|December 2006|2006-12-01|January 2008||2008-01-01|||||Interventional|||Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function|Phase 4 Study on the Efficacy of Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function|Unknown status|Not yet recruiting|Phase 4|10||Rabin Medical Center|||||f||||||||||||||2017-02-18 15:59:02.709013|2017-02-18 15:59:02.709013
NCT00418106|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2008-01-16|||November 2005||2005-11-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Kangaroo Holding Effects on Breast Milk|Early Kangaroo Holding Effects on Breast Milk Composition|Completed||N/A|20|Actual|Christiana Care Health Services|||1||f||||f||||||||||2017-02-18 15:59:02.787234|2017-02-18 15:59:02.787234
NCT00418093|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2014-06-18|2012-04-27||September 2006||2006-09-01|June 2014|2014-06-01|October 2011|Actual|2011-10-01|January 2011|Actual|2011-01-01||Interventional|||Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma|A Phase II Evaluation of Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma|Terminated||Phase 2|19|Actual|Dana-Farber Cancer Institute|The trial was closed after enrolling 19 of the 53 projected patient accrual.|1||THe study was terminated early due to a lack of accural|f||||||||||||||2017-02-18 15:59:02.87841|2017-02-18 15:59:02.87841
NCT00418080|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-10-05|||April 2002||2002-04-01|October 2007|2007-10-01|December 2006||2006-12-01|||||Interventional|||Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy|The Role of HER Receptor Family as Indicator of Prognosis and Drug Responsiveness in Locally Advanced Prostate Cancer|Completed||Phase 2|86||University of L'Aquila|||||f||||||||||||||2017-02-18 15:59:03.374228|2017-02-18 15:59:03.374228
NCT00415428|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2015-04-21|||January 2007||2007-01-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||A Quality Ensuring Project With Focus On Patients With Cardiovascular Diseases As Well As Type 2 Diabetes.|Patient And Physician Alliance -Guideline Education Treatment Optimization|Completed||N/A|2776|Actual|Pfizer|||1||f||||||||||||||2017-02-18 15:59:35.444967|2017-02-18 15:59:35.444967
NCT00418067|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2012-08-20|||October 2006||2006-10-01|August 2012|2012-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|ZEST||Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions|Comparison of the Efficacy and the Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions|Completed||Phase 4|2645|Actual|CardioVascular Research Foundation, Korea||3|||f||||t||||||||||2017-02-18 15:59:03.462576|2017-02-18 15:59:03.462576
NCT00418054|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-03|||December 2005||2005-12-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C|Phase II, Multi-Center, Randomized, Double-Blind Study of Nitazoxanide Tablets Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Chronic Hepatitis C|Completed||Phase 2|40||Romark Laboratories L.C.|||||f||||||||||||||2017-02-18 15:59:03.596841|2017-02-18 15:59:03.596841
NCT00418041|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2015-05-11|||October 2006||2006-10-01|May 2015|2015-05-01|December 2019|Anticipated|2019-12-01|March 2019|Anticipated|2019-03-01||Observational|||Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)|Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)|Active, not recruiting||N/A|10000|Anticipated|Tohoku University|||1||f||||t||||||||||2017-02-18 15:59:03.677413|2017-02-18 15:59:03.677413
NCT00418028|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2011-08-08|||September 2005||2005-09-01|March 2011|2011-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Standard Versus Continuous Capecitabine in Advanced Breast Cancer|Randomized Phase II Trial of Continuous Versus Standard Capecitabine in Advanced Breast Cancer.|Unknown status|Active, not recruiting|Phase 2/Phase 3|196|Anticipated|Hospital San Carlos, Madrid||2|||f||||f||||||||||2017-02-18 15:59:03.769845|2017-02-18 15:59:03.769845
NCT00418015|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-31|2014-03-17|2011-02-15||October 2005||2005-10-01|March 2014|2014-03-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Observational|||Mu-Opioid Receptor Genetic Polymorphism and Intrathecal Analgesia|Mu-Opioid Receptor Genetic Polymorphism and the Duration of Intrathecal Fentanyl Labor Analgesia. Mu-Opioid Receptor Genetic Polymorphism and the Efficacy of Postoperative Intrathecal Morphine Analgesia|Completed||N/A|293|Actual|Northwestern University|A limitation to the finding of this study was the relatively low number of OPRM1 heterozygous subjects.||2||f||||f||||||Samples With DNA|"~     Blood Samples~   "|||2017-02-18 15:59:03.884435|2017-02-18 15:59:03.884435
NCT00418002|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-06-21|||May 2006||2006-05-01|June 2007|2007-06-01||||||||Interventional|||Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.|A Randomized, Double-Blind, Ascending Dose, Placebo-Controlled Single Dose Study in Non-Smoking Healthy Elderly Subjects Interleaved With a 2-Week Multiple Once Daily Dose Study to Explore Safety, Tolerability, Pharmacokinetics and Cognitive Effects After Oral Administration of AQW051|Completed||Phase 1|72|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:59:04.572339|2017-02-18 15:59:04.572339
NCT00417989|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2015-04-06|2010-12-24||January 2007||2007-01-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|STAR3||Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy|The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy|Completed||Phase 4|485|Actual|Medtronic Diabetes||2|||f||||t||||||||||2017-02-18 15:59:04.654819|2017-02-18 15:59:04.654819
NCT00417976|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2015-09-15|2014-05-19||December 2006||2006-12-01|September 2015|2015-09-01|February 2011|Actual|2011-02-01|March 2010|Actual|2010-03-01||Interventional||42 patients enrolled in study; of which, 39 were evaluable for primary end point.|Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer|A Phase II Study of the Combination of Fixed Dose Rate Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer|Completed||Phase 2|42|Actual|Ohio State University Comprehensive Cancer Center|42 patients enrolled, 39 were evaluable for the primary end point.|1|||f||||t||||||||||2017-02-18 15:59:05.29313|2017-02-18 15:59:05.29313
NCT00417963|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2011-06-21|2011-04-16||October 2005||2005-10-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|January 2009|Actual|2009-01-01||Interventional|||ViVEXX Carotid Revascularization Trial (VIVA)|The ViVEXX Carotid Revascularization Trial (VIVA) for High Surgical Risk Patients With Extracranial Carotid Artery Stenosis Using the Bard ViVEXX Carotid Stent and Emboshield BareWire Rapid Exchange Embolic Protection System|Completed||Phase 3|407|Actual|C. R. Bard||1|||f||||t||||||||||2017-02-18 15:59:05.676958|2017-02-18 15:59:05.676958
NCT00417950|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-01|2007-01-03|||January 2007||2007-01-01|January 2007|2007-01-01||||||||Interventional|||Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes||Unknown status|Recruiting|N/A|30||Taichung Veterans General Hospital|||||f||||||||||||||2017-02-18 15:59:06.344556|2017-02-18 15:59:06.344556
NCT00417937|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2014-02-20|||January 2007||2007-01-01|February 2014|2014-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily|A Multicenter, Double-Blind Clinical Trial to Assess the Efficacy and Tolerability of Topical Azelaic Acid 15% Gel Once Daily Compared to Topical Azelaic Acid 15% gelTwice Daily in Subjects With Papulopustular Rosacea|Completed||Phase 4|98|Actual|Bayer||2|||f||||f||||||||||2017-02-18 15:59:06.432027|2017-02-18 15:59:06.432027
NCT00417924|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2007-01-02|||October 2004||2004-10-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||Eye on Diabetes: A Multidisciplinary Patient Education Intervention|Eye Health and Vision Care for Patients With Diabetes: Comparing Usual Care to a Targeted Intervention in a Randomized Controlled Trial|Completed||Early Phase 1|90||Nova Southeastern University|||||f||||||||||||||2017-02-18 15:59:06.540134|2017-02-18 15:59:06.540134
NCT00417911|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2010-06-17|||December 2005||2005-12-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients|Clinical Protocol Bortezomib Consolidation in Patients With Myeloma Following Treatment With High-dose Melphalan and Autologous Stem Cell Support. A Randomised NMSG Trial (15/05)|Completed||Phase 3|400|Anticipated|Nordic Myeloma Study Group||2|||f||||||||||||||2017-02-18 15:59:06.625165|2017-02-18 15:59:06.625165
NCT00417898|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2016-09-01|||March 2007||2007-03-01|January 2007|2007-01-01|December 2012|Anticipated|2012-12-01|||||Interventional|||Study of Aspirin and TPA in Acute Ischemic Stroke|Phase 1 Study to Assess the Safety of 500mg of Aspirin Added to IV TPA at Standard Doses to Prevent Re-occlusion of Cerebral Vessels After Successful Reperfusion.|Withdrawn||Phase 1|0|Actual|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:59:06.753994|2017-02-18 15:59:06.753994
NCT00417885|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2010-09-16|2010-07-09||June 2007||2007-06-01|September 2010|2010-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer|Phase 1/2 Open-Label Trial Of Sutent (Sunitinib Malate) And Aromasin(Exemestane) In The First-Line Treatment Of Hormone Receptor-Positive Metastatic Breast Cancer|Terminated||Phase 1/Phase 2|6|Actual|Pfizer||1||See Detailed Description for Termination Reason|f||||f||||||||||2017-02-18 15:59:06.855973|2017-02-18 15:59:06.855973
NCT00417872|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-03|||January 2004||2004-01-01|October 2005|2005-10-01|September 2005||2005-09-01|||||Interventional|||Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis|Multicenter, Double Blind, Metronidazole Controlled, Dose Range Finding Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis|Completed||Phase 2|114||Romark Laboratories L.C.|||||f||||||||||||||2017-02-18 15:59:07.449512|2017-02-18 15:59:07.449512
NCT00417859|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2015-12-01|||February 2004||2004-02-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Total Knee Arthroplasty: Comparison of Fixed and Mobile Bearings|Total Knee Arthroplasty: Comparison of Fixed and Mobile Bearings|Completed||Phase 4|64|Actual|University of Lausanne Hospitals||2|||f||||||||||||||2017-02-18 15:59:07.551031|2017-02-18 15:59:07.551031
NCT00417846|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2009-10-02|||January 2007||2007-01-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)|Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)|Completed||N/A|98|Actual|Johns Hopkins University|||1||f||||t||||||||||2017-02-18 15:59:07.662508|2017-02-18 15:59:07.662508
NCT00417833|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2008-10-17|||December 2005||2005-12-01|October 2008|2008-10-01|July 2006||2006-07-01|||||Interventional|||Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment||Completed||Phase 2/Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 15:59:07.755389|2017-02-18 15:59:07.755389
NCT00417820|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-11-28|||November 2006||2006-11-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.|A Multicenter, Double-Blind, Placebo Controlled Exploratory Study to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Administration of BCT194 in Healthy Volunteers and Multiple Administrations in Patients With Psoriasis.|Completed||Phase 1|35|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:59:07.824678|2017-02-18 15:59:07.824678
NCT00417807|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2010-12-23|||August 2005||2005-08-01|December 2010|2010-12-01||||June 2009|Actual|2009-06-01||Interventional|||Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors|Open-label Trial of Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors (DSRCT) Expressing PDGF-R|Completed||Phase 1/Phase 2|9|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:59:07.916358|2017-02-18 15:59:07.916358
NCT00417794|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2014-12-02|||August 2005||2005-08-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|B4Z-MC-X017||Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD|A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects|Unknown status|Active, not recruiting|Phase 3|60|Anticipated|University of Oklahoma||2|||f||||t||||||||||2017-02-18 15:59:08.031942|2017-02-18 15:59:08.031942
NCT00417781|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-31|2012-11-12|||January 2005||2005-01-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|||||Observational|||A Follow-up, Family Study on Attention-deficit Hyperactivity Disorder|A Follow-up, Family Study on Attention-deficit Hyperactivity Disorder|Completed||N/A|1800|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:59:08.14907|2017-02-18 15:59:08.14907
NCT00417768|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2014-01-13|||July 2005||2005-07-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|July 2012|Actual|2012-07-01||Interventional|||Safety and Effectiveness of tPA in Intra-abdominal Abscesses|Safety and Effectiveness of Local Instillation of tPA in the Management of Complex Intra-abdominal Fluid Collections: a Randomized, Double Blinded Controlled Clinical Trial|Terminated||Phase 2/Phase 3|35|Actual|University Health Network, Toronto||2||Change in patient population no longer fit study criteria.|f||||f||||||||||2017-02-18 15:59:08.240271|2017-02-18 15:59:08.240271
NCT00417755|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2007-01-03|||January 2007||2007-01-01|December 2006|2006-12-01|December 2007||2007-12-01|||||Observational|||Effect of Invasive and Non Invasive Mechanical Ventilation on Feeding Delivery in COPD Elderly Patients|Effect of Invasive and Non Invasive Mechanical Ventilation on the Nutritional Status of COPD Elderly Patients|Unknown status|Not yet recruiting|Phase 4|40||Rabin Medical Center|||||f||||||||||||||2017-02-18 15:59:08.352418|2017-02-18 15:59:08.352418
NCT00417742|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2014-08-20|||June 2002||2002-06-01|January 2007|2007-01-01|December 2004||2004-12-01|||||Interventional|||Project CHEER (Comprehensive Headache Evaluation, Education, Relief)|A Randomized Trial of Headache Management Programs|Completed||N/A|828||Duke University|||||f||||||||||||||2017-02-18 15:59:08.420505|2017-02-18 15:59:08.420505
NCT00417729|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-01|2010-05-11|||January 2007||2007-01-01|May 2010|2010-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM|Phase 4 Study Evaluation of the Effects of Acarbose Versus Glibenclamide on Mean Amplitude of Glycemic Excursions and Oxidative Stress in Patients With Type 2 Diabetes Insufficiently Controlled by Metformin|Completed||Phase 4|51|Actual|Taichung Veterans General Hospital||1|||f||||f||||||||||2017-02-18 15:59:08.532365|2017-02-18 15:59:08.532365
NCT00417716|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-01-03|||September 2005||2005-09-01|June 2006|2006-06-01|May 2006||2006-05-01|||||Interventional|||Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema|The Efficacy of a Single Intravitreal Injection of Bevacizumab in Patients With Diffuse Diabetic Macular Edema|Unknown status|Active, not recruiting|Phase 3|45||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 15:59:08.648586|2017-02-18 15:59:08.648586
NCT00417703|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2008-01-22|||January 2007||2007-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab|A Prospective Investigation of the Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab|Completed||Phase 4|75|Anticipated|Oklahoma State University Center for Health Sciences|||||f||||||||||||||2017-02-18 15:59:08.753937|2017-02-18 15:59:08.753937
NCT00340600|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 5, 1998||1998-03-05|October 27, 2016|2016-10-27||||||||Observational|||Continuation of Follow-up of DES-Exposed Cohorts|Continuation of Follow-up of DES-Exposed Cohorts|Active, not recruiting||N/A|12735|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:41.906766|2017-02-18 16:27:41.906766
NCT00417690|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2008-10-14|||January 2007||2007-01-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|December 2007|Actual|2007-12-01||Interventional|||High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease|A Prospective Randomized Double-Blind Study of PASER® in the Management of Patients Experiencing an Acute Flare of Crohn's Disease|Terminated||Phase 2|54|Anticipated|Jacobus Pharmaceutical||2||Efforts at recruitment have halted as recruitment was poor.|f||||||||||||||2017-02-18 15:59:08.846159|2017-02-18 15:59:08.846159
NCT00417677|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2007-12-19|||March 2007||2007-03-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma|A Phase I/II Study of Temsirolimus and Sunitinib in Subjects With Advanced Renal Cell Carcinoma|Terminated||Phase 1/Phase 2|124||Wyeth is now a wholly owned subsidiary of Pfizer||||Decision was made not to attempt a lower dose|f||||||||||||||2017-02-18 15:59:08.968165|2017-02-18 15:59:08.968165
NCT00417664|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-03|2007-01-03|||April 2002||2002-04-01|January 2007|2007-01-01|December 2003||2003-12-01|||||Interventional|||Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium When Compared to Propofol or Midazolam in Cardiac Surgery Patients|ICU Delirium: Can Dexmedetomidine Reduce Its Incidence?|Unknown status|Active, not recruiting|Phase 4|90||Stanford University|||||f||||||||||||||2017-02-18 15:59:09.06691|2017-02-18 15:59:09.06691
NCT00417651|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2011-12-13|||July 2006||2006-07-01|December 2011|2011-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Testing for Bacterial Contamination During Gastric Surgeries|Transgastric Bacterial Contamination of the Abdomen|Completed||Phase 1|50|Actual|Ohio State University|||1||f||||f||||||||||2017-02-18 15:59:09.16297|2017-02-18 15:59:09.16297
NCT00417638|ClinicalTrials.gov processed this data on February 17, 2017|2007-01-02|2010-01-14|||January 2007||2007-01-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Rapid Intravascular Cooling in Myocardial Infarction as Adjunctive to Percutaneous Coronary Intervention|A Randomized, Controlled Study of the Use of Central Venous Catheter Core Cooling Combined With Cold Saline, and Rewarming as an Adjunct to Percutaneous Coronary Intervention For the Treatment of Acute Myocardial Infarction|Completed||N/A|20|Actual|Philips Healthcare||2|||f||||f||||||||||2017-02-18 15:59:09.250768|2017-02-18 15:59:09.250768
NCT00417625|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-30|2017-01-24|||December 29, 2006||2006-12-29|July 19, 2010|2010-07-19|July 19, 2010||2010-07-19|||||Observational|||Validation of MRI Measurement of Cardiac Blood Flow|Validation of Cardiac MR Perfusion With Cardiac Catheterization Physiological Assessment|Completed||N/A|34|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 15:59:09.358095|2017-02-18 15:59:09.358095
NCT00417612|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2014-10-22|2014-08-02||January 2007||2007-01-01|October 2014|2014-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets|The Role of Parathyroid Hormone in the Pathogenesis of Skeletal Disease in X-linked Hypophosphatemic Rickets (XLH)|Completed||Phase 3|33|Actual|Yale University||2|||f||||t||||||||||2017-02-18 15:59:09.449982|2017-02-18 15:59:09.449982
NCT00417599|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2016-06-22|||December 2001||2001-12-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Preventing Overweight in USAF Personnel: Minimal Contact Program|Preventing Overweight in USAF Personnel: Minimal Contact Program|Completed||N/A|500|Actual|Baylor College of Medicine||2|||f||||f||||||||Yes|See publication: Hunter CM et al Weight management using the internet: a randomized clinical trial. Am J Prev Med 2998;34:119-126|2017-02-18 15:59:10.018405|2017-02-18 15:59:10.018405
NCT00417586|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2013-12-09|||June 2007||2007-06-01|December 2013|2013-12-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Observational|||Cost-Effectiveness of a Specialized Ultrasound Instrument to Diagnose Carotid Stenosis as a Way to Reduce the Risk of Stroke|New Ultrasound Instrument for Carotid Screening|Completed||Phase 1/Phase 2|984|Actual|DVX, LLC|||1||f||||t||||||||||2017-02-18 15:59:10.126037|2017-02-18 15:59:10.126037
NCT00417573|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2006-12-29|||December 2004||2004-12-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections|Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections|Completed||Phase 2|10||The Center for Rheumatic Disease, Allergy, & Immunology|||||f||||||||||||||2017-02-18 15:59:10.216035|2017-02-18 15:59:10.216035
NCT00417560|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2012-09-06|||January 2007||2007-01-01|September 2012|2012-09-01|January 2013|Anticipated|2013-01-01|December 2007|Actual|2007-12-01||Interventional|||Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses|A Single Center, Open-label, Phase I/II Study of Two 90 Microgram Doses of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses|Unknown status|Active, not recruiting|Phase 1/Phase 2|55|Actual|Centers for Disease Control and Prevention||1|||f||||||||||||||2017-02-18 15:59:10.30845|2017-02-18 15:59:10.30845
NCT00417547|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2009-02-04|||February 2006||2006-02-01|February 2009|2009-02-01|September 2006||2006-09-01|||||Observational|||Comparison of Body Dissatisfaction Among Islamic Veil Practicing (IVP), Non-Complete IVP, and Inconsiderate to IVP Women|Comparison of Body Dissatisfaction Among Islamic Veil Practicing (IVP), Non-Complete IVP, and Inconsiderate to IVP Women|Completed||N/A|3000||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 15:59:10.413116|2017-02-18 15:59:10.413116
NCT00417534|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2007-07-02|||June 2006||2006-06-01|December 2006|2006-12-01|December 2009|Anticipated|2009-12-01|||||Observational|||Genetic Predisposition of Coronary Artery Disease -- The COROGENE-Study|Genetic Predisposition of Coronary Artery Disease in Patients Verified With Coronary Angiogram The COROGENE-Study|Unknown status|Recruiting|N/A|5000|Anticipated|Helsinki University|||||f||||||||||||||2017-02-18 15:59:10.500737|2017-02-18 15:59:10.500737
NCT00417521|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2013-09-25|||July 2004||2004-07-01|December 2006|2006-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Open Trial of Family-Based Treatment for Anorexia Nervosa|Pilot Study of Manualized Family Therapy for Adolescents With Anorexia Nervosa|Completed||N/A|20|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 15:59:10.592981|2017-02-18 15:59:10.592981
NCT00417508|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2012-06-13|||December 2006||2006-12-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Nutritional Intervention in Malnourished Elderly Patients|Effectiveness of Nutritional Intervention in Malnourished Elderly Patients|Completed||Phase 4|23|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-02-18 15:59:10.689497|2017-02-18 15:59:10.689497
NCT00417495|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2016-01-05|||March 2006||2006-03-01|January 2016|2016-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Sentinel Lymph Node Technique in Multifocal Breast Cancer|Interest of Sentinel Lymph Node Technique in Women With a Multifocal Breast Cancer - IGASSU-0502|Completed||Phase 2|216|Actual|Centre Oscar Lambret|||||f||||||||||||||2017-02-18 15:59:10.80371|2017-02-18 15:59:10.80371
NCT00417482|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2013-03-14|2013-02-11||August 2004||2004-08-01|March 2013|2013-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|ADAD||Antipsychotic Discontinuation in Alzheimer's Disease|Antipsychotic Discontinuation in Alzheimer's Disease|Completed||Phase 4|180|Actual|New York State Psychiatric Institute|Comparisons of adverse events in Phase B were limited by the small sample & the truncated observation period for relapsed subjects. Identification of predictors of relapse after discontinuation of treatment was limited by the small sample.|3|||f||||t||||||||||2017-02-18 15:59:10.922254|2017-02-18 15:59:10.922254
NCT00417469|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2015-03-04|||January 2007||2007-01-01|March 2015|2015-03-01|February 2007|Actual|2007-02-01|||||Interventional|||A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)|A Single-Blind, Randomized, Single-Center Evaluation of Procedural and Post Procedural Pain Experienced With Injections of NADG With Lidocaine Injectable Gel as Compared to Captique® Injectable Gel in Subjects Undergoing Cutaneous Correction of Nasolabial Folds|Completed||Phase 3|45||Sanofi|||||||||||||||||||2017-02-18 15:59:11.710662|2017-02-18 15:59:11.710662
NCT00417456|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2012-03-14|||October 2005||2005-10-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||"The Development and Evaluation of an E-Visit Program for the Management of Acne"|"The Development and Evaluation of an E-Visit Program for the Management of Acne"|Completed||N/A|151|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 15:59:11.795239|2017-02-18 15:59:11.795239
NCT00417443|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2014-01-07|||December 2007||2007-12-01|December 2006|2006-12-01|December 2009||2009-12-01|||||Interventional|||Epidural Clonidine for Postoperative Hyperalgesia|A Study of Effect of Epidural Clonidine on Postoperative Pain Relief, Hyperalgesia and Chronic Pain in Patients Undergoing Colorectal Surgery|Withdrawn||Phase 3|0|Actual|Cambridge University Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 15:59:11.89918|2017-02-18 15:59:11.89918
NCT00417430|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2009-09-18|||September 2004||2004-09-01|September 2009|2009-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies|Phase II Study of Efficacy of ICI 182,780 (Faslodex) in the Treatment of Systemic Lupus Erythematosus: Clinical, Serologic, Molecular|Completed||Phase 2|20||The Center for Rheumatic Disease, Allergy, & Immunology|||||f||||||||||||||2017-02-18 15:59:11.990572|2017-02-18 15:59:11.990572
NCT00417417|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2012-04-25|2009-09-14||December 2006||2006-12-01|April 2012|2012-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Rilonacept to Improve Artery Function in Patients With Atherosclerosis|Effects of Interleukin-1 Inhibition on C-Reactive Protein Levels, Endothelial Progenitor Cell Mobilization and Endothelial Function in Patients With Coronary Artery Disease|Completed||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 15:59:12.090971|2017-02-18 15:59:12.090971
NCT00417404|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2010-06-24|||January 2007||2007-01-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Vitamin A and Very Low Birthweight Babies (VitAL)|Does Additional Vitamin A Supplementation Improve Retinal Function and Conjunctival Health in Very Low Birthweight Infants?|Completed||Phase 4|94|Actual|Glasgow Royal Infirmary||2|||f||||t||||||||||2017-02-18 15:59:15.208475|2017-02-18 15:59:15.208475
NCT00417391|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2008-05-25|||December 2006||2006-12-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Phase II Study of RR110 in Patients With Active Crohn's Disease|Phase II Study of RR110 in Patients With Active Crohn's Disease|Completed||Phase 2|24|Anticipated|R&R Inc.||2|||f||||||||||||||2017-02-18 15:59:15.327858|2017-02-18 15:59:15.327858
NCT00417378|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2007-11-27|||August 2004||2004-08-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)|Left Ventricular Assist Device (Impella LP 2.5) vs. Intraaortic Balloon Counterpulsation (IABP) in Patients With Cardiogenic Shock and Acute Coronary Syndromes|Completed||Phase 4|26|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 15:59:15.427718|2017-02-18 15:59:15.427718
NCT00417365|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2007-08-13|||August 2006||2006-08-01|August 2007|2007-08-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis|"A Comparison Study of the WaterWorks® Douching Device vs. Commercial OTC Douching Device for the Reduction or Abatement of Perceived Vaginal Odor With or Without Complaints of Discharge in Women With no Infectious Causes of Vaginitis"|Unknown status|Recruiting|N/A|100|Anticipated|Abbott Research Group|||||f||||||||||||||2017-02-18 15:59:15.529395|2017-02-18 15:59:15.529395
NCT00417352|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2010-08-05|||December 2006||2006-12-01|December 2006|2006-12-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Interventional|||Study of Compensatory Motion While Using an Upper Limb Prosthesis|Kinematic and Kinetic Profile of Common Tasks for the Development of Design Parameters of an Upper Limb Prosthesis|Completed||N/A|17|Actual|University of South Florida|||||f||||||||||||||2017-02-18 15:59:15.632802|2017-02-18 15:59:15.632802
NCT00417339|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2016-05-12|||December 2006||2006-12-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal Analysis|A Multicentric Observational Trial on Protein Bound Uremic Toxins in Nocturnal Hemodialysis|Completed||N/A|38|Actual|Universitaire Ziekenhuizen Leuven|||4||f||||f||||||Samples Without DNA|"~     serum, urine, dialysate~   "|No||2017-02-18 15:59:15.726252|2017-02-18 15:59:15.726252
NCT00417326|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2012-06-12|||December 2006||2006-12-01|June 2012|2012-06-01||||August 2009|Actual|2009-08-01||Interventional|||Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia|ONO-5046Na Phase II Study - A Pilot Study for Patients With Acute Respiratory Failure|Completed||Phase 2|174|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||||||||||||2017-02-18 15:59:15.839491|2017-02-18 15:59:15.839491
NCT00417313|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2006-12-28|||October 2004||2004-10-01|December 2006|2006-12-01|August 2006||2006-08-01|||||Interventional|||Osteopuncture for Osteoarthritis-Associated Knee Pain & Disability|Osteopuncture for Osteoarthritis-Associated Knee Pain & Disability|Completed||Phase 2|88||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 15:59:15.947855|2017-02-18 15:59:15.947855
NCT00417300|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2013-06-26|||February 2006||2006-02-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|||Comparing Behavioral Therapies for Treating Adolescents With Post-Traumatic Stress Disorder Related to Sexual Abuse|Treating Adolescents With CSA Related PTSD|Completed||Phase 2|90|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 15:59:16.273721|2017-02-18 15:59:16.273721
NCT00417287|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-29|2015-04-30||2015-04-30|December 2006||2006-12-01|April 2015|2015-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer|A Randomized Phase II Open-Label Study of Two Different Dose Levels of PX-12 in Patients With Advanced Carcinoma of the Pancreas Whose Tumors Have Progressed on Gemcitabine or on a Gemcitabine-Containing Combination|Terminated||Phase 2|17|Actual|Cascadian Therapeutics Inc.||2||Investigator decision|f||||t||||||||||2017-02-18 15:59:16.395706|2017-02-18 15:59:16.395706
NCT00417274|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-03-06|2011-06-28||December 2006||2006-12-01|September 2012|2012-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer|An Open-Label, Phase II Safety, Tolerability, Drug Level and Efficacy Trial of Quinacrine in Patients With Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|31|Actual|Cleveland BioLabs||1|||f||||f||||||||||2017-02-18 15:59:16.514727|2017-02-18 15:59:16.514727
NCT00417261|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2008-06-20|||November 2006||2006-11-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|||||Interventional|||Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.|A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Ascending Single and Multiple Dose, Seamless Design Study to Explore the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Orally Administered Compounds, ATF936 and AXT914, in Healthy Male and Female Subjects|Completed||Phase 1|65|Anticipated|Novartis||3|||f||||f||||||||||2017-02-18 15:59:16.782684|2017-02-18 15:59:16.782684
NCT00417248|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2016-06-13|2016-05-04||June 2007||2007-06-01|May 2016|2016-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer|A Phase II Trial of Concurrent Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib in Patients With Inoperable Stage III Non-Small Cell Lung Cancer (NSCLC): Hoosier Oncology Group LUN06-107|Terminated||Phase 1/Phase 2|8|Actual|Hoosier Cancer Research Network||1||Negative sorafenib results from ESCAPE trial and safety concerns of regimen|f||||t||||||||Yes||2017-02-18 15:59:16.886271|2017-02-18 15:59:16.886271
NCT00417235|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2016-05-23|||January 2007||2007-01-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|DRESSING||Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients|Dressing: Comparison of 3-day and 7-day Catheter Dressing Frequency and Efficacy of Antiseptic Impregnated Dressing in Preventing Catheter-related Infection in ICU|Completed||Phase 4|1600|Actual|University Hospital, Grenoble||4|||f||||t||||||||||2017-02-18 15:59:17.166899|2017-02-18 15:59:17.166899
NCT00417222|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2014-05-16|||November 2006||2006-11-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|March 2013|Actual|2013-03-01||Interventional|SUPPORT||Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan|Supplemental Benefit of Angiotensin II Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan (SUPPORT Trial)|Completed||Phase 3|1145|Actual|Tohoku University||2|||f||||t||||||||||2017-02-18 15:59:17.295547|2017-02-18 15:59:17.295547
NCT00417209|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2016-05-03||2016-04-06|December 2006||2006-12-01|May 2016|2016-05-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|PAPRIKA||Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen|A Randomized, Open Label Multi-Center Study Of Single Agent Larotaxel (XRP9881) Compared To Continuous Administration of 5-FU For The Treatment Of Patients With Advanced Pancreatic Cancer Previously Treated With A Gemcitabine-Containing Regimen|Completed||Phase 3|408|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 15:59:17.40712|2017-02-18 15:59:17.40712
NCT00417196|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2010-09-30|||December 2006||2006-12-01|September 2010|2010-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Single Escalating Doses of Intravenous QAX576|Completed||Phase 1|32|Actual|Novartis|||||f||||f||||||||||2017-02-18 15:59:17.532724|2017-02-18 15:59:17.532724
NCT00417183|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2006-12-28|||September 2005||2005-09-01|December 2006|2006-12-01|June 2007||2007-06-01|||||Interventional|||Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation|Randomized Controlled Trial Comparing the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation in Normal Responders|Unknown status|Recruiting|Phase 4|300||Eugonia|||||f||||||||||||||2017-02-18 15:59:17.610861|2017-02-18 15:59:17.610861
NCT00417170|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2011-09-22|2011-07-15||October 2007||2007-10-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome|A Double-blind, Double Dummy, Randomized Parallel Design Trial to Study the Effects of 12 Weeks of Treatment With 300mg Aliskiren vs. 5mg Amlodipine on Insulin Resistance and Endothelial Dysfunction in Hypertensive Patients With Metabolic Syndrome|Completed||Phase 2|48|Actual|Novartis||2|||f||||f||||||||||2017-02-18 15:59:17.711977|2017-02-18 15:59:17.711977
NCT00417157|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2013-12-13|||January 2007||2007-01-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH|Successful Application of Modified Natural Cycle in Poor Responders With High Basal FSH Prior to Oocyte Donation|Completed||Phase 4|135|Actual|Eugonia|||1||f||||||||||||||2017-02-18 15:59:18.33075|2017-02-18 15:59:18.33075
NCT00417144|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2006-12-28|||November 2003||2003-11-01|December 2006|2006-12-01|May 2007||2007-05-01|||||Interventional|||Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients|Randomized Controlled Trial Comparing the Effect of GnRH Agonist and Antagonist Ovarian Stimulation Protocols in PCOS Patients|Unknown status|Recruiting|Phase 4|200||Eugonia|||||f||||||||||||||2017-02-18 15:59:18.438174|2017-02-18 15:59:18.438174
NCT00417131|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2011-08-03|||October 2006||2006-10-01|July 2008|2008-07-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Imaging of Islet Transplantation With PET and MRT|Imaging of Islet Transplantation With PET and MRT|Completed||N/A|8|Actual|Uppsala University Hospital|||1||f||||f||||||||||2017-02-18 15:59:18.544583|2017-02-18 15:59:18.544583
NCT00416910|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-09-23|||July 1999||1999-07-01|September 2016|2016-09-01|September 2007|Actual|2007-09-01|September 2003|Actual|2003-09-01||Interventional|||Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia|Treatment of Advanced Chronic Lymphocytic Leukemia (CLL) Fludarabine, Mitoxantrone and Cyclophosphamide With or Without G-CSF|Terminated||Phase 3|83|Actual|German CLL Study Group||2||low recruitment|f||||f||||||||No||2017-02-18 15:59:22.688845|2017-02-18 15:59:22.688845
NCT00417118|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2016-04-25||2016-04-25|December 2006||2006-12-01|April 2016|2016-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder|An Eight-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study, With Escitalopram as an Active Control, to Evaluate the Efficacy, Safety and Tolerability of a Saredutant 100 mg Dose Once Daily, in Patients With Generalized Anxiety Disorder|Completed||Phase 3|365|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 15:59:18.639266|2017-02-18 15:59:18.639266
NCT00417105|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2009-03-04|||December 2006||2006-12-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Protein-Bound Uremic Retention Solutes in Long Nocturnal Hemodialysis|A Multicentric Observational Study on the Removal of Protein-Bound Uremic Retention Solutes in Nocturnal Hemodialysis: A Cross-Sectional Analysis|Completed||N/A|120|Actual|Universitaire Ziekenhuizen Leuven|||4||f||||t||||||Samples Without DNA|"~     serum, urine, dialysate~   "|||2017-02-18 15:59:18.751197|2017-02-18 15:59:18.751197
NCT00417092|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2007-09-21|||December 2006||2006-12-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Biventricular Pacing After Coronary Artery Bypass Grafting (BIVAC)||Completed||N/A|100|Anticipated|University of Schleswig-Holstein|||||f||||||||||||||2017-02-18 15:59:18.864361|2017-02-18 15:59:18.864361
NCT00417079|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-28|2011-03-04|2010-09-20||January 2007||2007-01-01|March 2011|2011-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|TROPIC||XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer|A Randomized, Open Label Multi-Center Study of XRP6258 at 25 mg/m^2 in Combination With Prednisone Every 3 Weeks Compared to Mitoxantrone in Combination With Prednisone For The Treatment of Hormone Refractory Metastatic Prostate Cancer Previously Treated With A Taxotere®-Containing Regimen|Completed||Phase 3|755|Actual|Sanofi||2|||f||||||||||||||2017-02-18 15:59:18.969161|2017-02-18 15:59:18.969161
NCT00417066|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2013-12-13|||September 2003||2003-09-01|January 2009|2009-01-01|July 2006|Actual|2006-07-01|||||Interventional|||Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders|The Flexible GnRH Antagonist Protocol Provides Better Results (IVF Outcomes) Than Flare up GnRH Agonist Protocol in Poor Responders|Completed||Phase 4|270||Eugonia|||||f||||||||||||||2017-02-18 15:59:20.606454|2017-02-18 15:59:20.606454
NCT00417053|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-08-01||||||December 2006|2006-12-01||||||||Interventional|||Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant|European Infant Neuroblastoma Study Final Protocol|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:20.698228|2017-02-18 15:59:20.698228
NCT00417040|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-04-15|||December 2006||2006-12-01|April 2016|2016-04-01||||March 2013|Actual|2013-03-01||Interventional|||Collection of Patient-Reported Symptoms and Performance Status Via the Internet|Collection of Patient-Reported Symptoms and Performance Status Via the Internet|Active, not recruiting||N/A|300|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 15:59:20.787637|2017-02-18 15:59:20.787637
NCT00417027|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2014-03-17|2011-06-28||August 2006||2006-08-01|March 2014|2014-03-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Programmed Intermittent Epidural Bolus Time Interval and Injection Volume|Effect of Manipulation of the Programmed Intermittent Bolus Time Interval and Injection Volume on Total Drug Use for Labor Epidural Analgesia: a Randomized Controlled Trial|Completed||N/A|190|Actual|Northwestern University|No group that received a continuous infusion or PCEA without a background infusion was included. Conclusions are limited to our patient population, drug concentrations, and mode of initiation of labor analgesia.|3|||f||||f||||||||||2017-02-18 15:59:21.228513|2017-02-18 15:59:21.228513
NCT00417014|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-08-01||||||December 2006|2006-12-01||||||||Interventional|||Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma|Hodgkins Disease Study|Unknown status|Active, not recruiting|N/A|358|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:21.940725|2017-02-18 15:59:21.940725
NCT00417001|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2009-01-20|||October 2006||2006-10-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|January 2008|Actual|2008-01-01||Interventional|||Reduction of Conscious Sedation Requirements by Olfactory Stimulation|Reduction of Conscious Sedation Requirements by Olfactory Stimulation|Completed||N/A|284|Anticipated|United States Naval Medical Center, Portsmouth||1|||f||||f||||||||||2017-02-18 15:59:22.023899|2017-02-18 15:59:22.023899
NCT00416988|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-06-19||||||July 2008|2008-07-01||||||||Interventional|||Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants|Skin Self-Examination for Early Detection of Melanoma: Intervention and Consequence|Completed||N/A|1135|Anticipated|Rhode Island Hospital|||||f||||||||||||||2017-02-18 15:59:22.116924|2017-02-18 15:59:22.116924
NCT00416975|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-04-23|||May 2000||2000-05-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|December 2005|Actual|2005-12-01||Interventional|||Individualized Risk-Based Education in Promoting Breast Cancer Screening in Healthy Women|Breast Cancer Risk-Tailored Messages for More Women|Completed||N/A|899|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 15:59:22.202737|2017-02-18 15:59:22.202737
NCT00416962|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2007-11-29|||August 2006||2006-08-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine|An Open-Label, Multiple Dose, Randomized, Three-Period Crossover Study in Healthy Volunteers to Evaluate the Effect of co-Administration of Amantadine 100 mg BID and Oseltamivir 75 mg BID on the Pharmacokinetic Properties of Amantadine and Oseltamivir.|Completed||Phase 1|18||Novartis|||||f||||||||||||||2017-02-18 15:59:22.301004|2017-02-18 15:59:22.301004
NCT00416949|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2014-08-06|||April 2006||2006-04-01|May 2013|2013-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Iodine I 131 in Treating Patients With Thyroid Cancer|Dose-Response in Radionuclide Therapy of Thyroid Cancer|Completed||N/A|9|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 15:59:22.386269|2017-02-18 15:59:22.386269
NCT00416936|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2009-02-09|||January 2007||2007-01-01|February 2009|2009-02-01|November 2007|Actual|2007-11-01|||||Observational|||Bacterial Contamination of Anaesthetists' Hands by Personal Mobile Phones Used in the Operating Theatre||Completed||N/A|40||Medical University Innsbruck|||||f||||||||||||||2017-02-18 15:59:22.507603|2017-02-18 15:59:22.507603
NCT00416923|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2015-02-12|||August 2002||2002-08-01|February 2015|2015-02-01|April 2007|Actual|2007-04-01|November 2005|Actual|2005-11-01||Interventional|||Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma|Phase I Study of Intrathecal Rituximab in Patients With Recurrent CNS Lymphoma|Completed||Phase 1|10|Anticipated|University of California, San Francisco||1|||f||||||||||||||2017-02-18 15:59:22.580473|2017-02-18 15:59:22.580473
NCT00416897|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-08-23|||March 2003||2003-03-01|June 2007|2007-06-01|December 2008|Actual|2008-12-01|||||Interventional|||Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure|A Randomised Controlled Trial of Adjunctive Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Renal Failure [MERIT] MyEloma Renal Impairment Trial|Completed||Phase 3|280|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:22.803166|2017-02-18 15:59:22.803166
NCT00416884|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2011-07-06|2011-05-31||May 2003||2003-05-01|July 2011|2011-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML|Fludarabine, Campath, TBI T-Cell Deplete NMSCT With Post-Transplant T-Cell Infusions for CML Failing Imatinib Therapy With Imatinib (STI571)|Terminated||Phase 2|1|Actual|OHSU Knight Cancer Institute|Study was terminated early due to low enrollment, hence the study did not have any treatment-related mortalities to report.|1||Low enrollment|f||||t||||||||||2017-02-18 15:59:22.946451|2017-02-18 15:59:22.946451
NCT00416871|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2012-09-25||||||September 2012|2012-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer|Cytokines in the Treatment of Metastatic Renal Cell Carcinoma (MRCC): Intravenous Interleukin and Subcutaneous Interferon-α Versus Subcutaneous Interleukin and Interferon-α for Good Prognosis Patients [PERCY DUO]|Completed||Phase 3|220|Anticipated|Centre Leon Berard|||||f||||||||||||||2017-02-18 15:59:23.265437|2017-02-18 15:59:23.265437
NCT00416858|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2014-03-03||||||April 2007|2007-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery|Randomized Study of Adjuvant Radiochemotherapy After Surgery Versus Radiochemotherapy Alone in Patients With Locally Advanced Esophageal Cancer|Completed||Phase 3|40|Anticipated|Federation Francophone de Cancerologie Digestive|||||f||||||||||||||2017-02-18 15:59:23.35419|2017-02-18 15:59:23.35419
NCT00416845|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2010-06-03|||October 2006||2006-10-01|June 2010|2010-06-01||||March 2007|Actual|2007-03-01||Interventional|||Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers|A Randomized, Parallel Group, Double-blind, Placebo Controlled, 14 Days Multiple-dose Treatment to Assess the Pulmonary and Cardiac Pharmacodynamics of FTY720 (0.5 and 1.25 mg) in Healthy Volunteers|Completed||Phase 1|39|Actual|Novartis|||||f||||||||||||||2017-02-18 15:59:23.454275|2017-02-18 15:59:23.454275
NCT00416832|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2015-11-17|||November 2002||2002-11-01|November 2015|2015-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma|Optimising Therapy for Boys With Hodgkin's Lymphoma and Quality Assurance of Therapy for Girls With Hodgkin's Lymphoma Until Start of a New Prospective Trial for Hodgkin's Lymphoma in Childhood and Adolescence|Completed||Phase 2|648|Anticipated|Martin-Luther-Universität Halle-Wittenberg|||||f||||||||||||||2017-02-18 15:59:23.539107|2017-02-18 15:59:23.539107
NCT00416819|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2015-08-18|||September 2003||2003-09-01|August 2015|2015-08-01|February 2012|Actual|2012-02-01|December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma|Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: A Pilot Study|Completed||N/A|10|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 15:59:23.634694|2017-02-18 15:59:23.634694
NCT00416793|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2014-05-12|2011-06-14||December 2006||2006-12-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer|A Phase II Study of Bortezomib in Combination With Carboplatin in Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|9|Actual|National Cancer Institute (NCI)|Given the toxicity and lack of objective responses observed with this regimen, the protocol met prospective criteria for early stopping and was terminated.|1|||f||||||||||||||2017-02-18 15:59:23.747413|2017-02-18 15:59:23.747413
NCT00416780|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-05-29||||||March 2006|2006-03-01|March 2006|Actual|2006-03-01|||||Interventional|||Psychosocial Support in Treating Women With Recurrent Breast Cancer or Stage I, Stage II, or Stage IV Breast Cancer|Psychobiological Pathways: Breast Cancer Interventions|Completed||N/A|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:23.97804|2017-02-18 15:59:23.97804
NCT00416767|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-05-27|||May 2004||2004-05-01|May 2016|2016-05-01|July 2007|Actual|2007-07-01|January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery|Study of First-Line Therapy Comprising Leucovorin Calcium, Fluorouracil, and Irinotecan (FOLFIRI) in Patients With Progressive Locally Advanced or Metastatic Duodenal-Pancreatic Endocrine Tumors|Completed||Phase 2|20|Actual|Federation Francophone de Cancerologie Digestive||1|||f||||||||||||||2017-02-18 15:59:24.056677|2017-02-18 15:59:24.056677
NCT00416754|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-04-06|||December 2000||2000-12-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Genetic Counseling in Women at Risk for BRCA1 or BRCA2 Mutations|Improving the Long-Term Outcomes of BRCA1/BRCA2 Mutation Testing|Active, not recruiting||N/A|1109|Actual|Georgetown University||1|||f||||f||||||||||2017-02-18 15:59:24.15779|2017-02-18 15:59:24.15779
NCT00416741|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2011-06-23|||February 2005||2005-02-01|June 2011|2011-06-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Observational|ATTEMPT||Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)|Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)|Completed||Phase 4|2000|Actual|Hellenic Atherosclerosis Society|||2||f||||t||||||||||2017-02-18 15:59:24.241179|2017-02-18 15:59:24.241179
NCT00416728|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2007-06-21|||November 2006||2006-11-01|June 2007|2007-06-01||||||||Interventional|||Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.|An Open-Label, Randomized, Two-Treatment, Two Period Crossover, Single-Dose Study to Determine the Relative Bioavailability of Fixed Combination of Final Market Image (FMI) Aliskiren/Valsartan 150/80 mg Tablets and the Free Combination of Aliskiren 150 mg and Valsartan 80 mg in Healthy Subjects|Completed||Phase 1|32||Novartis|||||f||||||||||||||2017-02-18 15:59:24.578926|2017-02-18 15:59:24.578926
NCT00416715|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-05-07|||October 2006||2006-10-01|May 2013|2013-05-01||||May 2010|Actual|2010-05-01||Interventional|||Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer|A Pilot Study of Vitamin D Deficiency and Myalgias, Arthralgias and/or Joint Stiffness Associated With Letrozole (Femara® )|Completed||Phase 2|100|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 15:59:24.668324|2017-02-18 15:59:24.668324
NCT00416702|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2008-06-09|||November 2006||2006-11-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|||||Interventional|||Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function|An Open-Label, Single-Dose, Parallel-Group Study to Assess the Pharmacokinetics of 600 µg Indacaterol in Subjects With Impaired Hepatic Function in Comparison With Healthy Control Subjects|Completed||Phase 1|32|Anticipated|Novartis||1|||f||||||||||||||2017-02-18 15:59:24.799936|2017-02-18 15:59:24.799936
NCT00416689|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-06-28|||April 2000||2000-04-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|March 2003|Actual|2003-03-01||Observational|||Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer|Determination of Utilities for Control of Chemotherapy-Induced Nausea or Vomiting|Completed||N/A|99|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 15:59:24.909226|2017-02-18 15:59:24.909226
NCT00416676|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-08-01||||||December 2006|2006-12-01||||||||Interventional|||Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma|UKCCSG Stage IIB/3 (INSS) Neuroblastoma Pilot Study [ENSG VI (Pilot 2B/3)]|Unknown status|Active, not recruiting|Phase 3|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:25.022653|2017-02-18 15:59:25.022653
NCT00416663|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2007-08-30|||August 2007||2007-08-01|December 2006|2006-12-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure|A Study for Testing Efficacy and Safety of the Administration of Vescell(TM) (Blood-Borne Autologous Angiogenic Cell Precursors) to Alleviate Anginal Symptoms and Myocardial Ischemia in Severe Anginal Syndrome +/- Heart Failure|Unknown status|Not yet recruiting|Phase 1/Phase 2|10|Anticipated|TheraVitae Ltd.||1|||f||||t||||||||||2017-02-18 15:59:25.114038|2017-02-18 15:59:25.114038
NCT00416650|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-04-02|||July 2002||2002-07-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|October 2007|Actual|2007-10-01||Interventional|||Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer|Multicenter Phase II Trial of OSI-774 (Erlotinib, Tarceva) in Patients With Advanced Bronchioalveolar Cell Lung Cancer.|Completed||Phase 2|16|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 15:59:25.227732|2017-02-18 15:59:25.227732
NCT00416637|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-07-05|||January 2004||2004-01-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Bevacizumab in Treating Patients With Advanced Solid Tumors|Biomarker and Clinical Evaluation of Bevacizumab (Avastin) to Determine the Role of Nitric Oxide in Anti-VEGF Therapy|Completed||Phase 1|27|Anticipated|Duke University||1|||f||||||||||||||2017-02-18 15:59:25.342018|2017-02-18 15:59:25.342018
NCT00416624|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-12-19|2015-09-10||May 2007||2007-05-01|September 2015|2015-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||All patients that were evaluable per protocol.|Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy|RC05CB A Pilot, Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week-Epoetin Alfa and Every 3-Week Darbepoetin Alfa|Completed||Phase 2|239|Actual|Mayo Clinic||4|||f||||t||||||||||2017-02-18 15:59:25.443675|2017-02-18 15:59:25.443675
NCT00416611|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-23|2009-01-28|||November 2006||2006-11-01|January 2009|2009-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|IMPULSION||IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study|IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study|Completed||Phase 4|1000|Anticipated|Hellenic Atherosclerosis Society|||1||f||||t||||||||||2017-02-18 15:59:27.263737|2017-02-18 15:59:27.263737
NCT00416598|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-12-05|2014-01-06||November 2006||2006-11-01|October 2016|2016-10-01||||January 2011|Actual|2011-01-01||Interventional||Participants who received investigational decatibine maitenance were analyzed.|Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia|Phase II Study of Maintenance Therapy With Decitabine (NSC #127716) Following Standard Induction and Cytogenetic Risk-Adapted Intensification in Previously Untreated Patients With AML &lt; 60 Years|Active, not recruiting||Phase 2|546|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:59:27.366931|2017-02-18 15:59:27.366931
NCT00416585|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2008-01-22|||October 2005||2005-10-01|January 2008|2008-01-01|November 2006||2006-11-01|||||Interventional|||Effects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment of Sever Acne|Effects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment|Completed||Phase 1|30||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 15:59:28.116565|2017-02-18 15:59:28.116565
NCT00416572|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-09-21|2015-08-25||January 1997||1997-01-01|September 2016|2016-09-01|April 2006|Actual|2006-04-01|May 2001|Actual|2001-05-01||Interventional|||Educational Program in Younger Women Who Have Recently Finished Treatment for Stage I or Stage II Breast Cancer|Adjustment to Breast Cancer Among Younger Women|Completed||N/A|252|Actual|Carnegie Mellon University||3|||f||||t||||||||||2017-02-18 15:59:28.210312|2017-02-18 15:59:28.210312
NCT00416559|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-09-19|||December 2004||2004-12-01|May 2007|2007-05-01||||||||Interventional|||Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only|Phase II Trial of Surgery as the Only Treatment for INSS Stage 2A & 2B Neuroblastoma|Unknown status|Active, not recruiting|Phase 2|140|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:28.741802|2017-02-18 15:59:28.741802
NCT00416546|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2008-08-08|||October 2006||2006-10-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects|A Double Blind, Randomized, Placebo-Controlled Study of AEB071 in Healthy Volunteers to Evaluate the Safety/Tolerability of 14 Day Multiple-Dose AEB071 and Measure the Effect of Ethnicity on Pharmacokinetics, Pharmacodynamics and Safety/Tolerability in Caucasian and Japanese Subjects Receiving Single and Multiple Doses of AEB071|Completed||Phase 1|96|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:59:28.817395|2017-02-18 15:59:28.817395
NCT00416533|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2017-01-17|||August 2004||2004-08-01|June 2013|2013-06-01||||October 2006|Actual|2006-10-01||Interventional|||Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study of Taxotere (Docetaxel) Plus Adriamycin (Doxorubicin) and Prednisone (TAP) in Hormone-Refractory Prostate Cancer|Completed||Phase 2|47|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 15:59:28.898441|2017-02-18 15:59:28.898441
NCT00415441|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2013-01-15|||March 2004||2004-03-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Effectiveness of Physiotherapy for Chronic Shoulder Pain|Efficacy and Cost-effectiveness of Physiotherapy for Chronic Rotator Cuff Pathology|Completed||Phase 3|120|Actual|University of Melbourne||2|||f||||f||||||||||2017-02-18 15:59:35.333194|2017-02-18 15:59:35.333194
NCT00416520|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2014-10-28|2014-08-22||June 2007||2007-06-01|October 2014|2014-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia|A Phase III, Randomised, Double-Blind, Multi-centre, Withdrawal Study Comparing MCI-196 Versus Placebo in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia|Completed||Phase 3|336|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-02-18 15:59:28.999556|2017-02-18 15:59:28.999556
NCT00416507|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-05-27|||March 2000||2000-03-01|May 2016|2016-05-01|January 2007|Actual|2007-01-01|July 2005|Actual|2005-07-01||Interventional|||Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery|Non Resectable But Non Metastatic Adenocarcinoma of the Exocrine Pancreas Non Resecables. Randomised Phase III: Initial Radiochimiotherapy (5-FU, Cisplatine, 60 GY Radiotherapy) Followed by Gemcitabine Versus Gemcitabine Alone|Completed||Phase 3|190|Anticipated|Federation Francophone de Cancerologie Digestive|||||f||||||||||||||2017-02-18 15:59:29.937536|2017-02-18 15:59:29.937536
NCT00416494|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2014-08-25|2013-02-12||September 2003||2003-09-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|January 2008|Actual|2008-01-01||Interventional|||Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer|Phase II Study of Oxaliplatin, Capecitabine and Bevacizumab in the Treatment of Metastatic Colorectal Cancer|Completed||Phase 2|50|Actual|Duke University||2|||f||||||||||||||2017-02-18 15:59:30.043839|2017-02-18 15:59:30.043839
NCT00416481|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-07-12|||December 2006||2006-12-01|July 2016|2016-07-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Assessing Older Patients With Cancer|Development of a Geriatric Assessment Measure for Older Patients With Cancer|Completed||N/A|93|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 15:59:30.587939|2017-02-18 15:59:30.587939
NCT00416468|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2007-06-21|||November 2006||2006-11-01|June 2007|2007-06-01||||||||Interventional|||Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.|An Open-Label, Randomized, Two-Treatment, Two Period Crossover, Single-Dose Study to Determine the Relative Bioavailability of Fixed Combination of Final Market Image (FMI) Aliskiren/Valsartan 75/160 mg Tablets and the Free Combination of Aliskiren 75 mg and Valsartan 160 mg in Healthy Subjects|Completed||Phase 1|32||Novartis|||||f||||||||||||||2017-02-18 15:59:30.700064|2017-02-18 15:59:30.700064
NCT00416455|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-11-14|2015-11-09||September 2007||2007-09-01|November 2016|2016-11-01||||September 2014|Actual|2014-09-01||Interventional||Adequate imaging and pathologically eligible patients (N =360)|Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer|Utility of Preoperative FDG-PET/CT Scanning Prior to Primary Chemoradiation Therapy to Detect Retroperitoneal Lymph Node Metastasis in Patients With Locoregionally Advanced Carcinoma of the Cervix (IB2, IIA ≥ 4 CM, IIB-IVA) or Endometrium (Grade 3 Endometrioid Endometrial Carcinoma; Serous Papillary Carcinoma, Clear Cell Carcinoma, or Carcinosarcoma (Any Grade); and Grade 1 OR 2 Endometrioid Endometrial Carcinoma With Cervical Stromal Involvement Overt in Clinical Examination or Confirmed by Endocervical Curettage|Active, not recruiting||Phase 1/Phase 2|384|Actual|National Cancer Institute (NCI)|Relatively small number of patients with abdominal metastasis in both cervical and endometrial cancer cohorts|1|||f||||||||||||||2017-02-18 15:59:30.79599|2017-02-18 15:59:30.79599
NCT00416442|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2011-11-01|||October 2006||2006-10-01|November 2011|2011-11-01||||November 2006|Actual|2006-11-01||Interventional|||Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.|A Randomized, Double-blind Placebo-controlled Single- to Multiple-dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of RSV604 Intravenous Formulation in Healthy Subjects|Completed||Phase 1|48||Novartis|||||f||||f||||||||||2017-02-18 15:59:31.694777|2017-02-18 15:59:31.694777
NCT00416429|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2012-09-25||||||September 2012|2012-09-01|February 2005|Actual|2005-02-01|||||Interventional|||Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer|Medroxyprogesterone, Interferon Alpha-2a, Interleukin 2 or Combination of Both Cytokines in Patients With Metastatic Renal Carcinoma of Intermediate Prognosis [PERCY QUATTRO]|Completed||Phase 3|456|Anticipated|Centre Leon Berard|||||f||||||||||||||2017-02-18 15:59:31.779639|2017-02-18 15:59:31.779639
NCT00416403|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2012-12-12|||July 2006||2006-07-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|September 2007|Actual|2007-09-01||Interventional|||Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer|Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer|Completed||Phase 2|35|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-02-18 15:59:31.883683|2017-02-18 15:59:31.883683
NCT00416390|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-09-19||||||October 2007|2007-10-01|March 2011|Actual|2011-03-01|||||Interventional|||Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia|The Effect of Lycopene on DNA Damage in Human Prostate|Completed||N/A|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:32.014233|2017-02-18 15:59:32.014233
NCT00416377|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-08-01||||||December 2006|2006-12-01||||||||Interventional|||Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma|Hodgkin's Disease Study|Unknown status|Active, not recruiting|N/A|353|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:32.106418|2017-02-18 15:59:32.106418
NCT00416364|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2007-12-04|||March 2006||2006-03-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Observational|||The Economic Impact of Four Varieties of Mesh Inguinal Hernia Repair- a Double-Blinded, Prospective, Randomized Trial|The Economic Impact of Four Varieties of Mesh Inguinal Hernia Repair- a Double-Blinded, Prospective, Randomized Trial|Terminated||N/A|23|Actual|United States Naval Medical Center, Portsmouth|||4|Inadequate accrural rates|f||||f||||||||||2017-02-18 15:59:32.198494|2017-02-18 15:59:32.198494
NCT00416351|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2016-03-28|||June 2006||2006-06-01|March 2016|2016-03-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment|A Phase I/II Study of Clofarabine in Patients With Relapsed T-Cell and NK-Cell Lymphomas|Active, not recruiting||Phase 1/Phase 2|29|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 15:59:32.31105|2017-02-18 15:59:32.31105
NCT00416338|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2007-05-09|||January 2007||2007-01-01|April 2007|2007-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Method of Exit Site Care in Chronic Peritoneal Dialysis Patients|Comparison of Two Exit-Site Care Methods, Film Dressing (F) Method and Simple Gauze Dressing (G) Method, in Chronic Peritoneal Dialysis (CPD) Patients|Terminated||Phase 4|11|Actual|Chinese University of Hong Kong||||"We encounter technical problems to continue with the study. (Notably difficulty in teaching~   the patients to use the dressing set involved in the study.)"|f||||||||||||||2017-02-18 15:59:32.434848|2017-02-18 15:59:32.434848
NCT00416325|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-06-25||||||September 2006|2006-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer|Phase I Multiple Dose Pharmacokinetic Study of Lycopene Delivered in a Well-Defined Food-Based Lycopene Delivery System (Tomato Paste-Oil Mixture) in Patients at Increased Risk for Developing Prostate Cancer|Completed||Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:32.51685|2017-02-18 15:59:32.51685
NCT00416312|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-27|2013-05-15|||July 2006||2006-07-01|May 2013|2013-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma|Dose-Response in Radioimmunotherapy of Lymphoma|Completed||N/A|9|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||||2017-02-18 15:59:32.611199|2017-02-18 15:59:32.611199
NCT00416299|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2009-01-29|||May 2007||2007-05-01|January 2009|2009-01-01|August 2007|Actual|2007-08-01|||||Observational|||Prognostic Value of New Cardiac Biomarkers in Elderly Patients Undergoing Cardiac Surgery|Observational Cohort Study on the Prognostic Value of New Cardiac Biomarkers in Elderly Patients Undergoing Cardiac Surgery|Completed||N/A|100|Actual|Klinikum Ludwigshafen|||||f||||f||||||||||2017-02-18 15:59:32.756514|2017-02-18 15:59:32.756514
NCT00415584|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2009-11-03|||January 2007||2007-01-01|November 2009|2009-11-01|November 2009||2009-11-01|||||Interventional|||Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients|Cinacalcet for Treatment of Persistent Secondary Hyperparathyroidism in Renal Transplant Recipients: Effect on Renal Function, Serum Calcium and Bone Histomorphometry|Withdrawn||N/A|18|Anticipated|Montefiore Medical Center||1||low enrollment|f||||||||||||||2017-02-18 15:59:32.832838|2017-02-18 15:59:32.832838
NCT00415571|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2010-02-02|||December 2006||2006-12-01|February 2010|2010-02-01|August 2008|Actual|2008-08-01|||||Interventional|||Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors|Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Study|Completed||Phase 2|72|Anticipated|QuatRx Pharmaceuticals Company||1|||f||||||||||||||2017-02-18 15:59:32.935144|2017-02-18 15:59:32.935144
NCT00415558|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2009-06-05|||May 2007||2007-05-01|June 2009|2009-06-01||||||||Interventional|||Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS Procedure|Prospective, Multicenter, Un-Blinded, Single Arm, Clinical Study Using the Guidant Microwave Ablation System Comprised of the Flex 10 Ablation Probe and Microwave Generator for Patients With Symptomatic Paroxysmal Atrial Fibrillation|Terminated||N/A|||Maquet Cardiovascular||1||Low enrollment|f||||||||||||||2017-02-18 15:59:33.046021|2017-02-18 15:59:33.046021
NCT00415545|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2013-06-06|||January 2007||2007-01-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Interventional|REMOTE-HF||Educational Program to Improve Heart Failure Outcomes in Adults Living in Rural Areas|Improving Self Care Behavior and Outcomes in Rural Patients With Heart Failure|Completed||Phase 3|614|Actual|University of California, San Francisco||3|||f||||t||||||||||2017-02-18 15:59:33.169942|2017-02-18 15:59:33.169942
NCT00415532|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2014-07-18|2010-10-01||December 2006||2006-12-01|July 2014|2014-07-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Interventional|||Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura|A Randomized, Controlled, Open-label Study Evaluating the Efficacy and Tolerability of AMG 531 Versus Medical Standard of Care as Chronic Therapy for Non-splenectomized Subjects With Immune (Idiopathic) Thrombocytopenic Purpura|Completed||Phase 3|234|Actual|Amgen||2|||f||||||||||||||2017-02-18 15:59:33.289882|2017-02-18 15:59:33.289882
NCT00415519|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2014-09-16|||December 2006||2006-12-01|September 2014|2014-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III|An Exploratory Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (Severity Classification III) in Double-Blind, Parallel-Group, Placebo-Controlled Manner|Completed||Phase 3|25|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 15:59:34.296172|2017-02-18 15:59:34.296172
NCT00415506|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2013-08-08|2013-05-20||January 2007||2007-01-01|August 2013|2013-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation|A PhaseI/II Prospective, Randomized, Dose-Ranging Pilot Study of Rituximab in the Treatment of Refractory Scleritis and Non-Infectious Orbital Inflammation|Completed||Phase 1/Phase 2|20|Actual|Oregon Health and Science University||2|||f||||||||||||||2017-02-18 15:59:34.396819|2017-02-18 15:59:34.396819
NCT00415493|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2012-09-26|2012-07-20||December 2006||2006-12-01|September 2012|2012-09-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation|Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation|Completed||N/A|24|Actual|Associated Scientists to Help Minimize Allergies||2|||f||||f||||||||||2017-02-18 15:59:34.751348|2017-02-18 15:59:34.751348
NCT00415467|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2012-08-01|||January 2005||2005-01-01|August 2012|2012-08-01|July 2008|Actual|2008-07-01|November 2007|Actual|2007-11-01||Interventional|||Treatment of Resectable Malignant Brain Tumors|Phase IV GliaSite® Radiation Therapy System Registry Protocol for the Treatment of Resectable Malignant Brain Tumors|Terminated||Phase 4|13|Actual|M.D. Anderson Cancer Center||1||Sponsor decision to terminate study.|f||||f||||||||||2017-02-18 15:59:35.108262|2017-02-18 15:59:35.108262
NCT00415454|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-06-21|||November 2006||2006-11-01|June 2011|2011-06-01||||||||Interventional|||Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma|Phase I Study Combining Replication-Competent Adenovirus-Mediated Suicide Gene Therapy With Chemoradiotherapy for the Treatment of Non-Metastatic Pancreatic Adenocarcinoma|Terminated||Phase 1|8|Actual|Henry Ford Health System||1||Poor enrollment|f||||t||||||||||2017-02-18 15:59:35.221526|2017-02-18 15:59:35.221526
NCT00415415|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2016-07-28|||September 2000||2000-09-01|December 2006|2006-12-01|March 2004|Actual|2004-03-01|||||Observational|||Factors Associated With Coronary Heart Disease in African Americans in the Jackson Heart Study|Disparities in CHD in the Jackson Heart Study|Completed||N/A|5302||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 15:59:35.535466|2017-02-18 15:59:35.535466
NCT00415402|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2012-08-21|||March 2007||2007-03-01|August 2012|2012-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|DIVIDS||Effect of Vitamin D Supplementation on Health of Low Birth Weight Infants|Randomised Controlled Trial to Evaluate the Preventive Effect on Mortality and Serious Morbidity/ Hospitalisations of Daily Vitamin D Supplements in Small for Gestational Age Term Infants|Completed||N/A|2000|Actual|Delhi University||2|||f||||t||||||||||2017-02-18 15:59:35.613796|2017-02-18 15:59:35.613796
NCT00415389|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2013-02-15|||February 2005||2005-02-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||The Stroke Warning Information and Faster Treatment Study (SWIFT)|The Stroke Warning Information and Faster Treatment Study (SWIFT)|Terminated||Phase 2|1635|Actual|Columbia University||2||Approval lapse|f||||f||||||||||2017-02-18 15:59:35.731266|2017-02-18 15:59:35.731266
NCT00415376|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2012-05-17|||February 2007||2007-02-01|May 2012|2012-05-01|July 2007||2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases|A Pilot Study of the Efficacy of Levetiracetam in Patients With Seizures From Brain Metastases|Withdrawn||N/A|0|Actual|Northwestern University||||Unable to accrue subjects|f||||||||||||||2017-02-18 15:59:35.831226|2017-02-18 15:59:35.831226
NCT00415363|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2011-04-05||2011-04-05|December 2006||2006-12-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy|A Double-blind, Randomized, Placebo-controlled Multicentre Phase II Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases From Lung Cancer|Completed||Phase 2|107|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 15:59:35.930474|2017-02-18 15:59:35.930474
NCT00415350|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2010-03-16|||April 2008||2008-04-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|BAT||Bronchiectasis and Long Term Azithromycin Treatment|Bronchiectasis and Long Term Azithromycin Treatment: A Randomised Placebo-controlled Trial Studying Disease Modifying Effects of Immunomodulating Treatment|Unknown status|Active, not recruiting|Phase 3|72|Anticipated|Medical Center Alkmaar||2|||f||||f||||||||||2017-02-18 15:59:36.27177|2017-02-18 15:59:36.27177
NCT00416286|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-25|2006-12-26||||||December 2006|2006-12-01||||||||Observational|||Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients|Phase 1: To Evaluate the Antibacterial Efficacy of Sustained Release Cetylpyridinium Chloride Varnish in Orthodontic Patients|Unknown status|Not yet recruiting|Phase 1|30|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 15:59:36.390997|2017-02-18 15:59:36.390997
NCT00416273|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2015-03-05|||December 2006||2006-12-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma|Consolidation Therapy With Bortezomib <= 60 Year Old Patients With Multiple Myeloma|Completed||Phase 3|217|Actual|Janssen-Cilag G.m.b.H||2|||f||||f||||||||||2017-02-18 15:59:36.462514|2017-02-18 15:59:36.462514
NCT00416260|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2014-06-21|||July 2006||2006-07-01|June 2014|2014-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Combined High Frequency Oscillation and Tracheal Gas Insufflation for Severe Acute Respiratory Distress Syndrome|Phase 1/Phase 2, Single-Center, Controlled Study of the Effectiveness of Combined High Frequency Oscillation and Tracheal Gas Insufflation in Improving the Clinical Course of Patients With Severe Acute Respiratory Distress Syndrome|Completed||Phase 1/Phase 2|54|Actual|University of Athens||2|||f||||t||||||||||2017-02-18 15:59:36.710207|2017-02-18 15:59:36.710207
NCT00416247|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2010-08-04|||December 2006||2006-12-01|December 2006|2006-12-01|June 2009|Actual|2009-06-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Hypnosis on Motor Cortex Excitability|Effect of Hypnosis on Motor Cortex Excitability|Completed||N/A|20|Actual|Rambam Health Care Campus||1|||f||||||||||||||2017-02-18 15:59:36.832973|2017-02-18 15:59:36.832973
NCT00416234|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2010-01-13|||September 2006||2006-09-01|June 2008|2008-06-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/Choledocholithiasis|Laparoendoscopic Rendez Vous (Intraoperative ERCP) vs Two Stage Approach (Preoperative ERCP Followed by Laparoscopic Cholecystectomy) for the Management of Cholelithiasis/Choledocholithiasis|Unknown status|Recruiting|N/A|300|Anticipated|University of Thessaly||2|||f||||t||||||||||2017-02-18 15:59:36.928262|2017-02-18 15:59:36.928262
NCT00416221|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2011-08-17|||April 2006||2006-04-01|August 2011|2011-08-01|January 2007|Actual|2007-01-01|||||Interventional|||PACEPro - Mood Management Pilot|Development and a Pilot Study of the PACEPRO Exercise and Mood Management Program in Depressed Patients on Escitalopram Oxalate (Lexapro)|Completed||N/A|40|Actual|University of California, San Diego|||||f||||||||||||||2017-02-18 15:59:37.041079|2017-02-18 15:59:37.041079
NCT00416208|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2015-03-04|||October 2006||2006-10-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma|Consolidation Therapy With Bortezomib in Patients With Multiple Myeloma Aged 61 to 75|Completed||Phase 3|154|Actual|Janssen-Cilag G.m.b.H||2|||f||||f||||||||||2017-02-18 15:59:37.146446|2017-02-18 15:59:37.146446
NCT00416195|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2014-06-26|2012-10-23||December 2006||2006-12-01|August 2013|2013-08-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Explore the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures|Completed||Phase 2|48|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 15:59:37.315561|2017-02-18 15:59:37.315561
NCT00416182|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2014-11-12|2012-10-02||December 2006||2006-12-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis|The Use of Nasally Delivered Pulmozyme in the Treatment of Sinusitis in Cystic Fibrosis Patients: A Pilot Study|Completed||Phase 2|16|Actual|University of Vermont|recruitment for a long trial was difficult so enrollment was truncated.|2|||f||||t||||||||||2017-02-18 15:59:37.679395|2017-02-18 15:59:37.679395
NCT00416169|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2011-06-06|||May 2003||2003-05-01|January 2011|2011-01-01|July 2004|Actual|2004-07-01|||||Interventional|||A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia|An Open Pilot Study to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Pick's Disease/Frontotemporal Dementia /Pick Complex|Completed||Phase 2|41|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 15:59:38.118398|2017-02-18 15:59:38.118398
NCT00416156|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-25|2006-12-26|||May 2005||2005-05-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Effect of Weight Reduction on Inflammatory Markers and Genes Expression in Obese Individuals||Completed||N/A|25||Taichung Veterans General Hospital|||||f||||||||||||||2017-02-18 15:59:38.215944|2017-02-18 15:59:38.215944
NCT00416143|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-24|2006-12-24|||June 2006||2006-06-01|December 2006|2006-12-01|December 2008||2008-12-01|||||Interventional|||Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss|Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss|Unknown status|Recruiting|Phase 2/Phase 3|60||Sheba Medical Center|||||f||||||||||||||2017-02-18 15:59:38.311729|2017-02-18 15:59:38.311729
NCT00416130|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2013-12-08|||January 2007||2007-01-01|December 2013|2013-12-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Clinical Trial of SAHA in Patients With Breast Cancer|Phase I/II Clinical Trial of Vorinostat in Patients With Recurrent and/or Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|49|Anticipated|National University Hospital, Singapore||1|||f||||f||||||||||2017-02-18 15:59:38.402678|2017-02-18 15:59:38.402678
NCT00416117|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2006-12-26|||July 2001||2001-07-01|December 2006|2006-12-01|June 2004||2004-06-01|||||Interventional|||Manual Physical Therapy and Exercise for Mechanical Neck Disorders|The Effectiveness of Manual Physical Therapy and Exercise for Mechanical Neck Disorders: A Randomized Controlled Trial|Completed||Phase 2/Phase 3|100||Brooke Army Medical Center|||||f||||||||||||||2017-02-18 15:59:38.525452|2017-02-18 15:59:38.525452
NCT00416104|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2006-12-26|||December 2006||2006-12-01|July 2006|2006-07-01|February 2007||2007-02-01|||||Observational|||Postcesarean Section Pain: Possible Demographic and Medical Predictors|Postcesarean Section Pain: Possible Demographic and Medical Predictors|Unknown status|Not yet recruiting|N/A|600||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 15:59:38.624988|2017-02-18 15:59:38.624988
NCT00416091|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2012-11-12|||January 2007||2007-01-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|||||Observational|||Neuropsychological Functioning Among Children With Tourret's Disorder and ADHD|Neuropsychological Functioning, Symptomatology, and Social Adjustment Among Children With Tourret's Disorder, Attention-Deficit/Hyperactivity Disorder, and Comorbid Conditions.|Completed||N/A|120|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 15:59:38.703873|2017-02-18 15:59:38.703873
NCT00416078|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2015-04-07|2014-12-16||August 2007||2007-08-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Online Caregiver Psychoeducation and Support for Alzheimer's|Caregiver Psychoeducation and Support: Improving Outcomes in AD/ADRD|Completed||Phase 2/Phase 3|53|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 15:59:38.789716|2017-02-18 15:59:38.789716
NCT00416065|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2006-12-26|||April 2004||2004-04-01|November 2006|2006-11-01||||||||Interventional|||"PET/CT to Identify Vulnerable Arterial Plaque"|"PET/CT to Identify Vulnerable Arterial Plaque"|Unknown status|Recruiting|N/A|800||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 15:59:39.308728|2017-02-18 15:59:39.308728
NCT00416052|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2011-05-18|||March 2004||2004-03-01|May 2011|2011-05-01|June 2006||2006-06-01|||||Observational|||Relation Between Bone Density and the Regulation of Mineral Metabolism in Renal Stone Formers|Relation Between Bone Mineral Density and the Regulation of Mineral Metabolism in Renal Stone Formers|Completed||N/A|90||University Hospital Inselspital, Berne|||1||f||||||||||||||2017-02-18 15:59:39.382491|2017-02-18 15:59:39.382491
NCT00416039|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2013-08-27|||January 2007||2007-01-01|August 2013|2013-08-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|MIDAZODOL||Efficacy of Sublingual Midazolam in Association With Oral Morphine in Children Analgesia After Bone Fracture|Clinical Randomized Study of Sublingual Midazolam in Association With Morphine by Oral Route in Arm Fracture in Children at the Emergency Children Care|Completed||Phase 3|60|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 15:59:39.487341|2017-02-18 15:59:39.487341
NCT00416026|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2006-12-26|||January 2002||2002-01-01|December 2006|2006-12-01|October 2004||2004-10-01|||||Interventional|||Translating Research: Patient Decision Support/Coaching||Completed||N/A|304||Michigan State University|||||f||||||||||||||2017-02-18 15:59:39.597771|2017-02-18 15:59:39.597771
NCT00416013|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2010-10-06|||December 2005||2005-12-01|October 2010|2010-10-01|December 2010|Anticipated|2010-12-01|||||Observational|||Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hemodialysis Patients|Correlations Between BNP and Dry Weight, and Between Troponin and Mortality, in Hemodialysis Patients|Unknown status|Active, not recruiting|N/A|151|Actual|Eastern Virginia Medical School|||1||f||||f||||||||||2017-02-18 15:59:39.695015|2017-02-18 15:59:39.695015
NCT00416000|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2014-05-20|||January 2006||2006-01-01|May 2014|2014-05-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Observational|||Mechanism and Prevention of Remote Organ Injury Following Ruptured Aortic Aneurysm|Phase 1 Study of Complement Activation Following Ruptured Abdominal Aortic Aneurysm: Combining Human Observation With Animal Experimentation to Establish a Framework for Human Therapy|Completed||N/A|24|Actual|University Health Network, Toronto|||1||f||||f||||||Samples Without DNA|"~     plasma~   "|||2017-02-18 15:59:39.777745|2017-02-18 15:59:39.777745
NCT00415987|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2008-06-19||||||June 2008|2008-06-01|September 2006||2006-09-01|||||Interventional|||Hematopoietic Stem Cell Transplantation in Myeloma||Unknown status|Active, not recruiting|Phase 2/Phase 3|||Azienda Ospedaliera San Giovanni Battista|||||f||||||||||||||2017-02-18 15:59:39.856119|2017-02-18 15:59:39.856119
NCT00415974|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-26|2012-08-15|||February 2008||2008-02-01|August 2012|2012-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||PACE-PC: Primary Care Management of Adolescent Obesity|PACE-PC: Primary Care Management of Adolescent Obesity|Completed||N/A|106|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 15:59:39.939192|2017-02-18 15:59:39.939192
NCT00415961|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2009-01-08|||November 2006||2006-11-01|January 2009|2009-01-01|May 2012|Anticipated|2012-05-01|||||Interventional|||Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety|Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety|Terminated||N/A|120|Anticipated|Conor Medsystems||1|||f||||||||||||||2017-02-18 15:59:40.127265|2017-02-18 15:59:40.127265
NCT00340587|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 2, 1997||1997-05-02|February 24, 2016|2016-02-24|February 24, 2016||2016-02-24|||||Observational|||Human Sperm Binding to Transgenic Mouse Eggs|Human Sperm Binding to Transgenic Mouse Eggs|Completed||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.014774|2017-02-18 16:27:42.014774
NCT00415948|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2009-12-17|||December 2006||2006-12-01|December 2009|2009-12-01|June 2008|Actual|2008-06-01|||||Observational|||Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement|Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement|Completed||N/A|300|Anticipated|Biosite|||1||f||||||||||Samples Without DNA|"~     Plasma Specimens~   "|||2017-02-18 15:59:40.23849|2017-02-18 15:59:40.23849
NCT00415935|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2006-12-23||||||December 2006|2006-12-01|December 2006||2006-12-01|||||Observational|||PRINTO (the Paediatric Rheumatology International Trials Organisation)||Unknown status|Recruiting|N/A|||Institute of Child Health|||||f||||||||||||||2017-02-18 15:59:40.349091|2017-02-18 15:59:40.349091
NCT00415922|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2007-06-21|||July 2006||2006-07-01|June 2007|2007-06-01||||||||Interventional|||Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers|A Randomized, Two-Way Crossover Study to Investigate the Bioavailability of a Single Oral Dose of 37.5 mg Carbidopa, 150 mg Levodopa and 200 mg Entacapone Compared to a Single Oral Combined Dose of Both 37.5 mg Carbidopa and 150 mg Levodopa and 200 mg Entacapone in Healthy Volunteers Under Fasting Conditions|Completed||Phase 1|42||Novartis|||||f||||||||||||||2017-02-18 15:59:40.424286|2017-02-18 15:59:40.424286
NCT00415909|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2014-05-29|2014-05-29||December 2006||2006-12-01|May 2014|2014-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Two participants withdrew from the study, and one died of a second, unrelated malignancy.|TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients|"Phase II Proof of Concept Study of TALL-104 (MHC Non-Restricted Cytotoxic T-Cell Line) and Imatinib Mesylate (Gleevec) in Chronic Myelogenous Leukemia in Chronic Phase"|Terminated||Phase 2|3|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f||||||||||2017-02-18 15:59:40.505345|2017-02-18 15:59:40.505345
NCT00415896|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2006-12-22|||December 2006||2006-12-01|December 2006|2006-12-01|June 2007||2007-06-01|||||Interventional|||Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance|Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance|Unknown status|Recruiting|N/A|10||Krankenhaus Kloster Grafschaft|||||f||||||||||||||2017-02-18 15:59:40.764145|2017-02-18 15:59:40.764145
NCT00415883|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2007-06-21|||July 2006||2006-07-01|June 2007|2007-06-01||||||||Interventional|||To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers|An Open-Label, Randomized, Single Dose, Two Period, Crossover Study to Determine the Relative Bioavailability of Valsartan 160 mg Japanese Formulation and Valsartan 160 mg Global Formulation in Healthy Adult Volunteers|Completed||Phase 1|40||Novartis|||||f||||f||||||||||2017-02-18 15:59:40.849934|2017-02-18 15:59:40.849934
NCT00415870|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2013-06-20|2013-06-20||June 2007||2007-06-01|June 2013|2013-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||mDiet - Ecological Momentary Intervention of Diet Via Mobile Technology|Ecological Momentary Intervention of Diet Via Mobile Technology|Completed||N/A|60|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 15:59:40.944837|2017-02-18 15:59:40.944837
NCT00415857|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2014-03-28|2014-03-28||December 2006||2006-12-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)|Potential of Immunotherapy to Convert a Complete Cytogenetic Remission in Chronic Myelogenous Leukemia to a Molecular Complete Remission: Randomized Phase II Study of Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and Peginterferon Alfa-2b [PEG-INTRON(R), Schering Corporation]|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center||2||Vaccine sponsor ceased operations.|f||||t||||||||||2017-02-18 15:59:43.994232|2017-02-18 15:59:43.994232
NCT00415844|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2007-06-21|||June 2006||2006-06-01|June 2007|2007-06-01||||||||Interventional|||Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers|A Randomized, Two-Way Crossover Study to Investigate the Bioavailability of a Single Oral Dose of 25 mg Carbidopa, 100 mg Levodopa and 200 mg Entacapone Compared to a Single Oral Combined Dose of Both 25 mg Carbidopa and 100 mg Levodopa and 200 mg Entacapone in Healthy Volunteers Under Fasting Conditions|Completed||Phase 1|42||Novartis|||||f||||||||||||||2017-02-18 15:59:44.336951|2017-02-18 15:59:44.336951
NCT00415831|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2007-06-21|||June 2006||2006-06-01|June 2007|2007-06-01||||||||Interventional|||Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers|A Randomized, Two-Way Crossover Study to Investigate the Bioavailability of a Single Oral Dose of 12.5 mg Carbidopa, 50 mg Levodopa and 200 mg Entacapone Compared to a Single Oral Combined Dose of Both 12.5 mg Carbidopa and 50 mg Levodopa and 200 mg Entacapone in Healthy Volunteers Under Fed Conditions|Completed||Phase 1|42||Novartis|||||f||||||||||||||2017-02-18 15:59:44.417014|2017-02-18 15:59:44.417014
NCT00415818|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2014-07-15|||December 2005||2005-12-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer|A Phase IIb Multicentric Controlled Study Evaluating the Therapeutic Vaccine TG4010(MVA-MUC1-IL2) as an Adjunct to Standard Chemotherapy in Advanced Non Small Cell Lung Cancer|Completed||Phase 2/Phase 3|148|Actual|Transgene||2|||f||||||||||||||2017-02-18 15:59:44.502314|2017-02-18 15:59:44.502314
NCT00415805|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2009-03-12|||December 2006||2006-12-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent|A Pilot, Open-Label, Multicenter Intra-Individual Comparison of Multihance and Vasovist for Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA) of Renal Arteries|Completed||Phase 3|39|Actual|Bracco Diagnostics, Inc||2|||f||||f||||||||||2017-02-18 15:59:44.64069|2017-02-18 15:59:44.64069
NCT00415792|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2007-01-04|||November 2003||2003-11-01|January 2007|2007-01-01|July 2005||2005-07-01|||||Interventional|||Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs|Administration of Human Chorionic Gonadotropin (hCG) Versus Gonadotropin Releasing Hormone (GnRH) Agonist for Ovulation Induction in Hyper-Responder Patients|Unknown status|Active, not recruiting|Phase 4|60||Eugonia|||||f||||||||||||||2017-02-18 15:59:44.732314|2017-02-18 15:59:44.732314
NCT00415779|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2010-02-23|||July 2006||2006-07-01|February 2010|2010-02-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|ZANTE||ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer|Phase I Study of the Combination of Zoledronic Acid and Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer|Completed||Phase 1|36|Anticipated|National Cancer Institute, Naples||1|||f||||f||||||||||2017-02-18 15:59:45.068415|2017-02-18 15:59:45.068415
NCT00415766|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2016-01-18|||June 2013||2013-06-01|January 2016|2016-01-01|July 2016|Anticipated|2016-07-01|December 2015|Actual|2015-12-01||Interventional|||Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders|Recombinant hCG (Ovitrelle) Vesrus Urinary hCG (Pregnyl) for Triggering Final Oocyte Maturation in High Responders|Active, not recruiting||Phase 4|150|Actual|Eugonia||3|||f||||f||||||||||2017-02-18 15:59:45.177949|2017-02-18 15:59:45.177949
NCT00415753|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2008-05-22|||June 2006||2006-06-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Procalcitonin as a Marker of Bacterial Pneumonia||Completed||N/A|223|Actual|Aarhus University Hospital Skejby|||||f||||f||||||||||2017-02-18 15:59:45.314233|2017-02-18 15:59:45.314233
NCT00415740|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2007-06-21|||May 2006||2006-05-01|June 2007|2007-06-01||||||||Interventional|||Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers|A Randomized, Two-Way Crossover Study to Investigate the Bioavailability of a Single Oral Dose of 12.5 mg Carbidopa, 50 mg Levodopa and 200 mg Entacapone Compared to a Single Oral Combined Dose of Both 12.5 mg Carbidopa and 50 mg Levodopa and 200 mg Entacapone in Healthy Volunteers Under Fasting Conditions|Completed||Phase 1|42||Novartis|||||f||||||||||||||2017-02-18 15:59:45.401431|2017-02-18 15:59:45.401431
NCT00415727|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2006-12-23|||November 2006||2006-11-01|December 2006|2006-12-01||||||||Interventional|||Prevention Of Morbidity In Sickle Cell Disease Pilot Phase||Unknown status|Recruiting|Phase 2|22||Institute of Child Health|||||f||||||||||||||2017-02-18 15:59:45.484864|2017-02-18 15:59:45.484864
NCT00415714|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2007-01-26|||September 2006||2006-09-01|December 2006|2006-12-01|October 2007||2007-10-01|||||Interventional|||Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia|A Randomized Controlled Pilot Trial Testing the Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia|Unknown status|Recruiting|N/A|132||Helicor|||||f||||||||||||||2017-02-18 15:59:45.577844|2017-02-18 15:59:45.577844
NCT00415701|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2010-03-03|||November 2006||2006-11-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery|Effect of an Anesthetic Induction Dose of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery|Completed||Phase 4|130|Anticipated|University Hospital Inselspital, Berne||3|||f||||f||||||||||2017-02-18 15:59:45.683948|2017-02-18 15:59:45.683948
NCT00415688|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2006-12-21|||July 2004||2004-07-01|December 2006|2006-12-01|January 2006||2006-01-01|||||Interventional|||Lifestyle Modification for Obesity-Related Type 2 Diabetes|A Randomized, Controlled Trial of a Low-Carbohydrate, Ketogenic Diet Versus a Low-Glycemic Index Diet for Obesity-Related Type 2 Diabetes|Completed||Phase 4|90||Robert C. Atkins Foundation|||||f||||||||||||||2017-02-18 15:59:45.809562|2017-02-18 15:59:45.809562
NCT00415675|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2012-10-22|||November 2004||2004-11-01|October 2012|2012-10-01||||October 2012|Actual|2012-10-01||Observational|||Respiratory Tumor and Normal Tissue Motion|Assessing the Magnitude and Potential Impact of Respiration-Induced Three-Dimensional Motion of Tumors and Normal Tissues Using Four-Dimensional CT Technology|Completed||N/A|86|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 15:59:45.89847|2017-02-18 15:59:45.89847
NCT00415662|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-22|2006-12-22|||June 2002||2002-06-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Effect of Biomagnetic Therapy on Gonarthrosis||Terminated||N/A|||University of Lausanne Hospitals|||||f||||||||||||||2017-02-18 15:59:45.999978|2017-02-18 15:59:45.999978
NCT00415649|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2012-03-20||||||March 2012|2012-03-01||||||||Interventional|||Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults|A Phase II, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine Followed by Recombinant, Multiclade HIV-1 Adenoviral Vector Vaccine in Healthy Adult Volunteers at Risk for HIV Infection|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 15:59:46.081993|2017-02-18 15:59:46.081993
NCT00415636|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2010-08-30|||December 2006||2006-12-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer|A Phase 1 Dose-Escalation Study to Examine the Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer|Completed||Phase 1|31|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:59:46.193703|2017-02-18 15:59:46.193703
NCT00415623|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2008-12-05|2008-10-16||January 2007||2007-01-01|December 2008|2008-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient|A Double-Blind, Comparative Study Between Amlodipine 5mg And 10mg In Patients With Essential Hypertension For Whom Amlodipine 5mg Is Insufficiently Effective|Completed||Phase 3|305|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 15:59:46.286024|2017-02-18 15:59:46.286024
NCT00415610|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2015-08-10|2015-03-03||July 2005||2005-07-01|August 2015|2015-08-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|ATACH|Group numbers were adjusted as adequate safety parameters were met in each successive treatment tier. A larger number of subjects were therefore evaluated in the final tier where safety is of greatest concern and SBP parameter is also of greatest challenge to meet.|Antihypertensive Treatment in Acute Cerebral Hemorrhage|Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)|Completed||Phase 1|60|Actual|University of Minnesota - Clinical and Translational Science Institute|Limited by small sample size and likelihood of imbalances in subject characteristics among the three tiers. Clinical measures may be insensitive. Not designed to provide comparative event rates and not powered toward prediction of clinical outcomes.|3|||f||||t||||||||||2017-02-18 15:59:46.842459|2017-02-18 15:59:46.842459
NCT00415597|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2013-09-13|2009-09-11||December 2006||2006-12-01|September 2013|2013-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain|A Long-Term, Open-Label Safety Study of ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended-Release) Capsules in Subjects With Chronic Moderate to Severe Nonmalignant Pain|Completed||Phase 3|467|Actual|Pfizer||1|||f||||||||||||||2017-02-18 15:59:47.881864|2017-02-18 15:59:47.881864
NCT00415337|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-12-13|||April 2007||2007-04-01|December 2011|2011-12-01||||||||Observational|||Endobronchial Ultrasound Guided Transbronchial Lung Biopsy With or Without Guide Sheath in Lung Tumors and the Analysis of Echoic Patterns of Lung Tumors and Mediastinal Lymph Nodes, and the Association Between Diagnostic Yield of Transbronchial Lung Biopsy and EBUS Echoic Features.||Unknown status|Active, not recruiting|N/A|200|Anticipated|Chang Gung Memorial Hospital|||1||f||||||||||||||2017-02-18 15:59:48.261426|2017-02-18 15:59:48.261426
NCT00415324|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2014-05-19|||December 2006||2006-12-01|April 2014|2014-04-01||||May 2014|Actual|2014-05-01||Interventional|||Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors|A Phase 1 Study of Halichondrin B Analog (E7389) in Combination With Cisplatin in Advanced Solid Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 15:59:48.347156|2017-02-18 15:59:48.347156
NCT00415311|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2011-08-08|||December 2006||2006-12-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.|A Multicenter, Open-Label, Randomized, Phase 1B Study Evaluating the Safety and Tolerability of Intravenous Recombinant Human Mannose‑Binding Lectin (rhMBL) in Liver Transplant Recipients|Terminated||Phase 1|24|Actual|Enzon Pharmaceuticals, Inc.||3||Sponsor decision to terminate the study|f||||t||||||||||2017-02-18 15:59:48.459145|2017-02-18 15:59:48.459145
NCT00415298|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2014-01-09|||May 2006||2006-05-01|May 2007|2007-05-01||||||||Interventional|||AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer|AP5346 for Recurrent/Unresectable Squamous Cell Carcinoma of the Head and Neck: A Pilot Study With Clinical and Biological Endpoints|Unknown status|Active, not recruiting|N/A|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 15:59:48.567271|2017-02-18 15:59:48.567271
NCT00415285|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2007-02-12|||December 2006||2006-12-01|February 2007|2007-02-01||||||||Interventional|||Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer|Randomized Phase II Trial of Sequential Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine as in Induction Therapy for Early Stage Breast Cancer|Unknown status|Recruiting|Phase 2|100||Georgia Center for Oncology Research & Education|||||f||||||||||||||2017-02-18 15:59:48.677589|2017-02-18 15:59:48.677589
NCT00415272|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2008-01-11||||||January 2008|2008-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease||Terminated||N/A|||University of California, San Francisco||||Inadequate enrollment.|f||||||||||||||2017-02-18 15:59:48.776471|2017-02-18 15:59:48.776471
NCT00415259|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2013-01-15|||May 2005||2005-05-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Shoes Insoles on Symptoms and Disease Progression in Knee Osteoarthritis|Effects of Shoes Insoles on Symptoms and Disease Progression in Knee Osteoarthritis|Completed||N/A|200|Actual|University of Melbourne||2|||f||||t||||||||||2017-02-18 15:59:48.853005|2017-02-18 15:59:48.853005
NCT00415246|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2007-11-15|||November 2006||2006-11-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Study to Evaluate a Subcutaneous Four Months Sustained-Release Formulation of Triptorelin in Patients With Prostate Cancer|A Phase III, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of a Subcutaneous Four Months Sustained-Release Formulation of Triptorelin, a Gonadotrophin Releasing Hormone Analogue in Patients With Prostate Cancer|Terminated||Phase 3|100|Anticipated|Ipsen||1||"The preliminary data do not support the expected sustainable blood levels of triptorelin for a~   duration of 4 months in all patients."|f||||||||||||||2017-02-18 15:59:48.956154|2017-02-18 15:59:48.956154
NCT00415233|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2015-12-03|||November 2006||2006-11-01|December 2015|2015-12-01|July 2020|Anticipated|2020-07-01|June 2011|Actual|2011-06-01||Interventional|HiLo||Iodine I 131 With or Without Thyroid-Stimulating Hormone in Treating Patients Who Have Undergone Surgery for Thyroid Cancer|Multicentre Randomised Trial of High Dose Versus Low Dose Radioiodine, With or Without Recombinant Human Thyroid Stimulating Hormone, for Remnant Ablation Following Surgery for Differentiated Thyroid Cancer [HILO]|Active, not recruiting||Phase 3|438|Actual|University College, London||4|||f||||t||||||||||2017-02-18 15:59:49.070774|2017-02-18 15:59:49.070774
NCT00415220|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2006-12-21|||January 2000||2000-01-01|December 2006|2006-12-01|May 2004||2004-05-01|||||Interventional|||Manipulation or Microdiscectomy For Sciatica? A Prospective Randomized Controlled Trial.|Comparison of Treatment Outcomes Between Chiropractic and Back Surgery for the Treatment of Sciatica Secondary to Lumbar Herniated Disc: A Prospective Randomized Controlled Trial.|Completed||Phase 2|40||McMorland, Gordon, D.C.|||||f||||||||||||||2017-02-18 15:59:49.19942|2017-02-18 15:59:49.19942
NCT00415207|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-08-04|||December 2006||2006-12-01|December 2006|2006-12-01|December 2010|Actual|2010-12-01|August 2008|Actual|2008-08-01||Observational|||Pharmacogenomics of Paclitaxel in Ovarian Cancer|Pharmacogenomics of Paclitaxel in Ovarian Cancer: Predictors of Toxicity and Response|Completed||N/A|300|Anticipated|University of Southern Denmark|||1||f||||||||||Samples With DNA|"~     paraffin embedded biopsies~   "|||2017-02-18 15:59:49.285514|2017-02-18 15:59:49.285514
NCT00415194|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2011-06-23|2011-03-10||December 2006||2006-12-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study for Patients With Head and Neck Cancer|A Randomized Phase 3 Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Monotherapy in Patients With Recurrent or Metastatic Head and Neck Cancer|Completed||Phase 3|795|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:59:49.394044|2017-02-18 15:59:49.394044
NCT00415181|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2015-01-12|||September 2006||2006-09-01|December 2006|2006-12-01|March 2013|Actual|2013-03-01|January 2009|Actual|2009-01-01||Observational|||Pharmacogenomics of Paclitaxel in Ovarian Cancer|The Pharmacogenomics of Paclitaxel in Patients With Ovarian Cancer: Predictors of Toxicity and Response|Completed||N/A|93|Actual|University of Southern Denmark|||1||f||||||||||Samples With DNA|"~     blood~   "|||2017-02-18 15:59:51.551918|2017-02-18 15:59:51.551918
NCT00415168|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2010-08-11|2010-07-13||December 2006||2006-12-01|August 2010|2010-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer|Phase 2 Study of ALIMTA® (Pemetrexed) Plus Cisplatin as First-Line Treatment of Gastric Cancer|Completed||Phase 2|53|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 15:59:51.64693|2017-02-18 15:59:51.64693
NCT00415155|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2008-08-27|||August 2008||2008-08-01|August 2008|2008-08-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|||A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma|An Open Label, Single Arm, Phase 1b/2 Study With Pharmacokinetic Sampling to Evaluate LY2181308 in Patients With Advanced Hepatocellular Carcinoma|Withdrawn||Phase 1/Phase 2|60|Anticipated|Eli Lilly and Company||1||Trial cancelled|f||||||||||||||2017-02-18 15:59:52.002221|2017-02-18 15:59:52.002221
NCT00414947|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2007-06-21|||December 2006||2006-12-01|June 2007|2007-06-01||||||||Interventional|||Bioequivalence of Vildagliptin Tablet Manufactured in China Compared to Imported Vildagliptin Tablet in Chinese Healthy Volunteers|A Single Center, Randomized, Open-Label, Crossover, Single Oral Dose Study to Assess the Bioequivalence of LAF237 Tablet Manufactured by Beijing Novartis Pharma Ltd. to Imported LAF237 Tablet in Chinese Healthy Subjects|Completed||Phase 1|30||Novartis|||||f||||||||||||||2017-02-18 15:59:54.813859|2017-02-18 15:59:54.813859
NCT00415142|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2016-04-25||2016-04-25|December 2006||2006-12-01|April 2016|2016-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder|An Eight-week, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled Study, With Escitalopram as an Active Control, to Evaluate the Efficacy, Safety and Tolerability of a Saredutant 100 mg Dose Once Daily, in Elderly Patients With Major Depressive Disorder|Completed||Phase 3|393|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 15:59:52.111553|2017-02-18 15:59:52.111553
NCT00415129|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2014-01-10|||June 2006||2006-06-01|January 2014|2014-01-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly||Completed||Phase 2|600|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 15:59:52.453553|2017-02-18 15:59:52.453553
NCT00415116|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-07-06|||August 2004||2004-08-01|November 2006|2006-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors|Phase I Trial of Three-Weekly Docetaxel, Carboplatin and Oral CC-5013 in Patients With Advanced Solid Tumors|Completed||Phase 1|14|Actual|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 15:59:52.567812|2017-02-18 15:59:52.567812
NCT00415103|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2009-09-17|||November 2006||2006-11-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|AMENO-2||AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors|AMENO-2: Fase IV Study, National, Multiple Centers, Competitive, Randomized, Double Blind, Controlled With Parallel Groups to Determinate the Security, Tolerability and Efficacy of Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors|Completed||Phase 4|196|Anticipated|PETHEMA Foundation||2|||f||||t||||||||||2017-02-18 15:59:52.663776|2017-02-18 15:59:52.663776
NCT00415090|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2008-10-30|||August 2004||2004-08-01|October 2008|2008-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only|Substitution by Nevirapine in HIV-1 Infected Patients on Triple Treatment of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors|Completed||Phase 4|28|Actual|Hospital de Calella||2|||f||||f||||||||||2017-02-18 15:59:52.787361|2017-02-18 15:59:52.787361
NCT00415077|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2010-07-15|||June 2004||2004-06-01|July 2010|2010-07-01||||||||Interventional|||A Comparison of Photorefractive Keratectomy (PRK), PRK With Mitomycin-C and Laser Subepithelial Keratomileusis (LASEK) in the Treatment of Moderate and High Myopia|A Prospective Comparison of Photorefractive Keratectomy (PRK), PRK With Mitomycin-C and Laser Subepithelial Keratomileusis (LASEK) in the Treatment of Moderate and High Myopia|Terminated||N/A|960|Anticipated|Walter Reed Army Medical Center||3||Change in excimer laser systems prior to completion of study|f||||||||||||||2017-02-18 15:59:52.908858|2017-02-18 15:59:52.908858
NCT00415064|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2012-07-03|||December 2006||2006-12-01|November 2011|2011-11-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma|An Open-Label Phase I Study of the Safety of Perifosine in Combination With Lenalidomide and Dexamethasone for Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|32|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 15:59:53.000411|2017-02-18 15:59:53.000411
NCT00415051|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2016-12-06|2016-12-06||August 2006||2006-08-01|December 2016|2016-12-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|MP-12||Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine|Safety and Immunogenicity of Live-Attenuated MP-12 Rift Valley Fever Vaccine in Humans, and Genetic Characterization of Virus Isolates Recovered From the Blood of Vaccinated Volunteers: A Phase II Study|Completed||Phase 2|20|Actual|U.S. Army Medical Research and Materiel Command||1|||f||||f||||||||Undecided||2017-02-18 15:59:53.113093|2017-02-18 15:59:53.113093
NCT00415038|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-06-16|||February 2005||2005-02-01|June 2011|2011-06-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy of Rostafuroxin in the Treatment of Essential Hypertension|A Double Blind, Dose Range, Placebo Controlled Study of the Effects of Rostafuroxin vs Placebo in Patients With Stable, Uncomplicated, Essential Hypertension.|Completed||Phase 2|438|Actual|sigma-tau i.f.r. S.p.A.||5|||f||||t||||||||||2017-02-18 15:59:53.554211|2017-02-18 15:59:53.554211
NCT00415025|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2015-10-15|||June 2004||2004-06-01|October 2015|2015-10-01|July 2007|Actual|2007-07-01|||||Observational|||Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer|Evaluation of Normal Tissue Toxicities in Head and Neck Cancer Patients Receiving Intensity Modulated Radiotherapy (IMRT)|Completed||N/A|20|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 15:59:53.679529|2017-02-18 15:59:53.679529
NCT00414999|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2007-07-27|||November 2006||2006-11-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|||||Interventional|||A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers|A Phase 1, Double-Masked, Placebo-Controlled, Dose-Escalation Study (in Two Parts) of TG100801 and a Colored Vehicle in Adult Healthy Volunteers|Completed||Phase 1|44|Actual|TargeGen|||||f||||||||||||||2017-02-18 15:59:53.7778|2017-02-18 15:59:53.7778
NCT00414986|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2012-11-21|||September 2005||2005-09-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|ULTRA-DM/MDD||Using Learning Teams for Reflective Adaptation for Diabetes and Depression|Using Learning Teams for Reflective Adaptation|Completed||N/A|1565|Actual|University of Colorado, Denver||3|||f||||f||||||||||2017-02-18 15:59:53.871443|2017-02-18 15:59:53.871443
NCT00414973|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2009-10-22|2009-07-16||December 2006||2006-12-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study for Patients With Osteoporosis|Comparison of Teriparatide and Calcitonin in the Treatment of Men and Postmenopausal Women With Osteoporosis|Completed||Phase 3|364|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:59:53.975321|2017-02-18 15:59:53.975321
NCT00414960|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-02-25||2011-02-25|November 2006||2006-11-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smokers|Phase IIB Randomized, Placebo-Controlled, Double-Blind Study of Enzastaurin HCL (LY317615) for Lung Cancer Prevention in Former Smokers|Completed||Phase 2|39|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 15:59:54.709115|2017-02-18 15:59:54.709115
NCT00414934|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2009-08-13|||October 2006||2006-10-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.|The Effectiveness of Whole-body 18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer: A Comparison Study With 99mTc-MDP Bone Scintigraphy.|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 15:59:54.89647|2017-02-18 15:59:54.89647
NCT00414921|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2009-05-20|||September 2003||2003-09-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|kiddie-CAT||Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)|Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)|Completed||Phase 2|30|Actual|University of Cincinnati||4|||f||||t||||||||||2017-02-18 15:59:54.997205|2017-02-18 15:59:54.997205
NCT00414908|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-08-08|2009-08-07||October 2007||2007-10-01|August 2011|2011-08-01|December 2009|Actual|2009-12-01|August 2008|Actual|2008-08-01||Interventional|||A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy|A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy|Completed||Phase 3|52|Actual|Solvay Pharmaceuticals|Only treatment emergent events have been presented. They are defined as events started at or after the 1st administration of study medication and includes events started prior to the 1st administration but which worsened after the 1st intake.|2|||f||||||||||||||2017-02-18 15:59:55.120953|2017-02-18 15:59:55.120953
NCT00414895|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2010-10-25|||December 2006||2006-12-01|October 2010|2010-10-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Observational|||Absolute Myocardial Perfusion Measurement in the Transplanted Heart|Absolute Myocardial Perfusion Measurement in the Transplanted Heart: a New Method for Accurate Detection of Allograft Rejection. A Pilot Study|Completed||N/A|90|Actual|University Hospital Inselspital, Berne|||1||f||||||||||||||2017-02-18 15:59:55.83631|2017-02-18 15:59:55.83631
NCT00414882|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2010-08-26|||June 2007||2007-06-01|September 2007|2007-09-01|June 2012||2012-06-01|||||Observational|||A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding|A Cluster-Randomized Trial of DOTS Versus DOTS Plus Active Case Finding to Reduce Tuberculosis Incidence in Rio de Janeiro, Brazil|Unknown status|Recruiting|N/A|200000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 15:59:55.916203|2017-02-18 15:59:55.916203
NCT00414869|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2017-02-07|||November 2005||2005-11-01|February 2017|2017-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure|Preliminary Efficacy And Tolerability Of Oral NCX-1000 After Repeated Administrations In Patients With Portal Hypertension: A Double-Blind Dose Escalating Study|Terminated||Phase 2|11|Actual|Forest Laboratories||2||Preliminary analysis of 11 patients did not demonstrate the efficacy required.|f||||f||||||||||2017-02-18 15:59:55.994529|2017-02-18 15:59:55.994529
NCT00414856|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2007-06-21|||August 2006||2006-08-01|June 2007|2007-06-01||||||||Interventional|||Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux|A Multi-Center, Randomized, Double-Blind, Placebo- and Positive-Control, Double-Dummy, 3 Parallel Cohort, Two-Way Crossover Single Oral Dose Study in GERD (Gastro Esophageal Reflux Disease) Patients to Evaluate the Effects of AFQ056 and Baclofen (Positive Control) on the Incidence of Meal-Induced Gastro Esophageal Reflux Events|Completed||Phase 1|34|Anticipated|Novartis|||||f||||||||||||||2017-02-18 15:59:56.108373|2017-02-18 15:59:56.108373
NCT00414843|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2016-02-22|||December 2006||2006-12-01|February 2016|2016-02-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Storage of Bile From Routine Procedures to Study Risk Factors|A Prospective Study of Human Bile and Molecular Predictors of Biliary Malignancy Risk|Terminated||N/A|390|Actual|Indiana University|||1|Decreasing interest in using samples; department infrastructure waned|f||||||||||Samples Without DNA|"~     Bile, plasma~   "|||2017-02-18 15:59:56.216965|2017-02-18 15:59:56.216965
NCT00414830|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2008-04-29|||January 2005||2005-01-01|April 2008|2008-04-01|September 2009|Anticipated|2009-09-01|||||Observational|||Systematic Prevention of Further Fractures in Patients With Hip Fractures and Osteoporosis.||Unknown status|Active, not recruiting|N/A|600|Anticipated|Odense University Hospital|||||f||||||||||||||2017-02-18 15:59:56.549746|2017-02-18 15:59:56.549746
NCT00414817|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2016-12-06|2015-07-23||June 2007||2007-06-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional||individuals who met our inclusion/exclusion criteria|Telephone-Based Program to Promote Inhaled Corticosteroid Adherence Among Individuals With Asthma|Phone Calls to Promote Adherence With Inhaled Corticosteroids|Completed||N/A|14064|Actual|Kaiser Permanente||2|||f||||f||||||||No||2017-02-18 15:59:56.636581|2017-02-18 15:59:56.636581
NCT00414804|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2012-02-13|||December 2006||2006-12-01|February 2012|2012-02-01||||||||Interventional|||Spinal Cord Stimulation Versus Nerve Blocks and Physical Therapy|Spinal Cord Stimulation (SCS) Versus Nerve Blocks and Physical Therapy for Complex Regional Pain Syndrome|Withdrawn||N/A|0|Actual|Boston Scientific Corporation||2||Investigator decided to withdraw participation in the study|f||||f||||||||||2017-02-18 15:59:57.266955|2017-02-18 15:59:57.266955
NCT00414778|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-01-12|||October 2006||2006-10-01|January 2011|2011-01-01||||October 2006|Actual|2006-10-01||Interventional|||Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects|A Single-center, Open-label, Single and Multiple Oral Dose Study to Assess Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects|Completed||Phase 1|12|Actual|Novartis|||||f||||||||||||||2017-02-18 15:59:57.371892|2017-02-18 15:59:57.371892
NCT00414765|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2013-02-09||2013-02-09|January 2006||2006-01-01|February 2013|2013-02-01||||March 2010|Actual|2010-03-01||Interventional|||Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma|Open-label Pharmacokinetic Trial of Aldesleukin (Rh-Interleukin-2 [IL-2]) Administered Intravenously to Subjects With Metastatic Renal Cell Carcinoma and Metastatic Melanoma With Immunologic Correlative Studies|Completed||Phase 1/Phase 2|26|Actual|Novartis||1|||f||||||||||||||2017-02-18 15:59:57.449919|2017-02-18 15:59:57.449919
NCT00414752|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2007-06-21|||September 2006||2006-09-01|June 2007|2007-06-01||||||||Interventional|||Effects of AFQ056 and Nicotine in Reducing Cigarette Smoking|A Randomized, Double Blind, Multiple Dose, Cross-Over, Placebo- and Active-Controlled Proof of Concept Study to Explore the Effects of AFQ056 and Nicotine (Active Comparator) on Craving and Withdrawal During Voluntary Smoking Abstinence in Healthy Smokers|Completed||Phase 1|36||Novartis|||||f||||||||||||||2017-02-18 15:59:57.562548|2017-02-18 15:59:57.562548
NCT00414739|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2006-12-21||||||December 2006|2006-12-01||||||||Interventional|||Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells||Unknown status|Recruiting|Phase 1|20||University of Rostock|||||f||||||||||||||2017-02-18 15:59:57.658193|2017-02-18 15:59:57.658193
NCT00414726|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2016-07-08|2010-07-01||January 2007||2007-01-01|July 2016|2016-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial|Clinical Trial of Normobaric Oxygen Therapy in Acute Ischemic Stroke|Terminated||Phase 2|85|Actual|Massachusetts General Hospital|Early termination leading to small numbers of subjects analyzed.|2||"Imbalance in deaths favoring control arm; deaths not attributed to treatment by the blinded~   external medical monitor."|f||||t||||||||||2017-02-18 15:59:57.758517|2017-02-18 15:59:57.758517
NCT00414713|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2010-12-28|||October 2002||2002-10-01|December 2010|2010-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Transfusion Requirements in Gastrointestinal (GI) Bleeding|Randomized and Controlled Clinical Trial of Transfusional Requirements in Patients With Acute Gastrointestinal Bleeding.|Unknown status|Recruiting|Phase 4|860|Anticipated|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau||2|||f||||t||||||||||2017-02-18 15:59:58.351008|2017-02-18 15:59:58.351008
NCT00414700|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-21|2011-09-22|2009-05-06||February 2002||2002-02-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|July 2006|Actual|2006-07-01||Interventional|TIGACT01||RCT of ChondroCelect® (in an ACI Procedure) vs Microfracture in the Repair of Cartilage Defects of the Knee|Prospective Multicenter Randomized Controlled Trial of ChondroCelect® (Via Autologous Chondrocyte Implantation) vs Microfracture (as Procedure) in the Repair of Symptomatic Cartilaginous Defects of the Femoral Condyles|Completed||Phase 3|118|Actual|TiGenix n.v.||2|||f||||f||||||||||2017-02-18 15:59:58.461699|2017-02-18 15:59:58.461699
NCT00414687|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2009-05-14|||July 1998||1998-07-01|May 2009|2009-05-01|May 2001|Actual|2001-05-01|||||Interventional|||Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension|An Explorative, Open-Label, Multicenter, Randomized, Parallel-Group Comparative Study of Safety, Tolerability, and the Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension Over 2 Years|Completed||Phase 2|63|Actual|Bayer||1|||f||||||||||||||2017-02-18 15:59:59.19147|2017-02-18 15:59:59.19147
NCT00414661|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2012-11-28|2012-11-28||April 2007||2007-04-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550|A Prospective Observational Study To Evaluate Long-Term Safety And Functional Status Of Subjects With Rheumatoid Arthritis Previously Enrolled In Studies Of CP-690,550|Completed||N/A|162|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 15:59:59.299934|2017-02-18 15:59:59.299934
NCT00414648|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2009-08-27|||December 2006||2006-12-01|August 2009|2009-08-01|September 2011|Anticipated|2011-09-01|September 2010|Anticipated|2010-09-01||Interventional|||Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)|Lymphangioleiomyomatosis Efficacy and Safety Trial|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|Office of Rare Diseases (ORD)||2|||f||||t||||||||||2017-02-18 15:59:59.916892|2017-02-18 15:59:59.916892
NCT00414635|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2012-02-09|2010-07-22||August 2006||2006-08-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment|A Randomized Controlled Trial of a Weekly Schedule of Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment (5/2 Intermittent Treatment Schedule) Versus Continuous Treatment in Individuals With Virologic Suppression on This Combination|Completed||Phase 4|60|Actual|Community Research Initiative of New England|"Conclusions are limited by the small n studied. The results are only applicable to the specific drug regimen studied and thus can not be generalized to all ART. We only studied individuals already virologically undetectable."|1|||f||||||||||||||2017-02-18 16:00:00.105139|2017-02-18 16:00:00.105139
NCT00414622|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2007-04-18|||November 2006||2006-11-01|December 2006|2006-12-01|April 2007|Actual|2007-04-01|||||Interventional|||GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease|A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety and Tolerability of GTS-21 (25 Mg TID, 50 Mg TID, 75 Mg TID and 150 Mg TID) When Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease|Completed||Phase 2|60||CoMentis|||||t||||||||||||||2017-02-18 16:00:00.628621|2017-02-18 16:00:00.628621
NCT00414609|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2012-07-05|2010-12-20||December 2006||2006-12-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|September 2009|Actual|2009-09-01||Interventional|||Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)|A 36-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Including a 2 Year Extension Study to Evaluate Efficacy and Safety of Aliskiren on the Prevention of Left Ventricular Remodeling in High Risk Post-acute Myocardial Infarction Patients When Added to Optimized Standard Therapy|Completed||Phase 3|820|Actual|Novartis||2|||f||||t||||||||||2017-02-18 16:00:00.728277|2017-02-18 16:00:00.728277
NCT00414596|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-05-04|2009-04-28||December 2006||2006-12-01|May 2016|2016-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pilot Study to Evaluate The Effectiveness And Safety Of Axiom Worldwide Drx9000™ Spinal Decompression System|Pilot Study to Evaluate The Effectiveness And Safety Of Axiom Worldwide Drx9000™ Spinal Decompression System For Treatment of Low Back Pain|Completed||Phase 2|20|Actual|NEMA Research, Inc.||1|||f||||f||||||||||2017-02-18 16:00:02.406653|2017-02-18 16:00:02.406653
NCT00414583|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-05-18|||January 2008||2008-01-01|May 2016|2016-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|sifap1||Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients|Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in an Unselected Group of Young Stroke Patients: an International, Multicentre Prevalence Study|Completed||N/A|5000|Actual|University of Rostock|||1||f||||t||||||Samples With DNA|"~     Fabry diagnostic will be done centrally: blood samples will be retained for analysis of~     a-galactosidase in blood to diagnose an a-galactosidase deficit; in females direct analysis~     of the gene has to be done since due to the Lyonisation effect a-galactosidase activity~     might be normal in blood although the patient might suffer from Fabry disease.~   "|||2017-02-18 16:00:02.735233|2017-02-18 16:00:02.735233
NCT00414570|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-03-14|||November 2006||2006-11-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Interventional|||An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine|An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine|Recruiting||N/A|30|Anticipated|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 16:00:02.890827|2017-02-18 16:00:02.890827
NCT00414557|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2006-12-21|||May 2004||2004-05-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Knee Malalignment and Thigh Muscle Strengthening in Individuals With Medial Knee Arthritis|The Effects of Knee Malalignment and Quadriceps Strengthening on the Adduction Moment in Individuals With Medial Knee Osteoarthritis|Completed||Phase 2/Phase 3|107||University of Melbourne|||||f||||||||||||||2017-02-18 16:00:02.997068|2017-02-18 16:00:02.997068
NCT00414544|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2011-06-22|2011-03-04||October 2006||2006-10-01|June 2011|2011-06-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|||Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds|A Randomized, Double-Blind, Multicenter Comparison of the Safety and Efficacy of CosmetaLife™ Versus Control for the Correction of Nasolabial Folds|Completed||Phase 2|145|Actual|Cosmeta||2|||f||||t||||||||||2017-02-18 16:00:03.100516|2017-02-18 16:00:03.100516
NCT00414531|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2014-12-02|||May 2005||2005-05-01|August 2009|2009-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity|Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity|Completed||Phase 4|53|Actual|University of Oslo School of Pharmacy||1|||f||||||||||||||2017-02-18 16:00:03.435831|2017-02-18 16:00:03.435831
NCT00414518|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2013-01-16|2012-09-06||January 2007||2007-01-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection|An Open-Label Randomized Clinical Trial to Evaluate the Efficacy and Safety of Short Course Antiretroviral Therapy for Acute or Recent HIV-1 Infection in Zimbabwe and the United States|Completed||N/A|16|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 16:00:03.544281|2017-02-18 16:00:03.544281
NCT00414505|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2014-05-29|||August 2006||2006-08-01|May 2014|2014-05-01|December 2014|Anticipated|2014-12-01|||||Interventional|||A Randomized Controlled Double Blinding Study of Intradermal Acupuncture Treatment on Obesity|Korea Institute of Oriental Medicine|Unknown status|Recruiting|Phase 3|180|Anticipated|Wonkwang University|||||f||||||||||||||2017-02-18 16:00:04.224391|2017-02-18 16:00:04.224391
NCT00414492|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2010-09-15|||December 2006||2006-12-01|September 2010|2010-09-01|June 2010|Actual|2010-06-01|||||Observational|||Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer|Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer|Completed||N/A|100|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||1||f||||||||||Samples With DNA|"~     liver tissue from surgical specimen~   "|||2017-02-18 16:00:04.317264|2017-02-18 16:00:04.317264
NCT00414479|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2010-01-13|||July 2006||2006-07-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment|Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment|Completed||N/A|1500|Actual|DBL -Institute for Health Research and Development|||1||f||||||||||||||2017-02-18 16:00:04.395236|2017-02-18 16:00:04.395236
NCT00414466|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2013-08-19|2010-12-22||December 2006||2006-12-01|August 2013|2013-08-01|August 2010|Actual|2010-08-01|December 2009|Actual|2009-12-01||Interventional|||A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain|A Randomized Double Blind, Placebo-controlled, Dose Response Study of Intraspinal Gabapentin (MDT2004) in Subjects With Chronic, Intractable Pain.|Terminated||Phase 2|254|Actual|MedtronicNeuro||4||Study closed and subject follow-up completed following analysis of blinded study data.|f||||t||||||||||2017-02-18 16:00:04.505786|2017-02-18 16:00:04.505786
NCT00414453|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2015-06-23|2015-03-11||January 2007||2007-01-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis|Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis (TALENT-MS)|Terminated||Phase 4|19|Actual|University of Rochester||1||Did not reach enrollment goals|f||||f||||||||||2017-02-18 16:00:07.836328|2017-02-18 16:00:07.836328
NCT00414440|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2015-01-13|2014-10-07||December 2006||2006-12-01|January 2015|2015-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease|A Multicenter, Randomized, Placebo-controlled, Double-blind Study on the Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease (ESRD) in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Completed||Phase 4|431|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:00:08.375059|2017-02-18 16:00:08.375059
NCT00414427|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2010-07-07|||December 2005||2005-12-01|December 2006|2006-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Using Ultrasonography to Predict Clinical Response to Intraarticular Corticosteroids in Knee Osteoarthritis|Using Ultrasonography to Predict Clinical Response to Intraarticular Corticosteroids in Knee Osteoarthritis|Completed||N/A|120|Anticipated|University of California, San Diego|||||f||||||||||||||2017-02-18 16:00:09.61208|2017-02-18 16:00:09.61208
NCT00414414|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2010-08-19|||February 2007||2007-02-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection|A Randomized, Prospective Double Blind Placebo Control Clinical Trial of Prednisone as Adjunctive Therapy for the Treatment of Hospitalized Patients With Pulmonary TB and HIV Co-infection|Completed||Phase 3|412|Anticipated|Ottawa Hospital Research Institute||2|||f||||||||||||||2017-02-18 16:00:09.708787|2017-02-18 16:00:09.708787
NCT00414401|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2015-04-06|||May 2001||2001-05-01|December 2006|2006-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Clinical Reminders in Test Reports to Improve Guideline Compliance|Clinical Reminders in Test Reports to Improve Guideline Compliance|Completed||N/A|1500|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 16:00:09.822762|2017-02-18 16:00:09.822762
NCT00414388|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2014-02-28|2013-05-03||December 2006||2006-12-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional||Recruitment was from our clinic population. Eligible patients were those who progressed while receiving chemotherapy (docetaxel or mitoxantrone)or within 12 weeks of stopping chemo|Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer|Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)|Completed||Phase 1/Phase 2|22|Actual|Oncology Specialists, S.C.||1|||f||||f||||||||||2017-02-18 16:00:09.923252|2017-02-18 16:00:09.923252
NCT00414375|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2009-03-02|||December 2006||2006-12-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Early Versus Delayed Operation for Perforated Appendicitis|Early Versus Delayed Operation for Perforated Appendicitis With Abscess, a Pilot Study|Completed||N/A|30|Actual|Children's Mercy Hospital Kansas City||2|||f||||||||||||||2017-02-18 16:00:10.50878|2017-02-18 16:00:10.50878
NCT00414362|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2015-12-16|||February 2007||2007-02-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin|Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin|Active, not recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:00:10.62144|2017-02-18 16:00:10.62144
NCT00414349|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2009-06-15|||December 2006||2006-12-01|June 2009|2009-06-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain|Safety and Efficacy of Lidocaine 5% Medicated Plaster in Comparison to Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain.|Completed||Phase 3|350|Anticipated|Grünenthal GmbH||3|||f||||||||||||||2017-02-18 16:00:10.717039|2017-02-18 16:00:10.717039
NCT00414336|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2017-01-24|||December 15, 2006||2006-12-15|August 4, 2009|2009-08-04|December 15, 2006|Actual|2006-12-15|December 15, 2006|Actual|2006-12-15||Interventional|||Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria|Randomized, Controlled, Phase 1 Study of the Safety and Immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 Vaccine for Plasmodium Falciparum Malaria in Semi-Immune Malian Adults|Completed||Phase 1|150||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:00:10.826152|2017-02-18 16:00:10.826152
NCT00414323|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2007-06-11|||November 2006||2006-11-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Evaluation of the Effects of Duloxetine on Norepinephrine|Evaluation of the Effects of Duloxetine on Norepinephrine Transporter Inhibition in Healthy Subjects|Completed||Phase 1|35|Actual|Eli Lilly and Company|||||f||||||||||||||2017-02-18 16:00:10.93811|2017-02-18 16:00:10.93811
NCT00414310|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2015-07-15|2015-07-15||December 2006||2006-12-01|July 2015|2015-07-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)|"Phase II Randomized Study of Low-Dose Decitabine (5-AZA-2'-Deoxycytidine) With or Without Valproic Acid in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia -SPORE"|Completed||Phase 2|153|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:00:11.035535|2017-02-18 16:00:11.035535
NCT00414297|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2010-10-25|||August 2006||2006-08-01|October 2010|2010-10-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease|External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease|Completed||N/A|30|Actual|University Hospital Inselspital, Berne||2|||f||||t||||||||||2017-02-18 16:00:11.564396|2017-02-18 16:00:11.564396
NCT00414284|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2010-12-06|||June 2006||2006-06-01|December 2010|2010-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)|Evaluation of the Pharmacokinetics and Tolerability of Increased Dosage of Lopinavir/Ritonavir(LPV/r) in Individuals Experiencing Viremia on Standard Dose LPV/r Using LPV/r Tablet Formulation|Terminated||Phase 4|||Community Research Initiative of New England||||"One subject's HIV RNA rebounded at week 12. A repeat PhenoSense GT combination resistance~   assay at week 12 revealed evolution in protease inhibitor resistance."|f||||||||||||||2017-02-18 16:00:11.680783|2017-02-18 16:00:11.680783
NCT00414271|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2008-12-16|||January 2006||2006-01-01|December 2008|2008-12-01||||||||Interventional|||Neo-Adjuvant Chemotherapy in Locally Advanced Gastric Cancer|A Phase II Study of Neo-Adjuvant Chemotherapy in Locally Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:00:11.794762|2017-02-18 16:00:11.794762
NCT00414258|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2011-04-12|||September 2006||2006-09-01|April 2011|2011-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Holding Study: Feeding Analgesia in Preterm Infants|The Holding Pilot Study: Feeding Analgesia in Preterm Infants|Completed||N/A|15|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:00:11.902802|2017-02-18 16:00:11.902802
NCT00414245|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2006-12-20|||January 2007||2007-01-01|December 2006|2006-12-01||||||||Interventional|||Metformin for the Treatment of Diabetes in Pregnancy|Metformin for the Treatment of Diabetes in Pregnancy|Unknown status|Not yet recruiting|Phase 3|200||Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:00:11.998376|2017-02-18 16:00:11.998376
NCT00414232|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2013-01-07|||November 2006||2006-11-01|January 2013|2013-01-01||||October 2010|Actual|2010-10-01||Observational|||Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy|Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy|Completed||N/A|13|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 16:00:12.084447|2017-02-18 16:00:12.084447
NCT00414219|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2010-12-29|||November 2004||2004-11-01|December 2010|2010-12-01|May 2007|Actual|2007-05-01|||||Observational|||Visual Prognosis in Non-Penetrating Corneal Blast Injuries|Visual Prognosis in Non-Penetrating Corneal Blast Injuries|Completed||N/A|40|Anticipated|Walter Reed Army Medical Center|||1||f||||||||||||||2017-02-18 16:00:12.176176|2017-02-18 16:00:12.176176
NCT00414206|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2010-10-26|2010-08-16||March 2007||2007-03-01|October 2010|2010-10-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)|"A Phase II Randomized, Double-Masked, Study Comparing the Safety and Efficacy of ATG003 in Patients With Neovascular (Wet) Age-Related Macular Degeneration (NV-AMD)"|Terminated||Phase 2|343|Actual|CoMentis||3||Sponsor decision|f||||t||||||||||2017-02-18 16:00:12.262304|2017-02-18 16:00:12.262304
NCT00414193|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2015-12-16|||February 2007||2007-02-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase|Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase|Active, not recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:00:12.953158|2017-02-18 16:00:12.953158
NCT00414180|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2011-03-10|||August 2003||2003-08-01|March 2011|2011-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Bupropion SR for Treating Smokeless Tobacco Use|Bupropion SR for Treating Smokeless Tobacco Use|Completed||Phase 3|225||Mayo Clinic|||||f||||||||||||||2017-02-18 16:00:13.058811|2017-02-18 16:00:13.058811
NCT00414167|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2014-02-12|2012-10-22||December 2005||2005-12-01|February 2014|2014-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Craving, Binge Eating and Obesity|Placebo-Controlled Trial of Bupropion for the Treatment of Binge Eating Disorder|Completed||Phase 2/Phase 3|61|Actual|Yale University||2|||f||||||||||||||2017-02-18 16:00:13.152892|2017-02-18 16:00:13.152892
NCT00414154|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2011-02-23|||May 2002||2002-05-01|March 2007|2007-03-01|May 2007||2007-05-01|||||Interventional|||The Importance of Patient Education - A Randomised Controlled Trial|The Effect of a Group Based Multidisciplinary Patient Education Programme for Patients With Osteoporosis - a Controlled Randomised Trial|Completed||Early Phase 1|300||Odense University Hospital|||||f||||||||||||||2017-02-18 16:00:13.537661|2017-02-18 16:00:13.537661
NCT00414141|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2010-06-16|||November 2006||2006-11-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety/Tolerability of Grass MATA MPL|Efficacy and Safety/Tolerability of Grass MATA MPL, a Randomized, Placebo-Controlled, Double-Blind Study|Completed||Phase 3|1028|Actual|Allergy Therapeutics||2|||f||||||||||||||2017-02-18 16:00:13.634474|2017-02-18 16:00:13.634474
NCT00414128|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2013-12-05|||March 2007||2007-03-01|December 2013|2013-12-01|February 2013|Actual|2013-02-01|July 2011|Actual|2011-07-01||Interventional|MYCYC||Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis|A Randomised Clinical Trial of Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in ANCA Associated Vasculitis.|Completed||Phase 2/Phase 3|140|Actual|Cambridge University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 16:00:14.077061|2017-02-18 16:00:14.077061
NCT00414115|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-05-30|||August 2005||2005-08-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children|Canadian Pharmacogenomics Network for Drug Safety|Recruiting||N/A|7000|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 16:00:14.195235|2017-02-18 16:00:14.195235
NCT00414102|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-06-27|||October 2006||2006-10-01|May 2010|2010-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.|"A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Demonstrate the Subjective Treatment Effects of Ramelteon on Sleep Using a Post Sleep Questionnaire - Interactive Voice Response System (PSQ-IVRS) in an At-Home Setting in an Adult Population With Chronic Insomnia"|Completed||Phase 4|552|Actual|Takeda||2|||f||||f||||||||||2017-02-18 16:00:14.308756|2017-02-18 16:00:14.308756
NCT00414089|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-02-12||||||July 2007|2007-07-01||||||||Interventional|||Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL|Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Previously Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma|Withdrawn||Phase 2|0|Actual|AHS Cancer Control Alberta||||Funding will not be provided for the drug|f||||||||||||||2017-02-18 16:00:14.485666|2017-02-18 16:00:14.485666
NCT00414076|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-11-04|||December 2006||2006-12-01|November 2016|2016-11-01||||December 2018|Anticipated|2018-12-01||Interventional|||Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma|A Randomized Phase II Study of Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma|Active, not recruiting||Phase 2|80|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:00:14.566233|2017-02-18 16:00:14.566233
NCT00414063|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2017-01-24|||December 15, 2006||2006-12-15|March 19, 2013|2013-03-19|March 19, 2013||2013-03-19|||||Observational|||Energy Metabolism and Nutrient Absorption in Lean and Obese Individuals|Investigation of Differences in Energy Metabolism and Nutrient Absorption Between Lean and Obese Individuals|Completed||N/A|70|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:00:14.678149|2017-02-18 16:00:14.678149
NCT00414050|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-20|2009-05-19|2008-10-15||September 2006||2006-09-01|May 2009|2009-05-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants|A Study to Assess the Safety, Tolerability, and Immunogenicity of 2 Antigen Doses of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process Administered to Healthy Infants at 2, 4, and 6 Months of Age|Completed||Phase 3|1718|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 16:00:14.761593|2017-02-18 16:00:14.761593
NCT00414037|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2015-10-23|||December 2006||2006-12-01|October 2015|2015-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||How do Sleeping Pills Affect Pain in the Brain?|Subchronic Effects of Eszopiclone (Lunesta) on Pain Behavior and Circuitry in Primary Insomnia|Terminated||Phase 4|40|Actual|University of California, San Diego||2||Funding terminated by sponsor, insufficient data collection|f||||f||||||||||2017-02-18 16:00:15.24167|2017-02-18 16:00:15.24167
NCT00414024|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2012-04-19|||February 2007||2007-02-01|April 2012|2012-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.|An Open Label 52-week Study to Evaluate the Safety and Efficacy of Tegaserod Given Orally for the Treatment of Opioid-induced Constipation (OIC) in Patients With Chronic Non-cancer Pain|Terminated||Phase 3|11|Actual|Novartis||||"This study was terminated early as a result of regulatory action suspending tegaserod use in~   2007"|||||||||||||||2017-02-18 16:00:15.357309|2017-02-18 16:00:15.357309
NCT00414011|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2013-06-26|2013-04-01|||||June 2013|2013-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional||35 out of 40 participants had complete data for analysis.|Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)||Completed||N/A|40|Actual|Walter Reed Army Medical Center||2|||f||||||||||||||2017-02-18 16:00:15.456457|2017-02-18 16:00:15.456457
NCT00413998|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2015-06-03|||January 2007||2007-01-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|April 2012|Actual|2012-04-01||Interventional|RIME||Randomised Ischaemic Mitral Evaluation (RIME) Trial|Randomized Evaluation of Mitral Annuloplasty During Coronary Artery Bypass Grafting for Moderate Functional Ischaemic Mitral Regurgitation.|Completed||Phase 3|73|Actual|Imperial College London||2|||f||||t||||||||||2017-02-18 16:00:15.695778|2017-02-18 16:00:15.695778
NCT00413985|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2013-12-30|||January 2004||2004-01-01|December 2013|2013-12-01||||November 2007|Actual|2007-11-01||Interventional|||Post Discharge Human Milk Fortifier in Preterm Infants|Growth and Development in Preterm Infants Fed Human Milk Containing a Powdered Human Milk Fortifier (HMF) Post Hospital Discharge|Completed||Phase 2|40||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 16:00:15.82916|2017-02-18 16:00:15.82916
NCT00413972|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2015-06-16|2010-04-28||April 2006||2006-04-01|June 2015|2015-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)|A Multicenter, Double-blind, Randomized, Placebo-controlled Parallel Groups Study Comparing the Efficacy and Safety of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia|Completed||Phase 3|392|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 16:00:15.942325|2017-02-18 16:00:15.942325
NCT00413959|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2013-10-17|2013-05-07||August 2006||2006-08-01|October 2013|2013-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|VRCD||VELCADE®,Rituximab,Cyclophosphamide and Decadron (VRCD Regimen)|Phase II Study Investigating the Efficacy of VELCADE®, Rituximab, Cyclophosphamide and Decadron (VRCD Regimen) in Front-line Therapy of Patients With Low-grade Non-Hodgkin's Lymphoma|Terminated||Phase 2|12|Actual|Oncology Specialists, S.C.||1|||f||||f||||||||||2017-02-18 16:00:16.39165|2017-02-18 16:00:16.39165
NCT00413946|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-02-23|||January 2006||2006-01-01|February 2015|2015-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Does Erythropoietin Improve Outcome in Very Preterm Infants?|Neuroprotective Effect of High Dose Erythropoietin in Very Preterm Infants|Completed||Phase 2|420|Actual|Swiss Neonatal Network||2|||f||||t||||||||||2017-02-18 16:00:16.670042|2017-02-18 16:00:16.670042
NCT00413933|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-04-20|||April 2008||2008-04-01|December 2006|2006-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Comprehensive Intervention for Falls Prevention in the Elderly||Terminated||N/A|8|Actual|Soroka University Medical Center||2||The study was stopped due to lack of funding|f||||||||||||||2017-02-18 16:00:16.793367|2017-02-18 16:00:16.793367
NCT00413920|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2011-04-19|2011-01-12||April 2007||2007-04-01|April 2011|2011-04-01||||March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients|A Multicenter Randomized Open Label Study to Assess Efficacy and Safety of a Steroid Avoidance Regimen in Comparison to a Treatment With Steroids, in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS) 2.16 g/d for 6 Weeks and Cyclosporine Microemulsion, in de Novo Adult Renal Transplant Recipients|Completed||Phase 3|222|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:00:16.90032|2017-02-18 16:00:16.90032
NCT00413894|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-01-17|2016-01-17||March 2007||2007-03-01|January 2016|2016-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Safety Population included all participants who received at least one dose of study medication independent of whether they completed the study or not.|A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.|An Open Label Study of the Effect of Intravenous Mircera on Hemoglobin Levels in Anemic Patients With Chronic Kidney Disease Who Are on Dialysis, and Who Have Previously Received Epoetin Alfa or Beta or Darbepoetin Alfa Treatment.|Completed||Phase 3|424|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:00:18.343694|2017-02-18 16:00:18.343694
NCT00413881|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2010-01-13|||July 2004||2004-07-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|||||Interventional|||A Prospective Comparison of Alcon LADARVision Wavefront-guided LASIK Enhancement and Conventional LASIK Enhancement for the Correction of Residual Refractive Errors Following LASIK Procedures|A Prospective Comparison of Alcon LADARVision Wavefront-guided LASIK Enhancement and Conventional LASIK Enhancement for the Correction of Residual Refractive Errors Following LASIK Procedures|Completed||N/A|50|Anticipated|Walter Reed Army Medical Center||2|||f||||||||||||||2017-02-18 16:00:18.992757|2017-02-18 16:00:18.992757
NCT00413868|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2008-03-31||||||March 2008|2008-03-01||||||||Interventional|||A Prospective Evaluation of Contrast Sensitivity and Disability Glare in Refractive Surgery, a Sub-Study of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)||Completed||N/A|50||Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 16:00:19.089604|2017-02-18 16:00:19.089604
NCT00413855|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2006-12-19|||September 1994||1994-09-01|December 2006|2006-12-01|June 2005||2005-06-01|||||Interventional|||Laparoscopic Appendectomy for Chronic Right Lower Abdominal Pain|Elective Laparoscopic Appendectomy for Chronic Right Lower Abdominal Pain; Outcome of a Prospective Randomized Double-Blind Controlled Surgical Trial|Completed||Phase 3|40||Maxima Medical Center|||||f||||||||||||||2017-02-18 16:00:19.178951|2017-02-18 16:00:19.178951
NCT00413842|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2017-01-24|||December 14, 2006||2006-12-14|August 20, 2008|2008-08-20|August 20, 2008||2008-08-20|||||Observational|||Effects of tDCS Over the Cerebellum on Motor Function|Effects of tDCS Over the Cerebellum on Motor Function|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:00:19.28524|2017-02-18 16:00:19.28524
NCT00413829|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2010-01-13|||October 2006||2006-10-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|May 2007|Actual|2007-05-01||Interventional|||Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)|Open-label, Phase II Study Assessing Immediate Effects of Lucentis®(Ranibizumab) Administered in Conjunction With Photodynamic Therapy With Visudyne® in Patients With Choroidal Neovascularization Secondary to AMD|Completed||Phase 2|20|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 16:00:19.365817|2017-02-18 16:00:19.365817
NCT00413816|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2006-12-19|||October 2006||2006-10-01|October 2006|2006-10-01|December 2006||2006-12-01|||||Observational|||The Israeli Trigger for Blood Transfusions in the ICU|A Multicenter Study of Anemia in the ICU Patient: Determination of the Israeli Trigger and Post ICU Course|Unknown status|Recruiting|N/A|500||Rabin Medical Center|||||f||||||||||||||2017-02-18 16:00:19.48027|2017-02-18 16:00:19.48027
NCT00413803|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2009-08-03|||December 2006||2006-12-01|August 2009|2009-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Four and Eight Hours Dialysis Sessions in Thrice Weekly Hemodialysis|Comparison of Four and Eight Hours Dialysis Sessions in Thrice Weekly Hemodialysis: Long Dialysis Study|Completed||Phase 4|410|Actual|Ege University||2|||f||||t||||||||||2017-02-18 16:00:19.564239|2017-02-18 16:00:19.564239
NCT00413790|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2008-01-14|||November 2006||2006-11-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Interventional|||Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects|A 3-Way Cross-Over, Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Assess the Pharmacologic Effects of a 7-Day Exposure to Darifenacin 15 mg o.d. and Tolterodine ER 4 mg o.d on Cardiovascular Parameters in Healthy Subjects 50 Years of Age and Older|Completed||Phase 4|162|Actual|Novartis||3|||||||||||||||||2017-02-18 16:00:19.673687|2017-02-18 16:00:19.673687
NCT00413777|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2012-05-30||2012-05-22|December 2005||2005-12-01|May 2012|2012-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|TEMPO 2/4||Tolvaptan Open-Label Pilot Efficacy, Tolerability and Safety Study in ADPKD|A Phase 2, Multi-center, Open-label Study to Determine Long-term Safety, Tolerability and Efficacy of Split-dose Oral Regimens of Tolvaptan Tablets in a Range of 30 to 120 mg/d in Patients With Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 2|46|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||||||||||||2017-02-18 16:00:19.787431|2017-02-18 16:00:19.787431
NCT00413764|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2014-05-23|||June 2004||2004-06-01|May 2014|2014-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)|A Multicenter, Randomized, Double-Blind, Double Dummy Trial to Compare the Effects Tibolone and Transdermal Continuous Combined Estradiol/Norethisterone on Sexual Desire and Arousal in Postmenopausal Women With Sexual Dysfunction|Completed||Phase 3|358|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:00:19.916193|2017-02-18 16:00:19.916193
NCT00413751|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2006-12-19||||||December 2006|2006-12-01||||||||Observational|||Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes||Completed||N/A|20||Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 16:00:20.011928|2017-02-18 16:00:20.011928
NCT00413738|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2009-01-26|||December 2006||2006-12-01|January 2009|2009-01-01|January 2009||2009-01-01|||||Interventional|||Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease|Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease.A Randomized Controlled Trial:Heparin-Coated Central Venous Catheters Versus Antiseptic-Coated Central Venous Catheters|Completed||Phase 3|||Centre National de Greffe de Moelle Osseuse|||||f||||||||||||||2017-02-18 16:00:20.094588|2017-02-18 16:00:20.094588
NCT00413725|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-07-02||2015-05-28|January 2007||2007-01-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults|A Multicenter Double-Blind Randomized Placebo-Controlled Phase IIB Test-of-Concept Study to Evaluate the Safety and Efficacy of a Three-Dose Regimen of the Clade B-based Merck Adenovirus Serotype 5 HIV-1 Gag/Pol/Nef Vaccine in HIV-1 Uninfected Adults in South Africa|Completed||Phase 2|801|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:00:20.185933|2017-02-18 16:00:20.185933
NCT00413712|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2017-02-09|||January 1997||1997-01-01|February 2017|2017-02-01|March 2001||2001-03-01|||||Interventional|||Effectiveness of Calcium Channel Blockers and Adenosine in the Emergency Management of SVT|Comparism Between Efficacy and Effectiveness Between Slow Infusion of Calcium Channel Blockers and Intravenous Bolus Adenosine in the Management of Supraventricular Tachycardia in the Emergency Department.|Completed||Phase 4|206||Singapore General Hospital|||||f||||||||||||||2017-02-18 16:00:20.318449|2017-02-18 16:00:20.318449
NCT00413699|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2017-02-01|||February 2007||2007-02-01|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|November 2016|Actual|2016-11-01||Interventional|||Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis|A Long-Term, Open-Label Follow-Up Study Of Tofacitinib (CP-690,550) For Treatment Of Rheumatoid Arthritis|Active, not recruiting||Phase 3|4500|Anticipated|Pfizer||2|||f||||t||||||||||2017-02-18 16:00:20.447188|2017-02-18 16:00:20.447188
NCT00413686|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2010-12-03|||December 2006||2006-12-01|December 2010|2010-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies|A Phase I Open Label Multi Center Dose Escalation Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD7762 Administered as a Single Intravenous Agent and in Combination With Weekly Standard Dose Gemcitabine in Patients With Advanced Solid Malignancies|Completed||Phase 1|42|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:00:21.362102|2017-02-18 16:00:21.362102
NCT00413673|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2008-03-31|||August 2001||2001-08-01|November 2007|2007-11-01|March 2008||2008-03-01|||||Interventional|||Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel|Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel|Completed||N/A|100|Anticipated|Walter Reed Army Medical Center||1|||f||||||||||||||2017-02-18 16:00:21.478045|2017-02-18 16:00:21.478045
NCT00413660|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2013-01-14|2012-12-04||January 2007||2007-01-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis|A Phase 2B, Randomized, Double Blind, Placebo-Controlled, Multicenter Study To Compare 6 Dose Regimens Of CP-690,550 Vs. Placebo, Each Combined With Methotrexate, Administered For 6 Months In The Treatment Of Subjects With Active Rheumatoid Arthritis Who Have Had An Inadequate Response To Methotrexate Alone|Completed||Phase 2|509|Actual|Pfizer||7|||f||||f||||||||||2017-02-18 16:00:21.64388|2017-02-18 16:00:21.64388
NCT00413647|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2013-06-10|||September 2006||2006-09-01|June 2013|2013-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease|A Phase I Study to Evaluate the Safety, Biodistribution and Radiation Dosimetry of CardioPET™ as a PET Tracer for Detection of Coronary Artery Disease|Completed||Phase 1|21|Actual|Fluoropharma, Inc.||1|||f||||f||||||||||2017-02-18 16:00:35.307269|2017-02-18 16:00:35.307269
NCT00412542|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2012-02-08|2012-02-08||October 2003||2003-10-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas|A Phase II Trial of Combination Therapy With Thalidomide and CPT-11 in Patients With Recurrent Anaplastic Gliomas or Glioblastoma Multiforme|Completed||Phase 2|78|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:01:15.391773|2017-02-18 16:01:15.391773
NCT00413634|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2014-06-06|2009-03-05||August 2006||2006-08-01|July 2010|2010-07-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)|A Phase II, Open-label, Multicentre, Pharmacokinetic, Pharmacodynamic and Safety Study of Anagrelide Hydrochloride in Young (18-50 Years) and Elderly (≥ 65 Years) Patients With Essential Thrombocythaemia.|Completed||Phase 2|24|Actual|Shire||1|||f||||||||||||||2017-02-18 16:00:35.425589|2017-02-18 16:00:35.425589
NCT00413621|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2017-01-24|||December 14, 2006||2006-12-14|October 7, 2009|2009-10-07||||October 7, 2009|Actual|2009-10-07||Observational|||MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems|MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:00:36.262347|2017-02-18 16:00:36.262347
NCT00413608|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2011-05-04|||January 2007||2007-01-01|July 2007|2007-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects|Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects|Completed||Phase 1|140|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 16:00:36.348714|2017-02-18 16:00:36.348714
NCT00413595|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-19|2016-10-13|||April 2007||2007-04-01|October 2016|2016-10-01|April 2017|Anticipated|2017-04-01|March 2017|Anticipated|2017-03-01||Observational|sifap2||Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation|Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation in Young Patients With Fabry Disease: An Epidemiological, International, Multicenter Prognosis Study|Recruiting||N/A|100|Anticipated|University of Rostock|||1||f||||t||||||Samples With DNA|"~     EDTA-blood and urine sample for central laboratory analysis of agalsidase antibodies and Gb3~     for safety issues.~      There will be a proteomic analysis in blood to check whether there will be the possibility~     to characterize a biomarker for Fabry disease.~   "|Undecided||2017-02-18 16:00:36.469042|2017-02-18 16:00:36.469042
NCT00413582|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2011-12-12|2011-12-12||October 2006||2006-10-01|December 2011|2011-12-01|October 2010|Actual|2010-10-01|May 2010|Actual|2010-05-01||Interventional|||Pain Management for Pectus Excavatum Repair|Prospective Randomized Trial: Pain Management Strategy After Pectus Excavatum Repair|Completed||N/A|110|Actual|Children's Mercy Hospital Kansas City||2|||f||||||||||||||2017-02-18 16:00:36.677325|2017-02-18 16:00:36.677325
NCT00413569|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2006-12-18||||||December 2006|2006-12-01||||||||Observational|||The Effect of Intubation Method on Outcome of Cervical Spine Surgery||Completed||N/A|||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 16:00:37.058201|2017-02-18 16:00:37.058201
NCT00413556|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2008-03-04|||January 2007||2007-01-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets|Randomised, Double-Blind, Placebo-Controlled Phase IIIb Study Investigating Changes in Immunological Parameters and Cutaneous Reactivity Induced by a Short Course Immunotherapy With ALK Grass Tablets|Completed||Phase 3|76|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-02-18 16:00:37.200248|2017-02-18 16:00:37.200248
NCT00413543|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-09-17|||October 2006||2006-10-01|September 2015|2015-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD) Exacerbation|Early Pulmonary Rehabilitation After Hospitalisation for Acute Exacerbation COPD|Terminated||N/A|17|Actual|Isala||2||enrollment insufficient: lack of motivated patients|f||||t||||||||||2017-02-18 16:00:37.312034|2017-02-18 16:00:37.312034
NCT00413517|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2010-07-15|||November 2006||2006-11-01|July 2010|2010-07-01|September 2009|Actual|2009-09-01|||||Interventional|||Evaluation of Epi-lasik in U.S. Army Personnel|Evaluation of Epi-lasik in U.S. Army Personnel|Completed||N/A|150|Anticipated|Walter Reed Army Medical Center||1|||f||||||||||||||2017-02-18 16:00:37.42305|2017-02-18 16:00:37.42305
NCT00413504|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2009-02-02|||April 2006||2006-04-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|||||Interventional|||Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism|Fondaparinux as Monotherapy for Deep Vein Thrombosis and/or Pulmonary Embolism (Pilot Study)|Completed||N/A|30|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 16:00:37.671566|2017-02-18 16:00:37.671566
NCT00413491|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2014-05-19|||January 2007||2007-01-01|January 2009|2009-01-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|MR BRCA||National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations|National Screening i Danmark Med MR-scanning af Brystet Kontra Klinisk Mammografi Hos Kvinder Der er bærere af Risikogivende BRCA1 Eller BRCA2 Mutationer|Unknown status|Recruiting|Phase 4|300|Anticipated|Danish Breast Cancer Cooperative Group||1|||f||||||||||||||2017-02-18 16:00:37.770783|2017-02-18 16:00:37.770783
NCT00413478|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2015-06-26|2015-06-03||September 2006||2006-09-01|June 2015|2015-06-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia|Phase II Study of 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia|Terminated||Phase 2|9|Actual|M.D. Anderson Cancer Center|Early termination led to small numbers of subjects analyzed.|1||Slow accrual.|f||||f||||||||||2017-02-18 16:00:37.872954|2017-02-18 16:00:37.872954
NCT00413465|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2006-12-18|||November 2006||2006-11-01|December 2006|2006-12-01|December 2007||2007-12-01|||||Interventional|||Study of Renal Blood Flow During Human Endotoxemia|Renal Plasma Flow During Experimental Human Endotoxemia|Unknown status|Recruiting|N/A|32||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:00:38.11999|2017-02-18 16:00:38.11999
NCT00413452|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2009-02-12|||December 2006||2006-12-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||Etanercept SFP in RA Patients|Open-Label Study to Assess the Safety and Immunogenicity of Etanercept SFP When Administered to Subjects Diagnosed With Rheumatoid Arthritis.|Completed||Phase 3|224|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:00:38.202602|2017-02-18 16:00:38.202602
NCT00413439|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2011-08-01|||May 2006||2006-05-01|August 2011|2011-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy|Open Label, Multi-center, Sequential Group Clinical Study to Determine the Safety and Efficacy of Escalating Dosing Regimens of Intravenous BAL8557 in the Prophylaxis of Patients Undergoing Chemotherapy for Acute Myeloid Leukemia|Completed||Phase 2/Phase 3|18|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:00:38.293488|2017-02-18 16:00:38.293488
NCT00412347|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2014-02-07|||August 2006||2006-08-01|February 2014|2014-02-01|December 2006||2006-12-01|||||Observational|||Insulin Infusion in the Hospital Wards|Insulin Infusion and Outcomes for Non-Critical Wards|Completed||N/A|200|Actual|Emory University|||1||f||||||||||||||2017-02-18 16:01:21.215945|2017-02-18 16:01:21.215945
NCT00413426|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2016-04-08|||June 2006||2006-06-01|April 2016|2016-04-01|September 2007|Actual|2007-09-01|||||Interventional|||Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects|An Open-labeled, Randomized, Single Dose, Three Period, 2-sequence Crossover Study to Investigate the Pharmacokinetics of Darifenacin When Given as 7.5 mg Oral Doses of a Modified Release Suspension, as Compared to the Commercial Modified Release Tablet in Healthy Adult|Completed||Phase 1|28||Novartis|||||f||||||||||||||2017-02-18 16:00:38.3995|2017-02-18 16:00:38.3995
NCT00413413|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2011-04-26|2009-08-06||January 2007||2007-01-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension|A Multi-national, Multicenter, Double-blind, Double-dummy, Randomized, Active-controled, Parallel Study, Comparing Efficacy and Safety of Valsartan/Amlodipine 80/5 mg to Valsartan 80 mg and Valsartan 160 mg Alone Once Daily in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Valsartan 80 mg Monotherapy.|Completed||Phase 3|1134|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:00:38.499669|2017-02-18 16:00:38.499669
NCT00413400|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2010-11-03|2010-08-31||December 2006||2006-12-01|November 2010|2010-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of TNF-Antagonism in the Metabolic Syndrome (II)|Effects of Etanercept in Patients With the Metabolic Syndrome (II)|Completed||N/A|40|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 16:00:39.210307|2017-02-18 16:00:39.210307
NCT00413387|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2008-04-21|||September 2004||2004-09-01|April 2008|2008-04-01|October 2005|Actual|2005-10-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)|Double Blind, Double Dummy, Multinational, Multicentre, Parallel-Group Design Clinical Trial of the Efficacy and Tolerability of CHF 1535 (Beclomethasone Dipropionate 100 µg + Formoterol 6 µg) pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler® (Symbicort®) in the 12-Week Treatment of Adult Patients With Moderate to Severe Persistent Asthma|Completed||Phase 3|219|Actual|Chiesi Farmaceutici S.p.A.||2|||f||||f||||||||||2017-02-18 16:00:39.847888|2017-02-18 16:00:39.847888
NCT00413374|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2012-04-27|2011-06-22||May 2006||2006-05-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism|Once Daily Enoxaparin for Outpatient Treatment of Acute Deep Venous Thrombosis and/or Pulmonary Embolism|Completed||N/A|40|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 16:00:40.143247|2017-02-18 16:00:40.143247
NCT00413361|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2011-01-26|||June 2007||2007-06-01|May 2007|2007-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS|Study of the Reduction of Systemic Lupus Erythematosus Flares Through Adaptation of the Dosage of Hydroxychloroquine to Its Whole-blood Concentration. National Multicenter Randomized Prospective Study|Completed||Phase 4|543|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 16:00:40.410054|2017-02-18 16:00:40.410054
NCT00413348|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2006-12-18|||November 2006||2006-11-01|December 2006|2006-12-01|December 2007||2007-12-01|||||Interventional|||Type 2 Diabetes and the Effect of Probiotics|Effect of Probiotics on Systemic Inflammation and Insulin Resistance in Type 2 Diabetics and Healthy Controls|Unknown status|Recruiting|N/A|48||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:00:40.521369|2017-02-18 16:00:40.521369
NCT00413335|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2013-07-15|2012-11-07||November 2005||2005-11-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth|Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth|Completed||N/A|21|Actual|Yale University||2|||f||||f||||||||||2017-02-18 16:00:40.613818|2017-02-18 16:00:40.613818
NCT00413322|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-07-07|||September 2005||2005-09-01|July 2015|2015-07-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors|A Phase I Safety, Pharmacodynamic, Anti-Tumor Activity, and Pharmacokinetic Study of PXD101 Alone and in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors|Completed||Phase 1|35|Actual|Onxeo||1|||f||||f||||||||||2017-02-18 16:00:40.987242|2017-02-18 16:00:40.987242
NCT00413309|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2009-02-02|||April 2006||2006-04-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention|Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention|Completed||N/A|30|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 16:00:41.098463|2017-02-18 16:00:41.098463
NCT00413296|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2014-07-18|||November 2005||2005-11-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|PTSD||Levetiracetam in Post-Traumatic Stress Disorder|A Double-Blind Discontinuation Study of Levetiracetam in Post- Traumatic Stress Disorder|Completed||Phase 2/Phase 3|16|Actual|Duke University||2|||f||||t||||||||||2017-02-18 16:00:41.209573|2017-02-18 16:00:41.209573
NCT00413283|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2013-09-18|2010-09-24||December 2006||2006-12-01|September 2013|2013-09-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)|Phase 2, Randomized, Double Blind, Placebo-Controlled Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 For Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Advanced Non-Small Cell Lung Cancer Already Receiving Gemcitabine and Platinum.|Completed||Phase 2|63|Actual|Amgen||4|||f||||||||||||||2017-02-18 16:00:41.337087|2017-02-18 16:00:41.337087
NCT00413270|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2011-07-12|||December 2006||2006-12-01|July 2011|2011-07-01||||||||Expanded Access|||Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant|A Canadian Open-label, Multicenter, Expanded Access Study of Oral Nilotinib in Adult Patients With Imatinib-resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase, or Chronic Phase|No longer available||Phase 3|||Novartis|||||f||||||||||||||2017-02-18 16:00:42.714762|2017-02-18 16:00:42.714762
NCT00413257|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2010-05-27|||December 2006||2006-12-01|May 2010|2010-05-01|November 2008|Actual|2008-11-01|December 2007|Actual|2007-12-01||Interventional|NefalCard||Effects of Nefopam on Hyperalgesia After Cardiac Surgery|Study of the Effects of Nefopam on Hyperalgesia Following Sternotomy in Cardiac Surgery|Completed||Phase 2/Phase 3|90|Actual|University Hospital, Bordeaux||3|||f||||t||||||||||2017-02-18 16:00:42.997116|2017-02-18 16:00:42.997116
NCT00413244|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2016-11-07|2016-05-25||January 2007||2007-01-01|November 2016|2016-11-01|November 2014|Actual|2014-11-01|January 2014|Actual|2014-01-01||Interventional|||The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery|The Cardiac Benefit of Androgen Replacement in Hypogonadal Males With Coronary Artery Disease Following Successful Percutaneous Coronary Intervention (PCI).|Completed||Phase 3|51|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 16:00:43.11847|2017-02-18 16:00:43.11847
NCT00413231|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2015-11-25|2011-12-23||December 2006||2006-12-01|October 2015|2015-10-01|October 2014|Actual|2014-10-01|August 2010|Actual|2010-08-01||Interventional|||Valor II: The Valiant Thoracic Stent Graft System Clinical Study|The Valiant Thoracic Stent Graft System. The Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft System in the Treatment of Descending Thoracic Aneurysms of Degenerative Etiology in Subjects Who Are Candidates for Endovascular Repair.|Completed||N/A|160|Actual|Medtronic Endovascular|Adverse Events and Serious Adverse Events listed in ClinicalTrials.gov were re-coded, using MedDRA 13.1. To do so, events were reclassified. As a result, data in listings may not match those in Clinical Update reports, SSEDs, or Instructions for Use.|1|||f||||t||||||||||2017-02-18 16:00:44.131275|2017-02-18 16:00:44.131275
NCT00413218|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-09-02||2015-08-17|December 2006||2006-12-01|August 2015|2015-08-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections|A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus Caspofungin Followed by Voriconazole in the Treatment of Candidemia and Other Invasive Candida Infections|Completed||Phase 3|450|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:00:44.980388|2017-02-18 16:00:44.980388
NCT00413205|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2016-11-01||2016-07-06|January 2007||2007-01-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)|A Double-blind, Placebo-controlled Efficacy (as Assessed by Post-bronchodilator FEV1) and Safety Study of RAR Gamma in Subjects With Smoking-related, Moderate to Severe COPD With Emphysema Receiving Concurrent Optimised COPD Drug Therapy.|Completed||Phase 2|491|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:00:45.34789|2017-02-18 16:00:45.34789
NCT00413192|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2014-06-30|||January 2007||2007-01-01|April 2014|2014-04-01|February 2013|Actual|2013-02-01|June 2012|Actual|2012-06-01||Interventional|||E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma|Phase II Study of E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma|Completed||Phase 2|128|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 16:00:45.680903|2017-02-18 16:00:45.680903
NCT00413179|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2006-12-18|||December 1997||1997-12-01|December 2006|2006-12-01|April 2003||2003-04-01|||||Interventional|||The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women|The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women: A Randomized Trial|Completed||Phase 3|56||Wilford Hall Medical Center|||||f||||||||||||||2017-02-18 16:00:45.800525|2017-02-18 16:00:45.800525
NCT00413166|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2016-02-15|||December 2006||2006-12-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab|Treatment of Acute Promyelocytic Leukemia (APL) With All-Trans Retinoic Acid, and Arsenic +/- Gemtuzumab|Completed||Phase 2|78|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 16:00:45.900334|2017-02-18 16:00:45.900334
NCT00413153|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2010-03-05|2009-11-04||May 2006||2006-05-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Metabolic Effects of Switching Kaletra to Boosted Reyataz|Metabolic Effects of Switching Kaletra to Boosted Reyataz|Completed||N/A|15|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:00:46.03279|2017-02-18 16:00:46.03279
NCT00413140|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2006-12-18|||June 2004||2004-06-01|November 2003|2003-11-01|May 2005||2005-05-01|||||Observational|||Non-Invasive Biomarkers in Cystic Fibrosis|Biomarkers in Exhaled Breath Indicate Presence, Control and Severity of Cystic Fibrosis|Completed||N/A|100||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 16:00:46.630101|2017-02-18 16:00:46.630101
NCT00413127|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-06-25|||September 2007||2007-09-01|June 2015|2015-06-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Perioperative Protective Effects of Lidocaine|Perioperative Protective Effects of Lidocaine - Clinical Study on the Route and Timing of Administration|Terminated||Phase 2/Phase 3|78|Actual|University Hospital Muenster||5||Less patients than expected for inclusion, therefore patient recruitment is to low|f||||f||||||||||2017-02-18 16:00:46.712019|2017-02-18 16:00:46.712019
NCT00413114|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2013-08-16||2013-08-16|December 2006||2006-12-01|August 2013|2013-08-01|November 2009|Actual|2009-11-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)|A Phase II Study of Obatoclax Mesylate (GX15-070MS) in Patients With Previously-Untreated Myelodysplastic Syndromes (MDS) With Anemia and/or Thrombocytopenia|Completed||Phase 2|24|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 16:00:46.834459|2017-02-18 16:00:46.834459
NCT00413101|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2009-05-13||||||May 2009|2009-05-01|March 2008|Actual|2008-03-01|||||Interventional|||A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.|An Open-Label Study to Investigate Improvement in Heart Function After Complete Anemia Correction With NeoRecormon in Patients With End-Stage Renal Disease Already Receiving Sub-Optimal Doses of NeoRecormon|Completed||Phase 4|50|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:00:46.953794|2017-02-18 16:00:46.953794
NCT00413088|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2011-03-17|||March 2006||2006-03-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly|Clinical Trial to Assess Bemiparin Pharmacokinetics at Therapeutic (115 IU/kg) and Prophylactic Doses (3500 IU) Administered Subcutaneously in Single or Multiple Doses in Renal Insufficiency and in the Elderly|Completed||Phase 1|60|Anticipated|Rovi Pharmaceuticals Laboratories|||||f||||||||||||||2017-02-18 16:00:47.055608|2017-02-18 16:00:47.055608
NCT00413075|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-07-07|||June 2006||2006-06-01|July 2015|2015-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma|Open Label, Dose Escalation Trial of Oral PXD101 in Patients With Advanced Solid Tumors|Completed||Phase 1|121|Actual|Onxeo||1|||f||||f||||||||||2017-02-18 16:00:47.148995|2017-02-18 16:00:47.148995
NCT00413062|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-08-26|2011-04-27||June 2006||2006-06-01|August 2015|2015-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)|A Randomized, Open-Label, Comparative, Multi -Center Trial to Evaluate Contraceptive Efficacy, Cycle Control, Safety and Acceptability of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2), Compared to a Monophasic COC Containing 3 mg Drospirenone (DRSP) and 30 µg Ethinyl Estradiol (EE)|Completed||Phase 3|2281|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:00:47.28098|2017-02-18 16:00:47.28098
NCT00413049|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2011-04-26|2011-01-11||January 2007||2007-01-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension|A Multi-national, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel Study Comparing the Efficacy and Safety of Valsartan/Amlodipine 80/5 mg to Amlodipine 5 mg Alone Once Daily in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Amlodipine 5 mg Monotherapy|Completed||Phase 3|698|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:00:48.029267|2017-02-18 16:00:48.029267
NCT00413036|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2016-11-22|2013-01-09||June 2006||2006-06-01|November 2016|2016-11-01|May 2011|Actual|2011-05-01|April 2011|Actual|2011-04-01||Interventional|||A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma|A Phase II, Multicenter, Single-Arm, Open-Label Study To Evaluate The Safety And Efficacy Of Single-Agent Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|217|Actual|Celgene Corporation||1|||f||||t||||||||||2017-02-18 16:00:48.426341|2017-02-18 16:00:48.426341
NCT00413023|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2016-10-26|||June 2005||2005-06-01|October 2016|2016-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)|A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Major Depressive Disorder (MDD)|Completed||Phase 2|348|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:00:49.08463|2017-02-18 16:00:49.08463
NCT00413010|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2009-12-03|2009-02-27||December 2006||2006-12-01|December 2009|2009-12-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).|An 8-Week, Double-Blind, Placebo-Controlled, Phase 3 Trial of Pregabalin (150-600 mg/Day) in the Adjunctive Treatment of Patients With Generalized Anxiety Disorder (GAD) Who Have Not Optimally Responded to Existing Therapies(GAD)|Completed||Phase 3|356|Actual|Pfizer|Further enrollment in this study was stopped based on the recommendation of an independent Data Monitoring Committee (DMC). An interim data analysis did not suggest the potential for robust efficacy. The study was not stopped for any safety findings.|2|||f||||t||||||||||2017-02-18 16:00:49.410303|2017-02-18 16:00:49.410303
NCT00412997|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2012-11-26|||November 2006||2006-11-01|November 2012|2012-11-01||||May 2008|Actual|2008-05-01||Interventional|||LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma|A Phase I Dose-escalation Study of LBH589 Administered Orally in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma|Completed||Phase 1|14|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:00:50.269314|2017-02-18 16:00:50.269314
NCT00412984|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2013-09-27|2013-01-25||December 2006||2006-12-01|September 2013|2013-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|ARISTOTLE|Randomized participants|Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation|A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation|Completed||Phase 3|18201|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 16:00:50.463939|2017-02-18 16:00:50.463939
NCT00412971|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2013-08-05|2013-08-05||April 2005||2005-04-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer|A Randomized, Comparative Phase III, 2-center Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer|Completed||Phase 3|233|Actual|Photocure||2|||f||||||||||||||2017-02-18 16:01:02.467991|2017-02-18 16:01:02.467991
NCT00412958|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2014-12-02|2012-12-20||December 2006||2006-12-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)|A Multicenter, Randomized, Placebo-Controlled, Double-Masked, Parallel Group, Dose-Ranging Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy: The MIVI III (Microplasmin For Vitreous Injection III) Trial|Completed||Phase 2|125|Actual|ThromboGenics||4|||f||||t||||||||||2017-02-18 16:01:03.122641|2017-02-18 16:01:03.122641
NCT00412932|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2009-09-15|2009-04-28||December 2006||2006-12-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension|A Prospective, Open Label, Single Arm Study to Evaluation the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Elderly Patients With Hypertension|Completed||Phase 4|178|Actual|Daiichi Sankyo Inc.||1|||f||||||||||||||2017-02-18 16:01:03.758296|2017-02-18 16:01:03.758296
NCT00412919|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-17|2013-12-12|||December 2006||2006-12-01|December 2006|2006-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma|A Prospective, Single-Arm, 2-Stage, Open-label, Phase II Trial of Azacitidine in Relapsed and Refractory Multiple Myeloma.|Terminated||Phase 2|7|Actual|Bayside Health||||Lack of efficacy|f||||||||||||||2017-02-18 16:01:04.156584|2017-02-18 16:01:04.156584
NCT00412906|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2008-05-20|||November 2006||2006-11-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls|Study of Gene Expression in Fat and Muscle Tissue in Type 2 Diabetics and Healthy Controls During Experimental Endotoxemia|Completed||N/A|48|Anticipated|Rigshospitalet, Denmark|||||f||||t||||||||||2017-02-18 16:01:04.267865|2017-02-18 16:01:04.267865
NCT00412126|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2006-12-13|||July 2002||2002-07-01|December 2006|2006-12-01|September 2005||2005-09-01|||||Interventional|||Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI|Does Reduction of Hyperglycemia With Insulin Impact Restenosis and Improve Clinical Outcomes Following PCI?|Completed||N/A|240||McMaster University|||||f||||||||||||||2017-02-18 16:01:23.551396|2017-02-18 16:01:23.551396
NCT00412893|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-06-05|2015-03-19||March 2007||2007-03-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Intent-to-treat (ITT) population consisted of all randomized participants who received at least one administration of study drug.|Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis|A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.|Completed||Phase 3|527|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||t||||||||||2017-02-18 16:01:04.593093|2017-02-18 16:01:04.593093
NCT00412880|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2014-04-30||2014-04-30|January 2007||2007-01-01|April 2014|2014-04-01||||June 2008|Actual|2008-06-01||Interventional|||BI 2536 Second Line Monotherapy in SCLC|An Open-label Phase II Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of a Single Dose of 200 mg i.v. BI 2536 Administered Every 21 Days in Patients With Sensitive Relapse Small Cell Lung Cancer|Completed||Phase 2|23|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:01:06.64093|2017-02-18 16:01:06.64093
NCT00412867|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-17|2012-09-11|2012-01-19||December 2006||2006-12-01|September 2012|2012-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）|Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Phase 4)|Completed||Phase 4|58|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||f||||||||||2017-02-18 16:01:06.76294|2017-02-18 16:01:06.76294
NCT00412854|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2016-12-20|2016-12-20||January 2007||2007-01-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.|Phase IIIb, Multicentre Study to Assess Safety & Immunogenicity of GSK Biologicals' Combined DTPa/Hib (Infanrix/Hib) Vaccine vs Separate Administration of DTPa (Infanrix) & Hib (Hiberix) Vaccines in Healthy Infants 3,4,&5 Months of Age as Compared With the Separate Administration of DTPa and Hib Vaccines at Different Injection Sites.|Completed||Phase 3|660|Actual|GlaxoSmithKline|None reported.||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:01:07.155156|2017-02-18 16:01:07.155156
NCT00412841|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2016-02-03|2014-05-28||November 2002||2002-11-01|February 2016|2016-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus|AVN Prevention With Lipitor in Lupus Erythematosus APLLE Trial|Terminated||Phase 2|43|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-02-18 16:01:07.889553|2017-02-18 16:01:07.889553
NCT00412828|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-18|2015-02-02||2015-02-02|June 2006||2006-06-01|February 2015|2015-02-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|||A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma|A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma|Completed||Phase 1/Phase 2|117|Actual|Celldex Therapeutics||1|||f||||t||||||||||2017-02-18 16:01:08.325644|2017-02-18 16:01:08.325644
NCT00412815|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2006-12-14|||July 1997||1997-07-01|December 2006|2006-12-01|January 2001||2001-01-01|||||Interventional|||Exercise Training, Insulin Resistance and Coronary Artery Disease|The Effects of Exercise Training on Insulin Resistance in Patients With Coronary Artery Disease and Insulin Resistance, the Exercise, Coronary Artery Disease and Insulin Resistance (EXCADIR) Randomized Controlled Trial|Completed||Phase 3|60||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:01:08.430337|2017-02-18 16:01:08.430337
NCT00412802|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2011-07-19|||December 2006||2006-12-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome|Validation of Enoxaparin Dose Adaptation in Patients With Moderate Renal Failure Hospitalized for an Acute Coronary Syndrome, the VALIDE Study|Completed||Phase 4|67|Actual|French Cardiology Society||2|||f||||t||||||||||2017-02-18 16:01:08.527655|2017-02-18 16:01:08.527655
NCT00412789|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2010-05-28|||August 2006||2006-08-01|May 2010|2010-05-01||||January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan|A Phase IA, Open-label, Dose Escalation Study of Patupilone Administered Intravenously Every 3 Weeks in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|15|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:01:08.638037|2017-02-18 16:01:08.638037
NCT00412776|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2015-12-22|||December 2005||2005-12-01|December 2015|2015-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer|A Randomized, Multicentre Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Proxinium Plus Best Supportive Care Versus Best Supportive Care Alone in Patients With Advanced SCCHN Who Have Received at Least One Anti-cancer Treatment Regimen for Advanced Disease|Terminated||Phase 2/Phase 3|165|Actual|Viventia Bio||2||Corporate reasons unrelated to safety and efficacy|f||||t||||||||||2017-02-18 16:01:08.821816|2017-02-18 16:01:08.821816
NCT00412763|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2006-12-15|||July 2003||2003-07-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||Efficacy of Silymarin for Acute Hepatitis|Efficacy of Silymarin for Treatment of Acute Hepatitis In Egypt: A Randomized, Double-Blinded, Controlled Trial|Completed||Phase 4|200||University of Maryland|||||f||||||||||||||2017-02-18 16:01:09.047342|2017-02-18 16:01:09.047342
NCT00412750|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2011-06-14|2010-12-02||December 2006||2006-12-01|June 2011|2011-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)|A Randomized, Open-label, Controlled, Multi-center Two-year Study Comparing Efficacy and Safety of Telbivudine, 600 mg PO in Combination With Peginterferon Alpha-2a sq 180 µg With Peginterferon Alpha-2a Monotherapy, and With Telbivudine Monotherapy in Treatment naïve Patients With HBeAg-positive CHB.|Terminated||Phase 3|159|Actual|Novartis||3||Enrollment stopped for safety issues|f||||||||||||||2017-02-18 16:01:09.144311|2017-02-18 16:01:09.144311
NCT00412334|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2016-04-02|||January 2007||2007-01-01|April 2016|2016-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.|Antiviral Effect of 4 Regimens of PEGASYS Plus Copegus in Patients With Genotype 1 Chronic Hepatitis C Non-responder to Previous Peginterferon Alfa-2a Plus Ribavirin Therapy|Completed||Phase 4|104|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 16:01:21.297368|2017-02-18 16:01:21.297368
NCT00412737|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2016-05-04|2009-08-03||January 2007||2007-01-01|May 2016|2016-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||The safety population included all participants who received at least 1 dose of study drug and had at least 1 post baseline safety assessment. Participants were analyzed as per actual treatment received.|A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants|A Double-blind, Randomized, Placebo Controlled, Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients|Completed||Phase 4|477|Actual|Hoffmann-La Roche|There were no overall limitations and caveats.|2|||f||||||||||||||2017-02-18 16:01:12.568712|2017-02-18 16:01:12.568712
NCT00412724|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2012-08-06|||November 2008||2008-11-01|August 2012|2012-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Development and Validation of the Food Acceptability Questionnaire|Development and Validation of the Food Acceptability Questionnaire|Completed||N/A|189|Actual|Physicians Committee for Responsible Medicine|||1||f||||t||||||||||2017-02-18 16:01:13.417991|2017-02-18 16:01:13.417991
NCT00412698|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2010-12-09|||December 2006||2006-12-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|ETERNAL||European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia|A European Randomized, Parallel Group, Two-arm Placebo-controlled, Double-blind Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Abdominally Obese Patients With Dyslipidemia With or Without Other Comorbidities|Terminated||Phase 3|645|Actual|Sanofi||2||"Company decision has been taken in light of recent demands by certain national health~   authorities"|f||||||||||||||2017-02-18 16:01:13.507618|2017-02-18 16:01:13.507618
NCT00412685|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2015-06-15|||August 2006||2006-08-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Myocardial Contrast Echocardiography in Congenital Heart Disease|Quantification of the Myocardial Microcirculation by Contrast Echocardiography In Adult Patients With Congenital Heart Disease|Completed||N/A|45|Actual|University Hospital Inselspital, Berne|||3||f||||||||||||||2017-02-18 16:01:13.634218|2017-02-18 16:01:13.634218
NCT00412672|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2015-06-15|||July 2010||2010-07-01|June 2015|2015-06-01||||||||Observational|||Protective Effect of Coronary Collaterals on Infarct Size in Patients With Acute Myocardial Infarction|Protective Effect of Coronary Collaterals on Infarct Size in Patients With Acute Myocardial Infarction|Withdrawn||N/A|0|Actual|University Hospital Inselspital, Berne|||1||f||||f||||||||||2017-02-18 16:01:13.719411|2017-02-18 16:01:13.719411
NCT00412659|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2016-05-31|||March 2006||2006-03-01|May 2016|2016-05-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Mid-line Excision Versus Karydakis Operation for Pilonidal Sinus|An Expertise-based Randomized Controlled Trial Comparing Midline Excision Versus Karydakis Operation at Surgery for Pilonidal Sinus|Completed||Phase 2/Phase 3|125|Actual|Umeå University||2|||f||||||||||||||2017-02-18 16:01:13.794122|2017-02-18 16:01:13.794122
NCT00412646|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2010-04-26|||June 2002||2002-06-01|April 2010|2010-04-01|November 2006|Actual|2006-11-01|||||Interventional|||TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients|A Randomized, Placebo-controlled Phase II Trial in HIV-1-infected, NRTI-, PI and NNRTI-experienced Subjects to Evaluate the Safety, Tolerability and Efficacy of Different Doses of TMC125 b.i.d. on Top of an Individually Optimized Antiretroviral Therapy by Means of a 2-stage Dose-escalating Design|Completed||Phase 2|260|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 16:01:13.90374|2017-02-18 16:01:13.90374
NCT00412633|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2012-06-08|||February 2004||2004-02-01|June 2012|2012-06-01|October 2010|Actual|2010-10-01|July 2007|Actual|2007-07-01||Interventional|||Clinical & Web-based Diet & Activity Counseling for Men|Clinical & Web-based Diet & Activity Counseling for Men|Completed||N/A|442|Actual|University of California, San Diego||1|||f||||||||||||||2017-02-18 16:01:13.982055|2017-02-18 16:01:13.982055
NCT00412620|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2011-04-25|||December 2006||2006-12-01|September 2010|2010-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia|Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia|Terminated||Phase 2|156|Actual|Abbott||4|||f||||t||||||||||2017-02-18 16:01:14.078514|2017-02-18 16:01:14.078514
NCT00412607|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2014-10-29|2014-09-23||January 2007||2007-01-01|October 2014|2014-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|VT-CoA|All enrolled subjects who signed the informed consent form and were eligible for inclusion in the clinical study|Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia|NaviStar ThermoCool Catheter for Endocardial RF Ablation in Patients With Ventricular Tachycardia|Completed||Phase 4|249|Actual|Biosense Webster, Inc.||1|||f||||||||||||||2017-02-18 16:01:14.201346|2017-02-18 16:01:14.201346
NCT00412594|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2017-01-24|||June 10, 2004|Actual|2004-06-10|January 2017|2017-01-01|June 1, 2019|Anticipated|2019-06-01|June 1, 2019|Anticipated|2019-06-01||Interventional|||2CDA With Rituximab in Hairy Cell Leukemia|Phase II Study of 2-Chlorodeoxyadenosine (2CDA) Followed By Rituximab in Hairy Cell Leukemia|Recruiting||Phase 2|150|Anticipated|M.D. Anderson Cancer Center||1|||f||||f|t|f||||||||2017-02-18 16:01:14.885047|2017-02-18 16:01:14.885047
NCT00412581|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2016-04-28|||September 2005||2005-09-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma|Phase I Safety Study of the Combination of Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy (CC-5013-MEL-003)|Completed||Phase 1|28|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:01:15.032959|2017-02-18 16:01:15.032959
NCT00412568|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2008-03-31|||May 2004||2004-05-01|November 2007|2007-11-01|March 2008||2008-03-01|||||Interventional|||Evaluation of Conventional Photorefractive Keratectomy (PRK) in U.S. Army Personnel, Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel|Evaluation of Conventional Photorefractive Keratectomy (PRK) in U.S. Army Personnel, Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel|Completed||N/A|150|Anticipated|Walter Reed Army Medical Center||1|||f||||||||||||||2017-02-18 16:01:15.162967|2017-02-18 16:01:15.162967
NCT00412555|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2016-11-01|||December 2006||2006-12-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.|An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.|Completed||Phase 4|52|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:01:15.26024|2017-02-18 16:01:15.26024
NCT00412529|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2015-02-23|2010-12-02||December 2006||2006-12-01|February 2015|2015-02-01||||February 2008|Actual|2008-02-01||Interventional|||Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B|A Randomized, Open-label, Controlled, Multicenter, Exploratory Trial to Characterize the Results of Daily Oral Administration of Telbivudine (LDT600) 600 mg or Entecavir (ETV) 0.5 mg Given Over 12 Weeks on the Kinetics of Hepatitis B Virus (HBV) DNA in Adults With HBeAg-positive, Compensated Chronic Hepatitis B (CHB)|Completed||Phase 3|44|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:01:15.913333|2017-02-18 16:01:15.913333
NCT00412516|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2014-10-03|2014-09-30||December 2006||2006-12-01|October 2014|2014-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||The baseline analysis population includes all subjects enrolled in the study|Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine|Long-Term Assessment at 24 Months Post-Vaccination of the Non-Inferiority of the Concurrent Administration of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Measles Vaccine to Measles Vaccine Given Alone|Completed||Phase 3|519|Actual|PATH||3|||f||||f||||||||||2017-02-18 16:01:16.443019|2017-02-18 16:01:16.443019
NCT00412503|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2009-08-06||||||August 2009|2009-08-01||||||||Interventional|||Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents|Phase 1 Study of Temozolomide Associated With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents|Completed||Phase 1|||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 16:01:17.026428|2017-02-18 16:01:17.026428
NCT00412490|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2016-01-27|||December 2005||2005-12-01|January 2016|2016-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Smoking Status and Body Image in Oral Cancer Patients|A Prospective Examination of Smoking Status and Body Image in Surgical Patients With Cancer of the Oral Cavity|Completed||N/A|75|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 16:01:17.116348|2017-02-18 16:01:17.116348
NCT00412477|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2015-04-24|||August 2004||2004-08-01|April 2015|2015-04-01|November 2006|Actual|2006-11-01|||||Interventional|||A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults|RV 151: A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults, WRAIR #984, HSRRB Log # A-11905.|Completed||Phase 1|18|Actual|U.S. Army Medical Research and Materiel Command|||||f||||f||||||||||2017-02-18 16:01:17.223571|2017-02-18 16:01:17.223571
NCT00412464|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2015-04-14|2011-07-28||September 2006||2006-09-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis|A Pilot Dose-finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-induced Thrombocytopenia|Completed||Phase 1|24|Actual|FDA Office of Orphan Products Development||1|||f||||t||||||||||2017-02-18 16:01:17.331079|2017-02-18 16:01:17.331079
NCT00412451|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2014-12-02|2013-07-04||December 2006||2006-12-01|April 2014|2014-04-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|MIVI-II||A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)|A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding Trial of Microplasmin Intravitreal Injection for Non-Surgical Posterior Vitreous Detachment (PVD) Induction for Treatment of DME.|Completed||Phase 2|51|Actual|ThromboGenics||4|||f||||t||||||||||2017-02-18 16:01:17.610549|2017-02-18 16:01:17.610549
NCT00412438|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2006-12-15|||October 2006||2006-10-01|December 2006|2006-12-01||||||||Observational|||Investigation of Genetic Risk of Atrial Fibrillation|Investigation of Genetic Risk of Atrial Fibrillation|Unknown status|Recruiting|N/A|1000||Nagoya University|||||f||||||||||||||2017-02-18 16:01:18.411644|2017-02-18 16:01:18.411644
NCT00412425|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2012-04-09|2012-02-07||November 2006||2006-11-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting|Evaluation of Two Different Schedules of Palonosetron for the Prevention of Nausea and Vomiting in Patients With Metastatic Melanoma Receiving Concurrent Biochemotherapy|Completed||Phase 1/Phase 2|30|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 16:01:18.492271|2017-02-18 16:01:18.492271
NCT00412412|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2012-06-07|||December 2007||2007-12-01|December 2011|2011-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study|A Ph1 Open-Label,Dose-Escalation,Safety,PK & PD Study of CNF2024 as a Single-Agent Treatment in Subjects w/HER2- Adv Breast Cancer or in Combo w/Trastuzumab in Subjects w/HER2+ Advanced Breast Cancer|Completed||Phase 1|34|Actual|Biogen||2|||f||||f||||||||||2017-02-18 16:01:18.80557|2017-02-18 16:01:18.80557
NCT00412399|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2006-12-15|||June 1999||1999-06-01|December 2006|2006-12-01|October 2001||2001-10-01|||||Observational|||Job Adaptation in Patients With Rheumatoid Arthritis|Job Adaptation in Patients With Rheumatoid Arthritis|Completed||N/A|244||Hospital for Special Surgery, New York|||||f||||||||||||||2017-02-18 16:01:18.914922|2017-02-18 16:01:18.914922
NCT00412386|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2013-12-02|||December 2006||2006-12-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|||||Observational|||Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve|Abnormal 3-dimensional MRI Flow Patterns and Plasma Matrix Metalloproteinase Levels Predict Dilatation of Ascending Aorta in Adolescent Patients With Bicuspid Aortic Valve|Completed||N/A|45|Actual|Emory University|||2||f||||f||||||||||2017-02-18 16:01:18.993783|2017-02-18 16:01:18.993783
NCT00412373|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2014-04-24|2009-07-01||December 2006||2006-12-01|April 2014|2014-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.|A Randomized, Double-blind, Placebo-controlled, Parallel- Group Study to Evaluate the Efficacy and Safety of Flexible-dose Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder.|Completed||Phase 3|307|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 16:01:19.094063|2017-02-18 16:01:19.094063
NCT00412360|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2016-06-27|2015-08-28||December 2006||2006-12-01|May 2016|2016-05-01|October 2014|Actual|2014-10-01|March 2014|Actual|2014-03-01||Interventional||Analysis based on intent-to-treat.|Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)|Multi-center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia (BMT CTN #0501)|Completed||Phase 3|224|Actual|Medical College of Wisconsin||2|||f||||t||||||||Yes|Findings were published in a manuscript.|2017-02-18 16:01:19.987863|2017-02-18 16:01:19.987863
NCT00412321|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2014-06-30|||May 2005||2005-05-01|June 2014|2014-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease|A Phase 1 Study of Multiple Intravenous Administrations of a Chimeric Antibody Against Interleukin-6 (CNTO 328) in Subjects With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease|Completed||Phase 1|67|Actual|Centocor, Inc.||8|||f||||f||||||||||2017-02-18 16:01:21.660718|2017-02-18 16:01:21.660718
NCT00412308|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2011-06-27|||December 2006||2006-12-01|June 2011|2011-06-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||A Comparison of High vs. Low Tidal Volumes in Ventilator Weaning for Individuals With Cervical Spinal Cord Injuries|A Comparison of High vs. Low Tidal Volumes in Ventilator Weaning for Individuals With Sub-Acute Cervical Spinal Cord Injuries|Completed||N/A|34|Actual|Craig Hospital||1|||f||||||||||||||2017-02-18 16:01:21.787627|2017-02-18 16:01:21.787627
NCT00412295|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2015-01-12||||||December 2014|2014-12-01||||||||Interventional|||Evaluation of Alcon Ladarvision Wavefront-Guided PRK|Evaluation of Alcon Ladarvision Wavefront-Guided PRK|Withdrawn||N/A|0|Actual|Walter Reed Army Medical Center||||"Lack of resources and not because of any concern with the safety or effectiveness of the~   procedures studied."|f||||||||||||||2017-02-18 16:01:21.887823|2017-02-18 16:01:21.887823
NCT00412269|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2016-01-22|||February 1998||1998-02-01|January 2016|2016-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin|Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin|Completed||N/A|160|Actual|Pennington Biomedical Research Center|||1||f||||t||||||||||2017-02-18 16:01:21.978303|2017-02-18 16:01:21.978303
NCT00412256|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2006-12-15|||September 2004||2004-09-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Interventional|||Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)|Clinical Trial to Evaluate the Effect of Parenteral Supplementation With Omega-3-Fatty Acids in Patients With Rheumatoid Arthritis|Completed||Phase 3|60||Humanis Klinikum Niederosterreich|||||f||||||||||||||2017-02-18 16:01:22.059504|2017-02-18 16:01:22.059504
NCT00412243|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2013-03-08|2013-01-25||March 2006||2006-03-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients|Phase I/II Study of Clofarabine Plus Cyclophosphamide for Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1/Phase 2|51|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:01:22.147722|2017-02-18 16:01:22.147722
NCT00412230|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2009-02-17|||October 2006||2006-10-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|||||Observational|||Insulin Resistance and Hypertensive Disorders in Pregnancy|The Role of Insulin Resistance in Gestational Hypertension and in Preeclampsia.|Completed||N/A|100|Anticipated|University of Messina|||2||f||||f||||||||||2017-02-18 16:01:22.3819|2017-02-18 16:01:22.3819
NCT00412217|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-15|2016-10-11|2016-08-02||November 2006||2006-11-01|October 2016|2016-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||Intent-to-Treat (ITT) Population: All participants who were randomized in the study.|A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer|Phase III Randomized, Controlled Trial of Erlotinib (Tarceva) as Maintenance Therapy in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Resection and Radiotherapy With or Without Concomitant Chemotherapy With Curative Aim|Terminated||Phase 3|94|Actual|Hoffmann-La Roche|The Study was terminated early as a result of slow recruitment. Results should be interpreted with consideration of the small sample size.|2||The study was terminated because recruitment was too slow.|f||||||||||||||2017-02-18 16:01:22.468709|2017-02-18 16:01:22.468709
NCT00412204|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2009-10-20|||June 2006||2006-06-01|October 2009|2009-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study to Evaluate the Effects of Tiotropium Bromide on Chronic Obstructive Pulmonary Disease (COPD) During Exercise|A Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Tiotropium Bromide on Gas Exchange in Subjects With COPD During Exercise|Completed||Phase 4|20|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 16:01:22.922644|2017-02-18 16:01:22.922644
NCT00412191|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2016-10-26|||February 2007||2007-02-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR|A Pivotal Single-dose Randomised, Parallel-group, Open-label Study to Demonstrate Bioequivalence of 300mg Lamotrigine XR Relative to 100mg + 200mg Lamotrigine XR and to Demonstrate Lack of Food Effect on 300mg Lamotrigine XR in Healthy Male and Female Volunteers|Completed||Phase 1|180|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:01:23.040265|2017-02-18 16:01:23.040265
NCT00412178|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2006-12-14|||December 2004||2004-12-01|December 2006|2006-12-01|April 2005||2005-04-01|||||Interventional|||Effect of Mobile Communication With a Cellular Phone With a Glucometer on Glucose Control in Type 2 Diabetic Patients||Terminated||N/A|80||The Catholic University of Korea|||||f||||||||||||||2017-02-18 16:01:23.135658|2017-02-18 16:01:23.135658
NCT00412165|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2012-08-15|||February 2006||2006-02-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||PACE-iDP: An Intervention for Youth at Risk for Diabetes|PACE-iDP: An Intervention for Youth at Risk for Diabetes|Completed||N/A|101|Actual|University of California, San Diego||4|||f||||||||||||||2017-02-18 16:01:23.247183|2017-02-18 16:01:23.247183
NCT00412152|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2012-08-09|||January 2006||2006-01-01|August 2012|2012-08-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Oxycodone-naloxone in Relieving Opioid-related Constipation|A Randomised, Double-blind, Parallel-group, Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-malignant Pain Taking Oxycodone Equivalent of >20 mg/Day and <50 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged Release Tablets Alone.|Completed||Phase 3|||Mundipharma Research GmbH & Co KG||1|||f||||f||||||||||2017-02-18 16:01:23.361164|2017-02-18 16:01:23.361164
NCT00412139|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-02-08|||December 2006||2006-12-01|December 2008|2008-12-01|January 2010|Actual|2010-01-01|November 2008|Actual|2008-11-01||Observational|||Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients|A Correlation Between Histological Findings of the Blood Vessels in Patients With Chronic Renal Failure and Serum Uremic Toxins and Its Diagnostic Performance in the Assessment of the Cardiovascular Morbidity and Mortality|Completed||N/A|100|Actual|University of Skopje|||1||f||||t||||||None Retained|"~     3 aliquots of 2-3 ml sera are retained for various uremic markers determination~   "|||2017-02-18 16:01:23.460758|2017-02-18 16:01:23.460758
NCT00412113|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2009-11-12|2009-04-13||January 2007||2007-01-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|TOGETHER||A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk|A 6-Week, Prospective, Randomized, Double-Blind, Double-Dummy Phase IV Clinical Trial Designed to Evaluate the Efficacy of an Aggressive Multi-Risk Factor Management Strategy With Caduet (A3841045) Versus a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensive Subjects With Additional Risk Factors.|Completed||Phase 4|245|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 16:01:23.655804|2017-02-18 16:01:23.655804
NCT00412100|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2012-08-09|||April 2006||2006-04-01|August 2012|2012-08-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation|A Randomsied, Double-blind, Double-dummy, Parallel-group Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-malignant Pain Taking Oxycodone Equivalent of 60-80 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged Release Tablets Alone|Completed||Phase 3|||Mundipharma Research GmbH & Co KG|||||f||||||||||||||2017-02-18 16:01:24.518677|2017-02-18 16:01:24.518677
NCT00412087|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2016-06-16|2016-05-04||January 2007||2007-01-01|June 2016|2016-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Vitamin D Status of Pregnant Women and Their Children in Eau Claire, South Carolina|Vitamin D Status of Pregnant Women and Their Children in Eau Claire, South Carolina: A Prevalence and Supplementation Model for Community Health Care Centers in the U.S.|Completed||Phase 3|564|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 16:01:24.63074|2017-02-18 16:01:24.63074
NCT00412074|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2016-07-26|2016-04-27||August 2006||2006-08-01|July 2016|2016-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Establishing the Vitamin D Requirements During Lactation|Establishing the Vitamin D Requirements During Lactation|Completed||Phase 3|460|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-02-18 16:01:24.968333|2017-02-18 16:01:24.968333
NCT00412061|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2014-11-11|2011-10-25||December 2006||2006-12-01|November 2014|2014-11-01|June 2013|Actual|2013-06-01|April 2010|Actual|2010-04-01||Interventional|RADIANT-2||Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor|A Randomized, Double-blind Placebo-controlled, Multicenter Phase III Study in Patients With Advanced Carcinoid Tumor Receiving Octreotide Depot and Everolimus 10 mg/Day or Octreotide Depot and Placebo|Completed||Phase 3|429|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:01:25.488129|2017-02-18 16:01:25.488129
NCT00412048|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2012-11-12|||April 2012||2012-04-01|November 2012|2012-11-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease|Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.|Withdrawn||N/A|0|Actual|University Hospital, Strasbourg, France||3|||f||||f||||||||||2017-02-18 16:01:27.379862|2017-02-18 16:01:27.379862
NCT00412035|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2014-12-22|||January 2007||2007-01-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|BOLLD||Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery|Safety and Efficacy of Botox Injection in Alleviating Post-Operative Pain and Improving Quality of Life in Lower Extremity Limb Lengthening and Deformity Correction|Completed||Phase 3|125|Actual|Shriners Hospitals for Children||2|||f||||t||||||||||2017-02-18 16:01:27.469162|2017-02-18 16:01:27.469162
NCT00412022|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2015-11-27|||March 2004||2004-03-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|March 2016|Anticipated|2016-03-01||Interventional|HOBOE||HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.|Phase III Randomized Study of the Effects on Bone Mineral Density of Tamoxifen, Letrozole, and Letrozole + Zoledronic Acid as Adjuvant Treatment of Patients With Early Breast Cancer; VERSION 2 AMENDED Phase 3 Study of Triptorelin and Tamoxifen, Letrozole, or Letrozole + Zoledronic Acid in Adjuvant Treatment of Premenopausal Endocrine Responsive Breast Cancer Patients.|Active, not recruiting||Phase 3|1050|Anticipated|National Cancer Institute, Naples||3|||f||||f||||||||||2017-02-18 16:01:27.586647|2017-02-18 16:01:27.586647
NCT00412009|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2006-12-14|||May 2003||2003-05-01|December 2006|2006-12-01|January 2005||2005-01-01|||||Interventional|||Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal|Investigation of a Novel Approach to Improve Adherence to Treatment and Treatment Success Rates for Tuberculosis Patients in Senegal|Completed||Phase 4|1500||Institut de Recherche pour le Developpement|||||f||||||||||||||2017-02-18 16:01:27.787032|2017-02-18 16:01:27.787032
NCT00411996|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2010-06-04|||December 2006||2006-12-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin|The Pharmacokinetics and Safety of Ritonavir-boosted Indinavir 600/100mg Bid Combined With NRTIs in ARV naïve HIV/TB Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy|Completed||Phase 1/Phase 2|20|Actual|The HIV Netherlands Australia Thailand Research Collaboration||1|||f||||t||||||||||2017-02-18 16:01:27.88149|2017-02-18 16:01:27.88149
NCT00411983|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2016-02-18|||November 2002||2002-11-01|February 2016|2016-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||A Long-term Follow-up of the HIV-NAT Cohort|A Long-term Follow-up Study for HIV-infected Individuals Who Have Participated in HIV-NAT Study Protocols|Recruiting||N/A|10000|Anticipated|The HIV Netherlands Australia Thailand Research Collaboration|||1||f||||t||||||Samples With DNA|"~     PBMC collection once a year~   "|||2017-02-18 16:01:27.988689|2017-02-18 16:01:27.988689
NCT00411970|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2007-10-24|||September 2004||2004-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||20- Versus 23- Gauge System for Pars Plana Vitrectomy|20- Versus 23- Gauge System for Pars Plana Vitrectomy: A Prospective Randomized Clinical Study|Completed||Phase 4|60|Actual|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery|||||f||||||||||||||2017-02-18 16:01:28.096723|2017-02-18 16:01:28.096723
NCT00411957|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2010-06-04|||January 2007||2007-01-01|June 2010|2010-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients|The Pharmacokinetics of Atazanavir / Ritonavir 200/100 OD Versus 300/100 mg OD in Combination With 2 NRTIs in HIV Pre-treated Patients|Completed||Phase 1/Phase 2|22|Actual|The HIV Netherlands Australia Thailand Research Collaboration||2|||f||||t||||||||||2017-02-18 16:01:28.184507|2017-02-18 16:01:28.184507
NCT00411944|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2006-12-13|||August 1999||1999-08-01|December 2006|2006-12-01|September 2005||2005-09-01|||||Observational|||Long-Term Pharmacokinetics of Tacrolimus in Renal Recipients|Prospective Study of the Influence of CYP3A4/CYP3A5 and MDR1 Gene Single Nucleotide Polymorphisms on Long-Term Tacrolimus Disposition in Renal Allograft Recipients: a Five Year Follow-up Study Using Abbreviated Concentration-Time Measurements.|Completed||Phase 4|100||Katholieke Universiteit Leuven|||||f||||||||||||||2017-02-18 16:01:28.287136|2017-02-18 16:01:28.287136
NCT00411931|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2008-01-10|||September 2006||2006-09-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Pharmacokinetics Study of MultiHance in Pediatric Patients|A Clinical Investigation of the Pharmacokinetics and Safety of MultiHance in Patients From 2-5 Years of Age Undergoing A Clinical Indicated MRI of the CNS|Completed||Phase 1|15|Actual|Bracco Diagnostics, Inc||1|||f||||||||||||||2017-02-18 16:01:28.364621|2017-02-18 16:01:28.364621
NCT00411905|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2007-03-09|||June 2006||2006-06-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes|Phase I/II Study of Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes|Unknown status|Recruiting|Phase 1/Phase 2|39||Groupe Francophone des Myelodysplasies|||||f||||f||||||||||2017-02-18 16:01:28.436802|2017-02-18 16:01:28.436802
NCT00411892|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2012-07-09||2009-11-09|November 2006||2006-11-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes|Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes|Terminated||Phase 3|196|Actual|Novo Nordisk A/S||2||See termination reason in detailed description|f||||f||||||||||2017-02-18 16:01:31.18052|2017-02-18 16:01:31.18052
NCT00411879|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2016-01-08|||June 2006||2006-06-01|January 2016|2016-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Combined Vasopressin, Methylprednisolone, and Epinephrine for Inhospital Cardiac Arrest|Phase 2, Single-Center, Placebo-Controlled Study of the Effects of Combined Administration of Vasopressin, Methylprednisolone, and Epinephrine During Cardiopulmonary Resuscitation on Survival After Cardiac Arrest|Completed||Phase 2|100|Actual|University of Athens||2|||f||||t||||||||||2017-02-18 16:01:31.394703|2017-02-18 16:01:31.394703
NCT00411866|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2012-03-15|||October 2006||2006-10-01|February 2011|2011-02-01||||||||Interventional|||Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812|Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole 400mg on Pharmacokinetics of SB-773812 20mg.|Completed||Phase 1|36|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:01:31.507103|2017-02-18 16:01:31.507103
NCT00411853|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2009-07-30|||June 2007||2007-06-01|July 2009|2009-07-01|June 2012|Anticipated|2012-06-01|June 2011|Anticipated|2011-06-01||Interventional|||Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients|An Open Phase II Clinical Trial of Fermented Wheat Germ Extract in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients|Unknown status|Recruiting|Phase 2|60|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 16:01:31.601175|2017-02-18 16:01:31.601175
NCT00411840|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2006-12-13|||July 2004||2004-07-01|December 2006|2006-12-01||||||||Interventional|||Novel Therapy of PAD by Combined Transplantation of BMCs|Transplantation of Autologous Mononuclear Bone Marrow Stem Cells in Patients With Peripheral Arterial Disease (TAM-PAD Study)|Unknown status|Recruiting|Phase 1|100||Heinrich-Heine University, Duesseldorf|||||f||||||||||||||2017-02-18 16:01:31.696875|2017-02-18 16:01:31.696875
NCT00411827|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2014-07-16|||January 2008||2008-01-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|February 2011|Actual|2011-02-01||Interventional|||Goblet Cell Response and Dry Eye Symptoms After PRK and LASIK|Goblet Cell Response and Dry Eye Symptoms After PRK and LASIK|Unknown status|Active, not recruiting|N/A|146|Anticipated|Walter Reed National Military Medical Center||2|||f||||||||||||||2017-02-18 16:01:32.03002|2017-02-18 16:01:32.03002
NCT00411814|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2012-03-15|||November 2006||2006-11-01|January 2012|2012-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers|A Dose-escalating Study of the Safety and Pharmacokinetics of GSK679586A in Healthy Volunteers and Mild Asthmatics.|Completed||Phase 1|56|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:01:32.134289|2017-02-18 16:01:32.134289
NCT00411801|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2015-10-24||2015-07-07|May 2007||2007-05-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)|A Blinded Non-inferiority Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)|Terminated||Phase 3|8|Actual|Octapharma||2||Insufficient enrollment|f||||t||||||||||2017-02-18 16:01:32.244097|2017-02-18 16:01:32.244097
NCT00411788|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2016-08-01|2016-06-17||December 2006||2006-12-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||Eleven patients were enrolled from study start date until February 2010.|A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer|A Phase II Study of Rapamycin (Rapamune, Sirolimus) and Trastuzumab (Herceptin) for Patients With HER-2 Receptor Positive Metastatic Breast Cancer|Completed||Phase 2|11|Actual|Yale University||1|||f||||f||||||||||2017-02-18 16:01:32.352525|2017-02-18 16:01:32.352525
NCT00411762|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2015-03-19|2015-03-10||December 2006||2006-12-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma|A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma|Completed||Phase 1/Phase 2|25|Actual|Yale University||1|||f||||f||||||||||2017-02-18 16:01:32.677544|2017-02-18 16:01:32.677544
NCT00411749|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2015-10-30|2010-07-19||December 2006||2006-12-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)|V501 Phase II Immunogenicity Study in Females Aged 9 to 17 Years|Completed||Phase 2|107|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:01:32.905055|2017-02-18 16:01:32.905055
NCT00411541|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2006-12-13|||April 1995||1995-04-01|December 2006|2006-12-01|January 2004||2004-01-01|||||Interventional|||Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia|Pulses of Vincristine and Dexamethasone During Maintenance in BFM Protocols for Children With Intermediate-Risk Acute Lymphoblastic Leukemia|Completed||Phase 4|2600||International BFM Study Group|||||f||||||||||||||2017-02-18 16:01:37.541875|2017-02-18 16:01:37.541875
NCT00411736|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-14|2014-03-13|||May 2008||2008-05-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Scandinavian Cystic Fibrosis Azithromycin Study|Supplementary Oral Azithromycin in Treatment of Intermittent Pseudomonas Aeruginosa Colonization in CF-patients With Inhaled Colistin and Oral Ciprofloxacin; Postponing Next Isolate of Pseudomonas and Prevention of Chronic Infection. A Prospective, Double-blinded, Placebo-controlled Scandinavian Multi-centre Study.|Completed||Phase 4|45|Actual|Rigshospitalet, Denmark||3|||f||||t||||||||||2017-02-18 16:01:33.329814|2017-02-18 16:01:33.329814
NCT00411723|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2009-02-19|||December 2006||2006-12-01|February 2009|2009-02-01|May 2009|Anticipated|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis|Phase 1 Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis|Unknown status|Active, not recruiting|Phase 1|34|Actual|Artielle ImmunoTherapeutics||2|||f||||||||||||||2017-02-18 16:01:33.45025|2017-02-18 16:01:33.45025
NCT00411697|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2016-10-27|||December 2006||2006-12-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge|Assess Long-term Persistence of Hepatitis B Antibodies & Immune Response to a Hepatitis B Vaccine (Engerix-B Kinder) Challenge in Children Aged 4-5 Years (Previously Primed & Boosted in the 1st 2 Years of Life With DTPa-HBV-IPV/Hib Vaccine)|Completed||Phase 4|301|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:01:33.556365|2017-02-18 16:01:33.556365
NCT00411684|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2010-06-16|||November 2006||2006-11-01|June 2010|2010-06-01||||||||Interventional|||Safety and Efficacy of CDB-2914 for Emergency Contraception|A Prospective, Open-Label, Single Arm, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of CDB-2914 as Emergency Contraception When Taken Between 48 Hours and 120 Hours of Unprotected Sex|Completed||Phase 3|1320|Anticipated|HRA Pharma|||||f||||||||||||||2017-02-18 16:01:33.949625|2017-02-18 16:01:33.949625
NCT00411671|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2016-01-13|2015-11-05||November 2006||2006-11-01|January 2016|2016-01-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||BATTLE Program: Sorafenib in Patients With NSCLC|A Phase II Study of Sorafenib (BAY 43-9006) in Chemorefractory Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|105|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 16:01:34.066373|2017-02-18 16:01:34.066373
NCT00411658|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2015-04-03||||||April 2015|2015-04-01||||||||Interventional|||Devitalized Non-valved Pulmonary Artery Allograft Implant for the Repair of Congenital Cardiac Abnormalities||Withdrawn||N/A|0|Actual|LifeNet Health||2||Submission converted to 510(k)|f||||||||||||||2017-02-18 16:01:34.615161|2017-02-18 16:01:34.615161
NCT00411645|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2015-06-03|2015-05-15||December 2006||2006-12-01|March 2014|2014-03-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients|A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants.|Completed||Phase 3|681|Actual|Shire||2|||f||||t||||||||||2017-02-18 16:01:34.70751|2017-02-18 16:01:34.70751
NCT00411632|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2016-09-19|||November 2006||2006-11-01|September 2016|2016-09-01||||November 2018|Anticipated|2018-11-01||Interventional|||BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase II Study of Erlotinib (Tarceva) in Combination With Bexarotene (Targretin) in Chemorefractory Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|72|Anticipated|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 16:01:36.183277|2017-02-18 16:01:36.183277
NCT00411619|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2014-10-17|2014-09-18||January 2007||2007-01-01|October 2014|2014-10-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex|Everolimus (RAD001)Therapy of Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex|Completed||Phase 1/Phase 2|28|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 16:01:36.304094|2017-02-18 16:01:36.304094
NCT00411606|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2009-04-03|||December 2006||2006-12-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Normal Values of Facial Thermography|Normal Values of Facial Thermography|Completed||N/A|300|Anticipated|West Penn Allegheny Health System|||1||f||||||||||||||2017-02-18 16:01:36.686093|2017-02-18 16:01:36.686093
NCT00411593|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2012-02-07|||November 2006||2006-11-01|February 2012|2012-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)|Phase I-II Study of Avastin®+ Bortezomib for Patients With Recurrent or Refractory Non-Squamous NSCLC|Withdrawn||Phase 1/Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Lack of Patient Accrual|f||||f||||||||||2017-02-18 16:01:36.79813|2017-02-18 16:01:36.79813
NCT00411580|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2013-03-27|||June 2005||2005-06-01|March 2013|2013-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)|A 52-week, Multi-center, Randomized, Double-blind, Placebo-controlled, Time-lagged, Parallel Group Study in Patients With Mild to Moderate Alzheimer's Disease (AD) to Investigate the Safety, Tolerability and Aß-specific Antibody Response Following Three Subcutaneous Injections of CAD106|Completed||Phase 1|58|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:01:36.923999|2017-02-18 16:01:36.923999
NCT00411567|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2007-06-21|||July 2006||2006-07-01|June 2007|2007-06-01||||||||Interventional|||A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma|An Open Label Study to Assess the Utility of Measuring Markers of Inflammation, to Detect Transition From Optimal to Sub-Optimal Inhaled Corticosteroid Therapy in Moderate-Severe Bronchial Asthma|Completed||Phase 1/Phase 2|26||Novartis|||||f||||f||||||||||2017-02-18 16:01:37.029431|2017-02-18 16:01:37.029431
NCT00411554|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2016-02-03|2009-08-19||January 2007||2007-01-01|February 2016|2016-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)|Sitagliptin (MK0431) Phase III Double-blind Comparative Study - Type 2 Diabetes Mellitus -|Completed||Phase 3|319|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:01:37.117645|2017-02-18 16:01:37.117645
NCT00006294|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-25|2014-03-14|||September 1999||1999-09-01|March 2014|2014-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||GenHAT--Genetics of Hypertension Associated Treatments||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:13:03.774783|2017-02-18 18:13:03.774783
NCT00411528|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2013-03-07|||September 2006||2006-09-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer|A Randomized Multicenter Phase II Trial of Patupilone (EPO906) Plus Prednisone Versus Docetaxel Plus Prednisone in Patients With Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|185|Actual|Novartis||4|||f||||||||||||||2017-02-18 16:01:37.647428|2017-02-18 16:01:37.647428
NCT00411515|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2006-12-14||||||December 2006|2006-12-01||||||||Interventional|||A Prospective Randomized Trial on Mycophenolate Mofetil in Risk Penetrating Keratoplasty||Completed||Phase 4|||University Hospital Freiburg|||||f||||||||||||||2017-02-18 16:01:37.777647|2017-02-18 16:01:37.777647
NCT00411489|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2008-03-17||||||June 2007|2007-06-01||||||||Interventional|||Endoscopic Stomach and Pouch Reduction in Patients With Weight Regain Following Roux-En-Y Bypass Surgery|Use of a New Endosurgical Operating System for Endoscopic Stoma and Pouch Reduction in Patients With Weight Regain Following Roux-En-Y Bypass Surgery|Completed||N/A|||USGI Medical|||||f||||||||||||||2017-02-18 16:01:38.087746|2017-02-18 16:01:38.087746
NCT00411463|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2013-01-20|||December 2006||2006-12-01|January 2013|2013-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Psychotherapy for Bipolar II Depression, Pilot Study, Phase II|Psychotherapy for Bipolar II Depression, Pilot Study, Phase II|Completed||Phase 2/Phase 3|24|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 16:01:38.171428|2017-02-18 16:01:38.171428
NCT00411450|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2016-01-15|2016-01-15||November 2006||2006-11-01|January 2016|2016-01-01|October 2010|Actual|2010-10-01|January 2009|Actual|2009-01-01||Interventional|PRECEPT||Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment|Multi Center, Open Label, Single Arm Trial Evaluating Panitumumab in Combination With FOLFIRI Therapy Following First Line FOLFOX and Bevacizumab Treatment of Metastatic Colorectal Cancer|Completed||Phase 2|116|Actual|Amgen||1|||f||||f||||||||||2017-02-18 16:01:38.287685|2017-02-18 16:01:38.287685
NCT00411437|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2008-06-10|||December 2006||2006-12-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effects Of Detrol LA On Memory And Cognition In Elderly Population|A Randomized, Double-Blind, Placebo-Controlled, Three Arm Study To Evaluate The Effects Of Tolterodine ER 4 mg Vs. Placebo Vs. Oxybutynin ER On Memory And Other Cognitive Abilities In Elderly Subjects|Completed||Phase 4|220||Pfizer|||||||||||||||||||2017-02-18 16:01:39.150953|2017-02-18 16:01:39.150953
NCT00411424|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2013-03-19|||September 2007||2007-09-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis|Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Initial Efficacy of ASK8007 in Comparison With Placebo in Patients With Active Rheumatoid Arthritis - a Randomized, Double Blind, Placebo-controlled, Combined Single Dose Escalation and Multiple Dose Study|Completed||Phase 1/Phase 2|54|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:01:39.24901|2017-02-18 16:01:39.24901
NCT00411411|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2014-07-21|2014-05-19||February 2007||2007-02-01|July 2014|2014-07-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes|Phase 3, Double Blinded, Placebo Controlled Study of the Effects of 12 Weeks DPP-IV Inhibitor Treatment on Secretion and Action of the Incretin Hormones in Patients With Type 2 Diabetes|Completed||Phase 3|49|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-02-18 16:01:39.375239|2017-02-18 16:01:39.375239
NCT00411398|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2014-12-09|2012-09-06||December 2006||2006-12-01|December 2014|2014-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder|A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder (GAD) or Social Anxiety Disorder (SAD), Who Are Only Partial Responders to Selective Serotonin-Norepinephrine Reuptake Inhibitors (SNRI's) or Selective Serotonin Reuptake Inhibitors (SSRI's).|Completed||Phase 3|15|Actual|State University of New York - Upstate Medical University||1|||f||||||||||||||2017-02-18 16:01:39.784506|2017-02-18 16:01:39.784506
NCT00411385|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2013-08-01||2009-09-17|February 2007||2007-02-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3|Phase3 Study to Evaluate the Efficacy and Safety of AlbuminInterferon in Combination With Ribavirin Compared With Peginterferon in Combination With Ribavirin in Interferon Alfa Naive Subjects With CHC Genotype 2/3.|Completed||Phase 3|933|Actual|Human Genome Sciences Inc.||3|||f||||||||||||||2017-02-18 16:01:40.057292|2017-02-18 16:01:40.057292
NCT00411372|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2015-02-19|||November 2006||2006-11-01|February 2015|2015-02-01||||||||Interventional|||Shortness Of Breath Questionnaire Validation Study|A Randomized, Double-blind, Parallel-group Study of Fluticasone Propionate/Salmeterol Combination (FSC 250/50mcg) Twice Daily and Salmeterol (SAL 50mcg) Twice Daily to Validate a New Shortness of Breath Questionnaire in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||||No subjects enrolled. Study was canceled before active|||||||||||||||2017-02-18 16:01:40.445222|2017-02-18 16:01:40.445222
NCT00411359|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2015-04-21|||December 2006||2006-12-01|April 2015|2015-04-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Cardiac Rehabilitation for the Treatment of Refractory Angina|Cardiac Rehabilitation for the Treatment of Refractory Angina|Completed||Phase 3|42|Actual|National Heart and Lung Institute||2|||f||||f||||||||||2017-02-18 16:01:40.546956|2017-02-18 16:01:40.546956
NCT00411346|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2006-12-13|||January 2003||2003-01-01|December 2006|2006-12-01|November 2004||2004-11-01|||||Interventional|||Patient Research In Self-Management of Asthma (PRISMA)|Nurse-Led Telemonitoring Programme in Asthmatic Outpatients: a Randomized Controlled Trial|Completed||Phase 4|112||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 16:01:40.679112|2017-02-18 16:01:40.679112
NCT00411333|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-13|2010-11-09|||July 2006||2006-07-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy|Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy|Completed||Early Phase 1|100|Anticipated|National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 16:01:40.778962|2017-02-18 16:01:40.778962
NCT00411320|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2011-08-03|||January 2007||2007-01-01|September 2008|2008-09-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Determinants of Corticosteroid Insensitivity in Smokers With Asthma|Determinants of Corticosteroid Insensitivity in Smokers With Asthma|Completed||N/A|53|Actual|University of Glasgow||5|||f||||t||||||||||2017-02-18 16:01:40.888217|2017-02-18 16:01:40.888217
NCT00411307|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-04-26||||||April 2010|2010-04-01|October 2001|Actual|2001-10-01|||||Interventional|||A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain|A Randomized, Open-Label, Single-Dose, Pilot Study to Evaluate the Safety and Efficacy of OROS Hydromorphone in Patients With Acute, Moderate-to-Severe Postoperative Pain|Completed||Phase 2|50|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:41.185218|2017-02-18 16:01:41.185218
NCT00411294|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2006-12-11||||||December 2006|2006-12-01||||||||Observational|||Ergocalciferol in Chronic Kidney Disease|The Effect of Ergocalciferol Treatment on 25-Hydroxyvitamin D Levels and Plasma Intact PTH in Patients With Chronic Kidney Disease Stage 3 and 4|Completed||N/A|||Saint Louis VA Medical Center|||||f||||||||||||||2017-02-18 16:01:41.28253|2017-02-18 16:01:41.28253
NCT00411281|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2015-09-28|||March 2006||2006-03-01|August 2013|2013-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder|Treatment of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)|Withdrawn||Phase 3|0|Actual|Children's Oncology Group||2||Per Group Chair: This study will not move forward.|f||||t||||||||||2017-02-18 16:01:41.366876|2017-02-18 16:01:41.366876
NCT00411268|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-04-26||||||April 2010|2010-04-01|June 2001|Actual|2001-06-01|||||Interventional|||Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain|Safety, Efficacy and Impact on Quality of Life of Long-Term Administration of Dilaudid CR (Hydromorphone HCI) in Patients With Chronic Low Back Pain|Completed||Phase 3|207|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:41.480426|2017-02-18 16:01:41.480426
NCT00411255|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2017-01-24|||June 22, 2006||2006-06-22|February 19, 2010|2010-02-19|April 7, 2009|Actual|2009-04-07|April 7, 2009|Actual|2009-04-07||Interventional|||Brain Stimulation to Treat Blepharospasm or Meige Syndrome|Blepharospasm and the Experimental Modulation of Cortical Excitability in Primary and Secondary Motor Areas. A Pilot Study.|Completed||Phase 2|22|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:01:41.564192|2017-02-18 16:01:41.564192
NCT00411242|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2012-05-02||2012-05-02|December 2006||2006-12-01|May 2012|2012-05-01||||January 2008|Actual|2008-01-01||Interventional|||Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder|An 8-week, Randomized, Double-blind, Fixed Dosage, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy, Safety and Tolerability of Agomelatine 25 mg and 50 mg in the Treatment of Major Depressive Disorder (MDD) Followed by a 52-week, Open-label Extension (CAGO178A2302E)|Completed||Phase 3|503|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:01:41.659181|2017-02-18 16:01:41.659181
NCT00411229|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2013-02-18|||June 2006||2006-06-01|February 2013|2013-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|CLASSIC||Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer|A Phase III Study Comparing Adjuvant Chemotherapy Consisting of Capecitabine/Oxaliplatin vs Surgery Alone in Patients With Stage II (T1N2, T2N1, T3N0), IIIa (T2N2, T3N1, T4NO), and IIIb (T3N2) Gastric Adenocarcinoma|Completed||Phase 3|1035|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:01:41.840211|2017-02-18 16:01:41.840211
NCT00411216|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2015-07-16|2013-12-20||August 2000||2000-08-01|July 2015|2015-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Recovery of Visual Acuity in People With Vestibular Deficits|Recovery of Visual Acuity in Vestibular Deficits|Completed||N/A|23|Actual|Emory University||2|||f||||f||||||||||2017-02-18 16:01:41.962585|2017-02-18 16:01:41.962585
NCT00411203|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2014-07-30|||April 2003||2003-04-01|July 2014|2014-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Tamoxifen in Treatment of Acute Mania|Double Blind Placebo Controlled Trial of a Protein Kinase C Inhibitor: Tamoxifen Citrate in Treatment of Acute Mania|Completed||Phase 3|66|Actual|Stanley Medical Research Institute||2|||f||||||||||||||2017-02-18 16:01:42.400833|2017-02-18 16:01:42.400833
NCT00411190|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2009-05-15|||October 2006||2006-10-01|May 2009|2009-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin|An Open-Label, Two-Period, Fixed Sequence, Randomized, Parallel Group, Interaction Study to Determine the Effects of Repeat Doses of Relacatib on the Metabolism of Acetaminophen, Ibuprofen and Atorvastatin in Healthy Postmenopausal Female Subjects|Completed||Phase 1|32|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:01:42.513343|2017-02-18 16:01:42.513343
NCT00411177|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2013-09-06|||January 2007||2007-01-01|September 2013|2013-09-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis|Comparison of Post-dilution On-line Hemodiafiltration and Hemodialysis (TURKISH HDF STUDY)|Completed||Phase 4|782|Actual|Ege University||2|||f||||t||||||||||2017-02-18 16:01:42.610843|2017-02-18 16:01:42.610843
NCT00411164|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2013-07-04|||November 2003||2003-11-01|July 2013|2013-07-01|May 2005|Actual|2005-05-01|||||Interventional|||A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With Osteoarthritis|A Phase 3, Randomized, Double-Blind, Fixed-Dose, Parallel Group Comparison of Controlled-Release Hydromorphone HCI vs Placebo in Subjects With Osteoarthritis|Completed||Phase 3|990|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 16:01:42.738389|2017-02-18 16:01:42.738389
NCT00411151|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2011-01-19|2010-11-29||December 2006||2006-12-01|January 2011|2011-01-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer|An Open-label, Multicenter Phase II Trial of Sunitinib for Patients With Chemo-refractory Metastatic Gastric Cancer|Completed||Phase 2|52|Actual|Johannes Gutenberg University Mainz||1|||f||||t||||||||||2017-02-18 16:01:42.854376|2017-02-18 16:01:42.854376
NCT00411138|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-04-24|||October 2006||2006-10-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|December 2017|Anticipated|2017-12-01||Interventional|PORTEC-3||Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer|Randomized Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy With Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma: PORTEC-3|Active, not recruiting||Phase 3|670|Anticipated|Leiden University Medical Center||2|||f||||t||||||||Undecided|Will be decided with international participating groups at time of final analysis|2017-02-18 16:01:43.470095|2017-02-18 16:01:43.470095
NCT00410722|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2013-01-08|||December 2006||2006-12-01|January 2013|2013-01-01||||December 2008|Actual|2008-12-01||Interventional|||Effect of Nuts vs. a Wheat Bran Muffin in Type 2 Diabetes|Effect of Nuts on Glycemic Control and Cardiovascular Disease Risk in Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|University of Toronto||3|||f||||||||||||||2017-02-18 16:01:48.547301|2017-02-18 16:01:48.547301
NCT00411125|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2006-12-11|||August 2006||2006-08-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Interventional|||Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women|A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled Crossover Phase I Study Assessing Pharmacokinetics and Pharmacodynamics of Two Different SMC021 0.8 mg Variants and the Effect of Timing of Drug Intake in Healthy Postmenopausal Women|Completed||Phase 1|86||Novartis|||||f||||||||||||||2017-02-18 16:01:43.601594|2017-02-18 16:01:43.601594
NCT00411112|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2009-01-09|||March 2007||2007-03-01|January 2009|2009-01-01||||March 2013|Anticipated|2013-03-01||Interventional|||Sentinel Node in Colon Cancer|Sentinel Node Study in Colon Cancer Surgery|Unknown status|Recruiting|N/A|140|Anticipated|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-02-18 16:01:43.688832|2017-02-18 16:01:43.688832
NCT00411099|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2012-05-02||2012-05-02|December 2006||2006-12-01|May 2012|2012-05-01||||January 2008|Actual|2008-01-01||Interventional|||Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder|An 8-week, Randomized, Double-blind, Fixed Dosage, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy, Safety and Tolerability of Agomelatine 25 mg and 50 mg in the Treatment of Major Depressive Disorder (MDD) Followed by a 52-week, Open-label Extension (CAGO178A2301E)|Completed||Phase 3|508|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:01:43.768869|2017-02-18 16:01:43.768869
NCT00411086|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-11-04|||November 2006||2006-11-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma|Single-Arm, Open-Label, Phase II Trial of Rituximab Plus Sargramostim for the Treatment of Newly Diagnosed Follicular B-Cell Lymphoma in Adults|Completed||Phase 2|52|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 16:01:43.906624|2017-02-18 16:01:43.906624
NCT00411073|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2016-10-27|||December 2006||2006-12-01|October 2016|2016-10-01||||||||Interventional|||Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart|A Study to Evaluate the Effect of Repeat Oral Doses of Darapladib on Cardiac Conduction as Compared to Placebo and a Single Oral Dose of Moxifloxacin|Completed||Phase 1|72|Anticipated|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:01:44.020148|2017-02-18 16:01:44.020148
NCT00411060|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2016-12-06|||January 2007||2007-01-01|December 2016|2016-12-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Clinical Orthopaedic Data Bank (Acute and Chronic)|Orthopaedic Data Bank; Collection and Storage of Data Relating to Orthopaedic Disorders|Recruiting||N/A|10000|Anticipated|University of Florida|||1||f||||f||||||||||2017-02-18 16:01:44.111965|2017-02-18 16:01:44.111965
NCT00411047|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2013-05-12|||September 2005||2005-09-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|January 2007|Actual|2007-01-01||Interventional|||Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II, Open Label Study of Gefitinib (IRESSA) in Treatment-Naïve Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer and Somatic Activating Mutations in the Epidermal Growth Factor Receptor|Completed||Phase 2|34|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:01:44.206712|2017-02-18 16:01:44.206712
NCT00411034|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-04-26||||||April 2010|2010-04-01|September 1999|Actual|1999-09-01|||||Interventional|||A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain|A Repeated-Dose Evaluation of Analgesic Use and Safety of Dilaudid SR( Hydromorphone HCI) in Patients With Chronic Cancer Pain|Completed||Phase 3|463|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:44.311327|2017-02-18 16:01:44.311327
NCT00411021|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2006-12-12||||||December 2006|2006-12-01||||||||Interventional|||Endometrial Sampling (Pipelle)in IVF Patients|Endometrial Sampling (Pipelle)in IVF Patients|Unknown status|Recruiting|N/A|70||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:01:44.387653|2017-02-18 16:01:44.387653
NCT00410995|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2007-10-10|||May 2004||2004-05-01|October 2007|2007-10-01|August 2006|Actual|2006-08-01|||||Interventional|||Effects of Naproxen on Physical Performance|Effects of Naproxen on Physical Performance|Terminated||Phase 4|40||University of Oklahoma||||Study never initiated.|f||||||||||||||2017-02-18 16:01:44.459014|2017-02-18 16:01:44.459014
NCT00410982|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-06-01|||December 2006||2006-12-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies|Gemcitabine Combined With Busulfan and Melphalan, With Hematopoietic Cell Transplantation, for Patients With Poor-prognosis Advanced Lymphoid Malignancies|Completed||Phase 1|145|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:01:44.633369|2017-02-18 16:01:44.633369
NCT00410969|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2008-09-25|||December 2006||2006-12-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|February 2008|Actual|2008-02-01||Interventional|||Pilot Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients|Pilot Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients|Completed||Phase 1|27|Anticipated|Life Recovery Systems||1|||f||||t||||||||||2017-02-18 16:01:44.753504|2017-02-18 16:01:44.753504
NCT00410956|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-10-24|||May 2007||2007-05-01|October 2016|2016-10-01||||July 2017|Anticipated|2017-07-01||Interventional|||Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery|A Phase II Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Bevacizumab (A Monoclonal Antibody to Vascular Endothelial Growth Factor-A), in Patients With Unresectable Primary Hepatic Malignancy|Active, not recruiting||Phase 2|55|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:01:44.876952|2017-02-18 16:01:44.876952
NCT00410943|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-04-26||||||April 2010|2010-04-01|June 1999|Actual|1999-06-01|||||Interventional|||Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain|A Randomized, Double-Blind, Repeated Dose, Parallel-Group Comparison of the Efficacy & Tolerability of Dilaudid SR Tablets and Immediate Release Dilaudid Tablets (Hydromorphone HCI) in Patients With Chronic Pain|Completed||Phase 3|169|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:44.995747|2017-02-18 16:01:44.995747
NCT00410930|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2006-12-15|||November 2002||2002-11-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients|Double-Blind Placebo-Controlled Study of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients|Terminated||Phase 2|160||Stallergenes|||||f||||||||||||||2017-02-18 16:01:45.089145|2017-02-18 16:01:45.089145
NCT00410904|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2014-09-19|2013-12-23||October 2006||2006-10-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|July 2013|Actual|2013-07-01||Interventional|||AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer|Phase 2 Study of AZD2171 (NSC 732208) in Combination With Pemetrexed in Relapsed Non-Small Cell Lung Cancer (NOS: 10029514)|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)|Pemetrexed was approved for front line therapy based on the results of a phase III study; it became known that pemetrexed is ineffective in pts.with squamous cell lung ca. It was also challenging to combine VEGF-TKIS with chemo this pt. population.|1|||f||||||||||||||2017-02-18 16:01:45.182549|2017-02-18 16:01:45.182549
NCT00410891|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2014-05-13|2014-05-13||July 2008||2008-07-01|May 2014|2014-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||patient undergoing IVT|Topical Antibiotics and Intravitreous Injections||Completed||Phase 4|129|Actual|Stanford University||1|||f||||||||||||||2017-02-18 16:01:45.846191|2017-02-18 16:01:45.846191
NCT00410878|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2017-02-15||||||April 2010|2010-04-01|August 1999|Actual|1999-08-01|||||Interventional|||A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain|A Repeated-Dose Pharmacokinetic Evaluation of Dilaudid SR Tablets (Hydromorphone HCI) in Patients With Chronic Pain|Completed||Phase 1|22|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:46.044913|2017-02-18 16:01:46.044913
NCT00410865|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2011-12-06|||June 2003||2003-06-01|December 2011|2011-12-01|November 2010|Actual|2010-11-01|March 2008|Actual|2008-03-01||Interventional|||Wild Type p53 Adenovirus for Oral Premalignancies|Clinical Protocol for Wild Type p53 Gene Induction in Premalignancies of Squamous Epithelium of the Oral Cavity and Oral Pharynx Via an Adenoviral Vector [NCI Supplied Agent Ad-p53, (INGN 201) (Advexin®) NSC 683550, IND# 7135]|Terminated||Phase 1|4|Actual|M.D. Anderson Cancer Center||1||Sponsor withdrawl prior to study completion.|f||||t||||||||||2017-02-18 16:01:46.12933|2017-02-18 16:01:46.12933
NCT00410852|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2007-10-31|||May 2005||2005-05-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Interventional|||Efficacy and Safety of Three Insulin Protocols in Medical Intensive Care Unit Patients|Randomized Study to Evaluate the Efficacy and Safety of Two Endovenous Insulin Protocols and a Subcutaneous Insulin Protocol in Critically Ill Patients|Completed||N/A|168|Actual|Hospital Israelita Albert Einstein||3|||f||||f||||||||||2017-02-18 16:01:46.254137|2017-02-18 16:01:46.254137
NCT00410839|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2006-12-12|||June 1999||1999-06-01|August 2004|2004-08-01|June 2003||2003-06-01|||||Interventional|||Studies of the Prevention of Atrial Fibrillation by ALA|Prevention of Atrial Fibrillation Recurrence By An Alpha-Linolenic Enriched Diet - A Pilot Study|Unknown status|Active, not recruiting|Phase 2|130||University of Toronto|||||f||||||||||||||2017-02-18 16:01:46.382793|2017-02-18 16:01:46.382793
NCT00410826|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2013-05-08|2012-12-14||June 2006||2006-06-01|May 2013|2013-05-01||||May 2012|Actual|2012-05-01||Interventional||204 patients were randomized. However, after completing study therapy, it became apparent that one participant had metastatic disease and was therefore, ineligible for study. This participant was excluded from subsequent results presented here.|Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Multicenter Randomized Phase II Study of Erlotinib, Cisplatin and Radiotherapy Versus Cisplatin and Radiotherapy in Patients With Stage III and IV Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|204|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:01:46.494941|2017-02-18 16:01:46.494941
NCT00410813|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2013-05-22|||March 2007||2007-03-01|May 2013|2013-05-01|September 2013|Anticipated|2013-09-01|January 2012|Actual|2012-01-01||Interventional|||S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone|Phase II Studies of Two Different Schedules of Dasatinib (NSC-732517) in Bone Metastasis Predominant Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 16:01:46.979867|2017-02-18 16:01:46.979867
NCT00410800|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2017-01-24|||August 19, 1996||1996-08-19|August 16, 2011|2011-08-16|August 16, 2011||2011-08-16|||||Observational|||Insulin Secretory Defects in Pima Indians at High Risk for NIDDM|Insulin Secretory Defects in Pima Indians at High Risk for NIDDM|Completed||N/A|310|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:01:47.21405|2017-02-18 16:01:47.21405
NCT00410787|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-04-26||||||April 2010|2010-04-01|April 2002|Actual|2002-04-01|||||Interventional|||Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain|Safety and Tolerability of Long-Term Administration of Dilaudid SR (Hydromorphone HCI) in Cancer Pain|Completed||Phase 3|68|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:47.299907|2017-02-18 16:01:47.299907
NCT00410774|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2012-09-13|||July 2006||2006-07-01|September 2012|2012-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery|A Phase I/II Study of Fixed-Dose Rate Gemcitabine and Bevacizumab for Postoperative Adjuvant Treatment of Patients With Resected Pancreatic Cancer|Terminated||Phase 1/Phase 2|20|Anticipated|University of California, San Francisco||1||low accrual-no data available|f||||t||||||||||2017-02-18 16:01:47.376245|2017-02-18 16:01:47.376245
NCT00410761|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2016-08-26|2011-04-27||November 2006||2006-11-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|July 2009|Actual|2009-07-01||Interventional|||An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer|An International, Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (ZACTIMATM) Versus Placebo in Subjects With Unresectable Locally Advanced or Metastatic Medullary Thyroid Cancer|Active, not recruiting||Phase 3|437|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:01:47.485036|2017-02-18 16:01:47.485036
NCT00410748|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-04-26||||||April 2010|2010-04-01|June 2000|Actual|2000-06-01|||||Interventional|||Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)|Safety and Tolerability of Long-term Administration of Dilaudid CR (Hydromorphone HCI)|Completed||Phase 3|388|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:48.350589|2017-02-18 16:01:48.350589
NCT00410735|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2012-06-12|||December 2006||2006-12-01|June 2012|2012-06-01||||June 2008|Actual|2008-06-01||Interventional|||Study of ONO-1078 in Patients With Chronic Sinusitis|Study of ONO-1078 in Patients With Chronic Sinusitis, a Double-blind, Randomized, Placebo-controlled, Parallel Group, Multi-center Study|Completed||Phase 3|495|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||||||||||||2017-02-18 16:01:48.428345|2017-02-18 16:01:48.428345
NCT00339365|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2012-05-16|||April 2007||2007-04-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Interventional|||Promoting Infant Mental Health in Foster Care|Promoting Infant Mental Health in Foster Care|Completed||Phase 2/Phase 3|236|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 16:27:51.869517|2017-02-18 16:27:51.869517
NCT00410709|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2008-07-31|||December 2006||2006-12-01|July 2008|2008-07-01|January 2007|Actual|2007-01-01|||||Interventional|||A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age|A Phase 1B Single Treatment, Pharmacokinetic and Tolerance Study of NatroVA Topical Creme (1%) i Pediatric Subjects 6 to 24 Months of Age|Completed||Phase 1|6|Actual|ParaPRO LLC||1|||f||||f||||||||||2017-02-18 16:01:48.649952|2017-02-18 16:01:48.649952
NCT00410696|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2013-06-28|||September 2006||2006-09-01|June 2013|2013-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy|Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy With Peripheral Autologous Stem Cell Reinfusion in Patients With Hematological Neoplasms and Solid Tumors: Phase II Randomised Trial|Completed||Phase 2|80|Actual|Istituto Clinico Humanitas||2|||f||||t||||||||||2017-02-18 16:01:48.734588|2017-02-18 16:01:48.734588
NCT00410683|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-06-09|||February 2007||2007-02-01|June 2016|2016-06-01|February 2022|Anticipated|2022-02-01|February 2017|Anticipated|2017-02-01||Interventional|LUNG ART||Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery|Phase III Study Comparing Post-Operative Conformal Radiotherapy to No Post-Operative Radiotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer and Mediastinal N2 Involvement [Lung ART]|Recruiting||Phase 3|700|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||t||||||||||2017-02-18 16:01:48.846511|2017-02-18 16:01:48.846511
NCT00410670|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2017-01-24|||June 30, 2003||2003-06-30|December 16, 2016|2016-12-16||||||||Observational|||Chordoma Family Study|The Chordoma Family Study: A Pilot Collaboration Between NCI and Massachusetts General Hospital (MGH) to Identify Chordoma Families|Completed||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:01:48.963213|2017-02-18 16:01:48.963213
NCT00410657|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2010-05-12|||July 2006||2006-07-01|May 2010|2010-05-01||||November 2006|Actual|2006-11-01||Interventional|||Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant|A Phase II Study to Evaluate Low-Dose Alemtuzumab as a Glucocorticoid-Sparing Agent for Initial Systemic Treatment of Acute Graft-Versus-Host Disease|Completed||Phase 2|53|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 16:01:49.054525|2017-02-18 16:01:49.054525
NCT00410644|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-04-26||||||April 2010|2010-04-01|February 1999|Actual|1999-02-01|||||Interventional|||A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain|A Repeated-Dose Evaluation of Analgesic Use and Safety of Dilaudid SR (Hydromorphone HCI) in Patients With Chronic Non-Malignant Pain|Completed||Phase 3|463|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:49.167511|2017-02-18 16:01:49.167511
NCT00410631|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2013-08-06|||October 2004||2004-10-01|January 2008|2008-01-01||||December 2010|Anticipated|2010-12-01||Interventional|||Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma|NB2004 Trial Protocol for Risk Adapted Treatment of Children With Neuroblastoma|Unknown status|Recruiting|Phase 3|642|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:01:51.919738|2017-02-18 16:01:51.919738
NCT00410618|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2015-12-02|||April 2003||2003-04-01|August 2012|2012-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer|Neurological Effects of Chemotherapy and Radiation Treatment: Colon Cancer|Completed||N/A|42|Anticipated|University of Arizona|||1||f||||||||||||||2017-02-18 16:01:52.12132|2017-02-18 16:01:52.12132
NCT00410605|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2014-04-09|||November 2006||2006-11-01|April 2014|2014-04-01||||December 2011|Actual|2011-12-01||Interventional|||Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma|Phase II Trial of Bevacizumab Combined With Lenalidomide and Dexamethasone (BEV/REV/DEX) in Relapsed or Refractory Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:01:52.22158|2017-02-18 16:01:52.22158
NCT00410592|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2009-03-10|||October 2006||2006-10-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|||||Interventional|||Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD|A Randomized, Open-Label, Comparative 3-Way Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40 mg, Lansoprazole 30 mg, and Pantoprazole 40 mg at Steady State in Hispanic Patients With Symptomatic GERD|Completed||Phase 4|90|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:01:52.332389|2017-02-18 16:01:52.332389
NCT00410579|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2010-12-15|||November 2006||2006-11-01|December 2010|2010-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers|Patient Reported Outcomes in Long Term Survivors With Colon and Rectal Cancer|Completed||N/A|744|Actual|NSABP Foundation Inc|||1||f||||f||||||||||2017-02-18 16:01:52.669758|2017-02-18 16:01:52.669758
NCT00410566|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2015-03-17|||December 2006||2006-12-01|March 2015|2015-03-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)|A Phase I, Single-Center, Single Dose, Dose Escalation Study of Recombinant Human Acid Sphingomyelinase (rhASM) in Adults With Acid Sphingomyelinase Deficiency (ASMD)|Terminated||Phase 1|11|Actual|Sanofi||5||Terminated by sponsor - Single dose safety objective achieved.|f||||t||||||||||2017-02-18 16:01:52.982366|2017-02-18 16:01:52.982366
NCT00410553|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2017-01-31|||November 2006||2006-11-01|November 2016|2016-11-01||||October 2012|Actual|2012-10-01||Interventional|||Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery|A Phase I Study of Halichondrin B Analog E7389 in Combination With Gemcitabine in Patients With Refractory or Advanced Solid Tumors|Active, not recruiting||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:01:53.099778|2017-02-18 16:01:53.099778
NCT00410540|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2010-04-26||||||April 2010|2010-04-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.|A Randomized, Double-Blind, Controlled Trial of Hydromorphone (Immediate and Sustained- Release) vs Morphine (Immediate and Sustained-release) in Cancer Pain|Completed||Phase 3|202|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:01:53.21897|2017-02-18 16:01:53.21897
NCT00406471|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2013-03-12|||May 2005||2005-05-01|March 2013|2013-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion|Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion|Completed||Phase 1|20|Actual|Greater Houston Retina Research||2|||f||||||||||||||2017-02-18 16:03:34.808462|2017-02-18 16:03:34.808462
NCT00410527|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2017-01-24|||August 11, 2006||2006-08-11|May 22, 2007|2007-05-22|May 22, 2007||2007-05-22|||||Interventional|||Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients|Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)|Completed||Phase 4|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:01:53.310298|2017-02-18 16:01:53.310298
NCT00410514|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2014-03-07|2012-08-02||December 2006||2006-12-01|September 2012|2012-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)|A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled, Multi-center Study to Evaluate the Urodynamics and Safety of YM178 in Male Subjects With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)|Completed||Phase 2|200|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|3|||f||||f||||||||||2017-02-18 16:01:53.428319|2017-02-18 16:01:53.428319
NCT00410501|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2007-06-18|||December 2006||2006-12-01|June 2007|2007-06-01||||||||Interventional|||Evaluation of Pharmacokinetic Interaction of Indacaterol With Ketoconazole in Healthy Adult Subjects|An Open Label, Single Dose, Two Period, Single Sequence Crossover Study to Assess the Pharmacokinetic Interaction of QAB149 (300 Mcg Via Inhalation) With Ketoconazole (200 mg Tablet b.i.d.) in Healthy Adult Subjects|Completed||Phase 1|20|Anticipated|Novartis|||||f||||f||||||||||2017-02-18 16:01:54.824197|2017-02-18 16:01:54.824197
NCT00410488|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2013-02-19|2012-06-28||December 2006||2006-12-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)|Dose/Schedule Finding Study of Palonosetron in Sarcoma Patients Receiving Multi-Day Chemotherapy With Adriamycin and Ifosfamide (AI)|Completed||N/A|51|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 16:01:54.908486|2017-02-18 16:01:54.908486
NCT00410475|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-12|2017-01-24|||September 8, 1997||1997-09-08|November 2, 2016|2016-11-02||||||||Observational|||Cancer Risk in X-Ray Technologists: Second Survey|Cancer Risk in X-Ray Technologists|Completed||N/A|146022|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:01:55.236377|2017-02-18 16:01:55.236377
NCT00410462|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2014-08-07|||October 2006||2006-10-01|July 2010|2010-07-01||||September 2008|Actual|2008-09-01||Interventional|||Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma|Randomized Phase II Study of Brostallicin (PNU-166196A) Versus Doxorubicin as First Line Chemotherapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma|Unknown status|Active, not recruiting|Phase 2|118|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 16:01:55.335177|2017-02-18 16:01:55.335177
NCT00410449|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2015-10-05|||May 2001||2001-05-01|December 2006|2006-12-01|May 2004||2004-05-01|||||Observational|||Oxidative Stress and Hemodialysis Access Failure|Study of the Effect of Oral Supplementation With Vitamin E on Circulating Oxidative Markers, Hemodialysis Vascular Access Occlusion, and Clinical Events in Patients With End Stage Renal Failure Treated by Hemodialysis|Completed||Phase 4|35||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 16:01:55.447148|2017-02-18 16:01:55.447148
NCT00410436|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2013-02-25|||October 2006||2006-10-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Resistance Exercise in Already-active Diabetic Individuals (READI) Trial|Resistance Exercise in Already-active Diabetic Individuals (READI) Trial|Completed||Phase 4|131|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 16:01:55.548822|2017-02-18 16:01:55.548822
NCT00410423|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2015-05-15|||January 2006||2006-01-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|May 2013|Actual|2013-05-01||Interventional|||Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias|Phase I/II Trial of VELCADE® (Bortezomib) in Combination With Mitoxantrone and Etoposide for Relapsed or Refractory Acute Leukemias|Completed||Phase 1/Phase 2|55|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 16:01:55.656835|2017-02-18 16:01:55.656835
NCT00410410|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2015-03-04|2010-08-12||December 2006||2006-12-01|March 2015|2015-03-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Abatacept in Patients With Active Ulcerative Colitis|A Phase 3, Multi-Center, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With Abatacept in Subjects With Active Ulcerative Colitis (UC) Who Have Had an Inadequate Clinical Response and/or Intolerance to Medical Therapy|Completed||Phase 3|591|Actual|Bristol-Myers Squibb|This study was terminated after review of the IP1C results due to lack of efficacy. Enrollment for the MP and for IP2C was not completed. Participants in MP, IP2C, and OL were early terminated at the time of study termination.|3|||f||||t||||||||||2017-02-18 16:01:56.051141|2017-02-18 16:01:56.051141
NCT00410397|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2008-01-08|||December 2006||2006-12-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||The Use of Manual Therapy to Treat Low-Back and Hip Pain|The Use of Myofascial Release in Lumbopelvic Pain|Completed||N/A|27|Actual|Oklahoma State University Center for Health Sciences||2|||f||||f||||||||||2017-02-18 16:02:00.617784|2017-02-18 16:02:00.617784
NCT00410384|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2016-12-02|2011-04-07||December 2006||2006-12-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|BLISS-76||A Study of Belimumab in Subjects With Systemic Lupus Erythematosus|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 76-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 3|819|Actual|Human Genome Sciences Inc.||3|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:02:00.753589|2017-02-18 16:02:00.753589
NCT00410371|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-10-26|||December 2006||2006-12-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study to Compare Two Formulations of Lamotrigine in Healthy Subjects|An Open-label, Randomised, Single-dose, Parallel-group Study to Evaluate the Pharmacokinetic Characteristics, Safety and Tolerability of up to Two Formulations (With Different Taste Masking Approaches) of an Orally Disintegrating Tablet (ODT) of Lamotrigine at 25mg and 200mg Versus the Immediate Release (IR) Lamotrigine in Healthy Subjects|Completed||Phase 1|96|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:02:02.713053|2017-02-18 16:02:02.713053
NCT00410358|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2012-10-15|||June 2006||2006-06-01|October 2012|2012-10-01||||February 2008|Actual|2008-02-01||Interventional|||A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.|A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor.|Completed||Phase 1|19|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:02:02.816141|2017-02-18 16:02:02.816141
NCT00410345|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2008-11-02|||August 2004||2004-08-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|||||Interventional|||Cervical Rippening With Antiprogesterone in Midtrimester Abortions|Cervical Rippening With Antiprogesterone in Midtrimester Abortions|Completed||Phase 4|50|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:02:02.921561|2017-02-18 16:02:02.921561
NCT00410332|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2012-02-19|||March 2011||2011-03-01|February 2012|2012-02-01||||December 2012|Anticipated|2012-12-01||Interventional|||Traumeel for Post-Tonsillectomy Pain|A Randomized, Double-Blind, Placebo-Controlled Pilot Study for Evaluating the Efficacy of the Homeopathic Remedy Traumeel S on Pain Reduction Following Tonsillectomy in Adult Patients.|Unknown status|Recruiting|Phase 3|20|Anticipated|Shaare Zedek Medical Center||2|||f||||||||||||||2017-02-18 16:02:03.01162|2017-02-18 16:02:03.01162
NCT00410319|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2007-04-25||||||April 2007|2007-04-01||||||||Interventional|||Information or Physical Activity for Chronic LBP||Unknown status|Active, not recruiting|N/A|||University of Southern Denmark|||||f||||||||||||||2017-02-18 16:02:03.103374|2017-02-18 16:02:03.103374
NCT00410306|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2010-09-23|||October 2006||2006-10-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|IPASS Nebido||Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice|International, Multi-center Post Authorization Surveillance Study on the Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice (IPASS Nebido)|Completed||N/A|1493|Actual|Bayer|||1||f||||f||||||||||2017-02-18 16:02:03.1738|2017-02-18 16:02:03.1738
NCT00410293|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2006-12-11|||December 2004||2004-12-01|December 2006|2006-12-01|August 2006||2006-08-01|||||Interventional|||NT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and Costs|NT-proBNP Testing in Patients Presenting to the Emergency Department With Acute Dyspnea: Evaluation of Effects on Treatment, Hospitalisation Rate and Costs|Completed||N/A|500||Erasmus Medical Center|||||f||||||||||||||2017-02-18 16:02:03.413593|2017-02-18 16:02:03.413593
NCT00410280|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2014-11-07|2014-11-07||March 2007||2007-03-01|November 2014|2014-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Intent-to-treat population (ITT) included all randomized participants who received at least 1 dose administration of the test article.|Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma|Allergen Challenge|Completed||Phase 2|30|Actual|Pfizer|The study was stopped early due to futility of the interim efficacy analysis results. Hence, only safety results and key efficacy results were presented for this study.|1|||f||||f||||||||||2017-02-18 16:02:03.511786|2017-02-18 16:02:03.511786
NCT00410267|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-08-08|||February 2006||2006-02-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells|A Randomized Prospective Double - Masked Controlled Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-Selective Laser Trabeculoplasty Anterior Chamber Flare and Cells|Terminated||N/A|1|Actual|University of Pittsburgh|||1|low recruitment|f||||f||||||||No||2017-02-18 16:02:04.424672|2017-02-18 16:02:04.424672
NCT00410254|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2007-12-03|||June 2007||2007-06-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects|An Open Label, Single-Dose Midazolam, Multiple-Dose HCV-796, Sequential 3-Period Study to Determine the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Midazolam|Completed||Phase 1|38|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:02:04.521679|2017-02-18 16:02:04.521679
NCT00410241|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-09|2017-01-24|||December 7, 2006||2006-12-07|November 3, 2016|2016-11-03||||||||Observational|||ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study|ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:02:04.603553|2017-02-18 16:02:04.603553
NCT00410228|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2007-06-21|||June 2006||2006-06-01|June 2007|2007-06-01||||||||Interventional|||Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects|A Single Center, Randomized, Double-Blind, Placebo-and Positive-Controlled, Interleaved, Ascending Single Dose Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHTT956 in Healthy Subjects|Completed||Phase 1|42||Novartis|||||f||||||||||||||2017-02-18 16:02:04.714299|2017-02-18 16:02:04.714299
NCT00410215|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2015-09-18|||February 2006||2006-02-01|September 2015|2015-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to Colonoscopy|A Randomized Controlled Trial Comparing Picosalax and Oral Sodium Phosphate for Colon Cleansing Prior to Colonoscopy|Completed||Phase 4|315|Actual|Queen's University||3|||f||||f||||||||||2017-02-18 16:02:04.791854|2017-02-18 16:02:04.791854
NCT00410202|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2013-10-29|2012-04-24||March 2008||2008-03-01|October 2013|2013-10-01|July 2012|Actual|2012-07-01|January 2011|Actual|2011-01-01||Interventional|DEFINE||Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus|A Comparative Study of Entecavir vs. Adefovir Plus Lamivudine vs Combination Entecavir Plus Adefovir in Lamivudine-resistant Chronic Hepatitis B Subjects: The DEFINE Study|Completed||Phase 3|629|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 16:02:04.912105|2017-02-18 16:02:04.912105
NCT00410189|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2015-03-17|2015-03-17||November 2006||2006-11-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC|A Phase II, Open Label Study of ZD6474 in Previously Treated Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|54|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 16:02:07.294022|2017-02-18 16:02:07.294022
NCT00410176|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2006-12-11|||January 2007||2007-01-01|December 2006|2006-12-01||||||||Interventional|||A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family||Unknown status|Not yet recruiting|N/A|400||Ministry of Health, Israel|||||f||||||||||||||2017-02-18 16:02:08.008954|2017-02-18 16:02:08.008954
NCT00410163|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2013-12-19|2011-07-28||January 2007||2007-01-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|March 2009|Actual|2009-03-01||Interventional|BIFROST||Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients|An Open-labeled, Randomized, Two-dose, Parallel Group Trial of Ofatumumab, a Fully Human Monoclonal Anti-CD20 Antibody, in Combination With Fludarabine and Cyclophosphamide, in Patients With Previously Untreated B-cell CLL|Completed||Phase 2|61|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 16:02:08.090548|2017-02-18 16:02:08.090548
NCT00410150|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2010-10-22|2010-09-15||April 2006||2006-04-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation|A Prospective, Randomized, Controlled, Single Center Trial of the Use of Heliox in Children Admitted to the Hospital With Status Asthmaticus|Terminated||Phase 2|42|Actual|Children's Hospital Medical Center, Cincinnati||2||Study was stopped after interim analysis and slow enrollment.|f||||t||||||||||2017-02-18 16:02:09.18083|2017-02-18 16:02:09.18083
NCT00410137|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-10|2006-12-11|||March 2006||2006-03-01|December 2006|2006-12-01|April 2008||2008-04-01|||||Observational|||Influence of Nutritional and Inflammational Status on Survival of Hemodialysis Patients||Unknown status|Recruiting|N/A|100||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 16:02:09.574265|2017-02-18 16:02:09.574265
NCT00410124|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2012-12-07|2012-10-23||November 2006||2006-11-01|December 2012|2012-12-01|October 2011|Actual|2011-10-01|February 2008|Actual|2008-02-01||Interventional|RECORD-1||RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib|A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Compare the Safety and Efficacy of RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed on VEGF Receptor Tyrosine Kinase Inhibitor|Completed||Phase 3|416|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:02:09.661127|2017-02-18 16:02:09.661127
NCT00410111|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2008-10-15|||January 2007||2007-01-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|||||Observational|||Pathogenesis and Cerebrovascular Manifestations of Septic Encephalopathy|A Pilotstudy on Pathogenesis and Cerebrovascular Manifestations of Septic Encephalopathy|Completed||N/A|23|Actual|University Hospital, Basel, Switzerland|||1||f||||||||||||||2017-02-18 16:02:11.483204|2017-02-18 16:02:11.483204
NCT00410098|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-10|2006-12-11|||June 2007||2007-06-01|December 2006|2006-12-01||||||||Interventional|||Bikram Yoga and Asthma|The Influence of Bikram Yoga (39 Degree Celsius Heat and 60% Humidity) on Basic Lung Function Tests,Bronchial Challenges and Pulmonary-Heart Endurance in Young Asthmatic Adults.|Unknown status|Not yet recruiting|N/A|30|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:02:11.556704|2017-02-18 16:02:11.556704
NCT00410085|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-10|2008-04-17|||January 2005||2005-01-01|April 2008|2008-04-01|November 2005||2005-11-01|||||Interventional|||Renal Hemodynamics and Tubular Function in Patients With Obstructive Sleep Apnea and Healthy Controls||Completed||Phase 4|40||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:02:11.6337|2017-02-18 16:02:11.6337
NCT00410072|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2013-03-13|2011-11-04||April 2007||2007-04-01|March 2013|2013-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B|A Comparative Study of Chronic Hepatitis B Subjects Treated With Entecavir Plus Tenofovir Combination Therapy vs. Entecavir Monotherapy in Adults Who Are Treatment-Naive to Nucleosides and Nucleotides: The BE-LOW Study|Completed||Phase 3|669|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 16:02:11.728701|2017-02-18 16:02:11.728701
NCT00410059|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2016-08-05|||November 2006||2006-11-01|August 2016|2016-08-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC|A Phase II, Open Label Study of Erlotinib (Tarceva) in Previously Treated Subjects With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|59|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 16:02:13.479982|2017-02-18 16:02:13.479982
NCT00410046|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2012-04-09|2009-10-30||December 2006||2006-12-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Extension Study Evaluating Etanercept in Ankylosing Spondylitis|An Open-label, Multicentre, Supplementary Extension Study of Etanercept in Subjects With Ankylosing Spondylitis|Completed||Phase 4|84|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 16:02:13.601464|2017-02-18 16:02:13.601464
NCT00410033|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-12-21|||December 1989||1989-12-01|December 2016|2016-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin|Safety/Efficacy Trial Using Stored Serum Samples to Investigate the Immunogenicity of Insulin Aspart and Soluble Human Insulin in Children and Adolescents From Onset of Type 1 Diabetes|Completed||N/A|74|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:02:14.126927|2017-02-18 16:02:14.126927
NCT00410020|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2006-12-11|||June 1999||1999-06-01|December 2006|2006-12-01|June 2003||2003-06-01|||||Interventional|||Arrhythmia Prevention With an Alpha-Linolenic Enriched Diet|Secondary Prevention of Atrial Fibrillation With an Alpha-Linolenic Enriched Diet : a Randomized Study|Completed||Phase 2|130||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:02:14.222093|2017-02-18 16:02:14.222093
NCT00410007|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-10|2011-12-04|||October 2006||2006-10-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|October 2010|Actual|2010-10-01||Interventional|||The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease|The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease, During Basal Conditions and After Hypertonic Saline Infusion.|Completed||N/A|29|Actual|Regional Hospital Holstebro||1|||f||||f||||||||||2017-02-18 16:02:14.315537|2017-02-18 16:02:14.315537
NCT00409994|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2016-01-27|||September 2006||2006-09-01|January 2016|2016-01-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer|A Clinical Trial Testing Rapamycin, an mTOR-inhibitor, in Combination With Preoperative Radiotherapy in Operable Rectum Cancer: a Phase I and Phase II Study|Active, not recruiting||Phase 1/Phase 2|65|Anticipated|Maastricht Radiation Oncology||1|||f||||t||||||||||2017-02-18 16:02:14.405468|2017-02-18 16:02:14.405468
NCT00409981|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2006-12-11|||July 2004||2004-07-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH – ISR II)|Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH – ISR II)|Completed||Phase 1/Phase 2|56||University Hospital, Saarland|||||f||||||||||||||2017-02-18 16:02:14.523359|2017-02-18 16:02:14.523359
NCT00409968|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2016-05-12|||November 2006||2006-11-01|May 2016|2016-05-01||||November 2018|Anticipated|2018-11-01||Observational|||BATTLE Program: Umbrella Protocol for Patients With Non-Small Cell Lung Cancer (NSCLC)|A Biomarker-Integrated Study in Chemorefractory Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||N/A|250|Anticipated|M.D. Anderson Cancer Center|||1||f||||t||||||Samples With DNA|"~     A sample of your tumor tissue will be collected for biomarker analysis, and based on the~     results, you will be assigned to one of four phase II studies.~   "|||2017-02-18 16:02:14.633447|2017-02-18 16:02:14.633447
NCT00409955|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2006-12-11|||December 2005||2005-12-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Lamellar Transplant With Lyophilized Corneas|Randomized Clinical Trial for Lamellar Transplants Using Lyophilized and Optisol Corneas|Completed||Phase 2|20||Federal University of São Paulo|||||f||||||||||||||2017-02-18 16:02:17.448897|2017-02-18 16:02:17.448897
NCT00409942|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2009-07-14|||March 2007||2007-03-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TORAFIC||Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure.|Prospective, Randomised, Open, Blinded-endpoint Study of Torasemide Prolonged Release vs Furosemide to Evaluate the Efficacy on Myocardial Fibrosis in Patients With Heart Failure|Completed||Phase 4|142|Actual|Ferrer Internacional S.A.||2|||f||||f||||||||||2017-02-18 16:02:17.557702|2017-02-18 16:02:17.557702
NCT00409929|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2010-10-18|||June 2006||2006-06-01|October 2010|2010-10-01||||July 2006|Actual|2006-07-01||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071|A Randomized, Double-blind, Placebo-controlled, Time Lagged, Parallel Group, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral AEB071 Doses Greater Than 500 mg in Healthy Subjects|Completed||Phase 1|16|Actual|Novartis|||||f||||||||||||||2017-02-18 16:02:17.703712|2017-02-18 16:02:17.703712
NCT00409916|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2009-06-01|||January 2007||2007-01-01|June 2009|2009-06-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing|Prevention of Heart Failure Events With Impedance Cardiography Testing (PREVENT-HF)|Unknown status|Recruiting|Phase 4|500|Anticipated|CardioDynamics||2|||f||||t||||||||||2017-02-18 16:02:17.780591|2017-02-18 16:02:17.780591
NCT00409903|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-10|2007-09-13|||November 2006||2006-11-01|September 2007|2007-09-01||||||||Interventional|||The Effect of Eprosartan on Hormones and Kidney Function in Healthy Humans.|The Effect of Eprosartan on Vasoactive Hormones and Renal Tubular Function in Healthy Humans.|Completed||Phase 4|18|Anticipated|Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:02:17.886996|2017-02-18 16:02:17.886996
NCT00409890|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-11|2006-12-11|||June 2005||2005-06-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term Pregnancies|The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term Pregnancies|Completed||Phase 2|120||University Hospital of the West Indies|||||f||||||||||||||2017-02-18 16:02:17.965237|2017-02-18 16:02:17.965237
NCT00409864|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2010-05-25|||October 2003||2003-10-01|December 2006|2006-12-01|December 2005|Actual|2005-12-01|July 2005|Actual|2005-07-01||Interventional|||Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer|Endoscopic Versus Percutaneous Biliary Drainage For Hilar Block Due to Carcinoma Gall Bladder: A Randomized Prospective Trial and Quality Of Life Assessment|Completed||N/A|182|Anticipated|All India Institute of Medical Sciences, New Delhi||2|||f||||||||||||||2017-02-18 16:02:18.058362|2017-02-18 16:02:18.058362
NCT00409851|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2011-11-07|||April 2003||2003-04-01|November 2011|2011-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension|A 52 Week, Open Label Extension to the Randomized, Double-blind, Multicenter, Multifactorial, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients.|Completed||Phase 3|1293|Actual|Novartis|||||f||||||||||||||2017-02-18 16:02:18.169868|2017-02-18 16:02:18.169868
NCT00409838|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2013-08-06|2009-11-16||April 2007||2007-04-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|July 2008|Actual|2008-07-01||Interventional|||A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate|A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Abatacept Administered Intravenously in Korean Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate|Completed||Phase 3|113|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 16:02:18.525502|2017-02-18 16:02:18.525502
NCT00409825|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2015-02-09|2015-01-13||March 2006||2006-03-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|April 2008|Actual|2008-04-01||Interventional|||Study of Pharmacology of 17-OHPC in Pregnancy|A Study of the Pharmacology of 17-Hydroxyprogesterone Caproate in Pregnancy|Completed||Phase 2|61|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:02:19.978024|2017-02-18 16:02:19.978024
NCT00409812|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2007-01-18|||February 2007||2007-02-01|January 2007|2007-01-01||||||||Observational|||A Study of the Effects of Sodium Citrate on Olfactory Thresholds|A Double Blinded Randomised Controlled Trial of the Effects of Sodium Citrate on Olfactory Thresholds|Unknown status|Not yet recruiting|Early Phase 1|||University Hospitals, Leicester|||||f||||||||||||||2017-02-18 16:02:20.284811|2017-02-18 16:02:20.284811
NCT00409799|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2012-03-15|||November 2006||2006-11-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting|A Phase 2 Randomized, Controlled, Open-label (Dose-blinded), Multi-center, Dose-finding Study of the Safety and Efficacy of I-0401 in the Treatment of Patients With Fractures of the Tibial Plateau Requiring Grafting.|Completed||Phase 2|208|Actual|Kuros Biosurgery AG||3|||f||||f||||||||||2017-02-18 16:02:20.349958|2017-02-18 16:02:20.349958
NCT00409786|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2011-03-23|2011-02-23||November 2006||2006-11-01|March 2011|2011-03-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Virtual Lifestyle Management: Prevention Through the UPMC Patient Portal|Virtual Lifestyle Management: Prevention Through the UPMC Patient Portal|Completed||N/A|50|Actual|University of Pittsburgh||1|||f||||||||||||||2017-02-18 16:02:20.493246|2017-02-18 16:02:20.493246
NCT00409396|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2015-06-05|||November 2006||2006-11-01|November 2014|2014-11-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease|Urinary PGE-M, A Metabolite of PGE2: A Novel Biomarker of Ulcerative Colitis Disease|Completed||N/A|35|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:02:30.393451|2017-02-18 16:02:30.393451
NCT00409773|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2015-09-02|2009-06-16||January 2007||2007-01-01|September 2015|2015-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Parallel Arm, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Metabolic Syndrome and Hypercholesterolemia at High Risk for Coronary Heart Disease|Completed||Phase 3|1143|Actual|Merck Sharp & Dohme Corp.|15 patients were randomized but not treated. Since these patients were not treated no Adverse Event Data was collected.|5|||f||||||||||||||2017-02-18 16:02:20.742276|2017-02-18 16:02:20.742276
NCT00409760|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2011-11-22|||January 2003||2003-01-01|November 2011|2011-11-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.|A Randomized, Double-blind, Multicenter, Multifactorial, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients.|Completed||Phase 3|1930|Actual|Novartis|||||f||||||||||||||2017-02-18 16:02:22.168832|2017-02-18 16:02:22.168832
NCT00409747|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2015-11-05|2012-10-22||November 2006||2006-11-01|November 2015|2015-11-01|April 2011|Actual|2011-04-01|June 2010|Actual|2010-06-01||Interventional||10 subjects completed the trial and had analyzable data at the 6 month mark. One child had csf collected after 3 months.|Minocycline to Treat Childhood Regressive Autism|Treatment of Childhood Regressive Autism With Minocycline: an Anti-Inflammatory Agent Active Within the CNS|Completed||Phase 4|11|Actual|National Institutes of Health Clinical Center (CC)|Small, uncontrolled pilot.|1|||f||||f||||||||||2017-02-18 16:02:22.259811|2017-02-18 16:02:22.259811
NCT00409734|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2006-12-08|||October 2006||2006-10-01|November 2006|2006-11-01||||||||Observational|||Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis|Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis|Unknown status|Recruiting|N/A|100||Maimonides Medical Center|||||f||||||||||||||2017-02-18 16:02:22.506979|2017-02-18 16:02:22.506979
NCT00409721|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2011-03-01|||March 2007||2007-03-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)|A Randomized, Double-blind, Dose Ranging Study to Determine the Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Patients With ALS|Completed||Phase 2|42|Anticipated|University of Alberta||2|||f||||t||||||||||2017-02-18 16:02:22.588738|2017-02-18 16:02:22.588738
NCT00409708|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2011-04-19|2010-12-06||November 2006||2006-11-01|April 2011|2011-04-01||||March 2008|Actual|2008-03-01||Interventional|||Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)|An Open-label, Behavioral-treatment-controlled Evaluation of the Effects of Extended Release Methylphenidate on the Frequency of Cytogenetic Abnormalities in Children 6 - 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2|142|Actual|Novartis|Since no cytogenetic effects were observed, blood samples were not analyzed for pharmacokinetics/pharmacodynamics.|2|||f||||||||||||||2017-02-18 16:02:22.929466|2017-02-18 16:02:22.929466
NCT00409695|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2012-01-19|||December 2006||2006-12-01|January 2012|2012-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Thymoglobulin (ATG) Dose Finding Study|Dose Finding Study of Thymoglobulin (ATG) in Patients With Steroid-Refractory Acute Graft Versus Host Disease (aGVHD)|Terminated||Phase 1/Phase 2|1|Actual|M.D. Anderson Cancer Center||2||Lack of Accrual|f||||t||||||||||2017-02-18 16:02:23.413245|2017-02-18 16:02:23.413245
NCT00409682|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2011-07-11|2011-05-18||April 2007||2007-04-01|July 2011|2011-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease|A Multi-Center, Double-Blind Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease|Completed||Phase 3|192|Actual|Abbott|Absence of placebo group comparative data.|3|||f||||t||||||||||2017-02-18 16:02:23.538606|2017-02-18 16:02:23.538606
NCT00409669|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2008-05-06|||November 2006||2006-11-01|May 2008|2008-05-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer|Study to Compare the Accuracy and Variability of the Barraquer Tonometer With Other Methods of Tonometry|Unknown status|Recruiting|N/A|300|Anticipated|Barnes Retina Institute||1|||f||||||||||||||2017-02-18 16:02:24.506598|2017-02-18 16:02:24.506598
NCT00409656|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2006-12-12|||December 2003||2003-12-01|December 2006|2006-12-01|December 2005||2005-12-01|||||Interventional|||Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients|Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients|Completed||Phase 2|||University Hospital Freiburg|||||f||||||||||||||2017-02-18 16:02:24.601713|2017-02-18 16:02:24.601713
NCT00409643|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2011-11-07|||January 2004||2004-01-01|November 2011|2011-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients|A Randomized, Double-blind, Multicenter, Multifactorial, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan (160 mg and 320 mg) and Amlodipine (10 mg) Combined and Alone in Hypertensive Patients|Completed||Phase 3|1259|Actual|Novartis|||||f||||||||||||||2017-02-18 16:02:24.68068|2017-02-18 16:02:24.68068
NCT00409630|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2012-04-11||||||April 2012|2012-04-01||||||||Interventional|||Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate Asthma|Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate Asthma|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||||Sponsor decided against going forward with the study.|f||||||||||||||2017-02-18 16:02:24.77192|2017-02-18 16:02:24.77192
NCT00409617|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2011-10-06|2009-07-24||December 2006||2006-12-01|October 2011|2011-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease|A Multi-Center, Open-Label Study of the Fully Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Moderate to Severe Crohn's Disease|Completed||Phase 3|945|Actual|Abbott||1|||f||||f||||||||||2017-02-18 16:02:24.87335|2017-02-18 16:02:24.87335
NCT00409604|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2010-08-30|||December 2006||2006-12-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)|Clinical Evaluation of Pacing During the Onset of Revascularization / Feasibility Study|Completed||Phase 2|60|Actual|Guidant Corporation||2|||f||||||||||||||2017-02-18 16:02:25.938754|2017-02-18 16:02:25.938754
NCT00409591|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2016-01-26|||July 2008||2008-07-01|January 2016|2016-01-01|June 2015|Actual|2015-06-01|November 2010|Actual|2010-11-01||Interventional|PHPT-5||Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand|Maternal and Infant Peripartum Nevirapine, Versus Infant Only Peripartum Nevirapine, or Maternal Lopinavir/Ritonavir in Addition to Standard Zidovudine Prophylaxis for the Prevention of Perinatal HIV in Thailand.|Terminated||Phase 3|435|Actual|Institut de Recherche pour le Developpement||3||Change in National PMTCT guidelines in Thailand|f||||t||||||||||2017-02-18 16:02:26.039202|2017-02-18 16:02:26.039202
NCT00409578|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2011-04-15|2011-01-11||February 2007||2007-02-01|April 2011|2011-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome|A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multinational Clinical Trial to Evaluate the Efficacy of Aliskiren and Valsartan Versus Placebo in Lowering Levels on NT-proBNP in Stabilized Patients Post Acute Coronary Syndromes|Completed||Phase 2|1101|Actual|Novartis||4|||f||||||||||||||2017-02-18 16:02:26.218837|2017-02-18 16:02:26.218837
NCT00409565|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2016-06-01|2014-02-12||September 2006||2006-09-01|May 2016|2016-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||STARTED 46; Overall Response Rate 7; COMPLETED 45; Not Completed 1|A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer|Completed||Phase 2|48|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-02-18 16:02:27.153147|2017-02-18 16:02:27.153147
NCT00409552|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2017-01-11|||November 2009||2009-11-01|September 2009|2009-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Human Factors Analysis in VR for Burn Treatment|Phase 1 and 2 Study of Human Factors Analysis in VR for Burn Treatment|Completed||Phase 1/Phase 2|10|Actual|National Institute on Drug Abuse (NIDA)||5|||f||||||||||||||2017-02-18 16:02:27.669797|2017-02-18 16:02:27.669797
NCT00409539|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2014-12-05|2014-09-26||December 2006||2006-12-01|December 2014|2014-12-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)|A 10-week Randomised, DB, PG, PC Phase 2 Study to Investigate the Extent of Symptom Relief and the Safety and Tolerability of SMP-986 (20, 40, 80 and 120 mg) Administered Once Daily for 8 Weeks to Patients With Overactive Bladder Syndrome|Completed||Phase 2|550|Actual|Sunovion||6|||f||||f||||||||||2017-02-18 16:02:27.77258|2017-02-18 16:02:27.77258
NCT00409526|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2014-05-30|||December 2006||2006-12-01|May 2014|2014-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.|Pilot Study: The Effect of Inhaled Iloprost on Oxygenation in Term and Near Term Infants With Pulmonary Hypertension. Testing Two Doses.|Terminated||Phase 4|1|Actual|University of Chicago||1||Sub-Investigator left U of C|f||||||||||||||2017-02-18 16:02:29.35241|2017-02-18 16:02:29.35241
NCT00409500|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2007-06-21|||October 2006||2006-10-01|June 2007|2007-06-01||||||||Interventional|||Effect of Food on the Pharmacokinetics of AQW051 in Japanese Healthy Male Subjects|A Randomized, Double-Blind, Placebo-Controlled, Interleaved, Ascending Dose Study, to Evaluate Safety, Tolerability and Pharmacokinetics of Single Oral Doses of AQW051; to Evaluate the Effect of Food on the Pharmacokinetics of AQW051, in Japanese Healthy Male Subjects|Completed||Phase 1|54||Novartis|||||f||||||||||||||2017-02-18 16:02:29.456806|2017-02-18 16:02:29.456806
NCT00409487|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2010-09-07|||December 2006||2006-12-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|December 2006|Actual|2006-12-01||Interventional|VALSAS||Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients|Comparative Study of Effect of Valsartan 160mg Treatment Versus Continuous Positive Airway Pressure on Arterial Blood Pressure in Patients Who Have an Obstructive Sleep Apnea Syndrome and a Weak or Moderate Hypertension.|Completed||Phase 4|60|Anticipated|University Hospital, Grenoble||2|||f||||t||||||||||2017-02-18 16:02:29.543913|2017-02-18 16:02:29.543913
NCT00409461|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-08|2006-12-08||||||December 2006|2006-12-01||||||||Interventional|||Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts|Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts|Terminated||N/A|||AZ-VUB|||||f||||||||||||||2017-02-18 16:02:29.660277|2017-02-18 16:02:29.660277
NCT00409448|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2014-09-18|||March 2007||2007-03-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|July 2012|Actual|2012-07-01||Interventional|CAPS||Internet-Based Treatment for Children With Traumatic Brain Injuries & Their Families: Counselor Assisted Problem Solving|Improving Mental Health Outcomes of Child Brain Injury|Completed||N/A|132|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-02-18 16:02:29.737026|2017-02-18 16:02:29.737026
NCT00409435|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2016-03-14|||October 2006||2006-10-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||A Study of Pyridostigmine in Postural Tachycardia Syndrome|Double-Blind, Placebo-Controlled Study of Pyridostigmine in Postural Tachycardia Syndrome|Recruiting||N/A|50|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:02:29.845023|2017-02-18 16:02:29.845023
NCT00409422|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2008-06-20|||May 2002||2002-05-01|June 2008|2008-06-01|February 2007|Actual|2007-02-01|October 2006|Actual|2006-10-01||Interventional|||Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children|Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children|Completed||N/A|200||Yale University|||||f||||f||||||||||2017-02-18 16:02:29.960649|2017-02-18 16:02:29.960649
NCT00409409|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2016-04-18|2016-01-25||December 2006||2006-12-01|April 2016|2016-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional||The Intent-to-treat (ITT) population included all patients who received at least one dose of the investigational product and had a Retrospective Rhinoconjunctivitis Total Symptom Score (RRTSS) and at least one Rhinoconjunctivitis Total Symptom Score (RTSS) during the pollen period while on treatment.|Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis|A Randomised, Double-blind, Placebo-controlled, Multi-national, Multi-centre, Phase III Paediatric Study of the Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Administered as Allergen-based Tablets Once Daily to Children Suffering From Grass Pollen Rhinoconjunctivitis|Completed||Phase 3|278|Actual|Stallergenes||2|||f||||f||||||||||2017-02-18 16:02:30.063534|2017-02-18 16:02:30.063534
NCT00339352|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 24, 1999||1999-02-24|September 21, 2016|2016-09-21||||||||Observational|||A Family Study of Adults With Glioma|A Family Study of Adults With Glioma|Completed||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:51.987752|2017-02-18 16:27:51.987752
NCT00409383|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2011-11-04|||November 2006||2006-11-01|July 2010|2010-07-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Abraxane and Temodar Plus Genasense in Advanced Melanoma|"A Pilot Study of Abraxane® (Albumin-bound Paclitaxel) and Temodar® (Temozolomide) Plus Genasense® (Oblimersen Sodium) in Subjects With Advanced Melanoma (The ATG Study)."|Unknown status|Active, not recruiting|Phase 1|28|Anticipated|Genta Incorporated||1|||f||||f||||||||||2017-02-18 16:02:30.497066|2017-02-18 16:02:30.497066
NCT00409370|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2006-12-07|||April 2003||2003-04-01|December 2006|2006-12-01|February 2005||2005-02-01|||||Interventional|||Trial of Safety Nets In Hospitalized Patients|A Randomized Clinical Trial to Compare The Use Of Safety Net Enclosures With Standard Restraints in Agitated Hospitalized Patients|Completed||Phase 3|60||Griffin Hospital|||||f||||||||||||||2017-02-18 16:02:30.606483|2017-02-18 16:02:30.606483
NCT00409357|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2009-10-01|||November 2004||2004-11-01|October 2009|2009-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia|A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of SL77.0499-10 Once Daily Tablets in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia (BPH)|Completed||Phase 2|473|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:02:30.694508|2017-02-18 16:02:30.694508
NCT00409344|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2009-09-16|2009-02-26||January 2007||2007-01-01|September 2009|2009-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms|Phase 4 Study of Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms|Terminated||Phase 4|0|Actual|Massachusetts General Hospital|Unable to enroll participants into the study|2||Surgical approach changed therefore subject enrollment not possible.|f||||t||||||||||2017-02-18 16:02:30.789073|2017-02-18 16:02:30.789073
NCT00409331|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2012-07-31|2009-12-11||December 2006||2006-12-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment|A Phase II Study To Assess The Efficacy of Amifostine for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment With Intensity- Modulated Radiation Therapy (IMRT) for Parotid Salivary Sparing|Terminated||Phase 2|3|Actual|M.D. Anderson Cancer Center||1||Study terminated by Principal Investigator; no patients completed study.|f||||f||||||||||2017-02-18 16:02:31.189935|2017-02-18 16:02:31.189935
NCT00409318|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2008-05-23|||April 2004||2004-04-01|May 2008|2008-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study of TNF-Antagonism in Metabolic Syndrome|Effects of TNF-Alpha Antagonism in Patients With the Metabolic Syndrome (I)|Completed||N/A|56|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 16:02:31.399355|2017-02-18 16:02:31.399355
NCT00409305|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2015-04-20|||January 2007||2007-01-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||The Effect of Betahistine on Body Weight in Obese Subjects|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Subjects|Completed||Phase 2|280||OBEcure Ltd.|||||f||||||||||||||2017-02-18 16:02:31.518725|2017-02-18 16:02:31.518725
NCT00409292|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2014-07-23|2014-04-30||January 2007||2007-01-01|July 2014|2014-07-01|May 2009|Actual|2009-05-01|January 2009|Actual|2009-01-01||Interventional||Our study design used a one-stage design with a target accrual of 35 eligible patients, with the assumption that an improvement in PFS at 2 months from 50% to 71% would warrant further study in this patient population.|RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer|Phase II Study of RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|33|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:02:31.626175|2017-02-18 16:02:31.626175
NCT00409279|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2008-02-28|||September 2003||2003-09-01|February 2008|2008-02-01|April 2008|Anticipated|2008-04-01|April 2008|Anticipated|2008-04-01||Interventional|||An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease|An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease|Unknown status|Recruiting|N/A|100|Anticipated|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 16:02:31.912978|2017-02-18 16:02:31.912978
NCT00409266|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2006-12-07||||||December 2006|2006-12-01||||||||Interventional|||CT Assessment of Minimally Invasive Surgery and Computer Assisted Navigation in Total Knee Arthroplasty||Unknown status|Not yet recruiting|Phase 4|||Stryker Instruments|||||f||||||||||||||2017-02-18 16:02:32.029827|2017-02-18 16:02:32.029827
NCT00409253|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2009-02-24|||June 2007||2007-06-01|February 2009|2009-02-01|August 2010|Anticipated|2010-08-01|June 2010|Anticipated|2010-06-01||Interventional|||Treatment of Severe Hypertension During Pre-Eclampsia: A Preliminary Equivalence Study Between Urapidil and Nicardipine|Treatment of Severe Hypertension During Pre-Eclampsia.A Preliminary Equivalence Study Between URAPIDIL and NICARDIPINE|Unknown status|Recruiting|Phase 3|72|Anticipated|University Hospital, Strasbourg, France||2|||f||||f||||||||||2017-02-18 16:02:32.126953|2017-02-18 16:02:32.126953
NCT00409240|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2014-03-06|2014-01-14||October 2006||2006-10-01|March 2014|2014-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes|Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes|Completed||Phase 3|103|Actual|Providence VA Medical Center|Only 1 in 5 patients responded to the invitation to join the study and was willing to participate, participants were mostly male veterans, and pharmacists had prescribing privileges in the VA and in this study.|2|||f||||t||||||||||2017-02-18 16:02:32.227404|2017-02-18 16:02:32.227404
NCT00409227|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2008-06-17|||December 2006||2006-12-01|June 2008|2008-06-01||||July 2009|Anticipated|2009-07-01||Interventional|||Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy|Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL.|Unknown status|Recruiting|Phase 2|150|Anticipated|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 16:02:32.543817|2017-02-18 16:02:32.543817
NCT00409214|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2012-11-14|||November 2006||2006-11-01|November 2012|2012-11-01||||February 2008|Actual|2008-02-01||Interventional|||Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma|A Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma (Defined for the Purposes of the Protocol as Anaplastic Astrocytoma [AA] or Glioblastoma Multiforme [GBM]) Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma|Completed||Phase 2|18|Anticipated|Light Sciences Oncology|||||f||||||||||||||2017-02-18 16:02:32.650164|2017-02-18 16:02:32.650164
NCT00409188|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2015-10-19|2015-07-23||January 2007||2007-01-01|October 2015|2015-10-01|April 2015|Actual|2015-04-01|April 2012|Actual|2012-04-01||Interventional|START|ITT population included all the subject who were randomized.|Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)|A Multi-center Phase III Randomized, Double-blind Placebo-controlled Study of the Cancer Vaccine Stimuvax® (L-BLP25 or BLP25 Liposome Vaccine) in Non-small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease.|Completed||Phase 3|1513|Actual|EMD Serono||2|||f||||t||||||||||2017-02-18 16:02:32.931723|2017-02-18 16:02:32.931723
NCT00409175|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2012-11-16|2012-11-16||January 2007||2007-01-01|November 2012|2012-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis|Safety and Efficacy of Orally Administered Fx-1006A in Patients With Familial Amyloid Polyneuropathy (FAP): A Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 2/Phase 3|128|Actual|Pfizer|Instead of the intended endpoint 'heat pain and cooling threshold', results of 'summated 3 score for small nerve fiber function' were reported.|2|||f||||t||||||||||2017-02-18 16:02:34.480191|2017-02-18 16:02:34.480191
NCT00409162|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2006-12-07|||December 2006||2006-12-01|December 2006|2006-12-01|October 2007||2007-10-01|||||Interventional|||Safety and Efficacy Study of a New Device for Tattoo Removal|A Prospective, Open Label, Non Randomized, First-In-Man (Feasibility) Study to Evaluate the Safety and Effectiveness of the Eraser Tattoo Removal Device|Unknown status|Not yet recruiting|N/A|30||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 16:02:35.212831|2017-02-18 16:02:35.212831
NCT00409149|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2011-01-16|||December 2006||2006-12-01|April 2007|2007-04-01|November 2009|Actual|2009-11-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of a Complementary Multi Disciplinary Program on Blood Pressure in Hypertensive Patients|Comprehensive Approach to Lower Measured Blood Pressure (CALM-BP) - Results From a Randomized Controlled Trial|Completed||Phase 3|113|Actual|Assaf-Harofeh Medical Center||2|||f||||f||||||||||2017-02-18 16:02:35.295358|2017-02-18 16:02:35.295358
NCT00409136|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2009-01-29|||March 2006||2006-03-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Multi-Center Human Alert Trial to Prevent DVT and PE|Physician Alerts to Prevent DVT and Pulmonary Embolism in Hospitalized Patients|Completed||N/A|2496|Actual|Brigham and Women's Hospital|||2||f||||t||||||||||2017-02-18 16:02:35.395744|2017-02-18 16:02:35.395744
NCT00409123|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2008-09-25|||September 2004||2004-09-01|September 2008|2008-09-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Observational|||Effect of Systemic Cooling in Vasospasms|Effect of Systemic Cooling in Vasospasms (Kühleffekte Beim Vasospastischen Syndrom)|Completed||N/A|28|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 16:02:35.533037|2017-02-18 16:02:35.533037
NCT00409110|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2011-08-08|||January 2006||2006-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Ocular Pulse Amplitude And Choroidal Laser Doppler Flowmetry|Relationship Between Ocular Pulse Amplitude And Choroidal Laser Doppler Flowmetry In Healthy Subjects|Terminated||N/A|10|Actual|University Hospital, Basel, Switzerland|||1|methodological problems|f||||f||||||||||2017-02-18 16:02:35.616622|2017-02-18 16:02:35.616622
NCT00409097|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2006-12-07|||April 2006||2006-04-01|December 2006|2006-12-01|December 2007||2007-12-01|||||Interventional|||Effect of Rosiglitazone on ADMA in Critical Illness||Unknown status|Recruiting|Phase 3|30||VU University Medical Center|||||f||||||||||||||2017-02-18 16:02:35.698196|2017-02-18 16:02:35.698196
NCT00409084|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2010-07-02|||December 2006||2006-12-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding|Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding|Terminated||Phase 3|2|Actual|Virginia Commonwealth University||2||Lack of enrollment|f||||t||||||||||2017-02-18 16:02:35.791886|2017-02-18 16:02:35.791886
NCT00409071|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2010-02-04|||September 2005||2005-09-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.|Placebo-controlled Evaluation of Homeopathic Remedy (Cocculine®) Efficacy in the Management of Nausea After Adjuvant Chemotherapy in Non Metastatic Breast Cancer.|Completed||Phase 3|431|Actual|Centre Leon Berard||2|||f||||f||||||||||2017-02-18 16:02:35.89041|2017-02-18 16:02:35.89041
NCT00409058|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2014-10-27|||October 2005||2005-10-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|TOPS||Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI|An Online Intervention for Families Following Adolescent TBI - Teen Online Problem Solving (TOPS)|Completed||N/A|42|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||f||||||||||2017-02-18 16:02:38.637497|2017-02-18 16:02:38.637497
NCT00409045|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2007-11-02|||November 2005||2005-11-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Observational|||Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism|Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism|Completed||Phase 1/Phase 2|300|Anticipated|Atlantic Health System|||1||f||||||||||||||2017-02-18 16:02:38.79859|2017-02-18 16:02:38.79859
NCT00409032|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2009-10-22|||December 2006||2006-12-01|October 2009|2009-10-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||A Dose-response Study With Strontium Malonate in Postmenopausal Women|A Dose-response Study With Strontium Malonate in Postmenopausal Women. A 12 Week, Multi National, Double Blind, Randomized, 5 Arms, Parallel Group Placebo Controlled Open Label Active Controlled, Phase II Study With 3 Dose Levels of Strontium Malonate and Protelos Within Post Menopausal Women With a BMDT-score Below -1|Completed||Phase 2|275||Osteologix|||||f||||||||||||||2017-02-18 16:02:38.869667|2017-02-18 16:02:38.869667
NCT00409019|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2015-03-05||||||March 2015|2015-03-01||||March 2011|Actual|2011-03-01||Interventional|||Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy|A Prospective, Randomized, Trial to Investigate the Effect of Continued Adefovir Versus Combination Regimens of Telbivudine Plus Adefovir, and Telbivudine Plus Tenofovir in Patients With Chronic Hepatitis B and Suboptimal Viral Suppression (PROACTIV Study)|Withdrawn||Phase 4|0|Actual|Novartis||3||Study cancelled: Withdrawn before enrollment of any participants|f||||||||||||||2017-02-18 16:02:38.975457|2017-02-18 16:02:38.975457
NCT00408928|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2016-10-19|2013-07-18||November 2005||2005-11-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease|Phase II Trial of VELCADE® (Bortezomib) for Steroid Refractory Acute GVHD|Completed||Phase 2|11|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 16:02:42.986168|2017-02-18 16:02:42.986168
NCT00409006|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2010-08-13|2010-08-13||February 2007||2007-02-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|August 2009|Actual|2009-08-01||Interventional|||Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers|"A Phase 2 Trial of Pemetrexed and Cisplatin Followed Sequentially by Gefitinib Versus Pemetrexed and Cisplatin in Asian Never Smoker Patients With Advanced Non-Small Cell Lung Cancer"|Completed||Phase 2|70|Actual|Eli Lilly and Company|Median overall survival cannot be estimated due to the high censor rate (25 participants per treatment group were censored). Most participants were still living at the end of the study.|2|||f||||f||||||||||2017-02-18 16:02:39.08761|2017-02-18 16:02:39.08761
NCT00408993|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2011-07-22|2009-02-05||December 2006||2006-12-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China|Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China|Completed||Phase 3|215|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 16:02:40.20769|2017-02-18 16:02:40.20769
NCT00408564|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2013-06-17|||January 2006||2006-01-01|June 2013|2013-06-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery|Phase II Study of Neoadjuvant Gemcitabine/Oxaliplatin and Cetuximab Followed by Surgery or Concurrent External Beam Radiation With Capecitabine for Patients With Locally Advanced Unresectable Nonmetastatic Pancreatic Cancer|Completed||Phase 2|37|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 16:02:41.381911|2017-02-18 16:02:41.381911
NCT00408551|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2013-12-18|||November 2005||2005-11-01|June 2009|2009-06-01||||June 2009|Anticipated|2009-06-01||Interventional|||Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver|A Phase II Multi-Institutional Efficacy and Safety Study of Chemotherapy With Selective Internal Radiation Treatment Using Y-90 Microspheres (CHEMO-SIRT) in Patients With Colorectal Cancer Liver Metastasis|Unknown status|Recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 16:02:41.498926|2017-02-18 16:02:41.498926
NCT00408538|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2009-05-01|||December 2006||2006-12-01|May 2009|2009-05-01|April 2008|Actual|2008-04-01|||||Interventional|||Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally|A Phase 1 Randomized, Blinded, Placebo-Controlled Safety and Acceptability Study of the UC-781 Vaginal Microbicide Gel Formulation Applied Rectally in HIV-1 Seronegative Adults|Completed||Phase 1|36|Anticipated|University of California, Los Angeles|||||f||||||||||||||2017-02-18 16:02:41.611837|2017-02-18 16:02:41.611837
NCT00408525|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2011-03-15|||December 2006||2006-12-01|March 2011|2011-03-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease|Efficacy of Donepezil in Normalizing Brain Activation Patterns in People Genetically at Risk for Alzheimer's Disease|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:02:41.712554|2017-02-18 16:02:41.712554
NCT00408512|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2011-06-24|||December 2006||2006-12-01|November 2009|2009-11-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|stayondiur||Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study|Increasing Stay-on-therapy in Hypertensive Patients Treated With First-line Diuretics: An Active Pharmacosurveillance and Pharmacogenetic Study.|Completed||Phase 4|2500|Anticipated|Federico II University||2|||f||||||||||||||2017-02-18 16:02:42.079211|2017-02-18 16:02:42.079211
NCT00408499|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2015-05-07|||August 2006||2006-08-01|May 2015|2015-05-01|December 2015|Anticipated|2015-12-01|September 2015|Anticipated|2015-09-01||Interventional|||Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer|Phase I/II Study of Erlotinib (TARCEVA) and Cetuximab (ERBITUX) in Advanced Solid Tumors, With Emphasis on Non Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 1/Phase 2|64|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 16:02:42.199483|2017-02-18 16:02:42.199483
NCT00408473|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2007-02-21||||||February 2007|2007-02-01||||||||Interventional|||Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.|A Randomised Double-Blind Pilot Study Comparing Flecainide CR and Placebo in the Early Treatment of Patients With a Documented First Episode of Atrial Fibrillation.|Terminated||Phase 4|256||MEDA Pharma GmbH & Co. KG|||||f||||||||||||||2017-02-18 16:02:42.318191|2017-02-18 16:02:42.318191
NCT00408460|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2013-05-07|||February 2006||2006-02-01|May 2013|2013-05-01||||August 2010|Actual|2010-08-01||Interventional|||Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of Intermittent Gleevec® (Imatinib Mesylate) and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|34|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 16:02:42.469117|2017-02-18 16:02:42.469117
NCT00408980|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-07|2006-12-07|||January 2007||2007-01-01|November 2006|2006-11-01||||||||Interventional|||is Dietary Manipulation of Human Milk Total Fat and Caloric Content Feasible?|is Dietary Manipulation of Human Milk Total Fat and Caloric Content Feasible?|Unknown status|Not yet recruiting|N/A|20||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:02:42.585988|2017-02-18 16:02:42.585988
NCT00408967|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2014-06-27|||December 2006||2006-12-01|October 2013|2013-10-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.|An Open-label Phase II Study of Two Dose Levels of EMD 273066 Administered With Low-dose Cyclophosphamide Following Objective Response to Second-line Chemotherapy in Women With Recurrent Ovarian Carcinoma|Terminated||Phase 2|140||EMD Serono||||Poor recruitment; study design not appropriate any longer.|||||||||||||||2017-02-18 16:02:42.659601|2017-02-18 16:02:42.659601
NCT00408954|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2010-11-12||2009-03-24|March 2007||2007-03-01|November 2010|2010-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms|A Multi Center Randomized Cross Over Double Blind Third Party Open Placebo Controlled Pilot Study to Assess the Urodynamic Effects of Modified Release UK-369,003 in Men With Lower Urinary Tract Symptoms.|Completed||Phase 2|27|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:02:42.752861|2017-02-18 16:02:42.752861
NCT00339118|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2006-06-19||||||June 2006|2006-06-01||||||||Interventional|||EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children||Unknown status|Not yet recruiting|Phase 4|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:27:56.879658|2017-02-18 16:27:56.879658
NCT00408915|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2012-03-06|||July 2006||2006-07-01|March 2012|2012-03-01||||||||Interventional|||Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion|Double-blind, Placebo-controlled, Randomized, Multicentre Phase II/III Study to Evaluate the Efficacy and Safety of Lisuride, Applied Subcutaneously by Means of a Minipump in Patients With Advanced Parkinson's Disease Refractory to Conventional Oral Therapy|Completed||Phase 3|60|Anticipated|Axxonis Pharma AG|||||f||||||||||||||2017-02-18 16:02:43.269192|2017-02-18 16:02:43.269192
NCT00408902|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2015-01-26|2015-01-26||November 2006||2006-11-01|May 2014|2014-05-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer|Phase II Study of MLN518 in Patients With Metastatic Clear Cell Renal Cell Carcinoma|Completed||Phase 2|10|Actual|National Cancer Institute (NCI)|Principal Investigator closed this study due to lack of response and toxicities of drug, therefore overall survival analysis was not done.|1|||f||||||||||||||2017-02-18 16:02:43.375899|2017-02-18 16:02:43.375899
NCT00408889|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2010-04-08|||December 2006||2006-12-01|December 2008|2008-12-01||||||||Observational|||Prospective Evaluation of Predictors for Organ Failure Following Liver Transplantation|Prospective Evaluation of Predictors for Organ Failure Following Liver Transplantation|Completed||N/A|150|Anticipated|Heidelberg University|||1||f||||||||||||||2017-02-18 16:02:43.658886|2017-02-18 16:02:43.658886
NCT00408876|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2009-11-19|2008-11-07||December 2006||2006-12-01|November 2009|2009-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Duloxetine Versus Placebo in Chronic Low Back Pain|Protocol F1J-MC-HMEO Duloxetine Versus Placebo in the Treatment of Chronic Low Back Pain|Completed||Phase 3|404|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 16:02:43.789953|2017-02-18 16:02:43.789953
NCT00408863|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2015-07-13|||May 2002||2002-05-01|July 2015|2015-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Livial Intervention Following Breast Cancer; Efficacy, Recurrence and Tolerability Endpoints (LIBERATE)(COMPLETED)(P05885)|A Multinational, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Investigate Safety and Efficacy of Tibolone (Org OD14) in Women With Climacteric Symptoms and a History of Breast Cancer|Completed||Phase 3|3148|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 16:02:48.780088|2017-02-18 16:02:48.780088
NCT00408850|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2013-01-16|||November 2008||2008-11-01|January 2013|2013-01-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity|Mechanisms of Sympathetic Overactivity in the Metabolic Syndrome: Effects of Reversing Insulin Resistance by Drug Treatment|Unknown status|Recruiting|Phase 3|44|Anticipated|Baker Heart Research Institute||2|||f||||f||||||||||2017-02-18 16:02:48.888681|2017-02-18 16:02:48.888681
NCT00408824|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2007-09-19|||September 2006||2006-09-01|September 2007|2007-09-01||||||||Observational|||Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)|Assessment of Genetic Risk of Metabolic Syndrome in Company Employee and Making New Health Guidance Program (NGK Study)|Unknown status|Recruiting|N/A|4000|Anticipated|Nagoya University|||||f||||||||||||||2017-02-18 16:02:49.0008|2017-02-18 16:02:49.0008
NCT00408798|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2010-09-23|||December 2010||2010-12-01|September 2010|2010-09-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin|Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin|Unknown status|Not yet recruiting|N/A|20|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:02:49.071555|2017-02-18 16:02:49.071555
NCT00408785|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2011-11-10|||November 2006||2006-11-01|November 2011|2011-11-01||||||||Interventional|||A Study Of BOTOX For The Treatment Of Glabellar Lines|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of BOTOX? (Botulinum Toxin Type A) in Subjects With Glabellar Lines|Completed||Phase 3|256||GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:02:49.175548|2017-02-18 16:02:49.175548
NCT00408772|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2017-01-13|||June 2007||2007-06-01|January 2017|2017-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer|Efficacy of Neoadjuvant XELOX/AVASTIN Therapy for Nonresectable Colorectal Liver Metastases With Secondary Hepatic Resection/Radiofrequency|Withdrawn||Phase 2|0|Actual|University of California, Davis||1||Lack of accrual|f||||t||||||||||2017-02-18 16:02:49.360604|2017-02-18 16:02:49.360604
NCT00408759|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2006-12-06|||November 2006||2006-11-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients|Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients|Unknown status|Recruiting|Phase 2|10||Bnai Zion Medical Center|||||f||||||||||||||2017-02-18 16:02:49.476816|2017-02-18 16:02:49.476816
NCT00408746|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2009-03-23|||January 2003||2003-01-01|February 2007|2007-02-01|August 2013|Anticipated|2013-08-01|January 2012|Anticipated|2012-01-01||Observational|||Orofacial Development of Preterm and Low Birthweight Infants Versus Term Infants|Prospective (Multicentre) Epidemiologic Longitudinal Study of Orofacial Development of Preterm and Low Birthweight Infants Compared to Term Infants in Consideration of Perinatal, Biometrical, Nutritional, Functional and Parental Parameters|Unknown status|Recruiting|N/A|80|Anticipated|University Hospital Muenster|||1||f||||f||||||||||2017-02-18 16:02:49.570602|2017-02-18 16:02:49.570602
NCT00408733|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2008-01-24|||January 2007||2007-01-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Evaluating a Low-Literacy Discharge Medication Education Tool|Evaluating a Low-Literacy Discharge Medication Education Tool|Completed||N/A|287|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 16:02:49.670596|2017-02-18 16:02:49.670596
NCT00408720|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2006-12-06|||October 2006||2006-10-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Observational|||Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies|Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies|Completed||N/A|25||The New York Eye & Ear Infirmary|||||f||||||||||||||2017-02-18 16:02:49.761904|2017-02-18 16:02:49.761904
NCT00408707|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2008-02-28|||September 2006||2006-09-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|||||Interventional|||Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Knee Arthroplasty|Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Knee Arthroplasty: a Placebo Controlled, Randomized, Double-Blinded Study.|Completed||Phase 4|16|Anticipated|Hvidovre University Hospital|||||f||||||||||||||2017-02-18 16:02:49.838819|2017-02-18 16:02:49.838819
NCT00408694|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2014-04-21|2013-03-01||December 2006||2006-12-01|October 2011|2011-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer|A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer|Completed||Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:02:50.129236|2017-02-18 16:02:50.129236
NCT00408681|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2016-11-23|2016-11-23||June 2006||2006-06-01|November 2016|2016-11-01||||November 2010|Actual|2010-11-01||Interventional|GVHD||Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant|A Pilot Study to Evaluate the Potential Efficacy of Lithium Carbonate for Stimulation of Intestinal Recovery In Patients With Acute Graft-versus-host Disease (GVHD)|Completed||N/A|20|Actual|Fred Hutchinson Cancer Research Center|This trial was not controlled in any scientifically valid sense of the term. Clinical management included many changes of treatment other than the use of the study product. The trial had no validated external benchmark for comparisons.|1|||f||||f||||||||||2017-02-18 16:02:50.856324|2017-02-18 16:02:50.856324
NCT00408668|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2006-12-05|||August 2005||2005-08-01|October 2006|2006-10-01|February 2006||2006-02-01|||||Interventional|||Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen|Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With the Virosomal Vaccine PEV3A and FP9-MVA ME-TRAP. A Phase I / IIa Controlled Challenge Trial|Completed||Phase 1/Phase 2|30||University of Oxford|||||f||||||||||||||2017-02-18 16:02:51.748992|2017-02-18 16:02:51.748992
NCT00408655|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2014-06-18|||February 2007||2007-02-01|June 2014|2014-06-01||||January 2012|Actual|2012-01-01||Interventional|||Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors|Phase I Study of CCI-779 (NSC 683864) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumours|Completed||Phase 1|38|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:02:51.842263|2017-02-18 16:02:51.842263
NCT00408642|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2016-01-29|||August 2007||2007-08-01|January 2016|2016-01-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|eASP||An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)|An Enhanced Adherence Support Programme for HAART|Completed||Phase 3|297|Actual|Centre for the AIDS Programme of Research in South Africa||2|||f||||f||||||||||2017-02-18 16:02:51.964137|2017-02-18 16:02:51.964137
NCT00408629|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2011-04-28|2011-03-03||November 2006||2006-11-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Moderately to Severely Active Ulcerative Colitis|Completed||Phase 3|518|Actual|Abbott||2|||f||||t||||||||||2017-02-18 16:02:52.091677|2017-02-18 16:02:52.091677
NCT00408616|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2009-03-06|||November 2006||2006-11-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy and Safety of Grazax in Children|A Phase III Trial Investigating the Efficacy and Safety of Grazax in Children Aged 5-16 Years With Grass Pollen Induced Rhinoconjunctivitis With or Without Asthma|Completed||Phase 3|253|Actual|ALK-Abelló A/S||2|||f||||t||||||||||2017-02-18 16:02:53.711276|2017-02-18 16:02:53.711276
NCT00408603|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2012-06-05|||November 2006||2006-11-01|November 2009|2009-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer|A Phase 2 Open-Label, Multicenter Study of SNS-595 Injection in Patients With Platinum-Resistant Ovarian Cancer|Completed||Phase 2|143|Actual|Sunesis Pharmaceuticals||1|||f||||t||||||||||2017-02-18 16:02:53.805402|2017-02-18 16:02:53.805402
NCT00408590|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2015-03-23|||April 2004||2004-04-01|March 2015|2015-03-01||||December 2015|Anticipated|2015-12-01||Interventional|||Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer|Phase I Trial of Intraperitoneal Administration of a) a CEA-Expressing Derivative, and b) a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Recurrent Ovarian Cancer|Active, not recruiting||Phase 1|46|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 16:02:53.944792|2017-02-18 16:02:53.944792
NCT00408577|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2006-12-11|||November 2004||2004-11-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Interventional|||Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.|Prevention of Cardiovascular Relapses by L-Arginine Oral Administration in Patients With CAD and IGT and/or Insulin Resistance.|Completed||Phase 3|150||IRCCS San Raffaele|||||f||||||||||||||2017-02-18 16:02:54.055889|2017-02-18 16:02:54.055889
NCT00408447|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2016-01-05|||September 2004||2004-09-01|January 2016|2016-01-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Stem Cell Transplant in Sickle Cell Disease and Thalassemia|Allogeneic Stem Cell Transplant to Induce Mixed Donor Chimerism in Patients With Sickle Cell Disease and Thalassemia|Recruiting||Phase 2|70|Anticipated|Columbia University||2|||f||||t||||||||||2017-02-18 16:02:54.143719|2017-02-18 16:02:54.143719
NCT00408434|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2010-02-12|||November 2006||2006-11-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study of an Experimental New Drug, PPAR Agonist Taken by Mouth by Patients With Advanced or Metastatic Cancer|A Phase I Dose Finding Study of an Experimental New Drug, PPAR Agonist Taken by Mouth by Patients With Advanced or Metastatic Cancer|Completed||Phase 1|32|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 16:02:54.27656|2017-02-18 16:02:54.27656
NCT00408421|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2009-07-07|2008-10-02||November 2006||2006-11-01|July 2009|2009-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Duloxetine Versus Placebo for Osteoarthritis Knee Pain|Duloxetine 60 to 120 mg Versus Placebo in the Treatment of Patients With Osteoarthritis Knee Pain|Completed||Phase 3|231|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 16:02:54.404227|2017-02-18 16:02:54.404227
NCT00408226|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2012-01-19|||October 2006||2006-10-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|June 2009|Actual|2009-06-01||Interventional|||Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer|Phase 1/2 Study of Oral MKC-1 Administered Twice Daily for 14 Consecutive Days Every 3 Weeks in Combination With Pemetrexed|Completed||Phase 1/Phase 2|27|Actual|CASI Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 16:02:59.046372|2017-02-18 16:02:59.046372
NCT00408408|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-06|2016-06-03|||November 2006||2006-11-01|May 2016|2016-05-01|March 2017|Anticipated|2017-03-01|March 2011|Actual|2011-03-01||Interventional|||Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery|A Randomized Phase III Trial of Neoadjuvant Therapy in Patients With Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel When Administered Before AC With or Without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR With Each of the Regimens|Active, not recruiting||Phase 3|1206|Actual|NSABP Foundation Inc||6|||f||||t||||||||||2017-02-18 16:02:56.369869|2017-02-18 16:02:56.369869
NCT00408395|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2016-11-30|||November 2006||2006-11-01|December 2011|2011-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children|A Phase II, Observer-Blind, Randomized, Parallel Groups, Multicenter, Exploratory Clinical Study to Evaluate the Immunogenicity and Safety of One and Two 0.25 mL Intramuscular Doses of a Commercially Available Influenza Vaccine Versus Two 0.25 mL Intramuscular Doses of a Commercially Available Influenza Vaccine in Healthy Children|Completed||Phase 2|281|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:02:57.230724|2017-02-18 16:02:57.230724
NCT00408382|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2011-11-15||||||December 2006|2006-12-01||||||||Interventional|||Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque||Completed||Phase 4|50||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 16:02:57.346804|2017-02-18 16:02:57.346804
NCT00408369|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2008-01-25|||November 2006||2006-11-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Prophylactic Antimalarial Activity of DB289 in Volunteers|Prophylactic Antimalarial Activity of DB289 in Volunteers Challenged With Plasmodium Falciparum|Completed||Phase 1/Phase 2|19|Anticipated|Immtech Pharmaceuticals, Inc|||||f||||||||||||||2017-02-18 16:02:57.4508|2017-02-18 16:02:57.4508
NCT00408356|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2009-02-19|||November 2004||2004-11-01|February 2009|2009-02-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional|||Immunological and Clinical Responses to Zinc in Children With Diarrhoea|Immunological and Clinical Responses to Zinc: A Randomized, Double-Blind Trial of Zinc Treatment vs. Zinc Treatment Plus Daily Supplementation for 3 Months Among Children Under 2 Years of Age With an Acute Diarrheal Illness.|Completed||Phase 3|338|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||t||||||||||2017-02-18 16:02:57.559468|2017-02-18 16:02:57.559468
NCT00408330|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2015-03-18|||December 2006||2006-12-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face|A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face|Completed||Phase 2|48|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:02:57.653593|2017-02-18 16:02:57.653593
NCT00408317|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2014-01-27|2014-01-27||November 2006||2006-11-01|January 2014|2014-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional||Intent-to-treat (ITT) population included all randomized participants.|Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)|A Multicenter, Randomized, Double-Blind, Crossover Study to Compare the Safety and Efficacy of Ultrase® MT20 to Placebo for the Correction of Steatorrhea in Patients With Cystic Fibrosis (CF)|Completed||Phase 3|36|Actual|Forest Laboratories||2|||f||||t||||||||||2017-02-18 16:02:57.772592|2017-02-18 16:02:57.772592
NCT00408304|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2006-12-05|||December 2006||2006-12-01|December 2006|2006-12-01|December 2007||2007-12-01|||||Interventional|||Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.|Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.|Unknown status|Recruiting|Phase 2|60||Bnai Zion Medical Center|||||f||||||||||||||2017-02-18 16:02:58.187241|2017-02-18 16:02:58.187241
NCT00408291|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2015-05-19|||December 2011||2011-12-01|July 2013|2013-07-01|January 2016|Anticipated|2016-01-01|January 2016|Anticipated|2016-01-01||Observational|||Evaluation of Treatment of Fractures of the Humerus With a Plate.|Evaluation of the Winsta PH Osteosynthesis Device in the Treatment of Three- and Four-Part Fractures of the Proximal Humerus A Prospective Migration and Bone Density Study|Unknown status|Recruiting|N/A|30|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-02-18 16:02:58.283951|2017-02-18 16:02:58.283951
NCT00408278|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2014-10-27|||July 2005||2005-07-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|April 2012|Actual|2012-04-01||Interventional|||Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)|Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005): Remission Induction With ATRA + Idarubicin. Risk-adapted Consolidation With ATRA and Anthracycline-based Chemotherapy (Idarubicin/Mitoxantrone) With Addition of Ara-C for High-risk Patients. Maintenance Therapy With ATRA + Low Dose Chemotherapy (Methotrexate + Mercaptopurine).|Completed||Phase 4|300|Anticipated|PETHEMA Foundation||1|||f||||||||||||||2017-02-18 16:02:58.400903|2017-02-18 16:02:58.400903
NCT00408265|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2011-11-17|||January 2004||2004-01-01|November 2011|2011-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Smoking Cessation in Substance Abuse Treatment Patients: A Feasibility Study|Smoking Cessation in Substance Abuse Treatment Patients: A Feasibility Study|Completed||Phase 3|80|Actual|UConn Health||1|||f||||t||||||||||2017-02-18 16:02:58.560638|2017-02-18 16:02:58.560638
NCT00408252|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2016-04-19|||February 2007||2007-02-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy of SU 011248 in Head And Neck Carcinoma|A Phase II Study Of Su011248 In Patients With Recurrent And/Or Metastatic Squamous Head And Neck Carcinoma.|Terminated||Phase 2|54|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1||Too frequent grade 3-4 toxicities|f||||f||||||||||2017-02-18 16:02:58.664072|2017-02-18 16:02:58.664072
NCT00408239|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2011-12-15|||December 2006||2006-12-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|PEARL-1||Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement|Factor Xa Inhibitor YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement: A Randomized, Enoxaparin-controlled, Open Label, Dose-escalation Study|Completed||Phase 2|367|Actual|Astellas Pharma Inc||3|||f||||||||||||||2017-02-18 16:02:58.791026|2017-02-18 16:02:58.791026
NCT00006253|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2011-12-06|||March 2003||2003-03-01|December 2011|2011-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Pain and Fatigue Study|Family Home Care for Cancer - A Community-Based Model|Completed||N/A|350|Actual|Michigan State University||2|||f||||f||||||||||2017-02-18 18:13:07.94627|2017-02-18 18:13:07.94627
NCT00408213|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2008-05-22|||June 2004||2004-06-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|||||Interventional|||A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.|A Randomized, Double-Blind Study to Evaluate the Safety of Continued Treatment With CellCept in Patients With Well-Controlled Myasthenia Gravis Receiving a Stable Dose of Prednisone|Completed||Phase 3|136|Anticipated|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:02:59.152047|2017-02-18 16:02:59.152047
NCT00408200|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2013-01-31|2012-09-12||November 2006||2006-11-01|June 2012|2012-06-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation|A Randomized Trial to Assess the Utility of Empirical Anti-Arrhythmic Drug Therapy to Prevent Atrial Arrhythmia During the 6 Weeks Following Pulmonary Vein Isolation to Treat Paroxysmal Atrial Fibrillation|Completed||N/A|110|Actual|University of Pennsylvania||2|||f||||||||||||||2017-02-18 16:02:59.285676|2017-02-18 16:02:59.285676
NCT00408187|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2009-07-29|||December 2006||2006-12-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ESSENCE||Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients|A Phase III, Randomized, Multicentre, Double-Blind, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients|Completed||Phase 3|642|Actual|Aurinia Pharmaceuticals Inc.||3|||f||||t||||||||||2017-02-18 16:02:59.704841|2017-02-18 16:02:59.704841
NCT00408174|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2009-12-21|||May 2006||2006-05-01|December 2009|2009-12-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis|A Multicenter, Randomized, Double-Blind, Actively-Controlled Trial to Evaluate the Safety and Efficacy of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium 3.3 g Bid Versus Mesalamine (5-ASA) as Asacol® 0.8 g Tid in Mildly to Moderately Active Ulcerative Colitis|Completed||Phase 3|400|Anticipated|Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:02:59.892194|2017-02-18 16:02:59.892194
NCT00408161|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2012-03-26|||August 2003||2003-08-01|March 2012|2012-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Contingency Management for Chronic Recidivist Alcohol-Dependent Patients|Contingency Management for Chronic Recidivist Alcohol-Dependent Patients|Completed||Phase 1/Phase 2|104|Actual|UConn Health||2|||f||||t||||||||||2017-02-18 16:03:00.057724|2017-02-18 16:03:00.057724
NCT00408148|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2010-12-09|||October 2006||2006-10-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||High Density Lipoprotein Turnover|A Randomized, Double-blind, Two Arm, Parallel, Placebo Controlled Study of Rimonabant 20 mg Effect on High Density Lipoprotein Kinetics in Patients With Abdominal Obesity and Additional Cardiometabolic Risk Factors|Terminated||Phase 3|64|Actual|Sanofi||2||"Company decision has been taken in light of recent demands by certain national health~   authorities"|f||||||||||||||2017-02-18 16:03:00.183136|2017-02-18 16:03:00.183136
NCT00408135|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2009-04-02|||August 2004||2004-08-01|April 2009|2009-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections|Evaluation of the Safety, Efficacy and Acceptability of HMR 3647 (20％ Fine Granules 1 g Sachet) in Children With Infections|Completed||Phase 3|111|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:03:00.301981|2017-02-18 16:03:00.301981
NCT00408122|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2014-10-15|||January 2007||2007-01-01|October 2014|2014-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Evaluation of Preoperative Investigations in Patients With Liver Cancer|Evaluation of Positron Emission Tomography/ CT Scan, Endoscopic Ultrasono¬Graphy, and Laparoscopic Ultrasonography in the Preoperative Assess¬Ment of Resectability in Patients With Primary and Secondary Liver Cancer|Completed||N/A|77|Actual|Odense University Hospital|||1||f||||||||||||||2017-02-18 16:03:00.404342|2017-02-18 16:03:00.404342
NCT00408109|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2017-01-24|||December 4, 2006||2006-12-04|August 28, 2008|2008-08-28|August 28, 2008||2008-08-28|||||Interventional|||Safety Study of Avian Flu Vaccine|VRC 304: A Phase I Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine (VRC-AVIDNA036-00-VP), Encoding for the Influenza Virus H5 Hemagglutinin Protein in Healthy Adults|Completed||Phase 1|45||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:03:03.251596|2017-02-18 16:03:03.251596
NCT00408096|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2014-10-21|||December 2006||2006-12-01|October 2014|2014-10-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Comparison of Two Resurfacing Prostheses in the Treatment of Osteoarthritis of the Shoulder|Comparison of Two Resurfacing Prostheses in the Treatment of Osteoarthritis of the Shoulder A Prospective, Randomized Migration and Bone Density Study|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-02-18 16:03:03.363361|2017-02-18 16:03:03.363361
NCT00408083|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2009-03-25|||December 2006||2006-12-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Crossover Study With MultiHance vs a Comparator for Peripheral MRA|A Phase IIIB, Double-Blind, Multi-Center, Randomized, Cross-Over Study to Compare 0.1 Mmol/kg of Multihance With 0.1 Mmol/kg of Magnevist for Contrast-Enhanced Magnetic Resonance Angiography(CE-MRA) of Peripheral Arteries|Completed||Phase 3|100|Anticipated|Bracco Diagnostics, Inc||2|||f||||f||||||||||2017-02-18 16:03:03.479851|2017-02-18 16:03:03.479851
NCT00408070|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-05|2010-11-16|2010-10-14||October 2006||2006-10-01|November 2010|2010-11-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Phase 2 Study of Bevacizumab in Combination With Carboplatin and Paclitaxel in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Terminated||Phase 2|5|Actual|UConn Health|This trial ended early after enrolling only 5 of 100 patients. Due to the small enrollment number and incomplete data set, no data analyses were performed.|1||Did not meet accrual goals.|f||||t||||||||||2017-02-18 16:03:03.58772|2017-02-18 16:03:03.58772
NCT00408057|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2008-05-12|||December 2005||2005-12-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|GUIDE||Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )|Quality Enhancement Research Initiative (QERI) in the Dyslipidemia Management Strategy Involving Ezetimibe With Statin in High Risk Patients Who Have Not Achieved Recommended LDL Targets|Completed||Phase 4|2500|Actual|Canadian Heart Research Centre|||1||f||||f||||||||||2017-02-18 16:03:03.899139|2017-02-18 16:03:03.899139
NCT00408044|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2008-05-19|||December 2006||2006-12-01|May 2008|2008-05-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Observational|||Dysesthesia Study After Sternotomy|Pain After Sternotomy|Completed||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||||f||||||||||||||2017-02-18 16:03:03.99011|2017-02-18 16:03:03.99011
NCT00408031|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-03|2012-08-02|||January 2007||2007-01-01|August 2012|2012-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||D-cycloserine for Major Depressive Disorder|N-methyl-D-aspartate Receptor (NMDAR)-Based Pharmacotherapy With D-cycloserine for Treatment-resistant Major Depressive Disorder|Completed||Phase 2|26|Actual|Herzog Hospital||1|||f||||||||||||||2017-02-18 16:03:04.07587|2017-02-18 16:03:04.07587
NCT00408018|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2008-12-31|||March 2006||2006-03-01|December 2008|2008-12-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms|An Open Label Multicentric Phase 1 Study of Selective Cyclin Dependent Kinase Inhibitor P276-00 in Patients With Advanced Refractory Neoplasms|Terminated||Phase 1|28|Actual|Piramal Enterprises Limited||1||"The decision to terminate this study after 202 mg/m2 cohort was taken as MTD achieved in other~   study at 185 mg/m2"|f||||f||||||||||2017-02-18 16:03:04.255079|2017-02-18 16:03:04.255079
NCT00408005|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2017-02-02|||January 2007||2007-01-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma|Intensified Methotrexate, Nelarabine (Compound 506U78) and Augmented BFM Therapy for Children and Young Adults With Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma|Active, not recruiting||Phase 3|1900|Anticipated|National Cancer Institute (NCI)||16|||f||||||||||||||2017-02-18 16:03:04.53638|2017-02-18 16:03:04.53638
NCT00407992|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2011-08-29|||December 2006||2006-12-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|Migraine||An Italian Randomized Open-label Study of Occipital Nerve Stimulation in the Treatment of Chronic Migraine Headache|An Italian, Randomized, Single-centre, Open-label Study of Occipital Nerve Stimulation in the Treatment of Chronic Migraine Headache|Completed||Phase 3|34|Anticipated|Ospedale Sacro Cuore - Don Calabria||2|||f||||||||||||||2017-02-18 16:03:05.312325|2017-02-18 16:03:05.312325
NCT00407979|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2017-01-10|||July 2005||2005-07-01|January 2017|2017-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis|Analysis and Correlation of Cathelicidin Expression in Skin and Saliva of Subjects With Atopic Dermatitis and Psoriasis|Completed||N/A|80|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||||||||Samples With DNA|"~     Blood, skin, and saliva samples will be retained~   "|Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 16:03:05.417195|2017-02-18 16:03:05.417195
NCT00407966|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2015-07-14|2012-05-01||October 2006||2006-10-01|December 2012|2012-12-01|November 2009|Actual|2009-11-01|July 2008|Actual|2008-07-01||Interventional|||Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|Phase II Study of Alvocidib (NSC 649890, Flavopiridol) in Timed Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Newly Diagnosed, Previously Untreated, Poor-Risk Acute Myelogenous Leukemias|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:03:05.528648|2017-02-18 16:03:05.528648
NCT00407953|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2013-02-04|||September 2005||2005-09-01|February 2013|2013-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||PROLIEVE® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)|Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)|Active, not recruiting||Phase 4|250|Anticipated|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 16:03:05.779255|2017-02-18 16:03:05.779255
NCT00407940|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2006-12-04|||December 2006||2006-12-01|December 2006|2006-12-01|December 2008||2008-12-01|||||Interventional|||ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion|ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion. A Prospective Randomized Trial Comparing Silverhawk™ Atherectomy to CryoPlasty® Therapy for Lower Extremity Claudication|Unknown status|Recruiting|Phase 4|100||University of California, San Diego|||||f||||||||||||||2017-02-18 16:03:05.912011|2017-02-18 16:03:05.912011
NCT00407927|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2015-10-09|||December 2006||2006-12-01|October 2015|2015-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis|A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis|Completed||Phase 2|571|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:03:06.023033|2017-02-18 16:03:06.023033
NCT00407914|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2009-10-06||2009-07-01|December 2006||2006-12-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds|A Double-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Aquamid and Restylane for the Aesthetic Treatment of Nasolabial Folds|Completed||N/A|315|Actual|Contura||2|||f||||||||||||||2017-02-18 16:03:06.120565|2017-02-18 16:03:06.120565
NCT00407901|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2008-01-16|||April 2006||2006-04-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Functional Assessment Questionnaire for the Visually Challenged|Functional Assessment Questionnaire for the Visually Challenged: Proposed Model to Quantitatively Measure the Functional Level of Individuals Who Are Legally Blind|Completed||N/A|31|Actual|George Washington University|||1||f||||f||||||||||2017-02-18 16:03:06.232017|2017-02-18 16:03:06.232017
NCT00407888|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2013-05-07|||May 2006||2006-05-01|May 2013|2013-05-01||||May 2009|Actual|2009-05-01||Interventional|||Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery|Adjuvant Therapy for High-Risk Localized Breast Cancer Using Weekly Adriamycin + Daily Oral Cytoxan With Continuous G-CSF Support for 12 Weeks Followed by Weekly Abraxane™ for 12 Weeks With Concurrent Herceptin for Subjects With HER-2/Neu Positive Disease, Phase II|Completed||Phase 2|60|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 16:03:06.32673|2017-02-18 16:03:06.32673
NCT00407680|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2007-10-21|||October 2006||2006-10-01|October 2007|2007-10-01|March 2009|Anticipated|2009-03-01|||||Interventional|||Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension|Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension|Unknown status|Recruiting|Phase 4|80|Anticipated|Kitasato University|||||f||||||||||||||2017-02-18 16:03:10.431805|2017-02-18 16:03:10.431805
NCT00407875|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2009-10-14|||March 2007||2007-03-01|October 2009|2009-10-01|November 2016||2016-11-01|||||Interventional|||Intensity Modulated Versus Interstitial - Radiation Therapy|A Randomized Phase II Study Comparing Intensity Modulated External Beam Radiation Therapy (IMRT) Versus Permanent Interstitial Prostate Brachytherapy (PIPB) for Low Risk and Low-tier Intermediate Risk Prostate Cancer|Suspended||Phase 2|50|Anticipated|British Columbia Cancer Agency||2||"Accrual has been very slow. We are currently determining whether or not to keep the trial~   going as is or to close the trial and write a new protocol."|f||||||||||||||2017-02-18 16:03:06.464355|2017-02-18 16:03:06.464355
NCT00407862|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2006-12-04|||January 2005||2005-01-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Telmisartan and Losartan in Hypertensive IGT|Telmisartan vs. Losartan in Hypertensive Patients With Impaired Glucose Tolerance: A Comparison of Their Antihypertensive, Metabolic, and Vascular Effects|Completed||Phase 4|24||Medical University of Graz|||||f||||||||||||||2017-02-18 16:03:06.557246|2017-02-18 16:03:06.557246
NCT00407849|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2008-05-06|||October 2006||2006-10-01|May 2008|2008-05-01|August 2008|Anticipated|2008-08-01|December 2007|Actual|2007-12-01||Interventional|||Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema|Phase I/II Study of Intravitreal Triamcinolone Acetonide Microspheres for Treatment of Diffuse Diabetic Macular Edema Unresponsive to Conventional Laser Photocoagulation Treatment.|Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Anticipated|Federal University of São Paulo||1|||f||||||||||||||2017-02-18 16:03:06.659207|2017-02-18 16:03:06.659207
NCT00407836|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-03|2009-12-01|||November 2006||2006-11-01|November 2006|2006-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy Study of T Cell Vaccination in HIV Infection|Phase II Study of Efficacy, Tolerability and Safety of CD4-Specific T-cell Vaccine in HIV Infection|Completed||Phase 2|40|Anticipated|Soroka University Medical Center||1|||f||||f||||||||||2017-02-18 16:03:06.751092|2017-02-18 16:03:06.751092
NCT00407823|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2006-12-04|||January 2004||2004-01-01|December 2006|2006-12-01|August 2005||2005-08-01|||||Interventional|||Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation Monitoring|An Outcomes Comparison of ACCM/PALS Guidelines For Pediatric Septic Shock With and Without Central Venous Oxygen Saturation Monitoring|Completed||N/A|268||University of Sao Paulo|||||f||||||||||||||2017-02-18 16:03:06.862633|2017-02-18 16:03:06.862633
NCT00407797|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2011-02-04|2010-08-12||March 2007||2007-03-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|PREPS MEXICO||Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial|Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial. A Phase IV Open-Label Trial Using 150,300, 600 mg/Day Of Pregabalin|Terminated||Phase 4|136|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:03:06.968466|2017-02-18 16:03:06.968466
NCT00407784|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2007-03-06|||January 2007||2007-01-01|March 2007|2007-03-01|November 2009||2009-11-01|||||Observational|||Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.|Aldosterone-Renin Ratio to Diagnose Primary Aldosteronism in a Population of Patients With Therapy-Resistant Hypertension: Test Characteristics, Diagnostic Value and Predictive Value for Antihypertensive Treatment. The Dutch ARRAT Study.|Unknown status|Recruiting|N/A|500||Erasmus Medical Center|||||f||||||||||||||2017-02-18 16:03:07.819408|2017-02-18 16:03:07.819408
NCT00407771|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2007-10-30|||November 2007||2007-11-01|October 2007|2007-10-01|December 2008|Anticipated|2008-12-01|||||Interventional|||The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention|A Pilot Study of The Effects of a Single High Dose Bolus Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention|Unknown status|Not yet recruiting|Phase 4|44|Anticipated|Jordan Hospital||2|||f||||||||||||||2017-02-18 16:03:07.934492|2017-02-18 16:03:07.934492
NCT00407758|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2012-07-18|||November 2006||2006-11-01|May 2007|2007-05-01||||January 2013|Anticipated|2013-01-01||Interventional|||Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Enzastaurin (Lilly IND # 60, 933) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Unknown status|Active, not recruiting|Phase 2|68|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:03:08.039423|2017-02-18 16:03:08.039423
NCT00407745|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2012-02-23|2011-11-03||January 2007||2007-01-01|February 2012|2012-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury|A 17-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Of Pregabalin For The Treatment Of Chronic Central Neuropathic Pain After Spinal Cord Injury|Completed||Phase 3|220|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:03:08.178755|2017-02-18 16:03:08.178755
NCT00407732|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2012-01-24|||January 2007||2007-01-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|February 2010|Actual|2010-02-01||Interventional|||Overcoming Psychiatric Barriers to the Treatment of Hepatitis C|Overcoming Neuropsychiatric Barriers to the Treatment of Hepatitis C|Completed||N/A|101|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 16:03:10.024675|2017-02-18 16:03:10.024675
NCT00407719|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2009-02-02|||June 2005||2005-06-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|April 2007|Actual|2007-04-01||Interventional|||Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)|An Open-Label, Pilot Study of Bevacizumab in Subjects With Choroidal Neovascularization Secondary to Diseases Other Than Age-Related Macular Degeneration|Completed||Phase 1|10||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:03:10.135232|2017-02-18 16:03:10.135232
NCT00407706|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2006-12-04|||December 2006||2006-12-01|December 2006|2006-12-01|December 2010||2010-12-01|||||Observational|||Using Test of SCM for Detection Breast Cancer|Breast Cancer- Early Detection of Cancer Disease and Pre-Cancer Disease, and in Women That Are at High Risk for Developing Breast Cancer by Identifying Lymphocytes Previously Exposed to Specific Cancer Antigen.|Unknown status|Recruiting|N/A|180||Ziv Hospital|||||f||||||||||||||2017-02-18 16:03:10.229612|2017-02-18 16:03:10.229612
NCT00407693|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-02|2017-01-24|||November 28, 2006||2006-11-28|July 21, 2016|2016-07-21|July 21, 2016|Actual|2016-07-21|||||Interventional|||PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28|PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28|Completed||Phase 1|51|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:03:10.320847|2017-02-18 16:03:10.320847
NCT00338546|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2009-05-19||||||May 2009|2009-05-01||||||||Interventional|||Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine|Cocaine and Sympathetic Nerve Activity in Humans|Unknown status|Recruiting|Phase 1|440|Anticipated|University of Texas Southwestern Medical Center|||||||||||||||||||2017-02-18 16:28:09.411224|2017-02-18 16:28:09.411224
NCT00407667|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2011-03-18|||December 2006||2006-12-01|November 2006|2006-11-01|December 2009|Actual|2009-12-01|August 2009|Actual|2009-08-01||Interventional|TraGAT||Transcranial Galvanic Stimulation After Stroke|Transcranial Direct Current Stimulation (tDCS) of the Lesioned or Non-lesioned Hemisphere Plus Computer-assisted Arm Trainer: a Randomized, Placebo-controlled Double-blind Multi-centre Study in Patients With Severe Arm Paresis Early After Stroke|Completed||N/A|96|Anticipated|Charite University, Berlin, Germany||3|||f||||||||||||||2017-02-18 16:03:10.545167|2017-02-18 16:03:10.545167
NCT00407654|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2015-07-22|2015-03-27||October 2006||2006-10-01|May 2013|2013-05-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer|Phase II Trial of VEGF Trap in Patients With Previously Treated Metastatic Colorectal Cancer|Completed||Phase 2|75|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:03:10.647727|2017-02-18 16:03:10.647727
NCT00407641|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2017-01-24|||March 2009||2009-03-01|January 2017|2017-01-01|January 2017|Anticipated|2017-01-01|January 2015|Actual|2015-01-01||Interventional|||Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis|"Effects of Tinzaparin Sodium on Cardio-vascular OUtcomes and on Blood Lipids in Diabetic Patients on Chronic HEmodialysis: A Long-term, Prospective Study (The Tinzaparin COULD HELP Study)."|Suspended||Phase 4|200|Anticipated|Anemia Working Group Romania||2||Financial and administrative matters did not allow collaboration among centers.|f||||||||||||||2017-02-18 16:03:11.026949|2017-02-18 16:03:11.026949
NCT00407628|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-03|2013-07-04|||August 2006||2006-08-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||Neural Correlates of Lower Extremity Motor Recovery in Stroke Patients: Longitudinal Diffusion Spectrum Imaging Studies|Neural Correlates of Lower Extremity Motor Recovery in Stroke Patients: Longitudinal Diffusion Spectrum Imaging Studies|Completed||N/A|24|Actual|National Taiwan University Hospital|||1||f||||||||||||||2017-02-18 16:03:11.150751|2017-02-18 16:03:11.150751
NCT00407615|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2007-09-20|||December 2006||2006-12-01|September 2007|2007-09-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Double-Blind Placebo Study on Magnetic Field Therapy in Chronic Lumbar Pain|A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY ON MAGNETIC FIELD THERAPY TO IMPROVE CHRONIC LUMBAR PAIN|Unknown status|Recruiting|Phase 4|40|Anticipated|Weintraub, Michael I., MD, FACP, FAAN|||||f||||||||||||||2017-02-18 16:03:11.235187|2017-02-18 16:03:11.235187
NCT00407602|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2015-05-28|||September 2006||2006-09-01|May 2015|2015-05-01|August 2019|Anticipated|2019-08-01|March 2012|Actual|2012-03-01||Interventional|||Argus® II Retinal Stimulation System Feasibility Protocol|Argus® II Retinal Stimulation System Feasibility Protocol|Active, not recruiting||Phase 2|30|Actual|Second Sight Medical Products||1|||f||||t||||||||||2017-02-18 16:03:11.331253|2017-02-18 16:03:11.331253
NCT00407589|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2011-12-07|||October 2006||2006-10-01|December 2011|2011-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Systemic Pharmacokinetics of BOL-303224-A|Systemic Pharmacokinetics of BOL-303224-A After Single and Multiple Instillations of BOL-303224-A in Subjects With Suspected Bacterial Conjunctivitis|Completed||Phase 1|24|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 16:03:11.449238|2017-02-18 16:03:11.449238
NCT00407576|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-02|2017-01-24|||December 1, 2006||2006-12-01|November 7, 2008|2008-11-07||||November 7, 2008|Actual|2008-11-07||Interventional|||PET Imaging of Brain Amyloid Using [11C]MeS-IMPY|PET Imaging of Brain Amyloid Using [11C]MeS-IMPY|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:03:11.554496|2017-02-18 16:03:11.554496
NCT00407563|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2012-03-08|2011-09-28||January 2007||2007-01-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer|A Phase 2 Study of Bevacizumab With Abraxane in Patients With Recurrent, Platinum-Resistant Primary Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|48|Actual|Accelerated Community Oncology Research Network||1|||f||||f||||||||||2017-02-18 16:03:11.648667|2017-02-18 16:03:11.648667
NCT00407550|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2016-04-19|2012-02-17||November 2006||2006-11-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|January 2008|Actual|2008-01-01||Interventional|||Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Randomized Phase II Study of ALIMTA® (Pemetrexed) and GEMZAR® (Gemcitabine) Every 14 Days Versus Pemetrexed and Gemcitabine Every 21 Days in Advanced Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|19|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:03:12.093946|2017-02-18 16:03:12.093946
NCT00407537|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2015-06-30|2010-10-06||March 2007||2007-03-01|June 2015|2015-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|CRUCIAL||Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors|A Cluster Randomized Trial On Cardiovascular Risk Factor Management: Caduet Versus Usual Care In Subjects With Hypertension And Additional Cardiovascular Risk Factors In Clinical Practice|Completed||Phase 4|1531|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:03:12.870362|2017-02-18 16:03:12.870362
NCT00407524|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2006-12-04|||October 2003||2003-10-01|December 2006|2006-12-01|March 2005||2005-03-01|||||Interventional|||AKL 1 Asthma Study|AKL1 Asthma Study - Randomised, Double-Blind, Placebo Controlled, Cross Over Study to Determine Safety and Efficacy of Oral AKL1 in Treating Patients With Asthma|Completed||Phase 2|40||University of Aberdeen|||||f||||||||||||||2017-02-18 16:03:14.579418|2017-02-18 16:03:14.579418
NCT00407511|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2009-10-08|2009-06-18||January 2007||2007-01-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP|A Prospective, Open Label, Multi-Center, Study Of Pregabalin In The Treatment Of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy, Postherpetic Neuralgia, HIV-Related Peripheral Neuropathic Pain And Chemotherapy Induced Peripheral Neuropathic Pain|Completed||Phase 4|121|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:03:14.666681|2017-02-18 16:03:14.666681
NCT00407498|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2008-12-31|||May 2005||2005-05-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms|An Open Label Multicentric Phase 1 Study of Selective Cyclin Dependent Kinase Inhibitor P276-00 in Patients With Advanced Refractory Neoplasms|Completed||Phase 1|50|Actual|Piramal Enterprises Limited||1|||f||||f||||||||||2017-02-18 16:03:15.38264|2017-02-18 16:03:15.38264
NCT00407277|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2009-03-17|||February 2007||2007-02-01|March 2009|2009-03-01||||August 2008|Actual|2008-08-01||Interventional|||Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia|Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia|Completed||N/A|120|Anticipated|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-02-18 16:03:17.636113|2017-02-18 16:03:17.636113
NCT00407485|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2014-10-10|2014-08-27||November 2006||2006-11-01|October 2013|2013-10-01|April 2014|Actual|2014-04-01|April 2010|Actual|2010-04-01||Interventional|||VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium|A Phase II Study of VEGF Trap (NSC 724770) in Patients With Recurrent or Metastatic Transitional Carcinoma of the Urothelium|Completed||Phase 2|22|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:03:15.497446|2017-02-18 16:03:15.497446
NCT00407472|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2013-10-21|||September 2005||2005-09-01|October 2013|2013-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency||Completed||Phase 1|38||EMD Serono|||||f||||||||||||||2017-02-18 16:03:15.814583|2017-02-18 16:03:15.814583
NCT00407459|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2011-08-31|||September 2007||2007-09-01|August 2011|2011-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma|Phase II Study of the Combination of Bevacizumab Plus Pemetrexed and Carboplatin as First-line Therapy in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|77|Actual|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-02-18 16:03:15.883516|2017-02-18 16:03:15.883516
NCT00407446|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2006-12-12|||January 2004||2004-01-01|December 2006|2006-12-01|February 2005||2005-02-01|||||Interventional|||PDE5-Inhibition With Sildenafil in Chronic Heart Failure|Long-Term Use of Sildenafil in the Therapeutic Management of Heart Failure|Completed||Phase 3|40||University of Milan|||||f||||||||||||||2017-02-18 16:03:15.993305|2017-02-18 16:03:15.993305
NCT00407433|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2009-08-06||||||August 2009|2009-08-01||||||||Interventional|||Clinical Studies of Gemcitabine-Oxaliplatin|Phase 2 Single-Arm Studies of Gemcitabine in Combination With Oxaliplatin Refractory and Relapsed Pediatric Solid Tumors|Completed||Phase 2|156|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 16:03:16.104972|2017-02-18 16:03:16.104972
NCT00407420|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2006-12-04||||||December 2006|2006-12-01||||||||Interventional|||"Can a Novel Treatment Using Mandometer® Technology Improve Weight Loss in a Childhood Obesity Clinic?"||Completed||N/A|90||University of Bristol|||||f||||||||||||||2017-02-18 16:03:16.198447|2017-02-18 16:03:16.198447
NCT00407407|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2012-04-06|||November 2006||2006-11-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma|A Phase I Dose Escalation Study of ABI-007 With Carboplatin TM as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma|Terminated||Phase 1|6|Actual|Celgene||1||MTD not determined|f||||f||||||||||2017-02-18 16:03:16.293643|2017-02-18 16:03:16.293643
NCT00407394|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-02|2006-12-02|||April 2004||2004-04-01|December 2006|2006-12-01|April 2006||2006-04-01|||||Interventional|||Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze|Randomized Double Blind Placebo Controlled Trial of Amoxycillin in the Treatment of Non-Severe Pneumonia With Wheeze in Children Aged 2- 59 Months of Age: A Multi-Centric Study|Completed||Phase 3|2000||King George's Medical University|||||f||||||||||||||2017-02-18 16:03:16.39144|2017-02-18 16:03:16.39144
NCT00407381|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2009-01-30|||December 2006||2006-12-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||The READ-2 Study: Ranibizumab for Edema of the mAcula in Diabetes|Ranibizumab for Edema of the Macula in Diabetes: a Phase 2 Study ( The Read-2 Study)|Unknown status|Active, not recruiting|Phase 2|126|Anticipated|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 16:03:16.490592|2017-02-18 16:03:16.490592
NCT00407368|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2006-12-04|||September 2006||2006-09-01|November 2006|2006-11-01|December 2007||2007-12-01|||||Observational|||Platelets Function and Cardiovascular Events in Patients With End Stage Renal Disease||Unknown status|Recruiting|N/A|150||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 16:03:16.638372|2017-02-18 16:03:16.638372
NCT00407355|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2013-10-07|2013-10-07||January 2006||2006-01-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|LVO||Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions|A Pilot, Open-Label Study of the Safety, Tolerability, and Bioactivity of Multiple Intravitreal Injections of Ranibizumab in Subjects With Macular Edema Secondary to Vein Occlusions.|Completed||Phase 1/Phase 2|40|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 16:03:16.72733|2017-02-18 16:03:16.72733
NCT00407342|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-04|2009-09-29|||February 2004||2004-02-01|September 2009|2009-09-01|September 2004|Actual|2004-09-01|June 2004|Actual|2004-06-01||Interventional|||Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis.|Prospective, Randomized Half-side Comparison of Alefacept (Amevive) With or Without UVB-311nm Phototherapy in Patients With Psoriasis (Translated From German)|Completed||N/A|14|Actual|Medical University of Graz||2|||f||||f||||||||||2017-02-18 16:03:17.133329|2017-02-18 16:03:17.133329
NCT00407329|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2013-11-05|||November 2006||2006-11-01|November 2013|2013-11-01|January 2012|Actual|2012-01-01|February 2008|Actual|2008-02-01||Observational|||Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia|Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia: A Possible Marker of Progression and Response to Medical Therapy|Completed||N/A|30|Actual|Queen's University|||1||f||||f||||||||||2017-02-18 16:03:17.237951|2017-02-18 16:03:17.237951
NCT00407316|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-02|2006-12-04|||June 2006||2006-06-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Observational|||Quality of Life and Visual Function in Uveitis Patients||Unknown status|Recruiting|Early Phase 1|50||The New York Eye & Ear Infirmary|||||f||||||||||||||2017-02-18 16:03:17.340196|2017-02-18 16:03:17.340196
NCT00407303|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2016-07-19||2013-08-16|October 2006||2006-10-01|July 2016|2016-07-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)|A Phase I/II Study of Obatoclax Mesylate (GX15-070MS) Administered in Combination With Bortezomib to Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)|Completed||Phase 1/Phase 2|24|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-02-18 16:03:17.438041|2017-02-18 16:03:17.438041
NCT00407290|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2006-12-04|||March 2006||2006-03-01|December 2006|2006-12-01|October 2006||2006-10-01|||||Interventional|||The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.|The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor, on Either Immediate Postpartum Perineal Pain or Development of Chronic Perineal Pain After Vaginal Delivery.|Unknown status|Recruiting|N/A|60||Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||||f||||||||||||||2017-02-18 16:03:17.549501|2017-02-18 16:03:17.549501
NCT00407264|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-29|||February 2002||2002-02-01|November 2006|2006-11-01|December 2005||2005-12-01|||||Interventional|||Randomized Trial of Fluticasone in Bronchial Premalignancy|The Influence of Fluticasone Inhalation on Intermediate Markers of Carcinogenesis in the Bronchial Epithelium of a High Risk Population : A Double Blind Placebo-Controlled Randomised Phase II Study|Completed||Phase 2|90||VU University Medical Center|||||f||||||||||||||2017-02-18 16:03:17.754713|2017-02-18 16:03:17.754713
NCT00407251|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2010-11-03|||February 2007||2007-02-01|November 2010|2010-11-01||||June 2010|Actual|2010-06-01||Interventional|||Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy|A Phase II Study of Patupilone (EPO906A) as a Second Line Chemotherapy in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|73|Anticipated|British Columbia Cancer Agency|||||f||||||||||||||2017-02-18 16:03:17.852546|2017-02-18 16:03:17.852546
NCT00407238|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2007-10-21|||November 2006||2006-11-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Interventional|||Corneal Barrier Function With Multi-Purpose Solutions|Comparison of Human Corneal Barrier Function With Three Marketed Multi-Purpose Solutions|Completed||N/A|25|Anticipated|Southern California College of Optometry|||||f||||||||||||||2017-02-18 16:03:17.949812|2017-02-18 16:03:17.949812
NCT00407225|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-12-05|||December 1999||1999-12-01|November 2006|2006-11-01|October 2000||2000-10-01|||||Interventional|||Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation|Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation After Cataract Surgery|Completed||Phase 2|24||Sirion Therapeutics, Inc.|||||f||||||||||||||2017-02-18 16:03:18.278692|2017-02-18 16:03:18.278692
NCT00407212|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2011-11-22|||January 2002||2002-01-01|November 2011|2011-11-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-ranging, Efficacy and Safety Study of Three Doses of TCH346 (1mg, 5mg and 20mg Daily) in Patients With Early Parkinson's Disease|Completed||Phase 1/Phase 2|301|Actual|Novartis|||||f||||||||||||||2017-02-18 16:03:18.361118|2017-02-18 16:03:18.361118
NCT00407199|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2011-10-26|||December 2006||2006-12-01|October 2011|2011-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment|The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Effects on Cue Reactivity in Response to Virtual Reality Public Speaking Environment|Completed||Phase 4|20|Actual|University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 16:03:18.559101|2017-02-18 16:03:18.559101
NCT00407186|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2011-08-27|||December 2006||2006-12-01|August 2011|2011-08-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)|A Multicenter Randomized Phase III Trial of Neo-adjuvant Chemotherapy Followed by Surgery and Chemotherapy or by Surgery and Chemoradiotherapy in Resectable Gastric Cancer (CRITICS Study)|Unknown status|Recruiting|Phase 3|788|Anticipated|Dutch Colorectal Cancer Group||2|||f||||t||||||||||2017-02-18 16:03:18.658938|2017-02-18 16:03:18.658938
NCT00407173|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2008-04-10|||November 2006||2006-11-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects|An Open-Label, Single-Dose, Parallel Group Study to Evaluate the Effects of Age and Gender on the Pharmacokinetics, Safety, and Tolerability of HCV-796 Administered Orally to Healthy Subjects|Completed||Phase 1|48|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 16:03:18.768329|2017-02-18 16:03:18.768329
NCT00407160|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2011-09-06|||August 2004||2004-08-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients|Comparison of Two Different Immunosuppression Protocols in Highly Sensitized Renal Transplant Recipients: Campath Induction With Tacrolimus Monotherapy vs Thymoglobulin Induction With Triple Drug Protocol.|Completed||N/A|60|Anticipated|The University of Texas Medical Branch, Galveston|||2||f||||t||||||||||2017-02-18 16:03:18.852598|2017-02-18 16:03:18.852598
NCT00407147|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2012-01-16|||July 2008||2008-07-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection|ProBac - Use of Procalcitonin Level as Part of a Decision Tree to Discontinue Antibiotics When Started Empirically in the ICU in Hemodynamically Stable Patients With no Site of Infection Identified|Terminated||Phase 4|11|Actual|Brahms AG||2||termination due to futility (very slow patient enrollment)|f||||t||||||||||2017-02-18 16:03:18.952928|2017-02-18 16:03:18.952928
NCT00407134|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2007-12-19|||December 2006||2006-12-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology|Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology|Completed||N/A|20||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:03:19.072016|2017-02-18 16:03:19.072016
NCT00407121|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2006-12-01|||August 2006||2006-08-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Interventional|||Intravitreal Bevacizumab for Inflammatory Neovascular Membranes|Intravitreal Bevacizumab for the Treatment of Neovascular Membranes in Patients With Intraocular Inflammation|Completed||Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:03:19.148581|2017-02-18 16:03:19.148581
NCT00407108|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-12-05|||March 2006||2006-03-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy||Unknown status|Recruiting|Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:03:19.237065|2017-02-18 16:03:19.237065
NCT00407095|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2010-09-10|||August 2007||2007-08-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.|An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.|Completed||Phase 3|140|Anticipated|Solvay Pharmaceuticals||1|||f||||t||||||||||2017-02-18 16:03:19.325174|2017-02-18 16:03:19.325174
NCT00406887|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-11-29|||August 2002||2002-08-01|November 2006|2006-11-01|November 2003||2003-11-01|||||Interventional|||Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis|Phase 3 Confirmatory Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Anterior Uveitis (Including Panuveitis).|Completed||Phase 3|140||Sirion Therapeutics, Inc.|||||f||||||||||||||2017-02-18 16:03:24.451128|2017-02-18 16:03:24.451128
NCT00407082|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2011-12-07|||December 2000||2000-12-01|December 2011|2011-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants|A Multicenter, Randomized, Double-Masked, Controlled Study to Evaluate the Safety & Efficacy of Intravitreal Fluocinolone Acetonide (0.59 or 2.1 mg) Implant in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye|Completed||Phase 2/Phase 3|278|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-02-18 16:03:22.165325|2017-02-18 16:03:22.165325
NCT00407069|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-10-14|||June 2005||2005-06-01|October 2016|2016-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus|Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus (ADVN AMP01)|Completed||N/A|286|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||6||f||||t||||||Samples With DNA|"~     Blood and skin samples will be retained~   "|Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 16:03:22.267644|2017-02-18 16:03:22.267644
NCT00407056|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-11-29|||August 2002||2002-08-01|November 2006|2006-11-01|June 2003||2003-06-01|||||Interventional|||Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis|Phase 3 Open-Labeled Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Severe Anterior Uveitis (Including Panuveitis).|Completed||Phase 3|20||Sirion Therapeutics, Inc.|||||f||||||||||||||2017-02-18 16:03:22.378205|2017-02-18 16:03:22.378205
NCT00407043|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2011-07-20|||November 2006||2006-11-01|July 2011|2011-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis|A Prospective, Multicenter, Randomized Controlled Study of the Effect of Lotepredol Etabonate on The Initiation of Dry Eye Treatment With Topical Cyclosporine|Completed||Phase 4|5|Actual|Ophthalmic Consultants of Long Island|||||f||||t||||||||||2017-02-18 16:03:22.456871|2017-02-18 16:03:22.456871
NCT00407030|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2013-07-12|2010-08-31||July 2006||2006-07-01|July 2013|2013-07-01|June 2009|Actual|2009-06-01|January 2008|Actual|2008-01-01||Interventional|||IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia|Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Trial With a Double-blind Parallel-group Extension Period to Investigate the Efficacy and Safety of Different Doses of IncobotulinumtoxinA (Xeomin) in the Treatment of Cervical Dystonia|Completed||Phase 3|233|Actual|Merz Pharmaceuticals GmbH||3|||f||||t||||||||||2017-02-18 16:03:22.559383|2017-02-18 16:03:22.559383
NCT00407017|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2007-08-17||||||August 2007|2007-08-01||||||||Interventional|||Therapeutic Variables in Cataract Surgery||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:03:23.483055|2017-02-18 16:03:23.483055
NCT00407004|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2006-12-01|||March 2003||2003-03-01|November 2006|2006-11-01|April 2004||2004-04-01|||||Interventional|||Elimination of Albumin-Bound Substances by MARS and Prometheus|Effect of Extracorporeal Liver Support by MARS and Prometheus on Albumin-Bound Substances in Acute-on-Chronic Liver Failure|Completed||N/A|10||Medical University of Graz|||||f||||||||||||||2017-02-18 16:03:23.570374|2017-02-18 16:03:23.570374
NCT00406991|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2015-10-28|||June 2003||2003-06-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Retinal Blood Flow and Microthrombi in Type 1 Diabetes|Retinal Blood Flow and Microthrombi in Type 1 Diabetes|Completed||Phase 2|100||Massachusetts Eye and Ear Infirmary|||||f||||||||||||||2017-02-18 16:03:23.670995|2017-02-18 16:03:23.670995
NCT00406978|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-05-09|||February 2006||2006-02-01|May 2016|2016-05-01|April 2014|Actual|2014-04-01|September 2010|Actual|2010-09-01||Interventional|MPTD||Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients|A Phase I/II, Multi-Center, Open Label Study of Melphalan, Prednisone, Thalidomide and Defibrotide in Advanced and Refractory Multiple Myeloma Patients|Completed||Phase 1/Phase 2|24|Actual|University of Turin, Italy||1|||f||||f||||||||||2017-02-18 16:03:23.764942|2017-02-18 16:03:23.764942
NCT00406965|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2007-12-31|||December 2006||2006-12-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of HAE1 (PRO98498) in Subjects With Moderate to Severe Allergic Asthma|Completed||Phase 2|50||Genentech, Inc.|||||f||||||||||||||2017-02-18 16:03:23.876775|2017-02-18 16:03:23.876775
NCT00406952|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2008-08-20|||November 2006||2006-11-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Study for Evaluating Different Methods of Measuring Depression Treatment Response|A Phase 4 Randomized, Double-Blind, Placebo Controlled Methodology Study to Evaluate the Time of Onset of AntiDepressant Response in Subjects With Major Depressive Disorder|Completed||N/A|165|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:03:23.950411|2017-02-18 16:03:23.950411
NCT00406939|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2008-07-08|||June 1998||1998-06-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Vector Delivery of the IL-12 Gene in Men With Prostate Cancer|Phase I Study of Adenoviral Vector Delivery of The IL-12 Gene in Men With Recurrence or Persistent Cancer of the Prostate After Primary Therapy With or Without Metastatic Disease (SPORE)|Completed||Phase 1|4|Actual|Baylor College of Medicine|||||f||||||||||||||2017-02-18 16:03:24.044442|2017-02-18 16:03:24.044442
NCT00406926|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-11-29|||August 1999||1999-08-01|November 2006|2006-11-01|August 2003||2003-08-01|||||Interventional|||The Effect of Growth Hormone in Very Young Girls With Turner Syndrome|The Effect of Recombinant Human Growth Hormone Treatment on the Growth of Infants and Toddlers With Turner Syndrome|Completed||Phase 3|100||Eli Lilly and Company|||||||||||||||||||2017-02-18 16:03:24.149241|2017-02-18 16:03:24.149241
NCT00406913|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2013-09-04|||October 2005||2005-10-01|September 2013|2013-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery|Assessment of Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery Using Intranasal Mupirocin Ointment|Completed||N/A|37|Actual|University of Chicago||2|||f||||||||||||||2017-02-18 16:03:24.234917|2017-02-18 16:03:24.234917
NCT00406900|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-12-05|||January 1999||1999-01-01|November 2006|2006-11-01|September 2006||2006-09-01|||||Observational|||Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma||Unknown status|Recruiting|N/A|560||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 16:03:24.341221|2017-02-18 16:03:24.341221
NCT00406874|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2013-06-03|||January 2007||2007-01-01|June 2013|2013-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Omega 3 Fats on Sperm Quality and Sexual Function|Effect of Omega 3 Fats on Sperm Quality and Sexual Function in Infertile Men Age 35-55|Terminated||Phase 2|6|Actual|Reproductive Partners Medical Group||1||reports indicating that increased folic acid intake may increase colin cancer|f||||f||||||||||2017-02-18 16:03:24.531727|2017-02-18 16:03:24.531727
NCT00406861|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2006-12-01|||December 2006||2006-12-01|November 2006|2006-11-01|June 2009||2009-06-01|||||Interventional|||Montelukast in ENL Reaction|Montelukast as an Alternative or Supplementary Treatment in ENL Reaction in Leprosy|Unknown status|Not yet recruiting|N/A|60||The Leprosy Mission Bangladesh|||||f||||||||||||||2017-02-18 16:03:24.863641|2017-02-18 16:03:24.863641
NCT00406848|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2010-09-13|2010-07-22||November 2006||2006-11-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|||A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients|Duloxetine Versus Placebo in the Long-Term Treatment of Patients With Late-Life Major Depression|Completed||Phase 4|370|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:03:24.980309|2017-02-18 16:03:24.980309
NCT00406835|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2006-11-30|||October 1999||1999-10-01|November 2006|2006-11-01|April 2005||2005-04-01|||||Observational|||Prospective Randomized Trial Between WBRT Plus SRS Versus SRS Alone for 1-4 Brain Metastases|Phase 3 Study of Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for 1-4 Brain Metastases|Completed||Phase 3|180||Hokkaido University Hospital|||||f||||||||||||||2017-02-18 16:03:27.168268|2017-02-18 16:03:27.168268
NCT00406822|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2008-04-25|||December 2006||2006-12-01|June 2007|2007-06-01||||||||Interventional|||OculusGen-Glaucoma Historical Control Study in Taiwan|Study of the Safety and Effectiveness of the OculusGen Collagen Matrix Implant as an Aid in Glaucoma Surgery|Terminated||Phase 3|48|Anticipated|Pro Top & Mediking Company Limited||||Terminated due to the change of supplier and sponsor|f||||||||||||||2017-02-18 16:03:27.250924|2017-02-18 16:03:27.250924
NCT00406809|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-11-10|||November 2006||2006-11-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies|A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies|Completed||Phase 2|81|Actual|AbbVie||4|||f||||f||||||||||2017-02-18 16:03:27.366289|2017-02-18 16:03:27.366289
NCT00406796|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2013-12-10|||January 2006||2006-01-01|December 2013|2013-12-01|October 2010|Actual|2010-10-01|September 2008|Actual|2008-09-01||Interventional|||Lucentis for Central Retinal Vein Occlusion (CRVO)|FVF3565s Intravitreal Ranibizumab (rhuFab V2) in the Treatment of Macular Edema Associated With Perfused Central (CRVO) Retinal Venous Occlusive Disease|Completed||Phase 1|20|Actual|California Retina Consultants||2|||f||||t||||||||||2017-02-18 16:03:27.493623|2017-02-18 16:03:27.493623
NCT00406783|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2015-05-15|2008-11-21||August 2006||2006-08-01|May 2015|2015-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)|Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Intermittent Allergic Rhinitis (IAR)|Completed||Phase 3|547|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:03:27.606183|2017-02-18 16:03:27.606183
NCT00406770|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2009-10-18|||December 2006||2006-12-01|October 2009|2009-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Bright Light Therapy for Weight Loss||Completed||N/A|41|Actual|Russian Academy of Medical Sciences||1|||f||||f||||||||||2017-02-18 16:03:27.940743|2017-02-18 16:03:27.940743
NCT00406757|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2012-05-31|||August 2006||2006-08-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma|Clinical Evaluation of 506U78 in Japanese Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma.|Completed||Phase 1|13|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-02-18 16:03:28.019117|2017-02-18 16:03:28.019117
NCT00406744|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2006-11-30|||May 2006||2006-05-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Efficacy of Retreatments With Intravitreal Bevacizumab|Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments|Unknown status|Recruiting|Phase 3|20||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:03:28.122959|2017-02-18 16:03:28.122959
NCT00406731|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2014-11-20|||January 2008||2008-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure|Role of endothelin-and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure|Withdrawn||Phase 2|0|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-02-18 16:03:28.202862|2017-02-18 16:03:28.202862
NCT00406718|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2015-09-01|2015-05-01||November 2006||2006-11-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||X2 for categorical, and one way anova for continuous to examine differences in demographics for participants not making it to randomization versus those randomized to treatment.|Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia|Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia|Completed||N/A|197|Actual|The University of Texas Health Science Center at San Antonio|Patients had long-standing illness and results may not apply to patients with a more recent onset of schizophrenia/schizoaffective disorder|3|||f||||f||||||||||2017-02-18 16:03:28.305804|2017-02-18 16:03:28.305804
NCT00406705|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2007-05-03|||March 2005||2005-03-01|March 2007|2007-03-01|January 2007|Actual|2007-01-01|||||Interventional|||The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPD|A Randomized Controlled Trial to Study the Effect of Exercise Training Breathing Helium-Hyperoxia on The Exercise Tolerance and Quality of Life of Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|38||University of Alberta|||||f||||||||||||||2017-02-18 16:03:28.805054|2017-02-18 16:03:28.805054
NCT00406692|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2010-05-06|2010-02-08||November 2006||2006-11-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|August 2008|Actual|2008-08-01||Interventional|||The Effects of Zonisamide on Alcohol Dependence|The Effects of Zonisamide on Alcohol Dependence|Completed||Phase 2|16|Actual|Boston University|Limitations of this trial include lack of a placebo controlled arm and small sample size.|1|||f||||t||||||||||2017-02-18 16:03:29.130099|2017-02-18 16:03:29.130099
NCT00406679|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2011-08-10|||November 2006||2006-11-01|August 2011|2011-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-containing Solutions in Post-Surgical Dental Pain|Single-Dose Comparison of the Analgesic Efficacy, Safety and Tolerability of Two Paracetamol 1%-Containing Solutions and Placebo in a Post-Surgical Dental Pain Model|Completed||Phase 3|135|Actual|Baxter Healthcare Corporation||3|||f||||f||||||||||2017-02-18 16:03:29.38301|2017-02-18 16:03:29.38301
NCT00406653|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2010-09-10|2010-07-30||December 2006||2006-12-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study of Abatacept in Patients With Active Crohn's Disease|A Phase 3, Multi-Center, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With Abatacept in Subjects With Active Crohn's Disease (CD) Who Have Had an Inadequate Clinical Response and/or Intolerance to Medical Therapy|Terminated||Phase 3|451|Actual|Bristol-Myers Squibb||3||Sponsor Decision|f||||t||||||||||2017-02-18 16:03:29.515124|2017-02-18 16:03:29.515124
NCT00406640|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2010-05-26|2009-02-27||December 2006||2006-12-01|May 2010|2010-05-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women|A Multicenter, Randomized, 8-Week Double-Blind Acute Phase Followed By a 6-Month Continuation Phase (Open-Label Or Double-Blind) Study to Evaluate the Efficacy, Safety, and Tolerability of DVS SR Versus Escitalopram in Postmenopausal Women With Major Depressive Disorder|Completed||Phase 3|595|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 16:03:32.619772|2017-02-18 16:03:32.619772
NCT00406627|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2008-09-08|||December 2006||2006-12-01|September 2008|2008-09-01|December 2011||2011-12-01|||||Observational|||Research for Elimination of Lymphatic Filariasis (ICIDR)|Research for Elimination of Lymphatic Filariasis (ICIDR)|Completed||N/A|117500||Washington University School of Medicine|||||f||||||||||||||2017-02-18 16:03:33.436612|2017-02-18 16:03:33.436612
NCT00406614|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2011-11-28|||September 2007||2007-09-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|August 2009|Actual|2009-08-01||Interventional|||Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans|Health Literacy Intervention for Korean Americans With High Blood Pressure (HBP)|Completed||Phase 2/Phase 3|360|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:03:33.521309|2017-02-18 16:03:33.521309
NCT00406601|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2010-09-01|||November 2006||2006-11-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|June 2010|Actual|2010-06-01||Interventional|||BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas|Phase II Prospective Study With BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas, After Anthracycline-based Therapy|Completed||Phase 2|69|Actual|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-02-18 16:03:33.632854|2017-02-18 16:03:33.632854
NCT00406588|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2015-02-09||2015-01-29|March 2007||2007-03-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of SLV308 as Adjunct Therapy to Levodopa in Patients With Parkinson's Disease Experiencing Motor Fluctuations.|Completed||Phase 3|295|Actual|Solvay Pharmaceuticals||2|||f||||t||||||||||2017-02-18 16:03:33.724954|2017-02-18 16:03:33.724954
NCT00406575|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2014-05-06|||November 2006||2006-11-01|May 2014|2014-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Recombinant Human Relaxin for the Treatment of Decompensated CHF|A Phase II Randomized, Double Blind, Placebo-Controlled Study of Recombinant Human Relaxin in Patients With Decompensated Congestive Heart Failure|Terminated||Phase 2|11|Actual|Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies||3|||f||||||||||||||2017-02-18 16:03:33.910994|2017-02-18 16:03:33.910994
NCT00406562|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2016-10-26|||January 2007||2007-01-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|||||Interventional|||Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.|Open, Booster Vaccination Study to Assess Safety and Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Administered to Healthy Chinese Children 6-8 Years of Age.|Completed||Phase 3|30||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:03:34.03222|2017-02-18 16:03:34.03222
NCT00406549|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2007-03-07|||December 2006||2006-12-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Observational|||Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus|Multi-Center Clinical Performance Evaluation of a Rapid In Vitro Diagnostic Device for Direct Detection of Staphylococcus Aureus Nasal Colonization: Comparative Analysis to Culture Screening Methods|Completed||N/A|2000||3M|||||f||||||||||||||2017-02-18 16:03:34.135353|2017-02-18 16:03:34.135353
NCT00406536|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2013-01-11|||January 2007||2007-01-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI|Phase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CF|Completed||Phase 2|110|Actual|Avanti Polar Lipids, Inc.||2|||f||||||||||||||2017-02-18 16:03:34.220644|2017-02-18 16:03:34.220644
NCT00406523|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2006-11-30|||February 2006||2006-02-01|November 2006|2006-11-01|September 2007||2007-09-01|||||Interventional|||A Single Center Prospective Randomized Controlled Clinical Study of JANUS Stent in Patients With Coronary Artery Disease||Completed||Phase 4|||Shenyang Northern Hospital|||||f||||||||||||||2017-02-18 16:03:34.383212|2017-02-18 16:03:34.383212
NCT00406510|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2007-05-30||||||May 2007|2007-05-01||||||||Interventional|||Comparison of Frequency of Use of Optive and Systane||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:03:34.44906|2017-02-18 16:03:34.44906
NCT00406497|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-11-29|||April 2003||2003-04-01|November 2006|2006-11-01|July 2003||2003-07-01|||||Interventional|||Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation|Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation|Completed||Phase 2|24||Sirion Therapeutics, Inc.|||||f||||||||||||||2017-02-18 16:03:34.522593|2017-02-18 16:03:34.522593
NCT00406484|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2014-01-15|||September 2004||2004-09-01|January 2014|2014-01-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||Brief Introductory Therapy for Opioid Dependence|Brief Introductory Therapy for Opioid Dependence|Completed||Phase 2|51|Actual|Yale University||2|||f||||f||||||||||2017-02-18 16:03:34.606027|2017-02-18 16:03:34.606027
NCT00338533|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-01-06|||April 1997||1997-04-01|January 2013|2013-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Endoscopic Goniotomy for Infantile Glaucoma|Endoscopic Goniotomy for Infantile Glaucoma|Completed||N/A|7|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:28:09.522526|2017-02-18 16:28:09.522526
NCT00406458|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2012-10-30||2012-10-30|November 2006||2006-11-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy|A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy|Completed||Phase 2|110|Actual|Sangamo Therapeutics||2|||f||||f||||||||||2017-02-18 16:03:34.92254|2017-02-18 16:03:34.92254
NCT00406445|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-25|2017-01-24|||November 21, 2006||2006-11-21|August 29, 2016|2016-08-29||||||||Observational|||Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome|Metabolic Regulation by Tumor Suppressor p53 in Li-Fraumeni Syndrome|Recruiting||N/A|246|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:03:35.042688|2017-02-18 16:03:35.042688
NCT00406432|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2012-05-31|||May 2006||2006-05-01|February 2011|2011-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects|A Steady-state Study to Assess the Pharmacokinetic Profile of Paroxetine After 14 Day Repeated Daily Dosing of the Controlled Release Paroxetine Tablet (25 mg) in Healthy Chinese Subjects|Completed||Phase 1|12|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:03:35.160596|2017-02-18 16:03:35.160596
NCT00406419|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2015-11-17||2013-06-28|December 2006||2006-12-01|November 2015|2015-11-01|April 2015|Actual|2015-04-01|September 2011|Actual|2011-09-01||Interventional|STAGE||A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)|A Randomized, Double-Blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment|Terminated||Phase 3|1015|Actual|Genentech, Inc.||3||"Based on analysis of results and consideration of available treatments, the overall benefit to~   risk profile of ocrelizumab was not favorable in RA."|f||||||||||||||2017-02-18 16:03:35.249735|2017-02-18 16:03:35.249735
NCT00406406|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2007-12-03|||November 2006||2006-11-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating SKI-606 Administered to Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SKI-606 Administered Orally to Healthy Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:03:35.351236|2017-02-18 16:03:35.351236
NCT00406393|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-02-08|2016-01-06||November 2006||2006-11-01|February 2016|2016-02-01|October 2015|Actual|2015-10-01|October 2012|Actual|2012-10-01||Interventional|||Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)|A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402)|Completed||Phase 3|304|Actual|Medical College of Wisconsin||2|||f||||t||||||||Yes|Findings will be published in a manuscript.|2017-02-18 16:03:35.607874|2017-02-18 16:03:35.607874
NCT00406380|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2006-12-01|||September 2006||2006-09-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Effect of Avastin in Juxtafoveal Telangiectasias|Does Avastin Change Evolution in Juxtafoveal Telangiectasias?|Unknown status|Recruiting|Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:03:36.688243|2017-02-18 16:03:36.688243
NCT00406367|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2013-03-13|2010-08-31||October 2006||2006-10-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|April 2008|Actual|2008-04-01||Interventional|||IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm|Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Trial With an Open-label Extension Period to Investigate the Efficacy and Safety of incobotulinumtoxinA (Xeomin) in the Treatment of Blepharospasm|Completed||Phase 3|109|Actual|Merz Pharmaceuticals GmbH||2|||f||||||||||||||2017-02-18 16:03:36.792284|2017-02-18 16:03:36.792284
NCT00406354|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2010-02-19|2010-01-14||November 2006||2006-11-01|February 2010|2010-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany|A Randomized, Double-Blind Comparison of Atomoxetine Versus Placebo in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder|Completed||Phase 4|181|Actual|Eli Lilly and Company||3|||f||||||||||||||2017-02-18 16:03:37.217702|2017-02-18 16:03:37.217702
NCT00406341|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-11-29|||April 2004||2004-04-01|November 2006|2006-11-01|March 2005||2005-03-01|||||Interventional|||Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation|Phase 3 Confimatory Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treament of Postoperative Inflammation|Completed||Phase 3|200||Sirion Therapeutics, Inc.|||||f||||||||||||||2017-02-18 16:03:39.225539|2017-02-18 16:03:39.225539
NCT00406315|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2010-02-02|2009-12-01||November 2006||2006-11-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone|A Sixteen-Week, Multi-Center, Open-Label Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone In Subjects Diagnosed With Schizophrenia Or Schizoaffective Disorder|Completed||Phase 4|255|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:03:39.33955|2017-02-18 16:03:39.33955
NCT00406302|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2014-04-28|||January 2007||2007-01-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)|Multicenter Phase II Study Evaluating Docetaxel, CDDP, and Cetuximab as Induction Regimen Prior to Surgery in Chemo-naive Patients With NSCLC Stage IB, II and IIIA|Completed||Phase 2|41|Actual|Medical University of Vienna||1|||f||||f||||||||||2017-02-18 16:03:42.687514|2017-02-18 16:03:42.687514
NCT00406289|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2010-09-03|||November 2006||2006-11-01|September 2010|2010-09-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor|Phase I Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) With Patients With Head and Neck Tumor|Completed||Phase 1|24|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:03:42.811963|2017-02-18 16:03:42.811963
NCT00406276|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2013-08-19|2012-03-30||November 2006||2006-11-01|August 2013|2013-08-01|February 2013|Actual|2013-02-01|December 2010|Actual|2010-12-01||Interventional|||Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer|Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|28|Actual|Emory University||1||data analysis showed insufficient drug efficacy|f||||t||||||||||2017-02-18 16:03:42.908486|2017-02-18 16:03:42.908486
NCT00406263|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-07-25|||November 2006||2006-11-01|July 2016|2016-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls|Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectony Surgery and Controls|Completed||N/A|49|Actual|Barnes Retina Institute|||1||f||||f||||||||||2017-02-18 16:03:43.191737|2017-02-18 16:03:43.191737
NCT00406250|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-02-05|||November 2006||2006-11-01|February 2016|2016-02-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Intravitreal Bevacizumab in Agioid Streaks|Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Angioid Streaks: 24 Months Follow-up|Completed||Phase 1|5|Actual|Second University of Naples||1|||f||||t||||||||||2017-02-18 16:03:43.293961|2017-02-18 16:03:43.293961
NCT00406237|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2011-04-01|||December 2006||2006-12-01|April 2011|2011-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis|Open Label, Single Dose Study Of The Pharmacokinetics Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis|Completed||Phase 1|8|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 16:03:43.409035|2017-02-18 16:03:43.409035
NCT00406224|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2006-12-01|||December 2002||2002-12-01|November 2006|2006-11-01|December 2003||2003-12-01|||||Interventional|||Effect of Oxygen Breathing on Flicker Induced Blood Flow Changes in the Optic Nerve Head||Completed||N/A|||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:03:43.779922|2017-02-18 16:03:43.779922
NCT00406211|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2016-09-14|||July 2004||2004-07-01|September 2016|2016-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine|Follow-up to Evaluate the the Immunogenicity & Safety of GSK Biologicals' MMRV Vaccine Given as a Two-dose Schedule in the Second Year of Life, as Compared to Separate Administration of GSK Biologicals' Priorix® & Varilrix®.|Completed||Phase 3|398|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:03:43.854776|2017-02-18 16:03:43.854776
NCT00406198|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2006-12-01|||March 1997||1997-03-01|November 2006|2006-11-01|December 1999||1999-12-01|||||Interventional|||Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis|Phase 4 Randomized Multicentric Controlled Study on Impact of Continuous Venovenous Hemofiltration on Organ Failure at the Early Phase of Severe Sepsis|Completed||Phase 4|400||Hopital Lariboisière|||||f||||||||||||||2017-02-18 16:03:44.014595|2017-02-18 16:03:44.014595
NCT00406185|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-10-06|||October 1994||1994-10-01|October 2016|2016-10-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Observational|||Database Registry of the Intermountain Heart Collaborative Study|Database Registry of the Intermountain Heart Collaborative Study|Active, not recruiting||N/A|30000|Anticipated|Intermountain Health Care, Inc.|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 16:03:44.116583|2017-02-18 16:03:44.116583
NCT00406172|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2006-12-04||||||November 2006|2006-11-01||||||||Interventional|||Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)|Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)|Unknown status|Recruiting|Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:03:44.221908|2017-02-18 16:03:44.221908
NCT00406159|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2009-08-06|||November 2006||2006-11-01|August 2009|2009-08-01|September 2007|Actual|2007-09-01|||||Interventional|||Effects of Hyperbaric Oxygen Therapy on Children With Autism|Effects of Hyperbaric Oxygen Therapy on Behavioral Measures of Short Term Memory, Learning, and Behavior in Children With Autism|Completed||Phase 1|30|Anticipated|Thoughtful House|||||f||||||||||||||2017-02-18 16:03:44.315329|2017-02-18 16:03:44.315329
NCT00406146|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2006-11-30|||October 2004||2004-10-01|November 2006|2006-11-01|December 2006||2006-12-01|||||Interventional|||Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children||Unknown status|Active, not recruiting|Phase 3|||University of Ghana Medical School|||||f||||||||||||||2017-02-18 16:03:44.437347|2017-02-18 16:03:44.437347
NCT00406133|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2010-09-30|2009-05-11||December 2006||2006-12-01|September 2010|2010-09-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|||Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 Diabetes|A Randomized Clinical Trial to Assess the Efficacy of Real-Time Continuous Glucose Monitoring (RT-CGM) in the Management of Type 1 Diabetes|Completed||Phase 3|451|Actual|JDRF Artificial Pancreas Project||2|||f||||t||||||||||2017-02-18 16:03:44.541608|2017-02-18 16:03:44.541608
NCT00406120|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2007-05-16|||January 2007||2007-01-01|May 2007|2007-05-01|December 2017|Anticipated|2017-12-01|||||Observational|||Validation of a Molecular Prognostic Test for Eye Melanoma|Validation of a Molecular Test for Predicting Metastasis in Patients With Uveal Melanoma|Withdrawn||N/A|2000|Anticipated|Washington University School of Medicine||||It has come to our attention that the site was not necessary for our research project.|f||||||||||||||2017-02-18 16:03:46.386845|2017-02-18 16:03:46.386845
NCT00406107|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2014-09-10|2013-01-30||January 2006||2006-01-01|September 2014|2014-09-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion|Open Label Macugen for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion|Completed||Phase 4|20|Actual|Palmetto Retina Center, LLC||2|||f||||t||||||||||2017-02-18 16:03:46.49025|2017-02-18 16:03:46.49025
NCT00406094|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2009-01-15|||November 2006||2006-11-01|January 2009|2009-01-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)|The Evaluation of Singulair for the Treatment of Non-Allergic Rhinitis Eosinophil Syndrome (NARES)|Unknown status|Recruiting|Phase 4|6|Anticipated|Bernstein, Jonathan A., M.D.||2|||f||||||||||||||2017-02-18 16:03:46.952245|2017-02-18 16:03:46.952245
NCT00406081|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2017-01-10|||December 2005||2005-12-01|January 2017|2017-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Immune Response to Varicella Vaccination in Children With Atopic Dermatitis|Immune Response to Varicella Vaccination in Subjects With Atopic Dermatitis Compared to Nonatopic Controls (VAR 05)|Completed||N/A|69|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||f||||||None Retained|"~     Blood collected for endpoint measurements.~   "|Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 16:03:47.079914|2017-02-18 16:03:47.079914
NCT00406068|ClinicalTrials.gov processed this data on February 17, 2017|2006-12-01|2016-07-26||2013-08-28|November 2006||2006-11-01|July 2016|2016-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer|Open-label, Multi-center Study of the Efficacy and Safety of MCC in the Treatment of Patients With Non-muscle Invasive (Superficial) Bladder Cancer at High Risk of Progression and Who Are Refractory to BCG|Completed||Phase 2/Phase 3|129|Actual|Bioniche Life Sciences Inc.||1|||f||||t||||||||||2017-02-18 16:03:47.198257|2017-02-18 16:03:47.198257
NCT00406055|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2013-07-24|||October 2006||2006-10-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||CHOICE: Carotid Stenting For High Surgical-Risk Patients|Carotid Stenting For High Surgical-Risk Patients; Evaluating Outcomes Through The Collection Of Clinical Evidence|Completed||Phase 4|18855|Actual|Abbott Vascular|||1||f||||||||||||||2017-02-18 16:03:47.356843|2017-02-18 16:03:47.356843
NCT00406042|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2007-03-28|||September 2005||2005-09-01|March 2007|2007-03-01|June 2006|Actual|2006-06-01|||||Interventional|||The Role of Steroids Following Selective Laser Trabeculoplasty|The Role of Topical Prednisolone Acetate Following Selective Laser Trabeculoplasty|Completed||N/A|25||West Virginia University|||||f||||f||||||||||2017-02-18 16:03:47.462377|2017-02-18 16:03:47.462377
NCT00406029|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-12-15|2016-09-28||November 2006||2006-11-01|December 2016|2016-12-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional||The Safety Population consisted of all participants who received at least one dose of study medication (either preladenant or placebo).|Dyskinesia in Parkinson's Disease (Study P04501)|A Phase 2, 12-Week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and Safety of a Range of SCH 420814 Doses in Subjects With Moderate to Severe Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesias|Completed||Phase 2|253|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 16:03:47.624927|2017-02-18 16:03:47.624927
NCT00406016|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2011-11-02|||May 2006||2006-05-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI|A Multi-center, Open-label, Cohort Study to Assess Feasibility, Acute Safety, Tolerability and Pharmacokinetics of 4 Dose Regimens of Continuous Intrathecal ATI355 Infusion and Two Regimen of Repeated Intrathecal Bolus Injections in Acute Spinal Cord Injury Paraplegic and Tetraplegic Patients|Completed||Phase 1|52|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:03:51.316051|2017-02-18 16:03:51.316051
NCT00406003|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2012-05-31|||March 2006||2006-03-01|February 2011|2011-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects|A Randomized, Open, Three-period Crossover Study to Compare the Pharmacokinetic Profile of Paroxetine After Single Dosing of Each Enteric-coated Geomatrix Control Release Tablet Strength (12.5, 25, 37.5mg) in Healthy Chinese Subjects|Completed||Phase 1|12||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:03:51.429379|2017-02-18 16:03:51.429379
NCT00405990|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2015-05-28|||November 2006||2006-11-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Interventional|||Male Partner Involvement in the Prevention of MTCT of HIV|Optimizing the Impact of Prevention of Mother to Child Transmission of HIV in South Africa: the Forgotten Half of the Equation.|Completed||Phase 4|1000|Anticipated|Imperial College London||1|||f||||t||||||||||2017-02-18 16:03:51.526181|2017-02-18 16:03:51.526181
NCT00405977|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2011-09-15|||May 2006||2006-05-01|September 2011|2011-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|MagRoc||The Effect of Magnesium Sulphate on the Time Course of Rocuronium Induced Neuromuscular Block|The Effect of Magnesium Sulphate on the Time Course of Rocuronium Induced Neuromuscular Block - A Randomised Electrophysiology Study|Completed||Phase 4|80|Actual|University Hospital, Geneva||2|||f||||f||||||||||2017-02-18 16:03:51.623794|2017-02-18 16:03:51.623794
NCT00405964|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2015-04-09|2009-03-25||September 2006||2006-09-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)|Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Persistent Allergic Rhinitis (PER)|Completed||Phase 3|716|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:03:51.730542|2017-02-18 16:03:51.730542
NCT00405951|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-30|2016-07-19||2013-08-16|October 2006||2006-10-01|July 2016|2016-07-01|September 2009|Actual|2009-09-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer|A Phase I/II Study of Obatoclax Mesylate (GX15-070MS) Administered Every 3 Weeks in Combination With Docetaxel to Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|47|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 16:03:52.61787|2017-02-18 16:03:52.61787
NCT00405938|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2013-12-05|2013-01-11||November 2006||2006-11-01|December 2013|2013-12-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer|A Phase II Trial of Open-Label Bevacizumab Administered With Anastrozole or Fulvestrant as First-Line Therapy in Postmenopausal Hormone Receptor- Positive Metastatic Breast Cancer (With Trastuzumab in HER2-Positive Patients)|Completed||Phase 2|79|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 16:03:52.733362|2017-02-18 16:03:52.733362
NCT00405925|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2010-05-31|||March 2003||2003-03-01|May 2010|2010-05-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||FREE Study: Efficacy and Toxicity of Trizivir|Free Study: a Randomised, Open Label, Multicentre Strategic Study to Evaluate the Efficacy and Toxicity of an Early Switch From a PI-containing Regimen to Trizivir ® on Guidance of Viral Load in HIV-1 Infected , Antiretroviral naïve Adults|Completed||Phase 3|207|Actual|Rijnstate Hospital||2|||f||||||||||||||2017-02-18 16:03:53.253986|2017-02-18 16:03:53.253986
NCT00405912|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2011-04-15|2011-01-24||September 2005||2005-09-01|April 2011|2011-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||St. John's Wort for Tobacco Cessation|St. John's Wort for Tobacco Cessation|Completed||Phase 2|118|Actual|Mayo Clinic||3|||f||||||||||||||2017-02-18 16:03:53.369476|2017-02-18 16:03:53.369476
NCT00405899|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2010-05-28|||October 2006||2006-10-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|||||Observational|||Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections|Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections|Completed||N/A|20|Anticipated|West Penn Allegheny Health System|||2||f||||||||||||||2017-02-18 16:03:53.898406|2017-02-18 16:03:53.898406
NCT00405886|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2011-03-10|||October 2005||2005-10-01|March 2011|2011-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Neramexane for Tinnitus|A Randomised, Double-Blind, Placebo-Controlled, Clinical Dose-Ranging Trial to Evaluate Efficacy and Safety of a NMDA Antagonist for Oral Administration in Patients With Subjective Tinnitus|Completed||Phase 2|431|Actual|Merz Pharmaceuticals GmbH||4|||f||||f||||||||||2017-02-18 16:03:53.98974|2017-02-18 16:03:53.98974
NCT00405873|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2013-03-19|||March 2007||2007-03-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003|A Prospective, Open, Single-arm, Multicenter Phase II Clinical Trial to Evaluate the Tumour Response and Safety in Patients With Advanced Primary Hepatocellular Carcinoma Treated With AMT2003|Terminated||Phase 2|73|Actual|Auron Healthcare GmbH||1||Lack of efficacy|f||||||||||||||2017-02-18 16:03:54.096237|2017-02-18 16:03:54.096237
NCT00405860|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2011-03-21|||December 2002||2002-12-01|March 2011|2011-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||CellCept in p-ANCA Vasculitis|A Pilot Study of Mycophenolate Mofetil (MMF) in Patients With p-ANCA Microscopic Polyangiitis and Mild to Moderate Renal Dysfunction.|Completed||Phase 1|18|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:03:54.208045|2017-02-18 16:03:54.208045
NCT00405847|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2016-10-26|||July 2006||2006-07-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|||||Interventional|||A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill Patients|A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill Patients|Completed||Phase 4|17|Actual|University of Arizona|||||f||||||||||||||2017-02-18 16:03:54.299095|2017-02-18 16:03:54.299095
NCT00405834|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2008-07-01|||June 2007||2007-06-01|June 2007|2007-06-01|October 2007|Actual|2007-10-01|||||Observational|||A Pilot Study of the Envision® Surface|A Pilot Study of the Envision® Surface in a Patient Population at High Risk for or Who Have Pressure Ulcers: Evaluation of Pressure Ulcer Incidence, Changes in Existing Pressure Ulcers, Clinical Staff Satisfaction and Patient Comfort|Completed||N/A|30|Actual|Hill-Rom|||||f||||f||||||||||2017-02-18 16:03:54.39467|2017-02-18 16:03:54.39467
NCT00405821|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2012-08-28|2012-07-18||November 2006||2006-11-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda|A Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir Prophylaxis Versus Placebo Among HIV-1/HSV-2 Co-Infected Individuals in Uganda|Completed||Phase 2|440|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 16:03:54.623159|2017-02-18 16:03:54.623159
NCT00405808|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2011-01-25|||December 2006||2006-12-01|January 2011|2011-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|PRADO||Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose|A Pan-European Randomized, Parallel Group, Two-arm Placebo-controlled, Double-blind Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Abdominally Obese Patients With Impaired Fasting Blood Glucose With or Without Other Comorbidities|Terminated||Phase 3|2666|Actual|Sanofi||2||EMEA recommendation to suspend Acomplia marketing authorisation|f||||||||||||||2017-02-18 16:03:55.178173|2017-02-18 16:03:55.178173
NCT00405795|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2008-07-01|||June 2007||2007-06-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|||||Observational|||Envision® Surface Evaluation|Envision® Surface Evaluation for Patients With Stage II, Stage III, or Stage IV Pressure Ulcers|Completed||N/A|30|Actual|Hill-Rom|||1||f||||f||||||||||2017-02-18 16:03:55.303209|2017-02-18 16:03:55.303209
NCT00405782|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-06-24|||August 2006||2006-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|August 2014|Actual|2014-08-01||Interventional|||Exercise Intervention in Women With Metastatic Breast Cancer|Pilot Study of a Moderate-Intensity Exercise Intervention in Women With Metastatic Breast Cancer|Completed||N/A|101|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 16:03:55.40123|2017-02-18 16:03:55.40123
NCT00405769|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2007-10-30|||January 2007||2007-01-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Lipid Lowering in Patients With Statin Intolerance|Alternative Lipid Lowering in Patients With Statin Intolerance: Use of Red Yeast Rice and Therapeutic Lifestyle Changes in a Randomized, Placebo-Controlled Trial|Completed||N/A|64|Actual|Chestnut Hill Health System||2|||f||||||||||||||2017-02-18 16:03:55.683733|2017-02-18 16:03:55.683733
NCT00405756|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2016-11-21|2012-04-16||January 2007||2007-01-01|November 2016|2016-11-01|April 2016|Actual|2016-04-01|November 2009|Actual|2009-11-01||Interventional|||A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.|A Phase III, Multicentre, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Parallel Group Study To Determine The Efficacy And Safety Of Lenalidomde (Revlimid®) In Combination With Melphalan And Prednisone Versus Placebo Plus Melphalan And Prednisone In Subjects With Newly Diagnosed Multiple Myeloma Who Are 65 Years Of Age Or Older|Completed||Phase 3|459|Actual|Celgene Corporation||3|||f||||t||||||||||2017-02-18 16:03:55.812215|2017-02-18 16:03:55.812215
NCT00405743|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2013-09-12||2013-09-12|May 2006||2006-05-01|September 2013|2013-09-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies|A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies|Completed||Phase 1/Phase 2|153|Actual|Clavis Pharma||2|||f||||f||||||||||2017-02-18 16:03:59.072149|2017-02-18 16:03:59.072149
NCT00405730|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2016-11-16|||November 2005||2005-11-01|April 2012|2012-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo|Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo (Nepafenac Vehicle) for the Prevention and Treatment of Ocular Inflammation and Ocular Pain Associated With Cataract Surgery: European Study|Completed||Phase 3|227|Actual|Alcon Research||3|||f||||f||||||||||2017-02-18 16:03:59.389151|2017-02-18 16:03:59.389151
NCT00405717|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2008-11-06|||February 2006||2006-02-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel|Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention|Completed||Phase 4|1300|Anticipated|Shenyang Northern Hospital|||||f||||||||||||||2017-02-18 16:03:59.503734|2017-02-18 16:03:59.503734
NCT00405522|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2013-08-19|||November 2006||2006-11-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children|Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children: Evaluation of Two Dose Combinations|Completed||Phase 3|34|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 16:04:02.534802|2017-02-18 16:04:02.534802
NCT00405704|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2015-04-15|2014-12-04||May 2007||2007-05-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|June 2013|Actual|2013-06-01||Interventional|RIVUR||Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)|Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)|Completed||Phase 3|607|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Results may not apply to children with different demographic or clinical characteristics or in locales where choice of TMP-SMZ may be limited by susceptibility patterns or clinical acceptability. Some subgroup analyses had limited statistical power.|2|||f||||t||||||||||2017-02-18 16:03:59.598926|2017-02-18 16:03:59.598926
NCT00405691|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2011-05-17|||September 2006||2006-09-01|January 2010|2010-01-01||||||||Interventional|||Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis|A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System|Completed||Phase 3|450|Anticipated|Impliant, Ltd.|||||f||||t||||||||||2017-02-18 16:04:00.122809|2017-02-18 16:04:00.122809
NCT00405678|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2014-07-09|||September 2006||2006-09-01|July 2013|2013-07-01|September 2010|Actual|2010-09-01|February 2010|Actual|2010-02-01||Interventional|||Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.|The Effects of Exercise Training on Tumor Vascularity and Response to Neoadjuvant Therapy in Operable Breast Cancer: A Phase I-II Study|Completed||Phase 1/Phase 2|23|Actual|Duke University||2|||f||||||||||||||2017-02-18 16:04:00.254572|2017-02-18 16:04:00.254572
NCT00405665|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2013-08-30|||November 2006||2006-11-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis|Pilot Study of the Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis|Completed||Phase 2|20|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 16:04:00.401666|2017-02-18 16:04:00.401666
NCT00405652|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2011-02-08|2010-12-01||January 2007||2007-01-01|February 2011|2011-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients|Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients (MyLiver)|Completed||Phase 3|34|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:04:00.539517|2017-02-18 16:04:00.539517
NCT00405639|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2014-02-04|2014-02-04||June 2006||2006-06-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|April 2011|Actual|2011-04-01||Interventional|||Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function|To Define in Human Preclinical Systolic Dysfunction (PSD) the Actions of Chronic Administration of Subcutaneous (SQ) BNP on the Left Ventricular, Renal, and Humoral Function and on the Integrated Response to Acute Sodium Loading|Completed||Phase 1/Phase 2|37|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:04:00.791106|2017-02-18 16:04:00.791106
NCT00405626|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-11-29|||April 2007||2007-04-01|February 2006|2006-02-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH|Phase 2 Study of the Effect of Bellis Perenis and Arnica Montana on Post Partum Hemmorhage|Unknown status|Not yet recruiting|Phase 1|210|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:04:01.244866|2017-02-18 16:04:01.244866
NCT00405613|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-28|||May 2003||2003-05-01|November 2006|2006-11-01|December 2005||2005-12-01|||||Interventional|||Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population|Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population|Completed||Phase 2|36||Carolinas Healthcare System|||||f||||||||||||||2017-02-18 16:04:01.347364|2017-02-18 16:04:01.347364
NCT00405600|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2013-02-13|||November 2006||2006-11-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone|A Prospective Randomized Clinical Investigation of Posterolateral Lumbosacral Spinal Fusions With BMP-2 and Titanium Pedicle Screw Instrumentation Versus BMP-2 Alone.|Completed||N/A|50|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-02-18 16:04:01.451731|2017-02-18 16:04:01.451731
NCT00405587|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2015-06-19|||November 2006||2006-11-01|June 2015|2015-06-01|September 2015|Anticipated|2015-09-01|August 2015|Anticipated|2015-08-01||Interventional|||Safety Study of PLX4032 in Patients With Solid Tumors|A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX4032 in Patients With Solid Tumors|Active, not recruiting||Phase 1|75|Anticipated|Plexxikon||1|||f||||f||||||||||2017-02-18 16:04:01.57306|2017-02-18 16:04:01.57306
NCT00405574|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2008-01-28|||November 2006||2006-11-01|January 2008|2008-01-01|September 2008|Anticipated|2008-09-01|June 2008|Anticipated|2008-06-01||Interventional|||Study of ATN-224 in Patients With Prostate Cancer|A Randomized, Phase II Study of Two Dose Levels of ATN-224 in Patients With Biochemically Relapsed, Early Stage Prostate Cancer Not on Hormone Therapy|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Attenuon||2|||f||||||||||||||2017-02-18 16:04:01.692314|2017-02-18 16:04:01.692314
NCT00405561|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2013-03-19|||October 2006||2006-10-01|March 2013|2013-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003|A Prospective, Open, Single-Arm, Multicenter Phase II Clinical Trial to Evaluate the Progression Free Survival and Safety in Patients With Advanced Colorectal Carcinoma Treated With AMT2003|Terminated||Phase 2/Phase 3|67|Actual|Auron Healthcare GmbH||1||Lack of efficacy|f||||||||||||||2017-02-18 16:04:01.819149|2017-02-18 16:04:01.819149
NCT00405548|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2015-06-03|2014-04-08||March 2008||2008-03-01|June 2015|2015-06-01|August 2012|Actual|2012-08-01|April 2011|Actual|2011-04-01||Interventional|||Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.|To Define in Human Preclinical Diastolic Dysfunction (PDD) the Actions of Chronic Administration of Subcutaneous (SQ) BNP on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading|Completed||Phase 1/Phase 2|41|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:04:01.930515|2017-02-18 16:04:01.930515
NCT00405535|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-12-15|||June 2004||2004-06-01|December 2016|2016-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Adjunctive Glycine for Obsessive Compulsive Disorder|Adjunctive Glycine for Obsessive Compulsive Disorder|Completed||N/A|24|Actual|Nathan Kline Institute for Psychiatric Research||2|||f||||f||||||||||2017-02-18 16:04:02.422413|2017-02-18 16:04:02.422413
NCT00405106|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2006-11-28|||December 2005||2005-12-01|May 2004|2004-05-01|May 2006||2006-05-01|||||Observational|||The Effect of Final Exam Preparation on Anxiety Level, Self-Perception, Ocular Symptoms, Accommodation and Vergence in Myopia||Completed||N/A|25||Southern California College of Optometry|||||f||||||||||||||2017-02-18 16:04:07.752307|2017-02-18 16:04:07.752307
NCT00405509|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-07-20|2009-05-08||October 2006||2006-10-01|July 2016|2016-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years|The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to <14 Years|Completed||N/A|33|Actual|West Penn Allegheny Health System|Respiratory viruses were not detected in approximately 2/3 of the enrolled subjects. Future studies will need to apply more stringent inclusion/exclusion criteria to circumvent this problem.||2||f||||||||||Samples With DNA|"~     Buccal brushing for genotyping~   "|||2017-02-18 16:04:02.651236|2017-02-18 16:04:02.651236
NCT00405496|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2006-11-29|||March 2000||2000-03-01|November 2006|2006-11-01|April 2001||2001-04-01|||||Interventional|||Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis|Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Anterior Uveitis (Inluding Iritis, Cyclitis, Iridocyclitis, and Panuveitis).|Completed||Phase 2|24||Sirion Therapeutics, Inc.|||||f||||||||||||||2017-02-18 16:04:03.258191|2017-02-18 16:04:03.258191
NCT00405483|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-06-22|||October 2005||2005-10-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2014|Actual|2014-12-01||Interventional|||RSA for a Comparison of MIS vs. Standard Exposure in Total Hip Arthroplasty|A Randomized Controlled Trial Utilizing RSA for a Comparison of Minimally Invasive Surgery (MIS) vs. Standard Exposure in Primary Total Hip Arthroplasty With the ProfemurZ Modular Femoral Stem|Active, not recruiting||N/A|100|Anticipated|Dalhousie University||2|||f||||f||||||||||2017-02-18 16:04:03.339018|2017-02-18 16:04:03.339018
NCT00405470|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2010-08-11|||July 2001||2001-07-01|August 2010|2010-08-01|June 2006|Actual|2006-06-01|June 2005|Actual|2005-06-01||Interventional|||A Prospective Randomized Trial Using Roentgen Stereophotogrammetric Analysis of the Advance Medial Pivot Knee|A Prospective Randomized Trial Using Roentgen Stereophotogrammetric Analysis of the Advance Medial Pivot Knee|Completed||N/A|80|Actual|Dalhousie University||2|||f||||f||||||||||2017-02-18 16:04:03.450332|2017-02-18 16:04:03.450332
NCT00405457|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2010-02-19|||November 2006||2006-11-01|February 2010|2010-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms|Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms|Completed||Phase 4|50|Anticipated|Innovative Medical||1|||f||||||||||||||2017-02-18 16:04:03.541377|2017-02-18 16:04:03.541377
NCT00405444|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2010-12-10|||November 2006||2006-11-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children|Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children|Completed||Phase 3|64|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 16:04:03.631844|2017-02-18 16:04:03.631844
NCT00405431|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-11-20|||March 2004||2004-03-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|June 2005|Actual|2005-06-01||Interventional|||Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?|Influence of Post-Operative Cyclosporine 0.05% (Restasis) on the Success of Glaucoma Filtering Surgery|Completed||N/A|43|Actual|Wills Eye||2|||f||||f||||||||Yes|manuscript has been published.|2017-02-18 16:04:03.739209|2017-02-18 16:04:03.739209
NCT00405418|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2009-09-14|||November 2006||2006-11-01|September 2009|2009-09-01||||June 2008|Actual|2008-06-01||Interventional|L2T3||Lantus Versus Levemir Treat-To-Target|Target Glycemic Control and the Incidence of Documented Symptomatic Hypoglycemia in Insulin naïve Subjects With Type 2 Diabetes Failing on Oral Hypoglycemic Agent(s) and Treated With Insulin Glargine or Insulin Detemir.|Completed||Phase 4|973|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:04:03.853236|2017-02-18 16:04:03.853236
NCT00405405|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2016-10-19|||December 2006||2006-12-01|October 2016|2016-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer|A Phase I Study of the Combination of Chemoradiotherapy With Biologic Therapy for Advanced Head and Neck Cancer|Completed||Phase 1|13|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 16:04:03.97885|2017-02-18 16:04:03.97885
NCT00405392|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2016-10-03|||March 2007||2007-03-01|October 2010|2010-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis|An Open-label, Multi-centre, Randomized Study to Investigate Patient Preference on Dosing in the Once-monthly Ibandronate and the Once-weekly Risedronate in Korean Women With Postmenopausal Osteoporosis. A Six-month, Two-sequence, and Two Period Crossover Study|Completed||Phase 4|364|Anticipated|Hoffmann-La Roche|||||f||||||||||||||2017-02-18 16:04:04.288322|2017-02-18 16:04:04.288322
NCT00405379|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2008-04-08|||July 2002||2002-07-01|April 2008|2008-04-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Interventional|||Trabecular Metal Mesh Tibial Monoblock RSA|"A Prospective Randomized Controlled Trial Using Roentgen Stereophotogrammetric Analysis of Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty Component TMM."|Completed||N/A|67|Actual|Dalhousie University||1|||f||||f||||||||||2017-02-18 16:04:04.383855|2017-02-18 16:04:04.383855
NCT00405366|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-01-20|||November 2006||2006-11-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|June 2009|Actual|2009-06-01||Interventional|NRR||Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer|A Pilot Neoadjuvant Clinical Trial With Evaluation of Molecular Effects With Sorafenib Tosylate for Patients With Stage II or Greater Renal Cell Carcinoma|Completed||N/A|30|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:04:04.483069|2017-02-18 16:04:04.483069
NCT00405353|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2013-07-11|||April 2002||2002-04-01|November 2006|2006-11-01|March 2004||2004-03-01|||||Observational|||Testosterone Treatment for Multiple Sclerosis|Testosterone Treatment for Multiple Sclerosis: A Preliminary Trial|Completed||Phase 1/Phase 2|10||University of California, Los Angeles|||||f||||||||||||||2017-02-18 16:04:04.597322|2017-02-18 16:04:04.597322
NCT00405340|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2015-10-23|||October 2006||2006-10-01|October 2015|2015-10-01|April 2012|Actual|2012-04-01|July 2010|Actual|2010-07-01||Interventional|||Rituximab in the Treatment of Idiopathic Membranous Nephropathy|Rituximab in the Treatment of Idiopathic Membranous Nephropathy|Completed||Early Phase 1|20|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 16:04:04.690058|2017-02-18 16:04:04.690058
NCT00405093|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2017-01-17|||July 2006||2006-07-01|January 2017|2017-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Aprotinin Use and Renal Outcome in Hypothermic Bypass and Circulatory Arrest for Surgical Repair of Thoracic Aorta.|Aprotinin Use and Renal Outcome in Hypothermic Bypass and Circulatory Arrest for Surgical Repair of Thoracic Aorta. A Retrospective Study.|Completed||N/A|1250|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-02-18 16:04:07.833388|2017-02-18 16:04:07.833388
NCT00405327|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2016-03-08||2015-06-29|June 2006||2006-06-01|March 2016|2016-03-01|September 2016|Anticipated|2016-09-01|June 2009|Actual|2009-06-01||Interventional|||A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation|A Pilot Study of Tumor Lysate-pulsed Dendritic Cell Vaccine for Immune Augmentation for High-risk Solid Tumor Patients Following Autologous Stem Cell Transplantation|Active, not recruiting||Phase 2|16|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 16:04:04.794631|2017-02-18 16:04:04.794631
NCT00405314|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2016-06-22|||July 2002||2002-07-01|June 2016|2016-06-01|March 2006||2006-03-01|||||Interventional|||Prehospital CPAP vs. Usual Care for Acute Respiratory Failure|Prehospital CPAP Versus Usual Care for Acute Respiratory Failure: a Randomized Controlled Trial|Completed||N/A|60||Dalhousie University|||||f||||||||||||||2017-02-18 16:04:04.905814|2017-02-18 16:04:04.905814
NCT00405301|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2012-02-14|||December 2006||2006-12-01|February 2012|2012-02-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage|Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Antituberculosis Treatment Induced Hepatotoxicity|Completed||Phase 4|175|Actual|All India Institute of Medical Sciences, New Delhi||3|||f||||f||||||||||2017-02-18 16:04:05.007305|2017-02-18 16:04:05.007305
NCT00405288|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2014-01-03|2013-08-16||November 2006||2006-11-01|January 2014|2014-01-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Observational|||The Safety of Proctofoam-HC in the Third Trimester of Pregnancy|The Safety of Proctofoam-HC in the Third Trimester of Pregnancy|Completed||Phase 4|408|Actual|The Hospital for Sick Children|||2||f||||t||||||||||2017-02-18 16:04:05.138897|2017-02-18 16:04:05.138897
NCT00405275|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2013-11-07|2013-06-05||July 2007||2007-07-01|November 2013|2013-11-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|RACAT||Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy|CSP #551 - Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy|Completed||N/A|353|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:04:05.850874|2017-02-18 16:04:05.850874
NCT00405262|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2013-08-19|||May 2006||2006-05-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Comparison of Bupivacaine and Ketorolac for Postoperative Analgesia After Iliac Crest Bone Harvesting|The Effectiveness of Bupivicaine Infusion Versus Intravenous Ketorolac for Postoperative Analgesia After Iliac Crest Bone Harvesting for Lefort I Osteotomy or Alveolar Cleft Repair.|Completed||Phase 3|54|Actual|The Hospital for Sick Children||3|||f||||f||||||||||2017-02-18 16:04:06.480458|2017-02-18 16:04:06.480458
NCT00405249|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-29|2009-02-03|||September 2006||2006-09-01|February 2009|2009-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety Study of Elvucitabine in HIV-1 Subjects|14-Day Randomized Double-Blind Comparative Viral Kinetic Study of Elvucitabine Versus Lamivudine Once Daily to HIv-1 Subjects With M184V|Completed||Phase 2|5|Anticipated|Thomas Jefferson University|||||f||||||||||||||2017-02-18 16:04:06.589488|2017-02-18 16:04:06.589488
NCT00405236|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2006-11-27|||October 2002||2002-10-01|November 2006|2006-11-01|January 2005||2005-01-01|||||Interventional|||Effect of Tiotropium on Inflammation and Exacerbations in COPD|A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Changes in Inflammatory Markers in Induced Sputum Following Treatment With Tiotropium Inhalation Capsules 18mcg Once Daily in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|220||Royal Free and University College Medical School|||||f||||||||||||||2017-02-18 16:04:06.871331|2017-02-18 16:04:06.871331
NCT00405210|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2011-05-20|||September 2006||2006-09-01|May 2011|2011-05-01|December 2009|Actual|2009-12-01|August 2008|Actual|2008-08-01||Interventional|||Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer|Open-label, Multicenter,PhaseI Trial in Order To Determine the Safety and Pharmacokinetics of BAY43-9006 in Combination With Docetaxel as First-line Treatment in Metastatic Hormone Refractory Prostate Cancer Patients|Completed||Phase 1|38|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||1|||f||||f||||||||||2017-02-18 16:04:06.964693|2017-02-18 16:04:06.964693
NCT00405197|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2007-12-10|||November 2006||2006-11-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study|Study on the Effect of Mono-Unsaturated Fatty Acids (MUFA) and the Mediterranean Diet on Hyperinsulinemia and Other Components of the Metabolic Syndrome|Completed||N/A|60|Anticipated|Wageningen University|||||f||||||||||||||2017-02-18 16:04:07.17545|2017-02-18 16:04:07.17545
NCT00405184|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2012-06-05|||May 2007||2007-05-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)|A Multi-centre, Open-label, Cross-over Study to Compare the Pharmacokinetics, Safety and Tolerability of Ig NextGen 10% With Intragam P in Patients With Primary Immune Deficiency (PID)|Completed||Phase 3|19|Actual|CSL Limited||1|||f||||f||||||||||2017-02-18 16:04:07.272522|2017-02-18 16:04:07.272522
NCT00405171|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2010-10-27|||June 2003||2003-06-01|October 2010|2010-10-01|February 2006||2006-02-01|||||Interventional|||Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia|Efavirenz to Nevirapine Switch in HIV-1 Infected Patients With Severe Dyslipidemia: A Randomized Controlled Study|Completed||Phase 4|40||University Hospital, Caen|||||f||||||||||||||2017-02-18 16:04:07.37021|2017-02-18 16:04:07.37021
NCT00405158|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-30|||January 2002||2002-01-01|November 2006|2006-11-01|March 2004||2004-03-01|||||Interventional|||Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding|A RCT in Sweden of Acupuncture and Care Interventions for the Relief of Inflammatory Symptoms of the Breast During Lactation|Completed||N/A|210||Karlstad University|||||f||||||||||||||2017-02-18 16:04:07.4661|2017-02-18 16:04:07.4661
NCT00405145|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2006-11-28|||July 2006||2006-07-01|November 2006|2006-11-01|July 2011||2011-07-01|||||Observational|||Mapping of the Epileptic Brain|Mapping of the Eloquent Cortex and of Epileptic Networks Using Functional Magnetic Resonance Imaging and Electroencephalography in Epileptic Patients|Unknown status|Recruiting|N/A|400||University Hospital, Grenoble|||||f||||||||||||||2017-02-18 16:04:07.581109|2017-02-18 16:04:07.581109
NCT00405119|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2017-01-18|||May 2006||2006-05-01|January 2017|2017-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.|A Randomized, Double-blind, Four Period Cross-over Comparison of the Effect of Two Doses Lavoltidine, Esomeprazole, and Placebo on 24 Hour Gastric pH and Frequency of Heartburn in Symptomatic GERD Subjects Without Esophageal Erosions|Completed||Phase 2|92|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:04:07.650325|2017-02-18 16:04:07.650325
NCT00405080|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2016-10-26|||November 2006||2006-11-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|||||Interventional|||A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).|An Open-Label, Two Period, Fixed Sequence Study of Healthy Subjects to Assess the Effect of Repeat Oral Dosing of [Rifampin] on the Pharmacokinetics of a Single Oral Dose of [GW679769]|Completed||Phase 1|12||GlaxoSmithKline|||||||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:04:07.9244|2017-02-18 16:04:07.9244
NCT00405067|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2014-01-15|2013-01-18||May 2006||2006-05-01|January 2014|2014-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia|A Randomized, Double-Blind, Active Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of the Combination BMS-201038 (AEGR-733) and Ezetimibe vs. Monotherapy in Subjects With Moderate Hypercholesterolemia|Completed||Phase 2|60|Actual|Aegerion Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 16:04:08.0317|2017-02-18 16:04:08.0317
NCT00405054|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2015-01-23|||December 2006||2006-12-01|January 2015|2015-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)|A Phase II Study of MK0457 in Patients With T315I Mutant Chronic Myelogenous Leukemia and Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia|Terminated||Phase 2|52|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 16:04:08.830837|2017-02-18 16:04:08.830837
NCT00405041|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2008-04-08|||November 2006||2006-11-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Randomized Controlled Study to Assess the Efficacy of a Dietary Ingredient in Patients With Herniated Lumbar Disc Compression|A Two-Center, Phase II/III, Randomized, Double-Blind, Placebo-Controlled, Study, to Assess the Therapeutic Efficacy of a Dietary Ingredient in Patients With Herniated Lumbar Disc Causing Nerve Root Compression|Completed||Phase 2/Phase 3|79|Actual|Tel-Aviv Sourasky Medical Center||1|||f||||||||||||||2017-02-18 16:04:08.923585|2017-02-18 16:04:08.923585
NCT00405015|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2010-08-23|||April 2007||2007-04-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.|The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy. A Double Blind Placebo- Controlled Cross-over Study in Subjects With the Metabolic Syndrome|Completed||Phase 2|13|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 16:04:09.020979|2017-02-18 16:04:09.020979
NCT00405002|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2011-11-30|||November 2006||2006-11-01|November 2011|2011-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||A Validation Study of a New System for Measuring the End Expiratory Lung Volume During Mechanical Ventilation|A Validation Study of a New System for Measuring the End Expiratory Lung Volume During Mechanical Ventilation Acute in Intubated Patients|Completed||N/A|30|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-02-18 16:04:09.125094|2017-02-18 16:04:09.125094
NCT00404989|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2017-01-04|||January 1989||1989-01-01|January 2017|2017-01-01|January 2099|Anticipated|2099-01-01|January 2099|Anticipated|2099-01-01||Observational|APR||Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.|Antiretroviral Pregnancy Registry|Recruiting||Phase 4|1600|Anticipated|INC Research|||1||f||||t||||||||||2017-02-18 16:04:09.224676|2017-02-18 16:04:09.224676
NCT00404976|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-28|||June 2004||2004-06-01|November 2003|2003-11-01|April 2005||2005-04-01|||||Observational|||Inflammatory Markers in Exhaled Breath (Condensate) in Childhood Asthma|Biomarkers in Exhaled Breath (Condensate) Indicate Presence, Severity and Control of Asthma|Completed||N/A|100||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 16:04:09.33477|2017-02-18 16:04:09.33477
NCT00404963|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2017-01-18|||October 2006||2006-10-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects|A Single-Blind, Randomized, Placebo Controlled, Ascending Single and Repeat Dose Study With Once Daily Dosing to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK376501 and to Evaluate Food Effects and the Relative Bioavailability of a Tablet Formulation Compared to the Powder for Reconstitution Formulation in Healthy Overweight and Obese Subjects (DIX109177)|Completed||Phase 1|72|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 16:04:09.406749|2017-02-18 16:04:09.406749
NCT00404950|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2017-02-02|||July 2005|Actual|2005-07-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|October 2010|Actual|2010-10-01||Observational|||Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function|Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function|Completed||N/A|200|Actual|Weill Medical College of Cornell University|||1||f||||f||||||Samples Without DNA|"~     At the following times when plasma glucose will be measured, an additional 6 mL of blood~     will be drawn (from indwelling routine arterial line catheter) into EDTA tubes and~     immediately centrifuged: baseline following induction, once during cardiopulmonary bypass,~     at arrival in the intensive care unit, and the morning after surgery- totaling 24 mls of~     blood. The platelet rich plasma will be withdrawn and one half of the volume immediately~     frozen for subsequent HPLC measurement of BH2 and BH4. The remaining plasma will be~     subjected to progressive centrifugation steps in order to concentrate the platelet fraction~     that will then be suspended in buffer and frozen. VASP expression and phosphorylation will~     be determined by Western blot.~   "|No|Will not share|2017-02-18 16:04:12.18103|2017-02-18 16:04:12.18103
NCT00404937|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2012-03-03|||December 2006||2006-12-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle|Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle|Withdrawn||Phase 3|0|Actual|Alcon Research|||||f||||||||||||||2017-02-18 16:04:12.278147|2017-02-18 16:04:12.278147
NCT00404924|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-08-24|2011-04-27||November 2006||2006-11-01|August 2016|2016-08-01|November 2014|Actual|2014-11-01|October 2009|Actual|2009-10-01||Interventional|||ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures|A Phase III Study to Assess the Efficacy of ZD6474 (ZACTIMA™) Plus Best Supportive Care Versus Best Supportive Care in Patients With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer After Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI)|Completed||Phase 3|1140|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:04:12.364259|2017-02-18 16:04:12.364259
NCT00404911|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2013-06-21|||October 2006||2006-10-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth|Family Groups to Reduce Youth Behavioral Difficulties|Completed||N/A|416|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 16:04:13.485703|2017-02-18 16:04:13.485703
NCT00404898|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-12-05|||December 2007||2007-12-01|December 2016|2016-12-01||||June 2019|Anticipated|2019-06-01||Observational|||NYU/Bellevue WTC Health Impacts Research Registry|NYU/Bellevue Red Cross WTC Health Impacts Research Registry|Recruiting||N/A|7000|Anticipated|New York University School of Medicine|||1||f||||||||||||||2017-02-18 16:04:13.596908|2017-02-18 16:04:13.596908
NCT00404885|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2012-06-21|||January 2007||2007-01-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|LUMINATE||A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis|A Double-Masked, Placebo-Controlled, Parallel-Group, Multi-Center, Dose-Ranging Study With an Optional Extension to Assess the Efficacy and Safety of LX211 as Therapy in Subjects With Active Sight Threatening, Non-infectious Anterior Uveitis|Completed||Phase 3|108|Actual|Lux Biosciences, Inc.||4|||f||||t||||||||||2017-02-18 16:04:13.70286|2017-02-18 16:04:13.70286
NCT00404872|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2014-04-10|||January 1989||1989-01-01|April 2014|2014-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Evaluating the Relationship Between Fatty Acids and Heart Disease|n-3 and Trans Fatty Acids and Major Cardiovascular Outcomes|Completed||N/A|4766||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 16:04:13.837609|2017-02-18 16:04:13.837609
NCT00404859|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-30|||January 2006||2006-01-01|December 2005|2005-12-01|June 2007||2007-06-01|||||Observational|||FLAME: Airway Inflammation Monitoring in Asthma and Cystic Fibrosis|Monitoring Chronic Airway Inflammation in Children With Asthma and Cystic Fibrosis|Completed||N/A|70||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 16:04:14.167045|2017-02-18 16:04:14.167045
NCT00404846|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2009-05-01|||November 2006||2006-11-01|May 2009|2009-05-01|December 2007|Anticipated|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Hyperbaric Oxygenation Therapy on Adaptive, Aberrant and Stereotyped Behaviors in Children With Autism||Unknown status|Active, not recruiting|N/A|40|Anticipated|The Center for Autism and Related Disorders|||||f||||||||||||||2017-02-18 16:04:14.260847|2017-02-18 16:04:14.260847
NCT00404833|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2013-10-22|||January 2003||2003-01-01|October 2013|2013-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental|A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Conventional Immunosuppressive Treatment on Proteinuria in Idiopathic Membranous Nephropathy (MN) and Focal Segmental Glomerulosclerosis (FSGS)|Completed||Phase 3|16|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 16:04:14.359174|2017-02-18 16:04:14.359174
NCT00404820|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2011-06-06|2011-01-05||October 2006||2006-10-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ROSE||Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis|A Multi-center, Randomized, Open-label, Controlled, One-year Trial to Measure the Effect of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteopenia and Osteoporosis|Completed||Phase 3|604|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:04:14.491379|2017-02-18 16:04:14.491379
NCT00404807|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-28|||January 2001||2001-01-01|November 2006|2006-11-01|June 2004||2004-06-01|||||Interventional|||Cardiac Function After CPAP Therapy in Patients With Chronic Heart Failure and Sleep Apnea. A Multicenter Study|Cardiac Function After CPAP Therapy in Patients With Chronic Heart Failure and Sleep Apnea. A Multicenter Study|Terminated||N/A|245||Sociedad Española de Neumología y Cirugía Torácica|||||f||||||||||||||2017-02-18 16:04:15.103144|2017-02-18 16:04:15.103144
NCT00404794|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2013-10-22|||November 2005||2005-11-01|October 2013|2013-10-01|October 2009|Actual|2009-10-01|||||Interventional|||A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis|A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Tacrolimus and Corticosteroid as Immunosuppressive Treatment for Lupus Membranous Nephritis|Completed||Phase 3|20|Anticipated|Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 16:04:15.214721|2017-02-18 16:04:15.214721
NCT00404781|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2009-10-13|||June 2006||2006-06-01|October 2009|2009-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention|Pilot Study of Personal Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes|Completed||Phase 4|305|Actual|Shenyang Northern Hospital||2|||f||||t||||||||||2017-02-18 16:04:15.310374|2017-02-18 16:04:15.310374
NCT00404768|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2015-08-06||2012-02-16|October 2007||2007-10-01|June 2013|2013-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor|A Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK221149A Administered Intravenously and to Investigate the Pharmacokinetics of GSK221149A Administered Orally to Healthy, Pregnant Females With Uncomplicated Pre-term Labor Between 300/7 and 356/7 Weeks' Gestation|Completed||Phase 2|75|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:04:15.417889|2017-02-18 16:04:15.417889
NCT00404755|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2012-04-26|||July 2006||2006-07-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Dichotic Listening as a Predictor of Medication Response in Depression|Dichotic Listening as a Predictor of Medication Response in Depression|Completed||Phase 4|25|Actual|New York State Psychiatric Institute||3|||f||||f||||||||||2017-02-18 16:04:15.581008|2017-02-18 16:04:15.581008
NCT00404742|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2012-06-21|||January 2007||2007-01-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|LUMINATE||A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis|A Double-Masked, Placebo-Controlled, Multi-Center, Parallel-Group, Dose-Ranging Study With an Optional Extension to Assess the Efficacy and Safety of LX211 as Therapy in Subjects With Clinically Quiescent Sight Threatening, Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis|Completed||Phase 3|232|Actual|Lux Biosciences, Inc.||4|||f||||t||||||||||2017-02-18 16:04:15.722117|2017-02-18 16:04:15.722117
NCT00404365|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2013-04-29|||April 2006||2006-04-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Depression Screening in Patients With Lung Cancer|Maximizing Utilization of Depression Screening in Lung Cancer Patients: A Randomized Trial|Completed||N/A|241|Actual|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-02-18 16:04:21.404873|2017-02-18 16:04:21.404873
NCT00404729|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-28|||February 2005||2005-02-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases|Phase 4 Study of Evaluation of Neural Conduction Along the Visual Pathways Before and After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases|Completed||Phase 4|60||Fondazione G.B. Bietti, IRCCS|||||f||||||||||||||2017-02-18 16:04:15.859682|2017-02-18 16:04:15.859682
NCT00404716|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-28|||December 2004||2004-12-01|November 2006|2006-11-01|February 2007||2007-02-01|||||Interventional|||Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation|Effects of Triple Versus Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Undergoing Coronary Stent Implantation|Completed||Phase 4|||Shenyang Northern Hospital|||||f||||||||||||||2017-02-18 16:04:15.959035|2017-02-18 16:04:15.959035
NCT00404703|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2016-08-23|||August 2006||2006-08-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer|An Open Label Study of the Safety of First-line Treatment With Avastin in Combination With Cisplatin-gemcitabine or Carboplatin-paclitaxel in Patients With Advanced or Recurrent Squamous Non-small Cell Lung Cancer, Who Are Considered to be at High Risk of Pulmonary Haemorrhage|Terminated||Phase 2|37|Actual|Hoffmann-La Roche||1||Primary (safety) endpoint reached|f||||||||||||||2017-02-18 16:04:16.028214|2017-02-18 16:04:16.028214
NCT00404690|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2016-01-27|||October 2006||2006-10-01|January 2016|2016-01-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|||Bedside Silo Versus Operative Closure for Gastroschisis|Bedside Silo Versus Attempted Operative Closure for Gastroschisis: A Pilot Study|Terminated||N/A|20|Anticipated|Children's Mercy Hospital Kansas City||2||Change in referral pattern changed the population we were studying|f||||f||||||||No||2017-02-18 16:04:16.391812|2017-02-18 16:04:16.391812
NCT00404677|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2008-01-18|||June 2006||2006-06-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||The Correlation Between Airway Inflammation and Loss of Deep Inhalation Bronchoprotection in Asthmatics|The Correlation Between Airway Inflammation and Loss of Deep Inhalation Bronchoprotection in Asthmatics|Completed||N/A|18|Actual|University of Saskatchewan||2|||f||||||||||||||2017-02-18 16:04:16.504081|2017-02-18 16:04:16.504081
NCT00404664|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-28|||September 2004||2004-09-01|November 2006|2006-11-01|April 2005||2005-04-01|||||Interventional|||Improving Influenza Vaccination Rates Among Health Care Professionals|A Novel Approach To Improve Influenza Vaccination Rates Among Health Care Professionals: A Prospective Randomized Controlled Trial|Completed||N/A|800||The Cleveland Clinic|||||f||||||||||||||2017-02-18 16:04:16.592763|2017-02-18 16:04:16.592763
NCT00404651|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2014-04-11|2014-02-14||November 2006||2006-11-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants|Lot to Lot Consistency Study of DTaP-IPV-Hep B-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Mexican Infants|Completed||Phase 3|1189|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 16:04:16.693591|2017-02-18 16:04:16.693591
NCT00404638|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-28|||December 2006||2006-12-01|November 2006|2006-11-01||||||||Interventional|||Treatment of Enuresis Nocturna by Circular Muscle Exercise (Paula Method)|Treatment of Enuresis Nocturna by Circular Muscle Exercise (Paula Method)|Unknown status|Not yet recruiting|N/A|40||Rabin Medical Center|||||f||||||||||||||2017-02-18 16:04:17.648701|2017-02-18 16:04:17.648701
NCT00404625|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2006-11-28|||October 2006||2006-10-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Observational|||Infections Caused by ESbL-Producing Enterobacteriaceae in Italy|Infections Caused by Enterobacteriaceae Producing Extended-Spectrum β-Lactamases in Italy: Molecular Epidemiology, Clinical Impact, Treatment Outcome and Risk Factors|Unknown status|Recruiting|N/A|813||University of Siena|||||f||||||||||||||2017-02-18 16:04:17.746897|2017-02-18 16:04:17.746897
NCT00404612|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2012-10-09|||January 2007||2007-01-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|LUMINATE||A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis|A Double-Masked, Placebo-Controlled, Parallel Group, Multi-Center, Dose-Ranging Study With an Optional Extension to Assess the Efficacy and Safety of LX211 as Therapy in Subjects With Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis|Completed||Phase 3|218|Actual|Lux Biosciences, Inc.||4|||f||||t||||||||||2017-02-18 16:04:17.85138|2017-02-18 16:04:17.85138
NCT00404599|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2008-06-09|||February 2007||2007-02-01|June 2008|2008-06-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Interventional|SOS||Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.|A Randomised, Double Blind, Parallel-Group Study of the Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.|Unknown status|Recruiting|Phase 4|60|Anticipated|VU University Medical Center||1|||f||||t||||||||||2017-02-18 16:04:18.003684|2017-02-18 16:04:18.003684
NCT00404586|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2017-01-18|||September 2006||2006-09-01|January 2017|2017-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber|A Randomised, Placebo-controlled, 4-period, Incomplete Block, Crossover Study of 7 Days Dosing of Intranasal GW784568X (100mcg, 200mcg and 400mcg od), Fluticasone Propionate (200mcg od) and Placebo (Blinded for GW784568X vs Placebo) to Evaluate the Efficacy and Safety Using an Environmental Chamber in Male Subjects With Allergic Rhinitis|Completed||Phase 1|45|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:04:18.113062|2017-02-18 16:04:18.113062
NCT00404573|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2008-01-03|||November 2006||2006-11-01|January 2008|2008-01-01||||August 2007|Actual|2007-08-01||Interventional|||Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia|A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia|Completed||Phase 2|375|Anticipated|Forest Laboratories|||||||||||||||||||2017-02-18 16:04:18.212454|2017-02-18 16:04:18.212454
NCT00404560|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-28|2017-01-24|||November 24, 2006||2006-11-24|November 22, 2016|2016-11-22||||||||Observational|||Detection and Characterization of Infections and Infection Susceptibility|Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:04:18.296603|2017-02-18 16:04:18.296603
NCT00399087|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2014-02-12|||November 2004||2004-11-01|February 2013|2013-02-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||Phase I Trial of Docetaxel With Perifosine|A Phase 1 Trial of the Combination of Perifosine and Docetaxel With or Without Prednisone|Completed||Phase 1|39|Actual|AEterna Zentaris||3|||f||||f||||||||||2017-02-18 16:06:26.383199|2017-02-18 16:06:26.383199
NCT00404547|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2016-12-02|2010-03-08||November 2006||2006-11-01|September 2016|2016-09-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)|An Open-Label Randomized, Multicenter Study in Patients With Asthma to Evaluate the Effectiveness of Alvesco® (Ciclesonide) Compared to Asthma Usual Care in a Primary Practice Setting|Completed||Phase 4|1121|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:04:18.417268|2017-02-18 16:04:18.417268
NCT00404534|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2010-03-29|||November 2006||2006-11-01|March 2010|2010-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|HEROES-12||Helicobacter Eradication Relief of Dyspeptic Symptoms|Dyspeptic Symptoms Evolution After Eradication of Helicobacter Pylori in Patients With Different Endoscopic Findings: a Randomized Double-blind Placebo-controlled Clinical Trial With 12 Months of Follow-up|Completed||Phase 3|407|Actual|Hospital de Clinicas de Porto Alegre||2|||f||||t||||||||||2017-02-18 16:04:19.282267|2017-02-18 16:04:19.282267
NCT00404521|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2014-03-25|||August 2005||2005-08-01|March 2014|2014-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors|A Phase I Single-institution, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM02734 Administered Every 3 Weeks, Intravenously, Over 30 Minutes, to Subjects With Advanced Malignant Solid Tumors.|Terminated||Phase 1|56|Actual|PharmaMar||1||Low rate recruitment|f||||f||||||||||2017-02-18 16:04:19.416607|2017-02-18 16:04:19.416607
NCT00404508|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-25|2006-11-27|||September 2005||2005-09-01|November 2006|2006-11-01|October 2006||2006-10-01|||||Interventional|||A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors|A Phase II Study of Epigenetic Therapy With Hydralazine and Magnesium Valproate to Overcome Chemotherapy Resistance in Refractory Solid Tumors|Completed||Phase 2|15||National Institute of Cancerología|||||f||||||||||||||2017-02-18 16:04:19.533557|2017-02-18 16:04:19.533557
NCT00404495|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2012-04-16|2012-01-13||April 2007||2007-04-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|January 2011|Actual|2011-01-01||Interventional|||Combination of Irinotecan and Temozolomide in Children With Brain Tumors.|Phase 2 Single-Arm, Open Label Study Of Irinotecan In Combination With Temozolomide In Children With Recurrent Or Refractory Medulloblastoma And In Children With Newly Diagnosed High-Grade Glioma.|Completed||Phase 2|83|Actual|Pfizer|This study had one treatment arm but two distinct cohorts with different diagnostics and treatment durations.|1|||f||||f||||||||||2017-02-18 16:04:19.634836|2017-02-18 16:04:19.634836
NCT00404482|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2009-06-02|||January 1991||1991-01-01|June 2009|2009-06-01|August 2006||2006-08-01|||||Observational|||Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis|Efficacy and Adverse Effects of Cyclosporine A in the Treatment of Chronic Anterior Uveitis in Patients With Juvenile Idiopathic Arthritis|Completed||N/A|60||St. Franziskus Hospital|||1||f||||||||||||||2017-02-18 16:04:20.500154|2017-02-18 16:04:20.500154
NCT00404469|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2008-05-21|||March 2006||2006-03-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Effects of Peritendinous Corticosteroid Injections, Eccentric Training and Heavy Slow Resistance Training in Patellar Tendinopathy|Effects of Peritendinous Corticosteroid Injections, Eccentric Training and Heavy Slow Resistance Training in Patellar Tendinopathy|Completed||N/A|39|Actual|Bispebjerg Hospital||3|||f||||||||||||||2017-02-18 16:04:20.581997|2017-02-18 16:04:20.581997
NCT00404456|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2008-01-28|||April 2005||2005-04-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The Efficacy of Melatonin in Sleep Problems of Hemodialysis and Peritoneal Dialysis Patients|The Efficacy of Melatonin in Sleep Problems of Hemodialysis and Peritoneal Dialysis Patients|Completed||Phase 3|40|Anticipated|Meander Medical Center|||||f||||||||||||||2017-02-18 16:04:20.676036|2017-02-18 16:04:20.676036
NCT00404443|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2008-05-06|||December 2004||2004-12-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Acupuncture for the Treatment of Rheumatoid Arthritis|Efficacy of Traditional Chinese Acupuncture in the Treatment of Rheumatoid Arthritis: a Double-Blind Controlled Pilot Study|Completed||Phase 2|36|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-02-18 16:04:20.763171|2017-02-18 16:04:20.763171
NCT00404430|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2016-08-18|||January 2007||2007-01-01|August 2016|2016-08-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Observational|||Protocol Chronic Obstructive Pulmonary Disease|Predictive Factors of Endothelial Function in Chronic Obstructive Disease Patients at the End of a Acute Exacerbation.|Active, not recruiting||N/A|121|Actual|University Hospital, Grenoble|||2||f||||t||||||Samples With DNA|"~     Serum samples for analysis of inflammatory and oxidative biological markers~   "|||2017-02-18 16:04:20.871919|2017-02-18 16:04:20.871919
NCT00404417|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2010-03-01|||March 2007||2007-03-01|February 2010|2010-02-01|February 2011|Anticipated|2011-02-01|February 2011|Anticipated|2011-02-01||Interventional|||Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain|Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain: A Prospective Randomized Double-blind Placebo-controlled Crossover Study|Unknown status|Active, not recruiting|Phase 4|160|Anticipated|Walter Reed Army Medical Center||4|||f||||t||||||||||2017-02-18 16:04:20.983812|2017-02-18 16:04:20.983812
NCT00404404|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2013-12-17|||October 2006||2006-10-01|April 2007|2007-04-01||||||||Interventional|||ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer|Phase II Trial of Abraxane Administered on a Weekly Schedule in Combination With Bevacizumab in Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:04:21.097868|2017-02-18 16:04:21.097868
NCT00404391|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-26|2011-01-14|||October 2003||2003-10-01|January 2011|2011-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery|A Randomized, Double-Blind, Placebo-Controlled Study Comparing the Analgesic Activity of Hydrocodone/Acetaminophen Extended Release and Placebo in Subjects With Pain Following Bunionectomy Surgery|Completed||Phase 2|210|Actual|Abbott||3|||f||||f||||||||||2017-02-18 16:04:21.197147|2017-02-18 16:04:21.197147
NCT00404378|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2016-10-26|||October 2006||2006-10-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]|An Open-label, Two Period, Fixed Sequence Study of Healthy Subjects to Assess the Effect of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of [GW679769]|Completed||Phase 1|15|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:04:21.308672|2017-02-18 16:04:21.308672
NCT00404352|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2013-12-18|2012-05-15||November 2006||2006-11-01|December 2013|2013-12-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|REFLEX||REbif FLEXible Dosing in Early Multiple Sclerosis (MS)|A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial of Rebif New Formulation (44 Microgram [Mcg] Three Times Weekly [Tiw] and 44 Mcg Once Weekly [ow]) in Subjects at High Risk of Converting to Multiple Sclerosis (REFLEX)|Completed||Phase 3|517|Actual|Merck KGaA||3|||f||||t||||||||||2017-02-18 16:04:21.527738|2017-02-18 16:04:21.527738
NCT00404339|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2016-04-14|||September 2005||2005-09-01|April 2016|2016-04-01|March 2014|Actual|2014-03-01|March 2011|Actual|2011-03-01||Interventional|||Vaccine Therapy in Treating Patients With Head and Neck Cancer|Adjuvant p53 Peptide Loaded DC-Based Therapy for Subjects With Squamous Cell Cancer of the Head and Neck (A Phase I Safety and Immunogenicity Trial)|Completed||Phase 1|17|Actual|University of Pittsburgh||1|||f||||||||||||||2017-02-18 16:04:23.309259|2017-02-18 16:04:23.309259
NCT00404326|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-25|2006-11-27|||May 2005||2005-05-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer|A Phase II Study of Transcriptional Therapy With the DNA Demethylating Hydralazine and the HDAC Inhibitor Valproate Associated to Concomitant Cisplatin Chemoradiation in FIGO Stage III Cervical Cancer.|Completed||Phase 2|18||National Institute of Cancerología|||||f||||||||||||||2017-02-18 16:04:23.420153|2017-02-18 16:04:23.420153
NCT00404313|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2015-10-19|||January 2008||2008-01-01|October 2015|2015-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of MK0633 in Patients With Chronic Asthma (0633-007)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of MK0633 in Adult Patients With Chronic Asthma|Terminated||Phase 2|688|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 16:04:23.530635|2017-02-18 16:04:23.530635
NCT00404300|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2010-03-02|||February 2007||2007-02-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Optivate in People With Von Willebrand Disease Undergoing Surgery|An Open Multi-centre Study to Investigate the Safety and Efficacy of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate, in Patients With Von Willebrand Disease Who Are Undergoing Surgery|Terminated||Phase 3|25|Anticipated|Bio Products Laboratory||1||Due to slow recruitment and a delay in reaching the recruitment target.|f||||||||||||||2017-02-18 16:04:23.641122|2017-02-18 16:04:23.641122
NCT00404287|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2014-10-13|||October 2006||2006-10-01|October 2014|2014-10-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.|Double Blind Randomized Phase IV Clinical Trial to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in the Haemodynamic Progression of Degenerative Aortic Stenosis. The AORTICA 1 Study.|Suspended||Phase 4|164|Anticipated|AORTICA Group||2||Funding not enough to complete the study|f||||t||||||||||2017-02-18 16:04:23.732945|2017-02-18 16:04:23.732945
NCT00404274|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2016-10-26|||November 2006||2006-11-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers|An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin When Co-administered With Repeat Doses of Casopitant [GW679769] in Healthy Adult Subjects.|Completed||Phase 1|72|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:04:23.847913|2017-02-18 16:04:23.847913
NCT00404261|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2012-10-17|||January 2007||2007-01-01|October 2012|2012-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).|An Open Label, Multicentre Study to Evaluate Patient Satisfaction With Fluticasone/Salmeterol HFA MDI With Counter in Adult Subjects (18 Years of Age and Older) With Asthma or COPD.|Completed||Phase 4|132|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:04:23.956713|2017-02-18 16:04:23.956713
NCT00404248|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2015-08-05|2014-11-05||January 2007||2007-01-01|August 2015|2015-08-01|February 2012|Actual|2012-02-01|June 2009|Actual|2009-06-01||Interventional||high grade gliomas (GBM, AA or AO) histologically confirmed|Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma|Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma|Completed||Phase 1/Phase 2|35|Actual|Sidney Kimmel Comprehensive Cancer Center|We were not able to complete the phase 2 portion of this study as the company had internal issues and no longer had funds to support the project. We did complete the phase I and determined the (Maxium Tolerated Dose) MTD, 1700mg/day x 5 days|2|||f||||t||||||||||2017-02-18 16:04:24.072014|2017-02-18 16:04:24.072014
NCT00404235|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2016-08-12|||October 2006||2006-10-01|August 2016|2016-08-01|March 2010|Actual|2010-03-01|December 2008|Actual|2008-12-01||Interventional|||Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery|A Phase II Trial of Carboplatin (CBDCA) and ABI-007(ABX) in Patients With Unresectable Stage IV Melanoma|Completed||Phase 2|76|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 16:04:25.165638|2017-02-18 16:04:25.165638
NCT00404222|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-26|2011-07-22|||November 2005||2005-11-01|July 2011|2011-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain Following Bunionectomy|A Randomized, Multicenter, Single-blind Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Immediate Release Hydrocodone/Acetaminophen (NORCO®) to Placebo in Subjects With Acute Pain Following Bunionectomy|Completed||Phase 2|90|Actual|Abbott||3|||f||||f||||||||||2017-02-18 16:04:25.6504|2017-02-18 16:04:25.6504
NCT00404209|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-11-29|||March 2007||2007-03-01|November 2007|2007-11-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment|Pressurized Perfluorocarbon Perfused 23 GA Vitrectomy in Complicated Diabetic Retinal Detachment|Unknown status|Recruiting|Phase 3|10|Anticipated|Asociación para Evitar la Ceguera en México||1|||f||||||||||||||2017-02-18 16:04:25.744267|2017-02-18 16:04:25.744267
NCT00404196|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-27|2007-08-02|||October 2006||2006-10-01|August 2007|2007-08-01|March 2007|Actual|2007-03-01|||||Interventional|||LEO19123 Cream in the Treatment of Hand Eczema|LEO19123 Cream in the Treatment of Hand Eczema|Completed||Phase 2|75|Anticipated|LEO Pharma|||||f||||||||||||||2017-02-18 16:04:25.821067|2017-02-18 16:04:25.821067
NCT00404183|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-26|2011-01-14|||August 2004||2004-08-01|January 2011|2011-01-01||||March 2005|Actual|2005-03-01||Interventional|||A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR)and Placebo in Subjects With Osteoarthritis|A Randomized, Multi-center, Double-blind Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen and Placebo in Subjects With Osteoarthritis|Completed||Phase 2|120|Actual|Abbott||2|||f||||f||||||||||2017-02-18 16:04:25.900851|2017-02-18 16:04:25.900851
NCT00404170|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2015-05-13|||November 2006||2006-11-01|May 2015|2015-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease|Assessing the Determinants of PD Progression - Long-term Dopamine Transporter Imaging in the PRECEPT Cohort|Completed||Phase 2|396|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 16:04:26.000491|2017-02-18 16:04:26.000491
NCT00404157|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2008-01-28||||||January 2008|2008-01-01||||||||Interventional|||A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970g|A Phase III, Extension Study to Evaluate the Safety of Rituximab Retreatment in Subjects With ISN/RPS 2003 Class III or IV Lupus Nephritis Previously Enrolled in Study U2970g|Withdrawn||Phase 3|140||Genentech, Inc.|||||f||||||||||||||2017-02-18 16:04:26.105412|2017-02-18 16:04:26.105412
NCT00404144|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2015-03-17|||January 2006||2006-01-01|March 2015|2015-03-01|September 2012|Actual|2012-09-01|August 2010|Actual|2010-08-01||Interventional|||PEPCAD I. The Paclitaxel-Eluting PTCA-Balloon Catheter to Treat Small Vessel|PEPCAD I, The Paclitaxel-Eluting PTCA-Balloon Catheter to Treat Small Vessel Coronary Artery Disease. A Pilot Study|Completed||Phase 2|120|Actual|Heart Centre Rotenburg||1|||f||||||||||||||2017-02-18 16:04:26.188876|2017-02-18 16:04:26.188876
NCT00404131|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2016-11-28|||March 2001||2001-03-01|November 2016|2016-11-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution vs. Placebo in Subjects With Dry Eye Disease|Completed||Phase 3|500|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:04:26.30599|2017-02-18 16:04:26.30599
NCT00404118|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2015-04-06|||September 2007||2007-09-01|August 2014|2014-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|SCORE||Senior Coordinated Referral Study|Senior Coordinated Referral (SCORE) Study|Completed||N/A|543|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 16:04:26.396617|2017-02-18 16:04:26.396617
NCT00404105|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2006-11-24|||June 2000||2000-06-01|November 2006|2006-11-01|May 2004||2004-05-01|||||Interventional|||A Comparison of PRK and LASIK for Correction of Myopia|A Prospective, Randomised Trial of Photo-Refractive Keratectomy (PRK) and Laser-in-Situ-Keratomileusis (LASIK) for Correction of Myopia|Completed||Phase 4|40||University of Aarhus|||||f||||||||||||||2017-02-18 16:04:26.505279|2017-02-18 16:04:26.505279
NCT00404092|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2013-07-25|2012-12-12||October 2006||2006-10-01|July 2013|2013-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis|A Phase II Dose Escalation Study of Caspofungin in Patients With Invasive Aspergillosis|Completed||Phase 2|46|Actual|University of Cologne||4|||f||||t||||||||||2017-02-18 16:04:26.606334|2017-02-18 16:04:26.606334
NCT00404079|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2011-04-04|2011-02-21||December 2006||2006-12-01|February 2011|2011-02-01|November 2010|Actual|2010-11-01|August 2009|Actual|2009-08-01||Interventional|||The Glucosamine-study: The Effect of Glucosamine in Treatment of Chronic Low Back Pain|Phase 4 Study of Glucosamine Sulphate in the Treatment for Chronic Low Back Pain Patients With Degenerative Lumbar MRI Findings|Completed||Phase 4|250|Actual|Oslo University Hospital|Free participation and the focus on glucosamine may attract a certain type of patients with specific personality traits. Adjunctive management was permitted, which may influence outcome. Compliance was assessed by capsule counts.|2|||f||||t||||||||||2017-02-18 16:04:28.075363|2017-02-18 16:04:28.075363
NCT00404066|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2012-11-06|||October 2006||2006-10-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Phase II Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer|Phase II Neoadjuvant Chemotherapy Trial in Clinical Stage II/III Her2Neu Positive Breast Cancer With Sequential AC -> Docetaxel With Concurrent Dual EGFR Kinase Blockade by GW572016 (Lapatinib) Followed by 1 Year Adjuvant Trastuzumab|Completed||Phase 2|21|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 16:04:28.439645|2017-02-18 16:04:28.439645
NCT00404053|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2006-11-28|||December 2004||2004-12-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation|One Year Effects of Different Clopidogrel Maintaining Dosage on Patients With Acute Coronary Syndrome Undergoing Coronary Drug Eluting Stent Implantation|Completed||Phase 4|||Shenyang Northern Hospital|||||f||||||||||||||2017-02-18 16:04:28.552412|2017-02-18 16:04:28.552412
NCT00404040|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2006-11-27|||October 2000||2000-10-01|November 2006|2006-11-01|July 2002||2002-07-01|||||Interventional|||Movicol in Childhood Constipation (ProMotion Study)|A Single Centre Study to Assess the Safety and Efficacy of Movicol in the Treatment of Faecal Impaction in Children Followed by a Double Blind, Randomised Phase to Compare the Safety and Efficacy of Movicol and Lactulose for Maintenance Therapy|Completed||Phase 2|60||Norgine|||||f||||||||||||||2017-02-18 16:04:28.619607|2017-02-18 16:04:28.619607
NCT00404027|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2015-05-12|||June 2007||2007-06-01|May 2015|2015-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Patient and Provider Attitudes in the Healthcare Context|Patient and Provider Attitudes in the Healthcare Context|Completed||N/A|300|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 16:04:28.70688|2017-02-18 16:04:28.70688
NCT00404014|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2012-10-18||2012-07-11|August 2006||2006-08-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery|A Phase II Study Designed to Evaluate the Safety, Tolerability, and Effect of a Single, Rising Dose of Intravenous AL-208, Followed by a Placebo-Controlled, Double-Blind, Parallel-Group Evaluation of a Single Dose of AL-208, on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery.|Completed||Phase 2|234|Actual|Allon Therapeutics||2|||f||||f||||||||||2017-02-18 16:04:28.966613|2017-02-18 16:04:28.966613
NCT00403429|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2016-01-13|||March 2006||2006-03-01|January 2016|2016-01-01|July 2008|Actual|2008-07-01|January 2008|Actual|2008-01-01||Interventional|||MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer|Phase II Study With Capecitabine as Monotherapy in the Treatment of Platinum Resistant or Refractory Ovarian Cancer.|Completed||Phase 2|36|Actual|National Cancer Institute, Naples||1|||f||||||||||||||2017-02-18 16:04:46.520305|2017-02-18 16:04:46.520305
NCT00404001|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2007-09-28|||November 2006||2006-11-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia|A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Safety and Efficacy of Orally Administered MD-0727 in Patients With Primary Hypercholesterolemia|Completed||Phase 2|150|Actual|Ironwood Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-02-18 16:04:29.103941|2017-02-18 16:04:29.103941
NCT00403988|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2008-11-03|||June 2004||2004-06-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|||||Interventional|||Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma|A Clinical Phase II Study of Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma|Terminated||Phase 2|40|Anticipated|American University of Beirut Medical Center||||"The results of a same study design have shown low response with important side effects.~   Accordingly & ethicly, the study has been stopped."|f||||||||||||||2017-02-18 16:04:29.210079|2017-02-18 16:04:29.210079
NCT00403975|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2016-02-19|||June 2004||2004-06-01|February 2016|2016-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease|A Multi-Center, Parallel Group, Double-Masked, Randomized, Placebo-Controlled Study of Multiple Ocular Instillations of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease|Completed||Phase 3|640|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:04:29.303957|2017-02-18 16:04:29.303957
NCT00403962|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-09-13|||November 2004||2004-11-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|||||Interventional|||A Combination Therapy In Patients With Social Anxiety Disorder|A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Comparing the Efficacy and Safety of GW597599/Paroxetine Combination or Paroxetine Monotherapy to Placebo in Patients With Social Anxiety Disorder (SAD)|Completed||Phase 2|204||GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:04:29.399552|2017-02-18 16:04:29.399552
NCT00403949|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2015-02-15|||November 2006||2006-11-01|February 2015|2015-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis|A 6-week, Vehicle-controlled, Randomized, Double-blind, Parallel-group Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Perioral Dermatitis|Completed||Phase 2|48|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:04:29.516372|2017-02-18 16:04:29.516372
NCT00403936|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2010-02-24|||April 2005||2005-04-01|February 2010|2010-02-01|May 2005||2005-05-01|||||Interventional|||Effects of OA Decompression on the Autonomic Nervous System|Effects of OA Decompression on Activity of the Autonomic Nervous System|Completed||N/A|100||Nova Southeastern University|||||f||||||||||||||2017-02-18 16:04:29.621906|2017-02-18 16:04:29.621906
NCT00403923|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2009-02-13|||April 2007||2007-04-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis|A Study to Determine the Threshold of Lactose Ingestion That Provokes Symptoms in Lactose Intolerant People Who Also Have Ulcerative Colitis|Completed||Early Phase 1|48|Anticipated|University Hospitals, Leicester|||1||f||||t||||||||||2017-02-18 16:04:29.709496|2017-02-18 16:04:29.709496
NCT00403910|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2009-04-16|||September 2002||2002-09-01|April 2009|2009-04-01|July 2006||2006-07-01|||||Interventional|||Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study|Phase 3 Study Of Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure|Completed||Phase 3|500||Heart Care Foundation|||||f||||||||||||||2017-02-18 16:04:29.801077|2017-02-18 16:04:29.801077
NCT00403897|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2008-04-15|||August 2001||2001-08-01|April 2008|2008-04-01|January 2003||2003-01-01|||||Interventional|||An Open Single Centre Study To Assess Treatment of Chronic Constipation in Children|An Open Single Centre Study To Assess the Safety and Efficacy of Movicol in the Treatment of Chronic Constipation in Children|Completed||Phase 3|81|Actual|Norgine||1|||f||||f||||||||||2017-02-18 16:04:29.951193|2017-02-18 16:04:29.951193
NCT00403884|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2010-01-11|||October 2004||2004-10-01|November 2006|2006-11-01|August 2010|Anticipated|2010-08-01|December 2009|Anticipated|2009-12-01||Interventional|||Selective RPE Laser Treatment (SRT) for Various Macular Diseases|Selective RPE Laser Treatment (SRT) for Various Macular Diseases|Unknown status|Active, not recruiting|N/A|60|Anticipated|University of Regensburg||1|||f||||f||||||||||2017-02-18 16:04:30.074172|2017-02-18 16:04:30.074172
NCT00403871|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2007-02-28|||November 2002||2002-11-01|February 2007|2007-02-01|June 2005||2005-06-01|||||Observational|||Anaesthetic Management of Women With Heart Disease For Labor and Delivery|Anaesthetic Management of Women With Heart Disease For Labor and Delivery|Completed||N/A|700||Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||||f||||||||||||||2017-02-18 16:04:30.182347|2017-02-18 16:04:30.182347
NCT00403858|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2007-01-03|||October 2000||2000-10-01|January 2007|2007-01-01|April 2002||2002-04-01|||||Interventional|||Movicol in Childhood Constipation (ProMotion Study)|A Single Centre Study to Assess the Safety and Efficacy of Movicol in the Treatment of Faecal Impaction in Children Followed by a Double Blind, Randomised Phase to Compare the Safety and Efficacy of Movicol and Lactulose for Maintenance Therapy|Completed||Phase 2|60||Norgine|||||f||||||||||||||2017-02-18 16:04:30.270801|2017-02-18 16:04:30.270801
NCT00403845|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2011-07-22|2011-07-22||December 2006||2006-12-01|July 2011|2011-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Placebo-controlled, 4-period 4-treatment Crossover, Multicenter, Dose-ranging Study to Assess the Efficacy and Safety of 3 Doses of Indacaterol (150, 300, and 600 µg) Delivered Via a Single Dose Dry Powder Inhaler in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|50|Actual|Novartis||4|||f||||f||||||||||2017-02-18 16:04:30.372808|2017-02-18 16:04:30.372808
NCT00403832|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2010-07-26|||August 2005||2005-08-01|August 2009|2009-08-01|February 2007||2007-02-01|||||Interventional|||Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients|Comparison of Two Different Acrylate Intraocular Lenses in Cataract Surgery in Patients With Non-infectious Uveitis|Completed||N/A|60||St. Franziskus Hospital|||||f||||||||||||||2017-02-18 16:04:30.836351|2017-02-18 16:04:30.836351
NCT00396890|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2017-01-24|||November 3, 2006||2006-11-03|December 15, 2008|2008-12-15|December 15, 2008||2008-12-15|||||Observational|||Enhancing Brain Activity With Magnetic Stimulation|Enhancing Interhemispheric Disinhibition Between Motor Cortices Using Bilateral Brain Stimulation|Completed||N/A|72||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:07:09.631853|2017-02-18 16:07:09.631853
NCT00403819|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2006-11-27|||April 2002||2002-04-01|November 2006|2006-11-01|April 2003||2003-04-01|||||Interventional|||Study to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children|A Phase III Multi-Centre Placebo-Controlled Crossover Study Followed by an Open Label Post-Study Follow-up to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children|Completed||Phase 3|60||Norgine|||||f||||||||||||||2017-02-18 16:04:30.919027|2017-02-18 16:04:30.919027
NCT00403806|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2010-08-13|||February 2005||2005-02-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dexamethasone for Paediatric Adeno-tonsillectomy - A Dose-finding Study|Antiemetic and Analgesic Efficacy and Safety of Dexamethasone for Paediatric Adeno-tonsillectomy - A Randomised, Placebo-controlled, Double-blind, Dose-finding Study|Terminated||Phase 4|215|Actual|University Hospital, Geneva||4||drug-related harm|f||||f||||||||||2017-02-18 16:04:31.031297|2017-02-18 16:04:31.031297
NCT00403793|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2015-07-13|||October 2003||2003-10-01|July 2015|2015-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)|A Phase II -b, Placebo-Controlled Trial Investigating the Efficacy, Safety and Pharmacokinetics of a Subcutaneous Etonogestrel Implant Combined With i.m. Testosterone Undecanoate for Male Contraception|Completed||Phase 2|350|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:04:31.152273|2017-02-18 16:04:31.152273
NCT00403780|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2015-05-06|||June 2006||2006-06-01|May 2015|2015-05-01|July 2015|Anticipated|2015-07-01|May 2015|Anticipated|2015-05-01||Interventional|||Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia|Pregabalin for Pain Reduction in Critical Limb Ischemia - A Double Blind, Randomized Controlled Study|Recruiting||Phase 4|50|Anticipated|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 16:04:31.237448|2017-02-18 16:04:31.237448
NCT00403767|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2014-04-10|2011-12-02||December 2006||2006-12-01|April 2014|2014-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation|A Prospective, Randomized, Double-Blind, Parallel-Group, Multicenter, Non-inferiority Study Comparing the Efficacy and Safety of Rivaroxaban (BAY 59-7939) With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation|Completed||Phase 3|14269|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-02-18 16:04:31.552185|2017-02-18 16:04:31.552185
NCT00403754|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2011-07-22|2011-07-22||November 2006||2006-11-01|July 2011|2011-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Dose Ranging Study for Indacaterol in Japanese Asthma Patients|A Randomized, Double-blind, Placebo-controlled, 4-period 4-treatment Crossover, Multicenter, Single-dose, Dose-ranging Study Followed by a Single Day's Treatment With Open Label Salmeterol Bid (100 µg/Day), to Assess the Efficacy and Safety of 3 Doses of Indacaterol (150, 300, & 600 µg) Delivered Via Single Dose Dry Powder Inhaler (SDDPI) in Japanese Asthma Patients|Completed||Phase 2|41|Actual|Novartis||4|||f||||f||||||||||2017-02-18 16:04:42.590968|2017-02-18 16:04:42.590968
NCT00403741|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2010-02-26|||January 2007||2007-01-01|February 2010|2010-02-01|July 2009|Actual|2009-07-01|January 2007|Actual|2007-01-01||Interventional|||Consultations in Adapted Physical Activity on Behaviours in Physical Exercise by Type 2 Diabetics|Effects of Individuals Consultations in Adapted Physical Activity on Behaviours in Physical Exercise by Type 2 Diabetics|Completed||N/A|120|Anticipated|University Hospital, Grenoble|||||f||||f||||||||||2017-02-18 16:04:43.058377|2017-02-18 16:04:43.058377
NCT00403728|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2007-04-26|||September 2004||2004-09-01|April 2007|2007-04-01||||||||Interventional|||Ciclosporin A and Acute Myocardial Infarction|Protection by Ciclosporine A During Reperfused Acute Myocardial Infarction.|Unknown status|Active, not recruiting|Phase 2/Phase 3|60||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:04:43.145791|2017-02-18 16:04:43.145791
NCT00403715|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2016-11-28|||February 2001||2001-02-01|November 2016|2016-11-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of Multiple Ocular Instillations of INS365 Ophthalmic Solution vs. Placebo in Subjects With Dry Eye Disease|Completed||Phase 3|500|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:04:43.237542|2017-02-18 16:04:43.237542
NCT00403702|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2009-06-28|||August 2006||2006-08-01|November 2006|2006-11-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Comparison High-Density Silicone Oils in Retinal Detachment|Comparison of Two High-Density Silicone Oils in Complicated Rhegmatogenous Retinal Detachment|Unknown status|Recruiting|Phase 2/Phase 3|10|Anticipated|Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:04:43.316832|2017-02-18 16:04:43.316832
NCT00403689|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2013-08-01|||November 2006||2006-11-01|August 2013|2013-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome|Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome|Completed||N/A|11|Actual|German Institute of Human Nutrition||2|||f||||||||||||||2017-02-18 16:04:43.42202|2017-02-18 16:04:43.42202
NCT00403676|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2012-06-27|||September 2005||2005-09-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Nursing Consultation in Out-patient Clinics for Patients With Inflammatory Rheumatic Disease|Nursing Consultation in Out-patient Clinics for Patients With Inflammatory Rheumatic Disease|Completed||N/A|68|Actual|Diakonhjemmet Hospital||2|||f||||f||||||||||2017-02-18 16:04:43.767904|2017-02-18 16:04:43.767904
NCT00403663|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2009-07-29|||October 2006||2006-10-01|July 2009|2009-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Body Mass Index on the Dose of Intrathecal Hyperbaric Bupivacaine for Elective Cesarean Section|Effect of Body Mass Index on the ED95 of Intrathecal Hyperbaric Bupivacaine for Elective Cesarean Section|Completed||N/A|52|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||1|||f||||f||||||||||2017-02-18 16:04:43.870512|2017-02-18 16:04:43.870512
NCT00403650|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2013-04-10|||November 2006||2006-11-01|April 2013|2013-04-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension|Inhaled Iloprost for Sarcoidosis Associated Pulmonary Hypertension|Completed||Phase 4|20|Actual|University of Cincinnati||1|||f||||f||||||||||2017-02-18 16:04:43.963534|2017-02-18 16:04:43.963534
NCT00396695|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2006-11-06|||October 2006||2006-10-01|November 2006|2006-11-01|December 2007||2007-12-01|||||Observational|||Neuroimmunological Model of Traumatic Memory|Neuroimmunological Model of Traumatic Memory|Unknown status|Recruiting|N/A|40||Ziv Hospital|||||f||||||||||||||2017-02-18 16:07:13.610571|2017-02-18 16:07:13.610571
NCT00403637|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2016-11-16|||November 2006||2006-11-01|November 2016|2016-11-01|February 2007||2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma|A Randomized, Double-blind, Double-dummy, Active (Formoterol 12 µg b.i.d) and Placebo Controlled, Multi-center, 5 Period Crossover Study to Assess the Bronchodilatory Efficacy and Safety of Single Doses of Indacaterol 150 µg, 300 µg and 600 µg Delivered Via Single Dose Dry Powder Inhaler (SDDPI) vs. Placebo in Patients With Persistent Asthma|Completed||Phase 2/Phase 3|45|Actual|Novartis|||||f||||||||||||||2017-02-18 16:04:44.075795|2017-02-18 16:04:44.075795
NCT00403624|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2010-08-26|||July 2001||2001-07-01|April 2008|2008-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer|Clinical Study to Evaluate a Protocol of Oxaliplatin -UFT- Radiotherapy for the Neoadjuvant Treatment Rectal Cancer|Completed||Phase 1/Phase 2|38||Sanofi|||||f||||||||||||||2017-02-18 16:04:44.171466|2017-02-18 16:04:44.171466
NCT00403611|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-24|2015-06-16|||March 2006||2006-03-01|June 2015|2015-06-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil|Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Highly Endemic Areas of Northeastern Brazil|Completed||Phase 4|196|Actual|Oswaldo Cruz Foundation||2|||f||||f||||||||||2017-02-18 16:04:44.241011|2017-02-18 16:04:44.241011
NCT00403598|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2006-11-23||||||November 2006|2006-11-01||||||||Observational|||Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders||Unknown status|Not yet recruiting|N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:04:44.3475|2017-02-18 16:04:44.3475
NCT00403585|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-23|2010-11-24|2009-04-24||July 2006||2006-07-01|November 2010|2010-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814|A Phase IV, Open Label, Single Arm, Multicenter, Extension Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814|Completed||Phase 4|80|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:04:44.437676|2017-02-18 16:04:44.437676
NCT00403572|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2016-10-14|||November 2006||2006-11-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia|A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia|Completed||Phase 4|8|Actual|Oslo University Hospital|||1||f||||||||||||||2017-02-18 16:04:44.791502|2017-02-18 16:04:44.791502
NCT00403559|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2009-03-31|||January 2007||2007-01-01|October 2007|2007-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis|A 4 Week Randomized Double-Blind Parallel Group Active Comparator Controlled Study of Elidel for the Treatment of Seborrheic Dermatitis|Completed||Phase 2|110|Anticipated|Dermatology Specialists Research|||||f||||||||||||||2017-02-18 16:04:44.881898|2017-02-18 16:04:44.881898
NCT00403546|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2011-07-05|||January 2006||2006-01-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|HDZ||High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms|High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms|Completed||Phase 3|80|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:04:44.995031|2017-02-18 16:04:44.995031
NCT00403533|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2006-11-22|||February 2006||2006-02-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus|Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus|Completed||Phase 2|10||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 16:04:45.129196|2017-02-18 16:04:45.129196
NCT00403520|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2014-07-11|||November 2006||2006-11-01|July 2014|2014-07-01|August 2010|Actual|2010-08-01|March 2008|Actual|2008-03-01||Interventional|||Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers|Assessment of the Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers in Patients With Mild Cognitive Disorders|Completed||Phase 4|240|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:04:45.236733|2017-02-18 16:04:45.236733
NCT00403507|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2011-05-09|||October 2006||2006-10-01|November 2006|2006-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Exercise Treatment of Mild-Stage Probable Alzheimer's Disease|Physical Activity as a Treatment of Mild-Stage Probable Alzheimer's Disease|Completed||Phase 2|79|Anticipated|Intermountain Health Care, Inc.||4|||f||||f||||||||||2017-02-18 16:04:45.347387|2017-02-18 16:04:45.347387
NCT00403494|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2014-09-04|||December 2006||2006-12-01|September 2014|2014-09-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||A Phase 2 Study of the Effects of 6R-BH4 on Symptomatic Peripheral Arterial Disease|A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel Study of the Effects of 6R-BH4 on Symptomatic Peripheral Arterial Disease|Completed||Phase 2|190|Actual|BioMarin Pharmaceutical||4|||f||||t||||||||||2017-02-18 16:04:45.461297|2017-02-18 16:04:45.461297
NCT00403481|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2016-09-28|2008-11-21||November 2006||2006-11-01|September 2016|2016-09-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes|A Prospective, Open Label, Single Arm Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Type II Diabetic Patients With Hypertension|Completed||Phase 4|192|Actual|Daiichi Sankyo Inc.||1|||f||||||||||||||2017-02-18 16:04:45.601215|2017-02-18 16:04:45.601215
NCT00403455|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2014-12-01|2014-11-14||October 2006||2006-10-01|December 2014|2014-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|MTG|The study recruited all veterans that with a CAPS score of >45 and were DSM-IV positive for PTSD. Both males and females with backgrounds in all ethnic groups were aloud to participate in the study.|Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities|Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities|Completed||Phase 3|38|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 16:04:46.171362|2017-02-18 16:04:46.171362
NCT00403442|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2008-07-29|||September 2006||2006-09-01|July 2008|2008-07-01||||||||Interventional|||Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD|Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD|Terminated||Phase 1|10|Anticipated|Vitreous -Retina- Macula Consultants of New York|||||f||||||||||||||2017-02-18 16:04:46.411088|2017-02-18 16:04:46.411088
NCT00403416|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2009-02-26|||October 2006||2006-10-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients|12-Month Open Label, Randomized, Multicenter Study Evaluating Efficacy, Safety and Tolerability of Oral AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), vs. Mycophenolic Acid Plus Tacrolimus in de Novo Renal Transplant Recipients|Completed||Phase 1/Phase 2|215|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:04:46.827978|2017-02-18 16:04:46.827978
NCT00403403|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2011-04-27|2010-01-28||March 2007||2007-03-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)|A Placebo-Controlled, Double-Blind, Multicenter, Randomized, Phase II Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|102|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:04:46.967432|2017-02-18 16:04:46.967432
NCT00403390|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2010-12-02|||November 2006||2006-11-01|December 2010|2010-12-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Generic vs. Name-Brand Levothyroxine|Generic vs. Name-Brand Levothyroxine: Assessment of Bioequivalence Using TSH as a Marker in Children With Permanent Hypothyroidism|Completed||Phase 3|34|Actual|Boston Children’s Hospital||1|||f||||f||||||||||2017-02-18 16:04:47.456718|2017-02-18 16:04:47.456718
NCT00403377|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2015-09-29|||April 2006||2006-04-01|September 2015|2015-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Investigation of a Behavioral Substitute for Sunbathing|Investigation of a Behavioral Substitute for Sunbathing|Completed||Phase 1/Phase 2|307|Actual|University of Massachusetts, Worcester||2|||f||||f||||||||||2017-02-18 16:04:47.56876|2017-02-18 16:04:47.56876
NCT00403364|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2006-11-22|||July 2003||2003-07-01|November 2006|2006-11-01|February 2006||2006-02-01|||||Interventional|||Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-Controlled Trial|Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-Controlled Trial|Completed||Phase 2/Phase 3|300||St. Orsola Hospital|||||f||||||||||||||2017-02-18 16:04:47.689673|2017-02-18 16:04:47.689673
NCT00403351|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2016-05-30|||October 2006||2006-10-01|May 2016|2016-05-01|November 2020|Anticipated|2020-11-01|June 2008|Actual|2008-06-01||Observational|||Alternative Risk Markers in Coronary Artery Disease (ARMCAD)|Correlation of Multiple Risk Factors With Presence and Severity of Coronary Artery Disease.|Active, not recruiting||N/A|750|Anticipated|Monash University|||2||f||||t||||||Samples Without DNA|"~     Serum specifically for future cardiac biomarkers~   "|||2017-02-18 16:04:47.814598|2017-02-18 16:04:47.814598
NCT00403338|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2009-10-05|||December 2004||2004-12-01|October 2009|2009-10-01|April 2006|Actual|2006-04-01|||||Observational|||The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)|Prospective Evaluation of the Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent, The e-CYPHER(SM)S.T.L.L.R., Registry [Study of Deployment Technique on Clinical Results]|Completed||Phase 4|1500|Actual|Cordis Corporation|||1||f||||f||||||||||2017-02-18 16:04:47.93033|2017-02-18 16:04:47.93033
NCT00403325|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2008-10-31|||August 2006||2006-08-01|October 2008|2008-10-01||||||||Interventional|||Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy|Phase I Study of Intravitreally Administered Ranibizumab in Subjects With Unresolving CSC and Subfoveal Fluid.|Completed||Phase 1|9|Actual|Vitreous -Retina- Macula Consultants of New York||1|||f||||||||||||||2017-02-18 16:04:48.025084|2017-02-18 16:04:48.025084
NCT00403312|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2008-06-30|||January 2003||2003-01-01|June 2008|2008-06-01||||||||Interventional|||Increasing Physical Activity as Part of a Smoking Cessation Program|Increasing Physical Activity to Aid Smoking Cessation|Completed||N/A|400|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:04:48.122364|2017-02-18 16:04:48.122364
NCT00403299|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2011-07-03|||March 2006||2006-03-01|April 2008|2008-04-01|March 2007|Actual|2007-03-01|||||Interventional|||MDCT of the Coronary Arteries in Heart Transplanted Patients|Multidetector Computer Tomography of the Coronary Arteries in Heart Transplanted Patients|Completed||N/A|50|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-02-18 16:04:48.21203|2017-02-18 16:04:48.21203
NCT00403286|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2009-06-26|||November 2006||2006-11-01|June 2009|2009-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Safety and Efficacy of Fluticasone Propionate Combined With Formoterol Fumarate in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|457|Actual|Dey||8|||||||||||||||||2017-02-18 16:04:48.304169|2017-02-18 16:04:48.304169
NCT00403273|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2016-09-28|2012-04-21||July 2006||2006-07-01|September 2016|2016-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Arthroplasty (TKA)|Botulinum Toxin A for Painful Total Knee Arthroplasty (TKA): Randomized, Controlled, Triple-blind Study|Completed||Phase 2|54|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-02-18 16:04:48.477162|2017-02-18 16:04:48.477162
NCT00403260|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2009-01-21|||January 2007||2007-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Pyronaridine Artesunate (3:1) Versus Mefloquine Artesunate in P Falciparum Malaria Patients|A Phase III Comparative, Open-Label, Randomised, Multi-Centre, Clinical Study to Assess the Safety and Efficacy of Fixed Dose Formulation Oral Pyronaridine Artesunate (180:60 mg Tablet) Versus Mefloquine (250 mg Tablet) Plus Artesunate (100 mg Tablet) in Children and Adult Patients With Acute Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 3|1269|Actual|Medicines for Malaria Venture||2|||f||||||||||||||2017-02-18 16:04:49.043839|2017-02-18 16:04:49.043839
NCT00403247|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2007-08-21|||July 2004||2004-07-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia|Double-Blind Vitamin Intervention to Lower Blood Homocysteine Levels: Amino Acid and Clinical Responses in Individuals With Schizophrenia.|Completed||N/A|50|Actual|Nathan Kline Institute for Psychiatric Research||2|||f||||f||||||||||2017-02-18 16:04:49.171735|2017-02-18 16:04:49.171735
NCT00402896|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2016-02-11|2015-09-02||October 2006||2006-10-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Malignant Pleural Effusion With ZD6474|Treatment of Malignant Pleural Effusion With ZD6474, a Novel Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor|Terminated||Phase 2|28|Actual|M.D. Anderson Cancer Center||1||Slow Accrual|f||||f||||||||||2017-02-18 16:05:02.46369|2017-02-18 16:05:02.46369
NCT00403234|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2012-08-27|2010-07-28||November 2006||2006-11-01|August 2012|2012-08-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study to Evaluate the Analgesic Efficacy of BTDS on Postoperative Pain During Rehabilitation Following Total Knee Arthroplasty|Terminated||Phase 2|10|Actual|Purdue Pharma LP|This trial was terminated early due to administrative reasons not related to efficacy or safety. The efficacy data are not presented since the objective of this study was changed prior to study unblinding, identifying it as a safety study.|4||due to administrative reasons not related to efficacy or safety.|f||||||||||||||2017-02-18 16:04:49.274741|2017-02-18 16:04:49.274741
NCT00403221|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2012-02-09|||August 2006||2006-08-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer|A Phase I Study of In-Situ, Neoadjuvant, Pre-Radical Prostatectomy RTVP-1 Gene Therapy in Patients With Locally Advanced Adenocarcinoma of the Prostate (SPORE)|Completed||Phase 1|19|Actual|Baylor College of Medicine||1|||f||||||||||||||2017-02-18 16:04:49.872962|2017-02-18 16:04:49.872962
NCT00403208|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2006-11-24|||March 2006||2006-03-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Analgesia-Based Sedation During Mechanical Ventilation|Clinical and Economical Impact of an Analgesia-Based, Goal-Directed, Nurse-Driven Sedation Protocol on Patients on Mechanical Ventilation. A Multicenter Study|Unknown status|Recruiting|N/A|280||Pontificia Universidad Catolica de Chile|||||f||||||||||||||2017-02-18 16:04:49.972772|2017-02-18 16:04:49.972772
NCT00403195|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2012-09-07|||November 2006||2006-11-01|September 2012|2012-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Clinical and Pathophysiological Description of Ocular Ischemic Syndrome|Pathophysiological Analysis of Ocular Ischemic Syndrome and the Response to Vascular Surgery|Completed||N/A|13|Actual|Glostrup University Hospital, Copenhagen|||1||f||||t||||||||||2017-02-18 16:04:50.077157|2017-02-18 16:04:50.077157
NCT00403182|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2012-05-31|||May 2006||2006-05-01|May 2012|2012-05-01||||||||Interventional|||Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer|The CORE Study (Chemotherapy OR Endocrine Treatment First?) A Randomized Study by the Scandinavian Breast Group [CORE]|Withdrawn||Phase 3|0|Actual|Technische Universität München||||study halted prematurely, prior to enrollment of first participant|f||||||||||||||2017-02-18 16:04:50.166012|2017-02-18 16:04:50.166012
NCT00403169|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2010-05-12|||August 2004||2004-08-01|January 2007|2007-01-01||||||||Interventional|||Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer|Phase II Study of CC-5013 in Patients With Advanced Renal Cell Carcinoma (RCC)|Unknown status|Active, not recruiting|Phase 2|26|Anticipated|The Cleveland Clinic|||||||||||||||||||2017-02-18 16:04:50.267722|2017-02-18 16:04:50.267722
NCT00403156|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2015-12-30|||November 2006||2006-11-01|December 2015|2015-12-01||||||||Interventional|||Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|A Phase I Study of the Inhibition of Platelet Derived Growth Factor Using Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|Withdrawn||Phase 1|0|Actual|Vitreous -Retina- Macula Consultants of New York||1||Lack of recruitment|f||||||||||||||2017-02-18 16:04:50.365602|2017-02-18 16:04:50.365602
NCT00403143|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2007-05-11|||October 2006||2006-10-01|May 2007|2007-05-01||||||||Interventional|||Do Blue-Blocking Lenses Block Blue Colour From Our Lives?|Do Blue-Blocking Lenses Block Colour From Our Lives? A Randomised Controlled Study Measuring Colour Vision Using the Gold Standard Colour Vision Test (an Anomaloscope)in Patients With Blue Light Filtering Intraocular Lenses (Tinted Yellow) and Comparing This With Patients Inserted With Clear, Non Blue Light Filtering Intraocular Lenses During Cataract Surgery|Unknown status|Recruiting|N/A|40|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 16:04:50.464132|2017-02-18 16:04:50.464132
NCT00403130|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2014-02-28|||February 2006||2006-02-01|February 2014|2014-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer|Phase II Open Label Study of Gemcitabine, Paclitaxel and Bevacizumab Combination as First Line Treatment for Metastatic Breast Cancer|Completed||Phase 2|26|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 16:04:50.561074|2017-02-18 16:04:50.561074
NCT00403117|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2016-10-25|||December 2006||2006-12-01|October 2016|2016-10-01|August 2010|Actual|2010-08-01|May 2008|Actual|2008-05-01||Interventional|||Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana||Completed||Phase 2|49|Actual|New York State Psychiatric Institute||2|||f||||||||||||||2017-02-18 16:04:50.854354|2017-02-18 16:04:50.854354
NCT00403104|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2012-06-12|||November 2006||2006-11-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Multi-centre, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Investigate Efficacy and Safety of ONO-2506PO Compared to Placebo, in the Presence of Riluzole, to Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS), Who Have Had Onset of Muscle Weakness Within 14 Months of Randomization|Completed||Phase 2|420|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||||||||||||2017-02-18 16:04:50.963156|2017-02-18 16:04:50.963156
NCT00403091|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2010-08-10|||April 2005||2005-04-01|August 2010|2010-08-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||Internet Intervention to Improve Rural Diabetes Care|Internet Intervention to Improve Rural Diabetes Care|Completed||N/A|205|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 16:04:51.116365|2017-02-18 16:04:51.116365
NCT00403078|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2014-02-07|||October 2006||2006-10-01|February 2014|2014-02-01|November 2014|Anticipated|2014-11-01|July 2014|Anticipated|2014-07-01||Observational|||SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy|Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)|Unknown status|Recruiting|Phase 4|21000|Anticipated|Cordis Corporation|||1||f||||t||||||||||2017-02-18 16:04:51.236777|2017-02-18 16:04:51.236777
NCT00402883|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2013-11-27|2013-08-15||November 2006||2006-11-01|November 2013|2013-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer|A Phase II Study of Pemetrexed/Carboplatin/Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer|Terminated||Phase 2|5|Actual|SCRI Development Innovations, LLC||1||Terminated due to bevacizumab and chemoradiotherapy toxicity|f||||f||||||||||2017-02-18 16:05:02.732048|2017-02-18 16:05:02.732048
NCT00403065|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2013-08-23|||October 2006||2006-10-01|January 2007|2007-01-01|March 2013|Actual|2013-03-01|||||Interventional|||Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery|Quality of Life After Radiotherapy & Steroids. A Phase III Multi-Centre Randomised Controlled Trial to Assess Whether Optimal Supportive Care Alone (Including Dexamathasone) is As Effective as Optimal Supportive Care (Including Dexamethasone ) Plus Whole Brain Radiotherapy in the Treatment of Patients With Inoperable Brain Metastases From Non-Small Cell Lung Cancer|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:04:51.349637|2017-02-18 16:04:51.349637
NCT00403052|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2016-08-23|||November 2006||2006-11-01|August 2016|2016-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer|Phase 1 Study of the Combination of 1018 ISS, Irinotecan and Cetuximab in Patients With Metastatic Colorectal Cancer Previously Treated With a Fluoropyrimidine, Oxaliplatin or Irinotecan With or Without Bevacizumab|Terminated||Phase 1|15|Anticipated|Dynavax Technologies Corporation||3||Administrative reasons|f||||t||||||||Undecided|a/o August 2016, decision still pending|2017-02-18 16:04:51.53591|2017-02-18 16:04:51.53591
NCT00403039|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2015-12-31|||November 2006||2006-11-01|December 2015|2015-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema|Phase I Study of Intravitreally Administered Ranibizumab in 20 Subjects With Macular Edema Associated With CRVO.|Completed||Phase 1|41|Actual|Vitreous -Retina- Macula Consultants of New York||1|||f||||||||||||||2017-02-18 16:04:51.658318|2017-02-18 16:04:51.658318
NCT00403026|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2006-11-22|||August 2006||2006-08-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Intravitreal Bevacizumab for Retinal Disorders|Off-Label,Intravitreal Use of Bevacizumab for Retinal Disorders|Unknown status|Recruiting|N/A|150||Narayana Nethralaya|||||f||||||||||||||2017-02-18 16:04:51.767802|2017-02-18 16:04:51.767802
NCT00403013|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2009-07-03|||April 2007||2007-04-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Plexus Anesthesia in Lateral, Head-Down Position for Elective Surgery of the Shoulder|Axillary Plexus Block for Perioperative Analgesia in Patients Scheduled for Elective Surgery of the Shoulder: Influence of Lateral, Head-Down Position|Completed||N/A|64|Actual|University Hospital Muenster||2|||f||||||||||||||2017-02-18 16:04:51.857472|2017-02-18 16:04:51.857472
NCT00403000|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2013-04-30|||December 2004||2004-12-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|March 2007|Actual|2007-03-01||Interventional|||Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy|Phase II Study of Dutasteride in Prostate Cancer Recurrent During Androgen Deprivation Therapy|Completed||Phase 2|27|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 16:04:51.9596|2017-02-18 16:04:51.9596
NCT00402987|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2009-06-08|2008-11-14||November 2006||2006-11-01|June 2009|2009-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat|A Double Blind, Randomized, Placebo-Controlled Comparison of the Efficacy, Safety, and Tolerability of Celecoxib 100-150 mg, Including Initial Doses of 50 and 100 mg, and Placebo in the Symptomatic Treatment of Patients With Painful Pharyngitis|Completed||Phase 3|269|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 16:04:52.113062|2017-02-18 16:04:52.113062
NCT00402974|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2008-06-05|||January 2007||2007-01-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|||||Interventional|||The Effect of Vitamin K Supplementation on Osteocalcin Carboxylation in Healthy Children|The VITAKIDS-Study: The Effect of Vitamin K Supplementation on Osteocalcin Carboxylation in Healthy Children|Completed||N/A|55|Actual|UMC Utrecht||2|||f||||||||||||||2017-02-18 16:05:01.540188|2017-02-18 16:05:01.540188
NCT00402961|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2015-10-09|||October 2006||2006-10-01|October 2015|2015-10-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Trial of Acupuncture for Reduction of Post-Colectomy Ileus|A Phase II Randomized Controlled Trial of Acupuncture for Reduction of Post-Colectomy Ileus|Completed||Phase 2|90|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 16:05:01.645|2017-02-18 16:05:01.645
NCT00402948|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2012-11-30|||February 2007||2007-02-01|November 2012|2012-11-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients|Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Groups, To Evaluate And Compare The Safety, Tolerability And Efficacy Of Two Dosages Of Inhaled TPI ASM8 Administered For 14 Days In Patients With Mild to Moderate Asthma.|Terminated||Phase 2|10|Actual|Pharmaxis||2||Lack of substantial enrollment|f||||f||||||||||2017-02-18 16:05:01.767877|2017-02-18 16:05:01.767877
NCT00402935|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2012-03-16|||February 2004||2004-02-01|March 2012|2012-03-01|May 2007|Actual|2007-05-01|||||Observational|||Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer|Effects of Cytotoxic Chemotherapy on Ovarian Structure and Function|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center|||1|slow accrual|f||||t||||||Samples With DNA|"~     Blood collection at the same time points for follicle-stimulating hormone, estradiol, and~     inhibin B levels.~   "|||2017-02-18 16:05:01.890483|2017-02-18 16:05:01.890483
NCT00402922|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-22|2017-01-24|||August 2006||2006-08-01|January 2017|2017-01-01|May 2012|Actual|2012-05-01|February 2008|Actual|2008-02-01||Observational|||Evaluating the Association Between Pericardial Fat and Coronary Heart Disease - Ancillary to MESA|Pericardial Fat and Subclinical and Clinical Measures of Coronary Heart Disease - Ancillary to MESA|Completed||N/A|6814|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 16:05:02.015053|2017-02-18 16:05:02.015053
NCT00402909|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2012-04-25|||November 2006||2006-11-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone|A 16-week, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Compare the Safety and Efficacy of Nateglinide vs. Placebo in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Basal Insulin Glargine in Combination With Metformin and/or Thiazolidinedione (Pioglitazone or Rosiglitazone)|Completed||Phase 4|28|Actual|Novartis|||||||||||||||||||2017-02-18 16:05:02.111321|2017-02-18 16:05:02.111321
NCT00402701|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2007-10-30|||November 2004||2004-11-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||Pedestrian Behavior Following Implementation of a Walking School Bus|Pedestrian Behavior Following Implementation of a Walking School Bus|Completed||N/A|735|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 16:05:06.515362|2017-02-18 16:05:06.515362
NCT00402870|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2007-12-03|||August 2007||2007-08-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Postoperative Analgesic Requirements for the ProSeal Laryngeal Mask Airway Versus the Tracheal Tube in Females Undergoing Gynecological Laparoscopic Surgery|Postoperative Analgesic Requirements for the ProSeal Laryngeal Mask Airway Versus the Tracheal Tube in Females Undergoing Gynecological Laparoscopic Surgery|Completed||N/A|100|Anticipated|Medical University Innsbruck||1|||f||||||||||||||2017-02-18 16:05:03.0637|2017-02-18 16:05:03.0637
NCT00402857|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2013-02-11|||November 2006||2006-11-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders|Advanced Parenting Education in Pediatrics: The APEP Project|Completed||Phase 3|345|Actual|Tufts Medical Center||2|||f||||f||||||||||2017-02-18 16:05:03.150195|2017-02-18 16:05:03.150195
NCT00402844|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2007-11-13|||August 2006||2006-08-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Safety Study of Pelvic Organ Prolapse Repair Using Transvaginal Mesh|A Multicenter Clinical Safety Assessment of Polypropylene Transvaginal Mesh in Pelvic Reconstructive Surgery|Completed||Phase 2/Phase 3|250||Karolinska Institutet|||||f||||f||||||||||2017-02-18 16:05:03.279309|2017-02-18 16:05:03.279309
NCT00402831|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2009-04-03|||October 2006||2006-10-01|April 2009|2009-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||ProQuad® Intramuscular vs Subcutaneous|An Open, Randomised, Comparative, Multicentre Study of the Immunogenicity and Safety of ProQuad® When Administered by Intramuscular (IM) Route or Subcutaneous (SC) Route to Healthy Children Aged 12 to 18 Months|Completed||Phase 3|405|Actual|MCM Vaccines B.V.||2|||f||||f||||||||||2017-02-18 16:05:03.541856|2017-02-18 16:05:03.541856
NCT00402818|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2014-08-28|||May 2006||2006-05-01|August 2014|2014-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|RESTORE||RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization|RESTORE (Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization Registry) Observational, Open-label, Multi-centre, Phase IV Study of Subcutaneously Administered Raptiva® (Efalizumab) in the Treatment of Adult Patients With Moderate to Severe Chronic Plaque Psoriasis Who Are Candidates for Treatment With Raptiva®|Terminated||Phase 4|294|Actual|Merck KGaA|||1|"The study was terminated after the EMEA recommended to suspend the marketing authorisation of~   Raptiva in the EU"|f||||||||||||||2017-02-18 16:05:03.655754|2017-02-18 16:05:03.655754
NCT00402805|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2008-04-15|||October 2006||2006-10-01|November 2006|2006-11-01|July 2007|Actual|2007-07-01|February 2007|Actual|2007-02-01||Interventional|||Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy|Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy|Completed||Phase 4|50|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:05:03.747942|2017-02-18 16:05:03.747942
NCT00402792|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2011-01-24|||December 2006||2006-12-01|January 2011|2011-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following Bunionectomy|A Randomized, Multicenter, Double-blind Study Comparing the Analgesic Efficacy and Safety of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) to Placebo in Subjects With Acute Pain Following Bunionectomy|Completed||Phase 3|150|Actual|Abbott||3|||f||||f||||||||||2017-02-18 16:05:03.847652|2017-02-18 16:05:03.847652
NCT00402779|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2016-09-22|||November 2006||2006-11-01|September 2016|2016-09-01||||November 2018|Anticipated|2018-11-01||Interventional|||Erlotinib Prevention of Oral Cancer (EPOC)|Erlotinib Prevention of Oral Cancer (EPOC)|Active, not recruiting||Phase 3|150|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:05:03.971969|2017-02-18 16:05:03.971969
NCT00402766|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2015-11-16|||August 2006||2006-08-01|November 2015|2015-11-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma|Phase I Trial of Cisplatin, Pemetrexed, and Imatinib Mesylate in Unresectable or Metastatic Malignant Mesothelioma|Completed||Phase 1|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:05:04.095078|2017-02-18 16:05:04.095078
NCT00402753|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2010-01-06|||January 2005||2005-01-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients|Physical Exercise to Improve Physical Performance and Health Related Quality of Life in Hematopoietic Stem Cell Transplantation Recipients|Completed||Early Phase 1|128|Anticipated|University of Zurich||2|||f||||t||||||||||2017-02-18 16:05:04.216745|2017-02-18 16:05:04.216745
NCT00402740|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2012-05-17|2012-05-07||November 2006||2006-11-01|May 2012|2012-05-01|October 2011|Actual|2011-10-01|June 2011|Actual|2011-06-01||Interventional|PROTECT||Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)|Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)|Completed||N/A|322|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 16:05:04.503372|2017-02-18 16:05:04.503372
NCT00402727|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2014-11-03|2009-10-13||September 2006||2006-09-01|November 2014|2014-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection|A Prospective, Randomized, Double Dummy, Double Blind, Multinational, Multicenter Trial Comparing the Safety and Efficacy of Sequential (Intravenous/Oral) Moxifloxacin 400 mg OD to Intravenous Piperacillin/Tazobactam 4.0/0.5 g Every 8 Hours Followed by Oral Amoxicillin/Clavulanic Acid Tablets 875/125 mg Every 12 Hours for the Treatment of Subjects With Complicated Skin and Skin Structure Infections|Completed||Phase 3|813|Actual|Bayer|Ten patients (six from the moxifloxacin group and 4 from the comparator group) did not receive study medication. They were excluded from the safety analyses. No adverse events were reported in these patients.|2|||f||||f||||||||||2017-02-18 16:05:04.946759|2017-02-18 16:05:04.946759
NCT00402714|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2016-11-23|2016-06-15||July 2006||2006-07-01|November 2016|2016-11-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional||Pent/TBI|A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies|A Randomized Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation Versus Pentostatin and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies|Completed||Phase 2|14|Actual|Yale University||2|||f||||f||||||||||2017-02-18 16:05:05.930336|2017-02-18 16:05:05.930336
NCT00402688|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2013-09-02|2009-03-20||November 2006||2006-11-01|September 2013|2013-09-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis|A Multicenter, Double-Blind, Phase 3B Study to Compare the Safety and Clinical Efficacy of Levofloxacin in 750mg for 2 Weeks and Levofloxacin 750mg for 3 Weeks to That of Levofloxacin 500mg for 4 Weeks in the Treatment of Chronic Prostatitis|Completed||Phase 3|242|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 16:05:06.618046|2017-02-18 16:05:06.618046
NCT00402675|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2010-01-04|||July 2006||2006-07-01|November 2006|2006-11-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|LIPSIA-NSTEMI||Randomized Trial of Immediate Versus Early and Selective Invasive Percutaneous Coronary Intervention in NSTEMI|Leipzig Immediate Versus Early and Late PercutaneouS Coronary Intervention triAl in NSTEMI - LIPSIA-NSTEMI TRIAL|Completed||Phase 4|600|Anticipated|University of Leipzig||3|||f||||t||||||||||2017-02-18 16:05:07.522375|2017-02-18 16:05:07.522375
NCT00402662|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2013-12-17|||February 2006||2006-02-01|December 2013|2013-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma|A Phase II Study of Everolimus in Combination With Imatinib in Metastatic Melanoma|Terminated||Phase 2|3|Actual|Yale University||||unexpected level of toxicity|f||||||||||||||2017-02-18 16:05:07.629321|2017-02-18 16:05:07.629321
NCT00402649|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2011-06-09|2008-10-16||February 2007||2007-02-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Open-Label Study of H5 Vaccine in Participants of Protocol 04-077|Open-Label Study of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Children Aged 2 Years to 10 Years|Completed||Phase 1/Phase 2|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 16:05:07.721504|2017-02-18 16:05:07.721504
NCT00402636|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2007-11-27|||March 2005||2005-03-01|November 2007|2007-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)|Prospective, Randomized Trial of Rapamycin Plus Estradiol-Eluting Stents Versus Rapamycin-Eluting Stents For The Reduction of Coronary Restenosis (ISAR-PEACE)|Completed||Phase 4|502|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 16:05:08.065|2017-02-18 16:05:08.065
NCT00402623|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2008-02-21|||January 2006||2006-01-01|February 2008|2008-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||The Effect of Quercetin in Sarcoidosis|The Effect of Quercetin on the Increased Inflammatory and Decreased Antioxidant Status in Sarcoidosis|Completed||N/A|18|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 16:05:08.175576|2017-02-18 16:05:08.175576
NCT00402610|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-18|2008-10-23|||January 1994||1994-01-01|November 2006|2006-11-01|December 1998||1998-12-01|||||Interventional|||A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy|A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy|Completed||Phase 4|332||Sociedad Andaluza de Enfermedades Infecciosas|||||f||||||||||||||2017-02-18 16:05:08.286671|2017-02-18 16:05:08.286671
NCT00402597|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2012-09-28|2012-07-25||November 2006||2006-11-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Escalation and Dose-Confirmation Study to Evaluate the Safety and Efficacy of Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Subjects With Acute Coronary Syndromes|Completed||Phase 2|3490|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||||||||||||2017-02-18 16:05:08.607752|2017-02-18 16:05:08.607752
NCT00402584|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2007-08-30|||August 2000||2000-08-01|August 2007|2007-08-01||||||||Interventional|||A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Examine the Efficacy and Safety of Meridia (Sibutramine Hydrochloride) in Binge-Eating Disorder|Completed||Phase 3|304|Actual|Abbott||2|||f||||f||||||||||2017-02-18 16:05:12.337423|2017-02-18 16:05:12.337423
NCT00402571|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2009-02-06|||January 2002||2002-01-01|February 2009|2009-02-01|July 2004||2004-07-01|||||Interventional|||Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics|Assessment of Hepatic Function in Alcoholic Patients Administered Therapeutic Dosing of Acetaminophen- a Multicenter Study|Completed||Phase 4|420||Denver Health and Hospital Authority|||||f||||||||||||||2017-02-18 16:05:12.416708|2017-02-18 16:05:12.416708
NCT00402558|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2015-05-06|||May 2006||2006-05-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|Alloreactive NK Cells With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplantation for AML and MDS|Completed||Phase 1|15|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:05:12.511837|2017-02-18 16:05:12.511837
NCT00402545|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2009-10-30|||January 2007||2007-01-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck|A Phase I Study of Cetuximab/Docetaxel(Taxotere)/Cisplatin/5-Fluorouracil (C-TPF) in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|29|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:05:12.64678|2017-02-18 16:05:12.64678
NCT00402532|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2011-12-07|||March 2005||2005-03-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|November 2011|Actual|2011-11-01||Interventional|||Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation|Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation|Completed||Phase 3|190|Actual|Hannover Medical School||2|||f||||||||||||||2017-02-18 16:05:12.753499|2017-02-18 16:05:12.753499
NCT00402519|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2016-05-12|||November 2004||2004-11-01|May 2016|2016-05-01|November 2019|Anticipated|2019-11-01|November 2009|Actual|2009-11-01||Interventional|||APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer|Interstitial Brachytherapy Alone Versus External Beam Radiation Therapy After Breast Conserving Surgery for Low-risk Invasive Carcinoma and Low-risk Ductal Carcinoma in Situ (DCIS) of the Female Breast|Active, not recruiting||Phase 3|1300|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||Undecided||2017-02-18 16:05:12.859197|2017-02-18 16:05:12.859197
NCT00395850|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2013-09-06|2013-03-14||April 2007||2007-04-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Disulfiram for Cocaine Abuse|Disulfiram for Cocaine Abuse|Completed||Phase 2|118|Actual|University of Arkansas||4|||f||||t||||||||||2017-02-18 16:07:18.396615|2017-02-18 16:07:18.396615
NCT00402506|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2007-11-15|||November 2006||2006-11-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG|MEND-CABG II: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG Surgery|Completed||Phase 3|3000|Anticipated|Medicure|||||f||||t||||||||||2017-02-18 16:05:12.978235|2017-02-18 16:05:12.978235
NCT00402493|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2016-09-27|||December 2006||2006-12-01|September 2016|2016-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops|A Prospective,Randomized,Masked,Study to Evaluate the Interaction of Non-Steroidal Anti-Inflammatory Agent With IOP-Lowering Effect of Brimonidine or Latanoprost.|Completed||N/A|51|Actual|Philadelphia Eye Associates||3|||f||||f||||||||||2017-02-18 16:05:13.074879|2017-02-18 16:05:13.074879
NCT00402480|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2013-06-17|||April 2003||2003-04-01|November 2006|2006-11-01|March 2006||2006-03-01|||||Interventional|||Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity|Effects of Hydroxyurea on the Prevention of Primary Stroke in Children With Sickle Cell Anemia and Elevated Transcranial Doppler (TCD) Flow Velocity|Completed||Phase 2|50||Duke University|||||f||||||||||||||2017-02-18 16:05:13.188542|2017-02-18 16:05:13.188542
NCT00402467|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2014-12-18|||February 2004||2004-02-01|December 2014|2014-12-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study||Completed||Phase 2|613|Actual|Bayer||6|||f||||t||||||||||2017-02-18 16:05:13.299138|2017-02-18 16:05:13.299138
NCT00402454|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-18|2007-01-09|||January 1994||1994-01-01|November 2006|2006-11-01|December 1998||1998-12-01|||||Interventional|||Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis|Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis|Completed||Phase 4|300||Sociedad Andaluza de Enfermedades Infecciosas|||||f||||||||||||||2017-02-18 16:05:13.448805|2017-02-18 16:05:13.448805
NCT00402441|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2009-04-28|||September 2002||2002-09-01|April 2009|2009-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Risedronate in the Prevention of Osteoporosis in Postmenopausal Women|A One-Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of 35-mg Risedronate Administered Once a Week in the Prevention of Osteoporosis in Postmenopausal Women|Completed||Phase 4|260|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:05:13.539617|2017-02-18 16:05:13.539617
NCT00402428|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2013-08-01||2009-09-17|December 2006||2006-12-01|August 2013|2013-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients|Phase 3 Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b in Combination With Ribavirin Compared With Peginterferon Alfa-2a in Combination With Ribavirin in Interferon Alfa Naive Subjects With CHC Genotype 1. ACHIEVE-1|Completed||Phase 3|1331|Actual|Human Genome Sciences Inc.||3|||f||||||||||||||2017-02-18 16:05:13.629961|2017-02-18 16:05:13.629961
NCT00402415|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2013-12-17|||February 2006||2006-02-01|December 2013|2013-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy|A Phase I Trial of the Combination of Sirolimus and SU11248 (Sutent(R)) in Patients With Advanced Solid Tumors That Are Non-Curable With Standard Therapy|Terminated||Phase 1|18|Actual|Yale University||1|||f||||f||||||||||2017-02-18 16:05:14.198248|2017-02-18 16:05:14.198248
NCT00402402|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-21|2008-04-15|||October 2006||2006-10-01|November 2006|2006-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease|Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing for Detecting Latent Mycobacterium Tuberculosis Infection in Patients With Chronic Liver Disease Awaiting Liver Transplantation|Completed||Phase 4|300|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:05:14.300576|2017-02-18 16:05:14.300576
NCT00402389|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2013-03-27|||June 2004||2004-06-01|March 2013|2013-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Use of Omega-3 Fatty Acids for Perinatal Depression|Randomized Controlled Trial of Omega-3 Fatty Acids for Perinatal Depression|Completed||Phase 2|50|Actual|University of Arizona||2|||f||||||||||||||2017-02-18 16:05:14.403445|2017-02-18 16:05:14.403445
NCT00402376|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2011-08-29|||April 2007||2007-04-01|August 2011|2011-08-01||||||||Interventional|||Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological Therapy|Effects of Combined Ventricular Unloading and Pharmacological Therapy on Left Ventricular Metabolic Dysfunction in Heart Failure|Terminated||Phase 4|20|Anticipated|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 16:05:14.516125|2017-02-18 16:05:14.516125
NCT00402363|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2016-12-01|2010-09-23||November 2006||2006-11-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Lovaza for the Prevention of Recurrent, Symptomatic Atrial Fibrillation|Completed||Phase 3|663|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:05:14.624422|2017-02-18 16:05:14.624422
NCT00402350|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2008-02-03|||April 2006||2006-04-01|February 2008|2008-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Staccato® Fentanyl Pharmacokinetics in Healthy Volunteers|Safety, Tolerability, and Pharmacokinetics of Staccato® Fentanyl for Inhalation in Normal, Healthy Volunteers|Completed||Phase 1|51|Actual|Alexza Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-02-18 16:05:16.51792|2017-02-18 16:05:16.51792
NCT00402337|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-18|2013-01-29|2012-09-28||November 2006||2006-11-01|January 2013|2013-01-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation|A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-group, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation|Completed||Phase 2|310|Actual|Ironwood Pharmaceuticals, Inc.||5|||f||||f||||||||||2017-02-18 16:05:16.635947|2017-02-18 16:05:16.635947
NCT00402324|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2009-05-28|2009-02-13||December 2006||2006-12-01|May 2009|2009-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients|A Double-Blind Placebo Controlled Trial of Divalproex and Olanzapine in Bipolar I Disorder, Mixed Episode|Completed||Phase 4|202|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 16:05:17.629359|2017-02-18 16:05:17.629359
NCT00402311|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2007-01-19|||April 2002||2002-04-01|November 2006|2006-11-01|August 2005||2005-08-01|||||Interventional|||The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients|A Prospective Randomized Trial on the Effects of a Psychogeriatric Diagnostic Day Hospital|Completed||N/A|216||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 16:05:18.445447|2017-02-18 16:05:18.445447
NCT00402298|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2011-04-01|||January 2008||2008-01-01|March 2011|2011-03-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||Randomized Placebo-controlled Study of MDMA-assisted Psychotherapy in People With PTSD - Israel|MDMA-assisted Psychotherapy in Twelve People With War and Terrorism-related Posttraumatic Stress Disorder (PTSD)|Terminated||Phase 2|12|Anticipated|Multidisciplinary Association for Psychedelic Studies||2||"This study was terminated after enrolling five subjects due to staff turnover and its effects~   on quality of data collection."|f||||f||||||||||2017-02-18 16:05:18.720699|2017-02-18 16:05:18.720699
NCT00402285|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2015-12-02|2012-09-13||April 2003||2003-04-01|December 2015|2015-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer|The Molecular Effects of Nutrition Supplements (MENS) Prostate Study|Completed||N/A|84|Actual|University of California, San Francisco||3|||f||||||||||||||2017-02-18 16:05:18.836464|2017-02-18 16:05:18.836464
NCT00402272|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2010-10-13|||November 2006||2006-11-01|October 2010|2010-10-01|June 2010|Actual|2010-06-01|February 2008|Actual|2008-02-01||Interventional|SPIRIT V||SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe|SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions|Completed||Phase 4|2700|Actual|Abbott Vascular||1|||f||||t||||||||||2017-02-18 16:05:19.173985|2017-02-18 16:05:19.173985
NCT00402259|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2009-03-11|||August 2006||2006-08-01|March 2009|2009-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding|A Randomised, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study to Assess the Efficacy and Safety of Esomeprazole or Omeprazole for 5 Days in Subjects With Acute Non-Variceal Upper Gastrointestinal Bleeding|Completed||Phase 3|440|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:05:19.389488|2017-02-18 16:05:19.389488
NCT00402246|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2011-02-23|2010-09-29||November 2006||2006-11-01|February 2011|2011-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|CONNECT||CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision|CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision|Completed||N/A|2009|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f||||||||||2017-02-18 16:05:19.499474|2017-02-18 16:05:19.499474
NCT00402233|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-19|2014-05-07|2009-09-22||November 2006||2006-11-01|May 2014|2014-05-01||||September 2008|Actual|2008-09-01||Interventional|||A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients|A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Efficacy Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over a 12-week Treatment Phase in Early Parkinson's Disease Patients (PramiBID)|Completed||Phase 4|312|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 16:05:20.528334|2017-02-18 16:05:20.528334
NCT00402220|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-18|2007-10-30|||January 2007||2007-01-01|October 2007|2007-10-01|January 2010|Anticipated|2010-01-01|||||Interventional|||A Double-Blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression|A Double-Blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression|Unknown status|Recruiting|N/A|120|Anticipated|Bayside Health||2|||f||||||||||||||2017-02-18 16:05:21.350983|2017-02-18 16:05:21.350983
NCT00402207|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2006-11-20|||August 2005||2005-08-01|September 2005|2005-09-01|October 2006||2006-10-01|||||Interventional|||The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry|The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Exhaled Nitric Oxide, Inflammatory Markers in Exhaled Breath Condensate and Conventional Parameters|Completed||N/A|33||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 16:05:21.456203|2017-02-18 16:05:21.456203
NCT00402194|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2013-09-20|2013-05-06||June 2005||2005-06-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|November 2011|Actual|2011-11-01||Interventional|||Treating the Endothelium to Restore Insulin Sensitivity|Treating the Endothelium to Restore Insulin Sensitivity|Completed||N/A|17|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 16:05:21.555521|2017-02-18 16:05:21.555521
NCT00402181|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2014-05-13|||October 2006||2006-10-01|May 2014|2014-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma|A Phase 2 Multicenter Study of CNTO 328 (Anti IL-6 Monoclonal Antibody) in Subjects With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|53|Actual|Centocor, Inc.||2|||f||||t||||||||||2017-02-18 16:05:21.974156|2017-02-18 16:05:21.974156
NCT00402168|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2016-11-07|2015-11-10||January 2007||2007-01-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|June 2009|Actual|2009-06-01||Interventional||Participants randomized to a treatment arm.|A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids|Belatacept Conversion Trial in Renal Transplantation|Completed||Phase 2|173|Actual|Bristol-Myers Squibb|CNI arm discontinued Year 3, and those not switching treatment discontinued from study. No formal comparisons in calculated GFR were planned post Month 36, and these data up to the final database lock should be interpreted with caution.|2|||f||||t||||||||||2017-02-18 16:05:22.138205|2017-02-18 16:05:22.138205
NCT00402155|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2009-11-11|||July 2004||2004-07-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|||||Observational|||Visual Discomfort and Reading|Visual Discomfort and Reading|Completed||N/A|100|Anticipated|Southern California College of Optometry|||2||f||||||||||||||2017-02-18 16:05:23.971675|2017-02-18 16:05:23.971675
NCT00333606|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-03|2006-06-03|||January 2005||2005-01-01|June 2006|2006-06-01||||||||Interventional|||Acupuncture and Auditory Evoked Potentials|Effects of Acupuncture on the Auditory Evoked Potentials: a Randomized Volunteer Crossover Study|Unknown status|Recruiting|Phase 1/Phase 2|10||University Medicine Greifswald|||||f||||||||||||||2017-02-18 16:29:58.008667|2017-02-18 16:29:58.008667
NCT00402142|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2014-02-25|||November 2006||2006-11-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Dendritic Cell Vaccine in HIV-1 Infection|"Phase II Study of Autologous Myeloid Dendritic Cells as a Cellular Adjuvant for a Therapeutic HIV-1 Vaccine in Early Stage HIV-1+ Patients (DCV-2)."|Completed||Phase 1/Phase 2|60|Actual|Hospital Clinic of Barcelona||5|||f||||t||||||||||2017-02-18 16:05:24.070524|2017-02-18 16:05:24.070524
NCT00402129|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2006-11-20|||January 2006||2006-01-01|November 2006|2006-11-01|May 2006||2006-05-01|||||Interventional|||Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI|Clinical Safety and Efficacy of Prototype Devices for Hair Growth Control: Task 2.4|Completed||N/A|22||United States Naval Medical Center, San Diego|||||f||||||||||||||2017-02-18 16:05:24.181848|2017-02-18 16:05:24.181848
NCT00402116|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2010-10-25||2010-10-25|September 2006||2006-09-01|October 2010|2010-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients|Phase 1/2 Study of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma|Completed||Phase 1/Phase 2|72|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:05:24.281077|2017-02-18 16:05:24.281077
NCT00402103|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-18|2011-03-08|2010-12-13||November 2006||2006-11-01|March 2011|2011-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure|A 54-week, Open-label, Multicenter Study to Assess the Long-term Safety and Tolerability of the Combination of Aliskiren 300 mg / Amlodipine 10 mg in Patients With Essential Hypertension|Completed||Phase 3|556|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:05:24.566476|2017-02-18 16:05:24.566476
NCT00402090|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2006-11-17|||April 2005||2005-04-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Observational|||DHPLC Determination of TPMT Polymorphisms.|Prevention of Thiopurines Related Toxicity Through the Determination by DHPLC TPMT Polymorphisms in Patients With ALL.|Unknown status|Recruiting|N/A|160||National Institute of Cancerología|||||f||||||||||||||2017-02-18 16:05:25.116496|2017-02-18 16:05:25.116496
NCT00402077|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2015-03-05|||November 2006||2006-11-01|February 2015|2015-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects|A Randomized, Parallel-Group, Multicenter Study to Examine the Safety, Tolerability, and Body Weight Effect of Subcutaneous Pramlintide Alone and in Combination With the Oral Antiobesity Agents Sibutramine or Phentermine in Overweight and Obese Subjects|Completed||Phase 2|258|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 16:05:25.20583|2017-02-18 16:05:25.20583
NCT00402064|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2009-01-28|||March 2007||2007-03-01|January 2009|2009-01-01|December 2008||2008-12-01|||||Observational|||The Influence of Bisphosphonates in the Oral Cavity in Children|The Influence of Bisphosphonates in the Oral Cavity in Children|Completed||N/A|60|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 16:05:25.347055|2017-02-18 16:05:25.347055
NCT00402051|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2010-02-01|2009-11-30||November 2006||2006-11-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)|A Randomized Phase 2 Study of Pemetrexed in Combination With Cisplatin or Carboplatin in the First Line Therapy of Advanced NSCLC|Completed||Phase 2|133|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:05:25.44501|2017-02-18 16:05:25.44501
NCT00402038|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2011-07-18|||February 2004||2004-02-01|July 2011|2011-07-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study of Methylnaltrexone (MNTX) for the Relief of Constipation|A Double-Blind, Phase 3, Two-Week, Placebo Controlled Study of Methylnaltrexone(MNTX) for the Relief of Constipation Due to Opioid Therapy in Advance Medical Illness.|Completed||Phase 3|134|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||t||||||||||2017-02-18 16:05:26.442283|2017-02-18 16:05:26.442283
NCT00402025|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-04-11|2015-11-19||November 2006||2006-11-01|April 2016|2016-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||The Intention-to-Treat (ITT) population included all participants who received at least 1 dose of talimogene laherparepvec.|Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer|Targeted Delivery of OncoVEX^GM-CSF by Endoscopic Ultrasound (EUS)-Guided Fine Needle Injection (FNI) in Patients With Irresectable Pancreatic Cancer: A Pilot Multinational Experiment on Safety and Proof of Concept|Completed||Phase 1|17|Actual|BioVex Limited||1|||f||||||||||||||2017-02-18 16:05:26.554729|2017-02-18 16:05:26.554729
NCT00402012|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2015-12-17|||November 2006||2006-11-01|December 2015|2015-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||"TAKE TIME Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM"|Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM|Completed||Phase 4|24|Actual|Pennington Biomedical Research Center||2|||f||||t||||||||||2017-02-18 16:05:27.58686|2017-02-18 16:05:27.58686
NCT00401999|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-18|2017-01-24|||November 16, 2006||2006-11-16|January 28, 2011|2011-01-28|January 28, 2011||2011-01-28|||||Observational|||OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine|OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine|Completed||N/A|35|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:05:27.697365|2017-02-18 16:05:27.697365
NCT00401986|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2012-05-25|||December 2006||2006-12-01|May 2012|2012-05-01||||||||Observational|||RISA Extension Study - Long Term Safety|Long Term Safety Evaluation of Bronchial Thermoplasty With the Alair® System in Patients With Severe Asthma|Unknown status|Active, not recruiting|N/A|15|Anticipated|Asthmatx, Inc.|||1||f||||t||||||||||2017-02-18 16:05:27.793381|2017-02-18 16:05:27.793381
NCT00401973|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2009-09-30|2009-08-27||November 2006||2006-11-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine|The Assessment of the Safety, Efficacy, and Practicality of an Algorithm Including Amantadine, Metformin and Zonisamide for the Prevention of Olanzapine-Associated Weight Gain in Outpatients With Schizophrenia|Completed||Phase 3|199|Actual|Eli Lilly and Company||3|||f||||||||||||||2017-02-18 16:05:27.912983|2017-02-18 16:05:27.912983
NCT00401960|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2012-06-27|||September 2006||2006-09-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.|Open Label Study to Assess the Efficacy and Safety of Daptomycin in Combination With Anti-Cell Wall Active Therapy in the Treatment of Enterococcal Endocarditis|Terminated||Phase 4|6|Actual|Weill Medical College of Cornell University||1||inadequate enrollment|f||||||||||||||2017-02-18 16:05:29.216476|2017-02-18 16:05:29.216476
NCT00401947|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2015-12-29|||November 2006||2006-11-01|December 2015|2015-12-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ACH-0137171 in Subjects With Chronic Hepatitis C Infection|A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Multiple Doses of ACH-0137171 in Subjects With Chronic Hepatitis C Infection|Terminated||Phase 2|30|Anticipated|Achillion Pharmaceuticals||||Nephrotoxicity|f||||||||||||||2017-02-18 16:05:29.323356|2017-02-18 16:05:29.323356
NCT00401934|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2010-08-26|||November 2006||2006-11-01|July 2007|2007-07-01||||||||Observational|||Immunity to Human Cholera in Bangladesh|Protective Immunity to Human Cholera in Bangladesh|Unknown status|Recruiting|N/A|325||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:05:32.188353|2017-02-18 16:05:32.188353
NCT00401921|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2011-06-22|||October 2006||2006-10-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy|A Randomized, Placebo-Controlled Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy|Terminated||Phase 2|4|Actual|Brigham and Women's Hospital||1||PI moved to a new facility|f||||t||||||||||2017-02-18 16:05:32.2706|2017-02-18 16:05:32.2706
NCT00401908|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2015-09-25|||November 2006||2006-11-01|September 2015|2015-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding|Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding|Withdrawn||N/A|0|Actual|Maimonides Medical Center|||1||f||||||||||||||2017-02-18 16:05:32.369071|2017-02-18 16:05:32.369071
NCT00401895|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2009-01-08|||January 2006||2006-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered Stents|Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered Stents in Cirrhotic Patients: A Randomized Controlled Study|Terminated||Phase 2|44|Actual|University of Roma La Sapienza||2||"An interim analysis revealed a significantly higher persistence/recurrence of complications of~   portal hypertension in the 8 mm-stent group."|f||||||||||||||2017-02-18 16:05:32.466279|2017-02-18 16:05:32.466279
NCT00401882|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2012-09-19|||January 2007||2007-01-01|September 2012|2012-09-01|March 2012|Actual|2012-03-01|June 2011|Actual|2011-06-01||Interventional|Shock n Block||Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial|Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial|Terminated||Phase 2|7|Actual|William Beaumont Hospitals||1||Difficult accrual|f||||||||||||||2017-02-18 16:05:32.577518|2017-02-18 16:05:32.577518
NCT00401869|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2010-04-05|||February 1999||1999-02-01|April 2010|2010-04-01|December 2001|Actual|2001-12-01|||||Interventional|||The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)|The Effect of PROCRIT on Hemoglobin and Hematocrit and the Relationship to Postoperative Function, Vigor and Strength in Patients Undergoing Primary Total Joint Arthroplasty: A Randomized, Parallel Group, Open-Label Trial|Completed||Phase 4|289|Actual|Ortho Biotech Clinical Affairs, L.L.C.|||||f||||||||||||||2017-02-18 16:05:32.69586|2017-02-18 16:05:32.69586
NCT00401856|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2008-12-10|||December 2007||2007-12-01|December 2008|2008-12-01|July 2010|Anticipated|2010-07-01|December 2009|Anticipated|2009-12-01||Interventional|||CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone|A Randomised, Double-Blinded, Placebo-Controlled Trial Using Cardiovascular Magnetic Resonance (CMR) Scanning to Assess Remodelling and Regression of Fibrosis in Cardiomyopathy With Eplerenone|Unknown status|Recruiting|Phase 4|140|Anticipated|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||||||||||||2017-02-18 16:05:32.78414|2017-02-18 16:05:32.78414
NCT00401843|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-09-30|2015-07-07||November 2006||2006-11-01|September 2016|2016-09-01|September 2020|Anticipated|2020-09-01|August 2011|Actual|2011-08-01||Interventional|||A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma|A Phase 2, Randomized, Double-blind, Placebo-controlled Study Comparing the Combination of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and Velcade Versus Velcade Alone in Subjects With Relapsed or Refractory Multiple Myeloma|Active, not recruiting||Phase 2|307|Actual|Janssen Research & Development, LLC||3|||f||||||||||||||2017-02-18 16:05:32.903944|2017-02-18 16:05:32.903944
NCT00401830|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2014-09-19|2009-09-22||October 2006||2006-10-01|December 2009|2009-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.|A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome|Completed||Phase 2|159|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 16:05:34.703613|2017-02-18 16:05:34.703613
NCT00401817|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2011-04-18|||November 2007||2007-11-01|April 2011|2011-04-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma|Phase II Study of Bevacizumab Plus CHOP-Rituximab in Patients With Untreated Mantle Cell Lymphoma (NHL)|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 16:05:35.69697|2017-02-18 16:05:35.69697
NCT00401804|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-20|2013-01-23|||February 2006||2006-02-01|July 2010|2010-07-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|||Bortezomib-Dexamethasone-Doxorubicin-Study|Bortezomib-Doxorubicin-Dexamethasone as Treatment for Patients With Multiple Myeloma Presenting With Acute Renal Failure|Completed||Phase 2|72|Actual|Austrian Forum Against Cancer||1|||f||||||||||||||2017-02-18 16:05:35.791335|2017-02-18 16:05:35.791335
NCT00401791|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-01-22|||November 2006||2006-11-01|January 2016|2016-01-01|October 2016|Anticipated|2016-10-01|December 2008|Actual|2008-12-01||Interventional|||ACTIV- Exercise Intervention in Healthy Young Men|"ACTIVValidation of a Paradigm for the Evaluation of Compounds That Activate Mitochondrial Biogenesis in Skeletal Muscle"|Active, not recruiting||Phase 4|78|Anticipated|Pennington Biomedical Research Center||2|||f||||t||||||||||2017-02-18 16:05:35.889704|2017-02-18 16:05:35.889704
NCT00401778|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-11-03|2015-01-23||November 2006||2006-11-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)|Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|33|Actual|Emory University||3|||f||||t||||||||||2017-02-18 16:05:35.99756|2017-02-18 16:05:35.99756
NCT00401765|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2014-05-23|||September 2005||2005-09-01|May 2014|2014-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer|A Phase I Study of a Chimeric Antibody Against Interleukin-6 (CNTO 328) Combined With Docetaxel in Subjects With Metastatic Hormone-Refractory Prostate Cancer|Completed||Phase 1|40|Actual|Centocor, Inc.||4|||f||||f||||||||||2017-02-18 16:05:36.727372|2017-02-18 16:05:36.727372
NCT00401752|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2010-06-10|2009-11-12||March 2006||2006-03-01|June 2010|2010-06-01|November 2008|Actual|2008-11-01|||||Interventional|||Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer|A Multicenter, Randomized, Double-blind, Double-dummy, Parallel-group, 8 Week Comparative Efficacy and Safety Study of Esomeprazole 20 mg Every Day (qd) Versus Ranitidine 150 mg Twice a Day (Bid) in Patients With an NSAID-associated Gastric Ulcer When Daily NSAID is Continued|Completed||Phase 3|397|Actual|AstraZeneca|According to the protocol, the sample size was 320 patients which could achieve 80% power of superiority. Since the patient recruitment is very difficult, total 219 patients were randomized in present study, the power decreased to 60%|2|||f||||||||||||||2017-02-18 16:05:36.845145|2017-02-18 16:05:36.845145
NCT00401739|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2009-09-14|||December 2006||2006-12-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia|Phase I Study of CSL360 in Patients With Relapsed, Refractory or High-Risk Acute Myeloid Leukemia|Completed||Phase 1|40|Actual|CSL Limited||1|||f||||f||||||||||2017-02-18 16:05:37.258222|2017-02-18 16:05:37.258222
NCT00401726|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2012-04-19|2009-03-31||June 2006||2006-06-01|April 2012|2012-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program|Patient Outcomes With Education, Drug Therapy, and Support (POETS): A Multicenter, Open-label, Randomized Study to Evaluate Depressed Subjects Treated With Venlafaxine Extended-release vs. Venlafaxine Extended-release Plus the Dialogues Time to Talk Program in a Primary Care Setting|Completed||Phase 4|537|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:05:37.365999|2017-02-18 16:05:37.365999
NCT00401713|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2008-09-21|||February 2004||2004-02-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD|Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD|Completed||N/A|40|Anticipated|The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery||1|||f||||||||||||||2017-02-18 16:05:38.181548|2017-02-18 16:05:38.181548
NCT00401700|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-04-22|||October 2006||2006-10-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|January 2008|Actual|2008-01-01||Observational|||Influenza Vaccine Postpartum Questionnaire|Acceptability and Feasibility of Influenza Vaccine Administration on the Post-partum Floor Prior to Discharge Home During Flu Season|Completed||N/A|150|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-02-18 16:05:38.293551|2017-02-18 16:05:38.293551
NCT00401687|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-05-19|||July 2006||2006-07-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|June 2007|Actual|2007-06-01||Interventional|||DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function|A Multicenter, Phase IV Study to Evaluate the Ability of Definity® Enhanced Versus Unenhanced Echocardiography to Improve the Accuracy and Reproducibility of Left Ventricular Ejection Fraction When Compared to Cardiac Magnetic Resonance Imaging|Completed||Phase 4|131|Actual|Lantheus Medical Imaging||1|||f||||f||||||||||2017-02-18 16:05:38.381285|2017-02-18 16:05:38.381285
NCT00401674|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-01-13|||June 2003||2003-06-01|January 2016|2016-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|MITO-5||MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer|Phase II Multicenter Study of the Combination of Weekly Carboplatin and Paclitaxel as First-line Chemotherapy for Elderly Patients With Ovarian Cancer.|Completed||Phase 2|26|Actual|National Cancer Institute, Naples||1|||f||||||||||||||2017-02-18 16:05:38.47689|2017-02-18 16:05:38.47689
NCT00401661|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2009-09-14|||June 2006||2006-06-01|September 2009|2009-09-01||||December 2007|Actual|2007-12-01||Interventional|SAMBA-Thailand||Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin|Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin 10mg Once Daily (XATRAL 10mg OD), Open, 24-week Study.|Completed||Phase 4|110|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:05:38.594901|2017-02-18 16:05:38.594901
NCT00401648|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2009-11-30|||September 2002||2002-09-01|November 2009|2009-11-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Effect of Brivaracetam in Photosensitive Epileptic Subjects|A Placebo-controlled, Single-blind, Multi-center Study to Explore the Photoparoxysmal Response in Photosensitive Epileptic Subjects After One Single Oral Dose of Brivaracetam in Capsules.|Completed||Phase 2|20||UCB Pharma|||||f||||||||||||||2017-02-18 16:05:38.702313|2017-02-18 16:05:38.702313
NCT00401635|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2007-09-04|||November 2002||2002-11-01|September 2007|2007-09-01||||||||Interventional|||END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin|Phase II Multicentered Study of First-Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With the Combination of Carboplatin and Liposomal Doxorubicin|Completed||Phase 2|42||National Cancer Institute, Naples|||||f||||||||||||||2017-02-18 16:05:38.800649|2017-02-18 16:05:38.800649
NCT00401622|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2010-08-20|2010-05-29||October 2006||2006-10-01|August 2010|2010-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes||Completed||N/A|320|Actual|LifeScan||2|||f||||f||||||||||2017-02-18 16:05:38.914898|2017-02-18 16:05:38.914898
NCT00401609|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-01-13|||November 2000||2000-11-01|January 2016|2016-01-01|February 2009|Actual|2009-02-01|December 2007|Actual|2007-12-01||Interventional|G-Step||G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients|Evaluation of Activity and Toxicity of Polychemotherapy With 2-drug Combinations Containing Gemcitabine as First Line Treatment of Elderly Patients With Small Cell Lung Cancer|Completed||Phase 1/Phase 2|85||National Cancer Institute, Naples|||||f||||||||||||||2017-02-18 16:05:39.384354|2017-02-18 16:05:39.384354
NCT00401596|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2014-03-18|||July 2000||2000-07-01|March 2014|2014-03-01|July 2002|Actual|2002-07-01|||||Interventional|||A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)|A Multicenter, Randomized, Controlled, Open-Label Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Subjects Already Treated With Other Therapies (ALTO)|Completed||Phase 3|1899||Genentech, Inc.|||||f||||||||||||||2017-02-18 16:05:39.506742|2017-02-18 16:05:39.506742
NCT00401583|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2011-04-21|||July 2006||2006-07-01|April 2011|2011-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes|A Multi-center, Open-Label, Multiple-probe Drug Interaction Study to Determine the Effects of GW786034 on the Metabolism of Cytochrome P450 Probe Drugs in Patients With Solid Tumors|Completed||Phase 1|26|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:05:39.589841|2017-02-18 16:05:39.589841
NCT00401570|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2013-01-28||2012-04-25|March 2005||2005-03-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer|Phase 2 Open-Label Study of Volociximab (M200) in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer Not Previously Treated With Chemotherapy|Completed||Phase 2|40|Actual|AbbVie||2|||f||||||||||||||2017-02-18 16:05:39.692274|2017-02-18 16:05:39.692274
NCT00401557|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-08-03|||December 2006||2006-12-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|||||Observational|||Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection|Intervenable Host - Leishmania (Viannia) Interactions - Project 3: Immune and Inflammatory Responses in L. (Viannia) Infection - Aim 3: Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection|Completed||N/A|34|Actual|Yale University|||1||f||||||||||||||2017-02-18 16:05:39.802589|2017-02-18 16:05:39.802589
NCT00401544|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2013-12-10|2011-03-04||December 2006||2006-12-01|December 2013|2013-12-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Darbepoetin Alfa With or Without Intravenous (IV) Iron|Once Per Cycle Treatment of Anemia With Darbepoetin Alfa With Iron in Subjects With Non Myeloid Malignancies|Completed||Phase 2|243|Actual|Amgen||4|||f||||||||||||||2017-02-18 16:05:39.896998|2017-02-18 16:05:39.896998
NCT00401531|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2014-02-14|2014-02-14||October 2006||2006-10-01|February 2014|2014-02-01|August 2008|Actual|2008-08-01|November 2007|Actual|2007-11-01||Interventional|||Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants|Immunogenicity Study of a DTaP IPV Hep B PRP T Combined Vaccine in Comparison to Infanrix Hexa™, Both Concomitantly Administered With Prevnar™ at 2, 4, and 6 Months of Age in Thai Infants|Completed||Phase 3|412|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:05:41.668506|2017-02-18 16:05:41.668506
NCT00401518|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2015-09-09|||October 2006||2006-10-01|September 2015|2015-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis|The Investigational Plan for the Evaluation of the ACADIA® Facet Replacement System|Active, not recruiting||Phase 3|390|Actual|Globus Medical Inc||2|||f||||t||||||||||2017-02-18 16:05:42.357466|2017-02-18 16:05:42.357466
NCT00401505|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-04-22|||September 2006||2006-09-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Rubella Susceptibility in Multiparous Women|Rubella Susceptibility in Multiparous Women|Completed||N/A|310|Actual|St. Michael's Hospital, Toronto|||1||f||||||||||||||2017-02-18 16:05:42.494766|2017-02-18 16:05:42.494766
NCT00401492|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2012-07-12|||June 2002||2002-06-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer|Phase II Study of Chemotherapy With Gemcitabine in Prolonged Infusion or With Schedules With Cisplatin in Non-small Cell Lung Cancer Elderly Patients|Completed||Phase 2|159|Actual|National Cancer Institute, Naples|||||f||||||||||||||2017-02-18 16:05:42.579015|2017-02-18 16:05:42.579015
NCT00401479|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2008-10-15|||October 2006||2006-10-01|October 2008|2008-10-01||||||||Interventional|||A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers|An Exploratory Phase I Study in Healthy Volunteers of GI Transit Following Administration of the ß3-Adrenergic Receptor Agonist, Solabegron (Study B3I106248)|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 16:05:42.687048|2017-02-18 16:05:42.687048
NCT00401466|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2011-01-14|||January 2004||2004-01-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|REFORM||Remote Follow-up of Patients Receiving Implantable Cardioverter Defibrillator for Prophylactic Therapy|Remote Follow-up for ICD-Therapy in Patients Meeting MADIT II Criteria (REFORM)|Completed||Phase 4|155|Actual|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-02-18 16:05:42.784115|2017-02-18 16:05:42.784115
NCT00401453|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2010-02-16|||January 2007||2007-01-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||OatMeal and Insulin Resistance: OMA-IR|Carbohydrate Days as Simple and Efficient Therapy for Patients With Type 2 Diabetes Mellitus and Insulin Resistance: Oatmeal and Insulin Resistance (OMA-IR).|Completed||Phase 3|15|Anticipated|Universitätsmedizin Mannheim||1|||f||||||||||||||2017-02-18 16:05:42.908756|2017-02-18 16:05:42.908756
NCT00401440|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2010-03-11|||January 2007||2007-01-01|December 2008|2008-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Two Regimens of Misoprostol for Second Trimester Medical Termination of Pregnancy|Comparison of Twq Different Regimen of Vaginal Misoprostol for Nid Trimester MTP|Completed||Phase 4|185|Actual|Nilratan Sircar Medical College||2|||f||||t||||||||||2017-02-18 16:05:43.006469|2017-02-18 16:05:43.006469
NCT00401427|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2012-07-12|||November 2002||2002-11-01|July 2012|2012-07-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Interventional|||HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer|A Single-centre Phase 2 Study of Vinorelbine Plus 3-weekly Trastuzumab in Metastatic Breast Cancer Overexpressing Her-2|Completed||Phase 2|50||National Cancer Institute, Naples|||||f||||||||||||||2017-02-18 16:05:43.11626|2017-02-18 16:05:43.11626
NCT00401414|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2013-07-30|2013-03-20||January 2007||2007-01-01|July 2013|2013-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information|CReating an Optimal Warfarin Nomogram (CROWN) Trial|Completed||N/A|344|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 16:05:43.231386|2017-02-18 16:05:43.231386
NCT00401245|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2011-10-24|2011-09-06||December 2006||2006-12-01|October 2011|2011-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms|The Effect of Dose Titration and Dose Tapering on the Tolerability of DVS SR in Women With Vasomotor Symptoms Associated With Menopause: The PRIMMUS (PRIstiq for Managing Menopause and Understanding Symptoms) Study|Completed||Phase 3|500|Actual|Pfizer||8|||f||||f||||||||||2017-02-18 16:05:46.356293|2017-02-18 16:05:46.356293
NCT00332631|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2009-07-06|||August 2004||2004-08-01|July 2009|2009-07-01|March 2006||2006-03-01|||||Interventional|||High-Dose N-Acetylcysteine in Cardiac Surgery|High-Dose N-Acetylcysteine in Cardiac Surgery Patients at High-Risk of Postoperative Renal Dysfunction.|Completed||Phase 2|60||Austin Health|||||f||||||||||||||2017-02-18 16:30:17.81759|2017-02-18 16:30:17.81759
NCT00401401|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2011-11-21|2011-10-07||December 2006||2006-12-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer|An Open-labeled Trial With a Dose-escalation Part and a Parallel Group Design(1) Investigating Zalutumumab, an Anti-EGF Receptor Antibody, in Combination With Chemo-Radiation as First Line Treatment of Patients With Cancer of the Head and Neck (1) The Parallel Group Part Was Cancelled|Terminated||Phase 1/Phase 2|30|Actual|Genmab|"All adverse events were collected during the 8 week treatment period and for additional 4 weeks. Serious adverse events were collected for the extended follow-up period of up to 3 years.~The planned parallell group of the study was cancelled."|4||"MTD was established and patients completed 16 months safety f-up and response assessments. It~   is considered of limited value to follow patients for 3 years."|f||||t||||||||||2017-02-18 16:05:43.837014|2017-02-18 16:05:43.837014
NCT00401388|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2013-03-04|||November 2006||2006-11-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|January 2011|Actual|2011-01-01||Interventional|||A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas|Sarcoma Alliance for Research Through Collaboration (SARC) Multicenter Trial: A Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas|Completed||Phase 2|72|Actual|AEterna Zentaris||3|||f||||t||||||||||2017-02-18 16:05:44.848774|2017-02-18 16:05:44.848774
NCT00401375|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-07-17|||October 2006||2006-10-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI).|A Phase 3, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)|Completed||Phase 3|515|Actual|Valeant Pharmaceuticals International, Inc.||3|||f||||||||||||||2017-02-18 16:05:44.949776|2017-02-18 16:05:44.949776
NCT00401362|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-07-18|||February 2003||2003-02-01|July 2011|2011-07-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients|A Double-Blind Placebo-Controlled Study of Methylnaltrexone (MNTX) for the Relief of Constipation Due to Chronic Opioid Therapy in Patients With Advanced Medical Illness|Completed||Phase 3|154|Actual|Valeant Pharmaceuticals International, Inc.||3|||f||||t||||||||||2017-02-18 16:05:45.058723|2017-02-18 16:05:45.058723
NCT00401349|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-08-03|||December 2006||2006-12-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|||||Observational|||Expression of Mif Alleles in Individuals With Leishmaniasis|Immune and Inflammatory Responses in L. (Viannia) Infection Aim 2: Expression of Mif Alleles in Individuals With Recurrent Leishmaniasis, Chronic Leishmaniasis and Asymptomatic Infection|Completed||N/A|438|Actual|Yale University|||1||f||||t||||||Samples With DNA|"~     DNA samples from bucal swabs are being retained for genetic analyses of MIF alleles and~     possibly other genes associated with disease (leishmaniasis) resistance/susceptibility.~   "|||2017-02-18 16:05:45.160393|2017-02-18 16:05:45.160393
NCT00401336|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2013-03-07|||November 2006||2006-11-01|July 2012|2012-07-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|SURFER||Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging|Quantification of Liver Iron Overload and Steatosis Using a New Magnetic Resonance Imaging Multiecho Gradient-echo Sequence|Completed||N/A|250|Anticipated|Rennes University Hospital||1|||f||||f||||||||||2017-02-18 16:05:45.243726|2017-02-18 16:05:45.243726
NCT00401323|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2011-01-19|||January 1998||1998-01-01|January 2011|2011-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma|A Randomized Phase II-III Multicenter Trial of Docetaxel Plus Cisplatin and Docetaxel Plus 5-FU Versus Cisplatin Plus 5-FU in 1st Line Treatment of Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.|Completed||Phase 2/Phase 3|568|Actual|Sanofi||3|||f||||||||||||||2017-02-18 16:05:45.356619|2017-02-18 16:05:45.356619
NCT00401310|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2015-07-21|||July 2007||2007-07-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)|A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo Controlled Clinical Trial to Study the Efficacy and Safety of MK0724 Intravenous Infusion on the Amelioration of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke|Terminated||Phase 2|150|Actual|Merck Sharp & Dohme Corp.||2||"Termination date was 20-Oct-2008. Subjects were monitored during the post treatment 90 day~   follow-up period (per protocol) resulting in LPLV 19-Jan-2009."|f||||||||||||||2017-02-18 16:05:45.711409|2017-02-18 16:05:45.711409
NCT00401297|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-08-03|||December 2006||2006-12-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|||||Observational|||Th1/Th2 Polarization and Linkage to L. Viannia Infection Outcomes|Intervenable Host- Leishmania (Vianna) Interactions Project 3: Immune and Inflammatory Responses in L. (Viannia) Infection Aim 1: To Determine if Th1/Th2 Polarization Occurs and is Linked to the Outcome of Infection by L. Viannia|Completed||N/A|122|Actual|Yale University|||1||f||||t||||||||||2017-02-18 16:05:45.804068|2017-02-18 16:05:45.804068
NCT00401284|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2008-01-02|||November 2006||2006-11-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Hypnotic Efficacy of EVT 201 in Elderly Patient With Daytime Sleepiness|Completed||Phase 2|135|Anticipated|Evotec Neurosciences GmbH|||||f||||||||||||||2017-02-18 16:05:45.887214|2017-02-18 16:05:45.887214
NCT00401271|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2007-03-06|||November 2006||2006-11-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis|A Phase II Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Four Oral Doses of OPC-67683 in Patients With Uncomplicated, Smear-Positive, Pulmonary Tuberculosis|Completed||Phase 2|54||Otsuka Frankfurt Research Institute GmbH|||||f||||||||||||||2017-02-18 16:05:45.984309|2017-02-18 16:05:45.984309
NCT00401258|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2010-08-06|2010-06-25||November 2006||2006-11-01|August 2010|2010-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome|An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome Without Comorbid Major Depressive Disorder|Completed||Phase 4|15|Actual|Mclean Hospital||1|||f||||f||||||||||2017-02-18 16:05:46.074626|2017-02-18 16:05:46.074626
NCT00395837|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2006-11-01|||September 2004||2004-09-01|November 2006|2006-11-01|May 2006||2006-05-01|||||Interventional|||Efficacy of Lifestyle Changes in Modifying Practical Markers of Wellness and Aging.|Efficacy of Lifestyle Changes in Modifying Practical Markers of Wellness and Aging|Completed||N/A|56||St. Anthony's Health Care|||||f||||||||||||||2017-02-18 16:07:19.038839|2017-02-18 16:07:19.038839
NCT00401232|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2016-12-06|||August 2006||2006-08-01|December 2016|2016-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development|Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development|Active, not recruiting||N/A|900|Anticipated|Pfizer||1|||f||||f||||||||||2017-02-18 16:05:48.548442|2017-02-18 16:05:48.548442
NCT00401219|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2007-12-04|||November 2006||2006-11-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation|An Open-Label, Single-Dose, Randomized, 4-Period, Crossover, Bioavailability Study Among 3 New Formulations of Premarin 0.625 mg/Medroxyprogesterone Acetate (Mpa) 2.5 mg Compared With a Reference Formulation of Premarin/Mpa (Prempro) 0.625 mg/2.5 mg in Healthy Postmenopausal Women|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:05:48.637953|2017-02-18 16:05:48.637953
NCT00401206|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-17|2007-11-02|||November 2006||2006-11-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Use of Dexmedetomidine for Sedation During Flexible Bronchoscopy in Patients With COPD: A Descriptive Study|Use of Dexmedetomidine for Sedation During Flexible Bronchoscopy in Patients With COPD: A Descriptive Study|Completed||N/A|12|Actual|The Cooper Health System||1|||f||||||||||||||2017-02-18 16:05:48.722341|2017-02-18 16:05:48.722341
NCT00401193|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-04-23|2009-08-31||November 2006||2006-11-01|April 2015|2015-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of XP12B in Women With Menorrhagia|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study To Evaluate Efficacy and Safety of XP12B for the Treatment of Menorrhagia|Completed||Phase 3|304|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-02-18 16:05:48.814276|2017-02-18 16:05:48.814276
NCT00401180|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-07-06|||June 2002||2002-06-01|September 2007|2007-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer|Phase I Trial of Weekly Docetaxel and Daily Temozolomide in Patients With Metastatic Disease|Completed||Phase 1|25|Actual|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 16:05:49.566593|2017-02-18 16:05:49.566593
NCT00401167|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2012-05-24|||November 2006||2006-11-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Memantine for Agitation and Aggression in Severe Alzheimer's Disease|Phase IV-An Open-Label Prospective Study of Memantine in Institutionalized Patients With Severe Alzheimer's Disease and Significant Behavioural and Psychological Symptoms of Dementia|Completed||Phase 4|32|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||||||||||||2017-02-18 16:05:49.679681|2017-02-18 16:05:49.679681
NCT00401154|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2014-12-04|||September 2003||2003-09-01|December 2014|2014-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|PEDALS||Study of a Stationary Cycling Intervention for Children With Spastic Diplegic Cerebral Palsy|Pediatric Endurance and Limb Strengthening (PEDALS)|Completed||N/A|64|Actual|University of Southern California||1|||f||||t||||||||||2017-02-18 16:05:49.791802|2017-02-18 16:05:49.791802
NCT00401141|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2008-08-07|||April 2004||2004-04-01|August 2008|2008-08-01||||||||Interventional|||Abnormalities of B Lymphocytes During Systemic Lupus|Phenotypic Characteristics and Transcriptomas of B Lymphocytes During Non Active Systemic Lupus Erythematosus|Completed||N/A|30|Anticipated|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 16:05:49.902787|2017-02-18 16:05:49.902787
NCT00401128|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-05-13|||May 2004||2004-05-01|May 2007|2007-05-01||||||||Interventional|||Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer|Phase II Study of Gemcitabine Plus Irinotecan in Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|30|Anticipated|The Cleveland Clinic|||||f||||||||||||||2017-02-18 16:05:49.988202|2017-02-18 16:05:49.988202
NCT00401115|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2010-07-22|||September 2006||2006-09-01|July 2010|2010-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy|A Phase 1, Open-Label, Dose-Escalation Clinical Study to Assess the Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy|Completed||Phase 1|50|Actual|Santen Inc.||2|||f||||f||||||||||2017-02-18 16:05:50.09753|2017-02-18 16:05:50.09753
NCT00401102|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-12-20|2012-12-20||November 2006||2006-11-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|IPT-ASI||Interpersonal Psychotherapy for Depressed Adolescents Engaging in Non-suicidal Self-injury|An Open-clinical Trial of Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) for Depressed Adolescents Engaged in Non-suicidal Self-injury|Completed||Phase 1|10|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 16:05:50.211537|2017-02-18 16:05:50.211537
NCT00401089|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-12-11|||December 2002||2002-12-01|December 2012|2012-12-01|October 2007|Actual|2007-10-01|December 2006|Actual|2006-12-01||Interventional|||Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia|A Placebo-controlled Cross Study of Panax Ginseng in Augmentation of Antipsychotics in 60 Partially Treatment Responsive Patients With Schizophrenia|Completed||Phase 1/Phase 2|60|Actual|Lawson Health Research Institute||2|||f||||t||||||||||2017-02-18 16:05:50.452751|2017-02-18 16:05:50.452751
NCT00401076|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-07-28|||July 2008||2008-07-01|July 2011|2011-07-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency|A One-year Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy|Completed||Phase 3|80|Actual|Abbott||1|||f||||f||||||||||2017-02-18 16:05:50.57886|2017-02-18 16:05:50.57886
NCT00401063|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2013-05-28|||September 2006||2006-09-01|May 2013|2013-05-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||Usefulness of Acupuncture in Cancer Pain and Quality of Life|Acupuncture Case Series: Cancer Pain and Quality of Life|Completed||N/A|11|Actual|Southern California University of Health Sciences||1|||f||||f||||||||||2017-02-18 16:05:50.695704|2017-02-18 16:05:50.695704
NCT00401050|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2010-04-16|||June 2006||2006-06-01|April 2010|2010-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison Study of Two Chiropractic Treatment Protocols for Knee Pain Due to Patellofemoral Pain Syndrome|A Randomized Clinical Trial Comparing Two Chiropractic Protocols for Patellofemoral Pain Syndrome: a Pilot Study|Completed||N/A|31|Actual|Cleveland Chiropractic College||2|||f||||f||||||||||2017-02-18 16:05:50.798919|2017-02-18 16:05:50.798919
NCT00401024|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2010-07-24|||July 2006||2006-07-01|July 2009|2009-07-01||||June 2009|Actual|2009-06-01||Interventional|||Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma|Determination of the In-Tumor-Concentration of Imatinib Mesylate in Malignant Glioma After Oral Administration|Completed||N/A|33|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:05:50.895762|2017-02-18 16:05:50.895762
NCT00401011|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-02-07|||August 2006||2006-08-01|February 2012|2012-02-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients|An Open-Label Phase I/II Study of the Safety and Efficacy of Perifosine and Bortezomib With or Without Dexamethasone for Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Bortezomib|Completed||Phase 1/Phase 2|84|Actual|Keryx / AOI Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 16:05:51.006901|2017-02-18 16:05:51.006901
NCT00400998|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-05-31|||March 2006||2006-03-01|February 2011|2011-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis|A Randomised, Double Blind, Placebo Controlled, 2-way Crossover, 3 Phase Study, to Investigate the Trial Models, Vienna Challenge Chamber, in and Out of Season, and Park Study in Season and the Clinical Efficacy of Rpt Doses of Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis|Completed||Phase 2|41|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 16:05:51.12239|2017-02-18 16:05:51.12239
NCT00400985|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-06|||January 2005||2005-01-01|April 2010|2010-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|SENSE-HF||Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure|Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure|Completed||N/A|501|Actual|Medtronic Bakken Research Center||1|||f||||f||||||||||2017-02-18 16:05:51.229892|2017-02-18 16:05:51.229892
NCT00400972|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2007-09-27|||November 2006||2006-11-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of GlideScope Videolaryngoscopy to Direct Laryngoscopy for Nasal Intubation|Comparison of GlideScope Videolaryngoscopy to Direct Laryngoscopy for Nasal Intubation|Completed||N/A|70|Anticipated|Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:05:51.326265|2017-02-18 16:05:51.326265
NCT00400959|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2006-11-15|||June 2004||2004-06-01|November 2006|2006-11-01|October 2006||2006-10-01|||||Interventional|||CD133+ Autologous Cells After Myocardial Infarction|Intracoronary Injection of CD133+ Autologous Hematopoietic Cells After Myocardial Infarction|Completed||Phase 1/Phase 2|15||Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|||||f||||||||||||||2017-02-18 16:05:51.413191|2017-02-18 16:05:51.413191
NCT00400946|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2015-03-17|||April 2005||2005-04-01|March 2015|2015-03-01|June 2015|Anticipated|2015-06-01|June 2015|Anticipated|2015-06-01||Interventional|||Treatment of Acute Lymphoblastic Leukemia in Children|Treatment of Acute Lymphoblastic Leukemia in Children|Active, not recruiting||Phase 3|800|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 16:05:51.498025|2017-02-18 16:05:51.498025
NCT00400933|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2012-02-09|||November 2006||2006-11-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of a Six-session Psycho-education Group Program|Evaluation of a Six-session Psycho-education Group Program Delivered to Family Members and Close Friends of Patients Suffering From Eating Disorders and Co-morbid Personality Disorders|Terminated||Phase 1|10|Actual|Norwegian University of Science and Technology||1||shortage of experienced health care personnel after reorganisation of units|f||||f||||||||||2017-02-18 16:05:51.655942|2017-02-18 16:05:51.655942
NCT00400907|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-12-17|||January 2006||2006-01-01|January 2007|2007-01-01||||||||Observational|||Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9|Follow-up Observational Study of the Randomised Intergroup Trial of First Line Treatment for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma With CHOP-Like Chemotherapy Regimen With or Without the Anti-CD20 Antibody Rituximab (IDEC-C2B8) [MINT]|Unknown status|Active, not recruiting|N/A|667|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:05:51.756683|2017-02-18 16:05:51.756683
NCT00400894|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2007-02-02|||September 2005||2005-09-01|February 2007|2007-02-01|September 2006||2006-09-01|||||Observational|||Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma|Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma|Unknown status|Active, not recruiting|N/A|750||ProteoSys AG|||||f||||||||||||||2017-02-18 16:05:51.843398|2017-02-18 16:05:51.843398
NCT00400881|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2015-10-29|2011-08-18||January 2007||2007-01-01|October 2015|2015-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Comparison Between Two Methods of Spontaneous Breathing Trial (SBT)|Comparison Between Two Methods of Spontaneous Breathing Trial (SBT)|Completed||Phase 4|122|Actual|Texas Tech University Health Sciences Center, El Paso|"General ICU population.~Two subjects in each group were randomized and data collected but were not included in analysis per protocol due to needing re-intubation for upper airway obstruction."|2|||f||||f||||||||||2017-02-18 16:05:51.925998|2017-02-18 16:05:51.925998
NCT00400868|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2010-02-23|||July 2006||2006-07-01|February 2010|2010-02-01|September 2009|Actual|2009-09-01|February 2009|Actual|2009-02-01||Interventional|||Effectiveness of Occupational Therapy in Patients With Rheumatoid Arthritis(RCT)|A Randomized Controlled Study to Evaluate the Short- and Long-term Effectiveness of an Individualized Resource Oriented Occupational Therapy for Patients With Rheumatoid Arthritis|Completed||N/A|54|Actual|University of Zurich||1|||f||||||||||||||2017-02-18 16:05:52.323097|2017-02-18 16:05:52.323097
NCT00400855|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-09-13|||January 2005||2005-01-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate|A Randomised, Double-blind, Placebo-controlled, Incomplete Block, 4-period Crossover, Study to Investigate the Effects of 5-day Repeat Inhaled Doses of Fluticasone Propionate (BID, 50-2000 mcg) on Airway Responsiveness to Adenosine 5-monophosphate (AMP) Challenge When Delivered After the Last Dose in Mild Asthmatic Subjects.|Completed||Phase 2|49|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:05:52.452139|2017-02-18 16:05:52.452139
NCT00400504|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2006-11-16|||November 2006||2006-11-01|November 2006|2006-11-01||||||||Observational|||Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)|Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)|Unknown status|Recruiting|N/A|500||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:06:03.974296|2017-02-18 16:06:03.974296
NCT00400842|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-07-27|||May 2007||2007-05-01|July 2011|2011-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency|A Double-blind, Placebo-controlled, Parallel-group, Comparative Study to Confirm the Safety and Efficacy of Oral 1.5 g/Day and 3.0 g/Day of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy|Completed||Phase 3|274|Actual|Abbott||3|||f||||f||||||||||2017-02-18 16:05:52.569382|2017-02-18 16:05:52.569382
NCT00400829|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2014-12-23|2014-12-23||November 2006||2006-11-01|October 2013|2013-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase 2 Study of the Halichondrin B Analog E7389 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Previously Treated With a Taxane|Completed||Phase 2|66|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:05:52.765502|2017-02-18 16:05:52.765502
NCT00400816|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2016-08-06|||August 2005||2005-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma|Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma|Active, not recruiting||Phase 2|60|Anticipated|The Cleveland Clinic||1|||f||||t||||||||||2017-02-18 16:05:53.205789|2017-02-18 16:05:53.205789
NCT00400803|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-10-22|2011-11-10||March 2007||2007-03-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer|Phase II Study of Biweekly Carboplatin and Gemcitabine With Bevacizumab as 1st Line Treatment in Patients With Advanced, Inoperable Stage IIIb/IV NSCLC|Completed||Phase 2|38|Actual|Masonic Cancer Center, University of Minnesota|Outcome data is available for 35 (of 38) patients only.|1|||f||||t||||||||||2017-02-18 16:05:53.323864|2017-02-18 16:05:53.323864
NCT00400790|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2010-06-28|||September 2007||2007-09-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane|A Randomised Controlled Study of Organ Protection Comparing Desflurane and Propofol in Adult Patients Undergoing Coronary Artery Surgery With Cardiopulmonary Bypass|Completed||N/A|182|Actual|University of Melbourne||1|||f||||f||||||||||2017-02-18 16:05:53.687488|2017-02-18 16:05:53.687488
NCT00400777|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2008-06-17|||August 2006||2006-08-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension|An Open-Label, Randomized, Multicenter Study to Evaluate the Efficacy of the Combination of Valsartan and Hydrochlorothiazide and Amlodipine in Hypertensive Patients Not Controlled With Valsartan and Hydrochlorothiazide|Completed||Phase 4|460|Anticipated|Novartis|||||f||||||||||||||2017-02-18 16:05:53.785498|2017-02-18 16:05:53.785498
NCT00400764|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2011-11-15|2011-09-01||June 2006||2006-06-01|November 2011|2011-11-01||||May 2010|Actual|2010-05-01||Interventional|||A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas|A Phase Ib/II, Open-Label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Dulanermin Administered Intravenously in Combination With Rituximab to Subjects With Follicular and Other Low-Grade, CD20+, B-Cell Non-Hodgkin's Lymphomas That Have Progressed Following Previous Rituximab Therapy|Terminated||Phase 1/Phase 2|72|Actual|Genentech, Inc.|The Sponsor terminated the study on 5 May 2010, prior to the completion of the 36-month follow-up (FU) period, based on the primary analysis results. All patients were off-study or in survival FU (the treatment period was completed).|5|||f||||||||||||||2017-02-18 16:05:53.88777|2017-02-18 16:05:53.88777
NCT00400751|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2006-11-16|||September 1999||1999-09-01|September 1999|1999-09-01|May 2003||2003-05-01|||||Interventional|||Family Consultation for Health-Compromised Smokers|Phase 1 Study of Family Consultation for Change-Resistant Smokers|Completed||Phase 1|40||University of Arizona|||||f||||||||||||||2017-02-18 16:06:00.215163|2017-02-18 16:06:00.215163
NCT00400738|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2012-04-03|||March 2004||2004-03-01|April 2012|2012-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients|Pharmacokinetics of and Rate of HIV-1 RNA Decline in ARV-naive HIV-1 Infected Patients Treated With Low- or Standard-dose Saquinavir HGC (Invirase®) and Lopinavir/Ritonavir (Kaletra®|Completed||Phase 2|48|Actual|The HIV Netherlands Australia Thailand Research Collaboration||4|||f||||f||||||||||2017-02-18 16:06:00.316718|2017-02-18 16:06:00.316718
NCT00400725|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2008-05-28|||September 2006||2006-09-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|||||Interventional|||Maintenance Effect of Clobex Shampoo on Subjects With Moderate to Severe Scalp Psoriasis|Comparison of the Maintenance Effect of Clobex® Shampoo 0.05% Used Twice Weekly vs. Vehicle on Scalp Psoriasis in Subjects Who Successfully Responded to a 4-Week Daily Course of Clobex® Shampoo 0.05%|Completed||Phase 3|288|Actual|Galderma||2|||f||||||||||||||2017-02-18 16:06:00.427817|2017-02-18 16:06:00.427817
NCT00400712|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2016-04-03|2015-11-06||December 2006||2006-12-01|April 2016|2016-04-01|January 2012|Actual|2012-01-01|November 2011|Actual|2011-11-01||Interventional||Hemiparetic stroke (hemorrhagic or ischemic), first ever associated with residual deficits/impairments (i.e. full recovery from previous stoke if applicable)|Client Centred 'Tune-ups': do They Enhance Community Reintegration After Stroke?|Client Centred 'Tune-ups': do They Enhance Community Reintegration and Mobility in Stroke Survivors?|Completed||N/A|103|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 16:06:00.534849|2017-02-18 16:06:00.534849
NCT00400699|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2014-01-30|||October 2004||2004-10-01|January 2014|2014-01-01||||November 2009|Actual|2009-11-01||Interventional|||Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer|UPMC McKeesport/ROCOG Radiation Oncology Minorities Outreach Program|Completed||N/A|3150|Actual|University of Pittsburgh||1|||f||||||||||||||2017-02-18 16:06:01.094837|2017-02-18 16:06:01.094837
NCT00400686|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2016-10-18|2015-06-03||September 2003||2003-09-01|October 2016|2016-10-01|August 2013|Actual|2013-08-01|January 2009|Actual|2009-01-01||Interventional|||Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma|A Single Institution, Open-Label, Nonrandomized Pilot Study of High Dose Epoetin Alfa Administered Once a Week in Patients With Multiple Myeloma: Its Effects on Hemoglobin, Blood Transfusion Requirements and Quality of Life|Completed||N/A|31|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-02-18 16:06:01.205355|2017-02-18 16:06:01.205355
NCT00006203|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2006-10-20||||||October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||Naltrexone, Craving, and Drinking|Naltrexone, Craving, and Drinking: Ecological Assessment|Completed||Phase 4|186||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:13:15.125849|2017-02-18 18:13:15.125849
NCT00400673|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2011-03-31|||May 2000||2000-05-01|March 2011|2011-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia|Two-Step Remission Induction With Risk-Oriented Consolidation (High-Risk: Allogeneic Stem Cell Transplant; Standard-Risk: Multicycle High-Dose Cytarabine With Autologous Blood Stem Cell Support) for Adult Acute Myelogenous Leukemia|Completed||Phase 2|581|Actual|Northern Italy Leukemia Group||1|||f||||f||||||||||2017-02-18 16:06:01.694321|2017-02-18 16:06:01.694321
NCT00400660|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-05-31|||November 2005||2005-11-01|February 2011|2011-02-01||||||||Interventional|||A First Time In Human Study To Assess The Compound GSK615915|A Randomised, Single and Repeat Dose, Double-blind, Placebo Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK615915 in Healthy Volunteers and Mild Asthmatics.|Completed||Phase 1|54||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:06:01.813984|2017-02-18 16:06:01.813984
NCT00400647|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2017-02-03|||July 2006||2006-07-01|February 2017|2017-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil|A 12-week Multicenter, Randomized, Open Study to Evaluate the Effects of Enteric-coated Mycophenolate Sodium (EC-MPS) in Terms of Quality of Life in Patients With Gastrointestinal (GI) Symptoms Treated With MMF (Mycophenolate Mofetil) After Kidney Transplant.|Completed||Phase 4|136|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:06:01.902009|2017-02-18 16:06:01.902009
NCT00400634|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-07-06|2012-05-24||November 2006||2006-11-01|July 2012|2012-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease|Multicenter, Randomized, Double-Blind, Sham Surgery-Controlled Study of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) to Assess the Efficacy and Safety of Bilateral Intraputaminal (IPu) Delivery in Subjects With Idiopathic Parkinson's Disease|Completed||Phase 2|58|Actual|Ceregene||2|||f||||t||||||||||2017-02-18 16:06:02.014914|2017-02-18 16:06:02.014914
NCT00400621|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2006-11-16|||April 2003||2003-04-01|November 2006|2006-11-01|September 2003||2003-09-01|||||Interventional|||Effects of Therapeutic Doses of Acetaminophen in Moderate Drinkers|Assessment of Hepatic Injury in Subjects Who Consume Moderate Amounts of Alcohol While Being Administered Therapeutic Doses of Acetaminophen:|Completed||Phase 4|150||Denver Health and Hospital Authority|||||f||||||||||||||2017-02-18 16:06:02.477459|2017-02-18 16:06:02.477459
NCT00400608|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-10-26|||October 2006||2006-10-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|||||Interventional|||A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS|A Repeat-dose, Open-label, Randomized, Incomplete Block Design in Pediatric Subjects With Asthma, Ages 4 - 11 Years, to Compare Systemic Exposure and Pharmacodynamics of Fluticasone Propionate and Salmeterol Following Advair HFA 45/21mcg (2 Inhalations), ADVAIR® HFA 45/21mcg (2 Inhalations) With Aerochamber Plus Spacer and Advair Diskus 100/50 Twice Daily|Completed||Phase 4|28|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:06:02.565219|2017-02-18 16:06:02.565219
NCT00400595|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2015-03-16|||February 2006||2006-02-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Use of Ointments in Prevention of Catheter Related Infections in PD|A Randomized Controlled Double Blind Study Using Mupirocin Versus Polysporin Triple for the Prevention of Catheter-related Infections in Patients Treated With Peritoneal Dialysis|Completed||Phase 4|200|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 16:06:02.676646|2017-02-18 16:06:02.676646
NCT00400582|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2011-07-20|||November 2006||2006-11-01|July 2011|2011-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Pharmacogenomic Study of Candesartan in Heart Failure|Effect of ACE Inhibitor Plus High Dose Candesartan on BNP and Inflammation in Patients With LV Dysfunction: Impact of Renin-angiotensin-aldosterone System Genetic Polymorphisms|Completed||Phase 4|300|Anticipated|Montreal Heart Institute||1|||f||||f||||||||||2017-02-18 16:06:02.791918|2017-02-18 16:06:02.791918
NCT00400569|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-07-25|2012-07-25||November 2006||2006-11-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma|Phase II Open-Label Study of Sunitinib Malate (SU011248) in Adult Patients With Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma|Completed||Phase 2|48|Actual|H. Lee Moffitt Cancer Center and Research Institute|The trial was amended to exclude fibrosarcoma after only one patient was accrued while the other cohorts had completed 75% or more of their planned accrual. Only patients with liposarcoma, leiomyosarcoma, or MFH were enrolled after this amendment.|1|||f||||f||||||||||2017-02-18 16:06:02.91111|2017-02-18 16:06:02.91111
NCT00400556|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2006-11-15|||March 2005||2005-03-01|November 2006|2006-11-01|May 2005||2005-05-01|||||Interventional|||ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells|A Phase I Study of Haematopoietic Stem Cell Mobilization Using G-CSF With ATRA in Patients With Cutaneous Lymphoma and Multiple Myeloma|Completed||Phase 1|6||Peter MacCallum Cancer Centre, Australia|||||f||||||||||||||2017-02-18 16:06:03.231486|2017-02-18 16:06:03.231486
NCT00400543|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2006-11-16|||January 2004||2004-01-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Early Signs of Atherosclerosis in Obstructive Sleep Apnea: Effects of Treatment|Effects of Continuous Positive Airway Pressure (CPAP) on Early Signs of Atherosclerosis in Patients With Obstructive Sleep Apnea: a Randomized Study|Completed||Phase 4|24||University of Sao Paulo|||||f||||||||||||||2017-02-18 16:06:03.34235|2017-02-18 16:06:03.34235
NCT00400530|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2006-11-16|||December 2005||2005-12-01|November 2006|2006-11-01||||||||Interventional|||Upper GI Handling of Branded vs. Generic Alendronate|A Randomized, Single-Blind Study to Evaluate Upper Gastrointestinal Handling of Branded Versus Generic Alendronate Tablets|Completed||Phase 3|25||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:03.530575|2017-02-18 16:06:03.530575
NCT00400517|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2016-10-18|||March 2003||2003-03-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer|Phase II Trial of Neoadjuvant GM-CSF + Thalidomide in High-Risk Patients With Prostate Cancer Undergoing Prostatectomy|Completed||Phase 2|28|Actual|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 16:06:03.850601|2017-02-18 16:06:03.850601
NCT00400491|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2008-05-22|||June 2006||2006-06-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||Vitamin D Supplementation to Patients With Type 2 Diabetes|Vitamin D Supplementation to Patients With Type 2 Diabetes|Completed||Phase 2|40|Actual|University of Tromso||2|||f||||f||||||||||2017-02-18 16:06:04.054236|2017-02-18 16:06:04.054236
NCT00400478|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-16|2016-05-25|||January 2006||2006-01-01|May 2016|2016-05-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13|A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation Alone in Patients With Aggressive B-cell Lymphoma: NHL-13|Completed||Phase 3|683|Actual|Arbeitsgemeinschaft medikamentoese Tumortherapie||2|||f||||t||||||||||2017-02-18 16:06:04.188953|2017-02-18 16:06:04.188953
NCT00400465|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2015-03-31|||December 2006||2006-12-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||Is the Routine Pressure Dressing After Thyroidectomy Necessary?|Is the Routine Pressure Dressing After Thyroidectomy Necessary? A Prospective Randomized Controlled Study|Completed||Phase 4|116|Actual|Khon Kaen University||2|||f||||f||||||||||2017-02-18 16:06:04.460664|2017-02-18 16:06:04.460664
NCT00400452|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2011-07-04|||May 2007||2007-05-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Manual Wheelchair Skills Training for Long-term-care Residents|Manual Wheelchair Skills Training for Long-term-care Residents: A Pilot Randomized Controlled Trial of Efficacy|Terminated||N/A|8|Actual|Nova Scotia Health Authority||1||poor enrollment|f||||f||||||||||2017-02-18 16:06:04.577054|2017-02-18 16:06:04.577054
NCT00400439|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-07-27||2016-07-26|January 2007||2007-01-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381|A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381|Completed||Phase 2|77|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:06:04.663601|2017-02-18 16:06:04.663601
NCT00400426|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2013-06-18|||November 2006||2006-11-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer|DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer|Completed||Phase 2|100|Anticipated|University of Aarhus||1|||f||||||||||||||2017-02-18 16:06:04.768621|2017-02-18 16:06:04.768621
NCT00400413|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2011-08-29|||November 2003||2003-11-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Interventional|||Neuroanatomy of Reading in Congenital Deafness.|Phonological Perception and Learning to Read : the Neuroanatomy of Reading in Congenitally Deaf Persons|Completed||N/A|60|Actual|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 16:06:04.860164|2017-02-18 16:06:04.860164
NCT00400400|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2011-07-14|2010-12-03||October 2006||2006-10-01|July 2011|2011-07-01||||June 2008|Actual|2008-06-01||Interventional|||Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance|A 4-week, Multicenter, Double-blind, Double-dummy, Randomized, Parallel Group Study to Compare the Gastrointestinal Safety and Tolerability of EC-MPS & MMF When Administered in Combination With Calcineurin Inhibitors in Renal Transplant Recipients Experiencing Gastrointestinal Intolerance|Completed||Phase 4|400|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:06:04.952508|2017-02-18 16:06:04.952508
NCT00400387|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2014-09-16|||November 2006||2006-11-01|September 2014|2014-09-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional|||Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss|Phase III Study Analyzing the Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss|Completed||Phase 3|449|Actual|University of Jena||2|||f||||||||||||||2017-02-18 16:06:05.591029|2017-02-18 16:06:05.591029
NCT00400374|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-02-26|||August 2007||2007-08-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|December 2012|Actual|2012-12-01||Interventional|||Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2|Phase I Study of Secondary Primary Tumor Prevention With Epidermal Growth Factor Receptor (EGFR), Tyrosine Kinase Inhibitor Erlotinib (OSI-774, Tarceva™), and Cyclooxygenase-2 (COX-2) Inhibitor (Celecoxib) in Early Stage (Stage I/II) Squamous Cell Carcinoma of Head and Neck|Active, not recruiting||Phase 1|10|Actual|Emory University||1|||f||||t||||||||||2017-02-18 16:06:05.985411|2017-02-18 16:06:05.985411
NCT00400361|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-11-01|||April 2006||2006-04-01|November 2016|2016-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.|A Dose-escalation Study of R1507 in Patients With Advanced Solid Tumors.|Completed||Phase 1|98|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:06:06.122755|2017-02-18 16:06:06.122755
NCT00400348|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2008-11-24|||October 2006||2006-10-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer|A Phase 2, Open-Label, Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion Administered Orally in Patients With Recurrent or Resistant Epithelial Ovarian Cancer|Completed||Phase 2|18|Actual|CASI Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 16:06:06.221017|2017-02-18 16:06:06.221017
NCT00400335|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2012-05-31|||October 2006||2006-10-01|February 2011|2011-02-01||||||||Interventional|||Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride|An Open Label Study to Evaluate the Impact of Novel Fixed-dose Testosterone/Dutasteride Combinations on the Relative Bioavailability of the Individual Dutasteride and Testosterone Components|Completed||Phase 1|60|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:06:06.313035|2017-02-18 16:06:06.313035
NCT00400322|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2009-01-21|||August 2006||2006-08-01|January 2009|2009-01-01|March 2009|Anticipated|2009-03-01|||||Interventional|||Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection|A Randomized Double Blind Controlled Proof of Concept Study of the Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma With Successful Surgical Resection of at Least 90 % of the Initial Tumor and CMV Infection Demonstrated Histologically and Immunohistochemically.|Unknown status|Active, not recruiting|N/A|40|Anticipated|Karolinska University Hospital||2|||f||||||||||||||2017-02-18 16:06:06.430385|2017-02-18 16:06:06.430385
NCT00400309|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2009-04-03|||June 2006||2006-06-01|April 2009|2009-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Safety of REPEVAX® Given One Month After REVAXIS®|A Double Blind, Controlled, Randomised, Clinical Study to Assess the Safety of Repevax® Administered One Month After Revaxis® or Placebo to Healthy Adults|Completed||Phase 3|500|Actual|MCM Vaccines B.V.||2|||f||||||||||||||2017-02-18 16:06:06.538069|2017-02-18 16:06:06.538069
NCT00399347|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-12|2006-11-12|||January 2005||2005-01-01|November 2006|2006-11-01|December 2005||2005-12-01|||||Observational|||Prevalence of Type 2 Diabetes Mellitus in Ethiopian Community in Israel: an Update|Prevalence of Diabetes Mellitus in Ethiopian Community in Israel: an Update|Unknown status|Active, not recruiting|N/A|500||HaEmek Medical Center, Israel|||||f||||||||||||||2017-02-18 16:06:23.955682|2017-02-18 16:06:23.955682
NCT00400296|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-11-01|||May 2005||2005-05-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study of R547 in Patients With Advanced Solid Tumors.|A Multiple Ascending Dose (MAD) Study of R547 Administered as an Intravenous Infusion on a Weekly Schedule in Patients With Advanced Solid Tumors|Completed||Phase 1|58|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:06:06.624044|2017-02-18 16:06:06.624044
NCT00400283|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2012-06-28|||January 2001||2001-01-01|September 2011|2011-09-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes|A Randomised, Double-blind, Placebo-controlled, Multiple Oral Dose, Dose Escalation Trial, Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC 55-0414 in Patients With Type 2 Diabetes|Completed||Phase 1|23|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:06:06.730477|2017-02-18 16:06:06.730477
NCT00400270|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2015-05-27|||October 2004||2004-10-01|November 2006|2006-11-01|January 2006||2006-01-01|||||Interventional|||Breathing and Relaxation Exercises for Asthma: a Randomised Controlled Trial|A Physical Therapy Treatment for Adults Diagnosed With Asthma in Primary Care: a Randomised Controlled Trial|Completed||N/A|56||University College London Hospitals|||||f||||||||||||||2017-02-18 16:06:06.824081|2017-02-18 16:06:06.824081
NCT00400257|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-05-30|||May 2007||2007-05-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|January 2010|Actual|2010-01-01||Observational|||Screening Evaluation of the Evolution of New Heart Failure (SCREEN-HF)|SCREEN-HF (Screening Evaluation of the Evolution of New Heart Failure)|Completed||N/A|3500|Anticipated|The Alfred|||1||f||||f||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 16:06:06.912792|2017-02-18 16:06:06.912792
NCT00400244|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2009-09-28|||January 2006||2006-01-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||French-Canadian Version of the Wheelchair Skills Program (WSP)|Translation, Validation and Evaluation of the Efficacy of the French-Canadian Version of the Wheelchair Skills Program (WSP)|Completed||N/A|41|Actual|Nova Scotia Health Authority||1|||f||||f||||||||||2017-02-18 16:06:07.012768|2017-02-18 16:06:07.012768
NCT00400231|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-08-15|||August 2005||2005-08-01|August 2016|2016-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study|The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study|Completed||Phase 2|124|Anticipated|University of Pennsylvania||4|||f||||||||||||||2017-02-18 16:06:07.096737|2017-02-18 16:06:07.096737
NCT00400218|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-05-13|||September 2005||2005-09-01|May 2016|2016-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)|Evaluate the Safety and Tolerability of Hyzaar(R) (Losartan 50 Mg/ Hydrochlorothiazide 12.5 Mg) In the Treatment of Hypertension|Completed||Phase 3|62|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:07.216521|2017-02-18 16:06:07.216521
NCT00400205|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2011-03-30|2010-12-06||August 2006||2006-08-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil|Phase II Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil Chemotherapy in Squamous Cell Carcinoma of the Oral Cavity With Molecular Endpoints|Terminated||Phase 2|14|Actual|Emory University||3||Safety reasons|f||||t||||||||||2017-02-18 16:06:07.303876|2017-02-18 16:06:07.303876
NCT00400192|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2013-04-11|||November 2006||2006-11-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|August 2010|Actual|2010-08-01||Observational|||Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury|Prospective Study of the Kinetics and Mechanisms of Transfusion-associated Microchimerism in Injured Patients|Completed||N/A|451|Actual|Blood Systems Research Institute|||1||f||||f||||||Samples With DNA|"~     Whole blood, plasma, peripheral blood mononuclear cells~   "|||2017-02-18 16:06:07.594365|2017-02-18 16:06:07.594365
NCT00400179|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-03-28|2012-01-06||May 2005||2005-05-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||A Safety and Efficacy Study in Patients With Gastric Cancer|An Open-Label Multicenter, Randomized, Phase 3 Study of S-1 in Combination With Cisplatin Against 5-Fu in Combination W/ Cisplatin in Patients W/ Advanced Gastric Cancer Previously Untreated W/ Chemotherapy for Advanced Disease|Completed||Phase 3|1053|Actual|Taiho Oncology, Inc.||2|||f||||f||||||||||2017-02-18 16:06:07.709102|2017-02-18 16:06:07.709102
NCT00400166|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2009-06-10|||December 2006||2006-12-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Recovery Guide Intervention for Recurrent Psychiatric Hospitalization|Recovery Guide Intervention for Recurrent Psychiatric Hospitalization|Completed||N/A|71|Actual|Yale University||2|||f||||f||||||||||2017-02-18 16:06:09.875165|2017-02-18 16:06:09.875165
NCT00400153|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2014-06-09|2009-04-03||November 2006||2006-11-01|June 2014|2014-06-01||||April 2008|Actual|2008-04-01||Interventional||The treated set (TS) included all randomized patients who were documented to have taken at least one actuation of the randomized treatment.|Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)|Safety and Efficacy of Combivent Respimat in Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|1480|Actual|Boehringer Ingelheim|The FEV1 and FVC measurements at each observation time point were used to derive the primary and secondary efficacy endpoints and are not reported here. All statistical analyses for secondary endpoints are exploratory and the p-values are nominal.|3|||f||||||||||||||2017-02-18 16:06:10.023056|2017-02-18 16:06:10.023056
NCT00400140|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2010-05-11|||November 2006||2006-11-01|May 2010|2010-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Pilot Study to Assess the Efficacy of Short Exposure to Defocus to Slow the Progression of Myopia in Children|Pilot Study to Assess the Efficacy of Short Exposure to Defocus to Slow the Progression of Myopia in Children|Completed||N/A|30|Anticipated|Singapore National Eye Centre||1|||f||||||||||||||2017-02-18 16:06:13.471875|2017-02-18 16:06:13.471875
NCT00400127|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2009-06-03|||September 2005||2005-09-01|June 2009|2009-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||The Effect of Silicone Suspension on Standing Balance for Transfemoral Amputees|The Effect of Silicone Suspension on Standing Balance for Transfemoral Amputees|Terminated||N/A|6|Actual|Nova Scotia Health Authority||1||poor recruitment, pilot outcome measures inappropriate|f||||||||||||||2017-02-18 16:06:13.572116|2017-02-18 16:06:13.572116
NCT00400114|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2016-03-07|||November 2006||2006-11-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer|Adjuvant Sutent Following Chemotherapy, Radiation and Surgery For Esophageal Cancer, A Phase II Trial (ASSET)|Active, not recruiting||Phase 2|36|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 16:06:13.664781|2017-02-18 16:06:13.664781
NCT00400101|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2006-11-15|||November 2003||2003-11-01|November 2006|2006-11-01|October 2005||2005-10-01|||||Interventional|||Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides|A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers|Terminated||Phase 1|46||Swiss Tropical & Public Health Institute|||||f||||||||||||||2017-02-18 16:06:13.777454|2017-02-18 16:06:13.777454
NCT00400088|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2013-02-26|||June 2007||2007-06-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide|A Randomized, Double-blind, Double-dummy, Controlled Trial of Lithium Versus Paroxetine in Subjects With Major Depression Who Have a Family History of Bipolar Disorder or Completed Suicide - a Pilot Study|Terminated||Phase 3|2|Actual|Nova Scotia Health Authority||2||Recruitment difficulties|f||||f||||||||||2017-02-18 16:06:13.860474|2017-02-18 16:06:13.860474
NCT00400075|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2006-11-15|||July 1996||1996-07-01|November 2006|2006-11-01||||||||Interventional|||CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors|CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors a Prospective Randomized Study in 125 Patients|Unknown status|Active, not recruiting|Phase 4|124||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:06:13.980261|2017-02-18 16:06:13.980261
NCT00400062|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2015-11-04|||July 2007||2007-07-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2010|Actual|2010-12-01||Observational|||MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care|MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care|Active, not recruiting||N/A|800|Anticipated|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 16:06:14.070804|2017-02-18 16:06:14.070804
NCT00400036|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2006-11-14|||February 2004||2004-02-01|November 2006|2006-11-01|December 2005||2005-12-01|||||Interventional|||Dietary Fish Protein in Subjects With Insulin Resistance|Assessment of Insulin Sensitivity in Insulin-Resistant Subjects Fed Fish Protein|Completed||Phase 2|24||Laval University|||||f||||||||||||||2017-02-18 16:06:14.16452|2017-02-18 16:06:14.16452
NCT00400023|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2011-04-07|||September 2006||2006-09-01|April 2011|2011-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors|A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of the Dihydropyrimidine Dehydrogenase (Dpd) Inhibitory Action of 5-Chloro-2,4-Dihydroxypyridine (Cdhp) as an S-1 Component|Completed||Phase 1|12|Anticipated|Taiho Oncology, Inc.||2|||f||||||||||||||2017-02-18 16:06:14.254741|2017-02-18 16:06:14.254741
NCT00400010|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2014-04-01|||October 2004||2004-10-01|April 2014|2014-04-01|November 2006|Actual|2006-11-01|November 2005|Actual|2005-11-01||Interventional|||Alcohol Expert System Intervention for Problematic Alcohol Use|Randomized Controlled Trial of a Expert System for Patients With At-risk Drinking, Alcohol Abuse and Alcohol Dependence in General Hospital|Completed||N/A|347|Actual|University of Luebeck||2|||f||||f||||||||||2017-02-18 16:06:14.35023|2017-02-18 16:06:14.35023
NCT00399997|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-15|2006-12-20|||January 2005||2005-01-01|November 2006|2006-11-01|August 2007||2007-08-01|||||Interventional|||Evaluation of Effect of Exercise on Prescription|Effect of Exercise on Prescription on Physical Activity, Physical Fitness, and Health in Patients With Lifestyle Diseases|Unknown status|Active, not recruiting|Phase 2/Phase 3|50||University of Southern Denmark|||||f||||||||||||||2017-02-18 16:06:14.456369|2017-02-18 16:06:14.456369
NCT00399984|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2013-06-11|||April 2004||2004-04-01|June 2013|2013-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Evaluating a Pediatric Asthma Management Education Program for Physicians|Enhancing Pediatric Asthma Management|Completed||N/A|40|Actual|University of California, San Francisco||2|||f||||||||||||||2017-02-18 16:06:14.566214|2017-02-18 16:06:14.566214
NCT00399971|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2008-11-07|||November 2002||2002-11-01|November 2008|2008-11-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia|Phase I/II Study of An Ex Vivo Immunotherapy for Treatment of Idiopathic Aplastic Anemia|Unknown status|Recruiting|Phase 1/Phase 2|100|Anticipated|Shenzhen Zhongxing Yangfan Biotech Co. Ltd.||1|||f||||t||||||||||2017-02-18 16:06:14.677596|2017-02-18 16:06:14.677596
NCT00399945|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2007-05-04|||May 2006||2006-05-01|May 2007|2007-05-01||||||||Interventional|||Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study|A Phase 1, Single-Dose, Open-Label, Two-Way Crossover, Pharmacoscintigraphy Study of Aerosol Delivery Characteristics (Measured by In Vivo Lung Deposition, Nebulization Time, Serum Tobramycin Concentrations, and Pharmacokinetic Parameters) and Safety of Tobramycin Administered for Inhalation by PARI eFlow® Rapid Electronic Nebulizer (No Compressor) vs. PARI LC PLUS (TM) Jet Nebulizer (With Compressor) in Healthy Subjects and in Subjects With Cystic Fibrosis|Completed||Phase 1|12||Novartis|||||f||||||||||||||2017-02-18 16:06:14.792163|2017-02-18 16:06:14.792163
NCT00399932|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2009-09-17|||March 2006||2006-03-01|September 2009|2009-09-01|May 2010|Anticipated|2010-05-01|May 2009|Actual|2009-05-01||Observational|||Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome||Unknown status|Recruiting|N/A|75|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||Samples Without DNA|"~     liver biopsy serum~   "|||2017-02-18 16:06:14.87953|2017-02-18 16:06:14.87953
NCT00399919|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2011-08-23|||April 2006||2006-04-01|June 2009|2009-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)|Safety and Efficacy pf Propionyl-L-Carnitine in Combination With Monitored Exercise Training in Peripheral Arterial Disease (Intermittent Claudication).|Completed||Phase 3|69|Actual|Sigma-Tau Research, Inc.||2|||f||||t||||||||||2017-02-18 16:06:14.973262|2017-02-18 16:06:14.973262
NCT00399906|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2015-11-06||2015-09-23|August 2007||2007-08-01|November 2015|2015-11-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety, and Pharmacokinetics of Three Different Doses of BMS-582949 Given Orally to Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 2|99|Actual|Bristol-Myers Squibb||4|||f||||t||||||||||2017-02-18 16:06:15.086257|2017-02-18 16:06:15.086257
NCT00399334|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2011-05-18|||June 2005||2005-06-01|April 2010|2010-04-01|December 2005|Actual|2005-12-01|||||Observational|||PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders|Study PROFILe3: Clinic Observations Profile of Relapse and Readmission in Emergency/Acute Settings: Epidemiologic Survey in Schizophrenic Patients|Completed||N/A|1607|Actual|Janssen-Cilag, S.A.|||1||f||||||||||||||2017-02-18 16:06:24.052818|2017-02-18 16:06:24.052818
NCT00399893|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2014-06-25|2013-01-28||December 2006||2006-12-01|June 2014|2014-06-01|September 2010|Actual|2010-09-01|April 2009|Actual|2009-04-01||Interventional|||Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)|Investigation of the Developmental, Nutritional and Hormonal Regulation of Ghrelin in Children and Young Adults With Prader-Willi Syndrome (PWS): Octreotide Intervention Sub-study|Terminated||N/A|5|Actual|Duke University||2||Inadequate recruitment|f||||f||||||||||2017-02-18 16:06:15.200995|2017-02-18 16:06:15.200995
NCT00399880|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2013-12-10|||November 2006||2006-11-01|December 2013|2013-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|IMAGE-ACS||Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes|Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes|Completed||N/A|130|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 16:06:16.010673|2017-02-18 16:06:16.010673
NCT00399867|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2006-12-19|||April 2005||2005-04-01|November 2006|2006-11-01|April 2007||2007-04-01|||||Interventional|||Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.|Determination of the Efficacy and Feasibility of Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma – a Phase II Clinical Trial.|Completed||Phase 2|30||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 16:06:16.11937|2017-02-18 16:06:16.11937
NCT00399854|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2006-11-14|||March 2006||2006-03-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Evaluation of the Efficacy of Endermologie in Treatment of Cellulite and Body Contouring|Clinical Study for Evaluation of the Efficacy of Mechanical Massage by Endermologie (Dhermia® – Industra Mecânica Fina Ltda) in Treatment of Cellulite and Body Contouring|Completed||Phase 4|45||Brazilan Center for Studies in Dermatology|||||f||||||||||||||2017-02-18 16:06:16.207234|2017-02-18 16:06:16.207234
NCT00399841|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2013-08-01|||November 2006||2006-11-01|August 2013|2013-08-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity|Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity: A Comparison of Electrode Placement at T7 and T8|Terminated||Phase 4|13|Actual|Boston Scientific Corporation||2||Investigator Resigned|f||||f||||||||||2017-02-18 16:06:16.482591|2017-02-18 16:06:16.482591
NCT00399828|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2008-03-11|||August 2006||2006-08-01|March 2008|2008-03-01|November 2006||2006-11-01|||||Interventional|||Evaluation Of The Efficacy and Safety Of Tri-ActiveTM In Treatment Of Cellulite|Clinical Study For Evaluation Of The Efficacy and Safety Of Tri-ActiveTM (Deka M.E.L.A., Itália) In Treatment Of Cellulite|Terminated||Phase 4|20||Brazilan Center for Studies in Dermatology|||||f||||||||||||||2017-02-18 16:06:16.587482|2017-02-18 16:06:16.587482
NCT00399815|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2009-09-17|||June 2006||2006-06-01|September 2009|2009-09-01|May 2010|Anticipated|2010-05-01|May 2009|Actual|2009-05-01||Observational|||Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C||Unknown status|Recruiting|N/A|40|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||1||f||||f||||||Samples Without DNA|"~     liver biopsy serum~   "|||2017-02-18 16:06:16.674164|2017-02-18 16:06:16.674164
NCT00399802|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2015-02-12|||November 2006||2006-11-01|February 2015|2015-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)|A Phase II Study to Assess the Safety, Tolerability, and Efficacy of MK-0822 (Cathepsin-K Inhibitor) in the Treatment of Women With Breast Cancer and Established Bone Metastases (MBD)|Completed||Phase 2|45|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 16:06:16.753644|2017-02-18 16:06:16.753644
NCT00399789|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2014-02-11|||September 2004||2004-09-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer|A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|121|Actual|AEterna Zentaris||3|||f||||f||||||||||2017-02-18 16:06:16.865159|2017-02-18 16:06:16.865159
NCT00399776|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2011-08-03|||October 2006||2006-10-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy|Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy|Completed||N/A|60|Anticipated|Creighton University|||2||f||||f||||||||||2017-02-18 16:06:16.988395|2017-02-18 16:06:16.988395
NCT00399763|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2015-06-12|2012-08-03||September 2005||2005-09-01|June 2015|2015-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder|A Randomized, Placebo-controlled Trial of Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder (SUD)|Completed||N/A|70|Actual|Denver Health and Hospital Authority|"The study was not powered to assess safety.~Participants received individual motivational interviewing/cognitive behavioral therapy for substance treatment. The results may not generalize to samples receiving different behavioral treatment."|2|||f||||f||||||||||2017-02-18 16:06:17.092679|2017-02-18 16:06:17.092679
NCT00399750|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2009-10-14|||November 2002||2002-11-01|October 2009|2009-10-01|June 2005||2005-06-01|||||Interventional|||TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer|A Randomized Prospective Study Comparing Three Regimens of Oxaliplatin Plus Fluoropyrimidine and Avastin for Evaluation of Safety and Tolerability in First-line Treatment of Patients With Advanced Colorectal Cancer.|Completed||Phase 2|373||Sanofi|||||f||||||||||||||2017-02-18 16:06:17.53967|2017-02-18 16:06:17.53967
NCT00399737|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2006-11-14|||October 2005||2005-10-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||Effects of Peptides Derived From Fermented Milk on Blood Pressure Regulation System in Healthy Volunteers.||Terminated||Phase 1|12||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:06:17.636611|2017-02-18 16:06:17.636611
NCT00399724|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2010-08-30|||March 2002||2002-03-01|August 2010|2010-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|AT-LANTUS||A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus|A Multicentre, Multinational, Randomised, Open Study to Establish the Optimal Method for Initiating and Maintaining Lantus® (Insulin Glargine) Therapy Based on a Comparison of Two Treatment Algorithms to Determine Optimal Metabolic Outcomes, Safety, and Satisfaction in Subjects With Type 2 Diabetes Mellitus.|Completed||Phase 4|7376||Sanofi|||||f||||||||||||||2017-02-18 16:06:17.723755|2017-02-18 16:06:17.723755
NCT00399100|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2006-11-13|||November 2006||2006-11-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Observational|||Is it Possible to Treat Cyanide Poisoning With HBO?||Unknown status|Recruiting|N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:06:26.299764|2017-02-18 16:06:26.299764
NCT00399711|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2017-02-09|||November 2006||2006-11-01|February 2017|2017-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes|Repaglinide and Metformin Combination Tablet (NN4440) in a TID Regimen Compared to a BID Regimen and BID Avandamet in Subjects With Type 2 Diabetes: A Twenty-Six Week, Open-Label, Multicenter, Randomized, Parallel Group Trial to Investigate Efficacy and Safety|Completed||Phase 3|560|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:06:17.816135|2017-02-18 16:06:17.816135
NCT00399698|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2016-06-21|||May 1999||1999-05-01|June 2016|2016-06-01|June 2005||2005-06-01|||||Interventional|||Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.|Effects of Risperidone on Cognitive-Motor Performance and Motor Movements in Chronically Medicated Children|Completed||Phase 3|30||Ohio State University|||||f||||||||||||||2017-02-18 16:06:18.208615|2017-02-18 16:06:18.208615
NCT00399685|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2011-04-13|||December 2006||2006-12-01|April 2011|2011-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Drug Interaction - Oral Contraceptive|Study to Evaluate the Effect of Efavirenz Coadministration on the Pharmacokinetics of the Active Moieties of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Female Subjects|Completed||Phase 1|28|Actual|Bristol-Myers Squibb||4|||f||||||||||||||2017-02-18 16:06:18.314924|2017-02-18 16:06:18.314924
NCT00399672|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2016-11-28|||June 2007||2007-06-01|November 2016|2016-11-01|December 2012|Actual|2012-12-01|August 2010|Actual|2010-08-01||Interventional|||Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)|Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)|Completed||N/A|370|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 16:06:18.428767|2017-02-18 16:06:18.428767
NCT00399659|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2012-04-30|||November 2006||2006-11-01|April 2012|2012-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.|A 52-week Extension to Study CHTF919N2201 to Evaluate the Safety and Efficacy of Tegaserod (6 mg b.i.d. and 12 mg o.d.) Given Orally for the Treatment of Opioid-induced Constipation (OIC) in Patients With Chronic Non-cancer Pain|Terminated||Phase 3|360|Actual|Novartis||||"This study was terminated early as a result of regulatory action suspending tegaserod use in~   2007"|||||||||||||||2017-02-18 16:06:18.543967|2017-02-18 16:06:18.543967
NCT00399646|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2009-05-11|||November 2005||2005-11-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|November 2007|Actual|2007-11-01||Interventional|GAAME||Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations.|Gemini Angioplasty and Arterial Measurement Evaluation (GAAME) An Evaluation of the Metricath Gemini System, a Percutaneous Interventional Device Intended to Make Arterial Lumen Measurements and Perform Percutaneous Transluminal Angioplasty Dilations.|Completed||Phase 2|145|Actual|Neovasc Inc.|||||f||||t||||||||||2017-02-18 16:06:18.685317|2017-02-18 16:06:18.685317
NCT00399633|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2008-05-13|||January 2007||2007-01-01|May 2008|2008-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Neuropeptides in the Humane Intra- og Extracerebral Circulation.|Neuropeptides in the Humane Intra- og Extracerebral Circulation - in Relation to Sumatriptan in Healthy Volunteers.|Completed||N/A|16|Actual|Danish Headache Center|||||f||||||||||||||2017-02-18 16:06:18.966432|2017-02-18 16:06:18.966432
NCT00399620|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2009-01-09|||March 2008||2008-03-01|January 2009|2009-01-01||||||||Interventional|||Chromogranin-A-Derived Peptides and Periodontitis in Diabetic Patients|Chromogranin-A-Derived Peptides in the Gingival Crevicular Fluid and the Saliva of Diabetic Patients With or Without Periodontitis|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Strasbourg, France|||||f||||f||||||||||2017-02-18 16:06:19.062477|2017-02-18 16:06:19.062477
NCT00399607|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2016-12-07|||June 2006||2006-06-01|December 2016|2016-12-01|August 2016|Actual|2016-08-01|February 2016|Actual|2016-02-01||Observational|PPS4B||Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention|Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention|Completed||N/A|264|Actual|Emory University|||2||f||||t||||||Samples Without DNA|"~     Biopsies of normal-appearing rectal mucosa will be collected from participants in an~     associated parent study.~   "|||2017-02-18 16:06:19.141755|2017-02-18 16:06:19.141755
NCT00399594|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2015-11-20|||March 2011||2011-03-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|April 2014|Actual|2014-04-01||Interventional|INCREMENTAL||Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.|Investigating Non-response to Cardiac Resynchronization: Evaluation of Methods to Eliminate Non-response & Target Appropriate Lead Location (INCREMENTAL).|Completed||Phase 2/Phase 3|96|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 16:06:19.265648|2017-02-18 16:06:19.265648
NCT00399581|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2013-02-26|||November 2006||2006-11-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of Two Methods of High Frequency Oscillatory Ventilation in Individuals With Acute Respiratory Distress Syndrome|Phase II Clinical Trial of Two Approaches to High Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome|Completed||Phase 2|100|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:06:19.379243|2017-02-18 16:06:19.379243
NCT00399568|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2016-09-08|2009-09-25||November 2006||2006-11-01|September 2016|2016-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery|Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel, Multiple-Dose Study of the Analgesic Efficacy and Safety of IV Acetaminophen (APAP) Versus Placebo Over 48 Hours(Hrs) for the Treatment of Postoperative Pain After Gynecologic Surgery|Completed||Phase 3|331|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 16:06:19.501097|2017-02-18 16:06:19.501097
NCT00399555|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2013-11-25|||November 2006||2006-11-01|November 2013|2013-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome|Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome—Correlation With Cerebral Non-invasive Infrared Spectroscopy (NIRS)|Completed||N/A|28|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:06:20.006595|2017-02-18 16:06:20.006595
NCT00399542|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2013-09-25|2008-10-07||May 2005||2005-05-01|September 2013|2013-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation|Phase 3, 12-Week, Multicenter, Double-Blind, Randomized, Efficacy and Safety Study of Lubiprostone for the Treatment of Irritable Bowel Syndrome With Constipation|Completed||Phase 3|581|Actual|Sucampo Pharma Americas, LLC|||||f||||||||||||||2017-02-18 16:06:20.120775|2017-02-18 16:06:20.120775
NCT00399529|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2012-12-11||2012-11-29|September 2006||2006-09-01|December 2012|2012-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer|A Feasibility Study of Combination Therapy With Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for HER-2/Neu-Overexpressing Metastatic Breast Cancer.|Completed||Phase 2|22|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:06:21.024523|2017-02-18 16:06:21.024523
NCT00399516|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2012-03-07|2012-02-13||November 2006||2006-11-01|March 2012|2012-03-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Pulse Width With Spinal Cord Stimulation|The Effect of Pulse Width on the Treatment of Chronic Low Back Pain With Spinal Cord Stimulation|Completed||Phase 4|21|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 16:06:21.143198|2017-02-18 16:06:21.143198
NCT00399503|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2016-06-13|||September 2001||2001-09-01|November 2006|2006-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Assessment of Noninvasive Methods to Identify Patients at Risk of Serious Arrhythmias After a Heart Attack|Risk Estimation Following Infarction Noninvasive Evaluation (REFINE)|Completed||N/A|350||University of Calgary|||||f||||||||||||||2017-02-18 16:06:21.364428|2017-02-18 16:06:21.364428
NCT00399490|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-14|2013-10-08||2009-04-06|September 2006||2006-09-01|October 2009|2009-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Open-label Extension Study Of RN624|Open-Label, Multiple-Dose Study Of The Safety And Efficacy Of RN624 In Adults With Pain Due To Osteoarthritis Of The Knee|Completed||Phase 2|281|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:06:21.574152|2017-02-18 16:06:21.574152
NCT00399477|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2011-04-08|||October 2006||2006-10-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease|Open-label, Multicenter, Effectiveness and Safety Study of Once Daily AZILECT® as Mono- or Adjunct Therapy in Patients With Idiopathic Parkinson's Disease (PD)|Completed||Phase 4|200|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 16:06:21.697701|2017-02-18 16:06:21.697701
NCT00399464|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2009-10-01|||November 2006||2006-11-01|October 2009|2009-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia|Efficacy and Safety of SL77.0499-10 10mg Once Daily in Comparison With Placebo and Tamsulosin Hydrochloride 0.2mg in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia (BPH).|Completed||Phase 3|1177|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:06:21.794503|2017-02-18 16:06:21.794503
NCT00399451|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2006-11-20|||December 2006||2006-12-01|November 2006|2006-11-01|June 2009||2009-06-01|||||Interventional|||Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)|Preliminary Study on Submucous Sclerosis of Pharynges With 1% Polidocanol to Treat Obstructive Sleep Apnea (OSA) & Snoring Subjects (SS)|Unknown status|Not yet recruiting|Phase 1/Phase 2|30||Liaoyang Central Hospital|||||f||||||||||||||2017-02-18 16:06:21.886444|2017-02-18 16:06:21.886444
NCT00399438|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2008-09-25|||December 2006||2006-12-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||A Study of BMS-562086 in Patients With Irritable Bowel Syndrome|A Dose-Ranging Study of the Pharmacodynamic Effects of BMS-562086 on Gastrointestinal Transit in Women With Diarrhea-Predominant Irritable Bowel Syndrome|Completed||Phase 2|39|Anticipated|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 16:06:21.964464|2017-02-18 16:06:21.964464
NCT00399425|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2006-11-13|||June 2001||2001-06-01|November 2006|2006-11-01|April 2004||2004-04-01|||||Interventional|||Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients|Triple-Blind Clinical Trial With Placebo Control to Evaluate the Efficacy of a Heparin of Low Molecular Weight (Bemiparin) for Treating Slow-Responding Ulcers in Diabetic Foot in Primary Care|Terminated||Phase 2/Phase 3|84||Spanish National Health System|||||f||||||||||||||2017-02-18 16:06:22.067746|2017-02-18 16:06:22.067746
NCT00399412|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2017-02-14|||November 2006||2006-11-01|October 2009|2009-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization Patients|Further Research on Human Feasibility of a Subcutaneous Implantable Defibrillator (S-ICD)- ECG Signal Collections From Various Patient Groups Whilst Attending Outpatient Follow-up|Completed||N/A|86|Actual|Boston Scientific Corporation|||4||f||||f||||||||||2017-02-18 16:06:22.164167|2017-02-18 16:06:22.164167
NCT00399399|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2006-11-13|||July 1996||1996-07-01|November 2006|2006-11-01||||||||Interventional|||CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors|CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors: a Prospective Randomized Study in 72 Patients.|Unknown status|Active, not recruiting|Phase 4|72||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:06:22.270671|2017-02-18 16:06:22.270671
NCT00399386|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2017-02-14|||November 2006||2006-11-01|October 2009|2009-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Electrocardiogram (ECG) Recordings in Paediatric Population|ECG Recordings From EP Study, Defibrillator Implantation or Ablation Procedure in Paediatric Population|Completed||N/A|62|Actual|Boston Scientific Corporation|||1||f||||||||||||||2017-02-18 16:06:22.370065|2017-02-18 16:06:22.370065
NCT00399373|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2006-11-13|||November 2005||2005-11-01|November 2006|2006-11-01|January 2007||2007-01-01|||||Observational|||Structuring the Integration of Care Management Services For Medicaid Enrollees Recipients With Chronic Illness, Substance Abuse Problems and Possible Psychiatric Disorders|Structuring the Integration of Services For Medicaid Recipients With Chronic Illness, Substance Abuse Problems and Possible Psychiatric Disorders|Unknown status|Active, not recruiting|N/A|258||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:06:22.636171|2017-02-18 16:06:22.636171
NCT00399360|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2012-09-13|2012-05-18||December 2006||2006-12-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Lifestyle Modification and Metformin Use in the Treatment of HIV|Strategies for the Treatment of HIV Associated Metabolic Syndrome|Completed||N/A|50|Actual|Massachusetts General Hospital|The study was relatively small and may have been underpowered to assess effect on secondary endpoints and to assess the effects of lifestyle modification. The sample size may have limited our ability to determine differences in dropout rates.|4|||f||||t||||||||||2017-02-18 16:06:22.720196|2017-02-18 16:06:22.720196
NCT00006160|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-02-12||||||February 2010|2010-02-01||||||||Interventional|||African-American Diabetes Intervention Project||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:24.336876|2017-02-18 18:13:24.336876
NCT00399321|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2016-06-02|||April 2006||2006-04-01|June 2016|2016-06-01||||September 2010|Actual|2010-09-01||Observational|||A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer|A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer|Active, not recruiting||N/A|60|Anticipated|University of Michigan Cancer Center|||1||f||||t||||||Samples Without DNA|"~     refer to protocol~   "|||2017-02-18 16:06:24.171312|2017-02-18 16:06:24.171312
NCT00399308|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2013-08-09|2013-03-18||January 2007||2007-01-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers|An Initial Evaluation Of The Safety And Activity Of Celaderm(TM) Treatment Regimens In Healing Venous Leg Ulcers|Completed||Phase 1/Phase 2|40|Actual|Shire Regenerative Medicine, Inc.|Limitations of the trial include the potential for outcome assessment bias as the study was not blinded.|3|||f||||f||||||||||2017-02-18 16:06:24.269551|2017-02-18 16:06:24.269551
NCT00399295|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2010-04-26||||||April 2010|2010-04-01|June 1997|Actual|1997-06-01|||||Interventional|||An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg|An Open-Label Evaluation of the Independent Effect of Coadministration of a High Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCL) 16 mg|Completed||Phase 1|30|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:06:24.866783|2017-02-18 16:06:24.866783
NCT00399282|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2007-04-17|||October 2006||2006-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Omega-3 and Vitamin E Supplementation in Patients With Rheumatoid Arthritis|Comparison of the Effects of Simultaneous Administration of Vitamin E and Omega-3 Fatty Acids in Patients With Rheumatoid Arthritis|Completed||Phase 1|75||Shahid Beheshti University of Medical Sciences|||||f||||t||||||||||2017-02-18 16:06:24.947508|2017-02-18 16:06:24.947508
NCT00399269|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-12|2009-06-10|||December 2006||2006-12-01|June 2009|2009-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure|Assessment of Efficacy & Safety of Recombinant Human Erythropoietin -Alpha, (rHu-EPO-Alpha) in Patients With Anemia of Chronic Renal Failure.|Completed||Phase 3|100|Actual|Cadila Pharnmaceuticals|||||f||||||||||||||2017-02-18 16:06:25.044821|2017-02-18 16:06:25.044821
NCT00399256|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2007-01-31|||March 2004||2004-03-01|January 2007|2007-01-01|March 2006||2006-03-01|||||Interventional|||Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn|Improved Estimation of Glomerular Filtration Rate by Serum Cystatin C in Preventing Contrast Induced Nephropathy by N-Acetylcysteine or Zinc|Terminated||N/A|60||Robert Bosch Gesellschaft für Medizinische Forschung mbH|||||f||||||||||||||2017-02-18 16:06:25.151611|2017-02-18 16:06:25.151611
NCT00399243|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-12|2009-01-29|||November 2006||2006-11-01|January 2009|2009-01-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache|4mg StatDose Imitrex for Acute Treatment of Cluster Headache|Unknown status|Recruiting|Phase 4|20|Anticipated|Diamond Headache Clinic||1|||f||||f||||||||||2017-02-18 16:06:25.24703|2017-02-18 16:06:25.24703
NCT00399230|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2007-08-17||||||August 2007|2007-08-01||||||||Interventional|||A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:06:25.344772|2017-02-18 16:06:25.344772
NCT00399217|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2017-02-14|||November 2006||2006-11-01|May 2010|2010-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System|Acute Intra-operative Testing of Subcutaneous Implantable Defibrillator Emulator and Parasternal Electrode, Acutely Implanted, for Comparison With Transvenous System|Completed||N/A|55|Actual|Boston Scientific Corporation|||1||f||||||||||||||2017-02-18 16:06:25.416473|2017-02-18 16:06:25.416473
NCT00399204|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2006-11-13|||January 2006||2006-01-01|November 2006|2006-11-01||||||||Interventional|||Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients|A Randomised Pilot Study to Compare the Effect of Pioglitazone and Metformin on Cardiovascular Morbidity and Mortality in Patients With Type 2 Diabetes|Unknown status|Recruiting|Phase 4|100||Postgraduate Institute of Medical Education and Research|||||f||||||||||||||2017-02-18 16:06:25.612793|2017-02-18 16:06:25.612793
NCT00399191|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2010-03-17|||August 2006||2006-08-01|March 2010|2010-03-01||||||||Interventional|||A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia||Completed||Phase 1|15|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 16:06:25.685081|2017-02-18 16:06:25.685081
NCT00399178|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2007-08-16|||November 2006||2006-11-01|November 2006|2006-11-01|June 2007|Actual|2007-06-01|||||Interventional|||A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol|A Randomised Open Controlled Parallel Group Multicenter Study to Evaluate the Efficacy and Safety of Norspan Versus Tiparol Retard in Subjects With Chronic Moderate to Severe OA Pain of the Hip and/or Knee.|Completed||Phase 4|160|Anticipated|Mundipharma AB|||||f||||||||||||||2017-02-18 16:06:25.777101|2017-02-18 16:06:25.777101
NCT00399165|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2008-09-18|||November 2006||2006-11-01|September 2008|2008-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Oral Androgens in Man-4: (Short Title: Oral T-4)|Oral Androgens in Man-4: Gonadotropin Suppression Medicated by Oral Testosterone Enanthate in Oil Plus Dutasteride (Short Title: Oral T-4)|Completed||Phase 1/Phase 2|20|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 16:06:25.86488|2017-02-18 16:06:25.86488
NCT00399152|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2014-02-14|||October 2006||2006-10-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||Perifosine + Sunitinib Malate for Patients With Advanced Cancers|An Open-Label Phase I Study of the Safety of Perifosine in Combination With Sunitinib Malate for Patients With Advanced Cancers|Completed||Phase 1|15|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 16:06:26.001476|2017-02-18 16:06:26.001476
NCT00399126|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2014-02-12|||November 2004||2004-11-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|January 2009|Actual|2009-01-01||Interventional|||Phase I Trial of Paclitaxel With Perifosine|A Phase 1 Trial of the Combination of Perifosine and Paclitaxel Given Either Weekly or Every 3 Weeks|Completed||Phase 1|24|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 16:06:26.112173|2017-02-18 16:06:26.112173
NCT00399113|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2011-07-12|||May 2007||2007-05-01|July 2011|2011-07-01||||June 2008|Actual|2008-06-01||Interventional|||Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma|An Open-Label Phase I Safety, Pharmacokinetic & Dosimetry Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma|Completed||Phase 1|12|Actual|Pain Therapeutics||1|||f||||f||||||||||2017-02-18 16:06:26.206065|2017-02-18 16:06:26.206065
NCT00399074|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2009-07-01|||October 2006||2006-10-01|July 2009|2009-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia|Presumptive Treatment With Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prophylaxis in Children With Sickle Cell Anemia|Completed||Phase 3|220|Anticipated|Makerere University||2|||f||||||||||||||2017-02-18 16:06:26.495422|2017-02-18 16:06:26.495422
NCT00399061|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2008-09-23|||November 2006||2006-11-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms|Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms|Completed||Phase 4|55|Actual|Innovative Medical||3|||f||||||||||||||2017-02-18 16:06:26.609283|2017-02-18 16:06:26.609283
NCT00399048|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2010-04-26||||||April 2010|2010-04-01|May 2001|Actual|2001-05-01|||||Interventional|||An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)|A Randomized, Repeated- Dose, Parallel-Group Comparison of Safety, Efficacy, and Quality of Life Measures With Dilaudid CR (Hydromorphone HCI) or Oxycontin (Oxycodone HCI) in Patients With Chronic Osteoarthritis|Completed||Phase 3|140|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:06:26.725733|2017-02-18 16:06:26.725733
NCT00399035|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2016-11-07|2012-03-29||November 2006||2006-11-01|October 2016|2016-10-01|August 2016|Actual|2016-08-01|March 2010|Actual|2010-03-01||Interventional|HORIZON II||Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer|A Randomised, Double-blind, Phase III Study to Compare the Efficacy and Safety of Cediranib (AZD2171, RECENTIN™) When Added to 5 Fluorouracil, Leucovorin and Oxaliplatin (FOLFOX) or Capecitabine and Oxaliplatin (XELOX) With the Efficacy and Safety of Placebo When Added to FOLFOX or XELOX in Patients With Previously Untreated Metastatic Colorectal Cancer.|Completed||Phase 3|1254|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 16:06:26.846207|2017-02-18 16:06:26.846207
NCT00399022|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2008-01-28||||||January 2008|2008-01-01||||||||Interventional|||Treatment With Duloxetine for OCD Patients||Withdrawn||N/A|40|Anticipated|Sheba Medical Center||||Funding was not recieved|f||||||||||||||2017-02-18 16:06:31.254243|2017-02-18 16:06:31.254243
NCT00399009|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2008-06-05|||January 2004||2004-01-01|June 2008|2008-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Comparative Study of Circular Stapling Instruments|Comparative Study of Circular Stapling Instruments Concerning the Risk of Anastomotic Dehiscence After Anterior Resection for Rectal Cancer.|Terminated||N/A|880|Anticipated|Uppsala University Hospital||||"One of the instruments in the study was withdrawn from the market before the calculated number~   of persons were included."|f||||||||||||||2017-02-18 16:06:31.340492|2017-02-18 16:06:31.340492
NCT00398996|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2011-03-23|||June 2005||2005-06-01|March 2011|2011-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|SAPIT||A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients|Study to Compare Three Existing Starting Points of ART Initiation in HIV/TB Co-infected Patients|Completed||Phase 3|642|Actual|Centre for the AIDS Programme of Research in South Africa||3|||f||||t||||||||||2017-02-18 16:06:31.432985|2017-02-18 16:06:31.432985
NCT00398983|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-01-25|2013-01-25||August 2006||2006-08-01|January 2013|2013-01-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML)|Randomized Study of Decitabine Versus Observation or Continued Standard Chemotherapy as Maintenance Therapy for Adults With Unfavorable Risk AML in First Complete Remission (CR) or Adults With Relapsed AML in Second or Greater CR|Completed||Phase 2/Phase 3|50|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:06:31.553518|2017-02-18 16:06:31.553518
NCT00398970|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2008-02-25|||June 2005||2005-06-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Utility of Endobronchial Ultrasound in the Investigation of Suspected Lung Cancer.|Diagnostic Utility of Endobronchial Ultrasound in the Investigation of Suspected Malignant Lung Lesions Where the Lesions Are Not Visible During Bronchoscopy.|Completed||N/A|240|Anticipated|Haukeland University Hospital||2|||f||||||||||||||2017-02-18 16:06:31.894437|2017-02-18 16:06:31.894437
NCT00398957|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2010-04-26||||||April 2010|2010-04-01|September 1998|Actual|1998-09-01|||||Interventional|||An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg|An Open Label Evaluation of the Dose Proportionality of Dilaudid SR (OROS� Hydromorphone HCL) Tablets 8mg, 16mg, 32mg, and 64mg|Completed||Phase 1|32|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:06:32.007065|2017-02-18 16:06:32.007065
NCT00398944|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2010-07-26|||November 2006||2006-11-01|November 2006|2006-11-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|ASTI||Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes|Impact of a Computerized Decision Support System, Based on EBM French Guidelines, on the Management of Hypertension and Diabetes: a Randomised Controlled Trial in Primary Care|Completed||N/A|2715|Actual|Société de Formation Thérapeutique du Généraliste||2|||f||||f||||||||||2017-02-18 16:06:32.10642|2017-02-18 16:06:32.10642
NCT00398931|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2015-02-16|||February 1998||1998-02-01|February 2015|2015-02-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)|A 5-year, Double-blind, Randomized, Placebo-controlled Extension Study to Examine the Long-term Safety and Efficacy of Oral Alendronate in Postmenopausal Women Who Previously Received Alendronate in Conjunction With the Fracture Intervention Trial|Completed||Phase 3|1099|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:32.219587|2017-02-18 16:06:32.219587
NCT00398918|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2010-04-27|2010-02-08||November 2006||2006-11-01|April 2010|2010-04-01|March 2009|Actual|2009-03-01|October 2007|Actual|2007-10-01||Interventional|||Alcohol Self Administration Laboratory|Alcohol Self Administration Laboratory|Completed||N/A|10|Actual|Boston University||2|||f||||f||||||||||2017-02-18 16:06:32.332122|2017-02-18 16:06:32.332122
NCT00398905|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2009-05-07|||January 2004||2004-01-01|May 2009|2009-05-01|September 2004|Actual|2004-09-01|||||Interventional|ODIXa-HIP2||Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement|Controlled, Double-Blind, Randomised, Dose-Ranging Study on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement- ODIXa-HIP2 Study BAY 59-7939|Completed||Phase 2|726|Actual|Bayer||6|||f||||||||||||||2017-02-18 16:06:32.605534|2017-02-18 16:06:32.605534
NCT00006137|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||May 2000||2000-05-01|September 2000|2000-09-01||||||||Interventional|||Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy||Completed||N/A|43||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:27.078736|2017-02-18 18:13:27.078736
NCT00398892|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2010-11-05|||December 2009||2009-12-01|October 2010|2010-10-01|January 2011|Anticipated|2011-01-01|January 2011|Anticipated|2011-01-01||Interventional|||The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes|The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes|Unknown status|Recruiting|Phase 2|18|Anticipated|University of Edinburgh||2|||f||||||||||||||2017-02-18 16:06:33.027112|2017-02-18 16:06:33.027112
NCT00398879|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2013-03-04|||August 2005||2005-08-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Interventional|||Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients|A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients|Completed||Phase 2|381|Actual|AEterna Zentaris||2|||f||||f||||||||||2017-02-18 16:06:33.146393|2017-02-18 16:06:33.146393
NCT00398866|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2015-08-17|||August 2006||2006-08-01|August 2015|2015-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of Hyaluronan for the Treatment of Osteoarthritis in the Thumb|A Study of Hyaluronan (Synvisc) for the Treatment of Osteoarthritis in the Thumb: Randomized Control Trial|Completed||Phase 3|213|Actual|Hospital for Special Surgery, New York||3|||f||||t||||||||||2017-02-18 16:06:33.30769|2017-02-18 16:06:33.30769
NCT00398853|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-04-07|||October 2003||2003-10-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes|Chromium and Insulin Action|Completed||Phase 4|100|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-02-18 16:06:33.430317|2017-02-18 16:06:33.430317
NCT00398840|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2009-01-08|||November 2006||2006-11-01|January 2009|2009-01-01||||||||Interventional|||A Study of ARQ 171 in Patients With Advanced Solid Tumors|A Phase 1 Dose Escalation Study of ARQ 171 in Adult Patients With Advanced Solid Tumors|Suspended||Phase 1|30|Anticipated|ArQule|||||f||||f||||||||||2017-02-18 16:06:33.539681|2017-02-18 16:06:33.539681
NCT00398827|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2015-07-22|||December 2006||2006-12-01|July 2015|2015-07-01|May 2007|Actual|2007-05-01|||||Interventional|||A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Dexmedetomidine for Sedation During Monitored Anesthesia Care|Completed||Phase 3|326|Actual|Hospira, Inc.||3|||f||||||||||||||2017-02-18 16:06:33.618709|2017-02-18 16:06:33.618709
NCT00398814|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2014-02-14|||October 2006||2006-10-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|September 2011|Actual|2011-09-01||Interventional|||Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers|An Open-Label Phase I Study of the Safety of Perifosine in Combination With Sorafenib for Patients With Advanced Cancers|Completed||Phase 1|30|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 16:06:33.89857|2017-02-18 16:06:33.89857
NCT00398801|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2014-06-16|||December 2006||2006-12-01|June 2014|2014-06-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Observational|GpR||Gastroparesis Registry|Gastroparesis Registry|Completed||N/A|591|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||Samples With DNA|"~     Plasma and serum~   "|||2017-02-18 16:06:34.011835|2017-02-18 16:06:34.011835
NCT00398788|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2010-04-26||||||April 2010|2010-04-01|November 2001|Actual|2001-11-01|||||Interventional|||A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain|An Open-Label, Repeated-Dose Trial to Characterize the Efficacy and Safety, and Impact on Quality of Life Measures of Dilaudid CR (Hydromorphone HCI) in Patients With Chronic Low Back Pain|Completed||Phase 2|207|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:06:34.122098|2017-02-18 16:06:34.122098
NCT00398775|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2007-11-19|||January 2007||2007-01-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Procalcitonin in Fever of Unknown Etiology|Procalcitonin Guided Antimicrobial Discontinuation in Hospitalised Patients With Fever of Unknown Etiology|Terminated||N/A|90|Anticipated|Changi General Hospital||||Very low recruitment|f||||||||||||||2017-02-18 16:06:34.20582|2017-02-18 16:06:34.20582
NCT00398749|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2012-11-05|||October 2005||2005-10-01|November 2012|2012-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)|Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2|Completed||Phase 4|1927|Actual|Janssen-Cilag B.V.|||1||f||||||||||||||2017-02-18 16:06:34.317552|2017-02-18 16:06:34.317552
NCT00398736|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2009-07-14||||||July 2009|2009-07-01||||||||Observational|||A Non-invasive Approach to the Assessment of Volume Status in Mechanically Ventilated Septic Patients.||Completed||Phase 2|||Charite University, Berlin, Germany|||1||f||||||||||||||2017-02-18 16:06:34.427751|2017-02-18 16:06:34.427751
NCT00398723|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2011-10-11|||November 2006||2006-11-01|October 2011|2011-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Narrowband UVB Treatment in Patients With Vitiligo|Effects of Narrowband UVB Phototherapy on Melanocyte Proliferation in Patients With Vitiligo|Completed||N/A|20|Actual|Rockefeller University||1|||f||||f||||||||||2017-02-18 16:06:34.502683|2017-02-18 16:06:34.502683
NCT00398710|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-03-04|||October 2006||2006-10-01|November 2011|2011-11-01|October 2011|Actual|2011-10-01|August 2011|Actual|2011-08-01||Interventional|||A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia|A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia|Completed||Phase 2|37|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 16:06:34.612869|2017-02-18 16:06:34.612869
NCT00398697|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2014-02-12|||August 2004||2004-08-01|January 2007|2007-01-01|January 2006||2006-01-01|||||Interventional|||Phase I Perifosine and Gemcitabine Study|Phase 1 Trial of the Combination of Perifosine and Gemcitabine|Completed||Phase 1|19||AEterna Zentaris|||||f||||||||||||||2017-02-18 16:06:34.723697|2017-02-18 16:06:34.723697
NCT00398684|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2008-05-02|||January 2001||2001-01-01|May 2008|2008-05-01|June 2004|Actual|2004-06-01|||||Interventional|||Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand||Completed||Phase 3|1792||Institut de Recherche pour le Developpement||3|||f||||||||||||||2017-02-18 16:06:35.000879|2017-02-18 16:06:35.000879
NCT00398671|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2015-02-26|||January 2006||2006-01-01|December 2008|2008-12-01||||June 2006|Actual|2006-06-01||Interventional|||"PreCoCa - Prehospital Cooling With Cool-Caps"||Completed||Phase 2|50|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 16:06:35.151206|2017-02-18 16:06:35.151206
NCT00398658|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2008-10-17|||March 2002||2002-03-01|November 2006|2006-11-01|December 2004||2004-12-01|||||Interventional|||Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis||Completed||Phase 4|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:06:35.244171|2017-02-18 16:06:35.244171
NCT00398645|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-10-27|||November 2006||2006-11-01|October 2016|2016-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of GW685698X 200 mcg Twice Daily, GW685698X 200 mcg and 400 mcg Once Daily in the Morning, and GW685698X 200 mcg and 400 mcg Once Daily in the Evening Compared With Placebo for 8 Weeks in Adolescent and Adult Subjects (12 Years of Age and Older) With Persistent Asthma|Completed||Phase 2|648|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:06:35.336107|2017-02-18 16:06:35.336107
NCT00398632|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2016-12-14|2015-04-19||November 2006||2006-11-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional||Adult patients taking an antidepressant drug and troubled by sexual side effects of the drug|Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction|Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction|Terminated||Phase 4|6|Actual|Stanford University|Open label trial, only six subjects enrolled, only 4 completed the trial|1||Unable to recruit subjects|f||||f||||||||||2017-02-18 16:06:35.548046|2017-02-18 16:06:35.548046
NCT00398619|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2012-01-20|||November 2006||2006-11-01|January 2012|2012-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes|A Double-blind, Placebo Controlled Pharmacodynamic Study of the Effect of INCB013739 on Systemic and Adipose Tissue 11βHSD1 Activity in Obese, Insulin Resistant Subjects.|Completed||Phase 1|||Incyte Corporation|||||f||||||||||||||2017-02-18 16:06:35.814882|2017-02-18 16:06:35.814882
NCT00398606|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-10|2013-05-28|||April 1995||1995-04-01|May 2013|2013-05-01||||February 1998|Actual|1998-02-01||Interventional|||A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)|A Triple-Blind, Randomized, Active-Controlled, Parallel-Group, Multicenter Study to Evaluate and Compare the Efficacy and Tolerability of Alendronate Sodium With Calcium Supplementation in the Treatment of Osteoporosis in Postmenopausal Women|Completed||Phase 3|650||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:35.915858|2017-02-18 16:06:35.915858
NCT00398593|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-13|2009-02-13|||December 2007||2007-12-01|February 2009|2009-02-01|April 2009|Anticipated|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Methods of Improvement Adherence With Therapy in Ulcerative Colitis.|Patient Adherence to Prescribed Therapy in Ulcerative Colitis: an Investigation of Barriers & Methods of Improvement.|Unknown status|Active, not recruiting|Phase 3|80|Anticipated|University Hospitals, Leicester||1|||f||||||||||||||2017-02-18 16:06:35.997655|2017-02-18 16:06:35.997655
NCT00398580|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2013-03-29|||October 2006||2006-10-01|March 2013|2013-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men|A Phase II, 28-Day, Randomized, Parallel-Group, Open-Label Study Evaluating the Efficacy and Safety of Twice Daily Oral Doses of Testosterone (150-400mg) Co-administered With 0.25mg Dutasteride Compared With 400mg Testosterone Alone and 0.25mg Dutasteride Alone in the Treatment of Hypogonadism|Completed||Phase 2|43|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:06:36.093787|2017-02-18 16:06:36.093787
NCT00398567|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-08-30||2011-02-25|April 2007||2007-04-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|July 2009|Actual|2009-07-01||Interventional|||A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer|A Phase I/II Study of HKI-272 in Combination With Trastuzumab (Herceptin) in Subjects With Advanced Breast Cancer|Active, not recruiting||Phase 1/Phase 2|45|Actual|Puma Biotechnology, Inc.||3|||f||||f||||||||||2017-02-18 16:06:36.20499|2017-02-18 16:06:36.20499
NCT00398554|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-11-17|||June 2005||2005-06-01|November 2015|2015-11-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Interventional|||Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma|Pilot Study for Therapy Optimising for Hodgkin's Lymphoma in Childhood and Adolescence; Optimising Therapy for Boys With Hodgkin's Lymphoma in Intermediate and Advanced Stages. Safety and Efficacy Study for Drug Combination VECOPA|Completed||Phase 2|16|Actual|Martin-Luther-Universität Halle-Wittenberg||1|||f||||t||||||||||2017-02-18 16:06:36.35002|2017-02-18 16:06:36.35002
NCT00398541|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-09-23|||March 2005||2005-03-01|September 2015|2015-09-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)|Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients|Completed||Phase 3|41|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 16:06:36.478215|2017-02-18 16:06:36.478215
NCT00398528|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2007-11-30|||September 2006||2006-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis|An fMRI Study of Treatment Optimization Recommendations Comparing Patients Changing Treatment From Glatiramer Acetate 20 mg qd SC (Copaxone®) to IFN-β-1a 30 Mcg qw IM (Avonex®) to Those Changing From to IFN-β-1a 30 Mcg qw IM (Avonex®) to Glatiramer Acetate 20 mg qd SC (Copaxone®) in a Multicenter Study of Patients With Relapsing Remitting Multiple Sclerosis Currently on Disease-Modifying Therapy.|Terminated||Phase 4|48|Anticipated|Neurognostics||||rate of enrollment|f||||||||||||||2017-02-18 16:06:36.556938|2017-02-18 16:06:36.556938
NCT00398515|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-09-27|||March 2007||2007-03-01|September 2013|2013-09-01||||February 2012|Actual|2012-02-01||Interventional|||Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma|A Phase I Trial of CC-5013 (Lenalidomide) and CCI-779 in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:06:36.658128|2017-02-18 16:06:36.658128
NCT00398502|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2011-07-22|||October 2006||2006-10-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone|A Randomized, Open-label, 3-period Crossover Study to Determine the Relative Bioavailability of Two Oral Formulations of MOA-728 and to Compare the Pharmacodynamics of the Two Oral Formulations of MOA-728 and the Subcutaneous Formulation in Subjects on Stable Methadone Maintenance|Completed||Phase 1|||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:06:36.891906|2017-02-18 16:06:36.891906
NCT00398489|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2010-11-06|||October 2006||2006-10-01|September 2008|2008-09-01||||||||Interventional|||Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery|Evaluation of Response Rate to Pre-Operative Docetaxel + Herceptin Study Part A and Docetaxel Study Part B in Locally Advanced Breast Cancer Patients, Stratified by HER2-Status Trial - PHASE II [(Herceptin Docetaxel Neoadjuvant) HEDON]|Unknown status|Active, not recruiting|Phase 2|94|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:06:36.98091|2017-02-18 16:06:36.98091
NCT00398476|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-03-01|||December 2006||2006-12-01|March 2013|2013-03-01||||December 2006|Actual|2006-12-01||Interventional|||Fluticasone Nasal Spray Patient Preference Study|A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Fluticasone Propionate Aqueous Nasal Spray in Subject With Allergic Rhinitis|Completed||Phase 3|125||GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:06:37.098019|2017-02-18 16:06:37.098019
NCT00398463|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2011-06-29|||May 2006||2006-05-01|June 2008|2008-06-01|May 2011|Actual|2011-05-01|July 2008|Actual|2008-07-01||Interventional|3T/2R||Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance|Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel|Completed||Phase 4|263|Actual|Università degli Studi di Ferrara||2|||f||||t||||||||||2017-02-18 16:06:37.215839|2017-02-18 16:06:37.215839
NCT00398450|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2009-02-06|||February 2006||2006-02-01|January 2007|2007-01-01||||May 2007|Anticipated|2007-05-01||Interventional|||Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma|A Phase I Study of 5-Azacytidine (Vidaza) With Interferon α2b in Metastatic Melanoma Patients|Unknown status|Active, not recruiting|Phase 1|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:06:37.333939|2017-02-18 16:06:37.333939
NCT00398437|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-08-09|||September 2006||2006-09-01|March 2007|2007-03-01||||||||Interventional|||Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer|Role of Gadolinium Enhanced Brain Magnetic Resonance in the Follow Up of Metastatic Breast Cancer Patients Overexpressing HER2 Neu. A Randomized Prospective Study|Unknown status|Recruiting|N/A|96|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:06:37.429878|2017-02-18 16:06:37.429878
NCT00398424|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2009-08-06|||February 2006||2006-02-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|||Evaluating Patients With Impaired Hepatic Function|A Phase I, Open-Label Study Evaluating The Pharmacokinetics of Components of S-1 Patients With Impaired Hepatic Function|Completed||Phase 1|24|Anticipated|Taiho Oncology, Inc.||1|||f||||||||||||||2017-02-18 16:06:37.535115|2017-02-18 16:06:37.535115
NCT00398411|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-06-01|2013-08-05||October 2006||2006-10-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|MoxiProph||Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells|Double-blind, Randomized, Mono-center, Placebo-controlled Pilot Study to Investigate the Efficacy and Safety of Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells|Completed||Phase 3|66|Actual|University of Cologne||2|||f||||t||||||||||2017-02-18 16:06:37.629842|2017-02-18 16:06:37.629842
NCT00398398|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-10-06|2013-12-15||November 2006||2006-11-01|October 2015|2015-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study of XELOX With Cetuximab in Advanced Gastric Cancer|A Prospective Phase II Study of Cetuximab (Erbitux®) in Combination With XELOX [XELoda® (Capecitabine) and OXaliplatin] in Patients With Advanced Gastric Cancer|Completed||Phase 2|44|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 16:06:38.489684|2017-02-18 16:06:38.489684
NCT00398385|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-08-09|||May 2005||2005-05-01|April 2008|2008-04-01||||April 2010|Anticipated|2010-04-01||Interventional|||Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer|A Randomized Phase II Study of Preoperative Versus Postoperative Gemcitabine and Cisplatin for Patients With Stage IB-II Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|170|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:06:38.767251|2017-02-18 16:06:38.767251
NCT00398372|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2011-05-31|||November 2000||2000-11-01|July 2010|2010-07-01|September 2009|Actual|2009-09-01|June 2007|Actual|2007-06-01||Interventional|||Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment|Le20: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment|Completed||N/A|500|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 16:06:38.872624|2017-02-18 16:06:38.872624
NCT00398359|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-09-30|||May 2006||2006-05-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Treatment of Childhood Obesity in Primary Care|Treatment of Childhood Obesity in Primary Care|Completed||Phase 3|145|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 16:06:38.973741|2017-02-18 16:06:38.973741
NCT00398333|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-06-19|||June 2005||2005-06-01|June 2013|2013-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients|Randomized Controlled, Open-label, Pilot Study to Assess the Effectiveness of a Nutritional Supplementation Enriched With Eicosapentaenoic Acid on Chemotherapy Tolerance in Patients With Advanced Colorectal Cancer|Terminated||Phase 4|13|Actual|Hospital Clinic of Barcelona||2||Impossibility to accomplish the sample size in assigned time.|f||||||||||||||2017-02-18 16:06:39.090642|2017-02-18 16:06:39.090642
NCT00398320|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-10-15|2013-10-15||November 2006||2006-11-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors|A Phase II Study of Capecitabine, Oxaliplatin and Bevacizumab for Metastatic or Unresectable Neuroendocrine Tumors|Completed||Phase 2|40|Actual|Stanford University||1|||f||||||||||||||2017-02-18 16:06:39.209251|2017-02-18 16:06:39.209251
NCT00398307|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2011-04-07|||February 2006||2006-02-01|April 2011|2011-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Evaluating Patients With Varying Degrees of Renal Function|A Phase I, Open-Label Study Evaluating the Pharmacokinetics of Components of S-1 in Patients With Varying Degrees of Renal Function|Completed||Phase 1|24|Anticipated|Taiho Oncology, Inc.||1|||f||||||||||||||2017-02-18 16:06:39.532421|2017-02-18 16:06:39.532421
NCT00398086|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2016-03-24|2013-06-14||November 2006||2006-11-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|September 2008|Actual|2008-09-01||Interventional|||Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer|A Phase I Trial of Gemcitabine (Gemzar) Plus ABI-007 (ABRAXANE) In Patients With Advanced Metastatic Pancreatic Cancer|Completed||Phase 1/Phase 2|67|Actual|Celgene Corporation||3|||f||||f||||||||||2017-02-18 16:06:43.072806|2017-02-18 16:06:43.072806
NCT00398294|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-10-21|||May 2005||2005-05-01|October 2015|2015-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264)|An Open-Label, Single-Arm, Prospective Study to Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet in Patients With Hypercholesterolemia|Completed||Phase 4|30|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:39.623887|2017-02-18 16:06:39.623887
NCT00398281|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2014-01-09|||November 2006||2006-11-01|June 2009|2009-06-01|September 2012|Actual|2012-09-01|July 2010|Actual|2010-07-01||Interventional|||Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer|Detection of Prostate Cancer With Contrast-Enhanced Ultrasound After Treatment With Dutasteride|Completed||Phase 3|450|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:06:39.713548|2017-02-18 16:06:39.713548
NCT00398268|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2006-11-08|||January 2006||2006-01-01|November 2006|2006-11-01||||||||Interventional|||Dislocated Unstable Distal Both-Bone Forearm Fractures in Children|Treatment of Unstable Dislocated Both-Bone Distal Forearm Fractures in Children: A Follow-up Study|Unknown status|Recruiting|N/A|60||Colaris, Joost, M.D.|||||f||||||||||||||2017-02-18 16:06:39.821499|2017-02-18 16:06:39.821499
NCT00398255|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-04-29|||February 2004||2004-02-01|April 2013|2013-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Healthier Living With Arthritis Online Program|Internet Arthritis Self-Management Study|Completed||N/A|900||Stanford University|||||f||||||||||||||2017-02-18 16:06:39.908231|2017-02-18 16:06:39.908231
NCT00398242|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2006-11-08|||January 2006||2006-01-01|November 2006|2006-11-01||||||||Interventional|||Treatment of Stable Both-Bone Midshaft Forearm Fractures in Children|Treatment of Stable Both-Bone Midshaft Forearm Fractures in Children: A Randomized Trial Between Treatment With Above Elbow Cast and a Combination of Above- and Below Elbow Armcast.|Unknown status|Recruiting|N/A|60||Colaris, Joost, M.D.|||||f||||||||||||||2017-02-18 16:06:40.007348|2017-02-18 16:06:40.007348
NCT00398229|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2008-12-31|||November 2006||2006-11-01|November 2007|2007-11-01|May 2008|Actual|2008-05-01|||||Interventional|||hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle|The Benefit of Human Chorionic Gonadotropin (hCG) Supplementation Throughout the Secretory Phase of Frozen-Thawed Embryo Transfer Cycles|Completed||Phase 2|300|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 16:06:40.098271|2017-02-18 16:06:40.098271
NCT00398216|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-02-05|2015-02-05||May 2006||2006-05-01|February 2015|2015-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery|A Phase IIb, Randomized, Parallel Group, Double-Blind, Double-Dummy, Multi-Center, Multi-National, Multi-Dose, Study of DU-176b Compared to Dalteparin in Patients Undergoing Elective Unilateral Total Hip Replacement|Completed||Phase 2|903|Actual|Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 16:06:40.216074|2017-02-18 16:06:40.216074
NCT00398203|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2012-06-11|||February 2008||2008-02-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and Treatment|Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and Treatment|Completed||N/A|60|Actual|Smart Medical Systems Ltd.||1|||f||||f||||||||||2017-02-18 16:06:41.576319|2017-02-18 16:06:41.576319
NCT00398190|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2008-10-16|||October 2006||2006-10-01|October 2008|2008-10-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Media Literacy to Prevent Adolescent Smoking|Media Literacy to Prevent Adolescent Smoking|Unknown status|Recruiting|N/A|1200|Anticipated|University of Pittsburgh||2|||f||||||||||||||2017-02-18 16:06:41.677824|2017-02-18 16:06:41.677824
NCT00398177|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-11-16|||January 1999||1999-01-01|November 2016|2016-11-01||||January 2099|Anticipated|2099-01-01||Observational|||Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease|Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease|Recruiting||N/A|9999|Anticipated|Stanford University|||1||f||||t||||||Samples Without DNA|"~     tumor tissue~   "|||2017-02-18 16:06:41.782435|2017-02-18 16:06:41.782435
NCT00398151|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-05-13|||August 2005||2005-08-01|May 2016|2016-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)|An Open-Label Study to Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy|Completed||Phase 3|58|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:41.892228|2017-02-18 16:06:41.892228
NCT00398138|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-02-02|2015-12-22||October 2006||2006-10-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma|Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Thoracic and Myeloid Neoplasms|Completed||Phase 1|22|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:06:41.984464|2017-02-18 16:06:41.984464
NCT00398125|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2012-07-26|||November 2006||2006-11-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults|A Phase 2a, Multicenter, Randomized, Parallel, Double-Blind, Dose Ranging, Placebo-Controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK364735 Monotherapy Versus Placebo Over 10 Days in HIV-1 Infected Adults.|Completed||Phase 2|30|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:06:42.430571|2017-02-18 16:06:42.430571
NCT00398112|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2014-04-28|2013-11-21||August 2007||2007-08-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|November 2008|Actual|2008-11-01||Interventional|||Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase II Study of Sunitinib Malate for Treatment of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)|Completed||Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:06:42.541147|2017-02-18 16:06:42.541147
NCT00398099|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2017-02-16|||July 2005||2005-07-01|February 2017|2017-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)|Clinical Evaluation for the Efficacy, Safety, Tolerability & Medical Resource Utilization of Invanz (Ertapenem Sodium) Therapy|Completed||Phase 3|30||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:42.974962|2017-02-18 16:06:42.974962
NCT00006136|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-11-04|||March 1999||1999-03-01|July 2004|2004-07-01||||||||Interventional|||Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia||Completed||Phase 2|15||Office of Rare Diseases (ORD)|||||||||||||||||||2017-02-18 18:13:27.156362|2017-02-18 18:13:27.156362
NCT00398073|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-03-12|||October 2006||2006-10-01|March 2013|2013-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma|Injection of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Mouse gp100 DNA: A Pilot Study to Compare Intramuscular Jet Injection With Particle Mediated Delivery|Completed||N/A|35|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 16:06:44.808008|2017-02-18 16:06:44.808008
NCT00398060|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2008-02-13|||January 2003||2003-01-01|February 2008|2008-02-01|March 2007|Actual|2007-03-01|December 2004|Actual|2004-12-01||Interventional|||GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes|GOAL Life-Style Change Implementation Intervention to Prevent Type 2 Diabetes in Primary Health Care|Completed||Phase 3|389|Actual|National Institute for Health and Welfare, Finland||1|||f||||f||||||||||2017-02-18 16:06:44.918741|2017-02-18 16:06:44.918741
NCT00398047|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2012-03-23|2011-01-21||September 2006||2006-09-01|March 2012|2012-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes|Combination of Azacitadine and Hematopoietic Growth Factors for Myelodysplastic Syndrome|Terminated||N/A|3|Actual|Wake Forest University Health Sciences||1||Slow accrual|f||||f||||||||||2017-02-18 16:06:45.046407|2017-02-18 16:06:45.046407
NCT00398034|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2006-11-08|||November 2006||2006-11-01|November 2006|2006-11-01|October 2008||2008-10-01|||||Interventional|||Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.|Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-Treated Chronic Pain Patients: A Pilot Study.|Unknown status|Recruiting|Phase 2|62||James J. Peters Veterans Affairs Medical Center|||||f||||||||||||||2017-02-18 16:06:45.348458|2017-02-18 16:06:45.348458
NCT00398021|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-10-01|||June 2006||2006-06-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|June 2009|Actual|2009-06-01||Observational|||Predictors of Constipation in Healthy Children|Predictors of Constipation in Healthy Children|Completed||N/A|1430|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 16:06:45.480005|2017-02-18 16:06:45.480005
NCT00398008|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-07-25|||October 2004||2004-10-01|July 2013|2013-07-01|December 2008|Anticipated|2008-12-01|December 2006|Actual|2006-12-01||Interventional|||HIV Risk Reduction and Drug Abuse Treatment in Iran|HIV Risk Reduction and Drug Abuse Treatment in Iran|Withdrawn||Phase 2|0|Actual|Yale University||2||Study was never able to start in IRAN|f||||||||||||||2017-02-18 16:06:45.5923|2017-02-18 16:06:45.5923
NCT00397995|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2006-11-08|||January 2006||2006-01-01|November 2006|2006-11-01||||||||Interventional|||Undislocated Distal Both-Bone Forearm Fractures in Children|Treatment of Undislocated Both-Bone Distal Forearm Fractures in Children: A Randomized Trial Between Treatment With Above- and Under Elbow Cast.|Unknown status|Recruiting|N/A|60||Colaris, Joost, M.D.|||||f||||||||||||||2017-02-18 16:06:45.836702|2017-02-18 16:06:45.836702
NCT00397982|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-07-28|||May 2007||2007-05-01|December 2015|2015-12-01||||July 2013|Actual|2013-07-01||Interventional|||Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma|A Phase II Study of CCI-779 in Combination With Bevacizumab in Stage III or IV Melanoma|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:06:45.929459|2017-02-18 16:06:45.929459
NCT00397969|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-12-18|||February 2005||2005-02-01|December 2006|2006-12-01|June 2008|Actual|2008-06-01|||||Interventional|||Improving the Frequency of Colonoscopy in Patients With a Previous Colorectal Polyp|Improving Surveillance for Colorectal Polyps|Completed||N/A|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:06:46.064549|2017-02-18 16:06:46.064549
NCT00397956|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-10-29|||September 2004||2004-09-01|October 2015|2015-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)|An Open-Label, Single-Arm, Non-Comparative Study to Evaluate the Efficacy, Tolerability & Convenience of Invanz(TM) (Ertapenem Sodium) In the Treatment of Community-Acquired Sepsis in Adults|Completed||Phase 3|30||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:46.160385|2017-02-18 16:06:46.160385
NCT00397943|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2012-03-09||2012-03-09|November 2006||2006-11-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults|Safety, Reactogenicity & Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Administered Intramuscularly According to a Schedule of 0, 1 Month, to Healthy Adults Aged 18 to 50 Years|Completed||Phase 2|110|Actual|GlaxoSmithKline||5|||f||||||||||||||2017-02-18 16:06:46.24188|2017-02-18 16:06:46.24188
NCT00397930|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-10-13|2014-08-20||October 2006||2006-10-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|April 2013|Actual|2013-04-01||Interventional|YOCAS||Yoga in Treating Sleep Disturbance in Cancer Survivors|Yoga for Persistent Sleep Disturbance in Cancer Survivors|Completed||Phase 2|410|Actual|University of Rochester|The study did not account for components such as time or attention, as this would have required the use of a placebo yoga intervention for the YOCAS program. The results are not generalizable for all yoga types, nor for all socioeconomic backgrounds.|2|||f||||t||||||||||2017-02-18 16:06:46.364186|2017-02-18 16:06:46.364186
NCT00397917|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2009-12-02|||November 2006||2006-11-01|December 2009|2009-12-01|September 2011|Anticipated|2011-09-01|May 2011|Anticipated|2011-05-01||Interventional|||Oral Cleft Prevention Program|Oral Cleft Prevention Program|Unknown status|Active, not recruiting|Phase 3|6000|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 16:06:47.746022|2017-02-18 16:06:47.746022
NCT00397904|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-10-22|2015-10-22||October 2006||2006-10-01|October 2015|2015-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin|Phase II Trial of Cetuximab Plus Cisplatin and Irinotecan in Patients With Irinotecan and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer|Completed||Phase 2|16|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:06:47.855617|2017-02-18 16:06:47.855617
NCT00397891|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2014-08-20|2014-08-20||October 2006||2006-10-01|August 2014|2014-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||Safety data set included all randomized participants who received at least 1 dose of study medication.|Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled, Safety, Tolerability, and Pharmakokinetic Study of Single Ascending Doses of AAB-001 in Japanese Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|80|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||t||||||||||2017-02-18 16:06:48.148106|2017-02-18 16:06:48.148106
NCT00397878|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2014-05-07|2013-12-17||November 2006||2006-11-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||AZD0530 in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer|Phase II Study of AZD0530 (NSC 735464) in Patients With Previously Treated Metastatic Colorectal Cancer|Terminated||Phase 2|10|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:06:49.597876|2017-02-18 16:06:49.597876
NCT00397865|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-10-01|||October 2006||2006-10-01|July 2010|2010-07-01|August 2007|Actual|2007-08-01|||||Interventional|||A Primary Care Educational Intervention for Families of Overweight Children|A Primary Care Educational Intervention for Families of Overweight Children|Completed||N/A|15|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 16:06:49.881116|2017-02-18 16:06:49.881116
NCT00397852|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2006-11-08|||January 2006||2006-01-01|November 2006|2006-11-01||||||||Interventional|||Dislocated Stable Distal Both-Bone Forearm Fractures in Children|Treatment of Stable Dislocated Both-Bone Distal Forearm Fractures in Children: A Randomized Trial Between Treatment With en Without Kirschner-Wires|Unknown status|Recruiting|N/A|110||Colaris, Joost, M.D.|||||f||||||||||||||2017-02-18 16:06:49.985338|2017-02-18 16:06:49.985338
NCT00397839|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2009-11-17|2009-11-17||January 2007||2007-01-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|STRONG||The Effect Of Oral Ibandronate In Male Osteoporosis|A Parallel, Placebo-controlled, Randomized (2:1) Double-blind Study of One Year Duration to Assess the Effect of Oral Ibandronate 150 mg Given Once-monthly Versus Placebo on LS BMD in Men With Osteoporosis|Completed||Phase 3|135|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:06:50.088381|2017-02-18 16:06:50.088381
NCT00397826|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-01-06|||January 2005||2005-01-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|January 2006|Actual|2006-01-01||Interventional|||Evaluation of the Effects of Simvastatin 40mg|Evaluation of the Effects of Simvastatin 40 Mg on Lipid Profiles and Specified Circulatory Parameters in Normotensive Hypercholesterolemia Patients(MK-0733-265)|Completed||Phase 4|20|Actual|Cardinal Tien Hospital||1|||f||||f||||||||No||2017-02-18 16:06:50.736709|2017-02-18 16:06:50.736709
NCT00397813|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2016-11-14|||January 2006||2006-01-01|November 2016|2016-11-01||||July 2017|Anticipated|2017-07-01||Interventional|||Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders|Low-Dose TBI Dose Escalation to Decrease Risks of Progression and Graft Rejection After Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning as Treatment for Untreated Myelodysplastic Syndrome or Myeloproliferative Disorders - A Multi-Center Trial|Recruiting||Phase 2|144|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 16:06:50.836336|2017-02-18 16:06:50.836336
NCT00397800|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2012-08-27|||June 2005||2005-06-01|August 2012|2012-08-01|May 2013|Anticipated|2013-05-01|May 2008|Actual|2008-05-01||Interventional|||Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma|Safety and Efficacy of Sequential Treatment With a Combination of Rituximab, Fludarabine and Cyclophosphamide Followed by Zevalin (Rituximab and Y-Ibritumomab Tiuxetan) - A Phase I/II Study for Treatment of Patients With Relapsed Indolent and Transformed CD20-Positive B-Cell Non-Hodgkin's-Lymphoma Ineligible for High-Dose Chemo(Radio)Therapy Supported by Autologous Peripheral Blood Stem-Cells|Unknown status|Active, not recruiting|Phase 1/Phase 2|12|Anticipated|Technische Universität München|||||f||||||||||||||2017-02-18 16:06:50.976605|2017-02-18 16:06:50.976605
NCT00397787|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2013-06-03|||November 2006||2006-11-01|June 2013|2013-06-01||||September 2007|Actual|2007-09-01||Interventional|||Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine|A Phase II Study of Sunitinib Malate (SU11248, NSC #736511, IND #74,019) in Patients With Previously Treated Pancreatic Adenocarcinoma With Measurable Metastatic Disease Following Progression on Front-Line Gemcitabine-Based Therapy|Completed||Phase 2|64|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:06:51.089496|2017-02-18 16:06:51.089496
NCT00397774|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-09|2015-03-28|||October 2006||2006-10-01|March 2015|2015-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Physical Activity and Functioning in Palliative Cancer Patients - a Clinical Randomised Trial|Phase 3 Physical Activity and Functioning in Palliative Cancer Patients - a Clinical Randomised Trial|Completed||Phase 3|231|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 16:06:51.196668|2017-02-18 16:06:51.196668
NCT00397761|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2009-02-06|||July 2006||2006-07-01|November 2006|2006-11-01||||||||Interventional|||Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer|Combination Capecitabine (Xeloda) and ABI-007 (Abraxane, Nanoparticle Albumin-Bound Paclitaxel) Chemotherapy as Neoadjuvant Treatment of Locally Advanced, Operable Breast Cancer|Unknown status|Recruiting|Phase 2/Phase 3|33|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:06:51.303081|2017-02-18 16:06:51.303081
NCT00397748|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2017-01-24|||September 15, 2006||2006-09-15|November 27, 2012|2012-11-27|November 27, 2012||2012-11-27|||||Observational|||PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)|PET Scanning of Brain Dopaminergic Signal Transduction Involving Arachidonic Acid in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|16|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:06:51.401811|2017-02-18 16:06:51.401811
NCT00397735|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2017-01-12|||October 2006||2006-10-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|||N-acetylcysteine in Intra-amniotic Infection/Inflammation|Effect of N-acetylcysteine in Preventing Adverse Neonatal Outcomes in Women With Intra-amniotic Infection/Inflammation|Completed||Phase 1/Phase 2|80|Actual|Ohio State University||2|||f||||f||||||||||2017-02-18 16:06:51.489372|2017-02-18 16:06:51.489372
NCT00397722|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2010-10-01|||November 2006||2006-11-01|October 2010|2010-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Treatment Of Patients With Social Anxiety Disorder|Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)|Completed||Phase 2|280||GlaxoSmithKline||1|||||||||||||||||2017-02-18 16:06:51.623596|2017-02-18 16:06:51.623596
NCT00397709|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2008-12-30|||March 1996||1996-03-01|November 2006|2006-11-01|February 2006||2006-02-01|||||Interventional|||Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection|Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection: A Randomized Clinical Trial.|Terminated||Phase 4|228||Hospital Virgen de la Luz|||||f||||||||||||||2017-02-18 16:06:51.756462|2017-02-18 16:06:51.756462
NCT00397696|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2014-04-16||2014-03-21|November 2006||2006-11-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons Disease|Evaluation of 5-[123I]-A-85380 and SPECT Imaging as a Marker of Nicotinic Receptor Density in the Brain of Parkinson Disease Subjects|Completed||Phase 2|9|Actual|Institute for Neurodegenerative Disorders||1|||f||||t||||||||||2017-02-18 16:06:51.861668|2017-02-18 16:06:51.861668
NCT00397683|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-10-30|||October 2006||2006-10-01|October 2015|2015-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011)|Proprietary Information - Exploratory (Non-Confirmatory) Trial|Terminated||Phase 2|2|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:06:54.641859|2017-02-18 16:06:54.641859
NCT00397670|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2006-11-08|||January 2004||2004-01-01|November 2006|2006-11-01|May 2006||2006-05-01|||||Interventional|||Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm|A Multicenter Open-Label Study of the Safety and Contraceptive Efficacy of BufferGel® Spermicide Used With Diaphragm|Completed||Phase 2/Phase 3|200||ReProtect Inc|||||f||||||||||||||2017-02-18 16:06:54.740473|2017-02-18 16:06:54.740473
NCT00397657|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2009-06-16|||November 2006||2006-11-01|June 2009|2009-06-01|October 2009|Anticipated|2009-10-01|August 2009|Anticipated|2009-08-01||Interventional|||Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis|ARBITER 6: ARterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6 - HDL and LDL Treatment Strategies in Atherosclerosis (HALTS)|Terminated||Phase 4|400|Anticipated|Walter Reed Army Medical Center||2||"Independent steering committee has stopped the trial based on results of a prespecified,~   blinded interim analysis. It was not stopped due to safety concerns."|f||||||||||||||2017-02-18 16:06:54.805576|2017-02-18 16:06:54.805576
NCT00397644|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2007-04-04|||March 2006||2006-03-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||Assisting Low-Income Families at Pediatric Well-Child Care Visits|Enhancing a Medical Home for Vulnerable Children by Addressing Family Psychosocial Problems at Well-Child Care Visits: THE WE CARE Project|Completed||N/A|200||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:06:54.92368|2017-02-18 16:06:54.92368
NCT00397631|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-01-27|2009-05-19||December 2006||2006-12-01|January 2015|2015-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Initial Combination With Pioglitazone Study (0431-064)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Initial Therapy With Coadministration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|520|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:06:55.018288|2017-02-18 16:06:55.018288
NCT00397605|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2014-09-16|||November 2006||2006-11-01|September 2014|2014-09-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Cannabinoids in Bipolar Affective Disorder|Cannabinoids in Bipolar Affective Disorder: A Controlled Pilot Study|Withdrawn||N/A|0|Actual|University of British Columbia||1||study was never started and no patients were ever enrolled|f||||||||||||||2017-02-18 16:06:55.536875|2017-02-18 16:06:55.536875
NCT00397592|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2007-07-02|||August 2006||2006-08-01|July 2007|2007-07-01|January 2007|Actual|2007-01-01|||||Interventional|||Growth Hormone's Effect on Endothelial Progenitor Cells|The Effect of Exogenous Growth Hormone on the Mobilization of Endothelial Progenitor Cells|Completed||N/A|18|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:06:55.885961|2017-02-18 16:06:55.885961
NCT00397579|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2016-09-02|||May 2013||2013-05-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes|Therapy Targeting the Interleukin-3 Receptor (IL3R) for Patients With Relapsed or Refractory and Elderly or Poor-Risk Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome With DTIL3 (IND# 11314): a Phase I/II Clinical Trial|Active, not recruiting||Phase 1/Phase 2|10|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-02-18 16:06:55.989104|2017-02-18 16:06:55.989104
NCT00397566|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2012-04-26|||February 2007||2007-02-01|April 2012|2012-04-01|February 2007|Actual|2007-02-01|||||Interventional|||A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects|Randomized, Placebo-Controlled, Ascending Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-707035 in HIV-1 Infected Subjects|Withdrawn||Phase 2|0|Actual|Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:06:56.101047|2017-02-18 16:06:56.101047
NCT00397553|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2009-09-17|||January 2005||2005-01-01|May 2009|2009-05-01||||December 2007|Actual|2007-12-01||Interventional|||Insulin Glulisine, Diabetes Mellitus Type 1|Multicenter, Open, Non-randomised Phase III Clinical Study of Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus Using Also Insulin Glargine|Completed||Phase 3|104|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:06:56.194318|2017-02-18 16:06:56.194318
NCT00397540|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2015-05-18|2009-09-22||October 2006||2006-10-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)|Prospective Cohort Study of the Effect of Serum HBV DNA Level on Intrahepatic Recurrence in Locally Treatable, HBV-related HCC Patients|Completed||Phase 4|145|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 16:06:56.298642|2017-02-18 16:06:56.298642
NCT00397527|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2008-05-15|||July 2006||2006-07-01|May 2008|2008-05-01||||||||Interventional|||Acceptability Dermacyd Wipes - Lactoserum - Hygiene|Safety Dermatological Evaluation: Acceptability With Gynecological Follow up of Dermacyd Wipes|Completed||Phase 3|30||Sanofi|||||f||||||||||||||2017-02-18 16:06:56.64874|2017-02-18 16:06:56.64874
NCT00397514|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2013-09-06|2013-03-13||October 2006||2006-10-01|September 2013|2013-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational||The number of participants analyzed was 25 due to the withdrawal of 9 participants after enrolment as specified.|Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery|Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery|Completed||Phase 4|34|Actual|University of British Columbia|The study was limited by a small sample.Our study patients underwent BiV pacing just prior to extubation, by which time myocardial dysfunction may have recovered, so they represented a potentially healthier subset in comparison to adults.||1||f||||f||||||||||2017-02-18 16:06:56.732014|2017-02-18 16:06:56.732014
NCT00396903|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2015-04-07|||April 2003||2003-04-01|April 2015|2015-04-01|November 2005|Actual|2005-11-01|||||Observational|||Evaluation of a Standard Epidural Catheter During Clinical Practice|Evaluation of a Standard Epidural Catheter During Clinical Practice|Completed||N/A|100||Maastricht University Medical Center|||||f||||f||||||||||2017-02-18 16:07:09.540179|2017-02-18 16:07:09.540179
NCT00397501|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2013-10-25|||October 2013||2013-10-01|October 2013|2013-10-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain|A Phase I/II Pilot Study of Patients With Brain Metastasis Secondary to Breast Cancer Treated With Methotrexate and Carboplatin in Conjunction With Blood-Brain Barrier Disruption, With Concurrent Trastuzumab in HER-2 Positive Patients|Withdrawn||Phase 1/Phase 2|0|Actual|OHSU Knight Cancer Institute||2||after original approval, IRB closed enrollment; major revisions required to re-open.|f||||t||||||||||2017-02-18 16:06:57.055314|2017-02-18 16:06:57.055314
NCT00397488|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-12-17|2015-12-17||September 2006||2006-09-01|December 2015|2015-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium|Phase II Study of Sunitinib in Metastatic Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|78|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:06:57.175244|2017-02-18 16:06:57.175244
NCT00397475|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2015-05-26|||November 2006||2006-11-01|May 2015|2015-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Evaluation of Colecalciferol Substitution in Dialysis Patients|Evaluation of Colecalciferol Substitution in Dialysis Patients|Completed||N/A|50|Anticipated|University Hospital, Saarland|||||f||||||||||||||2017-02-18 16:06:57.47044|2017-02-18 16:06:57.47044
NCT00397462|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2016-09-15|2016-07-22||October 2006||2006-10-01|September 2016|2016-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Blood Flow and Bone Density in Healthy Adult Women|Blood Flow and Bone Density in Healthy Adult Women|Completed||N/A|44|Actual|Binghamton University||3|||f||||f||||||||No||2017-02-18 16:06:57.558461|2017-02-18 16:06:57.558461
NCT00397449|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2007-08-09|||October 2006||2006-10-01|August 2007|2007-08-01|December 2007|Anticipated|2007-12-01|||||Interventional|||GMZ2-Aluminum Hydroxide Phase I, Tübingen|Assessment of the Safety and Immunogenicity of the Recombinant Lactococcus Lactis Hybrid GMZ2 [GLURP+MSP3] a Malaria Vaccine in Healthy Adult Volunteers. A Phase I, Double-Blind, Randomised, Dose-Selection, Unicentre Trial|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|European Malaria Vaccine Initiative||1|||f||||f||||||||||2017-02-18 16:06:58.010721|2017-02-18 16:06:58.010721
NCT00397436|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2016-05-13|||February 2007||2007-02-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|November 2011|Actual|2011-11-01||Interventional|||Pilot Study of Protein Profiling of the Human Epidermal Cells After Ultraviolet Irradiation|Pilot Study of Protein Profiling of the Human Epidermal Cells After Ultraviolet Irradiation|Completed||Early Phase 1|60|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-02-18 16:06:58.345816|2017-02-18 16:06:58.345816
NCT00397423|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2007-11-27|||December 2006||2006-12-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response|Granulocyte-Colony Stimulating Factor Treatment for Amyotrophic Lateral Sclerosis: A Randomized Control Trial Study Assessing Clinical Response|Completed||Phase 2|40|Actual|Peking University||2|||f||||||||||||||2017-02-18 16:06:58.441124|2017-02-18 16:06:58.441124
NCT00397410|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2012-05-10|||May 2005||2005-05-01|May 2012|2012-05-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Prevention of Hip Fractures With Soft and Hard Hip Protectors|Compliance With and Effect of Soft and Hard Hip Protectors in Norwegian Nursing Homes|Completed||N/A|1236|Actual|Norwegian Institute of Public Health||1|||f||||||||||||||2017-02-18 16:06:58.53309|2017-02-18 16:06:58.53309
NCT00397397|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2006-11-08|||January 2007||2007-01-01|November 2006|2006-11-01|March 2007||2007-03-01|||||Observational|||Comparative Treatment Study in Patients With Lower Ureteral Stones|Comparative Study in Patients With Lower Ureteral Stones Treated With 10 MG Alfuzosin,10 MG Alfuzosin With Rowatinex, and Rowatinex Alone|Unknown status|Not yet recruiting|Early Phase 1|60||Hillel Yaffe Medical Center|||||f||||||||||||||2017-02-18 16:06:58.623159|2017-02-18 16:06:58.623159
NCT00397384|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-09-28|||January 2007||2007-01-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer|A Phase I Clinical and Biological Evaluation of Combined EGFR Blockade With Erlotinib and Cetuximab in Patients With Advanced Cancer|Completed||Phase 1|43|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:06:58.707571|2017-02-18 16:06:58.707571
NCT00397358|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2007-06-29|||November 2006||2006-11-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients|Open-Label Study to Evaluate the Effects of Once Daily Extraneal (7.5% Icodextrin) Peritoneal Dialysis Solution on Triglyceride Levels in Peritoneal Dialysis Patients|Terminated||Phase 4|0|Actual|Baxter Healthcare Corporation||||Lack of enrollment|f||||f||||||||||2017-02-18 16:06:58.834133|2017-02-18 16:06:58.834133
NCT00397345|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2010-06-04|||September 2006||2006-09-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||TroVax Renal Immunotherapy Survival Trial|An International, Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Investigate Whether TroVax, Added to First-line Standard of Care Therapy, Prolongs the Survival of Patients With Locally Advanced or Metastatic Clear Cell Renal Adenocarcinoma.|Completed||Phase 3|700|Anticipated|Oxford BioMedica||2|||f||||t||||||||||2017-02-18 16:06:58.945915|2017-02-18 16:06:58.945915
NCT00397332|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2015-04-19|||October 2006||2006-10-01|February 2011|2011-02-01|July 2013|Actual|2013-07-01|January 2013|Actual|2013-01-01||Interventional|||Alefacept for Chronic Graft Versus Host Disease|An Investigator Initiated Open-label and Explorative Study of Alefacept Treatment for Chronic Extensive Graft Versus Host Disease|Completed||Phase 1/Phase 2|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 16:06:59.202647|2017-02-18 16:06:59.202647
NCT00397319|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2007-07-02|||August 2005||2005-08-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Observational|||Growth Hormone's Effect on the Cardiovascular System|The Role of Growth Hormone in Cardiovascular Health|Terminated||N/A|26||Vanderbilt University||||"Inadequate retention of GHD adults to maintain power to study the effect of GH on~   fibrinolysis. A comparison between GHD adults and controls was completed."|f||||||||||||||2017-02-18 16:06:59.301482|2017-02-18 16:06:59.301482
NCT00397306|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2009-04-07|||November 2006||2006-11-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of a Bioimpedance Method for Determination of Dry Weight in Dialysis Patients|Study for the Evaluation of a Bioimpedance Method for Determination of Dry Weight in Dialysis Patients|Completed||N/A|16|Actual|University Hospital, Saarland||1|||f||||f||||||||||2017-02-18 16:06:59.387532|2017-02-18 16:06:59.387532
NCT00397293|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2010-08-20||2010-08-12|November 2006||2006-11-01|August 2010|2010-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer|An Open-label, Multicenter, Phase I/II Study of AT-101 in Combination With Topotecan in Patients With Relapsed or Refractory Small Cell Lung Cancer After Prior Platinum Containing First Line Chemotherapy|Completed||Phase 1/Phase 2|36|Actual|Ascenta Therapeutics||1|||f||||f||||||||||2017-02-18 16:06:59.466477|2017-02-18 16:06:59.466477
NCT00397280|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2017-01-24|||November 6, 2006||2006-11-06|September 7, 2016|2016-09-07||||||||Observational|||Immune Cell Response to Stimuli|Innate Immunity Signal Transduction in Human Leukocytes|Recruiting||N/A|2040|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:06:59.580823|2017-02-18 16:06:59.580823
NCT00397267|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-08|2006-11-26|||January 2007||2007-01-01|October 2006|2006-10-01|December 2007||2007-12-01|||||Interventional|||Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids||Unknown status|Not yet recruiting|Phase 4|120||Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:06:59.677544|2017-02-18 16:06:59.677544
NCT00397254|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2010-06-07|2009-03-06||December 2006||2006-12-01|September 2009|2009-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Two Rizatriptan Prescribing Portions for Treatment of Migraine|An Observer-Blind, Randomized, Parallel-Group Study to Compare the Efficacy of Two Rizatriptan Prescribing Portions for the Treatment of Migraine|Completed||Phase 4|197|Actual|Clinvest||2|||f||||f||||||||||2017-02-18 16:06:59.767323|2017-02-18 16:06:59.767323
NCT00397241|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2014-05-09|||September 2006||2006-09-01|May 2014|2014-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||24-hour Intraocular Pressure (IOP) Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-angle Glaucoma|24-hour IOP With DTFC and LTFC Monotherapies and the Adjunctive Therapy of DTFC and Latanoprost in Open-angle Glaucoma Insufficiently Controlled With Latanoprost Monotherapy.|Completed||Phase 4|33|Actual|Aristotle University Of Thessaloniki||1|||f||||f||||||||||2017-02-18 16:07:00.159184|2017-02-18 16:07:00.159184
NCT00397228|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2016-12-15||2014-03-21|November 2006||2006-11-01|December 2016|2016-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||ALTROPANE® SPECT Imaging in Patients With Parkinson Disease|Optimizing the Performance of ALTROPANE® SPECT Imaging in Patients With Parkinson Disease|Completed||Phase 2|27|Actual|Molecular NeuroImaging||1|||f||||f||||||||||2017-02-18 16:07:00.257512|2017-02-18 16:07:00.257512
NCT00397215|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2016-11-03|2012-12-19||November 2006||2006-11-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|October 2007|Actual|2007-10-01||Interventional|||Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age|Evaluate Immunogenicity & Safety of a Single or Double-dose of the Pandemic Influenza Candidate Vaccine (GSK1562902A) Given Following a Two-administration Schedule (21 Days Apart) in Adults Over 60 Yrs|Completed||Phase 2|437|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:07:00.639285|2017-02-18 16:07:00.639285
NCT00397202|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2015-04-29|||November 2006||2006-11-01|April 2015|2015-04-01|June 2011|Actual|2011-06-01|June 2009|Actual|2009-06-01||Interventional|||FLOW-Finding Lasting Options for Women|FLOW-Finding Lasting Options for Women: A Prospective, Randomized, Multicenter Trial Comparing Tampons to a Menstrual Cup|Completed||N/A|110|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:07:03.894494|2017-02-18 16:07:03.894494
NCT00397189|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2015-04-21|2010-08-26||October 2006||2006-10-01|December 2010|2010-12-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients|A Double-blind, Parallel Group, Randomised, Placebo Controlled Study of Efficacy and Safety of Circadin® 2 mg in the Treatment of Insomnia Patients With Low Endogenous Melatonin|Completed||Phase 3|930|Actual|Neurim Pharmaceuticals Ltd.||2|||f||||||||||||||2017-02-18 16:07:03.994843|2017-02-18 16:07:03.994843
NCT00397176|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2007-12-19|||November 2006||2006-11-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women|Ascending, Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of DVS SR Administered Orally to Healthy Japanese Female Subjects|Completed||Phase 1|32||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:07:04.414208|2017-02-18 16:07:04.414208
NCT00397163|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2016-05-16|||December 2010||2010-12-01|May 2016|2016-05-01|November 2016|Anticipated|2016-11-01|July 2016|Anticipated|2016-07-01||Interventional|||Effect of Remote Ischemic Preconditioning in Patient Undergoing Cardiac Bypass Surgery|A Clinical Study Investigating Ischemic Preconditioning in Type II Diabetic Patients Undergoing Coronary Artery Bypass Graft Surgery.|Recruiting||Phase 1|200|Anticipated|University College London Hospitals||2|||f||||t||||||||||2017-02-18 16:07:04.489394|2017-02-18 16:07:04.489394
NCT00397150|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2015-02-20|2012-12-18||November 2006||2006-11-01|February 2015|2015-02-01|April 2011|Actual|2011-04-01|July 2008|Actual|2008-07-01||Interventional|||PROMISE EBF: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV in Sub-Saharan Africa|PROMISE EBF: Promoting Infant Health and Nutrition in Sub-Saharan Africa: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV|Completed||N/A|2579|Actual|Centre For International Health|Trial not entirely blinded.|2|||f||||f||||||||||2017-02-18 16:07:04.611884|2017-02-18 16:07:04.611884
NCT00397137|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2006-11-07|||September 2000||2000-09-01|November 2006|2006-11-01|December 2003||2003-12-01|||||Interventional|||Stapled Anopexy Versus Closed Haemorrhoidectomy for Haemorrhoids|Prospective Randomized Multi-Centre Trial Comparing the Clinical Efficacy, Safety and Patient Acceptability of Circular Stapled Anopexy With Closed Diathermy Haemorrhoidectomy for Haemorrhoids|Completed||N/A|182||University of Dundee|||||f||||||||||||||2017-02-18 16:07:05.10834|2017-02-18 16:07:05.10834
NCT00397124|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2006-11-07|||April 2002||2002-04-01|November 2006|2006-11-01||||||||Interventional|||The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients|Does the Vagus Nerve Play a Role in Tumor-to-Brain Communication? a Preliminary Study in Patients With Newly Diagnosed Lung Cancer|Unknown status|Recruiting|N/A|40||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:07:05.203162|2017-02-18 16:07:05.203162
NCT00397111|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2017-01-24|||November 3, 2006||2006-11-03|October 24, 2016|2016-10-24||||||||Observational|||Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders|Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders|Recruiting||N/A|280|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:07:05.275085|2017-02-18 16:07:05.275085
NCT00397098|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2009-03-10|||November 2006||2006-11-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|VEGA||Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder|A Double-Blind Randomized Withdrawal Study Evaluating the Efficacy and Safety of SR58611A Versus Placebo in the Prevention of Relapse of Anxiety up to 1 Year in Patients With GAD Improved After 12 Weeks of Open Label Treatment With SR58611A.|Terminated||Phase 3|257|Actual|Sanofi||||reprioritization of indications|f||||||||||||||2017-02-18 16:07:05.381075|2017-02-18 16:07:05.381075
NCT00397072|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2014-04-16|||June 2006||2006-06-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Epothilone in Recurrent Glioblastoma Patients|Phase II Study: Systemic Treatment With iv ZK219477-Epothilone in Recurrent Glioblastoma Patients|Completed||Phase 2|15|Actual|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta||1|||f||||||||||||||2017-02-18 16:07:05.489908|2017-02-18 16:07:05.489908
NCT00397059|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2008-02-05|||December 2006||2006-12-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Pupillary Changes as a Potential Biomarker for Escitalopram in Relation to CYP2C19 Polymorphism|Pupillary Changes as a Potential Biomarker for Escitalopram in Relation to CYP2C19 Polymorphism|Completed||Phase 4|16|Anticipated|University of Southern Denmark|||||f||||||||||||||2017-02-18 16:07:05.600346|2017-02-18 16:07:05.600346
NCT00397046|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2012-05-10|||November 2006||2006-11-01|May 2012|2012-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors|An Ascending and Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of HKI-272 Administered Orally to Japanese Subjects With Advanced Solid Tumors|Completed||Phase 1|21|Actual|Puma Biotechnology, Inc.||1|||f||||||||||||||2017-02-18 16:07:05.693175|2017-02-18 16:07:05.693175
NCT00397033|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2013-07-23|2009-03-16||November 2006||2006-11-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Two Dosages of Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder.|Completed||Phase 3|316|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 16:07:06.018984|2017-02-18 16:07:06.018984
NCT00397020|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2009-06-03|||December 2006||2006-12-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes|A Single-Blind, Randomized, Naturalistic Pilot Study, Comparison of Divalproex ER and Quetiapine for Adults With Acute Mania or Mixed Episodes|Completed||Phase 4|39|Actual|University of California, San Diego||2|||f||||f||||||||||2017-02-18 16:07:07.066851|2017-02-18 16:07:07.066851
NCT00397007|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2008-05-08|||May 2005||2005-05-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|||||Interventional|||Psychophysiological Treatment of Chronic Tinnitus|Evaluation of Psychological and Psychophysiological Effects of a Biofeedback-Based Cognitive-Behavioral Psychotherapy for Chronic Tinnitus-Sufferers|Completed||Phase 2|130|Anticipated|Philipps University Marburg Medical Center|||||f||||||||||||||2017-02-18 16:07:07.192007|2017-02-18 16:07:07.192007
NCT00396994|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2013-03-18|||February 2007||2007-02-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||"VIBES--Low Magnitude Mechanical Stimulation to Improve Bone Mineral Density"|Low Magnitude Mechanical Stimulation (LMMS) to Improve Bone Mineral Density (BMD)|Completed||N/A|174|Actual|Hebrew Rehabilitation Center, Boston||2|||f||||t||||||||||2017-02-18 16:07:07.290684|2017-02-18 16:07:07.290684
NCT00396981|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2016-01-19|2013-02-07||March 2007||2007-03-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|January 2011|Actual|2011-01-01||Interventional|MAPS||MAPS Trial: Matrix And Platinum Science|A Prospective, Randomized, Multicenter Trial Investigating Matrix 2® and GDC® Detachable Coils for the Treatment of Intracranial Saccular Aneurysms|Completed||Phase 4|626|Actual|Stryker Neurovascular||2|||f||||t||||||||||2017-02-18 16:07:07.417411|2017-02-18 16:07:07.417411
NCT00396968|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2014-02-10||||||February 2014|2014-02-01||||||||Interventional|||AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS|AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes|Withdrawn||Phase 1/Phase 2|0|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:07:08.989607|2017-02-18 16:07:08.989607
NCT00396955|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2007-12-19|||November 2006||2006-11-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee|A Multicenter, Randomized, Double-Blind Comparison of 4 Dose Regimens of Pla-695, Naproxen, and Placebo Administered Daily for 6 Weeks in Subjects With Active Osteoarthritis of the Knee|Terminated||Phase 2|560||Wyeth is now a wholly owned subsidiary of Pfizer||||imbalance of gastrointestinal and the lipase events|||||||||||||||2017-02-18 16:07:09.084221|2017-02-18 16:07:09.084221
NCT00396942|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2017-01-24|||November 2, 2006||2006-11-02|October 3, 2008|2008-10-03|October 3, 2008||2008-10-03|||||Observational|||Motor Skill Learning in People With Parkinson's Disease|Evaluation of the Plasticity of the Primary Motor Cortex and Motor Learning in Parkinson's Disease|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:07:09.264458|2017-02-18 16:07:09.264458
NCT00396929|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2007-05-15|||August 2005||2005-08-01|May 2007|2007-05-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Efficiency of a New Therapy to Treat Stenosis of Coronary Vessels in Comparison With Two Already Admitted Therapies|Local-Tax Trial: Local Intracoronary Administration of Paclitaxel After Stent Implantation for Prevention of Restenosis in Comparison With Stent Implantation Alone and With Implantation of a Paclitaxel-Eluting Stent|Unknown status|Active, not recruiting|Phase 3|204|Anticipated|University Hospital Tuebingen||3|||f||||t||||||||||2017-02-18 16:07:09.350198|2017-02-18 16:07:09.350198
NCT00396916|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2007-04-10|||December 2004||2004-12-01|April 2007|2007-04-01||||||||Interventional|||Hybrid PET/CT in Cancer Patients|The Value of Novel Imaging Modality, Hybrid PET/CT, Using F18-Flurodeoxyglucose(FDG) in the Assessment of Cancer Patients. Impact of PET/CT on Clinical Management of Patients With Rising Tumor Markers and no Other Evidence of Disease and in Patients With Metastatic Cancer of Unknown Origin|Completed||N/A|45||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:07:09.455866|2017-02-18 16:07:09.455866
NCT00006135|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||June 1997||1997-06-01|December 2003|2003-12-01||||||||Interventional|||Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth||Completed||Phase 3|66||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:27.259567|2017-02-18 18:13:27.259567
NCT00396877|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2014-10-14|2011-02-15||November 2006||2006-11-01|October 2014|2014-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|CLARINET||Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation|International Randomized Double Blind Study Evaluating the Efficacy and the Safety of Clopidogrel 0.2 mg/kg Once Daily Versus Placebo in Neonates and Infants With Cyanotic Congenital Heart Disease Palliated With Systemic to Pulmonary Artery Shunt|Completed||Phase 3|906|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:07:09.722046|2017-02-18 16:07:09.722046
NCT00396864|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2014-08-11|||May 2006||2006-05-01|August 2014|2014-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma|Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma|Completed||Phase 1|51|Actual|Triphase Research and Development I Corporation||1|||f||||f||||||||||2017-02-18 16:07:11.997229|2017-02-18 16:07:11.997229
NCT00396851|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2006-11-06|||January 2007||2007-01-01|November 2006|2006-11-01||||||||Interventional|||Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes||Unknown status|Not yet recruiting|N/A|100||Postgraduate Institute of Medical Education and Research|||||f||||||||||||||2017-02-18 16:07:12.101688|2017-02-18 16:07:12.101688
NCT00396838|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2008-10-11|||November 2006||2006-11-01|March 2008|2008-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Cardiac Autonomic Reactivity and Behavioral Response to Pain in Full-Term Neonates|Cardiac Autonomic Reactivity and Behavioral Response to Pain in Full-Term Neonates|Completed||N/A|300|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:07:12.187479|2017-02-18 16:07:12.187479
NCT00396825|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2012-08-10|||January 2007||2007-01-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Video-Based Coping Skills Training for Caregivers|Phase II Trial of a Video That Presents Training in Stress Coping Skills for Caregivers of a Relative With Alzheimer's Disease or Other Dementia|Completed||Phase 2|116|Actual|Williams LifeSkills||2|||f||||t||||||||||2017-02-18 16:07:12.263903|2017-02-18 16:07:12.263903
NCT00396812|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2013-02-06|2012-10-11||November 2006||2006-11-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)|An Open Label, Single Arm, Single Center, Phase I/II Trial of Rituximab (a Monoclonal Antibody to CD20) for the Treatment of Early Rheumatoid Arthritis|Terminated||Phase 1/Phase 2|4|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The trial terminated early due to rituximab’s risk-benefit ratio for individuals with early active Rheumatoid Arthritis. Mechanistic samples were not processed and corresponding endpoints were not assessed. Only descriptive statistics are presented.|1||The perceived risk-benefit ratio for individuals with early active RA|f||||||||||||||2017-02-18 16:07:12.378085|2017-02-18 16:07:12.378085
NCT00396799|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-07|2007-03-12|||November 2006||2006-11-01|March 2007|2007-03-01|November 2006||2006-11-01|||||Interventional|||Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women|An Open-Label, Single-Dose, Randomized-to-Sequence, 2-Period, Crossover, Pivotal Bioequivalence Study Between Bazedoxifene Acetate/Conjugated Estrogens (Premarin Current Process) and Bazedoxifene Acetate/Conjugated Estrogens (Premarin New Process) Tablets Administered to Healthy Postmenopausal Women|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:07:12.733563|2017-02-18 16:07:12.733563
NCT00396786|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2014-10-27|||November 2004||2004-11-01|October 2014|2014-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|ODIXaHIP-OD||Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement|Controlled, Double-Blind, Randomized, Dose-ranging Study of Once-daily Regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement- ODIXaHIP-OD|Completed||Phase 2|877|Actual|Bayer||6|||f||||t||||||||||2017-02-18 16:07:12.82098|2017-02-18 16:07:12.82098
NCT00396773|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2006-11-08|||February 2007||2007-02-01|November 2006|2006-11-01|January 2008|Anticipated|2008-01-01|||||Observational|||Neonatal Brain Waves After Electrocoagulation|Neonatal Brain Waves After Electrocoagulation|Unknown status|Not yet recruiting|Early Phase 1|60|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:07:13.008417|2017-02-18 16:07:13.008417
NCT00396760|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2006-11-06|||January 2005||2005-01-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery|The Influence of High-Dose Aprotinin and Tranexamic Acid on Bleeding Tendency and Allogeneic Blood Transfusion in Patients Undergoing Primary Aortic Valve Replacement or Coronary Artery Revascularization|Unknown status|Active, not recruiting|Phase 3|220||German Heart Center|||||f||||||||||||||2017-02-18 16:07:13.083401|2017-02-18 16:07:13.083401
NCT00396747|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2007-10-18|||June 2003||2003-06-01|October 2007|2007-10-01|September 2005|Actual|2005-09-01|||||Interventional|||A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study|Phase IV Study of Early RA: a Randomized Magnetic Resonance Imaging Study Comparing the Effects of Methotrexate Alone or in Combination With Infliximab or Intravenous Pulse Methylprednisolone|Completed||Phase 4|45|Actual|Université Catholique de Louvain||3|||f||||t||||||||||2017-02-18 16:07:13.180784|2017-02-18 16:07:13.180784
NCT00396734|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2010-06-09|||April 2007||2007-04-01|June 2010|2010-06-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|||The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence.|The Effects of Modafinil and Topiramate on Brain Mechanisms Underlying Cue-induced Cocaine Craving and Dependence in Methadone Maintained Cocaine Dependent Patients.|Suspended||N/A|40|Anticipated|Hadassah Medical Organization||1||Grant was not renewed|f||||t||||||||||2017-02-18 16:07:13.280363|2017-02-18 16:07:13.280363
NCT00396721|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2011-09-14|||January 2006||2006-01-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|SIREPNA||Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy|Pilot Trial of Treatment of Poor-Prognosis IgA Nephropathy With Low Exposure to Sirolimus.|Completed||Phase 2|23|Actual|Hospital Universitari de Bellvitge||2|||f||||t||||||||||2017-02-18 16:07:13.386518|2017-02-18 16:07:13.386518
NCT00396708|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2010-02-02|||August 2006||2006-08-01|February 2010|2010-02-01||||December 2007|Actual|2007-12-01||Interventional|||Wearable Robotic Functional Assistance for Stroke Rehabilitation|Wearable Robotic Functional Assistance for Stroke Rehabilitation|Completed||N/A|20|Anticipated|Myomo|||||f||||||||||||||2017-02-18 16:07:13.497907|2017-02-18 16:07:13.497907
NCT00396682|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2009-02-03|||February 2007||2007-02-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma|Elimination of CD4+CD25+ Regulatory T Cells in Patients With Advanced HCC After Treatment With Cyclophosphamide|Completed||Phase 3|12|Anticipated|Hannover Medical School||1|||f||||||||||||||2017-02-18 16:07:13.707761|2017-02-18 16:07:13.707761
NCT00396669|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2012-03-26|||July 2007||2007-07-01|March 2012|2012-03-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.|A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers, Using 11 C Raclopride in Positron Emission Tomography (PET)|Unknown status|Recruiting|N/A|24|Anticipated|Hadassah Medical Organization||1|||f||||t||||||||||2017-02-18 16:07:13.800266|2017-02-18 16:07:13.800266
NCT00396656|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2011-05-05|2011-01-07||December 2005||2005-12-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients|A Randomized, Open-label, Multicenter, Cross-over Trial to Evaluate the Efficacy of a 20 Week Treatment of Valsartan 320 mg Versus Atenolol 100 mg in Combination With Hydrochlorothiazide on Microcirculation in Hypertensive Patients|Completed||Phase 3|30|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:07:13.913122|2017-02-18 16:07:13.913122
NCT00396643|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2007-12-20|||May 2004||2004-05-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis|Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis: A Randomised, Double Blind, Placebo-Controlled Treatment Trial|Completed||Phase 4|81|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 16:07:14.242101|2017-02-18 16:07:14.242101
NCT00396630|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2016-11-03|2009-02-13||January 2007||2007-01-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.|A Phase IIIb, Randomized, Double-Blind, Placebo-Controlled Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.|Completed||Phase 3|200|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:07:14.486464|2017-02-18 16:07:14.486464
NCT00396617|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2012-06-28|||December 2007||2007-12-01|June 2012|2012-06-01|March 2014|Anticipated|2014-03-01|September 2013|Anticipated|2013-09-01||Interventional|||Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy|Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy|Unknown status|Recruiting|Phase 1|14|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-02-18 16:07:14.891146|2017-02-18 16:07:14.891146
NCT00396604|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2011-10-24|||October 2006||2006-10-01|October 2011|2011-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Double-dummy, Active (Formoterol 12 µg b.i.d) and Placebo Controlled, Multi-center, 5 Period Crossover Study to Assess the Bronchodilatory Efficacy and Safety of Single Doses of Indacaterol 150 µg, 300 µg and 600 µg Delivered Via Single Dose Dry Powder Inhaler vs. Placebo in Patients With Moderate to Severe COPD.|Completed||Phase 2/Phase 3|51|Actual|Novartis|||||f||||||||||||||2017-02-18 16:07:14.979377|2017-02-18 16:07:14.979377
NCT00396591|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2013-01-09|2012-08-17||October 2006||2006-10-01|July 2011|2011-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites|A Multicenter, Open-label, Single-arm Study of the Efficacy and Safety of Intravenous AVE0005 (VEGF Trap) Administered Every 2 Weeks in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites|Completed||Phase 2|16|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:07:15.076819|2017-02-18 16:07:15.076819
NCT00396578|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2006-11-06|||August 2003||2003-08-01|November 2006|2006-11-01|September 2004||2004-09-01|||||Interventional|||Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation|Aerosolized Antibiotics in Mechanically Ventilated Patients|Completed||Phase 2|80||Stony Brook University|||||f||||||||||||||2017-02-18 16:07:15.748887|2017-02-18 16:07:15.748887
NCT00396565|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2014-04-10|2012-03-27||July 2006||2006-07-01|April 2014|2014-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia|A Placebo-Controlled Double Blind Comparative Study of JNS007ER in Patients With Schizophrenia|Completed||Phase 3|394|Actual|Janssen Pharmaceutical K.K.||3|||f||||||||||||||2017-02-18 16:07:15.858739|2017-02-18 16:07:15.858739
NCT00396552|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2013-02-14|||June 2006||2006-06-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Treating Refractory Obsessive Compulsive Disorder With rTMS|Treating Refractory Obsessive Compulsive Disorder With Repetitive Transcranial Magnetic Stimulation: A Double-blind Sham Controlled Longitudinal Study|Completed||N/A|19|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 16:07:16.566973|2017-02-18 16:07:16.566973
NCT00395889|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2011-02-18|||November 2006||2006-11-01|February 2011|2011-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Physical Activities in Daily Life After Lung Transplantation|Effects of a 6-month Outpatient Rehabilitation Program Including Structured Exercise Training on Participation in Physical Activities in Daily Life in Lung Transplant Recipients|Completed||Phase 1|40|Actual|Katholieke Universiteit Leuven||2|||f||||f||||||||||2017-02-18 16:07:16.682943|2017-02-18 16:07:16.682943
NCT00395876|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2010-07-14|2010-07-14||November 2006||2006-11-01|July 2010|2010-07-01||||June 2008|Actual|2008-06-01||Interventional|TROPICS 1||A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters|Completed||Phase 3|100|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:07:16.820316|2017-02-18 16:07:16.820316
NCT00395863|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2015-03-24|2009-03-30||November 2006||2006-11-01|March 2015|2015-03-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Multihance at 3 Tesla in Brain Tumors|A Phase IV Double-blind Multicenter Randomized Crossover Study to Compare 0.10 mmol/kg of Multihance With 0.10 mmol.kg of Magnevist in Magnetic Resonance Imaging(MRI) of the Brain at 3T|Completed||Phase 4|46|Actual|Bracco Diagnostics, Inc||2|||f||||f||||||||||2017-02-18 16:07:17.435559|2017-02-18 16:07:17.435559
NCT00395824|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2006-11-02|||January 2005||2005-01-01|November 2006|2006-11-01|September 2005||2005-09-01|||||Interventional|||Citrate Anticoagulation vs. Heparin-Coated Dialyzers|Heparin-Coated Polyacrylonitrile Membrane Versus Regional Citrate Anticoagulation: a Prospective Randomised Study of 2 Anticoagulation Strategies in Patients at Risk of Bleeding|Completed||Phase 3|33||Universitaire Ziekenhuizen Leuven|||||f||||||||||||||2017-02-18 16:07:19.124849|2017-02-18 16:07:19.124849
NCT00395811|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2008-10-28|||January 2007||2007-01-01|October 2008|2008-10-01|June 2009|Anticipated|2009-06-01|April 2009|Anticipated|2009-04-01||Interventional|||Stem Cell Therapy to Improve Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting (CABG)||Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Anticipated|China National Center for Cardiovascular Diseases||1|||f||||t||||||||||2017-02-18 16:07:19.216608|2017-02-18 16:07:19.216608
NCT00395798|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2011-07-03|||January 2004||2004-01-01|May 2006|2006-05-01|August 2007||2007-08-01|||||Interventional|||Effect of Cervical Collar in Cervical Radicular Pain.|Effect of Conservative Treatment With Cervical Collar in Patients With Cervical Radiculopathy and Radicular Pain. A Randomized Controlled Study|Completed||Phase 2|120||Oslo University Hospital|||||f||||||||||||||2017-02-18 16:07:19.314212|2017-02-18 16:07:19.314212
NCT00395785|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2007-07-20|||November 2006||2006-11-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting|Protection During Carotid Stenting in High Risk Patients With the TriActiv ProGuard System|Terminated||Phase 2/Phase 3|400|Anticipated|Kensey Nash Corporation||||Sponsor elected to not pursue this indication for the study device.|f||||||||||||||2017-02-18 16:07:19.397318|2017-02-18 16:07:19.397318
NCT00395772|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2014-10-27|||December 2004||2004-12-01|October 2014|2014-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis|Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis The Einstein-DVT Dose-finding Study. A Phase II Evaluation.|Completed||Phase 2|543|Actual|Bayer||4|||f||||||||||||||2017-02-18 16:07:19.521405|2017-02-18 16:07:19.521405
NCT00395759|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2007-10-21|||September 2005||2005-09-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||The Visual Effect of an Investigational Artificial Tear in the Tear Layer.|The Visual Effect of an Investigational Artificial Tear in the Tear Layer.|Completed||N/A|30||Southern California College of Optometry|||||f||||||||||||||2017-02-18 16:07:22.434639|2017-02-18 16:07:22.434639
NCT00395746|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2014-11-17|2010-02-23||October 2006||2006-10-01|November 2014|2014-11-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Liraglutide in Combination With Sulfonylurea (SU) on Glycaemic Control in Subjects With Type 2 Diabetes|Completed||Phase 3|264|Actual|Novo Nordisk A/S||4|||f||||f||||||||||2017-02-18 16:07:22.546884|2017-02-18 16:07:22.546884
NCT00395733|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2013-11-25|2011-07-05||October 2006||2006-10-01|November 2013|2013-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients|A Single-blind, Intra-individual, Crossover, Multicenter Study of the Efficacy, Safety and Tolerability of Gadavist (1.0 M) in Comparison With Magnevist (0.5 M) as Contrast Agent in the Enhanced Magnetic Resonance Angiography (MRA) in Chinese Patients|Completed||Phase 3|83|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:07:23.871609|2017-02-18 16:07:23.871609
NCT00395720|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2011-03-25|||November 2006||2006-11-01|March 2011|2011-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV|A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Are Infected With HIV|Completed||Phase 1|20|Anticipated|University of Oxford||2|||f||||t||||||||||2017-02-18 16:07:24.440317|2017-02-18 16:07:24.440317
NCT00395707|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2009-02-06|||August 2005||2005-08-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration|Phase I Study Of Intravitreal Ranibizumab (Lucentis) For The Treatment Of Stage 1 And 2 Retinal Angiomatous Proliferations|Completed||Phase 1/Phase 2|20|Anticipated|The National Retina Institute||2|||f||||||||||||||2017-02-18 16:07:24.557685|2017-02-18 16:07:24.557685
NCT00395694|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2013-04-11|2012-08-16||August 2006||2006-08-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Clinical Evaluation of BW430C in Epilepsy|Clinical Evaluation of BW430C in Epilepsy<Phase III Study>|Completed||Phase 3|102|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:07:24.69288|2017-02-18 16:07:24.69288
NCT00395681|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2010-10-21|||September 2007||2007-09-01|November 2006|2006-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Population PK/PD of Propofol in the Morbidly Obese Patient|Population Pharmacokinetics and Pharmacodynamics of Propofol in the Morbidly Obese Patient|Completed||Phase 4|20|Actual|St. Antonius Hospital||2|||f||||||||||||||2017-02-18 16:07:25.513885|2017-02-18 16:07:25.513885
NCT00396539|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2009-02-01|||January 2007||2007-01-01|November 2006|2006-11-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Observational|||Hydrogen Sulfide Production by Oral Microflora|Detection of Hydrogen Sulfide Production by Oral Microflora Samples|Completed||N/A|60|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:07:25.614155|2017-02-18 16:07:25.614155
NCT00396526|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-04|2006-12-05|||April 2004||2004-04-01|December 2006|2006-12-01|April 2006||2006-04-01|||||Interventional|||ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia|Effectiveness of 3 Day Amoxycillin Versus 5 Day co-Trimoxazole in the Treatment of Non-Severe Pneumonia in Children Aged 2- 59 Months of Age: - A Multi-Centric Open Labeled Trial|Completed||Phase 3|2000||King George's Medical University|||||f||||||||||||||2017-02-18 16:07:25.693273|2017-02-18 16:07:25.693273
NCT00396513|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2006-11-03|||September 2005||2005-09-01|November 2006|2006-11-01||||||||Interventional|||Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.|Effect of Simvastatin and Metformin on Clinical, Endocrine, Metabolic and Endothelial Function of Women With Polycystic Ovary Syndrome: Prospective Randomised Trial|Unknown status|Recruiting|N/A|||Poznan University of Medical Sciences|||||f||||||||||||||2017-02-18 16:07:25.782467|2017-02-18 16:07:25.782467
NCT00396500|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-04|2006-11-06|||April 1994||1994-04-01|November 2006|2006-11-01|December 1996||1996-12-01|||||Interventional|||Deworming and Vitamin A (DEVTA) Prepilot Study|To Assess the Effectiveness of Six-Monthly Deworming With Vitamin A Administration on Growth in 1-5 Year Old Children in the Urban Slums of Lucknow|Completed||Phase 3|4000||King George's Medical University|||||f||||||||||||||2017-02-18 16:07:25.86826|2017-02-18 16:07:25.86826
NCT00396487|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2015-06-10|||November 2006||2006-11-01|June 2015|2015-06-01|February 2008|Actual|2008-02-01|||||Interventional|||Tailored Treatment in Metastatic Colorectal Cancer|Tailored Treatment of Metastatic Colorectal Cancer Based on Genetic Markers|Terminated||Phase 3|1|Actual|Vejle Hospital||||Only one patient included as per Feb. 4, 2008.|f||||||||||||||2017-02-18 16:07:25.963366|2017-02-18 16:07:25.963366
NCT00396474|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2015-04-21|||January 2009||2009-01-01|April 2015|2015-04-01|January 2012|Anticipated|2012-01-01|||||Observational|||Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height|Long-Term Metabolic Risk In Small for Gestational Age (SGA) Patients After Growth Hormone Treatment Compared To Matched, Untreated Controls|Withdrawn||Phase 4|0|Actual|Pfizer|||1|Study design no longer relevant and no patients were recruited.|f||||f||||||Samples Without DNA|"~     whole blood, serum~   "|||2017-02-18 16:07:26.067398|2017-02-18 16:07:26.067398
NCT00396461|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2013-07-18|||November 2006||2006-11-01|July 2013|2013-07-01|February 2011|Actual|2011-02-01|September 2010|Actual|2010-09-01||Interventional|ICULIP||ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients|Phase IV-IV. ICULIP,a Prospective,Multi-centre,Randomised,Comparative,Double-blind Study to Evaluate Two Different Types of Lipid Emulsions Used for Total Parenteral Nutrition in Critical Patients and Their Influence on Nosocomial Infection.|Terminated||Phase 4|212|Anticipated|B. Braun Medical SA||2|||f||||||||||||||2017-02-18 16:07:26.168031|2017-02-18 16:07:26.168031
NCT00396448|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2012-11-05||2009-08-11|February 2007||2007-02-01|November 2012|2012-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.|A 2-Year, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study To Evaluate The Long-Term Efficacy And Safety Of CP-945,598 In The Treatment Of Obese Subjects|Terminated||Phase 3|1253|Actual|Pfizer||3||See termination reason in detailed description.|f||||t||||||||||2017-02-18 16:07:26.319798|2017-02-18 16:07:26.319798
NCT00396435|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2010-05-26|||April 2004||2004-04-01|May 2010|2010-05-01|May 2010|Actual|2010-05-01|April 2009|Actual|2009-04-01||Interventional|||Correction of Anaemia and Progression of Renal Failure on Transplanted Patients|Multicenter, Prospective, Randomised, Open-label Study, Evaluating the Effect of Two Levels of Haemoglobin on Quality of Life and Speed of Progression of Renal Insufficiency on Renal Transplanted Patients With Chronic Graft Dysfunction (CGD)|Completed||Phase 4|128|Anticipated|Centre Hospitalier Universitaire, Amiens||2|||f||||f||||||||||2017-02-18 16:07:26.488474|2017-02-18 16:07:26.488474
NCT00396422|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2011-02-17|||September 2006||2006-09-01|February 2011|2011-02-01|March 2007|Actual|2007-03-01|||||Interventional|||Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis|A Phase IIa Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multi-Center, Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RWJ-445380 Administered to Patients With Plaque Psoriasis|Completed||Phase 2|60|Actual|Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:07:26.618137|2017-02-18 16:07:26.618137
NCT00396409|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-06|2011-05-05|2010-11-22||February 2006||2006-02-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis|A Randomized, 20 Week, Double-blind, Placebo-controlled, Parallel-group, Multiple-dose, Multicenter Study to Assess the Efficacy and Safety of Omalizumab in Combination With Depigoid, Versus Depigoid Only, in Adult and Adolescent Patients With Seasonal Allergic Asthma and Comorbid Seasonal Allergic Rhinoconjunctivitis - Open-label Depigoid Monotherapy Extension Periods 2007 and 2008-|Completed||Phase 3|128|Actual|Novartis|Study Start Date: February 2006 (core study)|2|||f||||||||||||||2017-02-18 16:07:26.721695|2017-02-18 16:07:26.721695
NCT00396396|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2006-11-03|||October 2006||2006-10-01|November 2006|2006-11-01||||||||Interventional|||Role of Acetylcysteine in Creatinine Clearance||Unknown status|Recruiting|N/A|35||Eastern Virginia Medical School|||||f||||||||||||||2017-02-18 16:07:28.247832|2017-02-18 16:07:28.247832
NCT00396383|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2014-02-10|2009-02-11||November 2004||2004-11-01|February 2014|2014-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation|Treatment With AMD3100 in Multiple Myeloma Patients to Mobilize Peripheral Blood Progenitor Cells For Collection and for Transplantation|Terminated||Phase 2|9|Actual|Sanofi|Study had limited enrollment prior to termination.|1||Insufficient cell mobilization for tandem transplants|f||||t||||||||||2017-02-18 16:07:28.326892|2017-02-18 16:07:28.326892
NCT00396370|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2013-09-12|||December 2008||2008-12-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||BCG Vaccination Delivered Intradermally, Orally and by Combined Routes|Phase I Studies of the Safety and Immunogenicity of Primary and Secondary BCG Vaccination Delivered Intradermally, Orally and by Combined Routes of Administration in Healthy and Previously Immunologically Naïve Volunteers|Completed||Phase 1|69|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-02-18 16:07:28.638313|2017-02-18 16:07:28.638313
NCT00396357|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2012-12-28||2012-12-28|October 2006||2006-10-01|December 2012|2012-12-01||||June 2008|Actual|2008-06-01||Interventional|||Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone|A Multicenter, Double-blind, Randomized Parallel-group, Study to Demonstrate the Effect of 24 Weeks Treatment With Vildagliptin 100 mg qd as add-on to Metformin 500 mg Bid Compared to Metformin 1000 mg Bid in Patients With Type 2 Diabetes Inadequately Controlled on Metformin 500 mg Bid Monotherapy|Completed||Phase 3|914|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:07:28.756284|2017-02-18 16:07:28.756284
NCT00396344|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2008-05-06|||October 2006||2006-10-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Cortisol Control of Human Inflammatory Responses to Endotoxin|The Effect of Glucocorticoid Pre-Treatment on the Systemic Cytokine Response to Endotoxin in Human Volunteers|Completed||N/A|36|Anticipated|Dartmouth-Hitchcock Medical Center||3|||f||||||||||||||2017-02-18 16:07:28.864918|2017-02-18 16:07:28.864918
NCT00396331|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2014-02-10|2010-11-02||October 2005||2005-10-01|February 2014|2014-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts|A Phase 2, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of AMD3100 (240 µg/kg) Added to a G-CSF Mobilization Regimen in Poor Mobilizing Adult Patients Who Have Previously Failed Stem Cell Collection/Attempts|Completed||Phase 2|100|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:07:28.97787|2017-02-18 16:07:28.97787
NCT00396318|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2011-03-29|2010-09-19||December 2006||2006-12-01|March 2011|2011-03-01||||June 2008|Actual|2008-06-01||Interventional|TROPICS 2||A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters|A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters|Completed||Phase 3|251|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 16:07:30.373008|2017-02-18 16:07:30.373008
NCT00396305|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2010-08-26|||November 2006||2006-11-01|May 2010|2010-05-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Interventional|||Th1 Response to Influenza: Aging and Vaccine Efficacy|Th1 Response to Influenza: Aging and Vaccine Efficacy|Terminated||Phase 4|41|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:07:30.70255|2017-02-18 16:07:30.70255
NCT00396292|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2013-10-15|2013-10-15||February 2005||2005-02-01|October 2013|2013-10-01|February 2006|Actual|2006-02-01|November 2005|Actual|2005-11-01||Interventional|||Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia|Comparison of the Safety and Efficacy of Intravenous Iron vs Oral Iron in Subjects Who Display Postpartum Anemia|Completed||Phase 3|361|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:07:30.816462|2017-02-18 16:07:30.816462
NCT00396279|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2014-07-11|2014-01-23||July 2006||2006-07-01|July 2014|2014-07-01|February 2011|Actual|2011-02-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone|An Open-Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162) in Subjects With Recurrent or Unresectable Giant Cell Tumor (GCT) of Bone|Completed||Phase 2|37|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:07:31.481926|2017-02-18 16:07:31.481926
NCT00396266|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2014-02-04|2010-10-30||January 2005||2005-01-01|February 2014|2014-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF|Treatment With AMD3100 in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF|Completed||Phase 2|22|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:07:32.020613|2017-02-18 16:07:32.020613
NCT00396253|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-11-25|2010-03-25||November 2006||2006-11-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|TROPICS 4||A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters|A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters|Completed||Phase 3|223|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 16:07:32.706624|2017-02-18 16:07:32.706624
NCT00396240|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2009-03-25|||February 2002||2002-02-01|March 2009|2009-03-01||||||||Interventional|||ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals|ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals|Withdrawn||Phase 4|1294||AstraZeneca||||study cancelled prior to FSI|f||||||||||||||2017-02-18 16:07:33.095563|2017-02-18 16:07:33.095563
NCT00396227|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-11-16|||October 2006||2006-10-01|November 2016|2016-11-01||||October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone|A Multi-center, Randomized, Open-label, Active Controlled, Parallel Arm Study to Compare the Efficacy of 12 Weeks of Treatment With Vildagliptin 100 mg, qd to Thiazolidinedione (TZD) as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy in a Community-based Practice Setting.|Completed||Phase 3|2665|Actual|Novartis||2|||||||||||||||||2017-02-18 16:07:33.181511|2017-02-18 16:07:33.181511
NCT00396214|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2008-05-30|||April 2007||2007-04-01|May 2008|2008-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients|A Randomized, Multicenter, Double-Blind, Parallel Group Study To Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients|Terminated||Phase 3|83|Actual|Solvay Pharmaceuticals||3||This trial discontinued on 2 May 2008 due to lack of enrolment|f||||f||||||||||2017-02-18 16:07:33.3048|2017-02-18 16:07:33.3048
NCT00396201|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2014-02-10|2009-02-10||November 2004||2004-11-01|February 2014|2014-02-01|January 2008|Actual|2008-01-01|October 2006|Actual|2006-10-01||Interventional|||AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease|Treatment With AMD3100 Added to a Mobilizing Regimen of G-CSF to Increase the Number of Peripheral Blood Stem Cells in Patients With Hodgkin's Disease|Completed||Phase 2|22|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:07:33.661125|2017-02-18 16:07:33.661125
NCT00396188|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2015-08-13|||February 2007||2007-02-01|August 2015|2015-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions|Corneal Analysis - Pathology Detection Aid|Completed||Phase 1|769|Actual|Carl Zeiss Meditec, Inc.|||6||f||||t||||||||||2017-02-18 16:07:34.061659|2017-02-18 16:07:34.061659
NCT00396175|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2014-09-25|||March 1998||1998-03-01|September 2014|2014-09-01||||January 2000|Actual|2000-01-01||Interventional|||Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)|A Double-Blind, Placebo-Controlled, Multicenter Study To Examine the Effects of Finasteride 1 MG on Serum Prostate-Specific Antigen in Men With Androgenetic Alopecia|Completed||Phase 3|355||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 16:07:34.163799|2017-02-18 16:07:34.163799
NCT00396162|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-08-11|2015-05-28||November 2006||2006-11-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis|Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis|Completed||Phase 4|77|Actual|University of Michigan||2|||f||||||||||||||2017-02-18 16:07:34.257671|2017-02-18 16:07:34.257671
NCT00396149|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2013-06-26|||November 2006||2006-11-01|April 2009|2009-04-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1|A Phase I Study to Investigate the Safety, Tolerability and Pharmacodynamic Effects of SLIT(Tablets) With Recombinant Bet v1 Given in Single Rising Doses and in Higher Multi Dose Regimens to Subjects Sensitised to Birch Pollen|Completed||Phase 1|57|Actual|Stallergenes||2|||f||||f||||||||||2017-02-18 16:07:35.008996|2017-02-18 16:07:35.008996
NCT00396136|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2012-04-27|2012-02-22||October 2006||2006-10-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||COSMO Post Approval Registry: Corox OTW Steroid LV Lead Monitoring|Corox OTW Steroid LV Lead Monitoring|Completed||Phase 4|221|Actual|Biotronik, Inc.||1|||f||||||||||||||2017-02-18 16:07:35.125583|2017-02-18 16:07:35.125583
NCT00396123|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2011-04-15|||November 2006||2006-11-01|April 2011|2011-04-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Observational|||Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study|Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study|Unknown status|Active, not recruiting|N/A|15|Anticipated|University of Michigan|||1||f||||f||||||||||2017-02-18 16:07:35.351566|2017-02-18 16:07:35.351566
NCT00396110|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2006-11-03|||February 2003||2003-02-01|February 2003|2003-02-01||||||||Observational|||Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)|Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)|Completed||Phase 4|3889||AstraZeneca|||||f||||||||||||||2017-02-18 16:07:35.433521|2017-02-18 16:07:35.433521
NCT00396097|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-03-09|2013-08-30||December 2006||2006-12-01|March 2016|2016-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature|A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin|Completed||Phase 3|316|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:07:35.516543|2017-02-18 16:07:35.516543
NCT00396084|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2011-06-09|2008-11-19||February 2004||2004-02-01|March 2010|2010-03-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis|Randomized, Open Label, Multiple Dose Phase I Study of the Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, and Moxifloxacin in HIV-non-infected Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis|Completed||Phase 1/Phase 2|70|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The small sample size had limited power to detect small differences in EBA between study arms even though we enrolled patients with smear-positive TB and high sputum bacillary burden to improve chances of detecting differences between treatment arms.|6|||f||||||||||||||2017-02-18 16:07:36.21418|2017-02-18 16:07:36.21418
NCT00396071|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-11-16|||October 2006||2006-10-01|November 2016|2016-11-01||||November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin|A Single-center, Double-blind, Randomized, Placebo-controlled, Cross-over Study to Assess the Effect of Vildagliptin on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin|Completed||Phase 3|22|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:07:37.700577|2017-02-18 16:07:37.700577
NCT00396058|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2008-03-26|||November 2006||2006-11-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|||||Interventional|||The Effect of Methylphenidate on Motor Learning in Stroke Patients|Methylphenidats Betydning for motoriskindlæring Hos Patienter Med Apopleksi|Terminated||Phase 4|13|Anticipated|University of Aarhus||||Recruitment of patients proved much too difficult based on the chosen criteria.|f||||f||||||||||2017-02-18 16:07:37.818226|2017-02-18 16:07:37.818226
NCT00396045|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2006-11-29|||January 2005||2005-01-01|November 2006|2006-11-01|January 2008||2008-01-01|||||Interventional|||Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma|A Multicenter, Open Label Study of Oral Melphalan, Prednisone, and CC-5013 (Revlimid) (MPR) as Induction Therapy in Elderly Newly Diagnosed Multiple Myeloma Patients|Completed||Phase 1/Phase 2|54||University of Turin, Italy|||||f||||||||||||||2017-02-18 16:07:37.909071|2017-02-18 16:07:37.909071
NCT00396032|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2010-05-01|2010-03-24||October 2006||2006-10-01|May 2010|2010-05-01||||December 2008|Actual|2008-12-01||Interventional|TROPICS 3||A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters|Completed||Phase 3|150|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:07:38.02494|2017-02-18 16:07:38.02494
NCT00396019|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-02-24|||November 2006||2006-11-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Study of PEG-Intron for Plexiform Neurofibromas|A Phase II Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas|Active, not recruiting||Phase 2|82|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:07:38.498984|2017-02-18 16:07:38.498984
NCT00396006|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2015-06-26|2010-12-15||October 2006||2006-10-01|March 2011|2011-03-01||||December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)|The Effect of Augmentation Therapy With ARALAST Fraction IV-1 (ARALAST) Alpha1-Proteinase Inhibitor (α1-PI) on the Level of α1-PI and Other Analytes in the Bronchoalveolar (BAL) Epithelial Lining Fluid (ELF)|Completed||Phase 4|21|Actual|Baxalta US Inc.|Isoelectric focusing (IEF) analyses that were intended to compare the profile of plasma α1-PI & ELF α1-PI were not carried out due to fact that ELF samples were either missing, insufficient or too dilute for such assays.||||f||||||||||||||2017-02-18 16:07:38.599568|2017-02-18 16:07:38.599568
NCT00395993|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2013-09-16|2013-09-16||May 2005||2005-05-01|September 2013|2013-09-01|June 2006|Actual|2006-06-01|April 2006|Actual|2006-04-01||Interventional||16 of the 246 subjects randomized to FCM were discontinued prior to dosing and 5 of the 231 subjects randomized to oral iron were discontinued prior to dosing.|Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding|Comparison of the Safety and Efficacy of Intravenous Iron vs Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding|Completed||Phase 3|456|Actual|Luitpold Pharmaceuticals||2|||f||||||||||||||2017-02-18 16:07:41.678499|2017-02-18 16:07:41.678499
NCT00395980|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2008-12-11|||October 2006||2006-10-01|December 2008|2008-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Muscle Pressure in the Flank Position|Muscle Pressure in the Flank Position|Completed||N/A|20|Actual|University of California, Irvine||4|||f||||||||||||||2017-02-18 16:07:42.077959|2017-02-18 16:07:42.077959
NCT00395967|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2015-04-10|2009-01-27||April 2005||2005-04-01|April 2015|2015-04-01|August 2006|Actual|2006-08-01|July 2005|Actual|2005-07-01||Interventional|||AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone|Effect of AMD3100 (240µg/kg) on the Apheresis Yield of CD34+ Cells When Given To Multiple Myeloma or Non-Hodgkin's Lymphoma Patients Predicted to be Unable to Mobilize ≥2 x 10^6 CD34+ Cells in Three Apheresis Days When Given G-CSF Alone|Terminated||Phase 2|5|Actual|Sanofi|Limited enrollment due to early termination of the study.|1||Enrollment terminated in 2005 to focus on Phase 3 study enrollment.|f||||f||||||||||2017-02-18 16:07:42.152316|2017-02-18 16:07:42.152316
NCT00395954|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2009-02-13|||November 2006||2006-11-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Amount of Lactose Causing Symptoms in Lactose Intolerant People|A Study to Determine the Threshold of Lactose Ingestion That Provokes Symptoms in Lactose Intolerant People.|Completed||Early Phase 1|48|Anticipated|University Hospitals, Leicester|||||f||||||||||||||2017-02-18 16:07:42.474459|2017-02-18 16:07:42.474459
NCT00395941|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2006-11-03|||December 2006||2006-12-01|November 2006|2006-11-01||||||||Interventional|||Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis||Unknown status|Not yet recruiting|Phase 2|40||Postgraduate Institute of Medical Education and Research|||||f||||||||||||||2017-02-18 16:07:42.540939|2017-02-18 16:07:42.540939
NCT00395928|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2006-11-03|||November 2001||2001-11-01|November 2006|2006-11-01|November 2004||2004-11-01|||||Observational|||Chronic and Acute Effects of Smoking on the Left and Right Ventricular Relaxation in Young Healthy Smokers|Chronic and Acute Effect of Smoking on the Left and Right Ventricular Systolic and Diastolic Function in Young Healthy Smokers|Completed||N/A|33||Medical University of Warsaw|||||f||||||||||||||2017-02-18 16:07:42.631627|2017-02-18 16:07:42.631627
NCT00395915|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-03|2009-02-17|||September 2006||2006-09-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|March 2009|Anticipated|2009-03-01||Interventional|CHAT||Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia|Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia. An Independent, Pragmatic, Multicentre, Parallel-Group, Superiority Trial.|Unknown status|Active, not recruiting|Phase 4|106|Actual|Universita di Verona|||||f||||t||||||||||2017-02-18 16:07:42.717079|2017-02-18 16:07:42.717079
NCT00395902|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2007-12-20|||August 2005||2005-08-01|December 2007|2007-12-01||||||||Observational|||Post Transplant Study|A Retrospective Evaluation of Sensipar Use in Renal Transplant Recipients|Completed||N/A|50||Amgen|||||f||||||||||||||2017-02-18 16:07:43.062596|2017-02-18 16:07:43.062596
NCT00395668|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2007-09-06|||November 2006||2006-11-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||TETRA (Terrestrial Trunked Radio)|Assessment of Acute Changes in Cognitive Performance Arising From Exposure to TETRA Handset.|Completed||Phase 4|56|Anticipated|University of Aarhus|||||f||||||||||||||2017-02-18 16:07:43.145809|2017-02-18 16:07:43.145809
NCT00395655|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2006-11-01|||June 2005||2005-06-01|November 2006|2006-11-01|August 2006||2006-08-01|||||Interventional|||Hydralazine and Valproate Added to Chemotherapy for Breast Cancer|A Phase II Clinical Study of Hydralazine and Valproic Acid in Combination With Neoadjuvant Cytotoxic Chemotherapy in Stage IIB and IIIA Breast Carcinoma|Terminated||Phase 2|43||National Institute of Cancerología|||||f||||||||||||||2017-02-18 16:07:43.255747|2017-02-18 16:07:43.255747
NCT00395642|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2010-01-15|2009-12-14||November 2006||2006-11-01|January 2010|2010-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||TRIAGE-CRT Telemonitoring in Patients With CHF and Indication of CRT-D|TRIAGE-CRT Telemonitoring in Patients With Congestive Heart Failure and Indication of ICD-Cardiac Resynchronization Therapy|Completed||Phase 4|66|Actual|Biotronik, Inc.||1|||f||||f||||||||||2017-02-18 16:07:43.355369|2017-02-18 16:07:43.355369
NCT00395629|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2011-05-24|2010-12-06||August 2006||2006-08-01|May 2011|2011-05-01|March 2009|Actual|2009-03-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis|A Phase I/II Open Label, Dose Escalation Trial and a Six Month Extension to Explore the Safety and Efficacy of ICL670 in Patients With Iron Overload Resulting From Hereditary Hemochromatosis.|Completed||Phase 1/Phase 2|49|Actual|Novartis||1|||f||||f||||||||||2017-02-18 16:07:43.629317|2017-02-18 16:07:43.629317
NCT00395616|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2006-11-02|||November 2006||2006-11-01|November 2006|2006-11-01||||||||Interventional|||Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow||Unknown status|Recruiting|N/A|40||E-DA Hospital|||||f||||||||||||||2017-02-18 16:07:44.605136|2017-02-18 16:07:44.605136
NCT00395603|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-05-13|||September 2006||2006-09-01|May 2016|2016-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)|Compare Ezetimibe 10mg and Simvastatin 40mg vs Atorvastatin 80mg Daily in Subjects With Cardiovascular Heart Disease and/or Diabetes Mellitus With Uncontrolled Lipids on Statin Therapy|Terminated||Phase 3|550|Anticipated|Merck Sharp & Dohme Corp.||||This study was terminated early due to poor recruitment.|f||||||||||||||2017-02-18 16:07:44.687633|2017-02-18 16:07:44.687633
NCT00395590|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2006-11-02|||November 2006||2006-11-01|February 2005|2005-02-01|November 2007||2007-11-01|||||Observational|||Polymorphisms in Inflammatory Cytokines Genes in Subjects With Obstructive Sleep Apnea|A Cross Sectional Study of Patients With Obstructive Sleep Apnea for Polymorphisms in Genes of Inflammatory Cytokines.|Unknown status|Not yet recruiting|N/A|100||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:07:44.769257|2017-02-18 16:07:44.769257
NCT00395577|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2007-12-05|||November 2006||2006-11-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702|A Phase 2, 12-Week, Randomized, Placebo-Controlled Study to Evaluate the Antiinflammatory Effects of VX-702 When Administered Concomitantly With Methotrexate|Completed||Phase 2|120||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-02-18 16:07:44.841364|2017-02-18 16:07:44.841364
NCT00395564|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2016-12-12|||November 2008||2008-11-01|December 2016|2016-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Chart Review of Those Who Have Had Open, Laparoscopic, Ureteroscopic, or Percutaneous Surgery|Retrospective Chart Review of Patients Who Have Had an Open, Laparoscopic, Ureteroscopic or Percutaneous Surgery|Completed||N/A|150|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 16:07:44.931637|2017-02-18 16:07:44.931637
NCT00395551|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2010-01-07|||December 2005||2005-12-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.|A Single Center Study of the Safety and Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects With CNV Secondary to Causes Other Than AMD.|Completed||Phase 1|30|Anticipated|Ophthalmic Consultants of Boston||1|||f||||f||||||||||2017-02-18 16:07:45.259575|2017-02-18 16:07:45.259575
NCT00395538|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2017-01-24|||October 27, 2006||2006-10-27|March 11, 2016|2016-03-11|September 30, 2017|Anticipated|2017-09-30|September 30, 2017|Anticipated|2017-09-30||Interventional|||Effects of PTH Replacement on Bone in Hypoparathyroidism|Effects of PTH Replacement on Bone in Hypoparathyroidism|Active, not recruiting||Phase 3|46|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:07:45.355031|2017-02-18 16:07:45.355031
NCT00395512|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2013-02-19|2013-02-19||November 2006||2006-11-01|February 2013|2013-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus|A Multicenter, Double-Blind Study to Determine the Efficacy and Safety of SYR-322 Plus Pioglitazone HCl (Actos®), SYR-322 Alone or Pioglitazone HCl Alone in Subjects With Type 2 Diabetes|Completed||Phase 3|655|Actual|Takeda||4|||f||||f||||||||||2017-02-18 16:07:45.495506|2017-02-18 16:07:45.495506
NCT00395499|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-06-21|||May 2001||2001-05-01|June 2016|2016-06-01|April 2003||2003-04-01|||||Observational|||Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva|Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva|Completed||N/A|19||Ohio State University|||||f||||||||||||||2017-02-18 16:07:48.725454|2017-02-18 16:07:48.725454
NCT00395486|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2011-06-30|2009-06-09||September 2006||2006-09-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||ROMEO (Rosuvastatin in Metabolic syndrOme)|A 6-week, Randomised, Open-label, Parallel Group, Multi-centre Study to Compare the Efficacy of Rosuvastatin 10mg With Atorvastatin 10mg in the Treatment of Metabolic Syndrome Subjects With Raised LDL-C|Completed||Phase 4|258|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:07:48.83628|2017-02-18 16:07:48.83628
NCT00395473|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2016-01-19|||March 2005||2005-03-01|January 2016|2016-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)|Ezetimibe Added to Statin Therapy|Completed||Phase 3|141|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:07:49.355456|2017-02-18 16:07:49.355456
NCT00395460|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-02|2015-05-13|2011-07-04||September 2006||2006-09-01|May 2015|2015-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients|A Single-blind, Multicenter, Randomized, Phase III Study of the Efficacy and Safety of Gadavist (1.0 M) in Comparison With Magnevist (0.5 M) as Contrast Agent for Enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions in Chinese Patients|Completed||Phase 3|147|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:07:49.441978|2017-02-18 16:07:49.441978
NCT00395447|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2015-03-24|2010-08-24||July 2007||2007-07-01|March 2015|2015-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|REPLACE||REPLACE: Implantable Cardiac Pulse Generator Replacement Registry|Prospective Assessment of the Complication Rate After Device Replacement Due to ERI, Advisory or Upgrade|Completed||Phase 4|1744|Actual|Biotronik, Inc.|||2||f||||t||||||||||2017-02-18 16:07:49.9665|2017-02-18 16:07:49.9665
NCT00395434|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2011-10-28|||September 2006||2006-09-01|October 2011|2011-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors|OXC4P1-105: A Phase I Study of the Safety, Tolerability, and Antitumor Activity of Escalating Doses of Combretastatin A4 Phosphate Given in Combination With Bevacizumab to Subjects With Advanced Solid Tumors|Completed||Phase 1|20|Anticipated|Mateon Therapeutics|||||f||||||||||||||2017-02-18 16:07:50.610719|2017-02-18 16:07:50.610719
NCT00395421|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2010-06-09|||October 2006||2006-10-01|June 2010|2010-06-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin|A Partially-blinded, Randomized, Parallel-group Study to Evaluate the Potential Pharmacokinetic and Pharmacodynamic Interactions Between Valopicitabine and Ribavirin When Administered in Combination With Pegylated Interferon Alfa-2a in Treatment-naive Patients With Chronic Hepatitis C|Completed||Phase 2|114|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 16:07:50.705155|2017-02-18 16:07:50.705155
NCT00395408|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2017-02-15|||June 2000||2000-06-01|February 2017|2017-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Linear Growth Study (0476-097)(COMPLETED)|A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing the Effect on Linear Growth of Montelukast With Placebo and Inhaled Beclomethasone in Pediatric Patients (Prepubertal, Tanner Stage I) With Mild Asthma|Completed||Phase 4|360|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:07:50.798744|2017-02-18 16:07:50.798744
NCT00395395|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2007-05-25|||October 2006||2006-10-01|May 2007|2007-05-01||||||||Interventional|||Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women|A Partially-Blind, Randomized, Single-Dose, Placebo-Controlled Crossover Phase I Study Assessing the Effect of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of SMC021 0.8 mg in Healthy Postmenopausal Women|Completed||Phase 1|56|Anticipated|Novartis|||||f||||||||||||||2017-02-18 16:07:50.885122|2017-02-18 16:07:50.885122
NCT00395382|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2010-02-08|||January 2007||2007-01-01|February 2010|2010-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease|Randomised Controlled Trial of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease: A Pilot Study|Completed||Phase 4|50|Anticipated|Monash University||2|||f||||t||||||||||2017-02-18 16:07:50.975223|2017-02-18 16:07:50.975223
NCT00395369|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2006-11-02|||December 2007||2007-12-01|November 2006|2006-11-01||||||||Interventional|||Effect of Intraoperative Aprotinin Administration on Post Cardiac Surgery Optic Nerve and Retinal Thickness.||Unknown status|Not yet recruiting|N/A|30||Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:07:51.09091|2017-02-18 16:07:51.09091
NCT00395356|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2006-11-01|||September 2005||2005-09-01|November 2006|2006-11-01|June 2007||2007-06-01|||||Interventional|||Efficacy and Feasibility of an Intermittent Weight Loss Program.|Efficacy and Feasibility of an Intermittent Weight Loss Program: A Pilot Study.|Completed||N/A|20||Université de Sherbrooke|||||f||||||||||||||2017-02-18 16:07:51.177869|2017-02-18 16:07:51.177869
NCT00395343|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2015-04-24|2009-09-18||December 2006||2006-12-01|April 2015|2015-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Sitagliptin Added-on to Insulin Study (0431-051)|A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin (MK0431) to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Therapy (Alone or In Combination With Metformin)|Completed||Phase 3|641|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:07:51.27789|2017-02-18 16:07:51.27789
NCT00395330|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2015-08-19|||April 2003||2003-04-01|August 2015|2015-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Airways Dysfunction Following WTC Dust Exposure|Airways Dysfunction Following WTC Dust Exposure|Completed||N/A|500||New York University School of Medicine|||1||f||||||||||||||2017-02-18 16:07:51.950605|2017-02-18 16:07:51.950605
NCT00395317|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2012-04-05||2010-08-12|December 2006||2006-12-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|||Study Of SB-683699 Compared To Placebo In Subjects With Relapsing-Remitting Multiple Sclerosis (MS)|Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the MRI Efficacy and the Safety of Six Months Administration of SB-683699 in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|343|Actual|GlaxoSmithKline||5|||f||||f||||||||||2017-02-18 16:07:52.021607|2017-02-18 16:07:52.021607
NCT00395304|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-02-24|2010-05-17||March 2007||2007-03-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|BADGER||Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)|Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)|Completed||Phase 3|182|Actual|Milton S. Hershey Medical Center|The study was not designed or powered to evaluate the long-term safety of long-acting beta-agonists in children. The duration of the trial and its sample size preclude statements regarding long-term risks.|1|||f||||t||||||||||2017-02-18 16:07:52.378737|2017-02-18 16:07:52.378737
NCT00395291|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2014-01-14|2011-08-02||August 2006||2006-08-01|January 2014|2014-01-01|May 2010|Actual|2010-05-01|January 2009|Actual|2009-01-01||Interventional|||Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients|Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients|Completed||N/A|49|Actual|University of Virginia|We completed the appropriate number of subjects to get the statistical data needed. We had several screen fails (subjects that did not meet the inclusion/exclusion criteria.)|1|||f||||t||||||||||2017-02-18 16:07:52.749938|2017-02-18 16:07:52.749938
NCT00395278|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2017-01-24|||October 27, 2006||2006-10-27|April 18, 2016|2016-04-18||||||||Observational|||Development of Serologic Assays for Human Herpes Virus-8|Development of Serologic Assays for Human Herpes Virus-8|Active, not recruiting||N/A|429|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:07:53.459904|2017-02-18 16:07:53.459904
NCT00395265|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2012-01-26|||June 2006||2006-06-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome|Association of Thrombophilia and Inflammation With Post-Thrombotic Syndrome|Completed||N/A|2211|Actual|University of Vermont|||1||f||||f||||||||||2017-02-18 16:07:53.538644|2017-02-18 16:07:53.538644
NCT00395252|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2015-10-01|||October 2006||2006-10-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|November 2010|Actual|2010-11-01||Interventional|ATIP||Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer|Multicenter Phase II-trial to Investigate Safety and Efficacy of an Adjuvant Therapy With Gemcitabine and Erbitux® in Patients With R0 or R1 Resected Pancreatic Cancer|Completed||Phase 2|76|Actual|Philipps University Marburg Medical Center||1|||f||||t||||||||||2017-02-18 16:07:53.636348|2017-02-18 16:07:53.636348
NCT00395239|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2016-05-24|||October 2006||2006-10-01|August 2010|2010-08-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Asthma/Steroid Withdrawal Study|The Temporal Sequence of Inflammatory Mediators During a Controlled Exacerbation of Asthma by Steroid Withdrawal.|Terminated||Phase 4|6|Actual|University of Alberta||1||This project will resume upon the completion of other research committments.|f||||t||||||||||2017-02-18 16:07:53.758403|2017-02-18 16:07:53.758403
NCT00395226|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2011-06-03|2011-06-03||July 2006||2006-07-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial|"Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial. Prospective, Double Blind, Randomized, Controlled Trial Comparing the Effects of Supplemental Zinc Sulfate and Placebo on the Severity of Rosacea."|Terminated||N/A|65|Actual|Essentia Health||2||Difficulty recruiting subjects|f||||f||||||||||2017-02-18 16:07:53.86963|2017-02-18 16:07:53.86963
NCT00395213|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2015-04-16|||May 2007||2007-05-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|ASK||Antidepressant Safety in Kids Study|Antidepressant Safety in Kids (ASK) Study: An Open-label, Prospective, Cohort Study of Antidepressants in Children and Adolescents With Anxiety Disorders, Depressive Disorders, Eating Disorders, or Obsessive-Compulsive Disorder|Completed||Phase 4|569|Actual|Duke University|||1||f||||t||||||||||2017-02-18 16:07:54.382348|2017-02-18 16:07:54.382348
NCT00395200|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2011-10-22|||July 2008||2008-07-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|MSCIMS||Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)|Autologous Adult Human Mesenchymal Stem Cells: a Neuroprotective Therapy for Multiple Sclerosis|Completed||Phase 1/Phase 2|10|Actual|University of Cambridge||1|||f||||t||||||||||2017-02-18 16:07:54.518485|2017-02-18 16:07:54.518485
NCT00395187|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2007-10-04|||October 2006||2006-10-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa|A Small Clinical Study: Photodynamic Therapy to Treat Hidradenitis Suppurativa|Completed||N/A|15|Anticipated|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 16:07:54.635649|2017-02-18 16:07:54.635649
NCT00395174|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2009-12-16|||October 2006||2006-10-01|December 2009|2009-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults|Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine, to a Licensed Egg-Grown Influenza Vaccine In Ambulatory Elderly Adults|Completed||Phase 3|870|Actual|Protein Sciences Corporation||2|||f||||t||||||||||2017-02-18 16:07:54.722611|2017-02-18 16:07:54.722611
NCT00395161|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-04-16|2012-11-14||April 2007||2007-04-01|April 2013|2013-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|CRISIS||The CRISIS Prevention Study|The Critical Illness Stress-induced Immune Suppression Prevention Trial|Terminated||Phase 3|293|Actual|University of Utah|The Data Safety Monitoring Board met on November 30, 2009. Interim analysis of the first 273 patients was presented. Per the Board's recommendations, the study was terminated based on futility.|2||Terminated for futility on 11/30/09 based on the recommendation of the DSMB|f||||t||||||||||2017-02-18 16:07:54.869434|2017-02-18 16:07:54.869434
NCT00395148|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2011-05-09|||March 2006||2006-03-01|October 2006|2006-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Improving Metabolism With HDL Cholesterol|A Novel Mechanism Mediating Anti-atherosclerotic and Metabolic Actions of HDL Cholesterol|Completed||N/A|13|Actual|Bayside Health|||||f||||f||||||||||2017-02-18 16:07:55.68925|2017-02-18 16:07:55.68925
NCT00395135|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-01-04|2013-01-04||November 2006||2006-11-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management|BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management; A 104-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients|Completed||Phase 3|3182|Actual|Arena Pharmaceuticals||2|||f||||t||||||||||2017-02-18 16:07:55.781068|2017-02-18 16:07:55.781068
NCT00395122|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2006-11-01|||April 2005||2005-04-01|November 2006|2006-11-01|October 2006||2006-10-01|||||Interventional|||Optical Coherence Tomography Measurements in Eyes With Band Atrophy|Evaluation of the Diagnostic Ability of Optical Coherence Tomography With a Normative Database to Detect Band Atrophy of the Optic Nerve|Completed||N/A|30||University of Sao Paulo|||||f||||||||||||||2017-02-18 16:07:56.881275|2017-02-18 16:07:56.881275
NCT00395109|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2009-02-10|||January 2007||2007-01-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||PET/CT to Image Hypoxia in Head and Neck Tumours|PET/CT to Image Hypoxia in Head and Neck Tumours|Unknown status|Recruiting|Early Phase 1|17|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 16:07:56.959315|2017-02-18 16:07:56.959315
NCT00395096|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2009-02-17|||July 2006||2006-07-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|||||Observational|||Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma|Environmental Exposures, NOS Genes, and Exhaled Nitric Oxide in Pediatric Asthma|Completed||N/A|225|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||f||||||Samples With DNA|"~     Blood and urine~   "|||2017-02-18 16:07:57.054201|2017-02-18 16:07:57.054201
NCT00395083|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2014-09-04|2014-08-04||July 2006||2006-07-01|September 2014|2014-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|BREATH||Bronchitis and Emphysema Advice and Training to Reduce Hospitalization|CSP #560 - Bronchitis and Emphysema Advice and Training to Reduce Hospitalization (BREATH)|Terminated||Phase 2|426|Actual|VA Office of Research and Development||2||The DMC detected an imbalance in safety outcomes between the two groups.|f||||t||||||||||2017-02-18 16:07:57.319721|2017-02-18 16:07:57.319721
NCT00395070|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-09-11|||October 2006||2006-10-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|March 2012|Actual|2012-03-01||Interventional|||A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma|A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment With 2 mg Intralesional Allovectin-7® Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects With Recurrent Metastatic Melanoma|Completed||Phase 3|390|Actual|Vical||2|||f||||t||||||||||2017-02-18 16:07:58.224089|2017-02-18 16:07:58.224089
NCT00395057|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2015-08-25|2011-11-09||January 2007||2007-01-01|August 2015|2015-08-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration||Terminated||Phase 2|138|Actual|Allergan|"The study was terminated early due to a company decision (non-safety related). Because the study was terminated early, data for certain outcome measures (ie, Visual Functioning Questionnaire [VFQ] at Month 3) were not analyzed."|4||The study was terminated early due to company decision (non-safety related).|f||||||||||||||2017-02-18 16:07:58.445799|2017-02-18 16:07:58.445799
NCT00395044|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2016-12-19|2013-03-15||August 2006||2006-08-01|December 2016|2016-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||All subjects who received a randomization number and packet of medication at week 1 were included in primary and secondary outcomes|Gabapentin Treatment of Cannabis Dependence|Gabapentin for Cannabis Withdrawal and Use|Completed||Phase 2|50|Actual|The Scripps Research Institute||2|||f||||f||||||||||2017-02-18 16:07:59.190197|2017-02-18 16:07:59.190197
NCT00395031|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2011-07-28|||September 2003||2003-09-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder|The Effects of Ziprasidone 320 mg on Glucose and Plasma Lipids in Patients With Diabetes Type II and Schizophrenia or Schizoaffective Disorder|Completed||Phase 2/Phase 3|57|Actual|Manhattan Psychiatric Center||1|||f||||t||||||||||2017-02-18 16:07:59.673475|2017-02-18 16:07:59.673475
NCT00395018|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2012-04-30|2012-03-29||April 2007||2007-04-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection|Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection|Completed||Phase 3|109|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:07:59.799246|2017-02-18 16:07:59.799246
NCT00395005|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2007-03-22|||October 2006||2006-10-01|October 2006|2006-10-01|October 2006||2006-10-01|||||Observational|||Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease Patients|The Correlation of Urine Tissue Kallikrein Protein Level With Cytokines, Degree of Proteinuria and Renal Function Deterioration in Chronic Renal Disease Patients After Angiotensin II Receptor Blocking|Completed||N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:08:00.680391|2017-02-18 16:08:00.680391
NCT00394992|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2014-02-03|||December 2006||2006-12-01|February 2014|2014-02-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer|Randomized Phase III Study Post Radical Resection of Liver Metastasis of Colorectal Cancer: Bevacizumab in Combination With XELOX as Adjuvant Chemotherapy vs XELOX Alone|Terminated||Phase 3|79|Actual|Dutch Colorectal Cancer Group||2||Data from the C08 study and Avant study|f||||t||||||||||2017-02-18 16:08:00.752556|2017-02-18 16:08:00.752556
NCT00394966|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2009-10-22|||September 2006||2006-09-01|October 2009|2009-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)|A Phase 2, MultiCenter, Randomized, Placebo-Controlled, Double-Blind, Dose Finding Study to Determine the Safety and Efficacy of SCH 619734 for the Treatment of Chemotherapy Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)|Completed||Phase 2|450|Anticipated|Schering-Plough||5|||f||||f||||||||||2017-02-18 16:08:00.871133|2017-02-18 16:08:00.871133
NCT00394602|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2017-01-10|||April 2004||2004-04-01|January 2017|2017-01-01||||April 2018|Anticipated|2018-04-01||Observational|||Chemoradiation-Induced Nausea and Emesis: Quality of Life|Chemoradiation-Induced Nausea and Emesis: A Prospective Study to Assess Patient Preferences and Quality of Life|Recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||2||f||||f||||||||||2017-02-18 16:08:16.181169|2017-02-18 16:08:16.181169
NCT00394953|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2016-11-23|2016-08-12||December 2006||2006-12-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional||The Safety Population was defined as all participants who received at least one dose of methoxy polyethylene glycol-epoetin beta or darbepoetin alfa and had a safety follow-up, whether withdrawn prematurely or not.|A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients|A Randomized, Controlled, Open Label, Multicenter, Parallel-group Study to Compare the Effect of Mircera With That of Darbepoetin Alfa, Administered Intravenously at Extended Dosing Intervals, for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Hemodialysis|Completed||Phase 3|490|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:08:01.175581|2017-02-18 16:08:01.175581
NCT00394940|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2016-06-02|||July 2006||2006-07-01|June 2016|2016-06-01||||January 2022|Anticipated|2022-01-01||Observational|||Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease|Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Mortality|Active, not recruiting||N/A|1200|Anticipated|University of Arizona|||1||f||||f||||||Samples With DNA|"~     DNA, serum, supernatants~   "|||2017-02-18 16:08:02.277752|2017-02-18 16:08:02.277752
NCT00394927|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2012-07-18|||April 2007||2007-04-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients|A Multicenter, Non-interventional Surveillance Study to Evaluate the Adverse Effects of Antiepileptic Drug Treatment in Patients With Epilepsy|Completed||N/A|1000|Anticipated|UCB Pharma|||1||f||||||||||||||2017-02-18 16:08:02.391789|2017-02-18 16:08:02.391789
NCT00394914|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2015-06-23|2013-08-27||August 2006||2006-08-01|June 2015|2015-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)|A Placebo-Controlled Study of the Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure|Completed||Phase 2|311|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:08:02.528874|2017-02-18 16:08:02.528874
NCT00394901|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2010-02-26|2008-11-07||September 2006||2006-09-01|February 2010|2010-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia|A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study To Evaluate Efficacy And Safety Of Pregabalin In The Treatment Of Postherpetic Neuralgia|Completed||Phase 3|372|Actual|Pfizer||4|||f||||||||||||||2017-02-18 16:08:03.428032|2017-02-18 16:08:03.428032
NCT00394888|ClinicalTrials.gov processed this data on February 17, 2017|2006-11-01|2013-09-17|2011-05-04||November 2005||2005-11-01|September 2013|2013-09-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||Hemangioma Associated With High Rates of Morbidity|Hemangioma Associated With High Rates of Morbidity:A Prospective Study|Completed||N/A|433|Actual|Medical College of Wisconsin||3|||f||||f||||||||||2017-02-18 16:08:09.162013|2017-02-18 16:08:09.162013
NCT00394875|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2006-10-31|||March 2002||2002-03-01|October 2006|2006-10-01|January 2005||2005-01-01|||||Interventional|||The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes|The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes in a Secondary Care Setting: a Randomized Controlled Trial.|Completed||N/A|81||Medical Research Foundation, The Netherlands|||||f||||||||||||||2017-02-18 16:08:09.649558|2017-02-18 16:08:09.649558
NCT00394862|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2012-03-29|||January 2006||2006-01-01|March 2012|2012-03-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy of Weekly Versus Daily Folic Acid Supplementation||Completed||N/A|460||Emory University|||||f||||||||||||||2017-02-18 16:08:09.752493|2017-02-18 16:08:09.752493
NCT00394849|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2015-08-28|||July 2000||2000-07-01|August 2015|2015-08-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Effect of Tonsillar Pillar Closure on Postoperative Pain and Bleeding Risk After Tonsillectomy|Effect of Tonsillar Pillar Closure on Postoperative Pain and Bleeding Risk After Tonsillectomy|Completed||N/A|763|Actual|Indiana University||1|||f||||f||||||||||2017-02-18 16:08:10.071657|2017-02-18 16:08:10.071657
NCT00394836|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-12-12|2011-07-28||May 2007||2007-05-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|April 2009|Actual|2009-04-01||Interventional|||HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab|A Single-arm, International, Multi-center Trial of HuMax-CD20, a Fully Human Monoclonal Anti-CD20 Antibody, in Patients With Follicular Lymphoma Who Are Refractory to Rituximab as Monotherapy or in Combination With Chemotherapy|Completed||Phase 2|116|Actual|GlaxoSmithKline|||||f||||t||||||||||2017-02-18 16:08:10.191558|2017-02-18 16:08:10.191558
NCT00394823|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2011-11-07|||November 2005||2005-11-01|November 2011|2011-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients|A Randomized, Open-label, Multicentric Parallel Group Study to Assess the Impact of Supportive Measures on the Drug Adherence of Patients With Essential Hypertension Treated With Valsartan or Valsartan Plus HCTZ for 34 Weeks With or Without Respective Measures|Completed||Phase 3|206|Actual|Novartis|||||f||||||||||||||2017-02-18 16:08:11.225343|2017-02-18 16:08:11.225343
NCT00394810|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2008-11-24|||November 2006||2006-11-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer|Phase 2 Efficacy and Pharmacodynamic Study of 2-Methoxyestradiol Nanocrystal Colloidal Dispersion(Panzem® NCD) in Patients With Taxane-Refractory, Metastatic,Hormone-Refractory Prostate Cancer|Completed||Phase 2|21|Actual|CASI Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 16:08:11.323969|2017-02-18 16:08:11.323969
NCT00394797|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2011-05-31||||||May 2011|2011-05-01||||||||Observational|||Surgical Correction of Moderate Ischemic Mitral Regurgitation||Completed||N/A|||Shaare Zedek Medical Center|||1||f||||||||||||||2017-02-18 16:08:11.435047|2017-02-18 16:08:11.435047
NCT00394589|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2015-04-07|2009-10-28||March 2006||2006-03-01|April 2015|2015-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|Re³||Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)|Randomised Controlled Trial Evaluating Strategies to Optimize Disease Activity Control in RA Patients Treated With Infliximab in Clinical Practice.|Terminated||Phase 3|43|Actual|Merck Sharp & Dohme Corp.||3||Study enrollment was stopped due to insufficient subject accrual.|f||||f||||||||||2017-02-18 16:08:16.306597|2017-02-18 16:08:16.306597
NCT00394576|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2009-02-13|||November 2006||2006-11-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Assessing Novel Methods of Improving Patient Education of Nutrition|Assessing Novel Methods of Improving Patient Education of Nutrition: eHealth, Health Literacy and Chronic Kidney Disease|Unknown status|Recruiting|N/A|180|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 16:08:16.958548|2017-02-18 16:08:16.958548
NCT00394784|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2015-12-16|||December 2006||2006-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates|Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates|Active, not recruiting||N/A|100|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:08:11.517612|2017-02-18 16:08:11.517612
NCT00394771|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2013-07-12|2013-04-25||October 2006||2006-10-01|July 2013|2013-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||ITT population|A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale|A Prospective, Multicenter, Double-Blinded, Randomized Study to Evaluate Bleeding Patterns in Women Using One of Three Different Doses of DR-1031 Oral Contraceptive Compared to Seasonale Oral Contraceptive Regimen|Completed||Phase 2|567|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-02-18 16:08:11.617507|2017-02-18 16:08:11.617507
NCT00394758|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2006-10-30|||January 2000||2000-01-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia|Comparison of Surgical Procedures in Vulvar and Vaginal Dysplasias|Completed||Phase 3|150||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-02-18 16:08:13.471614|2017-02-18 16:08:13.471614
NCT00394745|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2011-11-07|||November 2005||2005-11-01|November 2011|2011-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome|A 12 Week Treatment, Open-label, Multicenter Study to Investigate the Efficacy and Safety of Valsartan 160-320 mg With Regard to Effects on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome|Completed||Phase 3|45|Actual|Novartis|||||f||||||||||||||2017-02-18 16:08:13.572427|2017-02-18 16:08:13.572427
NCT00394732|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2012-10-11|||April 2004||2004-04-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Disc Prosthesis Versus Multidisciplinary Rehabilitation|Effect of Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation Program in Patients With Chronic Low Back Pain and Degenerative Disc. A Prospective Randomized Clinical Multicentre Trial.|Completed||N/A|179|Actual|Oslo University Hospital||1|||f||||||||||||||2017-02-18 16:08:13.680879|2017-02-18 16:08:13.680879
NCT00394706|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2012-04-26|2012-03-23||June 2007||2007-06-01|April 2012|2012-04-01|July 2010|Actual|2010-07-01|November 2009|Actual|2009-11-01||Interventional|||Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve|Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve and Early Versus Delayed Analysis|Terminated||Phase 3|11738|Actual|University of Washington||4||Terminated because preliminary data suggested no difference in the strategies.|f||||t||||||||||2017-02-18 16:08:13.803031|2017-02-18 16:08:13.803031
NCT00394693|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2014-07-15|||November 2006||2006-11-01|July 2014|2014-07-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma|Phase II Clinical Trial of Intra-lesional Administration of TG1042 (Adenovirus-Interferon-gamma) in Patients With Relapsing Primary Cutaneous B-Cell Lymphomas.|Completed||Phase 2|13|Actual|Transgene||1|||f||||||||||||||2017-02-18 16:08:14.806733|2017-02-18 16:08:14.806733
NCT00394680|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2011-05-26|||November 2006||2006-11-01|May 2011|2011-05-01|May 2007|Actual|2007-05-01|||||Observational|||Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.|Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.|Completed||N/A|700|Anticipated|Shaare Zedek Medical Center|||1||f||||||||||||||2017-02-18 16:08:14.913147|2017-02-18 16:08:14.913147
NCT00394667|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-04-19|||September 2006||2006-09-01|April 2013|2013-04-01|September 2007|Actual|2007-09-01|||||Interventional|||Effect of Tesofensine on Weight Reduction in Patients With Obesity.|Effect of Tesofensine on Weight Reduction in Patients With Obesity. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study.|Completed||Phase 2|200|Anticipated|NeuroSearch A/S|||||f||||||||||||||2017-02-18 16:08:14.981719|2017-02-18 16:08:14.981719
NCT00394654|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-10-18|2013-10-18||November 2006||2006-11-01|October 2013|2013-10-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma|A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy of MEDI-528, a Humanized Anti-Interleukin-9 Monoclonal Antibody, on Late Asthmatic Response Induced By Allergen Inhalation In Adults With Atopic Asthma|Completed||Phase 2|30|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 16:08:15.075374|2017-02-18 16:08:15.075374
NCT00394641|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2006-10-31||||||October 2006|2006-10-01||||||||Interventional|||Impact of Listening to Low Tones on Motor Function in Children With CP|Impact of Listening to Low Tones Via Sterephonic Headphones on Hypertonia and Motor Function in Children With Cerebral Palsy- Randomized Controlled Study|Unknown status|Not yet recruiting|N/A|30||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:08:15.941734|2017-02-18 16:08:15.941734
NCT00394628|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2007-05-29|||October 2006||2006-10-01|May 2007|2007-05-01||||||||Interventional|||AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme|A Phase 1b/2a, Multicenter, Open-Label Study of AQ4N in Combination With Radiation Therapy and Temozolomide, to Evaluate the Safety, Tolerability, and Efficacy in Subjects With Newly Diagnosed Glioblastoma Multiforme|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|Novacea|||||f||||||||||||||2017-02-18 16:08:16.015144|2017-02-18 16:08:16.015144
NCT00394615|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2010-03-25|||October 2003||2003-10-01|March 2010|2010-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA|Metabolic Imaging: Predicting Histopathologic Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer|Terminated||N/A|15|Anticipated|Stanford University||1||Protocol approval expired|f||||||||||||||2017-02-18 16:08:16.102565|2017-02-18 16:08:16.102565
NCT00394563|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2009-10-07||2009-04-04|March 2006||2006-03-01|October 2009|2009-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain|A Randomized, Parallel Arm, Placebo-Controlled, Double-Blind, Multiple-Dose Study of the Safety and Efficacy of RN624 in Adults With Moderate-to-Severe Pain Due to Osteoarthritis of the Knee|Completed||Phase 2|450|Actual|Pfizer||6|||f||||t||||||||||2017-02-18 16:08:17.075604|2017-02-18 16:08:17.075604
NCT00394550|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2016-11-16|||January 2002||2002-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Treatment of Children With Obstructive Sleep Apnea and Laryngomalacia: the Role of Laser Supraglottoplasty|Treatment of Children With Obstructive Sleep Apnea and Laryngomalacia: the Role of Laser Supraglottoplasty|Recruiting||N/A|757|Anticipated|Indiana University||2|||f||||t||||||||||2017-02-18 16:08:17.24036|2017-02-18 16:08:17.24036
NCT00394537|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2007-06-04||||||May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy||Completed||Phase 4|72|Anticipated|Rabin Medical Center|||||f||||||||||||||2017-02-18 16:08:17.379832|2017-02-18 16:08:17.379832
NCT00394524|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-11-12|2008-12-08||June 2006||2006-06-01|November 2013|2013-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU|Comparative Trial Between a Computer-Guided Intravenous Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU|Completed||N/A|157|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:08:17.463816|2017-02-18 16:08:17.463816
NCT00394511|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-02-08|||August 1988||1988-08-01|October 2006|2006-10-01||||December 2006|Actual|2006-12-01||Interventional|||Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer|Phase III Randomized Evaluation of Adjuvant Radiotherapy vs No Adjuvant Therapy Following Radical Prostatectomy and Pelvic Lymphadenectomy in Surgical Stage C Adenocarcinoma of the Prostate|Completed||Phase 3|408|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:08:17.925579|2017-02-18 16:08:17.925579
NCT00394498|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2006-10-30|||September 2005||2005-09-01|October 2006|2006-10-01|October 2006||2006-10-01|||||Interventional|||Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair|Stem Cell Mobilization by G-CSF by Granulocyte Colony Stimulating Factor Post Myocardial Infarction to Promote Myocyte Repair|Unknown status|Recruiting|Phase 2/Phase 3|86||University of Ottawa|||||f||||||||||||||2017-02-18 16:08:18.018053|2017-02-18 16:08:18.018053
NCT00394485|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2009-12-15|||May 2006||2006-05-01|December 2009|2009-12-01|April 2008||2008-04-01|||||Interventional|||Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients|A Randomized Crossover Trial Comparing the Efficacy and Safety of Tiotropium + Procaterol vs. Tiotropium + Placebo in Moderate COPD Patients|Terminated||Phase 4|50|Anticipated|Otsuka Pharmaceutical, Inc., Philippines||||Difficulty in recruting patients|f||||||||||||||2017-02-18 16:08:18.113257|2017-02-18 16:08:18.113257
NCT00394472|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-02-14|2011-08-11||November 2006||2006-11-01|February 2013|2013-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients|A Randomized, Double-blind, Placebo Controlled, Phase IIA Study to Assess the Effect on Gastroesophageal Reflux Disease (GERD) Symptoms, Pharmacokinetics, Safety and Tolerability of 4 Weeks Treatment With AZD3355 65 mg Bid as add-on Treatment to a Proton Pump Inhibitor (PPI) in Patients With an Incomplete Response to PPI.|Completed||Phase 2|244|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:08:18.218372|2017-02-18 16:08:18.218372
NCT00394459|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2011-05-12|||April 2005||2005-04-01|May 2011|2011-05-01|May 2009|Actual|2009-05-01|March 2008|Actual|2008-03-01||Interventional|||Safety of Two Epidural Catheters in Thoracic Epidural Anaesthesia (TEA)|Randomised, Prospective, Single-blind, Controlled Multicenter Study on the Safety of Two Epidural Catheters in Patients Undergoing Surgery Under Thoracic Epidural Anaesthesia|Completed||Phase 4|140|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 16:08:18.589374|2017-02-18 16:08:18.589374
NCT00394446|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2008-02-11|||March 2005||2005-03-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|April 2007|Actual|2007-04-01||Interventional|||Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors|Phase I Open Label, Dose Escalating, Multiple Dose Study to Determine the Safety, Tolerability, Maximum Tolerated Dose, and Pharmacokinetics of MPC-6827 Administered IV Weekly X 3, Repeated Every 28 Days, in Subjects With Refractory Solid Tumors.|Completed||Phase 1|48|Actual|Myrexis Inc.||1|||f||||f||||||||||2017-02-18 16:08:18.708783|2017-02-18 16:08:18.708783
NCT00394433|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2016-11-21|2016-09-26||September 2006||2006-09-01|September 2016|2016-09-01|October 2016|Actual|2016-10-01|November 2008|Actual|2008-11-01||Interventional||The analysis dataset is comprised of all enrolled patients.|Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer|A Phase II Trial of Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer|Completed||Phase 2|38|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 16:08:18.803498|2017-02-18 16:08:18.803498
NCT00394420|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2010-01-19|||September 2003||2003-09-01|January 2010|2010-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Emergency Department Telephone Quitline|A Telephone Quitline Intervention for Smoking Cessation Through the Emergency Department|Completed||N/A|40||Mayo Clinic|||||f||||||||||||||2017-02-18 16:08:19.268164|2017-02-18 16:08:19.268164
NCT00394407|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2013-11-20|||September 2005||2005-09-01|November 2013|2013-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes|Comparative Trial Between Insulin Glargine Plus Supplemental Glulisine (Apidra) Versus Sliding Scale Regular Insulin In Hospitalized Patients With Type 2 Diabetes|Completed||Phase 4|130|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:08:19.355771|2017-02-18 16:08:19.355771
NCT00394394|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2006-10-30|||February 2005||2005-02-01|October 2006|2006-10-01||||||||Interventional|||Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril|Hydrochlorothiazide and Amiloride vs Hydrochlorothiazide and Enalapril: a Randomized Clinical Trial of Antihypertensive Effectiveness.|Completed||Phase 2|||Hospital de Clinicas de Porto Alegre|||||f||||||||||||||2017-02-18 16:08:19.470233|2017-02-18 16:08:19.470233
NCT00394381|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2017-02-09|||October 2006||2006-10-01|February 2017|2017-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome|Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome|Completed||Phase 1/Phase 2|17|Actual|Singapore General Hospital||1|||f||||t||||||||||2017-02-18 16:08:19.553675|2017-02-18 16:08:19.553675
NCT00394368|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2006-10-30|||November 2004||2004-11-01|October 2006|2006-10-01|September 2005||2005-09-01|||||Interventional|||EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI|DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, PARALLEL-GROUP DESIGN CLINICAL TRIAL OF THE EFFICACY AND TOLERABILITY OF CHF 1535 (BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg) pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI (SERETIDE®) IN THE 12-WEEK TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE PERSISTENT ASTHMA|Completed||Phase 3|180||Chiesi Farmaceutici S.p.A.|||||f||||||||||||||2017-02-18 16:08:19.666333|2017-02-18 16:08:19.666333
NCT00394355|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2015-06-23|2010-10-22||September 2006||2006-09-01|June 2015|2015-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)|Comparative Study of the Effect of Two Doses of Mometasone Furoate Dry Powder Inhaler 200 mcg and 400 mcg QD PM, Fluticasone Propionate 250 mcg BID, and Montelukast 10 mg QD PM, on Bone Mineral Density in Adults With Asthma|Completed||Phase 4|566|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 16:08:19.878816|2017-02-18 16:08:19.878816
NCT00394329|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2013-04-05|2013-02-24||November 2006||2006-11-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|TREXA||Childhood Asthma Research and Education (CARE) Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)|Childhood Asthma Research and Education (CARE) Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)|Completed||Phase 3|288|Actual|Milton S. Hershey Medical Center||4|||f||||t||||||||||2017-02-18 16:08:20.528712|2017-02-18 16:08:20.528712
NCT00394316|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2017-01-24|||October 30, 2006||2006-10-30|April 8, 2014|2014-04-08|April 8, 2014|Actual|2014-04-08|April 8, 2014|Actual|2014-04-08||Interventional|||Gene Therapy for Chronic Granulomatous Disease|Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease|Terminated||Early Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:08:21.312398|2017-02-18 16:08:21.312398
NCT00394303|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2009-03-31|||February 2007||2007-02-01|June 2007|2007-06-01|August 2009|Anticipated|2009-08-01|||||Interventional|||Tight Intra-Operative Glucose Control During Coronary Artery Bypass Surgery|Tight Intra-Operative Glucose Control Using Continuous Insulin Infusion During Coronary Artery Bypass Surgery: Randomized Controlled Trial|Terminated||Phase 4|1400|Anticipated|Rabin Medical Center||2||"Trial suspended on 26 February, following the publication of a trial with negative results~   (Ann Intern Med 146(4), 2007). Pending ethics committee re-approval."|f||||t||||||||||2017-02-18 16:08:21.424671|2017-02-18 16:08:21.424671
NCT00394290|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-31|2012-10-18|||November 2006||2006-11-01|October 2012|2012-10-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|Morphee||Down Syndrome and Continuous Positive Pressure Therapy|Follow-up of the Therapeutic Coverage by Continuous Positive Pressure of the Obstructive Sleep Apnea Syndrome for Down Syndrome Patients|Unknown status|Recruiting|N/A|30|Anticipated|Institut Jerome Lejeune||1|||f||||f||||||||||2017-02-18 16:08:21.544023|2017-02-18 16:08:21.544023
NCT00394277|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2010-07-30|2010-05-27||February 2007||2007-02-01|July 2010|2010-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C|Randomized, Multicenter, Double-blinded, Phase IV Study Evaluating the Efficacy (as Measured by Sustained Virological Response) and Safety of 360 μg Induction Dosing of Pegasys® in Combination With Higher Copegus® Doses in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Baseline Body Weight Greater Than or Equal to 85 kg|Completed||Phase 4|1175|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 16:08:21.672516|2017-02-18 16:08:21.672516
NCT00394264|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2006-10-27|||October 2006||2006-10-01|October 2006|2006-10-01|October 2007||2007-10-01|||||Interventional|||How Does Manual Therapy Improve Low Back Pain for Soldiers?|Manual Manipulative Therapy for Back Pain in Active Duty Military Personnel|Unknown status|Recruiting|Phase 2|100||University of North Texas Health Science Center|||||f||||||||||||||2017-02-18 16:08:22.953509|2017-02-18 16:08:22.953509
NCT00394251|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2013-08-08|2010-11-02||August 2006||2006-08-01|August 2013|2013-08-01|February 2008|Actual|2008-02-01|March 2007|Actual|2007-03-01||Interventional|||Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer|An Open-label, Randomized, Comparative Pilot Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer|Completed||Phase 2|197|Actual|Celgene||2|||f||||t||||||||||2017-02-18 16:08:23.134321|2017-02-18 16:08:23.134321
NCT00394238|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-29|2006-10-30|||November 2006||2006-11-01|July 2006|2006-07-01|October 2008||2008-10-01|||||Observational|||Non Alcoholic Fatty Liver Disease in Rheumatoid Arthritis||Unknown status|Not yet recruiting|N/A|50||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:08:24.674518|2017-02-18 16:08:24.674518
NCT00394225|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2006-10-30|||July 2005||2005-07-01|October 2006|2006-10-01|May 2006||2006-05-01|||||Interventional|||Helium-Hyperoxia and 6MWT Distance in COPD|The Effects of Helium-Hyperoxia on 6-Minute Walking Distance in Chronic Obstructive Pulmonary Disease – A Randomized, Controlled Trial|Completed||N/A|16||University of Saskatchewan|||||f||||||||||||||2017-02-18 16:08:24.754109|2017-02-18 16:08:24.754109
NCT00394212|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2016-08-12|2011-08-03||November 2006||2006-11-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|September 2008|Actual|2008-09-01||Interventional|||Incisionless Treatment for Patients With Inadequate Weight Loss Following Roux-en-Y Gastric Bypass|Randomized Evaluation of Endoscopic Suturing Transorally for Anastomotic Outlet Reduction (RESTORe) for Patients With Inadequate Weight Loss Following Roux-en-Y Gastric Bypass Surgery|Terminated||Phase 3|77|Actual|C. R. Bard|Limitations of this study are that study enrollment was prematurely discontinued; therefore the study was underpowered for the analysis of both the primary and secondary effectiveness endpoints.|2||For business reasons|f||||t||||||||||2017-02-18 16:08:24.845337|2017-02-18 16:08:24.845337
NCT00394199|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2011-06-08||2010-08-24|June 2006||2006-06-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma|A Randomized, Double-blind, Active-controlled, Parallel Group, Stratified, Multi-center, 12-week Study Comparing the Safety & Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm) 100/10 µg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Fluticasone (100 µg Twice Daily) and Formoterol (10 µg Twice Daily) Alone in Adolescent & Adult Patients With Mild to Moderate Asthma|Completed||Phase 3|357|Actual|SkyePharma AG||3|||f||||||||||||||2017-02-18 16:08:27.988913|2017-02-18 16:08:27.988913
NCT00394186|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2009-05-15|||August 2006||2006-08-01|May 2009|2009-05-01||||||||Interventional|||A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)|A Randomized, Double-Blind, Placebo-Controlled, Crossover, Phase IIa Study to Evaluate Efficacy and Safety of the Beta-3-Adrenergic Receptor Agonist Solabegron in Subjects With Irritable Bowel Syndrome|Completed||Phase 2|100|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:08:28.124781|2017-02-18 16:08:28.124781
NCT00394173|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2008-10-01|||September 2006||2006-09-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of DNK333 25mg b.i.d. Given Orally for 4 Weeks in Female Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)|Completed||Phase 2|180|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:08:28.240413|2017-02-18 16:08:28.240413
NCT00394160|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2015-06-22|||December 2004||2004-12-01|June 2015|2015-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)|A Randomized, 3-Period, Multiple-Dose, Multicenter Study to Evaluate the Safety, Tolerability, and Plasma Concentration Profile of Montelukast Administered Once Daily as Oral Granules in Children Aged 1 to 3 Months|Completed||Phase 2|12|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:08:28.623658|2017-02-18 16:08:28.623658
NCT00394147|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2012-03-01|||October 2006||2006-10-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|August 2008|Actual|2008-08-01||Interventional|||Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer|Phase II Trial of Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer (SCCHN)|Terminated||Phase 2|17|Actual|Fox Chase Cancer Center||1||stopped for lack of efficacy|f||||t||||||||||2017-02-18 16:08:28.710635|2017-02-18 16:08:28.710635
NCT00394134|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2016-05-18|||April 2005||2005-04-01|May 2016|2016-05-01||||April 2018|Anticipated|2018-04-01||Interventional|||Targeted Intervention for Melanoma Prevention|A Targeted, Family-Focused Intervention for Melanoma Prevention|Active, not recruiting||N/A|570|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:08:28.825369|2017-02-18 16:08:28.825369
NCT00394121|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2010-08-24||2010-08-24|March 2006||2006-03-01|August 2010|2010-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma|Long-term Open-label Safety Study With SkyePharma FlutiForm HFA pMDI (100/10 µg and 250/10 µg) in Adult and Adolescent Patients With Asthma|Completed||Phase 3|400|Anticipated|SkyePharma AG|||||f||||||||||||||2017-02-18 16:08:28.934293|2017-02-18 16:08:28.934293
NCT00394108|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2007-12-19|||August 1999||1999-08-01|December 2007|2007-12-01|July 2002|Actual|2002-07-01|||||Interventional|||Changes in Cerebrovascular Reactivity During Cognitive Activation After Cardiopulmonary Bypass: Relation With Intraoperative Embolic Load and Postoperative Neuropsychological Dysfunctions|Changes in Cerebrovascular Reactivity During Cognitive Activation After Cardiopulmonary Bypass: Relation With Intraoperative Embolic Load and Postoperative Neuropsychological Dysfunctions|Completed||N/A|66|Actual|University Ghent||1|||f||||f||||||||||2017-02-18 16:08:29.048093|2017-02-18 16:08:29.048093
NCT00394095|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2013-04-03|2011-03-23||December 2006||2006-12-01|April 2013|2013-04-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine|A Double-Blind, Randomized, Placebo-Controlled, Pilot Study of Topiramate vs. Placebo in Combination With Olanzapine for the Prevention of Weight Gain in Manic or Mixed Youth With Bipolar Disorder|Completed||Phase 4|31|Actual|University of Cincinnati|One subject experienced hyperthermia and was admitted to hospital. Subject was discontinued from study.|2|||f||||t||||||||||2017-02-18 16:08:29.133966|2017-02-18 16:08:29.133966
NCT00394082|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2016-03-24|2013-04-03||June 2006||2006-06-01|March 2016|2016-03-01|February 2011|Actual|2011-02-01|September 2009|Actual|2009-09-01||Interventional|||ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer|A Phase II Trial of Weekly Administration of ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer|Completed||Phase 2|50|Actual|Celgene Corporation|Interpretation of results is limited since the cell receptor subtype status of patients is not known.|1|||f||||f||||||||||2017-02-18 16:08:29.540413|2017-02-18 16:08:29.540413
NCT00394069|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2015-05-05|||July 2003||2003-07-01|May 2015|2015-05-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED)|A Randomized, 3-Period, Multiple-Dose, Multicenter Study to Evaluate the Safety, Tolerability, and Plasma Concentration Profile of Montelukast Administered Once Daily as Oral Granules in Children Aged 3 to 6 Months|Completed||Phase 2|14|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 16:08:30.006592|2017-02-18 16:08:30.006592
NCT00394056|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2016-10-27|||December 2006||2006-12-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.|Randomised, Double-blind, Placebo Controlled, Cross-over Study Comparing the Effects of Both Single Dose and Repeated Dosing Treatment for 14 Days of Vestipitant or Vestipitant / Paroxetine Combination in an Enriched Population of Subjects With Tinnitus & Hearing Loss|Completed||Phase 2|26|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:08:30.095199|2017-02-18 16:08:30.095199
NCT00394043|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2006-10-27|||October 2006||2006-10-01|October 2006|2006-10-01|October 2009||2009-10-01|||||Interventional|||Treatment Efficacy of OMT for Carpal Tunnel Syndrome|Treatment Efficacy of OMT for Carpal Tunnel Syndrome|Unknown status|Recruiting|Phase 2|138||University of North Texas Health Science Center|||||f||||||||||||||2017-02-18 16:08:30.448865|2017-02-18 16:08:30.448865
NCT00394030|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2016-10-27|||October 2006||2006-10-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers|An Open-Label, Randomized, Multi-Site Study to Assess the Pharmacokinetics of Single Subcutaneous Injections of 16mg and 64mg of GSK716155 Administered at Three Different Injection Sites in Adult Male and Female Subjects With Type 2 Diabetes and of Single Subcutaneous Injections of 16mg and 64mg of GSK716155 Administered in the Abdomen of Healthy, Normal Volunteers|Completed||Phase 1|63|Actual|GlaxoSmithKline|||||||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:08:30.539363|2017-02-18 16:08:30.539363
NCT00394017|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2009-10-23|||November 2006||2006-11-01|October 2009|2009-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Use of Reminders in Implementing an E-learning Program in General Practice|Implementation of an E-learning Program in Diagnostic Evaluation of Dementia by Reminders: A RCT Among General Practitioners in Copenhagen|Completed||N/A|339|Actual|Research Unit Of General Practice, Copenhagen||2|||f||||||||||||||2017-02-18 16:08:30.637491|2017-02-18 16:08:30.637491
NCT00394004|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-28|2017-01-24|||October 26, 2006||2006-10-26|April 26, 2011|2011-04-26|April 26, 2011||2011-04-26|||||Observational|||Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials|Exploring Decision Making of Hispanics and African Americans With HIV/AIDS Participating in Clinical Trials|Completed||N/A|35|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:08:30.740805|2017-02-18 16:08:30.740805
NCT00393991|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2011-06-08||2010-08-24|July 2006||2006-07-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma|A Randomized, Double-blind, Placebo-controlled, Parallel, Stratified, Multi-center, 12-Week Study Comparing the Safety & Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm)100/10 µg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI)With the Administration of Placebo or Fluticasone (100 µg Twice Daily) and Formoterol (10 µg Twice Daily) Alone in Adolescent and Adult Patients With Mild to Moderate Asthma|Completed||Phase 3|475|Actual|SkyePharma AG||4|||f||||||||||||||2017-02-18 16:08:30.838028|2017-02-18 16:08:30.838028
NCT00393978|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2014-10-01|||November 2006||2006-11-01|October 2014|2014-10-01|March 2014|Actual|2014-03-01|December 2011|Actual|2011-12-01||Interventional|||Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania|Quetiapine Plus Topiramate or Placebo for Bipolar Mania & Cannabis Use in Adolescents|Completed||Phase 4|90|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 16:08:31.00245|2017-02-18 16:08:31.00245
NCT00393965|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2008-02-11|||December 2005||2005-12-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|August 2007|Actual|2007-08-01||Interventional|||Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases|Phase 1 Open Label, Dose Escalating, Multiple Dose Study to Determine the Safety, Tolerability, Maximum Tolerated Dose, and Pharmacokinetics of MPC-6827 Administered IV Weekly X 3, Repeated Every 28 Days, in Subjects With Refractory Brain Metastases|Completed||Phase 1|18|Actual|Myrexis Inc.||1|||f||||f||||||||||2017-02-18 16:08:31.115498|2017-02-18 16:08:31.115498
NCT00393952|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2011-06-08||2010-08-24|June 2006||2006-06-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma|A Randomized, Double-blind, Placebo-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm) 100/10 µg or 250/10 µg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Placebo or Fluticasone (250 µg Twice Daily) and Formoterol (10 µg Twice Daily) Alone in Adolescent and Adult Patients With Moderate to Severe Asthma|Completed||Phase 3|557|Actual|SkyePharma AG||5|||f||||||||||||||2017-02-18 16:08:31.204336|2017-02-18 16:08:31.204336
NCT00393939|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2012-07-13|2011-01-31||February 2007||2007-02-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|February 2010|Actual|2010-02-01||Interventional|SUN 1064||Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer|A Randomized Phase 3 Study Of Docetaxel In Combination With Sunitinib Versus Docetaxel In The First-Line Treatment Of Advanced Breast Cancer Patients|Completed||Phase 3|594|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:08:31.396936|2017-02-18 16:08:31.396936
NCT00393926|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2014-02-03|||July 2006||2006-07-01|February 2014|2014-02-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Robot-Assisted Motivating Rehabilitation|Robot-Assisted Motivating Rehabilitation to Increase Upper Limb Function After Stroke|Completed||Phase 1|24|Anticipated|Medical College of Wisconsin|||||f||||||||||||||2017-02-18 16:08:32.698924|2017-02-18 16:08:32.698924
NCT00393913|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2016-08-03|2014-02-18||October 2006||2006-10-01|August 2016|2016-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational||107 total, with 87 subjects with sleep apnea and 20 without sleep apnea.|Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness|Relating Sleep Disordered Breathing to Daytime Function|Completed||N/A|144|Actual|New York University School of Medicine|||1||f||||t||||||||||2017-02-18 16:08:32.798812|2017-02-18 16:08:32.798812
NCT00393900|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-30|2013-12-19|||August 2006||2006-08-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Middle Ear Pressure Disregulation After Tympanostomy Tube Insertion|Middle Ear Pressure Disregulation After Tympanostomy Tube Insertion|Completed||N/A|84|Actual|Children's Hospital of Pittsburgh|||1||f||||f||||||Samples With DNA|"~     Buccal cells obtained for DNA~   "|||2017-02-18 16:08:33.098655|2017-02-18 16:08:33.098655
NCT00393887|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2015-10-16|2015-07-29||March 2007||2007-03-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Inguinal Hernia Study Using Biodesign IHM|Inguinal Hernia Study: A Double Blinded Randomized Prospective Study|Completed||N/A|100|Actual|Cook||2|||f||||f||||||||||2017-02-18 16:08:33.205738|2017-02-18 16:08:33.205738
NCT00393874|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2016-09-06|2016-01-07||October 2006||2006-10-01|September 2016|2016-09-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|EASI-P||Efficacy of Sleep Interventions for Posttraumatic Stress Disorder (PTSD)|Efficacy of Adjunct Sleep Interventions for PTSD|Completed||N/A|50|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 16:08:33.560855|2017-02-18 16:08:33.560855
NCT00393861|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2016-02-26|2015-01-21||October 2006||2006-10-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|October 2012|Actual|2012-10-01||Interventional|||Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients|Phase II Study of Oxaliplatin Plus Bevacizumab Salvage Chemotherapy in Patients With Germ Cell Tumors|Completed||Phase 2|29|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 16:08:34.047199|2017-02-18 16:08:34.047199
NCT00393848|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2014-05-30|2014-01-06||October 2006||2006-10-01|May 2014|2014-05-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery|Restoration of Muscle Following Hip Surgery|Completed||Phase 2|40|Actual|University of Arkansas||4|||f||||t||||||||||2017-02-18 16:08:34.385814|2017-02-18 16:08:34.385814
NCT00393653|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2011-05-09|||October 2006||2006-10-01|May 2011|2011-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Prescription Methods Assessment Project (PMAP)|Prescription Methods Assessment Project (PMAP)|Terminated||N/A|800|Anticipated|American Academy of Family Physicians||||Funding ended early|f||||||||||||||2017-02-18 16:08:39.396622|2017-02-18 16:08:39.396622
NCT00393835|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2008-05-15|||November 2006||2006-11-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis|A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin Sustained Release (SR) For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis In Japan Adults|Completed||Phase 3|99|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:08:35.215423|2017-02-18 16:08:35.215423
NCT00393822|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2014-07-14|||August 2005||2005-08-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer|A Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) for Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer Receiving 5-FU and Leucovorin as Adjuvant Therapy|Completed||Phase 2/Phase 3|100|Actual|Amgen||2|||f||||f||||||||||2017-02-18 16:08:35.317927|2017-02-18 16:08:35.317927
NCT00393809|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2007-12-25|||January 2006||2006-01-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer|Phase 1/2a, Dose-Escalation, Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer|Completed||Phase 1/Phase 2|18|Actual|Hebrew University of Jerusalem||1|||f||||||||||||||2017-02-18 16:08:35.434734|2017-02-18 16:08:35.434734
NCT00393796|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2014-11-07|2014-06-19||May 2006||2006-05-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma|Randomized Blinded Phase II Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma|Terminated||Phase 2|54|Actual|University of Michigan Cancer Center|This multicenter study was limited by premature closure and a small sample size.|2||Low accrual|f||||t||||||||||2017-02-18 16:08:35.551393|2017-02-18 16:08:35.551393
NCT00393783|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2016-06-01|||May 2006||2006-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity|Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity|Active, not recruiting||Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:08:36.398634|2017-02-18 16:08:36.398634
NCT00393770|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2011-06-09|||February 2004||2004-02-01|June 2011|2011-06-01|September 2007|Actual|2007-09-01|October 2006|Actual|2006-10-01||Interventional|||Acetylcarnitine and Insulin Sensitivity|A Pilot Study to Evaluate the Short-term Effects of Acetyl-carnitine on Insulin Resistance and the Metabolic Syndrome in Patients at Increased Risk of Type 2 Diabetes: Acetyl-carnitine in Insulin Resistance|Completed||Phase 2|43|Actual|Mario Negri Institute for Pharmacological Research||1|||f||||f||||||||||2017-02-18 16:08:36.504246|2017-02-18 16:08:36.504246
NCT00393757|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2010-08-26|||October 2006||2006-10-01|October 2007|2007-10-01|January 2010||2010-01-01|||||Observational|||Malaria Transmission and Immunity in Highland Kenya|Malaria Transmission and Immunity in Highland Kenya|Unknown status|Recruiting|N/A|6400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:08:36.609386|2017-02-18 16:08:36.609386
NCT00393744|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2009-03-16|||October 2006||2006-10-01|March 2009|2009-03-01||||March 2008|Actual|2008-03-01||Interventional|PRI-angine||Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in Children|A Phase III, Open, Randomised, Multicentre Study Comparing the Efficacy and Safety of Pristinamycin, at Dosages of 50 mg/kg/d in 2 Doses for Children, and 1g Twice Daily in Adults for 4 Days Versus Amoxicillin at a Dosage of 50 mg/kg/d in 2 Doses in Children and 1 g Twice Daily in Adults for 6 Days, Consumed Orally, in the Treatment of Tonsillitis Induced by Group-A Beta-Haemolytic Streptococcus in Patients Aged Between 6 and 25 Years.|Completed||Phase 3|395|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:08:36.684561|2017-02-18 16:08:36.684561
NCT00393731|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2008-01-11|||January 2004||2004-01-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Randomized, Control Trial for Preinduction Cervical Ripening|A Randomized, Control Trial for Preinduction Cervical Ripening|Completed||Phase 2|540|Anticipated|The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 16:08:36.780736|2017-02-18 16:08:36.780736
NCT00393718|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2014-11-17|2010-02-23||November 2006||2006-11-01|November 2014|2014-11-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes|Completed||Phase 3|400|Actual|Novo Nordisk A/S||2|||f||||f||||||||||2017-02-18 16:08:36.877341|2017-02-18 16:08:36.877341
NCT00393705|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2010-07-15|2010-03-31||October 2006||2006-10-01|July 2010|2010-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|S019||Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)|A Comparison of Insulin Lispro MM Intensive Mixture Therapy With Progressive Dose-Titration of Insulin Lispro LM or Biphasic Insulin Aspart 30/70|Completed||Phase 4|302|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:08:37.755332|2017-02-18 16:08:37.755332
NCT00393692|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2016-04-25|||August 2000||2000-08-01|April 2016|2016-04-01|January 2019|Anticipated|2019-01-01|April 2016|Actual|2016-04-01||Observational|||Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy|Prospective Natural History Study of Fundus Autofluorescence Imaging in Age-related Macular Degeneration (FAM-Study) Using Confocal Scanning Laser Ophthalmoscopy|Active, not recruiting||N/A|700|Actual|University Hospital, Bonn|||1||f||||f||||||||Undecided||2017-02-18 16:08:39.066586|2017-02-18 16:08:39.066586
NCT00393679|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2014-01-31|||July 2007||2007-07-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children|Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children|Completed||Phase 3|4112|Actual|Institute of Tropical Medicine, Belgium||4|||f||||t||||||||||2017-02-18 16:08:39.174289|2017-02-18 16:08:39.174289
NCT00393666|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2016-01-25|||September 2006||2006-09-01|January 2016|2016-01-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Why Are Patients With Absence Seizures Absent? A Brain Imaging Study|Functional Neuroimaging in Childhood Absence Epilepsy|Completed||N/A|180|Actual|Yale University|||1||f||||||||||Samples With DNA|"~     Saliva samples~   "|||2017-02-18 16:08:39.305037|2017-02-18 16:08:39.305037
NCT00393640|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2009-09-18|||February 2005||2005-02-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|Pumping||Early and Regular Breast Milk Expression to Help Establish Lactation After Delivery: a Randomized Controlled Trial|Early and Regular Breast Milk Expression to Help Establish Lactation After Delivery: a Randomized Controlled Trial|Completed||N/A|120|Anticipated|National University Hospital, Singapore||4|||f||||t||||||||||2017-02-18 16:08:39.497374|2017-02-18 16:08:39.497374
NCT00393627|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2012-06-12|||June 2006||2006-06-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Behavioral Sleep Intervention in Adult Family Homes|Efficacy of Behavioral Interventions to Improve Sleep in Adult Family Homes|Completed||Phase 2|47|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:08:39.599929|2017-02-18 16:08:39.599929
NCT00393614|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2009-09-22|||May 2007||2007-05-01|February 2008|2008-02-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA)|Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) - a Placebo Controlled Double-blind Cross-over-study|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Oslo University Hospital||1|||f||||||||||||||2017-02-18 16:08:39.710167|2017-02-18 16:08:39.710167
NCT00393601|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2010-01-04|||December 2005||2005-12-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|||||Observational|||Chart Review of Laparoscopic Radical Cystectomy|Retrospective Chart Review of Laparoscopic Radical Cystectomy|Completed||N/A|200|Anticipated|University of California, Irvine|||1||f||||f||||||||||2017-02-18 16:08:39.80194|2017-02-18 16:08:39.80194
NCT00393588|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2017-01-24|||October 26, 2006||2006-10-26|September 29, 2011|2011-09-29|September 29, 2011||2011-09-29|||||Observational|||Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis|The Use of Magnetic Resonance Imaging to Investigate Cortical Damage in Patients With Multiple Sclerosis and Correlation With Cognitive Dysfunction|Completed||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:08:39.882379|2017-02-18 16:08:39.882379
NCT00393575|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2016-07-06|||January 2006||2006-01-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||C2P Mobilization Intervention (Pilot)|Connect To Protect® Partnerships for Youth Prevention Interventions: Phase III|Completed||N/A|15|Actual|Westat||1|||f||||t||||||||||2017-02-18 16:08:39.958885|2017-02-18 16:08:39.958885
NCT00393562|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2015-06-25|||March 2006||2006-03-01|June 2015|2015-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease|Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease|Withdrawn||N/A|0|Actual|VA Office of Research and Development||||Unable to recruit any subjects for this study|f||||f||||||||||2017-02-18 16:08:40.08792|2017-02-18 16:08:40.08792
NCT00393549|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-27|2007-06-05|||August 2006||2006-08-01|June 2007|2007-06-01|December 2006|Actual|2006-12-01|||||Interventional|||NeuroPath Comparative Validation Study Plan||Terminated||Phase 3|200|Anticipated|Excel-Tech Ltd.||||Sponsor decision to terminate.|f||||||||||||||2017-02-18 16:08:40.176959|2017-02-18 16:08:40.176959
NCT00393536|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2006-10-26|||July 1999||1999-07-01|October 2006|2006-10-01|December 2000||2000-12-01|||||Interventional|||Study of Whether Educational Visits to Primary Care Professionals Improves the Quality of Care They Provide.|A Pragmatic Randomized Controlled Trial of Untargeted Educational Outreach Visiting Delivered by Pharmaceutical Advisers in Primary Care.|Completed||N/A|73||Newcastle University|||||f||||||||||||||2017-02-18 16:08:40.257601|2017-02-18 16:08:40.257601
NCT00393523|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2015-02-26|2009-05-27||September 2006||2006-09-01|February 2015|2015-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Hepatitis B Vaccine Booster Study (V232-058)|A Study to Assess the Anamnestic Immune Response 4 to 8 Years After a Primary Vaccination Series With HBVAXPRO|Completed||Phase 3|1478|Actual|Merck Sharp & Dohme Corp.||5|||f||||f||||||||||2017-02-18 16:08:40.353807|2017-02-18 16:08:40.353807
NCT00393510|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2010-07-06|2009-11-23||November 2000||2000-11-01|July 2010|2010-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Herbal Preparation Used as Adjuvant Therapy on Diabetic Ulcers|An Evidence Base Study on the Clinical Effects of Integrated Western Medicine and Traditional Chinese Medicine for Diabetic Foot Ulcer Treatment|Completed||Phase 2|80|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 16:08:41.314111|2017-02-18 16:08:41.314111
NCT00393497|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2014-09-19|||April 2007||2007-04-01|September 2014|2014-09-01|January 2011|Actual|2011-01-01|October 2009|Actual|2009-10-01||Interventional|||A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment|A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment|Completed||Phase 1|11|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 16:08:41.661928|2017-02-18 16:08:41.661928
NCT00393484|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2014-11-06|2010-10-21||February 2007||2007-02-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|January 2009|Actual|2009-01-01||Interventional||All participants who received study drug|A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection|A Phase IV Study of the Antiviral Activity and Safety of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen in Korea|Completed||Phase 4|122|Actual|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 16:08:41.776092|2017-02-18 16:08:41.776092
NCT00393471|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2006-10-26|||October 2000||2000-10-01|October 2006|2006-10-01|October 2001||2001-10-01|||||Interventional|||Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.|A Double-Blind Study Evaluating the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Comparison to Etanercept Alone or Methotrexate Alone in Rheumatoid Arthritis Patients.|Completed||Phase 3|615||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:08:42.887949|2017-02-18 16:08:42.887949
NCT00393458|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2011-07-22|2011-07-22||October 2006||2006-10-01|July 2011|2011-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control|A 52-week Treatment, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol (300 and 600 µg Once Daily) in Patients With Chronic Obstructive Pulmonary Disease, Using Formoterol (12 µg Twice Daily) as an Active Control|Completed||Phase 3|1732|Actual|Novartis||4|||f||||||||||||||2017-02-18 16:08:43.11935|2017-02-18 16:08:43.11935
NCT00393445|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2011-10-02|||November 2006||2006-11-01|October 2011|2011-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans|Effect of GLP-1 on Glucose Metabolism in Healthy Subjects and Patients With T2DM. Part 1: A Pilot Study to Assess the Efficacy of Exendin(9-39)Amide as a GLP-1 Receptor Antagonist in Healthy Subjects|Completed||Phase 1|6|Actual|Ludwig-Maximilians - University of Munich||1|||f||||f||||||||||2017-02-18 16:08:44.532952|2017-02-18 16:08:44.532952
NCT00393432|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2017-01-24|||October 18, 2006||2006-10-18|July 18, 2008|2008-07-18|July 18, 2008||2008-07-18|||||Observational|||Enhancing Motor Task Training by Action Observation Watching Others Perform the Task|Enhancing Motor Memory Encoding by Action Observation|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:08:44.650815|2017-02-18 16:08:44.650815
NCT00393419|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2006-10-26|||June 2004||2004-06-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||Federal Study of Adherence to Medications in the Elderly (FAME)|Federal Study of Adherence to Medications in the Elderly (FAME)|Completed||N/A|200||Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 16:08:44.731152|2017-02-18 16:08:44.731152
NCT00393406|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2017-01-24|||October 24, 2006||2006-10-24|October 28, 2008|2008-10-28|October 28, 2008||2008-10-28|||||Observational|||The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method Approach|The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method Approach|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:08:44.823221|2017-02-18 16:08:44.823221
NCT00393393|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2006-10-26|||January 2006||2006-01-01|October 2006|2006-10-01|January 2006||2006-01-01|||||Interventional|||Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee|A Single-Blind Prospective Parallel Control Group Pilot Study to Assess the Effect of Hylan G-F 20 (Synvisc) Supplementation on Cartilage Preservation in Osteoarthritis of the Knee|Unknown status|Recruiting|Phase 4|80||Cabrini Medical Centre|||||f||||||||||||||2017-02-18 16:08:44.975914|2017-02-18 16:08:44.975914
NCT00393380|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-04-22|2012-11-06||September 2006||2006-09-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|November 2009|Actual|2009-11-01||Interventional|||Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor|A Phase II Study of Parathyroid Hormone Following Myeloablative Sequential Unrelated Cord Blood Transplantation|Terminated||Phase 2|13|Actual|The EMMES Corporation|The study was closed prematurely due to early mortality and lack of efficacy.|1||Study stopped because of toxicity concerns.|f||||t||||||||||2017-02-18 16:08:45.090485|2017-02-18 16:08:45.090485
NCT00393367|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2012-08-06|2010-04-09||December 2006||2006-12-01|August 2012|2012-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Budesonide Inhalation Suspension for Acute Asthma in Children|Budesonide Inhalation Suspension for Acute Asthma in Children|Completed||Phase 4|179|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 16:08:45.452292|2017-02-18 16:08:45.452292
NCT00393354|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2015-11-27|||April 2000||2000-04-01|November 2015|2015-11-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)|A Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial to Assess the Efficacy and Safety of MK0663 in Patients With Chronic Low Back Pain|Completed||Phase 3|325|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:08:48.819709|2017-02-18 16:08:48.819709
NCT00393341|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2015-08-27|||October 2006||2006-10-01|August 2015|2015-08-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Observational|EPC||Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer|Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer|Completed||N/A|68|Actual|Indiana University|||2||f||||||||||Samples With DNA|"~     Blood sample~   "|||2017-02-18 16:08:48.900057|2017-02-18 16:08:48.900057
NCT00393328|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2011-04-07|||November 2006||2006-11-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Bioequivalence Study of Atazanavir 300 mg Capsule|Bioequivalence Study of Atazanavir Single 300 mg Capsule Relative to Two Atazanavir 150 mg Capsules in Healthy Subjects|Completed||Phase 1|46||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 16:08:48.999159|2017-02-18 16:08:48.999159
NCT00393315|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2010-06-29|||November 2005||2005-11-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses|P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses: A Comparison to the Paclitaxel-Eluting Taxus™ Stent. A Pilot Study|Completed||Phase 2|120|Actual|University Hospital, Saarland||2|||f||||||||||||||2017-02-18 16:08:49.105921|2017-02-18 16:08:49.105921
NCT00393302|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2008-07-16|||September 2003||2003-09-01|July 2008|2008-07-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Observational|||HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy|HIV Testing in Pregnant Women: An Evaluation of an Opt-Out Strategy in an Ambulatory Care Clinic Setting|Completed||Phase 4|1074|Actual|St. Michael's Hospital, Toronto|||1||f||||f||||||||||2017-02-18 16:08:49.225281|2017-02-18 16:08:49.225281
NCT00393289|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2016-07-19|||November 2005||2005-11-01|July 2016|2016-07-01|March 2007|Actual|2007-03-01|April 2006|Actual|2006-04-01||Interventional|||Calcium Absorption and Retention From Marine Products|Calcium Absorption and Retention From Marine Products|Completed||N/A|12|Actual|University of Copenhagen||2|||f||||f||||||||Yes||2017-02-18 16:08:49.311022|2017-02-18 16:08:49.311022
NCT00393276|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2014-12-08|||August 2007||2007-08-01|December 2014|2014-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals|Optimizing Vaccine Responsiveness in HIV-1 and HCV Infections by Identifying Determinants of Responsiveness: A Pilot Study|Completed||Phase 1|29|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 16:08:49.414141|2017-02-18 16:08:49.414141
NCT00393263|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2014-05-08|||October 2006||2006-10-01|May 2014|2014-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus|A Double-Blind, Parallel-group Trial of Topical Pimecrolimus Cream 1% (Elidel®) Versus Clobetasol 0.05% Cream for the Treatment of Vulvar Lichen Sclerosus|Completed||Phase 2|38|Actual|Center for Vulvovaginal Disorders||2|||f||||||||||||||2017-02-18 16:08:49.554293|2017-02-18 16:08:49.554293
NCT00391508|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2006-10-23|||September 2003||2003-09-01|October 2006|2006-10-01|August 2005||2005-08-01|||||Observational|||Skin Problems in Ostomy Patients: An Epidemiological Study|An Epidemiological Study of Peristomal Skin Problems in Patient With an Ostomy in Roskilde County|Unknown status|Active, not recruiting|N/A|200||Zealand University Hospital|||||f||||||||||||||2017-02-18 16:09:27.162799|2017-02-18 16:09:27.162799
NCT00393250|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2017-01-24|||October 23, 2006||2006-10-23|March 22, 2016|2016-03-22|June 4, 2012|Actual|2012-06-04|June 4, 2012|Actual|2012-06-04||Interventional|||Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease|Hypnosis as a Pain and Symptom Management Strategy in Patients With Sickle Cell Disease|Completed||Phase 3|31|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:08:49.904055|2017-02-18 16:08:49.904055
NCT00393224|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2017-01-24|||June 29, 2005||2005-06-29|August 24, 2016|2016-08-24||||||||Observational|||Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families|Defining Markers of Susceptibility to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families|Completed||N/A|2400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:08:50.003075|2017-02-18 16:08:50.003075
NCT00393211|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2015-11-27|||April 2000||2000-04-01|November 2015|2015-11-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)|A Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial to Assess the Efficacy and Safety of MK0663 in Patients With Chronic Low Back Pain|Completed||Phase 3|319|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:08:50.095198|2017-02-18 16:08:50.095198
NCT00393198|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-26|2014-10-31|||October 2006||2006-10-01|October 2014|2014-10-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia|Multicenter Study to Investigate the Bleeding Profile and the Insertion Easiness in Women Inserted With a Second Consecutive MIRENA for Contraception or Menorrhagia|Completed||Phase 4|204|Actual|Bayer||3|||f||||f||||||||||2017-02-18 16:08:50.19163|2017-02-18 16:08:50.19163
NCT00393185|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2012-10-04|||January 2006||2006-01-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis|Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis: A Phase I Study|Withdrawn||Phase 1|0|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 16:08:50.324957|2017-02-18 16:08:50.324957
NCT00393172|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2014-12-11|||May 2006||2006-05-01|December 2014|2014-12-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|WISER||Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]|Women in Steady Exercise Research (WISER)|Completed||Phase 2/Phase 3|400|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 16:08:50.413377|2017-02-18 16:08:50.413377
NCT00393159|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2006-10-24|||October 2006||2006-10-01|October 2006|2006-10-01||||||||Interventional|||The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children|The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children|Unknown status|Recruiting|Phase 4|30||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 16:08:50.52402|2017-02-18 16:08:50.52402
NCT00393146|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2015-05-11|||October 2006||2006-10-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis|A Randomized, Double Blind, Placebo Controlled Study to Investigate the Safety and Tolerability and Clinical Activity of 28 Days of Oral Repeat Dosing With GW856553 at 7.5mg BID in Subjects With Active Rheumatoid Arthritis on Stable Anti-rheumatic Therapy.|Completed||Phase 2|57|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:08:50.61468|2017-02-18 16:08:50.61468
NCT00393120|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2012-01-20||2010-06-18|October 2006||2006-10-01|January 2012|2012-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients|A Randomized, Double-blind, Placebo-controlled Study Exploring the Safety, Tolerability, PK & Virological Effect of Once Daily Oral Dosing of INCB009471 as Monotherapy for 14 Days in ARV-naïve/Limited ARV-experienced, HIV-1 Infected Pts.|Completed||Phase 2|45|Actual|Incyte Corporation||3|||f||||f||||||||||2017-02-18 16:08:50.725141|2017-02-18 16:08:50.725141
NCT00393107|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2006-10-25|||March 2000||2000-03-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab|Phase II Study of Rituximab in Combination With Fludarabine and Cyclophosphamide for the Treatment of Relapsed Follicular Lymphoma|Completed||Phase 2|54||Gruppo Italiano Studio Linfomi|||||f||||||||||||||2017-02-18 16:08:50.828022|2017-02-18 16:08:50.828022
NCT00393094|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2012-07-06|2012-03-27||September 2006||2006-09-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Bevacizumab and Irinotecan to Treat Brain Tumors|A Phase II Trial of Bevacizumab and Irinotecan for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment w/Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (NCT00271609)(Bevacizumab Alone for Recurrent Gliomas)|Terminated||Phase 2|31|Actual|National Institutes of Health Clinical Center (CC)|Evaluating combination therapy, 19 GBM patients were enrolled. Accrual was terminated after it became clear that we could not reach our efficacy rule of 3 or more of 29 patients responding. The AG arm never fully accrued before the study was closed.|1||Terminated due to the limitations of accrual.|f||||f||||||||||2017-02-18 16:08:50.949657|2017-02-18 16:08:50.949657
NCT00393068|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2012-10-31|2012-08-22||February 2007||2007-02-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|September 2009|Actual|2009-09-01||Interventional|||Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer|A Phase II Trial of Preoperative Concurrent Chemotherapy/Radiation Therapy Plus Bevacizumab/Erlotinib in the Treatment of Localized Esophageal Cancer|Completed||Phase 2|62|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:08:51.354635|2017-02-18 16:08:51.354635
NCT00393055|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2011-09-09|||January 2007||2007-01-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Xylitol Adult Caries Trial (X-ACT)|Xylitol Adult Caries Trial (X-ACT)|Completed||Phase 3|709|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 16:08:51.884639|2017-02-18 16:08:51.884639
NCT00393042|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2010-09-27|||January 2006||2006-01-01|September 2010|2010-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR|Sleep and Tolerability of Extended Release Dexmethylphenidate vs. Mixed Amphetamine Salts: A Double Blind, Placebo Controlled Study (SAT STUDY)|Completed||Phase 3|77|Anticipated|University of Illinois at Chicago||2|||f||||t||||||||||2017-02-18 16:08:51.992216|2017-02-18 16:08:51.992216
NCT00393029|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2011-08-10|2011-06-01||October 2006||2006-10-01|August 2011|2011-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes|Phase II Study of Metastatic Cancer That Overexpresses p53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-p53 T Cell Receptor (TCR)-Gene Engineered Lymphocytes|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 16:08:52.129163|2017-02-18 16:08:52.129163
NCT00393003|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2009-08-28|||September 2006||2006-09-01|August 2009|2009-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index|Target-controlled Infusion of Propofol and Remifentanil for Postoperative Sedation Guided by the Bispectral Index: Comparison Between Manual Perfusion and Automated Perfusion|Completed||Phase 4|32||Hopital Foch|||||f||||f||||||||||2017-02-18 16:08:52.818848|2017-02-18 16:08:52.818848
NCT00392990|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2015-09-24|||October 2006||2006-10-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01||Interventional|||Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma|A Multicenter Phase II Study Incorporating DOXIL® and Rituximab Into the Magrath Regimen for HIV-Negative and HIV-Positive Patients With Newly Diagnosed Burkitt's and Burkitt-like Lymphoma|Active, not recruiting||Phase 2|25|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 16:08:52.923286|2017-02-18 16:08:52.923286
NCT00392977|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-12-17|||August 2006||2006-08-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Brain Manganese Deposition in High Risk Neonates|Brain Manganese Deposition in High Risk Neonates|Completed||N/A|43|Actual|Vanderbilt University|||1||f||||t||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 16:08:53.064725|2017-02-18 16:08:53.064725
NCT00392964|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2007-04-10|||January 2006||2006-01-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Observational|||Patterns of Antiacids Use in Patients With IHD Admitted to Department of Internal Medicine|Patterns of Antiacids Use in Patients With IHD Admitted to Department of Internal Medicine|Completed||N/A|1200||Rambam Health Care Campus|||||f||||f||||||||||2017-02-18 16:08:53.165444|2017-02-18 16:08:53.165444
NCT00392951|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2016-04-22|||December 2006||2006-12-01|April 2016|2016-04-01|February 2017|Anticipated|2017-02-01|February 2016|Actual|2016-02-01||Interventional|||Sirolimus for Autoimmune Disease of Blood Cells|Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series|Active, not recruiting||Phase 1/Phase 2|32|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 16:08:53.257007|2017-02-18 16:08:53.257007
NCT00392938|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-05-15|||December 2005||2005-12-01|May 2013|2013-05-01||||May 2010|Actual|2010-05-01||Interventional|||Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone|Positron Emission Tomography Imaging of Bone in Patients With Metastatic Prostate Cancer - A Pilot Study Evaluating Treatment Response|Completed||N/A|40|Anticipated|University of Washington|||||f||||||||||||||2017-02-18 16:08:53.379178|2017-02-18 16:08:53.379178
NCT00392925|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2015-03-26|2013-08-12||October 2006||2006-10-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional||177 participants enrolled into the study and started a 4 week lead-in period. 38 participants withdrew from the study during the lead-in period and 139 participants were randomized into one of 3 treatment groups. Baseline demographics presented for all 177 enrolled participants, by treatment group or those not randomized to a treatment group.|A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects|A Phase 2A, Randomized, Controlled, Double-Blind, Multicenter Study to Evaluate the Safety, Tolerability, and Effect on Body Weight of Recombinant-Methionyl Human Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects|Completed||Phase 2|177|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 16:08:53.50531|2017-02-18 16:08:53.50531
NCT00392912|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2010-08-18|||April 2007||2007-04-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|November 2009|Actual|2009-11-01||Interventional|||Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone|A Pilot Study of the Effect of Testosterone on Cerebral Glucose Metabolism in Hypogonadal Males With Alzheimer's Disease|Completed||N/A|10|Actual|VA Medical Center, Houston||1|||f||||f||||||||||2017-02-18 16:08:55.355624|2017-02-18 16:08:55.355624
NCT00392899|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2016-09-26|||October 2006||2006-10-01|July 2009|2009-07-01|September 2016|Actual|2016-09-01|October 2015|Actual|2015-10-01||Interventional|||Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery|Randomized Phase III Trial of Adjuvant Chemotherapy With UFT vs. Observation in Curatively Resected Stage II Colon Cancer|Completed||Phase 3|2025|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||t||||||||||2017-02-18 16:08:55.489608|2017-02-18 16:08:55.489608
NCT00392886|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-12-17|||March 2004||2004-03-01|October 2010|2010-10-01||||December 2010|Anticipated|2010-12-01||Interventional|||Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors|Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa and Carboplatin, With or Without Etoposide) and Autologous Stem Cell Rescue [HEAD START III]|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:08:55.872085|2017-02-18 16:08:55.872085
NCT00392873|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2015-05-06|||September 2006||2006-09-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity|"REFUEL Active Women's Study II: Increased Caloric Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity"|Completed||N/A|233|Actual|Penn State University||3|||f||||t||||||||||2017-02-18 16:08:56.117093|2017-02-18 16:08:56.117093
NCT00392860|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2014-01-04|2013-06-18||August 2008||2008-08-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|March 2011|Actual|2011-03-01||Interventional|||Development of an Ergonomic Wheelchair Pushrim|Development of an Ergonomic Manual Wheelchair Pushrim- Phase II|Completed||Phase 2|4|Actual|VA Pittsburgh Healthcare System||3|||f||||f||||||||||2017-02-18 16:08:56.216275|2017-02-18 16:08:56.216275
NCT00392847|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2012-07-06|||December 2006||2006-12-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|August 2011|Actual|2011-08-01||Interventional|CAPEDP||Promoting Parental Skills and Enhancing Attachment in Early Childhood|Promoting Parental Skills and Enhancing Attachment in Early Childhood|Completed||N/A|440|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 16:08:56.74554|2017-02-18 16:08:56.74554
NCT00392834|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2014-08-27|2013-01-24||September 2006||2006-09-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2011|Actual|2011-07-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma|Prospective Phase II Study of a High Dose, Short Course Regimen (R-CODOX-M/IVAC) Including CNS Penetration and Intensive IT Prophylaxis in HIV-Associated Burkitt's and Atypical Burkitt's Lymphoma|Completed||Phase 2|34|Actual|AIDS Malignancy Consortium||2|||f||||f||||||||||2017-02-18 16:08:56.871314|2017-02-18 16:08:56.871314
NCT00392821|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2014-02-10|2014-02-10||December 2006||2006-12-01|February 2014|2014-02-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer|Phase I/II Trial of Sorafenib (Nexavar) and RAD001 (Everolimus)in the Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma|Completed||Phase 1/Phase 2|78|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:08:57.413833|2017-02-18 16:08:57.413833
NCT00392808|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-08-06|2013-08-06||January 2007||2007-01-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|CSISP-MENC1||Immunogenicity of the Booster Dose of Two MenC Vaccines|Randomized, Open Label, Active Control, Parallel Assignment Clinical Trial to Evaluate the Immunogenicity of Polysaccharide Meningococcal C Vaccines Conjugated With Tetanus Toxoid or CRM197 Given as a Booster Dose at 14-18 Months of Life.|Completed||Phase 4|389|Actual|Centro Superior de Investigación en Salud Publica||4|||f||||f||||||||||2017-02-18 16:08:57.764945|2017-02-18 16:08:57.764945
NCT00392795|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2015-11-04|||January 2007||2007-01-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|December 2010|Actual|2010-12-01||Observational|BRAIN-ICU||The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors|The BRAIN ICU Study: Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors|Active, not recruiting||N/A|826|Actual|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 16:08:58.415987|2017-02-18 16:08:58.415987
NCT00392782|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2012-11-06|2011-06-15||July 2005||2005-07-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease|A Multicenter, Prospective Trial to Evaluate the Role of NK Cell KIR Epitope Mismatch on Mortality and Disease Relapse in T-Cell Depleted Hematopoietic Stem Cell Transplantation From HLA-C Mismatched, Unrelated Donors for Myeloid Malignancies|Completed||Phase 2|24|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:08:58.534716|2017-02-18 16:08:58.534716
NCT00392769|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2012-08-03|2012-08-03||October 2006||2006-10-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer|Phase II Study of Cetuximab (Erbitux) in Patients With Progressive or Recurrent Endometrial Cancer|Completed||Phase 2|33|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:08:58.978512|2017-02-18 16:08:58.978512
NCT00392756|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2017-01-17|||April 1989||1989-04-01|January 2017|2017-01-01|March 2018|Anticipated|2018-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)|Role of Gonadotropin Pulsations in the Reversal of Hypogonadotropic Hypogonadism|Recruiting||N/A|800|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 16:08:59.214202|2017-02-18 16:08:59.214202
NCT00392743|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2012-11-01|||December 2006||2006-12-01|October 2012|2012-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients|An Open-label, Cross-over Study, to Compare the PET and SPECT Measurement of Antipsychotic-induced D2 Receptor Occupancy, in a Group of Healthy Volunteers and in Another Group of Patients With Schizophrenia and Other Psychotic Disorders|Completed||N/A|60|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 16:08:59.356231|2017-02-18 16:08:59.356231
NCT00392730|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-12-18|||August 2006||2006-08-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children|Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children|Completed||N/A|122|Actual|Vanderbilt University|||3||f||||t||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 16:08:59.463099|2017-02-18 16:08:59.463099
NCT00392717|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2006-10-25|||February 1998||1998-02-01|October 2006|2006-10-01|March 2002||2002-03-01|||||Interventional|||Regulation of Lipoprotein Metabolism in Obese Men|Effect of Atorvastatin and Fish Oils on Lipoprotein Metabolism in Visceral Obesity|Completed||Phase 3|48||The University of Western Australia|||||f||||||||||||||2017-02-18 16:08:59.573904|2017-02-18 16:08:59.573904
NCT00392704|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-02-18|2013-01-14||December 2006||2006-12-01|February 2013|2013-02-01|May 2012|Actual|2012-05-01|August 2008|Actual|2008-08-01||Interventional|||Treatment of Head & Neck Cancer With Chemotherapy and Radiation|A Phase II Trial of Neoadjuvant Chemotherapy Plus Bevacizumab Followed By Concurrent Chemotherapy/Bevacizumab/Erlotinib/Radiation Therapy in the Treatment of Locally Advanced Squamous Carcinoma of the Head and Neck|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:08:59.764861|2017-02-18 16:08:59.764861
NCT00392691|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-07-09|||October 2006||2006-10-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|December 2012|Actual|2012-12-01||Interventional|||Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment|Ibritumomab Tiuxetan and High-Dose Melphalan as Conditioning Regimen Before Autologous Stem Cell Transplantation for Elderly Patients With Lymphoma in Relapse or Resistant to Chemotherapy. A Multicenter Phase I Trial|Completed||Phase 1|20|Actual|Swiss Group for Clinical Cancer Research||1|||f||||f||||||||||2017-02-18 16:09:00.287076|2017-02-18 16:09:00.287076
NCT00392678|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-07-25|2013-02-20||October 2006||2006-10-01|July 2013|2013-07-01|December 2010|Actual|2010-12-01|July 2008|Actual|2008-07-01||Interventional|TINSAL-T2D||Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)|Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate|Completed||Phase 2/Phase 3|277|Actual|Joslin Diabetes Center||4|||f||||t||||||||||2017-02-18 16:09:00.438133|2017-02-18 16:09:00.438133
NCT00392665|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2016-04-12|||October 2006||2006-10-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|August 2012|Actual|2012-08-01||Interventional|||Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck|Randomized Study of Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|36|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 16:09:01.293827|2017-02-18 16:09:01.293827
NCT00392652|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2016-12-28|||November 2006||2006-11-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Diindolylmethane in Healthy Volunteers|Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction Clinical Study of Nutritional-Grade, Absorption-Enhanced DIM (BR-DIM)|Completed||Phase 1|14|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:09:01.417671|2017-02-18 16:09:01.417671
NCT00392639|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2009-11-30|||November 2006||2006-11-01|July 2007|2007-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA Study)|Clinical Interest of Endovascular Cooling in the Management of Cardiac Arrest: Impact on Mortality in a Randomized Medico-economical Trial (the ICEREA Study)|Completed||Phase 4|389|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:09:01.521415|2017-02-18 16:09:01.521415
NCT00392613|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2010-01-06|||January 2005||2005-01-01|July 2007|2007-07-01||||December 2009|Actual|2009-12-01||Interventional|||RAte Control Efficacy in Permanent Atrial Fibrillation|RAte Control Efficacy in Permanent Atrial Fibrillation, a Comparison Between Lenient Versus Strict Rate Control in Patients With and Without Heart Failure.|Completed||N/A|500|Anticipated|University Medical Center Groningen|||||f||||||||||||||2017-02-18 16:09:01.640385|2017-02-18 16:09:01.640385
NCT00392587|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2012-05-31|||August 2006||2006-08-01|March 2011|2011-03-01||||||||Interventional|||A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)|A Randomised, Double-blind, Placebo-controlled Parallel Study to Assess the Safety, Tolerability,Pharmacodynamics and Steady State Pharmacokinetics of Repeated Doses of GW856553 in Patients With COPD|Completed||Phase 2|30|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:09:01.735687|2017-02-18 16:09:01.735687
NCT00392574|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2015-04-27||2010-08-27|August 2006||2006-08-01|August 2010|2010-08-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea|A Multicenter, Double-Blind, Randomized Study to Compare The Safety and Efficacy of Prulifloxacin Versus Placebo in the Treatment of Acute Gastroenteritis in Adult Travelers|Completed||Phase 3|282|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:09:01.836478|2017-02-18 16:09:01.836478
NCT00392561|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2016-08-29|||April 2006||2006-04-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|BEST||Bangladesh Vitamin E and Selenium Trial|Bangladesh Vitamin E and Selenium Trial|Active, not recruiting||N/A|7000|Actual|University of Chicago||4|||f||||t||||||||||2017-02-18 16:09:01.946763|2017-02-18 16:09:01.946763
NCT00392548|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2006-10-25|||October 2006||2006-10-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Observational|||URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol|Urinary VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence|Unknown status|Not yet recruiting|N/A|130||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 16:09:02.058729|2017-02-18 16:09:02.058729
NCT00392535|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2011-05-19|||October 2002||2002-10-01|July 2009|2009-07-01||||September 2012|Anticipated|2012-09-01||Interventional|||Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer|Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer: CHHIP|Unknown status|Recruiting|Phase 3|2163|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:09:02.145257|2017-02-18 16:09:02.145257
NCT00392522|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2007-10-04|||November 2006||2006-11-01|October 2007|2007-10-01||||||||Interventional|||50% Nitrous Oxide and 50% Oxygen (MEOPA) Conscious Sedation Versus Placebo in Fiberoptic Bronchoscopy|50% Nitrous Oxide and 50% Oxygen (MEOPA) Conscious Sedation Versus Placebo in Fiberoptic Bronchoscopy : Randomized, Double Blind, Placebo-Controlled Study|Unknown status|Active, not recruiting|Phase 3|64|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:09:02.280203|2017-02-18 16:09:02.280203
NCT00392509|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2009-05-13|||October 2006||2006-10-01|May 2009|2009-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CLI-001||ALD-301 for Critical Limb Ischemia, Randomized Trial|A Phase I-II Randomized Autologous Bone Marrow Derived Aldehyde Dehydrogenase-Bright (ALDHbr) Cells Against Unfractionated Autologous Mononuclear Bone Marrow in Patients With Rutherford 4 or 5 Peripheral Arterial Occlusive Disease|Completed||Phase 1/Phase 2|20|Anticipated|Aldagen||1|||f||||t||||||||||2017-02-18 16:09:02.363555|2017-02-18 16:09:02.363555
NCT00392496|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2014-04-28|2013-10-21||February 2007||2007-02-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||Two patients who were determined as ineligible were excluded from all analyses|Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma|A Phase II Study of Sunitinib (SU11248; NSC 736511; IND 74019), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:09:02.487483|2017-02-18 16:09:02.487483
NCT00392483|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2010-06-24|||November 2006||2006-11-01|November 2006|2006-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Reuptake of an E-Learning Programme in General Practice|The Use and Diffusion of an E-learning Programme in Diagnostic Evaluation of Dementia Among General Practitioners in Denmark|Completed||Phase 1|3632|Actual|Research Unit Of General Practice, Copenhagen|||1||f||||||||||||||2017-02-18 16:09:02.782872|2017-02-18 16:09:02.782872
NCT00392470|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2011-05-24|||August 2006||2006-08-01|April 2008|2008-04-01||||||||Interventional|||Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer|Neoadjuvant Conformal Radiotherapy and Concomitant CPT-11 and EGFR Inhibition With Cetuximab in Patients With Rectal Cancer Phase I Study|Unknown status|Recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:09:03.063196|2017-02-18 16:09:03.063196
NCT00392457|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2015-02-12|||July 1995||1995-07-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Investigating the Regulation of Reproductive Hormones in Adult Men|Feedback Control of FSH Secretion in the Human Male|Completed||N/A|175|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||||||||||||2017-02-18 16:09:03.166328|2017-02-18 16:09:03.166328
NCT00392444|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2014-05-05|2013-10-21||February 2007||2007-02-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||1 patient was cancelled due to intercurrent illness and another 3 were found to be ineligible after review. Those 4 patients were excluded from all analyses.|Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma|A Phase II Study of Sunitinib (SU11248; NSC 736511; IND 74019) in Patients With Advanced Malignant Pleural Mesothelioma|Completed||Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:09:03.285327|2017-02-18 16:09:03.285327
NCT00392431|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2007-03-21|||January 2003||2003-01-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Continuous Versus Episodic Amiodarone Treatment for the Prevention of Permanent Atrial Fibrillation|Continuous Versus Episodic Prophylactic Treatment With Oral Amiodarone for the Prevention of Permanent Atrial Fibrillation: a Randomized Study on Morbidity and Quality of Life|Completed||N/A|220||University Medical Center Groningen|||||f||||||||||||||2017-02-18 16:09:03.596951|2017-02-18 16:09:03.596951
NCT00392418|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2010-03-11|||May 2004||2004-05-01|January 2008|2008-01-01|March 2005||2005-03-01|||||Interventional|||Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.|The Effectiveness of Flexible Administration of Sprinkles® in a Mixed Population of Anemic and Non-anemic Infants and Young Children in Rural Bangladesh.|Completed||N/A|360||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 16:09:03.680214|2017-02-18 16:09:03.680214
NCT00392405|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2006-10-25|||November 2006||2006-11-01|October 2006|2006-10-01||||||||Interventional|||Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate|Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate|Unknown status|Not yet recruiting|Phase 2|656||Norton Community Hospital|||||f||||||||||||||2017-02-18 16:09:03.772318|2017-02-18 16:09:03.772318
NCT00392392|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-09-17|2013-01-11||October 2006||2006-10-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|April 2008|Actual|2008-04-01||Interventional|||Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer|Phase II Study of Preoperative Bevacizumab and Trastuzumab Administered With ABI-007 and Carboplatin in HER2 Overexpressing Breast Cancer|Completed||Phase 2|29|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:09:03.868448|2017-02-18 16:09:03.868448
NCT00392379|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2013-04-16|2010-06-02||January 2007||2007-01-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction|Evaluating Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction|Completed||Phase 3|270|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:09:04.415973|2017-02-18 16:09:04.415973
NCT00392366|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2009-12-30|||July 2006||2006-07-01|December 2009|2009-12-01|July 2008|Actual|2008-07-01|||||Interventional|||"Laser Interstitial Thermal Therapy Under Real Time MRI Guidance for Minimal Invasive Treatment of Liver Metastasis"|"The Clinical Evaluation of the Laser Interstitial Thermal Therapy (LITT ), Under Real Time MRI Guidance, for the Minimal Invasive Treatment of Liver Metastasis - a Phase IIa Mono-centric Study, Without Direct Benefice to the Patient"|Completed||N/A|25|Anticipated|BioTex, Inc.||1|||f||||||||||||||2017-02-18 16:09:04.838503|2017-02-18 16:09:04.838503
NCT00392353|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2017-01-31|||November 2006||2006-11-01|November 2016|2016-11-01||||May 2017|Anticipated|2017-05-01||Interventional|||Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia|A Phase 1/2 Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination With Azacitidine in Patients With the Myelodysplastic Syndrome (MDS)|Active, not recruiting||Phase 1/Phase 2|135|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:09:04.946472|2017-02-18 16:09:04.946472
NCT00392340|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2013-09-16|||March 2008||2008-03-01|June 2009|2009-06-01||||January 2010|Anticipated|2010-01-01||Interventional|||Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma|An Open-Label, Multicentre, Phase II Study of TVD as Treatment for Children With Stage 4 Neuroblastoma Failing to Respond to First-Line Treatment According to HR-NBL-01/ E-SIOP [Topotecan-Vincristine-Doxorubicin in Children With Stage 4 Neuroblastoma Failing to Respond to COJEC (TVD)]|Unknown status|Active, not recruiting|Phase 2|63|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:09:05.083354|2017-02-18 16:09:05.083354
NCT00392327|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2016-08-19|||March 2007||2007-03-01|August 2016|2016-08-01||||June 2018|Anticipated|2018-06-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma|Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients|Recruiting||Phase 3|400|Anticipated|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 16:09:05.208558|2017-02-18 16:09:05.208558
NCT00392314|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-25|2014-05-08|||October 2006||2006-10-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.|Phase 2 Study.Tailored Therapy for Hodgkin Lymphoma Based on Predefined Risk Factors and Early Interim PET/CT for Response Assessment and Further Therapy Decisions.|Completed||Phase 2|365|Actual|Rambam Health Care Campus||4|||f||||f||||||||||2017-02-18 16:09:05.595893|2017-02-18 16:09:05.595893
NCT00392301|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2009-06-17|||October 2009||2009-10-01|June 2009|2009-06-01||||||||Observational|||Split-Thickness Skin Graft Donor Site Wound Healing Study|Split-Thickness Skin Graft Donor Site Wound Healing Study|Suspended||N/A|30|Anticipated|University of Mississippi Medical Center|||1|Temporary loss of personnel|f||||f||||||||||2017-02-18 16:09:05.709121|2017-02-18 16:09:05.709121
NCT00392288|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2016-12-02|2009-07-01||September 2006||2006-09-01|September 2016|2016-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.|A Multicenter, Multi-national, Randomized, Double-blind, Placebo-controlled, Study to Assess the Efficacy and Safety of Ciclesonide Metered-dose Inhaler (MDI) at 80 μg BID or 40 μg BID for 12 Weeks in Patients Aged 4 to <12 Years With Persistent Asthma.|Completed||Phase 3|528|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:09:05.811262|2017-02-18 16:09:05.811262
NCT00392275|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2013-04-08|||November 2002||2002-11-01|December 2007|2007-12-01|May 2006|Actual|2006-05-01|||||Interventional|||Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs|Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs|Completed||Phase 4|48||Indiana University|||||f||||||||||||||2017-02-18 16:09:06.3082|2017-02-18 16:09:06.3082
NCT00388739|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2006-10-13|||November 2006||2006-11-01|October 2006|2006-10-01||||||||Interventional|||Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department|Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department|Unknown status|Not yet recruiting|N/A|251||Baylor College of Medicine|||||f||||||||||||||2017-02-18 16:10:36.079522|2017-02-18 16:10:36.079522
NCT00392262|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2016-11-16|||August 2006||2006-08-01|November 2016|2016-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients|An Multicenter Study to Evaluate the Efficacy and Tolerability of a 4-week Therapy With the Combination of Valsartan 160mg + Amlodipine 5mg in Hypertensive Patients Not Adequately Responding to 4-week Treatment With Amlo 5mg or Felodipine 5mg in Monotherapy|Completed||Phase 3|224|Actual|Novartis|||||f||||||||||||||2017-02-18 16:09:06.41456|2017-02-18 16:09:06.41456
NCT00392249|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2008-02-25|||November 2006||2006-11-01|February 2008|2008-02-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Supervised Treatment of Schizophrenia, a Randomized Controlled Trial.|Supervised Treatment in Outpatients for Schizophrenia (STOPS)Versus Treatment as Usual in Outpatients, a Randomized Controlled Trial.|Unknown status|Active, not recruiting|Phase 1/Phase 2|110|Anticipated|Lady Reading Hospital, Pakistan||2|||f||||||||||||||2017-02-18 16:09:06.519226|2017-02-18 16:09:06.519226
NCT00392236|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2014-03-10|2014-03-10||April 2006||2006-04-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers|2-Way Pagers to Improve Schizophrenia Medication Adherence|Completed||N/A|58|Actual|Northwell Health||2|||f||||t||||||||||2017-02-18 16:09:06.613194|2017-02-18 16:09:06.613194
NCT00392223|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2010-01-05|2009-06-11||October 2007||2007-10-01|January 2010|2010-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne|A Phase III, Multicenter, Randomized, Double Blind-Double Dummy Study, To Evaluate Efficacy And Safety Of Treatment With Azithromycin, Microspheres, Oral Powder For Suspension, 2 G, In One Administration A Week, For 8 Weeks, Compared With Treatment With Minocycline Capsules, 100 Mg Die For 8 Weeks, In Outpatients With Moderate To Severe Inflammatory Acne.|Terminated||Phase 3|118|Actual|Pfizer||2||See Detailed Description|f||||||||||||||2017-02-18 16:09:07.117884|2017-02-18 16:09:07.117884
NCT00392210|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2009-12-15|||October 2006||2006-10-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Assessment of Two Postoperative Techniques Used to Predict Voiding Efficiency After Gynecologic Surgery|Assessment of Two Postoperative Techniques Used to Predict Voiding Efficiency After Gynecologic Surgery|Completed||N/A|135|Actual|University of Rochester||1|||f||||f||||||||||2017-02-18 16:09:07.743571|2017-02-18 16:09:07.743571
NCT00392197|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2013-12-19|2013-12-19||November 2006||2006-11-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||"The glucose metabolism analysis set.~The numbers of excluded subjects from the data of partcipant flow were:~violation of inclusion/exclusion criteria: naïve arm- 4, prior treated arm- 1~no data of blood glucose level after treatment: naïve arm- 3, prior treated arm- 2"|Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-|Post Marketing Clinical Study of Aripiprazole in Patients With Schizophrenia - Effects on Glucose Metabolism-|Completed||Phase 4|111|Actual|Otsuka Pharmaceutical Co., Ltd.||1|||f||||||||||||||2017-02-18 16:09:07.839786|2017-02-18 16:09:07.839786
NCT00392184|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2015-05-29|||November 2000||2000-11-01|May 2015|2015-05-01|October 2010|Actual|2010-10-01|February 2009|Actual|2009-02-01||Interventional|||Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery|Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery|Completed||Phase 2|274|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-02-18 16:09:08.286042|2017-02-18 16:09:08.286042
NCT00392171|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2010-06-03|2010-04-21||June 2006||2006-06-01|June 2010|2010-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601AM1)(COMPLETED)|The Temozolomide RESCUE Study: A Phase II Trial of Continuous (28/28) Dose-intense Temozolomide (CDIT) Chemotherapy After Progression on Conventional 5/28 Day Temozolomide in Patients With Recurrent Malignant Glioma|Completed||Phase 2|120|Actual|Schering-Plough||1|||f||||||||||||||2017-02-18 16:09:08.388618|2017-02-18 16:09:08.388618
NCT00392158|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2016-09-23|||February 2006||2006-02-01|September 2016|2016-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Manual Administration of Propofol-remifentanil Versus Dual Closed-loop Using Bispectral Index as the Control Variable|Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by the Index Bispectral: Comparison Between Manual Perfusion and Automated Perfusion|Completed||Phase 4|240||Hopital Foch|||||f||||f||||||||No||2017-02-18 16:09:11.353932|2017-02-18 16:09:11.353932
NCT00392145|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2013-12-10|||November 2006||2006-11-01|December 2013|2013-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis|Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis: A Randomized Controlled Trial|Completed||Phase 4|226|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 16:09:11.444958|2017-02-18 16:09:11.444958
NCT00392132|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2008-11-24|||October 2005||2005-10-01|November 2008|2008-11-01|October 2006|Anticipated|2006-10-01|October 2006|Anticipated|2006-10-01||Observational|||Impact of Screening Patients With HIV for Kidney Disease|Impact of Screening Patients With HIV for Kidney Disease|Withdrawn||N/A|1400||University of Mississippi Medical Center||||Sufficient study funding was not obtained.|f||||||||||||||2017-02-18 16:09:11.545452|2017-02-18 16:09:11.545452
NCT00392119|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2009-12-30|||October 2006||2006-10-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|||||Interventional|||"MR Guided Laser Interstitial Thermal Therapy for the Minimal Invasive Treatment of Brain Metastasis and Primary Brain Tumors"|"The Clinical Evaluation of the Stereotactic, MR Guided, Laser Interstitial Thermal Therapy (LITT ) for the Minimal Invasive Treatment of Brain Metastasis and Primary Brain Tumors - a Phase I Study With Direct Patient Benefice"|Completed||Phase 1|18|Anticipated|BioTex, Inc.|||||f||||||||||||||2017-02-18 16:09:11.628858|2017-02-18 16:09:11.628858
NCT00392106|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2008-06-16|||April 2006||2006-04-01|June 2008|2008-06-01|June 2011|Anticipated|2011-06-01|December 2010|Anticipated|2010-12-01||Interventional|||High Intensity Focused Ultrasound (HIFU) Ablation System Study|Study of Focused Circumferential UltraSound for the Treatment of Atrial Fibrillation|Suspended||Phase 3|240|Anticipated|ProRhythm, Inc.||2||voluntarily by Sponsor to investigate an anticipated SAE|f||||||||||||||2017-02-18 16:09:11.720854|2017-02-18 16:09:11.720854
NCT00391495|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-22|2007-06-18|||September 2007||2007-09-01|August 2006|2006-08-01|December 2007|Anticipated|2007-12-01|||||Observational|ADHD_CYTO||Inflammation in Children With Attention-Deficit/Hyperactivity Disorder|Inflammation in Children With Attention-Deficit/Hyperactivity Disorder|Unknown status|Not yet recruiting|N/A|45|Anticipated|Tel-Aviv Sourasky Medical Center|||||f||||t||||||||||2017-02-18 16:09:27.232016|2017-02-18 16:09:27.232016
NCT00392093|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2006-10-23|||November 1997||1997-11-01|October 2006|2006-10-01|December 2001||2001-12-01|||||Interventional|||Effect of Hormone Replacement Therapy on Lupus Activity|Effect Of Hormone Replacement Therapy On Disease Activity, Menopausal Symptoms And Bone Mineral Density In Peri/Postmenopausal Women With Systemic Lupus Erythematosus.Randomized Clinical Trial|Completed||Phase 4|108||Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||||f||||||||||||||2017-02-18 16:09:11.869524|2017-02-18 16:09:11.869524
NCT00392080|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2008-03-18|||November 2006||2006-11-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|||||Interventional|||A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers|A Multicenter, Randomized, Placebo And Active-Controlled Study Of The Effect Of CJ-023,423 On The Incidence Gastroduodenal Endoscopic Ulcers In Healthy Subjects|Completed||Phase 1|340|Anticipated|Pfizer||3|||f||||f||||||||||2017-02-18 16:09:12.210301|2017-02-18 16:09:12.210301
NCT00392067|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2008-04-29|||October 2006||2006-10-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||LEO19123 Cream in the Treatment of Atopic Dermatitis|LEO19123 Cream in the Treatment of Atopic Dermatitis|Completed||Phase 2|75|Anticipated|LEO Pharma|||||f||||||||||||||2017-02-18 16:09:12.343511|2017-02-18 16:09:12.343511
NCT00392054|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2011-07-20|||August 2006||2006-08-01|July 2011|2011-07-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|RAAFT||First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)|First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment: A Multi-center Randomized Trial|Unknown status|Active, not recruiting|Phase 3|127|Actual|Population Health Research Institute||2|||f||||t||||||||||2017-02-18 16:09:12.431542|2017-02-18 16:09:12.431542
NCT00392041|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2014-02-19|||August 2006||2006-08-01|February 2014|2014-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Eszopiclone in the Treatment of Insomnia and Fibromyalgia|Eszopiclone in the Treatment of Insomnia and Associated Symptoms of Fibromyalgia|Completed||Phase 4|36|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 16:09:12.577707|2017-02-18 16:09:12.577707
NCT00392028|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2007-07-12|||November 2006||2006-11-01|July 2007|2007-07-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Penetration of Ertapenem Into Bone|Penetration of Ertapenem Into Bone in Patients With Diabetes Mellitus or Peripheral Vascular Diseases Who Underwent Bellow Knee Amputation|Withdrawn||N/A|12|Anticipated|HaEmek Medical Center, Israel||1||no recruitment|f||||f||||||||||2017-02-18 16:09:12.693065|2017-02-18 16:09:12.693065
NCT00392015|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2016-08-18||2015-06-08|October 2006||2006-10-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|October 2011|Actual|2011-10-01||Interventional|||NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1|A Two Part Clinical Trial Assessing the Safety, Tolerability, Immunogenicity and Protective Efficacy of NMRC-M3V-Ad-PfCA, a Multivalent, Adenovirus-Vectored Plasmodium Falciparum Malaria Vaccine, in Healthy, Malaria-Naïve Adults|Active, not recruiting||Phase 1/Phase 2|70|Anticipated|U.S. Army Medical Research and Materiel Command||2|||f||||f||||||||||2017-02-18 16:09:12.789542|2017-02-18 16:09:12.789542
NCT00392002|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2008-01-24|||October 2005||2005-10-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response|A Cluster-Randomized Study to Examine National Characteristics and Outcome Measures of GERD Patients Utilizing the PPI Acid Suppression Symptom (PASS) Test for Response [EncomPASS].|Completed||Phase 4|2000||AstraZeneca|||||f||||||||||||||2017-02-18 16:09:12.912478|2017-02-18 16:09:12.912478
NCT00391989|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2016-11-16|2014-01-23||September 2006||2006-09-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Adult Ph+ LAL With BMS-354825|A Phase II Multicenter Study on the Treatment of Adult de Novo Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) With the Protein Tyrosine Kinase Inhibitor BMS-354825. EudraCT Number 2005-005107-42.|Completed||Phase 2|53|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||||||||||||2017-02-18 16:09:13.011536|2017-02-18 16:09:13.011536
NCT00391976|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2011-07-29|2011-05-18||November 2003||2003-11-01|July 2011|2011-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|ELITE||Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis|The Microbiologic Efficacy and Safety of Two Treatment Regimens of Inhaled Tobramycin Nebuliser Solution (TNS) for the Treatment of Early Onset Pseudomonas Aeruginosa Lower Respiratory Tract Infection in Subjects With Cystic Fibrosis|Completed||Phase 3|123|Actual|Novartis||2|||f||||f||||||||||2017-02-18 16:09:13.282287|2017-02-18 16:09:13.282287
NCT00391963|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2009-01-14|||June 2006||2006-06-01|January 2009|2009-01-01|April 2007|Actual|2007-04-01|||||Observational|||Comparison of the Bispectral Index and the Entropy of the Electroencephalogram During Total Intravenous Anesthesia|Comparison of the Bispectral Index and the Entropy of the Electroencephalogram During Total Intravenous Anesthesia|Completed||N/A|84||Hopital Foch|||||f||||||||||||||2017-02-18 16:09:14.148281|2017-02-18 16:09:14.148281
NCT00391950|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2009-11-20|||October 2006||2006-10-01|November 2009|2009-11-01||||May 2007|Actual|2007-05-01||Interventional|||Maintaining Bone Strength in Men With Prostate Cancer|An Open-Label, Randomized, Multicentre Study to Evaluate the Efficacy of Two Zoledronic Acid Schedules on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy|Terminated||Phase 3|300|Anticipated|Novartis|||||f||||||||||||||2017-02-18 16:09:14.460229|2017-02-18 16:09:14.460229
NCT00391937|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2013-02-28|||October 2006||2006-10-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy of a New Resurfacing Hip Prosthesis|Efficacy of a New Resurfacing Hip Prosthesis. A Multicenter, Prospective, Randomized, Controlled Study|Completed||Phase 3|150|Actual|Erasmus Medical Center||2|||f||||||||||||||2017-02-18 16:09:14.562493|2017-02-18 16:09:14.562493
NCT00391924|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2006-10-24|||May 2000||2000-05-01|October 2006|2006-10-01|January 2003||2003-01-01|||||Interventional|||Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome|Fatigue and General Well-Being in Patients With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome: Effects of Dehydroepiandrosterone Administration|Completed||Phase 2|120||UMC Utrecht|||||f||||||||||||||2017-02-18 16:09:14.675542|2017-02-18 16:09:14.675542
NCT00391911|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2012-03-01|||November 2006||2006-11-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis|A Randomized Factorial Trial of N-Acetylcysteine and Continuous Veno-Venous Hemo(Dia)Filtration for Rhabdomyolysis|Completed||Phase 2|3|Actual|Royal Alexandra Hospital||4|||f||||f||||||||||2017-02-18 16:09:14.788838|2017-02-18 16:09:14.788838
NCT00391898|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2011-02-16|2011-01-04||October 2006||2006-10-01|February 2011|2011-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off|A 3-month, Multi-center, Double-blind, Randomized Study to Evaluate the Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Impairment of Activities of Daily Living and Early Wearing-off With Levodopa|Completed||Phase 4|95|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:09:14.92353|2017-02-18 16:09:14.92353
NCT00391885|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2016-09-26|||September 2006||2006-09-01|September 2016|2016-09-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy|Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy of the Electroencephalogram: Comparison Between Manual Perfusion and Automated Perfusion|Completed||Phase 4|60||Hopital Foch|||||f||||f||||||||No||2017-02-18 16:09:15.409562|2017-02-18 16:09:15.409562
NCT00391872|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2012-02-10|2011-01-31||October 2006||2006-10-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|PLATO||A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome|A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of Ticagrelor Compared With Clopidogrel for Prevention of Vascular Events in Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO- a Study of PLATelet Inhibition and Patient Outcomes]|Completed||Phase 3|18624|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:09:15.55893|2017-02-18 16:09:15.55893
NCT00391859|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-24|2014-03-14|||September 2006||2006-09-01|March 2014|2014-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Pharmacist-initiated Intervention Trial in OsteoArthritis (PhIT-OA)|Pharmacist-initiated Intervention Trial in OsteoArthritis (PhIT-OA)|Completed||N/A|135|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:09:19.92197|2017-02-18 16:09:19.92197
NCT00391846|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2012-06-18|2010-05-10||October 2006||2006-10-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone|A Randomised, Single Blind, Multicentre, 9-month, Phase IV Study, Comparing Treatment Guided by Clinical Symptoms and Signs and NT-proBNP vs Treatment Guided by Clinical Symptoms and Signs Alone, in Patients With Heart Failure (HF) and Left Ventricular Systolic Dysfunction|Completed||Phase 4|252|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:09:20.028826|2017-02-18 16:09:20.028826
NCT00391833|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-22|2006-10-22|||April 2004||2004-04-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||Effect of Panax Ginseng on the Cognitive Performance in Alzheimer’s Disease||Completed||Phase 1/Phase 2|||Seoul National University Hospital|||||f||||||||||||||2017-02-18 16:09:20.872249|2017-02-18 16:09:20.872249
NCT00391820|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2014-12-01|||October 2006||2006-10-01|December 2014|2014-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of TD-5108 for the Treatment of Chronic Constipation|Completed||Phase 2|360|Anticipated|Theravance Biopharma R & D, Inc.|||||f||||f||||||||||2017-02-18 16:09:20.950646|2017-02-18 16:09:20.950646
NCT00391807|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2013-04-15|2010-11-23||November 2006||2006-11-01|April 2013|2013-04-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Study of Safety and Efficacy of an Oral Contraceptive|Open-Label Study of the Safety and Efficacy of a Low Dose Oral Contraceptive Containing Norethindrone Acetate and Ethinyl Estradiol|Completed||Phase 3|1683|Actual|Warner Chilcott||1|||f||||f||||||||||2017-02-18 16:09:21.035001|2017-02-18 16:09:21.035001
NCT00391794|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2014-01-09|||September 2006||2006-09-01|January 2014|2014-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy of Early Stage Alzheimer's Support Groups|Efficacy of Early Stage Alzheimer's Support Groups|Completed||N/A|154|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:09:21.688879|2017-02-18 16:09:21.688879
NCT00391781|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2007-09-24|||December 2006||2006-12-01|August 2007|2007-08-01|December 2008||2008-12-01|||||Interventional|||Warm Contrast Media for Pain Reduction During Hystersalpingography|Prospective Randomised Controlled Trian of Warmed vs. Room Temperature Contrast Media for Hystersalpingography|Unknown status|Recruiting|N/A|||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:09:21.806032|2017-02-18 16:09:21.806032
NCT00391768|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2013-04-25|2011-03-17||January 2007||2007-01-01|February 2010|2010-02-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza|A Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Oseltamivir (Tamiflu®) for the Treatment of Children Less Than 24 Months of Age With Confirmed Influenza Infection (CASG 114)|Completed||Phase 1/Phase 2|87|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 16:09:21.921148|2017-02-18 16:09:21.921148
NCT00391755|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-22|2012-02-08|||October 2006||2006-10-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches|A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches|Terminated||Phase 4|4|Actual|Charlottesville Neuroscience||2||Failure to recruit necessary number of patients.|f||||t||||||||||2017-02-18 16:09:23.333814|2017-02-18 16:09:23.333814
NCT00391742|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2006-10-23|||October 2001||2001-10-01|October 2006|2006-10-01|June 2004||2004-06-01|||||Interventional|||Stepped Interventions for Problem Drinkers|A Stepped-Care Approach for General Practice Patients With Alcohol Use Disorders|Completed||N/A|450||University of Luebeck|||||f||||||||||||||2017-02-18 16:09:23.443305|2017-02-18 16:09:23.443305
NCT00391729|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2011-10-14|||October 2006||2006-10-01|October 2011|2011-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose-Ranging Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|221|Actual|Abbott||2|||f||||||||||||||2017-02-18 16:09:23.526995|2017-02-18 16:09:23.526995
NCT00391716|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2014-11-07|2014-06-09||February 2004||2004-02-01|November 2014|2014-11-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional||Sample size estimate was derived from results of a prior trial that found an odds ratio of 2.96 for complete abstinence, estimating a sample size of 150 would show a medium effect size for the difference between gabapentin and placebo in rate of complete abstinence.|Gabapentin Treatment of Alcohol Dependence|Gabapentin Treatment of Alcohol Dependence|Completed||Phase 2|150|Actual|The Scripps Research Institute||3|||f||||f||||||||||2017-02-18 16:09:23.832662|2017-02-18 16:09:23.832662
NCT00391703|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2010-11-10|||October 2006||2006-10-01|November 2010|2010-11-01|September 2010|Actual|2010-09-01|November 2009|Actual|2009-11-01||Interventional|STIMUCO||Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic Fibrosis|Assessment of Quadriceps Muscle Electrostimulation Used as an Additional Procedure for Effort Retraining in Patients Suffering From Cystic Fibrosis Associated With Severe Pulmonary Dysfunction|Terminated||N/A|40|Anticipated|University Hospital, Grenoble||2||enrolment difficulties|f||||f||||||||||2017-02-18 16:09:24.346175|2017-02-18 16:09:24.346175
NCT00391690|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2016-11-16|||February 2006||2006-02-01|November 2016|2016-11-01||||December 2010|Actual|2010-12-01||Interventional|||Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer|Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer|Completed||Phase 4|99|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:09:24.460916|2017-02-18 16:09:24.460916
NCT00391677|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2012-09-27|||January 2007||2007-01-01|September 2012|2012-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia|Effectiveness Trial of Attention Shaping for Schizophrenia|Completed||N/A|120|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-02-18 16:09:24.562395|2017-02-18 16:09:24.562395
NCT00391664|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2008-06-26|||February 2006||2006-02-01|June 2008|2008-06-01|February 2011||2011-02-01|||||Observational|||Questionnaire Study for Gynecological Cancer Survivors|Gynecologic Cancer Survivorship Survey|Unknown status|Recruiting|N/A|1000|Anticipated|Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 16:09:24.677545|2017-02-18 16:09:24.677545
NCT00391651|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2014-06-03|||January 2002||2002-01-01|June 2014|2014-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Short Course Nitrofurantoin for Acute Cystitis|Short Course Nitrofurantoin For Acute Cystitis|Completed||Phase 2|338|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 16:09:24.936331|2017-02-18 16:09:24.936331
NCT00391638|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2015-01-14|||January 2007||2007-01-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|May 2011|Actual|2011-05-01||Interventional|HB01EMVIPEG||Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients|Pilot Study on Efficacy and Tolerance of Peg-interferon Alpha-2a (Pegasys) Added to Tenofovir DF and Emtricitabine (Truvada) in AGHBe Positive HBV-HIV Co-infected Patients. ANRS HB 01 EMVIPEG.|Completed||Phase 2/Phase 3|56|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||1|||f||||t||||||||||2017-02-18 16:09:25.060979|2017-02-18 16:09:25.060979
NCT00391625|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2016-05-13|2014-03-04||February 2005||2005-02-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)|An Open-Label Extension of Study TKT025 Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A Enzyme Replacement Therapy|Completed||Phase 1/Phase 2|10|Actual|Shire|Imputation was applied to missing data.|1|||f||||f||||||||||2017-02-18 16:09:25.184194|2017-02-18 16:09:25.184194
NCT00391612|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2011-01-10|||May 2006||2006-05-01|January 2011|2011-01-01|December 2013|Anticipated|2013-12-01|October 2009|Anticipated|2009-10-01||Interventional|EASE||EASE Trial: Exhale Airway Stents for Emphysema|A Randomized, Double-blind Study to Evaluate the Safety and Effectiveness of the Exhale® Drug-Eluting Stent in Homogeneous Emphysema Subjects With Severe Hyperinflation|Unknown status|Active, not recruiting|Phase 3|450|Anticipated|Broncus Technologies||2|||f||||||||||||||2017-02-18 16:09:25.862901|2017-02-18 16:09:25.862901
NCT00391599|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-22|2016-03-05|2015-12-18||January 2009||2009-01-01|January 2016|2016-01-01||||October 2011|Actual|2011-10-01||Interventional|||Enemas Before Elective Cesarean Section|Are Enemas Given Before Elective Cesarean Section Useful?|Completed||Phase 2|130|Actual|Wolfson Medical Center||2|||f||||||||||||||2017-02-18 16:09:26.025825|2017-02-18 16:09:26.025825
NCT00391586|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2015-08-14|2015-06-15||July 2006||2006-07-01|August 2015|2015-08-01|May 2012|Actual|2012-05-01|May 2011|Actual|2011-05-01||Interventional||These are patients who received at least one dose of on-study erlotinib|Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung|INST 0601C: A Non-Randomized Phase II Protocol of Erlotinib for Patients With Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung|Terminated||Phase 2|45|Actual|New Mexico Cancer Care Alliance||1||PI left institution.|f||||t||||||||||2017-02-18 16:09:26.371232|2017-02-18 16:09:26.371232
NCT00391573|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2011-06-14|||March 2005||2005-03-01|June 2011|2011-06-01|June 2005||2005-06-01|||||Interventional|||Polyglactin Sutures Versus Nylon Sutures for Suturing of Conjunctival Autograft in Pterygium Surgery: a Randomised Controlled Trial|Polyglactin Sutures Versus Nylon Sutures for Suturing of Conjunctival Autograft in Pterygium Surgery: a Randomised Controlled Trial|Completed||N/A|32||Hospital Authority, Hong Kong|||||f||||||||||||||2017-02-18 16:09:26.65675|2017-02-18 16:09:26.65675
NCT00391560|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2013-03-04|||October 2006||2006-10-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia|Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia|Completed||Phase 2|19|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 16:09:26.735479|2017-02-18 16:09:26.735479
NCT00391547|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2007-10-18|||October 2006||2006-10-01|October 2007|2007-10-01|January 2007||2007-01-01|||||Interventional|||Pilot Efficacy Study to Treat Gingivitis|Phase II Pilot Efficacy Study to Treat Gingivitis|Completed||Phase 2|14||Biomedical Development Corporation|||||||||||||||||||2017-02-18 16:09:26.837605|2017-02-18 16:09:26.837605
NCT00391534|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2010-04-14|||October 2006||2006-10-01|January 2009|2009-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy|Safety and Efficacy of a Novel Modified Release Formulation of Oxcarbazepine (OXC MR) vs an Immediate Release Oxcarbazepine (OXC IR) Product in Patients With Partial Epilepsy|Terminated||Phase 3|100|Anticipated|Desitin Arzneimittel GmbH||2||Low recruitment rate|f||||f||||||||||2017-02-18 16:09:26.929102|2017-02-18 16:09:26.929102
NCT00391521|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2014-01-29|||August 2006||2006-08-01|January 2014|2014-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||AS703569 Phase I in Patients With Solid Tumours|A Phase I Multicenter, Open-Label, Dose Escalation Trial of AS703569 Given Orally to Subjects With Solid Tumours|Completed||Phase 1|104|Actual|EMD Serono||3|||f||||||||||||||2017-02-18 16:09:27.05206|2017-02-18 16:09:27.05206
NCT00391482|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2017-01-10|||June 2002||2002-06-01|November 2008|2008-11-01|February 2005||2005-02-01|||||Interventional|||Study to Reduce Intravenous Exposures (STRIVE)|Behavioral Intervention Trial to Reduce Transmission Risks and Improve HCV Treatment Access Among HCV-infected Injection Drug Users|Completed||Phase 2/Phase 3|750||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:09:27.445597|2017-02-18 16:09:27.445597
NCT00391469|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2014-11-23|2014-11-23||December 2007||2007-12-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|May 2013|Actual|2013-05-01||Interventional|||Induction of Mild Hypothermia Following Out-of-hospital Cardiac Arrest|Study of the Use of Mild Hypothermia in Out-of-hospital Cardiac Arrest Using a Rapid Infusion of 2 Liters of Cold Normal Saline|Completed||Phase 2/Phase 3|1359|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 16:09:27.541928|2017-02-18 16:09:27.541928
NCT00391456|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2016-06-01|||November 2001||2001-11-01|June 2016|2016-06-01|July 2004||2004-07-01|||||Interventional|||Animal-Assisted Therapy for Hospitalized Heart Failure Patients|Use of Animal-Assisted Therapy to Decrease Cardiopulmonary Pressures, Neurohormone Levels, and State Anxiety in Patients Hospitalized With Heart Failure|Completed||N/A|76||University of California, Los Angeles|||||f||||||||||||||2017-02-18 16:09:27.984226|2017-02-18 16:09:27.984226
NCT00391443|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2015-09-09|2012-04-25||February 2007||2007-02-01|August 2015|2015-08-01|July 2010|Actual|2010-07-01|February 2010|Actual|2010-02-01||Interventional|BUILD 3||BUILD 3: Bosentan Use in Interstitial Lung Disease|Effects of Bosentan on Morbidity and Mortality in Patients With Idiopathic Pulmonary Fibrosis - a Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Event-driven, Group Sequential, Phase III Study.|Completed||Phase 3|616|Actual|Actelion||2|||f||||||||||||||2017-02-18 16:09:28.097729|2017-02-18 16:09:28.097729
NCT00391430|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2016-04-21|||May 2005||2005-05-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder|Cognitive Behavioral Therapy vs. Sertraline in the Treatment of Post Traumatic Stress Disorder|Completed||Phase 4|90|Actual|New York University School of Medicine||3|||f||||||||||||||2017-02-18 16:09:29.529604|2017-02-18 16:09:29.529604
NCT00391417|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2006-10-20|||September 2003||2003-09-01|October 2006|2006-10-01|April 2005||2005-04-01|||||Interventional|||Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms|Phase III, Multicenter, Double-Blind Study of the Safety and Efficacy of Bio-E-Gel (Topical Estradiol Gel) Versus Placebo for Treatment of Vasomotor Symptoms and Vulvovaginal Atrophy in Postmenopausal Females|Completed||Phase 3|431||BioSante Pharmaceuticals|||||||||||||||||||2017-02-18 16:09:29.681666|2017-02-18 16:09:29.681666
NCT00391404|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2008-05-22|||May 2006||2006-05-01|May 2008|2008-05-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Fosamax for Childhood Cancer Survivors|Randomized Controlled Study on the Benefits and Safety of Bisphosphonate Treatment in Childhood Cancer Survivors|Unknown status|Recruiting|Phase 3|100|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 16:09:29.762245|2017-02-18 16:09:29.762245
NCT00391391|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-23|2011-11-21|2011-10-12||October 2006||2006-10-01|November 2011|2011-11-01|October 2007|Actual|2007-10-01|March 2007|Actual|2007-03-01||Interventional|||Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children|Immunogenicity and Safety of a Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route in Comparison With Intramuscular Vaccination With Standard Fluzone® in Healthy Infants and Young Children.|Completed||Phase 2|520|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 16:09:29.878095|2017-02-18 16:09:29.878095
NCT00391378|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-21|2017-01-24|||September 9, 2006||2006-09-09|January 3, 2011|2011-01-03|January 3, 2011||2011-01-03|||||Observational|||Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)|Cerebral Lesions and Outcomes After Cardiac Surgery (CLOCS)|Completed||N/A|363|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:09:30.994781|2017-02-18 16:09:30.994781
NCT00391365|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2016-10-27|2016-09-26||March 2005||2005-03-01|October 2016|2016-10-01|August 2018|Anticipated|2018-08-01|August 2015|Actual|2015-08-01||Observational|||Treatment Outcomes for Ankle Arthritis|Treatment Outcomes for Ankle Arthritis|Active, not recruiting||N/A|368|Actual|VA Office of Research and Development|This study was not randomized, and no chart review was conducted.||2||f||||f||||||None Retained|"~     No biospecimens are used in this project~   "|Undecided||2017-02-18 16:09:31.075317|2017-02-18 16:09:31.075317
NCT00391352|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2014-06-03|||February 2008||2008-02-01|May 2008|2008-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to Controls|A Phase 4, fMRI Study of Treatment Recommendations Comparing Patients Taking IFN-β-1a 44 mcg Tiw SC (Rebif®) to Controls of Patients Recently Diagnosed With Relapsing Remitting Multiple Sclerosis Currently Naive to Disease-Modifying Therapy.|Completed||Phase 4|21|Actual|Waukesha Memorial Hospital|||2||f||||f||||||||||2017-02-18 16:09:31.491858|2017-02-18 16:09:31.491858
NCT00391339|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2006-10-19|||November 2006||2006-11-01|October 2006|2006-10-01|October 2008||2008-10-01|||||Interventional|||Bryophyllum vs. Nifedipine|Bryophyllum p. Versus Nifedipine for the Treatment of Premature Contractions|Unknown status|Not yet recruiting|Phase 2/Phase 3|140||Weleda AG|||||f||||||||||||||2017-02-18 16:09:31.590797|2017-02-18 16:09:31.590797
NCT00391326|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2008-05-20|||November 2006||2006-11-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Efficacy and Safety of Prehospital Administration of Bivalirudin in STEMI Patients|Efficacy and Safety of Prehospital Administration of Bivalirudin in STEMI Patients Redirected for Primary PCI Based on Tele-Transmitted 12-Lead ECGs|Completed||N/A|102|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-02-18 16:09:31.667535|2017-02-18 16:09:31.667535
NCT00391313|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2015-08-27|||May 2006||2006-05-01|August 2015|2015-08-01|March 2007|Actual|2007-03-01|||||Interventional|||CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease|CuraChik : Double Blind Placebo-controlled Randomized Trial : Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease.|Terminated||Phase 3|||Assistance Publique Hopitaux De Marseille||||Terminated Chikungunya diseases has regressed and no more patients was suffering|f||||||||||||||2017-02-18 16:09:31.867942|2017-02-18 16:09:31.867942
NCT00391300|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2013-12-17|||October 2006||2006-10-01|October 2008|2008-10-01|April 2007|Anticipated|2007-04-01|April 2007|Anticipated|2007-04-01||Interventional|||Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions|Development of an Electrical Diagnostic for Melanoma and Other Cutaneous Malignancies|Unknown status|Active, not recruiting|Phase 1|100|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:09:31.944155|2017-02-18 16:09:31.944155
NCT00391287|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2014-10-02|||June 2006||2006-06-01|October 2014|2014-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|PRIMS||Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure|A Prospective, Immunogenicity Surveillance Registry (PRIMS) to Estimate the Incidence of Erythropoietin Antibody-Mediated Pure Red Cell Aplasia Among Subjects With Chronic Renal Failure and Subcutaneous Exposure to Recombinant Erythropoietin Products|Completed||Phase 4|15334|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||f||||||||||2017-02-18 16:09:32.047737|2017-02-18 16:09:32.047737
NCT00391274|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2011-04-08|2009-12-21||October 2006||2006-10-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|December 2008|Actual|2008-12-01||Interventional|||Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)|Phase 3 Study of Pemetrexed Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy|Completed||Phase 3|211|Actual|Eli Lilly and Company|The primary outcome measure of this trial was designed to include pooled data. In addition, the results for the outcome on Duration of Response could not be presented due to the low number of patients being analyzed in the docetaxel group.|2|||f||||f||||||||||2017-02-18 16:09:32.848502|2017-02-18 16:09:32.848502
NCT00391261|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2010-03-24|||July 2006||2006-07-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.|A Prospective Open-label Trial of Metformin for Weight Control of Pediatric Patients on Atypical Antipsychotic Medications.|Completed||Phase 4|11|Actual|Cambridge Health Alliance||1|||f||||f||||||||||2017-02-18 16:09:33.922251|2017-02-18 16:09:33.922251
NCT00391248|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2013-01-28|||November 2006||2006-11-01|April 2011|2011-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)|A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Patients With Non-small Cell Carcinoma of the Lung. (PEARL Trial)|Completed||Phase 2|40|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-02-18 16:09:34.01904|2017-02-18 16:09:34.01904
NCT00391235|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2010-12-02|||September 2005||2005-09-01|December 2010|2010-12-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Observational|||White Matter in Pediatric Bipolar Disorder: A DTI Study|White Matter Connectivity in Pediatric Bipolar Disorder: A Diffusion Tensor Imaging Study|Completed||N/A|28|Anticipated|Cambridge Health Alliance|||2||f||||f||||||||||2017-02-18 16:09:34.11328|2017-02-18 16:09:34.11328
NCT00391222|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2014-04-24|2010-04-19||November 2006||2006-11-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder|A Randomized, Double Blind, Placebo and Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of Risperidone Long-acting Injectable (LAI) for the Prevention of Mood Episodes in the Treatment of Subjects With Bipolar I Disorder|Completed||Phase 3|585|Actual|Janssen Pharmaceutica N.V., Belgium||3|||f||||f||||||||||2017-02-18 16:09:34.212588|2017-02-18 16:09:34.212588
NCT00391209|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2010-01-21|||October 2006||2006-10-01|January 2010|2010-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus|A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|379|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 16:09:35.136379|2017-02-18 16:09:35.136379
NCT00391196|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2012-11-05||2009-08-11|November 2006||2006-11-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients|A 1-Year, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study To Evaluate The Efficacy And Safety Of CP-945,598 In The Treatment Of Overweight, Oral Agent-Treated Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 3|975|Actual|Pfizer||3||See termination reason in detailed description.|f||||t||||||||||2017-02-18 16:09:35.2898|2017-02-18 16:09:35.2898
NCT00391183|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2013-07-10|||January 2006||2006-01-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.|Effect of Palliative Biliary Stenting Versus Conservative Treatment on the Quality of Life (QOL) of Patients With Unresectable Carcinoma of the Gallbladder With Hiliar Block: A Randomised Controlled Trial|Completed||Phase 2/Phase 3|60|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||||||||||||2017-02-18 16:09:35.497413|2017-02-18 16:09:35.497413
NCT00391170|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2017-02-15|||October 13, 2006||2006-10-13|February 13, 2017|2017-02-13|December 31, 2018|Anticipated|2018-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease|Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease|Recruiting||Phase 2|82|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:09:38.207419|2017-02-18 16:09:38.207419
NCT00391157|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2009-09-17|||August 2005||2005-08-01|September 2009|2009-09-01|January 2008|Actual|2008-01-01|June 2007|Actual|2007-06-01||Interventional|||VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma|VELCADEXA: A National, Multi-Center, Open-Label Study of Pretransplant Induction With Alternating VELCADE and Dexamethasone (VEL/Dex) in Younger (< 65 Yrs) Untreated Multiple Myeloma Patients.|Completed||Phase 2|40|Actual|PETHEMA Foundation||1|||f||||||||||||||2017-02-18 16:09:38.333481|2017-02-18 16:09:38.333481
NCT00391144|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2006-10-20|||July 2006||2006-07-01|October 2006|2006-10-01|October 2006||2006-10-01|||||Interventional|||Avastin for CNV Secondary to Pattern Dystrophy|Intravitreal Avastin Injection for the Treatment of Choroidal Neovascularization Secondary to Pattern Dystrophy|Unknown status|Recruiting|Phase 2/Phase 3|5||University of Trieste|||||f||||||||||||||2017-02-18 16:09:38.449369|2017-02-18 16:09:38.449369
NCT00391131|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2012-06-05|||April 2007||2007-04-01|June 2012|2012-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Subcutaneous Ig NextGen 16% in PID Patients|A Multi-centre, Open-label Study to Assess the Efficacy, Tolerability, Safety and Pharmacokinetics of Subcutaneous Infusions of Ig NextGen 16% in Patients With Primary Immunodeficiency (PID).|Completed||Phase 3|35|Actual|CSL Limited||1|||f||||||||||||||2017-02-18 16:09:38.546422|2017-02-18 16:09:38.546422
NCT00006134|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||September 1993||1993-09-01|December 2003|2003-12-01||||||||Observational|||Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture||Completed||N/A|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:27.374514|2017-02-18 18:13:27.374514
NCT00391118|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2012-07-19||2011-02-25|November 2006||2006-11-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|April 2010|Actual|2010-04-01||Interventional|||"Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo (Sugar Pill)"|A Randomized, Phase 2, Placebo-Controlled, Double-Blinded Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin as First-Line Treatment, Followed by Maintenance Treatment in Advanced Ovarian Cancer|Completed||Phase 2|149|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 16:09:38.654303|2017-02-18 16:09:38.654303
NCT00391105|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2006-10-19|||April 2004||2004-04-01|October 2006|2006-10-01|November 2005||2005-11-01|||||Interventional|||Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome|Comparative Study of the Use of Remifentanil Versus Morphine for Sedation and Analgesia of Premature Neonates During Mechanical Ventilation in the Treatment of Respiratory Distress Syndrome (RDS)|Completed||Phase 4|||Federal University of Minas Gerais|||||f||||||||||||||2017-02-18 16:09:38.772959|2017-02-18 16:09:38.772959
NCT00391092|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2015-08-21|2015-07-21||September 2006||2006-09-01|August 2015|2015-08-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional||Intent-to-treat (ITT) population: All randomized participants, regardless of whether they actually received study treatment or not.|A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.|A Randomized, Open-label Study to Compare the Effect of First-line Treatment With Avastin in Combination With Herceptin/Docetaxel and Herceptin/Docetaxel Alone on Progression-free Survival in Patients With HER2 Positive Locally Recurrent or Metastatic Breast Cancer.|Completed||Phase 3|424|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:09:41.391198|2017-02-18 16:09:41.391198
NCT00391079|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2013-06-13|2012-05-30||September 2006||2006-09-01|June 2013|2013-06-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|||Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS|A Double Blind, Randomised, Placebo Controlled, Parallel Group Study of Sativex When Added to the Existing Treatment Regimen, in the Relief of Central Neuropathic Pain in Subjects With Multiple Sclerosis|Completed||Phase 3|339|Actual|GW Pharmaceuticals Ltd.||2|||f||||f||||||||||2017-02-18 16:09:42.658001|2017-02-18 16:09:42.658001
NCT00391066|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2015-09-17||2015-09-17|November 2006||2006-11-01|April 2011|2011-04-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|LUCID||Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)|A Randomized, Open Label, Multicenter, Phase 2 Study to Evaluate the Safety and Efficacy of Lumiliximab in Combination With Fludarabine, Cyclophosphamide, and Rituximab Versus Fludarabine, Cyclophosphamide, and Rituximab Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia|Terminated||Phase 2|627|Actual|Biogen||2|||f||||t||||||||||2017-02-18 16:09:43.187441|2017-02-18 16:09:43.187441
NCT00391053|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2016-04-12|2010-01-14||October 2006||2006-10-01|April 2016|2016-04-01|February 2008|Actual|2008-02-01|July 2007|Actual|2007-07-01||Interventional|||Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly|Phase III Lot Consistency, Immunogenicity and Safety Study of Three Lots of Fluzone High Dose Vaccine Compared With One Lot of Standard Fluzone® in Adults ≥ 65 Years of Age.|Completed||Phase 3|3851|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 16:09:43.729268|2017-02-18 16:09:43.729268
NCT00391040|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2006-10-20|||November 2003||2003-11-01|October 2006|2006-10-01|May 2006||2006-05-01|||||Interventional|||SGS: a Structured Treatment and Teaching Programme for Elderly Patients With Diabetes Mellitus|SGS: a Structured Treatment and Teaching Programme for Elderly Patients With Diabetes Mellitus - a Prospective Randomized Controlled Multicenter Trial|Completed||N/A|200||German Diabetes Association|||||f||||||||||||||2017-02-18 16:09:45.500598|2017-02-18 16:09:45.500598
NCT00391027|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2015-06-30|2009-08-05||December 2006||2006-12-01|June 2015|2015-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®|A Six Month, Open-Label Outpatient, Randomized Parallel Group Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera®) On Glycemic Control Compared To Insulin Glargine (Lantus®) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Or More Oral Agents|Completed||Phase 4|261|Actual|Pfizer|Enrollment period concluded earlier than planned due to cancellation of Exubera® program by sponsor; enrollment was undersized to meet requirements of its inferential objectives. Revised analysis approach was descriptive with no inferential analyses.|2|||f||||f||||||||||2017-02-18 16:09:45.621538|2017-02-18 16:09:45.621538
NCT00391014|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2009-05-11|||January 2006||2006-01-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|AMBINEB||Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis|AMBINEB: Clinical Trial to Evaluate Tolerance and Safety of Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis in Patients With Acute Myeloid Leukemia and Allogeneic Haematopoietic Progenitor Cell Transplant (Alo-HPCT)|Completed||Phase 2|150|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 16:09:46.425097|2017-02-18 16:09:46.425097
NCT00391001|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2010-02-02|||February 2006||2006-02-01|June 2008|2008-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Taurine in Adolescents With Bipolar Disorder|Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder|Terminated||Phase 1|4|Actual|Cambridge Health Alliance||2|||f||||f||||||||||2017-02-18 16:09:46.554943|2017-02-18 16:09:46.554943
NCT00390988|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2009-02-19||||||February 2009|2009-02-01||||||||Observational|||Capillary and Venous Blood Count Parameters|Comparison of Capillary and Venous Blood Count Parameters|Completed||N/A|250||University of Magdeburg|||||f||||||||||||||2017-02-18 16:09:46.660966|2017-02-18 16:09:46.660966
NCT00390975|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2012-05-03|||January 2007||2007-01-01|May 2012|2012-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis|An Open-label Pilot Trial to Assess the Effect of Tegaserod on Improvement of Gastric Emptying in Patients With Diabetic Gastroparesis and Upper Gastrointestinal Symptoms|Terminated||Phase 4|40|Anticipated|Novartis||||"This study was terminated early as a result of regulatory action suspending tegaserod use in~   2007"|||||||||||||||2017-02-18 16:09:46.736838|2017-02-18 16:09:46.736838
NCT00390962|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2008-09-22|||November 2006||2006-11-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||"The COSMOS-Study (Copeptin in Osmoregulation and Stress Assessment)"|"Copeptin as a Novel Diagnostic and Prognostic Marker in the Management of Neurological and Neurosurgical Patients With Sodium Imbalance The COSMOS-Study (Copeptin in Osmoregulation and Stress Assessment)"|Completed||N/A|469|Actual|University Hospital, Basel, Switzerland|||1||f||||||||||Samples Without DNA|"~     bood sampling~   "|||2017-02-18 16:09:46.825274|2017-02-18 16:09:46.825274
NCT00390949|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2015-05-27|||July 1998||1998-07-01|October 2006|2006-10-01|February 2003||2003-02-01|||||Interventional|||Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in Zimbabwe|Impact and Process Evaluation of Integrated Community and Clinic-based HIV-1 Control: a Cluster-randomised Trial in Eastern Zimbabwe|Completed||N/A|||Imperial College London|||||f||||||||||||||2017-02-18 16:09:47.149395|2017-02-18 16:09:47.149395
NCT00390936|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2011-01-24|||October 2007||2007-10-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors|Phase I Multiple Ascending Dose Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-582664 in Japanese Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|13|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:09:47.247468|2017-02-18 16:09:47.247468
NCT00390923|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2013-08-27|||July 2007||2007-07-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence|Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence|Terminated||N/A|40|Anticipated|Centre for Addiction and Mental Health||2||Preliminary results did not support the utility of combining selegeline + NRT.|f||||f||||||||||2017-02-18 16:09:47.344158|2017-02-18 16:09:47.344158
NCT00390910|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2016-11-03||2009-05-20|October 2006||2006-10-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants|Study to Assess the Safety and Immunogenicity of GSK Biologicals 10-valent Pneumococcal Conjugate Vaccine When Co-administered With DTPa-HBV-IPV/Hib (Infanrix-Hexa) Vaccine in Preterm Infants as a 3-dose Primary Immunization Course During the First 6 Months of Life.|Completed||Phase 3|286|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:09:47.471277|2017-02-18 16:09:47.471277
NCT00390897|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2008-11-26|||July 2003||2003-07-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|October 2006|Actual|2006-10-01||Interventional|||Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia|Randomised Multicentre Phase IV Study to Compare Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec® in Combination With Interferon Alpha at Low Doses in the Treatment of Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukaemia|Completed||Phase 4|360||PETHEMA Foundation|||||f||||||||||||||2017-02-18 16:09:47.62104|2017-02-18 16:09:47.62104
NCT00390884|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-20|2016-04-12|2009-09-21||October 2006||2006-10-01|April 2016|2016-04-01|September 2008|Actual|2008-09-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.|Safety and Immunogenicity of Fluzone® Influenza Virus Vaccine (2006-2007 Formulation) Among Healthy Children Immunized in Fall 2005 With Fluzone Vaccine or Placebo|Completed||Phase 4|173|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:09:47.779956|2017-02-18 16:09:47.779956
NCT00390871|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2013-04-11|||April 2005||2005-04-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|ANIST||Acute Neurological ICU Sedation Trial (ANIST)|Acute Neurological ICU Sedation Trial (ANIST)|Completed||Phase 2|60|Actual|Johns Hopkins University||2|||f||||||||||||||2017-02-18 16:09:48.367785|2017-02-18 16:09:48.367785
NCT00390858|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2011-07-20|2010-12-21||September 2003||2003-09-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload.|A 4-year Extension to a Phase II a Multicenter Study Evaluating Long-term Safety, Tolerability, Pharmacokinetics and Effects on Liver Iron Concentration of Repeated Doses of 10 mg/kg/Day of Deferasirox in Pediatric Patients With Transfusion Dependent β-thalassemia Major.|Completed||Phase 2|40|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:09:48.487872|2017-02-18 16:09:48.487872
NCT00390845|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2010-11-04||2009-07-22|August 2006||2006-08-01|November 2010|2010-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain|A Double-blind Placebo-controlled Study of the Efficacy and Safety of the P38 Map Kinase Inhibitor SB681323 in Patients With Neuropathic Pain Following Nerve Trauma|Completed||Phase 2|40|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:09:49.250414|2017-02-18 16:09:49.250414
NCT00390832|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2010-12-16|||December 2006||2006-12-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|REVIVAL-3||Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3)|Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (REVIVAL-3)|Completed||Phase 3|138|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 16:09:49.348064|2017-02-18 16:09:49.348064
NCT00390819|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2006-10-19|||November 2006||2006-11-01|October 2006|2006-10-01||||||||Observational|||Epidemiology of Community Acquired Pneumonia in North Israel|Epidemiology of Community Acquired Pneumonia in North Israel|Unknown status|Not yet recruiting|N/A|100|Anticipated|HaEmek Medical Center, Israel|||||f||||||||||||||2017-02-18 16:09:49.462872|2017-02-18 16:09:49.462872
NCT00390806|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2013-12-05|2013-03-08||December 2006||2006-12-01|December 2013|2013-12-01|September 2013|Actual|2013-09-01|July 2012|Actual|2012-07-01||Interventional|||Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer|A Randomized, Phase III, Open-Label Study of Oral Topotecan Plus Whole-Brain Radiation Therapy (WBRT) Compared With WBRT Alone in Patients With Brain Metastases From Non-Small Cell Lung Cancer|Completed||Phase 3|472|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 16:09:49.801672|2017-02-18 16:09:49.801672
NCT00390793|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-03-22|||September 2006||2006-09-01|March 2016|2016-03-01||||August 2017|Anticipated|2017-08-01||Interventional|||Hyper-CVAD Plus Dasatinib in Philadelphia/BCR-ABL Positive ALL|Phase II Study of Combination of Hyper-CVAD and Dasatinib in Patients With Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)|Active, not recruiting||Phase 2|115|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 16:09:52.648238|2017-02-18 16:09:52.648238
NCT00390442|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2006-10-17||||||October 2006|2006-10-01||||||||Interventional|||Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema|Effect of Continuous Positive Airway Pressure as a First Line Therapy in Out-of-Hospital Management of Severe Cardiogenic Pulmonary Edema|Completed||Phase 3|||Hopital Lariboisière|||||f||||||||||||||2017-02-18 16:10:03.107015|2017-02-18 16:10:03.107015
NCT00390780|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2013-09-05|2012-09-07||July 2006||2006-07-01|February 2013|2013-02-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients|A Comparative Randomized, Double-blind, Double-Dummy, Multicenter Study of the Efficacy and Safety of Miconazole Lauriad 50mg Administered Once a Day and Mycelex Troches (Clotrimazole 10mg) Administered Five Times a Day in the Treatment of Oropharyngeal Candidiasis in Immunocompromised Patients|Completed||Phase 3|578|Actual|Onxeo||2|||f||||t||||||||||2017-02-18 16:09:52.804286|2017-02-18 16:09:52.804286
NCT00390767|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2015-03-04|||October 2006||2006-10-01|March 2015|2015-03-01|December 2024|Anticipated|2024-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD)|A Phase I Safety, Dose Escalating Study of MultiGeneAngio in Patients With Peripheral Arterial Disease|Active, not recruiting||Phase 1/Phase 2|12|Actual|MultiGene Vascular Systems Ltd.||1|||f||||t||||||||||2017-02-18 16:09:53.685579|2017-02-18 16:09:53.685579
NCT00390754|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2008-07-25|||October 2006||2006-10-01|July 2008|2008-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Usefulness of Home Pregnancy Testing|Utility of Home Pregnancy Testing in Medicaid Women at Risk for Unintended Pregnancy|Completed||N/A|198|Actual|Michigan State University||2|||f||||t||||||||||2017-02-18 16:09:53.803041|2017-02-18 16:09:53.803041
NCT00390741|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2008-05-27|||October 1998||1998-10-01|May 2008|2008-05-01|September 2005|Actual|2005-09-01|September 2004|Actual|2004-09-01||Interventional|Hip4||BHS4 - Bone/Muscle Changes Following Hip Fracture in Older White Women|Bone/Muscle Changes Following Hip Fracture in Older White Women|Completed||N/A|170|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 16:09:53.909468|2017-02-18 16:09:53.909468
NCT00390728|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2010-08-30|||April 2002||2002-04-01|August 2010|2010-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|AT-LANTUS||"Insulin Glargine in Type I Diabetes Mellitus> Main Study AT.LANTUS: A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: HALT(Hypoglycaemia Avoidance With Lantus Trial)"|"A Phase IIIb/IV, Multinational, Multicentre, Randomised, Open Study to Establish the Optimal Method for Initiating and Maintaining Lantus® (Insulin Glargine) Therapy Based on a Comparison of Two Treatment Algorithms to Determine Optimal Metabolic Outcomes, Safety, and Satisfaction in Subjects With Type 1 Diabetes Mellitus/ HALT Sub-study: Multicentre, Open Clinical Trial to Assess the Effect of Insulin Glargine on Symptomatic Hypoglycaemia, Fear of Hypoglycaemia and Quality of Life in Patients With Type 1 Diabetes"|Completed||Phase 4|2346||Sanofi|||||f||||||||||||||2017-02-18 16:09:54.020319|2017-02-18 16:09:54.020319
NCT00390715|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2010-03-11|||January 1999||1999-01-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|December 2007|Actual|2007-12-01||Observational|||Treatment of Acute Myeloblastic Leukemia in Younger Patients|Prospective Study of the Value of the Cytogenetic and of the Monitoring of the Minimal Residual Disease|Completed||Phase 4|600|Anticipated|PETHEMA Foundation|||1||f||||||||||||||2017-02-18 16:09:54.099474|2017-02-18 16:09:54.099474
NCT00390702|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2012-08-22|||October 2006||2006-10-01|August 2012|2012-08-01|August 2016|Anticipated|2016-08-01|August 2012|Actual|2012-08-01||Interventional|pfm-01/2005||Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System|International Multicentre Clinical Device Investigation on Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System for VSD Occlusion Developed by Pfm AG, Cologne|Suspended||Phase 2/Phase 3|338|Anticipated|pfm medical ag||1||"further recruitment terminated after CE mark attained; enclosed patients will be followed up~   to 5 years"|f||||t||||||||||2017-02-18 16:09:54.22227|2017-02-18 16:09:54.22227
NCT00390689|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2014-06-23|2009-03-05||October 2006||2006-10-01|April 2014|2014-04-01||||March 2008|Actual|2008-03-01||Interventional|||A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.|A Randomised, Double-blind Study to Evaluate the Efficacy and Safety of Pramipexole at Fixed Doses of 0.25 mg, 0.5 mg, and 0.75 mg in Patients With Idiopathic Restless Legs Syndrome for 6 Weeks, Followed by a 46-week Open-label Long-term Study|Completed||Phase 3|154|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 16:09:54.335301|2017-02-18 16:09:54.335301
NCT00390676|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2010-12-27|||November 2006||2006-11-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|||||Interventional|||A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine|A Phase 1, Multicenter, Dose-Escalation Study to Investigate the Safety and Tolerability of ADH-1 in Combination With 1) Carboplatin or 2) Docetaxel or 3) Capecitabine in Subjects With N-Cadherin Positive, Advanced Solid Tumors (Adherex Protocol Number AHX-01-006)|Completed||Phase 1|||Adherex Technologies, Inc.||1|||f||||||||||||||2017-02-18 16:09:55.367787|2017-02-18 16:09:55.367787
NCT00390663|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2006-10-19|||October 2006||2006-10-01|October 2006|2006-10-01||||||||Interventional|||A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children|A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children: Antiseptic Cream Alone v's Antiseptic Cream With Nasal Cautery|Unknown status|Recruiting|Phase 4|216||NHS Greater Glasgow Yorkhill Division|||||f||||||||||||||2017-02-18 16:09:58.127795|2017-02-18 16:09:58.127795
NCT00390650|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2011-04-05|||October 2006||2006-10-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder|An Eight-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study, With Escitalopram as an Active Control, to Evaluate the Efficacy, Safety and Tolerability of a Saredutant 100 mg Dose Once Daily, in Patients With Generalized Anxiety Disorder|Completed||Phase 3|366|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:09:58.198532|2017-02-18 16:09:58.198532
NCT00390637|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2009-01-20|||January 2006||2006-01-01|November 2007|2007-11-01|December 2007|Anticipated|2007-12-01|||||Interventional|DIOGENES||Diet, Obesity and Genes (DiOGenes)|Diet, Obesity and Genes|Unknown status|Active, not recruiting|Phase 4|1020|Anticipated|University of Copenhagen||5|||f||||t||||||||||2017-02-18 16:09:58.287878|2017-02-18 16:09:58.287878
NCT00390624|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2008-05-30|||July 2003||2003-07-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol|Prevention Of Nephrotoxicity Following Allogeneic Bone Marrow Transplantation Using Urodilatin (Ularitide,Atrial Natriuretic Peptide) and Mannitol.|Completed||Phase 2|20|Anticipated|Rocky Mountain Cancer Centers|||||||||t||||||||||2017-02-18 16:09:58.396315|2017-02-18 16:09:58.396315
NCT00388544|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2012-05-08|||May 2005||2005-05-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Enhancing Quality of Life for Nursing Home Residents|A Prescription for Enhancing Resident Quality of Life|Completed||Phase 2|128|Actual|Penn State University||4|||f||||t||||||||||2017-02-18 16:10:42.672858|2017-02-18 16:10:42.672858
NCT00390611|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2014-12-12|2014-12-12||October 2006||2006-10-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|July 2012|Actual|2012-07-01||Interventional|||Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer|A Randomized Phase II Study of Paclitaxel/Carboplatin With or Without Sorafenib in the First-Line Treatment of Patients With Stage III/IV Epithelial Ovarian Cancer|Completed||Phase 2|85|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 16:09:58.493538|2017-02-18 16:09:58.493538
NCT00390598|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2011-03-23|||September 2005||2005-09-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|TARE-05-073M||PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy|A Single Blind, Single Centre, Parallel Group, Randomized Controlled Trial Comparing PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy|Completed||Phase 2/Phase 3|490||Umeå University||2|||f||||||||||||||2017-02-18 16:09:59.292251|2017-02-18 16:09:59.292251
NCT00390585|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2010-03-12|||July 2006||2006-07-01|February 2008|2008-02-01|December 2008|Actual|2008-12-01|January 2008|Actual|2008-01-01||Interventional|||Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)|Prospective, Randomized, Comparative Study to Evaluate the Effect of Iodixanol 320 Compared to Iomeprol 350 on Contrast Medium Induced Nephropathy in Patients With Impaired Renal Function Undergoing PCI|Completed||Phase 4|324|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 16:09:59.413224|2017-02-18 16:09:59.413224
NCT00390572|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2015-04-06|2014-09-09||January 2007||2007-01-01|August 2014|2014-08-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional||Intent to Treat: All participants who were randomized to treatment condition.|Sleep Specialty Consultation: Improving Management of Sleep Disorders|Sleep Specialty Consultation: Improving Management of Sleep Disorders|Completed||N/A|156|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:09:59.536094|2017-02-18 16:09:59.536094
NCT00390559|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2012-07-06|2011-11-10||October 2005||2005-10-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3|Effects of Transdermal Nicotine on Tobacco Withdrawal and the Effects of Smoking-related Stimuli in Men and Women|Completed||N/A|80|Actual|Virginia Commonwealth University||4|||f||||f||||||||||2017-02-18 16:09:59.988817|2017-02-18 16:09:59.988817
NCT00390546|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2013-09-06|2013-03-11||October 2006||2006-10-01|September 2013|2013-09-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional||As 1 subject withdrew after being randomized to digoxin due to renal impairment and did not receive the study drug, the baseline analysis including age continuous data were assessed at enrolment with 32 study participants on digoxin and 39 participants on propranolol treatment.|Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia|Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia|Completed||Phase 3|72|Actual|University of British Columbia|Besides issues of recruitment, potential limitations of this study include the selected dosing for propranol, as a higher dosage is sometimes used, and the lack of dose titration before the 2-month visit, both of which could influence drug efficacy.|2|||f||||||||||||||2017-02-18 16:10:00.289067|2017-02-18 16:10:00.289067
NCT00390533|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2016-04-25||2016-04-25|September 2006||2006-09-01|April 2016|2016-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder|An Eight-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Efficacy, Safety and Tolerability of Two Fixed Doses (100 and 30 mg Once Daily) of Saredutant in Patients With Generalized Anxiety Disorder|Completed||Phase 3|428|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 16:10:00.750198|2017-02-18 16:10:00.750198
NCT00390520|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2009-07-13|||September 2006||2006-09-01|July 2009|2009-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes|A Single-center, Double-blind, Randomized, Placebo-controlled, Cross-over Study to Assess the Effect of Vildagliptin on Glucagon Counterregulatory Response During Hypoglycemia in Patients With Type 2 Diabetes.|Completed||Phase 3|28|Anticipated|Novartis|||||f||||||||||||||2017-02-18 16:10:00.861795|2017-02-18 16:10:00.861795
NCT00390507|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-19|2010-09-02|||October 2006||2006-10-01|September 2010|2010-09-01||||April 2010|Actual|2010-04-01||Interventional|||Modification of Posttetanic Count (PTC) for Monitoring Deep Neuromuscular Block II||Completed||Phase 4|45|Actual|Rigshospitalet, Denmark|||||f||||t||||||||||2017-02-18 16:10:00.950146|2017-02-18 16:10:00.950146
NCT00390494|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2008-06-26|||December 2005||2005-12-01|June 2008|2008-06-01|December 2010||2010-12-01|||||Observational|||Questionnaire Study to Assess Quality of Life After Treatment of Fibroids|Outcome From Fibroid Therapies: A Comparison With Normal Controls|Unknown status|Active, not recruiting|N/A|400|Anticipated|Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 16:10:01.03105|2017-02-18 16:10:01.03105
NCT00390481|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2013-07-29|||November 2004||2004-11-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of Carotid Occlusion and Neurocognition|Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON)|Completed||N/A|294|Anticipated|Columbia University||2|||f||||t||||||||||2017-02-18 16:10:01.1217|2017-02-18 16:10:01.1217
NCT00390468|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2014-05-13|2010-11-09||October 2006||2006-10-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases|A Phase II Study of Tandutinib (MLN518) in Androgen-Independent Prostate Cancer With Bone Metastases|Completed||Phase 2|18|Actual|National Cancer Institute (NCI)|The study was closed to further accrual per design specifications.|1|||f||||f||||||||||2017-02-18 16:10:01.221598|2017-02-18 16:10:01.221598
NCT00390455|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-11-22|2015-06-01||September 2006||2006-09-01|November 2016|2016-11-01||||July 2014|Actual|2014-07-01||Interventional||Four (4) participants who never started treatment were excluded from all analyses|Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive|Endocrine Therapy With or Without Inhibition of EGF and HER2 Growth Factor Receptors: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib (GW572016) for Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer|Active, not recruiting||Phase 3|295|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 16:10:01.7594|2017-02-18 16:10:01.7594
NCT00390429|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2012-08-27|||July 2002||2002-07-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2008|Actual|2008-08-01||Interventional|||Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors|Phase I/II Study of Docetaxel and OSI-774 (Erlotinib) in Solid Tumor Patients With an Emphasis on NSCLC Using Molecular Correlates as Potential Markers of Response|Completed||Phase 1/Phase 2|74|Actual|University of California, Davis||3|||f||||t||||||||||2017-02-18 16:10:03.437109|2017-02-18 16:10:03.437109
NCT00390416|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2016-02-16|2015-12-15||October 2006||2006-10-01|February 2016|2016-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma|A Phase II Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma|Completed||Phase 2|48|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:10:03.572498|2017-02-18 16:10:03.572498
NCT00390403|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2012-05-01|||February 2007||2007-02-01|May 2012|2012-05-01||||June 2009|Actual|2009-06-01||Interventional|||Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I, Open Label Study of AT-101 Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme|Completed||Phase 1|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:10:03.902151|2017-02-18 16:10:03.902151
NCT00390390|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2010-05-24|||June 2006||2006-06-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn|A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial of 14 Day Treatment With Lansoprazole 15 mg Once a Day in Frequent Heartburn|Completed||Phase 3|576||Novartis|||||||||||||||||||2017-02-18 16:10:04.021293|2017-02-18 16:10:04.021293
NCT00390377|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2006-10-18|||October 2006||2006-10-01|October 2006|2006-10-01||||||||Interventional|||Use of Hair to Diagnose Breast Cancer|A Study to Evaluate a Test for the Diagnosis of Breast Cancer Using X-Ray Diffraction of Hair Fibres.|Unknown status|Recruiting|Phase 2|240||Fermiscan Ltd|||||f||||||||||||||2017-02-18 16:10:04.138747|2017-02-18 16:10:04.138747
NCT00390364|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2014-10-07|2014-09-15||October 2006||2006-10-01|October 2014|2014-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy|Phase II Study of Single Agent RAD001 in Patients With Colon Cancer and Activating Mutations in the PI3KCA Gene|Terminated||Phase 2|1|Actual|Sidney Kimmel Comprehensive Cancer Center|Out of 28 subjects pre-screened/screened, only one was enrolled and treated, and she progressed after 1 cycle. Study terminated by investigator because of low enrollment.|1||Withdrawn due to low accrual|||||||||||||||2017-02-18 16:10:04.236768|2017-02-18 16:10:04.236768
NCT00390351|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2006-10-18|||February 2006||2006-02-01|October 2006|2006-10-01|July 2008||2008-07-01|||||Observational|||Investigate the Diagnostic Value and Possibilities of OCT in Non-Melanoma Skin Cancer.|Diagnosis of Non-Melanoma Skin Cancer With Optical Coherence Tomography|Unknown status|Recruiting|Phase 1/Phase 2|120||Zealand University Hospital|||||f||||||||||||||2017-02-18 16:10:04.561043|2017-02-18 16:10:04.561043
NCT00390338|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2015-12-23|||October 2006||2006-10-01|December 2015|2015-12-01|January 2015|Actual|2015-01-01|May 2012|Actual|2012-05-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|Phase I Evaluation of Alpha-Type-1 DC-Based and cDC-Based Intralymphatic Vaccines in Patients With Metastatic Melanoma|Completed||Phase 1|22|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 16:10:04.656655|2017-02-18 16:10:04.656655
NCT00390325|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2017-02-14|||October 2006||2006-10-01|February 2017|2017-02-01||||January 2017|Actual|2017-01-01||Interventional|||Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer|Phase II Study of Sorafenib (BAY 43-9006) in Patients With Metastatic Medullary Thyroid Carcinoma|Active, not recruiting||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:10:04.769475|2017-02-18 16:10:04.769475
NCT00390312|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2007-12-28|||September 2001||2001-09-01|December 2007|2007-12-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction|Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Single Dose Comparison of Analgesic Efficacy and Safety of Intranasal Morphine, Immediate Release Oral Morphine, Intravenous Morphine and Placebo in Postsurgical Dental Pain|Completed||Phase 2|225|Actual|Javelin Pharmaceuticals||7|||f||||f||||||||||2017-02-18 16:10:04.897646|2017-02-18 16:10:04.897646
NCT00390299|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-12-27|||October 2006||2006-10-01|November 2016|2016-11-01||||June 2017|Anticipated|2017-06-01||Interventional|||Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme|Phase I Trial of a Measles Virus Derivative Producing CEA (MV-CEA) in Patients With Recurrent Glioblastoma Multiforme (GBM)|Recruiting||Phase 1|40|Anticipated|Mayo Clinic||2|||f||||f||||||||||2017-02-18 16:10:05.010001|2017-02-18 16:10:05.010001
NCT00390286|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-10-24|||November 2016||2016-11-01|October 2016|2016-10-01|March 2020|Anticipated|2020-03-01|December 2019|Anticipated|2019-12-01||Observational|||Telemedicine's Utility for Augmenting Clinical Trials and Informed Consent TACTIC|Telemedicine's Utility for Augmenting Clinical Trials and Informed Consent TACTIC|Withdrawn||Phase 1|0|Actual|University of California, San Diego|||1|no funding|f||||f||||||||||2017-02-18 16:10:05.144772|2017-02-18 16:10:05.144772
NCT00390273|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2008-10-06|||December 2006||2006-12-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Metformin on Lactate Metabolism|Effect of Metformin on Lactate Metabolism in Healthy Subjects|Completed||Phase 1/Phase 2|20|Actual|Centre de Recherche en Nutrition Humaine Rhone-Alpe||1|||f||||t||||||||||2017-02-18 16:10:05.234728|2017-02-18 16:10:05.234728
NCT00390260|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2017-01-31|||February 2002||2002-02-01|January 2017|2017-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED)|Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Rofecoxib 50 mg and Hydrocodone 7.5 mg With Acetaminophen 750 mg in Patients With Postoperative Arthroscopic Pain|Completed||Phase 3|420||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:10:05.344708|2017-02-18 16:10:05.344708
NCT00390247|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-02-08|||January 2007||2007-01-01|April 2007|2007-04-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients|Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients: A Randomized Control Trial|Withdrawn||Phase 4|0|Actual|Chinese University of Hong Kong||||Fail of applying funding|f||||||||||||||2017-02-18 16:10:05.427106|2017-02-18 16:10:05.427106
NCT00390234|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2015-12-03|2014-11-14||September 2006||2006-09-01|May 2013|2013-05-01|August 2013|Actual|2013-08-01|September 2011|Actual|2011-09-01||Interventional|||Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma|A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas|Completed||Phase 2|63|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:10:05.526435|2017-02-18 16:10:05.526435
NCT00390221|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2016-05-31|2016-05-31||February 2008||2008-02-01|May 2016|2016-05-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|SELECT||Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis|Multicenter, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Safety and Efficacy of Daclizumab HYP (DAC HYP) as a Monotherapy Treatment in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|621|Actual|Biogen||3|||f||||t||||||||||2017-02-18 16:10:05.887127|2017-02-18 16:10:05.887127
NCT00390208|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2010-05-25|||August 2006||2006-08-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|PDEX||Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration|A Prospective Masked Pilot Study Comparing Group 1 Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Group 2 Monotherapy - Intravitreal Ranibizumab Alone.|Completed||Phase 2|60|Actual|Bay Area Retina Associates||2|||f||||t||||||||||2017-02-18 16:10:07.176031|2017-02-18 16:10:07.176031
NCT00390195|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2009-06-29|||October 2006||2006-10-01|June 2009|2009-06-01|June 2011|Anticipated|2011-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)|Randomized Phase I/II of Rapamycin Analog, RAD001, in Advanced Hepatocellular Carcinoma - With a Pharmacokinetic Study of RAD001|Unknown status|Recruiting|Phase 1/Phase 2|134|Anticipated|National Health Research Institutes, Taiwan||2|||f||||||||||||||2017-02-18 16:10:07.309111|2017-02-18 16:10:07.309111
NCT00390182|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2014-04-07|2013-01-16||October 2003||2003-10-01|April 2014|2014-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|GCC0319||Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)|GCC 0319: Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)|Completed||Phase 1/Phase 2|38|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 16:10:07.451335|2017-02-18 16:10:07.451335
NCT00390169|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2012-01-18|||October 2006||2006-10-01|August 2011|2011-08-01|July 2009||2009-07-01|||||Interventional|||Randomized Controlled Trial Comparing MBSR to SET in Breast Cancer Patients|Randomized Controlled Trial Comparing Mindfulness-Based Stress Reduction (MBSR) to Supportive-Expressive Therapy (SET) on Psychological and Biological Outcomes in Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 16:10:07.706473|2017-02-18 16:10:07.706473
NCT00390156|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2013-10-09|||August 2006||2006-08-01|October 2013|2013-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors|A Phase I Trial of Imatinib, Bevacizumab, & Metronomic Cyclophosphamide as Antiangiogenic Therapy in Refractory Metastatic Solid Tumors|Completed||Phase 1|35|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:10:07.80908|2017-02-18 16:10:07.80908
NCT00390143|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2016-10-21||2009-09-03|February 2007||2007-02-01|October 2016|2016-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612|Assess Long Term Persistence of a Primary Dose of GSK Biologicals' Meningococcal Vaccine 134612 Versus One Dose of Mencevax™ ACWY in Healthy Adolescents/Young Adults (15 to 19 Years at Vaccination)|Completed||Phase 2|46|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:10:07.923197|2017-02-18 16:10:07.923197
NCT00390130|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2013-11-10|||July 2006||2006-07-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|June 2007|Actual|2007-06-01||Interventional|||Does the Order in Which Vaccines Are Administered Affect Pain Response?|Does the Order in Which Vaccines Are Administered Affect Pain Response? A Randomized, Double-blind, Clinical Trial of Pentacel vs. Prevnar|Completed||Phase 4|120|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 16:10:08.047298|2017-02-18 16:10:08.047298
NCT00390117|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-11-25|||August 2006||2006-08-01|August 2012|2012-08-01|January 2013|Actual|2013-01-01|March 2012|Actual|2012-03-01||Interventional|||AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma|A Phase I Study of AT7519M Given Twice Weekly in Patients With Advanced Incurable Malignancy|Completed||Phase 1|34|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 16:10:08.153701|2017-02-18 16:10:08.153701
NCT00390104|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2011-07-21|||January 2002||2002-01-01|July 2011|2011-07-01|January 2015|Anticipated|2015-01-01|||||Observational|||Molecular Analysis of Patients With Neuromuscular Disease|Molecular Analysis of Nucleic Acids Derived From Patients With Neuromuscular Disease and Their Family Members|Unknown status|Recruiting|N/A|500|Anticipated|Boston Children’s Hospital|||1||f||||t||||||Samples With DNA|"~     DNA from blood or saliva and muscle samples from proband/ DNA from blood or saliva from~     family members~   "|||2017-02-18 16:10:08.273346|2017-02-18 16:10:08.273346
NCT00390091|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2015-08-31|||September 2006||2006-09-01|February 2007|2007-02-01||||||||Interventional|||Study of LJP 394 (Abetimus Sodium) in Lupus Patients|A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)|Withdrawn||Phase 2|0|Actual|La Jolla Pharmaceutical Company|||||||||||||||||||2017-02-18 16:10:08.371573|2017-02-18 16:10:08.371573
NCT00390078|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2009-07-09|||January 2007||2007-01-01|July 2009|2009-07-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection|Single-Blind, Randomized, Controlled, Phase I/II Vaccination Study on Safety and Immunogenicity of a Recombinant MVA-HIV Polytope Vaccine (MVA-mBN32) in HIV-1 Infected Patients With CD4 Counts > 250/µl|Completed||Phase 1/Phase 2|30|Anticipated|Bavarian Nordic||2|||f||||||||||||||2017-02-18 16:10:08.482453|2017-02-18 16:10:08.482453
NCT00390065|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2009-09-18|||October 2006||2006-10-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely|Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely With Respiratory and Neurodevelopmental Impact of Early Treatment With Inhaled Nitric Oxide|Completed||Phase 4|108|Actual|Maternite Regionale Universitaire||1|||f||||t||||||||||2017-02-18 16:10:08.59615|2017-02-18 16:10:08.59615
NCT00390052|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2013-12-13|||December 2006||2006-12-01|December 2013|2013-12-01||||February 2011|Actual|2011-02-01||Interventional|||3-AP in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I and Pharmacokinetic Study of Oral 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone(3-AP,Triapine) in the Treatment of Advanced Solid Tumors|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:10:08.717142|2017-02-18 16:10:08.717142
NCT00390039|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2008-01-11|||May 2006||2006-05-01|January 2008|2008-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery|Randomized, Double-Blind, Active- and Placebo-Controlled Study of Analgesic Efficacy and Safety of Repeated Dosing of MNS075 (Intranasal Morphine), IV Morphine, and Placebo in Acute Post-Operative Pain After Elective Orthopedic Surgery|Completed||Phase 3|256|Actual|Javelin Pharmaceuticals||6|||f||||f||||||||||2017-02-18 16:10:08.830918|2017-02-18 16:10:08.830918
NCT00390026|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2007-05-24|||November 2006||2006-11-01|May 2007|2007-05-01||||||||Interventional|||The Avastin vs Visudyne for Neovascular AMD Study|A Prospective, Randomized, Double-Masked, Controlled Study on Intravitreal Bevacizumab (Avastin) Versus Verteporfin (Visudyne) Photodynamic Therapy (PDT) for Patients With Neovascular Age-Related Macular Degeneration (AMD)|Withdrawn||Phase 3|100|Anticipated|St. Erik Eye Hospital||||Lucentis, a treatment superior to PDT, has become available i Sweden.|f||||||||||||||2017-02-18 16:10:08.952498|2017-02-18 16:10:08.952498
NCT00390013|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2009-03-12|||January 2007||2007-01-01|March 2009|2009-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||To Evaluate if the Medication Gabapentin Lessens Vulvar Pain|Vulvar Pain: Treatment Trial Using Gabapentin-Placebo in a Cross-Over Design, Pilot Study.|Completed||N/A|40|Anticipated|University of Iowa||1|||f||||t||||||||||2017-02-18 16:10:09.053714|2017-02-18 16:10:09.053714
NCT00390000|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-04-19|||January 2007||2007-01-01|April 2016|2016-04-01||||December 2016|Anticipated|2016-12-01||Interventional|||Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors|Phase I Study of PTK/ZK in Combination With Pemetrexed Disodium (ALIMTA)|Active, not recruiting||Phase 1|44|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 16:10:09.158775|2017-02-18 16:10:09.158775
NCT00389987|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2017-02-16|||September 2001||2001-09-01|February 2017|2017-02-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)|A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Sodium Versus Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections in Hospitalized Adults|Completed||Phase 3|300||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:10:09.269414|2017-02-18 16:10:09.269414
NCT00389974|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2015-02-04|2015-02-04||January 2007||2007-01-01|March 2014|2014-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||All treated patients|Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery|A Phase II Study of Sunitinib (SU11248; NSC 736511) an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Patients With Unresectable, Locally Advanced or Metastatic Cervical Carcinoma|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:10:09.358282|2017-02-18 16:10:09.358282
NCT00389948|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2007-04-13|||June 2006||2006-06-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn|A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of 14 Day Treatment With Lansoprazole 15 mg Once a Day in Frequent Heartburn|Completed||Phase 3|576||Novartis|||||||||||||||||||2017-02-18 16:10:09.643144|2017-02-18 16:10:09.643144
NCT00389935|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2011-08-01|||October 2006||2006-10-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|TAG||Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding|Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding|Completed||Phase 2|14|Actual|Northport Veterans Affairs Medical Center||1|||f||||t||||||||||2017-02-18 16:10:10.015271|2017-02-18 16:10:10.015271
NCT00389922|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2012-04-17|||December 2005||2005-12-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|April 2009|Actual|2009-04-01||Interventional|||Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors|Phase I Study of Two Different Schedules of Lapatinib (GW572016) in Combination With Vinorelbine in Advanced Solid Tumors|Completed||Phase 1|22|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 16:10:10.124283|2017-02-18 16:10:10.124283
NCT00389909|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2011-02-18|||November 2006||2006-11-01|April 2010|2010-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants|Evaluation of Dosing Chart Taking Into Account Age and Gender for Calculating the First Dose of Doxapram in Premature Infants|Completed||Phase 4|86|Actual|Maternite Regionale Universitaire||2|||f||||f||||||||||2017-02-18 16:10:10.252785|2017-02-18 16:10:10.252785
NCT00389896|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2015-05-18|||July 2001||2001-07-01|May 2015|2015-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Balanced, Three-Way Crossover Study to Evaluate the Efficacy of Simvastatin Therapy in Elevating HDL-C Levels in Patients With Type 2 Diabetic Dyslipidemia and Low HDL-C|Completed||Phase 3|150||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:10:10.372687|2017-02-18 16:10:10.372687
NCT00389883|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2012-07-06|||November 2006||2006-11-01|July 2012|2012-07-01|November 2011|Actual|2011-11-01|January 2010|Actual|2010-01-01||Interventional|||Anaesthesia for Supratentorial Tumor Resection|Anaesthesia for Supratentorial Tumor Resection : a Double-blind Comparison of Target Plasma Concentration of Propofol-remifentanil and Sevoflurane-sufentanil|Completed||Phase 3|69|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 16:10:10.460325|2017-02-18 16:10:10.460325
NCT00389870|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2013-08-23|||December 2006||2006-12-01|July 2007|2007-07-01||||March 2010|Anticipated|2010-03-01||Interventional|||Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil|A Randomised Clinical Trial of Treatment for Fluorouracil-Resistant Advanced Colorectal Cancer Comparing Standard Single-Agent Irinotecan Versus Irinotecan Plus Panitumumab and Versus Irinotecan Plus Ciclosporin [Panitumumab, Irinotecan & Ciclosporin in COLOrectal Cancer Therapy (PICCOLO)]|Unknown status|Recruiting|Phase 3|1269|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:10:10.582839|2017-02-18 16:10:10.582839
NCT00389857|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-04-12|2009-02-24||October 2006||2006-10-01|April 2016|2016-04-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Trial to Collect Safety Data and Sera for Immunogenicity Testing|Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2006-2007 Formulation)|Completed||Phase 4|31|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:10:10.730103|2017-02-18 16:10:10.730103
NCT00389844|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2008-05-27|||July 2000||2000-07-01|May 2008|2008-05-01|September 2005|Actual|2005-09-01|September 2004|Actual|2004-09-01||Interventional|Hip5||BHS5 - Testing the Effectiveness of the Exercise Plus Program|Testing the Effectiveness of the Exercise Plus Program on Efficacy Expectations, Exercise Behavior & Activity of Older Adults Following a Hip Fracture|Completed||N/A|240|Actual|University of Maryland||4|||f||||t||||||||||2017-02-18 16:10:11.292814|2017-02-18 16:10:11.292814
NCT00389831|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2014-09-24|2009-07-28||August 2006||2006-08-01|February 2011|2011-02-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms|A Randomized, Double-blind, Placebo-controlled, Parallel-group Proof-of-concept Trial to Assess the Efficacy, Safety and Tolerability of Ascending Doses of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms in Subjects With Idiopathic Restless Legs Syndrome|Completed||Phase 2|44|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 16:10:11.424466|2017-02-18 16:10:11.424466
NCT00389818|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2014-08-27|2012-05-29||January 2007||2007-01-01|August 2014|2014-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma|A Phase II Trial of Doxil, Rituximab, Cyclophosphamide, Vincristine, and Prednisone (DR-COP) in Patients With Newly Diagnosed AIDS-Associated B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|43|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-02-18 16:10:12.167546|2017-02-18 16:10:12.167546
NCT00389805|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2009-02-06|||March 2005||2005-03-01|July 2007|2007-07-01||||||||Interventional|||Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors|Phase I/II Study of Two Different Schedules of Bortezomib (VELCADE, PS-341) and Pemetrexed (ALIMTA) in Advanced Solid Tumors, With Emphasis on Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|86|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:10:12.573988|2017-02-18 16:10:12.573988
NCT00389792|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2009-03-10|||July 2006||2006-07-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers|A Randomized, Double-Blind, Placebo-Controlled Study of ATI-2042 in Patients With Paroxysmal Atrial Fibrillation and Pacemakers With Atrial Fibrillation Data Logging Capabilities|Completed||Phase 2|72|Actual|ARYx Therapeutics||4|||f||||f||||||||||2017-02-18 16:10:12.686988|2017-02-18 16:10:12.686988
NCT00389779|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2014-02-19||2014-01-03|September 2006||2006-09-01|February 2014|2014-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|Darusentan||DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension|A Phase 3 Randomized, Double-Blind, Placebo- and Active-Controlled, Multi-center, Parallel Group Study to Evaluate the Safety and Efficacy of Darusentan in Subjects With Resistant Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic, as Compared to Guanfacine or Placebo (Protocol DAR-312)|Completed||Phase 3|849|Actual|Gilead Sciences||3|||f||||t||||||||||2017-02-18 16:10:12.832868|2017-02-18 16:10:12.832868
NCT00389766|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2013-07-09|||July 2008||2008-07-01|June 2007|2007-06-01||||July 2008|Anticipated|2008-07-01||Interventional|||High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma|International Phase II Studies of I-mIBG in Combination With Topotecan and Peripheral Blood Stem Cell Rescue for (A) Primary Resistant High Risk Neuroblastoma and (B) Relapsed Stage 4 Neuroblastoma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)||||Withdrawn because protocol has been discontinued. It was never opened.|f||||||||||||||2017-02-18 16:10:13.318416|2017-02-18 16:10:13.318416
NCT00389753|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2010-09-28||||||September 2010|2010-09-01||||||||Interventional|||Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure|A Prospective, Randomized, Double Blinded Controlled Clinical Trial of the Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure|Suspended||N/A|25|Anticipated|University Hospital, Ghent||||study never started|f||||f||||||||||2017-02-18 16:10:13.419113|2017-02-18 16:10:13.419113
NCT00389740|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2017-01-27|||April 2001||2001-04-01|January 2017|2017-01-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)|A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Raloxifene on Bone Mineral Density in Postmenopausal Women With Osteoporosis|Completed||Phase 3|400|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:10:13.532068|2017-02-18 16:10:13.532068
NCT00389727|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2006-10-18|||September 2004||2004-09-01|September 2004|2004-09-01||||||||Interventional|||Simultaneous Integrated Boost (SIB)- IMRT|A Dose Escalation Study With Intensity Modulated Radiation Therapy (IMRT) in Moderately Advanced (T2N0, T2N1, T3N0) Squamous Cell Carcinomas (SCC) of the Oropharynx, Larynx and Hypopharynx Using a Simultaneous Integrated Boost (SIB) Approach.|Unknown status|Recruiting|Phase 2|||Cliniques universitaires Saint-Luc- Université Catholique de Louvain|||||f||||||||||||||2017-02-18 16:10:13.622307|2017-02-18 16:10:13.622307
NCT00389714|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2007-12-10|||February 2007||2007-02-01|December 2007|2007-12-01||||||||Interventional|IABN||Clinical Evaluation of Esthetic Restorations Placed in Primary Molars With Composite Resin Enriched With Insoluble Anti Bacterial Nano Particles|Phase 2 Clinical Study :Evaluation of the Efficacy of Insoluble Antibacterial Nanoparticles Incorporated Into Commercialy Used Composit Resins as an Esthetic Restoration Material in Children|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:10:13.707081|2017-02-18 16:10:13.707081
NCT00389701|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2014-01-09|||March 2006||2006-03-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|||Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment|Phase II Trial of Twice Weekly Induction Followed by Once Weekly IV Velcade (Bortezomib) With Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Following at Least 1 Prior Therapy|Unknown status|Recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:10:13.807457|2017-02-18 16:10:13.807457
NCT00389688|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2012-07-17|||August 2006||2006-08-01|July 2012|2012-07-01||||July 2008|Actual|2008-07-01||Interventional|||Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by Surgery|Randomized Phase II Study of Pemetrexed and Cisplatin as Either Induction or Adjuvant Chemotherapy in Stage IB-II Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|13|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 16:10:13.907752|2017-02-18 16:10:13.907752
NCT00389675|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2014-01-03||2014-01-03|May 2007||2007-05-01|January 2014|2014-01-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|Darusentan||DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension|A Double-Blind, Active-Controlled, Long-Term Safety Extension Study of Optimized Doses of Darusentan in Subjects With Resistant Hypertension Despite Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic, as Compared to Guanfacine (Protocol DAR-312-E)|Terminated||Phase 3|661|Actual|Gilead Sciences||2||Study DAR-312 did not meet its primary co-endpoints.|f||||t||||||||||2017-02-18 16:10:14.023711|2017-02-18 16:10:14.023711
NCT00389662|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2007-12-19|||November 2006||2006-11-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||The Effect of Wearing the 'Nike Free'Shoe on Isokinetic Muscle Strength of Foot and Ankle and on Proprioception.|The Effect of Wearing the 'Nike Free'Shoe on Isokinetic Muscle Strength of Foot and Ankle and on Proprioception.|Completed||N/A|45|Anticipated|University Ghent||1|||f||||f||||||||||2017-02-18 16:10:14.250069|2017-02-18 16:10:14.250069
NCT00389649|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2008-04-16|||November 2001||2001-11-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effect of Chronic Changes in Heart Rate on Congestive Heart Failure|Effect of Chronic Changes in Heart Rate on Congestive Heart Failure|Completed||N/A|24||University of Maryland|||||f||||||||||||||2017-02-18 16:10:14.330405|2017-02-18 16:10:14.330405
NCT00389636|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2008-05-05|||September 2006||2006-09-01|May 2008|2008-05-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers|TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers|Unknown status|Active, not recruiting|N/A|30|Actual|Soluble Systems, LLC||2|||f||||f||||||||||2017-02-18 16:10:14.430439|2017-02-18 16:10:14.430439
NCT00389610|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-08-22|||September 2006||2006-09-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery|A Safety and Efficacy Trial of Vaccine Boosting With Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected With the GM-CSF Gene for the Treatment of Pancreatic Adenocarcinoma|Active, not recruiting||Phase 2|56|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 16:10:14.555417|2017-02-18 16:10:14.555417
NCT00389597|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-07-07|2014-01-03||April 2006||2006-04-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|March 2010|Actual|2010-03-01||Interventional|||LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE|LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE|Completed||Phase 3|599|Actual|LDR Spine USA||2|||f||||t||||||||||2017-02-18 16:10:14.685605|2017-02-18 16:10:14.685605
NCT00389584|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2010-03-15|||December 2002||2002-12-01|March 2010|2010-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors|Phase I/II Study of Irinotecan and Whole Brain Radiation Therapy in Patients With Brain Metastases From Solid Tumors|Completed||Phase 1/Phase 2|30|Actual|University of California, Davis|||||f||||t||||||||||2017-02-18 16:10:15.520566|2017-02-18 16:10:15.520566
NCT00389558|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2009-09-18|||September 2006||2006-09-01|September 2009|2009-09-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Antiseptic Use and Dressing Application|Comparison of Amukin Versus Biseptine Use for Dressing Application of Epicutaneocavous Catheters for Nosocomial Infection Prevention|Completed||Phase 4|453|Actual|Maternite Regionale Universitaire||2|||f||||f||||||||||2017-02-18 16:10:15.622735|2017-02-18 16:10:15.622735
NCT00389545|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2006-10-18||||||October 2006|2006-10-01||||||||Interventional|||Intracoronary Stem Cells in Large Myocardial Infarction|Intracoronary Stem Cells in Large Myocardial Infarction|Unknown status|Active, not recruiting|Phase 2|||Charles University, Czech Republic|||||f||||||||||||||2017-02-18 16:10:15.744461|2017-02-18 16:10:15.744461
NCT00389532|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2016-04-12|2009-02-24||October 2006||2006-10-01|April 2016|2016-04-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|||Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine|Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity of Fluzone® Influenza Virus Vaccine (2006-2007 Formulation)|Completed||Phase 4|116|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:10:15.818238|2017-02-18 16:10:15.818238
NCT00389519|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2012-06-06|2010-01-21||October 2006||2006-10-01|June 2012|2012-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Arm Study Assessing the Efficacy, Safety, and Dose-Response of Ramipril for the Treatment of Hypertension in Children and Adolescents|Terminated||Phase 3|422|Actual|Pfizer||4||"A planned interim analysis was performed after approx. 240 subjects completed the trial. The~   study was stopped, as permitted by protocol, after the analysis."|||||||||||||||2017-02-18 16:10:16.254404|2017-02-18 16:10:16.254404
NCT00389506|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-18|2012-03-14|||September 2006||2006-09-01|March 2012|2012-03-01|May 2008|Actual|2008-05-01|||||Interventional|||Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma|A Pilot Study of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Hodgkin's Disease After Fludarabine and Cyclophosphamide|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 16:10:19.807759|2017-02-18 16:10:19.807759
NCT00389493|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2014-03-20|2013-10-29||October 2006||2006-10-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|June 2012|Actual|2012-06-01||Interventional|||Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder|Maximizing Treatment Outcome in OCD|Completed||N/A|100|Actual|New York State Psychiatric Institute||3|||f||||t||||||||||2017-02-18 16:10:19.936493|2017-02-18 16:10:19.936493
NCT00388895|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2008-11-17|||June 2002||2002-06-01|November 2008|2008-11-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Glivec in Ph Positive Lymphoblastic Leukemia|Positive Ph Acute Lymphoblastic Leucemia With Intensive Induction Chemotherapy and Glivec, Before and After the Hematopoetic Progenitor Transplant|Completed||Phase 2|35||PETHEMA Foundation|||||f||||||||||||||2017-02-18 16:10:31.835814|2017-02-18 16:10:31.835814
NCT00389480|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2009-08-07|||October 2006||2006-10-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies|A Phase I Study of DB-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) in Adult Patients With Refractory or Metastatic Solid Malignancies|Completed||Phase 1|26|Actual|Arno Therapeutics||1|||f||||t||||||||||2017-02-18 16:10:20.627973|2017-02-18 16:10:20.627973
NCT00389467|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2014-02-26|2013-04-12||May 2004||2004-05-01|February 2014|2014-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|MR RESCUE||Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy|Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy|Completed||Phase 2|127|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 16:10:20.734908|2017-02-18 16:10:20.734908
NCT00389454|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2007-10-30|||January 2004||2004-01-01|August 2006|2006-08-01|June 2007|Actual|2007-06-01|||||Observational|||Acetaminophen Concentration in Cerebrospinal Fluid in Infants|Acetaminophen Concentration in Cerebrospinal Fluid in Infants|Completed||N/A|||Assaf-Harofeh Medical Center|||||f||||||||||||||2017-02-18 16:10:21.712053|2017-02-18 16:10:21.712053
NCT00389441|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2013-09-24|2013-09-24||December 2006||2006-12-01|September 2013|2013-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer|A Pivotal Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Patients With 131I-Refractory Metastatic Or Unresectable Locally-Advanced Thyroid Cancer|Completed||Phase 2|52|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:10:21.810246|2017-02-18 16:10:21.810246
NCT00389428|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2012-05-16|||September 2006||2006-09-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.|Phase 1 Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Malignancies.|Completed||Phase 1|48|Actual|Celator Pharmaceuticals||1|||f||||||||||||||2017-02-18 16:10:22.471231|2017-02-18 16:10:22.471231
NCT00389415|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2008-11-26|||October 2006||2006-10-01|November 2008|2008-11-01||||||||Interventional|||Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes|A Multicenter, Open, Long Term Safety Study of 52 Weeks Treatment With Vildagliptin (100 mg qd) In Patients With Type 2 Diabetes (Extension Study of Study CLAF237A1303)|Completed||Phase 3|150||Novartis|||||f||||||||||||||2017-02-18 16:10:22.804777|2017-02-18 16:10:22.804777
NCT00389402|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2010-06-10|||July 2006||2006-07-01|June 2010|2010-06-01|July 2008|Actual|2008-07-01|||||Interventional|||BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes|A Randomised, Controlled, Open-Label, 48-Week, Study To Asses Differences in Changes In Plasma Lipid Profile Between Patients On Saquinavir/Ritonavir Or Atazanavir/Ritonavir In Combination With Tenofovir Disoproxil Fumarate And Emtricitabine As A First-line Regimen.|Completed||Phase 4|120|Anticipated|International Antiviral Therapy Evaluation Center||2|||f||||f||||||||||2017-02-18 16:10:22.887764|2017-02-18 16:10:22.887764
NCT00389389|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2009-04-30|||September 2006||2006-09-01|April 2009|2009-04-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 Administered Weekly or Every Two Weeks in Patients With Advanced Solid Malignancies|Completed||Phase 1|75|Anticipated|AstraZeneca||1|||f||||f||||||||||2017-02-18 16:10:22.984316|2017-02-18 16:10:22.984316
NCT00389376|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2008-02-15|||November 2006||2006-11-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|SyNCH||Phase I Trial of Silymarin for Chronic Liver Diseases|Single and Multiple Dose Escalation Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered Silymarin (Legalon) in Non-Cirrhotic Subjects With Chronic Hepatitis C or Non-Alcoholic Fatty Liver Disease|Completed||Phase 1|56|Actual|National Center for Complementary and Integrative Health (NCCIH)||7|||t||||t||||||||||2017-02-18 16:10:23.069877|2017-02-18 16:10:23.069877
NCT00389363|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2010-08-16|||August 2006||2006-08-01|August 2010|2010-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects|A Phase II-III Trial Assessing the Efficacy and Safety of Three Doses of the ALK HDM Tablet in House Dust Mite Allergic Patients|Completed||Phase 2/Phase 3|800|Anticipated|ALK-Abelló A/S|||||f||||||||||||||2017-02-18 16:10:23.191721|2017-02-18 16:10:23.191721
NCT00389350|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2006-10-17|||August 2005||2005-08-01|October 2006|2006-10-01|June 2006||2006-06-01|||||Interventional|||Effect of an Extract of Green Tea on Adults With Type 2 Diabetes|The Effect of an Extract of Green Tea on Glucose Control in Adults With Type 2 Diabetes|Completed||Phase 2/Phase 3|48||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 16:10:23.278728|2017-02-18 16:10:23.278728
NCT00389337|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2006-10-17|||January 2005||2005-01-01|October 2006|2006-10-01|December 2006||2006-12-01|||||Observational|||Sepsis: Prognosis and Evaluation of Early Diagnosis and Intervention (SPEEDI Study)|Sepsis: Prognosis and Evaluation of Early Diagnosis and Intervention (SPEEDI Study)|Unknown status|Active, not recruiting|N/A|300||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 16:10:23.36558|2017-02-18 16:10:23.36558
NCT00389324|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2015-03-31|2009-07-30||November 2006||2006-11-01|March 2015|2015-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency|An Open-Label Single-Sequence, Crossover Trial to Evaluate the Pharmacokinetics and Safety of Subcutaneous Gamunex® 10% (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) in Subjects With Primary Immunodeficiency|Completed||Phase 2|35|Actual|Grifols Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:10:23.452958|2017-02-18 16:10:23.452958
NCT00389311|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2015-03-30|||April 2007||2007-04-01|January 2009|2009-01-01|June 2009|Actual|2009-06-01|February 2008|Actual|2008-02-01||Interventional|||A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides|A Pilot Protocol to Determine the Effects of Chemical and Mechanical Stress on Rectal Permeability as a Surrogate for Toxicity Evaluation of Rectally Applied Microbicides|Completed||Early Phase 1|12|Actual|Johns Hopkins University||3|||f||||||||||||||2017-02-18 16:10:23.855901|2017-02-18 16:10:23.855901
NCT00389298|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2009-09-23|||October 2006||2006-10-01|September 2009|2009-09-01|June 2007|Actual|2007-06-01|||||Interventional|||A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.|A Phase 2, Multicenter, Randomized, Double-blinded, and Placebo-controlled Study of the Antiviral Activity, Safety and Pharmacokinetics of VCH-759 in Subjects With Chronic Hepatitis C-infection.|Completed||Phase 1/Phase 2|36|Anticipated|Vertex Pharmaceuticals Incorporated|||||f||||t||||||||||2017-02-18 16:10:23.969386|2017-02-18 16:10:23.969386
NCT00389285|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2009-05-26|||October 2006||2006-10-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma|A Phase 1/2, Open-Label, Dose Escalation Study to Assess the Safety and Pharmacokinetics of Recombinant Interleukin 21 (rIL-21) Administered Concomitantly With Sorafenib (Nexavar) in Subjects With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|52|Actual|ZymoGenetics||1|||f||||||||||||||2017-02-18 16:10:24.070839|2017-02-18 16:10:24.070839
NCT00389272|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2007-10-30|||September 2005||2005-09-01|October 2006|2006-10-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Adding a Second Drug for Febrile Children Treated With Acetaminophen|Adding a Second Drug for Febrile Children Treated With Acetaminophen|Unknown status|Recruiting|N/A|40|Anticipated|Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-02-18 16:10:24.177212|2017-02-18 16:10:24.177212
NCT00389259|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2011-04-04|||October 2007||2007-10-01|March 2010|2010-03-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Scopolamine Treatment for Patients With Organophosphate Poisoning|Scopolamine Treatment for Patients With Organophosphate Poisoning - a Randomized, Double Blind, Placebo-Controlled Study.|Withdrawn||N/A|50|Anticipated|Assaf-Harofeh Medical Center||2|||f||||||||||||||2017-02-18 16:10:24.255778|2017-02-18 16:10:24.255778
NCT00389246|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2006-10-17|||September 2002||2002-09-01|October 2006|2006-10-01|June 2005||2005-06-01|||||Interventional|||Evaluation of Consultation Including Genetic Aspects of Obesity|Evaluation of Consultation Including Genetic Aspects of Obesity|Completed||Phase 3|420||Philipps University Marburg Medical Center|||||f||||||||||||||2017-02-18 16:10:24.365201|2017-02-18 16:10:24.365201
NCT00389233|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2008-04-15|||June 2002||2002-06-01|April 2008|2008-04-01|December 2002||2002-12-01|||||Interventional|||A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution|A Randomised, Multi-Centre, Single-Blinded, Pivotal Phase III Trial to Assess the Efficacy, Acceptability and Safety of a New 2 Litre Gut Cleansing Solution NRL994 Versus a Standard Colon Preparation With 4L PEG+E.|Completed||Phase 3|360|Actual|Norgine||2|||f||||f||||||||||2017-02-18 16:10:24.457408|2017-02-18 16:10:24.457408
NCT00389220|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2013-09-23|||November 2006||2006-11-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|May 2008|Actual|2008-05-01||Interventional|LEADERS||Limus Eluted From A Durable Versus ERodable Stent Coating|A Randomized Comparison of a Biolimus-Eluting Stent With a Sirolimus-Eluting Stent for Percutaneous Coronary Intervention|Completed||Phase 3|1707|Actual|Biosensors Europe SA||2|||f||||t||||||||||2017-02-18 16:10:24.585107|2017-02-18 16:10:24.585107
NCT00389207|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2013-12-09|2012-01-13||October 2006||2006-10-01|December 2013|2013-12-01||||February 2011|Actual|2011-02-01||Interventional|||Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults|Randomized, Open Label Study Evaluating the Lipid Profile Difference and Efficacy of a Combined Therapy Including Tenofovir, Emtricitabine + Atazanavir / r or NVP in Naive HIV - 1 Infected Patients.|Completed||Phase 3|576|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 16:10:24.759835|2017-02-18 16:10:24.759835
NCT00389194|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2010-06-10|||April 2006||2006-04-01|June 2010|2010-06-01|October 2008|Actual|2008-10-01|||||Interventional|||PREventing Progression of Adipose Tissue Redistribution|A Randomized, Controlled, Open-Label, 48-Week Study of Continuing Successfully Suppressive Treatment in HIV-1 Infected Adults With First-Line Twice-Daily Zidovudine and Lamivudine-Based Regimens Versus Pro-actively Replacing of Zidovudine and Lamivudine by Once-Daily Emtricitabine and Tenofovir Disoproxil Fumarate to Prevent Progression of or Reverse Peripheral Lipoatrophy.|Completed||Phase 4|120|Anticipated|International Antiviral Therapy Evaluation Center||2|||f||||f||||||||||2017-02-18 16:10:27.136685|2017-02-18 16:10:27.136685
NCT00389181|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2015-06-02|||October 2006||2006-10-01|June 2015|2015-06-01|May 2015|Actual|2015-05-01|June 2013|Actual|2013-06-01||Interventional|ARUBA||A Randomized Trial of Unruptured Brain AVMs|A Randomized Trial of Unruptured Brain Arteriovenous Malformations|Completed||Phase 3|226|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 16:10:27.23959|2017-02-18 16:10:27.23959
NCT00389168|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2015-05-03|2012-08-19||April 1995||1995-04-01|May 2015|2015-05-01|April 1997|Actual|1997-04-01|April 1997|Actual|1997-04-01||Interventional|SILVHIA||Irbesartan and Atenolol in Hypertensive Heart Disease|Randomized, Double-blind Evaluation of the Effects of Irbesartan and Atenolol on Cardiovascular Structure and Function in Subjects With Hypertension and Left Ventricular Hypertrophy|Completed||Phase 2/Phase 3|115|Actual|Karolinska Institutet||2|||f||||f||||||||||2017-02-18 16:10:27.651617|2017-02-18 16:10:27.651617
NCT00389155|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2015-11-06||2010-09-10|January 2007||2007-01-01|November 2015|2015-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy|A Multicenter, Randomized Double-Blind Phase II/III Study in the First-Line Treatment of Advanced Transitional Cell Carcinoma (TCC) of the Urothelium Comparing Vinflunine/Gemcitabine to Placebo/Gemcitabine in Patients Who Are Ineligible to Receive Cisplatin-Based Therapy|Completed||Phase 2/Phase 3|34|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 16:10:28.148205|2017-02-18 16:10:28.148205
NCT00389142|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2011-07-21|||January 2006||2006-01-01|July 2011|2011-07-01|June 2012|Anticipated|2012-06-01|||||Observational|||Genetic Studies in Interstitial Cystitis|Genetic Studies in Interstitial Cystitis/Painful Bladder Syndrome/Chronic Pelvic Pain Syndrome|Unknown status|Recruiting|N/A|500|Anticipated|Boston Children’s Hospital|||1||f||||t||||||Samples With DNA|"~     We will collect and store DNA (via saliva) and urine on all participants.~   "|||2017-02-18 16:10:28.37802|2017-02-18 16:10:28.37802
NCT00389129|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2007-12-10|||November 2006||2006-11-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Danish Aspirin Resistance Trial - Pilot Study|Comparative Evaluation of Aspirin Resistance With Point-of-Care Testing - Danish Aspirin Resistance Trial (DANART) - Pilot Study|Completed||N/A|60||University of Aarhus|||||f||||f||||||||||2017-02-18 16:10:28.46597|2017-02-18 16:10:28.46597
NCT00389116|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2011-02-24|||November 2006||2006-11-01|February 2011|2011-02-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Interventional|||Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction|Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction|Completed||Phase 4|242|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-02-18 16:10:28.554185|2017-02-18 16:10:28.554185
NCT00388908|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2015-07-25|||November 2006||2006-11-01|July 2015|2015-07-01|July 2012|Actual|2012-07-01|December 2010|Actual|2010-12-01||Interventional|AVOID Fracture||Addressing Vertebral Osteoporosis Incidentally Detected to Prevent Future Fractures|Addressing Vertebral Osteoporosis Incidentally Detected to Prevent Future Fractures: The AVOID FRACTURE Study|Completed||N/A|240|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 16:10:31.706236|2017-02-18 16:10:31.706236
NCT00389103|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2014-01-17|||October 2006||2006-10-01|January 2014|2014-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)|A Phase 1, Placebo-Controlled, Double-Blind Study of the Safety and Immunogenicity of Two Injections of MVA3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Vaccinia Naive Adult Subjects With a History of Atopic Dermatitis (AD)|Withdrawn||Phase 1|0|Actual|Sanofi||1||Senior management decision|f||||t||||||||||2017-02-18 16:10:28.659765|2017-02-18 16:10:28.659765
NCT00389090|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2012-02-07|||October 2006||2006-10-01|February 2012|2012-02-01|February 2009|Actual|2009-02-01|June 2008|Actual|2008-06-01||Interventional|||A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma|A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma|Terminated||Phase 2|32|Actual|Keryx / AOI Pharmaceuticals, Inc.||1||AOI Pharma terminated the license agreement. IND Transferred to NCI|f||||f||||||||||2017-02-18 16:10:28.774|2017-02-18 16:10:28.774
NCT00389077|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2014-02-12|||January 2005||2005-01-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas|A Phase IIA Trial of Two Schedules of Perifosine|Completed||Phase 2|558|Actual|AEterna Zentaris||2|||f||||t||||||||||2017-02-18 16:10:28.897637|2017-02-18 16:10:28.897637
NCT00389064|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-17|2012-03-30|2009-04-15||September 2006||2006-09-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder|A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR) in the Treatment of Elderly Patients With Generalised Anxiety Disorder|Completed||Phase 3|450|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:10:29.010541|2017-02-18 16:10:29.010541
NCT00389051|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2007-08-20|||October 2006||2006-10-01|May 2007|2007-05-01|September 2007||2007-09-01|||||Interventional|||A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma|A Multicenter, Open Study to Assess the Tolerability, Pharmacokinetics and Antitumor Effect of Bendamustine Hydrochloride (SyB L-0501: 90 or 120 mg/m2/Day) Administered Intravenously for Two Days in Patients With Indolent Lymphoma|Completed||Phase 1|12|Anticipated|SymBio Pharmaceuticals|||||f||||||||||||||2017-02-18 16:10:29.686047|2017-02-18 16:10:29.686047
NCT00389038|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2011-04-21|||October 2006||2006-10-01|April 2011|2011-04-01|September 2012|Anticipated|2012-09-01|August 2012|Anticipated|2012-08-01||Interventional|||Pediatric Chronic Headache Trial|Drug and Non-Drug Treatment of Pediatric Chronic Headache|Unknown status|Active, not recruiting|Phase 3|132|Anticipated|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-02-18 16:10:29.784466|2017-02-18 16:10:29.784466
NCT00389025|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2016-11-18|||October 2006||2006-10-01|January 2010|2010-01-01||||April 2007|Actual|2007-04-01||Interventional|||Mast-Cell Stabilizing Effects of Olopatadine|Mast-Cell Stabilizing Effects of Olopatadine|Completed||Phase 4|24|Actual|Alcon Research|||||||||||||||||||2017-02-18 16:10:29.896937|2017-02-18 16:10:29.896937
NCT00389012|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2006-10-16|||May 2004||2004-05-01|October 2006|2006-10-01|January 2006||2006-01-01|||||Interventional|||Strength Training Effectiveness Post-Stroke (STEPS)|Strength Training Effectiveness Post-Stroke (STEPS)|Unknown status|Active, not recruiting|Phase 2|80||University of Southern California|||||f||||||||||||||2017-02-18 16:10:29.990368|2017-02-18 16:10:29.990368
NCT00388999|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2011-12-02|||September 2006||2006-09-01|December 2011|2011-12-01|May 2009|Actual|2009-05-01|February 2009|Actual|2009-02-01||Interventional|||Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant|Multi-Center,Open-Label,Randomized,Phase 1B Study Evaluating Safety & Tolerability of Intravenous rhMBL in Pts With Multiple Myeloma Receiving Melphalan-Based High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplant|Completed||Phase 1|46|Actual|Enzon Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-02-18 16:10:30.09327|2017-02-18 16:10:30.09327
NCT00388986|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2016-11-01|||October 2006||2006-10-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.|An Open-label, Crossover Study to Investigate the Potential Pharmacodynamic and Potential Pharmacokinetic Interaction Between Glyburide and GK Activator(2) in Type 2 Diabetes Patients Inadequately Controlled With Glyburide as Standard Prescribed Therapy.|Completed||Phase 1|18|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 16:10:30.210983|2017-02-18 16:10:30.210983
NCT00388973|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2010-03-22|2008-12-29||September 2006||2006-09-01|March 2010|2010-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder|A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR) in the Treatment of Elderly Patients With Major Depressive Disorder|Completed||Phase 3|338|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:10:30.315941|2017-02-18 16:10:30.315941
NCT00388960|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2016-11-21||2012-05-31|November 2006||2006-11-01|November 2016|2016-11-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|||Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer|Randomized Phase II Study of Amrubicin as Single Agent or in Combination With Cisplatin Versus Etoposide-cisplatin as First-line Treatment in Patients With Extensive Stage SCLC (ES)|Completed||Phase 2|99|Actual|Celgene Corporation||3|||f||||t||||||||||2017-02-18 16:10:31.110901|2017-02-18 16:10:31.110901
NCT00388947|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2016-07-11|2012-08-03||September 2006||2006-09-01|July 2016|2016-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|POWER1012||Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products|The Prolapse Registry: An Observational Collection of Short- and Long-Term Patient Outcomes Following Use of AMS Surgical Devices for the Repair of Female Genital Prolapse|Completed||N/A|1543|Actual|ASTORA Women's Health|||1||f||||f||||||||No||2017-02-18 16:10:31.252288|2017-02-18 16:10:31.252288
NCT00388934|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2013-07-29|||August 2004||2004-08-01|May 2007|2007-05-01|January 2009|Actual|2009-01-01|January 2006|Actual|2006-01-01||Interventional|SORT-OUTII||Comparison of Cypher Select and Taxus Express Coronary Stents|Randomized Clinical Comparison of Cypher Select and Taxus Express Stent Implantation in Unselected Patients With Coronary Artery Disease.|Completed||Phase 4|2095|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-02-18 16:10:31.497096|2017-02-18 16:10:31.497096
NCT00388921|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-15|2006-10-16|||October 2005||2005-10-01|November 2005|2005-11-01||||||||Interventional|||High/Low Dose Vit A in Diarrhea/ALRI in Severe PEM||Completed||N/A|260||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:10:31.604588|2017-02-18 16:10:31.604588
NCT00388882|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2013-10-31|||October 2006||2006-10-01|October 2013|2013-10-01||||October 2007|Actual|2007-10-01||Interventional|||Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.|A Randomized, Double-blind, Double-dummy, Parallel Group Trial Comparing 12 Weeks Treatment With Tiotropium Inhalation Capsules 18 Mcg Via the HandiHaler® Once Daily to Combivent® Inhalation Aerosol CFC MDI 2 Actuations q.i.d. in COPD Patients Currently Prescribed Combivent® Inhalation Aerosol CFC MDI|Completed||Phase 4|327|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 16:10:31.990158|2017-02-18 16:10:31.990158
NCT00388869|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-15|2006-10-16|||November 2006||2006-11-01|October 2006|2006-10-01||||||||Observational|||Renal Artery Calcium and Hypertension|Calcifications of the Renal Arteries and Renal Artery Stenosis in Patients With and Without Hypertension?|Unknown status|Not yet recruiting|N/A|300|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:10:32.140169|2017-02-18 16:10:32.140169
NCT00388856|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2010-02-16|||October 2006||2006-10-01|March 2007|2007-03-01|February 2010|Actual|2010-02-01|November 2009|Actual|2009-11-01||Interventional|||Antioxidant Supplementation in Pregnant Women With Low Antioxidant Status|Vitamin C and E Supplementation in Pregnant Women With Low Antioxidant Status|Completed||Phase 2|400|Actual|Showa University||2|||f||||t||||||||||2017-02-18 16:10:32.230188|2017-02-18 16:10:32.230188
NCT00388843|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2015-08-21|||August 2006||2006-08-01|August 2015|2015-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Carotid Plaque Regression With Statin Treatment Assessed by High Field Magnetic Resonance Imaging (MRI)|Short Term Carotid Plaque Regression in Patients With Atherosclerotic Disease Taking Statins Assessed by High Field MRI|Withdrawn||Phase 4|0|Actual|Medical College of Wisconsin|||2|PI has left institution|f||||f||||||||||2017-02-18 16:10:32.359254|2017-02-18 16:10:32.359254
NCT00388830|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2012-11-01|||May 2006||2006-05-01|November 2012|2012-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Emergency Ultrasound of the Gallbladder|"Emergency Bedside Ultrasonography of the Gallbladder: Does Fasting Matter?"|Completed||N/A|70||Christiana Care Health Services|||||f||||||||||||||2017-02-18 16:10:32.480509|2017-02-18 16:10:32.480509
NCT00388817|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-08|2006-10-16|||January 2002||2002-01-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||Improving Medication Use in Patients With Hypertension|Improving Medication Use in Patients With Hypertension|Completed||N/A|492||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 16:10:32.584086|2017-02-18 16:10:32.584086
NCT00388804|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-15|2012-06-29|2012-06-29||February 2005||2005-02-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer|Randomized Trial of External Beam Radiation With or Without Short-Course Hormonal Therapy in Intermediate Risk Prostate Cancer Patients|Terminated||Phase 3|39|Actual|M.D. Anderson Cancer Center||2||Slow accrual.|f||||t||||||||||2017-02-18 16:10:32.697053|2017-02-18 16:10:32.697053
NCT00388791|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2016-01-26|||October 2006||2006-10-01|January 2016|2016-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Comparison of Systane Free vs. Saline in the Treatment of Dry Eye|Comparison of Systane Free vs. Saline in the Treatment of Dry Eye|Completed||Phase 4|30||Southern California College of Optometry|||||f||||||||||||||2017-02-18 16:10:33.076146|2017-02-18 16:10:33.076146
NCT00388076|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2012-03-15|||April 2006||2006-04-01|February 2011|2011-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)|A Phase I, Open-Label, Study of the Safety, Tolerability and Pharmacokinetics of Pazopanib in Combination With Paclitaxel on a Weekly Schedule for 3 Consecutive Wks, Paclitaxel & Carboplatin on an Every 21 Days Schedule and Lapatinib & Paclitaxel on a Weekly Schedule for 3 Consecutive Weeks|Completed||Phase 1|86|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 16:10:33.165388|2017-02-18 16:10:33.165388
NCT00388063|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2007-12-17|||October 2006||2006-10-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma|A Phase II Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma|Completed||Phase 2|55|Actual|Callisto Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:10:33.285776|2017-02-18 16:10:33.285776
NCT00388050|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-04-27|||July 2006||2006-07-01|April 2015|2015-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Diabetes Medication Choice|Wiser Choices for Patients With Type II Diabetes: Diabetes Medication Choice|Completed||N/A|85|Actual|Mayo Clinic||2|||f||||||||||||||2017-02-18 16:10:33.385804|2017-02-18 16:10:33.385804
NCT00388037|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-01-15|2015-01-09||January 2007||2007-01-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional||All eligible patients|Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Study of Sunitinib (SU11248; NSC 736511) in Patients With Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Completed||Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:10:33.48925|2017-02-18 16:10:33.48925
NCT00388024|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-01-14|||February 2006||2006-02-01|January 2015|2015-01-01|January 2015|Actual|2015-01-01|December 2008|Actual|2008-12-01||Observational|||PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy|A Pilot Feasibility Study of PET-CT Imaging in Patients With Cancer of the Head and Neck Treated With Definitive Chemoradiation|Completed||N/A|19|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 16:10:33.892368|2017-02-18 16:10:33.892368
NCT00388011|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2008-01-11|||January 2005||2005-01-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery|Randomized, Double-Blind, Placebo and Comparator-Controlled, Dose-Response Trial of the Efficacy and Safety of Intranasal Morphine, Intravenous Morphine and Placebo in Patients With Moderate to Severe Pain Following Orthopedic Surgery|Completed||Phase 2|187|Actual|Javelin Pharmaceuticals||6|||f||||f||||||||||2017-02-18 16:10:33.990351|2017-02-18 16:10:33.990351
NCT00387998|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-08-28|||October 2004||2004-10-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Health Education in Improving the Understanding of Medical Information|Randomized Trial of a Primer to Help Patients Understand Risk|Completed||N/A|555|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-02-18 16:10:34.104292|2017-02-18 16:10:34.104292
NCT00006133|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||June 2000||2000-06-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus||Completed||N/A|970||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:27.45418|2017-02-18 18:13:27.45418
NCT00387296|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2009-02-25|||January 2010||2010-01-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Study of Functional Microarray-Facilitated Lidocaine Liposomal Cream Absorption for Cutaneous Anesthesia in Volunteers|"FAST Lidocaine, Study of Functional Microarray-Facilitated Lidocaine Liposomal Cream Absorption for Cutaneous Anesthesia in Volunteers"|Withdrawn||Phase 2|20|Anticipated|Massachusetts General Hospital||1||Funding nonavailability and principal investigator move|f||||t||||||||||2017-02-18 16:10:34.201587|2017-02-18 16:10:34.201587
NCT00387283|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2009-07-06|||October 2006||2006-10-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|December 2006|Actual|2006-12-01||Interventional|||Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020|Pharmacokinetic Study of AVI-4020 in Cerebral Spinal Fluid Among Healthy Adult Males Following Intravenous Administration|Completed||Phase 1|14||Sarepta Therapeutics|||||f||||||||||||||2017-02-18 16:10:34.273464|2017-02-18 16:10:34.273464
NCT00387270|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2008-01-03|||October 2006||2006-10-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease|A Multicenter, Phase 1-2A, Open-Label, Dosage-Escalation and Randomized, Double-Blinded, Placebo-Controlled Study of Dimebon in Subjects With Huntington's Disease|Completed||Phase 1/Phase 2|9|Actual|Medivation, Inc.||1|||f||||||||||||||2017-02-18 16:10:34.376806|2017-02-18 16:10:34.376806
NCT00387257|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2015-04-14|||October 2006||2006-10-01|April 2015|2015-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effect Of Rilapladib (SB-659032) On Platelet Aggregation|A Double Blind, Placebo Controlled, Parallel Study to Evaluate Effects of Repeat Doses of Rilapladib on Platelet Aggregation in Healthy Male Volunteers|Completed||Phase 1|58|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:10:34.488915|2017-02-18 16:10:34.488915
NCT00387244|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2013-08-01|||August 2006||2006-08-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy of the Spinal Cord Stimulation System as Salvage Therapy|Efficacy of the Precision Spinal Cord Stimulation System as Salvage Therapy for Patients With Chronic Intractable Pain of the Trunk and or Limbs Who Have Failed Treatment With an Intraspinal Infusion Pump or Other Spinal Cord Stimulation Device|Terminated||Phase 4|6|Actual|Boston Scientific Corporation||1||Insufficient Data Collected|f||||f||||||||||2017-02-18 16:10:34.577476|2017-02-18 16:10:34.577476
NCT00387231|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2006-10-10|||June 1991||1991-06-01|October 2006|2006-10-01|May 2006||2006-05-01|||||Interventional|||Comparison of Anti-Ischemic Drug Therapy and Percutaneous Transluminal Angioplasty After Myocardial Infarction|Swiss Interventional Study on Silent Ischemia (SWISSI 2)|Completed||N/A|||Luzerner Kantonsspital|||||f||||||||||||||2017-02-18 16:10:34.680175|2017-02-18 16:10:34.680175
NCT00387218|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2008-05-21|||December 2002||2002-12-01|May 2008|2008-05-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Exercise Study For People With Parkinson's Disease|Exercise, Physical Function, and Parkinson's Disease|Unknown status|Recruiting|N/A|170|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 16:10:34.770571|2017-02-18 16:10:34.770571
NCT00387205|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2017-01-11|||June 2006||2006-06-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|February 2013|Actual|2013-02-01||Interventional|||Study To Assess Long Term Safety Of Pazopanib|An Open-Label, Phase Ib Study to Assess the Long Term Safety Profile of Pazopanib in Cancer Patients|Active, not recruiting||Phase 1|195|Actual|Novartis||1|||f||||f||||||||||2017-02-18 16:10:35.038484|2017-02-18 16:10:35.038484
NCT00387192|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2010-03-02|||November 2006||2006-11-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||A Study With OPTIVATE® in People With Von Willebrand Disease|An Open Multi-centre Study in Patients With Von Willebrand Disease to Investigate the Pharmacokinetics, Efficacy and Safety of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate|Terminated||Phase 3|26|Anticipated|Bio Products Laboratory||1||Due to slow recruitment and a significant delay in reaching the recruitment target.|f||||f||||||||||2017-02-18 16:10:35.187462|2017-02-18 16:10:35.187462
NCT00387179|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2009-08-24|||October 2006||2006-10-01|August 2009|2009-08-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Effectiveness of Combining Light and Non-Light Treatments for Jet Lag and Sleep Disorders|Circadian Integration of Photic and Non-photic Stimuli|Unknown status|Recruiting|N/A|48|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||||||||||||2017-02-18 16:10:35.286696|2017-02-18 16:10:35.286696
NCT00387166|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2012-01-04|||October 2006||2006-10-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American Women|Cardiovascular Risk Disparities: Socio-Emotional Pathways|Completed||N/A|304|Actual|San Diego State University|||1||f||||t||||||Samples Without DNA|"~     Blood and urine specimens were collected to identify stress hormones and inflammatory~     markers. Whole blood, plasma, and serum are stored for possible future assays based on new~     discoveries.~   "|||2017-02-18 16:10:35.417343|2017-02-18 16:10:35.417343
NCT00387153|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2009-10-27|2009-06-23||August 2005||2005-08-01|October 2009|2009-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer|Phase 1 OL, Dose Escalating, Multiple Dose Study To Determine The Safety, Tolerability, MTD, And Pharmacokinetics Of MPC-2130 Administered As Daily IV Infusions For 5 Days, Repeated Every 21 Days, In Patients With Refractory Cancer|Terminated||Phase 1|8|Actual|Myriad Therapeutics, Inc.||1||Last subject enrolled experienced bradycardia; study was terminated by Sponsor.|f||||f||||||||||2017-02-18 16:10:35.532751|2017-02-18 16:10:35.532751
NCT00388778|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2008-01-22|||October 2005||2005-10-01|January 2008|2008-01-01|October 2006||2006-10-01|||||Interventional|||The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne|The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne|Unknown status|Recruiting|Phase 2/Phase 3|100|Anticipated|Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:10:35.800451|2017-02-18 16:10:35.800451
NCT00388765|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2015-10-01|||September 2006||2006-09-01|October 2008|2008-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Normal Control Cohort Sample Bank|Protocol to Establish a Research Sample Bank of Lung Biopsy and BAL Samples for a Non-Atopic, Non-Asthmatic Subject Cohort|Completed||N/A|10|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 16:10:35.894132|2017-02-18 16:10:35.894132
NCT00388752|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2007-06-05|||September 2006||2006-09-01|October 2006|2006-10-01||||||||Interventional|||Acupuncture for the Treatment of Phantom Limb and Residual Limb Pain After Amputation|Acupuncture for Post Amputation Limb Pain: A Pilot Study|Unknown status|Recruiting|Phase 1|21|Anticipated|Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 16:10:35.978445|2017-02-18 16:10:35.978445
NCT00388726|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2014-07-25|2011-12-22||October 2006||2006-10-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|June 2009|Actual|2009-06-01||Interventional|||E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer|"The EMBRACE Trial: Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389. A Phase III Open-Label, Randomized, Parallel, Two-arm, Multi-center Study of E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent, Metastatic Breast Cancer, Previously Treated With At Least Two and a Maximum of Five Prior Chemotherapy Regimens, Including an Anthracycline and a Taxane"|Completed||Phase 3|762|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:10:36.20552|2017-02-18 16:10:36.20552
NCT00388713|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-15|2007-05-15|||October 2006||2006-10-01|December 2005|2005-12-01|January 2010|Anticipated|2010-01-01|||||Observational|||Radiation Induced Atherosclerosis in Breast Cancer Patients|Radiation Induced Atherosclerosis in Breast Cancer Patients|Unknown status|Recruiting|N/A|350|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:10:37.334391|2017-02-18 16:10:37.334391
NCT00388700|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2016-08-08|||October 2006||2006-10-01|August 2016|2016-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer|Open-Label, Phase 2 Study of GM-CT-01 When Added to a Regimen of Leucovorin, 5-FU, and Avastin as First Line Treatment for Locally Advanced, Unresectable or Metastatic Colorectal Cancer in Subjects Unable to Tolerate Intensive Chemotherapy|Terminated||Phase 2|10|Actual|Galectin Therapeutics Inc.||1||Financing and re-organization|f||||f||||||||||2017-02-18 16:10:37.423462|2017-02-18 16:10:37.423462
NCT00388687|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2006-10-16|||July 2006||2006-07-01|October 2006|2006-10-01|July 2007||2007-07-01|||||Observational|||Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer|Hypoxia Imaging With the Novel Radiopharmaceutical 18F Fluoroazomycin Arabinoside (FAZA)- Prognostic Impact in Cervical Cancer|Unknown status|Recruiting|Phase 2|25||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:10:37.541438|2017-02-18 16:10:37.541438
NCT00388674|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2017-01-12|||December 2006||2006-12-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|September 2016|Actual|2016-09-01||Observational|||Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection|Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study|Active, not recruiting||N/A|12500|Anticipated|Bristol-Myers Squibb|||2||f||||t||||||Samples With DNA|"~     buccal~   "|||2017-02-18 16:10:37.647363|2017-02-18 16:10:37.647363
NCT00388661|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2011-07-19|||April 2007||2007-04-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||Melatonin and Quality of Life in Dialysis Patients|Double Blind Placebo-controlled Study on the Efficacy of Melatonin on Sleep, Resulting in an Improved Quality of Life in Hemodialysis Patients|Completed||Phase 3|68|Actual|Meander Medical Center||2|||f||||f||||||||||2017-02-18 16:10:40.706171|2017-02-18 16:10:40.706171
NCT00388648|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2006-10-16|||January 2000||2000-01-01|October 2006|2006-10-01|July 2005||2005-07-01|||||Interventional|||Very Low Protein Diet or Dialysis in Uremic Elderly?|Efficacy and Safety of a Very Low Protein Diet in Postponing Dialysis in Elderly: a Prospective Randomized Multicenter Controlled Study|Completed||Phase 4|160||Università degli Studi di Brescia|||||f||||||||||||||2017-02-18 16:10:40.825835|2017-02-18 16:10:40.825835
NCT00388635|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2011-01-08|||April 2004||2004-04-01|January 2011|2011-01-01|December 2008|Actual|2008-12-01|January 2007|Actual|2007-01-01||Interventional|||Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.|A National, Multi-Center, Open-Label Study of Velcade in Combination With Melphalan and Prednisone (V-MP) in Older Untreated Multiple Myeloma Patients.|Completed||Phase 1/Phase 2|60|Actual|PETHEMA Foundation||1|||f||||||||||||||2017-02-18 16:10:40.928847|2017-02-18 16:10:40.928847
NCT00388622|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-08|2006-10-16|||February 2001||2001-02-01|October 2006|2006-10-01|November 2004||2004-11-01|||||Interventional|||Improving Drug Use for Elderly Heart Failure Patients|Improving Drug Use for Elderly Heart Failure Patients|Completed||N/A|314||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 16:10:41.331784|2017-02-18 16:10:41.331784
NCT00388609|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2010-09-15||2010-09-10|November 2006||2006-11-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|September 2007|Actual|2007-09-01||Interventional|||Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese Subjects|A Randomized, Double-blind, Placebo-Controlled, Parallel Arm, Multiple-Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BMS-646256 in Obese and High Risk Overweight Subjects|Terminated||Phase 2|705|Actual|Bristol-Myers Squibb||7|||f||||f||||||||||2017-02-18 16:10:41.448766|2017-02-18 16:10:41.448766
NCT00388596|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2008-10-09|||October 2006||2006-10-01|October 2008|2008-10-01||||||||Interventional|||A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.|An Open-Label, Partially Randomized, Interaction Study to Evaluate the Effects of SB-751689 on the Pharmacokinetics of Rosuvastatin and Atorvastatin or the Effects of Ketoconazole on the Pharmacokinetics of SB-751689 in Healthy Postmenopausal Female Subjects|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 16:10:41.570517|2017-02-18 16:10:41.570517
NCT00388583|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2012-04-13|2011-07-14||September 2006||2006-09-01|April 2012|2012-04-01|September 2008|Actual|2008-09-01|June 2007|Actual|2007-06-01||Interventional|||Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects|Immunogenicity and Safety of The Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route in Comparison With Intramuscular Vaccination With Standard Fluzone® in Ambulatory Elderly Subjects|Completed||Phase 2|817|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:10:41.698728|2017-02-18 16:10:41.698728
NCT00388570|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2011-11-03|||October 2006||2006-10-01|November 2011|2011-11-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|eNOugh||Study of Monitoring Exhaled NO in Symptomatic Asthmatic Adults and Children During Anti-inflammatory Treatment|A Multicenter, Device Randomized, Open-label Prospective Single-cohort Study of Monitoring Exhaled NO in Symptomatic Asthmatic Adults and Children During Anti-inflammatory Treatment|Completed||N/A|151|Actual|Aerocrine AB||1|||f||||f||||||||||2017-02-18 16:10:42.446227|2017-02-18 16:10:42.446227
NCT00388557|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2016-09-16|||October 2005||2005-10-01|September 2016|2016-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Effect of Ketoconazole on the Pharmacokinetics of Vinflunine|Effect of Ketoconazole on the Pharmacokinetics of Intravenous (IV) Vinflunine in Patients With Advanced Cancer|Completed||Phase 1|35|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:10:42.556359|2017-02-18 16:10:42.556359
NCT00388531|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2011-09-16|||March 2006||2006-03-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|March 2011|Actual|2011-03-01||Interventional|||Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma|Multicenter, Prospective, Open Label Trial, Uncontrolled to Determine the Efficacy and Safety of Depocyt ® for the Treatment of CNS Relapse in Adult Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma|Completed||Phase 2|10|Anticipated|PETHEMA Foundation||1|||f||||||||||||||2017-02-18 16:10:42.797919|2017-02-18 16:10:42.797919
NCT00388518|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2016-11-01||2016-06-28|November 2006||2006-11-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Aleglitazar in Patients With Type 2 Diabetes|A Randomized, Double-blind Study to Investigate the Effect of Aleglitazar on Glycemic Control in Patients With Type 2 Diabetes Mellitus.|Completed||Phase 2|332|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-02-18 16:10:42.941865|2017-02-18 16:10:42.941865
NCT00388505|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-16|2012-06-19|2012-06-19||February 2006||2006-02-01|June 2012|2012-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|EAGER||Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis|A Randomized, Open-label Multicentre Phase 3 Trial to Assess the Safety of Tobramycin Inhalation Powder Compared to Tobramycin Solution for Inhalation in Cystic Fibrosis Subjects|Completed||Phase 3|517|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:10:43.359957|2017-02-18 16:10:43.359957
NCT00388492|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2007-01-10||||||October 2006|2006-10-01||||||||Observational|||BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects|"BLADE: A Comparison of Once Daily LPV/r to LPV/r BID in HIV-Infected Virologically Controlled Antiretroviral Experienced Subjects"|Unknown status|Not yet recruiting|Phase 4|45||Bellos, Nicholaos C., M.D.|||||f||||||||||||||2017-02-18 16:10:44.319405|2017-02-18 16:10:44.319405
NCT00388479|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-07-16|||December 2001||2001-12-01|July 2015|2015-07-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus|A Multicenter Phase III, Double-Blind, Placebo-Controlled, Parallel Study of ADL-8-2698 in Opioid-Induced Postoperative Bowel Dysfunction/Postoperative Ileus|Completed||Phase 3|666||Cubist Pharmaceuticals LLC|||||f||||f||||||||||2017-02-18 16:10:44.413626|2017-02-18 16:10:44.413626
NCT00388466|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2006-10-13|||June 2005||2005-06-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||Whole Body Vibration - a New Therapeutic Approach to Improve Muscle Function in CF|Cystic Fibrosis: Improvement of Muscle Force and Function by Whole Body Vibration Exercise|Completed||N/A|10||University of Cologne|||||f||||||||||||||2017-02-18 16:10:44.520181|2017-02-18 16:10:44.520181
NCT00388453|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2014-04-29|||October 2006||2006-10-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|September 2012|Actual|2012-09-01||Interventional|ADHERE||Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease|ADHERE Study: Application of Dx-pH Catheter for Extra-esophageal Reflux Evaluation|Completed||Phase 3|102|Actual|Vanderbilt University||3|||f||||f||||||||||2017-02-18 16:10:44.616517|2017-02-18 16:10:44.616517
NCT00388440|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2016-09-15|||November 2000||2000-11-01|September 2016|2016-09-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.|Phase IV Open Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-Mumps-Rubella (MMR) Vaccine When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.|Completed||Phase 4|150|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:10:44.735648|2017-02-18 16:10:44.735648
NCT00388427|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2015-05-27|||June 2007||2007-06-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|July 2009|Actual|2009-07-01||Interventional|||Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies|Phase I Study of Cetuximab Plus Dasatinib (BMS-354825) in Advanced Solid Malignancies|Completed||Phase 1|31|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:10:44.852643|2017-02-18 16:10:44.852643
NCT00388414|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2012-06-21|||September 2006||2006-09-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication|Functional MRI Neural Correlates of Medication Efficacy in Patients With Chronic Low Back Pain|Completed||N/A|53|Actual|Stanford University||2|||f||||||||||||||2017-02-18 16:10:44.969026|2017-02-18 16:10:44.969026
NCT00388401|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2015-07-16|||January 2002||2002-01-01|October 2008|2008-10-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus|A Multicenter Phase III, Double-Blind, Placebo-Controlled, Parallel Study of ADL-8-2698 in Opioid-Induced Postoperative Bowel Dysfunction/Postoperative Ileus|Completed||Phase 3|510||Cubist Pharmaceuticals LLC|||||f||||f||||||||||2017-02-18 16:10:45.101037|2017-02-18 16:10:45.101037
NCT00388388|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2015-05-18|||March 2007||2007-03-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects|Double-blind, Randomized, Parallel Design Study Comparing Effectiveness of Losartan vs. Hydrochlorothiazide in Reversing or Preventing the Progression of the Remodeling of Resistance Arteries in Pre-hypertensive Pre-diabetic Subjects|Terminated||Phase 2|1|Actual|Sir Mortimer B. Davis - Jewish General Hospital||2||Few subjects recruited, sponsor withdrew support.|f||||t||||||||||2017-02-18 16:10:45.22316|2017-02-18 16:10:45.22316
NCT00388375|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-10-17|||October 2006||2006-10-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Can Ultrasound be Used to Verify CVC Position and to Exclude Pneumothorax?|Can Ultrasound be Used as an Alternative to Chest Radiography After Central Venous Catheter Insertion to Confirm Proper Catheter Position and to Exclude Pneumothorax?|Terminated||N/A|23|Actual|Christiana Care Health Services||1||Not feasible, did not have the study population.|f||||||||||||||2017-02-18 16:10:45.366524|2017-02-18 16:10:45.366524
NCT00388362|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-03-29|||November 2005||2005-11-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease|A Phase II Trial of Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease|Completed||Phase 2|36|Actual|Stanford University||1|||f||||||||||||||2017-02-18 16:10:45.558844|2017-02-18 16:10:45.558844
NCT00388349|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-08-27|||September 2001||2001-09-01|August 2013|2013-08-01|September 2010|Actual|2010-09-01|March 2008|Actual|2008-03-01||Interventional|||Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease|Gemcitabine and High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease|Completed||Phase 2|146|Actual|Stanford University||1|||f||||||||||||||2017-02-18 16:10:45.858353|2017-02-18 16:10:45.858353
NCT00388336|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2011-05-17|||February 2004||2004-02-01|April 2010|2010-04-01|March 2005|Actual|2005-03-01|||||Interventional|||PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy|A Pilot Study to Evaluate the Response Rate of PROCRIT� (Epoetin Alfa) at 60,000 Units Every Two Weeks in Anemic Cancer Patients Not Receiving Chemotherapy Or Radiation Therapy|Completed||Phase 2|57|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:10:45.958811|2017-02-18 16:10:45.958811
NCT00388323|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2012-12-10|||November 2006||2006-11-01|November 2012|2012-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|RIHTA||Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human|Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human : Study of Pro- and Anti-inflammatory Cytokines and ADIPOKINES..|Completed||N/A|47|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 16:10:46.055714|2017-02-18 16:10:46.055714
NCT00388310|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2012-11-07|||February 2006||2006-02-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effective Antibiotic Treatment of MRSA|Effective Duration of Antibiotic Treatment of Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA)|Completed||N/A|33|Actual|Christiana Care Health Services||4|||f||||||||||||||2017-02-18 16:10:46.192625|2017-02-18 16:10:46.192625
NCT00388297|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2016-09-09|||October 2006||2006-10-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|August 2015|Actual|2015-08-01||Interventional|TSH||Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy|A Randomized Trial of Thyroxine Therapy for Subclinical Hypothyroidism or Hypothyroxinemia Diagnosed During Pregnancy|Completed||Phase 3|1203|Actual|The George Washington University Biostatistics Center||2|||f||||t||||||||Yes|The data will be shared after the completion of the trial and publication of the main analyses per NIH policy. When made available, requests for the dataset(s) can be sent to mfmudatasets@bsc.gwu.edu.|2017-02-18 16:10:46.306856|2017-02-18 16:10:46.306856
NCT00388284|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2015-12-07|||August 2006||2006-08-01|February 2008|2008-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Efficacy Study Comparing Thrombin for Arterial Sealing|Comparative Analysis of Thrombin Utilized in Endovascular Procedures of the Femoral Artery - CEASE Study|Completed||Phase 3|270||Vascular Solutions, Inc|||||||||||||||||||2017-02-18 16:10:46.454127|2017-02-18 16:10:46.454127
NCT00388271|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2017-02-08|||October 2006||2006-10-01|February 2017|2017-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Use of Alfuzosin in Stone Treatment With ESWL|To Investigate if Alpha-blocker Therapy (Alfuzosin) Increases Stone Free Rates and Improves Pain Control After ESWL (Extra-corporeal Shock Wave Lithotripsy) for Renal and Ureteric Stones.|Withdrawn||Phase 3|0|Actual|Singapore General Hospital||2||lack of funding|f||||f||||||||||2017-02-18 16:10:46.54789|2017-02-18 16:10:46.54789
NCT00388258|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2015-07-16|||March 2001||2001-03-01|July 2015|2015-07-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus|A Multicenter Phase III, Double-Blind, Placebo-Controlled, Parallel Study of ADL-8-2698 in Opioid-Induced Postoperative Bowel Dysfunction/Postoperative Ileus|Completed||Phase 3|451||Cubist Pharmaceuticals LLC|||||f||||f||||||||||2017-02-18 16:10:46.661818|2017-02-18 16:10:46.661818
NCT00388245|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2006-10-13|||January 2007||2007-01-01|October 2006|2006-10-01|December 2008||2008-12-01|||||Interventional|||Revascularization in Heart Failure Trial – REHEAT 2|Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: a Comparison Between Percutaneous Coronary Intervention and Coronary Artery Bypass Surgery|Unknown status|Not yet recruiting|Phase 4|150||Ministry of Science and Higher Education, Poland|||||f||||||||||||||2017-02-18 16:10:46.778029|2017-02-18 16:10:46.778029
NCT00388232|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2006-10-13||||||October 2006|2006-10-01||||||||Observational|||Prevalence of COPD: First Epidemiological Data From a Large Region of Turkey|Inonu University, The Department of Pulmonary Medicine|Completed||N/A|1200||Inonu University|||||f||||||||||||||2017-02-18 16:10:46.896862|2017-02-18 16:10:46.896862
NCT00388219|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2007-07-05|||October 2006||2006-10-01|July 2007|2007-07-01|November 2006||2006-11-01|||||Interventional|||Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations|Single Dose Bioequivalence Trial Comparing a New Analgesic Transdermal Patch Formulation to an Analgesic Reference Patch|Terminated||Phase 1|24||Grünenthal GmbH|||||f||||||||||||||2017-02-18 16:10:46.970553|2017-02-18 16:10:46.970553
NCT00388206|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2012-12-14|||May 2006||2006-05-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|ARIES||A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)|An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Cancer and Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Excluding Predominant Squamous Cell Histology)|Completed||Phase 4|3998|Actual|Genentech, Inc.|||1||f||||||||||Samples With DNA|"~     blood and tumor~   "|||2017-02-18 16:10:47.063915|2017-02-18 16:10:47.063915
NCT00388193|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2014-10-27|||August 2006||2006-08-01|February 2013|2013-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Rituximab Combined With Chemotherapy in Burkitt`s Lymphoma|Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)|Completed||Phase 2|20|Anticipated|PETHEMA Foundation||1|||f||||||||||||||2017-02-18 16:10:47.139372|2017-02-18 16:10:47.139372
NCT00388180|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2012-03-15|||December 2004||2004-12-01|February 2011|2011-02-01||||||||Observational|||An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation|A Randomized, Double-blind, Parallel Group Study to Evaluate the Effect of 12-week Treatment With GW590735X (20ug) or GW501516X (10mg) Relative to Placebo on Measures of Adiposity and Inflammation in Overweight and Obese Subjects|Completed||N/A|71|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 16:10:47.278542|2017-02-18 16:10:47.278542
NCT00385073|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2006-10-05|||April 2005||2005-04-01|October 2006|2006-10-01|December 2007||2007-12-01|||||Observational|||Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease|Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease|Unknown status|Recruiting|N/A|30||Austin Health|||||f||||||||||||||2017-02-18 16:12:03.630247|2017-02-18 16:12:03.630247
NCT00388167|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-13|2009-05-11|||March 2004||2004-03-01|May 2009|2009-05-01|February 2008|Actual|2008-02-01|||||Observational|||Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection|PROCAS: Study Observational Prospective and Multicenter to Determine the Clinic Effectiveness and the Safety of Caspofungin Acetate (CANCIDAS®) in the Treatment of Invader Fungal Infection|Completed||Phase 4|320|Anticipated|PETHEMA Foundation|||1||f||||||||||||||2017-02-18 16:10:47.371776|2017-02-18 16:10:47.371776
NCT00388154|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-11-12|2014-11-05||August 2004||2004-08-01|November 2014|2014-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||One participant of the 21 enrolled was not evaluable for response or toxicity after transitioning to comfort care without completing the first treatment cycle.|Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer|A Phase II Study of Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer|Completed||Phase 2|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:10:47.535695|2017-02-18 16:10:47.535695
NCT00388141|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2007-11-30|||March 2005||2005-03-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Nursing and Nurturing Premature Infants|Nursing and Nurturing Premature Infants. An Intervention Study Investigating Systematic Use of Newborn Individualized Developmental Care Assessment Program NIDCAP® Improves Development of Infants and the Mothers' Parental Competence|Completed||Early Phase 1|90|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 16:10:48.013884|2017-02-18 16:10:48.013884
NCT00388128|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2011-06-08|||September 2006||2006-09-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|||Caffeine and Intermittent Claudication|Effects of Caffeine in Patients With Intermittent Claudication.|Completed||Phase 3|80|Anticipated|University of Aarhus||1|||f||||t||||||||||2017-02-18 16:10:48.114159|2017-02-18 16:10:48.114159
NCT00388115|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2010-03-25|||October 2001||2001-10-01|March 2010|2010-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ|A Pilot Study of Radiofrequency Ablation of Early Invasive and In Situ Breast Cancer|Completed||N/A|15|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 16:10:48.220687|2017-02-18 16:10:48.220687
NCT00388089|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2010-06-25|||December 2004||2004-12-01|December 2007|2007-12-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors|Phase I Study of Weekly Bortezomib (VELCADE, PS-341) and Weekly Topotecan (HYCAMTIN) in Solid Tumor Patients With an Emphasis on Small Cell Lung Cancer (SCLC)|Completed||Phase 1|24|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 16:10:48.329118|2017-02-18 16:10:48.329118
NCT00387985|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2011-07-22|||August 2006||2006-08-01|July 2011|2011-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Bioequivalence Study in Healthy Volunteers|An Open-label, Single-dose, Randomized, 2-period Crossover, Bioequivalence Study Between the Current Formulation and the New Formulation of MOA-728 Administered Subcutaneously in Healthy Subjects|Completed||Phase 1|||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:10:48.442804|2017-02-18 16:10:48.442804
NCT00387972|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-04-15|||May 2006||2006-05-01|April 2015|2015-04-01|October 2007|Anticipated|2007-10-01|October 2007|Anticipated|2007-10-01||Interventional|||Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)|A Multi-center, Double-blind, Parallel-group, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects With Type 2 Diabetes Mellitus|Withdrawn||Phase 2/Phase 3|0|Actual|GlaxoSmithKline||||Study cancelled before enrollment|f||||||||||||||2017-02-18 16:10:48.528642|2017-02-18 16:10:48.528642
NCT00387959|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-12-22|2015-12-22||July 2006||2006-07-01|December 2015|2015-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma|A Non-Myeloablative Conditioning Regimen With Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With B Cell Lymphoid Malignancies|Completed||Phase 2|17|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||t||||||||||2017-02-18 16:10:48.665627|2017-02-18 16:10:48.665627
NCT00387946|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2012-02-15|||September 2006||2006-09-01|February 2012|2012-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)|An International, Seven-week, Double-blind, Placebo-controlled, Two Parallel Group Study to Assess the Efficacy of Dianicline 40 mg Bid as an Aid to Smoking Cessation in Cigarette Smokers|Completed||Phase 3|630|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:10:49.14063|2017-02-18 16:10:49.14063
NCT00387933|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-10-11|||July 2005||2005-07-01|November 2012|2012-11-01||||January 2009|Actual|2009-01-01||Interventional|||Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma|Phase I Dose Escalation of Gleevec in Combination With PTK787/ZK 222584 (PTK/ZK) Plus Hydroxyurea|Completed||Phase 1|37|Actual|Duke University||1|||f||||||||||||||2017-02-18 16:10:49.232134|2017-02-18 16:10:49.232134
NCT00387920|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-01-27|||October 2006||2006-10-01|January 2014|2014-01-01||||September 2012|Actual|2012-09-01||Interventional|||Sunitinib in Treating Young Patients With Refractory Solid Tumors|A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children With Refractory Solid Tumors|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:10:49.362766|2017-02-18 16:10:49.362766
NCT00387907|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2016-04-06||2016-04-06|October 2006||2006-10-01|April 2016|2016-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer|Open Label, Uncontrolled, Study of XRP9881 (Larotaxel) in Combination With Weekly Trastuzumab (Herceptin®) in Patients With HER2 Positive Metastatic Breast Cancer (MBC)|Completed||Phase 2|6|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:10:49.494425|2017-02-18 16:10:49.494425
NCT00387894|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-05-25|2013-04-12||January 2007||2007-01-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma|Phase-2 Study of Tarceva in Patients With Recurrent EGFR Positive and Phosphatase and Tensin Homolog (PTEN) Wild Type Glioblastoma Multiforme and Gliosarcoma|Terminated||Phase 2|6|Actual|University of California, San Francisco|The study was terminated early for 2 reasons: 1. ongoing literature at the time confirming that the selection process was not likely to enrich for a patient population expected to benefit, and 2. Rapid disease progression in the first 6 patients.|1||Insufficient accrual of population likely to benefit; progression in 6 patients|f||||t||||||||||2017-02-18 16:10:49.602617|2017-02-18 16:10:49.602617
NCT00387881|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2016-11-02|2009-02-19||September 2006||2006-09-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Tolerability of TREXIMA* (Sumatriptan Succinate/Naproxen Sodium) for a Single Moderate or Severe Headache in Adults Diagnosed With Probable Migraine Without Aura (ICHD-II 1.6.1) (*TREXIMET)|Completed||Phase 3|679|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:10:49.969971|2017-02-18 16:10:49.969971
NCT00387868|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2014-12-08|||October 2006||2006-10-01|December 2014|2014-12-01|November 2014|Actual|2014-11-01|October 2014|Actual|2014-10-01||Interventional|||Preoperative Treatment of Patients With High Risk Thymoma|Phase II Study of Trimodality Therapy for Patients With Thymoma or Thymic Carcinoma at Significant Risk for Recurrence|Completed||Phase 2|21|Actual|Valley Health System||3|||f||||t||||||||||2017-02-18 16:10:50.789438|2017-02-18 16:10:50.789438
NCT00387855|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2016-07-27|||September 2001||2001-09-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|December 2012|Actual|2012-12-01||Interventional|||An Evaluation of the SOS (Suicide Prevention) Program|An Outcome Evaluation of the SOS Suicide Prevention Program|Completed||N/A|6471|Actual|UConn Health||1|||f||||f||||||||||2017-02-18 16:10:50.903843|2017-02-18 16:10:50.903843
NCT00387842|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2006-10-12|||March 1997||1997-03-01|October 2006|2006-10-01|March 2008||2008-03-01|||||Interventional|||COlon Cancer Laparoscopic or Open Resection|A Randomized Clinical Trial Comparing Laparoscopic and Open Surgery for Colon Cancer|Unknown status|Active, not recruiting|Phase 3|1200||Erasmus Medical Center|||||f||||||||||||||2017-02-18 16:10:51.013744|2017-02-18 16:10:51.013744
NCT00387829|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-09-17|2013-06-07||October 2006||2006-10-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional||A total of 343 patients were randomized in the study (Intent-to-treat population). Four patients received treatment (1 Duragen Plus; 3 Surgery alone), but were not randomized correctly, and were followed-up for safety only. Hence the total patients in the Safety Population is 347.|DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery|Randomized Controlled Trial of DuraGen Plus® Adhesion Barrier Matrix to Minimize Adhesions Following Lumbar Discectomy|Terminated||N/A|347|Actual|Integra LifeSciences Corporation||2||Sponsor voluntarily terminated study|f||||f||||||||||2017-02-18 16:10:51.106888|2017-02-18 16:10:51.106888
NCT00387803|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2007-01-23|||February 1998||1998-02-01|January 2007|2007-01-01|August 2001||2001-08-01|||||Interventional|||Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation|VENTAK CHF/CONTAK CD Biventricular Pacing Study|Completed||Phase 2/Phase 3|581||Boston Scientific Corporation|||||||||||||||||||2017-02-18 16:10:51.603252|2017-02-18 16:10:51.603252
NCT00387790|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-05-07|2013-12-18||June 2007||2007-06-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma|A Phase II Study of Motexafin-Gadolinium (NSC 695238, IND #55583) and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood|Completed||Phase 2|64|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:10:51.698521|2017-02-18 16:10:51.698521
NCT00387777|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2016-01-08|||October 2006||2006-10-01|January 2016|2016-01-01|December 2006||2006-12-01|||||Interventional|||Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations|Multiple Dose Bioequivalence Trial Comparing a New Analgesic Transdermal Patch Formulation to an Analgesic Reference Patch.|Terminated||Phase 1|24||Grünenthal GmbH|||||f||||||||||||||2017-02-18 16:10:52.058252|2017-02-18 16:10:52.058252
NCT00387764|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-12-12|2013-08-15||September 2006||2006-09-01|October 2013|2013-10-01|October 2012|Actual|2012-10-01|December 2009|Actual|2009-12-01||Interventional|||Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer|An Open-label Extension Study to Assess the Safety and Efficacy of Pazopanib in Subjects With Renal Cell Carcinoma Previously Enrolled on Protocol VEG105192|Completed||Phase 3|80|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:10:52.157277|2017-02-18 16:10:52.157277
NCT00387751|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-06-03|2012-12-07||August 2006||2006-08-01|December 2013|2013-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma|A Phase II, Pharmacokinetic (PK), Pharmacodynamic (PD) and Biological Correlative Study of the Efficacy and Safety of Dual Antiangiogenic Inhibition Using Bevacizumab and Sorafenib in Patients With Advanced Malignant Melanoma|Completed||Phase 2|14|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:10:53.059092|2017-02-18 16:10:53.059092
NCT00387738|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2016-11-08|||April 2006||2006-04-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults|A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Dose-Regimen Study of the Efficacy and Safety of TOLAMBA™ in Ragweed-Allergic Rhinitis Adults|Terminated||Phase 2|738|Actual|Dynavax Technologies Corporation||3||"Interim data indicated that subjects exhibited no meaningful allergic disease during the first~   ragweed season, making it impossible to measure treatment effect."|f||||t||||||||No|The IND for Tolamba was withdrawn, it was reported to the agency that there was no plan to conduct clinical studies with this compound. [per email from EA 18Dec2015|2017-02-18 16:10:53.330377|2017-02-18 16:10:53.330377
NCT00387725|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2014-11-14|2014-11-14||November 2006||2006-11-01|November 2014|2014-11-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents|A Randomized, Observer-blinded, Parallel-group, Active-control, Phase ½ Trial Of The Safety, Immunogenicity, And Tolerability Of 20 Mg, 60 Mg, And 200 Mg Of Meningococcal Group B Rlp2086 Vaccine In Healthy Children And Adolescents Aged 8 To 14 Years|Completed||Phase 2|127|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 16:10:53.495452|2017-02-18 16:10:53.495452
NCT00387712|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-10-20|||October 2006||2006-10-01|October 2014|2014-10-01|August 2014|Actual|2014-08-01|August 2012|Actual|2012-08-01||Interventional|||Inflammatory Abnormalities in Muscle After Stroke: Effects of Exercise|Inflammatory Abnormalities in Muscle After Stroke: Effects of Exercise|Completed||Phase 1|120|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:10:54.350146|2017-02-18 16:10:54.350146
NCT00387530|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2009-02-06|||May 2006||2006-05-01|March 2008|2008-03-01||||January 2008|Anticipated|2008-01-01||Interventional|||Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer|A Phase II Study of Phenylbutyrate and Valganciclovir in Epstein-Barr Virus Positive Tumors|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:10:59.395461|2017-02-18 16:10:59.395461
NCT00387699|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-04-27|||October 2006||2006-10-01|October 2008|2008-10-01|April 2014|Actual|2014-04-01|October 2007|Actual|2007-10-01||Interventional|||Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Phase II Trial of Bevacizumab in Combination With Cisplatin/Etoposide and Twice Daily Radiation for Patients With Limited-Stage Small Cell Lung Cancer|Completed||Phase 2|79|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:10:54.463794|2017-02-18 16:10:54.463794
NCT00387686|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2013-02-21||2013-02-21|November 2006||2006-11-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|July 2009|Actual|2009-07-01||Interventional|||A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures|A Phase 2/3, Multicenter, Double-Blind, Randomized, Controlled Study Of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)/Calcium Phosphate Matrix (CPM) In Closed Diaphyseal Tibial Fracture|Terminated||Phase 2/Phase 3|367|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4||"Decision was taken by Wyeth Sr. Management to early terminate the 3100N7-210 study (terminate~   enrollment but complete follow-up)."|f||||f||||||||||2017-02-18 16:10:54.565388|2017-02-18 16:10:54.565388
NCT00387673|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-09-15|||October 2006||2006-10-01|September 2014|2014-09-01|June 2011|Actual|2011-06-01|October 2009|Actual|2009-10-01||Interventional|||Effect of Prolonged Electrical Stimulation on Neural Plasticity in Spinal Cord Injury|Effect of Prolonged Electrical Stimulation on Neural Plasticity in SCI|Completed||N/A|36|Anticipated|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 16:10:54.797065|2017-02-18 16:10:54.797065
NCT00387660|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2011-12-16|||October 2001||2001-10-01|December 2011|2011-12-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer|Phase II Study of Irinotecan and Carboplatin in Metastatic or Relapsed Small-Cell Lung Cancer|Completed||Phase 2|33|Actual|University of California, Davis||1|||f||||f||||||||||2017-02-18 16:10:54.911725|2017-02-18 16:10:54.911725
NCT00387647|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-08-19|2014-05-29||August 2006||2006-08-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|October 2013|Actual|2013-10-01||Interventional||All participants|Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy|A Multicenter, Phase 2 Study of Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia in Complete Remission After Induction Chemotherapy|Completed||Phase 2|24|Actual|H. Lee Moffitt Cancer Center and Research Institute|Only five participants completed study and defined follow-up period and one participant remained on follow-up at time of analysis.|1|||f||||f||||||||||2017-02-18 16:10:55.023118|2017-02-18 16:10:55.023118
NCT00387634|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2012-11-01|||September 2006||2006-09-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults|A Phase IV, Uncontrolled, Open-label, Single-center Study in Adolescents and Adults: Evaluation of Immunogenicity and Safety of the First Booster Immunization With Novartis' TBE Vaccine for Adults in Participants of Study V48P7 and Long-term Evaluation of Immunogenicity up to 5 Years After First Booster Immunization|Completed||Phase 4|323|Actual|Novartis||4|||f||||||||||||||2017-02-18 16:10:55.320884|2017-02-18 16:10:55.320884
NCT00387621|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2012-04-18|2011-10-26||February 2006||2006-02-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|PPG1||Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction|To Define in Normal Controls, Human Preclinical Systolic Dysfunction (PSD) and Preclinical Diastolic Dysfunction (PDD) the Actions of Acute Subcutaneous Nesiritide (BNP) on the Cardiorenal and Humoral Function and the Integrated Response to Acute Sodium Loading|Completed||Phase 1/Phase 2|58|Actual|Mayo Clinic|"Different baseline characteristics of the three groups of subjects~Did not define a mechanism for the impaired renal cGMP activation~Future studies needed to determine effects of chronic nesiritide therapy in preclinical HF."|2|||f||||t||||||||||2017-02-18 16:10:55.436093|2017-02-18 16:10:55.436093
NCT00387608|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2012-03-14|||June 2006||2006-06-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|February 2008|Actual|2008-02-01||Interventional|||ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer|A Phase 0 Pharmacokinetic, Pharmacodynamic Study of ABT-888, an Inhibitor of Poly (ADP-ribose) Polymerase (PARP), in Refractory Solid Tumors and Lymphoid Malignancies|Completed||Phase 1|23|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 16:10:58.823815|2017-02-18 16:10:58.823815
NCT00387595|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2008-08-06|||February 2003||2003-02-01|August 2008|2008-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Family Atherosclerosis Counseling and Testing Project|Family Atherosclerosis Counseling and Testing Project (FACT)|Completed||Phase 1/Phase 2|||University of British Columbia|||||f||||f||||||||||2017-02-18 16:10:58.936025|2017-02-18 16:10:58.936025
NCT00387582|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2014-05-05|||July 2006||2006-07-01|May 2014|2014-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema|Lucentis in the Treatment of Macular Edema - A Phase II, Single Center, Randomized Study to Evaluate the Efficacy of Ranibizumab Versus Focal Laser Treatment in Subjects With Diabetic Macular Edema|Completed||Phase 2|49|Actual|Rocky Mountain Retina Consultants||2|||f||||t||||||||||2017-02-18 16:10:59.014103|2017-02-18 16:10:59.014103
NCT00387569|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2008-05-06|||October 2006||2006-10-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Healthy Toddlers|A Randomized, Observer-Blinded, Parallel-Group, Active-Control, Phase 1/2 Trial of the Safety, Immunogenicity, and Tolerability of 20 µg, 60 µg, and 200 µg of Meningococcal Group B rLP2086 Vaccine in Healthy Adolescents Aged 10 to 12 Years|Completed||Phase 1|99|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||t||||||||||2017-02-18 16:10:59.122874|2017-02-18 16:10:59.122874
NCT00387556|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-05-09|||December 2002||2002-12-01|May 2013|2013-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Ondansetron Reduce Vomiting Associated With Ketamine PSA|Does Ondansetron Reduce the Incidence of Vomiting When Used in Conjunction With Ketamine During Procedural Sedation in the Pediatric Emergency Department|Completed||N/A|268|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 16:10:59.222227|2017-02-18 16:10:59.222227
NCT00387543|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2011-04-04|||January 2000||2000-01-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Alpha Lipoic Acid for Burning Mouth|Review of Mayo Clinic Experience With Burning Mouth Syndrome - Use of Alpha Lipoic Acid|Completed||N/A|200|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 16:10:59.323284|2017-02-18 16:10:59.323284
NCT00387517|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2017-02-03|||October 2006||2006-10-01|February 2017|2017-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension|An Eight-week Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren / HCTZ (150/25 mg and 300/25 mg) in Comparison With HCTZ 25 mg in Patients With Essential Hypertension Not Adequately Responsive to HCTZ 25 mg Monotherapy|Completed||Phase 3|726|Anticipated|Novartis|||||f||||||||||||||2017-02-18 16:10:59.497034|2017-02-18 16:10:59.497034
NCT00387504|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-09-10|||November 2006||2006-11-01|September 2013|2013-09-01||||July 2013|Actual|2013-07-01||Interventional|||Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors|Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients With Malignant Solid Tumors|Completed||Phase 1|21|Anticipated|California Cancer Consortium||1|||f||||||||||||||2017-02-18 16:10:59.824507|2017-02-18 16:10:59.824507
NCT00387491|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2011-07-22|||June 2006||2006-06-01|July 2011|2011-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Dose Ranging Study in Healthy Methadone Maintenance Subjects|A Randomized, Double-blind, 4-period Crossover, Dose-ranging Study to Determine the Effects on the Oral-cecal Transit Time of Single Doses of MOA-728 and the Safety and Tolerability of Multiple Doses of MOA-728 in Stable Methadone Maintenance Subjects|Completed||Phase 1|16||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:10:59.924437|2017-02-18 16:10:59.924437
NCT00387478|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2010-06-16|||October 2006||2006-10-01|June 2010|2010-06-01|June 2009|Anticipated|2009-06-01|March 2009|Anticipated|2009-03-01||Interventional|||Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis|A Double Blind Study to Investigate the Clinical Efficacy and Safety of TreeMATAMPL (Allergy Therapeutics, (UK) Ltd.), TreeMATA (Allergy Therapeutics, (UK) Ltd.) and Placebo in Patients With Seasonal Allergic Rhinitis Due to Birch Pollen Allergy, in an Environmental Exposure Chamber (EEC) Model When Exposed to Birch Pollen and Oak Pollen|Suspended||Phase 2|300|Anticipated|Allergy Therapeutics||3||Enrollement target could not be achieved, study will potentially be resumed|f||||||||||||||2017-02-18 16:11:00.008526|2017-02-18 16:11:00.008526
NCT00387465|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2015-04-30|||August 2006||2006-08-01|March 2014|2014-03-01|November 2014|Actual|2014-11-01|July 2014|Actual|2014-07-01||Interventional|||Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer|A Phase I/II Study of Entinostat in Combination With 5-Azacytidine in Patients With Recurrent Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|162|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:11:00.138417|2017-02-18 16:11:00.138417
NCT00387452|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2016-11-28|||February 2006||2006-02-01|November 2016|2016-11-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Exercise and Cardiovascular Control During Upright Tilt in Older Adults With Type 2 Diabetes|Exercise and Cardiovascular Control During Upright Tilt in Older Adults With Type 2 Diabetes|Completed||N/A|64|Actual|University of British Columbia||3|||f||||f||||||||No||2017-02-18 16:11:00.269486|2017-02-18 16:11:00.269486
NCT00387439|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-09-18|||October 2006||2006-10-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||ORALIA Trial Medical Treatment vs Anoperineal Physiotherapy for Adult Anal Incontinence.|ORALIA Trial Randomized Controlled Trial of Medical Treatment Alone vs Medical Treatment Associated With Anoperineal Physiotherapy for Adult Anal Incontinence. Assessment of Incontinence Symptoms and Quality of Life.|Terminated||N/A|173|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-02-18 16:11:00.395461|2017-02-18 16:11:00.395461
NCT00387426|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-05-12|2012-07-05||September 2006||2006-09-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Sunitinib in Treating Patients With Idiopathic Myelofibrosis|A Phase II Study of Sunitinib Malate in Idiopathic Myelofibrosis|Terminated||Phase 2|14|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:11:00.495539|2017-02-18 16:11:00.495539
NCT00387413|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2012-05-31|||October 2006||2006-10-01|February 2011|2011-02-01||||||||Interventional|||A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers|A Double-blind, Double-dummy, Placebo-controlled, Incomplete Block, Two Period Crossover Study of the Histamine H3 Antagonist GSK189254 and Duloxetine in the Electrical Hyperalgesia Model of Central Sensitisation in Healthy Volunteers|Completed||Phase 1|40|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:11:00.764318|2017-02-18 16:11:00.764318
NCT00387400|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2016-11-25|||July 2006||2006-07-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Temozolomide and Everolimus in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme|A Phase I Study of Temozolomide and RAD001C in Patients With Malignant Glioblastoma Multiforme|Completed||Phase 1|32|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 16:11:00.864948|2017-02-18 16:11:00.864948
NCT00387387|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2012-05-31|||October 2006||2006-10-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)|An Open-Label, Pharmacokinetic Study of the Safety and Tolerability of Pazopanib in Combination With FOLFOX 6 orCapeOx in Subjects With Colorectal Cancer|Completed||Phase 1|70|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:11:00.97685|2017-02-18 16:11:00.97685
NCT00387374|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2013-01-15|||October 2006||2006-10-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab|A Phase II Study of Prophylactic Radiation Therapy for the Prevention of Hemoptysis in Advanced Non Small Cell Lung Cancer in Combination With Bevacizumab, Paclitaxel, and Carboplatin in Patients at High Risk for Bevacizumab-Associated Hemoptysis|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:11:01.068385|2017-02-18 16:11:01.068385
NCT00387361|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2011-01-11|||December 2006||2006-12-01|January 2011|2011-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Osteopathic Manipulative Treatment for Post-Operative Nausea and Vomiting|Osteopathic Manipulative Treatment (OMT) as Possible Prophylaxis Against Post-Operative Nausea and Vomiting (PONV) in Patients Receiving Inhalational Anesthesia|Completed||Phase 1/Phase 2|20|Actual|University of North Texas Health Science Center||2|||f||||f||||||||||2017-02-18 16:11:01.184372|2017-02-18 16:11:01.184372
NCT00384501|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2006-10-05|||January 2000||2000-01-01|October 2006|2006-10-01|July 2006||2006-07-01|||||Interventional|||Management of Patients With Keratoconus With Intacs|Intacs for the Treatment of Keratoconus|Terminated||N/A|25||University Hospital of Crete|||||f||||||||||||||2017-02-18 16:12:13.571138|2017-02-18 16:12:13.571138
NCT00387348|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2012-11-02|2012-07-12||March 2006||2006-03-01|November 2012|2012-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer|Symptom Management Trial in Cancer Survivors|Terminated||Phase 3|24|Actual|Massachusetts General Hospital|After an interim analaysis, the DSMB decided to terminate the trial early because of the rate of adverse events (HAM-D scores increasing by at least 25%) and deaths were higher in participants receiving placebo.|3||DSMB stopped study because placebo arm had more adverse events|f||||t||||||||||2017-02-18 16:11:01.294648|2017-02-18 16:11:01.294648
NCT00387335|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2014-07-21|2013-12-04||August 2006||2006-08-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer|Phase II Study of Sunitinib Malate in Head and Neck Squamous Cell Carcinoma|Completed||Phase 2|22|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:11:01.834551|2017-02-18 16:11:01.834551
NCT00387322|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-12|2010-03-25|||March 2005||2005-03-01|March 2010|2010-03-01|May 2009|Actual|2009-05-01|October 2007|Actual|2007-10-01||Interventional|||Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors|Phase I/II Study of Two Different Schedules of Pemetrexed (ALIMTA) and Erlotinib (TARCEVA) in Advanced Solid Tumors, With Emphasis on Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|42|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 16:11:02.586815|2017-02-18 16:11:02.586815
NCT00387309|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2011-07-22|||December 2006||2006-12-01|July 2011|2011-07-01|November 2007|Actual|2007-11-01|||||Interventional|||Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of Post Operative Ileus.|Completed||Phase 3|495||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:11:02.718596|2017-02-18 16:11:02.718596
NCT00387140|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2015-10-30|||October 2006||2006-10-01|October 2015|2015-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study to Evaluate the Safety and Efficacy of an Investigational Drug in the Treatment of Postoperative Dental Pain (MK-2295-005)|A Randomized Double-blind, Placebo-and Active Comparator-Controlled 2-Part Study to Evaluate the Efficacy of MK2295 in Patients With Postoperative Dental Pain|Completed||Phase 2|89|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:11:02.91436|2017-02-18 16:11:02.91436
NCT00387127|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2015-05-28|2014-11-06||November 2006||2006-11-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|June 2009|Actual|2009-06-01||Interventional|||Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer|A Randomized, Double-blind, Placebo Controlled, Multicentre, Phase II Study of Oral Lapatinib in Combination With Concurrent Radiotherapy and Cisplatin Versus Radiotherapy and Cisplatin Alone, in Subjects With Stage III, IVA, B Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|67|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 16:11:03.016958|2017-02-18 16:11:03.016958
NCT00387114|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2006-10-10|||June 2005||2005-06-01|October 2006|2006-10-01|November 2005||2005-11-01|||||Interventional|||Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized Study|Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized Study|Terminated||Phase 3|80||University of Turin, Italy|||||f||||||||||||||2017-02-18 16:11:04.171385|2017-02-18 16:11:04.171385
NCT00387101|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2008-04-30|||February 2006||2006-02-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers|Pivotal Study to Evaluate the Efficacy and Safety of Dermal-Living Skin Replacement (Dermal-LSR) in the Treatment of Chronic Diabetic Foot Ulcers|Terminated||Phase 3|288|Anticipated|ApoPharma||||Low recruitment rate|f||||||||||||||2017-02-18 16:11:04.260271|2017-02-18 16:11:04.260271
NCT00387088|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2014-05-07|2009-11-13||September 2006||2006-09-01|September 2013|2013-09-01||||January 2009|Actual|2009-01-01||Interventional|||Tiotropium / Respimat One Year Study in COPD.|Efficacy {FEV1, COPD Exacerbations & HRQoL} & Safety of 5mcg Tiotropium Respimat in COPD|Completed||Phase 3|3991|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 16:11:04.627514|2017-02-18 16:11:04.627514
NCT00387075|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2016-07-12|||November 2006||2006-11-01|July 2016|2016-07-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease|Parkinson Associated Risk Factor Study (PARS): Evaluating Potential Screening Tools for Parkinson Disease|Active, not recruiting||Phase 2|3000|Anticipated|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 16:11:06.729761|2017-02-18 16:11:06.729761
NCT00387062|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2008-06-23|||October 2006||2006-10-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment|Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment, A Pilot Study|Completed||Phase 1|50|Anticipated|Posit Science Corporation|||||f||||||||||||||2017-02-18 16:11:06.839371|2017-02-18 16:11:06.839371
NCT00387049|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2010-10-21|||January 2005||2005-01-01|October 2006|2006-10-01|April 2010|Actual|2010-04-01|August 2009|Actual|2009-08-01||Interventional|||Anxiety Sensitivity Program for Smoking Cessation|Anxiety Sensitivity Program for Smoking Cessation|Completed||N/A|80|Anticipated|University of Vermont||2|||f||||t||||||||||2017-02-18 16:11:06.948754|2017-02-18 16:11:06.948754
NCT00387036|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2015-12-17|2010-04-08||December 2006||2006-12-01|December 2015|2015-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)|A Multicenter, Double-Blind Placebo-Controlled Crossover Study to Investigate the Effects of an Inhaled Corticosteroid on Cardiopulmonary Exercise Parameters in Patients With Chronic Obstructive Pulmonary Disease|Terminated||Phase 2|12|Actual|Merck Sharp & Dohme Corp.||2||Termininated for business reasons|f||||||||||||||2017-02-18 16:11:07.052674|2017-02-18 16:11:07.052674
NCT00387023|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2013-09-04|2013-09-04||February 2004||2004-02-01|September 2013|2013-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma|Pilot Trial of Radioimmunotherapy With Yttrium 90-Labeled (90Y) Zevalin for Low-Grade Follicular Non-Hodgkin's Lymphoma or MALT of the Orbit/Conjunctiva|Completed||N/A|12|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:11:07.35032|2017-02-18 16:11:07.35032
NCT00386802|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2009-09-17|||August 2006||2006-08-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Antifungal Use in Oncohematological Neutropenic Patients|ANTIVORIFUNGOL:Strategy of Antifungal Use in Oncohematological Neutropenic Patients. Use of Voriconazole as Early Treatment.|Completed||Phase 4|115|Anticipated|PETHEMA Foundation||1|||f||||t||||||||||2017-02-18 16:11:10.06306|2017-02-18 16:11:10.06306
NCT00387010|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2012-09-19|2012-08-17||December 2006||2006-12-01|September 2012|2012-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain|A 4-week Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain|Terminated||Phase 3|218|Actual|Teva Pharmaceutical Industries|This study was terminated early. Additional research is recommended to develop a valid measure of anxiety, specifically related to breakthrough pain.|1||"The sponsor felt enough information was available for the exploratory assessment of the effect~   of treatment with FBT on pain anxiety"|f||||f||||||||||2017-02-18 16:11:07.589144|2017-02-18 16:11:07.589144
NCT00386997|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2007-08-20|||November 2006||2006-11-01|August 2007|2007-08-01|September 2007||2007-09-01|||||Interventional|||ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia|ProphyALL - Pilot Study on Safety of Four Weekly Administrations of 7 mg/kg of Liposomal Amphotericin B (AmBisome®) in Antifungal Primary Prophylaxis Treatment of Elderly Patients With Acute Lymphoblastic Leukemia Undergoing Induction Chemotherapy Within the GMALL-Elderly Protocol|Terminated||Phase 4|20|Anticipated|Gilead Sciences||||Study closed due to recruitment challenges.|f||||||||||||||2017-02-18 16:11:08.262734|2017-02-18 16:11:08.262734
NCT00386984|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2006-10-11|||October 1999||1999-10-01|October 2006|2006-10-01|February 2003||2003-02-01|||||Interventional|||Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma|Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma|Completed||Phase 3|108||University Hospital Freiburg|||||f||||||||||||||2017-02-18 16:11:08.352013|2017-02-18 16:11:08.352013
NCT00386971|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2013-04-04|||October 2006||2006-10-01|April 2013|2013-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART|Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART|Completed||N/A|13|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 16:11:08.44972|2017-02-18 16:11:08.44972
NCT00386958|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2016-08-22|||November 2002||2002-11-01|October 2006|2006-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers|A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers|Completed||Phase 2|172||Los Angeles Biomedical Research Institute|||||f||||||||||||||2017-02-18 16:11:08.782243|2017-02-18 16:11:08.782243
NCT00386945|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2011-10-24|||May 2006||2006-05-01|October 2011|2011-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Tobacco Cessation Via Doctors of Chiropractic||Completed||N/A|201|Actual|Oregon Research Institute||1|||f||||f||||||||||2017-02-18 16:11:08.885383|2017-02-18 16:11:08.885383
NCT00386919|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2017-01-26|||April 2006||2006-04-01|January 2017|2017-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Short Course of Radiation for Gliomas in Elderly Patients|A Phase II Study of Hypofractionated Radiation With CyberKnife Stereotactic Radiosurgery Boost for High Grade Gliomas in Elderly Patients With Good Performance Status|Completed||Phase 2|26|Actual|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-02-18 16:11:08.988345|2017-02-18 16:11:08.988345
NCT00386906|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2016-02-25|||May 2000||2000-05-01|February 2016|2016-02-01||||May 2017|Anticipated|2017-05-01||Interventional|||Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma|Sentinel Lymph Node Localization and Biopsy for Conjunctival and Eyelid Melanoma|Active, not recruiting||Phase 1|38|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:11:09.085103|2017-02-18 16:11:09.085103
NCT00386893|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2015-04-13|||October 2006||2006-10-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Somatosensory Processing in Depression|Influence of Escitalopram on Somatosensory Processing in Patients With Major Depression|Withdrawn||Phase 4|0|Actual|Ludwig-Maximilians - University of Munich||1|||f||||||||||||||2017-02-18 16:11:09.198705|2017-02-18 16:11:09.198705
NCT00386880|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2014-08-04|2012-08-05||August 2006||2006-08-01|August 2014|2014-08-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Observational|||Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs|Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs|Completed||N/A|38|Actual|Thomas Jefferson University|||2||f||||f||||||||||2017-02-18 16:11:09.30901|2017-02-18 16:11:09.30901
NCT00386867|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2007-06-01|||October 2006||2006-10-01|June 2007|2007-06-01|March 2007||2007-03-01|||||Interventional|||A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP||Completed||N/A|1200|Anticipated|Gynuity Health Projects|||||||||t||||||||||2017-02-18 16:11:09.548505|2017-02-18 16:11:09.548505
NCT00386854|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2006-10-10|||April 2003||2003-04-01|October 2006|2006-10-01|August 2003||2003-08-01|||||Interventional|||Metabolic Study of Concentric and Eccentric Muscle Training||Completed||N/A|40||Vorarlberg Institute for Vascular Investigation and Treatment|||||f||||||||||||||2017-02-18 16:11:09.64951|2017-02-18 16:11:09.64951
NCT00386841|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2009-06-29|||April 2007||2007-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression|Associations Between Gene-Polymorphisms, Endo-Phenotypes for Depression and Antidepressive Treatment (AGENDA)|Completed||Phase 4|80|Actual|University of Copenhagen||2|||f||||t||||||||||2017-02-18 16:11:09.749948|2017-02-18 16:11:09.749948
NCT00386828|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2010-11-24|||October 2006||2006-10-01|November 2010|2010-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial|Phase II Study of Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial|Completed||Phase 2|43|Actual|British Columbia Cancer Agency||1|||f||||t||||||||||2017-02-18 16:11:09.865945|2017-02-18 16:11:09.865945
NCT00386815|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2007-04-10|||October 2006||2006-10-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma|Safety Confirmation Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|20||Eli Lilly and Company|||||f||||||||||||||2017-02-18 16:11:09.971426|2017-02-18 16:11:09.971426
NCT00386789|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2017-01-24|||October 5, 2006||2006-10-05|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Observational|||Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age|Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:11:10.193787|2017-02-18 16:11:10.193787
NCT00386776|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2013-06-11|2013-03-20||January 2005||2005-01-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Patient Computer Dialog in Primary Care|Cybermedicine for the Patient and Physician|Completed||Phase 3|45|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 16:11:10.288912|2017-02-18 16:11:10.288912
NCT00386763|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2009-03-11|||August 2006||2006-08-01|March 2009|2009-03-01|March 2007||2007-03-01|||||Interventional|||Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.|A Randomized, Investigator-Blinded, Multicenter, Parallel-Group Study to Compare Efficacy, Safety and Tolerability of Arthemeter/ Lumefantrine Dispersible Tablet Formulation vs. Artemether/ Lumefantrine 6-Dose Crushed Tablet in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Infants and Children.|Completed||Phase 3|890||Novartis|||||f||||||||||||||2017-02-18 16:11:10.597643|2017-02-18 16:11:10.597643
NCT00386750|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2012-04-25|||June 2005||2005-06-01|April 2012|2012-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function|An Open-label, Single-center Study of the Effects of Co-artemether, Atovaquone-proguanil, and Artesunate-mefloquine on Auditory Function Following the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Patients 12 Years of Age or Older.|Terminated||Phase 4|265||Novartis|||||f||||||||||||||2017-02-18 16:11:10.704565|2017-02-18 16:11:10.704565
NCT00386737|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-11|2006-10-11|||September 2004||2004-09-01|October 2006|2006-10-01|February 2007||2007-02-01|||||Observational|||Development of a Breath Analyzer for Asthma Screening|Development of a Breath Analyzer for Asthma Screening|Unknown status|Recruiting|Early Phase 1|2000||Ekips Technologies|||||f||||||||||||||2017-02-18 16:11:10.785414|2017-02-18 16:11:10.785414
NCT00386724|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2013-08-01|||October 2006||2006-10-01|August 2013|2013-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effectiveness of Precision Spinal Cord Stimulation With Artisan Paddle Electrode|Effectiveness of the Precision Spinal Cord Stimulation System With the Artisan Paddle Electrode in Patients With Back or Lower Extremity Pain|Terminated||Phase 4|8|Actual|Boston Scientific Corporation||1||Insufficient Data Collected|f||||f||||||||||2017-02-18 16:11:10.864804|2017-02-18 16:11:10.864804
NCT00386711|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2006-10-10|||October 2006||2006-10-01|October 2006|2006-10-01|January 2007||2007-01-01|||||Interventional|||A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care|A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary Care|Unknown status|Not yet recruiting|Phase 1|2160||Nanjing Medical University|||||f||||||||||||||2017-02-18 16:11:11.061713|2017-02-18 16:11:11.061713
NCT00386698|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2016-10-06|||October 2006||2006-10-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults|Evaluate Reactogenicity & Immunogenicity of Adjuvanted Influenza Vaccine in Elderly Adults Previously Vaccinated With the Same Candidate Vaccine. Fluarix™ Administered in Young & Elderly Adults Will be Used as Reference|Completed||Phase 2|200|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:11:11.153534|2017-02-18 16:11:11.153534
NCT00386685|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2011-04-11|||July 2006||2006-07-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|October 2008|Actual|2008-10-01||Interventional|||XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer|Open Label, Uncontrolled Study of XRP9881 in Combination With Trastuzumab (Herceptin®) in Patients With HER2 Positive Metastatic Breast Cancer (MBC)|Completed||Phase 2|51|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:11:11.248179|2017-02-18 16:11:11.248179
NCT00386672|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2017-01-09|||May 2006||2006-05-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)|Calcium Supplementation for a Healthy Weight- LITE|Completed||N/A|83|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:11:11.349262|2017-02-18 16:11:11.349262
NCT00386659|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2006-10-10||||||October 2006|2006-10-01||||||||Interventional|||Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.|A Randomized, Pilot Study on the Antiviral Activity and Immunological Effects of Lopinavir/Ritonavir vs. Efavirenz in Treatment-naïve HIV-Infected Patients With CD4 Cell Counts Below 100 Cells/mm3|Terminated||Phase 4|60||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:11:11.475752|2017-02-18 16:11:11.475752
NCT00386646|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2015-06-02|||February 2004||2004-02-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye|A Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye: A Randomized Controlled Trial|Completed||Phase 4|100||Chulalongkorn University|||||f||||||||||||||2017-02-18 16:11:11.56662|2017-02-18 16:11:11.56662
NCT00386633|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2015-01-26|||October 2006||2006-10-01|January 2015|2015-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection|Phase I, Open, Sequential Vaccination Study on Safety and Tolerability of Two Different Doses of a Recombinant MVA HIV Polytope Vaccine (MVA-mBN32) in HIV-negative 18-50 Year Old Healthy Volunteers|Completed||Phase 1|36|Anticipated|Bavarian Nordic||2|||f||||f||||||||||2017-02-18 16:11:11.674953|2017-02-18 16:11:11.674953
NCT00386620|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2015-07-06|||October 2004||2004-10-01|July 2015|2015-07-01||||July 2015|Actual|2015-07-01||Observational|||Spousal Relationships and Pain in Metastatic Breast Cancer|Spousal Relationships and Pain in Metastatic Breast Cancer|Completed||N/A|548|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 16:11:11.776977|2017-02-18 16:11:11.776977
NCT00385866|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2016-04-19|||October 2006||2006-10-01|April 2016|2016-04-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries|Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries|Completed||N/A|1272|Actual|Rutgers, The State University of New Jersey||2|||f||||||||||||||2017-02-18 16:11:37.921183|2017-02-18 16:11:37.921183
NCT00386607|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2014-01-14|2010-12-20||October 2006||2006-10-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.|A 54-week, Open-label, Multicenter Study to Assess the Long-term Safety and Tolerability of the Combination of Aliskiren 300 mg /Valsartan 320 mg in Patients With Essential Hypertension Followed by a 26 Week Open-label Extension to Assess the Long-term Safety and Tolerability of the Triple Combination of Aliskiren/Valsartan/Hydrochlorothiazide(HCTZ)|Completed||Phase 3|601|Actual|Novartis|Open label study with no comparator treatment/arm.|2|||f||||||||||||||2017-02-18 16:11:11.897353|2017-02-18 16:11:11.897353
NCT00386594|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-08|2009-01-20|||October 2006||2006-10-01|December 2006|2006-12-01|October 2012|Anticipated|2012-10-01|October 2010|Anticipated|2010-10-01||Interventional|||Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus||Terminated||N/A|10|Anticipated|Rogers, B.H. Gerald, M.D.||1|||f||||||||||||||2017-02-18 16:11:12.813197|2017-02-18 16:11:12.813197
NCT00386581|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2007-06-11|||July 2004||2004-07-01|June 2007|2007-06-01|February 2005|Actual|2005-02-01|||||Interventional|||Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder|Phase III Multicenter, Randomized, Double-Blind Placebo-Controlled Outpatient Study of Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|105|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 16:11:12.908445|2017-02-18 16:11:12.908445
NCT00386555|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2012-08-07|||May 2007||2007-05-01|May 2007|2007-05-01||||||||Interventional|||A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.|Phase 2 Study of CP-868,596 + Docetaxel, AG-013736 + Docetaxel, or CP-868,596 + AG-013736 + Docetaxel and of Docetaxel Alone in Patients With Stage IIIb or IV Non-Small Cell Lung Cancer.|Withdrawn||Phase 2|0|Actual|Arog Pharmaceuticals, Inc.||||Study was cancelled before patient enrollment|||||||||||||||2017-02-18 16:11:12.9962|2017-02-18 16:11:12.9962
NCT00386542|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2010-06-08|||October 2006||2006-10-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|November 2009|Actual|2009-11-01||Interventional|||Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children|Clinical Trial of Safety (Reactogenicity) and Immunogenicity of Needle-free Jet Injection of Reduced-dose, Intradermal Influenza Vaccine (INF) Administered to >= 6 to < 24 Month-old Infants and Toddlers in the Dominican Republic|Completed||Phase 1/Phase 2|450|Actual|Centers for Disease Control and Prevention||3|||f||||t||||||||||2017-02-18 16:11:13.088279|2017-02-18 16:11:13.088279
NCT00386529|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2010-12-14|||September 2006||2006-09-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|January 2007|Actual|2007-01-01||Interventional|||Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients|A Multi-center, Double-Blind Randomized, Cross-over, Active-control, Comparative Clinical Study to Evaluate the Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-Controlled Hypertensive Patients (Phase IV)|Completed||Phase 4|191|Actual|Boryung Pharmaceutical Co., Ltd|||||f||||t||||||||||2017-02-18 16:11:13.216589|2017-02-18 16:11:13.216589
NCT00386516|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2016-08-08|||September 2006||2006-09-01|August 2014|2014-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer|Phase 2, Multi-center, Open-label Trial to Evaluate Efficacy and Safety of GM-CT-01 in Combination With 5-FU as First Line Chemotherapy in Patients With Advanced Biliary Cancer|Terminated||Phase 2|17|Actual|Galectin Therapeutics Inc.||1||Financing and re-organization|f||||f||||||||||2017-02-18 16:11:13.335214|2017-02-18 16:11:13.335214
NCT00386503|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2008-12-08|||June 2006||2006-06-01|December 2008|2008-12-01||||December 2006|Actual|2006-12-01||Interventional|||Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions|A Randomized, Open-Label, Cross-Over Study, to Compare the Bioavailability of the Fixed Combination of Amodiaquine and Artesunate (COARSUCAM™) After Single Oral Administration Under Fed and Fasted Conditions in Healthy Subjects|Completed||Phase 1|22||Sanofi|||||f||||||||||||||2017-02-18 16:11:13.452608|2017-02-18 16:11:13.452608
NCT00386490|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2006-10-10|||January 2006||2006-01-01|October 2006|2006-10-01|February 2006||2006-02-01|||||Interventional|||Safety of AT-1001 in Healthy Volunteers|A Phase 1, Randomized, Double-Blind, Placebo Controlled, Multi-Dose Study to Determine the Safety, Tolerance and Pharmacokinetics of 3 Dose Levels of AT-1001 in Healthy Volunteers|Completed||Phase 1|24||Alba Therapeutics|||||||||||||||||||2017-02-18 16:11:13.541714|2017-02-18 16:11:13.541714
NCT00386477|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2010-01-14|2009-11-11||September 2006||2006-09-01|December 2010|2010-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial|Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial|Terminated||N/A|300|Actual|Indiana University|The study was stopped before the planned enrollment of 1000 due to difficulty recruiting. Results are of a planned safety analysis at 300 subjects.|1||Difficulty recruiting|f||||t||||||||||2017-02-18 16:11:13.637395|2017-02-18 16:11:13.637395
NCT00386464|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2007-11-08|||April 2002||2002-04-01|April 2007|2007-04-01|September 2007|Actual|2007-09-01|||||Interventional|||Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement|Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement|Completed||Phase 2/Phase 3|60|Anticipated|Johns Hopkins University|||||f||||f||||||||||2017-02-18 16:11:14.068269|2017-02-18 16:11:14.068269
NCT00386451|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2009-04-24|||November 2006||2006-11-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive Pressure|Prospective Study Which Compares the Use of a Closing System Without a Needle and With Positive Pressure to a Heparin Lock With Positive Pressure for Patients With a Catheter for Chemotherapy|Completed||N/A|60|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:11:14.16588|2017-02-18 16:11:14.16588
NCT00386438|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2006-10-10|||December 2005||2005-12-01|October 2006|2006-10-01|July 2006||2006-07-01|||||Interventional|||Efficacy of Honan Balloon in Intraocular Pressure Reduction Before Phacoemulsification||Completed||Phase 4|||Chulalongkorn University|||||f||||||||||||||2017-02-18 16:11:14.263101|2017-02-18 16:11:14.263101
NCT00385476|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2012-07-31|||August 2005||2005-08-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Cancer Patients' Medication Knowledge in the Emergency Center|Cancer Patients' Medication Knowledge in the Emergency Center|Completed||N/A|308|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 16:11:53.138224|2017-02-18 16:11:53.138224
NCT00386425|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2010-11-18|2010-08-26||November 2006||2006-11-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)|A Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated) Using Serial Measurements of Protein C in Patients With Severe Sepsis and Multiple Organ Dysfunction|Completed||Phase 2|486|Actual|Eli Lilly and Company|Fewer patients than planned had severe PC deficiency so only 2 higher doses were tested & fewer required longer infusions so a large proportion of alternative therapy patients in effect received standard therapy making treatment comparisons difficult|3|||f||||t||||||||||2017-02-18 16:11:14.375772|2017-02-18 16:11:14.375772
NCT00386412|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2009-09-17|||November 2005||2005-11-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant|Phase II, Multicentric, Prospective and Opened Clinical Trial of Advance Valganciclovir Treatment of CMV in Allogenic Hematopoietic Progenitors Transplant|Completed||Phase 2|132|Anticipated|PETHEMA Foundation||1|||f||||||||||||||2017-02-18 16:11:16.19692|2017-02-18 16:11:16.19692
NCT00386399|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2015-10-06|||October 2006||2006-10-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene|Phase II Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene|Withdrawn||Phase 2|0|Actual|Sidney Kimmel Comprehensive Cancer Center||1||"All 29 consented subjects tested negative for the BRCA2 mutation. None started study, so PI~   decided to close the study."|f||||||||||||||2017-02-18 16:11:16.309342|2017-02-18 16:11:16.309342
NCT00386386|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2008-03-12|||May 2007||2007-05-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial|Enzymatically Augmented Subcutaneous Infusion (EASI) In Out-Of-Hospital Care|Completed||Phase 3|20|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 16:11:16.413942|2017-02-18 16:11:16.413942
NCT00386373|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2012-07-31|||August 2003||2003-08-01|July 2012|2012-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients|Use and Tolerability of Imatinib Mesylate (Gleevec®) in Patients With Philadelphia-Positive Chronic Myeloid or Acute Leukemia During the First 100 Days Following Bone Marrow or Stem Cell Transplantation|Completed||N/A|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:11:16.525639|2017-02-18 16:11:16.525639
NCT00386360|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2011-12-06|2011-08-12||April 2006||2006-04-01|October 2011|2011-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method|A Non-Invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D-Peripheral Quantitative Computed Tomography (3D-pQCT)|Completed||Phase 3|161|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 16:11:16.651145|2017-02-18 16:11:16.651145
NCT00386347|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2012-05-31|||October 2006||2006-10-01|February 2011|2011-02-01||||||||Interventional|||A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.|A Single Dose, Randomized, 5-Period, Balanced, Crossover Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK364735 and Pharmacokinetics Following a Double Blind, Placebo Controlled, Repeat Dose Administration to Healthy Subjects.|Completed||Phase 1|56||GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:11:20.238675|2017-02-18 16:11:20.238675
NCT00386334|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2016-02-12|2009-02-13||October 2006||2006-10-01|February 2016|2016-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia|A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia|Completed||Phase 4|388|Actual|Sunovion|The data gathered was subjective (except for actigraphy endpoints) and relied either on self reporting or patient assessments derived from standardized questionnaires.|2|||f||||f||||||||||2017-02-18 16:11:20.610639|2017-02-18 16:11:20.610639
NCT00386321|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2010-11-17|||April 2006||2006-04-01|November 2010|2010-11-01|January 2010|Anticipated|2010-01-01|July 2007|Actual|2007-07-01||Interventional|||Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma|Yt90Zevalin Plus CHOP, Z-CHOP|Terminated||Phase 2|10|Actual|Chulalongkorn University||1||Participants are no longer being examined or treated.|f||||f||||||||||2017-02-18 16:11:23.445979|2017-02-18 16:11:23.445979
NCT00386308|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2011-05-03|2009-12-11||October 2006||2006-10-01|June 2010|2010-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety Study of XP12B in Women With Menorrhagia|A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study To Evaluate Efficacy and Safety of XP12B for the Treatment of Menorrhagia|Completed||Phase 3|196|Actual|Ferring Pharmaceuticals||2|||f||||t||||||||||2017-02-18 16:11:23.543775|2017-02-18 16:11:23.543775
NCT00386282|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2014-07-29|||September 2006||2006-09-01|July 2014|2014-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol|Acceptability and Feasibility of Medical Abortion in Mexico, Puerto Rico, Armenia and Azerbaijan: A Study of Buccal Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days' Gestation|Completed||N/A|1250|Actual|Gynuity Health Projects||1|||f||||f||||||||||2017-02-18 16:11:24.21338|2017-02-18 16:11:24.21338
NCT00386269|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2007-11-28|||January 2004||2004-01-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Double Blind Randomized Study Into the Efficacy of Codeine Phosphate Analgesia After Cleft Palate Repair in Infants|Double Blind Randomized Study Into the Efficacy of Codeine Phosphate Analgesia After Cleft Palate Repair in Infants|Completed||Phase 4|44|Anticipated|Institute of Child Health|||||f||||||||||||||2017-02-18 16:11:24.338811|2017-02-18 16:11:24.338811
NCT00386256|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2014-08-12|2013-09-11||October 2006||2006-10-01|August 2014|2014-08-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Home Telerehabilitation for Deconditioned Older Adults|Home Based Telerehabilitation for Deconditioned Older Adults|Completed||N/A|38|Actual|VA Office of Research and Development|Intervention was developed on a male Veteran population, direct comparisons between groups were formed based on the participant’s preference, exercise adherence was based on participants’ self reports, small convenience sample.|4|||f||||f||||||||||2017-02-18 16:11:24.436053|2017-02-18 16:11:24.436053
NCT00005888|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||January 1997||1997-01-01|April 2002|2002-04-01||||||||Interventional|||Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants||Completed||N/A|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:07.997082|2017-02-18 18:14:07.997082
NCT00386243|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2014-04-29|2013-09-25||December 2007||2007-12-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|May 2012|Actual|2012-05-01||Interventional|ESCAPE||Evaluation of Stepped Care for Chronic Pain in Iraq/Afghanistan Veterans (ESCAPE)|Evaluation of Stepped Care for Chronic Pain in Iraqi/Afghanistan Veterans|Completed||N/A|242|Actual|VA Office of Research and Development|Single VA Center; May not generalize to non-VA samples|2|||f||||t||||||||||2017-02-18 16:11:25.056794|2017-02-18 16:11:25.056794
NCT00386230|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2008-05-01|||June 1997||1997-06-01|May 2008|2008-05-01|August 2000|Actual|2000-08-01|||||Interventional|||Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1|Short ZDV Course to Prevent Perinatal HIV in Thailand|Completed||Phase 3|1554||Institut de Recherche pour le Developpement||4|||f||||||||||||||2017-02-18 16:11:25.465413|2017-02-18 16:11:25.465413
NCT00386217|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2012-07-31|||December 2004||2004-12-01|July 2012|2012-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Psychosocial Impact of Cancer-Related Female Infertility|Psychosocial Impact of Cancer-Related Female Infertility|Completed||N/A|239|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 16:11:25.580606|2017-02-18 16:11:25.580606
NCT00386204|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2008-06-02|||November 2005||2005-11-01|June 2008|2008-06-01|September 2006||2006-09-01|||||Interventional|||Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types|Efficacy and Side Effects of Q-Switched Ruby Laser Treatment of Solar Lentigines in Two Different Fitzpatrick Skin Types II and IV|Completed||Phase 2|90||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:11:25.68908|2017-02-18 16:11:25.68908
NCT00386191|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2010-02-23|||September 2006||2006-09-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment|Evaluation of the Safety and Efficacy of Clopidogrel sulfate50mg and Clopidogrel Sulfate 75mg for the Treatment of Cerebral Infarction|Completed||Phase 4|1110|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:11:25.772796|2017-02-18 16:11:25.772796
NCT00386178|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2010-12-20|||October 2006||2006-10-01|December 2010|2010-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma|Comparison of Gamma-tocopherol Supplementation in Allergic Asthmatics and Normal Volunteers|Completed||Phase 1|16|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 16:11:25.878627|2017-02-18 16:11:25.878627
NCT00386165|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2006-10-10|||January 2006||2006-01-01|October 2006|2006-10-01|February 2006||2006-02-01|||||Interventional|||Safety Study of AT1001 to Treat Celiac Disease.|A Phase Ib, Randomized, Double-Blind, Placebo Controlled Study to Determine the Safety, Tolerance, Pharmacokinetic and Pharmacodynamic Effects of Single Doses of AT-1001 in Celiac Disease Subjects.|Completed||Phase 1|24||Alba Therapeutics|||||||||||||||||||2017-02-18 16:11:25.989214|2017-02-18 16:11:25.989214
NCT00386152|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2013-07-12|2009-04-01||November 2006||2006-11-01|July 2013|2013-07-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy|A Randomized, Open-Label, Comparative Study of Epoetin Alfa (PROCRIT) 80,000 Units or 120,000 Units Q3W (Every 3 Weeks) Versus Darbepoetin Alfa (ARANESP) 500 Mcg Q3W in Anemic Cancer Subjects Receiving Chemotherapy|Terminated||Phase 2|235|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Due to the significantly reduced power (stopped prematurely when 235 patients enrolled), all protocol-specified hypothesis tests were not performed. Instead, desriptive statistics were presented for each of the endpoints by treatment group.|3||"No safety signals were noted. The study was stopped because it was no longer consistent with~   the company's scientific and strategic focus."|f||||t||||||||||2017-02-18 16:11:26.084715|2017-02-18 16:11:26.084715
NCT00386139|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2017-02-03|||September 2006||2006-09-01|February 2017|2017-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients|An Eight-week Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren / HCTZ (300/12.5 mg and 300/25 mg) in Comparison With Aliskiren 300 mg in Patients With Essential Hypertension Not Adequately Responsive to Aliskiren 300 mg Monotherapy|Completed||Phase 3|881|Actual|Novartis|||||f||||||||||||||2017-02-18 16:11:27.152567|2017-02-18 16:11:27.152567
NCT00386126|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2006-10-06|||August 2006||2006-08-01|August 2006|2006-08-01||||||||Interventional|||Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study|Randomized Trial to Assess the Effects of Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study|Unknown status|Recruiting|Phase 2/Phase 3|117||Hospital de Clinicas de Porto Alegre|||||f||||||||||||||2017-02-18 16:11:27.41719|2017-02-18 16:11:27.41719
NCT00386113|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2011-09-29|||October 2006||2006-10-01|September 2011|2011-09-01||||||||Interventional|||Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly|A Phase II, Open, Controlled Study to Evaluate the Reactogenicity and the Immunogenicity of GlaxoSmithKline Biologicals Adjuvanted Influenza Vaccine in Elderly Adults Previously Vaccinated With Either Fluarix™ or the Adjuvanted Vaccine.|Completed||Phase 2|83||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:11:27.520764|2017-02-18 16:11:27.520764
NCT00386100|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2016-10-11|2010-07-08||October 2006||2006-10-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin|A Randomized, Parallel Group, Double-blind, Multi-center Study Comparing the Efficacy and Safety of AVANDAMET and Metformin After 80 Weeks of Treatment.|Completed||Phase 4|688|Actual|GlaxoSmithKline|Ten participants who started the study and were randomized did not receive any study medication (6 participants in the metformin arm and 4 participants in the avandamet arm). These participants are not included in any of the analysis populations.|2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:11:27.638974|2017-02-18 16:11:27.638974
NCT00386087|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2008-06-05|||November 2006||2006-11-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|||||Interventional|||Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy|A Phase II Study of Oral Enzastaurin in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane-Containing Regimen|Completed||Phase 2|41|Anticipated|Eli Lilly and Company|||||||||||||||||||2017-02-18 16:11:30.322541|2017-02-18 16:11:30.322541
NCT00386074|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2010-04-20|||May 2004||2004-05-01|April 2010|2010-04-01|December 2004||2004-12-01|||||Interventional|||Iron-fortified Whole Maize Flour Trial|The Efficacy of Iron Fortified Whole Maize Flour on the Iron Status of School Children in Kenya|Completed||Phase 2|412||Wageningen University|||||f||||||||||||||2017-02-18 16:11:30.428756|2017-02-18 16:11:30.428756
NCT00386061|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2009-04-17|||October 2001||2001-10-01|April 2009|2009-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety of SR141716 in Obese Patients With or Without Comorbidities (RIO-Europe)|Completed||Phase 3|1507|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:11:30.52173|2017-02-18 16:11:30.52173
NCT00386048|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2012-09-17|||November 2006||2006-11-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Pain Management Protocol for Pediatric Sickle Cell Disease|Home-based Pain Management Protocol for Children With Sickle Cell Disease|Completed||N/A|50|Actual|University of South Carolina|||2||f||||t||||||||||2017-02-18 16:11:30.620445|2017-02-18 16:11:30.620445
NCT00386035|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2014-04-15|||January 2002||2002-01-01|April 2014|2014-04-01|September 2008|Actual|2008-09-01|January 2006|Actual|2006-01-01||Observational|||Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants|HIV Transmission Risk Behavior Substudy|Completed||N/A|883|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||t||||||||||2017-02-18 16:11:30.718517|2017-02-18 16:11:30.718517
NCT00386022|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2013-11-05|||January 2002||2002-01-01|November 2013|2013-11-01|January 2018|Anticipated|2018-01-01|January 2012|Actual|2012-01-01||Interventional|||The Effects of Aging and Estrogen on the Brain|Pituitary Contribution to the Decline in Gonadotropin Secretion With Age|Active, not recruiting||Phase 2/Phase 3|60|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 16:11:30.888213|2017-02-18 16:11:30.888213
NCT00386009|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2009-07-01|2009-05-04||October 2006||2006-10-01|July 2009|2009-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multicenter Study to Evaluate the Urodynamic Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 2|200|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:11:31.116194|2017-02-18 16:11:31.116194
NCT00385996|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2012-12-13|2012-10-12||October 2006||2006-10-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|November 2008|Actual|2008-11-01||Interventional|||Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer|A Pilot Study of Preoperative Tarceva (Erlotinib) Monotherapy in Patients With Early Stage (I/II) Non-Small Cell Lung Cancer|Completed||Phase 2|22|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 16:11:32.500006|2017-02-18 16:11:32.500006
NCT00385983|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2006-10-10||||||October 2006|2006-10-01||||||||Interventional|||Total Thyroidectomy With Harmonic Scalpel®|Total Thyroidectomy With Harmonic Scalpel® Versus Standard Surgery. Open Multicentric Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 4|280||Brazilian Society of Head and Neck Surgery|||||f||||||||||||||2017-02-18 16:11:35.36003|2017-02-18 16:11:35.36003
NCT00385970|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-08|2012-10-25|||March 2006||2006-03-01|October 2012|2012-10-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer|A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|380|Anticipated|Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group||2|||f||||t||||||||||2017-02-18 16:11:35.489219|2017-02-18 16:11:35.489219
NCT00385957|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2010-12-14||||||October 2006|2006-10-01||||||||Interventional|||Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100|Comparison of Antiretroviral Activity and Immunological Effect of Two Triple Treatments With and Without Protease Inhibitors in naïve HIV-1-infected Patients With CD4 < 100/mm3|Completed||Phase 4|70||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:11:35.602142|2017-02-18 16:11:35.602142
NCT00385944|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2010-08-25|2010-04-19||March 2007||2007-03-01|August 2010|2010-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)|A Randomized Double-Blind Cross-Over Study Comparing the Pharmacodynamic (PD)Response in Subjects With ACS Receiving 14 Days 10-mg Maintenance Dose (MD) Prasugrel vs 14 Days 150-mg MD Clopidogrel After Using a 900-mg Loading Dose (LD) of Clopidogrel to Reduce Ongoing Platelet Activation|Completed||Phase 2|56|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 16:11:35.713454|2017-02-18 16:11:35.713454
NCT00385931|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2011-11-07|||January 2002||2002-01-01|October 2006|2006-10-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin|A Multi-centre Study to Evaluate the Effects of Valsartan and the Combination of Valsartan and Simvastatin on Blood Pressure (Ambulatory and Std Cuff) and on Biochemical Markers of Endothelial Function (hsCRP, MCP-1, Serum F2 Isoprostanes, PAI-1, tPA, PICP, PIIINP, MMP9, MMP1, TIMP 1), Safety and Tolerability|Completed||Phase 3|412|Actual|Novartis|||||||||||||||||||2017-02-18 16:11:36.915469|2017-02-18 16:11:36.915469
NCT00385918|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2014-04-11|2013-11-12||October 2006||2006-10-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||The baseline analysis includes data from individuals who have completed the 3-month robotic and home-base interventions|Robotically Assisted Treadmill Training in Spinal Cord Injury (SCI)|Cardiovascular Parameters for Lokomat Training in Chronic Incomplete SCI|Completed||N/A|18|Actual|VA Office of Research and Development|"Skin irritation caused missed sessions.~Attendance rates were lower than desired given medical and transportation factors.~No clearly defined exclusion criteria for bone density in individuals with SCI using this type intervention."|2|||f||||t||||||||||2017-02-18 16:11:37.014247|2017-02-18 16:11:37.014247
NCT00385905|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2006-10-10|||February 2006||2006-02-01|October 2006|2006-10-01|January 2007||2007-01-01|||||Interventional|||Excel Drug-Eluting Stent Pilot Clinical Registry|Excel Drug-Eluting Stent Pilot Clinical Registry|Completed||Phase 4|100||JW Medical Systems Ltd|||||f||||||||||||||2017-02-18 16:11:37.65689|2017-02-18 16:11:37.65689
NCT00385892|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2006-10-10|||August 2005||2005-08-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||Safety Study of Textile Binder for Abdominal Compression|Feasibility Study DK150OS. Testing of Compression Textile. A Safety Study Among Healthy Volonteers|Terminated||N/A|11||Coloplast A/S|||||f||||||||||||||2017-02-18 16:11:37.749641|2017-02-18 16:11:37.749641
NCT00385879|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2006-10-10|||May 2006||2006-05-01|October 2006|2006-10-01|January 2008||2008-01-01|||||Interventional|||The Effects of Case Management in a Medicaid Managed Care Plan|The Effects of Case Management in a Medicaid Managed Care Plan|Unknown status|Recruiting|N/A|500||Metropolitan Jewish Health System|||||f||||||||||||||2017-02-18 16:11:37.831937|2017-02-18 16:11:37.831937
NCT00385853|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2013-10-18|||September 2006||2006-09-01|October 2013|2013-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs|A Phase I Study of PRK787/ZK 222584 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma|Completed||Phase 1|19|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:11:38.262375|2017-02-18 16:11:38.262375
NCT00385840|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2016-10-26|2013-03-07||October 2006||2006-10-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate|A Study to Evaluate the Immunogenicity, Safety and Reactogenicity of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate Compared to Fluarix™ Administered Intramuscularly in Elderly Aged 60 Years and Above.|Completed||Phase 2|678|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:11:38.379232|2017-02-18 16:11:38.379232
NCT00385827|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2014-08-18|2014-05-13||November 2006||2006-11-01|August 2014|2014-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional||Analysis population included all participants who received at least one dose of study drug in Part 1 and all randomized participants in Part 2.|A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)|A Phase 2, Multicenter, Open-Label Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) in Combination With Mitoxantrone Versus Mitoxantrone in Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)|Terminated||Phase 2|106|Actual|Centocor, Inc.|Results of few secondary endpoints were not reported as the study was terminated early due to the premature suspension and subsequent halting of study enrollment.|3||"Prematurely stopped after Independent Data Monitoring Committee (IDMC) evaluation for lack of~   efficacy."|f||||t||||||||||2017-02-18 16:11:38.942425|2017-02-18 16:11:38.942425
NCT00385801|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2013-11-06|||September 2005||2005-09-01|November 2013|2013-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence|A Double-Blind, Placebo-Controlled Study of the Effects of Risperdal Consta on Brain Reward Circuitry, Craving and Cocaine Use in Active Cocaine Dependence|Completed||Phase 2|31|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 16:11:40.015471|2017-02-18 16:11:40.015471
NCT00385788|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2016-08-19|||July 2005||2005-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease|Allogeneic Stem Cell Transplantation Followed By Adoptive Immunotherapy for Patients With Relapsed and Refractory Hodgkin's Disease|Completed||Phase 2|52|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:11:40.115248|2017-02-18 16:11:40.115248
NCT00385775|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2008-08-20|||June 2006||2006-06-01|August 2008|2008-08-01|November 2008|Anticipated|2008-11-01|October 2008|Anticipated|2008-10-01||Interventional|||Study of XIAP Antisense for Advanced Cancers|A Phase I Trial of AEG35156 Administered by 2-Hour Intravenous Infusion in Patients With Advanced Cancers|Terminated||Phase 1|30|Anticipated|Aegera Therapeutics||1||Dosing cohort (650mg) exceeded current 350mg dosing in other trials.|f||||f||||||||||2017-02-18 16:11:40.249979|2017-02-18 16:11:40.249979
NCT00385762|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2010-11-04|||January 2007||2007-01-01|November 2010|2010-11-01|September 2007|Anticipated|2007-09-01|||||Observational|||SSRI Effects on Semen Parameters in Men|Effect of Selective Serotonin Reuptake Inhibitor Antidepressants on Semen Parameters|Unknown status|Active, not recruiting|N/A|35|Actual|Weill Medical College of Cornell University|||1||f||||||||||Samples With DNA|"~     Serum samples Semen samples~   "|||2017-02-18 16:11:40.340118|2017-02-18 16:11:40.340118
NCT00385749|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2007-10-30|||October 2006||2006-10-01|October 2007|2007-10-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Right Ventricular Defibrillation Lead Select Site Study|Right Ventricular Defibrillation Lead Select Site Study|Unknown status|Recruiting|N/A|98|Anticipated|Associates in Cardiology, PA||1|||f||||||||||||||2017-02-18 16:11:40.414523|2017-02-18 16:11:40.414523
NCT00385736|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-09|2011-04-07|2010-04-30||November 2006||2006-11-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|April 2009|Actual|2009-04-01||Interventional|||Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis|A Multicenter, Randomized, Double-blind Placebo-controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Moderately to Severely Active Ulcerative Colitis|Completed||Phase 3|576|Actual|Abbott||3|||f||||f||||||||||2017-02-18 16:11:40.754944|2017-02-18 16:11:40.754944
NCT00385723|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2012-11-13|2012-08-28||September 2006||2006-09-01|November 2012|2012-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Fish Oil (Omega 3), Immune Function, and Mood|Omega-3 Dietary Supplementation, Immune Function, and Mood|Completed||Phase 2|138|Actual|Ohio State University||3|||f||||t||||||||||2017-02-18 16:11:42.384045|2017-02-18 16:11:42.384045
NCT00385710|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2012-11-02|||November 2006||2006-11-01|May 2011|2011-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)|Randomized Placebo-controlled Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy|Completed||Phase 2|28|Actual|Nantes University Hospital||2|||f||||||||||||||2017-02-18 16:11:42.997725|2017-02-18 16:11:42.997725
NCT00385697|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-07|2012-08-21||2011-11-10|October 2006||2006-10-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|June 2010|Actual|2010-06-01||Interventional|||The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus|A Phase 2/3, Randomized, Double-Blind, Multicenter, Multinational, 4-Arm, Controlled, Dose-Ranging Study to Evaluate Efficacy and Safety of MGA031, a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus|Completed||Phase 2/Phase 3|554|Actual|MacroGenics||4|||f||||t||||||||||2017-02-18 16:11:43.113502|2017-02-18 16:11:43.113502
NCT00385684|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2015-11-18|2014-06-02||October 2007||2007-10-01|November 2015|2015-11-01|June 2014|Actual|2014-06-01|December 2011|Actual|2011-12-01||Interventional|LDOT|Veterans with severe dementia residing in VA nursing home.|Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)|Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)|Completed||Phase 4|11|Actual|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 16:11:43.564963|2017-02-18 16:11:43.564963
NCT00005752|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-08|||April 1999||1999-04-01|August 2004|2004-08-01|March 2002||2002-03-01|||||Observational|||Overweight Adults--Ethnic, SES and Behavioral Influences||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 18:14:24.211574|2017-02-18 18:14:24.211574
NCT00385671|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2011-07-22|2010-08-23||September 2006||2006-09-01|July 2011|2011-07-01|November 2009|Actual|2009-11-01|August 2009|Actual|2009-08-01||Interventional|||An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain|An Open-Label, Randomized Comparison of Duloxetine, Pregabalin, and the Combination of Duloxetine and Gabapentin Among Patients With Inadequate Response to Gabapentin for the Management of Diabetic Peripheral Neuropathic Pain|Completed||Phase 4|407|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 16:11:43.874115|2017-02-18 16:11:43.874115
NCT00385658|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2011-11-07|||August 2006||2006-08-01|November 2011|2011-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome|A 16-week Multicenter, 2-period Study to Investigate the Effect of the Combination of Fluvastatin ER 80mg and Fenofibrate 200mg on HDL-C in Comparison to the Combination of Simvastatin 20mg and Ezetimibe 10mg in Patients With Metabolic Syndrome|Completed||Phase 4|75|Actual|Novartis|||||f||||||||||||||2017-02-18 16:11:48.470397|2017-02-18 16:11:48.470397
NCT00385645|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2010-03-30|||May 2006||2006-05-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis|Comparison of 2 Alternative Antiretroviral Combinations in HIV Post-exposure Prophylaxis: AZT-3TC (Combivir®) + Lopinavir-ritonavir (Kaletra®) Versus AZT-3TC (Combivir®)+ Atazanavir (Reyataz®). Multicentre, Prospective, Randomized, Open Study|Completed||Phase 4|255|Actual|Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:11:48.563408|2017-02-18 16:11:48.563408
NCT00385632|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2014-04-16|||January 2002||2002-01-01|April 2014|2014-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants|Quality of Life and Healthcare Utilization Substudy|Completed||N/A|1224|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||||||2017-02-18 16:11:48.763819|2017-02-18 16:11:48.763819
NCT00385606|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-10|2007-08-22|||January 2003||2003-01-01|August 2007|2007-08-01||||||||Interventional|||GECO: Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced Non-Small Cell Lung Cancer|Phase II-III, Factorial Multicenter Randomized Trial Evaluating the Addition of Rofecoxib to Polychemotherapy With Cisplatin and Gemcitabine and the Fixed Dose Rate Infusion of Gemcitabine in Association With Cisplatin in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer|Completed||Phase 2/Phase 3|400||National Cancer Institute, Naples|||||f||||||||||||||2017-02-18 16:11:48.934351|2017-02-18 16:11:48.934351
NCT00385593|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2010-11-30|2009-10-14||September 2006||2006-09-01|November 2010|2010-11-01|October 2008|Actual|2008-10-01|||||Interventional|||Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults|A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbuhaler 160/4.5 Micrograms, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults - a 26-week, Randomised, Open-label, Parallel-group, Multicentre Study. Study SPAIN|Terminated||Phase 3|654|Actual|AstraZeneca|The study was prematurely stopped, because it was not possible to recruit the sample size required in the period of time established.||||f||||||||||||||2017-02-18 16:11:49.065942|2017-02-18 16:11:49.065942
NCT00385580|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2013-04-24|2010-10-07||January 2007||2007-01-01|October 2012|2012-10-01|October 2010|Actual|2010-10-01|December 2008|Actual|2008-12-01||Interventional|||Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer|Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer|Completed||Phase 2|94|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 16:11:49.770858|2017-02-18 16:11:49.770858
NCT00385567|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-01|2010-08-24|||January 2007||2007-01-01|August 2010|2010-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Trial of PEHRG214 in HIV-Infected Patients|A Phase 2 Randomized, Controlled Trial of PEHRG214 in HIV-Infected Patients|Terminated||Phase 2|70|Anticipated|Virionyx Corporation Limited||2||Difficulty recruiting eligible patients in timely fashion|||||t||||||||||2017-02-18 16:11:51.703201|2017-02-18 16:11:51.703201
NCT00385554|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2012-08-15||||||August 2012|2012-08-01||||||||Interventional|||Botswana Study of UC-781 Vaginal Microbicide|Phase I Trial of the Safety, Toxicity, and Acceptability of the Microbicide UC-781 When Topically Applied by HIV-uninfected Women and Men in Botswana|Withdrawn||Phase 1|0|Actual|Centers for Disease Control and Prevention||||Study product is no longer being considered for further development.|||||||||||||||2017-02-18 16:11:51.800591|2017-02-18 16:11:51.800591
NCT00385541|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2015-03-03|2010-07-14||November 2003||2003-11-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)|The Comparison of Morphine and Hydromorphone Patient-Controlled Analgesia|Completed||Phase 4|50|Actual|Columbia University|This was a small study under typical clinical conditions.|2|||f||||f||||||||||2017-02-18 16:11:51.899042|2017-02-18 16:11:51.899042
NCT00385528|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2008-10-16|||November 2002||2002-11-01|October 2006|2006-10-01|April 2006||2006-04-01|||||Interventional|||Effects of a Multi-Faceted Psychiatric Intervention Targeted at the Complex Medically Ill: a Randomized Controlled Trial|Effects of a Multi-Faceted Psychiatric Intervention Targeted at the Complex Medically Ill: a Randomized Controlled Trial|Completed||Phase 4|200||University of Lausanne Hospitals|||||f||||||||||||||2017-02-18 16:11:52.448132|2017-02-18 16:11:52.448132
NCT00385515|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2009-04-08|2009-01-19||June 2006||2006-06-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy of SNX-1012 in the Treatment of Oral Mucositis|A Phase 2, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Efficacy of SNX-1012 in Reducing the Duration and Severity of Ulcerative Oral Mucositis in Patients Receiving Cytotoxic Chemotherapy for Breast or Lung Cancer|Completed||Phase 2|81|Actual|Mucosal Therapeutics||2|||f||||f||||||||||2017-02-18 16:11:52.559502|2017-02-18 16:11:52.559502
NCT00385502|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2009-02-05|||September 2006||2006-09-01|November 2007|2007-11-01|June 2008|Anticipated|2008-06-01|||||Interventional|||A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail|A Phase II Trial of the Safety, Local Tolerability, and Efficacy of EcoNail™ (Econazole 5%/SEPA® 18% Nail Lacquer) in Onychomycosis of the Great Toenail|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|MacroChem Corporation||1|||f||||f||||||||||2017-02-18 16:11:52.957839|2017-02-18 16:11:52.957839
NCT00385489|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2009-08-06|||August 2006||2006-08-01|August 2009|2009-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study Evaluating LXR-623 in Healthy Japanese Adults|Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of LXR-623 Administered Orally to Healthy Japanese Male Subjects.|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:11:53.063433|2017-02-18 16:11:53.063433
NCT00385463|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2016-06-15|||April 2006||2006-04-01|June 2016|2016-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo|A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray Versus Montelukast in Adolescents/Adults With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus(R) or Placebo|Withdrawn||N/A|0|Actual|Creighton University|||||f||||f||||||||||2017-02-18 16:11:53.244547|2017-02-18 16:11:53.244547
NCT00385450|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2015-04-27|||October 2006||2006-10-01|April 2015|2015-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor|Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor in the Perioperative Period|Terminated||Phase 1|41|Actual|Mayo Clinic||1||Study closed at Mayo prior to completion|f||||t||||||||||2017-02-18 16:11:53.349924|2017-02-18 16:11:53.349924
NCT00385437|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2006-10-05|||April 2003||2003-04-01|February 2006|2006-02-01|June 2004||2004-06-01|||||Interventional|||Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder|Antidepressant Response to a Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder|Completed||Phase 2|16||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:11:53.455075|2017-02-18 16:11:53.455075
NCT00385411|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2009-10-02|||March 2006||2006-03-01|October 2009|2009-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|VAPOP||Study of Valproate in Young Patients Suffering From Epilepsy|Therapeutic Follow-up Observational Study and Population Kinetics Ancillary Study of Valproate Microgranules (Micropakine® SR) in Patients Aged Between 6 Months and 15 Years Suffering From Epilepsy.|Completed||Phase 4|81|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:11:53.558863|2017-02-18 16:11:53.558863
NCT00385398|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2013-08-29|||July 2008||2008-07-01|August 2013|2013-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC|Phase II Quality of Life Study of Stereotactic RadioSurgery, Temozolomide and Erlotinib Chemotherapy for the Treatment of 1-3 Brain Metastases in Non-small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Rutgers, The State University of New Jersey||1||lack of funding and drug supply|f||||t||||||||||2017-02-18 16:11:53.666307|2017-02-18 16:11:53.666307
NCT00385385|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2007-04-27|||October 2006||2006-10-01|April 2007|2007-04-01|September 2008||2008-09-01|||||Interventional|||RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease|Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness|Unknown status|Recruiting|Phase 2|72|Anticipated|ActivBiotics|||||||||||||||||||2017-02-18 16:11:53.761425|2017-02-18 16:11:53.761425
NCT00385372|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2009-01-27|||January 2005||2005-01-01|February 2007|2007-02-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria|Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria|Completed||N/A|150||University Hospital Muenster|||||f||||||||||||||2017-02-18 16:11:53.855547|2017-02-18 16:11:53.855547
NCT00385359|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2006-10-06|||October 2006||2006-10-01|October 2006|2006-10-01||||||||Interventional|||A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control|A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control and Pari Nebulization for the Treatment of Adults With Moderate Asthma|Unknown status|Recruiting|Phase 4|10||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:11:53.957668|2017-02-18 16:11:53.957668
NCT00385346|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2010-06-29|||November 2006||2006-11-01|September 2009|2009-09-01|February 2009|Actual|2009-02-01|June 2008|Actual|2008-06-01||Interventional|||Expressive Writing in Male Infertility|Expressive Writing as a Therapeutic Intervention in Male Infertility|Completed||N/A|56|Actual|University Hospital, Bonn||1|||f||||||||||||||2017-02-18 16:11:54.050241|2017-02-18 16:11:54.050241
NCT00385333|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2017-01-24|||September 29, 2006||2006-09-29|September 16, 2010|2010-09-16|September 16, 2010|Actual|2010-09-16|June 1, 2008|Actual|2008-06-01||Interventional|||Metabolic Mapping to Measure Retinal Metabolism|A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism|Completed||Phase 2|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:11:54.159032|2017-02-18 16:11:54.159032
NCT00385320|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2016-09-15|||May 2001||2001-05-01|September 2016|2016-09-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months|To Assess the Efficacy, Immuno & Safety of 2 Doses of GSK HRV Vaccine at Different Virus Concentrations in Healthy Infants Aged 2 Months & Previously Uninfected With HRV, Concurrently Given With DTPw-HBV, Hib.|Completed||Phase 2|2640|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:11:54.249389|2017-02-18 16:11:54.249389
NCT00385307|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2009-03-24|||September 2006||2006-09-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)|An Eight-Week, Double-Blind, Placebo-Controlled, Multicenter Study With Paroxetine (10 mg qd) as Positive Control, Evaluating the Efficacy, Safety, Tolerability of Two Fixed Doses of SR58611A (175 mg q12/ 350 mg q12) in Outpatients With MDD|Completed||Phase 3|680|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:11:54.341003|2017-02-18 16:11:54.341003
NCT00385294|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2010-10-01|||September 2006||2006-09-01|October 2010|2010-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Role of B2 Adrenergic Receptors in Labor Pain|Role of B2 Adrenergic Receptors in Labor Pain|Completed||N/A|150|Actual|Columbia University|||1||f||||f||||||Samples With DNA|"~     DNA identified by subject number will be retained for analysis.~   "|||2017-02-18 16:11:54.429138|2017-02-18 16:11:54.429138
NCT00385281|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2010-08-26|||October 2006||2006-10-01|March 2010|2010-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Proteomic Profiling for Influenza Vaccination - FluMist|Proteomic Profiling for Influenza Vaccination, 2nd Study: FluMist|Completed||Phase 4|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:11:54.522586|2017-02-18 16:11:54.522586
NCT00385268|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2013-11-11|2013-08-28||November 2006||2006-11-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|CAMPRAL||Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence|A Phase II, Double-Blind, Placebo-controlled, Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence|Completed||Phase 2|60|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 16:11:57.243909|2017-02-18 16:11:57.243909
NCT00385255|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2016-10-26|||October 2006||2006-10-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults|A Study to Evaluate Immunogenicity and Safety of Boostrix When Co-administered With Fluarix in Subjects 19 Years of Age and Older|Completed||Phase 3|1726|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:11:57.627766|2017-02-18 16:11:57.627766
NCT00385242|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2017-01-09|||June 2000||2000-06-01|January 2017|2017-01-01|June 2011|Actual|2011-06-01|June 2006|Actual|2006-06-01||Interventional|||PET and Recovery Following Revascularization (PARR 2)|PET and Recovery Following Revascularization: Outcome and Cost-effectiveness of FDG PET in Left Ventricular Dysfunction (PARR 2)|Completed||Phase 3|430|Actual|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-02-18 16:11:57.731874|2017-02-18 16:11:57.731874
NCT00385229|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-06|2011-11-03|||September 2002||2002-09-01|November 2011|2011-11-01|July 2004|Actual|2004-07-01|December 2003|Actual|2003-12-01||Interventional|||Post Term Pregnancy - Induction of Labor or Monitoring of Pregnancy|Post Term Pregnancy - Induction of Labor or Monitoring of Pregnancy|Completed||N/A|508|Actual|St. Olavs Hospital||2|||f||||f||||||||||2017-02-18 16:11:57.839984|2017-02-18 16:11:57.839984
NCT00385216|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2010-12-01|2010-10-01||July 2004||2004-07-01|December 2010|2010-12-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Nicotine as an Adjuvant Analgesic for Third Molar Surgery|Effect of Nicotine on Pain After Third Molar Extraction.|Completed||Phase 4|20|Actual|Columbia University|This was a small study under typical clinical conditions.|2|||f||||f||||||||||2017-02-18 16:11:57.939596|2017-02-18 16:11:57.939596
NCT00385203|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2012-06-11|2012-03-28||September 2006||2006-09-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).|An Open-Label, Phase II Study to Evaluate the Biological Activity of Cediranib (AZD2171) as Measured by [F 18] Fluoro 2 Deoxy D Glucose - Positron Emission Tomography (FDG-PET) Response, in Patients With Metastatic Gastro-Intestinal Stromal Tumours (GIST) Resistant or Intolerant to Imatinib Mesylate|Completed||Phase 2|35|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:11:58.254578|2017-02-18 16:11:58.254578
NCT00385190|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2009-08-17|||July 2006||2006-07-01|August 2009|2009-08-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men|An Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of Study Drug Administred Orally to Healthy Japanese Male Subjects|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:12:01.356302|2017-02-18 16:12:01.356302
NCT00385177|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2009-06-02|||September 2006||2006-09-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors|A Multicenter Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors|Completed||Phase 1|61|Anticipated|OncoGenex Technologies||1|||f||||f||||||||||2017-02-18 16:12:01.441995|2017-02-18 16:12:01.441995
NCT00385164|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2012-01-18|||October 2006||2006-10-01|August 2011|2011-08-01||||||||Observational|||The Utility of FDG-PET for Radiation Treatment in NSCLC|The Utility of 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for Radiation Treatment Planning in Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|50|Anticipated|AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 16:12:01.552508|2017-02-18 16:12:01.552508
NCT00385151|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2013-11-15|||May 2006||2006-05-01|November 2013|2013-11-01|August 2006||2006-08-01|||||Observational|||To Compare the Ischemic Pre-conditioning and Post-conditioning on Reperfusion Injury in Humans.|The Mechanism of Ischemic Post Conditioning in Humans, Minimizing Reperfusion Injury.|Completed||N/A|20||Emory University|||||f||||||||||||||2017-02-18 16:12:01.635484|2017-02-18 16:12:01.635484
NCT00385138|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2014-04-18|2013-04-22||September 2006||2006-09-01|April 2014|2014-04-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|Platform|mITT population|Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.|A Clinical Trial Comparing Treatment With Cangrelor (in Combination With Usual Care) to Usual Care, in Subjects Who Require Percutaneous Coronary Intervention (PCI).|Terminated||Phase 3|5364|Actual|The Medicines Company|Discontinued per prespecified stopping rules after the 70% interim analyses was conducted indicating the trial was not likely not meet the goal of demonstrating superiority to clopidogrel administered as usual care. No safety issues were identified.|2||Insufficient evidence of the clinical effectiveness of cangrelor|f||||t||||||||||2017-02-18 16:12:01.749454|2017-02-18 16:12:01.749454
NCT00385125|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2006-10-05|||August 2004||2004-08-01|October 2006|2006-10-01|August 2010||2010-08-01|||||Interventional|||Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL|Phase II Study for Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL and Anthracycline Chemotherapy Pretreatment, Who Received or Did Not Qualify for Autologous Stem Cell Transplantation.|Unknown status|Recruiting|Phase 2|30||University of Magdeburg|||||f||||||||||||||2017-02-18 16:12:03.251533|2017-02-18 16:12:03.251533
NCT00385112|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2017-01-25|||November 2006||2006-11-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Follow Up on Freestyle Valves in Children|Follow Up on Freestyle Valves for Right Ventricular Outflow Tract Reconstruction in Children|Completed||N/A|98|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:12:03.344141|2017-02-18 16:12:03.344141
NCT00385099|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2009-07-22||2009-07-22|December 2006||2006-12-01|July 2009|2009-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome|A Phase IIa, Single-centre, Randomised, Placebo-controlled, Double-blind, Three-period Crossover Study Investigating the Effects on Gut Autonomic Responses of Single Administrations of Either 20 mg or 200 mg GW876008, a CRF1 Antagonist, to Adult Patients With Irritable Bowel Syndrome|Completed||Phase 2|10|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:12:03.440001|2017-02-18 16:12:03.440001
NCT00385086|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2015-10-15|||February 2007||2007-02-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|October 2012|Actual|2012-10-01||Interventional|||Lumbar Spinal Fibrosis and TNF Alpha Inhibition|Efficacy of TNF-alpha Inhibition in Sciatica With Post-operative Lumbar Spinal Fibrosis|Completed||Phase 3|38|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 16:12:03.524891|2017-02-18 16:12:03.524891
NCT00005751|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||December 1998||1998-12-01|July 2004|2004-07-01|November 2003|Actual|2003-11-01|||||Observational|||Endothelial Vasomotor Function in the Framingham Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:24.287737|2017-02-18 18:14:24.287737
NCT00385047|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2015-06-04|||September 2006||2006-09-01|June 2015|2015-06-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|||A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults|Phase I/IIa Study of the Safety, Immunogenicity and Preliminary Efficacy After Sporozoite Challenge of FMP2.1/AS01B and FMP2.1/AS02A Candidate Malaria Vaccines Administered Intramuscularly at Months 0, 1, and 2 in Malaria-naive Adults Living in the United States|Completed||Phase 1/Phase 2|41|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||f||||||||||2017-02-18 16:12:03.708512|2017-02-18 16:12:03.708512
NCT00385034|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2015-11-16|||March 2005||2005-03-01|November 2015|2015-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Computer-assisted Screening for Intimate Partner Violence in Family Practice|Computer-assisted Screening for Intimate Partner Violence in Family Practice - a Randomized Controlled Trial|Completed||N/A|280||St. Michael's Hospital, Toronto|||||f||||||||||||||2017-02-18 16:12:03.825908|2017-02-18 16:12:03.825908
NCT00385021|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2007-10-31|||October 2006||2006-10-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer|ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|20|Anticipated|Southwestern Regional Medical Center||1|||f||||f||||||||||2017-02-18 16:12:03.917523|2017-02-18 16:12:03.917523
NCT00385008|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2016-10-24|||September 2006||2006-09-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine|An Open Label, Single Dose, Parallel Group Study to Evaluate Absorption and Transit Characteristics of TREXIMA and RELPAX in Patients Inside and Outside of an Acute Migraine Attack.|Completed||Phase 3|20|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:12:04.01255|2017-02-18 16:12:04.01255
NCT00384995|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2010-11-29|||December 2006||2006-12-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Bicarbonate v Saline to Prevent Contrast Nephropathy|Phase 4 Study of Bicarbonate Versus Saline Infusion Therapy to Prevent Contrast Induced Nephropathy (CAN-IT PREVENT Protocol)|Terminated||Phase 4|61|Actual|Italian Society of Nephrology||2||Lack of funding|f||||t||||||||||2017-02-18 16:12:04.142891|2017-02-18 16:12:04.142891
NCT00384982|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2010-01-21|||January 2005||2005-01-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|MYSTAR||Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study|Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A Multicenter, Randomized Trial Comparing Early and Late Intracoronary or Combined (Intramyocardial and Intracoronary) Administration of Stem Cells|Completed||Phase 2|116|Actual|Medical University of Vienna||1|||f||||t||||||||||2017-02-18 16:12:04.50855|2017-02-18 16:12:04.50855
NCT00384969|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2014-08-15|||October 2006||2006-10-01|August 2014|2014-08-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Sorafenib and RAD001 Renal Cell Carcinoma|A Phase I Study of Sorafenib and RAD001 in Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1|21|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:12:04.62491|2017-02-18 16:12:04.62491
NCT00384956|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2016-10-27|2014-08-11||August 2006||2006-08-01|October 2016|2016-10-01|March 2010|Actual|2010-03-01|August 2008|Actual|2008-08-01||Interventional||25 patients were enrolled and 22 were evaluable (3 patients had acute myeloid leukemia according to the FAB classification on enrollment bone marrow biopsy review and were removed from the study)|A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes|A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes|Completed||Phase 2|25|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 16:12:04.739205|2017-02-18 16:12:04.739205
NCT00384943|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2006-10-04|||November 2001||2001-11-01|October 2006|2006-10-01|November 2004||2004-11-01|||||Interventional|||Study of Home-Based Exercise to Alleviate Postpartum Depression|Decreasing Health Care Utilization With Alternative Approaches for the Treatment of Depression: A Randomized Trial of Exercise for Postpartum Depression|Completed||N/A|90||McGill University|||||f||||||||||||||2017-02-18 16:12:05.327043|2017-02-18 16:12:05.327043
NCT00384930|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2009-08-26|2008-10-17||August 2006||2006-08-01|August 2009|2009-08-01|October 2008|Actual|2008-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, 5-Group, Multinational Study to Evaluate the Efficacy, Dose Response, and Safety of Tadalafil Once-a-Day Dosing for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 2/Phase 3|1058|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-02-18 16:12:05.444057|2017-02-18 16:12:05.444057
NCT00384917|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2009-07-08|||August 2006||2006-08-01|July 2009|2009-07-01|September 2006||2006-09-01|||||Interventional|||Study to Determine the Impact of Multiple Doses of Ketoconazole on Single-Dose Pharmacokinetics of HCV-796|An Open Label, 2-Period, Sequential Study to Determine the Impact of Multiple Doses of Ketoconazole on Single-Dose Pharmacokinetics of HCV-796|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:12:08.943467|2017-02-18 16:12:08.943467
NCT00384904|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2010-02-03||2010-02-03|December 2006||2006-12-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients|Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine With or Without Tenofovir on the Pharmacokinetics of Atazanavir When Given With Ritonavir in HIV-Infected Subjects|Completed||Phase 4|40|Actual|Bristol-Myers Squibb||6|||f||||f||||||||||2017-02-18 16:12:09.014684|2017-02-18 16:12:09.014684
NCT00384891|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2014-10-05|||February 2002||2002-02-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer|A Randomized Controlled Study Comparing Adjuvant Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG Immunotherapy (BCG) Adjuvant Treatment in Patients With Superficial Transitional Cell Carcinoma of the Bladder (STCCB)|Terminated||Phase 3|190|Actual|Medical Enterprises Europe B.V.||2||slow accrual|f||||||||||||||2017-02-18 16:12:09.141615|2017-02-18 16:12:09.141615
NCT00384488|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2006-10-05|||May 2004||2004-05-01|October 2006|2006-10-01|May 2006||2006-05-01|||||Interventional|||Automated Diabetes Prevention Program|Effectiveness of Automated Telephone Intervention on Behavioral and Weight Outcomes for Patients With Pre-Diabetes.|Completed||N/A|84||Kaiser Permanente|||||f||||||||||||||2017-02-18 16:12:13.838918|2017-02-18 16:12:13.838918
NCT00384878|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2009-02-06|||June 2006||2006-06-01|June 2006|2006-06-01||||March 2007|Actual|2007-03-01||Interventional|||Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer|A Phase II Study of Cetuximab Plus P-HDFL (Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin) for the First-Line Treatment of Advanced Gastric Cancer|Unknown status|Recruiting|Phase 2|35|Anticipated|Far Eastern Memorial Hospital||1|||f||||||||||||||2017-02-18 16:12:09.262137|2017-02-18 16:12:09.262137
NCT00384865|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-30|2013-01-31|||September 2006||2006-09-01|July 2009|2009-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension|A Clinical Trial of Aspirin and Simvastatin in Pulmonary Arterial Hypertension|Terminated||Phase 2|64|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 16:12:09.35519|2017-02-18 16:12:09.35519
NCT00384852|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2013-02-21||2013-02-21|January 2007||2007-01-01|February 2013|2013-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Study of rhBMP-2/CPM in Closed Fractures of the Humerus|A Phase 2, Multicenter, Double-Blind, Randomized, Stratified, Controlled, Efficacy, Safety and Feasibility Study of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)/Calcium Phosphate Matrix (CPM) as an Adjuvant Therapy in Closed Fractures of the Humerus|Completed||Phase 2|139|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||||||||||||2017-02-18 16:12:09.478614|2017-02-18 16:12:09.478614
NCT00384839|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2012-06-13|||April 2006||2006-04-01|June 2012|2012-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Vidaza to Restore Hormone Thx Prostate|Phase II Study for the Use of Vidaza™ to Restore Responsiveness of Patients' Prostate Cancers to Hormonal Therapy|Completed||Phase 2|53|Actual|US Oncology Research||1|||f||||f||||||||||2017-02-18 16:12:09.615297|2017-02-18 16:12:09.615297
NCT00384826|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2015-02-12|||September 2006||2006-09-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma|Effect of an Early Therapeutic Permutation on the Tumoral Control of Patients Receiving in First Line a Specific Inhibitor of Tyrosin Kinase of EGFR (Erlotinib) or a Taxan-based Chemotherapy for the Treatment of Not Resecable Adenocarcinoma With Bronchiolo-alveolar.|Completed||Phase 2|133|Actual|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||f||||||||||2017-02-18 16:12:09.731643|2017-02-18 16:12:09.731643
NCT00384813|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2014-07-03|2014-05-20||January 2007||2007-01-01|July 2014|2014-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|ASPIRE||Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma|Project ASPIRE: Improving Pediatric Asthma Management for Urban Families|Completed||Phase 2|43|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:12:09.846805|2017-02-18 16:12:09.846805
NCT00384800|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2009-02-06|||September 2006||2006-09-01|March 2006|2006-03-01||||||||Interventional|||A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)||Unknown status|Recruiting|Phase 2|41|Anticipated|Far Eastern Memorial Hospital||1|||f||||||||||||||2017-02-18 16:12:10.28022|2017-02-18 16:12:10.28022
NCT00384787|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2014-09-22|||November 2006||2006-11-01|September 2014|2014-09-01|December 2012|Actual|2012-12-01|November 2008|Actual|2008-11-01||Interventional|||Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults|A Phase Ib Clinical Trial to Compare the Safety, Tolerability, and Immunogenicity of an HIV-1 Adenoviral Vector Boost Administered Intramuscularly, Intradermally, or Subcutaneously After an HIV-1 DNA Plasmid Vaccine Prime Administered Intramuscularly to Healthy Adenovirus Type 5 Seropositive HIV-1-Uninfected Adults|Completed||Phase 1|90|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 16:12:10.37442|2017-02-18 16:12:10.37442
NCT00384774|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2008-12-04|||October 2006||2006-10-01|December 2008|2008-12-01|June 2007|Actual|2007-06-01|||||Interventional|||A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine|A Placebo-Controlled, Group Sequential, Adaptive Treatment Assignment Study of Intravenous COL-144 (LY573144) in the Acute Treatment of Migraine|Completed||Phase 2|160|Anticipated|CoLucid Pharmaceuticals|||||f||||||||||||||2017-02-18 16:12:10.490228|2017-02-18 16:12:10.490228
NCT00384761|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2013-11-15|||March 2006||2006-03-01|November 2013|2013-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Predictive Medicine Research|Predictive Medicine Research: Investigation of Predictors of Health, Sub-clinical and Clinical Organ System Disease|Completed||Phase 1|223|Actual|Emory University|||1||f||||||||||||||2017-02-18 16:12:10.582948|2017-02-18 16:12:10.582948
NCT00384748|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2014-11-12|2014-10-22||November 2008||2008-11-01|November 2014|2014-11-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Home-based Telehealth Stroke Care: A Randomized Trial for Veterans|Home-Based Tele-Health Stroke Care: A Randomized Trial for Veterans|Completed||Phase 2|48|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:12:10.906727|2017-02-18 16:12:10.906727
NCT00384735|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2014-11-13|||January 2006||2006-01-01|November 2014|2014-11-01|June 2015|Anticipated|2015-06-01|June 2010|Actual|2010-06-01||Observational|TOSS||An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial|An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial|Unknown status|Active, not recruiting|Phase 3|500|Actual|Terry Fox Foundation|||4||f||||t||||||||||2017-02-18 16:12:11.260664|2017-02-18 16:12:11.260664
NCT00384722|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2009-06-23|||March 2006||2006-03-01|June 2009|2009-06-01|May 2008|Actual|2008-05-01|July 2006|Actual|2006-07-01||Interventional|||EASYTRAK 3 Downsize Lead|EASYTRAK® 3 Downsize Lead Clinical Investigation|Completed||Phase 2/Phase 3|70|Actual|Boston Scientific Corporation||1|||f||||||||||||||2017-02-18 16:12:11.361102|2017-02-18 16:12:11.361102
NCT00384709|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2011-08-17|||September 2006||2006-09-01|August 2011|2011-08-01|October 2007|Actual|2007-10-01|||||Observational|||Geriatric Education and Its Effect on Certain Aspects of Hospital Care of Nursing Home Patients|Geriatric Education and Its Effect on Certain Aspects of Hospital Care of the Nursing Home Patients|Completed||N/A|||Maimonides Medical Center|||1||f||||||||||||||2017-02-18 16:12:11.463896|2017-02-18 16:12:11.463896
NCT00384696|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2016-06-06|||February 2006||2006-02-01|June 2016|2016-06-01||||December 2017|Anticipated|2017-12-01||Observational|||Risk Perception Among Quitting Smokers|Health Communications and Risk Processing Among Smokers|Active, not recruiting||Phase 1|220|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 16:12:11.544516|2017-02-18 16:12:11.544516
NCT00005750|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-08|||April 1996||1996-04-01|July 2001|2001-07-01|March 2001||2001-03-01|||||Observational|||School and Family-Based Obesity Prevention for Children||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 18:14:24.35729|2017-02-18 18:14:24.35729
NCT00384683|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2013-05-31|||March 2006||2006-03-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Endothelial Dysfunction As A Predictor Of Perioperative Outcome|Endothelial Dysfunction As A Predictor Of Perioperative Outcome In Major Thoracic Surgery - An Observational Study|Completed||N/A|90|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     Blood samples collected to measure number of circulating blood cells that become endothelial~     cells. During surgery a small sample of lung tissue collected, if available.~   "|||2017-02-18 16:12:11.65518|2017-02-18 16:12:11.65518
NCT00384670|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2014-01-10|2012-05-23||August 2003||2003-08-01|January 2014|2014-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children|A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children|Completed||Phase 1/Phase 2|7|Actual|U.S. Army Medical Research and Materiel Command||1|||f||||t||||||||||2017-02-18 16:12:11.748493|2017-02-18 16:12:11.748493
NCT00384657|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2017-01-24|||January 2008||2008-01-01|January 2017|2017-01-01|June 2021|Anticipated|2021-06-01|December 2019|Anticipated|2019-12-01||Interventional|||Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease|The Effects of Intravenous Iron Therapy for Anemia Correction in Patients With Severe Chronic Heart Failure and Concomitant Moderate Chronic Kidney Disease|Recruiting||Phase 3|200|Anticipated|Anemia Working Group Romania||2|||f||||f||||||||||2017-02-18 16:12:12.105518|2017-02-18 16:12:12.105518
NCT00384644|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2008-06-04|||April 2004||2004-04-01|June 2008|2008-06-01|December 2010|Anticipated|2010-12-01|January 2009|Anticipated|2009-01-01||Observational|||Skeletal Muscle Oxygenation in Critically Ill|Skeletal Muscle Oxygenation in Critically Ill|Unknown status|Recruiting|N/A|200|Anticipated|University Medical Centre Ljubljana|||2||f||||t||||||||||2017-02-18 16:12:12.253452|2017-02-18 16:12:12.253452
NCT00384631|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2008-02-14|||April 2006||2006-04-01|February 2008|2008-02-01|March 2007|Actual|2007-03-01|||||Interventional|IVB NVG||Intravitreal Bevacizumab for Neovascular Glaucoma|Intravitreal Bevacizumab for Neovascular Glaucoma; a Randomized Placebo Controlled Clinical Trial|Completed||N/A|26|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 16:12:12.356584|2017-02-18 16:12:12.356584
NCT00384618|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2006-10-04|||May 2001||2001-05-01|October 2006|2006-10-01|August 2005||2005-08-01|||||Interventional|||Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study|Effect of an Oxidative-Stress-Reducing Strategy Consisting of Pravastatin, Vitamin E and Homocysteine-Lowering on Carotid Intima-Media Thickness in Patients With Mild-to-Moderate Chronic Kidney Disease|Terminated||Phase 4|100||VU University Medical Center|||||f||||||||||||||2017-02-18 16:12:12.454902|2017-02-18 16:12:12.454902
NCT00384605|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2015-03-12|||October 2006||2006-10-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|January 2008|Actual|2008-01-01||Interventional|||An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)|A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Taranabant (MK0364) in Obese Patients and in Overweight Patients With Obesity-Related Co-Morbidities, Followed by a 1-Year Extension|Terminated||Phase 3|1000|Actual|Merck Sharp & Dohme Corp.||4||The overall profile does not support development for obesity|f||||||||||||||2017-02-18 16:12:12.725031|2017-02-18 16:12:12.725031
NCT00384592|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2009-03-10|||September 2006||2006-09-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||PPI Sequencing Study|A Study to Assess the Effectiveness of Esomeprazole 40 mg Once Daily in Subjects With Continuing Gastroesophageal Reflux Disease (GORD) Symptoms Following Treatment Wit a Previous Full Dose Proton Pump Inhibitor (PPI)|Completed||Phase 4|100||AstraZeneca|||||f||||||||||||||2017-02-18 16:12:12.825062|2017-02-18 16:12:12.825062
NCT00384579|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2010-03-01|||February 2008||2008-02-01|February 2010|2010-02-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain|Pilot Study to Assess the Efficacy of Botulinum Toxin B (Myobloc®) Treatment of Paravertebral Muscles on Pain and Disability in Subjects Suffering From Acute Low Back Pain|Terminated||Phase 4|0|Actual|Walter Reed Army Medical Center||2||No eligible candidates in 2 years of recruiting|f||||t||||||||||2017-02-18 16:12:12.934489|2017-02-18 16:12:12.934489
NCT00384566|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2015-06-23|||June 2005||2005-06-01|June 2015|2015-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure|The CAMERA Study: CArvedilol MEtoprolol Respiratory Assessment Investigator Trial|Withdrawn||Phase 4|0|Actual|The Alfred||2||"In order to join forces with another study already running which aims to answer the same~   question."|f||||||||||||||2017-02-18 16:12:13.061287|2017-02-18 16:12:13.061287
NCT00384553|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2006-10-05|||June 2004||2004-06-01|October 2006|2006-10-01|June 2010||2010-06-01|||||Interventional|||Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma|Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma|Unknown status|Recruiting|Phase 1/Phase 2|30||University of Magdeburg|||||f||||||||||||||2017-02-18 16:12:13.16225|2017-02-18 16:12:13.16225
NCT00384540|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2016-06-03|||September 2006||2006-09-01|June 2016|2016-06-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling|Allograft Vasculopathy After Heart Transplantation : Diagnostic Interest of Dobutamine Stress Echocardiography and Brain Natriuretic Peptide Coupling|Active, not recruiting||N/A|120|Anticipated|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-02-18 16:12:13.262194|2017-02-18 16:12:13.262194
NCT00384527|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2015-05-04|||December 2006||2006-12-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease|Multicenter, Double-blind Study of Nitazoxanide Compared to Vancomycin in the Treatment of Clostridium Difficile-associated Disease|Terminated||Phase 3|50|Actual|Romark Laboratories L.C.||2||Study was terminated early due to slow recruitment.|f||||f||||||||||2017-02-18 16:12:13.363791|2017-02-18 16:12:13.363791
NCT00384514|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2006-10-19|||July 2004||2004-07-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||EPC by Intracoronary Injection in Patients With Chronic Stable Angina|A Study for Testing Safety and Efficacy of the Administration of Blood-Borne Autologous Endothelial Progenitor Cells to Alleviate Anginal Symptoms and Myocardial Ischemia in Patients With Severe Anginal Syndrome|Unknown status|Active, not recruiting|Phase 2|24||TheraVitae Ltd.|||||f||||||||||||||2017-02-18 16:12:13.483075|2017-02-18 16:12:13.483075
NCT00384475|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2016-11-29|||October 2006||2006-10-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray (200 mcg, Once Daily), in the Treatment of Seasonal Allergic Rhinitis (SAR) in Patients 18 Years and Older|Completed||Phase 3|500||AstraZeneca|||||f||||||||||||||2017-02-18 16:12:13.926197|2017-02-18 16:12:13.926197
NCT00384462|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2009-02-03|||October 2006||2006-10-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Observational|||Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants|A Prospective, Non-Interventional Study to Evaluate the Incidence of Hospitalizations and Medically-Attended Lower Respiratory Tract Infection (MALRI) in Premature Infants 32 to 35 Weeks Gestational Age Who Are Not Recommended to Receive Prophylaxis for RSV|Completed||N/A|346|Actual|MedImmune LLC|||2||f||||f||||||||||2017-02-18 16:12:14.035028|2017-02-18 16:12:14.035028
NCT00384449|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2009-04-02|||October 2006||2006-10-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Lucentis (Ranibizumab) for Eales' Disease|The Use of a VEGF Inhibitor (Lucentis) in Refractory Macular Edema Due to Eales' Disease|Completed||Phase 2/Phase 3|5|Anticipated|Oregon Health and Science University||1|||f||||||||||||||2017-02-18 16:12:14.199197|2017-02-18 16:12:14.199197
NCT00384436|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2008-01-03|||October 2006||2006-10-01|January 2008|2008-01-01||||October 2007|Actual|2007-10-01||Interventional|||Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients|Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients|Completed||Phase 4|580|Anticipated|Forest Laboratories|||||||||||||||||||2017-02-18 16:12:14.304698|2017-02-18 16:12:14.304698
NCT00384423|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2008-01-29|||October 2006||2006-10-01|January 2008|2008-01-01||||October 2007|Actual|2007-10-01||Interventional|||Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept|A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study to Assess the Short-Term Effects of PRX-03140 Alone and in Combination With Donepezil in Subjects With Mild Alzheimer's Disease.|Completed||Phase 2|80|Anticipated|Epix Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 16:12:14.401071|2017-02-18 16:12:14.401071
NCT00384410|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2006-10-04|||December 2005||2005-12-01|November 2005|2005-11-01||||||||Interventional|||Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients|Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients: A Placebo-Controlled, Randomized, Crossover Insomnia Pilot Study|Unknown status|Recruiting|Phase 2|16||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:12:14.500445|2017-02-18 16:12:14.500445
NCT00384397|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2016-04-12|2011-05-10||September 2006||2006-09-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers|An Immunogenicity and Safety Evaluation of Two Doses of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) Given to Healthy Subjects at 9 and 12 Months of Age|Completed||Phase 3|1128|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 16:12:14.602152|2017-02-18 16:12:14.602152
NCT00384384|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2011-01-12|||August 2006||2006-08-01|January 2011|2011-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients|Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients|Completed||Phase 2|24||University Hospital Inselspital, Berne|||||||||||||||||||2017-02-18 16:12:15.437716|2017-02-18 16:12:15.437716
NCT00384371|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2009-03-04|||June 2008||2008-06-01|March 2009|2009-03-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain|Pilot Study to Assess the Efficacy of Botulinum Toxin A (BOTOX®) Treatment of Paravertebral Muscles on Pain and Disability in Subjects Suffering From Sub-Acute Low Back Pain.|Terminated||Phase 4|0|Actual|Walter Reed Army Medical Center||2||Funding was unable to be secured for this study|f||||t||||||||||2017-02-18 16:12:15.515333|2017-02-18 16:12:15.515333
NCT00384358|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2013-02-21||2013-02-21|December 2006||2006-12-01|February 2013|2013-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures|A Phase 2, Multicenter, Single-Blind, Randomized, Stratified, Standard-Of-Care Controlled, Feasibility And Safety Study Of rhBMP-2/CPM As An Adjuvant Therapy For Fractures Of The Proximal Femur|Completed||Phase 2|108|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 16:12:15.623587|2017-02-18 16:12:15.623587
NCT00384345|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2006-10-04|||September 2003||2003-09-01|July 2006|2006-07-01|December 2003||2003-12-01|||||Interventional|||Exercise and Bright Light Treatment: Effects on Body Weight and Composition|Moderate Exercise and Bright Light Treatment in Overweight Individuals|Completed||Phase 2|24||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:12:15.862794|2017-02-18 16:12:15.862794
NCT00384332|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2015-06-01|||January 2007||2007-01-01|June 2015|2015-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Medication, Weight Gain and GI Hormones|Orally-Disintegrating vs. Regular Olanzapine Tablets: Effects on Weight and GI Hormones|Completed||Phase 4|20|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 16:12:15.959429|2017-02-18 16:12:15.959429
NCT00384319|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2008-01-03|||October 2006||2006-10-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Pilot Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients|Pilot Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients|Completed||Phase 1|10|Actual|Life Recovery Systems||1|||f||||f||||||||||2017-02-18 16:12:16.088958|2017-02-18 16:12:16.088958
NCT00384306|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2015-04-15|||June 2004||2004-06-01|April 2015|2015-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease|Investigation of the Side Effects of Orally Administered Glucocorticoids. An Open Label Study to Investigate the Effects of Orally Administered Prednisolone on Bone Metabolism in Patients With COPD.|Completed||Phase 1|9|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:12:16.18725|2017-02-18 16:12:16.18725
NCT00384254|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2011-10-24|||January 2004||2004-01-01|October 2011|2011-10-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||Tobacco Quitlines:Adjunct to Dental Office Tobacco Intervention|Tobacco Quitlines as an Adjunct to Dental Office Tobacco Intervention|Completed||Phase 2|2177|Actual|Oregon Research Institute||3|||f||||t||||||||||2017-02-18 16:12:19.14848|2017-02-18 16:12:19.14848
NCT00384293|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2015-09-28|2009-07-23||September 2006||2006-09-01|September 2015|2015-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|ACHIEVE||Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)|A Worldwide, Double-Blind, Randomized, Placebo-Controlled Study of MK0524A 2g Coadministered With Intensive LDL-C Lowering Therapy Compared to Intensive LDL-C Lowering Therapy Alone on Carotid Artery Intima Media Thickening (cIMT) in Patients With Heterozygous Familial Hypercholesterolemia (heFH)|Terminated||Phase 3|937|Actual|Merck Sharp & Dohme Corp.|After a detailed review of pooled carotid IMT data from contemporary studies, the Steering Committee recommended that Merck prematurely stop the study; as designed, the study was significantly underpowered. Efficacy analyses were not performed.|2|||f||||||||||||||2017-02-18 16:12:16.282401|2017-02-18 16:12:16.282401
NCT00383604|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2013-05-28|||July 2005||2005-07-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Observational|||Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2|Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2|Completed||N/A|30|Actual|Stanford University|||1||f||||t||||||Samples With DNA|"~     blood~   "|||2017-02-18 16:12:16.740831|2017-02-18 16:12:16.740831
NCT00383591|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2011-09-29|||March 2002||2002-03-01|September 2011|2011-09-01||||||||Interventional|||Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years|A Phase III, Clinical Trial Comparing the Persistence of GSK Biologicals New Adjuvanted Hepatitis B Vaccine to a Double Dose of Engerix™-B at Months 24, 30, 36, in Pre-haemodialysis/Haemodialysis Patients (≥15 Years of Age)|Completed||Phase 3|120||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:12:16.992822|2017-02-18 16:12:16.992822
NCT00383578|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2013-01-02||2013-01-02|September 2006||2006-09-01|January 2013|2013-01-01||||May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 24 Weeks Treatment With Vildagliptin 100 mg qd or Metformin 1500 mg Daily in Elderly Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|335|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:12:17.08413|2017-02-18 16:12:17.08413
NCT00383565|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2014-05-02|2012-07-19||September 2006||2006-09-01|April 2013|2013-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Study of Depsipeptide, a Histone Deacetylase Inhibitor, in Relapsed or Refractory Mantle Cell or Diffuse Large Cell Non-Hodgkin's Lymphoma|Terminated||Phase 2|9|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:12:17.19246|2017-02-18 16:12:17.19246
NCT00383552|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2015-02-06|2010-07-15||September 2006||2006-09-01|February 2015|2015-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)|A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects With Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids|Completed||Phase 3|746|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 16:12:17.509779|2017-02-18 16:12:17.509779
NCT00383539|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2014-01-10|||September 2006||2006-09-01|January 2014|2014-01-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults||Completed||Phase 3|2256|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 16:12:18.312545|2017-02-18 16:12:18.312545
NCT00383526|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2014-01-10|||September 2006||2006-09-01|January 2014|2014-01-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly||Completed||Phase 3|3707|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:12:18.440953|2017-02-18 16:12:18.440953
NCT00383513|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2012-07-03||2012-07-03|June 2006||2006-06-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of Epratuzumab in Systemic Lupus Erythematosus|An Open-Label Re-treatment Trial for Patients Previously Randomized Into the SL0003 and SL0004, Randomized, Double-blind, Placebo-controlled, Multi-center Studies of Epratuzumab in Patients With Systemic Lupus Erythematosus|Completed||Phase 2|29|Actual|UCB Pharma||1|||f||||t||||||||||2017-02-18 16:12:18.556664|2017-02-18 16:12:18.556664
NCT00383500|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2011-10-25|||May 2005||2005-05-01|October 2011|2011-10-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status|To Prospectively Evaluate the Potential for Simple, Effective Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status|Unknown status|Recruiting|N/A|200|Anticipated|Stanford University||1|||f||||t||||||||||2017-02-18 16:12:18.682673|2017-02-18 16:12:18.682673
NCT00383487|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2013-01-25|||March 2005||2005-03-01|January 2013|2013-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer|A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer|Terminated||Phase 2|20|Actual|Stanford University||1||Extreme toxicity|f||||t||||||||||2017-02-18 16:12:18.776011|2017-02-18 16:12:18.776011
NCT00383474|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2015-04-14|||August 2006||2006-08-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase|A Phase I Dose-Escalation Study of R115777 (Tipifarnib) Plus PS-341 (Bortezomib) in Relapsed or Refractory Acute Leukemias|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:12:18.879877|2017-02-18 16:12:18.879877
NCT00384280|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2009-08-10|||September 2006||2006-09-01|August 2009|2009-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796|An Open Label, 2-period, Sequential Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:12:18.99042|2017-02-18 16:12:18.99042
NCT00384267|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2011-11-10|||October 2006||2006-10-01|September 2008|2008-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Congenital and Neonatal Malaria in Mali|Congenital and Neonatal Malaria in Mali|Completed||N/A|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 16:12:19.058757|2017-02-18 16:12:19.058757
NCT00383396|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2007-02-12||||||February 2007|2007-02-01||||||||Interventional|||Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:12:39.987673|2017-02-18 16:12:39.987673
NCT00384241|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2015-05-13|2013-06-21||August 2006||2006-08-01|May 2015|2015-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Evaluating the Relationship Between Inflammation, Genetics, and Stress in the Development of High Blood Pressure|Inflammatory Factors, Genes and Stress Induced Pressure Natriuresis in Youth|Completed||Phase 1|1099|Actual|Augusta University|No treatment was given.||2||f||||t||||||Samples With DNA|"~     Blood samples of 500 subjects have been collected and stored in previous funded studies.~      Buccal swabs from 599 biological parents have been collected from the current study.~   "|||2017-02-18 16:12:19.260473|2017-02-18 16:12:19.260473
NCT00384228|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-05|2012-04-11|||May 2005||2005-05-01|April 2012|2012-04-01||||January 2007|Actual|2007-01-01||Interventional|||A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL|A Phase I/II Multicenter, Dose-escalation Study of Oral Nilotinib on a Continuous Daily Dosing Schedule in Adult Patients With Imatinib-resistant or Imatinib-intolerant CML, or Relapse/Refractory Ph+ALL|Completed||Phase 1/Phase 2|42|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:12:19.703056|2017-02-18 16:12:19.703056
NCT00384215|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2011-01-10|||December 2001||2001-12-01|January 2011|2011-01-01|February 2005||2005-02-01|||||Interventional|||Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin|Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin: a Randomized, Open, Parallel Study|Completed||Phase 4|352||Sanofi|||||f||||||||||||||2017-02-18 16:12:19.801789|2017-02-18 16:12:19.801789
NCT00384202|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2014-07-07|||October 2006||2006-10-01|July 2014|2014-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients|A Multicenter, Open, Single Sequence Crossover Study to Assess the Safety and Efficacy of a Tacrolimus Modified Release, FK506E (MR4), Based Immunosuppressive Regimen in Stable Liver Transplant Patients Converted From a Prograf® Based Immunosuppressive Regimen|Completed||Phase 3|112|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-02-18 16:12:19.891266|2017-02-18 16:12:19.891266
NCT00384189|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2016-12-02|2016-07-06||September 2006||2006-09-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|RAINBOW|Full Analysis Set includes all randomized participants who received at least one dose of study drug, as treated.|A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma|A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children With Asthma|Completed||Phase 3|1080|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 16:12:20.118442|2017-02-18 16:12:20.118442
NCT00384176|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2015-06-18|2012-03-07||August 2006||2006-08-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|November 2009|Actual|2009-11-01||Interventional|HORIZON III||First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX|A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of Cediranib (RECENTIN™, AZD2171) in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer|Active, not recruiting||Phase 2/Phase 3|1814|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:12:22.130035|2017-02-18 16:12:22.130035
NCT00384163|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2013-11-25|||August 2007||2007-08-01|November 2013|2013-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Adult Pulmonary Valve Replacement: A Simple and Reproducible Technique|Adult Pulmonary Valve Replacement: A Simple and Reproducible Technique|Terminated||N/A|50||Emory University||||sufficient data collected|f||||||||||||||2017-02-18 16:12:23.997557|2017-02-18 16:12:23.997557
NCT00384150|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2015-10-30||2015-10-30|November 2007||2007-11-01|October 2015|2015-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkin's Lymphoma (NHL)|A Phase III, Open-Label, Multicenter, Single-Arm, Retreatment Study of Galiximab in Combination With Rituximab for Subjects With Relapsed, Follicular Non-Hodgkin's Lymphoma Who Previously Responded on Study 114-NH-301|Terminated||Phase 3|16|Actual|Biogen||||"Enrollment challenges due to changes in standards of care resulted in premature termination.~   No safety or efficacy events factored into this action."|f||||f||||||||||2017-02-18 16:12:24.088068|2017-02-18 16:12:24.088068
NCT00384137|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2014-07-07|||October 2006||2006-10-01|July 2014|2014-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients|A Multicenter, Open, Single Sequence Crossover Study to Assess the Safety and Efficacy of a Tacrolimus Modified Release, FK506E (MR4), Based Immunosuppressive Regimen in Stable Kidney Transplant Patients Converted From a Prograf® Based Immunosuppressive Regimen|Completed||Phase 3|128|Actual|Astellas Pharma Inc||1|||f||||t||||||||||2017-02-18 16:12:24.181675|2017-02-18 16:12:24.181675
NCT00384124|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-04|2008-03-25|||November 2006||2006-11-01|March 2008|2008-03-01||||November 2008|Anticipated|2008-11-01||Interventional|||Topical Imiquimod for Bowen's Disease of the Head and Neck|Phase III Trial of 6 Weeks of Imiquimod for the Treatment of Bowens Disease of the Head and Neck. Outcome is Histologic Clearance at 14 Weeks.|Unknown status|Enrolling by invitation|Phase 2/Phase 3|50|Anticipated|Brooke Army Medical Center||1|||f||||t||||||||||2017-02-18 16:12:24.312111|2017-02-18 16:12:24.312111
NCT00384111|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2011-03-07|||October 2006||2006-10-01|March 2011|2011-03-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular NHL|A Phase 3 Open-label Multicenter Randomized Study to Compare the Efficacy and Safety of Zevalin Therapeutic Regimen Following R CVP With R CVP Alone in High Risk Subjects With Previously Untreated CD20 Positive Follicular Non Hodgkin's Lymphoma|Terminated||Phase 3|26|Actual|Spectrum Pharmaceuticals, Inc||2||A pending new protocol will replace this study.|f||||f||||||||||2017-02-18 16:12:24.408446|2017-02-18 16:12:24.408446
NCT00384098|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2014-09-26|||September 2006||2006-09-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis|A Randomized, Double-blind, Parallel-group, 4-arm, 12-week Study to Evaluate the Safety and Efficacy of Topically Applied CTA018 vs Vehicle for the Treatment of Adult Subjects With Chronic Plaque Psoriasis|Completed||Phase 2|140||OPKO Health, Inc.|||||f||||f||||||||||2017-02-18 16:12:24.512383|2017-02-18 16:12:24.512383
NCT00383383|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2006-10-02|||December 1999||1999-12-01|October 2006|2006-10-01||||||||Interventional|||Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years|To Compare the Immunogenicity & Safety of GSK Biologicals New Adjuvanted Hepatitis B Vaccine to a Double Dose of Engerix™-B, in Pre-Haemodialysis/Haemodialysis Patients (≥15 Years of Age)|Completed||Phase 3|141||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:12:40.073887|2017-02-18 16:12:40.073887
NCT00384085|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2011-05-04|2011-03-31||May 2006||2006-05-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||"Insulin Glargine All to Target Trial"|All to Target Trial Lantus® (Insulin Glargine) With Stepwise Addition of APIDRA® (Insulin Glulisine) or Lantus With One Injection of Apidra vs a Twice-Daily Premixed Insulin Regimen (Novolog® Mix 70/30) in Adult Subjects With Type 2 Diabetes Failing Dual or Triple Therapy With Oral Agents: a 64-week, Multi-center, Randomized, Parallel, Open-label Clinical Study.|Completed||Phase 4|588|Actual|Sanofi||3|||f||||||||||||||2017-02-18 16:12:27.347984|2017-02-18 16:12:27.347984
NCT00384072|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2007-12-19|||May 2006||2006-05-01|May 2007|2007-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women|A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women|Completed||Phase 3|500|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:12:28.700156|2017-02-18 16:12:28.700156
NCT00384059|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2013-01-22|2010-03-26||October 2006||2006-10-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants|A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in the United Kingdom|Completed||Phase 3|286|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 16:12:28.83356|2017-02-18 16:12:28.83356
NCT00384046|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2013-04-15|||November 2006||2006-11-01|April 2013|2013-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen|24-Week Study to Evaluate the Efficacy/Safety of Transdermal Testosterone in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder Receiving Systemic Transdermal Estrogen Therapy.|Completed||Phase 3|272|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 16:12:30.936871|2017-02-18 16:12:30.936871
NCT00384033|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2012-02-09|2012-02-09||September 2006||2006-09-01|February 2012|2012-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Duloxetine-Referenced, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (50mg, 100mg) of Desvenlafaxine Sustained-Release Tablets in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|638|Actual|Pfizer||4|||||||||||||||||2017-02-18 16:12:31.08681|2017-02-18 16:12:31.08681
NCT00384020|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2010-01-29|||January 2006||2006-01-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Clinical Pharmacogenomics of Antidepressant Response|Phase 4 Clinical Pharmacogenomics of Antidepressant Response|Completed||Phase 4|402|Actual|National Health Research Institutes, Taiwan|||1||f||||||||||||||2017-02-18 16:12:32.361215|2017-02-18 16:12:32.361215
NCT00384007|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2009-06-04|||October 2006||2006-10-01|June 2009|2009-06-01||||||||Interventional|||A Randomized Trial Comparing SpineJet® Hydrodiscectomy to Open Lumbar Microdiscectomy for Treatment of Lumbar Radiculopathy Due to Disc Herniation|A Randomized Trial Comparing SpineJet® Hydrodiscectomy to Open Lumbar Microdiscectomy for Treatment of Lumbar Radiculopathy Due to Disc Herniation|Completed||N/A|58|Anticipated|Pinnacle Pain Medicine|||||||||||||||||||2017-02-18 16:12:32.455257|2017-02-18 16:12:32.455257
NCT00383994|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2016-03-02|||September 2006||2006-09-01|March 2016|2016-03-01||||September 2017|Anticipated|2017-09-01||Interventional|||Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation|Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 1|40|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:12:32.548711|2017-02-18 16:12:32.548711
NCT00383981|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2006-10-03|||March 2003||2003-03-01|April 2006|2006-04-01|December 2003||2003-12-01|||||Observational|||Lipid Peroxidation in Workers Exposed to Al,Ga,In,As,and Sb in Optoelectronic Industry||Completed||Phase 1|170||Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||||||||||||2017-02-18 16:12:32.671082|2017-02-18 16:12:32.671082
NCT00383968|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2006-10-03|||October 2006||2006-10-01|October 2006|2006-10-01|December 2006||2006-12-01|||||Observational|||Prevalence of Chronic KIdney Disease in Hypertensive Patients|Prevalence of Chronic KIdney Disease in Hypertensive Patients|Unknown status|Recruiting|N/A|248||Aga Khan University|||||f||||||||||||||2017-02-18 16:12:32.744141|2017-02-18 16:12:32.744141
NCT00383955|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2006-10-03|||October 2006||2006-10-01|October 2006|2006-10-01||||||||Observational|||Comparison of Screening Tools for Coronary Artery Disease|Comparison of Screening Tools for Coronary Artery Disease With Thallium Scintigraphy in Adult Population in Karachi.|Unknown status|Recruiting|N/A|450||Aga Khan University|||||f||||||||||||||2017-02-18 16:12:32.830814|2017-02-18 16:12:32.830814
NCT00383942|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2011-11-30|||July 2006||2006-07-01|November 2011|2011-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Cervical Ripening Interventions|Ripening Interventions: Prostaglandins vs. EASI Catheter|Terminated||Phase 3|80|Actual|Loyola University||2||Change in treatment plan for this population halted enrollment and project was terminated.|f||||||||||||||2017-02-18 16:12:32.913451|2017-02-18 16:12:32.913451
NCT00383929|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2008-03-19|||September 2006||2006-09-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg|A Double Blind, Randomised, 3-Arm Parallel Group, Multicentre, 8-Week, Phase III Study to Assess Antihypertensive Efficacy and Safety of the Combination of Candesartan Cilexetil (CC) /HCT 32/12.5mg and 32/25mg vs. CC 32mg Alone in Patients With Inadequate BP Control on Monotherapy With CC 32mg|Completed||Phase 3|1979|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:12:33.02833|2017-02-18 16:12:33.02833
NCT00383916|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2007-03-07|||October 2006||2006-10-01|March 2007|2007-03-01|October 2006||2006-10-01|||||Interventional|||Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.|An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study Between the Altana Formulation of Pantoprazole Delayed-Release Granules and the Wyeth Formulation of Pantoprazole Delayed-Release Granules in Healthy Subjects.|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:12:33.39707|2017-02-18 16:12:33.39707
NCT00382837|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2014-05-20|||January 2007||2007-01-01|March 2007|2007-03-01||||||||Interventional|||Study of Epratuzumab in Systemic Lupus Erythematosus|A Phase III Multi-Center, OpenLabel, Follow-Up Study to Assess the Safety & Efficacy of Epratuzumab in Patients With Acute Severe SLE Flares Excluding the Renal or Neurologic Systems|Withdrawn||Phase 3|0|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 16:12:54.425132|2017-02-18 16:12:54.425132
NCT00383903|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2016-09-14|||September 2003||2003-09-01|September 2016|2016-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa|A Phase II, Randomized, Double-blind, Placebo-controlled Study of Safety, Reactogenicity and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus Vaccine at 10E6.5 CCID50 Viral Concentration in Healthy Infants (Approximately 5-10 Weeks Old) in the Republic of South Africa|Completed||Phase 2|472|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:12:33.474968|2017-02-18 16:12:33.474968
NCT00383890|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2015-07-23|||August 2006||2006-08-01|July 2015|2015-07-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Dexmedetomidine Used for Sedation During Elective Awake Fiberoptic Intubation|Completed||Phase 3|124|Actual|Hospira, Inc.||2|||f||||||||||||||2017-02-18 16:12:33.57436|2017-02-18 16:12:33.57436
NCT00383877|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2014-11-20|||September 2006||2006-09-01|November 2014|2014-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes|Completed||Phase 3|263|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:12:33.694903|2017-02-18 16:12:33.694903
NCT00383864|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2006-10-05|||July 2001||2001-07-01|October 2006|2006-10-01|March 2006||2006-03-01|||||Interventional|||Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.|Randomized Study on the Efficacy and Safety of Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation|Completed||Phase 4|55||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:12:33.974195|2017-02-18 16:12:33.974195
NCT00383851|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2007-12-04|||September 2006||2006-09-01|December 2007|2007-12-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma|A Randomized Phase II Trial of ATN-224 in Combination With Temozolomide or Temozolomide Followed by ATN-224 in Patients With Advanced Melanoma|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Attenuon|||||f||||||||||||||2017-02-18 16:12:34.077539|2017-02-18 16:12:34.077539
NCT00383838|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2006-10-02|||September 2002||2002-09-01|October 2006|2006-10-01|June 2005||2005-06-01|||||Interventional|||Self-Selected Brief Alcohol Intervention for Adolescents|Self-Selected Brief Alcohol Intervention for Adolescents|Completed||N/A|1200||RAND|||||f||||||||||||||2017-02-18 16:12:34.193258|2017-02-18 16:12:34.193258
NCT00383825|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2006-10-02|||January 2003||2003-01-01|October 2006|2006-10-01|December 2004||2004-12-01|||||Interventional|||ICG Angiography in Amniotic Membrane Graft and Conjunctival Autograft After Pterygium Excision|Interventional Study of Vascularization Detected by ICG Angiography in Amniotic Membrane Graft and Conjunctival Autograft After Pterygium Excision|Completed||N/A|30||Baskent University|||||f||||||||||||||2017-02-18 16:12:34.282414|2017-02-18 16:12:34.282414
NCT00383812|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2006-10-03|||May 2006||2006-05-01|October 2006|2006-10-01|May 2008||2008-05-01|||||Interventional|||Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy|Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy|Unknown status|Recruiting|N/A|20||Asan Medical Center|||||f||||||||||||||2017-02-18 16:12:34.377819|2017-02-18 16:12:34.377819
NCT00383799|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2016-04-04|||September 2005||2005-09-01|March 2016|2016-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia|Comparison of Intravenous Amiodarone Versus Intravenous Procainamide for the Acute Treatment of Regular and Haemodynamically Well Tolerated Wide QRS Tachycardia (Probably of Ventricular Origen). The PROCAMIO Multicenter Study|Terminated||Phase 4|302|Actual|Hospital General Universitario Gregorio Marañon||2||"Steering Committee decision after inclusion of 74 patients after 6 years and very slow~   inclusion rate"|f||||t||||||||||2017-02-18 16:12:34.468716|2017-02-18 16:12:34.468716
NCT00383786|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2013-12-27|2013-09-05||September 2006||2006-09-01|December 2013|2013-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder|Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder|Completed||Phase 2|47|Actual|Baylor College of Medicine|Limitations include the small sample size and brief duration of the trial, as 8 weeks might have been insufficient to test the efficacy of GR205171 for chronic PTSD. Sample size was also a limitation.|2|||f||||t||||||||||2017-02-18 16:12:34.605881|2017-02-18 16:12:34.605881
NCT00383773|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-03|2006-10-03|||October 2006||2006-10-01|September 2006|2006-09-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion||Unknown status|Not yet recruiting|N/A|10|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:12:35.004338|2017-02-18 16:12:35.004338
NCT00383760|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2016-12-14|2014-04-18||August 2006||2006-08-01|December 2016|2016-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients|A Phase II Study of the Halichondrin B Analog E7389 as Second Line Therapy for Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer|Completed||Phase 2|15|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:12:35.09296|2017-02-18 16:12:35.09296
NCT00383747|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2013-11-06|||April 2004||2004-04-01|November 2013|2013-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Effects of Nicotine on Cognition in Schizophrenia|A Double Blind Placebo Controlled Trial of the Effects of Transdermal Nicotine on Cognitive Function in Non-Smokers With and Without Schizophrenia|Completed||Phase 4|60|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:12:35.429489|2017-02-18 16:12:35.429489
NCT00383734|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2011-12-21|||December 2006||2006-12-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE|Randomized, Comparative, Multicenter, Patient-blinded Trial of the Safety and Efficacy of Intradermal Injections of Polylactic Acid (Newfill TM) Versus Polyacrylamid Gel (Eutrophill) in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE|Completed||Phase 3|148|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||t||||||||||2017-02-18 16:12:35.551654|2017-02-18 16:12:35.551654
NCT00383721|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2015-09-02|2011-07-22||September 2006||2006-09-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED)|A Randomized, 26-Week, Placebo-Controlled Efficacy and Safety Study With a 26-Week Long-Term Safety Extension, of High- and Medium-Dose Inhaled Mometasone Furoate/Formoterol Fixed-Dose Combination Formulation Compared With Formoterol and High-Dose Inhaled Mometasone Furoate Monotherapy in Subjects With Moderate to Severe COPD|Completed||Phase 3|1196|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 16:12:35.672587|2017-02-18 16:12:35.672587
NCT00383708|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2012-06-18|||October 2006||2006-10-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients|Phase III, Multicentre, Open Study to Assess the Efficacy and Safety Profiles of the Co-administration of Lanreotide Autogel 120 mg (Administered Via Deep Subcutaneous Injections Every 28 Days) and Pegvisomant 40 to 120 mg Per Week (Administered Via Subcutaneous Route Once or Twice a Week) in Acromegalic Patients Failing to Respond to Lanreotide Autogel 120 mg Alone|Completed||Phase 3|125|Actual|Ipsen||1|||f||||f||||||||||2017-02-18 16:12:36.956621|2017-02-18 16:12:36.956621
NCT00383695|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2010-01-12|||September 2005||2005-09-01|January 2010|2010-01-01||||||||Interventional|EXPERT-C||Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer|A Multicentre Randomised Phase II Clinical Trial Comparing Oxaliplatin (Eloxatin), Capecitabine (Xeloda) and Pre-Operative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision for the Treatment of Patients With Magnetic Resonance Imaging (MRI) Defined High Risk Rectal Cancer|Unknown status|Active, not recruiting|Phase 2|164|Anticipated|Royal Marsden NHS Foundation Trust|||||f||||t||||||||||2017-02-18 16:12:37.109944|2017-02-18 16:12:37.109944
NCT00383682|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2006-09-29|||July 1997||1997-07-01|September 2006|2006-09-01|April 2003||2003-04-01|||||Interventional|||Efficacy of Opioids and Mexiletine for the Treatment of Postamputation Pain|Randomized, Placebo-Controlled, Double-Blind Cross-Over Trial of Opioids Versus Mexiletine in the Treatment of Postamputation Pain|Completed||Phase 2|60||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 16:12:37.401741|2017-02-18 16:12:37.401741
NCT00383669|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2011-09-02|||November 2006||2006-11-01|September 2011|2011-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Trial of Vitamins and HAART in HIV Disease Progression|Trial of Vitamins in HIV Progression and Transmission (A Trial of Vitamins and HAART in HIV Disease Progression)|Completed||Phase 3|4012|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-02-18 16:12:37.502492|2017-02-18 16:12:37.502492
NCT00383656|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2014-07-31|||January 1989||1989-01-01|July 2014|2014-07-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Interventional|||Pulsatile GnRH in Anovulatory Infertility|Pulsatile GnRH in Anovulatory Infertility|Recruiting||Phase 2|270|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:12:37.637716|2017-02-18 16:12:37.637716
NCT00383643|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2011-07-06|||May 2006||2006-05-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.|Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group Study.|Completed||N/A|45|Actual|Stanford University||1|||f||||||||||||||2017-02-18 16:12:37.763789|2017-02-18 16:12:37.763789
NCT00383630|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2013-03-06|||August 2007||2007-08-01|March 2013|2013-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure|The Effect of Intramyocardial Injection of Immunoselected Bone Marrow Cells on Myocardial Function in LVAD Bridge to Transplant Patients|Terminated||Phase 2|1|Actual|Columbia University||3||Study has been terminated due to logistical barriers to cell processing and poor enrollment|f||||t||||||||||2017-02-18 16:12:37.864787|2017-02-18 16:12:37.864787
NCT00383617|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2013-02-12|||July 2004||2004-07-01|February 2013|2013-02-01||||April 2007|Actual|2007-04-01||Observational|||Referral Recommendations for Axial Spondyloarthritis|Performance of Referral Recommendations in Patients With Chronic Back Pain and Suspected Axial Spondyloarthritis|Completed||N/A|500|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 16:12:37.997547|2017-02-18 16:12:37.997547
NCT00383461|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2013-05-28|||April 2006||2006-04-01|May 2013|2013-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Computer-Based Stop Smoking Program in Assisting Doctors in Helping Adults Stop Smoking|Computerized EMR-Assisted Smoking Cessation (CEASCE)|Completed||N/A|4314|Anticipated|Brigham and Women's Hospital|||||f||||f||||||||||2017-02-18 16:12:38.088211|2017-02-18 16:12:38.088211
NCT00383448|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2015-04-22|||September 2006||2006-09-01|April 2015|2015-04-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||HSCT for High Risk Inherited Inborn Errors|Treatment of High Risk, Inherited Lysosomal And Peroxisomal Disorders by Reduced Intensity Hematopoietic Stem Cell Transplantation|Completed||Phase 2|39|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-02-18 16:12:38.197725|2017-02-18 16:12:38.197725
NCT00383435|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2015-09-02|2011-07-05||October 2006||2006-10-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)|A Randomized, 26-Week, Placebo-Controlled Efficacy and Safety Study With a 26-Week Long-Term Safety Extension, of High- and Medium-Dose Inhaled Mometasone Furoate/Formoterol Fixed-Dose Combination Formulation Compared With Formoterol and High-Dose Inhaled Mometasone Furoate Monotherapy in Subjects With Moderate to Severe COPD|Completed||Phase 3|1055|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 16:12:38.337239|2017-02-18 16:12:38.337239
NCT00383422|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2010-01-26||2009-06-10|October 2006||2006-10-01|January 2010|2010-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis|The Comparison of the Efficacy and Safety of Arzoxifene Versus Raloxifene in Postmenopausal Women With Osteoporosis|Completed||Phase 3|320|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:12:39.765433|2017-02-18 16:12:39.765433
NCT00383409|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2006-10-02|||March 2006||2006-03-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||Multivitamins do Not Improve Radiation Therapy Related Fatigue|Multivitamins do Not Improve Radiation Therapy Related Fatigue: Results of a Double-Blind Randomized Cross-Over Trial|Completed||Phase 2|40||Faculdade de Medicina do ABC|||||f||||||||||||||2017-02-18 16:12:39.892629|2017-02-18 16:12:39.892629
NCT00383370|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2011-04-20|||October 2006||2006-10-01|April 2011|2011-04-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD|A Trial to Assess the Safety and Tolerability of Repeated Doses of Intravitreal Administration of Two VEGF Trap Formulations in Subjects With Neovascular Age Related Macular Degeneration|Completed||Phase 1|20|Actual|Regeneron Pharmaceuticals||3|||f||||f||||||||||2017-02-18 16:12:40.161724|2017-02-18 16:12:40.161724
NCT00383357|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2007-09-19|||August 2004||2004-08-01|September 2007|2007-09-01||||||||Interventional|||Sleepiness and the Risk of Falling|Aging, Hypnotics, Sleep Inertia and the Risk of Falling|Completed||N/A|24|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 16:12:40.266324|2017-02-18 16:12:40.266324
NCT00383344|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2007-04-05|||September 2006||2006-09-01|October 2006|2006-10-01|May 2007||2007-05-01|||||Interventional|||Use of FDG PET/CT to Evaluate Crohn Disease|Phase II Study on the Role of the Positron Emission Tomography Combined With CT Scan for the Evaluation on Crohn Disease|Unknown status|Recruiting|Phase 2|30||Université de Sherbrooke|||||f||||||||||||||2017-02-18 16:12:40.366214|2017-02-18 16:12:40.366214
NCT00383331|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2009-05-28|2009-01-06||February 2007||2007-02-01|May 2009|2009-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer|A Phase II Study of ALIMTA® (Pemetrexed) and GEMZAR® (Gemcitabine) Every 14 Days Versus Pemetrexed and Gemcitabine Every 21 Days in Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|19|Actual|Eli Lilly and Company|Trial was stopped early due to low enrollment. Some secondary outcomes were not analyzed due to the low numbers.|2||Trial was stopped early due to low enrollment|f||||f||||||||||2017-02-18 16:12:40.463817|2017-02-18 16:12:40.463817
NCT00383318|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2008-01-24|||September 2006||2006-09-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia|Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia|Completed||N/A|450|Anticipated|Mednax Center for Research, Education and Quality|||||f||||||||||||||2017-02-18 16:12:41.297145|2017-02-18 16:12:41.297145
NCT00383305|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2006-09-29|||July 1999||1999-07-01|September 2006|2006-09-01|September 2003||2003-09-01|||||Interventional|||CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic Encephalopathy|Brain-Cooling for the Treatment of Perinatal Hypoxic-Ischemic Encephalopathy|Completed||N/A|235||Olympic Medical|||||||||||||||||||2017-02-18 16:12:41.386789|2017-02-18 16:12:41.386789
NCT00383292|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2015-08-21||2012-02-10|November 2006||2006-11-01|August 2015|2015-08-01|July 2015|Actual|2015-07-01|September 2011|Actual|2011-09-01||Interventional|||A Study of LY573636 in Treating Patients With Malignant Melanoma|A Phase 2 Study of LY573636 Administered as an Intravenous Infusion on Day 1 of a 28-Day Cycle as Second-Line Treatment in Patients With Unresectable or Metastatic Melanoma|Completed||Phase 2|132|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:12:41.50899|2017-02-18 16:12:41.50899
NCT00383279|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2017-01-17|||February 2006||2006-02-01|June 2013|2013-06-01||||February 2007|Actual|2007-02-01||Interventional|||Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer|Improving Employment Among Gynecologic Cancer Survivors|Completed||N/A|70|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 16:12:41.631684|2017-02-18 16:12:41.631684
NCT00383266|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2015-12-04|2015-10-20||October 2006||2006-10-01|December 2015|2015-12-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer|A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer|Terminated||Phase 2|9|Actual|Washington University School of Medicine|The study was terminated due to lack of participant accrual.|1||Low accrual|f||||t||||||||||2017-02-18 16:12:41.732483|2017-02-18 16:12:41.732483
NCT00383253|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2009-03-20|||October 2006||2006-10-01|March 2009|2009-03-01|March 2008|Actual|2008-03-01|||||Interventional|||Methods Study to Characterize Early Indicators of Weight Loss in People|A Randomized, Open-Label, Parallel Group, Fixed Energy Deficit Methodology Trial to Characterize Early Efficacy Biomarkers During Treatment of Obesity in Adult, Obese, Male Subjects.|Completed||N/A|57|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 16:12:42.288026|2017-02-18 16:12:42.288026
NCT00383240|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2015-10-09|2010-06-30||September 2006||2006-09-01|October 2015|2015-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)|A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects With Persistent Asthma Previously Treated With Medium-Dose Inhaled Glucocorticosteroids|Completed||Phase 3|781|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 16:12:42.403854|2017-02-18 16:12:42.403854
NCT00383227|ClinicalTrials.gov processed this data on February 17, 2017|2006-10-02|2016-09-15|||December 1999||1999-12-01|September 2016|2016-09-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years|A Phase III, Clinical Trial Comparing the Immunogenicity and Safety of SmithKline Beecham Biologicals New Adjuvanted Hepatitis B Vaccine to a Double Dose of Engerix™-B, in Pre-haemodialysis/Haemodialysis Patients (>=15 Years of Age)|Completed||Phase 3|165|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:12:43.300278|2017-02-18 16:12:43.300278
NCT00383214|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2012-06-06|||May 2005||2005-05-01|June 2012|2012-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)|A Phase III, Randomized, Double Blind, Placebo Controlled, Multi-Center Study of Epratuzumab in Patients With Active Systemic Lupus Erythematosus.|Terminated||Phase 3|54|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 16:12:43.399849|2017-02-18 16:12:43.399849
NCT00383201|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2012-08-15|||March 2005||2005-03-01|September 2006|2006-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Effect of Multi-Purpose Solutions on Ex-Vivo Wetting Angles|Long-Term Effect of Multi-Purpose Solutions on Ex-Vivo Wetting Angles of Soft Contact Lenses|Completed||N/A|80||Alcon Research|||||f||||||||||||||2017-02-18 16:12:43.55676|2017-02-18 16:12:43.55676
NCT00382824|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2015-08-04|||September 2006||2006-09-01|August 2015|2015-08-01|January 2015|Actual|2015-01-01|September 2013|Actual|2013-09-01||Interventional|||Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)|Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study|Completed||Phase 2/Phase 3|62|Actual|Lahey Clinic||1|||f||||f||||||||||2017-02-18 16:12:57.256237|2017-02-18 16:12:57.256237
NCT00383188|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2009-10-07||2009-04-06|December 2006||2006-12-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|||||Interventional|||An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis|A 12-Week, Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study To Investigate The Safety, Pharmacokinetics, And Efficacy Of PH-797804, Administered Orally Once Daily In Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|305|Actual|Pfizer||5|||f||||f||||||||||2017-02-18 16:12:43.643615|2017-02-18 16:12:43.643615
NCT00383175|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2011-02-17|||August 2006||2006-08-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Reading Fluency and Accommodative Lag|Reading Fluency and Accommodative Lag|Completed||N/A|72|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-02-18 16:12:43.830793|2017-02-18 16:12:43.830793
NCT00383162|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2016-12-02|2008-10-03||November 2006||2006-11-01|December 2016|2016-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)|A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)|Completed||Phase 3|173|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:12:44.088495|2017-02-18 16:12:44.088495
NCT00383149|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2016-02-09|2010-09-24||January 2007||2007-01-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer|A Phase II, Open Label Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer|Completed||Phase 2|58|Actual|R-Pharm|Study CA163-116 was completed; however, the combination tested in this trial failed to meet the primary objective to demonstrate a 6-month survival rate greater than 50% in participants with metastatic pancreatic cancer.|1|||f||||f||||||||||2017-02-18 16:12:44.798876|2017-02-18 16:12:44.798876
NCT00383136|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2008-01-11|||June 2003||2003-06-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|FATA||FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab|FATA: Comparison Between Tirofiban and Abciximab in Facilitated Angioplasty With Stent Implantation: Randomized Multicentre Study|Completed||Phase 4|692|Actual|University of Bologna||2|||f||||t||||||||||2017-02-18 16:12:45.573322|2017-02-18 16:12:45.573322
NCT00383123|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2016-11-03|2008-10-15||November 2006||2006-11-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children|A Phase III, Single-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix® (GSK Biologicals') Compared With Fluzone® (Aventis Pasteur/Sanofi) Administered Intramuscularly in Children (6 Months and Older)|Completed||Phase 3|3327|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:12:45.711165|2017-02-18 16:12:45.711165
NCT00383110|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2015-04-06|2014-08-04||November 2004||2004-11-01|June 2014|2014-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational||Participants were adults (age 18 or older) with type 2 diabetes. All participants completed questionnaire, however, discrepancies in number of participants analyzed for specific measures is due to some participants choosing not to answer all questions. All participants are included in baseline measure for age.|Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes|Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes|Completed||N/A|300|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 16:12:46.381647|2017-02-18 16:12:46.381647
NCT00383097|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2012-05-22|||September 2006||2006-09-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|ALDI||Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma|Administration of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes Following CD45 Antibody to Patients With Relapsed EBV-Positive Hodgkin's or Non-Hodgkin's Lymphoma or Chronic Active EBV Infection (ALDI)|Terminated||Phase 1|6|Actual|Baylor College of Medicine||1||The trial was terminated in 2010 due to lack of enrollment.|f||||t||||||||||2017-02-18 16:12:47.054174|2017-02-18 16:12:47.054174
NCT00383084|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2013-06-28|2013-01-29||September 2006||2006-09-01|June 2013|2013-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Lifestyle Physical Activity to Reduce Pain and Fatigue in Adults With Fibromyalgia|Lifestyle Physical Activity for Fibromyalgia|Completed||N/A|84|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:12:47.161759|2017-02-18 16:12:47.161759
NCT00383071|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2016-04-21|2012-04-26||August 2006||2006-08-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|March 2010|Actual|2010-03-01||Interventional||All subjects enrolled into the study|Development of Immune Globulin Treatment for Avian Flu|A Phase II Vaccine Dose Finding Pilot Study for Development of an Anti-Influenza A (H5N1) Intravenous Hyper-Immune Globulin|Terminated||Phase 2|126|Actual|National Institutes of Health Clinical Center (CC)||4||"Not possible to achieve original goal of sufficient volume of high titer plasma to~   manufacturer a high titer IVIG for human trials."|f||||t||||||||||2017-02-18 16:12:47.594065|2017-02-18 16:12:47.594065
NCT00383058|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2009-08-31|||September 2006||2006-09-01|August 2009|2009-08-01|June 2007|Actual|2007-06-01|||||Interventional|||The Extract of Green Tea on Obese Women: a Randomized Double Blindness Clinical Trial|The Extract of Green Tea on Obese Women: a Randomized Double Blindness Clinical Trial|Completed||Phase 3|100||Taipei City Hospital|||||f||||t||||||||||2017-02-18 16:12:48.734571|2017-02-18 16:12:48.734571
NCT00383045|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2009-02-23|||April 2003||2003-04-01|February 2009|2009-02-01|August 2007|Actual|2007-08-01|||||Interventional|||HIV Risk Reduction and Drug Abuse Treatment in Malaysia|HIV Risk Reduction and Drug Abuse Treatment in Malaysia|Completed||Phase 2|180||Yale University|||||f||||||||||||||2017-02-18 16:12:48.840573|2017-02-18 16:12:48.840573
NCT00383032|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2007-12-27|||January 2004||2004-01-01|December 2007|2007-12-01|June 2006||2006-06-01|||||Interventional|||Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction|Randomized Controlled Trial of Mifepristone Versus Laminaria for Cervical Ripening In Midtrimester Induction|Completed||N/A|72||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 16:12:48.93631|2017-02-18 16:12:48.93631
NCT00382629|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2008-02-07|||February 2006||2006-02-01|February 2008|2008-02-01|June 2007||2007-06-01|||||Interventional|||BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis|BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis|Completed||Phase 2|252||Bayhill Therapeutics|||||||||||||||||||2017-02-18 16:13:01.533906|2017-02-18 16:13:01.533906
NCT00383019|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2009-08-03|2008-10-01||November 2006||2006-11-01|August 2009|2009-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).|A 8-Week, Randomized, Double-Masked, Parallel Group, Phase III Study Comparing The Efficacy And Safety Of Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).|Completed||Phase 3|289|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:12:49.016914|2017-02-18 16:12:49.016914
NCT00383006|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2009-06-02|||May 2006||2006-05-01|June 2009|2009-06-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Affect Management Group for Adult Survivors of Childhood Trauma||Withdrawn||Phase 1|16|Anticipated|University of Zurich||1||Difficulties in finding enough study participants.|f||||f||||||||||2017-02-18 16:12:49.741911|2017-02-18 16:12:49.741911
NCT00382993|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2016-12-02|2008-11-14||December 2006||2006-12-01|December 2016|2016-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)|A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)|Completed||Phase 3|169|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:12:49.859652|2017-02-18 16:12:49.859652
NCT00382980|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2010-08-26|||October 2006||2006-10-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Clinical Trial of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Immunization With Inactivated, Vero Cell-Culture Derived Influenza A/H5N1 Vaccine Given Alone or With Aluminum Hydroxide to Healthy Young Adults|Completed||Phase 1|308|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-02-18 16:12:50.577536|2017-02-18 16:12:50.577536
NCT00382967|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2012-08-29|2012-05-14||October 2006||2006-10-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms|A Multicentre, Randomised, Open Label, Comparative Phase 4 Trial to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism in a General Neurologist Setting.|Completed||Phase 4|273|Actual|GE Healthcare||2|||f||||t||||||||||2017-02-18 16:12:50.718559|2017-02-18 16:12:50.718559
NCT00382954|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2010-09-28|||February 2004||2004-02-01|September 2010|2010-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML|A Phase I Study Using Bortezomib (Velcade, Formerly Known as PS-341) With Weekly Idarubicin for the Treatment of Elderly (>/= 60 Years) and Relapsed Patients With Acute Myelogenous Leukemia|Completed||Phase 1|55|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-02-18 16:12:51.306315|2017-02-18 16:12:51.306315
NCT00382941|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2008-12-05||||||December 2008|2008-12-01||||||||Interventional|||Study of LED Phototherapy for Musculoligamentous Lesions||Completed||N/A|||Hermano Miguel Foundation|||||f||||||||||||||2017-02-18 16:12:51.418961|2017-02-18 16:12:51.418961
NCT00382928|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2015-06-22|2013-12-12||October 2006||2006-10-01|June 2015|2015-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Automatic External Defibrillation Monitoring in Cardiac Arrest|Automatic External Defibrillation Monitoring in Cardiac Arrest|Completed||Phase 1|192|Actual|Atlanta Research and Education Foundation||2|||f||||t||||||||||2017-02-18 16:12:51.498802|2017-02-18 16:12:51.498802
NCT00382915|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2013-05-24|||October 2006||2006-10-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Observational|||Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder|Nicotine Intake in Smokers With Schizophrenia|Completed||N/A|276|Actual|Rutgers, The State University of New Jersey|||3||f||||f||||||Samples With DNA|"~     Whole blood for DNA extraction~   "|||2017-02-18 16:12:52.146482|2017-02-18 16:12:52.146482
NCT00382902|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2012-08-15|||August 2004||2004-08-01|September 2006|2006-09-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Silicone Hydrogel Soft Contact Lenses|Clinical Evaluation of the Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution Compared to Two Marketed Multi-Purpose Solutions for Care of Silicone Hydrogel Soft Contact Lenses|Completed||N/A|233||Alcon Research|||||f||||||||||||||2017-02-18 16:12:52.257207|2017-02-18 16:12:52.257207
NCT00382889|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2006-09-29|||August 2002||2002-08-01|September 2006|2006-09-01|September 2004||2004-09-01|||||Interventional|||As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma|Multinational, Double Blind, Randomised, Parallel Group Study on the Therapeutic Efficacy and Safety of Beclomethasone Dipropionate 250 mg Combined With Salbutamol 100 mg in the Treatment of Patients With Mild Persistent Asthma.|Completed||Phase 3|480||Chiesi Farmaceutici S.p.A.|||||f||||||||||||||2017-02-18 16:12:52.343693|2017-02-18 16:12:52.343693
NCT00382876|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2006-10-16|||September 2006||2006-09-01|September 2006|2006-09-01||||||||Observational|||Identifying the Relative Change in Ventilation in Newborns With Placement in Car Bed or Car Seat|Identifying the Relative Change in Ventilation With Changes in Infant Sleeping Position|Unknown status|Recruiting|N/A|200||University Medical Centre Ljubljana|||||f||||||||||||||2017-02-18 16:12:52.459062|2017-02-18 16:12:52.459062
NCT00382863|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2012-06-07|2011-05-13||October 2006||2006-10-01|June 2012|2012-06-01|May 2012|Actual|2012-05-01|May 2011|Actual|2011-05-01||Interventional|PEERLESS-HF||Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) Trial|Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) Trial|Terminated||Phase 2/Phase 3|220|Actual|Paracor Medical, Inc|An interim analysis indicated trial futility based on a primary endpoint. Enrollment was suspended in July, 2009. Study was terminated as of April, 2011 due to insufficient resources.|2||Resources unavailable to continue study follow-up.|f||||t||||||||||2017-02-18 16:12:52.665978|2017-02-18 16:12:52.665978
NCT00382850|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2007-04-04|||November 2005||2005-11-01|April 2007|2007-04-01|November 2010|Anticipated|2010-11-01|||||Interventional|||Clinical Trial Comparing Open and Laparoscopic Nissen Fundoplication in Children|Randomized Controlled Trial of Laparoscopic Compared to Open Nissen Fundoplication in Children Younger Than 2 Years of Age|Unknown status|Recruiting|N/A|68||Johns Hopkins University|||||f||||t||||||||||2017-02-18 16:12:54.334624|2017-02-18 16:12:54.334624
NCT00382811|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2016-07-13||2016-07-12|October 2006||2006-10-01|July 2016|2016-07-01|April 2011|Actual|2011-04-01|April 2009|Actual|2009-04-01||Interventional|OVATURE||OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer|Multi-Center, Randomized, Double-Blind, Phase III Efficacy Study Comparing Phenoxodiol in Combination With Carboplatin Versus Carboplatin With Placebo in Patients With Platinum-Resistant or Platinum-Refractory Late-Stage Epithelial Ovarian, Fallopian or Primary Peritoneal Cancer Following at Least Second Line Platinum Therapy|Completed||Phase 3|142|Actual|MEI Pharma, Inc.||2|||f||||||||||||||2017-02-18 16:12:57.363817|2017-02-18 16:12:57.363817
NCT00382798|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2009-04-23|||October 2006||2006-10-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|R7128||Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin|A Multiple-Center, Observer-Blinded, Randomized, Placebo-Controlled, Single & Multiple Ascending Dose Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, & Food Effect of RO5024048 in Healthy Volunteers & in Patients With Chronic HCV Infection|Completed||Phase 1/Phase 2|75|Anticipated|Pharmasset||13|||f||||t||||||||||2017-02-18 16:12:57.541492|2017-02-18 16:12:57.541492
NCT00382785|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2010-11-23|2010-09-29||September 2006||2006-09-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Psychosocial Outcomes in Online Cancer Support Groups|Psychosocial Outcomes in Online Cancer Support Groups|Completed||N/A|51|Actual|Christiana Care Health Services|One limitation was the lack of a control group of women who did not take part in an online or face-to-face support group. The reasons for this are explained above.|2|||f||||f||||||||||2017-02-18 16:12:57.884659|2017-02-18 16:12:57.884659
NCT00382772|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2016-11-03|||November 2006||2006-11-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).|Study to Evaluate Clinical Consistency of the Liquid Formulation of GSK Biologicals' HRV Vaccine and to Evaluate Liquid Formulation Compared to Lyophilised Formulation of the HRV Vaccine Administered as a Two-dose Primary Vaccination.|Completed||Phase 3|1200||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:12:58.295719|2017-02-18 16:12:58.295719
NCT00382759|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-29|2009-07-31|||March 2000||2000-03-01|July 2009|2009-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Nonmyeloablative Stem Cell Transplant in Elderly|Nonmyeloablative Allogeneic Stem Cell Transplantation in Elderly Patients With Hematological Malignancies:Results From the GITMO (Gruppo Italiano Trapianto Midollo Osseo)Multicenter Prospective Clinical Trial|Completed||Phase 2/Phase 3|50|Actual|Azienda Ospedaliera San Giovanni Battista||1|||f||||f||||||||||2017-02-18 16:12:58.40758|2017-02-18 16:12:58.40758
NCT00382746|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2016-07-17|||October 2006||2006-10-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Observational|||EarlySense Monitoring Device Evaluation on CHF Patients|EarlySense Monitoring Device Evaluation on CHF Patients|Withdrawn||N/A|0|Actual|EarlySense Ltd.|||1|No need|f||||||||||||||2017-02-18 16:12:58.489784|2017-02-18 16:12:58.489784
NCT00382733|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2013-07-17|2013-05-10||November 2006||2006-11-01|July 2013|2013-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Oral Topotecan to Treat Recurrent or Persistent Solid Tumors|Oral Topotecan, Utilization for a Metronomic Dosing Schedule to Treat Recurrent or Persistent Solid Tumors|Completed||Phase 1/Phase 2|26|Actual|Accelerated Community Oncology Research Network||1|||f||||f||||||||||2017-02-18 16:12:58.598264|2017-02-18 16:12:58.598264
NCT00382720|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2012-12-19|2011-04-29||September 2006||2006-09-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Docetaxel and Oxaliplatin in Gastric Cancer|A Randomized Phase II Study of Docetaxel in Combination With Oxaliplatin With or Without 5-FU or Capecitabine in Metastatic or Locally Recurrent Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease|Completed||Phase 2|275|Actual|Sanofi||3|||f||||||||||||||2017-02-18 16:12:59.512029|2017-02-18 16:12:59.512029
NCT00382707|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2011-08-29|||May 2006||2006-05-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Interventional|||Transcranial Magnetic Stimulation and Anti-epileptic Effect: Optimization and Evaluation With Electrophysiology.|Transcranial Magnetic Stimulation and Anti-epileptic Effect: Optimization and Evaluation With Electrophysiology.|Completed||N/A|15|Anticipated|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 16:13:00.928331|2017-02-18 16:13:00.928331
NCT00382694|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2006-09-28|||May 2005||2005-05-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients|Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients: A Randomised, Placebo Controlled, Double Blind Phase II Trial: NMSG #13/03|Unknown status|Active, not recruiting|Phase 2|80||Nordic Myeloma Study Group|||||f||||||||||||||2017-02-18 16:13:01.019119|2017-02-18 16:13:01.019119
NCT00382681|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2012-02-01|||July 2004||2004-07-01|February 2012|2012-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Evaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact Lenses|Clinical Evaluation of the Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution Compared to a Marketed Multi-Purpose Solution for Care of Soft Contact Lenses|Completed||N/A|252|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 16:13:01.117645|2017-02-18 16:13:01.117645
NCT00382668|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2011-04-13|||October 2006||2006-10-01|April 2011|2011-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug|Single-Dose Pharmacokinetics of Dasatinib in Subjects With Hepatic Impairment Compared to Healthy Adult Subjects|Completed||N/A|40|Anticipated|Bristol-Myers Squibb|||3||f||||f||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 16:13:01.224133|2017-02-18 16:13:01.224133
NCT00382655|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2006-09-27|||February 2003||2003-02-01|September 2006|2006-09-01|August 2005||2005-08-01|||||Interventional|||Prehospital Screening to Prevent Injury and Illness|Prehospital Screening to Prevent Injury and Illness|Completed||N/A|700||University of Rochester|||||f||||||||||||||2017-02-18 16:13:01.335423|2017-02-18 16:13:01.335423
NCT00382642|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2012-02-03|||June 2006||2006-06-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|||Pharmacological Treatment for Alcoholism|Pharmacological Treatment for Alcoholism|Completed||Phase 3|283|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 16:13:01.419224|2017-02-18 16:13:01.419224
NCT00382616|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2006-11-06|||July 2004||2004-07-01|September 2006|2006-09-01|January 2005||2005-01-01|||||Interventional|||Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD|Studying the Effects of Phosphatidylserine Enriched With Omega-3 Fatty Acids on Symptoms of Attention-Deficit/Hyperactivity Disorder in Children|Completed||Phase 2|90||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 16:13:01.625587|2017-02-18 16:13:01.625587
NCT00382603|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2012-08-15|||August 2004||2004-08-01|September 2006|2006-09-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic Patients|Clinical Evaluation of the Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution Compared to a Marketed Multi-Purpose Solution for Care of Soft Contact Lenses in Symptomatic Patients|Completed||N/A|362||Alcon Research|||||f||||||||||||||2017-02-18 16:13:01.73053|2017-02-18 16:13:01.73053
NCT00382590|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2012-08-01|2009-08-13||August 2005||2005-08-01|August 2012|2012-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients|A Randomized Phase II Study of the Combination of 5-Azacytidine With Valproic Acid (VPA) Versus Low-Dose Ara-C in Patients With AML/MDS Not Eligible for Other Studies|Completed||Phase 2|11|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:13:01.846646|2017-02-18 16:13:01.846646
NCT00382577|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2017-02-07|||October 2006||2006-10-01|February 2017|2017-02-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy and Safety of Itopride vs Placebo in Heartburn|A Randomized, Double-blind, Two Period, Crossover Study to Evaluate the Effects of a Single Dose of Itopride 200 mg on Esophageal and Gastric pH and Reflux in Patients With Heartburn|Completed||Phase 3|48|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 16:13:02.243188|2017-02-18 16:13:02.243188
NCT00382564|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2017-01-24|||September 25, 2006||2006-09-25|May 1, 2012|2012-05-01|May 1, 2012||2012-05-01|||||Observational|||Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease|Magnetic Resonance Angiography (MRA) in the Diagnosis of Atherosclerotic Disease Using High Field (3T) MRI Scanners: A Pilot Technical Development Study|Completed||N/A|216|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:13:02.322005|2017-02-18 16:13:02.322005
NCT00382551|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2009-01-29|||October 2006||2006-10-01|January 2009|2009-01-01||||||||Interventional|||The Effect of Beer, Red Wine and Fruit Juice on Blood Vessel Function in Persons With Cardiovascular Disease|The Effect of Alcohol and Polyphenolic Compounds on Endothelial Function|Completed||Early Phase 1|49|Actual|Aalborg Universitetshospital|||||f||||||||||||||2017-02-18 16:13:02.403837|2017-02-18 16:13:02.403837
NCT00382538|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2008-10-03|||March 2005||2005-03-01|October 2008|2008-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Mifepristone and Mid-Trimester Termination of Pregnancy|A Randomized, Placebo-Controlled, Double-Blinded Study of Mifepristone in Midtrimester Termination of Pregnancy|Completed||N/A|64||Boston University|||||f||||||||||||||2017-02-18 16:13:02.489975|2017-02-18 16:13:02.489975
NCT00382525|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2013-04-08|||January 2005||2005-01-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|October 2012|Actual|2012-10-01||Observational|||PANORAMA Observational Study|Phase IV Long Term Observational Study of Patients Implanted With Medtronic CRDM Implantable Cardiac Devices|Completed||Phase 4|8586|Actual|Medtronic Bakken Research Center|||1||f||||f||||||||||2017-02-18 16:13:02.812585|2017-02-18 16:13:02.812585
NCT00382512|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2006-09-27|||May 2003||2003-05-01|September 2006|2006-09-01||||||||Interventional|||A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis|A Randomized, Placebo-Controlled, Single-Blind, Parallel-Group Study to Evaluate the Effects of 12 Weekly Subcutaneous Doses of 1.0 mg/kg Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis|Completed||Phase 1|60||Genentech, Inc.|||||||||||||||||||2017-02-18 16:13:02.937605|2017-02-18 16:13:02.937605
NCT00382499|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2009-09-09|||November 2006||2006-11-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Intraoperative Lidocaine Infusion for Analgesia (ILIA)|A Prospective Evaluation of the Addition of Intraoperative Intravenous Lidocaine Infusion to General Anesthetic in Total Abdominal Hysterectomy.|Completed||N/A|93|Actual|University of Ottawa||1|||f||||f||||||||||2017-02-18 16:13:03.02179|2017-02-18 16:13:03.02179
NCT00382486|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2007-12-13|||July 2001||2001-07-01|December 2007|2007-12-01|September 2003|Actual|2003-09-01|||||Observational|||Low Dose Irradiation for Small Bowel Transplant|Low Dose Ex-Vivo X-Irradiation of the Allograft and Simultaneous Bone Marrow Cell Infusion to Enhance Intestinal/Multivisceral Allograft Survival|Completed||N/A|100||University of Pittsburgh|||||f||||||||||||||2017-02-18 16:13:03.130719|2017-02-18 16:13:03.130719
NCT00382473|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2014-04-24|||September 2006||2006-09-01|April 2014|2014-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise|Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise|Terminated||N/A|29|Actual|University of Pittsburgh||1||lack of funding|f||||f||||||||||2017-02-18 16:13:03.222722|2017-02-18 16:13:03.222722
NCT00382460|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2011-04-07||2010-02-15|November 2000||2000-11-01|April 2011|2011-04-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)|Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)|Completed||Phase 4|4000||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:13:03.334689|2017-02-18 16:13:03.334689
NCT00382447|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2012-12-12|||October 2006||2006-10-01|December 2012|2012-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Breath Actuated Nebulizer Study Protocol|Breath Actuated Nebulizer Study Protocol|Withdrawn||N/A|0|Actual|Christiana Care Health Services||1||Unable to put forth the human resources for patient enrollment|f||||t||||||||||2017-02-18 16:13:03.412206|2017-02-18 16:13:03.412206
NCT00382434|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2010-01-13|||August 2005||2005-08-01|January 2010|2010-01-01|December 2006|Actual|2006-12-01|||||Observational|||Emergency Pharmacist Safety Study|The ED Pharmacist as a Safety Measure in Emergency Medicine|Completed||N/A|10224|Actual|University of Rochester|||1||f||||f||||||||||2017-02-18 16:13:03.521434|2017-02-18 16:13:03.521434
NCT00382421|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2006-10-10|||February 1992||1992-02-01|October 2006|2006-10-01|April 2006||2006-04-01|||||Interventional|||Study to Investigate Effects of Antiischemic Drug Therapy in Silent Ischemia|Swiss Interventional Study on Silent Ischemia (SWISSI 1)|Completed||N/A|||Luzerner Kantonsspital|||||f||||||||||||||2017-02-18 16:13:03.617571|2017-02-18 16:13:03.617571
NCT00005749|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-11|||July 1996||1996-07-01|August 2004|2004-08-01|December 2002||2002-12-01|||||Observational|||Project Andale--Increasing Exercise in Hispanic Women||Completed||N/A|||San Diego State University|||||f||||||||||||||2017-02-18 18:14:24.431722|2017-02-18 18:14:24.431722
NCT00382408|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2012-04-24|2011-07-28||September 2006||2006-09-01|April 2012|2012-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001|Completed||Phase 3|4041|Actual|Teva Pharmaceutical Industries|In the past 6 years, Type-7 ADV has only rarely been recovered from recruits with ARD (Russell 2007). Therefore, it may not be possible to directly measure the protective effect of the vaccine against Type-7 ADV in the proposed study.|2|||f||||t||||||||||2017-02-18 16:13:03.748834|2017-02-18 16:13:03.748834
NCT00382395|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2015-09-17|||November 2005||2005-11-01|September 2015|2015-09-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma|Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments|Suspended||Phase 3|180|Anticipated|SOLX, Inc.||2|||f||||f||||||||||2017-02-18 16:13:04.252655|2017-02-18 16:13:04.252655
NCT00382382|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2015-03-12|||July 2008||2008-07-01|March 2015|2015-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Diffusion Tensor Imaging in Autism|Diffusion Tensor Imaging in Autism|Withdrawn||N/A|0|Actual|University of Florida||2||"Study was completed but there were no participants. It was completed as a theoretical study.~   Requests for final progress report can be sent to Dr. Liu."|f||||f||||||||||2017-02-18 16:13:04.373698|2017-02-18 16:13:04.373698
NCT00382369|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2008-05-12|||May 2005||2005-05-01|November 2007|2007-11-01|December 2007|Anticipated|2007-12-01|||||Observational|||Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis|Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis|Unknown status|Recruiting|N/A|60|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"~     DNA prepared from blood~   "|||2017-02-18 16:13:04.483899|2017-02-18 16:13:04.483899
NCT00382356|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2012-10-18|||November 2004||2004-11-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)|A Pilot Investigation of Dutasteride (Avodart) After Failure of Finasteride (Proscar) In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)|Completed||N/A|20|Actual|North Florida/South Georgia Veterans Health System||1|||f||||t||||||||||2017-02-18 16:13:04.577782|2017-02-18 16:13:04.577782
NCT00382343|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2015-04-27|||November 1999||1999-11-01|April 2015|2015-04-01|March 2007|Actual|2007-03-01|March 2003|Actual|2003-03-01||Interventional|||A Randomized Controlled Trial on Antibiotic Prophylaxis in Children With Vesico-Ureteral Reflux|Antibiotic Prophylaxis After Acute Pyelonephritis for Prevention of Urinary Tract Infections in Children With Vesico-Ureteral Reflux.|Completed||Phase 4|96|Actual|IRCCS Burlo Garofolo||2|||f||||f||||||||||2017-02-18 16:13:04.686805|2017-02-18 16:13:04.686805
NCT00382330|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2013-09-05||||||April 2013|2013-04-01||||||||Interventional|||Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.|Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.|Withdrawn||N/A|0|Actual|Rutgers, The State University of New Jersey|||||f||||||||||||||2017-02-18 16:13:04.801379|2017-02-18 16:13:04.801379
NCT00382317|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2008-11-25|||August 2006||2006-08-01|November 2008|2008-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal Angiography|A Clinical Study of Iobitridol in Multislice CT Abdominal Angiography Indications|Completed||Phase 4|||Guerbet|||||f||||f||||||||||2017-02-18 16:13:04.889655|2017-02-18 16:13:04.889655
NCT00382304|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2015-03-17|||September 2006||2006-09-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea|A Study of the Pharmacokinetics of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea|Completed||Phase 2|24|Anticipated|Sanofi|||||||||||||||||||2017-02-18 16:13:04.962244|2017-02-18 16:13:04.962244
NCT00382291|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2013-02-06|2012-12-14||February 2009||2009-02-01|December 2012|2012-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder|SSRI-Induced Activation Syndrome in Pediatric Obsessive Compulsive Disorder|Completed||Phase 4|56|Actual|University of Florida|Temporary study suspension led to smaller number of subjects enrolled than initially planned and resulted in smaller number of subjects analyzed, reducing power.|3|||f||||t||||||||||2017-02-18 16:13:05.05685|2017-02-18 16:13:05.05685
NCT00382278|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2008-04-02|||November 2005||2005-11-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Safety Study of Autologous Stem Cell in Liver Cirrhosis|Phase 1/2 Study of Autologous Bone Marrow Derived Mononuclear Cells in Liver Cirrhosis|Terminated||Phase 1/Phase 2|15|Anticipated|Universidade Federal do Rio de Janeiro||1||"Other authors showed the same metabolic effect may be obtained when BMMC are delivered~   peripherally, with lower risk and cost than through hepatic artery."|f||||t||||||||||2017-02-18 16:13:05.547582|2017-02-18 16:13:05.547582
NCT00382265|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-28|2017-01-10|||January 2008||2008-01-01|January 2017|2017-01-01||||January 2017|Anticipated|2017-01-01||Interventional|STONE||Tamsulosin for Urolithiasis in the Emergency Dept|Study of Tamsulosin for Urolithiasis in the Emergency Department|Active, not recruiting||Phase 4|500|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 16:13:05.64979|2017-02-18 16:13:05.64979
NCT00382252|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2011-05-12|||September 2005||2005-09-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases|Study of Positron Emission Tomography/CT Scan for Response Evaluation After Radiofrequency Ablation in Patients With Lung Metastases|Completed||N/A|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:13:05.7611|2017-02-18 16:13:05.7611
NCT00382239|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2015-02-20|||September 2006||2006-09-01|January 2015|2015-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes|A Dose Response Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s) But Not Well Controlled|Completed||Phase 2|153|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 16:13:05.857519|2017-02-18 16:13:05.857519
NCT00382226|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2016-11-17|||September 2006||2006-09-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy|IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy|Completed||Phase 4|195|Anticipated|Alcon Research|||||f||||||||||||||2017-02-18 16:13:06.233002|2017-02-18 16:13:06.233002
NCT00382213|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2006-09-27|||June 2000||2000-06-01|September 2006|2006-09-01|December 2004||2004-12-01|||||Interventional|||A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis|A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis|Completed||Phase 3|210||Daiichi Sankyo Inc.|||||||||||||||||||2017-02-18 16:13:06.33197|2017-02-18 16:13:06.33197
NCT00382200|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-08-02|||July 2006||2006-07-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes|Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients With Myelodysplastic Syndromes|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:13:06.411656|2017-02-18 16:13:06.411656
NCT00382187|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2016-11-30|||November 2006||2006-11-01|February 2012|2012-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults|A Phase II, Randomized, Controlled, Observer-blind, Single-Center Study to Evaluate Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, and a Six Month Booster Dose of Two Surface Antigen Adjuvanted With MF59C.1 Influenza Vaccines Containing 7.5 Micrograms or 15 Micrograms of A/H5N1 Influenza Antigen and of a Non-adjuvanted Influenza Vaccine Containing 15 Micrograms of A/H5N1 Influenza Antigen, in Adults|Completed||Phase 2|40|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:13:06.530335|2017-02-18 16:13:06.530335
NCT00382174|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2010-01-06|2009-12-29||May 2006||2006-05-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Thymosin Beta 4 in Patients With Pressure Ulcers|A Randomized, Double-Blind, Placebo-Controlled, Dose Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Pressure Ulcers|Completed||Phase 2|72|Actual|RegeneRx Biopharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 16:13:06.646991|2017-02-18 16:13:06.646991
NCT00382161|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2009-02-12|||October 2006||2006-10-01|February 2009|2009-02-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors|Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction|Withdrawn||Phase 3|20|Anticipated|University Hospital, Saarland||||not enough patients meeting inclusion criteria|f||||t||||||||||2017-02-18 16:13:07.388114|2017-02-18 16:13:07.388114
NCT00382148|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2009-11-12|2009-11-05||November 2006||2006-11-01|November 2009|2009-11-01||||June 2008|Actual|2008-06-01||Interventional|||A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g|A Phase IIb, Open-Label Study of Xolair (Omalizumab) in Peanut-Allergic Subjects Randomized to Study Drug in Study Q2788g (TOPS)|Completed||Phase 2|10|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 16:13:07.500406|2017-02-18 16:13:07.500406
NCT00382135|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2007-10-23|||November 2003||2003-11-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg|An Evaluation of Semen Characteristics After 40 Weeks Daily Dosing With 20 mg Tadalafil|Completed||Phase 4|282|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 16:13:08.032389|2017-02-18 16:13:08.032389
NCT00382122|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2012-05-25|||September 2006||2006-09-01|September 2007|2007-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Prevalence of Ocular Surface Disease in Glaucoma Patients|Prevalence of Ocular Surface Disease in Glaucoma Patients|Completed||Phase 4|101|Actual|Alcon Research|||1||f||||||||||||||2017-02-18 16:13:08.15218|2017-02-18 16:13:08.15218
NCT00382109|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-12-16|2015-10-06||March 2007||2007-03-01|September 2016|2016-09-01||||May 2011|Actual|2011-05-01||Interventional|||Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission|A Randomized Trial of Sirolimus-Based Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplantation in Relapsed Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 3|146|Actual|Children's Oncology Group|Outcome Measures 6, 7, 8 and 9 are exploring in nature and did not investigate the actual relapse rates of the 2 treatment regiments.|2|||f||||t||||||||||2017-02-18 16:13:08.24149|2017-02-18 16:13:08.24149
NCT00382096|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2013-01-02||2013-01-02|September 2006||2006-09-01|January 2013|2013-01-01||||June 2008|Actual|2008-06-01||Interventional|||Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes|A Randomized, Double-blind, Active-controlled, Multicenter Study to Compare the Effect of 24 Weeks Treatment With a Fixed Combination Therapy of Vildagliptin and Metformin to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|1179|Actual|Novartis||4|||f||||||||||||||2017-02-18 16:13:09.125611|2017-02-18 16:13:09.125611
NCT00382083|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2006-09-27|||March 2006||2006-03-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Premedication to Reduce Discomfort With Screening Mammography||Completed||Phase 4|||Mountain States Tumor and Medical Research Institute|||||f||||||||||||||2017-02-18 16:13:09.233935|2017-02-18 16:13:09.233935
NCT00382070|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-02-05|||August 2006||2006-08-01|February 2016|2016-02-01|October 2018|Anticipated|2018-10-01|January 2016|Actual|2016-01-01||Interventional|||Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer|A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer|Active, not recruiting||Phase 3|3966|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 16:13:09.349824|2017-02-18 16:13:09.349824
NCT00382057|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2008-12-04|||May 2006||2006-05-01|November 2008|2008-11-01|March 2011|Anticipated|2011-03-01|||||Interventional|||Testosterone Effects on Men With the Metabolic Syndrome|Effect of Increasing Testosterone Levels on Insulin Sensitivity in Men With the Metabolic Syndrome|Withdrawn||Phase 2|72|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-02-18 16:13:10.842974|2017-02-18 16:13:10.842974
NCT00382044|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2008-05-22|||September 2006||2006-09-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Observational|||Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients|Audit of the Effect of Changing From IV to SC Administration of Erythropoiesis Stimulating Agents in Haemodialysis Patients - Real Life Clinical Experience|Completed||N/A|150|Anticipated|Sir Charles Gairdner Hospital|||2||f||||f||||||||||2017-02-18 16:13:10.932044|2017-02-18 16:13:10.932044
NCT00382031|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2013-08-09|2013-05-28||November 2006||2006-11-01|August 2013|2013-08-01|August 2011|Actual|2011-08-01|December 2009|Actual|2009-12-01||Interventional||The full analysis set (FAS) was based on the intent-to-treat principle and thus comprised all randomized patients. The FAS was used for evaluation of all efficacy endpoints and was the primary analysis population.|Zalutumumab in Patients With Non-curable Head and Neck Cancer|An Open-Labeled Randomized Parallel Group Trial of Zalutumumab, a Human Monoclonal Anti-EGFr Antibody, in Combination With Best Supportive Care (BSC) vs BSC, in Pts With Non-Curable SCCHN Who Have Failed Standard Platinum-Based Chemotherapy|Completed||Phase 3|286|Actual|Genmab||2|||f||||t||||||||||2017-02-18 16:13:11.034347|2017-02-18 16:13:11.034347
NCT00382018|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-08-02|||October 2006||2006-10-01|August 2016|2016-08-01|May 2017|Anticipated|2017-05-01|December 2015|Actual|2015-12-01||Interventional|||S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy|A Randomized Phase III Trial to Test the Strategy of Changing Therapy Versus Maintaining Therapy for Metastatic Breast Cancer Patients Who Have Elevated Circulating Tumor Cell Levels at First Follow-Up Assessment|Active, not recruiting||Phase 3|651|Anticipated|Southwest Oncology Group||4|||f||||t||||||||||2017-02-18 16:13:12.107979|2017-02-18 16:13:12.107979
NCT00381992|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2014-12-08|||September 2005||2005-09-01|December 2014|2014-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Risk Assessment of Long-Haul Truck Drivers|Risk Assessment of Long-Haul Truck Drivers|Completed||N/A|294|Actual|Wake Forest University Health Sciences|||1||f||||f||||||||||2017-02-18 16:13:12.541858|2017-02-18 16:13:12.541858
NCT00381979|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2015-10-21|||January 2004||2004-01-01|September 2015|2015-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Supportive Expressive Therapy for Depressed and Anxious Adolescents|Supportive Expressive Therapy for Depressed and Anxious Adolescents|Completed||N/A|20|Actual|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-02-18 16:13:12.652423|2017-02-18 16:13:12.652423
NCT00381966|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2012-11-15|||June 2006||2006-06-01|November 2012|2012-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|J0511||Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate Brachytherapy|A Pilot Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate Brachytherapy|Completed||N/A|5|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:13:12.763372|2017-02-18 16:13:12.763372
NCT00381953|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2015-03-12|||February 2003||2003-02-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|April 2006|Actual|2006-04-01||Interventional|||High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV|A Comparative Study of High-dose Interferon Alfa-2a and Pegylated Interferon Alfa-2a for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV|Completed||Phase 3|33|Actual|Foundation for Liver Research||3|||f||||f||||||||||2017-02-18 16:13:12.859681|2017-02-18 16:13:12.859681
NCT00381940|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2014-06-18|2014-01-08||January 2007||2007-01-01|June 2014|2014-06-01||||June 2008|Actual|2008-06-01||Interventional|||Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy|A Phase II Study of Bortezomib (Velcade, PS-341) in Combination With Ifosfamide/Vinorelbine in Pediatric Patients and Young Adults With Refractory/Recurrent Hodgkin Disease|Completed||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:13:12.95941|2017-02-18 16:13:12.95941
NCT00381927|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2007-09-19|||August 2003||2003-08-01|September 2006|2006-09-01|April 2006||2006-04-01|||||Observational|||Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer Development|Effect of Counseling on Psychological Stress Amongst Women Felt to be at High Risk for Breast Cancer Development|Completed||N/A|80||Baystate Medical Center|||||f||||||||||||||2017-02-18 16:13:13.330776|2017-02-18 16:13:13.330776
NCT00381914|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2012-03-01|||March 2007||2007-03-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Interventional|||Vitamin D Dose-Response Study to Establish Dietary Requirements in Infants|Vitamin D Dose-Response Study to Establish Dietary Requirements in Infants|Completed||Phase 2|132|Actual|McGill University||3|||f||||f||||||||||2017-02-18 16:13:13.429255|2017-02-18 16:13:13.429255
NCT00381901|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2011-05-12|||May 2006||2006-05-01|July 2009|2009-07-01||||May 2011|Actual|2011-05-01||Interventional|||Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery|Protocol of Herceptin Adjuvant With Reduced Exposure, a Randomised Comparison of 6 Months vs 12 Months in All Women Receiving Adjuvant Herceptin [PHARE]|Completed||Phase 3|3400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:13:13.541541|2017-02-18 16:13:13.541541
NCT00381888|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2012-11-06|2009-10-29||January 2007||2007-01-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer|Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial|Completed||Phase 2|44|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:13:13.831598|2017-02-18 16:13:13.831598
NCT00381875|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2012-05-01|||July 2006||2006-07-01|May 2012|2012-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV|A Pilot Study to Investigate the Safety and Immunogenicity of a Peptide Vaccine for HIV Infected HLA-A2 Individuals Designed to Impede the Development of Antiretroviral Resistance|Completed||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 16:13:14.122939|2017-02-18 16:13:14.122939
NCT00381862|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-02-09|2011-06-10||June 2006||2006-06-01|February 2016|2016-02-01|July 2008|Actual|2008-07-01|March 2008|Actual|2008-03-01||Interventional|||Phase II Trial Evaluating the Efficacy and Tolerability of Aprepitant & Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting|A Multi-Center, Open-Label Trial to Evaluate the Efficacy and Tolerability of Aprepitant and Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Colorectal Cancer (CRC) Patients Receiving FOLFOX or FOLFIRI Chemotherapy|Completed||Phase 2|54|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 16:13:14.219633|2017-02-18 16:13:14.219633
NCT00381849|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2016-01-04|2011-04-12||April 2006||2006-04-01|January 2016|2016-01-01|June 2010|Actual|2010-06-01|September 2009|Actual|2009-09-01||Interventional|||Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones|Cystone for Treatment of Nephrolithiasis|Completed||Phase 1/Phase 2|20|Actual|Mayo Clinic|There were no serious adverse events and no adverse events. Power of the study was diminished by failure of patients to return all required 24 hour urine samples. The botanical authenticity of Cystone was not documented.|3|||f||||f||||||||||2017-02-18 16:13:14.686308|2017-02-18 16:13:14.686308
NCT00381836|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2015-12-03|||October 2006||2006-10-01|February 2008|2008-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer|A Randomized, Multi-center Study to Assess the Effect of Darbepoetin Alfa (Aranesp®) for the Treatment of Anemia in Patients With Advanced Hormone Independent Prostate Cancer and Anaemia|Terminated||Phase 2/Phase 3|140|Anticipated|University of Aarhus||||Terminated by sponsor due to general risk that aranesp caused tumor progression|f||||f||||||||||2017-02-18 16:13:15.314772|2017-02-18 16:13:15.314772
NCT00381823|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2006-09-28|||July 2001||2001-07-01|September 2006|2006-09-01|August 2004||2004-08-01|||||Interventional|||Healthy Outcomes of Pregnancy Education|Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)|Unknown status|Active, not recruiting|Phase 2|1750||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 16:13:15.433097|2017-02-18 16:13:15.433097
NCT00381810|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2015-03-24|2009-11-11||June 2006||2006-06-01|March 2015|2015-03-01|February 2012|Actual|2012-02-01|July 2008|Actual|2008-07-01||Interventional|VOYAGER||A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus|An Open-label, Single-arm, Multicenter Phase II/III Extension Study to Evaluate the Safety of Rituximab Re-treatment in Subjects With Moderate to Severe Systemic Lupus Erythematosus Previously Enrolled in Protocol U2971g|Terminated||Phase 2/Phase 3|31|Actual|Genentech, Inc.|Since study U2971g did not demonstrate efficacy, a decision was made not to evaluate efficacy in this study and only safety results were evaluated.|1||"During a safety review of studies U2970g and U2971g, the Data Monitoring Committee recommended~   that enrollment in this extension trial be terminated."|f||||||||||||||2017-02-18 16:13:15.537278|2017-02-18 16:13:15.537278
NCT00381797|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-12-07|2012-01-17||August 2006||2006-08-01|December 2016|2016-12-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma|Phase II Study of Bevacizumab Plus Irinotecan (Camptosar™) in Children With Recurrent, Progressive, or Refractory Malignant Gliomas, Diffuse/Intrinsic Brain Stem Gliomas, Medulloblastomas, Ependymomas and Low Grade Gliomas|Completed||Phase 2|140|Actual|National Cancer Institute (NCI)|Neuroimaging data capturing Volume Enhancing and Perfusion Ratio was so limited to run any statistical model. Similarly, due to limited data, some PK and Biology objectives were not able to be addressed.|1|||f||||t||||||||||2017-02-18 16:13:15.858158|2017-02-18 16:13:15.858158
NCT00381784|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-03-01|||July 2006||2006-07-01|March 2016|2016-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||C2P - Phase III: MPowerment and Community Promise|Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment|Completed||Phase 3|15|Actual|Westat||2|||f||||t||||||||||2017-02-18 16:13:17.136519|2017-02-18 16:13:17.136519
NCT00381771|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2010-07-27|||February 2006||2006-02-01|July 2010|2010-07-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Observational|||Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus|Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus|Completed||Phase 2/Phase 3|340|Actual|Samsung Medical Center|||1||f||||f||||||||||2017-02-18 16:13:17.255011|2017-02-18 16:13:17.255011
NCT00381758|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2008-03-07|||May 2002||2002-05-01|March 2008|2008-03-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting|A Randomized, Double-Blind Comparison of the Time Course of Response to Two Extended-Release Oral Delivery Systems for Methylphenidate in Pediatric Patients With Attention Deficit Hyperactivity Disorder in an Analog Classroom Setting: The CoMACS Study|Completed||Phase 4|184||UCB Pharma|||||f||||||||||||||2017-02-18 16:13:17.354401|2017-02-18 16:13:17.354401
NCT00381732|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2007-11-06|||October 2003||2003-10-01|November 2007|2007-11-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction|A Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil (2.5mg and 5mg) Administered Once Daily to Men With Erectile Dysfunction|Completed||Phase 3|280|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 16:13:17.452864|2017-02-18 16:13:17.452864
NCT00381719|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2008-01-03|||October 2006||2006-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy||Completed||Phase 2|330|Actual|Allergan||4|||f||||||||||||||2017-02-18 16:13:17.557614|2017-02-18 16:13:17.557614
NCT00381706|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-12-09|||September 2006||2006-09-01|December 2016|2016-12-01||||April 2011|Actual|2011-04-01||Interventional|||Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer|Randomized Phase II Study of ECF-C, IC-C, or FOLFOX-C in Metastatic Esophageal and GE Junction Cancer|Completed||Phase 2|245|Actual|Alliance for Clinical Trials in Oncology||3|||f||||f||||||||||2017-02-18 16:13:17.665132|2017-02-18 16:13:17.665132
NCT00381693|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2011-04-19|2010-11-09||August 2006||2006-08-01|April 2011|2011-04-01|April 2009|Actual|2009-04-01|March 2008|Actual|2008-03-01||Interventional|||Azacitidine in Treating Patients With Myelofibrosis|Phase II Study of Azacitidine in Myelofibrosis|Terminated||Phase 2|10|Actual|Mayo Clinic||1||Due to lack of accrual and trial has demonstrated too little clinical benefit|f||||t||||||||||2017-02-18 16:13:20.674917|2017-02-18 16:13:20.674917
NCT00381680|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-11-15|||March 2007||2007-03-01|November 2016|2016-11-01||||March 2016|Actual|2016-03-01||Interventional|||Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia|Intensive Treatment for Intermediate-Risk Relapse of Childhood B-precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies|Active, not recruiting||Phase 3|275|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 16:13:21.00143|2017-02-18 16:13:21.00143
NCT00005748|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||May 1998||1998-05-01|March 2005|2005-03-01|April 2004|Actual|2004-04-01|||||Observational|||Stress Reduction and Prevention of Hypertension in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:24.509629|2017-02-18 18:14:24.509629
NCT00381667|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-10-26|||August 2006||2006-08-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study to Assess GW642444 in Asthma Patients|A Randomised, Double-blind, Placebo-controlled, Dose Ascending, Five-way Crossover Study, to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of a Single Administration of Three Inhaled Doses (25, 100 and 400 Âµg) of GW642444M|Completed||Phase 2|14|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:13:21.571904|2017-02-18 16:13:21.571904
NCT00381654|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2011-09-30|||October 2006||2006-10-01|September 2011|2011-09-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies|A Phase 1, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily Oral Administration of AV-412 in Patients With Refractory or Relapsed Solid Tumor Malignancies|Terminated||Phase 1|27|Actual|AVEO Pharmaceuticals, Inc.||1||Study did not meet pre-specified objectives.|f||||f||||||||||2017-02-18 16:13:21.690698|2017-02-18 16:13:21.690698
NCT00381641|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-12-26|||August 2006||2006-08-01|December 2016|2016-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery|Phase II Trial of Sunitinib (SU11248) in Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers and Medullary Thyroid Cancers|Active, not recruiting||Phase 2|60|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:13:21.801219|2017-02-18 16:13:21.801219
NCT00381628|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2017-02-10|2016-12-07||September 2006||2006-09-01|February 2017|2017-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations|Use of Nasal Epithelial Cells and Blood Lymphocytes to Identify Markers for Cystic Fibrosis and Cystic Fibrosis Pulmonary Exacerbations|Completed||N/A|59|Actual|University Hospitals Cleveland Medical Center|||4||f||||f|f|f||||||||2017-02-18 16:13:21.936682|2017-02-18 16:13:21.936682
NCT00381615|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2015-09-11|2015-02-04||September 2006||2006-09-01|September 2015|2015-09-01|August 2008|Actual|2008-08-01|July 2007|Actual|2007-07-01||Interventional||Analysis was performed on all enrolled subjects.|Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study|A Phase 2, Open Label, Multi-Center, Controlled, Randomized Study of the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine±OMV, When Administered to Healthy Infants at 2, 4, 6 and/or 12 Months of Age|Completed||Phase 2|147|Actual|Novartis||4|||f||||f||||||||||2017-02-18 16:13:22.406065|2017-02-18 16:13:22.406065
NCT00381602|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2011-03-25||2011-03-01|September 2006||2006-09-01|March 2011|2011-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis||Terminated||Phase 2|3|Actual|QLT Inc.||||Lack of enrolment|||||||||||||||2017-02-18 16:13:24.077967|2017-02-18 16:13:24.077967
NCT00381589|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2009-02-11|||October 2006||2006-10-01|February 2009|2009-02-01||||June 2008|Actual|2008-06-01||Interventional|||Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide|Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide|Completed||N/A|25|Anticipated|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-02-18 16:13:24.18241|2017-02-18 16:13:24.18241
NCT00381576|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2008-08-11|||November 2006||2006-11-01|August 2008|2008-08-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Multiple Sclerosis and Heavy Progressive Resistance Training|Multiple Sclerosis and Muscle Function - Effects of Heavy Progressive Resistance Training|Completed||N/A|36|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-02-18 16:13:24.294431|2017-02-18 16:13:24.294431
NCT00381563|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2009-05-21|||December 2006||2006-12-01|May 2009|2009-05-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Knee Bracing for People With Patellofemoral Osteoarthritis|Bracing in Patellofemoral Osteoarthritis: A Clinical Trial|Unknown status|Active, not recruiting|N/A|80|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||2|||f||||t||||||||||2017-02-18 16:13:24.406192|2017-02-18 16:13:24.406192
NCT00381550|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2014-12-16|2014-04-23||August 2006||2006-08-01|June 2014|2014-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia|Phase II Trial of Triapine (NSC #663249, 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbone) Plus Fludarabine (NSC #312887, Fludarabine Monophosphate) in Adults With Aggressive Myeloproliferative Disorders (MPDs) Including Chronic Myelomonocytic Leukemia (CMML) and Chronic Myelogenous Leukemia in Accelerated Phase (CML-AP) or Blast Crisis (CML-BC)|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:13:24.515448|2017-02-18 16:13:24.515448
NCT00381537|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2006-12-22||||||December 2006|2006-12-01||||||||Interventional|||Prediction of Childhood Epilepsy Outcome in Bangladesh||Completed||N/A|92||Institute of Child Health|||||f||||||||||||||2017-02-18 16:13:25.007185|2017-02-18 16:13:25.007185
NCT00381524|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2009-11-12|||June 2004||2004-06-01|November 2009|2009-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||HIV Prevention in the Primary Care Setting|Special Projects of National Significance|Completed||N/A|234|Actual|University of Alabama at Birmingham||1|||f||||||||||||||2017-02-18 16:13:25.088566|2017-02-18 16:13:25.088566
NCT00381511|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-27|2006-10-16|||January 1999||1999-01-01|September 2006|2006-09-01|April 2004||2004-04-01|||||Interventional|||Deferment of Imaging for Pulmonary Embolism|Objective Assessment of Pulmonary Embolism Can be Deferred Without Increased Risk|Completed||Phase 4|300||Azienda Ospedaliera Universitaria Policlinico|||||f||||||||||||||2017-02-18 16:13:25.184862|2017-02-18 16:13:25.184862
NCT00381485|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2015-08-20|2010-06-30||July 2006||2006-07-01|August 2015|2015-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)|A 12-Week Efficacy and Safety Study of Two Doses of Mometasone Furoate/Formoterol Combination Formulation Compared With Mometasone Furoate Monotherapy, in Persistent Asthmatics Previously Treated With High-Dose Inhaled Glucocorticosteroids|Completed||Phase 3|834|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 16:13:25.276883|2017-02-18 16:13:25.276883
NCT00005746|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1998||1998-04-01|May 2005|2005-05-01|March 2003|Actual|2003-03-01|||||Observational|||Community Site Coronary Risk Control in Black Families||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:24.583213|2017-02-18 18:14:24.583213
NCT00381472|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2017-01-16|||June 2003||2003-06-01|January 2017|2017-01-01|December 2004|Actual|2004-12-01|||||Interventional|||Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa|A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole CR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-dopa|Completed||Phase 3|393||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:13:25.894258|2017-02-18 16:13:25.894258
NCT00381446|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2007-09-26|||July 2005||2005-07-01|September 2007|2007-09-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations|Evaluation of Corneal Staining With Market Contact Lens/Solution Combinations|Unknown status|Recruiting|N/A|200|Anticipated|Andrasko, Gary, OD, LLC|||||f||||||||||||||2017-02-18 16:13:26.081716|2017-02-18 16:13:26.081716
NCT00381433|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2009-07-06|||September 2006||2006-09-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|October 2006|Actual|2006-10-01||Interventional|||Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid|Pharmacokinetic Study of AVI-4065 in Cerebral Spinal Fluid Among Healthy Adult Males Following Subcutaneous Administration|Completed||Phase 1|12||Sarepta Therapeutics|||||f||||||||||||||2017-02-18 16:13:26.179591|2017-02-18 16:13:26.179591
NCT00381420|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2008-10-30|||March 2001||2001-03-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|December 2002|Actual|2002-12-01||Interventional|C-SIRIUS||The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.|A Canadian Multi-Center, Randomized, Double-Blind Study of the Sirolimus-Coated BX Velocity Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions.|Completed||Phase 3|100|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 16:13:26.272009|2017-02-18 16:13:26.272009
NCT00381407|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2013-04-17|||September 2006||2006-09-01|April 2013|2013-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder|Organizational Skills Treatment for ADHD Children|Completed||N/A|157|Actual|New York University School of Medicine||3|||f||||f||||||||||2017-02-18 16:13:26.384362|2017-02-18 16:13:26.384362
NCT00381394|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2012-05-31|||August 2006||2006-08-01|February 2011|2011-02-01||||||||Interventional|||A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.|A Phase II, Multi-centre, Open-label, Randomised Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral Sitamaquine Compared With Amphotericin B in the Treatment of Visceral Leishmaniasis Caused by L. Donovani in Endemic Areas.|Completed||Phase 2|60||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:13:26.511936|2017-02-18 16:13:26.511936
NCT00381381|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2012-08-23|2010-08-03||May 2006||2006-05-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease|A Multi-center Study for the Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease|Completed||Phase 4|199|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 16:13:26.611625|2017-02-18 16:13:26.611625
NCT00381368|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2006-12-01|||October 2006||2006-10-01|November 2006|2006-11-01||||||||Interventional|||Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients|Phase II Open Label Study to Establish the Safety and Efficacy of Intravenous Loading Dose of Ibandronate 6 mg in 3 Consecutive Days in Breast Cancer Patients With Skeletal Metastases|Unknown status|Recruiting|Phase 2|60||University of Turku|||||f||||||||||||||2017-02-18 16:13:26.945967|2017-02-18 16:13:26.945967
NCT00381355|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2014-03-25|||October 2006||2006-10-01|March 2014|2014-03-01||||April 2007|Actual|2007-04-01||Interventional|||RCT of a Written Action Plan vs. Usual Care in Children With Acute Asthma|Does the Use of a New Written Action Plan Increase Short-term Adherence to Prescribed Medication and Asthma Control in Children Treated for an Asthma Attack in the Emergency Department: A Randomized Controlled Trial.|Completed||Phase 4|218|Actual|McGill University Health Center|||||f||||||||||||||2017-02-18 16:13:27.133013|2017-02-18 16:13:27.133013
NCT00381342|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2015-02-20|||September 2006||2006-09-01|January 2015|2015-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of Exenatide as Monotherapy|Safety and Efficacy of Exenatide as Monotherapy in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|233|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 16:13:27.225353|2017-02-18 16:13:27.225353
NCT00381329|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2009-01-29|||September 2007||2007-09-01|January 2009|2009-01-01|May 2010|Anticipated|2010-05-01|||||Interventional|||Pennsylvania Adolescent Smoking Study (PASStudy)|Pennsylvania Adolescent Smoking Study (PASS) - Randomized Controlled Trial Comparing Motivational Interviewing and Structured Brief Advice for the Reduction of Adolescent Cigarette Smoking|Unknown status|Active, not recruiting|Phase 2|330|Anticipated|Pennsylvania Department of Health||2|||f||||t||||||||||2017-02-18 16:13:27.358591|2017-02-18 16:13:27.358591
NCT00381316|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2007-12-03|||July 2006||2006-07-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches|Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches|Completed||Phase 4|291|Actual|GE Healthcare||2|||f||||||||||||||2017-02-18 16:13:27.47099|2017-02-18 16:13:27.47099
NCT00381303|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2014-04-02|2009-11-24||November 2006||2006-11-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.|GRACE: An Open-label, Multicenter Trial to Compare the Efficacy, Safety, and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race, When Administered in Combination With an Individually Optimized Background Regimen Over a 48-week Treatment Period.|Completed||Phase 3|429|Actual|Tibotec, Inc||1|||f||||t||||||||||2017-02-18 16:13:27.576126|2017-02-18 16:13:27.576126
NCT00381290|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2017-01-24|||October 2006||2006-10-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults|Intensive Diet and Exercise for Arthritis|Completed||N/A|454|Actual|Wake Forest University Health Sciences||3|||f||||f||||||||||2017-02-18 16:13:29.108102|2017-02-18 16:13:29.108102
NCT00381264|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2008-02-14|||September 2006||2006-09-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis|A Multicenter Trial Evaluating the Efficacy of Cesamet™ for the Symptomatic Treatment of Pain in Patients With Multiple Sclerosis|Completed||Phase 4|23|Anticipated|NEMA Research, Inc.|||||f||||||||||||||2017-02-18 16:13:29.327957|2017-02-18 16:13:29.327957
NCT00381251|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2007-06-08|||September 2006||2006-09-01|June 2007|2007-06-01|January 2007||2007-01-01|||||Interventional|||Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.|An Open-Label, Single-Dose, Randomized, 3-Period, Crossover, Bioequivalence Study Between Two New Formulations of 0.45 mg/1.5 mg Premarin / Medroxyprogesterone Acetate (MPA) Compared With a Reference Formulation of 0.45mg/1.5mg Premarin / MPA (Prempro™) in Healthy Postmenopausal Women.|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:13:29.441344|2017-02-18 16:13:29.441344
NCT00381238|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-10-26||2010-03-29|June 2006||2006-06-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease|An Open-label Extension to Study 49653/461, to Assess the Long-term Safety of Rosiglitazone (Extended Release Tablets) in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|33|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:13:29.529488|2017-02-18 16:13:29.529488
NCT00381225|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2006-09-26|||November 2006||2006-11-01|September 2006|2006-09-01|November 2008||2008-11-01|||||Interventional|||Feasibility of Radiofrequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance.|Feasibility of Radio-Frequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance|Unknown status|Not yet recruiting|N/A|20||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:13:29.650576|2017-02-18 16:13:29.650576
NCT00381212|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2009-01-28|||September 2006||2006-09-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|February 2008|Actual|2008-02-01||Interventional|||A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.|A Pilot Study (Phase I/II) Testing the Immunologic Activity and Safety of AGS-004, an Autologous HIV Immunotherapeutic, in HIV-Infected Adults on HAART|Completed||Phase 1/Phase 2|10|Actual|McGill University Health Center||1|||f||||t||||||||||2017-02-18 16:13:29.754357|2017-02-18 16:13:29.754357
NCT00381199|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2007-05-16|||April 2006||2006-04-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia|Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia|Completed||N/A|32|Actual|McGill University Health Center|||||f||||f||||||||||2017-02-18 16:13:29.867019|2017-02-18 16:13:29.867019
NCT00381186|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2016-11-08|||February 1999||1999-02-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Impact of 3-year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study|Impact of 3-year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study|Completed||N/A|150||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 16:13:29.975628|2017-02-18 16:13:29.975628
NCT00381173|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2013-05-13|||November 2006||2006-11-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing|A Phase 1 Open-Label Study of the Safety and Feasibility of ZYC300 Administration With Cyclophosphamide Pre-Dosing|Completed||Phase 1|22|Actual|Eisai Inc.||1|||f||||f||||||||||2017-02-18 16:13:30.067062|2017-02-18 16:13:30.067062
NCT00381160|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2012-08-08|||September 2006||2006-09-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|BASH||Reducing Sugar-sweetened Beverage Consumption in Overweight Adolescents|Reducing Sugar-Sweetened Beverage Consumption in Overweight Adolescents|Completed||N/A|224|Actual|Boston Children’s Hospital||2|||f||||||||||||||2017-02-18 16:13:30.178692|2017-02-18 16:13:30.178692
NCT00381147|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2009-01-06||||||September 2006|2006-09-01||||||||Interventional|||Use of Clarithromycin in Mustard-Induced Bronchiolitis|Phase III, Randomized, Double Blind Study of Low Dose Long Term Clarithromycin Versus Placebo in Treatment of Chronic Pulmonary Lesions Due to Sulfur Mustard|Completed||Phase 3|||Baqiyatallah Medical Sciences University|||||f||||||||||||||2017-02-18 16:13:30.288004|2017-02-18 16:13:30.288004
NCT00381134|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2010-03-01|||July 2003||2003-07-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Improving Outcomes in Patients With Kidney Disease Due to Diabetes|Improving Outcomes in Diabetic Nephropathy|Completed||Phase 2|92|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:13:30.368236|2017-02-18 16:13:30.368236
NCT00381121|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2016-10-24|||September 2006||2006-09-01|October 2016|2016-10-01|August 2056|Anticipated|2056-08-01|August 2056|Anticipated|2056-08-01||Observational|||"University of Michigan Nephrology Research BioBank"|"Michigan Nephrology Research BioBank for Molecular Analysis of Renal Disease Nephrology Research BioBank"|Recruiting||N/A|420|Anticipated|University of Michigan|||1||f||||f||||||Samples With DNA|"~     Tissue, blood, urine~   "|||2017-02-18 16:13:30.459144|2017-02-18 16:13:30.459144
NCT00381108|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2010-01-04|||September 2005||2005-09-01|January 2010|2010-01-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||Study of the Effects of Pomegranate Tablets on Enlarged Prostates|A Randomized, Double Blinded, Controlled Clinical Trial of Pomegranate Tablets vs Placebo: Effects on Symptoms of Benign Prostatic Hyperplasia|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-02-18 16:13:30.564434|2017-02-18 16:13:30.564434
NCT00381095|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2011-10-21|2011-08-18||December 2006||2006-12-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|COPE||A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer|A Randomized Placebo-Controlled Trial Of The Efficacy And Tolerability Of Flexibly Dosed Pregabalin In The Treatment Of Cancer-Induced Bone Pain|Terminated||Phase 4|152|Actual|Pfizer|Efficacy parameters baseline=the last non-missing observation, up to the baseline visit for that efficacy parameter. Baseline mBPI scores=average score in week preceding randomization, minimum 4 datapoints. No formal hypothesis testing conducted.|2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 16:13:30.77909|2017-02-18 16:13:30.77909
NCT00330694|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2008-09-01|||May 2006||2006-05-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Efficiency of Physiotherapeutic Care in Parkinson's Disease|Efficiency of Physiotherapeutic Care in Parkinson's Disease|Completed||Phase 3|708|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 16:30:25.493941|2017-02-18 16:30:25.493941
NCT00381082|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2006-12-08|||September 2004||2004-09-01|December 2006|2006-12-01|November 2004||2004-11-01|||||Interventional|||A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.|A Randomised, Controlled and Blinded Assessment Study of the Efficacy of MOOV Head Lice Treatment (Ego Pharmaceutical Pty. Ltd.) in the Treatment of Head Lice in Primary School Children.|Completed||Phase 2/Phase 3|152||Uniquest Pty Ltd|||||f||||||||||||||2017-02-18 16:13:31.672162|2017-02-18 16:13:31.672162
NCT00381069|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2010-01-19|||October 2006||2006-10-01|January 2010|2010-01-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||SDSU MOVE/Me Muevo Project|Obesity Prevention and Control in Community Recreation Centers|Unknown status|Active, not recruiting|N/A|541|Actual|San Diego State University||1|||f||||t||||||||||2017-02-18 16:13:31.788795|2017-02-18 16:13:31.788795
NCT00381056|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2006-09-26|||July 2000||2000-07-01|September 2006|2006-09-01|March 2004||2004-03-01|||||Interventional|||The Labor and Delivery Teamwork Intervention Trial|The Labor and Delivery Teamwork Intervention Trial|Completed||N/A|30000||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 16:13:31.89381|2017-02-18 16:13:31.89381
NCT00381043|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2013-02-18|2012-09-13||August 2006||2006-08-01|February 2013|2013-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic|Campral (Acamprosate) Treatment of Alcohol Dependence in a Family Medicine Setting: A Randomized, Double-Blind Placebo-Controlled Study|Completed||Phase 4|100|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 16:13:31.996369|2017-02-18 16:13:31.996369
NCT00381030|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2006-09-25|||October 2002||2002-10-01|September 2006|2006-09-01|March 2005||2005-03-01|||||Interventional|||Effects of Carvedilol on Health Outcomes in Heart Failure|Effects of Inpatient Initiation of Carvedilol and Nurse Management on Health Outcomes in Vulnerable Heart Failure Patients (ECHO Study): a Randomized Trial|Completed||Phase 4|100||Denver Health and Hospital Authority|||||f||||||||||||||2017-02-18 16:13:32.448906|2017-02-18 16:13:32.448906
NCT00381017|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2014-08-11|||September 2006||2006-09-01|August 2014|2014-08-01||||||||Interventional|||Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)|A Randomized, Open-label, Multi-center, Phase 3, 2-arm Study Evaluating the Efficacy and Safety of Peg Interferon Alfa-2b Low-dose Maintenance Monotherapy Versus Standard Supportive Care in Patients With Cirrhotic Hepatitis C Co-infected With Human Immunodeficiency Virus - The ENDURE Study|Withdrawn||Phase 3|0|Actual|Merck Sharp & Dohme Corp.||||Non-protocol feasibility|||||||||||||||2017-02-18 16:13:32.552414|2017-02-18 16:13:32.552414
NCT00381004|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2015-12-14|2015-07-20||September 2006||2006-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia|Fludarabine, Cyclophosphamide, and Rituximab (FCR) Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:13:32.630335|2017-02-18 16:13:32.630335
NCT00380991|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2008-05-15|||May 2006||2006-05-01|May 2008|2008-05-01||||||||Interventional|||Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene|Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability and Dermical Sensitivity) of Dermacyd Delicata (New Fragrance)|Completed||Phase 3|50||Sanofi|||||f||||||||||||||2017-02-18 16:13:32.900876|2017-02-18 16:13:32.900876
NCT00380978|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2014-03-17|2011-07-05||October 2001||2001-10-01|March 2014|2014-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Neuraxial Versus Systemic Analgesia for Latent Phase Labor Effect on Rate of Operative Delivery|Early Compared With Late Neuraxial Analgesia in Nulliparous Labor Induction|Completed||N/A|1026|Actual|Northwestern University|The study was not powered to detect a small difference between groups in the cesarean delivery rate. It was not blinded. Different obstetric providers have different management styles, and different triggers for performing cesarean delivery.|2|||f||||f||||||||||2017-02-18 16:13:32.979279|2017-02-18 16:13:32.979279
NCT00380965|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2008-02-14|||October 2006||2006-10-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy|A Multicenter Trial Evaluating the Safety and Efficacy of Cesamet™ for the Symptomatic Treatment of Chemotherapy-Induced Neuropathic Pain in Patients With Cancer|Completed||Phase 4|23|Anticipated|NEMA Research, Inc.|||||f||||||||||||||2017-02-18 16:13:33.547119|2017-02-18 16:13:33.547119
NCT00380952|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2008-05-25|||November 2006||2006-11-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|October 2007|Actual|2007-10-01||Interventional|||Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure|MAST Study Protocol|Completed||N/A|300|Actual|Dune Medical Devices||2|||f||||f||||||||||2017-02-18 16:13:33.643226|2017-02-18 16:13:33.643226
NCT00380939|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2006-11-29|||April 1999||1999-04-01|November 2006|2006-11-01|December 2000||2000-12-01|||||Interventional|||This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.|A Prospective, Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Atorvastatin Versus Pravastatin on the Progression and Quantification of Coronary Atherosclerotic Lesions as Measured by Intravascular Ultrasound (REVERSAL)|Completed||Phase 4|600||Pfizer|||||||||||||||||||2017-02-18 16:13:33.754825|2017-02-18 16:13:33.754825
NCT00380926|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2006-09-28|||April 2004||2004-04-01|September 2006|2006-09-01|November 2004||2004-11-01|||||Interventional|||Fish Oil and Asthma in House Dust Mite Allergy|Anti-Inflammatory Effect of Polyunsaturated Fatty Acids in Allergic Asthma After Allergen Challenge|Completed||Phase 2/Phase 3|23||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 16:13:33.874775|2017-02-18 16:13:33.874775
NCT00380913|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2008-02-14|||September 2006||2006-09-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy|A Multicenter Trial Evaluating the Efficacy of Cesamet™ for the Symptomatic Treatment of Pain in Patients With Diabetic Peripheral Neuropathy|Completed||Phase 4|23|Anticipated|NEMA Research, Inc.|||||f||||||||||||||2017-02-18 16:13:33.9576|2017-02-18 16:13:33.9576
NCT00380900|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2007-12-03|||July 2006||2006-07-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy|A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Test Article or Placebo Administered Orally to Healthy and Osteoarthritis Subjects.|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:13:34.062375|2017-02-18 16:13:34.062375
NCT00380887|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2006-09-26|||June 2005||2005-06-01|September 2006|2006-09-01||||||||Observational|||Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women|An Open-Label, Single-Dose, Randomized, 4-Period, Partial Crossover Bioequivalence/Bioavailability Study Among Four New Formulations of Premarin 0.45 mg/Medroxyprogesterone Acetate (MPA) 1.5 mg Compared With a Reference Formulation of Premarin/MPA (Prempro) 0.45 mg/1.5 mg in Healthy Postmenopausal Women|Completed||Phase 1|54||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:13:34.146814|2017-02-18 16:13:34.146814
NCT00380874|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2009-10-01|2009-03-10||January 2007||2007-01-01|October 2009|2009-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer|A Randomized, Double-Blind, Placebo-Controlled Trial Of The Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy Symptoms In Subjects With Advanced Colorectal Cancer|Terminated||Phase 4|64|Actual|Pfizer|Due to lack of symptom emergence, enrollment was halted, and endpoint modified because primary assumptions upon which it was powered (emergence of symptomatology) were not met, and not all endpoints were able to be reliably analyzed.|2||See detailed description for termination reason|f||||t||||||||||2017-02-18 16:13:34.244385|2017-02-18 16:13:34.244385
NCT00380861|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2013-08-06|2011-01-28||March 2006||2006-03-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Does Implant Design Improve Postoperative Flexion?|Does Implant Design Improve Postoperative Flexion?A Prospective, Randomized, Comparative, Multi-center Study Comparing PFC® Sigma™ RP Knee Versus PFC® Sigma™ RP-F Implanted in Simultaneous Bilateral Subjects|Completed||N/A|186|Actual|DePuy Orthopaedics||2|||f||||f||||||||||2017-02-18 16:13:35.623997|2017-02-18 16:13:35.623997
NCT00380848|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2007-04-11|||March 2006||2006-03-01|May 2006|2006-05-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Impact of Different Dialysis on Sleep Apnea in Patients With Renal Failure|Effect of Hemodiafiltration on Sleep-Disordered Breathing in Patients With End-Stage Renal Disease|Unknown status|Recruiting|N/A|15||McGill University Health Center|||||f||||||||||||||2017-02-18 16:13:35.957448|2017-02-18 16:13:35.957448
NCT00380835|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-26|2008-09-22||||||September 2008|2008-09-01|December 2007||2007-12-01|||||Interventional|||Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer|A Phase 2 Trial of Amrubicin With or Without Herceptin in the Treatment of Metastatic Breast Cancer|Withdrawn||Phase 2|66|Anticipated|Celgene||||Study Never Initiated|f||||||||||||||2017-02-18 16:13:36.061367|2017-02-18 16:13:36.061367
NCT00380822|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2006-09-25||||||September 2006|2006-09-01||||||||Interventional|||Double-Blind Study of Miglitol in Japanese With type2 Diabetes||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 16:13:36.175877|2017-02-18 16:13:36.175877
NCT00380809|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2013-01-04|||August 2006||2006-08-01|January 2013|2013-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Rotational Atherectomy Prior to Taxus Stent|Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease. A Multicenter, Prospective, Randomized Controlled Trial.|Completed||Phase 4|240|Actual|Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH||2|||f||||||||||||||2017-02-18 16:13:36.282801|2017-02-18 16:13:36.282801
NCT00380796|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2013-09-03|||April 2006||2006-04-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).|A Multicenter, Observational Study of the Long-term Safety of Infliximab (REMICADE) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). RESULTS COPD: REMICADE Safety Under Long Term Study in COPD|Completed||Phase 4|88|Actual|Centocor, Inc.|||1||f||||t||||||||||2017-02-18 16:13:36.394362|2017-02-18 16:13:36.394362
NCT00380783|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2011-05-27|||October 2006||2006-10-01|May 2011|2011-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis||Terminated||Phase 2|2|Actual|Allergan|||||f||||||||||||||2017-02-18 16:13:36.601888|2017-02-18 16:13:36.601888
NCT00380770|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2010-07-20|||January 2003||2003-01-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|KAART||HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT|A Prospective Randomized Trial Comparing the Response of HIV Kaposi's Sarcoma (KS) to HAART Versus the Combination of HAART and Chemotherapy (CXT)|Completed||Phase 4|112|Actual|University of KwaZulu||2|||f||||t||||||||||2017-02-18 16:13:36.697461|2017-02-18 16:13:36.697461
NCT00380757|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-23|2017-01-20|||October 2006||2006-10-01|May 2012|2012-05-01|November 2006|Actual|2006-11-01|||||Interventional|||Comparison of Bystander Fatigue and CPR Quality When Using Two Different CPR Ratios.|Comparison of Bystander Fatigue and CPR Quality When Using the New 30:2 Versus the Old 15:2 Chest Compression to Ventilation International Guidelines: A Randomised Crossover Trial|Completed||N/A|42|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 16:13:36.818819|2017-02-18 16:13:36.818819
NCT00380744|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2009-10-05||2009-01-30|November 2005||2005-11-01|October 2009|2009-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Safety and Pharmacokinetics Study in Patients With Rheumatoid Arthritis|A Phase 1b/2 Multiple-Dose Safety Study and Pharmacokinetic/ Pharmacodynamic Study of LY2189102 in Patients With Rheumatoid Arthritis|Completed||Phase 1/Phase 2|104|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-02-18 16:13:36.925427|2017-02-18 16:13:36.925427
NCT00380731|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2011-11-29|||September 2006||2006-09-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia|fMRI of Emotional Reactivity Cognitive Regulation and CBT for Social Phobia|Completed||N/A|124|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 16:13:37.037271|2017-02-18 16:13:37.037271
NCT00380718|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2010-11-01|2009-09-02||November 2006||2006-11-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|September 2008|Actual|2008-09-01||Interventional|||Chemotherapy for Patients With Non-Small Cell Lung Cancer|Open-Label Single-Arm Phase IV Study of Pemetrexed in Taiwanese Patients With Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy|Completed||Phase 4|33|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:13:37.152016|2017-02-18 16:13:37.152016
NCT00380705|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2015-12-17|||March 2005||2005-03-01|December 2015|2015-12-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)|Quality of Life in Asthma and Rhinitis Allergic With Singulair|Completed||Phase 4|91|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:13:37.664963|2017-02-18 16:13:37.664963
NCT00380692|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2010-05-05|2009-05-18||October 2006||2006-10-01|May 2010|2010-05-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder|A Randomized, Double-blind Comparison of Atomoxetine Hydrochloride and Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Autism Spectrum Disorder|Completed||Phase 4|97|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 16:13:37.753662|2017-02-18 16:13:37.753662
NCT00380679|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2006-09-25|||December 2005||2005-12-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department|Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department|Unknown status|Active, not recruiting|Phase 2|||Louisiana State University Health Sciences Center in New Orleans|||||f||||||||||||||2017-02-18 16:13:42.02646|2017-02-18 16:13:42.02646
NCT00380666|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2010-07-09|||June 2007||2007-06-01|July 2010|2010-07-01|July 2010|Anticipated|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer||Withdrawn||N/A|30|Anticipated|University of Aarhus||||Technical problems.|f||||f||||||||||2017-02-18 16:13:42.129761|2017-02-18 16:13:42.129761
NCT00380653|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-23|2009-10-18|||January 2006||2006-01-01|September 2006|2006-09-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes|A Phase I Pharmacologic Study of Oral Sapacitabine in Patients With Advanced Leukemias or Myelodysplastic Syndromes|Completed||Phase 1|||Cyclacel Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 16:13:42.221661|2017-02-18 16:13:42.221661
NCT00380640|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2013-08-01|||September 2006||2006-09-01|August 2013|2013-08-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa|The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa: A Randomized, Double Blinded, Placebo Controlled, Cross-over Pilot Study|Completed||Phase 2|10|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 16:13:42.301302|2017-02-18 16:13:42.301302
NCT00380627|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2015-03-16|||September 2005||2005-09-01|March 2015|2015-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)|Quality of Life With Arcoxia in Women With Dysmenorrhea|Completed||Phase 4|337||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:13:42.41354|2017-02-18 16:13:42.41354
NCT00380614|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2006-09-25|||January 2002||2002-01-01|September 2006|2006-09-01|March 2005||2005-03-01|||||Interventional|||A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B||Completed||Phase 4|||Maulana Azad Medical College|||||f||||||||||||||2017-02-18 16:13:42.503981|2017-02-18 16:13:42.503981
NCT00380601|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2009-12-22|||May 2006||2006-05-01|December 2009|2009-12-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)|An Open-label, PhaseⅢ Study to Evaluate the Efficacy and Safety of MRA in Patients With RA|Completed||Phase 3|20|Anticipated|Chugai Pharmaceutical||1|||f||||||||||||||2017-02-18 16:13:42.712001|2017-02-18 16:13:42.712001
NCT00380588|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2009-11-18|2009-10-15||September 2006||2006-09-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer|A Randomized Study of Gemcitabine/Cisplatin Versus Single-Agent Gemcitabine in Patients With Biliary Tract Cancer|Completed||Phase 2|84|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:13:42.82656|2017-02-18 16:13:42.82656
NCT00380575|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2014-04-30|||August 2000||2000-08-01|April 2014|2014-04-01|February 2003|Actual|2003-02-01|||||Interventional|||Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia|A 4-Day, Double-Blind, Placebo-Controlled, Multicenter Study of IV YM087 (CI-1025) to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia|Completed||Phase 3|84||Cumberland Pharmaceuticals|||||||||||||||||||2017-02-18 16:13:43.828641|2017-02-18 16:13:43.828641
NCT00380562|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2013-09-18|||July 2006||2006-07-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Baltimore Experience Corps Study|Experience Corps Trial: Improving Health of Older Populations Through Generativity|Completed||N/A|702|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:13:43.963985|2017-02-18 16:13:43.963985
NCT00380549|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-23|2010-08-19|||June 2006||2006-06-01|August 2010|2010-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Comparison of an Advanced Metal Hip System to a Resurfacing Hip System|A Prospective Case Series (Pilot Study) Comparing Ion Levels and Clinical Outcomes of the CONSERVE® A-Class Type Hip System With BFH™ Technology to the CONSERVE® Plus Total Hip Resurfacing System|Completed||Phase 4|20|Actual|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-02-18 16:13:44.071895|2017-02-18 16:13:44.071895
NCT00380536|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2013-11-18|||September 2006||2006-09-01|November 2013|2013-11-01|July 2010|Actual|2010-07-01|April 2009|Actual|2009-04-01||Interventional|||Medical Self-Management for Improving Health Behavior Among Individuals in Community Mental Health Settings|Adapting a Medical Self-Management Program for a Community Mental Health Center|Completed||N/A|111|Anticipated|Emory University||2|||f||||f||||||||||2017-02-18 16:13:44.17235|2017-02-18 16:13:44.17235
NCT00380523|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2015-03-16|||April 2005||2005-04-01|March 2015|2015-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Analgesic Treatment Mediated by Arcoxia (0663-093)|Analgesic Treatment Mediated by Arcoxia|Completed||Phase 4|237|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:13:44.273444|2017-02-18 16:13:44.273444
NCT00380510|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2006-09-25|||June 2004||2004-06-01|September 2006|2006-09-01|February 2005||2005-02-01|||||Observational|||The Safe Teen Study|The SAFE TEEN Study: Family Physicians' Reports of Facilitators of and Barriers to Preventive Care for Adolescents.|Completed||N/A|60||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 16:13:44.346183|2017-02-18 16:13:44.346183
NCT00380497|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2013-07-25|||September 2006||2006-09-01|July 2013|2013-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children|Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in children-a Single Blinded Randomized Controlled Trial|Completed||Phase 4|83|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 16:13:44.43462|2017-02-18 16:13:44.43462
NCT00005745|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||January 1998||1998-01-01|September 2004|2004-09-01|December 2002|Actual|2002-12-01|||||Observational|||Consequences and Correlates of Weight Fluctuations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:24.67523|2017-02-18 18:14:24.67523
NCT00380484|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2008-02-19|||September 2006||2006-09-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Short- and Long Term Growth in Children With Asthma|Short- and Long Term Growth in Children With Asthma Treated With Budesonide or Montelukast|Completed||Phase 4|52|Actual|Children´s Clinic, Randers||2|||f||||||||||||||2017-02-18 16:13:44.545145|2017-02-18 16:13:44.545145
NCT00380471|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2008-01-22|||January 2006||2006-01-01|January 2008|2008-01-01|August 2006|Anticipated|2006-08-01|||||Interventional|||Treatment and Complication of Bath PUVA in Vitiligo|Treatment and Complication of Bath PUVA in Vitiligo|Unknown status|Recruiting|Phase 2|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:13:44.657416|2017-02-18 16:13:44.657416
NCT00380458|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2015-08-25||||||August 2015|2015-08-01||||||||Interventional|||Study to Evaluate Recovery From Postoperative Pain After Sleep Apnea Surgery|Prospective, Randomized, Controlled Clinical Trial to Evaluate Recovery From Post-operative Pain in Adults After Sleep Apnea Surgery Using a Coblation Device Compared to Electrocautery|Withdrawn||Phase 4|0|Actual|ArthroCare Corporation||||No patients enrolled. Study did not start.|f||||f||||||||||2017-02-18 16:13:44.734025|2017-02-18 16:13:44.734025
NCT00380445|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2012-05-04|||January 2006||2006-01-01|May 2012|2012-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes|Effect of Vildagliptin on Adipose Tissue and Skeletal Muscle Metabolism in Obese Patients With Type 2 Diabetes|Completed||Phase 3|21|Actual|Novartis|||||f||||||||||||||2017-02-18 16:13:44.83666|2017-02-18 16:13:44.83666
NCT00380419|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2013-05-29|||October 2006||2006-10-01|May 2013|2013-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Interpersonal Psychotherapy on Depression During and After Pregnancy|Infant Outcomes and Depression Treatment in Pregnancy|Completed||N/A|120|Actual|University of Michigan||1|||f||||t||||||||||2017-02-18 16:13:44.927878|2017-02-18 16:13:44.927878
NCT00380406|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-23|2010-08-19|||January 2007||2007-01-01|August 2010|2010-08-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|PROOF||PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial|PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial: A Randomized Controlled Trial of Gonadotropin Releasing Hormone Agonist (GnRHa) for Fertility Preservation in Oncology Patients|Completed||Phase 3|30|Anticipated|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 16:13:45.060161|2017-02-18 16:13:45.060161
NCT00380393|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-25|2009-09-03||2009-09-03|January 2007||2007-01-01|September 2009|2009-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.|A Study of the Efficacy Against Episodes of Clinical Malaria Due to P. Falciparum Infection of GSK Bio's Candidate Vaccine RTS,S/AS01, Administered According to a 0,1,2-mths Schedule in Children Aged 5 to 17 Mths Living in Tanzania & Kenya|Completed||Phase 2|855|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:13:45.163893|2017-02-18 16:13:45.163893
NCT00380380|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2012-05-06|||January 2006||2006-01-01|May 2012|2012-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.|A Randomized, Single-blind, Placebo Controlled, Cross-over Study to Evaluate the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.|Completed||Phase 3|18||Novartis|||||f||||||||||||||2017-02-18 16:13:45.27418|2017-02-18 16:13:45.27418
NCT00380367|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2015-05-27|2009-01-22||May 2007||2007-05-01|May 2015|2015-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)|Evaluation of Safety, Tolerability and Immunogenicity of Quadrivalent HPV Vaccine in Healthy Females 9 to 15 Years of Age in India|Completed||Phase 3|110|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 16:13:45.617712|2017-02-18 16:13:45.617712
NCT00380354|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2012-05-31|||September 2006||2006-09-01|February 2011|2011-02-01|June 2007|Actual|2007-06-01|||||Interventional|||Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma|A Two-centre, Randomised, Double-blind, Placebo-controlled, 2-period Cross-over Study to Evaluate the Effect of Treatment With Repeat Doses of Inhaled GSK256066 on the Allergen-induced Late Asthmatic Response in Subjects With Mild Asthma|Completed||Phase 2|11|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:13:46.097435|2017-02-18 16:13:46.097435
NCT00380341|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2008-10-16|||September 2006||2006-09-01|October 2008|2008-10-01|November 2006||2006-11-01|||||Interventional|||Effects of Instrument-Applied Spinal Manipulative Therapy on Postureal Control and Autonomic Balance||Completed||N/A|20||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:13:46.192447|2017-02-18 16:13:46.192447
NCT00380328|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2012-05-10|||October 2006||2006-10-01|May 2012|2012-05-01|November 2006|Actual|2006-11-01|||||Interventional|||HKI-272 Ketoconazole Drug Interaction Study|An Open-label, Randomized, 2-period Crossover, Drug Interaction Study to Evaluate the Potential Pharmacokinetic Interaction Between Multiple Doses of Ketoconazole and a Single Dose of HKI-272 Administered Orally to Healthy Subjects|Completed||Phase 1|24|Actual|Puma Biotechnology, Inc.|||||f||||||||||||||2017-02-18 16:13:46.25643|2017-02-18 16:13:46.25643
NCT00380315|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2009-06-30|||March 2006||2006-03-01|June 2009|2009-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG1321001 in Chronic Cougher|Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG1321001 Capsule as an Anti-Tussive Agent in Cough Patients: Double Blinded, Randomized, Placebo and Active Rug Comparative, Parallel Designed Phase III Study|Completed||Phase 3|396|Actual|Ahn-Gook Pharmaceuticals Co.,Ltd||3|||||||||||||||||2017-02-18 16:13:46.340346|2017-02-18 16:13:46.340346
NCT00380302|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2008-12-18|||September 2006||2006-09-01|December 2008|2008-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.|A Double-Blind Placebo-Controlled Study of the Activity of AVE1625 at Doses of 10 mg and 40mg for 12 Weeks in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 1/Phase 2|162|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:13:46.439508|2017-02-18 16:13:46.439508
NCT00380289|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2006-09-22|||September 2006||2006-09-01|September 2006|2006-09-01||||||||Interventional|||Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension|Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension|Unknown status|Recruiting|N/A|66||University of Cambridge|||||f||||||||||||||2017-02-18 16:13:46.546031|2017-02-18 16:13:46.546031
NCT00005744|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1996||1996-09-01|August 2004|2004-08-01|August 2001|Actual|2001-08-01|||||Observational|||Increased Physical Activity in African-American Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:24.756549|2017-02-18 18:14:24.756549
NCT00380276|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2008-08-01|||September 2006||2006-09-01|August 2008|2008-08-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol|Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type|Terminated||Phase 3|1000|Anticipated|Myrexis Inc.||1||Myriad has discontinued the development of Flurizan.|f||||||||||||||2017-02-18 16:13:46.644923|2017-02-18 16:13:46.644923
NCT00380263|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2008-05-29|||November 2006||2006-11-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood Flow|Basic Scientific Research Investigating PACAP38 Headache Inducing Effects in Migraine Patients|Completed||N/A|12|Actual|Danish Headache Center|||||f||||t||||||||||2017-02-18 16:13:46.851421|2017-02-18 16:13:46.851421
NCT00380250|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2014-01-13|2008-10-07||May 2005||2005-05-01|January 2014|2014-01-01|July 2006|Actual|2006-07-01|||||Interventional||The Baseline participants data is taken from the intent to treat(ITT) population Whereas the Participant flow data is for all randomized subjects.|Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation|Phase 3, 12-Week, Multicenter, Double-Blind, Randomized, Efficacy and Safety Study of Lubiprostone for the Treatment of Irritable Bowel Syndrome With Constipation|Completed||Phase 3|590|Actual|Sucampo Pharma Americas, LLC||2|||f||||||||||||||2017-02-18 16:13:46.952733|2017-02-18 16:13:46.952733
NCT00380237|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2008-01-18|||October 2006||2006-10-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)|Phase 1 Inpatient Study of the Safety and Immunogenicity of H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H9N2 Infection in the Event of a Pandemic (Study B)|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||f||||||||||2017-02-18 16:13:48.03115|2017-02-18 16:13:48.03115
NCT00380224|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2007-12-18|||July 2006||2006-07-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.|A Multicenter, Randomized, Double-Blind, Parallel-Group Fixed-Dose Study of the Effect on Weight of Befeprunox Versus Olanzapine in the Treatment of Outpatients With Schizophrenia.|Completed||Phase 3|120|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:13:48.146682|2017-02-18 16:13:48.146682
NCT00380211|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2016-10-06|||September 2006||2006-09-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults|A Randomized, Double-Blind Trial Evaluating the Safety and Immunogenicity of an Influenza Vaccine With Reduced Preservative (FluLaval™ TR) and a Standard Influenza Vaccine (Fluarix®) in Subjects Between 18-60 and Over 60 Years of Age.|Completed||Phase 3|660|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:13:48.533721|2017-02-18 16:13:48.533721
NCT00380198|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2017-01-31|||July 2006||2006-07-01|January 2017|2017-01-01|November 2006||2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.|A Randomized, Double-Blind Comparison of Apadenoson and Adenosine to Treadmill Exercise Stress for Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)|Terminated||Phase 3|1500||Forest Laboratories||||Business decision to end program|f||||||||||||||2017-02-18 16:13:48.643667|2017-02-18 16:13:48.643667
NCT00380185|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2015-05-27|||April 2004||2004-04-01|May 2015|2015-05-01||||July 2008|Actual|2008-07-01||Observational|GenePAD||Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease|The Genetic Determinants of Peripheral Arterial Disease|Completed||N/A|1789|Actual|Stanford University|||3||f||||t||||||Samples With DNA|"~     Serum, Plasma, White Cells~   "|||2017-02-18 16:13:48.77835|2017-02-18 16:13:48.77835
NCT00380172|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2006-09-21|||October 2005||2005-10-01|September 2006|2006-09-01|October 2007||2007-10-01|||||Interventional|||Long-Term Efficacy in AMD of Rheopheresis in North America|A Multicenter, Open Label, Prospective Study to Determine Safety and Efficacy Over an Additional 12-Month Period With Non-Exudative Age-Related Macular Degeneration (With Follow-on to 12-Months)|Unknown status|Active, not recruiting|N/A|120||OccuLogix|||||||||||||||||||2017-02-18 16:13:48.871982|2017-02-18 16:13:48.871982
NCT00380159|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2014-02-18||2014-01-20|September 2006||2006-09-01|February 2014|2014-02-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Open-Label, 48 Week Extension Study of Elvucitabine in Combination With Background ART For Subjects Who Have Completed Study ACH443-014A|An Open-Label,48 Week Extension Study of Elvucitabine Administered In Combination With Background Antiretroviral Agents in Subjects Who Have Completed 14 Days of Treatment in Protocol ACH443-014A.|Completed||Phase 2|4|Actual|Achillion Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:13:48.967395|2017-02-18 16:13:48.967395
NCT00380146|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2016-10-25|||September 2006||2006-09-01|October 2016|2016-10-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women|An Open-label in Vivo Drug Study to Evaluate the Pharmacokinetics, Therapeutic Efficacy, Gametocyte Carriage and Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment (SP IPT) in Pregnant Women|Completed||N/A|31|Actual|University of Cape Town||1|||f||||t||||||||||2017-02-18 16:13:49.074578|2017-02-18 16:13:49.074578
NCT00380133|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2012-05-31|||June 2005||2005-06-01|March 2012|2012-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Five-way Crossover Study to Assess the Effects of Single Oral Doses of SB-681323 (7.5 mg and 25 mg) and Prednisolone (10 mg and 30 mg) on Biomarkers in Induced Sputum and Blood in COPD Patients.|Completed||Phase 1|20|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:13:49.187022|2017-02-18 16:13:49.187022
NCT00380120|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2008-03-17|||January 1999||1999-01-01|March 2008|2008-03-01|June 2006|Actual|2006-06-01|June 2003|Actual|2003-06-01||Interventional|AESOPUS||Ultrasound Findings to Adjust the Duration of Anticoagulation|The AESOPUS Study: Ultrasound Findings to Adjust the Duration of Anticoagulation in Patients With Deep Vein Thrombosis|Completed||Phase 3|538|Actual|University of Padova||2|||f||||t||||||||||2017-02-18 16:13:49.292008|2017-02-18 16:13:49.292008
NCT00380094|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2009-12-17|||August 2006||2006-08-01|December 2009|2009-12-01|December 2007|Actual|2007-12-01|||||Observational|||Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain|TRIAGE NOW: Triage in Acute General Chest Pain Patients Evaluation|Completed||Phase 2/Phase 3|1500|Anticipated|Biosite|||1||f||||||||||||||2017-02-18 16:13:49.478101|2017-02-18 16:13:49.478101
NCT00380081|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2012-02-10|2011-12-15||April 2006||2006-04-01|February 2012|2012-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia|A Randomized, Double-blind, Placebo-controlled, Crossover Study of the Efficacy and Safety of Sublingual Zolpidem Tartrate Tablet in Adult Patients With Insomnia Characterized by Difficulty Returning to Sleep After Middle-of-the-Night (MOTN) Awakening|Completed||Phase 3|82|Actual|Transcept Pharmaceuticals|Scheduled nocturnal awakening is an established method used to evaluate treatments for naturally occurring middle-of-the-night awakenings. Additional studies are needed to determine the generalizability of the findings to 'real world' conditions.|6|||f||||f||||||||||2017-02-18 16:13:49.576848|2017-02-18 16:13:49.576848
NCT00380068|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2012-04-02|2009-07-10||August 2006||2006-08-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension|ARIES-3: A Phase 3, Long-Term, Open-Label, Multicenter Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension|Completed||Phase 3|224|Actual|Gilead Sciences||1|||f||||t||||||||||2017-02-18 16:13:51.013481|2017-02-18 16:13:51.013481
NCT00380055|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2011-09-19|||October 2006||2006-10-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Reducing Cancer Disparities for American Indians in the Rural Intermountain West|Reducing Cancer Disparities for American Indians in the Rural Intermountain West|Completed||N/A|1800|Anticipated|University of Utah||4|||f||||f||||||||||2017-02-18 16:13:51.913366|2017-02-18 16:13:51.913366
NCT00380042|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2009-12-30|||September 2006||2006-09-01|September 2008|2008-09-01|March 2009|Actual|2009-03-01|October 2007|Actual|2007-10-01||Interventional|PROSPECT||Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder|Feasibility Study of the Safety and Effectiveness of Cortical Stimulation for Subjects With Major Depressive Disorder|Terminated||Phase 1|12|Anticipated|Northstar Neuroscience||2||Study terminated as a result of the dissolution of the Sponsor.|f||||t||||||||||2017-02-18 16:13:52.031|2017-02-18 16:13:52.031
NCT00380029|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2016-11-22|||May 2006||2006-05-01|November 2016|2016-11-01|August 2018|Anticipated|2018-08-01|August 2010|Actual|2010-08-01||Interventional|NRR||Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer|A Phase II Study of Erlotinib (Tarceva®) in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy|Active, not recruiting||Phase 2|27|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:13:52.147934|2017-02-18 16:13:52.147934
NCT00380016|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2017-01-24|||September 20, 2006||2006-09-20|March 3, 2009|2009-03-03|March 3, 2009||2009-03-03|||||Interventional|||Catheter-Based Treatment of Cardiovascular Disease|Catheter-Based Treatment of Cardiovascular Disease in Patients|Completed||N/A|150||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:13:52.262288|2017-02-18 16:13:52.262288
NCT00380003|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2008-01-29|||September 2006||2006-09-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Efficacy Study of EVT 201 to Treat Insomnia|A Randomized, Multicenter, Double-Blind, Placebo-Controlled Crossover Study to Assess the Efficacy of Two Doses of EVT 201 in the Treatment of Primary Insomnia in Adult Patients|Completed||Phase 2|66||Evotec Neurosciences GmbH|||||f||||||||||||||2017-02-18 16:13:52.355595|2017-02-18 16:13:52.355595
NCT00379990|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2012-06-21||2009-07-22|January 2006||2006-01-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.|A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Synovial Thickness and Vascularity of 28 Days Repeat Dosing of GW274150 or 7.5mg Prednisolone in RA Subjects.|Completed||Phase 2|48|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 16:13:52.451094|2017-02-18 16:13:52.451094
NCT00379977|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2016-10-11|||September 2006||2006-09-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age|Open, Primary Vaccination Study to Assess Safety and Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Administered to Healthy Chinese Infants at 3, 4 and 5 Months of Age.|Completed||Phase 3|30||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:13:52.565538|2017-02-18 16:13:52.565538
NCT00379964|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2015-02-23|||June 2005||2005-06-01|February 2015|2015-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)|A Noncomparative, Multicenter, Open-Label, Study to Evaluate the Safety, Tolerability and Efficacy of MK0991 as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia|Completed||Phase 3|50|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 16:13:52.661924|2017-02-18 16:13:52.661924
NCT00379951|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2017-02-16|||June 2005||2005-06-01|February 2017|2017-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)|A Prospective, Multicenter, Noncomparative, Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections|Completed||Phase 3|107|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 16:13:52.748511|2017-02-18 16:13:52.748511
NCT00379938|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2011-08-11||2011-07-20|August 2006||2006-08-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||B-19 Parvovirus Vaccine Study|A Phase I/II Study of the Safety and Immunogenicity of a Recombinant Human Parvovirus B-19 Vaccine|Terminated||Phase 1/Phase 2|43|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:13:52.842912|2017-02-18 16:13:52.842912
NCT00379925|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-22|2013-07-05|||July 2006||2006-07-01|July 2013|2013-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effectiveness of a Church-Based Program at Increasing Physical Activity and Healthy Dietary Habits in African Americans|A Partnership to Promote Physical Activity and Healthy Eating in AME Churches|Completed||Phase 3|1600|Actual|University of South Carolina||1|||f||||f||||||||||2017-02-18 16:13:52.952834|2017-02-18 16:13:52.952834
NCT00379912|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2016-02-17|||September 2006||2006-09-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes|Phase II Randomized Trial With A Modified Dose & Schedule of Subcutaneously Administered Azacitidine & Erythropoietin v Azacitidine Alone in Patients With Low-Risk Myelodysplastic Syndromes (Less Than 11% Marrow & Peripheral Blood Blasts)|Terminated||Phase 2|15|Actual|Hoosier Cancer Research Network||2||Insufficient response rate|f||||t||||||||No||2017-02-18 16:13:53.063676|2017-02-18 16:13:53.063676
NCT00379899|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2014-07-14|2010-10-01||September 2006||2006-09-01|July 2014|2014-07-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis|A Randomized Study to Evaluate the Effects of Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease (CKD) Receiving Hemodialysis|Completed||Phase 4|360|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:13:53.207377|2017-02-18 16:13:53.207377
NCT00379886|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2007-11-13|||January 2003||2003-01-01|November 2007|2007-11-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Comparison of Thiopental and Propofol as Anaesteticum During ECT|Comparison of Thiopental and Propofol as Anaesteticum During ECT|Unknown status|Recruiting|N/A|100|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:13:54.528145|2017-02-18 16:13:54.528145
NCT00379873|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2007-07-31|||October 2006||2006-10-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Chiropractic Adjustment on Physiological Measurements||Completed||N/A|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:13:54.616712|2017-02-18 16:13:54.616712
NCT00378872|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2008-05-13|||June 2006||2006-06-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Tranexamic Acid vs. Quixil - Reducing Blood Loss in Joint Replacement|Prospective Randomised Trial Comparing Intraoperative Topical Quixil and Intravenous Tranexamic Acid, in Reduction of Blood Loss Following Primary Hip & Knee Joint Replacement Surgery.|Completed||N/A|132|Actual|Golden Jubilee National Hospital|||||f||||f||||||||||2017-02-18 16:13:54.682677|2017-02-18 16:13:54.682677
NCT00378859|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2009-01-20|||November 2000||2000-11-01|September 2006|2006-09-01|March 2001||2001-03-01|||||Interventional|||The Effect of Milk and Meat on IGFs in Prepubertal Boys|The Effect of Milk and Meat on IGFs in Prepubertal Boys|Completed||N/A|24||University of Copenhagen|||||f||||||||||||||2017-02-18 16:13:54.793395|2017-02-18 16:13:54.793395
NCT00378846|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2012-03-14|||March 2006||2006-03-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|||||Interventional|||Three Different Types of Thermometers in Measuring Temperature in Young Patients With Fever and Without Fever|A Study Evaluating the Agreement of Devices for Measuring Temperature in Children|Completed||N/A|32|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:13:54.886501|2017-02-18 16:13:54.886501
NCT00378833|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2017-02-15|||July 2006||2006-07-01|February 2017|2017-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)|A Worldwide, Multicenter, Double-Blind, Parallel Study to Evaluate the Tolerability of MK0524A Versus Niacin Extended-Release|Completed||Phase 3|1300|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:13:54.970247|2017-02-18 16:13:54.970247
NCT00379860|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2007-03-08|||October 2006||2006-10-01|March 2007|2007-03-01|January 2007||2007-01-01|||||Interventional|||Study Evaluation LXR-623 in Healthy Adults|A Multiple Ascending Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of LXR-623 Administered Orally to Healthy Subjects|Terminated||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:13:55.060804|2017-02-18 16:13:55.060804
NCT00379847|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2014-04-30|||February 2004||2004-02-01|April 2014|2014-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia|A 4-day, Open-Label, Multicenter Phase 3b Study of IV YM087 in Patients With Euvolemic or Hypervolemic Hyponatremia|Completed||Phase 3|251|Actual|Cumberland Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:13:55.126734|2017-02-18 16:13:55.126734
NCT00379834|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2015-01-26|2013-07-25||September 2006||2006-09-01|January 2015|2015-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||12-Month Stability of Diurnal IOP Control on Cosopt|12-Month Stability of Diurnal IOP Control on Cosopt|Completed||Phase 4|10|Actual|West Virginia University||1|||f||||f||||||||||2017-02-18 16:13:55.253111|2017-02-18 16:13:55.253111
NCT00379821|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2014-08-07|2011-06-30||February 2007||2007-02-01|July 2014|2014-07-01|September 2012|Actual|2012-09-01|August 2009|Actual|2009-08-01||Interventional|||Chloroquine Alone or in Combination for Malaria in Children in Malawi|A Longitudinal Study of Chloroquine as Monotherapy or in Combination With Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria in Children in Blantyre, Malawi|Completed||Phase 3|640|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:13:55.706513|2017-02-18 16:13:55.706513
NCT00379808|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2012-06-07|2012-02-14||July 2006||2006-07-01|June 2012|2012-06-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease|Role of the Arachidonate 5-Lipoxygenase Pathway in Coronary Heart Disease|Completed||N/A|22|Actual|University of Florida|Because there were no order effects, the placebo groups were combined and the montelukast groups were combined. Therefore results from each of these are not reported by arm.|2|||f||||f||||||||||2017-02-18 16:13:57.782844|2017-02-18 16:13:57.782844
NCT00379795|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2013-01-30|2011-04-01||April 2005||2005-04-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO|An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) or Macular Edema Secondary to Retinal Vein Occlusion (RVO) Who Have Completed a Genentech-Sponsored Ranibizumab Study|Completed||N/A|853|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 16:13:58.164603|2017-02-18 16:13:58.164603
NCT00379782|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2011-05-26|||October 2006||2006-10-01|May 2011|2011-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project||Completed||N/A|628|Anticipated|Queen's Medical Centre||1|||f||||||||||||||2017-02-18 16:14:02.685946|2017-02-18 16:14:02.685946
NCT00005743|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||May 1996||1996-05-01|August 2004|2004-08-01|April 2001|Actual|2001-04-01|||||Interventional|||Exercise Adherence in a Behavioral Weight Loss Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:24.830949|2017-02-18 18:14:24.830949
NCT00379769|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2016-08-17|2009-08-24||April 2001||2001-04-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|RECORD||RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes|A Long Term, Open Label, Randomised Study in Patients With Type 2 Diabetes, Comparing the Combination of Rosiglitazone and Either Metformin or Sulfonylurea With Metformin Plus Sulfonylurea on Cardiovascular Endpoints and Glycaemia|Completed||Phase 3|4447|Actual|GlaxoSmithKline||4|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:14:03.125006|2017-02-18 16:14:03.125006
NCT00379756|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2012-06-07|||May 2006||2006-05-01|March 2011|2011-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia|Completed||Phase 4|510|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:14:13.146306|2017-02-18 16:14:13.146306
NCT00379743|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2012-06-18|||October 2006||2006-10-01|June 2012|2012-06-01|December 2012|Anticipated|2012-12-01|December 2010|Actual|2010-12-01||Interventional|||Partnership for Healthy Seniors|Cancer Prevention and Treatment Among African American Older Adults: Screening Trial|Unknown status|Active, not recruiting|Phase 3|2874|Anticipated|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||||2017-02-18 16:14:13.365162|2017-02-18 16:14:13.365162
NCT00379730|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2012-05-31|||March 2006||2006-03-01|February 2011|2011-02-01||||||||Interventional|||Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind Study of Treatment With a Known Anti-inflammatory (Prednisolone) to Evaluate Novel Endpoints in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 1|90||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:14:13.64581|2017-02-18 16:14:13.64581
NCT00379717|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2008-03-12|||November 2006||2006-11-01|September 2006|2006-09-01|April 2008||2008-04-01|||||Interventional|||Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)|Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC): a Phase I/II Trial of Radiation Dose Escalation and Fixed Dose Chemotherapy.|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|AZ-VUB||5|||f||||||||||||||2017-02-18 16:14:13.744784|2017-02-18 16:14:13.744784
NCT00379704|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2011-12-07|||October 2006||2006-10-01|March 2007|2007-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||TIFACT Study - Tissue Factor Expression by Adipose Tissue in Extremely Obese Subjects.|TIFACT Study - Tissue Factor Expression by Adipose Tissue in Extremely Obese Subjects. Relationship With Circulating Tissue Factor and Coagulation Activation Markers|Completed||N/A|85|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples Without DNA|"~     samples of plasma and serum and greasy fragments~   "|||2017-02-18 16:14:13.842304|2017-02-18 16:14:13.842304
NCT00379691|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2007-03-19|||August 2006||2006-08-01|March 2007|2007-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Ideal Dose of Phenylephrine to Treat Low Blood Pressure During Cesarean Section|Phenylephrine Dose-Finding Study to Minimize Hypotension Due to Spinal Anesthesia for Cesarean Section|Completed||N/A|50||Samuel Lunenfeld Research Institute, Mount Sinai Hospital|||||f||||f||||||||||2017-02-18 16:14:13.928381|2017-02-18 16:14:13.928381
NCT00379678|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2014-09-24|||September 2006||2006-09-01|September 2014|2014-09-01|March 2007|Actual|2007-03-01|||||Observational|||Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis|A Pilot Ex-vivo Study to Evaluate the Effect of Pimecrolimus on Antimicrobial Peptide Expression and Vaccinia Virus Growth in Perilesional Skin Cultures of Patients With Atopic Dermatitis|Completed||Phase 4|28|Anticipated|National Jewish Health|||1||f||||||||||||||2017-02-18 16:14:14.023779|2017-02-18 16:14:14.023779
NCT00379665|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2012-12-10|||October 2005||2005-10-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|December 2010|Actual|2010-12-01||Interventional|||Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy|Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy|Completed||Phase 2|25|Actual|Southwestern Regional Medical Center||1|||f||||f||||||||||2017-02-18 16:14:14.123719|2017-02-18 16:14:14.123719
NCT00379652|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2015-05-19|||October 2009||2009-10-01|August 2009|2009-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|CHAMPP||Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes|Community, Health Center, and Academic Medicine Partnership Project (CHAMPP)|Completed||N/A|1204|Anticipated|Harvard Medical School||4|||f||||t||||||||||2017-02-18 16:14:14.245684|2017-02-18 16:14:14.245684
NCT00379639|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2012-07-05|2012-07-05||July 2006||2006-07-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors|A Phase I/II Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors.|Completed||Phase 1|36|Actual|Celgene||1|||f||||||||||||||2017-02-18 16:14:14.366636|2017-02-18 16:14:14.366636
NCT00379626|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2017-02-13|||August 2003|Actual|2003-08-01|February 2017|2017-02-01|August 2010|Actual|2010-08-01|August 2008|Actual|2008-08-01||Interventional|||Cognitive and Hormonal Treatment of Sex Offenders|Cognitive Group and Hormonal Treatment of Sex Offenders.|Terminated||Phase 1|5|Actual|Norwegian University of Science and Technology||1||too few patients participated|f||||f||||||||||2017-02-18 16:14:15.814462|2017-02-18 16:14:15.814462
NCT00379613|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2015-05-19|||November 2003||2003-11-01|May 2015|2015-05-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)|A Multi-Center Randomized Safety Assessor-Blinded Placebo-Controlled Parallel and Dose Escalating Dose-Finding Trial in Subjects of ASA 1 - 2 to Assess the Safety, Efficacy and PK of Sugammadex Administered at 5 Min. After Administration of 1.2 mg/kg Esmeron|Completed||Phase 2|45|Actual|Merck Sharp & Dohme Corp.||5|||f||||t||||||||||2017-02-18 16:14:15.926005|2017-02-18 16:14:15.926005
NCT00379405|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2008-10-10|||June 2006||2006-06-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment|Open-Label, Comparative and Randomised Pilot Study to Evaluate the Efficacy and Safety of Saquinavir/Ritonavir in Single Therapy vs Standard HAART Therapy as Maintenance Therapy.|Completed||Phase 4|30|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 16:14:18.45844|2017-02-18 16:14:18.45844
NCT00379600|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2016-10-24|||November 2004||2004-11-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis|A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Investigate the Anti-inflammatory and Metabolic Effects of Rosiglitazone XR, 8mg Once Daily, in Subjects With Rheumatoid Arthritis|Completed||Phase 2|96|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:14:16.040034|2017-02-18 16:14:16.040034
NCT00379587|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2014-02-03|2014-02-03||September 2006||2006-09-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Rituximab for Prevention of Chronic GVHD|A Phase II Trial of Prophylactic Rituximab Therapy for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation|Completed||Phase 1/Phase 2|65|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:14:16.152957|2017-02-18 16:14:16.152957
NCT00379574|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2013-03-13|2011-02-04||September 2006||2006-09-01|March 2013|2013-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL|A Phase I/II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients With Advanced Stage Diffuse Large B-cell Lymphomas|Completed||Phase 1/Phase 2|49|Actual|Asan Medical Center||1|||f||||t||||||||||2017-02-18 16:14:16.416848|2017-02-18 16:14:16.416848
NCT00379561|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2009-10-27|||March 2006||2006-03-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|May 2007|Actual|2007-05-01||Interventional|||PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer|A Phase 1 Trial of PSA-Activated PSA-PAH1 Therapy for Locally Recurrent Prostate Cancer Without Metastases After Primary Radiation Therapy|Completed||Phase 1|36|Anticipated|Sophiris Bio Corp|||||||||||||||||||2017-02-18 16:14:16.711986|2017-02-18 16:14:16.711986
NCT00379548|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2014-03-25|||November 2005||2005-11-01|March 2014|2014-03-01|December 2014|Anticipated|2014-12-01|July 2008|Actual|2008-07-01||Interventional|||Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diets to American Diet - a Pilot Study|A Pilot Study of the Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diet to Typical American Diets|Unknown status|Active, not recruiting|N/A|50|Actual|Joslin Diabetes Center||2|||f||||t||||||||||2017-02-18 16:14:16.807506|2017-02-18 16:14:16.807506
NCT00379535|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2011-10-10|||December 2006||2006-12-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|December 2008|Actual|2008-12-01||Interventional|||Preventing Lack of Iodine During Pregnancy|Phase III : Preventing Lack of Iodine During Pregnancy. Effect of Supplying Woman With Potassium Iodine to the Neuro-Cognitive Children Development Until Two Years|Terminated||Phase 3|374|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 16:14:16.902953|2017-02-18 16:14:16.902953
NCT00379522|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2014-11-04|||July 2010||2010-07-01|November 2014|2014-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Vasopressin in Traumatic Hemorrhagic Shock Study|A Multicenter, Randomized, Controlled Trial Assessing Arginine Vasopressin Versus Saline Placebo in Refractory Traumatic Hemorrhagic Shock Patients (VITRIS-study)|Completed||Phase 2/Phase 3|64|Actual|Medical University Innsbruck||2|||f||||t||||||||||2017-02-18 16:14:17.193459|2017-02-18 16:14:17.193459
NCT00379509|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2016-01-17|||April 2006||2006-04-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|June 2010|Actual|2010-06-01||Interventional|||Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer|Phase I Radiosensitization Study of GW572016 With Biologic Correlates in Locoregionally Recurrent Breast Cancer|Completed||Phase 1|20|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:14:17.333743|2017-02-18 16:14:17.333743
NCT00379496|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-21|2006-09-21|||April 2000||2000-04-01|September 2006|2006-09-01|May 2002||2002-05-01|||||Interventional|||Trial of Acupuncture Added to Usual Treatment for Fibromyalgia|A Randomized Controlled Trial of Acupuncture Added to Usual Treatment for Fibromyalgia|Completed||Early Phase 1|58||University of Sao Paulo|||||f||||||||||||||2017-02-18 16:14:17.456776|2017-02-18 16:14:17.456776
NCT00379483|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-03-18|||July 2002||2002-07-01|March 2015|2015-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload|Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload|Completed||Phase 2|66|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:14:17.567992|2017-02-18 16:14:17.567992
NCT00379470|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2012-04-29|||September 2006||2006-09-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|November 2009|Actual|2009-11-01||Interventional|||Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)|A Prospective, Multi-center Trial of NovoTTF-100A Compared to Best Standard of Care in Patients With Progressive or Recurrent GBM|Completed||Phase 3|236|Actual|NovoCure Ltd.||2|||f||||t||||||||||2017-02-18 16:14:17.682014|2017-02-18 16:14:17.682014
NCT00379457|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2013-08-09|||June 2006||2006-06-01|July 2009|2009-07-01||||May 2011|Anticipated|2011-05-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma|A Protocol For Nonmetastatic Rhabdomyosarcoma [RMS-2005]|Unknown status|Recruiting|Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:14:17.835403|2017-02-18 16:14:17.835403
NCT00379444|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2012-03-08|||November 2006||2006-11-01|September 2006|2006-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Tobacco Cessation Treatment for Pregnant Alaska Natives|Tobacco Cessation Treatment for Pregnant Alaska Natives|Completed||Phase 1/Phase 2|35|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 16:14:18.152148|2017-02-18 16:14:18.152148
NCT00379431|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2014-12-04|||November 2006||2006-11-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab|A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:14:18.246243|2017-02-18 16:14:18.246243
NCT00379418|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2013-09-11|||January 2003||2003-01-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|AIR||Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients|Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients (AIR)|Completed||Phase 4|220|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:14:18.363154|2017-02-18 16:14:18.363154
NCT00379392|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2015-04-10|||January 2003||2003-01-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|July 2008|Actual|2008-07-01||Interventional|||Mental Imagery to Reduce Motor Deficits in Stroke|Mental Imagery to Reduce Motor Deficits in Stroke|Completed||Phase 1|20|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:14:18.586091|2017-02-18 16:14:18.586091
NCT00379379|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2006-09-20|||January 2005||2005-01-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Study of Improving Insulin Sensitivity by Electroacupuncture Therapy|Study of Improving Insulin Sensitivity by Combined Both Electroacupuncture and Drug Therapy|Completed||N/A|26||China Medical University Hospital|||||f||||||||||||||2017-02-18 16:14:18.695186|2017-02-18 16:14:18.695186
NCT00379366|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2015-03-17|||December 2006||2006-12-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|RASTA||External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular Access|Efficacy and Tolerance of Transcutaneous Ionizing Radiations to Prevent Restenosis Caused by Intimal Hyperplasia on Prosthetic Haemodialysis Vascular Access|Terminated||Phase 2/Phase 3|5|Actual|University Hospital, Bordeaux||2||lack of patients|f||||t||||||||||2017-02-18 16:14:18.793815|2017-02-18 16:14:18.793815
NCT00379353|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2013-01-31|2012-07-03||September 2006||2006-09-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Effects of Thalidomide on Symptom Clusters|The Effects of Thalidomide on Symptom Clusters|Completed||Phase 2|32|Actual|M.D. Anderson Cancer Center|Limited accrual and attrition led to small sample size.|2|||f||||t||||||||||2017-02-18 16:14:18.909665|2017-02-18 16:14:18.909665
NCT00379340|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2016-10-31|||February 2007||2007-02-01|October 2016|2016-10-01||||October 2015|Actual|2015-10-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor|Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors|Active, not recruiting||Phase 3|395|Actual|Children's Oncology Group||5|||f||||t||||||||||2017-02-18 16:14:19.604199|2017-02-18 16:14:19.604199
NCT00379327|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2010-11-17|||January 2006||2006-01-01|October 2010|2010-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Acupuncture for Promotion of Timely Delivery|Acupuncture for Promotion of Timely Delivery|Completed||Phase 3|103|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 16:14:20.104594|2017-02-18 16:14:20.104594
NCT00379314|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2006-10-31|||April 2004||2004-04-01|September 2006|2006-09-01|December 2010||2010-12-01|||||Interventional|||Randomized, Multicenter Trial Comparing TVT With TVT-O for Treatment of Female Urinary Incontinence|A Randomized, Prospective, Multicenter Trial Comparing TVT With TVT-O Procedures in Treatment of Female Primary Urinary Stress Incontinence|Unknown status|Active, not recruiting|Phase 3|260||Helsinki University|||||f||||||||||||||2017-02-18 16:14:20.21061|2017-02-18 16:14:20.21061
NCT00379301|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2012-06-13|||October 2006||2006-10-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|December 2009|Actual|2009-12-01||Interventional|RASTA||Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation|Efficacy of Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Permanent Atrial Fibrillation|Completed||N/A|166|Actual|University of Pennsylvania||3|||f||||||||||||||2017-02-18 16:14:20.299087|2017-02-18 16:14:20.299087
NCT00379288|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2015-01-12|2010-07-15||June 2006||2006-06-01|January 2015|2015-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139)|A 1-Year Safety Study of Medium and High Doses of Mometasone Furoate/Formoterol Combination Formulation and Medium and High Doses of Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Medium to High Doses of Inhaled Glucocorticosteroids|Completed||Phase 3|404|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 16:14:20.416374|2017-02-18 16:14:20.416374
NCT00379275|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2017-01-24|||September 18, 2006||2006-09-18|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Eye and Immunogenetic Features of Sarcoidosis|Ocular and Immuno-Genetic Manifestations of Sarcoidosis|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:14:21.234899|2017-02-18 16:14:21.234899
NCT00379262|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2016-08-15|||September 2006||2006-09-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2017|Anticipated|2017-05-01||Interventional|||Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma|Randomized Trial to Evaluate Therapeutic Gain by Changing Chemoradiotherapy From Concurrent-adjuvant to Induction-concurrent Sequence, and Radiotherapy From Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma|Active, not recruiting||Phase 3|798|Anticipated|Hong Kong Nasopharyngeal Cancer Study Group Limited||6|||f||||t||||||||||2017-02-18 16:14:21.321808|2017-02-18 16:14:21.321808
NCT00379249|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2009-03-25|||February 2002||2002-02-01|March 2009|2009-03-01|February 2004|Actual|2004-02-01|||||Interventional|||Rosuvastatin ORBITAL Germany|Effects of a Twelve Months ROSUVASTATIN Treatment Plus Additional Care (Drug Intake Adherence and Lifestyle Enhancing Initiatives ) Compared to ROSUVASTATIN Treatment Alone on Long-Term Disease-Related Costs in Patients With an Indication for Statin Treatment According to the Joint European Guidelines|Completed||Phase 3|8000||AstraZeneca|||||f||||||||||||||2017-02-18 16:14:21.460255|2017-02-18 16:14:21.460255
NCT00379236|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2011-12-20|2009-08-12||October 2006||2006-10-01|December 2011|2011-12-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Interventional|||A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee, With an Open-Label Safety Extension|Completed||N/A|588|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-02-18 16:14:21.55776|2017-02-18 16:14:21.55776
NCT00379223|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2011-03-03|||October 2006||2006-10-01|August 2008|2008-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|OVCR||Radial Optic Neurotomy in Central Retinal Vein Occlusion : a Randomized Trial|Multicenter Trial to Investigate the Safety and Efficacy of Vitrectomy With Radial Optic Neurotomy for the Preservation of Visual Function in Subjects With Central Retinal Vein Occlusion (CRVO)|Terminated||N/A|7|Actual|University Hospital, Bordeaux||2||lack of recruting|f||||t||||||||||2017-02-18 16:14:22.601412|2017-02-18 16:14:22.601412
NCT00379210|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2011-12-20|2010-07-20||September 2006||2006-09-01|November 2007|2007-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Neural Effects of Mindfulness Training on Attention|Neural Effects of Mindfulness Training on Attention|Completed||N/A|60|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 16:14:22.710202|2017-02-18 16:14:22.710202
NCT00379197|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2013-07-25|||July 2006||2006-07-01|July 2013|2013-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Naltrexone in Treating Women With Metastatic Breast Cancer That Did Not Respond to Hormone Therapy|Phase II Study of Naltrexone for the Treatment of Hormone-Refractory, Metastatic Breast Cancer|Terminated||Phase 2|13|Actual|Masonic Cancer Center, University of Minnesota||1||slow accrual|f||||t||||||||||2017-02-18 16:14:23.083704|2017-02-18 16:14:23.083704
NCT00379171|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2008-08-13|||May 2003||2003-05-01|August 2008|2008-08-01|March 2004||2004-03-01|||||Interventional|||Milk Types and Fish Oil in 9- to 12-Month-Old Infants|The Importance of Complementary Feeding on Growth, Nutritional Status and Markers for Disease. An Intervention Study With Milk Types and LC-PUFA Supplements in 9- to 12-Month-Old Infants|Completed||N/A|100||University of Copenhagen|||||f||||||||||||||2017-02-18 16:14:23.300603|2017-02-18 16:14:23.300603
NCT00379158|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2006-09-20|||October 2003||2003-10-01|September 2006|2006-09-01|April 2005||2005-04-01|||||Interventional|||Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements in Ghana|Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements Added to Complementary Foods for Infants in Ghana|Completed||Phase 4|393||University of California, Davis|||||f||||||||||||||2017-02-18 16:14:23.39577|2017-02-18 16:14:23.39577
NCT00379145|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2015-05-29|||June 2007||2007-06-01|May 2015|2015-05-01||||January 2012|Actual|2012-01-01||Interventional|||Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus|A Phase II Evaluation of Trabectedin (Yondelis, R279741) in the Treatment of Advanced, Persistent, or Recurrent Uterine Leiomyosarcomas|Completed||Phase 2|20|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 16:14:23.607951|2017-02-18 16:14:23.607951
NCT00379132|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2009-03-30|||August 2006||2006-08-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||131-I-TM-601 Study in Adults With Solid Tumors|A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labeled Chlorotoxin in Patients With Recurrent or Refractory Somatic and/or Cerebral Metastatic Solid Tumors|Completed||Phase 1|60|Anticipated|TransMolecular||1|||f||||||||||||||2017-02-18 16:14:23.753946|2017-02-18 16:14:23.753946
NCT00379119|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2012-10-09|||January 2005||2005-01-01|October 2012|2012-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer|Androgen Blockade Therapy and Thymic Function in Individuals Over 50 Years of Age With Adenocarcinoma of the Prostate: A Cross-Sectional Study|Terminated||N/A|20|Actual|University of California, San Francisco|||1|low accrual|f||||f||||||||||2017-02-18 16:14:23.860643|2017-02-18 16:14:23.860643
NCT00379106|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2010-01-06|||October 2003||2003-10-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|December 2005|Actual|2005-12-01||Interventional|||Arm Function and Quality of Life Following Mastectomy.|Arm Function and Quality of Life Following Mastectomy.|Completed||N/A|50|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 16:14:23.959669|2017-02-18 16:14:23.959669
NCT00379093|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2009-07-10|||August 2003||2003-08-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|April 2007|Actual|2007-04-01||Interventional|HLAYA||Healthy Living as You Age|Preventing Harm From Alcohol Use in Older Adults|Completed||Phase 2|631|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||t||||||||||2017-02-18 16:14:24.059613|2017-02-18 16:14:24.059613
NCT00379080|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2013-10-07|||January 2007||2007-01-01|October 2013|2013-10-01||||September 2012|Actual|2012-09-01||Interventional|||Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma|A Feasibility Assessment and a Phase I/II Trial of MLN518 for Treatment of Patients With Recurrent Glioblastoma|Completed||Phase 1/Phase 2|85|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:14:24.160122|2017-02-18 16:14:24.160122
NCT00379067|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2014-10-08|||October 2005||2005-10-01|October 2014|2014-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.|A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Tamsulosin OCAS 0.4 mg Tablets, Once Daily on Nocturia, Compared to Placebo, in Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia|Completed||Phase 4|882|Actual|Astellas Pharma Inc||2|||f||||||||||||||2017-02-18 16:14:24.278301|2017-02-18 16:14:24.278301
NCT00379054|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2010-11-18|||September 2005||2005-09-01|November 2010|2010-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Intervention for Support Persons to Help Smokers Quit|Intervention for Support Persons to Help Smokers Quit|Completed||Phase 1/Phase 2|70||Mayo Clinic|||||f||||||||||||||2017-02-18 16:14:24.565203|2017-02-18 16:14:24.565203
NCT00379041|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2016-10-25|||September 1993||1993-09-01|October 2016|2016-10-01||||October 1998|Actual|1998-10-01||Interventional|||Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma|Protocol H8 for a Prospective Controlled Trial in Clinical Stage I-II Supradiaphragmatic Hodgkin's Disease. Evaluation of Treatment Efficacy and (Long Term) Toxicity in Three Different Prognostic Subgroups [H8 Trial]|Active, not recruiting||Phase 3|1158|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 16:14:24.663897|2017-02-18 16:14:24.663897
NCT00379028|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2011-01-21|||September 2006||2006-09-01|January 2011|2011-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Airway Clearance Study|A Randomized, Double-blind, Two-way Cross-over Study Evaluating Systemic Bioavailability and Airway Clearance of SymbicortTurbuhaler 320/9mcg vs SeretideDiskus 50/500mcg After Single Inhalations in Patients With COPD and Healthy Volunteers|Completed||Phase 4|54|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:14:24.783007|2017-02-18 16:14:24.783007
NCT00379015|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2016-09-27|||January 2006||2006-01-01|September 2016|2016-09-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer|Neoadjuvant Epirubicin/Cyclophosphamide Followed by Docetaxel Combined With Trastuzumab for the Patients With HER-Positive Advanced Breast Cancer|Completed||Phase 2|38|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||1|||f||||f||||||||||2017-02-18 16:14:24.895687|2017-02-18 16:14:24.895687
NCT00379002|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2016-08-26|||July 2006||2006-07-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|||The Women's Urology Center/WISH Database Project|The Women's Urology Center/WISH Database Project|Enrolling by invitation||N/A|10000|Anticipated|William Beaumont Hospitals|||1||f||||f||||||||No||2017-02-18 16:14:25.020133|2017-02-18 16:14:25.020133
NCT00378989|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2015-02-09|||September 2004||2004-09-01|February 2015|2015-02-01|October 2006|Actual|2006-10-01|October 2005|Actual|2005-10-01||Interventional|||The Effectiveness of Health Advice and Occupational Health Intervention on Work Ability|The Effectiveness and Cost-effectiveness of Health Advice and Occupational Health Intervention on Work Ability. Two Randomised Trials.|Completed||N/A|418|Actual|Evalua International||2|||f||||f||||||||||2017-02-18 16:14:25.119555|2017-02-18 16:14:25.119555
NCT00005742|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||September 1995||1995-09-01|May 2005|2005-05-01|August 2001|Actual|2001-08-01|||||Observational|||Behavioral Interventions for Control of Tuberculosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:24.922677|2017-02-18 18:14:24.922677
NCT00378976|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2013-08-21|||August 2003||2003-08-01|August 2013|2013-08-01|July 2004|Actual|2004-07-01|||||Interventional|||HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.|A Randomized, Double-blind, Placebo-controlled Crossover Trial of Valacyclovir for Suppression of HSV and HIV Shedding in HIV-1, HSV-2 Coinfected Men Who Have Sex With Men (MSM).|Completed||Phase 3|20|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 16:14:25.231576|2017-02-18 16:14:25.231576
NCT00378963|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2007-07-31||||||May 2007|2007-05-01||||||||Interventional|||Instrument Applied and Manual Manipulation Induced EMG Response in Asymptomatic Subjects||Unknown status|Recruiting|N/A|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:14:25.342424|2017-02-18 16:14:25.342424
NCT00378950|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2016-05-27|||March 2007||2007-03-01|May 2016|2016-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure|Health Literacy and Self-Management in Heart Failure|Completed||N/A|605|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 16:14:25.428183|2017-02-18 16:14:25.428183
NCT00378937|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2013-08-01|||January 2004||2004-01-01|July 2007|2007-07-01|February 2006|Actual|2006-02-01|||||Interventional|||Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain|An Open, Randomized, Parallel Group Study in Patients With Cancer Pain, To Compare a Two-Step Analgesic Ladder (Non-Opioid to Oxycodone) With Conventional Management Using A Three-Step Approach|Completed||Phase 4|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:14:25.553108|2017-02-18 16:14:25.553108
NCT00378924|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2016-07-21|||December 2003||2003-12-01|July 2016|2016-07-01|April 2020|Anticipated|2020-04-01|March 2020|Anticipated|2020-03-01||Observational|||Cardiology Biobank Registry|Cardiology Biobank Registry|Recruiting||Phase 1|12000|Anticipated|Emory University|||1||f||||f||||||Samples With DNA|"~     60 cc of blood will be obtained from the participant. Blood will be processed and stored in~     -80F freezers as plasma, serum, extracted DNA and whole blood.~   "|||2017-02-18 16:14:25.644129|2017-02-18 16:14:25.644129
NCT00378911|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2014-06-11|||October 2006||2006-10-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|June 2007|Actual|2007-06-01||Interventional|||Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus|A Phase II Evaluation of Sunitinib Malate (Sutent®, SU11248, NCI-Supplied Agent , NSC # 736511) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:14:25.741778|2017-02-18 16:14:25.741778
NCT00378898|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2014-12-11|||September 2006||2006-09-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|bravo||Feasibility of Placing Bravo PH Capsule in Proximal Esophagus|DUAL BRAVO PH MONITORING: A Feasibility Trial|Completed||Phase 3|25|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:14:25.854294|2017-02-18 16:14:25.854294
NCT00378885|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2006-09-20|||January 2003||2003-01-01|September 2006|2006-09-01|August 2003||2003-08-01|||||Interventional|||Effect Study of a Theory-Based Internet Intervention on Safe-Sex Practices|The Effect of a Theory Based Tailored Intervention Online on the Reduction of Risk Behavior for HIV Transmission Among Men Who Have Sex With Men - a Randomized, Single-Blind, Active (Waiting-List) Controlled Trial|Terminated||N/A|642||Public Health Service of Amsterdam|||||f||||||||||||||2017-02-18 16:14:25.963279|2017-02-18 16:14:25.963279
NCT00378820|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2009-01-20|||July 2004||2004-07-01|September 2006|2006-09-01|April 2005||2005-04-01|||||Interventional|||The Effect of Whey and Casein on IGFs in Prepubertal Boys|The Effect of Whey and Casein With and Without Milk Minerals on IGFs in Prepubertal Boys|Unknown status|Active, not recruiting|N/A|60||University of Copenhagen|||||f||||||||||||||2017-02-18 16:14:26.05723|2017-02-18 16:14:26.05723
NCT00378781|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2012-02-22||||||February 2012|2012-02-01||||||||Interventional|||Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection|Prospective, Randomized Trial Comparing Heparin and Minocycline-EDTA Flush for the Prevention of Catheter-Related Infections and Occlusions|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||2||Study withdrawn.|f||||f||||||||||2017-02-18 16:14:26.16733|2017-02-18 16:14:26.16733
NCT00378768|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2011-11-28|||November 2005||2005-11-01|November 2011|2011-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma|A Phase II Study of Thymoglobulin in Patients With Multiple Myeloma Who Are Candidates for Allogeneic or Autologous Stem Cell Transplant|Completed||Phase 2|12|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 16:14:26.316563|2017-02-18 16:14:26.316563
NCT00378755|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2006-09-21|||March 2006||2006-03-01|September 2006|2006-09-01|July 2008||2008-07-01|||||Interventional|||Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM|Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Velcade, Thalidomide, Dexamethasone) Induction Followed by HDT With ASCT and Maintenance Treatment With Velcade for Newly Diagnosed MM|Unknown status|Recruiting|Phase 2|62||Korean Multiple Myeloma Working Party|||||f||||||||||||||2017-02-18 16:14:26.408342|2017-02-18 16:14:26.408342
NCT00378742|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2017-01-24|||September 6, 2006||2006-09-06|April 14, 2016|2016-04-14||||||||Observational|||Repository for Inherited Eye Diseases|National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases|Suspended||N/A|1107|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:14:26.501464|2017-02-18 16:14:26.501464
NCT00378729|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2011-10-03|||October 2006||2006-10-01|October 2007|2007-10-01|October 2011|Anticipated|2011-10-01|October 2011|Anticipated|2011-10-01||Interventional|PERCING||Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS)|PERCING : Ovarian Drilling Versus Ovarian Stimulation + Intra Uterine Insemination (IUI) + Metformin in the PCOS (PolyCystic Ovaries Syndrome) Treatment|Unknown status|Recruiting|Phase 4|252|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 16:14:26.626892|2017-02-18 16:14:26.626892
NCT00378716|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2010-01-08|||February 1997||1997-02-01|January 2010|2010-01-01|April 2009|Actual|2009-04-01|May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Resected Colon Cancer|A Clinical Trial Comparing Oral Uracil/Ftorafur (UFT) Plus Leucovorin (LV) With 5-Fluorouracil (5-FU) Plus LV in the Treatment of Patients With Stages II And III Carcinoma of the Colon|Completed||Phase 3|1608|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 16:14:26.742162|2017-02-18 16:14:26.742162
NCT00378118|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2007-11-05|||December 2006||2006-12-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Observational|||Use of OraQuick for Screening HIV in Children Less Than Eighteen Months Old|Evaluation of the Use of OraQuick in Children Less Than Eighteen Months Old|Completed||N/A|1000|Actual|Thrasher Research Fund|||1||f||||t||||||||||2017-02-18 16:14:42.379723|2017-02-18 16:14:42.379723
NCT00378703|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2016-12-28|2015-04-14||September 2007||2007-09-01|December 2016|2016-12-01||||February 2014|Actual|2014-02-01||Interventional||Eligible and treated patients are included in this analysis.|Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer|The BeST Trial: A Randomized Phase II Study of VEGF, RAF Kinase, and mTOR Combination Targeted Therapy (CTT) With Bevacizumab, Sorafenib and Temsirolimus in Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 2|361|Actual|National Cancer Institute (NCI)||4|||f||||f||||||||||2017-02-18 16:14:26.870289|2017-02-18 16:14:26.870289
NCT00378690|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2014-06-02|||March 2006||2006-03-01|June 2014|2014-06-01|December 2012|Actual|2012-12-01|June 2011|Actual|2011-06-01||Interventional|ICELAND||A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD|A Phase IIIb Randomized Study of Intermittent Versus Continuous Androgen Deprivation Therapy Using ELIGARD 22.5 mg 3-month Depot in Subjects With Relapsing and Locally Advanced Prostate Cancer Who Are Responsive to Such Therapy|Completed||Phase 3|706|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:14:29.229887|2017-02-18 16:14:29.229887
NCT00378677|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-20|2007-02-06|||February 2007||2007-02-01|February 2007|2007-02-01||||||||Interventional|||Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome|Pilot Study of Cyclosporine A Dry Powder Inhalation in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome|Unknown status|Recruiting|Early Phase 1|7||University Medical Center Groningen|||||f||||||||||||||2017-02-18 16:14:29.403422|2017-02-18 16:14:29.403422
NCT00378664|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2015-10-13|||September 2006||2006-09-01|October 2015|2015-10-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Lumbar to Sacral Ventral Nerve Re-Routing|Lumbar to Sacral Ventral Nerve Re-Routing|Completed||Phase 2|13|Actual|William Beaumont Hospitals||1|||f||||t||||||||||2017-02-18 16:14:29.712301|2017-02-18 16:14:29.712301
NCT00378651|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2007-12-14|||September 2006||2006-09-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Use of the Stethoscope to Confirm Breathing Tube Placement|Differentiation Between Esophageal and Tracheal Intubation Utilizing Neck Auscultation|Completed||N/A|23||University of Manitoba|||||f||||||||||||||2017-02-18 16:14:29.817355|2017-02-18 16:14:29.817355
NCT00378638|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2007-10-23|||June 2006||2006-06-01|October 2007|2007-10-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study|Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymp Node Positive Breast Cancer: A Pilot Study|Unknown status|Recruiting|Phase 2|30|Anticipated|Chap, Linnea I., M.D.|||||f||||f||||||||||2017-02-18 16:14:29.895761|2017-02-18 16:14:29.895761
NCT00378625|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2006-09-19|||April 2000||2000-04-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in Colombia|Randomised, Double Blind Clinical Trial of the Efficacy, Effect on Gametocytes and Tolerability of Amodiaquine Vs Amodiaquine Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Quibdo, Colombia|Completed||Phase 3|360||Centro Internacional de Entrenamiento e Investigaciones Médicas|||||f||||||||||||||2017-02-18 16:14:29.992587|2017-02-18 16:14:29.992587
NCT00378612|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2014-09-11|||June 2005||2005-06-01|September 2014|2014-09-01|September 2012|Actual|2012-09-01|April 2007|Actual|2007-04-01||Interventional|||ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial|Approaches to Chronic Occlusions With Sirolimus Stents-Cypher (ACROSS-Cypher) Total Occlusion Study of Coronary Arteries 4 Trial|Completed||Phase 3|200|Actual|Duke University||1|||f||||t||||||||||2017-02-18 16:14:30.079647|2017-02-18 16:14:30.079647
NCT00378599|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2015-04-07|2010-06-17||May 2006||2006-05-01|April 2015|2015-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)|PROTECT - Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation: Efficacy and Safety in Hepatitis C Recurrence Therapy|Completed||Phase 3|125|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 16:14:30.225881|2017-02-18 16:14:30.225881
NCT00378586|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2009-06-22|||January 2010||2010-01-01|June 2009|2009-06-01||||||||Observational|||Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic Shock|Barrier Function and Production of Inflammatory Cytokines in the Rectal Mucosa in Patients With Septic Shock|Unknown status|Not yet recruiting|N/A|30|Anticipated|Herlev Hospital|||1||f||||||||||||||2017-02-18 16:14:30.521244|2017-02-18 16:14:30.521244
NCT00378573|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2010-01-21|2009-09-17||January 2007||2007-01-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II, Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Terminated||Phase 2|17|Actual|Sanofi|Due to early termination of the study only 17/90 subjects enrolled. Efficacy analysis of Progression Free Survival and Overall Survival were not performed. Efficacy results limited to a descriptive summary of best overall response for each subject.|1||Incidence of GI Perforation|f||||||||||||||2017-02-18 16:14:33.158659|2017-02-18 16:14:33.158659
NCT00378560|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2015-03-23|2010-04-21||June 2006||2006-06-01|March 2015|2015-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||V501 Efficacy Study in Women Aged 18 to 26 (V501-027)|V501 Phase II Efficacy Study in Women Aged 18 to 26|Completed||Phase 2|1021|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:14:33.677148|2017-02-18 16:14:33.677148
NCT00378547|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2009-12-31|||January 2006||2006-01-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Having a Tonsillectomy|Effect of Paracetamol Versus Paracetamol Combined With Pregabalin Versus Paracetamol Combined With Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Tonsillectomy|Terminated||Phase 4|147|Actual|Glostrup University Hospital, Copenhagen||3||ENT surgery stopped at the recruiting hospital|f||||t||||||||||2017-02-18 16:14:36.887535|2017-02-18 16:14:36.887535
NCT00378534|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2015-10-05|2014-12-22||September 2006||2006-09-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants|Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back|Completed||Phase 2|115|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 16:14:37.002|2017-02-18 16:14:37.002
NCT00378521|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2007-05-29|||July 2006||2006-07-01|May 2007|2007-05-01|July 2006|Actual|2006-07-01|||||Interventional|||Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon|Phase II Dose Response Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, in the Treatment of Raynaud's Phenomenon|Completed||Phase 2|15|Anticipated|MediQuest Therapeutics|||||||||||||||||||2017-02-18 16:14:37.253563|2017-02-18 16:14:37.253563
NCT00378508|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2016-07-05|2012-09-04||September 2006||2006-09-01|July 2016|2016-07-01|August 2013|Actual|2013-08-01|August 2011|Actual|2011-08-01||Interventional|||Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes|Phase II Trial of hOKT3gamma1(Ala-Ala) Teplizumab for Treatment of Patients With Recent Onset Type 1 Diabetes|Completed||Phase 2|63|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:14:37.605529|2017-02-18 16:14:37.605529
NCT00378495|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2016-07-11|||April 2005||2005-04-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|April 2007|Actual|2007-04-01||Interventional|||Miltefosine for Brazilian Visceral Leishmaniasis||Terminated||Phase 1/Phase 2|80|Anticipated|AB Foundation||||accrual criteria being reviewed|f||||||||||||||2017-02-18 16:14:38.200524|2017-02-18 16:14:38.200524
NCT00378482|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2016-11-15|||March 2008||2008-03-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||A Rollover Study for Patients Who Received CP-675,206 in Other Protocols, to Allow the Patients Access to CP-675,206 Until This Agent Becomes Commercially Available or Development is Discontinued.|A Rollover Protocol For Patients Who Received CP-675,206 In Other Protocols|Active, not recruiting||Phase 2|38|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 16:14:38.303774|2017-02-18 16:14:38.303774
NCT00378469|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2007-07-11|||September 2006||2006-09-01|May 2007|2007-05-01||||||||Interventional|||Study of the Effects of Muscular Activity on Iron Metabolism|Study of the Effects of Muscular Activity on Iron Metabolism: A Pilot Study on Healthy Volunteers|Unknown status|Recruiting|N/A|14|Anticipated|Rennes University Hospital||2|||f||||f||||||||||2017-02-18 16:14:38.433696|2017-02-18 16:14:38.433696
NCT00378456|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2006-09-19||||||September 2006|2006-09-01||||||||Interventional|||Vitamins and Minerals for Children With Downs Syndrome||Completed||N/A|||Institute of Child Health|||||f||||||||||||||2017-02-18 16:14:38.523783|2017-02-18 16:14:38.523783
NCT00378443|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2006-09-21|||January 2006||2006-01-01|September 2006|2006-09-01|June 2007||2007-06-01|||||Interventional|||ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT||Unknown status|Active, not recruiting|N/A|||Peking University|||||f||||||||||||||2017-02-18 16:14:38.618018|2017-02-18 16:14:38.618018
NCT00378430|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2013-09-23|||September 2006||2006-09-01|September 2013|2013-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||" Patients Attitude Towards Physicians and Health Screening Issues Among First Generation Asian-Indian Immigrants to United States."||Terminated||N/A|200|Anticipated|University of California, San Francisco||||poor response to questionnaire|f||||||||||||||2017-02-18 16:14:38.712101|2017-02-18 16:14:38.712101
NCT00378417|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2006-09-19|||March 1995||1995-03-01|September 2006|2006-09-01|March 1999||1999-03-01|||||Interventional|||Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes|Efficacy Trial in Finnish Children of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Pneumococcal Serotypes in the Vaccines|Completed||Phase 3|3075||National Institute for Health and Welfare, Finland|||||||||||||||||||2017-02-18 16:14:38.788185|2017-02-18 16:14:38.788185
NCT00378404|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2015-06-03|||November 2004||2004-11-01|June 2015|2015-06-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC|A Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|10|Actual|University of Kentucky||1||Slow accrual|f||||f||||||||||2017-02-18 16:14:38.900156|2017-02-18 16:14:38.900156
NCT00378391|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2007-06-19|||November 2005||2005-11-01|June 2007|2007-06-01|February 2007||2007-02-01|||||Observational|||European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry|European Registry on Patients With ST-Elevation MI Transferred for Mechanical Reperfusion (PCI)With a Special Focus on Upstream Use of Abciximab|Completed||N/A|1800||Jagiellonian University|||||f||||||||||||||2017-02-18 16:14:39.013964|2017-02-18 16:14:39.013964
NCT00378378|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2015-05-27|2009-06-24||July 2006||2006-07-01|May 2015|2015-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)|Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old|Completed||Phase 3|127|Actual|Merck Sharp & Dohme Corp.|The standard deviation is pooled for Primary and Secondary Outcome Measures.|8|||f||||f||||||||||2017-02-18 16:14:39.127594|2017-02-18 16:14:39.127594
NCT00378365|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2014-04-15|||October 2006||2006-10-01|March 2007|2007-03-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Acute Promyelocytic Leukemia 2006 (APL)|A Randomized Trial Assessing the Role of Arsenic Trioxide and/or ATRA During Consolidation Course in Newly Diagnosed Acute Promyelocytic Leukemia (APL)|Unknown status|Recruiting|Phase 3|800|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:14:39.626726|2017-02-18 16:14:39.626726
NCT00378352|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2012-06-28|||September 2005||2005-09-01|October 2010|2010-10-01|January 2011|Actual|2011-01-01|July 2009|Actual|2009-07-01||Interventional|||REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction|Effects of Erythropoietin on Infarct Size and Left Ventricular Remodeling in Survivors of Large Myocardial Infarctions|Completed||Phase 2|250|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-02-18 16:14:39.987951|2017-02-18 16:14:39.987951
NCT00378339|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-19|2014-03-28|||January 2009||2009-01-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Gold Against Pains From Osteoarthrosis in the Knee|Clinical Effects From Implants of Gold Around the Arthrotic Knee Joint. A Randomized, Double Blind, Placebo Controlled Investigation.|Withdrawn||Phase 2|0|Actual|Northern Orthopaedic Division, Denmark||||Withdrawn because of lack of approvement from local medical authorities|f||||||||||||||2017-02-18 16:14:40.133235|2017-02-18 16:14:40.133235
NCT00378326|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2016-01-26|2015-11-02||April 2006||2006-04-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Immunotherapy of the Paraneoplastic Syndromes|Immunotherapy of the Paraneoplastic Syndromes|Completed||N/A|26|Actual|Rockefeller University||1|||f||||t||||||||||2017-02-18 16:14:40.227888|2017-02-18 16:14:40.227888
NCT00378313|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2008-11-24|||November 2001||2001-11-01|November 2008|2008-11-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer|A Phase 2 Study of Neoadjuvant Chemotherapy With Gemcitabine, Epirubicin and Paclitaxel (Taxol)[GET] in Locally Advanced Breast Cancer|Completed||Phase 2|76||NSABP Foundation Inc|||||f||||||||||||||2017-02-18 16:14:40.583682|2017-02-18 16:14:40.583682
NCT00378300|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2016-03-14|||July 2007||2007-07-01|March 2016|2016-03-01|June 2008|Anticipated|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Effects of Probiotics in Atopic Dermatitis|Probiotics Ameliorate Atopic Dermatitis by Induction of T Regulatory Cells|Withdrawn||N/A|0|Actual|University of California, Los Angeles||1||Inadequate funding to support this fellow-in-training initiated study.|f||||f||||||||||2017-02-18 16:14:40.694228|2017-02-18 16:14:40.694228
NCT00378287|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2012-12-07|||October 2005||2005-10-01|December 2012|2012-12-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole|A Randomized, Controlled, Double-blind, Cross-over Study of the Effect of Oral Rabeprazole 20mg and Intravenous Pantoprazole 40mg on Intragastric pH in Patients|Completed||Phase 1|37|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 16:14:40.804276|2017-02-18 16:14:40.804276
NCT00378274|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2007-11-15|||September 2006||2006-09-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Observational|||Descriptive Study of Pain, Anxiety and Depression|Pain, Anxiety and Depression in Chronic Pain Patients With and Without Neuropathic Pain Compared With Healthy Volunteers|Completed||N/A|75|Anticipated|Danish Pain Research Center|||||f||||t||||||||||2017-02-18 16:14:40.896436|2017-02-18 16:14:40.896436
NCT00378261|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2011-05-18|||January 2004||2004-01-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||APART Advanced Profiling of Anti-Rheumatic Therapies|A Multicenter, Randomized, Open Study to Evaluate the Impact of an Electronic Data Capture System on the Care of Patients With Rheumatoid Arthritis|Completed||Phase 4|1079|Actual|Centocor Ortho Biotech Services, L.L.C.||1|||f||||||||||||||2017-02-18 16:14:40.991991|2017-02-18 16:14:40.991991
NCT00378248|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2013-11-26|||May 2004||2004-05-01|November 2013|2013-11-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Ullevål PersonalityProject|Ullevål PersonalityProject. A Randomized Controlled Trial of Intensive Daytreatment Followed by Outpatient Long-term Combined Treatment Compared With Eclectic Individual Therapy for Patients With Personality Disorders|Unknown status|Active, not recruiting|N/A|120|Anticipated|Oslo University Hospital||2|||f||||||||||||||2017-02-18 16:14:41.086231|2017-02-18 16:14:41.086231
NCT00378235|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2014-11-11||||||November 2014|2014-11-01||||||||Interventional|||Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma|Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma|Withdrawn||Phase 1/Phase 2|0|Actual|INSYS Therapeutics Inc||||"There was a change of sponsor. The new sponsor company did not wish to conduct the study after~   all."|||||||||||||||2017-02-18 16:14:41.224336|2017-02-18 16:14:41.224336
NCT00378222|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2006-09-18|||January 1996||1996-01-01|September 2006|2006-09-01|November 2005||2005-11-01|||||Interventional|||Autologous Transplantation for Multiple Myeloma|A Prospective, Randomized Study of Single Versus Double Autologous Stem Cell Transplantation for Multiple Myeloma|Completed||Phase 3|324||University of Bologna|||||f||||||||||||||2017-02-18 16:14:41.324982|2017-02-18 16:14:41.324982
NCT00378209|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2016-10-18|2013-10-15||August 2006||2006-08-01|October 2016|2016-10-01|October 2016|Actual|2016-10-01|October 2012|Actual|2012-10-01||Interventional||65 patients were enrolled and 64 were treated. One patient who was never treated was excluded from the analysis.|Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma|Am Open-Label Phase II Study of the Safety and Efficacy of Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma|Completed||Phase 2|65|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:14:41.420236|2017-02-18 16:14:41.420236
NCT00378196|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2012-11-12|||September 2006||2006-09-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|September 2007|Actual|2007-09-01||Interventional|||Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial|Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial|Completed||Phase 1|10|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 16:14:41.753955|2017-02-18 16:14:41.753955
NCT00378183|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2010-04-26|||February 2001||2001-02-01|April 2010|2010-04-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.|A Randomized Open-Label, Rater Blinded Assessment of Optimal Treatment Change Strategy to Risperidone for Patients Intolerant of Olanzapine|Completed||Phase 4|120|Actual|Janssen, LP||1|||f||||||||||||||2017-02-18 16:14:41.873795|2017-02-18 16:14:41.873795
NCT00378170|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2006-12-01|||January 2006||2006-01-01|November 2006|2006-11-01||||||||Interventional|||Laryngoscope Prototype Tested Against the Traditional Macintosh Blade||Unknown status|Recruiting|N/A|210||Herlev Hospital|||||f||||||||||||||2017-02-18 16:14:41.962664|2017-02-18 16:14:41.962664
NCT00378157|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2011-02-21|||September 2006||2006-09-01|February 2011|2011-02-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Joint Attention Intervention and Young Children With Autism|Effectiveness of Joint Attention Intervention in Young Children With Autism - a Randomized Study|Completed||Phase 1/Phase 2|61|Actual|Oslo University Hospital||1|||f||||||||||||||2017-02-18 16:14:42.052568|2017-02-18 16:14:42.052568
NCT00378144|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2012-07-06|||January 2007||2007-01-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold|A Community Pharmacy Based Investigation in the Self-Medication Area Efficacy and Safety of Sinutab and Pseudoephedrine on Subjects With Nasal Congestion Accompanied by Headache in the Setting of a Common Cold|Completed||Phase 4|469|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||f||||||||||2017-02-18 16:14:42.152434|2017-02-18 16:14:42.152434
NCT00378131|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2013-08-30|||September 2006||2006-09-01|August 2013|2013-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia|A 12-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Phase II Study Comparing the Safety, Tolerability and Beneficial Effects of Daily Doses of RC-1291 and Placebo in Patients With Cancer Anorexia/Cachexia|Completed||Phase 2|51|Actual|Helsinn Therapeutics (U.S.), Inc||3|||f||||t||||||||||2017-02-18 16:14:42.270082|2017-02-18 16:14:42.270082
NCT00378105|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2016-01-21|2013-10-15||September 2006||2006-09-01|January 2016|2016-01-01|February 2016|Anticipated|2016-02-01|July 2009|Actual|2009-07-01||Interventional||The numbers excluded 2 patients who went off study prior to start of therapy (phase I part).|Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma|An Open-Label Phase I/II Study of the Safety and Efficacy of Bortezomib, Lenalidomide and Dexamethasone Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma|Active, not recruiting||Phase 1/Phase 2|68|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:14:42.489913|2017-02-18 16:14:42.489913
NCT00378092|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2014-05-07|||April 2006||2006-04-01|May 2014|2014-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode|A Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia|Completed||Phase 4|33|Actual|Janssen Cilag N.V./S.A.||2|||f||||f||||||||||2017-02-18 16:14:43.158232|2017-02-18 16:14:43.158232
NCT00378079|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2014-04-01|2013-08-14||September 2003||2003-09-01|April 2014|2014-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|MMP||Methadone Maintenance for Prisoners|Methadone Maintenance for Prisoners|Completed||Phase 3|211|Actual|Friends Research Institute, Inc.|See 2009 manuscript published in the Journal of Substance Abuse Treatment for the a discussion of study limitations. The study was conducted only on males from Baltimore. For results regarding HIV risk behaviors see manuscript by Wilson et. al.|3|||f||||t||||||||||2017-02-18 16:14:43.290966|2017-02-18 16:14:43.290966
NCT00378066|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2013-01-21|||August 2006||2006-08-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|August 2006|Actual|2006-08-01||Interventional|||Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer|A Phase II Study of Combination Chemotherapy With Bevacizumab, Capecitabine and Oxaliplatin in Patients With Previously Untreated Metastatic or Recurrent Colorectal Cancer|Completed||Phase 2|49|Actual|Asan Medical Center||1|||f||||t||||||||||2017-02-18 16:14:43.858939|2017-02-18 16:14:43.858939
NCT00378053|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2007-08-14|||September 2006||2006-09-01|August 2007|2007-08-01|December 2006||2006-12-01|||||Observational|||A Prospective Study of Radiation Exposure to Surgeons|A Prospective Study of Radiation Exposure to Surgeons|Completed||N/A|4||Vanderbilt University|||||f||||||||||||||2017-02-18 16:14:43.963443|2017-02-18 16:14:43.963443
NCT00378040|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2016-05-12|||June 2004||2004-06-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2006|Actual|2006-12-01||Observational|||Systematic Assessment of Vascular Risk|Toronto Vascular Disease Risk Factor Assessment Program: Systematic Assessment of Vascular Risk|Completed||N/A|800|Actual|University Health Network, Toronto|||1||f||||f||||||||Yes|See JAMA Surgery 2016 epublished First Author Dr M Hussain|2017-02-18 16:14:44.039973|2017-02-18 16:14:44.039973
NCT00378027|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2017-01-26|||August 2006|Actual|2006-08-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux|Phase IV, Single Arm Study to Obtain Information Regarding the Safety and Efficacy of Fondaparinux Given Outpatient for Treatment of Acute Pulmonary Embolism|Withdrawn||N/A|0|Actual|The Cleveland Clinic|||1|enrollment criteria not met by PI patient population|f||||f|t|f|||t|||No||2017-02-18 16:14:44.115503|2017-02-18 16:14:44.115503
NCT00378014|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2015-01-19|2014-01-16||August 2006||2006-08-01|January 2015|2015-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy|Presentation of Renal Function in Liver Transplant Recipients With Certican Therapy: PROTECT Study A Twelve-month, Multicenter, Randomized, Open-label Study of Safety, Tolerability and Efficacy of Certican-based Regimen Versus Calcineurin Inhibitor-based Regimen in de Novo Liver Transplant Recipients|Completed||Phase 3|276|Actual|Novartis||2|||f||||t||||||||||2017-02-18 16:14:44.242733|2017-02-18 16:14:44.242733
NCT00378001|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2015-02-12|||March 2005||2005-03-01|February 2015|2015-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF|A Prospective, Multicenter, Investigator Blinded, Randomized, Concurrent Control Study of Efficacy and Tolerability of Two FSH Preparations (Fostimon® Versus Gonal-F®) in Women Undergoing IVF|Completed||Phase 3|152||IBSA Institut Biochimique SA|||||||||||||||||||2017-02-18 16:14:46.321987|2017-02-18 16:14:46.321987
NCT00377988|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2016-07-15|||April 2002||2002-04-01|July 2016|2016-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control|The Risk of Venous Thromboembolism, Myocardial Infarction, and Ischemic Stroke Among Women Using the Transdermal Contraceptive System Compared With Women Using Norgestimate-containing Oral Contraceptives With 35 mcg Ethinyl Estradiol|Completed||N/A|423|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||2||f||||||||||||||2017-02-18 16:14:46.42545|2017-02-18 16:14:46.42545
NCT00377975|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-17|2016-01-22|||January 2003||2003-01-01|January 2016|2016-01-01|November 2004||2004-11-01|||||Interventional|||"Pecos B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat"|Synergistic Induction of UCP-1 by Ephedrine/Caffeine and Pioglitazone: A Rationale for Combination Therapy of Obesity|Completed||Phase 2|96||Pennington Biomedical Research Center|||||||||||||||||||2017-02-18 16:14:46.54451|2017-02-18 16:14:46.54451
NCT00377962|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2011-05-12|2011-03-23||December 2005||2005-12-01|May 2011|2011-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|NOCTET||Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation|Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation: Results at 24 Months|Completed||Phase 4|282|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:14:46.667992|2017-02-18 16:14:46.667992
NCT00377949|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2016-05-02|||February 2005||2005-02-01|May 2016|2016-05-01||||January 2016|Actual|2016-01-01||Observational|||Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients|The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension|Completed||N/A|602|Actual|Georgetown University|||1||f||||f||||||Samples Without DNA|"~     Serum stored for future analysis~   "|||2017-02-18 16:14:48.721723|2017-02-18 16:14:48.721723
NCT00377377|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2007-05-02|||November 2005||2005-11-01|July 2006|2006-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Oral Ghrelin Agonist in Healthy Subjects|Pharmacokinetics and Pharmacodynamic Effects of an Oral Ghrelin Agonist in Healthy Subjects|Completed||Phase 1|42||University Hospital, Basel, Switzerland|||||f||||f||||||||||2017-02-18 16:15:02.332758|2017-02-18 16:15:02.332758
NCT00377936|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2008-11-13|||September 2005||2005-09-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas|A Controlled, Randomized, Open Label Phase II Trial to Evaluate Safety and Efficacy of a 1st Line Combination Treatment With Weekly Infusions of Gemcitabine and Twice Weekly Administration of Lipid Complexed Paclitaxel (EndoTAG-1) in Three Dose Levels Compared With Gemcitabine Monotherapy in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas|Completed||Phase 2|212|Actual|MediGene||4|||f||||t||||||||||2017-02-18 16:14:49.088858|2017-02-18 16:14:49.088858
NCT00377923|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2006-09-19|||August 2005||2005-08-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers||Completed||Phase 1|24||IBSA Institut Biochimique SA|||||f||||||||||||||2017-02-18 16:14:49.199454|2017-02-18 16:14:49.199454
NCT00377910|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2014-03-28|||March 2008||2008-03-01|March 2014|2014-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy|Placebo Controlled Trial, Testing the Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles Tendinopathy.|Completed||Phase 4|48|Actual|Northern Orthopaedic Division, Denmark||2|||f||||t||||||||||2017-02-18 16:14:49.282522|2017-02-18 16:14:49.282522
NCT00377897|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2009-02-13|||January 2005||2005-01-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|September 2008|Anticipated|2008-09-01||Interventional|||Cell Therapy With Bone Marrow Mononuclear Cells in Critical Leg Ischemia (CLI)|Optimisation d'un Produit de thérapie Cellulaire Autologue Par Cellules mononucléées médullaires Dans l'ischémie Critique Des Membres inférieurs liée à l'athérosclérose|Unknown status|Recruiting|Phase 1|20|Anticipated|University of Paris 5 - Rene Descartes||1|||f||||||||||||||2017-02-18 16:14:49.403733|2017-02-18 16:14:49.403733
NCT00377884|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2014-04-02|||January 2004||2004-01-01|April 2014|2014-04-01|June 2009|Anticipated|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Serologic Characterization of Bone-healing|Serologic Based Molecular Characterization of Bone-healing After Cementless Total Hip Arthroplasty|Withdrawn||Phase 1|0|Actual|Northern Orthopaedic Division, Denmark|||1|Lack of patients, lack of funding for analysis|f||||||||||||||2017-02-18 16:14:49.505767|2017-02-18 16:14:49.505767
NCT00377871|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2015-05-31|||May 2007||2007-05-01|February 2008|2008-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Hemodynamic Performance in Stentless Heart Valves|Hemodynamic Performance in Stentless Heart Valves|Completed||N/A|15|Actual|University of Aarhus||3|||f||||f||||||||||2017-02-18 16:14:49.590706|2017-02-18 16:14:49.590706
NCT00377858|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2009-12-04|2009-09-16||August 2006||2006-08-01|December 2009|2009-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|IOOX||Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)|Comparison of Two Approaches to Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes and Inadequate Glycemic Control on Oral Therapy: Comparison of Premixed Insulin Lispro Mid Mixture With Separate Basal and Bolus Insulin Injections|Completed||Phase 4|484|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:14:49.707189|2017-02-18 16:14:49.707189
NCT00377845|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-18|2008-03-26|||September 2006||2006-09-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.|Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.|Completed||Early Phase 1|100|Anticipated|University of Aarhus|||||f||||f||||||||||2017-02-18 16:14:51.780281|2017-02-18 16:14:51.780281
NCT00377832|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2013-09-05|2010-12-22||July 2007||2007-07-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial|Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial|Terminated||N/A|13|Actual|Weill Medical College of Cornell University|Poor recruitment and lack of funding led to early termination of the trial|2||Poor recruitment and lack of funding|f||||f||||||||||2017-02-18 16:14:51.869953|2017-02-18 16:14:51.869953
NCT00377819|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2011-06-30|2010-07-01||September 2006||2006-09-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|March 2008|Actual|2008-03-01||Interventional|||Study of Transitioning From Alendronate to Denosumab|A Randomized Study to Evaluate Safety and Efficacy of Transitioning Therapy From Alendronate to Denosumab (AMG 162) in Postmenopausal Women With Low Bone Mineral Density|Completed||Phase 3|504|Actual|Amgen||2|||f||||||||||||||2017-02-18 16:14:52.364078|2017-02-18 16:14:52.364078
NCT00377806|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2007-12-07|||January 2003||2003-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins|A One Week, Double-Blind, Adaptive, Randomized, Multicenter Study to Compare the Efficacy, Safety and Tolerability of Topical Diclofenac Gel Versus Placebo in Patients With Superficial Thrombophlebitis|Completed||Phase 4|200||Novartis|||||f||||||||||||||2017-02-18 16:14:53.056361|2017-02-18 16:14:53.056361
NCT00377793|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2014-12-23|||July 2006||2006-07-01|December 2014|2014-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II|A Randomized, Double Blind, Parallel Group Study of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction and Their Female Partners Sexual Quality of Life. PARTNER II|Completed||Phase 4|352|Actual|Bayer||2|||f||||||||||||||2017-02-18 16:14:53.152064|2017-02-18 16:14:53.152064
NCT00377780|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2015-09-22|||August 2006||2006-08-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|MYOHERTAX||Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer|Phase II Multicentre Open Label Study Evaluating the Efficacy and Safety of Liposomal Doxorubicin, Trastuzumab, Docetaxel as First-line Treatment of Patients With HER2 Positive Metastatic Breast Cancer|Terminated||Phase 2|60|Actual|Catharina Ziekenhuis Eindhoven||1||wothdrawal of sponsor|f||||f||||||||||2017-02-18 16:14:53.301695|2017-02-18 16:14:53.301695
NCT00377767|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2006-09-15|||September 2006||2006-09-01|September 2006|2006-09-01|September 2009||2009-09-01|||||Interventional|||Improving Primary Care to Prevent Childhood Obesity|Improving Primary Care to Prevent Childhood Obesity|Unknown status|Recruiting|Phase 1/Phase 2|500||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 16:14:53.422545|2017-02-18 16:14:53.422545
NCT00377754|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2010-08-26|||September 2006||2006-09-01|October 2007|2007-10-01|September 2010||2010-09-01|||||Observational|||Prospective Study of Infant Dengue|A Prospective Study of Dengue Virus Infections During Infancy to Define Correlates of Protective Immunity|Unknown status|Recruiting|N/A|20000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:14:53.512653|2017-02-18 16:14:53.512653
NCT00377741|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2015-11-26|2015-11-26||December 2004||2004-12-01|November 2015|2015-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.|Relative Bioavailability Study of Ganciclovir From the Pro-drug, Valganciclovir, in Lung Transplant Recipients With or Without Cystic Fibrosis|Completed||Phase 1|31|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:14:53.588127|2017-02-18 16:14:53.588127
NCT00377728|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2015-04-14|||March 2006||2006-03-01|April 2015|2015-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber|A 14 Day, Randomised, Double Blinded, Placebo-controlled 2-way Crossover Trial of Repeat Doses of Intranasal GSK256066 and Placebo in an Environmental Exposition Unit (Vienna Challenge Chamber) in Subjects With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 2|44|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:14:54.160949|2017-02-18 16:14:54.160949
NCT00377715|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2015-11-09|||September 2005||2005-09-01|November 2015|2015-11-01||||August 2006|Actual|2006-08-01||Interventional|||Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease|Phase 2, Double-Blind, Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|183|Actual|Medivation, Inc.||2|||f||||||||||||||2017-02-18 16:14:54.251225|2017-02-18 16:14:54.251225
NCT00377702|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-02-17|||July 2006||2006-07-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|||||Observational|||Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups|Epidemiologic Study of Ethnicity and Lifetime Risks for Cardiovascular Disease|Completed||N/A|500000||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:14:54.339561|2017-02-18 16:14:54.339561
NCT00377689|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2008-10-27|||September 2006||2006-09-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke|Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke - a Randomized Controlled Study|Completed||Phase 2|34|Actual|Umeå University||1|||f||||||||||||||2017-02-18 16:14:54.42806|2017-02-18 16:14:54.42806
NCT00377676|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-05-09|2010-11-08||July 2004||2004-07-01|May 2016|2016-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability During Treatment of Type 2 Diabetes (T2DM) With Usual Diabetes Therapy (UDT) and Either Cycloset or Placebo|Completed||Phase 3|3095|Actual|VeroScience|Thus HbA1c was only performed on a subset of patients defined as failing (HbA1c >= 7.5) and who were on oral diabetes medications. Forced titration of study drug may have lead to a greater number of discontinuations.|2|||f||||t||||||||||2017-02-18 16:14:54.53377|2017-02-18 16:14:54.53377
NCT00377663|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2014-03-24|||July 2007||2007-07-01|March 2014|2014-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Internet-Based Program to Improve Asthma Management in Children|Internet-Based Patient-Centered Asthma Management System|Completed||N/A|600|Actual|Seattle Children's Hospital||2|||f||||||||||||||2017-02-18 16:14:55.042812|2017-02-18 16:14:55.042812
NCT00377650|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2007-01-16|||September 2005||2005-09-01|January 2007|2007-01-01|December 2007||2007-12-01|||||Interventional|||Polish-Italian-Hungarian RAndomized ThrombEctomy Trial|Polish-Italian-Hungarian RAndomized ThrombEctomy Trial. PIHRATE Trial.|Unknown status|Recruiting|Phase 4|200||Jagiellonian University|||||f||||||||||||||2017-02-18 16:14:55.152196|2017-02-18 16:14:55.152196
NCT00377637|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2011-10-31|2011-08-11||July 2005||2005-07-01|October 2011|2011-10-01|March 2010|Actual|2010-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.|A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis.|Completed||Phase 3|370|Actual|Hoffmann-La Roche|For many of the Maintenance Phase Outcomes, the total number of events precluded a meaningful time to event statistical analysis, therefore, only events numbers are reported.|4|||f||||||||||||||2017-02-18 16:14:55.265487|2017-02-18 16:14:55.265487
NCT00377624|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2011-01-10|||January 2002||2002-01-01|January 2011|2011-01-01|September 2004||2004-09-01|||||Interventional|||HUPS: Hyalgan Use in Painful Shoulder|Sodium Hyaluronate for Treatment of Chronic Painful Shoulder With Limitation of Motion Due to Glenohumeral Joint Osteoarthritis, Rotator Cuff Tear and/or Primary or Secondary Adhesive Capsulitis|Completed||Phase 3|602||Sanofi|||||f||||||||||||||2017-02-18 16:14:57.436841|2017-02-18 16:14:57.436841
NCT00377611|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2016-11-02|||October 2006||2006-10-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™|An Observational Study to Investigate the Incidence of Influenza and Influenza-related Complications, in Adults Between 50-64 Years and Elderly Adults 65 Years and Over Vaccinated With Fluarix™|Completed||Phase 4|3054|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:14:57.531864|2017-02-18 16:14:57.531864
NCT00377598|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2012-01-31|||October 2006||2006-10-01|January 2012|2012-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia|A Phase 2, Double Blind, Placebo Controlled, Dose-Ranging Study in Subjects With Postherpetic Neuralgia (PHN) to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Four Doses of TAK-583, Compared With Placebo|Completed||Phase 2/Phase 3|399|Actual|Takeda||5|||f||||f||||||||||2017-02-18 16:14:57.669235|2017-02-18 16:14:57.669235
NCT00377585|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-10-11|||September 2006||2006-09-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|||||Interventional|||Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population|A Phase II/III, Observer-blind, Multi-Country, Multi-Centre, Randomized Study to Demonstrate the Superiority in Terms of Immunogenicity of Adjuvanted Influenza Vaccine Administered in Adults Aged 50 Years and Older Compared to Fluarix™|Completed||Phase 2|3350||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:14:57.824831|2017-02-18 16:14:57.824831
NCT00377572|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2013-06-06|2013-01-11||October 2006||2006-10-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ICATA||Inner-City Anti-IgE Therapy for Asthma|Inner-City Anti-IgE Therapy for Asthma (ICAC-08)|Completed||Phase 4|419|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 16:14:57.966462|2017-02-18 16:14:57.966462
NCT00377559|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2015-10-05|||May 2006||2006-05-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|November 2009|Actual|2009-11-01||Interventional|MYOTAX||Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer|Phase II Multicentre Open Label Trial Evaluating the Efficacy and Safety of the Liposomal Doxorubicin (Myocet®) and Docetaxel (Taxotere®) Combination as First-line Treatment of Patients With Metastatic HER2/Neu Negative Breast Cancer|Completed||Phase 2|70|Actual|Catharina Ziekenhuis Eindhoven||1|||f||||f||||||||||2017-02-18 16:14:59.152188|2017-02-18 16:14:59.152188
NCT00375583|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2017-01-24|||September 9, 2006||2006-09-09|April 28, 2011|2011-04-28|April 28, 2011|Actual|2011-04-28|April 28, 2011|Actual|2011-04-28||Interventional|||Effect of Albendazole Dose on Clearance of Filarial Worms|Effect of Albendazole Dose and Interval on Wuchereria Bancrofti Microfilarial Clearance in India: A Randomized, Open Label Study|Completed||Phase 2|1000|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:14:59.275093|2017-02-18 16:14:59.275093
NCT00377546|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2008-09-23||||||September 2008|2008-09-01||||||||Interventional|||Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%||Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:14:59.378475|2017-02-18 16:14:59.378475
NCT00377533|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2010-04-01|||December 2004||2004-12-01|July 2009|2009-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Wheelchair Handling Skills of Caregivers: Comparison Between Anti-tip Devices and a New Design|Wheelchair Handling Skills of Caregivers: Comparison Between Conventional Rear Anti-tip Devices and a New Design|Completed||N/A|32|Actual|Nova Scotia Health Authority||1|||f||||||||||||||2017-02-18 16:14:59.471332|2017-02-18 16:14:59.471332
NCT00377520|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2009-11-13|2008-10-21||September 2006||2006-09-01|November 2009|2009-11-01|September 2008|Actual|2008-09-01|October 2007|Actual|2007-10-01||Interventional|||A Trial for Patients With Advanced/Recurrent Endometrial Cancer|A Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|27|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 16:14:59.568867|2017-02-18 16:14:59.568867
NCT00377507|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2013-07-14|||October 2006||2006-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Catechin Mouth-washing for Removal of Intraoral Bacteria|A Clinical Trial of Tea Catechin Mouth-washing for Removal of Intraoral Bacteria in the Elderly|Terminated||N/A|36|Actual|University of Shizuoka||1||difficult to achieve the sufficient subjects|f||||f||||||||||2017-02-18 16:15:00.025671|2017-02-18 16:15:00.025671
NCT00377494|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2010-08-26||||||February 2007|2007-02-01|July 2008||2008-07-01|||||Interventional|||CS DNA MVA Trial in Mampong, Ghana|A Phase I Trial of PFCSP DNA/MVA.CSO Prime/Boost Vaccine in Mampong, Ghana|Withdrawn||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 16:15:00.137696|2017-02-18 16:15:00.137696
NCT00377481|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2016-11-01|||September 2006||2006-09-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.|A Randomised, Cross-Over Study to Investigate the Comfort of Injection of Renal Anaemia Patients Receiving Subcutaneous NeoRecormon® Compared to Darbepoetin Alfa.|Completed||Phase 4|48|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:15:00.254148|2017-02-18 16:15:00.254148
NCT00377468|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2008-06-26|||September 2006||2006-09-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)|Low Dose Administration of Delta9-Tetrahydrocannabinol for the Prevention of Hyperalgesia and Chronic Pain in Patients With Acute Complex Regional Pain Syndrome (CRPS) of the Upper Limb|Unknown status|Recruiting|Phase 2|100|Anticipated|Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 16:15:00.358962|2017-02-18 16:15:00.358962
NCT00377455|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-08-16|2011-03-28||September 2006||2006-09-01|August 2016|2016-08-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|||Placebo Controlled Trial of Bosentan in Scleroderma Patients|Placebo Controlled Trial of Bosentan vs Placebo in NYHA Class I/II Scleroderma Patients With Exercise Induced Pulmonary Hypertension|Terminated||Phase 2|5|Actual|Georgetown University||2||Study was terminated due to inadequate enrolment|f||||f||||||||||2017-02-18 16:15:00.47411|2017-02-18 16:15:00.47411
NCT00377442|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2016-11-01|||August 2006||2006-08-01|November 2016|2016-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.|A Randomized, Open-label Crossover Study to Investigate the Potential Interaction Between GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes|Completed||Phase 1|33|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 16:15:00.892133|2017-02-18 16:15:00.892133
NCT00377429|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2012-07-16|2012-03-15||September 2006||2006-09-01|July 2012|2012-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy|An Open-Label, Single-Arm, Phase II Safety and Tolerability Study of Catumaxomab (Anti-EpCAM x Anti-CD3) in Women With Advanced Epithelial Ovarian Cancer After a Complete Response to Chemotherapy|Completed||Phase 2|47|Actual|Neovii Biotech||1|||f||||t||||||||||2017-02-18 16:15:01.004723|2017-02-18 16:15:01.004723
NCT00377416|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2017-02-08|||March 2004||2004-03-01|February 2017|2017-02-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency|Preclinical & Phase I/II Trials of AAV-AAT Vectors: Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Alpha 1-Antitrypsin (rAAV2-CB-hAAT) Gene Vector to AAT-Deficient Adults|Active, not recruiting||N/A|12|Anticipated|University of Massachusetts, Worcester||1|||f||||||||||||||2017-02-18 16:15:01.402373|2017-02-18 16:15:01.402373
NCT00377403|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2012-12-24|2011-03-31||October 2006||2006-10-01|December 2012|2012-12-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Interventional|||Treatment of Acute Sinusitis|Randomized Clinical Trial to Evaluate Guidelines for Acute Rhinosinusitis (Phase IV Study)|Completed||Phase 4|172|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 16:15:01.540102|2017-02-18 16:15:01.540102
NCT00377390|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2013-02-06|||October 2006||2006-10-01|February 2013|2013-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||ICATA Asthma Mechanistic Study|Inner-City Anti-IgE Therapy for Asthma Mechanistic Study|Completed||N/A|224|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     Blood samples, sputum, and nasal secretions~   "|||2017-02-18 16:15:02.193306|2017-02-18 16:15:02.193306
NCT00377364|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-04-01|2011-08-19||November 2006||2006-11-01|April 2016|2016-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Acetaminophen (Tylenol) for Mood and Memory Changes Associated With Corticosteroid Therapy|Acetaminophen for Mood and Memory Changes Associated With Prednisone Therapy|Completed||Phase 4|30|Actual|University of Texas Southwestern Medical Center|Limitations include the small sample size and relatively small changes in mood and memory in both groups that limited our ability to detect between-group differences.|2|||f||||f||||||||||2017-02-18 16:15:02.439214|2017-02-18 16:15:02.439214
NCT00377351|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2017-01-24|||September 11, 2006||2006-09-11|August 3, 2010|2010-08-03|August 3, 2010||2010-08-03|||||Observational|||Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) Cohort|Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) Cohort|Completed||N/A|21|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:15:03.120942|2017-02-18 16:15:03.120942
NCT00377338|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2013-07-29|||May 2006||2006-05-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|ALVEOLE||Safety and Accuracy of Alveoscopy in Interstitial Lung Diseases|Phase II Study of Broncho-Alveoscopy Using Fibered Confocal Fluorescence Microscopy|Completed||Phase 1/Phase 2|270|Actual|University Hospital, Rouen|||1||f||||t||||||Samples Without DNA|"~     distal lung biopsy if of tumoral nature (fixed or frozen sample)~   "|||2017-02-18 16:15:03.203769|2017-02-18 16:15:03.203769
NCT00377325|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2014-11-20|||June 2007||2007-06-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|June 2013|Actual|2013-06-01||Interventional|||The Effectiveness of Lower Cyclosporine Doses for Psoriasis|Cyclosporine in the Pharmacotherapy of Psoriasis|Withdrawn||Phase 2|0|Actual|University of Rochester||3||Study terminated by the DSMB due to low recruitment|f||||t||||||||||2017-02-18 16:15:03.295047|2017-02-18 16:15:03.295047
NCT00377312|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-03-18|2014-04-25||September 2006||2006-09-01|March 2016|2016-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional||Eleven subjects received parathyroid hormone (1-34) infusions intravenously for one week.|7 Day Continuous Parathyroid Hormone IV Infusion|Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone(1-34): Effects on Bone Formation|Completed||Early Phase 1|11|Actual|University of Pittsburgh|Small number of subjects in each group Study limited to Caucasians Only one timepoint for follow-up was measure Study did not include saline infused controls|2|||f||||t||||||||No||2017-02-18 16:15:03.415653|2017-02-18 16:15:03.415653
NCT00377299|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2013-07-05|2011-09-08||October 2006||2006-10-01|July 2013|2013-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence|A Double-blind, Placebo-controlled Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence|Completed||N/A|60|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 16:15:04.263669|2017-02-18 16:15:04.263669
NCT00377286|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2011-06-12|||September 2006||2006-09-01|June 2011|2011-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Glucosamine on Joint Structure and Quality of Life (JOG)|Development of Biomarker and Functional Assessment Tools to Evaluate the Effect of Glucosamine on Joint Structure and Quality of Life|Completed||N/A|201|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 16:15:04.953395|2017-02-18 16:15:04.953395
NCT00377273|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2008-04-08|||November 2003||2003-11-01|April 2008|2008-04-01|October 2005||2005-10-01|||||Interventional|||An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses||Completed||Phase 4|250||Sanofi|||||f||||||||||||||2017-02-18 16:15:05.060848|2017-02-18 16:15:05.060848
NCT00377260|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-10-24|2010-04-13||November 2006||2006-11-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Acute Otitis Media (AOM) Therapy Trial in Young Children|Efficacy of Antimicrobials in Young Children With Acute Otitis Media (AOM)|Completed||Phase 4|291|Actual|University of Pittsburgh|Long-term implications of abnormal otoscopic findings (bulging) without symptoms, and persistent middle-ear effusion without findings of acute inflammation as forerunners of subsequent acute otitis media episodes remains uncertain.|2|||f||||t||||||||No||2017-02-18 16:15:05.163677|2017-02-18 16:15:05.163677
NCT00377247|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-07-07|||April 2009||2009-04-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor|Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor (Phase I/II Study)|Terminated||Phase 1|5|Actual|University of Pittsburgh||1||study closed to accrual due to slow accrual|f||||t||||||||||2017-02-18 16:15:07.0303|2017-02-18 16:15:07.0303
NCT00377234|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2016-07-28|2015-06-25||May 2006||2006-05-01|July 2016|2016-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional||Safety Analysis Set|A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.|Randomized, Open-label, Multi-center Study to Investigate Patient Preference on Dosing in Women With Postmenopausal Osteoporosis Treated With Once Monthly Ibandronate and Once Weekly Risedronate. A Six Month, Two-sequence and Two-period Crossover Study.|Completed||Phase 4|356|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:15:07.144334|2017-02-18 16:15:07.144334
NCT00377221|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2006-09-15|||September 2006||2006-09-01|September 2006|2006-09-01||||||||Observational|||Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability|Rectal Health, Behaviors and Microbicide Acceptability|Unknown status|Recruiting|N/A|896||University of California, Los Angeles|||||f||||||||||||||2017-02-18 16:15:07.649732|2017-02-18 16:15:07.649732
NCT00377208|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2013-02-18|||January 2007||2007-01-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Individually Tailored Web-Based Program to Improve Blood Pressure Control|Efficacy of Web-Based Feedback to Improve Blood Pressure Control|Completed||N/A|500|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-02-18 16:15:07.723079|2017-02-18 16:15:07.723079
NCT00377195|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2017-01-23|||July 2007||2007-07-01|January 2017|2017-01-01|April 2019|Anticipated|2019-04-01|December 2017|Anticipated|2017-12-01||Interventional|||Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma|A Prospective Single Arm Trial of Involved Field Radiotherapy Alone for Stage I-II Low Grade Non-gastric Marginal Zone Lymphoma|Active, not recruiting||Phase 2|79|Actual|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||f||||||||||2017-02-18 16:15:07.82642|2017-02-18 16:15:07.82642
NCT00377182|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-15|2016-11-01||2016-07-08|September 2006||2006-09-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.|A Randomized, Double-blind Study to Evaluate the Safety and Tolerability of the HCV Polymerase Inhibitor Pro-drug in Combination With Pegasys, With or Without Copegus, Versus Pegasys Plus Copegus, in Treatment-naïve Patients With Chronic Hepatitis C, Genotype 1|Completed||Phase 2|107|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 16:15:07.950623|2017-02-18 16:15:07.950623
NCT00377169|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-10-31||||||September 2006|2006-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Collection of Blood Samples From SMART Study Participants for Future Genetic Studies|Genomics: A Substudy of a Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)|Completed||N/A|3261|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:15:08.061172|2017-02-18 16:15:08.061172
NCT00377156|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2016-08-11|||July 2006||2006-07-01|August 2016|2016-08-01||||October 2014|Actual|2014-10-01||Interventional|||Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases|Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients With One to Three Cerebral Metastases|Active, not recruiting||Phase 3|238|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 16:15:08.187343|2017-02-18 16:15:08.187343
NCT00377143|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2012-02-14|||July 2006||2006-07-01|September 2011|2011-09-01||||August 2006|Actual|2006-08-01||Interventional|||PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care|PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care|Withdrawn||Phase 4|0|Actual|University of Florida||||similar large study planned by NHLBI|f||||||||||||||2017-02-18 16:15:08.35114|2017-02-18 16:15:08.35114
NCT00377130|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2014-01-30|||December 2006||2006-12-01|September 2010|2010-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Stress Management Therapy in Patients Receiving Chemotherapy for Cancer|Stress Management Therapy for Patients Undergoing Chemotherapy|Completed||N/A|442|Actual|University of South Florida||2|||f||||t||||||||||2017-02-18 16:15:08.576108|2017-02-18 16:15:08.576108
NCT00377117|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2007-07-20|||May 2006||2006-05-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Observational|||Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II|Diabetes Screening, Risk Management, and Disease Management in a High-Risk Mental Health Population.|Completed||Phase 1/Phase 2|39|Actual|Lawson Health Research Institute|||||f||||f||||||||||2017-02-18 16:15:08.734858|2017-02-18 16:15:08.734858
NCT00377104|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2013-07-01|||September 2006||2006-09-01|July 2013|2013-07-01||||November 2012|Actual|2012-11-01||Interventional|||Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase I Dose-Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Following Cytoreduction With Chemotherapy|Terminated||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:15:08.824619|2017-02-18 16:15:08.824619
NCT00377091|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2013-05-28|||June 2007||2007-06-01|May 2013|2013-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy|Pilot Pharmacoeconomic Evaluation of Fondaparinux Treatment of Pulmonary Embolism (PE) Compared to Treatment With Unfractionated Heparin|Withdrawn||Phase 4|0|Actual|University of Minnesota - Clinical and Translational Science Institute||||Study pulled due to a grant disagreement between the U of M and SMDC|f||||||||||||||2017-02-18 16:15:08.935136|2017-02-18 16:15:08.935136
NCT00377078|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2006-09-14|||October 2005||2005-10-01|September 2006|2006-09-01|October 2007||2007-10-01|||||Interventional|||Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.|Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes to Manage Post-Antibiotic Colonization and Infection With Clostridium Difficile|Unknown status|Recruiting|N/A|30||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:15:09.028281|2017-02-18 16:15:09.028281
NCT00377065|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-04-21||||||April 2016|2016-04-01||||||||Expanded Access|||Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)|Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (OBT) in Highly Treatment Experienced HIV-1 Infected Patients With Limited to No Treatment Options|Approved for marketing||N/A|||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 16:15:09.112518|2017-02-18 16:15:09.112518
NCT00377052|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2011-06-21|||June 2006||2006-06-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|November 2009|Actual|2009-11-01||Interventional|||Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma|A Phase II Study of Bortezomib and Gemcitabine in Patients With Relapsed Mantle Cell Lymphoma|Completed||Phase 2|29|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 16:15:09.363952|2017-02-18 16:15:09.363952
NCT00377039|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2007-09-30|||August 2006||2006-08-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia|A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study to Investigate the Efficacy, Safety and Tolerability of AD 337 in the Treatment of Fibromyalgia in Female Subjects.|Completed||Phase 2|100|Anticipated|Sosei|||||f||||||||||||||2017-02-18 16:15:09.493986|2017-02-18 16:15:09.493986
NCT00377026|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2009-06-18|||September 2006||2006-09-01|June 2009|2009-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||FirstWIND: Weight Loss Interventions After Delivery|FirstWIND: Weight Loss Interventions After Delivery|Completed||N/A|50|Anticipated|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 16:15:09.585449|2017-02-18 16:15:09.585449
NCT00377000|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2007-10-05|||November 2005||2005-11-01|October 2007|2007-10-01|March 2006||2006-03-01|||||Interventional|||A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.||Completed||Phase 4|60||Sanofi|||||f||||||||||||||2017-02-18 16:15:09.691928|2017-02-18 16:15:09.691928
NCT00376987|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2017-01-18|||December 2003||2003-12-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|October 2006|Actual|2006-10-01||Interventional|||Zinc Supplements in Lowering Cadmium Levels in Smokers|Do Dietary Supplements of Zinc Reduce Serum Cadmium Levels in Smokers?|Completed||Phase 2|61|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 16:15:09.772834|2017-02-18 16:15:09.772834
NCT00376961|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2016-12-21|2013-01-02||August 2006||2006-08-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|December 2012|Actual|2012-12-01||Interventional|||S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma|A Phase II Study of Combination Rituximab-CHOP and Bortezomib (Velcade®) (R-CHOP-V) Induction Therapy Followed by Bortezomib Maintenance (VM) Therapy for Patients With Newly Diagnosed Mantle Cell Lymphoma|Active, not recruiting||Phase 2|68|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 16:15:09.995909|2017-02-18 16:15:09.995909
NCT00376948|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2015-12-07|2014-08-08||May 2005||2005-05-01|December 2015|2015-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|Phase II Trial of Novasoy®, Gemcitabine, and Erlotinib in Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|20|Actual|Barbara Ann Karmanos Cancer Institute|Stopped after 1st stage completed due to failure to meet preset efficacy endpoints; Lack of randomization in the design, which impaired the ability to detect whether the lack of activity is due to patient selection or in-activity of the regimen.|1|||f||||t||||||||||2017-02-18 16:15:10.747029|2017-02-18 16:15:10.747029
NCT00376935|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2015-06-01|2011-10-04||December 2006||2006-12-01|June 2015|2015-06-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults|A Double Blind Phase II Study of Multiple Doses of Palifermin (rHuKGF) for the Treatment of Inadequate CD4+ Lymphocyte Recovery in Subjects on Potent Antiretroviral Therapy With Plasma HIV-1 RNA Levels of 200 Copies Per Milliliter or Less|Completed||Phase 2|99|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:15:11.001835|2017-02-18 16:15:11.001835
NCT00376922|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2017-01-18|||June 2006||2006-06-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|May 2007|Actual|2007-05-01||Interventional|||Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases|Use of Music to Reduce Anxiety & Perceived Pain for Adult Patients With Hematological Malignancies Undergoing Bone Marrow Biopsy|Completed||N/A|65|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 16:15:13.000977|2017-02-18 16:15:13.000977
NCT00376909|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2014-11-26|||November 2001||2001-11-01|September 2006|2006-09-01||||April 2004|Actual|2004-04-01||Interventional|||A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women|New York Prevention Care Manager Project|Completed||Phase 2|2729|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||f||||||||||2017-02-18 16:15:13.126545|2017-02-18 16:15:13.126545
NCT00376896|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2011-04-06|||November 2006||2006-11-01|April 2011|2011-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers|A Phase IIa Experimental Medicine Study Assessing Alterations in Regional Cerebral Blood Flow by Functional Magnetic Resonance Imaging (fMRI) in Female IBS Patients and Healthy Controls Following Single Doses of GW876008, a Corticotrophin Releasing Factor 1 Receptor Antagonist (CRF1-RA)|Completed||Phase 1|40|Anticipated|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 16:15:13.239097|2017-02-18 16:15:13.239097
NCT00376883|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2007-01-03|||January 2000||2000-01-01|January 2007|2007-01-01|October 2006||2006-10-01|||||Interventional|||Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month|The Effect of i.v. Bisphosphonate on Health-Related Quality of Life and Skeletal Morbidity for Newly Diagnosed Treatment Demanding Multiple Myeloma. A Prospective Randomised Double Blinded Dose-Effective Study With Cost-Utility Analysis.|Completed||Phase 3|500||Nordic Myeloma Study Group|||||f||||||||||||||2017-02-18 16:15:13.348497|2017-02-18 16:15:13.348497
NCT00376870|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2008-07-30|||July 2008||2008-07-01|June 2008|2008-06-01|April 2011|Anticipated|2011-04-01|December 2010|Anticipated|2010-12-01||Interventional|||PIoglitazone for PrEvention of Restenosis in Diabetic Patients|Prevention of Coronary Artery in STENT Restenosis With the Combined Use of Pioglitazone and Sirolimus-Eluting Coronary Stent|Unknown status|Recruiting|Phase 3|160|Anticipated|University of Rome Tor Vergata||2|||f||||t||||||||||2017-02-18 16:15:13.45884|2017-02-18 16:15:13.45884
NCT00376857|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2006-09-13||||||September 2006|2006-09-01||||||||Interventional|||Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.|Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green: a Randomised Controlled Clinical Trial|Completed||N/A|60||University of Regensburg|||||f||||||||||||||2017-02-18 16:15:13.573051|2017-02-18 16:15:13.573051
NCT00376844|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2016-04-24|||May 2002||2002-05-01|April 2016|2016-04-01|April 2016|Actual|2016-04-01|May 2009|Actual|2009-05-01||Interventional|PORTEC-2||External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer|PORTEC-2, Postoperative Radiation Therapy for Endometrial Carcinoma - A Multicenter Randomised Phase III Trial Comparing External Beam Radiation and Vaginal Brachytherapy|Completed||Phase 3|427|Actual|Leiden University Medical Center||2|||f||||f||||||||Undecided|Will be decided late 2016|2017-02-18 16:15:13.655534|2017-02-18 16:15:13.655534
NCT00376831|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2007-08-09|||January 2007||2007-01-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||The Efficacy of Midazolam & Ketamine Versus Midazolam & Fentanyl for Sedation in Ambulatory Colonoscopies||Completed||Phase 4|91|Actual|Soroka University Medical Center||2|||f||||||||||||||2017-02-18 16:15:13.765144|2017-02-18 16:15:13.765144
NCT00376818|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2012-06-01|||June 2006||2006-06-01|June 2012|2012-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers|Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers|Completed||N/A|4|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:15:13.858115|2017-02-18 16:15:13.858115
NCT00376805|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2012-11-06|2010-07-13||April 2006||2006-04-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|September 2009|Actual|2009-09-01||Interventional|||Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer|Allogeneic Natural Killer Cells in Patients With Advanced Metastatic Breast Cancer|Terminated||Phase 2|6|Actual|Masonic Cancer Center, University of Minnesota||1||Withdrawn due to toxicity|f||||t||||||||||2017-02-18 16:15:13.972511|2017-02-18 16:15:13.972511
NCT00376077|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2016-05-05|||August 2005||2005-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|March 2016|Actual|2016-03-01||Interventional|||A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.|A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Rapidly Augmenting Platelet Counts in Childhood ITP.|Completed||Phase 3|32|Actual|The Hospital for Sick Children||2|||f||||t||||||||Yes|Manuscript preparation|2017-02-18 16:15:30.169993|2017-02-18 16:15:30.169993
NCT00376792|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2013-08-23|||October 2005||2005-10-01|June 2009|2009-06-01||||December 2012|Anticipated|2012-12-01||Interventional|||Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer|An Open Randomized Phase III Trial of Six Cycles of Docetaxel Versus Surveillance After Radical Prostatectomy in High Grade Prostate Cancer Patients With Margin Positive T2 or T3 Tumours|Unknown status|Recruiting|Phase 3|396|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:15:16.801844|2017-02-18 16:15:16.801844
NCT00376779|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-11-02|||October 2006||2006-10-01|November 2016|2016-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age|A Phase II, Observer-blind, Randomized Study to Evaluate the Immunogenicity, Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Combined DssiTgdPa-HBV-IPV/Hib Vaccine Containing Diphtheria Toxoid From the Statens Serum Institute (SSI) of Denmark and Tetanus Toxoid From GSK Biologicals' Kft [GD], Compared to the Currently Licensed GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine (Infanrix Hexa TM) When Administered to Healthy Infants at 2, 3 and 4 Months of Age.|Completed||Phase 2|450||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:15:16.905333|2017-02-18 16:15:16.905333
NCT00376766|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2015-05-27|||February 2007||2007-02-01|May 2015|2015-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures)|Rapid Oral Treatment of Cluster Epileptic Seizures. Efficacy Assessment of Levetiracetam in Cluster Seizures.|Terminated||Phase 3|112|Anticipated|University Hospital, Grenoble||||recruitment recruitment recruitment recruitment difficulties|f||||f||||||||||2017-02-18 16:15:17.006036|2017-02-18 16:15:17.006036
NCT00376753|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2017-01-24|||September 11, 2006||2006-09-11|May 11, 2011|2011-05-11|May 11, 2011||2011-05-11|||||Observational|||Muscle Contraction in Patients With Focal Hand Dystonia|The Effect of Surround Inhibition During Phasic Compared to Tonic Voluntary Finger Movement in Focal Hand Dystonia|Completed||N/A|84|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:15:17.126712|2017-02-18 16:15:17.126712
NCT00376740|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2011-08-22|||September 2005||2005-09-01|August 2011|2011-08-01||||November 2010|Actual|2010-11-01||Interventional|||Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole|Phase 3 Study of the Effect of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving the Aromatase Inhibitor, Letrozole, in the Adjuvant Setting|Completed||Phase 3|90|Actual|Soroka University Medical Center||2|||f||||f||||||||||2017-02-18 16:15:17.201191|2017-02-18 16:15:17.201191
NCT00376727|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2010-03-25|||December 2004||2004-12-01|March 2010|2010-03-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Cetuximab in Treating Patients With Advanced Solid Tumors|A Phase I Study of the Safety and Tolerability of Four Doses of Cetuximab (C225) in Patients With Advanced Solid Tumors|Completed||Phase 1|27|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 16:15:17.313576|2017-02-18 16:15:17.313576
NCT00376714|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2016-10-26|||August 2006||2006-08-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease|A Randomised, Double-Blind, Placebo-Controlled, Dose Ascending, 3 Period Crossover Study To Examine The Safety, Tolerability, Pharmacodynamics And Pharmacokinetics Of Repeat Inhaled Doses Of GSK233705B In COPD Subjects.|Completed||Phase 2|45||GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:15:17.421242|2017-02-18 16:15:17.421242
NCT00376701|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2011-09-27|||September 2006||2006-09-01|September 2011|2011-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Combination Therapy for Age-Related Macular Degeneration.|Combination Therapy in Neovascular Age-Related Macular Degeneration (AMD): A Three-armed, Randomized, Prospective Clinical Trial of Low Fluence Photodynamic Therapy(rPDT) With Adjunctive Avastin and Triamcinolone Acetonide (Kenalog)(Triple Therapy) Versus rPDT With Adjunctive Avastin (Double Therapy) Versus Monotherapy With Avastin.|Completed||Phase 2|103|Actual|Lawson Health Research Institute||3|||f||||t||||||||||2017-02-18 16:15:20.028812|2017-02-18 16:15:20.028812
NCT00376688|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2016-11-22|2013-12-19||July 2006||2006-07-01|November 2016|2016-11-01||||June 2008|Actual|2008-06-01||Interventional||Entire study population|Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer|Phase II Trial of CCI-779 (Temsirolimus) in Patients With Locally Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:15:20.166777|2017-02-18 16:15:20.166777
NCT00376675|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2016-07-01|2014-07-30||February 2008||2008-02-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Methylphenidate in Treating Patients With Fatigue Caused by Cancer|Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study|Completed||Phase 3|148|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 16:15:20.416697|2017-02-18 16:15:20.416697
NCT00376662|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2006-09-13|||August 1992||1992-08-01|September 2006|2006-09-01|October 2000||2000-10-01|||||Interventional|||HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.|HRT and/or Etidronate in the Prevention and Treatment of Osteoporosis and Fractures in Post-Menopausal Patients With Asthma Receiving Long-Term Oral and/or Inhaled Glucocorticoids:a Randomised Factorial Trial|Completed||Phase 4|750||British Thoracic Society|||||f||||||||||||||2017-02-18 16:15:22.048716|2017-02-18 16:15:22.048716
NCT00376649|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2015-09-20|||January 2007||2007-01-01|September 2006|2006-09-01|December 2009|Anticipated|2009-12-01|||||Interventional|||Development of Workshop for Lifestyle Changing for Crohn's Disease Patients and Its Affect on the Disease's Indexes|Development of Workshop for Lifestyle Changing for Crohn's Disease Patients and Its Affect on the Disease's Indexes|Withdrawn||N/A|0|Actual|Hadassah Medical Organization||||funding was not granted|f||||||||||||||2017-02-18 16:15:22.146716|2017-02-18 16:15:22.146716
NCT00376636|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2007-10-29|||October 2006||2006-10-01|September 2006|2006-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension|A Phase IIa, Double-Blind, Placebo-Controlled, Randomised, Parallel-Design, Four-Week Study to Investigate the Safety and Efficacy of the Oral Renin Inhibitor SPP635 Once Daily in Patients With Mild to Moderate Hypertension|Completed||Phase 2|35|Actual|Speedel Pharma Ltd.||2|||f||||f||||||||||2017-02-18 16:15:22.482711|2017-02-18 16:15:22.482711
NCT00376623|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2014-04-30||2014-04-30|July 2006||2006-07-01|April 2014|2014-04-01||||April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer|An Open, Randomised Clinical Phase II Trial to Investigate the Efficacy, Safety and Pharmacokinetics of a Single Dose of 200 mg of i.v. BI 2536 in Comparison to 50 mg of i.v. BI 2536 Administered on Days 1, 2 and 3 in Patients With Advanced or Metastatic Non Small Cell Lung Cancer|Completed||Phase 2|96|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:15:22.569331|2017-02-18 16:15:22.569331
NCT00375570|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2008-08-14|||October 2006||2006-10-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents|An Open Label, Multi-Centre, Phase III, Subject Initiated Safety Study of ME-609 in Treatment of Recurrent Herpes Simplex Labialis in Adolescents|Completed||Phase 3|254|Actual|Medivir||1|||f||||f||||||||||2017-02-18 16:15:22.664773|2017-02-18 16:15:22.664773
NCT00375557|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2015-05-26|||October 2006||2006-10-01|May 2015|2015-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients|An Open Label, Randomized, Flexible Dose, 6-week Clinical Trial of the Safety and Efficacy of Divalproex ER vs Quetiapine in the Treatment of Behavioral Symptoms in the Elderly With Moderate to Severe Alzheimer's Dementia|Withdrawn||Phase 4|0|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 16:15:22.761347|2017-02-18 16:15:22.761347
NCT00375544|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2009-08-12|||September 2006||2006-09-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|||||Interventional|||Study to Evaluate the Safety and Efficacy of a Low Level Light Device in Patients With Knee Osteoarthritis|A Phase I Single Center Open Label Study to Evaluate the Safety and Efficacy of a Low Level Light Device in Patients With Knee Osteoarthritis|Completed||Phase 1|10|Anticipated|Light Sciences LLC|||||f||||||||||||||2017-02-18 16:15:22.876054|2017-02-18 16:15:22.876054
NCT00376610|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2007-07-03||||||July 2007|2007-07-01||||||||Interventional|||Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty|Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty|Completed||Phase 4|||Frederiksberg University Hospital|||||f||||||||||||||2017-02-18 16:15:22.97512|2017-02-18 16:15:22.97512
NCT00376597|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2016-06-21|||June 2006||2006-06-01|June 2016|2016-06-01||||November 2015|Actual|2015-11-01||Interventional|||Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection|A Randomized Study to Prevent Lymphedema in Women Treated for Breast Cancer|Active, not recruiting||Phase 3|877|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 16:15:23.061828|2017-02-18 16:15:23.061828
NCT00376584|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2017-02-15|||July 2006||2006-07-01|February 2017|2017-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)|A Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Study to Evaluate the Efficacy of MK0524 to Improve Tolerability of Extended Release Niacin|Completed||Phase 3|825|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 16:15:23.257408|2017-02-18 16:15:23.257408
NCT00376571|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-09-23|||October 2004||2004-10-01|September 2016|2016-09-01|March 2011|Actual|2011-03-01|June 2005|Actual|2005-06-01||Interventional|BIFI||Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?|Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions? A Strategy of Routine Stenting Both Main Vessel and Side Branch Versus a Strategy of Routine Main Vessel Stenting and Optional Treatment of Side Branch|Completed||Phase 4|413|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-02-18 16:15:23.357345|2017-02-18 16:15:23.357345
NCT00376558|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2016-05-24|2012-12-12||July 2006||2006-07-01|May 2016|2016-05-01|January 2011|Actual|2011-01-01|July 2010|Actual|2010-07-01||Interventional|PET-CRA||Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence|Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence|Completed||N/A|50|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 16:15:23.480747|2017-02-18 16:15:23.480747
NCT00376545|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2017-01-24|||September 12, 2006||2006-09-12|November 13, 2009|2009-11-13||||November 13, 2008|Actual|2008-11-13||Observational|||Brain Connectivity Between Visual Input and Movement|Brain Connectivity Between Visual Input and Motor Output|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:15:23.864919|2017-02-18 16:15:23.864919
NCT00376532|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2014-05-05|2014-05-05||September 2006||2006-09-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|EMMA|Baseline analysis population was determined by the enrolled subjects for whom the MMP2 and MMP9 assays were completed.|Extracellular Matrix Marker of Arrhythmia Risk (EMMA)|Role of Matrix Metaloproteinase(MMP)9 and MMP 2 in Risk Stratification for Ventricular Tachycardia/Fibrillation in Patients With Implanted Cardioverter Defibrillator (ICD) Devices.|Completed||N/A|63|Actual|Thomas Jefferson University|||2||f||||f||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 16:15:23.93911|2017-02-18 16:15:23.93911
NCT00376519|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2012-11-06|||May 2007||2007-05-01|November 2012|2012-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases|Umbilical Cord Blood Transplant With Co-Infusion of T Regulatory Cells|Terminated||Phase 1|3|Actual|Masonic Cancer Center, University of Minnesota||1||Slow accrual|f||||t||||||||||2017-02-18 16:15:24.291037|2017-02-18 16:15:24.291037
NCT00376506|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2012-09-25|2011-11-01||July 2006||2006-07-01|September 2012|2012-09-01|January 2011|Actual|2011-01-01|September 2010|Actual|2010-09-01||Interventional|||A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia|A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia|Completed||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:15:24.414472|2017-02-18 16:15:24.414472
NCT00376493|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-14|2008-03-10|||May 2006||2006-05-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|APA||Prolonged Treatment for Infected Abortion After Hospital Discharge.|Prolonged Treatment for Infected Abortion After Hospital Discharge.|Terminated||Phase 4|56|Actual|Hospital de Clinicas de Porto Alegre||2||The rate of cure in both arms was higher than expected|f||||t||||||||||2017-02-18 16:15:25.131277|2017-02-18 16:15:25.131277
NCT00375687|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2006-09-12|||August 2005||2005-08-01|November 2005|2005-11-01|January 2020||2020-01-01|||||Interventional|||Investigation of Early Hormonotherapy Efficacy of Prostate Cancer|Investigation of Early Hormonotherapy Efficacy of High Risk Patients for Progression of Prostate Cancer After Radical Prostatectomy|Recruiting||N/A|61||Kaunas University of Medicine|||||f||||||||||||||2017-02-18 16:15:35.739395|2017-02-18 16:15:35.739395
NCT00376480|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2009-11-10|||March 2005||2005-03-01|July 2009|2009-07-01||||June 2010|Anticipated|2010-06-01||Interventional|||Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases|Delayed Infusion of Ex Vivo Anergized Peripheral Blood Mononuclear Cells Following CD34 Selected Peripheral Blood Stem Cell Transplantation From a Haploidentical Donor for Patients With Acute Leukemia and Myelodysplasia|Unknown status|Recruiting|Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:15:25.252679|2017-02-18 16:15:25.252679
NCT00376467|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2014-02-06|||December 2001||2001-12-01|February 2014|2014-02-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia|STI 571 (GLIVEC) in the Treatment of Philadelphia-chromosome Positive and/or BCR/ABL Rearranged Adult Acute Lymphoblastic Leukemia. GIMEMA LAL 0201.|Completed||Phase 2|105|Actual|Gruppo Italiano Malattie EMatologiche dell'Adulto||1|||f||||||||||||||2017-02-18 16:15:25.367315|2017-02-18 16:15:25.367315
NCT00376454|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2013-02-11|||November 2002||2002-11-01|February 2013|2013-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Tolerability of a 14 Day Treatment Course of GW493838 50mg Compared to Placebo in Subjects With Peripheral Neuropathic Pain|Completed||Phase 2|113||GlaxoSmithKline|||||||||||||||||||2017-02-18 16:15:25.495865|2017-02-18 16:15:25.495865
NCT00376441|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2011-08-19|||August 2006||2006-08-01|August 2011|2011-08-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|||Evaluate Women After Vaginal Surgery for Urinary Symptoms and Sexual Function|Study of Sexual Function and Urinary Symptoms in Women Having Vaginal Surgeries|Completed||N/A|41|Actual|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 16:15:25.615542|2017-02-18 16:15:25.615542
NCT00376428|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2015-02-24|||January 2003||2003-01-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients|Application of Functional Electrophysiological Tests to Evaluate Pharmacological Treatments in Patients With Cystic Fibrosis|Terminated||Phase 2|20||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:15:25.713205|2017-02-18 16:15:25.713205
NCT00376415|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2016-09-29|||September 2004||2004-09-01|September 2016|2016-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Safety Study of Lessertia Frutescens in Adults.|A Randomized, Double-blind Placebo-controlled Phase 1 Trial of Lessertia Frutescens in Adults.|Completed||Phase 1|25|Actual|University of Missouri-Columbia||2|||f||||t||||||||Undecided||2017-02-18 16:15:25.816368|2017-02-18 16:15:25.816368
NCT00376402|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-07-17|||October 2006||2006-10-01|November 2008|2008-11-01|June 2007||2007-06-01|||||Interventional|||Study of a Pandemic Influenza Vaccine in Elderly Participants|Phase II Study of a Pandemic Influenza Vaccine in Elderly Participants|Completed||Phase 2|200||Seqirus|||||f||||||||||||||2017-02-18 16:15:25.936083|2017-02-18 16:15:25.936083
NCT00376376|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2008-11-25|||September 2006||2006-09-01|November 2008|2008-11-01|November 2006||2006-11-01|||||Interventional|||Urinary Bactericidal Activity of 4 Doses of Levofloxacin Against Fluoroquinolone-Resistant E. Coli|Urinary Bactericidal Activity of 4 Doses of Levofloxacin (250, 500, &750, and 1000 mg) Against Fluoroquinolone-Resistant E. Coli|Completed||N/A|10||Michigan State University|||||f||||||||||||||2017-02-18 16:15:26.034255|2017-02-18 16:15:26.034255
NCT00376363|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2015-07-25|2015-05-17||November 2005||2005-11-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|December 2013|Actual|2013-12-01||Interventional|ABC|One eye of each patient will be randomized to receive either an Ahmed or a Baerveldt glaucoma drainage implant.|Ahmed Versus Baerveldt Comparison Study|Ahmed Versus Baerveldt Comparison Study|Completed||N/A|276|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 16:15:26.133707|2017-02-18 16:15:26.133707
NCT00376350|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2015-08-21|||March 2007||2007-03-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Dose of Spinal Manipulation for Chronic Low Back Pain|Dose-Response/Efficacy of Manipulation for Chronic LBP|Completed||Phase 2/Phase 3|400|Actual|University of Western States||4|||f||||t||||||||||2017-02-18 16:15:26.484819|2017-02-18 16:15:26.484819
NCT00376337|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2013-09-04|||June 2006||2006-06-01|October 2011|2011-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Micafungin Salvage Mono-therapy in Invasive Aspergillosis|A Phase II, Multicenter, Randomized, Open-label, Active Controlled Study to Evaluate the Safety and Efficacy of Micafungin Salvage Mono-therapy Versus Active Control Intravenous Salvage Mono-therapy in Patients With Invasive Aspergillosis|Terminated||Phase 2|17|Actual|Astellas Pharma Inc||2||"Study was stopped due to difficulties in recruitment and changes in standard care for invasive~   aspergillosis"|f||||t||||||||||2017-02-18 16:15:26.604799|2017-02-18 16:15:26.604799
NCT00376324|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2009-07-08|||September 2006||2006-09-01|July 2009|2009-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone|An Open-Label, Multiple-Dose Study of the Pharmacokinetics of Tigecycline in Human Bone|Completed||Phase 1|36|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 16:15:26.769075|2017-02-18 16:15:26.769075
NCT00376311|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2006-09-13|||September 2002||2002-09-01|June 2002|2002-06-01|May 2004||2004-05-01|||||Interventional|||Effects of Oral Salmon Calcitonin in Human Osteoarthritis|Phase IIa Study of the Effects of a New Oral Formulation of Salmon Calcitonin in Human Osteoarthritis|Terminated||Phase 2|54||Université Catholique de Louvain|||||f||||||||||||||2017-02-18 16:15:26.858399|2017-02-18 16:15:26.858399
NCT00376298|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2015-12-22|||February 2004||2004-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Urology Database to Evaluate Clinical Information and Improve Patient Care.|Urology Database for Outcomes Research|Completed||N/A|215|Actual|William Beaumont Hospitals|||1||f||||f||||||||||2017-02-18 16:15:26.970043|2017-02-18 16:15:26.970043
NCT00376285|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2015-04-21|||November 2006||2006-11-01|April 2015|2015-04-01||||||||Interventional|||Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033|A Phase 1, Randomized, Investigator and Subject Blind, Sponsor Open Study to Determine the Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033 When Co-Administered in Otherwise Healthy Obese Adult Subjects|Withdrawn||Phase 1|0|Actual|Pfizer|||||||||||||||||||2017-02-18 16:15:27.060595|2017-02-18 16:15:27.060595
NCT00375869|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2012-03-01|||November 2006||2006-11-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury|A Prospective Randomized Placebo Controlled Study of the Efficacy and Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury|Completed||Phase 2|10|Actual|Royal Alexandra Hospital||2|||f||||f||||||||||2017-02-18 16:15:33.253767|2017-02-18 16:15:33.253767
NCT00376272|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2009-04-17|||November 2004||2004-11-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence|Randomized, Prospective, Parallel Group, Placebo-Controlled, Multi-Center Study on the Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence|Completed||Phase 3|1442|Actual|Gruppo di Ricerca GISSI||2|||f||||t||||||||||2017-02-18 16:15:27.14318|2017-02-18 16:15:27.14318
NCT00376259|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2011-06-28|2010-12-20||January 2007||2007-01-01|June 2011|2011-06-01||||August 2008|Actual|2008-08-01||Interventional|||Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone|An Open-label, Multicenter, Randomized Study of Combination Therapy With Oral LDT600 (Telbivudine) Plus Adefovir Dipivoxil Versus Adefovir Dipivoxil Alone in HBeAg-positive Patients With Chronic Hepatitis B Who Are Lamivudine Resistant|Terminated||Phase 3|43|Actual|Novartis|The study was not completed as planned and was terminated early with agreement from the European Medicines Agency (EMEA).|2||"The study was not completed as planned and was terminated early with agreement from the~   European Medicines Agency (EMEA)"|f||||||||||||||2017-02-18 16:15:27.611508|2017-02-18 16:15:27.611508
NCT00376246|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2008-06-02|||September 2006||2006-09-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Ezetimibe on Flow-Mediated Brachial Artery Reactivity in Healthy Subjects|Effect of Ezetimibe on Flow-Mediated Brachial Artery Reactivity in Healthy Subjects|Completed||N/A|24|Anticipated|University of California, San Diego|||||f||||||||||||||2017-02-18 16:15:28.061371|2017-02-18 16:15:28.061371
NCT00376233|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2006-10-11|||February 2004||2004-02-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Observational|||Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia|First Detailed Study on Effects of Long Term Regular Cannabis Use on Arachidonic Acid-Prostaglandine Pathways in Schizophrenia|Completed||N/A|100||University of Jena|||||f||||||||||||||2017-02-18 16:15:28.141855|2017-02-18 16:15:28.141855
NCT00376220|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2011-06-22|||May 2004||2004-05-01|January 2011|2011-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Bipolar Depression Research Study|A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression|Completed||Phase 2|94|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:15:28.225941|2017-02-18 16:15:28.225941
NCT00376207|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2007-10-16|||January 2006||2006-01-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Physical Activity After Stroke: How Does it Effect Chronical Inflammation and Insulin Sensitivity||Completed||N/A|200|Anticipated|Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:15:28.336304|2017-02-18 16:15:28.336304
NCT00376194|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2013-09-17|||September 2006||2006-09-01|September 2013|2013-09-01|March 2007||2007-03-01|||||Interventional|||Mercury Chelation to Treat Autism|An Investigation of the Efficacy of Mercury Chelation as a Treatment for Autism Spectrum Disorder|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:15:28.428214|2017-02-18 16:15:28.428214
NCT00376181|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2010-06-17|||June 2006||2006-06-01|June 2010|2010-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus|A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study to Determine the Efficacy, Safety, and Tolerability of AD-4833-536 in the Treatment of Subjects With Type 2 Diabetes|Terminated||Phase 3|96|Actual|Takeda||3||Combination formulation concerns|f||||f||||||||||2017-02-18 16:15:28.524594|2017-02-18 16:15:28.524594
NCT00376168|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2012-07-25|2012-05-11||August 2007||2007-08-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease|A Phase III, Multicenter, Randomized, Double-Blind Trial to Assess the Safety and Efficacy of Two Parallel Dose Groups of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients With Gaucher Disease|Completed||Phase 3|32|Actual|Protalix||2|||f||||t||||||||||2017-02-18 16:15:28.723035|2017-02-18 16:15:28.723035
NCT00376155|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2017-02-09|||May 2006||2006-05-01|February 2017|2017-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Comparison of Two Strategies for the Delivery of IPTc|Comparison of Two Strategies for the Delivery of Intermittent Preventive Treatment in Children (IPTc) in an Area of Seasonal Malaria Transmission|Completed||Phase 4|14000|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 16:15:29.469323|2017-02-18 16:15:29.469323
NCT00376142|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2006-09-13|||April 2005||2005-04-01|September 2006|2006-09-01|November 2005||2005-11-01|||||Interventional|||Translating Clinicians' Beliefs Into Implementation Interventions (TRACII)|Translating Clinicians' Beliefs Into Implementation Interventions (TRACII): a Modelling Experiment to Change Clinicians' Intentions to Implement Evidence-Based Practice.|Completed||N/A|1200||Newcastle University|||||f||||||||||||||2017-02-18 16:15:29.578608|2017-02-18 16:15:29.578608
NCT00376129|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2007-12-07|||January 2006||2006-01-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis|Open-Label,Singel Center Study to Evaluate the Safety and Efficacy of an Intramuskcular 12 Week-Course of Alefacept in Patients With Atopic Dermatitis|Completed||Phase 2|10|Actual|University Hospital Inselspital, Berne||1|||f||||f||||||||||2017-02-18 16:15:29.676022|2017-02-18 16:15:29.676022
NCT00376116|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2008-11-14|||March 2005||2005-03-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|||||Observational|HomeCARE||Home Monitoring in Cardiac Resynchronisation Therapy|Home CARE - Home Monitoring in CArdiac REsynchronisation Therapy|Completed||N/A|513|Actual|Biotronik SE & Co. KG|||||f||||||||||||||2017-02-18 16:15:29.782448|2017-02-18 16:15:29.782448
NCT00376103|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2009-09-17|||August 2006||2006-08-01|September 2009|2009-09-01||||March 2008|Actual|2008-03-01||Interventional|||Radiation Boost for Newly Diagnosed Glioblastoma Multiforme|A Phase I/II Trial of Maximal Resection, Local Radiation Boost With Concomitant Temozolomide, Followed by External Radiation Therapy With Concomitant Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme|Terminated||Phase 1/Phase 2|3|Actual|Methodist Healthcare||1||Loss of funding from sponsor|f||||t||||||||||2017-02-18 16:15:29.944349|2017-02-18 16:15:29.944349
NCT00376090|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2011-09-02|||July 2005||2005-07-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults|A Phase I Double-Blind, Randomized, Dose Escalating, Placebo-Controlled, Study of Safety and Immunogenicity of WRAIR/NIH Live Recombinant MVA-CMDR (HIV-1 CM235 Env/ CM240 Gag/Pol) Administered by Intramuscular (IM) or Intradermal (ID) Route In HIV-Uninfected Adults|Completed||Phase 1|48|Actual|U.S. Army Medical Research and Materiel Command||8|||f||||f||||||||||2017-02-18 16:15:30.051073|2017-02-18 16:15:30.051073
NCT00376064|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2011-09-22|||March 2006||2006-03-01|September 2011|2011-09-01||||January 2010|Actual|2010-01-01||Interventional|||Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly|A Multicenter, Single Arm, Proof of Concept Study to Investigate the Efficacy of an 8 Month Combination Therapy of Octreotide and Cabergoline in Acromegalic Patients Only Partially Responsive to Somatostatin Analog Monotherapy|Completed||Phase 4|20|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:15:30.521475|2017-02-18 16:15:30.521475
NCT00376051|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2009-11-20|||September 2006||2006-09-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia|Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia|Completed||Phase 4|22|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-02-18 16:15:30.636297|2017-02-18 16:15:30.636297
NCT00376038|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2012-05-31|||August 2006||2006-08-01|February 2011|2011-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes|A Randomized Open-label, Repeat Dose, Two Sequence Cross-Over Study to Determine the Effect of GSK189075 on the Pharmacokinetic Parameters of Metformin (Glucophage) in Subjects With Type 2 Diabetes Mellitus.|Completed||Phase 1|13|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 16:15:30.740868|2017-02-18 16:15:30.740868
NCT00376025|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2008-02-12|||July 2007||2007-07-01|February 2008|2008-02-01|April 2009|Anticipated|2009-04-01|January 2009|Anticipated|2009-01-01||Interventional|||Antioxidant Supplementation in Patients With Kashin-Beck Disease|Study of the Effects of Antioxidant Supplementation in Patients Suffering From Kashin-Beck Disease|Unknown status|Recruiting|Phase 2|300|Anticipated|Innovative Humanitarian Solutions||1|||f||||t||||||||||2017-02-18 16:15:30.837002|2017-02-18 16:15:30.837002
NCT00376012|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2008-06-10|||February 2001||2001-02-01|May 2008|2008-05-01|September 2008|Anticipated|2008-09-01|September 2007|Anticipated|2007-09-01||Interventional|||Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis|Randomized Clinical Trial to Assess the Efficacy of Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis|Unknown status|Active, not recruiting|Phase 3|300|Actual|Tuberculosis Research Centre, India||2|||f||||||||||||||2017-02-18 16:15:30.945187|2017-02-18 16:15:30.945187
NCT00375999|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-13|2014-01-14|2014-01-14||September 2006||2006-09-01|January 2014|2014-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Docetaxel and Epirubicin in Advanced Gastric Cancer|A Phase II Study of Docetaxel and Epirubicin Combination in Patients With Advanced Gastric Cancer.|Completed||Phase 2|34|Actual|Yonsei University||1|||f||||||||||||||2017-02-18 16:15:31.059748|2017-02-18 16:15:31.059748
NCT00375986|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-11-12|||September 2006||2006-09-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section|A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section|Completed||N/A|150|Anticipated|University of Rochester|||||f||||f||||||||||2017-02-18 16:15:31.260324|2017-02-18 16:15:31.260324
NCT00375973|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2015-07-31|2015-03-18||September 2006||2006-09-01|July 2015|2015-07-01|March 2014|Actual|2014-03-01|June 2012|Actual|2012-06-01||Interventional|CFS||Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome|A Randomized, Placebo-Controlled, Double-Blind Trial of Duloxetine in the Treatment of Patients With Chronic Fatigue Syndrome|Completed||Phase 2/Phase 3|60|Actual|University of Cincinnati||2|||f||||f||||||||||2017-02-18 16:15:31.350625|2017-02-18 16:15:31.350625
NCT00375960|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-03-30|||June 2006||2006-06-01|March 2007|2007-03-01|April 2007||2007-04-01|||||Interventional|||A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Crossover Study of the Safety, Efficacy and Pharmacokinetics of Two Escalating, Oral Doses of V3381 (200 mg BID and 400 mg BID) for 28 Days in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)|Completed||Phase 2|50||Vernalis (R&D) Ltd|||||||||||||||||||2017-02-18 16:15:31.913467|2017-02-18 16:15:31.913467
NCT00375947|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-08-22|||November 2005||2005-11-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Study of Effectiveness of Hand Exercises to Treat Symptoms of Hand Osteoarthritis|Efficacy of a Home-Based Hand Range-of-Motion and Strength Training Exercise Program for Improvement of Hand Function in Older Adults With Hand Osteoarthritis: a Randomized Controlled Trial|Completed||N/A|65||The Arthritis Research Institute of America||2|||f||||||||||||||2017-02-18 16:15:32.029501|2017-02-18 16:15:32.029501
NCT00375934|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2010-09-17|2010-03-22||September 2006||2006-09-01|May 2010|2010-05-01||||January 2007|Actual|2007-01-01||Interventional|||Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery|Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery|Completed||Phase 3|200|Actual|Xanodyne Pharmaceuticals||2|||||||||||||||||2017-02-18 16:15:32.143982|2017-02-18 16:15:32.143982
NCT00375921|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-02-24|||November 2006||2006-11-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy|Evaluation of Chemosensory Function and Taste Preference of Head and Neck Cancer Patients Prior to, On Completion of and Six Weeks After Oncology Treatment|Completed||N/A|100|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 16:15:32.825479|2017-02-18 16:15:32.825479
NCT00375908|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2015-08-31|||October 2005||2005-10-01|August 2015|2015-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury|Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury|Completed||N/A|4|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 16:15:32.90968|2017-02-18 16:15:32.90968
NCT00375895|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2012-03-01|||June 2006||2006-06-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation|Prospective, Open-label, Single Arm Pilot Study Evaluating the Effect on Virological Response of the Switch From Tacrolimus to Cyclosporin Associated With a Peginterferon Alfa-2a / Ribavirin Bitherapy, in Non-responder or With Recurrent VHC+ Disease Liver Transplanted Patients.|Terminated||Phase 3|11|Actual|Rennes University Hospital||1||Insufficient enrollment|f||||f||||||||||2017-02-18 16:15:33.001489|2017-02-18 16:15:33.001489
NCT00375882|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2014-08-14|||March 2006||2006-03-01|August 2014|2014-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Safety Study to Evaluate the Effect of Lowering Body Temperature During Cochlear Implantation|Mild Hypothermia During Cochlear Implantation|Terminated||Phase 2|19|Actual|University of Miami||1||as specified in the protocol|f||||f||||||||||2017-02-18 16:15:33.146874|2017-02-18 16:15:33.146874
NCT00375856|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2016-09-26|||October 2006||2006-10-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Computer-Assisted Total Knee Replacement Kinematics: DePuy Sigma Posterior Cruciate Substituting Knee and the DePuy Sigma RP Rotating Platform Knee|An Investigation of Computer-Assisted Total Knee Replacement Kinematics on Patient Performance: An Examination of the DePuy P.F.C.® SigmaTM Posterior Cruciate Substituting Knee and the DePuy P.F.C.® Sigma RP Rotating Platform Knee Systems|Completed||Phase 4|91|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 16:15:33.377545|2017-02-18 16:15:33.377545
NCT00375843|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2013-02-05|||January 2005||2005-01-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|June 2007|Actual|2007-06-01||Interventional|||Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication|"Response Variability in Treatment Resistant Depression - an Ancillary Study to Sequenced Treatment Alternatives to Relieve Depression (STAR*D)"|Completed||Phase 4|118|Actual|National Institute of Mental Health (NIMH)||2|||f||||f||||||||||2017-02-18 16:15:33.492452|2017-02-18 16:15:33.492452
NCT00375830|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2017-01-17|||January 2006||2006-01-01|January 2017|2017-01-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Combined 18F NaF/18F FDG PET/MRI for Detection of Skeletal Metastases|Combined 18F NaF/18F FDG PET/MRI for Detection of Skeletal Metastases|Recruiting||Phase 4|120|Anticipated|Stanford University||1|||f||||t||||||||||2017-02-18 16:15:33.627937|2017-02-18 16:15:33.627937
NCT00375817|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-10-11|||November 2005||2005-11-01|October 2007|2007-10-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial|A Phase II, Open-Label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of MyoCell Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)|Unknown status|Active, not recruiting|Phase 2|40|Actual|Bioheart, Inc.||2|||f||||t||||||||||2017-02-18 16:15:33.743601|2017-02-18 16:15:33.743601
NCT00375804|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2012-04-27|||June 2003||2003-06-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|||||Observational|||Racial Disparity in Endometrial Cancer|Racial Disparity in Prevalence and Survival Rates in Endometrial Cancer|Terminated||N/A|43|Actual|James Graham Brown Cancer Center|||1|Funding and logistical difficuties resulted in the withdrawl of the study.|f||||t||||||||||2017-02-18 16:15:33.832933|2017-02-18 16:15:33.832933
NCT00375791|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2014-02-11|||December 2005||2005-12-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Interventional|||Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma|An Open-Label Phase II Study of the Safety and Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Relapsed or Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|67|Actual|AEterna Zentaris||1|||f||||f||||||||||2017-02-18 16:15:33.922437|2017-02-18 16:15:33.922437
NCT00375778|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2006-09-12|||April 2005||2005-04-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Parkinson's Disease Evaluated by PET and the Effect of Memantine|Parkinson's Disease Evaluated by Positron Emission Tomography and the Effect of the NMDA Receptor Antagonist Memantine|Completed||N/A|12||University of Aarhus|||||f||||||||||||||2017-02-18 16:15:34.04152|2017-02-18 16:15:34.04152
NCT00375765|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2017-01-17|||April 2005||2005-04-01|January 2017|2017-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer|A Randomized, Open-label, Parallel-group Study, to Assess the Pharmocodynamic Effect on Dihydrotestosterone Regulated Gene Expression, Longitudinally and in a Dose Dependent Manner, of 0.5mg and 3.5mg Dutasteride Administered Orally Once Daily, for One Year in Men With Symptomatic Benign Prostatic Hyperplasia and During a Two Month Period Between Baseline and Radical Prostatectomy in Men With Biopsy-proven, Clinically Localized Prostate Cancer|Completed||Phase 4|40||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:15:34.143034|2017-02-18 16:15:34.143034
NCT00375752|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-03-21|2012-03-30||June 2006||2006-06-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2010|Actual|2010-12-01||Interventional|FEMZONE||Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer|Neoadjuvant Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer. A Randomized Open Phase II Trial Evaluating the Efficacy of a 6 Months Preoperative Treatment With Letrozole (2.5 mg/Day) With or Without Zoledronic Acid (4 mg Every 4 Weeks)|Completed||Phase 4|168|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:15:34.244417|2017-02-18 16:15:34.244417
NCT00375739|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-01-26|||September 2006||2006-09-01|January 2016|2016-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses|A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses.|Completed||Phase 2|200||Peplin|||||||||||||||||||2017-02-18 16:15:34.967467|2017-02-18 16:15:34.967467
NCT00375726|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2010-12-13|||October 2006||2006-10-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of rDEN3/4delta30(ME), a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 3|Completed||Phase 1|58|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 16:15:35.09969|2017-02-18 16:15:35.09969
NCT00375713|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2011-08-30|2009-07-08||October 2005||2005-10-01|December 2009|2009-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema|A Multi-centre, Double-blind, Double-dummy, Randomized, Active-controlled Phase III Study to Evaluate the Efficacy and Safety of Xyzal® 5mg od vs Zyrtec® 10mg od in Subjects Aged 15 Years and Above With Dermatitis and Eczema|Completed||Phase 3|466|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 16:15:35.23267|2017-02-18 16:15:35.23267
NCT00375700|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-02-24|||November 2006||2006-11-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy|Efficacy of an Oral Nutrition Supplement on the Total Caloric and Protein Intake of Head and Neck Cancer Patients During the Last 2 Weeks of Radiation Therapy|Withdrawn||N/A|0|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 16:15:35.654199|2017-02-18 16:15:35.654199
NCT00375674|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2016-12-19|||August 2007||2007-08-01|December 2016|2016-12-01|August 2017|Anticipated|2017-08-01|April 2016|Actual|2016-04-01||Interventional|S-TRAC||A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer|Sunitinib Treatment Of Renal Adjuvant Cancer (S-trac): A Randomized Double-blind Phase 3 Study Of Adjuvant Sunitinib Vs. Placebo In Subjects At High Risk Of Recurrent Rcc|Active, not recruiting||Phase 3|720|Anticipated|Pfizer||2|||f||||t||||||||||2017-02-18 16:15:35.852128|2017-02-18 16:15:35.852128
NCT00375661|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2015-09-01|||September 2006||2006-09-01|September 2015|2015-09-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|||Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC|Phase 4 Study of Peg-interferon Plus Ribavirin Therapy for Prevention of Hepatocellular Carcinoma|Completed||Phase 4|100|Actual|Kyoto University||1|||f||||||||||||||2017-02-18 16:15:36.097444|2017-02-18 16:15:36.097444
NCT00375648|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2011-06-09|||June 2005||2005-06-01|June 2011|2011-06-01||||July 2007|Actual|2007-07-01||Interventional|TRAPEZE||Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer|Assessment of the Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer|Completed||Phase 3|61|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:15:36.208591|2017-02-18 16:15:36.208591
NCT00375635|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2006-09-12|||March 2006||2006-03-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Interventional|||Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis|Removal of Protein Bound Uremic Toxins in Chronic Hemodialysis Patients by Modified Plasma Separation and Adsorption Combined With Hemodialysis|Unknown status|Recruiting|N/A|10||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:15:36.322119|2017-02-18 16:15:36.322119
NCT00375622|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2006-09-12|||February 2005||2005-02-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial||Completed||Phase 2|60||Rabin Medical Center|||||f||||||||||||||2017-02-18 16:15:36.432089|2017-02-18 16:15:36.432089
NCT00375609|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-09-10|||May 2006||2006-05-01|September 2007|2007-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)|Evaluation of the Factor Xa Inhibitor, PRT054021, Against Enoxaparin in a Randomized Trial for the Prevention of Venous Thromboembolic Events After Unilateral Total Knee Replacement (EXPERT)|Completed||Phase 2|200|Anticipated|Portola Pharmaceuticals|||||f||||||||||||||2017-02-18 16:15:36.543757|2017-02-18 16:15:36.543757
NCT00375596|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2015-02-19||||||February 2015|2015-02-01||||||||Interventional|||A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis|Study Withdrawn Prior to Determining Official Title|Withdrawn||Phase 2|0|Actual|Bausch & Lomb Incorporated||||"Study withdrawn without starting or enrolling subjects due to a business decision to not~   proceed with the project."|f||||f||||||||||2017-02-18 16:15:36.637475|2017-02-18 16:15:36.637475
NCT00375531|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2015-04-27|||October 2006||2006-10-01|October 2007|2007-10-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Use of Mindfulness Meditation With Iraqi/Afghanistan War Veterans|Use of Mindfulness Meditation With Iraqi/Afghanistan War Veterans With Post Traumatic Stress Disorder|Withdrawn||N/A|0|Actual|Corporal Michael J. Crescenz VA Medical Center||||protocol revisions were deemed unable to be completed by 8/2007|f||||||||||||||2017-02-18 16:15:36.725841|2017-02-18 16:15:36.725841
NCT00375518|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2015-12-16|2015-12-16||July 2006||2006-07-01|December 2015|2015-12-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery|Double-Blind Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery|Completed||N/A|162|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 16:15:36.834246|2017-02-18 16:15:36.834246
NCT00375505|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2015-08-11|2015-05-18||October 2005||2005-10-01|August 2015|2015-08-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss|Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss|Completed||Phase 3|70|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:15:37.196078|2017-02-18 16:15:37.196078
NCT00375492|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2015-03-19|2009-02-25||September 2006||2006-09-01|March 2015|2015-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Effect on Weight Loss of Exenatide Versus Placebo|Effect on Weight Loss of Exenatide Versus Placebo in Subjects With Type 2 Diabetes Participating in a Lifestyle Modification Program|Completed||Phase 3|196|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:15:38.021098|2017-02-18 16:15:38.021098
NCT00375466|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2012-12-12|||September 2006||2006-09-01|December 2012|2012-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery.|Phase 4 Study of Tranexamic Acid for Elderly Patients Undergoing Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery.|Completed||N/A|63|Actual|St. Olavs Hospital||2|||f||||f||||||||||2017-02-18 16:15:38.853081|2017-02-18 16:15:38.853081
NCT00375453|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2014-12-30|||January 2007||2007-01-01|December 2014|2014-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Dose Escalation Study of SH U04722 in Solid Tumors|Phase I, Open-label, Dose Escalation Study for Evaluation of Safety, Tolerability, Pharmacokinetics, and Tumor-suppressive Efficacy of SH U04722 in Patients With Solid Tumors|Terminated||Phase 1|10|Actual|Bayer||1|||f||||||||||||||2017-02-18 16:15:38.96609|2017-02-18 16:15:38.96609
NCT00375440|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2015-10-02|||February 2005||2005-02-01|October 2015|2015-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Tranexamic Acid Study|Randomized Placebo Controlled Study Using Tranexamic Acid in Revision Total Hip Arthroplasty|Withdrawn||N/A|0|Actual|Texas Tech University Health Sciences Center||||Study halted prematurely as investigator left the institution.|f||||||||||||||2017-02-18 16:15:41.768306|2017-02-18 16:15:41.768306
NCT00375427|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2012-04-09|2011-02-28||February 2006||2006-02-01|July 2011|2011-07-01||||February 2010|Actual|2010-02-01||Interventional|||Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions|A Prospective, Randomized, Multi-center Comparative 2-arm Trial of Efficacy and Safety of Zoledronic Acid (Every 3-months vs. Every 4 Weeks) Beyond Approximately 1 Year of Treatment With Zoledronic Acid in Patients With Bone Lesions From Breast Cancer|Completed||Phase 3|430|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:15:41.88103|2017-02-18 16:15:41.88103
NCT00375414|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2007-05-04|||October 2003||2003-10-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Role of Prophylactic Antibiotics in New Introducer PEG-Gastropexy|New Introducer PEG-Gastropexy Does Not Need Prophylactic Antibiotics: Prospective Randomised Double Blind Placebo Controlled Trial|Completed||N/A|97|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||||||||||||2017-02-18 16:15:42.757544|2017-02-18 16:15:42.757544
NCT00375401|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2012-11-05||2009-08-11|October 2006||2006-10-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety|A 2-Year, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study To Evaluate The Long-Term Efficacy And Safety Of CP-945,598 In The Treatment Of Obese Subjects|Terminated||Phase 3|2536|Actual|Pfizer||3||See termination reason in detailed description.|f||||t||||||||||2017-02-18 16:15:42.862671|2017-02-18 16:15:42.862671
NCT00375388|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2006-09-12|||January 1998||1998-01-01|September 2006|2006-09-01|October 2002||2002-10-01|||||Interventional|||The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial|Study of Metformin HCL in Patients With Type 2 Diabetes Intensively Treated With Insulin: a Treatment Strategy for Insulin Resistance in Type 2 Diabetes Mellitus: a Randomized Controlled Trial|Completed||Phase 3|400||Bethesda General Hospital, Hoogeveen|||||f||||||||||||||2017-02-18 16:15:43.056694|2017-02-18 16:15:43.056694
NCT00375375|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2007-03-01|||January 2004||2004-01-01|March 2007|2007-03-01|December 2004||2004-12-01|||||Interventional|||Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life||Completed||Phase 4|80||Postgraduate Institute of Medical Education and Research|||||f||||||||||||||2017-02-18 16:15:43.15792|2017-02-18 16:15:43.15792
NCT00375362|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-12|2006-09-12|||July 2006||2006-07-01|July 2006|2006-07-01|September 2006||2006-09-01|||||Interventional|||The Analgesic Effect of Nitroglycerin Patch for Postoperative Pain After Total Knee Replacement|The Analgesic Efficacy of Nitroglycerin Patches for Postoperative Pain in Patients Undergoing Total Knee Arthroplasty|Unknown status|Recruiting|N/A|50||Rabin Medical Center|||||f||||||||||||||2017-02-18 16:15:43.254826|2017-02-18 16:15:43.254826
NCT00375349|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-09-29|||September 2006||2006-09-01|September 2016|2016-09-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Non Alcoholic Fatty Liver Disease Influence of Statin Therapy||Withdrawn||N/A|0|Actual|Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:15:43.352691|2017-02-18 16:15:43.352691
NCT00375336|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2008-12-31|||January 2005||2005-01-01|December 2008|2008-12-01|December 2008|Anticipated|2008-12-01|||||Observational|||Risk Factors Associated With Calcification of the Aortic Valve|Risk Markers of Coronary Artery Disease Associated With Calcific Aortic Valve Disease|Unknown status|Active, not recruiting|N/A|300|Anticipated|Charles University, Czech Republic|||3||f||||f||||||Samples Without DNA|"~     serum and plasma specimens retained at -80 deg. C~   "|||2017-02-18 16:15:43.441256|2017-02-18 16:15:43.441256
NCT00375323|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-04-19||||||April 2007|2007-04-01||||||||Interventional|||Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation|Effects of Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation in Patients With Hemophilia A and Antibodies to Factor VIII|Completed||Phase 3|||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:15:43.537199|2017-02-18 16:15:43.537199
NCT00375310|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-02-26|||September 2006||2006-09-01|February 2016|2016-02-01|November 2014|Actual|2014-11-01|November 2010|Actual|2010-11-01||Interventional|||Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer|Phase I Study of Gemcitabine With Novel RAF Kinase-Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib (BAY 43-9006) and Radiotherapy in Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma|Completed||Phase 1|27|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 16:15:43.632771|2017-02-18 16:15:43.632771
NCT00375297|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2006-09-08|||January 2001||2001-01-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women|Randomized Double Blind Placebo Controlled Study of Sildenafil for Treatment of Serotonergic Reuptake Inhibitor Associated Sexual Dysfunction in Women With Major Depression Treated to Remission|Completed||Phase 4|100||University of New Mexico|||||||||||||||||||2017-02-18 16:15:43.758667|2017-02-18 16:15:43.758667
NCT00375284|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2013-10-30|||September 2006||2006-09-01|October 2013|2013-10-01||||July 2007|Actual|2007-07-01||Interventional|||A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS|A Phase IV Randomised, Double-blind, Active and Placebo-controlled, 6-week Trial to Investigate the Efficacy and Safety of a Starting (and Fixed) Dose 0.25 mg Pramipexole (Mirapex®) in Patients With Idiopathic Restless Legs Syndrome|Completed||Phase 4|404|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:15:43.861824|2017-02-18 16:15:43.861824
NCT00375271|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2006-09-11|||August 2006||2006-08-01|September 2006|2006-09-01|June 2007||2007-06-01|||||Interventional|||Perioperative Hemodynamic Optimization in High-Risk Patients Using Less-Invasive Monitoring Methods|Multicenter Randomized Controled Trial of Perioperative Hemodynamic Optimization in High-Risk Patients Using Less-Invasive Monitoringng Methods|Unknown status|Recruiting|N/A|400||Centro de Estudos Mário César de Rezende|||||f||||||||||||||2017-02-18 16:15:44.000446|2017-02-18 16:15:44.000446
NCT00375258|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2011-06-29|||May 2005||2005-05-01|June 2011|2011-06-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage|A Large Randomised Placebo Controlled Trial Among Trauma Patients With, or at Risk of, Significant Haemorrhage, of the Effects of Antifibrinolytic Treatment on Death and Transfusion Requirement|Completed||Phase 3|20211|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 16:15:44.324573|2017-02-18 16:15:44.324573
NCT00375245|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2014-01-16|||September 2006||2006-09-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|May 2009|Actual|2009-05-01||Interventional|||Rapamycin With Grapefruit Juice for Advanced Malignancies|A Phase Ib Study Administering Rapamycin (Sirolimus) With Grapefruit Juice in Patients With Advanced Malignancies|Completed||Phase 1|41|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 16:15:44.448896|2017-02-18 16:15:44.448896
NCT00375232|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-01-05|||October 2006||2006-10-01|January 2016|2016-01-01||||||||Interventional|||Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes|Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes|Withdrawn||N/A|0|Actual|Indiana University|||||f||||||||||||||2017-02-18 16:15:44.561023|2017-02-18 16:15:44.561023
NCT00374608|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2012-05-30|||January 2007||2007-01-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Exercise in Chronically Paced Children|A Single Center, Prospective, Pilot Study Examining the Evaluation of Exercise Capacity in Chronically RV Paced Children and Young Adults|Completed||N/A|25|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:15:53.741367|2017-02-18 16:15:53.741367
NCT00375219|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2014-05-05|2014-05-05||September 2006||2006-09-01|May 2014|2014-05-01|September 2013|Actual|2013-09-01|December 2010|Actual|2010-12-01||Interventional||Intent to treat population includes all participants who provide written informed consent and receive at least one dose of study medication.|Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation|A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (Omacetaxine Mepesuccinate) in the Treatment of Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation|Completed||Phase 2|103|Actual|Teva Pharmaceutical Industries||1|||f||||t||||||||||2017-02-18 16:15:44.674254|2017-02-18 16:15:44.674254
NCT00375206|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-01-25|||September 2006||2006-09-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine|A Phase I Study to Assess Safety, Tolerability and Immunogenicity of a Trivalent Influenza Vaccine Administered by Particle Mediated Epidermal Delivery (PMED) to Healthy Subjects|Completed||Phase 1|189||PowderMed|||||||||||||||||||2017-02-18 16:15:46.256426|2017-02-18 16:15:46.256426
NCT00375193|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-09|2016-11-29||2009-05-19|November 2006||2006-11-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|May 2008|Actual|2008-05-01||Interventional|||Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy|A Phase 2 Trial of Single-Agent Amrubicin in Patients With Extensive Disease Small Cell Lung Cancer That is Refractory or Progressive Within 90 Days of Completion of First Line Platinum-based Chemotherapy|Completed||Phase 2|75|Actual|Celgene Corporation||1|||f||||f||||||||||2017-02-18 16:15:46.355149|2017-02-18 16:15:46.355149
NCT00375180|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-02-24|||November 2006||2006-11-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients|Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients Prior to, on Completion of and Six Weeks After Oncology Treatment|Completed||N/A|100|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 16:15:46.735924|2017-02-18 16:15:46.735924
NCT00375167|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2008-04-14|||September 2006||2006-09-01|April 2008|2008-04-01|May 2008||2008-05-01|||||Interventional|||Efficacy of the Recovery Workbook as a Psychoeducational Tool for Facilitating Recovery|Efficacy of the Recovery Workbook as a Psychoeducational Tool for Facilitating Recovery in Persons With Severe and Persistent Mental Illness|Completed||Phase 3|60|Anticipated|Queen's University|||||f||||||||||||||2017-02-18 16:15:46.818968|2017-02-18 16:15:46.818968
NCT00375154|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2011-07-19|||August 2006||2006-08-01|July 2011|2011-07-01||||||||Interventional|||HERMES STUDY: Study on the Feasibility and Efficiency of Noninvasive Positive-Pressure Ventilation (NPPV) in Prehospital Care|Noninvasive Positive-pressure Ventilation (NPPV) for Acute Respiratory Failure in Out-of-hospital Patients: a Multicenter, Prospective, Randomized Controlled Trial|Withdrawn||N/A|100|Anticipated|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||||major difficulties in training investigators in other centers|f||||||||||||||2017-02-18 16:15:46.918404|2017-02-18 16:15:46.918404
NCT00375141|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-06-04||||||June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation.||Terminated||N/A|||Bispebjerg Hospital||||Inclusion, treatments and follow-up are finished|f||||||||||||||2017-02-18 16:15:47.024886|2017-02-18 16:15:47.024886
NCT00375128|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-10|2007-10-18|||September 2006||2006-09-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Sporozoite Challenge of Polyprotein Vaccinees|Assessment of Protection Against Malaria by Sporozoite Challenge of Healthy Adults Vaccinated With the Polyprotein Malaria Vaccines 'FP9−PP, MVA−PP' and Control Non−Vaccinated Volunteers|Completed||Phase 1/Phase 2|26||European Malaria Vaccine Initiative|||||f||||f||||||||||2017-02-18 16:15:47.092432|2017-02-18 16:15:47.092432
NCT00375115|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-10|2007-11-05|||September 2006||2006-09-01|October 2007|2007-10-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Efficacy of Sambucol in the Treatment of Influenza|Efficacy of Sambucol on the Length of Time to Resolution of Influenza Illness|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:15:47.181334|2017-02-18 16:15:47.181334
NCT00375102|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2014-12-12|||November 2006||2006-11-01|December 2014|2014-12-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Acupuncture and the Relaxation Response for Substance Abuse|Acupuncture and the Relaxation Response for Homeless Veterans With Substance Abuse|Completed||Phase 2/Phase 3|67|Actual|VA Boston Healthcare System||3|||f||||f||||||||||2017-02-18 16:15:47.266978|2017-02-18 16:15:47.266978
NCT00375089|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2014-09-18|||September 2006||2006-09-01|September 2014|2014-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity|Prader-Willi Syndrome and Early-onset Morbid Obesity Natural History Clinical Protocol|Completed||N/A|392|Actual|University of Florida|||2||f||||t||||||Samples With DNA|"~     Blood samples for both DNA and RNA~   "|||2017-02-18 16:15:47.377857|2017-02-18 16:15:47.377857
NCT00375076|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2009-09-17|||June 2006||2006-06-01|September 2009|2009-09-01|May 2008|Actual|2008-05-01|||||Interventional|||Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients|Prevention of Venous Thrombosis in Cancer Patients: A Prospective, Randomized, Double-blind Study Comparing Two Different Dosages of Low-molecular Weight Heparin|Completed||Phase 3|||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:15:47.510127|2017-02-18 16:15:47.510127
NCT00375063|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2006-09-11|||January 2001||2001-01-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study)|Prospective Randomized Study of Unprotected Left Main Stenting Versus Bypass Surgery|Completed||Phase 4|130||Ministry of Science and Higher Education, Poland|||||f||||||||||||||2017-02-18 16:15:47.59043|2017-02-18 16:15:47.59043
NCT00375050|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2015-11-16|||May 2002||2002-05-01|November 2015|2015-11-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Treatment of Refractory Schizophrenia With Riluzole|Neuroprotective Treatment of Refractory Schizophrenia With Riluzole|Suspended||N/A|30|Anticipated|Yale University||2|||f||||f||||||||||2017-02-18 16:15:47.698291|2017-02-18 16:15:47.698291
NCT00375037|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2008-09-19|||January 2007||2007-01-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Multifaceted Intervention to Improve Hand Hygiene|Cluster Randomized Controlled Trial of a Multifaceted Intervention to Improve Hand Hygiene Among Healthcare Workers|Completed||N/A|1500|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 16:15:47.81839|2017-02-18 16:15:47.81839
NCT00375024|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2012-11-02|||May 2007||2007-05-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|September 2012|Actual|2012-09-01||Interventional|||Patient Navigator Project|Patient Navigator Project|Completed||N/A|1267|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-02-18 16:15:47.928358|2017-02-18 16:15:47.928358
NCT00375011|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-10|2012-02-15|||September 2008||2008-09-01|February 2010|2010-02-01|October 2011|Actual|2011-10-01|||||Observational|||Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics|Use of the BreathID to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Patients With Cirrhosis in Need of Liver Transplantation|Terminated||Phase 3|200|Anticipated|Exalenz Bioscience LTD.|||1|"Company restructured and protocol restructured. Resubmitted with IDE approval under new~   company name-Exalenz"|f||||||||||||||2017-02-18 16:15:48.03339|2017-02-18 16:15:48.03339
NCT00374998|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-10|2007-02-28|||April 2006||2006-04-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Interventional|||Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP|A Phase I Study to Assess the Safety and Immunogenicity of the Polyprotein Malaria Vaccine Candidates FP9 PP and MVA PP in Healthy Adults Using a Prime-Boost Delivery Schedule|Completed||Phase 1|35||European Malaria Vaccine Initiative|||||f||||||||||||||2017-02-18 16:15:48.145802|2017-02-18 16:15:48.145802
NCT00374985|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2014-11-27|||October 2005||2005-10-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction|Prospective, Open, Multicentre Phase I/II Study to Evaluate the Safety and Efficacy of a Neoadjuvant Radiochemotherapy With Docetaxel and Oxalipaltin in Patients With Adenocarcinoma of the Gastric-oesophageal Junction|Completed||Phase 1/Phase 2|25|Actual|Johannes Gutenberg University Mainz||1|||f||||t||||||||||2017-02-18 16:15:48.257652|2017-02-18 16:15:48.257652
NCT00374972|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2006-09-11||||||August 2006|2006-08-01||||||||Observational|||Combined Hormonal Versus Progestin Only Contraception During Lactation||Unknown status|Not yet recruiting|N/A|40||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:15:48.374374|2017-02-18 16:15:48.374374
NCT00374959|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2006-09-25|||October 2000||2000-10-01|September 2006|2006-09-01|October 2003||2003-10-01|||||Interventional|||Prevention of Pneumonia Comparing Ceftriaxone With Subglottic Aspiration|The Prevention of Primary Endogenous Ventilator-Associated Pneumonia: A Multicenter Randomized Trial Comparing Continuous Aspiration of Subglottic Content and a 3-Day Course of Ceftriaxone.|Completed||Phase 4|80||Hospital Universitario Principe de Asturias|||||f||||||||||||||2017-02-18 16:15:48.430747|2017-02-18 16:15:48.430747
NCT00374946|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2007-11-26||||||November 2007|2007-11-01||||||||Interventional|||A Clinical Evaluation of Wear Couples in THA||Completed||Phase 4|||Frederiksberg University Hospital|||||f||||||||||||||2017-02-18 16:15:48.536472|2017-02-18 16:15:48.536472
NCT00374933|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2016-06-07|||April 2007||2007-04-01|June 2016|2016-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation|Non-Myeloablative Conditioning With Allogeneic Peripheral Blood Progenitor Cell Transplantation Followed by Prophylactic Activated Donor Lymphocyte Infusion (DLI) for the Treatment of High Risk Acute Leukemia/MDS|Completed||Phase 1|18|Actual|Abramson Cancer Center of the University of Pennsylvania||1|||f||||||||||||||2017-02-18 16:15:48.598598|2017-02-18 16:15:48.598598
NCT00374920|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-09|2008-05-05|||September 2006||2006-09-01|May 2008|2008-05-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder|A Multicenter, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEM 1003 for the Treatment of Patients With Bipolar I Disorder Suffering Acute Manic or Mixed Episodes|Completed||Phase 2|60||Memory Pharmaceuticals|||||f||||f||||||||||2017-02-18 16:15:48.703885|2017-02-18 16:15:48.703885
NCT00374907|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2015-04-20|2010-12-26||September 2006||2006-09-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|January 2008|Actual|2008-01-01||Interventional|||A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise|Mechanism of Action and Efficacy of Saxagliptin (BMS-477118) in the Treatment of Type 2 Diabetic Patients|Completed||Phase 3|156|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:15:48.824397|2017-02-18 16:15:48.824397
NCT00374894|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2006-09-11|||March 2004||2004-03-01|April 2004|2004-04-01|August 2004||2004-08-01|||||Observational|||The Combined Effect of 2,3-Dimercaptosuccinic Acid and Multi-Nutrients on Children in Lead Poisoning||Completed||N/A|500||China Medical University, China|||||f||||||||||||||2017-02-18 16:15:49.814905|2017-02-18 16:15:49.814905
NCT00374881|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2008-04-14|||September 2006||2006-09-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|June 2007|Actual|2007-06-01||Interventional|||A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects|A Randomized, Double-Blind, Single-Center, 5 Way Cross-Over Study to Assess the Effect of Adding Oral Phenylephrine and Oral Sorbitol to Low Dose (1.5 mg) Plain Oral Morphine in Human Volunteers: Analgesia and Side Effect Assessment.|Completed||Phase 1/Phase 2|9|Actual|BioLineRx, Ltd.||5|||f||||f||||||||||2017-02-18 16:15:49.899426|2017-02-18 16:15:49.899426
NCT00374868|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-11|2010-10-20|2009-04-29||August 2006||2006-08-01|October 2010|2010-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)|Phase 1/2 Study of Biweekly ALIMTA Plus Cisplatin in Patients With Locally, Advanced, Non-Resectable or Metastatic Urothelial Cancer|Completed||Phase 1/Phase 2|59|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:15:50.01515|2017-02-18 16:15:50.01515
NCT00374855|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2007-05-11|||September 2006||2006-09-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study in People With Mild Hypertension|Protocol H8D-MC-EMBH PPAR Alpha (LY518674): a Phase 2 Dose-Response Study to Evaluate the Blood Pressure-Lowering Effect in Essential Hypertension|Completed||Phase 2|153||Eli Lilly and Company|||||||||||||||||||2017-02-18 16:15:50.464952|2017-02-18 16:15:50.464952
NCT00374842|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2016-10-06|2013-03-07||October 2006||2006-10-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate|A Study to Evaluate the Immunogenicity, Safety and Reactogenicity of Adjuvanted Influenza Vaccine Candidates Compared to Fluarix™ Administered Intramuscularly in Subjects Aged 18-59 Years.|Completed||Phase 2|300|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:15:50.575329|2017-02-18 16:15:50.575329
NCT00374829|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2009-05-06|||May 2004||2004-05-01|May 2007|2007-05-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Impact of an IT-Based and Healthcare Professional Support Program on Patients With High Blood Pressure|The Impact of a Multidisciplinary, Information Technology Supported Program on Blood Pressure Control in Primary Care (The Loyal Study)|Unknown status|Active, not recruiting|N/A|223|Actual|Université de Montréal||2|||f||||f||||||||||2017-02-18 16:15:51.262824|2017-02-18 16:15:51.262824
NCT00374803|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2016-03-28|2012-03-09||April 2006||2006-04-01|March 2016|2016-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal|A 12-month, Prospective, Randomized, Single Center, Open Label Pilot Study to Evaluate the Safety and Efficacy of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal|Completed||Phase 4|45|Actual|University of Cincinnati||2|||f||||f||||||||No||2017-02-18 16:15:51.375245|2017-02-18 16:15:51.375245
NCT00374790|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2006-09-08|||October 2006||2006-10-01|May 2006|2006-05-01||||||||Interventional|||Iron Supplementation of Lead-Exposed Infants|Pilot Study to Determine the Efficacy of Iron Supplementation in Preventing the Elevation of Blood Lead Concentrations in Young Children|Unknown status|Not yet recruiting|Phase 2|50||Cornell University|||||f||||||||||||||2017-02-18 16:15:51.900427|2017-02-18 16:15:51.900427
NCT00374777|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2014-08-19|||August 2006||2006-08-01|August 2014|2014-08-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients|FK199B (Zolpidem MR Tablet) Phase III Clinical Study -A Double-Blind, Placebo- and Nitrazepam-Controlled, Group-Comparison Study in Patients With Insomnia Associated With Schizophrenia and Manic-Depressive Psychosis|Completed||Phase 3|450|Actual|Astellas Pharma Inc||4|||f||||f||||||||||2017-02-18 16:15:51.99341|2017-02-18 16:15:51.99341
NCT00374764|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2007-02-15|||July 2000||2000-07-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone|Randomized Double Blind Comparison of Applied Behavioral Analysis Versus ABA and Risperidone|Completed||N/A|60||Washington University School of Medicine|||||||||||||||||||2017-02-18 16:15:52.115169|2017-02-18 16:15:52.115169
NCT00374751|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2015-04-27|||May 2006||2006-05-01|April 2015|2015-04-01||||January 2014|Actual|2014-01-01||Interventional|||Effect of Samarium on the Relief of Pain Due to Vertebral Metastases|Phase I/II Study of the Use of Vertebral Intracavitary Cement and Samarium (VICS) for Painful Vertebral Metastases|Completed||Phase 1/Phase 2|29|Actual|New York Methodist Hospital||1|||f||||t||||||||||2017-02-18 16:15:52.210218|2017-02-18 16:15:52.210218
NCT00374738|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-05-10|||November 2006||2006-11-01|May 2016|2016-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effects of an Alternative Treatment for Military Sexual Trauma on PTSD Symptoms, Neurosteroids and Brain Function|Effects of an Alternative Treatment for Military Sexual Trauma on PTSD Symptoms, Neurosteroids and Brain Function|Completed||N/A|34|Actual|Samueli Institute for Information Biology||2|||f||||f||||||||No|Study terminated/inactive.|2017-02-18 16:15:52.30935|2017-02-18 16:15:52.30935
NCT00374725|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2006-09-08|||February 2003||2003-02-01|November 2002|2002-11-01|May 2006||2006-05-01|||||Interventional|||Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus.|Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. A Randomised Placebo Controlled Trial|Completed||N/A|130||Odense University Hospital|||||f||||||||||||||2017-02-18 16:15:52.415527|2017-02-18 16:15:52.415527
NCT00374712|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-06|||January 2005||2005-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia|Study of Klotho Gene Polymorphisms in the Regulation of Serum Phosphate Levels in Hemodialysis Patients|Terminated||N/A|40|Actual|Assistance Publique - Hôpitaux de Paris|||1|terminated|f||||f||||||Samples With DNA|"~     DNA~   "|||2017-02-18 16:15:52.508705|2017-02-18 16:15:52.508705
NCT00374699|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2009-10-12|||April 2006||2006-04-01|June 2007|2007-06-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas|A Phase I/II Study of Bortezomib + CHOP in Patients With Advanced Stage Aggressive T Cell or NK/T Cell Lymphomas|Completed||Phase 1/Phase 2|55|Anticipated|Samsung Medical Center|||||f||||||||||||||2017-02-18 16:15:52.590734|2017-02-18 16:15:52.590734
NCT00374686|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2006-09-07|||March 2003||2003-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Study of Prophylactic Vs Preemptive Valganciclovir|Prophylactic Vs Preemptive Oral Valganciclovir for Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients: A Clinical and Pharmacoeconomic Study|Completed||N/A|120||Washington University School of Medicine|||||f||||||||||||||2017-02-18 16:15:52.681882|2017-02-18 16:15:52.681882
NCT00374673|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2015-12-02|||October 2006||2006-10-01|December 2015|2015-12-01|April 2012|Actual|2012-04-01|March 2012|Actual|2012-03-01||Interventional|||Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders|Efficacy of Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Idiopathic Pain Syndromes : a Double Blind Sham Controlled Study|Completed||Phase 3|60|Actual|Hospital Ambroise Paré Paris||2|||f||||f||||||||||2017-02-18 16:15:52.775141|2017-02-18 16:15:52.775141
NCT00374660|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2015-06-30|||June 2003||2003-06-01|June 2015|2015-06-01||||August 2007|Actual|2007-08-01||Interventional|||Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors|Phase I-II Clinical and Pharmacokinetic Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1/Phase 2|63|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 16:15:53.104292|2017-02-18 16:15:53.104292
NCT00374647|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2008-06-05|||March 2005||2005-03-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts|Open Label Randomized Single Study to Evaluate the Safety & Efficacy of Early CNI Withdrawal in Recipients of Primary Renal Allografts Maintained Long-Term on Mycophenolate Mofetil; MMF (CellCept) and Sirolimus (Rapamune)|Completed||Phase 4|17|Actual|University of Cincinnati|||||f||||f||||||||||2017-02-18 16:15:53.205851|2017-02-18 16:15:53.205851
NCT00374634|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2011-09-30|||September 2006||2006-09-01|September 2011|2011-09-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Individual Versus Standard Follicle Stimulating Hormone Dose for Controlled Ovarian Stimulation and Insemination|Individual Versus Standard rFSH Dose for Controlled Ovarian Stimulation and Intrauterine Insemination. A Prospective Randomised Multi Centre Study|Completed||Phase 4|234|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 16:15:53.298302|2017-02-18 16:15:53.298302
NCT00374621|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2011-06-13|||September 2006||2006-09-01|June 2011|2011-06-01|January 2010|Actual|2010-01-01|December 2007|Actual|2007-12-01||Interventional|||Trial of Cervical Ripening and Labor Induction Using Misoprostol With or Without Intravaginal Isosorbide Mononitrate|Randomized Clinical Trial of Cervical Ripening and Labor Induction Using Stepwise Oral Misoprostol With or Without Intravaginal Isosorbide Mononitrate|Completed||N/A|156|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 16:15:53.404757|2017-02-18 16:15:53.404757
NCT00374582|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2011-03-03|||September 2006||2006-09-01|March 2011|2011-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)|End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)|Completed||N/A|30|Anticipated|University of Cincinnati||1|||f||||f||||||||||2017-02-18 16:15:53.924868|2017-02-18 16:15:53.924868
NCT00374569|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2016-01-26|||June 2005||2005-06-01|January 2016|2016-01-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Dynamic Posturographic Testing and Motor Learning Predictability in Gymnasts|Dynamic Posturographic Testing and Motor Learning Predictability in Gymnasts|Completed||Early Phase 1|300|Actual|Carrick Institute for Graduate Studies||2|||f||||f||||||||No||2017-02-18 16:15:54.026723|2017-02-18 16:15:54.026723
NCT00374556|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2014-03-10|||January 2006||2006-01-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Insomnia and Osteoarthritis Study|The Efficacy of Eszopiclone (Lunesta) for Chronic Insomnia Associated With Osteoarthritis.|Completed||N/A|64|Anticipated|Johns Hopkins University||1|||f||||||||||||||2017-02-18 16:15:54.142085|2017-02-18 16:15:54.142085
NCT00374543|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2014-03-20|2013-05-20||February 2006||2006-02-01|March 2014|2014-03-01|November 2008|Actual|2008-11-01|October 2007|Actual|2007-10-01||Interventional|||Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder|Ziprasidone for the Treatment of Generalized Anxiety Comorbidity in Patients With Bipolar Disorder|Terminated||Phase 4|3|Actual|Massachusetts General Hospital|This study was terminated due to extreme difficulties in participant recruitment. Therefore, the sample size is extremely low, leaving inconclusive data.|2||Recruitment goal could not be achieved|f||||t||||||||||2017-02-18 16:15:54.243633|2017-02-18 16:15:54.243633
NCT00374530|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2007-07-31|||August 2006||2006-08-01|July 2007|2007-07-01||||||||Interventional|||Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2|Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2|Completed||N/A|12|Anticipated|Danish Headache Center|||||f||||||||||||||2017-02-18 16:15:54.587909|2017-02-18 16:15:54.587909
NCT00374517|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2017-01-24|||September 5, 2006||2006-09-05|February 2, 2010|2010-02-02|February 2, 2010|Anticipated|2010-02-02|February 2, 2010|Actual|2010-02-02||Interventional|||Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs|A Phase II Clinical Trial of Pimonidazole Hydrochloride as a Hypoxia Marker in Subjects Undergoing Elective Lung Resection for Treatment-Refractory Pulmonary Tuberculosis|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:15:54.671461|2017-02-18 16:15:54.671461
NCT00374504|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2006-09-08||||||February 2006|2006-02-01||||||||Observational|||Prediction of Postoperative Pain by an Electrical Pain Stimulus||Completed||N/A|46||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:15:54.774085|2017-02-18 16:15:54.774085
NCT00374491|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-01-04|||September 2006||2006-09-01|January 2016|2016-01-01||||||||Observational|||The Long-term Degradation Outcome of Bilok Screws Used for ACL Reconstruction|The Long-term Degradation Outcome of Bilok Biodegradable Interference Fixation Screws Used for Bone-Patellar Tendon-Bone ACL Reconstruction|Withdrawn||Phase 4|0|Actual|ArthroCare Corporation|||||f||||||||||||||2017-02-18 16:15:54.85833|2017-02-18 16:15:54.85833
NCT00374478|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2007-04-06|||April 2005||2005-04-01|April 2007|2007-04-01|April 2006|Actual|2006-04-01|||||Interventional|||Effects of Transdermal Scopolamine on Occupational Performance|Effects of Transdermal Scopolamine on Occupational Performance|Completed||Phase 2|33||Boston University|||||f||||f||||||||||2017-02-18 16:15:54.935506|2017-02-18 16:15:54.935506
NCT00374465|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2006-09-08|||January 2006||2006-01-01|September 2006|2006-09-01|May 2008||2008-05-01|||||Interventional|||Therapy With Verapamil or Carvedilol in Chronic Heart Failure|Prospective, Randomized Comparison of Therapy With Verapamil or Carvedilol on Long-Term Outcomes of Patients With Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy|Unknown status|Recruiting|Phase 4|100||Medical University of Silesia|||||f||||||||||||||2017-02-18 16:15:55.028677|2017-02-18 16:15:55.028677
NCT00374452|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2014-04-25|||January 2007||2007-01-01|April 2014|2014-04-01|March 2011|Actual|2011-03-01|May 2010|Actual|2010-05-01||Interventional|||VISN Collaborative for Improving Hypertension Management With ATHENA-HTN|VISN Collaborative for Improving Hypertension Management With ATHENA-HTN|Completed||N/A|103|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:15:55.121782|2017-02-18 16:15:55.121782
NCT00374439|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2013-12-16|||January 2004||2004-01-01|December 2013|2013-12-01|April 2006||2006-04-01|||||Interventional|||Cognitive Behavioral vs. Interpersonal Therapy (IPT) Prevention of Depression in Adolescents|Promoting Well-being in Teens|Completed||Phase 2/Phase 3|400||Vanderbilt University|||||f||||||||||||||2017-02-18 16:15:55.233261|2017-02-18 16:15:55.233261
NCT00374426|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2010-03-01|||March 1998||1998-03-01|March 2010|2010-03-01|October 2004||2004-10-01|||||Interventional|||Preventing Depression Recurrence in Diabetes|Preventing Depression Recurrence in Diabetes|Completed||Phase 4|262||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:15:55.34106|2017-02-18 16:15:55.34106
NCT00374413|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2013-08-31||2011-07-19|July 2005||2005-07-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|January 2010|Actual|2010-01-01||Interventional|||"Kineflex|C Artificial Disc System to Treat Cervical Degenerative Disc Disease (DDD)"|"Clinical Study Protocol for the Investigation of the Kineflex|C Spinal System - a Pivotal Study in Continued Access Stage"|Terminated||N/A|343|Actual|SpinalMotion||2||Economic and business factors|f||||f||||||||||2017-02-18 16:15:55.43498|2017-02-18 16:15:55.43498
NCT00374400|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2007-12-20|||September 2004||2004-09-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Observational|||The Paired Donation Consortium Paired Donation Program|The Paired Donation Consortium Paired Donation Program|Completed||N/A|100|Anticipated|University of Cincinnati|||||f||||||||||||||2017-02-18 16:15:55.573311|2017-02-18 16:15:55.573311
NCT00374387|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2011-03-30|||September 2006||2006-09-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|August 2009|Actual|2009-08-01||Interventional|||Psychosocial and Physiological Mechanisms in the Effect of Hormonal Contraception on the Female Sexual Desire|Psychosocial and Physiological Mechanisms in the Effect of Hormonal Contraception on the Female Sexual Desire|Completed||N/A|150|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:15:55.646748|2017-02-18 16:15:55.646748
NCT00374374|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2006-09-07|||May 2001||2001-05-01|April 2006|2006-04-01|November 2005||2005-11-01|||||Interventional|||Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn’s Disease.|Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn’s Disease.|Completed||N/A|30||Odense University Hospital|||||f||||||||||||||2017-02-18 16:15:55.73225|2017-02-18 16:15:55.73225
NCT00374361|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-06-06|||July 2003||2003-07-01|June 2016|2016-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Study of the Relationship Between Blood Vessels and Insulin Response in Adolescents|Relationship of Endothelial Function to Insulin Sensitivity in African American and Caucasian Adolescents|Completed||N/A|66||Ohio State University|||2||f||||f||||||||No|Observational|2017-02-18 16:15:55.828385|2017-02-18 16:15:55.828385
NCT00374348|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2011-09-15|||March 2005||2005-03-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)|"Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)."|Completed||N/A|10|Actual|Jamaica Hospital Medical Center||1|||f||||||||||||||2017-02-18 16:15:55.933279|2017-02-18 16:15:55.933279
NCT00374335|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2011-09-12|2011-08-09||September 2006||2006-09-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas|Multiple Hemangiomas and Large Cutaneous Hemangiomas of Infancy: Incidence of Hepatic Hemangiomatosis|Completed||N/A|261|Actual|Children's Mercy Hospital Kansas City||1|||f||||t||||||||||2017-02-18 16:15:56.045814|2017-02-18 16:15:56.045814
NCT00374322|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2014-08-14|2014-07-17||August 2006||2006-08-01|July 2014|2014-07-01|July 2013|Actual|2013-07-01|September 2011|Actual|2011-09-01||Interventional|||Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer|A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib (GW572016) in Women With Early-Stage ErbB2 Overexpressing Breast Cancer|Completed||Phase 3|3166|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 16:15:56.342926|2017-02-18 16:15:56.342926
NCT00374309|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2017-01-24|||September 5, 2006||2006-09-05|May 5, 2009|2009-05-05|May 5, 2009||2009-05-05|||||Interventional|||Experimental Vaccine for Prevention of Ebola Virus Infection|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Ebola Adenoviral Vector Vaccine, VRC-EBOADV018-00-VP, in Healthy Adults|Completed||Phase 1|48||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:15:58.782004|2017-02-18 16:15:58.782004
NCT00374296|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2015-06-04||2015-06-04|September 2006||2006-09-01|June 2015|2015-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease|A Phase II Study of MGCD0103 (MG-0103) in Patients With Acute Myelogenous Leukemia/High Risk MDS Who Are Elderly and Have Previously Untreated Disease or Who Are Adult and Have Relapsed/Refractory Disease|Terminated||Phase 2|35|Actual|Mirati Therapeutics Inc.||2||The Clinical Development Program for MGCD0103 is being re-evaluated|f||||f||||||||||2017-02-18 16:15:58.888112|2017-02-18 16:15:58.888112
NCT00374283|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2007-12-20|||June 2001||2001-06-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Observational|||Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients|Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients|Completed||N/A|40|Anticipated|University of Cincinnati|||||f||||f||||||||||2017-02-18 16:15:59.007269|2017-02-18 16:15:59.007269
NCT00374270|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2007-12-07|||May 2005||2005-05-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|SCRIP-HTN||Improving Blood Pressure Management in Patients With Diabetes|Improving Blood Pressure Management in Patients With Diabetes: SCRIP-HTN|Completed||Phase 4|227|Actual|University of Alberta|||||f||||f||||||||||2017-02-18 16:15:59.091208|2017-02-18 16:15:59.091208
NCT00374257|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2010-03-17|||August 2006||2006-08-01|March 2010|2010-03-01|August 2010|Anticipated|2010-08-01|September 2008|Actual|2008-09-01||Interventional|||UVB Phototherapy Treatment of Oral Chronic GVHD|Narrow-Band UVB Phototherapy for Treatment of Oral Chronic Graft-versus-Host Disease|Terminated||Phase 2|40|Anticipated|Brigham and Women's Hospital||1||Low/slow accrual|f||||t||||||||||2017-02-18 16:15:59.193039|2017-02-18 16:15:59.193039
NCT00374244|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-02-04|2013-01-10||January 2004||2004-01-01|February 2016|2016-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Efficacy of Pimozide Augmentation for Clozapine Partial Response|Efficacy of Pimozide Augmentation for Clozapine Partial Response|Completed||Phase 2|28|Actual|Yale University||2|||f||||f||||||||||2017-02-18 16:15:59.293165|2017-02-18 16:15:59.293165
NCT00374231|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2015-11-23|2013-12-19||October 2002||2002-10-01|November 2015|2015-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients|A Single Center, Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients Utilizing a Tacrolimus/Mycophenolate Mofetil Based Maintenance Immunosuppression Protocol|Completed||Phase 4|40|Actual|University of Cincinnati||1|||f||||f||||||||||2017-02-18 16:15:59.930212|2017-02-18 16:15:59.930212
NCT00374218|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2007-08-13|||September 2006||2006-09-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Effect of Replacing HFCS With Sucromalt in Subjects With Raised Waist Circumference|Effect of Replacing HFCS With Sucromalt on Glucose Tolerance, Blood Lipids and Inflammatory Markers in Subjects With Raised Waist Circumference|Completed||Phase 2|28|Actual|University of Toronto||2|||f||||f||||||||||2017-02-18 16:16:03.015053|2017-02-18 16:16:03.015053
NCT00374205|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2007-11-26|||September 2006||2006-09-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Randomized Trial on Effectiveness of ACTs in Ghana|A Comparative Assessment of the Effectiveness of Artemether Plus Lumefantrine Versus Artesunate Plus Amodiaquine for the Treatment of Children With Uncomplicated Plasmodium Falciparum Malaria|Terminated||Phase 4|245|Actual|Bernhard Nocht Institute for Tropical Medicine||2||Interim analysis showed more LCFs in one of the treatment arms|f||||t||||||||||2017-02-18 16:16:03.112997|2017-02-18 16:16:03.112997
NCT00374192|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2009-08-07|||February 2006||2006-02-01|August 2009|2009-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women|The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women|Completed||N/A|67|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:16:03.240348|2017-02-18 16:16:03.240348
NCT00374179|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-08|2009-02-23|||August 2006||2006-08-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma|A Phase 1, Escalating Dose Study of CT-322, a VEGFR-2 Antagonist, as Monotherapy in Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma|Completed||Phase 1|40|Actual|Adnexus, A Bristol-Myers Squibb R&D Company||1|||f||||f||||||||||2017-02-18 16:16:03.374352|2017-02-18 16:16:03.374352
NCT00374166|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-04-26||2016-04-26|August 2006||2006-08-01|April 2016|2016-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder|An Eight-week, Multicenter, Double-blind, Placebo- and Paroxetine-controlled Study Evaluating the Efficacy and Tolerability of Two Fixed Doses of SSR149415 (250 mg Bid and 100 mg Bid) in Outpatients With Generalized Anxiety Disorder|Completed||Phase 2|325|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 16:16:03.452885|2017-02-18 16:16:03.452885
NCT00374153|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2010-03-09|||September 2006||2006-09-01|March 2010|2010-03-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||Southern Methodist Alcohol Research Trial (SMART)|Dismantling Motivational Interviewing and Feedback for College Drinkers|Completed||N/A|363|Actual|The University of Texas Health Science Center, Houston||5|||f||||||||||||||2017-02-18 16:16:03.565882|2017-02-18 16:16:03.565882
NCT00374140|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2014-01-08|2014-01-08||October 2006||2006-10-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|December 2008|Actual|2008-12-01||Interventional|||Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer|Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer|Completed||Phase 2|40|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:16:03.686674|2017-02-18 16:16:03.686674
NCT00374127|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-10-25|||December 2004||2004-12-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison Between Marijuana Smoked in Cigarette Paper Versus Cigar Paper|Comparison Between Marijuana Smoked in Cigarette Paper (Joints) Versus Cigar Paper (Blunts)|Completed||Phase 2|36|Actual|New York State Psychiatric Institute||2|||f||||||||||||||2017-02-18 16:16:04.192821|2017-02-18 16:16:04.192821
NCT00374114|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2008-12-12|||January 2004||2004-01-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|||||Interventional|||A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia|A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia|Completed||N/A|20|Anticipated|University of Tennessee|||||f||||||||||||||2017-02-18 16:16:04.304909|2017-02-18 16:16:04.304909
NCT00374101|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2007-04-04|||January 2005||2005-01-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding|Proton Pump Inhibitors in Conjunction to Endoscopic Therapy for Bleeding Peptic Ulcers: a Randomized Clinical Trial of High vs Standard Doses|Completed||Phase 3|450||Casa Sollievo della Sofferenza IRCCS|||||f||||f||||||||||2017-02-18 16:16:04.403052|2017-02-18 16:16:04.403052
NCT00374088|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2011-12-14|2011-08-03||February 2005||2005-02-01|December 2011|2011-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)|Attenuation of Myocardial Dysfunction by N-Acetylcysteine in Infants Undergoing Arterial Switch Procedure|Completed||Phase 2|21|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 16:16:04.512074|2017-02-18 16:16:04.512074
NCT00374075|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-08-22|||September 2003||2003-09-01|August 2016|2016-08-01|February 2006||2006-02-01|||||Interventional|||Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy|In Vivo Study of Safety, Tolerability and Dosing Effect on SMN mRNA and Protein Levels of Valproic Acid in Patients With Spinal Muscular Atrophy|Completed||Phase 1|42||University of Utah|||||f||||||||||||||2017-02-18 16:16:04.901525|2017-02-18 16:16:04.901525
NCT00374062|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2014-07-14|||December 2007||2007-12-01|July 2014|2014-07-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effect of the Subconscious on Mohs Micrographic Surgery|Effect of the Subconscious on Mohs Micrographic Surgery|Completed||N/A|150|Anticipated|Northwestern University||3|||f||||f||||||||||2017-02-18 16:16:05.022726|2017-02-18 16:16:05.022726
NCT00374049|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-07-08|||June 2006||2006-06-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|January 2008|Actual|2008-01-01||Interventional|||MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer|A Pilot Dose Finding Study of MUC1 Vaccine in Conjunction With Poly-ICLC (Polyinosinic-polycytidylic Acid Stabilized With Polylysine and Carboxymethylcellulose) or HiltonolTM in Patients With Recurrent and/or Advanced Prostate Cancer|Completed||Phase 1|14|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:16:05.122454|2017-02-18 16:16:05.122454
NCT00374036|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2011-10-10|||June 2005||2005-06-01|October 2011|2011-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Metastatic Gastric Cancer FFCD 03-07|Strategy Phase III Intergroup Study for Chemotherapy of the Metastatic or Locally Advanced Cancers of the Stomach|Completed||Phase 3|416|Anticipated|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 16:16:05.238627|2017-02-18 16:16:05.238627
NCT00374023|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2006-09-07|||July 1993||1993-07-01|May 1993|1993-05-01|November 1995||1995-11-01|||||Interventional|||A Study on Immunological Effect of Vitamin A and Zinc in a Placebo Controlled 4 Cell Trial||Completed||N/A|147||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:16:05.355239|2017-02-18 16:16:05.355239
NCT00374010|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2008-03-27|||January 2005||2005-01-01|March 2008|2008-03-01|June 2008|Anticipated|2008-06-01|June 2007|Anticipated|2007-06-01||Interventional|||Improving Patient-Clinician Communication About End-of-Life Care|Improving Patient-Clinician Communication Among End-Stage Renal Disease African Patients and Their Families|Unknown status|Active, not recruiting|Phase 2|42|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-02-18 16:16:05.456025|2017-02-18 16:16:05.456025
NCT00373997|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2014-04-29|||September 2006||2006-09-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|March 2009|Actual|2009-03-01||Interventional|biopsy I||Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux|Role of Esophageal and Laryngeal Biopsies in Suspected Laryngopharyngeal Reflux|Completed||Phase 4|45|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:16:05.547221|2017-02-18 16:16:05.547221
NCT00373984|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2013-10-04|||January 2005||2005-01-01|October 2013|2013-10-01||||January 2006|Actual|2006-01-01||Observational|||A Study of the Incidence of Post-Thoracotomy Shoulder Pain|A Study of the Incidence of Post-Thoracotomy Shoulder Pain|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:16:05.641386|2017-02-18 16:16:05.641386
NCT00373971|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2006-09-07|||November 1995||1995-11-01|September 2006|2006-09-01|July 1998||1998-07-01|||||Interventional|||Preventing Loss of Weight, Fat Free Mass and Activities of Daily Living|Nutritional Care – Preventing Loss of Weight, Fat Free Mass and Activities of Daily Living Four Months After Surgery.|Completed||N/A|252||University of Aarhus|||||f||||||||||||||2017-02-18 16:16:05.725335|2017-02-18 16:16:05.725335
NCT00005741|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1995||1995-09-01|May 2002|2002-05-01|August 2001|Actual|2001-08-01|||||Observational|||Indigenous Outreach Among Injection Drug Users to Treat and Control TB||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:25.010105|2017-02-18 18:14:25.010105
NCT00373958|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2013-01-17|2010-03-26||September 2006||2006-09-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine|A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability and Immunologic Noninferiority of a 13-valent Pneumococcal Conjugate Vaccine Compared to a 7-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in the United States|Completed||Phase 3|666|Actual|Pfizer||2|||f||||||||||||||2017-02-18 16:16:06.102335|2017-02-18 16:16:06.102335
NCT00373945|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2009-05-15|||August 2006||2006-08-01|May 2009|2009-05-01|August 2007|Actual|2007-08-01|||||Observational|||HLA-B*5701 And Hypersensitivity To Abacavir|A Retrospective Case-Control Study to Estimate the Sensitivity and Specificity of a Pharmacogenetic Marker (HLA-B*5701) in Subjects With and Without Hypersensitivity to Abacavir.|Completed||N/A|280|Anticipated|GlaxoSmithKline|||1||||||||||||||||2017-02-18 16:16:09.542664|2017-02-18 16:16:09.542664
NCT00373932|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2009-12-03|||May 2006||2006-05-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Real-Time Support for Exercise Persistence in COPD|Real-Time Support for Exercise Persistence in COPD|Completed||Phase 1/Phase 2|17|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 16:16:09.671553|2017-02-18 16:16:09.671553
NCT00373919|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2007-03-02||||||August 2006|2006-08-01||||||||Interventional|||The Effect of Erythromycin on Occurrence of Leaks From Cervical Esophageal-Gastric Anastomosis After Trans-Hiatal Esophagectomy||Unknown status|Not yet recruiting|N/A|||Kaplan Medical Center|||||f||||||||||||||2017-02-18 16:16:09.775823|2017-02-18 16:16:09.775823
NCT00373906|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2013-11-26||||||May 2008|2008-05-01||||||||Interventional|||Velcade in MALT Lymphoma Patients|Phase II Trial pf Bortezomib in Patients With Advanced or Relapsed Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type|Completed||Phase 2|16|Anticipated|Medical University of Vienna|||||f||||||||||||||2017-02-18 16:16:09.843333|2017-02-18 16:16:09.843333
NCT00373893|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2006-09-07|||December 2005||2005-12-01|October 2005|2005-10-01|February 2006||2006-02-01|||||Interventional|||Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia|Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia|Completed||Phase 1|12||University of California, San Diego|||||f||||||||||||||2017-02-18 16:16:09.932344|2017-02-18 16:16:09.932344
NCT00373880|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-10-25|||April 2005||2005-04-01|October 2016|2016-10-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Effects of Aripiprazole on Cocaine Craving and Self-Administration|Effects of Aripiprazole on Cocaine Craving and Self-Administration|Completed||Phase 2|26|Actual|New York State Psychiatric Institute||2|||f||||||||||||||2017-02-18 16:16:10.028346|2017-02-18 16:16:10.028346
NCT00373867|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2013-01-24|||January 2006||2006-01-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effectiveness of Adding Behavioral Therapy to Physical Therapy to Treat Low Back Pain|Behavioral Interventions for Low Back Pain|Completed||N/A|108|Actual|University of Florida||3|||f||||t||||||||||2017-02-18 16:16:10.377159|2017-02-18 16:16:10.377159
NCT00373854|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-06-06|||September 2005||2005-09-01|June 2016|2016-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||Study of How Low Blood Sugar Affects the Way Blood Vessels Work|Hypoglycemia and Endothelial Function|Completed||N/A|13|Actual|Ohio State University|||2||f||||f||||||||No|Observational study|2017-02-18 16:16:10.487995|2017-02-18 16:16:10.487995
NCT00373841|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-01-04|||October 2005||2005-10-01|January 2016|2016-01-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|GAP||Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)|Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis|Recruiting||N/A|500|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     Blood samples necessary to analyze disease progression in patient with idiopathic pulmonary~     fibrosis over a long period of time.~   "|||2017-02-18 16:16:10.583039|2017-02-18 16:16:10.583039
NCT00373828|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2013-02-19|||June 2006||2006-06-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 1: Diagnosis.|Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 1: Diagnosis|Completed||N/A|302|Actual|Clinical Locomotion Science|||1||f||||||||||||||2017-02-18 16:16:10.6962|2017-02-18 16:16:10.6962
NCT00373815|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2014-05-28|||September 2006||2006-09-01|May 2014|2014-05-01|October 2009|Actual|2009-10-01|||||Interventional|||Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease|A Phase I Dose Escalation Study With Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Acute GVHD After Allogeneic Hematopoietic Stem Cell Transplantation|Terminated||Phase 1|10|Anticipated|University Hospital Tuebingen||||high incidence of TTP, poor recrual|f||||||||||||||2017-02-18 16:16:10.805479|2017-02-18 16:16:10.805479
NCT00373802|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2009-01-09|||January 2005||2005-01-01|January 2009|2009-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||The Use of Nasal Phenylephrine in Infants With Bronchiolitis|A Randomized, Double-Blinded Placebo Control Trial of Nasal Phenylephrine in Infants With Bronchiolitis|Completed||Phase 2|50||Akron Children's Hospital|||||f||||||||||||||2017-02-18 16:16:10.916595|2017-02-18 16:16:10.916595
NCT00373789|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2011-01-09|||June 2006||2006-06-01|October 2010|2010-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Refractory Urge Incontinence and Botox Injections|Refractory Urge Incontinence and Botox Injections|Terminated||Phase 3|87|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2||"higher than anticipated rate of increased post-void residual in subjects who received~   botulinum toxin A injection"|f||||t||||||||||2017-02-18 16:16:11.005445|2017-02-18 16:16:11.005445
NCT00373776|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2006-09-07|||April 2004||2004-04-01|September 2006|2006-09-01|May 2006||2006-05-01|||||Interventional|||Miltefosine for Mucosal Leishmaniasis||Completed||Phase 1/Phase 2|75||AB Foundation|||||f||||||||||||||2017-02-18 16:16:11.13827|2017-02-18 16:16:11.13827
NCT00373763|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2008-08-22|||January 2007||2007-01-01|August 2008|2008-08-01||||January 2008|Actual|2008-01-01||Interventional|||Fetoscopic Tracheal Balloon Occlusion in Unborns With Severe Congenital Diaphragmatic Hernia - EUROTRIAL I|Randomized Clinical Trial for the Assessment of the Life-Saving Potential of Fetoscopic Tracheal Balloon Occlusion in Fetuses With Severe Congenital Diaphragmatic Hernia - EUROTRIAL I|Withdrawn||N/A|98|Anticipated|University Hospital, Bonn||||"No patients could be recruited and randomized due to other center offering backdoor for~   treatment."|f||||||||||||||2017-02-18 16:16:11.233933|2017-02-18 16:16:11.233933
NCT00373750|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2015-01-09|||June 2006||2006-06-01|January 2015|2015-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Cradling Our Future Through Family Strengthening Study|In-home Prevention of SA Risks for Native Teen Families|Completed||N/A|322|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-02-18 16:16:11.337836|2017-02-18 16:16:11.337836
NCT00373737|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2010-07-23|||May 1999||1999-05-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Observational|||Microarray Analysis of Gene Expression in Liver Tumors|Microarray Analysis of Gene Expression in Liver Tumors|Completed||N/A|300|Anticipated|Stanford University|||1||f||||||||||Samples With DNA|"~     liver tumor~   "|||2017-02-18 16:16:11.456411|2017-02-18 16:16:11.456411
NCT00373724|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2008-05-07|||November 2005||2005-11-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Placebo-Controlled Study Assessing Lateral Branch Radiofrequency Denervation for Sacroiliac (SI) Joint Pain||Completed||N/A|30||Johns Hopkins University|||||f||||t||||||||||2017-02-18 16:16:11.537391|2017-02-18 16:16:11.537391
NCT00373711|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2011-04-07|||May 2007||2007-05-01|April 2011|2011-04-01||||||||Observational|||Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA|Comparison of I-124 PET/CT, F-18 FDG PET/CT and I-123 Whole Body Scintigraphy for Recurrent Thyroid Cancer Detection|Withdrawn||N/A|100|Anticipated|Stanford University|||1|Abandoned|f||||t||||||||||2017-02-18 16:16:11.63922|2017-02-18 16:16:11.63922
NCT00373698|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2015-04-06|2014-07-31||March 2008||2008-03-01|June 2014|2014-06-01|April 2012|Actual|2012-04-01|April 2010|Actual|2010-04-01||Interventional|RESPECT-PTSD|To be included, subjects had to meet diagnostic criteria for PTSD, have regular access to a telephone, and speak English. Exclusion criteria were cognitive impairment, history of psychosis or mania, prominent current suicidal ideation, current substance dependence, and current engagement in mental health treatment|Re-Engineering Systems for the Primary Care Treatment for PTSD|Reengineering Systems for the Primary Care Treatment of PTSD|Completed||Phase 3|195|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:16:11.73273|2017-02-18 16:16:11.73273
NCT00373685|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2012-02-02|2011-10-26||October 2006||2006-10-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|GI-REASONS||GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)|Gastrointestinal (GI) Randomized Event And Safety Open-Label NSAID Study (GI-Reasons): A Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS) In Osteoarthritis Patients|Completed||Phase 4|8067|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:16:12.384229|2017-02-18 16:16:12.384229
NCT00373672|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2010-02-22|||August 2006||2006-08-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder|Effect of Addition of Modafinil on the Tolerability and Efficacy for Cognition of Atypical Antipsychotic Drugs in Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|60|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 16:16:14.982219|2017-02-18 16:16:14.982219
NCT00373659|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2012-06-12|||August 2004||2004-08-01|June 2012|2012-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD|Prospective Optical Coherence Tomography (OCT) Imaging of Patients With Neovascular AMD Treated With Intra-Ocular Ranibizumab (Lucentis) (PrONTO) Study|Completed||Phase 2|40|Actual|University of Miami||1|||f||||f||||||||||2017-02-18 16:16:15.083438|2017-02-18 16:16:15.083438
NCT00373646|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2009-06-17|||June 2006||2006-06-01|June 2009|2009-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients|Phase II Trial of Thalidomide (Thalidomide Pharmion) in Patients With Advanced or Relapsed Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)|Completed||Phase 2|8|Actual|Medical University of Vienna||1|||f||||||||||||||2017-02-18 16:16:15.180514|2017-02-18 16:16:15.180514
NCT00373633|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2014-08-13|||September 2006||2006-09-01|August 2014|2014-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Extrapleural Intercostal Catheter vs. Thoracic Epidural for Thoracotomy Pain|A Prospective Randomized Trial Comparing Extrapleural Intercostal Local Anesthesia Versus Thoracic Epidural for the Managment of Acute Post Thoracotomy Pain|Terminated||Phase 1|26|Actual|Virginia Commonwealth University||2||terminated due to diminishing frequency of thorocotomies and slow enrollment|f||||||||||||||2017-02-18 16:16:15.276183|2017-02-18 16:16:15.276183
NCT00373620|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2006-09-06|||January 2006||2006-01-01|December 2005|2005-12-01||||||||Interventional|||A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients|A Phase II Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy in High-Risk Endometrial Cancer Patients After Operation.|Unknown status|Recruiting|Phase 2|50||Korean Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 16:16:15.385761|2017-02-18 16:16:15.385761
NCT00373607|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2010-09-13|||July 2003||2003-07-01|September 2010|2010-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru|Phase 3a: Efficacy, Safety, and Tolerability of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Peruvian Amazon Region|Completed||Phase 3|522|Actual|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||||2017-02-18 16:16:15.478889|2017-02-18 16:16:15.478889
NCT00373594|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2010-06-18|||June 2005||2005-06-01|June 2010|2010-06-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Therapy for Chronic Cold Agglutinin Disease|Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-randomized International Multicentre Study on the Safety and Efficacy of Rituximab in Combination With Fludarabine.|Completed||Phase 2|30|Anticipated|University of Bergen|||||f||||||||||||||2017-02-18 16:16:15.761|2017-02-18 16:16:15.761
NCT00373581|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-10-25|||April 2006||2006-04-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effects of Vigabatrin on Cocaine Self-Administration|Effects of Vigabatrin on Cocaine Self-Administration|Terminated||Phase 2|1|Actual|New York State Psychiatric Institute||2||Funding ran out|f||||f||||||||No||2017-02-18 16:16:15.879553|2017-02-18 16:16:15.879553
NCT00372580|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2006-09-05|||August 2006||2006-08-01|September 2006|2006-09-01|December 2007||2007-12-01|||||Observational|||Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of Psoriasis|Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of Psoriasis|Unknown status|Recruiting|N/A|110||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:16:16.003375|2017-02-18 16:16:16.003375
NCT00372567|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2011-03-15|2010-10-27||June 2007||2007-06-01|March 2011|2011-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors|A Phase IIIB, Randomized, Active Controlled Open-Label Study Of Sunitinib (Sutent) 37.5 Mg Daily Vs Imatinib Mesylate 800 Mg Daily In The Treatment Of Patients With Gastrointestinal Stromal Tumors (GIST) Who Have Had Progressive Disease While On 400 Mg Daily Of Imatinib|Terminated||Phase 3|69|Actual|Pfizer|On 18 June 2009, the study was prematurely stopped for operational reasons (poor recruitment, lack of interest, and change of clinical practice) and not related to safety concerns|2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 16:16:16.096795|2017-02-18 16:16:16.096795
NCT00372541|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2010-07-23|||September 2006||2006-09-01|July 2010|2010-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children|Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children Aged Less Than Five Years at Mulago Hospital: A Randomized Controlled Trial|Completed||Phase 3|348|Anticipated|Makerere University|||||f||||||||||||||2017-02-18 16:16:16.917844|2017-02-18 16:16:16.917844
NCT00372528|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2012-09-21|2012-09-21||March 2007||2007-03-01|September 2012|2012-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures|An Open-Label, Multi-Center, Add-On Study Of Pregabalin (LYRICA) In Subjects With Refractory Partial Seizures Who Have Completed Studies 1008-010, 1008-035, 1008-114 Or 1008-164|Terminated||Phase 3|21|Actual|Pfizer|This was a compassionate use study and no formal primary outcome measure was specified a priori. Descriptive safety data were collected, subsequently safety outcome was designated as primary outcome as per National Institute of Health (NIH) criteria.|1||"This study was terminated on April 8, 2011 as Pfizer Canada could no longer supply study drug.~   No efficacy or safety concerns factored into this decision."|f||||f||||||||||2017-02-18 16:16:17.027568|2017-02-18 16:16:17.027568
NCT00372515|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2014-10-20|||June 2006||2006-06-01|October 2014|2014-10-01|February 2015|Anticipated|2015-02-01|December 2012|Actual|2012-12-01||Interventional|||High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations|Phase I Study of High Dose Gefitinib (Iressa) for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations|Unknown status|Active, not recruiting|Phase 1|7|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:16:17.328097|2017-02-18 16:16:17.328097
NCT00372502|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2009-01-12|||January 2007||2007-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|LactATES||Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation|Lactate Assessment in the Treatment of Early Sepsis: The LactATES Trial|Completed||N/A|300|Actual|National Institute of General Medical Sciences (NIGMS)||2|||f||||t||||||||||2017-02-18 16:16:17.447843|2017-02-18 16:16:17.447843
NCT00373568|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2010-05-29|||April 2005||2005-04-01|May 2010|2010-05-01|December 2007||2007-12-01|||||Interventional|||Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis|Miltefosine (42 Days) for Mucosal Leishmaniasisi|Completed||Phase 1/Phase 2|25||AB Foundation|||||f||||||||||||||2017-02-18 16:16:17.55108|2017-02-18 16:16:17.55108
NCT00373555|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2008-09-30|||September 2006||2006-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|September 2007|Actual|2007-09-01||Interventional|||Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis|Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis|Completed||N/A|50|Anticipated|University of Calgary|||||f||||f||||||||||2017-02-18 16:16:17.644033|2017-02-18 16:16:17.644033
NCT00373542|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-10-27|||October 2006||2006-10-01|October 2016|2016-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|(CR-RLS)||12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome|A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep|Completed||Phase 4|39|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:16:17.739973|2017-02-18 16:16:17.739973
NCT00373529|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2014-03-17|2011-02-24||October 2006||2006-10-01|March 2014|2014-03-01|May 2010|Actual|2010-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)|A Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients With Acute Myelogenous Leukemia (AML) for Whom Standard Induction Chemotherapy is Unlikely to be of Benefit|Completed||Phase 2|116|Actual|Sanofi||1|||f||||t||||||||||2017-02-18 16:16:18.022693|2017-02-18 16:16:18.022693
NCT00373516|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2006-09-06|||September 2004||2004-09-01|September 2006|2006-09-01|March 2005||2005-03-01|||||Interventional|||Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Study of the Safety and Efficacy of Two Dosing Regimens of QRX-101 (Becocalcidiol) Ointment in the Treatment of Plaque-Type Psoriasis|Completed||Phase 2|150||QuatRx Pharmaceuticals Company|||||||||||||||||||2017-02-18 16:16:19.479384|2017-02-18 16:16:19.479384
NCT00373503|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2013-02-04|||August 2005||2005-08-01|February 2013|2013-02-01|September 2008|Actual|2008-09-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse|Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse|Completed||Phase 2|8|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 16:16:19.590881|2017-02-18 16:16:19.590881
NCT00373490|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2015-08-26|2008-10-20||July 2006||2006-07-01|August 2015|2015-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of Oral Suberoylanilide Hydroxamic Acid (Vorinostat) in Patients With Solid Tumors (0683-048)|MK0683 Phase1 Clinical Study - Solid Tumor -|Completed||Phase 1|16|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:16:19.730613|2017-02-18 16:16:19.730613
NCT00373477|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2006-09-06|||July 2003||2003-07-01|September 2006|2006-09-01|February 2005||2005-02-01|||||Interventional|||A Study of the Cost Effectiveness of Generalist Care Managers for Depression Treatment in Medicaid Recipients|A Randomized Trial of the Cost Effectiveness of Generalist Care Managers for the Treatment of Depression in Medicaid Recipients|Completed||N/A|300||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 16:16:20.35797|2017-02-18 16:16:20.35797
NCT00005740|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1995||1995-09-01|May 2002|2002-05-01|August 2000|Actual|2000-08-01|||||Observational|||TB Contact Investigation: Behavioral Intervention||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:25.076261|2017-02-18 18:14:25.076261
NCT00373464|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2011-06-30|||March 2006||2006-03-01|August 2005|2005-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Surgery|Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Gynaecologic Surgery With Expected Need of Post-operative Opioids|Completed||Phase 3|126||Oslo University Hospital|||||f||||||||||||||2017-02-18 16:16:20.448887|2017-02-18 16:16:20.448887
NCT00373451|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2012-05-07|||July 2006||2006-07-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|ISAR-REACT-4||Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome|Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Abciximab And Bivalirudin in Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Interventions (ISAR-REACT-4)|Completed||Phase 4|1721|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 16:16:20.547121|2017-02-18 16:16:20.547121
NCT00373438|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2009-01-05|||January 2009||2009-01-01|January 2009|2009-01-01|July 2014|Anticipated|2014-07-01|January 2014|Anticipated|2014-01-01||Interventional|||Fetoscopic Tracheal Balloon Occlusion in Left Diaphragmatic Hernia|Randomized Clinical Trial in Order to Assess the Effect of Fetoscopic Tracheal Balloon Occlusion on the Postnatal Disease Course in Neonates With Left Congenital Diaphragmatic Hernia - FDH-ECMO/BALLOON-TRIAL|Unknown status|Recruiting|Phase 2|98|Anticipated|University Hospital, Bonn||2|||f||||t||||||||||2017-02-18 16:16:20.69011|2017-02-18 16:16:20.69011
NCT00373425|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2015-09-01|2014-04-02||September 2006||2006-09-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|April 2013|Actual|2013-04-01||Interventional|RADIANT||A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors|A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva® (Erlotinib) Following Complete Tumor Resection With or Without Adjuvant Chemotherapy in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma Who Have EGFR-positive Tumors|Completed||Phase 3|1252|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the currency or completeness of the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose and shall not be liable for any damages.|2|||f||||t||||||||||2017-02-18 16:16:20.824625|2017-02-18 16:16:20.824625
NCT00373412|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2008-05-05|||October 2006||2006-10-01|October 2006|2006-10-01||||February 2008|Actual|2008-02-01||Interventional|||Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge|Randomized, Phase 1 Trial to Evaluate Safety and CMV-Specific Immune Response to a pDNA CMV Trivalent Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge in Healthy, CMV- Seronegative Adults|Completed||Phase 1|16||University of California, San Francisco|||||f||||f||||||||||2017-02-18 16:16:25.345252|2017-02-18 16:16:25.345252
NCT00373399|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2016-10-25|||May 2006||2006-05-01|October 2016|2016-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks|Effects of Smoked Marijuana on Risk Taking and Decision Making Tasks|Completed||Phase 2|278|Actual|New York State Psychiatric Institute||2|||f||||||||||||||2017-02-18 16:16:25.440805|2017-02-18 16:16:25.440805
NCT00373386|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2008-06-27|||January 2005||2005-01-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Growth Hormone and Endothelial Function in Children|Growth Hormone and Endothelial Function in Children|Completed||Phase 4|12|Actual|Ohio State University||1|||f||||f||||||||||2017-02-18 16:16:25.550774|2017-02-18 16:16:25.550774
NCT00373373|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2009-08-18|||September 2006||2006-09-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML|A Double-blind, Placebo-controlled, Randomized, Multi-center Phase II Trial to Assess the Efficacy of Sorafenib Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed AML|Completed||Phase 2|200|Anticipated|University Hospital Muenster||2|||f||||t||||||||||2017-02-18 16:16:25.649389|2017-02-18 16:16:25.649389
NCT00373360|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2013-01-03|2012-10-19||September 2006||2006-09-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin|Rapid Switch From Intravenous Epoprostenol to Intravenous Remodulin® (Treprostinil Sodium) in Patients With Stable Pulmonary Arterial Hypertension: Safety, Efficacy and Treatment Satisfaction|Completed||Phase 4|10|Actual|United Therapeutics||1|||f||||f||||||||||2017-02-18 16:16:25.777121|2017-02-18 16:16:25.777121
NCT00373347|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-11-08|||November 2004||2004-11-01|November 2016|2016-11-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Observational|||Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma|Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma|Recruiting||N/A|300|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"~     blood~   "|||2017-02-18 16:16:29.072521|2017-02-18 16:16:29.072521
NCT00373334|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2009-11-17|2009-08-03||August 2006||2006-08-01|November 2009|2009-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)|A Double-Blind, Randomized, Parallel, Multicenter Study of Axid (Nizatidine) Oral Solution in the Treatment of Gastroesophageal Reflux Disease (GERD) Symptoms in Infants Age 30 Days-1 Year|Completed||Phase 3|138|Actual|Braintree Laboratories||3|||f||||||||||||||2017-02-18 16:16:29.172123|2017-02-18 16:16:29.172123
NCT00373308|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-07-14|||September 2002||2002-09-01|July 2016|2016-07-01|July 2020|Anticipated|2020-07-01|July 2018|Anticipated|2018-07-01||Observational|||Quality of Life Following Radical Prostatectomy|Quality of Life Following Radical Prostatectomy|Recruiting||N/A|200|Anticipated|Stanford University|||1||f||||t||||||||||2017-02-18 16:16:32.26007|2017-02-18 16:16:32.26007
NCT00373295|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2013-02-04|||May 2006||2006-05-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Baclofen on Marijuana Withdrawal and Relapse|Effect of Baclofen on Marijuana Withdrawal and Relapse|Completed||Phase 2|13|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 16:16:32.354894|2017-02-18 16:16:32.354894
NCT00373282|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2006-10-11|||June 2001||2001-06-01|August 2006|2006-08-01|June 2003||2003-06-01|||||Interventional|||Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy||Completed||Phase 3|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:16:32.457901|2017-02-18 16:16:32.457901
NCT00327821|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2006-07-20|||July 2002||2002-07-01|May 2003|2003-05-01|March 2003||2003-03-01|||||Interventional|||The Effectiveness of Commercial Weight Loss Programmes|A Randomised Control Trial of Commercial Weight Loss Programme in a Community Based Sample of Obese Adults.|Completed||N/A|300||University of Surrey|||||f||||||||||||||2017-02-18 16:32:06.463861|2017-02-18 16:32:06.463861
NCT00373269|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2016-11-04|2016-11-04||October 2001||2001-10-01|November 2016|2016-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Procoagulant Effects of Hyperglycemia After Acute Stroke: A Pilot Study|Procoagulant Effects of Hyperglycemia After Acute Stroke: A Pilot Study|Completed||N/A|21|Actual|Temple University|||2||f||||f||||||||No||2017-02-18 16:16:32.545656|2017-02-18 16:16:32.545656
NCT00373256|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-07|2012-09-05|2010-06-01||November 2006||2006-11-01|September 2012|2012-09-01|August 2011|Actual|2011-08-01|June 2009|Actual|2009-06-01||Interventional|||A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer|A Phase 3 Study Of SU011248 In Combination With Paclitaxel Versus Bevacizumab With Paclitaxel In The First-Line Advanced Disease Setting In Patients Having Breast Cancer|Completed||Phase 3|488|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:16:32.945244|2017-02-18 16:16:32.945244
NCT00373243|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2009-05-15|||October 2005||2005-10-01|May 2009|2009-05-01||||||||Interventional|||A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment|An Open-Label, Non-Randomised Study of 20 mg GW406381 Single Dose Pharmacokinetics in Healthy Subjects and in Volunteers With Moderate Hepatic Impairment|Completed||Phase 1|24|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:16:35.975373|2017-02-18 16:16:35.975373
NCT00373230|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-10-22|||October 2007||2007-10-01|October 2008|2008-10-01|February 2010|Anticipated|2010-02-01|February 2010|Anticipated|2010-02-01||Interventional|||Treating Obesity in Underserved Overweight Populations|Treating Obesity and Its Consequences in Underserved Overweight Populations|Unknown status|Recruiting|N/A|320|Anticipated|Temple University||2|||f||||t||||||||||2017-02-18 16:16:36.068637|2017-02-18 16:16:36.068637
NCT00373217|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-08-11|||February 2008||2008-02-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|Evaluation of the Immunogenicity of Vaccination With Synthetic Peptides in Adjuvant in Patients With Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Terminated||Phase 2|6|Actual|University of Virginia||2||Slow enrollment rate.|f||||||||||||||2017-02-18 16:16:36.18543|2017-02-18 16:16:36.18543
NCT00373204|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2014-07-23|||May 2006||2006-05-01|July 2014|2014-07-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)|Phase II Trial of Motexafin Gadolinium and Docetaxel for Second Line Treatment of Patients With Advanced Non-small Cell Lung Cancer|Terminated||Phase 2|50|Actual|Pharmacyclics LLC.||1|||f||||||||||||||2017-02-18 16:16:36.309253|2017-02-18 16:16:36.309253
NCT00373191|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2015-10-09|||May 2006||2006-05-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|February 2009|Actual|2009-02-01||Observational|||Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery|Effects of Surgery, Radiation Therapy, Chemotherapy, and Endocrine Therapy on High-Sensitivity C-Reactive Protein in Women With Operable Breast Cancer|Completed||N/A|35|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||||||||Samples With DNA|"~     Serum~   "|||2017-02-18 16:16:36.444038|2017-02-18 16:16:36.444038
NCT00373178|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2012-11-01|||January 2005||2005-01-01|November 2012|2012-11-01|June 2008|Actual|2008-06-01|January 2007|Actual|2007-01-01||Interventional|||Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes|Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes|Completed||Phase 4|100|Actual|Aristotle University Of Thessaloniki||1|||f||||||||||||||2017-02-18 16:16:36.549961|2017-02-18 16:16:36.549961
NCT00373165|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2006-09-12|||August 2000||2000-08-01|September 2006|2006-09-01|October 2003||2003-10-01|||||Interventional|||Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients|Open, Randomised Study Comparing Preemptive Therapy With Intravenous Ganciclovir With and Without Additional Oral Ganciclovir for CMV Prophylaxis in Immunosuppressed Renal Transplant Patients Receiving Monitoring of CMV Viral Load|Completed||Phase 4|150||Lower Saxony Center for Nephrology|||||f||||||||||||||2017-02-18 16:16:36.660235|2017-02-18 16:16:36.660235
NCT00373152|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2011-08-11|||March 2005||2005-03-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer|Breast MRI Assessment of Tumor Viability After Radiofrequency Ablation (RFA)|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||1||No patient accrual|f||||t||||||||||2017-02-18 16:16:36.749303|2017-02-18 16:16:36.749303
NCT00373139|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2013-12-27|||July 2006||2006-07-01|December 2013|2013-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Accuracy of Whole-Blood Testing for Rapid Detection of Pregnancy|Accuracy of Whole-Blood Testing for Rapid Detection of Pregnancy|Completed||Early Phase 1|633|Actual|Maimonides Medical Center|||1||f||||f||||||||||2017-02-18 16:16:36.859737|2017-02-18 16:16:36.859737
NCT00373126|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2009-05-14|||April 2005||2005-04-01|May 2009|2009-05-01||||||||Interventional|||The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia|A Double-Blind, Placebo-Controlled Trial of Reward Responsivity During Nicotine Withdrawal in Smokers With Schizophrenia and Normal Controls|Completed||Phase 4|40|Anticipated|North Suffolk Mental Health Association|||||f||||||||||||||2017-02-18 16:16:36.942658|2017-02-18 16:16:36.942658
NCT00373113|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2012-06-15|2010-10-20||November 2006||2006-11-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|October 2009|Actual|2009-10-01||Interventional|||A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine|Phase III Randomized, Multi Center Study Of Sunitinib Malate (SU 011248) Or Capecitabine In Subjects With Advanced Breast Cancer Who Failed Both A Taxane And An Anthracycline Chemotherapy Regimen Or Failed With A Taxane And For Whom Further Anthracycline Therapy Is Not Indicated|Terminated||Phase 3|482|Actual|Pfizer|Due to patient enrollment termination, PFS/OR/TTP/DR were done by investigator assessment due to lack of central review data and TTR/EORTC QLQ-C30/QLQ BR23 analyses were not done. Those enrolled could receive capecitabine or enter an extension trial.|2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 16:16:37.070733|2017-02-18 16:16:37.070733
NCT00373100|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2009-07-03|||September 2006||2006-09-01|July 2009|2009-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children|The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children Admitted to Mulago Hospital, Uganda.|Completed||Phase 3|328|Anticipated|Makerere University||2|||f||||t||||||||||2017-02-18 16:16:39.199781|2017-02-18 16:16:39.199781
NCT00373087|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2010-04-28|||October 2006||2006-10-01|July 2007|2007-07-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|COMT||COMT Polymorphism and Entacapone Efficacy|Influence of Catechol-O-methyltransferase Polymorphism on Entacapone Efficacy in Parkinson's Disease|Completed||Phase 4|60|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 16:16:39.312155|2017-02-18 16:16:39.312155
NCT00373074|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2009-02-04|||September 2006||2006-09-01|February 2009|2009-02-01|July 2008|Actual|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH)|A Multi-Center, Randomized Controlled Study Trial to Investigate the Effect of Varying Volumes of Blood Patch on the Resolution of Postdural Puncture Headache (PDPH)|Terminated||Phase 2/Phase 3|0|Anticipated|The University of Texas Health Science Center, Houston||3||Lack of subject population for PI|f||||||||||||||2017-02-18 16:16:39.419135|2017-02-18 16:16:39.419135
NCT00373061|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2016-03-08|||October 2006||2006-10-01|March 2016|2016-03-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|EXPECT||An Observational Study of the Use and Safety of Xolair During Pregnancy|The Xolair Pregnancy Registry: An Observational Study of the Use and Safety of Xolair (Omalizumab) During Pregnancy|Active, not recruiting||Phase 4|304|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 16:16:39.521983|2017-02-18 16:16:39.521983
NCT00373048|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2011-05-23|||October 2005||2005-10-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|December 2007|Actual|2007-12-01||Interventional|||Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial|Mefloquine Malaria Prophylaxis in HIV-1 Infected Individuals and Its Influence on the Evolution Towards AIDS: a Randomized Placebo-controlled Trial|Completed||N/A|300|Anticipated|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||||2017-02-18 16:16:39.595193|2017-02-18 16:16:39.595193
NCT00373035|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2017-01-17|||February 2006||2006-02-01|June 2013|2013-06-01||||July 2006|Actual|2006-07-01||Observational|||Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy|Biomarkers of Prostate Cancer|Completed||N/A|60|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 16:16:39.69948|2017-02-18 16:16:39.69948
NCT00373022|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2010-05-26|||January 2004||2004-01-01|December 2006|2006-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer|The Effect of Moderate Physical Activity on the Physical and Emotional Recovery of Patients With a History of Colorectal Cancer|Completed||N/A|45|Anticipated|University of Arizona|||||f||||||||||||||2017-02-18 16:16:39.79551|2017-02-18 16:16:39.79551
NCT00373009|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2015-03-12|||February 2007||2007-02-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|POLM||Prevention of Low Back Pain in the Military|Prevention of Low Back Pain in the Military. A Randomized Clinical Trial|Completed||N/A|4325|Actual|University of Florida||4|||f||||t||||||||||2017-02-18 16:16:39.888208|2017-02-18 16:16:39.888208
NCT00372996|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2015-10-06|2015-06-03||February 2007||2007-02-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|September 2012|Actual|2012-09-01||Interventional||Safety population: all participants who started treatment, grouped according to main trial therapy treatment actually received.|Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer|A Two-arm Randomized Open Label Phase 2 Study Of Cp-751,871 In Combination With Exemestane Versus Exemestane Alone As First Line Treatment For Postmenopausal Patients With Hormone Receptor Positive Advanced Breast Cancer|Terminated||Phase 2|219|Actual|Pfizer||2||"This study was closed to enrollment as of 13 May 2011 due to business reasons. Premature~   closure was not prompted by any safety or efficacy concerns."|f||||f||||||||||2017-02-18 16:16:40.127143|2017-02-18 16:16:40.127143
NCT00372983|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2007-12-17|||August 2006||2006-08-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy|A Randomized, Placebo Controlled, Phase 1b Trial to Evaluate the Safety and Pharmacokinetics of NOV-205 in Chronic Viral Hepatitis C Subjects (Genotype 1) Who Have Failed Treatment With Pegylated Interferon Plus Ribavirin|Completed||Phase 1|30|Anticipated|Cellectar Biosciences, Inc.|||||f||||f||||||||||2017-02-18 16:16:41.553571|2017-02-18 16:16:41.553571
NCT00372970|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2015-05-19|2015-04-16||July 2003||2003-07-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||All patients with documented gastroparesis|Placebo Controlled Trial of Botulinum Toxin for Gastroparesis|Randomized Placebo-Controlled Double Blind Study of Botulinum Toxin Versus Placebo for the Treatment of Gastroparesis|Completed||N/A|32|Actual|Temple University||2|||f||||f||||||||||2017-02-18 16:16:41.651297|2017-02-18 16:16:41.651297
NCT00372957|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2010-10-01|||March 2006||2006-03-01|October 2010|2010-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus|PK/PD Study of GW823093 in Japanese Subjects With T2DM A Single-blind, Placebo Controlled, Randomized, Multi-dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GW823093C Administered Orally for 7 Days in Japanese Subjects With Type 2 Diabetes|Completed||Phase 2|30||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:16:42.019828|2017-02-18 16:16:42.019828
NCT00372944|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2014-08-12||2013-07-22|August 2006||2006-08-01|August 2014|2014-08-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|||AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy|A Phase II, Open, Randomised Study to Assess the Efficacy and Safety of AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy|Completed||Phase 2|70|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:16:42.096675|2017-02-18 16:16:42.096675
NCT00372931|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2008-04-21|||May 2006||2006-05-01|April 2008|2008-04-01||||August 2007|Actual|2007-08-01||Interventional|||A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension|A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|120||Alcon Research|||||||||||||||||||2017-02-18 16:16:42.219109|2017-02-18 16:16:42.219109
NCT00372918|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-06-04|||September 2006||2006-09-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|TNE||Interpretation of Transnasal Esophagoscopy Findings|An Interdisciplinary Interpretation of Transnasal Esophagoscopy Findings|Completed||Phase 4|98|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:16:42.293942|2017-02-18 16:16:42.293942
NCT00371787|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2011-01-05|2010-11-08||August 2006||2006-08-01|January 2011|2011-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of the Performance of Non-molded Soft Contact Lenses|Evaluation of the Performance of Non-molded Soft Contact Lenses|Completed||Phase 3|38|Actual|University of Waterloo||2|||f||||f||||||||||2017-02-18 16:17:06.541206|2017-02-18 16:17:06.541206
NCT00372905|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2015-09-18|||August 2006||2006-08-01|September 2015|2015-09-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Interventional|||Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma|A Phase I/II Trial of Combined Weekly Bortezomib (VELCADE®) and Y-90-Ibritumomab Tiuxetan (Zevalin) in Patients With Relapsed or Refractory Follicular Lymphoma and Transformed Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 1/Phase 2|24|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 16:16:42.393345|2017-02-18 16:16:42.393345
NCT00372892|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2012-06-06|||September 2006||2006-09-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|||Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)|A Randomized, Double Blind, Placebo Controlled Pilot Trial of Rituximab for Non-splenectomized Adults With Acute Immune Thrombocytopenic Purpura Receiving Standard Treatment (R-ITP)|Completed||Phase 2|60|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 16:16:42.510074|2017-02-18 16:16:42.510074
NCT00372879|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2016-03-01|||December 2006||2006-12-01|March 2016|2016-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With ALS|Randomized Crossover Design Trial of Vitamin E vs Placebo for Treatment of Cramps in Amyotrophic Lateral Sclerosis.|Completed||Phase 3|32|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 16:16:42.623091|2017-02-18 16:16:42.623091
NCT00372853|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2012-06-05|||November 2006||2006-11-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma|A Phase 1 Dose Escalation Trial To Evaluate The Safety And Tolerability Of CP-675,206 Administered In Combination With SU011248 To Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1|28|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:16:42.729799|2017-02-18 16:16:42.729799
NCT00372840|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-03-01|||May 2006||2006-05-01|March 2016|2016-03-01||||November 2010|Actual|2010-11-01||Interventional|||Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer|Efficacy and Feasibility of a Psychosocial Intervention Within the CCOP Context: Evaluation of the Facing Forward Guide to Facilitate Life After Active Cancer Treatment|Active, not recruiting||N/A|332|Anticipated|Fox Chase Cancer Center||2|||f||||||||||||||2017-02-18 16:16:42.962251|2017-02-18 16:16:42.962251
NCT00372827|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-11-18|||February 2004||2004-02-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension|Efficacy and Safety of Timolol Maleate 0.5% Compared to Brinzolamide 1% When Added to Travoprost 0.004% in Primary Open-angle Glaucoma or Ocular Hypertension|Completed||Phase 4|245||Alcon Research|||||f||||||||||||||2017-02-18 16:16:43.073341|2017-02-18 16:16:43.073341
NCT00372814|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2016-03-29|||March 2007||2007-03-01|March 2016|2016-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study of Intensive, Home-Based Family Therapy to Improve Illness Management in Youth With Diabetes|Adherence to IDDM Regimen in Urban Youth|Completed||N/A|146|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||No||2017-02-18 16:16:43.163173|2017-02-18 16:16:43.163173
NCT00372801|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-10-15|||August 2005||2005-08-01|October 2008|2008-10-01||||||||Interventional|||Effectiveness Of Single Doses Of Ibuprofen In Patients With Osteoarthritis Of The Knee|A Double-Blind, Randomised, Placebo-Controlled, Cross-Over Pilot Study to Investigate the Efficacy of Ibuprofen in Patients With Osteoarthritis of the Knee Following Administration of a Single Dose|Completed||Phase 1|36||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:16:43.279009|2017-02-18 16:16:43.279009
NCT00372788|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2014-08-12|||August 2006||2006-08-01|August 2014|2014-08-01|December 2008|Actual|2008-12-01|July 2007|Actual|2007-07-01||Interventional|||AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen|A Phase II, Open, Randomised Study to Assess the Efficacy and Safety of AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen|Completed||Phase 2|88|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:16:43.367212|2017-02-18 16:16:43.367212
NCT00372775|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2011-01-27|2010-12-08||March 2007||2007-03-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases|A Phase 2 Efficacy And Safety Study Of SU011248 In Patients With Non-Small Cell Lung Cancer And Brain Metastases|Completed||Phase 2|66|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:16:43.504543|2017-02-18 16:16:43.504543
NCT00372762|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2014-03-26|||January 2011||2011-01-01|March 2014|2014-03-01|June 2013|Anticipated|2013-06-01|January 2013|Anticipated|2013-01-01||Interventional|||Bumetanide Versus Furosemide in Heart Failure|Bumetanide Has a More Favourable Effect on Insulin Resistance Than Furosemide in Patients With Heart Failure - A Pilot Study|Withdrawn||Phase 3|0|Actual|Lawson Health Research Institute||2||Due to changes within the research program this study is not feasible at this time|f||||f||||||||||2017-02-18 16:16:44.197537|2017-02-18 16:16:44.197537
NCT00372749|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2011-03-25|||October 2006||2006-10-01|February 2007|2007-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Does the Threat of an Aversive Reaction Affect Craving of Alcohol During Cue Exposure in Alcohol Dependent Patients?|Does the Threat of an Aversive Reaction Affect Craving of Alcohol During Cue Exposure in Alcohol Dependent Patients?|Completed||N/A|30|Actual|Assistance Publique - Hôpitaux de Paris|||||f||||t||||||||||2017-02-18 16:16:44.313372|2017-02-18 16:16:44.313372
NCT00372736|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2015-10-05|||June 2006||2006-06-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors|A Phase I Study of AEG35156 Given as a 2 Hour Intravenous Infusion in Combination With Docetaxel in Patients With Solid Tumours|Completed||Phase 1|27|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 16:16:44.409022|2017-02-18 16:16:44.409022
NCT00372723|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2013-04-25|||July 2006||2006-07-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)|Pilot Study Comparing Remicade (Infliximab) vs. Standard Care in the Treatment of Toxic Epidermal Necrolysis|Withdrawn||Phase 2|0|Actual|Loyola University||1||slow enrollment|f||||||||||||||2017-02-18 16:16:44.513167|2017-02-18 16:16:44.513167
NCT00327431|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2008-05-21|||November 2006||2006-11-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Observational|||Relationship of Genes and Life Events to Blood Pressure||Completed||N/A|120|Anticipated|Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 16:32:15.428652|2017-02-18 16:32:15.428652
NCT00372710|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2009-11-20|||August 2002||2002-08-01|November 2009|2009-11-01||||||||Interventional|||Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions|Efficacy and Tolerability of Intravenous Zoledronic Acid 4mg as an Adjunct to Standard Therapies Including Conversion From Pamidronate in Breast Cancer Patients With Metastatic Bone Lesions. A Prospective, Randomised, Open-label, Clinical Study|Terminated||Phase 3|30||Novartis|||||f||||||||||||||2017-02-18 16:16:44.617735|2017-02-18 16:16:44.617735
NCT00372697|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2011-04-19|2011-01-12||December 2005||2005-12-01|April 2011|2011-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly|A Randomised, Open-label, Multicenter Study Comparing the Efficacy and Safety of Medical Treatment With Octreotide Acetate 30 mg Administered Every 21 Days for 6 Months With That of Octreotide Acetate 60 mg Administered Every 28 Days for 6 Months in Acromegalic Patients With Uncontrolled Disease|Completed||Phase 3|28|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:16:44.71986|2017-02-18 16:16:44.71986
NCT00372684|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2010-06-18|||September 2006||2006-09-01|July 2007|2007-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|PALUREA||PALUREA: Severe Imported Malaria in Adults|PALUREA: Severe Falciparum Imported Malaria in Adults: Clinical and Physiopathological Study|Completed||N/A|302|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples With DNA|"~     physiopathologic~   "|||2017-02-18 16:16:45.136258|2017-02-18 16:16:45.136258
NCT00372671|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2006-09-06|||June 2005||2005-06-01|September 2006|2006-09-01|August 2005||2005-08-01|||||Interventional|||Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation|Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation, the CR$P-2 Pilot Study.|Completed||Phase 3|60||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:16:45.24078|2017-02-18 16:16:45.24078
NCT00372658|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2006-09-06|||July 2002||2002-07-01|December 2005|2005-12-01|October 2004||2004-10-01|||||Interventional|||Intracervical Block Versus Placebo to Assess Pain Control During Hysterosalpingogram|Intracervical Block and Pain Perception During the Performance of a Hysterosalpingogram: A Randomized Controlled Trial|Completed||Phase 2|120||Wilford Hall Medical Center|||||f||||||||||||||2017-02-18 16:16:45.332948|2017-02-18 16:16:45.332948
NCT00372645|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2015-03-23|||May 2005||2005-05-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2008|Actual|2008-01-01||Interventional|||Increasing Folate Status of a General Population(FOLSUPP STUDY)|Effects Of A Mixed Diet Intervention Versus Folic Acid Supplementation And Metafolin® Supplementation On Folate Status And Cardiovascular Disease Risk Factors In Healthy Adults|Completed||N/A|180|Actual|Institute of Food Research||4|||f||||f||||||||||2017-02-18 16:16:45.439748|2017-02-18 16:16:45.439748
NCT00372632|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2010-09-12|||December 2005||2005-12-01|September 2010|2010-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||IPT of Malaria With SP in Different Zones of Drug Resistance in Rwanda|Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in Different Zones of Drug Resistance in Rwanda|Completed||Phase 4|1717|Actual|Institute of Tropical Medicine, Belgium||2|||f||||f||||||||||2017-02-18 16:16:45.742592|2017-02-18 16:16:45.742592
NCT00372619|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-10-24|2013-12-13||March 2007||2007-03-01|October 2016|2016-10-01||||August 2012|Actual|2012-08-01||Interventional|||Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia|Active, not recruiting||Phase 1/Phase 2|74|Actual|Children's Oncology Group||7|||f||||t||||||||||2017-02-18 16:16:45.884179|2017-02-18 16:16:45.884179
NCT00372606|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2009-10-06|||September 2004||2004-09-01|October 2009|2009-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Evaluation of a Culturally- and Linguistically-Appropriate Online Diet Program for U.S Hispanics|An Evaluation of a Culturally- and Linguistically-Appropriate eHealth Portal to Facilitate Improved Diets, Increased Fitness-Levels, and Weight-Loss Among U.S. Hispanics|Completed||Phase 2|1000|Anticipated|Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 16:16:48.518009|2017-02-18 16:16:48.518009
NCT00372593|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2016-03-10|2015-01-06||August 2006||2006-08-01|March 2016|2016-03-01||||August 2013|Actual|2013-08-01||Interventional|||Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Combined With Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults|Active, not recruiting||Phase 3|1070|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 16:16:48.631304|2017-02-18 16:16:48.631304
NCT00372489|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2012-06-22|2012-04-26||September 2006||2006-09-01|June 2012|2012-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD|An Open-Label, Multi-Center, Extension Study to Evaluate the Safety and Tolerability of Peginesatide for the Long-Term Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease|Terminated||Phase 2|81|Actual|Affymax|Early termination of study due to generation of controlled long-term data in Phase 3 studies. Amended dosing guidelines during the trial to reflect label changes for ESAs; the primary outcome was assessed after the dosing guideline change.|1||Due to more robust long-term data generated in other active-controlled studies|f||||f||||||||||2017-02-18 16:16:50.755626|2017-02-18 16:16:50.755626
NCT00372476|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2017-02-03|||June 2006||2006-06-01|February 2017|2017-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|INV181||Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer|Open-label Trial of Imatinib in Combination With Vinorelbine for Patients With Advanced Breast Carcinoma: ICON|Completed||Phase 4|33|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:16:51.228442|2017-02-18 16:16:51.228442
NCT00372463|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2011-07-25|||February 2006||2006-02-01|July 2011|2011-07-01|December 2007|Actual|2007-12-01|||||Interventional|||Internet Diabetes Self-Management|Internet Diabetes Self-Management: A Randomized Trial|Completed||Phase 2|700|Anticipated|Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 16:16:51.345607|2017-02-18 16:16:51.345607
NCT00372450|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-06|2009-05-09|||June 2006||2006-06-01|November 2008|2008-11-01||||June 2008|Anticipated|2008-06-01||Interventional|||Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer|A Quality of Life Comparison in Patients With Malignant Dysphagia Treated With Either Self-Expanding Plastic Stents (SEPS) or Self-Expanding Metal Stents (SEMS)|Unknown status|Active, not recruiting|N/A|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:16:51.452809|2017-02-18 16:16:51.452809
NCT00372437|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2015-06-04||2015-06-04|September 2006||2006-09-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Gemcitabine|A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Gemcitabine|Completed||Phase 1/Phase 2|47|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:16:51.564608|2017-02-18 16:16:51.564608
NCT00372424|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2012-12-21|2012-09-28||December 2006||2006-12-01|December 2012|2012-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive|An Explorative Study Of The Tolerability Of SU011248 In Combination With Docetaxel And Trastuzumab As First-Line Treatment In Patients With Breast Cancer Over-Expressing HER-2|Completed||Phase 1|26|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:16:51.681878|2017-02-18 16:16:51.681878
NCT00372411|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2013-12-18|2013-09-04||December 2005||2005-12-01|December 2013|2013-12-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|VA ROBOTICS||Robotic Assisted Upper-Limb Neurorehabilitation in Stroke Patients|CSP #558 - Robotic Assisted Upper-Limb Neurorehabilitation in Stroke Patients|Completed||Phase 2|127|Actual|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 16:16:52.187828|2017-02-18 16:16:52.187828
NCT00372398|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2010-09-15|||October 2006||2006-10-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Premature Coronary Atherosclerosis in Scleroderma|Premature Coronary Atherosclerosis in Scleroderma: A Case Control Study|Completed||N/A|28|Actual|Tuen Mun Hospital|||1||f||||t||||||||||2017-02-18 16:16:53.74889|2017-02-18 16:16:53.74889
NCT00372385|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2014-06-25|2011-06-22||August 2006||2006-08-01|June 2014|2014-06-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional||The Full Analysis set included all randomized subjects who received at least 1 dose of study drug.|Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C|A Phase 2 Study of VX-950 in Combination With Peginterferon Alfa-2a (Pegasys®), With and Without Ribavirin (Copegus®) in Subjects With Hepatitis C|Completed||Phase 2|334|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||t||||||||||2017-02-18 16:16:53.84549|2017-02-18 16:16:53.84549
NCT00372372|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2007-09-27|||January 2004||2004-01-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment||Completed||Phase 4|120||Tuen Mun Hospital|||||f||||t||||||||||2017-02-18 16:16:54.955118|2017-02-18 16:16:54.955118
NCT00372359|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-03|2012-09-19|||August 2006||2006-08-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|||||Observational|||Adverse Effect of Prolonged Methylphenidate Treatment on Cardiac Functions|Adverse Effect of Prolonged Methylphenidate Treatment on Cardiac Functions|Unknown status|Recruiting|N/A|50|Anticipated|Barzilai Medical Center|||1||f||||t||||||||||2017-02-18 16:16:55.048141|2017-02-18 16:16:55.048141
NCT00372346|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2006-09-05|||June 2006||2006-06-01|August 2006|2006-08-01|December 2007||2007-12-01|||||Interventional|||Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension||Unknown status|Recruiting|N/A|40||Zhejiang University|||||f||||||||||||||2017-02-18 16:16:55.158701|2017-02-18 16:16:55.158701
NCT00372333|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-04|2009-03-19|||August 2004||2004-08-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||IDEA-033 Open Label Study|A Multiple-Dose, Open-Label Safety, Compliance, and Usage Evaluation Study of Epicutaneously Applied IDEA-033 in Joint / Musculoskeletal Pain or Soft Tissue Inflammation|Completed||Phase 3|491|Actual|IDEA AG||1|||f||||||||||||||2017-02-18 16:16:55.234995|2017-02-18 16:16:55.234995
NCT00372320|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-02|2017-01-24|||August 30, 2006||2006-08-30|March 17, 2016|2016-03-17|March 19, 2014|Actual|2014-03-19|March 19, 2014|Actual|2014-03-19||Interventional|||Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer|Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of AdhAQP1, an Adenoviral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals With Irradiation-Induced Parotid Salivary Hypofunction|Completed||Phase 1|17|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:16:55.326162|2017-02-18 16:16:55.326162
NCT00372307|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-04|2007-12-19|||May 2004||2004-05-01|December 2007|2007-12-01|November 2004|Actual|2004-11-01|||||Interventional|||Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris|Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris|Completed||Phase 2|26||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:16:55.42214|2017-02-18 16:16:55.42214
NCT00372294|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-07-28|||July 2005||2005-07-01|June 2008|2008-06-01|November 2008|Anticipated|2008-11-01|August 2008|Anticipated|2008-08-01||Interventional|||To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis||Unknown status|Active, not recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 16:16:55.518491|2017-02-18 16:16:55.518491
NCT00372281|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-04|2009-02-24|||March 2007||2007-03-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Cliavist in Infectious and Degenerative Diseases of the Spine|Comparison of Cliavist Enhancement in Infectious and Degenerative Diseases of the Spine|Unknown status|Recruiting|Phase 3|40|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-02-18 16:16:55.607311|2017-02-18 16:16:55.607311
NCT00372268|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2012-04-12|||January 2006||2006-01-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Effects of Insufflated Gas on Core Temperature and Post-operative Pain During Laparoscopic Surgery|Evaluation of the Effects of Conditioning of Insufflated Gas on the Core Temperature and the Post-operative Pain During Laparoscopic Surgery|Completed||N/A|248|Actual|University Hospital, Strasbourg, France||4|||f||||f||||||||||2017-02-18 16:16:55.799416|2017-02-18 16:16:55.799416
NCT00372255|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2016-09-22|||November 2005||2005-11-01|September 2016|2016-09-01|March 2006|Actual|2006-03-01|||||Interventional|||Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years|An Open, Phase IV Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years|Completed||Phase 4|240||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:16:55.907331|2017-02-18 16:16:55.907331
NCT00372242|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-04|2006-09-04|||December 2000||2000-12-01|April 2003|2003-04-01|September 2002||2002-09-01|||||Interventional|||Feasible Means to Address Moderately Malnourished Children Within BINP Communities||Completed||N/A|1231||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:16:56.00471|2017-02-18 16:16:56.00471
NCT00372229|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2016-11-01|||May 2006||2006-05-01|November 2016|2016-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation|A Randomized Trial Comparing Valcyte CMV Prophylaxis Versus Pre-emptive Therapy After Renal Transplantation Using Proteomics for Monitoring of Graft Alteration|Completed||Phase 3|301|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:16:56.08979|2017-02-18 16:16:56.08979
NCT00372216|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-04|2010-11-18|||October 2006||2006-10-01|November 2010|2010-11-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction|CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction|Completed||Phase 3|337|Actual|Stiftung Institut fuer Herzinfarktforschung||2|||f||||t||||||||||2017-02-18 16:16:56.203597|2017-02-18 16:16:56.203597
NCT00372203|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-04|2016-07-28|||July 2006||2006-07-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Endobronchial Ultrasound vs Mediastinoscopy in NSCLC|Prospective Controlled Trial of Mediastinoscopy Compared With Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for Assessment of the Mediastinum in Lung Cancer.|Completed||Phase 2|200|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 16:16:56.337744|2017-02-18 16:16:56.337744
NCT00372190|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-06-06|||August 2006||2006-08-01|June 2008|2008-06-01||||October 2008|Anticipated|2008-10-01||Interventional|||Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse.|A Prospective and Comparative Study of the Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse|Unknown status|Recruiting|N/A|194|Anticipated|Radboud University||2|||f||||||||||||||2017-02-18 16:16:56.432798|2017-02-18 16:16:56.432798
NCT00372177|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-05-26|||July 2007||2007-07-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis|The Use of Anti-CD4 mAb-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis (an Open Proof of Concept Study)|Completed||Phase 1/Phase 2|5|Actual|Biotectid GmbH||1|||f||||t||||||||||2017-02-18 16:16:56.535397|2017-02-18 16:16:56.535397
NCT00372164|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2015-10-20|||January 1998||1998-01-01|October 2015|2015-10-01|July 2005||2005-07-01|||||Observational|||Retrospective Evaluation of ASIPP Guidelines Implementation|Evaluation of the Effectiveness of Implementation of American Society of Interventional Pain Physician Guidelines for Interventional Techniques: A Retrospective Evaluation|Withdrawn||N/A|0|Actual|Pain Management Center of Paducah|||1||f||||||||||||||2017-02-18 16:16:56.644315|2017-02-18 16:16:56.644315
NCT00372151|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-12-15|||October 2006||2006-10-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||L-Theanine in the Management of Schizophrenia|The Value of Augmenting L-Theanine in the Management of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 3|60|Actual|Sha’ar Menashe Mental Health Center||2|||f||||t||||||||||2017-02-18 16:16:56.721227|2017-02-18 16:16:56.721227
NCT00372138|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2012-03-01|||September 2006||2006-09-01|March 2012|2012-03-01|July 2008|Actual|2008-07-01|October 2007|Actual|2007-10-01||Interventional|||Prevention of Endoleaks Using Autologous Platelet Gel on Unruptured Abdominal Aortic Aneurysms|Prevention of Endoleaks Using Autologous Platelet Gel During Endovascular Procedures on Unruptured Abdominal Aortic Aneurysms: Pilot Study|Terminated||N/A|20|Actual|Rennes University Hospital||1|||f||||||||||||||2017-02-18 16:16:56.830059|2017-02-18 16:16:56.830059
NCT00372125|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2016-09-11|||April 2005||2005-04-01|September 2016|2016-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome|Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome|Completed||N/A|46|Actual|Karolinska University Hospital||2|||f||||t||||||||||2017-02-18 16:16:56.941855|2017-02-18 16:16:56.941855
NCT00372112|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-04|2016-10-26|||November 2006||2006-11-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A 2-wk Study to Evaluate the Safety, Tolerability,Pharmacodynamics and Pharmacokinetics of GW642444H(100 Administered Once Daily in the Morning Via DISKUS™ Dry-powder Inhaler)Compared With SEREVENT(Salmeterol)(50mcg Administered Twice Daily Via DISKUS Dry-powder Inhaler)and Placebo in Subject w/COPD|Completed||Phase 2|71|Actual|GlaxoSmithKline||4|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:16:57.055109|2017-02-18 16:16:57.055109
NCT00372099|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2011-12-22|||January 2007||2007-01-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women|Evaluation of the Effects of Salmon Calcitonin Nasal Spray Compared to Placebo on Bone Microarchitecture Measured by High Resolution Peripheral Micro- Computed-tomography Over 2 Years in Postmenopausal Women (a Pilot Study)|Completed||Phase 3|90|Actual|University Hospital, Geneva||1|||f||||||||||||||2017-02-18 16:16:59.845713|2017-02-18 16:16:59.845713
NCT00372086|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-03|2006-09-03|||August 2003||2003-08-01|September 2006|2006-09-01|September 2005||2005-09-01|||||Interventional|||Rosiglitazone and Insulin in T1DM Adolescents|The Addition of Rosiglitazone to Insulin in Adolescents With Type 1 Diabetes and Poor Glycaemic Control: a Randomized, Placebo Controlled Trial|Completed||Phase 4|32||The University of New South Wales|||||f||||||||||||||2017-02-18 16:16:59.975096|2017-02-18 16:16:59.975096
NCT00372073|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-03|2011-11-07|||July 2006||2006-07-01|November 2011|2011-11-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer|A Phase IIb Randomized Study of Oral Seliciclib in Patients With Previously Treated Non-Small Cell Lung Cancer|Terminated||Phase 2|160|Anticipated|Cyclacel Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 16:17:00.059273|2017-02-18 16:17:00.059273
NCT00372060|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2016-02-03|2009-01-27||August 2006||2006-08-01|February 2016|2016-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)|MK0431 (Sitagliptin) Phase III Clinical Study -Pioglitazone add-on Study for Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|134|Actual|Merck Sharp & Dohme Corp.|Period II (Weeks 12-52) was open-label and uncontrolled, with all patients receiving sitagliptin. Results are pooled data from both treatment groups and should be considered in the context of the Type 2 Diabetes Mellitus (T2DM) population studied.|2|||f||||||||||||||2017-02-18 16:17:00.182708|2017-02-18 16:17:00.182708
NCT00372008|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2008-06-18|||October 2006||2006-10-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males|A Phase II Randomised, Two-Way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered-Dose (MD) Lotion Doses in Hypogonadal Male Subjects|Completed||Phase 2|40|Anticipated|Acrux DDS Pty Ltd|||||||||||||||||||2017-02-18 16:17:01.158217|2017-02-18 16:17:01.158217
NCT00371995|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-05|2011-06-21|||October 2007||2007-10-01|September 2008|2008-09-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar|The Efficacy and Safety of a Short Course of Miltefosine and Liposomal Amphotericin B for Visceral Leishmaniasis in India|Completed||Phase 2|150|Anticipated|Banaras Hindu University||1|||f||||||||||||||2017-02-18 16:17:01.252133|2017-02-18 16:17:01.252133
NCT00371982|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2006-09-01|||December 2002||2002-12-01|November 2002|2002-11-01|April 2005||2005-04-01|||||Interventional|||Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women||Terminated||N/A|24||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:17:01.383973|2017-02-18 16:17:01.383973
NCT00371969|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2015-10-28|||October 2006||2006-10-01|October 2015|2015-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Reducing Unsafe Alcohol Use in HIV-Positive Individuals|Reducing Unsafe Drinking in HIV Primary Care|Completed||N/A|254|Actual|Research Foundation for Mental Hygiene, Inc.||2|||f||||||||||||||2017-02-18 16:17:01.490753|2017-02-18 16:17:01.490753
NCT00371956|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2010-09-15|||September 2006||2006-09-01|September 2010|2010-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy|Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy: a Randomized Double-blind Placebo-controlled Study|Completed||Phase 4|114|Actual|Tuen Mun Hospital||2|||f||||t||||||||||2017-02-18 16:17:01.601335|2017-02-18 16:17:01.601335
NCT00371943|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2006-09-14|||July 2001||2001-07-01|September 2006|2006-09-01|March 2005||2005-03-01|||||Interventional|||EVL Plus Drug to Prevent Variceal Rebleeding|A Controlled Trial of Ligation Plus Drug Vs. Drug Alone in the Prevention of Variceal Rebleeding|Terminated||Phase 4|120||National Science Council, Taiwan|||||f||||||||||||||2017-02-18 16:17:01.718637|2017-02-18 16:17:01.718637
NCT00371930|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2008-06-02||||||June 2008|2008-06-01||||||||Interventional|||Photodynamic Therapy for Permanent Hair Removal||Unknown status|Not yet recruiting|Phase 1/Phase 2|||University of Jena|||||f||||||||||||||2017-02-18 16:17:01.820819|2017-02-18 16:17:01.820819
NCT00371904|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2008-05-20|||April 2006||2006-04-01|May 2008|2008-05-01|January 2009|Anticipated|2009-01-01|||||Interventional|RAPTURE||Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients|"A Prospective Open Label Randomised Multicentre Study Evaluating the Efficacy & Safety of Rituximab Given Pre-Transplant to Sensitised Renal Allograft Recipients in Addition to a Standard Desensitisation Regimen Consisting of PE/IVIG & MMF"|Unknown status|Recruiting|Phase 2|192|Anticipated|Hunter and New England Health||2|||f||||||||||||||2017-02-18 16:17:01.89889|2017-02-18 16:17:01.89889
NCT00371891|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2010-11-24|||September 2006||2006-09-01|November 2010|2010-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)|The Ontario Multidetector Computed Tomography (MDCT) Coronary Angiography Study (OMCAS)|Completed||Phase 4|168|Actual|St. Joseph's Healthcare Hamilton||1|||f||||t||||||||||2017-02-18 16:17:02.030485|2017-02-18 16:17:02.030485
NCT00371878|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2008-08-07|||February 2003||2003-02-01|September 2006|2006-09-01|October 2003||2003-10-01|||||Interventional|||Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection|Open Label Study of Lung and Serum Immunoglobulin Responses to 7-Valent Pneumococcal Conjugate Vaccine in HIV Infected and Non-HIV Infected Malawian Adults|Completed||Phase 4|40||Royal Liverpool University Hospital|||||f||||||||||||||2017-02-18 16:17:02.125875|2017-02-18 16:17:02.125875
NCT00371865|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2015-03-26|2015-02-02||October 2006||2006-10-01|March 2015|2015-03-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Interventional|||Behavioral Treatments for Chronic Pain|Acceptance-Based Treatment for Chronic Pain|Completed||N/A|114|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:17:02.234393|2017-02-18 16:17:02.234393
NCT00371852|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2008-05-15|||May 2006||2006-05-01|May 2008|2008-05-01||||||||Interventional|||Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene|Safety Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability and Dermical Sensibility) of Dermacyd Wipes|Completed||Phase 3|50||Sanofi|||||f||||||||||||||2017-02-18 16:17:02.678467|2017-02-18 16:17:02.678467
NCT00371839|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2014-11-19|2014-11-06||September 2006||2006-09-01|November 2014|2014-11-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional||Number of participants who completed the study|Clinical Applications for Time-Compressed Speech Tests|Clinical Applications for Time-Compressed Speech Tests|Completed||N/A|78|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 16:17:02.75974|2017-02-18 16:17:02.75974
NCT00371826|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2013-06-13|2013-06-13||March 2006||2006-03-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus|A Prospective, Open-label, Controlled Multicenter Trial to Assess the Efficacy and Safety of an Induction Regimen of Cyclosporine Micro Emulsion, Enteric-coated Mycophenolate Sodium (EC-MPS) and Corticosteroids, Followed by Administration of Everolimus and Enteric-coated Mycophenolate Sodium (EC-MPS), With Either the Withdrawal of Cyclosporine Micro Emulsion or Corticosteroids in de Novo Kidney Transplant Recipients|Completed||Phase 4|126|Actual|Novartis||3|||f||||t||||||||||2017-02-18 16:17:03.122832|2017-02-18 16:17:03.122832
NCT00371813|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2015-04-21|||September 2006||2006-09-01|April 2015|2015-04-01|June 2007|Actual|2007-06-01|||||Interventional|||An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Multinational Study Of Efficacy And Safety Of Varenicline Tartrate For Smoking Cessation|Completed||Phase 3|334|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:17:06.344489|2017-02-18 16:17:06.344489
NCT00371800|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2006-08-31|||October 2005||2005-10-01|August 2006|2006-08-01|May 2006||2006-05-01|||||Interventional|||The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes|The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes|Completed||Phase 2/Phase 3|72||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 16:17:06.445396|2017-02-18 16:17:06.445396
NCT00371774|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2011-11-15|||June 2005||2005-06-01|November 2011|2011-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program|Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program|Completed||Phase 4|426|Actual|Astellas Pharma Inc|||1||f||||f||||||||||2017-02-18 16:17:07.023069|2017-02-18 16:17:07.023069
NCT00371761|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2015-10-07|2010-07-15||September 2006||2006-09-01|October 2015|2015-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)|An Open-Label, Randomized, Comparative Study With PegIntron vs. Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan|Completed||Phase 3|25|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:17:07.155612|2017-02-18 16:17:07.155612
NCT00371748|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2012-02-01|||February 2005||2005-02-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|December 2006|Actual|2006-12-01||Interventional|||A Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small Vessels|TAXUS ATLAS SMALL VESSEL: A Multi-center, Single-arm Study of the TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions in Small Vessels|Completed||Phase 3|261|Actual|Boston Scientific Corporation||3|||f||||t||||||||||2017-02-18 16:17:07.545088|2017-02-18 16:17:07.545088
NCT00371735|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2016-12-02|||April 2006||2006-04-01|December 2016|2016-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria|A Multi-centre, Randomised, Double-blind Study to Compare the Efficacy and Safety of Chlorproguanil-dapsone-artesunate Versus Chlorproguanil-dapsone in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children, Adolescents and Adults in Africa.|Completed||Phase 3|900|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:17:07.679143|2017-02-18 16:17:07.679143
NCT00371722|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2007-04-19|||July 2002||2002-07-01|April 2007|2007-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Appendectomy Versus no Appendectomy With Cesarean Section|A Randomized Controlled Trial Evaluating Appendectomy at the Time of Cesarean Section|Completed||N/A|100||Regional Obstetrical Consultants|||||f||||f||||||||||2017-02-18 16:17:07.795132|2017-02-18 16:17:07.795132
NCT00371709|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2012-02-01|||August 2004||2004-08-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|November 2005|Actual|2005-11-01||Interventional|||TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions|TAXUS ATLAS: A Multi-center, Single-arm Study of the TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions|Completed||Phase 3|871|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 16:17:07.881319|2017-02-18 16:17:07.881319
NCT00371696|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2006-09-01|||December 2001||2001-12-01|January 2003|2003-01-01|December 2003||2003-12-01|||||Interventional|||Feasibility of n-of-1 Trials - a Pilot Study|Pilot Study of the Feasibility of n-of-1 Trials: the Individualisation of Treatments for Osteoarthritis|Completed||Phase 2|10||University of Bristol|||||f||||||||||||||2017-02-18 16:17:08.269452|2017-02-18 16:17:08.269452
NCT00371683|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2015-11-25|2015-10-23||November 2006||2006-11-01|November 2015|2015-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Randomized participants were summarized.|Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery|A Phase 3 Randomized, Double-Blind Active-Controlled (Enoxaparin), Parallel-Group, Multi-Center Study to Evaluate the Safety and Efficacy of Oral Apixaban in Subjects Undergoing Elective Total Knee Replacement Surgery|Completed||Phase 3|3608|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 16:17:08.392491|2017-02-18 16:17:08.392491
NCT00371670|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2009-05-18|||December 2004||2004-12-01|May 2009|2009-05-01||||July 2006|Actual|2006-07-01||Interventional|||Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee|A Phase II, 12-Month, Double-Blind, Placebo-Controlled, Dose-Finding, Multicenter Study to Evaluate the Safety, Tolerability, and Disease Modifying Efficacy of Daily Oral AAE581 (10, 25 and 50 mg Tablets) in Patients With Painful Knee Osteoarthritis, Kellgren-Lawrence Grade 3 by X-Ray|Completed||Phase 2|223|Actual|Novartis|||||f||||||||||||||2017-02-18 16:17:10.538334|2017-02-18 16:17:10.538334
NCT00371657|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-01-31|||July 2006||2006-07-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Maternal Obesity and Small for Gestational Age Infants|Obesity as a Risk Factor for Small for Gestational Age and Intrauterine Growth Restriction Infants|Completed||N/A|420||Oklahoma State University Center for Health Sciences|||||f||||||||||||||2017-02-18 16:17:10.627131|2017-02-18 16:17:10.627131
NCT00371644|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2015-01-06|2014-11-17||February 2007||2007-02-01|January 2015|2015-01-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional||Numbers differ from enrollment due to participants excluded from data analysis for poor psychotherapeutic fidelity.|Treatment for Veterans With Military Sexual Trauma|Manualized Treatment for Veterans With Military Sexual Trauma|Completed||N/A|129|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:17:10.719644|2017-02-18 16:17:10.719644
NCT00371631|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2014-11-20|2014-11-13||October 2006||2006-10-01|November 2014|2014-11-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Colonizing Neurogenic Bladders With Benign Flora|Colonizing Neurogenic Bladders With Benign Flora|Completed||Phase 1|13|Actual|VA Office of Research and Development|Lack of placebo control.|1|||f||||f||||||||||2017-02-18 16:17:11.12753|2017-02-18 16:17:11.12753
NCT00371618|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2015-10-20|||January 1998||1998-01-01|October 2015|2015-10-01|May 2004||2004-05-01|||||Observational|||IPM Procedures With or Without Fluoroscopy: Outcome Comparison|Comparison of Outcomes of Interventional Pain Management Procedures Performed With or Without Fluoroscopy: A Retrospective Analysis|Withdrawn||N/A|0|Actual|Pain Management Center of Paducah|||1||f||||||||||||||2017-02-18 16:17:11.378083|2017-02-18 16:17:11.378083
NCT00371423|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2012-02-01|||March 2005||2005-03-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|June 2006|Actual|2006-06-01||Interventional|||Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions|A Multi-center, Single-arm Study of the TAXUS Liberté™-SR Stent for the Direct Stenting Treatment of Patients With de Novo Coronary Artery Lesions|Completed||Phase 3|247|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 16:17:16.344771|2017-02-18 16:17:16.344771
NCT00370786|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-07-09|||November 2005||2005-11-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)||Completed||Phase 3|31|Actual|Shahid Beheshti University of Medical Sciences||1|||f||||||||||||||2017-02-18 16:17:30.456177|2017-02-18 16:17:30.456177
NCT00371605|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2007-12-14|||December 2006||2006-12-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Observational|||An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study|An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study|Terminated||N/A|15|Anticipated|University of Pittsburgh|||1|Enrolled requested number of patients and completed study. In analysis|f||||||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:17:11.465145|2017-02-18 16:17:11.465145
NCT00371592|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2013-09-20|||September 2006||2006-09-01|September 2013|2013-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)|A Phase II, Randomized, Double-blind, Placebo-controlled Trial of Acyclovir for the Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viral Load and Mucosal Shedding in HIV-1, Herpes Simplex Virus, Type 2 (HSV-2) Co-Infected Women|Completed||Phase 2|50|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 16:17:11.549683|2017-02-18 16:17:11.549683
NCT00371579|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2015-06-02|||October 2006||2006-10-01|February 2009|2009-02-01|October 2007|Anticipated|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Rosuvastatin for Hepatitis C|Treatment With Rosuvastatin in Patients With Hepatitis C|Withdrawn||N/A|0|Actual|UMC Utrecht||||no actual patients recruited within year 1 after ethical committee approval|f||||||||||||||2017-02-18 16:17:11.682961|2017-02-18 16:17:11.682961
NCT00371566|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2010-04-01|2008-12-26||March 2006||2006-03-01|April 2010|2010-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer|A Randomized, Single Blinded, Placebo-controlled, Multi-centre, Phase II Study of Lapatinib in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|107|Actual|GlaxoSmithKline||2|||||||||||||||||2017-02-18 16:17:11.805559|2017-02-18 16:17:11.805559
NCT00371553|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2009-07-07|||November 2006||2006-11-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer|Prospective Open-Labeled Non Randomised Phase-II Study of SU011248 (Sunitinib) in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer - A CUOG / GTCSG Cooperative Phase II Study -|Completed||Phase 2|33|Actual|British Columbia Cancer Agency||1|||f||||t||||||||||2017-02-18 16:17:14.041891|2017-02-18 16:17:14.041891
NCT00371540|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2016-11-01|2016-08-29||February 2006||2006-02-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||HIV infected patients who were clinically stable on ART for at least 3 months|Extending HIV Care Beyond the Rural Health Center|Extending HIV Care Beyond the Rural Health Center|Completed||N/A|208|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 16:17:14.149478|2017-02-18 16:17:14.149478
NCT00371527|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2008-10-16|||October 2002||2002-10-01|August 2006|2006-08-01|January 2004||2004-01-01|||||Interventional|||Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease|Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease|Completed||N/A|200||Kaiser Permanente|||||f||||||||||||||2017-02-18 16:17:14.518357|2017-02-18 16:17:14.518357
NCT00371501|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2010-09-15|||June 2006||2006-06-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus|Low Dose Aspirin and Statins for Primary Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus: A Randomized Double-blind Placebo-controlled Trial|Completed||Phase 4|72|Actual|Tuen Mun Hospital||4|||f||||t||||||||||2017-02-18 16:17:14.606156|2017-02-18 16:17:14.606156
NCT00371488|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2017-01-16|||April 2006||2006-04-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer|Phase I/II Clinical Study of GW572016 (Lapatinib Ditosylate Monohydrate) in Combination With Trastuzumab in Patients With Breast Cancer Previously Treated With Trastuzumab|Completed||Phase 1|22|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 16:17:14.715719|2017-02-18 16:17:14.715719
NCT00371475|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2012-02-01|||March 2005||2005-03-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|February 2007|Actual|2007-02-01||Interventional|||A Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery Lesions|TAXUS ATLAS LONG LESION: A Multi-center, Single-arm Study of the TAXUS Liberté™-SR Stent for the Treatment of Patients With Long de Novo Coronary Artery Lesions|Completed||Phase 3|150|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 16:17:14.814334|2017-02-18 16:17:14.814334
NCT00371462|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2016-08-08|2016-05-24||October 2007||2007-10-01|August 2016|2016-08-01|September 2011|Actual|2011-09-01|September 2009|Actual|2009-09-01||Interventional|PDA+|One subject withdrew from the study.|PDA+: A Personal Digital Assistant for Obesity Treatment|PDA+: A Personal Digital Assistant for Obesity Treatment|Terminated||N/A|70|Actual|VA Office of Research and Development||2||"PI no longer has an appointment and has seperated from Hines VAH and project was not~   transferred to another PI?"|f||||||||||||||2017-02-18 16:17:15.047942|2017-02-18 16:17:15.047942
NCT00371449|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2015-04-08|2015-02-18||November 2006||2006-11-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Observational|||Predicting Success With Hearing Aids|Speech-in-Noise Measures as a Predictor of Hearing Aid Outcomes|Completed||N/A|120|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 16:17:15.596798|2017-02-18 16:17:15.596798
NCT00371436|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2015-03-24|2014-11-13||September 2008||2008-09-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Progressive Intervention Program for Tinnitus Management|Progressive Intervention Program for Tinnitus Management|Completed||N/A|181|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:17:15.843804|2017-02-18 16:17:15.843804
NCT00371410|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2006-08-31|||April 2005||2005-04-01|August 2006|2006-08-01|October 2007||2007-10-01|||||Interventional|||Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema|The Safety and the Efficacy of Combined Vitrectomy, Intravitreal Triamcinolone Acetonide and Macular Focal Laser Photocoagulation for the Treatment of Intractable Diffuse Diabetic Macular Edema|Completed||Phase 1|||Samsung Medical Center|||||f||||||||||||||2017-02-18 16:17:16.469899|2017-02-18 16:17:16.469899
NCT00371397|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2016-06-06|2009-09-16||September 2005||2005-09-01|June 2016|2016-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Yoga, Immune Function, and Health|Psychoneuroimmunology and Mind-Body Interventions|Completed||N/A|52|Actual|Ohio State University||3|||f||||t||||||||||2017-02-18 16:17:16.563801|2017-02-18 16:17:16.563801
NCT00371384|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2011-11-07|||August 2006||2006-08-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||Effect of Massage on Chronic Low Back Pain|Effect of Massage on Chronic Low Back Pain|Completed||Phase 2/Phase 3|399|Anticipated|Group Health Cooperative||2|||f||||t||||||||||2017-02-18 16:17:16.962872|2017-02-18 16:17:16.962872
NCT00371371|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2012-12-12|||September 2006||2006-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|JUVENTAS||Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)|Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients With Chronic Critical Limb Ischemia: a Randomized, Placebo-controlled Clinical Trial|Completed||Phase 1/Phase 2|160|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 16:17:17.075674|2017-02-18 16:17:17.075674
NCT00371345|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2011-04-21|2010-10-06||December 2006||2006-12-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer|Phase II Study of Dasatinib (BMS-354825) for Advanced Estrogen/Progesterone Receptor-Positive or Her2/Neu-Positive Breast Cancer|Completed||Phase 2|92|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:17:17.210012|2017-02-18 16:17:17.210012
NCT00371332|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2006-09-22|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Interventional|||Effect of Adjunctive Treatment With Arestin on the Subgingival Microflora in Patients With Moderate to Advanced Periodontitis||Completed||Phase 3|128||OraPharma|||||||||||||||||||2017-02-18 16:17:18.349553|2017-02-18 16:17:18.349553
NCT00371319|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2014-07-01|||September 2005||2005-09-01|July 2014|2014-07-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis|To Compare the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis|Completed||Phase 4|150|Actual|Tuen Mun Hospital||2|||f||||t||||||||||2017-02-18 16:17:18.43694|2017-02-18 16:17:18.43694
NCT00371306|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2007-04-19|||September 2002||2002-09-01|April 2007|2007-04-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Comparison of Glucovance to Insulin for Diabetes During Pregnancy|A Comparison of Glucovance (Glyburide and Metformin) to Insulin Therapy for the Treatment of Gestational Diabetes and Adult Onset Diabetes in Pregnancy|Unknown status|Recruiting|N/A|200||Regional Obstetrical Consultants|||||f||||f||||||||||2017-02-18 16:17:18.548591|2017-02-18 16:17:18.548591
NCT00371293|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2012-06-13|||September 2006||2006-09-01|June 2012|2012-06-01|August 2012|Anticipated|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease|Inflammatory Response to Sleep Apnea in Obese Subjects: The Cardiovascular Effects of Obstructive Sleep Apnea (COSA) Study|Unknown status|Active, not recruiting|N/A|181|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 16:17:18.645902|2017-02-18 16:17:18.645902
NCT00371280|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2010-05-10|||November 2005||2005-11-01|June 2008|2008-06-01|November 2006|Anticipated|2006-11-01|October 2006|Anticipated|2006-10-01||Interventional|||Prosthetic Motility and Complications in Pegged Versus Unpegged Hydroxyapatite Orbital Implants||Unknown status|Active, not recruiting|Phase 2/Phase 3|50|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||t||||||||||2017-02-18 16:17:18.753942|2017-02-18 16:17:18.753942
NCT00371267|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2014-10-29|2014-10-24||October 2006||2006-10-01|October 2014|2014-10-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Telephone-Delivered Cognitive Behavior Therapy for Chronic Pain|Telephone-Delivered Cognitive Behavior Therapy for Chronic Pain|Completed||N/A|101|Actual|VA Office of Research and Development|The fact that the study was conducted in California may have posed some threat to external validity when applying these findings to the nationwide VA system.|2|||f||||t||||||||||2017-02-18 16:17:18.860135|2017-02-18 16:17:18.860135
NCT00371254|ClinicalTrials.gov processed this data on February 17, 2017|2006-09-01|2011-02-18|2010-10-07||December 2006||2006-12-01|February 2011|2011-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer|Phase II Study of Dasatinib (BMS-354825) for Advanced 'Triple-negative' Breast Cancer|Completed||Phase 2|55|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 16:17:19.310829|2017-02-18 16:17:19.310829
NCT00371241|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2007-12-03|||September 2006||2006-09-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Observational|||Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO|Antibody Secreting Cell (ASC) and Immunoactive Protein Profiles in Neonates on Extracorporeal Membrane Oxygenation (ECMO)|Completed||N/A|12|Actual|The University of Texas Health Science Center, Houston|||1||f||||t||||||Samples With DNA|"~     Plasma and whole blood~   "|||2017-02-18 16:17:20.436249|2017-02-18 16:17:20.436249
NCT00371228|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-05-16|||September 2006||2006-09-01|May 2008|2008-05-01||||June 2009|Anticipated|2009-06-01||Interventional|||Timing of Cord Clamping and Neonatal Hemoglobin|Delayed Versus Immediate Cord Clamping and Changes in Neonatal Hemoglobin|Withdrawn||N/A|150|Anticipated|Oklahoma State University Center for Health Sciences||2||PI left university|f||||f||||||||||2017-02-18 16:17:20.711877|2017-02-18 16:17:20.711877
NCT00371215|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2009-03-06|||August 2006||2006-08-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting|A Phase 2 Study of Recombinant Human Thrombin (rThrombin) Administered Using a Spray Applicator in Subjects Undergoing Autologous Skin Grafting Following Burn or Traumatic Skin Injury|Completed||Phase 2|72|Actual|ZymoGenetics||1|||f||||t||||||||||2017-02-18 16:17:20.822183|2017-02-18 16:17:20.822183
NCT00371202|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2007-01-12|||July 2006||2006-07-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Comparison of Penetrating Keratoplasty and Deep Lamellar Keratoplasty With the Big Bubble Technique for Keratoconus||Unknown status|Active, not recruiting|Phase 3|50||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:20.931074|2017-02-18 16:17:20.931074
NCT00371189|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2014-09-18|||January 2007||2007-01-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Adenovirus Vaccine for Malaria|A Phase I Randomized, Controlled, Dosage-Escalation Trial to Evaluate the Immunogenicity, Safety, and Reactogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Healthy Adults 18 to 45 Years of Age|Completed||Phase 1|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:17:21.016257|2017-02-18 16:17:21.016257
NCT00371176|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2013-12-16|2013-08-30||October 2006||2006-10-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|September 2011|Actual|2011-09-01||Interventional|||A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD|A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD|Completed||N/A|26|Actual|VA Office of Research and Development|The study experienced sustained recruitment difficulties, ultimately recruiting a smaller number of participants (N=26) than originally projected (N=68).|2|||f||||t||||||||||2017-02-18 16:17:21.137154|2017-02-18 16:17:21.137154
NCT00371163|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2015-04-20|||September 2006||2006-09-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|Spongiotic||Molecular and Cellular Characterization of Spongiotic Dermatitis|Molecular and Cellular Characterization of Spongiotic Dermatitis|Completed||N/A|31|Actual|University of California, Davis|||4||f||||f||||||||||2017-02-18 16:17:21.76942|2017-02-18 16:17:21.76942
NCT00371150|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2012-03-22|2012-03-22||November 2006||2006-11-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection|A Study to Describe the Antiviral Effect of Entecavir (ETV) in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection Who Are Nucleoside-Naive|Completed||Phase 4|131|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:17:21.882008|2017-02-18 16:17:21.882008
NCT00371137|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2011-12-21|2011-09-08||August 2006||2006-08-01|December 2011|2011-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia|Completed||Phase 3|548|Actual|Jazz Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:17:22.986794|2017-02-18 16:17:22.986794
NCT00371124|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2010-08-30|||March 2006||2006-03-01|May 2010|2010-05-01||||||||Interventional|||Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children|A Randomised, Double-Masked Study to Compare The Safety and Efficacy of Bilateral 0.5%, 0.1% & 0.01% Atropine Treatment In Controlling Progression of Myopia In Children|Unknown status|Active, not recruiting|Phase 2/Phase 3|400|Anticipated|Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:17:23.981946|2017-02-18 16:17:23.981946
NCT00371111|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2008-07-28|||August 2006||2006-08-01|July 2008|2008-07-01|September 2008|Anticipated|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema||Unknown status|Active, not recruiting|Phase 1|40|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 16:17:24.086252|2017-02-18 16:17:24.086252
NCT00371098|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2007-10-21|||October 2004||2004-10-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study|Prospective, Randomized, Double-Blind Placebo Controlled Study on Influenza Vaccination in Prevention From Coronary Events in Patients With Coronary Artery Disease Confirmed by Angiography|Completed||Phase 2/Phase 3|658|Actual|Institute of Cardiology, Warsaw, Poland||2|||f||||f||||||||||2017-02-18 16:17:24.196445|2017-02-18 16:17:24.196445
NCT00371085|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2011-09-22|||October 2004||2004-10-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|COPE||Congestive Heart Failure Outreach Program|Congestive Heart Failure Outreach Program (The COPE Study)|Completed||Phase 4|539|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 16:17:24.310196|2017-02-18 16:17:24.310196
NCT00371072|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2006-10-06|||March 2004||2004-03-01|July 2003|2003-07-01|November 2005||2005-11-01|||||Interventional|||Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma||Completed||Phase 2/Phase 3|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:24.418188|2017-02-18 16:17:24.418188
NCT00371059|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-05-07|||September 2007||2007-09-01|May 2008|2008-05-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|MAGD||Memantine for Agitation in Dementia|Pragmatic Randomized Control Trial of Memantine For Agitation In Dementia|Unknown status|Recruiting|Phase 4|164|Anticipated|East Kent Hospitals University NHS Foundation Trust||1|||f||||t||||||||||2017-02-18 16:17:24.495192|2017-02-18 16:17:24.495192
NCT00371046|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2007-03-01|||October 2003||2003-10-01|March 2007|2007-03-01|December 2006||2006-12-01|||||Interventional|||Does Fetal Fibronectin and Ultrasound Cervical Length Help in the Evaluation of Women With Suspected Preterm Labor?|The Use of Fetal Fibronectin and Transvaginal Ultrasound Cervical Length in Women With Threatened Preterm Labor:A Randomized Trial|Completed||N/A|100||Thomas Jefferson University|||||f||||t||||||||||2017-02-18 16:17:24.60466|2017-02-18 16:17:24.60466
NCT00371033|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2011-03-15|||March 2006||2006-03-01|March 2011|2011-03-01|April 2008|Anticipated|2008-04-01|January 2008|Actual|2008-01-01||Interventional|CPCRN RCT#2||Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)|A Randomized, Placebo-controlled Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Pregabalin for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)|Unknown status|Active, not recruiting|Phase 3|318|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||||||||||||2017-02-18 16:17:24.690042|2017-02-18 16:17:24.690042
NCT00371020|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2007-07-11|||February 2005||2005-02-01|July 2007|2007-07-01|July 2007|Anticipated|2007-07-01|||||Interventional|||The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR||Unknown status|Active, not recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:24.798581|2017-02-18 16:17:24.798581
NCT00371007|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2016-02-03|||June 2004||2004-06-01|February 2016|2016-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)|MK0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus|Completed||Phase 2|126||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:17:24.889854|2017-02-18 16:17:24.889854
NCT00005732|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1993||1993-09-01|August 2000|2000-08-01|January 1997||1997-01-01|||||Observational|||Develop and Implement Asthma Controlling Strategies (1)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:27.319903|2017-02-18 18:14:27.319903
NCT00370994|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2015-10-20|2012-03-21||January 2006||2006-01-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|December 2009|Actual|2009-12-01||Interventional|||Effectiveness of Percutaneous Lumbar Epidural Adhesiolysis and Neurolysis on Low Back Pain|A Randomized, Prospective, Double-blind Controlled Evaluation of the Effectiveness of Percutaneous Lumbar Epidural Adhesiolysis and Hypertonic Saline Neurolysis|Completed||N/A|120|Actual|Pain Management Center of Paducah|The results of this study are limited by potentially inadequate double blinding, by the lack of a placebo group.|2|||f||||t||||||||||2017-02-18 16:17:24.979764|2017-02-18 16:17:24.979764
NCT00370981|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2013-12-03||2013-12-03|July 2006||2006-07-01|February 2007|2007-02-01|October 2006|Actual|2006-10-01|July 2006|Actual|2006-07-01||Interventional|||Exploratory Study of Pagoclone in Men With Premature Ejaculation.|A Four-arm, Randomized, Double-blind, Parallel, Placebo-controlled Exploratory Study of Pagoclone 0.15mg, 0.30mg, and 0.60mg in Men With Primary Premature Ejaculation.|Completed||Phase 2|100||Endo Pharmaceuticals||4|||f||||f||||||||||2017-02-18 16:17:25.486716|2017-02-18 16:17:25.486716
NCT00370968|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2010-05-12|||September 2003||2003-09-01|May 2010|2010-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Zinc-ORS in Severe and Complicated Acute Diarrhea|Extended Studies on Safety and Efficacy of Zinc-ORS Compared to ORS Alone in Hospitalized Children With Severe and Complicated Acute Diarrhea|Completed||Phase 2/Phase 3|352||Centre For International Health|||||f||||f||||||||||2017-02-18 16:17:25.602696|2017-02-18 16:17:25.602696
NCT00370955|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2009-12-24|||March 2007||2007-03-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification|The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification|Completed||N/A|60|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||f||||||||||2017-02-18 16:17:28.407755|2017-02-18 16:17:28.407755
NCT00370942|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2013-04-11|||April 2006||2006-04-01|July 2012|2012-07-01|October 2007|Actual|2007-10-01|February 2007|Actual|2007-02-01||Interventional|||GW823093C For The Treatment Of Type 2 Diabetes Mellitus|Clinical Evaluation of GW823093C in Patients With Type 2 Diabetes Mellitus -Double-Blind Dose Finding and the Extension Study- <Phase 2 Study>|Terminated||Phase 2|200|Actual|GlaxoSmithKline||3||Safety issue|f||||||||||||||2017-02-18 16:17:28.519049|2017-02-18 16:17:28.519049
NCT00370929|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2016-07-20|||May 2006||2006-05-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Meditation as a Treatment for Epilepsy|Treatment of Epilepsy by Meditation and Cultivation of Emotional Balance|Completed||N/A|8|Actual|University of California, Los Angeles||1|||f||||f||||||||No||2017-02-18 16:17:28.609257|2017-02-18 16:17:28.609257
NCT00370916|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2015-04-06|||October 2005||2005-10-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|March 2006|Actual|2006-03-01||Interventional|||Reducing Transition Drug Risk|Reducing Transition Drug Risks After Patient Transfer|Completed||N/A|612|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 16:17:28.706978|2017-02-18 16:17:28.706978
NCT00370903|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-01-31|||August 2006||2006-08-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Postpartum Depression and Cesarean Section|Retrospective Study of Relationship of Postpartum Depression to Planned Versus Emergent Cesarean Section|Completed||N/A|200||Oklahoma State University Center for Health Sciences|||||f||||||||||||||2017-02-18 16:17:28.809805|2017-02-18 16:17:28.809805
NCT00370890|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2017-01-13|||September 2006||2006-09-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy|A Multi-center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabine and Cisplatin in Nasopharyngeal Carcinoma Patients With Residual EBV DNA Following Primary Radiotherapy With or Without Concurrent Cisplatin|Active, not recruiting||Phase 3|150|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 16:17:28.891637|2017-02-18 16:17:28.891637
NCT00370877|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2015-03-26|||April 2007||2007-04-01|March 2015|2015-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||rhuFVIIa in Post-partum Hemorrhage|Recombinant Human Activated Factor VII as Salvage Therapy in Women With Severe Postpartum Hemorrhage|Completed||Phase 4|84|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-02-18 16:17:29.005574|2017-02-18 16:17:29.005574
NCT00370864|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2016-07-17|||September 2006||2006-09-01|November 2008|2008-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Study of a Pandemic Influenza Vaccine in Children|Phase II Study of a Pandemic Influenza Vaccine in Children|Completed||Phase 2|220|Anticipated|Seqirus|||||f||||||||||||||2017-02-18 16:17:29.121939|2017-02-18 16:17:29.121939
NCT00370851|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2009-11-23|||August 2006||2006-08-01|November 2009|2009-11-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial|Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial|Completed||Phase 3|82|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 16:17:29.218865|2017-02-18 16:17:29.218865
NCT00370838|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2011-09-01|2011-06-22||February 2007||2007-02-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|July 2008|Actual|2008-07-01||Interventional|||Comparison of Keppra and Clonidine in the Treatment of Tics|Comparison of Keppra and Clonidine in the Treatment of Tics in Children With Tourette Syndrome|Completed||Phase 4|12|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:17:29.555871|2017-02-18 16:17:29.555871
NCT00370825|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2008-09-11|||September 2006||2006-09-01|September 2008|2008-09-01||||||||Interventional|||Combination Chemotherapy for the Treatment of Indian Kala-Azar|Combination Chemotherapy for the Treatment of Indian Visceral Leishmaniasis: Miltefosine Plus Liposomal Amphotericin B - Dose and Duration Ranging Study|Completed||Phase 2|200||Banaras Hindu University|||||f||||||||||||||2017-02-18 16:17:30.096236|2017-02-18 16:17:30.096236
NCT00370812|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2008-09-23|||July 2006||2006-07-01|September 2008|2008-09-01|January 2009|Anticipated|2009-01-01|December 2008|Anticipated|2008-12-01||Interventional|||The Role of Amniotic Membrane Transplantation in Ocular Chemical Burns||Unknown status|Recruiting|Phase 2/Phase 3|90|Anticipated|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 16:17:30.203351|2017-02-18 16:17:30.203351
NCT00370799|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2013-08-14|||January 2007||2007-01-01|August 2013|2013-08-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Effectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity Pain|A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Caudal Epidural Injections in Lumbar Disc Herniations, Spinal Stenosis, Discogenic Pain, and Post-Lumbar Laminectomy Syndrome|Completed||Early Phase 1|240|Actual|Pain Management Center of Paducah||4|||f||||t||||||||||2017-02-18 16:17:30.305966|2017-02-18 16:17:30.305966
NCT00370773|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-09-04|||January 2006||2006-01-01|August 2008|2008-08-01|February 2007|Actual|2007-02-01|December 2006|Actual|2006-12-01||Interventional|||Comparison of Intraspinal Nerve Root Stimulation With Dorsal Column Stimulation|Treatment of Chronic Low Back Pain With Spinal Cord Stimulation: Comparison of Subthreshold Intraspinal Nerve Root Stimulation With Subthreshold and Suprathreshold Dorsal Column Stimulation and a Secondary Study of the Effect of Pulse Width|Terminated||Phase 4|4|Actual|Boston Scientific Corporation||1||Slow Enrolling|f||||f||||||||||2017-02-18 16:17:30.566595|2017-02-18 16:17:30.566595
NCT00370760|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-06-25|||September 2006||2006-09-01|June 2008|2008-06-01||||||||Interventional|||Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)||Unknown status|Recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 16:17:30.662|2017-02-18 16:17:30.662
NCT00370747|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2013-03-13|||September 2006||2006-09-01|March 2013|2013-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome|Efficacy and Safety of Ecabet Ophthalmic Solution for the Treatment of Dry Eye Syndrome|Completed||Phase 2|162||Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 16:17:30.764658|2017-02-18 16:17:30.764658
NCT00370734|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2007-02-26|||May 2005||2005-05-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease||Unknown status|Recruiting|Phase 2/Phase 3|50||Shahid Beheshti University of Medical Sciences|||||f||||t||||||||||2017-02-18 16:17:30.864017|2017-02-18 16:17:30.864017
NCT00370721|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-06-25|||March 2006||2006-03-01|June 2008|2008-06-01||||||||Interventional|||Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)||Unknown status|Recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences||1|||f||||||||||||||2017-02-18 16:17:30.945112|2017-02-18 16:17:30.945112
NCT00370708|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2006-09-06|||April 2003||2003-04-01|April 2004|2004-04-01|February 2004||2004-02-01|||||Interventional|||Early Oral Intake Following Cesarean Surgery|Early Oral Intake Following Elective Cesarean Surgery in Iranian Women; the Economic Burdens and Patient Satisfaction|Completed||N/A|||Tehran University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:31.039525|2017-02-18 16:17:31.039525
NCT00370695|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2013-08-01|||February 2006||2006-02-01|August 2013|2013-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Spinal Cord Stimulation for Chronic and Intractable Back Pain|Spinal Cord Stimulation for Chronic and Intractable Back Pain in Patients Who Are Not Surgical Candidates|Terminated||Phase 4|15|Actual|Boston Scientific Corporation||1||Insufficient Data Collected|f||||f||||||||||2017-02-18 16:17:31.124759|2017-02-18 16:17:31.124759
NCT00370682|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2015-12-28||2015-06-08|April 2007||2007-04-01|December 2015|2015-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand|Phase II, Randomized, Double-blind, Single Center, Controlled Study of Two Doses of Different Formulations of the WRAIR Live Attenuated Tetravalent Dengue Vaccine Compared to a Placebo Control, Administered on a 0-6 Month Schedule, to Healthy Adults|Completed||Phase 2|120|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||f||||||||||2017-02-18 16:17:31.223204|2017-02-18 16:17:31.223204
NCT00370669|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2007-02-21|||November 2005||2005-11-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema||Unknown status|Recruiting|Phase 3|150||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:31.331701|2017-02-18 16:17:31.331701
NCT00370656|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2009-11-16|||February 2007||2007-02-01|November 2009|2009-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effects of Pregabalin, Duloxetine & Amitriptyline on Pain & Sleep|A Double-blind, Randomised, Parallel Groups Investigation Into the Effects of Pregabalin, Duloxetine and Amitriptyline on Aspects of Pain, Sleep, and Next Day Performance in Patients Suffering From Diabetic Peripheral Neuropathy|Completed||Phase 2/Phase 3|90|Anticipated|University of Surrey||1|||f||||||||||||||2017-02-18 16:17:31.43256|2017-02-18 16:17:31.43256
NCT00370643|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2009-02-18|||October 2002||2002-10-01|February 2009|2009-02-01|November 2004||2004-11-01|||||Interventional|||Glucose Control in Open Heart Surgery|Intensive Glucose Control Versus Conventional:Tendency Of Better Clinical Outcome In Open Heart Surgery|Completed||Phase 1|98||University of Sao Paulo|||||f||||||||||||||2017-02-18 16:17:31.781254|2017-02-18 16:17:31.781254
NCT00370630|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-31|2007-02-20|||August 2006||2006-08-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)||Unknown status|Recruiting|Phase 2|15||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:31.890353|2017-02-18 16:17:31.890353
NCT00370617|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2006-11-13|||September 2006||2006-09-01|November 2006|2006-11-01|January 2009||2009-01-01|||||Interventional|||Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance|An Efficacy and Safety Study Comparing Pegylated-Interferon and Ribavirin Plus Metformin to Pegylated-Interferon and Ribavirin in the Treatment of naïve Patients With Genotype 1 Chronic HCV Infection and Insulin Resistance|Unknown status|Recruiting|Phase 4|200||University of Turin, Italy|||||f||||||||||||||2017-02-18 16:17:31.991131|2017-02-18 16:17:31.991131
NCT00370604|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2015-06-19|||June 2007||2007-06-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Small Versus Large Epidural Needles on Postdural Puncture Headache Study|Randomized Controlled Trial Examining the Effect of Small Versus Large Tuohy-type Epidural Needles on the Incidence and Severity of Postdural Puncture Headache|Completed||N/A|1081|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-02-18 16:17:32.101169|2017-02-18 16:17:32.101169
NCT00370591|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2016-09-13|||December 2002||2002-12-01|September 2016|2016-09-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.|Randomised, Double Blind, Parallel Group Study to Assess the Bronchodilative and Bronchoprotective Properties of SERETIDE DISKUS® Inhaler 50/100 mcg Twice Daily vs FLIXOTIDE® Inhaler 200 mcg Twice Daily|Completed||Phase 4|48|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:17:32.260447|2017-02-18 16:17:32.260447
NCT00005731|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1993||1993-09-01|April 2001|2001-04-01|May 1997||1997-05-01|||||Observational|||Develop and Implement Asthma Controlling Strategies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:27.381442|2017-02-18 18:14:27.381442
NCT00370565|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2007-02-09|||June 1999||1999-06-01|February 2007|2007-02-01|September 2000||2000-09-01|||||Interventional|||Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.|Efficacy And Safety Of Exubera (Inhaled Insulin) Therapy In Subjects With Type 2 Diabetes Mellitus Not Well Controlled With Combination Oral Agents: A Three-Month, Outpatient, Parallel Comparative Trial.|Completed||Phase 3|345||Pfizer|||||||||||||||||||2017-02-18 16:17:32.486804|2017-02-18 16:17:32.486804
NCT00370552|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2016-02-09|2011-03-24||March 2007||2007-03-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer|A Phase II Open Label, Randomized, 3 Arm Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab as First Line Therapy for Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 2|136|Actual|R-Pharm||3|||f||||f||||||||||2017-02-18 16:17:32.652953|2017-02-18 16:17:32.652953
NCT00370539|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2006-11-13|||September 2006||2006-09-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD||Unknown status|Recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:34.040142|2017-02-18 16:17:34.040142
NCT00370526|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2008-01-02|||February 2007||2007-02-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|April 2007|Actual|2007-04-01||Interventional|||HEAL-HF: A Cardiac Resynchronization Therapy (CRT) Outcomes Study|HEmodynamic Assessment of Optimal Left Heart Lead Placement for Heart Failure Enabled by Magnetic Navigation|Terminated||Phase 4|100|Anticipated|Stereotaxis||1||Insufficient enrollment|f||||t||||||||||2017-02-18 16:17:34.136504|2017-02-18 16:17:34.136504
NCT00370513|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2012-03-15|||December 2006||2006-12-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase I Study of Pazopanib in Adult Patients With Liver Cancer|A Phase I, Open-Label, Dose-Escalation, Multi-Center Study or Pazopanib (GW786034)in Adult Patients With Hepatocellular Cancer|Completed||Phase 1|28|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:17:34.468637|2017-02-18 16:17:34.468637
NCT00370500|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-07-09|||April 2007||2007-04-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Quetiapine and the Dopaminergic Epigenetic Control|Quetiapine and the Dopaminergic Epigenetic Control - a Pilot Study|Completed||Phase 4|100|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-02-18 16:17:34.579971|2017-02-18 16:17:34.579971
NCT00370487|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2006-09-05|||September 2003||2003-09-01|June 2005|2005-06-01|June 2004||2004-06-01|||||Observational|||Comparison of the Safety of First Trimester Abortions Performed by Physicians and Non-Physicians in South Africa and Viet Nam.|Complication Rates of First-Trimester Manual Vacuum Aspiration Abortion Performed by Physicians and Midlevel Providers (MLP) in South Africa and Viet Nam: a Randomised, Controlled, Equivalence Trial.|Completed||N/A|2860||World Health Organization|||||f||||||||||||||2017-02-18 16:17:34.690058|2017-02-18 16:17:34.690058
NCT00370474|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2007-06-14|||June 2006||2006-06-01|June 2007|2007-06-01|September 2006|Actual|2006-09-01|||||Interventional|||MAGNET CRT Feasibility - Efficiency of LV Lead Placement Comparing Conventional vs. Magnetic Guidance|Multi-Center Assessment of Gain in Navigation Efficiency To Cardiac Resynchronization Therapy|Terminated||Phase 4|27|Actual|Stereotaxis||1||Procedure protocol improved - study protocol became obsolete|f||||f||||||||||2017-02-18 16:17:34.762124|2017-02-18 16:17:34.762124
NCT00370461|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2015-11-16|||January 2006||2006-01-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|December 2010|Actual|2010-12-01||Observational|||Basic Life Support Termination of Resuscitation Implementation Study|Basic Life Support Termination of Resuscitation in the Prehospital Environment for Primary Care Paramedics - A Prospective Observational Study of the Implementation of a Clinical Prediction Rule|Completed||N/A|350|Actual|Sunnybrook Health Sciences Centre|||1||f||||f||||||||||2017-02-18 16:17:34.860784|2017-02-18 16:17:34.860784
NCT00370448|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-11-13|||September 2007||2007-09-01|November 2008|2008-11-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Evaluation of Interventions to Prevent Suicide of Medical Students Through the School-Based Social Support System|Evaluation of Interventions to Prevent Suicide of Medical Students Through the School-Based Social Support System|Unknown status|Recruiting|N/A|12000|Anticipated|Anhui Medical University||3|||f||||||||||||||2017-02-18 16:17:34.958317|2017-02-18 16:17:34.958317
NCT00370435|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-01-19|||August 2005||2005-08-01|January 2012|2012-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)|An Open-label, Single Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of 90mg of GW274150 in Adult and Elderly RA Subjects.|Completed||Phase 2|6|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:17:35.054172|2017-02-18 16:17:35.054172
NCT00370422|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2007-03-12|||November 2005||2005-11-01|October 2005|2005-10-01|September 2006||2006-09-01|||||Interventional|||Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial||Unknown status|Active, not recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:35.158559|2017-02-18 16:17:35.158559
NCT00370409|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-07-31|||January 2006||2006-01-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage||Completed||N/A|112|Actual|Shahid Beheshti University of Medical Sciences||2|||f||||||||||||||2017-02-18 16:17:35.272441|2017-02-18 16:17:35.272441
NCT00370396|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2016-11-03|||September 2006||2006-09-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.|To Assess the Safety, Reactogenicity & Immunogenicity of a 4th Dose of GSK Biologicals' Pneumococcal Vaccine or Prevenar™ in Children (12-18 Months) Previously Vaccinated in the Primary Study 105553 With Either Pneumococcal Vaccine or Prevenar™|Completed||Phase 3|1200|Anticipated|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:17:35.369162|2017-02-18 16:17:35.369162
NCT00370383|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2012-07-31||2012-07-10|July 2006||2006-07-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)|A Phase 2 Study Comparing Sequential Satraplatin and Erlotinib to Single-Agent Erlotinib in Patients ≥ 70 Years of Age With Unresectable Stage 3 OR 4 Non-Small Cell Lung Cancer as 1st-Line Therapy|Completed||Phase 2|100|Actual|Agennix||2|||f||||||||||||||2017-02-18 16:17:35.516018|2017-02-18 16:17:35.516018
NCT00370357|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-01-10|||August 2006||2006-08-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|||SPL7013 Gel - Male Tolerance Study|A Phase 1, Placebo Controlled Study of the Safety of 3% w/w SPL7013 Gel, Administered to the Penis of Healthy Male Volunteers Once Daily for Seven Days|Completed||Phase 1|36||Starpharma Pty Ltd|||||f||||||||||||||2017-02-18 16:17:35.74966|2017-02-18 16:17:35.74966
NCT00370344|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2015-04-23|||September 2006||2006-09-01|April 2015|2015-04-01|November 2011|Actual|2011-11-01|April 2011|Actual|2011-04-01||Interventional|||Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease|An Expertise-based Randomized Controlled Trial Comparing Minilaparotomy Cholecystectomy and Laparoscopic Cholecystectomy|Completed||Phase 2/Phase 3|355|Actual|Umeå University||2|||f||||f||||||||||2017-02-18 16:17:35.841709|2017-02-18 16:17:35.841709
NCT00370331|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2012-11-21|2009-07-17||November 2006||2006-11-01|November 2012|2012-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|RAISE||RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag|A Randomized, Double-blind, Placebo-controlled Phase III Study, to Evaluate the Efficacy, Safety and Tolerability of Eltrombopag Olamine (SB-497115-GR), a Thrombopoietin Receptor Agonist, Administered for 6 Months as Oral Tablets Once Daily in Adult Subjects With Previously Treated Chronic ITP.|Completed||Phase 3|197|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:17:35.974002|2017-02-18 16:17:35.974002
NCT00370318|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2016-10-27|||September 2006||2006-09-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines|Multicentre Study to Assess the Effect of Prophylactic Antipyretic Treatment on the Rate of Febrile Reactions Following Concomitant Administration of GSK Biologicals' 10-valent Pneumococcal Conjugate, Infanrix Hexa and Rotarix Vaccines|Completed||Phase 3|400||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:17:37.347329|2017-02-18 16:17:37.347329
NCT00370305|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2007-05-11|||May 2004||2004-05-01|May 2007|2007-05-01||||||||Interventional|||11ß-HSD1 and Metabolic Syndrome|The Pathogenic Role of 11ß-Hydroxysteroid Dehydrogenase in the Metabolic Syndrome - the Effect of Rosiglitazone|Unknown status|Recruiting|Phase 2|7|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 16:17:37.468985|2017-02-18 16:17:37.468985
NCT00370292|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2009-10-15|2009-09-09||September 2006||2006-09-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)|Pemetrexed Monochemotherapy in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer. A Pilot Study to Define the Best Dosing Schedule for a Planned Phase II Randomized Trial|Completed||Phase 2|19|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:17:37.562596|2017-02-18 16:17:37.562596
NCT00370279|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-06-25|||September 2005||2005-09-01|June 2008|2008-06-01||||||||Interventional|||Surgical Management of Pseudophakic and Aphakic Retinal Detachment; a Randomized Clinical Trial||Unknown status|Recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences||4|||f||||||||||||||2017-02-18 16:17:38.730166|2017-02-18 16:17:38.730166
NCT00370266|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-06-16|||February 2003||2003-02-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion||Completed||Phase 2|30|Anticipated|Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:38.830529|2017-02-18 16:17:38.830529
NCT00370253|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2008-04-09|||September 2006||2006-09-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Noradrenalin vs Terlipressin in Hepatorenal Syndrome|Noradrenalin vs Terlipressin in Patients With Hepatorenal Syndrome.A Prospective, Randomized Study|Completed||Phase 3|20|Actual|University of Turin, Italy||2|||f||||t||||||||||2017-02-18 16:17:38.925551|2017-02-18 16:17:38.925551
NCT00370240|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2012-05-14|||September 2006||2006-09-01|July 2007|2007-07-01|November 2008|Actual|2008-11-01|July 2007|Actual|2007-07-01||Interventional|||Chlorhydrate of Ropivacaine and Breast Cancer Surgery|Efficacy of Infiltration of Chlorhydrate of Ropivacaine in the Prevention of Chronic Breast Pain After Surgery for Breast Cancer.|Completed||Phase 4|260|Actual|Institut Curie||2|||f||||||||||||||2017-02-18 16:17:39.037653|2017-02-18 16:17:39.037653
NCT00370227|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2016-10-27|||October 2006||2006-10-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|||||Interventional|||Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine|To Assess Safety, Reactogenicity & Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine, Co-admin With GSK Biologicals' MMRV Vaccine in Children (2nd yr of Life) Primed With the Pneumococcal Conjugate Vaccine in Study 105553.|Completed||Phase 3|390||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:17:39.147307|2017-02-18 16:17:39.147307
NCT00370214|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2013-05-16|||March 2006||2006-03-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management|REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management|Completed||N/A|3515|Actual|Actelion|||1||f||||t||||||||||2017-02-18 16:17:39.257771|2017-02-18 16:17:39.257771
NCT00370201|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-30|2006-10-06|||March 2004||2004-03-01|March 2004|2004-03-01|August 2006||2006-08-01|||||Interventional|||Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment||Unknown status|Active, not recruiting|Phase 3|||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:39.422316|2017-02-18 16:17:39.422316
NCT00370188|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2015-07-20|||September 2006||2006-09-01|July 2015|2015-07-01||||||||Interventional|||Topiramate on Gambling-Related Behaviours|Clinical Assessment of Topiramate on Gambling-Related Behaviours in Problem Gamblers: Effects of Gender and Negative Emotionality|Withdrawn||Phase 2|0|Actual|Centre for Addiction and Mental Health||||Change to investigator's research affiliation and other employment.|f||||||||||||||2017-02-18 16:17:39.709027|2017-02-18 16:17:39.709027
NCT00370162|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2008-05-15|||June 2006||2006-06-01|May 2008|2008-05-01||||||||Interventional|||Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene|Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata New Fragrance|Completed||Phase 3|30||Sanofi|||||f||||||||||||||2017-02-18 16:17:39.811119|2017-02-18 16:17:39.811119
NCT00005730|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||January 1989||1989-01-01|March 2005|2005-03-01|December 1995||1995-12-01|||||Observational|||National Marrow Donor Program (NMDP)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:27.447476|2017-02-18 18:14:27.447476
NCT00370149|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2016-01-27|2015-10-19||September 2006||2006-09-01|January 2016|2016-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||Patients <18 years of age who had cardiovascular surgery with a case complexity warranting a central venous catheter received either an antibiotic impregnated catheter or a conventional non-impregnated catheter on a randomized, blinded 1:1 ratio.|Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children|A Randomized, Controlled Trial of Catheter Related Infectious Event Rates Using Antibiotic-impregnated Catheters vs. Conventional Catheters in Pediatric Cardiovascular Surgery Patients|Terminated||Phase 4|326|Actual|Indiana University|A blinded interim analysis by an independent Data Safety Monitoring Board resulted in early termination of the study: of 288 evaluable patients, the rates of CRBSI and line-related complications were similar between the 2 groups.|2||Blinded interim analysis resulted in early termination of the study.|f||||t||||||||No||2017-02-18 16:17:39.884468|2017-02-18 16:17:39.884468
NCT00370136|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2008-06-17|||August 2006||2006-08-01|June 2008|2008-06-01|April 2008||2008-04-01|March 2008||2008-03-01||Interventional|||Sentinel Node With Ultrasound Contrast in Melanoma|Sentinel Node Diagnostics With Ultrasound Contrast in Melanoma|Completed||N/A|20|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:17:40.276793|2017-02-18 16:17:40.276793
NCT00370123|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2011-06-26|||September 2006||2006-09-01|June 2011|2011-06-01||||||||Observational|||The Immune Base of Endometriosis|In This Study we Aim to Explore the Immune Nature of Endometriosis as Manifested in the Peripheral Blood, Endometriosis Lesions, Normal Peritoneum and Normal Endometrium of Patients Suffering From Documented Endometriosis.|Withdrawn||N/A|50|Anticipated|Sheba Medical Center|||1|The study was withrawn do to logistic difficulties|f||||||||||||||2017-02-18 16:17:40.350597|2017-02-18 16:17:40.350597
NCT00370110|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2017-02-07|||August 2005||2005-08-01|February 2017|2017-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effects of Itopride on Gastric Motor and Sensory Functions in Healthy Volunteers|A Double-blind, Randomized, Placebo-controlled, Single Center, Parallel Group Study to Evaluate the Effects of Itopride (100 mg and 200 mg t.i.d.) on Gastric Motor and Sensory Functions in Healthy Volunteers|Completed||Phase 1/Phase 2|45|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 16:17:40.425817|2017-02-18 16:17:40.425817
NCT00370097|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2016-10-26|||August 2006||2006-08-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects|PD of Hydrofluoroalkane Propellant of Inhaled Fluticasone Propionate Following Administration in Pediatric Subjects 6-12 Months of Age With Asthma|Completed||Phase 1|16|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:17:40.522142|2017-02-18 16:17:40.522142
NCT00370084|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2017-02-07|||March 2005||2005-03-01|February 2017|2017-02-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia|"Effects of Itopride Hydrochloride on Gastric Emptying, Glycaemia and Meal-related Symptoms in Patients With Type 1 and Type 2 Diabetes Mellitus"|Completed||Phase 1/Phase 2|25|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 16:17:40.625956|2017-02-18 16:17:40.625956
NCT00370071|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2015-09-29|2009-10-23||November 2006||2006-11-01|September 2015|2015-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis|Open Label Study to Evaluate the Effect, Safety and Tolerability of 250µg (8 MIU) Interferon Beta 1b (Betaferon) Given Subcutaneously Every Other Day (for 24 Weeks) in Patients of Chinese Origin With Multiple Sclerosis|Completed||Phase 3|39|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:17:40.729373|2017-02-18 16:17:40.729373
NCT00370058|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2008-07-09|||August 2006||2006-08-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels|Modulation of Homocysteine-Plasma Levels by ECT - Association With Clinical Response. A Pilot Study in Patients With Major Depression|Completed||Phase 4|10|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||||||||||||2017-02-18 16:17:41.237504|2017-02-18 16:17:41.237504
NCT00370045|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2006-08-29|||March 2006||2006-03-01|August 2006|2006-08-01||||||||Interventional|||Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin|Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin -The CLEAR PLATELETS-2 Study|Unknown status|Recruiting|Phase 4|200||LifeBridge Health|||||f||||||||||||||2017-02-18 16:17:41.326295|2017-02-18 16:17:41.326295
NCT00370032|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2015-05-15|2008-12-19||December 2006||2006-12-01|May 2015|2015-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Assess the Effect Of Alosetron On Mucosal Blood Flow|A Randomize, Placebo-controlled, Crossover Study to Measure the Effect of Alosetron on Mucosal Blood Flow in Female Healthy Volunteers and Diarrhea-predominant IBS Subjects|Completed||Phase 4|49|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:17:41.591963|2017-02-18 16:17:41.591963
NCT00370019|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2017-01-24|||August 25, 2006||2006-08-25|December 12, 2011|2011-12-12|December 12, 2011|Actual|2011-12-12|December 12, 2011|Actual|2011-12-12||Interventional|||Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure|Effect of Transdermal Estradiol Replacement Therapy on Ovulation Rate in Women With Premature Ovarian Failure: A Randomized, Placebo-Controlled Trial|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:17:42.217736|2017-02-18 16:17:42.217736
NCT00370006|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2007-01-10|||September 2006||2006-09-01|October 2006|2006-10-01|August 2007||2007-08-01|||||Interventional|||Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM|A Phase 1 Clinical Trial to Evaluate the Safety of, and Kinetics and Magnitude of the CMV-Specific Immune Response to, Challenge With a Live Attenuated Strain of CMV (Towne) in Healthy, CMV- Seronegative, Adult Subjects Who Previously Received a CMV Immunotherapeutic Trivalent pDNA Vaccine (VCL CT02) Administered Intradermally or Intramuscularly|Completed||Phase 1|10||University of California, San Francisco|||||||||||||||||||2017-02-18 16:17:42.314249|2017-02-18 16:17:42.314249
NCT00369811|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2007-11-16|||August 2006||2006-08-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Oxycodone vs Fentanyl for Pain Treatment After Laparoscopic Cholecystectomy|Comparative Study of Oxycodone and Fentanyl Given Intravenously in the Treatment of Early Postoperative Pain After Laparoscopic Cholecystectomy|Completed||Phase 4|80|Anticipated|Danish Pain Research Center|||||f||||t||||||||||2017-02-18 16:17:49.147692|2017-02-18 16:17:49.147692
NCT00369993|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2016-10-13|||March 2005||2005-03-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Spacer Comparison In Adult Asthmatics|A Randomised, Open Label, Five-way Crossover Study to Assess the Systemic Exposure of Fluticasone Propionate and Salmeterol From SERETIDE/ADVAIR 250HFA MDI Alone and With AeroChamber-Max Spacer and VOLUMATIC Both in Their Washed and Unwashed States in Adult Subjects With Mild or Intermittent Asthma|Completed||Phase 2|20|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:17:42.400345|2017-02-18 16:17:42.400345
NCT00369980|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2006-11-06|||September 1998||1998-09-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Diagnostic Usefulness of Fluorine–18-α–Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient||Completed||N/A|||Gunma University|||||f||||||||||||||2017-02-18 16:17:42.513448|2017-02-18 16:17:42.513448
NCT00369967|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2016-06-10|2015-12-10||February 2007||2007-02-01|June 2016|2016-06-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents|"Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents: A Randomized Controlled Trial"|Terminated||N/A|48|Actual|Virginia Commonwealth University||2||difficulty in subject recruitment|f||||f||||||||No|Not planned.|2017-02-18 16:17:42.587227|2017-02-18 16:17:42.587227
NCT00369954|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2013-06-07|||April 2006||2006-04-01|October 2007|2007-10-01||||||||Interventional|||Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin|A Phase II Trial of Intravenous Gemcitabine (NSC #613327) and Intraperitoneal Carboplatin (NSC # 241240) in the Treatment of Patients With Platinum-Sensitive Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma With Non-Measurable Disease|Withdrawn||Phase 2|0|Actual|Gynecologic Oncology Group||1||Trial was never activated|f||||||||||||||2017-02-18 16:17:43.179312|2017-02-18 16:17:43.179312
NCT00369941|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2015-09-01|2009-09-18||August 2006||2006-08-01|September 2015|2015-09-01|February 2012|Actual|2012-02-01|May 2009|Actual|2009-05-01||Interventional|||A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)|A Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA™|Completed||Phase 3|566|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:17:43.29521|2017-02-18 16:17:43.29521
NCT00369928|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2011-08-04|2011-08-04||August 2006||2006-08-01|August 2011|2011-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate|A Multicenter, Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses, 25 mg Twice Daily and 100 mg Twice Daily, of PG-760564 in Adult Patients With RA Receiving Methotrexate|Completed||Phase 2|254|Actual|Procter and Gamble||3|||f||||f||||||||||2017-02-18 16:17:45.492337|2017-02-18 16:17:45.492337
NCT00369915|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2016-09-22|2014-04-11||August 2006||2006-08-01|September 2016|2016-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||The Antidepressant Efficacy of the Anticholinergic Scopolamine|The Antidepressant Efficacy of the Anticholinergic Scopolamine|Terminated||Phase 2|17|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:17:46.399563|2017-02-18 16:17:46.399563
NCT00369902|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2009-07-19|||May 2006||2006-05-01|July 2009|2009-07-01|May 2007|Actual|2007-05-01|||||Observational|||The Effect of Acupuncture Treatment on the Perception of Pain and Coping With Pain|Pilot Study on the Effect of Acupuncture Treatment on Pain Perception and on the Ability to Cope With Pain|Completed||N/A|41|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 16:17:46.890815|2017-02-18 16:17:46.890815
NCT00369889|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2014-05-30|||August 2006||2006-08-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer|A Phase II Study of Erlotinib Plus Bevacizumab in the Treatment of Advanced Thymoma and Thymic Carcinoma|Completed||Phase 2|18|Actual|Indiana University||1|||f||||f||||||||||2017-02-18 16:17:46.971302|2017-02-18 16:17:46.971302
NCT00369876|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2007-01-23|||August 2004||2004-08-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Observational|||Anorexia in Children With Burn Injury and the Reactions of the Immune and Endocrine Systems|The Association Between Anorexia and the Level of Hormones, Cytokines and Neuroendocrine Peptides in Children After Burn Injury|Unknown status|Active, not recruiting|Phase 1|10||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:17:47.081065|2017-02-18 16:17:47.081065
NCT00369863|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-29|2007-02-27|||June 2002||2002-06-01|February 2007|2007-02-01|June 2003||2003-06-01|||||Interventional|||A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema||Completed||Phase 2|76||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:17:47.164092|2017-02-18 16:17:47.164092
NCT00369850|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2012-07-26|||May 2004||2004-05-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|May 2008|Actual|2008-05-01||Interventional|||Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98|Investigating Bone Density and Bone Loss Without Baseline Information|Completed||Phase 3|458|Actual|International Breast Cancer Study Group||4|||f||||t||||||||||2017-02-18 16:17:47.269678|2017-02-18 16:17:47.269678
NCT00369837|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2014-05-21|||September 2006||2006-09-01|May 2014|2014-05-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|VELOCITY||Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)|Evaluation of the Effect of Ultrashort-Acting Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)|Completed||Phase 3|131|Actual|The Medicines Company||1|||f||||f||||||||||2017-02-18 16:17:47.405904|2017-02-18 16:17:47.405904
NCT00369824|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2016-11-03|2009-09-03||September 2006||2006-09-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|||Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects|A Randomized, Open Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine Co-administered Intramuscularly With Boostrix® and/or Menactra™ in Healthy Female Subjects Aged 11-18 Years|Completed||Phase 3|1330|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:17:47.546726|2017-02-18 16:17:47.546726
NCT00369798|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2017-01-24|||August 2, 2006||2006-08-02|October 12, 2016|2016-10-12|October 12, 2016|Actual|2016-10-12|June 16, 2016|Actual|2016-06-16||Interventional|||Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients|Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE 4) in Depressed Patients|Completed||Phase 1|100|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:17:49.230587|2017-02-18 16:17:49.230587
NCT00369785|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2012-06-28|||January 2008||2008-01-01|December 2011|2011-12-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors|Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain|Completed||Phase 3|198|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 16:17:49.33475|2017-02-18 16:17:49.33475
NCT00369772|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2009-10-15|||February 2002||2002-02-01|October 2009|2009-10-01|May 2004||2004-05-01|||||Interventional|||STAAR-1 Clinical Study|A Multicenter Study Evaluating Once Every Other Week Subcutaneous Administration of Aranesp (Darbepoetin Alfa) in Subjects With Anemia of Chronic Renal Insufficiency (CRI)|Completed||Phase 4|2000||Amgen|||||f||||||||||||||2017-02-18 16:17:49.528825|2017-02-18 16:17:49.528825
NCT00369759|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2009-03-16|||September 2006||2006-09-01|March 2009|2009-03-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Observational|||An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants|An Epidemiological Study to Evaluate the Seasonality of Respiratory Syncytial Virus-Associated-Lower Respiratory Tract Infections (LRI) or Apnea in Infants in the Emergency Department|Completed||N/A|2048|Actual|MedImmune LLC|||3||f||||f||||||Samples Without DNA|"~     Nasal wash specimen (RSV)~   "|||2017-02-18 16:17:49.62039|2017-02-18 16:17:49.62039
NCT00369746|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2014-04-09|2011-11-23||September 2006||2006-09-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse|Treatment of Depression Concurrent With Alcohol Abuse, an Extension of Alcohol Use Disorder in Patients Treated for Depression|Completed||Phase 4|674|Actual|New York State Psychiatric Institute|||2||f||||f||||||||||2017-02-18 16:17:49.774981|2017-02-18 16:17:49.774981
NCT00369733|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2010-02-18|||May 2002||2002-05-01|February 2010|2010-02-01|May 2004|Actual|2004-05-01|March 2004|Actual|2004-03-01||Interventional|||STAAR-3 Clinical Study|Disease/Case Management of Patients Receiving ARANESP™ (Darbepoetin Alfa) to Treat the Anemia of Chronic Renal Insufficiency (CRI)|Completed||Phase 4|443|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:17:50.190053|2017-02-18 16:17:50.190053
NCT00369720|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2007-04-18|||January 2005||2005-01-01|April 2007|2007-04-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Use of Blended Oxygen for Delivery Room Resuscitation of Very Low Birth Weight Infants|Use of Blended Oxygen for Delivery Room Resuscitation of VLBW Infants|Unknown status|Active, not recruiting|N/A|40||University of California, San Diego|||||f||||||||||||||2017-02-18 16:17:50.309828|2017-02-18 16:17:50.309828
NCT00369707|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2016-10-19|||August 2006||2006-08-01|October 2016|2016-10-01|August 2019|Anticipated|2019-08-01|August 2018|Anticipated|2018-08-01||Interventional|||Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL|A Phase II Trial of Combination Bortezomib and Rituximab as Front-line Therapy for Low-grade Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 2|43|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 16:17:50.401873|2017-02-18 16:17:50.401873
NCT00369694|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2008-09-24|||August 2006||2006-08-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Short Course Terlipressin for Control of Acute Variceal Bleeding|Randomized Double Blind Dummy Controlled Trial Of 24 Versus 72 Hours Of Terlipressin As An Adjuvant Therapy In Acute Variceal Bleed|Completed||Phase 4|130|Actual|Aga Khan University||2|||f||||t||||||||||2017-02-18 16:17:50.523128|2017-02-18 16:17:50.523128
NCT00369681|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-07-27|2015-05-20||May 2006||2006-05-01|July 2015|2015-07-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin's Lymphoma|Phase II Trial of Rituximab -ABVD for Classical Hodgkin's Disease|Completed||Phase 2|50|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:17:50.634664|2017-02-18 16:17:50.634664
NCT00369668|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2012-06-12|2011-08-10||August 2006||2006-08-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Post Stroke Hand Functions: Bilateral Movements and Electrical Stimulation Treatments|Subacute Stroke Recovery (Upper Extremity Motor Function): Bimanual Coordination Training|Completed||Phase 2|30|Actual|University of Florida||3|||f||||f||||||||||2017-02-18 16:17:53.834352|2017-02-18 16:17:53.834352
NCT00369655|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2014-04-02|2013-11-25||January 2007||2007-01-01|November 2013|2013-11-01|January 2011|Actual|2011-01-01|March 2008|Actual|2008-03-01||Interventional|||VEGF Trap in Treating Patients With Metastatic Breast Cancer|Phase II Trial of VEGF Trap in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline and/or Taxane|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:17:54.375757|2017-02-18 16:17:54.375757
NCT00369642|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2010-08-05|||October 2004||2004-10-01|April 2008|2008-04-01|December 2006||2006-12-01|||||Interventional|||A Controlled Trial of Daily Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder|A Controlled Trial of Daily Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder|Completed||Phase 3|60||University of South Florida|||||f||||||||||||||2017-02-18 16:17:55.1399|2017-02-18 16:17:55.1399
NCT00369629|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2016-11-23|||June 2006||2006-06-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|May 2012|Actual|2012-05-01||Interventional|||Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome|Phase I/II Trial of Gemcitabine/Pemetrexed Combination in Patients With Advanced Cutaneous T-Cell Lymphoma|Terminated||Phase 1|14|Actual|Northwestern University||1||"This was planned as a phase I/II study originally, but due to a lack of funding, the phase II~   portion was never conducted."|f||||t||||||||||2017-02-18 16:17:55.237544|2017-02-18 16:17:55.237544
NCT00369616|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2010-11-11|||December 2003||2003-12-01|March 2008|2008-03-01|October 2005|Actual|2005-10-01|March 2005|Actual|2005-03-01||Interventional|||Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers|Evaluation of Efficacy and Safety of Nicotine-Qbeta (NicQb) Vaccine Versus Placebo in Healthy Smokers|Completed||Phase 2|341|Actual|Cytos Biotechnology AG||2|||f||||||||||||||2017-02-18 16:17:55.341161|2017-02-18 16:17:55.341161
NCT00369395|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2012-04-25|||December 2006||2006-12-01|April 2012|2012-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Volociximab in Metastatic Melanoma|A Phase 2, Open-Label, Two-Stage Study of Volociximab (M200) for the Treatment of Subjects With Metastatic Melanoma|Terminated||Phase 2|19|Actual|Abbott||1||Insufficient clinical activity|f||||f||||||||||2017-02-18 16:18:00.3043|2017-02-18 16:18:00.3043
NCT00369603|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2013-04-09|||October 2006||2006-10-01|June 2008|2008-06-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients|Functional Neuroimaging (fMRI) Biomarker of Allosteric Nicotinic Receptor Modulation in Mild Alzheimer's Disease Patients: A Razadyne vs. Aricept Dose Escalation Trial|Terminated||Phase 4|4|Actual|Duke University||2||Reduced access to AchEI medication-naive mild AD patients.|f||||t||||||||||2017-02-18 16:17:55.437007|2017-02-18 16:17:55.437007
NCT00369590|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-08-31|2015-06-03||August 2006||2006-08-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|December 2011|Actual|2011-12-01||Interventional||16 patients were anaplastic gliomas and 42 were glioblastomas all underwent central pathologic review|VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide|Phase II Single Arm Trial of VEGF Trap in Patients With Recurrent Temozolomide-Resistant Malignant Gliomas|Completed||Phase 2|58|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:17:55.553788|2017-02-18 16:17:55.553788
NCT00369577|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2007-01-18|||August 2006||2006-08-01|January 2007|2007-01-01||||||||Interventional|||StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Efficacy and Safety Study of StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.|Completed||Phase 2|120||Alexza Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 16:17:56.085181|2017-02-18 16:17:56.085181
NCT00369564|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2014-01-30|2013-12-09||May 2007||2007-05-01|December 2013|2013-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer|Glutamic Acid to Decrease Vincristine Toxicity in Children With Cancer|Completed||Phase 3|250|Actual|University of South Florida||2|||f||||t||||||||||2017-02-18 16:17:56.182504|2017-02-18 16:17:56.182504
NCT00369551|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2014-03-05|||June 2006||2006-06-01|January 2013|2013-01-01||||February 2008|Actual|2008-02-01||Interventional|||Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer|A Safety and Feasibility Study of Bevacizumab With Paclitaxel, Carboplatin and Chest Radiotherapy in Patients With Locally Advanced Non-Small Lung Cancer|Terminated||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:17:56.621034|2017-02-18 16:17:56.621034
NCT00369538|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2009-02-16|||August 2006||2006-08-01|February 2009|2009-02-01||||||||Interventional|||Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria|Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria|Suspended||Phase 4|20|Anticipated|University Hospital, Strasbourg, France||2||"principle investigator moved, new investigators will join, insurance expired - project needs~   to be re-examined by an ethic committee"|f||||||||||||||2017-02-18 16:17:56.738786|2017-02-18 16:17:56.738786
NCT00369512|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2013-08-06|2013-06-03||August 2006||2006-08-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|January 2012|Actual|2012-01-01||Interventional|RAD0503||A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma|A Phase II Trial of Erlotinib and Radiotherapy in Patients With Stage III Cutaneous Squamous Cell Carcinomas|Completed||Phase 2|15|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 16:17:56.846974|2017-02-18 16:17:56.846974
NCT00369499|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2008-02-22|||March 2007||2007-03-01|February 2008|2008-02-01|June 2009|Anticipated|2009-06-01|||||Interventional|||STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine?|STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine?|Terminated||N/A|656|Anticipated|St. Jude Medical||||Not enough patients/ ethical concerns|f||||||||||||||2017-02-18 16:17:57.368171|2017-02-18 16:17:57.368171
NCT00369486|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2016-08-25|2009-10-14||December 2004||2004-12-01|August 2016|2016-08-01|October 2007|Actual|2007-10-01|June 2006|Actual|2006-06-01||Interventional|Peribulbar||A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema|A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema|Completed||Phase 2|113|Actual|Jaeb Center for Health Research||5|||f||||t||||||||||2017-02-18 16:17:57.465294|2017-02-18 16:17:57.465294
NCT00369473|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2016-12-09||2016-12-09|September 2006||2006-09-01|December 2016|2016-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long-Term Assessment of Safety and Physical Function With AMG 108 in RA|A Long-Term Assessment of Safety and Physical Function With AMG 108 Subcutaneous Monthly Treatment in Subjects With Rheumatoid Arthritis|Completed||Phase 2|690|Actual|Amgen||2|||f||||||||||||||2017-02-18 16:17:59.417269|2017-02-18 16:17:59.417269
NCT00369460|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-10-08|||January 2006||2006-01-01|October 2015|2015-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Changes in Muscle Tissue in Patients With Pancreatic Cancer|Pilot Study of Changes in Fat-Free Mass in Pancreatic Carcinoma Patients|Completed||N/A|9|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||||||2017-02-18 16:17:59.512755|2017-02-18 16:17:59.512755
NCT00369447|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2011-06-30|||March 2009||2009-03-01|June 2011|2011-06-01|July 2011|Anticipated|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer|A Phase I-II Clinical Study of Nimotuzumab (TheraCIM h-R3) in Combination With External Radiotherapy in Stage IIB, III and IV NSCLC|Terminated||Phase 1/Phase 2|52|Actual|YM BioSciences||2||The study was closed due to slow accrual.|f||||f||||||||||2017-02-18 16:17:59.611317|2017-02-18 16:17:59.611317
NCT00369434|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2007-05-31|||June 2006||2006-06-01|May 2007|2007-05-01|February 2007|Actual|2007-02-01|||||Interventional|||Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women|A Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of DVS SR for Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|450|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:17:59.729785|2017-02-18 16:17:59.729785
NCT00369421|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2017-01-24|||November 23, 1976||1976-11-23|September 26, 2016|2016-09-26||||||||Observational|||Diagnosis and Treatment of Patients With Inborn Errors of Metabolism|Diagnosis and Treatment of Patients With Inborn Errors of Metabolism or Other Genetic Disorders|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:17:59.84095|2017-02-18 16:17:59.84095
NCT00369408|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2011-06-17|||June 2003||2003-06-01|June 2011|2011-06-01|March 2008|Actual|2008-03-01|August 2007|Actual|2007-08-01||Interventional|||Targeted Naltrexone for Problem Drinkers|Targeted Naltrexone for Problem Drinkers|Completed||Phase 4|163|Actual|UConn Health||2|||f||||t||||||||||2017-02-18 16:17:59.945629|2017-02-18 16:17:59.945629
NCT00369187|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2008-01-07|||July 2006||2006-07-01|January 2008|2008-01-01|October 2006|Actual|2006-10-01|||||Interventional|||Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase||Completed||Phase 4|15||Halozyme Therapeutics|||||||||||||||||||2017-02-18 16:18:05.212036|2017-02-18 16:18:05.212036
NCT00369382|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2011-05-25|2011-04-26||September 2006||2006-09-01|May 2011|2011-05-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients|A Randomized Open-Label Study To Compare The Safety And Efficacy Of Conversion From A Calcineurin Inhibitor To Sirolimus Vs Continued Use Of A Calcineurin Inhibitor In Heart Transplant Recipients With Mild-Moderate Impaired Renal Function|Completed||Phase 4|121|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||t||||||||||2017-02-18 16:18:00.424162|2017-02-18 16:18:00.424162
NCT00369356|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2013-01-20|||October 2006||2006-10-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|October 2009|Actual|2009-10-01||Interventional|||Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis|Clinical and Angiographic Outcome of Patients Treated With Bare Metal Stent (BMS) Implantation Compared With Drug Eluting Stents or BMS Plus Systemic Prednisone Therapy. A Randomized, Multicentre Study.|Completed||Phase 2/Phase 3|375|Actual|Universita di Verona||3|||f||||t||||||||||2017-02-18 16:18:01.276795|2017-02-18 16:18:01.276795
NCT00369343|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2012-04-09|2008-11-26||September 2006||2006-09-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|November 2007|Actual|2007-11-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women|A Multicenter, Randomized, 8-week, Double-blind, Placebo-controlled Study Followed by a 6-month Open-label Extension to Evaluate the Efficacy and Safety of DVS SR in Peri- and Postmenopausal Women With Major Depressive Disorder|Completed||Phase 3|381|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 16:18:01.409405|2017-02-18 16:18:01.409405
NCT00369330|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2012-08-31|||September 2006||2006-09-01|August 2006|2006-08-01||||||||Interventional|||KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation|Prospective, Randomized Parallel-group Study for Evaluation of Impact of Early Versus Delayed Cardioversion of Acute Atrial Fibrillation on Further Clinical Course|Withdrawn||N/A|0|Actual|German Atrial Fibrillation Network||||withdrawn because of insufficient financial capacities|f||||||||||||||2017-02-18 16:18:02.347281|2017-02-18 16:18:02.347281
NCT00369317|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2016-03-16|2015-01-06||March 2007||2007-03-01|March 2016|2016-03-01||||December 2013|Actual|2013-12-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes|The Treatment of Down Syndrome Children With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Under the Age of 4 Years|Active, not recruiting||Phase 3|205|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 16:18:02.44575|2017-02-18 16:18:02.44575
NCT00369304|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2009-08-06|||July 2006||2006-07-01|August 2009|2009-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate|A Randomized, Open Label, 2-Period Crossover Study to Determine the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate.|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:18:03.18236|2017-02-18 16:18:03.18236
NCT00369291|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2012-11-06|||September 2003||2003-09-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant|CPG 7909 Oligodeoxynucleotides (ODNS) After Autologous Transplantation to Enhance Immune Reconstitution|Terminated||Phase 1|19|Actual|Masonic Cancer Center, University of Minnesota||1||Slow accrual|f||||t||||||||||2017-02-18 16:18:03.26941|2017-02-18 16:18:03.26941
NCT00369278|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2011-03-25|2010-12-15||June 2006||2006-06-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients|Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating an Intensified Enteric-coated Mycophenolate Sodium (EC-MPS) Dosing Regimen in Comparison to a Standard Dosing Regimen of EC-MPS in Combination With Cyclosporin Microemulsion and Corticosteroids in de Novo Renal Transplant Patients|Completed||Phase 3|128|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:18:03.385351|2017-02-18 16:18:03.385351
NCT00369265|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2012-08-23|2012-07-11||August 2006||2006-08-01|August 2012|2012-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux|A Randomized, Placebo-Controlled Assessment of Lansoprazole 30 mg Bid in the Treatment of Gastroesophageal Reflux Associated With Laryngitis|Terminated||Phase 4|18|Actual|American Institute for Voice and Ear Research|The study was terminated due to inadequate subject recruitment.|2||Pharmaceutical company purchased by another company and funding was terminated.|f||||||||||||||2017-02-18 16:18:04.132714|2017-02-18 16:18:04.132714
NCT00369252|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2007-02-27|||June 2005||2005-06-01|February 2007|2007-02-01||||||||Interventional|||Phase I Study of Nimotuzumab in Solid Tumours|A Phase I Study of TheraCIM-hR3 (YMB1000) in Patients With Solid Tumours|Completed||Phase 1|18||YM BioSciences|||||f||||||||||||||2017-02-18 16:18:04.490623|2017-02-18 16:18:04.490623
NCT00369239|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2011-05-16|||March 2006||2006-03-01|April 2010|2010-04-01|November 2007|Actual|2007-11-01|||||Interventional|||Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis|Is Premorbid Functioning a Predictor of Outcome in Patients With Early Onset Psychosis Treated With Risperdal Consta?|Completed||Phase 4|303|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 16:18:04.56479|2017-02-18 16:18:04.56479
NCT00369226|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2013-06-19|2012-08-08||August 2006||2006-08-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|July 2010|Actual|2010-07-01||Interventional|||Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation|Phase I/II Trial of Bortezomib (Velcade) in Addition to Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Peripheral Blood Stem Cell Transplantation|Completed||Phase 1/Phase 2|45|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:18:04.658016|2017-02-18 16:18:04.658016
NCT00369213|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2006-08-24|||April 1998||1998-04-01|December 2004|2004-12-01|April 2002||2002-04-01|||||Interventional|||Randomised Controlled Trial of Condoms Plus Additional Lubrication|Randomised Controlled Trial of the Effect of Additional Spermicidal Lubrication on Condom Failure|Completed||Phase 4|200||University of Manchester|||||f||||||||||||||2017-02-18 16:18:05.034983|2017-02-18 16:18:05.034983
NCT00369200|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2013-12-10|||June 2006||2006-06-01|December 2013|2013-12-01||||January 2011|Actual|2011-01-01||Interventional|||AFP464 in Treating Patients With Advanced Solid Tumors|A Phase 1 Study of AFP464 (Aminoflavone Prodrug) in Patients With Advanced Solid Tumors|Terminated||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:18:05.115705|2017-02-18 16:18:05.115705
NCT00369161|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2011-03-25|2010-12-17||June 2006||2006-06-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients|A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With IL-2 Receptor Antagonist, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients|Completed||Phase 4|228|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:18:05.52752|2017-02-18 16:18:05.52752
NCT00369148|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2009-08-25|||July 2004||2004-07-01|August 2009|2009-08-01|March 2006||2006-03-01|||||Interventional|||Combination of Glinides With Premixed Insulin|Evaluation of Usefulness of Combination Therapy of Rapid Acting Insulin Secretagogue (Glinide) With Premixed Insulin in Type 2 Diabetes|Completed||Phase 4|60||Keio University|||||f||||||||||||||2017-02-18 16:18:06.367639|2017-02-18 16:18:06.367639
NCT00369135|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2008-11-20|||March 2006||2006-03-01|November 2008|2008-11-01|February 2009|Anticipated|2009-02-01|||||Interventional|||Cross-Disciplinary Workplace Intervention Strategy for Chronic Musculoskeletal Disorders|Cross-Disciplinary Workplace Intervention Strategy for Chronic Musculoskeletal Disorders|Unknown status|Recruiting|N/A|120|Anticipated|Institut Universitaire Romand de Sante au Travail||1|||f||||t||||||||||2017-02-18 16:18:06.469022|2017-02-18 16:18:06.469022
NCT00369122|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2014-09-22|2013-03-05||August 2006||2006-08-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer|A PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH DEFINITIVE RADIOTHERAPY AND CISPLATIN CHEMOTHERAPY IN UNTREATED PATIENTS WITH LOCALLY ADVANCED CERVICAL CARCINOMA|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)|Ineligible patients are included in the adverse event reporting on ClinicalTrials.gov, but not in endpoint results, nor in any publications, per the protocol.|1|||f||||||||||||||2017-02-18 16:18:06.566608|2017-02-18 16:18:06.566608
NCT00369109|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2013-04-05|||February 2006||2006-02-01|April 2013|2013-04-01|June 2007|Actual|2007-06-01|November 2006|Actual|2006-11-01||Observational|||Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors|Collection of Skin Biopsy With Hair Follicles as Surrogate to Develop Biomarker Assays From Patients With Advanced Solid Tumor Malignancies Receiving Either Single Agent Weekly Irinotecan or Gemcitabine|Completed||N/A|60|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||f||||||||||2017-02-18 16:18:07.019132|2017-02-18 16:18:07.019132
NCT00369096|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2010-05-13|||September 2006||2006-09-01|May 2010|2010-05-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)|Randomized, Controlled and Open Study to Assess the Efficacy (Peritoneal Biocompatibility) of the Addition of Bemiparin to Icodextrin Solution in Patients in Peritoneal Dialysis With Peritoneal Transport Disorders|Completed||Phase 2|76|Anticipated|Fundación Renal Iñigo Alvarez De Toledo||2|||f||||t||||||||||2017-02-18 16:18:07.131089|2017-02-18 16:18:07.131089
NCT00369083|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2006-08-28|||April 2004||2004-04-01|January 2004|2004-01-01|October 2005||2005-10-01|||||Interventional|||Hospitalization at Home of Elderly Patients With Exacerbated COPD|Home Hospitalizationfor Elderly Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Randomized Controlled Trial.|Completed||N/A|100||Azienda Ospedaliera San Giovanni Battista|||||f||||||||||||||2017-02-18 16:18:07.246544|2017-02-18 16:18:07.246544
NCT00369070|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2016-06-09||2015-12-14|January 2007||2007-01-01|May 2016|2016-05-01||||||||Interventional|||A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC|A Phase 2, Multicenter, Open Label, Randomized Trial of AMG 706 or Bevacizumab in Combination With Paclitaxel and Carboplatin for Advanced Non-squamous Non-small Cell Lung Cancer|Terminated||Phase 2|186|Actual|Amgen||3|||f||||t||||||||||2017-02-18 16:18:07.328086|2017-02-18 16:18:07.328086
NCT00369057|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2012-03-07|||February 2006||2006-02-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|||||Observational|||Intra Ocular Pressure During Robotic Prostatectomy|Intra Ocular Pressure During Robotic Prostatectomy|Completed||Phase 4|15|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 16:18:07.448724|2017-02-18 16:18:07.448724
NCT00369044|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2009-04-07|||October 2006||2006-10-01|June 2007|2007-06-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Prednisone for Decompensated Congestive Heart Failure|Chronic Administration of Prednisone in Management of Patients With Decompensated Congestive Heart Failure|Suspended||Phase 2/Phase 3|60|Anticipated|Hebei Medical University|||||f||||||||||||||2017-02-18 16:18:07.53506|2017-02-18 16:18:07.53506
NCT00369031|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2008-04-14|||September 2006||2006-09-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Interventional|||Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63|A Phase I, Open Label, Parallel Group Trial To Evaluate Safety And Immunogenicity Of Three Nasal Immunisations Using A Fixed Dose-Level Of HIV gp140 V2 Loop Deleted Protein Adjuvanted With LTK63 Followed By Intramuscular Boosting With HIV gp140 V2 Loop Deleted Protein Adjuvanted With MF59 When Administered To Healthy Adults|Terminated||Phase 1|31|Actual|St George's, University of London||3||Safety issues|f||||f||||||||||2017-02-18 16:18:07.647208|2017-02-18 16:18:07.647208
NCT00369018|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2010-11-26|||August 2006||2006-08-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.|Methyl Aminolevulinate (MAL) and Hexaminolevulinate (HAL) Photodynamic Therapy (PDT)of Cervical Intraepithelial Lesions (SIL) - a Double-blind Dose-finding Study|Completed||Phase 1/Phase 2|96|Anticipated|Photocure||6|||f||||f||||||||||2017-02-18 16:18:07.766381|2017-02-18 16:18:07.766381
NCT00369005|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2006-08-28|||December 1992||1992-12-01|August 2006|2006-08-01|June 1999||1999-06-01|||||Interventional|||Liberal Versus Restrictive Transfusion Guidelines for Preterm Infants|Randomized Trial of Liberal Versus Restrictive Guidelines for Red Blood Cell Transfusion in Preterm Infants|Completed||N/A|100||University of Iowa|||||f||||||||||||||2017-02-18 16:18:07.878333|2017-02-18 16:18:07.878333
NCT00368992|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-08-11|2012-10-30||August 2006||2006-08-01|February 2013|2013-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer|A Phase II Trial of Combination Carboplatin, Paclitaxel, Cetuximab and Bevacizumab (NSC-704865) Followed By Cetuximab and Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|110|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:18:08.001712|2017-02-18 16:18:08.001712
NCT00368979|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2014-04-17|2008-12-05||February 2006||2006-02-01|February 2014|2014-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects|Clinical Evaluation of Dutasteride in Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparative Study of GI198745 (Dutasteride) in Subjects With Benign Prostatic Hyperplasia.|Completed||Phase 3|378|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:18:08.400612|2017-02-18 16:18:08.400612
NCT00368966|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2012-07-06|2010-03-26||October 2006||2006-10-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.|A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Spain|Completed||Phase 3|619|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 16:18:09.059186|2017-02-18 16:18:09.059186
NCT00368953|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2010-02-01|||September 2006||2006-09-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||YUKON Choice Versus TAXUS Liberté in Diabetes Mellitus|A Prospective, Randomized, Multicenter Comparison of the Drug-Eluting Stent Systems YUKON Choice and TAXUS Liberté in Patients With Diabetes Mellitus|Completed||Phase 4|240|Anticipated|University of Leipzig||2|||f||||||||||||||2017-02-18 16:18:11.700099|2017-02-18 16:18:11.700099
NCT00368940|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-25|2014-03-06|||April 2006||2006-04-01|March 2014|2014-03-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Interventional|||Problem Adaptation Therapy (PATH) vs. Supportive Therapy in Treating Depressed, Cognitively Impaired Older Adults|A Treatment for Depressed, Cognitively Impaired Elders|Unknown status|Active, not recruiting|N/A|120|Anticipated|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 16:18:11.801421|2017-02-18 16:18:11.801421
NCT00368927|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2014-05-07|2013-11-14||August 2006||2006-08-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional||Two randomized participants (one in each arm) did not initiate their assigned study intervention, leaving 61 participants evaluable for all analyses.|Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia|Randomized, Phase IIb Trial of Sulindac in Smokers With Bronchial Dysplasia|Completed||Phase 2|61|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:18:11.916764|2017-02-18 16:18:11.916764
NCT00368914|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2010-08-05|||December 2004||2004-12-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors|Pharmacodynamic-Guided Dose Finding Study of Rapamycin (Rapamune®, Sirolimus) in Adult Patients With Solid Tumors|Completed||Phase 1|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:18:12.514148|2017-02-18 16:18:12.514148
NCT00368901|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2010-03-04|||January 2002||2002-01-01|March 2010|2010-03-01|May 2004|Actual|2004-05-01|March 2004|Actual|2004-03-01||Interventional|||STAAR-2 Clinical Study|A Multicenter Study Using Once Every Other Week Subcutaneous Administration of Aranesp™ (Darbepoetin Alfa) and Iron Guided Algorithms to Treat Subjects With Anemia of Chronic Renal Insufficiency (CRI)|Completed||Phase 4|618|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:18:12.61147|2017-02-18 16:18:12.61147
NCT00368888|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2006-09-11|||March 2004||2004-03-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Clinical Study of New Urine Collection Bag for Infants.||Completed||N/A|||Bergaliden Barnavårdscentral|||||f||||||||||||||2017-02-18 16:18:12.71754|2017-02-18 16:18:12.71754
NCT00368875|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-10-06|2015-06-18||July 2006||2006-07-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer|Phase I/II Study of a Combination of Suberoylanilide Hydroxamic Acid (Vorinostat) Plus Paclitaxel and Bevacizumab in Patients With Advanced Metastatic and/or Local Chest Wall Recurrent Breast Cancer|Completed||Phase 1/Phase 2|54|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:18:12.795496|2017-02-18 16:18:12.795496
NCT00368862|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-28|2006-08-28|||December 2005||2005-12-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Interventional|||Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.|Phase Four Double-Blind Randomized Comparative Study on Thestudy on the Efficacy of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism|Completed||Phase 4|80||National Institute for Health and Welfare, Finland|||||f||||||||||||||2017-02-18 16:18:13.099452|2017-02-18 16:18:13.099452
NCT00368849|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2012-12-18|2011-05-09||November 2005||2005-11-01|December 2012|2012-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Atomoxetine and Huntington's Disease|Atomoxetine for Attention Deficits in Adults With Mild HD: A Randomized, Placebo-Controlled Crossover Study|Completed||Phase 2|20|Actual|University of Iowa|We cannot rule out carryover effects. Additionally, the sample size may be too low to detect small treatment changes, the treatment duration may have been too brief, and our participants had only early-stage HD which may have limited the drug effect.|2|||f||||t||||||||||2017-02-18 16:18:13.19383|2017-02-18 16:18:13.19383
NCT00368836|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2008-09-29|||March 2006||2006-03-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Breath Analysis Technique to Diagnose Pulmonary Embolism|Expired CO2/O2 Analysis to Diagnose Pulmonary Embolism|Completed||Phase 2/Phase 3|475|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||1|||f||||t||||||||||2017-02-18 16:18:16.270269|2017-02-18 16:18:16.270269
NCT00368823|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2006-08-24|||November 1999||1999-11-01|August 2006|2006-08-01|December 2003||2003-12-01|||||Interventional|||A Trial of Point of Care Information in Ambulatory Pediatrics|A Randomized Clinical Trial to Improve Prescribing Patterns in Ambulatory Pediatrics|Completed||Phase 3|44||University of Washington|||||f||||||||||||||2017-02-18 16:18:16.378574|2017-02-18 16:18:16.378574
NCT00368810|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2017-01-24|||February 21, 2006||2006-02-21|November 30, 2006|2006-11-30|November 30, 2006||2006-11-30|||||Observational|||Study of Factors Involved in Resistance to Severe Malaria|Response to Plasmodium Falciparum-Derived TLR Ligands in Severe and Uncomplicated Malaria in Mali|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:16.475836|2017-02-18 16:18:16.475836
NCT00368797|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2008-11-14|||March 2002||2002-03-01|November 2008|2008-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|TALISMAN 201||Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.|Completed||Phase 2|125|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:18:16.555823|2017-02-18 16:18:16.555823
NCT00368784|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-04-20|||January 2007||2007-01-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||T Cell Repertoire Analysis of Immune Mediated Skin Diseases|T Cell Repertoire Analysis of Immune Mediated Skin Diseases|Recruiting||Phase 3|50|Anticipated|University of California, Davis|||2||f||||f||||||Samples With DNA|"~     Fifteen tablespoons of blood will be collected prior to the initiation of a treatment and~     again after the patient shows a clinical response to a treatment. The time between blood~     draws will be no less than 3 months. There will be no more than two blood draws per patient.~      Blood samples will be used to determine the patient's HLA haplotype via PCR and DNA~     sequencing. After the patient's haplotype has been established the activated T cell~     repertoire will be analyzed for clonal expansions. Clonal expansions in the T cell~     repertoire will be determined by immunoscope analysis, which is a PCR based technique.~   "|||2017-02-18 16:18:16.65731|2017-02-18 16:18:16.65731
NCT00368771|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2016-11-23|||July 2002||2002-07-01|November 2016|2016-11-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||A Six-month Study to Compare Outcome Differences and Visceral Response ... Irritable Bowel Syndrome|A Six-Month Study to Compare Outcome Differences and Visceral Response in Subjects Randomized to a Psychological Intervention for Irritable Bowel Syndrome|Completed||N/A|163|Actual|University of California, Los Angeles||3|||f||||||||||||||2017-02-18 16:18:16.764523|2017-02-18 16:18:16.764523
NCT00368758|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2006-08-24|||August 2006||2006-08-01|August 2006|2006-08-01|September 2007||2007-09-01|||||Interventional|||The Effect of Probioticson Bloating in IBS|The Effect of Probioticson Bloating in IBS|Unknown status|Recruiting|N/A|20||Royal Veterinary and Agricultural University, Denmark|||||f||||||||||||||2017-02-18 16:18:16.87389|2017-02-18 16:18:16.87389
NCT00368745|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2009-11-09|2009-08-10||September 2006||2006-09-01|November 2009|2009-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|GAD||Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Pregabalin in Subjects With Generalized Anxiety Disorder (GAD) Switching From Benzodiazepine Therapy.|Completed||Phase 3|108|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:18:16.981825|2017-02-18 16:18:16.981825
NCT00368732|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2016-07-28|||July 2006||2006-07-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Observational|||Genetic and Nutritional Causes of Heart Birth Defects|Gene and Nutrient Etiologies of Human Heart Defects|Completed||N/A|1610|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||Samples With DNA|"~     Buccal cell collection~   "|||2017-02-18 16:18:18.098721|2017-02-18 16:18:18.098721
NCT00368719|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-04-06|||September 2007||2007-09-01|April 2015|2015-04-01|July 2016||2016-07-01|||||Interventional|||Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis|APPLES: A Prospective Pediatric Longitudinal Evaluation To Assess The Long Term Safety Of Tacrolimus Ointment For The Treatment Of Atopic Dermatitis|Withdrawn||Phase 4|0|Actual|University of California, Davis||1||withdrawn due to contractual issues|f||||f||||||||||2017-02-18 16:18:18.189099|2017-02-18 16:18:18.189099
NCT00368706|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2008-04-09|||September 2006||2006-09-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients|A Randomized, Double-Blind, Paralleled, Active Controlled, Multi-Center Study of the Efficacy and Safety of 5mg Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder|Completed||Phase 3|246|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:18:18.302624|2017-02-18 16:18:18.302624
NCT00368693|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-04-06|||August 2005||2005-08-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers|Pivotal Study to Evaluate the Efficacy and Safety of Dermal - Living Skin Replacement (Dermal - LSR) in the Treatment of Chronic Diabetic Foot Ulcers|Terminated||Phase 3|20|Actual|University of California, Davis||1||Study terminated due to low enrollment.|f||||f||||||||||2017-02-18 16:18:18.41495|2017-02-18 16:18:18.41495
NCT00368680|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2010-12-23|||January 2007||2007-01-01|April 2007|2007-04-01|September 2009||2009-09-01|April 2008||2008-04-01||Interventional|||Early CPAP in Respiratory Distress Syndrome|Early Bubble CPAP (EBCPAP) in Very Low Birth Weight Infants (VLBWI)|Unknown status|Recruiting|Phase 4|256|Anticipated|Pontificia Universidad Catolica de Chile|||||f||||||||||||||2017-02-18 16:18:18.507011|2017-02-18 16:18:18.507011
NCT00368667|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2010-01-12|||April 2000||2000-04-01|January 2010|2010-01-01|December 2004||2004-12-01|||||Observational|||Energy Homeostasis in Anorexia Nervosa|Energy Homeostasis in Anorexia Nervosa|Completed||N/A|120||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:18:18.877081|2017-02-18 16:18:18.877081
NCT00368654|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2012-11-20|||January 2007||2007-01-01|November 2012|2012-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy|An Open-Label Study to Evaluate Whether a Short-Term Course of Methotrexate in Psoriasis Patients Treated With Efalizumab is Safe and Increases Efficacy|Completed||Phase 1/Phase 2|12|Actual|University of California, Davis||4|||f||||f||||||||||2017-02-18 16:18:18.959212|2017-02-18 16:18:18.959212
NCT00368641|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2009-04-30|2009-04-30||August 2006||2006-08-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Heart Failure and Peritoneal Ultrafiltration|Treatment-Resistant Heart Failure (HF) and Peritoneal Ultrafiltration (PUF): A Randomized Prospective Trial of Standard Care Versus Standard Care With Peritoneal Ultrafiltration in Patients With Treatment-Resistant Severe Heart Failure|Terminated||Phase 2|12|Actual|Baxter Healthcare Corporation|The number of subjects enrolled & duration of therapy were insufficient to complete the planned efficacy analyses & to draw any conclusion regarding all-cause hospitalization rates in both intervention and standard therapy arms.|2||Enrollment|f||||f||||||||||2017-02-18 16:18:19.091331|2017-02-18 16:18:19.091331
NCT00368628|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2009-03-02|||November 2004||2004-11-01|March 2009|2009-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Continuous Positive Airway Pressure for the Treatment of Stroke|Continuous Positive Airway Pressure for the Treatment of Acute Ischemic Stroke: A Feasibility Pilot Study|Completed||Phase 2|55|Actual|Yale University||1|||f||||||||||||||2017-02-18 16:18:19.65608|2017-02-18 16:18:19.65608
NCT00368212|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2013-03-15|||May 2005||2005-05-01|March 2013|2013-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Integrated Treatment Program for Hypochondriasis in Primary Care Settings|Treating Refractory Symptoms in Primary Care (Hypochondriasis: Diagnosis, Description and Medical Care)|Completed||Phase 3|91|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 16:18:27.339787|2017-02-18 16:18:27.339787
NCT00368615|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-04-20|||August 2007||2007-08-01|April 2015|2015-04-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Observational|Melanoma||Characterization of the Melanoma-Specific Immune Response|Characterization of the Melanoma-Specific Immune Response|Recruiting||Phase 4|20|Anticipated|University of California, Davis|||2||f||||f||||||Samples With DNA|"~     Peripheral blood will be collected prior to initiation of chemotherapy. There will be no~     more than two blood draws per subject. Most subjects will receive a single blood draw;~     however, some may be asked to return for an additional blood draw if investigators were~     unable to isolate melanoma-specific immune cells after the first blood draw. Two separate~     blood draws will be the maximum.~   "|||2017-02-18 16:18:19.759329|2017-02-18 16:18:19.759329
NCT00368602|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-24|2015-04-06|||June 2005||2005-06-01|April 2015|2015-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Beta Blocker for Chronic Wound Healing|Beta Adrenergic Receptor Modulation of Burn Wound Healing|Terminated||Phase 2|40|Actual|University of California, Davis||2||Lack of funding.|f||||f||||||||||2017-02-18 16:18:19.87783|2017-02-18 16:18:19.87783
NCT00368589|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2015-04-15|||July 2006||2006-07-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging|A 12 Week, Randomised, Double Blind Study Evaluating the Effects of Low Dose (10mg) and High Dose (80mg) Atorvastatin on Macrophage Activity and Carotid Plaque Inflammation as Determined by Ultra Small Super-Paramagnetic Iron Oxide (USPIO) Enhanced Carotid Magnetic Resonance Imaging (MRI)|Completed||N/A|47|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 16:18:19.992809|2017-02-18 16:18:19.992809
NCT00368576|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2016-12-02|||August 2006||2006-08-01|December 2016|2016-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study To Determine The Effect Of SB-480848 On Asthma|A Randomised, Double-blind, Placebo-controlled, Parallel Group, Repeat Dose Study to Assess the Effect of SB-480848 on Overall Asthma Control in Adult Subjects With Persistent Asthma Controlled on Stable, Low-dose, Inhaled Corticosteroids|Completed||Phase 1|67|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:18:20.094885|2017-02-18 16:18:20.094885
NCT00368563|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2009-02-10|||August 2006||2006-08-01|February 2009|2009-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Capacitance and Transepidermal Water Loss Test to Determine the Ability of Sunscreen to Moisturize Skin||Completed||Phase 2/Phase 3|||Loreal USA|||||||||||||||||||2017-02-18 16:18:20.206502|2017-02-18 16:18:20.206502
NCT00368550|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2011-06-17|2010-06-04||February 2004||2004-02-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Sertraline Pharmacotherapy for Alcoholism Subtypes|Sertraline Pharmacotherapy for Alcoholism Subtypes|Completed||Phase 4|134|Actual|UConn Health||2|||f||||t||||||||||2017-02-18 16:18:20.283035|2017-02-18 16:18:20.283035
NCT00368537|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2012-08-08|2009-09-30||September 2006||2006-09-01|August 2012|2012-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections|A Multicenter, Randomized, Open-Label Comparison of the Safety And Efficacy of Tigecycline With That of Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Complicated Skin And Skin Structure Infections|Completed||Phase 4|550|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 16:18:20.733487|2017-02-18 16:18:20.733487
NCT00368524|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2006-08-23|||November 2001||2001-11-01|August 2006|2006-08-01|November 2005||2005-11-01|||||Interventional|||Cost Effective Treatment for Dually Diagnosed Homeless|Cost Effective Treatment for Dually Diagnosed Homeless|Completed||N/A|160||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 16:18:21.578139|2017-02-18 16:18:21.578139
NCT00368511|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2008-05-05|||August 2006||2006-08-01|May 2008|2008-05-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Fall Prevention Strategies Including Music and Posturography|The Nolwenn Effect in Geriatric Nursing Homes in the Netherlands|Completed||Early Phase 1|50|Actual|Carrick Institute for Graduate Studies||1|||f||||t||||||||||2017-02-18 16:18:21.664247|2017-02-18 16:18:21.664247
NCT00368498|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2006-08-23|||June 2006||2006-06-01|August 2006|2006-08-01|December 2007||2007-12-01|||||Interventional|||A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely|A Randomized Single Blind Parallel Control Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely|Unknown status|Recruiting|Phase 4|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:18:21.776672|2017-02-18 16:18:21.776672
NCT00368485|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2011-09-19|||August 2006||2006-08-01|September 2011|2011-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Neural Control of Non-invasive Ventilation in the Preterm|Neural Control of Non-invasive Ventilation in the Preterm|Completed||Phase 1|24|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-02-18 16:18:21.871662|2017-02-18 16:18:21.871662
NCT00368472|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2015-11-05|2015-06-26||October 2006||2006-10-01|November 2015|2015-11-01|July 2014|Actual|2014-07-01|June 2014|Actual|2014-06-01||Interventional||Analysis of baseline characteristics are based on the Full Intent to Treat (ITT) Analysis Set, defined as participants who received at least 1 dose of open-label perampanel and had valid seizure data during the OLE study.|4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures|An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 (Perampanel) as an Adjunctive Therapy in Patients With Refractory Partial Seizures|Completed||Phase 2|138|Actual|Eisai Inc.||1|||f||||f||||||||||2017-02-18 16:18:21.97865|2017-02-18 16:18:21.97865
NCT00368459|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2015-03-20|2015-03-01||August 2006||2006-08-01|March 2015|2015-03-01|January 2012|Actual|2012-01-01|March 2011|Actual|2011-03-01||Interventional||Postmenopausal women with Alzheimer's disease of mild to moderate severity|Raloxifene for Women With Alzheimer's Disease|Raloxifene in Women With AD: Randomized Controlled Trial|Completed||Phase 2|42|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 16:18:22.343743|2017-02-18 16:18:22.343743
NCT00368446|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2017-01-24|||July 28, 2006||2006-07-28|May 19, 2016|2016-05-19||||||||Observational|||Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease|Genetic Disorders of Mucociliary Clearance|Completed||N/A|87|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:23.202108|2017-02-18 16:18:23.202108
NCT00368433|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2017-01-24|||August 21, 2006||2006-08-21|May 24, 2011|2011-05-24|May 24, 2011||2011-05-24|||||Observational|||Hypersensitivity in Tourette Syndrome|Hypersensitivity in Tourette Syndrome: An Evaluation of Perceived Intensity Versus Threshold|Completed||N/A|46|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:23.297977|2017-02-18 16:18:23.297977
NCT00368420|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2011-02-11|||September 2006||2006-09-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|July 2008|Actual|2008-07-01||Observational|||Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer|Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer|Completed||N/A|122|Actual|AGO Study Group|||1||f||||f||||||||||2017-02-18 16:18:23.382762|2017-02-18 16:18:23.382762
NCT00368407|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2006-08-23|||April 2005||2005-04-01|April 2005|2005-04-01|July 2006||2006-07-01|||||Observational|||Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck|Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck|Completed||N/A|||Fourth Military Medical University|||||f||||||||||||||2017-02-18 16:18:23.487103|2017-02-18 16:18:23.487103
NCT00368394|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2006-08-23|||January 2004||2004-01-01|August 2006|2006-08-01||||||||Interventional|||Dose-Exposure-Response in Type 1 Diabetes Mellitus|Dose-Exposure-Response Relationship of Insulin Glulisine (HMR1964) in Subjects With Type 1 Diabetes Mellitus Assessed With the Euglycemic Clamp Technique Using the Biostator (TM)|Completed||Phase 1|18||Sanofi|||||f||||||||||||||2017-02-18 16:18:23.577633|2017-02-18 16:18:23.577633
NCT00368381|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2012-02-10|||September 2006||2006-09-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis|A Blinded, Placebo Controlled Trial of Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis|Withdrawn||Phase 4|0|Actual|CAMC Health System||1||Study closed for PI failure to submit renewal paperwork|f||||f||||||||||2017-02-18 16:18:23.676762|2017-02-18 16:18:23.676762
NCT00368368|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2016-11-01|||January 2006||2006-01-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.|An Open-label Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics/Pharmacodynamics and Safety of GK Activator (2) Following a Single Oral Dose Administration in Patients With Type 2 Diabetes.|Completed||Phase 1|5|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 16:18:23.787483|2017-02-18 16:18:23.787483
NCT00368355|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-12-21|||April 2000||2000-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|MOHEL||T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts|CD-34 Selection for Ex-vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts Receiving Intensive Conditioning|Recruiting||Phase 2|87|Anticipated|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 16:18:23.89143|2017-02-18 16:18:23.89143
NCT00368342|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2009-02-17||||||January 2006|2006-01-01||||||||Interventional|||Chronic Bronchiolitis or Resistant Asthma?||Completed||Phase 4|||Baqiyatallah Medical Sciences University|||||f||||||||||||||2017-02-18 16:18:24.029696|2017-02-18 16:18:24.029696
NCT00368329|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2012-07-13|||June 2006||2006-06-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer|Phase I Study of Dose Escalation Using Image-guided Radiotherapy to Deliver a Stereotactic Radiosurgical Boost After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer|Terminated||Phase 1|4|Actual|Stanford University||1||low accrual|f||||t||||||||||2017-02-18 16:18:24.101468|2017-02-18 16:18:24.101468
NCT00368316|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2012-06-21|2012-05-09||January 2003||2003-01-01|June 2012|2012-06-01|February 2009|Actual|2009-02-01|January 2008|Actual|2008-01-01||Interventional|||Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel|Phase 3 Study (Safety, Immunogenicity and Efficacy) of Improved Shigella Conjugate Vaccines in 1-4 Year Olds in Israel|Completed||Phase 3|2799|Actual|National Institutes of Health Clinical Center (CC)|No efficacy could be assessed after 2nd injection of S. sonnei conjugate due to the small number of positive isolates at that time. There were too few cases of S. flexneri 2a infection for evaluation of vaccine B efficacy.|2|||f||||t||||||||||2017-02-18 16:18:24.206344|2017-02-18 16:18:24.206344
NCT00368303|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2012-05-31|||December 2006||2006-12-01|March 2011|2011-03-01||||||||Interventional|||A Local Register Study For Major Depression Of Paroxetine Controlled Release|A Multicentre, Double-blind, Active Controlled Trial to Evaluate the Clinical Effects of Immediate Release Paroxetine and Controlled Release Paroxetine in the Treatment of Major Depression|Completed||Phase 3|362||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:18:24.842936|2017-02-18 16:18:24.842936
NCT00368290|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2013-12-12|2013-12-12||September 2006||2006-09-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|MOD6||Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior|Modafinil Treatment for Cocaine Dependence and HIV-High Risk Behavior|Completed||Phase 2|94|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 16:18:24.97292|2017-02-18 16:18:24.97292
NCT00368277|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2011-02-28|2010-12-14||September 2006||2006-09-01|February 2011|2011-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly|A 36 Week Randomized, Double-blind, Parallel Group, Multi-center, Active-controlled, Optional Titration Study Comparing an Aliskiren-based Regimen to a Ramipril-based Regimen in Patients ≥ 65 Years Old With Systolic Essential Hypertension|Completed||Phase 3|901|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:18:25.362758|2017-02-18 16:18:25.362758
NCT00368264|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2009-10-02|||September 2006||2006-09-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )|A Double Blind, Randomized, Placebo Controlled, Multi-Center Trial of Anti-TNF-alpha Chimeric Monoclonal Antibody (Infliximab) and Azathioprine in Patients Suffering From Systemic Lupus Erythematosus (SLE) With WHO Class V Glomerulonephritis|Terminated||Phase 2/Phase 3|1|Actual|Medical University of Vienna||2||"Failure to recruit patients with membranous lupus nephritis not previously treated with~   azathioprine ."|f||||||||||||||2017-02-18 16:18:25.956974|2017-02-18 16:18:25.956974
NCT00368251|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2016-07-04|2016-03-14||November 2006||2006-11-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||The Baseline Analysis Population contains all randomized subjects who are identical with the Intent-To-Treat (ITT) population.|Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment for 12 Weeks in Adolescent and Adult Patients (≥ 16 Years) With Genetically Ascertained Unverricht-Lundborg Disease|Completed||Phase 3|56|Actual|UCB Pharma||3|||f||||f||||||||||2017-02-18 16:18:26.093444|2017-02-18 16:18:26.093444
NCT00368199|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2009-01-12|||September 2006||2006-09-01|January 2009|2009-01-01|September 2010|Anticipated|2010-09-01|||||Observational|||Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes|Diagnostic Value Transcranial Duplex Scanning and Single Photon Emission Tomography in Patients Suspected of Having Idiopathic Parkinson Disease or Atypical Parkinson Syndromes|Unknown status|Active, not recruiting|Early Phase 1|250|Anticipated|Maastricht University Medical Center|||1||f||||t||||||None Retained|"~     no biocpsicmens~   "|||2017-02-18 16:18:27.45046|2017-02-18 16:18:27.45046
NCT00368186|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2006-08-23|||May 2001||2001-05-01|August 2006|2006-08-01|November 2002||2002-11-01|||||Interventional|||Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants.|An Open, Multicenter Clinical Trial to Investigate the Immunogenicity and Safety of the Pneumococcal 7-Valent Conjugate Vaccine (PREVENAR) in Sickle Cell Disease Infants.|Terminated||Phase 4|51||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:18:27.546377|2017-02-18 16:18:27.546377
NCT00368173|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2012-09-11||||||September 2012|2012-09-01||||||||Interventional|||IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome||Completed||Phase 2/Phase 3|||Insmed Incorporated|||||||||||||||||||2017-02-18 16:18:27.630097|2017-02-18 16:18:27.630097
NCT00368160|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2012-02-21|||March 2004||2004-03-01|February 2012|2012-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers|The Effects of a Single Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability and Psychomotor/Memory Function in Healthy Volunteers Compared to Placebo|Completed||Phase 1|32|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 16:18:27.71452|2017-02-18 16:18:27.71452
NCT00368147|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2009-02-19|||April 2002||2002-04-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|||||Observational|||Access Creation for Hemodialysis: Association With Structural Changes of the Heart|Access Creation for Hemodialysis: Potential Contribution to Left Ventricular Remodelling|Completed||N/A|84|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 16:18:27.813408|2017-02-18 16:18:27.813408
NCT00368134|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2007-06-27|||August 2006||2006-08-01|June 2007|2007-06-01||||||||Interventional|||To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Compare the Effects of 12 Weeks Treatment With Vildagliptin 50 mg Bid to Voglibose 0.2 mg Tid in Patients With Type 2 Diabetes|Completed||Phase 3|370||Novartis|||||f||||||||||||||2017-02-18 16:18:27.894821|2017-02-18 16:18:27.894821
NCT00368121|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2012-07-12|||August 2006||2006-08-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|EMMA-1||EMMA-1 (Erbitux for Multiple Myeloma)|Phase II Study of Cetuximab for the Refractory or Relapsed Multiple Myeloma EMMA-1(Erbitux for Multiple Myeloma)|Terminated||Phase 2|13|Actual|University of Cologne||1||Lack of recruitable patients|f||||f||||||||||2017-02-18 16:18:27.982966|2017-02-18 16:18:27.982966
NCT00368108|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2013-05-13|2012-10-23||August 2006||2006-08-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|Completed||Phase 3|752|Actual|Eisai Inc.||3|||f||||||||||||||2017-02-18 16:18:28.093006|2017-02-18 16:18:28.093006
NCT00368095|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2008-08-02|||August 2006||2006-08-01|August 2008|2008-08-01|August 2016|Anticipated|2016-08-01|||||Observational|||Rajavithi Health Promotion Project (Population Base Cohort)|The Rajavithi Prospective Cohort Study on Community's Member Health (HPH-Cohort Study)|Unknown status|Recruiting|Phase 4|2000|Anticipated|Rajavithi Hospital|||1||f||||||||||Samples With DNA|"~     Human Genetic Bank will be storaged in Biomolecular center Rajavithi Hospital for determine~     the gene that influence the specific disease in the population~   "|||2017-02-18 16:18:29.169672|2017-02-18 16:18:29.169672
NCT00368082|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2016-09-16|||April 2006||2006-04-01|September 2016|2016-09-01|July 2031|Anticipated|2031-07-01|August 2017|Anticipated|2017-08-01||Interventional|TGF-beta||Autologous/Allogeneic TGFbeta-resistant LMP2A-specific CTL, Lymphoma (TGF-beta)|Administration of TGF-b Resistant LMP2A-Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma|Active, not recruiting||Phase 1|20|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 16:18:29.26911|2017-02-18 16:18:29.26911
NCT00368069|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2015-08-13|2009-04-01||August 2006||2006-08-01|August 2015|2015-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR|A Double-blind, Placebo-controlled, Randomized Efficacy and Safety Study of Keppra® Extended Release Formulation - XR Once Daily as add-on Therapy in Subjects From 12 to 70 Years With Refractory Epilepsy Suffering From Partial Onset Seizures.|Completed||Phase 3|158|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 16:18:29.383445|2017-02-18 16:18:29.383445
NCT00368056|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2012-02-21|||April 2005||2005-04-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability|Effects of a Single Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability and Psychomotor/Memory Function in Patients With Primary Insomnia Compared to Placebo|Completed||Phase 3|32|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 16:18:30.013147|2017-02-18 16:18:30.013147
NCT00368043|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2017-01-24|||August 18, 2006||2006-08-18|March 30, 2015|2015-03-30|March 30, 2015||2015-03-30|||||Observational|||Endocrine and Psychological Evaluation of Adopted Children|Biobehavioral Study of Recently Adopted Children|Terminated||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:30.122908|2017-02-18 16:18:30.122908
NCT00368030|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2012-02-21|||January 2004||2004-01-01|February 2012|2012-02-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder|Depression Response to Eszopiclone in Adults With Major Depressive Disorder (DREAMDD): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 8-Week, Safety & Efficacy Study of Eszopiclone 3 mg Compared to Placebo in Subjects With Insomnia Related to MDD Acronym: DREAMDD|Completed||Phase 3|545|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 16:18:30.210813|2017-02-18 16:18:30.210813
NCT00368017|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2010-11-01|||April 2006||2006-04-01|November 2010|2010-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease|Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease|Terminated||Phase 2|12|Actual|Vanderbilt University||2||unable to replace Fellow conducting the study who left institution in 2007|f||||f||||||||||2017-02-18 16:18:30.392765|2017-02-18 16:18:30.392765
NCT00367991|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2011-09-14|2011-08-09||November 2006||2006-11-01|September 2011|2011-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction|Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction|Completed||Phase 2|44|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:18:30.591148|2017-02-18 16:18:30.591148
NCT00367978|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2011-11-07|||December 2001||2001-12-01|August 2006|2006-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus|A Randomized, Multicenter, Study to Determine the Efficacy and Safety of Amlodipine/Benazepril Hydrochloride Versus Enalapril in the Treatment of Hypertension in an African-American Population With Type 2 Diabetes|Completed||Phase 4|275|Actual|Novartis|||||||||||||||||||2017-02-18 16:18:30.97425|2017-02-18 16:18:30.97425
NCT00367965|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-23|2012-02-21|||February 2004||2004-02-01|February 2012|2012-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis|The Effect of Eszopiclone 3 mg Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis|Completed||Phase 3|153|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 16:18:31.066655|2017-02-18 16:18:31.066655
NCT00367952|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2011-06-22|||August 2006||2006-08-01|June 2011|2011-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Long Term, Safety Study of Apricitabine in HIV-infected Subjects|An Open Label Long Term Safety Extension Study of Apricitabine in Treatment-experienced HIV-1 Infected Subjects|Completed||Phase 2|42|Actual|Avexa||1|||f||||t||||||||||2017-02-18 16:18:31.218577|2017-02-18 16:18:31.218577
NCT00367939|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2011-11-07|||December 2005||2005-12-01|November 2011|2011-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine|An Multicenter Study to Evaluate the Efficacy and Safety of a 5 Week Therapy With the Combination of Valsartan 160 mg Plus Amlodipine 10 mg in Hypertensive Patients Not Adequately Responding to a 5 Week Therapy With Ramipril 5 mg and Felodipine 5 mg|Completed||Phase 3|132|Actual|Novartis|||||f||||||||||||||2017-02-18 16:18:31.31879|2017-02-18 16:18:31.31879
NCT00367926|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2006-08-22|||June 2005||2005-06-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||The Effect of American Ginseng Root and Its Components on Glycemia in Healthy Individuals|Effect of American Ginseng Root and Derived Polysaccharides on Postprandial Glycemia in Healthy Individuals|Completed||Phase 3|12||Risk Factor Modification Centre|||||f||||||||||||||2017-02-18 16:18:31.404163|2017-02-18 16:18:31.404163
NCT00367913|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2006-08-21|||March 1995||1995-03-01|July 2006|2006-07-01|September 2004||2004-09-01|||||Interventional|||Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease|Treatment of Pulmonary Disease Caused by MAIS, M.Xenopi or M.Malmoense: A Comparison of Two Triple Drug Regimens and an Assessment of the Value of Immunotherapy With M.Vaccae|Completed||Phase 4|400||British Thoracic Society|||||f||||||||||||||2017-02-18 16:18:31.488485|2017-02-18 16:18:31.488485
NCT00367900|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2017-01-24|||February 7, 2006||2006-02-07|August 23, 2016|2016-08-23||||||||Observational|||Parkinson's Genes and Environment Study|The Parkinson's, Genes and Environment (PAGE) Study|Completed||N/A|9000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:31.582891|2017-02-18 16:18:31.582891
NCT00367887|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2013-02-07||2013-02-07|October 2006||2006-10-01|February 2013|2013-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects|A Phase 2, Randomized, Open-Label Study Of The Safety, Antiviral Activity, And Pharmacokinetics Of HCV-796 Administered In Combination With Peginterferon Alfa 2B (Peg-Intron) Plus Ribavirin (Rebetol) Versus Peg-Intron Plus Rebetol In Subjects With Hepatitis C Virus Genotype 1 Infection|Completed||Phase 2|246|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 16:18:31.68643|2017-02-18 16:18:31.68643
NCT00367874|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2006-08-22|||February 2003||2003-02-01|August 2006|2006-08-01|November 2003||2003-11-01|||||Interventional|||Treatment of Polydrug-Using Opiate Dependents During Withdrawal|Treatment of Polydrug-Using Opiate Dependents During Withdrawal|Completed||Phase 4|12||Sorlandet Hospital HF|||||f||||||||||||||2017-02-18 16:18:31.856146|2017-02-18 16:18:31.856146
NCT00367861|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2014-02-21|||May 2002||2002-05-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|April 2012|Actual|2012-04-01||Interventional|||Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance|A Prospective Multicentric Randomized Study of Glivec® in Patients With Advanced Gastrointestinal Stromal Tumors Expressing C-kit Comparing Treatment Interruption After 5 Years vs Treatment Maintenance|Completed||Phase 3|564|Actual|Centre Leon Berard||1|||f||||t||||||||||2017-02-18 16:18:31.958614|2017-02-18 16:18:31.958614
NCT00366873|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2009-03-04|||September 2006||2006-09-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of Mineral Absorption in Infants Fed Infant Formula|Evaluation of Mineral Absorption in Infants Fed Infant Formula|Completed||N/A|44|Anticipated|Mead Johnson Nutrition||2|||f||||f||||||||||2017-02-18 16:18:32.325148|2017-02-18 16:18:32.325148
NCT00366860|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2014-12-01|||January 2004||2004-01-01|December 2014|2014-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Soy Bread on Markers of Bone Metabolism and Cardiovascular Disease|Effect of Soy Bread on Markers of Bone Metabolism and Cardiovascular Disease|Completed||Phase 1|18|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 16:18:32.443153|2017-02-18 16:18:32.443153
NCT00366847|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2014-05-07|||June 2001||2001-06-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Computer Modeling of Congenital Heart Disease|Computer Modeling of Congenital Heart Disease|Completed||N/A|50|Anticipated|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 16:18:32.55126|2017-02-18 16:18:32.55126
NCT00366834|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-09-06|||July 2006||2006-07-01|June 2012|2012-06-01|October 2009|Actual|2009-10-01|October 2007|Actual|2007-10-01||Interventional|||Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting|A Phase III, Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group Study of the Safety and Efficacy of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonist Casopitant (GW679769) in Combination With Ondansetron and Dexamethasone for the Prevention of Nausea|Completed||Phase 3|1840|Actual|GlaxoSmithKline||4|||f||||f||||||||||2017-02-18 16:18:32.653344|2017-02-18 16:18:32.653344
NCT00366821|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2014-11-26|||January 2002||2002-01-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Retrospective Review of the Outcomes of Newborns With Genetic Abnormalities|Retrospective Review of the Outcomes of Newborns With Genetic Abnormalities|Completed||N/A|1000|Actual|Children's Healthcare of Atlanta|||2||f||||f||||||||||2017-02-18 16:18:33.063474|2017-02-18 16:18:33.063474
NCT00366808|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-10-01|||February 2006||2006-02-01|July 2006|2006-07-01|August 2007|Actual|2007-08-01|||||Interventional|||Mechanical vs. Alcohol Separation of the Corneal Epithelium During Surface Ablation Refractive Procedures|Mechanical vs. Alcohol Separation of the Corneal Epithelium During Surface Ablation Refractive Procedures|Completed||Phase 4|10|Anticipated|Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:18:33.158489|2017-02-18 16:18:33.158489
NCT00366795|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2016-04-18||2016-04-18|August 2006||2006-08-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|SPARe-2||Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver|Satavaptan in the Prevention of Ascites Recurrence: a Double-blind, Randomised, Parallel-group Comparison of Satavaptan at 5 to 10 mg Daily Versus Placebo in the Absence of Diuretics in Patients With Recurrent Ascites Due to Cirrhosis of the Liver.|Terminated||Phase 3|241|Actual|Sanofi||2||Study was terminated due to safety reason.|f||||||||||||||2017-02-18 16:18:33.243783|2017-02-18 16:18:33.243783
NCT00366782|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-02-29|||March 2007||2007-03-01|February 2012|2012-02-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults|A Phase 1 Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Chimeric Bovine/Human Parainfluenza Type 3 Virus Vaccine, rB/HPIV3, Lot PIV3 #101A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV3-Seropositive Children 15 to 59 Months of Age, and HPIV3-Seronegative Infants and Children 6 to 36 Months of Age|Completed||Phase 1|51|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||t||||||||||2017-02-18 16:18:33.376093|2017-02-18 16:18:33.376093
NCT00366769|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2006-08-17|||September 2005||2005-09-01|March 2006|2006-03-01|February 2006||2006-02-01|||||Interventional|||Evaluation of Outcomes Following LASIK Surgery Using CustomVue|Evaluation of Visual Outcomes, Contrast Sensitivity, Glare, and Induction of High Order Aberrations Following LASIK Surgery Using CustomVue|Completed||N/A|30||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:18:33.498171|2017-02-18 16:18:33.498171
NCT00366756|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2011-08-04|||July 2006||2006-07-01|December 2010|2010-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Evaluation of VisionQuest 20/20, a Visual Acuity Testing Software|Evaluation of a Visual Acuity Testing Software for Children, VisionQuest 20/20|Completed||Phase 3|97|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 16:18:33.576824|2017-02-18 16:18:33.576824
NCT00366743|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2006-08-17|||May 2003||2003-05-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Evaluation of Visual Outcomes After Myopic LASIK|Analysis of Visual Outcomes, Contrast Sensitivity, Glare, Induction of High Order Aberrations and Wavefront Technology, Following LASIK Surgery|Completed||N/A|120||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:18:33.667479|2017-02-18 16:18:33.667479
NCT00366730|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2006-08-18|||February 2004||2004-02-01|August 2006|2006-08-01|November 2005||2005-11-01|||||Interventional|||Study of Nitazoxanide in the Treatment of Amebiasis in Children|Multi-Center, Double-Blind, Placebo-Controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Entamoeba Histolytica in Children|Completed||Phase 3|50||Romark Laboratories L.C.|||||f||||||||||||||2017-02-18 16:18:33.75492|2017-02-18 16:18:33.75492
NCT00366717|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2006-08-18|||June 2005||2005-06-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy||Completed||N/A|20||Mackay Memorial Hospital|||||f||||||||||||||2017-02-18 16:18:33.843465|2017-02-18 16:18:33.843465
NCT00366704|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2013-02-07||2013-02-07|November 2006||2006-11-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint|A Multicenter, Randomized, Double-blind, Parallel-group Fixed-dose Study of the Effect on Weight of Bifeprunox Versus Risperidone in the Treatment of Outpatients With Schizophrenia.|Terminated||Phase 3|400|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 16:18:33.919347|2017-02-18 16:18:33.919347
NCT00366691|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-10-01|||February 2006||2006-02-01|June 2006|2006-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation|Comparison of Acular LS With Lotemax to Prevent Anterior Segment Inflammation After Phacoemulsification and Intraocular Lens Implantation|Completed||Phase 4|40|Anticipated|Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:18:34.078168|2017-02-18 16:18:34.078168
NCT00366678|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-07-06|2010-03-26||October 2006||2006-10-01|July 2012|2012-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants|A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in France.|Completed||Phase 3|613|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 16:18:34.217946|2017-02-18 16:18:34.217946
NCT00366665|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2006-08-17|||March 2005||2005-03-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems|Comparison of the Infiniti Vision and the Series 20000 Legacy Systems|Completed||N/A|30||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:18:39.826396|2017-02-18 16:18:39.826396
NCT00366652|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-05-25|||September 2006||2006-09-01|May 2007|2007-05-01|September 2006||2006-09-01|||||Interventional|||Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects|A Randomized, Open-Label, Crossover, Drug Interaction Study to Evaluate the Effects of DVS SR And Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects|Completed||Phase 3|20|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:18:39.894084|2017-02-18 16:18:39.894084
NCT00366639|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2009-10-29|||October 2001||2001-10-01|October 2009|2009-10-01|February 2006|Actual|2006-02-01|||||Observational|||Registry for Acute Decompensated Heart Failure Patients|ADHERE Core III - Acute Decompensated Heart Failure Registry|Completed||N/A|24118|Actual|Scios, Inc.|||1||f||||||||||||||2017-02-18 16:18:40.216825|2017-02-18 16:18:40.216825
NCT00366626|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2016-09-01|2012-04-19||April 2006||2006-04-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability.|Alcohol Research Center Grant. Component #1: Naltrexone Effects on Alcohol Reactivity and Consumption, Evaluating the Genetic Variability of Naltrexone Response|Completed||Phase 4|83|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 16:18:40.317168|2017-02-18 16:18:40.317168
NCT00366613|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-10-02|||July 2005||2005-07-01|August 2007|2007-08-01||||||||Interventional|||Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation|Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation|Withdrawn||Phase 4|20|Anticipated|Medical University of South Carolina||||We wish to wait until there is more data available using this substance.|f||||||||||||||2017-02-18 16:18:40.737498|2017-02-18 16:18:40.737498
NCT00365898|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2006-08-16|||July 2005||2005-07-01|August 2006|2006-08-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain|A Study of the Efficacy and Safety of 8 Mg Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain|Terminated||Phase 3|380||Purdue Pharma LP|||||||||||||||||||2017-02-18 16:18:40.825187|2017-02-18 16:18:40.825187
NCT00367848|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2008-05-19|||November 2006||2006-11-01|May 2008|2008-05-01||||||||Observational|||Efficacy of Ultrasound in Evaluating Occult Fractures|The Efficacy of Ultrasound in Evaluating Fractures in the Ankle and Foot in Children When the X-Ray Does Not Demonstrate Fractures.|Completed||N/A|50|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:18:40.928987|2017-02-18 16:18:40.928987
NCT00367835|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2010-10-07|2009-09-10||September 2006||2006-09-01|October 2010|2010-10-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms|A Double-Blind, Randomized, Multi-Center, Flexible Dose Study Evaluating the Efficacy and Safety of SPD503 (Guanfacine Hydrochloride) in Children Aged 6-12 With Symptoms of Oppositionality and a Diagnosis of Attention Deficit/Hyperactivity Disorder|Completed||Phase 3|217|Actual|Shire||2|||f||||||||||||||2017-02-18 16:18:41.004146|2017-02-18 16:18:41.004146
NCT00367822|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2012-03-06||||||January 2010|2010-01-01||||||||Interventional|||Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)|Transdermal Lisuride: a Double-blind, Randomized, Active- and Placebo-controlled Multi-centre Phase III Efficacy Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)|Completed||Phase 3|300||Axxonis Pharma AG|||||f||||||||||||||2017-02-18 16:18:41.64197|2017-02-18 16:18:41.64197
NCT00367809|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2008-09-12|||August 2003||2003-08-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|WIAT||Wellness Interventions After Transplant Study|Impact of Mind-Body Interventions Post Organ Transplant|Completed||Phase 3|140|Actual|National Institute of Nursing Research (NINR)||3|||f||||f||||||||||2017-02-18 16:18:41.844432|2017-02-18 16:18:41.844432
NCT00367796|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2017-01-24|||January 5, 2005||2005-01-05|December 23, 2008|2008-12-23|December 23, 2008||2008-12-23|||||Observational|||Genetic Analysis of Craniosynostosis, Philadelphia Type|Genetic Analysis of Craniosynostosis, Philadelphia Type (OMIM 601222)|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:41.949351|2017-02-18 16:18:41.949351
NCT00367783|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-07-29|||June 2006||2006-06-01|July 2011|2011-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity|A 12-Week, Phase 2A, Randomized, Subject And Investigator Blind, Placebo-Controlled Trial To Evaluate The Effect Of CP-741,952 On Weight Loss In Otherwise Healthy Overweight And Obese Adult Subjects|Terminated||Phase 2|100||Pfizer||||See Detailed Description for termination reason.|||||f||||||||||2017-02-18 16:18:42.027065|2017-02-18 16:18:42.027065
NCT00367770|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2016-08-16|2016-04-11||January 2004||2004-01-01|July 2016|2016-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology|A Multi-Center, Open-Label Extension Study to Protocol AC-052-405 to Evaluate the Safety and Efficacy of Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology|Completed||Phase 4|37|Actual|Actelion||1|||f||||f||||||||No||2017-02-18 16:18:42.131976|2017-02-18 16:18:42.131976
NCT00367757|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2009-07-30|||August 2006||2006-08-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial|Open, Prospective, Randomized Trial Comparing Trigger vs Substrate vs Hybrid Approaches for AF Ablation|Completed||N/A|107|Actual|St. Jude Medical||3|||f||||f||||||||||2017-02-18 16:18:42.396598|2017-02-18 16:18:42.396598
NCT00367744|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2016-12-08|2016-10-05||July 2006||2006-07-01|August 2006|2006-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Rosiglitazone Effect on Mitochondria and Lipoatrophy|Placebo Controlled Study of Rosiglitazone in HIV Lipoatrophy|Completed||Phase 2|71|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Limitations of the study include a relative small sample size as well as loss of follow up of 9 participants at the end of the study.|2|||f||||f||||||||No||2017-02-18 16:18:42.686511|2017-02-18 16:18:42.686511
NCT00367731|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2006-08-22|||January 2005||2005-01-01|August 2006|2006-08-01|September 2006||2006-09-01|||||Observational|||NOW Thai HAART Study|Neurological Outcomes With in THAI National HAART Program.|Completed||Phase 4|500||Rajavithi Hospital|||||f||||||||||||||2017-02-18 16:18:43.161439|2017-02-18 16:18:43.161439
NCT00367718|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2006-08-21||||||August 2006|2006-08-01||||||||Interventional|||Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma|A Phase II Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma|Unknown status|Not yet recruiting|Phase 2|25||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:18:43.238221|2017-02-18 16:18:43.238221
NCT00367705|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2009-08-16|||August 2009||2009-08-01|August 2006|2006-08-01|December 2010|Anticipated|2010-12-01|September 2010|Anticipated|2010-09-01||Interventional|||VSL#3 Treatment in Children With Crohn's Disease|Double-blind Placebo Controlled Trial of VSL#3 in Children With Crohn's Disease|Unknown status|Not yet recruiting|Phase 4|300|Anticipated|Hadassah Medical Organization||2|||f||||f||||||||||2017-02-18 16:18:43.333319|2017-02-18 16:18:43.333319
NCT00367692|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2009-09-04|||September 2006||2006-09-01|September 2009|2009-09-01|April 2007||2007-04-01|||||Interventional|||Study Evaluating PSI-697 in Patients With Scleritis|An Exploratory, Double Blind, Placebo-controlled, Randomized, Single-dose, Cross-over, Proof of Mechanism Study of Orally Administered PSI-697 in Patients With Scleritis|Terminated||Phase 1|12|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:18:43.438808|2017-02-18 16:18:43.438808
NCT00367679|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2012-06-07|2009-11-19||November 2006||2006-11-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer|A Phase II Open-Label Multicenter Study to Evaluate the Safety and Efficacy of Pazopanib (GW786034) as Neoadjuvant Therapy in Treatment-Naïve Subjects With Stage IA, IB, IIA or IIB (to T2) Resectable Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|35|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 16:18:43.522738|2017-02-18 16:18:43.522738
NCT00367666|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2016-08-15|||March 2002||2002-03-01|August 2016|2016-08-01|July 2007||2007-07-01|||||Interventional|||Using Diagnostic Tools to Stage Breast Cancer|Evaluation of Multimodality Breast Imaging: Lesion Staging|Active, not recruiting||N/A|400|Anticipated|University of Pennsylvania|||||f||||||||||||||2017-02-18 16:18:44.016674|2017-02-18 16:18:44.016674
NCT00367653|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2008-09-15|||November 2006||2006-11-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.|A Phase 3, Randomized, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Mefloquine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Africa|Completed||Phase 3|397|Actual|Pfizer||2|||f||||||||||||||2017-02-18 16:18:44.100969|2017-02-18 16:18:44.100969
NCT00367640|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2016-04-18|2016-01-25||November 2004||2004-11-01|April 2016|2016-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional||The intent-to-treat (ITT) population included all patients who received at least one dose of investigational product and had a Retrospective Rhinoconjunctivitis Total Symptom Score (RRTSS) and at least one Rhinoconjunctivitis Total Symptom Score (RTSS) in the pollen period while on treatment.|Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis|Randomised,Double-blind,Placebo-controlled,Multinational,Multi-centre,Phase IIb/III Study of the Efficacy and Safety of Three Doses of Sublingual Immunotherapy (SLIT) Administered as Tablets Once Daily to Patients Suffering From Grass Pollen Rhinoconjunctivitis|Completed||Phase 2/Phase 3|628|Actual|Stallergenes||4|||f||||f||||||||||2017-02-18 16:18:44.225889|2017-02-18 16:18:44.225889
NCT00367627|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2011-07-11|||December 2006||2006-12-01|August 2006|2006-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Relative Efficacy of Two Regimens of Ante-helminthic Treatment||Completed||N/A|200|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:18:44.683312|2017-02-18 16:18:44.683312
NCT00367614|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2007-12-07|||January 2007||2007-01-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating Pantoprazole in Adolescents With GERD|A Multicenter, Randomized, Open-Label, Single And Multiple Dose Study Of The Pharmacokinetics And Safety of Two Dose Levels of Pantoprazole Sodium Tablets In Adolescents Aged 12 Through 16 Years With A Clinical Daignosis Of GERD.|Completed||Phase 3|20|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:18:44.775759|2017-02-18 16:18:44.775759
NCT00367601|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2016-01-13|2016-01-13||August 2006||2006-08-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer|A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|25|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-02-18 16:18:44.858466|2017-02-18 16:18:44.858466
NCT00367588|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2016-10-24||||||June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Low Bacterial Diet in Patients With Cytopenia|Low Bacterial Diet in Patients With Cytopenia After Intensive Chemotherapy for Hematological Malignancy: a Study of Efficacy|Completed||N/A|20||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 16:18:45.420136|2017-02-18 16:18:45.420136
NCT00367575|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2010-08-13|||September 2006||2006-09-01|August 2010|2010-08-01|September 2009||2009-09-01|||||Interventional|||An Internet-based Intervention for Problem Drinking|An Internet-based Intervention for Problem Drinking|Completed||N/A|359|Anticipated|Centre for Addiction and Mental Health|||||f||||||||||||||2017-02-18 16:18:45.524103|2017-02-18 16:18:45.524103
NCT00367562|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2006-10-31|||January 1996||1996-01-01|January 1996|1996-01-01|December 2005||2005-12-01|||||Interventional|||Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy|Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy|Completed||Phase 4|20||Hospital Britanico|||||f||||||||||||||2017-02-18 16:18:45.618258|2017-02-18 16:18:45.618258
NCT00367549|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2011-07-03|||September 2006||2006-09-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||Nutrition as a Determinant of Labor Outcome|Nutrition as Determinant of Labor Outcome|Completed||N/A|200|Anticipated|Oslo University Hospital||1|||f||||||||||||||2017-02-18 16:18:45.906264|2017-02-18 16:18:45.906264
NCT00367536|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2015-04-30|||August 2006||2006-08-01|July 2009|2009-07-01|August 2006||2006-08-01|||||Interventional|||Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution|An Open-label, Single-dose, Randomized-to-sequence, 4-period Crossover Bioavailability Study of Bazedoxifene Contained in Bazedoxifene/Conjugated Estrogen Tablets Administered to Healthy Postmenopausal Women.|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:18:46.002854|2017-02-18 16:18:46.002854
NCT00367523|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2017-01-24|||June 15, 2006||2006-06-15|September 30, 2016|2016-09-30||||||||Observational|||Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria|Prevalence of Secondary Arterial Hypertension (PAH) in Patients With Sickle Cell Disease in Nigeria and the Role of HIV/AIDS and Endemic Parasitic Infections in the Natural History of Pulmonary Hypertension in Sickle Cell Disease|Completed||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:18:46.083504|2017-02-18 16:18:46.083504
NCT00367497|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2007-11-19|||August 2005||2005-08-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma|Phase 2 Study of Rituximab and ESHAP (Etoposide, Methylprednisolone, Cytarabine, and Cisplatin) in Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma|Terminated||Phase 2|5|Actual|Keio University||1||The stopping rule was applied because of low response rates.|f||||||||||||||2017-02-18 16:18:46.175194|2017-02-18 16:18:46.175194
NCT00367302|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2013-04-30|||August 2006||2006-08-01|April 2013|2013-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release|Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release|Completed||Phase 1/Phase 2|116|Actual|National Development and Research Institutes, Inc.||2|||f||||f||||||||||2017-02-18 16:18:49.061638|2017-02-18 16:18:49.061638
NCT00367484|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2014-01-26|2010-04-30||May 2004||2004-05-01|January 2014|2014-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In Multiple Sclerosis|Multicentre, Single Arm, Open, Phase IV Study To Evaluate Immunogenicity And Safety Of Subcutaneous r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In The Treatment Of Relapsing Remitting Multiple Sclerosis|Completed||Phase 4|460|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 16:18:46.268934|2017-02-18 16:18:46.268934
NCT00367471|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2017-02-02|||December 2006||2006-12-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2010|Actual|2010-12-01||Interventional|||Combination Of Lapatinib With Carboplatin, Paclitaxel and Trastuzumab In Metastatic Breast Cancer|A Phase I Dose Escalation Study of the Safety and Tolerability of Lapatinib in Combination With Carboplatin, Paclitaxel, and Herceptin in Patients With Metastatic Breast Cancer|Active, not recruiting||Phase 1|31|Actual|Novartis||2|||f||||f||||||||||2017-02-18 16:18:46.62009|2017-02-18 16:18:46.62009
NCT00367458|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-22|2009-11-25|||July 2006||2006-07-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers|A Randomized Placebo Controlled Trial of Atorvastatin in HIV Positive Patients Not on Antiretroviral Medications With the Specific Aims of Studying the Effects of Atorvastatin on HIV Viral Load and Immune Activation Markers|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:18:46.730748|2017-02-18 16:18:46.730748
NCT00367445|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2008-01-25|||September 2006||2006-09-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|||||Interventional|||A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus|A 1 Month, Open-Label Inpatient, Randomized Cross-Over Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera) On 24-Hour Glycemic Control Compared To Insulin Glargine (Lantus) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Oral Agents|Completed||Phase 4|30||Pfizer|||||||||||||||||||2017-02-18 16:18:46.846119|2017-02-18 16:18:46.846119
NCT00367432|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2015-04-01|2011-12-02||July 2006||2006-07-01|April 2015|2015-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures|A Multicenter, Open, Long-term Follow-up Study to Evaluate the Safety and Efficacy of L059 (Levetiracetam) at Individual Optimal Dose Ranging From 500 to 3000 mg/Day in Twice Daily Administration in Subjects From 16 to 65 Years With Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized Who Completed in a Previous Study|Completed||Phase 3|398|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 16:18:46.943063|2017-02-18 16:18:46.943063
NCT00367419|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2008-11-04||||||March 2006|2006-03-01||||||||Interventional|||Use of Erythromycin in Mustard-Induced Bronchiolitis|Low-Dose Long-Term Prescription of Erythromycin in Mustard-Induced Bronchiolitis Obliterans|Completed||Phase 4|||Baqiyatallah Medical Sciences University|||||f||||||||||||||2017-02-18 16:18:47.474654|2017-02-18 16:18:47.474654
NCT00367406|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2014-12-04|||November 2006||2006-11-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Comparison Between Gamma 3 Nail and ACE Trochanteric Nail|Comparison Between Gamma 3 Nail and ACE Trochanteric Nail|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:18:47.570775|2017-02-18 16:18:47.570775
NCT00367393|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2016-03-20|||March 2006||2006-03-01|March 2016|2016-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis|An Open-label Multicenter 12-month Long Term Study on Skin Reconstitution With Pimecrolimus Cream 1% in Adult Patients With Atopic Eczema and Corticosteroid Induced Skin Damage|Completed||Phase 4|41|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:18:47.669729|2017-02-18 16:18:47.669729
NCT00367380|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-19|2014-05-02|2014-03-27||December 2006||2006-12-01|May 2014|2014-05-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers|Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers|Completed||Phase 2|18|Actual|Malaria Vaccine and Drug Development Center||3|||f||||t||||||||||2017-02-18 16:18:47.784713|2017-02-18 16:18:47.784713
NCT00367367|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-20|2006-08-20|||December 2005||2005-12-01|August 2006|2006-08-01||||||||Interventional|||Endometrial Curettage Before Embryo Transfer|Endometrial Hysteroscopy and Curettage Prior to Embryo Transfer|Unknown status|Recruiting|N/A|90|Anticipated|HaEmek Medical Center, Israel|||||f||||||||||||||2017-02-18 16:18:48.278644|2017-02-18 16:18:48.278644
NCT00367354|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2014-12-08|||August 2006||2006-08-01|December 2014|2014-12-01|July 2011|Actual|2011-07-01|June 2010|Actual|2010-06-01||Observational|||Respiratory Motion Analysis in Children With MRI|Respiratory Motion Analysis in Children for Improvement of MR (Magnetic Resonance) Imaging of Congenital Heart Disease|Terminated||N/A|6|Actual|Emory University|||1|Lack of funding|f||||f||||||||||2017-02-18 16:18:48.366795|2017-02-18 16:18:48.366795
NCT00367341|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2013-11-21|2013-11-21||August 2006||2006-08-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|August 2011|Actual|2011-08-01||Interventional|||Imaging Predictors of Treatment Response in Depression|Imaging Predictors of Treatment Response in Depression|Completed||N/A|82|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:18:48.460548|2017-02-18 16:18:48.460548
NCT00367328|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-19|2015-04-06|||April 2005||2005-04-01|April 2015|2015-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa|To Determine The Efficacy Of A 1320nm Nd: YAG Nonablative Laser For Treatment of Hidradenitis Suppurativa|Terminated||Phase 3|10|Actual|University of California, Davis||1||Terminated: recruiting or enrolling participants has halted.|f||||f||||||||||2017-02-18 16:18:48.864175|2017-02-18 16:18:48.864175
NCT00367315|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2012-05-18|||September 2003||2003-09-01|May 2012|2012-05-01||||February 2004|Actual|2004-02-01||Interventional|||Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)|A 13-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Trial of 2 Different Dose Regimens of Lumiracoxib (100 mg od and 200 mg od Initial Dose for Two Weeks Followed by 100 mg od) in Patients With Primary Knee Osteoarthritis, Using Celecoxib (200 mg od) as a Comparator|Completed||Phase 3|1684||Novartis|||||||||||||||||||2017-02-18 16:18:48.973202|2017-02-18 16:18:48.973202
NCT00005729|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-11|||August 1992||1992-08-01|July 2000|2000-07-01|December 1996||1996-12-01|||||Observational|||CVD Nutrition Education for Low Literacy ESL Students||Completed||N/A|||San Diego State University|||||f||||||||||||||2017-02-18 18:14:27.508919|2017-02-18 18:14:27.508919
NCT00367289|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2011-04-27|||October 2007||2007-10-01|August 2006|2006-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||CT for Diagnosis of Implant Stability in Revision Arthroplasty|CT for Diagnosis of Implant Stability in Revision Arthroplasty|Completed||N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 16:18:49.272931|2017-02-18 16:18:49.272931
NCT00367276|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2013-10-10|||December 2002||2002-12-01|October 2013|2013-10-01|May 2004|Actual|2004-05-01|||||Interventional|||Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.|A Multicentre, Open, Uncontrolled Study to Assess Quality of Life During Six Cycles (24 Weeks) of Treatment With an Oral Contraceptive Containing 30 µg of Ethinylestradiol and 3 mg of Drospirenone (Yasmin).|Completed||Phase 3|221|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:18:49.349769|2017-02-18 16:18:49.349769
NCT00367263|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2007-04-30|||October 2006||2006-10-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary|A Randomized Cross-Over Design Study Evaluating a Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary in Subjects 12 Years and Older With Mild to Moderate Persistent Asthma Receiving Ciclesonide MDI (Alvesco) 80 ug BID|Completed||N/A|12|Actual|Allergy & Asthma Medical Group & Research Center||1|||f||||f||||||||||2017-02-18 16:18:49.462119|2017-02-18 16:18:49.462119
NCT00367250|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2010-09-27|||July 2006||2006-07-01|September 2010|2010-09-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Interventional|||Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer|Phase I Study Investigating the Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer With High and Moderate HER2 Expression|Unknown status|Recruiting|Phase 1|32|Anticipated|Medical University of Vienna||1|||f||||f||||||||||2017-02-18 16:18:49.557465|2017-02-18 16:18:49.557465
NCT00367237|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2015-05-27|2009-03-19||May 2006||2006-05-01|May 2015|2015-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)|A Randomized, Multicenter, International, Open-label Study of Infliximab Plus Methotrexate Versus Methotrexate (MTX) Alone for the Treatment of MTX naïve Subjects With Active Psoriatic Arthritis|Completed||Phase 3|115|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:18:49.652205|2017-02-18 16:18:49.652205
NCT00367224|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2009-01-28|||January 2006||2006-01-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo|Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo|Completed||N/A|17|Actual|Henry Ford Health System|||||f||||f||||||||||2017-02-18 16:18:49.994459|2017-02-18 16:18:49.994459
NCT00367211|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2008-04-21|||September 2006||2006-09-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.|A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.|Completed||Phase 3|400||POZEN|||||t||||||||||||||2017-02-18 16:18:50.27639|2017-02-18 16:18:50.27639
NCT00367198|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2011-07-11|||August 2006||2006-08-01|July 2011|2011-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Protein Supplementation in Dialysis Patients|Protein Supplementation in Dialysis Patients|Terminated||Phase 2|6|Actual|Vanderbilt University||4||lack of enrollment|f||||f||||||||||2017-02-18 16:18:50.374833|2017-02-18 16:18:50.374833
NCT00367185|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2006-08-21|||May 2000||2000-05-01|April 2006|2006-04-01|October 2005||2005-10-01|||||Interventional|||Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma|Comparison of Melphalan-Prednisone(MP),MP-THALIDOMIDE,and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma.|Completed||Phase 3|500||University Hospital, Lille|||||f||||||||||||||2017-02-18 16:18:50.476869|2017-02-18 16:18:50.476869
NCT00367172|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2009-08-03|||June 2001||2001-06-01|August 2009|2009-08-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Interventional|||Directly Observed Antiretroviral Therapy Among Active Drug Users|Directly Observed Antiretroviral Therapy Among Active Drug Users|Completed||N/A|125||Yale University|||||f||||t||||||||||2017-02-18 16:18:50.582506|2017-02-18 16:18:50.582506
NCT00367159|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2009-02-24|||January 2007||2007-01-01|February 2009|2009-02-01|February 2021|Anticipated|2021-02-01|August 2020|Anticipated|2020-08-01||Interventional|||Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in Children|Evaluation of the Efficiency of Autologous Adipocytes Graft in Endoscopic Treatment in Vesico-Renal Reflux in Children|Recruiting||Phase 3|14|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-02-18 16:18:50.700999|2017-02-18 16:18:50.700999
NCT00367146|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2011-05-19|||November 2004||2004-11-01|July 2007|2007-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||MMF After Pediatric Liver Transplantation||Completed||N/A|25|Actual|Hannover Medical School||1|||f||||f||||||||||2017-02-18 16:18:50.808329|2017-02-18 16:18:50.808329
NCT00367133|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2016-08-25|2009-07-14||July 2004||2004-07-01|August 2016|2016-08-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|IVT||Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema|A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema|Completed||Phase 3|840|Actual|Jaeb Center for Health Research||3|||f||||t||||||||||2017-02-18 16:18:50.93|2017-02-18 16:18:50.93
NCT00367120|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2010-03-15|||June 2006||2006-06-01|March 2010|2010-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Zmax Compared to Augmentin in Sinusitis|A Multicenter, Randomized, Open Label Comparative Study Of Azithromycin Extended Release (ZMAX) Versus Amoxicillin/Clavulanate Potassium In Subjects With Acute Bacterial Sinusitis (ABS) In A Physician Practice Environment|Completed||Phase 4|762|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:18:53.591225|2017-02-18 16:18:53.591225
NCT00367107|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2008-02-04|||August 2008||2008-08-01|February 2008|2008-02-01||||August 2009|Anticipated|2009-08-01||Observational|||Autism in Adult Patients and the Effects on Caregivers|Autism: Long Term Course and Impact|Unknown status|Not yet recruiting|N/A|240|Anticipated|Sheba Medical Center|||1||f||||||||||||||2017-02-18 16:18:53.679988|2017-02-18 16:18:53.679988
NCT00364624|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2009-01-15|||August 2006||2006-08-01|January 2009|2009-01-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Observational|||Adrenal Function in Patients With Newly Diagnosed Lung Cancer|Adrenal Cortical Function in Patients With Newly Diagnosed Lung Cancer|Completed||N/A|133|Actual|Princess Margaret Hospital, Hong Kong|||1||f||||f||||||||||2017-02-18 16:19:50.501|2017-02-18 16:19:50.501
NCT00367094|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2007-07-06|||July 2006||2006-07-01|March 2007|2007-03-01||||||||Interventional|||Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension|Efficacy and Safety of the Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Benazepril|Completed||Phase 3|296||Novartis|||||f||||||||||||||2017-02-18 16:18:53.755372|2017-02-18 16:18:53.755372
NCT00367081|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2007-07-29|||May 2003||2003-05-01|July 2007|2007-07-01|August 2004||2004-08-01|||||Interventional|||Treatment of Cerebral Toxoplasmosis in HIV/AIDS|Pyrimethamine Plus Sulfadiazine Versus Trimethoprim Plus Sulfamethoxazole for Treatment of Toxoplasmic Encephalitis in AIDS Patients: A Randomized Controlled Trial.|Completed||Phase 4|30||Rajavithi Hospital|||||f||||||||||||||2017-02-18 16:18:53.842097|2017-02-18 16:18:53.842097
NCT00367068|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2007-11-15|||January 2002||2002-01-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||Dutch National ITB Study in Children With Cerebral Palsy|Intrathecal Baclofen. Evaluation of a Therapy for Refractory Spasticity in Children With Cerebral Palsy|Completed||Phase 3|18||Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 16:18:53.942621|2017-02-18 16:18:53.942621
NCT00367055|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2010-07-20|2009-10-02||October 2004||2004-10-01|July 2010|2010-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes|Comparison of the Action of the Rosiglitazone-metformin Fixed-dose Combination and of a Metformin-sulfonylurea Free Combination on the B-cell Function in Type 2 Diabetic Patients Not Controlled With Metformin Alone.|Completed||Phase 4|84|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:18:54.038927|2017-02-18 16:18:54.038927
NCT00367042|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-19|2015-04-15|||July 2005||2005-07-01|April 2015|2015-04-01|July 2008|Actual|2008-07-01|July 2006|Actual|2006-07-01||Interventional|||Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks|Prospective Study To Determine Whether Tissue Scoring Results In Noticeable Marks Following Mohs Micrographic Surgery|Completed||Phase 2/Phase 3|98|Actual|University of California, Davis||1|||f||||t||||||||||2017-02-18 16:18:54.63416|2017-02-18 16:18:54.63416
NCT00367029|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2014-05-06|||August 2006||2006-08-01|March 2009|2009-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Individualized Motivational Print Materials to Encourage More Physical Activity|Achieving Physical Activity Guidelines Through an Enhanced Print Intervention|Completed||Phase 3|256|Actual|The Miriam Hospital||2|||f||||t||||||||||2017-02-18 16:18:54.734699|2017-02-18 16:18:54.734699
NCT00367016|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-19|2011-05-25|||February 2004||2004-02-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|Xolair||Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)|Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)|Completed||Phase 4|7|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 16:18:57.567163|2017-02-18 16:18:57.567163
NCT00367003|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2016-10-26|||September 2006||2006-09-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2018|Anticipated|2018-09-01||Interventional|||Deep Brain Stimulation for Treatment Resistant Depression|Deep Brain Stimulation for Treatment Resistant Depression|Recruiting||Phase 1/Phase 2|20|Anticipated|Emory University||1|||f||||t||||||||||2017-02-18 16:18:57.676035|2017-02-18 16:18:57.676035
NCT00366990|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2016-03-05|||January 2007||2007-01-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|December 2009|Actual|2009-12-01||Interventional|SAVE||Low Sodium Diet and Behavioral Intervention for Reversing Arterial Stiffening in Overweight Individuals|Clinical Trial to Reverse Early Arterial Stiffening|Completed||N/A|349|Actual|University of Pittsburgh||2|||f||||t||||||||No||2017-02-18 16:18:57.789885|2017-02-18 16:18:57.789885
NCT00366977|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2011-04-28|||June 2000||2000-06-01|April 2011|2011-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy and Cost of State Quitline Policies|Efficacy and Cost of State Quitline Policies|Completed||Phase 3|4614|Actual|Kaiser Permanente|||||f||||||||||||||2017-02-18 16:18:57.903033|2017-02-18 16:18:57.903033
NCT00366964|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-19|2015-04-06|||October 2004||2004-10-01|April 2015|2015-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||The Efficacy Of The Wavelight Mydon Laser for Hair Removal And Treatment of Leg Veins|Determine The Efficacy Of The Wavelight Mydon Laser For Hair Removal And Treatment of Leg Veins|Completed||N/A|10|Actual|University of California, Davis||1|||f||||f||||||||||2017-02-18 16:18:58.020192|2017-02-18 16:18:58.020192
NCT00366951|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2007-12-28|||April 2004||2004-04-01|December 2007|2007-12-01|November 2005|Actual|2005-11-01|||||Interventional|||A Randomized Study on Comparing the Efficacy of Foley Catheter and Extraamniotic Saline Infusion for Labor Induction|A Randomized Clinical Trial Comparing the Efficacy and Safety of Foley Catheter Balloon With Oxytocin and Extraamniotic Saline Infusion (EASI) With Oxytocin for Induction of Labor Requiring Cervical Ripening|Completed||N/A|200||Rush University Medical Center|||||f||||||||||||||2017-02-18 16:18:58.119013|2017-02-18 16:18:58.119013
NCT00366938|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2012-05-18|||September 2003||2003-09-01|May 2012|2012-05-01||||March 2004|Actual|2004-03-01||Interventional|||Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).|A 13-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Trial of 2 Different Dose Regimens of Lumiracoxib (100 mg od and 200 mg od Initial Dose for Two Weeks Followed by 100 mg od) in Patients With Primary Knee Osteoarthritis, Using Celecoxib (200 mg od) as a Comparator|Completed||Phase 3|1464||Novartis|||||||||||||||||||2017-02-18 16:18:58.21477|2017-02-18 16:18:58.21477
NCT00366925|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-21|2009-04-27|||April 2006||2006-04-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|||CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis|Randomized Controlled Multicenter Investigation to Compare the Efficacy and Safety of Adacolumn® Granulocytes, Monocytes/Macrophage Apheresis Device, 5 Versus 10 Treatments, in Patients With Active Ulcerative Colitis|Completed||N/A|174|Anticipated|Otsuka Frankfurt Research Institute GmbH|||||f||||||||||||||2017-02-18 16:18:58.307583|2017-02-18 16:18:58.307583
NCT00366912|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2009-08-10|||August 2006||2006-08-01|August 2009|2009-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Unloading Respiratory Muscles During NIV: Comparison of a Spontaneous and Auto-adjusting Controlled Mode||Terminated||N/A|10||Krankenhaus Kloster Grafschaft||||No longer recruiting: participants are no longer being recruited or enrolled|f||||||||||||||2017-02-18 16:18:58.380431|2017-02-18 16:18:58.380431
NCT00366080|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2011-03-10||2009-07-22|November 2006||2006-11-01|March 2011|2011-03-01||||||||Interventional|||Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy|An Open Label, Dose Escalation Study With A Double Blind Randomised Placebo Controlled Withdrawal To Examine The Effects Of The Histamine H3 Antagonist GSK189254 In Patients With Narcolepsy.|Terminated||Phase 2|70|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:19:14.331472|2017-02-18 16:19:14.331472
NCT00366899|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2013-01-17|2010-03-26||October 2006||2006-10-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants|A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety,Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Paediatric Vaccinations in Italy|Completed||Phase 3|605|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 16:18:58.759237|2017-02-18 16:18:58.759237
NCT00366886|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-06-12||||||June 2007|2007-06-01|July 2006||2006-07-01|||||Observational|||Patients With NMDA Biomarker Data Following Cardiac Surgery|Retrospective Review of 22 Patients With NMDA Biomarker Data Following Cardiac Surgery|Terminated||N/A|22||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:19:01.230636|2017-02-18 16:19:01.230636
NCT00366600|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-05-10|||July 2006||2006-07-01|May 2012|2012-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study Evaluating HKI-272 Administered to Healthy Subjects|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HKI-272 Administered Orally to Healthy Subjects.|Completed||Phase 1|56|Actual|Puma Biotechnology, Inc.|||||||||||||||||||2017-02-18 16:19:01.310083|2017-02-18 16:19:01.310083
NCT00366587|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-10-01|||February 2006||2006-02-01|July 2006|2006-07-01|August 2007|Actual|2007-08-01|||||Interventional|||Comparison of Visual Outcomes and Patient Satisfaction After Cataract Surgery and Implantation of ReSTOR and ReZoom IOLs|Contralateral Eye Comparison of Visual Outcomes and Patient Satisfaction After Routine Phacoemulsification and Implantation of ReSTOR and ReZoom IOLs|Completed||Phase 4|48|Anticipated|Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:19:01.393653|2017-02-18 16:19:01.393653
NCT00366574|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2006-08-17|||September 2004||2004-09-01|March 2005|2005-03-01|February 2005||2005-02-01|||||Interventional|||Comparison of a Laser Keratome to a Mechanical Microkeratome|Comparison of INTRALASE® to AMADEUS™ Microkeratome|Completed||N/A|20||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:19:01.469849|2017-02-18 16:19:01.469849
NCT00366561|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2014-11-26|||January 2002||2002-01-01|November 2014|2014-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Neonates With Neurological Complications|Retrospective Review of Neonates With Neurological Complications Following Cardiac Surgery|Completed||N/A|810|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 16:19:01.544964|2017-02-18 16:19:01.544964
NCT00366548|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-07-06|2010-03-26||November 2006||2006-11-01|July 2012|2012-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants|A Phase 3, Randomized, Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine Manufactured With and Without Polysorbate 80 in Healthy Infants Given in a 2-, 3-, 4-, and 12-Month Schedule With Routine Pediatric Vaccinations|Completed||Phase 3|500|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 16:19:01.657136|2017-02-18 16:19:01.657136
NCT00366535|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2016-08-31|||August 2006||2006-08-01|January 2016|2016-01-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Neurotropin to Treat Fibromyalgia|Neurotropin Treatment of Fibromyalgia|Completed||Phase 2|55|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:19:03.887284|2017-02-18 16:19:03.887284
NCT00366522|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2009-08-06|||August 2006||2006-08-01|August 2009|2009-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study Evaluating LXR-623 in Healthy Subjects|Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of LXR-623 Administered Orally to Healthy Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:19:03.994893|2017-02-18 16:19:03.994893
NCT00366509|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2017-01-24|||August 7, 2006||2006-08-07|October 27, 2016|2016-10-27||||||||Observational|||Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases|Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease|Completed||N/A|157|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:19:04.068223|2017-02-18 16:19:04.068223
NCT00366496|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2006-08-17|||July 2004||2004-07-01|July 2005|2005-07-01|May 2005||2005-05-01|||||Interventional|||Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens|Comparison of Visual Outcomes, Wavefront Analysis, Contrast Sensitivity and Glare Testing Following Cataract Extraction Between Acrysof Single-Piece IOL and Acrysof WF|Completed||N/A|30||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:19:04.160646|2017-02-18 16:19:04.160646
NCT00366483|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-03-15|||May 2006||2006-05-01|March 2007|2007-03-01||||||||Interventional|||Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects|A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of Lecozotan SR Administered Orally to Healthy Young and Elderly Subjects|Completed||Phase 1|40||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:19:04.245864|2017-02-18 16:19:04.245864
NCT00366470|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2012-07-04|||November 2009||2009-11-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients|A Double Blind, Randomized, Parallel, Placebo Control Design Study to Determine the Effect of Addition of Vitamin D to Conventional Anti TB Therapy|Completed||Phase 3|250|Actual|Christian Medical College, Vellore, India||2|||f||||t||||||||||2017-02-18 16:19:04.33394|2017-02-18 16:19:04.33394
NCT00366457|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-04-25|||August 2006||2006-08-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|August 2008|Actual|2008-08-01||Interventional|||Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer|Phase II Study of Gemcitabine, Bevacizumab and Erlotinib in Locally Advanced and Metastatic Pancreatic Cancer|Completed||Phase 2|32|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:19:04.439225|2017-02-18 16:19:04.439225
NCT00366444|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2011-04-12|2010-03-22||August 2006||2006-08-01|April 2011|2011-04-01||||October 2006|Actual|2006-10-01||Interventional|||Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery|Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery|Completed||Phase 3|201|Actual|Xanodyne Pharmaceuticals||2|||||||||||||||||2017-02-18 16:19:04.537547|2017-02-18 16:19:04.537547
NCT00366067|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2009-02-18|||August 2006||2006-08-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Study of Efficacy of Phenytoin in Therapy of Children With Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Phenytoin Efficacy in Children for Therapy of Bronchial Asthma|Completed||Phase 4|50||Centre of Chinese Medicine, Georgia|||||f||||t||||||||||2017-02-18 16:19:14.442031|2017-02-18 16:19:14.442031
NCT00366431|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2011-07-22|||August 2006||2006-08-01|July 2011|2011-07-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Non-Malignant Pain|Completed||Phase 2|420||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:19:05.380769|2017-02-18 16:19:05.380769
NCT00366418|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2017-01-24|||August 10, 2006||2006-08-10|February 23, 2011|2011-02-23|June 11, 2009|Actual|2009-06-11|June 11, 2009|Actual|2009-06-11||Interventional|||Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia|A Pilot Study of Fractionated Dose Subcutaneous Rituximab (RTX, Rituxan(Registered Trademark)) in Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia|Completed||Phase 1|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:19:05.547101|2017-02-18 16:19:05.547101
NCT00366405|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2010-10-01|||February 2006||2006-02-01|October 2010|2010-10-01|September 2007|Actual|2007-09-01|||||Observational|||Comparison of the Torsional Handpiece to Conventional Handpiece During Routine Phacoemulsification|Comparison of the Torsional Handpiece to Conventional Handpiece During Routine Phacoemulsification|Completed||Phase 4|30|Actual|Medical University of South Carolina|||1||f||||f||||||||||2017-02-18 16:19:05.638537|2017-02-18 16:19:05.638537
NCT00366392|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-10-02|||May 2005||2005-05-01|July 2006|2006-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Project Magnify - A Comparison of Two Strategies to Improve Reading Ability|Project Magnify - A Comparison of Two Strategies (Large Print Versus Optical Aids) for Helping Visually Impaired Students Improve Reading Abilities|Completed||Phase 4|20||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:19:05.723559|2017-02-18 16:19:05.723559
NCT00366379|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2016-11-01|||July 2006||2006-07-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.|An Open Label Study to Determine the Effect on Fasting Glucose Levels, and Safety, of Increasing Doses of GK Activator (2) in Patients With Type 2 Diabetes Not Optimally Controlled With One Previous Oral Antihyperglycemic Agent.|Completed||Phase 2|127|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-02-18 16:19:05.812635|2017-02-18 16:19:05.812635
NCT00366366|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2016-09-15|||September 2001||2001-09-01|September 2016|2016-09-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines|Phase III, Open, Randomised Immunogenicity and Reactogenicity Study to Assess the Interchangeability Between GSK Bios' DTPa-HBV-IPV/Hib and DTPa-IPV/Hib + HBV at 3rd Dose of Primary Vac. Course in Children Who Received HBV Vac. at Birth and One Month of Age and DTPa-IPV/Hib Vac at 3-4 Mth of Age|Completed||Phase 3|150|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:19:05.922884|2017-02-18 16:19:05.922884
NCT00366353|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2015-05-15|||June 2006||2006-06-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Sedation Versus No Sedation in a Spontaneous Breathing Trial|A Randomized Trial Comparing Sedation Versus No Sedation For Patients Undergoing a Spontaneous Breathing Trial.|Terminated||N/A|2|Actual|Memorial Medical Center||2||Difficulty obtaining enrollment|f||||f||||||||||2017-02-18 16:19:06.013086|2017-02-18 16:19:06.013086
NCT00366340|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-06-28|2010-03-26||October 2006||2006-10-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.|A Phase 3, Randomized, Active-Controlled, Double-blind Trial of the Safety, Tolerability, and Immunologic Non-Inferiority of a 13-valent Pneumococcal Conjugate Vaccine Compared to a 7-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in Germany.|Completed||Phase 3|604|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 16:19:06.145863|2017-02-18 16:19:06.145863
NCT00366327|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2013-02-07||2013-02-07|January 2007||2007-01-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating Bifeprunox in Patients With Schizophrenia.|An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Bifeprunox in the Treatment of Outpatients With Schizophrenia.|Terminated||Phase 3|400|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 16:19:09.554494|2017-02-18 16:19:09.554494
NCT00366314|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-06-12|||June 2003||2003-06-01|June 2007|2007-06-01||||||||Observational|||Frequency of Accessing Central Lines for Blood Samples|Frequency of Accessing Central Lines for Blood Samples and Medication Administration: A Comparison Between CICU, PICU and NICU|Terminated||N/A|320||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:19:09.905362|2017-02-18 16:19:09.905362
NCT00366301|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2010-10-26|2010-10-26||August 2006||2006-08-01|October 2010|2010-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes|The LANCET Trial: A Randomized Clinical Trial of Lantus for C-reactive Protein Reduction in Early Treatment of Type 2 Diabetes|Terminated||Phase 4|500|Actual|Brigham and Women's Hospital||4||Interim analyses demonstrated futility. Thus, recruitment curtailed 10/08.|f||||t||||||||||2017-02-18 16:19:09.983531|2017-02-18 16:19:09.983531
NCT00366288|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2009-07-08|||July 2006||2006-07-01|July 2009|2009-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Study Evaluating PAZ-417 in Healthy Young/Elderly|Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAZ-417 Administered Orally to Healthy Young and Healthy Elderly Subjects|Completed||Phase 1|56|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||7||f||||||||||Samples With DNA|"~     plasma and urine~   "|||2017-02-18 16:19:10.670646|2017-02-18 16:19:10.670646
NCT00366275|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-10-26|2009-02-18||January 2002||2002-01-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|January 2007|Actual|2007-01-01||Interventional|||Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma|Phase II of Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Patients With Relapsed or Refractory Follicular Lymphoma|Completed||Phase 2|64|Actual|IRCCS Policlinico S. Matteo||1|||f||||f||||||||||2017-02-18 16:19:10.770118|2017-02-18 16:19:10.770118
NCT00366262|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2008-08-01|||June 2006||2006-06-01|August 2008|2008-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen|A Randomized, Double-Blind, Parallel Group Study To Compare The 7-Day Gastrointestinal Safety of 2 Doses of PLA-695 To That Of Placebo And Naproxen|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:19:11.018646|2017-02-18 16:19:11.018646
NCT00366249|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2010-04-22|2009-07-14||January 2007||2007-01-01|April 2010|2010-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.|A Multicenter, Randomized, Double-Blind, Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline Versus Ertapenem for the Treatment of Foot Infections in Subjects With Diabetes|Completed||Phase 3|1061|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||t||||||||||2017-02-18 16:19:11.119779|2017-02-18 16:19:11.119779
NCT00366236|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2006-08-18|||February 2004||2004-02-01|August 2006|2006-08-01|November 2005||2005-11-01|||||Interventional|||Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents|Multi-Center, Double-Blind, Placebo-Controlled Study of Nitazoxanide Tablets in the Treatment of Diarrhea Caused by Entamoeba Histolytica in Adults and Adolescents|Completed||Phase 3|50||Romark Laboratories L.C.|||||f||||||||||||||2017-02-18 16:19:12.330793|2017-02-18 16:19:12.330793
NCT00366223|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2015-12-16|||August 2006||2006-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Changing Patterns of Candida Infections in Urban Medical Centers|Changing Patterns of Candida Infections in Urban Medical Centers: Emphasis on the Emergence of Non-albicans Species and Their Influence on Clinical Outcomes|Active, not recruiting||N/A|80|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:19:12.416455|2017-02-18 16:19:12.416455
NCT00366210|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2014-12-24|||October 2005||2005-10-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Constraint-Induced Therapy Modified for Rehabilitating Arm Function in Stroke Survivors w/Plegic Hands|Constraint-Induced Therapy Modified for Rehabilitating Arm Function in Stroke Survivors w/Plegic Hands|Completed||Phase 1/Phase 2|21|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-02-18 16:19:12.501321|2017-02-18 16:19:12.501321
NCT00366197|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2014-01-15|||January 2005||2005-01-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|||||Observational|||Prediction of Weaning Outcomes by Using Rate of Change of Rapid Shallow Breathing Index|Prediction of Weaning Outcomes by Using Rate of Change of Rapid Shallow Breathing Index|Terminated||Early Phase 1|100|Anticipated|Atlantic Health System|||1||f||||||||||||||2017-02-18 16:19:12.602235|2017-02-18 16:19:12.602235
NCT00366184|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2017-01-24|||August 8, 2006||2006-08-08|May 26, 2010|2010-05-26|May 26, 2010||2010-05-26|||||Observational|||Influence of Theta Burst Stimulation and Carbidopa-Levodopa on Motor Performance in Stroke Patients|Influencing Motor Performance in Patients With Stroke by Combined Theta Burst Stimulation and Carbidopa-Levodopa|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:19:12.683286|2017-02-18 16:19:12.683286
NCT00366171|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-12-18|||November 2006||2006-11-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Open Label Extension Study of Bifeprunox|An Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Bifeprunox in the Treatment of Outpatients With Schizophrenia.|Completed||Phase 3|120||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:19:12.774753|2017-02-18 16:19:12.774753
NCT00366158|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-18|2010-10-08|||August 2006||2006-08-01|October 2010|2010-10-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|||EVITA: Evaluation of VIP Feature in Pacemaker Patients|EVITA: Evaluation of VIP Feature in Pacemaker Patients|Completed||N/A|461|Actual|St. Jude Medical||2|||f||||f||||||||||2017-02-18 16:19:12.939189|2017-02-18 16:19:12.939189
NCT00366145|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2011-10-11||2010-08-24|July 2006||2006-07-01|October 2011|2011-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease|A Phase III, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal(Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Steroid Refractory Acute GVHD|Completed||Phase 3|240|Actual|Osiris Therapeutics||2|||f||||t||||||||||2017-02-18 16:19:13.040061|2017-02-18 16:19:13.040061
NCT00366132|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2006-08-17|||March 2006||2006-03-01|August 2006|2006-08-01||||||||Interventional|||Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers|DermaGold Indicated for Use of Shockwave Treat of Diabetic Foot Ulcers in Patients With Diabetes Mellitus|Unknown status|Recruiting|Phase 2|200||Tissue Regeneration Technologies|||||||||||||||||||2017-02-18 16:19:13.220697|2017-02-18 16:19:13.220697
NCT00366119|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2007-03-08|||June 2006||2006-06-01|March 2007|2007-03-01|June 2007||2007-06-01|||||Interventional|||Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension|Phase 4 Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Ramiprin Tab. in Essential Hypertension|Unknown status|Active, not recruiting|Phase 4|86||Pacific Pharmaceuticals|||||f||||||||||||||2017-02-18 16:19:13.316817|2017-02-18 16:19:13.316817
NCT00366106|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2012-04-04|2011-09-26||July 2006||2006-07-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma|A Phase II, Open Label Study Evaluating an Alternative Schedule of Velcade/Dexamethasone Plus Doxil in the Treatment of Multiple Myeloma|Terminated||Phase 2|32|Actual|Accelerated Community Oncology Research Network|The study was closed to enrollment when it became clear that enrollment was too slow to complete the planned enrollment target of 45 patients within the time frame allowed. Response rate was unable to be assessed due to missingness of required data.|1||"Study was closed to enrollment when it became clear that enrollment was too slow to complete~   full enrollment target within time frame allowed."|f||||f||||||||||2017-02-18 16:19:13.411022|2017-02-18 16:19:13.411022
NCT00366093|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-02-21|||February 2004||2004-02-01|February 2012|2012-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause|The Efficacy of Eszopiclone 3 mg Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause or Menopause|Completed||Phase 3|410|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 16:19:13.989544|2017-02-18 16:19:13.989544
NCT00366041|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2010-01-20|||February 2006||2006-02-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Tolerance of Cellularised LG002 Versus Uncellularised LG002 in the Treatment of Severe Burns Injuries|Multicentre Clinical Study to Compare the Efficacy and the Tolerance of Cellularised LG002 With the Efficacy and Tolerance of Uncellularised LG002 in the Treatment of Severe Burn Injury|Terminated||Phase 2|20|Anticipated|Laboratoires Genévrier||2||not appropriate to carry on the study|f||||t||||||||||2017-02-18 16:19:14.547439|2017-02-18 16:19:14.547439
NCT00366028|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-04-06|2014-06-06||January 2006||2006-01-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||Increasing Evidence-based Clinical Practices in VA|Strengthening Organization to Implement Evidence-based Clinical Practice|Completed||N/A|1624|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:19:14.663417|2017-02-18 16:19:14.663417
NCT00366015|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2011-08-03|||August 2003||2003-08-01|August 2011|2011-08-01|June 2012|Anticipated|2012-06-01|January 2012|Anticipated|2012-01-01||Interventional|||Coronary Stenting and Coronary Bypass Grafting at the Same Time in a Specialty Built Operating Room|Same Procedure Cardiac Hybrid Surgery in a Specialty Built OR-- A Pilot Study|Unknown status|Recruiting|N/A|50|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 16:19:15.081988|2017-02-18 16:19:15.081988
NCT00366002|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2008-01-14|||June 2006||2006-06-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Interventional|||Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder|A 12-Week, Open-Label, Non-Randomized, Multicenter Study to Evaluate the Patient's Perception of Outcome After Treatment With Darifenacin in Overactive Bladder (OAB) Patients Dissatisfied With Prior Anticholinergic Therapy|Completed||Phase 4|500|Actual|Novartis||1|||||||||||||||||2017-02-18 16:19:15.205981|2017-02-18 16:19:15.205981
NCT00365989|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-09-13|||October 2006||2006-10-01|September 2012|2012-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication|A Clinical Study To Evaluate the Safety and Efficacy of MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Techniques|Completed||Phase 3|50|Actual|InSightec||1|||f||||||||||||||2017-02-18 16:19:15.406776|2017-02-18 16:19:15.406776
NCT00365976|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-07-02|2013-03-19||August 2006||2006-08-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study of the Insomnia in Patients With Low Back Pain|Double-blind, Placebo-controlled Study of the Safety and Efficacy of Eszopiclone in the Treatment of Insomnia in Patients With Chronic Low Back Pain|Completed||Phase 4|58|Actual|Duke University|"We obtained only self-reported sleep outcomes.~The period of double-blind treatment was relatively short.~We excluded all subjects who might have required opioid therapy to manage their pain which limits study generalizability."|2|||f||||f||||||||||2017-02-18 16:19:15.525089|2017-02-18 16:19:15.525089
NCT00365963|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2016-02-03|||April 2005||2005-04-01|February 2016|2016-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers|Clinician Integration Study|Completed||Phase 3|252|Anticipated|University of Wisconsin, Madison||1|||f||||||||||||||2017-02-18 16:19:16.228006|2017-02-18 16:19:16.228006
NCT00365950|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2006-08-17|||September 1999||1999-09-01|January 2004|2004-01-01|December 2003||2003-12-01|||||Interventional|||3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE|Clinical Trial of Two Durations of Warfarin Therapy in the Treatment of Deep Vein Thrombosis and/or Pulmonary Embolism|Completed||Phase 4|2400||British Thoracic Society|||||f||||||||||||||2017-02-18 16:19:16.321608|2017-02-18 16:19:16.321608
NCT00365937|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2010-10-14|||August 2006||2006-08-01|October 2010|2010-10-01|August 2009|Anticipated|2009-08-01|||||Interventional|||Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides|Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides|Terminated||Phase 1/Phase 2|19|Actual|Cliniques universitaires Saint-Luc- Université Catholique de Louvain||4||New regulatories of the peptides by the pharmaceutical company (the seller)|f||||f||||||||||2017-02-18 16:19:16.421602|2017-02-18 16:19:16.421602
NCT00365924|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2009-03-20|||December 2006||2006-12-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|||||Interventional|||A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo|A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Recombinant Human Parathyroid Hormone, PTH (Forteo)|Completed||N/A|20|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:19:16.53452|2017-02-18 16:19:16.53452
NCT00365911|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2011-06-01|||March 2006||2006-03-01|June 2011|2011-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population|Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population|Completed||N/A|2000|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:19:16.6375|2017-02-18 16:19:16.6375
NCT00365885|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2014-07-09|||August 2006||2006-08-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Showing Health Information Value in a Community Network|Showing Health Information Value in a Community Network|Completed||N/A|20108|Actual|Duke University||6|||f||||||||||||||2017-02-18 16:19:16.739243|2017-02-18 16:19:16.739243
NCT00365872|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2014-02-10|2013-06-25||May 2006||2006-05-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||All evaluable participants available for follow-up at time of analysis.|External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma|Combination of External Beam Radiation With Intratumoral Injection of Dendritic Cells as Neo-adjuvant Treatment of High-risk Soft Tissue Sarcoma Patients|Completed||Phase 2|17|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 16:19:16.857978|2017-02-18 16:19:16.857978
NCT00365859|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2013-11-07|2009-12-17||September 2006||2006-09-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)|A 52-Week, Open-Label, Multicenter Study of the Safety and Tolerability of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents With Autistic Disorder|Completed||Phase 3|330|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||t||||||||||2017-02-18 16:19:17.500439|2017-02-18 16:19:17.500439
NCT00365846|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2012-09-21|2012-06-22||August 2000||2000-08-01|September 2012|2012-09-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"|"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"|Completed||Phase 2|29|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 16:19:19.438938|2017-02-18 16:19:19.438938
NCT00365833|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2011-09-28|||July 2006||2006-07-01|September 2011|2011-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|CEC||CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients|Circulating Endothelial Cell and Endothelial Progenitor Cell Evaluation of Kidney Transplant Patients|Terminated||N/A|8|Actual|University of Florida|||1|difficulty obtaining required data|f||||f||||||||||2017-02-18 16:19:19.76224|2017-02-18 16:19:19.76224
NCT00365820|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-04-19|||July 2006||2006-07-01|April 2012|2012-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain|A Randomized, Double-blind, Placebo-controlled Multicenter Phase II/III Study to Evaluate the Efficacy and Safety of Tegaserod and Placebo Given Orally for 12 Weeks for the Treatment of Opioid-induced Constipation (OIC) in Patients With Chronic Non-cancer Pain|Terminated||Phase 2/Phase 3|670||Novartis||||"This study was terminated early as a result of regulatory action suspending tegaserod use in~   2007"|f||||||||||||||2017-02-18 16:19:19.861506|2017-02-18 16:19:19.861506
NCT00365807|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-17|2012-11-02|||July 2006||2006-07-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|December 2009|Actual|2009-12-01||Interventional|||Examination of a Treatment Program for Overweight Children, Adolescents, and Their Families|Effectiveness of a Treatment Program for Pediatric Obesity|Completed||N/A|93|Actual|University of Kansas||2|||f||||f||||||||||2017-02-18 16:19:20.108262|2017-02-18 16:19:20.108262
NCT00365794|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-10-12|||August 2006||2006-08-01|October 2015|2015-10-01|December 2014|Actual|2014-12-01|December 2013|Actual|2013-12-01||Interventional|||Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men||Completed||Phase 2|20|Actual|University of Southern California||1|||f||||f||||||||||2017-02-18 16:19:20.21778|2017-02-18 16:19:20.21778
NCT00365781|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2007-10-15|||August 2006||2006-08-01|October 2007|2007-10-01|September 2006||2006-09-01|||||Interventional|||Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715|A Phase 1, Open-Label Examination of the Dermatologic Effects From Subcutaneous Administration of ISIS 113715, and Antisense Oligonucleotide Inhibitor of Protein Tyrosine Phosphatase 1B, in Healthy Volunteers|Completed||Phase 1|10||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:19:20.326417|2017-02-18 16:19:20.326417
NCT00365768|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2016-07-25|2015-11-06||October 2004||2004-10-01|July 2016|2016-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Fifty-six patients were enrolled and 49 were evaluable.|Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors|A Pilot Study Investigating the Effects of Glutamine and Vincristine-Induced Neuropathy in Pediatric Patients With Cancer|Completed||Phase 2|56|Actual|Columbia University||2|||f||||t||||||||Undecided||2017-02-18 16:19:20.417046|2017-02-18 16:19:20.417046
NCT00365755|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2013-08-01||||||March 2008|2008-03-01|March 2008|Actual|2008-03-01|||||Interventional|||Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma|Comparison of High Dose Rapid Schedule With Conventional Schedule Chemotherapy for Stage 4 Neuroblastoma Over the Age of One Year|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:19:20.770594|2017-02-18 16:19:20.770594
NCT00365742|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2006-08-16|||April 2006||2006-04-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Interventional|||Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements|Simvastatin Vs Therapeutic Lifestyle Changes and Supplements: A Primary Prevention Randomized Trial|Completed||N/A|80||Chestnut Hill Health System|||||f||||||||||||||2017-02-18 16:19:20.861936|2017-02-18 16:19:20.861936
NCT00365729|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2016-01-20|||October 2003||2003-10-01|January 2016|2016-01-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Observational|||Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men|Evaluation of Viral Load Determination and Other Biomarkers of High Risk HPV-Types as a Marker for Progression of Perianal HPV-infections in HIV-positive Men Who Have Sex With Men|Recruiting||N/A|1000|Anticipated|Deutsche Luft und Raumfahrt|||1||f||||||||||Samples With DNA|"~     Anogenital smears~   "|||2017-02-18 16:19:20.942829|2017-02-18 16:19:20.942829
NCT00365716|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-10-06|2010-05-19||May 2000||2000-05-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|May 2004|Actual|2004-05-01||Interventional|||Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)|A Placebo-Controlled, Dose-Ranging Study of Quadrivalent HPV Virus-Like Particle (VLP) Vaccine in 16- to 23-Year-Old Women|Completed||Phase 2|1158|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 16:19:21.055635|2017-02-18 16:19:21.055635
NCT00365703|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2007-12-15|||September 2006||2006-09-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Nasogastric Tube vs. Orogastric Feeding Tube in Preterm Infants: Which is Best?|Nasogastric Tube vs. Orogastric Feeding Tube in Preterm Infants: Which is Best?|Completed||N/A|115|Actual|Hillel Yaffe Medical Center||2|||f||||t||||||||||2017-02-18 16:19:22.003925|2017-02-18 16:19:22.003925
NCT00365690|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2013-05-06|||February 2007||2007-02-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Effectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIV|Telephone-Delivered Coping Improvement Intervention for HIV Infected Older Adults|Completed||Phase 2/Phase 3|360|Anticipated|Ohio University||3|||f||||t||||||||||2017-02-18 16:19:22.109771|2017-02-18 16:19:22.109771
NCT00365677|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2011-12-07|||October 2005||2005-10-01|December 2011|2011-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study to Investigate the Safety and Effectiveness of Aspheric Laser Refractive Surgery Treatments for Myopia|Compare the Safety and Effectiveness of Two Versions of the Bausch & Lomb Zyoptix™ Tissue Saving Aspheric Algorithm to the Current Zyoptix™ Tissue Saving Algorithm When Used for Myopia and Myopic Astigmatism Lasik Treatment|Completed||N/A|127|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 16:19:22.213825|2017-02-18 16:19:22.213825
NCT00365651|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2007-05-18|||June 2006||2006-06-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Nutrition and Soccer for Pediatric Overweight and Obesity|Multi Intervention Approach to Pediatric Overweight and Obesity: A Randomized Control Group Trial|Completed||Phase 1|22|Actual|Leach Chiropractic Clinic||2|||f||||t||||||||||2017-02-18 16:19:25.012112|2017-02-18 16:19:25.012112
NCT00365638|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2006-08-15|||April 2004||2004-04-01|September 2004|2004-09-01|February 2005||2005-02-01|||||Interventional|||Simvastatin Therapy in Women With Polycystic Ovary Syndrome.|Effects of Simvastatin on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Prospective, Randomized Trial.|Completed||N/A|||Poznan University of Medical Sciences|||||f||||||||||||||2017-02-18 16:19:25.101414|2017-02-18 16:19:25.101414
NCT00365625|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2010-02-01|||July 2005||2005-07-01|August 2009|2009-08-01|December 2007|Anticipated|2007-12-01|||||Observational|||Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris|Patient Orientated Basic Science Investigation: Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris|Unknown status|Recruiting|N/A|30|Anticipated|Johann Wolfgang Goethe University Hospital|||1||f||||||||||||||2017-02-18 16:19:25.189902|2017-02-18 16:19:25.189902
NCT00365612|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2008-04-09|||July 2006||2006-07-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients|Phase IV, Open-Label, Randomized, Multicenter Study Evaluating Efficacy and Tolerability of Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir DF Compared to Unmodified HAART in HIV-1 Infected Subjects Who Have Achieved Virological Suppression on Their HAART Regimen|Completed||Phase 4|300|Anticipated|Gilead Sciences||1|||f||||f||||||||||2017-02-18 16:19:25.291752|2017-02-18 16:19:25.291752
NCT00365599|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2014-11-10|2012-02-21||February 2006||2006-02-01|November 2014|2014-11-01|August 2012|Actual|2012-08-01|April 2011|Actual|2011-04-01||Interventional|||Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer|Phase II Trial of Suberoylanilide Hydroxamic Acid (SAHA, Vorinostat) in Combination With Tamoxifen for Patients With Advanced Breast Cancer Who Have Failed Prior Anti-hormonal Therapy.|Completed||Phase 2|43|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 16:19:25.44112|2017-02-18 16:19:25.44112
NCT00365586|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2008-08-13|||August 2006||2006-08-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Ketoprofen Topical Patch, 20% in the Treatment of Pain Associated With Osteoarthritis Flare of the Knee|A Phase III Study of the Efficacy, Tolerability and Safety of the Ketoprofen Topical Patch, 20% (KTP) in the Treatment of Pain Associated With Osteoarthritis Flare of the Knee, Including a Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase Followed by an Open-Label Treatment Phase|Completed||Phase 3|300|Anticipated|Endo Pharmaceuticals|||||f||||||||||||||2017-02-18 16:19:25.965393|2017-02-18 16:19:25.965393
NCT00365573|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2010-11-04|||February 2008||2008-02-01|October 2010|2010-10-01||||||||Observational|||Doppler Ultrasonography Evaluation of Tibial Fracture Site Vascularity|Doppler Ultrasonography Evaluation of Tibial Fracture Site Vascularity|Suspended||Phase 2|30|Anticipated|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 16:19:26.071147|2017-02-18 16:19:26.071147
NCT00365560|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2013-07-10|||August 2006||2006-08-01|July 2013|2013-07-01||||November 2007|Actual|2007-11-01||Interventional|||An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma|A Randomised, Double-Blind, Placebo-Controlled, Crossover Efficacy and Safety Evaluation of 8-Week Treatment Periods of Two Doses [5 Mcg (2 Actuations of 2.5 Mcg) and 10 Mcg (2 Actuations of 5 Mcg)] of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler® as Add-on Therapy in Patients With Severe Persistent Asthma|Completed||Phase 2|115||Boehringer Ingelheim|||||||||||||||||||2017-02-18 16:19:26.143664|2017-02-18 16:19:26.143664
NCT00365547|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2012-07-31|2012-05-15||September 2006||2006-09-01|July 2012|2012-07-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy|Phase II Clinical Study of Weekly Topotecan in Combination With Avastin™ in Patients With Stage IIIB/IV Non-Small Cell Lung Cancer Who Have Failed Prior Systemic Chemotherapy|Completed||Phase 2|46|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:19:26.247313|2017-02-18 16:19:26.247313
NCT00365534|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2010-03-25|||January 2006||2006-01-01|March 2010|2010-03-01||||||||Interventional|||Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure|A Double-Blinded Randomized Study Comparison the Mechanism of Looping Formation and Subject's Acceptance During CAC and Regular Colonoscopy by MEI (MIC Study)|Withdrawn||N/A|20|Anticipated|Chinese University of Hong Kong||||The study was incorporated in another study.|f||||||||||||||2017-02-18 16:19:26.589159|2017-02-18 16:19:26.589159
NCT00365521|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2008-05-30|||April 2009||2009-04-01|May 2008|2008-05-01||||||||Interventional|||Prophylactic Photodynamic Therapy to Organ Transplant Patients||Unknown status|Not yet recruiting|N/A|50|Anticipated|Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:19:26.671366|2017-02-18 16:19:26.671366
NCT00365508|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2016-03-01|2012-11-20||February 2006||2006-02-01|March 2016|2016-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking|Comparing the Lozenge to the Patch for Smoking Cessation|Completed||Phase 4|642|Actual|Fox Chase Cancer Center|The study was an effectiveness trial so external vs. internal validity was emphasized. Many participants were lost to follow-up.|2|||f||||f||||||||||2017-02-18 16:19:26.744738|2017-02-18 16:19:26.744738
NCT00365495|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2007-04-03|||August 2006||2006-08-01|April 2007|2007-04-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Influence of Physical Training on Mitochondrial Function in Type 2 Diabetic Patients||Unknown status|Active, not recruiting|N/A|30||Odense University Hospital|||||f||||||||||||||2017-02-18 16:19:27.109197|2017-02-18 16:19:27.109197
NCT00365482|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2012-05-15|||August 2006||2006-08-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Bipolar Disorder in Epilepsy|Bipolar Disorder in Epilepsy|Completed||N/A|102|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 16:19:27.190891|2017-02-18 16:19:27.190891
NCT00365469|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2014-01-07|||May 2006||2006-05-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 Years|A Follow-up Study to 5 Years of a Randomized, Double-blinded, Placebo-controlled Study on the Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora|Completed||Phase 2|253|Actual|National University Hospital, Singapore||2|||f||||t||||||||||2017-02-18 16:19:27.293004|2017-02-18 16:19:27.293004
NCT00365456|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-08-16|2012-05-04||July 2006||2006-07-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|PEAK||Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)|An Open Label, International, Multi Centre, Parallel Group, Phase III b, Randomised Trial, Investigating Lumbar Spine Bone Mineral Density (BMD) Changes in Postmenopausal Women With Primary Osteoporosis Initially Treated With 12 Months of Full Length Parathyroid Hormone (PTH 1-84) Followed by 12 Months of Treatment With Risedronate Followed by Either 12 Months Treatment With PTH (1-84) or Risedronate.|Completed||Phase 3|407|Actual|Takeda||2|||f||||t||||||||||2017-02-18 16:19:27.412149|2017-02-18 16:19:27.412149
NCT00005728|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||May 1992||1992-05-01|July 2000|2000-07-01|April 1996|Actual|1996-04-01|||||Observational|||Nutrition Education||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:27.582172|2017-02-18 18:14:27.582172
NCT00365430|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2009-01-22|||September 2006||2006-09-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes|SAFE or SORRY? Development and Testing of an Evidence Based Inpatient Safety Program for the Prevention of Common Complications.|Completed||N/A|3000|Actual|Radboud University||1|||f||||t||||||||||2017-02-18 16:19:28.425767|2017-02-18 16:19:28.425767
NCT00365417|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2015-10-05|2009-08-21||August 2006||2006-08-01|October 2015|2015-10-01|November 2009|Actual|2009-11-01|February 2008|Actual|2008-02-01||Interventional|||Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer|A Phase II Clinical Trial of Bevacizumab Beginning Concurrently With a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy Followed by Postoperative Bevacizumab Alone for Women With Locally Advanced Breast Cancer|Completed||Phase 2|45|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-02-18 16:19:28.541484|2017-02-18 16:19:28.541484
NCT00365404|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-11-25|||October 2003||2003-10-01|July 2006|2006-07-01|February 2006||2006-02-01|||||Interventional|||Activity, Rheumatoid and Osteoarthritis, and Weight Management|Weight Management, Physical Activity, Less Disability in Rheumatoid and Osteoarthritis|Completed||N/A|465||HealthPartners Institute|||||f||||||||||||||2017-02-18 16:19:28.940257|2017-02-18 16:19:28.940257
NCT00365391|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-06-10|2013-03-22||August 2006||2006-08-01|March 2013|2013-03-01|June 2010|Actual|2010-06-01|August 2008|Actual|2008-08-01||Interventional|||Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer|Phase II Study of Bevacizumab Plus Erlotinib in Patients With Advanced Hepatocellular Cancer (HCC)|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:19:29.039685|2017-02-18 16:19:29.039685
NCT00365378|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-10-22|2010-03-22||September 1999||1999-09-01|October 2015|2015-10-01|July 2009|Actual|2009-07-01|March 2004|Actual|2004-03-01||Interventional|||Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)|Study of Pilot Manufacturing Lot of HPV 16 Virus-Like Particle (VLP) Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females|Completed||Phase 2|2409|Actual|Merck Sharp & Dohme Corp.|Of note, the number of subjects reported in the results posting is slightly different than that specified in the publication by Koutsky, et al (2002). The data provided here is based on final data.|2|||f||||f||||||||||2017-02-18 16:19:29.368067|2017-02-18 16:19:29.368067
NCT00365365|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2012-08-16|2012-08-16||August 2006||2006-08-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer|A Phase IIb, Randomized, Multicenter, Noncomparative Pilot Study of the Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab ± Trastuzumab for the Adjuvant Treatment of Patients With Node-Positive & High-Risk Node-Negative Breast Cancer|Completed||Phase 2|214|Actual|Sanofi|The study was originally designed to last for 6-10 years. Based on a protocol amendment, the study was shortened to about 3 years, and the endpoint Overall Survival (OS) was deleted.|3|||f||||t||||||||||2017-02-18 16:19:30.262615|2017-02-18 16:19:30.262615
NCT00365352|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2013-07-15|2011-04-21||August 2006||2006-08-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||XP13512 vs. Placebo in Patients With Restless Legs Syndrome.|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of XP13512 in Patients With Restless Legs Syndrome.|Completed||Phase 3|325|Actual|XenoPort, Inc.||3|||f||||f||||||||||2017-02-18 16:19:31.357094|2017-02-18 16:19:31.357094
NCT00365339|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2011-04-07|||April 2006||2006-04-01|January 2009|2009-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir|Randomized, Open-Label, Multiple-Dose Study to Evaluate the Effect of Famotidine on the Pharmacokinetics of Atazanavir/Ritonavir/Tenofovir in Healthy Subjects|Completed||Phase 1|40||Bristol-Myers Squibb||5|||f||||||||||||||2017-02-18 16:19:32.610086|2017-02-18 16:19:32.610086
NCT00365326|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2011-03-08|||January 2006||2006-01-01|August 2006|2006-08-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions|Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions|Completed||Phase 1|9|Actual|Case Western Reserve University|||||||||||||||||||2017-02-18 16:19:32.723508|2017-02-18 16:19:32.723508
NCT00365313|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2006-10-26|||August 2002||2002-08-01|October 2006|2006-10-01|June 2005||2005-06-01|||||Interventional|||Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib|A Phase 3 Double Blinded, Randomized, Placebo Controlled Trial of Proton Pump Inhibitor for the Prevention of Recurrent Ulcer Bleeding in Patients Receiving a COX-2 Inhibitor|Completed||Phase 3|273||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 16:19:32.823526|2017-02-18 16:19:32.823526
NCT00365300|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2010-04-26|2009-11-30||September 2006||2006-09-01|April 2010|2010-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study of the Efficacy and Safety of Pantoprazole Sodium Enteric-Coated Granules in Infants (1 Through 11 Months) With Symptomatic GERD.|Completed||Phase 3|129|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 16:19:33.171854|2017-02-18 16:19:33.171854
NCT00365287|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2012-10-09|||June 2000||2000-06-01|October 2012|2012-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer|Transplantation of Umbilical Cord Blood From Unrelated Donors in Patients With Hematological Diseases Using a Non-Myeloablative Preparative Regimen|Completed||Phase 1/Phase 2|148|Actual|Masonic Cancer Center, University of Minnesota|||||f||||t||||||||||2017-02-18 16:19:33.836297|2017-02-18 16:19:33.836297
NCT00365274|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2014-05-29|2013-09-13||August 2006||2006-08-01|November 2013|2013-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma|A Phase II Study of SGN-30 in Combination With CHOP in Anaplastic Large Cell Lymphoma|Terminated||Phase 2|6|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:19:33.95019|2017-02-18 16:19:33.95019
NCT00365261|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2016-06-03|2011-08-24||September 2006||2006-09-01|June 2016|2016-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer|Effect of Eszopiclone (Lunesta) on Sleep Disturbance and Pain in Cancer|Completed||Phase 4|45|Actual|University of California, San Diego||2|||f||||f||||||||No||2017-02-18 16:19:34.219812|2017-02-18 16:19:34.219812
NCT00365248|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2012-05-04|||October 2005||2005-10-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|||||Interventional|||TachoSil Paediatric Liver Trial (TC-019-IN)|A Prospective, Multi-centre Phase III-b Study of TachoSil in Paediatric Patients Scheduled for Resection of the Liver With or Without Segmental Liver Transplantation.|Completed||Phase 3|16|Actual|Nycomed||1|||f||||t||||||||||2017-02-18 16:19:34.647304|2017-02-18 16:19:34.647304
NCT00365235|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2012-01-11|||July 2006||2006-07-01|January 2012|2012-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals|Genetic Susceptibility to Common Lipid Disorders in Mexico|Completed||N/A|998|Actual|University of California, Los Angeles|||1||f||||||||||Samples With DNA|"~     Whole blood sample is taken from all participants and adipose tissue sample from a subgroup.~   "|||2017-02-18 16:19:34.7403|2017-02-18 16:19:34.7403
NCT00365222|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2009-01-21|||July 2006||2006-07-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma|Phase II Study of Dose Intensive Temozolomide in Elderly Adults With Newly Diagnosed Glioblastoma|Terminated||Phase 2|1|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||IRB Study Closure|f||||t||||||||||2017-02-18 16:19:34.829646|2017-02-18 16:19:34.829646
NCT00365209|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-07-30|2014-04-18||October 2006||2006-10-01|March 2014|2014-03-01|January 2011|Actual|2011-01-01|September 2008|Actual|2008-09-01||Interventional||Stage 1: 2g curcumin (N = 22 participants due to 1 participant withdrew consent after start of treatment) Stage 2: 4g curcumin (N = 21 participants)|Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)|Phase IIA Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:19:34.965074|2017-02-18 16:19:34.965074
NCT00365196|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2016-02-17|||December 1999||1999-12-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Hostility Reduction Program to Improve Autonomic Regulation of the Heart|Hostility Reduction and Autonomic Control of the Heart|Completed||N/A|150||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:19:35.56154|2017-02-18 16:19:35.56154
NCT00365183|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2013-10-29|||June 2006||2006-06-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer|Phase II Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer|Terminated||Phase 2|74|Actual|Pharmacyclics LLC.||1|||f||||||||||||||2017-02-18 16:19:35.645269|2017-02-18 16:19:35.645269
NCT00365170|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-12-20|||September 2002||2002-09-01|December 2016|2016-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes|A Randomised, Parallel-group, Open-label, Multinational Trial Comparing the Safety and Efficacy of Insulin Aspart (NovoRapid®) Versus Human Insulin (Actrapid®), Used in a Multiple Injection Regimen, in the Treatment of Pregnant Women With Type 1 Diabetes, Focusing on Maternal Hypoglycaemia and Pregnancy Outcomes|Completed||Phase 4|419|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:19:35.769752|2017-02-18 16:19:35.769752
NCT00365157|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2016-12-26|||October 2006||2006-10-01|December 2016|2016-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction|A Phase I/II Study of E7389 Halichondrin B Analog (NSC # 707389) in Metastatic Urothelial Tract Cancer and Renal Insufficiency|Active, not recruiting||Phase 1/Phase 2|132|Anticipated|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:19:36.204995|2017-02-18 16:19:36.204995
NCT00365144|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2013-11-22|2013-09-18||February 2006||2006-02-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|January 2009|Actual|2009-01-01||Interventional|||Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine|A Phase II Trial of Bevacizumab Plus Erlotinib for Patients With Metastatic Gemcitabine-Refractory Pancreatic Cancer|Completed||Phase 2|36|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:19:36.347434|2017-02-18 16:19:36.347434
NCT00365131|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2015-03-04|||December 1997||1997-12-01|March 2015|2015-03-01|July 2004|Actual|2004-07-01|||||Interventional|||A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.||Completed||Phase 4|40||Sanofi|||||f||||||||||||||2017-02-18 16:19:36.637898|2017-02-18 16:19:36.637898
NCT00365118|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2008-06-02|||November 2005||2005-11-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser||Completed||N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:19:36.736589|2017-02-18 16:19:36.736589
NCT00365105|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2015-03-20|2014-11-03||July 2006||2006-07-01|March 2015|2015-03-01||||January 2012|Actual|2012-01-01||Interventional||Eligible patients|Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer|Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer|Active, not recruiting||Phase 3|261|Actual|Radiation Therapy Oncology Group|This study stopped accrual early with 261 accrued out of 352 planned, due to a lower than expected rate of skeletal related events in the control arm.|2|||f||||t||||||||||2017-02-18 16:19:36.828105|2017-02-18 16:19:36.828105
NCT00365092|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2006-08-15|||April 2002||2002-04-01|August 2006|2006-08-01|March 2005||2005-03-01|||||Interventional|||Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11|Early Otitis and Literacy and Attention at 9 to 11 Years|Completed||N/A|400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 16:19:37.756342|2017-02-18 16:19:37.756342
NCT00365014|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2013-07-19|||August 2003||2003-08-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Progression of Hematopoietic Diseases in Shanghai, China|Analysis of Disease Progression for Aplastic Anemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia and Benzene Poisoning in Shanghai, China.|Completed||N/A|10757|Actual|University of Colorado, Denver|||1||f||||||||||||||2017-02-18 16:19:41.130861|2017-02-18 16:19:41.130861
NCT00365053|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-16|2014-12-17|2014-07-09||June 2006||2006-06-01|June 2013|2013-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery|Phase II Study of PXD101 (NSC 726630) as Second-Line Therapy for Treatment of Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|13|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:19:38.026471|2017-02-18 16:19:38.026471
NCT00364338|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2015-09-20|||January 2007||2007-01-01|August 2006|2006-08-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Development of Gourmet Medical Cooking Workshop for Lifestyle Changing and Its Affect on Perimenopausal Women|Development of Gourmet Medical Cooking Workshop for Lifestyle Changing and Its Affect on Perimenopausal Women|Withdrawn||N/A|0|Actual|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:19:38.33165|2017-02-18 16:19:38.33165
NCT00364325|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2010-04-26|||July 2004||2004-07-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Observational|||Registry for Acute Decompensated Heart Failure Patients Admitted to the ER|Acute Decompensate Heart Failure National Registry ( ADHERE) Emergency Module (EM)|Completed||N/A|18920|Actual|Scios, Inc.|||1||f||||||||||||||2017-02-18 16:19:38.429712|2017-02-18 16:19:38.429712
NCT00364312|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2006-08-11|||May 2004||2004-05-01|August 2006|2006-08-01|December 2009||2009-12-01|||||Interventional|||Lifestyle Interventions for Long Term Diabetes Control|Improving Control With Activity and Nutrition|Unknown status|Active, not recruiting|N/A|390||University of Virginia|||||f||||||||||||||2017-02-18 16:19:38.541577|2017-02-18 16:19:38.541577
NCT00364299|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2006-10-19|||October 2002||2002-10-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Prevention of Ventilator-Associated Pneumonia by Automatic Control of the Tracheal Tube Cuff Pressure|Prevention of Ventilator-Associated Pneumonia by Automatic Control of the Tracheal Tube Cuff Pressure|Completed||N/A|142||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:19:38.657042|2017-02-18 16:19:38.657042
NCT00364286|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2013-06-12|2013-06-12||August 2006||2006-08-01|June 2013|2013-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)|Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)|Completed||Phase 2|17|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:19:38.767105|2017-02-18 16:19:38.767105
NCT00364273|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2016-10-17|||August 2005||2005-08-01|October 2016|2016-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||GSK159802 In Healthy Male Subjects And Asthmatics|A Randomised, Double-blind, Placebo Controlled Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Dry Powder Doses of GSK159802 in Healthy Male Subjects and Asthmatics|Completed||Phase 1|45|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:19:39.004986|2017-02-18 16:19:39.004986
NCT00364260|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2011-01-31|||December 1997||1997-12-01|January 2011|2011-01-01|August 2003|Actual|2003-08-01|||||Interventional|||A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.|A Study to Determine the Impact of Hemoglobin Maintenance and Other Interventional Strategies to Prevent or Delay the Progression of Left Ventricular Mass Growth in Subjects With Early Renal Insufficiency.|Completed||Phase 3|172|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 16:19:39.101397|2017-02-18 16:19:39.101397
NCT00364247|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2011-06-02||2011-06-02||||June 2011|2011-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.|A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Multiple Doses of CG5503 Immediate-Release Formulation in the Treatment of Acute Pain From Bunionectomy Followed by a Voluntary Open-Label Extension|Completed||Phase 3|602|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:19:39.193028|2017-02-18 16:19:39.193028
NCT00364234|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2015-04-13|||May 2006||2006-05-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Low Magnitude Mechanical Stimuli Effects on Bone Structure in ESRD|Low Magnitute Mechanical Stimuli Effects on Bone Structure in ESRD|Completed||N/A|30|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||f||||||||||2017-02-18 16:19:39.287571|2017-02-18 16:19:39.287571
NCT00364221|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2012-11-20|||November 2004||2004-11-01|November 2012|2012-11-01|October 2006|Actual|2006-10-01|July 2006|Actual|2006-07-01||Interventional|||Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome|The Effect of Rosiglitazone on Adipocyte-derived Cytokines in Nondiabetics With the Metabolic Syndrome|Completed||Phase 4|||University of Colorado, Denver|||||f||||||||||||||2017-02-18 16:19:39.386162|2017-02-18 16:19:39.386162
NCT00364195|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2009-01-08|||June 2006||2006-06-01|January 2009|2009-01-01||||||||Interventional|||Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer|A Pharmacokinetic Interaction and Safety and Efficacy Phase II, Open Label Study With a Safety Lead-in Evaluating Docetaxel Plus Tesmilifene (YMB1002) in Patients With Metastatic Breast Cancer Suitable for Treatment With Docetaxel|Completed||Phase 2|33|Anticipated|YM BioSciences|||||||||||||||||||2017-02-18 16:19:39.482067|2017-02-18 16:19:39.482067
NCT00364182|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2011-08-30|2011-07-25||May 2007||2007-05-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B|A Multicenter, Open-Label Study To Compare On-Demand Treatment With 2 Prophylaxis Regimens of Recombinant Coagulation Factor IX (BeneFIX) Reformulated Drug Product (rFIX-R) In Subjects With Severe Hemophilia B|Completed||Phase 3|50|Actual|Pfizer|Although the protocol-defined endpoint was days lost from work or school after hemarthrosis, data was collected and reported in hours.|2|||f||||f||||||||||2017-02-18 16:19:39.58532|2017-02-18 16:19:39.58532
NCT00364169|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2008-06-27|||September 2006||2006-09-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Prevention of Constipation: Systematic Nursing Interventions to Reduce Postoperative Constipation After Thoracic Surgery|Systematic Nursing Interventions to Reduce Postoperative Constipation After Thoracic Surgery|Completed||N/A|58|Actual|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:19:40.445466|2017-02-18 16:19:40.445466
NCT00364156|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2010-11-01|2010-10-06||June 2004||2004-06-01|November 2010|2010-11-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation|Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation|Completed||Phase 3|568|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 16:19:40.542641|2017-02-18 16:19:40.542641
NCT00365001|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2010-06-10||||||June 2010|2010-06-01|April 2008|Actual|2008-04-01|||||Interventional|||A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.|A Randomized, Open-label Study to Assess the Pharmacokinetics of Simvastatin and Methotrexate in Combination With Tocilizumab in Patients With Rheumatoid Arthritis.|Completed||Phase 1|23|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:19:41.236717|2017-02-18 16:19:41.236717
NCT00364988|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2014-10-23|||January 2005||2005-01-01|October 2014|2014-10-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||Pioglitazone and Losartan Provides Additional Renoprotection|Combination Therapy With Pioglitazone and Losartan Provides Additional Renoprotection in Subjects With Type 2 Diabetic Nephropathy|Completed||N/A|60|Actual|Shanghai Jiao Tong University School of Medicine||1|||f||||t||||||||||2017-02-18 16:19:41.345981|2017-02-18 16:19:41.345981
NCT00364975|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2015-09-20|||December 2006||2006-12-01|August 2006|2006-08-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Development of Gourmet Healthy Cooking Workshop for Cancer Patients|Development of Gourmet Healthy Cooking Workshop for Cancer Patients|Withdrawn||N/A|0|Actual|Hadassah Medical Organization||||Was not funded|f||||||||||||||2017-02-18 16:19:41.432179|2017-02-18 16:19:41.432179
NCT00364962|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2006-08-15|||April 2006||2006-04-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Observational|||Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients||Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:19:41.52749|2017-02-18 16:19:41.52749
NCT00364949|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2013-04-03|2010-07-19||January 2003||2003-01-01|April 2013|2013-04-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands|Genes, Androgens and Intrauterine Environment in PCOS|Completed||N/A|70|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||||||||Samples With DNA|"~     blood~   "|||2017-02-18 16:19:41.79282|2017-02-18 16:19:41.79282
NCT00364936|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2009-06-10|||March 2004||2004-03-01|June 2009|2009-06-01|December 2006||2006-12-01|||||Interventional|||Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)|Proposal to Create a Flagship Neurology and Palliative Care Service for South London|Completed||Phase 1/Phase 2|52|Actual|King's College London||2|||f||||t||||||||||2017-02-18 16:19:42.330511|2017-02-18 16:19:42.330511
NCT00364923|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2013-05-08|2009-10-23||August 2006||2006-08-01|May 2013|2013-05-01|February 2012||2012-02-01|January 2009|Actual|2009-01-01||Interventional|PROPEL||Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma|A Multi-Center, Phase 2, Open-Label Study of (RS)-10-Propargyl-10-Deazaaminopterin (Pralatrexate) With Vitamin B12 and Folic Acid Supplementation in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma|Completed||Phase 2|115|Actual|Spectrum Pharmaceuticals, Inc|Outcome Measure (primary and secondary), Serious Adverse Event and Adverse Event data presented have a cut-off date of August 2009.|1|||f||||t||||||||||2017-02-18 16:19:42.46579|2017-02-18 16:19:42.46579
NCT00364910|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2008-09-08|||April 2006||2006-04-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy of Cognitive Behavior Therapy for People With Post-Traumatic Stress and Cardiovascular Illness|PTSD Treatment in Cardiac Patients|Completed||Phase 1/Phase 2|60|Anticipated|National Institute of Mental Health (NIMH)||2|||f||||f||||||||||2017-02-18 16:19:42.915711|2017-02-18 16:19:42.915711
NCT00364897|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2007-04-10||||||February 2007|2007-02-01||||||||Observational|||Investigation of Clinical Outcome of ACL Reconstruction Utilizing Two Tibial Fixation Techniques, Concentric Tapered Interference Screws and Interference Screw and Sheath|Comparison Between Two Tibial Fixation Techniques in ACL Reconstruction|Withdrawn||Phase 2|140||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:19:43.02167|2017-02-18 16:19:43.02167
NCT00364884|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2006-08-15|||August 2006||2006-08-01|August 2006|2006-08-01|August 2007||2007-08-01|||||Interventional|||Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease|Comparison of the Effects Between Keto-/Amino Acid Supplemented Low Protein Diet and Non-Supplemented Low Protein Diet in Patients With Stage Ⅴ Chronic Kidney Disease|Unknown status|Not yet recruiting|Phase 4|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:19:43.081592|2017-02-18 16:19:43.081592
NCT00364871|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2008-04-18|||April 2005||2005-04-01|April 2008|2008-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity|Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled Study of Combination Therapy for Safety and Efficacy in Subjects With Uncomplicated Obesity|Completed||Phase 2|410|Actual|Orexigen Therapeutics, Inc||7|||f||||t||||||||||2017-02-18 16:19:43.172103|2017-02-18 16:19:43.172103
NCT00364858|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2015-03-17|2009-05-28||December 2001||2001-12-01|March 2015|2015-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease|A Phase IV, Multicenter, Randomized, Dose Frequency Study of the Safety and Efficacy of Cerezyme® Infusions Every Four Weeks Versus Every Two Weeks in the Maintenance Therapy of Patients With Type 1 Gaucher Disease|Completed||Phase 4|95|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:19:43.323814|2017-02-18 16:19:43.323814
NCT00364845|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2014-04-23|2010-12-02||September 2006||2006-09-01|April 2014|2014-04-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients|A Randomised Single-Blind Study to Improve Health-related Quality of Life as Measured by the Short-Form 36 (SF-36) Vitality Score by Correcting Anemia With Aranesp (Darbepoetin Alfa) in the Elderly.|Terminated||Phase 3|51|Actual|Amgen||2||"The reason for the discontinuation of the study is difficulty with recruitment and timely~   enrolment and is not related to safety concerns"|f||||f||||||||||2017-02-18 16:19:44.109984|2017-02-18 16:19:44.109984
NCT00364832|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2016-10-26|2016-05-03||October 2001||2001-10-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional||The Intent-to-Treat (ITT) population was considered for analysis which included all randomized participants.|A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.|An Open-label, Multicenter, Randomized Study to Determine Dose Conversion Factors at Different Frequencies of Administration After Switching From Maintenance Treatment With Subcutaneous Epoetin Alfa or Beta to Maintenance Treatment With Subcutaneous RO0503821 in Dialysis Patients With Chronic Renal Anemia|Completed||Phase 2|137|Actual|Hoffmann-La Roche||9|||f||||||||||||||2017-02-18 16:19:44.777551|2017-02-18 16:19:44.777551
NCT00005727|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-08-23|||August 1991||1991-08-01|August 2016|2016-08-01|January 2000|Actual|2000-01-01|December 1995|Actual|1995-12-01||Interventional|||CVD Nutrition Education||Completed||N/A|351|Actual|Stanford University||2|||f||||f||||||||No||2017-02-18 18:14:27.652811|2017-02-18 18:14:27.652811
NCT00364819|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2014-03-04|||January 2007||2007-01-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Initial Study of Rituximab to Treat Primary Biliary Cirrhosis|Effects of Rituximab (Rituxan) on B Cell and AMA Response in Patients With Primary Biliary Cirrhosis|Completed||Phase 1/Phase 2|10|Anticipated|University of California, Davis||1|||f||||t||||||||||2017-02-18 16:19:46.49048|2017-02-18 16:19:46.49048
NCT00364806|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2008-05-19|||August 2006||2006-08-01|May 2008|2008-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Clinical Trial Comparing Two Different Medications to Determine Which One is Better for Patients With an Acute Migraines in the Emergency Department|Prochlorperazine Verus Metoclopramide for the Treatment of Acute Migraine in the Emergency Department Setting|Completed||Phase 4|76||Montefiore Medical Center|||||f||||||||||||||2017-02-18 16:19:46.619089|2017-02-18 16:19:46.619089
NCT00364793|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2014-04-11|2014-03-06||February 2007||2007-02-01|April 2014|2014-04-01|July 2013|Actual|2013-07-01|December 2011|Actual|2011-12-01||Interventional||Treated participants who received at least one dose of study drug (EFV) were analyzed.|Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children|An Open-label Study of Liquid and Sprinkled Formulations of Efavirenz Administered in Combination With Didanosine and Emtricitabine in HIV-infected Infants and Children 3 Months to 6 Years of Age.|Completed||Phase 1/Phase 2|56|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 16:19:46.769098|2017-02-18 16:19:46.769098
NCT00364780|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2012-01-24||2012-01-24|July 2006||2006-07-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|||Study of XL647 in Subjects With Non-Small-Cell Lung Cancer|A Phase 2 Study of XL647 in Subjects With Non-Small-Cell Lung Cancer|Completed||Phase 2|55|Actual|Kadmon Corporation, LLC||2|||f||||t||||||||||2017-02-18 16:19:49.308344|2017-02-18 16:19:49.308344
NCT00364767|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2008-05-22|||October 2004||2004-10-01|May 2008|2008-05-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Moderate Alcohol Consumption, Fat and Carbohydrate Metabolism and Insulin Sensitivity|The Effect of Moderate Alcohol Consumption on Markers of Oxidative Phosphorylation and Lipid Oxidation and on Postprandial Glycemic Control in Healthy, Lean and Overweight, Young Men|Completed||N/A|19|Actual|TNO||2|||f||||t||||||||||2017-02-18 16:19:49.408195|2017-02-18 16:19:49.408195
NCT00364754|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2014-04-18|||May 2004||2004-05-01|April 2014|2014-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer|A PHARMACOKINETIC INTERACTION PHASE I, MULTI-CENTRE, OPEN-LABEL, CROSS-OVER Study Evaluating the Effect of Tesmilifene on the Plasma Pharmacokinetics of Epirubicin and Cyclophosphamide in Patients With Metastatic/Recurrent Breast Cancer|Completed||Phase 1|28|Actual|YM BioSciences||1|||f||||||||||||||2017-02-18 16:19:49.516304|2017-02-18 16:19:49.516304
NCT00364741|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2009-10-15|||October 2006||2006-10-01|October 2009|2009-10-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Supplemental Oxygen and Complications After Abdominal Surgery (The PROXI-trial)|PeRioperative OXygen Fraction - Effect on Surgical Site Infection and Pulmonary Complications After Abdominal Surgery (The PROXI-trial)|Completed||Phase 4|1400|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 16:19:49.629329|2017-02-18 16:19:49.629329
NCT00364728|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2010-05-20|||January 2006||2006-01-01|May 2010|2010-05-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Observational|||Efferocytosis and Genomic Polymorphism in Autoimmune Diseases|Efferocytosis (Clearance of Apoptotic Cells by Phagocytosis) and Autoimmune Diseases in Human|Unknown status|Recruiting|N/A|450|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 16:19:49.740581|2017-02-18 16:19:49.740581
NCT00364715|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2006-08-16|||January 2005||2005-01-01|August 2006|2006-08-01|December 2005||2005-12-01|||||Observational|||Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer|Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer|Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:19:49.829313|2017-02-18 16:19:49.829313
NCT00364702|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2011-08-16|||August 2006||2006-08-01|July 2006|2006-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder|Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder|Completed||Phase 2|40|Anticipated|Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:19:49.910282|2017-02-18 16:19:49.910282
NCT00364689|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2010-06-23|||August 2006||2006-08-01|April 2007|2007-04-01||||||||Interventional|||RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial|RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial|Unknown status|Recruiting|Phase 3|75|Anticipated|University of Miami|||||||||||||||||||2017-02-18 16:19:49.994339|2017-02-18 16:19:49.994339
NCT00364676|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2015-09-18|||July 2006||2006-07-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|June 2015|Actual|2015-06-01||Interventional|||Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease|A Phase 1 Study of Vinorelbine Liposomes Injection (VLI) for Treatment in Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease|Completed||Phase 1|67|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||||||||||||2017-02-18 16:19:50.084983|2017-02-18 16:19:50.084983
NCT00364663|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-15|2006-08-15|||August 2006||2006-08-01|August 2006|2006-08-01||||||||Observational|||The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer|The Utility and Cost-Effectiveness Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in Staging Potential Operable Non-Small Cell Lung Cancer|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:19:50.191102|2017-02-18 16:19:50.191102
NCT00364650|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2011-07-22|||July 2006||2006-07-01|July 2011|2011-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation|Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation: a Single Center Randomized Controlled Trial|Completed||N/A|44|Actual|Swedish Medical Center||2|||f||||t||||||||||2017-02-18 16:19:50.27287|2017-02-18 16:19:50.27287
NCT00364637|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2016-11-21|||January 2005||2005-01-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Volatile Anesthetics in Cardiac Protection|Pharmacological Preconditioning Properties of Volatile Anesthetics|Recruiting||Phase 4|||Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-02-18 16:19:50.383764|2017-02-18 16:19:50.383764
NCT00005726|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||August 1991||1991-08-01|May 2000|2000-05-01|May 1995|Actual|1995-05-01|||||Observational|||Evaluation of Low Literacy CVD Nutrition Education||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:27.75737|2017-02-18 18:14:27.75737
NCT00364611|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2012-07-20|2012-06-18||August 2006||2006-08-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|June 2011|Actual|2011-06-01||Interventional|||Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer|A Pilot, Phase II, Multicenter, Open-Label, Prospective Evaluation of Docetaxel and Bevacizumab ± Trastuzumab in the First-Line Treatment of Patients With Metastatic Breast Cancer|Completed||Phase 2|73|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:19:50.787447|2017-02-18 16:19:50.787447
NCT00364598|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2009-03-27|||December 2006||2006-12-01|March 2009|2009-03-01|February 2009|Anticipated|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant|A Phase I Open Label Pilot Study to Obtain Tissue for Histological Analysis After Application of Anginera™ in Adults With A Left Ventricular Assist Device As A Bridge To Transplant|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|Theregen, Inc.||1|||f||||f||||||||||2017-02-18 16:19:54.248556|2017-02-18 16:19:54.248556
NCT00364585|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2008-01-16|||May 2006||2006-05-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|||||Interventional|||A Prospective Evaluation of the GreenLight Model 120 Laser|A Prospective Evaluation of the GreenLight Model 120 Laser System for the Treatment of Benign Prostatic Hyperplasia|Completed||Phase 4|20||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 16:19:54.347826|2017-02-18 16:19:54.347826
NCT00364572|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2009-01-21|||May 2006||2006-05-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Epidural Etanercept in the Treatment of Sciatica|Efficacy of Epidural Etanercept in the Treatment of Sciatica|Completed||Phase 1/Phase 2|24|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:19:54.429034|2017-02-18 16:19:54.429034
NCT00364559|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2009-03-25|||August 2006||2006-08-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effect of Rosuvastatin in Intracerebral Hemorrhage|Effect of Rosuvastatin on Outcome by NIHSS After Intracerebral Hemorrhage|Completed||Phase 2|75|Actual|Universidad Autonoma de San Luis Potosí||1|||f||||||||||||||2017-02-18 16:19:54.535609|2017-02-18 16:19:54.535609
NCT00364546|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2011-06-02||2011-06-02|July 2006||2006-07-01|April 2010|2010-04-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain|A Randomized, Double-Blind, Active-Control, Parallel-Group, 90-Day Safety Study of CG5503 Immediate Release (IR) or Oxycodone IR in Subjects With Chronic Pain From Low Back Pain or Osteoarthritis of the Hip or Knee|Completed||Phase 3|877|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:19:54.88911|2017-02-18 16:19:54.88911
NCT00364533|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2014-04-03|2008-12-19||October 2006||2006-10-01|April 2014|2014-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety|A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Multiple Doses of CG5503 Immediate Release Formulation in the Treatment of Acute Pain From Total Hip Replacement Surgery Followed by a Voluntary Open-Label Extension|Terminated||Phase 3|367|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sponsor terminated study, sample size not reached. The protocol section describes 4 study arms defining the treatment groups in the study design. The participant flow module describes the 5 treatment groups analyzed for the primary endpoint|4||Slow enrollment|f||||f||||||||||2017-02-18 16:19:55.002108|2017-02-18 16:19:55.002108
NCT00364520|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2015-05-19|||August 2003||2003-08-01|May 2007|2007-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Molecular Epidemiology of Benzene-exposed Workers.|Molecular Epidemiology of Benzene-exposed Workers in Shanghai,China|Completed||N/A|2000|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-02-18 16:19:55.799254|2017-02-18 16:19:55.799254
NCT00364507|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2006-08-14|||January 2007||2007-01-01|August 2006|2006-08-01|December 2007|Anticipated|2007-12-01|||||Observational|||Serum Levels of Insulin- Like Growth Factor and Fertility|Serum Levels of Insulin-Like Growth Factor in Fertile and Infertile Women Over 40 Years Old|Unknown status|Not yet recruiting|Early Phase 1|60|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:19:55.909477|2017-02-18 16:19:55.909477
NCT00364494|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2009-08-13|||November 2006||2006-11-01|August 2009|2009-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Hemodilution and Outcome in Cardiac Surgery|Effect of Moderate Hemodilution During Cardiopulmonary Bypass on Postoperative Outcome Following Cardiac Surgery|Terminated||N/A|||Università Vita-Salute San Raffaele||2||difficult enrollment after the primary investigator left the centre|f||||t||||||||||2017-02-18 16:19:55.979215|2017-02-18 16:19:55.979215
NCT00364481|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2012-12-18|||August 2006||2006-08-01|December 2012|2012-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome|Effectiveness of Tongue Exercises and Laryngopharyngeal Reflux Therapy on Upper Airway Resistance Syndrome|Withdrawn||Phase 1|0|Actual|West Side ENT||1||Not enough subjects enrolled|f||||||||||||||2017-02-18 16:19:56.068975|2017-02-18 16:19:56.068975
NCT00364468|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2012-08-23|||March 2006||2006-03-01|August 2012|2012-08-01||||March 2008|Actual|2008-03-01||Interventional|||Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients|A Randomized Dose Finding Study of KRN125 (Pegfilgrastim) for the Treatment of Chemotherapy - Induced Neutropenia in Malignant Lymphoma|Completed||Phase 2|107|Actual|Kyowa Hakko Kirin Co., Ltd|||||f||||||||||||||2017-02-18 16:19:56.16126|2017-02-18 16:19:56.16126
NCT00364455|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2010-04-26|||December 2002||2002-12-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.|Randomized Trial of Epoetin Alfa in Men With Hormone-refractory Prostate Cancer and Anemia.|Completed||Phase 3|56|Actual|Janssen-Ortho Inc., Canada||1|||f||||||||||||||2017-02-18 16:19:56.263155|2017-02-18 16:19:56.263155
NCT00364442|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2016-09-13|||January 2005||2005-01-01|September 2016|2016-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics|A Repeat Dose, Randomised, Double Blind, 2-way Crossover Study to Assess the Safety and Systemic Exposure of an Investigational Formulation Compared to Concurrent Administration of Individual Fluticasone Propionate 50 and Salmeterol 50 DISKUS Inhalers in Subjects Aged 18 - 55 Years With Mild Asthma|Completed||Phase 1|12|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 16:19:56.356674|2017-02-18 16:19:56.356674
NCT00364429|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2016-01-07|||July 2005||2005-07-01|January 2016|2016-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia|Investigation of the NMDA Receptor System in Man as a Potential Surrogate Marker for Deficit Syndrome in Schizophrenia: a [123]I-CNS 1261 Single Photon Emission Tomography (SPET) Study|Terminated||Phase 1|55|Actual|GlaxoSmithKline||||terminated|f||||f||||||||||2017-02-18 16:19:56.471538|2017-02-18 16:19:56.471538
NCT00364416|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2010-04-26|||October 2002||2002-10-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|||||Observational|||Longitudinal Registry for Advanced Heart Failure Patients|ADHERE (Acute Decompensated Heart Failure National Registry) Longitudinal Module-Registry of Advanced Heart Failure Patients at High Risk for Rehospitalization|Completed||N/A|1466|Actual|Scios, Inc.|||1||f||||||||||||||2017-02-18 16:19:56.579871|2017-02-18 16:19:56.579871
NCT00364403|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2010-08-27|||February 2007||2007-02-01|August 2010|2010-08-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||A Low Glycemic Load Diet During Pregnancy in Overweight Women|Glycemic Load and Infant Birth Weight in Pregnant Overweight/Obese Women|Completed||N/A|60|Anticipated|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 16:19:56.673128|2017-02-18 16:19:56.673128
NCT00364390|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2009-03-27|||April 2006||2006-04-01|March 2009|2009-03-01|February 2009|Anticipated|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery|A Phase I Open Label Pilot Study to Evaluate the Safety, Efficacy and Tolerability of Anginera for Adults With Left Ventricular Dysfunction AND Reversible Myocardial Ischemia Undergoing CABG Surgery|Unknown status|Active, not recruiting|Phase 1|12|Anticipated|Theregen, Inc.||1|||f||||t||||||||||2017-02-18 16:19:57.014372|2017-02-18 16:19:57.014372
NCT00364377|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2011-11-01|2011-04-04||August 2006||2006-08-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Incretins in Impaired Fasting Glucose|The Role of Incretins in the Pathogenesis of Fasting and Postprandial Glucose Metabolism in People With Impaired Fasting Glucose|Completed||Phase 4|22|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 16:19:57.127484|2017-02-18 16:19:57.127484
NCT00364364|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2008-12-16|||May 2007||2007-05-01|December 2008|2008-12-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.|Pharmacokinetics, Biodistribution and Targeting of 111 In- Labeled Humanized PAM4IgG in Pre-Surgical Pancreatic Cancer Patients.An Examination of Protein Dose|Terminated||Phase 1|9|Anticipated|Sidney Kimmel Comprehensive Cancer Center||||Loss of funding|f||||||||||||||2017-02-18 16:19:57.484392|2017-02-18 16:19:57.484392
NCT00364351|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2016-11-15|2011-04-27||August 2006||2006-08-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy|A Phase III, International, Randomised, Double Blind, Parallel-Group Study to Assess the Efficacy of Zactima™ Versus Tarceva® in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Failure of at Least One Prior Chemotherapy|Completed||Phase 3|1574|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:19:57.607339|2017-02-18 16:19:57.607339
NCT00364143|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2012-01-25|||September 2006||2006-09-01|January 2012|2012-01-01||||||||Interventional|||Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors|A Phase I Study of IHL-305 (Irinotecan Liposome Injection) in Patients With Advanced Solid Tumors|Unknown status|Recruiting|Phase 1|40|Anticipated|Yakult Honsha Co., LTD|||||t||||||||||||||2017-02-18 16:19:58.712349|2017-02-18 16:19:58.712349
NCT00364130|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2014-08-20|2014-06-12||February 2007||2007-02-01|August 2014|2014-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial|Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus Trial|Completed||N/A|138|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-02-18 16:19:58.823605|2017-02-18 16:19:58.823605
NCT00364117|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2013-05-03|||August 2006||2006-08-01|May 2013|2013-05-01|August 2008|Actual|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||Remote Presence Timely Discharge Management|Remote Presence Timely Discharge Management|Withdrawn||Phase 2/Phase 3|0|Actual|Hackensack University Medical Center||||No patients were enrolled|f||||||||||||||2017-02-18 16:19:59.640034|2017-02-18 16:19:59.640034
NCT00364104|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2009-06-26|||March 2007||2007-03-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|HEIDC||Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children|Randomized Field Intervention Trial of H. Pylori Eradication to Reduce Iron Deficiency Among Children in El Paso, Texas|Completed||Phase 3|125|Actual|The University of Texas Health Science Center, Houston||4|||f||||t||||||||||2017-02-18 16:19:59.749985|2017-02-18 16:19:59.749985
NCT00364091|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2011-09-26|||August 2006||2006-08-01|September 2011|2011-09-01||||October 2006|Actual|2006-10-01||Interventional|||Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis|A Multi-Center, Randomized, Double-Masked Parallel Group Study Evaluating the Efficacy, Safety, and QOL of R89674 0.25% Ophthalmic Solution Compared to Vehicle or an Active Control in a Modified Model of Environmental Seasonal Allergic Conjunctivitis|Completed||Phase 3|365|Actual|Vistakon Pharmaceuticals|||||f||||||||||||||2017-02-18 16:19:59.869058|2017-02-18 16:19:59.869058
NCT00364078|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2008-05-19|||June 2006||2006-06-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Observational|||Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care|Transitoriness in Cancer Patients: a Cross-Sectional Study of Uncertainty, Locus of Control, Quality of Life and Existentials Views on Finality of Life in Cancer Patients|Completed||N/A|193|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 16:19:59.974364|2017-02-18 16:19:59.974364
NCT00364065|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2007-04-17|||September 2006||2006-09-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Study to Evaluate Ferris PainWrap in the Treatment of Chronic Low Back Pain|A Randomized, Controlled, Double-Blind, Pilot Study to Evaluate Ferris PainWrap, a Semipermeable Hydrophilic Polymeric Membrane, in the Treatment of Chronic Low Back Pain|Completed||Phase 4|20||Pain and Rehabilitation Medicine|||||f||||||||||||||2017-02-18 16:20:00.077862|2017-02-18 16:20:00.077862
NCT00364052|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2006-08-16|||August 2006||2006-08-01|August 2006|2006-08-01|January 2007||2007-01-01|||||Observational|||Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients|Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients: A Single Center Experience With Oral Ganciclovir Versus Valganciclovir|Unknown status|Not yet recruiting|Phase 4|200||Oregon Health and Science University|||||f||||||||||||||2017-02-18 16:20:00.172924|2017-02-18 16:20:00.172924
NCT00364039|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2007-02-27|||August 2006||2006-08-01|February 2007|2007-02-01||||||||Interventional|||Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650|A Phase 1 Double-Blind, Placebo-Controlled Single Center Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Dose and Multiple Dose Escalations of AV650 in Healthy Subjects|Completed||Phase 1|30||Avigen|||||||||||||||||||2017-02-18 16:20:00.279741|2017-02-18 16:20:00.279741
NCT00364026|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2007-01-17|||June 2004||2004-06-01|August 2006|2006-08-01|July 2005||2005-07-01|||||Interventional|||A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs|A Phase II Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic (Protocol DAR-201)|Completed||Phase 2|||Gilead Sciences|||||||||||||||||||2017-02-18 16:20:00.365098|2017-02-18 16:20:00.365098
NCT00364013|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2017-02-07|2014-02-13||August 2006||2006-08-01|February 2017|2017-02-01|March 2013|Actual|2013-03-01|August 2009|Actual|2009-08-01||Interventional|||PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy|A Randomized, Multicenter, Phase 3 Study to Compare the Efficacy of Panitumumab in Combination With Oxaliplatin/ 5-fluorouracil/ Leucovorin to the Efficacy of Oxaliplatin/ 5-fluorouracil/ Leucovorin Alone in Patients With Previously Untreated Metastatic Colorectal Cancer|Completed||Phase 3|1183|Actual|Amgen||2|||f||||t||||||||||2017-02-18 16:20:00.461732|2017-02-18 16:20:00.461732
NCT00364000|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2011-11-12|||January 2012||2012-01-01|November 2011|2011-11-01|December 2013|Anticipated|2013-12-01|July 2013|Anticipated|2013-07-01||Interventional|||Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate|Arterial Stiffness and Arterial Calcifications Evolution in ESRD Haemodialysis Patients Treated by Sevelamer or Calcium Acetate|Unknown status|Not yet recruiting|N/A|240|Anticipated|Romanian Society of Nephrology||2|||f||||t||||||||||2017-02-18 16:20:02.153771|2017-02-18 16:20:02.153771
NCT00363987|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-13|2010-09-01|||May 2006||2006-05-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)|A Multicenter, Randomized, Open-label, Parallel-group, Diabetic Diet-controlled Study to Evaluate the Efficacy and Safety of Compound α-Keto Acid Tablet in Combination With LPD in Delaying the Progress of Type 2 Diabetic Nephropathy|Completed||Phase 4|179|Actual|Fresenius Kabi||2|||f||||||||||||||2017-02-18 16:20:02.276674|2017-02-18 16:20:02.276674
NCT00363974|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2009-11-30|||October 2005||2005-10-01|November 2009|2009-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML|An Open-Label Phase I/II Study of XIAP Antisense AEG35156 Administered to Patients With Refractory/Relapsed AML in Combination With Chemotherapy|Completed||Phase 1/Phase 2|54|Anticipated|Aegera Therapeutics||1|||f||||f||||||||||2017-02-18 16:20:02.384902|2017-02-18 16:20:02.384902
NCT00363961|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2009-12-09|||April 2004||2004-04-01|December 2009|2009-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Resistance Training During Maintenance Dialysis|Resistance Training During Maintenance Dialysis|Completed||N/A|51|Actual|Tufts University||2|||f||||t||||||||||2017-02-18 16:20:02.739192|2017-02-18 16:20:02.739192
NCT00363948|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2012-06-12|||August 2006||2006-08-01|June 2012|2012-06-01||||February 2008|Actual|2008-02-01||Interventional|||Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus|MK-0431/ONO-5435 Phase III Clinical Study - Metformin Add-On Study for Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|188|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||||||||||||2017-02-18 16:20:02.856075|2017-02-18 16:20:02.856075
NCT00363935|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2007-04-17||||||April 2007|2007-04-01||||||||Interventional|||Bariatric Dose-Ranging Study With Dexmedetomidine|A Randomized, Double-Blind, Controlled Study of Dexmedetomidine (Precedex) Infusion for Improving Control of Acute Autonomic Response During Laparoscopic Bariatric Surgery|Completed||Phase 4|||University of Texas Southwestern Medical Center|||||||||||||||||||2017-02-18 16:20:02.976773|2017-02-18 16:20:02.976773
NCT00363922|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2015-09-28|||September 2006||2006-09-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Rehabilitation After Coronary Bypass Grafting. Comparison of Different Types of Rehabilitation Programs|Rehabilitation After Coronary Bypass Grafting: Home Based Rehabilitation Versus Rehabilitation in Institution and Rehabilitation in Institution Versus Out-patient Rehabilitation at the Hospital|Completed||Phase 2|30|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 16:20:03.057353|2017-02-18 16:20:03.057353
NCT00363909|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-12-09|||November 2006||2006-11-01|December 2016|2016-12-01|December 2010|Actual|2010-12-01|June 2007|Actual|2007-06-01||Interventional|||Citalopram in Treating Postmenopausal Women With Hot Flashes|Phase III Randomized, Double-Blind, Placebo-Controlled Evaluation of Citalopram for the Treatment of Hot Flashes|Completed||Phase 3|254|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-02-18 16:20:03.171083|2017-02-18 16:20:03.171083
NCT00363896|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-11-16|2012-08-14||July 2006||2006-07-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)|Clinical Trial Assessing Efficacy and Safety of LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients|Completed||Phase 3|843|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:20:03.49684|2017-02-18 16:20:03.49684
NCT00363883|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2015-01-28|2015-01-28||June 2006||2006-06-01|January 2014|2014-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium|Phase II Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Recurrent or Metastatic Transitional Cell Carcinoma of the Urothelium|Terminated||Phase 2|14|Actual|National Cancer Institute (NCI)|Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results.|1||Trial stopped early for futility|f||||||||||||||2017-02-18 16:20:04.86855|2017-02-18 16:20:04.86855
NCT00363870|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-11-02|||September 2006||2006-09-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults|A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine (Fluarix™) Administered Intramuscularly in Adults|Completed||Phase 4|7632||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:20:05.346452|2017-02-18 16:20:05.346452
NCT00363857|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2016-10-14|||August 2003||2003-08-01|October 2016|2016-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome|A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering From Restless Legs Syndrome (RLS)|Completed||Phase 3|360|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:20:05.461226|2017-02-18 16:20:05.461226
NCT00363844|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2012-06-12|||August 2006||2006-08-01|June 2012|2012-06-01||||February 2008|Actual|2008-02-01||Interventional|||Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus|MK-0431/ONO-5435 Phase III Clinical Study - Long-term Treatment Study for Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|209|Actual|Ono Pharmaceutical Co. Ltd||1|||f||||||||||||||2017-02-18 16:20:05.619222|2017-02-18 16:20:05.619222
NCT00363831|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2010-07-27|||July 2006||2006-07-01|July 2010|2010-07-01||||December 2009|Anticipated|2009-12-01||Interventional|||Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma|A Multi-center Phase II Trial of Capecitabine in Combination With Oxaliplatin (Xelox) as First Line Chemotherapy in Patients With Metastatic Nasopharyngeal Carcinoma (NPC)|Unknown status|Recruiting|Phase 2|42|Anticipated|The University of Hong Kong||1|||f||||||||||||||2017-02-18 16:20:05.726224|2017-02-18 16:20:05.726224
NCT00363818|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2008-04-08|||January 2006||2006-01-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Observational|||The Association of Platelet Function and Endothelial Function of the Brachial Artery|The Association Between Platelet Function and Endothelial Function of the Brachial Artery in Healthy Subjects and in Patients With Coronary Artery Disease|Completed||N/A|151|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 16:20:05.820805|2017-02-18 16:20:05.820805
NCT00363805|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2013-09-27|2013-07-02||May 2004||2004-05-01|September 2013|2013-09-01||||March 2009|Actual|2009-03-01||Interventional|||Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease|Chemoprevention of Lung Carcinogenesis Using Green Tea: Phase IIb Randomized, Double-Blinded, Placebo Controlled Trial of Green Tea and Polyphenon E in Former Smokers With Chronic Obstructive Lung Disease (COPD)|Completed||Phase 2|178|Actual|University of Arizona||3|||f||||||||||||||2017-02-18 16:20:05.915011|2017-02-18 16:20:05.915011
NCT00363792|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2006-08-11||||||August 2006|2006-08-01|May 2007||2007-05-01|||||Interventional|||Effect of GTN and Diamox Measured by BOLD-Response.|The Effect of Glyceryl Trinitrate and Diamox on Blood-Oxygenation-Level-Dependent.Signal (BOLD-Signal) and Cerebral Haemodynamics With the Use of a 3-Tesla MRI-Scan.|Unknown status|Recruiting|N/A|12||Danish Headache Center|||||f||||||||||||||2017-02-18 16:20:06.490065|2017-02-18 16:20:06.490065
NCT00363779|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2015-06-26|2012-03-30||June 2006||2006-06-01|June 2015|2015-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia|Microarray Analysis of the Effect of Cyclosporine Therapy on Gene Expression Patterns in Large Granular Lymphocytic Leukemia|Terminated||Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)|As there were only 5 patients treated, the primary endpoints of this protocol were not met and there is not enough data generated for statistical analysis. This protocol is being terminated due to low accrual and the investigator leaving the NIH.|1||Study terminated due to low accrual and the investigator left the NIH.|f||||f||||||||||2017-02-18 16:20:06.59694|2017-02-18 16:20:06.59694
NCT00363766|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2009-10-16||2009-10-16|September 2006||2006-09-01|October 2009|2009-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of LY573636 in Patients With Metastatic Non-Small Cell Lung Cancer|A Phase 2 Study of LY573636 Administered as an Intravenous Infusion on Day 1 of a 21-Day Cycle as Third-line Treatment in Patients With Unresectable, Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|52|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 16:20:06.979687|2017-02-18 16:20:06.979687
NCT00363753|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2007-03-30|||August 2006||2006-08-01|March 2007|2007-03-01|March 2007|Anticipated|2007-03-01|||||Interventional|||Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack|Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack|Withdrawn||Phase 1|20||University of California, San Diego|||||f||||||||||||||2017-02-18 16:20:07.091712|2017-02-18 16:20:07.091712
NCT00363740|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2013-04-11|||February 2005||2005-02-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study of GW685698X In Patients With Seasonal Allergic Rhinitis|Clinical Evaluation of GW685698 for Seasonal Allergic Rhinitis -A Placebo-controlled Study to Determine the Non-inferiority of GW685698 Over Fluticasone Propionate Using a Double-blind Manner-|Completed||Phase 3|38|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:20:07.185149|2017-02-18 16:20:07.185149
NCT00363727|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2017-01-16|||December 2003||2003-12-01|January 2017|2017-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's|A Two Year Phase IIIb Randomised, Multicenter, Double-blind, SINEMET Controlled, Parallel Group, Flexible Dose Study, to Assess the Effectiveness of Controlled Release Ropinirole add-on Therapy to L-dopa at Increasing the Time to Onset of Dyskinesia in Parkinson's Disease Subjects.|Completed||Phase 3|209|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:20:07.27424|2017-02-18 16:20:07.27424
NCT00363714|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2008-08-14|||November 2004||2004-11-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)||Completed||Phase 1/Phase 2|26|Actual|Allergan||6|||f||||||||||||||2017-02-18 16:20:07.448133|2017-02-18 16:20:07.448133
NCT00363701|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2006-08-14|||August 2006||2006-08-01|August 2006|2006-08-01|February 2008||2008-02-01|||||Interventional|||Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice|With-Drawal Study of Proton-Pump-Inhibitors in Patients From Primary Care Who Have Previously Been Treated on a Long-Term Basis|Unknown status|Recruiting|Phase 4|150||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 16:20:07.565764|2017-02-18 16:20:07.565764
NCT00363688|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2006-08-10|||January 1998||1998-01-01|December 1997|1997-12-01|May 2004||2004-05-01|||||Interventional|||Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin|Treating Patients With a History of Non-Life Threatening Allergic Reaction to Penicillin With Penicillin: Is It Safe?|Terminated||Phase 4|||Meir Medical Center|||||f||||||||||||||2017-02-18 16:20:07.779552|2017-02-18 16:20:07.779552
NCT00363675|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-02-29|2012-02-29||August 2006||2006-08-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Evaluation of Hand Assessments in Children With Severe Hand Burns|Evaluation of Hand Assessments in Children With Severe Hand Burns|Terminated||N/A|3|Actual|Massachusetts General Hospital|This pilot study was discontinued secondary to lack of grant funding for the project.|1||This was a pilot study, but the larger study was not funded.|f||||f||||||||||2017-02-18 16:20:07.90261|2017-02-18 16:20:07.90261
NCT00363662|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-06-12|||June 2006||2006-06-01|June 2012|2012-06-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Observational|||Diagnostic Utility of MRI in Intracerebral Hemorrhage|Diagnostic Utility of MRI in Intracerebral Hemorrhage|Unknown status|Recruiting|N/A|160|Anticipated|Stanford University|||1||f||||||||||||||2017-02-18 16:20:08.182489|2017-02-18 16:20:08.182489
NCT00363649|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-05-17|||September 2006||2006-09-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI|A Randomized Phase II Trial of Interferon + GM-CSF Versus K562/GM-CSF Vaccination in CML Patients Achieving a Complete Cytogenetic Response to Frontline Tyrosine Kinase Inhibitor Therapy|Recruiting||Phase 2|56|Anticipated|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||||2017-02-18 16:20:08.265022|2017-02-18 16:20:08.265022
NCT00363636|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2015-09-17||2015-09-17|September 2006||2006-09-01|March 2011|2011-03-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)|A Phase III, Randomized, Double-Blind Study of Galiximab in Combination With Rituximab Compared With Rituximab in Combination With Placebo for the Treatment of Subjects With Relapsed or Refractory, Follicular Non-Hodgkin's Lymphoma|Terminated||Phase 3|340|Actual|Biogen||2||"Enrollment challenges due to changes in standards of care resulted in premature termination.~   No safety or efficacy events factored into this action."|f||||t||||||||||2017-02-18 16:20:08.398171|2017-02-18 16:20:08.398171
NCT00363623|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2008-03-20|||August 2006||2006-08-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||Comparison of Contact Lens Maintenance Systems for Silicone Hydrogel Lenses||Completed||N/A|44||University of Melbourne|||||f||||||||||||||2017-02-18 16:20:08.503372|2017-02-18 16:20:08.503372
NCT00363610|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2008-05-16|||July 2006||2006-07-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma|A Multicenter, Open-Label, Phase I Study Evaluating the Safety and Tolerability of Intravenous Pegaspargase in Combination With Intravenous Gemcitabine HCl in the Treatment of Advanced and/or Metastatic Solid Tumors and Lymphoma|Terminated||Phase 1|19|Actual|Enzon Pharmaceuticals, Inc.||1||No recommended Phase II dose was determined.|f||||f||||||||||2017-02-18 16:20:08.574427|2017-02-18 16:20:08.574427
NCT00363597|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2012-02-28|||August 2006||2006-08-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Intestinal Permeability in Children/Adolescents With Functional Dyspepsia|Intestinal Permeability and Serum Zonulin Concentration in Children/Adolescents With Functional Dyspepsia|Completed||N/A|42|Actual|Children's Mercy Hospital Kansas City||1|||f||||f||||||||||2017-02-18 16:20:08.673976|2017-02-18 16:20:08.673976
NCT00363584|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2013-08-23|||March 2006||2006-03-01|October 2011|2011-10-01||||August 2013|Actual|2013-08-01||Interventional|||Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer|A Randomised Clinical Trial Evaluating Adjuvant Chemotherapy With Capecitabine Compared to Expectant Treatment Alone (Observation) Following Surgery for Biliary Tract Cancer|Completed||Phase 3|360|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:20:08.793999|2017-02-18 16:20:08.793999
NCT00363571|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-14|2006-08-14|||August 2006||2006-08-01|July 2006|2006-07-01|May 2007||2007-05-01|||||Interventional|||The Effect of Glyceryl Trinitate and Diamox on Cerebral Haemodynamics.|The Effect of Glyceryl Trinitrate (GTN) and Diamox on Cerebral Haemodynamics Judged With the Help of 3-Tesla MRI.|Unknown status|Not yet recruiting|N/A|12||Danish Headache Center|||||f||||||||||||||2017-02-18 16:20:09.124616|2017-02-18 16:20:09.124616
NCT00363558|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2006-08-10|||January 2002||2002-01-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||Fixation of Skin Grafts in Patients With Burns: Comparison Between Cyanoacrylate Glue and Skin Staples|Fixation of Skin Grafts in Patients With Burns: Comparison Between Cyanoacrylate Glue and Skin Staples|Completed||N/A|44||Rabin Medical Center|||||f||||||||||||||2017-02-18 16:20:09.217664|2017-02-18 16:20:09.217664
NCT00363545|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2017-01-04|||September 2006||2006-09-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)|A Study to Assess the Immunogenicity, Reactogenicity and Safety of 2 Different Formulations of GSK Biologicals' Live Attenuated HRV Vaccine, Given as a Two-dose Primary Vaccination, in Healthy Infants Previously Uninfected With HRV|Completed||Phase 3|1270|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:20:09.299336|2017-02-18 16:20:09.299336
NCT00363532|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2009-01-27|||September 2006||2006-09-01|January 2009|2009-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Functional MRI (fMRI) in CGRP Induced Migraine|Functional MRI (fMRI) in Patients With Migraine Without Aura Provoked by|Completed||N/A|12|Anticipated|Danish Headache Center|||||f||||||||||||||2017-02-18 16:20:09.420879|2017-02-18 16:20:09.420879
NCT00363519|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2012-06-12|||August 2006||2006-08-01|June 2012|2012-06-01||||January 2008|Actual|2008-01-01||Interventional|||Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus|MK-0431/ONO-5435 Phase III Clinical Study - Glimepiride add-on Study for Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|195|Actual|Ono Pharmaceutical Co. Ltd||2|||f||||||||||||||2017-02-18 16:20:09.511432|2017-02-18 16:20:09.511432
NCT00363506|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2008-04-22|||January 2006||2006-01-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|||||Interventional|||American Migraine Prevention Study|Nutritional Based Protocol to Balance Serotonin for the Prevention or Reduced Frequency/Duration/Intensity of Migraines|Unknown status|Recruiting|Phase 4|1000|Anticipated|Dynamic Health Resources|||||f||||||||||||||2017-02-18 16:20:09.639145|2017-02-18 16:20:09.639145
NCT00363480|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2017-01-20|||May 2006||2006-05-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data|Asthma Control Assessment Via ACT and DRC in Asthmatics Treated With Seretide (50/250) Over 12 Weeks|Completed||Phase 4|220|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:20:09.735588|2017-02-18 16:20:09.735588
NCT00363467|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2011-08-24|2010-08-09||May 2006||2006-05-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation|A Pilot Study of Intravenous, Targeted-Dose Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation in High-Risk AML|Terminated||N/A|3|Actual|H. Lee Moffitt Cancer Center and Research Institute|Two patients enrolled and transplanted out of 24 targeted transplant accrual goal. Due to poor enrollment study closed and no further analyses were conducted.|1||Low accrual|f||||t||||||||||2017-02-18 16:20:09.887632|2017-02-18 16:20:09.887632
NCT00363454|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-08-06|||April 2006||2006-04-01|May 2015|2015-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer|Phase I Pharmacokinetic and Pharmacodynamic, Open-Label, Dose Escalation Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer Which Have Activated Akt Demonstrated by Immunohistochemistry|Completed||Phase 1|19|Actual|Prescient Therapeutics, Ltd.||1|||f||||t||||||||||2017-02-18 16:20:10.215716|2017-02-18 16:20:10.215716
NCT00363441|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-01-18||||||January 2011|2011-01-01||||||||Interventional|||A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck|A Randomized Phase II Study of Conventional 3D Radiation (3DCRT) Versus Intensity-Modulated Radiation (IMRT) in Squamous Cell Cancer of the Head and Neck (SCCHN): Pilot Feasibility Study|Withdrawn||Phase 2/Phase 3|0|Actual|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 16:20:10.332756|2017-02-18 16:20:10.332756
NCT00363428|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-04-18|||August 2006||2006-08-01|April 2016|2016-04-01||||September 2016|Anticipated|2016-09-01||Interventional|||Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer|A Randomized Trial of Pulmonary Rehabilitation in Patients With Moderate to Severe COPD Who Require Lung Resection for Lung Cancer|Active, not recruiting||Phase 2|90|Anticipated|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:20:10.419958|2017-02-18 16:20:10.419958
NCT00363415|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2009-10-20|2009-06-05||August 2006||2006-08-01|October 2009|2009-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer|A Randomized Phase 3 Trial of Alimta (Pemetrexed) and Carboplatin Versus Etoposide and Carboplatin in Extensive-Stage Small Cell Lung Cancer|Completed||Phase 3|908|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 16:20:10.559581|2017-02-18 16:20:10.559581
NCT00363402|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2009-05-19|||August 2006||2006-08-01|August 2006|2006-08-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF)|18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF|Completed||N/A|20|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:20:15.60064|2017-02-18 16:20:15.60064
NCT00363389|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2007-08-06|||September 2006||2006-09-01|April 2007|2007-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Hysteroscopy and Misoprostol Project|Self-Administered Vaginal Misoprostol at Home for Cervical Ripening Prior to Outpatient Hysteroscopy: a Randomised Placebo-Controlled Trial.|Completed||Phase 3|86|Actual|Ullevaal University Hospital||2|||f||||t||||||||||2017-02-18 16:20:15.692717|2017-02-18 16:20:15.692717
NCT00363376|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-04-11|||January 2008||2008-01-01|April 2012|2012-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain|A Double-Blind, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain|Completed||Phase 3|42|Actual|Lindner Center of HOPE||2|||f||||f||||||||||2017-02-18 16:20:15.791059|2017-02-18 16:20:15.791059
NCT00363363|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2013-08-25|||August 2006||2006-08-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|June 2008|Actual|2008-06-01||Interventional|||Physical Activity in Fontan Patients|Identifying Determinants and Optimizing Rehabilitation of Physical Activity for Children After the Fontan Procedure|Completed||Phase 3|64|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 16:20:15.92769|2017-02-18 16:20:15.92769
NCT00363350|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2009-02-23|||August 2006||2006-08-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Rituximab Treatment in Sjogren's Syndrome|Rituximab for the Treatment of Primary Sjögren's Syndrome: a Double Blinded Randomized Placebo-Controlled Trial|Completed||Phase 1/Phase 2|30|Anticipated|University Medical Center Groningen||1|||f||||||||||||||2017-02-18 16:20:16.034151|2017-02-18 16:20:16.034151
NCT00363337|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2011-06-21|||August 2006||2006-08-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression||Completed||Phase 4|31|Actual|Lindner Center of HOPE||1|||f||||||||||||||2017-02-18 16:20:16.139226|2017-02-18 16:20:16.139226
NCT00363324|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2007-12-27|||January 2005||2005-01-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Bone Marrow Cells in Myocardial Infarction|Effects of Autologous Bone Marrow Celss on Acute ST-Elevation Myocardial Infarction|Completed||Phase 2/Phase 3|100|Anticipated|University of Oulu|||||f||||||||||||||2017-02-18 16:20:16.241851|2017-02-18 16:20:16.241851
NCT00363311|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2016-11-30|2011-03-31||July 2006||2006-07-01|November 2016|2016-11-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men|A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride in Extending the Time to Progression of Low-Risk, Localized Prostate Cancer in Men Who Are Candidates for or Undergoing Expectant Management|Completed||Phase 4|302|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:20:16.354312|2017-02-18 16:20:16.354312
NCT00363298|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-06-05|||August 2006||2006-08-01|June 2012|2012-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD|Double-blind Trial of Acute and Intermediate-term Dextro-amphetamine Versus Caffeine Augmentation in Treatment Resistant OCD|Completed||N/A|24|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 16:20:17.989007|2017-02-18 16:20:17.989007
NCT00363285|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2013-08-23|||January 2003||2003-01-01|October 2006|2006-10-01||||||||Interventional|||Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer|Intermittent Hormone Therapy for Newly Diagnosed Metastatic Prostate Cancer|Unknown status|Recruiting|Phase 3|900|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:20:18.169882|2017-02-18 16:20:18.169882
NCT00363272|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2013-01-15|||June 2006||2006-06-01|January 2013|2013-01-01||||October 2008|Actual|2008-10-01||Interventional|||Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma|A PHASE 1 STUDY OF ISPINESIB (SB-715992) IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:20:18.447672|2017-02-18 16:20:18.447672
NCT00363259|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2006-08-10|||July 2002||2002-07-01|August 2006|2006-08-01|November 2005||2005-11-01|||||Interventional|||Pegintron Induction Therapy in HCV Non-Responders|Pegintron Induction Therapy in Previous Non-Responders With Chronic HCV: A Dutch Multicenter Randomized Controlled Trial. (PIT-Study)|Completed||Phase 3|110||Foundation for Liver Research|||||f||||||||||||||2017-02-18 16:20:18.568983|2017-02-18 16:20:18.568983
NCT00363246|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2015-07-27|2015-06-05||June 2007||2007-06-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|November 2009|Actual|2009-11-01||Observational||Only data for 710 participants for some of the Baseline characteristics.|Characterizing Wheelchair-Related Falls in Elderly Veterans|Characterizing Wheelchair-Related Falls in Elderly Veterans|Completed||N/A|766|Actual|VA Office of Research and Development|||1||f||||t||||||||||2017-02-18 16:20:18.665052|2017-02-18 16:20:18.665052
NCT00363233|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2007-01-08|||March 2006||2006-03-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus|The Effects of Flax Lignans on Lipid Profile and Glucose Management in Type 2 Diabetes: a Randomized Double-Blind Cross-Over Study|Completed||Phase 2/Phase 3|80||Chinese Academy of Sciences|||||f||||||||||||||2017-02-18 16:20:19.063194|2017-02-18 16:20:19.063194
NCT00363220|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2015-12-16|||August 2006||2006-08-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Community - Associated Extended-spectrum Beta-lactamases (ESBL)|Community - Associated Extended-spectrum Beta-lactamases (ESBL)|Completed||N/A|100|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:20:19.158427|2017-02-18 16:20:19.158427
NCT00363207|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2008-05-19|||May 2007||2007-05-01|April 2007|2007-04-01|May 2008|Actual|2008-05-01|||||Observational|||Behavior of Children Related to Numbness After Dental Local Anesthesia|Behavior of Children in the Following Appointment Related to Numbness Perception After Dental Local Anesthesia|Completed||N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||t||||||||||2017-02-18 16:20:19.247155|2017-02-18 16:20:19.247155
NCT00363194|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2010-03-17||2010-03-17|September 2006||2006-09-01|March 2010|2010-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients|An Open-Label, Two-Period, Randomized, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Single Doses of Pazopanib in Cancer Patients|Completed||Phase 1|28|Anticipated|GlaxoSmithKline||1|||||||||||||||||2017-02-18 16:20:19.335867|2017-02-18 16:20:19.335867
NCT00363181|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2007-03-19|||April 2006||2006-04-01|March 2007|2007-03-01||||||||Observational|||Side Effects of Antipsychotic Medications|Does Olanzapine Inhibit the Secretory Response to Insulin Resistance?|Unknown status|Recruiting|N/A|120||Stanford University|||||f||||||||||||||2017-02-18 16:20:19.458728|2017-02-18 16:20:19.458728
NCT00363168|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-09-18|2012-04-03||August 2006||2006-08-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|June 2008|Actual|2008-06-01||Interventional|||Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial|Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial|Completed||Phase 1|7|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 16:20:19.550776|2017-02-18 16:20:19.550776
NCT00363155|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2006-08-10|||March 2003||2003-03-01|August 2006|2006-08-01|July 2006||2006-07-01|||||Interventional|||KRN7000 in Chronic Hepatitis B|Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis B Infection|Completed||Phase 1/Phase 2|28||Foundation for Liver Research|||||f||||||||||||||2017-02-18 16:20:19.935661|2017-02-18 16:20:19.935661
NCT00363142|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2010-10-21|2009-06-11||May 2006||2006-05-01|October 2010|2010-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects|See Detailed Description.|Completed||Phase 3|211|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:20:20.037157|2017-02-18 16:20:20.037157
NCT00363129|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-07-01|2014-07-17||December 2006||2006-12-01|July 2016|2016-07-01|August 2014|Actual|2014-08-01|December 2010|Actual|2010-12-01||Interventional|||Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer|The Use of Vitamin E for Prevention of Chemotherapy Induced Peripheral Neuropathy: A Phase III Double-Blind Placebo Controlled Study|Completed||Phase 3|207|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 16:20:20.910006|2017-02-18 16:20:20.910006
NCT00363116|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2013-10-24|||April 1999||1999-04-01|October 2013|2013-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients|An Open-Label, Comparative Trial of Two Daclizumab Dosing Strategies Versus No Induction Treatment in Combination With Tacrolimus, Mycophenolate Mofetil, and Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients|Completed||Phase 4|298|Actual|University of Cincinnati||3|||f||||||||||||||2017-02-18 16:20:22.119684|2017-02-18 16:20:22.119684
NCT00363090|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2013-09-19|||September 2006||2006-09-01|June 2009|2009-06-01||||December 2010|Anticipated|2010-12-01||Interventional|||Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma|Alemtuzumab and CHOP Chemotherapy for Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Centre Phase I and II Study|Unknown status|Recruiting|Phase 1/Phase 2|84|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:20:22.253284|2017-02-18 16:20:22.253284
NCT00005725|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1991||1991-08-01|May 2000|2000-05-01|May 1996|Actual|1996-05-01|||||Observational|||Low Literacy CVD Diet Education for Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:27.818487|2017-02-18 18:14:27.818487
NCT00363077|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2016-10-06|2013-03-21||October 2006||2006-10-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate|A Study to Evaluate the Immunogenicity, Safety and Reactogenicity of Adjuvanted Influenza Vaccine Candidate Compared to Fluarix™ (GlaxoSmithKline Biologicals) Administered Intramuscularly in Elderly Aged 60 Years and Older.|Completed||Phase 2|150|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:20:22.367796|2017-02-18 16:20:22.367796
NCT00363051|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2013-05-06|2011-12-02||June 2006||2006-06-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|January 2008|Actual|2008-01-01||Interventional|||Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy|An Open Label, Stratified, Single-arm Phase II Study of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumor (NET) After Failure of Cytotoxic Chemotherapy|Completed||Phase 2|160|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:20:23.100427|2017-02-18 16:20:23.100427
NCT00363038|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2014-05-22|2010-11-29||July 2006||2006-07-01|May 2014|2014-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effects of Topical Vitamin K, Vitamin K and Retinol, and Arnica on Post-Laser Bruising|Effects of Topical Vitamin K, Vitamin K and Retinol, and Arnica on Post-Laser Bruising|Completed||N/A|16|Actual|Northwestern University|As only laser-induced bruising on the inner arm was studied, it remains to be seen if this result can be generalized to other postoperative bruises and at other anatomical sites.|1|||f||||f||||||||||2017-02-18 16:20:24.087785|2017-02-18 16:20:24.087785
NCT00363025|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2008-02-20|||November 1999||1999-11-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.|A Randomized Multicenter Study of More Intensive Versus Less Intensive Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia (AML) or Transformed Refractory Anemia With Excess Blasts (RAEB-t).|Terminated||Phase 3|465||Acute Leukemia French Association|||||f||||||||||||||2017-02-18 16:20:24.47727|2017-02-18 16:20:24.47727
NCT00363012|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2013-10-11|||April 2006||2006-04-01|October 2013|2013-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2|Development of HER-2/Neu (HER2) ICD Memory Immunity After Vaccination With a Plasmid Encoding HER2 ICD in Patients With Advanced Stage HER2 Overexpressing Breast and Ovarian Cancers|Completed||N/A|56|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 16:20:24.586449|2017-02-18 16:20:24.586449
NCT00362999|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2011-07-06|||August 2006||2006-08-01|July 2011|2011-07-01||||||||Observational|||Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism|Histamine Pharmacodynamics in Patients With Allergic Rhinitis: Validation of Laser Doppler Flowmetry as a Surrogate Endpoint|Unknown status|Recruiting|N/A|70|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 16:20:24.693095|2017-02-18 16:20:24.693095
NCT00362986|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-12-09|||October 2006||2006-10-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|July 2007|Actual|2007-07-01||Interventional|||Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Prophylactic Topical Sunscreen to Prevent Erlotinib- or Cetuximab-Induced Skin Rash [or Other Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Skin Rash]|Completed||Phase 3|116|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 16:20:24.795738|2017-02-18 16:20:24.795738
NCT00362973|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-12-23|||May 2006||2006-05-01|May 2013|2013-05-01||||November 2009|Actual|2009-11-01||Observational|||PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer|Early Assessment of Response to Targeted Breast Cancer Therapy|Completed||N/A|42|Actual|University of Washington|||2||f||||||||||||||2017-02-18 16:20:25.123312|2017-02-18 16:20:25.123312
NCT00362960|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2006-10-06|||May 2003||2003-05-01|August 2006|2006-08-01|September 2004||2004-09-01|||||Interventional|||Olmesartan Medoxomil and Diabetic Nephropathy|Effect of Different Doses of Olmesartan Medoxomil Compared to Losartan on Proteinuria, Renal Function and Inflammatory Markers in Type 2 Diabetics With Nephropathy|Completed||Phase 3|300||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 16:20:25.253336|2017-02-18 16:20:25.253336
NCT00362947|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2016-11-22|||August 2006||2006-08-01|August 2012|2012-08-01|February 2011|Actual|2011-02-01|September 2010|Actual|2010-09-01||Interventional|||Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis|Randomized Clinical Study of Different Treatment Doses and Duration of Low Molecular Weight Heparin (Parnaparin) in Superficial Vein Thrombosis|Completed||Phase 3|664|Actual|St. Orsola Hospital||3|||f||||t||||||||No||2017-02-18 16:20:25.373534|2017-02-18 16:20:25.373534
NCT00362934|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-11|2009-07-07|||October 2006||2006-10-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin|A Multicenter, Double-Blind, Randomized, Forced-Titration Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 20 or 40 mg Simvastatin With Atorvastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not Adequately Controlled by 10 mg Atorvastatin Alone|Completed||Phase 3|516|Actual|Solvay Pharmaceuticals||2|||f||||||||||||||2017-02-18 16:20:25.485396|2017-02-18 16:20:25.485396
NCT00362921|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2014-07-09|||April 2004||2004-04-01|February 2013|2013-02-01|July 2008|Actual|2008-07-01|August 2007|Actual|2007-08-01||Interventional|||Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme|Phase II Trial of Gliadel Plus 06-Benzylguanine for Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|52|Actual|Duke University||1|||f||||f||||||||||2017-02-18 16:20:25.795037|2017-02-18 16:20:25.795037
NCT00362908|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2010-10-27|||September 2006||2006-09-01|October 2010|2010-10-01|June 2010|Actual|2010-06-01|September 2009|Actual|2009-09-01||Interventional|||Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome|Diets for Dyslipidemia in the Metabolic Syndrome|Completed||N/A|71|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 16:20:25.908331|2017-02-18 16:20:25.908331
NCT00362895|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-03-02|||April 2006||2006-04-01|March 2012|2012-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Bioequivalence Study of Tobradex AF|A Double-Masked, Parallel-Group, Randomized, Single-Dose Bioequivalence Study of Tobradex AF Suspension and TOBRADEX Ophthalmic Suspension|Completed||Phase 3|995|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:20:26.020239|2017-02-18 16:20:26.020239
NCT00362882|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2014-10-03|2014-04-08||July 2006||2006-07-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer|Randomized Phase II Trial of Sequential Versus Concurrent Docetaxel and PS-341 (NSC 681239) in Previously Treated Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|81|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 16:20:26.126995|2017-02-18 16:20:26.126995
NCT00362869|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-10|2016-12-22|||February 2008||2008-02-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Enteroaggregative E.Coli (EAEC)|Pathogenicity of Enteroaggregative E. Coli in Adult Volunteers; Dose-Escalation Study|Terminated||Phase 1|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-02-18 16:20:27.141472|2017-02-18 16:20:27.141472
NCT00362856|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2007-11-12|||August 2006||2006-08-01|February 2007|2007-02-01|March 2007|Actual|2007-03-01|||||Interventional|||Safety and Tolerability Study of AT1001 in Celiac Disease Subjects|A Phase 2a, Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Multicenter Study to Determine the Safety, Tolerance, and Efficacy of AT-1001 in Celiac Disease Subjects During Gluten Challenge.|Completed||Phase 2|79|Anticipated|Alba Therapeutics|||||f||||||||||||||2017-02-18 16:20:27.270043|2017-02-18 16:20:27.270043
NCT00362843|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2017-01-24|||August 7, 2006||2006-08-07|August 8, 2016|2016-08-08||||||||Observational|||Protein Synthesis in the Brain of Patients With Fragile X Syndrome|PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects With Fragile X Syndrome|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:20:27.352835|2017-02-18 16:20:27.352835
NCT00362830|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2016-09-16|||August 2006||2006-08-01|September 2016|2016-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of the Alternative Administration of Ixabepilone and Vinflunine|A Study of the Alternating Administration of Ixabepilone and Vinflunine Every Three Weeks in Patients With Advanced Cancer|Completed||Phase 1|60|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:20:27.466557|2017-02-18 16:20:27.466557
NCT00362817|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2015-05-04|2015-02-26||October 2004||2004-10-01|May 2015|2015-05-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases|Phase I/II Multicenter Trial of Intra-Arterial Carboplatin and Oral Temozolomide for the Treatment of Recurrent and Symptomatic Residual Brain Metastases.|Completed||Phase 1/Phase 2|17|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:20:27.58005|2017-02-18 16:20:27.58005
NCT00362804|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-07-04|||February 2002||2002-02-01|July 2012|2012-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Tetrabenazine for Partial Responders|Augmentation of Antipsychotic Partial Responders With Tetrabenazine|Completed||N/A|41|Actual|Centre for Addiction and Mental Health|||||f||||f||||||||||2017-02-18 16:20:27.875782|2017-02-18 16:20:27.875782
NCT00362791|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2006-08-09|||April 2003||2003-04-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Project RESPECT: The Efficacy of HIV/STD Prevention Counseling|Multicenter Randomized Controlled Trial Evaluating the Efficacy of HIV/STD Prevention Counseling and Testing in Preventing High Risk Behaviors and New Sexually Transmitted Diseases (Project RESPECT)|Completed||N/A|6000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 16:20:27.985615|2017-02-18 16:20:27.985615
NCT00362778|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2012-03-19|||January 2006||2006-01-01|March 2012|2012-03-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|INSUCOR||Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia|Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia|Completed||Phase 4|28|Actual|Hospital Clinic of Barcelona||1|||f||||||||||||||2017-02-18 16:20:28.071531|2017-02-18 16:20:28.071531
NCT00362765|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2008-08-12|||October 2006||2006-10-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study|Assessment of Insulin Sensitivity in Type 2 Diabetics Treated With Metformin, Fenofibrate and Their Combination.|Terminated||Phase 2/Phase 3|8|Actual|Solvay Pharmaceuticals||4||"The study was prematurely terminated, due to difficulties in the recruitment of T2DM patients~   who are not under statin therapy at inclusion."|f||||f||||||||||2017-02-18 16:20:28.16383|2017-02-18 16:20:28.16383
NCT00362752|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2016-12-06|||October 2006||2006-10-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|||A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome|A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome|Completed||Phase 2|9|Actual|St. Michael's Hospital, Toronto||2|||f||||f||||||||||2017-02-18 16:20:28.276699|2017-02-18 16:20:28.276699
NCT00362739|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2016-04-28|||September 2005||2005-09-01|April 2016|2016-04-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Blood Collection From Individuals With Lung Disease for Genetic Studies|Collection of Blood for Gene Expression/Genomic Studies in Individuals With Chronic Lung Disease|Completed||N/A|3087|Actual|Weill Medical College of Cornell University|||2||f||||t||||||Samples With DNA|"~     In this study, a small amount of blood for extraction of DNA for the study of the genetic~     basis of lung disease will be obtained from each subject. The collected blood (cells and~     serum) will be used for genetic testing in studies relating to the genetic material and/or~     gene expression, and/or studies of proteins or other substances in serum (the liquid portion~     of the blood after it has been allowed to clot). Because these latter protein studies will~     occur at a future date, the serum will be stored for use in these studies.~   "|Undecided||2017-02-18 16:20:28.403596|2017-02-18 16:20:28.403596
NCT00362726|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2011-04-07|||September 2006||2006-09-01|June 2008|2008-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone|Effect of Atazanavir Administered With and Without Ritonavir on the Pharmacokinetics of the Cytochrome P450 2C8 Substrate Rosiglitazone in Healthy Subjects|Completed||Phase 1|14||Bristol-Myers Squibb||5|||f||||||||||||||2017-02-18 16:20:28.500641|2017-02-18 16:20:28.500641
NCT00362713|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2016-09-29|||March 2007||2007-03-01|December 2009|2009-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection|A Phase 1b Safety and Dose-Assessment Study of Neoadjuvant Ipilimumab Monotherapy in Patients With Urothelial Carcinoma Undergoing Surgical Resection|Completed||Phase 1|12|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:20:28.625602|2017-02-18 16:20:28.625602
NCT00005724|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||August 1991||1991-08-01|July 2000|2000-07-01|May 1997||1997-05-01|||||Observational|||CVD Nutrition Modules Tailored to Low Literacy Skills||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.155298|2017-02-18 18:14:28.155298
NCT00362700|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2017-01-30|||July 2003||2003-07-01|June 2006|2006-06-01|October 2005||2005-10-01|||||Interventional|||Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201|An Open-Label, Phase II Study to Evaluate Safety, Tolerability, Antiviral Activity and Biochemical and Immunological Responses of Retreated Clevudine in Chronic Hepatitis B Patients Who Received Clevudine in L-FMAU-201|Terminated||Phase 2|33||Bukwang Pharmaceutical|||||f||||||||||||||2017-02-18 16:20:28.726891|2017-02-18 16:20:28.726891
NCT00362687|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2009-03-30|||November 2006||2006-11-01|March 2009|2009-03-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance|GMB: Phase IV, Multicenter, Randomized, Open-Label Pilot Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients Who Need to Interrupt HAART and Who Are Infected With HIV Isolates Containing at Least 2 TAMs (or K65R) and M184V|Completed||Phase 4|50|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 16:20:28.817112|2017-02-18 16:20:28.817112
NCT00362674|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2017-01-30|||June 2005||2005-06-01|December 2010|2010-12-01||||||||Observational|||Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial|An Open-label, Observation Study to Evaluate the Durability of Antiviral Activity in Chronic Hepatitis B Patients Who Showed Complete Response in L-FMAU-301,L-FMAU-302 or L-FMAU-303 Trial|Completed||N/A|||Bukwang Pharmaceutical|||1||f||||||||||||||2017-02-18 16:20:29.061387|2017-02-18 16:20:29.061387
NCT00362661|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2010-01-11|||June 2007||2007-06-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Low-dose Cortisol in Chronic Posttraumatic Stress Disorder|Low-dose Cortisol in Chronic Posttraumatic Stress Disorder|Terminated||N/A|20|Anticipated|University of Zurich||1||Recruitment: Insufficient number of patients eligible for enrollment|f||||||||||||||2017-02-18 16:20:29.162989|2017-02-18 16:20:29.162989
NCT00362648|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2015-10-08|2010-03-11||March 2007||2007-03-01|October 2015|2015-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Developing World Study for RotaTeq™ (V260-015)(COMPLETED)|Efficacy, Safety, and Immunogenicity of RotaTeq™ Among Infants in Asia and Africa|Completed||Phase 3|7504|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:20:29.276422|2017-02-18 16:20:29.276422
NCT00362635|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2012-07-24|||August 2006||2006-08-01|July 2012|2012-07-01||||December 2011|Actual|2011-12-01||Interventional|||Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection|A Double-blinded and Randomised Study to Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30 mg qd Versus Lamivudine 100 mg qd for Chronic Hepatitis B Infection|Completed||Phase 3|92|Anticipated|Bukwang Pharmaceutical|||||f||||||||||||||2017-02-18 16:20:30.965532|2017-02-18 16:20:30.965532
NCT00362622|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-08-14|||October 2005||2005-10-01|August 2012|2012-08-01|January 2008|Actual|2008-01-01|||||Observational|||Determinants of Compliance With Glaucoma Therapy|Determinants of Compliance With Glaucoma Therapy|Completed||N/A|59|Actual|University of Alabama at Birmingham|||1||f||||f||||||||||2017-02-18 16:20:31.065537|2017-02-18 16:20:31.065537
NCT00362609|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2010-04-22|2009-11-30||July 2006||2006-07-01|April 2010|2010-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD|A Multicenter, Open-Label, PK, PD and Safety Study of Pantoprazole Delayed-Release Granules Administered as a Suspension in Neonates and Preterm Infants With a Clinical Diagnosis of GERD|Completed||Phase 3|59|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 16:20:31.15627|2017-02-18 16:20:31.15627
NCT00362596|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2006-08-09|||January 2005||2005-01-01|August 2006|2006-08-01|August 2005||2005-08-01|||||Interventional|||A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand|A Randomized Controlled Crossover Trial of Acylcovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand|Completed||Phase 4|67||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 16:20:31.616564|2017-02-18 16:20:31.616564
NCT00362583|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2012-05-04|||June 2006||2006-06-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)|A Double-blind, Randomised, Placebo-controlled Trial Confirming the Efficacy of Intranasal Fentanyl Titrated to 50, 100 or 200 µg With an Open Long-term Safety Follow-up in Cancer Patients With Breakthrough Pain|Completed||Phase 3|100|Anticipated|Nycomed|||||f||||||||||||||2017-02-18 16:20:31.704645|2017-02-18 16:20:31.704645
NCT00362570|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2015-05-04|||May 2005||2005-05-01|May 2015|2015-05-01|March 2011|Actual|2011-03-01|April 2007|Actual|2007-04-01||Interventional|||Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma|Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma|Completed||Phase 2|1|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:20:31.78944|2017-02-18 16:20:31.78944
NCT00362557|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2015-08-31|||September 2001||2001-09-01|August 2015|2015-08-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Observational|||Imaging Techniques in Body MRI|Imaging Techniques in Body MRI|Active, not recruiting||N/A|1000|Anticipated|Johns Hopkins University|||1||f||||||||||||||2017-02-18 16:20:31.892222|2017-02-18 16:20:31.892222
NCT00362544|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2015-07-07|||October 2003||2003-10-01|July 2015|2015-07-01|March 2006||2006-03-01|||||Interventional|||PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia|Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia|Completed||Phase 4|30||Gilead Sciences|||||f||||||||||||||2017-02-18 16:20:31.971874|2017-02-18 16:20:31.971874
NCT00362531|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2006-08-09|||November 2004||2004-11-01|January 2006|2006-01-01|January 2007||2007-01-01|||||Interventional|||Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome|Phase 3 Study of Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome|Completed||Phase 2/Phase 3|||Peking University|||||f||||||||||||||2017-02-18 16:20:32.192481|2017-02-18 16:20:32.192481
NCT00362518|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2008-09-02|||July 2004||2004-07-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|June 2007|Actual|2007-06-01||Interventional|||Vitamins C and Vitamin E and Cardiovascular Risk|Vitamin C and Vitamin E Therapy in Type 2 Diabetes and Cardiovascular Risk|Completed||Phase 3|12|Actual|University of New Mexico||4|||f||||t||||||||||2017-02-18 16:20:32.283015|2017-02-18 16:20:32.283015
NCT00362505|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2017-01-30|||June 2004||2004-06-01|June 2006|2006-06-01|March 2006||2006-03-01|||||Interventional|||Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials|An Open-label, Phase III Clinical Trial to Evaluate the Safety and Antiviral Activity of Clevudine in Chronic Hepatitis B Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials|Terminated||Phase 3|||Bukwang Pharmaceutical|||||f||||||||||||||2017-02-18 16:20:32.395542|2017-02-18 16:20:32.395542
NCT00362492|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2010-10-27|||June 2004||2004-06-01|October 2010|2010-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement|9-10 Days Versus Prolonged Thromboprophylaxis in Patients Without Evidence of Ultrasound Proximal Thromboembolism After Total Knee Joint Replacement: a Randomized Controlled Trial|Completed||Phase 4|850|Anticipated|University Hospital, Caen||2|||f||||||||||||||2017-02-18 16:20:32.515262|2017-02-18 16:20:32.515262
NCT00362479|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2013-08-20|||August 2006||2006-08-01|August 2013|2013-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive|A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of the 28-Day Oral Contraceptive DR-1021|Completed||Phase 3|1347|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 16:20:32.622479|2017-02-18 16:20:32.622479
NCT00362466|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2009-11-18|2009-07-24||April 2007||2007-04-01|November 2009|2009-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy|An Open-Label Randomized Phase III Study of Dasatinib vs. High-Dose (600 mg) Imatinib Mesylate in the Treatment of Subjects With Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Are Imatinib Failures or Who Have Had a Suboptimal Response After 3-18 Months of Therapy With 400 mg Imatinib|Terminated||Phase 3|3|Actual|Bristol-Myers Squibb|Study was terminated early due to insufficient enrollment.|2||Insufficient Enrollment|f||||f||||||||||2017-02-18 16:20:32.992122|2017-02-18 16:20:32.992122
NCT00362453|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2016-04-20|2009-09-25||August 2005||2005-08-01|April 2016|2016-04-01|June 2009|Actual|2009-06-01|March 2008|Actual|2008-03-01||Interventional|||Tai Chi Mind-Body Therapy for Knee Osteoarthritis|Tai Chi Mind-Body Therapy for Knee Osteoarthritis: a Pilot Single-blind Randomized Controlled Trial|Completed||N/A|40|Actual|Tufts Medical Center|small sample size|2|||f||||t||||||||||2017-02-18 16:20:33.531384|2017-02-18 16:20:33.531384
NCT00362440|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2013-02-18|||August 2006||2006-08-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome|A Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome: A Randomized, Double-blind, Placebo-controlled Clinical Trial|Completed||Phase 2|15|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-02-18 16:20:34.438615|2017-02-18 16:20:34.438615
NCT00362427|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2014-01-10|||August 2006||2006-08-01|January 2014|2014-01-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®|A Randomized Trial to Assess the Immunogenicity and Safety of PR5I With an Adjuvant Composition Enhancement to the Hepatitis B Component and When Given Concomitantly With Prevnar®|Completed||Phase 2|460|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 16:20:34.558547|2017-02-18 16:20:34.558547
NCT00362414|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2016-08-16|2012-06-12||August 2006||2006-08-01|August 2016|2016-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|BETAS||Beta-hCG + Erythropoietin in Acute Stroke|Safety of Beta-hCG + Erythropoietin in Acute Stroke|Completed||Phase 2|15|Actual|University of California, Irvine||1|||f||||f||||||||||2017-02-18 16:20:34.696668|2017-02-18 16:20:34.696668
NCT00362401|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2009-08-03|2009-01-22||November 2005||2005-11-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|||||Observational|||Patients Perception of Mechanical Heart Valve Sounds: Psychoacoustics and Quality of Life|Patients Perception of Mechanical Heart Valve Sounds: Psychoacoustics and Quality of Life|Completed||Early Phase 1|90|Actual|University of Aarhus|||1||f||||f||||||||||2017-02-18 16:20:35.387457|2017-02-18 16:20:35.387457
NCT00362388|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2010-01-26|||January 2006||2006-01-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Cell Therapy in Chronic Ischemic Heart Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Intramyocardial Injection of Autologous Bone-Marrow Cells in Patients With Severe, Chronic Ischemic Heart Disease Undergoing Coronary Bypass Surgery|Terminated||Phase 3|300|Anticipated|Ministry of Health, Brazil||||low enrollling|f||||t||||||||||2017-02-18 16:20:36.051287|2017-02-18 16:20:36.051287
NCT00362375|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2010-04-27|2010-03-08||May 2006||2006-05-01|April 2010|2010-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women|Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women by SisterLove, Inc. in Atlanta, GA|Completed||Phase 1/Phase 2|313|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 16:20:36.167032|2017-02-18 16:20:36.167032
NCT00362362|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2017-01-24|||August 7, 2006||2006-08-07|September 9, 2013|2013-09-09|September 9, 2013||2013-09-09|||||Observational|||Collection of Blood Samples for DNA in Motor Neuron Disease|Collection of Blood Samples for DNA Analysis in Motor Neuron Diseases|Completed||N/A|23|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:20:36.62928|2017-02-18 16:20:36.62928
NCT00362349|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2016-07-14|||June 2007||2007-06-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients|A Single-arm, Open Label, Multi-centre Study Evaluating the Efficacy and Safety of Ig NexGen 10% in Patients With Idiopathic Thrombocytopenic Purpura (ITP)|Completed||Phase 3|19|Actual|CSL Limited||1|||f||||f||||||||||2017-02-18 16:20:36.720569|2017-02-18 16:20:36.720569
NCT00362336|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2014-04-01|2014-02-14||August 2006||2006-08-01|April 2014|2014-04-01|August 2009|Actual|2009-08-01|May 2008|Actual|2008-05-01||Interventional|||Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV|Immunogenicity Study of a DTaP-IPV-Hep B-PRP~T Combined Vaccine in Comparison to CombAct-HIB® Concomitantly Administered With Engerix B® Paediatric and OPV at 6, 10, and 14 Weeks of Age in South African Infants|Completed||Phase 3|622|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 16:20:36.843912|2017-02-18 16:20:36.843912
NCT00005723|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-28|||January 1991||1991-01-01|March 2016|2016-03-01|September 1996|Actual|1996-09-01|January 1996|Actual|1996-01-01||Observational|||Worksite Issues in Organizational Health Promotion (Take Heart)||Completed||N/A|||Oregon Research Institute|||||f||||f||||||||Undecided||2017-02-18 18:14:28.225487|2017-02-18 18:14:28.225487
NCT00362323|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2010-04-15|||October 2006||2006-10-01|April 2010|2010-04-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Interventional|||Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO|A Randomized, Double-blind Study Comparing the Efficacy and Safety of a Fixed Combination of Fenofibrate and Metformin vs Metformin Alone in Patients With Type 2 Diabetes Mellitus and Dyslipidemia Not Appropriately Controlled With a Statin.|Completed||Phase 3|482|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:20:38.028167|2017-02-18 16:20:38.028167
NCT00362310|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-09|2008-04-11|||June 2003||2003-06-01|April 2008|2008-04-01|July 2007||2007-07-01|||||Interventional|||Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir|A Phase II Trial With the HIV Protease Inhibitor Indinavir for the Treatment of Classical Kaposi's Sarcoma|Completed||Phase 2|28||Istituto Superiore di Sanità|||||f||||||||||||||2017-02-18 16:20:38.197867|2017-02-18 16:20:38.197867
NCT00362297|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2014-10-02|2012-03-23||September 2006||2006-09-01|October 2014|2014-10-01|September 2011|Actual|2011-09-01|December 2008|Actual|2008-12-01||Interventional|||Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2|A Randomized, Cross-Over Study to Evaluate the Suppressive Effect of High-Dose Acyclovir Versus Once Daily Valacyclovir on Herpes Simplex Virus Type 2 Genital Shedding in Herpes Simplex Virus-2 Seropositive Adults|Completed||Phase 4|31|Actual|University of Washington|The trial was performed at a single site, and enrolled mostly white, healthy, sexually active adults with high rates of genital HSV-2 recurrence. The results may not be generalizable to other populations.|2|||f||||f||||||||||2017-02-18 16:20:38.307453|2017-02-18 16:20:38.307453
NCT00362284|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2015-11-10|||September 2005||2005-09-01|November 2015|2015-11-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Comprehensive Support for Alzheimer's Disease Caregivers|Expanded Counseling and Support for Adult Children Caring for Parents With Alzheimer's Disease or Similar Disorders|Completed||N/A|161|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 16:20:38.754184|2017-02-18 16:20:38.754184
NCT00362271|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2013-11-07|||August 2006||2006-08-01|June 2008|2008-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Aripiprazole and Effexor XR Drug Interaction Study|Effects of Aripiprazole on the Steady-State Pharmacokinetics of Venlafaxine in Healthy Subjects|Completed||Phase 1|38||Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-02-18 16:20:39.040167|2017-02-18 16:20:39.040167
NCT00362258|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2011-04-01|||February 2006||2006-02-01|March 2011|2011-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||I PREVENT - Irbesartan In Hypertensive Diabetic Patients|Irbesartan In Hypertensive Diabetic Patients|Completed||Phase 4|797|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:20:39.150847|2017-02-18 16:20:39.150847
NCT00362245|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2015-11-01|||September 2006||2006-09-01|November 2015|2015-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Amikacin Penetration Into the Cerebrospinal Fluid|Amikacin Penetration Into the Cerebrospinal Fluid: Pharmacokinetic/Pharmacodynamic Analysis in Adults With Hospital Acquired Gram-negative Meningitis Associated With Intracranial Pressure Monitoring and Draining Devices|Withdrawn||Phase 4|0|Actual|Rambam Health Care Campus||||lack of participants|f||||||||||||||2017-02-18 16:20:39.241429|2017-02-18 16:20:39.241429
NCT00362232|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2014-10-28|2012-05-10||June 2006||2006-06-01|October 2014|2014-10-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|RECORD 4||Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.|RECORD 4 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE; a Controlled, Double-blind, Randomized Study of BAY59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement|Completed||Phase 3|3148|Actual|Bayer||2|||f||||t||||||||||2017-02-18 16:20:39.358834|2017-02-18 16:20:39.358834
NCT00362219|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2011-10-27|||December 2006||2006-12-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Topical Morphine for Analgesia in Patients With Skin Grafts|Topical Morphine for Analgesia in Patients With Skin Grafts|Completed||Phase 3|40|Actual|Rambam Health Care Campus||4|||f||||||||||||||2017-02-18 16:20:40.812634|2017-02-18 16:20:40.812634
NCT00362206|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2009-07-07|||September 2006||2006-09-01|July 2009|2009-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin|A Multicenter, Double-Blind, Randomized, Forced-Titration Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 20 or 40 mg Simvastatin With 40 mg Pravastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not Adequately Controlled by 40 mg Pravastatin Alone|Completed||Phase 3|423|Actual|Solvay Pharmaceuticals||3|||f||||f||||||||||2017-02-18 16:20:40.932066|2017-02-18 16:20:40.932066
NCT00362193|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2010-02-12|||June 2002||2002-06-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Glycemic Relapse Prevention: Maintenance Dose Assessment|Longitudinal Diabetes Care: A Randomized Controlled Trial to Prevent Glycemic Relapse|Completed||Phase 4|165||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:20:41.188083|2017-02-18 16:20:41.188083
NCT00362180|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2016-09-09|2013-02-25||July 2006||2006-07-01|September 2016|2016-09-01|September 2010|Actual|2010-09-01|March 2010|Actual|2010-03-01||Interventional|||Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Apolipoprotein B(ApoB) Reduction by ISIS 301012 on Liver Triglyceride Content in Subjects With Varying Degrees of Hyperlipidemia|Completed||Phase 2|38|Actual|Kastle Therapeutics, LLC|The limitations to this study are 1) post-hoc amendments that caused early termination of cohorts and limited the accomplishment of study objectives and 2) post-hoc amendments which added cohorts into the study that were not previously specified.|9|||f||||t||||||||||2017-02-18 16:20:41.284248|2017-02-18 16:20:41.284248
NCT00362167|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2017-01-24|||February 15, 2001||2001-02-15|December 13, 2006|2006-12-13|December 13, 2006||2006-12-13|||||Observational|||Pain Evaluation and Treatment|Evaluation and Treatment of Pain (Training Protocol)|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:20:42.959043|2017-02-18 16:20:42.959043
NCT00362141|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2007-03-30|||October 2006||2006-10-01|March 2007|2007-03-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus|Safety and Tolerability of Add-on Levetiracetam in Status Epilepticus|Unknown status|Recruiting|Phase 2|12||Medical Center Haaglanden|||||f||||f||||||||||2017-02-18 16:20:43.041303|2017-02-18 16:20:43.041303
NCT00362128|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2015-08-05|2015-07-06||January 2007||2007-01-01|August 2015|2015-08-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Observational|CHA-CHA||Cardiovascular Disease Risk Factors in Chinese American Immigrants|Chinese American Cardiovascular Health Assessment CHA-CHA|Completed||N/A|2072|Actual|Albert Einstein College of Medicine, Inc.|||1||f||||f||||||Samples With DNA|"~     Biospecimens are being analyzed to evaluate the relationship between biomarker, behaviors~     and sociodemographic variables. Stored specimens will permit future analysis that may~     involve genetic variables related to biomarker findings.~   "|||2017-02-18 16:20:43.149054|2017-02-18 16:20:43.149054
NCT00362115|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2011-03-24|2011-03-24||May 2006||2006-05-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension|A Phase 2, Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study of the Efficacy, Safety and Tolerability of TAK-491 in Subjects With Mild to Moderate Uncomplicated Essential Hypertension|Completed||Phase 2|449|Actual|Takeda||7|||f||||f||||||||||2017-02-18 16:20:43.403077|2017-02-18 16:20:43.403077
NCT00362102|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2016-11-21|||October 2005||2005-10-01|November 2016|2016-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal Carcinoma|A Multi-center, Open Label, Non-randomized, Phase II Study to Assess the Activity and Safety of Cetuximab Plus Irinotecan in Subjects With EGFR-detectable Metastatic Colorectal Carcinoma|Completed||Phase 2|38||Eli Lilly and Company|||||f||||||||||||||2017-02-18 16:20:46.024969|2017-02-18 16:20:46.024969
NCT00362089|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2014-02-03|||June 2006||2006-06-01|February 2014|2014-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Fatty Acids During Pregnancy and Lactation and Body Fat Mass in Newborns|The Impact of the Nutritional Fatty Acids During Pregnancy and Lactation for Early Human Adipose Tissue Development|Completed||N/A|208|Actual|Technische Universität München||2|||f||||t||||||||||2017-02-18 16:20:46.125357|2017-02-18 16:20:46.125357
NCT00362076|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2017-01-24|||September 3, 1998||1998-09-03|April 19, 2012|2012-04-19|April 19, 2012||2012-04-19|||||Observational|||The Role of Motion in Infants' Ability to Categorize|Categorization Based on Motion-Carried Information in Infancy|Completed||N/A|941|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:20:46.243781|2017-02-18 16:20:46.243781
NCT00362063|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2010-12-21|||January 2006||2006-01-01|December 2010|2010-12-01|August 2010|Anticipated|2010-08-01|July 2010|Anticipated|2010-07-01||Interventional|||Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency|Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency|Unknown status|Recruiting|N/A|20|Anticipated|Baylor College of Medicine||2|||f||||||||||||||2017-02-18 16:20:46.324826|2017-02-18 16:20:46.324826
NCT00362050|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2007-08-28|||June 2006||2006-06-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||RBx11160 Phase II Dose Ranging Study RBx/MMV05-06|A Phase II, Double-Blind, Parallel-Group, Randomized, Dose-Ranging Study Assessing the Antimalarial Activity and Safety of RBx 11160 Administered for 7 Days in Patients With Acute Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 2|255||Medicines for Malaria Venture|||||f||||||||||||||2017-02-18 16:20:49.116233|2017-02-18 16:20:49.116233
NCT00362037|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2011-05-27|||March 2006||2006-03-01|May 2011|2011-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy|Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy|Completed||Phase 4|281|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:20:49.253221|2017-02-18 16:20:49.253221
NCT00362024|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2016-05-13|||November 2006||2006-11-01|May 2016|2016-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)|MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease|Terminated||Phase 2|24|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:20:49.335508|2017-02-18 16:20:49.335508
NCT00362011|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2006-08-08|||March 2001||2001-03-01|February 2001|2001-02-01||||||||Interventional|||Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes|Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes|Completed||Phase 2|||St. Michael's Hospital, Toronto|||||f||||||||||||||2017-02-18 16:20:49.404137|2017-02-18 16:20:49.404137
NCT00361998|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2007-03-01|||September 2006||2006-09-01|March 2007|2007-03-01|January 2007||2007-01-01|||||Interventional|||Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis|Nitrofurantoin Macrocrystals 3 Days Vs. 7 Days in the Treatment of Women With Uncomplicated Cystitis|Withdrawn||Phase 4|400||HaEmek Medical Center, Israel||||recruitment failed|f||||||||||||||2017-02-18 16:20:49.485489|2017-02-18 16:20:49.485489
NCT00361985|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2016-10-31|||January 2008||2008-01-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|January 2011|Actual|2011-01-01||Interventional|||Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery|Randomized, Prospective, Double-blind Trial of PPI vs Placebo in Prevention of Gastrojejunal Strictures After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity|Withdrawn||Phase 4|0|Actual|Weill Medical College of Cornell University||1||Insufficient enrollment|f||||f||||||||||2017-02-18 16:20:49.580862|2017-02-18 16:20:49.580862
NCT00361972|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2016-06-25|2016-01-14||August 2006||2006-08-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Elucidation of Acid-Induced Pulmonary Inflammation|Elucidation of Acid-Induced Pulmonary Inflammation|Terminated||Phase 2/Phase 3|17|Actual|University of Utah|Questionnaires were not assessed as many of them were incomplete. Drop out occurred due to incomplete tissues Early termination: the total number of participants could not be enrolled in a timely manner..|2||limited recruitment|f||||f||||||||No||2017-02-18 16:20:49.690207|2017-02-18 16:20:49.690207
NCT00361959|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2017-01-19|||June 2003|Actual|2003-06-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease|Multicentre, Randomised, Double-Blind, Double Dummy, Parallel Group, 104-week Study to Compare the Effect of the Salmeterol/Fluticasone Propionate Combination Product (SERETIDE*) 50/500mcg Delivered Twice Daily Via the DISKUS*/ACCUHALER* Inhaler With Tiotropium Bromide 18 mcg Delivered Once Daily Via the HandiHaler Inhalation Device on the Rate of Health Care Utilisation Exacerbations in Subjects With Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|1270|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:20:50.036917|2017-02-18 16:20:50.036917
NCT00361946|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2006-08-08|||August 2006||2006-08-01|August 2006|2006-08-01||||||||Observational|||The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).|The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).|Unknown status|Recruiting|N/A|60||Baylor College of Medicine|||||f||||||||||||||2017-02-18 16:20:50.572002|2017-02-18 16:20:50.572002
NCT00361933|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2009-06-16|||December 2008||2008-12-01|June 2009|2009-06-01|May 2009|Anticipated|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease|Clinical and Virologic Response to HHV-8 Associated Multicentric Castleman's Disease to Valganciclovir|Withdrawn||Phase 4|8|Anticipated|University of Washington||1||Research never begun.|f||||t||||||||||2017-02-18 16:20:50.659367|2017-02-18 16:20:50.659367
NCT00361920|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2014-09-24|||August 2006||2006-08-01|September 2014|2014-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Cell Biology of Steroid Resistant Asthma|Investigating Biomarkers of Steroid Resistant Asthma|Completed||N/A|40|Anticipated|National Jewish Health|||||f||||||||||||||2017-02-18 16:20:50.772896|2017-02-18 16:20:50.772896
NCT00361907|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2016-08-08|||February 2005||2005-02-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes|Effect of Pulsatile IV Insulin Delivery on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes|Terminated||Phase 2/Phase 3|105|Actual|Florida Atlantic University||2||Administrative - Suspended by IRB|f||||t||||||||||2017-02-18 16:20:50.878931|2017-02-18 16:20:50.878931
NCT00361894|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2014-10-24|||February 2006||2006-02-01|October 2014|2014-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|RECORD 3||Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.|RECORD 3 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE; a Controlled., Double-blind, Randomized Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.|Completed||Phase 3|2531|Actual|Bayer||2|||f||||||||||||||2017-02-18 16:20:51.017246|2017-02-18 16:20:51.017246
NCT00361881|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2008-08-14|||July 2006||2006-07-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis|A Randomized, Double-Blind, Active Controlled, Vehicle-Controlled, Subject Initiated Study Comparing Efficacy and Safety of ME-609 Versus Acyclovir Cream for Treatment of Recurrent Herpes Simplex Labialis|Completed||Phase 3|1443|Actual|Medivir||3|||f||||f||||||||||2017-02-18 16:20:51.504727|2017-02-18 16:20:51.504727
NCT00361868|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2008-06-26|||June 2006||2006-06-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI|A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of a Fixed Combination of Fenofibrate and Metformin vs Rosiglitazone in Patients With Type 2 Diabetes Mellitus and Dyslipidemia|Terminated||Phase 3|88|Anticipated|Solvay Pharmaceuticals||2||The study was discontinued prematurely at the end of March 2007 due to slow enrolment.|f||||t||||||||||2017-02-18 16:20:51.624172|2017-02-18 16:20:51.624172
NCT00361855|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2008-09-09|||April 2006||2006-04-01|September 2008|2008-09-01||||||||Interventional|||Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle|A Phase 1 Open Label Dose Escalation Study Evaluate The Safety Of a Single Escalating Dose Of NX-CP105 (Human Adult Bone Marrow Derived Somatic Cells [hABM-SC] Administered by Endomyocardial Injection To Cohorts Of Adults 30-60 Days Following Acute Myocardial Infarction|Completed||Phase 1|18|Anticipated|Neuronyx|||||||||||||||||||2017-02-18 16:20:51.802606|2017-02-18 16:20:51.802606
NCT00361842|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2016-07-25||2012-05-16|July 2006||2006-07-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer|Multicenter, Open-Label, Phase 2 Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Carcinoma|Completed||Phase 2|59|Actual|Celator Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:20:51.912653|2017-02-18 16:20:51.912653
NCT00361829|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2017-01-24|||February 17, 1988||1988-02-17|October 17, 2016|2016-10-17||||||||Observational|||The Influence of Maternal Age, Employment Status, and Parenthood Status on Children's Cognitive Development|Specificity of Mother-Infant Interaction: The Influence of Maternal Age, Employment Status, and Parenthood Status|Active, not recruiting||N/A|5970|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:20:52.036949|2017-02-18 16:20:52.036949
NCT00361816|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2017-01-24|||May 3, 2002||2002-05-03|March 29, 2011|2011-03-29|March 29, 2011||2011-03-29|||||Observational|||Human MATER and Idiopathic Infertility|Human MATER and Idiopathic Infertility|Completed||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:20:52.134735|2017-02-18 16:20:52.134735
NCT00361803|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2012-05-31|||September 2006||2006-09-01|March 2011|2011-03-01||||||||Interventional|||Topotecan Pharmacokinetic Characterization Study|A Phase I Study to Characterize the Pharmacokinetics of Topotecan at 4 mg/m2 Administered Weekly as a 30-Minute Intravenous Infusion in Patients With Cancer|Completed||Phase 1|15||GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:20:52.219431|2017-02-18 16:20:52.219431
NCT00361790|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2013-11-07|||August 2006||2006-08-01|June 2008|2008-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Aripiprazole and Lexapro Drug Interaction Study|Effects on Aripiprazole on the Steady-State Pharmacokinetics of Escitalopram in Healthy Subjects|Completed||Phase 1|25||Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-02-18 16:20:52.320118|2017-02-18 16:20:52.320118
NCT00361777|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-08|2017-01-24|||September 18, 2002||2002-09-18|February 8, 2016|2016-02-08||||||||Observational|||Diagnostic Performance of Screening Tests for Cushing s Syndrome|The Diagnostic Performance of Screening Tests for the Diagnosis of Cushing's Syndrome|Active, not recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:20:52.429228|2017-02-18 16:20:52.429228
NCT00361751|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2010-02-12|||May 2003||2003-05-01|February 2010|2010-02-01|May 2005|Actual|2005-05-01|||||Interventional|||Substrate Cycling in Energy Metabolism|Phase 2 Trial to Examine the Metabolic Effects of Fenofibrate in Burned Patients|Completed||Phase 2|40||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:20:52.525034|2017-02-18 16:20:52.525034
NCT00005722|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1990||1990-09-01|May 2000|2000-05-01|September 1996||1996-09-01|||||Observational|||Stroke Belt Initiative||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.303262|2017-02-18 18:14:28.303262
NCT00361738|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2009-02-06|||July 2006||2006-07-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Response, Multicentre, Multinational Study Evaluating the Efficacy and Safety of AVE2268 Administered Either Twice Daily (Breakfast and Lunch) at a Dose of 300, 600 and 1200 mg or Once Daily (Breakfast) at a Dose of 1200 mg, in Patients With Type 2 Diabetes Treated With Metformin and Not Adequately Controlled|Completed||Phase 2|317|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:20:52.622896|2017-02-18 16:20:52.622896
NCT00361725|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2006-08-09|||March 2003||2003-03-01|June 2006|2006-06-01|October 2003||2003-10-01|||||Observational|||Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ Failure|Comparative Study of the Protein C Pathway in Septic and Non Septic Patients|Terminated||N/A|90||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:20:52.726056|2017-02-18 16:20:52.726056
NCT00361712|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-06|2016-04-11|||July 2006||2006-07-01|July 2006|2006-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effect of Preemptive Epidural Analgesia in Labor on Cytokine Production|Effect of Preemptive Epidural Analgesia in Labor on Pro and Anti-inflammatory Cytokine Production in a Mother and a Newborn|Completed||N/A|||Rabin Medical Center|||||f||||||||||||||2017-02-18 16:20:52.804442|2017-02-18 16:20:52.804442
NCT00361699|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2016-04-22|||March 2004||2004-03-01|April 2016|2016-04-01||||July 2014|Actual|2014-07-01||Interventional|||hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP)|Effect of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) Reductase Inhibitor Upon the Serum High Sensitive CRP in the Post-ischemic Patients With Hyperlipidemia During the Prospective Study of J-STARS.|Completed||Phase 3|1095|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||||||||||||2017-02-18 16:20:52.895277|2017-02-18 16:20:52.895277
NCT00361686|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-06|2015-11-23|||January 2006||2006-01-01|July 2006|2006-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Comparison of Tramadol vs Remifentanyl Patient Controlled Analgesia for Second Trimester Abortions|Randomized Double Blind Study Comparing Patient Controlled Analgesia With Tramadol vs. Remifentanyl for Women Undergoing 2nd Trimester Abortions|Completed||N/A|40|Anticipated|Rabin Medical Center|||||f||||||||||||||2017-02-18 16:20:53.006253|2017-02-18 16:20:53.006253
NCT00361673|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2013-12-23|||September 2006||2006-09-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Evaluating the Effect of Neighborhood Environments on Cardiovascular Risk Factors|Reducing CVD (Cardiovascular Disease) Risk and Health Disparities Through Active Living Communities|Completed||N/A|1140|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-02-18 16:20:53.096324|2017-02-18 16:20:53.096324
NCT00361660|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2015-06-25|||August 2006||2006-08-01|June 2015|2015-06-01|December 2007|Anticipated|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||The Effect of Different Schedules of Functional Task Practice for Improving Hand and Arm Function After Stroke|The Impact of Functional Task Practice Dosing on Motor Control in Hemiplegia From Chronic Stroke|Withdrawn||N/A|0|Actual|VA Office of Research and Development||2||"project was only internally funded and would complete for subjects with 2 newer externally~   funded projects"|f||||f||||||||||2017-02-18 16:20:53.187478|2017-02-18 16:20:53.187478
NCT00361647|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2008-06-10|||January 2006||2006-01-01|June 2008|2008-06-01||||May 2008|Actual|2008-05-01||Interventional|||Screening for Occult Malignancy in Idiopathic Venous Thromboembolism||Completed||N/A|||University of Padova|||||f||||||||||||||2017-02-18 16:20:53.29236|2017-02-18 16:20:53.29236
NCT00361634|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2013-07-10|2010-08-13||September 2006||2006-09-01|July 2013|2013-07-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis|DCE-MRI of the Wrist to Measure Short-Term Responses in Rheumatoid Arthritis Subjects Treated With Etanercept|Completed||Phase 1|14|Actual|Amgen||1|||t||||||||||||||2017-02-18 16:20:53.63119|2017-02-18 16:20:53.63119
NCT00361621|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2012-11-30|||July 2006||2006-07-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional|||Ph II CHOP+Velcade in Mediastinal LBCL|Phase II Study of CHOP/Rituxan Plus VELCADE in Mediastinal Large B-cell Lymphoma|Terminated||Phase 2|3|Actual|Dana-Farber Cancer Institute||1||Closed due to slow accrual|f||||||||||||||2017-02-18 16:20:54.071761|2017-02-18 16:20:54.071761
NCT00361608|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-06|2016-07-17|||July 2008||2008-07-01|April 2008|2008-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device|Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device|Withdrawn||N/A|0|Actual|EarlySense Ltd.|||1||f||||||||||||||2017-02-18 16:20:54.202379|2017-02-18 16:20:54.202379
NCT00361595|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2010-12-14|2010-10-13||August 2006||2006-08-01|October 2010|2010-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women|Open Label Proof of Concept Study of IV Zoledronic Acid (ZA) 5 mg After Forteo in Postmenopausal Women|Completed||N/A|35|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-02-18 16:20:54.301619|2017-02-18 16:20:54.301619
NCT00361582|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2011-06-03||2011-06-03|October 2006||2006-10-01|April 2010|2010-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery|A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Multiple Doses of CG5503 Immediate Release Formulation in Subjects Awaiting Primary Joint Replacement Surgery for End-Stage Joint Disease|Completed||Phase 3|669|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:20:54.585889|2017-02-18 16:20:54.585889
NCT00361569|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2015-03-30|2008-12-22||August 2006||2006-08-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy|A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Compare the Effects of 12 Weeks of Treatment With DR-2041(Synthetic Conjugated Estrogens, A) Vaginal Cream vs. Placebo Vaginal Cream on Vulvovaginal Atrophy in Healthy Postmenopausal Women|Completed||Phase 3|622|Actual|Teva Pharmaceutical Industries||4|||f||||f||||||||||2017-02-18 16:20:54.68617|2017-02-18 16:20:54.68617
NCT00361556|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2014-03-11|||October 2005||2005-10-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional|||Treatment for Nonspecific Low Back Pain in Primary Care: a Trial on Different Health Education Booklets|Treatment for Nonspecific Low Back Pain in Primary Care With Standardized Health Education Booklets: A Randomized Controlled Clinical Trial|Completed||Phase 2|240|Anticipated|Kovacs Foundation||3|||f||||t||||||||||2017-02-18 16:20:55.469259|2017-02-18 16:20:55.469259
NCT00361543|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2015-01-28|||August 2006||2006-08-01|January 2015|2015-01-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|SERM||Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia|Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia?|Completed||Phase 4|54|Actual|The Alfred||2|||f||||||||||||||2017-02-18 16:20:55.584943|2017-02-18 16:20:55.584943
NCT00361530|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2016-04-22|||March 2004||2004-03-01|April 2016|2016-04-01||||July 2014|Actual|2014-07-01||Interventional|||Carotid Intima-media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)|Effect of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) Reductase Inhibitor Upon Carotid Intima-media Complex Thickness in the Post-ischemic Patients With Hyperlipidemia During the Prospective Study of J-STARS.|Completed||Phase 3|854|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||||||||||||2017-02-18 16:20:55.697711|2017-02-18 16:20:55.697711
NCT00361517|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-06|2009-06-23|||June 2006||2006-06-01|June 2009|2009-06-01|June 2009|Anticipated|2009-06-01|October 2007|Actual|2007-10-01||Interventional|||To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early|Using Serum Galactomannan Levels in a Prospective, Randomised, Non-Blinded Trial to Guide Early Anti-Fungal Therapy in Haematology Patients at Risk of Invasive Aspergillosis.|Terminated||Phase 3|47|Actual|Singapore General Hospital||2||Gm test became routinely available. We could not compare the two arms anymore.|f||||t||||||||||2017-02-18 16:20:55.887269|2017-02-18 16:20:55.887269
NCT00361504|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2014-04-10|2009-07-24||November 2006||2006-11-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain|A One-Year, Randomized, Open-Label, Parallel-Arm, Phase 3 Long-Term Safety Trial, With Controlled Adjustment of Dose, of Multiple Doses of CG5503 PR and Oxycodone CR in Subjects With Chronic Pain|Completed||Phase 3|1123|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-02-18 16:20:56.014073|2017-02-18 16:20:56.014073
NCT00361491|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2009-01-15|||August 2006||2006-08-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|LENA||An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder|An Eight-Week, Multicenter, Double-Blind, Placebo- and Paroxetine-Controlled Study Evaluating the Efficacy, and Tolerability of Two Fixed Doses of SSR149415 (250 mg Bid and 100 mg Bid) in Patients With Major Depressive Disorder|Completed||Phase 2|324|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:20:56.921957|2017-02-18 16:20:56.921957
NCT00361478|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2008-08-11|||July 2005||2005-07-01|July 2006|2006-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effect of the 'Mother and Baby' Program on Well-Being|Effect of the 'Mother and Baby' Program on New Mothers' Psychological and Physical Well-Being.|Completed||Phase 3|160|Actual|University of Melbourne||2|||f||||f||||||||||2017-02-18 16:20:57.02711|2017-02-18 16:20:57.02711
NCT00361465|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2011-03-25|||August 2006||2006-08-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|||||Observational|||DYSCAR: Characterization of Dystonia|Characterization of Dystonia and Influence of Cognitive-attentional Factors|Completed||N/A|75|Anticipated|University Hospital, Grenoble|||4||f||||f||||||||||2017-02-18 16:20:57.155453|2017-02-18 16:20:57.155453
NCT00361452|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-06|2006-08-06|||December 2000||2000-12-01|November 2000|2000-11-01|May 2001||2001-05-01|||||Interventional|||Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study|Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study|Terminated||Phase 4|30||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:20:57.253609|2017-02-18 16:20:57.253609
NCT00361439|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2014-01-27|2012-07-20||August 2006||2006-08-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis|Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis|Terminated||Phase 4|17|Actual|University of Chicago|Early termination due to slow accrual|2||Study stopped early due to slow accrual.|f||||f||||||||||2017-02-18 16:20:57.349198|2017-02-18 16:20:57.349198
NCT00361426|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-06|2016-07-17|||January 2008||2008-01-01|January 2008|2008-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients|EarlySense Monitoring Device Evaluation on Patients in Med / Surg|Withdrawn||N/A|0|Actual|EarlySense Ltd.|||1|No need|f||||t||||||||||2017-02-18 16:20:57.767448|2017-02-18 16:20:57.767448
NCT00361413|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-04-19|||June 2006||2006-06-01|December 2010|2010-12-01|December 2013|Actual|2013-12-01|July 2013|Actual|2013-07-01||Interventional|||Alefacept for Prevention of Graft Versus Host Disease (GVHD)|An Investigator Initiated Double Blind Randomized Study of Alefacept Treatment Prevention of Graft Versus Host Disease in Myeloablative Stem Cell Transplantation|Terminated||Phase 3|26|Actual|Hadassah Medical Organization||2||company withdrawal of the drug|f||||f||||||||||2017-02-18 16:20:57.861125|2017-02-18 16:20:57.861125
NCT00361400|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2013-08-01|||August 2005||2005-08-01|August 2013|2013-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study|Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study|Completed||N/A|1387|Actual|University of California, San Francisco|||1||f||||||||||Samples Without DNA|"~     urine for pregnancy testing~   "|||2017-02-18 16:20:57.978169|2017-02-18 16:20:57.978169
NCT00361387|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2011-02-23|||June 2006||2006-06-01|February 2011|2011-02-01|January 2008|Actual|2008-01-01|June 2007|Actual|2007-06-01||Interventional|||Use of Focalin for Fatigue in Sarcoidosis|Randomized, Double-Blind, Placebo-Controlled Study of Dexmethylphenidate Hydrochloride, (d-MPH) in the Treatment of Fatigue in Sarcoidosis Subjects.|Completed||Phase 4|12|Anticipated|University of Cincinnati||1|||f||||f||||||||||2017-02-18 16:20:58.08261|2017-02-18 16:20:58.08261
NCT00361374|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2014-07-17|2014-04-03||July 2006||2006-07-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional||We randomized 196 of 389 screened patients. Nineteen subjects dropped out before completing at least one post-baseline visit, leaving 177 evaluable subjects for analysis.|Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression|Omega-3 Fatty Acids for Treatment of Major Depression: Differential Effects of EPA and DHA, and Associated Biochemical and Immune Parameters|Completed||Phase 3|196|Actual|Massachusetts General Hospital|The study was underpowered due to lower than expected recruitment. The high placebo response rate may have impeded signal detection. The n-3 preparations were not pure, but “enriched” for one n-3 or the other, and contained other FAs.|3|||f||||t||||||||||2017-02-18 16:20:58.197627|2017-02-18 16:20:58.197627
NCT00361361|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2008-02-19|||July 2006||2006-07-01|November 2006|2006-11-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||The Efficacy of 308nm Excimer Laser in White Striae|The Efficacy of 308nm Excimer Laser in White Striae|Completed||Phase 1|10|Anticipated|Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:20:58.730066|2017-02-18 16:20:58.730066
NCT00361348|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2014-11-05|||December 2005||2005-12-01|November 2014|2014-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Palifermin DDI (Drug Drug Interaction)|An Open-label, Randomized, 2-part, Parallel Design Study to Characterize the Effect of Heparin on Palifermin Pharmacokinetics and the Effect of Palifermin on Heparin Pharmacodynamics in Healthy Subjects|Completed||Phase 1|45||Swedish Orphan Biovitrum||3|||f||||f||||||||||2017-02-18 16:20:58.819863|2017-02-18 16:20:58.819863
NCT00361335|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2014-07-23|2010-02-24||September 2006||2006-09-01|July 2014|2014-07-01|September 2009|Actual|2009-09-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Intravenously, in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 3|643|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <=5% of patients.|5|||f||||t||||||||||2017-02-18 16:20:58.945017|2017-02-18 16:20:58.945017
NCT00361322|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-06|2006-08-06|||April 2005||2005-04-01|August 2006|2006-08-01|January 2006||2006-01-01|||||Interventional|||Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris|Topical Clindamycin Salicylic Acid Preparation for the Treatment of Acne Vulgaris|Completed||Phase 1/Phase 2|40||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:21:01.305043|2017-02-18 16:21:01.305043
NCT00361309|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2014-03-16|||April 2006||2006-04-01|March 2014|2014-03-01|March 2009|Actual|2009-03-01|November 2007|Actual|2007-11-01||Interventional|||SU011248 in Advanced Hepatocellular Carcinoma|A Phase II Study of SU011248 in Advanced Hepatocellular Carcinoma|Completed||Phase 2|34|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:21:01.409329|2017-02-18 16:21:01.409329
NCT00361296|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2015-10-30|||August 2006||2006-08-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes|K562/GM-CSF Vaccination in Patients With Myelodysplastic Syndrome|Active, not recruiting||Early Phase 1|7|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:21:01.534152|2017-02-18 16:21:01.534152
NCT00361283|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2012-04-16|2012-03-09||June 2004||2004-06-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis|Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis|Completed||Phase 4|108|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 16:21:01.645236|2017-02-18 16:21:01.645236
NCT00361270|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2016-11-03|2014-11-13||October 2006||2006-10-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|February 2010|Actual|2010-02-01||Interventional|CLBP||Treatment of Veterans With Chronic Low Back Pain|Treatment of Veterans With Chronic Low Back Pain|Active, not recruiting||N/A|161|Actual|VA Office of Research and Development|The study is done on a population of Veterans and may not generalize to the larger population. The same provider administered treatment for all four groups.|4|||f||||f||||||||No||2017-02-18 16:21:01.919894|2017-02-18 16:21:01.919894
NCT00361257|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2016-01-07|2011-01-28||March 2007||2007-03-01|January 2016|2016-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults|Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment|Terminated||Phase 2|107|Actual|AIDS Clinical Trials Group|Originally, 100 participants were expected to enroll. As of the early termination notice, 107 participants were randomized, yet not all subjects could complete the 24 week assessment.|2||This study was terminated early due to futility.|f||||t||||||||||2017-02-18 16:21:02.643453|2017-02-18 16:21:02.643453
NCT00361244|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2017-02-16|||July 2006|Actual|2006-07-01|February 2017|2017-02-01|August 2010|Actual|2010-08-01|October 2007|Actual|2007-10-01||Interventional|||SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer|A Phase I/II Study of SU011248 (Sutent) in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Patients With Stage IV Colorectal Cancer|Terminated||Phase 1/Phase 2|6|Actual|Massachusetts General Hospital||1||Slow Accrual|f||||||||||||||2017-02-18 16:21:04.270252|2017-02-18 16:21:04.270252
NCT00361231|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2016-12-14|2014-12-03||May 2006||2006-05-01|December 2016|2016-12-01|August 2012|Actual|2012-08-01|March 2009|Actual|2009-03-01||Interventional|||Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer|Phase II Study of Gemcitabine, Oxaliplatin in Combination With Bevacizumab (Avastin) in Unresectable or Metastatic Biliary Tract and Gallbladder Cancer|Completed||Phase 2|35|Actual|Massachusetts General Hospital||1|||f||||t||||||||No||2017-02-18 16:21:04.622866|2017-02-18 16:21:04.622866
NCT00361218|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2013-07-24|2013-07-24||October 2005||2005-10-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Biological Markers of Response to Treatment in Major Depressive Disorder|Serum Brain-Derived Neurotrophic Factor (BDNF) and QEEG as Biological Markers of Response to (Es)Citalopram Treatment in Major Depressive Disorder|Completed||Phase 3|72|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:21:04.956089|2017-02-18 16:21:04.956089
NCT00361205|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-07|2006-10-16|||November 2003||2003-11-01|December 2005|2005-12-01|September 2005||2005-09-01|||||Interventional|||Electronic Compliance Monitoring in Parkinson's Disease|Electronic Compliance Monitoring in Parkinson's Disease|Completed||N/A|120||South Glasgow University Hospitals NHS Trust|||||f||||||||||||||2017-02-18 16:21:05.209559|2017-02-18 16:21:05.209559
NCT00361192|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-06|2006-12-05|||August 2006||2006-08-01|August 2006|2006-08-01|January 2007||2007-01-01|||||Interventional|||Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis||Unknown status|Recruiting|Early Phase 1|||Shaare Zedek Medical Center|||||||||||||||||||2017-02-18 16:21:05.293758|2017-02-18 16:21:05.293758
NCT00361179|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2006-08-04|||May 2006||2006-05-01|August 2006|2006-08-01|December 2011||2011-12-01|||||Observational|||Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C|An Extension, Observational Protocol to Evaluate the Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C in the Original Study ML17862|Completed||N/A|320||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:21:05.380335|2017-02-18 16:21:05.380335
NCT00361166|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2007-03-20|||August 2005||2005-08-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone|A Randomized, Double Blind, Multi-Center Study to Assess the Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol or Risperidone to Schizophrenic Subjects|Completed||Phase 2|400||ACADIA Pharmaceuticals Inc.|||||||||||||||||||2017-02-18 16:21:05.475907|2017-02-18 16:21:05.475907
NCT00361153|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2008-06-24|||May 2006||2006-05-01|June 2008|2008-06-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Interventional|||Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus|Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|35|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 16:21:05.587127|2017-02-18 16:21:05.587127
NCT00361140|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2013-04-24|2013-01-30||August 2005||2005-08-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)|Busulfan Dose Escalation Study Based on AUC in the Setting of Busulfan/Fludarabine Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation (HCT)|Completed||Phase 4|72|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||t||||||||||2017-02-18 16:21:05.708282|2017-02-18 16:21:05.708282
NCT00361127|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2016-01-27|||August 2006||2006-08-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart Failure|Influence of ACE Genotype on Lung Diffusion at Rest and After Fluid Overload in Heart Failure Patients Treated With ACE-inhibitors|Completed||N/A|100|Actual|Centro Cardiologico Monzino||1|||f||||||||||||||2017-02-18 16:21:06.235894|2017-02-18 16:21:06.235894
NCT00361114|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2017-01-25|||July 2006||2006-07-01|January 2017|2017-01-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.|Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Uncomplicated Malaria and in 2-10 Month Old Asymptomatic Infants.|Terminated||Phase 3|112|Actual|London School of Hygiene and Tropical Medicine||3||SP arms were stopped due to high levels of treatment failure.CD not available.|f||||t||||||||||2017-02-18 16:21:06.346232|2017-02-18 16:21:06.346232
NCT00361101|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2014-02-10|||October 2005||2005-10-01|February 2014|2014-02-01|April 2010|Actual|2010-04-01|August 2006|Actual|2006-08-01||Interventional|||A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus|Multicenter, Dose-finding Safety and Activity Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus.|Completed||Phase 1|10|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:21:06.677699|2017-02-18 16:21:06.677699
NCT00361088|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2013-11-21|||August 2005||2005-08-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma|A Dose Escalation of Zarnestra (R115777) Combined With Velcade® (PS-341) in Patients With Relapsed Multiple Myeloma|Terminated||Phase 1/Phase 2|42|Actual|H. Lee Moffitt Cancer Center and Research Institute||2||Initial Principal Investigator left Moffitt|f||||t||||||||||2017-02-18 16:21:06.783659|2017-02-18 16:21:06.783659
NCT00361075|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2014-11-04|||July 1998||1998-07-01|November 2014|2014-11-01|May 2005|Actual|2005-05-01|||||Interventional|||Midlife Cholesterol Study|Mentored Patient Oriented Research Career Development Award|Completed||Phase 4|120||Northwestern University|||||f||||||||||||||2017-02-18 16:21:06.911924|2017-02-18 16:21:06.911924
NCT00361062|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2010-06-03|||September 2006||2006-09-01|June 2010|2010-06-01||||July 2008|Actual|2008-07-01||Interventional|||Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment|Aggressive Behavior Induced by SSRIs During the First Month of Treatment|Unknown status|Recruiting|N/A|60|Anticipated|HaEmek Medical Center, Israel||1|||f||||||||||||||2017-02-18 16:21:07.010234|2017-02-18 16:21:07.010234
NCT00361049|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2010-11-04|||September 2004||2004-09-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|June 2009|Actual|2009-06-01||Interventional|||Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant|Donor Mesenchymal Stem Cell Infusion for Treatment of Graft Versus Host Disease: A Phase I Trial|Completed||Phase 1|49|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:21:07.117285|2017-02-18 16:21:07.117285
NCT00361036|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2011-04-14|||August 2006||2006-08-01|April 2011|2011-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent|Feasibility Evaluation of the Embolic Agent BeadBlock™ in the Treatment of Uterine Fibroids With Uterine Artery Embolization With Comparison of Study Endpoints to Embosphere®|Completed||Phase 1|44|Actual|Worthington-Kirsch, Robert L., M.D.||2|||f||||f||||||||||2017-02-18 16:21:07.228812|2017-02-18 16:21:07.228812
NCT00361023|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2006-08-04|||January 2006||2006-01-01|January 2006|2006-01-01|July 2006||2006-07-01|||||Interventional|||Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy|Effects of Angiotensin Type 1 Receptor Blockade With Losartan on Insulin Sensitivity and Secretion in Subjects With Type 2 Diabetes and Nephropathy|Completed||N/A|25||Shanghai Jiao Tong University School of Medicine|||||f||||||||||||||2017-02-18 16:21:07.340715|2017-02-18 16:21:07.340715
NCT00361010|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2011-07-27|||December 2006||2006-12-01|July 2011|2011-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy|A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy|Completed||N/A|20|Anticipated|The Cleveland Clinic|||||f||||||||||||||2017-02-18 16:21:07.420497|2017-02-18 16:21:07.420497
NCT00360997|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2006-10-19|||March 2006||2006-03-01|August 2006|2006-08-01|September 2008||2008-09-01|||||Interventional|||Investigation of Acceptable Dose of Mobilisation and Tactile Stimulation to Enhance Upper Limb Recovery After Stroke|Mobilisation and Tactile Stimulation to Enhance Upper Limb Recovery After Stroke: Phase I Investigation of Acceptable Dose, Efficacy and Underlying Mechanisms|Unknown status|Recruiting|Phase 1|80||St George's, University of London|||||f||||||||||||||2017-02-18 16:21:07.516078|2017-02-18 16:21:07.516078
NCT00360984|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2006-08-04|||May 2003||2003-05-01|July 2006|2006-07-01|September 2004||2004-09-01|||||Interventional|||Prevention of Severe Hypoglycemia in Type 1 Diabetes|Can Hypoglycaemia Awareness Be Restored in Individuals With Type 1 Diabetes and Severe Hypoglycaemia Employing Optimised Subcutaneous Insulin Regime or Continuous Subcutaneous Insulin Infusion Pump|Completed||Phase 4|21||Newcastle University|||||f||||||||||||||2017-02-18 16:21:07.616842|2017-02-18 16:21:07.616842
NCT00360971|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2015-11-14|2014-04-16||July 2006||2006-07-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|May 2008|Actual|2008-05-01||Interventional||All eligible patients.|Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer|A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin (NSC# 740548; IND # 6370) for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Radiation Therapy With Concurrent Chemotherapy (Followed by Surgery for Selected Patients)|Terminated||Phase 3|21|Actual|Radiation Therapy Oncology Group|This study terminated early with 21 subjects accrued out of 298 planned, therefore no statistical testing was performed. The termination was decided due to positive preliminary results from other palifermin studies.|2||Due to positive preliminary results from other palifermin studies.|f||||t||||||||||2017-02-18 16:21:07.905001|2017-02-18 16:21:07.905001
NCT00360958|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2016-01-27|||August 2006||2006-08-01|January 2016|2016-01-01|December 2012|Actual|2012-12-01|October 2012|Actual|2012-10-01||Interventional|||Treatment of Severe Heart Failure by Ultrafiltration|Ultrafiltration for the Chronic Treatment of Severe Congestive Heart Failure|Completed||Phase 4|60|Actual|Centro Cardiologico Monzino||2|||f||||||||||||||2017-02-18 16:21:08.468873|2017-02-18 16:21:08.468873
NCT00360945|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2013-09-16|||April 2004||2004-04-01|November 2006|2006-11-01||||||||Interventional|||Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma|Phase II Study of the Combination of Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents at Diagnosis or in Relapse|Unknown status|Active, not recruiting|Phase 2|87|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:21:08.574927|2017-02-18 16:21:08.574927
NCT00360932|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2011-10-28|||October 2005||2005-10-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|FACES||"Facial Lipoatrophy Correction Experience With SCULPTRA (FACES Study)"|An Open-Label Registry Study of the Facial Lipoatrophy Correction Experience With SCULPTRA® in Subjects With Human Immunodeficiency Virus (FACES Study)|Completed||Phase 4|290|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:21:08.698095|2017-02-18 16:21:08.698095
NCT00360919|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2012-08-06|||September 2006||2006-09-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion|Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion|Completed||Early Phase 1|28|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-02-18 16:21:08.790281|2017-02-18 16:21:08.790281
NCT00360906|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2006-08-04|||December 2004||2004-12-01|August 2006|2006-08-01|July 2008||2008-07-01|||||Interventional|||Omega-3 Fatty Acid Treatment in Multiple Sclerosis|Omega-3 Fatty Acid Treatment in Multiple Sclerosis|Completed||Phase 2/Phase 3|100||Haukeland University Hospital|||||f||||||||||||||2017-02-18 16:21:08.902631|2017-02-18 16:21:08.902631
NCT00360893|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2016-05-18|||April 1994||1994-04-01|May 2016|2016-05-01||||June 2017|Anticipated|2017-06-01||Observational|||Epidemiology of Diabetes Interventions and Complications (EDIC)|Epidemiology of Diabetes Interventions and Complications (EDIC)|Active, not recruiting||N/A|1441|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||f||||||||Yes|NIDDK Repository|2017-02-18 16:21:09.005216|2017-02-18 16:21:09.005216
NCT00360867|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2015-09-24||2015-07-13|December 2005||2005-12-01|September 2015|2015-09-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||An Open Label Treatment Extension Study of AMG 706|An Open Label Treatment Extension Study of AMG 706|Terminated||Phase 2|94|Actual|Amgen||1||Amgen decision|f||||||||||||||2017-02-18 16:21:09.128931|2017-02-18 16:21:09.128931
NCT00360854|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2013-09-19|||May 2005||2005-05-01|June 2007|2007-06-01||||||||Interventional|||Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma|Phase I Studies of TARCEVA™ (ERLOTINIB HYDROCHLORIDE, OSI-774) as Single Agent in Children With Refractory and Relapsed Malignant Brain Tumors and in Combination With Irradiation in Newly Diagnosed Brain Stem Glioma|Unknown status|Active, not recruiting|Phase 1|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:21:09.224643|2017-02-18 16:21:09.224643
NCT00360841|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2012-12-04|||June 2006||2006-06-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting|Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting: A Prospective Randomized Double-blind Cross-over Study|Completed||Phase 3|103|Actual|National Taiwan University Hospital||3|||f||||f||||||||||2017-02-18 16:21:09.339466|2017-02-18 16:21:09.339466
NCT00360828|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2011-11-07|2011-10-03||February 2006||2006-02-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas|A Phase II Study of Irinotecan HCI in Patients With Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas|Terminated||Phase 2|10|Actual|H. Lee Moffitt Cancer Center and Research Institute|Low accrual prevented us from completing the planned analysis. The initial Principal Investigator (PI) left Moffitt and there were only 10 participants.|1||Principal Investigator left Moffitt and study had low accrual.|f||||t||||||||||2017-02-18 16:21:09.563412|2017-02-18 16:21:09.563412
NCT00360815|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2010-03-01|||August 1983||1983-08-01|March 2010|2010-03-01|April 1993||1993-04-01|||||Interventional|||Diabetes Control and Complications Trial (DCCT)|Diabetes Control and Complications Trial (DCCT)|Completed||N/A|1441||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:21:09.841396|2017-02-18 16:21:09.841396
NCT00360802|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2009-05-27|||May 2006||2006-05-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Effectiveness of Cognitive Behavioral Treatment and Mindfulness Based Stress Reduction (MBSR) for Chronic Low Back Pain|The Effectiveness of Cognitive Behavioral Treatment and Mindfulness Based Stress Reduction for Chronic Low Back Pain Treated in Pain Clinics|Completed||Phase 2|330|Anticipated|Kovacs Foundation||2|||f||||||||||||||2017-02-18 16:21:09.952732|2017-02-18 16:21:09.952732
NCT00360789|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2015-06-05|||June 2005||2005-06-01|August 2006|2006-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Evaluation of Whether Functional Strength Training Can Enhance Motor Recovery of the Upper Limb After Stroke|The Effects of Standardized Physical Therapy and Functional Strength Training on Upper Limb Function and Neuromuscular Weakness After Stroke: a Pilot Study|Completed||Phase 1/Phase 2|30|Anticipated|St George's, University of London|||||f||||||||||||||2017-02-18 16:21:10.063445|2017-02-18 16:21:10.063445
NCT00360776|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2013-06-11|||June 2006||2006-06-01|May 2013|2013-05-01||||April 2009|Actual|2009-04-01||Interventional|||Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia|A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia|Terminated||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:21:10.153827|2017-02-18 16:21:10.153827
NCT00360763|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2006-08-04||||||August 2006|2006-08-01|December 2006||2006-12-01|||||Interventional|||Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody||Unknown status|Recruiting|Phase 4|600||Huazhong University of Science and Technology|||||f||||||||||||||2017-02-18 16:21:10.26306|2017-02-18 16:21:10.26306
NCT00360750|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2013-09-16|||September 2005||2005-09-01|June 2009|2009-06-01||||July 2010|Anticipated|2010-07-01||Interventional|||Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye|A Data Collection Study to Compare the Outcome for Children With Advanced Unilateral Retinoblastoma Treated With or Without Post-Enucleation Chemotherapy ± Radiotherapy on RB 2005 11 With Historical Controls Receiving no Additional Therapy|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:21:10.520691|2017-02-18 16:21:10.520691
NCT00360737|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2011-06-08|||July 2006||2006-07-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|December 2006|Actual|2006-12-01||Interventional|||Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses|Pharmacokinetics of a Heptavalent Equine-derived Botulinum Antitoxin (NP-018)|Completed||Phase 1|40|Actual|Cangene Corporation||1|||t||||t||||||||||2017-02-18 16:21:10.633968|2017-02-18 16:21:10.633968
NCT00360724|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2016-04-25|2013-10-01||August 2006||2006-08-01|October 2013|2013-10-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Interventional|||Duloxetine for Chronic Depression: a Double-blind Study|Duloxetine for Chronic Depression: a Double-blind Study|Completed||Phase 4|65|Actual|New York State Psychiatric Institute||2|||f||||f||||||||No||2017-02-18 16:21:10.751538|2017-02-18 16:21:10.751538
NCT00360711|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2017-01-24|||June 1, 2006||2006-06-01|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||Genetic Counselors' Experiences of Moral Value Conflicts With Clients|Genetic Counselors' Experiences of Moral Value Conflicts With Clients|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:11.355878|2017-02-18 16:21:11.355878
NCT00360698|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2011-08-01|2009-08-20||July 2006||2006-07-01|August 2011|2011-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|Basal Plus||Insulin Glulisine in Type 2 Diabetic Patients|Comparison of Two Therapeutic Strategies for Treating Type 2 Diabetic Patients Poorly Controlled With Basal Insulin Associated With Oral Antidiabetic Drugs : 6-month Proof of Concept Study.|Completed||Phase 4|106|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:21:11.435682|2017-02-18 16:21:11.435682
NCT00360685|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2013-03-22|2012-03-30||September 2005||2005-09-01|March 2013|2013-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX|Safety of Tacrolimus And Methotrexate (MTX) Versus Tacrolimus And Mycophenolate Mofetil (MMF) As Graft Versus Host Disease Prophylaxis In Allogeneic Hematopoietic Cell Transplants (HCT)|Completed||N/A|89|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||t||||||||||2017-02-18 16:21:12.143482|2017-02-18 16:21:12.143482
NCT00360672|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-04|2013-08-05|2013-05-31||January 2009||2009-01-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome|Phase II Study of Lenalidomide in Patients With Relapsed/Refractory Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome Associated With Chromosome 5 Abnormalities|Completed||Phase 2|27|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:21:12.572703|2017-02-18 16:21:12.572703
NCT00360659|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2008-04-17|||February 2004||2004-02-01|April 2008|2008-04-01|February 2005||2005-02-01|||||Interventional|||Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea Before and After Treatment With CPAP.||Completed||Phase 4|50||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:21:12.821837|2017-02-18 16:21:12.821837
NCT00360646|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2017-02-06|||September 2004||2004-09-01|February 2017|2017-02-01|June 2018|Anticipated|2018-06-01|June 2017|Anticipated|2017-06-01||Observational|ILIAD||Drug-Induced Liver Injury (DILN)Network Retrospective|Idiosyncratic Liver Injury Associated With Drugs (ILIAD): A Retrospective Study|Recruiting||N/A|200|Anticipated|Duke University|||2||f||||t||||||Samples With DNA|"~     Samples with DNA~   "|||2017-02-18 16:21:12.900329|2017-02-18 16:21:12.900329
NCT00360633|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2017-01-23|||June 2006||2006-06-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Psychiatric and Cognitive Manifestations of Parkinson's Disease|Psychiatric and Cognitive Manifestations of Parkinson's Disease: A Prospective Cohort Study|Enrolling by invitation||N/A|500|Anticipated|New York University School of Medicine|||1||f||||t||||||||||2017-02-18 16:21:13.027593|2017-02-18 16:21:13.027593
NCT00360607|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2008-12-01|||July 2004||2004-07-01|December 2008|2008-12-01|April 2005|Actual|2005-04-01|||||Interventional|||A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections|A Randomized, Open Label, Multicentre Phase Iv Study To Evaluate The Efficacy And Safety Of Magnex (Cefoperazone-Sulbactam) In Comparison With Ceftazidime Plus Amikacin And Metronidazole In The Treatment Of Intra-Abdominal Infections|Completed||Phase 4|307|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:21:13.115522|2017-02-18 16:21:13.115522
NCT00360594|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2017-01-10|||October 2006||2006-10-01|June 2010|2010-06-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Acamprosate Initiated During Alcohol Detoxification|Initiating Acamprosate Within Versus Post-detoxification in the Rehabilitative Treatment of Alcohol Dependence.|Completed||Phase 2|40|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 16:21:13.236494|2017-02-18 16:21:13.236494
NCT00360581|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2008-02-07|||April 2006||2006-04-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|||||Interventional|||Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study|Preventing Postpartum Relapse to Smoking Using Yoga and Cognitive Behavioral Therapy: A Randomized Pilot Study|Completed||Phase 1|30|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 16:21:13.345766|2017-02-18 16:21:13.345766
NCT00360568|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2015-01-12|2015-01-12||June 2009||2009-06-01|January 2015|2015-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects|Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects|Completed||Phase 3|62|Actual|AbbVie||1|||f||||t||||||||||2017-02-18 16:21:13.449271|2017-02-18 16:21:13.449271
NCT00360555|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2016-06-06|2014-03-27||July 2006||2006-07-01|June 2016|2016-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||"Demographic data are available for participants who were included in the treated analysis population of 1,581 participants."|Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder|Best Tolerability: 50mg Twice Daily Versus 100 mg in the Evening Versus 25 mg Twice Daily Versus Placebo in Younger Women in North America|Completed||Phase 3|1584|Actual|Sprout Pharmaceuticals, Inc||4|||f||||t||||||||||2017-02-18 16:21:15.641889|2017-02-18 16:21:15.641889
NCT00360529|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2016-06-06|2012-03-14||July 2006||2006-07-01|June 2016|2016-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder|A Twenty Four Week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Flibanserin 50mg Every Evening and Flibanserin 100mg Every Evening in Women With Hypoactive Sexual Desire Disorder in North America|Completed||Phase 3|880|Actual|Sprout Pharmaceuticals, Inc||3|||f||||t||||||||||2017-02-18 16:21:16.623215|2017-02-18 16:21:16.623215
NCT00360516|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2011-06-28|||November 2005||2005-11-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Paleolithic Diet and Exercise Study|Paleolithic Diets, Exercise Physiology and Metabolism|Completed||N/A|10|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 16:21:18.163329|2017-02-18 16:21:18.163329
NCT00360503|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2009-02-06|||March 2006||2006-03-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|||||Observational|||Antimicrobial Resistance in Cystic Fibrosis (CF)|Antimicrobial Resistance in Sputum Obtained From Patients With Cystic Fibrosis (CF)|Completed||N/A|304|Actual|Seattle Children's Hospital|||1||f||||f||||||Samples With DNA|"~     Bacterial isolates~   "|||2017-02-18 16:21:18.256648|2017-02-18 16:21:18.256648
NCT00360490|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2013-11-14|2009-10-13||July 2006||2006-07-01|November 2013|2013-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)|A Multicenter, Randomized, Open Label, Parallel Group, Active Control Study to Evaluate the Efficacy and Safety of LNG IUS (Mirena®) as Compared to Medroxyprogesterone Acetate During 6 Cycles of Treatment in Patients With Idiopathic Menorrhagia|Completed||Phase 3|165|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:21:18.35158|2017-02-18 16:21:18.35158
NCT00360477|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2016-12-12|||June 2004||2004-06-01|December 2016|2016-12-01|January 2015|Actual|2015-01-01|October 2014|Actual|2014-10-01||Interventional|||FloSeal Tubeless Exit Versus Cope Loop Nephrostomy Versus Fascial Stitch Following Percutaneous Nephrolithotripsy|Prospective Randomized Trial of Floseal Tubeless Exit vs. Cope Loop Nephrostomy vs. Fascial Stitch Following Percutaneous Nephrolithotripsy|Completed||N/A|59|Actual|University of California, Irvine||3|||f||||f||||||||||2017-02-18 16:21:21.788219|2017-02-18 16:21:21.788219
NCT00360464|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2011-04-20|||October 2006||2006-10-01|April 2011|2011-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases|A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases In Japan Adults|Completed||Phase 3|64|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:21:22.125929|2017-02-18 16:21:22.125929
NCT00360451|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2015-09-09|||September 2002||2002-09-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents|Preventing Depression in School Children|Completed||Phase 3|400|Actual|University of Pennsylvania||3|||f||||||||||||||2017-02-18 16:21:22.241702|2017-02-18 16:21:22.241702
NCT00360438|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2012-07-31|||July 2006||2006-07-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS|Pharmacokinetic Evaluation of Rasburicase Dosed for 5 Consecutive Days as Uricolytic Therapy in Adult Patients With Leukemia and/or Lymphoma at High or Potential Risk of Tumor Lysis Syndrome (TLS)|Completed||Phase 1/Phase 2|18|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:21:22.357901|2017-02-18 16:21:22.357901
NCT00360425|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2011-11-17|||May 2006||2006-05-01|October 2007|2007-10-01|August 2006|Actual|2006-08-01|||||Interventional|||A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women|A Phase 1 Active- and Placebo-Controlled Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women|Completed||Phase 1|174||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:21:22.476746|2017-02-18 16:21:22.476746
NCT00360412|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2014-06-26|2012-10-23||October 2006||2006-10-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|Terminated||Phase 3|997|Actual|Eisai Inc.|Due to early termination, a limited number of subjects (only 2) completed this open-label extension study. The majority of subjects did not reach the scheduled Week 56 assessment. Many outcomes could only be analyzed to Week 68 as a result.|1||Study stopped due to lack of efficacy.|f||||||||||||||2017-02-18 16:21:22.588741|2017-02-18 16:21:22.588741
NCT00360399|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2016-07-27|2016-06-16||August 2006||2006-08-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||Participants who consented to participate in the trial and who were randomized to a treatment arm.|Identifying Factors That Predict Antidepressant Treatment Response|Predictors of Antidepressant Treatment Response: The Emory CIDAR|Completed||N/A|344|Actual|Emory University||3|||f||||t||||||||||2017-02-18 16:21:23.323152|2017-02-18 16:21:23.323152
NCT00360386|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2010-08-30|||March 2004||2004-03-01|August 2010|2010-08-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||"ALBION Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"|Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis.|Completed||Phase 2|110||Sanofi|||||f||||||||||||||2017-02-18 16:21:24.811289|2017-02-18 16:21:24.811289
NCT00360373|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2014-01-03|||August 2005||2005-08-01|January 2014|2014-01-01|February 2012|Actual|2012-02-01|March 2009|Actual|2009-03-01||Observational|||Adolescent Gastric By-pass and Diabetic Precursors|Adolescent Gastric By-pass and Diabetic Precursors|Completed||N/A|30|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||t||||||||||2017-02-18 16:21:24.915191|2017-02-18 16:21:24.915191
NCT00360360|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2013-11-11|2013-08-15||July 2006||2006-07-01|November 2013|2013-11-01|March 2009|Actual|2009-03-01|February 2008|Actual|2008-02-01||Interventional|||Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site|A Phase II Study of Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Patients With Carcinoma of Unknown Primary Site|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:21:25.227132|2017-02-18 16:21:25.227132
NCT00360347|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2008-01-23||||||January 2008|2008-01-01||||||||Interventional|||A Study of Mircera in Anemic Patients With Multiple Myeloma|Open Label, Randomized, Exploratory Study to Investigate the Hemoglobin Dose-Response, the Safety and the Pharmacokinetic Profile Following Subcutaneous Administration of Mircera Once Every Three Weeks to Anemic Patients With Multiple Myeloma|Completed||Phase 2|||Hoffmann-La Roche|||||f||||||||||||||2017-02-18 16:21:25.558804|2017-02-18 16:21:25.558804
NCT00360334|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2015-03-19|2009-04-14||June 2006||2006-06-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients|An Open Label Study Comparing Exenatide With Basal Insulin in Achieving an HbA1c of ≤ 7.4% With Minimum Weight Gain, in Type 2 Diabetes Patients Who Are Not Achieving Adequate HbA1c Control on Oral Anti Diabetic Therapies Alone|Completed||Phase 3|235|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:21:25.665362|2017-02-18 16:21:25.665362
NCT00360321|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2006-08-03||||||July 2006|2006-07-01||||||||Observational|||Descriptive Study of a French Sample of “at Risk” and Pathological Gamblers Followed in a French Structure Specialised in Addictive Disorders.|Descriptive Study of a French Sample of “at Risk” and Pathological Gamblers Followed in a French Structure Specialised in Addictive Disorders.|Unknown status|Not yet recruiting|N/A|||Nantes University Hospital|||||f||||||||||||||2017-02-18 16:21:26.958013|2017-02-18 16:21:26.958013
NCT00360308|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2014-06-26|2012-10-23||November 2006||2006-11-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|A Multi-centre, Randomised, Double-blind, Placebo and Entacapone Controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|Terminated||Phase 3|723|Actual|Eisai Inc.||3||Study stopped due to lack of efficacy.|f||||||||||||||2017-02-18 16:21:27.025728|2017-02-18 16:21:27.025728
NCT00360295|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2008-05-19|||September 2006||2006-09-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults|A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults|Completed||Phase 3|153|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:21:27.911751|2017-02-18 16:21:27.911751
NCT00360282|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2014-12-04|2012-11-07||August 2006||2006-08-01|December 2014|2014-12-01|March 2010|Actual|2010-03-01|January 2009|Actual|2009-01-01||Interventional||Twenty seven subjects completed screening tests and met study criteria. Twenty five of the 27 subjects enrolled completed both experimental study visits.|Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?|Effect of Rizatriptan on Rotational Motion Sickness in Migraineurs|Completed||N/A|36|Actual|University of Pittsburgh||4|||f||||f||||||||||2017-02-18 16:21:28.074923|2017-02-18 16:21:28.074923
NCT00360269|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2014-12-08|2011-11-07||November 2005||2005-11-01|December 2014|2014-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Atomoxetine Treatment for ADHD and Marijuana Dependence|Atomoxetine Treatment for ADHD and Marijuana Dependence|Completed||Phase 2|38|Actual|Medical University of South Carolina|Small sample size and poor retention|2|||f||||t||||||||||2017-02-18 16:21:28.442102|2017-02-18 16:21:28.442102
NCT00360256|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2012-04-18|||June 2006||2006-06-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Genetic Study of Liver Enzymes in Patients With Side Effects From Antidepressants|Pharmacogenetic Study of CYP450 2D6 and 2C19 in Patients With Significant Adverse Effects From Antidepressants|Completed||Phase 3|46|Actual|Augusta University|||2||f||||f||||||||||2017-02-18 16:21:28.910175|2017-02-18 16:21:28.910175
NCT00360243|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2016-06-06|2014-04-25||July 2006||2006-07-01|June 2016|2016-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA|6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA|Completed||Phase 3|1385|Actual|Sprout Pharmaceuticals, Inc||4|||f||||t||||||||||2017-02-18 16:21:29.021132|2017-02-18 16:21:29.021132
NCT00360230|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2009-09-03||2009-09-03|August 2006||2006-08-01|September 2009|2009-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children|A Partially-blind (Observer-blind) Study to Evaluate the Safety and Immunogenicity of 3 Different Vaccination Schedules With 2 GSK Biologicals' Candidate Plasmodium Falciparum Vaccines in Children Aged 5 to 17 Months Living in Ghana|Completed||Phase 2|540|Actual|GlaxoSmithKline||7|||f||||||||||||||2017-02-18 16:21:29.908459|2017-02-18 16:21:29.908459
NCT00360217|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2011-11-17|||January 2006||2006-01-01|July 2006|2006-07-01|May 2007|Actual|2007-05-01|||||Interventional|||The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes|The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)|Completed||N/A|60|Anticipated|Maine Center for Lipids and Cardiovascular Health|||||f||||||||||||||2017-02-18 16:21:30.032731|2017-02-18 16:21:30.032731
NCT00360204|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-03|2011-03-09|||September 2006||2006-09-01|August 2009|2009-08-01|February 2010|Actual|2010-02-01|August 2009|Actual|2009-08-01||Interventional|||Improving Health Outcomes for New Mothers and Babies|Improving Health Outcomes for New Mothers and Babies|Completed||Phase 3|1154|Anticipated|Penn State University||1|||f||||||||||||||2017-02-18 16:21:30.13002|2017-02-18 16:21:30.13002
NCT00360191|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2012-01-10|||April 2004||2004-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||A Placebo-Controlled Trial of Buspirone for Treatment of Marijuana Dependence|A Placebo-Controlled Trial of Buspirone for Treatment of Marijuana Dependence|Completed||Phase 2|81|Actual|Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:21:30.241226|2017-02-18 16:21:30.241226
NCT00358982|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-06-05||2015-06-05|August 2006||2006-08-01|June 2015|2015-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase II Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma|Terminated||Phase 2|51|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:22:04.259218|2017-02-18 16:22:04.259218
NCT00360178|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2016-11-16|||July 2006||2006-07-01|November 2016|2016-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide|An Open-label, Multicenter Study to Evaluate the Efficacy and Tolerability of a 4 Week Therapy With the Fixed Dose Combination of Valsartan 160 mg Plus HCTZ 25 mg in Hypertensive Patients Not Adequately Responding to a 4 Week Therapy With the Free Combination of an Angiotensin Receptor Blocker (Candesartan 32 mg) Plus HCTZ 25 mg|Completed||Phase 3|198|Actual|Novartis|||||f||||||||||||||2017-02-18 16:21:30.322557|2017-02-18 16:21:30.322557
NCT00360152|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2013-07-02|||August 2006||2006-08-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|January 2009|Actual|2009-01-01||Interventional|||Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes|Minimally Invasive Staging of the Axilla in Breast Cancer: A Pilot Study to Assess the Feasibility of Axillary Ultrasound, Fine Needle Aspiration Biopsy and Molecular Analysis|Completed||Early Phase 1|100|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 16:21:30.4268|2017-02-18 16:21:30.4268
NCT00360139|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2007-08-20||||||August 2007|2007-08-01|December 2008||2008-12-01|||||Interventional|||Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy|A Phase IV, Prospective, Non-Blinded, Non-Randomized, Single-Center Clinical Trial to Determine the Longevity, Duration, and Volume-Correcting Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy|Withdrawn||Phase 4|15|Anticipated|Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.|||||||||||||||||||2017-02-18 16:21:30.546709|2017-02-18 16:21:30.546709
NCT00360126|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2012-05-31|||October 2005||2005-10-01|February 2011|2011-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder|An Open-Label Extension Study to Assess the Safety of Lamotrigine in Subjects With Bipolar Disorder, Who Are in Remission Following a Manic/Hypomanic Index Episode or a Depressive Index Episode.|Completed||Phase 4|15||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:21:30.647304|2017-02-18 16:21:30.647304
NCT00360100|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2011-05-16|||August 2006||2006-08-01|May 2011|2011-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media|A Randomized, Multicenter, Comparative Study To Assess Tolerability Of A Single Oral 60 Mg/Kg Dose Of Zmax (Pediatric Concentration) Vs. Zmax (Adult Concentration) In Pediatric Patients With Acute Otitis Media|Completed||Phase 3|120|Actual|Pfizer|||||||||||||||||||2017-02-18 16:21:30.743557|2017-02-18 16:21:30.743557
NCT00360087|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2010-02-11|||March 2006||2006-03-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|ASSET-3||A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study|Long-Term, Open-Label, Multicenter, Extension Study of Bosentan in Patients With Pulmonary Hypertension Associated With Sickle Cell Disease Completing a Double-Blind ASSET Study (AC-052-368 or AC 052-369)|Terminated||Phase 3|236||Actelion||1||Slow enrollment|f||||||||||||||2017-02-18 16:21:30.847045|2017-02-18 16:21:30.847045
NCT00360074|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2008-06-06|||February 2004||2004-02-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|||||Interventional|||Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation|A Randomised, Controlled, Crossover Study: Treatment With Thyroxin Compared to Thyroxin + Triiodothyronin in Patients With Secondary Hypothyroidism|Completed||Phase 4|25||University Hospital Freiburg|||||f||||||||||||||2017-02-18 16:21:31.208463|2017-02-18 16:21:31.208463
NCT00360061|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2006-08-01|||September 2001||2001-09-01|June 2001|2001-06-01|June 2005||2005-06-01|||||Interventional|||CBT in Adolescents With Type 1 Diabetes|Randomised Controlled Trial of Cognitive Behaviour Therapy: Efficacy and Acceptability for Adolescents With Type 1 Diabetes.|Completed||N/A|90||University of Bristol|||||f||||||||||||||2017-02-18 16:21:31.311595|2017-02-18 16:21:31.311595
NCT00360048|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2007-12-10|||August 2006||2006-08-01|December 2007|2007-12-01||||||||Observational|||Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy Volunteers|Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy Volunteers|Completed||N/A|10||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:21:31.401271|2017-02-18 16:21:31.401271
NCT00360035|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2013-08-16||2013-08-16|July 2006||2006-07-01|August 2013|2013-08-01|February 2009|Actual|2009-02-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia|A Multi-Center, Open-Label, Phase II Study of Single-Agent GX15-070MS Administered as a 24-Hour Infusion Every 2 Weeks to Patients With Myelofibrosis With Myeloid Metaplasia (MF)|Completed||Phase 2|22|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 16:21:31.484186|2017-02-18 16:21:31.484186
NCT00360022|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2011-07-14|||August 2006||2006-08-01|July 2011|2011-07-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Transition Study of Inflammatory Bowel Disease (IBD) Patients From Pediatric Gastroenterologist to Adult Gastroenterologist|Improving the Transition of Care From Pediatric GI to Adult GI for Patients With IBD: A Prospective Randomized Trial of a New Model|Unknown status|Recruiting|N/A|60|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 16:21:31.606559|2017-02-18 16:21:31.606559
NCT00360009|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2012-10-25|2009-08-05||January 2004||2004-01-01|October 2012|2012-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's Disease|Cognition and Mood in Parkinson's Disease (PD) in Subthalamic Nucleus (STN) Versus Globus Pallidus Interna (GPi) Deep Brain Stimulation (DBS)|Completed||N/A|62|Actual|University of Florida||3|||f||||t||||||||||2017-02-18 16:21:31.710026|2017-02-18 16:21:31.710026
NCT00359996|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2016-04-11|||June 2000||2000-06-01|April 2016|2016-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Improving Diabetes Care Collaboratively in the Community|Improving Diabetes Care Collaboratively in the Community|Completed||N/A|6993|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 16:21:32.487392|2017-02-18 16:21:32.487392
NCT00359801|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2010-01-29|2009-12-22||July 2006||2006-07-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|VOLUME||Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety|An International, Multicenter, Large Simple Trial To Evaluate The Long-Term Pulmonary And Cardiovascular Safety Of Exubera In Patients With Diabetes Mellitus|Completed||Phase 4|1976|Actual|Pfizer|Pursuant to Pfizer’s announcement that it would exit marketing of Exubera®, study enrollment was halted on 26-October-2007.|2|||f||||t||||||||||2017-02-18 16:21:35.164148|2017-02-18 16:21:35.164148
NCT00359983|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2016-11-03|2012-06-15||September 2006||2006-09-01|November 2016|2016-11-01|May 2011|Actual|2011-05-01|November 2007|Actual|2007-11-01||Interventional|||Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB|A Study to Evaluate the Long-term Antibody Persistence at 1, 3 & 5 Years After the Administration of a Fourth Dose of Hib-MenCY-TT Vaccine Compared to ActHIB in Subjects Boosted in a Previous Study.|Completed||Phase 3|270|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:21:32.628951|2017-02-18 16:21:32.628951
NCT00359970|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2015-06-17|||June 2002||2002-06-01|June 2015|2015-06-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea|Loperamide Plus Azithromycin More Effectively Treats Travelers' Diarrhea In Mexico Than Azithromycin Alone|Completed||Phase 4|176|Actual|The University of Texas Health Science Center, Houston||3|||f||||f||||||||||2017-02-18 16:21:33.301343|2017-02-18 16:21:33.301343
NCT00359957|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2010-03-01|||July 2006||2006-07-01|March 2010|2010-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ADVANCE||Efficacy of Increasing Physical Activity to Reduce Children's Visceral Fat|Activity, Diet, and Visceral Adiposity: New Care Emerging (ADVANCE) Project|Completed||Phase 1/Phase 2|29|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 16:21:33.432004|2017-02-18 16:21:33.432004
NCT00359944|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2013-05-28|2011-04-11||February 2006||2006-02-01|May 2013|2013-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||132 subjects were from the full analysis set, which was defined as all randomized subjects who took at least one dose of study drug and had greater than/equal to one post-baseline ADAS-Cog assessment|Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease|A Phase II, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Assessing the Efficacy and Safety of AC-3933 Tablets Twice Daily in Adults With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|171|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 16:21:33.538912|2017-02-18 16:21:33.538912
NCT00359931|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2017-01-24|||July 28, 2006||2006-07-28|March 7, 2016|2016-03-07|March 7, 2016||2016-03-07|||||Observational|||Brain Imaging of Tinnitus|Neural Modeling and Brain Imaging of Tinnitus|Completed||N/A|58|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:34.186859|2017-02-18 16:21:34.186859
NCT00359918|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2009-08-06|||August 2006||2006-08-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|LIPSIA STEMI||Randomized Multicenter Trial of Prehospital Initiated Facilitated Percutaneous Coronary Intervention (PCI) Versus Primary PCI in ST-segment-Elevation MI (STEMI)|Randomized, Controlled Multicenter Trial of Prehospital Initiated Facilitated PCI Versus Primary PCI in Patients With STEMI LIPSIA-STEMI Trial|Completed||Phase 4|162|Actual|University of Leipzig||2|||f||||t||||||||||2017-02-18 16:21:34.289776|2017-02-18 16:21:34.289776
NCT00359905|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2009-02-18|||May 2006||2006-05-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|May 2007|Actual|2007-05-01||Interventional|||Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH|Evaluation of the Efficacy and Safety of Silodosin vs. Tamsulosin and Placebo in the Treatment of the Signs and Symptoms of BPH. Multicentre, Randomised, Double-Blind, Controlled Trial With an Optional Long-Term, Open-Label Extension Phase.|Completed||Phase 3|1228|Actual|Recordati Industria Chimica e Farmaceutica S.p.A.||3|||f||||f||||||||||2017-02-18 16:21:34.386739|2017-02-18 16:21:34.386739
NCT00359892|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2012-08-03|||July 2006||2006-07-01|August 2012|2012-08-01|November 2008|Actual|2008-11-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma|A Multi-Center, Open-Label Phase II Study of Single-Agent GX15-070MS Administered as a 24-Hour Infusion Every 2 Weeks to Patients With Relapsed or Refractory Hodgkin's Lymphoma|Completed||Phase 2|13|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 16:21:34.508625|2017-02-18 16:21:34.508625
NCT00359879|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2015-02-20|||September 2006||2006-09-01|January 2015|2015-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes|Safety and Efficacy of Exenatide Taken Before Lunch and Before Dinner Compared With Before Breakfast and Before Dinner in Patients With Type 2 Diabetes Using Oral Antidiabetic Therapy|Completed||Phase 3|377|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:21:34.611207|2017-02-18 16:21:34.611207
NCT00359866|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-02|2016-06-13|||February 2006||2006-02-01|June 2016|2016-06-01|January 2016|Actual|2016-01-01|July 2010|Actual|2010-07-01||Interventional|||Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients|Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients|Completed||Phase 1|28|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 16:21:34.73353|2017-02-18 16:21:34.73353
NCT00359853|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2006-08-01|||September 2000||2000-09-01|June 2004|2004-06-01|March 2005||2005-03-01|||||Interventional|||Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis|Randomized Double-Blid Placebo Controlled Trial Assessing Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis In Advanced Cirrhosis|Completed||Phase 4|70||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:21:34.834726|2017-02-18 16:21:34.834726
NCT00359840|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2012-08-30|||July 2006||2006-07-01|August 2012|2012-08-01||||September 2007|Actual|2007-09-01||Interventional|||A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor|A Randomized, Dose - Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor|Completed||Phase 2|120|Anticipated|Kyowa Hakko Kirin Co., Ltd|||||f||||||||||||||2017-02-18 16:21:34.931185|2017-02-18 16:21:34.931185
NCT00359814|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2009-02-13|||November 2004||2004-11-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation|Conversion Study to Optimize Immunosuppressive Regimen by Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction for Patients After Heart Transplantation in Lon-Term|Completed||N/A|23|Actual|Hannover Medical School||1|||f||||f||||||||||2017-02-18 16:21:35.02972|2017-02-18 16:21:35.02972
NCT00359788|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2014-05-07|2009-04-17||July 2006||2006-07-01|September 2013|2013-09-01||||April 2008|Actual|2008-04-01||Interventional|||A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.|A Randomized, Double-blind, Parallel Group Trial Comparing 12 Weeks Treatment With Tiotropium 18 mcg Daily to Combivent MDI 2 Actuations Qid in COPD Patients Previously Prescribed Combivent MDI|Completed||Phase 4|349|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:21:37.02965|2017-02-18 16:21:37.02965
NCT00359775|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2012-02-16|||July 2006||2006-07-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Coping Skills Training (CST) for Children With Chronic Health Conditions|Coping Skills Training (CST) for Children With Chronic Health Conditions: An Extension From Children With Diabetes to Children With Rheumatologic Conditions, Epilepsy, Spina Bifida, and Asthma|Completed||Phase 2|38|Actual|Children's Hospital and Health System Foundation, Wisconsin||1|||f||||||||||||||2017-02-18 16:21:43.01124|2017-02-18 16:21:43.01124
NCT00359762|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-08-17|2012-03-29||September 2006||2006-09-01|August 2015|2015-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Exenatide Versus Glimepiride in Patients With Type 2 Diabetes|Long Term Treatment With Exenatide Versus Glimepiride in Patients With Type 2 Diabetes Pretreated With Metformin (EUREXA: European Exenatide Study)|Completed||Phase 3|1029|Actual|AstraZeneca|Only patients who reached primary endpoint 12 months or more before the projected end of the study could enter period III.|2|||f||||f||||||||||2017-02-18 16:21:43.144054|2017-02-18 16:21:43.144054
NCT00359736|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2014-09-29|2013-09-10||July 2006||2006-07-01|September 2014|2014-09-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Interventional|||Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis|Vasodilator Therapy and Exercise Tolerance in IPF Patients|Completed||Phase 2|29|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:21:45.656302|2017-02-18 16:21:45.656302
NCT00359723|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2009-09-03|||July 2004||2004-07-01|September 2009|2009-09-01||||||||Interventional|||Methylphenidate and Parkinson's Disease|Subacute Trial of Methylphenidate in Parkinson's Disease|Completed||Phase 2|24||Oregon Health and Science University|||||f||||||||||||||2017-02-18 16:21:46.338602|2017-02-18 16:21:46.338602
NCT00359710|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||April 19, 2006||2006-04-19|February 23, 2011|2011-02-23|February 23, 2011||2011-02-23|||||Observational|||Patients' Perspectives on Identity, Ancestry and Genetics|Identity, Ancestry and Genetics: Patients' Perspectives|Completed||N/A|22|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:46.440384|2017-02-18 16:21:46.440384
NCT00359697|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2014-11-05||||||November 2014|2014-11-01||||||||Interventional|||Comparison of Two Different Medications Used to Treat Elevated Intracranial Pressure|Prospective, Randomized Clinical Trialto Compare Mannitol and Hypertonic Saline for Treatment of Increased Intracranial Pressure|Unknown status|Not yet recruiting|Phase 1|50|Anticipated|Thomas Jefferson University|||||f||||||||||||||2017-02-18 16:21:46.529351|2017-02-18 16:21:46.529351
NCT00359684|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||July 6, 1978||1978-07-06|December 2, 2016|2016-12-02|December 1, 2018|Anticipated|2018-12-01|December 1, 2018|Anticipated|2018-12-01||Interventional|||Use of Cysteamine in the Treatment of Cystinosis|Natural History Study of the Use of Cysteamine in the Treatment of Cystinosis|Recruiting||Phase 4|300|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:21:46.619539|2017-02-18 16:21:46.619539
NCT00359671|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2016-11-28|||December 2006||2006-12-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001)|Phase I Study Evaluating MK6592 in Combination With Docetaxel in Adult Patients With Relapsed or Refractory Advanced Solid Tumors|Terminated||Phase 1|38|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:21:46.745632|2017-02-18 16:21:46.745632
NCT00359658|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2009-02-12|||November 2004||2004-11-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation|Conversion Study to Optimize Immunosuppressive Regimen by Withdrawal of Steroids, Cyclosporine A Dose Reduction and a Switch to Mycophenolatmofetile for Patients After Heart Transplantation in the Long-Term.|Completed||N/A|40|Actual|Hannover Medical School||1|||f||||f||||||||||2017-02-18 16:21:46.841135|2017-02-18 16:21:46.841135
NCT00359645|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2012-03-27|||August 2006||2006-08-01|March 2012|2012-03-01|November 2016|Anticipated|2016-11-01|November 2016|Anticipated|2016-11-01||Interventional|||Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population|DEPISTORL - THANCS (Trial of Head And Neck Cancer Screening) Randomized Multicenter Trial to Assess the Impact of a Screening Program for Heavy Alcohol Drinkers and Smokers Treated in Alcohol Addiction Clinics on Upper Aerodigestive Tract Cancer Mortality.|Terminated||Phase 3|1993|Actual|Gustave Roussy, Cancer Campus, Grand Paris||2||Too low accrual|f||||||||||||||2017-02-18 16:21:46.970058|2017-02-18 16:21:46.970058
NCT00359632|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2015-06-03|2014-12-16||November 2008||2008-11-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater|Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater|Terminated||Phase 3|34|Actual|Pfizer|This pilot study was exploratory and not designed to be powered for safety or efficacy. Controls were not followed post-baseline whereas linezolid patients returned for multiple study visits. The study was terminated early due to slow enrollment.|2||"Study was stopped due to poor enrollment on 28 Feb 2012. Reason for termination was not due to~   safety concerns."|f||||f||||||||||2017-02-18 16:21:47.125458|2017-02-18 16:21:47.125458
NCT00359619|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-10-11|2012-12-19||September 2006||2006-09-01|October 2016|2016-10-01|August 2009|Actual|2009-08-01|February 2007|Actual|2007-02-01||Interventional|||Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine|A Long-term, Follow-up of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Novel HPV Vaccine in Healthy Female Subjects Vaccinated in the Primary Study|Completed||Phase 2|383|Actual|GlaxoSmithKline||7|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:21:47.664327|2017-02-18 16:21:47.664327
NCT00359606|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2015-05-05|||April 1999||1999-04-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer|Phase I Trial of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine|Completed||Phase 1|58|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 16:21:49.658676|2017-02-18 16:21:49.658676
NCT00359593|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2008-03-19|||September 2006||2006-09-01|July 2006|2006-07-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Stroke Canada Optimization of Rehabilitation by Evidence Implementation Trial SCORE-IT)|Stroke Canada Optimization of Rehabilitation by Evidence Implementation Trial (SCORE IT)|Unknown status|Recruiting|Phase 2/Phase 3|2000|Anticipated|Toronto Rehabilitation Institute|||||f||||||||||||||2017-02-18 16:21:49.793921|2017-02-18 16:21:49.793921
NCT00359567|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2011-07-06|||July 2006||2006-07-01|July 2011|2011-07-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy|Comparative Study of Intravenous Single Doses of Palonosetron (PALO) With Granisetron Hydrochloride as a Control in Patients Receiving Highly Emetogenic Chemotherapy|Completed||Phase 3|1140|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 16:21:50.209411|2017-02-18 16:21:50.209411
NCT00359554|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2007-02-06|||September 2006||2006-09-01|February 2007|2007-02-01|October 2007||2007-10-01|||||Interventional|||Influenza Vaccination of Nursing Home Workers.|VAXICOL: Effectiveness of Influenza Vaccination of Nursing Home Workers on Mortality of Nursing Home Residents. A Cluster Randomized Trial.|Terminated||N/A|4000||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:21:50.323014|2017-02-18 16:21:50.323014
NCT00359541|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||January 19, 2006||2006-01-19|June 25, 2010|2010-06-25|June 25, 2010||2010-06-25|||||Observational|||Voriconazole Blood Levels and Toxicity|Voriconazole Plasma Concentration and Toxicity|Completed||N/A|98|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:50.420659|2017-02-18 16:21:50.420659
NCT00359515|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||February 17, 2001||2001-02-17|February 3, 2009|2009-02-03|February 3, 2009||2009-02-03|||||Observational|||Genetic Analysis of Oculocerebrorenal Syndrome of Lowe|Mutation Detection for Lowe Syndrome|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:50.511466|2017-02-18 16:21:50.511466
NCT00359489|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2007-09-13|||April 2007||2007-04-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Observational|||Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.|A Randomized, Open-Label, Methodology Trial To Investigate The Utility Of Echocardiography In Assessment Of Cardiac Valvular Regurgitation In Adult Subjects|Completed||N/A|30||Pfizer|||||f||||||||||||||2017-02-18 16:21:50.601345|2017-02-18 16:21:50.601345
NCT00359476|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2010-02-27||2010-02-27|March 2007||2007-03-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||A Study of Vinflunine in Patients With Gastric Cancer|A Multicenter, Single-Arm, Phase II Study of Single-Agent Vinflunine in the Second-line Treatment of Patients With Gastric Cancer|Terminated||Phase 2/Phase 3|55|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:21:50.683897|2017-02-18 16:21:50.683897
NCT00359463|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2012-10-25|||April 2006||2006-04-01|October 2012|2012-10-01||||||||Interventional|||Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment|An Open-Label, Non-Randomized Pharmacokinetic and Safety Study of a Single Oral Dose of 50mg Eltrombopag in Healthy Subjects and in Volunteers With Mild, Moderate or Severe Hepatic Impairment|Completed||Phase 1|32|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:21:50.801187|2017-02-18 16:21:50.801187
NCT00359450|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2010-02-27||2010-02-27|July 2006||2006-07-01|September 2007|2007-09-01||||March 2007|Actual|2007-03-01||Interventional|||Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)|A Three Cohort Phase II Trial of BMS-275183 Given Orally on a Twice Weekly Schedule in Pretreated Locally Advanced or Metastatic NSCLC Patients|Terminated||Phase 2|186||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:21:50.898909|2017-02-18 16:21:50.898909
NCT00359437|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2016-04-25||2016-04-25|July 2006||2006-07-01|April 2016|2016-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|SPARe-1||Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver|Satavaptan in the Prevention of Ascites Recurrence: a Double-blind, Randomised, Parallel-group Comparison of Satavaptan at 5 to 10 mg Daily Versus Placebo With Concomitant Diuretics in Patients With Recurrent Ascites Due to Cirrhosis of the Liver.|Terminated||Phase 3|501|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:21:51.02449|2017-02-18 16:21:51.02449
NCT00359424|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2013-11-19|2013-07-04||August 2006||2006-08-01|November 2013|2013-11-01|April 2013|Actual|2013-04-01|July 2012|Actual|2012-07-01||Interventional|IMSIII|A sample of 900 was calculated to provide an effect size of 10 percentage points assuming that 40% of the patients had a good outcome in the IV t-PA group, as noted in patients in the NINDS rt-PA Stroke Study who had age and baseline stroke severity similar to the eligibility criteria for the IMS3 trial. The trial was halted at 656 subjects.|Interventional Management of Stroke (IMS) III Trial|Interventional Management of Stroke Trial (IMS III): A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone|Terminated||Phase 3|656|Actual|University of Cincinnati|The IMS III trial was stopped early because of futility, according to the prespecified rules. A limitation of our trial is that it did not compare the efficacy of the new stent retrievers with that of intravenous t-PA alone.|2||NINDS/NIH-DSMB recommended halting trial due to futility, no safety concerns.|f||||t||||||||||2017-02-18 16:21:51.202363|2017-02-18 16:21:51.202363
NCT00359411|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||May 22, 1996||1996-05-22|February 1, 2010|2010-02-01|February 1, 2010||2010-02-01|||||Observational|||Genetic Studies of X-linked Lymphoproliferative Disease|Genetic Studies of the X-Linked Lymphoproliferative Disease|Completed||N/A|12|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:53.765428|2017-02-18 16:21:53.765428
NCT00359398|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2016-04-13|||August 2006||2006-08-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Sequestration of Platelets Prior to Bypass Reduces Bleeding After Cardiac Surgery|Post-operative Administration of Platelet Rich Plasma Sequestered Prior to Cardiopulmonary Bypass Reduces the Coagulopathy Associated With Complex Cardiac Surgery|Terminated||Phase 2|30|Actual|Royal Brompton & Harefield NHS Foundation Trust||2||Funding expired, low recruitment|f||||t||||||||||2017-02-18 16:21:53.843452|2017-02-18 16:21:53.843452
NCT00359385|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2011-11-15|||July 2006||2006-07-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|AlenPostPara||The Effects of Alendronate After Cure of Primary Hyperparathyroidism|The Effects of Alendronate After Cure of Primary Hyperparathyroidism|Withdrawn||Phase 4|0|Actual|Columbia University||2||incomplete enrollment|f||||f||||||||||2017-02-18 16:21:53.959153|2017-02-18 16:21:53.959153
NCT00359372|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||July 28, 2006||2006-07-28|May 29, 2007|2007-05-29|May 29, 2007||2007-05-29|||||Observational|||Predicting Response to Cardiac Resynchronization Therapy in Heart Failure|Predicting Response to Cardiac Resynchronization Therapy in Heart Failure|Completed||N/A|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:54.074795|2017-02-18 16:21:54.074795
NCT00358969|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2006-07-31|||July 2006||2006-07-01|July 2006|2006-07-01||||||||Interventional|||Guanfacine to Treat Borderline Personality Disorder|Guanfacine in the Treatment of Borderline Personality Disorder|Unknown status|Recruiting|N/A|||Bronx VA Medical Center|||||f||||||||||||||2017-02-18 16:22:04.376584|2017-02-18 16:22:04.376584
NCT00359359|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2014-11-03|||July 2006||2006-07-01|November 2014|2014-11-01|August 2009|Actual|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer|Phase I/II Study to Investigate the Safety, Tolerability, Efficacy and Pharmacokinetics of ZK 219477 in Combination With Cisplatin as First-line Therapy in Chemotherapy-naïve Patients With Extensive-disease (ED) Stage Small-cell Lung Cancer (SCLC)|Completed||Phase 1/Phase 2|26|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:21:54.169545|2017-02-18 16:21:54.169545
NCT00359346|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||July 14, 2006||2006-07-14|April 16, 2009|2009-04-16|April 16, 2009||2009-04-16|||||Observational|||Plasma Exchange for Autoimmune Autonomic Failure|Plasma Exchange for Autoimmune Autonomic Failure|Completed||N/A|3||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:54.305875|2017-02-18 16:21:54.305875
NCT00359333|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2013-10-28|||December 2006||2006-12-01|October 2013|2013-10-01|March 2011|Actual|2011-03-01|April 2010|Actual|2010-04-01||Interventional|STS||Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST|Multiple Centers, Prospective, Phase II Trial of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Locally Advanced/Metastatic Soft Tissue Sarcoma or Imatinib Mesylate Refractory Advanced/Metastatic Malignant Gastrointestinal Stromal Tumor|Completed||Phase 2|58|Actual|National Health Research Institutes, Taiwan||1|||f||||t||||||||||2017-02-18 16:21:54.393464|2017-02-18 16:21:54.393464
NCT00359320|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2015-03-17|||July 2006||2006-07-01|March 2015|2015-03-01|December 2015||2015-12-01|July 2015||2015-07-01||Interventional|||A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy|A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy|Recruiting||N/A|||Thomas Jefferson University|||||f||||||||||||||2017-02-18 16:21:54.509775|2017-02-18 16:21:54.509775
NCT00359307|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||June 8, 2000||2000-06-08|March 21, 2013|2013-03-21|March 21, 2013||2013-03-21|||||Observational|||Genetic Factors in Atherosclerosis|Chemokine System Polymorphisms and Risk of Atherosclerosis (CAD)|Completed||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:54.622676|2017-02-18 16:21:54.622676
NCT00359294|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2009-04-20|||May 2006||2006-05-01|October 2008|2008-10-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma|A Phase I Multicenter, Open-Label, Dose-Escalating Clinical and Pharmacokinetic Study of PM00104 Administered Intravenously Over 1 Hour Daily for 5 Days, Every 3 Weeks, to Subjects With Advanced Malignant Solid Tumors or Lymphoma.|Terminated||Phase 1|35|Anticipated|PharmaMar||1||"Considered not necessary to continue with this trial; recommended dose was reached in other~   phase I trials"|f||||t||||||||||2017-02-18 16:21:54.701573|2017-02-18 16:21:54.701573
NCT00359281|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2014-01-15|2013-01-18||March 2006||2006-03-01|January 2014|2014-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents|A Phase II, Fixed-sequenced, Open- Label, Research Study to Assess Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Therapies in Healthy Volunteers|Completed||Phase 2|125|Actual|Aegerion Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 16:21:54.914765|2017-02-18 16:21:54.914765
NCT00359268|ClinicalTrials.gov processed this data on February 17, 2017|2006-08-01|2017-01-24|||April 26, 2001||2001-04-26|August 24, 2016|2016-08-24||||||||Observational|||Identification of Viruses Associated With Diseases of Unknown Cause|Identification of Novel Viruses|Enrolling by invitation||N/A|56|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:21:56.501357|2017-02-18 16:21:56.501357
NCT00359255|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-07-08|||July 2006||2006-07-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of Additional Arm Therapy on Arm Function After Stroke|The Effect of a Supplementary Exercise Program for Upper Extremity Function in Stroke Rehabilitation|Completed||N/A|120|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 16:21:56.611614|2017-02-18 16:21:56.611614
NCT00359242|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2011-03-09|||June 2006||2006-06-01|November 2008|2008-11-01|December 2009|Actual|2009-12-01|November 2008|Actual|2008-11-01||Interventional|||The SLeeping and Intake Methods Taught to Infants and Mothers Early in Life (SLIMTIME) Project|Primary Prevention of Obesity Through Infancy Interventions|Completed||Phase 1|160|Anticipated|Penn State University||4|||f||||||||||||||2017-02-18 16:21:56.723621|2017-02-18 16:21:56.723621
NCT00359229|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2009-09-14|||July 2006||2006-07-01|September 2009|2009-09-01||||September 2007|Actual|2007-09-01||Interventional|STEP||Stilnox Treatment in Elderly Patients With Insomnia|A Multicentre Prospective, Open Label ,3 Weeks Phase IV Study to Evaluate the Efficacy and Safety in Elder Patients With Insomnia in China|Completed||Phase 4|115|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:21:56.834104|2017-02-18 16:21:56.834104
NCT00359216|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-05-28|2009-01-23||May 2006||2006-05-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)|A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Single-Site Study of Mometasone Furoate Nasal Spray (MFNS) In Subjects With Sleep-disordered Breathing Associated With Perennial Allergic Rhinitis (PAR) Using Home-Monitored Cardio-Respiratory Methodology.|Completed||Phase 4|30|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:21:56.921696|2017-02-18 16:21:56.921696
NCT00359203|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-09-28|2013-05-22||September 2006||2006-09-01|September 2015|2015-09-01|November 2012|Actual|2012-11-01|September 2011|Actual|2011-09-01||Interventional|||ISSUE3: International Study on Syncope of Uncertain Etiology 3|ISSUE3: International Study on Syncope of Uncertain Etiology 3 Pacemaker Therapy for Patients With Asystolic Neurally-mediated Syncope|Completed||Phase 4|511|Actual|Medtronic Bakken Research Center||2|||f||||||||||||||2017-02-18 16:21:57.299204|2017-02-18 16:21:57.299204
NCT00359190|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-07-14|||June 2004||2004-06-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|June 2007|Actual|2007-06-01||Interventional|||Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer|A Phase I, Open Label Study of the Safety, Pharmacokinetics and Pharmacodynamics of GW572016 in Once Daily Versus Twice Daily Dosing Regimens in Patients With Treatment- Naive Breast Cancer|Completed||Phase 1|60|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:22:00.6037|2017-02-18 16:22:00.6037
NCT00358995|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2014-02-17|||July 2002||2002-07-01|February 2014|2014-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Cognitive Behavioral Therapy of Primary Obsessions in Obsessive Compulsive Disorder|A New Cognitive Behavioral Therapy to Target Distorted Appraisals Characteristic of Primary Obsessions in Obsessive Compulsive Disorder|Completed||N/A|84|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 16:22:04.151037|2017-02-18 16:22:04.151037
NCT00359177|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-10-20|||December 2005||2005-12-01|October 2016|2016-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment|An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment|Completed||Phase 1|24|Actual|GlaxoSmithKline|||||||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:22:00.711198|2017-02-18 16:22:00.711198
NCT00359164|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2008-08-12|||July 2006||2006-07-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab.|A Randomized, Controlled, Double-Masked, Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab (Avastin), in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age Related Macular Degeneration (AMD)|Completed||Phase 2|36|Anticipated|University of British Columbia||3|||f||||||||||||||2017-02-18 16:22:00.808415|2017-02-18 16:22:00.808415
NCT00359151|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2008-05-22|||November 2006||2006-11-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Celebrex Total Knee Arthroplasty Study|Multicenter, Double Blind, Randomized, Placebo Controlled Trial Of The Efficacy And Safety Of Usual Care Plus Celecoxib Compared To Placebo For Peri-Operative And Rehabilitation Pain Control And Return To Function In Osteoarthritis Patients Undergoing Total Knee Arthroplasty|Terminated||Phase 4|22|Actual|Pfizer||2||This study was terminated early due to slow enrollment.|f||||f||||||||||2017-02-18 16:22:00.922808|2017-02-18 16:22:00.922808
NCT00359138|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-05-29|2010-05-27||February 2006||2006-02-01|May 2015|2015-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441)|A Double-blind, Double-dummy, Parallel-group, Placebo-controlled, Randomized Study to Assess the Duration of the Suppressive Effects of Desloratadine on the Cutaneous Allergen-induced Wheal and Flare (1) Response After Discontinuation|Completed||Phase 4|36|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 16:22:01.050784|2017-02-18 16:22:01.050784
NCT00359125|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2014-01-21|||July 2006||2006-07-01|January 2014|2014-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||RU-486 in the Treatment of Bipolar Depression|Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression.|Withdrawn||Phase 2|0|Actual|University of British Columbia||2|||f||||||||||||||2017-02-18 16:22:01.437929|2017-02-18 16:22:01.437929
NCT00359112|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-05-15|||February 2004||2004-02-01|May 2009|2009-05-01||||||||Interventional|||AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes|A Randomised, Multi-Centre, Phase IV, Double-Blind, Parallel Group Study Comparing the Effects of 52 Weeks Administration of AVANDAMET and Metformin Plus Sulphonylurea on Change in HbA1c From Baseline in Overweight Type 2 Diabetics Poorly Controlled on Metformin.|Completed||Phase 3|544||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:22:01.820336|2017-02-18 16:22:01.820336
NCT00359099|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2013-11-25|||January 1980||1980-01-01|November 2013|2013-11-01|July 2006||2006-07-01|||||Observational|||Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening|Proposal for Retrospective Review of the Prevalence of Hepatitis C Infection in Adult Patients Who Underwent Congenital Heart Surgery Before Screening|Terminated||N/A|1000||Emory University|||||f||||||||||||||2017-02-18 16:22:02.070383|2017-02-18 16:22:02.070383
NCT00359086|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-06-04||2015-06-04|August 2006||2006-08-01|June 2015|2015-06-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma|A Phase II Study of MGCD0103 (MG-0103) Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma|Completed||Phase 2|74|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:22:02.171206|2017-02-18 16:22:02.171206
NCT00359073|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-02-17|||October 2006||2006-10-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma|Effect of Montelukast on Experimentally-Induced RV16 Infection in Volunteers With Mild Asthma|Completed||N/A|20|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 16:22:02.283314|2017-02-18 16:22:02.283314
NCT00359060|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2006-10-12|||January 2005||2005-01-01|July 2006|2006-07-01|September 2006||2006-09-01|||||Interventional|||Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE Study|Physical Activity and Breast Cancer Risk in Postmenopausal Women: the SHAPE Study|Completed||Phase 3|180||UMC Utrecht|||||f||||||||||||||2017-02-18 16:22:02.406592|2017-02-18 16:22:02.406592
NCT00359047|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-04-19|||June 2003||2003-06-01|April 2016|2016-04-01|December 2025|Anticipated|2025-12-01|October 2007|Actual|2007-10-01||Interventional|||Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme|Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme|Active, not recruiting||N/A|2830|Actual|Centre Hospitalier Universitaire de Québec, CHU de Québec||2|||f||||f||||||||||2017-02-18 16:22:02.517736|2017-02-18 16:22:02.517736
NCT00359034|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2014-02-04|||May 2006||2006-05-01|January 2013|2013-01-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Observational|||Fetal Aortic Pulsewave Velocity: A Novel Doppler Ultrasound Method of Measuring the Biophysical Properties of the Fetal Aorta|Fetal Aortic Pulsewave Velocity: A Novel Doppler Ultrasound Method of Measuring the Biophysical Properties of the Fetal Aorta|Withdrawn||N/A|0|Actual|University of British Columbia|||1|Could not resolve technical difficulties|f||||f||||||||||2017-02-18 16:22:02.649931|2017-02-18 16:22:02.649931
NCT00359021|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2014-05-06|2013-01-29||June 2006||2006-06-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).|An Open-label Trial With TMC125 as Part of an ART Including TMC114/Rtv and an Investigator-selected OBR in HIV-1 Infected Subjects Who Participated in a DUET Phase III Trial (TMC125-C206 or TMC125-C216).|Completed||Phase 3|503|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||f||||||||||2017-02-18 16:22:02.744754|2017-02-18 16:22:02.744754
NCT00359008|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-30|2008-01-10|||July 2006||2006-07-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Observational|||PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)|PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)|Completed||Phase 3|336|Actual|Notal Vision Ltd|||2||f||||t||||||||||2017-02-18 16:22:04.043801|2017-02-18 16:22:04.043801
NCT00358956|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-12-07|2011-04-27||August 2006||2006-08-01|December 2016|2016-12-01|May 2014|Actual|2014-05-01|January 2008|Actual|2008-01-01||Interventional|||A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer|A Phase II, Open-Label Study To Assess The Efficacy and Tolerability of ZD6474 (ZACTIMA™ ) 100 mg Monotherapy In Subjects With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer|Completed||Phase 2|19|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:22:04.478626|2017-02-18 16:22:04.478626
NCT00358943|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2016-02-18|||April 1991||1991-04-01|February 2016|2016-02-01|January 2030|Anticipated|2030-01-01|January 2030|Anticipated|2030-01-01||Observational|||International Collaborative Gaucher Group (ICGG) Gaucher Registry|International Collaborative Gaucher Group (ICGG) Gaucher Registry|Recruiting||N/A|12000|Anticipated|Sanofi|||1||f||||f||||||||||2017-02-18 16:22:05.077027|2017-02-18 16:22:05.077027
NCT00358930|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-04-27|||July 2006||2006-07-01|April 2009|2009-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck|A Phase 2 Study of ARQ 501 in Patients With Locally Advanced, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|60||ArQule|||||f||||||||||||||2017-02-18 16:22:05.241376|2017-02-18 16:22:05.241376
NCT00358917|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2011-04-07|2009-11-12||August 2006||2006-08-01|April 2011|2011-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects|A Phase 3, Randomized, Open-Label Study of Lopinavir/Ritonavir (LPV/r) Tablets 800/200 Milligram (mg) Once-Daily (QD) Versus 400/100 mg Twice-Daily (BID) When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) in Antiretroviral-Experienced, Human Immunodeficiency Virus Type 1 (HIV-1) Infected Subjects|Completed||Phase 3|599|Actual|Abbott||2|||f||||t||||||||||2017-02-18 16:22:05.342985|2017-02-18 16:22:05.342985
NCT00358904|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2011-04-26|||May 2006||2006-05-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Assessment of Weber Humeral Derotational Osteotomy Using CT Scan|Assessment of Weber Humeral Derotational Osteotomy Using CT Scan|Completed||N/A|20|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 16:22:06.165034|2017-02-18 16:22:06.165034
NCT00358891|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-30|2006-08-01|||August 2006||2006-08-01|July 2006|2006-07-01|July 2009||2009-07-01|||||Observational|||Follow-Up of VLBW Infants With Chronic Lung Disease: Respiratory Health and Neurodevelopment|Follow-Up of Very Low Birth Weight Preterm Infants With Chronic Lung Disease at Preschool Ages: Respiratory Health and Neurodevelopment|Unknown status|Not yet recruiting|N/A|98||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:22:06.250229|2017-02-18 16:22:06.250229
NCT00358878|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2016-04-26||2016-04-26|July 2006||2006-07-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|CATS||Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)|Satavaptan Cirrhotic Ascites Treatment Study: a Double-blind, Randomised, Parallel-group Comparison of Treatment With Satavaptan at 5 to 10 mg Daily Versus Placebo on Top of Conventional Treatment in Patients With Ascites Due to Cirrhosis of the Liver|Completed||Phase 3|463|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:22:06.339561|2017-02-18 16:22:06.339561
NCT00358865|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2008-04-30|||December 2005||2005-12-01|April 2008|2008-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Checking the Usability of a Virtual Reality System in Children With Brain Injury|Checking the Usability of Video Projected Virtual Reality Sytem in Children With Acquired Brain Injury|Completed||Phase 1|30|Anticipated|Sheba Medical Center|||||f||||f||||||||||2017-02-18 16:22:06.470426|2017-02-18 16:22:06.470426
NCT00358852|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2014-03-18|||August 2006||2006-08-01|March 2014|2014-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|PRE-COG||Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia|Scale Validation of Prediction of Relapse and Rehospitalization Short Term in Patients With Schizophrenia|Completed||Phase 4|2339|Actual|Janssen-Cilag, S.A.|||1||f||||f||||||||||2017-02-18 16:22:06.559881|2017-02-18 16:22:06.559881
NCT00358839|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2006-11-09|||July 2006||2006-07-01|November 2006|2006-11-01|October 2006||2006-10-01|||||Interventional|||Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.|Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.|Completed||N/A|20||Danish Headache Center|||||f||||||||||||||2017-02-18 16:22:06.670783|2017-02-18 16:22:06.670783
NCT00358826|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2012-07-19|2012-06-15||July 2006||2006-07-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Study Effect of VIA-2291 on Vascular Inflammation|Clinical Study Protocol No. VIA-2291-01, A Phase 2 Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-ranging Study of the Effect of VIA-2291 on Vascular Inflammation in Patients After an Acute Coronary Syndrome Event|Completed||Phase 2|191|Actual|Tallikut Pharmaceuticals, Inc.||4|||f||||t||||||||||2017-02-18 16:22:06.791091|2017-02-18 16:22:06.791091
NCT00358813|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-11-04|||September 2006||2006-09-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment|An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Renal Impairment|Completed||Phase 1|18|Actual|GlaxoSmithKline|||||||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:22:08.124631|2017-02-18 16:22:08.124631
NCT00358800|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2006-07-28|||February 2005||2005-02-01|July 2006|2006-07-01|December 2005||2005-12-01|||||Interventional|||REMStar Auto With C-Flex – In-Laboratory Performance v. Conventionally Titrated CPAP Therapy: Performances and Preferences|A Randomized Cross Over Study to Compare REMStar Auto With C-Flex to Standard CPAP Therapy in Patients With OSAHS, and to Assess Its Safety, Tolerability and Efficacy and Preference Over CPAP.|Completed||N/A|15||University of British Columbia|||||f||||||||||||||2017-02-18 16:22:08.221118|2017-02-18 16:22:08.221118
NCT00358787|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-05-30|||July 2008||2008-07-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Management of Displaced Supracondylar Fractures of the Humerus Using Lateral vs. Crossed K-wires|Management of Displaced Supracondylar Fractures of the Humerus Using Lateral Versus Cross K Wires: A Prospective Randomized Clinical Trial|Recruiting||N/A|42|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 16:22:08.31963|2017-02-18 16:22:08.31963
NCT00358774|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2015-10-13|||March 2001||2001-03-01|October 2015|2015-10-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Efficacy of Homeopathic Nasal Formulation for Management of Experimental Rhinoviral Colds|A Double-blind, Placebo-controlled Trial to Test the Efficacy of Homeopathic Nasal Formulation for the Management of Experimental Rhinoviral Colds in an Outpatient Setting|Completed||Phase 1/Phase 2|40||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 16:22:08.44223|2017-02-18 16:22:08.44223
NCT00358761|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-29|2017-01-24|||July 20, 2006||2006-07-20|December 11, 2012|2012-12-11|December 11, 2012||2012-12-11|||||Observational|||Investigation of Southern Tick-Associated Rash Illness (STARI)|Investigation of Southern Tick-Associated Rash Illness (STARI)|Terminated||N/A|3|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:08.52884|2017-02-18 16:22:08.52884
NCT00358748|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2011-04-11|||July 2005||2005-07-01|April 2011|2011-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants|Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants|Completed||Phase 3|40|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:22:08.61292|2017-02-18 16:22:08.61292
NCT00358735|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-30|2014-10-21|2014-09-14||June 2006||2006-06-01|October 2014|2014-10-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|SAFE||Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)|Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty (THA): Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)|Completed||N/A|411|Actual|Medical Compression Systems||2|||f||||t||||||||||2017-02-18 16:22:08.720618|2017-02-18 16:22:08.720618
NCT00358722|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2009-07-21||2009-07-21|July 2006||2006-07-01|July 2009|2009-07-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|ALCON||An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate|A Long-term, Open-label Continuation Study to Assess the Safety of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia|Terminated||Phase 2|44|Actual|Ineos Healthcare Limited||1||Limited number of subjects|f||||t||||||||||2017-02-18 16:22:09.636998|2017-02-18 16:22:09.636998
NCT00358709|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2008-06-18|||June 2002||2002-06-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions|Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Cognitive-Behavioral Therapy and Skills Training Symptom Management on Measures of Symptoms and on Other Indices of Well-Being|Completed||Phase 3|129|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 16:22:09.774028|2017-02-18 16:22:09.774028
NCT00358696|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-10-19|||July 2006||2006-07-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients|TEN Switch - An Observational Phase IV Study to Evaluate the Safety and Efficacy of Substituting Tenofovir for Didanosine in Virologically Controlled HIV-infected Patients Co-infected With Hepatitis C Virus.|Completed||Phase 4|30|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:22:09.88521|2017-02-18 16:22:09.88521
NCT00358683|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2012-05-25|||November 2007||2007-11-01|May 2012|2012-05-01||||||||Interventional|||A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease|Open Label Long Term Clinical Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol, a PEGylated Fab Fragment of Humanized Antibody to Tumor Necrosis Factor Alpha (TNF) in Patients Suffering From Crohn's Disease and Having Completed C87055 Study.|Withdrawn||Phase 3|0|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 16:22:09.995576|2017-02-18 16:22:09.995576
NCT00358670|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-01-22|2010-04-08||May 2006||2006-05-01|January 2015|2015-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)|A Long-Term Efficacy and Safety Study of Infliximab in the Treatment of Moderate to Severe Plaque-Type Psoriasis|Terminated||Phase 3|441|Actual|Merck Sharp & Dohme Corp.||2||"Infusion reactions during re-induction cycles after a period of no treatment. Please see~   Purpose section."|f||||t||||||||||2017-02-18 16:22:10.087452|2017-02-18 16:22:10.087452
NCT00358657|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-11-16|||May 2006||2006-05-01|November 2016|2016-11-01||||September 2017|Anticipated|2017-09-01||Interventional|||Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders|HLA-Haploidentical Related Marrow Grafts for the Treatment of Primary Immunodeficiencies and Other Nonmalignant Disorders Using Conditioning With Low-Dose Cyclophosphamide, TBI and Fludarabine and Postgrafting Cyclophosphamide|Recruiting||Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 16:22:10.604439|2017-02-18 16:22:10.604439
NCT00358644|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2013-05-13|2009-04-13||March 2005||2005-03-01|June 2010|2010-06-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)|A Phase II Study of Decitabine For the Front-line Treatment of Older Patients With Acute Myeloid Leukemia|Completed||Phase 2|55|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 16:22:10.773849|2017-02-18 16:22:10.773849
NCT00358631|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2009-04-10|||July 2006||2006-07-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder|An Eight-Week, Multicenter, Double-Blind, Placebo- and Escitalopram-Controlled Study Evaluating the Efficacy and Tolerability of Two Fixed Doses of SSR149415 (250 mg Bid and 100 mg Bid) in Outpatients With Major Depressive Disorder|Completed||Phase 2|319|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:22:11.224907|2017-02-18 16:22:11.224907
NCT00358618|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-08-17|||September 2008||2008-09-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||The Effects of the Anesthetic Drug Propofol on the Way the Heart Recovers Between Beats|The Effects of Three Effect-site-targeted Propofol Concentrations on Dispersion of Myocardial Repolarization in Children|Completed||N/A|60|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:22:11.327866|2017-02-18 16:22:11.327866
NCT00356902|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2007-09-14|||July 2005||2005-07-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of Different Oxygen Delivery Strategies During Resuscitation of Babies|Effect of Titrating Oxygen Concentration During Resuscitation of the Newborn on Achieving Normoxemia|Completed||N/A|215|Anticipated|University of Calgary|||||f||||||||||||||2017-02-18 16:22:50.715965|2017-02-18 16:22:50.715965
NCT00358605|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-05-18|||August 2005||2005-08-01|May 2016|2016-05-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||The Use of Oral Appliances as an Adjunct to Continuous Positive Airway Pressure (CPAP) in the Treatment of Obstructive Sleep Apnoea|A Randomized Study to Compare Oral Appliances to Standard CPAP Therapy in Patients With OSAHS, and to Assess Its Safety, Tolerability and Efficacy and Preference Over CPAP for Its Short-term Use.|Completed||N/A|22|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:22:11.424815|2017-02-18 16:22:11.424815
NCT00358592|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2013-05-20|||July 2006||2006-07-01|May 2013|2013-05-01|June 2014|Anticipated|2014-06-01|||||Interventional|||Comparison of Tissue Retractors During Cesarean Delivery in Obese Women|Randomized Controlled Trial of the Efficacy of the Mobius ™ Retractor in Performing Cesarean Sections in Patients With BMI ≥35kg/m2|Unknown status|Recruiting|N/A|60|Anticipated|Thomas Jefferson University|||||f||||||||||||||2017-02-18 16:22:11.560726|2017-02-18 16:22:11.560726
NCT00358579|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-30|2011-07-12|2010-08-03||March 2006||2006-03-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Interventional|PIVOT||Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest|A Randomised, Double-blinded Multi-centre Trial Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest at the Emergency Department. (Preadmission Intravenous Vasopressin, Adrenaline Outcome Trial: PIVOT vII)|Completed||Phase 3|727|Actual|Singapore General Hospital|As the study was conducted over a relatively long period, results may be affected by secular trends.Variations in post-resuscitation care can affect survival to discharge status and variations between institutions are difficult to account for.|2|||f||||t||||||||||2017-02-18 16:22:11.661289|2017-02-18 16:22:11.661289
NCT00358566|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2008-05-16|||June 2006||2006-06-01|May 2008|2008-05-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer|"Primovax - A Phase III Trial Comparing GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Advanced Un-Resectable Pancreatic Cancer."|Terminated||Phase 3|360|Actual|Pharmexa A/S||2||"Preliminary data showed no survival benefit in the GV1001 group compared to the gemcitabine~   group."|t||||t||||||||||2017-02-18 16:22:12.136327|2017-02-18 16:22:12.136327
NCT00358553|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2007-03-12||||||March 2007|2007-03-01||||||||Interventional|||A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin||Completed||Phase 1|||Baxter Healthcare Corporation|||||f||||||||||||||2017-02-18 16:22:12.570486|2017-02-18 16:22:12.570486
NCT00358540|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2012-03-15|||June 2006||2006-06-01|May 2011|2011-05-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide|An Open-label, Dose Ranging Study to Assess the Safety, Efficacy, and Pharmacokinetics of an Oral Thrombopoietin Receptor Agonist (Eltrombopag) Administered to Subjects Receiving Adriamycin and Ifosfamide (AI) Regimen|Completed||Phase 1|48|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:22:12.658512|2017-02-18 16:22:12.658512
NCT00358527|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-31|2015-07-21|2010-02-18||May 2006||2006-05-01|July 2015|2015-07-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)|A Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Multicenter Study of Mometasone Furoate Nasal Spray on Sleep Disturbances and Daytime Somnolence in Subjects With Symptomatic Seasonal Allergic Rhinitis|Completed||Phase 4|401|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:22:12.770843|2017-02-18 16:22:12.770843
NCT00358514|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2010-03-26|||September 2008||2008-09-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Continuous Pressure Monitoring In Lower Leg Fractures|Continuous Compartment Pressure Monitoring (Ccpm) Following Tibial Fracture: A Prospective Randomized Trial|Terminated||N/A|250|Anticipated|University of British Columbia||1||"Large sample size and change in Orthopaedic practice to use of CCPM in conjunction with~   Clinical Monitoring rendered project less timely."|f||||f||||||||||2017-02-18 16:22:13.14545|2017-02-18 16:22:13.14545
NCT00358501|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-12-02|2016-03-26||July 2006||2006-07-01|December 2016|2016-12-01|March 2015|Actual|2015-03-01|September 2008|Actual|2008-09-01||Interventional|||Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients|Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients: A Historically-Controlled, Multi-Center Phase 3 Study to Determine Safety & Efficacy|Completed||Phase 3|134|Actual|Jazz Pharmaceuticals|Primary endpoint was changed after all patients were treated and current results reflect the final protocol. Adverse event severity was only reported for treatment group as control group was not assessed for severity.|2|||f||||t||||||||||2017-02-18 16:22:13.25718|2017-02-18 16:22:13.25718
NCT00358488|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2016-10-26|||April 2006||2006-04-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients|A Multi-enter, Randomized, Double-blind, Placebo-controlled, Four-way Incomplete Block Crossover Study to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Administration of Three Inhaled Doses (10, 15, and 20 mcg) of GSK159797|Completed||Phase 2|54|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:22:14.434878|2017-02-18 16:22:14.434878
NCT00358475|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2013-04-11|||June 2005||2005-06-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Of Perennial Allergic Rhinitis|Study of Perennial Allergic Rhinitis -Long Term Treatment Study-|Completed||Phase 3|65|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:22:14.555796|2017-02-18 16:22:14.555796
NCT00358462|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2013-02-01|2013-02-01||January 2007||2007-01-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)|Mycoplasma Genitalium Antibiotic Susceptibility and Treatment: A Randomized Double-blind Trial of the Efficacy of Azithromycin and Doxycycline for Clinical and Microbiological Cure of M. Genitalium in Men With Nongonococcal Urethritis|Completed||Phase 3|606|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:22:14.646268|2017-02-18 16:22:14.646268
NCT00358280|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-03-25|||April 2006||2006-04-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery|A Randomised, Double-Blind, Multi-Centre, Parallel Group Study Comparing Efficacy and Safety of 5 mg/ml Ropivacaine and 5 mg/ml Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery|Completed||Phase 3|220||AstraZeneca|||||f||||||||||||||2017-02-18 16:22:23.825982|2017-02-18 16:22:23.825982
NCT00358449|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2016-11-15|2015-11-05||September 2006||2006-09-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Intravenous Mepolizumab In Children With Eosinophilic Esophagitis|A Randomized, Double-blind, Parallel Group Clinical Trial to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Mepolizumab (SB240563)(0.55mg/kg, 2.5mg/kg or 10mg/kg) in Pediatric Subjects With Eosinophilic Esophagitis, Aged 2 to 17 Years (Study MEE103219)|Completed||Phase 2|77|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:22:15.03954|2017-02-18 16:22:15.03954
NCT00358436|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-11-16|2012-08-14||August 2006||2006-08-01|November 2016|2016-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)||Completed||Phase 3|804|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:22:17.703536|2017-02-18 16:22:17.703536
NCT00358423|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2008-05-08|||July 2006||2006-07-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema|Pilot Study of the Effect of Pegaptanib Sodium in Patients With Chronic, Post-Operative Cystoid Macular Edema|Terminated||Phase 1/Phase 2|1|Actual|Johns Hopkins University||2||Difficulty enrolling eligible subjects|f||||f||||||||||2017-02-18 16:22:21.403863|2017-02-18 16:22:21.403863
NCT00358410|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2017-02-06|||January 2006||2006-01-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia|An Exploratory Study to Investigate the Effects of the NK1 Antagonist GW679769, 60 mg Once Daily for 4 Days, on Gastric Accommodation, Gastric Emptying and Gastric Distension-induced Perception and Discomfort in Adult Male and Female Patients With Functional Dyspepsia, in a Single Center, Placebo-controlled, Double-blind, Randomised, Two-period Crossover Study|Completed||Phase 2|13|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:22:21.517161|2017-02-18 16:22:21.517161
NCT00358397|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2016-10-12|||July 2006||2006-07-01|October 2016|2016-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy|Phase I Safety Study of Clostridium Novyi-NT Spores in Patients With Treatment-Refractory Solid Tumor Malignancies|Terminated||Phase 1|2|Actual|Sidney Kimmel Comprehensive Cancer Center||1||Design Problem|f||||t||||||||||2017-02-18 16:22:21.625294|2017-02-18 16:22:21.625294
NCT00358384|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2012-05-31|||September 2005||2005-09-01|February 2011|2011-02-01||||||||Interventional|||Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034|A Randomised (With Respect to Microplaque Treatment Positions), Single-Blind, Placebo-Controlled, Positive-Controlled, Microplaque Study to Assess the Effectiveness of a Topical Formulation of GW786034 in Patients With Chronic Plaque Psoriasis|Completed||Phase 1|15||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:22:21.734881|2017-02-18 16:22:21.734881
NCT00358371|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2017-01-17|||January 2005||2005-01-01|January 2017|2017-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)|A Mono-center, Open, Randomized, Three-way, Twelve-sequence, Cross-over Study to Determine the Extent of Absorption (Absolute Bioavailability), Rate of Absorption and to Further Characterize Distribution and Elimination Characteristics of a Commercial 250 mg and a 500 mg Capsule of Flucloxacillin Each Given as a Single Oral Dose vs. One 250 or 500 mg Intravenous Dose to 24 Healthy Male and/or Female Subjects in the Fasting State|Completed||Phase 1|24||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:22:21.814247|2017-02-18 16:22:21.814247
NCT00358358|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2017-01-19|||March 2006||2006-03-01|January 2017|2017-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Chronic Obstructive Pulmonary Disease Endpoints Study|A Randomized, Double-blind Placebo-controlled Study of Treatments With Salmeterol, Fluticasone Propionate and Their Combination to Evaluate Novel Endpoints in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|163|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:22:21.904727|2017-02-18 16:22:21.904727
NCT00358345|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2008-01-10|||October 2003||2003-10-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Observational|||PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization|PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization|Completed||Phase 4|347|Actual|Notal Vision Ltd|||2||f||||t||||||||||2017-02-18 16:22:22.026668|2017-02-18 16:22:22.026668
NCT00358332|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2011-10-18|2008-12-09||November 2006||2006-11-01|October 2011|2011-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Phase I Pediatric FMP2.1/AS02A Trial in Mali|Randomized, Controlled, Dose Escalation Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of WRAIR's AMA-1 Malaria Vaccine (FMP2.1) Adjuvanted in GSKBio's AS02A Vs. Rabies Vaccine in 1-6 Year Old Children in Bandiagara, Mali|Completed||Phase 1|100|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||||||||||||2017-02-18 16:22:22.12195|2017-02-18 16:22:22.12195
NCT00358319|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2013-11-21|||March 2005||2005-03-01|February 2011|2011-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma|Phase I/II Trial of Valproic Acid and Karenitecin for Metastatic Malignant Melanoma|Terminated||Phase 1/Phase 2|42|Actual|H. Lee Moffitt Cancer Center and Research Institute||2||PI left Moffitt|f||||t||||||||||2017-02-18 16:22:23.52763|2017-02-18 16:22:23.52763
NCT00358306|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2010-02-16|||April 2008||2008-04-01|February 2010|2010-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)|The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)|Completed||N/A|36|Actual|University of Alabama at Birmingham|||1||f||||t||||||||||2017-02-18 16:22:23.64588|2017-02-18 16:22:23.64588
NCT00358293|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2009-01-20|||December 2006||2006-12-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity|A Double-Blind, Randomized, Crossover Study to Evaluate the Clinical Efficacy and Safety of Oral Tizanidine HCl (12 mg) Versus Novel Sublingual Tizanidine HCl (12 mg) for the Treatment of Spasticity in MS Patients|Completed||Phase 1/Phase 2|20||Teva GTC|||||f||||||||||||||2017-02-18 16:22:23.729479|2017-02-18 16:22:23.729479
NCT00358267|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2016-02-24|||July 2006||2006-07-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Randomized Trial Comparing Partial Resection of Inferior Turbinate(PRIT) and Radiofrequency Ablation(RFA) for Inferior Turbinate Reduction|A Randomized Trial Comparing Two Surgical Techniques for Inferior Turbinate Reduction|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University||2|||f||||||||||||||2017-02-18 16:22:23.922272|2017-02-18 16:22:23.922272
NCT00358254|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2010-07-21|||October 2004||2004-10-01|November 2007|2007-11-01|December 2007|Actual|2007-12-01|||||Observational|||Noninvasive Skin Spectroscopy for Diabetes Screening|Noninvasive Skin Spectroscopy for Diabetes Screening|Completed||Phase 1|1000|Anticipated|InLight Solutions|||2||f||||||||||||||2017-02-18 16:22:24.03553|2017-02-18 16:22:24.03553
NCT00358241|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2006-07-27||||||July 2006|2006-07-01||||||||Interventional|||Effects of Nerve Block on Knee Function After Knee Replacement|Effects of Continuous Lumbar Plexus Nerve Block on Functional Restoration and Outcome After Unilateral Total Knee Arthroplasty|Unknown status|Recruiting|N/A|||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:22:24.1121|2017-02-18 16:22:24.1121
NCT00358228|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2010-12-09|||September 2002||2002-09-01|December 2010|2010-12-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US)|Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US, EFC4964) - A Randomized, Double-blind, 3-arm, Placebo-controlled, Parallel-group, Fixed-dose, 52-week, Multi-center Study.|Completed||Phase 3|787|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:22:24.198526|2017-02-18 16:22:24.198526
NCT00358215|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2014-07-14|2013-10-23||June 2006||2006-06-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia|Completed||Phase 3|2278|Actual|Amgen||2|||f||||t||||||||||2017-02-18 16:22:24.589008|2017-02-18 16:22:24.589008
NCT00358202|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2007-10-29|||March 2002||2002-03-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia|Phase 4 Study of Once-Daily Intramuscular Cefepime Versus Ceftriaxone for In-Home Treatment of Nursing Home-Acquired Pneumonia|Completed||Phase 4|69|Actual|CPL Associates||2|||f||||||||||||||2017-02-18 16:22:28.543613|2017-02-18 16:22:28.543613
NCT00358189|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-02-03|||October 2006||2006-10-01|July 2006|2006-07-01|May 2008|Actual|2008-05-01|||||Observational|||Effects of Deep Brain Stimulation for the Treatment of Parkinson's Disease|Deep Brain Stimulation and Motor Function in Parkinson's Patients|Completed||N/A|20|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 16:22:28.647444|2017-02-18 16:22:28.647444
NCT00358176|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-12-11|||July 2004||2004-07-01|December 2009|2009-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women|A Multicenter, Double-blind, Randomized, Active-controlled, Parallel Group, Noninferiority Study Comparing 75mg Risedronate Dosed on 2 Consecutive Days Monthly With 5mg Daily Risedronate in the Treatment of Postmenopausal Osteoporosis as Assessed Over 24 Months.|Completed||Phase 3|1231|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:22:28.898483|2017-02-18 16:22:28.898483
NCT00358163|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2009-10-30|||April 2006||2006-04-01|October 2009|2009-10-01|April 2010|Anticipated|2010-04-01|April 2008|Anticipated|2008-04-01||Interventional|||Trial of PTK787/ZK 222584 Plus Paclitaxel|Phase I Study of the Oral Vascular Endothelial Growth Factor Inhibitor PTK787/ZK 222584 in Combination With Paclitaxel in Patients With Advanced Solid Tumors.|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:22:29.012394|2017-02-18 16:22:29.012394
NCT00358150|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2016-12-22|2014-08-22||June 2006||2006-06-01|December 2016|2016-12-01|December 2015|Actual|2015-12-01|August 2009|Actual|2009-08-01||Interventional||Full analysis set consists of all participants who signed informed consent and received at least one dose of eliglustat.|A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients|A Phase 2, Open-Label, Multi-Center Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients|Completed||Phase 2|26|Actual|Sanofi|Due to the very small number of participants at Year 9, the point estimates of mean and standard deviation are not reliable.|1|||f||||||||||||||2017-02-18 16:22:29.142203|2017-02-18 16:22:29.142203
NCT00358137|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2016-02-17|||July 1997||1997-07-01|December 2007|2007-12-01|January 2003|Actual|2003-01-01|||||Interventional|||Effect of Aerobic Exercise on Blood Pressure Changes|Psychophysiologic Stress, Exercise, & Autonomic Control|Completed||N/A|149|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||||||||||||2017-02-18 16:22:30.490535|2017-02-18 16:22:30.490535
NCT00358124|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-28|2011-01-10|||January 2001||2001-01-01|January 2011|2011-01-01|June 2002||2002-06-01|||||Interventional|||Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy||Completed||Phase 4|220||Sanofi|||||f||||||||||||||2017-02-18 16:22:30.578417|2017-02-18 16:22:30.578417
NCT00358111|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2014-05-12|||July 2006||2006-07-01|May 2014|2014-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of LUMA Cervical Imaging System as Adjunct to Colposcopy|A Single Arm Multi-Center Post Approval Study of LUMA as Adjunct to Colposcopy|Terminated||Phase 4|10|Actual|SpectraScience||1||PMA withdrawn|f||||t||||||||||2017-02-18 16:22:30.666045|2017-02-18 16:22:30.666045
NCT00358098|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2014-09-26|||August 2006||2006-08-01|September 2014|2014-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer|For Women With Estrogen Positive Metastatic Breast Cancer Discordance of Pre-treatment FDG-PET and FES-PET in Addition to Presence of Ki-67 and Human Epidermal Growth Factor 2 (HER-2) Overexpression Will Predict for Hormone Refractory Disease When Compared to Standard Response Criteria|Terminated||N/A|51|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 16:22:30.93367|2017-02-18 16:22:30.93367
NCT00358085|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2006-07-26|||September 2006||2006-09-01|July 2006|2006-07-01|January 2008||2008-01-01|||||Interventional|||NExT ERA: National Expertise Based Trial of Elective Repair of Abdominal Aortic Aneurysms: A Pilot Study|Expertise Based Randomized Controlled Trial of Open Versus Endovascular Repair of Abdominal Aortic Aneurysms: A Pilot Study|Unknown status|Not yet recruiting|Phase 3|30||McMaster University|||||f||||||||||||||2017-02-18 16:22:31.028905|2017-02-18 16:22:31.028905
NCT00358072|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2010-12-28|||May 2000||2000-05-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|December 2006|Actual|2006-12-01||Interventional|||Treatment of Adult ALL With an MRD-directed Programme.|Treatment of Adult Acute Lymphoblastic Leukemia Using a Post-remission Programme Whose Intensity Varies Depending on the Risk Class Defined on the Basis of Minimal Residual Disease.|Completed||Phase 2|280|Actual|Northern Italy Leukemia Group||1|||f||||f||||||||||2017-02-18 16:22:31.119114|2017-02-18 16:22:31.119114
NCT00358059|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2006-07-26|||October 2000||2000-10-01|October 2005|2005-10-01|January 2006||2006-01-01|||||Interventional|||Behavior Therapy for Families of Diabetic Adolescents|Behavior Therapy for Families of Diabetic Adolescents|Completed||Phase 3|120||Nemours Children's Clinic|||||f||||||||||||||2017-02-18 16:22:31.25309|2017-02-18 16:22:31.25309
NCT00358046|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2007-02-05|||June 2006||2006-06-01|February 2007|2007-02-01||||||||Interventional|||Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia|A Phase 2, Randomized, Dose-Ranging, Single-Blind, Efficacy and Tolerability Study of ILY101 in Patients With Chronic Kidney Disease With Hyperphosphatemia on Hemodialysis|Unknown status|Active, not recruiting|Phase 2|120||Ilypsa|||||f||||||||||||||2017-02-18 16:22:31.365076|2017-02-18 16:22:31.365076
NCT00358033|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2014-04-14|||July 2003||2003-07-01|April 2014|2014-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic|Effectiveness of Different Strategies in Maintaining Target Goals of Cardiovascular Risk Factors in Patients Discharged From Cardiovascular Risk Reduction Clinic|Completed||Phase 3|200|Actual|Providence VA Medical Center||3|||f||||t||||||||||2017-02-18 16:22:31.477646|2017-02-18 16:22:31.477646
NCT00358020|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2006-11-30|||November 2004||2004-11-01|November 2006|2006-11-01|December 2008||2008-12-01|||||Interventional|||Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients|A Phase II, Multi-Center, Open Label Study Of Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients|Completed||Phase 2|30||University of Turin, Italy|||||f||||||||||||||2017-02-18 16:22:31.589335|2017-02-18 16:22:31.589335
NCT00358007|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2016-10-19|2014-06-12||March 2007||2007-03-01|October 2016|2016-10-01|September 2010|Actual|2010-09-01|February 2008|Actual|2008-02-01||Interventional|||Use of Cone Beam Kilovoltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer|Evaluation of Cone Beam Kilovoltage Imaging During Radiation Therapy for Tumors of the Head and Neck|Terminated||Phase 2|30|Actual|Thomas Jefferson University||1||Administratively Terminated by PI|f||||t||||||||||2017-02-18 16:22:31.708224|2017-02-18 16:22:31.708224
NCT00357994|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2015-01-12|2015-01-12||January 2009||2009-01-01|January 2015|2015-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects|A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations|Completed||Phase 3|36|Actual|AbbVie||2|||f||||t||||||||||2017-02-18 16:22:32.050948|2017-02-18 16:22:32.050948
NCT00357981|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-08-27||||||August 2013|2013-08-01||||||||Interventional|||Continuous Use of the Contraceptive Patch and the Personal Economic Impact.|Patient Experiences Using Evra for Management of Menstrual Related Symptoms.|Withdrawn||N/A|0|Actual|University of California, San Francisco||1||Both sponsor and UCSF decided this study was not clinical relevant at this time|f||||||||||||||2017-02-18 16:22:33.198275|2017-02-18 16:22:33.198275
NCT00357968|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2010-08-25|2010-04-19||August 2006||2006-08-01|August 2010|2010-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|PRINCIPLE||Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting|Protocol H7T-MC-TABL(a) PRasugrel IN Comparison to Clopidogrel for Inhibition of PLatelet Activation and AggrEgation (PRINCIPLE) - TIMI 44|Completed||Phase 2|201|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 16:22:33.318188|2017-02-18 16:22:33.318188
NCT00357955|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2014-04-14|2014-01-14||August 2004||2004-08-01|April 2014|2014-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Age, mean in years; Gender, % male; Baseline level of glycemic control|Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients|Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients|Completed||N/A|118|Actual|Providence VA Medical Center||2|||f||||t||||||||||2017-02-18 16:22:34.814172|2017-02-18 16:22:34.814172
NCT00357942|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2014-02-20|||September 2006||2006-09-01|February 2014|2014-02-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy|Local Administration of Morphine: An Evaluation of the Analgesic Effect at Stomatitis in Children|Completed||Phase 4|72|Actual|Danish University of Pharmaceutical Sciences||3|||f||||t||||||||||2017-02-18 16:22:35.225182|2017-02-18 16:22:35.225182
NCT00357929|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2007-05-29|||August 2006||2006-08-01|May 2007|2007-05-01||||||||Interventional|||Weaning From Mechanical Ventilation Using Permissive Hypercarbia|Weaning From Mechanical Ventilation Using Permissive Hypercarbia|Terminated||N/A|40|Anticipated|Penn State University||||insufficient recruitment|f||||||||||||||2017-02-18 16:22:35.332382|2017-02-18 16:22:35.332382
NCT00357916|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2016-04-04|||June 2006||2006-06-01|April 2016|2016-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design|A Randomized, Controlled Study to Evaluate the Sensitizing Potential of PEP005 Topical Gel (0.01% Concentration) in Healthy Volunteers Using a Repeat Insult Patch Test Design|Completed||Phase 1|200||Peplin|||||||||||||||||||2017-02-18 16:22:35.432046|2017-02-18 16:22:35.432046
NCT00357903|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-02-07|2010-11-04||April 1997||1997-04-01|February 2017|2017-02-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials|Open-Label Extension Treatment With Tumor Necrosis Factor Receptor Fusion Protein (TNFR:Fc) for Participating Patients in Tumor Necrosis Factor Receptor Fusion Protein (TNFR:Fc) Clinical Trials|Completed||Phase 3|639|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:22:35.545876|2017-02-18 16:22:35.545876
NCT00357890|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2016-06-10|||December 2005||2005-12-01|June 2016|2016-06-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)|A Pilot Study of the Effect of Continuous Subcutaneous Insulin Infusion in Adolescents With Newly-diagnosed Type 1 Diabetes on Insulin Resistance, Beta-cell Function and the Honeymoon Period.|Completed||N/A|12|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-02-18 16:22:37.206353|2017-02-18 16:22:37.206353
NCT00357864|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2007-08-29|||July 2006||2006-07-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Observational|||Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow|Basic Research on Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow in a Humane Experimental Headache Model|Completed||N/A|15|Actual|Danish Headache Center|||||f||||t||||||||||2017-02-18 16:22:37.415458|2017-02-18 16:22:37.415458
NCT00357851|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2010-10-13|||March 2005||2005-03-01|October 2010|2010-10-01||||||||Interventional|||Can Aprotinin Reduce Pancreatitis After Scoliosis Surgery||Completed||Phase 1|120|Anticipated|Nemours Children's Clinic|||||||||||||||||||2017-02-18 16:22:37.513752|2017-02-18 16:22:37.513752
NCT00357838|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-27|2006-10-17|||July 2006||2006-07-01|July 2006|2006-07-01||||||||Observational|||Pulse Waves and Tongue Diagnosis Differences Between Follicular and Luteal Phase in Normal Healthy Women||Unknown status|Recruiting|N/A|||China Medical University Hospital|||||f||||||||||||||2017-02-18 16:22:37.606027|2017-02-18 16:22:37.606027
NCT00357825|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-05-14|||August 2006||2006-08-01|May 2013|2013-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia|An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study of [S,S]-Reboxetine Administered Once Daily in Patients With Fibromyalgia|Completed||Phase 2|246||Pfizer|||||||||||||||||||2017-02-18 16:22:37.688697|2017-02-18 16:22:37.688697
NCT00357812|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-01-14|||September 2006||2006-09-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|||||Observational|||The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)|A Study to Compare the Efficacy of Two Potential Diagnostic Assays: a Fluorescein Conjugated Monoclonal Antibody in Vivo Assay and Nested Real Time PCR Assay to Rapidly and Accurately Diagnose Herpes Simplex Keratitis.|Completed||Phase 1|50|Anticipated|University of Ulster|||1||f||||||||||||||2017-02-18 16:22:38.021503|2017-02-18 16:22:38.021503
NCT00357799|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2011-08-22|||October 2006||2006-10-01|August 2011|2011-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||VeinViewer for Peripheral IV Placement in Children With Difficult Intravenous (IV) Access|VeinViewer for Peripheral IV Placement in Children With Difficult IV Access|Completed||Phase 2/Phase 3|170|Anticipated|Children's Hospital and Health System Foundation, Wisconsin||2|||f||||f||||||||||2017-02-18 16:22:38.119729|2017-02-18 16:22:38.119729
NCT00357786|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2011-08-16|||October 2003||2003-10-01|December 2008|2008-12-01||||December 2008|Actual|2008-12-01||Interventional|||An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease|An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal® (Registered Trademark) in Patients With Fabry Disease|Completed||Phase 1|3||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:22:38.230677|2017-02-18 16:22:38.230677
NCT00357773|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-26|||May 2004||2004-05-01|July 2006|2006-07-01|June 2005||2005-06-01|||||Interventional|||Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis|Clinical Efficacy and Safety of T1225 1.5% Eye Drops (3-Day Treatment) Versus Tobramycin 0.3 % Eye Drops (7-Day Treatment) in the Treatment of Purulent Bacterial Conjunctivitis|Completed||Phase 3|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:38.340914|2017-02-18 16:22:38.340914
NCT00357760|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2016-09-16|||December 2007||2007-12-01|September 2016|2016-09-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|90|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 16:22:38.43703|2017-02-18 16:22:38.43703
NCT00357747|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2011-09-16|||April 2005||2005-04-01|September 2011|2011-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||AEG35156 and Docetaxel in Treating Patients With Solid Tumors|A Phase I Study of AEG35156 in Combination With Docetaxel in Patients With Solid Tumors|Completed||Phase 1|10|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 16:22:38.970202|2017-02-18 16:22:38.970202
NCT00357734|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2016-08-29|2016-05-17||January 2005||2005-01-01|June 2016|2016-06-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Iressa Follow-up Trial|Multicenter Open-label, Long-term Safety Trial of Treatment Extension With ZD1839 in Patients Who Have Been Treated in Other ZD1839 Clinical Trials.|Completed||Phase 3|14|Actual|AstraZeneca|The study was stopped after enrolling 14 of 100 patients. The outcome was biased by the limited number of patients. Therefore, data allow only a limited statement on efficacy and long term safety.|1|||f||||f||||||||||2017-02-18 16:22:39.254005|2017-02-18 16:22:39.254005
NCT00357721|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2011-04-05|||June 2006||2006-06-01|April 2011|2011-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Atazanavir Twice Daily|Randomized, Open-Label, Multiple-Dose Study to Evaluate the Pharmacokinetics of Atazanavir Administered Twice-Daily in Health Subjects|Completed||Phase 1|18||Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 16:22:39.553228|2017-02-18 16:22:39.553228
NCT00357708|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-01-04|||June 2006||2006-06-01|January 2013|2013-01-01||||October 2009|Actual|2009-10-01||Interventional|||Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases|A Phase I Trial of SAHA (NSC 701852) and Decitabine (IND 50733, NSC 127716) in Patients With Relapsed, Refractory or Poor Prognosis Leukemia|Completed||Phase 1|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:22:39.669107|2017-02-18 16:22:39.669107
NCT00357695|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||November 18, 2003||2003-11-18|October 28, 2008|2008-10-28|October 28, 2008||2008-10-28|||||Observational|||Role of the Brain in Processing Visually Presented Objects|Role of the Parieto-Frontal Network in Automatic Processing of Visually Presented Objects|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:39.78989|2017-02-18 16:22:39.78989
NCT00357682|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2016-05-17|||March 2005||2005-03-01|May 2016|2016-05-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|AspECT||A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia|A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia|Active, not recruiting||Phase 3|2513|Actual|University of Oxford||4|||f||||t||||||||||2017-02-18 16:22:39.865498|2017-02-18 16:22:39.865498
NCT00357669|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2015-05-15|||November 2006||2006-11-01|May 2015|2015-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment for 12 Weeks in Adolescent and Adult Patients (≥16 Years) With Genetically Ascertained Unverricht-Lundborg Disease|Completed||Phase 3|50|Actual|UCB Pharma||3|||f||||f||||||||||2017-02-18 16:22:39.984495|2017-02-18 16:22:39.984495
NCT00357656|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2017-01-10|||June 2006||2006-06-01|January 2017|2017-01-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery|Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method (rAHF PFM): A Phase 3/4, Prospective, Controlled, Randomized, Multi-Center Study to Compare the Efficacy and Safety of Continuous Infusion (CI) Versus Intermittent Bolus Infusion (BI) in Subjects With Severe or Moderately Severe Hemophilia A Undergoing Major Orthopedic Surgery|Completed||Phase 4|85|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-02-18 16:22:40.135894|2017-02-18 16:22:40.135894
NCT00357643|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2006-07-26|||October 1992||1992-10-01|June 2005|2005-06-01|February 1996||1996-02-01|||||Interventional|||Effect of Calcium and Vitamin D on Bone Loss From the Hip|Effect of Calcium and Vitamin D on Bone Loss From the Hip|Completed||Phase 3|450||Tufts University|||||f||||||||||||||2017-02-18 16:22:40.269724|2017-02-18 16:22:40.269724
NCT00357630|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2009-04-11|||June 2006||2006-06-01|October 2008|2008-10-01||||February 2007|Actual|2007-02-01||Interventional|||Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary|Phase II Protocol: Gemcitabine for Metastatic Cancer With Unknown Primary Site - Analysis of Symptom Benefit|Completed||Phase 2|52|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:22:40.368758|2017-02-18 16:22:40.368758
NCT00357617|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2010-12-23|||June 2006||2006-06-01|January 2008|2008-01-01||||||||Interventional|||Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery|Evaluation of the Effect of Celecoxib on Angiogenesis Markers in Patients With Operable Head and Neck Squamous Cell Carcinoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:22:40.501928|2017-02-18 16:22:40.501928
NCT00357604|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2011-04-07|||July 2006||2006-07-01|June 2008|2008-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females|The Effect of the Co-administration of Atazanavir (ATV) and Ritonavir (RTV) on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Female Subjects|Completed||Phase 1|22||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 16:22:40.604542|2017-02-18 16:22:40.604542
NCT00357591|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2009-12-24|||September 2004||2004-09-01|August 2009|2009-08-01|January 2008|Actual|2008-01-01|January 2008|Anticipated|2008-01-01||Interventional|||Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation|MOMENTUM: Multicenter Trial of the Orqis Medical CRS for the Enhanced Treatment of CHF Unresponsive to Medical Therapy|Terminated||N/A|200|Anticipated|Orqis Medical Corporation||1||Projected neutral significance for primary composite efficacy endpoint.|f||||t||||||||||2017-02-18 16:22:40.71395|2017-02-18 16:22:40.71395
NCT00357578|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||April 14, 2000||2000-04-14|September 19, 2007|2007-09-19|September 19, 2007||2007-09-19|||||Observational|||Genetic Study of Age-Related Macular Degeneration|A Case Control Study of Age-Related Macular Degeneration (AMD) Examining Gene Expression Patterns in Circulating Monocytes From Peripheral Blood Samples|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:40.934862|2017-02-18 16:22:40.934862
NCT00357565|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2016-12-07|||December 2005||2005-12-01|December 2016|2016-12-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia|Hematopoietic Cell Transplantation in the Treatment of Infant Leukemia and Myelodysplastic Syndrome|Recruiting||Phase 2|20|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-02-18 16:22:41.019141|2017-02-18 16:22:41.019141
NCT00357552|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2015-09-29|2012-05-23||January 2008||2008-01-01|September 2015|2015-09-01|May 2012|Actual|2012-05-01|October 2010|Actual|2010-10-01||Interventional|||Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy|A Pilot Study of Lopinavir/Ritonavir in Participants Experiencing Virologic Relapse on NNRTI-Containing Regimens|Completed||N/A|123|Actual|AIDS Clinical Trials Group||1|||f||||t||||||||||2017-02-18 16:22:41.170239|2017-02-18 16:22:41.170239
NCT00357539|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-26|||February 2002||2002-02-01|July 2006|2006-07-01|March 2002||2002-03-01|||||Interventional|||Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers|Comparison of the Ocular Tolerance, the Safety and the Ocular Pharmacokinetics After One Drop of Three Different Concentrations of T1225 (0.5% - 1.0% - 1.5%) in 48 Healthy Volunteers|Completed||Phase 1|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:41.62091|2017-02-18 16:22:41.62091
NCT00357526|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2007-04-19|||April 2003||2003-04-01|March 2006|2006-03-01|August 2004||2004-08-01|||||Interventional|||Oral Contraceptive Pills Compared to Vaginal Rings|YOUNG WOMEN’S EXPERIENCES: ORAL CONTRACEPTIVE PILLS VS The VAGINAL RING|Completed||N/A|130||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:22:41.89115|2017-02-18 16:22:41.89115
NCT00357513|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||June 3, 2002||2002-06-03|December 15, 2008|2008-12-15|December 15, 2008||2008-12-15|||||Observational|||Genetic Studies to Identify Stroke Subtypes and Outcome|Stroke Genomics - A Correlative Study of Stroke Subtypes, Neuroimaging, Therapy and Outcome Measures|Completed||N/A|840||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:41.983227|2017-02-18 16:22:41.983227
NCT00357500|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2014-09-19|2012-12-13||January 2005||2005-01-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|February 2013|Actual|2013-02-01||Interventional||The analysis population represents patients who started treatment.|Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer|Anti-Angiogenic Chemotherapy: A Phase II Trial of the Oral 5-Drug Regimen (Thalidomide, Celecoxib, Fenofibrate, Etoposide and Cyclophosphamide) in Patients With Relapsed or Progressive Cancer|Completed||Phase 2|101|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:22:42.081098|2017-02-18 16:22:42.081098
NCT00357487|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2011-08-29|||June 2006||2006-06-01|August 2011|2011-08-01|December 2007||2007-12-01|||||Interventional|||Evaluation of Two New Medical Instruments Dedicated to the Sentinel Lymph Node Technique in Case of Breast Cancer|Sentinel Lymph Node Identification in Case of Breast Cancer. Clinical Evaluation of a New Intra-operative Probe and a Mini Gamma Camera|Completed||N/A|25||University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 16:22:42.611572|2017-02-18 16:22:42.611572
NCT00357474|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-12-02|||October 2005||2005-10-01|December 2013|2013-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs|A Multicenter, Randomized, Controlled Trial of the Effective Therapy for Multiple, Small Hepatocellular Carcinomas: Comparing Transarterial Chemoembolization With Percutaneous Ethanol Injection Therapy.|Completed||Phase 3|22|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 16:22:42.700233|2017-02-18 16:22:42.700233
NCT00357461|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-05-14|||May 2006||2006-05-01|May 2013|2013-05-01||||||||Interventional|||Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma|A Randomized Phase II Study of Fixed Dose Ipilimumab (MDX-010) 10 mg/kg Given Alone or in Combination With Two gp100 Peptides Emulsified With Montanide ISA-51 VG for Previously Treated HLA-A * 0201 Positive Subjects With Stage IV Melanoma|Withdrawn||Phase 2|0|Actual|Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:22:42.809902|2017-02-18 16:22:42.809902
NCT00357448|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2016-05-02|||April 2005||2005-04-01|May 2016|2016-05-01||||November 2009|Actual|2009-11-01||Interventional|||Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer|Phase I Dose Escalation Study of Intraperitoneal (I.P.) ONTAK® Administered to Patients With Advanced Stage Ovarian Cancer|Active, not recruiting||Phase 1|11|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 16:22:42.911266|2017-02-18 16:22:42.911266
NCT00357435|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||October 6, 2003||2003-10-06|July 21, 2016|2016-07-21|July 21, 2016||2016-07-21|||||Observational|||Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases|Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases|Completed||N/A|6|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:43.030661|2017-02-18 16:22:43.030661
NCT00357422|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-12-02|||October 2005||2005-10-01|December 2013|2013-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC)|Prospective Randomized Trial of the Effective Therapy for Small, Solitary HCC Comparing Operation and Percutaneous Ethanol Injection Therapy|Completed||Phase 3|36|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 16:22:43.127602|2017-02-18 16:22:43.127602
NCT00357409|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||February 11, 2002||2002-02-11|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||GABA Levels in the Brains of Blind People|GABA Levels in the Occipital Cortex of Blind Human Subjects|Completed||N/A|39||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:43.240709|2017-02-18 16:22:43.240709
NCT00357396|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2015-10-22|2015-10-22||June 2005||2005-06-01|October 2015|2015-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors|A Phase II Trial of a Chemotherapy Based Regimen of Intravenous Busulfan (Busulfex), Melphalan and Thiotepa as Myeloablative Regimen Followed by a T- Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant From and HLA-Compatible Donor in the Treatment of High Risk Ewing's Sarcoma Family Tumors|Completed||Phase 2|10|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:22:43.327148|2017-02-18 16:22:43.327148
NCT00357383|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-26|||October 2002||2002-10-01|July 2006|2006-07-01|October 2002||2002-10-01|||||Interventional|||Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers|Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers|Completed||Phase 1|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:43.715951|2017-02-18 16:22:43.715951
NCT00357370|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2015-03-20|||October 2006||2006-10-01|March 2015|2015-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes|A Pilot Study of the Efficacy and Safety of BMS-512148 on Glycemic Control in Subjects With Type 2 Diabetes Treated Aggressively But Not Controlled on Combination Antihyperglycemic Therapy With Metformin and/or Thiazolidinedione (TZD) and Insulin.|Completed||Phase 2/Phase 3|67|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 16:22:43.793345|2017-02-18 16:22:43.793345
NCT00357357|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2008-08-20|||July 2006||2006-07-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients|Clinical Safety/Tolerability of HF0220 and Its Effect on Biochemical Markers Relevant to Patients With a Diagnosis of Mild to Moderate Alzheimer' Disease|Completed||Phase 2|40|Anticipated|Hunter-Fleming Ltd||4|||f||||t||||||||||2017-02-18 16:22:43.918299|2017-02-18 16:22:43.918299
NCT00357344|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||May 24, 2006||2006-05-24|October 3, 2008|2008-10-03|October 3, 2008||2008-10-03|||||Observational|||Study of Effects From Gastric Bypass Weight Loss on Brain Tissue|Weight Changes and the Brain (Study of the Effects of a Large and Intentional Weight Loss Induced by Roux-en-Y Gastric Bypass on Brain Tissue Composition of Obese Patients Using Magnetic Resonance Imaging and Voxel-Based Morphometry)|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:44.027067|2017-02-18 16:22:44.027067
NCT00357331|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2010-11-04|||July 2006||2006-07-01|November 2010|2010-11-01||||December 2009|Anticipated|2009-12-01||Interventional|||The Effects of Potassium Citrate on Bone Metabolism|A Randomized Placebo Controlled Double Blind Investigation of the Effects of Potassium Citrate on Bone Metabolism in Postmenopausal Osteopenia|Unknown status|Recruiting|Phase 4|75|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 16:22:44.108231|2017-02-18 16:22:44.108231
NCT00357318|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2014-02-21|||June 2006||2006-06-01|June 2013|2013-06-01||||July 2012|Actual|2012-07-01||Interventional|||Bevacizumab and Sunitinib in Treating Patients With Solid Tumors|A Phase I Study of Bevacizumab in Combination With SU11248|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:22:44.196846|2017-02-18 16:22:44.196846
NCT00357305|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-05-01|||May 2006||2006-05-01|May 2013|2013-05-01||||November 2011|Actual|2011-11-01||Interventional|||Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders|Phase I Study of Vorinostat (Suberoylanilide Hydroxamic Acid, or SAHA) in Combination With Cytosine Arabinoside (Ara-C) and Etoposide for Patients With Relapsed and/or Refractory Acute Leukemias, Myelodysplasias and Myeloproliferative Disorders|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:22:44.431122|2017-02-18 16:22:44.431122
NCT00357292|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-26|||March 2002||2002-03-01|July 2006|2006-07-01|April 2002||2002-04-01|||||Interventional|||Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers|Comparison of the Ocular Tolerance, the Safety and the Ocular Pharmacokinetics After One Drop of Three Different Concentrations of T1225 (0.5% - 1.0% - 1.5%) in 48 Healthy Volunteers|Completed||Phase 1|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:44.559704|2017-02-18 16:22:44.559704
NCT00356265|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2006-12-01|||July 2006||2006-07-01|December 2006|2006-12-01|June 2008||2008-06-01|||||Interventional|||Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide|Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide|Unknown status|Recruiting|N/A|39||University of Michigan|||||f||||||||||||||2017-02-18 16:23:04.905493|2017-02-18 16:23:04.905493
NCT00357279|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2015-10-09||2011-03-24|July 2006||2006-07-01|October 2015|2015-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease|A Multi-Center, Double-Blind, Placebo-Controlled Randomized, Efficacy and Safety Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease|Completed||Phase 3|352|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:22:44.634521|2017-02-18 16:22:44.634521
NCT00357266|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||February 1, 2002||2002-02-01|October 24, 2007|2007-10-24|October 24, 2007||2007-10-24|||||Observational|||Differences in Genes and Proteins in Active and Controlled Uveitis|Analysis of Differential Gene Expression Profiles in Patients With Defined Ocular Inflammatory Diseases Using CDNA Microarrays and Proteomics|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:44.720642|2017-02-18 16:22:44.720642
NCT00357253|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2013-01-08|||January 2006||2006-01-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma|A Phase I Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas and High Grade Gliomas|Completed||Phase 1|24|Actual|Pediatric Brain Tumor Consortium||1|||f||||t||||||||||2017-02-18 16:22:44.805377|2017-02-18 16:22:44.805377
NCT00357240|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2011-04-07|||June 2006||2006-06-01|June 2008|2008-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Drug Interaction Study With Proton Pump Inhibitor|Randomized, Open-Label, Multiple-Dose Study to Evaluate the Effect of Omeprazole 20 mg on the Pharmacokinetics of Atazanavir Administered With Ritonavir in Healthy Subjects|Completed||Phase 1|56||Bristol-Myers Squibb||8|||f||||||||||||||2017-02-18 16:22:44.921654|2017-02-18 16:22:44.921654
NCT00357227|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2007-04-18|||January 2004||2004-01-01|April 2007|2007-04-01||||||||Observational|||Atrial Fibrillation and the Risk for Neurological Complications|Atrial Fibrillation and the Risk for Neurological Complications|Unknown status|Recruiting|Phase 4|1000||University Hospital Muenster|||||f||||||||||||||2017-02-18 16:22:45.060679|2017-02-18 16:22:45.060679
NCT00357214|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2011-08-08|||September 2006||2006-09-01|August 2011|2011-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Potassium Bicarbonate Supplementation on Bone and Muscle in Older Adults|Effect of Potassium Bicarbonate on Bone and Muscle|Completed||Phase 2|171|Actual|Tufts University||4|||f||||f||||||||||2017-02-18 16:22:45.159282|2017-02-18 16:22:45.159282
NCT00357201|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-26|||November 2004||2004-11-01|July 2006|2006-07-01|May 2005||2005-05-01|||||Interventional|||Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome|Evaluation of the Efficacy of T1675, a Per Os Omega 3 and Omega 6 Polyunsaturated Essential Fatty Acid Dietary Formulation Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome|Completed||Phase 2|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:45.277383|2017-02-18 16:22:45.277383
NCT00357188|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2011-04-07|||July 2006||2006-07-01|June 2008|2008-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects|Open-Label, Multiple Dose Study to Determine the Relative Bioavailability of Atazanavir (ATV) 400 mg Administered With Ritonavir (RTV) and Efavirenz (EFV) Compared to Atazanavir 300 mg Administered With Ritonavir Alone in Healthy Subjects|Completed||Phase 1|22||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 16:22:45.540002|2017-02-18 16:22:45.540002
NCT00357162|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2014-05-02|2013-02-13||May 2006||2006-05-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Belinostat in Treating Patients With Myelodysplastic Syndromes|Phase II Study of the Histone Deacetylase Inhibitor PXD101 for the Treatment of Myelodysplastic Syndrome|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:22:45.649562|2017-02-18 16:22:45.649562
NCT00357149|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2009-12-04|||January 2003||2003-01-01|December 2009|2009-12-01||||February 2008|Actual|2008-02-01||Interventional|||Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)|Randomized Phase II Trial of Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck.|Completed||Phase 2|101|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:22:45.976188|2017-02-18 16:22:45.976188
NCT00357136|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2014-02-24|||July 2006||2006-07-01|February 2014|2014-02-01|July 2007|Actual|2007-07-01|December 2006|Actual|2006-12-01||Observational|||Online Survey on Computer Password Usage.||Completed||N/A|50|Anticipated|Towson University|||||f||||||||||||||2017-02-18 16:22:46.083418|2017-02-18 16:22:46.083418
NCT00357123|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2011-02-18|||August 2006||2006-08-01|September 2010|2010-09-01|September 2011|Anticipated|2011-09-01|July 2011|Anticipated|2011-07-01||Interventional|||Effect of Rosuvastatin in Abdominal Sepsis|Use of Rosuvastatin in Integral Management of Abdominal Sepsis|Unknown status|Recruiting|Phase 2|60|Anticipated|Universidad Autonoma de San Luis Potosí||1|||f||||t||||||||||2017-02-18 16:22:46.17675|2017-02-18 16:22:46.17675
NCT00357110|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2010-12-03|2009-12-18||April 2006||2006-04-01|December 2010|2010-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|@FAME||Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer|A Randomised Phase II Study Comparing Anastrozole and Fulvestrant to Anastrozole for Adjuvant Treatment of Postmenopausal Patients With Early Breast Cancer and Disseminated Tumour Cells in Bone Marrow|Completed||Phase 2|13|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:22:46.288074|2017-02-18 16:22:46.288074
NCT00357097|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2012-05-31|2008-12-12||June 2006||2006-06-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome|A Multicenter 3:1-randomized Placebo-controlled Double-blind Phase IIIb Study on the Effects of Ropinirole on Mood/(Subclinical) Depression in the Therapy of Patients With Moderate to Severe Idiopathic RLS in Germany|Completed||Phase 3|240|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:22:46.695077|2017-02-18 16:22:46.695077
NCT00356889|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2014-05-12|2013-02-22||May 2006||2006-05-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|October 2008|Actual|2008-10-01||Interventional|||Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors|A Phase II Trial of Bevacizumab and Erlotinib in Patients With Advanced Biliary Tumors|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:22:50.816129|2017-02-18 16:22:50.816129
NCT00357084|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2010-09-10|||May 2006||2006-05-01|September 2010|2010-09-01||||August 2007|Actual|2007-08-01||Interventional|||Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant|A Phase II Study to Evaluate Efficacy and Tolerability of Methotrexate in Combination With Glucocorticoids for the Treatment of Newly Diagnosed Acute Graft-Versus-Host Disease After Nonmyeloablative Hematopoietic Cell Transplantation|Completed||Phase 2|53|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 16:22:47.47087|2017-02-18 16:22:47.47087
NCT00357071|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||April 3, 2003||2003-04-03|August 12, 2016|2016-08-12||||||||Observational|||Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases|Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases|Enrolling by invitation||N/A|217|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:47.597046|2017-02-18 16:22:47.597046
NCT00357058|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2017-01-24|||December 12, 2001||2001-12-12|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Role of Brain Region Changes in Tactile (Touch) Ability Following Nerve Block|Substrates Mediating Deafferentiation-Induced Enhancement of Tactile Spatial Acuity|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:22:47.693515|2017-02-18 16:22:47.693515
NCT00357045|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-25||||||December 2003|2003-12-01||||||||Interventional|||Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine|Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine; THE HEPDEP II STUDY|Completed||Phase 4|||Portland VA Medical Center|||||f||||||||||||||2017-02-18 16:22:47.768008|2017-02-18 16:22:47.768008
NCT00357032|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2014-10-08|2014-10-08||May 2006||2006-05-01|June 2013|2013-06-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||PXD101 in Treating Patients With Acute Myeloid Leukemia|A Phase 2 Study of PXD101 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia or Patients Over 60 With Newly-Diagnosed Acute Myelogenous Leukemia|Completed||Phase 2|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:22:47.843562|2017-02-18 16:22:47.843562
NCT00357019|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2006-07-26|||April 2001||2001-04-01|July 2006|2006-07-01|October 2002||2002-10-01|||||Interventional|||Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis|Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis|Completed||Phase 4|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:48.139392|2017-02-18 16:22:48.139392
NCT00357006|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2015-05-07|2015-03-01||July 2006||2006-07-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|October 2011|Actual|2011-10-01||Interventional|||A Definitive Estrogen Patch Study (ADEPT)|Multisite Double-Blind Randomized Controlled Study of Estradiol Plus Antipsychotic Versus Placebo Plus Antipsychotic in the Treatment of Psychotic Symptoms in Women With Schizophrenia|Completed||Phase 2|180|Actual|The Alfred||3|||f||||t||||||||||2017-02-18 16:22:48.219427|2017-02-18 16:22:48.219427
NCT00356993|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2016-06-29|||October 2005||2005-10-01|June 2016|2016-06-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP)|The STOP (Stop Smoking Therapy for Ontario Patients) Study: The Effectiveness of Nicotine Replacement Therapy in Ontario Smokers.|Recruiting||N/A|10000|Anticipated|Centre for Addiction and Mental Health||1|||f||||f||||||||No||2017-02-18 16:22:48.682633|2017-02-18 16:22:48.682633
NCT00356980|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2012-03-14|||May 2006||2006-05-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors|A Phase I Trial of TNF-Bound Colloidal Gold (CYT-6091) by Intravenous Administration in Subjects With Advanced Solid Organ Malignancies|Completed||Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 16:22:48.811987|2017-02-18 16:22:48.811987
NCT00356967|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2008-12-18|||June 2006||2006-06-01|December 2008|2008-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|EURODIAN||Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation|An International 7-Week, Double-Blind, Placebo-Controlled, 2-Parallel Group Study to Assess the Efficacy of Dianicline 40 mg BID as an Aid to Smoking Cessation in Cigarette Smokers|Completed||Phase 3|602|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:22:49.021742|2017-02-18 16:22:49.021742
NCT00356954|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2006-11-24|||February 2005||2005-02-01|November 2006|2006-11-01|April 2006||2006-04-01|||||Interventional|||NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization|N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization: NASPI Study-A Randomized Controlled Trial|Completed||Phase 4|250||Seoul National University Hospital|||||f||||||||||||||2017-02-18 16:22:49.11722|2017-02-18 16:22:49.11722
NCT00356941|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2010-01-20|||April 2006||2006-04-01|January 2010|2010-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC|Phase I Study of Oxaliplatin in Combination With Docetaxel and Radiotherapy in Patients With Unresectable or Recurrent Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|4|Actual|Masonic Cancer Center, University of Minnesota||1||Withdrawn due to lack of accrual|f||||t||||||||||2017-02-18 16:22:49.216086|2017-02-18 16:22:49.216086
NCT00356928|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-26|2016-08-03|||May 2006||2006-05-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|May 2011|Actual|2011-05-01||Interventional|||Cyclophosphamide Plus Transplantation of Partially HLA-mismatched, CD8+ T Cell-depleted Peripheral Blood Cells for Patients With Myelodysplastic Syndrome , Refractory Acute Myeloid Leukemia, Refractory Lymphoma or Myeloproliferative Disorders|Cyclophosphamide Plus Transplantation of Partially HLA-Mismatched (Haploidentical), CD8+ T Cell-Depleted Peripheral Blood Cells (PBCs) for Patients With Myelodysplastic (MDS) or Myeloproliferative Disorders (MPD)|Terminated||N/A|9|Actual|Sidney Kimmel Comprehensive Cancer Center||1||Poor accrual|f||||t||||||||||2017-02-18 16:22:49.333357|2017-02-18 16:22:49.333357
NCT00356915|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2016-12-16|2010-10-01||July 2006||2006-07-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.|A Phase III Randomized, Evaluator-Blind, Parallel Group Study of the Safety and Efficacy of Itraconazole Tablets, Itraconazole Capsules and Placebo in the Treatment of Onychomycosis of the Toenail.|Completed||Phase 3|1381|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 16:22:49.44569|2017-02-18 16:22:49.44569
NCT00356252|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2008-07-23|||April 2002||2002-04-01|July 2008|2008-07-01|December 2003||2003-12-01|||||Interventional|||Biological Functions of Carotenoids in Humans|Functional Bioavailability of Carotenoids in Humans|Completed||N/A|40||Tufts University|||||f||||||||||||||2017-02-18 16:23:05.001733|2017-02-18 16:23:05.001733
NCT00356863|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2015-11-16|2010-06-08||February 2004||2004-02-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|MECRIS||Effect of an Educational Intervention on Cardiac Patients' Participation Rate in Cardiac Rehabilitation Programs|The Influence of Increasing Awareness of Cardiac Patients Undergoing Coronary Artery Bypass Grafting (CABG) Surgery to Cardiac Rehabilitation (CR) on Actual Participation Rates and; Patients' Related Barriers to CR Programs Participation|Completed||N/A|1024|Actual|Sheba Medical Center|"Lack of randomization~No biochemical tests were performed by the study and information regarding biochemical parameters was drawn from the medical records during baseline and from medical documents during follow up."|2|||f||||f||||||||||2017-02-18 16:22:51.322971|2017-02-18 16:22:51.322971
NCT00356850|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-25|||May 2002||2002-05-01|July 2006|2006-07-01|June 2002||2002-06-01|||||Interventional|||Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers|Ocular Pharmacokinetics After a Single Drop Instillation, in Each Eye of One of Three Different Concentrations of T1225 (0.5% - 1% - 1.5% Dihydrate) in 91 Healthy Volunteers|Completed||Phase 1|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:51.858976|2017-02-18 16:22:51.858976
NCT00356837|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2010-12-10|||August 2006||2006-08-01|December 2010|2010-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Diagnosing Extremity Fractures and/or Dislocations Using Ultrasound Presenting to the Emergency Department|Diagnosing Extremity Fractures and/or Dislocations Using Ultrasound in Adult Patients Presenting to the Emergency Department|Terminated||N/A|323|Anticipated|United States Army Institute of Surgical Research||1||IRB terminated study due to non compliance with continuing review date.|f||||f||||||||||2017-02-18 16:22:51.928107|2017-02-18 16:22:51.928107
NCT00356824|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2010-07-30|||November 2005||2005-11-01|July 2010|2010-07-01|May 2010|Actual|2010-05-01|April 2007|Actual|2007-04-01||Observational|||Relationship Between HIV and Malaria in Ugandan Children|"Prospective Longitudinal Study of Interactions Between HIV and Malaria in Ugandan Children: A UCSF/Makerere University Children With HIV and Malaria Project"|Completed||N/A|300|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 16:22:52.027806|2017-02-18 16:22:52.027806
NCT00356811|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2014-06-19|2014-05-08||May 2006||2006-05-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|March 2008|Actual|2008-03-01||Interventional|||Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer|An Open-label, Single-arm, Multi-centre, Phase II Study of Oral Lapatinib in Combination With Paclitaxel as First-line Treatment for ErbB2-amplified Metastatic Breast Cancer Patients|Completed||Phase 2|57|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 16:22:52.143385|2017-02-18 16:22:52.143385
NCT00356798|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2007-11-08|||December 2005||2005-12-01|November 2007|2007-11-01|April 2006||2006-04-01|||||Interventional|||Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects|The Phase-I Clinical Trial Protocol for the Pandemic Inactivated Influenza Vaccine|Completed||Phase 1|120||Sinovac Biotech Co., Ltd|||||f||||||||||||||2017-02-18 16:22:52.618747|2017-02-18 16:22:52.618747
NCT00356785|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-25|||January 2001||2001-01-01|April 2006|2006-04-01|December 2001||2001-12-01|||||Interventional|||Changes in Body Composition and Metabolic Risk Parameters by Life Style Intervention.|Body Compositional and Endocrine-Metabolic Changes by Long-Term Lifestyle Intervention With Health Education, Diet (Almased®), Physical Activity or a Combination of Diet and Physical Activity in Overweight and Obese Persons.|Completed||N/A|90||University Hospital Freiburg|||||f||||||||||||||2017-02-18 16:22:52.708455|2017-02-18 16:22:52.708455
NCT00356772|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-25|||February 2003||2003-02-01|July 2006|2006-07-01|March 2003||2003-03-01|||||Interventional|||Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers|Comparison of Azithromycin Level in Tears and in Conjunctiva After Repeated Instillations of T1225 1.5% Eye Drops or After a Single Per Os Administration of Zithromax® (Azithromycin 1g), in 36 Healthy Volunteers|Completed||Phase 1|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:52.806608|2017-02-18 16:22:52.806608
NCT00356759|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2010-02-26|||December 2006||2006-12-01|December 2008|2008-12-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients|A Randomized Double-blind Study of 4-weekly Versus 12-weekly Monitoring of Stable Patients on Long-term Anticoagulation With Warfarin|Completed||Phase 2|250|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 16:22:52.879832|2017-02-18 16:22:52.879832
NCT00356746|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2015-06-23|||March 2006||2006-03-01|June 2008|2008-06-01|March 2009|Actual|2009-03-01|December 2007|Actual|2007-12-01||Observational|IRAS||Inflammatory Response During Anesthesia and Surgery|A Prospective, Randomized Trial to Study the Effects of Different Anesthetic Agents on the Perioperative Immune Response|Completed||N/A|120|Actual|UMC Utrecht|||2||f||||f||||||Samples Without DNA|"~     Full blood smaples~   "|||2017-02-18 16:22:52.987395|2017-02-18 16:22:52.987395
NCT00356733|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2011-11-30|||January 2007||2007-01-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome|Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome|Completed||Phase 3|62|Actual|UMC Utrecht||3|||f||||||||||||||2017-02-18 16:22:53.087838|2017-02-18 16:22:53.087838
NCT00356720|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-25|||January 2004||2004-01-01|July 2006|2006-07-01|May 2004||2004-05-01|||||Interventional|||Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma|Clinical Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% (Instilled Twice Daily for 2 or 3 Days) Versus Oral Azithromycin in Treatment of Trachoma|Completed||Phase 3|||Laboratoires Thea|||||f||||||||||||||2017-02-18 16:22:53.194163|2017-02-18 16:22:53.194163
NCT00356707|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2012-03-27|||June 2006||2006-06-01|March 2012|2012-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Evaluating the Link Between Neighborhood Environments and Obesity Among African American Women|Effect of Urban Form on Exercise and BMI in Black Women|Completed||N/A|23000|Actual|Boston University|||1||f||||f||||||||||2017-02-18 16:22:53.272646|2017-02-18 16:22:53.272646
NCT00356681|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2015-09-24||2015-04-16|December 2006||2006-12-01|September 2015|2015-09-01|August 2012|Actual|2012-08-01|February 2009|Actual|2009-02-01||Interventional|||A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer|A Randomized Phase 2 Trial of Double-Blind, Placebo Controlled AMG 706 in Combination With Paclitaxel, or Open-Label Bevacizumab in Combination With Paclitaxel, as First Line Therapy in Women With HER2 Negative Locally Recurrent or Metastatic Breast Cancer|Terminated||Phase 2|282|Actual|Amgen||3||Sponsor decision to close study|f||||t||||||||||2017-02-18 16:22:53.36406|2017-02-18 16:22:53.36406
NCT00356668|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2015-07-13|||July 2006||2006-07-01|July 2015|2015-07-01|September 2007|Actual|2007-09-01|||||Interventional|||Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure|Observational, Cross-over Study of the Positive Distending Pressure Generated by Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure|Completed||Phase 3|16|Actual|Children's Hospitals and Clinics of Minnesota||1|||f||||||||||||||2017-02-18 16:22:53.484711|2017-02-18 16:22:53.484711
NCT00356655|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2008-05-12|||July 2006||2006-07-01|May 2008|2008-05-01|January 2009|Anticipated|2009-01-01|||||Interventional|||The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response|A COHORT AND INTERVENTION STUDY EVALUATING ANTIDEPRESSANT EPIDEMIOLOGY AND ADHERENCE: The ACHIEVA Study|Terminated||N/A|106|Anticipated|University of Alberta||||Low recruitment|f||||||||||||||2017-02-18 16:22:53.582753|2017-02-18 16:22:53.582753
NCT00356642|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2012-05-31|||June 2005||2005-06-01|February 2011|2011-02-01||||||||Interventional|||Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis|A Randomised, Single-Blind, Dose-Rising Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Ten Day Repeat Topical Applications of GW842470X Cream on the Skin of Patients With Atopic Dermatitis|Completed||Phase 1|42||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:22:53.689376|2017-02-18 16:22:53.689376
NCT00356629|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2008-11-13|||July 2006||2006-07-01|November 2008|2008-11-01|July 2008|Anticipated|2008-07-01|||||Observational|||Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air|Development of a Noninvasive Method of Evaluation of the Pulmonary Inflammation in the Condensates of Exhaled Air|Terminated||N/A|100|Anticipated|University Hospital, Tours|||1|Technical problem|f||||f||||||||||2017-02-18 16:22:53.807282|2017-02-18 16:22:53.807282
NCT00356616|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2008-01-25|||September 2005||2005-09-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients|Open-Label, Single-Centre, Randomised Pilot Study to Evaluate Immunovirological and Clinical Evolution of a Combination With Nucleoside Analogues/Nucleotides (Trizivir +Tenofovir) in Multiresistant Patients With Virological Failure|Terminated||Phase 4|24|Actual|Germans Trias i Pujol Hospital||2||terminated|f||||f||||||||||2017-02-18 16:22:53.896781|2017-02-18 16:22:53.896781
NCT00356603|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2013-05-13|||June 2006||2006-06-01|May 2013|2013-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan|Clinical Evaluation of Sumatriptan Succinate Injection Kit Product in Patients With Migraine or Cluster Headache|Completed||Phase 3|40|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:22:54.007739|2017-02-18 16:22:54.007739
NCT00356590|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2013-05-10|2010-11-05||December 1998||1998-12-01|May 2013|2013-05-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012|Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012|Completed||Phase 3|468|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:22:54.108138|2017-02-18 16:22:54.108138
NCT00356564|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2016-10-11|||July 2006||2006-07-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib|Multicentre Study to Assess Persistence of Antibodies Against Hepatitis B and Immune Response to a Hepatitis B Challenge Dose in Healthy Children 7 to 9 Years Old Previously Vaccinated With 4 Doses of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine|Completed||Phase 4|350||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:22:57.960049|2017-02-18 16:22:57.960049
NCT00356551|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2016-07-29|||May 2002||2002-05-01|July 2016|2016-07-01|September 2005||2005-09-01|||||Interventional|||Family Spirit Study|Family Strengthening in Native Communities Project|Completed||N/A|320||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:22:58.106091|2017-02-18 16:22:58.106091
NCT00356525|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2010-08-09|2009-06-08||September 2006||2006-09-01|August 2010|2010-08-01|April 2009|Actual|2009-04-01|June 2008|Actual|2008-06-01||Interventional|||Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor|Phase II, Randomized, Open-Label Trial of Biweekly Pemetrexed Plus Gemcitabine vs. Pemetrexed or Pemetrexed Plus Carboplatin in Relapsed Non Small Cell Lung Cancer After Neoadjuvant or Adjuvant Chemotherapy|Terminated||Phase 2|41|Actual|Eli Lilly and Company|The trial terminated early due to slow enrollment. Secondary outcomes were not analyzed due to insufficient data. Original results reported were interim analyses. Results have now been updated with final data.|4||Stopped early due to low enrollment|f||||f||||||||||2017-02-18 16:22:58.219688|2017-02-18 16:22:58.219688
NCT00356512|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2017-01-24|||July 19, 2006||2006-07-19|September 2, 2009|2009-09-02||||September 2, 2009|Actual|2009-09-02||Observational|||Physiologic Regulation of FGF-23|Physiologic Regulation of FGF-23|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:00.123307|2017-02-18 16:23:00.123307
NCT00356486|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2009-09-02|||October 2005||2005-10-01|September 2009|2009-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV|Open, Multicentre and Randomised Phase IV Study to Evaluate Viral Kinetics in the First 12 Weeks of Patients With Chronic Hepatitis C Genotypes 1 and 4 Coinfected by the Human Immunodeficiency Virus Treated With Induction Doses of Peginterferon Alpha-2a (40 KD) (270 μg/Week) and Ribavirin (1600 mg/Day) With Epoetin β Support (450 IU/kg/Week)|Completed||Phase 4|74|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 16:23:00.236062|2017-02-18 16:23:00.236062
NCT00356473|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2012-06-21|||March 2003||2003-03-01|June 2006|2006-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis|Effects of Atorvastatin on Disease Activity and HDL Cholesterol Anti-inflammatory Properties in Patients With Rheumatoid Arthritis|Completed||Phase 4|20|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 16:23:00.375848|2017-02-18 16:23:00.375848
NCT00356460|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2014-03-17|||September 2006||2006-09-01|March 2014|2014-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma|A Phase 1 Study of the Safety and Efficacy of GC1008: A Human Anti Transforming Growth Factor-beta (TGFβ) Monoclonal Antibody in Patients With Advanced Renal Cell Carcinoma or Malignant Melanoma|Completed||Phase 1|29|Actual|Sanofi||8|||f||||t||||||||||2017-02-18 16:23:00.481393|2017-02-18 16:23:00.481393
NCT00356447|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2014-09-30|||May 2006||2006-05-01|September 2014|2014-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.|A Double-blind, Randomized, Placebo-controlled, Multicenter Study Investigating the Efficacy and Tolerability of Angeliq® (Drospirenone 2mg and Estradiol 1mg) in Postmenopausal Chinese Women With Vasomotor Symptoms Over Four 28-day Treatment Cycles.|Completed||Phase 3|249|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:23:00.617107|2017-02-18 16:23:00.617107
NCT00356434|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2016-07-22|||November 2008||2008-11-01|July 2016|2016-07-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population|Study of Patient Compliance and Comfort Using Sequential Compression Devices and Foot Pumps for DVT Prevention|Terminated||N/A|20|Actual|Johns Hopkins University||2||PI assigned to a different hospital;difficulty recruiting patients|f||||f||||||||||2017-02-18 16:23:00.73568|2017-02-18 16:23:00.73568
NCT00356421|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2009-08-25|2009-06-24||November 2006||2006-11-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®|A 52-Week Multicenter, Open-Label, Randomized, Parallel, Two - Arm Study Comparing Exubera® (Inhaled Human Insulin) Vs. Humalog® (Insulin Lispro), Both In Combination With Insulin Glargine In Subjects With Type 1 Diabetes Mellitus|Terminated||Phase 4|58|Actual|Pfizer|As a result of Pfizer’s decision to stop marketing Exubera ®, this study was terminated. Due to the early termination of the study and the low number of subjects who completed, no descriptive statistics for efficacy endpoints are provided.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 16:23:00.852789|2017-02-18 16:23:00.852789
NCT00356408|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2014-08-26|2011-02-23||January 2007||2007-01-01|April 2011|2011-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|COSPAR II||Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease|An Open-label, Multi-center Trial to Examine the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease Previously Enrolled in C87059 (COSPAR I, NCT00349752).|Completed||Phase 3|106|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 16:23:01.591446|2017-02-18 16:23:01.591446
NCT00356395|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2006-07-25|||August 2003||2003-08-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Safety and Effects of Ramipril Combined With Candesartan|Cardiovascular and Metabolic Effects of Combination Therapy With Ramipril and Candesartan In Hypertensive Patients|Completed||Phase 4|40||Gachon University Gil Medical Center|||||f||||||||||||||2017-02-18 16:23:03.030303|2017-02-18 16:23:03.030303
NCT00356382|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2008-05-12|||September 2006||2006-09-01|April 2007|2007-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Decreasing Rates of Illness in Kids (DRINK)|Decreasing Rates of Illnesses in Kids (DRINK)|Completed||Phase 3|638||Georgetown University|||||f||||t||||||||||2017-02-18 16:23:03.114704|2017-02-18 16:23:03.114704
NCT00356369|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2016-10-24||2012-07-26|December 2006||2006-12-01|October 2016|2016-10-01|February 2008|Actual|2008-02-01|September 2007|Actual|2007-09-01||Interventional|||Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine|Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)|Completed||Phase 2|500|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:23:03.218585|2017-02-18 16:23:03.218585
NCT00356356|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2013-05-10|||April 2002||2002-04-01|May 2013|2013-05-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||16.0040 Ankylosing Spondylitis Study|Open-label, Long-term Extension Study of Etanercept in the Treatment of Patients With Ankylosing Spondylitis Who Participated in Protocol 16.0037|Completed||Phase 3|257|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:23:03.343029|2017-02-18 16:23:03.343029
NCT00356343|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2011-01-09|||July 2004||2004-07-01|January 2011|2011-01-01||||September 2009|Anticipated|2009-09-01||Interventional|||Strength Training Using Neuromuscular Electrical Stimulation For Children With Cerebral Palsy|Strength Training Using NMES for Children With Cerebral Palsy|Unknown status|Active, not recruiting|Phase 1|45|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||t||||||||||2017-02-18 16:23:03.447627|2017-02-18 16:23:03.447627
NCT00356330|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-25|2007-04-09||||||April 2007|2007-04-01||||||||Observational|||Safety of Cardiac Pacemakers in 3 Tesla MRI|Study to Evaluate Safety of Cardiac Pacemakers in MR Imaging at 3T Tesla|Unknown status|Recruiting|N/A|75||University Hospital, Bonn|||||f||||||||||||||2017-02-18 16:23:03.563534|2017-02-18 16:23:03.563534
NCT00356317|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2015-12-17|||March 2015||2015-03-01|December 2015|2015-12-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia|A Culturally Based Family Therapy for Schizophrenia|Completed||Phase 2|400|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 16:23:03.649578|2017-02-18 16:23:03.649578
NCT00356304|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2014-04-10|2014-02-24||April 2006||2006-04-01|April 2014|2014-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression|Antidepressant Adherence Among Hispanics: A Motivational Interviewing Approach|Completed||Phase 1|50|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 16:23:03.757241|2017-02-18 16:23:03.757241
NCT00356291|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2013-07-23|||April 2007||2007-04-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Improving HIV Prevention Skills in People With Serious Mental Illnesses|HIV Prevention for the Mentally Ill: Motivation-Skills|Completed||Phase 2|53|Actual|Boston Medical Center||2|||f||||||||||||||2017-02-18 16:23:04.130724|2017-02-18 16:23:04.130724
NCT00356278|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2016-01-06|2014-11-07||September 2006||2006-09-01|January 2016|2016-01-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD|A Cognitive Enhancer May Facilitate Behavioral Exposure Therapy for Veterans With PTSD|Completed||Phase 2/Phase 3|156|Actual|Emory University|The study had a high dropout rate. 31 participants dropped out before the first treatment session. Although disheartening, the dropout rate is similar to rates in other studies with veterans and active duty personnel.|3|||f||||f||||||||||2017-02-18 16:23:04.241769|2017-02-18 16:23:04.241769
NCT00356239|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2007-04-09|||July 2006||2006-07-01|April 2007|2007-04-01||||||||Observational|||Implantable Cardioverter Defibrillators And Magnetic Resonance Imaging of the Heart at 1.5 Tesla|Evaluation of Safety and Feasibility Magnetic Resonance Imaging of the Heart at 1.5 Tesla In Patients With Implantable Cardioverter Defibrillators|Unknown status|Recruiting|N/A|25||University Hospital, Bonn|||||f||||t||||||||||2017-02-18 16:23:05.089064|2017-02-18 16:23:05.089064
NCT00356226|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2006-11-30|||October 2000||2000-10-01|October 2000|2000-10-01||||||||Interventional|||The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients|The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients With Ascites and Activation of Sympathetic Nervous System: a Randomized Double-Blind Placebo Controlled Study.|Completed||N/A|64||CHU de Charleroi|||||f||||||||||||||2017-02-18 16:23:05.173102|2017-02-18 16:23:05.173102
NCT00356213|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2017-01-23|||July 2006||2006-07-01|January 2017|2017-01-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Comparison of Laparoscopic Sleeve Gastrectomy and Roux-Y-gastric Bypass in the Treatment of Morbid Obesity|Laparoscopic Sleeve Gastrectomy or Laparoscopic Proximal Roux-Y-gastric Bypass in the Treatment of Morbid Obesity|Enrolling by invitation||Phase 3|200|Anticipated|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 16:23:05.491136|2017-02-18 16:23:05.491136
NCT00356200|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2010-12-20|2010-11-15||July 2006||2006-07-01|December 2010|2010-12-01|September 2008|Actual|2008-09-01|December 2007|Actual|2007-12-01||Interventional|||Fluphenazine Decanoate for Psoriasis|Ascending-Dose, Double-Blind, Placebo-Controlled, Bilateral Study of Intralesional Fluphenazine Decanoate in Psoriasis|Terminated||Phase 2|10|Actual|Tufts Medical Center||2||Enrollment criteria met|f||||f||||||||||2017-02-18 16:23:05.605765|2017-02-18 16:23:05.605765
NCT00356187|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2010-03-17||||||March 2010|2010-03-01||||||||Interventional|||Beta Blockade in Critical Injury|Beta-blockade Reduces Catabolism in Severely Injured Trauma Patients|Completed||N/A|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:23:06.068686|2017-02-18 16:23:06.068686
NCT00356174|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2016-09-26|||July 2006||2006-07-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2015|Actual|2015-08-01||Observational|||An Observational Study of Childhood Food Allergy|A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Food Allergy (CoFAR2)|Completed||N/A|515|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||t||||||Samples With DNA|"~     Buccal swab (DNA)~   "|||2017-02-18 16:23:06.14862|2017-02-18 16:23:06.14862
NCT00356161|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2006-07-24|||April 2002||2002-04-01|July 2006|2006-07-01|April 2008||2008-04-01|||||Interventional|||HAI Via Interventionally Implanted Port Catheter Systems|Open One-Arm Therapy Optimizing Trial on Regional Chemotherapy of the Liver Through an Interventionally Implanted A.Hepatica Port System in Patients With Liver Metastases or Primary Liver Neoplasms.|Unknown status|Recruiting|Phase 2|100||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 16:23:06.258662|2017-02-18 16:23:06.258662
NCT00356148|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2012-12-19|2012-04-20||October 2003||2003-10-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.|Phase IV Study of Determining the Efficacy of Ampicillin/Sulbactam Combination as Antibiotic Prophylaxis During Breast Cancer Surgery in Patients With a Body Mass Index (BMI) Over 25.|Completed||Phase 4|372|Actual|Marmara University||2|||f||||t||||||||||2017-02-18 16:23:06.365465|2017-02-18 16:23:06.365465
NCT00356135|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2010-10-20|2009-12-10||July 2006||2006-07-01|October 2010|2010-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|SWAP||Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event|A Pharmacodynamic Comparison of Prasugrel (LY640315) Versus Clopidogrel in Subjects With Acute Coronary Syndrome Who Are Receiving Clopidogrel|Completed||Phase 2|139|Actual|Eli Lilly and Company||3|||f||||||||||||||2017-02-18 16:23:06.696845|2017-02-18 16:23:06.696845
NCT00356122|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2011-10-07|2011-08-09||July 2006||2006-07-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)|A Phase II Multicenter Study of Docetaxel and Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Chemotherapy-Naïve Subjects With Unresectable Locally Advanced and/or Recurrent (Stage IIIB) or Metastatic (Stage IV) Non-Squamous Cell Histology Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|53|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:23:07.688149|2017-02-18 16:23:07.688149
NCT00356109|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2009-02-06|||August 2006||2006-08-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes|A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus|Completed||Phase 3|494|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 16:23:08.071027|2017-02-18 16:23:08.071027
NCT00356096|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2012-05-18|||July 2006||2006-07-01|May 2012|2012-05-01||||June 2007|Actual|2007-06-01||Interventional|||Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances|A Phase IV Randomised, Double-blind, Placebo-controlled, Dose Titration Trial With 0.125-0.75 mg/Day Pramipexole (Sifrol®, Mirapexin®) Orally for 12 Weeks to Investigate the Safety and Efficacy in Out-patients With Idiopathic Restless Legs Syndrome Associated With Mood Disturbances|Completed||Phase 4|404|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:23:08.225641|2017-02-18 16:23:08.225641
NCT00356083|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2016-07-28|||January 2004||2004-01-01|July 2016|2016-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain|Opioid Switching From Oral Slow Release Morphine to Oral Methadone May Improve Pain Control in Chronic Non-malignant Pain: a Nine-month Follow-up Study.|Completed||Phase 3|12|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 16:23:08.363043|2017-02-18 16:23:08.363043
NCT00356070|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2017-01-25|||January 2006||2006-01-01|January 2017|2017-01-01|December 2006||2006-12-01|||||Interventional|||Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison|Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison|Completed||N/A|40||Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 16:23:08.460314|2017-02-18 16:23:08.460314
NCT00355485|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2015-07-08|||September 2006||2006-09-01|July 2015|2015-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Microdermabrasion for Acne|Microdermabrasion for Acne Vulgaris|Completed||Phase 2|24|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 16:23:20.399542|2017-02-18 16:23:20.399542
NCT00356057|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2012-05-02|2008-12-02||December 2004||2004-12-01|May 2012|2012-05-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|AVAIL||Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace|AVAIL CLS/CRT: AV-node Ablation With CLS and CRT Pacing Therapies for the Treatment of AF|Terminated||N/A|153|Actual|Biotronik, Inc.|Early termination due lack of enrollment.|3||Slow enrollment.|f||||f||||||||||2017-02-18 16:23:08.550646|2017-02-18 16:23:08.550646
NCT00356044|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2007-07-10|||May 2004||2004-05-01|July 2007|2007-07-01|December 2005|Actual|2005-12-01|||||Interventional|||Arterial Access for Coronary Intervention in Myocardial Infarction|Femoral Versus Radial Access for Coronary Intervention in the Acute Phase of ST-Elevation Myocardial Infarction|Completed||Phase 4|439|Actual|Hospital Juan Canalejo||2|||f||||f||||||||||2017-02-18 16:23:09.213313|2017-02-18 16:23:09.213313
NCT00356031|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2010-04-27|||July 2006||2006-07-01|April 2010|2010-04-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Bevacizumab and Radiation Therapy for Sarcomas|A Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas|Unknown status|Recruiting|Phase 2|28|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:23:09.322305|2017-02-18 16:23:09.322305
NCT00356018|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2012-05-31|||July 2006||2006-07-01|May 2012|2012-05-01|February 2007|Actual|2007-02-01|||||Observational|||Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:|Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy: A Randomized, Parallel, Prospectively-Controlled Outpatient Comparison|Completed||Phase 4|5|Actual|Orlando Health, Inc.|||1||f||||f||||||||||2017-02-18 16:23:09.446221|2017-02-18 16:23:09.446221
NCT00356005|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2012-10-31|||August 2006||2006-08-01|October 2012|2012-10-01||||August 2007|Actual|2007-08-01||Interventional|||Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh|Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh: An Open Label Randomized Controlled Trial|Completed||Phase 2|228|Actual|Medical University of Vienna||2|||f||||||||||||||2017-02-18 16:23:09.542457|2017-02-18 16:23:09.542457
NCT00355992|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2009-05-11|||September 2006||2006-09-01|May 2009|2009-05-01|December 2007|Anticipated|2007-12-01|||||Observational|IMAgine||The Ischemia Modified Albumin In Diagnosing Ischemic New Events|The Ischemia Modified Albumin In Diagnosing Ischemic New Events (IMAGINE Study).|Terminated||N/A|1250|Anticipated|Inverness Medical Innovations|||1||f||||||||||||||2017-02-18 16:23:09.656514|2017-02-18 16:23:09.656514
NCT00355979|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2006-10-17|||March 2006||2006-03-01|July 2006|2006-07-01|March 2008||2008-03-01|||||Interventional|||Comparative Study of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity|Randomized Trial of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity|Unknown status|Recruiting|Phase 3|100||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 16:23:09.745582|2017-02-18 16:23:09.745582
NCT00355966|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2010-03-24|||August 2006||2006-08-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Misoprostol and PGE2 Gel for Induction of Labour in Women With Premature Rupture of Membranes at Term|Comparison of Misorostol & PGE2 Gel for Immediate Induction of Labour for Premature Ropture of Membranes at Term|Completed||Phase 4|212|Actual|Nilratan Sircar Medical College||2|||f||||t||||||||||2017-02-18 16:23:09.85387|2017-02-18 16:23:09.85387
NCT00355953|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2008-04-18|||January 2003||2003-01-01|April 2008|2008-04-01|June 2005||2005-06-01|||||Interventional|||Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women||Completed||Phase 2/Phase 3|400||University of Messina|||||f||||||||||||||2017-02-18 16:23:09.966408|2017-02-18 16:23:09.966408
NCT00355940|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2013-04-26|||August 2007||2007-08-01|April 2013|2013-04-01|April 2010|Actual|2010-04-01|January 2010|Actual|2010-01-01||Interventional|||Comparing Fluoroscopy and Technological Methods for Guidance During Endovascular Procedures|Comparing Fluoroscopy and Technological Methods for Guidance During Endovascular Procedures Traditional Fluoroscopy Navigation Based on Preoperative CT and Intraoperative DynaCT|Completed||Phase 1|17|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 16:23:10.080483|2017-02-18 16:23:10.080483
NCT00355927|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-23|2007-11-01|||September 2006||2006-09-01|August 2006|2006-08-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.|Changes of the Neuronal Activity in the Subthalamic Nucleus Under Propofol Sedation During Stereotactic Electrode Implantation.|Unknown status|Enrolling by invitation|N/A|20|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 16:23:10.20844|2017-02-18 16:23:10.20844
NCT00355914|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2013-09-27|2012-12-06||August 2003||2003-08-01|September 2013|2013-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effectiveness of Lumbar Facet Joint Nerve Blocks|A Randomized, Prospective, Double-Blind Controlled Evaluation of the Effectiveness of Lumbar Facet Joint Nerve Blocks|Completed||N/A|120|Actual|Pain Management Center of Paducah||2|||f||||t||||||||||2017-02-18 16:23:10.319316|2017-02-18 16:23:10.319316
NCT00355901|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2008-08-02|||September 2006||2006-09-01|August 2008|2008-08-01|November 2012||2012-11-01|||||Observational|||An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis|An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis|Terminated||Phase 2|300|Anticipated|Facet Biotech|||||||||t||||||||||2017-02-18 16:23:10.813118|2017-02-18 16:23:10.813118
NCT00355888|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2014-11-27|||June 2006||2006-06-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors|A Phase I, Open Label Study of MBP-426 Given by Intravenous Infusion in Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|39|Actual|Mebiopharm Co., Ltd||1|||f||||f||||||||||2017-02-18 16:23:10.950325|2017-02-18 16:23:10.950325
NCT00355875|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-22|2006-11-06|||July 2005||2005-07-01|November 2006|2006-11-01|October 2006||2006-10-01|||||Interventional|||The Effect of Oxygen Exposure During Newborn Resuscitation on Lung Injury|Oxygen Exposure During Newborn Resuscitation and Pulmonary Oxidative Stress|Completed||N/A|30||University of Calgary|||||f||||||||||||||2017-02-18 16:23:11.06788|2017-02-18 16:23:11.06788
NCT00353600|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2017-01-24|||August 19, 1994||1994-08-19|August 16, 2011|2011-08-16|August 16, 2011||2011-08-16|||||Observational|||Delaying the Progression of Diabetic Nephropathy in Pima Indians|Delaying the Progression of Diabetic Nephropathy in Pima Indians|Completed||N/A|25|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:54.083022|2017-02-18 16:23:54.083022
NCT00355862|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2014-07-29|||January 2006||2006-01-01|July 2009|2009-07-01|May 2014|Actual|2014-05-01|April 2009|Actual|2009-04-01||Interventional|||Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma|A Prospective Randomised, Open-labeled, Trial Comparing Sirolimus-Containing Versus mTOR-Inhibitor-Free Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma|Completed||Phase 3|525|Actual|University of Regensburg||2|||f||||t||||||||||2017-02-18 16:23:11.160523|2017-02-18 16:23:11.160523
NCT00355849|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2016-11-21|||August 2006||2006-08-01|November 2016|2016-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes|A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients With Type 2 Diabetes Treated With Once-Daily Insulin Glargine|Completed||Phase 3|555|Actual|Eli Lilly and Company||3|||f||||||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 16:23:11.288809|2017-02-18 16:23:11.288809
NCT00355836|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2015-11-04|||November 2004||2004-11-01|November 2015|2015-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Recovery of Hand Function Through Mental Practice.|Can Motor Imagery Enhance Recovery of Hand Function After Stroke? Evaluation of Motor Imagery Training.|Completed||N/A|135|Anticipated|University of Aberdeen|||||f||||||||||||||2017-02-18 16:23:11.482867|2017-02-18 16:23:11.482867
NCT00355823|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2008-05-20|||August 2006||2006-08-01|November 2006|2006-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Bioelectric Field Imaging Near Human Skin Wounds|Phase I Study of the Electric Field Near Human Skin Wounds|Completed||Phase 1|40|Actual|National Institute of General Medical Sciences (NIGMS)|||2||f||||f||||||||||2017-02-18 16:23:11.578137|2017-02-18 16:23:11.578137
NCT00355810|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2016-07-18|||January 2006||2006-01-01|July 2016|2016-07-01|December 2006|Actual|2006-12-01|April 2006|Actual|2006-04-01||Interventional|||Probiotics for Irritable Bowel Syndrome|Lactobacillus Plantarum MF 1298 vs Placebo for Irritable Bowel Syndrome.|Completed||N/A|19|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 16:23:11.661807|2017-02-18 16:23:11.661807
NCT00355797|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2012-12-18|2011-06-06||May 2006||2006-05-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|February 2008|Actual|2008-02-01||Interventional|CLEAR||Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response|CLEAR: Cylos Pacemaker Responds With Physiologic Rate Changes During Daily Activities|Completed||Phase 4|1491|Actual|Biotronik, Inc.||3|||f||||f||||||||||2017-02-18 16:23:11.784103|2017-02-18 16:23:11.784103
NCT00355784|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2015-12-02|2013-03-13||September 2005||2005-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2011|Actual|2011-12-01||Interventional|||Growth Hormone as a Determinant of Weight Regulation|Growth Hormone as a Determinant of Weight Regulation.|Completed||N/A|24|Actual|University of Michigan|The short duration of our intervention was a limitation. The metabolic measurements that were performed in the postabsorptive state was a limitation.|3|||f||||||||||||||2017-02-18 16:23:12.621442|2017-02-18 16:23:12.621442
NCT00355771|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2008-01-12|||June 2006||2006-06-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis|Placebo Controlled Pilot Study on the Efficacy of Levocetirizine 5 mg in Reducing Symptoms, Airway Resistance, and Sleep Impairment in Patients With Persistent Allergic Rhinitis|Completed||Phase 4|100|Actual|Institut für Atemwegsforschung GmbH||2|||f||||f||||||||||2017-02-18 16:23:13.435166|2017-02-18 16:23:13.435166
NCT00355758|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2010-08-31|||April 2005||2005-04-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|||||Observational|||UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling|Prostate Cancer Detection by Serum Proteomic Profiling|Terminated||N/A|200|Anticipated|University of California, Irvine|||1|Lack of personnel|f||||f||||||Samples Without DNA|"~     Whole blood is collected from subjects. The whole blood is spun down by centrifugation and~     only serum is retained and stored.~   "|||2017-02-18 16:23:13.551801|2017-02-18 16:23:13.551801
NCT00355745|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-22|2011-06-08|||July 2006||2006-07-01|May 2008|2008-05-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Using CBUS™ System for Ultrasound Breast Imaging Designed for Breast Tumor Diagnosis||Terminated||N/A|50|Anticipated|Helix Medical Systems||1|||f||||||||||||||2017-02-18 16:23:13.640277|2017-02-18 16:23:13.640277
NCT00355732|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-23|2006-10-25||||||July 2006|2006-07-01||||||||Interventional|||Chronic Obstructive Pulmonary Disease and Weaning From Mechanical Ventilation in Difficult to Wean Patients|Chronic Obstructive Pulmonary Disease and Weaning From Mechanical Ventilation in Difficult to Wean Patients; Randomized Prospective Study|Completed||Phase 4|||Dr. Josip Benčević General Hospital|||||f||||||||||||||2017-02-18 16:23:13.725785|2017-02-18 16:23:13.725785
NCT00355719|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2009-06-16|||January 2007||2007-01-01|June 2009|2009-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients|Clinical Pilot Trial to Evaluate the Influence of Nevirapine in Exposure to Atazanavir in Steady State Equilibrium in HIV-Infected Adult Patients.|Completed||Phase 4|14|Actual|Germans Trias i Pujol Hospital||1|||f||||f||||||||||2017-02-18 16:23:14.036644|2017-02-18 16:23:14.036644
NCT00355706|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-24|2013-09-27|2012-12-06||August 2003||2003-08-01|September 2013|2013-09-01|July 2011|Actual|2011-07-01|July 2006|Actual|2006-07-01||Interventional|||Effectiveness of Thoracic Facet Joint Nerve Blocks|Effectiveness of Thoracic Facet Joint Nerve Blocks: A Randomized, Prospective, Double-Blind Controlled Evaluation|Completed||N/A|100|Actual|Pain Management Center of Paducah||2|||f||||t||||||||||2017-02-18 16:23:14.151839|2017-02-18 16:23:14.151839
NCT00355693|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2006-08-23|||October 2006||2006-10-01|April 2006|2006-04-01|February 2007||2007-02-01|||||Interventional|||Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol in Anxious Patients|Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol A) in Oral Surgery Patients B) in General Dentistry Patients C) in Colonoscopy Patients|Unknown status|Not yet recruiting|Phase 4|60||University of Glasgow|||||f||||||||||||||2017-02-18 16:23:14.624228|2017-02-18 16:23:14.624228
NCT00005721|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-08|||September 1990||1990-09-01|April 2016|2016-04-01|December 1994||1994-12-01|December 1993|Actual|1993-12-01||Observational|||Retaining Donors and Increasing Donation Frequency||Completed||N/A|||Bloodworks (Puget Sound Blood Center)|||||f||||||||||||||2017-02-18 18:14:28.379859|2017-02-18 18:14:28.379859
NCT00355680|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2009-02-10|||December 2005||2005-12-01|February 2009|2009-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy|Comparative Study of Indigenous Green Laser With Already Available Green Laser in Proliferative Diabetic Retinopathy|Completed||Phase 3|24|Actual|Aurolab||2|||f||||f||||||||||2017-02-18 16:23:14.747201|2017-02-18 16:23:14.747201
NCT00355667|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2016-08-17|||June 2006||2006-06-01|August 2016|2016-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|J-MELODIC||Comparison of Long- and Short-acting Diuretics in Congestive Heart Failure|Japanese Multicenter Evaluation of Long- Versus Short-acting Diuretics in Congestive Heart Failure|Completed||Phase 4|320|Actual|Hyogo College of Medicine||2|||f||||t||||||||Undecided||2017-02-18 16:23:14.877958|2017-02-18 16:23:14.877958
NCT00355654|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2015-01-06|||September 2006||2006-09-01|January 2015|2015-01-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar®|Safety and Immunogenicity of Booster Vaccination With PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus Influenzae Type b Conjugate Vaccine (Adsorbed), Compared to Booster Vaccination With Infanrix® Hexa When Both Vaccines Are Co-Administered With Prevenar® to Toddlers 11-18 Months of Age|Completed||Phase 3|847|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:23:15.041669|2017-02-18 16:23:15.041669
NCT00355641|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2016-10-27|||October 2005||2005-10-01|October 2016|2016-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome|A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)|Completed||Phase 3|450|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:23:15.267927|2017-02-18 16:23:15.267927
NCT00355628|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2012-08-30|||July 2006||2006-07-01|August 2012|2012-08-01||||July 2007|Actual|2007-07-01||Interventional|||Clinical Study of KW-2246 in Patients With Cancer Pain|Phase II Clinical Study of KW-2246 in Patients With Cancer Pain - Maintenance Switch Study in Oral Morphine or Oral Oxycodone-treated Patients|Completed||Phase 2|40|Anticipated|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-02-18 16:23:15.462216|2017-02-18 16:23:15.462216
NCT00355615|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2011-08-29|2009-05-29||July 2006||2006-07-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin|A Phase IIIb, Efficacy, and Safety Study of Rosuvastatin in Children 10-17 Years of Age With Heterozygous Familial Hypercholesterolemia: a 12-week, Double-blind, Randomized, Multicenter, Placebo-controlled Study With a 40-week, Open-label, Follow-up|Completed||Phase 3|173|Actual|AstraZeneca||5|||f||||||||||||||2017-02-18 16:23:15.576848|2017-02-18 16:23:15.576848
NCT00355602|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2009-02-10|||July 2006||2006-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Antibiotics for the Treatment of Ulcerative Colitis|Use of Antibiotics to Eradicate Bacterial Pathogens Colonising the Colonic Mucosa in Ulcerative Colitis Patients|Completed||N/A|40|Anticipated|University of Dundee|||||f||||||||||||||2017-02-18 16:23:16.663963|2017-02-18 16:23:16.663963
NCT00355589|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2012-10-08|||July 2006||2006-07-01|October 2012|2012-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension|A Randomized, Double-Blind, Multicenter, Parallel Study Evaluating the Efficacy and Safety of a Combination of Ramipril Plus Hydrochlorothiazide Versus the Component Monotherapies in Subjects With Essential Hypertension|Completed||Phase 3|||Pfizer|||||||||||||||||||2017-02-18 16:23:16.774695|2017-02-18 16:23:16.774695
NCT00355576|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2011-01-31|||July 2006||2006-07-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis|Phase II Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis|Completed||Phase 2|86|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 16:23:16.91739|2017-02-18 16:23:16.91739
NCT00355563|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2009-01-08|||June 2006||2006-06-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|EPIC||Study of the PAS-Port® Proximal Anastomosis System in Coronary Bypass Surgery|Use of the PAS-Port Proximal Anastomosis System for Creation of Aorto-Venous Proximal Anastomoses in Coronary Bypass Surgery|Completed||Phase 3|220|Anticipated|Cardica, Inc|||||f||||t||||||||||2017-02-18 16:23:17.048507|2017-02-18 16:23:17.048507
NCT00355550|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2009-12-10|||July 2006||2006-07-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Ketasyn In Age-Associated Memory Impairment|A Double-Blind, Placebo-Controlled Study of Ketasyn (AC-1202) Administered For Ninety Days In Subjects With Age-Associated Memory Impairment|Completed||Phase 2|150||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 16:23:17.134264|2017-02-18 16:23:17.134264
NCT00355537|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2010-03-29|||February 2006||2006-02-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Testosterone Replacement in Diabetes With Vascular Disease (Version 2)|A Randomised, Double Blind, Placebo-controlled Parallel Study to Test the Effect of Testosterone Treatment on Peripheral Vascular Disease in Hypogonadal Men With Type 2 Diabetes Mellitus|Completed||Phase 4|19|Actual|Barnsley Hospital||2|||f||||f||||||||||2017-02-18 16:23:17.239958|2017-02-18 16:23:17.239958
NCT00355524|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-21|2013-07-05|||June 2006||2006-06-01|July 2013|2013-07-01|March 2011|Actual|2011-03-01|August 2007|Actual|2007-08-01||Interventional|||A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents|A Phase II, Open-label Trial, to Investigate Pharmacokinetics, Safety, Tolerability and Antiviral Activity of TMC114/Rtv b.i.d in Treatment-Experienced HIV-1 Infected Children and Adolescents|Completed||Phase 2|80|Actual|Tibotec Pharmaceuticals, Ireland||7|||f||||t||||||||||2017-02-18 16:23:17.338698|2017-02-18 16:23:17.338698
NCT00355511|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2015-04-25|||July 2007||2007-07-01|April 2015|2015-04-01|February 2009|Anticipated|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Heart Failure Evaluation Acute Referral Team Trial (HEARTT)|Heart Failure Evaluation Acute Referral Team Trial (HEARTT)|Withdrawn||N/A|0|Actual|University of Alberta||1||unable to recruit patients|f||||f||||||||||2017-02-18 16:23:17.490495|2017-02-18 16:23:17.490495
NCT00355498|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2015-12-02|||September 2005||2005-09-01|December 2015|2015-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Amyloid Plaque and Tangle Imaging in Aging and Dementia|Amyloid Plaque and Tangle Imaging in Aging and Dementia|Completed||N/A|194|Actual|University of California, Los Angeles|||4||f||||t||||||||||2017-02-18 16:23:20.306452|2017-02-18 16:23:20.306452
NCT00355472|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2012-10-17|2012-08-07||February 2007||2007-02-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL|Phase I Dose Escalation Study of KW-0761 in Patients With Relapsed Adult T-Cell Lymphoma (ATL) and Peripheral T-Cell Lymphoma (PTCL)|Completed||Phase 1|16|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-02-18 16:23:20.513063|2017-02-18 16:23:20.513063
NCT00355459|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2011-03-21|||August 2005||2005-08-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease|A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease|Terminated||N/A|0|Actual|University of Texas Southwestern Medical Center||||The PI has elected to terminate study at this time|f||||||||||||||2017-02-18 16:23:21.0633|2017-02-18 16:23:21.0633
NCT00355446|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2007-10-16|||July 2001||2001-07-01|October 2007|2007-10-01|October 2004||2004-10-01|||||Interventional|||Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.|Bioavailabilty of Bimatoprost Ophthalmic Solution in Human Aqueous.|Completed||Phase 4|48||Indiana University|||||f||||||||||||||2017-02-18 16:23:21.173672|2017-02-18 16:23:21.173672
NCT00355433|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2006-07-20|||July 2006||2006-07-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Comparison of Body and Room Temperature Saline in Urodynamics|Comparison of Urodynamic Volume Measurements Using Room and Body Temperature Saline|Unknown status|Recruiting|Phase 4|24||Tripler Army Medical Center|||||f||||||||||||||2017-02-18 16:23:21.267572|2017-02-18 16:23:21.267572
NCT00355420|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2014-03-03|||October 2006||2006-10-01|March 2013|2013-03-01||||||||Observational|||Evaluation of the Change in Length of the Leg in Children After Treatment of Femur Fractures.|Evaluation of the Change in Length of the Femur and Tibia in Children After Treatment of Femur Fractures With External Fixators, Plaster of Paris or Internal Fixation|Withdrawn||Phase 2|0|Actual|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 16:23:21.62264|2017-02-18 16:23:21.62264
NCT00355407|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2009-03-12|||June 2006||2006-06-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation|A Pilot Study of Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation|Completed||N/A|31||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 16:23:21.691551|2017-02-18 16:23:21.691551
NCT00355394|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2015-10-30|2013-01-08||August 2006||2006-08-01|October 2015|2015-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Treatment of Acute Migraine Headache in Children|Treatment of Acute Migraine Headache in Children|Completed||Phase 2|31|Actual|Children's Hospital of Philadelphia|Study was performed in tertiary care setting and may not be generalizable to all settings. Small number of subjects (n=31). None admitted or received additional rescue medication, suggesting most severely affected may not have been enrolled.|2|||f||||f||||||||||2017-02-18 16:23:21.796784|2017-02-18 16:23:21.796784
NCT00355381|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2009-01-27|||September 2004||2004-09-01|January 2009|2009-01-01|September 2009|Anticipated|2009-09-01|April 2008|Actual|2008-04-01||Interventional|||Evaluating Patient Information Prescriptions|Evaluating Patient Information Prescriptions in Different Service Environments|Unknown status|Active, not recruiting|Phase 2|299|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 16:23:22.299052|2017-02-18 16:23:22.299052
NCT00355368|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2011-11-10|2011-08-08||August 2006||2006-08-01|November 2011|2011-11-01|July 2010|Actual|2010-07-01|August 2006|Actual|2006-08-01||Interventional|||Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care|Phase 4 Study of Succinylcholine Versus Rocuronium as Neuromuscular Blocking Agent for Emergency Intubation in Intensive Care|Completed||Phase 4|420|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 16:23:22.401299|2017-02-18 16:23:22.401299
NCT00355355|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2015-01-22||2014-12-19|July 2006||2006-07-01|January 2015|2015-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)|A Phase 3 Randomized Study to Evaluate Survival of Patients Treated With Talaporfin Sodium (LS11) and Interstitial Light Emitting Diodes (LED) as Compared to the Standard of Care Therapies in the Treatment of Unresectable Hepatocellular Carcinoma (HCC)|Completed||Phase 3|208|Actual|Light Sciences Oncology||2|||f||||t||||||||||2017-02-18 16:23:22.847795|2017-02-18 16:23:22.847795
NCT00355342|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2016-10-27|||April 2004||2004-04-01|October 2016|2016-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.|A Randomized, Double-Blind, Parallel-Group Clinical Trial Evaluating the Effect of the Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Twice Daily Via DISKUS® Inhaler Versus Salmeterol 50mcg Twice Daily Via DISKUS® Inhaler on Bone Mineral Density in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|180|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:23:23.000702|2017-02-18 16:23:23.000702
NCT00355329|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2006-10-19||||||July 1999|1999-07-01||||||||Interventional|||Randomized Control Trial of Using Tongue Acupuncture in Autistic Spectrum Disorder Using PET Scan for Clinical Correlation|Randomized Control Trial of Using Tongue Acupuncture in Autistic Spectrum Disorder Using PET Scan for Clinical Correlation|Completed||Phase 3|30||The University of Hong Kong|||||f||||||||||||||2017-02-18 16:23:23.220021|2017-02-18 16:23:23.220021
NCT00355316|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-06-19|||November 2005||2005-11-01|June 2013|2013-06-01|February 2013|Actual|2013-02-01|November 2012|Actual|2012-11-01||Interventional|||A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients|Peripheral Blood Molecular Staging of Breast Cancer: A Prospective Cohort Study Designed to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Peripheral Blood of Stage IV Breast Cancer Patients|Completed||N/A|224|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 16:23:23.313946|2017-02-18 16:23:23.313946
NCT00355303|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2015-07-21|||August 2006||2006-08-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at Term|Comparison of Misoprostol and PGE2 Gel for Induction of Labour in in Premature Rupture of Membranes at Term- A Randomized Comparative Trial|Completed||Phase 4|932|Actual|Nilratan Sircar Medical College||1|||f||||t||||||||||2017-02-18 16:23:23.524641|2017-02-18 16:23:23.524641
NCT00355290|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2008-05-05|||August 2006||2006-08-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial|Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial|Completed||N/A|114|Anticipated|Hospital de Clinicas de Porto Alegre|||||f||||||||||||||2017-02-18 16:23:23.807543|2017-02-18 16:23:23.807543
NCT00355277|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2013-04-02|||November 2005||2005-11-01|April 2013|2013-04-01|December 2007||2007-12-01|||||Interventional|||Local Anaesthetic Effects of Transcutaneous Amitriptyline|Local Anaesthetic Effects of Transcutaneous Amitriptyline in Human Volunteers : a Controlled, Double-blinded, Randomised Study Versus Placebo and Transcutaneous Local Anaesthetic (EMLA(R))|Completed||Phase 1|16||University Hospital, Clermont-Ferrand|||||f||||||||||||||2017-02-18 16:23:23.8946|2017-02-18 16:23:23.8946
NCT00355264|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2014-08-11|||August 2006||2006-08-01|August 2014|2014-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency|Phase 2, Multicenter, Open Label Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to Primary BH4 Deficiency|Completed||Phase 2|12|Actual|BioMarin Pharmaceutical||1|||f||||||||||||||2017-02-18 16:23:23.992671|2017-02-18 16:23:23.992671
NCT00355251|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2014-03-19|||July 2006||2006-07-01|February 2014|2014-02-01|February 2007|Actual|2007-02-01|December 2006|Actual|2006-12-01||Interventional|||Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption|Study of the Influence of Atorvastatin in Plasma Viral Replication Given Prior to Antiretroviral Treatment Interruption in Patients With HIV-1 Infection and Viral Suppression.|Terminated||Phase 4|5|Actual|Germans Trias i Pujol Hospital||2||"On the basis of published results of SMART study, it has been observed that the results are~   worse in patients who have interrupted their treatments."|f||||f||||||||||2017-02-18 16:23:24.102478|2017-02-18 16:23:24.102478
NCT00355238|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2015-09-23||2012-04-18|December 2006||2006-12-01|September 2015|2015-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer|A Phase II Open Label Study of Brivanib (BMS582664), Administered Orally At A Dose of 800 mg Daily In Subjects With Unresectable, Locally Advanced or Metastatic Hepatocellular Carcinoma Who Have Received Either No Prior Systemic Therapy or One Prior Regimen of Angiogenesis Inhibitor Therapy|Completed||Phase 2|135|Actual|Bristol-Myers Squibb||1|||f||||t||||||||||2017-02-18 16:23:24.2223|2017-02-18 16:23:24.2223
NCT00355225|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2006-10-06||||||July 2006|2006-07-01||||||||Interventional|||Community-Effectiveness of the Distribution of Insecticide-Treated Bed Nets Through Social Marketing Antenatal Care Services in Malaria Control in Rural Burkina Faso||Completed||N/A|||Heidelberg University|||||f||||||||||||||2017-02-18 16:23:24.361803|2017-02-18 16:23:24.361803
NCT00355212|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2006-07-21|||January 2001||2001-01-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma|Comparative Study Between Radiofrequency and Ethanol Injection for the Ablation of Small Hepatocellular Carcinoma Associated With Liver Cirrhosis|Terminated||Phase 3|240||Azienda Ospedaliera San Giovanni Battista|||||f||||||||||||||2017-02-18 16:23:24.451985|2017-02-18 16:23:24.451985
NCT00355199|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2011-06-22|||May 2005||2005-05-01|June 2011|2011-06-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.|Multicentric Randomized Phase III Study Comparing High Doses of Chemotherapy With Rituximab Followed by Auto-transplant HPC Versus CHOP Plus Rituximab as First Line Therapy in High Risk Patients With DLBCL Non-Hodgkin's Lymphomas|Unknown status|Recruiting|Phase 3|240|Anticipated|Gruppo Italiano Terapie Innovative nei Linfomi||2|||f||||f||||||||||2017-02-18 16:23:24.550078|2017-02-18 16:23:24.550078
NCT00355186|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2012-11-08|||August 2006||2006-08-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|October 2012|Actual|2012-10-01||Interventional|||SWiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (SWISS-AMI)|SWiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (SWISS-AMI)|Completed||Phase 2|200|Actual|University of Zurich||3|||f||||||||||||||2017-02-18 16:23:24.688059|2017-02-18 16:23:24.688059
NCT00355173|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2011-05-11|||May 2006||2006-05-01|February 2010|2010-02-01|November 2010|Actual|2010-11-01|||||Interventional|||Pilot Study to Assess the Efficacy and Safety of the Lubo Cervical Collar|Pilot Study to Assess the Efficacy and Safety of the Lubo Cervical Collar|Completed||Phase 1|50|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-02-18 16:23:24.798363|2017-02-18 16:23:24.798363
NCT00355160|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-05-13|||July 2006||2006-07-01|May 2013|2013-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care Setting|Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care Setting|Completed||N/A|20|Actual|Penn State University|||1||f||||f||||||||||2017-02-18 16:23:24.884683|2017-02-18 16:23:24.884683
NCT00355147|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2015-04-06|2014-07-15||January 2009||2009-01-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|June 2011|Actual|2011-06-01||Interventional|TOOLS|Compared groups on strata, age, sex, race/ethnicity, education level, living status, has Caregiver Number of participants were determined by protocol and followed intention to treat. For 3 and 6 month outcomes, we included respondent's last score assuming no change among those with missing data.|Adapting Tools to Implement Stroke Risk Management to Veterans|Adapting Tools to Implement Stroke Risk Management to Veterans|Completed||N/A|174|Actual|VA Office of Research and Development|Both our intervention and control groups experienced attrition during the study period but the rate between groups did not differ significantly.|2|||f||||f||||||||||2017-02-18 16:23:24.995099|2017-02-18 16:23:24.995099
NCT00355134|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2012-08-02|2012-05-23||June 2006||2006-06-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|FREEDOMS II||Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis|24-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase|Completed||Phase 3|1083|Actual|Novartis||3|||f||||t||||||||||2017-02-18 16:23:25.765516|2017-02-18 16:23:25.765516
NCT00354952|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2006-07-19|||July 2002||2002-07-01|November 2003|2003-11-01|October 2003||2003-10-01|||||Interventional|||Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora|Impact of Azithromycin and Clarithromycin Therapy on Pharyngeal Carriage of Macrolide-Resistant Streptococci Among Healthy Volunteers: A Randomised, Double-Blind, Placebo-Controlled Trial|Completed||N/A|203||Universiteit Antwerpen|||||f||||||||||||||2017-02-18 16:23:32.481029|2017-02-18 16:23:32.481029
NCT00355121|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2011-08-22|2011-07-25||October 2006||2006-10-01|August 2011|2011-08-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®|Immunogenicity and Safety of Meningococcal (Serogroups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in Children Aged 4 to 6 Years in the US When Administered Concomitantly With a Fifth Dose Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed.|Completed||Phase 2|882|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 16:23:28.164718|2017-02-18 16:23:28.164718
NCT00355108|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2010-12-22|||September 2006||2006-09-01|December 2010|2010-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome|ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome. Beneficial or Iatrogenic Effects.|Completed||Phase 3|170|Actual|Hospices Civils de Lyon||1|||f||||t||||||||||2017-02-18 16:23:29.225038|2017-02-18 16:23:29.225038
NCT00355095|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2012-09-12|||August 2006||2006-08-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis|Double Blind, Placebo-controlled Study to Determine the Safety and Efficacy of Erythropoietin as an add-on Therapy of Methylprednisolone in Subjects With Acute Optic Neuritis (VISION PROTECT)|Completed||Phase 2|40|Actual|Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH||2|||f||||f||||||||||2017-02-18 16:23:29.329838|2017-02-18 16:23:29.329838
NCT00355082|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2016-11-15|2009-09-08||May 2006||2006-05-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy|A Multicenter, Double-Blind, Randomized Conversion to Monotherapy Comparison of Two Doses of Lamotrigine for the Treatment of Partial Seizures|Completed||Phase 3|226|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:23:29.46031|2017-02-18 16:23:29.46031
NCT00355069|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2014-05-27|||August 2001||2001-08-01|May 2014|2014-05-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Better Pediatric Asthma Outcomes Through Chronic Care|Better Pediatric Asthma Outcomes Through Chronic Care|Completed||N/A|548|Actual|UConn Health||4|||f||||t||||||||||2017-02-18 16:23:30.357946|2017-02-18 16:23:30.357946
NCT00355056|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2016-02-11|||January 2006||2006-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|February 2015|Actual|2015-02-01||Interventional|||Premium Migraine Trial|Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.|Completed||Phase 2|230|Actual|St. Jude Medical||2|||f||||t||||||||||2017-02-18 16:23:30.469113|2017-02-18 16:23:30.469113
NCT00355043|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-20|2011-07-11|||February 2006||2006-02-01|July 2006|2006-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy of Zinc in the Treatment of Bronchiolitis and Prevention of Wheezing Respiratory Illness in Children Less Than Two Years Old||Completed||Phase 3|330|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:23:30.712376|2017-02-18 16:23:30.712376
NCT00355030|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-08-24|2016-08-10||June 2006||2006-06-01|August 2016|2016-08-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|Phoenix|The full analysis set (FAS) includes all data from all randomized patients receiving at least one dose of the study drug according to the treatment to which the patients were assigned and with at least one follow-up visit.|Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature|Efficacy and Safety of Somatropin in Combination With Leuprorelin Compared to Somatropin Alone in Pubertal Children With Idiopathic Short Stature|Completed||Phase 3|91|Actual|Eli Lilly and Company|No statistical analyses was performed after the early treatment termination. All data represented is descriptive statistics only and no confirmatory conclusions can be drawn from this study.|2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 16:23:30.832346|2017-02-18 16:23:30.832346
NCT00355017|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2006-10-17|||September 2003||2003-09-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||BNP Guided Care in Addition to Multidisciplinary Care|NT-BNP Guided Care in Addition to Multidisciplinary Care in Patients With Chronic Heart Failure A Three-Arm, Prospective, Randomised Study|Terminated||N/A|||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:23:31.843964|2017-02-18 16:23:31.843964
NCT00355004|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-12-18|||March 2005||2005-03-01|January 2007|2007-01-01|February 2009|Actual|2009-02-01|||||Interventional|||Computerized and Mailed Reminders in Increasing the Rate of Colorectal Cancer Screening in Adults With an Average Risk for Colorectal Cancer|Improving Systems for Colorectal Cancer Screening|Completed||N/A|21860|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:23:31.920214|2017-02-18 16:23:31.920214
NCT00354991|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-05-13|||June 2006||2006-06-01|May 2016|2016-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Hyzaar Asia HEAALTH (0954A-950)|An Open Label Study to Assess the Efficacy of Losartan/HCTZ Combination Therapy in Patients With Essential Hypertension Who Were Inadequately Controlled on Current Antihypertensive Monotherapy|Completed||Phase 3|437|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 16:23:32.022327|2017-02-18 16:23:32.022327
NCT00354978|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2011-09-14|2011-06-14||January 2005||2005-01-01|September 2011|2011-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients|Phase II Study of Irinotecan, Leucovorin, 5-Fluorouracil (FOLFIRI) Plus Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer|Completed||Phase 2|49|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:23:32.124923|2017-02-18 16:23:32.124923
NCT00354965|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-10-27|||January 2006||2006-01-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients|A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days|Completed||Phase 1|52|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:23:32.366562|2017-02-18 16:23:32.366562
NCT00354939|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2010-08-30|||October 2003||2003-10-01|August 2010|2010-08-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|SAFIR||Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement|10-week, Open, National, Multicenter Clinical Trial to Evaluate the Safety of Insulin Glargine in Type 2 Diabetes Mellitus Patients, on Intensified Conventional Therapy (ICT)|Completed||Phase 4|480||Sanofi|||||f||||||||||||||2017-02-18 16:23:32.573764|2017-02-18 16:23:32.573764
NCT00354926|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-01-05|||July 2006||2006-07-01|January 2013|2013-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma|Open-Label, Multicenter, Phase 1/2 Dose-Escalation Study of AME-133v (LY 2469298), Administered Intravenously in Four Weekly Doses, in Subjects With CD20+ Follicular Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 1|67|Actual|Applied Molecular Evolution||1|||f||||f||||||||||2017-02-18 16:23:32.658667|2017-02-18 16:23:32.658667
NCT00354913|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-01-14|2012-12-07||May 2005||2005-05-01|December 2012|2012-12-01|October 2010|Actual|2010-10-01|March 2009|Actual|2009-03-01||Interventional|||Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma|A Phase II Study of Imatinib Mesylate Plus Hydroxyurea in the Treatment of Patients With Recurrent/Progressive Meningioma|Completed||Phase 2|21|Actual|Duke University||1|||f||||t||||||||||2017-02-18 16:23:32.792488|2017-02-18 16:23:32.792488
NCT00354900|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2009-08-03|||July 2006||2006-07-01|August 2009|2009-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Phase I Study of Aprotinin in Advanced Breast Cancer|Phase I Study of Aprotinin in Advanced Breast Cancer|Terminated||Phase 1|18||Dartmouth-Hitchcock Medical Center||||"The FDA changed the labeling for this agent, and we felt we could not offer it to patients on~   a non-surgical study."|f||||t||||||||||2017-02-18 16:23:33.095797|2017-02-18 16:23:33.095797
NCT00354887|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2012-10-22|2011-06-14||November 2004||2004-11-01|October 2012|2012-10-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater|A Phase II Study of Capecitabine and Oxaliplatin (XELOX) in Adenocarcinoma of the Small Bowel and Ampulla of Vater|Completed||Phase 2|31|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:23:33.192239|2017-02-18 16:23:33.192239
NCT00354874|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-09-13|||January 2005||2005-01-01|September 2016|2016-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Investigation Of A New Medication (GW642444) In Asthmatic Patients|A Multi-centre, Randomised, Double-blind, Placebo Controlled, Dose Ascending, Four Way Crossover Study to Examine Efficacy (FEV1), Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Doses of GW642444|Completed||Phase 2|28|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:23:33.471526|2017-02-18 16:23:33.471526
NCT00354861|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2008-04-22|||May 2005||2005-05-01|April 2008|2008-04-01|February 2006|Actual|2006-02-01|November 2005|Actual|2005-11-01||Interventional|||A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321|A Phase I, Single-Blind Study to Determine the Safety, Tolerability and Pharmacodynamic Profiles of a Hepatitis B Antigen Combined With IMP321 Versus the Hepatitis B Antigen Alone and a Reference Vaccine in Healthy Young Male Volunteers|Completed||Phase 1|48|Actual|Immutep S.A.||3|||f||||f||||||||||2017-02-18 16:23:33.582319|2017-02-18 16:23:33.582319
NCT00354835|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2016-02-01|||December 2006||2006-12-01|February 2016|2016-02-01||||September 2014|Actual|2014-09-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma|Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan (VI) for Patients With Intermediate-Risk Rhabdomyosarcoma (RMS)|Active, not recruiting||Phase 3|481|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 16:23:33.699433|2017-02-18 16:23:33.699433
NCT00354822|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2009-09-17|||August 2005||2005-08-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|Z0105||Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.|Phase II Study for Use of Oral Fludarabine Plus Cyclophosphamide and Rituximab Followed by Zevalin as Front-Line Treatment for Non-Follicular Indolent Lymphomas.|Terminated||Phase 2|25|Actual|A.O. Ospedale Papa Giovanni XXIII||1||Inability to recruit in time a sufficient number of patients|f||||f||||||||||2017-02-18 16:23:34.131456|2017-02-18 16:23:34.131456
NCT00354809|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2015-04-14|||May 2006||2006-05-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia|A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia|Completed||Phase 2|68|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:23:34.243635|2017-02-18 16:23:34.243635
NCT00354796|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2011-07-03|||July 2006||2006-07-01|June 2011|2011-06-01|October 2015|Anticipated|2015-10-01|||||Observational|||The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin|The Effect of Reduced Dose of Enoxaparin on the Laboratory and Clinical Outcomes of Treatment With Enoxaparin|Unknown status|Recruiting|N/A|500|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 16:23:34.355063|2017-02-18 16:23:34.355063
NCT00354783|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2006-07-18|||January 2007||2007-01-01|July 2006|2006-07-01|December 2007||2007-12-01|||||Observational|||Continuity of Leg Movements in VLBW Premature Infants: From Spontaneous Kicking and Supported Stepping to Independent Walking||Unknown status|Not yet recruiting|N/A|15||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:23:34.609147|2017-02-18 16:23:34.609147
NCT00354770|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-10-24|2012-03-01||July 2006||2006-07-01|October 2016|2016-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||N-Acetyl Cysteine in Trichotillomania|A Double-Blind, Placebo-Controlled Study of N-Acetyl Cysteine in Trichotillomania|Completed||Phase 2|50|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 16:23:34.691885|2017-02-18 16:23:34.691885
NCT00354757|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2012-11-30|||June 2005||2005-06-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing|The Influence of CYP2C19 Genetic Polymorphism and Dosage of Rabeprazole on the Accuracy of Proton-Pump Inhibitor Testing in Chinese Patients With Gastroesophageal Reflux Disease|Completed||Phase 4|200|Actual|National Taiwan University Hospital||2|||f||||||||||||||2017-02-18 16:23:35.094319|2017-02-18 16:23:35.094319
NCT00354744|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2016-09-14|2013-09-03||July 2006||2006-07-01|September 2016|2016-09-01||||January 2010|Actual|2010-01-01||Interventional|||High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma|Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients With High-Risk Rhabdomyosarcoma|Active, not recruiting||Phase 3|109|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 16:23:35.222867|2017-02-18 16:23:35.222867
NCT00354731|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2012-11-12|||August 2006||2006-08-01|October 2012|2012-10-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Efficacy of Pentoxifylline on Primary Nephrotic Syndrome|Clinical Efficacy of Pentoxifylline on Patients With Primary Nephrotic Syndrome|Completed||Phase 3|62|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 16:23:35.95238|2017-02-18 16:23:35.95238
NCT00354705|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-11-02|||January 2006||2006-01-01|November 2016|2016-11-01||||January 2018|Anticipated|2018-01-01||Observational|||Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients|Prognostic Molecular and Environmental Factors in High-Risk Stage II and Stage III Colon Cancer Patients|Active, not recruiting||N/A|200|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     20 ml of blood for genomic analysis collected at baseline, at completion of adjuvant~     chemotherapy ( <28 days after its completion) if applicable, at each subsequent surveillance~     visit (every 3 months after discontinuation of adjuvant chemotherapy, continuing for 2~     years), and at time of disease recurrence, if applicable.~      20 ml of blood for proteomic analysis studies collected at baseline, at completion of~     adjuvant chemotherapy, if applicable ( <28 days after its completion), and at time of~     disease recurrence, if applicable.~      Tissue (0.2gm of tissue) from primary resection obtained at time of study enrollment. A~     tissue sample (0.2gm of tissue) also obtained, if possible, from patients that require~     surgical intervention at M.D. Anderson Cancer Center, for recurrent disease.~   "|||2017-02-18 16:23:36.059153|2017-02-18 16:23:36.059153
NCT00354692|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2012-08-10|||June 2006||2006-06-01|August 2012|2012-08-01||||November 2006|Actual|2006-11-01||Interventional|||Effect of Two Iron Preparations on Protein in the Urine|A Randomized Cross-over Pilot Study of the Effect of Sodium Ferric Gluconate Complex vs. Iron Sucrose on Proteinuria in Non-dialysis Chronic Kidney Disease Patients|Completed||Phase 4|12|Actual|Watson Pharmaceuticals||1|||f||||||||||||||2017-02-18 16:23:36.168315|2017-02-18 16:23:36.168315
NCT00354679|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2016-04-12|2016-01-14||April 2006||2006-04-01|April 2016|2016-04-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer|Phase II Trial of Irinotecan, Cisplatin, Bevacizumab and Concurrent Radiotherapy in Locally Advanced Esophageal Adenocarcinoma|Completed||Phase 2|34|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:23:36.270179|2017-02-18 16:23:36.270179
NCT00354666|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-08-31|||September 2004||2004-09-01|August 2016|2016-08-01|December 2004|Actual|2004-12-01|||||Interventional|||Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma|A Randomised, Double-blind, Placebo-controlled, Dose Ascending Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled GSK159797 Delivered by Dry Powder Inhaler in Mild to Moderate Asthmatic Subjects|Completed||Phase 2|20||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:23:36.680604|2017-02-18 16:23:36.680604
NCT00354653|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2007-07-24|||February 2002||2002-02-01|July 2007|2007-07-01||||||||Interventional|||A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone|AN OPEN STUDY OF LAMIVUDINE TREATMENT IN ADULT HBeAg NEGATIVE (Presumed Pre-Core Mutant) CHRONIC HEPATITIS B PATIENTS IN IRAN.|Unknown status|Active, not recruiting|Phase 4|100||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:23:36.777997|2017-02-18 16:23:36.777997
NCT00354640|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-05-15|2013-03-18||June 2006||2006-06-01|May 2013|2013-05-01|November 2011|Actual|2011-11-01|October 2008|Actual|2008-10-01||Interventional|||Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer|A Trial Assessing the Effect of Simvastatin on the Pharmacokinetics of Anastrozole|Completed||Phase 2|11|Actual|Sidney Kimmel Comprehensive Cancer Center|Small sample size, difficulty in recruiting due to women either already taking a statin or on a different aromatase inhibitor.|1|||f||||f||||||||||2017-02-18 16:23:36.861307|2017-02-18 16:23:36.861307
NCT00354627|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2015-06-11|||January 2006||2006-01-01|June 2015|2015-06-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs|Early Access of TMC125 in Combination With Other Antiretrovirals in Treatment-experienced HIV-1 Infected Subjects With Limited Treatment Options|Completed||Phase 3|5178|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||f||||||||||2017-02-18 16:23:37.100019|2017-02-18 16:23:37.100019
NCT00354614|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2008-07-02|||June 2006||2006-06-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|||||Observational|||Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)|Validation of the ApneaLink Sleep Screener in a Suspected Sleep Disordered Breathing Population|Completed||N/A|81|Actual|ResMed|||1||f||||f||||||||||2017-02-18 16:23:40.146207|2017-02-18 16:23:40.146207
NCT00354601|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2015-09-29|2009-03-09||January 2006||2006-01-01|January 2012|2012-01-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer|A Phase II Study of Weekly Docetaxel and Capecitabine for Persistent or Recurrent Platinum Resistant Epithelial Carcinoma of the Ovary, Fallopian Tube or Peritoneum|Terminated||Phase 2|2|Actual|Wake Forest University Health Sciences|Early closure due to discontinuation of funding|1||funding withdrawn|f||||||||||||||2017-02-18 16:23:40.236727|2017-02-18 16:23:40.236727
NCT00354588|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2010-11-03|||January 2006||2006-01-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Arterial Stiffness, Wave Reflections and Renal Failure|Observational Study on the Prognostic Significance (Renal and Cardiovascular) of Arterial Stiffness and Arterial Wave Reflections in Patients With Mild to Moderate Renal Impairment|Completed||N/A|115|Actual|Klinikum Wels-Grieskirchen|||1||f||||||||||||||2017-02-18 16:23:40.480207|2017-02-18 16:23:40.480207
NCT00005720|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1990||1990-09-01|April 2001|2001-04-01|August 1996||1996-08-01|||||Observational|||Lay-Led Smoking Cessation Approach for Southeast Asian Men||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.451831|2017-02-18 18:14:28.451831
NCT00354575|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2008-08-14|||September 2006||2006-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Effect of Chinese Herb on Chronic Constipation for Residents in Long-Term Care Units|A Randomized, Placebo-Controlled, Double-Blind, Parallel Study on the Efficacy and Safety of Traditional Chinese Medicines for Chronic Constipation Residents in Long-Term Care Units|Completed||Phase 2|168|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 16:23:40.564452|2017-02-18 16:23:40.564452
NCT00354562|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2011-01-05|||February 2007||2007-02-01|September 2010|2010-09-01||||February 2008|Actual|2008-02-01||Interventional|||A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer|A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT-751 in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|75|Actual|Abbott||2|||f||||f||||||||||2017-02-18 16:23:40.676663|2017-02-18 16:23:40.676663
NCT00354549|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-04-09|||January 2006||2006-01-01|April 2013|2013-04-01|September 2010|Actual|2010-09-01|April 2009|Actual|2009-04-01||Interventional|||Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC|Bevacizumab and Erlotinib First-Line Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer (Stage IIIB/IV) Followed by Platinum-Based Chemotherapy at Disease Progression. A Multicenter Phase II Trial|Completed||Phase 2|104|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 16:23:41.04929|2017-02-18 16:23:41.04929
NCT00354536|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-10-24|||February 2006||2006-02-01|October 2016|2016-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus|A Single-blinded Randomized, Placebo-controlled, Staggered-parallel, Escalating-dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous Injections of GSK 716155 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|60|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:23:41.159746|2017-02-18 16:23:41.159746
NCT00354523|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2014-12-16|||December 2004||2004-12-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|November 2006|Actual|2006-11-01||Interventional|||Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma|A Phase I/II Study to Evaluate the Efficacy and Toxicity of Imatinib Mesylate in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma|Terminated||Phase 1/Phase 2|21|Actual|M.D. Anderson Cancer Center||1||Study closed following Phase I portion, insufficient activity to continue to Phase II.|f||||f||||||||||2017-02-18 16:23:41.270061|2017-02-18 16:23:41.270061
NCT00354510|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2012-05-31|||March 2006||2006-03-01|March 2011|2011-03-01||||||||Interventional|||Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis|Randomised, Double-blind, Placebo-controlled Study of Topical GW842470X Formulation in Adults With Moderate Atopic Dermatitis|Completed||Phase 2|190||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:23:41.385174|2017-02-18 16:23:41.385174
NCT00354497|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-09-19|||March 2002||2002-03-01|August 2008|2008-08-01||||||||Interventional|||Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men|Prostate Cancer Screening and Dietary HA Exposure in African-Americans: Phase II|Unknown status|Recruiting|Phase 2|800|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:23:41.484888|2017-02-18 16:23:41.484888
NCT00354484|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2013-10-08|2013-10-08||May 2006||2006-05-01|October 2013|2013-10-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients|Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients|Completed||Phase 3|291|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:23:41.579582|2017-02-18 16:23:41.579582
NCT00354471|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2009-02-04||||||July 2006|2006-07-01||||||||Observational|||Uterine Artery Embolization for Symptomatic Fibroids|Short and Long Term Outcomes of Uterine Artery Embolization.|Completed||Phase 3|||University of Manitoba|||||f||||||||||||||2017-02-18 16:23:41.978757|2017-02-18 16:23:41.978757
NCT00354458|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2009-10-08|||October 2006||2006-10-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effects of KW-3902 Injectable Emulsion on Heart Failure Signs and Symptoms and Renal Function in Subjects With Acute Heart Failure Syndrome and Renal Impairment Who Are Hospitalized for Volume Overload and Require Intravenous Diuretic Therapy|Completed||Phase 3|1102|Actual|NovaCardia, Inc.||2|||f||||t||||||||||2017-02-18 16:23:42.048697|2017-02-18 16:23:42.048697
NCT00354445|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2007-01-12|||June 2006||2006-06-01|January 2007|2007-01-01||||||||Interventional|||A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD|A Phase IV, Open Label, Multi-Center, Study of Maintenance Intravitreous Injections of Macugen (Pegaptanib Sodium) Given Every 6 Weeks for 48 Weeks in Subjects With Subfoveal Neovascular Age-Related Macular Degeneration (AMD) Initially Treated With a Modality Resulting in Maculopathy Improvement|Unknown status|Recruiting|Phase 4|1000||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 16:23:42.152855|2017-02-18 16:23:42.152855
NCT00354432|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2012-06-26|||February 2007||2007-02-01|June 2010|2010-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer|Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men With Prostate Cancer|Completed||Phase 3|120|Actual|Wake Forest University Health Sciences||4|||f||||t||||||||||2017-02-18 16:23:42.231277|2017-02-18 16:23:42.231277
NCT00354419|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2011-01-03|||February 2006||2006-02-01|January 2011|2011-01-01||||December 2010|Actual|2010-12-01||Interventional|||Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant|A Dose Finding Study of Total Body Irradiation for Conditioning Patients With Severe Aplastic Anemia Transplanted With Umbilical Cord Blood|Terminated||Phase 1|30|Anticipated|Fred Hutchinson Cancer Research Center||1||Low accrual|f||||f||||||||||2017-02-18 16:23:42.357609|2017-02-18 16:23:42.357609
NCT00353834|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2014-03-28|||August 2006||2006-08-01|March 2014|2014-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes|The Effect of Exenatide Compared to Lantus Insulin on Vascular Function Before and After a Meal Tolerance Test in Patients With Type 2 Diabetes|Completed||Phase 4|72|Actual|Joslin Diabetes Center||2|||f||||f||||||||||2017-02-18 16:23:50.888687|2017-02-18 16:23:50.888687
NCT00354406|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2011-11-13|||April 2006||2006-04-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty|A Randomized Trial Comparing the Efficacy on Myocardial Infarct Size Reduction of Early vs. Late Abciximab Administration During Primary Percutaneous Coronary Angioplasty|Completed||Phase 4|110|Actual|University of Pisa||2|||f||||f||||||||||2017-02-18 16:23:42.47661|2017-02-18 16:23:42.47661
NCT00354393|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2009-02-06|||August 2002||2002-08-01|October 2007|2007-10-01||||||||Interventional|||Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma|Aggressive Multi-Modality Management of Malignant Pleural Mesothelioma|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:23:42.586577|2017-02-18 16:23:42.586577
NCT00354380|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2006-10-23|||September 2006||2006-09-01|September 2006|2006-09-01|November 2006||2006-11-01|||||Interventional|||Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study||Completed||Phase 2|||Heidelberg University|||||f||||||||||||||2017-02-18 16:23:42.936986|2017-02-18 16:23:42.936986
NCT00354367|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2012-05-25|||January 2007||2007-01-01|May 2012|2012-05-01||||||||Interventional|||Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas|A Phase IIIB Multicenter, Open Label, Randomized Clinical Trial Evaluating Efficacy of Certolizumab Pegol, a PEGylated Fab Fragment of Humanized Antibody to Tumor Necrosis Factor (TNF) in Crohn's Disease Patients With Draining Fistulas.|Withdrawn||Phase 3|0|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 16:23:43.03585|2017-02-18 16:23:43.03585
NCT00354354|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2011-04-18|||March 2006||2006-03-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients|Bronchodilator Effect on O2 Deficit and V'O2 Kinetics During Moderate Intensity Exercise in Normoxemic COPD.|Completed||Phase 4|12|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 16:23:43.121197|2017-02-18 16:23:43.121197
NCT00354341|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2016-03-01|2016-03-01||September 2002||2002-09-01|March 2016|2016-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional||Intent-to-treat (ITT) population included all randomized participants who received at least one dose of study medication.|(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy|An Open, Randomized, Multi-centre Trial to Investigate the Effect of Anemia Correction on Cardiac Structure and Function in Patients With Early Diabetic Nephropathy|Completed||Phase 3|170|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:23:43.244|2017-02-18 16:23:43.244
NCT00354328|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2012-11-20|||May 2005||2005-05-01|November 2012|2012-11-01||||||||Observational|||Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy|Relationship of Diastolic Function and Functional Capacity in Hypertrophic Cardiomyopathy: A Post-Hoc Analysis of Protocols 01-H-0066 and 96-H-0144|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:43.872234|2017-02-18 16:23:43.872234
NCT00354315|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2009-02-13|||September 2006||2006-09-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||DÉCISION+, a Continuous Professional Development Program to Improve Optimal Drug Prescription : a Feasibility Study|DÉCISION+, a Continuous Professional Development Program to Improve Optimal Drug Prescription : a Feasibility Study|Completed||N/A|642|Actual|Centre Hospitalier Universitaire de Québec, CHU de Québec||2|||f||||f||||||||||2017-02-18 16:23:43.958076|2017-02-18 16:23:43.958076
NCT00354302|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2016-11-25|||April 2006||2006-04-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27|The Influence of Five Years of Adjuvant Anastrozole or Exemestane on Bone Mineral Density In Postmenopausal Women With Primary Breast Cancer|Completed||Phase 3|497|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 16:23:44.089752|2017-02-18 16:23:44.089752
NCT00354276|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2014-01-09|||May 2006||2006-05-01|May 2009|2009-05-01||||December 2008|Anticipated|2008-12-01||Interventional|||VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia|A Phase II Study of Cloretazine® (VNP40101M) for Elderly Patients With De Novo Poor Risk Acute Myelogenous Leukemia|Unknown status|Active, not recruiting|Phase 2|85|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:23:44.211675|2017-02-18 16:23:44.211675
NCT00354263|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2008-04-23|||April 2005||2005-04-01|April 2008|2008-04-01|February 2006|Actual|2006-02-01|September 2005|Actual|2005-09-01||Interventional|||Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen|IMP321 Phase I Study of Four Increasing Doses (3, 10, 30 and 100 µg) of a New Immunostimulatory Factor (IMP321) Given Alone or as an Adjuvant to a Reference Flu Antigen in Healthy Young Male Volunteers|Completed||Phase 1|60|Actual|Immutep S.A.||2|||f||||f||||||||||2017-02-18 16:23:44.314208|2017-02-18 16:23:44.314208
NCT00354250|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-06-04|||May 2006||2006-05-01|June 2013|2013-06-01||||February 2007|Actual|2007-02-01||Interventional|||Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Advanced Renal Cell Cancer|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:23:44.430797|2017-02-18 16:23:44.430797
NCT00354237|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2014-11-17|||July 2005||2005-07-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||DARE: Diabetes in cArdiac REhabilitation|Effect of Strict Glycemic Control on Improvement of Exercise Capacities (VO2 Peak, Peak Workload After Cardiac Rehabilitation, in Patients With Type 2 Diabetes Mellitus With Coronary Artery Disease.|Completed||N/A|60|Actual|Centre Hospitalier Universitaire Dijon||2|||f||||t||||||||||2017-02-18 16:23:44.536695|2017-02-18 16:23:44.536695
NCT00354224|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2009-01-23|||January 2005||2005-01-01|January 2008|2008-01-01||||August 2008|Actual|2008-08-01||Interventional|||Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer|A Phase II Study of XELOX in Locally Advanced or Metastatic Gastric Cancer|Completed||Phase 2|46|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:23:44.655583|2017-02-18 16:23:44.655583
NCT00354211|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2013-02-08|||July 2006||2006-07-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Observational|||Using Minimally Invasive Cardiac Output Data vs. Standard Care for Patients Emergently Admitted to the Intensive Care Unit Who Are Hemodynamically Unstable|TREASURE: Treatment With Minimally-Invasive Cardiac Output for Assessment of User Derived Results Evaluating Economic Benefit|Completed||Phase 4|392|Actual|Edwards Lifesciences|||2||f||||t||||||||||2017-02-18 16:23:44.760573|2017-02-18 16:23:44.760573
NCT00354198|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2012-11-12|||August 2006||2006-08-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis|Clinical Efficacy of Combined Pentoxifylline and Conventional Immunosuppressive Regimens on Patients With Rapidly Progressive Glomerulonephritis|Terminated||Phase 3|7|Actual|National Taiwan University Hospital||2||short of participants|f||||f||||||||||2017-02-18 16:23:44.871904|2017-02-18 16:23:44.871904
NCT00354185|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-05-15|||May 2006||2006-05-01|May 2013|2013-05-01||||February 2008|Actual|2008-02-01||Interventional|||PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma|A Phase I Study of PXD101 in Combination With 17-AAG in Advanced Malignancies|Terminated||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:23:45.004794|2017-02-18 16:23:45.004794
NCT00354172|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2012-11-06|2009-11-30||February 2006||2006-02-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.|Transplantation of Umbilical Cord Blood for Myeloid Leukemia Patients Not in CR With Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloablative Preparative Regimen and UCB NK Cells|Terminated||Phase 2|16|Actual|Masonic Cancer Center, University of Minnesota||1||Competing study was started.|f||||t||||||||||2017-02-18 16:23:45.14286|2017-02-18 16:23:45.14286
NCT00354159|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2012-08-07|2012-01-12||April 2006||2006-04-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|REDUCEhf||Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)|Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic HF (REDUCEhf)|Completed||N/A|442|Actual|Medtronic Cardiac Rhythm and Heart Failure|The study was terminated early after 400 of an estimated 1300 subjects required were randomized. The study was terminated due to a pressure lead integrity issue based on analysis of pressure leads from other clinical trials.|2|||f||||t||||||||||2017-02-18 16:23:45.816582|2017-02-18 16:23:45.816582
NCT00354146|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2011-01-31|||April 2001||2001-04-01|January 2011|2011-01-01|July 2003|Actual|2003-07-01|||||Interventional|||A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.|A Phase 2 Study Evaluating the Efficacy of the Farnesyl Transferase Inhibitor (FTI) R115777 in Patients With Refractory or Relapsed Acute Myeloid Leukemia (AML)|Completed||Phase 2|252|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:23:47.472348|2017-02-18 16:23:47.472348
NCT00354133|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2012-01-27|||July 2006||2006-07-01|August 2011|2011-08-01|June 2012|Anticipated|2012-06-01|December 2011|Actual|2011-12-01||Interventional|||Controlled Trial of Deep Brain Stimulation in Early Patients With Parkinson's Disease|The Effect of Deep Brain Stimulation of the Subthalamic Nucleus (STN-DBS) on Quality of Life in Comparison to Best Medical Treatment in Patients With Complicated Parkinson's Disease and Preserved Psychosocial Competence (EARLYSTIM-study)|Unknown status|Active, not recruiting|Phase 4|251|Actual|German Parkinson Study Group (GPS)||2|||f||||t||||||||||2017-02-18 16:23:47.556207|2017-02-18 16:23:47.556207
NCT00354120|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2014-03-20|||March 2005||2005-03-01|March 2014|2014-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|GLOBAL||Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant|Randomized Study for Comparison of Reduced Intensity Conditioning Protocols Containing Either Thymoglobuline or Alemtuzumab in Patients Undergoing Allogeneic Transplant From Voluntary Unrelated Donors|Completed||Phase 2/Phase 3|121|Actual|Gruppo Italiano Trapianto di Midollo Osseo||2|||f||||f||||||||||2017-02-18 16:23:47.69625|2017-02-18 16:23:47.69625
NCT00354107|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2014-05-05|2013-10-24||January 2007||2007-01-01|October 2011|2011-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma|A Phase I/II Pilot Study of Ifosfamide, Carboplatin and Etoposide Therapy (ICE) and SGN-30 (NSC# 731636, IND#) in Children With CD30+ Recurrent Anaplastic Large Cell Lymphoma|Terminated||Phase 1/Phase 2|5|Actual|National Cancer Institute (NCI)|Number of participants analyzed = 4. One patient was not evaluable for response.|1|||f||||t||||||||||2017-02-18 16:23:47.82423|2017-02-18 16:23:47.82423
NCT00354094|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2007-11-07|||November 2006||2006-11-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.|A Phase 2B Long-Term, Randomized, Open-Label, Safety And Tolerability Trial Comparing [S,S]-Reboxetine (PNU-165442g) With Routine Care In Patients With Postherpetic Neuralgia (PHN).|Terminated||Phase 2|600||Pfizer||||The study was stopped due to business/operational issues.|f||||||||||||||2017-02-18 16:23:48.417556|2017-02-18 16:23:48.417556
NCT00354081|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-07-11|||April 1999||1999-04-01|May 2010|2010-05-01|February 2008|Actual|2008-02-01|June 2007|Actual|2007-06-01||Interventional|WENBIT||WENBIT - Western Norway B Vitamin Intervention Trial|A Randomised Double Blind Study of the Effects of Homocysteine Lowering Therapy on Mortality and Cardiac Events in Patients Undergoing Coronary Angiography|Completed||Phase 3|3096|Actual|Haukeland University Hospital||4|||f||||t||||||||||2017-02-18 16:23:48.560495|2017-02-18 16:23:48.560495
NCT00354068|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-19|2013-03-26|||July 2004||2004-07-01|March 2013|2013-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma|A Phase I Study of Imatinib Mesylate in Combination With Temozolomide in Patients With Malignant Glioma|Completed||Phase 1|65|Actual|Duke University|||||f||||||||||||||2017-02-18 16:23:48.701244|2017-02-18 16:23:48.701244
NCT00354042|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2009-05-15|||August 2004||2004-08-01|May 2009|2009-05-01||||||||Interventional|||Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects|A Randomised, Double-Blind, Placebo-Controlled, Dose Ascending, 4 Period Crossover Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Repeat Inhaled Doses of GW597901X in Asthmatic Subjects|Completed||Phase 1|24||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:23:48.804284|2017-02-18 16:23:48.804284
NCT00354029|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2011-07-19|2011-05-24||August 2006||2006-08-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Perioperative i.v. Low-dose S(+) Ketamine|Effect of Perioperative i.v. Low-dose S(+) Ketamine in Patients Undergoing Hemorrhoidectomy|Completed||Phase 4|83|Actual|Asker & Baerum Hospital||2|||f||||||||||||||2017-02-18 16:23:48.893691|2017-02-18 16:23:48.893691
NCT00353821|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2017-01-24|||June 5, 2003||2003-06-05|September 6, 2016|2016-09-06||||||||Observational|||Investigating Cytokine Genes of Stem Cell Donors|Cytokine Gene Polymorphisms in Allotransplant Donors|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:51.110929|2017-02-18 16:23:51.110929
NCT00354016|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2007-03-12|||July 2006||2006-07-01|March 2007|2007-03-01||||||||Interventional|||Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects|A Phase III, Multicenter, Uncontrolled, Open-Label Study to Demonstrate Safety and Immunogenicity of a Commercially Available Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 When Administered to Non-Elderly Adult and Elderly Subjects|Completed||Phase 3|125||Novartis|||||f||||||||||||||2017-02-18 16:23:49.287006|2017-02-18 16:23:49.287006
NCT00354003|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2009-04-17|||July 2006||2006-07-01|April 2009|2009-04-01|August 2008|Actual|2008-08-01|||||Observational|||The Study of the Impact of Disclosing Imaging Study Information to Trial Participants|Impact of Disclosure of Dopamine Transporter Imaging Studies in PD Clinical Trials|Completed||N/A|800|Anticipated|Institute for Neurodegenerative Disorders|||1||f||||t||||||||||2017-02-18 16:23:49.376846|2017-02-18 16:23:49.376846
NCT00353990|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2007-04-24|||August 2006||2006-08-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Bioavailability of Insulin Administered in Duodenum|Bioavailability, Pharmacokinetics and Pharmacodynamics of Insulin Aspart Administered in the Duodenum in Healthy Volunteers – an Open Single Blinded and Uncontrolled Explorative Trial|Completed||Phase 1/Phase 2|12||University of Aarhus|||||f||||f||||||||||2017-02-18 16:23:49.468936|2017-02-18 16:23:49.468936
NCT00353977|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2014-06-05|2013-04-30||May 2004||2004-05-01|June 2014|2014-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors|A Pilot Trial of an Accelerated Immunization Schedule With ALVAC-pp65 (vCP260) for Inducing CMV-Specific Immunity in Stem Cell Allotransplant Donors and Healthy Volunteers|Completed||Phase 2|38|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 16:23:49.567225|2017-02-18 16:23:49.567225
NCT00353964|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2006-07-27||||||July 2006|2006-07-01||||||||Interventional|||Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery|A Multi-Center, Randomized, Double Masked, Placebo and Active Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of rEV131 2.5 Mg/mL, rEV131 1.25 Mg/mL, rEV131 0.625 Mg/mL, for the Treatment of Ocular Inflammation After Cataract Surgery|Unknown status|Recruiting|Phase 2|||Evolutec Group|||||||||||||||||||2017-02-18 16:23:49.817257|2017-02-18 16:23:49.817257
NCT00353951|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2008-05-19|||September 2006||2006-09-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||An Observational Study of Cough / Lower Respiratory Tract Infection (LRTI) in Primary Care|Genomics to Combat Resistance Against Antibiotics in Community-Acquired LRTI in Europe: GRACE. Workpackage 8. An Observational Study of Cough / Lower Respiratory Tract Infection (LRTI) in Primary Care|Completed||N/A|3402|Actual|Cardiff University|||||f||||||||||||||2017-02-18 16:23:49.894523|2017-02-18 16:23:49.894523
NCT00353938|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2014-05-12||2011-07-31|October 2006||2006-10-01|May 2014|2014-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder|Phase II Pilot Randomized Double-Blind Placebo-Controlled Study of 3,4-methylenedioxymethamphetamine (MDMA)Assisted Psychotherapy in Posttraumatic Stress Disorder (PTSD)- Switzerland|Completed||Phase 2|14|Actual|Multidisciplinary Association for Psychedelic Studies||2|||f||||f||||||||||2017-02-18 16:23:49.983981|2017-02-18 16:23:49.983981
NCT00353925|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2017-01-24|||October 5, 1999||1999-10-05|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Genetic Analysis of African-Americans With High Blood Pressure|Genetic Analysis of African-American Hypertensives|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:50.111779|2017-02-18 16:23:50.111779
NCT00353912|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2016-11-16|||June 2006||2006-06-01|November 2016|2016-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension|A 12-week, Multicenter Study to Evaluate the Efficacy and Safety of Orally Administered Valsartan/Amlodipine Combo Based Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension|Completed||Phase 3|571|Actual|Novartis|||||f||||||||||||||2017-02-18 16:23:50.191611|2017-02-18 16:23:50.191611
NCT00353899|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2017-01-24|||July 14, 2006||2006-07-14|October 14, 2016|2016-10-14||||||||Observational|||Cardiovascular Magnetic Resonance Imaging of Pediatric Normal Volunteers|Cardiovascular Magnetic Resonance Imaging of Pediatric Healthy Volunteers|Completed||N/A|41|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:50.292144|2017-02-18 16:23:50.292144
NCT00353886|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2007-07-19|||September 2002||2002-09-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Observational|||Study of Antiepileptic Drug Effects on Child Development|Retrospective Study of In Utero Antiepileptic Drug Effects in Neurodevelopment|Completed||N/A|81|Actual|Augusta University|||||f||||||||||||||2017-02-18 16:23:50.380984|2017-02-18 16:23:50.380984
NCT00353873|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2016-11-28|||November 2005||2005-11-01|November 2016|2016-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids|A Multicentre, Randomised, Double-blind, Double Dummy, Parallel Group Study to Compare the Salmeterol/Fluticasone Propionate Combination (SeretideTM) at a Dose of 50/100µg Twice Daily and Fluticasone Propionate (FlixotideTM) at a Dose of 200µg Twice Daily, Both Delivered Via a Dry Powder Inhaler (DiskusTM) for 12 Weeks in Asthma in Children Aged 4-11 Years Not Controlled by Inhaled Corticosteroids Alone at Medium Dose|Completed||Phase 4|506|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:23:50.489739|2017-02-18 16:23:50.489739
NCT00353860|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2017-01-24|||January 23, 2002||2002-01-23|November 21, 2016|2016-11-21|November 29, 2007|Actual|2007-11-29|November 29, 2007|Actual|2007-11-29||Interventional|||Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances|Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Role of Preparative Regimen and T Cell Dose in Graft Rejection and GVHD|Completed||Phase 2|70|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:23:50.667267|2017-02-18 16:23:50.667267
NCT00353847|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2006-11-15|||July 2006||2006-07-01|June 2006|2006-06-01||||||||Interventional|||Acupuncture for Treatment of Chronic LBP, RCT, Single Blinded|A Randomized, Single Blind, Controlled Clinical Trial to Evaluate the Pain Relief Efficacy, Functional Improvement and Safety of Acupuncture in Patients With Chronic Low Back Pain|Unknown status|Active, not recruiting|Phase 3|50||Korea Institute of Oriental Medicine|||||f||||||||||||||2017-02-18 16:23:50.776808|2017-02-18 16:23:50.776808
NCT00005719|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||July 1990||1990-07-01|July 2000|2000-07-01|June 1996||1996-06-01|||||Observational|||Sustaining Women's Smoking Cessation Postpartum||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.528659|2017-02-18 18:14:28.528659
NCT00353808|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2011-04-06|||July 2006||2006-07-01|April 2011|2011-04-01|October 2007|Actual|2007-10-01|||||Interventional|||A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.|An Open-Label Extension Trial Assessing The Safety And Tolerability Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN).|Terminated||Phase 2|112|Actual|Pfizer||1||"This study has been terminated early as the esreboxetine development program is being~   discontinued. There are no safety or efficacy concerns."|f||||||||||||||2017-02-18 16:23:51.203602|2017-02-18 16:23:51.203602
NCT00353795|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2010-05-25|2009-08-04||July 2005||2005-07-01|September 2009|2009-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)|Coronary Atherosclerosis Evaluation by Arterial Wall MRI|Completed||N/A|179|Actual|Johns Hopkins University|Cross sectional study||||f||||||||||||||2017-02-18 16:23:51.350168|2017-02-18 16:23:51.350168
NCT00353782|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2017-01-24|||September 10, 2003||2003-09-10|March 11, 2016|2016-03-11||||||||Observational|||Causes and Natural History of Dyslipidemias|Disease Pathogenesis and Natural History of Lipid Disorders|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:51.559041|2017-02-18 16:23:51.559041
NCT00353769|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2017-02-09|||November 2002||2002-11-01|February 2017|2017-02-01|February 2005||2005-02-01|||||Interventional|||Comparison Study on Hair Apposition Technique Performed Between Nurses and Doctors in Emergency Department.|A Single-blinded Comparative Study on Hair Apposition Technique Performed Between Nurses and Doctors in Emergency Department.(HAT2 Study)|Completed||Phase 3|360||Singapore General Hospital|||||f||||||||||||||2017-02-18 16:23:51.663139|2017-02-18 16:23:51.663139
NCT00353756|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2006-10-10|||September 2006||2006-09-01|September 2006|2006-09-01|September 2007||2007-09-01|||||Interventional|||Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn’s Disease|A Placebo-Controlled, Phase 1, Single and Multiple IV Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of C326 in Adults With Crohn’s Disease|Unknown status|Recruiting|Phase 1|52||Avidia|||||f||||||||||||||2017-02-18 16:23:51.927771|2017-02-18 16:23:51.927771
NCT00353743|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2008-12-18|||May 2006||2006-05-01|March 2007|2007-03-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|APA||The Use of Antibiotics After Hospital Discharge in Septic Abortion|A Randomized Clinical Trial on the Use or Not of Antibiotics After Hospital Discharge in Septic Abortion.|Terminated||N/A|56|Actual|Hospital de Clinicas de Porto Alegre||2||Rate of cure was higher than expected, IRB suspended for no additional benefit|f||||t||||||||||2017-02-18 16:23:52.018634|2017-02-18 16:23:52.018634
NCT00353730|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2017-01-24|||August 7, 2002||2002-08-07|November 3, 2016|2016-11-03||||||||Observational|||Identification of Genes Expressed in Atherosclerotic Plaque|Identification of Genes Expressed in Atherosclerotic Plaques|Completed||N/A|69|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:52.149186|2017-02-18 16:23:52.149186
NCT00353717|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2009-01-12|||November 2006||2006-11-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma|Phase II of Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|25|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 16:23:52.249193|2017-02-18 16:23:52.249193
NCT00353704|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2011-07-19|2011-05-24||November 2005||2005-11-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|||Analgetic and Anxiolytic Effect of Preoperative Pregabalin|Analgetic and Anxiolytic Effect of Preoperative Pregabalin in Patients Undergoing Surgery of the Vertebral Columna|Completed||Phase 4|50|Actual|Asker & Baerum Hospital||2|||f||||||||||||||2017-02-18 16:23:52.375965|2017-02-18 16:23:52.375965
NCT00353691|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2011-01-10|||October 2002||2002-10-01|January 2011|2011-01-01|November 2004||2004-11-01|||||Interventional|||Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus|Glimepiride Versus Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus: A Single Blind Comparison Study|Completed||Phase 3|100||Sanofi|||||f||||||||||||||2017-02-18 16:23:52.79611|2017-02-18 16:23:52.79611
NCT00353678|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2013-03-19|||June 2006||2006-06-01|March 2013|2013-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)|Direct Factor Xa Inhibitor YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement.---A Double Blind, Parallel, Dose-finding Study in Comparison With Open Label Enoxaparin|Completed||Phase 2|1141|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-02-18 16:23:52.893796|2017-02-18 16:23:52.893796
NCT00353665|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2009-03-30|||July 2005||2005-07-01|March 2009|2009-03-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)|Phase 2-3 - Memantine for Disability in Amyotrophic Lateral Sclerosis|Completed||Phase 2/Phase 3|63|Actual|University of Lisbon||2|||f||||t||||||||||2017-02-18 16:23:53.109751|2017-02-18 16:23:53.109751
NCT00353652|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2014-12-16|2014-12-02||January 2005||2005-01-01|December 2014|2014-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Evaluating the Link Between Thiazide Medications, the Nervous System, and Diabetes in Individuals With High Blood Pressure|Neural Mechanisms of Thiazide-induced Insulin Resistance|Completed||Phase 4|176|Actual|University of Texas Southwestern Medical Center||4|||f||||t||||||||||2017-02-18 16:23:53.243991|2017-02-18 16:23:53.243991
NCT00353639|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-18|2017-01-24|||January 27, 2006||2006-01-27|June 15, 2016|2016-06-15||||||||Observational|||Telomere Repair Gene Mutation in Inflammatory Bowel Disease|Telomere Repair Gene Mutations in Inflammatory Bowel Disease|Completed||N/A|95|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:23:53.812191|2017-02-18 16:23:53.812191
NCT00353626|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-16|2008-03-19|||June 2006||2006-06-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Observational|||Gait Evaluation of Experienced Below Knee Amputees|Gait Evaluation of Experienced Post Traumatic Below Knee Amputees|Completed||N/A|9|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 16:23:53.909786|2017-02-18 16:23:53.909786
NCT00353613|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2013-06-17|||March 2007||2007-03-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prevention of Surgical Site Infections|Prevention of Surgical Site Infections|Completed||N/A|900|Actual|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-02-18 16:23:53.981425|2017-02-18 16:23:53.981425
NCT00005718|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1990||1990-04-01|July 2000|2000-07-01|March 1993|Actual|1993-03-01|||||Observational|||Evaluation of Cholesterol Education for At-Risk Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.602744|2017-02-18 18:14:28.602744
NCT00353587|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2015-04-29|||May 2006||2006-05-01|April 2015|2015-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin|Phase 2/3, Randomized, Double-blind, Placebo- and Active Comparator-controlled, Parallel, Multicenter Study to Determine Safety and Efficacy of Metaglidasen in Treatment of Type 2 Diabetes Suboptimally Controlled on Insulin|Completed||Phase 2/Phase 3|396|Actual|CymaBay Therapeutics, Inc.||5|||f||||f||||||||||2017-02-18 16:23:54.162566|2017-02-18 16:23:54.162566
NCT00353574|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2014-02-19||2014-01-03|September 2006||2006-09-01|February 2014|2014-02-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Interventional|Darusentan||DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension|DORADO-EX - A Dose-Blinded, Long-Term Safety Extension Study of Fixed Doses of Darusentan in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic (Protocol DAR-311-E)|Terminated||Phase 3|282|Actual|Gilead Sciences||3||Study DAR-312 did not meet primary co-endpoints|f||||t||||||||||2017-02-18 16:23:54.439977|2017-02-18 16:23:54.439977
NCT00353561|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2008-05-21|||June 2004||2004-06-01|May 2008|2008-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Diabetes Mellitus and Vulvovaginal Candidiasis|Diabetes Mellitus and Vulvovaginal Candidiasis: Prevalence of Infection and Its Rationale Management|Completed||Phase 3|100|Actual|Indian Council of Medical Research||2|||f||||||||||||||2017-02-18 16:23:54.619267|2017-02-18 16:23:54.619267
NCT00353548|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2012-07-20|||April 2005||2005-04-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Determining the Response to Sipping Beverages Without Swallowing in People With Eating Disorders|Study of Response to the Taste of Beverages That Are Not Swallowed (Sipping and Spitting in Eating Disorders)|Completed||N/A|80|Actual|New York State Psychiatric Institute|||5||f||||f||||||||||2017-02-18 16:23:54.728883|2017-02-18 16:23:54.728883
NCT00353535|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2006-07-17|||January 2000||2000-01-01|September 2005|2005-09-01|December 2002||2002-12-01|||||Interventional|||Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft|Phase 1 Study of TLI Pretransplant to Prevent Recurrence of FSGS in the Graft|Completed||Phase 1|10||University of Sao Paulo|||||f||||||||||||||2017-02-18 16:23:54.820194|2017-02-18 16:23:54.820194
NCT00353522|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2016-11-01||2016-06-28|July 2006||2006-07-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.|A Phase II, Double-Blind, Randomized, Placebo-controlled, Parallel Group Study, Evaluating the Efficacy and Safety of RO4607381 Over a 24-week Period in Patients With CHD or a CHD Risk Equivalent|Completed||Phase 2|135|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:23:54.92246|2017-02-18 16:23:54.92246
NCT00353509|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-16|2013-10-08||||||October 2013|2013-10-01||||||||Interventional|||Safety and Effectiveness Study of the Solysafe Septal Occluder|Prospective Mono-center Clinical Study to Evaluate the Safety and Effectiveness of an Intracardiac Septal Closure Device in Patients With Atrial Septum Defect (ASD)|Completed||N/A|||Carag AG|||||f||||||||||||||2017-02-18 16:23:55.034135|2017-02-18 16:23:55.034135
NCT00353496|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2015-02-18|2015-01-15||June 2006||2006-06-01|February 2015|2015-02-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|CLARINET|Analysis based on intent-to-treat (ITT) population comprised of 204 subjects.|Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours|Phase III, Randomised, Double-blind, Stratified Comparative, Placebo Controlled, Parallel Group, Multi-centre Study to Assess the Effect of Deep Subcutaneous Injections of Lanreotide Autogel 120mg Administered Every 28 Days on Tumour Progression Free Survival in Patients With Non-functioning Entero-pancreatic Endocrine Tumour|Completed||Phase 3|264|Actual|Ipsen||2|||f||||||||||||||2017-02-18 16:23:55.122474|2017-02-18 16:23:55.122474
NCT00353483|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2016-07-20|||September 2005||2005-09-01|July 2016|2016-07-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||Effect of Chemotherapy Administered Before Surgery on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells|Effect of Neoadjuvant Chemotherapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells|Recruiting||N/A|200|Anticipated|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 16:23:58.876711|2017-02-18 16:23:58.876711
NCT00353470|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2015-12-03|||September 2006||2006-09-01|December 2015|2015-12-01|September 2012|Actual|2012-09-01|March 2012|Actual|2012-03-01||Interventional|||Comparison of Psychotherapy Programs to Treat Panic Disorder|Dynamic Treatment vs. CBT for Panic Disorder|Completed||Phase 3|201|Actual|Weill Medical College of Cornell University||3|||f||||t||||||||||2017-02-18 16:23:59.003657|2017-02-18 16:23:59.003657
NCT00353457|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2016-09-23|||February 2006||2006-02-01|September 2016|2016-09-01||||July 2011|Actual|2011-07-01||Interventional|||Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma|Phase II Study of Capecitabine, Oxaliplatin and Cetuximab Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma|Completed||Phase 2|6|Anticipated|Abramson Cancer Center of the University of Pennsylvania||1|||f||||t||||||||||2017-02-18 16:23:59.116742|2017-02-18 16:23:59.116742
NCT00353444|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2008-11-05|||December 2006||2006-12-01|November 2008|2008-11-01|March 2007||2007-03-01|||||Observational|||Transcranial Doppler Measurement and Prognosis in Moderate Head Injury|Transcranial Doppler Measurement and Prognosis in Moderate Head Injury|Suspended||Phase 2/Phase 3|70||Universidad Autonoma de San Luis Potosí||||Technical Conflicts|f||||||||||||||2017-02-18 16:23:59.448789|2017-02-18 16:23:59.448789
NCT00353431|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2012-05-10|2011-10-31||December 2006||2006-12-01|May 2012|2012-05-01|October 2010|Actual|2010-10-01|April 2010|Actual|2010-04-01||Interventional|||Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia|Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia|Completed||N/A|130|Actual|University Hospital, Basel, Switzerland|Small sample size|2|||f||||f||||||||||2017-02-18 16:23:59.546572|2017-02-18 16:23:59.546572
NCT00353418|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2010-07-30|2010-05-14||June 2006||2006-06-01|July 2010|2010-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection|A Randomized, Multicenter, Double Blinded Study Comparing the Safety and Efficacy of Pegasys® 180 ug Plus Copegus® 1000 or 1200 mg to the Currently Approved Combination of Pegasys® 180 ug Plus Copegus® 800 mg in Interferon-naïve Patients With Chronic Hepatitis C Genotype 1 Virus Infection and HIV-1|Completed||Phase 4|415|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:24:00.036961|2017-02-18 16:24:00.036961
NCT00353405|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2012-01-18|||October 2006||2006-10-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||HIV and STD Prevention for High-Risk, Inner-City, African American Youth|A Multilevel HIV Prevention Strategy for High-Risk Youth|Completed||Phase 3|1650|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 16:24:00.742649|2017-02-18 16:24:00.742649
NCT00353392|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2013-12-18|||March 2006||2006-03-01|November 2006|2006-11-01|August 2006||2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Q-Switched Nd:YAG in Macular Amyloidosis||Completed||Phase 1|20||Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:24:00.854282|2017-02-18 16:24:00.854282
NCT00353379|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2017-02-09|||September 1995|Actual|1995-09-01|February 2017|2017-02-01|May 1997|Actual|1997-05-01|May 1997|Actual|1997-05-01||Interventional|||Pharmacology of Cognition in Schizotypal Personality Disorder|Pharmacology of Cognition in Schizotypal Personality Disorder: Guanfacine for Cognitive Symptoms in Schizotypal Personality Disorder|Terminated||Phase 4|29|Actual|Icahn School of Medicine at Mount Sinai||2||low enrollment|f||||t||||||||||2017-02-18 16:24:00.947777|2017-02-18 16:24:00.947777
NCT00353366|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2012-11-21|2011-07-07||November 2006||2006-11-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination|Open, Multicentric, Post-marketing Surveillance Study to Evaluate Safety and Reactogenicity of GSK Bio's Live Attenuated Oral Human Rotavirus (HRV) Vaccine, Rotarix When Administered According to Prescribing Information, in Filipino Subjects Aged at Least 6 Weeks of Age at the Time of First Vaccination|Completed||N/A|1432|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 16:24:01.078633|2017-02-18 16:24:01.078633
NCT00353353|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2007-07-06|||July 2006||2006-07-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||The Bread Trial: Effects of Bread Fortified With Folic Acid and Vitamin B12|The Bread Trial: a Demonstration Trial to Show Effects of Fortification of Food With Both Folic Acid and Vitamin B12|Completed||N/A|150|Anticipated|Wageningen University|||||f||||f||||||||||2017-02-18 16:24:01.366559|2017-02-18 16:24:01.366559
NCT00353340|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2010-02-24|||January 2005||2005-01-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|January 2008|Actual|2008-01-01||Interventional|||Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine|Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine in Patients Undergoing Cardiac Catheterization|Completed||N/A|250|Anticipated|Shaare Zedek Medical Center||2|||f||||||||||||||2017-02-18 16:24:01.714727|2017-02-18 16:24:01.714727
NCT00353327|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2008-03-28|||October 2006||2006-10-01|March 2008|2008-03-01||||||||Interventional|||Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure|Passive Immunotherapy in HIV-Infected Patients Who Fail to Respond to Multiple Highly Active Antiretroviral Treatment. Randomized Study in Two Phases.|Suspended||Phase 2/Phase 3|30|Anticipated|Hospital Clinic of Barcelona||||low recruitment|f||||||||||||||2017-02-18 16:24:01.819244|2017-02-18 16:24:01.819244
NCT00353301|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2014-03-17|2013-12-23||July 2006||2006-07-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional||It was calculated that 25 participants will provide 80% power to detect an improvement in progression-free survival from 12 to 24 weeks in a pretreated population of renal cell carcinoma patients.|Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma|A Phase II Single Arm Clinical Trial to Evaluate the Efficacy and Safety of the Combination of Tarceva™ (Erlotinib Hydrochloride) and Rapamune™ (Sirolimus) in the Treatment of Metastatic Renal Cell Carcinoma.|Completed||Phase 2|25|Actual|University of Colorado, Denver|One limitation of this study was the lack of von Hippel–Lindau (VHL) mutational status assessment.|1|||f||||t||||||||||2017-02-18 16:24:01.922642|2017-02-18 16:24:01.922642
NCT00353288|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2016-10-06|||March 2006||2006-03-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™|Comparative Study Evaluating the Immunogenicity and Safety of MeMuRu-OKA Vaccine and Measles-mumps-rubella Vaccine (Priorix™) Co-administered With Varicella Vaccine (Varilrix™) in Children Primed With Measles-mumps-rubella Vaccine|Completed||Phase 2|446|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:24:02.279839|2017-02-18 16:24:02.279839
NCT00353275|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2014-05-02|2014-02-19||August 2009||2009-08-01|May 2014|2014-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Hyperglycemia in Surgical Infections|Studies on Hyperglycemia in Surgical Infections|Terminated||N/A|5|Actual|The University of Texas Health Science Center, Houston||2||Difficulty in enrolling eligible patients|f||||t||||||||||2017-02-18 16:24:02.449769|2017-02-18 16:24:02.449769
NCT00353262|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2016-02-04|2015-12-04||July 2005||2005-07-01|February 2016|2016-02-01|April 2008|Actual|2008-04-01|September 2006|Actual|2006-09-01||Interventional|||A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.|An Open-label Study to Assess the Pharmacokinetic Interaction Between Xeloda and Oxaliplatin in Patients With Metastatic Colorectal Cancer.|Completed||Phase 1|36|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:24:02.991208|2017-02-18 16:24:02.991208
NCT00353249|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2014-05-06|||June 2008||2008-06-01|May 2014|2014-05-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Homeless Women|Cognitive Behavioral Therapy for Homeless Women With Post-Traumatic Stress Disorder (PTSD)|Completed||Phase 1|31|Actual|RAND||2|||f||||||||||||||2017-02-18 16:24:03.649703|2017-02-18 16:24:03.649703
NCT00352235|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2006-07-13|||August 2003||2003-08-01|July 2006|2006-07-01|May 2005||2005-05-01|||||Interventional|||Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection|Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection|Completed||Phase 1/Phase 2|36||Foundation for Liver Research|||||f||||||||||||||2017-02-18 16:24:03.760212|2017-02-18 16:24:03.760212
NCT00352222|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2008-09-25|||January 2004||2004-01-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|July 2005|Actual|2005-07-01||Interventional|MELODIE||Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries|A Prospective, Multicenter, Single Arm Study to Obtain Additional Data on the Safety and Efficacy of the Express Vascular LD Implantation in the Treatment of Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries|Completed||Phase 3|150||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 16:24:03.856763|2017-02-18 16:24:03.856763
NCT00352209|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||May 2, 2006||2006-05-02|May 16, 2007|2007-05-16|May 16, 2007||2007-05-16|||||Observational|||Cardiomyopathy Following Stem Cell Transplantation|Retrospective Review of Cardiomyopathy Patient Cases Post Allogeneic Hematopoietic Stem Cell Transplantation|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:24:04.191394|2017-02-18 16:24:04.191394
NCT00352196|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2015-01-13|||November 2001||2001-11-01|January 2015|2015-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study|A Biological Basis of Therapy for Negative Symptom Spectrum Disorders: Risperdal Effect on Frontal Metabolism in Asperger's Disorder|Completed||Phase 4|23|Actual|Augusta University||2|||f||||f||||||||||2017-02-18 16:24:04.271457|2017-02-18 16:24:04.271457
NCT00352183|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2009-07-07|||January 2006||2006-01-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy|A Multicenter, Double-Blind, Randomized Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 40 mg Simvastatin With 40 mg Simvastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not Adequately Controlled by 40 mg Simvastatin Alone.|Completed||Phase 3|450|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:24:04.394297|2017-02-18 16:24:04.394297
NCT00352170|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2008-08-08|||May 2000||2000-05-01|August 2008|2008-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Calcium and Vitamin D Malnutrition in Elderly Women|Calcium and Vitamin D Malnutrition in Elderly Women|Completed||Phase 3|1180|Actual|Creighton University||3|||f||||t||||||||||2017-02-18 16:24:04.577756|2017-02-18 16:24:04.577756
NCT00352157|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2009-07-20|||July 2006||2006-07-01|July 2009|2009-07-01|March 2007|Actual|2007-03-01|||||Interventional|||Effect of Revival Soy on Weight Loss and Skin, Hair, and Nails in Premenopausal Women|Effect of Revival Soy on Weight Loss and Appearance of Skin, Hair, and Nails in High BMI Premenopausal Women|Completed||Phase 4|40||Physicians Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 16:24:04.69473|2017-02-18 16:24:04.69473
NCT00352144|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2012-02-21|||October 2003||2003-10-01|February 2012|2012-02-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia|A Six-Month, Chronic Efficacy and Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia: A Randomized Double-Blind, Placebo-Controlled Study|Completed||Phase 3|830|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 16:24:04.796107|2017-02-18 16:24:04.796107
NCT00352131|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2010-03-16|||February 2005||2005-02-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors|A Phase I Study to Assess the Safety and Pharmacokinetics of huC242-DM4 Administered as a Single Intravenous Infusion Once Every Three Weeks to Subjects With Solid Tumors|Completed||Phase 1|50|Anticipated|ImmunoGen, Inc.||1|||f||||||||||||||2017-02-18 16:24:04.957438|2017-02-18 16:24:04.957438
NCT00352118|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2012-11-06|2009-06-02||March 2006||2006-03-01|November 2012|2012-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer|Phase II Pilot Study of TPF (Docetaxel, Cisplatin, and 5-FU) Induction Chemotherapy Followed by Concurrent Cisplatin and Reduced Dose Radiation in Locally Advanced Head and Neck Cancer|Terminated||Phase 2|4|Actual|Masonic Cancer Center, University of Minnesota|All 4 patients received high dose radiation (66-70 Gy). The radiation oncologist on this study deemed low dose radiation treatment was not appropriate for these patients. Therefore, the study participants are not evaluable.|1||Low dose radiation treatment was not appropriate for these patients.|f||||f||||||||||2017-02-18 16:24:05.064951|2017-02-18 16:24:05.064951
NCT00352105|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2012-11-01|2011-11-17||April 2006||2006-04-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|September 2008|Actual|2008-09-01||Interventional|||Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer|A Phase I/II Trial of Concurrent Chemotherapy and ZD1839 (IRESSA) With Hyperfractionated Radiation Therapy, Followed by Maintenance ZD1839 (IRESSA) for Patients With Locally Advanced Squamous Cell Head and Neck Cancer|Completed||Phase 1/Phase 2|60|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:24:05.411859|2017-02-18 16:24:05.411859
NCT00352092|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-11-12|||June 2002||2002-06-01|November 2014|2014-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pilot Study for HLA Identical Living Donor Renal Transplant Recipients|A Pilot Study of Corticosteroid-Free, Calcineurin-Sparing Immunosuppression Protocol for HLA-Identical Living Donor Renal Transplant Recipient|Completed||Phase 4|20|Actual|University of Cincinnati||1|||f||||f||||||||||2017-02-18 16:24:05.760319|2017-02-18 16:24:05.760319
NCT00352079|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2012-12-17|||April 2006||2006-04-01|December 2012|2012-12-01|January 2012|Actual|2012-01-01|||||Interventional|||BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer|A Phase III Study of IRESSA in Combination With Intravesical BCG Versus Intravesical BCG Alone in High Risk Superficial Transitional Cell Carcinoma of the Bladder|Terminated||Phase 3|41|Actual|Canadian Cancer Trials Group||2||terminated due to poor accrual|f||||t||||||||||2017-02-18 16:24:05.870396|2017-02-18 16:24:05.870396
NCT00352066|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2011-06-21|||July 2006||2006-07-01|June 2011|2011-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together|A Phase I, Open Label, Controlled, Intra-subject Comparison Study to Investigate the Effect of Co-administration Upon the Pharmacokinetics of Tipranavir (Ritonavir Boosted) and Apricitabine.|Completed||Phase 1|18|Actual|Avexa||1|||f||||f||||||||||2017-02-18 16:24:05.986299|2017-02-18 16:24:05.986299
NCT00352053|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2015-06-15|2010-03-05||June 2006||2006-06-01|June 2015|2015-06-01|December 2013|Actual|2013-12-01|September 2008|Actual|2008-09-01||Interventional||Safety Analysis Set: participants were randomized and received at least 1 dose of study medication.|Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Tenofovir DF as Part of an Optimized Antiretroviral Regimen in HIV-1-Infected Adolescents|Completed||Phase 3|87|Actual|Gilead Sciences|Participants left the study for a number of reasons (eg, turned 18 years old, switched to a different HIV treatment regimen), which led to small numbers of participants analyzed at later time points, and the study was concluded earlier than planned.|2|||f||||t||||||||||2017-02-18 16:24:06.113755|2017-02-18 16:24:06.113755
NCT00005717|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1990||1990-08-01|June 2001|2001-06-01|July 1995|Actual|1995-07-01|||||Observational|||Medication Adherence in COPD--A Self-Regulation Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.675595|2017-02-18 18:14:28.675595
NCT00352027|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2016-09-19|2016-04-27||July 2006||2006-07-01|September 2016|2016-09-01|November 2022|Anticipated|2022-11-01|May 2015|Actual|2015-05-01||Interventional|||Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma|Stanford V Chemotherapy With Low-Dose Tailored-Field Radiation Therapy for Intermediate Risk Pediatric Hodgkin Lymphoma|Active, not recruiting||Phase 2|81|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 16:24:08.737104|2017-02-18 16:24:08.737104
NCT00353236|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2006-07-17||||||July 2006|2006-07-01||||||||Observational|||The Contribution of Internal Maternal Resources to Creation of Motherhood. Comparison Among Mothers to Twins and Singleton||Unknown status|Recruiting|N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:24:11.984843|2017-02-18 16:24:11.984843
NCT00353223|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2013-05-30|||July 2006||2006-07-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Interpersonal Psychotherapy for Depression in People With Heart Failure|Interpersonal Psychotherapy for Depression in Patients With Heart Failure|Completed||Phase 1/Phase 2|66|Actual|University of Iowa||2|||f||||f||||||||||2017-02-18 16:24:12.064482|2017-02-18 16:24:12.064482
NCT00353210|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-16|2016-09-01|||April 2004||2004-04-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||The Derivation of Human Embryonic Stem Cell Lines From PGD Embryos|The Derivation of Human Embryonic Stem Cell Lines From PGD Embryos|Recruiting||N/A|30|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"~     Retain serum samples of embryo donors.~   "|||2017-02-18 16:24:12.168673|2017-02-18 16:24:12.168673
NCT00353197|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-16|2016-09-01|||July 2002||2002-07-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Derivation of New Human Embryonic Stem Cell Lines Lines for Clinical Use|The Derivation of New Human Embryonic Stem Cell Lines for Clinical Use|Recruiting||N/A|40|Anticipated|Hadassah Medical Organization|||1||f||||t||||||Samples With DNA|"~     Blood serum samples of donor couple.~   "|||2017-02-18 16:24:12.271661|2017-02-18 16:24:12.271661
NCT00353184|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2010-02-23|||September 2001||2001-09-01|February 2010|2010-02-01|February 2005|Actual|2005-02-01|October 2004|Actual|2004-10-01||Interventional|||Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years|Randomized Controlled Trial of Oral Montelukast Added to Standard Therapy for Acute Asthma Exacerbations in Children Age 6 to 14 Years|Terminated||N/A|27|Actual|Washington University School of Medicine||||Results of the interim analysis suggested no significant diff between study groups.|f||||||||||||||2017-02-18 16:24:12.380684|2017-02-18 16:24:12.380684
NCT00353171|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-17|2017-01-24|||November 1, 2002||2002-11-01|June 24, 2016|2016-06-24||||||||Observational|||Organochlorine Exposure in Relation to Timing of Natural Menopause|Organochlorine Exposure in Relation to Timing of Natural Menopause|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:24:12.48762|2017-02-18 16:24:12.48762
NCT00353158|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2017-01-24|||July 9, 2006||2006-07-09|September 26, 2016|2016-09-26|September 20, 2011|Actual|2011-09-20|September 20, 2011|Actual|2011-09-20||Interventional|||A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity|A Pilot Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity|Completed||Phase 1|62|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:24:12.573911|2017-02-18 16:24:12.573911
NCT00353145|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2012-08-01|||February 2004||2004-02-01|August 2012|2012-08-01|January 2010|Actual|2010-01-01|March 2007|Actual|2007-03-01||Interventional|||Gemox as First and Second Line Therapy in Unknown Primary Cancer|A Phase II Study to Evaluate the Efficacy and Toxicity of Oxaliplatin in Combination With Gemcitabine as First and Second Line Therapy in Unknown Primary Cancer|Completed||Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:24:12.689635|2017-02-18 16:24:12.689635
NCT00353119|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2011-09-01|2010-11-23||April 2006||2006-04-01|September 2011|2011-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis|Phase 3 Study With a Placebo-Controlled, Double-blind, on the Safety and Efficacy of Etanercept in Palmo-Plantar Pustulosis|Completed||Phase 3|15|Actual|Innovaderm Research Inc.||2|||f||||f||||||||||2017-02-18 16:24:13.020551|2017-02-18 16:24:13.020551
NCT00353106|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2012-07-27|||February 2006||2006-02-01|July 2012|2012-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Experience of Having Chronic Graft-Versus-Host Disease|The Experience of Having Chronic Graft-Versus-Host Disease|Completed||N/A|187|Actual|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-02-18 16:24:13.527539|2017-02-18 16:24:13.527539
NCT00353093|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2006-10-19|||January 2003||2003-01-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||The ERASMUS Study: Limited vs Extended US for DVT Diagnosis|Limited Versus Extended Ultrasonography for the Diagnosis of Clinically Symptomatic Deep Vein Thrombosis of the Lower Extremities. A Randomized Study|Completed||N/A|2000||University of Padova|||||f||||||||||||||2017-02-18 16:24:13.641243|2017-02-18 16:24:13.641243
NCT00353080|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2009-12-11|||December 2002||2002-12-01|December 2009|2009-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women|A Two-year, Multicenter, Double-blind, Randomized, Placebo-controlled and Parallel Group Study of Oral Risedronate 5 mg Daily in the Prevention of Osteoporosis in Osteopenic Postmenopausal Women (More Than 5 Years Postmenopausal)|Completed||Phase 3|171|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:24:13.724883|2017-02-18 16:24:13.724883
NCT00353067|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2006-11-28|||May 2006||2006-05-01|November 2006|2006-11-01||||||||Interventional|||Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina|A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Veliflapon (DG-031) in Reducing the Risk of Acute Cardiovascular Events in African American Patients With Coronary Artery Disease(The LTCAD Study).|Suspended||Phase 3|3450||deCODE genetics|||||f||||||||||||||2017-02-18 16:24:13.830599|2017-02-18 16:24:13.830599
NCT00353054|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2006-07-14|||January 2003||2003-01-01|November 2002|2002-11-01|July 2005||2005-07-01|||||Interventional|||Effect of Calcium/Vitamin D Supplementation on Body Weight and Fat Loss.|A Double-Blind, Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Effect of Calcium/Vitamin D Supplementation (Caltrate 600+ D) on Body Weight and Fat Loss in Overweight and Obese Individuals on a Weight-Reducing Program.|Completed||Phase 4|80||Laval University|||||f||||||||||||||2017-02-18 16:24:13.941993|2017-02-18 16:24:13.941993
NCT00353041|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2006-07-13|||July 2006||2006-07-01|July 2006|2006-07-01|December 2006||2006-12-01|||||Interventional|||A Study of the Effect of Time on Topical Anesthetic Efficacy.|A Study of the Effect of Time on Topical Anesthetic Efficacy.|Unknown status|Recruiting|N/A|90||University of Toronto|||||f||||||||||||||2017-02-18 16:24:14.05312|2017-02-18 16:24:14.05312
NCT00353028|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2010-03-03|||October 2006||2006-10-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents|SME3110 (Fluvoxamine Maleate) in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents (8 Through 18 Years of Age) -A Double-blind, Randomized, Placeb-controlled Study|Completed||Phase 4|90|Actual|Solvay Pharmaceuticals||2|||f||||t||||||||||2017-02-18 16:24:14.138814|2017-02-18 16:24:14.138814
NCT00353015|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2012-08-01|||March 2003||2003-03-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|December 2007|Actual|2007-12-01||Interventional|||Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract|A Phase II Study of Irinotecan and Cisplatin for Metastatic or Unresectable High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract|Completed||Phase 2|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:24:14.278317|2017-02-18 16:24:14.278317
NCT00353002|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2007-04-12|||July 2006||2006-07-01|August 2006|2006-08-01|December 2007|Anticipated|2007-12-01|||||Interventional|||A Comparison of Amethocaine Cream vs. Liposomal Lidocaine Cream for Venipuncture in Children.|A Comparison of Amethocaine Creams Versus Liposomal Lidocaine Cream as Pain Reliever Prior to Venipuncture in Children at the Paediatric Emergency Department.|Unknown status|Recruiting|N/A|60||Lawson Health Research Institute|||||f||||t||||||||||2017-02-18 16:24:14.401125|2017-02-18 16:24:14.401125
NCT00352989|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2007-09-26|||July 2006||2006-07-01|September 2007|2007-09-01||||||||Interventional|||Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and Children|Efficacy of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and Children|Completed||Phase 3|300|Anticipated|Ipsen|||||f||||||||||||||2017-02-18 16:24:14.502456|2017-02-18 16:24:14.502456
NCT00352976|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2017-02-13|||May 18, 2006|Actual|2006-05-18|February 2017|2017-02-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||TBI Dose De-escalation for Fanconi Anemia|Total Body Irradiation Dose De-escalation Study in Patients With Fanconi Anemia Undergoing Alternate Donor Hematopoietic Cell Transplantation|Recruiting||Phase 2/Phase 3|120|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t|f|f||||||||2017-02-18 16:24:14.614857|2017-02-18 16:24:14.614857
NCT00352963|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2016-09-14|||September 2003||2003-09-01|September 2016|2016-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).|Study to Assess Immunogenicity and Reactogenicity of Three Doses of GSK Bio's Combined Hib-MenC Vaccine Co-admind With GSK Bio's DTPa-HBV-IPV Vaccine and of Two Doses of Baxters Meningococcal C Conjugate Vaccine Co-admind With GSK Bio's DTPa-HBV-IPV/Hib Vaccine|Completed||Phase 3|480|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:24:14.74739|2017-02-18 16:24:14.74739
NCT00352950|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2007-12-20|||March 2006||2006-03-01|December 2007|2007-12-01|February 2008||2008-02-01|||||Interventional|||Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer|An Open-Label Clinical Trial Evaluating the Safety and Pharmacodynamics of Sirolimus and Panitumumab in Subjects With Advanced Non-Small Cell Lung Cancer|Withdrawn||Phase 1|40||Amgen|||||||||||||||||||2017-02-18 16:24:14.876243|2017-02-18 16:24:14.876243
NCT00352937|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2014-05-14|||March 2006||2006-03-01|May 2014|2014-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test|Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test|Completed||Phase 3|98|Actual|Providence VA Medical Center|||1||f||||t||||||||||2017-02-18 16:24:14.967793|2017-02-18 16:24:14.967793
NCT00352924|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2017-02-14|||April 30, 1993||1993-04-30|January 25, 2017|2017-01-25||||||||Observational|||Agriculture Health Study|The Main Agricultural Health Study - A Prospective Study of Cancer and Other Diseases Among Men and Women in Agriculture|Active, not recruiting||N/A|90500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:24:15.063004|2017-02-18 16:24:15.063004
NCT00352911|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2010-03-04|2009-04-15||July 2006||2006-07-01|March 2010|2010-03-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects|A Randomized, Placebo-controlled, Dose Escalating, Phase II Trial of the Anti -HIV-Activity and Safety of VGX-410 (Mifepristone) in HIV-1 Infected Subjects|Completed||Phase 2|19|Actual|VGX Pharmaceuticals, LLC||2|||||||||||||||||2017-02-18 16:24:15.15463|2017-02-18 16:24:15.15463
NCT00352898|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2016-10-06|||April 2006||2006-04-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™|Comparative Study Evaluating the Immunogenicity & Safety of MeMuRu-OKA Vaccine & Measles-mumps-rubella Vaccine (Priorix™) Co-administered With Varicella Vaccine (Varilrix™) in Children Primed With Both Measles-mumps-rubella & Varicella Vaccines|Completed||Phase 2|400|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:24:15.521967|2017-02-18 16:24:15.521967
NCT00352885|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-10-02|2014-03-08||January 2006||2006-01-01|October 2014|2014-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Evaluating the Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment|IL-2 Neuropsychiatric Symptoms: Mechanism and Prevention|Completed||Phase 4|20|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:24:15.622649|2017-02-18 16:24:15.622649
NCT00352872|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2010-05-25|||February 2005||2005-02-01|May 2010|2010-05-01|February 2010|Anticipated|2010-02-01|||||Observational|||Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer|A Pilot Study of Cytochrome P450 Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Indiana University|||1||f||||||||||Samples With DNA|"~     Whole blood Plasma~   "|||2017-02-18 16:24:15.922787|2017-02-18 16:24:15.922787
NCT00352859|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2014-12-26|||August 2006||2006-08-01|December 2014|2014-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib|A Randomized Discontinuation Trial to Determine the Clinical Benefit of Continuation of Sorafenib Following Disease Progression in Patients With Advanced Renal Cell Carcinoma|Terminated||Phase 4|2|Actual|Bayer||2|||||||||||||||||2017-02-18 16:24:16.012374|2017-02-18 16:24:16.012374
NCT00352846|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2013-06-20|2013-04-30||January 2006||2006-01-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss|Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss in Non-Hodgkin's Lymphoma Patients Receiving Chemotherapy|Completed||Phase 3|135|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:24:16.140864|2017-02-18 16:24:16.140864
NCT00352833|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2007-10-25|||July 2006||2006-07-01|June 2007|2007-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma|Multicenter, Open-Label and Randomized Phase II Study to Evaluate Safety and Efficacy of the Trifunctional Bispecific Antibody Catumaxomab (Anti-EpCAM x Anti-CD3) in Patients After Curative Resection of a Confirmed Gastric Adenocarcinoma Compared With Surgery Alone|Completed||Phase 2|40|Anticipated|Neovii Biotech|||||f||||||||||||||2017-02-18 16:24:16.470183|2017-02-18 16:24:16.470183
NCT00352820|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2012-07-31|||April 2006||2006-04-01|July 2012|2012-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Experience of Brain Tumor Caregivers|The Experience of Informal Caregivers of Patients With Brain Tumors|Completed||N/A|40|Actual|M.D. Anderson Cancer Center|||1||f||||f||||||||||2017-02-18 16:24:16.563377|2017-02-18 16:24:16.563377
NCT00352807|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2007-10-16|||February 2005||2005-02-01|October 2007|2007-10-01|December 2005||2005-12-01|||||Interventional|||Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients|Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients.|Completed||N/A|22||Indiana University|||||||||||||||||||2017-02-18 16:24:16.751768|2017-02-18 16:24:16.751768
NCT00352794|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2016-06-27|||July 2006||2006-07-01|June 2016|2016-06-01||||September 2018|Anticipated|2018-09-01||Interventional|||Lenalidomide for Patients With Myelofibrosis (MF)|Evaluation of Lenalidomide (CC-5013) and Prednisone as a Therapy for Patients With Myelofibrosis (MF)|Active, not recruiting||Phase 2|41|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:24:16.854839|2017-02-18 16:24:16.854839
NCT00352781|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2013-08-15|2012-02-15||July 2006||2006-07-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Interventional|STOP||Stop Smoking Therapy for Ontario Patients|The STOP (Stop Smoking Therapy for Ontario Patients) Study: The Effectiveness of Nicotine Replacement Therapy in Ontario Smokers PHASE II|Completed||N/A|1767|Actual|Centre for Addiction and Mental Health|Many participants could not be reached 6 and 12 months after treatment to complete the follow-up questionnaires. Data pertaining to smoker and provider satisfaction and healthcare utilization were not collected.|1|||f||||f||||||||||2017-02-18 16:24:16.968273|2017-02-18 16:24:16.968273
NCT00352768|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2010-03-03|||August 2006||2006-08-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents|SME3110 (Fluvoxamine Maleate) in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents (8 Through 18 Years of Age) -A Double-blind, Randomized, Placebo-controlled Study|Terminated||Phase 4|20|Actual|Solvay Pharmaceuticals||2||This study was prematurely terminated (26 June 2009) due to slow recruitment|f||||t||||||||||2017-02-18 16:24:17.215134|2017-02-18 16:24:17.215134
NCT00352755|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2016-10-19|2016-10-19||May 2006||2006-05-01|October 2016|2016-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis|A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis|Terminated||Phase 2|18|Actual|Washington University School of Medicine||1||"after interim analysis it was determined that the risks were too great in comparision to the~   results"|f||||||||||||||2017-02-18 16:24:17.503739|2017-02-18 16:24:17.503739
NCT00352742|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2008-10-27|||June 2006||2006-06-01|October 2008|2008-10-01|December 2008|Anticipated|2008-12-01|September 2008|Anticipated|2008-09-01||Interventional|||A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma|A Phase I/II Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma Relapsed From or Refractory to Bortezomib|Terminated||Phase 1/Phase 2|46|Anticipated|Attenuon||1|||f||||||||||||||2017-02-18 16:24:17.890488|2017-02-18 16:24:17.890488
NCT00352729|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2015-07-20|||November 2006||2006-11-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|ACell||Evaluation of ACell Hydrated Wound Dressing for Autogenous Skin Donor Sites|Evaluation of ACell Hydrated Wound Dressing for Autogenous Skin Donor Sites|Withdrawn||N/A|0|Actual|United States Army Institute of Surgical Research||1||PI decided to use another product|f||||f||||||||||2017-02-18 16:24:18.025181|2017-02-18 16:24:18.025181
NCT00352716|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2007-09-26|||June 2006||2006-06-01|September 2007|2007-09-01||||||||Interventional|||Effectiveness of Smecta in the Treatment of Acute Diarrhoea in Children|Efficacy of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and Children|Completed||Phase 3|300||Ipsen|||||f||||||||||||||2017-02-18 16:24:18.138034|2017-02-18 16:24:18.138034
NCT00352703|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-10-31|||April 2006||2006-04-01|October 2014|2014-10-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation|An Open-label, Single-arm Study of Palifermin for Reduction of Mucositis in Subjects With Non-Hodgkin's Lymphoma or Multiple Myeloma Undergoing High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell (PBSC) Transplantation|Completed||Phase 4|145|Actual|Swedish Orphan Biovitrum||1|||f||||f||||||||||2017-02-18 16:24:18.240339|2017-02-18 16:24:18.240339
NCT00352690|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2016-10-27|2015-04-13||April 2006||2006-04-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer|A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer|Terminated||Phase 2|10|Actual|Washington University School of Medicine|(3) grade 5 serious adverse events occurred and led to the study closing early for the safety of participants.|2||Safety of patients|f||||t||||||||||2017-02-18 16:24:18.348683|2017-02-18 16:24:18.348683
NCT00352677|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2009-05-29|||July 2006||2006-07-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia|A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of INNO-406 in Adult Patients With Imatinib-Resistant or Intolerant Philadelphia Chromosome-Positive (Ph+) Leukemias|Completed||Phase 1|100|Anticipated|CytRx||1|||f||||f||||||||||2017-02-18 16:24:18.954785|2017-02-18 16:24:18.954785
NCT00352664|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2016-04-05|2009-05-21||November 2003||2003-11-01|December 2009|2009-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The Effect of Donepezil on Sedation and Other Symptoms|Donepezil for Cancer Patients With Sedation Related to Opioid Treatment: A Double-blind Placebo Controlled Randomized Study|Terminated||Phase 3|27|Actual|M.D. Anderson Cancer Center|Insufficient drug supply and low patient accrual closed study early.|2||Low patient accrual|f||||f||||||||||2017-02-18 16:24:19.069075|2017-02-18 16:24:19.069075
NCT00352651|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2011-04-12|||June 2006||2006-06-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo|Placebo-Controlled Study of Pregabalin for the Pain of Acute Herpes Zoster|Terminated||Phase 2|34|Anticipated|University of California, San Francisco||||"This study should be terminated as the study has been closed for years and the investigator~   has since retired. No records are available.~    Thank you, Marlene"|f||||||||||||||2017-02-18 16:24:19.358149|2017-02-18 16:24:19.358149
NCT00352638|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-05-15|||August 2005||2005-08-01|May 2014|2014-05-01|November 2013|Actual|2013-11-01|February 2012|Actual|2012-02-01||Interventional|||Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer|Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients|Completed||Phase 3|660|Anticipated|Fox Chase Cancer Center|||||f||||f||||||||||2017-02-18 16:24:19.450223|2017-02-18 16:24:19.450223
NCT00352625|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-08-13|||June 2006||2006-06-01|August 2008|2008-08-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study of the Efficacy, Tolerability and Safety of Ketoprofen Topical Patch, 20% (KTP) in the Treatment of Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee|Completed||Phase 3|330||Endo Pharmaceuticals|||||f||||||||||||||2017-02-18 16:24:19.557885|2017-02-18 16:24:19.557885
NCT00352612|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2013-04-01|2012-04-10||September 2006||2006-09-01|April 2013|2013-04-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|||Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections|Comparison of Cephalexin Versus Clindamycin in the Empiric, Outpatient Treatment of Suspected Staphylococcal Cutaneous Infections in the Era of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA)|Completed||Phase 4|200|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:24:19.652129|2017-02-18 16:24:19.652129
NCT00352599|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2016-11-18|||September 2009||2009-09-01|November 2016|2016-11-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|NF1||Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)|Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)|Completed||Phase 1|44|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 16:24:19.990819|2017-02-18 16:24:19.990819
NCT00352586|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||April 3, 2002||2002-04-03|February 1, 2008|2008-02-01|February 1, 2008||2008-02-01|||||Observational|||Effect of D-cycloserine on Extinction of Fear Conditioning|Psychopharmacology Investigations of Fear Conditioning in Humans|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:24:20.097264|2017-02-18 16:24:20.097264
NCT00352573|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||August 15, 2002||2002-08-15|May 20, 2016|2016-05-20||||||||Observational|||Ethical Dilemmas in Clinical Practice: A Survey of European Physicians|Values at the Bedside: A Survey of European Physicians Regarding Ethical Dilemmas in Clinical Practice|Completed||N/A|3850|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:24:20.177282|2017-02-18 16:24:20.177282
NCT00352560|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2010-02-15||2010-02-15|July 2006||2006-07-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)|Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)|Completed||Phase 3|44|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 16:24:20.359649|2017-02-18 16:24:20.359649
NCT00352547|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||May 21, 2004||2004-05-21|December 2, 2013|2013-12-02|December 2, 2013||2013-12-02|||||Observational|||Influence of Genes on Sirolimus Metabolism in Patients With Kidney Transplantation|Influence of MDR-1 CYP3A4 and CYP3A5 Genotypes/Haplotypes on Sirolimus Pharmacokinetics and Pharmacodynamics in Patients With Renal Transplantation|Completed||N/A|93|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:24:20.465128|2017-02-18 16:24:20.465128
NCT00352534|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2016-05-18|||October 2006||2006-10-01|May 2016|2016-05-01|September 2015|Actual|2015-09-01|December 2014|Actual|2014-12-01||Interventional|||Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor|Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor|Completed||Phase 3|808|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 16:24:20.554276|2017-02-18 16:24:20.554276
NCT00352521|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-07-18|||April 2006||2006-04-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|December 2006|Actual|2006-12-01||Interventional|||Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma|Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Bevacizumab in Combination With Irinotecan for Malignant Gliomas|Completed||Phase 2|20|Actual|Duke University||1|||f||||t||||||||||2017-02-18 16:24:23.612938|2017-02-18 16:24:23.612938
NCT00352508|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-19|2006-07-13|||September 2004||2004-09-01|March 2006|2006-03-01|December 2004||2004-12-01|||||Interventional|||The Dietary Intervention in e-Shopping Trial|The Dietary Intervention in e-Shopping Trial|Completed||N/A|500||The George Institute|||||f||||||||||||||2017-02-18 16:24:23.723665|2017-02-18 16:24:23.723665
NCT00352495|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-02-11|||June 2006||2006-06-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|||Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma|A Phase I Study of Vinblastine in Combination With Carboplatin for Children With Newly Diagnosed and Recurrent Low-Grade Gliomas|Completed||Phase 1|26|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 16:24:23.807914|2017-02-18 16:24:23.807914
NCT00352482|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2016-07-28|||November 2004||2004-11-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension|Sildenafil Treatment in Patients With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension - a Pilot Cross-over Study|Completed||Phase 2|20|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:24:23.945351|2017-02-18 16:24:23.945351
NCT00352469|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2008-12-05|||February 2006||2006-02-01|December 2008|2008-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety|12 Week Prospective Double Blind Placebo Controlled Randomized Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety|Completed||Phase 4|20|Anticipated|Creighton University||1|||f||||t||||||||||2017-02-18 16:24:24.041854|2017-02-18 16:24:24.041854
NCT00352456|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||August 27, 2004||2004-08-27|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Psychological Mechanisms of Behavioral Dysregulation|Psychobiological Mechanisms of Behavioral Dysregulation|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:24:24.142406|2017-02-18 16:24:24.142406
NCT00352443|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2015-03-05|||September 2006||2006-09-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|August 2007|Actual|2007-08-01||Interventional|||S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|Phase I Study Evaluating the Combination of Lapatinib (GW572016; NSC-727989) and Everolimus (RAD001) in Patients With Advanced Solid Tumors|Completed||Phase 1|66|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 16:24:24.451705|2017-02-18 16:24:24.451705
NCT00352430|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||July 9, 2006||2006-07-09|December 7, 2015|2015-12-07|March 10, 2010|Actual|2010-03-10|March 10, 2010|Actual|2010-03-10||Interventional|||Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension|Cardiopulmonary Function Assessment and NO Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension|Completed||Phase 1|31|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:24:24.577604|2017-02-18 16:24:24.577604
NCT00352417|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2012-07-19|2012-06-15||July 2006||2006-07-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy|A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Effects of VIA-2291, a 5-Lipoxygenase Inhibitor, on Atherosclerotic Plaque and Biomarkers of Vascular Inflammation in Patients With Carotid Stenosis Undergoing Elective Carotid Endarterectomy|Completed||Phase 2|50|Actual|Tallikut Pharmaceuticals, Inc.|The small number, less than optimal quality, and diversity of types of plaque samples posed a significant limitation to the interpretation of the plaque data in this study.|2|||f||||t||||||||||2017-02-18 16:24:24.692851|2017-02-18 16:24:24.692851
NCT00352404|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2006-07-13|||August 2003||2003-08-01|August 2003|2003-08-01|November 2004||2004-11-01|||||Interventional|||Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia|Diagnosis of Intraepithelial Neoplasia in Patients With Long Standing Ulcerative Colitis With Chromoscopic Guided Endomicroscopy|Completed||Phase 3|114||Johannes Gutenberg University Mainz|||||f||||||||||||||2017-02-18 16:24:25.247306|2017-02-18 16:24:25.247306
NCT00352391|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2016-02-02|||August 2004||2004-08-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|January 2016|Actual|2016-01-01||Observational|||Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients|Vanguard Study Characterizing Occurrence of Recurrent or Second Primary Tumors in Patients With Prior History of Definitively Treated Stage I/II Head and Neck or Non-Small Cell Lung Cancer Who Are Current or Former Smokers|Completed||Phase 2|54|Actual|M.D. Anderson Cancer Center|||1||f||||t||||||Samples With DNA|"~     Samples of lung tissue, saliva, blood, and scrapings from inside of cheek. Fluid and mucous~     collected during bronchoscopies.~   "|||2017-02-18 16:24:25.342054|2017-02-18 16:24:25.342054
NCT00352378|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2011-06-23|||June 2002||2002-06-01|September 2007|2007-09-01|January 2006|Actual|2006-01-01|October 2005|Actual|2005-10-01||Interventional|||Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer|A Phase III Randomized Study of Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer|Completed||Phase 3|209|Actual|National Cancer Center, Korea||2|||f||||f||||||||||2017-02-18 16:24:25.446106|2017-02-18 16:24:25.446106
NCT00352365|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-07-25|2013-05-15||June 2006||2006-06-01|January 2014|2014-01-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional||Eligible patients who began protocol therapy|Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia|A Phase II Study of Lenalidomide (REVLIMID, NSC-703813) for Previously Untreated Non-M3, Deletion 5q Acute Myeloid Leukemia (AML) in Patients Age 60 or Older Who Decline Remission Induction Chemotherapy|Completed||Phase 2|41|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:24:25.558108|2017-02-18 16:24:25.558108
NCT00352352|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2006-07-13||||||July 1999|1999-07-01||||||||Interventional|||Use of Acupuncture In Children With Autistic Spectrum Disorder|Randomized Control Trial of Using Acupuncture In Children With Autistic Spectrum Disorder|Completed||Phase 3|30||The University of Hong Kong|||||f||||||||||||||2017-02-18 16:24:26.428192|2017-02-18 16:24:26.428192
NCT00352339|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2009-08-03|||August 2006||2006-08-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||The New Strategy for Pharmacological Treatment in People With Schizophrenia|Switch Risperidone to Aripiprazole in Early Stage of Pharmacotherapy of Schizophrenia|Unknown status|Recruiting|Phase 4|90|Anticipated|Inje University||3|||f||||t||||||||||2017-02-18 16:24:26.517234|2017-02-18 16:24:26.517234
NCT00352326|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2015-05-28|||January 2006||2006-01-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity|Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity|Completed||Phase 1/Phase 2|60|Anticipated|University of Southern California||1|||f||||||||||||||2017-02-18 16:24:26.638484|2017-02-18 16:24:26.638484
NCT00352313|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2012-05-01|||May 2006||2006-05-01|May 2012|2012-05-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma|A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma|Completed||Phase 1/Phase 2|82|Anticipated|National Institutes of Health Clinical Center (CC)||2|||||||||||||||||2017-02-18 16:24:26.721076|2017-02-18 16:24:26.721076
NCT00352300|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-12-29|||June 2006||2006-06-01|December 2014|2014-12-01||||July 2010|Actual|2010-07-01||Interventional|||Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer|A Phase I Trial of Dose Dense (Biweekly) Carboplatin Combined With Paclitaxel and Pegfilgrastim (Neulasta): A Feasibility Study in Patients With Untreated Stage III and IV Ovarian, Tubal or Primary Peritoneal Cancer|Completed||Phase 1|43|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 16:24:26.828596|2017-02-18 16:24:26.828596
NCT00352261|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2009-03-25|||January 2006||2006-01-01|March 2009|2009-03-01|April 2007|Actual|2007-04-01|||||Interventional|||An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients|An Open-Label, 2-Way Crossover Study of Steady-State Intragastric pH Control Comparing 2 Dosage Regimens of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients|Completed||Phase 4|80||AstraZeneca|||||f||||||||||||||2017-02-18 16:24:27.05718|2017-02-18 16:24:27.05718
NCT00352248|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2006-07-13||||||July 1999|1999-07-01||||||||Interventional|||Randomized Controlled Trial of Acupuncture Versus Sham Acupuncture in Autistic Spectrum Disorder|Randomized Controlled Trial of Acupuncture Versus Sham Acupuncture in Autistic Spectrum Disorder|Completed||Phase 3|50||The University of Hong Kong|||||f||||||||||||||2017-02-18 16:24:27.158591|2017-02-18 16:24:27.158591
NCT00352014|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2006-07-13|||January 2006||2006-01-01|July 2006|2006-07-01|May 2008||2008-05-01|||||Observational|||Evaluation and Comparison of Several Point-of-Care Platelet Function Tests in Predicting Clinical Outcomes in Clopidogrel Pre-Treated Patients Undergoing Elective PCI.|Do Point-of-Care Platelet Function Assays Predict Clinical Outcomes in Clopidogrel Pre-Treated Patients Undergoing Elective PCI. (The POPular Study)|Unknown status|Recruiting|N/A|1000||R&D Cardiologie|||||f||||||||||||||2017-02-18 16:24:27.258237|2017-02-18 16:24:27.258237
NCT00352001|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2013-02-13|||May 2006||2006-05-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes|A Phase I/II Study of Revlimid (Lenalidomide) in Combination With Vidaza (Azacitidine) in Patients With Advanced Myelodysplastic Syndrome (MDS)|Completed||Phase 1/Phase 2|36|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:24:27.3472|2017-02-18 16:24:27.3472
NCT00351988|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2016-08-24|||January 2006||2006-01-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Observational|||Effects of Cancer Symptoms on Caregivers|Effects of Cancer Symptoms on Minority Caregivers|Recruiting||N/A|250|Anticipated|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-02-18 16:24:27.468959|2017-02-18 16:24:27.468959
NCT00351975|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2014-12-22|||June 2006||2006-06-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases|A Phase I Study of PXD101 in Combination With Azacitidine (5-Aza) for Advanced Hematologic Malignancies|Completed||Phase 1|56|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:24:27.606075|2017-02-18 16:24:27.606075
NCT00351962|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2012-01-18|||September 2006||2006-09-01|January 2012|2012-01-01||||||||Interventional|||Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours|Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours|Unknown status|Recruiting|Phase 1/Phase 2|58|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 16:24:27.729798|2017-02-18 16:24:27.729798
NCT00351949|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2010-01-06|||September 2005||2005-09-01|January 2010|2010-01-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)|IMP321 Phase 1 Study in Advanced or Metastatic Renal Cell Carcinoma Patients (P003)|Completed||Phase 1|24|Actual|Immutep S.A.||1|||f||||||||||||||2017-02-18 16:24:27.826895|2017-02-18 16:24:27.826895
NCT00351936|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2013-01-30|2012-12-20||December 2005||2005-12-01|January 2013|2013-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Placebo-Controlled, Cross-Over Trial of Aripiprazole|A Placebo-Controlled, Cross-Over Trial of Aripiprazole Added to Obese Olanzapine-Treated Patients With Schizophrenia|Completed||Phase 4|16|Actual|North Suffolk Mental Health Association|The small sample size and the short duration of active treatment and washout period may have prevented detection of other metabolic benefits, including possible reductions in fasting insulin and insulin resistance (measured by HOMA-IR).|2|||f||||f||||||||||2017-02-18 16:24:27.940705|2017-02-18 16:24:27.940705
NCT00351923|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2008-10-09|||March 2006||2006-03-01|October 2008|2008-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes|Open, Multicenter, Randomised, Controlled Phase IIIb Study Evaluating the Immunogenicity and Safety of Subcutaneous Versus Alternative Administration Route of Combined MeMuRu-OKA Vaccine to Healthy Children Aged 11 to 21 Months.|Completed||Phase 3|330||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:24:28.322314|2017-02-18 16:24:28.322314
NCT00351910|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2011-01-25|||May 2006||2006-05-01|January 2011|2011-01-01|April 2007|Actual|2007-04-01|||||Interventional|ONYX||Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder|A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) in Combination With an Antidepressant in the Treatment of Patients With Major Depressive Disorder With Inadequate Response to an Antidepressant Treatment|Completed||Phase 3|494|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:24:28.429442|2017-02-18 16:24:28.429442
NCT00351897|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2008-02-19|||April 2006||2006-04-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||The Efficacy of Pulsed Dye Laser in Dermatophytosis|The Efficacy of Pulsed Dye Laser in Dermatophytosis|Completed||Phase 1|10|Actual|Shahid Beheshti University of Medical Sciences|||||f||||||||||||||2017-02-18 16:24:28.834505|2017-02-18 16:24:28.834505
NCT00351884|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2016-11-16|||May 2006||2006-05-01|November 2016|2016-11-01||||November 2007|Actual|2007-11-01||Interventional|||Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes|A Multicenter, Double-blind, Randomized, Parallel-Group Study to Compare the Effect of 24 Weeks Treatment With Vildagliptin 100 MG QD to Placebo as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy|Completed||Phase 3|370|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:24:28.93362|2017-02-18 16:24:28.93362
NCT00351871|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2009-02-03|||April 2002||2002-04-01|February 2009|2009-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy|Influence of Marker of Insulin Resistance Upon HCV Treatment Responses to PEG Intron and Rebetol Therapy|Completed||Phase 4|400|Actual|Louisiana State University Health Sciences Center in New Orleans||1|||f||||||||||||||2017-02-18 16:24:29.045536|2017-02-18 16:24:29.045536
NCT00351442|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2014-04-08|||February 2007||2007-02-01|April 2014|2014-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Examining Factors That May Influence Resistance to HIV-1 Infection|Prospective Study of the Determinants of Host Resistance to HIV-1 Infection|Completed||N/A|522|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||||||||||||2017-02-18 16:24:34.195037|2017-02-18 16:24:34.195037
NCT00351858|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2015-04-30|||July 2006||2006-07-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|||||Interventional|IV REXBC 02||Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer|Phase II Study of the Trifunctional Anti-HER-2/Neu x Anti-CD3 Antibody Ertumaxomab for Hormone Therapy Refractory Patients With Her-2/Neu 1+ or 2+ Expressing Advanced or Metastatic Breast Cancer|Terminated||Phase 2|40|Anticipated|Neovii Biotech||||company focus on other projects|f||||||||||||||2017-02-18 16:24:29.13568|2017-02-18 16:24:29.13568
NCT00351845|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2009-04-21|||April 2004||2004-04-01|April 2009|2009-04-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Clinical Study to Test the Effects of a Low-Carbohydrate Diet on Body Weight|A Clinical Study to Evaluate the Effect of a Modified Carbohydrate Diet on Body Weight in Overweight or Obese Men and Women|Completed||N/A|86|Actual|Provident Clinical Research||1|||f||||f||||||||||2017-02-18 16:24:29.243541|2017-02-18 16:24:29.243541
NCT00351832|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2007-05-07|||June 2006||2006-06-01|May 2007|2007-05-01||||||||Interventional|||A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes|A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 12 Weeks Treatment With Vildagliptin (50mg qd, 50mg Bid, 100mg qd) to Placebo in Patients With Type 2 Diabetes|Completed||Phase 3|236||Novartis|||||f||||||||||||||2017-02-18 16:24:29.318735|2017-02-18 16:24:29.318735
NCT00351819|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2014-07-18|||April 2006||2006-04-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|TAP||Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception|Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception in Men With Chronic Pain Syndrome|Completed||N/A|84|Actual|Boston University||2|||f||||f||||||||||2017-02-18 16:24:29.405099|2017-02-18 16:24:29.405099
NCT00351806|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2013-08-05|||July 2005||2005-07-01|August 2013|2013-08-01|November 2006||2006-11-01|||||Interventional|||AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine|AISTCM-The Pathological Pattern Differentiation and Outcome Measurement of Acute Ischemic Stroke Treated With Traditional Chinese Medicine|Completed||Phase 4|500||Guangzhou University of Traditional Chinese Medicine||2|||f||||||||||||||2017-02-18 16:24:29.508073|2017-02-18 16:24:29.508073
NCT00351793|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2017-01-30|||January 2003||2003-01-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement|A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement|Active, not recruiting||N/A|186|Actual|Nova Scotia Health Authority|||2||f||||f||||||||||2017-02-18 16:24:29.631537|2017-02-18 16:24:29.631537
NCT00351780|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2011-07-15|||June 2004||2004-06-01|July 2011|2011-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Fractional Flow Reserve-guided Provisional Side Branch Intervention|Physiologic Evaluation of the Provisional Side Branch Intervention Strategy for Bifurcation Lesions Using Fractional Flow Reserve|Completed||Phase 4|100|Anticipated|Seoul National University Hospital||1|||f||||||||||||||2017-02-18 16:24:29.732098|2017-02-18 16:24:29.732098
NCT00351767|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2013-01-16||2013-01-16|January 2006||2006-01-01|January 2013|2013-01-01||||January 2008|Actual|2008-01-01||Interventional|||A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers|A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Diabetic Foot Ulcers|Completed||Phase 2|170|Actual|Genentech, Inc.||4|||f||||||||||||||2017-02-18 16:24:29.829057|2017-02-18 16:24:29.829057
NCT00351754|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-01-03|||July 2006||2006-07-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|||||Interventional|||Detection of Pulmonary Embolism With CECT|Detection of Pulmonary Embolism Comparing Isovue-370 and Visipaque 320 Using 64-Slice Multi-Detector Computed Tomographic Angiography|Completed||Phase 4|120||Bracco Diagnostics, Inc|||||f||||f||||||||||2017-02-18 16:24:29.940319|2017-02-18 16:24:29.940319
NCT00351741|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2015-09-08|2010-07-16||July 2006||2006-07-01|September 2015|2015-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||BEST (Burn Center Evaluation of Standard Therapies) Ventilator Mode Study-|BEST (Burn Center Evaluation of Standard Therapies) Ventilator Mode Study: A Prospective Randomized Controlled Trial|Terminated||N/A|62|Actual|United States Army Institute of Surgical Research|After 3 yrs of enrollment, interim analysis revealed a significant number of subjects in the Conventional arm required rescue, which served as the trigger to close the study to further enrollment.|2|||f||||f||||||||||2017-02-18 16:24:30.022745|2017-02-18 16:24:30.022745
NCT00351728|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2016-07-05|||June 2006||2006-06-01|July 2016|2016-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone||Completed||N/A|174|Actual|Jonsson Comprehensive Cancer Center|||1||f||||||||||||||2017-02-18 16:24:30.56093|2017-02-18 16:24:30.56093
NCT00351715|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2013-01-24|||July 2008||2008-07-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients|Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients: a Phase II Multicenter, Open Label, Feasibility Study|Terminated||Phase 2|60|Anticipated|AHS Cancer Control Alberta||||Study stopped due to low accrual|f||||||||||||||2017-02-18 16:24:30.645837|2017-02-18 16:24:30.645837
NCT00351702|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2016-06-06|||February 2001||2001-02-01|June 2016|2016-06-01|June 2011|Actual|2011-06-01|September 2008|Actual|2008-09-01||Interventional|||Preventive Therapy for Tuberculosis in HIV Infected Persons|Evaluation of Two Different Preventive Therapy Regimens for Tuberculosis in HIV Infected Persons|Completed||Phase 3|650|Actual|Tuberculosis Research Centre, India||1|||f||||f||||||||||2017-02-18 16:24:30.741057|2017-02-18 16:24:30.741057
NCT00351689|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2012-10-02|||January 2004||2004-01-01|October 2012|2012-10-01|July 2004||2004-07-01|||||Interventional|||Placebo-controlled Assessment of the Effect of a Food Supplement on Skin Protection After Exposure to UV Radiation|Placebo-controlled Assessment of the Effect of a Food Supplement on Skin Protection After Exposure to UV Radiation|Completed||Phase 1|50||L'Oreal|||||f||||t||||||||||2017-02-18 16:24:30.863333|2017-02-18 16:24:30.863333
NCT00351676|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2007-12-07|||February 2006||2006-02-01|February 2006|2006-02-01|July 2007|Actual|2007-07-01|||||Interventional|||Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment|Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment (COLLABORATE)|Completed||Phase 4|452|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 16:24:30.957056|2017-02-18 16:24:30.957056
NCT00351663|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2016-04-19|||February 2007||2007-02-01|April 2016|2016-04-01|September 2015|Actual|2015-09-01|April 2014|Actual|2014-04-01||Interventional|||The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients|Prospective Randomised Study of the Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients|Completed||Phase 4|39|Actual|Shaare Zedek Medical Center||3|||f||||f||||||||||2017-02-18 16:24:31.070527|2017-02-18 16:24:31.070527
NCT00351650|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2017-01-24|||July 9, 2006||2006-07-09|February 6, 2008|2008-02-06|February 6, 2008||2008-02-06|||||Observational|||Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan|Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:24:31.190774|2017-02-18 16:24:31.190774
NCT00351637|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2012-01-18|||December 2006||2006-12-01|January 2012|2012-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients|Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients: a Phase II Multicenter, Open Label, Feasibility Study|Terminated||Phase 2|60|Anticipated|AHS Cancer Control Alberta||1||Study suspended due to low accrual|f||||||||||||||2017-02-18 16:24:31.281037|2017-02-18 16:24:31.281037
NCT00351624|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2014-05-16|||May 2006||2006-05-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in Preschool Children|Completed||Phase 3|216|Actual|DSM Nutritional Products, Inc.||2|||f||||||||||||||2017-02-18 16:24:31.378112|2017-02-18 16:24:31.378112
NCT00351611|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2017-01-25|||July 2006||2006-07-01|January 2017|2017-01-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Interventional|||Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo|Prospective Randomized 12-week Controlled Study Of Visual Field Change In Subjects With Partial Seizures Receiving Pregabalin Or Placebo|Recruiting||Phase 4|284|Anticipated|Pfizer||2|||f||||f||||||||||2017-02-18 16:24:31.49908|2017-02-18 16:24:31.49908
NCT00351598|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2014-07-31|||September 1999||1999-09-01|July 2014|2014-07-01|November 2012|Actual|2012-11-01|February 2009|Actual|2009-02-01||Observational|||Lung Tumour Volume Database|Tumour Volume as an Independent Prognostic Factor in Patients With Non-Small Cell Lung Cancer - A Protocol for a Prospective Database.|Completed||N/A|531|Actual|Trans-Tasman Radiation Oncology Group (TROG)|||1||f||||f||||||||||2017-02-18 16:24:32.030257|2017-02-18 16:24:32.030257
NCT00351585|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2012-05-04|||July 2004||2004-07-01|May 2012|2012-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes|A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Effects of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|39|Actual|Novartis|||||f||||||||||||||2017-02-18 16:24:32.163035|2017-02-18 16:24:32.163035
NCT00351572|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2011-04-15|||July 2006||2006-07-01|April 2011|2011-04-01||||||||Observational|||Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients|Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients|Completed||N/A|30|Anticipated|AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 16:24:32.24817|2017-02-18 16:24:32.24817
NCT00351559|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2009-11-18|||January 2005||2005-01-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|||||Interventional|||IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection|Invasive Monitoring Attenuation Through Gene Expression (IMAGE) Trial|Completed||N/A|629|Actual|XDx|||||f||||||||||||||2017-02-18 16:24:32.329015|2017-02-18 16:24:32.329015
NCT00351546|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2012-05-04|||February 2005||2005-02-01|May 2012|2012-05-01|December 2005|Actual|2005-12-01|November 2005|Actual|2005-11-01||Interventional|||A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes|A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes|Completed||Phase 3|12|Actual|Novartis|||||f||||||||||||||2017-02-18 16:24:32.45241|2017-02-18 16:24:32.45241
NCT00351533|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2011-08-26|2011-02-16||July 2006||2006-07-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Interventional|||A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)|A Randomized, Double-blind Study of the Effect of Fish Oil (Eicosapentaenoic Acid and Docosahexanoic Acid) on Lung and Systemic Inflammation in Patients With Acute Lung Injury (ALI)|Completed||Phase 2|90|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:24:32.552688|2017-02-18 16:24:32.552688
NCT00351520|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2011-09-19|||May 2006||2006-05-01|September 2011|2011-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica|Phase 3, Clinical Trials of Drug Against Cutaneous Leishmaniasis|Completed||Phase 3|148|Actual|Tehran University of Medical Sciences||1|||f||||||||||||||2017-02-18 16:24:33.500001|2017-02-18 16:24:33.500001
NCT00351507|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2012-05-04|||May 2005||2005-05-01|May 2012|2012-05-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes|A Double-blind, Crossover, Placebo-Controlled, Multiple-dose Study to Evaluate the Effects of Vildagliptin on Gastric Emptying, Gastric Volume and Satiety in Patients With Type 2 Diabetes|Completed||Phase 3|10|Actual|Novartis|||||f||||||||||||||2017-02-18 16:24:33.59811|2017-02-18 16:24:33.59811
NCT00351494|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2007-11-21|||July 2006||2006-07-01|November 2007|2007-11-01|June 2009|Anticipated|2009-06-01|||||Observational|||Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization|Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Tours|||1||f||||f||||||||||2017-02-18 16:24:33.69428|2017-02-18 16:24:33.69428
NCT00351481|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2008-05-28|||July 2006||2006-07-01|April 2007|2007-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Failure of Implantation After Recurrent Embryo Transfers|Recurrent Embryo Implantation Failure in Women Undergoing IVF/ ICSI; an Investigation of the Intra-Uterine Environment During the Window of Implantation|Completed||N/A|80|Anticipated|UMC Utrecht|||||f||||||||||||||2017-02-18 16:24:33.798945|2017-02-18 16:24:33.798945
NCT00351468|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2016-03-22|||June 2006||2006-06-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|EXTEND||EXTEND (Eltrombopag Extended Dosing Study)|EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.|Completed||Phase 3|302|Actual|Novartis||1|||f||||f||||||||||2017-02-18 16:24:33.892168|2017-02-18 16:24:33.892168
NCT00351416|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2013-11-05|||July 2004||2004-07-01|November 2013|2013-11-01|December 2018|Anticipated|2018-12-01|December 2011|Actual|2011-12-01||Interventional|||Letrozole Treatment in Normal and GnRH Deficient Women|Letrozole Treatment in Normal and GnRH Deficient Women|Active, not recruiting||Phase 2/Phase 3|70|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-02-18 16:24:34.408731|2017-02-18 16:24:34.408731
NCT00351403|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2010-02-05|||July 2006||2006-07-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection|Individually Adapted Therapy Duration From 24 to 72 Weeks for the Treatment of a Chronic Hepatitis C Genotype 1 Infection With Peginterferon Alfa-2b Plus Ribavirin in Dependence of the Initial Concentration and the Decline of the HCV RNA|Completed||Phase 4|390|Anticipated|FGK Clinical Research GmbH||2|||f||||f||||||||||2017-02-18 16:24:34.52065|2017-02-18 16:24:34.52065
NCT00351390|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2015-04-26|||September 2005||2005-09-01|April 2015|2015-04-01|December 2017|Anticipated|2017-12-01|June 2009|Actual|2009-06-01||Interventional|PROTECT||Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting.|The Use of Pro-Brain Natriuretic Peptide Targeted Therapy to Tailor Medical Management of Patients With Congestive Heart Failure Followed in an Outpatient Setting: the ProBNP Outpatient Tailored CHF Therapy (PROTECT) Study|Active, not recruiting||Phase 3|300|Anticipated|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 16:24:34.64843|2017-02-18 16:24:34.64843
NCT00351377|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2011-04-19|2010-12-14||June 2006||2006-06-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate|Measurement and Analysis of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate (MPA)|Completed||Phase 3|111|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:24:34.749854|2017-02-18 16:24:34.749854
NCT00351364|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2014-12-01|||July 2006||2006-07-01|December 2014|2014-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease|The Effect of Leukotriene Receptor Blockade on Endothelial Function in Acute Coronary Syndrome Patients|Terminated||Phase 4|40|Actual|University of Calgary||2||Diffic;ulty recruiting|f||||t||||||||||2017-02-18 16:24:35.353812|2017-02-18 16:24:35.353812
NCT00351351|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2013-02-22|2012-12-04||July 2006||2006-07-01|February 2013|2013-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Trial Comparing Dual Probe Ultrasonic Lithotripsy to a Single Probe Ultrasonic Lithotripsy|Randomized Control Trial Comparing Dual Probe Ultrasonic Lithotripsy to a Single Probe Ultrasonic Lithotripsy|Completed||N/A|70|Actual|Indiana Kidney Stone Institute|Multiple surgeons were involved,thus subtle differences in PCNL technique existed between sites. Some surgeons may have defined the stone removal time differently.|2|||f||||f||||||||||2017-02-18 16:24:35.477207|2017-02-18 16:24:35.477207
NCT00351338|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2007-04-10|||July 2006||2006-07-01|July 2006|2006-07-01||||||||Observational|||Nutritional Deficiencies in the Bariatric Patients|Preoperative Nutritional Deficiencies in the Bariatric Surgery Patients|Unknown status|Recruiting|N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:24:35.93624|2017-02-18 16:24:35.93624
NCT00351325|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2009-09-03|||September 2007||2007-09-01|September 2009|2009-09-01|March 2009|Anticipated|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies|A Phase I, Multiple Ascending Dose Study of BMS-663513, an Agonistic Anti-CD137 Monoclonal Antibody, Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies|Terminated||Phase 1|45|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:24:36.01544|2017-02-18 16:24:36.01544
NCT00351312|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2006-07-11|||June 2006||2006-06-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Creation of a Pressure Reducing Areas in Socks|Evaluation of Foot Pressure in Volunteers Wearing Socks Weaved With Pressure Reducing Soles|Unknown status|Active, not recruiting|N/A|4||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:24:36.136238|2017-02-18 16:24:36.136238
NCT00351299|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2010-05-03|||January 2006||2006-01-01|May 2010|2010-05-01|September 2011|Anticipated|2011-09-01|February 2011|Anticipated|2011-02-01||Interventional|||Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium|Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium|Unknown status|Active, not recruiting|Phase 2|130|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 16:24:36.238321|2017-02-18 16:24:36.238321
NCT00351286|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2006-10-17|||March 2006||2006-03-01|July 2006|2006-07-01||||||||Interventional|||Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease|Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral L-Citrulline Compared to Placebo in Patients Taking Background Simvastatin 40 mg qD and With Peripheral Arterial Disease Including Intermittent Claudication|Unknown status|Active, not recruiting|Phase 2|160||Angiogenix|||||f||||||||||||||2017-02-18 16:24:36.350416|2017-02-18 16:24:36.350416
NCT00351273|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2016-08-10|2009-08-05||May 2006||2006-05-01|June 2016|2016-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria|Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis|Completed||Phase 3|42|Actual|University of South Florida||3|||f||||f||||||||Yes||2017-02-18 16:24:36.464062|2017-02-18 16:24:36.464062
NCT00351260|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2008-04-15|||January 2005||2005-01-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|BBC ONE||BBC ONE - British Bifurcation Coronary Study|British Bifurcation Coronary Study - Old, New and Evolving Strategies.|Completed||Phase 3|500|Actual|Royal Sussex County Hospital|||||f||||t||||||||||2017-02-18 16:24:37.001003|2017-02-18 16:24:37.001003
NCT00351247|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2006-07-11|||July 2006||2006-07-01|July 2006|2006-07-01|May 2007||2007-05-01|||||Interventional|||Postconditioning in Primary PCI and Direct Stenting|Clinical and MRI Evaluation of 2 Vs 4 Cycles of Postconditioning During Primary PCI With Direct Stenting|Unknown status|Not yet recruiting|N/A|45||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:24:37.09882|2017-02-18 16:24:37.09882
NCT00351234|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2012-02-24|||October 2004||2004-10-01|February 2012|2012-02-01|April 2007|Actual|2007-04-01|||||Observational|||Carnitine Levels and Carnitine Supplementation in Type I Diabetes|Correlation Between Carnitine Deficiency and Hypoglycemic Events in Type I Diabetes; Effects of Carnitine Supplementation on Hypoglycemic Events in Type I Diabetes|Completed||N/A|200|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-02-18 16:24:37.20084|2017-02-18 16:24:37.20084
NCT00351221|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2007-03-29||||||February 2007|2007-02-01||||||||Interventional|||Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome|A Phase 2, Open-Label, Multicenter, Clinical Trial to Evaluate the Pharmacokinetics, Safety and Efficacy of Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 in Children With Growth Failure Due to Noonan Syndrome|Terminated||Phase 2|24||Insmed Incorporated||||Terminated due to a patent legal settlement|||||||||||||||2017-02-18 16:24:37.310771|2017-02-18 16:24:37.310771
NCT00351208|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2006-07-11|||May 2006||2006-05-01|June 2006|2006-06-01|August 2006||2006-08-01|||||Interventional|||Spinal Cord Stimulation Efficacy Measures|The Efficacy of Spinal Cord Stimulation at Varying Stimulation Frequencies and Pulse-Widths|Unknown status|Recruiting|Phase 1|20||New York Neurosurgery & Neuroscience Associates, PLLC|||||f||||||||||||||2017-02-18 16:24:37.398131|2017-02-18 16:24:37.398131
NCT00351195|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2008-08-25|||February 2006||2006-02-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)|A Phase II Study of Etoposide, Oxaliplatin and Capecitabine in Patients With Advanced HCC|Terminated||Phase 2|39|Anticipated|Rigshospitalet, Denmark||||Did not meet the criteria for continuation to second stage|f||||||||||||||2017-02-18 16:24:37.490918|2017-02-18 16:24:37.490918
NCT00351182|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2006-07-11|||September 2005||2005-09-01|June 2006|2006-06-01||||||||Interventional|||Controlled Trial: 5-Day Course of Telithromycin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus|Phase 3 Study of Controlled Trial: 5-Day Course of Telithromycin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus|Unknown status|Recruiting|Phase 3|||Chosun University Hospital|||||f||||||||||||||2017-02-18 16:24:37.584046|2017-02-18 16:24:37.584046
NCT00351169|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2008-12-18|||May 2006||2006-05-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|AMBER||Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder|A Multi-Centre, Double-Blind, Randomised, Parallel Group, Placebo- Controlled and Active Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) as Mono- Therapy in the Treatment of Adult Patients With Major Depressive Disorder|Completed||Phase 3|450|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:24:37.679874|2017-02-18 16:24:37.679874
NCT00351156|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2010-08-17||2010-08-17|July 2006||2006-07-01|August 2010|2010-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease|A Multicenter Study to Evaluate and Characterize the Ex Vivo Effect of Pharmacological Chaperone Therapy in Blood Cell Lines Derived From Patients With Gaucher Disease|Completed||N/A|50||Amicus Therapeutics|||1||f||||||||||Samples With DNA|"~     Blood~   "|||2017-02-18 16:24:37.803905|2017-02-18 16:24:37.803905
NCT00351143|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2011-11-10|||July 2005||2005-07-01|November 2011|2011-11-01||||||||Interventional|||A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control|A Randomized, Open Label Comparative Study to Determine the Proportion of Asthma Patients on SERETIDE Diskus 50/250 Mcg b.i.d. Achieving Total Control When Given Medication and Compliance Enhancement Training Compared to Those Receiving Medication Only.|Completed||Phase 4|550||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:24:37.900307|2017-02-18 16:24:37.900307
NCT00351130|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2011-11-07|||June 2006||2006-06-01|November 2011|2011-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy|An 8 Week Extension to a Randomized, Double-blind, Parallel Group, Active-controlled, Multi-center, 14 Week Study to Evaluate the Effectiveness of a Valsartan Versus and Amlodipine Treatment Strategy in Achieving Blood Pressure Control in Patients With Stage 1 or Stage 2 Hypertension or Uncontrolled on Present Monotherapy|Completed||Phase 4|79|Actual|Novartis|||||f||||||||||||||2017-02-18 16:24:38.093518|2017-02-18 16:24:38.093518
NCT00351117|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2009-07-10|||March 2007||2007-03-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||St. John's Wort in the Treatment of Raynaud's Phenomenon|A Randomized, Placebo-controlled Trial of St.John's Wort(a Natural Health Product) in the Treatment on Raynaud's Phenomenon|Completed||Phase 3|20|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 16:24:38.185809|2017-02-18 16:24:38.185809
NCT00351104|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-08-13|||June 2006||2006-06-01|August 2008|2008-08-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase III Study of the Efficacy, Tolerability and Safety of Ketoprofen Topical Patch, 20% (KTP) in the Treatment of Pain Associated With Grade 1 or Grade 2 Ankle Sprain or Strain|Completed||Phase 3|200|Actual|Endo Pharmaceuticals||2|||f||||||||||||||2017-02-18 16:24:38.304354|2017-02-18 16:24:38.304354
NCT00351091|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2012-02-15|||November 2002||2002-11-01|February 2012|2012-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Risedronate in Postmenopausal Women With Low Bone Density|a Six Month, Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group Study to Estimate the Pharmacodynamic Response of Two Risedronate Regimens Compared With 5mg Daily : 150mg Monthly Dose for Six Months and 15mg Daily for Thirty Days Followed by 150mg Monthly Dose for 5 Months in Postmenopausal Women With Low Bone Density.|Completed||Phase 2|150|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:24:38.398703|2017-02-18 16:24:38.398703
NCT00351078|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2007-10-16|||December 2006||2006-12-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||PTC124 for the Treatment of Cystic Fibrosis|A Phase 2b Extension Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis|Completed||Phase 2|23|Anticipated|PTC Therapeutics|||||f||||||||||||||2017-02-18 16:24:38.476012|2017-02-18 16:24:38.476012
NCT00351065|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2006-07-11|||September 2004||2004-09-01|July 2006|2006-07-01|March 2005||2005-03-01|||||Interventional|||Phase II Trial of SK3530 in Erectile Dysfunction|an 8week, Multi-Center, Randomized, Double Blind, Placebo-Controlled,Parallel Group, Fixed Dose, Dose-Finding Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction.|Terminated||Phase 2|120||SK Chemicals Co.,Ltd.|||||f||||||||||||||2017-02-18 16:24:38.574565|2017-02-18 16:24:38.574565
NCT00351052|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2008-01-15|||December 2001||2001-12-01|January 2008|2008-01-01|September 2004|Actual|2004-09-01|||||Interventional|||Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis|A 24-Week, Randomized, Multicenter, Parallel-Group, Double-Blind, Vehicle-Controlled Study on Pimecrolimus Cream 1% Assessing the Steroid-Sparing Effect in the Long Term Management of Pediatric Patients With Severe Atopic Dermatitis|Completed||Phase 3|184|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:24:38.654765|2017-02-18 16:24:38.654765
NCT00351039|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2010-08-09|2009-10-09||July 2006||2006-07-01|August 2010|2010-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer|Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in the First-Line Treatment of Elderly Patients With Advanced (Stage IIIB(With Malignant Pleural Effusion) or IV) Non-Squamous Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1/Phase 2|8|Actual|H. Lee Moffitt Cancer Center and Research Institute|This study was closed early due to poor accrual. The recommended Phase II dose was determined after the brief Phase I run-in, but the Phase II component of this study was never initiated.|1||slow accrual|f||||t||||||||||2017-02-18 16:24:38.768546|2017-02-18 16:24:38.768546
NCT00351026|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2016-09-06|||June 2008||2008-06-01|September 2016|2016-09-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Methadone Maintenance & HIV Risk in Ukraine|Methadone Maintenance & HIV Risk in Ukraine|Completed||Phase 3|50|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 16:24:41.795401|2017-02-18 16:24:41.795401
NCT00351013|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2009-02-03|||June 2006||2006-06-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||The Use of Homeopathic-Based Treatment Approaches to Reduce the Prevalence of Malaria in Depressed Communities|A Pilot Study of the Use of Homeopathic-Based Treatment Approaches to Reduce the Prevalence of Malaria in Depressed Communities|Completed||Phase 4|731|Actual|Malamed||1|||f||||t||||||||||2017-02-18 16:24:41.896165|2017-02-18 16:24:41.896165
NCT00351000|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2016-11-16|2012-12-20||January 2005||2005-01-01|November 2016|2016-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus|An Open Label Trial of Ziprasidone as an Adjuvant for Clozapine- or Olanzapine-Associated Diabetes Mellitus or Impaired Fasting Glucose in Chronic Schizophrenia|Completed||Phase 4|24|Actual|North Suffolk Mental Health Association|The sample size in this study may not have been adequate to demonstrate the effectiveness of ziprasidone as an adjuvant therapy. The receptor-binding profile of ziprasidone may not significantly counteract the mechanisms of metabolic disturbances.|1|||f||||||||||||||2017-02-18 16:24:42.010448|2017-02-18 16:24:42.010448
NCT00350987|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-11|2008-09-22|||October 2006||2006-10-01|September 2008|2008-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||"Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The ProHOSP Study"|"Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The ProHOSP Study"|Completed||N/A|1002|Actual|University Hospital, Basel, Switzerland||2|||f||||||||||||||2017-02-18 16:24:42.265555|2017-02-18 16:24:42.265555
NCT00350974|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2006-12-01|||July 2006||2006-07-01|December 2006|2006-12-01|June 2007||2007-06-01|||||Observational|||ADMA Levels in End-Stage Renal Disease|Determination of Asymmetrical Dimethylarginine (ADMA) Accumulation in End Stage Renal Disease|Unknown status|Recruiting|N/A|63||University of Michigan|||||f||||||||||||||2017-02-18 16:24:42.370047|2017-02-18 16:24:42.370047
NCT00350961|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2008-08-25|||June 2004||2004-06-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|||||Interventional|||Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma|Phase I-II Study of bi-Weekly Fixed Dose Rate Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma|Completed||Phase 1/Phase 2|39|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:24:42.453127|2017-02-18 16:24:42.453127
NCT00350948|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2013-11-26|||May 2006||2006-05-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ASSIST-5||Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer|Phase 3 Randomized Study of TLK286 (Telcyta®) in Combination With Liposomal Doxorubicin (Doxil/Caelyx)Versus Liposomal Doxorubicin (Doxil/Caelyx) as Second-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer (ASSIST-5)|Terminated||Phase 3|244|Actual|Telik||2||Business reasons|f||||t||||||||||2017-02-18 16:24:42.550519|2017-02-18 16:24:42.550519
NCT00350935|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2010-06-25|||September 2006||2006-09-01|June 2010|2010-06-01|April 2009|Actual|2009-04-01|||||Observational|||Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study|Attention and Grouping of Visual Information: What is Disturbed in Patients With Schizophrenia?|Completed||N/A|52|Anticipated|University Hospital, Strasbourg, France|||2||f||||||||||||||2017-02-18 16:24:42.968495|2017-02-18 16:24:42.968495
NCT00350922|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-08|2006-07-08|||September 2003||2003-09-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina|A Psychoeducation Trial for People With Chronic Stable Angina|Unknown status|Active, not recruiting|Phase 1|130||University of Toronto|||||f||||||||||||||2017-02-18 16:24:43.061444|2017-02-18 16:24:43.061444
NCT00350909|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2008-10-16|||September 2005||2005-09-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Brief Intervention for Drug Abusing Adolescents|Brief Intervention for Drug Abusing Students|Completed||Phase 2|160|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 16:24:43.137631|2017-02-18 16:24:43.137631
NCT00350896|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2006-07-10|||December 2003||2003-12-01|January 2006|2006-01-01|December 2005||2005-12-01|||||Interventional|||Safety Study of Thumb Orthoses in Osteoarthritis in the Base of the Thumb (BTOA)|Comparative Study of the Efficacy of Thumb Orthoses in the Base of the Thumb (BTOA)|Completed||N/A|120||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:24:43.239775|2017-02-18 16:24:43.239775
NCT00350883|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2012-05-02|||July 2006||2006-07-01|May 2012|2012-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Cognitive Therapy for Negative Symptoms and Functioning|Cognitive Therapy for Negative Symptoms and Functioning|Completed||Phase 2|61|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 16:24:43.317103|2017-02-18 16:24:43.317103
NCT00350870|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2014-11-26|2014-11-12||April 2005||2005-04-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||CBT With Disulfiram and Contingency Management|Maximizing the Efficacy of Cognitive Behavioral Therapy With Medication and Contingency Management|Completed||Phase 1|181|Actual|Yale University||4|||f||||t||||||||||2017-02-18 16:24:43.444403|2017-02-18 16:24:43.444403
NCT00350857|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2014-02-19|||July 2006||2006-07-01|November 2009|2009-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Young Adult and Pediatric Bipolar Study|A Phase IV, Multi-Center, Open-Label, Safety and Effectiveness Study of Extended-Release Carbamazepine in the Treatment of Mania in Children and Adolescents Aged 10-17 Years With Acute Manic or Mixed Bipolar I Disorder.|Completed||Phase 4|161|Actual|Validus Pharmaceuticals||1|||f||||||||||||||2017-02-18 16:24:44.050998|2017-02-18 16:24:44.050998
NCT00350844|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2013-03-28|2013-02-18||July 2006||2006-07-01|March 2013|2013-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension|A Pilot Study of Hydroxyurea for the Treatment of Pulmonary Hypertension in Children and Young Adults With Sickle Cell Disease|Terminated||Phase 1/Phase 2|6|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|Early termination leading to no data analysis completed.|1||Low subject accrual|f||||f||||||||||2017-02-18 16:24:44.161372|2017-02-18 16:24:44.161372
NCT00350831|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2008-08-14|||July 2006||2006-07-01|August 2008|2008-08-01||||||||Interventional|||Study of XL820 Given Orally Daily to Subjects With Solid Tumors|A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the KIT Inhibitor XL820 Administered Orally Daily to Subjects With Solid Tumors|Completed||Phase 1|30|Anticipated|Exelixis|||||||||||||||||||2017-02-18 16:24:44.371765|2017-02-18 16:24:44.371765
NCT00350818|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2012-07-27|||October 2005||2005-10-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)|Azacitidine Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for AML and MDS|Completed||Phase 1|90|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:24:44.44861|2017-02-18 16:24:44.44861
NCT00350805|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2016-09-15|||September 2005||2005-09-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Measuring Time Windows in Patients With Schizophrenia and Healthy Controls|Relating the 'Experienced Present' With the Mechanisms of Neuronal Function: A Comparative Study in Patients With Schizophrenia and Healthy Controls Using Psychophysical and Neurophysiological Methods|Recruiting||N/A|228|Anticipated|University Hospital, Strasbourg, France|||2||f||||f||||||||||2017-02-18 16:24:44.571807|2017-02-18 16:24:44.571807
NCT00350792|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2010-10-11|2009-11-05||August 2006||2006-08-01|October 2010|2010-10-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|||Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients|A Phase II Trial Pemetrexed Carboplatin as First Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC) in Elderly Patients|Completed||Phase 2|62|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:24:44.9229|2017-02-18 16:24:44.9229
NCT00350779|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2016-02-03|2009-05-13||June 2006||2006-06-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|September 2007|Actual|2007-09-01||Interventional|||Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)|A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin (MK0431) in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Metformin and a PPARg Agonist|Completed||Phase 3|262|Actual|Merck Sharp & Dohme Corp.|Non-serious adverse event results represent those events included in the primary safety analysis for this study (events occurred prior to initiation of glycemic rescue therapy). Site 0520039 was non-compliant with GDP, data was removed from analyses.|2|||f||||f||||||||||2017-02-18 16:24:45.369534|2017-02-18 16:24:45.369534
NCT00350766|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2007-09-19|||July 2006||2006-07-01|August 2006|2006-08-01|July 2008|Anticipated|2008-07-01|||||Interventional|EMRTCC||Cell Therapy in Myocardial Infarction|Multicenter Prospective Randomized Double Blind Trial of Bone Marrow Mononuclear Cells Transplantation Through Intracoronary Injection in Patients With Acute Myocardial Infarction.|Unknown status|Recruiting|Phase 3|300|Anticipated|Ministry of Health, Brazil||2|||f||||t||||||||||2017-02-18 16:24:46.109788|2017-02-18 16:24:46.109788
NCT00350753|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2009-07-14|||June 2006||2006-06-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Avastin and Tarceva for Upper Gastrointestinal Cancers|A Phase II Study of Erlotinib and Bevacizumab in Patients With Advanced Upper Gastrointestinal Carcinomas, Refractory or Intolerable to Standard Systemic Therapy|Completed||Phase 2|126|Anticipated|Rigshospitalet, Denmark||1|||f||||||||||||||2017-02-18 16:24:46.248107|2017-02-18 16:24:46.248107
NCT00350727|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2013-04-11|2010-12-26||December 2006||2006-12-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|VEG102857||Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma|Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma|Completed||Phase 2|75|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 16:24:46.384465|2017-02-18 16:24:46.384465
NCT00350714|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2011-06-19|||July 2006||2006-07-01|June 2011|2011-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||BreathID Multi-center HCV Liver Breath Test Study|Validation of a Breath Test for Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C Viral Infection|Terminated||Phase 2|75|Actual|Exalenz Bioscience LTD.||1||Due to FDA comments, protocol changed; new trial will be proposed shortly|f||||f||||||||||2017-02-18 16:24:48.786766|2017-02-18 16:24:48.786766
NCT00350701|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2012-12-17|||July 2006||2006-07-01|December 2012|2012-12-01|July 2013|Anticipated|2013-07-01|June 2013|Anticipated|2013-06-01||Interventional|||Effect of Androgel on Type 2 Diabetic Males With Hypogonadism|Effect of Androgel on Inflammatory Mediators and Oxidative Stress in Type 2 Diabetic Males With Hypogonadism|Unknown status|Active, not recruiting|Phase 4|36|Anticipated|Kaleida Health||3|||f||||f||||||||||2017-02-18 16:24:48.897802|2017-02-18 16:24:48.897802
NCT00350688|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2012-07-11|||November 2005||2005-11-01|July 2007|2007-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy|Phase II Trial To Evaluate The Potential For Helical Tomotherapy IMRT To Improve Bladder Cancer Chemoradiation|Terminated||Phase 2|9|Actual|Ottawa Hospital Research Institute||1||More advanced treatments superceded study design|f||||f||||||||||2017-02-18 16:24:49.016937|2017-02-18 16:24:49.016937
NCT00350675|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-09|2006-07-09|||July 2006||2006-07-01|July 2006|2006-07-01||||||||Observational|||Medical Utilization in Israel During Second Intifada|Medical Utilization, Psychotropic Prescriptions, and Somatic Complaints in Israel During the Second Intifada: An Ecological Study of the Impact of Stress.|Unknown status|Not yet recruiting|N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:24:49.108054|2017-02-18 16:24:49.108054
NCT00350662|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2012-11-16|||January 2002||2002-01-01|November 2012|2012-11-01||||||||Interventional|||Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients|Randomized Open-label Phase III Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients|Completed||Phase 3|95|Actual|Lipomed||3|||f||||f||||||||||2017-02-18 16:24:49.168404|2017-02-18 16:24:49.168404
NCT00350649|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2011-09-26|||December 2004||2004-12-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management|Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management|Completed||Phase 2|205|Actual|Yale University||4|||f||||t||||||||||2017-02-18 16:24:49.290131|2017-02-18 16:24:49.290131
NCT00350636|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2010-04-13|2010-04-13||June 2006||2006-06-01|April 2010|2010-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo|Multi-Center, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Daily Dosing With Oxybutynin Topical Gel to Treat the Symptoms of Overactive Bladder With a 14-Week Open-Label Safety Extension|Completed||Phase 3|789|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:24:49.409852|2017-02-18 16:24:49.409852
NCT00350623|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2015-08-11|2010-10-20||October 2006||2006-10-01|August 2015|2015-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)|A Phase IIa Dose-Refinement Study of the Safety and Immunogenicity of a 3-Dose Regimen of the Merck Adenovirus Serotype 5 HIV-1 Gag/Pol/Nef Vaccine in Healthy Adults|Terminated||Phase 2|210|Actual|Merck Sharp & Dohme Corp.|An interim analysis of a related study, V520-023 (NCT00095576), showed that the vaccine used in V520-027 (NCT00350623) was not efficacious; therefore, vaccinations in V520-027 were stopped and only a high level summary of safety data was performed.|3|||f||||||||||||||2017-02-18 16:24:50.005897|2017-02-18 16:24:50.005897
NCT00350610|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2013-01-28|||November 2007||2007-11-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|CBT4CBT||Computer-Based Training in Cognitive Behavior Therapy|Computer-Based Training in Cognitive Behavior Therapy|Completed||Phase 1|100|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:24:50.854963|2017-02-18 16:24:50.854963
NCT00350597|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2006-07-10|||September 2004||2004-09-01|July 2006|2006-07-01|July 2010||2010-07-01|||||Interventional|||GM-CSF as Adjuvant Therapy of Melanoma|Immunologic and Antibody Responses in Patients Receiving GM-CSF, (Leukine, Sargramostim) as Adjuvant Therapy of Stage II (T4), III and IV Melanoma.|Completed||Phase 2|50||Northern California Melanoma Center|||||f||||||||||||||2017-02-18 16:24:50.960194|2017-02-18 16:24:50.960194
NCT00350584|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-10|2011-07-28|||February 2007||2007-02-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of Telehealth Interventions for Post-Trauma Stress|Evaluation of Two Telehealth Interventions Targeting Post-Trauma Stress in Combat Veterans: Comparing Mindfulness and Psychoeducation|Completed||N/A|33|Actual|VA Boston Healthcare System||2|||f||||f||||||||||2017-02-18 16:24:51.061628|2017-02-18 16:24:51.061628
NCT00350571|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2014-09-16|||November 2004||2004-11-01|September 2014|2014-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Brief Interventions for Drop-out Re-engagement|Adaptive Brief Interventions for Drop-out Re-engagement|Completed||Phase 1|299|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:24:51.168261|2017-02-18 16:24:51.168261
NCT00350545|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-12-12|||August 2006||2006-08-01|December 2013|2013-12-01|June 2014|Anticipated|2014-06-01|May 2012|Actual|2012-05-01||Interventional|||A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease|A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease|Unknown status|Active, not recruiting|N/A|36|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 16:24:51.277306|2017-02-18 16:24:51.277306
NCT00350532|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-03-05|2009-03-23||September 2004||2004-09-01|March 2014|2014-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain|Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain|Completed||Phase 2|43|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 16:24:51.396409|2017-02-18 16:24:51.396409
NCT00350519|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2013-07-02|2009-02-20||August 2006||2006-08-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery|An Open Label, Multicenter, Randomized, Controlled Study to Evaluate Efficacy and Safety of PROCRIT in Subjects Undergoing Elective Major Abdominal and/or Pelvic Surgery|Terminated||Phase 4|37|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|No formal analysis was conducted due to early termination.|2||The study was stopped due to slow enrollment|f||||f||||||||||2017-02-18 16:24:51.739394|2017-02-18 16:24:51.739394
NCT00350506|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2007-08-15|||October 2005||2005-10-01|August 2007|2007-08-01||||||||Interventional|||A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT|An Open-Label, Non-Randomized, Multi-Center Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT|Completed||N/A|144||GE Healthcare|||||f||||||||||||||2017-02-18 16:24:52.363642|2017-02-18 16:24:52.363642
NCT00350493|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2008-09-25|||January 2005||2005-01-01|September 2008|2008-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness|Three Year Follow up of a Randomised Controlled Trial of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness|Completed||Phase 4|298||The University of New South Wales|||||f||||||||||||||2017-02-18 16:24:52.43778|2017-02-18 16:24:52.43778
NCT00350480|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2015-03-10|||April 2003||2003-04-01|March 2015|2015-03-01|June 2005||2005-06-01|||||Interventional|||Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial|Treatment of Non-Gestational Acute Uterine BleedingComparing Oral Medroxyprogesterone Acetate and Monophasic Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol|Completed||N/A|240||Kaiser Permanente|||||f||||||||||||||2017-02-18 16:24:52.510854|2017-02-18 16:24:52.510854
NCT00350467|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2011-05-18|||June 2006||2006-06-01|May 2010|2010-05-01|September 2007|Actual|2007-09-01|||||Interventional|||A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia|A Randomized, 6-week Double-blind, Parallel Study to Evaluate the Efficacy and the Safety of Flexible Doses of Extended Release OROS Paliperidone Compared With Olanzapine in the Treatment of Patients With Schizophrenia|Completed||Phase 3|288|Actual|Xian-Janssen Pharmaceutical Ltd.|||||f||||||||||||||2017-02-18 16:24:52.606691|2017-02-18 16:24:52.606691
NCT00350454|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2008-01-10|||June 2006||2006-06-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)|Prospective, Randomized Trial of 3 Rapamycin-Eluting Stents With Different Polymer Coating Strategies For The Reduction of Coronary Restenosis (ISAR-TEST-3)|Completed||Phase 4|605|Actual|Deutsches Herzzentrum Muenchen||3|||f||||t||||||||||2017-02-18 16:24:52.71116|2017-02-18 16:24:52.71116
NCT00005716|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||August 1994||1994-08-01|May 2002|2002-05-01|July 1999|Actual|1999-07-01|||||Observational|||Asthma Partnership for Minority Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.738969|2017-02-18 18:14:28.738969
NCT00350441|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2006-10-10|||June 2006||2006-06-01|July 2006|2006-07-01||||||||Interventional|||Does Sildenafil Protect Against Pulmonary Related Complications Following Cardiopulmonary Bypass?|A Randomised, Double-Blind, Placebo-Controlled, Single-Centre Study of the Pre-Operative Effect of Sildenafil Citrate on Pulmonary Related Complications Following Cardiopulmonary Bypass in Children Undergoing Cardiac Surgical Repair.|Unknown status|Recruiting|Phase 4|12||NHS Greater Glasgow Yorkhill Division|||||f||||||||||||||2017-02-18 16:24:52.829571|2017-02-18 16:24:52.829571
NCT00350428|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2006-10-23|||October 2001||2001-10-01|October 2004|2004-10-01|October 2007||2007-10-01|||||Interventional|||Laser Iridotomy Versus Phacoemulsification in Acute Angle Closure|Angle Closure: Laser Iridotomy Versus Phacoemulsification Study (ACLIPS)- A Study of Acute Primary Angle Closure Glaucoma Comparing Two Treatment Modalities: Laser Peripheral vs Phacoemulsification With Posterior Intraocular Lens Implant|Completed||N/A|70||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:24:52.907896|2017-02-18 16:24:52.907896
NCT00350415|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2013-04-15|||June 2006||2006-06-01|April 2013|2013-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Double Blind Study for the Treatment of Acute Ulcerative Colitis|A Double-blind, Randomized, 6-week, Parallel-group Design Clinical Trial to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day for the Treatment of Moderately Active Ulcerative Colitis.|Completed||Phase 3|772|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 16:24:53.005979|2017-02-18 16:24:53.005979
NCT00350402|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2012-04-04|2012-02-06||December 2004||2004-12-01|April 2012|2012-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Masked Faces in Parkinson Disease: Mechanism and Treatment|Masked Faces in Parkinson Disease: A Randomized Double-blind Sham-treatment Controlled Clinical Trial of High Intensity Respiratory Muscle Strength Training (MST) for Treatment of Reduced Facial Expression in Parkinson Disease|Completed||Phase 2|44|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 16:24:53.354587|2017-02-18 16:24:53.354587
NCT00350389|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2015-06-01|||June 2005||2005-06-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|VISIBLE||VISIBLE Study (Visual Intervention Strategy Incorporating Bifocal & Long-distance Eyewear)|Randomised Controlled Falls Prevention Trial of Plain Distance Glasses in Elderly Multifocal Wearers.|Completed||N/A|606|Actual|The University of New South Wales||2|||f||||t||||||||||2017-02-18 16:24:53.784275|2017-02-18 16:24:53.784275
NCT00350376|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2006-07-05|||June 2006||2006-06-01|July 2006|2006-07-01||||||||Observational|||Impact of Asthma Treatments on Daily Activities|Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)|Unknown status|Recruiting|N/A|1500||Ovation Research Group|||||f||||||||||||||2017-02-18 16:24:53.883179|2017-02-18 16:24:53.883179
NCT00350363|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2015-01-26|2014-05-15||January 2007||2007-01-01|January 2015|2015-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional||patients undergoing eye surgery|One Hour Preoperative Gatifloxacin|One Hour Preoperative Gatifloxacin|Completed||Phase 4|60|Actual|Stanford University||1|||f||||||||||||||2017-02-18 16:24:53.962096|2017-02-18 16:24:53.962096
NCT00350350|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2012-04-20|||October 2003||2003-10-01|July 2006|2006-07-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Observational|||OGT Spray in the Management of Xerostomia in the Elderly|Multicenter, Controlled Parallel Groups Trial to Evaluate the Efficacy, Safety and Acceptability of OGT Oromucosal Spray Versus a Saliva Substitute in the Treatment of Xerostomia in Geriatrics|Completed||Phase 3|74|Actual|Laboratoires CARILENE|||1||f||||t||||||||||2017-02-18 16:24:54.322166|2017-02-18 16:24:54.322166
NCT00350337|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2008-07-16|||January 2006||2006-01-01|July 2008|2008-07-01||||July 2008|Actual|2008-07-01||Interventional|||A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults|Phase II, Randomized, Observer-Blind, Single Center, Controlled Study of Two Doses of Various Formulations of WRAIR Live Attenuated Tetravalent Dengue Vaccine Compared to Placebo Control Administered on 0-6-Month Schedule, to Healthy Adults|Completed||Phase 2|88||Walter Reed Army Institute of Research (WRAIR)|||||f||||||||||||||2017-02-18 16:24:54.423213|2017-02-18 16:24:54.423213
NCT00350311|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2008-09-25|||February 2007||2007-02-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility Study|Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility Study|Completed||Phase 2|43|Actual|The University of New South Wales|||||f||||||||||||||2017-02-18 16:24:54.52296|2017-02-18 16:24:54.52296
NCT00350298|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2010-10-26||2010-10-25|July 2006||2006-07-01|October 2010|2010-10-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease|A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Clinical Effectiveness of a Human Monoclonal Antibody to Clostridium Difficile Toxin A (GS-CDA1) and a Human Monoclonal Antibody to Clostridium Difficile Toxin B (MDX-1388) in Patients Being Treated for Clostridium Difficile Associated Disease|Completed||Phase 2|200|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 16:24:54.612714|2017-02-18 16:24:54.612714
NCT00350285|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2008-10-21|||September 2004||2004-09-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|TMCU3||The Teen Marijuana Check-Up|Reaching and Motivating Change in Teen Marijuana Smokers|Completed||Phase 2|310|Actual|University of Washington||3|||f||||f||||||||||2017-02-18 16:24:54.75691|2017-02-18 16:24:54.75691
NCT00350272|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2016-05-16|2016-02-22||May 2006||2006-05-01|May 2016|2016-05-01|April 2009|Actual|2009-04-01|August 2007|Actual|2007-08-01||Interventional||The baseline analysis population was the safety population, defined as all randomized subjects who received at least one dose of study drug.|Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects|A Randomized, Blinded, 12-week Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects. There is a 36 Week, Open Label, Extension Phase for Eligible Subjects.|Completed||Phase 2|76|Actual|Achillion Pharmaceuticals||2|||f||||t||||||||Yes|Individual Participant Data is available to only this study's Principal Investigator upon request.|2017-02-18 16:24:54.869341|2017-02-18 16:24:54.869341
NCT00349219|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2016-01-14|||December 2006||2006-12-01|January 2016|2016-01-01|June 2012|Actual|2012-06-01|December 2011|Actual|2011-12-01||Interventional|TORCH||TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer|An International Randomized Phase III Study of First-line Erlotinib Followed by Second-line Cisplatin + Gemcitabine Versus First-line Cisplatin + Gemcitabine Followed by Second-line Erlotinib in Advanced Non Small Cell Lung Cancer|Completed||Phase 3|760|Actual|National Cancer Institute, Naples||2|||f||||t||||||||||2017-02-18 16:24:55.940717|2017-02-18 16:24:55.940717
NCT00349206|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-04-09|||April 2006||2006-04-01|February 2013|2013-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma|Phase 1 Study of the Combination of BAY 43-9006 (Sorafenib) and CCI-779 (Temsirolimus) in Patients With Metastatic Melanoma|Completed||Phase 1|69|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:24:56.140736|2017-02-18 16:24:56.140736
NCT00349193|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2011-04-07|||March 2005||2005-03-01|April 2011|2011-04-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|||A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod|A Multinational, Multicenter Randomized Double-Blind, Parallel-Group, Placebo-Controlled Study, to Evaluate the Efficacy, Tolerability and Safety of Two Doses of, Oral Laquinimod in Relapsing Remitting (R-R) Multiple Sclerosis (MS) Subjects|Completed||Phase 2|306|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-02-18 16:24:56.255153|2017-02-18 16:24:56.255153
NCT00348452|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2012-06-20|||September 2002||2002-09-01|June 2012|2012-06-01|August 2003||2003-08-01|||||Interventional|||A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA)|Double-blind, Randomized, Dose-ranging, Parallel-group Comparison of the Efficacy and Safety of Extended Release Tramadol Hydrochloride (Tramadol HCl ER) 100 mg, 200 mg, 300 mg, Celecoxib 200 mg and Placebo in the Treatment of Osteoarthritis of the Knee and/or Hip.|Completed||Phase 3|1000||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:24:56.345921|2017-02-18 16:24:56.345921
NCT00348439|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2011-12-07|||April 2006||2006-04-01|December 2011|2011-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment|A Multicenter, Randomized, Double Masked, Placebo Controlled, Sequential Dose Response Study of Intravitreally Administered Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)|Terminated||Phase 2|29|Actual|Bausch & Lomb Incorporated||2||Lack of Efficacy|f||||t||||||||||2017-02-18 16:24:56.430578|2017-02-18 16:24:56.430578
NCT00348426|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-02|2006-11-07|||June 2006||2006-06-01|November 2006|2006-11-01|September 2006||2006-09-01|||||Observational|||Botulism Outbreak in Thailand (Episode II)|Clinical Manifestations of Botulism Outbreak in Northern Thailand: A Case Series of Botulism Treated With Botulinum Anti-Toxin.|Completed||Phase 4|200||Rajavithi Hospital|||||f||||||||||||||2017-02-18 16:24:56.517501|2017-02-18 16:24:56.517501
NCT00348413|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2010-05-11|||June 2003||2003-06-01|May 2010|2010-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Thyroid Treatment Trial|Comparison of Efficacy and Safety of Intravenous Pulsed Methylprednisolone and Oral Methotrexate Versus Intravenous Pulsed Methylprednisolone and Oral Placebo in the Treatment of Active Moderate and Severe Thyroid Eye Disease - a Prospective, Randomized, Double-blind, Parallel, Controlled Multidisciplinary Clinical Trial and Imaging Study.|Completed||N/A|80|Anticipated|Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:24:56.621429|2017-02-18 16:24:56.621429
NCT00348400|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-05-30||||||May 2007|2007-05-01||||||||Interventional|||Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost|Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:24:56.731256|2017-02-18 16:24:56.731256
NCT00348387|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2014-01-20|||June 2006||2006-06-01|January 2014|2014-01-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV||Completed||Phase 3|600|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:24:56.908221|2017-02-18 16:24:56.908221
NCT00348374|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2010-03-02|2009-08-03||June 2006||2006-06-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes|A Phase 3b, Randomized, Open-Label, Parallel Group, Multicenter Trial Assessing The Efficacy Of Exubera Vs. Lispro Introduced Into A Lantus Based Regimen In Suboptimally Controlled Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|191|Actual|Pfizer|Due to cancellation of the EXUBERA program the sample size was too small to adequately address the inferential objectives of this study. Descriptive statistics for the PSIT Questionnaire and the markers of cardiovascular risk were not provided.|2|||f||||f||||||||||2017-02-18 16:24:57.038867|2017-02-18 16:24:57.038867
NCT00348361|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-10-09|||April 2005||2005-04-01|October 2008|2008-10-01||||||||Interventional|||Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)|A Study to Validate Key Therapeutic Targets and Biomarkers During Allergen Exposure in Subjects With Allergic Rhinitis|Completed||Phase 1|48||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:24:58.413699|2017-02-18 16:24:58.413699
NCT00348348|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2015-03-04|2009-06-30||June 2006||2006-06-01|March 2015|2015-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis|A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vigamox in the Treatment of Bacterial Conjunctivitis|Completed||Phase 3|1161|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 16:24:58.515268|2017-02-18 16:24:58.515268
NCT00348335|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2011-07-28|||June 2006||2006-06-01|July 2011|2011-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy of Topical Cyclosporin for Ocular Rosacea|Efficacy of Topical Cyclosporin 0.05% for the Treatment of Ocular Rosacea|Completed||Phase 4|35|Actual|Ophthalmic Consultants of Long Island||2|||f||||t||||||||||2017-02-18 16:24:59.106495|2017-02-18 16:24:59.106495
NCT00348322|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-09-23|||July 2006||2006-07-01|September 2008|2008-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety/Efficacy of Systane Free vs Refresh Tears|An Evaluation of the Safety and Efficacy of Systane Free FID 105783 - II|Completed||N/A|100||Alcon Research|||||f||||||||||||||2017-02-18 16:24:59.201388|2017-02-18 16:24:59.201388
NCT00348309|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2016-10-28||2010-03-29|July 2006||2006-07-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|REFLECT-2||Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease|A 54-week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy to Donepezil on Cognition and Overall Clinical Response in APOE ε4-stratified Subjects With Mild to Moderate Alzheimer's Disease.|Completed||N/A|1496|Actual|GlaxoSmithKline||3|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:24:59.293932|2017-02-18 16:24:59.293932
NCT00348296|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2010-07-28|||July 2006||2006-07-01|July 2010|2010-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis|A Randomized, Double-blind, Placebo-controlled Multi-center Study of GB-0998 for Treatment of Systemic Sclerosis|Completed||Phase 3|60|Anticipated|Benesis Corporation|||||f||||||||||||||2017-02-18 16:24:59.775935|2017-02-18 16:24:59.775935
NCT00348283|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2011-04-07|2009-09-15||August 2006||2006-08-01|April 2011|2011-04-01||||September 2008|Actual|2008-09-01||Interventional|||Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab Endoscopy Trial to Evaluate the Effects on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon|Completed||Phase 3|135|Actual|Abbott||2|||f||||f||||||||||2017-02-18 16:24:59.87314|2017-02-18 16:24:59.87314
NCT00350259|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2008-04-29|||April 2006||2006-04-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 16:25:03.390387|2017-02-18 16:25:03.390387
NCT00350246|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2010-01-27|||July 2004||2004-07-01|January 2010|2010-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Long-term Effects of Laser Refractive Surgery|Long-term Effects of Laser Refractive Surgery|Completed||Phase 4|62|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:25:03.437116|2017-02-18 16:25:03.437116
NCT00350233|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2012-09-13|||May 2006||2006-05-01|September 2012|2012-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors|MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors|Completed||Phase 1|10|Actual|InSightec||1|||f||||||||||||||2017-02-18 16:25:03.515096|2017-02-18 16:25:03.515096
NCT00350220|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2015-05-29|2010-01-19||July 2006||2006-07-01|May 2015|2015-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Transfusion Strategies in Pediatric Cardiothoracic Surgery|A Prospective, Randomized, Controlled Clinical Trial Comparing Two Transfusion Strategies in Pediatric Patients Undergoing Cavopulmonary Connection.|Completed||Phase 2|60|Actual|University of Rochester|There were no limitations to this study. There was 100% compliance with study procedures. There were no adverse events.|2|||f||||||||||||||2017-02-18 16:25:03.624614|2017-02-18 16:25:03.624614
NCT00350207|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2013-11-27|2009-08-24||July 2006||2006-07-01|September 2013|2013-09-01||||September 2008|Actual|2008-09-01||Interventional||Treated set includes all patients who were dispensed randomised study medication and were documented to have taken at least one dose of investigational treatment.|Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg|A 16-week Randomised, Placebo-controlled, Double-blind, Double-dummy, Parallel-group Study Comparing the Efficacy and Safety of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler (2 Actuations of 2.5 Mcg Once Daily) With That of Salmeterol From the Hydrofluoroalkane Metered Dose Inhaler (2 Actuations of 25 Mcg Twice Daily) in Moderate Persistent Asthma Patients With the B16-Arg/Arg Genotype|Completed||Phase 2|388|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:25:04.051087|2017-02-18 16:25:04.051087
NCT00350194|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2012-02-29|||October 2006||2006-10-01|February 2012|2012-02-01|June 2012|Anticipated|2012-06-01|October 2011|Actual|2011-10-01||Interventional|||The Effects of Omega-3 Fatty Acids on Metabolic Syndrome|Pilot Study: The Effects of Omega-3 Fatty Acids on Metabolic Syndrome and Vascular Structure in Metabolic Syndrome as Assessed by Carotid IMT|Unknown status|Active, not recruiting|Early Phase 1|100|Anticipated|University of Washington||1|||f||||t||||||||||2017-02-18 16:25:06.629799|2017-02-18 16:25:06.629799
NCT00350181|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2010-10-07|||August 2006||2006-08-01|October 2010|2010-10-01|April 2010|Actual|2010-04-01|August 2007|Actual|2007-08-01||Interventional|||Sirolimus and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Myeloablative Matched Related Donor Hematopoietic Cell Transplant|Sirolimus and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Myeloablative Matched Related Donor Hematopoietic Cell Transplantation|Completed||Phase 2|38|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 16:25:06.74082|2017-02-18 16:25:06.74082
NCT00350168|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2016-11-16|||June 2006||2006-06-01|November 2016|2016-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension|An 8-week Multicenter Study to Evaluate the Efficacy and Safety of Orally Administered Valsartan/Amlodipine Combination Based Therapy Versus Amlodipine Monotherapy in Patients With Stage II Hypertension|Completed||Phase 3|647|Actual|Novartis|||||f||||||||||||||2017-02-18 16:25:06.838881|2017-02-18 16:25:06.838881
NCT00350155|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2007-12-12|||May 2006||2006-05-01|December 2007|2007-12-01||||||||Interventional|||Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel|A 16-Day, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group Trial Comparing Lumiracoxib 100mg o.d. With Naproxen 500 mg b.i.d. Plus Omeprazole 20mg o.d. and Placebo in Healthy Volunteers to Investigate on the Safety and Tolerability of Lumiracoxib in the Small Bowel.|Completed||Phase 4|150||Novartis|||||f||||||||||||||2017-02-18 16:25:06.940397|2017-02-18 16:25:06.940397
NCT00350142|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2016-12-26|2013-12-06||April 2006||2006-04-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer|Phase II Study to Evaluate the Efficacy of Trilogy Stereotactic Radiosurgery for Pancreatic Cancer|Completed||Phase 2|20|Actual|Stanford University||1|||f||||t||||||||No||2017-02-18 16:25:07.03026|2017-02-18 16:25:07.03026
NCT00350129|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2008-09-25|||December 2002||2002-12-01|September 2008|2008-09-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Observational|||Effect of Glucose on Ocular Blood Flow|Influence of Plasma Glucose Levels on Retinal Vascular Diameter and Choroidal Blood Flow in Vasospastic Subjects|Completed||N/A|24|Actual|University Hospital, Basel, Switzerland|||2||f||||f||||||||||2017-02-18 16:25:07.293288|2017-02-18 16:25:07.293288
NCT00350116|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2006-07-06|||January 2001||2001-01-01|July 2006|2006-07-01|December 2004||2004-12-01|||||Interventional|||Topical Vitamin B12 in Chronic Plaque Psoriasis|Topical Vitamin B12 in Chronic Plaque Psoriasis|Completed||Phase 3|48||Ruhr University of Bochum|||||f||||||||||||||2017-02-18 16:25:07.388671|2017-02-18 16:25:07.388671
NCT00350103|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2014-09-19|||June 2006||2006-06-01|September 2009|2009-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy|A Multicenter, Randomized, Double-blind, Placebo Controlled Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy Using Two Different Titration Schemes|Completed||Phase 3|537|Anticipated|UCB Pharma|||||f||||||||||||||2017-02-18 16:25:07.476345|2017-02-18 16:25:07.476345
NCT00350090|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2011-05-17|||September 2002||2002-09-01|March 2010|2010-03-01|March 2004|Actual|2004-03-01|||||Interventional|||A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.|A Pilot Study to Evaluate the Response Rate of PROCRIT (Epoetin Alfa) at 40,000 Units Once Weekly in Anemic Cancer Patients Not Receiving Chemotherapy|Terminated||Phase 3|98|Actual|Ortho Biotech Products, L.P.||||This study was stopped early due to slow enrollment.|f||||f||||||||||2017-02-18 16:25:07.566107|2017-02-18 16:25:07.566107
NCT00350077|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2011-12-19|||July 2006||2006-07-01|December 2011|2011-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|Vitamin C||The Effect of High Dose Vitamin C in Burn Patients|The Effect of High Dose Versus Low Dose Intravenous Vitamin C (Ascorbic Acid)on Burn Injury Resuscitation|Withdrawn||N/A|0|Actual|United States Army Institute of Surgical Research||1||Inadequate resources to submit for approval|f||||f||||||||||2017-02-18 16:25:07.668168|2017-02-18 16:25:07.668168
NCT00350064|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2008-08-07|||April 2004||2004-04-01|August 2008|2008-08-01|December 2008|Anticipated|2008-12-01|June 2006|Anticipated|2006-06-01||Interventional|||Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome|Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome|Unknown status|Active, not recruiting|N/A|165|Anticipated|University of Virginia||1|||f||||f||||||||||2017-02-18 16:25:07.780696|2017-02-18 16:25:07.780696
NCT00350051|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2014-12-02|||August 2006||2006-08-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer|Phase 2 Study of ZK-Epothilone (ZK-Epo; ZK219477) Plus Prednisone as First-line Chemotherapy in Patients With Metastatic Androgen-independent Prostate Cancer|Completed||Phase 2|53|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:25:07.890555|2017-02-18 16:25:07.890555
NCT00350038|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2008-01-18|||February 2005||2005-02-01|January 2008|2008-01-01|August 2007||2007-08-01|||||Interventional|||Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions|Investigations of the Effects of Aprovel, Lipanor and Their Combination Onto the Endothelial Functions of Dyslipidemic Patients Measure by Laser Doppler Flow-Metry.|Completed||Phase 4|60||Sanofi|||||f||||||||||||||2017-02-18 16:25:08.043679|2017-02-18 16:25:08.043679
NCT00350025|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2014-05-05|||August 2006||2006-08-01|May 2014|2014-05-01|September 2012|Actual|2012-09-01|July 2010|Actual|2010-07-01||Interventional|||Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer|Randomized Phase II Trial of Cetuximab With and Without Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer|Completed||Phase 2|26|Actual|Fox Chase Cancer Center||2|||f||||t||||||||||2017-02-18 16:25:08.144406|2017-02-18 16:25:08.144406
NCT00350012|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2016-02-22|||May 2004||2004-05-01|February 2016|2016-02-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Observational|||Spatial Neglect and Bias in Near and Far Space|Spatial Neglect and Bias in Near and Far Space|Recruiting||N/A|950|Anticipated|Kessler Foundation|||2||f||||t||||||||||2017-02-18 16:25:08.265583|2017-02-18 16:25:08.265583
NCT00349999|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2013-09-05|||June 2008||2008-06-01|October 2009|2009-10-01|December 2012|Actual|2012-12-01|January 2012|Actual|2012-01-01||Observational|||Protective Immunity to Human Cholera in Bangladesh|Protective Immunity to Human Cholera in Bangladesh-EGD Substudy|Completed||N/A|125|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Duodenal biopsy samples and blood.~   "|||2017-02-18 16:25:08.369688|2017-02-18 16:25:08.369688
NCT00349986|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2009-12-04|||September 2006||2006-09-01|December 2009|2009-12-01||||June 2007|Actual|2007-06-01||Interventional|||LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus|The Determination of the First Dose and the Optimal Time of Administration of Insulin Glargine Combined With Oral Antidiabetic Drug in Poorly Controlled Type II Diabetic Patients|Terminated||Phase 4|4|Actual|Sanofi||2||prematurely terminated due to loss of interest|f||||||||||||||2017-02-18 16:25:08.457845|2017-02-18 16:25:08.457845
NCT00349973|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-01-11|||May 2001||2001-05-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|September 2008|Actual|2008-09-01||Interventional|||Clinical Trial of Dipyridamole in Schizophrenia|Clinical Trial of Dipyridamole in Schizophrenia|Completed||N/A|29|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 16:25:08.553042|2017-02-18 16:25:08.553042
NCT00349960|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2006-07-06|||March 2004||2004-03-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Epoetin Dosing Regimens in Haemodialysis|Once-Weekly Versus Once-Fortnightly Subcutaneous Epoetin Beta Administration in the Maintenance Phase of Anaemia Treatment in Haemodialyzed Patients|Completed||N/A|200||Romanian Society of Nephrology|||||f||||||||||||||2017-02-18 16:25:08.675002|2017-02-18 16:25:08.675002
NCT00349947|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2013-06-05|||November 2006||2006-11-01|June 2013|2013-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|AAA:STOP||Exercise Therapy to Treat Adults With Abdominal Aortic Aneurysms|Abdominal Aortic Aneurysms: Simple Treatment or Prevention (AAA: STOP)|Completed||Phase 1|2400|Anticipated|Stanford University||2|||f||||t||||||||||2017-02-18 16:25:08.772837|2017-02-18 16:25:08.772837
NCT00349934|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2010-01-06|||July 2006||2006-07-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|November 2009|Actual|2009-11-01||Interventional|||IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma|IMP321 Phase I Study in Metastatic Breast Carcinoma Patients Receiving First-line Paclitaxel|Completed||Phase 1|33|Actual|Immutep S.A.||1|||f||||f||||||||||2017-02-18 16:25:08.883909|2017-02-18 16:25:08.883909
NCT00349921|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-01-08|2009-05-12||August 2004||2004-08-01|January 2014|2014-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Clonidine Versus Adenosine to Treat Neuropathic Pain|Clonidine Versus Adenosine to Treat Neuropathic Pain|Completed||Phase 2|24|Actual|Wake Forest University Health Sciences||4|||f||||t||||||||||2017-02-18 16:25:08.999367|2017-02-18 16:25:08.999367
NCT00349908|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2014-05-28|2011-02-02||September 2006||2006-09-01|May 2014|2014-05-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|||A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries|A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries|Completed||Phase 1|20|Actual|Codman & Shurtleff||2|||f||||f||||||||||2017-02-18 16:25:09.754703|2017-02-18 16:25:09.754703
NCT00349895|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-04-07|||August 2006||2006-08-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2008|Actual|2008-01-01||Interventional|||Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth|Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth. A Clinical, Multi-center, Prospective, Non-Randomized Study|Completed||Phase 4|100|Actual|OrbusNeich||1|||f||||t||||||||||2017-02-18 16:25:10.531106|2017-02-18 16:25:10.531106
NCT00349843|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2015-12-15|||June 2005||2005-06-01|December 2015|2015-12-01||||||||Interventional|||Investigation of Multi-Purpose Solution-Based Corneal Staining and Ocular Comfort|Investigation of Multi-Purpose Solution-Based Corneal Staining and Ocular Comfort With Daily Wear FDA Group IV Hydrogel Lenses|Completed||Phase 4|30||University of Waterloo|||||f||||||||||||||2017-02-18 16:25:10.97596|2017-02-18 16:25:10.97596
NCT00349830|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2016-07-11|||January 2002||2002-01-01|July 2016|2016-07-01||||January 2022|Anticipated|2022-01-01||Observational|||Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy|Development of Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy|Recruiting||N/A|2000|Anticipated|Stanford University|||1||f||||||||||Samples Without DNA|"~     blood~   "|||2017-02-18 16:25:11.067057|2017-02-18 16:25:11.067057
NCT00349817|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2006-07-06|||October 2005||2005-10-01|July 2006|2006-07-01|January 2007||2007-01-01|||||Interventional|||Genetics Education: Preparing Physicians for the Future||Unknown status|Recruiting|N/A|64||University of Toronto|||||f||||||||||||||2017-02-18 16:25:11.171706|2017-02-18 16:25:11.171706
NCT00349804|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2012-03-09|||June 2006||2006-06-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Intermittent Cold and Dry Air Underneath Football Shoulder Pads|Intermittent Cold and Dry Air Underneath Football Shoulder Pads as a Method to Assist in Temperature Homeostasis: Evaluation of Efficacy|Completed||Phase 3|15|Actual|University of Florida||1|||f||||||||||||||2017-02-18 16:25:11.261165|2017-02-18 16:25:11.261165
NCT00349791|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2013-04-15|||June 2002||2002-06-01|April 2013|2013-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido|A Study to Evaluate the Efficacy/Safety of Transdermal Testosterone for 24 Weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Oral Hormone Replacement Therapy.|Completed||Phase 3|549|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 16:25:11.360919|2017-02-18 16:25:11.360919
NCT00349778|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2010-10-07|||August 2006||2006-08-01|October 2010|2010-10-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||High -Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma|High -Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma|Completed||Phase 1/Phase 2|49|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 16:25:11.474476|2017-02-18 16:25:11.474476
NCT00349765|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-09-12|||March 2005||2005-03-01|September 2007|2007-09-01|February 2006||2006-02-01|||||Interventional|||Effects of Various Higher Fat and Lower Fat Snacks on Cardiovascular Risk Factors in Men and Women.|Cardiovascular Health Effects of Isocaloric Substitution of Polyunsaturated Fat Rich Snacks for Saturated and Trans Fat or Refined Carbohydrate Snacks in Moderately Hypercholesterolemic Individuals.|Completed||Phase 2|42||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 16:25:11.574178|2017-02-18 16:25:11.574178
NCT00349752|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2014-08-26|2010-07-01||November 2006||2006-11-01|October 2010|2010-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|COSPAR1||Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease|A Phase IIIb Multicenter, Double-blind, Placebo-controlled,Randomized Trial to Examine the Corticosteroid-sparing Effect of Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease.|Terminated||Phase 3|174|Actual|UCB Pharma|Recruitment was stopped early due to slow enrolment of this population. With no safety concerns, the study continued normally for the 174 subjects already recruited. Results should be treated with caution due to the early termination of this study.|2||"Recruitment was stopped early due to slow enrolment of this population. With no safety~   concerns, the study continued normally for subjects already recruited"|f||||f||||||||||2017-02-18 16:25:11.675755|2017-02-18 16:25:11.675755
NCT00349739|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2010-01-14|||January 2003||2003-01-01|January 2010|2010-01-01|August 2008|Anticipated|2008-08-01|||||Expanded Access|||Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate|Clinical Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate Sterile Suspension|No longer available||N/A|||University of Iowa|||||||||||||||||||2017-02-18 16:25:12.483564|2017-02-18 16:25:12.483564
NCT00349726|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2015-07-27|||June 2006||2006-06-01|July 2015|2015-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|INS-1||Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants|Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants|Completed||Phase 2|74|Actual|NICHD Neonatal Research Network||4|||f||||t||||||||||2017-02-18 16:25:12.58549|2017-02-18 16:25:12.58549
NCT00349713|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2012-06-19|||November 2004||2004-11-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|December 2005|Actual|2005-12-01||Interventional|||FMP2.1 Trial in Bandiagara, Mali|Double Blind Randomized, Controlled Phase 1 Dose Escalation Trial to Evaluate the Safety and Immunogenicity of the WRAIR AMA1 Malaria Antigen (FMP2.1) Adjuvanted in GSK's AS02A Versus Rabies Vaccine in Malaria-experienced Adults in Bandiagara, Mali|Completed||Phase 1|60|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||f||||||||||2017-02-18 16:25:12.715732|2017-02-18 16:25:12.715732
NCT00349700|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2016-05-05|||January 2003||2003-01-01|July 2006|2006-07-01|May 2005||2005-05-01|||||Interventional|||Wound Dressings Adapted to Wound Exudate and Bacterial Load in Therapy Resistant Large Sized Leg Ulcers|An Open Prospective Controlled Trial: Efficiency of Wound Dressings Adapted to Wound Exudate and Bacterial Load in Therapy Resistant Large Sized Leg Ulcers|Completed||N/A|139||Ruhr University of Bochum|||||f||||||||||||||2017-02-18 16:25:12.82509|2017-02-18 16:25:12.82509
NCT00349687|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2011-11-22|||May 2004||2004-05-01|November 2011|2011-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Practicing Self-Control Lowers the Risk of Smoking Lapse|Practicing Self-Control Lowers the Risk of Smoking Lapse|Completed||Phase 1/Phase 2|120|Actual|University at Albany||1|||f||||f||||||||||2017-02-18 16:25:12.911711|2017-02-18 16:25:12.911711
NCT00349674|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2007-10-09|||January 1999||1999-01-01|October 2007|2007-10-01||||||||Interventional|||WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides|Treatment of ANCA-Associated Vasculitides : Corticosteroids and Pulse Cyclophosphamide Followed by Maintenance Therapy With Methotrexate or Azathioprine: a Prospective Multicenter Randomized Trial|Unknown status|Active, not recruiting|Phase 3|126||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:25:12.999172|2017-02-18 16:25:12.999172
NCT00349661|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2008-08-22|||June 2006||2006-06-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel|Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel Associated To Aspirin: Double-Blind Randomized Trial Against Placebo|Completed||Phase 3|120|Anticipated|University Hospital, Brest|||||f||||||||||||||2017-02-18 16:25:13.091634|2017-02-18 16:25:13.091634
NCT00349648|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2006-07-06|||March 2001||2001-03-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Conservative or Operative Treatment for the Shoulder Impingement Syndrome?|Conservative or Operative Treatment for the Shoulder Impingement Syndrome? A Randomized Controlled Trial of 140 Patients Followed Up for Two Years.|Unknown status|Active, not recruiting|N/A|140||Central Hospital of Kanta-Hame|||||f||||||||||||||2017-02-18 16:25:13.178931|2017-02-18 16:25:13.178931
NCT00349635|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2007-08-31|||October 2004||2004-10-01|August 2007|2007-08-01||||||||Interventional|||A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.|A Double-Blind, 3-Arm Study on Weight Loss With a Combination of Micronised Fenofibrate 267 mg and Metformin 1,700 mg Per Day Compared to Metformin 1,700 mg and to Placebo, at 6 Months, in Obese Patients, Followed by: A Double-Blind, 2-Arm Investigation of Weight-Loss Maintenance With the Same Combination of Micronised Fenofibrate 267 mg and Metformin 1,700 mg Compared to Placebo, at 6 Months, in the Responders.|Completed||Phase 2|148||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 16:25:13.271619|2017-02-18 16:25:13.271619
NCT00349622|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-04-01|2013-10-23||July 2006||2006-07-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Clinical Trial Ceftriaxone in Subjects With ALS|Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 3|513|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 16:25:13.376319|2017-02-18 16:25:13.376319
NCT00349596|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2014-10-13|||July 2006||2006-07-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)|Phase I Study of Low Dose 5-Aza-2'-Deoxycytidine Administered Daily for 5 Days Every Other Week for Patients With Relapsed or Refractory Acute Lymphocytic Leukemia|Completed||Phase 1|40|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:25:14.855868|2017-02-18 16:25:14.855868
NCT00349583|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2007-05-30||||||May 2007|2007-05-01||||||||Interventional|||Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation|Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:25:14.979116|2017-02-18 16:25:14.979116
NCT00349570|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2008-10-20|||August 2006||2006-08-01|October 2008|2008-10-01|March 2008|Actual|2008-03-01|||||Interventional|||Xtract™ Aspiration Catheter Registry Study|Xtract™ Aspiration Catheter Registry Study|Completed||N/A|||Lumen Biomedical|||||f||||f||||||||||2017-02-18 16:25:15.059607|2017-02-18 16:25:15.059607
NCT00349557|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-07-15|||April 2006||2006-04-01|July 2014|2014-07-01||||||||Interventional|||Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer|Pilot Phase II Trial of Bevacizumab in Combination With Hormonal and Radiotherapy in Patients With High-Risk Prostate Cancer|Completed||Phase 2|18|Anticipated|Benaroya Research Institute|||||||||||||||||||2017-02-18 16:25:15.142962|2017-02-18 16:25:15.142962
NCT00349544|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2008-05-07|||October 2005||2005-10-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|||||Observational|||Validation of the Spanish Version of the Neck Disability Index|Validation of the Transcultural Adaptation of the Neck Disability Index in the Spanish Population|Completed||N/A|221|Actual|Kovacs Foundation|||1||f||||t||||||||||2017-02-18 16:25:15.237201|2017-02-18 16:25:15.237201
NCT00349531|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2012-05-18|||July 2006||2006-07-01|May 2012|2012-05-01||||May 2007|Actual|2007-05-01||Interventional|||A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS|A Phase IV Randomised, Double-blind, Placebo-controlled, Dose Titration Trial With Pramipexole (Sifrol®, Mirapexin®) 0.125-0.75 mg/Day Per os for 12 Weeks to Investigate the Effects on RLS Symptoms (IRLS) and Sleep Disturbance (MOS Sleep Scale) in Out-patients With Idiopathic Restless Legs Syndrome|Completed||Phase 4|369|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:25:15.344344|2017-02-18 16:25:15.344344
NCT00349518|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2016-02-16|||December 2006||2006-12-01|April 2011|2011-04-01||||January 2007|Actual|2007-01-01||Interventional|||Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL|A Phase II Study of Dasatinib (BMS-354825) in Subjects With Chronic or Advanced Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Who Are Resistant or Intolerant to Imatinib|Withdrawn||Phase 2/Phase 3|0|Actual|Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 16:25:15.476446|2017-02-18 16:25:15.476446
NCT00349505|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2006-10-05|||September 2004||2004-09-01|September 2006|2006-09-01||||||||Interventional|||Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma|Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma|Unknown status|Recruiting|Phase 2|67||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 16:25:15.588025|2017-02-18 16:25:15.588025
NCT00349492|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-12-03|||June 2006||2006-06-01|March 2012|2012-03-01|October 2013|Actual|2013-10-01|December 2011|Actual|2011-12-01||Interventional|||A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer|Randomized, Phase III Trial Comparing Etoposide/Cisplatin (EP) With Irinotecan/Cisplatin (IP) in Patients With Previously Untreated, Extensive Disease (ED) Small Cell Lung Cancer (SCLC)|Completed||Phase 3|372|Anticipated|Clinical Research Center for Solid Tumor, Korea||1|||f||||||||||||||2017-02-18 16:25:15.677965|2017-02-18 16:25:15.677965
NCT00349479|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-02-22|||May 2005||2005-05-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|INSTINCT||Increasing Stroke Treatment Through Interventional Change Tactics Study|Clinical Trial to Increase t-PA Use in Stroke Treatment|Completed||N/A|24|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 16:25:15.799631|2017-02-18 16:25:15.799631
NCT00349466|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2015-02-12|2011-06-20||January 2007||2007-01-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca|A Phase 2, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Daily CF101 Administered Orally in Patients With Moderate-to-Severe Keratoconjunctivitis Sicca|Completed||Phase 2|80|Actual|Can-Fite BioPharma||2|||f||||f||||||||||2017-02-18 16:25:15.911935|2017-02-18 16:25:15.911935
NCT00349453|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2011-12-09|||March 2005||2005-03-01|December 2011|2011-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients|Retrospective and Prospective Multicenter Study Using Deferiprone (L1) Alone or in Combination With Desferrioxamine for the Treatment of Iron Overload in Transfusion-dependent Patients|Completed||Phase 2|24|Actual|Lipomed||2|||f||||f||||||||||2017-02-18 16:25:16.279314|2017-02-18 16:25:16.279314
NCT00349440|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2008-09-23|||September 2006||2006-09-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy|Efficacy of Topical Cyclosporine Ophthalmic Emulsion for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy|Completed||Phase 4|93|Actual|Innovative Medical||2|||f||||||||||||||2017-02-18 16:25:16.404752|2017-02-18 16:25:16.404752
NCT00349427|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2012-05-31|||October 2005||2005-10-01|February 2011|2011-02-01||||||||Interventional|||A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients|A Randomized, Double-Blind, Placebo-Control, Clinical Evaluation of Insulin Plus Rosiglitazone Compared to Insulin Plus Placebo for 24 Weeks in Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin|Completed||Phase 3|256|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:25:16.505301|2017-02-18 16:25:16.505301
NCT00349414|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2008-05-13|||July 2006||2006-07-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma|A Comparison of the Safety and Efficacy of Conventional Versus Micropulse Transscleral Diode Laser Cyclophotocoagulation in Refractory Glaucoma|Unknown status|Recruiting|Phase 1/Phase 2|70|Anticipated|National University Hospital, Singapore|||||f||||||||||||||2017-02-18 16:25:16.614613|2017-02-18 16:25:16.614613
NCT00349401|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2015-06-02|||December 2006||2006-12-01|May 2009|2009-05-01||||||||Interventional|||Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation|Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation|Withdrawn||Phase 2|0|Actual|Wake Forest University Health Sciences||||Study was not initiated. No subjects were screened or enrolled.|||||||||||||||2017-02-18 16:25:16.715629|2017-02-18 16:25:16.715629
NCT00349388|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-08-13|2014-07-24||July 2006||2006-07-01|August 2014|2014-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||No patients enrolled into intervention arm due to lack of enrollment.Only 1 subject was enrolled in Control arm. Therefore no data can be compared for study outcome|Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients|A Randomized Trial Comparing Once Daily Dosing vs. Multiple Doses a Day of Mesalamine in Pediatric Patients With Quiescent Ulcerative Colitis|Terminated||N/A|1|Actual|Atlantic Health System|No subjects were analysed due to lack of enrollment. No subject was enrolled into the once a day dosing arm to answer our primary or secondary outcomes.|2||none enrolled in second arm, therfore no analysis|f||||f||||||||||2017-02-18 16:25:16.804271|2017-02-18 16:25:16.804271
NCT00349375|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2009-07-07|||November 2005||2005-11-01|July 2009|2009-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy|A Multicenter, Double-Blind, Randomized, Active Comparator, Forced-Titration Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 20 or 40 mg Simvastatin With 40 mg Simvastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not Adequately Controlled by 20 mg Simvastatin Alone|Completed||Phase 3|1040|Actual|Solvay Pharmaceuticals||3|||f||||||||||||||2017-02-18 16:25:17.164412|2017-02-18 16:25:17.164412
NCT00349362|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2010-03-29|||July 2006||2006-07-01|March 2010|2010-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Testosterone for Men With Insulin Treated Type 2 Diabetes|A Randomised Double Blind Placebo Controlled, Parallel Pilot Study to Test the Effect of Testosterone Replacement on Glycaemic Control and Arterial Wall Properties of Hypogonadal Men With Type 2 Diabetes Treated With Insulin|Completed||Phase 4|40|Anticipated|Barnsley Hospital||2|||f||||||||||||||2017-02-18 16:25:17.575768|2017-02-18 16:25:17.575768
NCT00349349|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2014-05-29|2011-10-20||June 2006||2006-06-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|May 2008|Actual|2008-05-01||Interventional|||HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab|A Single-arm, International, Multi-center Trial of HuMax-CD20, a Fully Human Monoclonal Anti-CD20 Antibody, in Patients With B-cell Chronic Lymphocytic Leukemia Who Have Failed Fludarabine and Alemtuzumab|Completed||Phase 2|223|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:25:17.70447|2017-02-18 16:25:17.70447
NCT00349336|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2012-09-12|2009-06-02||August 2006||2006-08-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.|A Randomized, Open Label Trial to Assess the Steady State Pharmacokinetics of Avastin Given With Either XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer|Completed||Phase 3|64|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:25:19.341337|2017-02-18 16:25:19.341337
NCT00349323|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-06|2008-05-07|||August 2006||2006-08-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Observational|||Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in Zambia|Community-Directed Treatment in the Control of Soil-Transmitted Helminths Among Children Aged 12-59 Months in Mazabuka District of Zambia|Completed||N/A|100|Anticipated|DBL -Institute for Health Research and Development|||||f||||f||||||||||2017-02-18 16:25:19.988157|2017-02-18 16:25:19.988157
NCT00349310|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-10-31|||April 2006||2006-04-01|October 2013|2013-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Profile of Depressive Symptoms in Parkinsons Disease|Profile of Depressive Symptoms in Parkinson's Disease (PRODEST-PD)|Completed||Phase 4|1018||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:25:20.07632|2017-02-18 16:25:20.07632
NCT00349297|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2010-05-11|||November 2003||2003-11-01|May 2010|2010-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||The Microbiological Spectrum in Acute Dacryocystitis||Completed||N/A|||Singapore National Eye Centre|||1||f||||||||||||||2017-02-18 16:25:20.179431|2017-02-18 16:25:20.179431
NCT00349284|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2007-08-31|||January 2005||2005-01-01|August 2007|2007-08-01||||||||Interventional|||A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome|A Randomised, Double-Blind Study Comparing the Efficacy and Safety of 145 mg Fenofibrate, 10 mg Ezetimibe and Their Combination in Patients With Type IIb Dyslipidemia and Features of the Metabolic Syndrome|Completed||Phase 3|181||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 16:25:20.249501|2017-02-18 16:25:20.249501
NCT00349271|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2010-01-24|||January 2006||2006-01-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Cell Therapy in Chagas Cardiomyopathy|Multicenter Randomized Study Of Cell Therapy In Cardiopathies - Chagas Cardiomyopathy|Terminated||Phase 3|182|Actual|Ministry of Health, Brazil||2||Change the sample size due to smaller variance than expected|f||||||||||||||2017-02-18 16:25:20.370719|2017-02-18 16:25:20.370719
NCT00349258|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2006-07-05|||August 2004||2004-08-01|February 2006|2006-02-01|May 2006||2006-05-01|||||Interventional|||The Use of GnRH Agonist Trigger in the Prevention of OHSS|A Prospective Randomized Study Comparing the Use of hCG or GnRH Agonist to Trigger Final Oocyte Maturation in High Responders Undergoing in-Vitro Fertilization Treatment|Completed||Phase 4|66||UConn Health|||||f||||||||||||||2017-02-18 16:25:20.471931|2017-02-18 16:25:20.471931
NCT00349245|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2016-03-22|||June 2006||2006-06-01|March 2016|2016-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Dexmedetomidine vs. Remifentanil for Sedation During AFI|A Randomized, Double-Blind Comparison Of Dexmedetomidine And Remifentanil For Sedation During Awake Fiberoptic Intubations|Completed||Phase 4|30|Actual|The University of Texas Health Science Center, Houston||1|||f||||||||||||||2017-02-18 16:25:20.806283|2017-02-18 16:25:20.806283
NCT00349232|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2006-07-06|||July 2006||2006-07-01|July 2006|2006-07-01|July 2007||2007-07-01|||||Interventional|||Lifestyle Intervention in Obese Children Attending Special Primary Education.|Prevalence of Overweight and Obesity in Children Attending Special Primary Education and the Effect of a Lifestyle Intervention.|Unknown status|Not yet recruiting|Phase 1/Phase 2|100||University College of Antwerp|||||f||||||||||||||2017-02-18 16:25:20.919208|2017-02-18 16:25:20.919208
NCT00349180|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2009-03-26|||June 2006||2006-06-01|March 2009|2009-03-01||||||||Interventional|||Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)|Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Enoxaparin Sodium（RP54563）20mg qd and 20mg Bid for 14 Days in Patients With Total Hip Replacement|Completed||Phase 3|156||Sanofi|||||f||||||||||||||2017-02-18 16:25:21.028216|2017-02-18 16:25:21.028216
NCT00349167|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2012-11-29|||December 2005||2005-12-01|November 2012|2012-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||PR-104 in Treating Patients With Advanced Solid Tumors|A Phase I, Multi-Center, Open Label, Dose Escalation Trial of the Safety and Pharmacokinetics of Intravenous PR-104 Given Every 3 Weeks in Patients With Solid Tumors|Completed||Phase 1|27|Actual|Proacta, Incorporated||1|||f||||f||||||||||2017-02-18 16:25:21.113348|2017-02-18 16:25:21.113348
NCT00349141|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2015-10-07|||June 2006||2006-06-01|October 2007|2007-10-01||||||||Interventional|||Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)|A Phase I/II Dose Escalation Study of a Vero Cell-Derived, Whole Virus H5N1 Influenza Vaccine in Healthy Volunteers Aged 18 to 45 Years|Completed||Phase 1/Phase 2|270||Nanotherapeutics, Inc.|||||f||||||||||||||2017-02-18 16:25:21.214695|2017-02-18 16:25:21.214695
NCT00349128|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2007-08-31|||January 2004||2004-01-01|August 2007|2007-08-01||||||||Interventional|||Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes|A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Low and Standard Doses of Fenofibrate in Combination With Metformin on the Lipid Profile in Patients With Type 2 Diabetes and Dyslipidemia.|Completed||Phase 2/Phase 3|382||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 16:25:21.298747|2017-02-18 16:25:21.298747
NCT00349115|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2008-05-05|||June 2006||2006-06-01|July 2006|2006-07-01|June 2008|Anticipated|2008-06-01|||||Interventional|||TCD Followed by autoSCT for Newly Diagnosed MM Patients|Induction Therapy With TCD Regimen (Thalidomide, Cyclophosphamide, Dexamethasone) Followed by Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients|Unknown status|Recruiting|Phase 2|43|Anticipated|Korean Multiple Myeloma Working Party|||||f||||||||||||||2017-02-18 16:25:21.458916|2017-02-18 16:25:21.458916
NCT00349102|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2017-01-31|||July 2006|Actual|2006-07-01|January 2017|2017-01-01|January 2014|Actual|2014-01-01|January 2012|Actual|2012-01-01||Interventional|||Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer|Evaluation of the Interest of Breath Holding for the Prevention of Radiation Pneumonitis Following Conformal Radiation Therapy|Completed||Phase 3|242|Actual|Centre Leon Berard||2|||f||||t||||||||||2017-02-18 16:25:21.560099|2017-02-18 16:25:21.560099
NCT00349089|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2011-05-02|||October 2006||2006-10-01|May 2011|2011-05-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy|Adjuvant Chemotherapy With Pemetrexed and Cisplatin vs. Vinorelbine and Cisplatin in NSCLC IB, IIA, IIB, T3N1: a Randomized Phase II Study|Unknown status|Active, not recruiting|Phase 2|134|Anticipated|Thoraxklinik am Universitätsklinikum Heidelberg||2|||f||||t||||||||||2017-02-18 16:25:21.702998|2017-02-18 16:25:21.702998
NCT00349076|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2016-07-29|||July 2006||2006-07-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|December 2015|Actual|2015-12-01||Interventional|||Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer|Prospective Randomised Multicenter Phase-III-study: Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil Plus Oxaliplatin Versus Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil for Locally Advanced Rectal Cancer|Completed||Phase 3|1256|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||||||||||||2017-02-18 16:25:21.851965|2017-02-18 16:25:21.851965
NCT00349063|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2006-07-17|||July 2005||2005-07-01|July 2006|2006-07-01||||||||Interventional|||Contact Lens Wettability|The Impact of Short Term Wearing Time on In Vivo and Ex Vivo Wettability|Completed||Phase 4|55||University of Waterloo|||||f||||||||||||||2017-02-18 16:25:22.049736|2017-02-18 16:25:22.049736
NCT00349050|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2012-04-26|||July 2006||2006-07-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception|Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception|Withdrawn||Phase 2/Phase 3|0|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 16:25:22.147324|2017-02-18 16:25:22.147324
NCT00349037|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2007-01-25|||September 2006||2006-09-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Study of the Ability of a Flu Vaccine to Prevent Flu Infection|A Prospective, Randomised, Double Blind, Placebo-Controlled Study to Assess the Efficacy of a Trivalent (A/New Caledonia/20/99, A/Panama/2007/99, B/Jiangsu/10/20) DNA Influenza Vaccine Administered by Particle Mediated Epidermal Delivery (PMED) Against a Controlled Influenza Virus Challenge.|Completed||Phase 1|105||PowderMed|||||f||||||||||||||2017-02-18 16:25:22.263944|2017-02-18 16:25:22.263944
NCT00349024|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-09-19|||July 2005||2005-07-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|||Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer|Efficacy of Gelclair™ in Reducing the Pain of Oral Mucositis in Children and Young People With Cancer (SC 2005 07)|Unknown status|Active, not recruiting|N/A|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:25:22.37065|2017-02-18 16:25:22.37065
NCT00349011|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2006-07-05|||August 2002||2002-08-01|July 2006|2006-07-01|March 2004||2004-03-01|||||Interventional|||Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer|Menopausal Therapy in Women at Increased Risk for Breast Cancer: Does a Personalized Risk Assessment and Counseling Intervention Aid in Decision-Making?|Completed||N/A|60||Yale University|||||f||||||||||||||2017-02-18 16:25:22.505174|2017-02-18 16:25:22.505174
NCT00348998|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-11-05|||April 2006||2006-04-01|November 2008|2008-11-01||||||||Interventional|||Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer|Pilot Phase II Trial of Bevacizumab in Combination With Hormonal and Radiotherapy in Patients With High-Risk Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|18|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:25:22.61546|2017-02-18 16:25:22.61546
NCT00348985|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-05-01|||March 2006||2006-03-01|May 2013|2013-05-01||||January 2010|Actual|2010-01-01||Interventional|||PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas|A Phase 1 Study of PXD101 in Combination With Bortezomib (PS-341) in Patients With Advanced Solid Tumors and Lymphoma|Completed||Phase 1|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:25:22.714854|2017-02-18 16:25:22.714854
NCT00348972|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2006-07-04|||February 2002||2002-02-01|July 2006|2006-07-01||||||||Interventional|||Lantus in Prediabetes|Assessment of Safety and Tolerability of Lantus® (Insulin Glargine) in Subjects With Impaired Fasting Glucose (IFG) or Impaired Glucose Tolerance (IGT)|Completed||Phase 1|20||Sanofi|||||||||||||||||||2017-02-18 16:25:22.844475|2017-02-18 16:25:22.844475
NCT00348959|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2012-06-12|||August 2006||2006-08-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||An Evaluation of the Effect of 'Open Window' on Psychological Well-being and Experience of Stem Cell Transplantation|An Evaluation of the Effect of 'Open Window', an Art Intervention, on Psychological Well-being and Experience of Stem Cell Transplantation for the Treatment of Haematological Malignancies|Completed||N/A|198|Actual|St. James's Hospital, Ireland||1|||f||||f||||||||||2017-02-18 16:25:22.950283|2017-02-18 16:25:22.950283
NCT00348946|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2016-10-18|||July 2006||2006-07-01|October 2016|2016-10-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Androgen Effect on Klinefelter Syndrome Motor Outcome|Androgen Effect on Motor/Cognitive Outcome in Klinefelter Syndrome|Active, not recruiting||Phase 2|150|Anticipated|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 16:25:23.058903|2017-02-18 16:25:23.058903
NCT00348933|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2012-09-21|2011-06-16||July 2006||2006-07-01|September 2012|2012-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Dietary Supplements for the Treatment of Angelman Syndrome|Efficacy of a Therapeutic Treatment Trial in Angelman Syndrome|Completed||N/A|90|Actual|University of California, San Diego||1|||f||||t||||||||||2017-02-18 16:25:23.175054|2017-02-18 16:25:23.175054
NCT00348920|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-07-22|||February 2007||2007-02-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||The Effects of High Spinal Anesthesia on Heart Function, Stress Response and Pain Control in Aortic Valve Surgery|The Effects of High Spinal Anesthesia on Hemodynamics, Stress Response, Renal Function and Post-operative Pain Control in Patients Undergoing Aortic Valve Replacement for Aortic Stenosis|Completed||N/A|14|Actual|University of Manitoba||2|||f||||t||||||||||2017-02-18 16:25:23.488888|2017-02-18 16:25:23.488888
NCT00348907|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2007-10-31|||July 2006||2006-07-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|||EVENT: Hydrotherapy and Deep Venous Thrombosis|Evaluation of the Efficacy of the Thermal Cure in the Prevention of the Post-Thrombotic Syndrome After a Deep Venous Thrombosis of Lower Limbs.|Terminated||Phase 3|3|Actual|Association Francaise pour la Recherche Thermale||2||decision to stop the study because of enrollment difficulties.|f||||f||||||||||2017-02-18 16:25:23.614372|2017-02-18 16:25:23.614372
NCT00348894|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2011-05-31|||July 2006||2006-07-01|May 2011|2011-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||[S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.|A Phase 2b Long-Term, Randomized, Open-Label, Safety And Tolerability Trial Comparing [S,S]-Reboxetine (PNU-165442g) With Routine Care In Patients With Chronic Painful Diabetic Peripheral Neuropathy (DPN).|Terminated||Phase 2|136|Actual|Pfizer||2||"- Study was terminated due to insufficient clinical efficacy observed in previous studies~   conducted in postherpetic neuralgia."|f||||f||||||||||2017-02-18 16:25:23.74587|2017-02-18 16:25:23.74587
NCT00348881|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-08-15|2013-06-10||June 2006||2006-06-01|August 2013|2013-08-01|June 2008|Actual|2008-06-01|October 2007|Actual|2007-10-01||Interventional|||Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants|Large Scale Safety and Immunogenicity Study of a DTaP-Hep B-PRP-T Combined Vaccine Compared to Tritanrix HepB/Hib™, Both Given Concomitantly With OPV at 6, 10, and 14 Weeks of Age in Healthy Filipino Infants|Completed||Phase 3|2133|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:25:24.013265|2017-02-18 16:25:24.013265
NCT00348868|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2008-03-14|||July 2006||2006-07-01|April 2007|2007-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Buprenorphine HIV Care Integration Project|Miami Buprenorphine HIV Care Integration Project|Completed||N/A|10|Actual|University of Miami||2|||f||||f||||||||||2017-02-18 16:25:27.197406|2017-02-18 16:25:27.197406
NCT00348855|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2011-11-12|||November 2006||2006-11-01|November 2011|2011-11-01|March 2010|Actual|2010-03-01|September 2009|Actual|2009-09-01||Interventional|ESCAPE||Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice|Effects of a Series of Intensified Prevention Consultations on the Changes in Goals and Risk Factors in Hypertensive Patients at High Cardiovascular Risk|Completed||Phase 4|1836|Actual|Collège National des Généralistes Enseignants||2|||f||||t||||||||||2017-02-18 16:25:27.317562|2017-02-18 16:25:27.317562
NCT00348842|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2011-04-07|||March 2006||2006-03-01|February 2006|2006-02-01|June 2006|Anticipated|2006-06-01|||||Interventional|||Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-cancer Modalities|Phase II: Safety and Primary Efficacy of Clinical Application of Newcastle Disease Virus for the Treatment of Patients Resistant to All Conventional Modalities|Withdrawn||Phase 2|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:25:27.428173|2017-02-18 16:25:27.428173
NCT00348829|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2016-10-25|||June 2006||2006-06-01|May 2009|2009-05-01|September 2012|Actual|2012-09-01|December 2008|Actual|2008-12-01||Interventional|||Mitral Valve Reconstruction in Chronic Heart Failure (CHF): Identification of Predictors for a Successful Therapy|Mitral Valve Reconstruction in Patients With Chronic Heart Failure and Secondary Mitral Insufficiency: Identification of Predictors for a Successful Therapy|Terminated||Phase 2|5|Actual|University of Leipzig||2||not enough patients to e recruited, problems with the conductance catheter|f||||f||||||||||2017-02-18 16:25:27.521923|2017-02-18 16:25:27.521923
NCT00348816|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2016-01-25|||May 2006||2006-05-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer|A Phase II Study to Assess the Feasibility and Activity of Concomitant Radiation and Docetaxel Chemotherapy Followed by Docetaxel Chemotherapy in Prostate Cancer Patients With a Persistent or Rising PSA After Radical Prostatectomy|Active, not recruiting||Phase 2|50|Anticipated|The University of Texas Health Science Center at San Antonio||1|||f||||||||||||||2017-02-18 16:25:27.61853|2017-02-18 16:25:27.61853
NCT00348803|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2006-07-05||||||June 2006|2006-06-01||||||||Observational|||Gene Mutations in Secondary Pulmonary Hypertension||Unknown status|Recruiting|N/A|||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:25:27.72996|2017-02-18 16:25:27.72996
NCT00348790|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-10-21|2014-10-21||May 2006||2006-05-01|October 2014|2014-10-01|July 2013|Actual|2013-07-01|November 2010|Actual|2010-11-01||Interventional|||Vatalanib in Treating Patients With Recurrent or Progressive Meningioma|A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas|Completed||Phase 2|25|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 16:25:27.802257|2017-02-18 16:25:27.802257
NCT00348777|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-04|2011-06-21|||June 2006||2006-06-01|June 2011|2011-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||THERMARTHROSE: Gonarthrosis and Water Cure|Evaluation of the Effects of a Water Cure on Gonarthrosis: Randomized Clinical Study Including Water Cure Versus Continuation of the Usual Treatment|Completed||Phase 3|462|Actual|Association Francaise pour la Recherche Thermale||2|||f||||f||||||||||2017-02-18 16:25:30.687105|2017-02-18 16:25:30.687105
NCT00348764|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2006-07-05|||March 2004||2004-03-01|July 2006|2006-07-01|December 2006||2006-12-01|||||Interventional|||ESGVS: Sclerotherapy With Lauromacrogol|Treatment of Greater Saphenous Vein (GSV) Insufficiency Using Echo-Guided Sclerotherapy With Lauromacrogol 400 Foam –Comparative Study of 3% Versus 1% Concentration.|Completed||Phase 3|150||University Hospital, Grenoble|||||f||||||||||||||2017-02-18 16:25:30.796963|2017-02-18 16:25:30.796963
NCT00348751|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-05-07|||June 2004||2004-06-01|June 2006|2006-06-01|November 2005||2005-11-01|||||Interventional|||CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners|The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners - The CholGate Randomized Trial|Completed||N/A|||Erasmus Medical Center|||||f||||||||||||||2017-02-18 16:25:30.883499|2017-02-18 16:25:30.883499
NCT00348738|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2007-10-31|||July 2000||2000-07-01|October 2007|2007-10-01|July 2009|Anticipated|2009-07-01|||||Interventional|||Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome|The Influence of the Pre-Therapeutic Increase in the Hemoglobin Level in the Blood Through Erythropoietin to the Therapy Results of the Primary Radiation Therapy for Carcinoma of the Cervix|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 16:25:30.975302|2017-02-18 16:25:30.975302
NCT00348725|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2007-08-31|||April 2005||2005-04-01|August 2007|2007-08-01||||||||Interventional|||Acceptability of a Fixed Combination of Fenofibrate and Metformin|An Open Label, Parallel-Arm, Multicenter Trial Assessing the Acceptability of 4 Dosages of a New Fixed Dose Combination of Fenofibrate and Metformin in Patients With Type 2 Diabetes and Dyslipidemia|Completed||Phase 3|69||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 16:25:31.083713|2017-02-18 16:25:31.083713
NCT00348712|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2012-07-09||2009-11-09|October 2006||2006-10-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes|Efficacy and Safety of Inhaled Pre-prandial Human Insulin Plus Metformin Versus Rosiglitazone Plus Metformin in Type 2 Diabetes|Terminated||Phase 3|301|Actual|Novo Nordisk A/S||2||See termination reason in detailed description|f||||f||||||||||2017-02-18 16:25:31.19545|2017-02-18 16:25:31.19545
NCT00348699|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2014-02-21|||July 2006||2006-07-01|December 2011|2011-12-01||||January 2013|Actual|2013-01-01||Interventional|||AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery|A Phase I Study and Pharmacological Trial of Once Weekly Aminoflavone Prodrug (AFP464) Administered 3 Out of Every 4 Weeks in Solid Tumor Patients|Completed||Phase 1|68|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:25:31.560154|2017-02-18 16:25:31.560154
NCT00348686|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2012-03-05|2009-06-08||June 2006||2006-06-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)|A Multicenter, Non-comparative, Phase IV Study to Evaluate the Effect of Candesartan Based Therapy in the Percent Change of proBNP Level After 24 Week Treatment in the Patients With Hypertension With Left Ventricular Hypertrophy|Completed||Phase 4|315|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:25:31.680722|2017-02-18 16:25:31.680722
NCT00348673|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-05|2013-08-14|2013-08-14||February 2006||2006-02-01|August 2013|2013-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061|A Randomised, Double Blind, Placebo-controlled, Multicenter Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061|Completed||Phase 2|49|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:25:31.996244|2017-02-18 16:25:31.996244
NCT00348660|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2016-04-22|||August 2005||2005-08-01|April 2016|2016-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal Clinic|The Seroprevalence of Hepatitis C and Course of Infection Among Pregnant Women Attending a Toronto Inner City Antenatal Care Clinic|Completed||N/A|653|Actual|St. Michael's Hospital, Toronto|||1||f||||||||||||||2017-02-18 16:25:33.23349|2017-02-18 16:25:33.23349
NCT00348647|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-07-03|||December 2004||2004-12-01|December 2004|2004-12-01|March 2006||2006-03-01|||||Interventional|||Prevention of Injuries by an Exercise Program – a RCT|Can Lower Extremity Overuse Injuries Be Prevented by an Exercise Program Aiming at Muscular Strength, Flexibility and Coordination – a RCT|Unknown status|Active, not recruiting|N/A|900||Amager Hospital|||||f||||||||||||||2017-02-18 16:25:33.313449|2017-02-18 16:25:33.313449
NCT00348634|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2016-03-02|||July 2006||2006-07-01|March 2016|2016-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients|The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation|Terminated||Phase 4|60|Anticipated|Novartis||||Terminated early due to regulatory action suspending tegaserod use in 2007|||||||||||||||2017-02-18 16:25:33.397604|2017-02-18 16:25:33.397604
NCT00348621|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-07-03|||June 1999||1999-06-01|January 2006|2006-01-01|June 2002||2002-06-01|||||Interventional|||A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents|Clinical Trial of Interventions for Visual Loss in Nursing Home Residents|Unknown status|Active, not recruiting|Phase 4|1600||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:25:33.496144|2017-02-18 16:25:33.496144
NCT00348608|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-06-28|||June 2006||2006-06-01|June 2007|2007-06-01||||||||Interventional|||Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast–Enhanced CT Angiography of Arteries of the Heart||Completed||Phase 3|540||GE Healthcare|||||||||||||||||||2017-02-18 16:25:33.595114|2017-02-18 16:25:33.595114
NCT00348595|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2016-06-30|||May 2006||2006-05-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer|Phase I/II Double Blinded Randomized Study to Determine the Tolerability and Efficacy of 2 Different Doses of Revlimid (CC-5013, Lenalidomide) in Biochemically Relapsed Prostate Cancer Patients (M0) After Local Treatment|Completed||Phase 1/Phase 2|60|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||t||||||||Undecided||2017-02-18 16:25:33.930364|2017-02-18 16:25:33.930364
NCT00348582|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-06-21||||||June 2007|2007-06-01||||||||Interventional|||Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery|Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:25:34.045696|2017-02-18 16:25:34.045696
NCT00348569|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-08-15|||May 2006||2006-05-01|August 2007|2007-08-01||||||||Interventional|||A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain|A Prospective, Multicenter Study of GE LightSpeed Volume Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain Patients Suspected of Coronary Artery Disease|Completed||N/A|304||GE Healthcare|||||f||||||||||||||2017-02-18 16:25:34.141572|2017-02-18 16:25:34.141572
NCT00348556|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2012-09-14|2012-09-14||December 2005||2005-12-01|September 2012|2012-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure|Efficacy of Intra-renal Infusion of BNP in Enhancing Renal Function in Human CHF With Cardiorenal Syndrome: A Pilot Study|Terminated||Phase 1/Phase 2|4|Actual|Mayo Clinic|The study was terminated early because the company providing catheter was bought out, and funding and supplies were terminated.|1||Company providing catheter bought out, funding and supplies terminated|f||||t||||||||||2017-02-18 16:25:34.226587|2017-02-18 16:25:34.226587
NCT00348543|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2011-08-03|||December 1999||1999-12-01|October 1999|1999-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Prophylactic Laser Treatment of Drusen Maculopathy|Prophylactic Laser Treatment of Drusen Maculopathy in Age-related Macular Degeneration.|Completed||N/A|150||University Hospital, Linkoeping|||||f||||||||||||||2017-02-18 16:25:34.473497|2017-02-18 16:25:34.473497
NCT00348530|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-10-17|||January 2006||2006-01-01|January 2006|2006-01-01|December 2007||2007-12-01|||||Interventional|||Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy|Prospective, Randomized Comparison of Therapy With Verapamil or Carvedilol on Long-Term Outcomes of Patients With Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy|Unknown status|Recruiting|Phase 4|120||Medical University of Silesia|||||f||||||||||||||2017-02-18 16:25:34.571784|2017-02-18 16:25:34.571784
NCT00348517|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2012-03-02|||July 2006||2006-07-01|March 2012|2012-03-01|November 2006||2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety/Efficacy of Systane Free vs Refresh Liquigel|An Evaluation of the Safety and Efficacy of Systane Free FID 105783|Completed||N/A|100|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:25:34.669894|2017-02-18 16:25:34.669894
NCT00348504|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-11-16|||March 2003||2003-03-01|November 2007|2007-11-01|June 2005|Actual|2005-06-01|||||Interventional|||Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.|Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.|Completed||Phase 3|1300||Abbott|||||f||||||||||||||2017-02-18 16:25:34.762451|2017-02-18 16:25:34.762451
NCT00348491|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2016-11-16|||February 2006||2006-02-01|November 2016|2016-11-01||||May 2006|Actual|2006-05-01||Interventional|||Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib|A Randomized, Double-blind, Double-dummy, Parallel Group, Single-center Study Evaluating the Analgesic Effect of Single Doses of Lumiracoxib 400 mg, Celecoxib 400 mg and Placebo in the Treatment of Post-dental Surgery Pain|Completed||Phase 4|364||Novartis|||||||||||||||||||2017-02-18 16:25:34.856599|2017-02-18 16:25:34.856599
NCT00348478|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2011-10-27|||December 2005||2005-12-01|November 2005|2005-11-01|January 2008||2008-01-01|||||Interventional|||Impact of Water and Health Education Programs on Trachoma and Ocular C. Trachomatis in Niger|Determination of the Impact of Water and Health Education on Trachoma and Ocular C. Trachomatis in Niger|Completed||Phase 4|720||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:25:34.961491|2017-02-18 16:25:34.961491
NCT00348465|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2008-05-20|||May 2006||2006-05-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|||||Observational|||Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds|An Observational Study to Evaluate the Changes in Prostate Volume Over Time With The Use of Transrectal Ultrasound and Computed Tomography Following Permanent Prostate Brachytherapy With Iodine-125 Seeds.|Completed||N/A|29|Actual|New York Methodist Hospital|||1||f||||t||||||||||2017-02-18 16:25:35.057858|2017-02-18 16:25:35.057858
NCT00348270|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2010-05-11|||July 2005||2005-07-01|May 2010|2010-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Comparison of the Quality of Vision Provided by AMO Tecnis Z9000 and Alcon Laboratories MA60 Acrysof Posterior Chamber Intraocular Lenses|Comparison of the Quality of Vision Provided by AMO Tecnis Z9000 Three-piece Silicone Posterior Chamber Intraocular Lens and Alcon Laboratories MA60 Acrysof Three-piece Acrylic Posterior Chamber Intraocular Lens|Completed||Phase 4|80|Anticipated|Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:35.145432|2017-02-18 16:25:35.145432
NCT00348257|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-02|2007-02-27|||July 2006||2006-07-01|February 2007|2007-02-01|September 2006||2006-09-01|||||Interventional|||Safety and Efficacy of Using LEORTEC-300 System For Hair Removal Treatment|Safety and Efficacy of Using LEORTEC-300 System For Hair Removal Treatment|Completed||Phase 1/Phase 2|30||Leortec Medical Systems Ltd|||||f||||t||||||||||2017-02-18 16:25:35.249301|2017-02-18 16:25:35.249301
NCT00348218|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2010-05-10|||June 2006||2006-06-01|May 2010|2010-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Pilot Study of Neurovision to Improve Vision and Slow Myopia Progression in Children With Myopia|Pilot Study To Evaluate The Efficacy Of Neurovision'S NVC™- Vision Correction Technology For The Improvement In Visual Acuity In Myopic Children And Slowing Down Of Myopia Progression|Completed||Phase 1|30|Anticipated|Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:35.558373|2017-02-18 16:25:35.558373
NCT00348205|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2012-12-20||2010-04-09|June 2005||2005-06-01|December 2012|2012-12-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia||Completed||N/A|97|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 16:25:35.661411|2017-02-18 16:25:35.661411
NCT00348192|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2009-05-28|||May 2006||2006-05-01|May 2009|2009-05-01||||||||Interventional|||SB-742457 And Donepezil In Alzheimer's Disease|A Double-Blind, Randomised, Placebo-Controlled, Parallel Group Study to Investigate the Effects of SB-742457, Donepezil and Placebo on Cognition in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|200||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:25:35.766764|2017-02-18 16:25:35.766764
NCT00348179|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-01-23|||April 2004||2004-04-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Vascular Function in Adolescent, Diabetic Children|Vascular Function in Adolescent, Diabetic Children|Completed||N/A|85|Actual|Children's Mercy Hospital Kansas City||1|||f||||f||||||||||2017-02-18 16:25:35.893099|2017-02-18 16:25:35.893099
NCT00348166|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2011-10-03|||December 2005||2005-12-01|October 2011|2011-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?|Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten|Withdrawn||Phase 1|180|Anticipated|KK Women's and Children's Hospital||||Stringent eligibility criterion caused difficulties in recruiting patients.|f||||||||||||||2017-02-18 16:25:35.988546|2017-02-18 16:25:35.988546
NCT00348153|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2012-11-30|||August 2006||2006-08-01|November 2012|2012-11-01|March 2013|Anticipated|2013-03-01|September 2012|Actual|2012-09-01||Interventional|||Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)|Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients With Different Forms of Refractory Uveitis Acronym: Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)|Unknown status|Active, not recruiting|Phase 2/Phase 3|40|Anticipated|Heidelberg University||2|||f||||||||||||||2017-02-18 16:25:36.060435|2017-02-18 16:25:36.060435
NCT00348140|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2016-10-28||2010-03-29|July 2006||2006-07-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|REFLECT-3||Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease|A 54-week, Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy to Acetylcholinesterase Inhibitors on Cognition and Overall Clinical Response in APOE e4-stratified Subjects With Mild to Moderate Alzheimer's Disease (REFLECT-3)|Completed||Phase 3|1450|Actual|GlaxoSmithKline||3|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:25:36.274327|2017-02-18 16:25:36.274327
NCT00348127|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2010-06-23|||March 2003||2003-03-01|January 2010|2010-01-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Singapore Pilot Study to Assess Neurovision in Treatment of Low Myopia|A Singapore Pilot Study To Evaluate The Efficacy Of A Computerized System For The Vision Improvement Of People With Low Myopia|Completed||Phase 1|||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:36.813619|2017-02-18 16:25:36.813619
NCT00348114|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-07-03|||May 2002||2002-05-01|January 2002|2002-01-01|May 2006||2006-05-01|||||Interventional|||Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell Deficiency|Transplantation of Ex-Vivo Expanded Human Limbal Epithelial Stem Cells (LSC) on Amniotic Membrane (AM) for Limbal Stem Cell Deficiency (LSCD).|Suspended||Phase 2|8||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:36.915203|2017-02-18 16:25:36.915203
NCT00348101|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2007-05-29|||June 2006||2006-06-01|April 2007|2007-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation|The Influence of Continuous Perioperative Beta-Blocker Therapy in Combination With Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation and Myocardial Ischaemia in High-Risk Vascular Surgery Patients|Completed||Phase 3|75|Actual|Klinikum Ludwigshafen|||||f||||f||||||||||2017-02-18 16:25:36.993575|2017-02-18 16:25:36.993575
NCT00348088|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2012-12-12|||May 2006||2006-05-01|December 2012|2012-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Melanoma Biomarker Study|CXCL1 Biomarker Study in Metastatic Melanoma|Completed||N/A|20|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||||||||||||2017-02-18 16:25:37.08709|2017-02-18 16:25:37.08709
NCT00348075|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2010-05-11|||January 2004||2004-01-01|May 2010|2010-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Singapore Study to Assess How Neurovision Improve the Vision of Adults With Low to Moderate Myopia|A Singapore Study To Evaluate The Efficacy OF Neurovision'S NVC™- Vision Correction Technology For The Visual Improvement In Subjects With Low Or Moderate Adult Myopia|Completed||N/A|||Singapore National Eye Centre||1|||f||||||||||||||2017-02-18 16:25:37.1783|2017-02-18 16:25:37.1783
NCT00348062|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-05-30||||||May 2007|2007-05-01||||||||Interventional|||A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension|A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:25:37.285302|2017-02-18 16:25:37.285302
NCT00348049|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-10-23|||November 2002||2002-11-01|October 2002|2002-10-01|August 2005||2005-08-01|||||Interventional|||Efficacy of LASIK Versus PRK in Asians With Mild and Moderate Myopia|A Prospective, Randomized Trial Evaluating the Operational Efficacy of LASIK vs. PRK for the Correction of Low and Moderate Myopia in the Singapore Armed Forces|Completed||N/A|||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:37.36346|2017-02-18 16:25:37.36346
NCT00348036|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2013-04-29|||September 2008||2008-09-01|April 2013|2013-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Group Intervention for Interpersonal Trauma|Trauma Interventions for Low-income Women in Primary Care|Completed||N/A|27|Actual|Georgetown University||2|||f||||f||||||||||2017-02-18 16:25:37.452822|2017-02-18 16:25:37.452822
NCT00005715|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1990||1990-08-01|May 2000|2000-05-01|July 1995|Actual|1995-07-01|||||Observational|||Community Intervention for Minority Children With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.81383|2017-02-18 18:14:28.81383
NCT00348023|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-02-07||||||February 2007|2007-02-01||||||||Interventional|||Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension|Comparison of Bimatoprost 0.03% Monotherapy vs. Dual Therapy With Travoprost 0.004% and Timolol 0.5% in Patients With Glaucoma and Ocular Hypertension|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:25:37.559226|2017-02-18 16:25:37.559226
NCT00348010|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-02|2012-06-20|||November 2000||2000-11-01|June 2012|2012-06-01|July 2001||2001-07-01|||||Interventional|||A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the Knee|Double-blind, Randomized, Dose-titration, Parallel-group Comparison of the Efficacy and Safety of Extended Release Tramadol Hydrochloride (Tramadol HCl ER) and Placebo in the Treatment of Osteoarthritis of the Knee.|Completed||Phase 3|245||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:25:37.637583|2017-02-18 16:25:37.637583
NCT00347997|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2011-12-07||||||December 2011|2011-12-01||||||||Interventional|||A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for Lasik||Withdrawn||N/A|0|Actual|Bausch & Lomb Incorporated||1||Decision made by B&L to cancel the study, no subjects enrolled.|f||||f||||||||||2017-02-18 16:25:37.729506|2017-02-18 16:25:37.729506
NCT00347984|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2012-04-07|||December 2005||2005-12-01|August 2008|2008-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use|The Effect of Systane® Compared to Marketed Artificial Tears on Frequency of Drop Use|Completed||N/A|50||Alcon Research|||||f||||||||||||||2017-02-18 16:25:37.814886|2017-02-18 16:25:37.814886
NCT00347971|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-09-04|||June 2006||2006-06-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma|Phase 1, Open-Label, Dose-Escalation Study to Assess the Safety and Pharmacokinetics of Recombinant Interleukin 21 (rIL-21) Administered in Combination With Rituxan (Rituximab) in Subjects With B-Cell Non Hodgkin's Lymphoma|Completed||Phase 1|23|Actual|ZymoGenetics||1|||f||||||||||||||2017-02-18 16:25:37.892594|2017-02-18 16:25:37.892594
NCT00347958|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2013-11-11|2010-05-14||August 2006||2006-08-01|November 2013|2013-11-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Interventional|||Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine|Safety Among Adolescents and Adults of Revaccination With Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®) 4 to 5 Years After a Previous Dose|Completed||Phase 4|545|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:25:37.998256|2017-02-18 16:25:37.998256
NCT00347945|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-07-03|||October 2000||2000-10-01|January 2002|2002-01-01|November 2001||2001-11-01|||||Interventional|||Randomized Trial of Treatments for Convergence Insufficiency|A Randomized Clinical Trial of Pencil Push-Ups Versus Office Based Vision Therapy For the Treatment of Convergence Insufficiency|Completed||Phase 3|90||Pennsylvania College of Optometry|||||f||||||||||||||2017-02-18 16:25:38.328374|2017-02-18 16:25:38.328374
NCT00347932|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2015-03-04|2009-06-29||June 2006||2006-06-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.|A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis.|Completed||Phase 3|957|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 16:25:38.441271|2017-02-18 16:25:38.441271
NCT00347919|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2016-01-28|2009-11-19||July 2006||2006-07-01|January 2016|2016-01-01|March 2015|Actual|2015-03-01|August 2008|Actual|2008-08-01||Interventional|||Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer|A Phase II, Open-Label, Randomized, Multicenter Trial of GW786034 (Pazopanib) in Combination With Lapatinib (GW572016) Compared to Lapatinib Alone as First Line Therapy in Subjects With Advanced or Metastatic Breast Cancer With ErbB2 Fluorescence In Situ Hybridization (FISH) Positive Tumors|Completed||Phase 2|189|Actual|GlaxoSmithKline|In 2008 at primary completion, study was terminated. In 2011, protocol amendment 4 (Am4), allowed continuation of treatment until PD for the 1 par. This par. completed the study per Am 4. Par. last visit occurred, the study is considered completed.|3|||f||||f||||||||||2017-02-18 16:25:38.937692|2017-02-18 16:25:38.937692
NCT00347906|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2010-01-11|||November 2003||2003-11-01|November 2003|2003-11-01|September 2005||2005-09-01|||||Interventional|||Photodynamic Therapy (PDT) Versus Transpupillary Thermotherapy (TTT) in Occult Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (AMD)|Photodynamic Therapy Versus Transpupillary Thermotherapy in Occult CNV in Age-related Macular Degeneration|Terminated||N/A|||University Hospital, Linkoeping||2||Difficulties in recruiting patients|f||||f||||||||||2017-02-18 16:25:40.315774|2017-02-18 16:25:40.315774
NCT00347893|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-06-30|||May 2006||2006-05-01|June 2006|2006-06-01||||||||Observational|||The Efficacy of Selective Laser Trabeculoplasty|Clinical Results of Selective Laser Trabeculoplasty in Treatment of Open Angle Glaucoma|Unknown status|Recruiting|N/A|||Glaucoma Research & Education Group|||||f||||||||||||||2017-02-18 16:25:40.386657|2017-02-18 16:25:40.386657
NCT00347880|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2012-03-01|||September 2004||2004-09-01|March 2012|2012-03-01|July 2007|Actual|2007-07-01|||||Observational|||Atrial and Brain Natriuretic Peptides in Bronchiolitis|Atrial and Brain Natriuretic Peptides in Bronchiolitis|Completed||Phase 1|100|Actual|University of Florida|||1||f||||t||||||||||2017-02-18 16:25:40.483049|2017-02-18 16:25:40.483049
NCT00347867|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-07-03|||July 2006||2006-07-01|June 2006|2006-06-01||||||||Interventional|||Viagra for the Treatment of IUGR|Improvement of Utero-Placental Perfusion and Fetal Growth in IUGR and PET by Administration of Sildenafil Citrate in Pregnancy|Unknown status|Not yet recruiting|Phase 4|20||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:25:40.580911|2017-02-18 16:25:40.580911
NCT00347854|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2016-11-18|||April 2006||2006-04-01|February 2012|2012-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Fluorophotometry Evaluation of Lubricant Eye Drops|Fluorophotometry Evaluation of Lubricant Eye Drops FID 105783|Completed||N/A|40|Actual|Alcon Research||4|||f||||f||||||||||2017-02-18 16:25:40.680088|2017-02-18 16:25:40.680088
NCT00347841|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-05-30||||||May 2007|2007-05-01||||||||Interventional|||Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost|Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:25:40.786162|2017-02-18 16:25:40.786162
NCT00345722|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2007-05-07|||June 2006||2006-06-01|May 2007|2007-05-01|February 2007|Actual|2007-02-01|||||Interventional|||The Effect of Strawberries in a Cholesterol-Lowering Dietary Portfolio|The Long-Term Effect of Viscous Fibers, Soy Protein, and Plant Sterol Foods in Combination on Serum Cholesterol and Other Risk Factors for Cardiovascular Disease|Completed||Phase 2|50||University of Toronto|||||f||||||||||||||2017-02-18 16:25:42.505739|2017-02-18 16:25:42.505739
NCT00347828|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-07-03|||June 2006||2006-06-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose|Prospective Study Comparing the Effectiveness of Zymar and Vigamox for Preoperative Antibiotic Sterilization of the Ocular Surface After Loading Dose|Unknown status|Active, not recruiting|Phase 4|40||Ophthalmic Consultants of Boston|||||f||||||||||||||2017-02-18 16:25:40.862952|2017-02-18 16:25:40.862952
NCT00347815|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-07-03|||June 2006||2006-06-01|June 2006|2006-06-01|August 2006||2006-08-01|||||Interventional|||Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers|Pharmacokinetics and Pharmacodynamics of Buprenorphine After Intravenous Administration in Healthy Volunteers|Unknown status|Recruiting|Phase 1|24||Danish University of Pharmaceutical Sciences|||||f||||||||||||||2017-02-18 16:25:40.956516|2017-02-18 16:25:40.956516
NCT00347802|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-05-30||||||May 2007|2007-05-01||||||||Interventional|||Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%|Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:25:41.0275|2017-02-18 16:25:41.0275
NCT00347789|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-06-30|||May 1997||1997-05-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Observational|||Effectiveness of a Procedure for Previously Failed Glaucoma Surgery|Efficacy of Transconjunctival Mitomycin-C in Needle Revisions of Failing Trabeculectomy|Completed||N/A|100||Glaucoma Research & Education Group|||||f||||||||||||||2017-02-18 16:25:41.116822|2017-02-18 16:25:41.116822
NCT00347776|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2013-04-03|||August 2001||2001-08-01|April 2013|2013-04-01|December 2006|Actual|2006-12-01|December 2003|Actual|2003-12-01||Interventional|STAR||Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia|Trial of Antibiotics to Reduce Recurrent Trichiasis (STAR)|Completed||Phase 4|1450||Johns Hopkins University||3|||f||||t||||||||||2017-02-18 16:25:41.213802|2017-02-18 16:25:41.213802
NCT00347763|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2013-04-12|||June 2000||2000-06-01|May 2004|2004-05-01|October 2002|Actual|2002-10-01|September 2002|Actual|2002-09-01||Interventional|||Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania|Strategies for the Control of Blinding Trachoma: Effect of Fly Spray|Completed||Phase 4|350||Johns Hopkins University||2|||f||||||||||||||2017-02-18 16:25:41.341488|2017-02-18 16:25:41.341488
NCT00347750|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2015-11-01|||September 2006||2006-09-01|April 2007|2007-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations|Pharmacokinetics and Pharmacodynamics of Lopinavir an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations|Withdrawn||Phase 3|0|Actual|Rambam Health Care Campus||||lack of participants|f||||||||||||||2017-02-18 16:25:41.44954|2017-02-18 16:25:41.44954
NCT00347737|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2013-01-14|||June 2006||2006-06-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL|The Effects of Therapy With Teriparatide (Recombinant Parathyroid Hormone (1-34) on Vascular Compliance and Osteoprotegerin/RANKL|Withdrawn||N/A|0|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 16:25:41.541772|2017-02-18 16:25:41.541772
NCT00347724|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-02|2012-06-20|||November 2000||2000-11-01|June 2012|2012-06-01|November 2001||2001-11-01|||||Interventional|||A Study Comparing the Effectiveness and Safety of Extended-release Tramadol Versus Placebo in the Treatment of Chronic Low Back Pain|Double-blind, Randomized, Placebo-controlled, Parallel Group Comparison of the Efficacy and Safety of Extended Release Tramadol (Tramadol ER) 300 mg and 200 mg to Placebo in the Treatment of Chronic Low Back Pain|Completed||Phase 3|600||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:25:41.649181|2017-02-18 16:25:41.649181
NCT00345800|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2015-06-18|||April 2006||2006-04-01|June 2015|2015-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes|Single Center, Therapeutic Exploratory Clinical Trial to Evaluate the Safety of Sodium Oxybate (Xyrem) 500 mg/mL Oral Solution on Potential Endocrine Changes at Currently Labeled Therapeutic Dose Regimens (4.5 - 9 g/Day Divided Into Two Equal Doses) During 12 Weeks of Treatment of Cataplexy in Adult Patients With Narcolepsy.|Completed||Phase 4|25|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 16:25:41.733559|2017-02-18 16:25:41.733559
NCT00345787|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2008-04-11|||May 2006||2006-05-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain|A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Determine the Efficacy and Safety of BTDS Compared to Placebo in Subjects With Moderate to Severe Osteoarthritic Pain of the Hip or Knee|Completed||Phase 3|262|Actual|Mundipharma Pte Ltd.||2|||f||||||||||||||2017-02-18 16:25:41.856729|2017-02-18 16:25:41.856729
NCT00345774|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2008-05-27|||June 2006||2006-06-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|||||Interventional|||Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Short-Term Efficacy and Safety of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease|Completed||Phase 2|72|Anticipated|Epix Pharmaceuticals, Inc.|||||f||||f||||||||||2017-02-18 16:25:41.989963|2017-02-18 16:25:41.989963
NCT00345761|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2010-08-13|||February 2006||2006-02-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer|Phase I/II Study of R340 (Capecitabine), L-OHP (Oxaliplatin) and R435 (Bevacizumab) in Advanced and/or Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|64|Actual|Chugai Pharmaceutical||3|||f||||f||||||||||2017-02-18 16:25:42.089465|2017-02-18 16:25:42.089465
NCT00345748|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2011-04-11||2011-04-11|June 2006||2006-06-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate|A Phase II, Multi-center, Randomized, Double-Blind, Placebo Controlled, Dose Response Study to Evaluate the Safety and Efficacy of Two Different Doses of Abatacept (BMS-188667) Administered Intravenously to Japanese Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate|Completed||Phase 2|194|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 16:25:42.201993|2017-02-18 16:25:42.201993
NCT00345735|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2012-05-04|||May 2006||2006-05-01|May 2012|2012-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)|Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients. A Randomised, Double-blind, Placebo-controlled, Cross-over Confirmatory Trial Testing Fentanyl and Placebo in Eight Breakthrough Pain Episodes|Completed||Phase 2|150|Anticipated|Nycomed|||||f||||||||||||||2017-02-18 16:25:42.419957|2017-02-18 16:25:42.419957
NCT00347698|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-06-30|||March 2006||2006-03-01|June 2006|2006-06-01|August 2007||2007-08-01|||||Interventional|||Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy|Intravitreal Bevacizumab Vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-Year Prospective, Contralateral Eye Study|Unknown status|Recruiting|Phase 2/Phase 3|30||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:25:42.787097|2017-02-18 16:25:42.787097
NCT00347685|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-01|2012-06-20|||October 2000||2000-10-01|June 2012|2012-06-01|February 2003||2003-02-01|||||Interventional|||A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.|Open-label Assessment of the Safety and Effectiveness of Extended Release Tramadol (Tramadol ER) in the Treatment of Chronic Non-malignant Pain.|Completed||Phase 3|650||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:25:43.071098|2017-02-18 16:25:43.071098
NCT00347672|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2008-01-18|||June 2006||2006-06-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults|Phase 1 Inpatient Study of the Safety and Immunogenicity of Live Influenza A Vaccine H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca), a Live Attenuated Virus Vaccine Candidate for the Prevention of Avian Influenza H5N1 Infection in the Event of a Pandemic|Completed||Phase 1|42|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||f||||||||||2017-02-18 16:25:43.164889|2017-02-18 16:25:43.164889
NCT00347659|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-02-27|||June 2006||2006-06-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|December 2006|Actual|2006-12-01||Interventional|||US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study|Phase 1 Study of the Biologic Lung Volume Reduction (BLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema|Completed||Phase 1|6|Actual|Aeris Therapeutics||1|||f||||t||||||||||2017-02-18 16:25:43.285115|2017-02-18 16:25:43.285115
NCT00347646|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2011-12-07|||September 2006||2006-09-01|December 2011|2011-12-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)|An Open Label Sequential Dose Response Observational Study of Intravitreally Administered Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)|Terminated||Phase 1/Phase 2|4|Actual|Bausch & Lomb Incorporated||1||Lack of Efficacy|f||||t||||||||||2017-02-18 16:25:43.39818|2017-02-18 16:25:43.39818
NCT00347620|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2010-03-12|||August 2000||2000-08-01|March 2010|2010-03-01|December 2003||2003-12-01|||||Interventional|||Improving Vision and Quality of Life in the Nursing Home|Improving Vision and Quality of Life in the Nursing Home|Completed||N/A|400||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 16:25:43.489889|2017-02-18 16:25:43.489889
NCT00347607|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2011-10-27|||April 2002||2002-04-01|March 2002|2002-03-01|November 2005||2005-11-01|||||Interventional|||Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania|Cost-effectiveness of Three Alternative Azithromycin Treatment Strategies for Trachoma Control in Tanzania|Completed||Phase 4|2700||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:25:43.601848|2017-02-18 16:25:43.601848
NCT00347594|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2014-01-15|||August 2005||2005-08-01|January 2014|2014-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)|A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)|Completed||N/A|76|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 16:25:43.692953|2017-02-18 16:25:43.692953
NCT00347581|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2006-07-03|||May 2003||2003-05-01|January 2005|2005-01-01|August 2004||2004-08-01|||||Interventional|||A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children|A Randomized Clinical Trial of the Effectiveness of Base-in Prism Reading Glasses Vs. Placebo Reading Glasses for Symptomatic Convergence Insufficiency in Children|Completed||Phase 3|72||Pennsylvania College of Optometry|||||f||||||||||||||2017-02-18 16:25:43.79596|2017-02-18 16:25:43.79596
NCT00347568|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2012-06-04|||July 2006||2006-07-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|September 2007|Actual|2007-09-01||Interventional|||BC-DAISY: A Breast Cancer Decision Aid System|BC-DAISY: A Breast Cancer Decision Aid System|Completed||N/A|195|Actual|Rhode Island Hospital||1|||f||||||||||||||2017-02-18 16:25:43.911194|2017-02-18 16:25:43.911194
NCT00347555|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2013-04-11|||May 2006||2006-05-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly|Phase I, Double-Blinded, Placebo-Controlled Dosage-Escalation Study of the Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly|Completed||Phase 1|80|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:25:43.998269|2017-02-18 16:25:43.998269
NCT00347542|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2013-05-31|||July 2006||2006-07-01|May 2013|2013-05-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese Men|A Double Blind Randomized Control Trial to Study the Effect of Vitamin D Supplementation on Peripheral Insulin Sensitivity in Centrally Obese Men|Completed||N/A|100||Sitaram Bhartia Institute of Science and Research|||||f||||||||||||||2017-02-18 16:25:44.118062|2017-02-18 16:25:44.118062
NCT00347529|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2007-01-25|||August 2006||2006-08-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu|A Randomised Double Blind Dose-Ranging Study to Assess the Safety, Tolerability and Immunogenicity of a Monovalent H5 DNA Influenza Vaccine (A Vietnam/1194/2004) Administered by Particle Mediated Epidermal Delivery (PMED) to Healthy Adults|Completed||Phase 1|75||PowderMed|||||f||||||||||||||2017-02-18 16:25:44.211358|2017-02-18 16:25:44.211358
NCT00347516|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2010-05-11|||December 2005||2005-12-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Comparative Study of Three IOL Power Calculation Formulae for Asian Eyes Shorter Than 22mm or Longer Than 25mm|Comparative Study of Three Intraocular Lens Power Calculation Formulae for Asian Eyes With Axial Lengths Less Than 22mm and Greater Than 25mm|Completed||N/A|210|Anticipated|Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:44.296402|2017-02-18 16:25:44.296402
NCT00347503|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2007-07-12||||||July 2007|2007-07-01||||||||Interventional|||Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients|Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients|Completed||Phase 4|||Innovative Medical|||||f||||||||||||||2017-02-18 16:25:44.382492|2017-02-18 16:25:44.382492
NCT00005714|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1990||1990-08-01|August 2004|2004-08-01|July 1996|Actual|1996-07-01|||||Observational|||Development and Evaluation of Community Asthma Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:28.886182|2017-02-18 18:14:28.886182
NCT00347477|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2009-04-30|||September 2005||2005-09-01|March 2009|2009-03-01|March 2009||2009-03-01|April 2007|Actual|2007-04-01||Interventional|||Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest|Fluid Shift in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest, and How do They Manage Life Afterwards?|Completed||Phase 3|23|Anticipated|Haukeland University Hospital||2|||f||||||||||||||2017-02-18 16:25:44.560488|2017-02-18 16:25:44.560488
NCT00347464|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2015-12-01|||June 2006||2006-06-01|December 2015|2015-12-01|August 2008|Anticipated|2008-08-01|||||Observational|||Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome|Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 16:25:44.653265|2017-02-18 16:25:44.653265
NCT00347451|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2010-05-11|||October 2005||2005-10-01|May 2010|2010-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Optical Coherence Tomography Imaging of the Posterior Segment in High Myopia.|Optical Coherence Tomography Imaging of the Posterior Segment in High Myopia.|Completed||N/A|150|Anticipated|Singapore National Eye Centre|||1||f||||||||||||||2017-02-18 16:25:44.729307|2017-02-18 16:25:44.729307
NCT00347438|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2015-11-05|2015-10-05||September 2006||2006-09-01|November 2015|2015-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer|A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer|Terminated||Phase 2|18|Actual|University of Chicago||1||a result of slow accrual|f||||t||||||||||2017-02-18 16:25:44.828487|2017-02-18 16:25:44.828487
NCT00347425|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-05-20|||December 2006||2006-12-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Switch Study of Existing Atypical Antipsychotics to Bifeprunox|A Multicenter, Open-Label, Parallel-Group, Randomized, Flexible Dose Study To Evaluate the Safety and Tolerability of Switching From Existing Atypical Antipsychotics to Bifeprunox in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|286|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:25:45.10096|2017-02-18 16:25:45.10096
NCT00347412|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2011-11-07|||November 2006||2006-11-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer|Phase 3 Trial, Randomized, Open-Label, of NOV-002 in Combination With Paclitaxel and Carboplatin vs. Paclitaxel and Carboplatin Alone for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)|Completed||Phase 3|880|Anticipated|Cellectar Biosciences, Inc.||2|||f||||t||||||||||2017-02-18 16:25:45.484915|2017-02-18 16:25:45.484915
NCT00347399|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-06-30|||March 2006||2006-03-01|June 2006|2006-06-01|June 2007||2007-06-01|||||Interventional|||Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration|Effects of Intravitreal Injection of Bevacizumab in Combination With Verteporfin Photodynamic Therapy|Unknown status|Recruiting|Phase 2|25||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:25:45.84478|2017-02-18 16:25:45.84478
NCT00347386|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2010-12-06|||July 2005||2005-07-01|December 2010|2010-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Therapeutic Zinc in Infant Bacterial Illness|Zinc as an Immunomodulator in the Treatment of Possible Serious Bacterial Infections in Infants 7 Days and up to 4 Months of Age|Completed||Phase 2/Phase 3|700|Actual|Centre For International Health||2|||f||||t||||||||||2017-02-18 16:25:45.94607|2017-02-18 16:25:45.94607
NCT00347373|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-06-30|||August 2004||2004-08-01|June 2006|2006-06-01|September 2005||2005-09-01|||||Interventional|||Effect of Conjugated Linoleic Acid Supplement on Body Composition|Conjugated Linoleic Acid and Body Fat Mass in Obese Humans|Completed||N/A|60||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 16:25:46.085605|2017-02-18 16:25:46.085605
NCT00347360|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2016-11-03|2009-04-22||July 2006||2006-07-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial|A Randomized, Double-Blind, Double-Dummy, Parallel Group, Factorial Design Trial to Assess the Efficacy and Safety of up to Six Weeks Treatment With 20mg, 40mg, or 80mg QD Doses of Carvedilol Controlled Release Formulation (COREG CR) or 10mg, 20mg, or 40mg QD Doses of Lisinopril (Zestril) or a Combination of One of the Doses of Each Medication|Completed||Phase 3|654|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:25:46.205609|2017-02-18 16:25:46.205609
NCT00347347|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2010-05-11|||February 2006||2006-02-01|May 2010|2010-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Comparative Study of Cycloplegic Refraction and Subjective Refraction With Fogging in School Age Children||Completed||N/A|150|Anticipated|Singapore National Eye Centre|||1||f||||||||||||||2017-02-18 16:25:50.271805|2017-02-18 16:25:50.271805
NCT00347334|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2016-01-27|||March 2006||2006-03-01|January 2014|2014-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Is Home Positioning Time Associated With Torticollis Rate of Recovery?|Is Home Positioning Time Associated With Torticollis Rate of Recovery?|Completed||Phase 1|150|Anticipated|The Cleveland Clinic|||||f||||||||||||||2017-02-18 16:25:50.355636|2017-02-18 16:25:50.355636
NCT00347321|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2009-12-02|||July 2006||2006-07-01|March 2007|2007-03-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|ETOC||Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC)|Evaluation of Early Percutaneous Tracheostomy in Patients Undergoing Cardiovascular Surgery and Requiring Prolonged Mechanical Ventilation|Completed||Phase 3|212|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:25:50.4347|2017-02-18 16:25:50.4347
NCT00347308|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2012-04-29|2009-08-10||July 2007||2007-07-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Observational|||Photographic Assessment of Eyebrow Position and Range of Motion|Photographic Assessment of Eyebrow Position and Range of Motion|Completed||N/A|40|Actual|The New York Eye & Ear Infirmary|||1||f||||f||||||||||2017-02-18 16:25:50.547422|2017-02-18 16:25:50.547422
NCT00347295|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2013-10-31|||June 2006||2006-06-01|October 2013|2013-10-01|January 2007||2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Randomised, Double-blind Study to Investigate the Safety and Efficacy of Brotizolam in Insomnia Outpatients.|A Randomised, Double-blinded, Double-dummy, Multi-center, Paralleled Study to Investigate the Safety and Efficacy of Brotizolam (Lendormin) Compared With Estazolam in Insomnia Outpatients.|Completed||Phase 3|253||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:25:50.750528|2017-02-18 16:25:50.750528
NCT00347282|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2010-05-11|||March 2006||2006-03-01|May 2010|2010-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Post Enucleation Socket Syndrome Study|Post-enucleation Socket Syndrome Study (PESSS): Part 1 - Three Dimensional Volumetric Assessment of Anophthalmic Sockets With the New Multi-detector Computed Tomographic Technology|Completed||N/A|10|Anticipated|Singapore National Eye Centre|||1||f||||||||||||||2017-02-18 16:25:50.851025|2017-02-18 16:25:50.851025
NCT00347269|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2014-10-17|||June 2006||2006-06-01|October 2014|2014-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Primary Care Intervention Strategy for Anxiety Disorders|Coordinated Anxiety Learning and Management (CALM): Improving Primary Care Anxiety Outcomes|Completed||Phase 4|1004|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:25:50.939423|2017-02-18 16:25:50.939423
NCT00347256|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-12-09||||||December 2008|2008-12-01||||||||Interventional|||Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer|Preoperative Radiotherapy and Concomitant Chemotherapy Followed by Surgery for Advanced Paranasal Sinus Carcinoma|Withdrawn||N/A|60|Anticipated|University of Tennessee|||||f||||||||||||||2017-02-18 16:25:51.240791|2017-02-18 16:25:51.240791
NCT00347243|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-10-25|||September 2005||2005-09-01|March 2006|2006-03-01|June 2006||2006-06-01|||||Interventional|||Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses|Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical|Completed||Phase 4|||Federal University of São Paulo|||||f||||||||||||||2017-02-18 16:25:51.320298|2017-02-18 16:25:51.320298
NCT00347230|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-07-03|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||Intacs for Keratoconus|Intacs for Keratoconus|Unknown status|Recruiting|N/A|20||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:51.396483|2017-02-18 16:25:51.396483
NCT00347217|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2011-08-29|||February 2006||2006-02-01|August 2011|2011-08-01|January 2009|Actual|2009-01-01|||||Observational|||Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event|An Observational Study Into the Usage and Efficacy of Crestor 5mg as a Start Dosage in Achieving the LDL-C Target Level in Both Statin-naive and Treated Primary and Secondary Prevention Patients With a High Risk of a Cardiovascular Event.|Completed||Phase 4|3840|Anticipated|AstraZeneca|||1||f||||||||||||||2017-02-18 16:25:51.505497|2017-02-18 16:25:51.505497
NCT00347204|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2006-06-29|||January 2006||2006-01-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK|Double Masked Evaluation of Acular LS Versus Nevanac for Postoperative Pain Control in Eyes Undergoing PRK|Completed||Phase 4|40||Center For Excellence In Eye Care|||||f||||||||||||||2017-02-18 16:25:52.013286|2017-02-18 16:25:52.013286
NCT00347191|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2011-06-22|||January 2006||2006-01-01|June 2011|2011-06-01|June 2006|Actual|2006-06-01|||||Observational|||Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments.|Phase 4 Study Evaluating the Relationship Between Intraocular Pressure and Central Corneal Thickness Using Various Instruments in Ocular Hypertension, Normal-tension Glaucoma, Primary Open Angle Glaucoma, Keratoconus and Normal Eyes.|Completed||Phase 4|1000||Aston University|||1||f||||f||||||||||2017-02-18 16:25:52.097897|2017-02-18 16:25:52.097897
NCT00347178|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-06-30|||January 2005||2005-01-01|June 2006|2006-06-01|January 2013||2013-01-01|||||Interventional|||Asymptomatic Narrow Angles - Laser Iridotomy Study; Multicentric RCT|Prophylactic Laser Iridotomy for Eyes With Narrow Drainage Angles; A Randomised Controlled Trial|Unknown status|Recruiting|N/A|544||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:52.17846|2017-02-18 16:25:52.17846
NCT00347165|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2006-06-30|||September 2005||2005-09-01|June 2006|2006-06-01|September 2006||2006-09-01|||||Interventional|||Intravitreal Bevacizumab for Age-Related Macular Degeneration|Intravitreal Bevacizumab Therapy for Neovascular Age-Related Macular Degeneration: A Pilot Study|Unknown status|Recruiting|Phase 2|50||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:25:52.27258|2017-02-18 16:25:52.27258
NCT00347152|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-09-10|||November 2006||2006-11-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellectual Disability|Overnight Versus Progressive Conversion of Multiple Daily Dose Enteric-Coated Divalproex to Once-Daily Divalproex Extended Release: Which Strategy is Better Tolerated by Patients With Intellectual Disabilities?|Completed||N/A|18|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 16:25:52.458235|2017-02-18 16:25:52.458235
NCT00347139|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2016-10-26|||May 2006||2006-05-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients|Multi-centre, Randomised, Double-blind, Placebo-controlled, Four-way Incomplete Block Crossover Study, to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Administration of Three Inhaled Doses (25, 100 and 400 mcg Once Daily) of GW642444|Completed||Phase 2|56|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:25:52.577423|2017-02-18 16:25:52.577423
NCT00347126|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2010-05-11|||April 2006||2006-04-01|May 2010|2010-05-01|April 2008|Actual|2008-04-01|||||Observational|||Results of Mass Switch From Latanoprost to Travoprost|Efficacy and Safety of a Systematic Switch From Latanoprost to Travoprost in Patients With Glaucoma|Completed||N/A|372|Anticipated|Singapore National Eye Centre|||1||f||||||||||||||2017-02-18 16:25:52.690927|2017-02-18 16:25:52.690927
NCT00347113|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2014-09-22|||July 2006||2006-07-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania|The Effect of Schistosome and Soil-transmitted Helminth Infections on Malaria,Infection, Morbidity and Antibody Response Among School and Pre-school Children in Mwanza, Tanzania|Completed||N/A|620|Anticipated|DBL -Institute for Health Research and Development|||||f||||||||||||||2017-02-18 16:25:52.964127|2017-02-18 16:25:52.964127
NCT00347100|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2009-09-14|||June 2006||2006-06-01|September 2009|2009-09-01||||May 2008|Actual|2008-05-01||Interventional|TARGET||Insulin Glargine in Type 2 Diabetic Patients|Treatment of Early Insulinization With Glargine in Type 2 Diabetes Patients Uncontrolled on Sulfonylurea or Metformin Monotherapy|Completed||Phase 4|387|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:25:53.067733|2017-02-18 16:25:53.067733
NCT00346814|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2009-06-28|||July 2006||2006-07-01|June 2006|2006-06-01|November 2006|Anticipated|2006-11-01|||||Interventional|||Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome|Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome|Unknown status|Recruiting|Phase 2/Phase 3|||Asociación para Evitar la Ceguera en México|||||f||||||||||||||2017-02-18 16:25:59.456933|2017-02-18 16:25:59.456933
NCT00347087|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2007-10-30|||July 2004||2004-07-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure|Effect of the Angiotensin II Receptor Antagonist Irbesartan on Insulin Sensitivity and Metabolic Profile in Patients With Chronic Heart Failure|Completed||Phase 4|36|Actual|Charite University, Berlin, Germany||1|||f||||||||||||||2017-02-18 16:25:53.178806|2017-02-18 16:25:53.178806
NCT00347074|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-07-03|||September 2003||2003-09-01|September 2003|2003-09-01|March 2005||2005-03-01|||||Observational|||A Clinical Study of Keratoconus in Asian Patients and Assessment of Different Topographic Patterns of Keratoconus in Asian Patients||Completed||N/A|120||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:25:53.26974|2017-02-18 16:25:53.26974
NCT00347061|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2009-10-01|||May 2006||2006-05-01|October 2009|2009-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH|A Long-term Safety and Efficacy of SL77.0499-10 10mg Once-daily Tablets in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia (BPH).A Multicenter, 52-week, Open Label, Uncontrolled Study.|Completed||Phase 3|148|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:25:53.359823|2017-02-18 16:25:53.359823
NCT00347048|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2014-08-25|||September 2006||2006-09-01|August 2014|2014-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients|Tacrolimus (FK506) P-III Placebo-Controlled Double-Blind Study in Moderate to Severe Refractory Ulcerative Colitis Patients|Completed||Phase 3|62|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:25:53.46075|2017-02-18 16:25:53.46075
NCT00347035|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2006-10-25||||||June 2006|2006-06-01||||||||Interventional|||INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE|INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE|Terminated||Phase 4|||Federal University of São Paulo|||||f||||||||||||||2017-02-18 16:25:53.580454|2017-02-18 16:25:53.580454
NCT00347022|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2013-04-08|2011-12-23||May 2006||2006-05-01|April 2013|2013-04-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications||Completed||Phase 4|145|Actual|Guerbet||2|||f||||||||||||||2017-02-18 16:25:53.653615|2017-02-18 16:25:53.653615
NCT00347009|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2012-05-31|2010-09-20||May 2005||2005-05-01|March 2011|2011-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis|An Open Label Study of Adefovir Dipivoxil for the Treatment of Patients With Chronic Hepatitis B Related Advanced Fibrosis or Cirrhosis.|Completed||Phase 4|155|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:25:54.078399|2017-02-18 16:25:54.078399
NCT00346996|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2012-08-31|||May 2007||2007-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|November 2011|Actual|2011-11-01||Interventional|||Insulin Analogues and Severe Hypoglycaemia|The Effect of Insulin Analogues and Human Insulin on the Incidence of Severe Hypoglycaemia in Hypoglycaemia Prone Type 1 Diabetic Patients|Completed||Phase 4|179|Actual|Steno Diabetes Center||2|||f||||f||||||||||2017-02-18 16:25:54.518183|2017-02-18 16:25:54.518183
NCT00346983|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-05-08|||June 2006||2006-06-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics|Pilot Study of the Effect of Pegaptanib Sodium to Prevent Worsening of Cystoid Macular Edema Following Cataract Surgery in Diabetics|Terminated||Phase 1/Phase 2|4|Actual|Johns Hopkins University||2||Difficulty enrolling eligible subjects|f||||f||||||||||2017-02-18 16:25:54.628612|2017-02-18 16:25:54.628612
NCT00346970|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2008-05-05|||July 2006||2006-07-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|||||Interventional|||The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)|Randomized Clinical Trial to Study the Effect of Extended Release Niacin on Endothelial Function, Oxidative Stress and Endothelial Progenitor Cells in Patients With the Metabolic Syndrome.|Completed||Phase 4|32|Actual|Hannover Medical School||2|||f||||||||||||||2017-02-18 16:25:54.852015|2017-02-18 16:25:54.852015
NCT00346957|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2012-03-03|||April 1999||1999-04-01|March 2012|2012-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration||Completed||Phase 2|128|Actual|Alcon Research||4|||f||||||||||||||2017-02-18 16:25:54.963106|2017-02-18 16:25:54.963106
NCT00346944|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2012-08-27|||September 2002||2002-09-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Health Effects From Removal of Amalgam Restorations in Patients With Symptoms Allegedly Related to Dental Amalgam|Health Effects From Removal of Amalgam Restorations in Patients With Symptoms Allegedly Related to Dental Amalgam - A Study of Patients Examined at the Dental Biomaterials Adverse Reaction Unit in 1993 to 1999|Completed||Phase 4|50|Actual|University of Bergen||2|||f||||t||||||||||2017-02-18 16:25:55.048484|2017-02-18 16:25:55.048484
NCT00346931|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2010-07-22|||December 2004||2004-12-01|June 2006|2006-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular Pressure|Phacotrabeculotomy vs. CCI+Phaco in Patients With Borderline Control of Intraocular Pressure|Terminated||N/A|9|Actual|Medical University of Vienna||2|||f||||||||||||||2017-02-18 16:25:55.148095|2017-02-18 16:25:55.148095
NCT00346918|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2014-02-26|||June 2006||2006-06-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Sirolimus (Rapamune®) for Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD): a Randomized Controlled Study.|Completed||Phase 3|100|Actual|University of Zurich||2|||f||||t||||||||||2017-02-18 16:25:55.24216|2017-02-18 16:25:55.24216
NCT00346905|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-03-19|||October 2003||2003-10-01|June 2006|2006-06-01|February 2008||2008-02-01|||||Interventional|||Endoscopic Implantation of Enteryx for the Treatment of GERD|Endoscopic Implantation of Enteryx for the Treatment of Gastroesophageal Reflux Disease (GERD): Post Market Study|Unknown status|Active, not recruiting|N/A|300||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 16:25:55.364294|2017-02-18 16:25:55.364294
NCT00346892|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2016-09-08|||November 2001||2001-11-01|September 2016|2016-09-01||||March 2003|Actual|2003-03-01||Interventional|||To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV|Reactogenicity & Immunogenicity Study of Two Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine Co-administered With Either OPV or IPV in Healthy Infants (Approximately 5-10 Weeks Old) in South Africa|Completed||Phase 2|450||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:25:55.460288|2017-02-18 16:25:55.460288
NCT00346879|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-02-22|||August 2006||2006-08-01|February 2016|2016-02-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Study to Determine Effective Dosing of Fondaparinux in Obese Persons|Thromboprophylaxis in the Morbidly Obese With Weight Based Dosing of Fondaparinux: A Pharmacodynamic Study|Withdrawn||Phase 1|0|Actual|Indiana University||1||Funding withdrawn; study closed due to lack of accrual.|f||||t||||||||||2017-02-18 16:25:55.571412|2017-02-18 16:25:55.571412
NCT00346866|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2008-08-04|||May 2000||2000-05-01|August 2008|2008-08-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Anecortave Acetate Versus Placebo in AMD Patients Following PDT|Anecortave Acetate Versus Placebo in AMD Patients Following PDT|Completed||Phase 2|136||Alcon Research|||||||||||||||||||2017-02-18 16:25:55.668849|2017-02-18 16:25:55.668849
NCT00346853|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2008-07-09|||November 2005||2005-11-01|July 2008|2008-07-01|September 2006|Actual|2006-09-01|May 2006|Actual|2006-05-01||Interventional|||Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy|Clinical Interventions Against Stargardt Macular Dystrophy: Phase 1 Pilot Study of 4-MP as an Inhibitor of Dark Adaptation|Completed||Phase 1|10|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 16:25:55.751072|2017-02-18 16:25:55.751072
NCT00346840|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2012-06-15|||June 2003||2003-06-01|June 2012|2012-06-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Interventional|||Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour|Controlled-Release Misoprostol Vaginal Insert in Parous Women for Labor Induction: Randomized Trial|Completed||Phase 2|124|Actual|Ferring Pharmaceuticals||4|||f||||f||||||||||2017-02-18 16:25:55.858392|2017-02-18 16:25:55.858392
NCT00345696|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2011-08-23|||June 2006||2006-06-01|August 2011|2011-08-01|January 2011|Actual|2011-01-01|October 2008|Actual|2008-10-01||Interventional|||1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.|Phase II Study of First Line Capecitabine Administered on Continuous Way Combined With Oxaliplatin and Bevacizumab Every Two Weeks in Metastatic Colorectal Cancer Patients.|Completed||Phase 2|32|Actual|Unidad Integral de Investigación en Oncología S.L.||1|||f||||f||||||||||2017-02-18 16:25:56.159124|2017-02-18 16:25:56.159124
NCT00345683|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2016-10-18|2012-06-15||July 2007||2007-07-01|October 2016|2016-10-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.|Single-blind, Randomized, Controlled, Multinational Study for the Evaluation of Safety of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to Monovalent Hib Control Vaccine in Healthy Infants at 2, 4, 6, and 12 to 15 Months of Age.|Completed||Phase 3|4021|Actual|GlaxoSmithKline|Only information about specific categories of AEs (SAEs, NOCIs, rash and AEs resulting in ER visits) were collected in this study.|2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:25:56.281993|2017-02-18 16:25:56.281993
NCT00345670|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2008-09-02|||June 2006||2006-06-01|September 2008|2008-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-534, a Live, Attenuated Intranasal Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy RSV and PIV3 Seropositive 1-9 Year-Old Children|Completed||Phase 1|120||MedImmune LLC||3|||f||||t||||||||||2017-02-18 16:25:56.882291|2017-02-18 16:25:56.882291
NCT00345657|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2006-06-27|||July 2003||2003-07-01|June 2006|2006-06-01|May 2004||2004-05-01|||||Interventional|||Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care|Extended-Release Niacin/Lovastatin Versus Usual Care for Treatment of Dyslipidemia in a Primary Care Setting (EXTEND Study)|Completed||Phase 4|100||In His Image|||||f||||||||||||||2017-02-18 16:25:57.017137|2017-02-18 16:25:57.017137
NCT00345644|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2009-12-04|||March 2006||2006-03-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|OSMAUSE||Risedronate in Osteopenic Postmenopausal Women|A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 24 Month, Monocenter Study Comparing Weekly Oral Risedronate 35 mg and Placebo|Completed||Phase 3|156|Anticipated|Sanofi||2|||f||||f||||||||||2017-02-18 16:25:57.12762|2017-02-18 16:25:57.12762
NCT00345631|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2012-05-25|2012-02-27||February 2007||2007-02-01|May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device|ECLIPSE Trial - Ensure's Vascular Closure Device Speeds Hemostasis Trial|Completed||Phase 3|488|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 16:25:57.243531|2017-02-18 16:25:57.243531
NCT00345618|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2016-02-19||2016-02-19|June 2006||2006-06-01|February 2016|2016-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|CASSIOPEA||Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach|An International, Multicenter, Randomized, Double-blind, Double-dummy, Parallel Group, Study of 3-month or 6-month Treatment With SSR126517E (3.0 mg s.c. Once-weekly) Versus Oral INR-adjusted Warfarin in the Treatment of Patients With Symptomatic Pulmonary Embolism With or Without Symptomatic Deep Venous Thrombosis|Completed||Phase 3|3202|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:25:58.237602|2017-02-18 16:25:58.237602
NCT00345605|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2015-10-06|2014-05-15||February 2008||2008-02-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|May 2011|Actual|2011-05-01||Interventional|||Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder|A Randomized, Double-Blind, Crossover Study of Sodium Phenylbutyrate and Low-Dose Arginine Compared to High-Dose Arginine Alone on Liver Function, Ureagenesis and Subsequent Nitric Oxide Production in Patients With Argininosuccinic Aciduria|Completed||Phase 2|12|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 16:25:58.398732|2017-02-18 16:25:58.398732
NCT00345592|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2014-05-13|2014-04-04||October 2006||2006-10-01|May 2014|2014-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|TRADE HF||TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients|TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients|Completed||Phase 4|420|Actual|Guidant Corporation||2|||f||||t||||||||||2017-02-18 16:25:58.943175|2017-02-18 16:25:58.943175
NCT00346827|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2006-06-29||||||June 2006|2006-06-01||||||||Interventional|||"Apomorphine Nasal Powder in the Treatment of Parkinson's Disease Off Periods."||Unknown status|Not yet recruiting|Phase 2/Phase 3|||Britannia Pharmaceuticals Ltd.|||||f||||||||||||||2017-02-18 16:25:59.32172|2017-02-18 16:25:59.32172
NCT00346801|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2012-10-19|||September 2003||2003-09-01|October 2012|2012-10-01||||October 2012|Actual|2012-10-01||Interventional|||CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)|A Phase I Study of Concurrent CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|20|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:25:59.623505|2017-02-18 16:25:59.623505
NCT00346788|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2011-06-27|||January 2005||2005-01-01|May 2008|2008-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||The Subvastus Approach in Total Knee Arthroplasty|The Subvastus Approach in Total Knee Arthroplasty|Completed||Phase 4|126|Actual|Nova Scotia Health Authority||2|||f||||f||||||||||2017-02-18 16:25:59.743977|2017-02-18 16:25:59.743977
NCT00346775|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-10-20|||May 2006||2006-05-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)|A Randomized, Single-Blind, Cross-Over, Multicenter Study to Validate the Preference Module of the Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) Administered to Adult Subjects With Seasonal Allergic Rhinitis During a Three-week Cross-over Study|Completed||Phase 3|97|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:25:59.837555|2017-02-18 16:25:59.837555
NCT00346762|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2014-05-16|||September 2005||2005-09-01|May 2014|2014-05-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China|Host and Viral Factors in HIV-1-Infected Typical Progressors and Long-Term Survivors Among Former Blood Donors in Anhui Province, China|Completed||N/A|186|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Whole blood and urine~   "|||2017-02-18 16:25:59.946812|2017-02-18 16:25:59.946812
NCT00346749|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-10-27|||December 2006||2006-12-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.|A Randomized, Double-Blind, Parallel-Group, 12-Week Study to Evaluate the Anti-Inflammatory Effect of Fluticasone Propionate/Salmeterol DISKUS 250/50mcg BID Compared With Salmeterol DISKUS 50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Terminated||Phase 4|180||GlaxoSmithKline||1||"The study was terminated due to difficulties with finding sites and subjects willing to~   participate."|f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:00.242619|2017-02-18 16:26:00.242619
NCT00346736|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-09-01|||May 2005||2005-05-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|June 2006|Actual|2006-06-01||Interventional|||Use of Acupuncture In Children With Autistic Spectrum Disorder|Use of Acupuncture In Autistic Spectrum Disorder|Completed||Phase 3|80|Anticipated|The University of Hong Kong|||||f||||||||||||||2017-02-18 16:26:00.375209|2017-02-18 16:26:00.375209
NCT00346723|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2009-01-29|||July 2006||2006-07-01|January 2009|2009-01-01||||||||Interventional|||Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.|Immunogenicity and Reactogenicity of Trivalent Influenza Subunit Vaccine Influvac® for the Season 2006/2007. An Open, Baseline-Controlled Study in Two Groups of Healthy Subjects: Adults and Elderly.|Completed||Phase 3|120||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 16:26:00.479249|2017-02-18 16:26:00.479249
NCT00346710|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2006-06-28||||||November 2005|2005-11-01||||||||Interventional|||Patient Experiences in Rheumatology|Communication Skills in Rheumatology Fellows|Unknown status|Active, not recruiting|N/A|60||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:26:00.568838|2017-02-18 16:26:00.568838
NCT00346697|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2014-11-04|2014-07-15||October 2006||2006-10-01|November 2014|2014-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients|A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy|Completed||Phase 4|48|Actual|Brown, Todd, M.D., Ph.D.||2|||f||||f||||||||||2017-02-18 16:26:00.673289|2017-02-18 16:26:00.673289
NCT00346684|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-08-11|||July 2006||2006-07-01|August 2008|2008-08-01||||November 2007|Actual|2007-11-01||Interventional|||Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL)|Rituximab in Primary LPHD (RIPL) - First Line Therapy for Patients With Lymphocyte Predominant Hodgkin´s Disease (LPHD) in Clinical Stage IA Using the Monoclonal Anti-CD20 Antibody Rituximab.|Completed||Phase 2|||University of Cologne|||||f||||||||||||||2017-02-18 16:26:01.407792|2017-02-18 16:26:01.407792
NCT00346671|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2012-09-20|||January 2006||2006-01-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|October 2009|Actual|2009-10-01||Interventional|||Effects of Reiki on Stress|Effects of Reiki on Physiological Consequences of Acute Stress|Completed||Phase 1|257|Actual|The Cleveland Clinic||3|||f||||t||||||||||2017-02-18 16:26:01.49794|2017-02-18 16:26:01.49794
NCT00346658|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2008-12-12|||July 2002||2002-07-01|December 2008|2008-12-01|September 2006||2006-09-01|||||Interventional|||Magnesium Supplementation to Prevent Bone Loss|Magnesium Supplementation to Prevent Bone Loss|Completed||Phase 1|74||University of Tennessee|||||f||||||||||||||2017-02-18 16:26:01.610839|2017-02-18 16:26:01.610839
NCT00346645|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2013-02-05|||June 2006||2006-06-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|May 2007|Actual|2007-05-01||Interventional|||A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer|A Phase II Study of Velcade® (Bortezomib) in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Chemotherapy|Terminated||Phase 2|46|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||||stopped after planned interim analysis for lack of efficacy|f||||||||||||||2017-02-18 16:26:01.710424|2017-02-18 16:26:01.710424
NCT00346632|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-08-16|2016-07-29||June 2006||2006-06-01|August 2016|2016-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia|Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of KW-2449 in Acute Leukemias (AML), Myelodysplastic Syndromes (MDS), and Chronic Myelogenous Leukemia (CML)|Terminated||Phase 1|37|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1||Terminated due to suboptimal dosing schedule|f||||t||||||||Undecided||2017-02-18 16:26:01.842847|2017-02-18 16:26:01.842847
NCT00346619|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2010-01-19|||October 2005||2005-10-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults|Investigating the Time of Nelfinavir Treatment Necessary for an Increase in Thymic Naive T Cells in Adults.|Completed||Phase 1|25|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:26:05.82021|2017-02-18 16:26:05.82021
NCT00346606|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2006-06-29|||January 2006||2006-01-01|May 2006|2006-05-01||||||||Interventional|||The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria|A Randomized, Double-Blind, Active-Controlled, Parallel-Group Study to Compare the Efficacy and Safety of Desloratadine 5mg (Denosin®) With Levocetirizine 5mg (Xyzal®) in the Treatment of Chronic Idiopathic Urticaria Patients|Unknown status|Recruiting|Phase 4|60||Lotus Pharmaceutical|||||f||||||||||||||2017-02-18 16:26:05.9242|2017-02-18 16:26:05.9242
NCT00346593|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2007-02-08|||May 2004||2004-05-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||Investigation of the Clinical Performance of Silicone Hydrogel Contact Lenses During Continuous Wear||Completed||N/A|||University of Melbourne|||||f||||||||||||||2017-02-18 16:26:06.202053|2017-02-18 16:26:06.202053
NCT00346580|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2011-04-01|||June 2003||2003-06-01|April 2011|2011-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||The Effects of HIV Protease Inhibitors in Severe Sepsis|The Effects of HIV Protease Inhibitors in Severe Sepsis|Completed||Phase 1|60||Mayo Clinic|||||f||||||||||||||2017-02-18 16:26:06.277868|2017-02-18 16:26:06.277868
NCT00346567|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2016-02-22|||June 2006||2006-06-01|February 2009|2009-02-01|April 2011|Actual|2011-04-01|October 2010|Actual|2010-10-01||Interventional|||Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)|Clinical Trial: Backup With Combivir (AZT/3TC) or Single Dose (sd) Truvada (FTC/TDF) in Order to Avoid NNRTI Resistance After sd Nevirapine for the Prevention of Mother-to-child Transmission (MTCT)|Completed||N/A|566|Actual|Rigshospitalet, Denmark||2|||f||||||||||||||2017-02-18 16:26:06.373899|2017-02-18 16:26:06.373899
NCT00346554|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2014-02-01|||April 2006||2006-04-01|February 2014|2014-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.|To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.|Completed||N/A|50|Actual|Hackensack University Medical Center|||1||f||||t||||||||||2017-02-18 16:26:06.49417|2017-02-18 16:26:06.49417
NCT00346541|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2006-06-29|||July 2005||2005-07-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Observational|||Role of Polymorphisms in the IL-1 Gene Cluster|Investigating the Genetic Basis of Glaucoma: Role of Polymorphisms in the IL-1 Gene Cluster|Completed||N/A|400||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:26:06.597307|2017-02-18 16:26:06.597307
NCT00346528|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2012-03-01|||July 2006||2006-07-01|March 2012|2012-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety of NGOIS Compared to BSS Plus in Pediatric Patients|Safety of NGOIS Compared to BSS Plus in Pediatric Patients|Completed||Phase 3|18|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 16:26:06.687165|2017-02-18 16:26:06.687165
NCT00346515|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-10-20|||June 2006||2006-06-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|||||Interventional|||EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting|Evaluating the Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting: The EPIC US Feasibility Study|Completed||N/A|30||Lumen Biomedical|||||f||||t||||||||||2017-02-18 16:26:06.780782|2017-02-18 16:26:06.780782
NCT00346502|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2013-12-10|||January 2006||2006-01-01|December 2013|2013-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)|Phase I/II Evaluation of Topical Application of 20% Betulinic Acid Ointment in the Treatment of Dysplastic Nevi With Moderate to Severe Dysplasia|Suspended||Phase 1/Phase 2|200|Anticipated|University of Illinois at Chicago||1||The study has been temporarily suspended due to funding issues|f||||||||||||||2017-02-18 16:26:06.870679|2017-02-18 16:26:06.870679
NCT00346489|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2007-12-21|||September 2004||2004-09-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C|Intermediate Term Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin c in Trabeculectomy Surgery.|Completed||Phase 4|70||Indiana University|||||f||||||||||||||2017-02-18 16:26:06.988359|2017-02-18 16:26:06.988359
NCT00346476|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2011-02-09|2011-01-14||April 2006||2006-04-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa|A Study of the Effects of Antiretroviral Therapy on Rates and Transmission of Tuberculosis|Completed||N/A|1250|Actual|CIPRA SA|||1||f||||f||||||Samples With DNA|"~     Sputum, Saliva~   "|||2017-02-18 16:26:07.104883|2017-02-18 16:26:07.104883
NCT00346463|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2008-04-25|||July 2006||2006-07-01|June 2006|2006-06-01|July 2013|Anticipated|2013-07-01|||||Interventional|||Antenatal Allopurinol in Intrauterine Growth Restriction|Does Antenatal Allopurinol Administration Improve Maternal and Neonatal Outcome in Intrauterine Growth Restriction?|Unknown status|Not yet recruiting|N/A|50|Anticipated|UMC Utrecht|||||f||||||||||||||2017-02-18 16:26:07.353372|2017-02-18 16:26:07.353372
NCT00346450|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-29|2010-01-11|||October 2001||2001-10-01|January 2010|2010-01-01|December 2003|Actual|2003-12-01|||||Interventional|||Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation|Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface|Completed||Phase 3|80|Anticipated|Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:26:07.444939|2017-02-18 16:26:07.444939
NCT00346437|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2012-02-08|||October 2001||2001-10-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3)|A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Patients With Stable Angina|Completed||Phase 2/Phase 3|416|Actual|Cardium Therapeutics||3|||f||||t||||||||||2017-02-18 16:26:07.545026|2017-02-18 16:26:07.545026
NCT00346424|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2008-08-12|||September 2005||2005-09-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters|Phase 3, Multicenter, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects With Occluded Central Venous Access Devices|Completed||Phase 3|300|Actual|ARCA Biopharma, Inc.||2|||f||||t||||||||||2017-02-18 16:26:07.640007|2017-02-18 16:26:07.640007
NCT00346398|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2015-04-30|2013-08-29||May 2006||2006-05-01|April 2015|2015-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|GPAC||Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study|A Phase II Multicenter, Controlled, Double-Blind Study Using Immunoprophylaxis in the Primary Prevention of Allergic Disease (ITN025AD)|Completed||Phase 2|51|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|One participant in the placebo group could not be included in intent-to-treat analyses because a sibling was also in the study|2|||f||||t||||||||||2017-02-18 16:26:07.81574|2017-02-18 16:26:07.81574
NCT00346385|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2015-03-24|||March 2002||2002-03-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors|A Phase I, Open-Label, Dose Escalation Study of Daily Dosing With BB-10901|Completed||Phase 1|97|Actual|ImmunoGen, Inc.||1|||f||||||||||||||2017-02-18 16:26:08.397158|2017-02-18 16:26:08.397158
NCT00346372|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2017-01-05|||March 2004||2004-03-01|January 2017|2017-01-01||||December 2017|Anticipated|2017-12-01||Observational|||Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy||Recruiting||N/A|800|Anticipated|Jonsson Comprehensive Cancer Center|||1||f||||||||||||||2017-02-18 16:26:08.51092|2017-02-18 16:26:08.51092
NCT00346359|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2010-05-12|||March 2006||2006-03-01|May 2010|2010-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer|Conditioning For Hematopoietic Cell Transplantation With Fludarabine Plus Targeted IV Busulfan and GVHD Prophylaxis With Thymoglobulin, Tacrolimus and Methotrexate in Patients With Myeloid Malignancies|Completed||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 16:26:08.605821|2017-02-18 16:26:08.605821
NCT00346346|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2017-01-24|||April 17, 2006||2006-04-17|January 23, 2013|2013-01-23|January 23, 2013||2013-01-23|||||Observational|||Analysis of the Immune Response to the Malaria Parasite in Mali, West Africa|Longitudinal Analysis of the B-Cell Immune Response to Plasmodium Falciparum in Mali|Completed||N/A|237|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:08.71478|2017-02-18 16:26:08.71478
NCT00346333|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2013-12-12|2012-06-18||July 2003||2003-07-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A|Randomized Clinical Trial for Retinitis Pigmentosa|Completed||Phase 3|240|Actual|National Eye Institute (NEI)||2|||f||||t||||||||||2017-02-18 16:26:08.80407|2017-02-18 16:26:08.80407
NCT00346320|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-11-25|||April 2006||2006-04-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|February 2012|Actual|2012-02-01||Interventional|||Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery|A Phase II Study of Accelerated Hypofractionated 3-Dimensional Conformal Radiotherapy (3DCRT) For Inoperable Stage I/II Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|80|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 16:26:09.438808|2017-02-18 16:26:09.438808
NCT00346294|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2009-02-19|||January 2006||2006-01-01|February 2009|2009-02-01|July 2006|Actual|2006-07-01|March 2006|Actual|2006-03-01||Interventional|||An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-Injector in Subjects With Rheumatoid Arthritis|An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-Injector in Subjects With Rheumatoid Arthritis|Completed||Phase 4|115|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:26:09.576932|2017-02-18 16:26:09.576932
NCT00346281|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2006-06-28|||June 2006||2006-06-01|June 2006|2006-06-01|June 2008||2008-06-01|||||Interventional|||32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer|A Phase IIa, Safety Study of the Active Implantable(Radiological) Medical Device 32P BioSilicon, Administered Intratumourally to Patients With Advanced, Unresectable Pancreatic Cancer, in Addition to Standard IV Gemcitabine Chemotherapy|Unknown status|Recruiting|Phase 2|15||pSiMedica Limited|||||f||||||||||||||2017-02-18 16:26:09.82602|2017-02-18 16:26:09.82602
NCT00346268|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2011-09-21|2011-09-21||December 2006||2006-12-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|PROSTATECTOMY||Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy|Randomized, Double-Blind Study Of The Morphine-Sparing Efficacy And Safety Of Parecoxib Sodium 40 Mg IV Followed By 20 Mg IV Every 12 Hours In The Treatment Of Pain Following Radical Prostatectomy|Terminated||Phase 4|105|Actual|Pfizer|This study was terminated prematurely due to slow recruitment.|2||See termination reason in detailed description.|f||||t||||||||||2017-02-18 16:26:09.933577|2017-02-18 16:26:09.933577
NCT00346255|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2013-04-22|||April 2005||2005-04-01|April 2013|2013-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|IMGN901||BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma|A Phase I Study to Assess The Safety and Pharmacokinetics of BB-10901 (huN901-DM1) Given as an Intravenous Infusion Weekly for Two Consecutive Weeks Every Three Weeks to Subjects With Relapsed and Relapsed Refractory CD56-Positive Multiple Myeloma|Completed||Phase 1|37|Actual|ImmunoGen, Inc.||1|||f||||f||||||||||2017-02-18 16:26:10.64054|2017-02-18 16:26:10.64054
NCT00346242|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2012-04-29|||March 2004||2004-03-01|April 2012|2012-04-01||||March 2006|Actual|2006-03-01||Interventional|||Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events|Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events|Completed||Phase 4|60||Novartis|||||f||||||||||||||2017-02-18 16:26:10.754718|2017-02-18 16:26:10.754718
NCT00346229|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-03-18|||April 2006||2006-04-01|October 2013|2013-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer|A Phase I, Dose Escalation and Pharmacokinetics Study of Temperature Sensitive Liposome Encapsulated Doxorubicin (ThermoDox™) and Hyperthermia in Patients With Local-Regionally Recurrent Breast Cancer|Terminated||Phase 1|29|Actual|Duke University||1||Funding|f||||||||||||||2017-02-18 16:26:10.843927|2017-02-18 16:26:10.843927
NCT00346216|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-07-25|||October 2006||2006-10-01|July 2016|2016-07-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|PRECISION||Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen|A Randomized, Double Blind, Parallel-Group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen|Completed||Phase 4|24222|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 16:26:10.99018|2017-02-18 16:26:10.99018
NCT00346190|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2007-04-11|||January 2003||2003-01-01|January 2006|2006-01-01|April 2007|Anticipated|2007-04-01|||||Interventional|||The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.|A Six Month Double-Blind, Placebo-Controlled Trial Followed by Six Month Open-Label Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.|Unknown status|Recruiting|Phase 3|10||McGill University Health Center|||||f||||||||||||||2017-02-18 16:26:17.711488|2017-02-18 16:26:17.711488
NCT00346177|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2010-09-10|||September 2010||2010-09-01|September 2010|2010-09-01|September 2012|Anticipated|2012-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Stem Cell Study for Patients With Heart Failure|Injection of Autologous CD34+ Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF < 40%|Withdrawn||Phase 2|30|Anticipated|Losordo, Douglas, M.D.||2||Funding not obtained. No subjects enrolled.|f||||t||||||||||2017-02-18 16:26:18.034537|2017-02-18 16:26:18.034537
NCT00346164|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2014-09-08|||February 2007||2007-02-01|September 2014|2014-09-01||||September 2014|Anticipated|2014-09-01||Interventional|||Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma|Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age|Unknown status|Active, not recruiting|Phase 3|588|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 16:26:18.147132|2017-02-18 16:26:18.147132
NCT00346151|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2014-12-30|2011-06-08||December 2006||2006-12-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|BESTT||Belatacept to Prevent Organ Rejection in Kidney Transplant Patients|The Safety and Efficacy of Belatacept, Antithymocyte Globulin, and Sirolimus in Recipients of Non-HLA-identical Living-donor Renal Transplants (ITN023ST)|Terminated||Phase 2|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The trial was stopped early due to meeting an acute rejection threshold of three acute rejections based on local pathology reads in the first five participants enrolled.|1||Stopping rule-acute rejection threshold-was met based on local biopsy results|f||||t||||||||||2017-02-18 16:26:18.502841|2017-02-18 16:26:18.502841
NCT00346138|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2010-01-14|||June 2005||2005-06-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema|Deep Lamellar Endothelial Keratoplasty as Surgical Treatment for Corneal Endothelial Decompensation|Completed||N/A|29|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:26:18.990557|2017-02-18 16:26:18.990557
NCT00346125|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-04-19|||April 2006||2006-04-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma|An Evaluation of PET/CT Imaging as a Predictor of Disease Free Survival Following Neo-Adjuvant Chemotherapy for Soft Tissue Sarcoma|Active, not recruiting||N/A|70|Actual|Masonic Cancer Center, University of Minnesota||2|||f||||f||||||||||2017-02-18 16:26:19.072147|2017-02-18 16:26:19.072147
NCT00346112|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2010-11-05|||June 2006||2006-06-01|November 2010|2010-11-01|December 2009||2009-12-01|||||Interventional|||Rehabilitation, Quality of Life, and Exercise Tolerance in Patients With an ICD|Rehabilitation, Quality of Life, and Exercise Tolerance in Internal Cardioverter-Defibrillator-patients, RELAX-ICD Trial|Terminated||N/A|||University Hospital Inselspital, Berne||||insufficient recruitment|f||||||||||||||2017-02-18 16:26:19.190059|2017-02-18 16:26:19.190059
NCT00346099|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2007-12-21|||June 2006||2006-06-01|December 2007|2007-12-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum|A Phase II Study to Determine the Efficacy and Safety of Panitumumab in Combination With Chemoradiotherapy for Unresectable or Locally Recurrent Adenocarcinoma of the Rectum With or Without Metastatic Disease|Withdrawn||Phase 2|0|Actual|NSABP Foundation Inc||1||"Protocol closed based on new (and as yet unpublished) information from a phase II clinical~   trial."|f||||f||||||||||2017-02-18 16:26:19.274012|2017-02-18 16:26:19.274012
NCT00346086|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2006-06-27|||May 2001||2001-05-01|June 2006|2006-06-01||||||||Interventional|||DNA Vaccine for Ragweed Allergic Adults|A Phase II Observer-Blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety, Tolerability, and Immunogenicity of Subcutaneously Administered Dynavax Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate (AIC) in Ragweed-Allergic Adults (Sponsor's Protocol NRH01)|Completed||Phase 2|36||Johns Hopkins University|||||||||||||||||||2017-02-18 16:26:19.367607|2017-02-18 16:26:19.367607
NCT00346073|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-10-26|||July 2006||2006-07-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years|A Study to Evaluate Immunogenicity and Safety of Boostrix Compared to Adacel When Administered as a Booster Vaccination in Adults Aged 19 to 64 Years of Age|Completed||Phase 3|2337|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:19.452419|2017-02-18 16:26:19.452419
NCT00346060|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2014-03-12|||February 2002||2002-02-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.|Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.|Completed||Phase 2|10|Actual|Radtke, Norman D., M.D.||1|||f||||||||||||||2017-02-18 16:26:19.829215|2017-02-18 16:26:19.829215
NCT00346047|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2008-04-11|||May 2006||2006-05-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back Pain|A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Determine the Efficacy and Safety of BTDS Compared to Placebo in Subjects With Moderate to Severe Low Back Pain|Completed||Phase 3|238|Actual|Mundipharma Pte Ltd.||2|||f||||||||||||||2017-02-18 16:26:19.933021|2017-02-18 16:26:19.933021
NCT00346034|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2009-03-30|2009-02-12||December 2006||2006-12-01|March 2009|2009-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia|A 12 Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia|Completed||Phase 3|357|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:26:20.069672|2017-02-18 16:26:20.069672
NCT00346021|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2012-06-19|||February 2005||2005-02-01|June 2012|2012-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Sun Protection for Florida's Children|Sun Protection for Florida's Children|Completed||N/A|2984|Actual|University of South Florida||2|||f||||f||||||||||2017-02-18 16:26:20.366257|2017-02-18 16:26:20.366257
NCT00346008|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2013-05-29|||October 2005||2005-10-01|December 2008|2008-12-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Observational|||Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members|Genetic Epidemiologic Studies of Melanoma in Iceland|Completed||N/A|2500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:26:20.475963|2017-02-18 16:26:20.475963
NCT00345982|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2010-09-24|||September 2006||2006-09-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Augmenting Clozapine With Sertindole - SERCLOZ|Augmenting Clozapine With Sertindole - a Double Blinded Randomized Placebo Study|Completed||N/A|50|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 16:26:20.588451|2017-02-18 16:26:20.588451
NCT00345969|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2012-04-17|||November 2004||2004-11-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|||Exercise and Testosterone Therapy in Elderly Men With Physical Frailty|Exercise and Testosterone Therapy in Elderly Men With Physical Frailty|Completed||Phase 3|25|Actual|Washington University School of Medicine||2|||f||||||||||||||2017-02-18 16:26:20.703935|2017-02-18 16:26:20.703935
NCT00345956|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-10-27|||September 2006||2006-09-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|||||Interventional|||To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)|A Placebo-controlled Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Two Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Liquid Vaccine, When Given to Healthy Infants, in Vietnam|Completed||Phase 3|375|Anticipated|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:20.819693|2017-02-18 16:26:20.819693
NCT00345943|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-05-17|||October 2004||2004-10-01|May 2016|2016-05-01|June 2017|Anticipated|2017-06-01|November 2016|Anticipated|2016-11-01||Observational|||An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa|An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa|Active, not recruiting||N/A|80|Anticipated|New York State Psychiatric Institute|||2||f||||t||||||||||2017-02-18 16:26:20.922531|2017-02-18 16:26:20.922531
NCT00345930|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2017-02-06|||September 2004||2004-09-01|June 2016|2016-06-01|July 2018|Anticipated|2018-07-01|July 2017|Anticipated|2017-07-01||Observational|||DILIN's Prospective Study|A Multi-Center, Longitudinal Study of Drug-and CAM-Induced Liver Injury|Recruiting||N/A|1600|Anticipated|Duke University|||2||f||||t||||||Samples With DNA|"~     Samples with DNA~   "|||2017-02-18 16:26:21.035354|2017-02-18 16:26:21.035354
NCT00345917|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2012-04-10|||February 2002||2002-02-01|April 2012|2012-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety Study in Retinal Transplantation for Retinitis Pigmentosa.|Safety Study in Retinal Transplantation for Retinitis Pigmentosa.|Completed||Phase 2|10|Actual|Radtke, Norman D., M.D.||1|||f||||||||||||||2017-02-18 16:26:21.163923|2017-02-18 16:26:21.163923
NCT00345904|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-09-27|||July 2006||2006-07-01|September 2016|2016-09-01|August 2006|Actual|2006-08-01|||||Interventional|||Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above|A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2006/2007 in People Aged 18 Years or Above|Completed||Phase 3|120||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:21.267679|2017-02-18 16:26:21.267679
NCT00345891|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2014-07-23|||June 2004||2004-06-01|May 2010|2010-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project)|Quite Smoking Program for Lung Cancer Patients' Families|Completed||N/A|496|Actual|Duke University|||||f||||f||||||||||2017-02-18 16:26:21.366564|2017-02-18 16:26:21.366564
NCT00345878|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-11-03|2009-11-12||September 2006||2006-09-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years|Phase 3, Open, Age-stratified Study to Assess Immunogenicity and Safety of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly According to 3-dose Schedule (0,1,6 Months) in Healthy Female Subjects Aged 15 - 55 Years and Long Term Follow-up|Completed||Phase 3|271|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:21.481581|2017-02-18 16:26:21.481581
NCT00345865|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2016-08-15|||August 2005||2005-08-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Interventional|||Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma|Autologous Peripheral Blood Stem Cell Transplant for Patients With Lymphoma|Recruiting||Phase 2|325|Anticipated|Masonic Cancer Center, University of Minnesota||3|||f||||t||||||||||2017-02-18 16:26:21.939052|2017-02-18 16:26:21.939052
NCT00345852|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2007-06-28|||March 2002||2002-03-01|June 2006|2006-06-01|May 2007||2007-05-01|||||Interventional|||Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome|A Prospective, Randomized Multicenter Trial of Amnioreduction Vs Selective Fetoscopic Laser Photocoagulation for the Treatment of Severe Twin-Twin Transfusion Syndrome|Unknown status|Active, not recruiting|N/A|150||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 16:26:22.065678|2017-02-18 16:26:22.065678
NCT00345839|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2014-07-11|2013-06-06||August 2006||2006-08-01|July 2014|2014-07-01|May 2012|Actual|2012-05-01|January 2012|Actual|2012-01-01||Interventional|EVOLVE||E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events|EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events|Completed||Phase 3|3883|Actual|Amgen||2|||f||||t||||||||||2017-02-18 16:26:22.197477|2017-02-18 16:26:22.197477
NCT00345826|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2013-01-07|||November 2005||2005-11-01|January 2013|2013-01-01||||July 2010|Actual|2010-07-01||Interventional|||Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia|Long-Term Safety and Efficacy of Dasatinib (BMS-354825) in Subjects Who Experienced Clinical Benefit on Protocol CA 180-002|Completed||Phase 1|19|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:26:26.766189|2017-02-18 16:26:26.766189
NCT00345813|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-28|2015-09-30|||October 2003||2003-10-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|July 2006|Actual|2006-07-01||Interventional|||Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer|Randomized Phase IIb Preprostatectomy Study of Dietary Supplementation With Soy and Biomarkers of Prostate Cancer Risk and Progression|Active, not recruiting||Phase 2|62|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 16:26:26.868084|2017-02-18 16:26:26.868084
NCT00345579|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2016-11-03|2012-06-15||September 2006||2006-09-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age|A Single-blind, Randomized, Controlled, Multinational Study for the Evaluation of Safety of GlaxoSmithKline (GSK) Biologicals' Investigational Vaccination Regimen Compared to Monovalent Haemophilus Influenzae Type b (Hib) Control Vaccine in Healthy Infants at 2, 4, 6, and 12 to 15 Months of Age.|Completed||Phase 3|4432|Actual|GlaxoSmithKline|Solicited symptoms and unslocited AEs were not collected during this study. Only information about specific categories of AEs (SAEs, NOCIs, rash and AEs resulting in ER visits) were collected in this study.|2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:26.975578|2017-02-18 16:26:26.975578
NCT00345566|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2006-06-27|||August 2006||2006-08-01|June 2006|2006-06-01|December 2007||2007-12-01|||||Interventional|||Effect of Protein Composition on Gastric Emptying|Effect of the Protein Composition on the Gastric Emptying Rate in Children With Cerebral Paresis|Unknown status|Not yet recruiting|N/A|25||Ullevaal University Hospital|||||f||||||||||||||2017-02-18 16:26:27.862957|2017-02-18 16:26:27.862957
NCT00345553|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2016-09-20|||May 2006||2006-05-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|BASIC||Biliary Atresia Study in Infants and Children|Biliary Atresia Study in Infants and Children (BASIC)|Recruiting||N/A|1265|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||t||||||Samples With DNA|"~     Samples of blood and urine will be collected for research purposes.~   "|Yes|The data will be transferred to NIDDK at the end of the study.|2017-02-18 16:26:27.954471|2017-02-18 16:26:27.954471
NCT00345540|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2015-02-25|2013-07-09||July 2006||2006-07-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer|Phase 2 Trial of NOV-002 With Carboplatin in Women With Recurrent and Platinum Resistant Tumors of Mullerian Origin|Completed||Phase 2|15|Actual|Cellectar Biosciences, Inc.|The criterion for continuing to Stage II of the study (≥ 2 responses) was not met.|1|||f||||f||||||||||2017-02-18 16:26:28.121505|2017-02-18 16:26:28.121505
NCT00345527|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2013-02-11||||||February 2013|2013-02-01||||November 2006|Actual|2006-11-01||Interventional|||A Randomized Control Trial Examining Two Treatments for Problem Gambling|A Randomized Control Trial Examining Two Treatments for Problem Gambling|Withdrawn||N/A|0|Actual|Centre for Addiction and Mental Health||||Study moved to British Columbia|f||||f||||||||||2017-02-18 16:26:28.418375|2017-02-18 16:26:28.418375
NCT00345514|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2012-11-08|||September 2002||2002-09-01|November 2012|2012-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||The Provider and Organization in Asthma Guidelines|The Provider and Organization in Asthma Guidelines|Completed||N/A|36|Actual|UConn Health||3|||f||||f||||||||||2017-02-18 16:26:28.507164|2017-02-18 16:26:28.507164
NCT00345501|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2007-08-22|||November 2005||2005-11-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention|Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients With Preexisting Renal Dysfunction Undergoing a Coronary Procedure|Completed||Phase 2/Phase 3|208|Actual|Onassis Cardiac Surgery Centre||2|||f||||t||||||||||2017-02-18 16:26:28.617542|2017-02-18 16:26:28.617542
NCT00345488|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2006-06-27|||September 2002||2002-09-01|May 2006|2006-05-01|June 2005||2005-06-01|||||Observational|||Fast Track Admittance of Hip Fracture Patients|Fast Track ER Admittance of Hip Fracture Patients|Unknown status|Active, not recruiting|Phase 4|300||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 16:26:28.726269|2017-02-18 16:26:28.726269
NCT00345475|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2016-09-01|||December 2004||2004-12-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Observational|||UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)|A Prospective Study Of Pregnancies Exposed to UCB Antiepileptic Drugs to Determine if There is a Potential Increase in the Risk of Major Birth Defects|Completed||Phase 4|516|Actual|UCB Pharma|||1||f||||t||||||||||2017-02-18 16:26:28.792998|2017-02-18 16:26:28.792998
NCT00345462|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2010-02-05|||June 2006||2006-06-01|February 2010|2010-02-01||||||||Interventional|||Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.|Immunogenicity and Reactogenicity of Trivalent Virosomal Influenza Vaccine Invivac® for the Season 2006/2007. An Open, Baseline-controlled Study in Two Groups of Healthy Subjects: Adults and Elderly.|Withdrawn||Phase 3|120||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 16:26:28.884382|2017-02-18 16:26:28.884382
NCT00345449|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2009-07-08|||September 2006||2006-09-01|July 2009|2009-07-01|September 2008|Actual|2008-09-01|||||Interventional|||Evaluation of a Decision Aid for Adult Cystic Fibrosis Patients Considering Bilateral Lung Transplantation|Evaluation of a Decision Aid for Adult Cystic Fibrosis Patients Considering Bilateral Lung Transplantation|Completed||N/A|200|Anticipated|Ottawa Hospital Research Institute|||||f||||||||||||||2017-02-18 16:26:28.970755|2017-02-18 16:26:28.970755
NCT00345436|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2017-01-24|||February 8, 2006||2006-02-08|May 11, 2011|2011-05-11|May 11, 2011||2011-05-11|||||Observational|||Exercise in Insulin-Resistant Minority Adolescents|An Exercise Intervention in Insulin-Resistant Minority Adolescents|Completed||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:29.063787|2017-02-18 16:26:29.063787
NCT00345410|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2008-12-18|||June 2006||2006-06-01|December 2008|2008-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Three Doses of AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia|Completed||Phase 2|345|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:26:29.156391|2017-02-18 16:26:29.156391
NCT00345397|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2016-12-05|2015-02-26||May 2006||2006-05-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|March 2014|Actual|2014-03-01||Interventional|||A Colonic Tube to Improve Bowel Function in Spinal Cord Injury|Percutaneous Colostomy for Bowel Management in Spinal Cord Injury|Active, not recruiting||N/A|7|Actual|VA Office of Research and Development|"Difficulty in recruitment from a limited population reduced our intended enrollment and prolonged our study.~This also reduced our statistical significance and limited our conclusions."|1|||f||||f||||||||No||2017-02-18 16:26:29.250325|2017-02-18 16:26:29.250325
NCT00005689|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||July 1991||1991-07-01|March 2001|2001-03-01|June 1995||1995-06-01|||||Observational|||Trial of Smoking Cessation Programs in Black Churches||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.856155|2017-02-18 18:14:30.856155
NCT00345384|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2016-01-12|2011-08-10||May 2008||2008-05-01|January 2016|2016-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||13 were withdrawn from study prior to initiation of drug due to exclusion criteria that required an overnight stay in Recovery or ICU.|Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients|Post-Operative Infusion of Low-Dose Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients: A Randomized, Double-Blind, Controlled Pilot Study|Completed||Phase 1/Phase 2|38|Actual|Baylor Research Institute|Pilot study with small numbers of participants.|2|||f||||f||||||||||2017-02-18 16:26:29.534589|2017-02-18 16:26:29.534589
NCT00345371|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2007-12-21|||April 2006||2006-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|August 2008|Anticipated|2008-08-01||Interventional|||Topiramate for the Treatment of Methamphetamine Dependence - 1|Phase 2, Double-Blind, Placebo-Controlled Trial of Topiramate for the Treatment of Methamphetamine Dependence|Completed||Phase 2|140|Anticipated|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-02-18 16:26:29.961932|2017-02-18 16:26:29.961932
NCT00345358|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2012-09-06||2012-03-09|September 2006||2006-09-01|August 2012|2012-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine|Evaluate Immunogenicity, Safety & Reactogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine Given as Catch-up Immunization in Children Older Than 7 mo of Age or as 3-dose Primary Immunization in Children Before 6 mo of Age|Completed||Phase 3|600|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 16:26:30.06812|2017-02-18 16:26:30.06812
NCT00345345|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2017-01-24|||June 20, 2006||2006-06-20|November 7, 2016|2016-11-07|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia|Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Alemtuzumab (Campath)|Recruiting||Phase 2|39|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:26:30.197959|2017-02-18 16:26:30.197959
NCT00345332|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2011-08-02|||October 2005||2005-10-01|September 2010|2010-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial of Botox for Severe Refractory Urge Urinary Incontinence|Completed||N/A|40|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 16:26:30.315623|2017-02-18 16:26:30.315623
NCT00345319|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2011-12-12|||March 2006||2006-03-01|December 2011|2011-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Purified Rabies Vaccine for Human Use (Chick-embryo Cell)|Evaluate the Immunogenicity and Safety of Rabies Vaccine Given in a Post-exposure Prophylaxis Regimen to Healthy Children and Adults Aged 10-60 Years.|Completed||Phase 3|630|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:26:30.543725|2017-02-18 16:26:30.543725
NCT00345306|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2008-05-06|||March 2007||2007-03-01|June 2006|2006-06-01||||||||Interventional|||Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan|Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan - a Clinical Comparative Study|Suspended||Phase 4|120|Anticipated|Hadassah Medical Organization||||no patient was recruited till 1/2008|f||||f||||||||||2017-02-18 16:26:30.661917|2017-02-18 16:26:30.661917
NCT00345293|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2016-04-01|2015-06-24||June 2006||2006-06-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|December 2013|Actual|2013-12-01||Interventional|||Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer|A Phase I/II Study of Autologous Dendritic Cells Pulsed With Apoptotic Tumor Cells (DC/PC3) Administered Subcutaneously to Prostate Cancer Patients.|Completed||Phase 1/Phase 2|13|Actual|Rockefeller University||1|||f||||t||||||||||2017-02-18 16:26:30.753931|2017-02-18 16:26:30.753931
NCT00345280|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-27|2008-06-16|||August 2006||2006-08-01|June 2008|2008-06-01|September 2008|Anticipated|2008-09-01|||||Observational|||Ocular Surface Changes in Patients With Cystic Fibrosis|Chosen Parameters of the Immune Response in the Origin of Ocular Changes in Patients With Cystic Fibrosis|Unknown status|Recruiting|Phase 1|26|Anticipated|University of Bialystok|||1||f||||f||||||||||2017-02-18 16:26:31.140088|2017-02-18 16:26:31.140088
NCT00345267|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2006-06-26|||August 2004||2004-08-01|June 2006|2006-06-01|March 2005||2005-03-01|||||Interventional|||Effect of an Integrated Care Pathway on Asthma Care in Hospital|Cluster Randomised Controlled Trial of the Effect of the Introduction of an Acute Wheeze/Asthma Integrated Care Pathway on Patient Outcome|Completed||N/A|180||University of Edinburgh|||||f||||||||||||||2017-02-18 16:26:31.238515|2017-02-18 16:26:31.238515
NCT00345254|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2016-11-11|2016-11-11||September 2003||2003-09-01|November 2016|2016-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Severing Nuchal Cord at the Time of Delivery.|Study That Clarifies Whether Cord Around the Neck Should be Severed at Delivery.|Completed||N/A|60|Actual|Wolfson Medical Center||2|||f||||f||||||||No||2017-02-18 16:26:31.338236|2017-02-18 16:26:31.338236
NCT00345241|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2008-06-19|||January 2006||2006-01-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points|Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points|Completed||N/A|12|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 16:26:31.879673|2017-02-18 16:26:31.879673
NCT00345228|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2006-06-26|||June 2004||2004-06-01|May 2004|2004-05-01|December 2006||2006-12-01|||||Observational|||Myopic Macular Haemorrhages|Myopic Macular Haemorrhages|Completed||N/A|30||Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:26:31.982217|2017-02-18 16:26:31.982217
NCT00345215|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-24|2011-06-27|||May 2006||2006-05-01|June 2011|2011-06-01|May 2007|Actual|2007-05-01|December 2006|Actual|2006-12-01||Interventional|||The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans.|The Effect of High and Low Sodium Intake on Aquaporin-2 in Healthy Humans, During Basal Conditions and After Hypertonic Saline Infusion.|Completed||N/A|26|Actual|Regional Hospital Holstebro||1|||f||||f||||||||||2017-02-18 16:26:32.08277|2017-02-18 16:26:32.08277
NCT00345202|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-24|2008-05-14|||September 2004||2004-09-01|May 2008|2008-05-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects|Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects.|Completed||Phase 4|20||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:26:32.193279|2017-02-18 16:26:32.193279
NCT00005688|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1989||1989-07-01|July 2000|2000-07-01|February 1997|Actual|1997-02-01|||||Observational|||Cardiac Arrhythmias and the Perception of Symptoms||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.922344|2017-02-18 18:14:30.922344
NCT00345189|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2009-07-10|||February 2006||2006-02-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|July 2008|Actual|2008-07-01||Interventional|||Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors|A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, PK, and PD Study of CNF2024 Administered Orally Twice Weekly for 3 Weeks of a 4 Week Course or Twice Weekly for 4 Weeks of a 4 Week Course to Patients With Advanced Solid Tumors|Completed||Phase 1|70|Actual|Biogen||2|||f||||t||||||||||2017-02-18 16:26:32.284683|2017-02-18 16:26:32.284683
NCT00345176|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2015-04-13|2013-11-01||September 2006||2006-09-01|April 2015|2015-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|AREDS2||Age-Related Eye Disease Study 2 (AREDS2)|Age-Related Eye Disease Study 2 (AREDS2): A Multi-center, Randomized Trial of Lutein, Zeaxanthin and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration|Completed||Phase 3|4203|Actual|National Eye Institute (NEI)||4|||f||||t||||||||||2017-02-18 16:26:32.428384|2017-02-18 16:26:32.428384
NCT00345163|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2014-02-28|||July 2006||2006-07-01|February 2014|2014-02-01||||September 2007|Actual|2007-09-01||Interventional|BRAIN||A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)|A Phase II, Multicenter, Randomized, Non-Comparative Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme in First or Second Relapse|Completed||Phase 2|167|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:26:33.278378|2017-02-18 16:26:33.278378
NCT00345150|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-24|2006-06-24||||||June 2006|2006-06-01||||||||Interventional|||Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls|Phase 1 Study of the Effects of Systemic Nitric Oxide Inhibition With Ng-Monomethyl-L-Arginine on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls|Completed||Phase 1|30||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:26:33.3883|2017-02-18 16:26:33.3883
NCT00345137|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-24|2006-06-24||||||June 2006|2006-06-01||||||||Interventional|||Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis|Phase 1 Study of Systemic Effects of Ng-Monomethyl-L-Arginine on Renal Hemodynamics in Patients With Polycystic Kidney Disease and Chronic Glomerulonephritis|Completed||Phase 1|75||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:26:33.470039|2017-02-18 16:26:33.470039
NCT00345124|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-24|2011-06-27|||May 2006||2006-05-01|June 2011|2011-06-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|||The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension|The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension, During Basal Conditions and After Hypertonic Saline Infusion.|Completed||N/A|50|Actual|Regional Hospital Holstebro||1|||f||||f||||||||||2017-02-18 16:26:33.557579|2017-02-18 16:26:33.557579
NCT00345111|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2014-09-26|||July 2005||2005-07-01|September 2014|2014-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)|ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance With RESTOR IOL Compared With SN60WF IOL (Control Group)|Withdrawn||Phase 4|0|Actual|University of Texas Southwestern Medical Center||||Verified with former investigator that recruitment activity did not take place|f||||||||||||||2017-02-18 16:26:33.654593|2017-02-18 16:26:33.654593
NCT00345098|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2009-03-10|||May 2006||2006-05-01|March 2009|2009-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|CALYPSO||A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder|A Double-Blind, Multi-Center, Multinational, Randomized Withdrawal Study Evaluating the Efficacy and Safety of SR58611A (350mg q12) Versus Placebo in the Prevention of Depression Relapse up to 1 Year in Patients With Major Depressive Disorder Improved After 12 Weeks of Open Treatment With SR58611A (350mg q12)|Completed||Phase 3|704|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:26:33.736931|2017-02-18 16:26:33.736931
NCT00345085|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2014-07-24|||March 2005||2005-03-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|||||Observational|||Comparison of Higher Order Aberrations and Contrast Sensitivity Between Acrysof SN60AT, SN60WF and Restore Intraocular Lenses|Comparison of Higher Order Aberrations and Contrast Sensitivity Between Acrysof SN60AT, SN60WF and Restore Intraocular Lenses|Completed||N/A|40|Actual|University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:26:33.845461|2017-02-18 16:26:33.845461
NCT00345072|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2006-06-26|||July 2003||2003-07-01|June 2006|2006-06-01||||||||Interventional|||A Menopause Interactive Decision Aid System|A Menopause Interactive Decision Aid System|Unknown status|Active, not recruiting|N/A|296||Rhode Island Hospital|||||f||||||||||||||2017-02-18 16:26:33.928171|2017-02-18 16:26:33.928171
NCT00345059|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2016-01-13|||May 2005||2005-05-01|January 2016|2016-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|DISTAL-2||The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer|Single Agent Chemotherapy With Weekly Docetaxel vs Combination Chemotherapy in Second-line Treatment of Advanced Non Small Cell Lung Cancer|Terminated||Phase 3|84|Actual|National Cancer Institute, Naples||3||slow accrual|f||||f||||||||||2017-02-18 16:26:34.017344|2017-02-18 16:26:34.017344
NCT00345046|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2015-06-02|2013-12-24||September 2002||2002-09-01|March 2014|2014-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Comparison of Three Different Formulations of Prednisolone Acetate 1%|A Comparison of Three Different Formulations of Topical Prednisolone Acetate 1% for Control of Post Glaucoma and/or Cataract Surgery Inflammation.|Completed||Phase 4|60|Actual|Indiana University||3|||f||||f||||||||||2017-02-18 16:26:34.279709|2017-02-18 16:26:34.279709
NCT00345033|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2014-06-10|2012-04-26||March 2005||2005-03-01|June 2014|2014-06-01|October 2010|Actual|2010-10-01|October 2009|Actual|2009-10-01||Interventional|||Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia|Aripiprazole for Clozapine Associated Medical Morbidity|Completed||Phase 4|38|Actual|Massachusetts General Hospital|The limitations of this study include the relatively small sample size, short intervention period (8 weeks) and the lack of generalizability of our findings to patients with schizophrenia treated by antipsychotic agents other than clozapine.|2|||f||||t||||||||||2017-02-18 16:26:34.653968|2017-02-18 16:26:34.653968
NCT00345020|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2008-06-19|||May 2006||2006-05-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Deep Lamellar Endothelial Keratoplasty: Small Incision Technique|Deep Lamellar Endothelial Keratoplasty: Small Incision Technique|Completed||N/A|0|Actual|University of Texas Southwestern Medical Center|||||f||||f||||||||||2017-02-18 16:26:35.152558|2017-02-18 16:26:35.152558
NCT00344994|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2011-05-12|||May 2006||2006-05-01|May 2011|2011-05-01|April 2010|Actual|2010-04-01|September 2007|Actual|2007-09-01||Interventional|||SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole|An Open-Label Prospective Study of Restless Legs Patients Switched to Ropinirole From Pramipexole to Help Determine the Equipotent Dose|Completed||Phase 4|20|Anticipated|Augusta University||1|||f||||||||||||||2017-02-18 16:26:35.317765|2017-02-18 16:26:35.317765
NCT00344981|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2010-05-21|||June 2003||2003-06-01|May 2010|2010-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|HADIT||Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression|A Study to Probe The Safety And Durability of Tenofovir And a Cell Cycle Agent to Maintain Viral Suppression|Completed||N/A|9|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 16:26:35.429677|2017-02-18 16:26:35.429677
NCT00344968|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2014-04-08|2013-09-27||September 2007||2007-09-01|April 2014|2014-04-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|FAME|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema|A Randomized, Double-Masked, Parallel Group, Multi-center, Dose-Finding Comparison of the Safety and Efficacy of ASI-001A 0.5 μg/Day and ASI-001B 0.2 μg/Day Fluocinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects With Diabetic Macular Edema|Completed||Phase 3|956|Actual|Alimera Sciences||3|||f||||||||||||||2017-02-18 16:26:35.556267|2017-02-18 16:26:35.556267
NCT00344955|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-24|2008-05-14|||January 2003||2003-01-01|May 2008|2008-05-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects|Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects|Completed||Phase 4|20||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:26:40.540312|2017-02-18 16:26:40.540312
NCT00344942|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2009-12-04|||April 2006||2006-04-01|December 2009|2009-12-01||||April 2007|Actual|2007-04-01||Interventional|RhiCNANI||Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults|A Randomised, Double-blind, French Multi-centre Study, to Evaluate the Efficacy and Tolerance, in Comparison With Placebo, of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults|Terminated||Phase 3|77|Actual|Sanofi||2||patient's recruitment too difficult|f||||f||||||||||2017-02-18 16:26:40.630289|2017-02-18 16:26:40.630289
NCT00344929|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2007-04-26|||November 2005||2005-11-01|April 2007|2007-04-01||||||||Observational|||Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks|Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks|Unknown status|Recruiting|N/A|6500|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:26:40.726195|2017-02-18 16:26:40.726195
NCT00344916|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-24|2006-07-10||||||June 2006|2006-06-01||||||||Interventional|||Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis|NO-Synthesis in Patients With Liver Cirrhosis: Effect of L-NMMA on Renal Hemodynamics, Sodium Excretion and Plasma Levels of Vasoactive Hormones|Completed||Phase 1|30||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:26:40.801711|2017-02-18 16:26:40.801711
NCT00344903|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2010-07-07|||September 2007||2007-09-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Observational|||Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort|Longitudinal Cohort Study of Dallas County Residents to Identify Novel Determinants of Atherosclerotic Heart Disease: The DHS 2|Completed||N/A|3400|Actual|University of Texas Southwestern Medical Center|||1||f||||t||||||Samples With DNA|"~     Plasma Serum DNA~   "|||2017-02-18 16:26:40.879993|2017-02-18 16:26:40.879993
NCT00344890|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2015-04-03|||September 2006||2006-09-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety Study of Preservon-Treated Bone Implants for Cervical Fusion in the Treatment of Cervical Radiculopathy or Myelopathy|A Safety and Efficacy Comparison of Preservon Treated Allograft Bone Dowels Versus Traditional Freeze-Dried Allograft Bone Dowels for Fusion of Degenerated Cervical Intervertebral Discs in the Treatment of Cervical Radiculopathy or Myelopathy|Completed||N/A|106|Actual|LifeNet Health||2|||f||||t||||||||||2017-02-18 16:26:40.969955|2017-02-18 16:26:40.969955
NCT00344877|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||June 19, 2006||2006-06-19|May 5, 2009|2009-05-05|May 5, 2009||2009-05-05|||||Observational|||Electrical Brain Stimulation to Reduce Epileptic Seizures|Anticonvulsive Effects of Transcranial DC Stimulation in Pharmacoresistant Focal Epilepsy|Completed||N/A|56||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:41.064346|2017-02-18 16:26:41.064346
NCT00344864|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2011-03-22|||January 2006||2006-01-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||A Prospective Clinical Research Project Evaluating The Effects of Soft Contact Lenses on Higher Order Visual Aberrations|A Prospective Clinical Research Project Evaluating The Effects of Soft Contact Lenses on Higher Order Visual Aberrations|Terminated||N/A|30|Anticipated|University of Texas Southwestern Medical Center|||1|Terminated due to lack of patient recruitment|f||||f||||||||||2017-02-18 16:26:41.149831|2017-02-18 16:26:41.149831
NCT00344851|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2007-07-10|||June 2006||2006-06-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Exenatide and Metformin Therapy in Overweight Women With PCOS|Comparison of the Effects of Monotherapy With Exenatide or Metformin to Combined Exenatide and Metformin Therapy on Menstrual Cyclicity in Overweight Women With Polycystic Ovary Syndrome|Completed||Phase 2|60|Actual|Metabolic Center of Louisiana Research Foundation||3|||f||||f||||||||||2017-02-18 16:26:41.252172|2017-02-18 16:26:41.252172
NCT00344838|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2006-06-23|||September 2003||2003-09-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Customized Laser Ablation: Comparing Results of LADAR Vision and VISX Platforms|Customized Laser Ablation: Comparing Results of LADAR Vision and VISX Platforms|Unknown status|Recruiting|N/A|50||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:26:41.350072|2017-02-18 16:26:41.350072
NCT00344825|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2013-12-02|||January 2004||2004-01-01|December 2013|2013-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)|Observational Study for Evaluation of Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia.|Completed||N/A|300|Actual|Sanofi|||1||f||||f||||||||||2017-02-18 16:26:41.432436|2017-02-18 16:26:41.432436
NCT00344812|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2006-06-26|||January 1996||1996-01-01|March 2006|2006-03-01|June 1998||1998-06-01|||||Interventional|||Opioid Maintenance Medications Comparison Study||Completed||Phase 2|220||Johns Hopkins University|||||||||||||||||||2017-02-18 16:26:41.77687|2017-02-18 16:26:41.77687
NCT00344786|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2009-06-04|||February 2006||2006-02-01|June 2009|2009-06-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Phase 1, Dose-Escalation Study of Oral CNF2024(BIIB021) in CLL|A Phase 1, Dose-Escalation Study of CNF2024 Administered Orally to Patients With B Cell Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 1|15|Actual|Biogen||1||Sponsor's decision|f||||f||||||||||2017-02-18 16:26:41.96214|2017-02-18 16:26:41.96214
NCT00344773|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2010-06-24|2008-12-19||March 2006||2006-03-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation|An Open-label, Multi-centre Study to Evaluate Efficacy and Safety of Gefitinib as the First-line Treatment for Locally Advanced (IIIB), Metastatic (IV) or Recurrent Pulmonary Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation.|Completed||Phase 2|46|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:26:42.072051|2017-02-18 16:26:42.072051
NCT00344760|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2013-02-07|||January 2005||2005-01-01|February 2013|2013-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy|Viral Decay Kinetics During Induction Therapy With or Without the Use of Enfuvirtide in HAART-naÃ-ve Patients With Advanced HIV|Completed||Phase 4|2|Anticipated|University of Maryland||2|||f||||t||||||||||2017-02-18 16:26:42.32534|2017-02-18 16:26:42.32534
NCT00344747|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-25|2010-09-19|||September 2006||2006-09-01|September 2010|2010-09-01|August 2009|Actual|2009-08-01|||||Interventional|||Multidisciplinary Ambulatory Intervention Program in Family of Children and Adolescents With Obesity|Multidisciplinary Ambulatory Intervention Program (Dietary Behavioral Physical Activity) in Family of Children and Adolescents With Obesity|Completed||N/A|40|Anticipated|Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:26:42.449178|2017-02-18 16:26:42.449178
NCT00344734|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-24|2006-06-24||||||June 2006|2006-06-01||||||||Interventional|||Effects of Acute L-NMMA Treatment on Renal Hemodynamics and Vasoactive Hormones in Patients With Congestive Heart Failure|Effects of Acute L-NMMA Treatment on Renal Hemodynamics, Sodium and Water Excretion and Plasma Levels of Vasoactive Hormones in Patients With Congestive Heart Failure and Healthy Controls|Completed||Phase 1|30||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:26:42.533195|2017-02-18 16:26:42.533195
NCT00344721|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2006-06-23|||September 2004||2004-09-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome|A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome|Unknown status|Recruiting|Phase 4|36||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:26:42.618829|2017-02-18 16:26:42.618829
NCT00344708|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2008-06-19|||September 2000||2000-09-01|June 2008|2008-06-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces|Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces|Unknown status|Recruiting|N/A|20|Anticipated|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 16:26:42.719002|2017-02-18 16:26:42.719002
NCT00344695|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2006-06-23||||||June 2006|2006-06-01|April 2003||2003-04-01|||||Interventional|||Bupropion Treatment for Youth Smoking Cessation||Completed||Phase 3|||University of Arizona|||||||||||||||||||2017-02-18 16:26:42.816696|2017-02-18 16:26:42.816696
NCT00344682|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2014-01-09|2013-01-16||June 2006||2006-06-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Memantine Augmentation of Antidepressants|A Randomized Double-Blind Pilot Study of Memantine Augmentation in Antidepressant Nonresponders or Incomplete Responders|Completed||Phase 4|31|Actual|University of Massachusetts, Worcester|Early termination due to slow enrollment, leading to small numbers of subjects enrolled.|2|||f||||f||||||||||2017-02-18 16:26:42.901808|2017-02-18 16:26:42.901808
NCT00344669|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2006-10-16|||August 2000||2000-08-01|June 2006|2006-06-01|November 2003||2003-11-01|||||Interventional|||Effect of Mass Deworming on Child Growth|"Increased Weight Gain in Preschool Children Due to Mass Albendazole Treatment Given During Child Health Days in Uganda"|Completed||N/A|10000||Makerere University|||||f||||||||||||||2017-02-18 16:26:43.36113|2017-02-18 16:26:43.36113
NCT00344656|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2012-04-18|||October 2004||2004-10-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|April 2010|Actual|2010-04-01||Observational|||Appetite-Related Brain Activity in Women With Anorexia Nervosa|The Study of Appetite-Related Brain Activity With Functional Magnetic Resonance Imaging in Women With Anorexia Nervosa|Completed||N/A|15|Actual|New York State Psychiatric Institute|||1||f||||t||||||||||2017-02-18 16:26:43.571154|2017-02-18 16:26:43.571154
NCT00344643|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2008-06-19|||October 2004||2004-10-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Comparison of 12 Month Daily Wear of Two Novel O2 Permeable Silicone Hydrogel CLs (HOP/SiH) and A Control, Standard O2 Lens|A Comparison of 12 Month Daily Wear of Two Novel Hyper-Oxygen Permeable Silicone Hydrogel Contact Lenses (HOP/SiH) and A Control, Standard Oxygen Permeable Lens; and, 30-Night Versus 6-Night Immediate Extended Wear of Two HOP/SiH Lenses.|Completed||N/A|187|Actual|University of Texas Southwestern Medical Center|||||f||||f||||||||||2017-02-18 16:26:43.661858|2017-02-18 16:26:43.661858
NCT00344630|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2008-10-07|||May 2006||2006-05-01|October 2008|2008-10-01|June 2006||2006-06-01|||||Interventional|||TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?|TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?|Completed||N/A|2500||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 16:26:43.747181|2017-02-18 16:26:43.747181
NCT00344617|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2007-09-25|||June 2006||2006-06-01|September 2007|2007-09-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy|Off-Label Use of AVASTIN (BEVACIZUMAB)Intravitreal Injection For the Treatment of Serosanguinous Maculopathy|Unknown status|Active, not recruiting|Phase 3|50|Anticipated|Singapore National Eye Centre|||||f||||||||||||||2017-02-18 16:26:43.83197|2017-02-18 16:26:43.83197
NCT00344604|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2008-06-19|||March 2004||2004-03-01|June 2008|2008-06-01|June 2006|Actual|2006-06-01|||||Observational|||The Role of Psychosocial and Other Quality of Life Parameters in Evaluating Functional Changes Prior to and Following Laser in-Situ Keratomileusis (LASIK)Changes Laser in-Situ Keratomileusis (LASIK)|The Role of Psychosocial and Other Quality of Life Parameters in Evaluating Functional Changes Prior to and Following Laser in-Situ Keratomileusis (LASIK)|Terminated||N/A|0|Actual|University of Texas Southwestern Medical Center||||PI decided to terminate the study at this time|f||||f||||||||||2017-02-18 16:26:43.932233|2017-02-18 16:26:43.932233
NCT00344591|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2015-07-22|||January 2005||2005-01-01|July 2015|2015-07-01||||June 2009|Actual|2009-06-01||Interventional|||Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison|Ecosystems Therapy for Men Reintegrating Into Their Family|Completed||Phase 2|162|Actual|University of California, San Francisco||2|||f||||||||||||||2017-02-18 16:26:44.017798|2017-02-18 16:26:44.017798
NCT00344578|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2011-03-22|||March 2006||2006-03-01|June 2006|2006-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review|Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review|Completed||Phase 4|120|Anticipated|University of Texas Southwestern Medical Center|||1||f||||f||||||||||2017-02-18 16:26:44.122174|2017-02-18 16:26:44.122174
NCT00344565|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-26|2012-11-30|||November 2005||2005-11-01|November 2012|2012-11-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence|Combined Treatment of Modafinil and Cognitive Behavioral Therapy for Cocaine Dependence|Completed||Phase 2|15|Actual|Research Foundation for Mental Hygiene, Inc.||2|||f||||t||||||||||2017-02-18 16:26:44.21258|2017-02-18 16:26:44.21258
NCT00344552|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2009-11-12|||June 2006||2006-06-01|November 2009|2009-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer|Phase II Study to Evaluate Efficacy and Safety of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer. This Study is an Extension Study for Japanese Registration Only.|Completed||Phase 2|53|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:26:44.31437|2017-02-18 16:26:44.31437
NCT00344539|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2013-05-30|||May 2005||2005-05-01|March 2013|2013-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||AMA1-C1/Alhydrogel + CpG 7909 for Malaria|Phase I Study of the Safety and Immunogenicity of AMA1-C1/Alhydrogel® + CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria|Completed||Phase 1|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 16:26:44.425064|2017-02-18 16:26:44.425064
NCT00344526|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2007-06-27|||January 2000||2000-01-01|June 2007|2007-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis|Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone in Patients With AL (Primary)Amyloidosis. A Prospective Randomized Trial .|Completed||Phase 3|100||University Hospital, Limoges|||||f||||||||||||||2017-02-18 16:26:44.703309|2017-02-18 16:26:44.703309
NCT00344513|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2016-09-13|||December 2002||2002-12-01|September 2016|2016-09-01|June 2005|Actual|2005-06-01|||||Interventional|||Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)|Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): An Internet-based Registry and Process of Care Improvement Program for Heart Failure Patients|Completed||Phase 4|50000||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:44.813083|2017-02-18 16:26:44.813083
NCT00344500|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2016-03-08|2015-04-03||October 2005||2005-10-01|March 2016|2016-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|MAMAO|Participants (14) randomized to Usual Care group who later elected to change over to Lifestyle Balance were excluded from statistical analysis.|Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications|Management of Antipsychotic Medication Associated Obesity|Completed||N/A|122|Actual|VA Office of Research and Development|Limitations to our study were its single-site recruitment yielding subjects mostly male and all veterans, limiting of statistical power by control subjects allowed to join treatment group resulting in exclusion from data, and a high dropout rate.|2|||f||||t||||||||||2017-02-18 16:26:44.917823|2017-02-18 16:26:44.917823
NCT00344487|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2014-12-17|2012-08-03||December 2005||2005-12-01|December 2014|2014-12-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|||Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study|The Effect of Kaletra on CD4 Immune Reconstitution in HIV-infected Patients With Long-term Virologic Suppression on a Non-Kaletra Containing ART Regimen, But With a Blunted Immune Response|Terminated||N/A|3|Actual|University of Maryland||1||Inability to enroll subjects.|f||||t||||||||||2017-02-18 16:26:46.656251|2017-02-18 16:26:46.656251
NCT00344474|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2011-06-24|||November 2003||2003-11-01|February 2006|2006-02-01|July 2008|Actual|2008-07-01|May 2006|Actual|2006-05-01||Interventional|Preventure||Personality-targeted Interventions for Adolescent Alcohol Misuse|A New School-based Drug Prevention Programme for Teenagers: Interventions That Target Personality Risk for Substance Abuse and Mental Illness|Completed||Phase 2/Phase 3|710|Actual|King's College London||4|||f||||||||||||||2017-02-18 16:26:46.897384|2017-02-18 16:26:46.897384
NCT00344461|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-08-03|||March 2004||2004-03-01|August 2012|2012-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine|Cell Cycle Independent Antiretroviral Therapy: Combination of Nevirapine, FTC, and Tenofovir|Completed||Phase 4|54|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 16:26:47.018301|2017-02-18 16:26:47.018301
NCT00344448|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2015-11-17|2011-02-14||June 2006||2006-06-01|November 2015|2015-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pilot Study of Raptiva to Treat Sjogren's Syndrome|A Randomized, Placebo Controlled, Proof of Concept, Study of Raptiva, a Humanized Anti-CD-11a Monoclonal Antibody, in Patients With Sjogren's Syndrome|Terminated||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)|Early termination due to serious adverse event described in psoriasis which led to the withdrawal of the drug from market.|2||Increased risk of PML associated with raptiva in other studies|f||||t||||||||||2017-02-18 16:26:47.112798|2017-02-18 16:26:47.112798
NCT00344435|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||May 24, 2005||2005-05-24|April 5, 2016|2016-04-05|April 5, 2016||2016-04-05|||||Observational|||Genetic Susceptibility to Factor VIII Inhibitors|Factor VIII Inhibitor Formation: Identifying Predisposing Genetic Factors|Completed||N/A|3500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:47.531917|2017-02-18 16:26:47.531917
NCT00319306|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2009-03-16|||September 2005||2005-09-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|||||Interventional|RELEASE||Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy|Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy|Completed||Phase 3|550||AstraZeneca|||||f||||||||||||||2017-02-18 16:35:43.017836|2017-02-18 16:35:43.017836
NCT00344422|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2011-06-08|||October 2000||2000-10-01|April 2010|2010-04-01|June 2004|Actual|2004-06-01|||||Interventional|||Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma|A Multi-Center Randomized Study of Vincristine, Doxil and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Multiple Myeloma|Completed||Phase 3|198|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:26:47.74189|2017-02-18 16:26:47.74189
NCT00344409|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-08-30|||March 2006||2006-03-01|August 2012|2012-08-01||||May 2007|Actual|2007-05-01||Interventional|||A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients|A Double-blind, Placebo Controlled, Randomized Study of KRN321 for the Treatment of Anemia in Cancer Patients|Completed||Phase 3|200||Kyowa Hakko Kirin Co., Ltd|||||f||||||||||||||2017-02-18 16:26:47.850732|2017-02-18 16:26:47.850732
NCT00344383|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2011-03-03|||November 2003||2003-11-01|March 2011|2011-03-01|July 2004|Actual|2004-07-01|||||Interventional|||An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen|An Open-Label Study Evaluating the Bleeding Profile of Ortho Tri-Cyclen Lo (Norgestimate/Ethinyl Estradiol) Administered as an Extended Regimen|Completed||Phase 2|61|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||||||||||||||||2017-02-18 16:26:47.947982|2017-02-18 16:26:47.947982
NCT00344370|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2010-01-25|2009-09-01||August 2006||2006-08-01|January 2010|2010-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia|Double-Blind, Follow-On Study of Pitavastatin (4 mg) Versus Atorvastatin (20 mg and 40 mg), With a Single-Blind Extension of Treatment, in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia|Completed||Phase 3|214|Actual|Kowa Research Europe||2|||f||||f||||||||||2017-02-18 16:26:48.034865|2017-02-18 16:26:48.034865
NCT00344344|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||October 19, 2000||2000-10-19|September 11, 2006|2006-09-11|September 11, 2006||2006-09-11|||||Observational|||A Pilot Study to Evaluate the Efficacy of Refined Methods to Mitigate Indoor Allergens in North Carolina and Boston, Massachusetts Homes|A Pilot Study to Evaluate the Efficacy of Refined Methods to Mitigate Indoor Allergens in North Carolina and Boston, Massachusetts Homes|Completed||N/A|88||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:48.470675|2017-02-18 16:26:48.470675
NCT00344331|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-02-14|||June 16, 2006||2006-06-16|January 26, 2017|2017-01-26||||||||Observational|||Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C|Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:48.545711|2017-02-18 16:26:48.545711
NCT00344318|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2016-11-03|||August 2006||2006-08-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine|To Assess the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Pneumococcal Conjugate Vaccine Compared to Prevenar™, Co-administered With DTPw-HBV/Hib & OPV or IPV Vaccines as a 3-dose Primary Immunization Course During the First 6 Months of Age|Completed||Phase 3|806|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:48.825165|2017-02-18 16:26:48.825165
NCT00344305|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-09-05|2010-07-29||May 2006||2006-05-01|September 2012|2012-09-01|December 2006|Actual|2006-12-01|July 2006|Actual|2006-07-01||Interventional|||A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children|A Phase 2, Open-Label, Single Arm Trial to Evaluate the Shedding and Safety of CAIV-T Administered to Children 6 to Less Than 60 Months of Age|Completed||Phase 2|200|Actual|MedImmune LLC||1|||f||||t||||||||||2017-02-18 16:26:48.975299|2017-02-18 16:26:48.975299
NCT00344292|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2013-01-23|||March 2006||2006-03-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Understanding the Genetic and Hereditary Basis of Atherosclerosis|SNPs and Extent of Atherosclerosis (SEA) Study|Completed||N/A|2763|Actual|Wake Forest University Health Sciences|||1||f||||t||||||Samples With DNA|"~     DNA~   "|||2017-02-18 16:26:49.846273|2017-02-18 16:26:49.846273
NCT00344279|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||August 8, 2005||2005-08-08|January 31, 2012|2012-01-31|January 31, 2012||2012-01-31|||||Observational|||Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis|Changes in HIV Viral Load in Patients Undergoing Treatment for Filarial Infection|Completed||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:49.949069|2017-02-18 16:26:49.949069
NCT00344266|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||June 16, 2006||2006-06-16|April 15, 2016|2016-04-15||||||||Observational|||Gene Expression and Inflammation in Overweight Subjects|Gene Expression and Release of Inflammatory Mediators in Overweight Subjects Before and After Weight Loss|Completed||N/A|144|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:50.032408|2017-02-18 16:26:50.032408
NCT00344253|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-11-30|||March 2006||2006-03-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|March 2011|Actual|2011-03-01||Interventional|||Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis|A Monocentric, Randomized, Controlled Trial to Test the Efficacy of Interferon-beta in the Treatment of Disseminated Encephalomyelitis (ED)-Associated and Primary Intermediate Uveitis in Comparison to Standard Treatment (TEAM)|Completed||Phase 3|19|Actual|Heidelberg University||2|||f||||t||||||||||2017-02-18 16:26:50.141879|2017-02-18 16:26:50.141879
NCT00344240|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2010-02-02|||August 2005||2005-08-01|April 2007|2007-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Exercise and Activity Guidance in Older Adults With Diabetes|Aerobic Performance,Mobility Limitations and Exercise in Older Adults With Diabetes|Completed||N/A|240|Anticipated|University of Michigan|||||f||||||||||||||2017-02-18 16:26:50.264427|2017-02-18 16:26:50.264427
NCT00344227|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2006-06-23|||August 2004||2004-08-01|June 2006|2006-06-01|April 2007||2007-04-01|||||Interventional|||Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)|Prospective Optical Coherence Tomography (OCT) Imaging of Patients With Neovascular Age-Related Macular Degeneration (AMD) Treated With Intra-Ocular Lucentis™ (Ranibizumab): PrONTO Study|Completed||Phase 2|40||University of Miami|||||||||||||||||||2017-02-18 16:26:50.357411|2017-02-18 16:26:50.357411
NCT00319293|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2006-10-10||||||October 2006|2006-10-01||||||||Interventional|||Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome||Unknown status|Not yet recruiting|N/A|20||Aarhus University Hospital Skejby|||||f||||||||||||||2017-02-18 16:35:43.162223|2017-02-18 16:35:43.162223
NCT00344214|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2012-09-27|||October 2006||2006-10-01|September 2012|2012-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||STD Risk Reduction for Heterosexual Methamphetamine Users|Reducing HIV/STD Risk, Methamphetamine Use, and Depression Among Heterosexuals|Completed||N/A|432|Actual|University of California, San Diego||2|||f||||||||||||||2017-02-18 16:26:50.45906|2017-02-18 16:26:50.45906
NCT00344201|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2010-05-11|||November 2004||2004-11-01|May 2010|2010-05-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery|Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of Ocular Surface Reconstruction|Completed||Phase 1|32|Actual|Singapore National Eye Centre|||||f||||t||||||||||2017-02-18 16:26:50.569669|2017-02-18 16:26:50.569669
NCT00344188|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||August 20, 2001||2001-08-20|October 28, 2016|2016-10-28||||||||Observational|||Diagnosis and Treatment of Leishmanial Infections|Diagnosis and Treatment of Leishmanial Infections|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:50.678075|2017-02-18 16:26:50.678075
NCT00344175|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2010-01-25|2009-09-01||June 2006||2006-06-01|January 2010|2010-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors|Double-blind follow-on Study of Pitavastatin (4mg) Versus Simvastatin (40mg and 80mg) With a Single-blind Extension of Treatment in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or More Risk Factors for Coronary Heart Disease|Completed||Phase 3|178|Actual|Kowa Research Europe||2|||f||||f||||||||||2017-02-18 16:26:50.779332|2017-02-18 16:26:50.779332
NCT00344162|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||January 31, 2005||2005-01-31|September 22, 2006|2006-09-22|September 22, 2006||2006-09-22|||||Observational|||Family Study on Preeclampsia|A Familial Genetic Study on Preeclampsia: A Pilot Study|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:51.234106|2017-02-18 16:26:51.234106
NCT00344149|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2014-03-25|||June 2006||2006-06-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Rituximab as Second Line Treatment for ITP|"Rituximab as Second Line Treatment for ITP; A Multicenter, Randomized, Double Blind, Placebo-controlled, Phase III Study. The RITP Study"|Completed||Phase 3|112|Actual|Ostfold Hospital Trust||2|||f||||t||||||||||2017-02-18 16:26:51.315943|2017-02-18 16:26:51.315943
NCT00344136|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2016-07-28|||September 2000||2000-09-01|October 2006|2006-10-01|March 2004|Actual|2004-03-01|||||Observational|||Identifying Genes That May Increase the Risk for Heart Disease in African Americans|Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study|Completed||N/A|5302||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:26:51.428106|2017-02-18 16:26:51.428106
NCT00344123|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2016-02-02|||February 2007||2007-02-01|February 2016|2016-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects|Pharmacokinetic Evaluation of Single-dose Rosuvastatin 10 mg When Co-administered With Steady-state Tipranavir 500 mg/Ritonavir 200 mg TPV/r) B.I.D. in Healthy Adult Volunteers|Completed||Phase 1|29|Actual|Johns Hopkins University||1|||f||||t||||||||No|This is a prospective, open-label pharmacokinetic study|2017-02-18 16:26:51.515834|2017-02-18 16:26:51.515834
NCT00344110|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2016-11-16|||June 2006||2006-06-01|November 2016|2016-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension|A Randomized, Double-blind, Placebo and Active-controlled, Multicenter, Parallel-group Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg to Evaluate Efficacy, Safety and Pharmacokinetics in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 3|768|Actual|Novartis|||||f||||||||||||||2017-02-18 16:26:51.620729|2017-02-18 16:26:51.620729
NCT00344097|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2013-03-21|||March 2006||2006-03-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||The Effects of Soy Protein on Post-thoracotomy Pain|The Effects of Soy Protein Supplementation on Post-thoracotomy Pain|Withdrawn||Phase 2|0|Actual|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 16:26:51.826904|2017-02-18 16:26:51.826904
NCT00344084|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||March 16, 2006||2006-03-16|September 17, 2012|2012-09-17|September 17, 2012||2012-09-17|||||Observational|||Surveillance for Leishmaniasis Skin Lesions in Mali|Active Surveillance for Cutaneous Leishmaniasis in Mali|Completed||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:51.919334|2017-02-18 16:26:51.919334
NCT00344071|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2017-01-24|||September 8, 2004||2004-09-08|September 23, 2009|2009-09-23||||April 27, 2007|Actual|2007-04-27||Observational|||Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia|Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia|Completed||N/A|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:26:52.00532|2017-02-18 16:26:52.00532
NCT00344058|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2006-06-23|||January 2001||2001-01-01|August 2005|2005-08-01|August 2004||2004-08-01|||||Interventional|||Abbreviated MgSO4 Therapy in Post-Partum Preeclampsia|Abbreviated Post-Partum Magnesium Sulfate Seizure Prophylaxis in Preeclampsia: A Comparison of 12 and 24 Hour Regimens|Completed||N/A|200||Case Western Reserve University|||||f||||||||||||||2017-02-18 16:26:52.096731|2017-02-18 16:26:52.096731
NCT00344045|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2015-10-12||2015-09-23|April 2006||2006-04-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study to Evaluate The Analgesic Efficacy and Safety of Intravenous Paracetamol in Subjects With Postoperative Pain After Total Hip Arthroplasty|A Phase IV, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy And Safety of IV Paracetamol Versus Placebo in Subjects With Postoperative Pain After Total Hip Arthroplasty|Completed||Phase 4|86|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 16:26:52.181555|2017-02-18 16:26:52.181555
NCT00344032|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2016-11-03|2009-11-12||July 2006||2006-07-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women|Phase IIIb, Double-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV-16/18 VLP/AS04 Vaccine Administered Intramuscularly at 0, 1, 6 Months in Healthy Indian Female Subjects Aged 18-35 Yrs|Completed||Phase 3|354|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:52.294606|2017-02-18 16:26:52.294606
NCT00344019|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2008-03-10|||July 2006||2006-07-01|March 2008|2008-03-01||||||||Interventional|||Effects of Atorvastatin on Myonecrosis|Effects of Single-Dose Atorvastatin on Peri-Procedural Myonecrosis During Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes - The NO-MI Study|Unknown status|Not yet recruiting|N/A|150|Anticipated|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 16:26:52.731232|2017-02-18 16:26:52.731232
NCT00344006|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2016-12-02|||June 2006||2006-06-01|December 2016|2016-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria|A Multi-centre, Randomised, Double-blind, Double Dummy Study Comparing the Efficacy and Safety of Chlorproguanil-dapsone-artesunate Versus Artemether-lumefantrine in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children and Adolescents in Africa.|Completed||Phase 3|1395|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:52.994318|2017-02-18 16:26:52.994318
NCT00343993|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-23|2007-04-03|||June 2006||2006-06-01|April 2007|2007-04-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Noninvasive Positive Pressure Ventilation for ALI/ARDS:a Multicentre Randomized Controlled Trial||Unknown status|Recruiting|Phase 1|200||Beijing Chao Yang Hospital|||||f||||t||||||||||2017-02-18 16:26:53.106814|2017-02-18 16:26:53.106814
NCT00343980|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-07-09||2009-11-09|October 2006||2006-10-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes|Safety and Efficacy of Inhaled Pre-prandial Human Insulin Plus Glimepiride Versus Rosiglitazone Plus Glimepiride in Type 2 Diabetes|Terminated||Phase 3|363|Actual|Novo Nordisk A/S||2||See termination reason in detailed description|f||||f||||||||||2017-02-18 16:26:53.216773|2017-02-18 16:26:53.216773
NCT00343954|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2006-06-21||||||June 2006|2006-06-01||||||||Interventional|||PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease|Phase 1 Pharmacokinetic and Pharmacodynamic Responses to Oral L-Citrulline in Patients With Sickle Cell Disease|Unknown status|Not yet recruiting|Phase 1|12||Angiogenix|||||||||||||||||||2017-02-18 16:26:53.334907|2017-02-18 16:26:53.334907
NCT00343941|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2008-10-09|||November 2004||2004-11-01|October 2008|2008-10-01||||||||Interventional|||Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults|A Phase II Multicentre, Randomized, Double Blind, Parallel Group, Placebo Controlled Pilot Study of Tucaresol at Two Dosing Levels (25,50 mg) in HIV-1 Infected Adult Subjects With Plasma HIV-1 RNA < 50 Copies/ml on Stable Highly Active Antiretroviral Therapy Regimen for at Least 3 Months|Completed||Phase 2|45||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:26:53.422069|2017-02-18 16:26:53.422069
NCT00343928|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2013-02-19|||June 2006||2006-06-01|February 2013|2013-02-01||||June 2008|Actual|2008-06-01||Interventional|||Amino Acids, Serotonin, and Body Weight Regulation|Amino Acids, Serotonin, and Body Weight Regulation|Completed||Phase 2|21|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 16:26:53.515196|2017-02-18 16:26:53.515196
NCT00343915|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-09-29|2008-12-23||April 2004||2004-04-01|September 2016|2016-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs|Long-term Study of Immune Response Persistence of GSK Biologicals' 2-dose Thiomersal-free Engerix™-B and 3-dose Preservative-free Engerix™-B Vaccines in Subjects Aged 11-15 Yrs|Completed||Phase 3|267|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:53.630293|2017-02-18 16:26:53.630293
NCT00343902|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2006-06-21|||January 2000||2000-01-01|June 2006|2006-06-01|May 2004||2004-05-01|||||Interventional|||Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial|Randomized Clinical Trial of a Crataegus Oxycantha Extract in Chronic Heart Failure|Completed||Phase 3|120||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 16:26:54.351755|2017-02-18 16:26:54.351755
NCT00343889|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2013-11-11|2013-09-09||August 2006||2006-08-01|November 2013|2013-11-01|April 2008|Actual|2008-04-01|November 2007|Actual|2007-11-01||Interventional|||Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine|Immunogenicity Study of a DTaP-Hep B-PRP-T Combined Vaccine Compared to Tritanrix-HepB/Hib™, Both Given Concomitantly With the Oral Polio Vaccine at 6, 10, and 14 Weeks of Age in Healthy Infants in the Philippines|Completed||Phase 3|379|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:26:54.45342|2017-02-18 16:26:54.45342
NCT00343876|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2008-08-20|||July 2005||2005-07-01|August 2008|2008-08-01|November 2006|Actual|2006-11-01|||||Interventional|||Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial|A Single Center, Double-Blind, Randomized Trial to Evaluate the Effects of Aspirin 325 mg + Clopidogrel 75 mg v. Aspirin 325 mg + Placebo on Plasma Concentration of C-Reactive Protein: The CATER Trial Protocol|Completed||Phase 4|100|Anticipated|Intermountain Health Care, Inc.|||||||||||||||||||2017-02-18 16:26:55.069288|2017-02-18 16:26:55.069288
NCT00343863|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2013-05-07|||January 2006||2006-01-01|May 2013|2013-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer|Efficacy of Palonosetron in the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Following Dose Dense Adriamycin-Cyclophosphamide Chemotherapy in Early Stage Breast Cancer Patients|Completed||N/A|41|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 16:26:55.179701|2017-02-18 16:26:55.179701
NCT00343850|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2013-01-09|||September 2006||2006-09-01|January 2013|2013-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis|Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis: A Randomized Pilot Trial|Completed||Phase 3|30|Actual|University of Chicago|||||f||||||||||||||2017-02-18 16:26:55.299709|2017-02-18 16:26:55.299709
NCT00343824|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2014-12-04|||August 2006||2006-08-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings|Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings|Unknown status|Active, not recruiting|N/A|100|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 16:26:55.402788|2017-02-18 16:26:55.402788
NCT00343811|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2014-05-08|||June 2006||2006-06-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|||||Interventional|||Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment|A 6-week, Double-Blind, Placebo-Controlled, Parallel Group Randomized Withdrawal Study to Evaluate the Continued Efficacy of Modafinil Treatment in Dosages up to 425mg/Day in Patients With Attention-Deficit/Hyperactivity Disorder Who Are Responders to Modafinil Treatment, Followed by a 12-Month Open-Label Extension Period|Completed||Phase 3|120||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 16:26:55.513592|2017-02-18 16:26:55.513592
NCT00343798|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2015-02-10|||April 2006||2006-04-01|February 2015|2015-02-01||||July 2013|Actual|2013-07-01||Interventional|||A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies|A Pilot Study to Evaluate the Co-infusion of Ex Vivo Expanded Umbilical Cord Blood Progenitors With an Unmanipulated Cord Blood Graft in Patients Undergoing Umbilical Cord Blood Transplantation for Hematologic Malignancies|Completed||Phase 1|23|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 16:26:55.625234|2017-02-18 16:26:55.625234
NCT00343785|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-09-18|||February 2006||2006-02-01|September 2012|2012-09-01||||May 2012|Actual|2012-05-01||Interventional|||Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant|Cyclophosphamide and Antithymocyte Globulin Conditioning Regimen for Marrow Transplantation From HLA-Matched Family Members for Severe Aplastic Anemia: Effect of Marrow Cell Dose on Chronic Graft-vs.-Host Disease: A Multi-Center Trial|Completed||Phase 2|16|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 16:26:55.767805|2017-02-18 16:26:55.767805
NCT00343759|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2015-12-09|||June 2006||2006-06-01|December 2015|2015-12-01|December 2009|Anticipated|2009-12-01|May 2009|Anticipated|2009-05-01||Interventional|||Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy||Withdrawn||Phase 2|0|Actual|University of Pennsylvania||1|||f||||||||||||||2017-02-18 16:26:55.902913|2017-02-18 16:26:55.902913
NCT00343746|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-10|||October 2005||2005-10-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|||Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging|Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging|Active, not recruiting||N/A|1009|Actual|New York University School of Medicine|||1||f||||t||||||||Undecided||2017-02-18 16:26:56.102216|2017-02-18 16:26:56.102216
NCT00343733|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2014-05-08|||August 2006||2006-08-01|May 2014|2014-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain|A 12-Week Open-Label Study With 3 Within-Patient Double-Blind Placebo-Controlled Periods to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain|Completed||Phase 3|120||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 16:26:56.192403|2017-02-18 16:26:56.192403
NCT00343720|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2008-03-11||||||March 2008|2008-03-01||||October 2007|Actual|2007-10-01||Interventional|||Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy|A Randomized, Open-Label, Multicenter Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Antineoplastic Therapy|Completed||Phase 2|||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:26:56.294098|2017-02-18 16:26:56.294098
NCT00343707|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2016-09-13|||November 2004||2004-11-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients|A Double-blind, Triple Dummy, Placebo-controlled, Randomised, Parallel Group Positron Emission Tomography Study to Investigate the Effects of a 8 Week Administration of GW597599 and Paroxetine Either Alone or in Combination on Regional Cerebral Blood Flow During a Public Speaking Test in Subjects Affected by Social Phobia.|Completed||Phase 2|72|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:26:56.388102|2017-02-18 16:26:56.388102
NCT00343681|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2014-01-16|||July 2006||2006-07-01|January 2014|2014-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine|Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2006-2007 Formulation (Intramuscular Route)|Completed||Phase 2|120|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:26:56.499101|2017-02-18 16:26:56.499101
NCT00343668|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2010-05-25|||September 2005||2005-09-01|June 2006|2006-06-01|July 2008|Anticipated|2008-07-01|March 2007|Actual|2007-03-01||Interventional|||S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer|A Phase II Study of S-1 and Irinotecan Combination Chemotherapy in Patients With Advanced Gastric Cancer as a First-Line Therapy|Unknown status|Recruiting|Phase 2|44|Anticipated|Korean Cancer Study Group||1|||f||||f||||||||||2017-02-18 16:26:56.608136|2017-02-18 16:26:56.608136
NCT00343655|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2008-06-13|||January 2007||2007-01-01|June 2008|2008-06-01|August 2007|Actual|2007-08-01|||||Interventional|||Evaluation of Atorvastatin Treatment on Carotid Plaque.|A Randomized Clinical Trial Of Atorvastatin 10 Mg And 80 Mg In The Reversal Of Or Stabilization Of Carotid Atheroma Lipid Pool|Terminated||Phase 3|160||Pfizer||||"The study was terminated on June 22, 2007 for inability to enroll patients within an~   appropriate timeframe. There were no efficacy/safety concerns."|f||||||||||||||2017-02-18 16:26:56.706671|2017-02-18 16:26:56.706671
NCT00343642|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2014-01-24|||September 2006||2006-09-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Dietary Treatment of Crohn's Disease|Dietary Treatment of Crohn's Disease|Completed||Phase 1/Phase 2|73|Actual|Rush University Medical Center||3|||f||||t||||||||||2017-02-18 16:26:56.803291|2017-02-18 16:26:56.803291
NCT00343629|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2015-04-27|||April 2006||2006-04-01|December 2006|2006-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers|Bioequivalency Study of Sulindac in Capsule vs. Tablet Formulations|Completed||N/A|28|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 16:26:56.931164|2017-02-18 16:26:56.931164
NCT00343616|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-07-26|||April 2005||2005-04-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98|Investigating Cognitive Function for Patients Participating in the BIG Trial 1-98 in Select Centers|Completed||Phase 3|135|Actual|International Breast Cancer Study Group||4|||f||||t||||||||||2017-02-18 16:26:57.196826|2017-02-18 16:26:57.196826
NCT00343603|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2016-10-24|||October 2004||2004-10-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Observational|||Tracking Optical Coherence Tomography|Tracking Optical Coherence Tomography|Completed||Phase 2|100|Actual|University of Pittsburgh|||1||f||||f||||||||Undecided||2017-02-18 16:26:57.342525|2017-02-18 16:26:57.342525
NCT00343590|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2008-10-16|||June 2006||2006-06-01|October 2008|2008-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study|Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study|Completed||N/A|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:26:57.439694|2017-02-18 16:26:57.439694
NCT00343577|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2013-11-17|||January 2001||2001-01-01|June 2006|2006-06-01|December 2006||2006-12-01|||||Observational|||Antiproteinuric Agents and Fabry Disease|Observational Study of Antiproteinuric Agents in Patients With Fabry Disease Treated With Enzyme Replacement Therapy|Completed||N/A|12||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 16:26:57.540891|2017-02-18 16:26:57.540891
NCT00343564|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2016-08-08|2016-08-08||April 2006||2006-04-01|August 2016|2016-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma|A Phase I-II Study to Determine the Safety, Pharmacokinetics and Potential Efficacy of Intravenous Administration of SB-743921 on Days 1 and 15 of a 28-Day Dosing Schedule in Patients With Non-Hodgkin Lymphoma and Hodgkin Lymphoma|Completed||Phase 1/Phase 2|68|Actual|Cytokinetics||2|||f||||||||||||||2017-02-18 16:26:57.653589|2017-02-18 16:26:57.653589
NCT00343551|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2008-07-15|||May 2006||2006-05-01|July 2008|2008-07-01||||January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.|A Nine-Week, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of Aliskiren 300 mg Compared to Irbesartan 300 mg and Ramipril 10 mg in the Setting of a Missed Dose in Patients With Essential Hypertension|Completed||Phase 3|654||Novartis||2|||f||||||||||||||2017-02-18 16:27:00.210216|2017-02-18 16:27:00.210216
NCT00343525|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2008-04-28|||May 2006||2006-05-01|April 2008|2008-04-01||||January 2007|Actual|2007-01-01||Interventional|||Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C|A Phase Ib Open-Label, Escalating Repeat-Dose Trial of Bavituximab (Chimeric Anti-Phosphatidylserine Monoclonal Antibody) in Patients With Chronic Hepatitis C|Completed||Phase 1|24|Actual|Peregrine Pharmaceuticals|||||f||||f||||||||||2017-02-18 16:27:00.300244|2017-02-18 16:27:00.300244
NCT00343512|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-04-21|2010-10-11||February 2004||2004-02-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2008|Actual|2008-03-01||Interventional|||Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer|Pilot Study of Neoadjuvant Dose Dense Docetaxel With Correlative Molecular Studies in Stage II/III Breast Cancer|Terminated||Phase 2|34|Actual|Vanderbilt-Ingram Cancer Center|"All adverse events have been included in the other adverse event section. They are not differentiated by causality (eg. related to disease, con-meds)."|1||closed due to competing neoadjuvant studies for a small patient population|f||||t||||||||||2017-02-18 16:27:00.522318|2017-02-18 16:27:00.522318
NCT00343499|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2008-08-20|||November 2004||2004-11-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|||||Interventional|||The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)|A Single Center, Randomized Trial to Evaluate the Effects of Diovan to Maintain Sinus Rhythm in Patients With Persistent Atrial Fibrillation|Terminated||Phase 4|200|Anticipated|Intermountain Health Care, Inc.||||Inability to recruit|f||||||||||||||2017-02-18 16:27:00.905446|2017-02-18 16:27:00.905446
NCT00343486|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2009-05-15|||May 2006||2006-05-01|May 2009|2009-05-01||||||||Interventional|||Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms|An Eight- Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group Proof of Concept Study to Assess the Efficacy, Safety and Tolerability as Well as the Pharmacokinetic Profile of Oral Solabegron (GW427353) 125mg and 50mg Administered Twice Daily vs Placebo in Women With Overactive Bladder|Completed||Phase 2|240||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:27:01.011125|2017-02-18 16:27:01.011125
NCT00343473|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-10|||October 2005||2005-10-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye|Novel Diagnostics With Optical Coherence Tomography: Imaging of the Anterior Eye|Active, not recruiting||N/A|201|Actual|New York University School of Medicine|||1||f||||t||||||||Undecided||2017-02-18 16:27:01.183564|2017-02-18 16:27:01.183564
NCT00343460|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2016-10-31|2016-09-09||June 2006||2006-06-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional||Modified Intent-to-Treat Population|APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer|A Pivotal Phase 3 Observer-Blind, Randomized Clinical Trial of the Efficacy and Safety of APF530 Compared to Aloxi For The Prevention of Acute-Onset and Delayed-Onset Chemotherapy-Induced Nausea and Vomiting Following The Administration of Either Moderately or Highly Emetogenic Chemotherapy Regimens|Completed||Phase 3|1428|Actual|Heron Therapeutics||3|||f||||f||||||||No||2017-02-18 16:27:01.283531|2017-02-18 16:27:01.283531
NCT00343447|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2012-05-01|||August 2006||2006-08-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia|Phase II Randomized Trial of Early Versus Late Vaccination in Patients With High Risk CLL|Withdrawn||Phase 2|0|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 16:27:06.200366|2017-02-18 16:27:06.200366
NCT00343434|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2017-01-17|||January 2005||2005-01-01|June 2013|2013-06-01||||July 2007|Actual|2007-07-01||Interventional|||Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight|Use of a Soy-Based Meal Replacement Weight Loss Intervention for Survivors of ER/PR Negative Breast Cancer|Completed||N/A|25|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 16:27:06.302542|2017-02-18 16:27:06.302542
NCT00343421|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2016-06-01|||July 2006||2006-07-01|June 2016|2016-06-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|||Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers|Immunogenicity and Safety of PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus Influenzae Type b Conjugate Vaccine (Adsorbed), Compared to Infanrix®-IPV+Hib When Both Vaccines Are Co-Administered With Prevenar® to Infants and Toddlers at 2, 3, 4 and 12-18 Months of Age|Completed||Phase 3|588|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:27:06.406961|2017-02-18 16:27:06.406961
NCT00343408|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2010-11-07|||August 2005||2005-08-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||AZD2171 and Standard Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer or Colorectal Cancer|A Phase I, Open-Label, Dose-Seeking Study of AZD2171 Given Daily Orally in Combination With Selected Standard Chemotherapy Regimens (CT) in Patients With Advanced Incurable Non-Small Cell Lung Cancer (NSCLC) or Colorectal Cancer|Completed||Phase 1|30|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 16:27:06.531145|2017-02-18 16:27:06.531145
NCT00343395|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2011-03-15|||June 2006||2006-06-01|March 2011|2011-03-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study|A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Combined Rosiglitazone/Metformin (Avandamet®) vs. Placebo on Serological Outcomes in Non-Diabetic Patients With Stable Coronary Syndromes|Terminated||Phase 4|200|Anticipated|Intermountain Health Care, Inc.||2||FDA concerns regarding Avandamet|f||||f||||||||||2017-02-18 16:27:06.630434|2017-02-18 16:27:06.630434
NCT00343382|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2016-07-12|2014-07-16||December 2006||2006-12-01|July 2016|2016-07-01|December 2012|Actual|2012-12-01|July 2009|Actual|2009-07-01||Interventional|||Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer|Pilocarpine for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study|Completed||Phase 3|201|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-02-18 16:27:06.778978|2017-02-18 16:27:06.778978
NCT00343369|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-22|2013-08-23|||January 2003||2003-01-01|June 2006|2006-06-01||||||||Interventional|||Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia|Multicentric Study for the Treatment of Children With Acute Lymphoblastic Leukemia|Unknown status|Recruiting|N/A|550|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:27:08.212623|2017-02-18 16:27:08.212623
NCT00343356|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2006-06-21|||June 1996||1996-06-01|May 1996|1996-05-01|July 2003||2003-07-01|||||Interventional|||Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder|Clinical Study of Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder After Surgical Management|Completed||Phase 2|138||LanZhou University|||||f||||||||||||||2017-02-18 16:27:08.337558|2017-02-18 16:27:08.337558
NCT00343343|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-06|||June 2006||2006-06-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Comparison of NovoFine® Needles (4 mm vs. 6 mm)|A Comparative, Randomised Study With NovoFine® 4 mm Needle Versus NovoFine® 6 mm Needle in Regard to Anatomical Deposition of Sterile Air in Children and Thin Adults With Diabetes and Backflow of Test Medium (Only Adults) After Injection in Thigh and Abdomen|Completed||Phase 2|62|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:27:08.427761|2017-02-18 16:27:08.427761
NCT00343317|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2006-06-21|||February 2003||2003-02-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women|Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women|Completed||N/A|1372||University of KwaZulu|||||f||||||||||||||2017-02-18 16:27:08.530682|2017-02-18 16:27:08.530682
NCT00343304|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2006-06-20|||April 2005||2005-04-01|April 2005|2005-04-01|May 2006||2006-05-01|||||Interventional|||Pilot Study - Comparison of Upper Body Ergometer Vs. Robot in Upper Extremity Motor Recovery Post-Stroke||Completed||N/A|30||Burke Rehabilitation Hospital|||||f||||||||||||||2017-02-18 16:27:08.627663|2017-02-18 16:27:08.627663
NCT00343291|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2011-05-13|2011-05-13||December 2006||2006-12-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC|Phase II Randomized, Open-Label Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Patients With Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|121|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:27:08.742372|2017-02-18 16:27:08.742372
NCT00343278|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2015-04-13|||July 2005||2005-07-01|April 2015|2015-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets|Post-Marketing Clinical Study of Valaciclovir Hydrochloride Tablets -Single Oral Dose Study in Hemodialysis Patients-|Completed||Phase 4|18||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:27:10.174225|2017-02-18 16:27:10.174225
NCT00343265|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2013-08-14|||June 2006||2006-06-01|August 2013|2013-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Vaginal Progesterone Versus Placebo in Multiple Pregnancy|Pilot Randomized Trial of Vaginal Progesterone to Prevent Preterm Birth in Multiple Pregnancy|Completed||N/A|84|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 16:27:10.269876|2017-02-18 16:27:10.269876
NCT00343252|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2011-05-20|2010-06-08||June 2006||2006-06-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis|The Effect of Teriparatide Compared With Risedronate on Back Pain in Postmenopausal Women With Osteoporotic Vertebral Fractures|Completed||Phase 3|712|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:27:10.414287|2017-02-18 16:27:10.414287
NCT00343239|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2014-11-03|||June 2006||2006-06-01|November 2014|2014-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|NEOTAX||Docetaxel in Locally Advanced Gastric Adenocarcinoma|Docetaxel, Cisplatin and Fluorouracil Combination in the Neoadjuvant Treatment of Locally Advanced Gastric Adenocarcinoma : Phase II Clinical Study|Completed||Phase 2|59|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:27:12.647334|2017-02-18 16:27:12.647334
NCT00343226|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2010-08-24|||May 2002||2002-05-01|August 2010|2010-08-01||||April 2005|Actual|2005-04-01||Interventional|||"An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in de Novo Liver Transplantation."|"An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in de Novo Liver Transplantation."|Completed||Phase 4|48|Actual|Novartis|||||f||||||||||||||2017-02-18 16:27:12.742061|2017-02-18 16:27:12.742061
NCT00343213|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2011-08-29|||June 2006||2006-06-01|August 2011|2011-08-01||||||||Interventional|||Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix.|Diagnostic and Prognostic Value of p16INK4a Expression in Low Grade Squamous Intraepithelial Lesions of the Cervix. Immunohistochemical Study on Biopsies (Retrospective and Prospective Analysis) and on Liquid Based (SurePath) Cervical Cytology (Prospective Analysis). Correlation With HPV Typing and Clinical Outcome.|Unknown status|Recruiting|N/A|300|Anticipated|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 16:27:13.00329|2017-02-18 16:27:13.00329
NCT00343200|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2008-09-09|||July 2006||2006-07-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.|A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Flexible-Dose Study To Assess The Efficacy And Safety Of Viagra (Sildenafil Citrate) In Men With Erectile Dysfunction (ED) Who Do Not Self Identify.|Completed||Phase 4|371|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:27:13.093693|2017-02-18 16:27:13.093693
NCT00343187|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2011-05-27|||June 2006||2006-06-01|May 2011|2011-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash|A Phase II, Randomized, Double-Blind, Parallel Design Study to Evaluate ACZONE™ (Dapsone) Gel, 5% As a Treatment For Rash Related to the Human Epidermal Growth Factor Receptor 1 (HER1)/Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor Tarceva® (Erlotinib)|Terminated||Phase 2|2|Actual|Allergan||||Lack of enrollment|f||||||||||||||2017-02-18 16:27:13.247256|2017-02-18 16:27:13.247256
NCT00343174|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2006-06-20||||||January 2002|2002-01-01||||||||Interventional|||Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms|Multicenter Parallel Randomized Double-Blind Placebo Controlled Study of Efficacy and Safety of Intravenous Ancrod ( Arvin ) Given Within 6 Hours After the Onset of Acute Ischemic Stroke: European Stroke Treatment With Ancrod Trial ESTAT|Completed||Phase 3|||Heidelberg University|||||f||||||||||||||2017-02-18 16:27:13.354586|2017-02-18 16:27:13.354586
NCT00343161|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2011-01-21|||August 2006||2006-08-01|January 2011|2011-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|SYMPATHY||Symptom Adapted Therapy in GERD Patients|A Randomized, Open, Parallel-group, Multi-national, Multi-centre, Phase IV Study to Evaluate the Efficacy of Three Different Patient Management Strategies With and Without Esomeprazole 20 mg During a 3 Months Maintenance Phase Following an Initial 4-weeks Acute Treatment Phase in Subjects With Symptoms Thought to be GERD Related|Completed||Phase 4|441||AstraZeneca|||||f||||||||||||||2017-02-18 16:27:13.436678|2017-02-18 16:27:13.436678
NCT00343148|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2009-07-06|||June 2006||2006-06-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2006|Actual|2006-06-01||Interventional|||Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid|Pharmacokinetic Study of AVI-4126 in Cerebral Spinal Fluid Among Healthy Adult Males Following Intravenous Administration|Completed||Phase 1|6||Sarepta Therapeutics|||||f||||||||||||||2017-02-18 16:27:13.628232|2017-02-18 16:27:13.628232
NCT00343135|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2012-11-21|||December 2004||2004-12-01|November 2012|2012-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||AUGMENTIN 1gm In Skin And Soft Tissue Infection|An Open, Non-comparative Study to Evaluate the Efficacy and Safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic Acid) po q 12 Hours in the Treatment of Uncomplicated Skin and Soft Tissue Infections in Pakistan|Completed||Phase 4|195|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:27:13.707075|2017-02-18 16:27:13.707075
NCT00343122|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2007-09-14|||June 2006||2006-06-01|September 2007|2007-09-01||||||||Observational|||Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus Polygeline|Evaluation of Two Methods for the Echocardiographic Assessment of Intrapulmonary Vasodilatation in Patients With Liver Cirrhosis: Agitated Saline Versus Polygelatine|Unknown status|Recruiting|Phase 4|100|Anticipated|Medical University of Vienna|||||f||||||||||||||2017-02-18 16:27:13.811754|2017-02-18 16:27:13.811754
NCT00343109|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2016-08-08|||March 2004||2004-03-01|August 2016|2016-08-01||||June 2015|Actual|2015-06-01||Interventional|||Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer|Phase II Study of a HER-2/Neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine Administered to Patients With Locally Advanced or Stage IV HER2 Positive Breast Cancer|Active, not recruiting||Phase 2|38|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 16:27:13.89664|2017-02-18 16:27:13.89664
NCT00343096|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-21|2012-07-09|||June 2006||2006-06-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.|Buccal, Intranasal or Intravenous Lorazepam for the Treatment of Acute Convulsions in Children in Blantyre, Malawi: a Randomized Trial|Terminated||Phase 3|800|Actual|University of Malawi College of Medicine||||"The buccal arm of the study was 30% less effective in stopping seizures within 10 minutes~   compared with the IV dose. This met a stopping rule for the study"|f||||||||||||||2017-02-18 16:27:14.193559|2017-02-18 16:27:14.193559
NCT00343083|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2016-02-18|2013-04-12||December 2004||2004-12-01|February 2016|2016-02-01|May 2012|Actual|2012-05-01|June 2011|Actual|2011-06-01||Interventional|||Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)|A Phase II Study of Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck|Completed||Phase 2|43|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 16:27:14.288143|2017-02-18 16:27:14.288143
NCT00343070|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2010-08-30|||March 2007||2007-03-01|August 2010|2010-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Functional Neuroimaging in Depression|Functional Neuroimaging in Depression: Longitudinal Study of PET Metabolism in Correlation With Changes in Attentional Bias, Autobiographical Memory, Future Fluency and Facial Recognition in Depressed Patients Treated With Escitalopram.|Completed||Phase 2|40|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:27:14.583163|2017-02-18 16:27:14.583163
NCT00343057|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2009-09-03|||September 2003||2003-09-01|September 2009|2009-09-01|June 2004|Actual|2004-06-01|||||Observational|||DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP)|Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP): a Quasi-experimental Study in a Primary Care Setting.|Completed||N/A|2830|Actual|Sanofi|||2||f||||||||||||||2017-02-18 16:27:14.678574|2017-02-18 16:27:14.678574
NCT00343044|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2015-04-29|2013-07-29||June 2006||2006-06-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|January 2010|Actual|2010-01-01||Interventional|||Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers|Phase II Study of Weekly Topotecan With Bevacizumab in Platinum Resistant Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers|Completed||Phase 2|40|Actual|Benaroya Research Institute||1|||f||||f||||||||||2017-02-18 16:27:14.767138|2017-02-18 16:27:14.767138
NCT00343031|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 11, 2001||2001-05-11|December 16, 2016|2016-12-16||||||||Observational|||Effect of the Antiandrogen DDE on Anthropometric Measures at Birth|Effect of the Antiandrogen DDE on Anthropometric Measures at Birth|Completed||N/A|2300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:15.277726|2017-02-18 16:27:15.277726
NCT00343018|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 21, 2004||2004-01-21|October 5, 2006|2006-10-05|October 5, 2006||2006-10-05|||||Observational|||Interviewing Children About Past Events: Evaluating the NICHD Interview Protocol|Evaluating the NICHD Interview Protocol in an Analog Study|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:15.370959|2017-02-18 16:27:15.370959
NCT00343005|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 23, 2004||2004-04-23|January 22, 2008|2008-01-22|January 22, 2008||2008-01-22|||||Interventional|||Experimental Vaccine for Malaria in Adults in Mali|Double-Blind, Randomized, Controlled, Phase 1 Study of the Safety and Immunogenicity of AMA1-C1/Alhydrogel Vaccine for Plasmodium Falciparum Malaria, in Semi-Immune Adults in Doneguebougou, Mali|Completed||Phase 1|54||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:15.445999|2017-02-18 16:27:15.445999
NCT00342992|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 31, 1985||1985-08-31|December 9, 2016|2016-12-09||||||||Observational|||Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study|Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study (ATBC Study) Population|Completed||N/A|29133|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:15.539751|2017-02-18 16:27:15.539751
NCT00342966|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 14, 1999||1999-06-14|July 23, 2010|2010-07-23|July 23, 2010||2010-07-23|||||Observational|||Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation|Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation|Completed||N/A|34|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:15.64618|2017-02-18 16:27:15.64618
NCT00342953|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 9, 2003||2003-01-09|April 26, 2016|2016-04-26||||||||Observational|||Study of Health Effects of Cosmetic Breast Augmentation|Extended Mortality Follow-Up of Women With Augmentation Mammoplasty|Completed||N/A|17424|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:15.737069|2017-02-18 16:27:15.737069
NCT00342940|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2007-03-07|||October 2006||2006-10-01|March 2007|2007-03-01||||||||Interventional|||Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older|A Phase II, Open-Label, Uncontrolled, Single Center Study to Evaluate Safety and Immunogenicity of a Commercially Available Surface Antigen, Inactivated Influenza Vaccine, Formulation 2006-2007, When Administered to Non-Elderly Adult and Elderly Subjects|Suspended||Phase 2|125||Novartis||||Lack of Vaccine Supplies|f||||||||||||||2017-02-18 16:27:15.836894|2017-02-18 16:27:15.836894
NCT00342927|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-14|||March 5, 2001||2001-03-05|February 2, 2017|2017-02-02||||||||Observational|||Family Investigation of Nephropathy and Diabetes (F.I.N.D.)|Family Investigation of Nephropathy and Diabetes (F.I.N.D.)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:15.940844|2017-02-18 16:27:15.940844
NCT00342888|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 29, 2001||2001-10-29|May 25, 2016|2016-05-25||||||||Observational|||Case-Control Study of Pesticides and Childhood Leukemia|A Case-Control Study of Pesticides and Childhood Leukemia|Completed||N/A|629|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:16.06235|2017-02-18 16:27:16.06235
NCT00342875|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 27, 2002||2002-02-27|January 18, 2017|2017-01-18||||||||Observational|||The New England Bladder Cancer Study|The New England Bladder Cancer Study|Completed||N/A|2681|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:16.162194|2017-02-18 16:27:16.162194
NCT00342862|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2013-12-10|||December 2003||2003-12-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||AMEVIVE® Pregnancy Registry|Assessment and Tracking of Long-Term Alefacept (LFA-3/IgG1 Fusion Protein) Pregnancy Exposure Registry|Terminated||N/A|3|Actual|Astellas Pharma Inc|||1|"The Sponsor has made a decision, driven by business needs, to cease promotion, manufacturing,~   distribution and sales of Amevive"|f||||t||||||||||2017-02-18 16:27:16.275284|2017-02-18 16:27:16.275284
NCT00342849|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 15, 1994||1994-07-15|June 10, 2015|2015-06-10|June 10, 2015|Actual|2015-06-10|August 29, 2007|Actual|2007-08-29||Interventional|||Treatment of Lead-Exposed Children Trial|Treatment of Lead-Exposed Children (TLC) Trial|Completed||Phase 3|1332|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:27:16.39241|2017-02-18 16:27:16.39241
NCT00342836|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2007-03-22|||April 2005||2005-04-01|February 2006|2006-02-01||||||||Interventional|||Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer|Immunohistochemical Analysis of Human Transbronchial Biopsy Specimens Collected in a Phase I Chemoprevention Trial of Myo-Inositol in Heavy Smokers Conducted Outside the Intramural NCI Program|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:16.504838|2017-02-18 16:27:16.504838
NCT00342823|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 20, 2003||2003-10-20|June 30, 2010|2010-06-30|June 30, 2010||2010-06-30|||||Observational|||Immunogenetics of Visceral Leishmaniasis|Immunogenetics of Visceral Leishmaniasis|Completed||N/A|7000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:16.603747|2017-02-18 16:27:16.603747
NCT00342810|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 24, 2003||2003-06-24|May 3, 2016|2016-05-03||||||||Observational|||Analyses of Existing Framingham Data|Continued Analyses of Epidemiologic Risk Factors Using Existing Framingham Eye and Heart Study Data|Completed||N/A|6061|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:16.689999|2017-02-18 16:27:16.689999
NCT00342797|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 17, 1993||1993-11-17|November 29, 2016|2016-11-29||||||||Observational|||Retinoblastoma Biomarker Study|Retinoblastoma Biomarker Study|Active, not recruiting||N/A|1995|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:16.801209|2017-02-18 16:27:16.801209
NCT00005687|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||April 1989||1989-04-01|July 2000|2000-07-01|April 1999|Actual|1999-04-01|||||Observational|||Recycling Attempters and Relapsers in Smoking Cessation||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.991377|2017-02-18 18:14:30.991377
NCT00342771|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 28, 2004||2004-10-28|September 21, 2016|2016-09-21||||||||Observational|||An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian Males|A Case-Control Study of Prostate Cancer in the Greater Baltimore Area: An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian Males|Active, not recruiting||N/A|2033|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:16.973822|2017-02-18 16:27:16.973822
NCT00342758|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 1, 2001||2001-10-01|October 15, 2007|2007-10-15|October 15, 2007||2007-10-15|||||Observational|||Early Life Factors and Respiratory Health in Mexico City Children|Early Life Factors and Respiratory Health in Mexico City Children|Completed||N/A|6800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:17.061261|2017-02-18 16:27:17.061261
NCT00342732|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 7, 1999||1999-04-07|July 28, 2016|2016-07-28||||||||Observational|||The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for Obesity|The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for Obesity|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:17.136364|2017-02-18 16:27:17.136364
NCT00342706|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 10, 2005||2005-01-10|April 29, 2011|2011-04-29|April 29, 2011|Actual|2011-04-29|April 29, 2011|Actual|2011-04-29||Interventional|||Building Healthy Teen Relationships and Reproductive Practices to Increase Intervals Between Pregnancies|Building Healthy Teen Relationships and Reproductive Practices to Increase Interpregnancy Intervals|Completed||Phase 2|750|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:17.232717|2017-02-18 16:27:17.232717
NCT00342693|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 21, 2006||2006-02-21|September 3, 2013|2013-09-03|September 3, 2013||2013-09-03|||||Observational|||Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine|Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia|Terminated||N/A|360|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:17.315394|2017-02-18 16:27:17.315394
NCT00342667|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 8, 1997||1997-12-08|October 5, 2016|2016-10-05||||||||Observational|||Clinical, Biochemical, Histological and Biophysical Parameters in the Prediction of Cerebral Palsy in Patients With Preterm Labor and Premature Rupture of Membranes|Clinical, Biochemical, Histological and Biophysical Parameters in the Prediction of Cerebral Palsy in Patients With Preterm Labor and Premature Rupture of Membranes|Completed||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:17.398865|2017-02-18 16:27:17.398865
NCT00342654|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||May 20, 1999||1999-05-20|February 13, 2017|2017-02-13||||||||Observational|||Nutrition Intervention Trials in Linxian Follow-up Study|Nutritional Intervention Trials in Linxian China- Continued Follow-up|Active, not recruiting||N/A|34000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:17.490313|2017-02-18 16:27:17.490313
NCT00342641|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 8, 2005||2005-06-08|December 13, 2011|2011-12-13|December 13, 2011||2011-12-13|||||Observational|||Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers|Associations of Hematologic Malignancies and Thyroid Cancer With HCV Infection Among US Military Veterans|Completed||N/A|815000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:17.584505|2017-02-18 16:27:17.584505
NCT00342628|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2012-05-22|2012-03-30||July 2006||2006-07-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|April 2008|Actual|2008-04-01||Interventional|||Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants|Evaluation of the Safety, Immunogenicity and Compatibility With DTP of an Investigational Vi-rEPA Conjugate Vaccine for Typhoid Fever When Administered to Infants in Vietnam Concurrently With DTP|Completed||Phase 2|301|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||t||||||||||2017-02-18 16:27:17.67006|2017-02-18 16:27:17.67006
NCT00342602|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2009-03-16|||August 2005||2005-08-01|June 2006|2006-06-01||||||||Observational|||Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome|Influence of Host Genetic Factors in Development of PML in an AIDS Cohort|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:18.431961|2017-02-18 16:27:18.431961
NCT00342589|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 10, 1999||1999-04-10|October 4, 2016|2016-10-04||||||||Observational|||New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia|Studies of Human Pneumocystis Infection|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:18.514351|2017-02-18 16:27:18.514351
NCT00342576|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 23, 1994||1994-04-23|September 21, 2016|2016-09-21||||||||Observational|||Host Response to Infection and Treatment in Lymphatic Filarial Disease in India|Host Response to Infection and Treatment in Lymphatic Filarial Disease Strongyloidiasis in India|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:18.613345|2017-02-18 16:27:18.613345
NCT00342563|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2015-11-05|||May 2004||2004-05-01|November 2015|2015-11-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients|Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients|Completed||Phase 2|136|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:27:18.713447|2017-02-18 16:27:18.713447
NCT00342550|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 11, 1998||1998-03-11|October 20, 2016|2016-10-20||||||||Observational|||Cervical Volume by Three-Dimensional Ultrasound as a Predictor of Preterm Delivery|Cervical Volume by Three-Dimensional Ultrasound as a Predictor of Preterm Delivery|Completed||N/A|680|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:18.823467|2017-02-18 16:27:18.823467
NCT00342537|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 31, 2003||2003-12-31|August 24, 2016|2016-08-24||||||||Observational|||Genetics of Familial Testicular Cancer|Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Studies of Familial Testicular Germ Cell Tumors|Completed||N/A|2600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:18.919489|2017-02-18 16:27:18.919489
NCT00342524|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 6, 2005||2005-07-06|February 8, 2007|2007-02-08|February 8, 2007||2007-02-08|||||Observational|||Collection of Convalescent SARS Plasma by Apheresis|Collection of Convalescent SARS Plasma by Apheresis|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.185486|2017-02-18 16:27:19.185486
NCT00342511|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 9, 2006||2006-01-09|December 13, 2011|2011-12-13|December 13, 2011||2011-12-13|||||Observational|||Pilots of Self-Collection for HPV DNA Detection|Pilots of Self-Collection Devices for HPV DNA Detection|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.26838|2017-02-18 16:27:19.26838
NCT00342485|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 12, 1993||1993-04-12|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients|In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients|Completed||N/A|5000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.424932|2017-02-18 16:27:19.424932
NCT00342472|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 14, 1998||1998-07-14|August 24, 2016|2016-08-24||||||||Observational|||Environmental and Biological Monitoring Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian, China|Environmental and Biological Monitoring Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian, China|Completed||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.493375|2017-02-18 16:27:19.493375
NCT00342446|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 5, 1996||1996-06-05|November 7, 2016|2016-11-07||||||||Observational|||A Follow-up Study of Women Evaluated and Treated for Infertility|Follow-Up Study of Women Evaluated and Treated for Infertility|Completed||N/A|12193|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.591876|2017-02-18 16:27:19.591876
NCT00342433|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 29, 1999||1999-04-29|December 19, 2016|2016-12-19||||||||Observational|||Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study|Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study|Completed||N/A|850|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.677665|2017-02-18 16:27:19.677665
NCT00342407|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 5, 2001||2001-11-05|May 3, 2016|2016-05-03||||||||Observational|||The Incidence of Breast and Other Cancers Among Female Flight Attendants|The Incidence of Breast and Other Cancers Among Female Flight Attendants|Active, not recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.778655|2017-02-18 16:27:19.778655
NCT00342394|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 14, 2001||2001-11-14|May 1, 2013|2013-05-01|May 1, 2013||2013-05-01|||||Observational|||Fungicide Exposure Assessment Among Apple and Peach Farmers in the Argicultural Health Study|Fungicide Exposure Assessment Among Apple and Peach Farmers in the Agricultural Health Study|Completed||N/A|75|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:19.873011|2017-02-18 16:27:19.873011
NCT00342381|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2007-12-12|||June 2006||2006-06-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation|Fatigue in Multiple Sclerosis: Evaluated With 3 Tesla MRI and Transcranial Magnetic Stimulation|Completed||Phase 2|120|Anticipated|University of Aarhus||2|||f||||t||||||||||2017-02-18 16:27:19.954477|2017-02-18 16:27:19.954477
NCT00342368|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2007-10-31|||June 2005||2005-06-01|October 2007|2007-10-01|March 2009|Anticipated|2009-03-01|||||Interventional|HelmetCPAP||Helmet CPAP vs Venturi O2 to Treat Early ALI/ARDS|A Comparison of CPAP Delivered by Helmet and O2 Therapy With a Venturi Mask as First Line Intervention in Early ALI/ARDS|Unknown status|Recruiting|N/A|190|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-02-18 16:27:20.07559|2017-02-18 16:27:20.07559
NCT00342355|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2013-04-29|2009-09-14||January 2004||2004-01-01|April 2013|2013-04-01|August 2008|Actual|2008-08-01|March 2008|Actual|2008-03-01||Interventional|||Antiretroviral Therapy for Advanced HIV Disease in South Africa|Randomized, Open-Label 2x2 Factorial Study to Compare the Safety and Efficacy of Different Combination Antiretroviral Therapy Regimens in Treatment Naive Patients With Advanced HIV Disease and/or CD4+ Cell Counts Less Than 200 Cells/MicroL|Completed||Phase 4|1771|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||t||||||||||2017-02-18 16:27:20.187812|2017-02-18 16:27:20.187812
NCT00342342|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 4, 2002||2002-12-04|June 23, 2016|2016-06-23||||||||Observational|||Family Studies of Eye Traits|Family Studies of Ocular Traits|Completed||N/A|8000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:20.754648|2017-02-18 16:27:20.754648
NCT00342329|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 16, 2001||2001-04-16|March 7, 2007|2007-03-07|March 7, 2007||2007-03-07|||||Observational|||Lupus Nephritis: Role of Environmental and Occupational Exposures|Lupus Nephritis: Role of Environmental and Occupational Exposures|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:20.859364|2017-02-18 16:27:20.859364
NCT00342316|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2016-09-22|||December 2003||2003-12-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|July 2017|Anticipated|2017-07-01||Interventional|||Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia|Prospective Controlled Clinical Study of Allogeneic Stem Cell Transplantation With Reduced Conditioning (RICT) Versus Best Standard of Care in Acute Myeloid Leukemia (AML)in First Complete Remission (CR)|Active, not recruiting||Phase 3|360|Actual|Vastra Gotaland Region||2|||f||||t||||||||||2017-02-18 16:27:20.9435|2017-02-18 16:27:20.9435
NCT00342303|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 8, 1993||1993-06-08|July 13, 2010|2010-07-13|July 13, 2010||2010-07-13|||||Observational|||Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo|Essential Fatty Acid Metabolism in the Newborn: Equivalence of Precusors and Mediators in the Synthesis of Long Chain Polyunsaturated Fatty Acids of the n-6 and n-3 Series|Completed||N/A|110|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.089886|2017-02-18 16:27:21.089886
NCT00342290|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 22, 1998||1998-03-22|June 29, 2012|2012-06-29|June 29, 2012||2012-06-29|||||Observational|||Early Pregnancy Evaluation by Three-Dimensional Ultrasound|Early Pregnancy Evaluation by Three-Dimensional Ultrasound|Terminated||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.18243|2017-02-18 16:27:21.18243
NCT00342277|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 8, 1999||1999-12-08|October 4, 2016|2016-10-04||||||||Observational|||Microarray Expression Profiling to Identify Stereotypic mRNA Profiles for Preterm Delivery in Order to Unravel the Biological Mechanisms|Microarray Expression Profiling to Identify Stereotypic mRNA Profiles in Human Parturition|Completed||N/A|11128|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.271929|2017-02-18 16:27:21.271929
NCT00342264|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 12, 1999||1999-01-12|October 3, 2016|2016-10-03||||||||Observational|||A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners|Diesel Exhaust Among Miners Study|Completed||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.37901|2017-02-18 16:27:21.37901
NCT00005686|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-29|||April 1989||1989-04-01|February 2016|2016-02-01|April 2003||2003-04-01|||||Observational|||Dietary Intervention Methods for Clinical Trials||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:14:31.057066|2017-02-18 18:14:31.057066
NCT00342225|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 19, 2002||2002-12-19|December 21, 2006|2006-12-21|December 21, 2006||2006-12-21|||||Observational|||Mother-Child Relationships During Pregnancy Among Bofi Foragers|Mother-Child Relationships During Pregnancy Among the Bofi Foragers in the Northern Congo|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.573274|2017-02-18 16:27:21.573274
NCT00342212|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2011-05-24|||March 2006||2006-03-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|||||Observational|||Actigraph Accelerometer Validation Study|Actigraph Accelerometer Validation Study|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.657195|2017-02-18 16:27:21.657195
NCT00342199|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 3, 2001||2001-07-03|February 26, 2014|2014-02-26|February 26, 2014||2014-02-26|||||Observational|||Surveillance of Streptococcal Infections in Children in India|Epidemiological Surveillance in India of Group A Streptococcal Infections Including Pharyngitis and Impetigo Supported by Indo-US Vaccine Action Program|Completed||N/A|663|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.757597|2017-02-18 16:27:21.757597
NCT00342186|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-14|||September 25, 2002||2002-09-25|January 26, 2017|2017-01-26||||||||Observational|||Genes Involved in Resistance or Susceptibility to Hepatitis B Virus|Human Genes Involved in Susceptibility or Resistance to Hepatitis B Virus|Completed||N/A|3400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.842015|2017-02-18 16:27:21.842015
NCT00342173|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||May 20, 1999||1999-05-20|February 10, 2017|2017-02-10||||||||Observational|||Costa Rican Natural History Study of HPV and Cervical Neoplasia|Costa Rican Natural History Study of HPV and Cervical Neoplasia|Completed||N/A|12000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:21.94136|2017-02-18 16:27:21.94136
NCT00342160|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 15, 2006||2006-02-15|November 13, 2012|2012-11-13|November 13, 2012||2012-11-13|||||Observational|||Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda|Virologic and Immunologic Factors Contributing to the Lack of HIV-1 Transmission in HIV-Discordant Couples in Rakai, Uganda|Completed||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:22.046299|2017-02-18 16:27:22.046299
NCT00342147|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 7, 1995||1995-11-07|July 20, 2016|2016-07-20||||||||Observational|||Family Study of Head and Neck Cancers in Taiwan|Family Study of Head and Neck Cancers in Taiwan|Active, not recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:22.133724|2017-02-18 16:27:22.133724
NCT00342134|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 1, 2002||2002-05-01|May 4, 2011|2011-05-04|May 4, 2011|Actual|2011-05-04|May 4, 2011|Actual|2011-05-04||Interventional|||Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis|Immunological Mechanisms of Immune Ablation and Autologous Hematopoietic Stem Cell Transplantation in Secondary Progressive Multiple Sclerosis|Completed||Phase 2|34|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:22.223371|2017-02-18 16:27:22.223371
NCT00342121|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 2, 2002||2002-05-02|September 19, 2016|2016-09-19||||||||Observational|||Influence of Corn Farming on the Immune System|Influence of Corn Farming on the Immune System|Completed||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:22.306322|2017-02-18 16:27:22.306322
NCT00342108|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2010-11-02|||September 2007||2007-09-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|July 2009|Actual|2009-07-01||Interventional|||Cortical Visual Impairment and Visual Attentiveness|Cortical Visual Impairment and Visual Attentiveness: The Effect of Visual and Cross-Modal Environments on Children Diagnosed With Cerebral Palsy and Cortical Visual Impairment|Completed||N/A|60|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 16:27:22.394419|2017-02-18 16:27:22.394419
NCT00342095|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 17, 1996||1996-12-17|March 7, 2007|2007-03-07|March 7, 2007||2007-03-07|||||Observational|||Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study|Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study|Completed||N/A|640||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:22.493572|2017-02-18 16:27:22.493572
NCT00342082|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 25, 2004||2004-06-25|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Effects of Anti-HIV Therapy on Red Blood Cells of HIV-infected Mothers and Their Infants|A Pilot Study to Investigate Micronucleated Erythrocyte Frequencies in Infants Exposed to Nucleoside Antiretrovial Drugs in Utero and for 6 Weeks Postnatally|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:22.717096|2017-02-18 16:27:22.717096
NCT00342069|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 17, 2004||2004-12-17|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Prevalence of Ambivalence Regarding Prenatal Testing|Facilitating Informed for Prenatal Testing: The Role of Ambivalence|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:22.79873|2017-02-18 16:27:22.79873
NCT00342056|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2011-05-24|||January 2005||2005-01-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|||||Observational|||Role of Gene Variation in Effectiveness of Gleevec Treatment|Analysis of ABCG2 Genotype in Gleevec Treated Cancer Patients to Assess the Association of a Single Nucleotide Polymorphism (C421A) in ABCG2 and Response to Treatment|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:22.878629|2017-02-18 16:27:22.878629
NCT00342043|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 2, 2005||2005-08-02|April 16, 2009|2009-04-16|April 16, 2009||2009-04-16|||||Observational|||Examination of Protective Factors Against Severe Malaria|Multidisciplinary Studies of Malaria Protection by Hemoglobinopathies and G6PD Deficiency in Mali|Completed||N/A|4850||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:22.959063|2017-02-18 16:27:22.959063
NCT00342030|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 1, 2002||2002-11-01|April 12, 2012|2012-04-12|April 12, 2012||2012-04-12|||||Observational|||Dietary and Genetic Factors in Asthma & Chronic Bronchitis in a Cohort of Chinese Singaporeans|Dietary and Genetic Factors in Asthma & Chronic Bronchitis in a Cohort of Chinese Singaporeans|Completed||N/A|63257|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:23.043951|2017-02-18 16:27:23.043951
NCT00342017|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 20, 2002||2002-05-20|August 4, 2009|2009-08-04||||September 2, 2008|Actual|2008-09-02||Observational|||The Effect of Parasitic Worm Infections on the Immune Response to Tuberculosis Bacteria|Immunological Consequences of Helminth and Mycobacterial Coinfection|Completed||N/A|5200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:23.130933|2017-02-18 16:27:23.130933
NCT00342004|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 12, 1997||1997-05-12|March 21, 2016|2016-03-21||||||||Observational|||A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women|A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women|Active, not recruiting||N/A|76000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:23.421287|2017-02-18 16:27:23.421287
NCT00341991|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 31, 2001||2001-10-31|January 4, 2017|2017-01-04||||||||Observational|||Molecular Epidemiology of Cutaneous Malignant Melanoma|Molecular Epidemiology of Cutaneous Malignant Melanoma|Completed||N/A|17500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:23.518353|2017-02-18 16:27:23.518353
NCT00341965|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 27, 1999||1999-01-27|November 4, 2013|2013-11-04|November 4, 2013||2013-11-04|||||Observational|||Pesticide Exposure and Health Status in North Carolina African American Male Farmers and Farm Workers|Pesticide Exposure and Health Status in NC African American Male Farmers and Farm Workers|Completed||N/A|389|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:23.614337|2017-02-18 16:27:23.614337
NCT00341952|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-10|||January 27, 1998||1998-01-27|January 25, 2017|2017-01-25||||||||Observational|||Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma|Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma|Completed||N/A|2400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:23.694226|2017-02-18 16:27:23.694226
NCT00341939|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 7, 2004||2004-09-07|October 27, 2016|2016-10-27||||||||Observational|||Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data|Retrospective Analysis of Drug Disposition and Response-related Genotypes in Cancer Patients and Correlation With Pharmacokinetics and Pharmacodynamics Data|Completed||N/A|1587|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:23.781153|2017-02-18 16:27:23.781153
NCT00341913|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 16, 2000||2000-03-16|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Observational|||Network on Antimicrobial Resistance in Staphylococcus Aureus|Network on Antimicrobial Resistance in Staphylococcus Aureus|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.041967|2017-02-18 16:27:24.041967
NCT00341900|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 9, 2001||2001-11-09|May 3, 2016|2016-05-03||||||||Observational|||Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews|Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews|Completed||N/A|140|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.121766|2017-02-18 16:27:24.121766
NCT00341887|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 14, 2004||2004-01-14|November 7, 2012|2012-11-07|November 7, 2012||2012-11-07|||||Observational|||Epidemiological Study of HIV in the South African National Defense Force|PHIDISA I: A Prospective, Observational Cohort Study of HIV Infection (Both Treated and Untreated) and Risk-Related Co-Infections in the South African National Defence Force (SANDF)|Terminated||N/A|50000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.222376|2017-02-18 16:27:24.222376
NCT00341874|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||July 15, 1992||1992-07-15|February 13, 2017|2017-02-13||||||||Observational|||Non-Syndrome Hereditary Hearing Impairment - Gene Mapping: India/Pakistan Protocol|Non-Syndromic Hereditary Hearing Impairment - Gene Mapping: India/Pakistan Protocol|Recruiting||N/A|24000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.314175|2017-02-18 16:27:24.314175
NCT00341861|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 14, 1998||1998-06-14|November 17, 2016|2016-11-17||||||||Observational|||Interdisciplinary Case-Control Study of Bladder Cancer in Spain|Interdisciplinary Case-Control Study of Bladder Cancer in Spain|Completed||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.423567|2017-02-18 16:27:24.423567
NCT00341848|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 5, 2001||2001-12-05|July 5, 2016|2016-07-05||||||||Observational|||Postpartum Uterine Regression|Postpartum Uterine Regression|Completed||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.523426|2017-02-18 16:27:24.523426
NCT00341835|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 26, 2003||2003-08-26|July 6, 2016|2016-07-06||||||||Observational|||Genetic Epidemiology of Lung Cancer|Genetic Epidemiology of Lung Cancer|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.619384|2017-02-18 16:27:24.619384
NCT00341822|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 29, 2006||2006-03-29|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Invasive Prenatal Testing Decisions in Pregnancy After Infertility|Prenatal Testing Decisions in Pregnancy After Infertility|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.730747|2017-02-18 16:27:24.730747
NCT00341809|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 30, 2004||2004-07-30|September 4, 2012|2012-09-04|September 4, 2012||2012-09-04|||||Observational|||Genetic Analysis of Psoriasis and Psoriatic Arthritis|Role of HLA and KIR in the Natural History of Psoriasis|Completed||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.823879|2017-02-18 16:27:24.823879
NCT00341796|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2008-03-03|||June 2002||2002-06-01|August 2006|2006-08-01|August 2006||2006-08-01|||||Observational|||Interventions to Decrease the Risk of Mother-to-Child Transmission of HIV in India|A Prospective Cohort Study of the Seroprevalence of, and Interventions to Decrease the Risk of Mother-to-Child Transmission of, Human Immunodeficiency Virus Type 1 (HIV) in Tamil Nadu, India|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:24.915304|2017-02-18 16:27:24.915304
NCT00341783|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2009-01-06|||July 2002||2002-07-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, Mali|Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Doneguebougou, Mali|Terminated||N/A|515||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.00283|2017-02-18 16:27:25.00283
NCT00341770|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 12, 1991||1991-04-12|November 23, 2010|2010-11-23|November 23, 2010||2010-11-23|||||Observational|||Assessment of Sympathetic Nervous System Activity by Microneurography Recording Technique|Assessment of Sympathetic Nervous System Activity by Microneurography Recording Technique|Completed||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.084613|2017-02-18 16:27:25.084613
NCT00341757|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 12, 2000||2000-09-12|July 7, 2011|2011-07-07|July 7, 2011||2011-07-07|||||Observational|||Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)|Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)|Completed||N/A|5190|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.157674|2017-02-18 16:27:25.157674
NCT00341718|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 29, 2006||2006-03-29|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics|The Experiences of Genetics Patients With Visible Differences Who Facilitate Teaching in Genetics Clinics|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.434468|2017-02-18 16:27:25.434468
NCT00341705|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 27, 2001||2001-04-27|April 2, 2013|2013-04-02|April 2, 2013||2013-04-02|||||Observational|||The Second Multicenter Hemophilia Cohort Study|The Second Multicenter Hemophilia Cohort Study|Completed||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.52608|2017-02-18 16:27:25.52608
NCT00341692|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 3, 2003||2003-04-03|April 15, 2016|2016-04-15||||||||Observational|||Studying Normal Breast Tissue and Cancer Risk|Pilot Study to Collect Normal Breast Tissue From Organ and Tissue Donors|Active, not recruiting||N/A|20|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.676371|2017-02-18 16:27:25.676371
NCT00341679|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 11, 2005||2005-07-11|December 13, 2016|2016-12-13||||||||Observational|||Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases|Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases|Completed||N/A|719|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.766232|2017-02-18 16:27:25.766232
NCT00341666|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 3, 2006||2006-04-03|July 15, 2011|2011-07-15|July 15, 2011||2011-07-15|||||Observational|||Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites|Regulation of Innate and Adaptive Immune Responses in Individuals Infected Concurrently With Malarial and Filarial Parasites|Completed||N/A|360|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.855752|2017-02-18 16:27:25.855752
NCT00341653|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 24, 1998||1998-07-24|September 29, 2016|2016-09-29||||||||Observational|||A Cohort Study of Smoking Prevention and Health Promotion for Middle School Students in Wuhan, China|A Cohort Study of Smoking Prevention and Health Promotion for Middle School Students in Wuhan, China|Completed||N/A|7000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:25.934906|2017-02-18 16:27:25.934906
NCT00341640|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 6, 2005||2005-01-06|December 1, 2006|2006-12-01|December 1, 2006||2006-12-01|||||Interventional|||Metabolism of Nicotine and Cotinine in Pregnant African-American Women|Pharmacokinetics of Nicotine and Cotinine in Pregnant African-American Women and Implications for Pharmacological Interventions|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.011628|2017-02-18 16:27:26.011628
NCT00341627|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 12, 1999||1999-01-12|August 24, 2016|2016-08-24||||||||Observational|||Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families|Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families|Completed||N/A|140|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.094274|2017-02-18 16:27:26.094274
NCT00341614|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2007-08-14|||June 2006||2006-06-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Exercise Training in Older Diabetic Women|The Effects of an Exercise and Diet Intervention on Cardiovascular Risk Factors in Postmenopausal Type 2 Diabetics|Completed||Phase 1|35|Anticipated|University of San Francisco||1|||f||||f||||||||||2017-02-18 16:27:26.20406|2017-02-18 16:27:26.20406
NCT00341601|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 23, 2004||2004-12-23|August 23, 2016|2016-08-23||||||||Observational|||Multi-Drug Resistant Tuberculosis in Korea|A Natural History Study of Multidrug-Resistant Tuberculosis Strains and Host Susceptibility Genes in Korean Patients With Pulmonary Tuberculosis|Active, not recruiting||N/A|2040|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.298948|2017-02-18 16:27:26.298948
NCT00341588|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 17, 2002||2002-01-17|May 20, 2016|2016-05-20||||||||Observational|||A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen|A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen|Completed||N/A|3600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.393862|2017-02-18 16:27:26.393862
NCT00341575|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 28, 2005||2005-09-28|August 2, 2010|2010-08-02|August 2, 2010||2010-08-02|||||Observational|||Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer|Psychosocial Aspects of Genetic Testing for HNPCC|Completed||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.500335|2017-02-18 16:27:26.500335
NCT00341562|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2008-03-03|||September 2005||2005-09-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Observational|||Genomics of In-Stent Restenosis|Genomics of In-Stent Restenosis: Endarterectomy Study|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.580892|2017-02-18 16:27:26.580892
NCT00341549|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-01|||April 24, 2002||2002-04-24|January 17, 2017|2017-01-17||||||||Observational|||Family Myopia Study|Family Myopia Study|Completed||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.65313|2017-02-18 16:27:26.65313
NCT00341536|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 17, 2004||2004-06-17|November 20, 2013|2013-11-20|November 20, 2013||2013-11-20|||||Observational|||Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India|A Feasibility Study for Prospective Cohort in India|Completed||N/A|4044|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.858458|2017-02-18 16:27:26.858458
NCT00341523|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 16, 1994||1994-05-16|November 22, 2016|2016-11-22||||||||Observational|||Early Detection of Esophageal Cancer|Early Detection of Esophageal Cancer|Recruiting||N/A|8000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:26.941023|2017-02-18 16:27:26.941023
NCT00341510|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 17, 2005||2005-10-17|November 28, 2006|2006-11-28|November 28, 2006||2006-11-28|||||Observational|||Health Behaviors in School-age Children: A World Health Organization Cross-National Study|U.S. Health Behavior in School Children Survey|Completed||N/A|14350||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.045029|2017-02-18 16:27:27.045029
NCT00341497|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 28, 1996||1996-08-28|June 10, 2016|2016-06-10||||||||Observational|||Biomarkers for Oral Cancer|Biomarkers for Oral Cancer|Completed||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.127704|2017-02-18 16:27:27.127704
NCT00341484|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 18, 1998||1998-05-18|April 8, 2016|2016-04-08||||||||Observational|||Genetic Susceptibility to Oncogenic Viruses|Genetic Susceptibility to Oncogenic Viruses|Completed||N/A|2600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.23149|2017-02-18 16:27:27.23149
NCT00341471|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 18, 2006||2006-01-18|May 18, 2011|2011-05-18|October 8, 2008|Actual|2008-10-08|October 8, 2008|Actual|2008-10-08||Interventional|||Building Futures for Youth - Phase III|Adolescent Pregnancy Prevention: Building Futures for Youth|Completed||Phase 3|2500|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:27.323514|2017-02-18 16:27:27.323514
NCT00341458|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 25, 1999||1999-08-25|August 31, 2016|2016-08-31||||||||Observational|||Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics|Breast, Ovarian and Endometrial Cancer Case-Control Study in Poland|Completed||N/A|6600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.399216|2017-02-18 16:27:27.399216
NCT00341445|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 12, 2004||2004-08-12|September 11, 2013|2013-09-11|February 12, 2007|Actual|2007-02-12|February 12, 2007|Actual|2007-02-12||Interventional|||Cockroach Allergen Reduction by Extermination Alone in Low-Income, Urban Homes: A Randomized Control Trial|Cockroach Allergen Reduction by Extermination Alone in Low-Income, Urban Homes-A Randomized Control Trial|Completed||Phase 1|65|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:27.490409|2017-02-18 16:27:27.490409
NCT00341432|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 16, 2005||2005-08-16|April 20, 2011|2011-04-20|April 20, 2011|Actual|2011-04-20|||||Interventional|||Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers|Nicotine Replacement Therapy Methods for Pregnant Women|Completed||Phase 2|300|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:27.570035|2017-02-18 16:27:27.570035
NCT00341419|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 16, 2005||2005-02-16|May 14, 2013|2013-05-14|May 14, 2013||2013-05-14|||||Observational|||Genetic Analysis of Patients With Pseudoxanthoma Elasticum|Genetic Analysis of Patients With Pseudoxanthoma Elasticum (PXE)|Completed||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.660453|2017-02-18 16:27:27.660453
NCT00341406|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 3, 2003||2003-09-03|September 22, 2016|2016-09-22||||||||Observational|||Fat Cell Size in Insulin Resistance|Adipose Cell Size In Human Insulin Resistance|Recruiting||N/A|9999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.751976|2017-02-18 16:27:27.751976
NCT00341393|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 16, 2006||2006-02-16|November 15, 2007|2007-11-15|November 15, 2007||2007-11-15|||||Observational|||Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa|Validation of Algorithm for Monitoring the Virological Efficacy of Antiretroviral Therapy in Africa|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.840475|2017-02-18 16:27:27.840475
NCT00341380|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-28|||September 24, 2002||2002-09-24|January 23, 2017|2017-01-23||||||||Observational|||Prevention of Tumor Spread Due to Lung Cancer Surgery|Venous or Arterial Ligation and Intraoperative Dissemination (VALID) of Cancer Cells: A Randomized Clinical Trial For Patients With Resectable Non-Small Cell Lung Cancer|Completed||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.917522|2017-02-18 16:27:27.917522
NCT00341367|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 10, 2002||2002-12-10|March 11, 2010|2010-03-11|March 11, 2010||2010-03-11|||||Observational|||Blood Sample Donations to Study the Role of Genes in Pain|Genetic Risk of Chronic Pain After Acute Sciatica|Completed||N/A|320|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:27.998321|2017-02-18 16:27:27.998321
NCT00341354|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 27, 2006||2006-01-27|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Interventional|||Coated Endotracheal Tube and Mucus Shaver to Prevent Hospital-Acquired Infections|Evaluation of Silver-Sulfadiazine Tracheal Tubes / Mucus Shaver in Intubated Patients Expected to Have a Prolonged Mechanical Ventilation|Completed||Phase 2|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:28.084063|2017-02-18 16:27:28.084063
NCT00341341|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 7, 2004||2004-12-07|July 16, 2010|2010-07-16|July 16, 2010||2010-07-16|||||Observational|||Impact of Lung Cancer Diagnosis on Relatives' Understanding of Genetic Risk and Receptivity to Quit Smoking|Impact of a Patient's Lung Cancer Diagnosis on Relatives' Understanding of Genetic Risk Information and Receptivity to Quit Smoking|Completed||N/A|757|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:28.161877|2017-02-18 16:27:28.161877
NCT00341328|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2013-04-25|||March 2007||2007-03-01|April 2013|2013-04-01|March 2012|Actual|2012-03-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.|Efficacy and Safety of Immunomodulator (Mycobacterium w.) as an Adjunct Therapy in Category I Pulmonary Tuberculosis and Along With Assessment of Immunological Parameters|Completed||Phase 3|300|Actual|Ministry of Science and Technology, India||2|||f||||t||||||||||2017-02-18 16:27:28.235943|2017-02-18 16:27:28.235943
NCT00341315|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 14, 2004||2004-05-14|April 25, 2016|2016-04-25||||||||Observational|||Breast Cancer, Breast Disease, and Pesticides|A Study of Breast Cancer, Breast Disease, Mammographic Density and Pesticides Among a Population From Triana, Alabama|Completed||N/A|228|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:28.353712|2017-02-18 16:27:28.353712
NCT00341302|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 24, 2002||2002-07-24|May 16, 2016|2016-05-16||||||||Observational|||A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries|A Prospective, Observational Study of HIV-Infected Pregnant Women and HIV-Exposed, Uninfected Children at Clinical Sites in Latin American Countries|Completed||N/A|3554|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:28.441008|2017-02-18 16:27:28.441008
NCT00341289|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 17, 2003||2003-03-17|September 2, 2009|2009-09-02||||January 10, 2007|Actual|2007-01-10||Observational|||Environmental and Behavioral Risk Factors for Childhood Drowning|Environmental and Behavioral Risk Factors for Childhood Drowning|Completed||N/A|1430||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:28.540601|2017-02-18 16:27:28.540601
NCT00341276|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 27, 1995||1995-06-27|October 24, 2016|2016-10-24||||||||Observational|||Esophageal Cancer Genetics Studies|Esophageal Cancer Genetics Studies|Recruiting||N/A|8000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:28.6221|2017-02-18 16:27:28.6221
NCT00341263|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-14|||November 19, 2003||2003-11-19|January 25, 2017|2017-01-25||||||||Observational|||Maternal and Umbilical Cord Hormone Concentrations in Twin and Singleton Pregnancies|Study of Maternal and Umbilical Cord Hormone Concentrations in Monochorionic and Dichorionic Pregnancies|Completed||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:28.715283|2017-02-18 16:27:28.715283
NCT00341250|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 19, 2006||2006-01-19|April 29, 2009|2009-04-29|December 8, 2006||2006-12-08|||||Interventional|||Malaria Vaccine in Children in Mali|Randomized, Controlled, Phase 1/2 Study of the Safety and Immunogenicity of AMA1-C1/Alhydrogel Vaccine for Plasmodium Falciparum Malaria in Children in Doneguebougou and Bancoumana, Mali|Completed||Phase 1/Phase 2|900||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:28.802843|2017-02-18 16:27:28.802843
NCT00341237|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-14|||November 20, 2003||2003-11-20|January 31, 2017|2017-01-31||||||||Observational|||Environmental Polymorphisms Registry|Environmental Polymorphism Registry (EPR)|Recruiting||N/A|20000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:31.610132|2017-02-18 16:27:31.610132
NCT00341224|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 23, 2003||2003-07-23|December 9, 2009|2009-12-09|December 9, 2009|Actual|2009-12-09|December 9, 2009|Actual|2009-12-09||Interventional|||Steppin' Up: Positive Youth Development Program|Steppin' Up: Positive Youth Development Program|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:31.704983|2017-02-18 16:27:31.704983
NCT00341211|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 11, 1996||1996-04-11|December 1, 2010|2010-12-01|December 1, 2010||2010-12-01|||||Observational|||Specimens From Normal Controls|Specimens From Normal Controls|Completed||N/A|27|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:31.787099|2017-02-18 16:27:31.787099
NCT00341198|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 2, 2002||2002-04-02|December 12, 2006|2006-12-12|December 12, 2006||2006-12-12|||||Observational|||Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study|Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study|Completed||N/A|700||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:31.855478|2017-02-18 16:27:31.855478
NCT00341185|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 5, 1998||1998-03-05|November 18, 2016|2016-11-18|November 18, 2016||2016-11-18|||||Observational|||Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing|Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing|Completed||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:31.939214|2017-02-18 16:27:31.939214
NCT00341172|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 12, 2004||2004-10-12|June 9, 2016|2016-06-09||||||||Observational|||The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis|Discovery of Genetic Variants Contributing to the Incidence or Course of CMV Disease in AIDS Patients|Completed||N/A|2500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:32.058372|2017-02-18 16:27:32.058372
NCT00341159|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 18, 2005||2005-01-18|February 24, 2015|2015-02-24|February 24, 2015||2015-02-24|||||Observational|||Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study|Genetic Analysis of Cancer Susceptibility Alleles in the CARE Case-Control Study|Completed||N/A|9257|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:32.154457|2017-02-18 16:27:32.154457
NCT00341146|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 20, 2001||2001-11-20|May 5, 2016|2016-05-05||||||||Observational|||Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)|Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NPC Susceptibility Gene(s)|Completed||N/A|9100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:32.23863|2017-02-18 16:27:32.23863
NCT00341133|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 13, 1999||1999-12-13|August 4, 2009|2009-08-04||||November 27, 2006|Actual|2006-11-27||Observational|||Genetic Analysis of Left-Right Axis Formations|Genetic Analysis of Left-Right Axis Malformations|Completed||N/A|900||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:32.326596|2017-02-18 16:27:32.326596
NCT00341120|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 2, 2003||2003-01-02|August 29, 2012|2012-08-29|August 29, 2012||2012-08-29|||||Observational|||Genetic Causes of Male Infertility|Methylenetetrahydrofolate Reductase C677T Mutation, Other Variant Genotypes, and Male Infertility|Completed||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:32.402214|2017-02-18 16:27:32.402214
NCT00341107|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2008-03-03|||February 1999||1999-02-01|January 2006|2006-01-01||||||||Observational|||Physicians Survey on Genetic Testing|Physicians Survey on Genetic Testing|Completed||N/A|1350||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:32.485384|2017-02-18 16:27:32.485384
NCT00341094|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 1, 1995||1995-05-01|November 2, 2016|2016-11-02||||||||Observational|||Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident|Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Diseases in Ukraine Following the Chernobyl Accident|Active, not recruiting||N/A|70000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:32.550832|2017-02-18 16:27:32.550832
NCT00341081|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2011-05-24|||October 2002||2002-10-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|||||Observational|||Validation of Self-Reported Needle Sharing Among Injection Drug Users|Validation of Self-Reported Needle Sharing Among Injection Drug Users|Completed||N/A|442||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:32.971126|2017-02-18 16:27:32.971126
NCT00341068|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 15, 1999||1999-12-15|November 29, 2016|2016-11-29||||||||Observational|||Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish Population|Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish Population|Completed||N/A|8000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.048059|2017-02-18 16:27:33.048059
NCT00341055|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2011-06-08|||June 2003||2003-06-01|March 2010|2010-03-01|May 2004|Actual|2004-05-01|||||Interventional|||A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.|A Pilot Study to Evaluate the Hematologic Response Rate of PROCRIT� (Epoetin Alfa) at 80,000 Units Once Weekly in Anemic Cancer Patients Receiving Chemotherapy|Completed||Phase 3|69|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:27:33.137186|2017-02-18 16:27:33.137186
NCT00341042|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 4, 2005||2005-01-04|May 1, 2013|2013-05-01|May 1, 2013||2013-05-01|||||Observational|||Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research|Establishment of Normal Parameters for Blood and Sputum With Samples Obtained From Volunteers in Bamako|Terminated||N/A|480|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.238296|2017-02-18 16:27:33.238296
NCT00341029|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 7, 2005||2005-12-07|June 26, 2009|2009-06-26|September 30, 2007|Actual|2007-09-30|September 30, 2007|Actual|2007-09-30||Observational|||Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate|Measurement of Cytogenetic Endpoints in Lymphocytes of Children Diagnosed With Attention Deficit/Hyperactivity Disorder (ADHD) and Treated With Methylphenidate or Adderall|Completed||N/A|84||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.319536|2017-02-18 16:27:33.319536
NCT00341016|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 26, 1996||1996-07-26|March 2, 2016|2016-03-02||||||||Observational|||Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident|Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.401717|2017-02-18 16:27:33.401717
NCT00341003|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 22, 2005||2005-07-22|January 14, 2011|2011-01-14|January 14, 2011||2011-01-14|||||Observational|||Severe Malaria and Anti-malarial Drug Resistance in Cambodia|Multidisciplinary Studies of Severe Malaria and Antimalarial Drug Resistance in Cambodia|Completed||N/A|2090|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.494415|2017-02-18 16:27:33.494415
NCT00340990|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 6, 2003||2003-10-06|November 27, 2015|2015-11-27|November 27, 2015||2015-11-27|||||Observational|||Immune Responses to Mycobacterium Tuberculosis|Pilot Study of CD4+ T Cell Immune Responses to Mycobacterium Tuberculosis|Completed||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.576835|2017-02-18 16:27:33.576835
NCT00340977|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 6, 1995||1995-09-06|January 3, 2017|2017-01-03||||||||Observational|||Svangerskap, Arv, og Miljo (Pregnancy, Heredity and Environment)|Svangerskap, Arv, Og Miljo (Pregnancy, Heredity and Environment)|Completed||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.66581|2017-02-18 16:27:33.66581
NCT00340964|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 13, 2005||2005-06-13|January 6, 2014|2014-01-06|January 6, 2014||2014-01-06|||||Observational|||Positive Exposure: A Photography and Video Intervention for Individuals With Craniofacial Differences|Positive Exposure: A Photography and Video Intervention for Individuals With Craniofacial Differences|Completed||N/A|70|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.760176|2017-02-18 16:27:33.760176
NCT00340951|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 23, 2005||2005-06-23|April 13, 2007|2007-04-13|April 13, 2007||2007-04-13|||||Observational|||Can Immune Parameters Predict Acute and Chronic Rejection in Lung Recipients?|Can Immune Parameters Predict Acute and Chronic Rejection in Lung Recipients?|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:33.850772|2017-02-18 16:27:33.850772
NCT00340938|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-26|||November 4, 2004||2004-11-04|January 11, 2017|2017-01-11|January 25, 2017|Actual|2017-01-25|August 20, 2009|Actual|2009-08-20||Interventional|||Family Management of Childhood Diabetes Study|Family Management of Childhood Diabetes Study|Completed||Phase 1|1540|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:33.930549|2017-02-18 16:27:33.930549
NCT00340912|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 7, 1988||1988-12-07|October 1, 2009|2009-10-01||||December 7, 1988|Actual|1988-12-07||Observational|||Use of Biopsy Punch for Skin Biopsies for Fibroblasts Culturing|Use of Biopsy Punch for Skin Biopsies for Fibroblasts Culturing|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:34.022189|2017-02-18 16:27:34.022189
NCT00340899|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 4, 1997||1997-12-04|October 31, 2016|2016-10-31||||||||Observational|||Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study|Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Restriction: A Longitudinal Study|Active, not recruiting||N/A|27778|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:34.090119|2017-02-18 16:27:34.090119
NCT00340886|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 1, 2001||2001-10-01|May 19, 2010|2010-05-19|May 19, 2010||2010-05-19|||||Observational|||NIEHS/UNC Environmental Polymorphism Study|Environmental Polymorphism Study (EPS)|Completed||N/A|485|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:34.181635|2017-02-18 16:27:34.181635
NCT00340873|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 12, 1994||1994-12-12|April 25, 2016|2016-04-25||||||||Observational|||Molecular Epidemiology of Dioxin-Related Illness in Seveso|Molecular Epidemiology of Dioxin-Related Illness in Seveso|Completed||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:34.262322|2017-02-18 16:27:34.262322
NCT00340860|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 14, 2002||2002-05-14|January 9, 2017|2017-01-09||||||||Observational|||The Norwegian Mother and Child Study - Environmental Specimen Collection|The Norwegian Mother and Child Study - Environmental Specimen Collection|Completed||N/A|85000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:34.35739|2017-02-18 16:27:34.35739
NCT00340847|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 9, 2001||2001-08-09|May 19, 2010|2010-05-19|May 19, 2010||2010-05-19|||||Observational|||Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer|Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer|Completed||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:34.438213|2017-02-18 16:27:34.438213
NCT00340834|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2014-01-14|2011-01-04||May 2006||2006-05-01|January 2014|2014-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|TRANSFORMS||Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase|A 12-month Double-blind, Randomized, Multicenter, Active-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Interferon ß-1a (Avonex) Administered im Once Weekly in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase|Completed||Phase 3|1292|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:27:34.5497|2017-02-18 16:27:34.5497
NCT00340821|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 17, 1993||1993-05-17|March 1, 2011|2011-03-01|March 1, 2011||2011-03-01|||||Observational|||A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis|A Study of Familial and Genetic Aspects of Adult T-Cell Leukemia/Lymphoma, Tropical Spastic Paraparesis and Infective Dermatitis in Jamaica|Completed||N/A|1800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:37.642313|2017-02-18 16:27:37.642313
NCT00340808|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 17, 2004||2004-03-17|September 21, 2016|2016-09-21||||||||Observational|||Molecular Staging of Endometrial Cancer|Integration of an Epidemiologic Questionnaire Into Gynecologic Oncology Group Trials: First Project, Protocol 210|Completed||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:37.769429|2017-02-18 16:27:37.769429
NCT00340795|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 4, 2005||2005-08-04|March 7, 2007|2007-03-07|March 7, 2007||2007-03-07|||||Observational|||Media-Smart Youth Program Evaluation Study|Media-Smart Youth Program Evaluation Study|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:37.860204|2017-02-18 16:27:37.860204
NCT00340782|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 13, 2006||2006-04-13|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Influence of Social and Environmental Factors on Women's Reproductive Function in a Maya Community of Guatemala|The Influence of Social and Environmental Factors on Fecundability in a Maya Community of Guatemala|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:37.94496|2017-02-18 16:27:37.94496
NCT00340769|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 18, 2001||2001-04-18|December 20, 2006|2006-12-20|December 20, 2006||2006-12-20|||||Observational|||Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic|Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:38.022696|2017-02-18 16:27:38.022696
NCT00340756|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 6, 2003||2003-08-06|February 25, 2011|2011-02-25|February 25, 2011||2011-02-25|||||Observational|||Evaluating Serum Sex Steroid Hormones|Reproducibility of Serum Sex Steroid Measurement: A Proof of Performance Study|Completed||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:38.102959|2017-02-18 16:27:38.102959
NCT00340743|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 19, 2004||2004-04-19|September 27, 2016|2016-09-27||||||||Observational|||Diet and Genetic Damage|Inhibition of Fried Meat-Induced DNA Damage: A Dietary Intervention Study|Completed||N/A|16|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:38.181041|2017-02-18 16:27:38.181041
NCT00340730|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 4, 2001||2001-12-04|November 2, 2006|2006-11-02|November 2, 2006||2006-11-02|||||Observational|||Community Based Youth Injury Prevention Program|Community Based Youth Injury Prevention Program|Completed||N/A|392||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:38.280104|2017-02-18 16:27:38.280104
NCT00340717|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2008-03-03|||May 2003||2003-05-01|September 2006|2006-09-01||||||||Observational|||Markers for Early Detection of Prostate Cancer|Multi-Institutional Pilot Study to Evaluate Molecular Markers in Urine and Serum in the Early Detection of Prostate Cancer|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:38.358425|2017-02-18 16:27:38.358425
NCT00340704|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2016-01-20|2015-08-10||April 2006||2006-04-01|January 2016|2016-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||Treated Set: Includes all patients who are dispensed study medication and are documented to have taken at least one dose of treatment. In this study, some of the subjects are in multiple phases: PK and Group D-Denovo. Thus, the baseline characteristics are based on the unique subject entered into the study.|PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder|An Uncontrolled, Open-label, Titration, Long-term Safety (up to 12 Months) and Efficacy Study of Tamsulosin Hydrochloride in Children With Neuropathic Bladder, With a Randomized Pharmacokinetic Sub-study Investigating Low, Medium and High Dose Ranges.|Completed||Phase 2|143|Actual|Boehringer Ingelheim|In Group D-527.51 Rollover study, due to the early termination caution should be used in interpreting these results due to the impact of the early termination, as well as the impact of the study design on interpretation of results by dose.|3|||f||||f||||||||||2017-02-18 16:27:38.452607|2017-02-18 16:27:38.452607
NCT00340691|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 6, 2004||2004-12-06|November 25, 2008|2008-11-25||||October 4, 2007|Actual|2007-10-04||Interventional|||Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis|Treatment of Mansonella Perstans Infection in an Area Coendemic for Lymphatic Filariasis: A Pilot Study of the Effects of Doxycycline|Completed||Phase 2|1500||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:40.329139|2017-02-18 16:27:40.329139
NCT00340678|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2014-07-16|2013-03-26||August 1995||1995-08-01|October 2013|2013-10-01|March 2014|Actual|2014-03-01|May 2012|Actual|2012-05-01||Interventional||Of 170 subjects enrolled, one lost follow up. So all analysis was performed based on 169 subjects.|Renoprotection in Early Diabetic Nephropathy in Pima Indians|Renoprotection in Early Diabetic Nephropathy in Pima Indians|Completed||Phase 3|170|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||t||||||||||2017-02-18 16:27:40.66731|2017-02-18 16:27:40.66731
NCT00340665|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 5, 2003||2003-05-05|August 22, 2012|2012-08-22|August 22, 2012||2012-08-22|||||Observational|||Study of Infant Diets on Estrogen Activity and Development|Study of Estrogen Activity & Development (SEAD) SEAD2: Physical Exam and Ballard Markers; Sead 3: Biochemistry|Completed||N/A|456|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:41.439792|2017-02-18 16:27:41.439792
NCT00340652|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 26, 2003||2003-08-26|August 22, 2012|2012-08-22|August 22, 2012||2012-08-22|||||Observational|||Effects of Infant Diets on Estrogen Activity and Development|Study of Estrogen Activity & Development (SEAD) - SEAD 1 Sonography|Completed||N/A|156|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:41.534959|2017-02-18 16:27:41.534959
NCT00340639|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 28, 2003||2003-01-28|November 2, 2006|2006-11-02|November 2, 2006||2006-11-02|||||Observational|||Management of Type 1 Diabetes Among Adolescents|Developmental Influences on Management of Type I Diabetes|Completed||N/A|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:41.639415|2017-02-18 16:27:41.639415
NCT00340626|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 25, 1997||1997-06-25|May 11, 2016|2016-05-11||||||||Observational|||Genetic Analysis of Hereditary Non-Syndromic Oral Clefts|Genetic Analysis of Hereditary Non-Syndromic Oral Clefts|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:41.717085|2017-02-18 16:27:41.717085
NCT00340613|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2016-07-12|||June 2006||2006-06-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes|A School Intervention: Lunch Time Insulin Injections in Children With Poorly Controlled Type 1 Diabetes|Completed||Phase 4|36|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 16:27:41.808615|2017-02-18 16:27:41.808615
NCT00340574|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 8, 2005||2005-03-08|July 2, 2008|2008-07-02|July 2, 2008||2008-07-02|||||Interventional|||Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)|Phase I Study of the Safety and Immunogenicity of AMA-1-C1/Alhydrogel + CPG 7909, An Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria|Completed||Phase 1|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.103689|2017-02-18 16:27:42.103689
NCT00340561|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2008-03-03|||January 2005||2005-01-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Observational|||Effect of Experience on Driving Performance in New Teenage Drivers|Effects of Experience on the Driving Performance of Novice Teen Drivers|Completed||N/A|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.19828|2017-02-18 16:27:42.19828
NCT00340548|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 29, 2002||2002-03-29|December 28, 2015|2015-12-28||||||||Observational|||Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)|Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)|Completed||N/A|333|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.275815|2017-02-18 16:27:42.275815
NCT00340535|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 18, 2004||2004-06-18|August 9, 2016|2016-08-09||||||||Observational|||Effect of Genetic Differences on Levels of Water Disinfection Byproducts in Blood After Showering|Levels of Selected Potentially Carcinogenic Drinking Water Disinfection Byproducts in Whole Blood After Showering|Completed||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.388289|2017-02-18 16:27:42.388289
NCT00340522|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 7, 2004||2004-09-07|August 11, 2014|2014-08-11|August 11, 2014||2014-08-11|||||Observational|||Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development|Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development|Completed||N/A|20|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.481806|2017-02-18 16:27:42.481806
NCT00340509|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 26, 2001||2001-10-26|July 23, 2013|2013-07-23|July 23, 2013||2013-07-23|||||Observational|||A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study|A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study|Completed||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.572146|2017-02-18 16:27:42.572146
NCT00340496|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2008-03-03|||August 1996||1996-08-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Observational|||Analysis of NF2 Mutations in Radiation-Related Neural Tumors|Analysis of NF2 Mutations in Radiation-Related Neural Tumors|Completed||N/A|112||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.663184|2017-02-18 16:27:42.663184
NCT00340483|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 25, 2004||2004-05-25|December 14, 2006|2006-12-14|December 14, 2006||2006-12-14|||||Interventional|||Smoking Cessation Aid for Young Smokers|X-Pack: A Smoking Cessation Aid for Young Smokers|Completed||Phase 1|291||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.737639|2017-02-18 16:27:42.737639
NCT00340470|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 24, 2003||2003-07-24|February 6, 2007|2007-02-06|February 6, 2007||2007-02-06|||||Interventional|||Michigan Driver Education Study|Michigan Young Drivers Intervention Study|Completed||Phase 3|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.833099|2017-02-18 16:27:42.833099
NCT00340457|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||November 15, 2001||2001-11-15|February 10, 2017|2017-02-10||||||||Observational|||Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States|Case-Control Study of Renal Cell Cancer Among Caucasians and African Americans in the United States|Completed||N/A|2424|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:42.923655|2017-02-18 16:27:42.923655
NCT00340444|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 6, 2003||2003-11-06|September 19, 2007|2007-09-19|September 19, 2007||2007-09-19|||||Observational|||Genetic Studies of Inflammatory Bowel Disease|Genetic Study of Inflammatory Bowel Disease|Completed||N/A|10000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:43.017381|2017-02-18 16:27:43.017381
NCT00340431|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 9, 2004||2004-06-09|February 6, 2008|2008-02-06|February 6, 2008||2008-02-06|||||Interventional|||Experimental Vaccine for Plasmodium Falciparum Malaria|Phase 1 Study of the Safety and Immunogenicity of MSP1(42)-FVO/Alhydrogel and MSP1(42)-3D7/Alhydrogel, Asexual Blood-Stage Vaccines for Plasmodium Falciparum Malaria|Completed||Phase 1|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:43.102385|2017-02-18 16:27:43.102385
NCT00340418|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 23, 2005||2005-06-23|April 13, 2007|2007-04-13|April 13, 2007||2007-04-13|||||Observational|||Mechanisms of Lung Allograft Rejection|Mechanisms of Lung Allograft Rejection|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:43.18887|2017-02-18 16:27:43.18887
NCT00340405|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 23, 1992||1992-04-23|December 19, 2016|2016-12-19||||||||Observational|||Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China|Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China|Active, not recruiting||N/A|11000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:43.269449|2017-02-18 16:27:43.269449
NCT00340392|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 7, 2006||2006-04-07|March 23, 2011|2011-03-23|March 23, 2011||2011-03-23|||||Observational|||Isolation and Characterization of Mammary Stem Cells|Isolation and Characterization of Mammary Stem Cells|Completed||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:43.362039|2017-02-18 16:27:43.362039
NCT00340379|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2014-08-15|2011-06-28||April 2003||2003-04-01|February 2012|2012-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression|A Comparison of Two Different Treatments for Major Depression With Psychotic Features: Ziprasidone vs. Combined Sertraline and Haloperidol|Completed||Phase 2/Phase 3|72|Actual|Duke University||2|||f||||f||||||||||2017-02-18 16:27:43.437603|2017-02-18 16:27:43.437603
NCT00340366|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 16, 2003||2003-12-16|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Influence of Genetics on Vitamin Metabolism in Pregnant Women|Investigation Into the Influence of Genetic Variation on Folate, Cobalamin and Related Metabolites|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:43.903406|2017-02-18 16:27:43.903406
NCT00005685|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1983||1983-09-01|January 2006|2006-01-01|July 2002|Actual|2002-07-01|||||Observational|||Blood Pressure Control--Racial and Psychosocial Influences||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:31.14149|2017-02-18 18:14:31.14149
NCT00340353|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 7, 2005||2005-04-07|April 12, 2012|2012-04-12|April 12, 2012||2012-04-12|||||Observational|||Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research|Procurement of Blood and Tissue From Patients With Primary and Metastatic Alveolar Soft Part Sarcoma and Blood From Healthy Controls for In Vitro and In Vivo Model Development|Completed||N/A|99999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:43.992809|2017-02-18 16:27:43.992809
NCT00340340|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||June 27, 2001||2001-06-27|February 10, 2017|2017-02-10||||||||Observational|||Genetic Epidemiology of Lung Cancer and Smoking|Genetic Epidemiology of Lung Cancer and Smoking Current Title: Environmental And Genetic Lung Cancer Etiology (EAGLE)|Completed||N/A|4500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:44.075824|2017-02-18 16:27:44.075824
NCT00340327|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2007-12-03|||June 2006||2006-06-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Evaluating IMA-638 in Healthy Japanese|An Ascending Single Dose Study of the Safety and Pharmacokinetics of IMA-638 Administered to Healthy Japanese Subjects|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:27:44.182209|2017-02-18 16:27:44.182209
NCT00340314|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2010-07-27|||January 2005||2005-01-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|APAF2||A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)|A Controlled Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Treating Paroxysmal Atrial Fibrillation. The Ablation for Paroxysmal Atrial Fibrillation (APAF2) Trial|Completed||Phase 4|198||IRCCS San Raffaele|||||f||||||||||||||2017-02-18 16:27:44.264224|2017-02-18 16:27:44.264224
NCT00340301|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 2, 2003||2003-06-02|February 12, 2016|2016-02-12||||||||Observational|||Exposure to Neurotoxins as Risk Factors for ALS|Exposure to Neurotoxins as Risk Factors for ALS: Measurement of Genes, Proteins, Neurotoxicants, and Other Factors Potentially Associated With ALS|Completed||N/A|397|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:44.360163|2017-02-18 16:27:44.360163
NCT00340288|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 26, 2001||2001-06-26|December 28, 2016|2016-12-28||||||||Observational|||Fibroid Growth Study|Fibroid Growth Study|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:44.445925|2017-02-18 16:27:44.445925
NCT00340275|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 14, 1999||1999-04-14|November 18, 2010|2010-11-18|November 18, 2010||2010-11-18|||||Observational|||Longitudinal Study of Vaginal Flora|Longitudinal Study of Vaginal Flora|Completed||N/A|5500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:44.618823|2017-02-18 16:27:44.618823
NCT00340262|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 7, 2000||2000-04-07|March 15, 2016|2016-03-15||||||||Observational|||Bone Mineral Density and Subsequent Cancer Risk|Bone Mineral Density and Subsequent Cancer Risk|Completed||N/A|22695|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:44.696163|2017-02-18 16:27:44.696163
NCT00340249|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2012-06-13|||July 1995||1995-07-01|June 2012|2012-06-01||||||||Observational|||Use of the Perinatal Database and Biologic Tissue Bank at The Perinatology Research Branch (PRB)|Use of a Perinatal Database and Biologic Tissue Bank at the Perinatology Research Branch (PRB)|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:44.780585|2017-02-18 16:27:44.780585
NCT00340223|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2012-05-09|||September 2005||2005-09-01|May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Observational|||HLA-B35 Alleles and AIDS|Comparison of HIV-1 Epitopes That May be Recognized by HLA-B*3501 (PY) and -B*3503 (Px) Early After Seroconversion and After Development of AIDS|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:44.860518|2017-02-18 16:27:44.860518
NCT00340210|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 21, 1998||1998-12-21|August 24, 2016|2016-08-24||||||||Observational|||Extended Follow-up of Columbia, MO Serum Bank Participants|Extended Follow-up of Columbia, MO Serum Bank Participants|Completed||N/A|6720|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:44.94032|2017-02-18 16:27:44.94032
NCT00340184|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2010-10-17|||August 2004||2004-08-01|January 2006|2006-01-01||||||||Interventional|||A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients|A Phase II Trial of Radiation Therapy With Concurrent Paclitaxel/Carboplatin Chemotherapy in High-risk Cervical Cancer Patients After Radical Hysterectomy|Completed||Phase 2|55||Korean Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 16:27:45.054269|2017-02-18 16:27:45.054269
NCT00340171|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 10, 1997||1997-11-10|October 5, 2016|2016-10-05||||||||Observational|||Fetal Growth Evaluation by Three-Dimensional Ultrasound|Fetal Growth Evaluation by Three-Dimensional Ultrasound|Completed||N/A|4518|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:45.317701|2017-02-18 16:27:45.317701
NCT00340158|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2010-04-22|||June 2003||2003-06-01|April 2009|2009-04-01||||||||Observational|||Establishing an Inflammatory Breast Cancer Registry|The Establishment of an Inflammatory Breast Cancer Registry and Biospecimen Repository|Completed||N/A|164|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:45.403477|2017-02-18 16:27:45.403477
NCT00340132|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 18, 1982||1982-08-18|December 6, 2016|2016-12-06||||||||Observational|||"Cross-Sectional and Longitudinal Studies of Pre-Diabetes in the Pima Indians"|"Cross-Sectional and Longitudinal Studies of Pre-Diabetes"|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:45.484026|2017-02-18 16:27:45.484026
NCT00340119|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 21, 2005||2005-03-21|March 1, 2012|2012-03-01|March 1, 2012||2012-03-01|||||Observational|||Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis|Prospective Study of Inflammatory Markers and Genes as Predictors of Atherosclerotic Cardiovascular Disease in Dialysis Patients|Completed||N/A|871|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:45.58141|2017-02-18 16:27:45.58141
NCT00340106|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 25, 2005||2005-07-25|May 18, 2011|2011-05-18|May 18, 2010|Actual|2010-05-18|March 5, 2010|Actual|2010-03-05||Interventional|||Prevention of Environmental Tobacco Smoke Exposure in Children 0-12 Months Old|Prevention of Environmental Tobacco Smoke (ETS) Exposure to Children, Ages 0-12 Months|Completed||Phase 2|375|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:45.674199|2017-02-18 16:27:45.674199
NCT00340093|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 23, 2002||2002-08-23|March 6, 2007|2007-03-06|March 6, 2007||2007-03-06|||||Interventional|||Diabetes Management Personal Trainer|The Diabetes Management Study|Completed||Phase 1|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:45.760341|2017-02-18 16:27:45.760341
NCT00340080|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2010-01-21|||April 2006||2006-04-01|January 2010|2010-01-01||||||||Interventional|||Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity|A Phase IV, Randomised, Multicentre, Double-blind, Study to Evaluate the Clinical Utility of Prospective Genetic Screening (HLA-B*5701) for Susceptibility to Abacavir Hypersensitivity|Completed||Phase 4|1806||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:27:45.854871|2017-02-18 16:27:45.854871
NCT00340054|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2012-03-07|||October 2005||2005-10-01|March 2012|2012-03-01|March 2007|Actual|2007-03-01|||||Observational|||Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields|Assessment of Occupational EMF Exposure - Validation of Interview Procedures Used in Brain Tumor Study|Completed||N/A|108|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:46.396151|2017-02-18 16:27:46.396151
NCT00340028|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 13, 2005||2005-01-13|February 23, 2016|2016-02-23||||||||Observational|||Hormonal Changes in Early Pregnancy|Hormonal Changes in Early Pregnancy: Pilot Study to Evaluate Stored Urine Specimens|Completed||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:46.492522|2017-02-18 16:27:46.492522
NCT00340015|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||October 18, 1995||1995-10-18|February 14, 2017|2017-02-14||||||||Observational|||A Prospective Study of Diet and Cancer in Members of the American Association of Retired Persons|NCI-AARP Diet and Health Study|Completed||N/A|566401|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:46.58083|2017-02-18 16:27:46.58083
NCT00340002|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 6, 1997||1997-11-06|November 18, 2016|2016-11-18||||||||Observational|||Fetal Anatomy by Three-Dimensional Ultrasound|Fetal Anatomy by Three-Dimensional Ultrasound|Completed||N/A|7000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:46.66258|2017-02-18 16:27:46.66258
NCT00339989|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 10, 2003||2003-09-10|September 19, 2016|2016-09-19||||||||Observational|||Cervical Cancer Early Endpoints and Determinants|A Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED)|Active, not recruiting||N/A|3500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:46.756624|2017-02-18 16:27:46.756624
NCT00339976|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 6, 2002||2002-08-06|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis|Ascertainment of Death in ALS Patients|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:46.844304|2017-02-18 16:27:46.844304
NCT00339963|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 9, 2001||2001-11-09|November 8, 2016|2016-11-08||||||||Observational|||Genome Expression in Lymphoma, Leukemia and Multiple Myeloma|Expression of the Genome in Lymphoid Malignancies|Active, not recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:46.923797|2017-02-18 16:27:46.923797
NCT00339950|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 14, 2000||2000-02-14|August 24, 2016|2016-08-24||||||||Observational|||Colorectal Neoplasia Screening With Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Centers: The CONCeRN Trial|Diet, Other Risk Factors, Genetics and the Risk of Colorectal Neoplasia in a Screening Trial of Asymptomatic Women: A Sub-Study of the CONCeRN Trial|Completed||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:47.025174|2017-02-18 16:27:47.025174
NCT00339937|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||April 1, 1998||1998-04-01|February 13, 2017|2017-02-13||||||||Observational|||Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily|Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily|Completed||N/A|8000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:47.284081|2017-02-18 16:27:47.284081
NCT00339924|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 8, 2005||2005-07-08|February 10, 2016|2016-02-10||||||||Observational|||Physicians' Understanding of Human Genetic Variation|Physicians' Understanding of Human Genetic Variation|Completed||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:47.378601|2017-02-18 16:27:47.378601
NCT00339911|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 13, 1999||1999-10-13|July 15, 2016|2016-07-15||||||||Observational|||Collection and Distribution of Blood Samples From Healthy Donors for In Vitro Research at the NCI Frederick Cancer Research and Development Center|Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick|Enrolling by invitation||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:47.471865|2017-02-18 16:27:47.471865
NCT00339898|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 12, 2004||2004-03-12|January 13, 2015|2015-01-13|January 13, 2015||2015-01-13|||||Observational|||Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma|Prospective Evaluation of the Prognostic Relevance of PCR Positivity in Blood and Bone Marrow in Non-Metastatic Ewings Sarcoma|Completed||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:47.560841|2017-02-18 16:27:47.560841
NCT00339885|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 24, 1995||1995-03-24|December 14, 2016|2016-12-14||||||||Observational|||Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes Mellitus|Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes Mellitus|Recruiting||N/A|60000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:47.652303|2017-02-18 16:27:47.652303
NCT00339872|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-20|2007-12-03|||February 2006||2006-02-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Study Evaluating IMA-638 in Asthma|Randomized, Double-Blind, Placebo-Controlled, Sequential-Group, Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IMA-638 Administered Subcutaneously and Intravenously to Subjects With Asthma|Completed||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:27:47.752306|2017-02-18 16:27:47.752306
NCT00339859|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 2, 1995||1995-06-02|November 30, 2016|2016-11-30||||||||Observational|||DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer|DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:47.843546|2017-02-18 16:27:47.843546
NCT00339846|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 5, 2005||2005-01-05|September 17, 2008|2008-09-17|September 17, 2008||2008-09-17|||||Observational|||Genetic Analysis of Craniofrontonasal Syndrome|Genetic Analysis of Craniofrontonasal Syndrome|Completed||N/A|152||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:47.943818|2017-02-18 16:27:47.943818
NCT00339833|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2013-01-29|2010-12-29||March 2003||2003-03-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers|The Effect of Salsalate Treatment on Insulin Sensitivity and Insulin Secretion in Obese Non-Diabetic Individuals|Completed||Phase 4|54|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 16:27:48.03421|2017-02-18 16:27:48.03421
NCT00339807|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 17, 2002||2002-01-17|August 11, 2011|2011-08-11|August 11, 2011||2011-08-11|||||Observational|||Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica|Natural History of HTVL-I: A Cross-Sectional Study of a Cohort of Blood Donors in Jamaica|Completed||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:48.60528|2017-02-18 16:27:48.60528
NCT00339794|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 7, 2004||2004-12-07|July 16, 2010|2010-07-16|July 16, 2010||2010-07-16|||||Observational|||Clinical Integration of Genetic Risk Assessment in Family Medicine|Clinical Integration of Genetic Risk Assessment in Family Medicine|Completed||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:48.692063|2017-02-18 16:27:48.692063
NCT00339781|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2009-09-22|||February 2005||2005-02-01|September 2009|2009-09-01||||September 2007|Actual|2007-09-01||Observational|||Predictive and Protective Factors in the Cause of Diabetes - A Study in Twins|Predictive and Protective Factors in the Cause of Diabetes: A Study in Twins|Completed||N/A|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:48.770201|2017-02-18 16:27:48.770201
NCT00339768|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||May 8, 1995||1995-05-08|February 10, 2017|2017-02-10|June 10, 1996|Actual|1996-06-10|June 10, 1996|Actual|1996-06-10||Interventional|||A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province|Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province, China|Completed||Phase 3|3600|Anticipated|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 16:27:48.848632|2017-02-18 16:27:48.848632
NCT00339742|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||March 21, 2003||2003-03-21|February 14, 2017|2017-02-14||||||||Observational|||Stomach and Esophageal Cancers in Northern Iran|Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Phase I: Case-Control Study|Completed||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:48.949622|2017-02-18 16:27:48.949622
NCT00339729|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||May 7, 1997||1997-05-07|May 24, 2007|2007-05-24|May 24, 2007||2007-05-24|||||Observational|||Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)|Johnston County ADHD Study: Environmental, Reproductive and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|8000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:49.044407|2017-02-18 16:27:49.044407
NCT00339716|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-27|||March 21, 1994||1994-03-21|January 25, 2017|2017-01-25||||||||Observational|||Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident|Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident|Recruiting||N/A|21000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:49.116286|2017-02-18 16:27:49.116286
NCT00339703|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2006-06-19|||November 2004||2004-11-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Observational|||Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.|Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.|Unknown status|Active, not recruiting|N/A|50||Wilford Hall Medical Center|||||f||||||||||||||2017-02-18 16:27:49.209579|2017-02-18 16:27:49.209579
NCT00339690|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 6, 2005||2005-06-06|November 27, 2015|2015-11-27|February 11, 2009|Actual|2009-02-11|February 11, 2009|Actual|2009-02-11||Interventional|||Dust Mite Allergen Reduction Study|Dust Mite Allergen Reduction Study|Completed||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:49.285184|2017-02-18 16:27:49.285184
NCT00339677|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 4, 2003||2003-11-04|March 4, 2016|2016-03-04||||||||Observational|||Recontacting Participants in the Observing Protein and Energy Nutrition (OPEN) Study: Re-OPEN|Recontacting Participants in the Observing Protein and Energy Nutrition Study: ReOPEN|Completed||N/A|484|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:49.38165|2017-02-18 16:27:49.38165
NCT00339664|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 30, 2003||2003-06-30|August 9, 2016|2016-08-09||||||||Observational|||Analyses of Human Samples Collected in Clinical Trials|Pharmacological Analysis of Human Samples Collected in Clinical Trials Performed Outside of the Intramural National Cancer Institute|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:49.468732|2017-02-18 16:27:49.468732
NCT00339651|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 22, 2002||2002-11-22|April 11, 2016|2016-04-11||||||||Observational|||Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer|Preliminary Study of Endometrial Hyperplasia: Groundwork for a Study to Define an Optimal Classification of Endometrial Carcinoma Precursors|Active, not recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:49.579941|2017-02-18 16:27:49.579941
NCT00339638|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 21, 2004||2004-12-21|May 26, 2011|2011-05-26|May 26, 2011||2011-05-26|||||Observational|||Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1|Prediagnostic Markers of Adult T-Cell Leukemia/Lymphoma Among Carriers of Human T-Lymphoma Virus Type I: A Collaborative Study|Completed||N/A|228|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:49.665816|2017-02-18 16:27:49.665816
NCT00339625|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 19, 1991||1991-06-19|March 15, 2016|2016-03-15|April 14, 2011|Actual|2011-04-14|||||Interventional|||Polyp Prevention Trial|Polyp Prevention Trial|Completed||Phase 3|2440|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:27:49.871663|2017-02-18 16:27:49.871663
NCT00339612|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 26, 2002||2002-07-26|August 25, 2016|2016-08-25||||||||Observational|||NISDI Pediatric Latin American Countries Epidemiologic Study (PLACES): A Prospective Observational Study of HIV-Infected Children at Clinical Sites in Latin American Countries|NISDI Pediatric Latin American Countries Epidemiologic Study (PLACES): A Prospective Observational Study of HIV-Infected Children at Clinical Sites in Latin American Countries|Completed||N/A|2500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:49.975529|2017-02-18 16:27:49.975529
NCT00339599|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 20, 2005||2005-09-20|August 3, 2015|2015-08-03|August 3, 2015||2015-08-03|||||Observational|||Genetic Predictors of Cardiovascular Disease|Study of Chemokine Markers and Genes as Predictors of Cardiovascular Disease|Completed||N/A|2306|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:50.078351|2017-02-18 16:27:50.078351
NCT00316030|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2016-06-07|||January 2004||2004-01-01|March 2008|2008-03-01||||||||Interventional|||Study of Bexarotene in Patients With Acute Myeloid Leukemia|A Phase I Study of Bexarotene in Patients With Acute Myeloid Leukemia|Completed||Phase 1|54||Abramson Cancer Center of the University of Pennsylvania|||||f||||||||||||||2017-02-18 16:36:47.601921|2017-02-18 16:36:47.601921
NCT00339586|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2006-06-19|||January 2006||2006-01-01|January 2006|2006-01-01||||||||Interventional|||First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene|Prospective Evaluation of Small Molecule EGFR-1 Tyrosine Kinase Inhibition as a First-Line Treatment in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Harbouring a Mutant EGFR Gene|Unknown status|Recruiting|Phase 2|40||AZ-VUB|||||f||||||||||||||2017-02-18 16:27:50.161243|2017-02-18 16:27:50.161243
NCT00339573|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 23, 1998||1998-06-23|December 5, 2016|2016-12-05||||||||Observational|||National Survey of Lead and Allergen Hazards in Housing|National Survey of Lead Hazards and Allergens in Housing|Completed||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:50.248422|2017-02-18 16:27:50.248422
NCT00339560|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-26|||May 2, 1997||1997-05-02|January 25, 2017|2017-01-25||||||||Observational|||A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China|A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China|Completed||N/A|3200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:50.331599|2017-02-18 16:27:50.331599
NCT00339547|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 1, 1995||1995-11-01|July 19, 2016|2016-07-19||||||||Observational|||Risk Factors for Uterine Fibroids: A Case Control Study|Risk Factors for Uterine Fibroids: A Case Control Study and Follow-up Amendment to Study Disease Progression|Completed||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:50.420567|2017-02-18 16:27:50.420567
NCT00339534|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 24, 2002||2002-06-24|November 7, 2016|2016-11-07||||||||Observational|||Survey of Prostate Cancer in Accra, Ghana|Survey of Prostate Cancer in Accra, Ghana|Completed||N/A|1950|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:50.506997|2017-02-18 16:27:50.506997
NCT00339521|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 15, 1998||1998-10-15|December 14, 2016|2016-12-14||||||||Observational|||Genetic Susceptibility to Childhood Respiratory IIlness in Mexico City|Genetic Susceptibility to Childhood Respiratory Illness in Mexico City|Completed||N/A|2400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:50.6084|2017-02-18 16:27:50.6084
NCT00339508|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 19, 2002||2002-03-19|August 1, 2016|2016-08-01||||||||Observational|||Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics|Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics|Completed||N/A|25000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:50.695593|2017-02-18 16:27:50.695593
NCT00339495|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 21, 1997||1997-07-21|January 4, 2017|2017-01-04||||||||Observational|||Early Marker and Etiologic Studies in the PLCO Trial|Etiologic and Early Marker Studies in the PLCO Trial|Active, not recruiting||N/A|156000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:50.947659|2017-02-18 16:27:50.947659
NCT00339482|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 3, 1976||1976-09-03|December 1, 2016|2016-12-01||||||||Observational|||Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian Community|Prospective Studies of Diabetes Mellitus and Its Complications in the Gila River Indian Community|Completed||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:51.036502|2017-02-18 16:27:51.036502
NCT00339469|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-15|||August 2, 2005||2005-08-02|February 14, 2017|2017-02-14|May 19, 2008|Actual|2008-05-19|May 19, 2008|Actual|2008-05-19||Interventional|||Effect of High-Legume Diet on Colorectal Cancer Risk|The Effects of a High Legume Low Glycemic Index Diet on Insulin Resistance and Inflammation in Patients at High Risk for Colorectal Adenoma Recurrence|Completed||Early Phase 1|65|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:51.13915|2017-02-18 16:27:51.13915
NCT00339456|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 21, 2002||2002-08-21|May 20, 2014|2014-05-20|February 1, 2008|Actual|2008-02-01|February 1, 2008|Actual|2008-02-01||Interventional|||Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda|A Randomized, Controlled Trial of Short Cycle Intermittent Versus Continuous HAART for the Treatment of Chronic HIV Infection in Uganda|Completed||Phase 3|200|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:51.250835|2017-02-18 16:27:51.250835
NCT00339443|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 6, 2001||2001-11-06|May 19, 2010|2010-05-19|May 19, 2010||2010-05-19|||||Observational|||Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods|Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods|Completed||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:51.347631|2017-02-18 16:27:51.347631
NCT00339430|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 15, 2002||2002-07-15|August 18, 2010|2010-08-18|August 18, 2010||2010-08-18|||||Observational|||HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)|HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)|Completed||N/A|3500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:51.423895|2017-02-18 16:27:51.423895
NCT00339417|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 22, 2006||2006-02-22|August 17, 2011|2011-08-17|August 17, 2011|Actual|2011-08-17|August 1, 2008|Actual|2008-08-01||Interventional|||Effect of Albendazole Dose on Clearance of Filarial Worms|Effect of Albendazole and Ivermectin Dose on Wuchereria Bancrofti Microfilarial Clearance in Mali: A Randomized, Open Label Study|Completed||Phase 2|1000|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:27:51.502838|2017-02-18 16:27:51.502838
NCT00339404|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||March 4, 1999||1999-03-04|March 7, 2011|2011-03-07|March 7, 2011||2011-03-07|||||Observational|||Genetic Analysis of Familial Melanoma|Genetic Analysis of Familial Melanoma|Completed||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:51.613389|2017-02-18 16:27:51.613389
NCT00339391|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 19, 2001||2001-08-19|November 30, 2016|2016-11-30|November 30, 2016||2016-11-30|||||Observational|||Socioenvironmental Determinants of Psychological Functioning, Mental Health and AIDS in Mali|Socio-Environmental Determinants of Psychological Functioning, Mental Health and AIDS in Mali|Completed||N/A|1002|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:51.695776|2017-02-18 16:27:51.695776
NCT00339378|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 28, 2000||2000-06-28|June 11, 2007|2007-06-11|June 11, 2007||2007-06-11|||||Observational|||Incidence and Mortality of Childhood Cancer Among Children of Farmer Pesticide Applications|Incidence and Mortality of Childhood Cancer Among Children of Farmer Pesticide Applicators|Completed||N/A|21985||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:51.787745|2017-02-18 16:27:51.787745
NCT00339339|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 26, 2004||2004-07-26|January 22, 2013|2013-01-22|January 22, 2013||2013-01-22|||||Observational|||Levels of Bisphenol A in Urine and Saliva Following Placement of Composite Restorations|Bisphenol A and Metabolites in Urine and Saliva Associated With Placement of Composite Restorations|Completed||N/A|76|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.079505|2017-02-18 16:27:52.079505
NCT00339326|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-14|||August 18, 2002||2002-08-18|January 25, 2017|2017-01-25||||||||Observational|||Risk Factors for Non-HIV-Related Kaposi s Sarcoma|Cofactors for Classical Kaposi's Sarcoma and for Kaposi's Sarcoma-Associated Herpesvirus Infection: A Case-Control Study in Sicily|Completed||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.156944|2017-02-18 16:27:52.156944
NCT00339313|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||January 12, 2000||2000-01-12|June 24, 2011|2011-06-24|June 24, 2011||2011-06-24|||||Observational|||Food Intake and Appetite in the Children of Mothers With Diabetes|Food Intake and Appetite in the Children of Mothers With Diabetes|Completed||N/A|240|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.250311|2017-02-18 16:27:52.250311
NCT00339300|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 12, 1994||1994-08-12|August 9, 2016|2016-08-09||||||||Observational|||A Case-Referent Study of Brain Tumors in Adults|A Case-Referent Study of Brain Tumors in Adults|Completed||N/A|1600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.338331|2017-02-18 16:27:52.338331
NCT00339287|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||February 8, 2001||2001-02-08|August 24, 2016|2016-08-24||||||||Observational|||Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens|Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.43523|2017-02-18 16:27:52.43523
NCT00339274|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||October 14, 1999||1999-10-14|March 16, 2012|2012-03-16|March 16, 2012||2012-03-16|||||Observational|||International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks|The Chernobyl Tissue Bank|Completed||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.530028|2017-02-18 16:27:52.530028
NCT00339261|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 16, 2003||2003-12-16|October 26, 2006|2006-10-26|October 26, 2006||2006-10-26|||||Observational|||Disease Progression and Activity in Patients With Systemic Lupus Erythematosus|Disease Progression and Activity in the Carolinas Lupus Study - MUSC Medical University of South Carolina Follow up|Completed||N/A|716||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.621379|2017-02-18 16:27:52.621379
NCT00339248|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2009-03-12|||December 2004||2004-12-01|October 2007|2007-10-01||||||||Observational|||Markers for Breast Cancer|Risk of Breast Cancer and Hyperplastic Conditions in the Breast Cancer Serum Bank in Relation to Inherited Genetic Variants|Completed||N/A|2632||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.701557|2017-02-18 16:27:52.701557
NCT00339235|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||December 15, 1997||1997-12-15|November 22, 2016|2016-11-22||||||||Observational|||Establishment of a Perinatal Database and a Bank of Biological Materials|Establishment of a Clinical Perinatal Database and Bank of Biological Materials|Completed||N/A|43000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.805418|2017-02-18 16:27:52.805418
NCT00339222|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||November 3, 2001||2001-11-03|June 3, 2016|2016-06-03||||||||Observational|||Family Study of Melanoma in Italy|Family Study of Melanoma in Italy|Recruiting||N/A|1600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.898597|2017-02-18 16:27:52.898597
NCT00339209|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||June 23, 2005||2005-06-23|April 13, 2007|2007-04-13|April 13, 2007||2007-04-13|||||Observational|||Prospective Lung Transplant Database for Genetic Research|Prospective Lung Transplant Database for Genetic Research|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:27:52.998701|2017-02-18 16:27:52.998701
NCT00339196|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2011-05-06|||July 2006||2006-07-01|March 2007|2007-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS|Multi Centers, Open-trial Phase II Study Evaluating 5-azacytidine (Vidaza®) + Valproic Acid (Depakine ®) Before Administration of Retinoic Acid (Vesanoid®) in Patients With Acute Myelogenous Leukemia and High Risk Myelodysplasia.|Completed||Phase 2|25|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:27:53.073881|2017-02-18 16:27:53.073881
NCT00339183|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2017-02-07|2014-04-03||June 2006||2006-06-01|February 2017|2017-02-01|November 2010|Actual|2010-11-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone|A Randomized, Multicenter Phase 3 Study to Compare the Efficacy of Panitumumab in Combination With Chemotherapy to the Efficacy of Chemotherapy Alone in Patients With Previously Treated Metastatic Colorectal Cancer|Completed||Phase 3|1186|Actual|Amgen||2|||f||||||||||||||2017-02-18 16:27:53.194734|2017-02-18 16:27:53.194734
NCT00339170|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2016-04-08|||April 2000||2000-04-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|June 2013|Actual|2013-06-01||Interventional|||Cognitive Training and Enhanced Supported Employment in Schizophrenia|Cognitive Training and Enhanced Supported Employment|Completed||N/A|98|Actual|Yale University||2|||f||||||||||||||2017-02-18 16:27:54.816221|2017-02-18 16:27:54.816221
NCT00339157|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2010-07-19|||June 2006||2006-06-01|July 2010|2010-07-01|July 2008|Actual|2008-07-01|||||Interventional|||Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS|ANAkinra in Severe Juvenile Idiopathic Arthritis of Systemic Onset (ANAJIS)|Completed||Phase 2/Phase 3|24||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||f||||||||||2017-02-18 16:27:54.925509|2017-02-18 16:27:54.925509
NCT00339144|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2010-11-19|2010-10-07||January 2007||2007-01-01|November 2010|2010-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study of Dasatinib (BMS-354825) in Patients With Solid Tumors|A Phase I Study of BMS-354825 in Patients With Solid Tumors|Completed||Phase 1|16|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-02-18 16:27:55.211457|2017-02-18 16:27:55.211457
NCT00339131|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-17|2011-10-07|||June 2006||2006-06-01|October 2011|2011-10-01|January 2007|Actual|2007-01-01|||||Interventional|||ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid|Phase 1 Study Evaluating the Safety, Distribution, Metabolism, and Radiation Dosimetry of ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid|Completed||Phase 1|24|Anticipated|Molecular Insight Pharmaceuticals, Inc.|||||f||||f||||||||||2017-02-18 16:27:56.781251|2017-02-18 16:27:56.781251
NCT00339105|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2007-01-14|||June 2006||2006-06-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Observational|||The Usefulness of HyperQ Recordings for the Early Diagnosis of Acute Coronary Syndrome in Patients Presenting With Chest Pain|The Usefulness of HyperQ Recordings for the Early Diagnosis of Acute Coronary Syndrome in Patients Presenting With Chest Pain|Unknown status|Recruiting|Phase 3|50||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:27:56.952308|2017-02-18 16:27:56.952308
NCT00339092|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-04-17|||January 2003||2003-01-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV|Project Title: A RCT of HIV Adherence Case Management and Modified Directly Observed Therapy|Completed||N/A|150|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:27:57.054227|2017-02-18 16:27:57.054227
NCT00339079|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2012-08-14|||June 2006||2006-06-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|May 2011|Actual|2011-05-01||Interventional|||Comparing Cognitive Behavioral Therapy, Antidepressant Medication, and Combined Treatment in Individuals With Hypochondriasis|Treatment of Hypochondriasis With CBT and/or SSRI|Completed||Phase 1/Phase 2|94|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-02-18 16:27:57.157381|2017-02-18 16:27:57.157381
NCT00339066|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-08-07|||August 2001||2001-08-01|February 2008|2008-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Effect of Brain Lesion Severity on Treatment Response in Late-Life Depression|Treatment Outcomes of Vascular Depression|Completed||N/A|131|Actual|Duke University|||||f||||||||||||||2017-02-18 16:27:57.276111|2017-02-18 16:27:57.276111
NCT00339053|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2006-10-20|||September 2004||2004-09-01|October 2006|2006-10-01|January 2008||2008-01-01|||||Interventional|||Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair|The Effect of Immunonutrition on Outcome and Postoperative Recovery in Patients Undergoing Elective Surgical Repair of a Thoraco (Abdominal) Aneurysm Aorta|Unknown status|Recruiting|Phase 4|142||St. Antonius Hospital|||||f||||||||||||||2017-02-18 16:27:57.374759|2017-02-18 16:27:57.374759
NCT00339040|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2014-12-30|2011-09-07||October 2006||2006-10-01|December 2014|2014-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children|Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age|Completed||Phase 2|130|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:27:57.478033|2017-02-18 16:27:57.478033
NCT00339027|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2006-09-07|||May 2004||2004-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||HealthSpark: Health Access for Children in Federally-Subsidized Child Care||Completed||N/A|960||University of Miami|||||f||||||||||||||2017-02-18 16:27:58.522019|2017-02-18 16:27:58.522019
NCT00339014|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-18|2008-04-18|||May 2006||2006-05-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity|A Dose Parallel, Randomized, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Multiple Regimens of the Combination of Zonisamide CR Plus Bupropion SR in the Treatment of Subjects With Uncomplicated Obesity|Completed||Phase 2|611|Actual|Orexigen Therapeutics, Inc||7|||f||||t||||||||||2017-02-18 16:27:58.595637|2017-02-18 16:27:58.595637
NCT00339001|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2006-06-19|||April 2006||2006-04-01|June 2006|2006-06-01|December 2006||2006-12-01|||||Observational|||Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity|The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurity|Unknown status|Recruiting|N/A|400||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:27:58.717468|2017-02-18 16:27:58.717468
NCT00338988|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2012-07-27|2010-11-03||August 2003||2003-08-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma|A Phase II Study of Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma, Including Carcinoma of the Gallbladder and Biliary Tract|Completed||Phase 2|44|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:27:58.796328|2017-02-18 16:27:58.796328
NCT00338975|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2015-06-01|||June 2005||2005-06-01|June 2015|2015-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Cognitive Behavioral Social Skills Training for Improving Social Functioning in People With Schizophrenia|Cognitive Behavioral Skills Training for Schizophrenia|Completed||N/A|179|Actual|Veterans Medical Research Foundation||2|||f||||t||||||||||2017-02-18 16:27:59.056729|2017-02-18 16:27:59.056729
NCT00338962|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2016-01-06|2015-11-04||October 2001||2001-10-01|January 2016|2016-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Naltrexone & SSRI in Alcoholics With Depression/PTSD|Naltrexone & SSRI in Alcoholics With Depression/PTSD|Completed||Phase 3|88|Actual|Yale University||4|||f||||t||||||||||2017-02-18 16:27:59.174393|2017-02-18 16:27:59.174393
NCT00338949|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-08-06|||June 2006||2006-06-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes|The Metabolic Syndrome in Patients With Schizophrenia|Completed||Phase 4|77|Actual|Veterans Medical Research Foundation||2|||f||||f||||||||||2017-02-18 16:28:02.459954|2017-02-18 16:28:02.459954
NCT00338936|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-11-07|||May 2006||2006-05-01|November 2011|2011-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)|A 52-week Extension to the Factorial Study to Evaluate the Efficacy and Safety of VAH631 (Valsartan and Hydrochlorothiazide Combined) and Alone in Essential Hypertensive Patients - Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study) -|Completed||Phase 3|362|Actual|Novartis|||||f||||||||||||||2017-02-18 16:28:02.575134|2017-02-18 16:28:02.575134
NCT00338923|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2007-08-16|||June 2006||2006-06-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Wound Healing Effects of HO/03/03 In Patients With Diabetic Neuropathic Plantar and Venous Ulcers, Pilot Study.|Wound Healing Effects of HO/03/03 In Patients With Diabetic Neuropathic Plantar and Venous Ulcers, Pilot Study.|Completed||Phase 1|22|Actual|HealOr||1|||f||||||||||||||2017-02-18 16:28:02.657301|2017-02-18 16:28:02.657301
NCT00338910|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2007-12-10|||May 2006||2006-05-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers|Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers|Completed||Phase 4|12|Actual|University Hospital Tuebingen||1|||f||||t||||||||||2017-02-18 16:28:02.756751|2017-02-18 16:28:02.756751
NCT00338897|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2008-12-09|||May 2006||2006-05-01|December 2008|2008-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|DRIVE||Dose Ranging Study in Elective Total Hip Replacement Surgery|A Multicenter, Randomized, Double-Blind, Double Dummy, Parallel Group, Dose Ranging Study of Subcutaneous SR123781A With an Enoxaparin Calibrator Arm in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery|Completed||Phase 2/Phase 3|1090|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:28:02.851903|2017-02-18 16:28:02.851903
NCT00338884|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2012-08-22|2010-04-20||September 2006||2006-09-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer|A Phase II Efficacy And Safety Study Of Sunitinib Malate (SU011248) Administered In A Continuous Daily Regimen In Patients With Advanced (First-Line) Renal Cell Cancer|Completed||Phase 2|120|Actual|Pfizer||1|||f||||||||||||||2017-02-18 16:28:02.995717|2017-02-18 16:28:02.995717
NCT00338871|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2016-04-07|||June 2006||2006-06-01|April 2007|2007-04-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Home Based Exercise Program for Brain Injury Children||Completed||N/A|40|Actual|Alyn Pediatric & Adolecent Rehabilitation Center||2|||f||||||||||||||2017-02-18 16:28:04.835022|2017-02-18 16:28:04.835022
NCT00338858|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2011-02-14|||June 2006||2006-06-01|June 2006|2006-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||The Connection Between Gait Variability Parameters and Balance Performance in Children With Physical Disability|The Connection Between Gait Variability Parameters and Balance Performance in Children With Physical Disability|Completed||N/A|60|Actual|Alyn Pediatric & Adolecent Rehabilitation Center||3|||f||||t||||||||||2017-02-18 16:28:04.918334|2017-02-18 16:28:04.918334
NCT00338845|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-04-09|||December 2003||2003-12-01|April 2013|2013-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Share Safer Sex Counseling Program for Changing Sexual Risk Behaviors in Mexican Female Sex Workers|Safer Sex Intervention for At-risk Women in Mexico|Completed||Phase 2|1800|Actual|University of California, San Diego||2|||f||||||||||||||2017-02-18 16:28:05.014558|2017-02-18 16:28:05.014558
NCT00338832|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-08-06|||June 2006||2006-06-01|August 2013|2013-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia|Adapting a Physical Activity Intervention for Schizophrenia|Completed||Phase 3|86|Actual|Veterans Medical Research Foundation||2|||f||||t||||||||||2017-02-18 16:28:05.12604|2017-02-18 16:28:05.12604
NCT00337792|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2016-03-16|||June 2006||2006-06-01|March 2016|2016-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparing the Effectiveness of Oral Versus Intravenous Pain Medicine for Suction Curettage (D&C)|A Randomized Clinical Trial Comparing Oral Conscious Sedation With Intravenous Conscious Sedation for First Trimester Surgical Abortion|Terminated||N/A|132|Actual|Planned Parenthood League of Massachusetts||||DSMB review at 50% recruitment, further recruitment unlikely to change result|f||||t||||||||||2017-02-18 16:28:05.236174|2017-02-18 16:28:05.236174
NCT00337779|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2011-10-06|2010-01-18||August 2006||2006-08-01|October 2011|2011-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).|A Multinational, Multicenter, Randomized, Parallel-Group, Double-Blind Study to Compare the Efficacy, Tolerability and Safety of Glatiramer Acetate Injection 40 mg/ml to That of Glatiramer Acetate Injection 20 mg/ml Administered Once Daily by Subcutaneous Injection in Subjects With Relapsing Remitting (R-R) Multiple Sclerosis (MS)|Completed||Phase 3|1155|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 16:28:05.32846|2017-02-18 16:28:05.32846
NCT00337766|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-10-20|||June 2006||2006-06-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|September 2009|Actual|2009-09-01||Interventional|||Desmopressin in Cardiac Surgery|Efficacy of Desmopressin (1-deamin0-8-D-arginine-vasopressin) in Reducing Active Microvascular Bleeding After Cardiac Surgery|Completed||Phase 4|||Università Vita-Salute San Raffaele||2|||f||||||||||||||2017-02-18 16:28:06.592935|2017-02-18 16:28:06.592935
NCT00338819|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-18|2006-06-18||||||June 2006|2006-06-01||||||||Observational|||ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients|ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients|Unknown status|Not yet recruiting|N/A|||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 16:28:06.70489|2017-02-18 16:28:06.70489
NCT00338806|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2009-03-25|||November 2006||2006-11-01|March 2009|2009-03-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Early Detection and Prevention of Mood Disorders in Children of Parents With Bipolar Disorder|Prevention for Symptomatic Offspring of Bipolar Parents|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|National Institute of Mental Health (NIMH)||2|||f||||t||||||||||2017-02-18 16:28:06.772054|2017-02-18 16:28:06.772054
NCT00338793|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2008-08-25|||July 2006||2006-07-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|||||Interventional|||Corticosteroids in the Treatment of Tuberculous Pleurisy|A Multicenter, Placebo-Controlled, Double-Blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Corticosteroids for Treatment of Patients With Tuberculous Pleurisy|Completed||N/A|1500|Anticipated|Guangxi Medical University|||||f||||t||||||||||2017-02-18 16:28:06.884579|2017-02-18 16:28:06.884579
NCT00338780|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2006-10-27|||November 2000||2000-11-01|October 2006|2006-10-01|January 2005||2005-01-01|||||Interventional|||Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)|A Randomised, Double-Blinded, Placebo-Controlled Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)|Completed||Phase 4|||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 16:28:06.9798|2017-02-18 16:28:06.9798
NCT00338767|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-11-13|||January 2001||2001-01-01|November 2013|2013-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy|Depression Treatment to Improve Antiretroviral Adherence|Completed||Phase 2|150|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:28:07.084143|2017-02-18 16:28:07.084143
NCT00338754|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-18|2007-09-10|||November 2005||2005-11-01|September 2007|2007-09-01||||||||Interventional|||Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase 2/3, Randomized, Double-Blind, Placebo Controlled, Multicenter Study of Efficacy and Safety of Adalimumab in Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2/Phase 3|160||Abbott|||||f||||||||||||||2017-02-18 16:28:07.197072|2017-02-18 16:28:07.197072
NCT00005684|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||March 1996||1996-03-01|February 2005|2005-02-01|January 2001|Actual|2001-01-01|||||Observational|||Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:31.222819|2017-02-18 18:14:31.222819
NCT00338741|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-08-02|2010-04-30||December 2002||2002-12-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Observational|||Rebif® Pregnancy Registry|Rebif® Pregnancy Registry|Completed||Phase 4|36|Actual|EMD Serono|Despite a consistent and exhaustive expenditure of resources over 5 years only 36 subjects were enrolled into the Registry, a number which precludes meaningful statistical analysis of the potential risks of Rebif® during pregnancy.||2||f||||||||||||||2017-02-18 16:28:07.288253|2017-02-18 16:28:07.288253
NCT00338728|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2016-11-02|||October 2003||2003-10-01|November 2016|2016-11-01||||October 2018|Anticipated|2018-10-01||Interventional|||Letrozole (Femara) Plus Imatinib Mesylate (Gleevec) for Breast Cancer Patients|Phase II Study of Letrozole (Femara) Plus Imatinib Mesylate (Gleevec) for Postmenopausal Patients With ER and/or PR Positive Metastatic Breast Cancer|Active, not recruiting||Phase 2|45|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:28:07.652375|2017-02-18 16:28:07.652375
NCT00338715|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2011-02-07|||July 2006||2006-07-01|February 2011|2011-02-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Effectiveness of Pulmonary Vein Isolation in Prevention of Atrial Fibrillation Following Heart Bypass Surgery|A Randomized Controlled Trial of Prophylactic Pulmonary Vein Isolation as Adjunct to Coronary Artery Bypass Grafting|Completed||Phase 3|193|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 16:28:07.764013|2017-02-18 16:28:07.764013
NCT00338702|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2015-05-19|||March 2008||2008-03-01|May 2015|2015-05-01|October 2009|Anticipated|2009-10-01|October 2009||2009-10-01||Interventional|||A Randomized, Controlled Trial of Autologous Platelet Gel Treatment in Diabetic Foot Ulcers||Withdrawn||Phase 4|0|Actual|St. Michael's Hospital, Toronto||||Industry support and funding not forthcoming|f||||f||||||||||2017-02-18 16:28:07.884197|2017-02-18 16:28:07.884197
NCT00338689|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2015-09-14|||October 2002||2002-10-01|September 2015|2015-09-01|September 2015|Anticipated|2015-09-01|August 2006|Actual|2006-08-01||Interventional|CHOP||European Childhood Obesity Project: Early Programming by Infant Nutrition?|Childhood Obesity - Programming by Infant Nutrition|Active, not recruiting||N/A|1678|Actual|Ludwig-Maximilians - University of Munich||3|||f||||f||||||||||2017-02-18 16:28:07.978926|2017-02-18 16:28:07.978926
NCT00338676|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2016-02-24|||November 2006||2006-11-01|February 2016|2016-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Aortic Stenosis in Elderly : Determinant of Progression|Aortic Stenosis in Elderly : Determinant of Progression. COFRASA (French Cohort)|Active, not recruiting||Phase 4|273|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"~     blood samples~   "|No||2017-02-18 16:28:08.0947|2017-02-18 16:28:08.0947
NCT00338663|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2007-08-22|||May 2006||2006-05-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study on Knee Immobilization and Pain Levels After an Anterior Cruciate Ligament (ACL) Reconstruction Surgery|The Effect of Knee Immobilization on Postoperative Pain Following an Anterior Cruciate Ligament (ACL) Reconstruction: A Randomized Clinical Trial|Completed||N/A|88||LifeMark Health Research Group|||||f||||t||||||||||2017-02-18 16:28:08.177629|2017-02-18 16:28:08.177629
NCT00338650|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2007-11-28|||June 2006||2006-06-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)|A Multi-Center, Open-Label Treatment Protocol of the Human Anti-TNF Monoclonal Antibody Adalimumab in Patients With Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab|Completed||Phase 3|1000||Abbott|||||||||||||||||||2017-02-18 16:28:08.268784|2017-02-18 16:28:08.268784
NCT00338637|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2006-06-19|||April 2006||2006-04-01|June 2006|2006-06-01|October 2006||2006-10-01|||||Interventional|||Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) Kit||Unknown status|Recruiting|Phase 2|30||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:28:08.67318|2017-02-18 16:28:08.67318
NCT00338624|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-05-20|||May 2004||2004-05-01|April 2010|2010-04-01|June 2005|Actual|2005-06-01|||||Interventional|||An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.|A Double-Blind, Randomized, Parallel Group Trial of Ditropan XL (Oxybutynin Chloride) Extended Release Tablets or Placebo in Combination With FLOMAX (Tamsulosin Hydrochloride) for the Treatment of Lower Urinary Tract Symptoms.|Completed||Phase 3|420|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||||||||||||||||2017-02-18 16:28:08.750214|2017-02-18 16:28:08.750214
NCT00338611|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2010-03-24|||July 2005||2005-07-01|October 2008|2008-10-01|September 2009|Anticipated|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Convergence Insufficiency Treatment Trial (CITT)|Convergence Insufficiency Treatment Trial (CITT)|Unknown status|Active, not recruiting|Phase 3|221|Actual|National Eye Institute (NEI)||1|||f||||||||||||||2017-02-18 16:28:08.850945|2017-02-18 16:28:08.850945
NCT00338598|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2016-07-11|||June 2003||2003-06-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism|Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism|Completed||Phase 2|20|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:28:08.96709|2017-02-18 16:28:08.96709
NCT00338585|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2008-01-08|||April 2006||2006-04-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery|Phase 3, Multicenter, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects With Acute Peripheral Arterial Occlusion (NAPA-3)|Terminated||Phase 3|300||ARCA Biopharma, Inc.||||Based upon preliminary safety and efficacy results from a similar study.|f||||t||||||||||2017-02-18 16:28:09.079953|2017-02-18 16:28:09.079953
NCT00338572|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2012-06-07|||June 2006||2006-06-01|June 2012|2012-06-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effect of Exercise and Diet on Inflammation in Hypertensive Individuals|Sympathetic Nervous System Regulation of Cell Adhesion|Completed||N/A|185|Actual|University of California, San Diego||3|||f||||t||||||||||2017-02-18 16:28:09.195579|2017-02-18 16:28:09.195579
NCT00338559|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2014-12-02|||May 2006||2006-05-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Does LMA Instead of ET Tube Affect Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction?|Does Using Laryngeal Mask Airway (LMA) Instead of an Endotracheal Tube (ET Tube) Affect the Incidence of Postoperative Vomiting in Children Undergoing Strabismus Correction? - An Observational Study|Completed||Phase 2|71|Actual|The University of Texas Health Science Center, Houston|||2||f||||f||||||||||2017-02-18 16:28:09.31062|2017-02-18 16:28:09.31062
NCT00338520|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2012-10-19|||October 2007||2007-10-01|October 2012|2012-10-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Hyperphenylalaninemia in Cerebral Malaria|Hyperphenylalaninemia in Cerebral Malaria|Completed||N/A|285|Actual|University of Utah|||4||f||||f||||||Samples With DNA|"~     urine, CSF, blood~   "|||2017-02-18 16:28:09.633923|2017-02-18 16:28:09.633923
NCT00338507|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2007-12-05|||March 2006||2006-03-01|December 2007|2007-12-01||||||||Interventional|||Phase 2 Study - Erdosteine in Patients With CB/COPD|A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Dose_Ranging Study of Erdosteine for the Treatment of Stable Chronic Bronchitis Associated With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|400||Adams Respiratory Therapeutics|||||||||||||||||||2017-02-18 16:28:09.745723|2017-02-18 16:28:09.745723
NCT00338494|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-01-28|||October 2005||2005-10-01|January 2015|2015-01-01|April 2011|Actual|2011-04-01|March 2010|Actual|2010-03-01||Interventional|||Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma|Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermed.Grade B-Cell/T-Cell Lymphoma|Completed||Phase 1|16|Actual|Yale University||1|||f||||f||||||||||2017-02-18 16:28:09.834428|2017-02-18 16:28:09.834428
NCT00338481|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-07-26|||April 2006||2006-04-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||"Red Morphine Drops for Symptomatic Treatment of Dyspnoea in Lung Cancer"|"Red Morphine Drops for Symptomatic Treatment of Dyspnoea in Terminal Patients With Primary Lung Cancer or Lung metastases-a Pilot Study"|Completed||Phase 4|20|Actual|Sankt Lukas Hospice||2|||f||||t||||||||||2017-02-18 16:28:09.940791|2017-02-18 16:28:09.940791
NCT00338468|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-05-17|||November 2003||2003-11-01|March 2010|2010-03-01|September 2005|Actual|2005-09-01|||||Interventional|||A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)|An Open-Label Pilot Study to Assess Disability in Anemic Elderly Patients With Chronic Kidney Disease Receiving PROCRIT (Epoetin Alfa)|Terminated||Phase 4|13|Actual|Ortho Biotech Products, L.P.||||The study was stopped early due to slow enrollment.|f||||f||||||||||2017-02-18 16:28:10.051367|2017-02-18 16:28:10.051367
NCT00338455|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2014-11-20|2008-10-22||September 2006||2006-09-01|November 2014|2014-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC|Investigation of the Use of Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC|Terminated||Phase 2|16|Actual|Scios, Inc.|Early termination of the study due to enrollment difficulties (change in standard of care for patient population as well as changing organ allocation rules by United Network for Organ Sharing); efficacy not analyzed due to limited sample size (n=16).|2||"DSMC acknowledged no safety concerns with the trial, recommending that the trial be terminated~   due to slow enrollment"|f||||t||||||||||2017-02-18 16:28:10.149222|2017-02-18 16:28:10.149222
NCT00338442|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-04-01|||February 2006||2006-02-01|April 2013|2013-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Expanded Access|||Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection|Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection|Approved for marketing||N/A|||Cangene Corporation|||||||||f||||||||||2017-02-18 16:28:10.670291|2017-02-18 16:28:10.670291
NCT00338429|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2016-09-01|||April 2005||2005-04-01|September 2016|2016-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|Sleep||Better Days, Better Nights: Treatment for Sleep Difficulties (Telephone Coached)|Better Days, Better Nights: Treatment for Sleep Difficulties (A Sleep Intervention Module of the Family Help Program)|Completed||Phase 2|61|Actual|IWK Health Centre||2|||f||||f||||||||No|Aggregate summary data would be made available but not individual data.|2017-02-18 16:28:10.764997|2017-02-18 16:28:10.764997
NCT00338416|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-06-08|||March 2003||2003-03-01|April 2010|2010-04-01|January 2005|Actual|2005-01-01|||||Interventional|||An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks|An Open-Labeled Pilot Study to Evaluate the Effects of High Dose PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Anemic Cancer Patients Receiving Chemotherapy on a Every Three Week Regimen|Completed||Phase 2|115|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:28:10.87487|2017-02-18 16:28:10.87487
NCT00338403|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-09-04|||June 2006||2006-06-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Effects of Continuous Airway Pressure on the Ability to Heat and Humidify Air|Effects of Continuous Airway Pressure on the Ability to Heat and Humidify Air|Completed||N/A|10||University of Chicago|||||f||||||||||||||2017-02-18 16:28:10.976788|2017-02-18 16:28:10.976788
NCT00338390|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-03-19|||April 2005||2005-04-01|October 2008|2008-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC|Study of Changes in CD4 Lymphocyte Count in Patients With a HAART Regimen Including DDI + Tenofovir and With Viral Suppression Following the Replacement of Tenofovir With Abacavir Once Daily or Following the Double Replacement of DDI + Tenofovir With Abacavir + Lamivudine in a Single Tablet|Completed||Phase 3|75|Actual|Hospital de Granollers||3|||f||||f||||||||||2017-02-18 16:28:11.076963|2017-02-18 16:28:11.076963
NCT00338377|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2017-01-18|||February 2006||2006-02-01|January 2017|2017-01-01||||February 2019|Anticipated|2019-02-01||Interventional|||Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma|Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma|Recruiting||Phase 2|189|Anticipated|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 16:28:11.21227|2017-02-18 16:28:11.21227
NCT00338364|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-09-11|||January 2006||2006-01-01|September 2013|2013-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|ERPain||Painful Procedures in the Emergency Department: A Distraction Intervention|Painful Procedures in the Emergency Department:Does a Formal Program in Distracting Techniques for Parents and Children Reduce Pain and Anxiety in Children?|Completed||Phase 2|189|Actual|IWK Health Centre||2|||f||||f||||||||||2017-02-18 16:28:11.366151|2017-02-18 16:28:11.366151
NCT00338351|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2016-09-27|||April 2006||2006-04-01|September 2016|2016-09-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.|To Assess Reactogenicity and Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine, When Co-administered With GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine (Infanrix™ Hexa) at 2, 4 and 6 Months of Age.|Completed||Phase 2|240||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:28:11.481845|2017-02-18 16:28:11.481845
NCT00338338|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-05-26|||November 2005||2005-11-01|May 2011|2011-05-01||||||||Interventional|||The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients|A Randomized, Double-blind, Parallel Group, Single-Centre Study to Evaluate the Efficacy and Safety of Lacidipine and Amlodipine Once-daily Treatment in Hypertensive Adult Patients|Completed||Phase 4|70||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:28:11.581745|2017-02-18 16:28:11.581745
NCT00338325|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-06-15|||June 2005||2005-06-01|June 2015|2015-06-01|April 2006|Actual|2006-04-01|June 2005|Actual|2005-06-01||Interventional|||Reading Preoperatively to Reduce Anxiety in Day Surgery|A Randomized Trial Of Reading Preoperatively To Day Surgery Children To Reduce Anxiety and Pain|Completed||Phase 2|200|Actual|IWK Health Centre||2|||f||||f||||||||||2017-02-18 16:28:11.670097|2017-02-18 16:28:11.670097
NCT00338312|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-04-15|||June 2002||2002-06-01|April 2013|2013-04-01|July 2006|Actual|2006-07-01|December 2004|Actual|2004-12-01||Interventional|||Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido|A Study to Evaluate the Efficacy/Safety of Transdermal Testosterone for 52 Weeks and Safety for 52 Weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Oral Hormone Replacement Therapy.|Completed||Phase 3|610|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 16:28:11.761538|2017-02-18 16:28:11.761538
NCT00338299|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-05-19|||August 2003||2003-08-01|April 2010|2010-04-01|April 2004|Actual|2004-04-01|||||Interventional|||Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia|An Open-Label Pilot Study to Evaluate the Effects of Alternate Dosing of PROCRIT� (Epoetin Alfa) in the Treatment of Patients With Cancer and Chemotherapy Induced Anemia (60,000 Units Weekly for Four Weeks Followed by 60,000 Units Every Two Weeks)|Completed||Phase 2|51|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:28:11.873832|2017-02-18 16:28:11.873832
NCT00338286|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2016-12-02|2015-12-22||March 2006||2006-03-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|July 2014|Actual|2014-07-01||Interventional||The intent to treat (ITT) population included all participants who were randomized in either Standard of Care (SOC) or Epoetin alfa group.|A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy|A Randomized, Open-label, Multicenter, Phase 3 Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy|Active, not recruiting||Phase 3|2098|Actual|Janssen Research & Development, LLC||2|||f||||t||||||||||2017-02-18 16:28:12.210969|2017-02-18 16:28:12.210969
NCT00338273|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-11-07|||December 2006||2006-12-01|February 2012|2012-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode|Withdrawn||Phase 3|0|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 16:28:13.804194|2017-02-18 16:28:13.804194
NCT00338260|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-07-29|||June 1995||1995-06-01|July 2015|2015-07-01|November 2001|Actual|2001-11-01|September 2001|Actual|2001-09-01||Interventional|||Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)|A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy|Completed||Phase 3|496|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:28:13.916289|2017-02-18 16:28:13.916289
NCT00338247|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2016-04-04|||July 2006||2006-07-01|April 2016|2016-04-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Expanded Access|||EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer|An Open-Label Expanded Access Study of Lapatinib and Capecitabine Therapy in Subjects With ErbB2 Overexpressing Locally Advanced or Metastatic Breast Cancer|Approved for marketing||Phase 4|||Novartis|||||||||||||||||||2017-02-18 16:28:14.048011|2017-02-18 16:28:14.048011
NCT00338234|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2008-05-05|||June 2006||2006-06-01|April 2007|2007-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|FAIRe||Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients|Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients, Role of Hepcidin|Completed||N/A|153|Actual|Assistance Publique - Hôpitaux de Paris|||2||f||||f||||||Samples Without DNA|"~     Blood serum~   "|||2017-02-18 16:28:14.829314|2017-02-18 16:28:14.829314
NCT00338221|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2008-10-27|||August 2004||2004-08-01|October 2008|2008-10-01|April 2005||2005-04-01|||||Interventional|||Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition|Prospective Double Blinded Randomized Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition|Withdrawn||Phase 3|108||University of Virginia|||||f||||f||||||||||2017-02-18 16:28:14.924571|2017-02-18 16:28:14.924571
NCT00338208|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-08-19|||October 2003||2003-10-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|PAVE||Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot|Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot|Completed||N/A|2|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 16:28:15.014456|2017-02-18 16:28:15.014456
NCT00338195|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-03-06|||May 2001||2001-05-01|March 2013|2013-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Assessment and Treatment of Caffeine Dependence||Completed||Phase 1|94|Actual|Johns Hopkins University||1|||f||||||||||||||2017-02-18 16:28:15.122654|2017-02-18 16:28:15.122654
NCT00338182|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2017-01-09|||May 2006||2006-05-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|June 2008|Actual|2008-06-01||Interventional|||AZD1152 in Patients With Advanced Solid Malignancies|A Phase I, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1152 Given as a 2-hour or 48-hour Intravenous Infusions in Patients With Advanced Solid Malignancies|Active, not recruiting||Phase 1|43|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:28:15.236123|2017-02-18 16:28:15.236123
NCT00338156|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2015-07-27|||August 2003||2003-08-01|July 2010|2010-07-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Observational|||Observational Study of the Remodelling Process Following Myocardial Infarct|Assessment of the Relationship Between Collagen Turnover, Left Ventricular Remodelling and Myocardial Scarring Assessed by Cardiac Magnetic Resonance and Neurohumoral Activation in Patients With Previous Myocardial Infarction|Completed||N/A|119|Actual|Helse Stavanger HF|||1||f||||f||||||Samples Without DNA|"~     Serum Plasma~   "|||2017-02-18 16:28:15.346842|2017-02-18 16:28:15.346842
NCT00338143|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2014-02-28|||October 2003||2003-10-01|February 2014|2014-02-01|May 2004|Actual|2004-05-01|||||Interventional|||A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies|A Phase IIIb, Open-Label, Multicenter Study to Evaluate the Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Moderate to Severe Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies or Have Recently Transitioned From Systemic Therapies|Completed||Phase 3|1200||Genentech, Inc.|||||||||||||||||||2017-02-18 16:28:15.554703|2017-02-18 16:28:15.554703
NCT00338130|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2014-08-12|||July 2006||2006-07-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|September 2007|Actual|2007-09-01||Interventional|||Randomised Study to Compare the Efficacy of AZD6244 vs TMZ|A Phase II, Multi-centre, Open-Label, Parallel Group, Randomised Study To Compare the Efficacy of AZD6244 vs Temozolomide in Patients With Unresectable AJCC Stage 3 or 4 Malignant Melanoma|Completed||Phase 2|239|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:28:15.642536|2017-02-18 16:28:15.642536
NCT00338117|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2010-04-26|||August 1995||1995-08-01|April 2010|2010-04-01|May 1997|Actual|1997-05-01|||||Interventional|||Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease|A European Multi-Center Study to Determine the Safety and Efficacy of Galanthamine Hydrobromide 40mg/Day (32 mg /Day GAL Base, Tid Dose Regimen) in Patients Diagnosed With Alzheimer-Type Dementia|Completed||Phase 3|554|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:28:15.79565|2017-02-18 16:28:15.79565
NCT00338104|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2009-04-03|2008-12-01||July 2004||2004-07-01|March 2009|2009-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin|Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin|Completed||Phase 4|75|Actual|Northwestern University|not all patients were analyzed in each group because insulin not given appropriately to those patients|3|||f||||f||||||||||2017-02-18 16:28:15.879331|2017-02-18 16:28:15.879331
NCT00338091|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2006-06-16|||January 2002||2002-01-01|January 2002|2002-01-01|May 2006||2006-05-01|||||Interventional|||Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency||Terminated||N/A|||Southern Medical University, China|||||f||||||||||||||2017-02-18 16:28:16.289234|2017-02-18 16:28:16.289234
NCT00338078|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2008-07-01|||March 1999||1999-03-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration|Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration. A Randomized Double-Blind Placebo Controlled Cross-Over Study|Completed||N/A|62|Actual|Umeå University||2|||f||||||||||||||2017-02-18 16:28:16.381045|2017-02-18 16:28:16.381045
NCT00338065|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2016-12-22|||June 2006||2006-06-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Observational|||External Influences Upon Ocular Homeostasis|External Influences Upon Ocular Homeostasis|Recruiting||N/A|200|Anticipated|Vanderbilt University Medical Center|||4||f||||f||||||||Undecided||2017-02-18 16:28:16.47522|2017-02-18 16:28:16.47522
NCT00338052|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2008-05-07|||June 2006||2006-06-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study of Bleeding With Extended Administration of an Oral Contraceptive|Open-Label Study of Cycle Control With Extended Administration of Norethindrone Acetate 1 mg / Ethinyl Estradiol 20 Mcg Oral Tablets|Completed||Phase 2|207|Actual|Warner Chilcott||1|||f||||f||||||||||2017-02-18 16:28:16.865566|2017-02-18 16:28:16.865566
NCT00338039|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2013-02-18|2012-06-26||September 2005||2005-09-01|February 2013|2013-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients|Induction Cetuximab (IM-C225), Gemcitabine and Oxaliplatin, Followed by Radiotherapy With Concurrent Capecitabine, and Cetuximab, Followed by Maintenance Cetuximab and Gemcitabine for Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 2|69|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:28:16.990215|2017-02-18 16:28:16.990215
NCT00338026|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2008-07-10|||February 2006||2006-02-01|July 2008|2008-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Phase I Study of ECO-4601 in Patients With Advanced Cancer|A Phase I, Dose Finding, Pharmacokinetic, and Safety Study of Continuous IV Infusion of ECO-4601 in Patients With Advanced Cancer Including an Extension Portion to Obtain Safety Data at the Highest Tolerable Dose|Completed||Phase 1|26|Actual|Thallion Pharmaceuticals||1|||f||||t||||||||||2017-02-18 16:28:17.27307|2017-02-18 16:28:17.27307
NCT00338013|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-01-06|||February 2001||2001-02-01|January 2013|2013-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Patient Sleep Position Questionnaire|Patient Sleep Position Questionnaire|Completed||N/A|140|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 16:28:17.388769|2017-02-18 16:28:17.388769
NCT00338000|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-01-31|||June 2001||2001-06-01|January 2011|2011-01-01|May 2005|Actual|2005-05-01|||||Interventional|||EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure|An Open-Label Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure|Completed||Phase 4|292|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 16:28:17.593772|2017-02-18 16:28:17.593772
NCT00337987|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-02-09|2015-01-28||November 2005||2005-11-01|February 2015|2015-02-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma|A Pilot Phase II Study to Determine the Safety of the Combination of ONTAK (DAB389IL-2), an Interleukin-2 Fusion Toxin, in Combination With CHOP in Peripheral T-Cell Lymphoma|Completed||Phase 2|49|Actual|Yale University||1|||f||||||||||||||2017-02-18 16:28:17.677115|2017-02-18 16:28:17.677115
NCT00337974|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-10-29|||March 2005||2005-03-01|October 2015|2015-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Computer-Based Training for Cognitive Enhancement: In Home Study|Computer-Based Training for Cognitive Enhancement: In Home Study|Completed||N/A|182|Actual|Posit Science Corporation||3|||f||||f||||||||||2017-02-18 16:28:17.92751|2017-02-18 16:28:17.92751
NCT00337961|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-01-06|||July 2000||2000-07-01|January 2013|2013-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Optic Nerve Sheath Fenestration|Optic Nerve Sheath Fenestration|Completed||N/A|20|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:28:18.03832|2017-02-18 16:28:18.03832
NCT00005560|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||August 1999||1999-08-01|January 2008|2008-01-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Observational|||Prevalence and Correlates of Childhood Sleep Apnea||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:46.406343|2017-02-18 18:14:46.406343
NCT00337948|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2011-06-08|||February 2003||2003-02-01|January 2011|2011-01-01|February 2005|Actual|2005-02-01|||||Interventional|||An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks|An Open-Labeled Pilot Study to Evaluate the Effects of High Dose PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Anemic Cancer Patients Receiving Chemotherapy on a Weekly or Every Four Week Regimen|Completed||Phase 2|129|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:28:18.12464|2017-02-18 16:28:18.12464
NCT00337935|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2013-05-07|2010-07-16||July 2006||2006-07-01|May 2013|2013-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.|An Open-Label, Randomized, Multi-center, Controlled Study of PROCRIT (Epoetin Alfa) for the Treatment of Anemia of Chronic Kidney Disease in the Long Term Care Setting|Completed||Phase 2|157|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Upper 95% confidence limit for the Standard of Care Group was not estimable because an insufficient number of participates reached the event at the final time point for assessment.|2|||f||||f||||||||||2017-02-18 16:28:18.228722|2017-02-18 16:28:18.228722
NCT00337922|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-16|2008-10-15|||July 2006||2006-07-01|October 2008|2008-10-01||||||||Interventional|||Pharmacokinetic Study Of EPZICOM Tablet|Post-Marketing Clinical Study of EPZICOM Tablet (Lamivudine / Abacavir Sulfate) - Pharmacokinetic Study in HIV-Infected Patients -|Completed||Phase 4|8||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:28:18.807925|2017-02-18 16:28:18.807925
NCT00337909|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-10-29|||September 2005||2005-09-01|October 2015|2015-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Computer-Based Training for Cognitive Enhancement: Classroom Study|Computer-Based Training for Cognitive Enhancement: Classroom Study|Completed||N/A|94|Actual|Posit Science Corporation||3|||f||||f||||||||||2017-02-18 16:28:18.894733|2017-02-18 16:28:18.894733
NCT00337896|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-08-15|||March 2006||2006-03-01|April 2011|2011-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||T and B Cell Response to Avian Flu Vaccine|T and B Cell Immune Responses to Influenza A/H5N1 Vaccine|Completed||N/A|30|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples Without DNA|"~     blood~   "|||2017-02-18 16:28:19.109206|2017-02-18 16:28:19.109206
NCT00337883|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2014-02-28|||July 2003||2003-07-01|February 2014|2014-02-01|October 2005|Actual|2005-10-01|||||Interventional|||A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)|A Phase II, Multicenter, Open-Label Trial of the Safety and Efficacy of Tarceva (Erlotinib Hydrochloride) in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)|Completed||Phase 2|110||Genentech, Inc.|||||||||||||||||||2017-02-18 16:28:19.192191|2017-02-18 16:28:19.192191
NCT00337870|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2013-09-11|||March 2006||2006-03-01|September 2013|2013-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|ERPain||Painful Procedures in the Emergency Department: A Distraction Intervention (3-5 Year Olds)|Painful Procedures in the Emergency Department: Does a Formal Program in Distracting Techniques for Parents and Children Reduce Pain and Anxiety in Children (3-5 Year Olds)?|Completed||Phase 2|131|Actual|IWK Health Centre||2|||f||||f||||||||||2017-02-18 16:28:19.2718|2017-02-18 16:28:19.2718
NCT00337831|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2011-06-29|||May 2006||2006-05-01|June 2011|2011-06-01|May 2007|Actual|2007-05-01|February 2007|Actual|2007-02-01||Interventional|||Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment.|Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment.|Completed||N/A|17|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:28:19.372083|2017-02-18 16:28:19.372083
NCT00337818|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2011-11-10|2009-11-12||June 2006||2006-06-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|June 2006|Actual|2006-06-01||Interventional|||Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women|A Long-term, Open, Follow-up of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV-16/18 L1/AS04 Vaccine in Healthy Female Subjects Vaccinated Either Pre- or Post-menarche in the Primary Study|Completed||Phase 3|770|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 16:28:19.458054|2017-02-18 16:28:19.458054
NCT00337805|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2009-09-17|||September 2004||2004-09-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery|A Randomized Trial of Synthetic vs Normal Saline for the Flow-based Algorithmic Hemodynamic Resuscitation of Patients Post-cardiac Surgery|Completed||Phase 2/Phase 3|240|Actual|McGill University Health Center||2|||f||||f||||||||||2017-02-18 16:28:20.02259|2017-02-18 16:28:20.02259
NCT00337753|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2010-01-04|||June 2006||2006-06-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Cognitive Behavioral Therapy for Pathological Gambling|Cognitive Behavioral Therapy for Pathological Gambling|Completed||Phase 2|76|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 16:28:20.12441|2017-02-18 16:28:20.12441
NCT00337740|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2012-04-20||||||September 2006|2006-09-01||||||||Interventional|||Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding|Randomized Study Comparing Ligation With Propranolol for Primary Prophylaxis of Variceal Bleeding in Candidates for Liver Transplantation|Terminated||Phase 3|120|Anticipated|University of Padova||||"From the interim analysis resulted that more than 1000 patients were required to demonstrate a~   significant difference between the 2 treatments."|f||||||||||||||2017-02-18 16:28:20.232163|2017-02-18 16:28:20.232163
NCT00337727|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2015-06-08|2009-09-30||January 2007||2007-01-01|June 2015|2015-06-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)|A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Moderately Emetogenic Chemotherapy (MEC)|Completed||Phase 3|848|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:28:20.314186|2017-02-18 16:28:20.314186
NCT00337714|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2011-05-13|||July 2006||2006-07-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|||||Interventional|NanoAgCVC||Comparison of Central Venous Catheters With Silver Nanoparticles Versus Conventional Catheters|A Parallel, Randomized Multicenter Comparison of Triple Lumen Central Venous Catheters Impregnated With Silver Nanoparticles (AgTive®) Versus Conventional Catheters in Intensive Care Unit Patients|Completed||Phase 4|472|Anticipated|Catholic University of the Sacred Heart||2|||f||||f||||||||||2017-02-18 16:28:20.954435|2017-02-18 16:28:20.954435
NCT00337701|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2015-11-02|||June 2006||2006-06-01|November 2015|2015-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection|Biojector 2000 Open-Label Safety Study (BOSS) to Evaluate Signs and Symptoms Associated With a Needle-free Injection Device for Administration of Fuzeon to Patients With HIV-1 Infection|Completed||Phase 4|326|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:28:21.052048|2017-02-18 16:28:21.052048
NCT00337688|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2011-09-13|||July 2006||2006-07-01|September 2011|2011-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Power Wheelchair Joystick Use in Spastic Cerebral Palsy|Joystick Use for Virtual Electric Power Wheelchair Driving in Individuals With Spastic Cerebral Palsy|Completed||N/A|50|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 16:28:23.943127|2017-02-18 16:28:23.943127
NCT00337675|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2016-04-07|2010-02-19||October 2006||2006-10-01|April 2016|2016-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast (Daily Dosing and Intermittent, Episode-Driven Dosing) Compared With Placebo in the Treatment of Episodic Asthma in Children Aged 6 Months to 5 Years|Completed||Phase 3|1771|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 16:28:24.037634|2017-02-18 16:28:24.037634
NCT00337662|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2010-02-08|2008-12-03||May 2006||2006-05-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia|Predicting Response to Risperidone Treatment Through Identification of Early-onset of Antipsychotic Drug Action in Schizophrenia.|Completed||Phase 4|628|Actual|Eli Lilly and Company||3|||f||||||||||||||2017-02-18 16:28:24.931154|2017-02-18 16:28:24.931154
NCT00337649|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2016-11-01|||May 2004||2004-05-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer.|An Open -Label Study to Evaluate the Effect of Combination Therapy With Epothilone D and Herceptin on Tumor Response in Patients With HER-2 Overexpressing Locally Advanced or Metastatic Breast Cancer.|Completed||Phase 2|27|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:28:26.521925|2017-02-18 16:28:26.521925
NCT00337636|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2015-01-13|||May 2006||2006-05-01|January 2015|2015-01-01|September 2009|Actual|2009-09-01|February 2009|Actual|2009-02-01||Interventional|||Study of HuCNS-SC Cells in Patients With Infantile or Late Infantile Neuronal Ceroid Lipofuscinosis (NCL)|A Phase I Study of the Safety and Preliminary Effectiveness of Human CNS Stem Cells (HuCNS-SC) in Patients With Neuronal Ceroid Lipofuscinosis Caused by Palmitoyl Protein Thioesterase 1 (PPT1) or Tripeptidyl Peptidase 1 (TPP-I) Deficiency|Completed||Phase 1|6|Actual|StemCells, Inc.||1|||f||||t||||||||||2017-02-18 16:28:26.863449|2017-02-18 16:28:26.863449
NCT00337623|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2006-06-22|||June 2000||2000-06-01|June 2006|2006-06-01|July 2006||2006-07-01|||||Interventional|||Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence.|Corticosteroids and Cataracts : Prospective Study of the Impact of Systemic Corticosteroid Therapy on Lens Transparency Evaluated by Scheimpflug Photography and Quantification of Lens Autofluorescence.|Completed||N/A|22||University Hospital, Clermont-Ferrand|||||f||||||||||||||2017-02-18 16:28:26.974091|2017-02-18 16:28:26.974091
NCT00337610|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2016-05-11|2009-09-24||June 2006||2006-06-01|May 2016|2016-05-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus|A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy|Completed||Phase 3|190|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:28:27.070536|2017-02-18 16:28:27.070536
NCT00337597|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2008-07-18|||May 2006||2006-05-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||Continuous Regional Analgesia After Total Knee Arthroplasty|Continuous Regional Analgesia After Total Knee Arthroplasty. Normal Saline or Dextrose 5% in Water as Fluid Medium for Pre-Placement Expansion in Order to Facilitate the Catheter Passing|Completed||Phase 3|50|Actual|Nantes University Hospital||2|||f||||||||||||||2017-02-18 16:28:27.62176|2017-02-18 16:28:27.62176
NCT00337584|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2007-08-07|||December 2005||2005-12-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||A Pre-Operative Screening Questionnaire (AMS-Q) for Ambulatory Orthopedic Surgery Patients||Completed||N/A|||Hospital for Special Surgery, New York|||||f||||||||||||||2017-02-18 16:28:27.719746|2017-02-18 16:28:27.719746
NCT00337571|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2013-11-07|2009-06-03||June 2006||2006-06-01|November 2009|2009-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)|A Multicenter Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Three Fixed Doses of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)|Completed||Phase 3|218|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||t||||||||||2017-02-18 16:28:27.803469|2017-02-18 16:28:27.803469
NCT00337558|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2014-09-17|||May 2006||2006-05-01|September 2014|2014-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|SOLAR||A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)|Solifenacin Succinate in a Flexible Dose Regimen With Simplified Bladder Training Versus Solifenacin Succinate in a Flexible Dose Regimen Alone in a Prospective, Randomized, Parallel Group, Overactive Bladder Symptom Study|Completed||Phase 4|643|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:28:29.053163|2017-02-18 16:28:29.053163
NCT00337545|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2007-10-05|||May 2006||2006-05-01|October 2007|2007-10-01|April 2007||2007-04-01|||||Interventional|||Phase II Trial of RAD001 in Refractory Colorectal Cancer|Phase II Trial of RAD001 in Patients With Refractory Colorectal Cancer|Completed||Phase 2|22|Actual|Swedish Medical Center|||||f||||||||||||||2017-02-18 16:28:29.221971|2017-02-18 16:28:29.221971
NCT00337532|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2010-02-02||2010-02-02|May 2005||2005-05-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer|A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck Cancer|Completed||Phase 2/Phase 3|50||Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 16:28:29.310681|2017-02-18 16:28:29.310681
NCT00005559|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1997||1997-07-01|March 2004|2004-03-01|June 2000|Actual|2000-06-01|||||Observational|||Statistical Basis for Hemochromatosis Screening||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:46.493802|2017-02-18 18:14:46.493802
NCT00337519|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2009-01-28|||January 2003||2003-01-01|January 2009|2009-01-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia|Chemo-Immunotherapy With Allogeneic Blood Stem Cell Transplantation in Patients With Chronic Lymphocytic Leukemia (Study #02)|Unknown status|Active, not recruiting|Phase 2|82|Anticipated|Charite University, Berlin, Germany||1|||f||||||||||||||2017-02-18 16:28:29.414731|2017-02-18 16:28:29.414731
NCT00337506|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2006-06-15|||August 2003||2003-08-01|August 2004|2004-08-01||||||||Interventional|||Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma|A Multicenter Open-Label Phase II Study of Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma|Terminated||Phase 2|50||Nantes University Hospital|||||f||||||||||||||2017-02-18 16:28:29.761162|2017-02-18 16:28:29.761162
NCT00337493|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2012-09-14|||December 2005||2005-12-01|September 2012|2012-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.|A Study to Investigate the Impact of Pharmacogenetics on CellCept Use, in Patients Participating in a Study in Renal Transplantation|Completed||Phase 4|155|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 16:28:29.862247|2017-02-18 16:28:29.862247
NCT00337480|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2013-04-12|||July 2006||2006-07-01|April 2013|2013-04-01|September 2009|Actual|2009-09-01|July 2008|Actual|2008-07-01||Interventional|||Study of the Efficiency of Education About Cardiovascular Risk Factors in Patients After an Acute Coronary Syndrome|A Network to Control Risk Factors After Acute Coronary Syndrome|Completed||N/A|504|Actual|Resicard||2|||f||||t||||||||||2017-02-18 16:28:29.982114|2017-02-18 16:28:29.982114
NCT00337467|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2010-06-18|2010-05-21||June 2006||2006-06-01|June 2010|2010-06-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|OREY||Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression|Phase IIIb Multicenter, Single Arm, Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Maintenance With Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-Infected Patients Evidencing Virologic Suppression OREY (Only REYataz) Study|Completed||Phase 3|61|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:28:30.110007|2017-02-18 16:28:30.110007
NCT00337454|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2011-04-07||2010-02-04|July 2005||2005-07-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan|A Phase I/II Study of BMS-354825 in Subjects With Imatinib Resistant or Intolerant Philadelphia Chromosome Positive Chronic Myelogenous Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Who Are Resistant or Intolerant to Treatment|Completed||Phase 1/Phase 2|48||Bristol-Myers Squibb||6|||f||||||||||||||2017-02-18 16:28:30.661669|2017-02-18 16:28:30.661669
NCT00337441|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2006-06-14|||January 2003||2003-01-01|June 2006|2006-06-01|July 2005||2005-07-01|||||Interventional|||Treatment of Chronic Anemia With Epoetin Alfa in Elderly|Chronic Anemia And Fatigue In Elderly Patients: A Randomized Double-Blind Placebo-Controlled Cross-Over Study With Epoetin Alfa.|Unknown status|Active, not recruiting|Phase 2|62||Research and Education Foundation of Michael Reese Hospital|||||f||||||||||||||2017-02-18 16:28:30.788048|2017-02-18 16:28:30.788048
NCT00337428|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2016-09-27|2010-01-14||May 2006||2006-05-01|September 2016|2016-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)|An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Gardasil (V501) Given Concomitantly With REPEVAX™ in Healthy Adolescents 11-17 Years of Age|Completed||Phase 3|843|Actual|Merck Sharp & Dohme Corp.|Safety results have been previously reported in the literature.|4|||f||||||||||||||2017-02-18 16:28:30.906784|2017-02-18 16:28:30.906784
NCT00337415|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2015-05-15|||May 2006||2006-05-01|May 2015|2015-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||MK0354 Clinical Efficacy and Tolerability Study (0354-004)|Proprietary Information - Exploratory (Non-Confirmatory) Trial|Terminated||Phase 2|65|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 16:28:31.89281|2017-02-18 16:28:31.89281
NCT00337402|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-15|2006-11-20|||January 2002||2002-01-01|June 2006|2006-06-01|June 2005||2005-06-01|||||Observational|||Effects of Gastrostomy on Amyotrophic Lateral Sclerosis|Effects of Gastrostomy on Quality of Life and Survival in Patients With Amyotrophic Lateral Sclerosis|Completed||N/A|380||University Hospital, Clermont-Ferrand|||||f||||||||||||||2017-02-18 16:28:31.978227|2017-02-18 16:28:31.978227
NCT00337389|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2007-11-15|||May 2006||2006-05-01|November 2007|2007-11-01||||||||Interventional|||Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.|A Phase III Multi-Center Randomized Clinical Trial to Evaluate the Safety and Efficacy of CoFactor and 5-Fluorouracil (5-FU) Plus Bevacizumab Versus Leucovorin and 5-FU Plus Bevacizumab as Initial Treatment for Metastatic Colorectal Carcinoma|Unknown status|Active, not recruiting|Phase 3|1200|Anticipated|Mast Therapeutics, Inc.||2|||f||||||||||||||2017-02-18 16:28:32.069231|2017-02-18 16:28:32.069231
NCT00337376|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2014-01-13|||February 2006||2006-02-01|January 2014|2014-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers|A Phase I Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane (Paclitaxel Protein-bound Particles) in Advanced Solid Cancers|Terminated||Phase 1|23|Actual|Yale University||1|||f||||f||||||||||2017-02-18 16:28:32.435536|2017-02-18 16:28:32.435536
NCT00337350|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2015-04-15|2012-12-19||September 2003||2003-09-01|April 2015|2015-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment|A Double-Blind, Placebo-Controlled Trial of Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment: Bergman's Minimal Model Analysis|Completed||Phase 4|20|Actual|Massachusetts General Hospital|Our findings in this study were limited by the small sample size. It is possible that with a larger sample, significant improvements might be observed not only in glucose metabolism but also in lipid metabolism.|2|||f||||||||||||||2017-02-18 16:28:32.539783|2017-02-18 16:28:32.539783
NCT00337337|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2006-10-17|||April 2005||2005-04-01|June 2006|2006-06-01|February 2007||2007-02-01|||||Interventional|||Multiple Grain in Type 2 Diabetes|Effect of Reconstitute Multiple Grain on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes|Unknown status|Recruiting|Phase 4|30||National Cheng-Kung University Hospital|||||f||||||||||||||2017-02-18 16:28:32.988771|2017-02-18 16:28:32.988771
NCT00337324|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2006-06-14|||March 2002||2002-03-01|March 2002|2002-03-01|May 2004||2004-05-01|||||Interventional|||Electromagnetic Stimulation (FREMS) in Patients With Painful Diabetic Neuropathy|Clinical Assessment of Transcutaneous Neurostimulation and Biofeedback (FREMS)in Patients With Diabetic Neuropathy|Completed||Phase 2/Phase 3|38||IRCCS San Raffaele|||||f||||||||||||||2017-02-18 16:28:33.082303|2017-02-18 16:28:33.082303
NCT00337298|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2009-06-22|||July 2006||2006-07-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes|Lack of Effect of Antihypertensive Treatment With Amlodipine and Lisinopril on Retinal Autoregulation in Patients With Type 1 Diabetes and Mild Diabetic Retinopathy. A Prospective Randomized Clinical Trial.|Completed||N/A|25|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 16:28:33.194258|2017-02-18 16:28:33.194258
NCT00337285|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2012-08-16|2009-05-28||July 2006||2006-07-01|August 2012|2012-08-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|A Long-Term, Open-Label, and Single-Arm Study of NRP104 30 mg, 50 mg, or 70 mg Per Day in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|349|Actual|New River Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:28:33.31377|2017-02-18 16:28:33.31377
NCT00337272|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2011-08-18|2009-06-02||August 2006||2006-08-01|August 2011|2011-08-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||Treating Chronic Insomnia in Breast Cancer Patients|Phase IV: Treatment of Chronic Insomnia in Patients With Breast Cancer Following Completion of Chemotherapy|Terminated||Phase 4|16|Actual|Accelerated Community Oncology Research Network|Early study termination due to slow enrollment; Small sample size analyzed; Some IVRS and Patient Care Monitor (PCM) data were lost and could not be retrieved; Some subject non-compliance with study requirements|2||Lack of enrollment.|f||||f||||||||||2017-02-18 16:28:33.663515|2017-02-18 16:28:33.663515
NCT00337259|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2016-02-13|||June 2006||2006-06-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Gemcitabine for Marginal Zone Lymphoma|Phase II Study of Gemcitabine in Patients With Advanced Stage Marginal Zone B-cell Lymphoma|Terminated||Phase 2|43|Actual|Asan Medical Center||1||poor accrual and response less than expected on interim analysis|f||||t||||||||No||2017-02-18 16:28:34.373206|2017-02-18 16:28:34.373206
NCT00337246|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2013-08-01|||July 2005||2005-07-01|May 2007|2007-05-01|March 2011|Actual|2011-03-01|||||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia|A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) With or Without Rituximab in Previously Treated Chronic Lymphocytic Leukemia|Completed||Phase 2|56|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:28:34.486589|2017-02-18 16:28:34.486589
NCT00337233|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2015-09-30|||January 2004||2004-01-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|November 2006|Actual|2006-11-01||Interventional|||Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer|Restorative Yoga for Symptom Management and Stress Reduction in Women With Ovarian Cancer|Active, not recruiting||N/A|106|Actual|Wake Forest University Health Sciences||1|||f||||t||||||||||2017-02-18 16:28:34.602|2017-02-18 16:28:34.602
NCT00337220|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2013-08-13|||June 2006||2006-06-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Urine Testing to Detect Kidney Transplant Rejection|Noninvasive Diagnosis of Renal Allograft Rejection by Urinary Cell mRNA Profiling|Completed||N/A|492|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"~     Blood and urine collection~   "|||2017-02-18 16:28:34.706212|2017-02-18 16:28:34.706212
NCT00337207|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2016-05-27|2012-10-21||March 2006||2006-03-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|November 2008|Actual|2008-11-01||Interventional|||Bevacizumab in Treating Patients With Recurrent or Progressive Glioma|A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas|Active, not recruiting||Phase 2|55|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 16:28:34.808119|2017-02-18 16:28:34.808119
NCT00337194|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2015-02-10|2015-02-10||April 2006||2006-04-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|September 2008|Actual|2008-09-01||Interventional|||SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma|A Randomized Double-Blinded Placebo Controlled Phase II Study of the Anti-CD30 Antibody, SGN-30 (NSC #731636), in Combination With Gemcitabine, Vinorelbine, and Pegylated Liposomal Doxorubicin (GVD) for Patients With Relapsed/Refractory Hodgkin Lymphoma|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:28:35.168939|2017-02-18 16:28:35.168939
NCT00337181|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2015-12-30|||May 2006||2006-05-01|December 2015|2015-12-01|June 2017|Anticipated|2017-06-01|December 2006|Actual|2006-12-01||Observational|||Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial|Extended Evaluation of the Virologic, Immunologic, and Clinical Course of Volunteers Who Become HIV-1 Infected During Participation in a Phase III Vaccine Trial of ALVAC-HIV and AIDSVAX® B/E.|Active, not recruiting||N/A|130|Anticipated|U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-02-18 16:28:36.015935|2017-02-18 16:28:36.015935
NCT00337168|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2015-03-05|2012-06-05||October 2006||2006-10-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|December 2008|Actual|2008-12-01||Interventional|||S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|A Phase II Trial of Cytarabine and Clofarabine in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2|36|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 16:28:36.103392|2017-02-18 16:28:36.103392
NCT00337155|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2014-12-23|||May 2006||2006-05-01|December 2014|2014-12-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||BAY88-8223, Dose Finding Study in Patients With HRPC|A Double Blind, Randomised, Dose Finding, Repeat Dose, Phase II, Multicentre Study of Alpharadin® for the Treatment of Patients With Hormone Refractory Prostate Cancer and Skeletal Metastases|Completed||Phase 2|122|Actual|Bayer||3|||f||||f||||||||||2017-02-18 16:28:36.84203|2017-02-18 16:28:36.84203
NCT00337142|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2009-06-28|||June 2006||2006-06-01|June 2009|2009-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Follow up Glucose Levels Among Infants of Diabetic Mothers||Completed||Phase 1|250|Anticipated|Sheba Medical Center|||1||f||||||||||||||2017-02-18 16:28:36.976941|2017-02-18 16:28:36.976941
NCT00331331|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-27|2017-01-24|||May 19, 2006||2006-05-19|October 26, 2016|2016-10-26||||||||Observational|||The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease|The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease|Enrolling by invitation||N/A|70|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:30:48.69009|2017-02-18 16:30:48.69009
NCT00337129|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2015-08-11|2012-07-20||May 2006||2006-05-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|August 2008|Actual|2008-08-01||Interventional|||S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Phase II Evaluation of E7389 (NSC-707389) in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:28:37.068509|2017-02-18 16:28:37.068509
NCT00337116|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2010-01-27|||January 2007||2007-01-01|January 2007|2007-01-01|January 2008|Anticipated|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients|Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients|Withdrawn||Phase 4|80|Anticipated|Soroka University Medical Center||2||LOGISTIC DIFFICULTIES|f||||f||||||||||2017-02-18 16:28:37.592263|2017-02-18 16:28:37.592263
NCT00337103|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2016-12-17|2013-07-31||June 2006||2006-06-01|November 2016|2016-11-01|December 2016|Anticipated|2016-12-01|March 2012|Actual|2012-03-01||Interventional|||E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes|A Phase III Open Label, Randomized Two-Parallel-Arm Multicenter Study of E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes|Active, not recruiting||Phase 3|1102|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:28:37.695874|2017-02-18 16:28:37.695874
NCT00337090|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2013-07-01||||||July 2013|2013-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)|A Randomized, Double-blind, Parallel Group, Placebo and Active Controlled, Multicenter Dose Ranging Study With the Beta-3 Agonist YM178 in Patients With Symptomatic Overactive Bladder|Completed||Phase 2|1108|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-02-18 16:28:38.756246|2017-02-18 16:28:38.756246
NCT00337077|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2014-05-21|2014-02-14||November 2006||2006-11-01|April 2014|2014-04-01|November 2013|Actual|2013-11-01|June 2009|Actual|2009-06-01||Interventional||Eligible and treated patients are included in this analysis.|Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Trial of E7389 (Halichondrin B Analog), in Patients With Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|121|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:28:41.695643|2017-02-18 16:28:41.695643
NCT00337064|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2006-06-13|||June 2006||2006-06-01|May 2006|2006-05-01||||||||Interventional|||Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women|Phase I/II Trial to Evaluate Partial Breast Radiation to the Region of the Lumpectomy Cavity Using Intensity Modulated Radiation in Elderly Women With Breast Cancer|Unknown status|Recruiting|Phase 1/Phase 2|75||University of Vermont|||||f||||||||||||||2017-02-18 16:28:42.594339|2017-02-18 16:28:42.594339
NCT00337051|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2010-06-22|||June 2006||2006-06-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|SévoRein||Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)|Sevoflurane-induced Prevention of Ischemia-reperfusion Lesions in Renal Allograft Transplants Recipients|Completed||Phase 3|120|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 16:28:42.687496|2017-02-18 16:28:42.687496
NCT00337038|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2012-06-21|||June 2006||2006-06-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients||Completed||Early Phase 1|50|Actual|Soroka University Medical Center||1|||f||||||||||||||2017-02-18 16:28:42.79676|2017-02-18 16:28:42.79676
NCT00337012|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2008-11-28|||July 2007||2007-07-01|November 2008|2008-11-01||||||||Observational|||The Effect of Duloxetine on Interoceptive Awareness|The Effect of Duloxetine on Interoceptive Awareness, Thermal Heat Pain Perception, and Bodily Symptoms in Major Depressive: a Pilot Study With fMRI.|Unknown status|Recruiting|Phase 4|36|Anticipated|University Hospital, Bonn|||||f||||||||||||||2017-02-18 16:28:42.875339|2017-02-18 16:28:42.875339
NCT00336986|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2016-11-10|||September 2004||2004-09-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy Study of IL-21 to Treat Metastatic Melanoma|An Open-label, Dose Escalation Safety and Tolerability Study of Recombinant Human Interleukin-21 (Phase 1) Followed by an Open-label Treatment Study (Phase 2a) in Patients With Stage IV Malignant Melanoma|Completed||Phase 2|54|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:28:42.94554|2017-02-18 16:28:42.94554
NCT00336973|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2015-07-01|2009-04-15||May 2006||2006-05-01|April 2009|2009-04-01||||February 2008|Actual|2008-02-01||Interventional|||A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent|A Phase IV Open-Label Study to Evaluate the Efficacy and Safety of 1.0 mg/kg Raptiva (Efalizumab) in Adult Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent|Completed||Phase 4|73|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 16:28:43.055462|2017-02-18 16:28:43.055462
NCT00336960|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2013-03-02|||July 2002||2002-07-01|March 2013|2013-03-01|March 2008|Actual|2008-03-01|November 2004|Actual|2004-11-01||Interventional|||Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery|Phase II Pilot Study of Pre-Operative Celecoxib (Celebrex) in Combination With Prolonged Venous Infusion 5FU and Radiation Therapy for Patients With Stage II/III Resectable Rectal Cancer|Completed||Phase 2|24|Actual|Vanderbilt-Ingram Cancer Center||1|||f||||t||||||||||2017-02-18 16:28:43.262925|2017-02-18 16:28:43.262925
NCT00336947|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2013-05-14|||April 2006||2006-04-01|December 2008|2008-12-01||||March 2012|Anticipated|2012-03-01||Interventional|||S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer|Controlled Randomized Trial to Evaluate Efficacy of Adjuvant Chemotherapy Between S-1 and UFT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Phase III Study|Unknown status|Active, not recruiting|Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:28:43.378033|2017-02-18 16:28:43.378033
NCT00336934|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2011-08-08||2011-03-15|November 2005||2005-11-01|August 2011|2011-08-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer|A Randomized, Double-Blind, Placebo-Controlled Study of The Effects of Pomegranate Extract On Rising Prostate-Specific Antigen Levels In Men Following Primary Therapy|Completed||N/A|183|Actual|Roll International Corporation||2|||f||||t||||||||||2017-02-18 16:28:43.770826|2017-02-18 16:28:43.770826
NCT00336921|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-14|2009-09-14|||February 2006||2006-02-01|September 2009|2009-09-01||||April 2007|Actual|2007-04-01||Interventional|||Alfuzosin for Treating Acute Urinary Retention|A Double-blind, Randomized,Placebo Controlled Study of Alfuzosin 10mg od in the Return to Successful Voiding in Patients With a First Episode of Acute Urinary Retention Due to Benign Prostatic Hyperplasia|Completed||Phase 2|156|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:28:43.876452|2017-02-18 16:28:43.876452
NCT00336908|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2007-11-26|||November 2005||2005-11-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery|Inflammatory Responses of Intravenous Fish Oil, Soybean Oil and Medium Chain Triglyceride Fat Emulsions in Young Children Before and After Open Heart Surgery|Completed||Phase 2/Phase 3|32|Anticipated|University of Alberta|||||f||||||||||||||2017-02-18 16:28:43.979298|2017-02-18 16:28:43.979298
NCT00336895|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2016-11-03|2016-05-19||November 2006||2006-11-01|November 2016|2016-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional||30 potential participants were screened but only 29 enrolled.|Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant Recipients|Conversion of CellCept to Myfortic: A Prospective Study on the Tolerability and Safety of Myfortic in Liver Transplant Recipients|Completed||N/A|29|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:28:44.075652|2017-02-18 16:28:44.075652
NCT00336882|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2012-03-01|||June 2006||2006-06-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|PROMIS||Anaesthesia With Propofol Versus Midazolam : Effect on Oxidative Stress in the Brain of Head Trauma Patients|Anaesthesia With Propofol Versus Midazolam : Effect on Oxidative Stress in the Brain of Head Trauma Patients|Terminated||Phase 3|30|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-02-18 16:28:44.347939|2017-02-18 16:28:44.347939
NCT00336869|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2013-11-15|||December 2005||2005-12-01|November 2013|2013-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|Meta-Health||Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership|Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership|Completed||Phase 2|680|Actual|Emory University|||1||f||||||||||Samples Without DNA|"~     Blood samples metabolic testing~   "|||2017-02-18 16:28:44.473865|2017-02-18 16:28:44.473865
NCT00336856|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2016-06-01|2016-01-12||June 2006||2006-06-01|June 2016|2016-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional||Patients who received at least one dose of Irinotecan administered at a dose of 150a or 180 mg/m2 IV every two weeks, were thus evaluable and included in outcome analyses.|Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy|A Phase 2 Study of Irinotecan and Cetuximab on an Every 2 Week Schedule, as Second Line Therapy in Patients With Advanced Colorectal Cancer|Completed||Phase 2|35|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:28:44.576512|2017-02-18 16:28:44.576512
NCT00336843|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2016-02-13|||November 2005||2005-11-01|February 2016|2016-02-01|May 2010|Actual|2010-05-01|February 2009|Actual|2009-02-01||Interventional|||Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma|Combining 90Y-ibritumomab Tiuxetan With High-dose Chemotherapy of BuCyE and Autologous Stem Cell Transplantation in Patients With B-cell Non-Hodgkin's Lymphoma - an Open-labeled Phase II Study|Completed||Phase 2|19|Actual|Asan Medical Center||1|||f||||t||||||||No||2017-02-18 16:28:44.938592|2017-02-18 16:28:44.938592
NCT00336830|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2014-03-26|||May 2003||2003-05-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|June 2007|Actual|2007-06-01||Interventional|||Improving Cardiac Rehabilitation Participation in Women and Men|Improving Cardiac Rehabilitation Participation in Women and Men|Completed||Phase 3|1035|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 16:28:45.065573|2017-02-18 16:28:45.065573
NCT00336817|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2008-10-02|||November 2006||2006-11-01|October 2008|2008-10-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients|A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients|Unknown status|Recruiting|N/A|30|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:28:45.187005|2017-02-18 16:28:45.187005
NCT00336791|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2012-02-13|||September 2003||2003-09-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|August 2007|Actual|2007-08-01||Interventional|||Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer|Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression Profile-Based Test to Select Patients for Preoperative Taxane/Anthracycline Chemotherapy for Stage I-III Breast Cancer|Completed||Phase 3|273|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 16:28:45.278987|2017-02-18 16:28:45.278987
NCT00336778|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2010-05-21|||January 2004||2004-01-01|May 2010|2010-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression|A Phase I Pilot Study Of An Antiretroviral Bridging Regimen In Highly Experienced Patients Unable To Achieve Viral Suppression.|Completed||Phase 1|6|Actual|University of Maryland||1|||f||||t||||||||||2017-02-18 16:28:45.404067|2017-02-18 16:28:45.404067
NCT00336765|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2011-10-17|||July 2006||2006-07-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Study of XL647 Administered Orally Daily to Patients With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL647 Administered Orally Daily to Subjects With Solid Tumors|Completed||Phase 1|31|Actual|Kadmon Corporation, LLC||1|||f||||t||||||||||2017-02-18 16:28:45.493504|2017-02-18 16:28:45.493504
NCT00336752|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2016-09-06|||June 2003||2003-06-01|September 2016|2016-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Operative Versus Non Operative Treatment for Unstable Ankle Fractures|A Prospective Randomized Multi-Centre Study to Compare Operative Versus Non Operative Functional Treatment in Patients With Unstable Isolated Fibula Fractures|Completed||N/A|80|Actual|Lawson Health Research Institute||2|||f||||f||||||||No||2017-02-18 16:28:45.576765|2017-02-18 16:28:45.576765
NCT00336739|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2007-07-20|||April 2006||2006-04-01|June 2007|2007-06-01|March 2007|Actual|2007-03-01|||||Interventional|||The Effect of Cinacalcet on Gastric Acid Output in Healthy Subjects||Completed||N/A|17|Actual|Tufts University||2|||f||||f||||||||||2017-02-18 16:28:45.678807|2017-02-18 16:28:45.678807
NCT00336726|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2011-03-23||||||December 2004|2004-12-01||||||||Observational|||Neuroendocrine Dysfunction in Traumatic Brain Injury: Correlation With Cognitive Dysfunction and Repair||Terminated||N/A|||Denver Research Institute|||1||f||||||||||||||2017-02-18 16:28:45.766272|2017-02-18 16:28:45.766272
NCT00336713|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2016-04-13||2016-04-13|May 2006||2006-05-01|April 2016|2016-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)|A Multicenter, 24-52-week, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, and Safety of Saredutant 100 mg Once Daily in the Prevention of Relapse of Depressive Symptoms in Outpatients With Major Depressive Disorder|Completed||Phase 3|430|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:28:45.831797|2017-02-18 16:28:45.831797
NCT00336700|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2016-07-27|2015-12-23||June 2006||2006-06-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|October 2011|Actual|2011-10-01||Interventional|||A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer|A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer|Terminated||Phase 2|25|Actual|University of Pittsburgh||1||Study published November 2010 and no further work will be done|f||||t||||||||||2017-02-18 16:28:45.926586|2017-02-18 16:28:45.926586
NCT00336687|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2010-03-26|||July 2005||2005-07-01|March 2010|2010-03-01|November 2006|Actual|2006-11-01|||||Observational|||Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.|Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.|Completed||N/A|322|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-02-18 16:28:46.496452|2017-02-18 16:28:46.496452
NCT00336674|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2016-10-05|||December 2006||2006-12-01|May 2015|2015-05-01|December 2024|Anticipated|2024-12-01|August 2024|Anticipated|2024-08-01||Interventional|INITII||Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes|A Randomised, Double-blind, Placebo-controlled Trial of Intranasal Insulin (440 IU) in Children and Young Adults at Risk of Type 1 Diabetes: Intranasal Insulin Trial II|Active, not recruiting||Phase 2|110|Actual|Melbourne Health||2|||f||||t||||||||No||2017-02-18 16:28:46.591198|2017-02-18 16:28:46.591198
NCT00336661|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2007-05-17|||January 2006||2006-01-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|||PerioWave Re-Treatment Protocol Compared to Scaling and Root Planing (SRP) and a Single Treatment With PerioWave|A Multicenter, Randomized, Blinded Study of Two Treatments of Photoactivated Disinfection With SRP Against One Treatment of Photoactivated Disinfection With SRP Against SRP Alone in the Treatment of Chronic Periodontitis|Completed||Phase 3|105|Actual|Ondine Research Laboratories||3|||f||||||||||||||2017-02-18 16:28:46.702738|2017-02-18 16:28:46.702738
NCT00336648|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2012-07-26|||June 2006||2006-06-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Preop Chemoradiation Resectable Pancreas|A Phase II Pilot Study of Preoperative Gemcitabine and Bevacizumab-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreas|Completed||Phase 2|11|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:28:46.81503|2017-02-18 16:28:46.81503
NCT00336635|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2007-04-17|||June 2006||2006-06-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Safety and Immunogenicity of CJ-50300|Randomized, Double Blind, Placebo Control Study to Evaluate the Safety and Immunogenicity of CJ-50300 in Healthy Volunteers : Phase I|Completed||Phase 1|24||Seoul National University Hospital|||||f||||t||||||||||2017-02-18 16:28:46.930198|2017-02-18 16:28:46.930198
NCT00336622|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2011-02-18|||June 2004||2004-06-01|February 2011|2011-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Efficacy of Wrist/Hand Splints and Tendon/Nerve Gliding Exercises for Carpal Tunnel Syndrome: A RCT|The Efficacy of a Wrist and Hand Splint in Conjunction With Tendon and Nerve Gliding Exercise for the Treatment of Carpal Tunnel Syndrome: A Randomized Clinical Trial|Completed||N/A|56|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 16:28:47.017643|2017-02-18 16:28:47.017643
NCT00336609|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2007-04-19|||November 2005||2005-11-01|April 2007|2007-04-01|May 2007||2007-05-01|||||Observational|||TRIAD Burden of Illness Mucositis Study|Risk and Outcomes of Mucositis in Subjects Being Treated for Breast, Colorectal, Head and Neck, Non-Small Cell Lung Cancers or Non-Hodgkin's Lymphoma|Unknown status|Recruiting|N/A|1600||TRIAD Burden of Illness|||||f||||||||||||||2017-02-18 16:28:47.116683|2017-02-18 16:28:47.116683
NCT00336596|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2007-04-25|||June 2006||2006-06-01|April 2007|2007-04-01|June 2009|Anticipated|2009-06-01|||||Interventional|||Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion|Transcranial Ultrasound Enhanced Thrombolysis (TRUST)|Unknown status|Recruiting|Phase 3|400||University of Zurich|||||f||||t||||||||||2017-02-18 16:28:47.190651|2017-02-18 16:28:47.190651
NCT00336583|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-13|2010-05-25|2009-05-05||June 2006||2006-06-01|September 2009|2009-09-01|January 2008|Actual|2008-01-01|December 2006|Actual|2006-12-01||Interventional|||Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)|Phase II Study of Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOX) for Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 2|27|Actual|Asan Medical Center||1|||f||||t||||||||||2017-02-18 16:28:47.290723|2017-02-18 16:28:47.290723
NCT00336570|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2013-11-15|||February 2006||2006-02-01|November 2013|2013-11-01|October 2010|Actual|2010-10-01|||||Observational|||Predictive Medicine Research. (PRE MED)|Predictive Medicine Research (PRE MED) :Investigation of Predictors of Health, Sub-clinical and Clinical Organ System Diseases in Healthy Adult Population.|Completed||N/A|288|Actual|Emory University|||1||f||||f||||||Samples With DNA|"~     Whole Blood and Urine were collected. Samples of Serum, Plasma and Urine are stored.~   "|||2017-02-18 16:28:47.559308|2017-02-18 16:28:47.559308
NCT00336557|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2013-10-29|||July 2006||2006-07-01|October 2013|2013-10-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Observational|||Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy|A Randomized, Controlled, Open-Label Parallel Group Study to Evaluate the Effect of Regularly Scheduled Neutralizing Antibody Testing on Treatment Patterns Versus Usual Care in High-Dose Interferon Treated Patients|Completed||Phase 4|1230|Actual|Teva Pharmaceutical Industries|||2||f||||f||||||Samples Without DNA|"~     blood drawn for a Binding Antibody (BAb) and Neutralizing Antibody (NAb) test.~   "|||2017-02-18 16:28:47.654848|2017-02-18 16:28:47.654848
NCT00336544|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2010-01-29|2009-09-03||June 2006||2006-06-01|January 2010|2010-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia|A Double-Blinded, Randomized, Parallel Group, Multi-Center, Multi-National Comparative Study of the Safety and Efficacy of Cethromycin 300 mg QD to Clarithromycin 250 mg BID for the Treatment of Community-Acquired Pneumonia in Adults|Completed||Phase 3|522|Actual|Advanced Life Sciences, Inc.||2|||f||||f||||||||||2017-02-18 16:28:47.812583|2017-02-18 16:28:47.812583
NCT00336531|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-11|2008-11-17|||April 2006||2006-04-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation|Clinical Study to Evaluate the Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors|Completed||Phase 4|100|Anticipated|Samsung Medical Center||1|||f||||||||||||||2017-02-18 16:28:48.268337|2017-02-18 16:28:48.268337
NCT00336518|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2006-06-12|||June 2006||2006-06-01|August 2005|2005-08-01|July 2009||2009-07-01|||||Interventional|||Continuing Treatment With Pegasys and Copegus|Efficacy and Safety of Continuing for a Total of 48 or Prolonging for a Total of 72 Weeks of Combined Treatment of Patients Receiving Pegasys and Copegus Who Are Biochemical Responders But Virological Non-Responders at Week 12 or Week 24|Unknown status|Recruiting|Phase 3|100||Májbetegekért Alapítvány|||||f||||||||||||||2017-02-18 16:28:48.37572|2017-02-18 16:28:48.37572
NCT00336505|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2010-01-29|2009-09-03||December 2005||2005-12-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)|A Double-Blinded, Randomized, Parallel Group, Multi-Center, Multi-National Comparative Study of the Safety and Efficacy of Cethromycin 300 mg QD to Clarithromycin (BIAXIN® Filmtab®) 250 mg BID for the Treatment of Community-Acquired Pneumonia in Adults|Completed||Phase 3|584|Actual|Advanced Life Sciences, Inc.||2|||f||||f||||||||||2017-02-18 16:28:48.465145|2017-02-18 16:28:48.465145
NCT00336492|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2013-07-24|2011-07-14||September 2006||2006-09-01|July 2013|2013-07-01|April 2010|Actual|2010-04-01|May 2009|Actual|2009-05-01||Interventional|||A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis|A Phase 3, Randomized, Open-label, Parallel-group, Multicenter Trial to Evaluate the Safety and Efficacy of Infliximab (REMICADE�) in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis|Completed||Phase 3|60|Actual|Centocor, Inc.||2|||f||||||||||||||2017-02-18 16:28:48.878283|2017-02-18 16:28:48.878283
NCT00336479|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2014-06-25|2011-06-22||June 2006||2006-06-01|June 2014|2014-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||The Full Analysis set included all randomized subjects who received at least 1 dose of study drug.|Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C|A Phase 2 Study of VX-950 in Combination With Peginterferon Alfa-2a (Pegasys®), With Ribavirin (Copegus®) in Subjects With Genotype 1 Hepatitis C Who Have Not Received Prior Treatment|Completed||Phase 2|263|Actual|Vertex Pharmaceuticals Incorporated||4|||f||||t||||||||||2017-02-18 16:28:49.607597|2017-02-18 16:28:49.607597
NCT00336466|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2007-11-26|||September 2004||2004-09-01|November 2007|2007-11-01|May 2005||2005-05-01|||||Interventional|||The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)|The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS): A Randomized, Double-Blind, Placebo Controlled Proof-of-Concept Clinical Trial.|Completed||Phase 2|32||University of Calgary|||||f||||||||||||||2017-02-18 16:28:50.839767|2017-02-18 16:28:50.839767
NCT00336453|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2009-12-16|||October 2006||2006-10-01|December 2009|2009-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics|Evaluation of the Safety, Reactogenicity and Immunogenicity of FluBlok Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine Administered Intramuscularly to Healthy Children Aged 6 To 59 Months|Completed||Phase 1/Phase 2|156|Actual|Protein Sciences Corporation||5|||f||||t||||||||||2017-02-18 16:28:50.940396|2017-02-18 16:28:50.940396
NCT00336427|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2006-06-09|||September 2005||2005-09-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Observational|||MRSA Colonization in Peripartum Women and Their Offspring|A Prospective Study of MRSA Colonization in Peripartum Women and Their Offspring|Completed||N/A|600||Orlando Regional Medical Center|||||f||||||||||||||2017-02-18 16:28:51.078316|2017-02-18 16:28:51.078316
NCT00336414|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2007-06-27|||June 2006||2006-06-01|June 2007|2007-06-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis|Five-Year Single-Blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis: Oral Cyclophosphamide Versus High Dose Intravenous Cyclophosphamide Versus Intermediate Dose Intravenous Cyclophosphamide|Withdrawn||Phase 3|159||Istituto Giannina Gaslini||||the study is withdrawn due to low and unexpected enrollment rate|f||||||||||||||2017-02-18 16:28:51.143794|2017-02-18 16:28:51.143794
NCT00336401|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2010-07-29|||October 2006||2006-10-01|September 2006|2006-09-01|February 2008|Actual|2008-02-01|||||Interventional|||Peri-Operative And Long-Term Cardioprotective Properties Of Sevoflurane In High Risk Patients Undergoing Non-Cardiac Surgery|Peri-Operative And Long-Term Cardioprotective Properties Of Sevoflurane In High Risk Patients Undergoing Non-Cardiac Surgery|Completed||Phase 4|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:28:51.252005|2017-02-18 16:28:51.252005
NCT00336388|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-10|2010-03-08|||July 2006||2006-07-01|March 2010|2010-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Use of Rapid Diagnostic Tests for Malaria Case Management in Kenya|Introduction of Malaria Rapid Diagnostic Tests, Artemisinin-based Combination Therapy, and Malaria Case Management Guidelines at Health Facilities in Kenya: A Cluster Randomized Trial to Evaluate Adherence and Acceptance by Health Care Workers, Impact on Antimalarial Prescription Practices, and Patient Perceptions|Completed||N/A|3600||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 16:28:51.338223|2017-02-18 16:28:51.338223
NCT00336375|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2007-10-31|||June 2006||2006-06-01|October 2007|2007-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Treatment of Uncomplicated Childhood Malaria in Tanzania by Artemether+Lumefantrine - Efficacy and Genotyping|Treatment of Uncomplicated Childhood Malaria by an Artemisinin Derivative in Combination With Lumefantrine. Efficacy, Safety and Genotyping.|Completed||Phase 4|50|Actual|Karolinska University Hospital||2|||f||||||||||||||2017-02-18 16:28:51.436019|2017-02-18 16:28:51.436019
NCT00336362|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2012-12-18|||July 2006||2006-07-01|December 2012|2012-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia Major|A Pilot Study to Assess the Safety and Efficacy of G-CSF Mobilization With and Without Hydroxyurea Pretreatment in Adults With Beta Thalassemia Major|Completed||N/A|26|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:28:51.550666|2017-02-18 16:28:51.550666
NCT00331318|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-27|2017-01-24|||May 24, 2006||2006-05-24|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Improving Hand Movement Training Through Electrical Stimulation of the Brain|Encoding a Motor Memory Through Metaplasticity|Completed||N/A|31||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:30:48.772472|2017-02-18 16:30:48.772472
NCT00336349|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2011-07-25|||June 2006||2006-06-01|July 2011|2011-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain|A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain|Completed||N/A|30|Actual|Taipei Medical University Hospital|||||f||||f||||||||||2017-02-18 16:28:51.877684|2017-02-18 16:28:51.877684
NCT00336336|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2015-08-13|||August 2002||2002-08-01|September 2010|2010-09-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHF|A Large Scale Clinical Trial Testing the Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic Congestive Heart Failure|Completed||Phase 3|6975|Actual|Gruppo di Ricerca GISSI||4|||f||||t||||||||||2017-02-18 16:28:52.00362|2017-02-18 16:28:52.00362
NCT00336323|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2016-08-25|2011-03-16||June 2006||2006-06-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|November 2006|Actual|2006-11-01||Interventional|Bevacizumab||A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)|A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)|Completed||Phase 2|121|Actual|Jaeb Center for Health Research||5|||f||||t||||||||||2017-02-18 16:28:52.702242|2017-02-18 16:28:52.702242
NCT00336310|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2006-06-12|||July 2006||2006-07-01|June 2006|2006-06-01||||||||Interventional|||A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients|A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients|Unknown status|Not yet recruiting|Phase 4|50||National Cheng-Kung University Hospital|||||f||||||||||||||2017-02-18 16:28:56.001511|2017-02-18 16:28:56.001511
NCT00336297|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2006-11-28|||May 2004||2004-05-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Testing Methods of Screening for Woman Abuse in Health Care Settings.|Testing Screening Formats for Indicator-Based and Universal Screening Measurements in the Identification of Woman Abuse.|Completed||N/A|2000||McMaster University|||||f||||||||||||||2017-02-18 16:28:56.097242|2017-02-18 16:28:56.097242
NCT00336284|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2010-07-28|2010-01-12||November 2005||2005-11-01|July 2010|2010-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TRUST||TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up|TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up|Completed||Phase 4|1450|Actual|Biotronik, Inc.||2|||f||||f||||||||||2017-02-18 16:28:56.432925|2017-02-18 16:28:56.432925
NCT00336271|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2007-03-14|||April 2006||2006-04-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Observational|||The Effects of Coffee|The Effects of Coffee|Completed||Phase 1|50||American University|||||f||||||||||||||2017-02-18 16:28:57.014491|2017-02-18 16:28:57.014491
NCT00336258|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2010-12-13|||June 2006||2006-06-01|April 2007|2007-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status|US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status|Completed||N/A|100|Anticipated|Rambam Health Care Campus|||1||f||||||||||||||2017-02-18 16:28:57.101215|2017-02-18 16:28:57.101215
NCT00336245|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-11|2015-03-05|||June 2002||2002-06-01|August 2009|2009-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in Zambia|A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in Zambia|Completed||Phase 3|600||University of Alabama at Birmingham||2|||f||||||||||||||2017-02-18 16:28:57.1865|2017-02-18 16:28:57.1865
NCT00336232|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2016-04-22|2016-03-07||May 2006||2006-05-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Determinants of Vitamin K Metabolism|Dietary and Non-dietary Components of Vitamin K Metabolism|Completed||N/A|59|Actual|Tufts University||1|||f||||f||||||||Yes||2017-02-18 16:28:57.296155|2017-02-18 16:28:57.296155
NCT00336219|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2012-05-04|||August 2006||2006-08-01|October 2008|2008-10-01|April 2007|Actual|2007-04-01|November 2006|Actual|2006-11-01||Interventional|||Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)|COMPETITION: Investigation of Clinical Endpoints for Treatment-induced Gastroesophageal Reflux Disease (GERD) Symptom Changes|Completed||Phase 3|628|Actual|Takeda||1|||f||||||||||||||2017-02-18 16:28:57.634841|2017-02-18 16:28:57.634841
NCT00336206|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2006-07-21|||July 2006||2006-07-01|June 2006|2006-06-01|October 2009||2009-10-01|||||Interventional|||Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia|Subcutaneous Injection, Low Dose Alemtuzumab for Consolidation and Maintenance of Patients in Clinical Response After Having Achieved Partial or Complete Remission After 1st or 2nd Line Anti-Tumor Therapy for B-Cell CLL|Unknown status|Not yet recruiting|N/A|60||Tawam Hospital|||||f||||||||||||||2017-02-18 16:28:57.791018|2017-02-18 16:28:57.791018
NCT00336193|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-10|2011-02-10|||August 2005||2005-08-01|February 2011|2011-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Competency Training, Staff Performance, & Family Outcomes|University of Colorado Health Sciences Center: Competency Training, Staff Performance, & Family Outcomes|Completed||Phase 2|1075|Anticipated|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-02-18 16:28:57.879829|2017-02-18 16:28:57.879829
NCT00336180|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2013-03-19|||September 2003||2003-09-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Adolescent Drug and HIV Prevention in South Africa|Adolescent Drug and HIV Prevention in South Africa|Completed||Phase 2/Phase 3|7695|Actual|Penn State University||1|||f||||t||||||||||2017-02-18 16:28:57.982438|2017-02-18 16:28:57.982438
NCT00336167|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2007-04-06|||June 2006||2006-06-01|April 2007|2007-04-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Bezafibrate Trial in CPT2 Deficiency|Clinical Trial on the Effect of Bezafibrate in the Muscular Form of Carnitine Palmitoyltransferase 2 Deficiency|Unknown status|Recruiting|Phase 3|12||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:28:58.095036|2017-02-18 16:28:58.095036
NCT00336154|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2006-06-12||||||June 2006|2006-06-01||||||||Interventional|||Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa|Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa|Unknown status|Not yet recruiting|Phase 4|20||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:28:58.204709|2017-02-18 16:28:58.204709
NCT00005534|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-03-05|||January 1997||1997-01-01|March 2014|2014-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||Prevalence of Asymptomatic Ventricular Dysfunction||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-02-18 18:14:48.363861|2017-02-18 18:14:48.363861
NCT00336141|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2014-05-19|||June 2006||2006-06-01|May 2014|2014-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer|Phase I/II Clinical Trial With Vorinostat and Infusional 5-FU/LV in Patients With Metastatic Colorectal Cancer Who Failed 5-FU-Based Chemotherapy|Completed||Phase 1|10|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 16:28:58.296014|2017-02-18 16:28:58.296014
NCT00336128|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-12|2008-05-06|||October 2003||2003-10-01|May 2008|2008-05-01|July 2009|Anticipated|2009-07-01|May 2006|Actual|2006-05-01||Interventional|||Population Based Intervention to Prevent Obesity in Kindergartens (TigerKids)||Unknown status|Active, not recruiting|N/A|30000|Anticipated|Ludwig-Maximilians - University of Munich||1|||f||||||||||||||2017-02-18 16:28:58.39118|2017-02-18 16:28:58.39118
NCT00336115|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2007-10-22|||July 2006||2006-07-01|October 2007|2007-10-01|May 2008|Anticipated|2008-05-01|||||Interventional|||The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients|Safety and Immunogenicity of Adult Formulation Tetanus and Diphtheria Toxoids Adsorbed Combined With Acellular Pertussis (Tdap) Vaccine Following Blood and Morrow Transplantation in Adults|Unknown status|Enrolling by invitation|Phase 4|10|Anticipated|Queen Elizabeth II Health Sciences Centre|||||f||||f||||||||||2017-02-18 16:28:58.494483|2017-02-18 16:28:58.494483
NCT00336102|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2015-07-07|||April 2006||2006-04-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers|Thyroid Function & Breast Cancer: A Pilot Study to Estimate the Prevalence of Thyroid Dysfunction in Women Diagnosed With Breast Cancer and the Magnitude of Change in Thyroid Function Post-Chemotherapy|Completed||N/A|541|Actual|University of South Florida|||2||f||||t||||||Samples Without DNA|"~     Markers of thyroid function including thyroid stimulating hormone (TSH), Free thyroxine~     (free T4) and Thyroid peroxidase antibody (TPO Ab). These will be performed at baseline, in~     12 months and again 24 months after enrollment. All thyroid function marker assays will be~     performed by LabCorp.~   "|||2017-02-18 16:28:58.574759|2017-02-18 16:28:58.574759
NCT00336089|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2013-09-16|||January 2006||2006-01-01|July 2009|2009-07-01||||December 2008|Anticipated|2008-12-01||Interventional|||Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors|The Effects of Cross Training on Fatigue and Pain Levels in Breast Cancer Survivors|Unknown status|Recruiting|N/A|54|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:28:58.7233|2017-02-18 16:28:58.7233
NCT00336076|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-11-03|||July 2004||2004-07-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Observational|||Molecular Mechanisms and Diagnosis of Mastocytosis|Investigation of Cellular and Molecular Pathologic Mechanisms in Mast Cell Disorders.|Completed||N/A|136|Actual|University of Michigan|||1||f||||f||||||Samples With DNA|"~     Plasma and nucleic acid.~   "|No||2017-02-18 16:28:58.822257|2017-02-18 16:28:58.822257
NCT00336063|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2017-01-31|||March 2006||2006-03-01|November 2016|2016-11-01||||April 2013|Actual|2013-04-01||Interventional|||Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma|A Phase I Trial of 5Azacitidine and Suberoylanilide Hydroxamic Acid in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma and Nasal NK-T Cell Lymphoma|Active, not recruiting||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:28:58.940559|2017-02-18 16:28:58.940559
NCT00336050|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2016-07-28|||November 2000||2000-11-01|February 2009|2009-02-01|September 2010|Actual|2010-09-01|||||Observational|FACES||Effect of Air Pollution on Long-Term Asthma Severity and Lung Function in Children|Fresno Asthmatic Children's Environment Study|Unknown status|Active, not recruiting|N/A|315|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||f||||||Samples With DNA|"~     Password-protected database and storage facility that is part of the UCB SPH biorepository~   "|||2017-02-18 16:28:59.072223|2017-02-18 16:28:59.072223
NCT00336024|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2017-02-14|||August 2007||2007-08-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2016|Actual|2016-12-31||Interventional|||Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma|A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children &lt;36 Months Old With Intensive Induction Chemotherapy With Methotrexate Followed by Consolidation With Stem Cell Rescue Versus the Same Therapy Without Methotrexate|Completed||Phase 3|96|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 16:28:59.159198|2017-02-18 16:28:59.159198
NCT00336011|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2006-06-09|||December 2002||2002-12-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Safety of Cardiac Pacemakers in 1.5T Tesla MRI|Studie Zur Sicherheit Von Medtronic Schrittmachern Bei Magnetresonanz-Bildgebungsverfahren an 1,5 Tesla-Systemen Study to Evaluate Safety Medtronic Pacemakers in MR Imaging at 1.5T Tesla)|Completed||N/A|75||University Hospital, Bonn|||||f||||||||||||||2017-02-18 16:28:59.489046|2017-02-18 16:28:59.489046
NCT00335998|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2013-01-10|||March 2006||2006-03-01|January 2013|2013-01-01||||October 2008|Actual|2008-10-01||Interventional|||Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies|Phase I Study of Intravenous Triapine® (IND #68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies.|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:28:59.576423|2017-02-18 16:28:59.576423
NCT00335985|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2014-11-03|||June 2006||2006-06-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)|A Randomized, Double-blind, Controlled Clinical Study of GB-0998 for the Steroid-resistant Polymyositis and Dermatomyositis|Completed||Phase 3|26|Actual|Japan Blood Products Organization||2|||f||||f||||||||||2017-02-18 16:28:59.695948|2017-02-18 16:28:59.695948
NCT00335972|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-05-05|||June 2006||2006-06-01|May 2016|2016-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of DexMed and Desflurane on Carotid Patients|Phase 4: The Effects of Dexmedetomidine and Desflurane on Postoperative Cognitive Dysfunction in Patients Undergoing Carotid Endarterectomy|Terminated||Phase 4|4|Actual|The Cleveland Clinic||4||Closed due to lack of enrollment|f||||t||||||||||2017-02-18 16:28:59.80064|2017-02-18 16:28:59.80064
NCT00335959|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2012-07-12|2012-07-12||May 2006||2006-05-01|July 2012|2012-07-01||||April 2009|Actual|2009-04-01||Interventional|||S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery|Neoadjuvant Chemoradiation Therapy With Oxaliplatin and Capecitabine for Patients With Surgically Resectable Gastric Cancer: A Pilot Phase II Trial With Molecular Correlates|Terminated||Phase 2|7|Actual|Southwest Oncology Group||1||Closed due to slow accrual|f||||t||||||||||2017-02-18 16:28:59.916992|2017-02-18 16:28:59.916992
NCT00335946|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2008-10-16|||June 2006||2006-06-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Pilot Investigational Study: Treatment of Anxiety With Non-Needle Electro-Acupuncture||Completed||Phase 1|40||Logan College of Chiropractic|||||f||||f||||||||||2017-02-18 16:29:02.967561|2017-02-18 16:29:02.967561
NCT00335933|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2007-08-01|||May 2006||2006-05-01|June 2006|2006-06-01|July 2007|Actual|2007-07-01|||||Interventional|||Safety and Efficacy of Gabapentin in Postherpetic Neuralgia|A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Patients With Postherpetic Neuralgia|Completed||Phase 3|378|Anticipated|Depomed|||||||||||||||||||2017-02-18 16:29:03.052556|2017-02-18 16:29:03.052556
NCT00335920|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2008-02-04|||October 2003||2003-10-01|February 2008|2008-02-01|July 2007|Actual|2007-07-01|July 2006|Actual|2006-07-01||Interventional|||Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss|A Prospective, Randomized, Double Blind, Placebo Controlled, Multicenter Study on the Safety and Efficacy of Continuous Infusion of Corticosteroid Delivered Via Catheter in Patients With Idiopathic Sudden Sensorineural Hearing Loss|Completed||Phase 3|23|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-02-18 16:29:05.709159|2017-02-18 16:29:05.709159
NCT00335907|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2010-08-23|||September 2006||2006-09-01|August 2010|2010-08-01|January 2011|Anticipated|2011-01-01|June 2010|Anticipated|2010-06-01||Interventional|||Protocol-driven Hemodynamic Support for Patients With Septic Shock|Protocol-driven Hemodynamic Support for Patients With Septic Shock|Unknown status|Recruiting|N/A|70|Anticipated|National Institute of General Medical Sciences (NIGMS)||1|||f||||||||||||||2017-02-18 16:29:05.831994|2017-02-18 16:29:05.831994
NCT00335894|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2010-03-09|||May 2005||2005-05-01|December 2008|2008-12-01|March 2009||2009-03-01|May 2008|Actual|2008-05-01||Interventional|||Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).|A Prospective, Randomized, Investigator-blind, Controlled, Clinical Study of Phase III on the Efficacy and Tolerability of hMG-IBSA (IBSA) vs Menopur (Ferring) Administered s.c. in Women Undergoing COH in an ART Programme (IVF)|Completed||Phase 3|144|Anticipated|IBSA Institut Biochimique SA|||||f||||||||||||||2017-02-18 16:29:05.928305|2017-02-18 16:29:05.928305
NCT00335881|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2016-10-06|||June 2006||2006-06-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib|Multicentre Study to Assess Persistence of Antibodies Against Hepatitis B & Immune Response to a Hepatitis B Challenge Dose in Healthy Children 4 to 6 Years Old Previously Vaccinated With 4 Doses of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine|Completed||Phase 4|300||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:29:06.02336|2017-02-18 16:29:06.02336
NCT00335868|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2013-12-17|||March 2007||2007-03-01|July 2009|2009-07-01||||December 2009|Anticipated|2009-12-01||Interventional|||PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy|A Pilot Phase II Study of PHA-739358 in Patients With Chronic Myeloid Leukemia Relapsing on Gleevec or c-ABL Therapy|Unknown status|Active, not recruiting|Phase 2|16|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:29:06.148956|2017-02-18 16:29:06.148956
NCT00335855|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2010-08-26||||||April 2009|2009-04-01|October 2006||2006-10-01|||||Interventional|||Pharma-Pen (Formerly Innoject) Auto-injectory TIV|Demonstration of Safety, Effectiveness, and Ease-of-Use of an Advanced Self-Delivery System (Pharma-Pen™) for IM and SC Administration of Vaccines by Untrained Users - Phase I|Withdrawn||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:29:06.255828|2017-02-18 16:29:06.255828
NCT00335829|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2012-12-11|||May 2006||2006-05-01|December 2012|2012-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery|Phase II Trial of Bevacizumab Combined With Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma|Completed||Phase 2|26|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:29:06.335191|2017-02-18 16:29:06.335191
NCT00335816|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-10-18|||August 2008||2008-08-01|October 2016|2016-10-01||||December 2017|Anticipated|2017-12-01||Interventional|||Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer|Timing of Rectal Cancer Response to Chemoradiation|Active, not recruiting||Phase 2|248|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||t||||||||||2017-02-18 16:29:06.449835|2017-02-18 16:29:06.449835
NCT00335803|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2009-01-22|||March 2006||2006-03-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|||||Observational|||A Research Study To Compare Two Kinds Of Daily Headache|A Comparison Of Subjects With New Daily Persistent Headache (NDPH) And Subjects With Transformed Migraine (TM)|Completed||N/A|||Thomas Jefferson University|||||f||||||||||||||2017-02-18 16:29:06.83973|2017-02-18 16:29:06.83973
NCT00335790|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2007-04-09|||June 2006||2006-06-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||A Controlled Trial of the Clinical Effects of Hyperbaric Therapy in Autistic Children|A Prospective, Randomized, Double-Blind, Controlled Study on the Clinical Effects of Hyperbaric Therapy in Autistic Children|Completed||N/A|60||International Hyperbarics Association|||||f||||||||||||||2017-02-18 16:29:06.914336|2017-02-18 16:29:06.914336
NCT00335777|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2014-03-21|2010-10-26||August 2006||2006-08-01|March 2014|2014-03-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||A Research Study Examining Migranal and Skin Sensitivity in Subjects With Migraine|An Open-Label Pilot Trial To Collect And Evaluate Data On The Use Of Migranal® In The Treatment Of Two Acute Migraine Attacks Associated With Cutaneous Allodynia|Completed||Phase 4|64|Actual|Thomas Jefferson University||2|||f||||||||||||||2017-02-18 16:29:07.00591|2017-02-18 16:29:07.00591
NCT00331305|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2013-08-28|||August 1999||1999-08-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Exercise Training Versus Drug Therapy for Treating Depression in Older Adults|Exercise Training and Depression in Older Adults II|Completed||Phase 3|457|Actual|Duke University|||||f||||t||||||||||2017-02-18 16:30:48.850511|2017-02-18 16:30:48.850511
NCT00335764|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-12-28|||April 2006||2006-04-01|December 2016|2016-12-01|September 2012|Actual|2012-09-01|February 2010|Actual|2010-02-01||Interventional|||Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma|Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma|Completed||Phase 1/Phase 2|31|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||No||2017-02-18 16:29:07.244383|2017-02-18 16:29:07.244383
NCT00335751|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-01-29|||January 2006||2006-01-01|January 2016|2016-01-01|October 2011|Actual|2011-10-01|July 2008|Actual|2008-07-01||Interventional|||PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma|Glucose Metabolic Response by PET/CT to Sarcoma Treatments|Completed||N/A|120|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||No||2017-02-18 16:29:07.374071|2017-02-18 16:29:07.374071
NCT00335738|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2013-06-10|||December 2005||2005-12-01|June 2013|2013-06-01||||September 2011|Actual|2011-09-01||Interventional|||Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma|A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy|Completed||Phase 3|331|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 16:29:07.482632|2017-02-18 16:29:07.482632
NCT00335725|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2015-03-23|2015-02-12||March 2003||2003-03-01|March 2015|2015-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.|Multicentric Prospective, Randomised, Controlled Clinical Study on Clinical Efficacy and Tolerability of Urinary FSH (Fostimon® , IBSA) Versus r-FSH (Gonal-F®, Serono) in ICSI.|Completed||Phase 3|151|Actual|IBSA Institut Biochimique SA||2|||f||||||||||||||2017-02-18 16:29:07.65706|2017-02-18 16:29:07.65706
NCT00335712|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2012-06-12|||June 2006||2006-06-01|June 2012|2012-06-01||||||||Interventional|||Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus|Phase II Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|81|Actual|Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 16:29:07.987752|2017-02-18 16:29:07.987752
NCT00335699|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2007-12-12|||August 2005||2005-08-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome|A 6-Week, Randomised, Open-Label, Parallel Group, Multi-Centre Study to Compare the Efficacy of Rosuvastatin 10mg With Atorvastatin 10mg in the Treatment of Non-Diabetic Metabolic Syndrome Subjects With Raised LDL-C|Completed||Phase 4|370||AstraZeneca|||||f||||||||||||||2017-02-18 16:29:08.078392|2017-02-18 16:29:08.078392
NCT00335686|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2008-02-19|||October 2003||2003-10-01|June 2007|2007-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients|Randomised, Prospective Multicentre Clinical Study on the Effect of the Combination of Lopinavir/Rtv + Nevirapine as Maintenance Bitherapy (Without Nucleoside Analogues) in Comparison With a Triple Therapy Including Lopinavir/Rtv + Nucleoside Analogues in HIV-Infected Patients|Completed||Phase 4|67|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 16:29:08.403104|2017-02-18 16:29:08.403104
NCT00335673|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2011-03-31|||February 2006||2006-02-01|March 2011|2011-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients|Irbesartan in Mild to Moderate Hypertensive Patients|Completed||Phase 4|1630|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:29:08.533119|2017-02-18 16:29:08.533119
NCT00335660|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2008-02-15|||June 2006||2006-06-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity|Terminated||Phase 2|62|Anticipated|Avera Pharmaceuticals||||Animal Safety Data|f||||||||||||||2017-02-18 16:29:08.634876|2017-02-18 16:29:08.634876
NCT00335647|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2013-11-05|||January 2006||2006-01-01|April 2008|2008-04-01||||April 2008|Actual|2008-04-01||Interventional|||Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma|A Phase I/IIa, Open-Label, Dose-Escalation Study to Determine the Safety, Tolerance, and Preliminary Activity of Intravenous High-Dose Fluphenazine HCI in Patients With Advanced Multiple Myeloma|Completed||Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:29:08.745151|2017-02-18 16:29:08.745151
NCT00335634|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2015-12-09|||June 2006||2006-06-01|December 2015|2015-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery|Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery: Steps Towards a Bio-Psychosocial Model of Treatment|Completed||N/A|50|Actual|University Health Network, Toronto|||1||f||||||||||||||2017-02-18 16:29:08.857353|2017-02-18 16:29:08.857353
NCT00335621|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2010-07-27|||June 2006||2006-06-01|May 2006|2006-05-01|December 2007||2007-12-01|||||Interventional|||Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD)|Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable COPD|Withdrawn||Phase 4|45|Anticipated|NHS Greater Glasgow and Clyde||||Study terminated prior to recruitment - recruitment proved impossible|f||||||||||||||2017-02-18 16:29:08.968851|2017-02-18 16:29:08.968851
NCT00335595|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2013-02-19|||July 2006||2006-07-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients|Randomized, Multicenter, Phase III Study, to Evaluate the Efficacy and Safety of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy After Initial Chemotherapy Treatment With Capecitabine, Oxaliplatin and Bevacizumab in Metastatic Colorectal Cancer Patients|Completed||Phase 3|480|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||2|||f||||f||||||||||2017-02-18 16:29:09.079479|2017-02-18 16:29:09.079479
NCT00335582|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2009-10-08|||June 2006||2006-06-01|May 2009|2009-05-01|December 2009|Anticipated|2009-12-01|August 2009|Actual|2009-08-01||Interventional|||EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine)|The EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine) Study: A Randomized, Double-blinded Trial of Clonidine for Reducing Cardiac Morbidity and Mortality Following Non-cardiac Surgery.|Unknown status|Active, not recruiting|Phase 4|165|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 16:29:09.200068|2017-02-18 16:29:09.200068
NCT00335569|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-09|2011-05-31|||August 2005||2005-08-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|||||Interventional|||Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation|A Prospective, Randomized, Controlled Clinical Study on the Assessment of Tolerance and Clinical Equivalence of hCG- IBSA (IBSA) Versus Ovitrelle (Serono), Both Administered Sub-cutaneously in Women Undergoing in Vitro Fertilization (IVF).|Completed||Phase 3|144|Anticipated|IBSA Institut Biochimique SA|||||f||||f||||||||||2017-02-18 16:29:09.300558|2017-02-18 16:29:09.300558
NCT00335556|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-04-14|||June 2006||2006-06-01|April 2016|2016-04-01||||December 2015|Actual|2015-12-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors|Treatment of High Risk Renal Tumors: A Groupwide Phase II Study|Completed||Phase 2|294|Actual|Children's Oncology Group||6|||f||||t||||||||||2017-02-18 16:29:09.4277|2017-02-18 16:29:09.4277
NCT00335543|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2013-08-09|||June 2003||2003-06-01|August 2009|2009-08-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery|Preoperative Chemoradiation in Locally Resectable Adenocarcinoma of Pancreatic Head Without Metastasis|Completed||Phase 2|254|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:29:09.759308|2017-02-18 16:29:09.759308
NCT00335517|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2014-12-03|2012-02-16||June 2006||2006-06-01|December 2012|2012-12-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|DepoDur||Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients|Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients|Completed||N/A|98|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 16:29:10.110052|2017-02-18 16:29:10.110052
NCT00335504|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-12-28|2012-11-26||March 2006||2006-03-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia|Randomized, Phase II Trial of Atorvastatin, RAFTILOSE Synergy 1, and Sulindac Among Patients at Increased Risk for Sporadic Colorectal Neoplasia|Completed||Phase 2|85|Actual|National Cancer Institute (NCI)|Variation in endpoint measurement across sites, relatively small sample size, and rectal biomarker assessments only may have contributed to challenges in full data interpretation.|4|||f||||||||||||||2017-02-18 16:29:10.33808|2017-02-18 16:29:10.33808
NCT00335491|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2011-09-28|||March 2006||2006-03-01|September 2011|2011-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors|A RENEW Intervention for Elderly Cancer Survivors|Completed||N/A|49|Actual|University of Utah||1|||f||||t||||||||||2017-02-18 16:29:11.073253|2017-02-18 16:29:11.073253
NCT00335478|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2015-10-20|2011-06-07||December 2006||2006-12-01|October 2015|2015-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Daptomycin in Treating Neutropenia and Fever in Patients With Cancer|Phase II Open Label Pilot Trial of Empiric Daptomycin Treatment for Oncology Patients With Neutropenic Fever|Completed||Phase 2|54|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 16:29:11.186546|2017-02-18 16:29:11.186546
NCT00335465|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2009-12-04|||September 2005||2005-09-01|December 2009|2009-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Lantus Effect on Myocardial Glucose Metabolism in T2|Pilot Study for the Evaluation of the Effects of Insulin Treatment on Myocardial Function, Perfusion, and Glucose Metabolism in Patients With Primary Left Ventricular Dysfunction and Type 2 Diabetes.|Completed||Phase 4|15|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:29:11.431379|2017-02-18 16:29:11.431379
NCT00335452|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2010-11-09|2010-09-15||June 2006||2006-06-01|November 2010|2010-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|CURRENT/OASIS7||Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS|Randomized, Multinational, Double-blind Study, Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Myocardial Infarction Managed With an Early Invasive Strategy.|Completed||Phase 3|25086|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 16:29:11.549676|2017-02-18 16:29:11.549676
NCT00335439|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-01-12|||June 2006||2006-06-01|January 2016|2016-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effect of Prophylactic Ketorolac on CME After Cataract Surgery|Effect of Prophylactic NSAID Drops on Cystoid Macular Edema After Cataract Surgery Using Optical Coherence Tomography|Completed||N/A|98|Actual|Queen's University|||||f||||||||||||||2017-02-18 16:29:15.73912|2017-02-18 16:29:15.73912
NCT00335426|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2009-08-28|||June 2006||2006-06-01|August 2009|2009-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Influence of Spinal Manipulative Therapy Upon Stroop Task Performance||Completed||N/A|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:29:15.815707|2017-02-18 16:29:15.815707
NCT00335413|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2008-06-04|||June 2006||2006-06-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|||||Interventional|||Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy|Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy|Completed||Phase 4|17|Actual|Steno Diabetes Center|||||f||||||||||||||2017-02-18 16:29:15.896854|2017-02-18 16:29:15.896854
NCT00335400|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2016-01-12|||March 2006||2006-03-01|January 2016|2016-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Anesthetic and Dilating Gel for Cataract Surgery|Comparison of an Anesthetic and Dilating Gel Cocktail Versus the Standard Pre-operative Pharmacologic Regimen for Cataract Surgery on Corneal Anesthesia and Pupil Dilation.|Completed||N/A|20|Anticipated|Queen's University|||||f||||||||||||||2017-02-18 16:29:15.985392|2017-02-18 16:29:15.985392
NCT00335374|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2009-02-05|||August 2007||2007-08-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients|An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients|Completed||Phase 3|202|Actual|Solvay Pharmaceuticals||1|||f||||t||||||||||2017-02-18 16:29:16.083284|2017-02-18 16:29:16.083284
NCT00335361|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2007-04-05|||September 2006||2006-09-01|April 2007|2007-04-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Implantable Device for Male Reproductive Sterilization|The Intra Vas Device (IVD) As A Means of Male Reproductive Sterilization A Single Armed Feasibility Study|Unknown status|Active, not recruiting|Phase 1|90||Shepherd Medical Company|||||f||||||||||||||2017-02-18 16:29:16.505654|2017-02-18 16:29:16.505654
NCT00331292|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2008-10-15|||August 2006||2006-08-01|October 2008|2008-10-01||||||||Observational|||A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients|A Study to Identify a Transcriptomic Profile Indicative of Cycle AMP Pathway Activation in the Lung|Terminated||N/A|30||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:30:48.954462|2017-02-18 16:30:48.954462
NCT00335348|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-01-07|||June 2006||2006-06-01|August 2011|2011-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse|Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse An Australian Myeloma Forum Multi-Centre Phase II Trial|Completed||Phase 2|101|Actual|Peter MacCallum Cancer Centre, Australia||1|||f||||||||||||||2017-02-18 16:29:16.588876|2017-02-18 16:29:16.588876
NCT00335335|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2007-06-28|||May 2006||2006-05-01|June 2007|2007-06-01||||||||Interventional|||Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast–Enhanced CT Angiography of Arteries of the Heart||Completed||Phase 3|540||GE Healthcare|||||||||||||||||||2017-02-18 16:29:16.688866|2017-02-18 16:29:16.688866
NCT00335322|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2012-04-17|2012-04-17||February 2007||2007-02-01|April 2012|2012-04-01|November 2011|Actual|2011-11-01|March 2011|Actual|2011-03-01||Interventional|||ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens|A Randomised, Open-label, 96-week Study Comparing the Safety and Efficacy of Three Different Combination Antiretroviral Regimens as Initial Therapy for HIV Infection.|Completed||Phase 4|329|Actual|Kirby Institute|Inadequate sample size for true comparison of non-inferiority|3|||f||||t||||||||||2017-02-18 16:29:16.774144|2017-02-18 16:29:16.774144
NCT00335309|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2013-10-06|||October 2005||2005-10-01|October 2013|2013-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Maxillary Sinus Irrigation in the Management of Chronic Rhinosinusitis|Effectiveness of Maxillary Sinus Saline Irrigation in Conjunction With Systemic Antibiotic Therapy Versus Systemic Antibiotic Therapy Alone in the Management of Chronic Rhinosinusitis, a Prospective Randomized Controlled Trial|Completed||N/A|50|Actual|Carmel Medical Center||2|||f||||t||||||||||2017-02-18 16:29:17.497884|2017-02-18 16:29:17.497884
NCT00335296|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2007-12-18|||May 2006||2006-05-01|December 2007|2007-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|||PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)|The Paradigm IIca/III Trial: PFx Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness|Suspended||N/A|100|Anticipated|Cierra|||||f||||||||||||||2017-02-18 16:29:17.613311|2017-02-18 16:29:17.613311
NCT00335283|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2012-07-17|2011-03-28||August 2006||2006-08-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PND||Efficacy of Lansoprazole in Chronic Post Nasal Drip|Randomized Placebo-Controlled Trial of BID Lansoprazole in Isolated Chronic Post Nasal Drip|Completed||Phase 3|75|Actual|Vanderbilt University|Sample size of 75 participants is small. Lack of an objective measure of postnasal drainage limited the study outcome to be symptom based.|2|||f||||f||||||||||2017-02-18 16:29:17.72134|2017-02-18 16:29:17.72134
NCT00335270|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-05-13|||March 2006||2006-03-01|May 2013|2013-05-01|December 2007||2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination|A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination|Completed||Phase 4|100||Duke University|||||f||||||||||||||2017-02-18 16:29:18.215621|2017-02-18 16:29:18.215621
NCT00335257|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2014-11-14|2014-11-06||August 2005||2005-08-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|January 2013|Actual|2013-01-01||Observational|||International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)|International Active Surveillance Study of Women Taking Oral Contraceptives (INAS OC)|Completed||Phase 4|85109|Actual|Center for Epidemiology and Health Research, Germany|In non-experimental studies the possibility of bias and residual confounding can never be entirely eliminated. The findings may exclude large, but not small relative risks.||2||f||||t||||||||||2017-02-18 16:29:18.336393|2017-02-18 16:29:18.336393
NCT00335244|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2015-01-26||2013-05-21|May 2006||2006-05-01|January 2015|2015-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery|A Phase III Single-Blind, Randomized, Placebo Controlled, Clinical Trial to Determine the Safety and Efficacy of Intravenous L-Citrulline Versus Placebo in Children Undergoing Cardiopulmonary Bypass|Completed||Phase 3|77|Actual|Asklepion Pharmaceuticals, LLC||2|||f||||t||||||||||2017-02-18 16:29:19.143323|2017-02-18 16:29:19.143323
NCT00335231|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2007-05-17|||June 2006||2006-06-01|May 2006|2006-05-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery|The Effect of Preoperative Topical Gatifloxacin on Anterior Chamber Sample Cultures After Cataract Surgery.|Suspended||N/A|30|Anticipated|Queen's University||||Protocol changes underway.|f||||||||||||||2017-02-18 16:29:19.253024|2017-02-18 16:29:19.253024
NCT00335218|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2014-12-29|||July 2002||2002-07-01|December 2014|2014-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Fat Distribution in Healthy Early Postmenopausal Women|A Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled, Two-arm, Phase IV Study to Investigate the Influence of a Continuous Combined Estrogen-progestin Regimen Containing 2 mg Estradiol Valerate and 2 mg Dienogest (Climodien® / Lafamme®) on the Fat Distribution in Otherwise Healthy Early Postmenopausal Women|Completed||Phase 4|67|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:29:19.33498|2017-02-18 16:29:19.33498
NCT00335205|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2006-06-08|||April 2003||2003-04-01|June 2006|2006-06-01||||||||Interventional|||A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.|A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression.|Unknown status|Recruiting|Phase 4|60||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:29:19.440655|2017-02-18 16:29:19.440655
NCT00335192|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2008-09-05|||January 2005||2005-01-01|September 2008|2008-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir|Determination of Plasma and Intracellular Levels of Nucleoside Reverse Transcriptase Inhibitors (NRTI) and of Nucleotide Analog Tenofovir Disoproxil Fumarate (TDF) in Patients Treated With Abacavir and/or Lamivudine Given With or Without TDF.|Completed||Phase 4|32|Actual|Germans Trias i Pujol Hospital||3|||f||||f||||||||||2017-02-18 16:29:19.536637|2017-02-18 16:29:19.536637
NCT00335179|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2010-07-22|||January 2003||2003-01-01|July 2010|2010-07-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream|Double-Blind, Vehicle-Controlled Study to Evaluate Cellular and Molecular Events During Four Weeks of Treatment for Actinic Keratosis With Aldara (Imiquimod) Cream, 5%|Completed||Phase 2|17|Actual|Graceway Pharmaceuticals, LLC||2|||f||||f||||||||||2017-02-18 16:29:19.641217|2017-02-18 16:29:19.641217
NCT00335166|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2008-04-01|||November 2006||2006-11-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease|A Multicenter, Randomized, Double Blind, Parallel-Group Placebo and Pramipexole Controlled Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients With Early Stage Parkinson's Disease.|Completed||Phase 3|330|Anticipated|Solvay Pharmaceuticals||3|||f||||t||||||||||2017-02-18 16:29:19.860836|2017-02-18 16:29:19.860836
NCT00335153|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-08|2015-01-12|2015-01-12||January 2008||2008-01-01|January 2015|2015-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease|An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications|Completed||Phase 3|354|Actual|AbbVie||1|||f||||t||||||||||2017-02-18 16:29:20.061194|2017-02-18 16:29:20.061194
NCT00335140|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2012-07-11|||December 2006||2006-12-01|February 2010|2010-02-01||||June 2016|Anticipated|2016-06-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma|Phase II Study of Rituximab Given in Conjunction With Standard Chemotherapy in Primary Central Nervous System (CNS) Lymphoma|Suspended||Phase 2|43|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:29:21.313218|2017-02-18 16:29:21.313218
NCT00335114|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2006-06-08|||November 2005||2005-11-01|June 2006|2006-06-01|April 2006||2006-04-01|||||Interventional|||Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers|Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers|Completed||N/A|40||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 16:29:21.618442|2017-02-18 16:29:21.618442
NCT00335101|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2007-05-14|||June 2006||2006-06-01|May 2007|2007-05-01||||||||Interventional|||Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography||Terminated||Phase 4|384||GE Healthcare|||||f||||||||||||||2017-02-18 16:29:21.710893|2017-02-18 16:29:21.710893
NCT00335088|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2007-05-31|||June 2006||2006-06-01|March 2007|2007-03-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations||Unknown status|Recruiting|Phase 3|500|Anticipated|HaEmek Medical Center, Israel|||||f||||f||||||||||2017-02-18 16:29:21.799168|2017-02-18 16:29:21.799168
NCT00335075|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2015-04-08|||March 2005||2005-03-01|April 2015|2015-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)|A Multicenter, Open-Label, Randomized, Active-Controlled Parallel Groups Study Comparing the Efficacy and Safety of Temodal vs Semustine in the Treatment of Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma|Completed||Phase 3|151|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:29:21.894313|2017-02-18 16:29:21.894313
NCT00335062|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2014-07-24|||August 2005||2005-08-01|July 2014|2014-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||TSH Receptor Antibody Heterogeneity in Children and Adolescents With Graves' Disease|TSH Receptor Antibody Heterogeneity in Children and Adolescents With Graves' Disease|Completed||Phase 1|19|Actual|Boston Children’s Hospital|||1||f||||t||||||Samples With DNA|"~     whole blood, serum, white cells.~   "|||2017-02-18 16:29:21.981398|2017-02-18 16:29:21.981398
NCT00335049|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2010-10-07|||December 2006||2006-12-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Study of Theories About Myopia Progression (STAMP)|Study of Theories About Myopia Progression (STAMP)|Completed||N/A|85|Actual|Ohio State University||2|||f||||t||||||||||2017-02-18 16:29:22.07164|2017-02-18 16:29:22.07164
NCT00335036|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2009-08-03|||June 2006||2006-06-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pediatric Lead Extractability and Survival Evaluation (PLEASE)|Pediatric Lead Extractability and Survival Evaluation (PLEASE)Study: A Prospective Assessment of Implantable Cardioverter Defibrillator (ICD) Lead Extractability and Survival in Children and Congenital Heart Disease Patients|Terminated||Phase 4|55|Actual|Boston Children’s Hospital||2||Lead was recalled and manufacturing halted|f||||t||||||||||2017-02-18 16:29:22.184878|2017-02-18 16:29:22.184878
NCT00335023|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2011-07-19|||May 2004||2004-05-01|July 2011|2011-07-01||||March 2011|Actual|2011-03-01||Interventional|WOMB||Well Being of Obstetric Patients on Minimal Blood Transfusions|Well Being of Obstetric Patients on Minimal Blood Transfusions|Completed||Phase 4|500|Actual|Sanquin Research & Blood Bank Divisions||2|||f||||f||||||||||2017-02-18 16:29:22.28335|2017-02-18 16:29:22.28335
NCT00335010|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2006-06-07|||May 2005||2005-05-01|June 2006|2006-06-01|December 2005||2005-12-01|||||Interventional|||Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction|A Prospective Double Blinded Study on the Effect of Intravenously Administrated Nitroglycerine on Gastric Tissue Microvascular Bloodflow and Microvascular Hemoglobin Saturation During Gastric Tube Reconstruction|Completed||N/A|32||Erasmus Medical Center|||||f||||||||||||||2017-02-18 16:29:22.379803|2017-02-18 16:29:22.379803
NCT00334997|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-12-18|||September 2005||2005-09-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis|Early Stage Glottic Cancer: Endoscopic Excision or Radiotherapy [EaStER]|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:29:22.474843|2017-02-18 16:29:22.474843
NCT00334984|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-07-09|||January 2007||2007-01-01|July 2013|2013-07-01||||||||Interventional|||Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma|Prevention of Mucositis in Children With AES-14 (IND#36978), a Glutamine Based Oral Care Regimen, for Patients Diagnosed With Solid Tumors: A Randomized Placebo-Controlled Clinical Study|Withdrawn||N/A|0|Actual|Children's Oncology Group||||Withdrawn due to inability to reach an acceptable agreement with industry sponsor|||||||||||||||2017-02-18 16:29:22.752693|2017-02-18 16:29:22.752693
NCT00334971|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-11-05|||September 2004||2004-09-01|November 2013|2013-11-01|January 2018|Anticipated|2018-01-01|January 2012|Actual|2012-01-01||Interventional|||Aromatase Activity and Ovarian Growth Factors in African-American Versus Caucasian Women|Aromatase Activity and Ovarian Growth Factors in Preovulatory Follicles|Active, not recruiting||N/A|116|Anticipated|Massachusetts General Hospital||4|||f||||t||||||||||2017-02-18 16:29:22.844242|2017-02-18 16:29:22.844242
NCT00005533|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-07-14|||February 1997||1997-02-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Hostility, Depression, Social Environment and CHD Risk|Hostility, Depression, Social Environment and CHD Risk|Completed||N/A|592|Actual|Duke University|||1||f||||||||||||||2017-02-18 18:14:48.513336|2017-02-18 18:14:48.513336
NCT00334958|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-01-02|2012-04-16||February 2006||2006-02-01|January 2013|2013-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures|A Double-Blind, Placebo-Controlled, Parallel-Group Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures|Completed||Phase 3|356|Actual|Eisai Inc.||2|||f||||f||||||||||2017-02-18 16:29:22.980617|2017-02-18 16:29:22.980617
NCT00334945|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2011-11-11|||April 2006||2006-04-01|November 2011|2011-11-01|August 2011|Actual|2011-08-01|June 2010|Actual|2010-06-01||Observational|||Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent|Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23 (a Known Phosphaturic Agent)|Completed||N/A|35|Actual|University of Alabama at Birmingham|||2||f||||f||||||||||2017-02-18 16:29:23.692087|2017-02-18 16:29:23.692087
NCT00334932|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2014-01-09|||February 2006||2006-02-01|August 2008|2008-08-01||||January 2010|Anticipated|2010-01-01||Interventional|||Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma|Phase I/II Study of Liposomal Doxorubicin (Doxil®)/ Melphalan/Bortezomib (Velcade®) in Relapsed/Refractory Multiple Myeloma|Unknown status|Recruiting|Phase 1/Phase 2|32|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:29:23.790021|2017-02-18 16:29:23.790021
NCT00334919|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2010-06-23|||May 2006||2006-05-01|May 2009|2009-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||RCT of the Naturopathic Anti-Inflammatory Diet|Randomized Clinical Trial of the Naturopathic Anti-Inflammatory Diet|Completed||Phase 2|30|Actual|National College of Natural Medicine||1|||f||||t||||||||||2017-02-18 16:29:23.897931|2017-02-18 16:29:23.897931
NCT00334906|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2008-01-03|||July 2005||2005-07-01|January 2008|2008-01-01||||November 2007|Actual|2007-11-01||Interventional|||Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)|An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI and Cognition in Patients With Moderate Dementia of the Alzheimer's Type|Completed||Phase 4|75||Forest Laboratories|||||||||||||||||||2017-02-18 16:29:24.005163|2017-02-18 16:29:24.005163
NCT00334893|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2014-04-29|2013-10-16||April 2006||2006-04-01|December 2011|2011-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer|A Multi-Center Phase II Study of the Halichondrin B Analog E7389 in Recurrent Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer|Completed||Phase 2|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:29:24.095913|2017-02-18 16:29:24.095913
NCT00334880|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2009-07-01|||May 2006||2006-05-01|July 2009|2009-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|A Phase III, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Parallel-Group, Forced Dose Titration, Safety and Efficacy Study of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|420|Actual|New River Pharmaceuticals||4|||f||||f||||||||||2017-02-18 16:29:24.524646|2017-02-18 16:29:24.524646
NCT00334867|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-06-27|||December 2005||2005-12-01|June 2013|2013-06-01||||January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma|A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma|Withdrawn||Phase 3|0|Actual|Children's Oncology Group||2||withdrawn|f||||||||||||||2017-02-18 16:29:24.776253|2017-02-18 16:29:24.776253
NCT00334854|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-08-09|||March 2006||2006-03-01|July 2009|2009-07-01||||May 2010|Anticipated|2010-05-01||Interventional|||Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma|Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas|Unknown status|Recruiting|Phase 3|250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:29:24.893532|2017-02-18 16:29:24.893532
NCT00334841|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2007-11-05|||July 2006||2006-07-01|May 2006|2006-05-01||||||||Observational|||Leptin and Cytokines in Diabetic Pregnancy - Physiologic or Pathogenic Role|Leptin and Cytokines in Diabetic Pregnancy - Physiologic or Pathogenic Role|Unknown status|Recruiting|N/A|30|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:29:25.024493|2017-02-18 16:29:25.024493
NCT00334828|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2014-06-30||2013-05-21|June 2006||2006-06-01|January 2013|2013-01-01||||January 2011|Actual|2011-01-01||Interventional|||ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis|ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis|Completed||Phase 3|2000|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:29:25.098962|2017-02-18 16:29:25.098962
NCT00334815|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2016-11-01|2015-09-22||June 2006||2006-06-01|November 2016|2016-11-01||||July 2014|Actual|2014-07-01||Interventional||All eligible patients who received protocol treatment.|Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery|A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Addition of Bevacizumab (NSC-704865) in Three Cohorts of Patients With Inoperable Locally Advanced Stage III Non-small Cell Lung Cancer|Active, not recruiting||N/A|29|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 16:29:28.150672|2017-02-18 16:29:28.150672
NCT00334802|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2010-03-10|2009-05-29||June 2006||2006-06-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|February 2008|Actual|2008-02-01||Interventional|||Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer|Combination Study of LY188011 and Paclitaxel in Patients With Metastatic/Recurrent Breast Cancer After Neo-adjuvant/Adjuvant Chemotherapy With Anthracycline|Completed||Phase 2|62|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 16:29:29.215999|2017-02-18 16:29:29.215999
NCT00334789|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2016-12-26|||June 2006||2006-06-01|December 2016|2016-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery|A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies|Active, not recruiting||Phase 1|42|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:29:30.149266|2017-02-18 16:29:30.149266
NCT00334191|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2009-07-06|||June 2006||2006-06-01|July 2009|2009-07-01|June 2006||2006-06-01|||||Interventional|||Sodium Bicarbonate in Cardiac Surgery|A Randomised, Double Blind, Placebo Controlled Pilot Study of the Effect of Sodium Bicarbonate on Postoperative Renal Function and Oxidative Stress in Patients Undergoing Elective Cardiopulmonary Bypass.|Completed||Phase 2|100||Austin Health|||||f||||||||||||||2017-02-18 16:29:37.586743|2017-02-18 16:29:37.586743
NCT00334776|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2014-05-19|||October 2003||2003-10-01|May 2014|2014-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|A Phase II Trial of an Intradermally Administered MART-1gp100/Tyrosinase Peptide-Pulsed Dendritic Cell Vaccine Matured With a Cytokine Cocktail for Patients With Metastatic Melanoma|Completed||Phase 2|6|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 16:29:30.264109|2017-02-18 16:29:30.264109
NCT00334763|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2012-07-09|||May 2006||2006-05-01|July 2012|2012-07-01|November 2007|Actual|2007-11-01|May 2007|Actual|2007-05-01||Interventional|||Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Radiation Followed by Paclitaxel, Carboplatin, and Bevacizumab (PCA) in Patients With Stage IIIB and IV Squamous Non-Small Cell Lung Cancer|Terminated||Phase 2|32|Anticipated|Northwestern University||1||Principal Investigator felt risk to patients was too high.|||||||||||||||2017-02-18 16:29:30.365049|2017-02-18 16:29:30.365049
NCT00334750|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2010-09-08|||November 2007||2007-11-01|September 2010|2010-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada|Distribution of Risk Factors Amongst Ocular Hypertension and Open-Angle Glaucoma Patients in Canada|Completed||N/A|410|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 16:29:30.704987|2017-02-18 16:29:30.704987
NCT00334737|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-11-06|||June 2006||2006-06-01|September 2013|2013-09-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Darbepoetin Administration to Preterm Infants|A Randomized, Masked, Placebo Controlled Study to Assess the Safety and Efficacy of Darbepoetin Alfa Administered to Preterm Infants|Unknown status|Active, not recruiting|Phase 2|102|Actual|University of New Mexico||3|||f||||t||||||||||2017-02-18 16:29:30.839572|2017-02-18 16:29:30.839572
NCT00334724|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2015-12-28|||October 2006||2006-10-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study|Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study|Withdrawn||Phase 4|0|Actual|Kyoto University, Graduate School of Medicine||2||Patients were not appropriately enrolled|f||||t||||||||||2017-02-18 16:29:30.961912|2017-02-18 16:29:30.961912
NCT00334711|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2006-11-28|||January 2004||2004-01-01|June 2006|2006-06-01|January 2006||2006-01-01|||||Interventional|||Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations|A Prospective Study of Sulfonylureas in Patients With Diabetes Due to Kir6.2 Mutations|Completed||N/A|50||Royal Devon and Exeter NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:29:31.06819|2017-02-18 16:29:31.06819
NCT00334698|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2010-02-02|||July 2006||2006-07-01|May 2007|2007-05-01|September 2006|Actual|2006-09-01|||||Interventional|||Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis|A Randomized, Double Blind, Placebo-controlled, Four Way Cross-over Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms Scores and Rhinomanometry in Patients With Allergic Rhinitis Following Pollen Exposure in the Fraunhofer Environmental Challenge Chamber (ECC)|Completed||N/A|51|Anticipated|Fraunhofer-Institute of Toxicology and Experimental Medicine|||||f||||||||||||||2017-02-18 16:29:31.151206|2017-02-18 16:29:31.151206
NCT00334685|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2008-07-15|||July 2006||2006-07-01|July 2008|2008-07-01||||||||Interventional|||[S,S]-Reboxetine Add-On Trial|[S,S]-Reboxetine Add-On Trial: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN) Concomitantly Treated With Pregabalin.|Terminated||Phase 2|354||Pfizer||||The DMC terminated the study on the basis of futility (insufficient clinical response).|f||||t||||||||||2017-02-18 16:29:31.233101|2017-02-18 16:29:31.233101
NCT00334672|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-09-16|||March 2006||2006-03-01|June 2009|2009-06-01||||November 2010|Anticipated|2010-11-01||Interventional|||Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis|Hemophagocytic Lymphohistiocytosis|Unknown status|Active, not recruiting|Phase 3|288|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:29:31.413993|2017-02-18 16:29:31.413993
NCT00334659|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2011-06-21|||June 2006||2006-06-01|June 2011|2011-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects|A Double-blind, Placebo-controlled, Positive Controlled, Randomized, Crossover Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects|Completed||Phase 1|37|Actual|Avexa||1|||f||||f||||||||||2017-02-18 16:29:31.530717|2017-02-18 16:29:31.530717
NCT00334646|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2012-07-26|||August 2005||2005-08-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Cyclophosphamide Drug Interaction Study In Cancer Patients|An Open Label, Repeat Dose, Randomized, Two Period Crossover Study to Investigate the Potential Pharmacokinetic Interactions Between Oral GW679769 and Intravenous Cyclophosphamide in Cancer Patients|Terminated||Phase 1|10|Actual|GlaxoSmithKline||2||compound terminated|f||||||||||||||2017-02-18 16:29:31.620044|2017-02-18 16:29:31.620044
NCT00334633|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2011-05-24|2011-03-03||November 2004||2004-11-01|February 2011|2011-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Treatment of Bacterial Vaginosis (BV) With Tinidazole|Tinidazole for the Treatment of Bacterial Vaginosis|Completed||Phase 4|593|Actual|University of Alabama at Birmingham||3|||f||||||||||||||2017-02-18 16:29:31.732728|2017-02-18 16:29:31.732728
NCT00334620|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2006-06-07|||July 1998||1998-07-01|November 2005|2005-11-01|May 2005||2005-05-01|||||Interventional|||Effectiveness of Radon Spa Therapy in Multimodal Rehabilitative Treatment of Rheumatoid Arthritis||Completed||Phase 4|140||Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster|||||f||||||||||||||2017-02-18 16:29:32.196223|2017-02-18 16:29:32.196223
NCT00334607|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2016-11-02|||June 2006||2006-06-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|||Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA|Assess the Immunogenicity of 3 Doses of Pediarix®, Prevnar® & ActHIB® Given to Healthy Infants When Administered With GSK Biologicals' 2 Dose Oral Live Attenuated Human Rotavirus Vaccine Given During the Same Vaccination Visit or Separately|Completed||Phase 3|484|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:29:32.292373|2017-02-18 16:29:32.292373
NCT00005532|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-06|||May 1996||1996-05-01|January 2016|2016-01-01|August 2005||2005-08-01|||||Observational|||Dietary Fat, Plasma Lipids, and Other CHD Risk Factors||Completed||N/A|||Tufts University|||||f||||||||||||||2017-02-18 18:14:48.597288|2017-02-18 18:14:48.597288
NCT00334594|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2015-03-10|||November 2005||2005-11-01|March 2015|2015-03-01|June 2018|Anticipated|2018-06-01|December 2013|Actual|2013-12-01||Interventional|||Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma|Neoadjuvant Chemotherapy and Extrapleural Pneumonectomy of Malignant Pleural Mesothelioma (MPM) With or Without Hemithoracic Radiotherapy. A Randomized Multicenter Phase II Trial|Terminated||Phase 2|153|Actual|Swiss Group for Clinical Cancer Research||2||"1. Lower accrual due to new less extensive suregery techniques.~      2. Patients exposed to asbestos increases in age leading to a lower accrual rate."|f||||f||||||||||2017-02-18 16:29:32.523196|2017-02-18 16:29:32.523196
NCT00334581|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2009-09-14|||May 2006||2006-05-01|September 2009|2009-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria|A Study of Irbesartan 150mg Verses 300mg in Chinese Hypertensive Patients With Diabetes and Microalbuminuria|Completed||Phase 4|192|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:29:32.645082|2017-02-18 16:29:32.645082
NCT00334568|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2013-01-10|||December 2004||2004-12-01|January 2013|2013-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease|A Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilisation and Cognition in Subjects With Mild to Moderate Alzheimers Disease (AD)|Terminated||Phase 2|12|Actual|GlaxoSmithKline||2||Slow recruitment|f||||||||||||||2017-02-18 16:29:32.740684|2017-02-18 16:29:32.740684
NCT00334555|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2009-08-11|||May 2003||2003-05-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Control of Trichomoniasis|Control of Trichomoniasis - A Paradigm for STD Control|Completed||N/A|599|Actual|University of Alabama at Birmingham||3|||f||||||||||||||2017-02-18 16:29:33.015019|2017-02-18 16:29:33.015019
NCT00334542|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2013-07-03|2013-03-18||March 2006||2006-03-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|June 2009|Actual|2009-06-01||Interventional|||Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer|A Phase II Study of Simvastatin in Women at High Risk for a New Breast Cancer|Completed||Phase 2|50|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:29:33.14752|2017-02-18 16:29:33.14752
NCT00334529|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2017-01-24|||June 5, 2006||2006-06-05|September 23, 2009|2009-09-23|April 10, 2007|Actual|2007-04-10|April 10, 2007|Actual|2007-04-10||Interventional|||Alternative Oseltamivir Dosing Strategies|Evaluation of Alternative Oseltamivir (Tamiflu[R]) Dosing Strategies for Use During Influenza Prophylaxis|Completed||Phase 2|48||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:29:33.389764|2017-02-18 16:29:33.389764
NCT00334516|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-07|2017-01-24|||June 6, 2006||2006-06-06|August 3, 2015|2015-08-03|August 3, 2015||2015-08-03|||||Observational|||Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis|Cortical Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis|Completed||N/A|77|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:29:33.496591|2017-02-18 16:29:33.496591
NCT00334503|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2008-10-08||||||October 2008|2008-10-01||||||||Interventional|||Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 16:29:33.587124|2017-02-18 16:29:33.587124
NCT00334490|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2015-07-30|||March 2005||2005-03-01|July 2015|2015-07-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?|A Phase II, Double Blind Randomized Controlled Trial to Determine the Safety and Efficacy of 12.5mg of Oral Sildenafil (Viagra) Compared to Placebo to Decrease Pulmonary Hypertension in Cardiac Patients After Cardiopulmonary Bypass|Completed||Phase 2|40|Actual|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-02-18 16:29:33.685956|2017-02-18 16:29:33.685956
NCT00334477|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2006-06-06||||||April 2006|2006-04-01||||||||Interventional|||Efficacy and Safety of Tadalafil in Hemodialysis Patients|Efficacy and Safety of Tadalafil 20mg for the Treatment of Erectile Dysfunction in Chronic Renal Patients in Hemodialysis.|Unknown status|Not yet recruiting|Phase 2|60||University of Pernambuco|||||f||||||||||||||2017-02-18 16:29:33.801606|2017-02-18 16:29:33.801606
NCT00334464|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2008-08-20|||February 2006||2006-02-01|August 2008|2008-08-01|November 2007|Actual|2007-11-01|||||Interventional|||"A Pharmacogenetic Study of Warfarin Dosing, The COUMA-GEN Study"|A Controlled Clinical Pharmacogenetic Study of a CYP2C9 Plus VKORC1 Polymorphism-Based Individualized Dosing Algorithm for Warfarin to Increase Efficiency of Achieving Therapeutic Dosing|Completed||N/A|200|Anticipated|Intermountain Health Care, Inc.|||||f||||||||||||||2017-02-18 16:29:33.906731|2017-02-18 16:29:33.906731
NCT00334451|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2014-02-20|||May 2006||2006-05-01|February 2014|2014-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||RAPID-RF: Remote Active Monitoring in Patients With Heart Failure|Remote Active Monitoring in Patients With Heart Failure|Completed||Phase 4|891|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-02-18 16:29:34.010123|2017-02-18 16:29:34.010123
NCT00334438|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2016-12-22|||July 2006||2006-07-01|December 2016|2016-12-01|October 2011|Actual|2011-10-01|October 2008|Actual|2008-10-01||Interventional|||Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma|A Phase I Study Evaluating Combined Zevalin (Ibritumomab Tiuxetan) and Valcade (Bortezomib) in Relapsed/Refractory Low-Grade or Follicular B-Cell and Mantle Cell Lymphoma|Completed||Phase 1|12|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:29:34.094917|2017-02-18 16:29:34.094917
NCT00334425|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2006-06-09|||April 2006||2006-04-01|June 2006|2006-06-01||||||||Interventional|||The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.|The Effect of LH-Priming During Early Follicular Phase on Ovarian Response and Pregnancy Outcome in GnRHa Down-Regulated Women, Stimulated With Exogenous Gonadotrophins in IVF Treatment|Unknown status|Recruiting|Phase 4|150||Central Jutland Regional Hospital|||||f||||||||||||||2017-02-18 16:29:34.216056|2017-02-18 16:29:34.216056
NCT00334412|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2015-07-07|||March 2004||2004-03-01|July 2015|2015-07-01|May 2006||2006-05-01|||||Interventional|||COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis|AmBisome® in Combination With Caspofungin Versus AmBisome® High Dose Regimen for the Treatment of Invasive Aspergillosis in Immunocompromized Patients: Randomized Pilot Study.|Completed||Phase 4|30||Gilead Sciences|||||f||||||||||||||2017-02-18 16:29:34.298406|2017-02-18 16:29:34.298406
NCT00334399|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2008-10-08||||||October 2008|2008-10-01||||||||Interventional|||Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 16:29:34.385912|2017-02-18 16:29:34.385912
NCT00334386|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2015-03-05|||April 2005||2005-04-01|March 2015|2015-03-01|February 2006||2006-02-01|||||Interventional|||Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.|Multicentre, Multinational, Parallel, Randomised, Double Blind Clinical Trial, to Evaluate the Non-inferiority of PR Torasemide Versus IR Torasemide in Patients With Mild or Moderate Arterial Hypertension.|Completed||Phase 4|388||Ferrer Internacional S.A.|||||f||||||||||||||2017-02-18 16:29:34.476776|2017-02-18 16:29:34.476776
NCT00334373|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2015-05-26|||June 2006||2006-06-01|May 2015|2015-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Post Conditioning in PCI for Acute ST Elevation Myocardial Infarction|Post Conditioning in PCI for Acute ST Elevation Myocardial Infarction|Completed||Phase 4|102|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 16:29:34.580068|2017-02-18 16:29:34.580068
NCT00334360|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2016-06-27|||September 2004||2004-09-01|June 2016|2016-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Dexmed/Buspirone Synergism on Shivering|Do Dexmedetomidine and Buspirone Synergistically Reduce the Threshold, Gain, and Maximum Intensity of Shivering?|Completed||Phase 4|8|Actual|The Cleveland Clinic||4|||f||||f||||||||||2017-02-18 16:29:34.691598|2017-02-18 16:29:34.691598
NCT00334347|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2007-12-03|||June 2006||2006-06-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR|A Comparison Study of the Efficacy and Tolerability Between Depakote ER and Depakote in the Acute Treatment of Mania and Mixed Mania|Completed||Phase 4|5|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:29:34.804822|2017-02-18 16:29:34.804822
NCT00334334|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2016-11-03|||June 2006||2006-06-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.|To Assess Safety, Reactogenicity and Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine, When Co-administered With DTPa-combined Vaccines and MenC or Hib-MenC Vaccines During the First 6 Months of Age.|Completed||Phase 3|1572|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:29:34.921039|2017-02-18 16:29:34.921039
NCT00334321|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2015-10-01|||April 2006||2006-04-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|April 2011|Actual|2011-04-01||Interventional|||Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients|Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Endometrial Cancer Patients|Completed||Phase 1|65|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 16:29:35.082127|2017-02-18 16:29:35.082127
NCT00334308|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2009-01-16||||||January 2009|2009-01-01||||||||Interventional|||Barley Protein and CVD|Barley Protein and Coronary Heart Disease Risk Reduction|Completed||Phase 2|40|Anticipated|University of Toronto|||||f||||||||||||||2017-02-18 16:29:35.189574|2017-02-18 16:29:35.189574
NCT00334295|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2012-06-11|2012-01-11||December 2002||2002-12-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.|An Open, Non-randomised Multicentre Phase II Study to Assess the Efficacy and Tolerability of a 250 mg Monthly Dose of i.m. Applied Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.|Completed||Phase 2|35|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:29:35.275175|2017-02-18 16:29:35.275175
NCT00334282|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2016-01-11|2009-11-19||April 2006||2006-04-01|August 2015|2015-08-01|December 2014|Actual|2014-12-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma|A Randomised, Double-blind, Placebo Controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients With Locally Advanced and/or Metastatic Renal Cell Carcinoma|Completed||Phase 3|435|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 16:29:35.640281|2017-02-18 16:29:35.640281
NCT00334269|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2009-09-27|||May 2004||2004-05-01|September 2009|2009-09-01|December 2005||2005-12-01|||||Interventional|||Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Action Toward Obesity Prevention (SHARE-AP Action)|Study of Health Assessment and Risk Evaluation (SHARE) in Aboriginal Peoples (AP) Action Toward Obesity Prevention (SHARE-AP Action)|Completed||N/A|174||Population Health Research Institute|||||f||||||||||||||2017-02-18 16:29:36.855005|2017-02-18 16:29:36.855005
NCT00334256|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2011-12-02|||October 2006||2006-10-01|December 2011|2011-12-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|TEmAA||Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)|Phase II Trial, Multicentre, Opened Label Evaluating the Pharmacokinetics and the Safety and Toxicity of the Tenofovir-Emtricitabine Combination in Pregnant Women and Infants in Africa and Asia|Completed||Phase 2|72|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-02-18 16:29:36.95933|2017-02-18 16:29:36.95933
NCT00334243|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2011-10-05|||June 2006||2006-06-01|October 2011|2011-10-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||Protocols for Improved in Vitro Fertilization (IVF) Outcomes|Protocol Evaluation for Improved In Vitro Fertilization Outcomes|Terminated||Phase 4|2|Actual|University of California, San Francisco||1||"stopped due to limited enrollment. 2 subjects were enrolled. There was NO enrollment after~   November 2007."|f||||t||||||||||2017-02-18 16:29:37.077516|2017-02-18 16:29:37.077516
NCT00334230|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-06|2017-01-24|||June 2, 2006||2006-06-02|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Gait Training and Brain Changes in Stroke Patients|Mechanisms of Training Induced Improvements in Gait Function After Stroke|Completed||N/A|58||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:29:37.175259|2017-02-18 16:29:37.175259
NCT00334217|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2009-06-17|||August 2005||2005-08-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|August 2007|Actual|2007-08-01||Interventional|||Cognitive Remediation in Early Substance Abuse Treatment|Cognitive Remediation in the Initial Phase of Substance Abuse Treatment: Feasibility and Efficacy|Terminated||N/A|40|Anticipated|VA Office of Research and Development||2||"The intervention could not be successfully carried out in the SADP setting because of issues~   independent of the cognitive training intervention."|f||||||||||||||2017-02-18 16:29:37.255344|2017-02-18 16:29:37.255344
NCT00334204|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2013-06-26|2013-04-11||August 2004||2004-08-01|June 2013|2013-06-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?|Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?|Terminated||Phase 4|58|Actual|University of Mississippi Medical Center|Early termination leading to lesser-than-planned numbers of subjects analyzed|1||run out of independent funding|f||||f||||||||||2017-02-18 16:29:37.361409|2017-02-18 16:29:37.361409
NCT00334178|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2007-09-06|||November 2004||2004-11-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine|A Multi-Center, Randomized, Parallel, Double-Blind, Placebo-Controlled Study in Evaluation the Efficacy and Safety of Laxymig® ER as Prophylactic Treatment in Patients With Migraine|Completed||Phase 3|74|Actual|Lotus Pharmaceutical|||||f||||f||||||||||2017-02-18 16:29:37.681773|2017-02-18 16:29:37.681773
NCT00334165|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-03|2011-02-25|||June 2005||2005-06-01|February 2011|2011-02-01|June 2008||2008-06-01|March 2007|Actual|2007-03-01||Interventional|||Auricular Acupuncture for Analgesia During Total Hip Arthroplasty|Auricular Acupuncture (AA) vs. Sham Acupuncture for Complementary Analgesia During Elective Total Hip Arthroplasty: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|360|Anticipated|University Medicine Greifswald|||||f||||||||||||||2017-02-18 16:29:37.784346|2017-02-18 16:29:37.784346
NCT00334152|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2016-10-24|||March 2006||2006-03-01|October 2016|2016-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women|A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis|Completed||Phase 3|515|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:29:37.862268|2017-02-18 16:29:37.862268
NCT00334139|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2017-02-03|||May 2006|Actual|2006-05-01|February 2017|2017-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer|A Prospective, Single-arm Multicenter Study to Evaluate Effect of Intravenous Zoledronic Acid on Bone Metabolism Given Over 4 Months in Patients With Prostate Cancer or Breast Cancer and Bone Metastasis|Completed||Phase 4|411|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:29:38.013987|2017-02-18 16:29:38.013987
NCT00334126|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2011-05-17|||April 2006||2006-04-01|March 2010|2010-03-01|September 2007|Actual|2007-09-01|||||Interventional|||Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Paliperidone ER Compared to Quetiapine in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 3|399|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:29:38.129564|2017-02-18 16:29:38.129564
NCT00334113|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2014-12-16|2014-11-21||January 2009||2009-01-01|December 2014|2014-12-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Telerehabilitation Intervention to Promote Exercise for Diabetes|Telerehabilitation Intervention to Promote Exercise for Diabetes|Completed||N/A|89|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:29:38.302437|2017-02-18 16:29:38.302437
NCT00334100|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2014-10-07|||April 2006||2006-04-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|September 2011|Actual|2011-09-01||Interventional|||Treadmill Training in Chronic MS: Efficacy and Cost-effectiveness|Treadmill Training in Chronic MS: Efficacy and Cost-Effectiveness|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||Difficulty with recruiting|f||||t||||||||||2017-02-18 16:29:38.630117|2017-02-18 16:29:38.630117
NCT00334087|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2007-04-15|||June 2007||2007-06-01|April 2007|2007-04-01|September 2007||2007-09-01|||||Observational|||The Relation Between Pregnancy,Birth Outcome, Feeding , Oral Hygiene Habits and Early Childhood Caries Development.|Assessment of Pregnancy History, Birth Outcome, Feeding and Oral Practices With Development of Early Childhood Caries in Offspring of Women Who Have Not Participated in Previous Birth Preparation Class|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:29:38.734073|2017-02-18 16:29:38.734073
NCT00334074|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2013-07-15|2013-04-01||August 2005||2005-08-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS|Phase II Trial of Clofarabine and Cytarabine in Relapsed Standard-Risk AML and Untreated High-Risk MDS in Adult Patients, and Untreated AML in Selected Elderly Patients at High Risk of Anthracycline Toxicity|Completed||Phase 2|30|Actual|Baylor Research Institute||1|||f||||f||||||||||2017-02-18 16:29:39.001937|2017-02-18 16:29:39.001937
NCT00334061|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2009-01-09|2008-11-20||June 2006||2006-06-01|December 2008|2008-12-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||Study to Assess the Safety and Effectiveness of the Penumbra System|Evaluation of the Penumbra™ Stroke System in the Revascularization of Patients With Acute Ischemic Stroke Secondary to Intracranial Large Vessel Occlusive Disease|Completed||Phase 2|125|Actual|Penumbra Inc.||1|||||||t||||||||||2017-02-18 16:29:39.303347|2017-02-18 16:29:39.303347
NCT00334048|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2015-02-18|||June 2006||2006-06-01|February 2015|2015-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo|Treatment of Sexual Dysfunction Secondary to Antidepressant Pharmacotherapy: A Double-blind Comparison of Requip (Ropinirole) vs. Placebo in Patients Taking SSRI Antidepressants|Completed||Phase 4|9|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||f||||||||||2017-02-18 16:29:39.587244|2017-02-18 16:29:39.587244
NCT00334035|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2011-02-17|||August 2003||2003-08-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Antipsychotic Therapy and First Episode|Duration of Maintenance Anti-psychotic Therapy After First -Episode Schizophrenia: a Double-blind Randomized Placebo-control Relapse Prevention Study|Completed||Phase 4|169|Actual|The University of Hong Kong|||||f||||||||||||||2017-02-18 16:29:39.703458|2017-02-18 16:29:39.703458
NCT00334022|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2012-06-04|||February 2006||2006-02-01|June 2012|2012-06-01|January 2010|Actual|2010-01-01|July 2007|Actual|2007-07-01||Interventional|||Fuzeon Viral Decay Pilot Study|A Pilot Randomized Controlled Trial of Adding Enfuvirtide to Standard Combination Antiretroviral Therapy in HIV-infected Individuals With Full Virologic Suppression to Further Suppress Proviral HIV DNA|Completed||N/A|18|Actual|Canadian Immunodeficiency Research Collaborative||2|||f||||||||||||||2017-02-18 16:29:39.801635|2017-02-18 16:29:39.801635
NCT00334009|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2008-03-03|||June 2006||2006-06-01|March 2008|2008-03-01|November 2006||2006-11-01|||||Observational|||Catecholamine-O-Methyl-Transferase(COMT)-Polymorphism in Cardiac Surgery|Impact of Catecholamine-O-Methyl-Transferase Enzyme Activity on Clinical and Biological Parameters in Patients After Cardiac Surgery.|Completed||N/A|250||Austin Health|||||f||||||||||||||2017-02-18 16:29:39.908761|2017-02-18 16:29:39.908761
NCT00333983|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2014-02-03|2013-08-30||June 2006||2006-06-01|February 2014|2014-02-01|February 2011|Actual|2011-02-01|April 2010|Actual|2010-04-01||Interventional|||Evaluation of Robotic Arm Rehabilitation in Stroke Patients|Evaluation of Robotic Arm Rehabilitation in Stroke Patients|Completed||N/A|62|Actual|VA Office of Research and Development|This study was terminated early with the current number of subjects analyzed. A midstudy futility analysis showed a need for 99 participants per group to determine signifcance between the robotic training over the intensive conventional exercise.|2|||f||||t||||||||||2017-02-18 16:29:40.103605|2017-02-18 16:29:40.103605
NCT00333970|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2014-10-06|2014-10-02||August 2004||2004-08-01|October 2014|2014-10-01|July 2014|Actual|2014-07-01|October 2013|Actual|2013-10-01||Interventional||individuals randomized to Arm 1 or Arm 2|Predictors of Response to Cognitive Remediation in Schizophrenia|Predictors of Response to Cognitive Remediation in Schizophrenia|Completed||N/A|103|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:29:40.61456|2017-02-18 16:29:40.61456
NCT00333957|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2007-11-05|||July 2006||2006-07-01|October 2007|2007-10-01|July 2007||2007-07-01|||||Observational|||Capsule Endoscopy in Cystic Fibrosis|Capsule Endoscopy in Cystic Fibrosis-Screening for Small Bowel Disease in Cystic Fibrosis Patient.|Unknown status|Recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:29:41.044071|2017-02-18 16:29:41.044071
NCT00333944|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2006-06-05|||May 2000||2000-05-01|May 2000|2000-05-01|June 2003||2003-06-01|||||Interventional|||Study to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.|Effectiveness of High Dose Pralidoxime in the Treatment of Organophosphorus Pesticide Poisoning – a Randomised Controlled Trial|Completed||N/A|200||Giriraj Hospital|||||f||||||||||||||2017-02-18 16:29:41.125841|2017-02-18 16:29:41.125841
NCT00333931|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2006-06-02|||June 2006||2006-06-01|June 2006|2006-06-01||||||||Interventional|||Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression|Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression|Unknown status|Recruiting|N/A|12||VA Medical Center, Houston|||||f||||||||||||||2017-02-18 16:29:41.214353|2017-02-18 16:29:41.214353
NCT00333918|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-04|2013-02-13|||June 2006||2006-06-01|February 2013|2013-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery|Efficacy and Safety Study of Topical Bromfenac Ophthalmic Solution vs. Placebo for Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery|Completed||Phase 3|522|Actual|Bausch & Lomb Incorporated||2|||f||||||||||||||2017-02-18 16:29:41.321497|2017-02-18 16:29:41.321497
NCT00333905|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2009-02-03|||March 2006||2006-03-01|June 2006|2006-06-01|February 2008|Actual|2008-02-01|||||Interventional|||The Effect of Ischemic Training on Exercise Endurance|The Effect of Ischemic Training on Exercise Endurance|Completed||N/A|50|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 16:29:41.422185|2017-02-18 16:29:41.422185
NCT00333892|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2012-06-04|||August 2003||2003-08-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|||||Observational|||Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients|Leukapheresis Procedures to Obtain Lymphocytes for Research Studies on Antiretroviral Naive HIV-infected Patients|Completed||Phase 2|220|Actual|Canadian Immunodeficiency Research Collaborative|||1||f||||||||||Samples With DNA|"~     Obtain lymphocytes for research studies on anti-retroviral naive HIV-infected patients.~   "|||2017-02-18 16:29:41.516814|2017-02-18 16:29:41.516814
NCT00333879|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2013-11-20|2013-09-16||March 2009||2009-03-01|November 2013|2013-11-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||Virtual Reality Mobility Training System for Veterans With Vision Loss|Virtual Reality Mobility Training System for Veterans With Vision Loss|Completed||N/A|4|Actual|VA Office of Research and Development|Early termination leading to small numbers of subjects analyzed. Technical problems with Virtual Sound System. None of the first 4 Subjects could distinguish between sounds in front versus sounds beside them.|1|||f||||f||||||||||2017-02-18 16:29:41.612081|2017-02-18 16:29:41.612081
NCT00333866|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2013-04-25|2008-11-20||July 2006||2006-07-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional||Full Analysis Set (FAS) included all randomized participants who received at least 1 dose of study medication, regardless of medication compliance.|Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.|A 14 Week, Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin Twice Daily In Patients With Fibromyalgia.|Completed||Phase 3|747|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 16:29:41.865914|2017-02-18 16:29:41.865914
NCT00333853|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2008-05-12|||August 2003||2003-08-01|May 2008|2008-05-01|June 2005||2005-06-01|||||Interventional|||Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)|Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm) to Improve Glycemic Control Through Behavioral and Therapeutic Changes|Completed||N/A|250||LifeScan|||||f||||f||||||||||2017-02-18 16:29:44.943913|2017-02-18 16:29:44.943913
NCT00333840|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2013-08-07|2013-03-15||June 2000||2000-06-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia|A Phase III Study of STI571 Versus Interferon-α (IFN-α) Combined With Cytarabine (Ara-C) in Patients With Newly Diagnosed Previously Untreated Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|Completed||Phase 3|1106|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:29:45.106842|2017-02-18 16:29:45.106842
NCT00333827|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2008-11-19|||January 2006||2006-01-01|June 2006|2006-06-01|February 2009|Anticipated|2009-02-01|December 2008|Anticipated|2008-12-01||Interventional|||Cell Therapy In Dilated Cardiomyopathy|Multicenter Randomized Study Of Cell Therapy In Cardiopathies - Dilated Cardiomyopathy|Unknown status|Recruiting|Phase 3|300|Anticipated|Ministry of Health, Brazil||2|||f||||||||||||||2017-02-18 16:29:52.304597|2017-02-18 16:29:52.304597
NCT00333814|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2011-03-11|2010-10-12||May 2006||2006-05-01|March 2011|2011-03-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis||Completed||Phase 2/Phase 3|229|Actual|Allergan||3|||f||||||||||||||2017-02-18 16:29:52.401934|2017-02-18 16:29:52.401934
NCT00333619|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2015-04-06|2014-10-23||January 2007||2007-01-01|October 2014|2014-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Non-Pharmacological Interventions on Sleep in Post-Acute Rehabilitation|Non-Pharmacological Interventions on Sleep in Post-Acute Rehabilitation|Completed||N/A|219|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:29:57.639207|2017-02-18 16:29:57.639207
NCT00333801|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2015-03-06|2014-11-25||April 2006||2006-04-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|April 2010|Actual|2010-04-01||Interventional||Veterans with PTSD were randomly assigned to a treatment goup.|The Impact of Vocational Rehabilitation on Mentally III Veterans|The Impact of Vocational Rehabilitation on Mentally III Veterans|Completed||N/A|100|Actual|VA Office of Research and Development|The elements of the study that limit generalizability include the single-site design, the small number of IPS interventionists, low number of women in the sample, and the exclusion of nonveterans.|2|||f||||f||||||||||2017-02-18 16:29:52.947016|2017-02-18 16:29:52.947016
NCT00333788|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2011-08-30|2011-04-13||October 2006||2006-10-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|Welcome2||Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease|Open Label Long Term Clinical Trial Evaluating Efficacy and Safety of Chronic Therapy With Certolizumab Pegol, a PEGylated Fab Fragment of Humanized Antibody to Tumor Necrosis Factor Alpha (TNF) in Patients Suffering From Crohn's Disease and Having Completed C87042 Study.|Completed||Phase 3|233|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 16:29:53.649728|2017-02-18 16:29:53.649728
NCT00333775|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2015-12-21|2015-07-22||March 2006||2006-03-01|December 2015|2015-12-01|October 2013|Actual|2013-10-01|October 2007|Actual|2007-10-01||Interventional||Intent-to-treat population: All randomized participants, regardless of whether they received study drug or not.|A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer|A Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Docetaxel in Comparison With Docetaxel Plus Placebo, as First Line Treatment for Patients With HER2 Negative Metastatic and Locally Recurrent Breast Cancer.|Completed||Phase 3|736|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 16:29:54.52292|2017-02-18 16:29:54.52292
NCT00333762|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2015-10-30|2013-09-24||June 2006||2006-06-01|October 2015|2015-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||"Use of Smart Wheelchairs to Provide Independent Mobility to Visual and Mobility Impairments"|"Use of Smart Wheelchairs to Provide Independent Mobility to Visual and Mobility Impairments"|Completed||N/A|4|Actual|VA Office of Research and Development|Only four subjects actually tested the chair. It was decided to stop after these four subject tests because the chairs were clearly not viable for this population of persons who were totally blind, and thus there was no need for further testing.|1|||f||||f||||||||||2017-02-18 16:29:56.085304|2017-02-18 16:29:56.085304
NCT00333749|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2009-09-03|||January 2006||2006-01-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases|Phase 1 1 Study Assesing the Benefit of Pasteurized Goat Milk in Reducing Disease Severity of Young Children With Oral Ulcer Diseases|Completed||Phase 1|65|Actual|HaEmek Medical Center, Israel||2|||f||||f||||||||||2017-02-18 16:29:56.293358|2017-02-18 16:29:56.293358
NCT00333736|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2012-06-04|||May 2005||2005-05-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Interventional|||Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration|Prospective Study to Assess Patient Satisfaction, Quality of Life and Adverse Events of Patients Using the Biojector Versus Standard Needles for Enfuvirtide Administration|Completed||Phase 2|337|Actual|Canadian Immunodeficiency Research Collaborative||1|||f||||t||||||||||2017-02-18 16:29:56.398883|2017-02-18 16:29:56.398883
NCT00333723|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2016-09-22|||July 2000||2000-07-01|September 2016|2016-09-01||||||||Interventional|||AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone|A 24-Week Randomized, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of AVANDIA (8mg Once Daily) in Combination With Glyburide in African American and Hispanic Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled on Glyburide Monotherapy|Completed||Phase 4|245|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:29:56.487527|2017-02-18 16:29:56.487527
NCT00333710|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2014-12-09|2014-11-19||September 2006||2006-09-01|December 2014|2014-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD|Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD|Completed||N/A|53|Actual|VA Office of Research and Development|Small sample size, all male, reliance on self-report measures.|3|||f||||f||||||||||2017-02-18 16:29:56.577523|2017-02-18 16:29:56.577523
NCT00333697|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2011-03-17|||November 2005||2005-11-01|March 2011|2011-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients|Ultrasound-sparing Strategy for Suspected DVT: A Prospective Clinical Cohort Study|Completed||N/A|199|Actual|Intermountain Health Care, Inc.||1|||f||||f||||||||||2017-02-18 16:29:56.927195|2017-02-18 16:29:56.927195
NCT00333684|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2012-06-04|||December 2004||2004-12-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|November 2006|Actual|2006-11-01||Interventional|||Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid|A Prospective Study Evaluating the Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid Soft Tissue Endoprosthesis|Completed||Phase 2|36|Actual|Canadian Immunodeficiency Research Collaborative||2|||f||||||||||||||2017-02-18 16:29:57.14336|2017-02-18 16:29:57.14336
NCT00333671|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2012-09-18|||December 2004||2004-12-01|September 2012|2012-09-01|April 2007|Actual|2007-04-01|February 2006|Actual|2006-02-01||Interventional|||Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema)|Diabetic Macular Oedema: the Retinal Thickness as a Function of Changes in Plasma Osmolality Evaluated by OCT.|Completed||N/A|15|Actual|Glostrup University Hospital, Copenhagen||1|||f||||f||||||||||2017-02-18 16:29:57.248604|2017-02-18 16:29:57.248604
NCT00333658|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2009-06-24|||December 2003||2003-12-01|June 2009|2009-06-01|September 2008|Actual|2008-09-01|October 2007|Actual|2007-10-01||Interventional|||A Behavioral Intervention to Improve Work Outcomes|A Behavioral Intervention to Improve Outcomes in VA Work Programs|Completed||N/A|57|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:29:57.341147|2017-02-18 16:29:57.341147
NCT00333645|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-04|2007-04-12|||October 2003||2003-10-01|December 2006|2006-12-01|March 2007||2007-03-01|||||Interventional|||Prophylaxis With Caspofungin in High-Risk Liver Transplantation|Prophylaxis With Caspofungin for the Prevention of Invasive Fungal Infections in High-Risk Liver Transplant Recipients|Unknown status|Recruiting|Phase 2|70||Grupo de Estudio de Infecciones en Transplantados|||||f||||||||||||||2017-02-18 16:29:57.442188|2017-02-18 16:29:57.442188
NCT00333593|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-05|2006-12-26|||June 2006||2006-06-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Interventional|||Super High-Flux - High Volume Dialysis in Sepsis-Induced Acute Renal Failure|Randomized, Cross Over Study Comparing Standard Hemodialysis to Hemodialysis With a Novel Polyamide Membrane (P2SH) in Patients With Sepsis and Acute Renal Failure|Completed||Phase 1/Phase 2|10||Austin Health|||||f||||||||||||||2017-02-18 16:29:58.086452|2017-02-18 16:29:58.086452
NCT00333580|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2015-04-07|||July 2006||2006-07-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Veteran-Centered Outcomes Using Qualitative and Quantitative Methods|Veteran-Centered Outcomes Using Qualitative and Quantitative Methods|Completed||N/A|15|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 16:29:58.350273|2017-02-18 16:29:58.350273
NCT00333567|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2007-12-12|||August 2006||2006-08-01|December 2007|2007-12-01||||||||Interventional|||Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Compare Efficacy of a Single Dose of Lumiracoxib 400 mg Given Pre-Emptively Versus Post-Operatively, in Reducing Pain Associated With Ambulatory Arthroscopic Knee Surgery|Completed||Phase 4|110||Novartis|||||f||||||||||||||2017-02-18 16:29:58.444947|2017-02-18 16:29:58.444947
NCT00333554|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2016-05-13|||June 2006||2006-06-01|May 2016|2016-05-01|April 2013|Actual|2013-04-01|February 2008|Actual|2008-02-01||Interventional|||Nutritional Intervention to Prevent Diabetes||Completed||N/A|99|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 16:29:58.533572|2017-02-18 16:29:58.533572
NCT00333541|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2015-03-03|||June 2006||2006-06-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Internet Access and Use in Adolescent Women Initiating Contraception|Internet Access and Use in Women at High Risk for Unintended Pregnancy: A Randomized Clinical Trial|Completed||N/A|100|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 16:29:58.661958|2017-02-18 16:29:58.661958
NCT00333528|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2015-06-26|||December 2007||2007-12-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly|A Phase 1, Randomized, Observer-Blinded, Single Dose, Placebo Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Plasma-Derived Human Butyrylcholinesterase (HuBChE) Administered Intramuscularly (IM)|Completed||Phase 1|8|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-02-18 16:29:58.760067|2017-02-18 16:29:58.760067
NCT00333515|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2015-06-26|||January 2007||2007-01-01|April 2014|2014-04-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously|A Phase 1, Randomized, Observer-blinded, Single Dose, Placebo Controlled Dosage-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Plasma-Derived Human Butyrylcholinesterase (HuBChE) Administered Intravenously (IV)|Completed||Phase 1|28|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-02-18 16:29:58.857083|2017-02-18 16:29:58.857083
NCT00333502|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-07-30|||May 2006||2006-05-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|November 2011|Actual|2011-11-01||Interventional|||Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors|A Phase 1b/2a Safety and Pharmacokinetic Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors|Completed||Phase 1/Phase 2|62|Actual|Cerulean Pharma Inc.||1|||f||||||||||||||2017-02-18 16:29:58.952445|2017-02-18 16:29:58.952445
NCT00333489|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2011-11-07|||March 2004||2004-03-01|June 2006|2006-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension|A National, Multicentric and Comparative Study to Evaluate Efficacy and Tolerability of the Association of Valsartan and Amlodipine Versus Amlodipine Alone in the Treatment of Essential Arterial Hypertension - Stages I and II (Mild to Moderate).|Completed||Phase 4|551|Actual|Novartis|||||f||||||||||||||2017-02-18 16:29:59.06531|2017-02-18 16:29:59.06531
NCT00333476|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2007-11-27|||May 2006||2006-05-01|November 2007|2007-11-01||||||||Interventional|||"A Study of MSI-1256F (Squalamine Lactate) To Treat Wet Age-Related Macular Degeneration"|A Phase 2, Randomized, Open Label, Safety, and Pharmacodynamic Study of Squalamine Lactate for Injection for the Treatment of Minimally Classic or Active Occult Choroidal Neovascularization Associated With Age-Related Macular Degeneration|Terminated||Phase 2|140||Genaera Corporation|||||||||||||||||||2017-02-18 16:29:59.168134|2017-02-18 16:29:59.168134
NCT00333463|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2016-11-17|||June 2006||2006-06-01|March 2010|2010-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Compliance With Once Daily Glaucoma Medication|Compliance With Once Daily Glaucoma Medication|Completed||N/A|700|Anticipated|Alcon Research|||2||f||||||||||||||2017-02-18 16:29:59.273883|2017-02-18 16:29:59.273883
NCT00333450|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2016-10-06|||August 2006||2006-08-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.|Multicentre Immune Memory Study in Healthy Children Following a 3 Dose Primary Vaccination With Prevenar or GSK Biologicals' Pneumococcal Conjugate Vaccine Via the Administration of a Single Booster Dose of Pneumovax 23|Completed||Phase 3|120||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:29:59.368301|2017-02-18 16:29:59.368301
NCT00333437|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2013-09-23|2013-05-06||May 2006||2006-05-01|September 2013|2013-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement|Pulmonary Involvement in Scleroderma: Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients|Completed||N/A|7|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 16:29:59.502598|2017-02-18 16:29:59.502598
NCT00333424|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-06-11|||August 2007||2007-08-01|June 2012|2012-06-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|||Thai Prophylactic HIV Vaccine Phase I Study|A Randomised, Placebo-Controlled, Double-Blind, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Candidate Prophylactic pHIS-HIV-AE DNA Prime and rFPV-HIV-AE Boost HIV Vaccination Strategy|Terminated||Phase 1/Phase 2|8|Actual|Kirby Institute||1||"Vaccines safe but not immunogenic in 8 participants; trial closed to further recruitment by~   the protocol steering committee & DSMB."|f||||t||||||||||2017-02-18 16:29:59.813312|2017-02-18 16:29:59.813312
NCT00005531|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||December 1996||1996-12-01|August 2004|2004-08-01|November 2000|Actual|2000-11-01|||||Observational|||Genetic Epidemiology of Sarcoidosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:48.672447|2017-02-18 18:14:48.672447
NCT00333411|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2014-06-13||2014-04-30|June 2006||2006-06-01|June 2014|2014-06-01||||June 2008|Actual|2008-06-01||Interventional|||Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis|A 12 Week Double-blind, Randomised, Placebo-controlled, Modified Dose-escalation Trial to Investigate Safety, Efficacy, and Pharmacokinetics of BIRT 2584XX Tablets at Doses of 100, 300 and 500 mg Administered Once Daily in Patients With Moderate to Severe Psoriasis With a 12 Week Treatment Extension|Completed||Phase 2|360|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 16:29:59.922874|2017-02-18 16:29:59.922874
NCT00333398|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2010-08-26|||June 2006||2006-06-01|June 2008|2008-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults|A Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults Greater Than or Equal to 18 to Less Than 65 Years of Age|Completed||Phase 3|1359|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-02-18 16:30:00.232654|2017-02-18 16:30:00.232654
NCT00333385|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2006-06-02|||October 2001||2001-10-01|March 2001|2001-03-01|April 2004||2004-04-01|||||Interventional|||Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis||Terminated||Phase 4|120||Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche|||||f||||||||||||||2017-02-18 16:30:00.380924|2017-02-18 16:30:00.380924
NCT00333372|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2009-01-12|||April 2006||2006-04-01|January 2009|2009-01-01||||||||Interventional|||To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia|To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia, Focusing on the Assessment of Subjective Symptoms|Completed||Phase 2|440||Zeria Pharmaceutical|||||f||||||||||||||2017-02-18 16:30:00.491555|2017-02-18 16:30:00.491555
NCT00333359|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2013-07-15|2011-04-28||June 2006||2006-06-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.|An Open-Label, 52-Week Extension Study Assessing XP13512 Safety and Efficacy in Patients With Restless Legs Syndrome.|Completed||Phase 3|581|Actual|XenoPort, Inc.||1|||f||||f||||||||||2017-02-18 16:30:00.580019|2017-02-18 16:30:00.580019
NCT00333346|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2010-08-30|||September 2006||2006-09-01|August 2010|2010-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Tramadol iv. : Influence of Dose and Dose Intervals on Therapeutic Accuracy and Side Effects When Used for Postoperative Pain Relief in Ambulatory Surgery|Tramadol iv. : Influence of Dose and Dose Intervals on Therapeutic Accuracy and Side Effects When Used for Postoperative Pain Relief in Ambulatory Surgery|Completed||Phase 2|200|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:30:01.894496|2017-02-18 16:30:01.894496
NCT00333333|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2008-06-12|||June 2006||2006-06-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Observational|||Mechanism of Thrombocytopenia in Infants|Mechanism of Thrombocytopenia in Small for Gestational Age Infants Versus Infants With Maternal Preeclampsia Exposure|Completed||N/A|30|Anticipated|Christiana Care Health Services|||2||f||||f||||||Samples Without DNA|"~     Cord blood~   "|||2017-02-18 16:30:02.004132|2017-02-18 16:30:02.004132
NCT00333320|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2012-10-22|||September 2006||2006-09-01|October 2012|2012-10-01|November 2011|Actual|2011-11-01|July 2010|Actual|2010-07-01||Interventional|||Positive Effect of Ischemic Postconditioning During Acute Myocardial Infarction|Positive Effect of Ischemic Postconditioning During Acute Myocardial Infarction|Completed||Phase 1/Phase 2|46|Actual|French Cardiology Society||2|||f||||t||||||||||2017-02-18 16:30:02.126502|2017-02-18 16:30:02.126502
NCT00333307|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2010-03-12|||October 2006||2006-10-01|March 2010|2010-03-01||||||||Interventional|||Evaluation of the Safety of Relaxin in Preeclampsia|A Phase I Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety of Recombinant Human Relaxin (rhRlx) in Subjects With Preeclampsia|Suspended||Phase 1|18|Anticipated|Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies|||||||||||||||||||2017-02-18 16:30:02.236164|2017-02-18 16:30:02.236164
NCT00333294|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-02|2007-12-16|||September 2004||2004-09-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Phase II Iressa + Irradiation Followed by Chemo in NSCLC|A Phase II Open-Label Multicentre Study Of The Efficacy Of ZD1839 (IRESSA™) In Combination With Irradiation Followed By Chemotherapy In Patients With Inoperable Stage III Non Small Cell Lung Cancer|Completed||Phase 2|50||AstraZeneca|||||f||||||||||||||2017-02-18 16:30:02.337679|2017-02-18 16:30:02.337679
NCT00333281|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2007-10-23|||June 2005||2005-06-01|October 2007|2007-10-01|August 2006|Actual|2006-08-01|||||Interventional|||A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months|A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evaluate the Effects of 5 mg Tadalafil (IC351, LY450190) and 50 mg Sildenafil Administered Once Daily for 6 Months on Visual Function in Healthy Subjects or Subjects With Mild Erectile Dysfunction|Completed||Phase 4|198||Eli Lilly and Company|||||||||||||||||||2017-02-18 16:30:02.431366|2017-02-18 16:30:02.431366
NCT00333268|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-03-01|||September 2004||2004-09-01|March 2012|2012-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus|Clinical Evaluation of the Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus for Use During Cataract Extraction and IOL Implantation|Completed||Phase 3|369|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:30:02.528008|2017-02-18 16:30:02.528008
NCT00333255|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2009-07-07|||September 2005||2005-09-01|July 2009|2009-07-01||||March 2006|Actual|2006-03-01||Interventional|||Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery|Preoperative and Postoperative Nevanac 0.1% Compared to Acular LS for the Treatment of Ocular Inflammation Associated With Cataract Surgery|Completed||Phase 3|267|Actual|Alcon Research|||||||||||||||||||2017-02-18 16:30:02.625702|2017-02-18 16:30:02.625702
NCT00333242|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2017-01-10|||September 2002||2002-09-01|August 2008|2008-08-01||||August 2006|Actual|2006-08-01||Interventional|||Hyperalgesia in Methadone Patients: Can it be Treated?||Unknown status|Active, not recruiting|Phase 1|40|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-02-18 16:30:02.702508|2017-02-18 16:30:02.702508
NCT00333229|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2014-11-17|2014-11-17||March 2006||2006-03-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss|Influence of Zoledronic Acid on Bone Mineral Density and Bone Ultrasonometry in Premenopausal Women With Hormone Receptor Negative Breast Cancer and Adjuvant Chemotherapeutic Treatment|Terminated||Phase 4|11|Actual|Novartis||2||"Due to rare patient population, planned number of patients could not be recruited in a~   reasonable timeframe. Recruitment was stopped prematurely."|f||||||||||||||2017-02-18 16:30:02.796287|2017-02-18 16:30:02.796287
NCT00333216|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2012-11-27||2012-11-27|May 2005||2005-05-01|December 2011|2011-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Anecortave Acetate Risk-Reduction Trial (AART)|Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) Versus Sham Administration in Singaporean Patients at Risk for Progressing to Exudative Age-Related Macular Degeneration (AMD)|Terminated||Phase 3|24|Actual|Alcon Research||3||Lack of efficacy|f||||f||||||||||2017-02-18 16:30:03.212553|2017-02-18 16:30:03.212553
NCT00333203|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-03-01|||October 2005||2005-10-01|March 2012|2012-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Next Generation Ophthalmic Irrigating Solution Posterior Segment Study|Clinical Evaluation of the Safety of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus for Use During Surgery for Removal of Epimacular Membrane and Vitrectomy|Completed||Phase 3|369|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 16:30:03.414977|2017-02-18 16:30:03.414977
NCT00333190|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2012-03-15|||September 2005||2005-09-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|March 2007|Actual|2007-03-01||Interventional|||CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation|CD8+ T Cell Depletion as Graft Versus Host Disease Prophylaxis After HLA-Matched Unrelated Donor Non-myeloablative Peripheral Blood Stem Cell Transplantation|Completed||N/A|30|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:30:03.509029|2017-02-18 16:30:03.509029
NCT00333177|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2013-03-27|||March 2006||2006-03-01|March 2013|2013-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia|Developmental Processes in Schizophrenic Disorders: Cognitive Remediation, Medication Adherence, and Work Outcome in Recent-Onset Schizophrenia|Completed||Phase 4|153|Actual|University of California, Los Angeles||4|||f||||t||||||||||2017-02-18 16:30:03.609992|2017-02-18 16:30:03.609992
NCT00333164|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-08-02|||May 2006||2006-05-01|August 2012|2012-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis|Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis (CATHARSIS)|Completed||Phase 3|200|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||||||||||||2017-02-18 16:30:03.733059|2017-02-18 16:30:03.733059
NCT00333151|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2017-01-24|||May 2006||2006-05-01|January 2017|2017-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|LEAD-4||Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect on Glycemic Control of Liraglutide in Combination With Rosiglitazone Plus Metformin Versus Rosiglitazone Plus Metformin in Subjects With Type 2 Diabetes|Completed||Phase 3|576|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:30:03.837659|2017-02-18 16:30:03.837659
NCT00333138|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2013-12-24|2012-04-05||May 2003||2003-05-01|December 2013|2013-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis|Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study Evaluating the Safety, Tolerability and Effect on MRI Lesion Parameters of FTY720 vs Placebo in Patients With Relapsing Multiple Sclerosis Including 18 Month Extension Phase|Completed||Phase 2|281|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:30:04.214456|2017-02-18 16:30:04.214456
NCT00333125|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2016-11-17|||April 2006||2006-04-01|May 2012|2012-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 3|319|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:30:05.480367|2017-02-18 16:30:05.480367
NCT00333112|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2014-09-17|||May 2006||2006-05-01|September 2014|2014-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|VICTOR||A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Safety and Efficacy, Phase 4 Study of VESIcare® (Solifenacin Succinate) or Placebo in Combination With Tamsulosin HCl for the Treatment of Residual OAB Symptoms of Urgency and Frequency in Men VICTOR: VESIcare® In Combination With Tamsulosin in OAB Residual Symptoms|Completed||Phase 4|398|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:30:05.583097|2017-02-18 16:30:05.583097
NCT00333099|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-09-13|||May 2006||2006-05-01|September 2012|2012-09-01|September 2011|Actual|2011-09-01|September 2010|Actual|2010-09-01||Interventional|||INEC Study: Immuno-modulating Enteral Nutrition in Cancer|Effect of Enteral Immunonutrition During Chemoradiotherapy in Patients With Head and Neck Cancer or Esophageal Cancer|Completed||Phase 4|250|Actual|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 16:30:05.758441|2017-02-18 16:30:05.758441
NCT00333086|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-04-18|||January 2000||2000-01-01|April 2012|2012-04-01||||June 2006|Actual|2006-06-01||Interventional|||A Study of Letrozole in the Treatment of Endometrial Cancer|A PHASE II STUDY OF LETROZOLE IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CANCER|Completed||Phase 2|36|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:30:05.874592|2017-02-18 16:30:05.874592
NCT00333073|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2014-02-14|||March 2006||2006-03-01|July 2013|2013-07-01|May 2010|Actual|2010-05-01|October 2008|Actual|2008-10-01||Interventional|||Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence|Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence|Completed||N/A|125|Actual|Contura||1|||f||||||||||||||2017-02-18 16:30:05.960338|2017-02-18 16:30:05.960338
NCT00333060|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2008-03-31|||November 2005||2005-11-01|March 2008|2008-03-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal|Phase 2 Study of OT-551 Ophthalmic Solution to Prevent or Delay Progression of Nuclear Cataract Formation In Post-Vitrectomy Patients|Terminated||Phase 2|164|Anticipated|Othera Pharmaceuticals|||||f||||||||||||||2017-02-18 16:30:06.182035|2017-02-18 16:30:06.182035
NCT00333047|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2009-11-18|||July 2002||2002-07-01|November 2009|2009-11-01||||||||Interventional|||Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy|A Study of Letrozole in the Treatment of Metastatic Breast Cancer in Combination With Chemotherapy|Completed||Phase 2/Phase 3|24||Novartis|||||f||||||||||||||2017-02-18 16:30:06.287162|2017-02-18 16:30:06.287162
NCT00333034|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2007-12-04|||June 2006||2006-06-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis|A Multicenter, Parallel, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Moderate to Severe Plaque Psoriasis|Completed||Phase 3|120|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:30:06.376221|2017-02-18 16:30:06.376221
NCT00333021|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2009-07-09|||May 2006||2006-05-01|July 2009|2009-07-01|February 2007|Actual|2007-02-01|||||Interventional|||Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients|Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) After Abdominal Surgery|Completed||Phase 3|127|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:30:06.488394|2017-02-18 16:30:06.488394
NCT00333008|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2006-09-25|||May 2006||2006-05-01|September 2006|2006-09-01||||||||Interventional|||A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.|Phase II Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell NHL > 60 Years or With Compromised Cardiac Status|Unknown status|Recruiting|Phase 2|27||The Alvin and Lois Lapidus Cancer Institute|||||f||||||||||||||2017-02-18 16:30:06.608319|2017-02-18 16:30:06.608319
NCT00332995|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2009-08-31|||July 2005||2005-07-01|August 2009|2009-08-01|August 2005||2005-08-01|||||Interventional|||Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium|Double-blind, Randomized, Placebo Controlled Trial to Study Safety, Local and Systemic Availability of TMC120 From a Vaginal Ring.|Completed||Phase 1|13||International Partnership for Microbicides, Inc.|||||f||||||||||||||2017-02-18 16:30:06.70696|2017-02-18 16:30:06.70696
NCT00332982|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2006-11-20|||November 2005||2005-11-01|June 2005|2005-06-01|September 2007||2007-09-01|||||Interventional|||Ontario ICU Clinical Best Practices Demonstration Project|Ontario ICU Clinical Best Practices Demonstration Project|Completed||N/A|||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 16:30:06.980318|2017-02-18 16:30:06.980318
NCT00332969|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2011-11-23|||September 2005||2005-09-01|November 2011|2011-11-01||||October 2010|Actual|2010-10-01||Interventional|||Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma|Efficacy of Medical Treatment With Octreotide in Patients With Primary Inoperable Thymoma to Reduce Tumor Size|Completed||Phase 2|25|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:30:07.07825|2017-02-18 16:30:07.07825
NCT00332956|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2011-11-28||2011-06-29|May 2006||2006-05-01|November 2011|2011-11-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Interventional|||Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers|A Phase 2 (a), Dose-Blinded, Block-Randomized, Dose and Schedule Selection Study to Evaluate the Immunogenicity and Safety of the Recombinant Plague Vaccine rF1V in Healthy Volunteers|Completed||Phase 2|400|Actual|DynPort Vaccine Company LLC, A CSC Company||4|||f||||t||||||||||2017-02-18 16:30:07.186133|2017-02-18 16:30:07.186133
NCT00332943|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2007-09-19|||December 2005||2005-12-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|||||Interventional|||MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil|MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil|Completed||Phase 4|20|Anticipated|Herlev Hospital|||||f||||||||||||||2017-02-18 16:30:07.320161|2017-02-18 16:30:07.320161
NCT00332930|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2007-02-26|||September 2002||2002-09-01|June 2006|2006-06-01|September 2003||2003-09-01|||||Interventional|||ITV Extension Study|An Extension Study to Protocol VIR-NCHR-01 to Assess the Antiretrovirological Properties of a Therapeutic HIV Vaccine Candidate Based on Recombinant Fowlpox Virus (rFPV) (ITV Extension Study)|Completed||Phase 1/Phase 2|35||Kirby Institute|||||f||||||||||||||2017-02-18 16:30:07.405417|2017-02-18 16:30:07.405417
NCT00332917|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2009-01-23|||February 2007||2007-02-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients|An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients|Completed||Phase 3|224|Actual|Solvay Pharmaceuticals||1|||f||||t||||||||||2017-02-18 16:30:07.518705|2017-02-18 16:30:07.518705
NCT00332904|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2010-06-03|||August 2006||2006-08-01|June 2010|2010-06-01|December 2010|Anticipated|2010-12-01|July 2008|Actual|2008-07-01||Interventional|PEKASYS||Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis|Effect of Betablocker or Aldosterone Antagonist Therapy on Oxygenation, Peripheral and Cardiac Hemodynamics and Humoral Systems|Unknown status|Active, not recruiting|Phase 4|22|Actual|Hvidovre University Hospital||3|||f||||t||||||||||2017-02-18 16:30:07.76216|2017-02-18 16:30:07.76216
NCT00332891|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2009-03-06|||March 2006||2006-03-01|March 2009|2009-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|ELECTRA||An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder|An 8-Week, Double-Blind, Placebo-Controlled, Multicenter Study With Paroxetine (20 mg q24) as Positive Control, Evaluating the Efficacy and Safety of 2 Fixed Doses of SR58611A (175 mg q12 and 350 mg q12) in Outpatients With GAD|Completed||Phase 3|508|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:30:07.870698|2017-02-18 16:30:07.870698
NCT00332878|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2015-01-22|||March 2003||2003-03-01|January 2015|2015-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Stepping Stones Program for Preventing HIV Infection in Residents of Rural South African Communities|RCT of Stepping Stones Behavioural Intervention for HIV|Completed||Phase 3|2801|Actual|Medical Research Council, South Africa||2|||f||||t||||||||||2017-02-18 16:30:07.971738|2017-02-18 16:30:07.971738
NCT00332865|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2013-06-18|||June 2006||2006-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy|Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy|Completed||Phase 1/Phase 2|60|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-02-18 16:30:08.090155|2017-02-18 16:30:08.090155
NCT00332852|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2011-07-07|||March 2006||2006-03-01|July 2011|2011-07-01||||July 2010|Actual|2010-07-01||Interventional|||Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer|An Open Phase III Trial With Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer|Completed||Phase 3|655|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:30:08.186709|2017-02-18 16:30:08.186709
NCT00332839|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2014-08-15|2014-03-14||November 2005||2005-11-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.|Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a CNI-free Regimen With Enteric-coated Mycophenolate Sodium and Everolimus in Comparison to Standard Therapy With Enteric-coated Mycophenolate Sodium and Ciclosporin Microemulsion in Stable Renal Transplant Patients|Terminated||Phase 4|93|Actual|Novartis|Adverse Events data were not collected during the Follow-up period.|2||"The trial was terminated early due to slow enrollment. It was determined that the planned~   sample size of 300 could not be achieved."|f||||||||||||||2017-02-18 16:30:08.345906|2017-02-18 16:30:08.345906
NCT00005530|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-10|||May 1994||1994-05-01|May 2016|2016-05-01|April 2000||2000-04-01|||||Observational|||Diet, Insulin Resistance, and Cardiovascular Risk||Completed||N/A|||University of South Carolina|||||f||||||||||||||2017-02-18 18:14:48.751595|2017-02-18 18:14:48.751595
NCT00332826|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-05-03|||June 2006||2006-06-01|May 2012|2012-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma|A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma|Terminated||Phase 3|3|Actual|Mannkind Corporation||||Non-safety related business decision to combine special population protocols|||||||||||||||2017-02-18 16:30:08.882309|2017-02-18 16:30:08.882309
NCT00332813|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2013-03-26|||February 2006||2006-02-01|January 2006|2006-01-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Reducing HIV Risk Among Pregnant Women in Drug Treatment|Reducing HIV Risk Among Pregnant Women in Drug Treatment|Completed||Phase 1/Phase 2|98|Anticipated|Rhode Island Hospital|||||f||||||||||||||2017-02-18 16:30:09.143595|2017-02-18 16:30:09.143595
NCT00332800|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2006-05-31|||October 2003||2003-10-01|June 2005|2005-06-01|December 2005||2005-12-01|||||Interventional|||Study Impact of Nutritional Supplementary Treatment of Undernourished Stroke Patient on Functional Outcome Measures|What Impact Does Intensive Vs. Standard Nutritional Supplementary Treatment of Undernourished Stroke Patient Have on Functional Outcome Measures on an Acute Rehabilitation Unit – a Pilot Study|Completed||N/A|100||Burke Rehabilitation Hospital|||||f||||||||||||||2017-02-18 16:30:09.223582|2017-02-18 16:30:09.223582
NCT00332787|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2014-01-07|||June 2000||2000-06-01|January 2014|2014-01-01|October 2005||2005-10-01|||||Interventional|||Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents|Childhood Depression: Remission and Relapse|Completed||N/A|200||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:30:09.309148|2017-02-18 16:30:09.309148
NCT00332774|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2012-03-01|||February 2006||2006-02-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Nevanac 3-Month Safety Study With QID Dosing|A 3-Month Clinical Safety Comparison of Nevanac 0.1% to Acular LS 0.4% and Vehicle Following Cataract Surgery|Completed||Phase 3|149|Actual|Alcon Research||3|||f||||||||||||||2017-02-18 16:30:09.408597|2017-02-18 16:30:09.408597
NCT00332761|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2008-08-19|||June 2006||2006-06-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|||||Interventional|CUSP||Caduet in an Untreated Subject Population|An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial Examining The Efficacy And Safety Of Caduet® In Simultaneously Achieving Blood Pressure And Lipid Goals In An Untreated Hypertensive And Dyslipidemic Subject Population. (CUSP - Caduet in Untreated Subject Population)|Completed||Phase 4|220||Pfizer|||||f||||||||||||||2017-02-18 16:30:09.514809|2017-02-18 16:30:09.514809
NCT00332748|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2010-02-27||2010-02-27|December 2006||2006-12-01|September 2007|2007-09-01||||December 2007|Actual|2007-12-01||Interventional|||A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer|Effect of Esomeprazole on the Pharmacokinetics of BMS-275183 in Patients With Advanced Malignancies|Terminated||Phase 1|36||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:30:09.644205|2017-02-18 16:30:09.644205
NCT00332735|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2007-04-18|||May 2006||2006-05-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Spinal Anesthesia With Articaine and Bupivacaine for Outpatient Lower Limb Surgery|Spinal Anesthesia With 5% Articaine and 0.5% Bupivacaine for Outpatient Lower Limb Surgery. A Double-Blind Randomised Clinical Trial|Completed||Phase 3|80||Reinier de Graaf Groep|||||f||||||||||||||2017-02-18 16:30:09.723541|2017-02-18 16:30:09.723541
NCT00332722|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2013-09-27|2012-12-06||September 2003||2003-09-01|September 2013|2013-09-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Effectiveness of Cervical Facet Joint Nerve Blocks|Effectiveness of Cervical Facet Joint Nerve Blocks: A Randomized, Prospective, Double-Blind Controlled Evaluation|Completed||N/A|120|Actual|Pain Management Center of Paducah|The study limitations include the lack of a placebo group.|2|||f||||t||||||||||2017-02-18 16:30:09.819127|2017-02-18 16:30:09.819127
NCT00332709|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2011-10-10|2011-08-11||January 2006||2006-01-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer|An Open Phase III Trial With Letrozole Alone or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer|Completed||Phase 3|83|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:30:10.219892|2017-02-18 16:30:10.219892
NCT00332696|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2011-09-20|2011-01-17||September 2005||2005-09-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis|Evaluation of the Effect of Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis|Completed||Phase 2|64|Actual|Novartis|Study was terminated prematurely due to low enrollment|2|||f||||f||||||||||2017-02-18 16:30:13.480752|2017-02-18 16:30:13.480752
NCT00332683|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2010-06-02|||September 2006||2006-09-01|June 2010|2010-06-01|December 2011|Anticipated|2011-12-01|August 2011|Anticipated|2011-08-01||Interventional|||Reducing Dysphagia Associated With Anterior Cervical Spine Surgery by Maintaining Low Endotracheal Tube Cuff Pressure|Endotracheal Tube Cuff Pressure Protocol to Reduce Dysphagia Following Anterior Cervical Spine Surgery: A Prospective Randomized Pilot Study|Unknown status|Recruiting|N/A|40|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 16:30:16.713085|2017-02-18 16:30:16.713085
NCT00332670|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2008-08-12|||January 2003||2003-01-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Light Therapy for Elderly Depression|High Cortisol Levels as a Risk Factor for Depression in the Elderly and the Effect of Bright Light Treatment on Mood, Sleep-Wake Pattern and Self-Sufficiency|Terminated||Phase 2/Phase 3|89|Actual|GGZ Buitenamstel||2||End of research time, time-resources|f||||f||||||||||2017-02-18 16:30:16.820311|2017-02-18 16:30:16.820311
NCT00332657|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2012-11-27||2012-11-27|September 2006||2006-09-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Anecortave Acetate Risk Reduction Trial (AART)||Terminated||Phase 3|36|Actual|Alcon Research||3||Management Decision|f||||||||||||||2017-02-18 16:30:16.939879|2017-02-18 16:30:16.939879
NCT00332644|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-01|2011-10-21|2011-10-21||September 2004||2004-09-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms|Pharmacotherapies: Efficacy, Mechanisms and Algorithms|Completed||Phase 4|1504|Actual|University of Wisconsin, Madison||6|||f||||f||||||||||2017-02-18 16:30:17.038747|2017-02-18 16:30:17.038747
NCT00332618|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2006-06-06|||September 2003||2003-09-01|March 2003|2003-03-01|April 2004||2004-04-01|||||Observational|||Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia|Multicenter Controlled Parallel-Groups Trial to Evaluate the Efficacy, Safety and Acceptability of TGO Buccal Spray Versus a Saliva Substitute in the Treatment of Psychotropic Medicines-Induced Xerostomia|Completed||Phase 2|74||Laboratoires CARILENE|||||f||||||||||||||2017-02-18 16:30:18.152079|2017-02-18 16:30:18.152079
NCT00332605|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2014-07-07|2012-03-01||June 2006||2006-06-01|July 2014|2014-07-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence|A Double-Blind Study of N-Acetyl Cysteine Plus Naltrexone in the Treatment of Methamphetamine Dependence|Completed||Phase 2|45|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 16:30:18.247532|2017-02-18 16:30:18.247532
NCT00332592|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2011-07-20|||October 2006||2006-10-01|May 2008|2008-05-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Observational|||Intragastric and Peritoneal Microdialysis in Infants With Necrotizing Enterocolitis (NEC)|Intragastric and Intraperitoneal Microdialysis in Infants With NEC|Completed||Phase 4|14|Actual|Odense University Hospital|||1||f||||f||||||||||2017-02-18 16:30:18.693528|2017-02-18 16:30:18.693528
NCT00332579|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2012-04-09|2012-03-01||May 2006||2006-05-01|April 2012|2012-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Double-Blind Naltrexone in Kleptomania|A Double-Blind, Placebo-Controlled Study of Naltrexone in Kleptomania|Completed||Phase 2|25|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 16:30:18.781996|2017-02-18 16:30:18.781996
NCT00332566|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2016-09-27|||June 2006||2006-06-01|September 2016|2016-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib|Immunogenicity, Reactogenicity & Safety of a Booster Dose of GSK Biologicals' DTPw-HBV/Hib Kft Vaccine Vs GSK Biologicals' DTPw-HBV/Hib Vaccine, in Infants Who Received a 3-Dose Primary Vaccination Course With the Same Vaccines.|Completed||Phase 3|148|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:30:19.155179|2017-02-18 16:30:19.155179
NCT00332553|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2007-05-11|||February 2002||2002-02-01|May 2007|2007-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen|Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen|Completed||Phase 2|150||Eli Lilly and Company|||||||||||||||||||2017-02-18 16:30:19.262267|2017-02-18 16:30:19.262267
NCT00330837|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2008-02-07|||February 2006||2006-02-01|February 2008|2008-02-01|February 2007|Actual|2007-02-01|||||Observational|||Ultrasound Scanning of Vascular Access Sites|Ultrasound Scanning of Vascular Access Sites|Completed||Phase 1|100|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 16:30:19.346146|2017-02-18 16:30:19.346146
NCT00330824|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2009-08-06|||April 2006||2006-04-01|August 2009|2009-08-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery|Efficacy of Antibiotic Steroid Combination Compared With Individual Administration in Prevention of Post Operative Inflammation in Patients Having LASIK Surgery|Completed||N/A|64|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 16:30:19.438842|2017-02-18 16:30:19.438842
NCT00330811|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2016-11-30|||April 2006||2006-04-01|November 2016|2016-11-01|May 2007|Actual|2007-05-01|January 2007|Actual|2007-01-01||Observational|||B-type Natriuretic Peptide in the Non-Cardiac Pediatric Patient|B-type Natriuretic Peptide in the Non-Cardiac Pediatric Patient|Completed||N/A|87|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:30:19.554386|2017-02-18 16:30:19.554386
NCT00330798|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2016-11-17|||February 2006||2006-02-01|May 2012|2012-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief|A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status Post-Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study|Completed||Phase 4|40|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:30:19.659295|2017-02-18 16:30:19.659295
NCT00330785|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2010-01-06|||October 2004||2004-10-01|April 2007|2007-04-01|September 2005||2005-09-01|||||Interventional|JEWEL I||Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia|An International, Multicentre, Open Label Study To Assess The Effectiveness Of Amlodipine -Atorvastatin Combination In Subjects With Hypertension and Dyslipidaemia. (The JEWEL Study)|Completed||Phase 3|1250||Pfizer|||||f||||||||||||||2017-02-18 16:30:19.775475|2017-02-18 16:30:19.775475
NCT00332540|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-05-27|||August 2001||2001-08-01|May 2011|2011-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|520|Actual|Allergan|||||f||||||||||||||2017-02-18 16:30:20.222798|2017-02-18 16:30:20.222798
NCT00332514|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2016-02-19|||March 2004||2004-03-01|March 2006|2006-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care|Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care|Completed||Phase 2|200||Boston Medical Center||1|||f||||f||||||||||2017-02-18 16:30:20.30517|2017-02-18 16:30:20.30517
NCT00332488|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2014-10-09|2014-07-22||December 2004||2004-12-01|October 2014|2014-10-01||||March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes|A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents (Metformin and a Secretagogue) in Subjects With Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue.|Completed||Phase 3|547|Actual|Mannkind Corporation|Wks 12–24 was a non-randomized treatment period of the trial; outcomes were not analyzed for Wks 12–24. Safety results include entire trial; patients counted in multiple treatments for safety.|3|||f||||||||||||||2017-02-18 16:30:20.411102|2017-02-18 16:30:20.411102
NCT00332293|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2016-11-16|||May 2006||2006-05-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||AL-15469A for the Treatment of Bacterial Conjunctivitis|An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in India|Completed||Phase 3|695|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:30:28.326366|2017-02-18 16:30:28.326366
NCT00332462|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-03-01|2010-12-13||May 2006||2006-05-01|March 2011|2011-03-01|January 2009|Actual|2009-01-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients|A Multicenter, Open-label, Exploratory Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine During the First 7 Days Post Transplant Followed by Treatment With Cyclosporine Micro Emulsion in de Novo Liver Transplant Recipients|Completed||Phase 4|34|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:30:21.16209|2017-02-18 16:30:21.16209
NCT00332449|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2008-04-14|||June 2007||2007-06-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|June 2008|Anticipated|2008-06-01||Observational|||Early Breast Feeding and Glucose Levels in High Risk Newborns|Does Early Breast Feeding Prevents Neonatal Hypoglycemia in High Risk Newborns|Unknown status|Recruiting|N/A|100|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 16:30:21.626104|2017-02-18 16:30:21.626104
NCT00332436|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-05-27|||December 1999||1999-12-01|May 2011|2011-05-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|586|Actual|Allergan|||||f||||||||||||||2017-02-18 16:30:21.714617|2017-02-18 16:30:21.714617
NCT00332410|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2015-12-16|||May 2006||2006-05-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Intravenous Voriconazole in Patients With Renal Compromise|Intravenous Voriconazole in Patients With Renal Compromise|Completed||N/A|150|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:30:21.794422|2017-02-18 16:30:21.794422
NCT00332397|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2008-06-16|||March 2006||2006-03-01|June 2008|2008-06-01|July 2007|Actual|2007-07-01|||||Interventional|ISAR-TEST-2||The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis|Randomized Comparison of 3 Limus Agent-Eluting Stents for the Reduction of Coronary Restenosis|Completed||Phase 4|1007|Actual|Deutsches Herzzentrum Muenchen||3|||f||||t||||||||||2017-02-18 16:30:21.879741|2017-02-18 16:30:21.879741
NCT00332384|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-05-27|||January 2000||2000-01-01|May 2011|2011-05-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|573|Actual|Allergan|||||f||||||||||||||2017-02-18 16:30:22.002582|2017-02-18 16:30:22.002582
NCT00332371|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2012-07-05|||December 2006||2006-12-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||COMPACT - COMbining Plasma-filtration and Adsorption Clinical Trial|COMPACT (COMbining Plasma-filtration and Adsorption Clinical Trial): Efficacy and Safety of CPFA (Coupled Plasma Filtration Adsorption) for Septic Shock in the ICU|Terminated||N/A|184|Actual|Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva||2||The study was prematurely interrupted for futility.|f||||t||||||||||2017-02-18 16:30:22.327863|2017-02-18 16:30:22.327863
NCT00330772|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2007-05-25|||July 2006||2006-07-01|May 2007|2007-05-01||||||||Interventional|PAPA CABG||Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study|Pilot Study of Preoperative Aspirin and Postoperative Clopidogrel's Effects on Graft Patency and Cardiac Events in Coronary Artery Bypass Surgery|Unknown status|Recruiting|Phase 3|150|Anticipated|McMaster University|||||f||||f||||||||||2017-02-18 16:30:22.471799|2017-02-18 16:30:22.471799
NCT00330759|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2014-07-14|2010-12-09||June 2006||2006-06-01|July 2014|2014-07-01|October 2011|Actual|2011-10-01|April 2009|Actual|2009-04-01||Interventional|||Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.|A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma.|Completed||Phase 3|1779|Actual|Amgen||2|||f||||t||||||||||2017-02-18 16:30:22.58904|2017-02-18 16:30:22.58904
NCT00330746|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2012-05-17|||November 2005||2005-11-01|May 2012|2012-05-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|CALC-1||CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer|Randomized Phase II Study of Cetuximab in Combination With Gemcitabine or Gemcitabine Followed by Cetuximab in Advanced Non Small-cell Lung Cancer Patients Who Are Not Candidates for Platinum Based Therapy.|Completed||Phase 2|100|Actual|National Cancer Institute, Naples||2|||f||||f||||||||||2017-02-18 16:30:24.500096|2017-02-18 16:30:24.500096
NCT00330733|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2014-04-15|2013-12-18||January 2007||2007-01-01|April 2014|2014-04-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional||Seventy-eight individuals entered the placebo run-in phase. Of these, 71 were randomised and 70 returned to receive study medication|Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk|Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk|Completed||Phase 2/Phase 3|71|Actual|VA Office of Research and Development|Since we did not measure endogenous glucose production and lipolysis, the effects on hepatic glucose and lipid metabolism deserve further study. Sufficient numbers of women were not included, with which to confidently extend these results to women|2|||f||||t||||||||||2017-02-18 16:30:24.642999|2017-02-18 16:30:24.642999
NCT00330720|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2006-05-26|||November 2002||2002-11-01|September 2004|2004-09-01|June 2004||2004-06-01|||||Interventional|||Impact of An Emergency Response System on Anxiety and Health-Care Use|A Randomized Clinical Trial To Asses The Impact of An Emergency Response System on Anxiety and Health-Care Use Among Older Emergency Patients After A Fall|Completed||N/A|80||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 16:30:25.298482|2017-02-18 16:30:25.298482
NCT00330707|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2011-03-02|||October 1995||1995-10-01|March 2011|2011-03-01|June 2005||2005-06-01|||||Interventional|||Combined Use of BCG and Interferon Alpha in Bladder Cancer|A Multi-centre Randomised Controlled Double-blinded Trial of BCG and Interferon Alpha in High Risk Superficial Bladder Cancer|Completed||Phase 2/Phase 3|140||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 16:30:25.398526|2017-02-18 16:30:25.398526
NCT00330681|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2014-09-16|||May 2006||2006-05-01|September 2014|2014-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)|A Confirmatory Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis in Double-blind, Parallel-group, Placebo-controlled Manner.|Completed||Phase 3|206|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 16:30:25.621334|2017-02-18 16:30:25.621334
NCT00330668|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2011-05-31|2011-02-28||November 2005||2005-11-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency|Recombinant Human Insulin-Like Growth Factor-1 (IGF-1) Treatment of Children With Growth Failure Associated With Primary IGF-1 Deficiency: An Open-Label, Multi-Center, Extension Study|Terminated||Phase 3|114|Actual|Ipsen|The study was terminated by the sponsor on identification of an unacceptable frequency of hypoglycemia which was reported at doses of ≥200 mcg/kg once daily. Only safety results are presented as efficacy data were not analyzed according to protocol.|1||Unacceptable frequency of hypoglycemia observed at and above 200 ug/kg/day|f||||t||||||||||2017-02-18 16:30:25.722351|2017-02-18 16:30:25.722351
NCT00330655|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2007-08-10|||May 2006||2006-05-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder|An Open-Label, Prospective Trial of Memantine in the Treatment of Moderate to Severe Binge Eating Disorder Associated With Obesity|Completed||Phase 4|15|Actual|Mclean Hospital|||||f||||f||||||||||2017-02-18 16:30:26.06488|2017-02-18 16:30:26.06488
NCT00330642|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2015-12-14|||July 2006||2006-07-01|December 2015|2015-12-01||||July 2006|Actual|2006-07-01||Observational|||Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study|Rapid Detection of Group B Streptococcus Using a Bedside Microfluidics Device: Labor and Delivery Study|Withdrawn||N/A|0|Actual|University of Michigan|||1|HandyLab device did not work for the science|f||||f||||||||||2017-02-18 16:30:26.159687|2017-02-18 16:30:26.159687
NCT00330629|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2016-07-01|||January 2002||2002-01-01|July 2016|2016-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|PREFER||Preference and Vegetarian Diet in Weight Loss Treatment|Preference and Vegetarian Diet in Weight Loss Treatment|Completed||N/A|200|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 16:30:26.248306|2017-02-18 16:30:26.248306
NCT00330616|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2015-04-13|2008-11-26||May 2006||2006-05-01|June 2009|2009-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan|Clinical Evaluation of Bupropion SR (323U66)in Patients With Depression - Investigation in Elderly Patients With Depression|Completed||Phase 2|35|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:30:26.368391|2017-02-18 16:30:26.368391
NCT00330603|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2011-03-04|||April 2006||2006-04-01|March 2011|2011-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Observational|||Serial Exhaled Breath pH Monitoring|Serial Exhaled Breath pH Monitoring|Unknown status|Recruiting|N/A|99|Anticipated|University of Virginia|||1||f||||||||||||||2017-02-18 16:30:26.873342|2017-02-18 16:30:26.873342
NCT00330590|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2008-02-07||||||February 2008|2008-02-01|December 2006|Actual|2006-12-01|||||Observational|||Central Venous Access Catheter Placement Using the Sonic Flashlight|Central Venous Access Catheter Placement by Interventional Radiologists Using the Sonic Flashlight for Real Time Ultrasound Guidance|Completed||Phase 1|150|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 16:30:26.975807|2017-02-18 16:30:26.975807
NCT00330577|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2014-05-09|||April 2006||2006-04-01|May 2014|2014-05-01|July 2007|Actual|2007-07-01|April 2007|Actual|2007-04-01||Interventional|||24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients|24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients|Completed||Phase 4|30||Aristotle University Of Thessaloniki|||||f||||||||||||||2017-02-18 16:30:27.056439|2017-02-18 16:30:27.056439
NCT00330564|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2012-02-23|2011-06-01||May 2006||2006-05-01|February 2012|2012-02-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow|A Phase 2 Study of SU011248 (Sunitinib Malate) in Von Hippel-Lindau Syndrome|Terminated||Phase 2|15|Actual|M.D. Anderson Cancer Center|Limitations include the conclusion of the study before maximum enrollment and the use of archival tissue that was not related to the participants in the clinical trial.|1||Slow accrual.|f||||f||||||||||2017-02-18 16:30:27.152052|2017-02-18 16:30:27.152052
NCT00330551|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2013-11-02|||March 2006||2006-03-01|November 2013|2013-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia|Effects of Risperdal Consta Versus Oral Antipsychotic Medication on Clinical and Functional Outcome and Neurocognition in First-episode Schizophrenia|Completed||Phase 4|135|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-02-18 16:30:27.542276|2017-02-18 16:30:27.542276
NCT00332345|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-05-27|||July 1999||1999-07-01|May 2011|2011-05-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 2|73|Actual|Allergan|||||f||||||||||||||2017-02-18 16:30:27.669351|2017-02-18 16:30:27.669351
NCT00332332|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2014-07-18|2010-11-05||March 2006||2006-03-01|July 2014|2014-07-01|February 2010|Actual|2010-02-01|July 2009|Actual|2009-07-01||Interventional|||Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis|Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel (Etanercept) in Psoriasis|Completed||Phase 4|246|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:30:27.756254|2017-02-18 16:30:27.756254
NCT00332319|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2015-04-15|||January 2006||2006-01-01|March 2011|2011-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients|See Detailed Description|Terminated||Phase 2|1|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:30:28.095796|2017-02-18 16:30:28.095796
NCT00332306|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2009-10-07|||June 2006||2006-06-01|January 2009|2009-01-01|December 2011|Anticipated|2011-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment|Evaluation of Safety and Efficacy of Two Different Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment in Patients With HIV-1 and Tuberculosis|Unknown status|Active, not recruiting|Phase 3|180|Anticipated|Tuberculosis Research Centre, India||2|||f||||t||||||||||2017-02-18 16:30:28.204793|2017-02-18 16:30:28.204793
NCT00332280|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2013-03-19|||May 2006||2006-05-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo|A Prospective, Randomised, Multicenter Phase II/III Clinical Trial to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT Versus Placebo|Terminated||Phase 2/Phase 3|67|Actual|Auron Healthcare GmbH||1||Lack of efficacy. Stopped at first interim evaluation point|f||||||||||||||2017-02-18 16:30:28.432148|2017-02-18 16:30:28.432148
NCT00332267|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2008-09-02|||May 2006||2006-05-01|September 2008|2008-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia|Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia|Completed||N/A|36|Actual|Rigshospitalet, Denmark||3|||f||||f||||||||||2017-02-18 16:30:28.733977|2017-02-18 16:30:28.733977
NCT00332254|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2013-05-29|||March 2006||2006-03-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study to Prevent Cartilage Damage Following Acute Knee Injury.|IL-1ra for Prevention of Chondropathy Following Knee Injury|Completed||Phase 1/Phase 2|10|Actual|Duke University||2|||f||||t||||||||||2017-02-18 16:30:28.841002|2017-02-18 16:30:28.841002
NCT00332241|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2013-11-07|2009-06-03||June 2006||2006-06-01|December 2009|2009-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)|A Multicenter Double-Blind, Randomized, Placebo-Controlled, Flexible-Dosed, Parallel-Group Study of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents With Autistic Disorder (AD)|Completed||Phase 3|98|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||t||||||||||2017-02-18 16:30:29.059382|2017-02-18 16:30:29.059382
NCT00332228|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2012-10-25|||June 2002||2002-06-01|October 2012|2012-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence|Study Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence|Completed||Phase 2|125|Actual|New York State Psychiatric Institute||4|||f||||t||||||||||2017-02-18 16:30:29.840826|2017-02-18 16:30:29.840826
NCT00332215|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2008-11-26|||February 2006||2006-02-01|November 2008|2008-11-01||||||||Interventional|||A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.|Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. A Phase I, Double Blind, Placebo Controlled, Safety Study.|Terminated||Phase 1|70|Anticipated|University of Minnesota - Clinical and Translational Science Institute||||"Dr. Milla has left University of Minnesota. The study is no longer being conducted at this~   site."|||||||||||||||2017-02-18 16:30:29.964425|2017-02-18 16:30:29.964425
NCT00332202|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2013-10-30||2013-04-30|June 2006||2006-06-01|October 2013|2013-10-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin|A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin|Completed||Phase 3|709|Anticipated|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 16:30:30.066488|2017-02-18 16:30:30.066488
NCT00332189|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2012-10-17|2012-09-13||July 2006||2006-07-01|October 2012|2012-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006|A Phase 3b, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006|Completed||Phase 3|111|Actual|BioMarin Pharmaceutical||1|||f||||||||||||||2017-02-18 16:30:30.342073|2017-02-18 16:30:30.342073
NCT00332176|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2008-04-03|||June 2006||2006-06-01|April 2008|2008-04-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C|A Phase II Randomized, Active-Controlled Study to Assess the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin Over 12 Weeks in Treatment-Naïve Patients With Chronic Hepatitis C|Unknown status|Recruiting|Phase 2|50|Anticipated|BioWest Therapeutics Inc||3|||f||||||||||||||2017-02-18 16:30:30.672657|2017-02-18 16:30:30.672657
NCT00332163|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2016-01-26|2016-01-12||April 2006||2006-04-01|January 2016|2016-01-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Interventional|STEPP||Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy|A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in Subjects Receiving Second-line FOLFIRI or Irinotecan Only Chemotherapy Concomitantly With Panitumumab|Completed||Phase 2|95|Actual|Amgen||2|||f||||f||||||||||2017-02-18 16:30:30.79031|2017-02-18 16:30:30.79031
NCT00332150|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2013-01-23|||March 2006||2006-03-01|January 2013|2013-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Mothers' Approach to Clinical Research Amongst Their Preterm or Healthy Newborns|Mothers' Approach to Clinical Research Amongst Their Preterm or Healthy Newborns|Completed||N/A|200|Actual|Sheba Medical Center|||1||f||||||||||||||2017-02-18 16:30:31.869239|2017-02-18 16:30:31.869239
NCT00332137|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-03-21|||September 2005||2005-09-01|March 2011|2011-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects|Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects|Completed||Phase 2|36||Mayo Clinic|||||f||||||||||||||2017-02-18 16:30:31.959641|2017-02-18 16:30:31.959641
NCT00332124|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2017-01-26|||June 2006||2006-06-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development|Double-blind Trial of Phosphatidylcholine During Pregnancy and Infant Serum Choline Levels|Suspended||Phase 1|900|Anticipated|University of Colorado, Denver||2||reconsidering study design|f||||t||||||||||2017-02-18 16:30:32.061567|2017-02-18 16:30:32.061567
NCT00330525|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2010-01-19|||January 2005||2005-01-01|January 2010|2010-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity|Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity|Completed||Phase 2|72|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:30:34.045786|2017-02-18 16:30:34.045786
NCT00330512|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2009-06-28|||May 2006||2006-05-01|June 2009|2009-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Maternal Hypotension During Cesarean Section and Short Term Neonatal Outcome.|Maternal Hypotension During Elective Cesarean Section and Short Term Neonatal Outcome.|Terminated||Phase 1|500|Anticipated|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 16:30:34.136564|2017-02-18 16:30:34.136564
NCT00332111|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2013-01-15|||April 2006||2006-04-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Infectious Outcomes Following Pancreas Transplantation|Infectious Outcomes Following Pancreas Transplantation|Completed||N/A|300|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:30:32.171084|2017-02-18 16:30:32.171084
NCT00332098|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2014-05-16|||August 2006||2006-08-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents|Family-Focused Treatment for Bipolar Adolescents|Completed||Phase 3|145|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 16:30:32.259548|2017-02-18 16:30:32.259548
NCT00332085|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2007-10-29|||January 2006||2006-01-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Interventional|||Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes|Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes: Impact on Blood Sugar Control and Insulin Resistance|Terminated||Phase 1|40|Anticipated|Bastyr University||||Issues w/recruitment|f||||||||||||||2017-02-18 16:30:32.375273|2017-02-18 16:30:32.375273
NCT00332072|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-05-27|||August 2001||2001-08-01|May 2011|2011-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension||Completed||Phase 3|541|Actual|Allergan|||||f||||||||||||||2017-02-18 16:30:32.46522|2017-02-18 16:30:32.46522
NCT00332059|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-05-27|||May 2003||2003-05-01|May 2011|2011-05-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|445|Actual|Allergan|||||f||||||||||||||2017-02-18 16:30:32.736008|2017-02-18 16:30:32.736008
NCT00332046|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2008-10-15|||January 2006||2006-01-01|October 2008|2008-10-01||||||||Interventional|||fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder|A Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Parallel Group, fMRI Study Comparing BOLD Activation Patterns Before and After 12 Weeks of Treatment With Placebo, Comparator and GW679769 in Subjects With Social Anxiety Disorder (SAD).|Completed||Phase 1|57||GlaxoSmithKline|||||||||||||||||||2017-02-18 16:30:32.828242|2017-02-18 16:30:32.828242
NCT00332033|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-31|2017-01-24|||May 25, 2006||2006-05-25|February 16, 2007|2007-02-16|February 16, 2007||2007-02-16|||||Interventional|||Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)|Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)|Completed||Phase 2|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:30:32.916953|2017-02-18 16:30:32.916953
NCT00332020|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2015-01-26|||February 2006||2006-02-01|January 2015|2015-01-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|RECORD 2||Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement|RECORD 2 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE, Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Hip Replacement.|Completed||Phase 3|2457|Actual|Bayer||2|||f||||||||||||||2017-02-18 16:30:33.01042|2017-02-18 16:30:33.01042
NCT00332007|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2009-08-28|||May 2006||2006-05-01|August 2009|2009-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Tonabersat in the Prophylaxis of Migraine With Aura|A Single Centre, Double-blind, Randomised, Placebo Controlled Crossover Study to Evaluate the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine in Patients Presenting With Migraine With Aura|Completed||Phase 2|39|Actual|Minster Research Ltd||2|||f||||f||||||||||2017-02-18 16:30:33.289065|2017-02-18 16:30:33.289065
NCT00331994|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2009-07-17|||April 2006||2006-04-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth|Efficacy Evaluation of Enterogermina, 2 Billion Bacillus Clausii Spores, on Eradication of Small Intestinal Bacterial Overgrowth: a Randomised, Parallel-group, Open Study.|Completed||Phase 4|250|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:30:33.40166|2017-02-18 16:30:33.40166
NCT00331981|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2008-04-08|||February 2004||2004-02-01|April 2008|2008-04-01||||||||Interventional|||Amisulpride in Schizophrenic Patients|Study of the Efficacy and Safety After Long-Term Treatment With Amisulpride in Schizophrenic Patients|Completed||Phase 4|138||Sanofi|||||f||||f||||||||||2017-02-18 16:30:33.513186|2017-02-18 16:30:33.513186
NCT00331955|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2013-07-01|||March 2006||2006-03-01|July 2013|2013-07-01||||June 2012|Actual|2012-06-01||Interventional|||Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors|Phase I Trial of Vorinostat (NSC-701852, Suberoylanilide Hydroxamic Acid) and Doxorubicin (NSC-123127, Adriamycin)|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:30:33.610693|2017-02-18 16:30:33.610693
NCT00331942|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-27|2007-03-01|||July 2006||2006-07-01|April 2006|2006-04-01|May 2008||2008-05-01|||||Observational|||Breast Cancer Associated Antibodies|Study of Breast Cancer Associated Antibodies|Unknown status|Recruiting|N/A|100||Lab Discoveries Ltd.|||||f||||||||||||||2017-02-18 16:30:33.743251|2017-02-18 16:30:33.743251
NCT00331929|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-28|2008-06-18|||September 2006||2006-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Respiratory Health Study of Children in Kiryat Tivon|Respiratory Health Study of Children in Kiryat Tivon|Completed||N/A|638|Actual|Carmel Medical Center||1|||f||||t||||||||||2017-02-18 16:30:33.844933|2017-02-18 16:30:33.844933
NCT00330538|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2007-04-05|||March 2004||2004-03-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Observational|||Osteoporosis in Children With ALL|Incidence of Osteoporosis in Children With Acute Lymphoblastic Leukemia Undergoing Therapy|Completed||N/A|20||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 16:30:33.966338|2017-02-18 16:30:33.966338
NCT00330499|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2017-01-22|||October 2002||2002-10-01|January 2017|2017-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.|A Randomised Trial of Radical Chemo/Radiotherapy vs Radiotherapy Alone in the Definitive Management of Localised Muscle Invasive TCC of the Urinary Bladder|Completed||Phase 3|67|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-02-18 16:30:34.213171|2017-02-18 16:30:34.213171
NCT00330486|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2008-09-18|||April 2006||2006-04-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Open Label Trial of Acamprosate in Bipolar Alcoholics|The Use of Acamprosate in Alcohol-Dependent Individuals With Bipolar Disorder|Completed||Phase 1/Phase 2|9|Actual|Medical University of South Carolina||2|||f||||||||||||||2017-02-18 16:30:34.35352|2017-02-18 16:30:34.35352
NCT00330473|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2016-11-21|||June 2006||2006-06-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes|A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients With Type 2 Diabetes Mellitus: Two Populations With Different Insulin Treatment Options|Completed||Phase 3|1019|Actual|Eli Lilly and Company||2|||f||||||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 16:30:34.443813|2017-02-18 16:30:34.443813
NCT00330460|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2011-01-20|2010-06-18||May 2006||2006-05-01|January 2011|2011-01-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.|A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Denisty|Completed||Phase 3|1189|Actual|Amgen||2|||f||||||||||||||2017-02-18 16:30:34.621925|2017-02-18 16:30:34.621925
NCT00330447|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2016-11-18|||August 2005||2005-08-01|November 2016|2016-11-01|April 2025|Anticipated|2025-04-01|April 2025|Anticipated|2025-04-01|18 Years|Observational [Patient Registry]|||Effects of Oncological Treatment During Pregnancy|Oncological Treatment During Pregnancy: Pharmacokinetics of Chemotherapy and Long Term Follow up of the Offspring|Recruiting||N/A|5000|Anticipated|University Hospital, Gasthuisberg|||2||f||||f||||||None Retained|"~     serum and sediment of blood; from 2010 on we collect umbilical cord blood~   "|||2017-02-18 16:30:35.473049|2017-02-18 16:30:35.473049
NCT00330434|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2008-04-07|||December 2005||2005-12-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism|Human CYP2B6: Induction by Ethanol and Polymorphisms|Completed||N/A|80|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||2|||f||||f||||||||||2017-02-18 16:30:35.612469|2017-02-18 16:30:35.612469
NCT00330421|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2014-04-01|2013-11-05||June 2006||2006-06-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)|A Phase II Clinical and Correlative Study of BAY 43-9006 (Sorafenib) IND 69,896 in Sarcoma|Completed||Phase 2|15|Actual|National Cancer Institute (NCI)|No Grade 4 toxicities were noted (15 patients). IFP measurements were obtained in only 6 of 15 patients at baseline. Only 2 of these 6 patients had SD at 28 and 56 days and therefore, second IFP measurements were only obtained in those 2 patients.|2|||f||||||||||||||2017-02-18 16:30:35.706732|2017-02-18 16:30:35.706732
NCT00330408|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2006-05-25|||September 2005||2005-09-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Impact of Training of GPs on Adherence of Hypertensive Individuals to Antihypertensive Medication|Impact of Training of GPs on Adherence of Hypertensive Individuals to Antihypertensive Medication|Unknown status|Active, not recruiting|N/A|178||Aga Khan University|||||f||||||||||||||2017-02-18 16:30:35.986061|2017-02-18 16:30:35.986061
NCT00330395|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2015-11-09|||May 2006||2006-05-01|November 2015|2015-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)|A Multicenter, Sequential-Panel, Open-Label, Noncomparative Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Caspofungin Acetate in Neonates and Infants Less Than 3 Months of Age.|Completed||Phase 2|16|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:30:36.079629|2017-02-18 16:30:36.079629
NCT00330382|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2014-12-16|2014-10-03||January 1999||1999-01-01|February 2014|2014-02-01|May 2013|Actual|2013-05-01|July 2010|Actual|2010-07-01||Interventional|||Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia|Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial|Completed||Phase 2|325|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:30:36.196304|2017-02-18 16:30:36.196304
NCT00330369|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2014-02-19||2014-01-03|June 2006||2006-06-01|February 2014|2014-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension|DORADO - A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group Study to Evaluate the Efficacy and Safety of Fixed Doses of Darusentan in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic (Protocol DAR-311)|Completed||Phase 3|352|Actual|Gilead Sciences||4|||f||||t||||||||||2017-02-18 16:30:39.579004|2017-02-18 16:30:39.579004
NCT00330356|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2006-05-25|||September 2005||2005-09-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Effects of Low Salt Diet Versus High Salt Diet on Blood Pressure|Effects of Low Salt Diet Versus High Salt Diet on Blood Pressure|Unknown status|Active, not recruiting|N/A|200||Aga Khan University|||||f||||||||||||||2017-02-18 16:30:39.77829|2017-02-18 16:30:39.77829
NCT00330343|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2006-05-25|||May 2004||2004-05-01|July 2005|2005-07-01|May 2005||2005-05-01|||||Interventional|||Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents|The Optimal Dose of Prophylactic Naloxone in Ameliorating Opioid Induced Side Effects in Children and Adolescents Receiving IVPCA Morphine for Moderate to Severe Pain: A Pharmacodynamic, Pharmacokinetic, and Pharmacogenetic Study|Unknown status|Recruiting|N/A|99||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:30:40.098902|2017-02-18 16:30:40.098902
NCT00330330|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2008-02-04|||February 2003||2003-02-01|February 2008|2008-02-01|August 2006||2006-08-01|||||Interventional|||Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment|A Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Activity of ISIS 113715 in Patients With Type 2 Diabetes Mellitus Who Have Not Received Prior Therapy|Completed||Phase 2|96||Ionis Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 16:30:40.191956|2017-02-18 16:30:40.191956
NCT00330317|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2017-02-03|||February 2006||2006-02-01|February 2017|2017-02-01|November 16, 2010|Actual|2010-11-16|March 2010|Actual|2010-03-01||Interventional|||Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer|Neoadjuvant Hormone Therapy for Postmenopausal Women With HR+ Primary Breast Cancer: A Multi-center Study to Determine the Optimum Length of Treatment With Letrozole on Tumour Regression to Permit Breast Conserving Surgery.|Completed||Phase 3|300|Actual|Novartis||1|||f||||f||||||||||2017-02-18 16:30:40.283694|2017-02-18 16:30:40.283694
NCT00330304|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2010-09-07|||January 2003||2003-01-01|September 2010|2010-09-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children|Long Term Study of 2 Isoniazid (INH) Prophylactic Regimens With Concomitant Cotrimoxazole (CTX) in HIV-infected Children - Impact on Morbidity, Mortality, Bacterial Resistance and Incidence of Tuberculosis|Unknown status|Active, not recruiting|Phase 3|450|Actual|University of Cape Town||2|||f||||||||||||||2017-02-18 16:30:40.431498|2017-02-18 16:30:40.431498
NCT00330291|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2012-09-06|||August 2005||2005-08-01|September 2012|2012-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Xyrem for Treatment Refractory Insomnia Due to PTSD|Xyrem for Treatment Refractory Insomnia Due to PTSD|Withdrawn||Phase 2|0|Actual|State University of New York - Upstate Medical University||||terminated due to inability to recruit subjects|||||||||||||||2017-02-18 16:30:40.549995|2017-02-18 16:30:40.549995
NCT00331916|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2009-09-25|||November 2005||2005-11-01|September 2009|2009-09-01||||May 2007|Actual|2007-05-01||Interventional|||AL-15469A for the Treatment of Bacterial Conjunctivitis|AL-15469A for the Treatment of Bacterial Conjunctivitis|Completed||Phase 3|600|Anticipated|Alcon Research|||||||||||||||||||2017-02-18 16:30:40.639737|2017-02-18 16:30:40.639737
NCT00331890|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2012-06-19|||October 2006||2006-10-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|ICTUS||ICTUS Study: International Citicoline Trial on Acute Stroke|Citicoline in the Treatment of Acute Ischemic Stroke. An International Randomized Multicenter Placebo-controlled Study|Terminated||Phase 3|2298|Actual|Ferrer Internacional S.A.||2||With 2078 patients, a statistical stopping boundary has now been crossed|f||||t||||||||||2017-02-18 16:30:40.723883|2017-02-18 16:30:40.723883
NCT00331877|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2006-05-30|||May 2005||2005-05-01|May 2006|2006-05-01|January 2006||2006-01-01|||||Interventional|||A Communication Strategy for Families of Patients Dying in the ICU|A Proactive Communication Strategy for Family Members of Patients Dying in the ICU: A Multicenter Randomized Controlled Trial|Terminated||N/A|136||Famirea Study Group|||||f||||||||||||||2017-02-18 16:30:40.905064|2017-02-18 16:30:40.905064
NCT00331864|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2011-02-15|2010-12-09||April 2006||2006-04-01|February 2011|2011-02-01|April 2008||2008-04-01|April 2008|Actual|2008-04-01||Interventional|||SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|A Phase IIIb, Open-label, Multi-center 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of Ranibizumab (0.3 mg and/or 0.5 mg) in Patients With Subfoveal Choroidal Neovasculariza-tion Secondary to Age-related Macular Degeneration|Completed||Phase 3|531|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:30:40.99594|2017-02-18 16:30:40.99594
NCT00331851|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2017-01-25|||May 2006||2006-05-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|LEAD-5||Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes|Liraglutide Effect and Action in Diabetes (LEAD-5): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Glimepiride and Metformin Versus Glimepiride and Metformin Combination Therapy, and Versus Insulin Glargine Added to Glimepiride and Metformin Combination Therapy in Subjects With Type 2 Diabetes.A Six-month Randomised, Double-blind, Parallel-group, Multi-centre, Multi-national Trial With an Open-label Treat-to-target Insulin Glargine Control Arm.|Completed||Phase 3|584|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:30:42.041707|2017-02-18 16:30:42.041707
NCT00331838|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2013-01-14|||May 2006||2006-05-01|January 2013|2013-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|TREK||Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery|A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel Group, Dose Response Study of Subcutaneous AVE5026 With an Enoxaparin Calibrator Arm in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery|Completed||Phase 2|705|Actual|Sanofi||8|||f||||t||||||||||2017-02-18 16:30:42.277493|2017-02-18 16:30:42.277493
NCT00331825|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2006-05-30|||July 2000||2000-07-01|February 2000|2000-02-01|July 2003||2003-07-01|||||Interventional|||Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism|A Randomized Controlled Trial Study of Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism|Completed||Phase 4|70||Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan|||||f||||||||||||||2017-02-18 16:30:42.444741|2017-02-18 16:30:42.444741
NCT00331812|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2011-01-18|||February 2006||2006-02-01|January 2011|2011-01-01|February 2008|Anticipated|2008-02-01|||||Observational|||Mitochondrial Functions and Oxidative Stress in ALS Patients|Study of Mitochondrial Functions and Oxidative Stress in ALS Patients.|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Clermont-Ferrand|||1||f||||||||||||||2017-02-18 16:30:42.539252|2017-02-18 16:30:42.539252
NCT00331799|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2013-07-01|2013-04-15||April 2007||2007-04-01|June 2013|2013-06-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Pilot Study of Duloxetine in Psychological Resilience|A Pilot Study of Duloxetine in Psychological Resilience and Its Correlation With Blockade of Serotonin and Norepinephrine Transporter|Completed||Phase 2|18|Actual|Duke University||1|||f||||t||||||||||2017-02-18 16:30:42.636203|2017-02-18 16:30:42.636203
NCT00331786|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2009-02-06|||July 2006||2006-07-01|May 2007|2007-05-01||||||||Interventional|||Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer|Phase I Multiple-Dose Safety, Pharmacokinetic and Pharmacodynamic Clinical Study of Nitric Oxide Releasing Aspirin (NCX 4016)|Completed||Phase 1|240|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 16:30:42.889621|2017-02-18 16:30:42.889621
NCT00331773|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2016-03-03|||April 2006||2006-04-01|March 2016|2016-03-01||||July 2015|Actual|2015-07-01||Interventional|||Radiation Therapy in Treating Patients With Stage II Prostate Cancer|A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer|Active, not recruiting||Phase 3|1115|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 16:30:42.996766|2017-02-18 16:30:42.996766
NCT00331760|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2016-12-30|2013-04-12||March 2006||2006-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|February 2009|Actual|2009-02-01||Interventional||All registered patients.|Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery|A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvis ± Chemotherapy for Post-Operative Patients With Either Endometrial or Cervical Carcinoma|Completed||Phase 2|106|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 16:30:43.662844|2017-02-18 16:30:43.662844
NCT00331747|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2006-07-05|||May 2006||2006-05-01|July 2006|2006-07-01||||||||Interventional|||Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate|Three Dimensional Gait Evaluation in Relapsing Remitting Multiple Sclerosis Patients Treated With Glatiramer Acetate|Unknown status|Recruiting|N/A|20||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:30:44.360678|2017-02-18 16:30:44.360678
NCT00331721|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2008-05-21|||May 2006||2006-05-01|May 2008|2008-05-01|May 2009|Anticipated|2009-05-01|May 2009|Anticipated|2009-05-01||Interventional|||Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST|A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Dose-Escalating Parallel-Group Study to Investigate the Tolerability of Enecadin (INN) in Acute Ischemic Stroke|Terminated||Phase 2|24|Actual|PAION Deutschland GmbH||2||Scientific data called into question the viability of the substance class|f||||t||||||||||2017-02-18 16:30:44.454314|2017-02-18 16:30:44.454314
NCT00331708|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2016-10-25|||April 2006||2006-04-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria|An Open-label in Vivo Drug Study to Evaluate Artesunate Plus Sulfadoxine-pyrimethamine (ASSP) Pharmacokinetics, Therapeutic Efficacy, Gametocyte Carriage and Birth Outcomes in Pregnant Women With Uncomplicated Falciparum Malaria|Terminated||N/A|3|Actual|University of Cape Town||1||Lack of suitable participants|f||||t||||||||||2017-02-18 16:30:44.580522|2017-02-18 16:30:44.580522
NCT00331695|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-05-06|||June 2006||2006-06-01|March 2007|2007-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery|Evaluation of the Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery|Completed||Phase 4|560|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:30:44.931599|2017-02-18 16:30:44.931599
NCT00331682|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2014-05-12|2013-11-21||March 2006||2006-03-01|November 2013|2013-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer|An Open-Label, Non-Randomized Phase II Study of Alvocidib (Flavopiridol) in Combination With Docetaxel in Refractory, Metastatic Pancreatic Cancer (NCI #6366)|Completed||Phase 2|10|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:30:45.069689|2017-02-18 16:30:45.069689
NCT00331669|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2009-03-03|||May 2006||2006-05-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|||||Interventional|||Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia|Multicenter, Randomized Trial on the Effects of Pallidal Deep Brain Stimulation for Tardive Dystonia|Unknown status|Recruiting|Phase 2|24|Anticipated|Charite University, Berlin, Germany||1|||f||||t||||||||||2017-02-18 16:30:45.627938|2017-02-18 16:30:45.627938
NCT00331656|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2008-05-06|||June 2008||2008-06-01|May 2006|2006-05-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Comparative Study of Non-Invasive Mask Ventilation vs Cuirass Ventilation in Patients With Acute Respiratory Failure.|Non-Invasive Positive Pressure Mask Ventilation vs Extrathoracic Biphasic Cuirass Ventilation in Patients With Acute Respiratory Failure: A Randomized Prospective Study.|Unknown status|Not yet recruiting|Phase 4|40|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:30:45.743266|2017-02-18 16:30:45.743266
NCT00331643|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2014-11-13|||April 2006||2006-04-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|October 2007|Actual|2007-10-01||Interventional|||Ixabepilone in Treating Young Patients With Refractory Solid Tumors|Phase II Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Children and Young Adults With Refractory Solid Tumors|Completed||Phase 2|120|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:30:45.843017|2017-02-18 16:30:45.843017
NCT00331630|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2014-09-23|||May 2006||2006-05-01|September 2014|2014-09-01|August 2015|Anticipated|2015-08-01|August 2009|Actual|2009-08-01||Interventional|||Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer|Pilot Neoadjuvant Trial in Breast Cancer With Combination of ABI-007 (Abraxane) and GW572016 (Lapatinib)|Unknown status|Active, not recruiting|Early Phase 1|30|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 16:30:45.959751|2017-02-18 16:30:45.959751
NCT00331604|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2012-07-09||2009-11-09|August 2006||2006-08-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes|Inhaled Pre-prandial Human Insulin With the AERx® iDMS Versus s.c. Insulin Aspart in Type 2 Diabetes: A 104 Week, Open-label, Multicenter, Randomised, Trial Followed by a 12 Week Re-randomised Extension to Investigate Safety and Efficacy|Terminated||Phase 3|618|Actual|Novo Nordisk A/S||3||See termination reason in detailed description|f||||f||||||||||2017-02-18 16:30:46.100917|2017-02-18 16:30:46.100917
NCT00331578|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2009-01-19|||June 2006||2006-06-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|||||Interventional|CREATE||Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent|Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent|Completed||Phase 4|2077|Actual|JW Medical Systems Ltd||1|||f||||t||||||||||2017-02-18 16:30:46.246751|2017-02-18 16:30:46.246751
NCT00331565|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-29|2014-12-02|||August 2006||2006-08-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin|Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin|Completed||Phase 4|36|Actual|University of Oslo School of Pharmacy||1|||f||||||||||||||2017-02-18 16:30:46.320192|2017-02-18 16:30:46.320192
NCT00331552|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2013-05-07|||February 2006||2006-02-01|May 2013|2013-05-01||||February 2011|Actual|2011-02-01||Interventional|||Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer|Phase I - II Study of Doxil® In Combination With Daily Oral Cyclophosphamide and Herceptin for Patients With HER-2/Neu Positive Disease In Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|30|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 16:30:46.436127|2017-02-18 16:30:46.436127
NCT00331539|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2006-10-06|||May 2006||2006-05-01|July 2005|2005-07-01|June 2008||2008-06-01|||||Interventional|||Relationship Between Auto NRT and Behavioural T & C Levels With the Nucleus Freedom Cochlear Implant|Relationship Between Auto NRT and Behavioural T & C Levels With the Nucleus Freedom Cochlear Implant|Unknown status|Recruiting|Phase 4|20||Bnai Zion Medical Center|||||f||||||||||||||2017-02-18 16:30:46.577038|2017-02-18 16:30:46.577038
NCT00331526|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2013-03-22|||February 1999||1999-02-01|March 2013|2013-03-01|April 2012|Actual|2012-04-01|December 2008|Actual|2008-12-01||Interventional|||Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme|Phase II Trial of Intralesional Adoptive Cellular Therapy of Glioblastoma With Interleukin-2-Stimulated Lymphocytes|Completed||Phase 2|83|Actual|Hoag Memorial Hospital Presbyterian||1|||f||||||||||||||2017-02-18 16:30:46.671033|2017-02-18 16:30:46.671033
NCT00331513|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2013-09-27|||March 2006||2006-03-01|September 2013|2013-09-01||||January 2010|Actual|2010-01-01||Interventional|||Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes|A Phase 1 Study of Suberoylanilide Hydroxamic Acid (Vorinostat, SAHA) in Combination With Idarubicin in Relapsed or Refractory Leukemia|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:30:46.776848|2017-02-18 16:30:46.776848
NCT00331500|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2016-11-17|||August 2006||2006-08-01|June 2008|2008-06-01||||August 2007|Actual|2007-08-01||Interventional|||Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis|A Comparative Study of Olopatadine 0.2% Versus Vehicle in Patients With Seasonal Allergic Conjunctivitis or Rhinoconjunctivitis|Completed||Phase 3|250|Anticipated|Alcon Research|||||||||||||||||||2017-02-18 16:30:46.893191|2017-02-18 16:30:46.893191
NCT00331487|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2012-02-27|||September 2000||2000-09-01|February 2012|2012-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia|Pioglitazone Versus Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia|Completed||Phase 3|719|Actual|Takeda||2|||f||||f||||||||||2017-02-18 16:30:46.978827|2017-02-18 16:30:46.978827
NCT00331474|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2009-02-13|||May 2006||2006-05-01|February 2009|2009-02-01|August 2009|Anticipated|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of Bacille Calmette Guerin (BCG) Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants|The Effect of BCG Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants|Unknown status|Active, not recruiting|Phase 1/Phase 2|180|Anticipated|University of Stellenbosch||2|||f||||||||||||||2017-02-18 16:30:47.174902|2017-02-18 16:30:47.174902
NCT00331448|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2006-08-10|||June 2000||2000-06-01|May 2006|2006-05-01|July 2007||2007-07-01|||||Observational|||Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults|Fat Redistribution and Metabolic Change in HIV Infection (FRAM)|Unknown status|Active, not recruiting|N/A|1483||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:30:47.277229|2017-02-18 16:30:47.277229
NCT00331435|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2011-03-30|||June 2006||2006-06-01|March 2011|2011-03-01|January 2010|Actual|2010-01-01|January 2009|Actual|2009-01-01||Interventional|||PDT Study for Exudative AMD With PCV|Clinical Research of Photodynamic Therapy for Exudative Age-related Macular Degeneration Accompanied With Polypoidal Choroidal Vasculopathy|Completed||Phase 4|113|Actual|Ophthalmic PDT Study Group||2|||f||||t||||||||||2017-02-18 16:30:47.368512|2017-02-18 16:30:47.368512
NCT00331422|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2012-11-06|2009-11-23||October 2005||2005-10-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer|A Phase II Study of Carboplatin and Paclitaxel as Neoadjuvant Chemotherapy Followed by Interval Cytoreduction in Women With Advanced Staged Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma for High-Risk Surgical Candidates or Patients Unlikely to be Optimally Surgically Cytoreduced|Terminated||Phase 2|7|Actual|Masonic Cancer Center, University of Minnesota|1 of the 2 evaluable patients was switched from Paclitaxel to Taxotere during the course of her treatment due to toxicity (adverse effects), but since it remains a platinum-based chemotherapy she is included in the evaluable group.|1||Study was terminated due to lack of available funding.|f||||t||||||||||2017-02-18 16:30:47.508185|2017-02-18 16:30:47.508185
NCT00331409|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2016-02-17|2011-06-13||January 2006||2006-01-01|February 2016|2016-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Phase II Study of the Mammalian Target of Rapamycin (mTOR) Inhibitor RAD001 in Combination With Imatinib Mesylate in Patients With Previously Treated Advanced Renal Carcinoma|Completed||Phase 2|23|Actual|OHSU Knight Cancer Institute|Our phase II study closed after the first stage of accrual due to an insufficient number of participants who remained progression-free at 3 months, per the study design.|1|||f||||t||||||||||2017-02-18 16:30:47.844011|2017-02-18 16:30:47.844011
NCT00331370|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2006-05-30|||May 2006||2006-05-01|May 2006|2006-05-01|June 2009||2009-06-01|||||Interventional|||Hypertension Related Damage to the Microcirculation in South Asian: Emergence, Predictive Power and Reversibility|Hypertension Related Damage to the Microcirculation in South Asian: Emergence,Predictive Power and Reversibility|Unknown status|Not yet recruiting|N/A|2880||Aga Khan University|||||f||||||||||||||2017-02-18 16:30:48.389303|2017-02-18 16:30:48.389303
NCT00331357|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-29|2006-05-29|||June 2006||2006-06-01|May 2006|2006-05-01|December 2008||2008-12-01|||||Observational|||Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire|Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire|Unknown status|Not yet recruiting|N/A|100||University Hospital, Angers|||||f||||||||||||||2017-02-18 16:30:48.483138|2017-02-18 16:30:48.483138
NCT00331344|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-30|2012-09-19|||April 2006||2006-04-01|September 2012|2012-09-01||||November 2010|Actual|2010-11-01||Interventional|||Ixabepilone, Mitoxantrone Hydrochloride, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy|Phase I/II Trial of Epothilone Analog BMS-247550 (Ixabepilone), Mitoxantrone, and Prednisone in Hormone Refractory Prostate Cancer Patients Previously Treated With Chemotherapy|Completed||Phase 1/Phase 2|106|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:30:48.572072|2017-02-18 16:30:48.572072
NCT00331279|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2012-12-06|||August 2005||2005-08-01|January 2011|2011-01-01|February 2006|Actual|2006-02-01|September 2005|Actual|2005-09-01||Interventional|||The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: A Pilot Study|The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: A Pilot Study|Completed||Phase 1|1|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 16:30:49.024609|2017-02-18 16:30:49.024609
NCT00331253|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2007-04-25|||April 2007||2007-04-01|April 2007|2007-04-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).|A 54-WEEK, PHASE 2, MULTICENTER, MASKED, RANDOMIZED, CONTROLLED TRIAL TO ESTABLISH THE SAFETY AND EFFICACY OF INDOCYANINE GREEN-MEDIATED PHOTOTHROMBOSIS (i-MP) FOR THE TREATMENT OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.|Unknown status|Recruiting|Phase 2|280||Opto Eletronica S.A.|||||f||||t||||||||||2017-02-18 16:30:49.155203|2017-02-18 16:30:49.155203
NCT00331240|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2014-05-09|||March 2006||2006-03-01|May 2014|2014-05-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination|24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination|Completed||Phase 3|32||Aristotle University Of Thessaloniki|||||f||||f||||||||||2017-02-18 16:30:49.241395|2017-02-18 16:30:49.241395
NCT00331227|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2007-03-14|||May 2006||2006-05-01|March 2007|2007-03-01|December 2006||2006-12-01|||||Interventional|||Flavonoid Supplementation and Endothelial Function|Effect of Supplemental Flavonoids on Endothelial Function, Lipids, and Markers of Inflammation|Completed||Phase 4|25||Carolinas Healthcare System|||||f||||||||||||||2017-02-18 16:30:49.322331|2017-02-18 16:30:49.322331
NCT00331214|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2013-04-15|||June 2002||2002-06-01|April 2013|2013-04-01|July 2006|Actual|2006-07-01|December 2003|Actual|2003-12-01||Interventional|||Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido|Study to Evaluate the Efficacy and Safety of Transdermal Testosterone in Women With Hypoactive Sexual Desire Disorder on Concurrent Estrogen Replacement Therapy and Undergone Hysterectomy/Bilateral Oophorectomy|Completed||Phase 3|533|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 16:30:49.403959|2017-02-18 16:30:49.403959
NCT00331201|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2006-11-27|||July 2005||2005-07-01|November 2006|2006-11-01|April 2006||2006-04-01|||||Interventional|||SAFEstart Feeding Intolerance Study Phase II|SAFEstart Treatment for NICU Patients With Feeding Intolerance; a Phase II Randomized, Controlled Trial|Completed||Phase 2|20||Intermountain Health Care, Inc.|||||f||||||||||||||2017-02-18 16:30:49.508851|2017-02-18 16:30:49.508851
NCT00331188|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2008-07-07|||May 2006||2006-05-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding|The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension|Completed||Phase 3|70|Actual|Debiovision||1|||f||||f||||||||||2017-02-18 16:30:49.601429|2017-02-18 16:30:49.601429
NCT00331175|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2006-12-14|||July 2006||2006-07-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults|A Phase 1, Randomized, Placebo- And Positive Controlled Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Escalating Doses Of Intravenous Peptide YY3-36 In Otherwise Healthy Overweight Adult Subjects|Completed||Phase 1|31||Pfizer|||||||||||||||||||2017-02-18 16:30:49.741949|2017-02-18 16:30:49.741949
NCT00331162|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2017-01-10|||February 2005||2005-02-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation|Alemtuzumab Versus Thymoglobulin Induction Therapy in Kidney and Pancreas Transplantation|Active, not recruiting||Phase 4|275|Anticipated|Wake Forest University Health Sciences||2|||f||||f||||||||No||2017-02-18 16:30:49.82643|2017-02-18 16:30:49.82643
NCT00331149|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2013-03-07|||June 2006||2006-06-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's|A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment With Ropinirole Immediate Release Tablets (REQUIP IR) or Ropinirole Prolonged Release Tablets (SK&F-101468) in Advanced Stage Parkinson's Disease Subjects Who Are Not Adequately Controlled on L-dopa.|Completed||Phase 3|344|Anticipated|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:30:49.938998|2017-02-18 16:30:49.938998
NCT00331136|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2008-05-19|||June 2006||2006-06-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria|An Open-Label, Phase II, Dose-Escalation Clinical Study to Assess the Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of Fixed Dose Combination of Pyronaridine and Artesunate (3:1) In Children With Acute Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 2|45|Actual|Medicines for Malaria Venture||3|||f||||||||||||||2017-02-18 16:30:50.060019|2017-02-18 16:30:50.060019
NCT00331123|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2013-04-15|||May 2002||2002-05-01|April 2013|2013-04-01|July 2006|Actual|2006-07-01|December 2003|Actual|2003-12-01||Interventional|||Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido|Study to Evaluate Efficacy and Safety of Transdermal Testosterone and Safety for an Open-label Period in Women With Hypoactive Sexual Desire Disorder on Estrogen Replacement Therapy and Undergone Hysterectomy/Bilateral Oophorectomy.|Completed||Phase 3|562|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 16:30:50.204407|2017-02-18 16:30:50.204407
NCT00331110|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2007-12-20|||May 2006||2006-05-01|April 2007|2007-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of How An Ankle Strap Changes Effects of Insole Treatment for Knee Osteoarthritis|Immediate and Short-Term Analgesic and Biomechanical Effects of a Laterally Wedged Insole With Ankle Strapping for Medial Compartment Knee Osteoarthritis|Completed||Phase 2/Phase 3|14||University of Iowa|||||f||||||||||||||2017-02-18 16:30:50.31483|2017-02-18 16:30:50.31483
NCT00331097|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2015-11-27|||July 2003||2003-07-01|November 2015|2015-11-01|March 2017|Anticipated|2017-03-01|May 2014|Actual|2014-05-01||Interventional|||ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment|Adjuvant Chemotherapy in Elderly Patients With Breast Cancer: Weekly Docetaxel vs. CMF|Active, not recruiting||Phase 3|300|Actual|National Cancer Institute, Naples||2|||f||||f||||||||||2017-02-18 16:30:50.403867|2017-02-18 16:30:50.403867
NCT00326040|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2008-07-23|||April 2003||2003-04-01|July 2008|2008-07-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects|A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects.|Completed||Phase 4|45|Actual|Glaukos Corporation||1|||f||||t||||||||||2017-02-18 16:32:49.31097|2017-02-18 16:32:49.31097
NCT00331084|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2009-08-06|||April 2006||2006-04-01|August 2009|2009-08-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Postoperative Inflammation in Cataract Surgery|Efficacy of Antibiotic Steroid Combination Compared With Individual Administration in Prevention of Postoperative Inflammation in Patients Having Cataract Surgery|Completed||N/A|132|Actual|Federal University of São Paulo||2|||f||||t||||||||||2017-02-18 16:30:50.526876|2017-02-18 16:30:50.526876
NCT00331071|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2016-07-15|||April 2002||2002-04-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks|Postmarketing Study of ORTHO EVRA in Relation to Venous Thromboembolism, Ischemic Stroke, and Myocardial Infarction|Completed||N/A|334|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||2||f||||||||||||||2017-02-18 16:30:50.64251|2017-02-18 16:30:50.64251
NCT00331058|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2013-02-14|||February 2006||2006-02-01|February 2013|2013-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects|A Study To Validate Key Therapeutic Targets and Characterise Their Response to Corticosteroids in Multiple Asthma Phenotypes|Terminated||Phase 1|58|Actual|GlaxoSmithKline||2||"The study was truncated due to the long period of enrollment and the collection of a~   sufficient amount of data that allowed the scientific objectives to be met"|f||||f||||||||||2017-02-18 16:30:50.749746|2017-02-18 16:30:50.749746
NCT00331045|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2015-09-01|||April 2006||2006-04-01|September 2009|2009-09-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid|Clinical Evaluation of Alvimopan (SB767905) on Constipation and Related Symptoms Associated With Opioid -A Placebo-controlled Double-blind Study in Cancer Patients-|Terminated||Phase 2|21|Actual|Cubist Pharmaceuticals LLC||4||"Subject registration did not proceed as expected; difficult to complete within scheduled time~   frame; prematurely terminated w/ 21 subjects randomized."|f||||||||||||||2017-02-18 16:30:50.862481|2017-02-18 16:30:50.862481
NCT00331032|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2013-08-22|||December 2006||2006-12-01|August 2013|2013-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||VivaGel™ in Healthy Young Women|An Expanded Phase I Randomized Placebo Controlled Trial of the Safety and Tolerability of 3 Percent w/w SPL7013 Gel (VivaGel™) in Healthy Young Women When Administered Twice Daily for 14 Days|Completed||Phase 1|56|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:30:50.96337|2017-02-18 16:30:50.96337
NCT00331019|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2015-12-14|||July 2006||2006-07-01|December 2015|2015-12-01||||July 2006|Actual|2006-07-01||Observational|||Rapid Detection of Group B Strep- 35-37 Week Study|Rapid Detection of Group B Streptococcus Using a Bedside Microfluidics Device: 35-37 Week Study|Withdrawn||N/A|0|Actual|University of Michigan|||1|HandyLab device determined to not work for the science|f||||f||||||||||2017-02-18 16:30:51.070778|2017-02-18 16:30:51.070778
NCT00331006|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2013-06-07|2013-01-07||June 2006||2006-06-01|June 2013|2013-06-01|January 2012|Actual|2012-01-01|November 2010|Actual|2010-11-01||Interventional|RICH|All subjects who began the screening phase|Rituximab to Treat Severe Hemophilia A|Rituximab for the Treatment of Inhibitors in Congenital Hemophilia A (A TMH CTN Study)|Completed||Phase 2|23|Actual|New England Research Institutes|The study was terminated before reaching its target sample size of 50 subjects due to low enrollment rates. Therefore, confidence intervals for proportions are wide.|1|||f||||t||||||||||2017-02-18 16:30:51.168223|2017-02-18 16:30:51.168223
NCT00330993|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2007-01-24|||March 2006||2006-03-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation|Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation|Completed||Phase 2|120||University of Pittsburgh|||||||||||||||||||2017-02-18 16:30:51.588872|2017-02-18 16:30:51.588872
NCT00330980|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2014-03-19|||April 2000||2000-04-01|July 2008|2008-07-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels|Statins and Noncardiovascular Endpoints|Completed||Phase 4|1000|Anticipated|University of California, San Diego||3|||f||||||||||||||2017-02-18 16:30:51.676472|2017-02-18 16:30:51.676472
NCT00330967|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2015-03-17|2015-01-22||April 2006||2006-04-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|January 2012|Actual|2012-01-01||Observational|||Mechanisms of Insulin Resistance in Humans|Mechanisms of Insulin Resistance in Humans|Completed||N/A|25|Actual|VA Office of Research and Development|The study's original Principal Investigator left the VA prior to the completion of data acquisition and no further subjects were enrolled. The data entered were analyzed based solely on study files in the system.||2||f||||f||||||Samples Without DNA|"~     Blood samples, muscle biopsies~   "|||2017-02-18 16:30:51.788581|2017-02-18 16:30:51.788581
NCT00330954|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2010-03-03|||June 2006||2006-06-01|March 2010|2010-03-01|April 2008|Actual|2008-04-01|||||Observational|||Gene Expression Profiling in Type 1 Diabetes|Gene Expression Profiling in Type 1 Diabetes|Completed||N/A|64|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"~     Whole Blood saved frozen for 1 year~   "|||2017-02-18 16:30:52.177956|2017-02-18 16:30:52.177956
NCT00330941|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2016-06-27|||January 2003||2003-01-01|June 2016|2016-06-01|December 2004||2004-12-01|||||Interventional|||Intravenous Lidocaine and Acute Rehabilitation|Intravenous Lidocaine Infusion Improves Outcome After Laparoscopic Colectomy|Completed||Phase 4|45||The Cleveland Clinic|||||f||||||||||||||2017-02-18 16:30:52.260773|2017-02-18 16:30:52.260773
NCT00330928|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2016-08-29|2009-01-28||January 2006||2006-01-01|August 2016|2016-08-01|October 2008|Actual|2008-10-01|October 2007|Actual|2007-10-01||Interventional|SPECTACL||SPECTACL: SPECTroscopic Assessment of Coronary Lipid|Coronary Artery Plaque Characterization by NIR Spectroscopy in Patients Undergoing Elective Percutaneous Coronary Intervention|Completed||Phase 2/Phase 3|106|Actual|InfraReDx|Technical limits of the prototype device factored into the data set reduction(28 patients).Data made available to evaluate handling of the device(30 patients) could not be prospectively evaluated for the primary endpoint of Spectral Similarity.|1|||f||||t||||||||||2017-02-18 16:30:52.589586|2017-02-18 16:30:52.589586
NCT00330915|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2009-06-03|2009-06-03||June 2006||2006-06-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.|A Feasibility Study of Pemetrexed Single Agent and Folic Acid Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer|Completed||Phase 2|37|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:30:52.901286|2017-02-18 16:30:52.901286
NCT00330902|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2007-10-30|||January 2004||2004-01-01|October 2007|2007-10-01|November 2004|Actual|2004-11-01|||||Interventional|||Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan|Randomized Trial of Sulfadoxine-Pyrimethamine Plus Artesunate (SP+AS) Versus SP+AS Plus Primaquine for Clearance of Low Density P. Falciparum Infection in Eastern Sudan|Completed||Phase 3|104|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-02-18 16:30:53.3605|2017-02-18 16:30:53.3605
NCT00330889|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2012-10-18|||February 2004||2004-02-01|October 2012|2012-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Effects Of Prednisolone On Rheumatoid Arthritis Patients|A Study of the Pharmacodynamic Effects of Prednisolone on Whole Blood Protein and Gene Expression in Rheumatoid Arthritis Patients|Completed||N/A|32|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 16:30:53.485235|2017-02-18 16:30:53.485235
NCT00330876|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2010-03-09|2009-08-26||June 2006||2006-06-01|March 2010|2010-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia|Open-Label, Long-Term (> 1 Year) Extension Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia|Completed||Phase 3|545|Actual|Kowa Research Europe||2|||f||||f||||||||||2017-02-18 16:30:53.596738|2017-02-18 16:30:53.596738
NCT00330863|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2014-07-14|||May 2006||2006-05-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|PROACTIVE||Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy|Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)|Completed||Phase 4|357|Actual|Northwell Health||2|||f||||t||||||||||2017-02-18 16:30:54.119577|2017-02-18 16:30:54.119577
NCT00330850|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-26|2007-03-30|||May 2006||2006-05-01|March 2007|2007-03-01|December 2006||2006-12-01|||||Interventional|||An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack||Completed||Phase 3|650||ProEthic Pharmaceuticals|||||||||||||||||||2017-02-18 16:30:54.267222|2017-02-18 16:30:54.267222
NCT00330278|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2007-09-26|||January 2003||2003-01-01|January 2006|2006-01-01|January 2006|Actual|2006-01-01|||||Interventional|||Timing of Prophylactic Antibiotics for Cesarean Sections|A Randomized, Double-Blind, Placebo Controlled Trial of Cefazolin Given Either 30 Minutes Prior to Cesarean Section or at Cord Clamping|Completed||N/A|350||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:30:54.357537|2017-02-18 16:30:54.357537
NCT00330265|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2008-08-25|||January 2006||2006-01-01|August 2008|2008-08-01|September 2009|Anticipated|2009-09-01|March 2009|Anticipated|2009-03-01||Interventional|KC-002PT||Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers|A Prospective, Randomized, Controlled, Unmasked, Multiple Treatment, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of an Interactive Wound Dressing Containing Cultured Keratinocytes Versus Conventional Wound Therapy for the Treatment of Diabetic Foot Ulcers|Unknown status|Recruiting|Phase 2|300|Anticipated|KeraCure||2|||f||||t||||||||||2017-02-18 16:30:54.450821|2017-02-18 16:30:54.450821
NCT00330252|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2016-05-11|||May 2006||2006-05-01|May 2016|2016-05-01|January 2014|Actual|2014-01-01|January 2013|Actual|2013-01-01||Interventional|||Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL|Weekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLL|Completed||Phase 1|29|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:30:54.562311|2017-02-18 16:30:54.562311
NCT00330239|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2007-10-02|||January 2003||2003-01-01|October 2007|2007-10-01|May 2005||2005-05-01|||||Interventional|||Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence|Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence|Completed||Phase 4|25||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:30:54.67455|2017-02-18 16:30:54.67455
NCT00330226|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2010-07-21|||January 2006||2006-01-01|July 2010|2010-07-01|December 2012|Anticipated|2012-12-01|||||Observational|||Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders|Naturalistic Prospective Follow-Up of Patients With Schizophrenia or Bipolar Disorders Receiving Atypical Antipsychotics and/or Mood Stabilizers|Unknown status|Recruiting|N/A|500|Anticipated|Seoul National University Hospital|||1||f||||t||||||Samples Without DNA|"~     regular lab tests for evaluating the changes in medical condition~   "|||2017-02-18 16:30:54.77117|2017-02-18 16:30:54.77117
NCT00330213|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2006-05-24|||October 2004||2004-10-01|September 2004|2004-09-01|April 2005||2005-04-01|||||Interventional|||Effects of Red Wine and Cognac on Coronary Circulation|Effects of Red Wine and Cognac on Coronary Circulation|Completed||N/A|25||University of Turku|||||f||||||||||||||2017-02-18 16:30:54.881434|2017-02-18 16:30:54.881434
NCT00330200|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2008-04-25|||November 2006||2006-11-01|April 2008|2008-04-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics|A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of ISIS 113715 Monotherapy on Insulin Sensitivity, Glucose and Lipid Metabolism and Energy Expenditure in Subjects With Type 2 Diabetes Mellitus|Terminated||Phase 2|2|Actual|Ionis Pharmaceuticals, Inc.||1||Due to poor enrollment|f||||f||||||||||2017-02-18 16:30:54.974284|2017-02-18 16:30:54.974284
NCT00330187|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2006-05-25|||March 2004||2004-03-01|April 2006|2006-04-01|September 2008||2008-09-01|||||Interventional|||Combined Pharmaco/Behavior Therapy in Adolescent Smokers|Combined Pharmaco/Behavior Therapy in Adolescent Smokers|Unknown status|Recruiting|N/A|216||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:30:55.070673|2017-02-18 16:30:55.070673
NCT00330174|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2015-04-10|2013-05-29||April 2006||2006-04-01|April 2015|2015-04-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Acamprosate in Alcoholics With Comorbid Anxiety or Depression|The Use of Acamprosate in Individuals With Alcohol Dependence and Comorbid Anxiety or Depression|Completed||Phase 4|90|Actual|Medical University of South Carolina||2|||f||||f||||||||||2017-02-18 16:30:55.241765|2017-02-18 16:30:55.241765
NCT00330161|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-25|2014-04-25|2014-04-25||March 2006||2006-03-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|September 2009|Actual|2009-09-01||Interventional||Of the 29 patients enrolled, only 27 were analyzed. Two patients were deemed ineligible after treatment started and they were excluded from all analysis except adverse event collection.|Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer|Phase II Evaluation of Suberoylanilide Hydroxamic Acid (NSC 701852) in Patients With Advanced Prostate Cancer That Has Progressed on One Prior Chemotherapy|Completed||Phase 2|29|Actual|National Cancer Institute (NCI)|The primary objective was to determine the number of patients wtih progression-free survival at 6 months. Unfortunately all eligible patients were off therapy before the 6 month time point.|1|||f||||||||||||||2017-02-18 16:30:55.702092|2017-02-18 16:30:55.702092
NCT00330148|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2006-05-24|||March 2001||2001-03-01|May 2006|2006-05-01|June 2004||2004-06-01|||||Interventional|||Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis|Clinical Trial Comparing the Therapeutic Combinations Melarsoprol-Nifurtimox, Melarsoprol-Eflornithine and Eflornithine-Nifurtimox in the Treatment of Gambiense Human African Trypanosomiasis in the Meningo-Encephalitic Phase|Terminated||Phase 3|435||Epicentre|||||f||||||||||||||2017-02-18 16:30:56.016729|2017-02-18 16:30:56.016729
NCT00330135|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2008-01-07|||January 2005||2005-01-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis|Multicentre, Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Investigate the Efficacy of Sodium Hyaluronate in Patients With Symptomatic Hip Osteoarthritis|Terminated||Phase 3|85|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 16:30:56.121734|2017-02-18 16:30:56.121734
NCT00330122|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2006-05-24|||March 2006||2006-03-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Restoration of the Radial Length in Compound Wrist Fractures Using Anterior Locking Plates|Restoration of the Radial Length in Compound Wrist Fractures Using Anterior Locking Plates|Unknown status|Recruiting|N/A|120||University Hospital, Angers|||||f||||||||||||||2017-02-18 16:30:58.907592|2017-02-18 16:30:58.907592
NCT00330109|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2017-01-13|||June 2006||2006-06-01|July 2016|2016-07-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology|Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology|Active, not recruiting||N/A|113|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 16:30:59.031749|2017-02-18 16:30:59.031749
NCT00330096|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2015-10-28|||March 2006||2006-03-01|October 2013|2013-10-01|April 2009|Actual|2009-04-01|||||Interventional|||Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women||Completed||Phase 3|110|Anticipated|Nestlé||2|||f||||||||||||||2017-02-18 16:30:59.119659|2017-02-18 16:30:59.119659
NCT00330083|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2007-09-20|||May 2006||2006-05-01|September 2007|2007-09-01||||||||Interventional|||Safety of ALK Ragweed Tablet|A RANDOMIZED, MULTIPLE DOSE, DOSE-ESCALATION, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE I TRIAL INVESTIGATING THE OPTIMAL SAFE DOSE OF ALK RAGWEED TABLET AMBROSIA ARTEMISIIFOLIA IN ADULT SUBJECTS WITH SEASONAL RHINOCONJUNCTIVITIS CAUSED BY RAGWEED POLLEN ALLERGY|Completed||Phase 1|72|Anticipated|ALK-Abelló A/S|||||f||||||||||||||2017-02-18 16:30:59.214193|2017-02-18 16:30:59.214193
NCT00330070|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2007-02-14|||May 2006||2006-05-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Interventional|||Control of Asthma Patients Symptomatic on Inhaled Corticosteroids|An 8 Week, Randomized, Double-Blind, Parallel Group, Multicenter Trial Comparing the Efficacy and Safety of Oral IPL512,602 to Placebo in Subjects With Moderate to Severe Persistent Asthma Inadequately Controlled on Inhaled Corticosteroids|Completed||Phase 2|200||Inflazyme Pharmaceuticals Ltd|||||f||||||||||||||2017-02-18 16:30:59.290406|2017-02-18 16:30:59.290406
NCT00330044|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2016-12-01|||April 2006||2006-04-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer|A Phase I Study of Premetrexed (Alimta) and Carboplatin and Radiation Therapy in Patients With Inoperable Non Small Cell Lung Cancer.|Completed||Phase 1|18|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 16:30:59.403555|2017-02-18 16:30:59.403555
NCT00330018|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2015-04-19|||February 2006||2006-02-01|August 2009|2009-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)|An Investigator Initiated Prospective Randomized, Controlled Pilot Study in Order to Evaluate the Place of Valganciclovir in Prevention of Cytomegalovirus Reactivation Following Allogeneic Stem Cell Transplantation|Completed||Phase 3|40|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 16:30:59.505874|2017-02-18 16:30:59.505874
NCT00330005|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2006-05-24|||July 2002||2002-07-01|May 2006|2006-05-01|January 2005||2005-01-01|||||Interventional|||A Pilot Study of Psychodynamic Psychotherapy for Bipolar Disorder|A Pilot Study of Psychodynamic Psychotherapy for Bipolar Disorder|Completed||N/A|24||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 16:30:59.608281|2017-02-18 16:30:59.608281
NCT00329992|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2010-01-19|||April 2004||2004-04-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Brief Eclectic Psychotherapy for PTSD - a Randomized Controlled Trial|Brief Eclectic Psychotherapy for PTSD - a Randomized Controlled Trial|Completed||Phase 3|30|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 16:30:59.699038|2017-02-18 16:30:59.699038
NCT00329979|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2010-06-09|||May 2006||2006-05-01|June 2010|2010-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Femoral vs Radial Approach and MRI Evaluation of Strokes|Silent Cerebral Infarction After Heart Catheterization: A Randomized Comparison of Radial and Femoral Arterial Access.|Completed||N/A|152|Anticipated|University Hospital, Caen|||2||f||||||||||||||2017-02-18 16:30:59.798484|2017-02-18 16:30:59.798484
NCT00329966|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2006-09-13|||June 2006||2006-06-01|September 2006|2006-09-01||||||||Interventional|||Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older|A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Commercially Available Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2006-2007, When Administered to Non-Elderly Adult and Elderly Subjects|Completed||Phase 2|100||Novartis|||||f||||||||||||||2017-02-18 16:31:00.126709|2017-02-18 16:31:00.126709
NCT00329940|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2012-08-06|||November 2005||2005-11-01|August 2012|2012-08-01||||January 2008|Actual|2008-01-01||Interventional|||Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer|Assessment of Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer Having Discontinued Anastrozole Adjuvant Treatment Due to Musculoskeletal Disorders|Completed||Phase 3|200|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:31:00.234351|2017-02-18 16:31:00.234351
NCT00329927|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2006-09-13|||June 2006||2006-06-01|September 2006|2006-09-01||||||||Interventional|||Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects|A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Commercially Available Surface Antigen, Inactivated, (Adjuvanted With MF59C.1) Influenza Vaccine, Formulation 2006-2007, When Administered to Elderly Subjects.|Completed||Phase 2|60||Novartis|||||f||||||||||||||2017-02-18 16:31:00.339991|2017-02-18 16:31:00.339991
NCT00329914|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2011-07-22|||June 2006||2006-06-01|February 2009|2009-02-01|September 2010|Actual|2010-09-01|February 2009|Actual|2009-02-01||Interventional|||Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?|Effectiveness of Vaginally Administered Progesterone to Prevent Preterm Delivery in Twin Pregnancies - A Multicentre Randomized Trial|Completed||Phase 2|677|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 16:31:00.435887|2017-02-18 16:31:00.435887
NCT00329901|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2014-06-16|2013-08-27||April 2006||2006-04-01|June 2014|2014-06-01|December 2007|Actual|2007-12-01|May 2007|Actual|2007-05-01||Interventional||Baseline Characteristics are summarized for all enrolled population|Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years|A Phase 3, Multi-Center, Observer Blind, Controlled, Randomized Study to Compare the Immunogenicity and Safety of the Concomitant Administration of a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis (Tdap) Vaccine and Chiron (Now Novartis) Meningococcal ACWY Conjugate Vaccine, With Either One Dose of Acellular Pertussis (Tdap) Vaccine, or One Dose of Chiron (Now Novartis) Meningococcal ACWY Conjugate Vaccine, in Healthy Subjects Aged 11-25 Years|Completed||Phase 3|1072|Actual|Novartis||3|||f||||f||||||||||2017-02-18 16:31:00.589228|2017-02-18 16:31:00.589228
NCT00329888|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2006-05-24|||March 2006||2006-03-01|April 2006|2006-04-01|May 2006||2006-05-01|||||Observational|||Comparison of Papillary Balloon Dilatation Vs.Sphincterotomy for Lithotripsy in Difficult Sphincterotomy or Distal CBD Tapering|Comparison of Endoscopic Papillary Balloon Dilatation and Sphincterotomy for CBD Stones With Difficult Sphincterotomy or Distal CBD Tapering|Unknown status|Active, not recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:31:01.40308|2017-02-18 16:31:01.40308
NCT00329862|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2011-11-14|||May 2006||2006-05-01|November 2011|2011-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy|Pilot Study Assessing Advantage of Adding Truncal Vagotomy to LAGB|Terminated||N/A|25|Anticipated|Central Carolina Surgery, PA||||study size reached|f||||||||||||||2017-02-18 16:31:01.494662|2017-02-18 16:31:01.494662
NCT00329849|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2013-08-30|2013-08-30||May 2006||2006-05-01|August 2013|2013-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional||Analysis was done on all enrolled subjects.|Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age|A Phase 3, Randomized, Observer-blind, Controlled, Multi-Center Study to Compare the Safety of One Dose of Novartis Meningococcal ACWY Conjugate Vaccine With That of a Licensed Meningococcal ACWY Polysaccharide Vaccine (Menomune®) Administered to Healthy Children 2 to 10 Years of Age|Completed||Phase 3|1500|Actual|Novartis||2|||f||||f||||||||||2017-02-18 16:31:01.592582|2017-02-18 16:31:01.592582
NCT00329836|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2011-07-21|2011-07-21||August 2006||2006-08-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||A Research Study to Examine Cutaneous Allodynia and Cluster Headache||Completed||Phase 4|41|Actual|Thomas Jefferson University|||1||f||||f||||||||||2017-02-18 16:31:02.512741|2017-02-18 16:31:02.512741
NCT00329823|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2006-05-23|||September 2005||2005-09-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Etanercept in Hidradenitis Suppurativa|A Phase 2 Study of the Safety and Efficacy of Etanercept for the Therapy of Hydradenitis Suppurativa|Completed||Phase 2|10||University of Athens|||||f||||||||||||||2017-02-18 16:31:02.731736|2017-02-18 16:31:02.731736
NCT00329810|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-07|||March 2005||2005-03-01|February 2012|2012-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Effect on Cognitive Function of a Treatment With Aripiprazole|A Prospective, Multicenter, Open-Label Study to Evaluate the Effectiveness and the Effect on Cognitive Function of a Treatment With Aripiprazole in a Board Range of Schizophrenic Patients|Completed||Phase 4|500|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-02-18 16:31:02.830019|2017-02-18 16:31:02.830019
NCT00329797|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2015-03-17|||March 2006||2006-03-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy|A Phase III Randomized Study to Evaluate the Efficacy of Zometa® for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy and Long Term LHRH Agonists for High-Grade and/or Locally Advanced Prostate Cancer|Completed||Phase 3|109|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 16:31:02.922521|2017-02-18 16:31:02.922521
NCT00329784|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2016-11-01|2016-11-01||December 2006||2006-12-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|LEAP|Intent-to-treat|Promoting Tolerance to Peanut in High-Risk Children|Induction of Tolerance Through Early Introduction of Peanut in High-Risk Children (ITN032AD)|Completed||Phase 2|640|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|The plan is to share data in: 1.)ImmPort, a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools that are available to researchers who register online and subsequently receive DAIT approval; and 2.)TrialShare, a clinical trials research portal developed by the Immune Tolerance Network that makes data from the consortium's clinical trials publicly available without charge.|2017-02-18 16:31:03.141214|2017-02-18 16:31:03.141214
NCT00329771|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2014-03-14|2014-03-04||March 2006||2006-03-01|March 2014|2014-03-01|March 2008|Actual|2008-03-01|December 2006|Actual|2006-12-01||Observational|||Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.|Brush Allodynia in Patients With Episodic Migraine During an Acute Attack.|Completed||N/A|28|Actual|Thomas Jefferson University|||1||f||||f||||||||||2017-02-18 16:31:04.470385|2017-02-18 16:31:04.470385
NCT00329758|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2010-06-23|||July 2006||2006-07-01|March 2009|2009-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head Injury|Phase II Study of Rosuvastatin´s Effect on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Humans With Moderate Head Injury|Completed||Phase 2|20|Actual|Universidad Autonoma de San Luis Potosí||2|||f||||t||||||||||2017-02-18 16:31:04.682916|2017-02-18 16:31:04.682916
NCT00329745|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2016-10-27|2009-07-02||January 2007||2007-01-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)|A Phase III, Double-blind, Randomized, Placebo-controlled, Multi-country and Multi-center Study to Assess the Efficacy and Safety of Two Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants.|Completed||Phase 3|8687|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:31:04.81556|2017-02-18 16:31:04.81556
NCT00329732|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2015-04-16|2011-05-24||March 2006||2006-03-01|April 2015|2015-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks|Double-Blind, Placebo Controlled Trial Of Greater Occipital Nerve Block For The Treatment Of Migraine Status|Terminated||N/A|2|Actual|Thomas Jefferson University||2||Study terminated due to inadequate recruitment|f||||||||||||||2017-02-18 16:31:05.187112|2017-02-18 16:31:05.187112
NCT00329719|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2016-11-01|2014-06-02||March 2006||2006-03-01|November 2016|2016-11-01||||February 2013|Actual|2013-02-01||Interventional|||Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma|A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma|Active, not recruiting||Phase 1/Phase 2|115|Actual|National Cancer Institute (NCI)||4|||f||||t||||||||||2017-02-18 16:31:05.507637|2017-02-18 16:31:05.507637
NCT00329706|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2016-01-13|||June 2006||2006-06-01|January 2016|2016-01-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)|Early and Long-Term Value of Imaging Brain Metabolism|Recruiting||N/A|710|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 16:31:07.429597|2017-02-18 16:31:07.429597
NCT00329693|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2011-05-18|||June 2006||2006-06-01|May 2011|2011-05-01|May 2008|Actual|2008-05-01|August 2007|Actual|2007-08-01||Interventional|||Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide|A Randomised, Double-blind, Parallel Groups, Dose-finding, Placebo-controlled, Multi-centre, Proof of Concept Study Assessing the Effect of 3-wk Treatment With 1 of 3 Oral Doses of Quinagolide & Placebo in Preventing Ovarian Hyperstimulation Syndrome in Women Undergoing Controlled Ovarian Hyperstimulation.|Completed||Phase 2|182|Actual|Ferring Pharmaceuticals||4|||f||||t||||||||||2017-02-18 16:31:07.655772|2017-02-18 16:31:07.655772
NCT00329680|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2009-12-30|||June 2007||2007-06-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of Sepsis|Investigating Nutritional Therapy With EPA, GLA and Antioxidants Role in Sepsis Treatment-INTERSEPT STUDY|Completed||Phase 4|115|Actual|Fernandes Tavora Hospital||2|||f||||t||||||||||2017-02-18 16:31:07.767127|2017-02-18 16:31:07.767127
NCT00329667|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2010-09-09|||January 2003||2003-01-01|September 2010|2010-09-01|September 2008|Actual|2008-09-01|March 2006|Actual|2006-03-01||Interventional|EPIC||Observational Study of Prosthetic Tissue Aortic and Mitral Heart Valve|An Observational, Prospective Evaluation of the SJM Epic Valve|Completed||N/A|761|Actual|St. Jude Medical||1|||f||||||||||||||2017-02-18 16:31:07.894041|2017-02-18 16:31:07.894041
NCT00329654|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2015-07-30|||March 2006||2006-03-01|July 2015|2015-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||James EMBAR® Light Therapy in the Treatment of Burn Wounds of Intermediate Depth|A Prospective, Randomized, Single Blinded, Controlled Clinical Investigation of James Embar® Light Therapy in the Treatment of Burn Wounds With Little Healing Potential|Completed||N/A|40|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:31:07.973801|2017-02-18 16:31:07.973801
NCT00329641|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2014-07-25|2012-06-05||February 2011||2011-02-01|October 2013|2013-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye|Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) in Combination With Carboplatin and Paclitaxel in Patients With Metastatic Uveal Melanoma|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:31:08.083352|2017-02-18 16:31:08.083352
NCT00329628|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2014-10-27|||February 2006||2006-02-01|October 2014|2014-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin|RECORD 1 Study: REgulation of Coagulation in ORthopedic Surgery to Prevent DVT and PE, Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement|Completed||Phase 3|4541|Actual|Bayer||2|||f||||||||||||||2017-02-18 16:31:08.402844|2017-02-18 16:31:08.402844
NCT00329615|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2009-08-20|||January 2000||2000-01-01|August 2009|2009-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Insulin Treatment in Cancer Cachexia|Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism and Physical Functioning. A Randomized Prospective Study.|Completed||Phase 4|135||Göteborg University|||||f||||||||||||||2017-02-18 16:31:08.788373|2017-02-18 16:31:08.788373
NCT00329602|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2016-11-04|2009-09-10||March 2006||2006-03-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Long-term Study Of Ropinirole In Restless Legs Syndrome|A Parallel Group Study to Evaluate the Efficacy and Safety of Ropinirole for 26 Weeks and to Further Evaluate the Incidence of Augmentation and Rebound for a Further 40 Weeks Open-label Extension Treatment Period in Subjects Suffering From Moderate to Severe Restless Legs Syndrome.|Completed||Phase 4|404|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:31:09.084167|2017-02-18 16:31:09.084167
NCT00329589|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-24|2010-08-19|||September 2005||2005-09-01|August 2010|2010-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients|A Phase I Open-labeled, Dose-escalation, Safety Study of the Combination of Velcade and Chemoradiation for the Treatment of Cancer Patients|Completed||Phase 1|54|Actual|Thomas Jefferson University|||||f||||t||||||||||2017-02-18 16:31:09.973963|2017-02-18 16:31:09.973963
NCT00329576|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2016-09-27|||May 2006||2006-05-01|September 2016|2016-09-01|August 2006|Actual|2006-08-01|||||Interventional|||Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine|Evaluate the Anti-HBs Antibody Persistence, in Subjects Who Received GSK Biologicals' Preservative-free or Thiomersal-free Engerix™-B or Engerix™-B Containing Thiomersal, Approximately 5 to 6 Yrs Earlier|Completed||Phase 4|632||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:31:10.079368|2017-02-18 16:31:10.079368
NCT00329563|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2007-12-18|||November 2004||2004-11-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Pilot Community Clinical Study of Hypothermia in Cardiac Arrest|Pilot Community Clinical Study of Hypothermia in Cardiac Arrest|Completed||Phase 1/Phase 2|125|Actual|University of Washington||2|||f||||||||||||||2017-02-18 16:31:10.176239|2017-02-18 16:31:10.176239
NCT00329550|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2015-02-27|2009-04-07||May 2006||2006-05-01|February 2015|2015-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease|A 26-week, Multi-center, Open-label Study to Investigate the Efficacy and Safety of CDP870 in Active Crohn's Disease Patients, Who Showed Clinical Efficacy in a Remission Induction Study (Study C87037 [NCT00291668]), at Week 26 After Subcutaneous Administration of CDP870 400 mg From Week 8 Until Week 24 at 4-week Intervals|Completed||Phase 2|40|Actual|UCB Pharma|Due to the small number of subjects in this study, the percentages of subjects with adverse events may be misleading.|3|||f||||f||||||||||2017-02-18 16:31:10.293661|2017-02-18 16:31:10.293661
NCT00329537|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2013-12-02|||June 2006||2006-06-01|December 2013|2013-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study of Sargramostim in Moderately to Severely Active Crohn's Disease|Open-Label Phase 1 Study to Assess the Tolerability, Pharmacokinetics and Safety of 2 and 6 µg/kg Sargramostim (SH L 04023) Administered Subcutaneously Once Daily for 4 Weeks, and Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess the Efficacy and Safety of 6 µg/kg Sargramostim (SH L 04023) Administered Subcutaneously Once Daily for 8 Weeks in Patients With Active Crohn's Disease (Sargramostim Phase 1/2 Study)|Terminated||Phase 2|11|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:31:13.411352|2017-02-18 16:31:13.411352
NCT00329524|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2015-04-07|2009-06-17||June 2006||2006-06-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Using PET-CT to Target and Validate Low-frequency TMS as Treatment for Tinnitus|Using PET-CT to Target and Validate Low-frequency TMS as Treatment for Tinnitus|Completed||N/A|5|Actual|University of Arkansas|Study was ended early and analysis was limited to only 5 subjects. A follow up study using a revised protocol is underway.|1|||f||||f||||||||||2017-02-18 16:31:13.528404|2017-02-18 16:31:13.528404
NCT00329511|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2013-12-09|||September 2004||2004-09-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy|A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy|Terminated||N/A|2|Actual|University of California, Irvine||2||Inadequate Enrollment|f||||f||||||||||2017-02-18 16:31:13.804281|2017-02-18 16:31:13.804281
NCT00329498|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2006-10-25|||May 1998||1998-05-01|October 2006|2006-10-01|August 2005||2005-08-01|||||Interventional|||L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes|Manipulation of L-Ascorbic Acid Level For The Treatment of Selected Cases Of Acute Myeloid Leukemia and Myelodysplastic Syndromes|Suspended||Phase 2|25||Samsung Medical Center|||||f||||||||||||||2017-02-18 16:31:13.922959|2017-02-18 16:31:13.922959
NCT00329485|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2007-08-01|||June 2006||2006-06-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients|The Effect of Ribose on B-Type Natriuretic Peptide Levels in Congestive Heart Failure Patients|Terminated||N/A|120||Valen Labs||||Poor recruitment and through put|f||||f||||||||||2017-02-18 16:31:14.022895|2017-02-18 16:31:14.022895
NCT00329472|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2010-08-26|||April 2006||2006-04-01|July 2010|2010-07-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer|Randomized Phase III Trial of Neoadjuvant Chemotherapy Followed by Surgery Plus Adjuvant Chemotherapy Versus Surgery Plus Adjuvant Chemotherapy in Stage IB, IIA, IIB and T3N1 Non-small Cell Lung Cancer (ICON)|Withdrawn||Phase 3|0|Actual|Samsung Medical Center||2||poor enrollment|f||||||||||||||2017-02-18 16:31:14.140062|2017-02-18 16:31:14.140062
NCT00329459|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2016-10-20|||May 2006||2006-05-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea|A Randomized, Double-blind, Single Migraine Attack, Placebo -Controlled, Patallel-group Multicenter Study to Evaluate the Efficacy and Tolerability or Trexima (Sumatriptan Succinate/Naproxen Sodium) Tablets vs Placebo When Administered During the Mild Pain Phase of Menstrual Migraine in Women With Dysmenorrhea|Completed||Phase 3|320|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:31:14.247308|2017-02-18 16:31:14.247308
NCT00329446|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2009-03-24|||April 2006||2006-04-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|||||Interventional|GOLD||Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Controlled Study of the Efficacy and Safety of Sustained-Release Quetiapine Fumarate (SEROQUEL®) Compared With Placebo in the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|800|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:31:14.408288|2017-02-18 16:31:14.408288
NCT00329433|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2011-06-14|2011-03-11||May 2006||2006-05-01|June 2011|2011-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery|The Use of Desirudin Versus Heparin for Thrombosis Prophylaxis in Cardiothoracic Surgery Patients|Completed||Phase 2/Phase 3|120|Actual|Washington University School of Medicine|The study size was small and a surrogate end point was the primary outcome. The study was not powered to show statistical differences in clinical outcomes. Many patients received both desirudin and heparin during the study.|2|||f||||t||||||||||2017-02-18 16:31:14.578658|2017-02-18 16:31:14.578658
NCT00329420|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2015-02-27|2009-05-01||May 2006||2006-05-01|February 2015|2015-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)|A Multi-center, Open-label Study to Investigate the Efficacy and Safety of CDP870 in Active Crohn's Disease Patients, Who Showed no Clinical Efficacy in a Remission Induction Study (Study C87037) But Showed Clinical Efficacy After Additional Remission Induction Therapy Was Applied, at Week 26 After Subcutaneous Administration of CDP870 400 mg From Week 8 Until Week 24 at 4-week Intervals|Completed||Phase 2|46|Actual|UCB Pharma|Due to the small number of subjects in this study, the percentages of subjects with adverse events may be misleading.|3|||f||||f||||||||||2017-02-18 16:31:15.006179|2017-02-18 16:31:15.006179
NCT00329407|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2010-08-30|2010-07-07||September 2003||2003-09-01|August 2010|2010-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects||Completed||Phase 4|10|Actual|Boston University|Limitation of this trial include the small number of subjects included and lack of blinding, and inculsion of a placebo control group. An other limitation was the testing the active medication topiramate at om=nly one dose level (i.e. 400 mg daily).|1|||f||||||||||||||2017-02-18 16:31:22.081586|2017-02-18 16:31:22.081586
NCT00329394|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2008-10-07|||April 2006||2006-04-01|October 2008|2008-10-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient|Study of the Efficacity of the Systemic Ketamine for the Improvement of Post-Operative Analgesia After ORL Carcinological Surgery at the Alcohol-Dependent Patient.|Suspended||Phase 3|56|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 16:31:22.33609|2017-02-18 16:31:22.33609
NCT00329381|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2008-06-03|||May 2006||2006-05-01|January 2007|2007-01-01|October 2007|Actual|2007-10-01|May 2007|Actual|2007-05-01||Interventional|||Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy|A26-wk,Randomized,Dble-Blinded,Parallel-Grp,Placebo-Controlled,Multi-Centered Study to Eval.the Effect of Xolair(Omalizumab)on Improving the Tolerability of Spec.Immunotherapy in Patients With at Least Mod. Persistent Allergic Asthma Inadequately Controlled w/Inhaled Corticosteroids|Completed||Phase 4|14|Actual|University of Mississippi Medical Center||2|||f||||t||||||||||2017-02-18 16:31:22.431864|2017-02-18 16:31:22.431864
NCT00329368|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2012-03-08|||September 2005||2005-09-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer|A Phase I Study of EC90 With GPI-0100 Adjuvant Followed by EC17 With Cytokines (Interleukin-2 [IL-2] and Interferon-alpha [IFN-alpha]) in Patients With Refractory or Metastatic Cancer|Completed||Phase 1|13|Actual|Endocyte||1|||f||||f||||||||||2017-02-18 16:31:22.543666|2017-02-18 16:31:22.543666
NCT00329355|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2017-01-20|||May 2006||2006-05-01|January 2017|2017-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)|A Randomized, Double-blind, Single Migraine Attack, Placebo-controlled, Parallel-group Multicenter Study to Evaluate the Efficacy and Tolerability of Trexima (Sumatriptan Succinate.Naproxen Sodium) Tablets vs Placebo When Administered During the Mild Pain Phase of Menstrual Migraine in Women With Dysmenorrhea|Completed||Phase 3|351|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:31:22.6582|2017-02-18 16:31:22.6582
NCT00329342|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2007-11-26|||April 2006||2006-04-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Return to Work Interventions for Patients With Low Back Pain|Return to Work Interventions for Patients With Low Back Pain During Inpatient Rehabilitation: a Quasi-Experimental Study|Completed||N/A|80|Actual|Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster||2|||f||||f||||||||||2017-02-18 16:31:22.798796|2017-02-18 16:31:22.798796
NCT00329329|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2012-03-21|||May 2006||2006-05-01|March 2012|2012-03-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies|Phase 1 Study of the Oral Platinum Agent Satraplatin in Combination With Capecitabine for the Treatment of Patients With Advanced Solid Malignancies|Terminated||Phase 1|24|Actual|Agennix||1||Sponsor decided to discontinue study drug development|f||||||||||||||2017-02-18 16:31:22.897302|2017-02-18 16:31:22.897302
NCT00329316|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2008-06-26||||||June 2007|2007-06-01||||||||Interventional|||Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent||Withdrawn||N/A|||The Baruch Padeh Medical Center, Poriya||||"Study withdrawn for financial problems. We didnwt get a grant we needed for purchesing the~   medication for the study."|f||||||||||||||2017-02-18 16:31:22.989664|2017-02-18 16:31:22.989664
NCT00329303|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2013-09-06|||April 2006||2006-04-01|September 2009|2009-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis|Efficacy and Safety of Re-treatment With Cimzia® at 2 Dose Regimens for 12 Weeks in Subject Suffering From Moderate to Severe Chronic Plaque Psoriasis Having Relapsed After Response to First Treatment|Completed||Phase 2|75||UCB Pharma|||||f||||||||||||||2017-02-18 16:31:23.07111|2017-02-18 16:31:23.07111
NCT00329290|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2013-02-06|||February 2002||2002-02-01|February 2013|2013-02-01|April 2007|Actual|2007-04-01|||||Observational|||Evaluation of Maternal and Fetal Outcomes in Pregnancies in Women With Prosthetic Heart Valves||Completed||N/A|100|Anticipated|University of California, Irvine|||1||f||||||||||||||2017-02-18 16:31:23.181134|2017-02-18 16:31:23.181134
NCT00329277|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2008-05-22|||April 2006||2006-04-01|November 2006|2006-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration||Completed||N/A|30|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:31:23.337418|2017-02-18 16:31:23.337418
NCT00329264|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2009-03-24|||April 2006||2006-04-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|||||Interventional|TITANIUM||Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Sustained-Release Quetiapine Fumarate (SEROQUEL®) Compared With Placebo in the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|876|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:31:23.596211|2017-02-18 16:31:23.596211
NCT00329251|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2006-05-22|||April 2003||2003-04-01|May 2006|2006-05-01|March 2006||2006-03-01|||||Interventional|||Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV|Study of the Influence of Immunological Repeated Stimuli With Commercial Vaccines Over the Viral Load (VL), Resistance Development and Specific Immunological Response Against HIV in Early Stage HIV Patients With Undetectable VL After HAART|Completed||Phase 4|26||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:31:23.745596|2017-02-18 16:31:23.745596
NCT00329238|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2014-05-08|2011-08-10||May 2006||2006-05-01|December 2013|2013-12-01||||October 2010|Actual|2010-10-01||Interventional|RE-MEDY|The FAS consisted of all randomised patients who were documented to have taken at least 1 dose of study drug.|Secondary Prevention of Venous Thrombo Embolism (VTE).|A Phase III, Randomised, Multicenter, Double-blind, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of Oral Dabigatran Etexilate (150 mg Bid) Compared to Warfarin (INR 2.0-3.0) for the Secondary Prevention of Venous Thromboembolism.|Completed||Phase 3|2867|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 16:31:23.880872|2017-02-18 16:31:23.880872
NCT00329056|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2010-07-19|||May 2006||2006-05-01|July 2010|2010-07-01|November 2007|Actual|2007-11-01|||||Interventional|||A Trial of MitoQ for the Treatment of People With Parkinson's Disease|A Double-Blind, Prospective, Randomized Comparison of 2 Doses of MitoQ and Placebo for the Treatment of Patients With Parkinson's Disease|Completed||Phase 2|128|Actual|Antipodean Pharmaceuticals, Inc.||3|||f||||t||||||||||2017-02-18 16:31:30.251226|2017-02-18 16:31:30.251226
NCT00329225|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2016-09-13|||September 2002||2002-09-01|September 2016|2016-09-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Control, Clinical Evaluation of Insulin Plus Rosiglitazone (2mg and 4mg) Compared to Insulin Plus Placebo for 24 Weeks in Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled on Insulin|Completed||Phase 4|630|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:31:27.970755|2017-02-18 16:31:27.970755
NCT00329212|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2006-11-14||||||November 2006|2006-11-01||||||||Observational|||The Pharmacokinetics Study of Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans|Bioequivalence of Bioactive Markers Between Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans|Completed||N/A|||Committee on Chinese Medicine and Pharmacy|||||f||||||||||||||2017-02-18 16:31:28.201515|2017-02-18 16:31:28.201515
NCT00329199|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2007-08-16|||December 2006||2006-12-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Pennsylvania Adolescent Intervention Research Study (PAIRStudy)|TRIAD Project: Pennsylvania Adolescent Intervention Research Study (PAIRStudy; Project 3a)|Terminated||Phase 2|240|Anticipated|Pennsylvania Department of Health||||Trial was rewritten and will no longer focus on the link between smoking and depression.|f||||||||||||||2017-02-18 16:31:28.280987|2017-02-18 16:31:28.280987
NCT00329186|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2013-02-06|||May 2006||2006-05-01|July 2009|2009-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects|A Randomized, Open-Label, Two-Period, Parallel Group, Crossover Study to Evaluate the Pharmacokinetics of Venlafaxine Extended-Release and DVS SR in Healthy Subjects Who Are Extensive or Poor Cytochrome P450 2D6 Substrate Metabolizers|Completed||Phase 3|14|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:31:28.377486|2017-02-18 16:31:28.377486
NCT00329173|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2009-03-13|||November 2003||2003-11-01|March 2009|2009-03-01|August 2004|Actual|2004-08-01|||||Interventional|||PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.|A 6-Week Open-Label, Randomised, Multicentre, Phase IIIb, Parallel-Group Study to Compare the Efficacy and Safety of Rosuvastatin (10 mg) With Atorvastatin (20 mg) in Subjects With Hypercholesterolaemia and Either a History of CHD or Clinical Evidence of CHD|Completed||Phase 3|1000||AstraZeneca|||||f||||||||||||||2017-02-18 16:31:28.472505|2017-02-18 16:31:28.472505
NCT00329160|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2011-08-29|2011-03-17||October 2005||2005-10-01|August 2011|2011-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease|A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease as Measured by Intravascular Ultrasonography|Completed||Phase 4|214|Actual|AstraZeneca|Because there was no placebo arm the net effect of rosuvastatin was not clarified. This study examined only single measurable plaques, which might not represent pan-coronary nature of plaque.|1|||f||||||||||||||2017-02-18 16:31:28.554437|2017-02-18 16:31:28.554437
NCT00329147|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-23|2007-12-06|||May 2006||2006-05-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects|A Randomized, Open-Label, Cross-Over Drug Interaction Study to Evaluate the Effects of Desvenlafaxine (DVS SR) and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects|Completed||Phase 3|20|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:31:29.080333|2017-02-18 16:31:29.080333
NCT00329134|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2009-04-16|||July 2006||2006-07-01|April 2009|2009-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria|Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria|Completed||Phase 2|56|Anticipated|University Ghent||1|||f||||f||||||||||2017-02-18 16:31:29.167538|2017-02-18 16:31:29.167538
NCT00329121|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2015-01-16|||May 2006||2006-05-01|January 2015|2015-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ|Multi-centre, Open-label Study to Determine the Safety and Efficacy of PEP005 0.05% Topical Gel in Patients With Cutaneous Squamous Cell Carcinoma In Situ (SCCIS, Bowen's Disease)|Completed||Phase 2|24||Peplin|||||f||||||||||||||2017-02-18 16:31:29.258093|2017-02-18 16:31:29.258093
NCT00329108|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2009-04-01|2008-12-22||November 2006||2006-11-01|April 2009|2009-04-01|January 2008|Actual|2008-01-01|July 2007|Actual|2007-07-01||Interventional|ZOOM||Ziprasidone And Olanzapine's Outcomes In Mania|A Multicenter, Randomized, Double-Blind, Parallel Group Study, Comparing The Efficacy And Tolerability Of Ziprasidone (Zeldox, Geodon) vs. Olanzapine (Zyprexa) In The Treatment And Maintenance Of Response In Patients With Acute Mania|Terminated||Phase 4|29|Actual|Pfizer|The study was terminated due to poor recruitment. No efficacy data were summarized due to very low sample size. Only safety data were summarized.|2||Please see Brief Summary for Termination Reason.|f||||f||||||||||2017-02-18 16:31:29.368582|2017-02-18 16:31:29.368582
NCT00329095|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2006-05-22|||December 2005||2005-12-01|May 2006|2006-05-01|April 2006||2006-04-01|||||Interventional|||An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance|An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures|Completed||Phase 4|60||Robin, Alan L., M.D.|||||f||||||||||||||2017-02-18 16:31:29.754036|2017-02-18 16:31:29.754036
NCT00329082|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2009-10-05||2009-06-10|May 2006||2006-05-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers|LY2062430: Multiple-Dose Safety in Subjects With Mild-to-Moderate Alzheimer's Disease and Single-Dose Safety in Healthy Volunteers|Completed||Phase 2|25|Actual|Eli Lilly and Company||5|||f||||t||||||||||2017-02-18 16:31:29.839009|2017-02-18 16:31:29.839009
NCT00329069|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2006-05-22|||May 2002||2002-05-01|May 2006|2006-05-01|March 2006||2006-03-01|||||Interventional|||The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia|Vascular Endothelial Receptor Activity in Patients With Coronary Artery Disease on Medication With Statins|Completed||N/A|50||University of Ulm|||||f||||||||||||||2017-02-18 16:31:30.135987|2017-02-18 16:31:30.135987
NCT00005529|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|November 2001|2001-11-01|August 2000|Actual|2000-08-01|||||Observational|||Self-Scored Cardiovascular Disease Risk Appraisal||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:48.820016|2017-02-18 18:14:48.820016
NCT00329043|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2016-09-12|||May 2006||2006-05-01|September 2016|2016-09-01||||December 2018|Anticipated|2018-12-01||Interventional|||Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy|A Phase II Neoadjuvant Trial of Sunitinib Malate (SU011248) Plus Hormonal Ablation for Patients Who Have High Risk Localized Prostate Cancer and Will Undergo Prostatectomy|Active, not recruiting||Phase 2|64|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:31:30.374591|2017-02-18 16:31:30.374591
NCT00329030|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2016-06-10|2016-01-28||December 2005||2005-12-01|June 2016|2016-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (BMT CTN 0401)|Phase III Rituxan/BEAM vs. Bexxar/BEAM With Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large B-cell Non-Hodgkin's Lymphoma (BMT CTN #0401)|Completed||Phase 3|224|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||Yes|Findings will be published in a manuscript|2017-02-18 16:31:30.499791|2017-02-18 16:31:30.499791
NCT00329017|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2017-02-13|||May 2005||2005-05-01|February 2017|2017-02-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Observational|||Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer|Correlation of SNP Patterns With Fine Needle Aspiration Cytomorphology in High Risk Postmenopausal Women|Active, not recruiting||N/A|500|Anticipated|University of Kansas Medical Center|||1||f||||f||||||Samples With DNA|"~     Fine needle aspirate~   "|No|Global results will be published.|2017-02-18 16:31:31.574137|2017-02-18 16:31:31.574137
NCT00329004|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2011-01-24|||August 2006||2006-08-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors|A Phase I Dose Escalation Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|89|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 16:31:31.685179|2017-02-18 16:31:31.685179
NCT00328991|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2006-05-22|||October 2004||2004-10-01|January 2006|2006-01-01|December 2005||2005-12-01|||||Interventional|||Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts|Double-Blind, Randomized Control Trial To Evaluate the Efficacy of Duct Tape Versus Placebo for the Treatment of Verruca Vulgaris|Completed||N/A|90||Minneapolis Veterans Affairs Medical Center|||||f||||||||||||||2017-02-18 16:31:31.804294|2017-02-18 16:31:31.804294
NCT00328978|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2009-03-24|||October 2003||2003-10-01|March 2009|2009-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects|A Canadian, Multicenter, Double-Blind, Randomized, Parallel-Group Study of the Safety, Tolerability, and Efficacy of Treatment With Higher Doses of Quetiapine Fumarate (Seroquel®) Greater Than 800 mg/Day in Schizophrenic or Schizoaffective Subjects.|Completed||Phase 3|330||AstraZeneca|||||f||||||||||||||2017-02-18 16:31:31.89398|2017-02-18 16:31:31.89398
NCT00328965|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2010-08-12|||November 2004||2004-11-01|August 2010|2010-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea|An Open Label, Multi-centre, Single Arm Phase IV Study to Evaluate the Antihypertensive Effect of Lacidipine in Mild to Moderate Essential Hypertension Patients With Type 2 Diabetes in Korea|Completed||Phase 4|||GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 16:31:31.988983|2017-02-18 16:31:31.988983
NCT00328952|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2009-09-15|||August 2004||2004-08-01|September 2009|2009-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia|Naturalistic Multicenter Study of Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Schizophrenia|Completed||N/A|40|Actual|Seoul National University Hospital|||1||f||||t||||||Samples Without DNA|"~     routine lab tests for changes in medical condition~   "|||2017-02-18 16:31:32.087108|2017-02-18 16:31:32.087108
NCT00328939|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2012-05-31|||May 2004||2004-05-01|February 2011|2011-02-01||||||||Interventional|||ARIXTRA Local Study For Registration In China.|Randomized, Single Blind, Parallel Study to Compare the Safety and Efficacy of ARIXTRA to Enoxaparine in Patients Undergoing Elective Major Hip or Knee Replacement or a Revision of Components.|Completed||Phase 3|240||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:31:32.191004|2017-02-18 16:31:32.191004
NCT00328926|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-20|2013-08-04|2013-05-22||March 2006||2006-03-01|August 2013|2013-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])|A Phase IV, Multicenter, Randomized, Double-blinded, Clinical Trial to Confirm the Efficacy of the 75 IU Dose of Luveris® vs. Placebo When Administered With Follitropin Alfa for Induction of Follicular Development and Pregnancy in Hypogonadotropic Hypogonadal Women With Profound LH Deficiency, as Defined by a Baseline LH Level <1.2 IU/L|Terminated||Phase 4|11|Actual|EMD Serono||3||"Please see Purpose statement"|f||||||||||||||2017-02-18 16:31:32.414086|2017-02-18 16:31:32.414086
NCT00328913|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2007-01-08|||March 2006||2006-03-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||The Effect of 5-Hydroxytryptophan (5-HTP) on Satiety|Effectiveness of 5-Hydroxytryptophan on Satiety in a Randomised, Placebo Controlled, Time Blinded Study, in Overweight Women|Completed||Phase 2|24||TNO|||||f||||||||||||||2017-02-18 16:31:32.903173|2017-02-18 16:31:32.903173
NCT00328900|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2012-05-31|||January 2006||2006-01-01|April 2007|2007-04-01||||||||Interventional|||"Measurement of Stress During Anesthesia With Pain Detector on Patients Receiving Atropine"||Unknown status|Recruiting|N/A|24|Anticipated|Rikshospitalet University Hospital|||||f||||f||||||||||2017-02-18 16:31:32.992913|2017-02-18 16:31:32.992913
NCT00328887|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-22|2016-05-02|||November 2004||2004-11-01|May 2016|2016-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma|Phase I, Initial Safety/Toxicity Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdCUCD40L) to Patients With Stage III or IV Esophageal Carcinoma|Withdrawn||Phase 1|0|Actual|Weill Medical College of Cornell University||1||No funding was obtained for this study. No subject were receruited.|f||||t||||||||No||2017-02-18 16:31:33.090979|2017-02-18 16:31:33.090979
NCT00328874|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-21|2008-03-25|||May 2006||2006-05-01|March 2008|2008-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy|Mono-Center, Prospective, Double-Blind, Placebo-Controlled, Randomized Clinical Phase IIa Trial to Assess the Safety, Tolerability, and Immediate Biological Effects of Coenzyme Q10 - nanoQuinon® in Progressive Supranuclear Palsy|Completed||Phase 2|20|Actual|German Parkinson Study Group (GPS)||2|||f||||f||||||||||2017-02-18 16:31:33.192589|2017-02-18 16:31:33.192589
NCT00328861|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-20|2012-10-04|2012-10-04||May 2006||2006-05-01|October 2012|2012-10-01|April 2009|Actual|2009-04-01|July 2007|Actual|2007-07-01||Interventional|||Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer|Phase II Study in Metastatic Melanoma or Kidney Cancer Using Autologous Natural Killer Cells Plus Aldesleukin (IL-2) Following a Lymphodepleting Chemotherapy|Completed||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 16:31:33.301732|2017-02-18 16:31:33.301732
NCT00328848|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2014-07-16|||October 2005||2005-10-01|July 2014|2014-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||After Discharge Management of Low Income Frail Elderly|After Discharge Management of Low Income Frail Elderly (AD-LIFE)|Completed||N/A|530|Actual|Summa Health System||1|||f||||t||||||||||2017-02-18 16:31:34.148929|2017-02-18 16:31:34.148929
NCT00328835|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2006-10-16|||March 2006||2006-03-01|May 2006|2006-05-01|April 2006||2006-04-01|||||Interventional|||Optic Nerve Compliance Study|Optic Nerve Compliance Study|Completed||N/A|100||Capital Vision Research Trust|||||f||||||||||||||2017-02-18 16:31:34.260078|2017-02-18 16:31:34.260078
NCT00328822|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2008-03-17|||December 2006||2006-12-01|October 2006|2006-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial|Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial|Completed||N/A|16|Anticipated|Khon Kaen University||2|||f||||||||||||||2017-02-18 16:31:34.372112|2017-02-18 16:31:34.372112
NCT00328809|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2013-06-03||||||June 2013|2013-06-01||||||||Interventional|||Spironolactone Safety in Dialysis Patients|Subjects With Severe Heart Failure and End-Stage Renal Disease on Hemodialysis: A Pilot Study to Assess Safety and Tolerability of Spironolactone|Withdrawn||Phase 4|0|Actual|State University of New York - Upstate Medical University||1||personnel shortage|f||||||||||||||2017-02-18 16:31:34.483446|2017-02-18 16:31:34.483446
NCT00328796|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2008-10-03|||May 2006||2006-05-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|July 2007|Actual|2007-07-01||Interventional|||Acupuncture for Pain Relief During Perineal Repair After Childbirth|Acupuncture or Local Anaesthetics for Pain Relief During Perineal Repair After Vaginal Delivery: A Randomised Controlled Trial|Completed||N/A|207|Actual|Sonderborg Hospital|||||f||||||||||||||2017-02-18 16:31:34.582859|2017-02-18 16:31:34.582859
NCT00328783|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2016-10-19|2014-01-27||October 2002||2002-10-01|October 2016|2016-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Using the Active Breathing Control Device to Reduce Radiation Side Effects to Critical Structures in Breast Cancer|A Pilot Study Investigating Active Breathing Coordinator (ABC) to Reduce Radiation Dose to Normal Structures in Breast Cancer Patients|Completed||N/A|112|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 16:31:34.679473|2017-02-18 16:31:34.679473
NCT00328770|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2013-06-18|2012-06-12||December 1996||1996-12-01|June 2013|2013-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma|De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma: Long-Term Outcomes and Side Effects|Completed||Phase 2/Phase 3|70|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 16:31:34.93789|2017-02-18 16:31:34.93789
NCT00328757|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2011-06-27|||May 2006||2006-05-01|June 2011|2011-06-01|April 2007|Anticipated|2007-04-01|||||Interventional|||Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer|Regular Versus Liquid Diet as the First Meal in Patients Undergoing Major Abdominal Gynecologic Cancer Operation: A Randomized Controlled Trial|Withdrawn||Phase 3|240|Anticipated|Chiang Mai University||||"Before starting the recruitment process, new data from literature were available. The~   investigators considered that this study was no longer needed."|f||||||||||||||2017-02-18 16:31:35.204448|2017-02-18 16:31:35.204448
NCT00328744|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2012-04-19|||July 2006||2006-07-01|October 2008|2008-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Reducing Snack Variety in Weight Loss Treatment|Reducing Snack Food Variety During Obesity Treatment|Completed||N/A|202|Actual|The Miriam Hospital||2|||f||||||||||||||2017-02-18 16:31:35.304001|2017-02-18 16:31:35.304001
NCT00328731|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2006-05-19|||January 2005||2005-01-01|January 2005|2005-01-01|January 2006||2006-01-01|||||Interventional|||Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques).|The Effectiveness of Milk Allergy Elimination Through NAET Treatments|Completed||Phase 1/Phase 2|26||Nambudripad's Allergy Research Foundation|||||f||||||||||||||2017-02-18 16:31:35.406786|2017-02-18 16:31:35.406786
NCT00328718|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2017-01-19|||October 2005|Actual|2005-10-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets|Randomised, Double-blind, Double-dummy, Parallel-group, Comparative Study of Salmeterol/FP 50/100mcg bd Inhalation Powder Via Diskus With Oral Montelukast (5mg QD) Chewable Tablets in Children 6-14 Years|Completed||Phase 3|526||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:31:35.503077|2017-02-18 16:31:35.503077
NCT00328705|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2008-02-11|||May 2006||2006-05-01|February 2008|2008-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management|D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management|Completed||N/A|65|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-02-18 16:31:35.62878|2017-02-18 16:31:35.62878
NCT00328692|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2009-10-08|||August 2006||2006-08-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||PROTECT-1: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effects of KW-3902 Injectable Emulsion on Heart Failure Signs and Symptoms and Renal Function in Subjects With Acute Heart Failure Syndrome and Renal Impairment Who Are Hospitalized for Volume Overload and Require Intravenous Diuretic Therapy|Completed||Phase 3|932|Actual|NovaCardia, Inc.||2|||f||||t||||||||||2017-02-18 16:31:35.730227|2017-02-18 16:31:35.730227
NCT00328679|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2008-10-06|||June 2006||2006-06-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Evaluation of Food Hypersensitivity in Children/Adolescents With Functional Dyspepsia|Food-Specific IgE, IgG, IgG4, Skin Prick Testing and Atopy Patch Testing in Children/Adolescents With Functional Dyspepsia: A Pilot Study|Completed||Phase 1|41|Actual|Children's Mercy Hospital Kansas City||1|||f||||f||||||||||2017-02-18 16:31:35.839277|2017-02-18 16:31:35.839277
NCT00328666|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2015-11-24|||February 2005||2005-02-01|November 2015|2015-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||The Penn Lifestyle Modification and Blood Pressure Study|Cardiovascular Effects of Iyengar Yoga vs. Enhanced Usual Care in Patients With High-normal to Stage I Hypertension|Completed||N/A|60||University of Pennsylvania|||||f||||||||||||||2017-02-18 16:31:35.945765|2017-02-18 16:31:35.945765
NCT00328653|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2008-08-20|||May 2006||2006-05-01|August 2008|2008-08-01||||||||Interventional|||Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC)|Phase II/III, Multicenter, Double-Masked, Randomized, Parallel Group, Dose Ranging, Controlled Trial of Efficacy and Tolerance of Nova22007 (Cyclosporine A [CSA] 0.05% & 0.1% Ophthalmic Cationic Emulsion) Versus Vehicle in Patients With VKC|Completed||Phase 2/Phase 3|114|Anticipated|Santen SAS|||||f||||||||||||||2017-02-18 16:31:36.045564|2017-02-18 16:31:36.045564
NCT00328640|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2007-04-25|||December 2005||2005-12-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Quality Improvement in Stroke Prevention (QUISP)|Secondary Prevention After Ischemic Stroke: A Trial of an Evidence-Based System-Wide Intervention|Completed||Phase 4|1500||University of California, San Francisco|||||f||||t||||||||||2017-02-18 16:31:36.128917|2017-02-18 16:31:36.128917
NCT00328627|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2013-02-19|2013-02-19||May 2006||2006-05-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of the Combination of SYR-322 (SYR110322) and Pioglitazone HCl (ACTOS®), in Subjects With Type 2 Diabetes|Completed||Phase 3|1554|Actual|Takeda||12|||f||||f||||||||||2017-02-18 16:31:36.287804|2017-02-18 16:31:36.287804
NCT00328614|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2016-10-19|2013-06-24||March 2003||2003-03-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|February 2009|Actual|2009-02-01||Interventional|||Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer|A Phase I Pilot Study of Samarium-153 Combined With Neoadjuvant Hormonal Therapy and Radiation Therapy in Men With Locally Advanced Prostate Cancer|Completed||Phase 1|32|Actual|Thomas Jefferson University||6|||f||||t||||||||||2017-02-18 16:31:55.493756|2017-02-18 16:31:55.493756
NCT00328601|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2008-07-29|||February 2005||2005-02-01|July 2008|2008-07-01|June 2005||2005-06-01|||||Interventional|||Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)|Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) Randomised, Double-Blind,Placebo-Controlled Multicentre Trial With 4 Parallel Groups|Completed||Phase 3|170||MEDA Pharma GmbH & Co. KG|||||f||||||||||||||2017-02-18 16:31:56.279574|2017-02-18 16:31:56.279574
NCT00328588|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2007-12-26|||December 2006||2006-12-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy||Completed||Phase 2|37|Actual|Astellas Pharma Inc||1|||f||||||||||||||2017-02-18 16:31:56.399951|2017-02-18 16:31:56.399951
NCT00328575|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2016-10-19|||October 2005||2005-10-01|October 2016|2016-10-01|June 2011|Actual|2011-06-01|July 2009|Actual|2009-07-01||Interventional|||Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases|Phase I Dose Escalation Trial in Patients With Brain Metastases Using IMRT|Completed||Phase 1|10|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 16:31:56.504795|2017-02-18 16:31:56.504795
NCT00328562|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2016-10-19|2014-06-09||December 2003||2003-12-01|October 2016|2016-10-01|September 2010|Actual|2010-09-01|April 2008|Actual|2008-04-01||Interventional|||ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer|A Phase I Study of ZD1839 (Iressa) and Hypofractionated Thoracic Radiotherapy With Stereotactic Body Frame Immobilization for Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|13|Actual|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 16:31:56.61242|2017-02-18 16:31:56.61242
NCT00328549|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2011-05-17|||October 2001||2001-10-01|April 2010|2010-04-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)|A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN|Completed||Phase 2|105|Actual|Ortho Biotech Products, L.P.|||||f||||||||||||||2017-02-18 16:31:56.959784|2017-02-18 16:31:56.959784
NCT00328536|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2009-05-07|||April 2007||2007-04-01|May 2009|2009-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus|Effects of Treatment With Omacor for 6 Weeks on Preprandial and Postprandial Endothelial Function Following a High Fat Meal in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|34|Anticipated|Ruhr University of Bochum|||||f||||f||||||||||2017-02-18 16:31:57.050695|2017-02-18 16:31:57.050695
NCT00328523|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2015-01-11|||June 2004||2004-06-01|January 2015|2015-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)|Ezetimibe Together With Any Statin Cholesterol Enhancement|Completed||Phase 3|1496|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:31:57.137005|2017-02-18 16:31:57.137005
NCT00328510|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2016-10-19|2013-04-30||February 2005||2005-02-01|October 2016|2016-10-01|September 2009|Actual|2009-09-01|January 2008|Actual|2008-01-01||Interventional|||Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy|A Randomized Trial Comparing Two Forms of Immobilization of the Head for Fractioned Stereotactic Radiotherapy|Completed||Phase 3|83|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 16:31:57.218632|2017-02-18 16:31:57.218632
NCT00328497|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2010-03-09|||May 2006||2006-05-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors|A Phase 1-2 Safety and Efficacy Study of Panzem Nanocrystal Colloidal Dispersion Administered Orally in Combination With rhuMAb VEGF (Bevacizumab) in Patients With Locally Advanced or Metastatic Carcinoid Tumors|Completed||Phase 2|31|Actual|CASI Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 16:31:57.839416|2017-02-18 16:31:57.839416
NCT00328484|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2016-07-28|||January 2002||2002-01-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease|Exercise and Disability in COPD Patients|Completed||Phase 3|318|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 16:31:57.940691|2017-02-18 16:31:57.940691
NCT00328471|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2012-01-06|||June 2002||2002-06-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|January 2008|Actual|2008-01-01||Interventional|||A Post Discharge Intervention to Improve Stroke Outcomes|A Post Discharge Intervention to Improve Stroke Outcomes|Completed||N/A|380|Actual|Summa Health System||1|||f||||t||||||||||2017-02-18 16:31:58.048808|2017-02-18 16:31:58.048808
NCT00328458|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2011-03-11|||February 2004||2004-02-01|March 2011|2011-03-01|July 2009|Actual|2009-07-01|May 2008|Actual|2008-05-01||Interventional|||EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients|A Phase I, Open-label, Dose-escalation, Safety Study of the Combination of EPO906 and Radiation Therapy for the Treatment of Patients With Cancer|Completed||Phase 1|39|Actual|Thomas Jefferson University||1|||t||||t||||||||||2017-02-18 16:31:58.144138|2017-02-18 16:31:58.144138
NCT00328445|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2017-01-11|||April 2001||2001-04-01|September 2014|2014-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Randomized Trial of the Positive Action Program in Hawaii Schools|The Positive Action Program: Outcomes and Mediators|Completed||N/A|2500|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 16:31:58.255423|2017-02-18 16:31:58.255423
NCT00328432|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2008-09-15|||June 2003||2003-06-01|September 2008|2008-09-01|December 2005||2005-12-01|||||Interventional|||A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy|Phase IB Study of Biomarker Modulation by Celecoxib vs. Placebo in Women With Newly-Diagnosed Breast Cancer|Completed||Phase 1|100||University of Kansas Medical Center|||||f||||||||||||||2017-02-18 16:31:58.367266|2017-02-18 16:31:58.367266
NCT00328419|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-19|2011-12-28|||May 2006||2006-05-01|December 2011|2011-12-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Consequences of Parenteral Nutrition Photoprotection on Oxidant Related Diseases Among Extremely Low Birth Weight Infants|Consequences of Parenteral Nutrition Photoprotection on the Oxidant Related Diseases Among Extremely Low Birth Weight Infants : A Randomized Controlled Study|Completed||N/A|591|Actual|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 16:31:58.480219|2017-02-18 16:31:58.480219
NCT00328393|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2012-07-06|||March 2007||2007-03-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Pioglitazone on Ambulatory Blood Pressure|Effect of Pioglitazone on Ambulatory Blood Pressure|Completed||Phase 3|2|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||||||||||||2017-02-18 16:31:58.591436|2017-02-18 16:31:58.591436
NCT00328380|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2009-12-21|||December 2005||2005-12-01|December 2009|2009-12-01|September 2008|Actual|2008-09-01|December 2006|Actual|2006-12-01||Interventional|||Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety of Rifaximin for the Prevention of Travelers' Diarrhea in Subjects Traveling Outside the United States|Completed||Phase 3|660|Anticipated|Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:31:58.704005|2017-02-18 16:31:58.704005
NCT00328367|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2008-10-28|||December 2005||2005-12-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|December 2006|Actual|2006-12-01||Interventional|||Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia|A Double-Blind Randomized Placebo Controlled Study of Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia|Completed||Phase 4|61|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 16:31:58.799181|2017-02-18 16:31:58.799181
NCT00328354|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2006-05-18||||||January 2006|2006-01-01||||||||Observational|||Mammography SPECT With Rotating Slant Hole Collimator||Unknown status|Not yet recruiting|N/A|20||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:31:58.925414|2017-02-18 16:31:58.925414
NCT00328341|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2013-09-18|||April 2006||2006-04-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|April 2009|Actual|2009-04-01||Observational|||The Use of Tissue Oxygen Monitoring in Critically Injured Patients|The Use of Tissue Oxygen Monitoring in Critically Injured Patients|Terminated||N/A|67|Actual|University of California, San Francisco|||1|Slow to enroll.|f||||f||||||||||2017-02-18 16:31:58.996748|2017-02-18 16:31:58.996748
NCT00328315|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2007-01-03|||October 2006||2006-10-01|January 2007|2007-01-01||||||||Observational|||Cardiac SPECT With Rotating Slant Hole Collimator||Unknown status|Recruiting|N/A|60||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:31:59.082621|2017-02-18 16:31:59.082621
NCT00328302|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2006-05-18|||September 2000||2000-09-01|June 2000|2000-06-01|April 2006||2006-04-01|||||Interventional|||Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy|Studies of Early Diabetic Glomerulopathy-the Relation Between Histopathology, Kidney Function and Metabolic Control. Natural History and Effect of ARB|Unknown status|Active, not recruiting|Phase 4|13||Karolinska University Hospital|||||f||||||||||||||2017-02-18 16:31:59.159857|2017-02-18 16:31:59.159857
NCT00328289|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2011-01-12|||May 2006||2006-05-01|January 2011|2011-01-01|March 2007|Actual|2007-03-01|||||Interventional|||Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy|Effect of Intradialytic Electrical Muscle Stimulation and Passive Leg Mobilisation on Blood Pressure and Dialysis Efficacy|Completed||N/A|12||University Hospital Inselspital, Berne|||||f||||||||||||||2017-02-18 16:31:59.2463|2017-02-18 16:31:59.2463
NCT00328276|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2006-05-18|||December 2004||2004-12-01|May 2006|2006-05-01|December 2005||2005-12-01|||||Interventional|||Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia|NMDA Enhancers in the Treatment of Schizophrenia|Completed||Phase 2|20||China Medical University Hospital|||||f||||||||||||||2017-02-18 16:31:59.331755|2017-02-18 16:31:59.331755
NCT00328263|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2014-07-15|2012-08-28||March 2006||2006-03-01|July 2014|2014-07-01|October 2007|Actual|2007-10-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients|A Double-blind, Randomized, Placebo Controlled, Multicenter Study of the Efficacy and Safety of BIO-K*+ CL-1285* in the Prevention of Antibiotic-associated Diarrhea in Adult Patients Exposed to Nosocomial Infection.|Completed||Phase 3|472|Actual|Bio-K Plus International Inc.||2|||f||||t||||||||||2017-02-18 16:31:59.421651|2017-02-18 16:31:59.421651
NCT00328250|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2012-01-11|||October 2006||2006-10-01|January 2012|2012-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effectiveness of Internet Cognitive Behavioral Therapy Intervention for Treating Insomnia|Internet Insomnia Intervention: Development and Feasibility|Completed||Phase 1/Phase 2|44|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 16:31:59.91156|2017-02-18 16:31:59.91156
NCT00328237|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2006-06-23|||November 2005||2005-11-01|November 2005|2005-11-01||||||||Interventional|||Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation|Treatment of Hematologic Malignancies With High-Dose Chemo-Radiotherapy Followed by Single-Unit or Double-Unit Cord Blood Transplantation: A Phase II Study|Unknown status|Recruiting|Phase 2|20||Colorado Blood Cancer Institute|||||f||||||||||||||2017-02-18 16:32:00.044333|2017-02-18 16:32:00.044333
NCT00328042|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2015-04-06|2014-08-26||May 2007||2007-05-01|July 2014|2014-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Hepatitis C Self-Management|A Self-Management Intervention for Veterans With Hepatitis C|Completed||N/A|134|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:32:04.070903|2017-02-18 16:32:04.070903
NCT00328224|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2007-10-31|||May 2006||2006-05-01|May 2006|2006-05-01|October 2007|Actual|2007-10-01|||||Observational|||Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)|Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|50|Actual|Hadassah Medical Organization|||2||f||||||||||||||2017-02-18 16:32:00.156771|2017-02-18 16:32:00.156771
NCT00328211|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2016-12-06|||September 2005||2005-09-01|December 2016|2016-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Intralumenal Effects on Cholesterol Absorption/Synthesis|Intralumenal Effects on Cholesterol Absorption/Synthesis|Completed||N/A|35|Actual|Children's Hospital Medical Center, Cincinnati||4|||f||||t||||||||Undecided||2017-02-18 16:32:00.26845|2017-02-18 16:32:00.26845
NCT00328198|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2014-02-10|2012-06-25||May 2006||2006-05-01|February 2014|2014-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia|A Phase II Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Alemtuzumab (CAMPATH®, MabCampath®) in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|86|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:32:00.397113|2017-02-18 16:32:00.397113
NCT00328185|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2012-03-14|||January 2006||2006-01-01|January 2006|2006-01-01|December 2006|Actual|2006-12-01|||||Observational|||Allograft Fibrosis Following Pediatric Cardiac Transplantation|Allograft Fibrosis: Its Regulation and Significance Following Pediatric Cardiac Transplantation|Terminated||N/A|100|Actual|Children's Healthcare of Atlanta|||1|unable to gather sufficient data|f||||||||||||||2017-02-18 16:32:01.299606|2017-02-18 16:32:01.299606
NCT00328172|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2014-02-15|2011-05-13||May 2006||2006-05-01|February 2014|2014-02-01||||August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients|A Randomized, Double-blind, Placebo-controlled, Five Parallel Group Study Investigating the Efficacy and Safety of BI 1356 BS (0.5 mg, 2.5 mg and 5.0 mg Administered Orally Once Daily) Over 12 Weeks in Drug Naive and Treated Patients With Type 2 Diabetes With Insufficient Glycemic Control (Study Includes an Open-label Metformin Treatment Arm)|Completed||Phase 2|302|Actual|Boehringer Ingelheim||5|||||||||||||||||2017-02-18 16:32:01.397151|2017-02-18 16:32:01.397151
NCT00328159|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2011-02-16|||June 2006||2006-06-01|March 2007|2007-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids|Dietary Therapy of Mitochondrial Fatty Acids Oxidation. A Clinical Study of Treatment With Odd Carbons Medium-chain Fatty Acids|Completed||N/A|20|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:32:02.539223|2017-02-18 16:32:02.539223
NCT00328146|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2006-05-18|||February 2001||2001-02-01|April 2006|2006-04-01|February 2006||2006-02-01|||||Observational|||A Technique for Sternal Re-Entry|Re-Operative Surgery in Children: A Technique for Sternal Re-Entry|Unknown status|Active, not recruiting|N/A|450||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:32:02.635216|2017-02-18 16:32:02.635216
NCT00328133|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2012-05-09|||June 2006||2006-06-01|May 2012|2012-05-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Observational|||The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry|The Use of rFVIIa in Trauma Patients: A WTA/AAST Multi-Center Case Registry|Completed||N/A|380|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 16:32:02.825837|2017-02-18 16:32:02.825837
NCT00328120|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2010-11-16|||April 2004||2004-04-01|November 2010|2010-11-01|June 2010|Actual|2010-06-01|April 2006|Actual|2006-04-01||Interventional|||Faslodex 500mg Multiple Dose Tolerability Study in BC Patients|An Open, Multicentre Phase I Clinical Study to Assess the Tolerability of Fulvestrant 500 mg in Postmenopausal Women With Hormone Receptor Positive Advanced or Recurrent Breast Cancer|Completed||Phase 1|20|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:32:02.913684|2017-02-18 16:32:02.913684
NCT00328107|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2010-01-08|||November 2004||2004-11-01|January 2010|2010-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults|Evaluation of the Immunogenicity and Safety of Two Preparations of Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine Administered Intramuscularly in Healthy Adults Ages 18-49 Years.|Completed||Phase 2/Phase 3|459|Actual|Protein Sciences Corporation||3|||f||||f||||||||||2017-02-18 16:32:03.012897|2017-02-18 16:32:03.012897
NCT00328094|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2013-04-10|2013-02-28||March 2006||2006-03-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|April 2008|Actual|2008-04-01||Interventional||assessed for eligibility 252. 10 were found ineligible. 242 were randomized.6 patients did not receive interventions they were supposed to. Total number of patients analyzed were 236.|Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery|Impact of Tight Control of Perioperative Blood Glucose in Patients Undergoing Vascular Surgery on Their Perioperative Cardiovascular and Overall Morbidity and Mortality|Terminated||N/A|242|Actual|Beth Israel Deaconess Medical Center|A trial to adequately address mortality would require 5000 to 6000 patients. The alpha levels for significance were not adjusted for the interim analyses because of the unplanned issues with subject recruitement as surgery became percutaneous.|2||The recruitment rate slowed considerably|f||||t||||||||||2017-02-18 16:32:03.132242|2017-02-18 16:32:03.132242
NCT00328081|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2007-09-13|||May 2006||2006-05-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Observational|||State of Obesity Care in Canada Evaluation Registry|State of Obesity Care in Canada Evaluation Registry An Observational Study of Clinical Care of Patients With Obesity|Terminated||N/A|1906|Actual|McMaster University||||Principal Investigator left the institution|f||||||||||||||2017-02-18 16:32:03.563868|2017-02-18 16:32:03.563868
NCT00328068|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2013-02-12|||July 2006||2006-07-01|February 2013|2013-02-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Observational|||Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)|Prospective, International, Multi-centre Study on ASAS Classification Criteria for SpA|Unknown status|Recruiting|N/A|992|Anticipated|Charite University, Berlin, Germany|||1||f||||t||||||Samples With DNA|"~     DNA and RNA will be collected in selected centres for analysis of candidate gene variants in~     ankylosing spondylitis/ spondyloarthritis. Serum and plasma sample will be collected for~     biomarker analysis with special focus on markers of bone metabolism~   "|||2017-02-18 16:32:03.647676|2017-02-18 16:32:03.647676
NCT00328055|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2011-04-21|||August 2004||2004-08-01|April 2011|2011-04-01|July 2005||2005-07-01|||||Interventional|||Comparison of an Easy to Read Advance Directive Versus a Standard Advance Directive|Effects of an Easy to Read Advance Directive on Acceptability, Knowledge, and Self-efficacy Compared to a Standard Advance Directive|Completed||N/A|200||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 16:32:03.964543|2017-02-18 16:32:03.964543
NCT00328029|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2009-02-24|||July 2006||2006-07-01|February 2009|2009-02-01|June 2012|Anticipated|2012-06-01|January 2012|Anticipated|2012-01-01||Interventional|||Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population|Assessment of Respiratory Functions After a Conditioning Regimen With Busulfan for Allograft or Autograft in a Unicenter Pediatric and Prospective Population|Unknown status|Recruiting|Phase 2|35|Anticipated|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-02-18 16:32:04.63986|2017-02-18 16:32:04.63986
NCT00328016|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2012-08-02|||April 2006||2006-04-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Breathe: Slow Paced Breathing to Lower Blood Pressure|Respiratory Adaptations to Behavioral Interventions in Elevated Blood Pressure|Completed||N/A|44|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:32:04.746392|2017-02-18 16:32:04.746392
NCT00327990|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2017-01-18|||April 2005||2005-04-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate|A Multi Centre, Randomised, Open Label, Cross-over Study to Evaluate the Percentage of False Negative Osteoporosis Diagnosis's Using the Standard Case-finding Procedure as Described by the Dutch Institute for Healthcare (CBO) and to Determine the Preference of Adult Osteoporosis Patients Between Once Monthly Dosing of Ibandronate (150 mg) and Once Weekly Dosing of Alendronate (70 mg)|Completed||Phase 4|300|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:32:04.862562|2017-02-18 16:32:04.862562
NCT00327977|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2014-11-25|||January 2001||2001-01-01|November 2014|2014-11-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Hypoxemia in Infants After Palliative Surgery|A Retrospective Study of Hypoxemia in Infants After Palliative Neonatal Surgery for Congenital Heart Disease|Completed||N/A|375|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 16:32:05.277586|2017-02-18 16:32:05.277586
NCT00327964|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2008-10-01|||October 2005||2005-10-01|October 2008|2008-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda|Utility of Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda|Completed||N/A|600|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     Dried blood spots on filter paper~   "|||2017-02-18 16:32:05.367218|2017-02-18 16:32:05.367218
NCT00327951|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2012-03-14|||January 2001||2001-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|March 2006|Actual|2006-03-01||Observational|||Infant Weight Gain With Trisomy 21 and CAVC|The Impact of Weight Gain in the Pre-operative Infant With Trisomy 21 (Down Syndrome) and Complete Atrioventricular Canal (CAVC)|Terminated||N/A|46|Actual|Children's Healthcare of Atlanta|||1|sufficient data collected for significant conclusion|f||||f||||||||||2017-02-18 16:32:05.476274|2017-02-18 16:32:05.476274
NCT00327938|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2007-04-19|||May 2006||2006-05-01|April 2007|2007-04-01||||||||Interventional|||Genetic Variation – The Need for Opioids During Surgery|Genetically Variation – May the Need of Opioids During Surgery be Known Beforehand by Giving Noxious Stimulation and Measure the Skin Conductance Response Before Surgery?|Completed||N/A|50||Rikshospitalet University Hospital|||||f||||f||||||||||2017-02-18 16:32:05.560787|2017-02-18 16:32:05.560787
NCT00327925|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2007-03-01|||July 2006||2006-07-01|May 2006|2006-05-01|June 2008||2008-06-01|||||Observational|||Blood Test for Ovarian Cancer Associated Antibodies (CAAb)|Study to Assess the Effectiveness of the CAAb Test With Ovarian Cancer Patients|Unknown status|Recruiting|N/A|60||Lab Discoveries Ltd.|||||f||||||||||||||2017-02-18 16:32:05.654365|2017-02-18 16:32:05.654365
NCT00327912|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2017-02-01|||April 2006||2006-04-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|ASGARD||Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Biliopancreatic Diversion (BPD)- Duodenal Switch for Superobesity|Laparoscopic Roux-en-Y Gastric Bypass vs. Laparoscopic BPD-Duodenal Switch for Superobesity (BMI > 50 kg/m2)- A Randomized Clinical Trial|Active, not recruiting||Phase 4|60|Anticipated|Göteborg University||2|||f||||||||||||||2017-02-18 16:32:05.748255|2017-02-18 16:32:05.748255
NCT00327899|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2011-11-18|||March 2006||2006-03-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Observational|||Home Inotropic Therapy in Children|Home Inotropic Therapy in Children|Terminated||N/A|13|Actual|Children's Healthcare of Atlanta|||1|Per PI instruction.|f||||f||||||||||2017-02-18 16:32:05.852656|2017-02-18 16:32:05.852656
NCT00327886|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2007-06-12|||February 2006||2006-02-01|June 2007|2007-06-01|February 2006||2006-02-01|||||Observational|||Managing Cyanosis Following Bidirectional Glenn Operation|A Retrospective Review of Postoperative Management of Cyanosis Following Bidirectional Glenn Operation|Terminated||N/A|150||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:32:05.925105|2017-02-18 16:32:05.925105
NCT00327873|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2009-12-10|||May 2005||2005-05-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Palliative Oxygen for the Relief of Breathlessness|A Multi-center Randomized Double-blind Controlled Trial of Oxygen Versus Medical Air for the Relief of Breathlessness in Patients With Intractable Dyspnea and PaO2>55mmHg|Completed||N/A|240|Anticipated|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 16:32:06.008864|2017-02-18 16:32:06.008864
NCT00327860|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2016-05-10|||October 2003||2003-10-01|February 2016|2016-02-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Observational|CKiD||Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)|Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)|Active, not recruiting||N/A|891|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||t||||||Samples With DNA|"~     Blood and urine specimens will be collected at the baseline visit and at each annual~     follow-up visit. Nail clippings and hair samples will be collected at baseline.Specimens~     will be stored at the NIDDK Biosample Repository, which is Fisher BioServices Corporation in~     Rockville, MD.~      The genetics repository will receive blood samples and process them to create immortalized~     cell lines, and DNA samples. Whole blood for the genetic repository will be collected at~     baseline. The genetics repository is at Rutgers, the State University of New Jersey in New~     Brunswick, NJ.~   "|||2017-02-18 16:32:06.135523|2017-02-18 16:32:06.135523
NCT00327847|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2008-09-23|||December 2004||2004-12-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Optimizing Vitamin D Nutrition in Healthy Adults|Optimizing Vitamin D Nutrition in Healthy Adults|Completed||N/A|150|Anticipated|Winthrop University Hospital|||||f||||||||||||||2017-02-18 16:32:06.256425|2017-02-18 16:32:06.256425
NCT00327834|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2011-06-21|||May 2006||2006-05-01|June 2011|2011-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Atomoxetine in the Treatment of Binge Eating Disorder|Atomoxetine in the Treatment of Binge Eating Disorder: A Single-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study in Outpatients|Completed||Phase 4|||Lindner Center of HOPE|||||f||||||||||||||2017-02-18 16:32:06.364474|2017-02-18 16:32:06.364474
NCT00327808|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2012-11-30|||May 2006||2006-05-01|November 2012|2012-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma|Multi-Center, Randomized, Double-Blind, Repeated Doses Study to Evaluate the Safety, Tolerability and Pharmacodynamic Activity of Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma|Completed||Phase 2|27|Actual|Pharmaxis||2|||f||||f||||||||||2017-02-18 16:32:06.560227|2017-02-18 16:32:06.560227
NCT00327795|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2012-03-14|||January 2006||2006-01-01|January 2006|2006-01-01|November 2007|Actual|2007-11-01|||||Observational|||Surgical Outcomes in Pediatric Patients With Coarctation and VSD|Staged Approach to Coarctation and VSD Can Offer Optimal Outcomes|Terminated||N/A|32||Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 16:32:06.681016|2017-02-18 16:32:06.681016
NCT00327782|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2007-05-02|||January 1995||1995-01-01|May 2007|2007-05-01|April 2006||2006-04-01|||||Observational|||Palliative Care of Children With End-Stage Heart Failure|Palliative Care of Children With End-Stage Heart Failure|Terminated||N/A|||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:32:06.784214|2017-02-18 16:32:06.784214
NCT00327769|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2011-01-24|||November 2005||2005-11-01|January 2011|2011-01-01|September 2007|Actual|2007-09-01|||||Interventional|||Faslodex Advanced Breast Cancer Local Chinese Study|A Double Blind, Double Dummy, Randomised, Multicentre Study to Compare the Efficacy and Safety of Fulvestrant 250mg With Arimidex 1mg as a Secondary-line Therapy in the Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer|Completed||Phase 3|234|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:32:06.864141|2017-02-18 16:32:06.864141
NCT00327756|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-18|2011-11-22|||May 2006||2006-05-01|May 2009|2009-05-01||||May 2009|Actual|2009-05-01||Interventional|||Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder|An Investigation Examining the Evidence for Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:32:06.974162|2017-02-18 16:32:06.974162
NCT00327743|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2016-04-18||2016-04-18|August 2006||2006-08-01|April 2016|2016-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer|A Dose-escalating, Multicenter, Single Arm, Open-Label Study of XRP9881 in Combination With Capecitabine (Xeloda), in Metastatic Breast Cancer Patients With Disease Progressing After Anthracycline and Taxane Therapy|Completed||Phase 1/Phase 2|34|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:32:07.078559|2017-02-18 16:32:07.078559
NCT00327730|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2014-04-17|||April 2006||2006-04-01|April 2014|2014-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical Trial|Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain|Completed||Phase 3|240|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 16:32:07.188959|2017-02-18 16:32:07.188959
NCT00327717|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2014-08-14|2010-10-28||September 2006||2006-09-01|August 2014|2014-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures|A Multicenter, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures|Completed||Phase 3|240|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:32:07.403456|2017-02-18 16:32:07.403456
NCT00327704|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2011-04-05|||July 2006||2006-07-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|June 2010|Actual|2010-06-01||Interventional|||Early Albumin Resuscitation During Septic Shock|Multicenter, Prospective, Randomized, Controlled Open Study Albumin 20% Versus Saline|Completed||Phase 4|794|Actual|Laboratoire français de Fractionnement et de Biotechnologies||2|||f||||||||||||||2017-02-18 16:32:07.970791|2017-02-18 16:32:07.970791
NCT00327691|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2007-05-01|||April 1998||1998-04-01|May 2007|2007-05-01|August 2004||2004-08-01|||||Interventional|TNT||A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels|The Effect Of LDL-Cholesterol, Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse (CHD) Recurrence In Patients With Pre-Existing CHD|Completed||Phase 4|8600||Pfizer|||||||||||||||||||2017-02-18 16:32:08.107187|2017-02-18 16:32:08.107187
NCT00327678|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-06-23|||May 2006||2006-05-01|March 2016|2016-03-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults|Young Adult With Acute Lymphoblastic Leukemia (ALL) : a Multicentric Protocol. GRAALL 2005 : T ALL or B ALL Non Ph GRAALL 2005 R : B ALL Non Ph CD20+ GRAAPH 2005 : ALL Ph|Completed||Phase 3|1080|Actual|Assistance Publique - Hôpitaux de Paris|||||f||||f||||||||||2017-02-18 16:32:08.793027|2017-02-18 16:32:08.793027
NCT00327665|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2016-10-11|||May 2006||2006-05-01|October 2016|2016-10-01|June 2007|Actual|2007-06-01|January 2007|Actual|2007-01-01||Interventional|||Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population|A Phase I/II, Randomized, Observer Blinded Study to Evaluate and Compare the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline Biologicals' Investigational Pneumococcal Vaccine Formulations Versus a Licensed Non-GlaxoSmithKline Biologicals' Vaccine and GlaxoSmithKline Biologicals' Aluminum-based 10-valent Pneumococcal Conjugate Vaccine, in Healthy Elderly Subjects|Completed||Phase 1|335|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:32:08.901525|2017-02-18 16:32:08.901525
NCT00327652|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2008-04-22|||October 2006||2006-10-01|April 2008|2008-04-01||||February 2008|Actual|2008-02-01||Interventional|||Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases|Phase 1 Dose-Escalation Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases|Completed||Phase 1|9|Actual|Anza Therapeutics, Inc.||1|||f||||t||||||||||2017-02-18 16:32:09.026703|2017-02-18 16:32:09.026703
NCT00327639|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2006-05-17|||July 2005||2005-07-01|July 2005|2005-07-01||||||||Observational|||Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto|Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto|Unknown status|Recruiting|N/A|50||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:32:09.121272|2017-02-18 16:32:09.121272
NCT00327418|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2007-05-08|||January 1997||1997-01-01|May 2007|2007-05-01|February 2004||2004-02-01|||||Interventional|CARDS||CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events|A Double Blind Placebo Controlled Study of Atorvastatin as Prevention of CHD in High Risk Patients With Non-Insulin Dependent Diabetes Mellitus (Collaborative Atorvastatin Study - CARDS)|Completed||Phase 4|2800||Pfizer|||||||||||||||||||2017-02-18 16:32:15.53173|2017-02-18 16:32:15.53173
NCT00327626|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2007-05-18|||May 2006||2006-05-01|May 2007|2007-05-01|March 2008||2008-03-01|||||Interventional|||Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of ISIS 113715 Administered Daily in Patients With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea|Withdrawn||Phase 2|96||Ionis Pharmaceuticals, Inc.||||study was never started due to regional geopolitical conflict|f||||||||||||||2017-02-18 16:32:09.201124|2017-02-18 16:32:09.201124
NCT00327613|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2008-09-25|||June 2005||2005-06-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma|Plasma Levels of Matrix Metalloproteinases and Degree of DNA Fragmentation in Patients With Pseudoexfoliation Syndrome and Open-Angle Glaucoma (PEXG)|Completed||N/A|60|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 16:32:09.279923|2017-02-18 16:32:09.279923
NCT00327600|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2010-09-14|||July 2005||2005-07-01|September 2010|2010-09-01|December 2007|Actual|2007-12-01|January 2007|Actual|2007-01-01||Interventional|||Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma|A Phase 1/2 Trial of Amplimexon® (Imexon, Inj.) Plus Dacarbazine (DTIC) in Chemotherapy Naive Patients With Unresectable Stage III or Stage IV Malignant Melanoma|Completed||Phase 1/Phase 2|68|Actual|AmpliMed Corporation||1|||f||||t||||||||||2017-02-18 16:32:09.363216|2017-02-18 16:32:09.363216
NCT00327587|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2011-11-07|||May 2006||2006-05-01|November 2011|2011-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension|An 8-week, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Valsartan/HCTZ/Amlodipine Compared to Valsartan/HCTZ, Valsartan/Amlodipine, and HCTZ/Amlodipine in Patients With Moderate to Severe Hypertension.|Completed||Phase 3|2279|Actual|Novartis|||||f||||||||||||||2017-02-18 16:32:09.476321|2017-02-18 16:32:09.476321
NCT00327574|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2006-05-25|||June 2004||2004-06-01|May 2006|2006-05-01|September 2007||2007-09-01|||||Interventional|||Population Based Strategies for Effective Control of High Blood Pressure in Pakistan||Unknown status|Active, not recruiting|N/A|||Aga Khan University|||||f||||||||||||||2017-02-18 16:32:09.578233|2017-02-18 16:32:09.578233
NCT00327561|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2006-05-16|||September 2003||2003-09-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Effect of Intensive Periodontal Therapy on Vascular Function|Effects of Non-Surgical Periodontal Therapy on Endothelial Function A Randomized Controlled Clinical Trial|Completed||Phase 3|120||Eastman Dental Insitute and Hospital|||||f||||||||||||||2017-02-18 16:32:09.686827|2017-02-18 16:32:09.686827
NCT00327548|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2006-10-04||||||July 2002|2002-07-01||||||||Interventional|||Use of Guided Imagery for Functional Abdominal Pain in Children:|Treatment of Functional Abdominal Pain in Children:Evaluation of Relaxation/Guided Imagery and Chamomile Tea as Therapeutic Modalities|Completed||Phase 3|||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 16:32:09.89248|2017-02-18 16:32:09.89248
NCT00327535|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-08-09|||May 2006||2006-05-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.|A Multicenter, Randomized, Open Label Dose Finding Study of Mircera in Anemic Patients With Stage IIIB or IV Non-small Cell Lung Cancer Receiving First Line Myelosuppressive Chemotherapy|Completed||Phase 2|153|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 16:32:09.971656|2017-02-18 16:32:09.971656
NCT00327522|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2008-10-09|||June 2006||2006-06-01|October 2008|2008-10-01||||||||Interventional|||Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.|An Open, Phase I/II Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' 11PCV Vaccine Given as a 2-Dose Vaccination in Adults Aged 18-40 Years Old.|Completed||Phase 2|10||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:32:10.139091|2017-02-18 16:32:10.139091
NCT00327509|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2009-08-19|||January 2004||2004-01-01|August 2009|2009-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||mRNA Expression in Lymphocytes of Glaucoma Patients|Messenger Ribonucleic Acid Expression in Lymphocytes of Glaucoma Patients|Completed||N/A|60|Actual|University Hospital, Basel, Switzerland|||6||f||||f||||||Samples With DNA|"~     white cells~   "|||2017-02-18 16:32:10.226065|2017-02-18 16:32:10.226065
NCT00327496|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2006-05-16|||June 2005||2005-06-01|June 2005|2005-06-01|June 2006||2006-06-01|||||Interventional|||Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells||Unknown status|Active, not recruiting|N/A|10||Mackay Memorial Hospital|||||f||||||||||||||2017-02-18 16:32:10.318043|2017-02-18 16:32:10.318043
NCT00327483|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2006-05-16|||July 2005||2005-07-01|May 2006|2006-05-01|April 2006||2006-04-01|||||Interventional|||Web Based Renal Transplant Patient Medication Education|Web Based Renal Transplant Patient Medication Education|Unknown status|Recruiting|Phase 4|250||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 16:32:10.392191|2017-02-18 16:32:10.392191
NCT00327470|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2012-04-02|2010-04-13||July 2006||2006-07-01|January 2011|2011-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|PERSPECTIVES||An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD|A 102-Week, Open Label, Multicenter Trial To Investigate The Efficacy Of Macugen For The Preservation Of Visual Function In Subjects With Neovascular Age-Related Macular Degeneration (AMD) And To Assess The Benefit Of Treating Early Choroidal Neovascularization (CNV).|Terminated||Phase 4|288|Actual|Pfizer||1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 16:32:10.490704|2017-02-18 16:32:10.490704
NCT00327457|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2011-02-18|||June 2002||2002-06-01|February 2011|2011-02-01|March 2005||2005-03-01|||||Interventional|||Coordinated Endoscopic Colorectal Cancer Screening|Coordinated Endoscopic Colorectal Cancer Screening|Completed||N/A|599|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 16:32:14.319634|2017-02-18 16:32:14.319634
NCT00327444|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2012-11-30|2012-08-17||July 2006||2006-07-01|July 2011|2011-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Effect of Intravenous Aflibercept Administered Every 2 Weeks in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites|Completed||Phase 2/Phase 3|58|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:32:14.42205|2017-02-18 16:32:14.42205
NCT00005528|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1995||1995-04-01|August 2004|2004-08-01|February 2000|Actual|2000-02-01|||||Observational|||Genetics of CVD Risk Factors in Samoans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:48.879734|2017-02-18 18:14:48.879734
NCT00327392|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2012-05-17|2012-03-01||May 2006||2006-05-01|May 2012|2012-05-01|December 2007|Actual|2007-12-01|||||Interventional|||A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.|A Phase 3 Open-Label, Single Arm Study to Assess the Safety of AQUAVAN® (Fospropofol Disodium) Injection for Minimal-to-Moderate Sedation in Patients Undergoing Minor Surgical Procedures|Completed||Phase 2/Phase 3|123|Actual|Eisai Inc.|||||||||||||||||||2017-02-18 16:32:15.841511|2017-02-18 16:32:15.841511
NCT00327379|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2014-11-27|||February 2006||2006-02-01|November 2014|2014-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery|Completed||Phase 3|54|Actual|Bayer||2|||f||||||||||||||2017-02-18 16:32:16.448475|2017-02-18 16:32:16.448475
NCT00327366|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2009-10-18|||September 2003||2003-09-01|October 2009|2009-10-01|April 2006|Actual|2006-04-01|||||Interventional|||Effect of Bright Light on Sex Hormones and Ovulation in Humans||Completed||N/A|27|Actual|Russian Academy of Medical Sciences||1|||f||||f||||||||||2017-02-18 16:32:16.580815|2017-02-18 16:32:16.580815
NCT00327353|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2009-05-21|||January 2004||2004-01-01|May 2009|2009-05-01||||||||Interventional|||Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol|Single-Centre Randomised Open Crossover Study to Examine the Influence of Different Internal Resistances of Discus and Turbohaler Respectively on the Effects of Salmeterol and Formoterol in Asthmatic Subjects|Completed||Phase 4|77||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:32:16.665634|2017-02-18 16:32:16.665634
NCT00327340|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2012-10-02|2012-07-26||July 2006||2006-07-01|October 2012|2012-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC|Title: A Pilot Study Evaluating the Safety and Feasibility of Custirsen (OGX-011) in Combination With Second Line Chemotherapy in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|70|Actual|OncoGenex Technologies||2|||f||||f||||||||||2017-02-18 16:32:16.774182|2017-02-18 16:32:16.774182
NCT00327327|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2010-09-14|||February 2004||2004-02-01|September 2010|2010-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma|A Phase 1 Trial of Amplimexon® (Imexon, Inj.) Plus Gemcitabine in Advanced, Previously Untreated Pancreatic Adenocarcinoma|Completed||Phase 1|105|Actual|AmpliMed Corporation||1|||f||||t||||||||||2017-02-18 16:32:17.58248|2017-02-18 16:32:17.58248
NCT00327314|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2006-12-27|||December 2002||2002-12-01|December 2006|2006-12-01|October 2006||2006-10-01|||||Interventional|||Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma||Unknown status|Recruiting|Phase 2|100||Azienda Ospedaliera San Giovanni Battista|||||f||||||||||||||2017-02-18 16:32:17.693709|2017-02-18 16:32:17.693709
NCT00327301|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2015-03-09|||October 2006||2006-10-01|March 2015|2015-03-01||||May 2008|Actual|2008-05-01||Observational|||Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease|Systematic Characterization of the Cellular Proteome From Human Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease|Withdrawn||N/A|0|Actual|University Hospital, Basel, Switzerland|||1|was replaced by an other study|f||||f||||||None Retained|"~     plasma~   "|||2017-02-18 16:32:17.776433|2017-02-18 16:32:17.776433
NCT00327288|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2015-06-22|||October 2005||2005-10-01|June 2015|2015-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients|A Phase 1 Trial of Amplimexon® (Imexon, Inj.) Plus Taxotere® (Docetaxel) in Previously Treated Inoperable Stage III and Stage IV Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic Previously Treated Breast Cancer or Hormone Refractory Prostate Cancer|Completed||Phase 1|34|Actual|AmpliMed Corporation||1|||f||||f||||||||||2017-02-18 16:32:17.856898|2017-02-18 16:32:17.856898
NCT00327275|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2006-05-16|||March 2004||2004-03-01|May 2006|2006-05-01|January 2005||2005-01-01|||||Interventional|||The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis|The Strength Training and Remicade Study|Completed||N/A|35||University of Arizona|||||f||||||||||||||2017-02-18 16:32:17.96523|2017-02-18 16:32:17.96523
NCT00327262|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2006-06-16|||January 2004||2004-01-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Interventional|||Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase|Multicenter, Phase III Study Comparing Imatinib (STI571, Glivec®) Standard Dose (400 Mg/Day) With Imatinib High Dose Induction (800 Mg/Day) Followed by Standard Dose Maintenance (400 Mg/Day) in Pretreated CML Patients in Chronic Phase|Unknown status|Recruiting|Phase 3|240||Central European Leukemia Study Group|||||f||||||||||||||2017-02-18 16:32:18.039954|2017-02-18 16:32:18.039954
NCT00327249|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2009-08-07|||October 2005||2005-10-01|August 2009|2009-08-01|January 2008|Actual|2008-01-01|July 2006|Actual|2006-07-01||Interventional|||Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients|A Phase 1/2 Trial of Amplimexon® (Imexon, Inj.) for Patients With Previously Treated Multiple Myeloma|Completed||Phase 1/Phase 2|||AmpliMed Corporation|||||f||||f||||||||||2017-02-18 16:32:18.139056|2017-02-18 16:32:18.139056
NCT00327236|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2017-01-03|||January 1995||1995-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes|Killer T Cell Activity in the Paraneoplastic Neurologic Syndromes|Recruiting||N/A|100|Anticipated|Rockefeller University|||1||f||||f||||||Samples With DNA|"~     serum, cells)~   "|||2017-02-18 16:32:18.219001|2017-02-18 16:32:18.219001
NCT00327223|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2008-03-12|||November 2005||2005-11-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy|A Phase 1 Trial of Amplimexon® (Imexon, Inj.) Administered Daily for 5 Days Every 3 Weeks to Patients With Metastatic Cancer or Disseminated Malignancy|Completed||Phase 1|18|Actual|AmpliMed Corporation||1|||f||||f||||||||||2017-02-18 16:32:18.323793|2017-02-18 16:32:18.323793
NCT00327210|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2008-08-06|||May 2005||2005-05-01|August 2008|2008-08-01|July 2009|Anticipated|2009-07-01|||||Interventional|||Feasibility and Efficacy of Delivering Blood Glucose Awareness Training Over the Internet|Blood Glucose Awareness Training Delivered Over the Internet (BGATHome.Com): Feasibility and Efficacy|Unknown status|Active, not recruiting|Phase 1/Phase 2|100||University of Virginia|||||f||||||||||||||2017-02-18 16:32:18.423231|2017-02-18 16:32:18.423231
NCT00327197|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2012-12-19|||August 2005||2005-08-01|December 2012|2012-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma|A Study to Assess Disease Pathology and Key Therapeutic Targets in Severe Asthma|Terminated||Phase 1|47|Actual|GlaxoSmithKline||||"The study was truncated due to the long period of enrollment and the collection of a~   sufficient amount of data that allowed the scientific objectives to be met"|f||||||||||||||2017-02-18 16:32:18.523733|2017-02-18 16:32:18.523733
NCT00327184|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-10-06|||April 2006||2006-04-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine|Study to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC Given With Infanrix™ Penta Versus NeisVac-C™ Given With Infanrix™ Hexa at 3, 5 Months of Age and Persistence Prior to a Hib-MenC Booster at 11 Months and Immunogenicity of the Booster|Completed||Phase 3|709|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:32:18.620608|2017-02-18 16:32:18.620608
NCT00327171|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-05-04|2012-08-17||May 2006||2006-05-01|May 2016|2016-05-01|March 2010|Actual|2010-03-01|April 2008|Actual|2008-04-01||Interventional|||Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer|A Multicenter, Randomized, Double-blind, Parallel-arm, Two-stage Study of the Efficacy and Safety of AVE0005 (VEGF Trap) Administered Intravenously Every 2 Weeks in Patients With Platinum-resistant and topotecan-and/or Liposomal Doxorubicin-resistant Advanced Ovarian Cancer|Completed||Phase 2|218|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:32:19.002162|2017-02-18 16:32:19.002162
NCT00327158|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2010-01-27|||May 2006||2006-05-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||A Prospective Study to Determine the Effectiveness of Reaming in Reducing Fat Emboli to the Lungs|Using Transesophageal Echocardiography To Assess Fat Emboli As A Result Of Reaming In A Prospective Randomized Control Trial To Determine The Effectiveness Of Reaming In Diminishing Fat Emboli To The Lungs|Completed||N/A|24|Anticipated|University of Kentucky||1|||f||||f||||||||||2017-02-18 16:32:20.079979|2017-02-18 16:32:20.079979
NCT00327145|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-11-16|||March 2006||2006-03-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy|A Double-blind, Randomized, Multicenter Study to Evaluate the Effectiveness of the Combination of Valsartan & Amlodipine in Hypertensive Patients Not Controlled on Monotherapy|Completed||Phase 3|894|Actual|Novartis|||||f||||||||||||||2017-02-18 16:32:20.17473|2017-02-18 16:32:20.17473
NCT00327132|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2016-03-23|||July 2006||2006-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome|Multicentre,Prospective Study of First-line Antibiotic Therapy for Early-stage Low-grade and High-grade Gastric Mucosa-associated Lymphoid Tissue-type Lymphoma and Potential Predicting Factor for Treatment Outcome|Completed||N/A|47|Actual|National Health Research Institutes, Taiwan||1|||f||||||||||||||2017-02-18 16:32:20.277778|2017-02-18 16:32:20.277778
NCT00327119|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2009-09-11|||April 2006||2006-04-01|September 2009|2009-09-01||||||||Interventional|||Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer|A Phase 2 Multicenter Single Arm Clinical Trial of ABX EGF (Panitumumab) Monotherapy in Japanese Subjects With Metastatic Colorectal Cancer Who Developed Progressive Disease or Relapsed While on or After Prior Fluoropyrimidine, Irinotecan and Oxaliplatin Chemotherapy|Completed||Phase 2|50||Amgen||1|||f||||||||||||||2017-02-18 16:32:20.405187|2017-02-18 16:32:20.405187
NCT00327106|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2009-06-09|||April 2005||2005-04-01|June 2009|2009-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|THIF||Tranexamic Acid in HIp Fracture Surgery (THIF Study)|Efficacy of Tranexamic Acid on Perioperative Blood Loss During Hip Fracture Surgery.|Completed||Phase 3|110|Actual|Centre Hospitalier Universitaire de Saint Etienne||2|||f||||t||||||||||2017-02-18 16:32:20.496504|2017-02-18 16:32:20.496504
NCT00327093|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2009-02-06|||May 2006||2006-05-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases|Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases|Terminated||Phase 4|31|Actual|Hospices Civils de Lyon||2||The scientific commitee decided to stop the inclusions and exploit the results.|f||||||||||||||2017-02-18 16:32:20.629567|2017-02-18 16:32:20.629567
NCT00327080|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2017-01-24|||May 12, 2006||2006-05-12|November 13, 2012|2012-11-13|March 18, 2009|Actual|2009-03-18|March 18, 2009|Actual|2009-03-18||Interventional|||Sildenafil to Treat HIV-Associated Pulmonary Hypertension|Evaluation of Endothelial and Hemodynamic Function in HIV Associated Pulmonary Hypertension and a Phase I/II Safety and Efficacy Trial of Sildenafil in HIV Associated Pulmonary Hypertension|Terminated||Phase 1|20|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:32:20.747994|2017-02-18 16:32:20.747994
NCT00327067|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-17|2017-01-24|||May 12, 2006||2006-05-12|March 1, 2012|2012-03-01|March 1, 2012||2012-03-01|||||Observational|||Iron Replacement in Blood Donors|Iron Replacement in Blood Donors|Completed||N/A|1820|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:32:20.851779|2017-02-18 16:32:20.851779
NCT00327054|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2015-06-30|||February 2006||2006-02-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia|Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia: A Randomized Controlled Trial|Completed||Phase 1/Phase 2|80|Actual|Aga Khan University||2|||f||||f||||||||||2017-02-18 16:32:20.945611|2017-02-18 16:32:20.945611
NCT00327041|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-05-15|||January 2006||2006-01-01|May 2006|2006-05-01|September 2006||2006-09-01|||||Observational|||Monitoring Response to Antiplatelet Therapy|Pilot Study Investigating the Use of a Variety of Assays to Detect Individual Response to Antiplatelet Therapy|Unknown status|Recruiting|Phase 4|40||NHS Greater Glasgow and Clyde|||||f||||||||||||||2017-02-18 16:32:21.05607|2017-02-18 16:32:21.05607
NCT00327028|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2009-02-18|||September 2005||2005-09-01|February 2009|2009-02-01|December 2005||2005-12-01|||||Interventional|||Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Phenytoin Efficacy in Bronchial Asthma Therapy|Completed||Phase 4|61||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-02-18 16:32:21.134227|2017-02-18 16:32:21.134227
NCT00327015|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2015-04-08|2009-08-17||May 2006||2006-05-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|November 2007|Actual|2007-11-01||Interventional|||A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise|A Multicenter, Randomized, Double-Blind Active-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR as Initial Therapy Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|Completed||Phase 3|1306|Actual|AstraZeneca||4|||f||||t||||||||||2017-02-18 16:32:21.240169|2017-02-18 16:32:21.240169
NCT00327002|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2015-12-09|||January 2006||2006-01-01|December 2009|2009-12-01|November 2006|Actual|2006-11-01|September 2006|Actual|2006-09-01||Interventional|||A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism|A Mechanistic Study of the Effects of LY518674 on HDL C Metabolism|Completed||Phase 2|40|Actual|University of Pennsylvania|||||f||||||||||||||2017-02-18 16:32:22.756137|2017-02-18 16:32:22.756137
NCT00326989|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2015-03-31|||May 2006||2006-05-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Cell-Wave Study: Combined Extracorporal Shock Wave Therapy and Intracoronary Cell Therapy in Chronic Ischemic Myocardium|Extracorporal Shock Wave Therapy for Induction of Therapeutic Neovascularization and Homing of Bone Marrow Progenitor Cells in Patients With Chronic Ischemic Heart Disease|Completed||Phase 1/Phase 2|103|Actual|Johann Wolfgang Goethe University Hospital||5|||f||||f||||||||||2017-02-18 16:32:22.845983|2017-02-18 16:32:22.845983
NCT00326976|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2007-12-03|||August 2006||2006-08-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury|"A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Measure the Effect of FX06 (a Fibrin Derived Peptide Bbeta15-42) on Ischemia Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention (PCI): The F.I.R.E. Study"|Completed||Phase 2|234|Actual|Fibrex Medical Research & Development GmbH||2|||f||||t||||||||||2017-02-18 16:32:22.956577|2017-02-18 16:32:22.956577
NCT00326963|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-07-07|2016-03-23||March 2006||2006-03-01|July 2016|2016-07-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional||Baseline analysis was performed on all randomized participants including two participants who does not received study drug.|BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.|A Multicenter, Open-label Study Evaluating the Safety and Efficacy of a New Protease Inhibitor (Darunavir) With Fuzeon® (Enfuvirtide) Plus Background Antiretroviral Regimen in HIV-1 Infected, Triple-class Treatment-experienced Patients|Completed||Phase 4|142|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:32:23.103258|2017-02-18 16:32:23.103258
NCT00326950|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2012-03-06|2011-11-16||June 2006||2006-06-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Phase I Clinical Study of E7389|Phase I Clinical Study of E7389 in Patients With Solid Tumors|Completed||Phase 1|15|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 16:32:23.633823|2017-02-18 16:32:23.633823
NCT00326924|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2014-11-02|||May 2006||2006-05-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Age of Red Blood Cells in Premature Infants Study (ARIPI)|Age of Red Blood Cells in Premature Infants Study (ARIPI)|Completed||N/A|377|Actual|Ottawa Hospital Research Institute||2|||f||||t||||||||||2017-02-18 16:32:23.944287|2017-02-18 16:32:23.944287
NCT00326911|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2011-05-19|2009-11-03||May 2006||2006-05-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer|A Phase II, Randomized, Open-Label Study of Cetuximab and Bevacizumab Alone or in Combination With Fixed-Dose Rate Gemcitabine as First-Line Therapy of Patients With Metastatic Adenocarcinoma of the Pancreas|Terminated||Phase 2|61|Actual|ImClone LLC|Accrual on the trial was stopped earlier than planned due to insufficient efficacy in both arms.|2||"The planned enrollment was 130 patients and the study was halted prematurely due to lack of~   efficacy in both arms. Enrolled patients continued treatment."|f||||t||||||||||2017-02-18 16:32:24.06384|2017-02-18 16:32:24.06384
NCT00326898|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-12-15|2016-10-18||April 2006||2006-04-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|December 2010|Actual|2010-12-01||Interventional|ASSURE|All randomized patients|Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery|ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma|Completed||Phase 3|1943|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-02-18 16:32:25.360843|2017-02-18 16:32:25.360843
NCT00326885|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2016-08-18|2011-06-15||June 2006||2006-06-01|August 2016|2016-08-01|August 2010|Actual|2010-08-01|December 2009|Actual|2009-12-01||Interventional|||Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites|A Single-Arm, Open-Label, Phase II Study to Assess the Safety and Efficacy of the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3) Administered Intraperitoneally in Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites|Completed||Phase 2|32|Actual|Neovii Biotech||1|||f||||||||||||||2017-02-18 16:32:28.124795|2017-02-18 16:32:28.124795
NCT00326872|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-06-17|2013-07-10||May 2006||2006-05-01|June 2016|2016-06-01||||October 2011|Actual|2011-10-01||Interventional|||AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine|A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas|Active, not recruiting||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:32:28.551165|2017-02-18 16:32:28.551165
NCT00326859|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2006-10-12|||August 2005||2005-08-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||Comparison of Monitored Anesthesia Care Using Remifentanil or Fentanyl for Major Dressing Changes in Burns||Terminated||Phase 4|40||Montreal Burn Centre|||||f||||||||||||||2017-02-18 16:32:29.108789|2017-02-18 16:32:29.108789
NCT00326833|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2008-08-07|||January 2006||2006-01-01|August 2008|2008-08-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||How Many Patients Are in Need of Vitamin B12 Injections?|How Many Patients Are in Need of Vitamin B12 Injections?|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|University of Aarhus||1|||f||||||||||||||2017-02-18 16:32:29.20353|2017-02-18 16:32:29.20353
NCT00326612|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2011-09-19|2011-03-10||June 2006||2006-06-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures|Intranasal Midazolam Versus Rectal Diazepam for the Home Treatment of Seizure Activity in Pediatric Patients With Epilepsy|Completed||Phase 2|358|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 16:32:33.687378|2017-02-18 16:32:33.687378
NCT00326820|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2013-03-12|||January 2006||2006-01-01|March 2013|2013-03-01|October 2015|Anticipated|2015-10-01|December 2012|Actual|2012-12-01||Interventional|||Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer|Zoledronate Versus Ibandronate Comparative Evaluation: A Randomized Phase III, Open-Label, Multicenter, Parallel Group Clinical Trial to Evaluate and Compare the Efficacy, Safety Profile and Tolerability of Oral Ibandronate Versus Intravenous Zoledronate in the Treatment of Breast Cancer Patients With Bone Metastases|Unknown status|Active, not recruiting|Phase 3|1404|Actual|Wales Cancer Trials Unit||2|||f||||t||||||||||2017-02-18 16:32:29.314272|2017-02-18 16:32:29.314272
NCT00326807|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-05-15|||June 2001||2001-06-01|May 2006|2006-05-01|June 2004||2004-06-01|||||Interventional|||Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling|A Randomized, Double-Blind, Placebo-Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling|Completed||N/A|50||Centre for Addiction and Mental Health|||||f||||||||||||||2017-02-18 16:32:29.51661|2017-02-18 16:32:29.51661
NCT00326794|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-05-15|||October 2002||2002-10-01|June 2005|2005-06-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Shoulder Mobilisation Versus Conventional Immobilisation for Nonsurgically Proximal Humerus Fracture|Effectiveness at 3 Months of Immediate Shoulder Mobilisation Versus Conventional Immobilisation for Impacted Nonsurgically Treated Proximal Humerus Fracture: a Randomised Controlled Trial.|Terminated||Phase 3|76||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:32:29.644096|2017-02-18 16:32:29.644096
NCT00326781|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2010-08-16|2009-05-15||December 1999||1999-12-01|March 2010|2010-03-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)|Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy - Transdisciplinary Tobacco Use Research Center (TTURC), Project 2|Completed||Phase 4|674|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 16:32:29.740386|2017-02-18 16:32:29.740386
NCT00326768|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2013-11-11|||May 2006||2006-05-01|November 2013|2013-11-01|August 2007||2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension|An Open-Label, Long-term (52-week), Safety Trial of the Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlorothiazide 12.5mg and Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg in Patients With Essential Hypertension - Efficacy and Safety Evaluation|Completed||Phase 3|184|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:32:30.165375|2017-02-18 16:32:30.165375
NCT00326742|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2007-05-09|||July 2005||2005-07-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Observational|||Validation in Humans of Genes Involved in Alcohol Drinking, Stress-Induced Alcohol Drinking and Relapse|Validation in Humans of Genes Involved in Alcohol Drinking, Stress-Induced Alcohol Drinking and Relapse|Completed||N/A|281|Actual|Central Institute of Mental Health, Mannheim|||||f||||||||||||||2017-02-18 16:32:30.264264|2017-02-18 16:32:30.264264
NCT00326729|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-06-15|||May 2006||2006-05-01|May 2006|2006-05-01||||||||Observational|||Fluid Shifts During Resuscitation: Impacts on Macrocirculation and Microcirculation||Unknown status|Recruiting|Phase 4|40||Montreal Burn Centre|||||f||||||||||||||2017-02-18 16:32:30.358437|2017-02-18 16:32:30.358437
NCT00326716|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2011-11-04|2011-01-05||June 2006||2006-06-01|November 2011|2011-11-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Interventional|||Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women|A Study of the Pharmacokinetics of Atazanavir (ATV)/Ritonavir(RTV) Administered as Part of Highly Active Antiretroviral Therapy (HAART) in HIV-1 Infected Pregnant Women|Completed||Phase 1|69|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:32:30.57799|2017-02-18 16:32:30.57799
NCT00326703|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-10-16|||October 2002||2002-10-01|May 2006|2006-05-01|April 2003||2003-04-01|||||Interventional|||Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort|Investigation to Determine the Effects of Aircraft Cabin Altitudes on Passenger Comfort and Discomfort|Completed||N/A|500||The Boeing Company|||||f||||||||||||||2017-02-18 16:32:32.970237|2017-02-18 16:32:32.970237
NCT00326690|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-06-08|||November 2005||2005-11-01|May 2006|2006-05-01|July 2007||2007-07-01|||||Interventional|||Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity|A Prospective, Randomized Trial Using a reproduciBLe volUmE-Measurement stratEGy in the surGical Reconstruction of the Ischemic Cardiomyopathic Heart|Unknown status|Recruiting|Phase 4|100||BioVentrix|||||f||||||||||||||2017-02-18 16:32:33.052282|2017-02-18 16:32:33.052282
NCT00326677|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2011-02-17|||May 2006||2006-05-01|February 2011|2011-02-01|December 2013|Anticipated|2013-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Primary Prevention of Major Depression in Later Life|Primary Prevention of Major Depression in Later Life|Unknown status|Active, not recruiting|N/A|306|Anticipated|University of Pittsburgh||1|||f||||f||||||||||2017-02-18 16:32:33.160605|2017-02-18 16:32:33.160605
NCT00326664|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-03-04|||March 2006||2006-03-01|March 2016|2016-03-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors|A Phase I Clinical Trial of AZD2171 in Children With Recurrent or Progressive Central Nervous System (CNS) Tumors|Completed||Phase 1|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:32:33.25002|2017-02-18 16:32:33.25002
NCT00326651|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2007-01-31|||May 2006||2006-05-01|January 2007|2007-01-01|May 2007||2007-05-01|||||Observational|||Home Usage of Conception Kit Instructions|Home Usage of Conception Kit Instructions|Unknown status|Active, not recruiting|Phase 4|60||Conceivex|||||f||||||||||||||2017-02-18 16:32:33.362107|2017-02-18 16:32:33.362107
NCT00326638|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2016-09-15|||March 2005||2005-03-01|September 2016|2016-09-01|March 2018|Anticipated|2018-03-01|January 2015|Actual|2015-01-01||Interventional|||3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer|Randomized Phase III Trial of 3D Conformal Radiotherapy Versus Helical Tomotherapy IMRT in High-Risk Prostate Cancer|Active, not recruiting||Phase 3|72|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 16:32:33.464671|2017-02-18 16:32:33.464671
NCT00326625|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2013-08-29|||July 2006||2006-07-01|August 2013|2013-08-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)|A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of 40 mg Glatiramer Acetate Injection in Subjects With Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|366|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 16:32:33.574317|2017-02-18 16:32:33.574317
NCT00005526|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1991||1991-08-01|August 2004|2004-08-01|November 2001|Actual|2001-11-01|||||Observational|||Genetic Basis of Abdominal Aortic Aneurysm||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:48.959819|2017-02-18 18:14:48.959819
NCT00326599|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2016-12-07|2016-12-07||June 2007||2007-06-01|December 2016|2016-12-01|February 2010|Actual|2010-02-01|April 2009|Actual|2009-04-01||Interventional||All participants who received treatment.|Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|101|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 16:32:34.325119|2017-02-18 16:32:34.325119
NCT00326586|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2011-01-24|||May 2006||2006-05-01|July 2009|2009-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer|A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer|Completed||Phase 1|54|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 16:32:36.130127|2017-02-18 16:32:36.130127
NCT00326573|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-05-15|||October 2001||2001-10-01|October 2004|2004-10-01|June 2005||2005-06-01|||||Interventional|||Trial of Motivational Interviewing in Adolescents With Diabetes|A Multicentre, Randomised Controlled Trial of Motivational Interviewing in Adolescents With Diabetes|Terminated||Phase 1/Phase 2|80||Cardiff University|||||f||||||||||||||2017-02-18 16:32:36.232415|2017-02-18 16:32:36.232415
NCT00326560|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-06-15|||May 2006||2006-05-01|May 2006|2006-05-01|September 2007||2007-09-01|||||Interventional|||Comparison of Glue With Sutures for Pterygium Surgery|Comparison of Cut and Paste With Sutured Autograft Pterygium Excision|Unknown status|Recruiting|Phase 3|40||Wellington Hospital|||||f||||||||||||||2017-02-18 16:32:36.321697|2017-02-18 16:32:36.321697
NCT00326534|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2009-03-06|||September 2006||2006-09-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Observational|||Rickettsial Genesis to Sarcoidosis in Denmark|Rickettsial Genesis to Sarcoidosis in Denmark|Completed||N/A|36|Actual|Statens Serum Institut|||2||f||||f||||||Samples With DNA|"~     Buffy coats, serum, bronchoalveolar lavage fluid and transbronchial biopsies~   "|||2017-02-18 16:32:36.412304|2017-02-18 16:32:36.412304
NCT00326521|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2008-06-05|||October 2006||2006-10-01|June 2008|2008-06-01|May 2009|Anticipated|2009-05-01|||||Observational|||Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia|Evaluation of Intrapartum Fever in Patients Receiving Epidural Anesthesia|Unknown status|Recruiting|Phase 1|50|Anticipated|MemorialCare|||1||f||||f||||||Samples With DNA|"~     Maternal serum, amniotic fluid, and umbilical cord blood~   "|||2017-02-18 16:32:36.513515|2017-02-18 16:32:36.513515
NCT00326508|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2017-01-24|||May 11, 2006||2006-05-11|December 20, 2006|2006-12-20|December 20, 2006||2006-12-20|||||Interventional|||Combination Daclizumab/Denileukin Diftitox to Treat Uveitis|Combination Daclizumab/Denileukin Diftitox (Ontak) Therapy for the Induction of Immune Tolerance in Non-infectious Intermediate and Posterior Uveitis|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:32:36.61188|2017-02-18 16:32:36.61188
NCT00326495|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2015-09-29|2015-07-10||May 2006||2006-05-01|September 2015|2015-09-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer|A Phase II Study of BAY 43-9006 (Sorafenib) in Combination With Cetuximab (Erbitux ) in EGFR Expressing Metastatic Colorectal Cancer (CRC)|Completed||Phase 2|51|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 16:32:36.723677|2017-02-18 16:32:36.723677
NCT00326482|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-16|2017-01-24|||May 12, 2006||2006-05-12|April 25, 2016|2016-04-25||||||||Observational|||Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy|A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients With Chronically Elevated Transaminases on Antiretroviral Therapy|Recruiting||N/A|180|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:32:37.209905|2017-02-18 16:32:37.209905
NCT00326469|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2010-11-30|||May 2006||2006-05-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours|Phase II, Open, Single Group, Multicentre Study to Evaluate the Efficacy and Safety of Lanreotide Autogel Administered Every 4 Weeks by Deep Subcutaneous Injection in the Tumour's Growth Stabilization of Patients With Progressive Neuroendocrine Tumours Who Are Not Eligible to be Treated With Either Surgery or Chemotherapy|Completed||Phase 2|30|Actual|Ipsen||1|||f||||||||||||||2017-02-18 16:32:37.317585|2017-02-18 16:32:37.317585
NCT00326456|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2016-01-22|||January 2003||2003-01-01|January 2016|2016-01-01|May 2016|Anticipated|2016-05-01|December 2013|Actual|2013-12-01||Interventional|||MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer|Phase III Randomized Multicentre Trial of Carboplatin + Liposomal Doxorubicin vs Carboplatin + Paclitaxel in Patients With Ovarian Cancer|Active, not recruiting||Phase 3|820|Actual|National Cancer Institute, Naples||2|||f||||t||||||||||2017-02-18 16:32:37.556254|2017-02-18 16:32:37.556254
NCT00326443|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2014-05-08|||February 2006||2006-02-01|February 2010|2010-02-01|August 2008|Actual|2008-08-01|September 2007|Actual|2007-09-01||Interventional|||CVD 909 Vi Prime Boost Study|Phase I Randomized, Double-Blind, Heterologous Prime-Boost Study of the Safety and Immunogenicity of Vi Polysaccharide Typhoid Vaccine After Priming by Live Attenuated Oral Vi+ Salmonella Typhi Strain CVD 909|Completed||Phase 1|21|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:32:37.699511|2017-02-18 16:32:37.699511
NCT00326430|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-05-15|||October 2001||2001-10-01|May 2006|2006-05-01|June 2004||2004-06-01|||||Interventional|||Residential Cognitive and Interpersonal Therapy for Social Phobia|Residential Cognitive Therapy Versus Residential Interpersonal Therapy for Social Phobia: A Randomized Controlled Trial|Completed||Phase 2/Phase 3|80||Modum Bad|||||f||||||||||||||2017-02-18 16:32:37.811452|2017-02-18 16:32:37.811452
NCT00326417|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2016-10-03|2016-08-10||January 2006||2006-01-01|August 2016|2016-08-01|January 2016|Actual|2016-01-01|September 2015|Actual|2015-09-01||Interventional|||Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)|Fludarabine-based Conditioning for Allogeneic Marrow Transplantation From HLA-compatible Unrelated Donors in Severe Aplastic Anemia (BMT CTN #0301)|Completed||Phase 1/Phase 2|97|Actual|Medical College of Wisconsin||4|||f||||t||||||||Yes|Findings will be published in a manuscript.|2017-02-18 16:32:37.912707|2017-02-18 16:32:37.912707
NCT00326404|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2008-07-17|||May 2006||2006-05-01|July 2008|2008-07-01|May 2009|Anticipated|2009-05-01|May 2008|Anticipated|2008-05-01||Interventional|||Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents|Continuous Versus Cyclic Use of an Oral Contraceptive Pills in Adolescents|Unknown status|Recruiting|Phase 3|130|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 16:32:39.016173|2017-02-18 16:32:39.016173
NCT00326391|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2011-05-20|||April 2006||2006-04-01|April 2010|2010-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder|A Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Titration Study to Evaluate the Efficacy and Safety of CONCERTA (Methylphenidate HCl) Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder at Doses of 36 mg, 54 mg, 72 mg, 90 mg, or 108 mg Per Day.|Completed||Phase 3|229|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||||||||||||||||2017-02-18 16:32:39.138278|2017-02-18 16:32:39.138278
NCT00326378|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2015-06-03|||October 2005||2005-10-01|November 2012|2012-11-01|May 2015|Actual|2015-05-01|March 2013|Actual|2013-03-01||Interventional|||Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer|A Multinational, Multicenter, Phase III Open Randomized Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-small Cell Lung Cancer (CCheIN)|Completed||Phase 3|434|Actual|Samsung Medical Center||2|||f||||||||||||||2017-02-18 16:32:39.250933|2017-02-18 16:32:39.250933
NCT00326365|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2007-10-30|||June 2006||2006-06-01|May 2006|2006-05-01||||||||Interventional|||Effect of Homeopathic Remedy Kalium Bichromicum on Viscosity and Amount of Sputum Mechanically Ventilated ICU Patients.|A Multicenter, Randomized, Double Blind, Placebo Controlled Trial to Investigate the Efficacy and Safety of the Homeopathic Remedy Kalium Bichromicum (Potassium Dichromate) to Decrease Viscosity and Amount of Sputum as Well as Time to Extubation, in Intubated Mechanically Ventilated ICU Patients.|Unknown status|Not yet recruiting|Phase 3|56|Anticipated|Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:32:39.360837|2017-02-18 16:32:39.360837
NCT00326352|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2006-05-15|||July 2003||2003-07-01|May 2006|2006-05-01|June 2005||2005-06-01|||||Interventional|||Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil|Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil|Terminated||N/A|40||University of Edinburgh|||||f||||||||||||||2017-02-18 16:32:39.458824|2017-02-18 16:32:39.458824
NCT00326339|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2009-04-16|||August 2006||2006-08-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Dose Ranging Study to Evaluate Up to Three Doses of R935788 in Rheumatoid Arthritis Patients Failing to Respond to Methotrexate|Completed||Phase 2|189|Actual|Rigel Pharmaceuticals||4|||f||||t||||||||||2017-02-18 16:32:39.568968|2017-02-18 16:32:39.568968
NCT00326326|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2009-05-06|||July 2006||2006-07-01|May 2009|2009-05-01|June 2007|Actual|2007-06-01|||||Interventional|||Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Effect Of CP-778,875 On HDL-Cholesterol In Adult Subjects With Dyslipidemia And Type 2 Diabetes Mellitus|Completed||Phase 2|84||Pfizer|||||||||||||||||||2017-02-18 16:32:39.750665|2017-02-18 16:32:39.750665
NCT00326313|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-14|2006-05-15|||June 2006||2006-06-01|May 2006|2006-05-01||||||||Observational|||Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study|Clinical Outcome of Neonate With GBS Positive Culture-12 Year Retrospective Study|Unknown status|Not yet recruiting|N/A|74||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:32:39.87078|2017-02-18 16:32:39.87078
NCT00326300|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2011-05-20|||April 2006||2006-04-01|April 2010|2010-04-01|August 2007|Actual|2007-08-01|||||Interventional|||A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder|An Open-Label, Dose-Titration, Long-Term Safety Study to Evaluate CONCERTA (Methylphenidate HCL) Extended-release Tablets at Doses of 36 mg, 54 mg, 72 mg, 90 mg, and 108 mg Per Day in Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 3|560|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||||||||||||||||2017-02-18 16:32:39.942759|2017-02-18 16:32:39.942759
NCT00326287|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2012-07-25||2011-06-03|June 2006||2006-06-01|July 2012|2012-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia|A Randomized, Double-Blind, Multicenter Study of Ceftobiprole Medocaril Versus Placebo in the Treatment of Subjects Hospitalized With Community-Acquired Pneumonia|Completed||Phase 3|638|Actual|Basilea Pharmaceutica||2|||||||t||||||||||2017-02-18 16:32:40.051238|2017-02-18 16:32:40.051238
NCT00326274|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2009-02-10|||May 2006||2006-05-01|February 2009|2009-02-01|November 2006||2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream||Completed||Phase 3|||Loreal USA|||||||||||||||||||2017-02-18 16:32:40.16513|2017-02-18 16:32:40.16513
NCT00326261|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2008-12-17||||||April 2006|2006-04-01||||||||Observational|||Randomized Controlled Trial of Ultrasound Guided Needle Placement Versus Nerve Stimulation for Coracoid Infraclavicular Brachial Plexus Block|Randomized Controlled Trial of Ultrasound Guided Needle Placement Versus Nerve Stimulation for Coracoid Infraclavicular Brachial Plexus Block|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:32:40.240759|2017-02-18 16:32:40.240759
NCT00326248|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2016-10-24|||March 2006||2006-03-01|October 2016|2016-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women|A Phase III, Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of 50mg Oral Dosing With the Neurokinin-1 Receptor Antagonist GW679769 for the Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis|Completed||Phase 3|482|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:32:40.315755|2017-02-18 16:32:40.315755
NCT00326235|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2017-01-11|||January 2002||2002-01-01|March 2005|2005-03-01|July 2004||2004-07-01|||||Interventional|||Effects of Buspirone in Opiate Withdrawal|Effects of Buspirone in Withdrawal From Opiates|Completed||Phase 4|||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:32:40.483104|2017-02-18 16:32:40.483104
NCT00326222|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2016-07-18|||May 2006||2006-05-01|July 2016|2016-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Patient Education in NorthTrondelag Hospital Trust|Patient Education in NorthTrondelag Hospital Trust - Interventions, Effects and Patient Experience|Completed||N/A|146|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 16:32:40.587256|2017-02-18 16:32:40.587256
NCT00307983|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-03-27|||April 2004||2004-04-01|March 2006|2006-03-01|February 2006||2006-02-01|||||Observational|||Effect of Malnutrition on the Prognosis in Hemodialysis Patients|Effect of Malnutrition on the Prognosis in Hemodialysis Patients|Unknown status|Recruiting|N/A|600||University of Shizuoka|||||f||||||||||||||2017-02-18 16:39:43.328314|2017-02-18 16:39:43.328314
NCT00326209|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2011-06-13|||December 2005||2005-12-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission|A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation|Completed||Phase 3|394|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||||||||||||2017-02-18 16:32:40.701012|2017-02-18 16:32:40.701012
NCT00326196|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2014-04-07|2013-07-01||July 2006||2006-07-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|VA CARDS||Coronary Artery Revascularization in Diabetes|CSP #557 - Coronary Artery Revascularization in Diabetes (VA CARDS)|Terminated||Phase 4|198|Actual|VA Office of Research and Development|Low participant recruitment led to the study being terminated early.|2||Lack of participant enrollment|f||||t||||||||||2017-02-18 16:32:40.956601|2017-02-18 16:32:40.956601
NCT00326183|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2009-02-19|2008-10-21||May 2006||2006-05-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study|An Open, Multicenter Study of the Safety and Tolerability of VAQTA(TM) and ProQuad(TM) in Healthy Children 12 to 23 Months of Age|Completed||Phase 3|1800|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:32:41.471342|2017-02-18 16:32:41.471342
NCT00326170|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2012-06-12|2011-06-06||July 2005||2005-07-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||Phase II 5-Azacytidine Plus VPA Plus ATRA|Phase II Study of the Combination of 5-azacytidine With Valproic Acid and All-trans Retinoic Acid in Patients With High Risk Myelodysplastic Syndrome and Acute Myelogenous Leukemia|Completed||Phase 2|34|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:32:41.951613|2017-02-18 16:32:41.951613
NCT00326157|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2010-02-11|||June 2006||2006-06-01|February 2010|2010-02-01|November 2009|Actual|2009-11-01|January 2009|Actual|2009-01-01||Interventional|||PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation|Phase II Pilot Study on Safety of Administration of 3mg/kg/Day Three Times a Week Until Day 22 (21 Days After Transplantation Day) and 7 mg/kg Weekly From Day 29 to the End of Treatment (Day 50-8th Week) of AmBisome® in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem-cell Transplantation|Completed||Phase 2|34|Actual|Gilead Sciences||1|||f||||f||||||||||2017-02-18 16:32:42.21262|2017-02-18 16:32:42.21262
NCT00326144|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2009-03-24|||April 2006||2006-04-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|||||Interventional|OPAL||Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR®) as Mono-Therapy in the Treatment of Adult Patients With Major Depressive Disorder|Completed||Phase 3|310|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:32:42.324695|2017-02-18 16:32:42.324695
NCT00326131|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2010-02-27|||April 2006||2006-04-01|August 2007|2007-08-01||||March 2007|Actual|2007-03-01||Interventional|||A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer|Pharmacokinetics and Metabolism of [14C] BMS-275183 in Patients With Advanced Cancer|Terminated||Phase 1|6||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:32:45.071579|2017-02-18 16:32:45.071579
NCT00326118|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2016-09-28|2009-09-18||June 2006||2006-06-01|September 2016|2016-09-01|October 2012|Actual|2012-10-01|November 2007|Actual|2007-11-01||Interventional|||Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.|Study to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC With Priorix™, Versus MenC-CRM197 Vaccine With Hiberix™ & Priorix™ in Toddlers Primed With Hib But Not MenC & to Evaluate Persistence up to 5 Years After Vaccination.|Completed||Phase 3|433|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:32:45.175937|2017-02-18 16:32:45.175937
NCT00326105|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2009-03-24|||April 2006||2006-04-01|March 2009|2009-03-01|July 2007|Actual|2007-07-01|||||Interventional|PEARL||Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo- Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) in Combination With an Antidepressant in the Treatment of Patients With Major Depressive Disorder With Inadequate Response to an Antidepressant Treatment (PEARL STUDY)|Completed||Phase 3|450|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:32:48.504567|2017-02-18 16:32:48.504567
NCT00326092|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2016-11-17|||May 2006||2006-05-01|September 2007|2007-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension|A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 2|88||Alcon Research|||||f||||||||||||||2017-02-18 16:32:48.648727|2017-02-18 16:32:48.648727
NCT00326079|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2013-03-28|||August 2004||2004-08-01|March 2013|2013-03-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2|A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2 Stents|Unknown status|Active, not recruiting|Phase 4|61|Actual|Glaukos Corporation||2|||f||||t||||||||||2017-02-18 16:32:48.740774|2017-02-18 16:32:48.740774
NCT00326066|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2013-03-28|||February 2005||2005-02-01|March 2013|2013-03-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|||A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.|A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Newly Diagnosed Open Angle Glaucoma and Subjects Diagnosed With Ocular Hypertension|Unknown status|Active, not recruiting|Phase 4|47|Actual|Glaukos Corporation||2|||f||||t||||||||||2017-02-18 16:32:48.851353|2017-02-18 16:32:48.851353
NCT00326053|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2011-01-21|||May 2006||2006-05-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|||||Interventional|PARADE||Prevention of Asthma Relapse After Discharge From Emergency|A Comparison of Budesonide/Formoterol Turbuhaler® 160/4.5 µg 2 Inhalations BID Plus as Needed to Budesonide Turbuhaler® 320 µg 2 Inhalations BID Plus Terbutaline Turbuhaler® 0.4 mg as Needed for the Prevention of Asthma Relapse|Completed||Phase 3|600|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:32:48.963623|2017-02-18 16:32:48.963623
NCT00005525|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||August 1998||1998-08-01|March 2005|2005-03-01|July 2002|Actual|2002-07-01|||||Observational|||Sleep Apnea in Elderly Male Twins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:49.035731|2017-02-18 18:14:49.035731
NCT00326027|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2012-05-04|||October 2006||2006-10-01|May 2012|2012-05-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)|Profi-Study: Symptom Reduction in Hospitalized Patients Suffering From Symptomatic Non-erosive or Erosive Gastroesophageal Reflux Disease Treated With Pantoprazole 20 or 40 mg o.d. for 7 Days|Completed||Phase 3|29|Actual|Nycomed||2|||f||||f||||||||||2017-02-18 16:32:49.425277|2017-02-18 16:32:49.425277
NCT00326014|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2015-06-03|||April 2003||2003-04-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Interventional|||A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.|A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.|Completed||Phase 4|58|Actual|Glaukos Corporation||1|||f||||t||||||||||2017-02-18 16:32:49.564573|2017-02-18 16:32:49.564573
NCT00326001|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2010-02-03|2009-05-13||June 2004||2004-06-01|August 2009|2009-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8)|AURUM 8 - Ablation of the Cavotricuspid Isthmus in Patients With Atrial Flutter Using an 8 mm Gold Alloy Tip Electrode|Completed||Phase 4|463|Actual|Biotronik SE & Co. KG||2|||f||||||||||||||2017-02-18 16:32:49.682032|2017-02-18 16:32:49.682032
NCT00325988|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2017-01-24|||December 17, 2004||2004-12-17|February 3, 2014|2014-02-03|February 3, 2014||2014-02-03|||||Observational|||Biomarkers in Multiple Sclerosis|NINDS Biomarkers in Multiple Sclerosis Study (BioMS)|Completed||N/A|858|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:32:50.172032|2017-02-18 16:32:50.172032
NCT00325975|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-15|2017-01-24|||February 4, 2003||2003-02-04|March 15, 2016|2016-03-15|March 15, 2016||2016-03-15|||||Observational|||Immune Responses to Smallpox Vaccination|Immune Responses to Vaccinia Virus Vaccination|Completed||N/A|69|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:32:50.253916|2017-02-18 16:32:50.253916
NCT00325962|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2009-07-17|||May 2006||2006-05-01|July 2009|2009-07-01|December 2008|Actual|2008-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension|Completed||Phase 2|84||BioMarin Pharmaceutical|||||f||||||||||||||2017-02-18 16:32:50.347693|2017-02-18 16:32:50.347693
NCT00325949|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2011-07-22|||May 2006||2006-05-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||A Study of Pain Relief in Low Back Pain|A Phase 3, Open-Label Period Followed By a Randomized, Double-Blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) Compared to Placebo in Subjects With Chronic Low Back Pain|Completed||Phase 3|770|Actual|Abbott||3|||f||||f||||||||||2017-02-18 16:32:50.467706|2017-02-18 16:32:50.467706
NCT00325936|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2008-08-26|||July 2005||2005-07-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||The Effects of Cilnidipine on Metabolic Syndrome Improvement|A Multi-Center, Double-Blind, Randomized, Superiority Clinical Study to Compare the Effects of Cilnidipine on Metabolic Syndrome Improvement With Nifedipine GITS in Hypertensive Patients With Metabolic Syndrome (Phase IV) [SLIMS]|Completed||Phase 4|186|Actual|Boryung Pharmaceutical Co., Ltd||2|||f||||f||||||||||2017-02-18 16:32:50.884201|2017-02-18 16:32:50.884201
NCT00325923|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2010-03-24|||April 2006||2006-04-01|April 2006|2006-04-01|June 2006||2006-06-01|||||Interventional|||Impact of a Decision Aid Regarding Natural Health Products for Menopausal Symptoms|A Patient Decision Aid Regarding Natural Health Products for Menopausal Symptoms:a Randomized Controlled Trial|Completed||N/A|70||Centre Hospitalier Universitaire de Québec, CHU de Québec|||||f||||f||||||||||2017-02-18 16:32:51.001339|2017-02-18 16:32:51.001339
NCT00325910|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2008-05-12|||May 2006||2006-05-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study|Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study|Terminated||Phase 3|100||University of Alberta||||Insufficient study participants|f||||||||||||||2017-02-18 16:32:51.104155|2017-02-18 16:32:51.104155
NCT00325897|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2016-08-25|2011-08-18||March 2006||2006-03-01|August 2016|2016-08-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease|Effect of Chronic Macrolide Administration on the Frequency and Severity of COPD Exacerbations|Completed||N/A|1142|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-02-18 16:32:51.221144|2017-02-18 16:32:51.221144
NCT00325884|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2011-08-25|||August 2001||2001-08-01|August 2011|2011-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Long-term Outcomes of Patients After Coronary Bifurcation Stenting|Long-term Outcomes of Patients After Coronary Bifurcation Stenting|Completed||Phase 4|160|Actual|VA Boston Healthcare System|||1||f||||f||||||||||2017-02-18 16:32:51.943117|2017-02-18 16:32:51.943117
NCT00325871|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2006-05-12|||April 2006||2006-04-01|March 2006|2006-03-01||||||||Observational|||Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer|The Effect of Concurrent Chemoradiation on Circulating Endothelial Progenitor Cells in Colorectal Cancer|Unknown status|Recruiting|N/A|30||Mackay Memorial Hospital|||||f||||||||||||||2017-02-18 16:32:52.033053|2017-02-18 16:32:52.033053
NCT00325858|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2012-08-24|||January 2002||2002-01-01|September 2006|2006-09-01|December 2003||2003-12-01|||||Interventional|||A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip|Double-Blind, Randomized,Dose-Ranging, Parallel-Group Comparison Of The Efficacy And Safety Of Extended-Release Tramadol Hydrochloride(Tramadol HCl ER)100 Mg, 200 Mg, 300 Mg, And 400 Mg With Placebo In The Treatment Of Osteoarthritis Of Knee And/Or Hip|Completed||Phase 3|1000||Valeant Pharmaceuticals International, Inc.|||||f||||f||||||||||2017-02-18 16:32:52.110354|2017-02-18 16:32:52.110354
NCT00325845|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2006-09-12|||May 2006||2006-05-01|September 2006|2006-09-01|May 2008||2008-05-01|||||Interventional|||Synvisc Injections for Lumbar Facet Joint Pain|Efficacy and Safety of Intra-Articular Synvisc Injections as Treatment of Painful Lumbar Facet Joint Arthrosis|Unknown status|Recruiting|Phase 3|15||Sheltering Arms Physical Rehabilitation Hospitals|||||||||||||||||||2017-02-18 16:32:52.206815|2017-02-18 16:32:52.206815
NCT00325832|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2010-08-20|||January 2006||2006-01-01|May 2008|2008-05-01||||||||Interventional|CAMBO||Conventional Versus Automated Measurement of Blood Pressure in the Office (The CAMBO Study)||Completed||Phase 4|750|Anticipated|Sunnybrook Health Sciences Centre|||||f||||f||||||||||2017-02-18 16:32:52.309536|2017-02-18 16:32:52.309536
NCT00325819|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2014-02-25|2013-07-17||May 2006||2006-05-01|February 2014|2014-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||Participants who did not receive acetaminophen or placebo due to postal problems (3), who were not given a first dose of acetaminophen or placebo (13) or who were lost to follow-up due to study diary not being returned (6) were not included in analysis.|Acetaminophen Before Vaccines for Infants Study (AVIS)|A Randomized Placebo-controlled Trial of Acetaminophen for Prevention of Post-vaccination Fever in Infants|Completed||Phase 3|374|Actual|Group Health Cooperative||2|||f||||t||||||||||2017-02-18 16:32:52.395553|2017-02-18 16:32:52.395553
NCT00325806|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2013-03-07|||May 2000||2000-05-01|March 2013|2013-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Ramipril - Hypertension|Prevention of Hypertension in Patients With High-Normal Blood Pressure With the Angiotensin-Converting-Enzyme-Inhibitor Ramipril - a Randomised Prevention Trial of the German Hypertension League.|Completed||Phase 4|1008|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:32:52.933152|2017-02-18 16:32:52.933152
NCT00325793|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2006-05-12|||January 2004||2004-01-01|May 2006|2006-05-01||||||||Interventional|||IV Double and Triple Concentrated Nicardipine for Stroke and ICH|An Open-Label Prospective Study to Evaluate the Safety and Efficacy of Double or Triple Concentrated Intravenous Nicardipine for Treatment of Hypertension in Patients With Ischemic Stroke, Intracerebral Hemorrhage or Subarachnoid Hemorrhage|Unknown status|Recruiting|Phase 4|50||OSF Healthcare System|||||f||||||||||||||2017-02-18 16:32:53.011495|2017-02-18 16:32:53.011495
NCT00325780|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2010-01-25|2009-08-26||July 2006||2006-07-01|January 2010|2010-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia|Open-Label, Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia|Completed||Phase 3|1355|Actual|Kowa Research Europe||1|||f||||f||||||||||2017-02-18 16:32:53.118745|2017-02-18 16:32:53.118745
NCT00325767|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2006-05-12|||May 2004||2004-05-01|April 2006|2006-04-01|September 2005||2005-09-01|||||Interventional|||Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol|Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol|Completed||Phase 4|10||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:32:53.832395|2017-02-18 16:32:53.832395
NCT00325754|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2016-10-17|2016-05-20||March 2005||2005-03-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Benefits of Lightweight Ambulatory Oxygen Systems for Individuals With Chronic Obstructive Pulmonary Disease|Benefits of Ambulatory Oxygen in Hypoxemic COPD Patients|Terminated||N/A|22|Actual|University of Minnesota - Clinical and Translational Science Institute|The Data Safety and Monitoring Board requested termination of this study due to low recruitment. 22 participants were randomized out of a goal of 100.|2||low recruitment|f||||t||||||||No||2017-02-18 16:32:53.925607|2017-02-18 16:32:53.925607
NCT00325741|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2009-08-06|||June 2004||2004-06-01|August 2009|2009-08-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus|Allogeneic Hematopoietic Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus Using a Non-Myeloablative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin|Unknown status|Recruiting|Phase 1|15|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||1|||f||||t||||||||||2017-02-18 16:32:54.665473|2017-02-18 16:32:54.665473
NCT00325728|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2012-02-27|||March 2006||2006-03-01|February 2012|2012-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of 8 Week Treatment of Rozerem 8 mg (QHS) in Sleep Disturbed, Mild to Moderately Severe Alzheimer's Disease Subjects|Completed||Phase 2|74|Actual|Takeda||2|||f||||f||||||||||2017-02-18 16:32:54.769941|2017-02-18 16:32:54.769941
NCT00325715|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2011-06-01|||April 2006||2006-04-01|June 2011|2011-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers||Completed||Phase 1|150|Actual|Allergan||2|||f||||||||||||||2017-02-18 16:32:54.963565|2017-02-18 16:32:54.963565
NCT00325702|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2011-10-17|||October 2006||2006-10-01|October 2011|2011-10-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|Get REAL||Addressing Young Men's Substance Use and HIV Risk|Addressing Young Men's Substance Use and HIV Risk|Completed||N/A|761|Actual|Public Health Management Corporation||1|||f||||f||||||||||2017-02-18 16:32:55.056736|2017-02-18 16:32:55.056736
NCT00325689|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2013-11-07|||July 2006||2006-07-01|April 2011|2011-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.|A Multicenter, Randomized, Double-blind, Placebo-controlled, 16 Week Study of Aripiprazole Used as Dual Therapy in the Treatment of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder Demonstrating an Inadequate Response to Quetiapine or Risperidone Monotherapy.|Completed||Phase 4|323|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 16:32:55.15627|2017-02-18 16:32:55.15627
NCT00325676|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2012-05-04|||June 2006||2006-06-01|June 2007|2007-06-01||||||||Interventional|||Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)|CONFIRM - Confirmation of Superiority of Complete Remission Concept Versus Classical Healing Concept for Treatment of Patients With Erosive GERD|Completed||Phase 4|639|Actual|Takeda|||||f||||||||||||||2017-02-18 16:32:55.311909|2017-02-18 16:32:55.311909
NCT00325663|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2006-05-12|||April 2004||2004-04-01|April 2004|2004-04-01|April 2005||2005-04-01|||||Interventional|||Acupuncture in Osteoarthritis of the Knee|Specific and Non-Specific Effects of Acupuncture: A Double-Blinded, Randomized, Controlled Trial in Patients With Osteoarthritis of the Knee|Completed||Phase 1/Phase 2|125||Heidelberg University|||||f||||||||||||||2017-02-18 16:32:55.68997|2017-02-18 16:32:55.68997
NCT00325650|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2016-04-19||2016-04-19|May 2006||2006-05-01|April 2016|2016-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|RAPSODI||Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy and Safety of Long-term Administration of Rimonabant in the Prevention of Type 2 Diabetes in Patients With Prediabetic Status (i.e., Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or Both)|Terminated||Phase 3|2420|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 16:32:55.784259|2017-02-18 16:32:55.784259
NCT00325637|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2008-12-11|||January 2005||2005-01-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension|A Multi-Center, Double Blind, Randomized and Non-Inferiority Clinical Study of Cilnidipine to Compare the Effects on Cerebral Blood Flow With Losartan in Patients With Ischemic Stroke Hypertension|Completed||Phase 3|250|Actual|Boryung Pharmaceutical Co., Ltd||1|||f||||t||||||||||2017-02-18 16:32:55.906195|2017-02-18 16:32:55.906195
NCT00325624|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2012-05-21|||November 2006||2006-11-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|DREAM-Tel||Diabetes Risk Evaluation and Management Tele-monitoring Study (DREAM-Tel)|Diabetes Risk Evaluation and Management Tele-monitoring Study (DREAM-Tel)|Completed||Phase 1|40|Actual|Sunnybrook Health Sciences Centre||1|||f||||||||||||||2017-02-18 16:32:56.03202|2017-02-18 16:32:56.03202
NCT00325611|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2006-05-12|||April 2002||2002-04-01|May 2006|2006-05-01|July 2004||2004-07-01|||||Interventional|||Multidisciplinary Inpatient Palliative Care Intervention|A Multi-Site Replication of an Inpatient Palliative Care Program|Completed||N/A|550||Kaiser Permanente|||||f||||||||||||||2017-02-18 16:32:56.133643|2017-02-18 16:32:56.133643
NCT00325598|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2016-11-09|2016-09-19||February 2006||2006-02-01|November 2016|2016-11-01|April 2017|Anticipated|2017-04-01|April 2013|Actual|2013-04-01||Interventional|||Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer|Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer: A Phase I/II Feasibility Study|Active, not recruiting||Phase 1/Phase 2|100|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 16:32:56.252101|2017-02-18 16:32:56.252101
NCT00325585|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2013-04-05|||April 2005||2005-04-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||HIV Prevention Intervention for Couples|Couples HIV Intervention Randomized Controlled Trial|Completed||Phase 2|780|Anticipated|National Development and Research Institutes, Inc.|||||f||||||||||||||2017-02-18 16:32:56.998134|2017-02-18 16:32:56.998134
NCT00325572|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2013-01-13|||November 2006||2006-11-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism|Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism|Completed||Phase 1|3|Actual|Penn State University||2|||f||||t||||||||||2017-02-18 16:32:57.107992|2017-02-18 16:32:57.107992
NCT00325559|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2011-01-12|||June 2006||2006-06-01|January 2011|2011-01-01||||March 2007|Actual|2007-03-01||Interventional|||The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes Mellitus|The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes Mellitus|Completed||N/A|10|Anticipated|University Hospital Inselspital, Berne|||||f||||||||||||||2017-02-18 16:32:57.221274|2017-02-18 16:32:57.221274
NCT00325546|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2009-04-06|||April 2006||2006-04-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose (Rimonabant 20mg), Multi-National, Multicentre Study of Weight-Reducing Effect and Safety of Rimonabant in Obese Patients With or Without Comorbidities|Completed||Phase 3|643|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:32:57.313412|2017-02-18 16:32:57.313412
NCT00325533|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2014-06-11|||May 2006||2006-05-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Effectiveness of a Barbershop-Based Program to Improve High Blood Pressure Control and Awareness in Black Men|Group Randomized Trial of a Barber-Based Intervention to Improve Hypertension Control in Black Men|Completed||N/A|2319|Actual|Cedars-Sinai Medical Center||2|||f||||f||||||||||2017-02-18 16:32:57.410026|2017-02-18 16:32:57.410026
NCT00325520|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-12|2014-08-14|||May 2006||2006-05-01|July 2013|2013-07-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Observational|||A Neurocognitive Model of Anorexia Nervosa|A Neurocognitive Model of Anorexia Nervosa|Completed||N/A|152|Actual|New York State Psychiatric Institute|||2||f||||t||||||||||2017-02-18 16:32:57.525671|2017-02-18 16:32:57.525671
NCT00325507|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2008-07-31|||November 2005||2005-11-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Evaluate Safety and Biological Activity of TroVax® Vaccine Given in Conjunction With IL-2 to Treat Locally Advanced or Metastatic Renal Cell Carcinoma|Safety, Immunology, and Biological Activity Evaluation of TroVax® in Treatment of Patients With Locally Advanced or Metastatic Renal Carcinoma|Completed||Phase 2|25|Anticipated|Oxford BioMedica|||||||||||||||||||2017-02-18 16:32:57.618806|2017-02-18 16:32:57.618806
NCT00325494|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2014-07-16|||May 2006||2006-05-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer|A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-009, a Chimeric Monoclonal Antibody, in Subjects With Advanced Mesothelin-expressing Tumors|Completed||Phase 1|24|Actual|Morphotek||6|||f||||||||||||||2017-02-18 16:32:57.718414|2017-02-18 16:32:57.718414
NCT00325481|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2007-07-17|||June 2006||2006-06-01|July 2007|2007-07-01|December 2006||2006-12-01|||||Interventional|||Study To Evaluate the Safety of Bivalent Vaccine|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|Completed||Phase 3|300||MedImmune LLC|||||||||||||||||||2017-02-18 16:32:57.838072|2017-02-18 16:32:57.838072
NCT00325468|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2013-12-04|2013-01-03||May 2006||2006-05-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|March 2011|Actual|2011-03-01||Interventional|||An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density|An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density|Completed||Phase 3|200|Actual|Amgen||1|||f||||f||||||||||2017-02-18 16:32:57.945944|2017-02-18 16:32:57.945944
NCT00325455|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2015-02-27|||June 2006||2006-06-01|February 2015|2015-02-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||MK0859 Dose-Ranging Study (0859-003)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of MK-0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia|Terminated||Phase 2|500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:33:00.284303|2017-02-18 16:33:00.284303
NCT00322959|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2008-09-19|||August 2004||2004-08-01|September 2008|2008-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Tai-Chi-Chuan on Differentiation and Maturation of Dendritic Cells|Effect of Tai-Chi-Chuan on Differentiation and Maturation of Human Dendritic Cells|Completed||N/A|20|Actual|Mackay Memorial Hospital|||1||f||||t||||||||||2017-02-18 16:34:21.710004|2017-02-18 16:34:21.710004
NCT00325442|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2017-02-01|2013-01-18||October 2006||2006-10-01|February 2017|2017-02-01|December 2010|Actual|2010-12-01|September 2008|Actual|2008-09-01||Interventional|||FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)|A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Combination With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 3|354|Actual|United Therapeutics||2|||f||||||||||||||2017-02-18 16:33:00.392579|2017-02-18 16:33:00.392579
NCT00325429|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2009-01-06|||April 2006||2006-04-01|January 2009|2009-01-01||||||||Interventional|||Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes|A Multicenter, Open, Long Term Safety Study of 52 Weeks Treatment With Vildagliptin in Patients With Type 2 Diabetes|Completed||Phase 3|150||Novartis|||||f||||||||||||||2017-02-18 16:33:01.740015|2017-02-18 16:33:01.740015
NCT00325416|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2016-09-09|2014-03-17||November 2001||2001-11-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|July 2013|Actual|2013-07-01||Interventional||Participants: 177 included in Baseline; 129 included in Phase I Maximum Tolerated Dose Outcome; 51 Phase II participants with responsive disease prior to transplant were re-evaluated for the Overall Response Rate; 79 treated in Phase II and evaluable at time of analysis are included in the Event Free Survival and Overall Survival Outcome Measures.|Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.|A Study of Intensive-Dose Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.|Active, not recruiting||Phase 1/Phase 2|177|Actual|H. Lee Moffitt Cancer Center and Research Institute|Data on presence of chromosomal abnormalities at time of diagnosis were not available for majority of patients. The cancer center will continue to collect information about the participant's disease and its treatment for the rest of their life.|2|||f||||t||||||||||2017-02-18 16:33:01.863619|2017-02-18 16:33:01.863619
NCT00325403|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2013-02-12|2013-01-03||October 2006||2006-10-01|February 2013|2013-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)|A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 3|349|Actual|United Therapeutics||2|||f||||t||||||||||2017-02-18 16:33:02.717132|2017-02-18 16:33:02.717132
NCT00325390|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2009-03-24|||July 2004||2004-07-01|March 2009|2009-03-01||||||||Interventional|||Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation|Double-Blind Parallel Comparison Study of SR25990C Versus Standard Therapy in Japan(Ticlopidine) in Patients With Acute Coronary Syndrome Without ST-Segment Elevation Who Are Planned for Percutaneous Coronary Intervention|Completed||Phase 3|800||Sanofi|||||f||||||||||||||2017-02-18 16:33:04.068775|2017-02-18 16:33:04.068775
NCT00325377|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2007-07-08|||April 2006||2006-04-01|July 2007|2007-07-01|January 2008|Anticipated|2008-01-01|||||Interventional|||The Effects of the MME Procedure on Chronic Low Back Pain|A Randomized Sham-Controlled Clinical Study to Evaluate the Effects of the Magnetic Molecular Energizer (MME)on Chronic Low Back Pain|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|Advanced Magnetic Research Institute International|||||f||||f||||||||||2017-02-18 16:33:04.162088|2017-02-18 16:33:04.162088
NCT00325364|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2016-11-21|||April 2006||2006-04-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes|A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients With Type 2 Diabetes Mellitus.|Completed||Phase 3|415|Actual|Eli Lilly and Company||2|||f||||||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 16:33:04.264393|2017-02-18 16:33:04.264393
NCT00325351|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2014-10-31|||August 2006||2006-08-01|October 2014|2014-10-01|March 2009|Actual|2009-03-01|July 2008|Actual|2008-07-01||Interventional|||ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer|Phase 1/2 Study of ZK-Epothilone (ZK-Epo; ZK-219477) in Combination With Carboplatin in Patients With Platinum-sensitive Recurrent Ovarian Cancer|Completed||Phase 2|45|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:33:04.41824|2017-02-18 16:33:04.41824
NCT00325338|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2010-06-16|||May 2006||2006-05-01|June 2010|2010-06-01|July 2006||2006-07-01|||||Interventional|||Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis|Follow-up Study to Evaluate the Sustained Clinical Efficacy of Ragweed MATA MPL (Allergy Therapeutics®) in Patients With Ragweed-induced Seasonal Allergic Rhinitis Upon Re-exposure to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Model, Approximately One Year After Pre-seasonal Treatment in 2005|Completed||Phase 2|100||Allergy Therapeutics|||||f||||||||||||||2017-02-18 16:33:04.726142|2017-02-18 16:33:04.726142
NCT00325325|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2006-10-25|||January 2006||2006-01-01|May 2006|2006-05-01|June 2007||2007-06-01|||||Interventional|||Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus|A Pilot Study to Investigate Pharmacokinetic Characteristics of Everolimus in Patients Treated With Tacrolimus-Based Immunosuppression in De Novo Kidney Transplantation|Unknown status|Recruiting|Phase 2|40||Hospital Universitario Ramon y Cajal|||||f||||||||||||||2017-02-18 16:33:04.824981|2017-02-18 16:33:04.824981
NCT00325312|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2006-05-12|||January 2001||2001-01-01|May 2006|2006-05-01|March 2003||2003-03-01|||||Interventional|||Subcutaneous Carbon Dioxide Insufflations for Acute Non Specific Neck Pain|Evaluation of the Efficacy of Subcutaneous Carbon Dioxide Insufflations for Treating Acute Non Specific Neck Pain in General Practice|Completed||Phase 2|114||Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster|||||f||||||||||||||2017-02-18 16:33:04.93321|2017-02-18 16:33:04.93321
NCT00325299|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2006-05-11||||||May 2006|2006-05-01|September 2005||2005-09-01|||||Interventional|||Magnesium After Alcohol Withdrawal Treatment|Magnesium After Alcohol Withdrawal Treatment|Completed||Phase 4|178||Finnish Foundation for Alcohol Studies|||||f||||||||||||||2017-02-18 16:33:05.025421|2017-02-18 16:33:05.025421
NCT00005524|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-08|||September 1998||1998-09-01|July 2005|2005-07-01|August 2003||2003-08-01|||||Observational|||Mental Stress, Autonomic Function, and Heart Disease||Completed||N/A|||Hebrew Rehabilitation Center, Boston|||||f||||||||||||||2017-02-18 18:14:49.102034|2017-02-18 18:14:49.102034
NCT00325286|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2007-12-13|||May 2006||2006-05-01|December 2007|2007-12-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder|Open Label Prophylaxis Study of Lithium Plus Extended- Release Carbamazepine (Equetro®) Combination for Rapid Cycling Bipolar Disorder|Unknown status|Active, not recruiting|Phase 4|20|Anticipated|Creighton University||1|||f||||f||||||||||2017-02-18 16:33:05.115304|2017-02-18 16:33:05.115304
NCT00325273|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2015-03-16|||April 2005||2005-04-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|April 2008|Actual|2008-04-01||Interventional|||Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal Period|Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonate|Completed||Phase 3|180|Actual|Chang Gung Memorial Hospital||1|||f||||t||||||||||2017-02-18 16:33:05.226221|2017-02-18 16:33:05.226221
NCT00325260|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2006-10-31|||March 2006||2006-03-01|October 2006|2006-10-01||||||||Interventional|||Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China|A Randomized, Endpoint-Blind, Parallel Group Study to Demonstrate the Non-Inferiority of the Subunit Influenza Vaccine Influvac® to the Subunit Influenza Vaccine Agrippal® in Healthy Children, Adults and Elderly in China.|Completed||Phase 3|900||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 16:33:05.343858|2017-02-18 16:33:05.343858
NCT00325247|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2011-07-11|||February 2005||2005-02-01|May 2006|2006-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy of Zinc Therapy in Acute Diarrhoea in Young Children|Efficacy of Short Course Zinc Therapy (5 vs 10 d) With 20 mg Elemental Zinc Daily in the Treatment of Acute Diarrhoea: A Double-blind Individually Randomized Controlled Community Trial.|Completed||Phase 3|2050|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:33:05.441598|2017-02-18 16:33:05.441598
NCT00325234|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2011-04-26|2011-04-26||June 2006||2006-06-01|April 2011|2011-04-01|August 2010|Actual|2010-08-01|April 2010|Actual|2010-04-01||Interventional|||Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer|A Randomized Phase II Study of Two Chemotherapy Regimens, Pemetrexed-Carboplatin, and Gemcitabine-Vinorelbine, in Anthracycline and Taxanes Pretreated Advanced Breast Cancer Patients|Completed||Phase 2|135|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:33:05.561303|2017-02-18 16:33:05.561303
NCT00325221|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2013-01-30|||August 2006||2006-08-01|January 2013|2013-01-01|October 2012|Actual|2012-10-01|January 2012|Actual|2012-01-01||Interventional|||Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM)|QUANTUM - Quality-of-Life, Anxiety and Depression in ICD Patients Using Home Monitoring|Completed||N/A|148|Actual|Biotronik SE & Co. KG||2|||f||||f||||||||||2017-02-18 16:33:06.748818|2017-02-18 16:33:06.748818
NCT00325208|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2006-12-22||||||December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Feeding Bottle Design, Milk Intake and Infant Growth||Unknown status|Recruiting|N/A|152||Institute of Child Health|||||f||||||||||||||2017-02-18 16:33:06.854964|2017-02-18 16:33:06.854964
NCT00325195|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2011-02-24|2010-10-13||May 2006||2006-05-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout|Randomized, Multicenter, Double-blind, Placebo-controlled Efficacy and Safety Study of 8 mg PEG-uricase in Two Dose Regimens in Hyperuricemic Subjects With Symptomatic Gout|Completed||Phase 3|225|Actual|Savient Pharmaceuticals||3|||f||||f||||||||||2017-02-18 16:33:06.951966|2017-02-18 16:33:06.951966
NCT00325182|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2007-04-04|||January 2006||2006-01-01|April 2007|2007-04-01|July 2007|Anticipated|2007-07-01|||||Interventional|||The Effects of Levetiracetam on Alcohol Dependent Subjects|The Effects of Levetiracetam on Alcohol Dependent Subjects|Unknown status|Active, not recruiting|Phase 4|50||Boston University|||||f||||||||||||||2017-02-18 16:33:08.212222|2017-02-18 16:33:08.212222
NCT00325169|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2016-10-19|||December 2005||2005-12-01|October 2016|2016-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||SERETIDE Plus Tiotropium Versus Individual Components|A Randomised, Double-blind, Double Dummy, 3 Way Crossover Study Evaluating the Effects of a Combination of Seretide 50/500mcg Twice Daily Plus Tiotropium Bromide 18mcg Once Daily Compared With the Individual Agents (Tiotropium Bromide 18mcg Alone and Seretide50/500mcg Alone) in the Treatment of Subjects With COPD|Completed||Phase 2|41|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:33:08.302418|2017-02-18 16:33:08.302418
NCT00325156|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2016-12-14|2016-12-14||November 2004||2004-11-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants|An Open, Multicentric, Post-marketing Surveillance Study to Assess the Safety and Reactogenicity of GlaxoSmithKline Biologicals' DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 and 18 Months of Age, in Healthy Infants.|Completed||Phase 4|2590|Actual|GlaxoSmithKline|None reported.|1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:33:08.415398|2017-02-18 16:33:08.415398
NCT00325143|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2016-12-13|2016-12-13||December 2003||2003-12-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine|Assess Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Admnd at 3 & 4 Mths & DTPa-HBV-IPV/Hib Vaccine Admnd at 5 Mths, Followed by DTPa-IPV/Hib Vaccine at 18 Mths in Infants Who Received hepatitisB Vaccine at Birth & at One Month of Age|Completed||Phase 3|702|Actual|GlaxoSmithKline|None reported.|1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:33:08.793297|2017-02-18 16:33:08.793297
NCT00325130|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2015-02-23|2009-05-19||April 2006||2006-04-01|February 2015|2015-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)|An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of V501 Given Concomitantly With Menactra™ and ADACEL™ in Healthy Adolescents 11-17 Years of Age|Completed||Phase 3|1042|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:33:09.157053|2017-02-18 16:33:09.157053
NCT00307970|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2011-09-16|||April 2003||2003-04-01|June 2004|2004-06-01|September 2003||2003-09-01|||||Interventional|||Impact of Anti-static Chamber/Mask|The Impact of an Anti-static Valved-holding Chamber on Bioavailability of Inhaled Fluticasone Propionate in Young Children With Asthma|Completed||Phase 4|12||University of Florida|||||||||||||||||||2017-02-18 16:39:43.401979|2017-02-18 16:39:43.401979
NCT00325117|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2007-05-10|||April 2006||2006-04-01|May 2007|2007-05-01||||||||Interventional|||To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy|A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 12 Weeks Treatment With Vildagliptin to Placebo as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy|Completed||Phase 3|200||Novartis|||||f||||||||||||||2017-02-18 16:33:10.061794|2017-02-18 16:33:10.061794
NCT00325104|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2017-01-24|||May 9, 2006||2006-05-09|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Interventional|||Cinacalcet to Treat Familial Primary Hyperparathyroidism|Cinacalcet Actions in Familial Primary Hyperparathyroidism|Completed||Phase 3|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:33:10.150022|2017-02-18 16:33:10.150022
NCT00325091|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2017-01-24|||May 9, 2006||2006-05-09|January 6, 2014|2014-01-06|January 6, 2014||2014-01-06|||||Observational|||Long-Term Motor Learning in Focal Hand Dystonia|Long-Term Motor Learning in Focal Hand Dystonia|Completed||N/A|19|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:33:10.240132|2017-02-18 16:33:10.240132
NCT00325078|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2015-11-19|2014-03-18||May 2006||2006-05-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease|Tumor Necrosis Factor Alpha Inhibitor (Lnfliximab, Adalimumab) Treatment for Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences|Terminated||Phase 1/Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)|Due to limited subject participation and lack of sustained clinical benefits (1 year), there is insufficient complete data to generate meaningful statistics for the outcome measures. Instead, this data are reported as a case series.|2||Insufficient patient participation|f||||t||||||||||2017-02-18 16:33:10.328854|2017-02-18 16:33:10.328854
NCT00325065|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-11|2017-01-24|||May 5, 2006||2006-05-05|April 16, 2010|2010-04-16|April 16, 2010||2010-04-16|||||Observational|||Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders|Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders|Completed||N/A|71|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:33:11.192218|2017-02-18 16:33:11.192218
NCT00325039|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2013-12-12|2012-03-26||April 2006||2006-04-01|December 2013|2013-12-01|June 2013|Actual|2013-06-01|June 2010|Actual|2010-06-01||Interventional|TOMUS||TOMUS-Trial Of Mid-Urethral Slings|TOMUS-Trial Of Mid-Urethral Slings|Completed||Phase 4|597|Actual|New England Research Institutes||2|||f||||t||||||||||2017-02-18 16:33:11.285786|2017-02-18 16:33:11.285786
NCT00325026|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2012-03-01|||April 2005||2005-04-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation|Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation|Completed||Phase 2|130|Actual|University of Florida|||||||||||||||||||2017-02-18 16:33:11.776943|2017-02-18 16:33:11.776943
NCT00325013|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2015-03-10|||December 2005||2005-12-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Evaluation of DHA for the Treatment of PSC|Evaluation of Docosahexaenoic Acid (DHA) for the Treatment of Primary Sclerosing Cholangitis (PSC)|Completed||Phase 1|10|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 16:33:11.889169|2017-02-18 16:33:11.889169
NCT00325000|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2006-12-19|||November 2000||2000-11-01|October 2000|2000-10-01|August 2004||2004-08-01|||||Interventional|||Interpersonal Psychotherapy for Severely Depressed Inpatients|An Intensive Treatment Program of Interpersonal Psychotherapy Plus Pharmacotherapy for Severely Depressed Inpatients|Terminated||N/A|||German Research Foundation|||||f||||||||||||||2017-02-18 16:33:11.999074|2017-02-18 16:33:11.999074
NCT00324987|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2015-08-28|||April 2008||2008-04-01|April 2015|2015-04-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor|A Phase III Randomized Study of Imatinib, With or Without Bevacizumab (NSC-704865), in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors|Completed||Phase 3|12|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 16:33:12.283139|2017-02-18 16:33:12.283139
NCT00324974|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2010-07-20|||June 2006||2006-06-01|July 2010|2010-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux|A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Study Assessing the Safety and Efficacy of Lansoprazole Microgranules Oral Suspension in Infants With Symptomatic Gastroesophageal Reflux|Completed||Phase 3|162|Actual|Takeda||2|||f||||f||||||||||2017-02-18 16:33:12.649283|2017-02-18 16:33:12.649283
NCT00324961|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2009-10-26|2009-08-27||January 2006||2006-01-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B|A 2-year Multi-centre, Open-label, Local Phase IV Study to Demonstrate the Efficacy and Safety of Adefovir Dipivoxil Tablets (10mg) in Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B|Completed||Phase 4|533|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:33:12.806122|2017-02-18 16:33:12.806122
NCT00324948|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2009-03-09|||September 2004||2004-09-01|March 2009|2009-03-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional|||Topical Alprostadil for Female Sexual Arousal Disorder|A Double-Blind, Randomized, 6-Month Evaluation of the Safety and Efficacy of Topical Alprostadil in Hysterectomized Women With Female Sexual Arousal Disorder (FSAD)|Completed||Phase 2|300||VIVUS, Inc.|||||||||||||||||||2017-02-18 16:33:13.173548|2017-02-18 16:33:13.173548
NCT00324922|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2009-07-27|||May 2006||2006-05-01|July 2009|2009-07-01|May 2011|Anticipated|2011-05-01|May 2011|Anticipated|2011-05-01||Interventional|||Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus (MRSA) Osteomyelitis (VOTSMO)|A Prospective, Randomized Trial Comparing Vancomycin With Trimethoprim/Sulfamethoxazole for the Treatment of MRSA Osteomyelitis|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Washington||2|||f||||t||||||||||2017-02-18 16:33:13.273739|2017-02-18 16:33:13.273739
NCT00324909|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2007-04-09||||||April 2007|2007-04-01||||||||Interventional|||Effects of Hyperbaric Oxygen Therapy in Autistic Children: A Pilot Study|Effects of Hyperbaric Oxygen Therapy on Clinical Symptoms and Markers of Inflammation and Oxidative Stress in Autistic Children: A Pilot Study|Completed||N/A|18||International Hyperbarics Association|||||f||||||||||||||2017-02-18 16:33:13.382104|2017-02-18 16:33:13.382104
NCT00324896|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2013-04-24|2013-01-23||May 2006||2006-05-01|April 2013|2013-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone|Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone|Completed||Phase 3|30|Actual|Rutgers, The State University of New Jersey|This was only a 6-week trial with small group of participants.|2|||f||||f||||||||||2017-02-18 16:33:13.460845|2017-02-18 16:33:13.460845
NCT00324883|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2013-07-08|||March 2006||2006-03-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium|Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium|Completed||N/A|81|Actual|Weill Medical College of Cornell University|||1||f||||f||||||Samples Without DNA|"~     urine~   "|||2017-02-18 16:33:13.880625|2017-02-18 16:33:13.880625
NCT00324870|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2015-12-10|2015-08-10||February 2006||2006-02-01|October 2013|2013-10-01|November 2013|Actual|2013-11-01|June 2013|Actual|2013-06-01||Interventional|||Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer|Phase I/II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With the VEGF Inhibitor Bevacizumab in Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:33:13.977815|2017-02-18 16:33:13.977815
NCT00324857|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2015-12-15|2014-12-18||September 2006||2006-09-01|December 2015|2015-12-01|September 2011|Actual|2011-09-01|July 2011|Actual|2011-07-01||Interventional|||Educational Intervention for Knee Pain|Knee Replacement Disparity: A Randomized, Controlled Intervention|Completed||N/A|663|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 16:33:14.220325|2017-02-18 16:33:14.220325
NCT00324831|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2013-12-17||||||March 2007|2007-03-01||||||||Interventional|||GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma|Phase III, Double-Blind, Randomized, Placebo-Controlled Trial of FavID® (Id/KLH) and GM-CSF Following CHOP/Rituximab as First-Line Therapy in Subjects With High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma|Suspended||Phase 3|480|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:33:14.78695|2017-02-18 16:33:14.78695
NCT00324818|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2009-11-13|||July 2002||2002-07-01|November 2009|2009-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Treatment of Bacterial Vaginosis|Therapy and Prevention for Sexually Associated Bacterial Vaginosis|Completed||Phase 4|600||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 16:33:14.9166|2017-02-18 16:33:14.9166
NCT00324805|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2017-02-16|||June 2007||2007-06-01|October 2016|2016-10-01||||January 2018|Anticipated|2018-01-01||Interventional|||Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery|A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (≥ 4 cm) - IIIA Non-small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 3|1500|Anticipated|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 16:33:15.062546|2017-02-18 16:33:15.062546
NCT00324792|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2008-06-11|||May 2006||2006-05-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|||||Interventional|||I3LTE4: Intensive Insulin Therapy and Production of LTE4 in Patients With Diabetes|Effect of an Intensive Insulin Therapy on the Production of LTE4 in Patients With Diabetes|Completed||N/A|45|Anticipated|University Hospital, Grenoble|||||f||||||||||||||2017-02-18 16:33:21.877291|2017-02-18 16:33:21.877291
NCT00324779|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2015-09-24|||March 2004||2004-03-01|September 2015|2015-09-01||||April 2011|Actual|2011-04-01||Interventional|||Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia|Multicenter Therapy Study for Children With Mature B-NHL or B-ALL With a Rituximab - Window Before Chemotherapy|Completed||Phase 2|79|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:33:21.974652|2017-02-18 16:33:21.974652
NCT00324766|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2012-06-25|||June 2006||2006-06-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|September 2011|Actual|2011-09-01||Interventional|||Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.|Safety and Efficacy of Levosimendan in Patients With Acute Myocardial Infarction Complicated by Symptomatic Left Ventricular Failure.|Completed||Phase 4|61|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 16:33:22.102062|2017-02-18 16:33:22.102062
NCT00324753|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2015-04-24|||April 2007||2007-04-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Quality Improvement of Patient-Provider Communication For Colorectal Cancer Screening|Improving Patient-Provider Communication For Colorectal Cancer Screening|Completed||N/A|450|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:33:22.208121|2017-02-18 16:33:22.208121
NCT00324740|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2015-10-22|2015-07-20||March 2006||2006-03-01|June 2014|2014-06-01|May 2014|Actual|2014-05-01|February 2011|Actual|2011-02-01||Interventional|||Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer|A Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Combination With Isotretinoin (13-cis Retinoic Acid, 13-CRA) in the Treatment of Patients With Advanced Renal Cell Carcinoma|Terminated||Phase 1/Phase 2|14|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:33:22.564364|2017-02-18 16:33:22.564364
NCT00324727|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2013-10-22|||February 2006||2006-02-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma|A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver|Completed||Phase 3|93|Actual|Delcath Systems Inc.||2|||f||||||||||||||2017-02-18 16:33:22.872266|2017-02-18 16:33:22.872266
NCT00324714|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2012-11-28|||February 2003||2003-02-01|November 2012|2012-11-01||||||||Interventional|||Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS|A Randomised, Double-Blind Trial to Assess the Effects on Bone Mineral Density and Bone Biomarkers of Anastrozole When Used to Prevent Breast Cancer in Postmenopausal Women|Withdrawn||Phase 3|0|Actual|International Breast Cancer Study Group|||||f||||||||||||||2017-02-18 16:33:22.998672|2017-02-18 16:33:22.998672
NCT00323908|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2012-02-06|||June 2005||2005-06-01|February 2012|2012-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer|QM-MSP, Ki-67, and Cytomorphology of RPFNA Specimens From High Risk Women|Completed||N/A|281|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-02-18 16:33:37.60165|2017-02-18 16:33:37.60165
NCT00324701|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2015-04-06|2014-11-06||September 2006||2006-09-01|September 2014|2014-09-01|October 2012|Actual|2012-10-01|July 2011|Actual|2011-07-01||Interventional||Older adult Veterans (age 60 or older) presenting for services at VA primary care clinics and meeting DSM-IV criteria for major depressive disorder.|Telepsychology-Service Delivery for Depressed Elderly Veterans|Telepsychology-Service Delivery for Depressed Elderly Veterans|Completed||N/A|241|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:33:23.159671|2017-02-18 16:33:23.159671
NCT00324688|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2014-03-11|||March 2003||2003-03-01|March 2014|2014-03-01|June 2006||2006-06-01|||||Interventional|3OD||Safety Study of Once a Day ART and Opiate Substitute.|Open-label Multicenter Study to Assess the Efficacy, the Tolerability and the Adherence of a Once Daily (QD) Taken Antiretroviral Therapy (ART) Containing the NtRTI Tenofovir DF 300 mg in Combination With the Best Suitable Once a Day Regimen Being 1 NRTI Plus 1 PI or 1 NRTI Plus 1 NNRTI in HIV-1-infected IVDU- Patients With Opiate Substitution Being Either Antiretroviral-naive or With Suppressed Viral Load and Without a History of Virological Failure|Completed||Phase 4|60||Gilead Sciences|||||f||||f||||||||||2017-02-18 16:33:23.729645|2017-02-18 16:33:23.729645
NCT00324675|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2011-10-27|2011-09-15||August 2006||2006-08-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy|Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy|Completed||N/A|28|Actual|Technische Universität Dresden||2|||f||||t||||||||||2017-02-18 16:33:23.834599|2017-02-18 16:33:23.834599
NCT00324662|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2008-09-29|||August 2003||2003-08-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)|ADRIA - Belos A+ vs DR Clinical Investigation of Arrhythmia Discrimination|Completed||Phase 4|260|Anticipated|Biotronik SE & Co. KG|||||f||||||||||||||2017-02-18 16:33:24.217476|2017-02-18 16:33:24.217476
NCT00324649|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2015-08-13|2009-03-30||May 2006||2006-05-01|August 2015|2015-08-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|RECOMB||Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada|Pilot Phase IV, Multicenter, Randomized, Open-label and Controlled Study to Assess the Evolution of Peripheral Body Fat Distribution After Switching From Zidovudine Containing Backbone to Truvada in HIV-1-infected Patients on HAART (RECOMB Study).|Completed||Phase 4|80|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 16:33:24.321438|2017-02-18 16:33:24.321438
NCT00324623|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2012-11-19|||September 2005||2005-09-01|November 2012|2012-11-01||||November 2011|Actual|2011-11-01||Interventional|||Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma|Phase I Study of In Vivo Expansion of Melan-A/MART-1 Antigen-Specific CD8 T Lymphocytes Following Transient Immunosuppression in Patients With Advanced Melanoma|Completed||Phase 1|8|Actual|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||||2017-02-18 16:33:25.223692|2017-02-18 16:33:25.223692
NCT00324610|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2006-05-16|||March 2006||2006-03-01|May 2006|2006-05-01||||||||Interventional|||Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen|Phase I/II Study of Tolerance and Pharmacokinetics With Capecitabine Given 5 Days Out of 7 in Metastatic Breast Cancer|Unknown status|Recruiting|Phase 1/Phase 2|46||Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie|||||f||||||||||||||2017-02-18 16:33:25.332359|2017-02-18 16:33:25.332359
NCT00324597|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2013-09-16|||October 2005||2005-10-01|April 2007|2007-04-01||||||||Interventional|||AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase Ib, Open-Label, Sequential, Dose-Finding, Study of AMG 706 in Combination With Gemcitabine to Treat Subjects With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 16:33:25.417814|2017-02-18 16:33:25.417814
NCT00324584|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2006-07-04|||April 2003||2003-04-01|July 2006|2006-07-01|September 2004||2004-09-01|||||Interventional|||Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study|Surveillance Des données De l’Autosurveillance glycémique Via Internet Et Le réseau téléphonique GSM Chez Le diabétique De Type 1 Sous Traitement Insulinique Par Pompe Externe : Etude Prospective randomisée PumpNet.|Completed||Phase 3|40||University Hospital, Grenoble|||||f||||||||||||||2017-02-18 16:33:25.752358|2017-02-18 16:33:25.752358
NCT00324571|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2015-03-17|||March 2001||2001-03-01|March 2015|2015-03-01|February 2006||2006-02-01|||||Interventional|||Dialysis Clinical Outcomes Revisited (DCOR) Trial|A Randomized, Open Label, Parallel Design Study of Renagel® Phosphate Binder Versus Calcium-Based Phosphate Binders in Hemodialysis Patients|Completed||Phase 4|2000||Sanofi|||||||||||||||||||2017-02-18 16:33:25.85463|2017-02-18 16:33:25.85463
NCT00324558|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2012-06-07|||June 2005||2005-06-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|February 2010|Actual|2010-02-01||Interventional|||Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)|Multicenter, Randomized, Open and Sequential Study to Evaluate the Efficacy and Safety of Bemiparin Administration on the Response to Treatment in Patients Diagnosed With Limited Small Cell Lung Cancer|Terminated||Phase 2|39|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2||Sponsor stopped due to difficulties to recruit 130 patients required by protocol|f||||f||||||||||2017-02-18 16:33:26.014839|2017-02-18 16:33:26.014839
NCT00324545|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2006-05-09|||January 2000||2000-01-01|May 2006|2006-05-01|December 2002||2002-12-01|||||Interventional|||Cardiovascular Outcomes Of Diet Counseling|Long-Term Adherence and Cardiovascular Outcomes of a Randomized Controlled Trial of Medium-Intensity Minimally-Directive Counseling for Different Diets|Completed||Phase 2|120||The Camelot Foundation|||||f||||||||||||||2017-02-18 16:33:26.145815|2017-02-18 16:33:26.145815
NCT00324532|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2015-01-26|||May 2006||2006-05-01|May 2006|2006-05-01|May 2007|Actual|2007-05-01|||||Interventional|||to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD|An Open Label, Non Comparative, Prospective Pilot Study, to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD|Completed||Phase 3|60|Anticipated|BioBalance Corporation|||||f||||||||||||||2017-02-18 16:33:26.249678|2017-02-18 16:33:26.249678
NCT00324519|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2012-03-01|||February 2005||2005-02-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester|Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester|Completed||Phase 4|30|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 16:33:26.320857|2017-02-18 16:33:26.320857
NCT00324506|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2013-06-17|||May 2006||2006-05-01|June 2013|2013-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis|A Randomized, Open-label, Parallel-Group Multicenter Study to Determine the Safety/Efficacy of Mycophenolate Mofetil in Mono & Combination Therapy With Interferon Beta 1a in Patients With Relapsing Remitting Multiple Sclerosis|Completed||Phase 2|43|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-02-18 16:33:26.42317|2017-02-18 16:33:26.42317
NCT00324493|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2006-11-29|||June 2004||2004-06-01|June 2005|2005-06-01|June 2009||2009-06-01|||||Observational|||Musculoskeletal Function in Hemophilia|Musculoskeletal Function in Hemophilia in Developing Countries|Unknown status|Active, not recruiting|N/A|250||Christian Medical College, Vellore, India|||||f||||||||||||||2017-02-18 16:33:26.527913|2017-02-18 16:33:26.527913
NCT00324480|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2014-02-21|||March 2006||2006-03-01|October 2011|2011-10-01||||April 2009|Actual|2009-04-01||Interventional|||Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors|A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Flavopiridol in Advanced Solid Tumors|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:33:26.62162|2017-02-18 16:33:26.62162
NCT00324467|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2016-04-22|||August 2006||2006-08-01|April 2016|2016-04-01||||July 2017|Anticipated|2017-07-01||Interventional|LYTPET||Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment|Phase II Trial Investigating Tailoring First-Line Therapy For Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Based on Mid-Treatment Positron Emission Tomography (PET) Scan Results|Active, not recruiting||Phase 2|150|Actual|British Columbia Cancer Agency||2|||f||||f||||||||||2017-02-18 16:33:26.740154|2017-02-18 16:33:26.740154
NCT00324454|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2013-06-17|||May 2006||2006-05-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease|A Pilot Trial of Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease|Completed||Phase 2|20|Actual|Duke University||1|||f||||f||||||||||2017-02-18 16:33:26.903417|2017-02-18 16:33:26.903417
NCT00324441|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2006-05-09|||January 2004||2004-01-01|August 2003|2003-08-01|July 2005||2005-07-01|||||Interventional|||Mild Water-Filtered Near Infrared Whole-Body-Hyperthermia as an Adjunct in the Treatment of Fibromyalgia|A Randomized Controlled Trial on the Effectiveness of Mild Water-Filtered Near Infrared Hyperthermia as an Adjunct to a Standard Multimodal Rehabilitation in the Treatment of Fibromyalgia|Completed||Phase 2|132||Forschungsinstitut für Balneologie und Kurortwissenschaft Bad Elster|||||f||||||||||||||2017-02-18 16:33:27.015921|2017-02-18 16:33:27.015921
NCT00324428|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2010-02-03|||May 2006||2006-05-01|February 2010|2010-02-01|February 2008|Anticipated|2008-02-01|February 2008|Anticipated|2008-02-01||Interventional|||TMS for the Treatment of Pancreatic Cancer Pain|The Effect of a 10-day Course of Transcranial Magnetic Stimulation on Abdominal Pain in Patients With Locally Advanced and Advanced Pancreatic Cancer, a Randomized Phase II Study.|Unknown status|Active, not recruiting|Phase 2|32|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-02-18 16:33:27.108434|2017-02-18 16:33:27.108434
NCT00324415|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2016-06-14|2015-07-22||September 2006||2006-09-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|April 2014|Actual|2014-04-01||Interventional|||Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer|Phase II Trial of Combined Modality Therapy Plus Cetuximab in HIV-Associated Anal Carcinoma|Completed||Phase 2|45|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-02-18 16:33:27.230518|2017-02-18 16:33:27.230518
NCT00324402|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2008-07-08|||August 2006||2006-08-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|||||Observational|||Plasma Brain Natriuretic Peptide Levels in Pregnancy|Plasma Brain Natriuretic Peptide Levels in Pregnancy|Completed||N/A|50|Anticipated|Oklahoma State University Center for Health Sciences|||1||f||||f||||||||||2017-02-18 16:33:27.707254|2017-02-18 16:33:27.707254
NCT00324389|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2010-08-26|||May 2006||2006-05-01|April 2009|2009-04-01|June 2006||2006-06-01|||||Interventional|||Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes|A Pilot Study to Characterize Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes Using High Density Oligonucleotide Microarray Expression Analysis in Caucasian and African American Patients With Chronic Hepatitis C|Completed||Phase 2|2||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:33:27.793356|2017-02-18 16:33:27.793356
NCT00324376|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2015-03-04|||March 2003||2003-03-01|March 2015|2015-03-01|May 2004|Actual|2004-05-01|||||Interventional|||Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing|A Randomized, Cross-Over Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing|Completed||Phase 2|24||Sanofi|||||||||||||||||||2017-02-18 16:33:27.878954|2017-02-18 16:33:27.878954
NCT00324363|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2015-02-20|||January 2006||2006-01-01|January 2015|2015-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin|Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin|Completed||Phase 3|466|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:33:27.968228|2017-02-18 16:33:27.968228
NCT00324350|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2012-09-05|2012-03-15||October 2003||2003-10-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|ACCORD-BONE||Intensive Glycemic Control and Skeletal Health Study|Intensive Glycemic Control and Skeletal Health Study - Ancillary Study to the Action to Control Cardiovascular Risk in Diabetes Trial (ACCORD-BONE)|Completed||Phase 3|7287|Actual|University of California, San Francisco|The initial identification of a possible fracture event relied on self-report at annual visits with the possibility of under- or over-reporting of fractures.|2|||f||||t||||||||||2017-02-18 16:33:28.086215|2017-02-18 16:33:28.086215
NCT00324324|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2013-03-14|||May 2006||2006-05-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|April 2007|Actual|2007-04-01||Interventional|||Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant|Randomized, Double Blinded, Placebo-Controlled Trial of Antibacterial Prophylaxis for the Prevention of Bacterial Infections in the Post-Engraftment Phase After Allogeneic Hematopoeitic Stem Cell Transplantation|Terminated||Phase 3|240|Anticipated|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-02-18 16:33:28.533728|2017-02-18 16:33:28.533728
NCT00324311|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2011-05-08|||December 2005||2005-12-01|July 2009|2009-07-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|||Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care|Enzymatic Debridement in Burns Patients (Children & Adults): A Comparison to Standard of Care (Protocol MW 2004-11-02)|Completed||Phase 3|182|Actual|MediWound Ltd||2|||f||||t||||||||||2017-02-18 16:33:28.900635|2017-02-18 16:33:28.900635
NCT00324298|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2013-08-09|||July 2003||2003-07-01|January 2007|2007-01-01|March 2011|Actual|2011-03-01|||||Interventional|||Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles|A Randomized Phase III Toxicity Study of Day 2, 3, 8, 15 Short (30 Minute) Versus Day 1, 2, 3 Long (72 Hours) Infusion Bleomycin for Patients With IGCCCG Good Prognosis Germ Cell Tumors, TE3|Completed||Phase 3|210|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:33:29.022285|2017-02-18 16:33:29.022285
NCT00324285|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-10|2013-03-20|||July 2001||2001-07-01|May 2006|2006-05-01|October 2004||2004-10-01|||||Interventional|||Oral Rehydration SolutionContaining Amylase Resistant Starch in Severely Malnourished Children.|Oral Rehydration SolutionContaining Amylase Resistant Starch in Severely Malnourished Children With Watery Diarrhoea Due to Vibrio Cholerae|Completed||Phase 3|180||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:33:29.131371|2017-02-18 16:33:29.131371
NCT00324272|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2011-07-18|2011-04-12||January 2003||2003-01-01|May 2006|2006-05-01|June 2010|Actual|2010-06-01|December 2006|Actual|2006-12-01||Interventional|||Post-Operative Drainage Following Lymph Node Dissection|Can Fibrin Sealant be Used to Reduce Post-operative Drainage Following Lymph Node Dissection: a Prospective Randomised Double Blind Trial.|Completed||Phase 4|74|Actual|Oxford University Hospitals NHS Trust||4|||f||||f||||||||||2017-02-18 16:33:29.245084|2017-02-18 16:33:29.245084
NCT00324259|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2015-01-29|2014-10-08||August 2004||2004-08-01|January 2015|2015-01-01|August 2014|Actual|2014-08-01|March 2011|Actual|2011-03-01||Interventional|||Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer|A Phase II Randomized Study of Physiological (6 mg Daily) and High Dose (30 mg Daily) Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer|Completed||Phase 2|66|Actual|Washington University School of Medicine|The slight imbalance in numbers assigned to the 2 groups was a because of yearly data and safety monitoring, which led to early closure of the 30mg group for toxicity concerns after 32 patients had been enrolled.|2|||f||||f||||||||||2017-02-18 16:33:30.083523|2017-02-18 16:33:30.083523
NCT00324246|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2008-06-19|||September 2006||2006-09-01|January 2007|2007-01-01|December 2007|Actual|2007-12-01|||||Observational|||Feasibility Study of the NEW NORMA-SENSE|Feasibility Study of the NEW NORMA-SENSE Indicator Strip and Vaginal Secretion Buffer Capacity Measurement - IN-VITRO Study.|Completed||Phase 3|160|Actual|Carmel Medical Center|||1||f||||t||||||None Retained|"~     Vaginal secretions.~   "|||2017-02-18 16:33:30.867399|2017-02-18 16:33:30.867399
NCT00324233|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2012-11-29|2012-01-09||April 2006||2006-04-01|November 2012|2012-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Evaluation of Residual Urine After Intermittent Catheterisation|Evaluation of Residual Urine After Intermittent Catheterisation - Comparison of 2 Hydrophilic Coated, Intermittent Catheters|Completed||N/A|36|Actual|Coloplast A/S||2|||f||||||||||||||2017-02-18 16:33:30.948706|2017-02-18 16:33:30.948706
NCT00324220|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2015-06-04||2015-06-04|January 2006||2006-01-01|June 2015|2015-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase I/II Study of MGCD0103 With Azacitidine in Patients With High-Risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia|A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Azacitidine in Patients With High-Risk Myelodysplastic Syndrome or Acute Myelogenous Leukemia|Completed||Phase 1/Phase 2|66|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:33:31.323355|2017-02-18 16:33:31.323355
NCT00324207|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2010-03-03|||February 2006||2006-02-01|March 2010|2010-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Molecular Quantification of Insulin mRNA|Prediction of Type 1 Diabetes: Molecular Quantification of Insulin mRNA in the While Cell Fraction of Whole Blood|Completed||N/A|400|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||f||||||||||2017-02-18 16:33:31.436587|2017-02-18 16:33:31.436587
NCT00324194|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2015-01-06|||February 2005||2005-02-01|January 2015|2015-01-01|August 2008|Actual|2008-08-01|March 2008|Actual|2008-03-01||Interventional|||A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes|A Phase I Study of MGCD0103 Given as a Twice Weekly Oral Dose in Patients With Leukemia or Myelodysplastic Syndromes|Completed||Phase 1|25|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:33:31.526628|2017-02-18 16:33:31.526628
NCT00324181|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2009-08-03|||June 2006||2006-06-01|August 2009|2009-08-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Observational|||Psychopathology of Normal-tension Glaucoma in Hong Kong Chinese Out-patient|Psychopathology of Normal-tension Glaucoma in Hong Kong Chinese Out-patient|Unknown status|Active, not recruiting|N/A|100|Anticipated|Chinese University of Hong Kong|||1||f||||t||||||||||2017-02-18 16:33:31.83962|2017-02-18 16:33:31.83962
NCT00324168|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2013-12-12|2012-11-29||September 2006||2006-09-01|December 2013|2013-12-01|December 2012|Actual|2012-12-01|February 2011|Actual|2011-02-01||Interventional|SCUT||Steroids for Corneal Ulcers Trial|Steroids for Corneal Ulcers Trial|Completed||Phase 4|500|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 16:33:31.948402|2017-02-18 16:33:31.948402
NCT00324155|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2014-10-24|2014-01-22||August 2006||2006-08-01|October 2014|2014-10-01|October 2013|Actual|2013-10-01|January 2011|Actual|2011-01-01||Interventional||Number of Randomized Participants|Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma|A Multi-center, Randomized, Double-Blind, Two-Arm, Phase III Study in Patients With Untreated Stage III (Unresectable) or IV Melanoma Receiving Dacarbazine Plus 10 mg/kg Ipilimumab (MDX-010) vs. Dacarbazine With Placebo|Completed||Phase 3|681|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 16:33:32.6405|2017-02-18 16:33:32.6405
NCT00324142|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2012-07-31||||||July 2012|2012-07-01||||||||Interventional|||A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis|A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis|Withdrawn||Phase 2|0|Actual|Kaiser Permanente||||Study Terminated Prematurely|f||||||||||||||2017-02-18 16:33:34.627745|2017-02-18 16:33:34.627745
NCT00324129|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2015-01-06|||February 2005||2005-02-01|January 2015|2015-01-01|December 2008|Actual|2008-12-01|July 2006|Actual|2006-07-01||Interventional|||A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes|A Phase I Study of MGCD0103 Given as a Three-Times Weekly Oral Dose In Patients With Leukemia Or Myelodysplastic Syndromes|Completed||Phase 1|29|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:33:34.732435|2017-02-18 16:33:34.732435
NCT00323934|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2015-01-06|||April 2004||2004-04-01|January 2015|2015-01-01|October 2008|Actual|2008-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|A Phase I Study of MGCD0103 Given as a Three-Times Weekly Oral Dose in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|Completed||Phase 1|42|Actual|Mirati Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:33:37.422869|2017-02-18 16:33:37.422869
NCT00324116|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2010-03-15|2009-08-25||July 2006||2006-07-01|March 2010|2010-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions|A Prospective, Open-Label Multi Center Trial Evaluating The Safety And Efficacy Of 0.3 Mg/Eye Pegaptanib Sodium (Macugen) Intravitreous Injection Given Every 6 Weeks For 54 Weeks In Patients With Small Neovascular Age-Related Macular Degeneration (AMD) Lesions|Completed||Phase 4|81|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:33:34.855213|2017-02-18 16:33:34.855213
NCT00324103|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2006-05-08|||June 2001||2001-06-01|October 2005|2005-10-01|June 2004||2004-06-01|||||Interventional|||Structured Treatment Interruptions in Chronic HIV Infection|Antiretroviral Treatment With Structured Treatment Interruptions (STI) Versus Continuous Antiretroviral Treatment in HIV+ Patients With Persistent Suppression of Viral Replication|Completed||Phase 3|600||Istituto Superiore di Sanità|||||f||||||||||||||2017-02-18 16:33:35.242074|2017-02-18 16:33:35.242074
NCT00324090|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2009-01-20|||March 2002||2002-03-01|February 2002|2002-02-01|July 2002||2002-07-01|||||Interventional|||Glycemic Index, Body Weight and Health|Glycemic Index, Body Weight and Health|Completed||N/A|43||University of Copenhagen|||||f||||||||||||||2017-02-18 16:33:35.33756|2017-02-18 16:33:35.33756
NCT00324077|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2016-02-16|||August 2006||2006-08-01|April 2011|2011-04-01||||February 2007|Actual|2007-02-01||Interventional|||Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase|A Phase I Dose Escalation Study of the Combination of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase|Withdrawn||Phase 1|0|Actual|Bristol-Myers Squibb||||Insufficient Enrollment|f||||||||||||||2017-02-18 16:33:35.413345|2017-02-18 16:33:35.413345
NCT00324064|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2010-03-03|||July 2007||2007-07-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing|Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing|Completed||N/A|90|Anticipated|Children's Mercy Hospital Kansas City||1|||f||||f||||||||||2017-02-18 16:33:35.503447|2017-02-18 16:33:35.503447
NCT00324051|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2016-11-21|||May 2006||2006-05-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|PREFERENCE||Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet|PREFERENCE: 12-Week Open Label Trial On Olanzapine Orodispersible Tablet Vs. Oral Olanzapine Preference Study|Completed||Phase 4|284|Actual|Eli Lilly and Company|||||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 16:33:35.603797|2017-02-18 16:33:35.603797
NCT00324038|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2011-06-13|2009-07-17||March 2006||2006-03-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly|An Open, Randomised, Multicentre Study to Compare Buprenorphine Transdermal Delivery System (BTDS) With Standard Treatment in Elderly Subjects With OA of the Hip and/or Knee|Completed||Phase 4|219|Actual|Napp Pharmaceuticals Limited||2|||f||||||||||||||2017-02-18 16:33:35.712981|2017-02-18 16:33:35.712981
NCT00324025|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2008-12-11|||March 2007||2007-03-01|December 2008|2008-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Mycograb® as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS|Terminated||Phase 2|3|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:33:36.401488|2017-02-18 16:33:36.401488
NCT00324012|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2012-02-20|||April 2006||2006-04-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma|Phase II Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma|Completed||Phase 2|19|Actual|Rigshospitalet, Denmark||1|||f||||f||||||||||2017-02-18 16:33:36.51273|2017-02-18 16:33:36.51273
NCT00323999|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2006-05-09|||December 2004||2004-12-01|May 2006|2006-05-01|December 2007||2007-12-01|||||Interventional|||Hysteroscopic Monopolar and Bipolar Resection|A Randomised Trial to Compare the Differences Between Monopolar Surgery (Loop Resection) With Glycine 1,5% and Bipolar Surgery With Saline (Olympus,Versapoint) on Hysteroscopic Surgery.|Unknown status|Recruiting|N/A|||Ullevaal University Hospital|||||f||||||||||||||2017-02-18 16:33:36.631494|2017-02-18 16:33:36.631494
NCT00323986|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2006-05-08|||October 2004||2004-10-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy|Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy. Effects on Recurrent Respiratory Infections, Inflammatory Parameters and Bacterial Persistence|Terminated||Phase 2|30||University of Milan|||||f||||||||||||||2017-02-18 16:33:36.720639|2017-02-18 16:33:36.720639
NCT00323973|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-11-23|||July 2003||2003-07-01|November 2010|2010-11-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity|A Randomized Double-blind Placebo Force-titration Controlled Study With Bisoprolol in Patients With Chronic Heart Failure Secondary to Chagas´ Cardiomyopathy.|Completed||Phase 3|500|Actual|Fundación Cardiovascular de Colombia||2|||f||||t||||||||||2017-02-18 16:33:36.816368|2017-02-18 16:33:36.816368
NCT00323960|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2011-02-16|||May 2006||2006-05-01|February 2011|2011-02-01|May 2011|Anticipated|2011-05-01|December 2006|Actual|2006-12-01||Interventional|PRINTOJDMTR||Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis|Five-year Single-blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: Prednisone Versus Prednisone Plus Cyclosporine a Versus Prednisone Plus Methotrexate|Unknown status|Recruiting|Phase 3|120|Anticipated|Istituto Giannina Gaslini||3|||f||||f||||||||||2017-02-18 16:33:37.170327|2017-02-18 16:33:37.170327
NCT00323947|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2013-07-31|||May 2003||2003-05-01|July 2013|2013-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy|Double Blind, Placebo Controlled, Crossover Study of Extended Release Methylphenidate for Treatment of ADHD in Children With Epilepsy|Completed||Phase 4|33|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 16:33:37.300822|2017-02-18 16:33:37.300822
NCT00323895|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2010-07-28|||March 2006||2006-03-01|July 2010|2010-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|CRISTAL||The Intra-Drug Eluting Stent (DES) Restenosis Study|A Prospective, Randomized, Multi-Center Comparison of the CYPHER Select™ Sirolimus-Eluting Stent and Balloon Re-Angioplasty for Treatment of Patients With Intra-Des Restenosis|Completed||Phase 4|320|Anticipated|Cordis Corporation||3|||f||||t||||||||||2017-02-18 16:33:37.702313|2017-02-18 16:33:37.702313
NCT00323882|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2014-08-14|2014-07-23||January 2006||2006-01-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|September 2009|Actual|2009-09-01||Interventional||All participants who received at least one dose of study therapy.|Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer|A Phase I/II, Open-label, Dose-escalation Study of MDX-010 Administered Every 3 Weeks for 4 Doses in Patients With Metastatic Hormone-Refractory Prostate Cancer|Completed||Phase 1/Phase 2|75|Actual|Bristol-Myers Squibb|Due to the small number of participants who underwent more than 4 doses of treatment (induction period) and the exploratory nature of this study, not all of the secondary objectives were completed.|1|||f||||f||||||||||2017-02-18 16:33:37.842419|2017-02-18 16:33:37.842419
NCT00323869|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2016-07-30|2016-04-20||June 2006||2006-06-01|July 2016|2016-07-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer|Phase II Trial of Bevacizumab in Combination With Gemcitabine and Carboplatin in Patients With Newly Diagnosed Non-Small Cell Lung Cancer (Excluding Squamous Cell Carcinoma)|Completed||Phase 2|48|Actual|Stanford University||1|||f||||t||||||||No||2017-02-18 16:33:40.589177|2017-02-18 16:33:40.589177
NCT00323856|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2017-01-20|||January 2003|Actual|2003-01-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A|Phase IV A Study of Immunologic Safety for Alphanate in Previously Treated Patients Diagnosed With Severe Hemophilia A|Recruiting||Phase 4|60|Anticipated|Grifols Biologicals Inc.||1|||f||||f||||||||||2017-02-18 16:33:41.037524|2017-02-18 16:33:41.037524
NCT00323843|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2007-01-29|||June 2006||2006-06-01|January 2007|2007-01-01|February 2007||2007-02-01|||||Interventional|||Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone|RIRS - A Method of Treating the ESWL Resistant Kidney Stone|Unknown status|Active, not recruiting|Phase 2|10||Fredericia Hosptial|||||f||||||||||||||2017-02-18 16:33:41.160886|2017-02-18 16:33:41.160886
NCT00323830|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2011-11-08|||October 2004||2004-10-01|November 2011|2011-11-01|April 2011|Actual|2011-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma|Phase III Randomized Controlled Trial of Adjuvant Capecitabine/Cisplatin Chemotherapy and Chemoradiation Therapy for Gastric Adenocarcinoma|Completed||Phase 3|458|Actual|Samsung Medical Center||2|||f||||||||||||||2017-02-18 16:33:41.251342|2017-02-18 16:33:41.251342
NCT00321802|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2014-12-30|||April 2006||2006-04-01|December 2014|2014-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|PAFRIOSIES||Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins|Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins|Completed||Phase 2|40|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 16:33:41.362111|2017-02-18 16:33:41.362111
NCT00321789|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2015-04-06|2014-09-02||September 2007||2007-09-01|August 2014|2014-08-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|CouPLES||A Patient-Spouse Intervention for Self-Managing High Cholesterol|A Patient-Spouse Intervention for Self-Managing High Cholesterol|Completed||N/A|255|Actual|VA Office of Research and Development|The dietary measure underestimates dietary intake but should not invalidate differences between groups or across time. Sample size for dietary analyses was reduced due to missing data, but non-responders did not differ on measured characteristics.|2|||f||||f||||||||||2017-02-18 16:33:41.482473|2017-02-18 16:33:41.482473
NCT00321763|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2016-09-23|2013-03-21||April 2006||2006-04-01|September 2016|2016-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate|Demonstrate the Lot-to-lot Consistency of 3 Consecutive Production Lots of an Adjuvanted Influenza Vaccine Candidate and Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate Versus Fluarix™ Administered Intramuscularly in Elderly|Completed||Phase 2|3124|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:33:45.400492|2017-02-18 16:33:45.400492
NCT00321750|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2006-10-17|||December 2004||2004-12-01|May 2006|2006-05-01|April 2005||2005-04-01|||||Interventional|||Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream|Phase 2 Study of the Treatment of Oral Erosive Lichen Planus With 1% Pimecrolimus Cream: a Double Blind Randomized Prospective Trial With Measurement of Pimecrolimus Levels in the Blood|Terminated||Phase 2|14||Centre Hospitalier Universitaire de Nice|||||f||||||||||||||2017-02-18 16:33:47.238615|2017-02-18 16:33:47.238615
NCT00321737|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2012-02-01|2009-02-20||May 2006||2006-05-01|February 2012|2012-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis|A Phase 3 Study to Evaluate the Safety and Efficacy of TAK-390MR (30 mg QD and 60 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis.|Completed||Phase 3|445|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:33:47.328065|2017-02-18 16:33:47.328065
NCT00321724|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2013-01-14|||May 2006||2006-05-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia|A Phase II Trial of AZD2171 in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia Patients|Completed||Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:33:48.687361|2017-02-18 16:33:48.687361
NCT00321711|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2013-07-31|2010-11-18||October 2006||2006-10-01|July 2013|2013-07-01|October 2010|Actual|2010-10-01|April 2009|Actual|2009-04-01||Interventional|||Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents|A Randomized, Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim (AMG 531) Treatment of Subjects With Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Hypomethylating Agents|Completed||Phase 2|69|Actual|Amgen||5|||f||||||||||||||2017-02-18 16:33:48.817491|2017-02-18 16:33:48.817491
NCT00322972|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2015-09-05|||June 2006||2006-06-01|September 2015|2015-09-01|May 2014|Actual|2014-05-01|November 2009|Actual|2009-11-01||Interventional|TANA||Trachoma Amelioration in Northern Amhara (TANA)|Eliminating Trachoma With Repeat Mass Drug Treatment|Completed||Phase 4|33000|Actual|University of California, San Francisco||6|||f||||t||||||||||2017-02-18 16:34:21.590971|2017-02-18 16:34:21.590971
NCT00321698|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2016-12-30|2014-12-30||January 2006||2006-01-01|December 2016|2016-12-01|January 2021|Anticipated|2021-01-01|October 2009|Actual|2009-10-01||Interventional|||Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer|Phase I/II Study of Preoperative Radiation and Docetaxel Activity in High Risk Localized Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|25|Actual|OHSU Knight Cancer Institute|Patient accrual was not completed due to the sponsor withdrawing funding.|2|||f||||t||||||||||2017-02-18 16:33:51.088146|2017-02-18 16:33:51.088146
NCT00321685|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2016-07-01|2015-04-21||July 2006||2006-07-01|June 2016|2016-06-01|May 2020|Anticipated|2020-05-01|August 2013|Actual|2013-08-01||Interventional||Eligible and treated patients|Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer|Phase II Study of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients With Locally Advanced Rectal Cancer|Active, not recruiting||Phase 2|57|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:33:51.80761|2017-02-18 16:33:51.80761
NCT00321672|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2011-05-13|2010-06-16||June 2006||2006-06-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy|A Multicenter Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy|Completed||Phase 3|494|Actual|NeurogesX|Differences between the 60- and 30-minute Control groups prevented pooling according to prespecified criteria resulting in treatment comparisons between 60- and 30-minute NGX-4010 groups and their respective Control groups with relatively low power.|4|||f||||f||||||||||2017-02-18 16:33:52.311347|2017-02-18 16:33:52.311347
NCT00321659|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2006-09-29|||October 2002||2002-10-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Optimizing Fibromyalgia Self-Management|Short and Long-Term Effects of Exercise and Education as Self-Management in Women With Fibromyalgia|Unknown status|Active, not recruiting|N/A|200||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 16:33:53.330272|2017-02-18 16:33:53.330272
NCT00323817|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2015-05-26|||April 2006||2006-04-01|May 2015|2015-05-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia||Completed||Phase 2|282|Anticipated|Zeria Pharmaceutical||1|||f||||||||||||||2017-02-18 16:33:53.42198|2017-02-18 16:33:53.42198
NCT00323804|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2014-09-03|||May 2006||2006-05-01|August 2014|2014-08-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|||Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.|Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating the Interest of a Long-term (3 Years) Treatment With Peginterferon Alfa-2b and Ribavirin on Liver Fibrosis in Non-responder Chronic Hepatitis C Patients.|Completed||Phase 2/Phase 3|372|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 16:33:53.503698|2017-02-18 16:33:53.503698
NCT00323791|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2009-12-10|||April 2006||2006-04-01|December 2009|2009-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Phase II Trial of Gemzar (Gemcitabine) and Gleevec (Imatinib Mesylate) in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|100|Anticipated|Rutgers, The State University of New Jersey||||slow accrual|f||||t||||||||||2017-02-18 16:33:53.652318|2017-02-18 16:33:53.652318
NCT00323778|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2008-02-04|||May 2006||2006-05-01|February 2008|2008-02-01||||September 2007|Actual|2007-09-01||Interventional|||Prospective Assessment of the Efficacy of Hyaluronate Knee Injections in Patients With Osteoarthritis|Prospective Assessment of the Efficacy of Intra-Articular Hyaluronate to Affect Extracellular Matrix Changes in Patients With Osteoarthritis|Terminated||Phase 3|40|Anticipated|Hospital for Special Surgery, New York|||||||||||||||||||2017-02-18 16:33:53.75747|2017-02-18 16:33:53.75747
NCT00323765|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-09|2017-01-24|||May 5, 2006||2006-05-05|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Observational|||Plasticity in Cervical Dystonia|Plasticity in Cervical Dystonia|Completed||N/A|44||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:33:53.845693|2017-02-18 16:33:53.845693
NCT00323752|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2008-09-24|||October 2004||2004-10-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Recombinant Human Erythropoietin Compared to Autologous Pre-Donation Prior to Scoliosis Surgery in Children.|Recombinant Human Erythropoietin Compared to Autologous Pre-Donation Prior to Scoliosis Surgery in Children.|Completed||Phase 3|20|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 16:33:53.922512|2017-02-18 16:33:53.922512
NCT00323739|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2013-07-18|2012-12-19||May 2006||2006-05-01|July 2013|2013-07-01|March 2011|Actual|2011-03-01|November 2008|Actual|2008-11-01||Interventional|||Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma|Phase II Trial of Bevacizumab(Avastin) and RAD001(Everolimus)in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma|Completed||Phase 2|80|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:33:54.188836|2017-02-18 16:33:54.188836
NCT00323726|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2015-06-16|||December 2005||2005-12-01|June 2015|2015-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study|Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study|Withdrawn||N/A|0|Actual|New Mexico Cancer Care Alliance|||1|The study was limited to IRB Exempt chart review; not an applicable trial.|f||||||||||||||2017-02-18 16:33:54.546261|2017-02-18 16:33:54.546261
NCT00323713|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2011-06-23|||February 2005||2005-02-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|July 2011|Anticipated|2011-07-01||Interventional|||Very Low Protein Diet and Renal Death in Chronic Kidney Disease (CKD)-ERIKA Study|Effects of Very Low Protein Diet Supplemented With Ketoanalogs on Renal Death in Phase 4/5 Chronic Kidney Disease (CKD) - ERIKA Study|Unknown status|Active, not recruiting|N/A|360|Anticipated|Azienda Sanitaria ASL Avellino 2||2|||f||||t||||||||||2017-02-18 16:33:54.621801|2017-02-18 16:33:54.621801
NCT00323700|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2009-04-17|||December 2008||2008-12-01|April 2009|2009-04-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD)|A Naturalistic Prospective Study of Treatment Effectiveness for ADHD|Withdrawn||N/A|200|Anticipated|University of British Columbia|||1|Merged with the study NCT00307268|f||||f||||||||||2017-02-18 16:33:54.763183|2017-02-18 16:33:54.763183
NCT00323687|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2008-06-06|||September 2004||2004-09-01|June 2008|2008-06-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada|"Switch to a Completely ONce Daily Regimen Containing Emtricitabine/Tenofovir - Fixed Dose Combination Plus Third QD Partner: SONETT"|Completed||Phase 4|50|Anticipated|Gilead Sciences||1|||f||||f||||||||||2017-02-18 16:33:55.018433|2017-02-18 16:33:55.018433
NCT00323674|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-07|2014-12-04|||March 2006||2006-03-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Minimally Invasive Open Preperitoneal Surgery With Polysoft Mesh Versus a Classic Open Surgery With Light Weight Mesh|Prospective Randomized Study to Evaluate the Recovery of a Hernia Inguinalis by a Minimally Invasive Open Preperitoneal Surgery With Polysoft Mesh Versus a Classic Open Surgery According to Modified Lichtenstein Procedure With Light Weight Mesh|Unknown status|Active, not recruiting|N/A|50|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 16:33:55.104191|2017-02-18 16:33:55.104191
NCT00323661|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2012-02-10|||May 2006||2006-05-01|February 2012|2012-02-01|March 2011|Actual|2011-03-01|November 2010|Actual|2010-11-01||Interventional|COGNITION||Closed Loop Stimulation, Cognitive Performance, and Quality of Life in Pacemaker Patients|COGNITION - Cognitive Performance & Closed Loop Stimulation|Completed||Phase 4|405|Actual|Biotronik SE & Co. KG||2|||f||||||||||||||2017-02-18 16:33:55.213298|2017-02-18 16:33:55.213298
NCT00323648|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-07|2014-12-04|||May 2006||2006-05-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|May 2010|Actual|2010-05-01||Interventional|||Does it Make Sense to Give Postoperative Antibiotics to Patients With an Uncomplicated Acute Cholecystitis|Does it Make Sense to Give Postoperative Antibiotics to Patients With an Uncomplicated Acute Cholecystitis|Completed||Phase 2|50|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:33:55.376524|2017-02-18 16:33:55.376524
NCT00323635|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2014-12-02|2013-08-09||April 2006||2006-04-01|December 2014|2014-12-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.|A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women.|Terminated||Phase 4|19|Actual|Brigham and Women's Hospital||2||New department chairman instructed PI to discontinue study.|f||||t||||||||||2017-02-18 16:33:55.485846|2017-02-18 16:33:55.485846
NCT00323622|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-10-27|2013-03-29||April 2005||2005-04-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine|An Open Study for a 2-year Period to Confirm the Safety and Immunogenicity of the Candidate Malaria Vaccine RTS,S/AS02A in Mozambican Children Aged 1 to 4 Years at the Time of First Vaccine Dose.|Completed||Phase 2|1737|Actual|GlaxoSmithKline||8|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:33:55.949903|2017-02-18 16:33:55.949903
NCT00323609|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2013-03-18|2012-06-29||August 2006||2006-08-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures|A Multicenter, Randomized, Prospective Clinical Trial to Compare the Short- and Long-term Safety and Effectiveness of Balloon Kyphoplasty to Vertebroplasty in the Treatment of Painful, Acute Osteoporosis-related Vertebral Body Compression Fractures (VCFs).|Terminated||Phase 4|404|Actual|Medtronic Spine LLC|The original study design required n=1,234 randomized patients; however, the study was stopped early with only n=404 enrolled patients, due to low enrollment, difficulty in willingness to randomize patients and a high proportion of early terminations|2||"Due to high number of patients terminating study early, low patient enrollment and difficulty~   in patient/investigator willingness for randomization"|f||||||||||||||2017-02-18 16:33:57.226095|2017-02-18 16:33:57.226095
NCT00323596|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2009-10-23|||September 2004||2004-09-01|October 2009|2009-10-01|December 2008|Actual|2008-12-01|||||Observational|||Trial of a Home Based Strength and Balance Retraining Program in Reducing Falls Risk Factors|Action Seniors!: A 12-month Randomized Controlled Trial of a Home Based Strength and Balance Retraining Program in Reducing Falls Risk Factors|Completed||N/A|71|Anticipated|University of British Columbia|||1||f||||f||||||None Retained|"~     None retained~   "|||2017-02-18 16:33:59.620543|2017-02-18 16:33:59.620543
NCT00323583|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2007-05-07|||May 2006||2006-05-01|May 2007|2007-05-01||||||||Interventional|||Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer|Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer|Unknown status|Recruiting|Phase 2|80|Anticipated|Seattle Cancer Treatment and Wellness Center|||||f||||||||||||||2017-02-18 16:33:59.707684|2017-02-18 16:33:59.707684
NCT00323570|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2012-06-26|||May 2006||2006-05-01|March 2012|2012-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma|A Multi-center, Randomized, Double-blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven®/ NiaStase®) in the Treatment of Refractory Bleeding in Severely Injured Trauma Patients|Withdrawn||Phase 3|0|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:33:59.808801|2017-02-18 16:33:59.808801
NCT00323557|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2012-12-03|2012-04-06||June 2004||2004-06-01|December 2012|2012-12-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients|Immuno-Augmentation With GM-CSF in Patients Receiving Pneumococcal Vaccine While Undergoing Treatment for Advanced Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|39|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 16:33:59.931257|2017-02-18 16:33:59.931257
NCT00323544|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2008-06-30|||October 2004||2004-10-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|June 2007|Actual|2007-06-01||Interventional|||SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection|A Phase 3, Open Label, Randomised, Parallel Group Study to Compare the Effect on Prevention and Resolution of Treatment Related Adverse Events of a Simplified, Once Daily Regimen of a Fixed Dose Combination Tablet of Emtricitabine and Tenofovir DF Versus Twice Daily co-Formulated Zidovudine and Lamivudine (Combivir®) or Zidovudine and Lamivudine, in Virologically Suppressed, HIV Infected Patients Taking Efavirenz|Completed||Phase 3|220||Gilead Sciences|||||f||||f||||||||||2017-02-18 16:34:00.270096|2017-02-18 16:34:00.270096
NCT00323531|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2008-05-06|||March 2006||2006-03-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Thoracoscopy Versus Fibrinolysis in Children With Empyema|Thoracoscopy Versus Fibrinolysis in Children With Empyema|Completed||Phase 2/Phase 3|36|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-02-18 16:34:00.380935|2017-02-18 16:34:00.380935
NCT00323518|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2016-03-14||2015-02-02|May 2006||2006-05-01|March 2016|2016-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis|A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant|Completed||Phase 2|390|Actual|Celldex Therapeutics||4|||f||||t||||||||||2017-02-18 16:34:00.600872|2017-02-18 16:34:00.600872
NCT00323505|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2006-05-08|||March 2001||2001-03-01|May 2006|2006-05-01|December 2004||2004-12-01|||||Interventional|||A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma||Completed||Phase 2|||Royal Marsden NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:34:00.73125|2017-02-18 16:34:00.73125
NCT00323492|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-01-13|2009-03-20||September 2005||2005-09-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|July 2007|Actual|2007-07-01||Interventional|TOTEM||TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada|Open-label Randomized Multicenter Trial to Evaluate the Impact on the Lipid Profile of the Substitution of the NRTIs of a HAART Regimen by a Once Daily Fixed Dose Combination Tablet of Emtricitabine and Tenofovir DF Versus Maintained Treatment in HIV Infected Controlled Patients.|Completed||Phase 4|92|Actual|Gilead Sciences|Comparison of adverse events between Truvada and maintain baseline regimen groups is inappropriate since numbers at risk (and exposure to study drug) are not balanced, as described in the adverse event treatment group descriptions.|4|||f||||f||||||||||2017-02-18 16:34:00.814809|2017-02-18 16:34:00.814809
NCT00323479|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2012-03-13|2010-01-26||June 2006||2006-06-01|March 2012|2012-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Arthralgia During Anastrozole Therapy for Breast Cancer|A Multicentre, Open Study Assessing Joint Disorders Under ARIMIDEX® (1mg/Day) as Adjuvant Treatment in Post Menopausal Women With Early Breast Cancer|Completed||Phase 4|114|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:34:01.737552|2017-02-18 16:34:01.737552
NCT00323466|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2014-12-04|||May 2007||2007-05-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||A Study of the Effect on Oro-dental Complications of Intensity Modulated Radiotherapy (IMRT) Versus Conventional Radiotherapy in Patients With Cancer of the Head or Neck|A Study of the Effect on Oro-dental Complications of Intensity Modulated Radiotherapy (IMRT) Versus Conventional Radiotherapy in Patients With Cancer of the Head or Neck|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:34:02.039629|2017-02-18 16:34:02.039629
NCT00323453|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2012-12-18|||March 2006||2006-03-01|May 2009|2009-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Wound Infection Alexis Wound Retractor|Rate of Surgical Wound Infection After Open Appendectomy Using the Alexis Wound Retractor|Completed||Phase 4|119|Actual|Santa Barbara Cottage Hospital||2|||f||||t||||||||||2017-02-18 16:34:02.139657|2017-02-18 16:34:02.139657
NCT00323440|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-07|2008-05-18||||||May 2008|2008-05-01||||||||Observational|||Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission|Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission|Withdrawn||N/A|80|Anticipated|Sheba Medical Center||||Collaboration could not be established|f||||t||||||||||2017-02-18 16:34:02.264074|2017-02-18 16:34:02.264074
NCT00323427|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2014-01-17|2013-09-26||May 2007||2007-05-01|January 2014|2014-01-01|September 2010|Actual|2010-09-01|February 2009|Actual|2009-02-01||Interventional|||"Clinical Trial of the Living Well With Hearing Loss Workshop"|"Clinical Trial of the Living Well With Hearing Loss Workshop"|Completed||Phase 2|135|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:34:02.36617|2017-02-18 16:34:02.36617
NCT00323414|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2013-03-28|||April 2006||2006-04-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Polyunsaturated Fatty Acids (PUFA) in the Treatment of Non-Alcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes Mellitus (PUFA)|Randomized Controlled Trial of Omega-3 Fatty Acids in the Treatment of Non-Alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|32|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 16:34:02.81061|2017-02-18 16:34:02.81061
NCT00323401|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2011-11-04|||May 2006||2006-05-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2009|Actual|2009-12-01||Interventional|||The Influence of Antenatal Classes on Pregnancy, Birth and Parenthood|The Influence of Antenatal Classes on Pregnancy, Birth and Parenthood|Unknown status|Active, not recruiting|Phase 4|1000|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-02-18 16:34:02.922591|2017-02-18 16:34:02.922591
NCT00321646|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2016-04-13|2013-11-06||June 2006||2006-06-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|November 2008|Actual|2008-11-01||Interventional||42 enrolled, 1 participant withdrew before receiving treatment.|Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy|A Phase II Study of Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy|Completed||Phase 2|42|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:34:03.038409|2017-02-18 16:34:03.038409
NCT00321633|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2013-08-23|||September 2005||2005-09-01|July 2009|2009-07-01||||September 2009|Actual|2009-09-01||Interventional|||Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer|A Randomized Phase II Pilot Trial of Carboplatin Compared to Docetaxel for Patients With Metastatic Genetic Breast Cancer [BRCA Trial]|Completed||Phase 2|148|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:34:03.327559|2017-02-18 16:34:03.327559
NCT00321620|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2016-02-19|2010-12-10||April 2006||2006-04-01|February 2016|2016-02-01|February 2012|Actual|2012-02-01|October 2009|Actual|2009-10-01||Interventional|||Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer|A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Metastases in Men With Hormone-Refractory Prostate Cancer|Completed||Phase 3|1904|Actual|Amgen||2|||f||||t||||||||||2017-02-18 16:34:03.474984|2017-02-18 16:34:03.474984
NCT00321594|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2013-01-30|||May 2006||2006-05-01|December 2012|2012-12-01||||August 2010|Actual|2010-08-01||Interventional|||Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery|A Phase I/II Study of PXD101 in Patients With Unresectable Hepatocellular Carcinoma With Pharmacokinetic and Pharmacodynamic Evaluation|Completed||Phase 1/Phase 2|61|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:34:05.410075|2017-02-18 16:34:05.410075
NCT00005523|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1998||1998-08-01|January 2006|2006-01-01|December 2003|Actual|2003-12-01|||||Observational|||Home Based Environmental Adherence Trial||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:49.17535|2017-02-18 18:14:49.17535
NCT00321581|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2017-01-24|||May 1, 2006||2006-05-01|June 29, 2012|2012-06-29|October 6, 2011|Actual|2011-10-06|||||Interventional|||AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia|Phase I Trial of CEDIRANIB (AZD2171), an Orally Bioavailable Antiangiogenic Agent, in Children and Adolescents With Refractory or Recurrent Solid Tumors|Completed||Phase 1|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:34:05.528498|2017-02-18 16:34:05.528498
NCT00321568|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2017-01-24|||May 1, 2006||2006-05-01|April 19, 2011|2011-04-19|April 19, 2011||2011-04-19|||||Observational|||Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis|An Exploratory Study on Detection of Cortical and White Matter Damage in Patients With Multiple Sclerosis Using Magnetic Resonance Imaging at 7 Tesla|Completed||N/A|60|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:34:05.628171|2017-02-18 16:34:05.628171
NCT00321555|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2017-01-24|||April 27, 2006||2006-04-27|December 20, 2016|2016-12-20|March 31, 2019|Anticipated|2019-03-31|March 31, 2018|Anticipated|2018-03-31||Interventional|||LMB-2 to Treat Hairy Cell Leukemia|A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia|Active, not recruiting||Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:34:05.715775|2017-02-18 16:34:05.715775
NCT00321542|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2015-07-28|||September 2006||2006-09-01|February 2015|2015-02-01|September 2017|Anticipated|2017-09-01|September 2015|Anticipated|2015-09-01||Observational|||Coronary CT Angiography in Asymptomatic Diabetes Mellitus|Assessment of the Additive Value of Multislice Computed Tomographic Angiography of the Coronary Arteries in the Prediction of Acute Cardiac Events in Asymptomatic Individuals With Type II Diabetes Mellitus|Active, not recruiting||Phase 3|793|Actual|Carmel Medical Center|||1||f||||t||||||||||2017-02-18 16:34:05.837047|2017-02-18 16:34:05.837047
NCT00321529|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2007-05-23||||||May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Observational|||Comparison of the ProAdjuster Analysis to the Penning Method of Determining Intersegmental Motion of the Cervical Spine||Completed||N/A|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:34:08.614169|2017-02-18 16:34:08.614169
NCT00321516|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2013-11-07|||July 2006||2006-07-01|June 2008|2008-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder|Effects of Aripiprazole on the Steady-State Pharmacokinetics of Lamotrigine in Subjects With Bipolar I Disorder|Completed||Phase 1|20||Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-02-18 16:34:08.739278|2017-02-18 16:34:08.739278
NCT00321503|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2013-12-06|||May 2006||2006-05-01|December 2013|2013-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)|Diagnosis and Response to Treatment of Laryngopharyngeal Reflux Using an Oropharyngeal Aerosolized pH Probe|Completed||N/A|45|Actual|Emory University|||1||f||||||||||||||2017-02-18 16:34:08.849059|2017-02-18 16:34:08.849059
NCT00321490|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2009-03-24|||April 2006||2006-04-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|||||Interventional|DIAMOND||Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled and Active-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained-Release (SEROQUEL®) as Monotherapy in the Treatment of Patients With MDD|Completed||Phase 3|600||AstraZeneca|||||f||||||||||||||2017-02-18 16:34:08.937823|2017-02-18 16:34:08.937823
NCT00321477|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2017-01-19|||December 2005||2005-12-01|January 2017|2017-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder|NK1 Receptor Antagonist vs Placebo in the Treatment of Overactive Bladder Symptoms|Completed||Phase 2|160|Anticipated|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:34:09.071465|2017-02-18 16:34:09.071465
NCT00321464|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2014-07-11|2010-12-10||April 2006||2006-04-01|July 2014|2014-07-01|April 2012|Actual|2012-04-01|March 2009|Actual|2009-03-01||Interventional|||A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.|A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Metastases in Subjects With Advanced Breast Cancer|Completed||Phase 3|2049|Actual|Amgen||2|||f||||t||||||||||2017-02-18 16:34:11.81656|2017-02-18 16:34:11.81656
NCT00321451|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2016-01-28|||May 2006||2006-05-01|January 2016|2016-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia|Behavioral Insomnia Therapy With Fibromyalgia|Completed||Phase 2/Phase 3|111|Actual|Duke University||3|||f||||t||||||||||2017-02-18 16:34:13.973268|2017-02-18 16:34:13.973268
NCT00321438|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2009-05-15|||July 2005||2005-07-01|May 2009|2009-05-01||||||||Observational|||Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus|Prospective, Observational Study of Subjects With CXCR4-Tropic or Non-Phenotypeable HIV to Assess Changes in Tropism Over Time|Terminated||N/A|150||GlaxoSmithKline|||1||||||||||||||||2017-02-18 16:34:14.366383|2017-02-18 16:34:14.366383
NCT00321425|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2008-05-20|||May 2006||2006-05-01|October 2007|2007-10-01||||||||Interventional|||Ultrasound Guidance Vs. Electrical Nerve Stimulation for Infraclavicular Brachial Plexus Block||Completed||N/A|80|Anticipated|Rikshospitalet University Hospital|||||f||||||||||||||2017-02-18 16:34:14.469459|2017-02-18 16:34:14.469459
NCT00321412|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-05-27||2014-05-27|March 2006||2006-03-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas|A Double-blind, Randomized, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Mild to Moderately Active Crohn's Patients With Fistulas|Completed||Phase 3|191|Actual|Ocera Therapeutics||2|||f||||f||||||||||2017-02-18 16:34:14.562991|2017-02-18 16:34:14.562991
NCT00323388|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-01-06|||November 2005||2005-11-01|November 2009|2009-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Identification of Risk Allels for Prostate Cancer|Identification of Risk Allels for Prostate Cancer|Completed||N/A|||University of New Mexico|||1||f||||t||||||||||2017-02-18 16:34:14.764966|2017-02-18 16:34:14.764966
NCT00323375|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2006-05-05|||August 1999||1999-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Phase 1 Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine|Randomized Controlled Trial of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine|Completed||Phase 1|122||Tulane University Health Sciences Center|||||||||||||||||||2017-02-18 16:34:14.845159|2017-02-18 16:34:14.845159
NCT00323362|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2014-04-25|2013-11-18||April 2006||2006-04-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer|Phase II Study of Imatinib Mesylate and Gemcitabine for Recurrent/Metastatic Non-small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|17|Actual|Rutgers, The State University of New Jersey||1||Toxicity|f||||f||||||||||2017-02-18 16:34:14.949425|2017-02-18 16:34:14.949425
NCT00323349|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-06|2007-06-27|||April 2003||2003-04-01|June 2007|2007-06-01|December 2004||2004-12-01|||||Interventional|||A Study of Attitudes About the Risk of Developing Type 2 Diabetes|Cues to Action in Diabetes Risk Education (CADRE): Randomized Study Assessing the Impact of Knowledge of Impaired Glucose Tolerance on Perceived Risk and Behavior Change Motivation|Completed||N/A|276||Eastern Virginia Medical School|||||f||||||||||||||2017-02-18 16:34:15.266373|2017-02-18 16:34:15.266373
NCT00323336|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-01-22|||May 2006||2006-05-01|January 2010|2010-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Markers of Bone Turnover in Saliva and How This Compares to Urine and Blood|Salivary Markers of Bone Turnover Compared to Urine and Blood|Completed||N/A|100|Actual|Mayo Clinic|||2||f||||||||||||||2017-02-18 16:34:15.351169|2017-02-18 16:34:15.351169
NCT00323323|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2017-01-19|||March 2004||2004-03-01|January 2017|2017-01-01|October 2016|Actual|2016-10-01|August 2012|Actual|2012-08-01||Interventional|||CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas|A Phase I Study of CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas|Completed||Phase 1|24|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:34:15.430967|2017-02-18 16:34:15.430967
NCT00323310|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-10-13|2010-08-16||April 2006||2006-04-01|October 2010|2010-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy of MultiHance in Pediatric Patients|A Phase III Multi-Center Open Label Study to Evaluate Safety and Efficacy of MultiHance at the Dose of 0.10 mmol/kg in Magnetic Resonance Imaging of the Central Nervous System in Pediatric Patients|Terminated||Phase 3|92|Actual|Bracco Diagnostics, Inc||1||Adequate statistical power at 92 dosed pts to meet study objectives.|f||||f||||||||||2017-02-18 16:34:15.56932|2017-02-18 16:34:15.56932
NCT00323297|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2014-10-27|2013-08-23||September 2006||2006-09-01|October 2014|2014-10-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension|A Multinational, Multicentre, Randomized, Double-blind Study To Assess The Efficacy And Safety Of Oral Sildenafil 20mg Tid Or Placebo When Added To Bosentan In The Treatment Of Subjects, Aged 18 Years And Above, With Pulmonary Arterial Hypertension (Pah)|Completed||Phase 4|105|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:34:16.06346|2017-02-18 16:34:16.06346
NCT00323284|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-06|2016-03-24|2012-09-04||June 2005||2005-06-01|March 2016|2016-03-01|March 2010|Actual|2010-03-01|July 2009|Actual|2009-07-01||Interventional|||A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma|A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.|Completed||Phase 3|240|Actual|Glaukos Corporation|Open label given no way to mask treatment group to surgeon and visibility of iStent device upon gonioscopy.|2|||f||||f||||||||||2017-02-18 16:34:17.042923|2017-02-18 16:34:17.042923
NCT00323271|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2015-08-25|2015-07-21||July 2006||2006-07-01|August 2015|2015-08-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Cognitive-behavior Therapy for MS-Related Chronic Pain|Cognitive-behavior Therapy for MS-Related Chronic Pain|Completed||N/A|26|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:34:17.49028|2017-02-18 16:34:17.49028
NCT00323258|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2013-01-11|2012-03-19||June 2006||2006-06-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|PILOT-EBM||Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease|PILOT-EBM: Patient Focused Intervention to Improve Long-term Adherence to Evidence Based Medications|Completed||N/A|143|Actual|Duke University||2|||f||||f||||||||||2017-02-18 16:34:18.024307|2017-02-18 16:34:18.024307
NCT00323245|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2011-04-12|||March 2006||2006-03-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Regaining Bladder Control in Postmenopausal Women With Osteoporosis|Regaining Urinary Continence in Postmenopausal Women With Osteoporosis: A Randomized Controlled Trial.|Completed||N/A|48|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:34:18.451451|2017-02-18 16:34:18.451451
NCT00323232|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2011-04-26|||December 2010||2010-12-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Comparison of Treatment Outcomes in Hip Fractures Surgically Fixed With Either a Two or Four Hole Device.|Two-Hole Versus Four-Hole Dynamic Hip Screw (DHS) for the Treatment of Intertrochanteric Fractures: A Prospective Randomized Trial|Completed||Phase 4|400|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:34:18.548925|2017-02-18 16:34:18.548925
NCT00323219|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2012-02-06|||January 2004||2004-01-01|February 2012|2012-02-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department|Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department|Unknown status|Recruiting|Phase 3|390|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:34:18.644026|2017-02-18 16:34:18.644026
NCT00323206|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2009-01-27|||June 2004||2004-06-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma|Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma|Completed||Phase 1|24|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||||f||||t||||||||||2017-02-18 16:34:18.741449|2017-02-18 16:34:18.741449
NCT00323193|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2014-10-06|2014-10-01||July 2006||2006-07-01|October 2014|2014-10-01|August 2011|Actual|2011-08-01|January 2010|Actual|2010-01-01||Interventional|||Using MOVE! With Seriously Mentally Ill Veterans|Using MOVE! With Seriously Mentally Ill Veterans|Completed||N/A|109|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:34:18.83018|2017-02-18 16:34:18.83018
NCT00323180|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-01-06|||August 2005||2005-08-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Investigation of Protein Biomarkers of Prostate Cancer|Investigation of Protein Biomarkers of Prostate Cancer|Completed||N/A|||University of New Mexico|||1||f||||t||||||||||2017-02-18 16:34:19.371493|2017-02-18 16:34:19.371493
NCT00005522|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||May 1998||1998-05-01|October 2005|2005-10-01|April 2004|Actual|2004-04-01|||||Observational|||Social Dominance, Gender, and Cardiovascular Reactivity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:49.247145|2017-02-18 18:14:49.247145
NCT00323167|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2016-03-07|||May 2006||2006-05-01|March 2016|2016-03-01|January 2019|Anticipated|2019-01-01|October 2012|Actual|2012-10-01||Observational|||Rare Genetic Disorders of the Breathing Airways|Rare Genetic Disorders of the Airways: Cross-sectional Comparison of Clinical Features, and Development of Novel Screening and Genetic Tests|Active, not recruiting||N/A|360|Anticipated|University of North Carolina, Chapel Hill|||1||f||||t||||||Samples With DNA|"~     Respiratory cultures, nasal samples, and blood samples~   "|||2017-02-18 16:34:19.464992|2017-02-18 16:34:19.464992
NCT00323154|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2008-09-24|||March 2004||2004-03-01|September 2008|2008-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Nalbuphine for the Treatment of Opioid Induced Pruritus in Children|Nalbuphine for the Treatment of Opioid Induced Pruritus in Children|Completed||Phase 3|134|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 16:34:19.654771|2017-02-18 16:34:19.654771
NCT00323141|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-07|2014-12-04|||March 2006||2006-03-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Intraperitoneal Mesh With 3cm Overlap Versus a Rives-Stoppa Repair With a 6cm Overlap in Hernia Umbilicalis|Prospective Randomized Trial to Study the Effectiveness of an Intraperitoneal Mesh With an Overlap of 3cm Versus a Rives-Stoppa Repair With an Overlap of 6cm With Patients With a Hernia Umbilicalis|Unknown status|Active, not recruiting|N/A|50|Anticipated|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 16:34:19.750168|2017-02-18 16:34:19.750168
NCT00323128|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2011-06-01|||May 2006||2006-05-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|April 2008|Actual|2008-04-01||Interventional|||Validation of Serum Creatinine Dosage and Renal Clearance|Validation of Serum Creatinine Dosage and Renal Clearance|Completed||Phase 1|30|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:34:19.850228|2017-02-18 16:34:19.850228
NCT00323115|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2015-10-08|2012-08-24||May 2006||2006-05-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|April 2008|Actual|2008-04-01||Interventional|||Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme|A Phase II Feasibility Study of Adjuvant Intra-Nodal Autologous Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|11|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-02-18 16:34:19.94389|2017-02-18 16:34:19.94389
NCT00323102|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2008-01-18|||May 2006||2006-05-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|||||Interventional|ENHANCE||A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain|Phase IV, Double-Blind, Multi-Center, Randomized, Cross-Over Study to Compare 0.10 Mmol/kg of MultiHance With 0.10 Omniscan in Magnetic Resonance Imaging (MRI) of the Brain|Completed||Phase 4|114||Bracco Diagnostics, Inc|||||f||||f||||||||||2017-02-18 16:34:20.372608|2017-02-18 16:34:20.372608
NCT00323089|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2012-09-05|||April 2003||2003-04-01|September 2012|2012-09-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Removal of Lung Nodules After Being Marked With a Microcoil|Thoracoscopic Resection of Subcentimetre Lung Nodules After Localization Using Percutaneous Inserted Platinum Microcoil Under CT Guidance: a Pilot Study|Unknown status|Recruiting|N/A|50|Anticipated|University of British Columbia||1|||f||||||||||||||2017-02-18 16:34:20.444138|2017-02-18 16:34:20.444138
NCT00323076|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2014-10-01|||September 2004||2004-09-01|January 2014|2014-01-01|April 2015|Anticipated|2015-04-01|April 2015|Anticipated|2015-04-01||Interventional|||Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours|A Phase I/II Imaging Study of 1-a-D-(5-deoxy-5-[18]F-fluoroarabinofuranosyl)-2-nitroimidazole ([18]F-FAZA) in Patients With Known Squamous Cell Carcinoma of the Head & Neck, Small Cell and Non-Small Cell Carcinoma of the Lung, Lymphoma, Glioblastoma Multiforme, Neuroendocrine Tumours or Renal Cell Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|160|Anticipated|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 16:34:20.544741|2017-02-18 16:34:20.544741
NCT00323063|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-08|2017-02-02|||May 1, 2006|Actual|2006-05-01|February 2017|2017-02-01|June 20, 2016|Actual|2016-06-20|June 20, 2016|Actual|2016-06-20||Interventional|||Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer|Randomized Phase II Trial of Gemcitabine and Imatinib Mesylate Versus Gemcitabine Alone in Patients With Previously Treated Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|49|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 16:34:20.656931|2017-02-18 16:34:20.656931
NCT00323050|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2016-09-15|||November 2004||2004-11-01|September 2016|2016-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects|Evaluate Immunogenicity,Safety & Reactogenicity of a Booster Dose of Hib-MenC Conjugate Vaccine When Given to Healthy Subjects Aged 13-14 Months Who Were Primed With 3 Doses of Hib-MenC vs a Booster Dose of Infanrix Hexa Given to Subjects Primed With 3 Doses of Infanrix Hexa and Meningitec|Completed||Phase 3|468|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:34:20.776339|2017-02-18 16:34:20.776339
NCT00323037|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2016-02-26|2009-01-16||March 2006||2006-03-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|COMPARE||A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure|A Multicenter,Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects With Stable Chronic Heart Failure|Completed||Phase 3|318|Actual|CTI-1, LLC||2|||f||||f||||||||||2017-02-18 16:34:20.888267|2017-02-18 16:34:20.888267
NCT00323024|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2007-08-29|||September 2006||2006-09-01|July 2006|2006-07-01|May 2007||2007-05-01|||||Interventional|||Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension|An Open-Label, Dose-Determination Safety, Tolerability, and Activity Study of Inhaled NX1011 in Patients With Pulmonary Arterial Hypertension|Withdrawn||Phase 2|72||NITROX, LLC|||||||||||||||||||2017-02-18 16:34:21.297793|2017-02-18 16:34:21.297793
NCT00323011|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2014-05-20|||May 2006||2006-05-01|May 2014|2014-05-01|November 2007|Actual|2007-11-01|||||Interventional|||FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer|A Randomized Pilot Study of the Activation of the Hemostatic Pathway by FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer|Terminated||Phase 2|5|Actual|University of Southern California||3||drug not available|f||||||||||||||2017-02-18 16:34:21.390059|2017-02-18 16:34:21.390059
NCT00322985|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2016-03-14|||June 2006||2006-06-01|March 2016|2016-03-01|July 2014|Actual|2014-07-01|May 2014|Actual|2014-05-01||Interventional|||A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma|A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma|Completed||Phase 2|40|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 16:34:21.487754|2017-02-18 16:34:21.487754
NCT00322946|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2009-08-05|||January 2007||2007-01-01|November 2008|2008-11-01||||August 2009|Actual|2009-08-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of rDEN4delta30-4995, a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 4|Completed||Phase 1|84|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 16:34:21.792355|2017-02-18 16:34:21.792355
NCT00322933|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2006-10-25|||April 2001||2001-04-01|April 2005|2005-04-01|March 2005||2005-03-01|||||Observational|||Intermittent Versus Continuous Renal Replacement Therapy for Acute Renal Failure|Multicentre Randomised Trial of Intermittent Versus Continuous Renal Replacement Therapy for Acute Renal Failure|Terminated||N/A|1628||Ziekenhuis Netwerk Antwerpen (ZNA)|||||f||||||||||||||2017-02-18 16:34:21.902719|2017-02-18 16:34:21.902719
NCT00322920|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2008-02-13|||July 2005||2005-07-01|February 2008|2008-02-01||||||||Interventional|||Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer|A Phase I Study of Weekly Topotecan With Cisplatin for the Management of Advanced Stage or Recurrent Carcinoma of the Cervix|Terminated||Phase 1|30|Anticipated|University of Alabama at Birmingham||||Low accrual|f||||||||||||||2017-02-18 16:34:21.990366|2017-02-18 16:34:21.990366
NCT00322907|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2006-05-05|||April 2000||2000-04-01|October 1999|1999-10-01|January 2003||2003-01-01|||||Interventional|||Cotrifazid Safety and Efficacy Against Malaria|A Randomised Safety and Efficacy Trial of Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine+SP Against Resistant Malaria in Papua New Guinea|Terminated||Phase 2|330||Policlinique Médicale Universitaire|||||f||||||||||||||2017-02-18 16:34:22.084518|2017-02-18 16:34:22.084518
NCT00322894|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2016-06-07|||February 2006||2006-02-01|June 2016|2016-06-01|October 2017|Anticipated|2017-10-01|October 2016|Anticipated|2016-10-01|20 Years|Observational [Patient Registry]|||Expanded Breast Cancer Registry and Tissue Repository|Expanded Breast Cancer Registry and Tissue Repository|Recruiting||N/A|500|Anticipated|New Mexico Cancer Care Alliance|||1||f||||t||||||Samples With DNA|"~     Sample of tumor, buccal cells and blood collected at the time of study enrollment.~   "|No||2017-02-18 16:34:22.194707|2017-02-18 16:34:22.194707
NCT00322881|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2016-03-29|2015-01-06||April 2006||2006-04-01|December 2015|2015-12-01|April 2010|Actual|2010-04-01|April 2008|Actual|2008-04-01||Interventional|||Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer|A Phase II Study of Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer|Terminated||Phase 2|12|Actual|Dana-Farber Cancer Institute|This study terminated early due to 3 deaths on study and consequently results are limited.|1||Early closure based on audit by study investigators after 3 patients died on study.|f||||t||||||||||2017-02-18 16:34:22.312552|2017-02-18 16:34:22.312552
NCT00322868|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2007-09-20|||April 2006||2006-04-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety and Efficacy of Pioglitazone as an Anti-Inflammatory for the Treatment of CF Lung Disease|A Pilot Study Assessing the Safety and Efficacy of Pioglitazone as an Anti-Inflammatory Agent for the Treatment of CF Lung Disease in Patients With Cystic Fibrosis|Completed||N/A|20|Anticipated|University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-02-18 16:34:22.603172|2017-02-18 16:34:22.603172
NCT00322855|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2015-07-10|2015-06-16||August 2005||2005-08-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Observational|||Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma|Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma|Terminated||N/A|1|Actual|New Mexico Cancer Care Alliance|||1|Low accrual|f||||t||||||||||2017-02-18 16:34:22.706469|2017-02-18 16:34:22.706469
NCT00322842|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2014-02-10|2010-10-30||September 2004||2004-09-01|February 2014|2014-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients|Treatment With AMD3100 in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF|Completed||Phase 2|35|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:34:22.887339|2017-02-18 16:34:22.887339
NCT00322829|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2008-09-18|||May 2006||2006-05-01|September 2008|2008-09-01|February 2009|Anticipated|2009-02-01|||||Observational|||Development and Optimization of a GBS Diagnostic Test|Development and Optimization of a GBS Micro Total Analysis System (µTAS) Prototype for the Direct Detection of Group B Streptococci in Vaginal/Anal Specimens From Intrapartum Maternity Patients|Suspended||N/A|320|Anticipated|Laval University|||1|Temporarily suspended in between validating test systems.|f||||t||||||Samples With DNA|"~     Vaginal/anal swab samples taken from pregnant women admitted for delivery to the Centre~     Hospitalier Universitaire de Québec (CHUQ).~   "|||2017-02-18 16:34:23.572477|2017-02-18 16:34:23.572477
NCT00322816|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2010-08-26|||June 2006||2006-06-01|February 2008|2008-02-01|January 2007||2007-01-01|||||Observational|||Malaria Prevalence in Children|Malaria Prevalence, Incidence and Mortality in Children|Unknown status|Recruiting|N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:34:23.654871|2017-02-18 16:34:23.654871
NCT00322803|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2006-09-27|||May 2006||2006-05-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Interventional|||ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment|International, Multicenter, Randomized, Double-Blind, Placebo Controlled, Two-Period, Cross-Over Study to Demonstrate Safety, Tolerability and Anxiolytic Effects of 600 mg ELB139 Given Orally t.i.d. to Patients With Concurrent Panic Disorder, Challenged by Inhalation of 35% CO2 After a Single Dose and One Week of Treatment|Terminated||Phase 2|24||elbion AG|||||f||||||||||||||2017-02-18 16:34:23.726741|2017-02-18 16:34:23.726741
NCT00321399|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-07-15|||June 2006||2006-06-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|March 2010|Actual|2010-03-01||Observational|SPARC||Study of Perfusion and Anatomy's Role in Coronary Artery (CAD)|SPARC, Including Its Pilot CT Angiographic Study, is a Prospective, Open-label, Multicenter, Sequentially Sampled, Observational Registry to Define the Clinical Value of Stress Perfusion (Stress SPECT, Stress PET), Noninvasive Angiography (CTA) and Combined Perfusion-anatomy (PET/CT) Studies in Patients With Known or Suspected CAD With Respect to Post-test Resource Utilization and Prediction of Cardiac Death and Non-fatal Myocardial Infarction|Completed||N/A|3019|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 16:34:23.995968|2017-02-18 16:34:23.995968
NCT00322712|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2015-03-02|2015-02-11||September 2006||2006-09-01|February 2015|2015-02-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Observational|||INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer|INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer|Completed||N/A|12|Actual|University of New Mexico|||1||f||||t||||||||||2017-02-18 16:34:27.076177|2017-02-18 16:34:27.076177
NCT00321386|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2011-06-27|||December 2003||2003-12-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|December 2008|Actual|2008-12-01||Observational|||Analysis of Clinical Profiles of Chinese Patients With Normal Tension Glaucoma|Parameters for Disease Progression in Chinese Patients With Normal Tension Glaucoma|Unknown status|Recruiting|N/A|500|Anticipated|Chinese University of Hong Kong|||1||f||||t||||||Samples With DNA|"~     Blood taking for glaucoma genetics analysis shall be performed.~   "|||2017-02-18 16:34:24.128487|2017-02-18 16:34:24.128487
NCT00321373|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-09-23|2013-03-14||May 2006||2006-05-01|September 2016|2016-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study to Evaluate an Influenza Vaccine Candidate|A Study to Demonstrate the Non-Inferiority of Influenza Vaccine Candidate, Compared With Fluarix™ Administered Intramuscularly in Elderly Aged 60 Years Old and Above|Completed||Phase 2|1220|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:34:24.241196|2017-02-18 16:34:24.241196
NCT00321360|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2012-02-04|||May 2006||2006-05-01|February 2012|2012-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol in Healthy Volunteers|Reaction Time Monitored Patient Maintained Propofol Sedation: a Volunteer Safety Study|Completed||Phase 4|20|Anticipated|University of Glasgow|||||f||||t||||||||||2017-02-18 16:34:25.095436|2017-02-18 16:34:25.095436
NCT00321347|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2012-06-21|||May 2006||2006-05-01|June 2012|2012-06-01|May 2009|Anticipated|2009-05-01|||||Interventional|||Intravenous (IV) Lidocaine for Opioid-refractory Pain|A Randomized, Placebo Controlled Phase II Study of Parenteral Lidocaine's Ability To Acutely Relieve Opioid Refractory Pain|Withdrawn||Phase 2|0|Actual|San Diego Hospice & Palliative Care||||No patients enrolled and clinician no longer at institution.|f||||t||||||||||2017-02-18 16:34:25.204066|2017-02-18 16:34:25.204066
NCT00321334|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-08-04|||March 2006||2006-03-01|August 2014|2014-08-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC|Survival Study of Neo-adjuvant Versus Adjuvant Chemotherapy With Docetaxel Combined Carboplatin in Resectable Stage IB to IIIA Non-small Lung Cancer|Completed||Phase 3|410|Actual|Chinese Society of Lung Cancer||1|||f||||t||||||||||2017-02-18 16:34:25.298493|2017-02-18 16:34:25.298493
NCT00321321|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2015-06-23|2008-09-29||May 2006||2006-05-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes|Phase 2 Study of The Beta Cell Responsiveness to GIP With and Without Sulfonylurea in Patients With Type 2 Diabetes|Completed||Phase 2|12|Actual|University Hospital, Gentofte, Copenhagen||1|||f||||t||||||||||2017-02-18 16:34:25.407049|2017-02-18 16:34:25.407049
NCT00321308|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2009-09-24||2009-09-24|September 2006||2006-09-01|September 2009|2009-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer|A Randomized Phase II Trial Of Pemetrexed With Or Without PF-3512676 For The Treatment Of Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer After Failure Of One Prior Chemotherapy Regimen For Advanced Disease|Terminated||Phase 2|36|Actual|Pfizer||2||See Termination Reason in Detailed Description.|f||||f||||||||||2017-02-18 16:34:25.623448|2017-02-18 16:34:25.623448
NCT00321295|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2011-04-02|||August 2004||2004-08-01|April 2011|2011-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Biventricular Pacing In Patients With Left Ventricular Dysfunction After Cardiovascular Surgery|Prospective Evaluation Of Biventricular Pacing In Patients With Left Ventricular Dysfunction After Cardiovascular Surgery|Completed||Phase 3|40||William Beaumont Hospitals|||||f||||||||||||||2017-02-18 16:34:25.760045|2017-02-18 16:34:25.760045
NCT00321282|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2013-09-26|||February 2006||2006-02-01|September 2013|2013-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Retrospective Analysis of the Predictive Potential of Pre-operative|A Retrospective Analysis of the Predictive Potential of Pre-operative Data on Post-operative Atrial Fibrillation|Terminated||Phase 2|600|Anticipated|Emory University||||The study never started.|f||||f||||||||||2017-02-18 16:34:25.86772|2017-02-18 16:34:25.86772
NCT00322790|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2015-04-02|||January 2006||2006-01-01|March 2015|2015-03-01|September 2013|Actual|2013-09-01|January 2010|Anticipated|2010-01-01||Observational|||Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study|INST 0549C Differences in 30-year Trends in Incidence and Survival for Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study|Withdrawn||N/A|0|Actual|New Mexico Cancer Care Alliance|||1||f||||t||||||||||2017-02-18 16:34:25.951488|2017-02-18 16:34:25.951488
NCT00322777|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2016-02-04|2015-06-17||January 2005||2005-01-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2006|Actual|2006-12-01||Interventional|||Spirituality Teaching Program for Depressed Adults|A Spirituality Teaching Program for Depression in Adults: A Randomized Controlled Trial|Completed||N/A|84|Actual|Canadian Institute of Natural and Integrative Medicine||2|||f||||f||||||||No||2017-02-18 16:34:26.03098|2017-02-18 16:34:26.03098
NCT00322764|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2007-11-08|||March 2006||2006-03-01|November 2007|2007-11-01||||||||Interventional|||Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression|Dose-Escalating, Phase II Study to Assess the Safety and Tolerability of RG2417 in the Treatment of Bipolar I Depression|Completed||Phase 2|80|Anticipated|Repligen Corporation|||||||||||||||||||2017-02-18 16:34:26.738391|2017-02-18 16:34:26.738391
NCT00322751|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-01-06|||April 2006||2006-04-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer|Phase I Study of Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer (NSCLC) (Stage I to IIIA)|Completed||Phase 1|10|Anticipated|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:34:26.827132|2017-02-18 16:34:26.827132
NCT00322738|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2010-08-26|||June 2006||2006-06-01|February 2008|2008-02-01|January 2007||2007-01-01|||||Observational|||Time to Infection With Malaria Parasites|Time to Infection With Malaria Parasites in Adults|Unknown status|Recruiting|N/A|552||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:34:26.917487|2017-02-18 16:34:26.917487
NCT00322725|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2016-02-24|||February 2006||2006-02-01|February 2016|2016-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review|Bevacizumab(Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review|Completed||N/A|25|Actual|University of New Mexico|||1||f||||t||||||||||2017-02-18 16:34:26.992519|2017-02-18 16:34:26.992519
NCT00322699|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2012-10-25|||February 2005||2005-02-01|August 2011|2011-08-01|March 2011|Actual|2011-03-01|April 2010|Actual|2010-04-01||Interventional|||Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer|Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer|Completed||Phase 1/Phase 2|22|Actual|North Florida/South Georgia Veterans Health System||1|||f||||t||||||||||2017-02-18 16:34:27.293022|2017-02-18 16:34:27.293022
NCT00322686|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2012-03-16|||May 2006||2006-05-01|March 2012|2012-03-01||||December 2006|Actual|2006-12-01||Interventional|||Study of Oglemilast for the Treatment of Asthma|Efficacy and Safety of Oglemilast in the Prevention of Allergen-induced Bronchospasm|Completed||Phase 2|6|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 16:34:27.405258|2017-02-18 16:34:27.405258
NCT00322673|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2010-02-18|||May 2006||2006-05-01|February 2010|2010-02-01|May 2007|Actual|2007-05-01|November 2006|Actual|2006-11-01||Interventional|||Study of XL999 in Patients With Acute Myeloid Leukemia (AML)|A Phase 2 Study of XL999 Administered Intravenously to Subjects With Acute Myeloid Leukemia|Terminated||Phase 2|14|Actual|Symphony Evolution, Inc.||1||Study was terminated due to cardiac toxicities|f||||t||||||||||2017-02-18 16:34:27.497325|2017-02-18 16:34:27.497325
NCT00322660|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2007-06-27|||June 2006||2006-06-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Adrenaline Injections to Children Born at Elective CS|Can the Risk of RD and Hypoglycemia in Children Born at Elective CS be Reduced by Injection of Adrenaline|Completed||N/A|270|Actual|Hvidovre University Hospital|||||f||||t||||||||||2017-02-18 16:34:27.586643|2017-02-18 16:34:27.586643
NCT00322647|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2010-01-06|||January 2005||2005-01-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|||||Observational|||Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting|Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting|Completed||N/A|20|Actual|University of New Mexico|||1||f||||t||||||||||2017-02-18 16:34:27.674881|2017-02-18 16:34:27.674881
NCT00322634|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2012-09-17|||February 2006||2006-02-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors|Investigator Initiated Trial: Prospective Study of Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors|Completed||N/A|25|Actual|New Mexico Cancer Care Alliance|||1||f||||t||||||||||2017-02-18 16:34:30.451661|2017-02-18 16:34:30.451661
NCT00322621|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2011-02-03|2008-10-30||April 2006||2006-04-01|February 2011|2011-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)|Maintenance of Effect of Duloxetine 60 mg Once Daily in Patients With Diabetic Peripheral Neuropathic Pain|Completed||Phase 4|216|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 16:34:30.557734|2017-02-18 16:34:30.557734
NCT00322608|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2011-01-06|||April 2006||2006-04-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or Lymphoma|Phase I Study of the Vascular Disrupting Agent NPI-2358 Administered Via Intravenous Infusion in Patients With Advanced Solid Tumor Malignancies or Lymphoma|Completed||Phase 1|35|Anticipated|Nereus Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 16:34:32.057694|2017-02-18 16:34:32.057694
NCT00322595|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2008-12-18|||May 2006||2006-05-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|SILVER||Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder|An International, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Controlled Study of the Efficacy and Safety of Sustained-Release Quetiapine Fumarate (Seroquel SR™ ) in the Treatment of Generalized Anxiety Disorder (SILVER)|Completed||Phase 3|800|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:34:32.153112|2017-02-18 16:34:32.153112
NCT00322582|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2012-01-24|||May 2007||2007-05-01|January 2007|2007-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||The Genetic Basis for Familial Cardiomyopathy in Patients With Idiopathic Cardiomyopathy|Open Labeled of the Study the Genetic Basis for Familial Cardiomyopathy in Patients With Idiopathic|Terminated||N/A|41|Actual|Carmel Medical Center|||1|no financial resources were available to complete the study|f||||||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 16:34:32.330289|2017-02-18 16:34:32.330289
NCT00322569|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2013-03-05|||July 2006||2006-07-01|March 2013|2013-03-01|May 2012|Actual|2012-05-01|October 2007|Actual|2007-10-01||Interventional|||A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)|A Randomized, Multi-Center Study of the Pimecrolimus-Eluting (Corio™) and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System (SymBio™) in Patients With De Novo Lesions of the Native Coronary Arteries|Completed||Phase 3|246|Actual|Cordis Corporation||3|||f||||t||||||||||2017-02-18 16:34:32.667584|2017-02-18 16:34:32.667584
NCT00322556|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2012-09-27|2012-09-27||November 2005||2005-11-01|September 2012|2012-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)|A Multicenter Extension Study on the Safety and Efficacy of IgPro10 in Patients With Primary Immunodeficiency (PID)|Completed||Phase 3|55|Actual|CSL Behring||1|||f||||||||||||||2017-02-18 16:34:32.793134|2017-02-18 16:34:32.793134
NCT00322543|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2008-10-16|||May 2006||2006-05-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|November 2006|Actual|2006-11-01||Interventional|||Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)|Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID) A Multi-Center Study of the Pimecrolimus-Eluting Cobalt Chromium Coronary Stent System (Corio™) in Patients With De Novo Lesions of the Native Coronary Arteries|Terminated||Phase 3|3|Actual|Conor Medsystems||1|||f||||f||||||||||2017-02-18 16:34:33.269167|2017-02-18 16:34:33.269167
NCT00322530|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2012-08-23|||April 2006||2006-04-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|rescue||Comparison of Dialysis Strategies in Critically Ill Patients With Acute Renal Failure|Comparison of Dialysis Strategies in Critically Ill Patients With Acute Renal Failure on the Intensive Care Unit|Completed||N/A|230|Actual|Heidelberg University||2|||f||||f||||||||||2017-02-18 16:34:33.376403|2017-02-18 16:34:33.376403
NCT00322517|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2011-05-10||2009-05-09|April 2006||2006-04-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|June 2008|Actual|2008-06-01||Interventional|||Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer|A Phase 2 Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer|Completed||Phase 2|90|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:34:33.485453|2017-02-18 16:34:33.485453
NCT00322491|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2014-02-10|2010-10-30||March 2004||2004-03-01|February 2014|2014-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients|Treatment With AMD3100 in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients to Increase the Number of Peripheral Blood Stem Cells When Given a Mobilizing Regimen of G-CSF|Completed||Phase 2|49|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:34:33.696081|2017-02-18 16:34:33.696081
NCT00322478|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2015-10-30|||April 2006||2006-04-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Interventional|||Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes|Non-Significant Risk Investigational Device Study of the Wireless GlucoMON™ Glucose Meter Accessory and Real-time Blood Glucose Alerts as an Enabling Technology for People Who Team Manage Diabetes|Completed||Phase 2/Phase 3|432|Actual|Diabetech||1|||f||||t||||||||||2017-02-18 16:34:34.437366|2017-02-18 16:34:34.437366
NCT00322465|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2014-11-13|2010-06-17||November 2006||2006-11-01|May 2011|2011-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)|Phase II Randomized, Placebo-Controlled Double-Blind 4-Arm Trial for the Treatment of Non-Gonococcal Urethritis (NGU): Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)|Completed||Phase 2|305|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:34:34.5507|2017-02-18 16:34:34.5507
NCT00322452|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2013-10-14|2009-04-29||March 2006||2006-03-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|April 2008|Actual|2008-04-01||Interventional|IPASS||First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia|Open Label, Randomised, Parallel Group, Multicentre, Ph III Study To Assess Efficacy, Safety & Tolerability Of Gefitinib (IRESSA™) Versus Carboplatin/Paclitaxel DC As 1st-Line Treatment In Selected Patients With Stage IIIB / IV NSCLC In Asia|Completed||Phase 3|1329|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:34:35.884277|2017-02-18 16:34:35.884277
NCT00322439|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-05|2016-02-19|2014-02-11||May 2006||2006-05-01|February 2016|2016-02-01|February 2013|Actual|2013-02-01|December 2012|Actual|2012-12-01|5 Years|Observational [Patient Registry]||Full Analysis Set, which consisted of all participants who received at least one dose of etanercept during the study.|Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis|Observational Post-Marketing Safety Surveillance Registry of Enbrel (Etanercept) for Treatment of Psoriasis|Completed||N/A|2511|Actual|Amgen|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, plasma.~   "|||2017-02-18 16:34:37.117008|2017-02-18 16:34:37.117008
NCT00322426|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2006-06-22|||July 2006||2006-07-01|May 2006|2006-05-01|January 2007||2007-01-01|||||Interventional|||Sensory Cues for Freezing in Parkinson's Disease|Effect of Randomized Patient-Triggered Sensory Cues for Freezing of Gait in Parkinson's Disease|Unknown status|Not yet recruiting|N/A|20||Austin Health|||||f||||||||||||||2017-02-18 16:34:38.196348|2017-02-18 16:34:38.196348
NCT00322413|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2006-07-20|||January 1997||1997-01-01|May 2006|2006-05-01|April 1997||1997-04-01|||||Interventional|||Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial|Efficacy and Safety of Epoetin Omega in Patients Undergoing Regular Dialysis. Part II: Comparative Trial Versus Epoetin Alfa|Completed||Phase 3|80||General Hospital Sveti Duh|||||f||||||||||||||2017-02-18 16:34:38.286022|2017-02-18 16:34:38.286022
NCT00322400|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2013-07-30|||March 2006||2006-03-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|April 2009|Actual|2009-04-01||Interventional|||Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer|An Open-label, Dose-finding Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 1|46|Actual|Amgen||9|||f||||f||||||||||2017-02-18 16:34:38.381899|2017-02-18 16:34:38.381899
NCT00322387|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2014-02-10|2010-06-15||April 2004||2004-04-01|February 2014|2014-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients|Treatment With Plerixafor in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given With A Mobilizing Regimen of Chemotherapy and G-CSF|Completed||Phase 2|40|Actual|Sanofi|The number and complexity of the cohorts make generalizations regarding the data problematic. Each cohort was small, and mobilizing and high-dose conditioning regimens varied across sites. AEs may include residual effects of chemotherapy.|4|||f||||t||||||||||2017-02-18 16:34:38.51038|2017-02-18 16:34:38.51038
NCT00322374|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2016-02-09|2010-07-06||August 2006||2006-08-01|February 2016|2016-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Phase I Combination w/ Epirubicin|A Phase I Study of Ixabepilone in Combination With Epirubicin in Patients With Metastatic Breast Cancer|Completed||Phase 1|42|Actual|R-Pharm||3|||f||||f||||||||||2017-02-18 16:34:39.703941|2017-02-18 16:34:39.703941
NCT00322361|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2016-05-13|||May 2006||2006-05-01|May 2016|2016-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)|A Study in Healthy Neonates of Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured Using a Modified Process|Completed||Phase 2|566|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:34:40.738249|2017-02-18 16:34:40.738249
NCT00322348|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2010-12-22|2010-11-11||April 2006||2006-04-01|December 2010|2010-12-01|November 2009|Actual|2009-11-01|||||Interventional|||Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women|An Open-label, Randomised, Parallel Group, Multicentre Study to Compare ZOLADEX 10.8 mg Given Every 12 Weeks With ZOLADEX 3.6 mg Given Every 4 Weeks in Pre-menopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer|Completed||Phase 2|98|Actual|AstraZeneca|The criteria for non-inferiority were not met for the primary efficacy endpoint (PFS at Week 24). However, since recruitment was terminated prematurely, the study was no longer adequately powered to detect non-inferiority.|2|||f||||||||||||||2017-02-18 16:34:40.835045|2017-02-18 16:34:40.835045
NCT00322335|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2016-09-23|2010-09-17||May 2006||2006-05-01|September 2016|2016-09-01|September 2010|Actual|2010-09-01|July 2006|Actual|2006-07-01||Interventional|||Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC|Phase III, Open, Multicenter Study to Assess the Long-Term Persistence of a Booster Dose of GSK Biologicals' Hib-MenC Compared to a Booster Dose of Infanrix™ Hexa When Given to 14 Month-old Subjects Primed in Study DTPa-HBV-IPV-097 & Boosted in Study Hib-MenC-TT-010 BST: DTPa-HBV-IPV-097|Completed||Phase 3|230|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:34:41.588579|2017-02-18 16:34:41.588579
NCT00322322|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2011-05-03|||June 2006||2006-06-01|March 2007|2007-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Early Administration of L-carnitine in Hemodialysis Patients|Early Administration of L-carnitine in Hemodialysis Patients: Double Blind Randomized Trial Versus Placebo|Completed||Phase 3|110|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:34:42.352891|2017-02-18 16:34:42.352891
NCT00322309|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2010-08-30|||September 2005||2005-09-01|August 2010|2010-08-01|September 2010|Anticipated|2010-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects|The Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects|Unknown status|Active, not recruiting|Phase 2|64|Anticipated|Boston University||1|||f||||t||||||||||2017-02-18 16:34:42.459853|2017-02-18 16:34:42.459853
NCT00322296|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2013-04-15|||April 2001||2001-04-01|May 2006|2006-05-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis|A Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis: a Topical Chemoprevention Strategy for Cutaneous T-cell Lymphoma.|Terminated||Phase 2|8|Actual|Fox Chase Cancer Center||||The response rate (5/8) had reached a statistical significant endpoint.|||||||||||||||2017-02-18 16:34:42.572355|2017-02-18 16:34:42.572355
NCT00322283|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2012-04-07|||May 2006||2006-05-01|April 2012|2012-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of Oglemilast for the Prevention of Asthma.|Efficacy and Safety of Oglemilast in the Prevention of Exercise-Induced Bronchospasm|Completed||Phase 2|24|Actual|Forest Laboratories||2|||f||||||||||||||2017-02-18 16:34:42.664429|2017-02-18 16:34:42.664429
NCT00322270|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2008-08-12|||January 2006||2006-01-01|August 2008|2008-08-01||||||||Interventional|||Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters|Phase 3, Multicenter, Multinational, Open-Label Study to Evaluate the Safety and Efficacy of Alfimeprase in Subjects With Occluded Central Venous Access Devices (SONOMA-3)|Completed||Phase 3|||ARCA Biopharma, Inc.|||||f||||f||||||||||2017-02-18 16:34:42.764299|2017-02-18 16:34:42.764299
NCT00322257|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2012-07-09||2009-11-09|May 2006||2006-05-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes|Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy|Terminated||Phase 3|596|Actual|Novo Nordisk A/S||2||See termination reason in detailed description|f||||f||||||||||2017-02-18 16:34:42.879652|2017-02-18 16:34:42.879652
NCT00322244|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2011-01-31|||January 2003||2003-01-01|January 2011|2011-01-01|October 2003||2003-10-01|||||Interventional|||Massage Therapy for Osteoarthritis of the Knee|Massage Therapy for Osteoarthritis of the Knee|Completed||N/A|66||Rutgers, The State University of New Jersey|||||f||||||||||||||2017-02-18 16:34:43.080728|2017-02-18 16:34:43.080728
NCT00322231|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2015-01-14|2010-05-12||May 2006||2006-05-01|January 2015|2015-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)|A Phase III Clinical Trial to Study the Safety, Tolerability and Immunogenicity of Zoster Vaccine Live in Subjects With a History of Herpes Zoster|Completed||Phase 3|101|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:34:43.181588|2017-02-18 16:34:43.181588
NCT00322218|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2008-10-22|||May 2006||2006-05-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study Comparing the Zevalin Regimen With no Further Treatment in DLBCL Patients Who Are in Complete Remission After CHOP-R|A Phase III, Open-Label, Prospective, Two-Armed, Multicenter, Randomized, Group Sequential Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study Regimen Versus Observation in Patients With Diffuse Large B-Cell Lymphoma Who Are in Complete Remission After First-Line CHOP-Rituximab (CHOP-R) Therapy|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|CTI BioPharma||2|||f||||||||||||||2017-02-18 16:34:43.734389|2017-02-18 16:34:43.734389
NCT00322205|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2017-01-10|||June 1999||1999-06-01|May 2006|2006-05-01|March 2002||2002-03-01|||||Interventional|||Bio-behavioral Lung Cancer Prevention Program|Bio-behavioral Lung Cancer Prevention Program|Completed||Phase 4|555||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:34:43.92868|2017-02-18 16:34:43.92868
NCT00322192|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2015-06-08|||January 2004||2004-01-01|May 2006|2006-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Evaluation of Whether Functional Strength Training Can Enhance Recovery of Mobility After Stroke|The Effects of Functional Strength Training on Weakness and Function of the Lower Limb After Stroke|Completed||Phase 2|300|Anticipated|St George's, University of London|||||f||||||||||||||2017-02-18 16:34:44.013712|2017-02-18 16:34:44.013712
NCT00322179|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2015-03-04|||November 2005||2005-11-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2007|Actual|2007-11-01||Observational|||Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C|Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C|Completed||N/A|22|Actual|Palo Alto Veterans Institute for Research|||2||f||||||||||||||2017-02-18 16:34:44.106762|2017-02-18 16:34:44.106762
NCT00322166|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2009-10-20|||July 2006||2006-07-01|October 2009|2009-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||The FREEDOM Study: a Randomised Controlled Trial of Sunlight and Calcium in Older People|A Randomised Controlled Trial of Sunlight and Calcium Supplementation to Reduce Vitamin D Deficiency and Falls in Older People in Residential Care|Completed||N/A|600|Anticipated|University of Sydney||3|||f||||f||||||||||2017-02-18 16:34:44.374123|2017-02-18 16:34:44.374123
NCT00322153|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2010-08-25|2010-07-20||June 2005||2005-06-01|August 2010|2010-08-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Patients With Moderate-to-Severe Dementia of the Alzheimer's Type|Completed||Phase 3|677|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 16:34:44.495842|2017-02-18 16:34:44.495842
NCT00322140|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2017-01-24|||May 1, 2006||2006-05-01|August 25, 2011|2011-08-25|January 14, 2008|Actual|2008-01-14|January 14, 2008|Actual|2008-01-14||Interventional|||CDDO to Treat Solid Tumors and Lymphomas|Phase I Study of CDDO in Solid Tumors and Lymphomas|Completed||Phase 1|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:34:45.231668|2017-02-18 16:34:45.231668
NCT00322127|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-04|2017-01-26|||May 2, 2006||2006-05-02|January 24, 2017|2017-01-24|January 23, 2015|Actual|2015-01-23|January 23, 2015|Actual|2015-01-23||Interventional|||An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers|A Pilot Study of the Safety and Activity of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers|Completed||Phase 1|44|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:34:45.322118|2017-02-18 16:34:45.322118
NCT00322114|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2013-09-19|||February 2006||2006-02-01|July 2009|2009-07-01||||February 2009|Anticipated|2009-02-01||Interventional|||Lycopene in Preventing Prostate Cancer in Healthy Participants|Mechanism of Prostate Cancer Prevention by Lycopene|Unknown status|Recruiting|N/A|150|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 16:34:45.416847|2017-02-18 16:34:45.416847
NCT00322101|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2014-10-23|2013-04-04||January 2006||2006-01-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|April 2012|Actual|2012-04-01||Interventional|||Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia|A Multi-center Phase III Study Comparing Myeloablative to Nonmyeloablative Transplant Conditioning in Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia|Completed||Phase 3|25|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 16:34:45.523773|2017-02-18 16:34:45.523773
NCT00322075|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2007-09-11|||April 2006||2006-04-01|September 2007|2007-09-01|November 2006||2006-11-01|||||Interventional|||LANCGMS - Lantus Continuous Glucose Monitoring Subcutaneous|Comparison of Glycaemic Fluctuations During 3 Days Subcutaneous Continuous Monitoring in Patients With Basal Substitution Human Insulin NPH vs Insuline Glargine|Completed||Phase 4|35||Sanofi|||||f||||||||||||||2017-02-18 16:34:46.088272|2017-02-18 16:34:46.088272
NCT00322062|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2008-04-15|||April 2002||2002-04-01|April 2008|2008-04-01|March 2003||2003-03-01|||||Interventional|||MOVIPREP® Versus NaP Pivotal Phase III Study|A Prospective Randomised Single-Blinded Multicentric and Pivotal Phase III Study Comparing the Efficacy, Safety and Acceptability of a New 2 Litres Gut Lavage Solution NRL994 Versus a Sodium Phosphate Solution for Colonoscopy Preparation|Completed||Phase 3|340|Actual|Norgine||2|||f||||f||||||||||2017-02-18 16:34:46.18621|2017-02-18 16:34:46.18621
NCT00322049|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2017-02-16||2017-02-16|February 2004||2004-02-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants|A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants|Completed||Phase 1/Phase 2|49|Actual|U.S. Army Medical Research and Materiel Command||3|||f||||t||||||||Yes|GSK|2017-02-18 16:34:46.324838|2017-02-18 16:34:46.324838
NCT00322036|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2008-08-01|||May 2006||2006-05-01|August 2008|2008-08-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's|Phase 3 Multinational, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment With MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subjects With Mild Dementia of the Alzheimer's Type|Terminated||Phase 3|800|Actual|Myrexis Inc.||2||Myriad has discontinued the development of Flurizan.|f||||t||||||||||2017-02-18 16:34:46.43977|2017-02-18 16:34:46.43977
NCT00322023|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2008-10-27|||March 2006||2006-03-01|October 2008|2008-10-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Safety and Effectiveness of D-Serine in Schizophrenia|PK/PD Study of Escalating Dose D-Serine as Adjunctive Treatment in Schizophrenia|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Institute of Mental Health (NIMH)||1|||f||||t||||||||||2017-02-18 16:34:46.633753|2017-02-18 16:34:46.633753
NCT00322010|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2014-03-17|||June 2005||2005-06-01|March 2014|2014-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Early Directed Physical Therapy in the Management of Mechanically Ventilated Patients in a Medical Intensive Care Unit|A Randomized Trial of Early Physical and Occupational Therapy in Mechanically Ventilated, Critically Ill Patients|Completed||Phase 2|104|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 16:34:46.743568|2017-02-18 16:34:46.743568
NCT00321997|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2006-05-02|||May 2001||2001-05-01|May 2006|2006-05-01|October 2007||2007-10-01|||||Interventional|||A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.|A PHASE II/III RANDOMIZED, DOUBLE-MASKED, CONTROLLED, DOSE-RANGING, MULTI-CENTER COMPARATIVE TRIAL, IN PARALLEL GROUPS, TO ESTABLISH THE SAFETY AND EFFICACY OF INTRAVITREAL INJECTIONS OF EYE001 (ANTI-VEGF PEGYLATED APTAMER) GIVEN EVERY 6 WEEKS FOR 54 WEEKS, IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD)|Completed||Phase 2/Phase 3|540||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 16:34:46.837776|2017-02-18 16:34:46.837776
NCT00321984|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2011-04-25|2009-02-26||June 2006||2006-06-01|April 2011|2011-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease|A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (30 mg QD and 60 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Nonerosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|947|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:34:46.906991|2017-02-18 16:34:46.906991
NCT00321971|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2009-03-25|||February 2007||2007-02-01|March 2009|2009-03-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Prevention of Depression in Spouses of People With Cognitive Impairment|Prevention of Psychiatric Morbidity in AD Caregivers|Unknown status|Recruiting|Phase 1|100|Anticipated|National Institute of Mental Health (NIMH)||2|||f||||t||||||||||2017-02-18 16:34:48.201642|2017-02-18 16:34:48.201642
NCT00321958|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2008-01-23|||April 2006||2006-04-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer|Cryotherapy Ablation of Barrett's Esophagus and Early Esophageal Cancer|Terminated||Phase 2|23|Actual|CSA Medical, Inc.||1||The sponsor determined that adequate data had been acquired.|f||||t||||||||||2017-02-18 16:34:48.324431|2017-02-18 16:34:48.324431
NCT00321945|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2013-09-26|||December 2005||2005-12-01|September 2013|2013-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers|A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers on Post-Operative Atrial Fibrillation|Completed||Phase 2|546|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:34:48.4594|2017-02-18 16:34:48.4594
NCT00318279|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2006-04-24|||May 2006||2006-05-01|April 2006|2006-04-01|September 2007||2007-09-01|||||Interventional|||Evaluation of Surgical Simulator for Practicing a Vascular Anastomosis|Benefits of a Surgical Skills Lab Vascular Anastomosis Simulator: A Randomized Controlled Trial|Unknown status|Not yet recruiting|N/A|40||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:36:04.618361|2017-02-18 16:36:04.618361
NCT00321932|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2014-08-21|2012-05-04||July 2005||2005-07-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|March 2011|Actual|2011-03-01||Interventional|||Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant|A Randomized Phase II of Zoledronic Acid (Zometa) in the Prevention of Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|61|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 16:34:48.573311|2017-02-18 16:34:48.573311
NCT00321919|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2016-05-27|2016-02-24||July 2000||2000-07-01|May 2016|2016-05-01|December 2004|Actual|2004-12-01|October 2004|Actual|2004-10-01||Interventional||Baseline characteristics were described for the intent-to-treat (ITT) population, which included all participants randomized according to their randomized treatment group, regardless of the treatment actually received.|A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia|A Randomized, Open-label Study of the Effect of NeoRecormon on Reduction of Cardiovascular Risk in Patients With Chronic Renal Anemia Who Are Not on Renal Replacement Therapy.|Completed||Phase 3|605|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:34:49.213841|2017-02-18 16:34:49.213841
NCT00321906|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2016-09-19|2013-12-17||April 2002||2002-04-01|September 2016|2016-09-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Comparison of Sirolimus and Azathioprine in Lung Transplantation|Comparison of a Tacrolimus/Sirolimus/Prednisone Regimen Versus Tacrolimus/Azathioprine/Prednisone Immunosuppressive Regimen in Lung Transplantation|Completed||Phase 4|181|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 16:34:53.84988|2017-02-18 16:34:53.84988
NCT00321893|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2015-12-21|2014-10-08||January 2006||2006-01-01|October 2014|2014-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Three (3) participants in Arm I: Budesonide, and one (1) in Arm II: Placebo later refused follow up CT and were excluded from overall analysis.|Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer|Randomized Phase II Trial of Budesonide Turbuhaler® 800 Micrograms/Twice Daily Versus Placebo in High-Risk Population With Undetermined Lung Nodules Detected at Screening Low Dose CT Scan|Completed||Phase 2|225|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 16:34:54.314144|2017-02-18 16:34:54.314144
NCT00321880|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2017-01-18|||February 2006||2006-02-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|February 2007|Actual|2007-02-01||Interventional|||Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia|Healing Touch as a Supportive Intervention for Adult Acute Leukemia Patients: A Pilot Study|Completed||N/A|40|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 16:34:55.182788|2017-02-18 16:34:55.182788
NCT00321867|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2014-05-27|||January 2004||2004-01-01|May 2014|2014-05-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||Graft-Augmented Rectocele Repair-A Randomized Surgical Trial|Porcine-Derived Small Intestine Submucosa Graft-Augmented Rectocele Repair-A Randomized Trial|Completed||N/A|160|Actual|Women and Infants Hospital of Rhode Island||2|||f||||f||||||||||2017-02-18 16:34:55.286492|2017-02-18 16:34:55.286492
NCT00321854|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2014-05-07|2009-12-18||May 2006||2006-05-01|March 2014|2014-03-01||||April 2009|Actual|2009-04-01||Interventional|||Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)|A Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Trial to Examine the Efficacy and Safety of Early Pramipexole (PPX) Treatment Versus Delayed Pramipexole Treatment in Patients With New Onset Parkinson's Disease.|Completed||Phase 4|535|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 16:34:55.418706|2017-02-18 16:34:55.418706
NCT00321828|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2013-01-16|2012-10-31||March 2006||2006-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|November 2009|Actual|2009-11-01||Interventional|||Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery|A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy Plus Bevacizumab for Patients With Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor|Completed||Phase 2|90|Actual|NSABP Foundation Inc||1|||f||||t||||||||||2017-02-18 16:34:57.526925|2017-02-18 16:34:57.526925
NCT00321815|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-03|2010-12-16||2010-08-09|August 2006||2006-08-01|December 2010|2010-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer|A Randomized Phase 2 Trial Of Erlotinib With Or Without PF-3512676 For The Treatment Of Patients With Advanced EGFR-Positive Non-Small Cell Lung Cancer After Failure Of At Least One Prior Chemotherapy Regimen|Completed||Phase 2|43|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:34:58.150955|2017-02-18 16:34:58.150955
NCT00321269|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2015-11-23|2014-11-12||October 2007||2007-10-01|November 2015|2015-11-01|December 2010|Actual|2010-12-01|October 2010|Actual|2010-10-01||Interventional|||Depression and Congestive Heart Failure in Outpatients.|Depression and CHF in Outpatients|Completed||N/A|134|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:34:58.291987|2017-02-18 16:34:58.291987
NCT00321256|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2012-03-01|||July 2003||2003-07-01|March 2012|2012-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.|Transplantation d'Ilots Pancreatiques Allogeniques Adultes Pour le Traitement du Diabete Insulino-dependant: Etude GRAGIL 2.|Completed||Phase 1/Phase 2|22||University Hospital, Grenoble|||||f||||||||||||||2017-02-18 16:34:58.630641|2017-02-18 16:34:58.630641
NCT00321243|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2008-06-03|||May 2006||2006-05-01|June 2008|2008-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Evaluation of Emergency Triage Using a Computerized Simulator|Evaluation of a Four-Level Triage Scale (the Geneva Emergency Triage Scale) Using a Computer Triage Simulator|Completed||N/A|150||University Hospital, Geneva|||||f||||||||||||||2017-02-18 16:34:58.731941|2017-02-18 16:34:58.731941
NCT00321230|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2008-04-15|||January 2001||2001-01-01|April 2008|2008-04-01|May 2001||2001-05-01|||||Interventional|||Clinical Evaluation of a New Reduced Volume Bowel Preparation|"A Pilot Monocentric, Open Phase II Study to Investigate the Efficacy and Safety of a New Oral Gut Cleansing Solution (Low Dose Bowel Prep) in 30 Patients Submitted to Colonoscopy"|Completed||Phase 2|30||Norgine|||||f||||f||||||||||2017-02-18 16:34:58.828328|2017-02-18 16:34:58.828328
NCT00321217|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2012-08-15|||May 2004||2004-05-01|November 2011|2011-11-01|April 2014|Anticipated|2014-04-01|November 2013|Anticipated|2013-11-01||Observational|||Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis|Pharmacogenomics of Anti-TNF Treatment in Patients With Rheumatoid Arthritis|Unknown status|Recruiting|N/A|700|Anticipated|Radboud University|||1||f||||f||||||||||2017-02-18 16:34:58.929632|2017-02-18 16:34:58.929632
NCT00321204|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-04-21|||December 2005||2005-12-01|April 2014|2014-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias|A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias in Patients After Cardiac Surgery|Terminated||Phase 2|600||Emory University||||Terminated: We are no longer recruiting.|f||||f||||||||||2017-02-18 16:34:59.013886|2017-02-18 16:34:59.013886
NCT00321191|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2015-06-23|||May 2006||2006-05-01|August 2008|2008-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Measurement of the Second Gas Effect on Sevoflurane in Anaesthetised Patients|Measurement of the Second Gas Effect on Sevoflurane in Anaesthetised Patients|Completed||Phase 4|14|Actual|Austin Health||2|||f||||||||||||||2017-02-18 16:34:59.107252|2017-02-18 16:34:59.107252
NCT00321178|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2010-06-29|||May 2006||2006-05-01|April 2010|2010-04-01|February 2009|Actual|2009-02-01|January 2008|Actual|2008-01-01||Interventional|BURULICO||BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA|Randomised Trial for Early Lesions Caused by M. Ulcerans - Comparison Between 8 Weeks Streptomycin and Rifampicin (SR), or 4 Weeks SR Followed by 4 Weeks R Plus Clarithromycin|Completed||Phase 2/Phase 3|151|Actual|University Medical Center Groningen||2|||f||||t||||||||||2017-02-18 16:34:59.21414|2017-02-18 16:34:59.21414
NCT00321165|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2009-02-10|||June 2006||2006-06-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The AOT (Acridine Orange and Taurolidine) Trial|The AOT (Acridine Orange and Taurolidine) Trial: a Survey on Diagnosis and Prevention of Catheter-Related Infections in Patients on Home Parenteral Nutrition|Completed||Phase 3|60|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 16:34:59.33763|2017-02-18 16:34:59.33763
NCT00321152|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2010-06-07|||November 2006||2006-11-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|August 2008|Actual|2008-08-01||Interventional|||A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)|A Double-Blind, Placebo Controlled Study of 6(S)-5-MTHF Among SSRI-Resistant Outpatients With Major Depressive Disorder (MDD)|Completed||Phase 4|150|Anticipated|Massachusetts General Hospital||3|||f||||f||||||||||2017-02-18 16:34:59.43851|2017-02-18 16:34:59.43851
NCT00321139|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-12-12|||April 2006||2006-04-01|September 2014|2014-09-01||||January 2007|Actual|2007-01-01||Observational|||Assessment of Translesional Markers and Metabolomics|An Assessment of Translesional Markers and Metabolomics|Completed||Phase 4|50|Anticipated|Emory University|||||f||||||||||||||2017-02-18 16:34:59.558935|2017-02-18 16:34:59.558935
NCT00321126|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2006-05-02|||January 1999||1999-01-01|May 2006|2006-05-01|April 2002||2002-04-01|||||Interventional|||Zinc Supplementation in Shigella Patients|Effect of Zinc Supplementation on the Immune and Inflammatory Responses of Children to Shigella Flexneri Infection, and Correlation With Clinical Severity of Illness and Growth Following recoveryEffect of Zinc Supplementation on the Immune and Inflammatory Responses of Children to Shigella Flexneri Infection, and Correlation With Clinical Severity of Illness and Growth Following Recovery|Completed||Phase 3|56||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:34:59.6462|2017-02-18 16:34:59.6462
NCT00321113|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2009-04-07|||September 2004||2004-09-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|TIGRE||Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys|An Open, Multicentre, Randomised, Parallel Group Study to Compare in Marginal Old-for-Old Renal Transplant Patients the Safety and Efficacy of Two Treatments: Sequential Mycophenolate Mofetil/Delayed Tacrolimus Plus Steroids vs Tacrolimus Plus Mycophenolate Mofetil in Patients Requiring Induction With Anti-IL2 Antibody|Completed||Phase 3|142|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:34:59.738052|2017-02-18 16:34:59.738052
NCT00321100|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-05-05|||April 2006||2006-04-01|May 2014|2014-05-01|December 2013|Actual|2013-12-01|April 2009|Actual|2009-04-01||Interventional|||Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab|Phase II Study of the Combination of Cetuximab, Capecitabine, and Oxaliplatin With Out Without Bevacizumab as Initial Therapy for Metastatic Colorectal Cancer|Terminated||Phase 2|23|Actual|Fox Chase Cancer Center||2||Enrollment closed 10/15/2008 based on data about KRAS.|f||||t||||||||||2017-02-18 16:34:59.862195|2017-02-18 16:34:59.862195
NCT00321087|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-01-19|||August 2006||2006-08-01|January 2014|2014-01-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||A Study of T2000 in Essential Tremor|Phase II Efficacy and Safety of Taro Pharmaceuticals' Pro-Drug T2000 (1,3-Dimethoxymethyl-5,5-Diphenyl-Barbituric Acid) In Patients With Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled, Sequential Dose Escalation Study|Terminated||Phase 2|10|Actual|Taro Pharmaceuticals USA||3||Slow enrollment|f||||t||||||||||2017-02-18 16:34:59.97733|2017-02-18 16:34:59.97733
NCT00321074|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-08-25|||May 2005||2005-05-01|August 2014|2014-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|PANTERA||Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts|AN OPEN, MULTICENTRE, RANDOMISED PARALLEL GROUP CLINICAL STUDY TO COMPARE SAFETY AND EFFICACY OF TACROLIMUS (FK506) WITH MONOCLONAL ANTI-IL2R ANTIBODIES (DACLIZUMAB) VS TACROLIMUS (FK506) WITH STEROIDS AND EVALUATE PHARMACOKINETICS IN LIVER ALLOGRAFT RECIPIENTS RECEIVING SUBOPTIMAL LIVERS|Completed||Phase 3|101|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:35:00.080973|2017-02-18 16:35:00.080973
NCT00321061|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-02|2017-01-24|||April 25, 2006||2006-04-25|December 2, 2009|2009-12-02|December 2, 2009|Actual|2009-12-02|December 2, 2009|Actual|2009-12-02||Interventional|||Phase I Study of Vaccination Schedule of Experimental HIV Vaccines|VRC 011: A Phase I Clinical Trial of Intramuscular, Subcutaneous and Intradermal Administration of an HIV-1 Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, and an HIV-1 Multiclade Adenoviral Vector Vaccine,VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers|Completed||Phase 1|60|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:35:00.210596|2017-02-18 16:35:00.210596
NCT00321048|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2014-11-25|||June 2006||2006-06-01|March 2014|2014-03-01|October 2017|Anticipated|2017-10-01|January 2010|Actual|2010-01-01||Interventional|||Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With Active Breathing Coordinator|Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With Active Breathing Coordinator|Active, not recruiting||Phase 3|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:35:00.315595|2017-02-18 16:35:00.315595
NCT00321035|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2008-05-21|||December 2005||2005-12-01|May 2008|2008-05-01||||January 2008|Actual|2008-01-01||Interventional|||Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital|Study of the Safety and Effectiveness of the OculusGen Collagen Matrix Implant as an Aid in Glaucoma and Pterygium Surgery|Completed||Phase 3|60|Anticipated|Pro Top & Mediking Company Limited|||||f||||||||||||||2017-02-18 16:35:00.431479|2017-02-18 16:35:00.431479
NCT00321022|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2012-03-16|||August 2003||2003-08-01|May 2006|2006-05-01|September 2005||2005-09-01|||||Interventional|||Transient Ischemic Attack (TIA) Accelerated Diagnostic Protocol|Costs and Outcomes of an Emergency Department-based Accelerated Diagnostic Protocol vs Hospitalization for Patients With Transient Ischemic Attack: a Randomized Controlled Trial.|Completed||N/A|154||William Beaumont Hospitals|||||f||||||||||||||2017-02-18 16:35:00.528502|2017-02-18 16:35:00.528502
NCT00321009|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2006-05-01|||March 2000||2000-03-01|May 2006|2006-05-01|April 2004||2004-04-01|||||Interventional|||LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin|A Prospective Randomized Trial Comparing Enoxaparin to Warfarin for the Prevention of LV Thrombus Formation After Anterior Wall Myocardial Infarction: A 60 Patient Pilot Study|Completed||N/A|60||William Beaumont Hospitals|||||||||||||||||||2017-02-18 16:35:00.625487|2017-02-18 16:35:00.625487
NCT00320996|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2010-01-06|||March 2002||2002-03-01|October 2008|2008-10-01|February 2005|Actual|2005-02-01|July 2004|Actual|2004-07-01||Observational|||SGO Society of Gynecologic Oncologists Data Outcomes Project|SGO Society of Gynecologic Oncologists Data Outcomes Project|Completed||N/A|100|Actual|University of New Mexico|||1||f||||t||||||||||2017-02-18 16:35:00.748097|2017-02-18 16:35:00.748097
NCT00320983|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2010-01-06|||March 2002||2002-03-01|October 2008|2008-10-01|December 2005|Actual|2005-12-01|June 2004|Actual|2004-06-01||Interventional|||Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer|A Phase I Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer|Completed||Phase 1|11|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:35:00.829991|2017-02-18 16:35:00.829991
NCT00320970|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2007-08-01|||August 2002||2002-08-01|March 2006|2006-03-01|September 2004||2004-09-01|||||Interventional|||Angiotensin II Antagonism of TGF-Beta 1|Angiotensin II Antagonism of TGF-Beta 1: A Candesartan Dose - TGF-Beta 1 Response Relationship Study|Completed||N/A|36||Providence Health & Services|||||f||||||||||||||2017-02-18 16:35:00.940402|2017-02-18 16:35:00.940402
NCT00320957|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2008-05-23|||January 2006||2006-01-01|May 2008|2008-05-01|December 2006||2006-12-01|||||Interventional|||Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital|Study of the Safety and Effectiveness of the Ologen (OculusGen) Collagen Matrix Implant as an Aid in Glaucoma and Pterygium Surgery|Completed||Phase 3|61|Actual|Pro Top & Mediking Company Limited||1|||f||||||||||||||2017-02-18 16:35:01.051565|2017-02-18 16:35:01.051565
NCT00320931|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2008-04-16|||March 2006||2006-03-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Assessment of Coronary Artery Disease by Hybrid PET/CT|Assessment of Coronary Flow Reserve and CT Angiography By Hybrid PET/CT: Relation to Clinically Indicated SPECT Studies|Completed||Phase 4|30|Anticipated|University of Maryland|||||f||||||||||||||2017-02-18 16:35:01.163363|2017-02-18 16:35:01.163363
NCT00320918|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2010-01-06|||November 2005||2005-11-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Observational|||Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib|Chart Review on Patients With Unresectable/Metastatic Cholangiocarcinoma Treated in the UNM Cancer Center With a Combination of Irinotecan, Capecitabine and Celecoxib|Completed||N/A|10|Actual|University of New Mexico|||1||f||||t||||||||||2017-02-18 16:35:01.330023|2017-02-18 16:35:01.330023
NCT00320905|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2010-07-19|||March 2006||2006-03-01|July 2010|2010-07-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Observational|||Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation|Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation|Completed||N/A|70|Actual|Summa Health System|||1||f||||f||||||||||2017-02-18 16:35:01.430176|2017-02-18 16:35:01.430176
NCT00320892|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2012-07-03|||January 2007||2007-01-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|December 2009|Actual|2009-12-01||Interventional|||"Death Rattle - A Double Blind, Randomly Controlled, Crossover Trial"|"Death Rattle - A Double Blind, Randomly Controlled, Crossover Trial"|Terminated||N/A|2|Actual|Soroka University Medical Center||1||Difficulties in recruiting appropriate participants to the study|f||||||||||||||2017-02-18 16:35:01.722765|2017-02-18 16:35:01.722765
NCT00320879|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2006-05-17|||September 2003||2003-09-01|July 2003|2003-07-01|November 2004||2004-11-01|||||Interventional|||Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria|Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria|Completed||Phase 4|52||Steno Diabetes Center|||||f||||||||||||||2017-02-18 16:35:01.83509|2017-02-18 16:35:01.83509
NCT00320866|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2008-04-29|||February 2002||2002-02-01|May 2006|2006-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Evaluation of Symptoms, Complications and Side Effects of Adding Medications Continuously To Subcutaneous Infusion (Hypodermoclysis) In Home Care Hospice Patients||Completed||N/A|27||Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:35:01.954955|2017-02-18 16:35:01.954955
NCT00320853|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2006-05-01|||April 2006||2006-04-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion|A Pilot Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Secretion and Peripheral Insulin Sensitivity|Completed||N/A|30||Sitaram Bhartia Institute of Science and Research|||||f||||||||||||||2017-02-18 16:35:02.058894|2017-02-18 16:35:02.058894
NCT00320840|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-30|2006-04-30|||May 2006||2006-05-01|April 2006|2006-04-01|May 2012||2012-05-01|||||Observational|||Internal and Familial Resources and Motherhood. Follow Up of Mothers With Twins and Preterm Infants Versus Mothers With Single Full Term Infants|The Contribution of Internal and Familial Resources to the Development of Motherhood. Long Term Follow Up of Mothers With Twins and Preterm Infants Versus Mothers With Single Full Term Infants|Unknown status|Not yet recruiting|N/A|150||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:35:02.169027|2017-02-18 16:35:02.169027
NCT00320827|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2007-09-10||||||September 2007|2007-09-01||||||||Interventional|||Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)|Phase 1 Study of CS-1008, a Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5), Administered Weekly to Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)|Completed||Phase 1|40|Anticipated|Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 16:35:02.272059|2017-02-18 16:35:02.272059
NCT00320814|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2011-06-08|||April 2006||2006-04-01|June 2011|2011-06-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema|An Exploratory Study of the Safety, Tolerability and Biological Effect of a Single Intravitreal Administration of VEGF Trap in Patients With Diabetic Macular Edema|Completed||Phase 1|5|Actual|Regeneron Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:35:02.359186|2017-02-18 16:35:02.359186
NCT00320801|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2012-08-27|2010-07-28||January 2004||2004-01-01|August 2012|2012-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.|A Randomized, Double-Blind, Multicenter Study Evaluating The Safety and Efficacy of BTDS in Subjects With Moderate to Severe Osteoarthritis Pain. Includes a 52-Week Extension Phase.|Terminated||Phase 3|188|Actual|Purdue Pharma LP|Study terminated due to administrative reasons. The primary objective was changed to a safety study prior to unblinding.|2||This study was terminated early due to administrative reasons.|f||||t||||||||||2017-02-18 16:35:02.471906|2017-02-18 16:35:02.471906
NCT00320788|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2012-01-27|2011-12-16||April 2006||2006-04-01|January 2012|2012-01-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)|A Randomized, Controlled Study of the Safety, Tolerability and Biological Effect of Repeated Intravitreal Administration of VEGF Trap in Patients With Neovascular Age-Related Macular Degeneration|Completed||Phase 2|159|Actual|Regeneron Pharmaceuticals|This is a phase 2 study with small numbers of patients per group limiting the conclusions that can be drawn from the resulting data.|5|||f||||f||||||||||2017-02-18 16:35:03.09158|2017-02-18 16:35:03.09158
NCT00320775|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2015-03-16|||June 2005||2005-06-01|March 2015|2015-03-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD|An Exploratory Study of the Safety, Tolerability and Biological Effect of Intravitreal Administration of VEGF Trap in Patients With Neovascular Age-Related Macular Degeneration|Completed||Phase 1|51|Actual|Regeneron Pharmaceuticals||3|||f||||f||||||||||2017-02-18 16:35:04.8223|2017-02-18 16:35:04.8223
NCT00320762|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2008-05-21|||January 2006||2006-01-01|May 2008|2008-05-01||||December 2007|Actual|2007-12-01||Interventional|||Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital|Study of the Safety and Effectiveness of the Ologen (OculusGen) Collagen Matrix Implant as an Aid in Glaucoma and Pterygium Surgery|Completed||Phase 3|60|Anticipated|Pro Top & Mediking Company Limited|||||f||||||||||||||2017-02-18 16:35:04.940347|2017-02-18 16:35:04.940347
NCT00320749|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2016-05-25|2015-09-15||December 2005||2005-12-01|May 2016|2016-05-01|January 2011|Actual|2011-01-01|October 2008|Actual|2008-10-01||Interventional|||Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer|A Dose Escalating (Phase I) Study Looking at the Biomodulation of Capecitabine by Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer|Completed||Phase 1|21|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:35:05.029851|2017-02-18 16:35:05.029851
NCT00320736|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2009-05-15|||January 2004||2004-01-01|May 2009|2009-05-01|May 2006||2006-05-01|||||Interventional|||Galantamine for Cognition in People With Schizophrenia|Effect of Nicotine Agonist Galantamine Added to High Potency Medications for Cognitive Function in Patients With Schizophrenia and Schizoaffective Disorder|Completed||Phase 4|20||North Suffolk Mental Health Association|||||f||||||||||||||2017-02-18 16:35:05.386705|2017-02-18 16:35:05.386705
NCT00320723|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2009-05-15|||July 2001||2001-07-01|May 2009|2009-05-01|December 2005||2005-12-01|||||Interventional|||Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia|Nicotine Replacement Therapy Added to Cognitive Behavioral Therapy for Smoking Cessation in Patients With Major Mental Illness|Completed||Phase 4|100||North Suffolk Mental Health Association|||||f||||||||||||||2017-02-18 16:35:05.657004|2017-02-18 16:35:05.657004
NCT00320710|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2014-08-18|2014-07-08||February 2006||2006-02-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer|A Prospective, Randomized, Double-blind, Stratified, Multi-center, 2-arm Trial of the Continued Efficacy and Safety of Zoledronic Acid (Every 4 Weeks vs. Every 12 Weeks) in in the 2nd Year of Treatment in Patients With Documented Bone Metastases From Breast Cancer|Completed||Phase 3|416|Actual|Novartis||3|||f||||t||||||||||2017-02-18 16:35:05.771855|2017-02-18 16:35:05.771855
NCT00320697|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2016-09-23|||April 2006||2006-04-01|September 2016|2016-09-01|August 2009|Actual|2009-08-01|October 2008|Actual|2008-10-01||Interventional|||Smoking Relapse Prevention in Schizophrenia|A Trial of the Effects of Bupropion, Nicotine Replacement Therapy and CBT on Smoking Cessation and Smoking Relapse in Patients With Schizophrenia|Completed||Phase 4|25|Actual|North Suffolk Mental Health Association||3|||f||||||||||||||2017-02-18 16:35:06.9802|2017-02-18 16:35:06.9802
NCT00320684|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2012-06-28|||July 2003||2003-07-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Serotonin Transporter Concentrations in Women With a History of Anorexia Nervosa|A Positron Emission Tomography Study of the Serotonin Transporter in Weight-Restored Women With Anorexia Nervosa|Completed||N/A|20|Actual|New York State Psychiatric Institute|||2||f||||f||||||||||2017-02-18 16:35:07.091955|2017-02-18 16:35:07.091955
NCT00320671|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2016-09-07|2016-03-22||December 2005||2005-12-01|September 2016|2016-09-01|December 2015|Actual|2015-12-01|December 2014|Actual|2014-12-01||Interventional|||Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis|Preventing Morbidity in First Episode Schizophrenia, Part II|Completed||Phase 4|198|Actual|Northwell Health|Metabolic data only capture initial effects and may been impacted by Healthy Lifestyles program neg symptoms are only assessed in the initial context of pos symptoms and may not generalize to neg symptoms in the absence of pos symptoms.|2|||f||||t||||||||Yes||2017-02-18 16:35:07.187912|2017-02-18 16:35:07.187912
NCT00320658|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2008-01-18|||March 2006||2006-03-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant|Phase 1 Study of the Safety and Immunogenicity of MSP1 42-C1/Alhydrogel With and Without CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 16:35:08.206207|2017-02-18 16:35:08.206207
NCT00320632|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2015-08-17|||August 1990||1990-08-01|August 2015|2015-08-01|July 1993||1993-07-01|||||Interventional|||Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression|Psychopharmacology of Biogenic Amines in Depression|Completed||Phase 4|43||Harvard Medical School|||||f||||||||||||||2017-02-18 16:35:08.318461|2017-02-18 16:35:08.318461
NCT00320619|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2016-07-28|||September 2000||2000-09-01|March 2009|2009-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery|Aminocaproic Acid and Bleeding in Spinal Surgery|Completed||N/A|182|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||||||||||||2017-02-18 16:35:08.428742|2017-02-18 16:35:08.428742
NCT00320606|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2016-10-05|2011-06-08||May 2006||2006-05-01|October 2016|2016-10-01|March 2017|Anticipated|2017-03-01|August 2010|Actual|2010-08-01||Interventional|WISP-R||Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients|Immunosuppression Withdrawal for Pediatric Living-donor Liver Transplant Recipients (ITN029ST)|Active, not recruiting||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||Yes|Participant level data and additional study materials are available to the public in: 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal.|2017-02-18 16:35:08.545396|2017-02-18 16:35:08.545396
NCT00320593|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2016-07-15|2011-05-17||April 2005||2005-04-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|COMET2||Correction of Myopia Evaluation Trial 2|Correction of Myopia Evaluation Trial 2 (COMET2): A Randomized Trial of the Effect of Progressive Addition Lenses Versus Single Vision Lenses on Low Myopia Associated With Large Accommodative Lags and Near Esophoria in Children|Completed||Phase 3|118|Actual|Jaeb Center for Health Research|Limitations include: differential loss to follow up , differential compliance between the groups, power of near addition was not customized in PAL group, and we have no data on whether PAL group was looking through the near addition.|2|||f||||t||||||||||2017-02-18 16:35:08.94199|2017-02-18 16:35:08.94199
NCT00320580|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2011-06-30||||||June 2011|2011-06-01|March 2003|Actual|2003-03-01|||||Interventional|||An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen|A Randomized, Open-Label, Multicenter Study Comparing the Bleeding Profile of Ortho Evra (Norelgestromin/Ethinyl Estradiol) Continuous Regimen vs. Ortho Evra Cyclic Regimen|Completed||Phase 2|239|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.||1|||||||||||||||||2017-02-18 16:35:10.522112|2017-02-18 16:35:10.522112
NCT00320567|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2011-06-30||||||June 2011|2011-06-01|April 2004|Actual|2004-04-01|||||Interventional|||The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa|The Effect of Ortho Tri-Cyclen on Bone Mineral Density in Pediatric Subjects With Anorexia Nervosa: A Double-Blind, Placebo-Controlled Study|Completed||Phase 2|123|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.||1|||||||||||||||||2017-02-18 16:35:10.634321|2017-02-18 16:35:10.634321
NCT00320554|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2007-05-23||||||May 2007|2007-05-01|September 2006|Actual|2006-09-01|||||Observational|||Motion Characteristics of the Foot and Ankle as Measured by Durometer Readings||Completed||N/A|||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:35:10.739854|2017-02-18 16:35:10.739854
NCT00320541|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2013-07-15|2010-04-26||May 2006||2006-05-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|April 2009|Actual|2009-04-01||Interventional|||A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer|A Randomized Phase II Trial of Paclitaxel and Bevacizumab Versus Gemcitabine, Paclitaxel, and Bevacizumab as First Line Treatment for Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|187|Actual|Eli Lilly and Company|Of 191 randomized patients, 4 patients were disqualified from inclusion in any efficacy or safety analyses due to significant Good Clinical Practice (GCP) violations; data is reported for the remaining 187 randomized patients.|2|||f||||t||||||||||2017-02-18 16:35:10.839291|2017-02-18 16:35:10.839291
NCT00320528|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2009-12-02|2009-09-30||April 2006||2006-04-01|December 2009|2009-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)|An Open-Label Study of the Efficacy of Atomoxetine Hydrochloride on Quality of Life of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder With or Without Comorbid Conditions|Completed||Phase 3|269|Actual|Eli Lilly and Company|The original intent was to also calculate change and 95% confidence intervals at end of Period III; however, due to low number of patients completing Period III, variations from baseline (LOCF), are not suitable for further analysis or description.|3|||f||||f||||||||||2017-02-18 16:35:12.832789|2017-02-18 16:35:12.832789
NCT00320515|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2009-08-19|2009-07-09||March 2004||2004-03-01|August 2009|2009-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer|Phase 1/2 Study of Pemetrexed Plus Cisplatin in Unresectable, Advanced Gastric Carcinoma.|Completed||Phase 1/Phase 2|89|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:35:14.265987|2017-02-18 16:35:14.265987
NCT00320502|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-30|2008-08-21|||May 2006||2006-05-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|March 2008|Actual|2008-03-01||Interventional|||A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effects of BXT-51072 on CK-MB in High-Risk Type 2 Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention|Completed||Phase 2|60|Anticipated|Synvista Therapeutics, Inc|||||f||||f||||||||||2017-02-18 16:35:14.611763|2017-02-18 16:35:14.611763
NCT00320489|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2012-01-19|2010-09-29||April 2006||2006-04-01|January 2012|2012-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia|A Randomized, Open-label Study Comparing the Effects of Olanzapine Pamoate Depot With Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia|Completed||Phase 3|524|Actual|Eli Lilly and Company|Results for Outcome Measures 17 and 18 were corrected as a result of an identified programming error.|2|||f||||f||||||||||2017-02-18 16:35:14.715269|2017-02-18 16:35:14.715269
NCT00320476|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2008-05-05|||April 2006||2006-04-01|April 2006|2006-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates|Velcade®, Thalidomide, Dexamethasone (VTD) Induction Therapy Followed By Melphalan, Prednisone, Thalidomide (MPT) Maintenance As a First Line Treatment For The Patients With Multiple Myeloma Who Are Non-Transplant Candidates|Completed||Phase 2|35|Actual|Korean Multiple Myeloma Working Party||1|||f||||t||||||||||2017-02-18 16:35:19.313676|2017-02-18 16:35:19.313676
NCT00320463|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2016-10-11|||April 2006||2006-04-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|||||Interventional|||Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants|Compare Immunogenicity & Reactogenicity of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine (New vs Current) Given in Healthy Infants. The DTPa-HBV-IPV Vaccine (New Formulation) Will Also be Assessed in a 3rd Group of Subjects|Completed||Phase 3|415||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:35:19.408917|2017-02-18 16:35:19.408917
NCT00320450|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2013-10-31|||November 2005||2005-11-01|May 2012|2012-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||SB-681323 In Subjects With Rheumatoid Arthritis|A Randomised, Parallel Group, Placebo-controlled, Double Blind Study to Assess the Safety and Tolerability of SB-681323 at 7.5mg Daily Dose for 28 Days and Its Effect on the Levels of Serum C-reactive Protein (CRP) in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 2|78|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:35:19.510542|2017-02-18 16:35:19.510542
NCT00320437|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-30|2006-11-29|||May 2007||2007-05-01|November 2006|2006-11-01|December 2008|Anticipated|2008-12-01|||||Observational|||Intergenerational Transmission of Terror|The Intergenerational Transmission of Trauma From Terror: A Developmental Perspective|Unknown status|Not yet recruiting|Phase 1|300|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:35:19.627742|2017-02-18 16:35:19.627742
NCT00320424|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2010-10-01|||February 2006||2006-02-01|October 2010|2010-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Hip Fracture Study of GSK576428 (Fondaparinux Sodium)|Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism After Hip Fracture Surgery|Completed||Phase 3|50||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:35:19.717981|2017-02-18 16:35:19.717981
NCT00320411|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2013-04-11|2009-11-10||November 2005||2005-11-01|May 2012|2012-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer|Phase II Clinical Study of Lapatinib (GW572016) in Patients With ErbB2 Over - Expressing Advanced or Metastatic Breast Cancer|Completed||Phase 2|62|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:35:20.060357|2017-02-18 16:35:20.060357
NCT00320398|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2010-10-01|||January 2006||2006-01-01|October 2010|2010-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)|Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism After Elective Total Hip Replacement Surgery|Completed||Phase 3|100||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:35:20.626917|2017-02-18 16:35:20.626917
NCT00320385|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2016-01-28|2011-10-20||November 2005||2005-11-01|April 2015|2015-04-01|October 2010|Actual|2010-10-01|June 2007|Actual|2007-06-01||Interventional|||Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer|A Randomized, Multicenter, Open-Label, Phase III Study of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Subjects With HER2-positive Metastatic Breast Cancer Whose Disease Has Progressed on Trastuzumab-Containing Regimens|Completed||Phase 3|296|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:35:20.741516|2017-02-18 16:35:20.741516
NCT00320372|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2015-12-22|2015-12-18||January 2006||2006-01-01|December 2015|2015-12-01|May 2015|Actual|2015-05-01|March 2015|Actual|2015-03-01||Observational||A total of 878 subjects were screened. Thirty-seven were not eligible and 46 were eligible but not treated for various reasons. This left a total of 795 patients in the Safety Population (SP). The total number of patients in each group may be lower than SP if there was missing D-21 assessment data, as D-21 baseline data was not identical to D-23.|Treatment-Resistant Depression Registry|A Long-term, Prospective, Observational, Multi-center Patient Outcome Registry to Collect Data in Patients With Treatment-resistant Depression (TRD) Who Are Currently in a Major Depressive Episode.|Completed||N/A|795|Actual|Cyberonics, Inc.|||2||f||||f||||||||||2017-02-18 16:35:21.898859|2017-02-18 16:35:21.898859
NCT00320359|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2012-07-19|||August 2002||2002-08-01|March 2011|2011-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer|An Open-Label, Multicentre, Randomised, Phase III Study Comparing Topotecan/Cisplatin and Topotecan/Etoposide Versus Etoposide/Cisplatin as Treatment for Chemotherapy-naive Patients With Extensive Disease-Small Cell Lung Cancer|Completed||Phase 3|700|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:35:23.123522|2017-02-18 16:35:23.123522
NCT00320346|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2016-07-17|||July 2006||2006-07-01|November 2008|2008-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Phase II Study of Pandemic Influenza Vaccine|A Double-Blind, Randomised, Multi-Centre Study to Evaluate the Safety, Tolerability, Immunogenicity and Lot to Lot Consistency of Two Formulations of CSL Limited's Inactivated Prototype Pandemic Influenza Vaccine in a Healthy Adult Population (≤18 Years to ≥64 Years of Age).|Completed||Phase 2|400||Seqirus|||||f||||||||||||||2017-02-18 16:35:23.315538|2017-02-18 16:35:23.315538
NCT00319670|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2013-02-06|||March 2006||2006-03-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children|A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children|Completed||Phase 4|25||Braintree Laboratories|||||||||||||||||||2017-02-18 16:35:23.413955|2017-02-18 16:35:23.413955
NCT00319657|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2016-11-28|||July 2004||2004-07-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Interventional|||Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs|Total Lymphoid Irradiation, Anti-Thymocyte Globulin and Purified Donor CD34+ and T-Cell Transfusion in HLA-Matched Living Donor Kidney Transplantation|Recruiting||Phase 1|15|Anticipated|Stanford University||1|||f||||t||||||||No|Individual Patient Data will not be shared|2017-02-18 16:35:23.504324|2017-02-18 16:35:23.504324
NCT00319644|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2012-10-16|2011-03-24||May 2006||2006-05-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Impact of Using Mini-Bronchoalveolar Lavage as a Diagnostic Test for Ventilator-Associated Pneumonia|Impact of Using Mini-Bronchoalveolar Lavage as a Diagnostic Test for Ventilator-Associated Pneumonia|Completed||N/A|37|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 16:35:23.621775|2017-02-18 16:35:23.621775
NCT00319631|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2017-01-27|||January 2006|Actual|2006-01-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Observational|||Role of Vascular Endothelial Growth Factor (VEGF) in Acute Lung Injury/Adult Respiratory Distress Syndrome (ARDS)|Role of Vascular Endothelial Growth Factor (VEGF) in Acute Lung Injury/Adult Respiratory Distress Syndrome (ARDS)|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University|||1|Under the discretion of the PI the study has been withdrawn.|f||||t||||||||Undecided||2017-02-18 16:35:24.237544|2017-02-18 16:35:24.237544
NCT00319618|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2007-12-14|||June 2003||2003-06-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer|A Randomised Phase II Study: Treatment With Daily p.o. Iressa™ (ZD1839) or Placebo in Combination With Weekly IV Infusion of Docetaxel in Patients With Metastatic Breast Cancer|Completed||Phase 2|66||AstraZeneca|||||f||||||||||||||2017-02-18 16:35:24.323951|2017-02-18 16:35:24.323951
NCT00319605|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2012-05-24|||April 2006||2006-04-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam|Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam (Keppra®) (SOLUCION Study)|Completed||Phase 4|600|Anticipated|UCB Pharma|||1||f||||||||||||||2017-02-18 16:35:24.412901|2017-02-18 16:35:24.412901
NCT00320333|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2006-05-17|||December 2004||2004-12-01|May 2006|2006-05-01|December 2007||2007-12-01|||||Observational|||COPD Rehabilitation in Primary and Secondary Health Care|Comparison of Pulmonary Rehabilitation of Patients With Chronic Obstructive Pulmonary Disease in Primary and Secondary Health Care|Unknown status|Recruiting|N/A|120||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 16:35:24.550743|2017-02-18 16:35:24.550743
NCT00320320|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2008-11-24|||April 2005||2005-04-01|November 2008|2008-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer|A Pilot Phase II Trial of Irinotecan Discontinuation and Reintroduction in Patients With Previously Untreated Advanced Colorectal Cancer|Terminated||Phase 2|72||Gachon University Gil Medical Center||||Poor accrual|f||||f||||||||||2017-02-18 16:35:24.648542|2017-02-18 16:35:24.648542
NCT00320307|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2008-10-15|||September 2005||2005-09-01|October 2008|2008-10-01||||||||Interventional|||Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects|An Open-Label, Two-Period, Crossover, Pharmacokinetic Study of Abacavir and Its Intracellular Anabolite Carbovir Triphosphate Following Once-Daily and Twice-Daily Administration of Abacavir in HIV-Infected Subjects.|Completed||Phase 1|30|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 16:35:24.745228|2017-02-18 16:35:24.745228
NCT00320294|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2007-03-09|||February 2005||2005-02-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||ILF With/Without Cisplatin for Advanced Gastric Cancer|A Randomized Trial of Irinotecan, Leucovorin, 5-FU (ILF) Versus ILF Plus Cisplatin (PILF) Combination Chemotherapy in Patients With Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|86||Gachon University Gil Medical Center|||||f||||||||||||||2017-02-18 16:35:24.841818|2017-02-18 16:35:24.841818
NCT00320281|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2013-06-22|2013-03-01||April 2006||2006-04-01|June 2013|2013-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.|Botulinum Toxin A for the Treatment of Cervical/Shoulder Pain Following Acute Spinal Cord Injury.|Completed||Phase 4|19|Actual|Craig Hospital||2|||f||||t||||||||||2017-02-18 16:35:24.938076|2017-02-18 16:35:24.938076
NCT00320268|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2009-03-24|||April 2006||2006-04-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|||||Interventional|MOONSTONE||Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained-Release (SEROQUEL®) as Monotherapy in the Treatment of Patients With MDD|Completed||Phase 3|600||AstraZeneca|||||f||||||||||||||2017-02-18 16:35:25.348937|2017-02-18 16:35:25.348937
NCT00320255|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2016-08-11|2016-03-14||June 2006||2006-06-01|August 2016|2016-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||All participants who were randomized to receive treatment|A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer|A Randomized, Double-blind, Placebo-controlled Study of Apixaban for the Prevention of Thromboembolic Events in Patients Undergoing Treatment for Advanced Cancer: A Phase 2 Pilot Study|Completed||Phase 2|130|Actual|Bristol-Myers Squibb||6|||f||||t||||||||||2017-02-18 16:35:25.496228|2017-02-18 16:35:25.496228
NCT00320242|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2009-07-31|||April 2006||2006-04-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Laser Light Cues for Gait Freezing in Parkinson's Disease|An Open Label Study to Assess the Efficacy of Visual Cues in the Form of the Laser Cane or the U-Step Walker With Laser Accessory in Parkinson's Disease Patients Who Experience Freezing of Gait.|Completed||Phase 3|26|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 16:35:27.870335|2017-02-18 16:35:27.870335
NCT00320229|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-05-15|||December 2004||2004-12-01|January 2006|2006-01-01|July 2005||2005-07-01|||||Interventional|||Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen||Terminated||Phase 4|84||Azienda Sanitaria Ospedaliera|||||f||||||||||||||2017-02-18 16:35:27.967813|2017-02-18 16:35:27.967813
NCT00320216|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2015-03-31|2009-10-23||November 2003||2003-11-01|March 2015|2015-03-01|March 2005|Actual|2005-03-01|June 2004|Actual|2004-06-01||Interventional|||A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis|A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Study of Single and Multiple Dose Regimens With Subcutaneous CNTO 1275 (Human Monoclonal Antibody to IL-12) in Subjects With Moderate to Severe Psoriasis|Completed||Phase 2|320|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <=5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|5|||f||||f||||||||||2017-02-18 16:35:28.058508|2017-02-18 16:35:28.058508
NCT00320203|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2012-11-27||2012-11-27|March 2006||2006-03-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Anecortave Acetate in Patients With Open-angle Glaucoma|A Study of the Safety and IOP-Lowering Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma|Completed||Phase 2|86|Actual|Alcon Research||4|||f||||||||||||||2017-02-18 16:35:29.186659|2017-02-18 16:35:29.186659
NCT00320190|ClinicalTrials.gov processed this data on February 17, 2017|2006-05-01|2013-10-01|2011-06-06||August 2006||2006-08-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib|An Open-label, Randomized Study of Dasatinib vs High-dose (800-mg) Imatinib in the Treatment of Subjects With Chronic Phase Chronic Myeloid Leukemia Who Have Had a Suboptimal Response After at Least 3 Months of Therapy With 400 mg Imatinib|Terminated||Phase 2|52|Actual|Bristol-Myers Squibb|Enrollment terminated prematurely on September 5, 2008, due to slow accrual. Only 32 of 156 planned participants were randomized from August 2, 2006. Per BMS standards, findings were reported in a synopsis format, with only safety results included.|2||Terminated due to slow participant accrual|f||||f||||||||||2017-02-18 16:35:29.292283|2017-02-18 16:35:29.292283
NCT00320177|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-29|2017-01-24|||November 26, 2003||2003-11-26|October 28, 2014|2014-10-28|October 28, 2014||2014-10-28|||||Observational|||Eating Behavior in Children|Eating Behavior in Children|Completed||N/A|263|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:35:30.325111|2017-02-18 16:35:30.325111
NCT00320164|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-09-19|||January 2006||2006-01-01|September 2016|2016-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals|Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals|Completed||N/A|8|Actual|Weill Medical College of Cornell University|||2||f||||f||||||||Undecided||2017-02-18 16:35:30.410522|2017-02-18 16:35:30.410522
NCT00320151|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-09-19|||April 2006||2006-04-01|September 2016|2016-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|||Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases|Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases|Completed||N/A|3087|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||Undecided||2017-02-18 16:35:30.495039|2017-02-18 16:35:30.495039
NCT00320138|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2012-01-11|||March 2006||2006-03-01|January 2012|2012-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel|Acupuncture for the Treatment of Trauma Survivors|Completed||Phase 1|55|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||2|||f||||f||||||||||2017-02-18 16:35:30.588562|2017-02-18 16:35:30.588562
NCT00320125|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2015-05-01|||March 2002||2002-03-01|October 2008|2008-10-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Effects of Dairy Foods on Adolescent Pregnant Mothers and Their Newborns|Effects of Dairy Foods on Adolescent Pregnant Mothers and Their Newborns|Completed||Phase 3|72|Actual|University of Utah||3|||f||||||||||||||2017-02-18 16:35:30.701053|2017-02-18 16:35:30.701053
NCT00320112|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2015-04-06|2014-09-19||February 2007||2007-02-01|August 2014|2014-08-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Interventional||125 participants were randomized to Reciprocal Peer Support (RPS), and 119 to Nurse case management (NCM).|Improving Insulin Therapy With Enhanced Care Management|Improving Insulin Therapy With Enhanced Care Management and Peer Support|Completed||Phase 3|244|Actual|VA Office of Research and Development|"study only included male patients.~intervention only lasted six months.~the nature of the intervention prevented blinding to treatment group.~A final limitation is the relatively low rate of uptake of the intervention."|2|||f||||f||||||||||2017-02-18 16:35:30.823734|2017-02-18 16:35:30.823734
NCT00320099|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2010-04-05|||January 2006||2006-01-01|April 2010|2010-04-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|COIITSS||Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock|Phase 3 Study of Corticotherapy (Hydrocortisone Alone Versus Hydrocortisone Plus Fludrocortisone) Versus Corticotherapy Plus Intensive Insulin Therapy for Septic Shock|Completed||Phase 3|508|Actual|University of Versailles||4|||f||||t||||||||||2017-02-18 16:35:31.607798|2017-02-18 16:35:31.607798
NCT00320086|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2009-01-13|||August 2005||2005-08-01|September 2008|2008-09-01|November 2008|Anticipated|2008-11-01|||||Observational|||Microalbuminuria in Children With and Without Diabetes|Microalbuminuria in Children With and Without Diabetes|Unknown status|Recruiting|N/A|220|Anticipated|University of New Mexico|||1||f||||||||||||||2017-02-18 16:35:31.738696|2017-02-18 16:35:31.738696
NCT00320073|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2012-05-14|||August 2006||2006-08-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|October 2008|Actual|2008-10-01||Interventional|||Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors|A Two Arm Phase I Dose Escalation Trial of Vinflunine With Erlotinib or Pemetrexed in Refractory Solid Tumors|Completed||Phase 1|41|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 16:35:31.815781|2017-02-18 16:35:31.815781
NCT00320060|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2006-04-27|||October 2001||2001-10-01|April 2006|2006-04-01|January 2003||2003-01-01|||||Interventional|||Effect of Pyridorin in Patients With Diabetic Nephropathy|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study to Evaluate the Safety and Tolerability of Pyridorin (Pyridoxamine Dihydrochloride) in Patients With Diabetic Nephropathy Associated With Type 1 or Type 2 Diabetes|Completed||Phase 2|128||BioStratum|||||||||||||||||||2017-02-18 16:35:31.920809|2017-02-18 16:35:31.920809
NCT00320047|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2013-08-08|||April 2005||2005-04-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|June 2006|Actual|2006-06-01||Interventional|||Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder|Effects of Baclofen on Binge Eating in Bulimia Nervosa and Binge Eating Disorder|Completed||N/A|10|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 16:35:31.992609|2017-02-18 16:35:31.992609
NCT00320034|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2011-02-28|||April 2006||2006-04-01|July 2009|2009-07-01|November 2009|Actual|2009-11-01|June 2008|Actual|2008-06-01||Interventional|||Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma|Double-blind, Crossover, Placebo-controlled Evaluation of the Effect of Levalbuterol (R-albuterol) on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma|Completed||Phase 2|15|Anticipated|McMaster University|||||f||||||||||||||2017-02-18 16:35:32.106965|2017-02-18 16:35:32.106965
NCT00320021|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2006-04-27|||July 2002||2002-07-01|April 2006|2006-04-01|September 2003||2003-09-01|||||Interventional|||Effect of Pyridorin in Patients With Diabetic Nephropathy|A Randomized, Double-Blind, Placebo-Controlled, Escalating Dose, Pilot Study to Evaluate the Safety, Tolerability and Biologic Activity of Pyridorin (Pyridoxamine Dihydrochloride) in Patients With Diabetic Nephropathy Associated With Type 1 or Type 2 Diabetes|Completed||Phase 2|80||BioStratum|||||||||||||||||||2017-02-18 16:35:32.203199|2017-02-18 16:35:32.203199
NCT00320008|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-04-11|||January 1992||1992-01-01|April 2016|2016-04-01|December 2025|Anticipated|2025-12-01|December 2001|Actual|2001-12-01||Interventional|Steno-2||Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria|Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria|Active, not recruiting||N/A|160|Actual|Steno Diabetes Center||2|||f||||t||||||||No||2017-02-18 16:35:32.284488|2017-02-18 16:35:32.284488
NCT00319995|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2015-10-19|||March 2006||2006-03-01|October 2015|2015-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)|Efficacy and Safety of Combination Loratadine/Montelukast QD vs Pseudoephedrine and Placebo in the Treatment of Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|1095|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:35:32.481495|2017-02-18 16:35:32.481495
NCT00319787|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2011-01-24|||December 2003||2003-12-01|January 2011|2011-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer|A Randomized Placebo Controlled Study to Assess the Rate of PSA Decrease, Anatomical & Metabolic Changes in the Prostate Determined by MRI/3D-MRS & Histological Changes by Biopsy in Subjects With Locally Advanced Prostate Carcinoma Treated With Either Casodex® (Bicalutamide) Alone or the Combination of Casodex® & ZD1839 (Iressa™)|Completed||Phase 2|102||AstraZeneca|||||f||||||||||||||2017-02-18 16:35:34.712421|2017-02-18 16:35:34.712421
NCT00319982|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2015-03-24|2015-01-26||January 2006||2006-01-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional||Participants enrolled through Brigham and Women’s Hospital (Boston, MA), Boston Children’s Hospital, and Royal Prince Alfred Hospital (Sydney, Australia) were randomized 1:1 to diltiazem or placebo. Participants were 5-39 years old, carried the sarcomere mutation presumed to cause HCM in the family, and had normal LV wall thickness by echo.|Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem|Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem|Completed||Phase 2/Phase 3|39|Actual|Brigham and Women's Hospital|Small number of participants and short follow-up duration. Currently available tools to monitor treatment response/ phenotypic progression are may lack adequate resolution. The penetrance of sarcomere mutations is variable and may not be complete.|2|||f||||t||||||||||2017-02-18 16:35:32.563128|2017-02-18 16:35:32.563128
NCT00319969|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2009-09-28||2009-09-28|April 2006||2006-04-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|||Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.|A Randomized Phase 2 Trial Comparing Amrubicin Versus Topotecan as Second-Line Treatment in Patients With Extensive Small Cell Lung Cancer Sensitive to First-Line Chemotherapy|Completed||Phase 2|76|Actual|Celgene||2|||t||||f||||||||||2017-02-18 16:35:33.044173|2017-02-18 16:35:33.044173
NCT00319956|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2012-06-07|||September 2004||2004-09-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Trial II of Lung Protection With Azithromycin in the Preterm Infant|Trial II of Lung Protection With Azithromycin in the Preterm Infant|Completed||Phase 2|220|Actual|University of Kentucky||2|||f||||t||||||||||2017-02-18 16:35:33.373333|2017-02-18 16:35:33.373333
NCT00319943|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2006-04-27|||September 2004||2004-09-01|April 2006|2006-04-01|July 2006||2006-07-01|||||Interventional|||Computer-Based Therapy for Mild Cognitive Impairment|Computer-Based Therapy for Mild Cognitive Impairment|Completed||Phase 1|48||Posit Science Corporation|||||f||||||||||||||2017-02-18 16:35:33.483698|2017-02-18 16:35:33.483698
NCT00319930|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2010-03-04|||May 2005||2005-05-01|March 2010|2010-03-01|May 2007|Actual|2007-05-01|||||Interventional|||Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL|A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Pharmacodynamic Study of Intravenously Administered CNF1010 (17-(Allylamino)-17-demethoxy-geldanamycin [17-AAG]) in Patients With ZAP-70 Positive B-Cell Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 1|10|Actual|Biogen||||Discontinuation of program|||||||||||||||2017-02-18 16:35:33.59211|2017-02-18 16:35:33.59211
NCT00319917|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2014-08-19|||April 2006||2006-04-01|August 2014|2014-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients|FK506 Phase 4 Study: A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients|Completed||Phase 4|123|Actual|Astellas Pharma Inc||2|||f||||||||||||||2017-02-18 16:35:33.682764|2017-02-18 16:35:33.682764
NCT00319904|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-03-16|||March 2001||2001-03-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|October 2016|Anticipated|2016-10-01||Observational|||The Partners Genetics Collaborative Study of Schizophrenia|The Partners Genetics Collaborative Study of Schizophrenia|Active, not recruiting||N/A|500|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"~     DNA is extracted and stored for future anaysis of genes that may be associated with~     schizophrenia~   "|||2017-02-18 16:35:33.815642|2017-02-18 16:35:33.815642
NCT00319891|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2013-05-13|||September 2004||2004-09-01|May 2013|2013-05-01|October 2006||2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Computer-Based Training for Mild Alzheimer's Disease|Computer-Based Training for Mild Cognitive Impairment and Mild Alzheimer's Disease|Completed||Phase 1|6||Posit Science Corporation|||||f||||||||||||||2017-02-18 16:35:33.919968|2017-02-18 16:35:33.919968
NCT00319878|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2008-10-06|||May 2006||2006-05-01|October 2008|2008-10-01|December 2009|Anticipated|2009-12-01|July 2009|Anticipated|2009-07-01||Interventional|||Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia|A Phase I/II Trial of Sirolimus (Rapamune) and Cyclosporine in Patients With Refractory Aplastic Anemia|Unknown status|Recruiting|Phase 1/Phase 2|52|Anticipated|Office of Rare Diseases (ORD)||1|||f||||||||||||||2017-02-18 16:35:34.009994|2017-02-18 16:35:34.009994
NCT00319865|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2006-04-28|||November 2005||2005-11-01|April 2006|2006-04-01|September 2008||2008-09-01|||||Interventional|||PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma|PS-341 (Bortezomib, Velcade®), Adriamycin and Dexamethasone (PAD) Combination Therapy Followed by Thalidomide With Dexamethasone (Thal/Dex) for Relapsed or Refractory Multiple Myeloma|Unknown status|Recruiting|Phase 2|47||Korean Multiple Myeloma Working Party|||||f||||||||||||||2017-02-18 16:35:34.122495|2017-02-18 16:35:34.122495
NCT00319852|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2012-04-13|||April 2006||2006-04-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV||Completed||Phase 3|442|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:35:34.223492|2017-02-18 16:35:34.223492
NCT00319839|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2010-01-13|||March 2006||2006-03-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab|UCI 05-46:A Phase II Study of AlbuminBound-Paclitaxel (AbraxaneTM) for Treatment of Recurrent or Metastatic Head and Neck Cancer With the Addition of Cetuximab (Erbitux) (IMC-225) on Disease Progression|Unknown status|Active, not recruiting|Phase 2|44|Anticipated|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:35:34.338392|2017-02-18 16:35:34.338392
NCT00319826|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-04-26|||March 2004||2004-03-01|April 2016|2016-04-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Virulence Determinants in S Aureus Bacteremia|Virulence Determinants in Staphylococcus Aureus Bacteremia|Completed||N/A|1354|Actual|Duke University|||2||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 16:35:34.441991|2017-02-18 16:35:34.441991
NCT00319813|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2008-04-15||||||April 2008|2008-04-01|September 2007||2007-09-01|||||Observational|||General Practice Quality Assurance Project. Chronic Obstructive Pulmonary Disease (COPD) Diagnosis and Treatment|General Practice Quality Assurance Project. COPD Diagnosis and Treatment|Completed||Phase 4|8000||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:35:34.549725|2017-02-18 16:35:34.549725
NCT00319800|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2008-03-10|||February 2006||2006-02-01|March 2008|2008-03-01|March 2007||2007-03-01|||||Interventional|||Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC|A Phase II Study of Second-Line Therapy With Irinotecan or Gefitinib in Docetaxel Pretreated Patients With Non-Small Cell Lung Cancer: a New Treatment Strategy According to Clinical Predictors for Response|Unknown status|Active, not recruiting|Phase 2|50||Gachon University Gil Medical Center|||||f||||||||||||||2017-02-18 16:35:34.621638|2017-02-18 16:35:34.621638
NCT00319774|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2006-04-27|||December 2002||2002-12-01|September 2003|2003-09-01|July 2003||2003-07-01|||||Interventional|||Hemocontrol and Blood Pressure Control in Dialysis Patients|Assessment of Hemocontrol Biofeedback System Efficiency on Long Term Blood Pressure Control, Nursing Interventions, and Quality of Life in Hemodialysis Patients: a Randomized Controlled Trial|Completed||Phase 3|60||Université de Montréal|||||f||||||||||||||2017-02-18 16:35:34.807639|2017-02-18 16:35:34.807639
NCT00319761|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2009-01-29|||May 2006||2006-05-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy|The Safety and Short-Term Efficacy of Calcitriol in the Treatment of Immunoglobulin A Nephropathy|Completed||Phase 4|10||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 16:35:34.904116|2017-02-18 16:35:34.904116
NCT00319748|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2010-01-04|2009-08-17||April 2006||2006-04-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers|Phase II Study of 852A Administered Subcutaneously in Patients With Metastatic Refractory Breast, Ovarian, Endometrial and Cervical Cancers|Completed||Phase 2|15|Actual|Masonic Cancer Center, University of Minnesota|Other Adverse Events that occurred were noted as targeted toxicities and not captured as adverse events.|2|||f||||t||||||||||2017-02-18 16:35:35.010144|2017-02-18 16:35:35.010144
NCT00319735|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-03-28|2016-01-11||April 2006||2006-04-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas|A Pilot Study With Cetuximab and Radiation Therapy for Patients With Surgically Resectable Esophageal and GE Junction Carcinomas: Hoosier Oncology Group Study (GI05-92)|Completed||Phase 2|41|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-02-18 16:35:35.511316|2017-02-18 16:35:35.511316
NCT00319722|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2010-05-03|||February 2006||2006-02-01|May 2010|2010-05-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Observational|||EEG Studies of Sensory Processing in Autistic Children|Electrophysiologic Indicators of Gating and Timing Abnormalities in Autism|Unknown status|Recruiting|Phase 1|130|Anticipated|Massachusetts General Hospital|||1||f||||||||||||||2017-02-18 16:35:36.064592|2017-02-18 16:35:36.064592
NCT00319709|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2009-03-10|||April 2006||2006-04-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|ZEPHIR||An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression|An Eight-Week, Double-Blind Placebo Controlled, Multicenter Study Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Elderly Patients With Major Depressive Disorder (MDD)|Completed||Phase 3|288|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:35:36.163715|2017-02-18 16:35:36.163715
NCT00319696|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2012-09-27|2012-06-29||July 2004||2004-07-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|RAPIDS 2 OL||Bosentan in Digital Ulcers|Long-term Bosentan Open Label Extension of the AC-052-331 Study in Systemic Sclerosis Patients With Ischemic Digital Ulcers|Completed||Phase 3|116|Actual|Actelion||1|||f||||f||||||||||2017-02-18 16:35:36.466019|2017-02-18 16:35:36.466019
NCT00319683|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2008-12-12||||||December 2008|2008-12-01||||||||Interventional|||A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma|A Phase 1/2 Study in Subjects With Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma, Evaluating the Safety, and Anti-Tumor Activity of ADH300004 (Eniluracil) With Escalating Doses of 5 Fluorouracil Administered Orally Once Weekly for 3 Weeks Out of Every 4 (Adherex Protocol Number AHX-03-103)|Terminated||Phase 1/Phase 2|||Adherex Technologies, Inc.||||Lack of funds|t||||||||||||||2017-02-18 16:35:37.289219|2017-02-18 16:35:37.289219
NCT00319592|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2012-08-16|2012-07-11||May 2005||2005-05-01|August 2012|2012-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX|Randomized, Double-blind, Phase II Study of the Safety, Tolerability and Immunogenicity Following Administration of Live Attenuated JE Vaccine (ChimeriVax™ JE) Compared With Mouse Brain-derived Inactivated JE Vaccine (JE VAX®).|Completed||Phase 2|60|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:35:37.40592|2017-02-18 16:35:37.40592
NCT00319579|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-05-24|||January 2005||2005-01-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||A Prospective Study of Living Kidney Donation|The Long Term Medical and Psychological Implications of Becoming a Living Kidney Donor: A Prospective Pilot Study|Active, not recruiting||N/A|600|Anticipated|Lawson Health Research Institute|||1||f||||f||||||Samples Without DNA|"~     Serum and urine samples~   "|||2017-02-18 16:35:38.028515|2017-02-18 16:35:38.028515
NCT00319566|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2006-04-27|||July 1992||1992-07-01|January 2002|2002-01-01|July 2001||2001-07-01|||||Interventional|||Heart and Estrogen-Progestin Replacement Study (HERS)|Heart and Estrogen-Progestin Replacement Study (HERS)|Completed||Phase 3|2430||University of California, San Francisco|||||||||||||||||||2017-02-18 16:35:38.119791|2017-02-18 16:35:38.119791
NCT00319553|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2012-09-28|2010-09-28||May 2006||2006-05-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®|Comparison in US Adolescents of the Safety and Immunogenicity of Two Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccines: ADACEL™ and BOOSTRIX®|Completed||Phase 4|647|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:35:38.218537|2017-02-18 16:35:38.218537
NCT00319540|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2006-04-28|||March 2001||2001-03-01|January 2001|2001-01-01|March 2002||2002-03-01|||||Interventional|||RCT of Psychoeducational Program of Depression|A Randomized Controlled Trial of a Psychoeducational Group Program for Unipolar Depression in Adults in Norway|Completed||Phase 2|155||Norwegian Institute of Public Health|||||f||||||||||||||2017-02-18 16:35:38.83357|2017-02-18 16:35:38.83357
NCT00319527|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2009-07-06|||May 2004||2004-05-01|July 2009|2009-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Long-Term Study of Living Kidney Donors|Long-Term Medical and Psychological Implications of Becoming a Living Kidney Donor: A Historical Matched Cohort Study|Completed||N/A|311|Actual|Lawson Health Research Institute|||1||f||||f||||||Samples Without DNA|"~     Serum and urine samples~   "|||2017-02-18 16:35:38.924967|2017-02-18 16:35:38.924967
NCT00319514|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2008-03-10|||April 2004||2004-04-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC|Randomized Phase II Trial of Two Different Schedules of Docetaxel Plus Cisplatin as First-Line Therapy in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|78||Gachon University Gil Medical Center|||||f||||||||||||||2017-02-18 16:35:39.023377|2017-02-18 16:35:39.023377
NCT00319501|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-08-17|2016-07-06||January 2006||2006-01-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional||Participants who were randomized to receive treatment|Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.|A Phase 3, Randomized, Double-blind, Parallel, Placebo-controlled, Multicenter Study, With Optional Open-label Continuation, Of The Efficacy And Safety Of Vanquix(tm) Auto-injector (Diazepam Injection) For The Management Of Selected, Refractory, Patients With Epilepsy Who Require Intermittent Medical Intervention To Control Episodes Of Acute Repetitive Seizures|Completed||Phase 3|234|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:35:39.130663|2017-02-18 16:35:39.130663
NCT00319488|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-07-28|||February 2004||2004-02-01|April 2012|2012-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|AIMS||Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)|Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)|Completed||N/A|238|Actual|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||t||||||||||2017-02-18 16:35:40.904684|2017-02-18 16:35:40.904684
NCT00319475|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2006-10-08|||February 2006||2006-02-01|October 2006|2006-10-01|July 2006||2006-07-01|||||Interventional|||Evaluation of Mechanical Stapler for Aortic Anastomoses|Evaluation of Mechanical Stapler for Aortic Anastomoses|Unknown status|Active, not recruiting|N/A|10||SVSE 2000 Ltd.|||||f||||||||||||||2017-02-18 16:35:41.028062|2017-02-18 16:35:41.028062
NCT00319462|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2007-04-18|||November 2006||2006-11-01|April 2006|2006-04-01|April 2007|Anticipated|2007-04-01|||||Interventional|||Localization of Point A in Cervical Cancer|Localization of Anatomic Point A in Cervical Cancer Patients|Unknown status|Recruiting|N/A|20||Mackay Memorial Hospital|||||f||||t||||||||||2017-02-18 16:35:41.109164|2017-02-18 16:35:41.109164
NCT00319449|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-28|2015-10-09|2011-04-14||September 2005||2005-09-01|October 2015|2015-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)|A Single Center, Randomized, Parallel Groups, Placebo-Controlled Study Comparing The Efficacy, Safety, And Tolerability Of The Daily Co-administration Of Ezetimibe 10 Mg Or Ezetimibe Placebo To Ongoing Treatment With Atorvastatin 10 Mg In Subjects With Primary Hypercholesterolemia And Multiple Coronary Heart Disease Risk Factors in Indonesian Population.|Completed||Phase 4|22|Actual|Merck Sharp & Dohme Corp.|Protocol deviations may have occurred that resulted in quality issues associated with reporting of the data.|2|||f||||||||||||||2017-02-18 16:35:41.207247|2017-02-18 16:35:41.207247
NCT00319436|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2016-10-27|2010-11-05||August 2004||2004-08-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Stage I Randomized Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers|Fostering Mothers' Emotionally Responsive Parenting|Completed||N/A|47|Actual|Yale University|Sample most representative of addicted mothers in mid-30’s, Caucasian, high school educated, unemployed, moderate involvement with child welfare. Caution in generalizing to higher risk mothers (adolescent mothers, ethnic minority,less educated).|2|||f||||t||||||||||2017-02-18 16:35:41.612663|2017-02-18 16:35:41.612663
NCT00319423|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2010-02-04|||April 2005||2005-04-01|April 2006|2006-04-01||||February 2009|Actual|2009-02-01||Interventional|||Exercise Therapy and Patient Education for Individuals With Hip Osteoarthritis. a RCT.|Evaluation of Function and Effect of Exercise Therapy in Patients With Osteoarthritis of the Hip. A Randomized Controlled Trial.|Completed||N/A|110|Anticipated|Ullevaal University Hospital||2|||f||||||||||||||2017-02-18 16:35:42.046854|2017-02-18 16:35:42.046854
NCT00319410|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2006-11-27|||July 2005||2005-07-01|April 2006|2006-04-01|December 2005||2005-12-01|||||Interventional|||Comparison of Two Hysteroscopy Approaches|A New Approach to Office Hysteroscopy Compared With Traditional Hysteroscopy|Completed||Phase 3|130||Wolfson Medical Center|||||f||||||||||||||2017-02-18 16:35:42.152657|2017-02-18 16:35:42.152657
NCT00319397|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2009-12-10|||April 2004||2004-04-01|January 2009|2009-01-01|March 2007||2007-03-01|||||Observational|||Effects of Age and Exercise on Blood Pressure Regulation|Arterial Stiffness With Age: Part 1 and 2|Unknown status|Recruiting|N/A|80|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 16:35:42.253989|2017-02-18 16:35:42.253989
NCT00319384|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2012-10-03|||April 2006||2006-04-01|October 2012|2012-10-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Outpatient Ultrafiltration Therapy in Heart Failure Patients Trial|Outpatient Ultrafiltration Therapy in Heart Failure Feasibility Trial|Withdrawn||N/A|0|Actual|Minneapolis Medical Research Foundation||||Lack of enrollment|f||||f||||||||||2017-02-18 16:35:42.343462|2017-02-18 16:35:42.343462
NCT00319371|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2008-09-25|||November 2005||2005-11-01|September 2008|2008-09-01|June 2006|Actual|2006-06-01|||||Observational|||Registration of Skin-Temperatures and Sleep-Wake Behaviour|Registration of Skin-Temperatures and Sleep-Wake Behaviour in the Daily Life of Women With Vasospasm in Comparison to Controls|Completed||N/A|40|Actual|University Hospital, Basel, Switzerland|||2||f||||f||||||||||2017-02-18 16:35:42.431695|2017-02-18 16:35:42.431695
NCT00319358|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2009-01-28|||October 2003||2003-10-01|January 2009|2009-01-01|October 2006|Actual|2006-10-01|||||Interventional|||Role of Antioxidants Supplementation in Chronic Pancreatitis|Effect of Antioxidant Supplementation on Pain, Antioxidant Profile and Oxidative Stress in Patients With Chronic Pancreatitis|Completed||Phase 3|127|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||t||||||||||2017-02-18 16:35:42.513897|2017-02-18 16:35:42.513897
NCT00319345|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2010-06-22|||November 2003||2003-11-01|April 2006|2006-04-01|November 2005||2005-11-01|||||Interventional|||Sodium-Lactate and Traumatic Brain Injury|Sodium-Lactate Versus Mannitol in the Treatment of Intracranial Hypertensive Episodes in Severe Traumatic Brain Injured Patients|Terminated||Phase 2/Phase 3|34||Institut d'Anesthesiologie des Alpes Maritimes|||||f||||||||||||||2017-02-18 16:35:42.623899|2017-02-18 16:35:42.623899
NCT00319332|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2015-04-15|||September 2005||2005-09-01|April 2015|2015-04-01|February 2021|Anticipated|2021-02-01|February 2021|Anticipated|2021-02-01||Interventional|||A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen|A Multi-center, Randomized, Phase 3 Study of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen for Patients With Relapsed or Transformed Follicular Non-Hodgkin's Lymphoma|Withdrawn||Phase 3|0|Actual|GlaxoSmithKline||||This study has been cancelled prior to enrollment|f||||||||||||||2017-02-18 16:35:42.713121|2017-02-18 16:35:42.713121
NCT00319319|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2007-04-18|||January 2003||2003-01-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Nicotinic Receptor Augmentation of SSRI Antidepressants|A Double-Blind,Randomized,Placebo-Controlled Trial of Mecamylamine Hydrochloride for the Treatment of SSRI-Refractory Major Depressive Disorder.|Completed||Phase 2|60||Yale University|||||f||||f||||||||||2017-02-18 16:35:42.922455|2017-02-18 16:35:42.922455
NCT00319280|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2014-03-28|||December 2004||2004-12-01|March 2014|2014-03-01|December 2008|Actual|2008-12-01|June 2006|Actual|2006-06-01||Interventional|||Proximal Tibial Open Wedge Osteotomy. A Clinical Prospective, Randomized RSA-trial.|Proximal Tibial Open Wedge Osteotomy. Stability and Healing Evaluated in a Clinical Prospective, Randomized Trial Using RSA.|Completed||Phase 4|45|Actual|Northern Orthopaedic Division, Denmark||3|||f||||f||||||||||2017-02-18 16:35:43.237365|2017-02-18 16:35:43.237365
NCT00319267|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2016-05-23|||May 2005||2005-05-01|May 2016|2016-05-01|February 2007|Actual|2007-02-01|December 2006|Actual|2006-12-01||Interventional|FUTURE-1||Bosentan in Children With Pulmonary Arterial Hypertension|An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension|Completed||Phase 3|36|Actual|Actelion||1|||f||||||||||||||2017-02-18 16:35:43.337562|2017-02-18 16:35:43.337562
NCT00319254|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2012-12-21|2012-10-04||May 2006||2006-05-01|December 2012|2012-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer|Phase II Study Of SKI-606 In Subjects With Advanced Or Metastatic Breast Cancer|Completed||Phase 2|75|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:35:43.643662|2017-02-18 16:35:43.643662
NCT00319241|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2008-06-16|||January 1998||1998-01-01|June 2008|2008-06-01|November 2003|Actual|2003-11-01|October 2003|Actual|2003-10-01||Interventional|||Relational Parenting Group for Opioid-Addicted Mothers|Relational Parenting Group for Opioid-Addicted Mothers|Completed||Phase 2|120||Yale University|||||f||||||||||||||2017-02-18 16:35:44.05564|2017-02-18 16:35:44.05564
NCT00319228|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2017-01-20|||January 2006|Actual|2006-01-01|January 2017|2017-01-01|March 2019|Anticipated|2019-03-01|December 2018|Anticipated|2018-12-01||Interventional|||Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.|A Phase II/III Pivotal Trial Evaluating the Safety, Pharmacokinetic Properties and Efficacy of a Plasma-Derived Anti-thrombin III Concentrate With Administration in Surgery, Pregnancy and Thromboembolic or Thrombotic Events.|Recruiting||Phase 2/Phase 3|30|Anticipated|Grifols Biologicals Inc.||1|||f||||t||||||||||2017-02-18 16:35:44.162358|2017-02-18 16:35:44.162358
NCT00319215|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2007-04-24|||March 2006||2006-03-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Interventional|||Effects of Ramelteon on Driving Ability|A Study to Investigate the Residual Effects of Ramelteon (8 mg), Zopiclone (7.5 mg) and Placebo on Actual Driving, Memory, Psychomotor Performance and Mood|Completed||Phase 1|30||Utrecht Institute for Pharmaceutical Sciences|||||f||||||||||||||2017-02-18 16:35:44.287003|2017-02-18 16:35:44.287003
NCT00319202|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2012-11-02|||June 2006||2006-06-01|November 2012|2012-11-01|February 2012|Actual|2012-02-01|February 2010|Actual|2010-02-01||Interventional|ARAMIA||Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects|"A Randomized, Double Blind, Cross-Over, Placebo-Controlled Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism, of Non Diabetic, Non Hypertensive Subjects With Dysglycemia and Abdominal Obesity.ARAMIA"|Terminated||Phase 4|56|Actual|Fundación Cardiovascular de Colombia||2||Difficulties in completing the required sample size|f||||t||||||||||2017-02-18 16:35:44.381138|2017-02-18 16:35:44.381138
NCT00319189|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2006-05-09|||November 2002||2002-11-01|April 2006|2006-04-01|November 2003||2003-11-01|||||Interventional|||Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients|Efficacy and Safety of Nateglinide Treatment in Renal Treatment Recipients With Post Transplant Diabetes Mellitus or Impaired Glucose Tolerance|Completed||Phase 4|15||University of Oslo School of Pharmacy|||||f||||||||||||||2017-02-18 16:35:44.502928|2017-02-18 16:35:44.502928
NCT00319176|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2013-02-06|||April 2004||2004-04-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|||||Observational|||Evaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During Pregnancy||Completed||N/A|15|Anticipated|University of California, Irvine|||1||f||||||||||||||2017-02-18 16:35:44.600768|2017-02-18 16:35:44.600768
NCT00319163|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2009-08-05|||May 2006||2006-05-01|August 2009|2009-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women|An Open-label, Single-dose, Randomized, 2-period, Crossover, Bioequivalence Study to Compare Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women|Completed||Phase 1|26||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:35:44.68574|2017-02-18 16:35:44.68574
NCT00319150|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2009-02-11|||October 2006||2006-10-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial|Resistance to ErythroPoietin Effectiveness Algorithm Trial|Terminated||Phase 3|6|Actual|Queen's University||2||New evidence and trouble recruiting|f||||t||||||||||2017-02-18 16:35:44.776268|2017-02-18 16:35:44.776268
NCT00319137|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2012-05-31|||December 2005||2005-12-01|February 2011|2011-02-01||||||||Interventional|||An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine|A Randomized, Single-Blind, Single-Attack, Placebo-Controlled, Adaptive Design Study to Assess the Safety and Efficacy of Doses of 5-180 mg of the iNOS Inhibitor GW274150 in the Treatment of Acute Migraine During the Mild Headache Phase|Completed||Phase 2|126||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:35:44.8991|2017-02-18 16:35:44.8991
NCT00319124|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-03-01|||April 2005||2005-04-01|May 2012|2012-05-01|October 2010|Actual|2010-10-01|August 2008|Actual|2008-08-01||Observational|||Exercise Therapy and Patient Education for Individuals With Hip Osteoarthritis of the Hip. A Case-Control Study|Evaluation of Function and Effect of Exercise in Patients With Osteoarthritis of the Hip.A Case-control Study.|Completed||N/A|52|Actual|Oslo University Hospital|||2||f||||f||||||||||2017-02-18 16:35:44.998605|2017-02-18 16:35:44.998605
NCT00319111|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2012-11-29|2012-05-24||January 2006||2006-01-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|BENEFIT OL||Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|Long-term Open-label Extension Study in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Who Completed Protocol AC-052-366 (BENEFIT, NCT00313222)|Completed||Phase 3|151|Actual|Actelion||1|||f||||||||||||||2017-02-18 16:35:45.124656|2017-02-18 16:35:45.124656
NCT00318890|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2011-02-11|||October 2002||2002-10-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|April 2007|Actual|2007-04-01||Interventional|||Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck|A Phase I/II Trial of Induction Cisplatin and Docetaxel Followed by Concomitant Docetaxel/Radiotherapy With Subcutaneous Amifostine for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|48|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 16:35:50.489951|2017-02-18 16:35:50.489951
NCT00319098|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2016-11-03|||May 2006||2006-05-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|January 2007|Actual|2007-01-01||Interventional|||Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above|A Phase III, Observer-blind, Randomised Study to Evaluate the Safety and Immunogenicity of One and Two Administrations of Pandemic Monovalent (H5N1) Influenza Vaccine (Adjuvanted Split Virus Formulation) in Adults Aged 18 Years and Older|Completed||Phase 3|5075|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:35:45.705651|2017-02-18 16:35:45.705651
NCT00319085|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2015-04-09|||May 2006||2006-05-01|April 2015|2015-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Preheating of Femur Component in Hybrid Total Hip Arthroplasty|Comparison Between Preheated and Non-preheated Femur Component in Hybrid Total Hip Arthroplasty (THA) A Prospective Randomized Study of the 80 THA Using Radiostereometry.|Completed||Phase 2|80|Actual|Northern Orthopaedic Division, Denmark||1|||f||||t||||||||||2017-02-18 16:35:45.856969|2017-02-18 16:35:45.856969
NCT00319072|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2006-04-26|||March 2004||2004-03-01|April 2006|2006-04-01|December 2005||2005-12-01|||||Interventional|||Hormone Replacement Therapy (HRT) Website Tool|Testing an Interactive Website for Hormone Replacement|Completed||Phase 2|280||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 16:35:45.948885|2017-02-18 16:35:45.948885
NCT00319059|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2016-04-21|||March 2006||2006-03-01|April 2016|2016-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance|The Influence of the 34C>T Variant in the AMPD1 Gene on Individual Susceptibility for Ischemia-reperfusion.|Completed||N/A|14||Radboud University|||||f||||||||||||||2017-02-18 16:35:46.051695|2017-02-18 16:35:46.051695
NCT00319046|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2012-05-24|2012-04-24||February 2006||2006-02-01|May 2012|2012-05-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease|Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease|Completed||Phase 3|42|Actual|Actelion||1|||f||||||||||||||2017-02-18 16:35:46.243669|2017-02-18 16:35:46.243669
NCT00319033|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2015-04-28|||July 2004||2004-07-01|April 2015|2015-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|BUILD 2 OL||Open-label Study With Bosentan in Interstitial Lung Disease|Long-term Open-label Study in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis Who Completed the Protocol AC-052-330.|Completed||Phase 2/Phase 3|132||Actelion|||||f||||||||||||||2017-02-18 16:35:46.639799|2017-02-18 16:35:46.639799
NCT00319020|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2016-06-02||2012-03-09|August 2005||2005-08-01|June 2016|2016-06-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|FUTURE 2||Bosentan in Children With Pulmonary Arterial Hypertension Extension Study|An Open Label, Long-term, Safety, and Tolerability Extension Study Using the Pediatric Formulation of Bosentan in the Treatment of Children With Idiopathic or Familial Pulmonary Arterial Hypertension Who Completed FUTURE 1|Completed||Phase 3|33|Actual|Actelion||1|||f||||||||||||||2017-02-18 16:35:46.756753|2017-02-18 16:35:46.756753
NCT00319007|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-27|2007-08-09|||April 2006||2006-04-01|August 2007|2007-08-01|December 2006||2006-12-01|||||Interventional|||Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis|Adenoma-Carcinoma Sequence in the Ileal Pouch Anal Anastomosis in Patients With Familial Adenomatous Polyposis: Studies on Luminal and Mucosal Risk Factors and Chemoprevention|Unknown status|Recruiting|Phase 2|30|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 16:35:46.876736|2017-02-18 16:35:46.876736
NCT00318994|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2008-01-11|||February 2002||2002-02-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|September 2005|Actual|2005-09-01||Interventional|||Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis|Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis|Completed||Phase 4|6||AstraZeneca|||||f||||||||||||||2017-02-18 16:35:46.960323|2017-02-18 16:35:46.960323
NCT00318981|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2006-09-08|||December 2004||2004-12-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD|Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD|Unknown status|Active, not recruiting|Phase 4|40||University of Maryland|||||||||||||||||||2017-02-18 16:35:47.046932|2017-02-18 16:35:47.046932
NCT00318968|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2009-01-23|||May 2006||2006-05-01|January 2009|2009-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Nexium RESPONSE Trial|Development of an Algorithm for Identification of Responders to Short Term Treatment With Esomeprazole (Nexium) in Primary Care|Completed||Phase 4|1000|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:35:47.147564|2017-02-18 16:35:47.147564
NCT00318955|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2015-06-29|||November 2005||2005-11-01|June 2015|2015-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients|A Post-Marketing, Open-Label, Randomized, Comparative Study Comparing the Usefulness of Dexmedetomidine at the Time of Extubation and Post Extubation Period to Other Sedative Management in Post-Operative Patients|Completed||Phase 4|85|Actual|Hospira, Inc.||2|||f||||f||||||||||2017-02-18 16:35:47.264499|2017-02-18 16:35:47.264499
NCT00318942|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-06-29|||February 2003||2003-02-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|August 2012|Actual|2012-08-01||Interventional|||Efficacy and Safety of Colloids Versus Crystalloids for Fluid Resuscitation in Critically Ill Patients|CRISTAL: Colloids Compared to Crystalloids in Fluid Resuscitation of Critically Ill Patients: A Multinational Randomised Controlled Trial|Completed||Phase 3|2857|Actual|University of Versailles||2|||f||||t||||||||||2017-02-18 16:35:47.389605|2017-02-18 16:35:47.389605
NCT00318929|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2012-02-21|2009-03-31||April 2006||2006-04-01|June 2010|2010-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Tolerability and Efficacy of Depakote-extended Release in the Elderly|Tolerability and Efficacy of Depakote-ER in the Elderly|Completed||N/A|14|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 16:35:50.139718|2017-02-18 16:35:50.139718
NCT00318903|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2010-12-30|||January 2002||2002-01-01|December 2010|2010-12-01|April 2006|Actual|2006-04-01|||||Interventional|||Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer|A Phase II Study of Irinotecan and Taxotere With Concurrent Radiotherapy as a Preoperative Treatment in Resectable Esophageal Cancer|Completed||Phase 2|25|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 16:35:50.372513|2017-02-18 16:35:50.372513
NCT00318851|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2010-08-25|||September 2003||2003-09-01|March 2006|2006-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Carotid Artery Stenting With Protection Registry|Treatment of Carotid Stenosis With Carotid Stenting and Neurologic Protection With Pre-Procedure and Follow-Up With MRI DIffusion Imaging and Neuropsychological Testing|Completed||Phase 3|62|Actual|Providence Health & Services||1|||f||||f||||||||||2017-02-18 16:35:53.373428|2017-02-18 16:35:53.373428
NCT00318838|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2017-01-31|||April 2006||2006-04-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effect of Azimilide Dihydrochloride on Renal Function|A Double-blind, Randomized, Parallel-group, Placebo-controlled, Multiple-dose Study to Assess the Effect of 125 mg/Day Orally Administered Azimilide Dihydrochloride on Renal Function and Hemodynamics in Healthy Volunteers|Completed||Phase 1|21|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 16:35:53.493482|2017-02-18 16:35:53.493482
NCT00318825|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2010-11-30|||April 2006||2006-04-01|April 2006|2006-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Nitrous Oxide for Analgesia During Colonoscopy|Use of Nitrous Oxide for Analgesia During Colonoscopy - A Randomised Trial|Completed||Phase 4|200|Anticipated|Rikshospitalet University Hospital|||||f||||||||||||||2017-02-18 16:35:53.5999|2017-02-18 16:35:53.5999
NCT00318812|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2016-04-05|2013-06-26||May 2007||2007-05-01|April 2016|2016-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure|Heme Iron Polypeptide for the Treatment of Iron Deficiency Anemia in Pre-Dialysis Patients: A Pilot Randomized Controlled Study|Completed||Phase 2/Phase 3|55|Actual|Ottawa Hospital Research Institute|Recruitment for the trial was a challenge; over 1100 patients screened - 55 consented - 40 randomized|2|||f||||f||||||||||2017-02-18 16:35:53.692368|2017-02-18 16:35:53.692368
NCT00318799|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2013-11-20|||April 2006||2006-04-01|November 2013|2013-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters|A Single-centre, Open-label, Crossover, Controlled, Randomized Study to Investigate the Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters in 30 Healthy Female Volunteers Over 3 Treatment Cycles|Completed||Phase 2|29|Actual|Bayer||2|||f||||||||||||||2017-02-18 16:35:54.051708|2017-02-18 16:35:54.051708
NCT00318786|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2017-01-05|||April 2006||2006-04-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes|Trial to Investigate the Efficacy and the Safety of Thrice-Daily NN2000-Mix70 (NovoRapid 70 Mix) Compared to Twice-Daily NN-X14Mix30 (NovoRapid 30 Mix) in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|289|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:35:54.163565|2017-02-18 16:35:54.163565
NCT00318773|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2009-02-26|||February 2002||2002-02-01|April 2006|2006-04-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS)|Short-Term Versus Long-Term Treatment for Severe PMS|Completed||Phase 4|174|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-02-18 16:35:54.268966|2017-02-18 16:35:54.268966
NCT00318760|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2017-01-24|||June 14, 2005||2005-06-14|July 8, 2014|2014-07-08|August 7, 2013|Actual|2013-08-07|||||Interventional|||Effect of Clonidine on Responses to Imagery Scripts|Effect of Clonidine on Responses to Imagery Scripts|Completed||Phase 1|160|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:35:54.379444|2017-02-18 16:35:54.379444
NCT00318747|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2013-02-01|||April 2006||2006-04-01|February 2013|2013-02-01|November 2006|Actual|2006-11-01|||||Interventional|||Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug|Asthma Immunotherapy With a Ragweed Allergen Immunostimulatory Sequence Conjugate|Terminated||Phase 2|140||National Institute of Allergy and Infectious Diseases (NIAID)||||Poor enrollment|||||||||||||||2017-02-18 16:35:54.56831|2017-02-18 16:35:54.56831
NCT00318734|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2016-04-15|||May 2006||2006-05-01|December 2011|2011-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults|Trace Elements and CVD Risk Factors Among Young Adults|Completed||N/A|4362|Actual|University of North Carolina, Chapel Hill|||1||f||||||||||||||2017-02-18 16:35:54.855136|2017-02-18 16:35:54.855136
NCT00318721|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2009-11-03|||June 2006||2006-06-01|June 2009|2009-06-01|November 2009|Actual|2009-11-01|December 2008|Actual|2008-12-01||Interventional|KALANET||Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar|Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar|Completed||N/A|20000|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 16:35:54.948776|2017-02-18 16:35:54.948776
NCT00318708|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2012-12-28|2012-04-27||June 2006||2006-06-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|MIA||Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)|Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)|Completed||Phase 3|92|Actual|Milton S. Hershey Medical Center|Participants underwent endobronchial biopsy for characterization of lower airway status for M pneumoniae or C pneumoniae. The target sample size was 72 positives and 72 negatives. Only 80 and 12 were recruited, respectively.|2|||f||||t||||||||||2017-02-18 16:35:55.063399|2017-02-18 16:35:55.063399
NCT00318695|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2009-01-21|||May 2004||2004-05-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|July 2008|Actual|2008-07-01||Interventional|||Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses|Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses- A Randomized Double-Blind Placebo Controlled Trial|Completed||Phase 2|253|Actual|National University Hospital, Singapore||2|||f||||t||||||||||2017-02-18 16:35:55.47518|2017-02-18 16:35:55.47518
NCT00318682|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2009-02-11|||May 2006||2006-05-01|September 2006|2006-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|FIBROSTIC||Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral Hepatitis|Evaluation and Medico Economic Study of FIBROSCAN in Patients With Viral Hepatitis|Terminated||N/A|2000|Actual|Assistance Publique - Hôpitaux de Paris|||1|enough patients have been enrolled for the statistic analysis|f||||f||||||Samples Without DNA|"~     biological samples to evaluate the hepato-fibrosis~   "|||2017-02-18 16:35:55.579647|2017-02-18 16:35:55.579647
NCT00005521|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||June 1998||1998-06-01|December 2004|2004-12-01|July 2004|Actual|2004-07-01|||||Observational|||Exercise and Blood Pressure in Children: A Meta-Analysis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:49.31295|2017-02-18 18:14:49.31295
NCT00318669|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2013-04-11|||December 2005||2005-12-01|July 2012|2012-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Social Anxiety Disorder Study Of Paroxetine|Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Social Phobia/Social Anxiety Disorder (SAD) -A Double-blind, Placebo-controlled Study- <Phase III Study>|Completed||Phase 3|390|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:35:55.667318|2017-02-18 16:35:55.667318
NCT00318656|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2009-04-10|2008-10-17||November 2005||2005-11-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes|Comparison of the Effects of Rosiglitazone and Glimepiride, Both Given in Combination With Metformin, on 24-Hour Glycemia in Type 2 Diabetes Patients Not Controlled With Metformin Alone. A 3-Month Multicentre, Randomized, Parallel-Group, Open-Label Study.|Completed||Phase 4|23|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:35:55.778123|2017-02-18 16:35:55.778123
NCT00318643|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2008-04-03|||March 2006||2006-03-01|April 2008|2008-04-01||||||||Interventional|||A Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Patients With Superficial Bladder Cancer|A Phase I-IIa, Multicenter, Open-Label, Multiple Dose, Safety, Tolerability and Pharmacokinetic Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Patients With Non-Muscular-Invasive Bladder Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|27|Actual|Halozyme Therapeutics||1|||f||||f||||||||||2017-02-18 16:35:56.397745|2017-02-18 16:35:56.397745
NCT00318630|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2016-10-17|||July 2005||2005-07-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||The Effect Of AVANDIA On The Late Asthmatic Response|A Randomised Double-blind Two-period Crossover Study to Investigate the Effect of Treatment With Repeat Doses of a PPAR Gamma Agonist on the Allergen-induced Late Asthmatic Response in Subjects With Mild Asthma Compared With Repeat Doses of Placebo.|Completed||Phase 1|34|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:35:56.508634|2017-02-18 16:35:56.508634
NCT00318617|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2012-03-15|||December 2005||2005-12-01|February 2011|2011-02-01||||||||Observational|||Effect Of GW501516X On How The Heart Obtains And Uses Energy|A Two Part Study to Separately Evaluate the Effect of 4-week Treatment With GW501516X Relative to Placebo on Cardiac Energetics in a Randomized, Single-blind, Repeat Dose, Parallel Group Design in Healthy Male Subjects|Terminated||N/A|30||GlaxoSmithKline|||1||||||||||||||||2017-02-18 16:35:56.60611|2017-02-18 16:35:56.60611
NCT00318604|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2006-05-11||||||April 2006|2006-04-01||||||||Observational|||Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker||Unknown status|Not yet recruiting|N/A|||Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 16:35:56.932|2017-02-18 16:35:56.932
NCT00318591|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-26|2015-08-06|2011-02-23||April 2006||2006-04-01|August 2015|2015-08-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections|A Prospective, Randomized, Parallel-group, Multi-center Study to Compare the Occurrence of Urinary Tract Infections in Patients With Spinal Cord Injury Using Either Coated or Uncoated Intermittent Catheters.|Completed||Phase 4|219|Actual|Coloplast A/S||2|||f||||t||||||||||2017-02-18 16:35:57.00386|2017-02-18 16:35:57.00386
NCT00318578|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2007-08-13|||March 2005||2005-03-01|August 2007|2007-08-01|January 2007||2007-01-01|||||Observational|||Prognosis Factors Associated With Convulsive Status Epilepticus in Adults|Prognosis Factors Associated With Convulsive Status Epilepticus in Adults: A Multicenter Cohort Study|Completed||N/A|100|Anticipated|Versailles Hospital|||||f||||||||||||||2017-02-18 16:35:57.521631|2017-02-18 16:35:57.521631
NCT00318565|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2012-03-01|2009-07-08||January 2006||2006-01-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|September 2007|Actual|2007-09-01||Interventional|||Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter|Navistar Thermocool Evaluation of the Catheter With the Stockert 70 Radiofrequency Generator for Endocardial Ablation in Patients With Typical Atrial Flutter|Completed||Phase 4|291|Actual|Biosense Webster, Inc.||1|||f||||f||||||||||2017-02-18 16:35:57.642705|2017-02-18 16:35:57.642705
NCT00318552|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2011-01-25|||January 2002||2002-01-01|January 2011|2011-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients.|Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients. An Open, Randomized Multi-center Study.|Completed||Phase 4|160||AstraZeneca|||||f||||||||||||||2017-02-18 16:35:57.94552|2017-02-18 16:35:57.94552
NCT00318539|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2011-01-20|||December 2003||2003-12-01|January 2011|2011-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study|Quetiapine Augmentation to SRIs for Patients With Obsessive Compulsive Disorder, a Double-blind, Placebo-controlled Study|Completed||Phase 2|90||AstraZeneca|||||f||||||||||||||2017-02-18 16:35:58.049849|2017-02-18 16:35:58.049849
NCT00318513|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2006-05-09||||||April 2006|2006-04-01||||||||Interventional|||Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema|Phase I Study Evaluating the Safety of Bevacizumab in Women With a History of Breast Cancer Suffering From Moderate to Severe Upper Extremity Lymphedema|Unknown status|Not yet recruiting|Phase 1|35||Premiere Oncology of Arizona|||||||||||||||||||2017-02-18 16:35:58.139381|2017-02-18 16:35:58.139381
NCT00318500|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2007-12-07|||May 2006||2006-05-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 75 mg and 150 mg Doses of ERB-041 on the Reduction of Symptoms Associated With Endometriosis During Treatment and Post Treatment in Reproductive-Aged Women|Completed||Phase 2|150||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:35:58.248921|2017-02-18 16:35:58.248921
NCT00318487|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-12-04|||September 2007||2007-09-01|December 2014|2014-12-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Bilateral Sinus Floor Augmentation in Conjunction With Immediate Implant Loading - Study on 3i Dental Implants|Bilateral Sinus Floor Augmentation in Conjunction With Immediate Implant Loading - A Clinical and Histomorphometric Follow-Up Study on 3i Dental Implants|Unknown status|Active, not recruiting|N/A|15|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:35:58.407058|2017-02-18 16:35:58.407058
NCT00318474|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2016-02-04|2014-06-03||January 2002||2002-01-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2008|Actual|2008-03-01||Interventional|||Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy|A Randomized Controlled Trial of Mycophenolate Mofetil in Patients With IgA Nephropathy|Terminated||Phase 3|184|Actual|St. Joseph's Hospital and Medical Center, Phoenix||2||DSMB recommended stopping the trial because of lack of effect.|f||||t||||||||||2017-02-18 16:35:58.521695|2017-02-18 16:35:58.521695
NCT00318461|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2014-10-14|2010-02-23||May 2006||2006-05-01|October 2014|2014-10-01|November 2008|Actual|2008-11-01|May 2007|Actual|2007-05-01||Interventional|LEAD-2||To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together|Liraglutide Effect and Action in Diabetes (LEAD-2): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Metformin Versus Metformin Monotherapy Versus Metformin and Glimepiride Combination Therapy in Subjects With Type 2 Diabetes|Completed||Phase 3|1091|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-02-18 16:35:58.96289|2017-02-18 16:35:58.96289
NCT00318448|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2009-04-06|||April 2006||2006-04-01|April 2009|2009-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|Zolkids||Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia|Efficacy, Safety and Tolerability of Zolpidem in the Treatment of Children Aged 6 to 17 Years With ADHD-Associated Insomnia. A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study|Completed||Phase 3|201|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:36:01.721605|2017-02-18 16:36:01.721605
NCT00318435|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2008-08-17|||May 2006||2006-05-01|April 2006|2006-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Fluency Stent-Graft Versus Luminex Stent for Angioplasty of Recurrent Stenosis of the Cephalic Arch in Autogenous Arteriovenous (AV) Access for Hemodialysis||Completed||Phase 4|50||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:36:01.815697|2017-02-18 16:36:01.815697
NCT00318422|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2017-01-24|||May 2006||2006-05-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|LEAD-1||Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes|Liraglutide Effect and Action in Diabetes (LEAD-1): Effect on Glycaemic Control After Once Daily Administration of Liraglutide in Combination With Glimepiride Versus Glimepiride Monotherapy Versus Glimepiride and Rosiglitazone Combination Therapy in Subjects With Type 2 Diabetes.|Completed||Phase 3|1041|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:36:01.895496|2017-02-18 16:36:01.895496
NCT00318409|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2014-10-09|2013-04-24||September 2006||2006-09-01|October 2014|2014-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM|Pilot Study of Acceptability of Bupropion Treatment for Methamphetamine Dependence Among Men Who Have Sex With Men.|Completed||Phase 2|30|Actual|San Francisco Department of Public Health||2|||f||||t||||||||||2017-02-18 16:36:02.365947|2017-02-18 16:36:02.365947
NCT00318396|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-23|2015-03-19|||June 2004||2004-06-01|March 2015|2015-03-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Compaction Femur Preparation for Cementless Total Hip Arthroplasty (THA) Unilateral|Compaction Femur Total Hip Arthroplasty (THA) Uni-lateral|Active, not recruiting||N/A|26|Actual|Northern Orthopaedic Division, Denmark||2|||f||||t||||||||||2017-02-18 16:36:02.883536|2017-02-18 16:36:02.883536
NCT00318383|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2017-01-11|||May 2006||2006-05-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy of NicVAX in Smokers Who Want to Quit Smoking|A Phase 2, Multi-center, Randomized, Double-blinded, Placebo-controlled Study to Assess Efficacy of 3'-Aminomethylnicotine-P.Aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) in Smokers Who Want to Quit Smoking|Completed||Phase 2|313|Actual|National Institute on Drug Abuse (NIDA)||6|||f||||t||||||||||2017-02-18 16:36:02.987224|2017-02-18 16:36:02.987224
NCT00318370|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2015-09-04|2012-01-27||May 2006||2006-05-01|September 2015|2015-09-01|June 2010|Actual|2010-06-01|February 2010|Actual|2010-02-01||Interventional|||Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy|A Study of the Efficacy of MORAb-003 in Subjects With Platinum-Sensitive Epithelial Ovarian Cancer in First Relapse|Completed||Phase 2|58|Actual|Morphotek||2|||f||||f||||||||||2017-02-18 16:36:03.112815|2017-02-18 16:36:03.112815
NCT00318357|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2008-05-30|||September 2006||2006-09-01|May 2008|2008-05-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|||CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up|CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up|Unknown status|Active, not recruiting|Phase 4|550|Anticipated|Medtronic Bakken Research Center|||1||f||||t||||||None Retained|"~     No biospecimens are retained~   "|||2017-02-18 16:36:03.664036|2017-02-18 16:36:03.664036
NCT00318344|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2010-02-01|||April 2006||2006-04-01|February 2010|2010-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Evaluation of Atuna Racemosa Toxicity|Evaluation of Atuna Racemosa Toxicity|Completed||Phase 1|20|Actual|Mayo Clinic|||||||||||||||||||2017-02-18 16:36:03.770293|2017-02-18 16:36:03.770293
NCT00318331|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2008-03-10|||May 2006||2006-05-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Enteral Glutamine in Critical Illness|Randomized Clinical Trial Comparing Enteral Glutamine Supplementation to Standard of Care Enteral Feeding in Critical Illness|Terminated||Phase 2/Phase 3|20|Actual|Christiana Care Health Services||2||Unable to meet enrollment numbers|f||||t||||||||||2017-02-18 16:36:03.855655|2017-02-18 16:36:03.855655
NCT00318318|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2009-07-08|||March 2006||2006-03-01|July 2009|2009-07-01|February 2007|Actual|2007-02-01|December 2006|Actual|2006-12-01||Interventional|||Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array|Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array|Completed||Phase 1|20|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 16:36:03.994512|2017-02-18 16:36:03.994512
NCT00318305|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2009-12-01|||March 2005||2005-03-01|December 2009|2009-12-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Patient Preference With Visicol Tablet Preparation for Colonoscopy|Patient Preference and Acceptance With Sodium Phosphate Tablet Preparation for Colonoscopy: A Prospective Study|Completed||N/A|53|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 16:36:04.214441|2017-02-18 16:36:04.214441
NCT00318292|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2010-10-22|2009-02-18||April 2006||2006-04-01|October 2010|2010-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Preemptive Local Anesthesia in Vaginal Surgery|Preemptive Local Anesthesia in Vaginal Surgery, A Prospective, Randomised Trial|Completed||Phase 4|90|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 16:36:04.290654|2017-02-18 16:36:04.290654
NCT00318266|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2008-11-12|||January 2006||2006-01-01|November 2008|2008-11-01|January 2009|Anticipated|2009-01-01|||||Observational|||NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers.|NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers|Unknown status|Recruiting|N/A|100|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-02-18 16:36:04.710248|2017-02-18 16:36:04.710248
NCT00318253|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2009-07-08|||March 2006||2006-03-01|July 2009|2009-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Effects of Cranberry Juice on Bacterial Adhesion|The Effects of Cranberry Juice on Urine and Bacterial Adhesion to Cells|Completed||N/A|12|Actual|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 16:36:04.793714|2017-02-18 16:36:04.793714
NCT00318240|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2009-02-10|||April 2006||2006-04-01|February 2009|2009-02-01|April 2009|Anticipated|2009-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU)|Feasibility Study for Locally Recurrent Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU)|Unknown status|Recruiting|N/A|40|Anticipated|Lawson Health Research Institute||1|||f||||f||||||||||2017-02-18 16:36:04.875156|2017-02-18 16:36:04.875156
NCT00318227|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2009-04-15|||June 2005||2005-06-01|April 2009|2009-04-01|May 2009|Anticipated|2009-05-01|April 2008|Anticipated|2008-04-01||Interventional|||Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients|Evaluation of a Liberal Versus Restrictive Blood Transfusion Strategy in Elderly Patients Following Coronary Bypass or Aortic Valve Surgery|Unknown status|Recruiting|N/A|74|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 16:36:04.97507|2017-02-18 16:36:04.97507
NCT00318214|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2012-05-24||2008-12-04|June 2006||2006-06-01|May 2012|2012-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers||Terminated||Phase 2|16|Actual|Pfizer||2||"The study had poor enrollment with only 16 patients randomized across 19 study centers over an~   18-month period."|f||||f||||||||||2017-02-18 16:36:05.066505|2017-02-18 16:36:05.066505
NCT00318201|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2012-04-05|||April 2006||2006-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers|The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers|Completed||Phase 4|7|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 16:36:05.371518|2017-02-18 16:36:05.371518
NCT00318188|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2014-07-17|||September 2005||2005-09-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|December 2011|Actual|2011-12-01||Interventional|SCLEREDUC||Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis|Effects of a Personalized Standardized Rehabilitation Program on the Quality of Life of Patients With Systemic Sclerosis Patients : a Randomized Controlled Trial|Completed||N/A|220|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 16:36:05.479077|2017-02-18 16:36:05.479077
NCT00318175|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2007-09-07|||June 2006||2006-06-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis|Study to Assess the Effect of Bosentan on the Treatment of Skin Fibrosis in Patients With Systemic Sclerosis (BTSF)|Completed||Phase 2|10|Anticipated|Heinrich-Heine University, Duesseldorf|||||f||||||||||||||2017-02-18 16:36:05.58608|2017-02-18 16:36:05.58608
NCT00318162|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2006-05-02||||||April 2006|2006-04-01||||||||Interventional|||Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)|Randomized Double-Blind Trial of Low-Dose Naltrexone for Children With PDD|Unknown status|Not yet recruiting|Phase 1/Phase 2|50|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:36:05.685791|2017-02-18 16:36:05.685791
NCT00318149|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2016-09-23|||October 2005||2005-10-01|September 2016|2016-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population|Demonstrate the Non-inferiority in Term of Cellular Mediated Immune Response of GSK Biologicals' Influenza Candidate Vaccines Containing Various Adjuvants Administered in Elderly Population (Aged 65 Years &Amp; Older) vs Fluarix™ (Known as Alpha-Rix™ in Belgium) Administered in Adults (18-40 Years)|Completed||Phase 2|425|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:05.784583|2017-02-18 16:36:05.784583
NCT00318136|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2010-05-05|2010-03-19||September 2005||2005-09-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)|A Pilot Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer|Completed||Phase 2|47|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 16:36:05.886338|2017-02-18 16:36:05.886338
NCT00318123|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2008-01-25|||April 2004||2004-04-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients|Multicentre, Open Label, Prospective, Randomised Clinical Trial to Evaluate the Effectiveness of Abacavir 600 mg+ Lamivudine 300 mg as QD+ Efavirenz 600 mg QD Versus Kaletra 400/100 mg BID as Initial Antiretroviral Treatment|Completed||Phase 3|126|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 16:36:06.170496|2017-02-18 16:36:06.170496
NCT00318110|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2016-07-25|||April 2006||2006-04-01|July 2016|2016-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma|Multicenter Phase II Study of Non-Myeloablative Allogeneic Stem Cell Transplantation Using Matched Unrelated Donor for Metastatic Renal Cell Carcinoma|Terminated||Phase 2|4|Actual|Center for International Blood and Marrow Transplant Research||1||Unable to meet subject enrollment goal.|f||||t||||||||No|Only 2 subjects enrolled prior to study closure due to slow accrual.|2017-02-18 16:36:06.297999|2017-02-18 16:36:06.297999
NCT00318097|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2006-05-01|||November 2003||2003-11-01|November 2004|2004-11-01||||||||Observational|||Histamine Responsiveness in McCune-Albright Syndrome|Histamine Responsiveness in Patients With McCune-Albright Syndrome|Unknown status|Recruiting|N/A|30||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 16:36:06.414579|2017-02-18 16:36:06.414579
NCT00318084|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2007-08-15|||January 2003||2003-01-01|August 2007|2007-08-01||||||||Interventional|||PPI Test in GP Patients|The Proton Pump Inhibitor Test in Reflux Disease: a Study Using Nexium in General Practice Patients|Completed||Phase 4|100||AstraZeneca|||||f||||||||||||||2017-02-18 16:36:06.514554|2017-02-18 16:36:06.514554
NCT00318071|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2014-11-06|||January 2004||2004-01-01|November 2014|2014-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|Multi-MERCI||Multi MERCI (Mechanical Embolus Removal in Cerebral Ischemia [MERCI™])|A Multinational Controlled Registry to Evaluate the Concentric Merci Retriever System (Mechanical Embolus Removal in Cerebral Ischemia [MERCI™])|Completed||N/A|164|Actual|Stryker Neurovascular||1|||f||||t||||||||||2017-02-18 16:36:06.614302|2017-02-18 16:36:06.614302
NCT00318058|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-25|2016-09-20|||October 2005||2005-10-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population|A Phase I/II, Open, Controlled Study in Order to Evaluate the Reactogenicity and the Immunogenicity of GlaxoSmithKline Biologicals Influenza Candidate Adjuvanted Vaccine in an Elderly Population Aged Over 65 Years Previously Vaccinated in 2004 With the Same Candidate Vaccine|Completed||Phase 1|84|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:06.72558|2017-02-18 16:36:06.72558
NCT00318045|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2006-04-21|||October 2005||2005-10-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Effects of Optical Blur on Performance and Comfort of Computer Users|Effects of Optical Blur on Performance and Comfort of Computer Users|Unknown status|Active, not recruiting|Phase 3|35||Vision Council of America|||||f||||||||||||||2017-02-18 16:36:06.814976|2017-02-18 16:36:06.814976
NCT00318032|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2014-07-01|||August 2004||2004-08-01|July 2014|2014-07-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Interventional|ADDITION||A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes|A Randomised Trial of the Cost Effectiveness of Screening and Intensive Multi-factorial Intervention for Type 2 Diabetes|Unknown status|Active, not recruiting|N/A|8579|Actual|University Hospitals, Leicester||1|||f||||||||||||||2017-02-18 16:36:06.904264|2017-02-18 16:36:06.904264
NCT00318019|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2011-11-16|||June 2006||2006-06-01|November 2011|2011-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of OPC Factor on Energy Levels|The Effect of OPC Factor on Energy Levels in Healthy Individuals Aged 45-65: A Randomized Controlled Trial|Completed||Phase 2|27|Actual|University of Pennsylvania||2|||f||||||||||||||2017-02-18 16:36:07.012411|2017-02-18 16:36:07.012411
NCT00318006|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2015-01-28|||December 2005||2005-12-01|January 2015|2015-01-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms|A Randomized Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms|Completed||Phase 4|127|Actual|University of Michigan||2|||f||||||||||||||2017-02-18 16:36:07.109763|2017-02-18 16:36:07.109763
NCT00317993|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2014-12-02|||April 2004||2004-04-01|December 2014|2014-12-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||LDL Receptor Under Ezetimibe and Simvastatin|Effects of Ezetimibe and Simvastatin on LDL Receptor Protein Expression and on LDL Receptor and HMG-CoA Reductase mRNA Expression in Mononuclear Cells: a Randomized Controlled Study in Healthy Men|Completed||Phase 4|60||University of Cologne|||||f||||||||||||||2017-02-18 16:36:07.235803|2017-02-18 16:36:07.235803
NCT00317980|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2009-01-20|||February 2006||2006-02-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|Lowdosesb||Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis|Phase IV Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of Low-Dose Pentavalent Antimony Compared to the Standard Dose in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)Braziliensis|Completed||Phase 4|280|Actual|University of Brasilia||2|||f||||f||||||||||2017-02-18 16:36:07.32506|2017-02-18 16:36:07.32506
NCT00317967|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2013-12-05|||April 2007||2007-04-01|December 2013|2013-12-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart|Statin Induced Regression of Cardiomyopathy Trial - SirCat|Completed||Phase 3|22|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 16:36:07.440224|2017-02-18 16:36:07.440224
NCT00317954|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2006-04-21|||September 2003||2003-09-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Spironolactone in Diabetic Nephropathy|Spironolactone in Diabetic Nephropathy|Completed||Phase 4|48||Steno Diabetes Center|||||f||||||||||||||2017-02-18 16:36:07.552047|2017-02-18 16:36:07.552047
NCT00317941|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2013-08-15|2013-05-24||March 2006||2006-03-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif|The AVANTAGE Study - A Randomized, Multicenter, Phase IV, Open-label Prospective Study Comparing Injection Site Reaction and Injection Site Pain in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) or After a First Demyelinating Event Suggestive of MS Newly Started on Interferon Beta-1b (Betaferon®) or Interferon Beta-1a (Rebif®).|Completed||Phase 4|220|Actual|Bayer||3|||f||||f||||||||||2017-02-18 16:36:07.654076|2017-02-18 16:36:07.654076
NCT00317928|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2006-10-10|||August 2001||2001-08-01|August 2001|2001-08-01|September 2004||2004-09-01|||||Interventional|||Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors||Unknown status|Active, not recruiting|N/A|50||Aarhus University Hospital Skejby|||||f||||||||||||||2017-02-18 16:36:08.619851|2017-02-18 16:36:08.619851
NCT00317915|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2006-04-24||||||April 2006|2006-04-01||||||||Interventional|||Irbesartan in Type 2 Diabetes|The Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2)|Completed||Phase 3|||Steno Diabetes Center|||||f||||||||||||||2017-02-18 16:36:08.699401|2017-02-18 16:36:08.699401
NCT00317902|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2011-05-17|||October 2002||2002-10-01|April 2010|2010-04-01|May 2004|Actual|2004-05-01|||||Interventional|||An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)|An Open-Label Study to Evaluate The Effect of Every Other Week PROCRIT (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients|Completed||Phase 4|292|Actual|Ortho Biotech Products, L.P.|||||f||||||||||||||2017-02-18 16:36:08.769357|2017-02-18 16:36:08.769357
NCT00317889|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-23|2016-01-21|||May 2001||2001-05-01|January 2016|2016-01-01|September 2018|Anticipated|2018-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Compaction Total Hip Arthroplasty (THA) Bilateral|Compaction THA Bilateral|Active, not recruiting||N/A|20|Actual|Northern Orthopaedic Division, Denmark||2|||f||||||||||||||2017-02-18 16:36:08.85695|2017-02-18 16:36:08.85695
NCT00005497|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1998||1998-04-01|October 2005|2005-10-01|March 2004|Actual|2004-03-01|||||Observational|||Risk Factors for Pulmonary Hypertension of the Newborn||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.44426|2017-02-18 18:14:54.44426
NCT00317876|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2012-04-18|||June 1998||1998-06-01|April 2012|2012-04-01||||July 2003|Actual|2003-07-01||Interventional|||Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia|Dose-Finding Study for Cyclophosphamide as Conditioning Regimens for Bone Marrow Transplantation From Related Donors in Patients With Fanconi Anemia|Completed||Phase 1|25|Actual|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 16:36:08.955016|2017-02-18 16:36:08.955016
NCT00317863|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-23|2014-03-28|||January 2004||2004-01-01|March 2014|2014-03-01|December 2006||2006-12-01|||||Observational|||Zink and Bone Strength|Zink and Bone Strength|Suspended||N/A|0||Northern Orthopaedic Division, Denmark||||The researcher has left the organization|f||||t||||||||||2017-02-18 16:36:09.066459|2017-02-18 16:36:09.066459
NCT00317850|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2012-02-29|||April 2004||2004-04-01|February 2012|2012-02-01|February 2006||2006-02-01|||||Interventional|||Gabapentin for the Treatment of Tinnitus|Gabapentin for the Relief of Idiopathic Subjective Tinnitus|Terminated||Phase 2/Phase 3|160||Washington University School of Medicine|||||f||||||||||||||2017-02-18 16:36:09.147438|2017-02-18 16:36:09.147438
NCT00317837|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-23|2014-03-28|||October 2004||2004-10-01|March 2014|2014-03-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Bipolar Versus Unipolar Hemiarthroplasty for Patients With a Hip Fracture|Bipolar vs. Unipolar Hemiarthroplasty for Patients Aged 70 Years or Above, With a Dislocated Medial Femoral Neck Fracture|Withdrawn||N/A|0|Actual|Northern Orthopaedic Division, Denmark||2||Recruitment was too slow, primary investigator has left the organisation|f||||||||||||||2017-02-18 16:36:09.224611|2017-02-18 16:36:09.224611
NCT00317811|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2013-11-05|||November 2005||2005-11-01|June 2011|2011-06-01||||February 2009|Actual|2009-02-01||Interventional|||Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma|A Phase II Trial of Bortezomib + Ascorbic Acid + Melphalan (BAM) Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma|Completed||Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:36:09.322643|2017-02-18 16:36:09.322643
NCT00317798|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2011-08-29|||April 2006||2006-04-01|August 2011|2011-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma|A Pilot, Phase-I Trial of Rabbit Anti-Thymocyte Globulin (rATG, Thymoglobulin™) in Combination With Rapamycin in Relapsed Multiple Myeloma (MM)|Completed||Phase 1|18|Anticipated|University of Rochester||1|||f||||||||||||||2017-02-18 16:36:09.435479|2017-02-18 16:36:09.435479
NCT00317785|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2010-05-05|||May 2005||2005-05-01|May 2010|2010-05-01||||November 2007|Actual|2007-11-01||Interventional|||Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases|A Phase II Trial of Total Body Irradiation Plus Metabolism-Based Cyclophosphamide Dosing as Preparative Therapy for Allogeneic Hematopoietic Cell Transplant for Patients With Hematological Malignancy|Completed||Phase 2|50|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 16:36:09.714869|2017-02-18 16:36:09.714869
NCT00317772|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2016-10-24|||September 2004||2004-09-01|October 2016|2016-10-01||||November 2006|Actual|2006-11-01||Interventional|||Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer|A Phase I/II Study of Weekly Topotecan and Gefitinib (Iressa) in Patients With Platinum-Resistant Ovarian, Peritoneal, of Fallopian Tube Cancer|Active, not recruiting||Phase 1/Phase 2|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:36:09.848366|2017-02-18 16:36:09.848366
NCT00317759|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2015-09-30|||May 2003||2003-05-01|May 2010|2010-05-01|October 2008|Actual|2008-10-01|||||Interventional|||Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma|Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following Fludarabine Lymphodepletion for Patients With Metastatic Melanoma|Completed||Phase 1|12|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 16:36:09.979478|2017-02-18 16:36:09.979478
NCT00317746|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2014-04-04|||November 2006||2006-11-01|April 2014|2014-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|PICCO||Trial of Citalopram for the Prevention of Depression|A Randomized, Placebo Controlled Trial of Citalopram for the Prevention of Depression and Its Consequences in HIV-Hepatitis C Co-infected Individuals Initiating Pegylated Interferon/Ribavirin Therapy|Completed||Phase 3|76|Actual|McGill University Health Center||2|||f||||t||||||||||2017-02-18 16:36:10.076417|2017-02-18 16:36:10.076417
NCT00317733|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2009-03-19||||||March 2009|2009-03-01|January 2004||2004-01-01|||||Interventional|||Ketoprofen in Transfersome Compared to Oral Celecoxib and Placebo for Pain Associated With Osteoarthritis of the Knee|A Double-Blind, Placebo-Controlled Evaluation of Safety and Efficacy of Epicutaneously Applied IDEA-033 (Ketoprofen in Transfersome) in Comparison to Oral Celecoxib for the Treatment of Pain Associated With Osteoarthritis of the Knee|Completed||Phase 2|360||IDEA AG|||||f||||||||||||||2017-02-18 16:36:10.203717|2017-02-18 16:36:10.203717
NCT00317720|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2014-06-12|2013-04-30||April 2006||2006-04-01|June 2014|2014-06-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Participants were pooled from 2 separate clinical trials (MDACC ClinicalTrials.gov ID NCT00317720) and (BIDMC/DFCI ClinicalTrials.gov ID NCT00458237)|Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer|Phase I-II Study of Trastuzumab in Combination With RAD001 in Patients With HER-2 Overexpressing, PTEN-deficient Metastatic Breast Cancer Progressing on Trastuzumab-Based Therapy|Completed||Phase 1/Phase 2|40|Actual|M.D. Anderson Cancer Center|Trial Results were combined for the 2 trials at MDACC & BIDMC/DFCI with US Food & Drug Administration approval for completion with adequate power. As results were pooled for analytic purposes, BIDMC/DFCI protocol was amended to match MDACC protocol.|1|||f||||f||||||||||2017-02-18 16:36:10.315352|2017-02-18 16:36:10.315352
NCT00317707|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2012-01-17|||February 2004||2004-02-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk|Risk and Prevention Study: Optimisation of the Preventive Strategies and Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk|Completed||Phase 3|12513|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||t||||||||||2017-02-18 16:36:10.632084|2017-02-18 16:36:10.632084
NCT00317694|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2009-07-21||2009-07-21|March 2006||2006-03-01|July 2009|2009-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients|A Multicentre Phase II Study With Magnesium Iron Hydroxycarbonate: an Open-label, Dose-ranging Phase Followed by a Placebo-controlled, Double-blind, Parallel-group Comparison in Haemodialysis Subjects With Hyperphosphataemia|Completed||Phase 2|111|Actual|Ineos Healthcare Limited||2|||f||||t||||||||||2017-02-18 16:36:10.741701|2017-02-18 16:36:10.741701
NCT00317681|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2007-09-07|||August 2005||2005-08-01|September 2007|2007-09-01|February 2007|Actual|2007-02-01|||||Interventional|||Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)|The Efficacy of Topical Tacrolimus in the Treatment of Cutaneous Lupus Erythematosus - a Multi-Center-Trial|Completed||Phase 2|30|Anticipated|Heinrich-Heine University, Duesseldorf|||||f||||||||||||||2017-02-18 16:36:10.879566|2017-02-18 16:36:10.879566
NCT00317668|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-23|2007-04-29|||November 2006||2006-11-01|April 2006|2006-04-01||||||||Observational|||Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients||Unknown status|Recruiting|N/A|250|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:36:10.985969|2017-02-18 16:36:10.985969
NCT00317655|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-23|2007-05-16|||April 2006||2006-04-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain|Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain - a Randomized, Double Blind, Placebo-Controlled Clinical Investigation With Parallel Groups for 3 Months to Enlighten Joint Health|Completed||Phase 4|175|Actual|Ferrosan AS||4|||f||||||||||||||2017-02-18 16:36:11.07084|2017-02-18 16:36:11.07084
NCT00317642|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2014-03-17|2011-08-11||August 2006||2006-08-01|March 2014|2014-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)|A Phase III Randomized, Double-blind, Controlled Study Comparing Clofarabine and Cytarabine Versus Cytarabine Alone in Adult Patients 55 Years and Older With Acute Myelogenous Leukemia (AML) Who Have Relapsed or Are Refractory After Receiving up to Two Prior Induction Regimens|Completed||Phase 3|326|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:36:11.229854|2017-02-18 16:36:11.229854
NCT00317629|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2010-11-23|||May 2006||2006-05-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis|Double Blind, Randomized Controlled Trial, to Evaluate the Effectiveness of a Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis|Terminated||Phase 3|178|Actual|Fundación Cardiovascular de Colombia||2||An interim analysis showed that nitric oxide patches are not enough effective|f||||t||||||||||2017-02-18 16:36:18.060975|2017-02-18 16:36:18.060975
NCT00317616|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-24|2016-07-18|||April 2006||2006-04-01|July 2016|2016-07-01||||December 2019|Anticipated|2019-12-01||Observational|Pre-fALS||The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study|The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study|Recruiting||N/A|500|Anticipated|University of Miami|||1||f||||f||||||Samples With DNA|"~     Serum, Plasma, CSF, DNA, Urine, Cell lines~   "|||2017-02-18 16:36:18.183284|2017-02-18 16:36:18.183284
NCT00317603|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2016-09-28|||November 2005||2005-11-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients|A Phase I Trial of Vaccination With Autologous, Lethally Irradiated Breast Cancer Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Colony Stimulating Factor in Metastatic Breast Cancer Patients|Active, not recruiting||Phase 1|20|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:36:18.276366|2017-02-18 16:36:18.276366
NCT00317590|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-23|2007-10-30|||April 2006||2006-04-01|October 2007|2007-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Effectiveness and Cost-Effectiveness of a Rapid Diagnostic Test for Malaria|Evaluation de l'utilité et du coût-efficacité du Test Rapide Paracheck® Pour la Prise en Charge Des Cas de Paludisme Dans Les régions Des Hauts Bassins et Des Cascades, au Burkina Faso|Completed||Phase 4|4000|Anticipated|Centro per le Malattie Tropicali|||||f||||||||||||||2017-02-18 16:36:18.372974|2017-02-18 16:36:18.372974
NCT00317577|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-23|2006-04-23|||December 1998||1998-12-01|April 2006|2006-04-01|May 2004||2004-05-01|||||Interventional|||Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma|A Multicenter, Double-Masked, 2-Arm Parallel Group Study Comparing the Effect of Brimonidine 0.2% Versus Timolol 0.5% on Visual Field Stability in Patients With Low-Pressure Glaucoma|Completed||Phase 2|160||Chicago Center for Vision Research|||||f||||||||||||||2017-02-18 16:36:18.456913|2017-02-18 16:36:18.456913
NCT00317564|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2013-12-05|||April 2006||2006-04-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Observational|||Betaseron Pregnancy Registry|Betaseron Pregnancy Registry|Completed||Phase 4|113|Actual|INC Research|||1||f||||t||||||||||2017-02-18 16:36:18.557627|2017-02-18 16:36:18.557627
NCT00317551|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2006-10-16|||April 2005||2005-04-01|December 2005|2005-12-01||||||||Interventional|||Cambridge Anti-Myopia Trial: Accommodation Training and Aberration Control in Myopia Development|Accommodation Training and Aberration Control in Myopia Development|Completed||Phase 2|200||Anglia Ruskin University|||||f||||||||||||||2017-02-18 16:36:18.651109|2017-02-18 16:36:18.651109
NCT00317538|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2011-05-18|||June 2003||2003-06-01|April 2010|2010-04-01|November 2004|Actual|2004-11-01|||||Interventional|||Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept|Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept|Completed||Phase 3|28|Actual|Centocor Ortho Biotech Services, L.L.C.|||||||||||||||||||2017-02-18 16:36:18.742533|2017-02-18 16:36:18.742533
NCT00317525|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2006-09-07|||May 2005||2005-05-01|May 2005|2005-05-01|June 2006||2006-06-01|||||Interventional|||Effects of Different Add Powers on the Comfort and Productivity of Computer Users With Fixed or Free Head Movement|Effects of Different Add Powers on the Comfort and Productivity of Computer Users With Fixed or Free Head Movement|Completed||Phase 3|36||American Optometric Association|||||f||||||||||||||2017-02-18 16:36:19.08399|2017-02-18 16:36:19.08399
NCT00317512|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2008-05-15|||December 2003||2003-12-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|April 2005|Actual|2005-04-01||Interventional|||Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization|A Multi-Center,Randomized,Double-Blind,Placebo-Controlled,Dose Finding Pilot Study, to Evaluate Safety/Feasibility of HBOC-201 in Elective Percutaneous Coronary Revascularization of Subjects With Acute Coronary Syndromes|Completed||Phase 2|45|Actual|Biopure Corporation||3|||f||||t||||||||||2017-02-18 16:36:19.18909|2017-02-18 16:36:19.18909
NCT00317499|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2010-12-22|||April 2000||2000-04-01|December 2010|2010-12-01|July 2002|Actual|2002-07-01|June 2002|Actual|2002-06-01||Interventional|||Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis|Double-Blind, Randomized, Placebo-Controlled Study of Etanercept (ENBREL) in the Treatment of Psoriatic Arthritis (PsA) and Psoriasis|Completed||Phase 3|205|Actual|Amgen||2|||f||||||||||||||2017-02-18 16:36:19.313523|2017-02-18 16:36:19.313523
NCT00317486|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2010-02-11||2010-02-11|September 2003||2003-09-01|February 2010|2010-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology|A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Tracleer (Bosentan) on Oxygen Saturation and Cardiac Hemodynamics in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology|Completed||Phase 4|54|Actual|Actelion|||||f||||||||||||||2017-02-18 16:36:19.410985|2017-02-18 16:36:19.410985
NCT00317473|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2016-08-19|||June 2003||2003-06-01|August 2016|2016-08-01|July 2005|Actual|2005-07-01|July 2004|Actual|2004-07-01||Interventional|||Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children|Double-blind,Randomized,Controlled,Dose Escalation Phase 1 Trial in 12-47 Month Old Children in Western Kenya to Evaluate the Safety and Immunogenicity of WRAIR's MSP-1(FMP1) Malaria Vaccine Adjuvanted in GSK's AS02A Versus Rabies Vaccine.|Completed||Phase 1|135||U.S. Army Medical Research and Materiel Command|||||f||||f||||||||||2017-02-18 16:36:19.506635|2017-02-18 16:36:19.506635
NCT00317460|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2014-07-08|||September 2005||2005-09-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|October 2009|Actual|2009-10-01||Interventional|||Buprenorphine and Integrated HIV Care|On-Site Addiction Treatment With Buprenorphine in HIV Clinical Care Settings|Completed||Phase 4|52|Actual|Yale University||2|||f||||f||||||||||2017-02-18 16:36:19.6039|2017-02-18 16:36:19.6039
NCT00317447|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2006-04-20|||February 2002||2002-02-01|April 2006|2006-04-01|April 2004||2004-04-01|||||Interventional|||The Efficacy of Oral Steroids in the Treatment of Acute Sciatica|Oral Steroids in the Treatment of Acute Sciatica A Randomized Controlled Study|Completed||Phase 3|160||Kaiser Permanente|||||f||||||||||||||2017-02-18 16:36:19.722339|2017-02-18 16:36:19.722339
NCT00317434|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2009-12-10|||November 2005||2005-11-01|December 2009|2009-12-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer|A Phase I Trial of Lapatinib in Combination With Carboplatin in Patients With Platinum Sensitive Recurrent Epithelial Ovarian Cancer|Terminated||Phase 1|12|Actual|University of Alabama at Birmingham||1||"Due to unacceptable non-dose limiting toxicities, excessive treatment delays and limited~   clinical responses."|||||||||||||||2017-02-18 16:36:19.828397|2017-02-18 16:36:19.828397
NCT00317421|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2006-04-20|||March 2004||2004-03-01|February 2004|2004-02-01|November 2005||2005-11-01|||||Interventional|||Effect of Regular Sildenafil on Blood Pressure and Arterial Function in Hypertension|Effects of Regular Treatment With Sildenafil on Blood Pressure and Endothelial Function in Untreated Hypertensives|Completed||Phase 2|20||University of Edinburgh|||||f||||||||||||||2017-02-18 16:36:19.922637|2017-02-18 16:36:19.922637
NCT00317408|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2015-09-24|||April 2004||2004-04-01|September 2015|2015-09-01||||February 2014|Actual|2014-02-01||Interventional|||Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma|Treatment Protocol for Relapsed Anaplastic Large Cell Lymphoma of Childhood and Adolescence|Active, not recruiting||N/A|96|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:36:20.031267|2017-02-18 16:36:20.031267
NCT00317395|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2014-11-17||2010-08-24|June 2006||2006-06-01|November 2014|2014-11-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|SEPIA-ACS1||Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome|A Randomized, Double-blind, Triple-dummy, Dose-ranging Study, Including an Active Control of Unfractionated Heparin and Eptifibatide, to Evaluate the Clinical Efficacy and Safety of Otamixaban, in Patients With Non-ST Elevation Acute Coronary Syndrome and Planned Early Invasive Strategy|Completed||Phase 2|3241|Actual|Sanofi||6|||f||||t||||||||||2017-02-18 16:36:20.372689|2017-02-18 16:36:20.372689
NCT00317382|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2015-02-18|||December 2004||2004-12-01|February 2015|2015-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Does Static Ultrasound-Preview Reduce the Incidence of Difficult Lumbar Puncture?|Does Static Ultrasound-Preview Reduce the Incidence of Traumatic and/or Difficult Lumbar Puncture? A Randomized Control Trial|Terminated||N/A|60|Actual|St. Luke's-Roosevelt Hospital Center||2||We could not get physicians in the ED to enroll patients.|f||||t||||||||||2017-02-18 16:36:20.707446|2017-02-18 16:36:20.707446
NCT00317369|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2008-04-28|||May 2006||2006-05-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease|A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease|Terminated||Phase 2|60|Anticipated|Otsuka Pharmaceutical Co., Ltd.||||Efficacy was not cleared at US study|f||||f||||||||||2017-02-18 16:36:20.814874|2017-02-18 16:36:20.814874
NCT00317356|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-21|2008-04-28|||May 2006||2006-05-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis|A Dose-Finding Study of OPC-6535 in Patients With Active Ulcerative Colitis|Terminated||Phase 2|160|Anticipated|Otsuka Pharmaceutical Co., Ltd.||||Efficacy was not cleared at US study|f||||f||||||||||2017-02-18 16:36:20.906869|2017-02-18 16:36:20.906869
NCT00317343|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2012-05-04|||March 2006||2006-03-01|May 2012|2012-05-01|February 2008|Anticipated|2008-02-01|||||Observational|||RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)|RIAPRE - A Non-interventional Registry on the Anticoagulation Treatment in High Risk Elective Percutaneous Coronary Interventions|Withdrawn||Phase 4|0|Actual|Nycomed|||1||f||||t||||||||||2017-02-18 16:36:20.997581|2017-02-18 16:36:20.997581
NCT00317330|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2010-08-26|||December 2004||2004-12-01|August 2006|2006-08-01|June 2005||2005-06-01|||||Interventional|||A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis|A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis|Completed||Phase 3|6400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:36:21.083434|2017-02-18 16:36:21.083434
NCT00317317|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2009-08-27|||October 2005||2005-10-01|August 2009|2009-08-01|November 2009|Anticipated|2009-11-01|November 2009|Anticipated|2009-11-01||Interventional|||The Effect of Acupuncture on Infertility With In-Vitro Fertilization (IVF) Patients|Acupuncture for Infertility Patients: The Effect on IVF|Unknown status|Active, not recruiting|Phase 1|60|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||1|||f||||t||||||||||2017-02-18 16:36:21.169191|2017-02-18 16:36:21.169191
NCT00317304|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2012-10-03|||January 2005||2005-01-01|October 2012|2012-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Mindfulness Based Stress Reduction for Hot Flashes|Mindfulness Based Stress Reduction for Hot Flashes|Completed||Phase 1|110|Actual|University of Massachusetts, Worcester||1|||f||||t||||||||||2017-02-18 16:36:21.270028|2017-02-18 16:36:21.270028
NCT00317291|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2009-09-16|||November 2005||2005-11-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Acupuncture/Moxibustion for Peripheral Neuropathy in HIV|Acu/Moxa for Peripheral Neuropathy in Persons With HIV|Completed||Phase 2|50|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 16:36:21.388503|2017-02-18 16:36:21.388503
NCT00317278|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2009-12-04|||October 2005||2005-10-01|December 2009|2009-12-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Effects of Massage on the Immune System of Preterm Infants|Effects of Massage on Immune System of Preterm Infants|Completed||Phase 1/Phase 2|120|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 16:36:21.483725|2017-02-18 16:36:21.483725
NCT00317265|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2006-10-12|||January 1999||1999-01-01|March 2006|2006-03-01|January 2005||2005-01-01|||||Interventional|||Coronary Bypass Surgery Trial: Complete Arterial Revascularization and Conventional Coronary Artery Surgery|Complete Arterial Revascularization and Conventional Coronary Artery Surgery Study (CARACCASS)-European Multicenter Study|Terminated||N/A|2000||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:36:21.588747|2017-02-18 16:36:21.588747
NCT00317252|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2012-10-19|||July 2006||2006-07-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization|"Angiotensin Converting Enzyme Inhibitors and Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization The CAPTAIN Trial"|Completed||Phase 2|220|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 16:36:21.696406|2017-02-18 16:36:21.696406
NCT00317239|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2013-09-16|2013-09-16||May 2005||2005-05-01|September 2013|2013-09-01|August 2007|Actual|2007-08-01|February 2007|Actual|2007-02-01||Interventional|||VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease|Comparison of Safety & Efficacy of a Unique Intravenous Iron (VIT45) Preparation vs Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease|Completed||Phase 3|255|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:36:21.817914|2017-02-18 16:36:21.817914
NCT00317226|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2015-06-08|2013-09-16||June 2005||2005-06-01|June 2015|2015-06-01|September 2007|Actual|2007-09-01|March 2007|Actual|2007-03-01||Interventional|||Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease|Open Label Extension Study Evaluating the Long Term Safety, Tolerability and Efficacy of an Iron Maintenance Dosing Strategy Utilizing Intravenous VIT45 in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease|Completed||Phase 3|145|Actual|Luitpold Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:36:22.222879|2017-02-18 16:36:22.222879
NCT00317213|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2008-04-09|||February 2002||2002-02-01|April 2008|2008-04-01|July 2002||2002-07-01|||||Interventional|||Smoking Cessation Assistance With LIBERTAL, A Phospholipid Mixture|Phase IIB Study of the Efficacy and Safety of LIBERTAL, A Phosphatidic-Acid-Enriched Phospholipid, on Smoking Cessation|Completed||Phase 2|500||Kaplan Medical Center|||||f||||||||||||||2017-02-18 16:36:22.472796|2017-02-18 16:36:22.472796
NCT00317200|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2011-04-28|||April 2006||2006-04-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer|Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer (SCLC): A Safety, Feasibility and Efficacy Study|Completed||Phase 2|34|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-02-18 16:36:22.557648|2017-02-18 16:36:22.557648
NCT00317187|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2011-09-29|||June 2004||2004-06-01|September 2011|2011-09-01||||||||Interventional|||Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.|Partially Blinded Study to Assess Reactogenicity & Safety of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ in Healthy Infants After a Hepatitis B Birth Dose|Completed||Phase 3|500||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:36:22.789584|2017-02-18 16:36:22.789584
NCT00317174|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2016-09-08|||July 2003||2003-07-01|September 2016|2016-09-01|April 2004|Actual|2004-04-01|||||Interventional|||A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.|Assess Immune Persistence & Memory by Giving Plain PRP,PSA & PSC (10 Mths Age), & Immunogenicity & Safety of a Tritanrix™-HBV/Hib-MenAC/ Tritanrix™-HBV/Hib2.5 Booster (15-18 Mths Age) in Previously Primed Subjects|Completed||Phase 2|450||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:22.878689|2017-02-18 16:36:22.878689
NCT00317161|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2016-09-19|||August 2004||2004-08-01|September 2016|2016-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.|Study to Show Lot-to-lot Consistency of Hib-MenAC Mixed With Tritanrix™-HBV, Its Non-inferiority to Tritanrix™-HBV/Hiberix™ With or Without Meningitec™, and MenA Response in 2, 4, 6 Month Infants With Hepatitis B Birth Dose|Completed||Phase 3|1000|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:22.973969|2017-02-18 16:36:22.973969
NCT00317148|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2006-09-06|||August 2005||2005-08-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Effect of Dehydroepiandrosterone (DHEA) on Hot Flashes in Postmenopausal Women|Phase II-III Placebo-Controlled, Study to Evaluate the Effects of DHEA on Vasomotor Symptoms (Hot Flashes) in Postmenopausal Women|Unknown status|Active, not recruiting|Phase 2/Phase 3|50||Centre Hospitalier Universitaire de Québec, CHU de Québec|||||f||||||||||||||2017-02-18 16:36:23.081401|2017-02-18 16:36:23.081401
NCT00317135|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2011-09-29|||December 2003||2003-12-01|September 2011|2011-09-01||||||||Interventional|||Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.|Assess Reactogenicity & Safety of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Compared to Tritanrix™-HepB/Hiberix™ (Control) in Healthy Infants (2,4,6 Mths Age), After a Hepatitis B Birth Dose|Completed||Phase 3|500||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:36:23.179102|2017-02-18 16:36:23.179102
NCT00316953|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2013-02-04|||March 2006||2006-03-01|January 2013|2013-01-01||||September 2009|Actual|2009-09-01||Interventional|||Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate|A Phase I Study of BMS-354825 (Dasatinib) in Children With Recurrent/Refractory Solid Tumors or Imatinib Resistant Ph+ Leukemia (BMS Trial CA180038)|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:36:25.590305|2017-02-18 16:36:25.590305
NCT00317122|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2016-09-20|||October 2004||2004-10-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth|Demonstrate Non-inferiority of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ With Respect to Anti-HBs Immune Response, When Given to Healthy Infants at 6,10 & 14 Weeks Age, After a Birth Dose of Hepatitis B Vaccine|Completed||Phase 3|192|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:23.2719|2017-02-18 16:36:23.2719
NCT00317109|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2016-10-27|||April 2006||2006-04-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects|Booster Vaccination Study to Assess Safety & Reactogenicity of a Dose of DTPw-HBV/Hib Vaccine and to Assess the Immunogenicity, Safety & Reactogenicity of a Dose of Mencevax™ ACW in Subjects Primed in Study 759346/007|Completed||Phase 3|168|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:23.373485|2017-02-18 16:36:23.373485
NCT00317096|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2016-09-06|||November 1998||1998-11-01|September 2016|2016-09-01|June 2021|Anticipated|2021-06-01|June 2001|Actual|2001-06-01||Interventional|||FCM Versus R-FCM Followed by R-Maintenance or Observation Only|Treatment of Relapsed CBCC, CC and LPIC Lymphoma With FCM Chemotherapy Alone or in Combination With the Monoclonal Anti CD 20 Antibody Rituximab Followed by Anti-CD 20 Maintenance or Observation Only|Active, not recruiting||Phase 3|319|Actual|Ludwig-Maximilians - University of Munich||4|||f||||f||||||||||2017-02-18 16:36:23.490328|2017-02-18 16:36:23.490328
NCT00317083|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2006-04-21|||November 2001||2001-11-01|January 2004|2004-01-01|February 2003||2003-02-01|||||Interventional|||Cough Reflex and Obstructive Sleep Apnea Syndrome|Effect of Obstructive Sleep Apnea Syndrome Associated With Obesity on Cough Reflex Threshold to Citric Acid|Completed||N/A|40||Bichat Hospital|||||f||||||||||||||2017-02-18 16:36:23.603086|2017-02-18 16:36:23.603086
NCT00317070|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2009-05-08|||April 2006||2006-04-01|May 2008|2008-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)|A Randomized Controlled Trial to Evaluate the Efficacy and Tolerability of Intravesical Cocktail and Comparison With Intravesical Dimethyl Sulfoxide (DMSO) for the Treatment of Painful Bladder Syndrome Including Interstitial Cystitis (PBS/IC)|Terminated||Phase 2|10|Actual|Nova Scotia Health Authority||2||Poor recruitment, poor patient compliance, lack of funding|f||||||||||||||2017-02-18 16:36:23.700088|2017-02-18 16:36:23.700088
NCT00317057|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2007-01-04|||April 2006||2006-04-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease|Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease|Unknown status|Recruiting|N/A|1500||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 16:36:23.972965|2017-02-18 16:36:23.972965
NCT00317044|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2014-05-09|2009-04-23||April 2006||2006-04-01|May 2014|2014-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|RELAX||Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma|A 6-month Randomized, Double-blind, Parallel-group, Multicentre, Placebo-controlled Phase II Study to Compare Anti-asthmatic Effect and Safety of Esomeprazole (Nexium®) 40 mg Twice Daily or 40 mg Once Daily With Placebo in Adults With Asthma|Completed||Phase 2|961|Actual|AstraZeneca|Numbers of patients analyzed in each of the Outcome Measures varies due to the amount of qualifying data captured for the patients.|3|||f||||||||||||||2017-02-18 16:36:24.067543|2017-02-18 16:36:24.067543
NCT00317031|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2008-06-26|||November 2002||2002-11-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Individually Adapted Therapy of Alcoholism|Individually Adapted Therapy of Alcoholism: Clinical Studies|Completed||Phase 4|435|Actual|Central Institute of Mental Health, Mannheim||3|||f||||||||||||||2017-02-18 16:36:24.936103|2017-02-18 16:36:24.936103
NCT00317018|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2014-04-25|||May 2008||2008-05-01|April 2014|2014-04-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Implementing Telemedicine-Based Collaborative Care for MDD in Contract CBOCs|Implementing Telemedicine-Based Collaborative Care for MDD in Contract CBOCs|Withdrawn||N/A|0|Actual|VA Office of Research and Development||2||This study was withdrawn prior to enrollment.|f||||f||||||||||2017-02-18 16:36:25.061298|2017-02-18 16:36:25.061298
NCT00317005|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-04-20|||April 2003||2003-04-01|May 2005|2005-05-01|March 2005||2005-03-01|||||Interventional|||Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events|Randomized Clinical Trial of Folate Therapy/Placebo for Reduction of Homocysteine Serum Levels in Uremic Patients and Influence on Cardiovascular Mortality|Completed||Phase 4|186||Universidade Estadual de Londrina|||||f||||||||||||||2017-02-18 16:36:25.17461|2017-02-18 16:36:25.17461
NCT00316992|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2010-05-31|||April 2006||2006-04-01|May 2010|2010-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease|A Study of the Safety of Ramelteon in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease|Completed||Phase 4|25|Actual|Takeda||1|||f||||f||||||||||2017-02-18 16:36:25.275405|2017-02-18 16:36:25.275405
NCT00316979|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2010-06-06|||April 2006||2006-04-01|June 2010|2010-06-01||||||||Interventional|||Efficacy of rTMS in the Treatment of Patients With Migraine|Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Migraine Using Somatosensory Evoked High-Frequency Oscillations as a Parameter: A 3-year Study.|Unknown status|Recruiting|N/A|80|Anticipated|Taipei Veterans General Hospital, Taiwan|||||f||||f||||||||||2017-02-18 16:36:25.418873|2017-02-18 16:36:25.418873
NCT00316966|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2010-08-09|||June 2003||2003-06-01|May 2005|2005-05-01||||||||Interventional|||A Clinical Trial to Determine Outcomes and Cost Effectiveness of Nutritional Intervention in Elderly Patients||Completed||N/A|180||Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:36:25.503267|2017-02-18 16:36:25.503267
NCT00316940|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2013-09-19|||December 2005||2005-12-01|December 2007|2007-12-01|February 2011|Actual|2011-02-01|June 2008|Actual|2008-06-01||Interventional|||Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase I Study of Samarium Sm-153 Lexidronam Combined With Bortezomib for Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 16:36:25.704643|2017-02-18 16:36:25.704643
NCT00316927|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2013-06-25|||December 2002||2002-12-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer|A Randomized Phase III Trial of Dexamethasone and Aspirin (DA) Versus Dexamethasone, Diethylstilbestrol and Aspirin (DAS) in Locally Advanced or Metastatic Cancer of the Prostate - Immediate Versus Deferred Diethylstilbestrol|Completed||Phase 3|260|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:36:25.802861|2017-02-18 16:36:25.802861
NCT00316914|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2016-07-11|2012-11-26||January 2006||2006-01-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|January 2008|Actual|2008-01-01||Interventional|||Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery|A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity|Completed||Phase 3|104|Actual|Alliance for Clinical Trials in Oncology|Data cutoff was done after 127 days because of premature study closure and because of the protocol modification mandating that the Ca/Mg therapy be discontinued.|2|||f||||t||||||||||2017-02-18 16:36:25.920556|2017-02-18 16:36:25.920556
NCT00316901|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2012-03-14|||April 2006||2006-04-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial|PET/CT Evaluation of Subjects Treated on Surgery Branch Adoptive Cell Therapy Protocols|Completed||Phase 2|70|Anticipated|National Institutes of Health Clinical Center (CC)||1|||||||||||||||||2017-02-18 16:36:26.978415|2017-02-18 16:36:26.978415
NCT00316888|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2016-10-17|2016-07-18||January 2007||2007-01-01|October 2016|2016-10-01|May 2022|Anticipated|2022-05-01|November 2015|Actual|2015-11-01||Interventional||all eligible and treated patients|Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer|Phase II Trial of Cetuximab Plus Cisplatin, 5- Fluorouracil and Radiation in Immunocompetent Patients With Anal Carcinoma|Active, not recruiting||Phase 2|63|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-02-18 16:36:27.079584|2017-02-18 16:36:27.079584
NCT00316875|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2013-11-06|||May 2006||2006-05-01|November 2013|2013-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer|A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of Lapatinib in Combination With Liposomal Doxorubicin in Patients With Metastatic Breast Cancer|Completed||Phase 1|23|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 16:36:28.107018|2017-02-18 16:36:28.107018
NCT00316862|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2016-08-11|||February 2006||2006-02-01|August 2016|2016-08-01||||December 2012|Actual|2012-12-01||Interventional|||Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery|A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer|Active, not recruiting||Phase 2|90|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 16:36:28.226359|2017-02-18 16:36:28.226359
NCT00316849|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2013-04-09|||May 2006||2006-05-01|April 2013|2013-04-01||||November 2010|Actual|2010-11-01||Interventional|||Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I Study of CCI-779, and Temozolomide in Combination With Radiation Therapy in Glioblastoma Multiforme|Completed||Phase 1|56|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:36:28.372974|2017-02-18 16:36:28.372974
NCT00316836|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2016-07-01|||April 2006||2006-04-01|July 2016|2016-07-01||||October 2010|Actual|2010-10-01||Observational|||Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole|The Association of Breast Density Changes, Plasma Hormone Changes, and Breast Cancer Recurrence: A Companion Study to NCIC CTG MA.27|Active, not recruiting||N/A|550|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     blood samples~   "|||2017-02-18 16:36:28.504453|2017-02-18 16:36:28.504453
NCT00316823|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2014-02-21|||July 2005||2005-07-01|December 2008|2008-12-01||||December 2009||2009-12-01||Interventional|||Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules|Gene Expression Analysis in Thyroid Nodule FNA Samples|Completed||N/A|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:36:29.024193|2017-02-18 16:36:29.024193
NCT00316810|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2012-06-18|||April 2006||2006-04-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Simultaneous Pancreas-kidney Transplantation With Campath Protocol|An Open-label, Randomized, Prospective Study to Investigate the Safety and Efficacy of Campath-1H as an Induction Agent in Combination With Tacrolimus Monotherapy Compared to Short-course ATG-induction in Combination With Tacrolimus, Mycophenolate Mofetil and Short-term Steroids Application in de Novo SPK Transplanted Diabetic Patients|Completed||Phase 3|30|Actual|Medical University Innsbruck||2|||f||||||||||||||2017-02-18 16:36:29.112482|2017-02-18 16:36:29.112482
NCT00316797|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2014-04-09|||April 2006||2006-04-01|April 2014|2014-04-01|January 2014|Actual|2014-01-01|December 2013|Actual|2013-12-01||Interventional|||Biodistribution and Safety of a Radiopharmaceutical in Healthy Subjects|Phase 1 Assessment of the Biodistribution and Safety of 123-I INER in Healthy Subjects|Completed||Phase 1|35|Actual|Institute for Neurodegenerative Disorders||1|||f||||t||||||||||2017-02-18 16:36:31.986285|2017-02-18 16:36:31.986285
NCT00316784|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2009-03-19|||July 2005||2005-07-01|March 2009|2009-03-01|May 2006||2006-05-01|||||Interventional|||IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA|A Double-Blind, Placebo-Controlled Evaluation of Dose Related Safety and Efficacy of Epicutaneously Applied IDEA-033 for 3 Months Treatment of OA of the Knee Followed by a Double-Blind, Dose-Controlled Evaluation of Safety and Efficacy of Epicutaneously Applied IDEA-033 for 12 Weeks Treatment of OA of the Knee|Completed||Phase 3|704||IDEA AG|||||f||||||||||||||2017-02-18 16:36:32.099906|2017-02-18 16:36:32.099906
NCT00316771|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2016-11-01||2016-07-07|November 2005||2005-11-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy|A Randomized, Double-blind, Placebo-controlled, Study to Determine the Efficacy and Safety of 5 Dose Regimens of RO4402257 in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate (MTX) Therapy.|Completed||Phase 2|374|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-02-18 16:36:32.177597|2017-02-18 16:36:32.177597
NCT00316758|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2016-11-01|||February 2006||2006-02-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.|A Multi-center, Open Label, Extension Study to Evaluate the Long-term Safety and Tolerability of GK Activator (2) in Type 2 Diabetic Patients From Studies BM18248 or BM18249|Completed||Phase 2|259|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 16:36:32.632547|2017-02-18 16:36:32.632547
NCT00316745|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2007-10-31|||April 2006||2006-04-01|October 2007|2007-10-01|March 2009|Anticipated|2009-03-01|||||Interventional|||IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer|Irinotecan Combined With S-1( IRIS ) Followed by mFOLFOX6 Regimen Versus mFOLFOX6 Followed by IRIS Regimen in Advanced Colorectal Cancer|Suspended||Phase 3|200|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||2||"Because of approval of Bevacizumab, it was difficult to perform clinical study in 1st line~   setting."|f||||t||||||||||2017-02-18 16:36:32.791744|2017-02-18 16:36:32.791744
NCT00316732|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2012-10-18|||October 2004||2004-10-01|October 2012|2012-10-01||||||||Interventional|||Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS|An Observational Study to Assess the Effectiveness of Avodart™(Dutasteride)in Subjects With Benign Prostatic Hyperplasia in Day to Day Clinical Practice|Completed||Phase 4|530||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:36:32.91474|2017-02-18 16:36:32.91474
NCT00316719|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2009-10-01|2009-06-15||January 2006||2006-01-01|October 2009|2009-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients|Phase III Study of Adefovir Dipivoxil Tablets in Patients With Compensated Chronic Hepatitis B -Comparative Study Against Lamivudine-|Completed||Phase 3|105|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:36:33.024941|2017-02-18 16:36:33.024941
NCT00316706|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2012-09-13|2009-11-12||October 2005||2005-10-01|September 2012|2012-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine|A Long-term, Open Follow-up of the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine (580299) in Healthy Female Subjects Vaccinated in Study HPV-013|Completed||Phase 3|1245|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:36:33.551555|2017-02-18 16:36:33.551555
NCT00316693|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2016-10-11|2009-11-12||April 2006||2006-04-01|October 2016|2016-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine|A Phase II Study to Assess the Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 (Cervarix TM) Vaccine Administered Intramuscularly According to a 0, 1, 6 Month Schedule in Healthy Japanese Female Subjects Aged 20 - 25 Years.|Completed||Phase 2|1046|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:34.306306|2017-02-18 16:36:34.306306
NCT00316680|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2016-10-06|||March 2006||2006-03-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.|Study to Assess Immunogenicity and Safety of GlaxoSmithKline Biologicals' Kft's DTPw-HBV/Hib vs DTPwCSL-HBV/Hib Kft and vs Concomitant Administration of CSL's Triple Antigen and GlaxoSmithKline Biologicals' Hiberix, to Infants at 2, 4, 6 Months of Age, After a Birth Dose of Hepatitis B|Terminated||Phase 3|288||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:36.14002|2017-02-18 16:36:36.14002
NCT00316667|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2012-10-02|||June 2006||2006-06-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|||||Observational|||Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and Allergy|Health2006 - an Observational Population-based Study of Cardiovascular Disease, Type 2 Diabetes, Asthma and Allergy|Completed||N/A|3471|Actual|Glostrup University Hospital, Copenhagen|||1||f||||||||||Samples With DNA|"~     Extracted DNA, urine, serum~   "|||2017-02-18 16:36:36.251834|2017-02-18 16:36:36.251834
NCT00316654|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2006-09-13|||February 2005||2005-02-01|September 2006|2006-09-01||||||||Interventional|||Persistence of Antibody Response to N. Meningitidis Group C in Children|A Phase IV, Multi-Center, Open-Label, Unrandomized Study to Evaluate the Persistence of Antibody Response to N. Meningitidis Group C, Before and After 2 Doses of the Conjugate Pneumococcal Vaccine, in Children Seven Months and Older Who Previously Received Immunization With Chiron Meningococcal C Conjugate Vaccine and a Hexavalent Infant Vaccine According to the Applicable Infant Immunization Schedule|Completed||Phase 4|573||Novartis|||||f||||||||||||||2017-02-18 16:36:36.343345|2017-02-18 16:36:36.343345
NCT00316641|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2006-11-06||||||March 2006|2006-03-01||||||||Interventional|||The Clinical Evaluation of Efficacy of Lipid-Lowing Tea on Hyperlipidemia Patients’ Lipid Profiles||Unknown status|Recruiting|Phase 3|||China Medical University Hospital|||||f||||||||||||||2017-02-18 16:36:36.434557|2017-02-18 16:36:36.434557
NCT00316628|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2006-09-13|||June 2005||2005-06-01|September 2006|2006-09-01||||||||Interventional|||Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.|A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, (Adjuvanted With MF59C.1) Influenza Vaccine, Formulation 2005-2006, When Administered to Elderly Subjects.|Completed||Phase 2|50||Novartis|||||f||||||||||||||2017-02-18 16:36:36.509056|2017-02-18 16:36:36.509056
NCT00316615|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2006-09-13|||June 2005||2005-06-01|September 2006|2006-09-01||||||||Interventional|||Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.|A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2005-2006, When Administered to Non-Elderly Adult and Elderly Subjects|Completed||Phase 2|100||Novartis|||||f||||||||||||||2017-02-18 16:36:36.593683|2017-02-18 16:36:36.593683
NCT00316602|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-20|2015-10-08|||July 2006||2006-07-01|October 2015|2015-10-01|April 2010|Actual|2010-04-01|November 2009|Actual|2009-11-01||Interventional|||A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis|A Multicenter, Open-label, Controlled Phase II Study to Evaluate Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in 18-40 Year Old Subjects With Diagnosed Atopic Dermatitis|Completed||Phase 2|632|Actual|Bavarian Nordic||2|||f||||t||||||||||2017-02-18 16:36:36.682564|2017-02-18 16:36:36.682564
NCT00316589|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2015-09-28|||June 2006||2006-06-01|September 2015|2015-09-01|October 2009|Actual|2009-10-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients|A Multicenter, Open-label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA-BN® (IMVAMUNE) Smallpox Vaccine in 18-55 Year Old Naive and Previously Vaccinated HIV Infected Subjects With CD4 Counts >200 - 750/µl.|Completed||Phase 2|581|Actual|Bavarian Nordic||3|||f||||t||||||||||2017-02-18 16:36:36.812354|2017-02-18 16:36:36.812354
NCT00316576|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2008-01-16|||May 2006||2006-05-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|||||Observational|||Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)|Evaluation of the Impact of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on the Development of Acute Renal Failure in Critically Ill Patients|Terminated||N/A|160|Anticipated|University Hospital, Caen||||The study was stopped on november 2006 after inclusion was fulfilled|f||||||||||||||2017-02-18 16:36:36.960947|2017-02-18 16:36:36.960947
NCT00316563|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2010-02-08|||August 2006||2006-08-01|November 2007|2007-11-01|November 2009|Actual|2009-11-01|||||Interventional|||Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study|A Double-blind, Randomized, Placebo Controlled Clinical Trial to Evaluate the Efficacy of Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study|Completed||Phase 2|80|Anticipated|AHS Cancer Control Alberta||2|||f||||t||||||||||2017-02-18 16:36:37.061193|2017-02-18 16:36:37.061193
NCT00316550|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2008-02-15|||April 2006||2006-04-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Interventional|||Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome|A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study to Assess the Effects of AV608 on Central Processing of Visceral Stimuli in Subjects With Irritable Bowel Syndrome|Terminated||Phase 1|24|Anticipated|Avera Pharmaceuticals||2||Animal Safety Data|f||||f||||||||||2017-02-18 16:36:37.18056|2017-02-18 16:36:37.18056
NCT00316537|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2007-08-07|||October 2006||2006-10-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers|A Multicenter, Randomized Study of the Safety and Preliminary Efficacy of Low-Dose Nicotine Gel (ATG002) in Patients With Plantar Diabetic Foot Ulcers|Terminated||Phase 1/Phase 2|48|Anticipated|CoMentis||||Sponsor Decision|f||||||||||||||2017-02-18 16:36:37.271824|2017-02-18 16:36:37.271824
NCT00316524|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2015-06-02|||May 2006||2006-05-01|June 2015|2015-06-01|August 2007|Actual|2007-08-01|||||Interventional|||A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects|A Partially Randomized, Partially Double-blind, Placebo-controlled Phase II Non-inferiority Study to Evaluate Immunogenicity and Safety of One and Two Doses of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in 18-55 Year Old Healthy Subjects|Completed||Phase 2|745|Actual|Bavarian Nordic||4|||f||||||||||||||2017-02-18 16:36:37.377553|2017-02-18 16:36:37.377553
NCT00316511|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2008-10-24|||March 2006||2006-03-01|October 2008|2008-10-01||||June 2008|Actual|2008-06-01||Interventional|||Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma|A Phase 1 Multi-Center, Dose Escalation and Pharmacokinetic Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma|Completed||Phase 1|21|Actual|Agenus Inc.|||||||||||||||||||2017-02-18 16:36:37.490084|2017-02-18 16:36:37.490084
NCT00316498|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2017-01-24|||October 17, 2002||2002-10-17|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease|A Phase I/II Randomized, Controlled Study of OGT 918 in Adult and Juvenile Patients With Niemann Pick C Disease|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:36:37.579087|2017-02-18 16:36:37.579087
NCT00316485|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2017-01-24|||April 14, 2006||2006-04-14|January 28, 2013|2013-01-28|January 28, 2013||2013-01-28|||||Observational|||Diagnosis, Evaluation and Treatment of Patients in Need of Third Molar Removal|Diagnosis, Evaluation and Treatment of Patients in Need of Third Molar Removal|Completed||N/A|718|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:36:37.670644|2017-02-18 16:36:37.670644
NCT00316472|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2009-01-14|||April 2006||2006-04-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|April 2007|Actual|2007-04-01||Interventional|||The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients|The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients|Completed||Phase 1|40||Washington University School of Medicine|||||f||||||||||||||2017-02-18 16:36:37.761409|2017-02-18 16:36:37.761409
NCT00316459|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2007-04-11|||May 2006||2006-05-01|April 2007|2007-04-01||||||||Interventional|||Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects|A Randomized, Double-Blind, Placebo and Moxifloxacin (Open-Label) Controlled, 4-Period, Crossover Study of the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects|Completed||Phase 1|64||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:36:37.938102|2017-02-18 16:36:37.938102
NCT00316446|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2012-09-18|||January 2006||2006-01-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Study to Determine Incidence of Hypoventilation in Patients Who Have Undergone Gastric Bypass|A Prospective Double Blind Pilot Study to Determine the Incidence of Postoperative Hypoventilation in Patients With Clinically Significant Obesity Who Have Undergone Gastric Bypass Procedures Under General Anesthesia|Completed||N/A|20|Actual|University of South Florida|||1||f||||f||||||||||2017-02-18 16:36:38.199712|2017-02-18 16:36:38.199712
NCT00316433|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2007-04-04|||February 2005||2005-02-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer|Phase II Study of Oxaliplatin and CPT-11 as First Line Treatment for Extensive Stage Small Cell Lung Cancer|Terminated||Phase 2|24||Swedish Medical Center|||||||||||||||||||2017-02-18 16:36:38.281436|2017-02-18 16:36:38.281436
NCT00316420|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2010-03-04|||December 2003||2003-12-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|February 2009|Actual|2009-02-01||Interventional|||Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer|Phase I Trial of Gemcitabine and Capecitabine (Xeloda) in Patients With Advanced Pancreatic Carcinoma|Completed||Phase 1|20|Actual|Swedish Medical Center||1|||f||||f||||||||||2017-02-18 16:36:38.361783|2017-02-18 16:36:38.361783
NCT00316407|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2011-02-16|||August 2005||2005-08-01|March 2010|2010-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients|Phase I/II Lapatinib Plus Carboplatin and Paclitaxel in Stage III or IV Relapsed Ovarian or Stage IV Breast Cancer Patients|Completed||Phase 1/Phase 2|30|Actual|Swedish Medical Center||1|||f||||f||||||||||2017-02-18 16:36:38.465745|2017-02-18 16:36:38.465745
NCT00316394|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-10-10|||November 2002||2002-11-01|April 2006|2006-04-01|March 2003||2003-03-01|||||Interventional|||Improving Preventive Service Delivery at Adult Complete Health Check-Ups|Improving Preventive Service Delivery at Adult Complete Health Check-Ups: the Preventive Health Evidence-Based Recommendation Form (PERFORM) Cluster Randomized Controlled Trial|Completed||N/A|||St. Michael's Hospital, Toronto|||||f||||||||||||||2017-02-18 16:36:38.595805|2017-02-18 16:36:38.595805
NCT00316381|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2008-05-20|||November 2004||2004-11-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Stem Cell Therapy to Improve Myocardial Function in Patients With Acute Myocardial Infarction|Myocardial REGeneration by Intracoronary Infusion of Selected Population of stEm Cells in Acute Myocardial iNfarcTion. Randomized Multicenter Trial|Completed||N/A|200|Anticipated|Silesian School of Medicine||3|||f||||t||||||||||2017-02-18 16:36:38.72038|2017-02-18 16:36:38.72038
NCT00316368|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2009-12-22|||October 2006||2006-10-01|December 2009|2009-12-01|October 2008|Actual|2008-10-01|||||Interventional|||A Study to Determine the Effect of Bi-Ventricular Pacing on Cardiac Hemodynamics After Coronary Artery Bypass Graft|A Study to Determine the Effect of Bi-Ventricular Pacing on Cardiac Hemodynamics After Coronary Artery Bypass Graft|Completed||Phase 1|60|Anticipated|St. Michael's Hospital, Toronto|||||f||||||||||||||2017-02-18 16:36:38.882854|2017-02-18 16:36:38.882854
NCT00316355|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2016-05-05|2016-03-29||June 2006||2006-06-01|May 2016|2016-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Participants randomized to treatment conditions|Stepped Care for Treating Obsessive-Compulsive Disorder|Stepped Care for Obsessive-Compulsive Disorder|Completed||N/A|34|Actual|Hartford Hospital||2|||f||||t||||||||No||2017-02-18 16:36:39.055396|2017-02-18 16:36:39.055396
NCT00316342|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2007-11-28|||January 1997||1997-01-01|November 2007|2007-11-01|November 2004|Actual|2004-11-01|||||Interventional|||Workplace Based Rehabilitation for Low Back Disorders|Workplace Based Rehabilitation for Low Back Disorders|Completed||Phase 3|433||Rush University Medical Center|||||f||||||||||||||2017-02-18 16:36:39.403113|2017-02-18 16:36:39.403113
NCT00316329|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2008-04-21|||March 2006||2006-03-01|April 2008|2008-04-01||||||||Interventional|||ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria|Multinational, Randomized, Comparative Study of the Efficacy and Safety of Three Therapeutic Regimens: Coarsucam™ (Artesunate + Amodiaquine Fixed-Dose Combination) Administered in 1 or 2 Intakes Per Day Versus Coartem® (Artemether + Lumefantrine) in the Treatment of Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 3|1032||Sanofi|||||f||||||||||||||2017-02-18 16:36:39.502032|2017-02-18 16:36:39.502032
NCT00316316|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2012-03-15|||March 2006||2006-03-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Cognitive Behavioral Therapy Plus Motivational Interviewing for Treatment of Obsessive-Compulsive Disorder|Cognitive Behavioral Therapy Plus Motivational Interviewing for Obsessive Compulsive Disorder|Completed||Phase 1|30|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 16:36:39.592062|2017-02-18 16:36:39.592062
NCT00316303|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2013-04-04|2013-04-04||February 2006||2006-02-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|April 2009|Actual|2009-04-01||Interventional|||Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder|The STIRR Intervention for Dually Diagnosed Clients|Completed||Phase 2|236|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||||||||||||2017-02-18 16:36:39.717742|2017-02-18 16:36:39.717742
NCT00316290|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2013-02-22|||April 2006||2006-04-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder|Integrated Treatment for Depressed Mothers of ADHD Children|Completed||N/A|98|Anticipated|University of Maryland||2|||f||||||||||||||2017-02-18 16:36:40.301058|2017-02-18 16:36:40.301058
NCT00316277|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2013-02-01|2012-05-08||May 2006||2006-05-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|July 2009|Actual|2009-07-01||Interventional|||Prescription Opioid Addiction Treatment Study (POATS)|A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Standard Medical Management or Enhanced Medical Management for Opioid Analgesic Dependence|Completed||Phase 3|653|Actual|Mclean Hospital|A treatment providing infrequent or no medical management was not included. It is not known if less intensive medical management would affect outcomes. Length of the trial may have also affected results. Pain severity was only moderate on average.|2|||f||||t||||||||||2017-02-18 16:36:40.40758|2017-02-18 16:36:40.40758
NCT00316264|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2012-11-13|2012-10-03||April 2006||2006-04-01|November 2012|2012-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season|A Phase 2, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), and Palivizumab When Administered in the Same Season|Completed||Phase 2|260|Actual|MedImmune LLC||3|||f||||t||||||||||2017-02-18 16:36:40.963178|2017-02-18 16:36:40.963178
NCT00316251|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-11-20|||April 2006||2006-04-01|April 2006|2006-04-01|September 2006||2006-09-01|||||Interventional|||Application of Specific Frequencies to Stimulate the Spinocerebellar Tract in Subjects With Unilateral Dysafferentation||Completed||N/A|2||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:36:42.089992|2017-02-18 16:36:42.089992
NCT00316238|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2007-06-06|||April 2006||2006-04-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia|A Double-Blind Dose-Response Study Comparing Rapid Acting Intramuscular Olanzapine and Intramuscular Placebo in Agitated Patients With Schizophrenia|Completed||Phase 2|160|Anticipated|Eli Lilly and Company|||||f||||||||||||||2017-02-18 16:36:42.173537|2017-02-18 16:36:42.173537
NCT00316225|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2010-06-10|2010-03-10||December 2006||2006-12-01|June 2010|2010-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen|A Phase 2 Study of ALIMTA in Solid Tumor Patients With Stable Third-Space Fluid|Completed||Phase 2|31|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:36:42.277304|2017-02-18 16:36:42.277304
NCT00316212|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2016-11-17|||April 2006||2006-04-01|November 2016|2016-11-01||||August 2006|Actual|2006-08-01||Interventional|||Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass|Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass|Terminated||Phase 2|160||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 16:36:43.00445|2017-02-18 16:36:43.00445
NCT00316199|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2009-06-12|2009-04-22||April 2006||2006-04-01|June 2009|2009-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer|Phase II Study of Gemcitabine-Paclitaxel 3-Weekly Schedule as First-Line Treatment in Metastatic Breast Cancer After Anthracycline Failure|Completed||Phase 2|60|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:36:43.11838|2017-02-18 16:36:43.11838
NCT00316186|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2015-04-20|2009-04-29||June 2005||2005-06-01|April 2015|2015-04-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin|An Open-label Phase II Study of Weekly Intravenous Hycamtin and Carboplatin as First-line Treatment of Chemonaive Subjects With Extensive Disease Small Cell Lung Cancer|Completed||Phase 2|33|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:36:43.537567|2017-02-18 16:36:43.537567
NCT00316173|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2012-11-21|2009-10-20||March 2005||2005-03-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer|An Open-Label, Single-Arm, Phase II Study of IV Weekly (Days 1 and 8 Every 21 Days) HYCAMTIN in Combination With Carboplatin (Day 1 Every 21 Days) as Second-Line Therapy in Subjects With Potentially Platinum-Sensitive Relapsed Ovarian Cancer|Completed||Phase 2|77|Actual|GlaxoSmithKline|As only 17 of 55 participants had CR/PR, the treatment was not effective. The follow up of participants for survival was thus stopped early (original plan: every 3 months for 2 years; then every 6 months for 3-5 years; then annually/until death).|1|||f||||t||||||||||2017-02-18 16:36:43.897778|2017-02-18 16:36:43.897778
NCT00316160|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2017-01-13|||September 2004||2004-09-01|February 2013|2013-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Sexual Functioning Study With Antidepressants|A Twelve-week, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group, Active Controlled, Escalating Dose Study to Compare the Effects on Sexual Functioning of Bupropion Hydrochloride Extended-release (WELLBUTRIN XL, 150-450 mg/Day) and Extended-release Venlafaxine (EFFEXOR XR, 75-225 mg/Day) in Subjects With Major Depressive Disorder|Completed||Phase 4|347||GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:36:44.646091|2017-02-18 16:36:44.646091
NCT00316147|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2016-09-27|||December 2005||2005-12-01|September 2016|2016-09-01|August 2006|Actual|2006-08-01|||||Interventional|||Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules|Phase IIIb, Open, Randomized, Multicenter Study to Assess the Immunogenicity & Safety of GSK Biologicals' Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants When Given at 6-10-14 Weeks of Age or at 2-4-6 Months of Age|Completed||Phase 3|224||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:44.804321|2017-02-18 16:36:44.804321
NCT00316134|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2011-11-07|||March 2006||2006-03-01|November 2011|2011-11-01|February 2008|Actual|2008-02-01|||||Observational|||Multiple Biomarkers in Undiagnosed Pleural Effusion|Evaluation of Multiple Biomarkers in Serum and Pleural Fluid to Estimate the Probability of Cancer in Patients Presenting With an Undiagnosed Pleural Effusion|Terminated||N/A|200|Actual|Fujirebio Diagnostics, Inc.|||1|The study was terminated on completion of the Pilot Study phase.|f||||f||||||Samples Without DNA|"~     Serum and pleural fluids~   "|||2017-02-18 16:36:44.916836|2017-02-18 16:36:44.916836
NCT00316121|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2011-02-08|2011-01-19||April 2006||2006-04-01|February 2011|2011-02-01||||January 2010|Actual|2010-01-01||Interventional|||Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease|A Prospective, Multicenter, Randomized Study Comparing the Use of HEALOS® to Autograft in a Transforaminal Lumbar Interbody Fusion (TLIF) Approach|Completed||Phase 3|138|Actual|Advanced Technologies and Regenerative Medicine, LLC (ATRM)|Stringent criteria for endpoint.Minimum sample size not reached; no hypothesis testing.High portion of current/prior smokers in both groups may impact fusion success.Product usage was appropriate and not low.This study is not on label for HEALOS.|2|||f||||||||||||||2017-02-18 16:36:45.044748|2017-02-18 16:36:45.044748
NCT00316108|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2014-08-26|||February 2002||2002-02-01|August 2014|2014-08-01|November 2007|Actual|2007-11-01|May 2005|Actual|2005-05-01||Interventional|BEACH||Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)|Boston Scientific EPI: A Carotid Stenting Trial for High-Risk Surgical Patients|Completed||N/A|747|Actual|Boston Scientific Corporation||1|||f||||t||||||||||2017-02-18 16:36:45.563251|2017-02-18 16:36:45.563251
NCT00316095|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-19|2013-10-31|||April 2006||2006-04-01|October 2013|2013-10-01|August 2007||2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia|Reduced Factorial Design, Randomized, Double Blind Trial Comparing Combinations of Telmisartan 20 or 80 mg and Simvastatin 20 or 40 mg With Single Component Therapies in the Treatment of Hypertension and Dyslipidemia|Completed||Phase 3|1695||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:36:45.738478|2017-02-18 16:36:45.738478
NCT00316082|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2015-04-08|2009-08-17||June 2006||2006-06-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise|Completed||Phase 3|365|Actual|AstraZeneca||5|||f||||||||||||||2017-02-18 16:36:46.187023|2017-02-18 16:36:46.187023
NCT00316069|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2017-01-24|||April 12, 2006||2006-04-12|December 23, 2016|2016-12-23||||||||Observational|||Stem Cell Collection|Peripheral Blood Collection of Adult Stem Cells|Recruiting||N/A|999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:36:47.314156|2017-02-18 16:36:47.314156
NCT00316056|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2017-01-24|||April 14, 2006||2006-04-14|August 25, 2009|2009-08-25||||October 17, 2007|Actual|2007-10-17||Observational|||Use of Virtual Reality to Communicate Concepts of Genomics to the General Public|Using Virtual Reality to Test Communication Strategies for Genomic Concepts|Completed||N/A|346||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:36:47.422487|2017-02-18 16:36:47.422487
NCT00316043|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2007-07-30|||May 2006||2006-05-01|July 2007|2007-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Prevention of Renal Failure in Children With Urinary Tract Infections|Prevention of Renal Failure in Children With Urinary Tract Infections in General Practice: Current Clinical Management, Possibilities for Improvement and Potential Cost-Efficiency|Completed||N/A|124|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 16:36:47.503801|2017-02-18 16:36:47.503801
NCT00316017|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2011-02-25|2010-09-02||May 2006||2006-05-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Hypertonic Resuscitation Following Traumatic Injury|Phase 3 Study of Hypertonic Resuscitation Following Traumatic Injury With Hypovolemic Shock|Terminated||Phase 3|895|Actual|University of Washington|The trial was stopped early for futility in the presence of a potential safety concern regarding increased mortality among patients receiving hypertonic solutions and no blood transfusions. This was no longer evident 6 hr after hospital admission.|3||"Futility & potential safety concern (increased early mortality in the HS/HSD arms for those~   with no PRBC in 1st 24 hr, post-randomization subgp)"|f||||t||||||||||2017-02-18 16:36:47.720488|2017-02-18 16:36:47.720488
NCT00316004|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2011-05-16|2011-02-11||May 2006||2006-05-01|May 2011|2011-05-01|January 2010|Actual|2010-01-01|May 2009|Actual|2009-05-01||Interventional|||Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)|Phase 3 Study of Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)|Terminated||Phase 3|1331|Actual|University of Washington|The trial was stopped early for futility at a planned data and safety monitoring board review. The futility boundary was crossed for each of the 2 group comparisons (hypertonic saline/dextran vs normal saline and hypertonic saline vs normal saline).|3||Futility|f||||t||||||||||2017-02-18 16:36:48.96993|2017-02-18 16:36:48.96993
NCT00315991|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2013-01-14|||April 2006||2006-04-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Blood Glucose Awareness Training for Parents|Parent-Child Co-Regulation of Pediatric Diabetes, Phase 2|Completed||N/A|77|Actual|University of Virginia||2|||f||||||||||||||2017-02-18 16:36:52.707202|2017-02-18 16:36:52.707202
NCT00315978|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2007-07-09|||June 2003||2003-06-01|April 2006|2006-04-01|February 2004||2004-02-01|||||Interventional|||The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention|Decision Aid to Improve Coronary Heart Disease Risk Modification: a Pilot Randomized Trial|Completed||N/A|120||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 16:36:52.812495|2017-02-18 16:36:52.812495
NCT00315965|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2007-06-13|||July 2006||2006-07-01|May 2007|2007-05-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects|Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy Subjects|Unknown status|Recruiting|Phase 1|107|Anticipated|University Hospital Tuebingen|||||f||||t||||||||||2017-02-18 16:36:52.909476|2017-02-18 16:36:52.909476
NCT00315952|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2008-02-15|||April 2006||2006-04-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|||||Interventional|||Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes|Open-Label Randomized Two-Way Crossover Pilot Study to Estimate the Effects of Inhaled vs. IV Infusion of Human Insulin With Regards to Glucose Disposal in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 4|12|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 16:36:53.009216|2017-02-18 16:36:53.009216
NCT00315939|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2014-09-09|2014-08-08||January 2006||2006-01-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|BPK002||Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 Diabetes|Improving Metabolic Control and Reducing Hypoglycemic Risk in Type 1 Diabetes Mellitus With Biological and Behavioral Feedback|Completed||N/A|120|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 16:36:53.106344|2017-02-18 16:36:53.106344
NCT00315926|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2010-06-29|||January 2007||2007-01-01|November 2006|2006-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Melatonin and Cardiac Outcome After Major Surgery|Melatonin and Cardiac Morbidity After Elective Abdominal Aortic Aneurism Repair|Completed||Phase 2/Phase 3|52|Actual|University Hospital, Gentofte, Copenhagen||2|||f||||t||||||||||2017-02-18 16:36:53.421968|2017-02-18 16:36:53.421968
NCT00315913|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2014-12-05|||January 2004||2004-01-01|December 2014|2014-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor|Placebo-Controlled Randomized Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Dysfunctional Labor|Terminated||Phase 2|2|Actual|University of California, Irvine||2||Low study enrollment|f||||f||||||||||2017-02-18 16:36:53.770219|2017-02-18 16:36:53.770219
NCT00315900|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2012-08-30|||May 2006||2006-05-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia|Depakote ER vs. Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia|Completed||Phase 3|20|Actual|Tuscaloosa Research & Education Advancement Corporation||2|||f||||f||||||||||2017-02-18 16:36:53.886591|2017-02-18 16:36:53.886591
NCT00315887|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-05-01|||April 1999||1999-04-01|April 2006|2006-04-01|October 1999||1999-10-01|||||Interventional|||The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.|A Double-Blind Comparative Study of Buprenorphine Transdermal System (BTDS) and Hydrocodone/Acetaminophen Tablets in Patients With Chronic Back Pain|Completed||Phase 3|250||Purdue Pharma LP|||||||||||||||||||2017-02-18 16:36:54.000973|2017-02-18 16:36:54.000973
NCT00315874|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2013-05-13|||April 1997||1997-04-01|May 2013|2013-05-01|January 1998||1998-01-01|||||Interventional|||The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.|Safety and Efficacy of Buprenorphine TDS (Transdermal Delivery System) 5, 10 and 20 Applied Every 7 Days for Sixty Days vs. 5 mg Oxycodone/325 mg Acetaminophen Tablets q6h Prn vs. Placebo in Patients With Chronic Low Back Pain|Completed||Phase 3|225||Purdue Pharma LP|||||||||||||||||||2017-02-18 16:36:54.114073|2017-02-18 16:36:54.114073
NCT00315861|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2009-01-22|||March 2006||2006-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|May 2008|Actual|2008-05-01||Interventional|||Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies|A Phase I Study of Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies|Completed||Phase 1|15|Anticipated|SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 16:36:54.219796|2017-02-18 16:36:54.219796
NCT00315848|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-04-29|||November 1996||1996-11-01|April 2006|2006-04-01|December 1999||1999-12-01|||||Interventional|||The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.|A Multi-Center, Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy of Buprenorphine Transdermal Delivery System Vs. Oxycodone/Acetaminophen Tablets Vs. Placebo in Patients With Chronic Pain Due to Osteoarthritis|Completed||Phase 3|225||Purdue Pharma LP|||||||||||||||||||2017-02-18 16:36:54.321615|2017-02-18 16:36:54.321615
NCT00005496|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1998||1998-09-01|February 2005|2005-02-01|August 2002|Actual|2002-08-01|||||Observational|||Inflammation, Infection, and Future Cardiovascular Risk||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.515398|2017-02-18 18:14:54.515398
NCT00315835|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2006-04-17|||October 1996||1996-10-01|April 2006|2006-04-01|November 1997||1997-11-01|||||Interventional|||Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.|A Single Dose, Randomized, Double-Blind, Parallel Group Study of the Safety and Pharmacokinetics of Buprenorphine TDS (12.5, 25, 50 Mcg/Hour) Vs. Placebo in Patients With Moderate to Severe Pain Following Orthopedic Surgery|Completed||Phase 2|100||Purdue Pharma LP|||||||||||||||||||2017-02-18 16:36:54.428938|2017-02-18 16:36:54.428938
NCT00315822|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2009-02-05|||May 2006||2006-05-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Supplemental Postoperative Oxygen and Wound Infection in Morbidly Obese Patients|Supplemental Postoperative Oxygen & Wound Infection in Morbidly Obese Patients|Terminated||Phase 3|1276|Anticipated|Outcomes Research Consortium||2||Study was terminated due to futility|f||||f||||||||||2017-02-18 16:36:54.535982|2017-02-18 16:36:54.535982
NCT00315809|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2011-06-22|||April 2006||2006-04-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|||||Observational|||Molecular Epidemiology of Leprosy - Philippines|Molecular Epidemiology of Leprosy - Philippines|Completed||N/A|310|Actual|Colorado State University|||1||f||||f||||||||||2017-02-18 16:36:54.645215|2017-02-18 16:36:54.645215
NCT00315796|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2015-03-31|||August 2004||2004-08-01|January 2005|2005-01-01|June 2005||2005-06-01|||||Interventional|||Nature Sights and Sounds to Reduce Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy|Nature Sights and Sounds to Reduce Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy|Completed||Phase 3|120||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:36:54.739353|2017-02-18 16:36:54.739353
NCT00315783|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2006-04-17|||April 2006||2006-04-01|April 2006|2006-04-01|June 2006||2006-06-01|||||Observational|||Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy|Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy|Unknown status|Recruiting|N/A|30||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:36:54.830391|2017-02-18 16:36:54.830391
NCT00315770|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-04-20|||January 2004||2004-01-01|April 2006|2006-04-01|April 2005||2005-04-01|||||Interventional|||Health of Young European Families and Fish Consumption|Health of Young European Families and Fish Consumption|Unknown status|Active, not recruiting|Phase 1|320||Landspitali University Hospital|||||f||||||||||||||2017-02-18 16:36:54.91403|2017-02-18 16:36:54.91403
NCT00315757|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2013-08-01||2011-03-30|May 2006||2006-05-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma|A Phase 2, Multi-Center, Open-Label, Randomized Study of Mapatumumab (TRM-1 [HGS1012], a Fully Human Monoclonal Antibody to TRAIL-R1) in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|105|Actual|Human Genome Sciences Inc.||3|||f||||f||||||||||2017-02-18 16:36:55.00315|2017-02-18 16:36:55.00315
NCT00315744|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2011-03-17|||November 2004||2004-11-01|March 2011|2011-03-01||||||||Interventional|||Viapaed Study In Children And Adolescents With Asthma|Steroid-sparing Management of the Salmeterol/Fluticasone 50/100µg b.i.d. Combination Compared to Fluticasone 200µg b.i.d. in Children and Adolescents With Moderate Asthma|Completed||Phase 4|380||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:36:55.126356|2017-02-18 16:36:55.126356
NCT00315731|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2016-11-18|2012-03-29||March 2003||2003-03-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|December 2006|Actual|2006-12-01||Interventional|||A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma|A Multi-Center Study to Examine the Pharmacokinetics, Whole Body and Organ Dosimetry, and Biodistribution of Fission-Derived Iodine I 131 Tositumomab for Patients With Previously Untreated or Relapsed Follicular or Transformed Follicular Non-Hodgkin's Lymphoma|Completed||Phase 1|15|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:36:55.523651|2017-02-18 16:36:55.523651
NCT00315718|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-04-18|||June 2002||2002-06-01|April 2006|2006-04-01|June 2005||2005-06-01|||||Interventional|||Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)|Controlled Clinical Trial on Long Term Effects of Hintonia Latiflora Extract in Mild to Moderate Type 2 Diabetes|Completed||Phase 3|10||Harras Pharma Curarina GmbH|||||f||||||||||||||2017-02-18 16:36:56.13381|2017-02-18 16:36:56.13381
NCT00315705|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2014-03-17|2011-04-27||March 2006||2006-03-01|March 2014|2014-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.|A Phase 1/2 Dose-Escalation Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Pediatric Patients With Refractory or Relapsed Acute Leukemias.|Completed||Phase 1/Phase 2|50|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:36:56.26683|2017-02-18 16:36:56.26683
NCT00315692|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2011-11-07|||December 2005||2005-12-01|November 2011|2011-11-01|February 2007|Actual|2007-02-01|||||Observational|||Risk of Ovarian Cancer in Patients With a Pelvic Mass|Evaluation of a Multiple Biomarker Assay to Estimate the Risk of Ovarian Cancer in Patients Presenting With a Pelvic Mass.|Completed||N/A|566|Actual|Fujirebio Diagnostics, Inc.|||2||f||||f||||||Samples Without DNA|"~     Serum, plasma and urine~   "|||2017-02-18 16:37:00.17636|2017-02-18 16:37:00.17636
NCT00315679|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2006-04-18|||June 1996||1996-06-01|March 2006|2006-03-01|November 1998||1998-11-01|||||Interventional|||A Trial of Pentoxifylline for the Treatment of Recurrent Aphthous Stomatitis||Completed||N/A|30||Central Manchester University Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:37:00.306777|2017-02-18 16:37:00.306777
NCT00315666|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2009-02-19|||May 2006||2006-05-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Prophylactic Effect of Memantine in Chronic Tension-Type Headache|Prophylactic Effect of Memantine in Chronic Tension-Type Headache|Completed||Phase 3|40||Danish Headache Center|||||f||||t||||||||||2017-02-18 16:37:00.417751|2017-02-18 16:37:00.417751
NCT00315653|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-18|2008-03-12|||September 2005||2005-09-01|March 2008|2008-03-01|November 2007|Actual|2007-11-01|||||Observational|||Survivin Urine mRNA Assay Risk of Bladder Cancer Study|Evaluation of the Survivin Urine mRNA Assay to Estimate Risk of Bladder Cancer Found on Cystoscopy|Completed||N/A|600||Fujirebio Diagnostics, Inc.|||||f||||||||||||||2017-02-18 16:37:00.512021|2017-02-18 16:37:00.512021
NCT00314873|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2014-05-30|||April 2006||2006-04-01|May 2014|2014-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma|Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma|Completed||Phase 1|11|Actual|Indiana University||1|||f||||||||||||||2017-02-18 16:37:18.083068|2017-02-18 16:37:18.083068
NCT00315640|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2012-11-27||2012-11-27|December 2005||2005-12-01|January 2010|2010-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation|A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation|Completed||Phase 2|70|Actual|Alcon Research||4|||f||||||||||||||2017-02-18 16:37:00.86421|2017-02-18 16:37:00.86421
NCT00315627|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-11-09|||July 2005||2005-07-01|November 2016|2016-11-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation|Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation|Completed||Phase 2|3|Actual|University of Miami||1|||f||||f||||||||||2017-02-18 16:37:00.984202|2017-02-18 16:37:00.984202
NCT00315614|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2014-04-16|2013-12-20||December 2000||2000-12-01|March 2014|2014-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus|Islet Cell Transplantation Alone and CD34+ Enriched Donor Bone Marrow Cell Infusion in Patients With Type 1 Diabetes Mellitus; Steroid Free Regimen|Completed||Phase 2|3|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 16:37:01.106703|2017-02-18 16:37:01.106703
NCT00315601|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2009-02-12|||January 2006||2006-01-01|February 2009|2009-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Intrapulmonary Pharmacokinetics of Antibiotics|Comparison of the Intrapulmonary and Plasma Concentrations of Telithromycin and Azithromycin in Healthy Adult Subjects|Terminated||Phase 4|35|Actual|University of Illinois at Chicago||1||Sanofi-Aventis wanted the study terminated.|f||||f||||||||||2017-02-18 16:37:01.357518|2017-02-18 16:37:01.357518
NCT00315588|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-11-09|||December 2000||2000-12-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation|Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation|Completed||Phase 2|7|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 16:37:01.47352|2017-02-18 16:37:01.47352
NCT00315575|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2009-01-22|||August 2005||2005-08-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Memory Imaging of Normal Aging|BOLD and Perfusion fMRI of Alzheimer's Disease Risk|Completed||N/A|90|Anticipated|National Institute on Aging (NIA)|||2||f||||f||||||||||2017-02-18 16:37:01.603149|2017-02-18 16:37:01.603149
NCT00315562|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2015-02-03|||April 2006||2006-04-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Study of Early Versus Delayed Carotid Endarterectomy (CEA) for Small to Medium-sized Ischemic Stroke Caused by High-grade Carotid Stenosis|Pilot Study of Early Versus Delayed Carotid Endarterectomy (CEA) for Small to Medium-sized Ischemic Stroke Caused by High-grade Carotid Stenosis|Withdrawn||Phase 1|0|Actual|University of California, San Diego||2|||f||||||||||||||2017-02-18 16:37:01.732597|2017-02-18 16:37:01.732597
NCT00315549|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2009-04-02|||February 2006||2006-02-01|April 2009|2009-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults|Multinational, Randomized, Double Blind, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 800 mg od Versus 10 Days Penicillin V 500 mg Tid in Adolescent and Adult Subjects Equal to or Over 13 Years With Streptococcus Pyogenes Tonsillitis/Pharyngitis|Terminated||Phase 3|233|Actual|Sanofi||||Pediatric development program terminated by sponsor|f||||||||||||||2017-02-18 16:37:01.83721|2017-02-18 16:37:01.83721
NCT00315536|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2012-01-03|||May 2006||2006-05-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children|Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children|Completed||Phase 2|63|Actual|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:37:01.937632|2017-02-18 16:37:01.937632
NCT00315523|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2013-12-13|||July 2006||2006-07-01|May 2012|2012-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen|Double-blind, 3 Parallel Randomized Groups, Therapeutic Confirmatory. Clinical Trial to Compare the Efficacy of Levocetirizine 5 mg and Montelukast 10 mg to Placebo in Reducing SAR Symptoms in Ragweed Sensitive Subjects in an EEC.|Completed||Phase 3|403||UCB Pharma|||||f||||||||||||||2017-02-18 16:37:02.030785|2017-02-18 16:37:02.030785
NCT00315510|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2008-09-22|||April 2006||2006-04-01|September 2008|2008-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Rosuvastatin and Ischemia Reperfusion|Does Rosuvastatin Reduce Ischemia/Reperfusion Injury in Humans In-Vivo? A Randomized Double Blind Placebo Controlled Trial|Completed||Phase 2|20||Radboud University|||||f||||||||||||||2017-02-18 16:37:02.133286|2017-02-18 16:37:02.133286
NCT00315497|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-11-11|||April 2006||2006-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis|Longitudinal Protocol for Giant Cell Arteritis|Recruiting||N/A|500|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"~     Blood (serum and plasma), urine, and DNA~   "|No||2017-02-18 16:37:02.229982|2017-02-18 16:37:02.229982
NCT00315484|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2011-05-17|||February 2003||2003-02-01|April 2010|2010-04-01|October 2004|Actual|2004-10-01|||||Interventional|||Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia|A Randomized, Open-Label Study Of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) To Evaluate Hematologic Response Rate In Anemic Cancer Patients Receiving Chemotherapy|Completed||Phase 4|358|Actual|Ortho Biotech Products, L.P.|||||f||||||||||||||2017-02-18 16:37:02.357547|2017-02-18 16:37:02.357547
NCT00315471|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-11-11|||April 2006||2006-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis|VCRC Longitudinal Protocol for Takayasu's Arteritis|Recruiting||N/A|250|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"~     Blood (serum and plasma), urine, and DNA~   "|No||2017-02-18 16:37:02.449111|2017-02-18 16:37:02.449111
NCT00315276|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2012-08-22|||May 2006||2006-05-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD|A 9-week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With Attention Deficit/Hyperactivity Disorder|Completed||Phase 2|370||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 16:37:11.484935|2017-02-18 16:37:11.484935
NCT00315458|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2012-08-27|2010-07-28||December 2003||2003-12-01|August 2012|2012-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.|Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Determine Efficacy and Safety of Buprenorphine Transdermal System in Subjects With Moderate To Severe Osteoarthritis Pain Requiring Daily Treatment With Opioids|Terminated||Phase 3|107|Actual|Purdue Pharma LP|This study was terminated early for administrative reasons. The efficacy data are not presented since the primary objective of this study was changed identifying it as a safety study.|2||Administrative reasons.|f||||||||||||||2017-02-18 16:37:02.75805|2017-02-18 16:37:02.75805
NCT00315445|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2012-08-27|2011-05-17||December 1997||1997-12-01|August 2012|2012-08-01|May 1998|Actual|1998-05-01|May 1998|Actual|1998-05-01||Interventional|BP96-0604||The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.|A Comparative Study of Buprenorphine TDS, Oxycodone/ Acetaminophen Tablets Qid and Placebo in Patients With Chronic Back Pain|Completed||Phase 3|134|Actual|Purdue Pharma LP|There was a large percentage of discontinuations across treatment groups.|3|||f||||||||||||||2017-02-18 16:37:03.250299|2017-02-18 16:37:03.250299
NCT00315432|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2011-05-17|||September 2000||2000-09-01|April 2010|2010-04-01|November 2003|Actual|2003-11-01|||||Interventional|||NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection|)A Study to Evaluate the Erythropoietic Response in HCV/HIV Co-Infected Patients Receiving Combination Ribavirin/Interferon Therapy|Completed||Phase 2|91|Actual|Ortho Biotech Products, L.P.|||||f||||||||||||||2017-02-18 16:37:04.612744|2017-02-18 16:37:04.612744
NCT00315419|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2010-04-19|||April 2006||2006-04-01|July 2009|2009-07-01|July 2009|Anticipated|2009-07-01|July 2009|Anticipated|2009-07-01||Observational|||Identifying Characteristics of Bone Marrow Failure Syndromes|Screening Protocol and Longitudinal Study of Bone Marrow Failure Syndromes and Cytopenias|Unknown status|Active, not recruiting|N/A|450|Anticipated|Office of Rare Diseases (ORD)|||1||f||||||||||Samples With DNA|"~     Residual samples from peripheral blood and bone marrow aspiration/biopsies~   "|||2017-02-18 16:37:04.708612|2017-02-18 16:37:04.708612
NCT00315406|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-11-11|||April 2006||2006-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa|Longitudinal Protocol of Polyarteritis Nodosa|Recruiting||N/A|150|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"~     Blood (serum and plasma), urine, and DNA~   "|No||2017-02-18 16:37:04.806411|2017-02-18 16:37:04.806411
NCT00315393|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-11-11|||April 2006||2006-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis|Determining Disease Activity Biomarkers in Individuals With Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis|Recruiting||N/A|1200|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"~     Blood (serum and plasma), urine, and DNA~   "|||2017-02-18 16:37:04.930596|2017-02-18 16:37:04.930596
NCT00315380|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-11-11|||April 2006||2006-04-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|||Determining Disease Activity Biomarkers in Individuals With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)|Longitudinal Protocol for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)|Recruiting||N/A|500|Anticipated|University of Pennsylvania|||1||f||||t||||||Samples With DNA|"~     Blood (serum and plasma), urine, and DNA~   "|No||2017-02-18 16:37:05.054961|2017-02-18 16:37:05.054961
NCT00315367|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2007-10-15|||September 2004||2004-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties|A Double-Blind, Crossover Trial of Aricept® in Memory-Impaired Patients With Multiple Sclerosis: A Phase IV Demonstration of Functional MRI (fMRI) as a Surrogate Marker of Brain Activity Associated With Improvement in Memory Function|Completed||Phase 4|26|Anticipated|Neurognostics|||||f||||||||||||||2017-02-18 16:37:05.177505|2017-02-18 16:37:05.177505
NCT00315354|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-11-22|||April 2006||2006-04-01|November 2016|2016-11-01|April 2013|Actual|2013-04-01|June 2010|Actual|2010-06-01||Interventional|||Popular Diets Study|Popular Diets, Metabolism, and CVD Risk|Completed||N/A|24|Actual|Boston Children’s Hospital||3|||f||||||||||||||2017-02-18 16:37:05.274537|2017-02-18 16:37:05.274537
NCT00315341|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-16|2016-11-09|2013-05-17||April 2006||2006-04-01|November 2016|2016-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Starting Treatment With Agonist Replacement Therapies (START)|Starting Treatment With Agonist Replacement Therapies (START)|Completed||Phase 4|1269|Actual|University of California, Los Angeles||2|||f||||t||||||||No||2017-02-18 16:37:05.396789|2017-02-18 16:37:05.396789
NCT00315328|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-05-19|2009-09-09||August 2005||2005-08-01|May 2016|2016-05-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|ATS9||Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds|A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds|Completed||Phase 3|233|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-02-18 16:37:05.884718|2017-02-18 16:37:05.884718
NCT00315315|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2012-05-16|||February 2005||2005-02-01|May 2012|2012-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|NLD2||Study of Surgical Procedures for Treatment of Persistent Nasolacrimal Duct Obstruction in Children < 4 Years Old|A Prospective Study of Surgical Procedures for the Treatment of Persistent Nasolacrimal Duct Obstruction in Children Less Than Four Years Old|Completed||Phase 3|194|Actual|Jaeb Center for Health Research|||1||f||||t||||||||||2017-02-18 16:37:08.865086|2017-02-18 16:37:08.865086
NCT00315302|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2016-07-15|2009-08-03||February 2005||2005-02-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|ATS8||Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old|A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye As Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old|Completed||Phase 3|240|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-02-18 16:37:08.969985|2017-02-18 16:37:08.969985
NCT00315289|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2010-02-26|||February 2005||2005-02-01|January 2010|2010-01-01|September 2006|Actual|2006-09-01|||||Observational|NLD1||Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years Old|A Prospective Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years Old|Completed||Phase 3|973|Actual|Jaeb Center for Health Research|||1||f||||t||||||||||2017-02-18 16:37:11.371467|2017-02-18 16:37:11.371467
NCT00315263|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2011-08-25|||April 2006||2006-04-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|October 2008|Actual|2008-10-01||Observational|||Genomics, Single Nucleotide Polymorphisms (SNPs), and Clinical Neonatology|Genomics, SNPs, and Clinical Neonatology|Completed||N/A|63|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 16:37:11.704408|2017-02-18 16:37:11.704408
NCT00315250|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2014-04-21||2014-03-21|January 2006||2006-01-01|April 2014|2014-04-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease|Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease|Completed||Phase 2|225|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 16:37:11.796055|2017-02-18 16:37:11.796055
NCT00315237|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2010-01-06|||July 2005||2005-07-01|January 2010|2010-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract|Prospective, Randomized Phase III Trial of I.V. Vinflunine Plus Best Supportive Care as Second Line Therapy Versus Best Supportive Care After a Platinum-containing Regimen, in Patients With Advanced Transitional Cell Carcinoma of Urothelial Tract|Completed||Phase 3|364|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 16:37:11.905921|2017-02-18 16:37:11.905921
NCT00315224|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2006-04-14|||February 2005||2005-02-01|March 2005|2005-03-01|October 2005||2005-10-01|||||Interventional|||Sports in Hypertension of the Elderly|The Impact of Pulse Pressure on Cardiovascular Effects of Exercise Training in Hypertension of the Elderly|Completed||N/A|54||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 16:37:12.015837|2017-02-18 16:37:12.015837
NCT00315211|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-17|2007-10-31|||November 2004||2004-11-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer|Phase 2 Study of Weekly Topotecan With Docetaxel for Recurrent Small Cell Lung Cancer|Terminated||Phase 2|40|Anticipated|Aultman Hospital||1||Slow Accrual|f||||||||||||||2017-02-18 16:37:12.105625|2017-02-18 16:37:12.105625
NCT00315198|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2010-03-23|||February 2005||2005-02-01|May 2009|2009-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ATS6||Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old|A Randomized Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old|Completed||Phase 3|425|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-02-18 16:37:12.199487|2017-02-18 16:37:12.199487
NCT00315185|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2010-09-22|||December 2004||2004-12-01|September 2010|2010-09-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer|Phase II Study as First Line Treatment for Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|53|Actual|Fox Chase Cancer Center|||||f||||t||||||||||2017-02-18 16:37:12.317344|2017-02-18 16:37:12.317344
NCT00315172|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-15|2017-01-24|||April 13, 2006||2006-04-13|November 7, 2008|2008-11-07|November 7, 2008||2008-11-07|||||Interventional|||Non-Exercise Activity Thermogenesis (NEAT) in Children|Non-Exercise Activity Thermogenesis (NEAT) in Children|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:37:12.421221|2017-02-18 16:37:12.421221
NCT00315159|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2015-01-09|||August 2003||2003-08-01|January 2015|2015-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.|Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients With Sentinel Lymph Nodes Determined to be Negative for Metastatic Disease.|Completed||N/A|74|Actual|Women and Infants Hospital of Rhode Island||1|||f||||t||||||||||2017-02-18 16:37:12.502623|2017-02-18 16:37:12.502623
NCT00315146|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2015-12-18|2013-03-07||April 2006||2006-04-01|December 2015|2015-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional||These numbers match the number of people who STARTED in each group in the flow module.|Optimizing Body Composition for Function in Older Adults|Optimizing Body Composition for Function in Older Adults (OPTIMA) - A Pepper Pilot Study|Completed||Phase 4|88|Actual|Wake Forest University Health Sciences||4|||f||||t||||||||||2017-02-18 16:37:12.796222|2017-02-18 16:37:12.796222
NCT00315133|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2017-01-13|||December 2003||2003-12-01|January 2017|2017-01-01|December 2014|Actual|2014-12-01|December 2010|Actual|2010-12-01||Interventional|||Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus|Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes Mellitus- a Phase I/II Study|Completed||Phase 1/Phase 2|25|Actual|University of Sao Paulo||1|||f||||t||||||||Undecided|IPD may be shared if the responsible investigators feel it may increase understanding, reliability and reproducibility of the present study.|2017-02-18 16:37:13.421682|2017-02-18 16:37:13.421682
NCT00315120|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2016-05-24|2013-10-17||August 2006||2006-08-01|May 2016|2016-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial|A Randomized Controlled Trial of Osteopathic Manipulative Treatment and Ultrasound Physical Therapy for Chronic Low Back Pain|Completed||Phase 3|455|Actual|University of North Texas Health Science Center|Co-morbid conditions, work disability and low back pain co-treatments were self reported by participants, but were not verified through medical or employment records. Missing data were imputed for 13% of participants at the final encounter.|4|||f||||t||||||||No||2017-02-18 16:37:13.55962|2017-02-18 16:37:13.55962
NCT00315107|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2006-05-25|||May 2006||2006-05-01|May 2006|2006-05-01|August 2007||2007-08-01|||||Interventional|||Estrogen Treatment in Acromegalic Women||Unknown status|Recruiting|Phase 2|30||Université de Montréal|||||f||||||||||||||2017-02-18 16:37:14.612065|2017-02-18 16:37:14.612065
NCT00315094|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2012-02-27|||April 2006||2006-04-01|February 2012|2012-02-01|November 2011|Actual|2011-11-01|July 2010|Actual|2010-07-01||Interventional|||Technological Home Care: Improving HPN Care With Videophone And Internet Education|Prevention of Home Parenteral Nutrition (HPN) Infection, Depression and Improving Caregiving Problem Solving|Completed||N/A|172|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 16:37:14.698375|2017-02-18 16:37:14.698375
NCT00315081|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2006-04-13|||May 2006||2006-05-01|November 2005|2005-11-01|May 2008||2008-05-01|||||Interventional|||Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine|Therapy With Bromocriptine in Patients With Symptomatic Risperidone-Induced Hyperprolactinemia|Unknown status|Not yet recruiting|Phase 3|20||University Hospital, Bonn|||||f||||||||||||||2017-02-18 16:37:14.797806|2017-02-18 16:37:14.797806
NCT00314223|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2006-04-12|||February 2006||2006-02-01|April 2006|2006-04-01|December 2006||2006-12-01|||||Observational|||Identification of Gene Polymorphism in Patients With Sick Sinus Syndrome in Chinese Population in Taiwan||Unknown status|Recruiting|N/A|300||China Medical University Hospital|||||f||||||||||||||2017-02-18 16:37:31.687314|2017-02-18 16:37:31.687314
NCT00315068|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2007-04-19|||April 2004||2004-04-01|April 2007|2007-04-01|August 2007|Anticipated|2007-08-01|||||Observational|||Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation|The Value of Amino-Terminal Brain Natriuretic Peptide and C-Reactive Protein Serum Levels for Predicting Recurrence of Atrial Fibrillation and/or Atrial Flutter After Radiofrequency Catheter Ablation|Unknown status|Active, not recruiting|N/A|180||University Hospital, Geneva|||||f||||||||||||||2017-02-18 16:37:14.900763|2017-02-18 16:37:14.900763
NCT00315055|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2014-09-04|2013-09-09||July 2006||2006-07-01|September 2014|2014-09-01|February 2008|Actual|2008-02-01|July 2007|Actual|2007-07-01||Interventional|||Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule|Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2, 3, and 4 Months Primary Schedule in Healthy Turkish Infants|Completed||Phase 3|310|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:37:15.011451|2017-02-18 16:37:15.011451
NCT00315042|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2009-04-02|||March 2006||2006-03-01|April 2009|2009-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||TELI TON - Telithromycin in Tonsillitis|Multinational, Randomized, Double-Blind, Double Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 10 Days Penicillin V 13.3 mg/kg Tid in Children 6 Months to Less Than 13 Years With Streptococcus Pyogenes Tonsillitis/Pharyngitis|Terminated||Phase 3|314|Actual|Sanofi||||Pediatric development program terminated by sponsor|f||||||||||||||2017-02-18 16:37:15.656387|2017-02-18 16:37:15.656387
NCT00315029|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2008-10-24|||November 2006||2006-11-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Patient-Centered Implementation Trial for Single Embryo Transfer|Patient-Centered Implementation of Elective Single Embryo Transfer (eSET) in in Vitro Fertilisation (IVF) and Intracytoplasmic Sperm Injection (ICSI)|Completed||N/A|230|Actual|Radboud University||2|||f||||||||||||||2017-02-18 16:37:15.753977|2017-02-18 16:37:15.753977
NCT00315016|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2012-05-25|||January 2007||2007-01-01|May 2012|2012-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Eplerenone, ACE Inhibition and Albuminuria|Eplerenone, ACE Inhibition and Albuminuria|Completed||Phase 2|30|Actual|Radboud University||3|||f||||f||||||||||2017-02-18 16:37:15.896744|2017-02-18 16:37:15.896744
NCT00315003|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2009-04-02|||January 2006||2006-01-01|April 2009|2009-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||TELI COM - Telithromycin in Children With Otitis Media|Multinational, Randomized, Double-Blind, Double-Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 5 Days Azithromycin 10 mg/kg od Followed by 5 mg/kg od for 4 Days, in Children With Acute Otitis Media|Terminated||Phase 3|1500||Sanofi||||Pediatric development program terminated by sponsor|f||||||||||||||2017-02-18 16:37:16.011648|2017-02-18 16:37:16.011648
NCT00314990|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2006-04-14|||January 1996||1996-01-01|April 2006|2006-04-01|January 2003||2003-01-01|||||Interventional|||VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis|Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomized, Placebo-Controlled, Double Blind Trial.|Completed||N/A|620||Radboud University|||||f||||||||||||||2017-02-18 16:37:16.25074|2017-02-18 16:37:16.25074
NCT00314977|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2010-03-17|||February 2006||2006-02-01|March 2010|2010-03-01||||April 2009|Actual|2009-04-01||Interventional|INTENS||Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.|Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable and/or Locally Advanced Breast Cancer. The INTENS Study|Completed||Phase 3|200|Anticipated|Radboud University||2|||f||||f||||||||||2017-02-18 16:37:16.341994|2017-02-18 16:37:16.341994
NCT00314964|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2011-03-14|||August 2006||2006-08-01|March 2011|2011-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study Evaluating PD-0299685 for Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 2|527|Actual|Pfizer|||||||||||||||||||2017-02-18 16:37:16.492502|2017-02-18 16:37:16.492502
NCT00314951|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2016-06-07|2011-07-01||May 2006||2006-05-01|June 2016|2016-06-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)|A Multi-National, Multi-Center, Double-Blind, Randomized, Parallel Group Study to Compare the Safety and Efficacy of 200 mg PAR-101 Taken q12h With 125 mg Vancomycin Taken q6h for Ten Days in Subjects With Clostridium Difficile-Associated Diarrhea|Completed||Phase 3|629|Actual|Optimer Pharmaceuticals LLC||2|||f||||t||||||||||2017-02-18 16:37:16.824052|2017-02-18 16:37:16.824052
NCT00314938|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2011-05-12|||April 2006||2006-04-01|May 2011|2011-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency|A Double Blind, Single Dose Study To Explore The Safety, Pharmacokinetics And Pharmacodynamics Of PHA-794428 In Pediatric Patients With Growth Hormone Deficiency|Terminated||Phase 2|32||Pfizer||||See termination reason in detailed description.|f||||f||||||||||2017-02-18 16:37:17.580937|2017-02-18 16:37:17.580937
NCT00314925|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2010-02-23|||April 2006||2006-04-01|February 2010|2010-02-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features|Phase I Dose-Escalation Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Patients With Advanced Solid Tumors With Neuroendocrine Features|Unknown status|Active, not recruiting|Phase 1|60|Anticipated|Neotropix||1|||f||||||||||||||2017-02-18 16:37:17.687786|2017-02-18 16:37:17.687786
NCT00314912|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2007-07-13|||May 2006||2006-05-01|July 2007|2007-07-01||||||||Interventional|||Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease|An Open-Label Extension of the Phase III Study CL-758007 With Tramiprosate (3APS) in Patients With Alzheimer's Disease|Unknown status|Active, not recruiting|Phase 3|650||Bellus Health Inc|||||||||||||||||||2017-02-18 16:37:17.815364|2017-02-18 16:37:17.815364
NCT00314899|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2010-08-26|||May 2007||2007-05-01|October 2007|2007-10-01|September 2011||2011-09-01|||||Observational|||Fetal Immunity to Falciparum Malaria|Fetal Immunity to Plasmodium Falciparum Malaria|Unknown status|Recruiting|N/A|1020||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:37:17.90397|2017-02-18 16:37:17.90397
NCT00314886|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2011-01-18|||January 2005||2005-01-01|January 2011|2011-01-01|July 2005|Anticipated|2005-07-01|||||Interventional|||Effect of Butyrogenic Fibers in IBS Patients|Effect of an Enriched Butyrogenic Fibres Diet on Rectal Sensitivity in Healthy Control and IBS Patients.|Unknown status|Recruiting|N/A|15|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 16:37:17.977971|2017-02-18 16:37:17.977971
NCT00314860|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2016-10-17|||February 2006||2006-02-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole|A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)|Completed||Phase 3|568|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:37:18.20039|2017-02-18 16:37:18.20039
NCT00314847|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2010-07-30|||June 2005||2005-06-01|July 2010|2010-07-01|October 2009|Actual|2009-10-01|||||Interventional|||Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic Shock|National Multicenter Randomized Trial, Comparing Two Treatments of Myocardial Infarction Complicated With Cardiogenic Shock: Standard Treatment vs Standard Treatment Plus ECLS (Extracorporeal Life Support)|Terminated||Phase 4|19|Actual|University Hospital, Caen||2||The study was stopped prematurely due to insufficient recruitment|f||||t||||||||||2017-02-18 16:37:18.386099|2017-02-18 16:37:18.386099
NCT00314834|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-14|2006-04-14|||January 2001||2001-01-01|March 2005|2005-03-01|December 2004||2004-12-01|||||Interventional|||Effect of Intradialytic Parenteral Nutrition on Morbidity and Mortality of Malnourished Hemodialysis Patients|Effect of Intradialytic Parenteral Nutrition on Morbidity and Mortality of Malnourished Hemodialysis Patients|Terminated||Phase 4|204||EZUS-LYON 1|||||f||||||||||||||2017-02-18 16:37:18.500747|2017-02-18 16:37:18.500747
NCT00314821|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2006-10-19|||February 2006||2006-02-01|October 2006|2006-10-01|April 2006||2006-04-01|||||Interventional|||Ropinirole in the Treatment of Bipolar Depression|A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder|Unknown status|Recruiting|Phase 4|40||Cambridge Health Alliance|||||||||||||||||||2017-02-18 16:37:18.578863|2017-02-18 16:37:18.578863
NCT00314808|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2014-07-10|2013-05-02||April 2006||2006-04-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|||A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas|A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas|Completed||Phase 1|33|Actual|Duke University||1|||f||||f||||||||||2017-02-18 16:37:18.672157|2017-02-18 16:37:18.672157
NCT00314795|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2016-11-29||2016-11-29|April 2006||2006-04-01|November 2016|2016-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease|An Open-Label Study to Investigate the Efficacy and Safety of Peginesatide in the Treatment of Anemia Caused by Antibody-Mediated Pure Red Cell Aplasia in Patients With Chronic Kidney Disease|Completed||Phase 2|22|Actual|Takeda||1|||f||||f||||||||||2017-02-18 16:37:18.945206|2017-02-18 16:37:18.945206
NCT00314782|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2013-03-11|||March 2006||2006-03-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC|A Phase I Study of ZD4054 (Zibotentan) in Combination With Docetaxel in 2 Parts, an Open-Label, Non-Randomized, Dose-Finding Part and a Double-Blind, Placebo-Controlled, Randomized Dose Expansion Part, in Patients With Metastatic Hormone-Refractory Prostate Cancer|Completed||Phase 1|44|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 16:37:19.064605|2017-02-18 16:37:19.064605
NCT00314769|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2017-01-24|||April 7, 2006||2006-04-07|December 16, 2013|2013-12-16|December 16, 2013||2013-12-16|||||Observational|||Long-Term Improvement in Motor Learning by Transcranial Direct Current Stimulation|Long-Term Improvement in Training Effects by Transcranial DC Stimulation|Completed||N/A|196|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:37:19.179313|2017-02-18 16:37:19.179313
NCT00314756|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2006-04-12|||March 2005||2005-03-01|March 2005|2005-03-01|November 2005||2005-11-01|||||Interventional|||Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage|Topical Imiquimod 5% Cream in the Treatment of Nodular Basal Cell Carcinoma After Initial Treatment With Curettage|Completed||Phase 4|15||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 16:37:19.260207|2017-02-18 16:37:19.260207
NCT00314743|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2013-05-22|||October 2005||2005-10-01|May 2013|2013-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation|A Study Evaluating the Efficacy and Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation|Completed||Early Phase 1|48|Actual|Washington University School of Medicine||2|||f||||||||||||||2017-02-18 16:37:19.345319|2017-02-18 16:37:19.345319
NCT00314730|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2007-04-18|||May 2006||2006-05-01|April 2007|2007-04-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Outcomes in the Palm of Your Hand: Improving the Quality and Continuity of Patient Care|Outcomes in the Palm of Your Hand: Improving the Quality and Continuity of Patient Care|Unknown status|Active, not recruiting|N/A|400||University of Toronto|||||f||||||||||||||2017-02-18 16:37:19.452876|2017-02-18 16:37:19.452876
NCT00314717|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-13|2011-06-20|||April 2006||2006-04-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||The Effect of a Low Glycemic Index Diet on Blood Sugar Control in Women With Gestational Hyperglycemia|The Effect of a Low Glycemic Index Diet on Blood Sugar Control in Women With Gestational Hyperglycemia|Completed||Phase 2|47|Actual|University of Toronto||1|||f||||f||||||||||2017-02-18 16:37:19.638478|2017-02-18 16:37:19.638478
NCT00314704|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2010-01-29|||December 2003||2003-12-01|April 2006|2006-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Dopamine and Norepinephrine in Shock Patients|Comparison of Dopamine and Norepinephrine as the First Vasopressor Agent in the Management of Shock|Completed||Phase 3|1679|Actual|Sepsis Occurrence in Acutely Ill Patients||2|||f||||||||||||||2017-02-18 16:37:19.734054|2017-02-18 16:37:19.734054
NCT00314691|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2011-07-27|||April 2006||2006-04-01|July 2007|2007-07-01|September 2006||2006-09-01|||||Interventional|||Development of New Prenatal Diagnostic Tests From Maternal Blood|Development of New Prenatal Diagnostic Tests From Maternal Blood|Terminated||N/A|10|Actual|University Hospital, Strasbourg, France||||Leaving of the person responsible for the data collection|f||||||||||||||2017-02-18 16:37:19.840654|2017-02-18 16:37:19.840654
NCT00313703|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2011-04-15|2010-10-06||March 2005||2005-03-01|April 2011|2011-04-01|May 2008|Actual|2008-05-01|||||Observational|||Prospective ED Headache Cohort Study|Predicting Poor Pain and Functional Outcomes After Discharge From the Emergency Department With a Primary Headache|Completed||N/A|477|Actual|Montefiore Medical Center|||1||f||||||||||||||2017-02-18 16:37:43.418932|2017-02-18 16:37:43.418932
NCT00314678|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2016-12-06|||September 2005||2005-09-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer|Cisplatin Induction Followed by Paclitaxel Consolidation for the Treatment of Stage III and IV Epithelial Ovarian Cancer and Primary Peritoneal Cancer With In Vitro Correlates of Response|Completed||Phase 2|40|Anticipated|University of California, Irvine|||||f||||||||||||||2017-02-18 16:37:19.92711|2017-02-18 16:37:19.92711
NCT00314665|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2007-12-03|||January 2004||2004-01-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Use of Thalidomide in Chronic Uveitis|Use of Thalidomide in Chronic Uveitis|Terminated||Phase 4|15||University of Cincinnati||1|||f||||||||||||||2017-02-18 16:37:20.027924|2017-02-18 16:37:20.027924
NCT00314652|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2006-04-29|||June 1999||1999-06-01|April 2006|2006-04-01|October 1999||1999-10-01|||||Interventional|||Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.|A Double-Blind Placebo-Controlled Study of Buprenorphine Transdermal System (BTDS) in Patients With Osteoarthritis of the Hip or Knee|Completed||Phase 3|260||Purdue Pharma LP|||||||||||||||||||2017-02-18 16:37:20.130555|2017-02-18 16:37:20.130555
NCT00314639|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2009-02-11|||September 2005||2005-09-01|April 2007|2007-04-01||||June 2008|Actual|2008-06-01||Interventional|||Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia|The Impact of Modafinil as an Adjunctive to a Second Generation Antipsychotic on Cognitive Functioning in Schizophrenia and Schizophrenia Spectrum Psychosis.|Completed||Phase 1/Phase 2|30|Anticipated|Laval University||1|||f||||||||||||||2017-02-18 16:37:20.247877|2017-02-18 16:37:20.247877
NCT00314626|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2008-01-25|||November 2004||2004-11-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily|Multicentre, Open Label, Prospective, Randomised Clinical Trial of an Antiretroviral Simplification Treatment With Efavirenz + Abacavir + 3TC Once Daily|Completed||Phase 3|99|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 16:37:20.335991|2017-02-18 16:37:20.335991
NCT00314613|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2013-06-19|||April 2006||2006-04-01|May 2010|2010-05-01||||December 2006||2006-12-01||Interventional|||Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal|Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal|Terminated||Phase 4|30|Anticipated|Duke University|||||f||||||||||||||2017-02-18 16:37:20.655224|2017-02-18 16:37:20.655224
NCT00314600|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2007-02-23|||January 2006||2006-01-01|November 2006|2006-11-01||||||||Interventional|||Treatment of Non-Dislocated Midshaft Both-Bone Fractures|Above Elbow Cast in Non-Dislocated Both-Bone Midshaft Forearm Fractures in Children: Necessity or Needless Cruelty? A Randomized Trial|Unknown status|Recruiting|N/A|60||Colaris, Joost, M.D.|||||f||||||||||||||2017-02-18 16:37:20.750303|2017-02-18 16:37:20.750303
NCT00314587|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2007-02-23|||January 2006||2006-01-01|November 2006|2006-11-01||||||||Interventional|||Treatment of Unstable Both-Bone Midshaft Forearm Fractures in Children|Treatment of Unstable Both-Bone Midshaft Forearm Fractures in Children: A Randomized Trial Between 1 and 2 Elastic Stable Intramedullary Nails|Unknown status|Recruiting|N/A|60||Colaris, Joost, M.D.|||||f||||||||||||||2017-02-18 16:37:20.845081|2017-02-18 16:37:20.845081
NCT00314574|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2012-02-08|2011-03-31||December 2005||2005-12-01|February 2012|2012-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)|A Phase IIIb Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Xolair in Subjects With Moderate to Severe Persistent Asthma Who Are Inadequately Controlled With High-Dose Inhaled Corticosteroids and Long-Acting Beta-Agonists|Completed||Phase 3|850|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:37:20.950358|2017-02-18 16:37:20.950358
NCT00314561|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2011-06-30|||May 2006||2006-05-01|September 2008|2008-09-01|December 2006||2006-12-01|||||Interventional|||The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome|The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome: A Prospective, Randomized, Open-label, Crossover Trial|Completed||Phase 4|40||Korea University Anam Hospital|||||f||||||||||||||2017-02-18 16:37:21.600827|2017-02-18 16:37:21.600827
NCT00314548|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2010-05-18|||May 2006||2006-05-01|November 2009|2009-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension|Trial of Inhaled Alprostadil to Improve Hypoxia and Pulmonary Hypertension|Completed||N/A|67|Actual|Aga Khan University||2|||f||||t||||||||||2017-02-18 16:37:21.751024|2017-02-18 16:37:21.751024
NCT00314119|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2017-01-24|||April 7, 2006||2006-04-07|September 26, 2016|2016-09-26||||||||Observational|||Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1|Natural History and Biology of Dermal Neurofibromas in Neurofibromatosis Type 1|Completed||N/A|17|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:37:21.866181|2017-02-18 16:37:21.866181
NCT00314106|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-09-18|2012-09-18||April 2006||2006-04-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma|Phase II Study Using a Myeloablative Lymphocyte Depleting Regimen of Chemotherapy and Intensive Total Body Irradiation Followed by Infusion of Tumor Reactive Lymphocytes and Reconstitution With CD34+ Stem Cells in Metastatic Melanoma|Completed||Phase 2|26|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 16:37:21.977352|2017-02-18 16:37:21.977352
NCT00314093|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2013-08-19|||April 2006||2006-04-01|August 2013|2013-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||RFT-5-dgA in Patients With Metastatic Melanoma|Phase II Evaluation of RFT5-dgA in Patients With Metastatic Melanoma|Completed||Phase 2|41|Anticipated|University of Texas Southwestern Medical Center||1|||f||||||||||||||2017-02-18 16:37:22.685873|2017-02-18 16:37:22.685873
NCT00314080|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2008-10-23|||March 2006||2006-03-01|August 2007|2007-08-01|April 2006||2006-04-01|||||Observational|||Treatment of Survivors After Botulism Outbreak|An Outbreak of Botulism in Thailand: Clinical Manifestations and Management of Severe Respiratory Failure|Completed||N/A|18||Rajavithi Hospital|||||f||||||||||||||2017-02-18 16:37:22.771837|2017-02-18 16:37:22.771837
NCT00314067|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-10-17|||July 2006||2006-07-01|June 2008|2008-06-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||Evaluation of Case Management to Improve the Outpatient Care of Alcohol-related Disorders|Comprehensive Quality Management in Out-patient Care for Alcohol-related Disorders (AQAH). Transfer and Dissemination Into Routine Practice|Completed||N/A|112|Actual|University Hospital Freiburg||3|||f||||||||||||||2017-02-18 16:37:22.861512|2017-02-18 16:37:22.861512
NCT00314054|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2008-04-10|||May 2006||2006-05-01|April 2008|2008-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults|An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of HCV-796 in Subjects With Chronic Hepatic Impairment and in Matched Healthy Adults|Completed||Phase 1|27|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||f||||||||||2017-02-18 16:37:22.973016|2017-02-18 16:37:22.973016
NCT00314041|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-02-20|||June 1997||1997-06-01|February 2013|2013-02-01|April 1998|Actual|1998-04-01|April 1998|Actual|1998-04-01||Interventional|||Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants|A Randomized, Double-blind, Controlled, Active Comparator, Phase II Study to Assess the Tolerance and Immunogenicity of Conjugate Meningococcal C (MnCC) Vaccine in Infants When Administered in Conjunction With Primary DTP/Hib Vaccination at 2, 3, and 4 Months of Age.|Completed||Phase 2|240||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:37:23.066728|2017-02-18 16:37:23.066728
NCT00314028|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-12-13|||April 2003||2003-04-01|December 2013|2013-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effectiveness of HIV Risk Reduction Program Among African American Men|Promoting HIV Risk Reduction Among African American Men|Completed||Phase 3|270|Actual|University of Kentucky||2|||f||||||||||||||2017-02-18 16:37:23.148774|2017-02-18 16:37:23.148774
NCT00314015|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-12-04|||January 2007||2007-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of the Success Rate of Immediately Loaded Implants|Evaluation of the Success Rate of Immediately Loaded Implants|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:37:23.235047|2017-02-18 16:37:23.235047
NCT00314002|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2009-08-06|||October 2005||2005-10-01|August 2009|2009-08-01|April 2007||2007-04-01|||||Interventional|||Catheter Thrombectomy in Patients With Massive Pulmonary Embolism|Compassionate Use of Catheter Thrombectomy (Aspirex 11F) in Patients With Massive Pulmonary Embolism|Terminated||Phase 1/Phase 2|50|Anticipated|Straub Medical AG||||"After treatment of 7 patients, it was decided that the handling characteristics of the test~   device should be upgraded before continuing the trial as planned."|f||||||||||||||2017-02-18 16:37:23.424334|2017-02-18 16:37:23.424334
NCT00314535|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2016-02-24|||July 2005||2005-07-01|March 2012|2012-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe|Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe|Completed||N/A|40|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 16:37:23.523856|2017-02-18 16:37:23.523856
NCT00314522|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2016-02-23|||September 2005||2005-09-01|December 2011|2011-12-01|March 2006||2006-03-01|||||Observational|||Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe|Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe|Completed||N/A|5|Actual|AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 16:37:23.597364|2017-02-18 16:37:23.597364
NCT00314509|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2016-12-02|||July 2005||2005-07-01|December 2016|2016-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)|ADVICE: A Dose Range Finding Study of Formoterol Administered Once Daily in the Evening in Combination With Ciclesonide Using the Ultrahaler™ Versus Monotherapy of Each Drug in Asthmatic Patients|Completed||Phase 2|240||AstraZeneca|||||f||||||||||||||2017-02-18 16:37:23.667608|2017-02-18 16:37:23.667608
NCT00314496|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2016-02-24|||September 2005||2005-09-01|January 2012|2012-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Development of Magnetic Resonance (MR) Simulation for Treatment Planning|Development of MR Simulation for Treatment Planning|Completed||N/A|10|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 16:37:23.789122|2017-02-18 16:37:23.789122
NCT00314483|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2007-07-03|||June 2007||2007-06-01|July 2007|2007-07-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease|Evaluation of Potential Mesenchymal Stem Cells for the Treatment of Graft Versus Host Disease Following an Allogeneic Stem Cell Transplant|Unknown status|Recruiting|Phase 1/Phase 2|25|Anticipated|Christian Medical College, Vellore, India||1|||f||||t||||||||||2017-02-18 16:37:23.85613|2017-02-18 16:37:23.85613
NCT00314470|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2016-02-24|||January 2006||2006-01-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute|Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute|Completed||N/A|40|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 16:37:23.938512|2017-02-18 16:37:23.938512
NCT00314457|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2009-07-10|||August 2005||2005-08-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy Study of Continuous Intraarticular Infusion in Patients Undergoing Arthroscopic Knee and Shoulder Operations|A Randomized, Double-blind Trial Comparing the Analgesic Efficacy and Side Effects of Continuous Intraarticular Infusion of Bupivacaine Versus Normal Saline in Patients Undergoing Knee and Shoulder Operations|Terminated||Phase 4|16|Actual|Children's Hospital of Philadelphia||1||Bupivacaine has recently been shown to inhibit osteoclast formation in vitro.|f||||f||||||||||2017-02-18 16:37:24.007069|2017-02-18 16:37:24.007069
NCT00314444|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2017-01-24|||April 7, 2006||2006-04-07|April 14, 2009|2009-04-14|April 14, 2009||2009-04-14|||||Observational|||Treatment for Psychogenic Disorders|Treatment for Psychogenic Movement Disorders|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:37:24.0977|2017-02-18 16:37:24.0977
NCT00314431|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2006-04-11|||May 1996||1996-05-01|April 2006|2006-04-01|August 2000||2000-08-01|||||Interventional|||Post-Hospitalization Nursing Effectiveness (PHONE) Study|Randomized Comparison of Two Models of Post-NICU Care for Preterm Infants With Neonatal Chronic Lung Disease|Completed||Phase 3|150||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 16:37:24.170607|2017-02-18 16:37:24.170607
NCT00314418|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2006-04-11|||September 2005||2005-09-01|April 2006|2006-04-01|March 2006||2006-03-01|||||Interventional|||Patient Position and Impact on Colonoscopy Time|Patient Position and Impact on Colonoscopic Cecal Intubation Time|Completed||N/A|120||VA Connecticut Healthcare System|||||f||||||||||||||2017-02-18 16:37:24.2635|2017-02-18 16:37:24.2635
NCT00295698|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2006-02-23|||August 2001||2001-08-01|February 2006|2006-02-01|November 2002||2002-11-01|||||Interventional|||Interaction Between HIV and Lymphatic Filariasis|Studies on the Interaction Between HIV Infection, Lymphatic Filariasis and Diethylcarbamazine|Completed||N/A|||DBL -Institute for Health Research and Development|||||f||||||||||||||2017-02-18 16:44:12.367951|2017-02-18 16:44:12.367951
NCT00314405|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2008-08-07|||April 2006||2006-04-01|February 2008|2008-02-01||||April 2007|Actual|2007-04-01||Interventional|||Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope|Identification of Sentinel Lymph Node (SLN) in Breast Cancer Care: Clinical and Economical Evaluation of a Double Method Using Isotope and Methylene Blue Dye Injection.|Completed||N/A|100|Anticipated|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 16:37:24.350502|2017-02-18 16:37:24.350502
NCT00314392|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2008-02-04|||September 2006||2006-09-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|||||Interventional|||Gender, Pain, and Placebo Analgesia|Effect of Participant Gender, Experimenter Gender, and Drug-Related Information on Placebo Analgesia|Completed||N/A|74|Anticipated|University Hospital of North Norway|||||f||||||||||||||2017-02-18 16:37:24.444386|2017-02-18 16:37:24.444386
NCT00314379|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2009-01-20|||April 2006||2006-04-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Endothelial Function in a Sample Group of Patients From the ICARE Study|Vitamin E Treatment and Endothelial Function in Type 2 Diabetic Patients With Hp 2-2 Phenotype From the I CARE Study (EFI)|Completed||Phase 2/Phase 3|50|Anticipated|Technion, Israel Institute of Technology|||||f||||||||||||||2017-02-18 16:37:24.532347|2017-02-18 16:37:24.532347
NCT00314366|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2016-10-17|2015-06-05||April 2006||2006-04-01|October 2016|2016-10-01|April 2021|Anticipated|2021-04-01|August 2009|Actual|2009-08-01||Interventional|||Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)|Phase IB Randomized Controlled Double-Blind Trial of Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells Under Electromechanical Guidance for Therapeutic Angiogenesis|Active, not recruiting||Phase 1|21|Actual|Texas Heart Institute|The study is a preliminary study based on a small sample size which limits the statistical rigor of the analysis.|2|||f||||t||||||||No|Relevant results are summarized and published. No need for individual results to be shared.|2017-02-18 16:37:24.640864|2017-02-18 16:37:24.640864
NCT00314353|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2010-06-08|2008-11-07||March 2006||2006-03-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|May 2008|Actual|2008-05-01||Interventional|||Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon|Randomized Phase II Clinical Trial of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Line Treatment for Metastatic Colorectal Cancer|Terminated||Phase 2|7|Actual|NSABP Foundation Inc|The study was closed early due to low enrollment and new information regarding the benefit of the study regimen.|2||"The study was closed early due to low enrollment and new information regarding the benefit of~   the study regimen."|f||||f||||||||||2017-02-18 16:37:28.176502|2017-02-18 16:37:28.176502
NCT00314340|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2013-07-11|2012-11-20||November 2005||2005-11-01|July 2013|2013-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine|A CTSC Clinical Research Center Study: A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine|Completed||Phase 4|12|Actual|University of California, Davis||3|||f||||f||||||||||2017-02-18 16:37:28.553389|2017-02-18 16:37:28.553389
NCT00314327|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2015-06-10|2015-04-13||April 2006||2006-04-01|June 2015|2015-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|ORP||Optimizing Response in Psychosis Study|Optimizing Response in Psychosis Study|Terminated||Phase 4|1|Actual|Northwell Health||1||Recruitment for the study was limited.|f||||t||||||||||2017-02-18 16:37:28.815974|2017-02-18 16:37:28.815974
NCT00314314|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2009-07-09|||May 2006||2006-05-01|May 2008|2008-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder|A Randomized, Double-Blind Controlled Trial Evaluating the Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder|Completed||Phase 3|60|Anticipated|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 16:37:29.270705|2017-02-18 16:37:29.270705
NCT00314301|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2006-04-14|||April 2006||2006-04-01|April 2006|2006-04-01|September 2007||2007-09-01|||||Interventional|||Motion Analysis of Sit-to-Stand Movements in Children With Spastic Diplegia|Motion Analysis of Sit-to-Stand Movements in Children With Spastic Diplegia Before and After Loaded Sit-to-Stand Training|Unknown status|Not yet recruiting|N/A|20||Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 16:37:29.384424|2017-02-18 16:37:29.384424
NCT00314288|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-12|2017-01-19|||July 2002||2002-07-01|January 2017|2017-01-01|July 2003||2003-07-01|||||Interventional|||Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia|A Multicenter, Multinational, Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-finding Study to Investigate the Anti-dyskinetic Efficacy and Safety of Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia|Completed||Phase 2|360||EMD Serono|||||||||||||||||||2017-02-18 16:37:29.478899|2017-02-18 16:37:29.478899
NCT00314275|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-04-19|||January 2006||2006-01-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|May 2006|Actual|2006-05-01||Interventional|ENDEAVOR PK||The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System|Evaluation of Pharmacokinetics (PK) and Safety of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Completed||N/A|43|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-02-18 16:37:29.608122|2017-02-18 16:37:29.608122
NCT00314262|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-10-21|2014-09-08||October 2006||2006-10-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor|Phase I/II Study of Chemoprevention With Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Erlotinib (OSI-774, Tarceva) and Cyclooxygenase-2 (COX-2) Inhibitor (Celecoxib) in Premalignant Lesions of Head and Neck of Former Smokers|Completed||Phase 1/Phase 2|17|Actual|Emory University|One limitation is the small number of patients who were evaluable for response.|1|||f||||t||||||||||2017-02-18 16:37:29.716314|2017-02-18 16:37:29.716314
NCT00314249|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2010-01-14|2009-06-30||April 2006||2006-04-01|January 2010|2010-01-01||||June 2008|Actual|2008-06-01||Interventional|||Study of Milnacipran for the Treatment of Fibromyalgia|A Phase III Pivotal, Multicenter, Double-blind, Randomized, Placebo-Controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia.|Completed||Phase 3|1025|Actual|Forest Laboratories||2|||f||||||||||||||2017-02-18 16:37:30.093526|2017-02-18 16:37:30.093526
NCT00314236|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2015-12-17|2015-11-05||December 2005||2005-12-01|December 2015|2015-12-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|||Trial Comparing BST-CarGel and Microfracture in Repair of Articular Cartilage Lesions in the Knee|A Randomized, Comparative Multicenter Clinical Trial Evaluating BST-CarGel™ and Microfracture in Repair of Focal Articular Cartilage Lesions on the Femoral Condyle|Completed||N/A|80|Actual|Piramal Healthcare Canada Ltd||2|||f||||f||||||||||2017-02-18 16:37:30.715674|2017-02-18 16:37:30.715674
NCT00314210|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2009-03-24|||March 2006||2006-03-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|||||Interventional|PLATINUM||Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.|A Multi-Centre,Double-Blind,Randomised-Withdrawal,Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine SR as Monotherapy in the Maintenance Treatment of Patients With GAD Following an Open-Label Stabilisation Period|Completed||Phase 3|575||AstraZeneca|||||f||||||||||||||2017-02-18 16:37:31.766911|2017-02-18 16:37:31.766911
NCT00314197|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2007-09-24|||April 2006||2006-04-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Improving Health Behaviors Through Telephone Linked Care|Study That Examines Integration of the Telephone Linked Care Behavioral Change (Automated Counseling) System Into Primary Care|Completed||N/A|400|Actual|American Academy of Family Physicians||2|||f||||f||||||||||2017-02-18 16:37:31.98602|2017-02-18 16:37:31.98602
NCT00314184|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2008-12-19|||March 2005||2005-03-01|December 2008|2008-12-01|July 2007|Actual|2007-07-01|||||Interventional|SPaRCLe||Quetiapine Fumarate Bipolar Maintenance Monotherapy|Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Quetiapine Fumarate and Lithium as Monotherapy for up to 104 Weeks Maintenance Treatment of Bipolar I Disorder in Adult Patients|Completed||Phase 3|1255|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:37:32.09256|2017-02-18 16:37:32.09256
NCT00314171|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2016-11-17|||October 2005||2005-10-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension|A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|437|Actual|Alcon Research||2|||f||||f||||||||||2017-02-18 16:37:32.516052|2017-02-18 16:37:32.516052
NCT00314158|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2016-11-17|||November 2005||2005-11-01|March 2012|2012-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 3|523|Actual|Alcon Research||3|||f||||||||||||||2017-02-18 16:37:32.63354|2017-02-18 16:37:32.63354
NCT00314145|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-12-04|2012-11-06||November 2005||2005-11-01|December 2012|2012-12-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Interventional|||A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX|A Multicentre, Randomized, Double-blind, Phase III Study of The Comparative Immunogenicity, Safety and Tolerability of Two Japanese Encephalitis Vaccines (ChimeriVax™-JE and JE-VAX®)|Completed||Phase 3|820|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:37:32.748694|2017-02-18 16:37:32.748694
NCT00314132|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-12-04|2012-11-06||October 2005||2005-10-01|December 2012|2012-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.|Randomised, Double Blind, Multicentre, Placebo Controlled Phase III Study of the Safety and Tolerability Following Administration of Live Attenuated JE Vaccine (ChimeriVax™-JE)|Completed||Phase 3|2004|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:37:33.306186|2017-02-18 16:37:33.306186
NCT00313989|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-12-04|||September 2007||2007-09-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology|Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal Oncology|Unknown status|Recruiting|N/A|200|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:37:33.876213|2017-02-18 16:37:33.876213
NCT00313976|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2015-03-09||||||December 2008|2008-12-01||||||||Interventional|||Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)|A Scandinavian, Randomized, Rater-blinded Study of Single and Double-dose Betaferon in Patients With Early Secondary Progressive Multiple Sclerosis|Withdrawn||Phase 3|0|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:37:33.968723|2017-02-18 16:37:33.968723
NCT00313963|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-08-09|||April 2006||2006-04-01|August 2013|2013-08-01|July 2013|Actual|2013-07-01|August 2008|Actual|2008-08-01||Interventional|||MAST - Magnesium for Sickle Cell Acute Crisis in Children|MAST - Magnesium for Sickle Cell Acute Crisis in Children|Completed||Phase 3|120|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 16:37:34.117736|2017-02-18 16:37:34.117736
NCT00313950|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-01-17|||September 2006||2006-09-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine|Immunogenicity and Safety of AVAXIM™ 80U-Pediatric Administered Alone or Concomitantly With TRIMOVAX™ in 12-13 Months Old Healthy Hepatitis A Seronegative Turkish Children|Completed||Phase 4|470|Actual|Sanofi||3|||f||||f||||||||||2017-02-18 16:37:34.231582|2017-02-18 16:37:34.231582
NCT00313937|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2009-12-04|||November 2001||2001-11-01|December 2009|2009-12-01||||June 2004|Actual|2004-06-01||Interventional|||SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1|Single Centre, Open, Controlled, Randomised (1:1), Parallel Group: Insulin Glargine vs. NPH: FPG (Fasting Plasma Glucose) in Patients With DM Type 1 Who Skip the Morning Meal During Treatment With MDI (Multiple Daily Injection) Basal/Bolus Insulin|Completed||Phase 4|91|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:37:34.341289|2017-02-18 16:37:34.341289
NCT00313924|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2007-02-19|||February 2006||2006-02-01|February 2007|2007-02-01|March 2006||2006-03-01|||||Interventional|||Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome|The Applicability of the OAB Assessment Tool for Evaluation of Treatment Efficacy of Overactive Bladder.|Unknown status|Recruiting|Phase 4|100||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:37:34.434305|2017-02-18 16:37:34.434305
NCT00313911|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-04-02|2012-09-18||July 2006||2006-07-01|April 2014|2014-04-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.|Large Scale Safety Study of a DTaP-IPV-Hep B-PRP~T Combined Vaccine, in Comparison to Tritanrix-Hep B/Hib™ and OPV Administered at 2, 4, and 6 Months of Age in Latin American Infants|Completed||Phase 3|2133|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:37:34.534176|2017-02-18 16:37:34.534176
NCT00313898|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2007-05-16|||September 2005||2005-09-01|April 2006|2006-04-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males|The Effect of Treatment for ED on Quality of Life and Satisfaction in a Group of Patients Without Prior Complaints of Sexual Dysfunction|Unknown status|Recruiting|Phase 4|100|Anticipated|Rambam Health Care Campus|||||f||||f||||||||||2017-02-18 16:37:35.19497|2017-02-18 16:37:35.19497
NCT00313885|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2010-11-29|||April 2004||2004-04-01|November 2010|2010-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia|Efficacy and Safety of SR46349B (1 and 5mg/Day) Administered During 8 Weeks in Patients With Sleep Disorders in Fibromyalgia: Multi-center, Randomized, Double-blind, Placebo-controlled Study.|Completed||Phase 2|205|Actual|Sanofi||3|||f||||||||||||||2017-02-18 16:37:35.540748|2017-02-18 16:37:35.540748
NCT00313872|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-01-10|||May 2003||2003-05-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer|Phase III Randomized Trial of Taxotere/Cisplatin Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer|Completed||Phase 3|200|Actual|Samsung Medical Center||2|||f||||||||||||||2017-02-18 16:37:35.664833|2017-02-18 16:37:35.664833
NCT00313859|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-01-31|||September 2005||2005-09-01|January 2012|2012-01-01|August 2007|Actual|2007-08-01|||||Interventional|||Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC|Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic Colorectal Cancer|Completed||Phase 2|50|Actual|Samsung Medical Center|||||f||||||||||||||2017-02-18 16:37:35.773327|2017-02-18 16:37:35.773327
NCT00313846|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-08-27|2010-07-28||April 2003||2003-04-01|August 2012|2012-08-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of the Buprenorphine Transdermal Delivery System in Subjects With Moderate to Severe Osteoarthritic Pain of Hip or Knee|Completed||Phase 3|529|Actual|Purdue Pharma LP||2|||f||||||||||||||2017-02-18 16:37:35.871282|2017-02-18 16:37:35.871282
NCT00313833|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2006-04-29|||December 2000||2000-12-01|April 2006|2006-04-01|November 2001||2001-11-01|||||Interventional|||Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.|A Randomized, Double Blind, Pilot Evaluation of the Effectiveness of BTDS Versus Placebo on Health Outcomes Associated With Analgesic Management of Elderly Residents in Supervised Living Environments|Completed||Phase 3|100||Purdue Pharma LP|||||||||||||||||||2017-02-18 16:37:36.318755|2017-02-18 16:37:36.318755
NCT00313820|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2009-10-09|2009-09-08||August 2006||2006-08-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain|A 13-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety And Tolerability Of Pregabalin (150-600 Mg/Day) Using A Flexible Dosing Schedule In The Treatment Of Subjects With Central Post-Stroke Pain (CPSP)|Completed||Phase 4|220|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:37:36.441655|2017-02-18 16:37:36.441655
NCT00313807|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2015-03-10|||November 2005||2005-11-01|March 2015|2015-03-01|September 2008||2008-09-01|||||Interventional|||Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage|CoNTRST - Contrast Nephropathy and Travasol for Renal Safety Trial: Intravenous Amino Acid Infusion for the Prevention of Contrast-mediated Acute Renal Failure Following Coronary Catheterization|Withdrawn||Phase 2|0|Actual|Queen's University||2||Abandoned due to lack of recruitment Oct 2006|f||||t||||||||||2017-02-18 16:37:37.309052|2017-02-18 16:37:37.309052
NCT00313794|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2012-06-05||2009-03-20|May 2006||2006-05-01|June 2012|2012-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment|Phase 2, Single Arm Study Of Ticilimumab In Patients With Refractory Metastatic Adenocarcinoma Of The Colon Or Rectum|Completed||Phase 2|49|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 16:37:37.416644|2017-02-18 16:37:37.416644
NCT00313781|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-03-05|2013-01-18||May 2006||2006-05-01|March 2013|2013-03-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|||Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)|A Phase 2, Randomized, Non-Comparative, Two-Arm Open Label, Multiple-Center Study Of CP-751,871 In Combination With Docetaxel/Prednisone In Chemotherapy- Naive (Arm A) And Docetaxel/Prednisone Refractory (Arm B) Patients With Hormone Insensitive Prostate Cancer|Completed||Phase 2|204|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:37:37.55019|2017-02-18 16:37:37.55019
NCT00313768|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2009-09-24||2009-09-24|December 2005||2005-12-01|September 2009|2009-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC|A Randomized Phase 2 Trial Of Paclitaxel, Carboplatin And Bevacizumab With Or Without PF-3512676 As First-Line Treatment Of Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer|Terminated||Phase 2|23|Actual|Pfizer||2||See Termination Reason in Detailed Description.|f||||f||||||||||2017-02-18 16:37:39.962225|2017-02-18 16:37:39.962225
NCT00313755|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2007-11-15|||April 2006||2006-04-01|November 2006|2006-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Magnification Narrow Band Imaging Colonoscopy for Hereditary Non-Polyposis Colorectal Cancer Surveillance|Back-to Back Trial of Narrow Band Imaging (NBI) With Magnification Versus Standard Colonoscopy for Colonic Neoplasia Surveillance in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients|Completed||N/A|60||London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 16:37:40.100674|2017-02-18 16:37:40.100674
NCT00313742|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-11-25|||April 2006||2006-04-01|November 2014|2014-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins|An Assessment of the Impact of Performing Physical Exercise on the Maximum Plasma Glucose Decline in Subjects With Type 1 Diabetes Managed on a Basal Bolus Insulin Regimen: A Comparison of 3 Basal Insulin Treatments - Insulin Detemir, Insulin Glargine and NPH Insulin|Completed||Phase 4|51|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:37:40.196428|2017-02-18 16:37:40.196428
NCT00313729|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2015-05-28|||May 1999||1999-05-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|January 2015|Actual|2015-01-01||Interventional|||Temozolomide in Treating Patients With Low-Grade Glioma|A Phase II Study of Temozolomide (TEMODAR) in the Treatment of Adult Patients With Supratentorial Low Grade Glioma|Completed||Phase 2|120|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:37:40.293006|2017-02-18 16:37:40.293006
NCT00313716|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2014-09-02|2014-07-28||April 2006||2006-04-01|September 2014|2014-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury|Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury|Completed||Phase 2/Phase 3|200|Actual|Baylor College of Medicine||6|||f||||t||||||||||2017-02-18 16:37:40.415423|2017-02-18 16:37:40.415423
NCT00313690|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2014-05-20|||April 2006||2006-04-01|May 2014|2014-05-01||||||||Interventional|||Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer|Phase I/II Study of Neoadjuvant Bortezomib in Combination With Docetaxel and Cisplatin Followed by Surgery in Early Stage Non-Small Cell Lung Cancer.|Withdrawn||Phase 1/Phase 2|0|Actual|University of Southern California||1||Recruitment difficulties|f||||||||||||||2017-02-18 16:37:43.821933|2017-02-18 16:37:43.821933
NCT00313677|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2016-12-21|||April 2006||2006-04-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|March 2020|Anticipated|2020-03-01||Observational|||Clinical Trial Readiness for the Dystroglycanopathies|Clinical Trial Readiness for the Dystroglycanopathies|Recruiting||N/A|120|Anticipated|University of Iowa|||1||f||||f||||||Samples With DNA|"~     fibroblasts, whole blood~   "|No||2017-02-18 16:37:43.899625|2017-02-18 16:37:43.899625
NCT00313625|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2010-09-20|||September 2005||2005-09-01|September 2010|2010-09-01||||July 2007|Actual|2007-07-01||Interventional|||Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma|A Phase II Study of Intravenous Melphalan and Busulfan Followed by HLA-Matched, Allogeneic Peripheral Blood Stem Cell Transplant for the Treatment of Multiple Myeloma|Completed||Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 16:37:43.997806|2017-02-18 16:37:43.997806
NCT00313612|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2015-10-27|2015-04-13||January 2006||2006-01-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|May 2011|Actual|2011-05-01||Interventional|||Oxaliplatin and Topotecan in Advance Ovarian Cancer|A Phase II Study of Oxaliplatin Combined With Continuous Infusion Topotecan as Chemotherapy for Patients With Previously Treated Ovarian Cancer|Terminated||Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:37:44.098944|2017-02-18 16:37:44.098944
NCT00313599|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-07-01|||February 2006||2006-02-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors|A Phase I Dose Escalation Study of a 2 Day Oral Lapatinib Chemosensitization Pulse Given Prior To Weekly Intravenous Abraxane™ in Patients With Advanced Solid Tumors|Completed||Phase 1|28|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:37:44.449811|2017-02-18 16:37:44.449811
NCT00313586|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2016-12-08|2014-11-18||August 2006||2006-08-01|December 2016|2016-12-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional||All treated patients were included in the analysis.|Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia|A Randomized Phase II Trial of Azacitidine With or Without the Histone Deacetylase Inhibitor Entinostat for the Treatment of Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (Dysplastic Type), and Acute Myeloid Leukemia With Multilineage Dysplasia|Completed||Phase 2|197|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 16:37:44.583572|2017-02-18 16:37:44.583572
NCT00313573|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2013-09-19|||February 2006||2006-02-01|May 2009|2009-05-01||||January 2010|Anticipated|2010-01-01||Interventional|||Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By Cancer|TeleCare Management of Pain and Depression in Cancer|Unknown status|Active, not recruiting|Phase 3|480|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:37:45.832933|2017-02-18 16:37:45.832933
NCT00313560|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2016-04-05|||January 2006||2006-01-01|January 2016|2016-01-01||||December 2008|Actual|2008-12-01||Interventional|||Erlotinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer That Can Be Removed By Surgery|Phase II Study of Erlotinib (Tarceva) Combined With Chemoradiation and Adjuvant Chemotherapy in Patients With Resectable Pancreatic Cancer|Completed||Phase 2|52|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||||2017-02-18 16:37:45.957778|2017-02-18 16:37:45.957778
NCT00313547|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2008-05-02|||April 2006||2006-04-01|August 2007|2007-08-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|||High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients|Impact of High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine on Autonomic Regulation and on Sympathetic Activation in Response to Cold Exposure in Hypertensive Patients With Impaired Glucose Tolerance, Diabetes or Coronary Artery Disease|Terminated||Phase 4|40|Anticipated|Montreal Heart Institute||||Very difficult to recruit patients/slow recruitment(2 patients in nearly 2 years).|f||||||||||||||2017-02-18 16:37:46.079751|2017-02-18 16:37:46.079751
NCT00313534|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-10-09|||June 2005||2005-06-01|October 2012|2012-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer|A Phase I Study of NDGA in Patients With Non-Metastatic Biochemically Relapsed Prostate Cancer|Terminated||Phase 1|15|Actual|University of California, San Francisco||||Ran out of drug|f||||t||||||||||2017-02-18 16:37:46.178955|2017-02-18 16:37:46.178955
NCT00313521|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2013-09-19|||June 1995||1995-06-01|December 2006|2006-12-01||||November 1997|Anticipated|1997-11-01||Interventional|||Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors|Continuous Infusion Thiotepa in High Grade Astrocytic Tumors of Childhood and Adolescence A UKCCSG Phase II Study Involving the Brain Tumour and New Agent Groups|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:37:46.277502|2017-02-18 16:37:46.277502
NCT00313508|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2014-02-20|||February 2006||2006-02-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Dendritic Cell Vaccination During Lymphoid Reconstruction|A Dose Ranging Trial of MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured Using Cytokines With Autologous Lymphocyte Infusion With or Without Escalating Doses of Fludarabine for Patients With Chemotherapy-naive Metastatic Melanoma|Completed||Phase 1|18|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-02-18 16:37:46.366653|2017-02-18 16:37:46.366653
NCT00313495|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2011-03-04|||February 2006||2006-02-01|March 2011|2011-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Cooperative Huntington's Observational Research Trial|Cooperative Huntington's Observational Research Trial|Recruiting||N/A|5000|Anticipated|HP Therapeutics Foundation|||1||f||||f||||||Samples With DNA|"~     Blood, DNA and Urine~   "|||2017-02-18 16:37:46.63604|2017-02-18 16:37:46.63604
NCT00313482|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2012-05-09|||April 2006||2006-04-01|May 2012|2012-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC|A Phase II Trial of Docetaxel/Prednisone in Combination With Sargramostim as Treatment for Hormone-refractory Prostate Cancer|Terminated||Phase 2|35|Actual|Veeda Oncology||1||Low accrual|f||||f||||||||||2017-02-18 16:37:46.831972|2017-02-18 16:37:46.831972
NCT00313469|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2011-08-24|||September 2005||2005-09-01|August 2011|2011-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Sources of the Variability of the Response to Fluindione in Elderly Patients (PREPA)|Sources of the Variability of the Response to Fluindione in Elderly Patients (PREPA) [Etude Des Sources de variabilité de la réponse à la Fluindione Chez Les Personnes âgées de 80 Ans et Plus (PREPA) ]|Completed||Phase 4|152|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"~     Blood samples for the measure of drug concentrations Blood samples with DNA measurements~   "|||2017-02-18 16:37:46.943393|2017-02-18 16:37:46.943393
NCT00313456|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2012-05-09|||March 2006||2006-03-01|May 2012|2012-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel|A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel|Terminated||Phase 1|25|Actual|Agennix||1||Sponsor decided to discontinue study drug development|f||||||||||||||2017-02-18 16:37:47.032448|2017-02-18 16:37:47.032448
NCT00313443|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2011-07-06|2009-06-18||April 2006||2006-04-01|June 2009|2009-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|ATACA||Concentrations of Amiodarone in Fat Tissue During Chronic Treatment|Study of Concentrations of Amiodarone in Fat Tissue Obtained by Needle Aspiration in Patients on Chronic Treatment|Completed||Phase 4|30|Actual|Hopital Lariboisière|Small number of patients included. High variability of amiodarone concentrations in fat tissue between the 2 simultaneous samples for some patients. Incidence of amiodarone-related adverse effects probably overestimated.|1|||f||||f||||||||||2017-02-18 16:37:47.123503|2017-02-18 16:37:47.123503
NCT00313430|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2015-08-19|||May 2004||2004-05-01|August 2015|2015-08-01||||March 2008|Actual|2008-03-01||Observational|||Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension|Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease or Hypertension|Completed||N/A|50|Actual|Regional Hospital Holstebro|||2||f||||||||||||||2017-02-18 16:37:47.574711|2017-02-18 16:37:47.574711
NCT00313417|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2013-04-03|||January 2007||2007-01-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Creatine as a New Therapeutic Strategy in Depression|A Double-blind, Parallel, Randomized, add-on Clinical Trial of Creatine Versus Placebo Added to Antidepressant Treatment of Patients With Major Depressive Episode.|Terminated||Phase 4|18|Actual|Herzog Hospital||2|||f||||t||||||||||2017-02-18 16:37:47.666681|2017-02-18 16:37:47.666681
NCT00313404|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-11-18|||February 2006||2006-02-01|November 2013|2013-11-01|April 2011|Actual|2011-04-01|January 2007|Actual|2007-01-01||Interventional|||Infectivity of Norovirus in Groundwater-Human Challenge Study|Assessment of Calicivirus Survival in Surface Water and Subsurface Water|Completed||N/A|13|Actual|Emory University||1|||f||||f||||||||||2017-02-18 16:37:47.774138|2017-02-18 16:37:47.774138
NCT00313391|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2014-09-23|||December 2005||2005-12-01|September 2014|2014-09-01||||December 2007|Actual|2007-12-01||Interventional|||Risperdal Consta and Health Care Utilization in Patients With Schizophrenia|The Effects of Risperdal Consta on Health Care Utilization Costs in Chronically Ill Schizophrenic Patients|Completed||Phase 4|||Emory University|||||f||||||||||||||2017-02-18 16:37:47.876651|2017-02-18 16:37:47.876651
NCT00313378|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2013-04-02|||April 2004||2004-04-01|April 2013|2013-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Perioperative Systemic Ketamine on Development of Long-term Neuropathic Pain After Thoracotomy|Effects of Perioperative Systemic Ketamine on Development of Long-term Neuropathic Pain After Thoracotomy.|Completed||Phase 3|78|Actual|University Hospital, Clermont-Ferrand||2|||f||||||||||||||2017-02-18 16:37:47.963677|2017-02-18 16:37:47.963677
NCT00313365|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-09-23|||April 2006||2006-04-01|September 2013|2013-09-01|July 2013|Anticipated|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Surgical Lavage vs Serial Needle Aspiration for Infected Joints|Arthrotomy With Irrigation and Debridement Versus Serial Arthrocentesis as Treatment for Septic Arthritis in Adults|Withdrawn||Phase 3|0|Actual|Emory University||||Study was never started because Dr. Hammerberg left before it could be started.|f||||||||||||||2017-02-18 16:37:48.076288|2017-02-18 16:37:48.076288
NCT00313352|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-11-08|||January 1997||1997-01-01|November 2013|2013-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Effects of Beta-adrenergic in Adults w/Transposition of Great Arteries on Systemic Ventricular Function|Effects of Beta-adrenergic Blocking Agents in Adult Patients With Transposition of the Great Arteries on Systemic Ventricular Function|Completed||N/A|110|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:37:48.176644|2017-02-18 16:37:48.176644
NCT00313339|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-11-15|||March 2006||2006-03-01|November 2013|2013-11-01|March 2013|Actual|2013-03-01|March 2009|Actual|2009-03-01||Interventional|AMR-1||Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction|AMORCYTE MYOCARDIAL REPAIR STUDY- A Phase I Trial of Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction. (AMRS)|Completed||Phase 1|31|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:37:48.268661|2017-02-18 16:37:48.268661
NCT00313326|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2008-10-07|||February 2005||2005-02-01|October 2008|2008-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Comparative Study of Duration of Respiratory Weaning Between Adaptive Support Ventilation and Succession of Controlled Ventilation Then Spontaneous Ventilation for Patients After Surgery|Comparative Study of Duration of Respiratory Weaning Between Adaptive Support Ventilation and Succession of Controlled Ventilation Then Spontaneous Ventilation for Patients After Surgery|Terminated||Phase 3|66|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 16:37:48.376501|2017-02-18 16:37:48.376501
NCT00313313|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2015-04-14|2009-08-17||April 2006||2006-04-01|March 2015|2015-03-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas|A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin in Combination With Glyburide in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Glyburide Alone|Completed||Phase 3|768|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:37:48.480047|2017-02-18 16:37:48.480047
NCT00313300|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2015-11-25|2015-09-11||May 2006||2006-05-01|November 2015|2015-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||All randomized participants were summarized.|Safety Study of Apixaban in Recent Acute Coronary Syndrome|A Phase 2, Placebo-Controlled, Randomized, Double Blind, Parallel Arm, Dose Ranging Study to Evaluate Safety and Efficacy of Apixaban in Patients With a Recent Acute Coronary Syndrome.|Completed||Phase 2|1741|Actual|Bristol-Myers Squibb||4|||f||||t||||||||||2017-02-18 16:37:49.274884|2017-02-18 16:37:49.274884
NCT00313287|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2017-01-30|||June 2003||2003-06-01|April 2006|2006-04-01|November 2004||2004-11-01|||||Interventional|||Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV|A Double-Blind, Randomized, Parallel, Placebo-Controlled Phase III Study to Evaluate the Safety and Antiviral Activity of Clevudine 30 mg QD in Patients Chronically Infected With Hepatitis B Virus|Terminated||Phase 3|180||Bukwang Pharmaceutical|||||f||||||||||||||2017-02-18 16:37:52.780724|2017-02-18 16:37:52.780724
NCT00313274|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2017-01-30|||July 2003||2003-07-01|April 2006|2006-04-01|December 2004||2004-12-01|||||Interventional|||Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV|A Double-Blind, Randomized, Parallel, Placebo-Controlled Phase III Study to Evaluate the Safety and Antiviral Activity of Clevudine (L-FMAU) 30 mg QD in Patients With HBeAg Negative Chronic Hepatitis B|Terminated||Phase 3|80||Bukwang Pharmaceutical|||||f||||||||||||||2017-02-18 16:37:53.001131|2017-02-18 16:37:53.001131
NCT00313261|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2012-10-16|||June 2003||2003-06-01|October 2012|2012-10-01|February 2005||2005-02-01|||||Interventional|||Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group|An Open-Label, Phase II Study to Evaluate Safety, Tolerability, Antiviral Activity and Biochemical and Immunological Responses of L-FMAU (Clevudine) in Chronic Hepatitis B Patients of L-FMAU-201 Placebo Group|Terminated||Phase 2|||Bukwang Pharmaceutical|||||f||||||||||||||2017-02-18 16:37:53.113115|2017-02-18 16:37:53.113115
NCT00313248|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2015-11-11||2015-09-24|April 2006||2006-04-01|November 2015|2015-11-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer|Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer|Completed||Phase 2|65|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:37:53.201796|2017-02-18 16:37:53.201796
NCT00313235|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2013-06-12|||March 2006||2006-03-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2011|Actual|2011-06-01||Interventional|||Combined Modality Treatment for Patients With Stage IV Melanoma|Combined Modality Treatment for Patients With Stage IV Melanoma: Cyclophosphamide and a Dendritic Cell Vaccine Loaded With Killed Allogeneic Melanoma Cells|Completed||Phase 1/Phase 2|41|Actual|Baylor Research Institute||1|||f||||t||||||||||2017-02-18 16:37:53.333991|2017-02-18 16:37:53.333991
NCT00313222|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2010-02-11||2010-02-11|October 2005||2005-10-01|February 2010|2010-02-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension|Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|Completed||Phase 3|157|Actual|Actelion||2|||f||||||||||||||2017-02-18 16:37:53.444572|2017-02-18 16:37:53.444572
NCT00313209|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-11|2016-11-01|2011-03-17||April 2006||2006-04-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|July 2007|Actual|2007-07-01||Interventional|EOS||Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)|Effect of Roflumilast in COPD Patients Treated With Salmeterol. A 24-week, Double-blind Study With 500 μg Roflumilast Once Daily Versus Placebo. The EOS Study|Completed||Phase 3|933|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:37:53.75703|2017-02-18 16:37:53.75703
NCT00313196|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2012-01-11||2010-02-11|April 2006||2006-04-01|January 2012|2012-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|ASSET-2||Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)|Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Symptomatic Pulmonary Hypertension Associated With Sickle Cell Disease|Terminated||Phase 3|12|Actual|Actelion||2||Slow enrollment|f||||||||||||||2017-02-18 16:37:54.454423|2017-02-18 16:37:54.454423
NCT00313183|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2015-03-05|||April 2006||2006-04-01|January 2015|2015-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus|A Randomized, Single-Blind, Dose-Rising, Placebo-Controlled, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of SYMLIN in Adolescent Subjects With Type 1 Diabetes Mellitus|Completed||Phase 2|12|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 16:37:54.773309|2017-02-18 16:37:54.773309
NCT00313170|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2016-11-09|2009-06-10||May 2006||2006-05-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|June 2008|Actual|2008-06-01||Interventional|FINDER II||A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg|Phase II Study to Evaluate the Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg in Postmenopausal Women With ER +ve Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy|Active, not recruiting||Phase 2|161|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:37:54.883555|2017-02-18 16:37:54.883555
NCT00313157|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2014-05-11|||April 2006||2006-04-01|May 2014|2014-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|RATAF||RATe Control in Atrial Fibrillation|Rate Control in Atrial Fibrillation|Completed||Phase 3|80|Actual|Asker & Baerum Hospital||4|||f||||f||||||||||2017-02-18 16:37:55.47052|2017-02-18 16:37:55.47052
NCT00313144|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2015-06-26|2011-03-04||June 2006||2006-06-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Aralast alpha1-proteinase Inhibitor Surveillance Study|ARALAST alpha1-proteinase Inhibitor (α1-PI) Surveillance Study|Terminated||Phase 4|127|Actual|Baxalta US Inc.|Study was terminated early due to Aralast being phased out of the market.|1||Study terminated early due to Aralast being phased out of the market.|f||||f||||||||||2017-02-18 16:37:55.774546|2017-02-18 16:37:55.774546
NCT00313131|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2006-04-07|||January 2004||2004-01-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments|A Randomised Controlled Trial of Single Dose Tinidazole+Fluconazole Versus Longer Courses of Metronidazole+Clotrimazole in the Management of West African Women With Vaginal Discharge|Completed||Phase 3|1524||Université de Sherbrooke|||||f||||||||||||||2017-02-18 16:37:57.01313|2017-02-18 16:37:57.01313
NCT00313118|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2015-10-01|||January 2006||2006-01-01|October 2015|2015-10-01|September 2016|Anticipated|2016-09-01|September 2010|Actual|2010-09-01||Observational|||Mean Values of Oxidative Stress Parameters in Healthy Subjects|Determination of the Mean Values of Oxidative Stress Parameters in the Plasma of Healthy Subjects|Suspended||N/A|40|Anticipated|University Hospital, Basel, Switzerland|||1|Problems with recruiting|f||||f||||||None Retained|"~     plasma~   "|||2017-02-18 16:37:57.111342|2017-02-18 16:37:57.111342
NCT00313105|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2009-09-14|||April 2006||2006-04-01|September 2009|2009-09-01|August 2010|Anticipated|2010-08-01|April 2010|Anticipated|2010-04-01||Interventional|||Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches|Smoking Cessation by Nurses With Smokeless Tobacco Buccal Tablets, Nicotine Buccal Tablets, Nicotine Patches With Repeated Therapy Every 6 Months for 2 Years|Unknown status|Active, not recruiting|Phase 2/Phase 3|600|Anticipated|University Hospital, Gentofte, Copenhagen||3|||f||||f||||||||||2017-02-18 16:37:57.187571|2017-02-18 16:37:57.187571
NCT00313092|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2015-10-01|||January 2005||2005-01-01|October 2015|2015-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Obstructive Sleep Apnea Syndrome in Glaucoma|Does Plasma Matrix-metalloproteinase Activity Predict Glaucomas in Patients With OSAS (Obstructive Sleep Apnea Syndrome) and Does the Level of Plasma Matrix-metalloproteinase Activity Decrease After One Month of nCPAP-treatment|Terminated||N/A|60|Actual|University Hospital, Basel, Switzerland|||1|recruiting problems|f||||f||||||None Retained|"~     plasma~   "|||2017-02-18 16:37:57.291972|2017-02-18 16:37:57.291972
NCT00313079|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2012-06-29|||May 2006||2006-05-01|June 2012|2012-06-01|July 2009|Actual|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia|A Phase I Study of mAb 216 With Chemotherapy for the Treatment of Adult Patients With Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia|Completed||Phase 1|9|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 16:37:57.3901|2017-02-18 16:37:57.3901
NCT00313066|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-09|2006-04-09|||November 2005||2005-11-01|April 2006|2006-04-01|November 2006||2006-11-01|||||Observational|||Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion|Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion Among Tuberculous Pleurisy and Malignant Pleural Effusion Patients|Unknown status|Recruiting|Phase 4|80||Taichung Veterans General Hospital|||||f||||||||||||||2017-02-18 16:37:57.4795|2017-02-18 16:37:57.4795
NCT00313053|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2016-06-01|||September 2004||2004-09-01|November 2012|2012-11-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|||Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia|A Phase I Study of mAb 216 With Chemotherapy for the Treatment of Pediatric Patients With Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia|Terminated||Phase 1|4|Actual|Stanford University||1|||f||||||||||||||2017-02-18 16:37:57.563363|2017-02-18 16:37:57.563363
NCT00313040|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2011-06-08|||March 2004||2004-03-01|June 2011|2011-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study to Promote Physical Activity Among Overweight Persons|Promoting Increased Physical Activity as the Main Outcome of Treatment for Overweight Persons: A Pilot Randomized Controlled Trial|Completed||Phase 1/Phase 2|30||Stanford University|||||f||||||||||||||2017-02-18 16:37:57.658572|2017-02-18 16:37:57.658572
NCT00313027|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2012-07-05|||November 2002||2002-11-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation|Cervical Nodal Metastasis in Squamous Cell Carcinoma of the Head and Neck - Novel MRI, FDG-PET, and Histopathologic Correlation|Completed||N/A|30|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 16:37:57.76915|2017-02-18 16:37:57.76915
NCT00313014|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2012-08-27|2010-07-28||February 2004||2004-02-01|August 2012|2012-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain|A Multicenter, Randomized, Double-blind, Active Comparator Study to Determine the Efficacy and Safety of BTDS 20 or Oxycodone Immediate-release Versus BTDS 5 in Subjects With Moderate to Severe Low Back Pain|Terminated||Phase 3|660|Actual|Purdue Pharma LP|BUP3015 was terminated early due to administrative reasons unrelated to efficacy or safety.|3||Terminated early due to administrative reasons unrelated to efficacy or safety.|f||||f||||||||||2017-02-18 16:37:57.986662|2017-02-18 16:37:57.986662
NCT00313001|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-08|2017-01-05|||April 2006||2006-04-01|January 2017|2017-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.|Effects of NovoLog® Mix 70/30 (Biphasic Insulin Aspart 70/30) BID and QD vs. Byetta™ Exenatide) BID on Glycemic Control: A Multicenter, 24-Week, Open-Label, Parallel Group Study in Patients With Type 2 Diabetes Mellitus Not Achieving Glycemic Targets With Metformin and a Sulfonylurea|Completed||Phase 3|373|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:37:59.002238|2017-02-18 16:37:59.002238
NCT00312988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-04-10|||January 2000||2000-01-01|September 2005|2005-09-01|December 2009||2009-12-01|||||Interventional|||Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy|Topotecan-Monotherapy Vs. Topotecan + Etoposide Vs. Topotecan + Gemcitabine in Therapy in Patients With Recurrent Ovarian Cancer|Completed||Phase 3|450||North Eastern Germany Society of Gynaecologic Oncology|||||f||||||||||||||2017-02-18 16:37:59.108871|2017-02-18 16:37:59.108871
NCT00312975|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2012-06-05||2009-04-20|May 2006||2006-05-01|June 2012|2012-06-01|February 2010|Actual|2010-02-01|April 2008|Actual|2008-04-01||Interventional|||Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)|Phase 2 Randomized, Non-Comparative Study Of CP-675,206 Or Best Supportive Care Immediately Following First-Line, Platinum-Based Therapy In Patients With Stage IIIB (With Effusion) Or Stage IV Non-Small Cell Lung Cancer That Has Responded Or Remained Stable|Completed||Phase 2|90|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:37:59.222103|2017-02-18 16:37:59.222103
NCT00312962|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2014-03-07|||April 2004||2004-04-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|March 2012|Actual|2012-03-01||Interventional|CRIS||Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia|Neuroscience-Guided Remediation of Cognitive Deficits in Schizophrenia|Completed||Phase 1/Phase 2|80|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 16:37:59.351748|2017-02-18 16:37:59.351748
NCT00312949|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2015-04-15|||April 2006||2006-04-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia|Consumer Internet Education About Mental Health Quality|Completed||N/A|56|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-02-18 16:37:59.457848|2017-02-18 16:37:59.457848
NCT00312936|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2016-05-12|||July 2006||2006-07-01|May 2016|2016-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Mindfulness Based Approach to HIV Treatment Side Effects|A Mindfulness Based Approach to HIV Treatment Side Effects|Completed||Phase 1/Phase 2|76|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 16:37:59.576255|2017-02-18 16:37:59.576255
NCT00312923|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2013-07-19|2013-05-23||September 2005||2005-09-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional||54 eligible participants were randomized to the study arms. 39 participants completed the study. An intent-to-treat analysis was performed.|Preliminary Study of Safety and Efficacy of Policosanol|Preliminary Study of Safety and Efficacy of Policosanol|Completed||Phase 2|54|Actual|Rush University Medical Center|It is possible that other constituents underlie policosanol’s lipid-lowering activity. One study found that triacontanol inhibited HMG-CoA reductase in rat liver cells. Triacontanol was not detected in either lot of policosanol used in this study.|2|||f||||t||||||||||2017-02-18 16:37:59.684319|2017-02-18 16:37:59.684319
NCT00312910|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-09|2008-05-21|||April 2005||2005-04-01|April 2007|2007-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Probiotics for the Prevention of Major Complications of Cirrhosis|Probiotics for the Prevention of Major Complications of Cirrhosis|Completed||N/A|50|Anticipated|Meir Medical Center|||||f||||||||||||||2017-02-18 16:38:00.075963|2017-02-18 16:38:00.075963
NCT00312897|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2015-10-23|||December 2005||2005-12-01|October 2015|2015-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Omega-3 Fatty Acids in Adolescent Depression|Omega-3 Fatty Acids in Adolescent Depression|Completed||N/A|57|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 16:38:00.185941|2017-02-18 16:38:00.185941
NCT00312884|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2016-04-26|2015-10-27||May 2006||2006-05-01|November 2007|2007-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Home-HF: Evaluation of Patients With Heart Failure Using Home Telemonitoring|Home-HF: a Randomised Controlled Evaluation of Home Telemonitoring of Patients With Heart Failure Recently Discharged From Hospital.|Completed||Phase 3|182|Actual|Imperial College London||2|||f||||||||||||||2017-02-18 16:38:00.305016|2017-02-18 16:38:00.305016
NCT00312871|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2011-05-16|||February 2001||2001-02-01|April 2010|2010-04-01|June 2003|Actual|2003-06-01|||||Interventional|||Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency|Effect of Early Correction of Anemia on the Progression of Chronic Renal Insufficiency (ECAP)|Terminated||Phase 4|217|Actual|Janssen Cilag S.A.S.||||"Study was stopped due to restrictions in labeling for the subcutaneous route of administration~   of EPREX."|f||||f||||||||||2017-02-18 16:38:00.747635|2017-02-18 16:38:00.747635
NCT00312858|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2015-10-29|2009-03-24||April 2006||2006-04-01|October 2015|2015-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)|An Open, Randomized, Multicenter Study of the Safety, Tolerability, & Immunogenicity of VAQTA™ Given Concomitantly With PROQUAD™ and PREVNAR™ in Healthy Children 12 Months of Age|Completed||Phase 4|653|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:38:00.843865|2017-02-18 16:38:00.843865
NCT00312845|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2012-06-19|2011-06-29||March 2006||2006-03-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma|A Randomized, Open-Label, Multicenter Study of VELCADE With Rituximab or Rituximab Alone in Subjects With Relapsed or Refractory, Rituximab Naive or Sensitive Follicular B-cell Non-Hodgkin's Lymphoma|Completed||Phase 3|676|Actual|Millennium Pharmaceuticals, Inc.||2|||f||||||||||||||2017-02-18 16:38:01.90626|2017-02-18 16:38:01.90626
NCT00312832|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2006-10-23|||January 2004||2004-01-01|January 2004|2004-01-01|February 2005||2005-02-01|||||Interventional|||Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy|A Randomized Open Label Study Comparing the Impact of Reducing the Dose of Stavudine Versus Switching to Tenofovir on Plasma Lipids, Body Composition and Mitochondrial Function in HIV-Infected Patients Receiving Antiretroviral Therapy|Completed||N/A|60||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:38:03.584956|2017-02-18 16:38:03.584956
NCT00312819|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2010-08-30|||March 2006||2006-03-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer|Randomized Phase 2 Trial of Treatment of Advanced Non Small Cell Lung Carcinoma With/Without Disulfiram and Cisplatin Navelbine|Completed||Phase 2/Phase 3|60|Anticipated|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 16:38:03.664483|2017-02-18 16:38:03.664483
NCT00312806|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2012-05-04|||May 2006||2006-05-01|December 2008|2008-12-01|July 2007|Actual|2007-07-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)|Real Life: Treatment Response in Patients With Symptoms Due to Gastroesophageal Reflux Disease Either With or Without Esophagitis Treated With Pantoprazole Sodium 40 mg o.d. Over 8 Weeks|Completed||Phase 3|2000|Anticipated|Takeda||1|||f||||||||||||||2017-02-18 16:38:03.781077|2017-02-18 16:38:03.781077
NCT00312793|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-10|2009-06-21||||||June 2009|2009-06-01||||||||Interventional|||The Efficacy and Safety of Electronic Stimulation in Patients Who Underwent Reconstruction of the Anterior Cruciate Ligament|Phase 2 Study to Evaluate the Efficacy and Safety of Electronic Stimulation of the Quadriceps Muscle in the Thigh by the MyoSpare Device, in Patients Who Underwent Reconstruction of the Anterior Cruciate Ligament (ACL)|Terminated||Phase 1/Phase 2|60|Anticipated|Hadassah Medical Organization||||the study stopped becaust the sponsor did not wish to proceede with the study|f||||||||||||||2017-02-18 16:38:04.164422|2017-02-18 16:38:04.164422
NCT00312780|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2010-02-22|||March 2006||2006-03-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy|A Randomized, Double-Blind, Placebo-Controlled Study of XL784 Administered Orally to Subjects With Albuminuria Due to Diabetic Nephropathy|Completed||Phase 2|125|Actual|Symphony Evolution, Inc.||2|||f||||t||||||||||2017-02-18 16:38:04.25585|2017-02-18 16:38:04.25585
NCT00312767|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2014-02-04|||April 2006||2006-04-01|February 2014|2014-02-01||||||||Interventional|||A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.|A Multicenter, Open-Label, Cross-Over Trial to Evaluate the Pharmacokinetics of Fabrazyme During Simultaneous Fabrazyme Infusion and Chronic Hemodialysis in Patients With Fabry Disease.|Withdrawn||Phase 4|0|Actual|Sanofi|||||||||||||||||||2017-02-18 16:38:04.394292|2017-02-18 16:38:04.394292
NCT00312754|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2016-09-16|||June 2005||2005-06-01|September 2016|2016-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome|A Phase IV, One-arm, Open-label, Multicenter Study Evaluating Effect of Treatment Change to Atazanavir/Ritonavir on Brachial Endothelial Function of HIV Infected Patient Receiving Function in HIV Infected Patient Receiving Potent Antiretroviral Combination Therapy|Terminated||Phase 4|70||Bristol-Myers Squibb||||insufficient enrollment|f||||||||||||||2017-02-18 16:38:04.497737|2017-02-18 16:38:04.497737
NCT00312741|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2009-02-26|||April 2006||2006-04-01|February 2009|2009-02-01|May 2008|Anticipated|2008-05-01|||||Observational|||Usefulness of Microbiological Tests in Community-Acquired Pneumonia|Prospective Study on Benefits Derived From Microbiological Tests in Community-Acquired Pneumonia|Unknown status|Recruiting|N/A|250|Anticipated|Hospital Arnau de Vilanova|||||f||||f||||||||||2017-02-18 16:38:04.586322|2017-02-18 16:38:04.586322
NCT00312728|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2011-08-03|2011-03-18||March 2006||2006-03-01|August 2011|2011-08-01||||June 2009|Actual|2009-06-01||Interventional|||A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)|A Phase II Trial of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous Non-Small Cell Lung Cancer|Completed||Phase 2|115|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 16:38:04.673038|2017-02-18 16:38:04.673038
NCT00312715|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-08|2017-01-24|||April 3, 2006||2006-04-03|July 8, 2014|2014-07-08|July 8, 2014||2014-07-08|||||Observational|||Thyroid and Fat Tissue Metabolism|Thyroid Hormone-Induced Lipolysis: An In Vivo Microdialysis Study|Completed||N/A|41|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:38:04.99824|2017-02-18 16:38:04.99824
NCT00312702|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2012-08-09|||April 2006||2006-04-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|October 2006|Actual|2006-10-01||Interventional|||Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America|A Phase I/IIa Controlled Study of the Safety, Immunogenicity and Preliminary Efficacy of FMP011/AS02A Candidate Malaria Vaccine in Malaria-naive Adults Living in the United States|Completed||Phase 1/Phase 2|36|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-02-18 16:38:05.085484|2017-02-18 16:38:05.085484
NCT00312689|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2007-04-11|||March 2006||2006-03-01|April 2007|2007-04-01|April 2007|Anticipated|2007-04-01|||||Observational|||Microbiological Examination of Children Operated for Congenital Lacrimal Stenosis|Microbiological Examination of Children Operated for Congenital Lacrimal Stenosis|Unknown status|Active, not recruiting|N/A|120||University Hospital Muenster|||||f||||||||||||||2017-02-18 16:38:05.194063|2017-02-18 16:38:05.194063
NCT00312676|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2006-04-06|||March 2006||2006-03-01|March 2006|2006-03-01|October 2006||2006-10-01|||||Interventional|||Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Different Forms of Depakote|Conversion From Multiple-Daily Dose Enteric-Coated Depakote to Once-Daily Depakote ER in Elderly Outpatients With Epilepsy or Behavioral Disturbances:|Unknown status|Recruiting|Phase 4|20||Veterans Affairs Medical Center, Miami|||||f||||||||||||||2017-02-18 16:38:07.977513|2017-02-18 16:38:07.977513
NCT00312663|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2012-08-09|||April 2006||2006-04-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|October 2006|Actual|2006-10-01||Interventional|||Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America|A Phase I/IIa Controlled Study of the Safety, Immunogenicity and Preliminary Efficacy of FMP011/AS01B Candidate Malaria Vaccine in Malaria-naive Adults Living in the United States|Completed||Phase 1/Phase 2|36|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-02-18 16:38:08.120318|2017-02-18 16:38:08.120318
NCT00312650|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2015-01-09|||April 2006||2006-04-01|January 2015|2015-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Doxil and Gemcitabine in Recurrent Ovarian Cancer|A Phase II Study of Every 2 Week Doxil and Gemcitabine in Recurrent Ovarian Cancer|Terminated||Phase 2|24||Women and Infants Hospital of Rhode Island|||||f||||||||||||||2017-02-18 16:38:08.223908|2017-02-18 16:38:08.223908
NCT00312637|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2012-04-27|||March 2005||2005-03-01|April 2012|2012-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease|High-Resolution Axillary MRI With Magnetic Resonance Spectroscopy as a Non-Invasive Test for Determining Pathologic Lymph Node Status in Patients With Invasive Breast Cancer|Withdrawn||N/A|0|Actual|UNC Lineberger Comprehensive Cancer Center||1||Lack of funding.|f||||t||||||||||2017-02-18 16:38:08.309678|2017-02-18 16:38:08.309678
NCT00312624|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2011-06-09|||April 2006||2006-04-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|||||Observational|||Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies|Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies|Completed||N/A|50|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 16:38:08.391109|2017-02-18 16:38:08.391109
NCT00312611|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-06-22|||August 2004||2004-08-01|June 2016|2016-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Screened Health Assessment & Pacer Evaluation|Screened Health Assessment & Pacer Evaluation|Completed||N/A|200||University of Pennsylvania|||||||||||||||||No||2017-02-18 16:38:08.47803|2017-02-18 16:38:08.47803
NCT00312598|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2014-01-10|||August 2005||2005-08-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Observational|||Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine|Investigation of Body Mass Index, Body Composition, Resting Energy Expenditure, Respiratory Quotient and Metabolic Changes Following a Switch From Olanzapine, Quetiapine or Risperidone to Aripiprazole|Completed||Phase 4|30|Actual|University of North Carolina, Chapel Hill|||1||f||||t||||||Samples Without DNA|"~     serum collected at baseline and end of study to be assayed in the future for related~     metabolic tests which are not specified at this time.~   "|||2017-02-18 16:38:08.566166|2017-02-18 16:38:08.566166
NCT00312585|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2016-04-05|||February 2005||2005-02-01|May 2011|2011-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Acupuncture for the Prevention of Postdates Pregnancy|A Randomized Controlled Trial of Acupuncture to Prevent Postdates Pregnancy|Completed||Phase 2|89|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-02-18 16:38:08.670601|2017-02-18 16:38:08.670601
NCT00312572|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2012-08-27|2010-07-29||June 2003||2003-06-01|August 2012|2012-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain|A Randomized, Double-Blind Study Evaluating the Dose Conversion From Vicodin® to Buprenorphine Transdermal System (BTDS) in Subjects With Osteoarthritis (OA) Pain|Completed||Phase 3|204|Actual|Purdue Pharma LP||2|||f||||||||||||||2017-02-18 16:38:08.77938|2017-02-18 16:38:08.77938
NCT00312559|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2007-08-17|||February 2006||2006-02-01|August 2007|2007-08-01|March 2007|Actual|2007-03-01|||||Interventional|||The Therapeutics Effects of Yoga in Individuals With Parkinson's Disease|The Therapeutic Effects of Yoga in Individuals With Parkinson's Disease|Completed||N/A|18||University of Kansas Medical Center|||||f||||||||||||||2017-02-18 16:38:09.436272|2017-02-18 16:38:09.436272
NCT00005495|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1998||1998-07-01|November 2002|2002-11-01|June 1999|Actual|1999-06-01|||||Observational|||Primary Prevention of CHD Risk Factors Occurring in US||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.597371|2017-02-18 18:14:54.597371
NCT00312546|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2012-05-11|||June 2006||2006-06-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Study of Valproic Acid to Treat HIV Infected Adults|Inhibiting Histone Deacetylase: Toward Eradication of HIV|Terminated||Phase 1|14|Actual|University of North Carolina, Chapel Hill||4|||f||||||||||||||2017-02-18 16:38:09.525618|2017-02-18 16:38:09.525618
NCT00312533|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2008-08-22|||April 2006||2006-04-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Outcome Following Hylan F- 20 (Synvisc) + Corticosteroid Injections for the Treatment of Osteoarthritis of the Knee|Outcome Following Hylan F- 20 (Synvisc) + Corticosteroid Injections for the Treatment of Osteoarthritis of the Knee|Completed||N/A|60|Anticipated|Steadman Hawkins Research Foundation|||||f||||||||||||||2017-02-18 16:38:09.645604|2017-02-18 16:38:09.645604
NCT00312520|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2013-08-01|||July 2002||2002-07-01|August 2013|2013-08-01|June 2005||2005-06-01|||||Interventional|||Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy|The Efficacy and Safety of Intravenous Pulse Steroids Compared to Standard Oral Steroids in the Treatment of Problematic Hemangiomas in Infants: A Randomized Controlled Trial|Completed||Phase 3|20||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 16:38:09.735312|2017-02-18 16:38:09.735312
NCT00312507|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2006-10-16|||April 2006||2006-04-01|October 2006|2006-10-01||||||||Interventional|||Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration|Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration|Unknown status|Recruiting|Phase 3|20||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 16:38:09.84311|2017-02-18 16:38:09.84311
NCT00312494|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2010-02-02|2009-12-17||April 2006||2006-04-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects|A Three-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Add-On Oral Ziprasidone in Subjects With Acute Mania Treated With Lithium or Divalproex|Completed||Phase 3|680|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 16:38:10.203017|2017-02-18 16:38:10.203017
NCT00312481|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2007-12-12|||July 2005||2005-07-01|December 2007|2007-12-01|May 2006|Actual|2006-05-01|||||Interventional|||MOVIPREP® Versus PICOLAX® Pilot Study|A Randomised, Single-Centre, Parallel-Group, Pilot Study to Assess the Efficacy, Safety and Patient Acceptability of a New 2-Litre Bowel Preparation Agent (MOVIPREP®) Compared With a Standard Bowel Preparation Agent (PICOLAX®)|Completed||Phase 2|65|Actual|Norgine||2|||f||||f||||||||||2017-02-18 16:38:11.390872|2017-02-18 16:38:11.390872
NCT00312468|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2006-10-18|||October 2006||2006-10-01|October 2006|2006-10-01||||||||Observational|||Examining the Link Between Heart Disease and HIV Infection in Women|Mechanisms of Atherosclerosis and CVD in HIV+ Women|Unknown status|Active, not recruiting|N/A|1000||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:38:11.504782|2017-02-18 16:38:11.504782
NCT00312455|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2017-01-11|||July 2004||2004-07-01|August 2008|2008-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Effects of Fatty Acid Supplementation on Substance Dependent Individuals|Cholesterol and Fatty Acids in Cocaine Addiction Relapse|Completed||Phase 2|||National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 16:38:11.579222|2017-02-18 16:38:11.579222
NCT00312442|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2010-05-31|||May 2006||2006-05-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|July 2008|Actual|2008-07-01||Interventional|||Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy|Study of Photodynamic Therapy With WST09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy|Terminated||Phase 2/Phase 3|16|Actual|STEBA France||1||"STEBA decided to develop WST11 that is soluble in aqueous solutions. The property of WST 11~   make it safer and better candidate for therapeutic applications."|f||||t||||||||||2017-02-18 16:38:11.675076|2017-02-18 16:38:11.675076
NCT00312429|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2012-04-02|||January 2002||2002-01-01|April 2012|2012-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer|Cord Blood Transplantation in Adult Recipients|Completed||Phase 1/Phase 2|34|Actual|Duke University||1|||f||||f||||||||||2017-02-18 16:38:11.77196|2017-02-18 16:38:11.77196
NCT00312416|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2007-02-09|||February 2004||2004-02-01|February 2007|2007-02-01|December 2004||2004-12-01|||||Interventional|||Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise|Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise|Completed||Phase 4|18||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:38:11.863972|2017-02-18 16:38:11.863972
NCT00312403|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2010-01-14|||November 2005||2005-11-01|January 2010|2010-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?|Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?|Completed||N/A|400|Anticipated|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 16:38:11.948186|2017-02-18 16:38:11.948186
NCT00312390|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2014-12-05|||July 2003||2003-07-01|November 2014|2014-11-01||||||||Interventional|||Amblyopia and Neurovascular Coupling in the Retina of Humans|Amblyopia and Neurovascular Coupling in the Retina of Humans|Withdrawn||N/A|0|Actual|Medical University of Vienna||2|||f||||t||||||||||2017-02-18 16:38:12.059744|2017-02-18 16:38:12.059744
NCT00312377|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2016-08-24|2011-04-27||May 2006||2006-05-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|August 2008|Actual|2008-08-01||Interventional|ZODIAC||ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer|A Phase III, Randomized, Double-Blinded, Multi-Center, Study to Assess the Efficacy of Docetaxel (TAXOTERE™) in Combination With ZD6474 (ZACTIMA™) Versus Docetaxel (TAXOTERE™) With Placebo in Subjects With Locally Advanced or Metastatic NSCLC|Completed||Phase 3|1690|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:38:12.18986|2017-02-18 16:38:12.18986
NCT00312364|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2012-05-24||2008-12-04|December 2005||2005-12-01|May 2012|2012-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers||Completed||Phase 2|322|Actual|Pfizer|||||||||||||||||||2017-02-18 16:38:13.710173|2017-02-18 16:38:13.710173
NCT00312169|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2008-05-20|||April 2006||2006-04-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)|Evolution of L74V or K65R Mutations in VIremic Subjects on TDF or ABC (EVITA)|Completed||Phase 4|20|Anticipated|Orlando Immunology Center|||||f||||||||||||||2017-02-18 16:38:19.062862|2017-02-18 16:38:19.062862
NCT00312351|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2007-01-12|||April 2006||2006-04-01|January 2007|2007-01-01|November 2006||2006-11-01|||||Interventional|||A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)|An Exploratory Randomized, Double-Masked, Multi-Center Comparative Trial, in Parallel Groups, to Explore the Safety and Efficacy of Three Different Doses of Intravitreous Injections of Pegaptanib Sodium (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks for 102 Weeks, in Patients With Subfoveal Neovascular Age-Related Macular Degeneration (AMD)|Terminated||Phase 4|262||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 16:38:13.860784|2017-02-18 16:38:13.860784
NCT00312338|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2012-10-31|2009-07-15||June 2006||2006-06-01|February 2010|2010-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora|Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora|Completed||Phase 4|137|Actual|Alcon Research|Limited source documents.|2|||f||||||||||||||2017-02-18 16:38:13.952812|2017-02-18 16:38:13.952812
NCT00312325|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2006-04-07|||July 2005||2005-07-01|March 2006|2006-03-01|August 2005||2005-08-01|||||Interventional|||Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans|Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans|Completed||Phase 4|24||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:38:14.320051|2017-02-18 16:38:14.320051
NCT00312312|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2007-06-11|||March 2006||2006-03-01|September 2006|2006-09-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide|Does Specific Immunotherapy Possess Immunomodulative Effects at the Bronchial Mucosa Level Among Adults With Atopic Diseases?|Unknown status|Recruiting|N/A|40|Anticipated|Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:38:14.401878|2017-02-18 16:38:14.401878
NCT00312299|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-07|2012-07-11|||April 2006||2006-04-01|July 2012|2012-07-01|January 2012|Actual|2012-01-01|July 2011|Actual|2011-07-01||Interventional|||Posterior Capsule Opacification Study|Posterior Capsule Opacification After Implantation of Square Edge PMMA, Round Edge PMMA and Acrysof Intraocular Lenses: Randomized Controlled Study|Completed||Phase 4|100|Actual|Aurolab||4|||f||||f||||||||||2017-02-18 16:38:14.48199|2017-02-18 16:38:14.48199
NCT00312286|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2016-09-12||2016-09-12|April 2006||2006-04-01|September 2016|2016-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.|A Randomized, Placebo-Controlled Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B Gel for the Treatment of Cervical High Risk HPV Infection|Terminated||Phase 2|538|Actual|Takeda||11||Lack of efficacy|f||||f||||||||||2017-02-18 16:38:14.596398|2017-02-18 16:38:14.596398
NCT00312273|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2006-07-26|||January 2001||2001-01-01|September 2003|2003-09-01|July 2004||2004-07-01|||||Interventional|||Aminophylline in Bradyasystolic Cardiac Arrest|Aminophylline in Bradyasystolic Cardiac Arrest: A Randomized Placebo-Controlled Trial|Completed||Phase 2|966||Vancouver General Hospital|||||f||||||||||||||2017-02-18 16:38:15.06274|2017-02-18 16:38:15.06274
NCT00312260|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2016-04-25|||April 2006||2006-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|May 2010|Actual|2010-05-01||Interventional|||Comparing Gabapentin and Amitriptyline for the Treatment of Neuropathic Pain in Children and Adolescents|Randomized Controlled Trial Comparing Gabapentin and Amitriptyline for the Treatment of Neuropathic Pain in Children and Adolescents|Active, not recruiting||Phase 3|40|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 16:38:15.175997|2017-02-18 16:38:15.175997
NCT00312247|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2015-05-18|||April 2006||2006-04-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Observational|||Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy|Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy|Completed||N/A|85|Actual|Shriners Hospitals for Children|||2||f||||f||||||||||2017-02-18 16:38:15.287043|2017-02-18 16:38:15.287043
NCT00312234|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2013-12-17|||August 2005||2005-08-01|December 2013|2013-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Qigong vs. Aerobic Exercise in the Treatment of Childhood Chronic Musculoskeletal Pain|Feasibility and Impact of Qigong as Compared to Aerobic Exercise in the Treatment of Childhood Chronic Musculoskeletal Pain: A Pilot Randomized Controlled Trial.|Completed||Phase 2|30||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 16:38:15.399051|2017-02-18 16:38:15.399051
NCT00312221|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2012-09-05|2010-07-15||April 2004||2004-04-01|September 2012|2012-09-01|August 2005|Actual|2005-08-01|July 2005|Actual|2005-07-01||Interventional|||Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain|Randomized, Double-blind, Multicenter Study to Determine the Efficacy and Safety of BTDS 20 or Oxycodone Immediate-Release (OxyIR) Versus BTDS 5 in Subjects With Moderate to Severe Osteoarthritis (OA) Pain|Terminated||Phase 3|418|Actual|Purdue Pharma LP|This study was terminated early for administrative reasons not related to safety or efficacy. Low enrollment at termination led to reduced power.|3||terminated early for administrative reasons unrelated to safety or efficacy|f||||f||||||||||2017-02-18 16:38:15.514815|2017-02-18 16:38:15.514815
NCT00312208|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2013-12-04|2009-10-29||November 2001||2001-11-01|December 2013|2013-12-01|October 2013|Actual|2013-10-01|October 2008|Actual|2008-10-01||Interventional|||Docetaxel in Breast Cancer|A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination With Doxorubicin and Cyclophosphamide Versus Doxorubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment of Operable Breast Cancer HER2neu Negative Patients With Positive Axillary Lymph Nodes|Completed||Phase 3|3299|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:38:16.310933|2017-02-18 16:38:16.310933
NCT00312195|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2012-09-05|2010-07-29||March 2001||2001-03-01|September 2012|2012-09-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain|An Open-label Run-in, Followed by a Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Show the Effectiveness of Buprenorphine Transdermal System in Management of Patients With Chronic Nonmalignant Pain Syndromes|Completed||Phase 3|267|Actual|Purdue Pharma LP||2|||f||||||||||||||2017-02-18 16:38:18.453941|2017-02-18 16:38:18.453941
NCT00312182|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2009-04-09|||March 2006||2006-03-01|April 2009|2009-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Thorough QT Study of Nelfinavir|Evaluation Of The Effect Of Nelfinavir On QT Intervals At Steady-State After Twice-Daily Administration Of Nelfinavir Tablets To Healthy Volunteers|Completed||Phase 4|68|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:38:18.980128|2017-02-18 16:38:18.980128
NCT00005494|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||June 1998||1998-06-01|July 2005|2005-07-01|May 2004|Actual|2004-05-01|||||Observational|||Prospective Study of Health in Runners and Walkers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.673657|2017-02-18 18:14:54.673657
NCT00312156|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2017-01-26|||August 2002||2002-08-01|January 2017|2017-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes|Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes|Completed||Phase 3|347|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:38:19.172192|2017-02-18 16:38:19.172192
NCT00312143|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2011-02-01|||February 2004||2004-02-01|February 2011|2011-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients|A Prospective, Open Label, Multicenter Study to Assess the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients|Completed||Phase 4|35|Actual|Novartis|||||f||||||||||||||2017-02-18 16:38:19.321079|2017-02-18 16:38:19.321079
NCT00312130|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-06|2016-11-16|||April 2005||2005-04-01|November 2016|2016-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes|A Single-blind, Single-treatment Study to Evaluate the Effects of Vildagliptin on Response to an Intravenous Glucose Load in Pre-diabetic Subjects With Impaired Fasting Glucose|Completed||Phase 3|20||Novartis|||||f||||||||||||||2017-02-18 16:38:19.391594|2017-02-18 16:38:19.391594
NCT00312117|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2015-03-10|||January 2006||2006-01-01|March 2015|2015-03-01|February 2006|Actual|2006-02-01|||||Interventional|||Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate|A Randomized Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate|Completed||Phase 3|300||Kaiser Permanente|||||f||||t||||||||||2017-02-18 16:38:19.502584|2017-02-18 16:38:19.502584
NCT00312104|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2017-01-26|||April 2002||2002-04-01|January 2017|2017-01-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes|Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes.|Completed||Phase 3|325|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:38:19.600736|2017-02-18 16:38:19.600736
NCT00312091|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2012-09-10||2009-09-01|December 2006||2006-12-01|September 2012|2012-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children|A Phase I/II Comparative Pharmacokinetic Study of the Fixed-Dose Combination (FDC) of Stavudine (d4T), Lamivudine (3TC), and Nevirapine (NVP) as GPO-VIR Pediatric Chewable Tablets Versus the Individual Liquid Formulations in HIV Infected Children 6 Months and Older to Less Than 13 Years of Age in Thailand|Completed||Phase 1/Phase 2|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:38:19.736024|2017-02-18 16:38:19.736024
NCT00312078|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2007-10-31|||November 2005||2005-11-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Effect of Yogurt on Minimal Hepatic Encephalopathy|Effect of Yogurt Supplementation on Psychometric Test Performance in Cirrhotic Patients With Minimal Hepatic Encephalopathy. A Prospective Pilot Trial.|Completed||N/A|30|Anticipated|Medical College of Wisconsin|||||f||||f||||||||||2017-02-18 16:38:19.879828|2017-02-18 16:38:19.879828
NCT00312065|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2015-04-06|||October 2003||2003-10-01|April 2015|2015-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study of the Need for Temperature Probe Covers for Newborn Babies on Radiant Warmers|Servocontrolled Radiant Warmers and the Role of Thermistor Probe Reflective Shields in Neonates|Completed||Phase 1|11|Actual|Maimonides Medical Center||1|||f||||f||||||||||2017-02-18 16:38:19.966874|2017-02-18 16:38:19.966874
NCT00312052|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2016-12-01||2013-05-21|September 2007||2007-09-01|November 2016|2016-11-01|August 2009|Actual|2009-08-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease|A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease|Completed||Phase 2|720|Actual|Eisai Inc.||4|||f||||||||||||||2017-02-18 16:38:20.064541|2017-02-18 16:38:20.064541
NCT00312039|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2014-01-20|||March 2006||2006-03-01|January 2014|2014-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|Resistance||Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation|A 14 Day Randomized, Double Blind, Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation|Completed||Phase 1/Phase 2|20|Anticipated|Achillion Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:38:20.169427|2017-02-18 16:38:20.169427
NCT00312026|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2017-02-13|||March 30, 2006||2006-03-30|February 2017|2017-02-01|November 28, 2006|Actual|2006-11-28|November 28, 2006|Actual|2006-11-28||Interventional|||A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet|A Phase IV Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 1.0 mg/kg Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis Involving the Hands and/or Feet|Completed||Phase 4|75||Genentech, Inc.|||||f||||||||||||||2017-02-18 16:38:20.280256|2017-02-18 16:38:20.280256
NCT00312013|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2016-11-28|||May 2006||2006-05-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer|A Randomized, Controlled Trial to Evaluate the Effects of Nadroparin on Survival and Disease Progression in Patients With Advanced Malignancies of the Lung, Pancreas, or Prostate|Completed||Phase 3|503|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:38:20.47356|2017-02-18 16:38:20.47356
NCT00312000|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2008-09-05|||January 2003||2003-01-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|February 2006|Actual|2006-02-01||Interventional|||Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma|A Randomised Study of Sequential Versus Combination Chemotherapy in Patients With Previously Untreated Advanced Colorectal Carcinoma|Completed||Phase 3|820|Actual|Dutch Colorectal Cancer Group||2|||f||||t||||||||||2017-02-18 16:38:20.68599|2017-02-18 16:38:20.68599
NCT00311987|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2013-04-01|||April 2006||2006-04-01|April 2006|2006-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients|A Randomized, Double-Blind Placebo-Controlled Study of 3,5-diiodothyropropionic Acid (DITPA) in Combination With Standard Therapy to Attain NCEP ATP III Goal for LDL Cholesterol in Hypercholesterolemic Patients|Terminated||Phase 1/Phase 2|60|Anticipated|Johns Hopkins University||||Curtailment of funding by sponsor|||||f||||||||||2017-02-18 16:38:20.794839|2017-02-18 16:38:20.794839
NCT00311974|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2010-02-17|||April 2006||2006-04-01|February 2010|2010-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals|The Effect of Dihydralazine on Renal Tubular Function and Vasoactive Hormones in Healthy Individuals|Completed||Phase 4|16||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:38:21.059548|2017-02-18 16:38:21.059548
NCT00311961|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2009-08-25|||June 2001||2001-06-01|August 2009|2009-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Intravenous Versus Oral Administration of Prednisolone in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)|A Comparison of Intravenous Versus Oral Administration of Prednisolone in the Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease|Completed||Phase 4|256||Isala|||||f||||||||||||||2017-02-18 16:38:21.142122|2017-02-18 16:38:21.142122
NCT00311948|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2012-09-27|||March 2006||2006-03-01|September 2006|2006-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|QWIThelper||Telephone and Web-based Teen Tobacco Cessation in HMOs|Telephone and Web-based Teen Tobacco Cessation in HMOs|Completed||Phase 3|600|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 16:38:21.238441|2017-02-18 16:38:21.238441
NCT00311935|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2009-02-02|||April 2006||2006-04-01|February 2009|2009-02-01|May 2010|Anticipated|2010-05-01|||||Interventional|||Laparoscopic vs Open Hernia Mesh Repair for Inguinal Hernia|Randomized Controlled Trial of Laparoscopic vs. Open Mesh Inguinal Hernia Repair in Men Under the Age of 60|Unknown status|Recruiting|N/A|350|Anticipated|Waitemata District Health Board|||||f||||f||||||||||2017-02-18 16:38:21.374647|2017-02-18 16:38:21.374647
NCT00311922|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2008-02-15|||March 2006||2006-03-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Improving Care for Patients With Diabetes and Poor Numeracy Skills|Improving Care for Patients With Diabetes and Poor Numeracy Skills|Completed||N/A|106|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 16:38:21.466989|2017-02-18 16:38:21.466989
NCT00311909|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2006-04-05|||June 2005||2005-06-01|April 2006|2006-04-01||||||||Interventional|||Thalamic Deep Brain Stimulation for Tourette Syndrome|Thalamic Deep Brain Stimulation for Tourette Syndrome: A Prospective Clinical Trial|Completed||Phase 2|5||University Hospitals Cleveland Medical Center|||||||||||||||||||2017-02-18 16:38:21.578876|2017-02-18 16:38:21.578876
NCT00311896|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2012-06-07|||July 2005||2005-07-01|June 2012|2012-06-01|December 2010|Actual|2010-12-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)|Multicentric, Randomized, Placebo Controlled and Double-blind Study to Evaluate the Efficacy and Safety of Antithrombotic Prophylaxis With Bemiparin (3,500 UI/Day) in Cancer Patients With a Central Venous Catheter (CVC)(BECAT)|Terminated||Phase 3|402|Actual|Clinica Universidad de Navarra, Universidad de Navarra||2||Sponsor stopped due to difficulties to recruit 402 patients required by protocol|f||||f||||||||||2017-02-18 16:38:21.68826|2017-02-18 16:38:21.68826
NCT00311883|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2008-01-25|||March 2006||2006-03-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Hydroxychloroquine in Cystic Fibrosis|Phase 1 Study of Hydroxychloroquine in Cystic Fibrosis|Completed||Phase 1|20|Actual|Vanderbilt University||1|||f||||t||||||||||2017-02-18 16:38:21.822471|2017-02-18 16:38:21.822471
NCT00311870|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2006-04-04|||March 1993||1993-03-01|April 1999|1999-04-01|April 1999||1999-04-01|||||Interventional|||Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy||Completed||Phase 4|52||Steno Diabetes Center|||||f||||||||||||||2017-02-18 16:38:21.916838|2017-02-18 16:38:21.916838
NCT00311857|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2006-09-07|||February 2006||2006-02-01|September 2006|2006-09-01||||||||Interventional|||Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)|Treatment of Primary Glioblastoma Multiforme With Cetuximab, Radiotherapy and Temozolomide (GERT) – Phase I/II Trial|Unknown status|Recruiting|Phase 1/Phase 2|46||Heidelberg University|||||f||||||||||||||2017-02-18 16:38:22.003957|2017-02-18 16:38:22.003957
NCT00311844|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2015-04-28|||March 2005||2005-03-01|April 2015|2015-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)|A Double-blind, Placebo-controlled, Crossover, Single-center Study to Evaluate the Anti-allergic and Anti-inflammatory Effects of Multiple Doses of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms|Completed||Phase 4|41|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 16:38:22.10213|2017-02-18 16:38:22.10213
NCT00311831|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2013-12-10|||March 2006||2006-03-01|December 2013|2013-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||The Implementation of a Gastroenteritis Education Program|The Implementation of a Gastroenteritis Education Program|Completed||Phase 3|105|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 16:38:22.175368|2017-02-18 16:38:22.175368
NCT00311818|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2009-09-14|||June 2003||2003-06-01|September 2009|2009-09-01||||May 2005|Actual|2005-05-01||Interventional|||Insulin Glargine in Type 2 Diabetes Mellitus|44-week, Parallel, Open, Randomized, Multinational, Multi-center Clinical Trial to Compare Efficacy and Safety of the Combination Therapy of an Oral Anti-diabetic Drug Treatment With Either HOE901 Insulin Once Daily or Lispro Insulin Analogue at Mealtime in Type 2 Diabetes Mellitus Patients Poorly Controlled With Oral Anti-diabetic Drug Treatment.|Completed||Phase 4|||Sanofi|||||f||||||||||||||2017-02-18 16:38:22.288251|2017-02-18 16:38:22.288251
NCT00311805|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2015-03-30|||April 2006||2006-04-01|March 2015|2015-03-01||||December 2012|Actual|2012-12-01||Interventional|||Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg Pain)|Injection of Autologous CD34-Positive Stem Cells for Neovascularization and Symptom Relief in Patients With Severe Intermittent Claudication|Active, not recruiting||Phase 1|24|Anticipated|Losordo, Douglas, M.D.||3|||f||||t||||||||||2017-02-18 16:38:22.374619|2017-02-18 16:38:22.374619
NCT00311792|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2007-08-29|||August 2006||2006-08-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Transfer of Skills From VR-Trainer to Operation Room|Transfer of Skills From LapSimGyn VR-Simulator to a Laparoscopic Salpingectomy|Completed||Phase 2/Phase 3|24|Actual|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 16:38:22.475876|2017-02-18 16:38:22.475876
NCT00311779|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2006-07-11|||March 2006||2006-03-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis|Phase 2 Study of Efficacy and Safety of Different Strengths of Spinosad Topical Creme Rinse (0%, 0.5% or 1.0%) in Subjects 2 Years of Age or Older With Pediculosis Capitis - A Dose Ranging Study|Completed||Phase 2|120||ParaPRO LLC|||||||||||||||||||2017-02-18 16:38:22.587205|2017-02-18 16:38:22.587205
NCT00311766|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2014-04-25|2013-05-22||February 2006||2006-02-01|April 2014|2014-04-01|November 2012|Actual|2012-11-01|July 2010|Actual|2010-07-01||Interventional|||A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa|A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Epidermolysis Bullosa|Terminated||Phase 2|30|Actual|RegeneRx Biopharmaceuticals, Inc.|Early termination of the study leading to randomizing 30 of the 36 participants planned. This was due to the small pool of participants and therefore resulting in low availability of eligible participants.|2||Lack of patient availability and expiration of study drug|f||||f||||||||||2017-02-18 16:38:22.68107|2017-02-18 16:38:22.68107
NCT00311753|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2010-06-07|||February 2006||2006-02-01|June 2010|2010-06-01||||December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients|An Open-label Comparison of the Efficacy and Safety of the Low-molecular-weight Heparin (3000 U Anti-Xa Once Daily) With Unfractionated Heparin for the Prevention of Thromboembolic Complications in Acutely Ill Non-surgical Patients|Completed||Phase 3|342|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:38:23.057445|2017-02-18 16:38:23.057445
NCT00311740|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2011-11-07|||March 2006||2006-03-01|November 2011|2011-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)|A Multi-center, Factorial Study to Evaluate Efficacy & Safety of 8 Wks Treatment With VAH631 [Valsartan (40 & 80 mg) and Hydrochlorothiazide (6.25 & 12.5 mg) Combined & Alone in Essential Hypertensive Patients] - Double-blind Study of VAH631 in Patients With Essential Hypertension (Factorial Study)|Completed||Phase 3|582|Actual|Novartis|||||f||||||||||||||2017-02-18 16:38:23.171121|2017-02-18 16:38:23.171121
NCT00311727|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2013-08-15|||October 2005||2005-10-01|May 2007|2007-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine|Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine|Completed||N/A|339|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 16:38:23.277934|2017-02-18 16:38:23.277934
NCT00311714|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2016-05-20|||April 2007||2007-04-01|May 2016|2016-05-01|December 2007||2007-12-01|||||Interventional|||Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958|CS-8958 - A Phase I, Double-Blind, Placebo-Controlled, Ascending Single Inhaled Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects|Completed||Phase 1|40||Aviragen Therapeutics|||||||||||||||||||2017-02-18 16:38:23.387442|2017-02-18 16:38:23.387442
NCT00311701|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2011-05-12|||November 2005||2005-11-01|October 2007|2007-10-01|December 2006||2006-12-01|||||Observational|||Chart Review of Antivirals for Influenza in Infants|A Retrospective Chart Review to Assess the Safety of Oseltamivir (Tamiflu®) Compared to Alternate Antiviral Therapy (Amantadine or Rimantadine) Administered to Children Less Than 12 Months of Age With Diagnosed or Suspected Influenza (CASG 113)|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:38:23.475265|2017-02-18 16:38:23.475265
NCT00311688|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2016-11-08|||December 2003||2003-12-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01|5 Years|Observational [Patient Registry]|||Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies|An Omnibus Proleukin (IL-2) Trial in HIV Infected Patients Including Interrupted Versus Continuous Antiretrovirals (OPTICA)|Completed||Phase 1/Phase 2|||National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||||||2017-02-18 16:38:23.587229|2017-02-18 16:38:23.587229
NCT00311675|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2010-08-26|||April 2006||2006-04-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||St. Jude Open Label H5 Trial|A Single Center, Open-Label, Phase I/II Study of Two 90-µg Doses of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Adult Subjects|Completed||Phase 1/Phase 2|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 16:38:23.701981|2017-02-18 16:38:23.701981
NCT00311662|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2009-08-28|||April 2006||2006-04-01|August 2009|2009-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache|Multi-centre, Parallel Group, Double-blind, Placebo Controlled Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache|Completed||Phase 2|124|Actual|Minster Research Ltd||2|||f||||f||||||||||2017-02-18 16:38:23.811548|2017-02-18 16:38:23.811548
NCT00311649|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2011-08-11|||November 2005||2005-11-01|March 2007|2007-03-01|September 2006||2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities|Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities|Completed||Phase 1/Phase 2|83|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:38:23.92468|2017-02-18 16:38:23.92468
NCT00311636|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2013-06-25|||September 2003||2003-09-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery|Prevention of Chemotherapy-induced Menopause by Temporary Ovarian Suppression With Triptorelin Vs. Control in Young Breast Cancer Patients. A Randomized Phase III Multicenter Study [PROMISE]|Completed||Phase 3|280|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:38:24.011304|2017-02-18 16:38:24.011304
NCT00311623|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2011-02-18|||August 2006||2006-08-01|February 2009|2009-02-01||||January 2008|Anticipated|2008-01-01||Interventional|||Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer|A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin in Men With Advanced Localized Prostate Cancer|Unknown status|Active, not recruiting|N/A|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:38:24.120981|2017-02-18 16:38:24.120981
NCT00311610|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2016-06-28|||January 2006||2006-01-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|January 2007|Actual|2007-01-01||Interventional|||Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer|Phase II Trial of LE SN38 in Patients With Metastatic Colorectal Cancer After Progression on Oxaliplatin|Completed||Phase 2|30|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 16:38:24.207535|2017-02-18 16:38:24.207535
NCT00311597|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2015-09-30|||June 2002||2002-06-01|September 2015|2015-09-01|November 2016|Anticipated|2016-11-01|September 2007|Actual|2007-09-01||Interventional|||Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors|A Phase I/II Dose-Escalation/Efficacy Study of Palliative Extracranial Radiosurgery Using the Elektra Stereotactic Body Frame System|Active, not recruiting||Phase 1/Phase 2|48|Anticipated|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 16:38:24.323684|2017-02-18 16:38:24.323684
NCT00311584|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2014-09-16|2013-12-02||April 2006||2006-04-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|March 2009|Actual|2009-03-01||Interventional||Patients were evaluable for inclusion in the analysis of response if eligible, had an event (relapse, PD, death or secondary malignancy) any time after enrollment, or completed at least 2 courses of Irinotecan/Temozolomide therapy. Patients off therapy before completion of 2 courses by choice or toxicity were not evaluable for response analysis.|Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma|A Phase II Study of Irinotecan + Temozolomide in Children With Recurrent Neuroblastoma|Completed||Phase 2|59|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 16:38:24.427783|2017-02-18 16:38:24.427783
NCT00311571|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2006-09-01|||August 2001||2001-08-01|April 2006|2006-04-01|June 2003||2003-06-01|||||Interventional|||Toulouse Male Long Term Bed Rest 2001-2002|Simulation of a Mission Aboard the International Space Station by a Long Duration Anti-Orthostatic Bed Confinement at – 6° (90 Days) on Healthy Subjects:1/Perfecting of Preventive Methods (Muscular Exercise and Biphosphonates) and Evaluation of the Effects on the Locomotion and Cardiovascular Systems and on the Lipid and Energy Metabolisms. 2/Pharmacokinetic Assessment: Effects of Position on the Absorption Mechanisms: Pharmacokinetics of Paracetamol Used as Model to Study Oral Absorption in Simulated Weightlessness|Completed||Phase 1|28||Centre National d'Etudes Spatiales|||||f||||||||||||||2017-02-18 16:38:25.471691|2017-02-18 16:38:25.471691
NCT00311558|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2016-09-20|||October 2005||2005-10-01|September 2016|2016-09-01|January 2012|Actual|2012-01-01|May 2011|Actual|2011-05-01||Interventional|||Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma|Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon α-2b for Solid Tumors, Lymphoma or Myeloma|Terminated||Phase 1|18|Actual|The Cleveland Clinic||1|||f||||t||||||||||2017-02-18 16:38:25.583949|2017-02-18 16:38:25.583949
NCT00311545|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2013-02-19||||||February 2013|2013-02-01||||||||Interventional|||S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer|A Phase II Study of CNTO 328, A Monoclonal Antibody Against Interleukin-6 (IL-6), In Patients With Advanced or Metastatic Renal Cell Cancer|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||1||withdrawal of support for drug supply|f||||t||||||||||2017-02-18 16:38:25.716032|2017-02-18 16:38:25.716032
NCT00311532|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2007-07-16|||March 2006||2006-03-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Observational|||Observational Study of Pergolide Mesylate and Cardiac Valvulopathy|Observational Study to Determine the Incidence of New-Onset Valvulopathy in Patients Treated With Pergolide as Second-Line Therapy for Parkinson's Disease|Completed||N/A|200|Anticipated|Eli Lilly and Company|||||f||||||||||||||2017-02-18 16:38:25.826739|2017-02-18 16:38:25.826739
NCT00311519|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2006-04-05|||November 2005||2005-11-01|April 2006|2006-04-01|January 2006||2006-01-01|||||Interventional|||A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects|A Phase IIIB Double Blind, Randomized, Placebo-Controlled, Dose-Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects|Completed||Phase 4|50||Halozyme Therapeutics|||||||||||||||||||2017-02-18 16:38:25.93234|2017-02-18 16:38:25.93234
NCT00311506|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-25|2006-04-04||||||April 2006|2006-04-01||||||||Observational|||A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease|A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease|Completed||Phase 4|25||Genentech, Inc.|||||f||||||||||||||2017-02-18 16:38:26.02684|2017-02-18 16:38:26.02684
NCT00311493|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2007-03-12|||February 2006||2006-02-01|March 2007|2007-03-01||||||||Interventional|||Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults|A Phase IV, Randomized, Open-Label, Multi-Center Study in Adults: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a New TBE Vaccine for Adults (Free of Protein-Derived Stabilizer) in Study V48P2E1, 5 Years After First Booster Immunization and Evaluation of Booster Kinetics in Subjects Boosted With a New TBE Vaccine for Adults (Free of Protein-Derived Stabilizer), 5 Years After First Booster Immunization|Completed||Phase 4|179||Novartis|||||f||||||||||||||2017-02-18 16:38:26.090613|2017-02-18 16:38:26.090613
NCT00311480|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2007-03-12|||March 2006||2006-03-01|March 2007|2007-03-01||||||||Interventional|||Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects|A Phase II, Randomized, Controlled, Observer-Blind, Multi-Center Study to Evaluate Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two (Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines Containing 7.5 mg or 15 mg of H5N1 Influenza Antigen, in Non-Elderly Adult and Elderly Subjects|Completed||Phase 2|520||Novartis|||||f||||||||||||||2017-02-18 16:38:26.179109|2017-02-18 16:38:26.179109
NCT00311467|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-05|2012-05-15|||March 2004||2004-03-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma|Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma: a Prospective, Randomized, Multi-center phaseIII-Trial|Terminated||Phase 3|172|Actual|Central European Cooperative Oncology Group||2||no patient recruitment|f||||f||||||||||2017-02-18 16:38:26.280265|2017-02-18 16:38:26.280265
NCT00311454|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2006-04-04|||April 2006||2006-04-01|April 2006|2006-04-01||||||||Interventional|||Quaternium-15, Use Test|An Open Single Centre Evaluation of the Reactivity of the T.R.U.E. Test Quaternium-15 Patch and a Real Use Exposure in Subjects Known to Be Allergic to Quaternium-15|Unknown status|Not yet recruiting|Phase 4|10||Mekos Laboratories AS|||||||||||||||||||2017-02-18 16:38:26.394376|2017-02-18 16:38:26.394376
NCT00311441|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2008-03-14|||March 2005||2005-03-01|March 2008|2008-03-01||||||||Interventional|||Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children|A Phase IV, Randomized, Controlled, Single-Blind, Multi-Center Study in Children to Evaluate the Safety, Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules.|Completed||Phase 4|300||Novartis|||||f||||||||||||||2017-02-18 16:38:26.4717|2017-02-18 16:38:26.4717
NCT00311428|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-09-13|||October 2005||2005-10-01|September 2006|2006-09-01||||||||Interventional|||Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months|A Phase IV, Observer-Blind, Randomized, Parallel Groups, Single-Center, Exploratory Clinical Study to Evaluate the Immunogenicity and Safety of Two 0.25 mL Intramuscular Doses of Three Commercially Available Influenza Vaccines in Healthy Subjects Aged 6 to <36 Months.|Completed||Phase 4|270||Novartis|||||f||||||||||||||2017-02-18 16:38:26.562232|2017-02-18 16:38:26.562232
NCT00311415|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2012-02-06|||October 2005||2005-10-01|February 2012|2012-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children|A Phase III, Multi-Center, Open-Label, Controlled, Randomized Study to Evaluate the Immunogenicity, Safety, Tolerability and the Ability to Prime for Memory of Chiron Meningococcal C Conjugate Vaccine When Administered to Healthy Infants as One Dose Given at 2 or 6 Months of Age With a Booster at 12-16 Months of Age, in Comparison to Two Doses in the First Year of Life, Given Two Months Apart, With a Booster at 12-16 Months of Age; and in Comparison to One Dose Given at 12-16 Months of Age|Completed||Phase 3|257|Actual|Novartis||4|||f||||f||||||||||2017-02-18 16:38:26.654206|2017-02-18 16:38:26.654206
NCT00311402|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2014-01-21|2010-02-16||April 2006||2006-04-01|January 2014|2014-01-01||||March 2009|Actual|2009-03-01||Interventional|||JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme|JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme, Phase III Study to Compare the Preventive Effect of Recurrent Brain Infarction and Safety of Aggrenox (Combination Drug Containing Sustained-release Dipyridamole 200 mg/Acetylsalicylic Acid 25 mg) Twice Daily vs. Acetylsalicylic Acid 81 mg Once Daily|Completed||Phase 3|1295|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 16:38:26.790793|2017-02-18 16:38:26.790793
NCT00311389|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2012-02-11|||January 2003||2003-01-01|February 2012|2012-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension|A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|408|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:38:27.949275|2017-02-18 16:38:27.949275
NCT00311376|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2015-11-05|2011-09-09||August 2006||2006-08-01|November 2015|2015-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder||Completed||Phase 3|416|Actual|Allergan||4|||f||||||||||||||2017-02-18 16:38:28.046303|2017-02-18 16:38:28.046303
NCT00311363|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2013-07-15|2011-04-28||April 2006||2006-04-01|May 2011|2011-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional||"Single-blind (SB) Safety Population: subjects who received at least 1 dose of SB study drug~1 subject withdrew from the SB period prior to receiving drug due to protocol non-compliance, and thus was excluded from the SB-Safety Population"|Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.|A Long-Term Study of XP13512 Versus Placebo Treatment Assessing Maintenance of Efficacy and Safety in Patients With Restless Legs Syndrome.|Completed||Phase 3|327|Actual|XenoPort, Inc.||2|||f||||f||||||||||2017-02-18 16:38:28.77387|2017-02-18 16:38:28.77387
NCT00311350|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2011-07-22|||March 2006||2006-03-01|July 2011|2011-07-01|August 2006||2006-08-01|||||Interventional|||Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects|Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of MOA-728 Administered Orally to Healthy Subjects|Completed||Phase 1|48||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:38:32.989093|2017-02-18 16:38:32.989093
NCT00311337|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-04-04|||October 2005||2005-10-01|March 2006|2006-03-01|October 2010||2010-10-01|||||Interventional|||VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)|Evaluation of Safety and Efficacy of VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following High-Dose Melphalan Treatment and Autologous PBSCT (Minimal Residual Disease, Partial Remission or Stable Disease)|Unknown status|Recruiting|Phase 2|61||University of Wuerzburg|||||f||||||||||||||2017-02-18 16:38:33.079265|2017-02-18 16:38:33.079265
NCT00311324|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2015-12-03|||February 2001||2001-02-01|December 2015|2015-12-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||A Church Based Intervention to Improve Diabetes Care|A Church Based Intervention to Improve Diabetes Care|Completed||N/A|201|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 16:38:33.183867|2017-02-18 16:38:33.183867
NCT00311311|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2013-07-19|2011-12-12||April 2006||2006-04-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients|A Prospective, Randomized, Open-Label, Pilot Study To Compare The Effect On Carotid Atherosclerosis Of A Tacrolimus-Based Regimen With Conversion From A Tacrolimus- To A Sirolimus-Based Regimen At 3-4 Months Post-Transplant In De Novo Renal Transplant Recipients|Terminated||Phase 3|72|Actual|Pfizer||2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 16:38:33.316498|2017-02-18 16:38:33.316498
NCT00311298|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2009-08-03|||April 2006||2006-04-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Nutrition, Diabetes and Pulmonary TB/HIV|The Role of Nutritional Support and Diabetes During Treatment of Pulmonary TB: Two Randomized Nutritional Supplementation Trials in Tanzania|Completed||Phase 3|1250|Actual|University of Copenhagen||4|||f||||||||||||||2017-02-18 16:38:34.792006|2017-02-18 16:38:34.792006
NCT00311285|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2007-06-28||||||March 2006|2006-03-01|March 2007||2007-03-01|||||Interventional|||Physical and Mental Load in the Surgeon Performing Laparoscopic Tasks|Physical and Mental Load During Laparoscopic Tasks. A Prospective Randomized Trial of the Ergonomics in a Black Box Model|Unknown status|Not yet recruiting|N/A|12|Anticipated|University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 16:38:34.902502|2017-02-18 16:38:34.902502
NCT00311272|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2009-02-17|||November 2004||2004-11-01|February 2009|2009-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer|Vaccination With Autologous Dendritic Cells Pulsed With Allogenous Melanoma Lysate (MelCancerVac) for Treatment of Patients With Advanced Colorectal Cancer|Completed||Phase 2|40|Anticipated|University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 16:38:34.99193|2017-02-18 16:38:34.99193
NCT00311259|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-04-03|||May 2006||2006-05-01|February 2006|2006-02-01|November 2006||2006-11-01|||||Observational|||Melatonin Treatment and Inflammation, Oxidative Stress and Autonomic Function in Connection With Surgery||Unknown status|Not yet recruiting|Phase 2|40||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 16:38:35.066981|2017-02-18 16:38:35.066981
NCT00311246|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2011-06-28|||April 2006||2006-04-01|June 2011|2011-06-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||Trial of Adalimumab in Progressive Sarcoidosis|A Prospective Open-Label Trial of Adalimumab in Progressive Sarcoidosis|Terminated||Phase 2|11|Actual|University of Chicago||1||Difficulty in recruiting subjects|f||||t||||||||||2017-02-18 16:38:35.143921|2017-02-18 16:38:35.143921
NCT00311233|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2008-05-22|||February 2006||2006-02-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|||||Observational|||Recurrent Abdominal Pain in Childhood -Characteristics and Course|Recurrent Abdominal Pain in Childhood, Characteristics and Course|Completed||N/A|152|Actual|Sykehuset Innlandet HF|||1||f||||||||||Samples Without DNA|"~     All patients have blood tests for hemoglobin, total leucocyte and differential count,~     sedimention rate, C-reactive protein, total IgE and IgE screen for food allergies, and~     antiendomysial and antigliadin antibodies (IgG and IgA) and anti-tissue transglutaminase~     antibodies for celiac disease. Furthermore, urine analyses for protein, blood and and~     leucocytes, three stool specimen for occult blood and one stool specimen for quantification~     of calprotectin.~   "|||2017-02-18 16:38:35.235629|2017-02-18 16:38:35.235629
NCT00311220|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-04-03|||January 2004||2004-01-01|April 2006|2006-04-01|November 2006||2006-11-01|||||Interventional|||Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers|Phase IV Study of the Quantiferon-RD1 Test|Unknown status|Recruiting|Phase 4|300||Taichung Veterans General Hospital|||||f||||||||||||||2017-02-18 16:38:35.329251|2017-02-18 16:38:35.329251
NCT00311207|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2006-04-03|||December 2005||2005-12-01|April 2006|2006-04-01|November 2006||2006-11-01|||||Observational|||Development of Tuberculosis Diagnostic Kit|Development of Tuberculosis Diagnostic Kit|Unknown status|Recruiting|Phase 3|200||Taichung Veterans General Hospital|||||f||||||||||||||2017-02-18 16:38:35.417808|2017-02-18 16:38:35.417808
NCT00311194|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-04-03|||February 1998||1998-02-01|May 2002|2002-05-01|July 2002||2002-07-01|||||Interventional|||Trial of an Interactive CD-Program on 6 Months Readmission Rate in Patients With Heart Failure|A Randomised, Controlled Trial of an Interactive CD-Program on 6 Months Readmission Rate in Patients With Heart Failure|Completed||N/A|206||Swedish Heart Lung Foundation|||||f||||||||||||||2017-02-18 16:38:35.497073|2017-02-18 16:38:35.497073
NCT00311181|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2012-07-27|2011-07-24||August 2006||2006-08-01|July 2012|2012-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||POWER (Pulse Width Optimized Waveform Evaluation Trial)|Phase 4 Study That Compares the DFT (Defibrillation Threshold) Efficacy of 3 Different Membrane Time Constant Based Biphasic Defibrillation Waveforms|Completed||Phase 4|217|Actual|St. Jude Medical||1|||f||||f||||||||||2017-02-18 16:38:35.590937|2017-02-18 16:38:35.590937
NCT00311168|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2011-03-28|||February 2006||2006-02-01|March 2011|2011-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)|Reduce Ventricular Pacing Using Ventricular Intrinsic Preference: VIP™ Study|Completed||Phase 4|100|Anticipated|St. Jude Medical|||||f||||f||||||||||2017-02-18 16:38:36.060676|2017-02-18 16:38:36.060676
NCT00311155|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2010-11-23|2010-10-12||March 2006||2006-03-01|November 2010|2010-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|OLMETREAT||Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension|Treat-to-Target Study of Olmesartan Medoxomil and an Add-on Treatment Algorithm Consisting of Hydrochlorothiazide and Amlodipine Besylate in Patients With Mild to Moderate Hypertension|Completed||Phase 4|694|Actual|Daiichi Sankyo Inc.||1|||f||||f||||||||||2017-02-18 16:38:36.152151|2017-02-18 16:38:36.152151
NCT00311142|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2008-04-15|||March 2003||2003-03-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Actigraphic Sleep Patterns in Newborns Delivered Via Vacuum Extraction vs. Partum Spontaneous and Cesarean Section|Actigraphic Sleep Patterns in Newborns Delivered Via Vacuum Extraction vs. Partum Spontaneous and Cesarean Section.|Completed||N/A|24|Actual|Sheba Medical Center|||1||f||||f||||||||||2017-02-18 16:38:36.646175|2017-02-18 16:38:36.646175
NCT00311129|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2013-12-02|||December 2005||2005-12-01|December 2013|2013-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL|A Multicenter Study to Assess the Antitumor Effect and Safety of Fludarabine Phosphate Tablet (SH T 586) in Combination With Rituximab Administered in 6 Treatment Cycles (1 Treatment Cycle: Rituximab 375 mg/m2 iv on Day 1 Along With 5-Consecutive Day Oral Dosing of SH T 586 40 mg/m2/Day From Day 1 to Day 5, Followed by an Observation Period of 23 Days) in Patients With Indolent Lymphoma|Completed||Phase 2|41|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:38:36.723217|2017-02-18 16:38:36.723217
NCT00311116|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2013-12-17|||July 2002||2002-07-01|December 2013|2013-12-01|February 2005||2005-02-01|||||Interventional|||Vitamin E to Prevent Mucositis in Children With Cancer|Serial Controlled N-of-1 Trials of Topical Vitamin E as Prophylaxis for Chemotherapy-induced Oral Mucositis in Pediatric Patients|Completed||Phase 2/Phase 3|16||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 16:38:36.840854|2017-02-18 16:38:36.840854
NCT00311103|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2014-09-12|||October 2005||2005-10-01|September 2014|2014-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|DIME||Disability of Musculoskeletal Origin in Community-dwelling Elderly|Disability of Musculoskeletal Origin in Community-dwelling Elderly: Efficacy of a Specific Clinical Intervention.|Completed||N/A|214|Actual|Spanish Foundation of Rheumatology||2|||f||||t||||||||||2017-02-18 16:38:36.93817|2017-02-18 16:38:36.93817
NCT00311090|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2016-02-19||2016-02-19|April 2006||2006-04-01|February 2016|2016-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|EQUINOX||Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs|International, Multicenter, Randomized, Parallel Group, Double-blind Study, in Patients With Acute Symptomatic Deep Vein Thrombosis of the Lower Limbs, Demonstrating the Bioequipotency at Steady State of Equimolar Doses of SSR126517E (3.0 mg) Once a Week and SR34006 (2.5 mg) Once a Week, Documenting the Safety and Efficacy of Both Compounds During a 6-month Treatment, and Demonstrating the Neutralizing Effect of SSR29261 on the SSR126517E-induced Anti-Xa Activity|Completed||Phase 3|757|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:38:37.060201|2017-02-18 16:38:37.060201
NCT00311077|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2009-12-04|||April 2004||2004-04-01|December 2009|2009-12-01||||October 2004|Actual|2004-10-01||Interventional|||Insulin Glulisine in Healthy Lean and Obese Subjects|Pharmacodynamic and Pharmacokinetic Properties of Insulin Glulisine (Apidra) in Comparison to Insulin Lispro (Humalog) in Healthy Lean and Obese Subjects|Completed||Phase 1|||Sanofi|||||f||||||||||||||2017-02-18 16:38:37.199453|2017-02-18 16:38:37.199453
NCT00311064|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2007-08-20|||March 2006||2006-03-01|August 2007|2007-08-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Inflammatory Response and Pregnancy Outcome in Women With Type 2 Diabetes or Overweight|Inflammatory Response and Pregnancy Outcome in Women With Type 2 Diabetes or Only Overweight. The Influence of Physical Activity|Withdrawn||Phase 1|280|Anticipated|Rigshospitalet, Denmark||||because of lack of funding and recruitment problems the study has been closed.|f||||||||||||||2017-02-18 16:38:37.279929|2017-02-18 16:38:37.279929
NCT00311051|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-01|2012-04-13|||April 2005||2005-04-01|April 2012|2012-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite|A Randomized Double-blind and Placebo-controlled Study to the Influence of Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Patients With Mild to Moderate Atopic Asthma (House Dust Mite)|Withdrawn||Phase 2/Phase 3|0|Actual|Research Center Borstel|||||f||||||||||||||2017-02-18 16:38:37.361962|2017-02-18 16:38:37.361962
NCT00311038|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2012-06-12|||April 2006||2006-04-01|June 2012|2012-06-01||||||||Interventional|||Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT|Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice Computed Tomography (CT) Due to Suspected Coronary Artery Disease|Completed||Phase 2|90|Anticipated|Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 16:38:37.568189|2017-02-18 16:38:37.568189
NCT00311025|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-04-03|||September 2003||2003-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications?|Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications? How to Cope Daily Life Activities for as Long as Possible.|Completed||Phase 1/Phase 2|60||Oslo University College|||||f||||||||||||||2017-02-18 16:38:37.658368|2017-02-18 16:38:37.658368
NCT00311012|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2011-11-07|||August 2004||2004-08-01|June 2006|2006-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||SPP100 Dose Finding Study in Japan|Dose-finding Study of SPP100 in Essential Hypertension|Completed||Phase 2|445|Actual|Novartis|||||f||||||||||||||2017-02-18 16:38:37.751289|2017-02-18 16:38:37.751289
NCT00310999|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2007-04-12|||March 2006||2006-03-01|September 2006|2006-09-01|June 2006|Actual|2006-06-01|||||Interventional|||C-Spine Movement - Shikani Optical Scope vs Macintosh Laryngoscope for Patients With Cervical Spine Injury|Comparison of Shikani Optical Scope to Macintosh Laryngoscope for Intubation of Patients With Potential Cervical Spine Injury|Completed||N/A|24||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:38:37.83575|2017-02-18 16:38:37.83575
NCT00310986|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2010-05-27|||April 2006||2006-04-01|August 2009|2009-08-01|May 2011|Anticipated|2011-05-01|December 2009|Anticipated|2009-12-01||Interventional|||Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder|Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder Children: A Randomized Controlled Trial|Unknown status|Recruiting|N/A|22|Anticipated|Khon Kaen University|||||f||||||||||||||2017-02-18 16:38:37.939084|2017-02-18 16:38:37.939084
NCT00310973|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2015-04-20|||February 2003||2003-02-01|April 2015|2015-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||HIV Prevention Within High-Risk Bulgarian and Hungarian Social Networks|HIV Prevention Within High-Risk Social Networks|Completed||Phase 2/Phase 3|320|Actual|Medical College of Wisconsin|||||f||||f||||||||||2017-02-18 16:38:38.048338|2017-02-18 16:38:38.048338
NCT00310960|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2011-08-31|||June 2004||2004-06-01|August 2011|2011-08-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Observational|||An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia|An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia|Completed||Phase 3|293|Actual|Jaeb Center for Health Research|||1||f||||t||||||||||2017-02-18 16:38:38.158624|2017-02-18 16:38:38.158624
NCT00310947|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-04-04|||March 2005||2005-03-01|March 2003|2003-03-01|January 2006||2006-01-01|||||Observational|||Impact of Patient-Prosthesis-Mismatch on Coronary Flow Reserve|Impact of Patient-Prosthesis-Mismatch and Aortic Valve Design on Coronary Flow Reserve Following Aortic Valve Replacement|Completed||N/A|48||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 16:38:38.254422|2017-02-18 16:38:38.254422
NCT00310934|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-10-23|||August 2005||2005-08-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||A Stepwise Strategy Utilizing Buprenorphine and Methadone|Graded Strategy for Pharmacological Treatment of Heroin Dependence|Completed||Phase 4|96||Karolinska University Hospital|||||f||||||||||||||2017-02-18 16:38:38.329333|2017-02-18 16:38:38.329333
NCT00310921|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2007-04-10|||May 2001||2001-05-01|November 2005|2005-11-01|May 2006||2006-05-01|||||Interventional|||A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination|A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination: Effects on Pain, Ease of Procedure and Complications|Completed||Phase 2|200||Kaiser Permanente|||||||||||||||||||2017-02-18 16:38:38.424206|2017-02-18 16:38:38.424206
NCT00310908|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2009-02-15|||September 2006||2006-09-01|September 2006|2006-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic|Efficacy of Tramadol Hcl in the Treatment of Renal Colic|Completed||Phase 4|100|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 16:38:38.508317|2017-02-18 16:38:38.508317
NCT00310895|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2015-12-22|||March 2006||2006-03-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies|A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and MTD of GRN163L in Patients With Refractory or Relapsed Solid Tumor Malignancies|Completed||Phase 1|85|Anticipated|Geron Corporation||1|||f||||f||||||||||2017-02-18 16:38:38.780076|2017-02-18 16:38:38.780076
NCT00310882|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-04|2011-04-07|||May 2006||2006-05-01|May 2008|2008-05-01|May 2008|Anticipated|2008-05-01|||||Observational|||Involvement of Endogenous Digitalis-like Compounds in Breast Cancer|Involvement of Endogenous Digitalis-like Compounds in Breast Cancer|Withdrawn||N/A|250|Anticipated|Hadassah Medical Organization|||1|the PI is no longer work at Hadassah|f||||f||||||Samples Without DNA|"~     blood samples~   "|||2017-02-18 16:38:38.892641|2017-02-18 16:38:38.892641
NCT00310869|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2011-10-03|||January 2005||2005-01-01|October 2011|2011-10-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Adolescents Born Preterm; Nurtured Beginnings|Adolescents Born Preterm: Nurtured Beginnings|Unknown status|Recruiting|N/A|70|Anticipated|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 16:38:38.983676|2017-02-18 16:38:38.983676
NCT00310856|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2013-08-29|2013-08-29||June 2005||2005-06-01|August 2013|2013-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional||Analysis was done for all enrolled subjects.|Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)|A Phase 2, Partially Randomized, Open Label, Multicenter Study to Evaluate the Safety and Immunogenicity After One or Two Doses of Novartis (Formerly Chiron) Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infants and Young Children|Completed||Phase 2|175|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:38:39.10591|2017-02-18 16:38:39.10591
NCT00310843|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2013-07-31|||February 2006||2006-02-01|July 2013|2013-07-01||||September 2008|Actual|2008-09-01||Observational|||Case-Control Viramune (Nevirapine) Toxicogenomics Study|A Case-Control Toxicogenomics Study to Identify Unique Genetic Polymorphisms in Patients Who Have Experienced Symptomatic Hepatotoxicity or Severe Cutaneous Toxicity Within the First 8 Weeks of Nevirapine Therapy|Completed||Phase 4|889|Actual|Boehringer Ingelheim|||1||f||||||||||||||2017-02-18 16:38:39.809544|2017-02-18 16:38:39.809544
NCT00310830|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2010-02-11||2010-02-11|March 2006||2006-03-01|February 2010|2010-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)|Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Symptomatic Pulmonary Arterial Hypertension Associated With Sickle Cell Disease|Terminated||Phase 3|14|Actual|Actelion||2||Slow enrollment|f||||||||||||||2017-02-18 16:38:40.031973|2017-02-18 16:38:40.031973
NCT00310817|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2015-10-06|2013-08-29||March 2005||2005-03-01|October 2015|2015-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.|A Phase II, Randomized, Observer Blind, Multi-Center, Active Controlled Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.|Completed||Phase 2|623|Actual|Novartis||4|||||||||||||||||2017-02-18 16:38:40.187118|2017-02-18 16:38:40.187118
NCT00310804|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2013-01-18|2012-12-11||September 2005||2005-09-01|January 2013|2013-01-01|April 2006|Actual|2006-04-01|October 2005|Actual|2005-10-01||Interventional|||Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults (>=18 to <=60)|A Phase III, Randomized, Controlled, Observer-Blind, Multi-Center Study to Evaluate Safety, Tolerability and Immunogenicity of a Single Intramuscular Dose of Three Lots of a Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Or of a Trivalent Subunit Influenza Vaccine Produced in Embryonated Hen Eggs, in Healthy Adult Subjects Aged >=18 to <=60|Completed||Phase 3|1200|Actual|Novartis|Because of potential issues related to Good Clinical Practice (GCP), data from one of the sites were not used in the analyses.|4|||f||||f||||||||||2017-02-18 16:38:42.058733|2017-02-18 16:38:42.058733
NCT00310791|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2012-12-27|2011-06-22||April 2004||2004-04-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|October 2009|Actual|2009-10-01||Interventional|||Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa|Effects of Adrenal and Gonadal Hormone Replacement in Young Women With Anorexia Nervosa|Completed||Phase 2/Phase 3|80|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 16:38:42.8738|2017-02-18 16:38:42.8738
NCT00310778|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2008-09-19|||March 2006||2006-03-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker|Effects of Sodium Intake on Pharmacokinetic/Pharmacodynamic Relationship of a Single Dose of a Renin Angiotensin System-Blocker, or a Beta-Blocker in Normotensive Sodium-Depleted or Replated Volunteers in a Cross-Over Study|Completed||Phase 1|64|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:38:43.275204|2017-02-18 16:38:43.275204
NCT00310765|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2012-09-04|||March 2006||2006-03-01|September 2012|2012-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Pregabalin for Abdominal Pain From Adhesions|Pregabalin for the Treatment of Abdominal Pain From Adhesions: Placebo Controlled Trial|Terminated||Phase 4|18|Actual|Henry Ford Health System||2||Study was terminated by the sponsor due to low accrual.|f||||f||||||||||2017-02-18 16:38:43.394914|2017-02-18 16:38:43.394914
NCT00310752|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2008-07-31|||March 2006||2006-03-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Evaluation of DermStream(tm) - an Irrigation Product for Chronic Wound Management||Completed||Phase 1/Phase 2|11|Actual|EnzySurge||1|||f||||||||||||||2017-02-18 16:38:43.511736|2017-02-18 16:38:43.511736
NCT00310037|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-06-17|||June 2006||2006-06-01|June 2016|2016-06-01||||December 2013|Actual|2013-12-01||Interventional|||Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma|A Randomized Phase II Trial of Maintenance vs Consolidation Bortezomib Therapy Following Aggressive Chemo-Immunotherapy and Autologous Stem Cell Transplant for Previously Untreated Mantle Cell Lymphoma|Active, not recruiting||Phase 2|151|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 16:38:43.606978|2017-02-18 16:38:43.606978
NCT00310024|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2013-02-06|||November 2005||2005-11-01|February 2013|2013-02-01||||February 2008|Actual|2008-02-01||Interventional|||Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase I Study of SAHA in Combination With Bortezomib in Relapsed and Refractory Multiple Myeloma|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:38:43.758617|2017-02-18 16:38:43.758617
NCT00310011|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2017-01-17|||June 1998||1998-06-01|June 2013|2013-06-01|August 2009|Actual|2009-08-01|October 2005|Actual|2005-10-01||Interventional|||Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium|A Phase II Trial of Gemzar (Gemcitabine), Taxol (Paclitaxel), and Platinol (Cisplatin) (GTP) in Treatment of Advanced Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|71|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 16:38:43.887176|2017-02-18 16:38:43.887176
NCT00309998|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2014-09-16|||September 2005||2005-09-01|September 2014|2014-09-01||||May 2007|Actual|2007-05-01||Interventional|||Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Vinorelbine Plus Bevacizumab as First Line Therapy in Patients ≥ 70 Years of Age With Stage IIIB/IV Non-Squamous, Non-Small Cell Lung Cancer|Completed||Phase 2|50|Anticipated|University of Rochester||1|||||||||||||||||2017-02-18 16:38:43.997784|2017-02-18 16:38:43.997784
NCT00309985|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-02-01|2015-12-17||July 2006||2006-07-01|February 2016|2016-02-01|December 2022|Anticipated|2022-12-01|December 2013|Actual|2013-12-01||Interventional|CHAARTED|All randomized patients|Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer|CHAARTED: ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer|Active, not recruiting||Phase 3|790|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-02-18 16:38:44.121975|2017-02-18 16:38:44.121975
NCT00309764|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-03-31|||November 2001||2001-11-01|March 2006|2006-03-01|August 2002||2002-08-01|||||Interventional|||CHF Management Using Telemedicine|Improving CHF Outcomes Through Interactive Voice Recognition (IVR) Data Acquisition and Targeted Nurse Follow-Up|Completed||N/A|106||Kaiser Permanente|||||f||||||||||||||2017-02-18 16:38:48.773073|2017-02-18 16:38:48.773073
NCT00309972|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2014-12-01|||December 2005||2005-12-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Interventional|SOCCAR||Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery|A Randomized Phase III Trial of Sequential Chemotherapy Followed By Radical Radiotherapy Versus Concurrent Chemo-Radiotherapy Followed by Chemotherapy in Patients With Inoperable Stage III Non-Small Cell Lung Cancer and Good Performance Status|Completed||Phase 3|130|Actual|University College, London||2|||f||||t||||||||||2017-02-18 16:38:45.345717|2017-02-18 16:38:45.345717
NCT00309959|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2014-12-29|||November 2006||2006-11-01|December 2014|2014-12-01||||February 2011|Actual|2011-02-01||Interventional|||ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix|Completed||Phase 2|37|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 16:38:45.474388|2017-02-18 16:38:45.474388
NCT00309946|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2014-07-25|2013-07-01||December 2005||2005-12-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery|Phase II Study of AZD2171 (NSC#732208) in Patients With Malignant Mesothelioma|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:38:45.653889|2017-02-18 16:38:45.653889
NCT00309933|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2010-03-09|||October 2005||2005-10-01|March 2010|2010-03-01||||||||Observational|||Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance|Quality of Life in Younger Breast Cancer Survivors|Unknown status|Active, not recruiting|N/A|2697|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:38:46.033088|2017-02-18 16:38:46.033088
NCT00309920|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2009-02-06|||January 2004||2004-01-01|April 2006|2006-04-01||||||||Interventional|||Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer|Adjuvant Therapy of Breast Cancer: Impact of Erythropoiesis Stimulating Factors on Event Free Survival High Risk Breast Cancer Treatment|Unknown status|Recruiting|N/A|1234|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:38:46.368888|2017-02-18 16:38:46.368888
NCT00309907|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-02-23|2014-01-06||April 2006||2006-04-01|February 2016|2016-02-01||||September 2011|Actual|2011-09-01||Interventional|||Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant|Soluble Tumor Necrosis Factor Receptor: Enbrel® (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation|Active, not recruiting||Phase 2|39|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 16:38:46.523164|2017-02-18 16:38:46.523164
NCT00309894|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2012-10-09|||April 2004||2004-04-01|October 2012|2012-10-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy|Phase II Trial to Assess the Activity of Ketoconazole Plus GM-CSF in Patients With Prostate Cancer Progressive After Androgen Deprivation|Completed||Phase 2|49|Actual|University of California, San Francisco|||||f||||t||||||||||2017-02-18 16:38:47.137596|2017-02-18 16:38:47.137596
NCT00309881|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-09-30|||April 2003||2003-04-01|September 2016|2016-09-01|March 2011|Actual|2011-03-01|March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)|CHOP Plus Rituximab (CHOP-R) in Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) or CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)|Completed||Phase 2|75|Anticipated|German CLL Study Group|||||f||||f||||||||Undecided||2017-02-18 16:38:47.259135|2017-02-18 16:38:47.259135
NCT00309868|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2014-03-24|||December 2002||2002-12-01|March 2014|2014-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study of Nesiritide in Diastolic Heart Failure.|A Study of the Acute Hemodynamic and Myocardial Effects of Nesiritide in Diastolic Heart Failure.|Completed||Phase 1/Phase 2|20|Anticipated|Massachusetts General Hospital||1|||f||||||||||||||2017-02-18 16:38:47.406075|2017-02-18 16:38:47.406075
NCT00309855|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2012-07-27|||December 2005||2005-12-01|July 2012|2012-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men|Mechanisms of Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men: Modulation of GHRH, GHRP and Somatostatin Action by Estrogenic Versus Androgenic Steroids|Completed||Phase 1|80|Actual|Mayo Clinic||4|||f||||||||||||||2017-02-18 16:38:47.503211|2017-02-18 16:38:47.503211
NCT00309842|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-12-07|||July 2005||2005-07-01|December 2016|2016-12-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases|Transplantation of Unrelated Umbilical Cord Blood for Patients With Hematological Diseases With Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloablative Preparative Regimen|Recruiting||Phase 2|150|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:38:47.629925|2017-02-18 16:38:47.629925
NCT00309816|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2006-03-30|||December 2001||2001-12-01|March 2006|2006-03-01|February 2006||2006-02-01|||||Interventional|||Study of Sildenafil in Patient With Heart Failure.|Measurement of the Effect of Sildenafil Citrate (Viagra) on the Hemodynamics of Exercise Tolerance in Advanced Congestive Heart Failure.|Completed||Phase 3|40||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 16:38:47.7928|2017-02-18 16:38:47.7928
NCT00309803|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2008-10-20|||March 2006||2006-03-01|October 2008|2008-10-01||||||||Interventional|||EPIC European Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting|Evaluating the Use of the FiberNet® Embolic Protection Device in Carotid Artery Stenting: The EPIC European Study|Completed||N/A|50|Anticipated|Lumen Biomedical|||||f||||f||||||||||2017-02-18 16:38:47.889386|2017-02-18 16:38:47.889386
NCT00309790|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2009-08-07|||May 2003||2003-05-01|August 2009|2009-08-01|March 2006|Actual|2006-03-01|||||Interventional|||Study of Sildenafil in Advanced Heart Failure.|Phase 3 Study of the Effects of Chronic Sildenafil Citrate Therapy on Exercise Tolerance and Hemodynamics in Patients With Advanced Heart Failure.|Completed||Phase 3|40|Anticipated|Massachusetts General Hospital|||||||||||||||||||2017-02-18 16:38:47.989866|2017-02-18 16:38:47.989866
NCT00309777|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2010-01-07|2009-08-26||September 2005||2005-09-01|January 2010|2010-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin|Study of Pitavastatin Vs. Simvastatin (Following Up-Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia|Completed||Phase 3|857|Actual|Kowa Research Europe||4|||f||||f||||||||||2017-02-18 16:38:48.092108|2017-02-18 16:38:48.092108
NCT00310726|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2011-07-26|||May 2001||2001-05-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Zambia Exclusive Breastfeeding Study|Short Duration Exclusive Breastfeeding With Abrupt Weaning to Reduce the Risk of Mother-to-Child HIV Transmission|Completed||N/A|1435|Actual|Boston Medical Center||2|||f||||t||||||||||2017-02-18 16:38:48.925642|2017-02-18 16:38:48.925642
NCT00310713|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2014-09-18|||April 2006||2006-04-01|September 2014|2014-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine|A Phase IV, Single Centre, Open-label Study to Investigate the Kinetics of the B Cell Response to the C Saccharide Component of Chiron's Meningococcal C Conjugate Vaccine Administered to Healthy Children at Least 12 Months of Age After Priming With a Commercially Available Men ACWY Conjugate Vaccine at 2, 3 and 4 Months of Age|Completed||Phase 4|33|Actual|Novartis||5|||f||||||||||||||2017-02-18 16:38:49.061045|2017-02-18 16:38:49.061045
NCT00310700|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2014-09-18|||May 2005||2005-05-01|September 2014|2014-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Kinetics of B Cell Response in Infants Menjugate Vaccination|A Phase IV, Single Centre, Open-label Study to Investigate the Kinetics of the B Cell Response to the First and the Third Immunization With Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Infants at 2, 3 and 4 Months of Age|Completed||Phase 4|75||Novartis|||||f||||||||||||||2017-02-18 16:38:49.171479|2017-02-18 16:38:49.171479
NCT00310687|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2014-09-18|||October 2004||2004-10-01|September 2014|2014-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Persistence of Immune Response After Vaccination With MCC|A Phase IV, Single Centre, Open-label Study to Evaluate the Persistence of Antibodies in Adolescents 14-16 Years of Age, Vaccinated With Chiron Meningococcal C Conjugate Vaccine During the 1999-2001 UK MenCC Immunization Campaign, at One Year After Either a Challenge Dose of Aventis Pasteur MSD Meningococcal A/C Polysaccharide Vaccine or a Booster Dose of MenC Vaccine, in Parallel to Subjects Aged 11-20 Evaluated at 4 Years After Vaccination During the 1999-2001 UK MenCC Immunization Campaign|Completed||Phase 4|1244||Novartis|||||f||||||||||||||2017-02-18 16:38:49.381898|2017-02-18 16:38:49.381898
NCT00310674|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2007-03-12|||September 2004||2004-09-01|March 2007|2007-03-01||||||||Interventional|||Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age|A Phase III, Single Center, Open Label, Uncontrolled Study to Evaluate the Immunogenicity, Safety and Tolerability, of the Chiron Meningococcal C Conjugate Vaccine When Administered to Healthy Premature and Non Premature Children at 3, 5, 11 Months of Age Concomitantly With a Hexavalent Infant Vaccine|Completed||Phase 3|150||Novartis|||||f||||||||||||||2017-02-18 16:38:49.466077|2017-02-18 16:38:49.466077
NCT00310661|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2015-07-22|||December 2004||2004-12-01|July 2015|2015-07-01|March 2008||2008-03-01|September 2006|Actual|2006-09-01||Interventional|||Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia|A Dual-centre, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Determine the Effects of Various Adjunctive Doses of Sarizotan in the Treatment of Patients With Neuroleptic-induced Tardive Dyskinesia|Terminated||N/A|60|Actual|Centre for Addiction and Mental Health||2||Funding|f||||f||||||||||2017-02-18 16:38:49.549054|2017-02-18 16:38:49.549054
NCT00310648|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-09-13|||January 2006||2006-01-01|September 2006|2006-09-01||||||||Interventional|||Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)|Part 1:Phase I Open-Label, Single-Center to Evaluate the Safety of a Commercially Available Adjuvanted Influenza Vaccine When Administered to Elderly Subjects Part 2: A Phase III, Randomized, Controlled, Observer-Blind, Single-Center Study to Evaluate the Immunogenicity and Safety of a Commercially Available Influenza Vaccine and a Conventional Commercially Available Influenza Vaccine When Administered to Elderly Subjects|Completed||Phase 3|600||Novartis|||||f||||||||||||||2017-02-18 16:38:49.663819|2017-02-18 16:38:49.663819
NCT00310635|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2006-10-25|||June 2005||2005-06-01|October 2006|2006-10-01||||||||Interventional|||Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age|A Phase IV, Multi-Center, Controlled Open-Label Study to Evaluate the Safety, Tolerability and Immunogenicity of a Commercially Available Meningococcal C Vaccine When Given as First, Third or Fourth Immunization to Children 32-40 Months of Age|Completed||Phase 4|241||Novartis|||||f||||||||||||||2017-02-18 16:38:49.750069|2017-02-18 16:38:49.750069
NCT00310622|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-02|2007-02-28|||March 2006||2006-03-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG|An Assessment of the HyperQ Signal for Detecting Ischemia During Dobutamine Stress Echocardiography (DSE)|Unknown status|Recruiting|Phase 3|150||BSP Biological Signal Processing Ltd.|||||f||||||||||||||2017-02-18 16:38:49.834119|2017-02-18 16:38:49.834119
NCT00310609|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2014-12-29|||December 2003||2003-12-01|December 2014|2014-12-01|October 2004|Actual|2004-10-01|||||Interventional|||Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches|Multicenter, Open-label Study of the Safety (Open-label) and Efficacy (Open-label and Blinded Reader) of a Single Administration of Approximately 0.1 mmol/kg of Magnevist® Injection-enhanced Magnetic Resonance Arteriography (MRA) and 2-dimensional-time-of-flight (2D-TOF) MRA in Patients With Known or Suspected Disease of the Aortic Arch and Cerebral Branches Who Are Undergoing MRA of These Vessels With Intra-arterial Digital Subtraction Arteriography (i.a. DSA) as the Standard of Reference.|Completed||Phase 3|123|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:38:49.924288|2017-02-18 16:38:49.924288
NCT00310596|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2014-12-29|||January 2004||2004-01-01|December 2014|2014-12-01|March 2004|Actual|2004-03-01|||||Interventional|||Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects|Cardiovascular Safety Study of 0.1 and 0.3 mmol/kg Magnevist® Injection at Two Injection Rates (Bolus and 10 mL/15 Sec.) in Normal Subjects Following a Randomized, Cross-over Design Using Placebo and a Concurrent Positive Control|Completed||Phase 1|71|Actual|Bayer||6|||f||||||||||||||2017-02-18 16:38:50.026573|2017-02-18 16:38:50.026573
NCT00310583|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2007-04-04|||July 2006||2006-07-01|April 2006|2006-04-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Effects of Pregabalin on Mechanical Hyperalgesia|Effects of Pregabalin on Mechanical Hyperalgesia - EPOM|Unknown status|Recruiting|Phase 4|120||Professional Associations Clinic Bergmannsheil|||||f||||||||||||||2017-02-18 16:38:50.140561|2017-02-18 16:38:50.140561
NCT00310570|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-02|2006-04-02|||May 2006||2006-05-01|April 2006|2006-04-01|September 2007||2007-09-01|||||Interventional|||Comparison of Splinting Interventions for Treating Mallet Finger Injuries|Comparison of Splinting Interventions for Minimising Extensor Lag in Mallet Finger Injuries|Unknown status|Not yet recruiting|N/A|100||Bayside Health|||||f||||||||||||||2017-02-18 16:38:50.259412|2017-02-18 16:38:50.259412
NCT00310557|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2014-12-28|||December 2003||2003-12-01|December 2014|2014-12-01|December 2004|Actual|2004-12-01|||||Interventional|||Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries|Multicenter, Open-label Study of the Safety (Open-label) and Efficacy (Open-label and Blinded Reader) of a Single Administration of Approximately 0.1 mmol/kg of Magnevist® Injection-enhanced Magnetic Resonance Arteriography (MRA) and 2-dimensional-time-of-flight (2D-TOF) MRA in Patients With Known or Suspected Renal Artery Disease Undergoing MRA of the Renal Arteries With Intra-arterial Digital Subtraction Arteriography (i.a. DSA) as the Standard of Reference|Completed||Phase 3|116|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:38:50.359677|2017-02-18 16:38:50.359677
NCT00310544|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2014-12-11|||March 2006||2006-03-01|December 2014|2014-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction|Multicenter, Single-blind, Randomized, Intraindividual Study of the Safety and Efficacy of Magnevist Gadopentetate Dimeglumine (Magnevist® Injection) at 0.1 and 0.2 mmol/kg for the Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction|Completed||Phase 2|73|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:38:50.457729|2017-02-18 16:38:50.457729
NCT00310531|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2014-12-29|||February 2004||2004-02-01|December 2014|2014-12-01|June 2007|Actual|2007-06-01|||||Interventional|||3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women|A Multicenter, Double-Blind, Double-Dummy, Randomized, Active- Controlled, 3-Year Study to Evaluate the Antiresorptive Efficacy, Safety and Tolerability of a Ultra-Low Dose Estradiol Transdermal Delivery System Releasing 0.014 mg / Day Versus Oral Raloxifene Hydrochloride 60 mg / Day - as a Therapy for the Prevention of Osteoporosis in Postmenopausal Female Osteopenic Patients.|Completed||Phase 3|500|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:38:50.568895|2017-02-18 16:38:50.568895
NCT00310518|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2009-04-28|||February 2006||2006-02-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma|A Phase 2 Multi Center Open Label Study of ARQ 501 in Adult Patients With Recurrent, Persistent or Metastatic Leiomyosarcoma|Completed||Phase 2|30||ArQule|||||f||||||||||||||2017-02-18 16:38:50.679906|2017-02-18 16:38:50.679906
NCT00310505|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2008-09-11|||January 2003||2003-01-01|September 2008|2008-09-01||||||||Interventional|||Amphotericin B Treatment in Visceral Leishmaniasis|Randomised Double Blind Dose Ranging Study of Amphotericin B in Visceral Leishmaniasis|Completed||N/A|1500||Banaras Hindu University|||||f||||||||||||||2017-02-18 16:38:50.7598|2017-02-18 16:38:50.7598
NCT00310492|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-02|2015-12-28|||April 2006||2006-04-01|December 2015|2015-12-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis|Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Group Study to Demonstrate the Efficacy of a 12-month Subcutaneous Specific Immunotherapy With ALK-depot SQ Milbenmischung in Patients With Atopic Dermatitis and Proven IgE-mediated Sensitization to House Dust Mites|Completed||Phase 3|154|Actual|ALK-Abelló A/S||2|||f||||f||||||||||2017-02-18 16:38:50.853557|2017-02-18 16:38:50.853557
NCT00310479|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2016-02-24|||June 2006||2006-06-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer|Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer|Completed||N/A|16|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 16:38:50.949074|2017-02-18 16:38:50.949074
NCT00310466|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-02|2013-04-29|2009-03-12||June 2005||2005-06-01|April 2013|2013-04-01|January 2007|Actual|2007-01-01|August 2006|Actual|2006-08-01||Interventional|||Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever|A Multicentre, Randomised, Double-blind, Placebo-controlled Parallel Group Clinical Trial to Investigate the Efficacy and Safety of Specific Sublingual Immunotherapy With SLITone Birch in Patients With Seasonal Birch Pollen Induced Rhinoconjunctivitis|Completed||Phase 3|226|Actual|ALK-Abelló A/S|Clinical improvement following SLIT is thought to be due to immunological mechanisms that develop over time. Even though clear immunological changes were observed in this trial it appears that the treatment was too short to reach full clinical effect|2|||f||||f||||||||||2017-02-18 16:38:51.054437|2017-02-18 16:38:51.054437
NCT00310453|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-02|2006-05-03|||March 2006||2006-03-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Tolerability of ALK Grass Tablet in Children|A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Phase I Trial Investigating the Safety of ALK Grass Tablet in Children Aged 5-12 Years With Grass Pollen Induced Rhinoconjunctivitis (With/Without Asthma)|Completed||Phase 1|32||ALK-Abelló A/S|||||f||||||||||||||2017-02-18 16:38:54.453578|2017-02-18 16:38:54.453578
NCT00310440|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-03|2016-01-13|2015-12-10||January 2006||2006-01-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|May 2014|Actual|2014-05-01||Interventional|||An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation|An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation|Active, not recruiting||N/A|319|Actual|CeraPedics, Inc||2|||f||||t||||||||||2017-02-18 16:38:54.536189|2017-02-18 16:38:54.536189
NCT00310427|ClinicalTrials.gov processed this data on February 17, 2017|2006-04-01|2010-04-13|2010-03-05||March 2006||2006-03-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of LY686017 on Alcohol Craving|NK1 Receptor Antagonism for Treatment of Anxiety and Craving in Anxious Alcohol Dependent Subjects During Early Abstinence|Completed||Phase 2|66|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 16:38:55.715781|2017-02-18 16:38:55.715781
NCT00310414|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2017-01-24|||March 30, 2006||2006-03-30|March 13, 2012|2012-03-13|March 13, 2012||2012-03-13|||||Observational|||fMRI Studies of Task Specificity in Focal Hand Dystonia|fMRI Studies of Task Specificity in Focal Hand Dystonia|Completed||N/A|51|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:38:56.219076|2017-02-18 16:38:56.219076
NCT00310401|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2013-08-30|2013-06-24||April 2007||2007-04-01|August 2013|2013-08-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||The Effect of Nebulized Albuterol on Donor Oxygenation|The Effect of Nebulized Albuterol on Donor Oxygenation|Completed||Phase 2|506|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 16:38:56.309782|2017-02-18 16:38:56.309782
NCT00310388|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2016-04-25|||July 2006||2006-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097|A Multicenter, Open-Label, Long-Term, Safety, Tolerability and Efficacy Study of Retigabine in Adult Epilepsy Patients With Partial-Onset Seizures (Extension of Study VRX-RET-E22-302)|Active, not recruiting||Phase 3|376|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 16:38:56.710576|2017-02-18 16:38:56.710576
NCT00310375|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2016-10-04|2016-07-27||May 2006||2006-05-01|July 2016|2016-07-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial|A Multicenter, Open-label, Long-term, Safety, Tolerability and Efficacy Study of Retigabine in Adult Epilepsy Patients With Partial-onset Seizures (Extension of Study VRX-RET-E22-301)|Completed||Phase 3|181|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 16:38:57.1787|2017-02-18 16:38:57.1787
NCT00310362|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2015-04-06|2014-09-16||July 2007||2007-07-01|July 2014|2014-07-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|GIVER||Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates|Use of Telehealth In-Home Messaging to Improve GI Endoscopy Completion Rates|Completed||N/A|3610|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 16:39:00.613747|2017-02-18 16:39:00.613747
NCT00310349|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2007-12-12|||March 2006||2006-03-01|March 2006|2006-03-01|January 2009|Anticipated|2009-01-01|||||Interventional|||PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease|PneuMum: A Randomised Controlled Trial of Pneumococcal Polysaccharide Vaccination for Aboriginal and Torres Strait Islander Mothers to Protect Their Babies From Ear Disease|Unknown status|Not yet recruiting|Phase 3|210|Anticipated|University of Melbourne|||||f||||||||||||||2017-02-18 16:39:01.022519|2017-02-18 16:39:01.022519
NCT00310336|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2010-10-27|||August 2006||2006-08-01|October 2010|2010-10-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine|Chronic Hepatitis C: Treatment of (Peg)Interferon Alpha - Ribavirin Non-Responders With Pegylated Interferon alpha2b, Ribavirin, AdoMet and Betaine|Completed||Phase 2/Phase 3|30|Anticipated|University Hospital, Basel, Switzerland|||||f||||||||||||||2017-02-18 16:39:01.130597|2017-02-18 16:39:01.130597
NCT00310323|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2009-03-17|||January 2003||2003-01-01|March 2009|2009-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea|Effect of Chronic Intermittent Nocturnal Hypoxia on Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea|Completed||N/A|69|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 16:39:01.228476|2017-02-18 16:39:01.228476
NCT00310310|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2014-07-14|||April 2006||2006-04-01|July 2014|2014-07-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Self-Management on Improving Sleep Apnea Outcomes|Effect of Self-Management on Improving Sleep Apnea Outcomes|Completed||Phase 2/Phase 3|240|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:39:01.346575|2017-02-18 16:39:01.346575
NCT00310297|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2011-01-10|||November 2004||2004-11-01|July 2008|2008-07-01||||December 2004|Actual|2004-12-01||Interventional|||Insulin Glulisine in Type 2 Diabetes Mellitus|A Randomized, Open Label, Two-arm, Cross-over Design Study to Compare the Pharmacodynamics and Pharmacokinetics of Insulin Glulisine and Insulin Lispro in Obese Patients With Type 2 Diabetes.|Completed||Phase 1|||Sanofi|||||f||||||||||||||2017-02-18 16:39:01.456254|2017-02-18 16:39:01.456254
NCT00310284|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-03-31|||January 2006||2006-01-01|March 2006|2006-03-01||||||||Interventional|||A Treatment Study Comparing Two Non-Drug, Self-Help Treatment of Chronic Insomnia.|Computerized Self-Help Treatment for Primary Insomnia|Unknown status|Recruiting|N/A|200||PICS, Inc.|||||f||||||||||||||2017-02-18 16:39:01.541203|2017-02-18 16:39:01.541203
NCT00310271|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2008-11-20|||April 2006||2006-04-01|November 2008|2008-11-01|December 2006||2006-12-01|||||Interventional|||A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects|A Phase I Study Assessing Safety and Tolerability of a DNA Vaccine With a DNA Encoded Immunostimulator , Administered by Particle Mediated Epidermal Delivery Using the PowderMed ND10 Delivery System in HSV-2 Seronegative Healthy Volunteers|Completed||Phase 1|42||PowderMed|||||||||||||||||||2017-02-18 16:39:01.644235|2017-02-18 16:39:01.644235
NCT00310258|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2017-01-10|||April 2005||2005-04-01|March 2006|2006-03-01|February 2006||2006-02-01|||||Interventional|||Drug Use Prevention Among Girls Through a Mother-Daughter Intervention|Drug Abuse Prevention: A Mother-Daughter Intervention|Completed||Phase 3|2000||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:39:01.745786|2017-02-18 16:39:01.745786
NCT00310245|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-07-21|||November 2000||2000-11-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||BASTA Study on STI in HIV Infected Patients|Strategic Long Term, Immunologically Driven Treatment Interruptions in Patients on Effective HAART: a Controlled, Randomized Study|Completed||Phase 3|130||A.O. Ospedale Papa Giovanni XXIII|||||f||||||||||||||2017-02-18 16:39:01.839924|2017-02-18 16:39:01.839924
NCT00310232|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2007-06-29|||February 2001||2001-02-01|March 2006|2006-03-01|April 2004|Actual|2004-04-01|||||Interventional|||Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)|Randomized Trial of Epoetin Alfa in Patients With Advanced Non-Small Cell Carcinoma of the Lung (EPO-CAN-20)|Terminated||Phase 3|70|Actual|Ontario Clinical Oncology Group (OCOG)||2||Recommendation of DSMB for safety issue, increased mortality with study drug.|f||||t||||||||||2017-02-18 16:39:01.950681|2017-02-18 16:39:01.950681
NCT00310219|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2014-01-23|||February 2006||2006-02-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|November 2010|Actual|2010-11-01||Interventional|||Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer|Comparative Study of Gross Tumor Volume Definition With or Without PET Fusion for Patients With Non-Small Cell Lung Carcinoma|Completed||N/A|52|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 16:39:02.067678|2017-02-18 16:39:02.067678
NCT00310206|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2013-05-30|||July 2005||2005-07-01|October 2009|2009-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults|A Randomized, Open-Label, Phase I Clinical Trial Comparing the Safety, Reactogenicity, and Immunogenicity of Immunization With Inactivated Influenza A/H5N1 Vaccine Administered by the Intradermal or the Intramuscular Route Among Healthy Adults|Completed||Phase 1|100|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:39:02.18483|2017-02-18 16:39:02.18483
NCT00310180|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2017-02-16|||April 2006||2006-04-01|November 2016|2016-11-01||||December 2017|Anticipated|2017-12-01||Interventional|TAILORx||Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)|Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment:The TAILORx Trial|Active, not recruiting||Phase 3|11248|Anticipated|National Cancer Institute (NCI)||4|||f||||t||||||||||2017-02-18 16:39:02.330442|2017-02-18 16:39:02.330442
NCT00310167|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-11-21|||October 2005||2005-10-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|July 2013|Actual|2013-07-01||Interventional|FoRT||Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma|A Phase III Multi-Center Randomized Controlled Trial of Low-Dose Radiotherapy for Follicular Lymphoma and Marginal Zone Lymphoma|Active, not recruiting||Phase 3|614|Actual|University College, London||2|||f||||t||||||||||2017-02-18 16:39:09.14325|2017-02-18 16:39:09.14325
NCT00310154|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2017-01-18|||November 2003||2003-11-01|November 2011|2011-11-01|August 2010|Actual|2010-08-01|July 2007|Actual|2007-07-01||Interventional|||Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|ZD-1839 (Iressa®) With Concurrent Docetaxel and Conformal Three Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and ZD-1839 for Patients With Stage III Non Small Cell Lung Cancer: A Phase I Study|Completed||Phase 1|45|Anticipated|Wake Forest University Health Sciences|||||f||||f||||||||||2017-02-18 16:39:09.255007|2017-02-18 16:39:09.255007
NCT00310141|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-09-21|||April 2002||2002-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional|||Computer-Assisted Counseling in Helping African American Smokers Stop Smoking|Treatment of Nicotine Dependence Among African Americans|Completed||N/A|462|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 16:39:09.366738|2017-02-18 16:39:09.366738
NCT00310128|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-02-01|||February 2006||2006-02-01|February 2016|2016-02-01||||||||Interventional|||Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma|Phase II Study of Induction Therapy Comprising Etoposide, Methylprednisolone, Cytarabine, and Cisplatin (ESHAP) Followed by Consolidation Therapy Comprising Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma|Withdrawn||Phase 2|0|Actual|AIDS Malignancy Consortium||||Drug supply unavailable|f||||||||||||||2017-02-18 16:39:09.478093|2017-02-18 16:39:09.478093
NCT00310115|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-09-21|||April 2002||2002-04-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Observational|||Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy|Smoking Relapse Prevention Among Postpartum Women|Completed||N/A|469|Actual|M.D. Anderson Cancer Center|||3||f||||f||||||||||2017-02-18 16:39:09.575821|2017-02-18 16:39:09.575821
NCT00310089|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2013-06-18|||January 2006||2006-01-01|January 2007|2007-01-01|July 2007|Actual|2007-07-01|||||Interventional|||AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer|A Pilot Study to Evaluate The Effects of Neoadjuvant AZD2171, a VEGF Receptor Tyrosine Kinase Inhibitor With Docetaxel, Doxorubicin, and Cyclophosphamide Chemotherapy in Previously Untreated Locally Advanced Breast Cancer|Completed||N/A|33|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 16:39:09.686692|2017-02-18 16:39:09.686692
NCT00310076|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2012-10-16|2012-07-24||October 2002||2002-10-01|October 2012|2012-10-01|September 2012|Actual|2012-09-01|July 2011|Actual|2011-07-01||Interventional|||Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer|Phase II Trial of Adjuvant Thalidomide Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis or Adenomucinosis From Colorectal/Appendiceal Cancer|Completed||Phase 2|29|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 16:39:09.784345|2017-02-18 16:39:09.784345
NCT00310063|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2012-07-11|||April 2005||2005-04-01|July 2012|2012-07-01||||May 2007|Actual|2007-05-01||Interventional|||Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy|Acupressure for the Prevention of Chemotherapy-Associated Nausea and Vomiting in Children|Completed||N/A|28|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 16:39:10.335796|2017-02-18 16:39:10.335796
NCT00310050|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2012-07-12|||October 2005||2005-10-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer|A Phase I Dose-Escalating Study of Induction Gemcitabine/Pemetrexed Followed by Pemetrexed and Concurrent Upper Abdominal Radiation Therapy in Patients With Locally Advanced Pancreatic Cancer|Terminated||Phase 1|4|Actual|Wake Forest University Health Sciences||1||slow accrual|f||||f||||||||||2017-02-18 16:39:10.444349|2017-02-18 16:39:10.444349
NCT00309751|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2010-02-17|2009-08-26||December 2005||2005-12-01|February 2010|2010-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia|Study of Pitavastatin Vs. Atorvastatin (Following Up-Titration) in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia|Completed||Phase 3|418|Actual|Kowa Research Europe||2|||f||||f||||||||||2017-02-18 16:39:10.555423|2017-02-18 16:39:10.555423
NCT00309738|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2010-03-09|2009-08-26||September 2005||2005-09-01|March 2010|2010-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin|Study of Pitavastatin Vs. Simvastatin (Following Up-Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or More Risk Factors for Coronary Heart Disease|Completed||Phase 3|355|Actual|Kowa Research Europe||2|||f||||f||||||||||2017-02-18 16:39:11.207944|2017-02-18 16:39:11.207944
NCT00309725|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2011-05-17||||||January 2011|2011-01-01|October 1999|Actual|1999-10-01|||||Interventional|||A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.|Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: A Cardiac Safety Study.|Completed||Phase 3|139|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:39:11.675559|2017-02-18 16:39:11.675559
NCT00309712|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2008-08-20|||August 2002||2002-08-01|August 2008|2008-08-01|September 2006||2006-09-01|||||Interventional|||Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study|Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study: A Randomized, Double-Blind Study of Simvastatin, Fenofibrate, and Combined Fenofibrate and Simvastatin in Patients With Controlled Type II Diabetics Without Evidence of Coronary Disease|Completed||N/A|300||Intermountain Health Care, Inc.|||||f||||||||||||||2017-02-18 16:39:11.779774|2017-02-18 16:39:11.779774
NCT00309530|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-03-31|||October 1990||1990-10-01|April 1999|1999-04-01||||||||Interventional|||Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C|A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).|Completed||Phase 3|598||Austrian Breast & Colorectal Cancer Study Group|||||f||||||||||||||2017-02-18 16:39:14.606237|2017-02-18 16:39:14.606237
NCT00309699|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2014-06-19|||April 2006||2006-04-01|June 2014|2014-06-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder|Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared With Flexibly-Dosed Quetiapine and Placebo in the Treatment of Acute Manic and Mixed Episodes in Bipolar Disorder|Completed||Phase 3|493|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||f||||||||||2017-02-18 16:39:11.892652|2017-02-18 16:39:11.892652
NCT00309686|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2011-05-17|||April 2006||2006-04-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood Stabilizers in the Treatment of Acute Manic and Mixed Episodes Associated With Bipolar I Disorder|Completed||Phase 3|300|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:39:12.288414|2017-02-18 16:39:12.288414
NCT00309673|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-03-31||||||March 2006|2006-03-01||||||||Interventional|||Local Anesthesia and Tuberculin Skin Test in Infants and Children|Local Anesthesia Effect on Tuberculin Skin Test Results in Infants and Children|Unknown status|Not yet recruiting|N/A|60||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:39:12.398543|2017-02-18 16:39:12.398543
NCT00309660|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2006-09-20|||November 2005||2005-11-01|September 2006|2006-09-01|June 2007||2007-06-01|||||Interventional|||Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis||Unknown status|Recruiting|Phase 1/Phase 2|20||Herlev Hospital|||||f||||||||||||||2017-02-18 16:39:12.493416|2017-02-18 16:39:12.493416
NCT00309647|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2014-09-08|||March 2006||2006-03-01|November 2012|2012-11-01||||||||Interventional|||Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years|A Partially-blind Multi-centric Study in Adults Aged Between 18-60 Yrs Designed to Evaluate the Reactogenicity & Immunogenicity of 1 & 2 Doses of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) Administered at Different Doses & Adjuvanted or Not|Completed||Phase 1|400||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:39:12.587033|2017-02-18 16:39:12.587033
NCT00309634|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2016-09-27|||March 2006||2006-03-01|September 2016|2016-09-01|October 2006|Actual|2006-10-01|||||Interventional|||Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years|Observer-blind Monocentric Study in Adults Aged Between 18-60 Years to Evaluate Reactogenicity and Immunogenicity of 1 and 2 Administrations of Pandemic Monovalent Influenza Vaccines Administered at Different Antigen Doses and Adjuvanted or Not|Completed||Phase 1|400||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:39:12.703706|2017-02-18 16:39:12.703706
NCT00309621|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2010-07-16|||April 2006||2006-04-01|July 2010|2010-07-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis|Safety and Efficacy of Alitretinoin in the Treatment of Severe Refractory Chronic Hand Dermatitis|Completed||Phase 3|250||Basilea Pharmaceutica|||||f||||||||||||||2017-02-18 16:39:13.040217|2017-02-18 16:39:13.040217
NCT00309608|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2014-06-24|2011-05-13||April 2006||2006-04-01|December 2013|2013-12-01||||August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes|A Randomised, Double-blind, Placebo-controlled, Five Parallel Groups Study Investigating the Efficacy and Safety of BI 1356 BS (1 mg, 5 mg and 10 mg Administered Orally Once Daily) Over 12 Weeks as add-on Therapy in Patients With Type 2 Diabetes and Insufficient Glycaemic Control Despite Metformin Therapy, Including an Open-label Glimepiride Treatment Arm.|Completed||Phase 2|333|Actual|Boehringer Ingelheim||5|||f||||||||||||||2017-02-18 16:39:13.190958|2017-02-18 16:39:13.190958
NCT00309595|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2009-06-10|||December 2005||2005-12-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|SIT-UP||The Study to Compare SMART Nitinol Stent and Balloon Angioplasty|A Multi-Center Prospective, Randomized, Two-Arm Clinical Investigation of the Cordis SMARTTM Nitinol Self Expandable Stent Versus Balloon Angioplasty Only for the Treatment of Superficial Femoral Artery Occlusions.|Completed||Phase 4|50|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 16:39:14.062879|2017-02-18 16:39:14.062879
NCT00309582|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2006-03-30||||||November 2005|2005-11-01||||||||Observational|||Nevirapine Levels and Fluconazole|Plasma Nevirapine Levels and Adverse Events Among HIV-Infected Patients Concurrently Receiving Nevirapine-Based Antiretroviral Therapy and Fluconazole|Completed||N/A|||Bamrasnaradura Infectious Diseases Institute|||||f||||||||||||||2017-02-18 16:39:14.180335|2017-02-18 16:39:14.180335
NCT00309569|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-03-31|||October 1991||1991-10-01|October 1999|1999-10-01||||||||Interventional|||Randomized Study Comparing Pre- and Postoperative Vs. Conventional Adjuvant Treatment in Receptor-Negative Patients|A Randomized Phase III Study Comparing Pre- and Postoperative Vs. Conventional Adjuvant Treatment Hormone Receptor-Negative Breast Cancer Patients|Completed||Phase 3|480||Austrian Breast & Colorectal Cancer Study Group|||||f||||||||||||||2017-02-18 16:39:14.247715|2017-02-18 16:39:14.247715
NCT00309556|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2011-12-29|||February 2005||2005-02-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|November 2009|Actual|2009-11-01||Interventional|||Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer|A Randomized Phase III Study Comparing Epirubicin, Docetaxel and Capecitabine + G-CSF to Epirubicin and Docetaxel + G-CSF as Neoadjuvant Treatment for Early HER-2 Negative Breast Cancer and Comparing Epirubicin, Docetaxel and Capecitabine + G-CSF ± Trastuzumab to Epirubicin and Docetaxel + G-CSF ± Trastuzumab as Neoadjuvant Treatment for Early HER-2 Positive Breast Cancer|Completed||Phase 3|536|Actual|Austrian Breast & Colorectal Cancer Study Group||2|||f||||f||||||||||2017-02-18 16:39:14.352165|2017-02-18 16:39:14.352165
NCT00309543|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-03-31|||November 1993||1993-11-01|March 2006|2006-03-01||||||||Interventional|||Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B|A Prospectively Randomized Study on Adjuvant Chemotherapy in Patients With Operated Colon Carcinoma Dukes B (Stage II; T3-4, N0, M0).|Completed||Phase 3|636||Austrian Breast & Colorectal Cancer Study Group|||||f||||||||||||||2017-02-18 16:39:14.501482|2017-02-18 16:39:14.501482
NCT00309517|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-03-31|||July 1997||1997-07-01|October 2000|2000-10-01||||||||Interventional|||Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C|A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C (pT2, pN1-3; pT3-4, pN0-3; M0.|Terminated||Phase 3|700||Austrian Breast & Colorectal Cancer Study Group|||||f||||||||||||||2017-02-18 16:39:14.709606|2017-02-18 16:39:14.709606
NCT00309504|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2016-02-24|||March 2006||2006-03-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy|Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy|Completed||N/A|40|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 16:39:15.053835|2017-02-18 16:39:15.053835
NCT00309491|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2016-04-08|||December 1990||1990-12-01|April 2016|2016-04-01||||||||Interventional|||Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients|A Randomized Phase III Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal, Hormone Receptor-positive Patients|Completed||Phase 3|2020|Actual|Austrian Breast & Colorectal Cancer Study Group||2|||f||||f||||||||Undecided||2017-02-18 16:39:15.138535|2017-02-18 16:39:15.138535
NCT00309478|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-31|2006-05-18|||December 1990||1990-12-01|June 1999|1999-06-01||||||||Interventional|||Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-Positive Patients|A Randomized Phase III Study Comparing Cyclophosphamide + Methotrexate + Fluorouracil Vs. Goserelin + Tamoxifen in Premenopausal, Hormone Receptor-Positive, Lymph Node-Positive or -Negative Patients|Completed||Phase 3|1099||Austrian Breast & Colorectal Cancer Study Group|||||f||||||||||||||2017-02-18 16:39:15.249325|2017-02-18 16:39:15.249325
NCT00309465|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2012-11-01|2012-10-01||October 2005||2005-10-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Perioperative Insulin Glargine Dosing Study|A Study of the Relationship Between the Proportional Insulin Glargine Evening Dose and the Perioperative Serum Glucose Values in Patients With Diabetes Undergoing Surgery|Completed||Phase 4|402|Actual|William Beaumont Hospitals|Limitations include use of point-of-care glucometers, which are less precise than central laboratory testing; estimated 75% power in the insulin glargine only group; and varying fasting lengths, usual glycemic control and surgery starting times.|3|||f||||f||||||||||2017-02-18 16:39:15.341171|2017-02-18 16:39:15.341171
NCT00309452|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-12-12|2016-05-25||March 2006||2006-03-01|December 2016|2016-12-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|STEP||Specialized Treatment Early in Psychosis (STEP)|Randomized Trial of Usual Care Versus Specialized, Phase-specific Care in the Public Sector for First Episode Psychosis.|Completed||N/A|120|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:39:16.304478|2017-02-18 16:39:16.304478
NCT00309439|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2012-06-12||||||June 2012|2012-06-01||||||||Interventional|||ALA and Prostate Cancer|Studies of Serum PSA to Help Resolve the Current Implication of Alpha-linolenic Acid (ALA) and Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|||University of Toronto|||||f||||||||||||||2017-02-18 16:39:16.952836|2017-02-18 16:39:16.952836
NCT00309426|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-05-18|||March 2001||2001-03-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Observational|||Effect of Fetuin A in Hemodialysis Patients|The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients|Unknown status|Active, not recruiting|N/A|300||University of Shizuoka|||||f||||||||||||||2017-02-18 16:39:17.033375|2017-02-18 16:39:17.033375
NCT00309413|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2008-07-23|||March 2006||2006-03-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|March 2008|Actual|2008-03-01||Interventional|||A Clinical Trial on the Antipsychotic Properties of Cannabidiol|A Placebo-Controlled Randomized Cross-Over Clinical Trial on the Antipsychotic Properties of the Endocannabinoid Modulator Cannabidiol|Completed||Phase 2|29|Actual|University of Cologne||2|||f||||f||||||||||2017-02-18 16:39:17.117898|2017-02-18 16:39:17.117898
NCT00309400|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2014-08-19|||January 2006||2006-01-01|August 2014|2014-08-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Observational|||The Early History of Universal Screening for Metabolic Disorders|The Early History of Universal Screening for Metabolic Disorders|Completed||N/A|10|Actual|University of Miami|||1||f||||f||||||||||2017-02-18 16:39:17.229308|2017-02-18 16:39:17.229308
NCT00309387|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2013-04-30|2012-03-28||May 1995||1995-05-01|April 2013|2013-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|CTNS||Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)|Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)|Completed||Phase 3|1020|Actual|National Eye Institute (NEI)||2|||f||||t||||||||||2017-02-18 16:39:17.330272|2017-02-18 16:39:17.330272
NCT00309374|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2007-01-04|||March 2006||2006-03-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Anti-Inflammatory Effect of Statins in the Human Endotoxin Model|Anti-Inflammatory Effect of Statins in the Human Endotoxin Model|Completed||Phase 1|6||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:39:17.836375|2017-02-18 16:39:17.836375
NCT00309361|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2006-11-16|||February 2006||2006-02-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular Procedures|A Phase 3, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Efficacy, Pharmacodynamics and Safety in Dental Patients Undergoing Mandibular Procedures|Completed||Phase 3|240||Novalar Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:39:17.942282|2017-02-18 16:39:17.942282
NCT00309348|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2010-03-02|||February 2006||2006-02-01|March 2010|2010-03-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Ultrasound Instrument to Prevent Dialysis Graft Failure|New Doppler Instrument for Preventing Impending Access-Graft Failure Randomized Trial|Unknown status|Active, not recruiting|Phase 2/Phase 3|220|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||||||||||||2017-02-18 16:39:18.037121|2017-02-18 16:39:18.037121
NCT00309335|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2006-11-16|||February 2006||2006-02-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures|A Phase 3, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Efficacy, Pharmacodynamics and Safety in Dental Patients Undergoing Maxillary Procedures|Completed||Phase 3|240||Novalar Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:39:18.119086|2017-02-18 16:39:18.119086
NCT00309322|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2006-11-16|||March 2006||2006-03-01|November 2006|2006-11-01|August 2006||2006-08-01|||||Interventional|||Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Procedures|A Phase 2, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Mandibular and Maxillary Procedures|Completed||Phase 2|150||Novalar Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:39:18.198771|2017-02-18 16:39:18.198771
NCT00309309|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2007-07-02|||April 2005||2005-04-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant|A Prospective, Longitudinal Study to Assess the Metabolic and Renal Effects of Rosiglitazone in Albuminuric Kidney Transplant Recipients|Completed||Phase 2|10|Actual|Mario Negri Institute for Pharmacological Research|||||f||||f||||||||||2017-02-18 16:39:18.285699|2017-02-18 16:39:18.285699
NCT00309296|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2011-02-11|||November 2005||2005-11-01|February 2011|2011-02-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Longitudinal Care: Smoking Reduction to Aid Cessation|Longitudinal Care: Smoking Reduction to Aid Cessation; Part of Hatsukami's Tobacco Exposure Reduction|Completed||N/A|443|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-02-18 16:39:18.3731|2017-02-18 16:39:18.3731
NCT00309283|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2013-04-23|||April 2006||2006-04-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|ALADIN||Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study|Effect of a Long-acting Somatostatin on Disease Progression in Nephropathy Due to Autosomal Dominant Polycystic Kidney Disease: a Long-term Three Year Follow up Study|Completed||Phase 3|78|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-02-18 16:39:18.479608|2017-02-18 16:39:18.479608
NCT00309270|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2006-05-18|||February 2003||2003-02-01|March 2006|2006-03-01|April 2010||2010-04-01|||||Interventional|||Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation|A Prospective, Randomized Study to Compare the Effect of Campath-1,Low Dose Sirolimus Versus Campath-1H, Low Dose CsA Both in Addition to Low Dose Mycophenolate Mofetil on Phenotypic and Functional Profiles of PBMCs in Kidney Transplant Recipients in a Steroid-Free Regimen|Completed||Phase 2|21||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-02-18 16:39:18.590564|2017-02-18 16:39:18.590564
NCT00309257|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2009-10-05|||January 2004||2004-01-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|June 2008|Actual|2008-06-01||Interventional|||Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome|Effects of an Intensified Treatment With ACE-inhibitors, Angiotensin II Receptor Antagonists and Statins in Alport Syndrome|Completed||Phase 2|9|Actual|Mario Negri Institute for Pharmacological Research||1|||f||||f||||||||||2017-02-18 16:39:18.677105|2017-02-18 16:39:18.677105
NCT00309244|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2014-10-09|2014-07-22||February 2006||2006-02-01|October 2014|2014-10-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional||Safety population (23 Subjects randomized but never dosed are not included).|Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up|A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere /Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up|Completed||Phase 3|677|Actual|Mannkind Corporation||2|||f||||||||||||||2017-02-18 16:39:18.785531|2017-02-18 16:39:18.785531
NCT00309231|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2010-06-08||||||June 2010|2010-06-01|January 2008||2008-01-01|||||Observational|||Clinical Islet Transplantation Using the Edmonton Protocol|Clinical Islet Transplantation Using the Edmonton Protocol|Withdrawn||Phase 3|8|Anticipated|Lawson Health Research Institute|||1|no funding|f||||f||||||||||2017-02-18 16:39:19.91179|2017-02-18 16:39:19.91179
NCT00309218|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2015-04-22|||March 1999||1999-03-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)|Multicenter, Open-label, Randomized Study on Steroid-free Immunosuppression, in Comparison With Daily Steroid Therapy, in Children With Stable Renal Transplant Function Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)|Completed||Phase 3|42|Actual|Klinik für Kinder- und Jugendmedizin||2|||f||||t||||||||||2017-02-18 16:39:20.001066|2017-02-18 16:39:20.001066
NCT00309205|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2009-08-31|||December 2005||2005-12-01|August 2009|2009-08-01||||||||Interventional|||A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium|A Phase I/II Single-Centre Double-Blinded Randomized Study of the Safety and Tolerability of TMC120 Vaginal Microbicide Gel vs. HEC-Based Universal Placebo Gel in Healthy HIV-Negative Women.|Completed||Phase 1/Phase 2|36||International Partnership for Microbicides, Inc.|||||f||||||||||||||2017-02-18 16:39:20.108737|2017-02-18 16:39:20.108737
NCT00309192|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2006-09-13|||April 2006||2006-04-01|September 2006|2006-09-01|April 2008||2008-04-01|||||Interventional|||Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema|Efficacy and Safety of Intravitreal Triamcinolone as Treatment of the Diffuse Diabetic Macular Edema|Unknown status|Recruiting|Phase 3|292||Instituto Universitario de Oftalmobiología Aplicada|||||f||||||||||||||2017-02-18 16:39:20.194749|2017-02-18 16:39:20.194749
NCT00309179|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-08-09||2016-04-11|September 2007||2007-09-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|December 2009|Actual|2009-12-01||Interventional|||A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors|A Single Arm Phase II Study of the Efficacy, Safety, and Biomarkers of Activity of E7820 Plus Cetuximab in Advanced Solid Tumors Preceded by a Run-In Study to Determine Safety of the Combination|Active, not recruiting||Phase 2|41|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 16:39:20.296546|2017-02-18 16:39:20.296546
NCT00309166|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2016-09-08|||April 2006||2006-04-01|September 2016|2016-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.|An Observer-blind, Randomized, Controlled Study to Assess the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine Administered Intramuscularly According to a 0, 1, 6 Month Schedule in Healthy Male Subjects Aged 10-18 Years|Completed||Phase 2|270|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:39:20.397341|2017-02-18 16:39:20.397341
NCT00309140|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2010-05-27||2010-05-27|March 2006||2006-03-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||An Open Label Study of Oral Enzastaurin in Patients With Cancer|An Open-Label Study of Oral Enzastaurin HCl in Patients With Advanced or Metastatic Malignancies|Completed||Phase 2|23|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:39:20.490364|2017-02-18 16:39:20.490364
NCT00295074|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2008-02-07|||October 2004||2004-10-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|||||Interventional|||The Effect of Mild Traumatic Brain Injury on Recovery From Injury|The Effect of Mild Traumatic Brain Injury on Recovery From Injury|Completed||N/A|800|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 16:44:19.712941|2017-02-18 16:44:19.712941
NCT00309127|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2015-08-21|||May 2003||2003-05-01|August 2015|2015-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy|A Multicentre, Randomised Study to Examine the Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy|Completed||N/A|205|Actual|Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 16:39:20.598782|2017-02-18 16:39:20.598782
NCT00309114|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2010-11-30|||February 2004||2004-02-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)|Prevention of UTI in Persons With Spinal Cord Injury|Completed||Phase 2|160|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 16:39:20.691919|2017-02-18 16:39:20.691919
NCT00309101|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2009-06-02|||February 2006||2006-02-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||An Open Study for Steroid Resistant, Non-Thymectomized MG Patients|FK506 Phase 3 Study: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients|Completed||Phase 3|11|Actual|Astellas Pharma Inc||1|||f||||||||||||||2017-02-18 16:39:20.791794|2017-02-18 16:39:20.791794
NCT00309088|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2014-08-22|||April 2006||2006-04-01|August 2014|2014-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients|FK506 Phase 3 Study: a Double Blind Placebo Controlled Study for Steroid Non-Resistant Myasthenia Gravis Patients|Completed||Phase 3|80|Actual|Astellas Pharma Inc||2|||f||||||||||||||2017-02-18 16:39:20.896595|2017-02-18 16:39:20.896595
NCT00309075|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2014-12-29|||December 2003||2003-12-01|December 2014|2014-12-01|November 2004|Actual|2004-11-01|||||Interventional|||Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries|Multicenter, Open-label Study of the Safety (Open-label) and Efficacy (Open-label and Blinded Reader) of a Single Administration of Approximately 0.1 mmol/kg of Magnevist® Injection-enhanced Magnetic Resonance Arteriography (MRA) and 2-dimensional-time-of-flight (2D-TOF) MRA in Patients With Known or Suspected Disease of the Calf and/or Pedal Arteries Undergoing MRA of the Calf and Pedal Arteries With Intra-arterial Digital Subtraction Arteriography (i.a. DSA) as the Standard of Reference.|Completed||Phase 3|126|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:39:21.025885|2017-02-18 16:39:21.025885
NCT00309062|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2013-03-08|||December 2003||2003-12-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis|A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Immunotherapy With an Aluminium Hydroxide-adsorbed Recombinant Hypoallergenic Derivative of the Major Birch Pollen Allergen, Bet v 1|Completed||Phase 3|||Allergopharma GmbH & Co. KG|||||f||||f||||||||||2017-02-18 16:39:21.133502|2017-02-18 16:39:21.133502
NCT00309049|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2017-01-27|||April 2006||2006-04-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Ixabepilone Administered as an Enteric Coated Formulation.|An Exploratory Study of Ixabepilone Administered as an Enteric Coated Formulation in Patients With Advanced Cancer.|Completed||Phase 1/Phase 2|30||R-Pharm||3|||f||||||||||||||2017-02-18 16:39:21.220179|2017-02-18 16:39:21.220179
NCT00309036|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-30|2013-03-08|||January 2004||2004-01-01|March 2013|2013-03-01|May 2008|Actual|2008-05-01|September 2006|Actual|2006-09-01||Interventional|||Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis|A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Immunotherapy With an Aluminium Hydroxide-adsorbed Cocktail of Recombinant Derivatives of Major Allergens of Timothy Grass (Phleum Pratense).|Completed||Phase 3|||Allergopharma GmbH & Co. KG|||||f||||||||||||||2017-02-18 16:39:21.318889|2017-02-18 16:39:21.318889
NCT00309023|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2015-09-23||2010-09-10|December 2005||2005-12-01|September 2015|2015-09-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Interventional|||Study of BMS-663513 in Patients With Advanced Cancer|A Phase I/II, Ascending Multi-Dose Study of BMS-663513, An Agonistic Anti-CD137 Monoclonal Antibody, Administered Every Three Weeks to Patients With Metastatic or Locally Advanced Solid Malignancies|Terminated||Phase 1/Phase 2|115|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:39:21.401916|2017-02-18 16:39:21.401916
NCT00309010|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2017-01-24|||March 28, 2006||2006-03-28|February 24, 2009|2009-02-24|February 24, 2009||2009-02-24|||||Observational|||Neurophysiology of Task-Specificity of Focal Hand Dystonia|Neurophysiology of Task-Specificity of Focal Hand Dystonia|Completed||N/A|115||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:39:21.511515|2017-02-18 16:39:21.511515
NCT00308997|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2012-12-13|2012-11-14||February 2006||2006-02-01|December 2012|2012-12-01|April 2012|Actual|2012-04-01|September 2011|Actual|2011-09-01||Interventional|||"Transcranial Magnetic Stimulation for Voices"|"Transcranial Magnetic Stimulation Guided by Neuroimaging for Patients With Persistent Voices"|Completed||Phase 2|85|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:39:21.603476|2017-02-18 16:39:21.603476
NCT00308984|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2012-03-06|||January 2006||2006-01-01|March 2012|2012-03-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Observational|||CARE--Childhood Awareness and Recall Evaluation|Multi-Center Study on the Incidence of Intra-operative Awareness and Recall in the Pediatric Population Undergoing General Anesthesia: CARE--Childhood Awareness and Recall Evaluation|Completed||Phase 4|1784|Actual|Medtronic - MITG|||1||f||||f||||||||||2017-02-18 16:39:22.004795|2017-02-18 16:39:22.004795
NCT00308971|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2009-07-08|||March 2006||2006-03-01|July 2009|2009-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)|Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)|Completed||Phase 2|62|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 16:39:22.087744|2017-02-18 16:39:22.087744
NCT00308958|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2013-05-28|||February 2006||2006-02-01|May 2013|2013-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic Fibrosis|Comparison of Airway Clearance Efficacy of Sine Wave and Triangular Wave High Frequency Chest Wall Oscillation (HFCWO) Devices in Patients With Cystic Fibrosis|Completed||N/A|15||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 16:39:22.188801|2017-02-18 16:39:22.188801
NCT00308178|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2013-02-15|||March 2006||2006-03-01|February 2013|2013-02-01|June 2008|Actual|2008-06-01|September 2006|Actual|2006-09-01||Interventional|||Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer|Dose Dense AB1-007 (Abraxane) in Adjuvant Chemotherapy for Breast Cancer: A Feasibility Study|Completed||N/A|66|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:39:38.47546|2017-02-18 16:39:38.47546
NCT00308945|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2008-01-14|||November 2003||2003-11-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients|Influence of Travoprost 0.004% and Latanoprost 0.005% on Retinal Vascular Diameter and Choroidal Blood Flow in Glaucoma Patients|Completed||Phase 4|20|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 16:39:22.280952|2017-02-18 16:39:22.280952
NCT00308932|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2011-09-16|||February 2003||2003-02-01|August 2004|2004-08-01|April 2004||2004-04-01|||||Interventional|||Effect of Age and Device on Delivery of Fluticasone|Relative Amount of Fluticasone Delivered by HFA-MDI Through Chamber/Mask to Young Children With Asthma|Completed||Phase 4|60||University of Florida|||||||||||||||||||2017-02-18 16:39:22.381474|2017-02-18 16:39:22.381474
NCT00308919|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2010-06-18|||April 2004||2004-04-01|May 2010|2010-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation Therapy|Phase II Study of Photodynamic Therapy With WST-09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure : Effect of the Light Dose and the Number of Fibres|Completed||Phase 2|28|Actual|STEBA France||1|||f||||||||||||||2017-02-18 16:39:22.472726|2017-02-18 16:39:22.472726
NCT00308906|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2016-01-30|||June 2006||2006-06-01|January 2016|2016-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children|Assessment of Gene and Urinary Protein Expression in Aminoglycoside-treated and Untreated Infants, Children and Adolescents|Completed||N/A|166|Actual|Virginia Commonwealth University|||3||f||||f||||||Samples With DNA|"~     Waste blood samples will be collected in order to evaluate potential genetic mechanisms of~     aminoglyoside induced renal injury. Waste urine samples will be collected in order to~     evaluate candidate protein biomarkers of aminoglycoside induced renal injury.~   "|||2017-02-18 16:39:22.5746|2017-02-18 16:39:22.5746
NCT00308893|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2013-12-17|||July 2006||2006-07-01|December 2013|2013-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||BDNF Gene Polymorphism and Antidepressants Treatment|Brain Derived Neurotrophic Factor (BDNF) Gene Polymorphism and Response to Antidepressants Treatment in Major Depression|Completed||Phase 4|188|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-02-18 16:39:22.905127|2017-02-18 16:39:22.905127
NCT00308880|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2006-03-29|||March 2006||2006-03-01|March 2006|2006-03-01|March 2007||2007-03-01|||||Interventional|||Tranexamic Acid and Head and Neck Surgery Patients|If Tranexamic Acid Could Reduce the Duration of Drainage Tube Placement ? —A Prospective Randomized Study in Head and Neck Surgery Patients|Unknown status|Recruiting|Phase 3|80||Taichung Veterans General Hospital|||||f||||||||||||||2017-02-18 16:39:23.019615|2017-02-18 16:39:23.019615
NCT00308867|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2008-04-10|||March 2006||2006-03-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK|Photodynamic Therapy With PD P 506 A or Its Placebo Compared With Cryosurgery for the Treatment of Mild to Moderate Actinic Keratosis|Completed||Phase 3|349|Actual|photonamic GmbH & Co. KG||3|||f||||f||||||||||2017-02-18 16:39:23.118098|2017-02-18 16:39:23.118098
NCT00308854|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2008-04-10|||March 2006||2006-03-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK|PD P 506 A or Its Placebo in Combination With Red Light for Photodynamic Therapy of Mild to Moderate Actinic Keratosis|Completed||Phase 3|107|Actual|photonamic GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 16:39:23.246685|2017-02-18 16:39:23.246685
NCT00308841|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2008-10-17||||||September 2005|2005-09-01||||||||Interventional|||"Anesthetic Efficacy of Intrauterine Lidocaine for Removal of a Lost Intrauterine Device"||Completed||Phase 1|||Suleyman Demirel University|||||f||||||||||||||2017-02-18 16:39:23.359743|2017-02-18 16:39:23.359743
NCT00308828|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2008-06-05|||January 2005||2005-01-01|June 2008|2008-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||The Prevalence of Osteoporosis in Hemodialysis Patients|Prevalence of Osteoporosis in Hemodialysis Patients and Relevance With Renal Bone Disease|Completed||Phase 4|166|Actual|Papageorgiou General Hospital|||1||f||||||||||||||2017-02-18 16:39:23.446975|2017-02-18 16:39:23.446975
NCT00308815|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2006-03-28|||January 2005||2005-01-01|October 2004|2004-10-01||||||||Interventional|||Comparison of Manual Cardiopulmonary Resuscitation (CPR) Versus Automatic CPR Machine During Ambulance Transport.|Comparison of Manual Cardiopulmonary Resuscitation (CPR) Versus Automatic CPR Machine on the CPR Performance for Out-of-Hospital Cardiac Arrest During Ambulance Transport.|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:39:23.522202|2017-02-18 16:39:23.522202
NCT00308802|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2013-08-29|||March 2006||2006-03-01|August 2013|2013-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients|Noninvasive Monitoring to Predict Outcome in De Novo Kidney Transplant Recipients|Completed||N/A|280|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"~     Blood samples may be retained~   "|||2017-02-18 16:39:23.611098|2017-02-18 16:39:23.611098
NCT00308789|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2009-05-04|||April 2006||2006-04-01|May 2009|2009-05-01|December 2009|Anticipated|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||A Trial of Infant Flow Biphasic Nasal Continuous Airway Pressure (NCPAP) Versus Infant Flow NCPAP for the Facilitation of Extubation in Infants </= 1250 Grams|Infant Flow Biphasic NCPAP Versus Infant Flow NCPAP for the Facilitation of Successful Extubation in Infants </= 1250 Grams: A Randomized Controlled Trial|Terminated||Phase 2|136|Actual|Mount Sinai Hospital, Canada||2||Poor enrollment|f||||f||||||||||2017-02-18 16:39:23.724896|2017-02-18 16:39:23.724896
NCT00308776|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2012-05-25|||October 2003||2003-10-01|May 2012|2012-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa|Effect of Cholecystokinin on Binge Eating in Bulimia Nervosa|Terminated||N/A|6|Actual|New York State Psychiatric Institute||2||Unable to recruit subjects|f||||f||||||||||2017-02-18 16:39:23.835355|2017-02-18 16:39:23.835355
NCT00308763|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2014-05-20|||January 2004||2004-01-01|May 2014|2014-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals|Clinical Trial of Two Medications on Smoking Cessation|Completed||N/A|594|Actual|University of Tennessee||3|||f||||t||||||||||2017-02-18 16:39:23.946056|2017-02-18 16:39:23.946056
NCT00005493|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||April 1998||1998-04-01|August 2004|2004-08-01|March 2001|Actual|2001-03-01|||||Observational|||Observational Aspirin Use and CVD in the Physicians' Health Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.745156|2017-02-18 18:14:54.745156
NCT00308750|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2010-05-27||2010-05-27|March 2006||2006-03-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||First Line Chemotherapy Treatment of Advanced NSCLC|A Randomized, Open-label Phase II Study of Pemetrexed (Alimta) Plus Carboplatin With or Without Enzastaurin Hydrochloride, or Docetaxel Plus Carboplatin as First Line Treatment in Patients With Advanced Stage Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|217|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 16:39:24.063944|2017-02-18 16:39:24.063944
NCT00308737|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2014-10-09|2014-07-22||June 2005||2005-06-01|October 2014|2014-10-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional||Safety population, excluding subjects who were not dosed with study medication (17 diabetics randomized but not dosed, 1 non-diabetic elected not to participate)|Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes|Pulmonary Outcomes Within a 2-Year Period in Subjects With Diabetes Mellitus Treated With Technosphere /Insulin or Usual Antidiabetic Treatment and in Subjects Without Abnormalities in Glucose Control.|Completed||Phase 3|2053|Actual|Mannkind Corporation||3|||f||||||||||||||2017-02-18 16:39:24.20085|2017-02-18 16:39:24.20085
NCT00308724|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2015-07-21|||March 2004||2004-03-01|January 2015|2015-01-01|April 2015|Actual|2015-04-01|January 2008|Actual|2008-01-01||Interventional|||Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care|Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care|Completed||Phase 3|148|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 16:39:25.681193|2017-02-18 16:39:25.681193
NCT00308711|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2012-06-15|2009-07-29||April 2006||2006-04-01|June 2012|2012-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor|A Multi-center, Randomized, Double-blind Phase III Study of the Efficacy and Safety of the Misoprostol Vaginal Insert Compared to Cervidil for Women Requiring Cervical Ripening and Induction of Labor (The MVP Study).|Completed||Phase 3|1308|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-02-18 16:39:25.79888|2017-02-18 16:39:25.79888
NCT00308698|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2006-03-29||||||July 2004|2004-07-01||||||||Observational|||Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning Hemodialysis (HD)|Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis|Completed||N/A|||Hamamatsu University|||||f||||||||||||||2017-02-18 16:39:29.620035|2017-02-18 16:39:29.620035
NCT00308685|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2015-10-29||2013-08-27|July 2007||2007-07-01|October 2015|2015-10-01||||July 2008|Actual|2008-07-01||Interventional|||Chronic-dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics||Completed||Phase 3|100|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 16:39:29.691792|2017-02-18 16:39:29.691792
NCT00308672|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2006-03-29|||August 2005||2005-08-01|March 2006|2006-03-01|July 2006||2006-07-01|||||Observational|||The Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban City|The Study for the Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban City- Comparison of Agreement for Prevalence of Metabolic Syndrome Among the WHO, NCEP ATP III and Taiwan Definitions|Unknown status|Recruiting|N/A|3000||China Medical University Hospital|||||f||||||||||||||2017-02-18 16:39:30.066396|2017-02-18 16:39:30.066396
NCT00308659|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2006-03-28|||March 2006||2006-03-01|March 2006|2006-03-01||||||||Interventional|||Study to Evaluate Two Diagnostic Strategies for the Treatment of Severe Community Acquired Pneumonia (SCAP)|Diagnostic Strategy Evaluation Study of Two Diagnostic Strategies for the Treatment of SCAP : Noninvasive Strategy and Semiinvasive Strategy Including FOB Distal Samplings|Unknown status|Recruiting|N/A|||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:39:30.149865|2017-02-18 16:39:30.149865
NCT00308646|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-29|2006-03-29|||October 2004||2004-10-01|March 2006|2006-03-01|July 2005||2005-07-01|||||Observational|||Instrument Development of Screening Prediabetes Patients|Instrument Development of Screening Prediabetes Patients|Terminated||N/A|3000||China Medical University Hospital|||||f||||||||||||||2017-02-18 16:39:30.230803|2017-02-18 16:39:30.230803
NCT00308633|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2017-01-24|||March 23, 2006||2006-03-23|October 30, 2009|2009-10-30||||December 28, 2007|Actual|2007-12-28||Observational|||Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants|Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:39:30.297245|2017-02-18 16:39:30.297245
NCT00308620|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2012-07-09|2011-09-26||March 2006||2006-03-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine|A Randomized, Pilot Study of the Anti-Viral and Anti-Inflammatory Effects of Chloroquine in Early HIV Infection|Terminated||Phase 2/Phase 3|13|Actual|University of Minnesota - Clinical and Translational Science Institute||2||Insufficient financial support; lack of efficacy for primary endpoint|f||||f||||||||||2017-02-18 16:39:30.388577|2017-02-18 16:39:30.388577
NCT00308607|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2009-04-02|||August 2005||2005-08-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma|Bevacizumab, Dacarbazine and Interferon Alfa-2a Combination as a First-Line Therapy in Patients With Locally Advancing or Metastatic Melanoma|Completed||Phase 2|27|Actual|University of Turku||1|||f||||f||||||||||2017-02-18 16:39:30.882988|2017-02-18 16:39:30.882988
NCT00308594|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2011-04-27|||November 2006||2006-11-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Oral Dexamethasone for the Treatment of Cervical Radiculopathy|Oral Dexamethasone for the Treatment of Cervical Radiculopathy: A Double Blinded, Randomized, Placebo Controlled Trial|Terminated||Phase 2|100||University of Manitoba||||Study terminated due to withdrawl of participating co-investigators.|f||||f||||||||||2017-02-18 16:39:30.987134|2017-02-18 16:39:30.987134
NCT00308581|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2011-08-30|2009-07-07||April 2006||2006-04-01|April 2011|2011-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab|Phase IIIb Open-label Induction and Double-blind Comparison of 2 Maintenance Schedules Evaluating Clinical Benefit and Tolerability of Certolizumab Pegol in Crohn's Disease Patients With Prior Loss of Response or Intolerance to Infliximab|Completed||Phase 3|539|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 16:39:31.137487|2017-02-18 16:39:31.137487
NCT00308568|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2014-04-28|||February 2006||2006-02-01|April 2014|2014-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||RCT of Mailed Brochure to Boost Adherence to Screening Colonoscopy|Randomized Controlled Trial of a Mailed Brochure to Increase Adherence to Referrals for Screening Colonoscopy|Completed||N/A|628||University of Colorado, Denver|||||f||||||||||||||2017-02-18 16:39:33.276195|2017-02-18 16:39:33.276195
NCT00308555|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2016-10-26|2013-05-23||May 2006||2006-05-01|October 2016|2016-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Opioid and Cannabinoid Pharmacokinetic Interactions|Opioid and Cannabinoid Pharmacokinetic Interactions: A Pilot Study|Completed||Phase 1|24|Actual|University of California, San Francisco|Small number of participants, powered to detect a 25% change in AUC(12).Further research is needed to determine how cannabis delivery systems other than vapor affect metabolism of opioids and other drugs.|1|||f||||||||||||||2017-02-18 16:39:33.361786|2017-02-18 16:39:33.361786
NCT00308542|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2012-02-09||||||February 2012|2012-02-01||||||||Interventional|||A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema||Completed||Phase 1/Phase 2|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 16:39:33.765814|2017-02-18 16:39:33.765814
NCT00308529|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2010-06-18|||March 2006||2006-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|April 2007|Actual|2007-04-01||Interventional|||Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer|Phase II Study of Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Patients With Limited Stage Small Cell Lung Cancer|Completed||Phase 2|55||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 16:39:33.856256|2017-02-18 16:39:33.856256
NCT00308516|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2013-05-14|2013-03-26||March 2006||2006-03-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|April 2009|Actual|2009-04-01||Interventional|||5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer|A Phase II Study of 5-Fluorouracil, Bevacizumab (Avastin), and Radiation in the Preoperative or Adjuvant Treatment of Patients With Stage II / III Rectal Cancer|Completed||Phase 2|66|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 16:39:33.972565|2017-02-18 16:39:33.972565
NCT00308503|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2010-11-29|||February 2006||2006-02-01|November 2010|2010-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|EPOCH||Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia|Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: A 6 Week, Multicenter, Randomized, Double -Blind, Placebo-controlled Study|Completed||Phase 3|608|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:39:34.733797|2017-02-18 16:39:34.733797
NCT00308490|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2007-03-12|||September 2005||2005-09-01|September 2006|2006-09-01|January 2007||2007-01-01|||||Interventional|||Changes in Iron Markers Following Iron Loading in Hemodialysis Patients|Phase IV Study of Iron Indices' Kinetics in Hemodialysis Patients|Completed||Phase 4|160||Papageorgiou General Hospital|||||f||||||||||||||2017-02-18 16:39:34.840251|2017-02-18 16:39:34.840251
NCT00308477|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2012-02-09||||||February 2012|2012-02-01||||||||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion||Completed||Phase 1/Phase 2|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 16:39:34.927539|2017-02-18 16:39:34.927539
NCT00308464|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2011-05-17|||July 2006||2006-07-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency|A Double Blind Parallel Group Randomised Multiple Dose Study To Evaluate The Pharmacodynamic Response And Safety Of PHA-794428 In Adult Growth Hormone Deficient Patients|Terminated||Phase 2|136||Pfizer||||See termination reason in detailed description.|f||||||||||||||2017-02-18 16:39:35.020771|2017-02-18 16:39:35.020771
NCT00308451|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-03-27|||November 2003||2003-11-01|March 2006|2006-03-01|April 2004||2004-04-01|||||Interventional|||A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM|”A Randomized, Double Blinded, Placebo Controlled, Parallel Arm, Study to Evaluate the Improvement in Glycemic Control After Daily Administration of Chromium Picolinate and Biotin in Patients With Type 2 Diabetes Mellitus”|Completed||N/A|40||Nutrition 21, Inc.|||||f||||||||||||||2017-02-18 16:39:35.150849|2017-02-18 16:39:35.150849
NCT00308438|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-10|||March 2004||2004-03-01|January 2015|2015-01-01|June 2006|Actual|2006-06-01|November 2005|Actual|2005-11-01||Interventional|||Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008|An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008|Completed||Phase 2|67|Actual|Shire||1|||t||||f||||||||||2017-02-18 16:39:35.241561|2017-02-18 16:39:35.241561
NCT00308425|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2011-01-28|||October 2002||2002-10-01|January 2011|2011-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS|Effect of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Valsartan as Part of Intensified Multi-factorial Intervention Compared to EC-MPS Plus Standard Practice of Care on Development of Transplant Nephropathy in Cadaver Donor Kidney Recipients Given Basiliximab, Cyclosporine Microemulsion (CsA-ME) and Short-term Steroids: a 12-month, Prospective, Randomized, Open-label Multicentre Study (MYTHOS)|Completed||Phase 3|119|Actual|Novartis|||||f||||||||||||||2017-02-18 16:39:35.374762|2017-02-18 16:39:35.374762
NCT00308412|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2010-07-15|||June 2006||2006-06-01|July 2010|2010-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants|Phase 1 Study to Determine the Safety, Infectivity, and Tolerability of Two Doses of Live Attenuated Recombinant Cold Passaged (cp) 45 Parainfluenza Type 3 Virus Vaccine, rHPIV3cp45, Lot PIV3 102A, Delivered as Nose Drops to Infants 6 to 12 Months of Age, and to HPIV3 Seronegative Infants and Children 6 to 36 Months of Age|Completed||Phase 1|45|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 16:39:35.456185|2017-02-18 16:39:35.456185
NCT00308399|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2011-03-22|||November 2005||2005-11-01|March 2011|2011-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.|A Double Blind, Randomized, Placebo-controlled, Single Center, Parallel Group Study to Evaluate the Effects of Itopride (100 mg and 200 mg t.i.d.) on Gastric Motor and Sensory Functions in Healthy Volunteers.|Completed||Phase 2/Phase 3|45|Actual|Mayo Clinic|||||||||||||||||||2017-02-18 16:39:35.569618|2017-02-18 16:39:35.569618
NCT00308386|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2011-02-28|||August 2006||2006-08-01|February 2011|2011-02-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change)|Impact of Nurse Case Management on Diabetes Co-morbidities|Unknown status|Active, not recruiting|Phase 3|820|Anticipated|Milton S. Hershey Medical Center||1|||f||||t||||||||||2017-02-18 16:39:35.651213|2017-02-18 16:39:35.651213
NCT00005492|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1997||1997-08-01|March 2005|2005-03-01|July 2000|Actual|2000-07-01|||||Observational|||Pooled Analysis of NHANES I/II--Race, Gender, and CHD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.818198|2017-02-18 18:14:54.818198
NCT00308373|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2010-01-19|||July 2004||2004-07-01|January 2010|2010-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus|Effects of Elevated Free Fatty Acids on Endogenous Glucose Production in People With and Without Type 2 Diabetes Mellitus|Completed||N/A|73|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:39:35.759171|2017-02-18 16:39:35.759171
NCT00308360|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2006-03-28|||September 1999||1999-09-01|March 2006|2006-03-01|April 2004||2004-04-01|||||Interventional|||Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility|Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility|Completed||Phase 4|46||Nathan Kline Institute for Psychiatric Research|||||f||||||||||||||2017-02-18 16:39:35.862721|2017-02-18 16:39:35.862721
NCT00308347|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2015-02-18|||May 1996||1996-05-01|February 2015|2015-02-01|April 2001|Actual|2001-04-01|February 2001|Actual|2001-02-01||Interventional|||A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes Mellitus and Nephropathy|Completed||Phase 3|1513|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:39:35.973324|2017-02-18 16:39:35.973324
NCT00308334|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2009-06-10|||October 2003||2003-10-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Domperidone on the Nutrient Composition of Preterm Mother's Breast Milk|A Double Blind Placebo Controlled Trial Examining the Effect of Domperidone on the Composition of Breast Milk|Completed||Phase 2/Phase 3|46|Actual|IWK Health Centre||2|||f||||||||||||||2017-02-18 16:39:36.072379|2017-02-18 16:39:36.072379
NCT00308321|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2007-11-28|||September 2003||2003-09-01|November 2007|2007-11-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Long Term Tapering or Standard Steroids for Nephrotic Syndrome|Long Term Tapering or Standard Steroids for Nephrotic Syndrome|Unknown status|Recruiting|Phase 4|50|Anticipated|Institute of Child Health||1|||f||||||||||||||2017-02-18 16:39:36.18041|2017-02-18 16:39:36.18041
NCT00308308|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2014-10-09|2014-07-22||February 2006||2006-02-01|October 2014|2014-10-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional||ITT Population (589 were randomized - 24 Subjects randomized but never dosed)|Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes|A Prospective, Multi-Center, Open-Label, Randomized, Controlled Clinical Trial Comparing the Efficacy and Safety in Subjects With Type 1 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Basal and Prandial Insulin Over a 52-Week Treatment Period and a 4-Week Follow Up|Completed||Phase 3|589|Actual|Mannkind Corporation||2|||f||||||||||||||2017-02-18 16:39:36.382844|2017-02-18 16:39:36.382844
NCT00308295|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2007-10-15|||April 2006||2006-04-01|October 2007|2007-10-01|May 2006||2006-05-01|||||Interventional|||A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients|A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients|Completed||N/A|27||Indiana University|||||f||||||||||||||2017-02-18 16:39:37.286118|2017-02-18 16:39:37.286118
NCT00308282|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2008-09-17|||March 2006||2006-03-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Patients With Rheumatoid Arthritis|Phase II Study of Safety and Efficacy of Intravenous LY2127399 in Patients With Rheumatoid Arthritis Treated With Methotrexate|Completed||Phase 2|126|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 16:39:37.368066|2017-02-18 16:39:37.368066
NCT00308269|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2014-12-18|||March 2006||2006-03-01|December 2014|2014-12-01|July 2008|Actual|2008-07-01|August 2007|Actual|2007-08-01||Interventional|||Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)|Protocol EC-FV-01: A Phase 1 Study of EC145 Administered in Weeks 1 and 3 of a 4-Week Cycle|Completed||Phase 1|32|Actual|Endocyte||5|||f||||f||||||||||2017-02-18 16:39:37.483274|2017-02-18 16:39:37.483274
NCT00308256|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2011-12-28|||March 2006||2006-03-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Effects of Nurse-counselling in the Improvement of the type1 Diabetes Control in Adolescents|Effects of Nurse-counselling in the Improvement of the type1 Diabetes Control in Adolescents: a Randomized Controlled Trial|Completed||N/A|77|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-02-18 16:39:37.593506|2017-02-18 16:39:37.593506
NCT00308243|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2011-07-17|||March 2006||2006-03-01|July 2011|2011-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.|Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. A Phase I, Double Blind, Placebo Controlled, Safety Study. Stage 1)|Completed||Phase 1|15|Anticipated|Emphycorp|||||||||||||||||||2017-02-18 16:39:37.693632|2017-02-18 16:39:37.693632
NCT00308230|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2014-07-16|2013-09-10||December 2001||2001-12-01|July 2014|2014-07-01|September 2004|Actual|2004-09-01|March 2004|Actual|2004-03-01||Interventional|||Pilot Study of B-Type Natrieutic Peptide (BNP) Levels in Patients With Congenital Heart Disease(BNP)|A Pilot Study of B-Type Natriuretic Peptide (BNP) Levels in Patients With Congenital Heart Disease and Systemic Right Ventricles or Volume Overloaded Pulmonic Right Ventricles|Completed||N/A|34|Actual|Emory University||3|||f||||f||||||||||2017-02-18 16:39:37.793275|2017-02-18 16:39:37.793275
NCT00308217|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2013-12-11|||June 2005||2005-06-01|December 2013|2013-12-01|June 2005||2005-06-01|||||Observational|||Single Ventricle Outcome|The Examination of Outcome in Children With Single Ventricle Physiology|Completed||N/A|30||Emory University|||||f||||||||||||||2017-02-18 16:39:38.196214|2017-02-18 16:39:38.196214
NCT00308204|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2007-05-22|||March 2006||2006-03-01|May 2007|2007-05-01||||||||Interventional|||Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva|Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva|Terminated||Phase 2|10|Anticipated|The Cleveland Clinic||||inadequate number of enrolled study subjects|||||||||||||||2017-02-18 16:39:38.279263|2017-02-18 16:39:38.279263
NCT00308191|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2008-03-05|||April 2006||2006-04-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|May 2006|Actual|2006-05-01||Interventional|||A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD|A 6-Week Double-Blind, Parallel-Group, Active-Controlled Trial to Compare the Efficacy and Safety of Concomitant Treatment of Formoterol Fumarate Inhalation Solution 20 Mcg Twice Daily and Tiotropium 18 Mcg Once Daily to Tiotropium 18 Mcg Once Daily Alone in the Treatment of Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|128||Dey|||||||||||||||||||2017-02-18 16:39:38.370195|2017-02-18 16:39:38.370195
NCT00005490|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-11-04|||August 1997||1997-08-01|February 2005|2005-02-01|June 2003|Actual|2003-06-01|||||Observational|||Modeling DNA Diversity in Cardiovascular Health/Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.88989|2017-02-18 18:14:54.88989
NCT00308165|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2015-01-13|||March 2004||2004-03-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|September 2011|Actual|2011-09-01||Interventional|||Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors|A Phase I Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors|Unknown status|Active, not recruiting|Phase 1/Phase 2|18|Actual|Columbia University||1|||f||||t||||||||||2017-02-18 16:39:38.577449|2017-02-18 16:39:38.577449
NCT00308152|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2016-07-25|||February 2006||2006-02-01|July 2016|2016-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Intravenous Saline Pre-hydration in Patients Undergoing Outpatient Colonoscopy|Randomised, Controlled Trial of Intravenous Saline Pre-hydration in Patients Undergoing Outpatient Colonoscopy|Completed||Phase 2|1000|Anticipated|The Canberra Hospital||2|||f||||f||||||||No||2017-02-18 16:39:38.689|2017-02-18 16:39:38.689
NCT00308139|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2015-07-29|2012-02-14||April 2006||2006-04-01|July 2015|2015-07-01|August 2014|Actual|2014-08-01|July 2008|Actual|2008-07-01||Interventional|||Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)|A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Examine the Effects of Exenatide Long-Acting Release on Glucose Control (HbA1c) and Safety in Subjects With Type 2 Diabetes Mellitus Managed With Diet Modification and Exercise and/or Oral Antidiabetic Medications|Completed||Phase 3|303|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:39:38.820678|2017-02-18 16:39:38.820678
NCT00308126|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2007-12-07|||June 2005||2005-06-01|March 2006|2006-03-01|September 2006||2006-09-01|||||Interventional|||Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery|Phase IV, Open-Label, Randomized, Albumin-Controlled, Parallel Group, Multicenter Study to Evaluate the Effect of Medium Molecule HES (130/0.4) in Complications for Patients After Abdominal Surgery|Completed||Phase 4|624||Fresenius Kabi|||||f||||f||||||||||2017-02-18 16:39:40.950335|2017-02-18 16:39:40.950335
NCT00308113|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2013-10-16|2013-08-07||April 2007||2007-04-01|October 2013|2013-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||CoQ10 and Prednisone in Non-Ambulatory DMD|PITT0503: Clinical Trial of Coenzyme Q10 and Prednisone in Duchenne Muscular Dystrophy|Terminated||Phase 3|3|Actual|Cooperative International Neuromuscular Research Group|In December 2007 the CINRG Data Safety and Monitoring Board (DSMB) met and recommended to close the study as the AAN had released practice parameters recommending that all patients with DMD should be offered treatment with corticosteroids.|4||New enrollment has been suspended, currently following previously enrolled participants|f||||t||||||||||2017-02-18 16:39:41.055811|2017-02-18 16:39:41.055811
NCT00308100|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2009-01-14|||October 2005||2005-10-01|January 2009|2009-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation|A Multicenter, Randomized, Open-Label, Parallel-Group, Albumin-Controlled Phase IV Study to Evaluate the Efficacy and Safety of Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Patients Undergoing Liver Transplantation|Terminated||Phase 4|53|Actual|Fresenius Kabi||2||Study is prematurely ended due to poor patient recruitment rate.|f||||t||||||||||2017-02-18 16:39:41.510049|2017-02-18 16:39:41.510049
NCT00308087|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2013-12-02|2010-06-11||May 2006||2006-05-01|December 2013|2013-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|PREMIER||Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma|Randomized, Open Label, Phase II Trial Comparing Rituximab Plus Sargramostim to Rituximab Monotherapy for the Treatment of Relapsed Follicular B-cell Lymphoma|Terminated||Phase 2|75|Actual|Sanofi|One hundred ninety-six patients were planned and 75 enrolled prior to termination. The study was terminated early due to low enrollment, and the extent of changes needed to the protocol to keep pace with therapeutic changes for indolent lymphoma.|2||Terminated by sponsor due to low enrollment; see details below|f||||t||||||||||2017-02-18 16:39:41.633724|2017-02-18 16:39:41.633724
NCT00308074|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-28|2016-12-30|2015-03-11||February 2006||2006-02-01|December 2016|2016-12-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders|A Prospective Open-Label Trial of Aripiprazole Monotherapy in the Autism Spectrum Disorders (ASD)|Completed||Phase 2|14|Actual|Cambridge Health Alliance||1|||f||||f||||||||||2017-02-18 16:39:42.494061|2017-02-18 16:39:42.494061
NCT00308061|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2016-10-24|||July 2003||2003-07-01|October 2006|2006-10-01|July 2004||2004-07-01|||||Interventional|||Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali|Dbl Blind Randomized Controlled Phase I Trial to Eval the Safety and Immunogenicity of WRAIR's MSP1 Candidate Malaria Vaccine (FMP1) Adjuvant in GSK Bio's AS02A vs. Rabies Vaccine in Semi-immune Adults in Bandiagara, Mali.|Completed||Phase 1|40||U.S. Army Medical Research and Materiel Command|||||||||||||||||||2017-02-18 16:39:42.764052|2017-02-18 16:39:42.764052
NCT00308048|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2011-07-03|||March 2004||2004-03-01|March 2006|2006-03-01|September 2006||2006-09-01|||||Interventional|||14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response|14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response|Completed||Phase 3|435||Oslo University Hospital|||||f||||||||||||||2017-02-18 16:39:42.860281|2017-02-18 16:39:42.860281
NCT00308035|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2008-06-12|||November 2005||2005-11-01|June 2008|2008-06-01|June 2006|Actual|2006-06-01|||||Observational|||Foot Posture in People With Paralysis on One Side After Stroke|Foot Posture in People With Hemiplegia After Stroke|Completed||Phase 1|17|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-02-18 16:39:42.972095|2017-02-18 16:39:42.972095
NCT00308022|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2006-09-08|||January 2006||2006-01-01|March 2006|2006-03-01|December 2009||2009-12-01|||||Interventional|||Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation|A Prospective Randomized Controlled Trial Comparing High Frequency Percussive Ventilation With Conventional Mechanical Ventilation Utilizing Protective Lung Strategies in Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome|Unknown status|Recruiting|Phase 2/Phase 3|180||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:39:43.050722|2017-02-18 16:39:43.050722
NCT00308009|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2015-04-27|||February 2002||2002-02-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of the Result of TVT Performed at the Time of Prolapse Surgery or 3 Months After|Multicenter Prospective Randomized Trial Comparing to Strategies When Incontinence Surgery is Needed in Addition to Prolapse Surgery|Completed||N/A|194|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 16:39:43.13947|2017-02-18 16:39:43.13947
NCT00307996|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-03-27|||March 2004||2004-03-01|March 2006|2006-03-01|December 2004||2004-12-01|||||Interventional|||The Effect of CoQ10 Administration on Hemodialysis Patients|The Effect of CoQ10 Administration on the Oxidative and Antioxidative Markers in Hemodialysis Patients|Completed||Phase 4|40||University of Shizuoka|||||f||||||||||||||2017-02-18 16:39:43.234542|2017-02-18 16:39:43.234542
NCT00307957|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2007-12-10|||October 2005||2005-10-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea|Pillar Palatal Implant System Multi-Institutional, Randomized Placebo-Controlled Study for Obstructive Sleep Apnea|Completed||Phase 4|100|Anticipated|University of Cincinnati|||||f||||||||||||||2017-02-18 16:39:43.49259|2017-02-18 16:39:43.49259
NCT00307944|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2007-12-10|||August 2004||2004-08-01|December 2007|2007-12-01|August 2006||2006-08-01|||||Interventional|||Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea|Randomized, Placebo-Controlled Trial of Pantoprazole for Sleepiness Associated With Acid Reflux and Obstructive Sleep Disordered Breathing|Completed||Phase 4|68||University of Cincinnati|||||f||||||||||||||2017-02-18 16:39:43.582535|2017-02-18 16:39:43.582535
NCT00307931|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2011-08-30|2009-09-08||April 2007||2007-04-01|December 2009|2009-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab|Certolizumab Pegol in the Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Have Been Previously Treated Successfully With Infliximab But Who Have Subsequently Lost Response or Developed Intolerance to Infliximab|Terminated||Phase 3|16|Actual|UCB Pharma|This study was terminated early due to slow recruitment, namely only 17 subjects were recruited although the sample size had planned for approximately 50 subjects. As a consequence, the majority of secondary outcome measures were not summarized.|1||Study was terminated early because of slow recruitment|f||||f||||||||||2017-02-18 16:39:43.76147|2017-02-18 16:39:43.76147
NCT00307918|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2007-09-30|||May 2006||2006-05-01|September 2007|2007-09-01||||||||Interventional|||Acupuncture for Elevated Intraocular Pressure|Acupuncture Treatment for Elevated Intraocular Pressure: A Pilot Study|Terminated||Phase 3|10|Anticipated|Shaare Zedek Medical Center||||lack of patients|f||||||||||||||2017-02-18 16:39:44.111199|2017-02-18 16:39:44.111199
NCT00307905|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2010-10-28|||January 2011||2011-01-01|October 2010|2010-10-01||||June 2012|Anticipated|2012-06-01||Interventional|||TRAUMEEL for Pain After Fracture of Neck of Femur|A Randomised, Double - Blind, Placebo Controlled Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Controlling Post-operative Pain After Fracture of Neck of Femur|Withdrawn||Phase 3|224|Anticipated|Shaare Zedek Medical Center||2||Anticipation of inadequate recruitment according to current format.|f||||||||||||||2017-02-18 16:39:44.196252|2017-02-18 16:39:44.196252
NCT00307892|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2010-10-28|||January 2011||2011-01-01|October 2010|2010-10-01||||January 2012|Anticipated|2012-01-01||Interventional|||Traumeel S for Reduction of Post Operative Pain Following Arthroscopy|A Randomised, Double- Blind, Placebo Controlled, Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Reducing Pain After Arthroscopy|Suspended||Phase 3|98|Anticipated|Shaare Zedek Medical Center||2||Inability to recruit patients|f||||||||||||||2017-02-18 16:39:44.296477|2017-02-18 16:39:44.296477
NCT00307879|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-03-27|||March 2004||2004-03-01|March 2004|2004-03-01|February 2005||2005-02-01|||||Interventional|||Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion|Phase 2 MAGIC Cell (Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion) Trial|Terminated||Phase 2|20||Seoul National University Hospital|||||f||||||||||||||2017-02-18 16:39:44.584152|2017-02-18 16:39:44.584152
NCT00307866|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2009-05-15|||April 2001||2001-04-01|May 2009|2009-05-01|May 2003|Actual|2003-05-01|||||Interventional|||Identification of Hepatic Lesions|A Prospective, Multicenter, Phase III b Clinical Study to Evaluate the Effectiveness of Unenhanced and SH U 555A (Resovist) Enhanced MRI, Compared to Contrast-Enhanced Dual-Phase Spiral CT in Assessing the Correct Final Therapy-Deciding Diagnosis, in Patients With Primary or Secondary Hepatic Malignancies.|Completed||Phase 3|218|Actual|Bayer||1|||f||||||||||||||2017-02-18 16:39:44.678797|2017-02-18 16:39:44.678797
NCT00307853|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2009-10-18|||August 2008||2008-08-01|October 2009|2009-10-01||||August 2009|Anticipated|2009-08-01||Interventional|||TRAUMEEL for Pain After Total Knee/Hip Arthroplasty|A Randomised, Double - Blind, Placebo Controlled Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Controlling Pain After Total Knee and Total Hip Arthroplasty.|Terminated||Phase 3|224|Anticipated|Shaare Zedek Medical Center||2||lack of patients|f||||||||||||||2017-02-18 16:39:44.799333|2017-02-18 16:39:44.799333
NCT00307840|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-03-27|||February 2005||2005-02-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism|Initial Dosing of Paricalcitol Based on iPTH Parathyroid Hormone Levels in Hemodialysis Patients With Secondary Hyperparathyroidism|Completed||Phase 4|||Papageorgiou General Hospital|||||f||||||||||||||2017-02-18 16:39:44.900983|2017-02-18 16:39:44.900983
NCT00307827|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2012-04-26|||April 2006||2006-04-01|April 2012|2012-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)|A Phase 2, Randomized, Double-blind, Multicenter, Dose-exploration Study of Visilizumab in Subjects With Intravenous Steroid-refractory Ulcerative Colitis|Terminated||Phase 2|38|Actual|Abbott||3||Study Canceled|f||||t||||||||||2017-02-18 16:39:44.982428|2017-02-18 16:39:44.982428
NCT00307814|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2011-05-17|||January 2002||2002-01-01|April 2010|2010-04-01|January 2004|Actual|2004-01-01|||||Interventional|||A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)|A Randomized, Open-Label Clinical Evaluation of PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease|Completed||Phase 2|519|Actual|Ortho Biotech Products, L.P.|||||f||||||||||||||2017-02-18 16:39:45.110451|2017-02-18 16:39:45.110451
NCT00307801|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2014-12-08|2011-03-02||February 2006||2006-02-01|December 2014|2014-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, 7 Cycle Duration (196 Days), Phase 3 Study of Oral Estradiol Valerate/Dienogest Tablets for the Treatment of Dysfunctional Uterine Bleeding.|Completed||Phase 3|231|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:39:45.216912|2017-02-18 16:39:45.216912
NCT00307788|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2012-05-24|||May 2004||2004-05-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|LBP||Acupuncture Analgesia in Relation to Psychiatric Comorbidity|The Association Amongst Acupuncture Analgesia, Expectancy, and Psychiatric Comorbidity in Patients With Low Back Pain|Completed||Phase 3|60|Actual|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 16:39:47.102567|2017-02-18 16:39:47.102567
NCT00005489|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-28|||January 1998||1998-01-01|December 2015|2015-12-01|December 2001||2001-12-01|||||Observational|||Salt Sensitivity, Cardiovascular and Metabolic Disease||Completed||N/A|||Indiana University|||||f||||||||||||||2017-02-18 18:14:54.960569|2017-02-18 18:14:54.960569
NCT00307775|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2012-04-28|||March 2006||2006-03-01|February 2007|2007-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Vaginal Estrogen for the Treatment of Faecal Incontinence in Women|A Pilot Study to Examine the Efficacy of Vaginally Administered Oestradiol in the Treatment of Faecal Incontinence in Post Menopausal Women|Terminated||N/A|43||London North West Healthcare NHS Trust||||Lack of recruitment|f||||||||||||||2017-02-18 16:39:47.204376|2017-02-18 16:39:47.204376
NCT00307762|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2015-03-30|||May 2003||2003-05-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Interventional|||Gait Trainer vs Traditional Physiotherapy in Acute Stroke|Body-weight Supported Therapy Using Gait Trainer Versus Traditional Gait-oriented Physiotherapy in Acute Phase of Stroke. The Effectiveness of Gait Training and Brain Networks Using NBS (Navigating Brain Stimulation)|Completed||Phase 3|57|Actual|Kuopio University Hospital||3|||f||||f||||||||||2017-02-18 16:39:47.307009|2017-02-18 16:39:47.307009
NCT00307749|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2007-12-26|||March 2006||2006-03-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy|A Phase II, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Finding Study to Evaluate the Efficacy and Safety of 20mg, 40mg and 80mg of MCC-257 in Patients With Mild to Moderate Diabetic Polyneuropathy|Completed||Phase 2|420|Actual|Mitsubishi Tanabe Pharma Corporation||4|||f||||||||||||||2017-02-18 16:39:47.418547|2017-02-18 16:39:47.418547
NCT00307736|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2012-04-25|||May 2006||2006-05-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|April 2010|Actual|2010-04-01||Interventional|||Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer|A Phase I/II Study of Bevacizumab, Erlotinib and 5-fluorouracil With Concurrent External Beam Radiation Therapy in Locally Advanced Rectal Cancer|Completed||Phase 1/Phase 2|32|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:39:47.530515|2017-02-18 16:39:47.530515
NCT00307723|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2009-08-07|||May 2006||2006-05-01|August 2009|2009-08-01|July 2009|Actual|2009-07-01|August 2007|Actual|2007-08-01||Interventional|||Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer|A Tolerability and Efficacy Study of the Angiogenesis Inhibitor Bevacizumab in Combination With 5-Fluorouracil, Oxaliplatin, and External Beam Radiation Therapy Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer|Terminated||Phase 1/Phase 2|52|Actual|Massachusetts General Hospital||2||poor accrual|f||||t||||||||||2017-02-18 16:39:47.643154|2017-02-18 16:39:47.643154
NCT00307710|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2012-07-27|||August 2004||2004-08-01|July 2012|2012-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma|Evaluation of the Reactogenicity and Immunogenicity of Different Doses of Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma: A Phase II, Double-Blind Pilot Study - Version 4|Completed||Phase 2|28|Actual|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 16:39:47.762456|2017-02-18 16:39:47.762456
NCT00307697|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2013-11-26|||June 2006||2006-06-01|March 2006|2006-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Letter Intervention in Primary Care Patients to Improve Depression and Anxiety Disorders|A Randomised Controlled Trial of a Letter Intervention in Primary Care Patients to Improve Depression and Anxiety Disorders|Completed||Phase 1|200|Anticipated|Bayside Health|||||f||||f||||||||||2017-02-18 16:39:47.883816|2017-02-18 16:39:47.883816
NCT00307684|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2014-04-02|2009-07-16||January 2006||2006-01-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|An Open International Multicentre Long-Term Follow Up Study to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 3|155|Actual|Janssen-Cilag International NV|Planned sample size for DB phase was 80 subjects. Of 99 subjects at the end of OL phase only 45 subjects consented. No cutoffs for key efficacy assessments in DB entry criteria.|3|||f||||f||||||||||2017-02-18 16:39:47.994553|2017-02-18 16:39:47.994553
NCT00307671|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2011-09-09|||July 2005||2005-07-01|March 2007|2007-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|CORTAGE||Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years|Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years Comparison of Two Strategies Combining Steroids With or Without Immunosuppressants|Completed||Phase 4|108|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 16:39:48.697395|2017-02-18 16:39:48.697395
NCT00307658|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-05-18|||March 2001||2001-03-01|April 2003|2003-04-01|July 2006||2006-07-01|||||Interventional|||Intravenous Immunoglobulin After Relapse in Vasculitis|Intravenous Immunoglobulin After Relapse in Vasculitis (Microscopic Polyangiitis, Wegener’s Granulomatosis and SHURG-STRAUSS Syndrome) During and After Corticosteroids and Immunosuppressant Therapies a Multicenter Prospective Trial|Terminated||Phase 3|40||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:39:48.814627|2017-02-18 16:39:48.814627
NCT00307645|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-04-07|||May 2003||2003-05-01|March 2003|2003-03-01|August 2009||2009-08-01|||||Interventional|||IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis|Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis|Terminated||Phase 3|160||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 16:39:48.91902|2017-02-18 16:39:48.91902
NCT00307632|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2014-05-14|||February 2003||2003-02-01|May 2014|2014-05-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol|An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol|Completed||Phase 4|580|Actual|Janssen-Cilag Farmaceutica Ltda.||1|||f||||||||||||||2017-02-18 16:39:49.03134|2017-02-18 16:39:49.03134
NCT00307619|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2011-01-27|||November 2003||2003-11-01|January 2011|2011-01-01|April 2005|Actual|2005-04-01|||||Interventional|||An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.|Randomized, Double-blind Placebo Controlled Trial With Topiramate for the Treatment of Obese Patients With Binge Eating Disorder|Completed||Phase 3|73|Actual|Janssen-Cilag Farmaceutica Ltda.|||||f||||||||||||||2017-02-18 16:39:49.143018|2017-02-18 16:39:49.143018
NCT00307606|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2007-09-05|||December 2005||2005-12-01|December 2005|2005-12-01|December 2007||2007-12-01|||||Interventional|||Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma|Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma|Unknown status|Recruiting|Phase 4|40|Anticipated|Herlev Hospital|||||f||||t||||||||||2017-02-18 16:39:49.348481|2017-02-18 16:39:49.348481
NCT00307593|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2007-11-16|||May 2004||2004-05-01|March 2007|2007-03-01|June 2007|Actual|2007-06-01|||||Interventional|||RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides|Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides With Positive ANCA After Relapse or Resistant Immunosuppressant Therapies|Completed||N/A|20|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 16:39:49.460957|2017-02-18 16:39:49.460957
NCT00307580|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-25|2014-04-08|||April 2002||2002-04-01|April 2014|2014-04-01|May 2003|Actual|2003-05-01|||||Interventional|||Cathflo Activase Pediatric Study|Cathflo Activase (Alteplase) Pediatric Study (CAPS)|Completed||Phase 4|300||Genentech, Inc.|||||f||||||||||||||2017-02-18 16:39:49.568047|2017-02-18 16:39:49.568047
NCT00307567|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2016-09-22|||November 2005||2005-11-01|September 2016|2016-09-01|March 2006|Actual|2006-03-01|||||Interventional|||Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488|A Phase II, Multicentre Booster Study to Evaluate Booster Vaccination With GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or to Evaluate the Immune Memory Following the Administration of a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children, Previously Vaccinated in Infancy in the Primary Study 11PN-PD-DIT-002 (103488)|Completed||Phase 2|689||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:39:49.655018|2017-02-18 16:39:49.655018
NCT00307554|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2016-09-23|||November 2005||2005-11-01|September 2016|2016-09-01|June 2006|Actual|2006-06-01|||||Interventional|||A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study|Assess Lot-to-lot Consistency of 3 Lots (Double Blind Design) of GlaxoSmithKline Biologicals' 10-valent Pneumococcal Vaccine and Evaluate Non-inferiority to Prevenar™ (Single Blind Design) When Administered as 3-dose Primary Immunization Course Before 6 Months of Age|Completed||Phase 3|1600||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:39:49.801386|2017-02-18 16:39:49.801386
NCT00307541|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2016-09-22|||October 2005||2005-10-01|September 2016|2016-09-01|April 2006|Actual|2006-04-01|||||Interventional|||Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine|Phase IIIa Randomized, Controlled Study to Assess the Immunogenicity of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine, When Administered as a 3-dose Primary Immunization Course Before 6 Months of Age|Completed||Phase 3|120||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:39:50.118558|2017-02-18 16:39:50.118558
NCT00307528|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2011-10-27|||January 2004||2004-01-01|October 2011|2011-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population|A Study to Evaluate the Safety, Reactogenicity & Immunogenicity of the GSK Biologicals Candidate Pneumococcal Vaccine Without or With Adjuvant, Administered at 2 Different Concentrations, in Healthy Elderly Subjects|Completed||Phase 2|146|Actual|GlaxoSmithKline||6|||f||||||||||||||2017-02-18 16:39:50.460457|2017-02-18 16:39:50.460457
NCT00307515|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2009-01-08|||February 2006||2006-02-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery|A Prospective, Randomized, Controlled Evaluation of Fibrin Sealant 2 (FS2) as an Adjunct to Hemostasis for Soft Tissue Bleeding During Retroperitoneal or Intra-Abdominal Surgery|Completed||Phase 3|135|Actual|Ethicon, Inc.||2|||f||||f||||||||||2017-02-18 16:39:50.580664|2017-02-18 16:39:50.580664
NCT00307502|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2010-02-22|||January 2005||2005-01-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV|Cross-sectional Study for the Characterisation of the Pharmacokinetic Parameters of Protease Inhibitors and Non-nucleoside Analog Reverse Transcriptase Inhibitors in the Spanish Population of HIV-infected Subjects|Completed||Phase 1|675|Anticipated|Germans Trias i Pujol Hospital||11|||f||||f||||||||||2017-02-18 16:39:50.713147|2017-02-18 16:39:50.713147
NCT00307489|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2011-10-04|2009-01-30||March 2006||2006-03-01|October 2011|2011-10-01|October 2010|Actual|2010-10-01|January 2008|Actual|2008-01-01||Interventional|||Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil|A Phase 2, Randomized, Double-Blind Study Exploring the Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus Emtricitabine Plus Tenofovir DF Fixed-Dose Combination Therapy in Subjects Currently Being Treated With Adefovir Dipivoxil for Chronic Hepatitis B and Having Persistent Viral Replication|Completed||Phase 2|106|Actual|Gilead Sciences|The randomized and treated (RAT) analysis set includes all subjects who were ongoing at the time of analysis (i.e., those on blinded therapy and those who switched to open-label FTC/TDFdue to persistent viremia).|2|||f||||f||||||||||2017-02-18 16:39:50.86069|2017-02-18 16:39:50.86069
NCT00307476|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2007-12-19|||September 2005||2005-09-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Comparison of Rectal Trumpet and Standard Care|A Clinical Comparison of the Rectal Trumpet and Standard Care in Acutely Ill Patients With Fecal Incontinence|Terminated||N/A|100|Anticipated|Christiana Care Health Services||||Unable to recruit target enrollment numbers|f||||||||||||||2017-02-18 16:39:51.813017|2017-02-18 16:39:51.813017
NCT00307463|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2013-09-06|||September 2005||2005-09-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation|Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation: a Randomised, Prospective and Controlled Study|Completed||Phase 4|258|Actual|Ege University||2|||f||||t||||||||||2017-02-18 16:39:51.905855|2017-02-18 16:39:51.905855
NCT00307450|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2009-07-31|||March 2006||2006-03-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional|LeLeDys||Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease|Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease (LeLeDys Study) - A Multicenter, Randomized, Stratified, Double-blinded, Placebo-controlled Phase IV Study|Completed||Phase 4|34|Anticipated|Technische Universität Dresden||1|||f||||t||||||||||2017-02-18 16:39:52.023864|2017-02-18 16:39:52.023864
NCT00307437|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2013-01-16|2009-10-23||May 2005||2005-05-01|January 2013|2013-01-01|October 2011|Actual|2011-10-01|December 2006|Actual|2006-12-01||Interventional|||A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis.|Completed||Phase 3|1230|Actual|Centocor Research & Development, Inc.|The count of patients with any nonserious adverse event (NAE) excludes patients who only had NAE that occured in <=5% of patients. This information may vary from existing approved labeling and publications due to the requirements of this website.|3|||f||||t||||||||||2017-02-18 16:39:52.154028|2017-02-18 16:39:52.154028
NCT00307424|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-03-27|||August 2004||2004-08-01|August 2004|2004-08-01|June 2005||2005-06-01|||||Interventional|||Comparison Between Auto CPAP and Fixed CPAP in Chinese Patients With OSA|Comparison of Auto-Continuous Positive Airway Pressure Device(Auto-CPAP) With Conventional Fixed CPAP in Chinese Patients With Obstructive Sleep Apnea (OSA)|Completed||N/A|||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 16:39:54.901315|2017-02-18 16:39:54.901315
NCT00307411|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-27|2006-04-03|||August 2006||2006-08-01|March 2006|2006-03-01|July 2007||2007-07-01|||||Interventional|||Effect of Growth Hormone in Metabolic Syndrome|Effects of Growth Hormone on Body Fat Distribution, Insulin Action and Cardiovascular Risk Factors in Middle-Aged Men With Metabolic Syndrome|Unknown status|Not yet recruiting|Phase 4|32||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 16:39:54.98413|2017-02-18 16:39:54.98413
NCT00307398|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2012-11-27||2012-11-27|March 2004||2004-03-01|May 2009|2009-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Anecortave Acetate Risk-Reduction Trial (AART)||Terminated||Phase 3|2596|Actual|Alcon Research||2||Management decision|f||||||||||||||2017-02-18 16:39:55.078785|2017-02-18 16:39:55.078785
NCT00307385|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-25|2017-01-24|||March 23, 2006||2006-03-23|March 27, 2008|2008-03-27|March 27, 2008||2008-03-27|||||Observational|||Transcranial Direct Current Stimulation to Improve Hand Movement in Stroke Patients|Modulation of Motor Learning After Stroke Using Principles of Metaplasticity|Completed||N/A|82||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:39:55.17484|2017-02-18 16:39:55.17484
NCT00307346|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2017-01-24|||March 23, 2006||2006-03-23|January 25, 2011|2011-01-25|January 25, 2011||2011-01-25|||||Observational|||Physiology of Weakness in Movement Disorders|Physiology of Weakness With Movement Disorders|Completed||N/A|6|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:39:55.256033|2017-02-18 16:39:55.256033
NCT00307333|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2013-05-16|2012-04-03||August 2005||2005-08-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|February 2011|Actual|2011-02-01||Interventional|HeRO||Impact of Heart Rate Characteristics Monitoring in Neonates|Impact of Heart Rate Characteristics Monitoring in Neonates|Completed||N/A|3003|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 16:39:55.343901|2017-02-18 16:39:55.343901
NCT00307320|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2009-12-29|||March 2006||2006-03-01|August 2008|2008-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study Examining Stress During Pregnancy|Coping With Stress During Pregnancy|Unknown status|Active, not recruiting|N/A|40|Anticipated|University of Virginia||2|||f||||||||||||||2017-02-18 16:39:55.890787|2017-02-18 16:39:55.890787
NCT00307307|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2006-05-18|||January 2000||2000-01-01|March 2006|2006-03-01|September 2005||2005-09-01|||||Interventional|||Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.|Magnetic Resonance Characterization of Carotid Atherosclerotic Plaque in Vivo: Effect of High Density Lipoprotein Elevation on Plaque Morphology|Completed||Phase 4|69||University of Pennsylvania|||||f||||||||||||||2017-02-18 16:39:55.986318|2017-02-18 16:39:55.986318
NCT00307294|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2016-01-14|2016-01-14||March 2006||2006-03-01|January 2016|2016-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)|Phase II Trial of Thalidomide and Doxil® (Doxorubicin HCL Liposome Injection) in Patients With Androgen Independent Prostate Cancer (AIPC) With a Rising PSA While on Chemotherapy|Completed||Phase 2|40|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:39:56.086403|2017-02-18 16:39:56.086403
NCT00307281|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2015-12-01|||August 2000||2000-08-01|December 2015|2015-12-01|July 2030|Anticipated|2030-07-01|July 2030|Anticipated|2030-07-01|2 Years|Observational [Patient Registry]|||Emphysema Research Registry|Emphysema Research Registry; Screening Study and Genetic Testing|Recruiting||N/A|3000|Anticipated|University of Pittsburgh|||1||f||||f||||||||Undecided||2017-02-18 16:39:56.385424|2017-02-18 16:39:56.385424
NCT00307268|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2013-01-21|||March 2008||2008-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|January 2010|Actual|2010-01-01||Observational|||Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD|Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adolescents With ADHD: An Observational, Long-Term Follow-up Study of Routine Clinical Care|Completed||N/A|195|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 16:39:56.505727|2017-02-18 16:39:56.505727
NCT00307255|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2012-04-02|||August 2006||2006-08-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors|Phase I Trial of Abraxane in Combination With Gemcitabine in Patients With Solid Tumors|Completed||Phase 1|18|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:39:56.595149|2017-02-18 16:39:56.595149
NCT00307242|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2014-12-08|||May 2005||2005-05-01|December 2014|2014-12-01||||||||Interventional|||Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B|A Single Center Open-Label, Randomized Study Comparing the Safety of Immediately Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir for 12 Weeks Before Instituting Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B|Completed||Phase 4|40|Anticipated|Thomas Jefferson University|||||f||||t||||||||||2017-02-18 16:39:56.69279|2017-02-18 16:39:56.69279
NCT00307229|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2012-05-31|||March 2006||2006-03-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|July 2009|Actual|2009-07-01||Interventional|||Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)|A Phase I Trial Investigating the Safety and Immunogenicity of an Adenovirus Encoding Rat HER-2 Administered Intradermally to Patients With Metastatic or Locally Recurrent Breast Cancer|Completed||Phase 1|8|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||||||||||||2017-02-18 16:39:56.784915|2017-02-18 16:39:56.784915
NCT00005488|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||July 1998||1998-07-01|January 2005|2005-01-01|August 2002||2002-08-01|||||Observational|||Common Variants in Candidate Genes and Premature MI Risk||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:14:55.034155|2017-02-18 18:14:55.034155
NCT00307216|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2013-03-28|||April 2006||2006-04-01|March 2013|2013-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis|Randomized Controlled Trial of the Graduated Recovery Intervention Program for First-Episode Psychosis|Completed||N/A|46|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 16:39:56.873611|2017-02-18 16:39:56.873611
NCT00307203|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2017-01-10|||August 1998||1998-08-01|September 2008|2008-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke|Nicotine and Smoking Cessation in Schizophrenia|Completed||Phase 4|51|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 16:39:56.984696|2017-02-18 16:39:56.984696
NCT00307190|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2012-05-25|||October 2004||2004-10-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Hormone Release and Stomach Disturbances in People With Binge Eating Disorder|Postprandial Cholecystokinin Release and Gastric Emptying in Binge Eating Disorder|Completed||N/A|24|Actual|New York State Psychiatric Institute|||2||f||||f||||||Samples Without DNA|"~     Blood serum~   "|||2017-02-18 16:39:57.110659|2017-02-18 16:39:57.110659
NCT00307177|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2014-12-04|||August 2004||2004-08-01|November 2006|2006-11-01|April 2005||2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma|Evaluation of the Reactogenicity and Immunogenicity of Different Doses of Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma: A Phase II, Double-Blind Pilot Study|Completed||Phase 2|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:39:57.206743|2017-02-18 16:39:57.206743
NCT00307164|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2013-11-25|2011-08-23||September 2006||2006-09-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy|A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy|Completed||Phase 2/Phase 3|167|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:39:57.317619|2017-02-18 16:39:57.317619
NCT00307151|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2015-12-03|2011-07-05||December 2005||2005-12-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|October 2010|Actual|2010-10-01||Interventional|P1060||Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV|Phase II, Parallel, Randomized, Clinical Trials Comparing the Responses to Initiation of NNRTI-Based Versus PI-Based Antiretroviral Therapy in HIV Infected Infants Who Have and Have Not Previously Received Single Dose Nevirapine for Prevention of Mother-to-Child HIV Transmission|Active, not recruiting||Phase 2|452|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|Accrual to Cohort I was terminated early by the Data Safety Monitoring Committee after enrollment of 164 of the planned 288 subjects.|4|||f||||t||||||||||2017-02-18 16:40:01.580078|2017-02-18 16:40:01.580078
NCT00307138|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2006-05-19|||September 2004||2004-09-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Hetastarch and Bleeding Complications After Off-Pump Coronary Bypass Surgery|Hetastarch (Hextend) and Bleeding Complications After Off-Pump Coronary Bypass Surgery|Completed||Phase 3|330||Kaiser Permanente|||||f||||||||||||||2017-02-18 16:40:03.746186|2017-02-18 16:40:03.746186
NCT00307125|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2015-03-11|2015-02-27||March 2006||2006-03-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional||Intent-to-treat|Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies|B-Cell Depletion by Anti-CD20 (Rituximab) in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies Will Result in Inhibition of Alloantibody Production and Attenuation of Chronic Humoral Rejection|Completed||Phase 2|757|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Slow accrual. In order to ensure the study was completed within the time frame allotted, randomization to the control arm (Pilot Phase-Placebo plus immunosuppression) was suspended. Enrollment continued to lag. The study was stopped early.|2|||f||||t||||||||||2017-02-18 16:40:03.847137|2017-02-18 16:40:03.847137
NCT00307112|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2010-08-26|||August 2006||2006-08-01|September 2007|2007-09-01|August 2008||2008-08-01|||||Observational|||Rheumatic Heart Disease Prevalence in Leon, Nicaragua|Study of the Prevalence of Rheumatic Heart Disease in Leon, Nicaragua|Unknown status|Recruiting|N/A|3600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:40:04.715714|2017-02-18 16:40:04.715714
NCT00307099|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2013-06-06|||October 2006||2006-10-01|February 2007|2007-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU|Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU): Impact on Antimicrobial Resistance, Superinfections, Length of ICU Stay and Hospitalization, and Mortality|Terminated||Phase 3|460|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:40:04.80406|2017-02-18 16:40:04.80406
NCT00307086|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2013-08-09|2013-03-05||June 2005||2005-06-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants|An Evaluation of Bortezomib (VelcadeR ) Followed by High-Dose Melphalan and Bortezomib (VelcadeR) as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants in Patients With Primary Refractory Multiple Myeloma and Plasma Cell Leukemia|Completed||Phase 2|30|Actual|H. Lee Moffitt Cancer Center and Research Institute|per protocol subjects are followed for 2 years post transplant; however, subjects are followed on our long-term follow-up protocol(MCC12567/IRB6101) to assess overall and disease free survival. additional data available at time manuscript was written|1|||f||||t||||||||||2017-02-18 16:40:04.913923|2017-02-18 16:40:04.913923
NCT00307073|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2006-10-11|||May 2005||2005-05-01|October 2006|2006-10-01|November 2005||2005-11-01|||||Interventional|||Adapta Pacing System Clinical Study|Adapta Clinical Study to Evaluate the Overall System Safety and Clinical Performance of the Adapta Pacing System|Completed||N/A|120||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:40:05.176657|2017-02-18 16:40:05.176657
NCT00307060|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2014-12-18|||December 2004||2004-12-01|December 2014|2014-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||MK0954A-264 Filter Study (0954A-264)(COMPLETED)|A Randomized, Double-Blind, Parallel-Filter Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan-HCTZ Combination as Compared to Losartan Monotherapy in Patients With Essential Hypertension|Completed||Phase 3|274|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:40:05.280457|2017-02-18 16:40:05.280457
NCT00307047|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2012-10-08|2010-08-30||August 2006||2006-08-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|August 2009|Actual|2009-08-01||Interventional|||SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System|SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions|Completed||Phase 3|3687|Actual|Abbott Vascular||2|||f||||t||||||||||2017-02-18 16:40:05.394721|2017-02-18 16:40:05.394721
NCT00307034|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2016-10-11|||January 2006||2006-01-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule|An Open, Randomized, Phase IIIa Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine, When Administered Intramuscularly According to a 2-4-11 Months Vaccination Schedule|Completed||Phase 3|351|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:40:08.461916|2017-02-18 16:40:08.461916
NCT00307021|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-09-29|||April 2006||2006-04-01|September 2011|2011-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children|Bridging Safety & Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine RTS,S/AS01E (0.5 mL Dose) to RTS,S/AS02D (0.5 mL Dose) Administered IM According to a 0, 1, 2-Month Schedule in Gabonese Children Aged 18 Months to 4 Years|Completed||Phase 2|180|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:40:08.601951|2017-02-18 16:40:08.601951
NCT00307008|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-24|2013-04-11|||October 2003||2003-10-01|September 2011|2011-09-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.|An Open, Phase II Study to Evaluate the Response Rate to the Licensed Single-Dose Polysaccharide Pneumococcal Vaccine Pneumovax 23™ (MSD Aventis Pasteur) in Elderly Population.|Completed||Phase 2|1198|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:40:08.699694|2017-02-18 16:40:08.699694
NCT00306995|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2016-09-23|||May 2005||2005-05-01|September 2016|2016-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population|A Phase III, Open, Randomized, Multicenter, Comparative Vaccination Study to Evaluate the Immunogenicity and Reactogenicity of Various Formulations of a Monovalent Candidate Pandemic Influenza A Vaccine in Individuals Over 60 Years of Age|Completed||Phase 2|385||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:40:08.995634|2017-02-18 16:40:08.995634
NCT00306982|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2016-10-11|||March 2006||2006-03-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™|An Observational Study to Investigate the Incidence of Influenza, Downstream Complications of Influenza and Hospitalizations, in Elderly Subjects Vaccinated With GSK Biologicals' Influenza Vaccine (Fluarix™) Administered Intramuscularly.|Completed||N/A|1524|Actual|GlaxoSmithKline|||1||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:40:09.101163|2017-02-18 16:40:09.101163
NCT00306969|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2006-03-23|||December 2001||2001-12-01|September 2004|2004-09-01|April 2004||2004-04-01|||||Interventional|||Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma|Phase I/II Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma|Completed||Phase 1/Phase 2|18||Boston University|||||f||||||||||||||2017-02-18 16:40:09.211982|2017-02-18 16:40:09.211982
NCT00306956|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2008-09-18|||March 2006||2006-03-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|August 2007|Actual|2007-08-01||Interventional|||Influence of Pacifiers on Breastfeeding Duration|Influence of Pacifiers on Breastfeeding Duration: a Multicentre, Randomised Controlled Trial|Completed||Phase 3|1021|Actual|Fundacion para la Salud Materno Infantil||2|||f||||t||||||||||2017-02-18 16:40:09.311267|2017-02-18 16:40:09.311267
NCT00306943|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-09-20|||July 2005||2005-07-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Annual Study for Fluarix Registration|Phase III Vaccination Study for Evaluation of Immunogenicity and Reactogenicity of Influsplit SSW 2004/2005 in People Age 18 or Beyond|Completed||Phase 3|120|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:40:09.417777|2017-02-18 16:40:09.417777
NCT00306930|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2014-07-28|||July 2000||2000-07-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement|Multi-center, Prospective, Clinical Evaluation of Pinnacle Acetabular Implants in Total Hip Arthroplasty|Completed||N/A|1593|Actual|DePuy Orthopaedics||1|||f||||f||||||||||2017-02-18 16:40:09.512509|2017-02-18 16:40:09.512509
NCT00306917|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2011-12-01|2010-01-29||November 2002||2002-11-01|December 2011|2011-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement|A Prospective, Randomized Study of Summit™ Porocoat® Versus Summit™ DuoFix™ HA in Cementless Total Hip Arthroplasty|Terminated||Phase 4|245|Actual|DePuy Orthopaedics|The protocol called for 400 subjects to be followed for 5 years, but due to slow enrollment the study closed early. 245 subjects were enrolled & study endpoint was modified to 2 years. Enrollment closed on June 30, 2006; study closed on Jan 29, 2009.|2||Terminated due to limited enrollment and follow up.|f||||f||||||||||2017-02-18 16:40:09.624543|2017-02-18 16:40:09.624543
NCT00306904|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2008-07-24|||January 2006||2006-01-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema|A Phase II, Pharmacokinetic, Randomized, Double-Masked, Controlled, Dose Comparison Study of Cand5 for Intravitreal Injection for the Treatment of Diabetic Macular Edema|Completed||Phase 2|48|Actual|OPKO Health, Inc.||3|||f||||t||||||||||2017-02-18 16:40:09.994912|2017-02-18 16:40:09.994912
NCT00306319|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2008-05-20|||January 2006||2006-01-01|May 2008|2008-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia|Pharmacokinetic Interaction Study of Rifampicin, Isoniazid and Moxifloxacin in Tuberculosis Patients in Bandung, Indonesia|Completed||Phase 2|23||Radboud University|||||f||||||||||||||2017-02-18 16:40:24.465403|2017-02-18 16:40:24.465403
NCT00306891|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2012-10-03|2012-04-03||June 2006||2006-06-01|October 2012|2012-10-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)|Open-label, Randomised, Phase 2 Study in Patients With Advanced Solid Tumours to Determine Effect of Food Upon Pharmacokinetics of a Single Oral Dose of Cediranib (AZD2171, Recentin™), Followed by an Assessment of the Safety & Tolerability of Fixed and Individualised Daily Dosing|Completed||Phase 2|60|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 16:40:10.115745|2017-02-18 16:40:10.115745
NCT00306878|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2011-04-11|||August 1995||1995-08-01|April 2011|2011-04-01|May 1997|Actual|1997-05-01|May 1997|Actual|1997-05-01||Interventional|||Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris|Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris|Completed||Phase 1|45||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:40:11.071855|2017-02-18 16:40:11.071855
NCT00306865|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2017-01-24|||March 17, 2006||2006-03-17|October 14, 2010|2010-10-14|October 14, 2010||2010-10-14|||||Observational|||Brain Changes in Patients With Focal Hand Dystonia|Evaluation of Density and Pattern of Distribution of GABA A Receptors in the Brain of Patients With Focal Hand Dystonia Studied With PET Using [11C] Flumazenil|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:40:11.173064|2017-02-18 16:40:11.173064
NCT00306852|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2015-10-22|2015-07-24||October 1999||1999-10-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Tube Versus Trabeculectomy (TVT) Study|Tube Versus Trabeculectomy (TVT) Study|Completed||N/A|212|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 16:40:11.257012|2017-02-18 16:40:11.257012
NCT00306839|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2009-02-12|||February 2006||2006-02-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|||||Interventional|||Efficacy Study of Tissucol/Tisseel Fibrin Sealant to Treat Inguinal Hernia|Prospective, Controlled, Randomized Study to Evaluate Pain and Further Disabling Complications in Patients Undergoing Lichtenstein Technique for Primary Inguinal Hernia Repair by Fixing the Mesh With Fibrin Sealant Versus Sutures|Completed||Phase 4|325|Actual|University of Milan||2|||f||||t||||||||||2017-02-18 16:40:11.775689|2017-02-18 16:40:11.775689
NCT00306826|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2010-02-01||||||June 2008|2008-06-01|May 2009||2009-05-01|||||Interventional|||Pioglitazone in Impaired Glucose Tolerance|Effect of Pioglitazone on Intima Media Thickness, Endothelial Function, and Heart Rate Variability in Patients With Impaired Glucose Tolerance|Withdrawn||Phase 4|120||University of Leipzig||||financial support withdrawn|f||||||||||||||2017-02-18 16:40:12.008252|2017-02-18 16:40:12.008252
NCT00306813|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2009-08-03|||September 2004||2004-09-01|March 2006|2006-03-01|December 2008||2008-12-01|||||Interventional|||Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma|A Multicenter Phase I/II Trial Evaluating the Safety and Efficacy of Lenalidomide (Revlimid, CC-5013) in Combination With Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|53|Anticipated|University of Wuerzburg|||||f||||||||||||||2017-02-18 16:40:12.121697|2017-02-18 16:40:12.121697
NCT00306800|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2010-09-01|||September 2007||2007-09-01|September 2010|2010-09-01|October 2007|Actual|2007-10-01|||||Interventional|||Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp|A Multicenter, Double Blind, Vehicle-Controlled, Randomized Study of Photodynamic Therapy (PDT) With Metvix 160 Mg/g Cream and Aktilite CL128 LED Light in Patients With Multiple Actinic Keratosis on the Face and/or Scalp|Completed||Phase 3|80|Anticipated|Galderma|||||f||||||||||||||2017-02-18 16:40:12.221519|2017-02-18 16:40:12.221519
NCT00306787|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2011-06-28|2009-08-20||March 2006||2006-03-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes|A Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Patient-initiated Famciclovir 1000 mg b.i.d. x 1 Day to Valacyclovir 500 mg b.i.d. x 3 Days in Immunocompetent Adults With Recurrent Genital Herpes|Completed||Phase 3|1179|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:40:12.324957|2017-02-18 16:40:12.324957
NCT00306774|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2011-09-21|||March 2006||2006-03-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Vitamin D to Slow Progression of Knee Osteoarthritis|Trial of Vitamin D to Reduce the Progression of Knee Osteoarthritis: A Double-Blind, Placebo-Controlled Once Daily Dosing Regimen|Completed||Phase 2|146|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-02-18 16:40:13.018128|2017-02-18 16:40:13.018128
NCT00306761|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2014-09-15|||April 2006||2006-04-01|September 2014|2014-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Dynamic Wheelchair Seating on Spasticity and Functional Mobility in Children|Effects of Dynamic Wheelchair Seating on Spasticity and Functional Mobility in Children|Completed||N/A|20|Anticipated|Montana State University|||||f||||f||||||||||2017-02-18 16:40:13.132519|2017-02-18 16:40:13.132519
NCT00306748|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2009-03-22|||March 2006||2006-03-01|March 2009|2009-03-01|August 2006||2006-08-01|||||Interventional|||Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation|A Randomized, Multicenter, Double-Blind, Parallel-Design, Phase 2 Trial of Oral MD-1100 Acetate Administered for 14 Days Once Daily at 100 ug, 300 ug, 1000 ug, or Placebo to Patients With Chronic Constipation|Completed||Phase 2|40||Ironwood Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:40:13.226051|2017-02-18 16:40:13.226051
NCT00306735|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2016-12-01|||March 2006||2006-03-01|November 2015|2015-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.|A Double-blind Phase 2 Study to Assess the Safety and Efficacy of Aloxi (Palonosetron HCl) for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving High-dose Melphalan as Conditioning Chemotherapy for Stem Cell Transplantation|Completed||Phase 2|75|Anticipated|Eisai Inc.||1|||f||||f||||||||||2017-02-18 16:40:13.335569|2017-02-18 16:40:13.335569
NCT00306722|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2008-11-06|||April 2006||2006-04-01|November 2008|2008-11-01|May 2007|Actual|2007-05-01|||||Interventional|||An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy|A Phase 3, Randomized, Double-Blind, Dose-Controlled Study To Assess The Efficacy And Safety Of AQUAVAN® (Fospropofol Disodium) Injection For Minimal-To-Moderate Sedation In Patients Undergoing Flexible Bronchoscopy|Completed||Phase 3|250||Eisai Inc.|||||||||||||||||||2017-02-18 16:40:13.447134|2017-02-18 16:40:13.447134
NCT00306709|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2010-09-17|||February 2005||2005-02-01|September 2010|2010-09-01|June 2010|Actual|2010-06-01|June 2007|Actual|2007-06-01||Interventional|||Take HEED (Healthy Eating and Exercise Decisions)|Take HEED (Healthy Eating and Exercise Decisions)|Completed||N/A|223|Actual|Kaiser Permanente||1|||f||||f||||||||||2017-02-18 16:40:13.570915|2017-02-18 16:40:13.570915
NCT00306696|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2016-09-13|||October 2002||2002-10-01|September 2016|2016-09-01|January 2004|Actual|2004-01-01|||||Interventional|||Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.|A Randomised Study Examining the Effect of Different Diuretics on Fluid Balance in Diabetics Treated With Avandia|Completed||Phase 4|388|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:40:13.68052|2017-02-18 16:40:13.68052
NCT00306683|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2011-02-17|||April 2006||2006-04-01|April 2007|2007-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions|Clinical Assessment of the Treatment With Diazoxide in Children Suffering From Obesity and Hyperinsulinemia Secondary to Surgery of Hypothalamic-pituitary Lesions|Completed||Phase 3|40|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:40:13.833273|2017-02-18 16:40:13.833273
NCT00306670|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2016-12-20|2016-12-20||April 2006||2006-04-01|December 2016|2016-12-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional||Patients diagnosed with acquired FVIII inhibitors were to be randomized to Rituximab versus oral cyclophosphamide to evaluate efficacy of inhibitor eradication and safety|Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A|A Prospective, Phase II/III Randomized, Mult-institutional Controlled, Open-label, Phase II Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Patients With Acquired Hemophilia A|Terminated||Phase 2/Phase 3|2|Actual|Georgetown University|Sponsor terminated study prior to patient receiving first dose of study drug.|2||Sponsor no longer funding study.|f||||f||||||||||2017-02-18 16:40:13.935192|2017-02-18 16:40:13.935192
NCT00306657|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2011-06-23|||March 2006||2006-03-01|April 2007|2007-04-01|December 2012|Anticipated|2012-12-01|||||Interventional|||Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition|Normal Tension and Chronic Open Angle Glaucoma, Cerebrospinal Fluid Composition in Subarachnoid Space of Affected Optic Nerves|Unknown status|Recruiting|N/A|30|Anticipated|Kantonsspital Aarau|||||f||||||||||||||2017-02-18 16:40:14.244865|2017-02-18 16:40:14.244865
NCT00306644|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2016-08-31|||May 2002||2002-05-01|August 2016|2016-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes|Effect of Rosiglitazone and Placebo on Carotid Intima Media Thickness in Patients With Insulin Resistance Syndrome and/or Type 2 Diabetes|Completed||Phase 4|556|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:40:14.348232|2017-02-18 16:40:14.348232
NCT00306631|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2009-06-02|||January 2006||2006-01-01|June 2009|2009-06-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|||A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1|A Phase 2 Study of Oral MKC-1 Administered Twice Daily for 14 Consecutive Days Every 4 Weeks in Patients With Advanced or Metastatic Breast Cancer|Completed||Phase 2|65|Actual|CASI Pharmaceuticals, Inc.||1|||f||||t||||||||||2017-02-18 16:40:14.457451|2017-02-18 16:40:14.457451
NCT00306618|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2008-12-09|||January 2006||2006-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma|A Single-Center, Open-Label, Phase II, Safety, Pharmacokinetic and Efficacy of Panzem Nanocrystal Colloidal Dispersion Administered Orally to Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|27|Actual|CASI Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 16:40:14.555564|2017-02-18 16:40:14.555564
NCT00306605|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2008-11-06|||March 2006||2006-03-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Observational|||Emotional Experiences in Fathers of NICU Infants|Emotional Experiences in Fathers of NICU Babies: A Comparison of Fathers in Medical and Surgical NICUs.|Completed||N/A|50|Anticipated|Christiana Care Health Services|||1||f||||f||||||||||2017-02-18 16:40:14.646038|2017-02-18 16:40:14.646038
NCT00306592|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-03-11|2009-06-30||March 2006||2006-03-01|March 2015|2015-03-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional||Participants from 101-MS-322 (NCT00306592) and 101-MS-321 (NCT00297232) are combined.|Natalizumab Re-Initiation of Dosing|An Open-Label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801, C-1802, or C-1803 and a Dosing Suspension Safety Evaluation|Completed||Phase 3|404|Actual|Biogen||1|||f||||f||||||||||2017-02-18 16:40:14.953912|2017-02-18 16:40:14.953912
NCT00306579|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2006-03-23|||August 2003||2003-08-01|March 2006|2006-03-01|May 2005||2005-05-01|||||Observational|||Myocardial Damage In Patients With Cerebral Infarction|Myocardial Damage In Patients With Cerebral Infarction. Prevalence and Characteristics as Measured by Troponins, Electrocardiographic Changes and Myocardial Perfusion Imaging.|Completed||Phase 4|250||Danish Heart Foundation|||||f||||||||||||||2017-02-18 16:40:15.500209|2017-02-18 16:40:15.500209
NCT00306566|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2007-09-19||||||September 2007|2007-09-01||||||||Interventional|||Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients|A Phase IIa Study to Evaluate Safety, Tolerability, and Immunogenicity of a Melan-A VLP Vaccine in HLA-A2 Positive Patients With Stage II Malignant Melanoma|Completed||Phase 1/Phase 2|||Cytos Biotechnology AG|||||f||||||||||||||2017-02-18 16:40:15.569136|2017-02-18 16:40:15.569136
NCT00306553|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2006-09-18||||||September 2006|2006-09-01||||||||Interventional|||Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients||Completed||Phase 2|||Cytos Biotechnology AG|||||f||||||||||||||2017-02-18 16:40:15.641337|2017-02-18 16:40:15.641337
NCT00306540|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2010-12-08|||December 2004||2004-12-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|September 2007|Actual|2007-09-01||Interventional|||Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder|A Multicentre, Parallel Group, Randomised, Double Blind, Placebo Controlled Study of the Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder|Completed||Phase 3|90|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:40:15.7176|2017-02-18 16:40:15.7176
NCT00306332|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2009-08-17|||March 2006||2006-03-01|August 2009|2009-08-01||||||||Interventional|||T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation|T-cel and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation by Using Immunomagnetic Negative and Positive Selection Procedures|Terminated||Phase 3|250|Anticipated|Radboud University||||Interim analysis has shown that the objectives of this study can not be reached|f||||||||||||||2017-02-18 16:40:24.375823|2017-02-18 16:40:24.375823
NCT00306527|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2016-02-08|2012-12-06||September 2005||2005-09-01|February 2016|2016-02-01|April 2006|Actual|2006-04-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly|A Phase III, Observer-Blind, Randomized, Multi-Center Study to Evaluate Safety, Tolerability and Immunogenicity (in a Subset) Following a Single Intramuscular Dose of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs, in Healthy Adult and Elderly Subjects Who Received Either One or the Other Vaccine One Year Before in the V58P4 Study.|Completed||Phase 3|2235|Actual|Novartis||8|||f||||||||||||||2017-02-18 16:40:15.831537|2017-02-18 16:40:15.831537
NCT00306514|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-23|2007-09-19||||||September 2007|2007-09-01||||||||Interventional|||Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients|A Phase IIa Study to Evaluate Safety, Tolerability, and Immunogenicity of a Melan-A VLP Vaccine in HLA-A2 Positive Patients With Stage III/IV Malignant Melanoma|Completed||Phase 1/Phase 2|||Cytos Biotechnology AG|||||f||||||||||||||2017-02-18 16:40:17.429495|2017-02-18 16:40:17.429495
NCT00306501|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2017-01-24|||March 17, 2006||2006-03-17|October 29, 2010|2010-10-29|December 16, 2009|Actual|2009-12-16|December 16, 2009|Actual|2009-12-16||Interventional|||Volitional Swallowing in Stroke Patients With Chronic Dysphagia|Induction of Volitional Swallowing in Chronic Dysphagia Post Stroke: A Novel Mechanism-Based Intervention|Completed||Phase 2|34|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-02-18 16:40:17.508159|2017-02-18 16:40:17.508159
NCT00306488|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2011-08-16|2011-04-21||March 2006||2006-03-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration|A Phase II Study of OT-551 Antioxidant Eye Drop in Participants With Bilateral Geographic Atrophy Associated With Age-Related Macular Degeneration|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 16:40:17.62309|2017-02-18 16:40:17.62309
NCT00306475|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2010-01-06|||March 2006||2006-03-01|January 2010|2010-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?|Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?|Completed||Phase 4|60|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 16:40:18.038239|2017-02-18 16:40:18.038239
NCT00306462|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2009-11-06|||March 2006||2006-03-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor|Randomized Double-Blinded Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor Between 24 to 32 6/7 Weeks' Gestation|Terminated||N/A|33|Actual|University of Cincinnati||2||No enrollment in past year, lack of interest|f||||f||||||||||2017-02-18 16:40:18.137672|2017-02-18 16:40:18.137672
NCT00306449|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2006-03-21|||September 2002||2002-09-01|March 2006|2006-03-01|September 2005||2005-09-01|||||Interventional|||Prevention of Weight Gain in Young Adults|Prevention of Weight Gain in Young Adults|Completed||N/A|110||Université de Sherbrooke|||||f||||||||||||||2017-02-18 16:40:18.250817|2017-02-18 16:40:18.250817
NCT00306436|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2007-06-12|||May 2006||2006-05-01|June 2007|2007-06-01|May 2008|Anticipated|2008-05-01|||||Interventional|||Comprehensive Management of Diabetic Patients With Renal Impairment : Impact on Blood Pressure and Glycemic Control|Evaluation of the Impact of a Comprehensive Clinical Management on the Quality of Blood Pressure and Glycemic Control in Diabetic Uremic Patients|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Bordeaux||1|||f||||t||||||||||2017-02-18 16:40:18.345339|2017-02-18 16:40:18.345339
NCT00306423|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2012-06-15|||June 2003||2003-06-01|June 2012|2012-06-01|September 2012|Anticipated|2012-09-01|December 2011|Actual|2011-12-01||Interventional|||Rehabilitation Post Lumbar Microdiscectomy||Unknown status|Active, not recruiting|Phase 1|100|Anticipated|University of Southern California||1|||f||||||||||||||2017-02-18 16:40:18.446916|2017-02-18 16:40:18.446916
NCT00306410|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2007-02-28|||January 2006||2006-01-01|February 2007|2007-02-01|July 2007||2007-07-01|||||Interventional|||The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients|The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients|Unknown status|Recruiting|Phase 2|85||Radboud University|||||f||||||||||||||2017-02-18 16:40:18.53639|2017-02-18 16:40:18.53639
NCT00306397|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2010-06-29|||January 2005||2005-01-01|June 2010|2010-06-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients|Open, Single Centre, Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for De Novo Renal Transplant Recipients Followed by Randomisation to Calcineurin Inhibitor Containing or Calcineurin Inhibitor Free Immunosuppression|Completed||Phase 4|100|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 16:40:18.632118|2017-02-18 16:40:18.632118
NCT00306384|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2013-02-17|2013-02-17||March 2006||2006-03-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus|A Long-Term, Open-Label Extension Study to Investigate the Long-Term Safety of SYR110322 (SYR-322) in Subjects With Type 2 Diabetes|Completed||Phase 3|3323|Actual|Takeda||2|||f||||f||||||||||2017-02-18 16:40:18.758878|2017-02-18 16:40:18.758878
NCT00306371|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2006-03-22|||July 2004||2004-07-01|July 2004|2004-07-01|February 2006||2006-02-01|||||Observational|||Comparison of Stacked-Pulses Vs. Double-Pass Treatments of Facial Acne With a 1450 Nm Laser|Comparison of Stacked-Pulses Vs. Double-Pass Treatments of Facial Acne With a 1450 Nm Laser|Completed||N/A|15||Skincare Physicians of Chestnut Hill|||||f||||||||||||||2017-02-18 16:40:24.118767|2017-02-18 16:40:24.118767
NCT00306358|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2006-03-22|||May 2005||2005-05-01|March 2006|2006-03-01|October 2005||2005-10-01|||||Interventional|||Plasma Holotranscobalamin as Compared to Plasma Cobalamins for Assessment of Vitamin B12 Absorption|Plasma Holotranscobalamin as Compared to Plasma Cobalamins for Assessment of Vitamin B12 Absorption. Optimisation of a Non-Radioactive Vitamin B12 Absorption Test (CobaSorb)|Completed||N/A|78||University of Aarhus|||||f||||||||||||||2017-02-18 16:40:24.197967|2017-02-18 16:40:24.197967
NCT00306345|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2007-07-11|||January 2006||2006-01-01|February 2007|2007-02-01|December 2008||2008-12-01|||||Observational|||Outreach: A Programme for Timely Treatment of Critically Ill Patients in a University Hospital|Outreach: A Programme for Early Recognition, Quick Response and Timely Treatment of Critically Ill Patients in a University Hospital|Unknown status|Recruiting|N/A|1500|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 16:40:24.278525|2017-02-18 16:40:24.278525
NCT00306306|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2008-08-04|||March 2006||2006-03-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||COOL RCN: Cooling to Prevent Radiocontrast Nephropathy|COOL RCN: Cooling to Prevent Radiocontrast Nephropathy in Patients Undergoing Diagnostic or Interventional Catheterization|Terminated||Phase 2/Phase 3|400|Anticipated|Radiant Medical|||||||||||||||||||2017-02-18 16:40:24.562059|2017-02-18 16:40:24.562059
NCT00306293|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2016-12-21|||February 2006||2006-02-01|December 2016|2016-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2|The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection|Completed||Phase 4|66|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:40:24.64697|2017-02-18 16:40:24.64697
NCT00306280|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2006-09-19|||March 2006||2006-03-01|September 2006|2006-09-01|March 2007||2007-03-01|||||Interventional|||Feasibility Study of Phototherapy System to Treat H Pylori|Phase 1 Study of Phototherapy System to Treat H Pylori|Unknown status|Recruiting|N/A|60||LumeRx|||||||||||||||||||2017-02-18 16:40:24.752546|2017-02-18 16:40:24.752546
NCT00306267|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2011-05-17|||March 2006||2006-03-01|March 2010|2010-03-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy|A Pilot Study to Evaluate the Safety and Efficacy of PROCRIT (Epoetin Alfa) 80,000 Units Once Every Four Weeks (Q4W) vs. 40,000 Units Once Every Two Weeks (Q2W) in Cancer Subjects With Non-Chemotherapy Anemia (NCA)|Terminated||Phase 2|61|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"Study stopped as it would not address important survival concerns raised in other recently~   conducted clinical studies."|||||f||||||||||2017-02-18 16:40:24.830067|2017-02-18 16:40:24.830067
NCT00306254|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2007-10-05|||March 2006||2006-03-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery|A Phase 2B, Randomized, Multicenter, Dose-Ranging Study Assessing the Safety and Efficacy of PD 0348292 in the Prevention of Venous Thromboembolic Events (VTE) in Subjects Undergoing an Elective, Unilateral Total Knee Replacement|Completed||Phase 2|1225||Pfizer|||||f||||||||||||||2017-02-18 16:40:25.183779|2017-02-18 16:40:25.183779
NCT00306241|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-11-02|||March 2006||2006-03-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years|A Phase III, Double-blind, Randomized, Controlled Study to Evaluate Immunogenicity and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine, Administered Intramuscularly (0, 1, 6 Month Schedule) in Healthy Females Aged 18 - 35 Years|Completed||Phase 3|300|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:40:25.411228|2017-02-18 16:40:25.411228
NCT00306228|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2009-09-25|||October 2004||2004-10-01|September 2009|2009-09-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|GRACIA3||Role of Tirofiban and the Paclitaxel Eluting Stent in Postfibrinolysis Angioplasty|A Randomised Trial to Evaluate the Role of Paclitaxel Eluting Stent and Tirofiban to Improve the Results of Facilitated PCI in the Treatment of Acute ST- Segment Elevation Myocardial Infarction|Completed||Phase 4|436|Actual|GRACIA Group||4|||f||||t||||||||||2017-02-18 16:40:25.52425|2017-02-18 16:40:25.52425
NCT00306215|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2012-02-08|||March 2006||2006-03-01|February 2012|2012-02-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease|A Multinational, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease|Completed||Phase 2|436|Actual|ChemoCentryx||4|||f||||t||||||||||2017-02-18 16:40:25.651941|2017-02-18 16:40:25.651941
NCT00306202|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2016-12-08|2012-06-11||March 2006||2006-03-01|December 2016|2016-12-01|October 2022|Anticipated|2022-10-01|May 2011|Actual|2011-05-01||Interventional|||Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia|Phase I Study of SRC/ABL Tyrosine Kinase Inhibitor Dasatinib [BMS-354825] in Children and Adolescents With Relapsed or Refractory Leukemia, Protocol ITCC 005|Active, not recruiting||Phase 1|58|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 16:40:26.033162|2017-02-18 16:40:26.033162
NCT00306189|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2013-06-13|2009-12-22||January 2006||2006-01-01|June 2013|2013-06-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects|Dose Response Study of AMG 162 (Denosumab) in Subjects With Osteoporosis - A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects -|Completed||Phase 2|212|Actual|Amgen||4|||f||||||||||||||2017-02-18 16:40:30.315181|2017-02-18 16:40:30.315181
NCT00306176|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2007-04-03|||January 2005||2005-01-01|April 2007|2007-04-01|October 2006||2006-10-01|||||Interventional|||Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus|Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|100||Aristotle University Of Thessaloniki|||||f||||||||||||||2017-02-18 16:40:30.916215|2017-02-18 16:40:30.916215
NCT00306163|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-22|2016-12-02|2010-04-06||May 2006||2006-05-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)|Nebulizer Trial: Evaluation of the Influence of Particle Size of Aerosolized AMP on Bronchial Responsiveness in Patients With Asthma and the Effects of Treatment With Ciclesonide Versus Fluticasone.|Completed||Phase 3|37|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:40:31.017677|2017-02-18 16:40:31.017677
NCT00306150|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-12-16|||December 2005||2005-12-01|December 2014|2014-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy|A Multi-center, Randomized, Double Blind, Placebo Controlled Study to Investigate the Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients With Bladder Cancer Undergoing Radical or Total Cystectomy.|Terminated||Phase 3|57|Actual|Bayer||2|||f||||||||||||||2017-02-18 16:40:31.311344|2017-02-18 16:40:31.311344
NCT00294853|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2011-07-03|||December 2005||2005-12-01|April 2008|2008-04-01|June 2007||2007-06-01|||||Interventional|||Multi Detector-Row Computed Tomography (MDCT) Calcium Score of Heart Transplanted Patients|MDCT Calcium Score of Heart Transplanted Patients|Completed||N/A|240|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-02-18 16:44:25.418002|2017-02-18 16:44:25.418002
NCT00306137|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-12-08|||December 2005||2005-12-01|December 2014|2014-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung Cancer or Esophageal Cancer|Terminated||Phase 3|104|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:40:31.461838|2017-02-18 16:40:31.461838
NCT00306124|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2007-10-24|||January 2006||2006-01-01|October 2007|2007-10-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment|Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Dementia/MCI)|Unknown status|Recruiting|Phase 4|120|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-02-18 16:40:31.584768|2017-02-18 16:40:31.584768
NCT00306111|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2014-05-28|||January 2006||2006-01-01|December 2012|2012-12-01|December 2011|Actual|2011-12-01|December 2008|Actual|2008-12-01||Interventional|||Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma|Pegfilgrastim Versus Filgrastim - Intraindividual Comparison of Quantity and Quality of Mobilized Peripheral Blood Stem Cells in Patients With Non Hodgkin-lymphoma|Completed||Phase 2|14|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-02-18 16:40:31.684707|2017-02-18 16:40:31.684707
NCT00306098|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2016-11-09|||December 2000||2000-12-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Interventional|||Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression|Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression|Active, not recruiting||Phase 2|40|Anticipated|University of Miami||1|||f||||t||||||||||2017-02-18 16:40:31.796556|2017-02-18 16:40:31.796556
NCT00306085|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-03-21|||April 2005||2005-04-01|March 2006|2006-03-01|April 2006||2006-04-01|||||Interventional|||Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis|Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis|Unknown status|Recruiting|Phase 1|20||University of Naples|||||f||||||||||||||2017-02-18 16:40:31.908612|2017-02-18 16:40:31.908612
NCT00306072|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2010-01-26|||June 2005||2005-06-01|March 2006|2006-03-01|September 2005||2005-09-01|||||Interventional|||Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes|Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes|Completed||Phase 1/Phase 2|82||Ross Products|||||f||||||||||||||2017-02-18 16:40:31.989995|2017-02-18 16:40:31.989995
NCT00306059|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-12-04|||January 2013||2013-01-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Early Goal Directed Therapy for Acute Kidney Injury|Early Goal Directed Therapy for Acute Kidney Injury|Unknown status|Recruiting|Phase 2|340|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:40:32.095204|2017-02-18 16:40:32.095204
NCT00306046|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2006-03-20|||February 2002||2002-02-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone|Use of 18F-Fluoride Positron Emission Tomography in the Assessment and Evaluation of Therapy in Monostotic Paget's Disease of Bone|Completed||N/A|20||Université Catholique de Louvain|||||f||||||||||||||2017-02-18 16:40:32.300442|2017-02-18 16:40:32.300442
NCT00306033|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2006-03-31|||March 2004||2004-03-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis|IVIG Treatment Compared to Placebo in Patients With Myasthenia Gravis: A Randomized Clinical Trial|Completed||Phase 3|50||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:40:32.395996|2017-02-18 16:40:32.395996
NCT00306020|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2012-07-03|||January 2006||2006-01-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain|Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain|Withdrawn||N/A|0|Actual|Soroka University Medical Center||||"The study was withdrawn due to difficulties in recruiting appropriate patients in community~   clinic setting"|f||||||||||||||2017-02-18 16:40:32.486283|2017-02-18 16:40:32.486283
NCT00306007|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2013-06-23|||November 2005||2005-11-01|June 2013|2013-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|LMUP||Evaluation of the Reliability, Validity, and Acceptability of the London Measure of Unplanned Pregnancy in a U.S. Population of Women|Evaluation of the Reliability, Validity, and Acceptability of the London Measure of Unplanned Pregnancy in a U.S. Population of Women|Completed||Phase 4|320|Actual|University of California, San Francisco|||4||f||||f||||||||||2017-02-18 16:40:32.577823|2017-02-18 16:40:32.577823
NCT00305981|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2007-04-17|||October 2005||2005-10-01|October 2005|2005-10-01||||||||Observational|||The ICU Care Knowledge Study|The ICU Care Knowledge Study: A Prospective Study of Family Members' Knowledge of ICU Care and Prognosis|Completed||N/A|154||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:40:32.659617|2017-02-18 16:40:32.659617
NCT00305968|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2011-12-20|||January 2006||2006-01-01|December 2011|2011-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of Patient Education in Irritable Bowel Syndrome|Evaluation of Patient Education in Patients With Irritable Bowel Syndrome - a Randomized Multi Center Study|Completed||Phase 3|200|Actual|Sorlandet Hospital HF||1|||f||||||||||||||2017-02-18 16:40:32.723283|2017-02-18 16:40:32.723283
NCT00305955|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2010-03-23|||August 2004||2004-08-01|October 2009|2009-10-01|October 2006|Actual|2006-10-01|July 2006|Actual|2006-07-01||Observational|ATS7||Bilateral Refractive Amblyopia Treatment Study|Bilateral Refractive Amblyopia Treatment Study|Completed||Phase 3|113|Actual|Jaeb Center for Health Research|||1||f||||f||||||||||2017-02-18 16:40:32.811486|2017-02-18 16:40:32.811486
NCT00305942|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2013-01-24|2012-12-18||March 2006||2006-03-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|||Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer|A Phase II Trial of Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|61|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:40:32.916157|2017-02-18 16:40:32.916157
NCT00305929|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2010-05-31|||March 2006||2006-03-01|May 2010|2010-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure|Phase II Study of Photodynamic Therapy With WST09 in Patients With Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure - Repeat Procedure|Completed||Phase 2|8|Anticipated|STEBA France||1|||f||||f||||||||||2017-02-18 16:40:33.467215|2017-02-18 16:40:33.467215
NCT00305916|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2008-02-22|||February 2006||2006-02-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|CMD-scanner||Multislice Spiral Computed Tomography and Cardiomyopathy|"Accuracy of Multislice Spiral Computed Tomography in Diagnosis of Coronary Artery Disease Associated to Idiopathic Cardiomyopathy in Sinus Rhythm (MSCT-IC Study)."|Completed||N/A|60|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-02-18 16:40:33.57878|2017-02-18 16:40:33.57878
NCT00305903|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2007-12-17|||March 2006||2006-03-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease|A Prospective, 26-Week, Open-Label, Multi-Center, Single-Arm Pilot Study to Evaluate the Safety and Tolerability of Rivastigmine Capsule With Add on Memantine HCl in Patients With Probable Alzheimer's Disease (MMSE 10-20)|Completed||Phase 4|150|Anticipated|Novartis|||||||||||||||||||2017-02-18 16:40:33.707703|2017-02-18 16:40:33.707703
NCT00305890|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2014-07-11|||January 2004||2004-01-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Weight Management and Coping Skills Training For Patients With Knee Osteoarthritis|Duke University Pain Prevention: Weight Management and Coping Skills Training For Patients With Osteoarthritis of the Knee|Completed||N/A|412|Actual|Duke University||4|||f||||t||||||||||2017-02-18 16:40:33.800181|2017-02-18 16:40:33.800181
NCT00305877|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-05-06|2013-09-24||February 2006||2006-02-01|December 2012|2012-12-01|February 2012|Actual|2012-02-01|July 2008|Actual|2008-07-01||Interventional||All treated patients are included in this analysis.|Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery|An Intergroup Randomized Phase II Study of Bevacizumab (NSC 704865) or Cetuximab (NSC 714692) in Combination With Gemcitabine and in Combination With Chemoradiation (Capecitabine and Radiation) in Patients With Completely-Resected Pancreatic Carcinoma|Completed||Phase 2|137|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:40:33.917426|2017-02-18 16:40:33.917426
NCT00305864|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-04-29|2013-03-05||February 2006||2006-02-01|October 2011|2011-10-01|March 2011|Actual|2011-03-01|February 2011|Actual|2011-02-01||Interventional|||Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma|A PHASE I/II TRIAL OF TEMOZOLOMIDE, MOTEXAFIN GADOLINIUM, AND 60 GY FRACTIONATED RADIATION FOR NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA MULTIFORME|Completed||Phase 1/Phase 2|118|Actual|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 16:40:34.484109|2017-02-18 16:40:34.484109
NCT00305851|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2016-02-19|||April 2006||2006-04-01|February 2016|2016-02-01||||April 2012|Actual|2012-04-01||Interventional|||Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant|Music Video and Adolescent/Young Adult Resilience During Transplant|Completed||Phase 3|118|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 16:40:36.044785|2017-02-18 16:40:36.044785
NCT00305838|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2013-08-09|||March 2004||2004-03-01|June 2009|2009-06-01||||December 2008|Anticipated|2008-12-01||Interventional|||CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen|Use of Changes in CA 125 Doubling Time to Detect Activity of Cytostatic Agents in Women Relapsing With Ovarian Carcinoma. Study 1-Tamoxifen|Unknown status|Recruiting|Phase 2|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:40:36.174526|2017-02-18 16:40:36.174526
NCT00305825|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2015-01-09|||August 2004||2004-08-01|January 2015|2015-01-01|November 2017|Anticipated|2017-11-01|November 2015|Anticipated|2015-11-01||Interventional|||Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery|A Phase II Study of Letrozole in Combination With Bevacizumab in Patients With Estrogen Receptor- and/or Progesterone Receptor-Positive Unresectable Locally Advanced and/or Metastatic (Stage IV) Breast Cancer|Active, not recruiting||Phase 2|43|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:40:36.295858|2017-02-18 16:40:36.295858
NCT00305812|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2010-11-07|||December 2005||2005-12-01|March 2010|2010-03-01|June 2008|Actual|2008-06-01|||||Interventional|||Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma|A Randomized Phase II Dose Finding Study of Revlimid™ and Melphalan in Patients With Previously Untreated Multiple Myeloma|Completed||Phase 2|92|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 16:40:36.41332|2017-02-18 16:40:36.41332
NCT00305799|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-11-20|||November 2005||2005-11-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|December 2012|Actual|2012-12-01||Observational|||Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors|Auditory and Vestibular Function Evaluation in Patients With Solid Tumors Treated With Oxaliplatin-Containing Chemotherapy|Completed||N/A|59|Actual|Case Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 16:40:36.709461|2017-02-18 16:40:36.709461
NCT00305786|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2016-12-14|||August 2005||2005-08-01|December 2016|2016-12-01|May 2010|Actual|2010-05-01|December 2007|Actual|2007-12-01||Interventional|||Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Oxaliplatin in Combination With Gemcitabine for 2 Line Treatment of NSCLC Patients With Advanced and Metastatic Disease|Completed||Phase 2|30|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 16:40:36.819509|2017-02-18 16:40:36.819509
NCT00305773|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-04-30|2013-03-28||January 2006||2006-01-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|May 2009|Actual|2009-05-01||Interventional|||Vorinostat in Treating Patients With Acute Myeloid Leukemia|A Phase 2 Study of Suberoylanilide Hydroxamic Acid (SAHA) in Acute Myeloid Leukemia (AML)|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:40:36.934478|2017-02-18 16:40:36.934478
NCT00305760|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2015-06-18|2015-06-18||December 2005||2005-12-01|June 2015|2015-06-01||||February 2009|Actual|2009-02-01||Interventional|||Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer|A Safety and Efficacy Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected With the GM-CSF Gene in Combination With Erbitux (Cetuximab) for the Treatment of Advanced Pancreatic Adenocarcinoma|Completed||Phase 2|60|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:40:37.760886|2017-02-18 16:40:37.760886
NCT00305747|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-01-14|||August 2005||2005-08-01|January 2014|2014-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy|Phase I Study of Bioresponse-dim in Non-Metastatic, Hormone-Refractory Prostate Cancer Patients With Rising Serum PSA|Completed||Phase 1|12|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 16:40:38.024904|2017-02-18 16:40:38.024904
NCT00305734|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2013-01-24|||August 2006||2006-08-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer|Phase II Trial of PS-341 (Bortezomib, NSC-681239) Followed by the Addition of Gemcitabine at Progression in Recurrent or Metastatic Nasopharyngeal Carcinoma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:40:38.15267|2017-02-18 16:40:38.15267
NCT00305708|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2012-11-08|||August 2000||2000-08-01|November 2012|2012-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission|Bone Marrow Stem Cell Transplantation for Children With Stem Cell Defects, Marrow Failure Syndromes, or Myeloid Leukemia in 1Remission|Completed||Phase 1/Phase 2|40|Anticipated|University of California, San Francisco|||||f||||||||||||||2017-02-18 16:40:38.263225|2017-02-18 16:40:38.263225
NCT00305695|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2010-05-05|||November 2005||2005-11-01|April 2010|2010-04-01||||March 2013|Anticipated|2013-03-01||Observational|||Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries|A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Surgery That Results in Removal of Both Ovaries|Unknown status|Active, not recruiting|Phase 2|222|Anticipated|National Cancer Institute (NCI)|||2||f||||||||||||||2017-02-18 16:40:38.371061|2017-02-18 16:40:38.371061
NCT00305682|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2016-12-07|||June 2005||2005-06-01|December 2016|2016-12-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|||Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant|Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematological Malignancies Using a Non-Myeloablative Preparative Regimen|Recruiting||Phase 2|320|Anticipated|Masonic Cancer Center, University of Minnesota||6|||f||||t||||||||||2017-02-18 16:40:38.540241|2017-02-18 16:40:38.540241
NCT00305669|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2014-06-24|||July 2006||2006-07-01|June 2014|2014-06-01|June 2014|Actual|2014-06-01|January 2011|Actual|2011-01-01||Interventional|||GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer|A Pilot Study of Two Dose Schedules of Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) as Neo-Adjuvant Therapy in Patients With Localized Prostate Cancer|Completed||Phase 1|24|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:40:38.704141|2017-02-18 16:40:38.704141
NCT00305656|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2013-08-14||2013-07-26|January 2006||2006-01-01|July 2013|2013-07-01||||April 2012|Actual|2012-04-01||Interventional|||AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme|A Phase II Study of AZD2171 in Recurrent Glioblastoma|Completed||Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:40:38.811733|2017-02-18 16:40:38.811733
NCT00305643|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2015-11-19|2012-01-25||February 2006||2006-02-01|November 2015|2015-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer|A Multicenter Phase III Placebo-Controlled Trial of Celecoxib for Prevention of Capecitabine-Induced Palmar/Plantar (Hand/Foot) Syndrome in Patients With Metastatic Breast and Colorectal Cancer|Terminated||Phase 3|11|Actual|M.D. Anderson Cancer Center|Due to low accrual in this trial, no outcome measures were evaluable.|2||Terminated due to low accrual. No data analyzed.|f||||t||||||||||2017-02-18 16:40:38.925724|2017-02-18 16:40:38.925724
NCT00305630|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2006-03-20|||July 2002||2002-07-01|March 2006|2006-03-01|November 2005||2005-11-01|||||Interventional|||Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)|Neovascular Age Related Macular Degeneration, Periocular Corticosteroids, and Photodynamic Therapy|Completed||Phase 2/Phase 3|100||Johns Hopkins University|||||||||||||||||||2017-02-18 16:40:39.415438|2017-02-18 16:40:39.415438
NCT00305617|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2011-05-13|||January 2004||2004-01-01|July 2009|2009-07-01||||December 2007|Actual|2007-12-01||Interventional|||Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer|Evaluation of CSF Levels of Tarceva (OSI-774) in Patients With Stage III Non-Small Cell Lung Cancer and No CNS Involvement Undergoing Treatment With Tarceva|Completed||N/A|10|Anticipated|The Cleveland Clinic|||||f||||||||||||||2017-02-18 16:40:39.502403|2017-02-18 16:40:39.502403
NCT00305604|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2015-02-03|2009-02-24||March 2006||2006-03-01|February 2015|2015-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)|A Multicenter, Double-Blind, Randomized, Parallel Group Study to Evaluate the Safety and Efficacy of Sitagliptin in Elderly Patients With Type 2 Diabetes Mellitus|Completed||Phase 3|206|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:40:39.594781|2017-02-18 16:40:39.594781
NCT00305591|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2015-05-28|||March 2006||2006-03-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.|Functional Magnetic Resonance Imaging and Spectroscopy of the Brain in Patients With Chronic Hepatic Encephalopathy|Completed||N/A|50|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 16:40:40.132175|2017-02-18 16:40:40.132175
NCT00305578|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-06-16|2015-06-30||August 2005||2005-08-01|June 2016|2016-06-01|December 2011|Actual|2011-12-01|December 2010|Actual|2010-12-01||Interventional|||Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression|Memantine Augmentation of Lamotrigine Incomplete Response in Bipolar Depression: A Randomized Placebo Controlled Clinical Trial|Completed||Phase 4|29|Actual|Indiana University|Small number of subjects|2|||f||||t||||||||No||2017-02-18 16:40:40.232915|2017-02-18 16:40:40.232915
NCT00305565|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2013-12-06|2011-01-06||January 2006||2006-01-01|December 2013|2013-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses|Randomized Comparison of Outcomes in Patients With Treatment-Resistant Depression Who Receive VNS Therapy Administered at Different Amounts of Electrical Charge|Completed||Phase 4|331|Actual|Cyberonics, Inc.||3|||f||||t||||||||||2017-02-18 16:40:40.645873|2017-02-18 16:40:40.645873
NCT00305552|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2011-04-29|||February 2005||2005-02-01|January 2007|2007-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||SARCOTHAL. Thalidomide in Skin Sarcoidosis|Randomized Controlled Trial of Thalidomide vs Placebo in Skin Sarcoidosis|Completed||Phase 3|40|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:40:45.119823|2017-02-18 16:40:45.119823
NCT00005465|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||August 1991||1991-08-01|May 2001|2001-05-01|July 1996||1996-07-01|||||Observational|||Genetic Mapping of Atherogenic Lipoprotein Phenotypes||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:14:57.111329|2017-02-18 18:14:57.111329
NCT00305539|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2012-07-06|||May 2006||2006-05-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis|HECTHOR: A Pilot Multicenter Double-blind Randomised Study of 3 Months Treatment With Humira Added to Steroids in Giant Cell Arteritis|Completed||Phase 3|69|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 16:40:45.224818|2017-02-18 16:40:45.224818
NCT00305526|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2007-08-08|||April 2006||2006-04-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||REBEAT Resynchronisation and Beta-Blocker European Trial|Resynchronisation and Beta-Blocker European Trial|Terminated||Phase 4|354|Anticipated|Guidant Corporation||||lack of enrolment|f||||||||||||||2017-02-18 16:40:45.562881|2017-02-18 16:40:45.562881
NCT00305513|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2010-06-02||||||March 2006|2006-03-01||||||||Interventional|||Effectiveness of Rehabilitation on the Recovery of Patients Post Right Stroke With Unilateral Spatial Neglect|Effectiveness of Rehabilitation (Phasic Alerting and Visual Spatial Scanning Training) on the Recovery of Patients Post Right Stroke With Unilateral Spatial Neglect: Using Functional Imaging PET and Standardized Neurobehavioral and Functional Tests|Unknown status|Not yet recruiting|Phase 2|6|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:40:45.650342|2017-02-18 16:40:45.650342
NCT00305500|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2006-07-25|||March 2006||2006-03-01|March 2006|2006-03-01|December 2006||2006-12-01|||||Interventional|||Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)|Phase III Open Study of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder in Adults|Completed||Phase 3|100||Abarbanel Mental Health Center|||||f||||||||||||||2017-02-18 16:40:45.738985|2017-02-18 16:40:45.738985
NCT00305487|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2016-11-29|||March 2006||2006-03-01|October 2016|2016-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Clinical Trial Designed to Assess the Safety and Efficacy of Ciclesonide (200mcg and 100mcg, Once Daily) Applied as a Nasal Spray for Two Weeks in the Treatment of Seasonal Allergic Rhinitis (SAR) in Patients 6 to 11 Years of Age|Completed||Phase 3|660||AstraZeneca|||||f||||||||||||||2017-02-18 16:40:45.846639|2017-02-18 16:40:45.846639
NCT00305474|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2009-06-23|||December 2003||2003-12-01|June 2009|2009-06-01||||January 2010|Anticipated|2010-01-01||Interventional|||Identification and Treatment of the Liability to Develop Schizophrenia|Identification and Treatment of the Liability to Develop Schizophrenia|Unknown status|Recruiting|Phase 4|100|Anticipated|Central South University||1|||f||||||||||||||2017-02-18 16:40:46.023498|2017-02-18 16:40:46.023498
NCT00305461|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-21|2016-12-02|||February 2006||2006-02-01|September 2016|2016-09-01|February 2008|Actual|2008-02-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)|A Pilot Study on the Impact of Two Different Doses of Ciclesonide (160 mcg/Day and 320 mcg/Day) Administered in the Evening on Quality of Life in Patients With Moderate Persistent Asthma.|Completed||Phase 3|101|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:40:46.117062|2017-02-18 16:40:46.117062
NCT00305448|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2012-02-14|2009-03-17||March 2006||2006-03-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|March 2008|Actual|2008-03-01||Interventional|FINDER I||A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg|Phase II Study to Evaluate the Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg in Postmenopausal Women With ER +ve Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy|Completed||Phase 2|143|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:40:46.236592|2017-02-18 16:40:46.236592
NCT00305435|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2014-09-11|||February 2006||2006-02-01|September 2014|2014-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety Study of AMG 531 in Japanese Subjects With ITP|An Open Label Phase 2 Study Evaluating the Safety of Starting Dose of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura|Completed||Phase 2|12|Actual|Kyowa Hakko Kirin Co., Ltd||1|||f||||f||||||||||2017-02-18 16:40:46.786312|2017-02-18 16:40:46.786312
NCT00305422|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2009-06-09|||November 2001||2001-11-01|June 2009|2009-06-01|January 2003|Actual|2003-01-01|||||Interventional|||Effect of Quetiapine on Negative Symptoms and Cognition|Efficacy of Quetiapine Compared to Risperidone on Negative Symptoms and Cognition With Regard to Underlying Neurobiological Mechanisms and Brain Activation.|Completed||Phase 3|45|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:40:46.885881|2017-02-18 16:40:46.885881
NCT00305409|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2009-02-10|||June 2006||2006-06-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Synbiotic Treatment in Crohn's Disease Patients|Synbiotic Treatment in Crohn's Disease Patients|Completed||N/A|50|Anticipated|University of Dundee|||||f||||||||||||||2017-02-18 16:40:46.964832|2017-02-18 16:40:46.964832
NCT00305396|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2006-03-20|||April 2004||2004-04-01|March 2006|2006-03-01|March 2005||2005-03-01|||||Interventional|||Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation|Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplant Recipients.|Completed||Phase 4|80||Vanderbilt University|||||f||||||||||||||2017-02-18 16:40:47.300941|2017-02-18 16:40:47.300941
NCT00305383|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2012-06-21|||November 2005||2005-11-01|June 2012|2012-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C|Analysis of Hepatitis C Viral Kinetics and Viramidine Pharmacokinetics Utilizing Two Treatment Regimens in Therapy-Naive Patients With Chronic Hepatitis C|Terminated||Phase 2|100||Valeant Pharmaceuticals International, Inc.||||Dose levels were determined to be subtherapeutic|f||||||||||||||2017-02-18 16:40:47.408233|2017-02-18 16:40:47.408233
NCT00305370|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-19|2008-08-06|||August 2005||2005-08-01|March 2006|2006-03-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD|Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Cross-Over Placebo Controlled Trial|Completed||Phase 4|20|Anticipated|Federal University of Rio Grande do Sul|||||f||||||||||||||2017-02-18 16:40:47.52516|2017-02-18 16:40:47.52516
NCT00305357|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2011-04-12|||November 2001||2001-11-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|November 2005|Actual|2005-11-01||Observational|||Evolution of Pain From Herpes Zoster|Evolution of Pain and Neural Dysfunction From Acute Herpes Zoster to Post-Herpetic Neuralgia|Completed||N/A|100|Anticipated|University of California, San Francisco|||1||f||||||||||||||2017-02-18 16:40:47.632747|2017-02-18 16:40:47.632747
NCT00305344|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2012-07-03|2012-03-02||April 2005||2005-04-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Umbilical Cord Blood Infusion to Treat Type 1 Diabetes|Transfusion of Autologous Umbilical Cord Blood to Reverse Hyperglycemia in Children With Type 1 Diabetes - A Pilot Study|Completed||Phase 1/Phase 2|23|Actual|University of Florida|Small sample size. No randomized control group|1|||f||||t||||||||||2017-02-18 16:40:47.721569|2017-02-18 16:40:47.721569
NCT00305331|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2012-07-26|||March 2006||2006-03-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease|Phase II Clinical Trial of Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease|Terminated||Phase 2|25|Anticipated|University Health Network, Toronto||1||lack of recruitment|f||||||||||||||2017-02-18 16:40:47.998348|2017-02-18 16:40:47.998348
NCT00305305|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2017-01-09|||August 2003||2003-08-01|January 2017|2017-01-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Brain Development Research Program|Disorders of Cerebral Development: A Phenotypic and Genetic Analysis|Recruiting||N/A|2000|Anticipated|University of California, San Francisco|||1||f||||||||||||||2017-02-18 16:40:48.100878|2017-02-18 16:40:48.100878
NCT00305292|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2011-03-23|||March 2006||2006-03-01|March 2011|2011-03-01|August 2006||2006-08-01|||||Interventional|||Modafinil-Alcohol Interactions in Healthy Volunteers|"Modafinil-Alcohol Interactions Assessed Using Tests of Thermal Stimulation, Cognition, Mood, and Motor Function in Healthy Volunteers"|Terminated||N/A|32||University of California, San Francisco||||"This study should be terminated as the study closed prior to 2007 and the investigator has~   since retired. No records are available."|f||||||||||||||2017-02-18 16:40:48.216566|2017-02-18 16:40:48.216566
NCT00305279|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2013-10-09|||February 2006||2006-02-01|October 2013|2013-10-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||The Effects of Dietary Phosphate Intake on Calciotropic Hormones and FGF23.|The Effects of Dietary Phosphate Intake on Calciotropic Hormones and FGF23|Withdrawn||N/A|0|Actual|University of California, San Francisco||3|||f||||||||||||||2017-02-18 16:40:48.302997|2017-02-18 16:40:48.302997
NCT00305266|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2007-11-30|||August 2005||2005-08-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Observational|||Study of CIDP Patients During IVIG Treatment|"Clinical Study of Intravenous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy"|Completed||N/A|11|Actual|University of Aarhus|||||f||||f||||||||||2017-02-18 16:40:48.414535|2017-02-18 16:40:48.414535
NCT00305253|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2013-05-09|2009-07-07||April 2006||2006-04-01|May 2013|2013-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy Study of the Non-Pneumatic Anti-Shock Garment (NASG) in Egypt|Efficacy Study of the Non-Pneumatic Anti-Shock Garment (NASG) in Egypt|Completed||Phase 1/Phase 2|990|Actual|University of California, San Francisco|Non-randomized, non-blinded pre-intervention/intervention design|2|||f||||t||||||||||2017-02-18 16:40:48.512791|2017-02-18 16:40:48.512791
NCT00305240|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2008-02-11|||October 2003||2003-10-01|February 2008|2008-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients|Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER I)|Completed||N/A|656||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:40:48.891226|2017-02-18 16:40:48.891226
NCT00305227|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2016-01-13|2014-06-03||March 2006||2006-03-01|January 2016|2016-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection|Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections|Completed||Phase 2|100|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:40:49.128593|2017-02-18 16:40:49.128593
NCT00305214|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2008-02-11|||October 2003||2003-10-01|February 2008|2008-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients|Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER II)|Completed||N/A|405||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:40:49.515099|2017-02-18 16:40:49.515099
NCT00305201|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2016-05-22|||April 2006||2006-04-01|May 2016|2016-05-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease|Cardiovascular Risk Markers Before and After Therapy With Statins in Patients With History of Kawasaki Disease|Withdrawn||Phase 2|0|Actual|Pontificia Universidad Catolica de Chile||||Withdrawn due to lack of study participants|f||||f||||||||||2017-02-18 16:40:49.644061|2017-02-18 16:40:49.644061
NCT00305188|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2016-04-06||2016-04-06|December 2005||2005-12-01|April 2016|2016-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.|A Multicenter, Randomized Double-blind Placebo Controlled Phase III Study of the Efficacy of Xaliproden in Preventing the Neurotoxicity of Oxaliplatin in First-line Treatment of Patients With Metastatic Colorectal Cancer Treated With Oxaliplatin / 5-FU/LV|Completed||Phase 3|879|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:40:49.757227|2017-02-18 16:40:49.757227
NCT00305175|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2016-06-07|||March 2006||2006-03-01|June 2016|2016-06-01|January 2026|Anticipated|2026-01-01|January 2026|Anticipated|2026-01-01||Observational|||Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease|Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease|Active, not recruiting||N/A|260|Actual|St. Jude Children's Research Hospital|||2||f||||f||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 16:40:50.111302|2017-02-18 16:40:50.111302
NCT00305162|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2014-04-22|2013-04-22||April 2006||2006-04-01|April 2014|2014-04-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|PCI|Intent-to-treat (ITT) population|A Clinical Trial to Demonstrate the Efficacy of Cangrelor|A Clinical Trial Comparing Cangrelor to Clopidogrel in Subjects Who Require Percutaneous Coronary Intervention (PCI).|Terminated||Phase 3|8882|Actual|The Medicines Company|Discontinued per prespecified stopping rules after the 70% interim analyses was conducted indicating the trial was not likely to meet the goal of demonstrating superiority to clopidogrel administered as usual care. No safety issues were identified.|2||Insufficient evidence of the clinical effectiveness of cangrelor|f||||t||||||||||2017-02-18 16:40:50.243513|2017-02-18 16:40:50.243513
NCT00305149|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2006-03-20|||July 1999||1999-07-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Interventional|||Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma|Use of Risk Factors for Initiation Therapy With Beacopp or Escalated Beacopp and Interim Evaluation and Modification of Therapy Based on Scintigraphy Results.|Completed||N/A|130||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:40:51.433826|2017-02-18 16:40:51.433826
NCT00305136|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-19|2007-07-08|||December 2005||2005-12-01|June 2007|2007-06-01|June 2007||2007-06-01|||||Observational|||Advancement of Psychophysics of Pain Modulation From Lab to Clinic: Constructing Susceptibility Profile for Appearance of Postoperative Neuropathic Pain|Advancement of Psychophysics of Pain Modulation From Lab to Clinic: Constructing Susceptibility Profile for Appearance of Postoperative Neuropathic Pain|Unknown status|Active, not recruiting|N/A|130|Actual|Rambam Health Care Campus|||||f||||f||||||||||2017-02-18 16:40:51.522209|2017-02-18 16:40:51.522209
NCT00305123|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2013-02-14|||April 2006||2006-04-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Molecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali|The Molecular Epidemiology of Streptococcus Pyogenes Among Children in Bamako, Mali (Bamako BGAS2000)|Completed||N/A|1757|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     GAS isolates.~   "|||2017-02-18 16:40:51.609232|2017-02-18 16:40:51.609232
NCT00305110|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2009-02-17|||January 2006||2006-01-01|February 2009|2009-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain|Safety and Speed of Onset of a Fixed Dose of Intravenous Hydromorphone in the Treatment of Adult Patients Presenting to the Emergency Department With Acute Severe Pain|Completed||Phase 4|300|Anticipated|Montefiore Medical Center||1|||f||||||||||||||2017-02-18 16:40:51.688625|2017-02-18 16:40:51.688625
NCT00305097|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2011-02-10|||March 2006||2006-03-01|February 2011|2011-02-01|September 2008|Anticipated|2008-09-01|September 2008|Anticipated|2008-09-01||Interventional|||Effects of Caffeinated and Decaffeinated Coffee on Body Weight and Glucose Tolerance|Effects of Caffeinated and Decaffeinated Coffee on Body Weight and Glucose Tolerance|Unknown status|Active, not recruiting|N/A|45|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 16:40:51.7908|2017-02-18 16:40:51.7908
NCT00305084|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-01-28|||January 2006||2006-01-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|May 2007|Actual|2007-05-01||Interventional|||Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors|A Phase IB Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Solid Tumors|Completed||Phase 1|15|Actual|MolMed S.p.A.||1|||f||||f||||||||||2017-02-18 16:40:51.906411|2017-02-18 16:40:51.906411
NCT00305071|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-19|2006-03-19|||April 2006||2006-04-01|March 2006|2006-03-01||||||||Interventional|||Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets (UmayC) in Acute Bacterial Cystitis.|Unknown status|Not yet recruiting|Phase 2|60||Min-Sheng General Hospital|||||f||||||||||||||2017-02-18 16:40:52.018696|2017-02-18 16:40:52.018696
NCT00305058|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2006-03-17|||July 2005||2005-07-01|June 2005|2005-06-01||||||||Interventional|||Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain|A Randomized Clinical Trial Comparing Intravenous Morphine and Intravenous Hydromorphone in the Treatment of Adult ED Patients With Moderate to Severe Pain|Unknown status|Recruiting|Phase 4|178||Montefiore Medical Center|||||f||||||||||||||2017-02-18 16:40:52.106615|2017-02-18 16:40:52.106615
NCT00305045|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-19|2012-01-23|||March 2005||2005-03-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic Stimulation|Treating Refractory Major Depressive Disorder With Repetitive Transcranial Magnetic Stimulation: A Double-blind, Sham-controlled, Longitudinal Study.|Completed||N/A|73|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-02-18 16:40:52.199028|2017-02-18 16:40:52.199028
NCT00305032|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2016-02-26|||March 2006||2006-03-01|February 2016|2016-02-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Effect of Endoscopic Gastric Balloon Insertion on Obstructive Sleep Apnea in Patients With Morbid Obesity|Effect of Endoscopic Gastric Balloon Insertion on Obstructive Sleep Apnea in Patients With Morbid Obesity|Completed||N/A|60|Actual|Chinese University of Hong Kong||1|||f||||t||||||||||2017-02-18 16:40:52.311385|2017-02-18 16:40:52.311385
NCT00305019|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2006-04-11|||July 2002||2002-07-01|April 2006|2006-04-01|March 2004||2004-03-01|||||Interventional|||Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus|A Double- Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Clevudine 30 Mg QD and 50 Mg QD Doses in Patients Infected With Hepatitis B Virus|Terminated||Phase 2|120||Bukwang Pharmaceutical|||||f||||||||||||||2017-02-18 16:40:52.41215|2017-02-18 16:40:52.41215
NCT00305006|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2011-01-12|||July 2007||2007-07-01|January 2011|2011-01-01|February 2011|Anticipated|2011-02-01|December 2009|Anticipated|2009-12-01||Interventional|CIMT||Constraint-induced Movement Therapy (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegic Cerebral Palsy|Constraint-induced Movement Therapy (CIMT) and Bimanual Training (HABIT) in Children With Hemiplegic Cerebral Palsy|Unknown status|Recruiting|Phase 1|40|Anticipated|Columbia University||1|||f||||f||||||||||2017-02-18 16:40:52.505994|2017-02-18 16:40:52.505994
NCT00304993|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2006-03-17|||January 2001||2001-01-01|March 2006|2006-03-01|February 2005||2005-02-01|||||Interventional|||Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia|Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia|Completed||Phase 4|30||Foundation Research, Florida|||||f||||||||||||||2017-02-18 16:40:52.707476|2017-02-18 16:40:52.707476
NCT00304980|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-20|2010-09-12|||March 2003||2003-03-01|September 2010|2010-09-01|April 2005||2005-04-01|||||Interventional|||Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status|Comparative Evaluation of the Safety and the Efficacy of Artemether + Lumefantrine (Coartem™) vs. Sulfadoxine + Pyrimethamine (SP) in Both HIV+ and HIV- Adults With Uncomplicated P. Falciparum Malaria in Zambia|Terminated||N/A|3000||Institute of Tropical Medicine, Belgium|||||f||||||||||||||2017-02-18 16:40:52.803346|2017-02-18 16:40:52.803346
NCT00304967|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-18|2017-01-24|||March 15, 2006||2006-03-15|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||Dynamic Light Scattering to Study Crystalline Proteins in Young Normal Lenses|A Study of Crystalline Proteins in Young Normal Lenses Using the NASA-NEI Dynamic Light Scattering (DLS) Device|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:40:52.889655|2017-02-18 16:40:52.889655
NCT00304954|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2016-11-28|2011-01-31||February 2006||2006-02-01|November 2016|2016-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|AMDB1||Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration|Treatment of Choroidal Subretinal Neovascularization With Agents Directed Against the Immune Response|Completed||Phase 2|13|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||t||||||||||2017-02-18 16:40:52.985051|2017-02-18 16:40:52.985051
NCT00304941|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2017-01-24|||March 14, 2006||2006-03-14|September 17, 2010|2010-09-17|September 17, 2010||2010-09-17|||||Observational|||Insulin Resistance and Breast Cancer|Breast Cancer and Insulin Resistance: Implications for Preventive Counseling in Familial and Sporadic Cases|Completed||N/A|25|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:40:54.238993|2017-02-18 16:40:54.238993
NCT00304915|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-11-10|2014-09-10||February 2007||2007-02-01|November 2016|2016-11-01|November 2016|Actual|2016-11-01|July 2009|Actual|2009-07-01||Interventional|HI-TIDES||HIV Translating Initiatives for Depression Into Effective Solutions|HIV Translating Initiatives for Depression Into Effective Solutions|Completed||N/A|249|Actual|VA Office of Research and Development||2|||f||||t||||||||Yes|Investigators can request IPD by contacting the PI.|2017-02-18 16:40:54.330513|2017-02-18 16:40:54.330513
NCT00304902|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2010-09-09|||February 2006||2006-02-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Observational|||Chart Review of Outcome of Treatment for S. Aureus Bacteremia|Retrospective Chart Review of the Outcome of Treatment for Staphylococcus Aureus Bacteremia|Completed||N/A|120|Actual|VA Medical Center, Houston|||1||f||||f||||||||||2017-02-18 16:40:54.769329|2017-02-18 16:40:54.769329
NCT00304889|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2015-06-01|||January 2006||2006-01-01|February 2013|2013-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis|Vancomycin Vs. Nitazoxanide to Treat Clostridium Difficile Colitis That Has Failed Therapy With Metronidazole|Completed||Phase 3|52|Actual|VA Medical Center, Houston|||1||f||||||||||||||2017-02-18 16:40:54.850496|2017-02-18 16:40:54.850496
NCT00304876|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2010-09-09|||October 2005||2005-10-01|September 2010|2010-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea|Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea|Completed||N/A|5|Actual|VA Medical Center, Houston|||1||f||||f||||||||||2017-02-18 16:40:54.948135|2017-02-18 16:40:54.948135
NCT00304863|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-05-02||||||May 2016|2016-05-01||||||||Interventional|||Addition of Lactobacillus to Metronidazole in Treatment of CDAD|Addition of a Probiotic (Lactobacillus GG) to Metronidazole for the Treatment of Clostridium Difficile Associated Disease|Withdrawn||Phase 4|0|Actual|VA Medical Center, Houston||2||The assistant who was going to do this study moved to a different med center|f||||||||||||||2017-02-18 16:40:55.033439|2017-02-18 16:40:55.033439
NCT00304850|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2009-12-24|||March 2006||2006-03-01|December 2009|2009-12-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|PoLyDOL||Polyamine-free Diet to Prevent Post Surgery Hyperalgesia|Efficacy of a Polyamine-free Diet Associated or Not With Ketamine on Early and Late Hyperalgesia After Breast Cancer Surgery|Completed||Phase 2|160|Anticipated|University Hospital, Bordeaux||4|||f||||t||||||||||2017-02-18 16:40:55.137226|2017-02-18 16:40:55.137226
NCT00304837|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2010-10-18||||||April 2008|2008-04-01|April 2008|Actual|2008-04-01|||||Interventional|||VEGF Gene Transfer for Critical Limb Ischemia||Completed||Phase 1|||Losordo, Douglas, M.D.|||||||||||||||||||2017-02-18 16:40:55.280412|2017-02-18 16:40:55.280412
NCT00304824|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2008-09-25|||October 2004||2004-10-01|September 2008|2008-09-01|November 2005|Actual|2005-11-01|||||Observational|||Assessment of the Ability to Distinguish Odors in Glaucoma Patients|Olfactory Function in Glaucoma Patients|Completed||N/A|30|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 16:40:55.359235|2017-02-18 16:40:55.359235
NCT00304811|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2009-09-25|||January 2006||2006-01-01|September 2009|2009-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection|Vancomycin Versus Vancomycin Plus Gentamycin For Treating Bacteremic Infection Due to Methicillin-Resistant Staphylococcus Aureus (MRSA)|Completed||Phase 4|160|Anticipated|VA Medical Center, Houston|||||f||||||||||||||2017-02-18 16:40:55.439093|2017-02-18 16:40:55.439093
NCT00304798|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2015-02-03|||March 2006||2006-03-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Study of Admission Versus Discharge After Transient Ischemic Attack (TIA)|Pilot Study of Admission Versus Discharge After Transient Ischemic Attack (TIA)|Withdrawn||Phase 1|0|Actual|University of California, San Diego||2|||f||||||||||||||2017-02-18 16:40:55.538983|2017-02-18 16:40:55.538983
NCT00304785|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2007-10-23|||May 2005||2005-05-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Latanoprost Versus Fotil||Completed||Phase 4|36|Anticipated|Pharmaceutical Research Network|||||f||||||||||||||2017-02-18 16:40:55.637096|2017-02-18 16:40:55.637096
NCT00304772|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2009-03-24|||August 2006||2006-08-01|March 2009|2009-03-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients|A Randomized Comparative Study of Fluconazole Versus Micafungin for the Treatment of Candida Bloodstream Infection in Non-Neutropenic Patients|Withdrawn||Phase 4|190|Anticipated|Kyoto University||2||Subjects were not recruited as intended.|f||||f||||||||||2017-02-18 16:40:55.73043|2017-02-18 16:40:55.73043
NCT00304759|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2016-12-06|||May 2006||2006-05-01|December 2016|2016-12-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||PROFIT - Prostate Fractionated Irradiation Trial|A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer|Active, not recruiting||Phase 3|1204|Anticipated|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-02-18 16:40:55.846231|2017-02-18 16:40:55.846231
NCT00304746|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2010-11-17|2010-09-24||April 2006||2006-04-01|November 2010|2010-11-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment|A Parallel-Group, Placebo-Controlled Trial of AndroGel in Men With Major Depressive Disorder Who Display an Incomplete Response to Standard Antidepressant Treatment|Completed||Phase 4|100|Actual|Mclean Hospital|The small number of participants limited statistical power. Also, the study recruited “treatment-resistant” men, who are often poorly responsive. For a detailed discussion, see the published report of the study.|2|||f||||f||||||||||2017-02-18 16:40:55.994974|2017-02-18 16:40:55.994974
NCT00304733|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2006-03-16|||August 2001||2001-08-01|August 2001|2001-08-01|April 2005||2005-04-01|||||Interventional|||Wound Healing: Total Contact Cast Vs. Custom-Made Temporary Footwear for Patients With Diabetic Foot Ulceration|Wound Healing: Total Contact Cast Vs. Custom-Made Temporary Footwear for Patients With Diabetic Foot Ulceration|Unknown status|Active, not recruiting|N/A|43||Rehabilitation Centre Amsterdam|||||f||||||||||||||2017-02-18 16:40:56.413978|2017-02-18 16:40:56.413978
NCT00303719|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-08-15|||March 2002||2002-03-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy|Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy|Recruiting||Phase 2|300|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-02-18 16:41:16.410317|2017-02-18 16:41:16.410317
NCT00304720|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2008-02-06|||March 2004||2004-03-01|March 2004|2004-03-01||||||||Interventional|||Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor|Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression After Conditioning With Fludarabine and Low-Dose Total Body Irradiation for Recipients of HLA-Matched Family Donor Hematopoietic Cell Transplants|Unknown status|Recruiting|Phase 2|40|Anticipated|Colorado Blood Cancer Institute|||||f||||||||||||||2017-02-18 16:40:56.49716|2017-02-18 16:40:56.49716
NCT00304707|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2009-09-04|||April 2005||2005-04-01|September 2009|2009-09-01|February 2010|Anticipated|2010-02-01|July 2009|Anticipated|2009-07-01||Interventional|||Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence|Bupropion Treatment for Smokers in Recovery|Unknown status|Recruiting|Phase 3|236|Anticipated|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-02-18 16:40:56.58721|2017-02-18 16:40:56.58721
NCT00304694|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2006-03-16|||March 2006||2006-03-01|March 2006|2006-03-01||||||||Observational|||Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients|Whole-Body 18F-FDG PET in Evaluating Induction Chemotherapeutic Response for Locally Advanced Nasopharyngeal Cancer Patients and Correlating With Histopathology: a Prospective Study|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:40:56.691451|2017-02-18 16:40:56.691451
NCT00304681|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2011-05-16||||||April 2010|2010-04-01|February 2004|Actual|2004-02-01|||||Interventional|||An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children|The Effectiveness of CONCERTA® vs. Usual Clinical Care With Immediate Release Methylphenidate (IR MPH) in Children (6-12 Years) With Attention Deficit Hyperactivity Disorder (ADHD): A Randomized, Open-Label Trial|Completed||Phase 3|147|Actual|Janssen-Ortho Inc., Canada||1|||f||||||||||||||2017-02-18 16:40:56.77652|2017-02-18 16:40:56.77652
NCT00304668|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2015-12-08||||||May 2006|2006-05-01||||||||Interventional|||A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa|A Phase I/II Single-Centre Double-Blinded Randomized Study of the Safety and Tolerability of TMC120 Vaginal Microbicide Gel (TMC120 Gel-002) vs. HEC-Based Universal Placebo Gel in Healthy HIV-Negative Women.|Withdrawn||Phase 1/Phase 2|0|Actual|International Partnership for Microbicides, Inc.||1|||f||||||||||||||2017-02-18 16:40:56.862471|2017-02-18 16:40:56.862471
NCT00304655|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2009-12-15|||July 2004||2004-07-01|December 2009|2009-12-01|October 2007|Actual|2007-10-01|May 2006|Actual|2006-05-01||Interventional|||Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)|Multicenter, Single Group Study of Aripiprazole Efficacy and Safety in the Acute Psychosis Treatment of Schizophrenia, Schizophreniform Disorder and Schizoaffective Disorder.|Completed||Phase 4|300||Korea Otsuka Pharmaceutical Co., Ltd.|||||f||||||||||||||2017-02-18 16:40:56.939427|2017-02-18 16:40:56.939427
NCT00304642|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2006-06-01|||November 2005||2005-11-01|June 2006|2006-06-01||||||||Interventional|||A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel|A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel in Healthy HIV-Negative Women.|Completed||Phase 1|18||International Partnership for Microbicides, Inc.|||||||||||||||||||2017-02-18 16:40:57.029681|2017-02-18 16:40:57.029681
NCT00304629|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2011-01-31|||March 2000||2000-03-01|January 2011|2011-01-01|March 2002|Actual|2002-03-01|||||Interventional|||Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease|Long Term Safety and Efficacy of Galantamine in Alzheimer's Disease (Extension INT-8)|Completed||Phase 3|241|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:40:57.106856|2017-02-18 16:40:57.106856
NCT00304616|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2009-12-15|||October 2004||2004-10-01|December 2009|2009-12-01|October 2007|Actual|2007-10-01|June 2006|Actual|2006-06-01||Interventional|||SWitching to Abilify Trial (SWAT)|A Multi-center, Randomized, Open, Treatment-switching Study From Orally Administered Antipsychotic Monotherapy in the Treatment of Chronic Schizophrenic and Schizoaffective Patients|Completed||Phase 4|500||Korea Otsuka Pharmaceutical Co., Ltd.|||||f||||||||||||||2017-02-18 16:40:57.189687|2017-02-18 16:40:57.189687
NCT00304603|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2012-11-27|||April 2004||2004-04-01|November 2012|2012-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Observational|||Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus|A Study to Evaluate the Mode of Action of Topiramate in the Treatment of Obese Subjects With and Without Type 2 Diabetes Mellitus Using DNA Samples From Subjects Who Were Randomized Within Select Previous Topiramate Studies|Completed||Phase 3|1145|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 16:40:57.289723|2017-02-18 16:40:57.289723
NCT00304590|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2010-02-18|||February 2006||2006-02-01|February 2010|2010-02-01|May 2007|Actual|2007-05-01|December 2006|Actual|2006-12-01||Interventional|||Study of XL999 in Patients With Multiple Myeloma|A Phase 2 Study of XL999 in Subjects With Relapsed/Refractory Multiple Myeloma|Terminated||Phase 2|4|Actual|Symphony Evolution, Inc.||1||Study was terminated due to cardiac toxicities in the subjects|f||||t||||||||||2017-02-18 16:40:57.636701|2017-02-18 16:40:57.636701
NCT00304577|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2006-03-17|||January 1998||1998-01-01|September 2005|2005-09-01|December 2001||2001-12-01|||||Observational|||Bilateral Recession or Unilateral Recession-Resection as Surgery for Infantile Esotropia|A Randomized Comparison of Bilateral Recession With Unilateral Recession-Resection as Surgery for Infantile Esotropia|Completed||Phase 3|||Erasmus Medical Center|||||f||||||||||||||2017-02-18 16:40:57.734524|2017-02-18 16:40:57.734524
NCT00304564|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-01-26|||February 2006||2006-02-01|January 2016|2016-01-01|March 2007|Actual|2007-03-01|April 2006|Actual|2006-04-01||Interventional|||Study of the Effect of the Music of Nolwenn Leroy in Fall Prevention Strategies in Texas Nursing Homes|Fall Prevention and The Nolwenn Effect in Texas Geriatric Nursing Home Settings|Completed||N/A|100|Actual|Carrick Institute for Graduate Studies||1|||f||||f||||||||No||2017-02-18 16:40:57.82926|2017-02-18 16:40:57.82926
NCT00304551|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-05|2010-06-01|||June 2006||2006-06-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|December 2009|Actual|2009-12-01||Interventional|||A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)|A Phase II/III Study of Peginterferon Alfa-2a in Combination With Ribavirin for the Treatment of CHC With Compensated LC|Completed||Phase 3|180|Anticipated|Chugai Pharmaceutical||3|||f||||f||||||||||2017-02-18 16:40:57.921405|2017-02-18 16:40:57.921405
NCT00304148|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2016-08-18|||July 2003||2003-07-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Observational|CRIC||SDCC - Prospective Cohort Study of Chronic Renal Insufficiency|Prospective Cohort Study of Chronic Renal Insufficiency|Active, not recruiting||N/A|5112|Anticipated|University of Pennsylvania|||2||f||||t||||||Samples With DNA|"~     DNA, urine, serum, blood~   "|||2017-02-18 16:41:02.24072|2017-02-18 16:41:02.24072
NCT00304538|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2006-08-21|||March 2006||2006-03-01|August 2006|2006-08-01|July 2006||2006-07-01|||||Interventional|||A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus|A Phase 1b, Single-Blind Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Three Separate Dose Levels of Very Low Dose-Glucagon Administered Subcutaneously Overnight for 6, 9 or 12 Hours in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 1|10||DiObex|||||||||||||||||||2017-02-18 16:40:58.029903|2017-02-18 16:40:58.029903
NCT00304525|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2016-11-15|||April 2006||2006-04-01|November 2016|2016-11-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|CHIR-265-MEL01||A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma|A Phase I/II, Open-label, Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of RAF265 (CHIR-265)Administered Orally to Patients With Locally Advanced or Metastatic Melanoma.|Completed||Phase 2|104|Actual|Novartis||5|||f||||f||||||||||2017-02-18 16:40:58.11932|2017-02-18 16:40:58.11932
NCT00304512|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2015-04-08||2010-08-17|May 2006||2006-05-01|April 2015|2015-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A 12-Week Safety and Pharmacodynamic Study of AT1001 in Female Patients With Fabry Disease|A Phase 2, Open-Label, Multiple Dose Level, 12-Week Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AT1001 in Female Patients With Fabry Disease|Completed||Phase 2|9|Actual|Amicus Therapeutics||3|||f||||f||||||||||2017-02-18 16:40:58.255218|2017-02-18 16:40:58.255218
NCT00304499|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2011-05-18|||December 1995||1995-12-01|April 2010|2010-04-01|December 1996||1996-12-01|||||Interventional|||Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence|Efficacy and Safety of OROS® Oxybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence|Completed||Phase 3|176||Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 16:40:58.365833|2017-02-18 16:40:58.365833
NCT00304473|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-17|2009-03-24|||August 2004||2004-08-01|March 2009|2009-03-01|April 2006|Actual|2006-04-01|||||Interventional|||Fast Titration in the Treatment of Schizophrenia, Taiwan|Fast Titration of Quetiapine Versus Conventional Titration in the Treatment of Schizophrenia/Schizoaffective Disorder: a Randomised, Parallel Group Open Trial|Completed||Phase 3|40||AstraZeneca|||||f||||||||||||||2017-02-18 16:40:58.450046|2017-02-18 16:40:58.450046
NCT00304460|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2017-01-24|||March 13, 2006||2006-03-13|February 27, 2014|2014-02-27|February 27, 2014|Actual|2014-02-27|February 27, 2014|Actual|2014-02-27||Interventional|||Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer|Studies on the Mechanism of Action of High-Dose IL-2 in Metastatic Melanoma and Renal Cell Cancer|Completed||Phase 1|138|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:40:58.535103|2017-02-18 16:40:58.535103
NCT00304447|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2009-07-28|||April 2002||2002-04-01|July 2009|2009-07-01|January 2004||2004-01-01|||||Interventional|||Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia|A Phase IV Study of Corticosteroids As Prophylaxis for Infusion-Related Adverse Events to Mylotarg® in Patients With Acute Myelogenous Leukemia (AML)|Completed||Phase 4|30||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:40:58.633053|2017-02-18 16:40:58.633053
NCT00304434|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2009-09-21|||February 2005||2005-02-01|September 2009|2009-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.|Oseltamivir (Tamiflu) Dosing Strategies for Use During Influenza Prophylaxis (VA01)|Completed||Phase 4|48|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 16:40:58.707371|2017-02-18 16:40:58.707371
NCT00304421|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2007-09-14|||January 2004||2004-01-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD|Comparison of the Nighttime Effects of Rabeprazole 20 mg to Pantoprazole 40 mg on Standard Meal Stimulated Gastric Acid Secretion and Intragastric pH in H. Pylori Negative Volunteer Subjects With GERD|Completed||Phase 4|23|Anticipated|VA Greater Los Angeles Healthcare System|||||f||||||||||||||2017-02-18 16:40:58.81996|2017-02-18 16:40:58.81996
NCT00304408|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2010-09-09|||January 2005||2005-01-01|September 2010|2010-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody|Association Between Clinical Response of Clostridium Difficile Colitis to Treatment and Emergence of Anti-C.Difficile Toxin Antibody|Completed||Phase 4|10|Actual|VA Medical Center, Houston|||1||f||||f||||||||||2017-02-18 16:40:58.910534|2017-02-18 16:40:58.910534
NCT00304395|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2010-09-09|||January 2004||2004-01-01|September 2010|2010-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Pulmonary Infections Masquerading as Community-Acquired Pneumonia|Pulmonary Infections Masquerading as Community-Acquired Pneumonia|Completed||Phase 4|40|Actual|VA Medical Center, Houston|||1||f||||f||||||||||2017-02-18 16:40:58.997016|2017-02-18 16:40:58.997016
NCT00304382|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2013-02-14|||January 2003||2003-01-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|September 2006|Actual|2006-09-01||Interventional|||Humoral Determinants of Immunity to Pneumococcal Infection|Humoral Determinants of Immunity to Pneumococcal Infection|Completed||Phase 4|114|Anticipated|VA Medical Center, Houston||4|||f||||t||||||||||2017-02-18 16:40:59.08123|2017-02-18 16:40:59.08123
NCT00304369|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2013-02-14|||June 2005||2005-06-01|February 2013|2013-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Response of Clostridium Difficile Infection to Metronidazole Therapy|The Response of Clostridium Difficile Infection to Metronidazole Therapy|Completed||N/A|290|Anticipated|VA Medical Center, Houston|||||f||||f||||||||||2017-02-18 16:40:59.192727|2017-02-18 16:40:59.192727
NCT00304356|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2007-02-08||||||February 2006|2006-02-01||||||||Interventional|||Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection|Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy|Unknown status|Recruiting|Phase 3|100||VA Medical Center, Houston|||||f||||||||||||||2017-02-18 16:40:59.291375|2017-02-18 16:40:59.291375
NCT00304161|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-12-01|2012-06-12||July 2004||2004-07-01|December 2016|2016-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease|Depression Diagnosis and Treatment in Parkinson Disease|Completed||Phase 4|55|Actual|University of Pennsylvania|First, the sample size was relatively small. Second, the diagnostic criteria for depression which are typically used in clinical trials were not used as an inclusion criterion. Third, antidepressant use at baseline was common in our population.|2|||f||||f||||||||||2017-02-18 16:41:01.810156|2017-02-18 16:41:01.810156
NCT00304330|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2015-12-16|||September 2006||2006-09-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients|Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients; a Comparative Study With a Non-transplant Population|Recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:40:59.583669|2017-02-18 16:40:59.583669
NCT00304317|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2017-01-23|||March 2006||2006-03-01|January 2017|2017-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Celecoxib (Celebrex) in the Management of Acute Renal Colic|Celecoxib in the Management of Acute Renal Colic|Withdrawn||Phase 4|0|Actual|University of Minnesota - Clinical and Translational Science Institute||2||PI is no longer at the University of Minnesota|f||||f||||||||||2017-02-18 16:40:59.677306|2017-02-18 16:40:59.677306
NCT00304304|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-02-14|||February 2006||2006-02-01|February 2016|2016-02-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||HealthSpark 2: Improving Asthma Care for Preschool Children|Community - Based Asthma Intervention in Subsidized Preschools|Completed||N/A|2000|Actual|University of Miami||2|||f||||f||||||||No||2017-02-18 16:40:59.787837|2017-02-18 16:40:59.787837
NCT00304291|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2006-11-27|||August 2001||2001-08-01|March 2006|2006-03-01|May 2004||2004-05-01|||||Interventional|||A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)|A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)|Completed||Phase 4|5||State University of New York at Buffalo|||||f||||||||||||||2017-02-18 16:40:59.89173|2017-02-18 16:40:59.89173
NCT00304278|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-08-01|||March 2006||2006-03-01|August 2016|2016-08-01|December 2015|Actual|2015-12-01|May 2015|Actual|2015-05-01||Interventional|||Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)|Phase II Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)|Completed||Phase 2|21|Actual|Southern Illinois University||1|||f||||t||||||||||2017-02-18 16:40:59.988027|2017-02-18 16:40:59.988027
NCT00304265|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-04-12|2011-02-10||March 2006||2006-03-01|April 2016|2016-04-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine|Reactogenicity of Acellular Pertussis Vaccine Booster in Adolescents Who Have Received 5 Prior Doses of BIKEN Acellular Pertussis Vaccine in Combination With Diphtheria and Tetanus Toxoids (TRIPEDIA®) or Who Have Received Primary Vaccination With 3 Doses of Whole-Cell Pertussis Vaccine, Plus at Least 1 Pertussis Booster Vaccination|Completed||Phase 4|215|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:41:00.111099|2017-02-18 16:41:00.111099
NCT00304252|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2013-08-04|||November 2001||2001-11-01|August 2013|2013-08-01|September 2003|Actual|2003-09-01|||||Interventional|||Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease|A Phase II, Multicenter, Randomised, Double-blind, Placebo Controlled, Dose Finding Study of Subcutaneously Administered Interferon Beta-1a for Maintenance of Remission in Patients With Crohn's Disease|Terminated||Phase 2|192||EMD Serono||||Lack of Efficacy|f||||||||||||||2017-02-18 16:41:00.584612|2017-02-18 16:41:00.584612
NCT00304239|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2010-09-01|||March 2006||2006-03-01|September 2010|2010-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp|A Multicenter, Double Blind, Vehicle-controlled, Randomized Study of Photodynamic Therapy (PDT) With Metvix 160 mg/g Cream and Aktilite CL128 LED Light in Patients With Multiple Actinic Keratosis on the Face and/or Scalp|Completed||Phase 3|80||Galderma|||||||||f||||||||||2017-02-18 16:41:00.85703|2017-02-18 16:41:00.85703
NCT00304226|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-11-15|||February 2006||2006-02-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy|A 14 Week Study to Evaluate Effectiveness of a Valsartan Versus an Amlodipine Treatment Strategy in Achieving Blood Pressure Control in Patients With Stage 1 or Stage 2 Hypertension or Uncontrolled on Present Monotherapy|Completed||Phase 4|1288|Actual|Novartis|||||f||||||||||||||2017-02-18 16:41:00.967242|2017-02-18 16:41:00.967242
NCT00304213|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2015-02-12|||March 2006||2006-03-01|February 2015|2015-02-01|April 2009|Anticipated|2009-04-01|||||Interventional|||Does Testosterone Improve Function in Hypogonadal Older Men|Does Testosterone Improve Function in Hypogonadal Older Men|Withdrawn||Phase 4|0|Actual|North Florida Foundation for Research and Education||||Study never started, PI relocation|f||||||||||||||2017-02-18 16:41:01.075604|2017-02-18 16:41:01.075604
NCT00304200|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-12|2009-02-03|||March 2006||2006-03-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|October 2007|Actual|2007-10-01||Interventional|||Temodar and Sutent as Therapy for Melanoma|Temodar and Sutent as Therapy for Patients With Malignant Melanoma, a Phase I/II Study|Terminated||Phase 1/Phase 2|7|Actual|Northern California Melanoma Center||1||Funding was inadequate to continue; Companies requested closure.|f||||t||||||||||2017-02-18 16:41:01.180335|2017-02-18 16:41:01.180335
NCT00304187|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-06-21|2013-04-24||September 2004||2004-09-01|May 2013|2013-05-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa|Effects of Erythromycin on Binge Eating and GI Function in Bulimia Nervosa|Completed||Phase 2|29|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 16:41:01.319342|2017-02-18 16:41:01.319342
NCT00304174|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-05-23|||May 2005||2005-05-01|May 2016|2016-05-01|May 2016|Actual|2016-05-01|June 2014|Actual|2014-06-01||Observational|||Motivating Factors That Play a Role in Bulimia Nervosa|Translational Research on Eating Disorders: Behavioral Assessment of Motivation to Eat|Completed||N/A|90|Actual|New York State Psychiatric Institute|||2||f||||f||||||||||2017-02-18 16:41:01.706455|2017-02-18 16:41:01.706455
NCT00304135|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-05-27|||October 2005||2005-10-01|December 2006|2006-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery|Randomized Phase II-III Study of Chemoradiation With Fluorouracil and Cisplatin Versus Chemotherapy (Gemcitabine/Oxaliplatin) in Non Resectable But Non Metastatic Cancer of the Biliary Tract|Completed||Phase 2/Phase 3|34|Actual|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||||2017-02-18 16:41:02.38583|2017-02-18 16:41:02.38583
NCT00304096|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-02-26|2013-01-15||December 2005||2005-12-01|February 2013|2013-02-01|April 2008|Actual|2008-04-01|June 2007|Actual|2007-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer|Evaluation of the Safety and Immunogenicity of Vaccination With Multiple Synthetic Peptides in Participants With Advanced Breast Cancer|Completed||Phase 1|12|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 16:41:02.521564|2017-02-18 16:41:02.521564
NCT00304083|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-10-12|||December 2005||2005-12-01|December 2014|2014-12-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors|Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Malignant Peripheral Nerve Sheath Tumors|Completed||Phase 2|74|Actual|Sarcoma Alliance for Research through Collaboration||2|||f||||f||||||||||2017-02-18 16:41:02.900647|2017-02-18 16:41:02.900647
NCT00304070|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-03-17|||September 2006||2006-09-01|March 2016|2016-03-01||||December 2015|Actual|2015-12-01||Interventional|||Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor|Treatment of Adrenocortical Tumors With Surgery Plus Lymph Node Dissection and Multiagent Chemotherapy: A Groupwide Phase III Study|Active, not recruiting||Phase 3|78|Actual|Children's Oncology Group||3|||f||||||||||||||2017-02-18 16:41:03.03364|2017-02-18 16:41:03.03364
NCT00304031|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-12-30|2014-03-28||January 2006||2006-01-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|February 2011|Actual|2011-02-01||Interventional||Eligible patients who were randomized.|Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma|Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma|Completed||Phase 3|1173|Actual|Radiation Therapy Oncology Group|This was a two-stage study in which participants were registered, received concomitant RT and TMZ, and then were randomized to standard or dose-dense adjuvant TMZ. Some patients were not randomized, resulting in the third arm (No adjuvant TMZ).|3|||f||||t||||||||||2017-02-18 16:41:03.384699|2017-02-18 16:41:03.384699
NCT00304018|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-08-13|||October 2002||2002-10-01|August 2013|2013-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer|Pilot Study of Umbilical Cord Blood Transplantation in Adult Patients With Advanced Hematopoietic Malignancies|Completed||Phase 1|5|Actual|University of California, San Francisco||1|||f||||||||||||||2017-02-18 16:41:05.81247|2017-02-18 16:41:05.81247
NCT00304005|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-07-17|||July 2005||2005-07-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|October 2005|Actual|2005-10-01||Interventional|||VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders|A Phase I/II Study of Cloretazine in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia or Richter's Syndrome|Completed||Phase 1/Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 16:41:05.934161|2017-02-18 16:41:05.934161
NCT00303992|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2015-03-13|||May 2004||2004-05-01|March 2015|2015-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer|Weekly Trastuzumab (Herceptin) and Irinotecan in Patients With HER-2 Positive Advanced Breast Cancer: A Phase II Trial|Completed||Phase 2|9|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:41:06.016751|2017-02-18 16:41:06.016751
NCT00303979|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2012-11-21|2012-11-21||May 2005||2005-05-01|November 2012|2012-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|IMPROVE-HF||IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting|Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting|Completed||N/A|34810|Actual|Medtronic Cardiac Rhythm and Heart Failure|||3||f||||f||||||||||2017-02-18 16:41:06.127231|2017-02-18 16:41:06.127231
NCT00303966|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2014-04-17|2013-11-08||November 2005||2005-11-01|January 2014|2014-01-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic Leukemia|A Phase II Study of BAY 43-9006 in Relapsed Chronic Lymphocytic Leukemia|Terminated||Phase 2|5|Actual|National Cancer Institute (NCI)|Early termination leading to small number of subjects|1||Slow accrual|f||||||||||||||2017-02-18 16:41:07.109048|2017-02-18 16:41:07.109048
NCT00303953|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2014-04-23|2012-02-28||January 2006||2006-01-01|April 2013|2013-04-01|August 2010|Actual|2010-08-01|January 2010|Actual|2010-01-01||Interventional|||PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma|Phase II Study of PXD101 (NSC-726630) in Relapsed and Refractory Aggressive B-Cell Lymphomas|Completed||Phase 2|22|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:41:07.408952|2017-02-18 16:41:07.408952
NCT00303940|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2012-03-14|||December 2005||2005-12-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|||||Interventional|||Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors|A Phase I Trial and Pharmacokinetic Study of Talabostat (PT-100, Val-Boro-Pro) in Combination With Temozolomide or Carboplatin in Pediatric Patients With Relapsed or Refractory Solid Tumors Including Brain Tumors|Completed||Phase 1|26|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 16:41:07.929109|2017-02-18 16:41:07.929109
NCT00303927|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2010-03-18|||December 2005||2005-12-01|March 2010|2010-03-01||||September 2007|Actual|2007-09-01||Interventional|||Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene|Thymidylate Synthase (TS) Genotype-Directed Phase II Trial of Oral Capecitabine for 2-Line Treatment of Advanced Pancreatic Cancer|Completed||Phase 2|65|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:41:08.036153|2017-02-18 16:41:08.036153
NCT00303914|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2012-07-19|||April 2006||2006-04-01|August 2009|2009-08-01||||||||Observational|||Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer|A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment|Unknown status|Active, not recruiting|N/A|2310|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:41:08.142859|2017-02-18 16:41:08.142859
NCT00303901|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2015-02-09|2015-02-09||November 2005||2005-11-01|February 2015|2015-02-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery|Percutaneous Thoracic Cryotherapy (PTC) for Inoperable Primary Lung Cancer and Metastatic Management|Completed||N/A|40|Actual|Barbara Ann Karmanos Cancer Institute|There were no study limitations.|1|||f||||t||||||||||2017-02-18 16:41:08.394185|2017-02-18 16:41:08.394185
NCT00303888|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2010-10-28|||April 2006||2006-04-01|June 2009|2009-06-01||||June 2008|Anticipated|2008-06-01||Interventional|||Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer|A Randomized Placebo-Controlled Phase Ib/IIa Safety, Tolerability and Efficacy Study of Oral Phenoxodiol in Combination With Docetaxel Versus Docetaxel Alone in Patients With Recurrent Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer|Unknown status|Recruiting|Phase 1/Phase 2|60|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:41:08.675445|2017-02-18 16:41:08.675445
NCT00303875|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-04-09|||December 2003||2003-12-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|June 2008|Actual|2008-06-01||Interventional|||Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight|RENEW: Reach Out to Enhance Wellness in Older Survivors|Completed||Phase 2|641|Actual|Duke University||2|||f||||t||||||||||2017-02-18 16:41:08.802406|2017-02-18 16:41:08.802406
NCT00303862|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2014-05-05|2013-07-08||March 2006||2006-03-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer|A Phase 2 Study of AZD2171 in Patients With Advanced Renal Cell Carcinoma|Terminated||Phase 2|10|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:41:08.921139|2017-02-18 16:41:08.921139
NCT00303849|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-11-17|||September 2005||2005-09-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors|Phase I/II Study of Carboplatin, Melphalan and Etoposide Phosphate in Conjunction With Osmotic Opening of the Blood-Brain Barrier and Delayed Intravenous Sodium Thiosulfate Chemoprotection, in Previously Treated Subjects With Anaplastic Oligodendroglioma or Oligoastrocytoma|Recruiting||Phase 1/Phase 2|43|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 16:41:09.212013|2017-02-18 16:41:09.212013
NCT00303836|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-06-05|||November 2005||2005-11-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma|A Phase II Study Using a Peptide Vaccine With or Without Aldesleukin Following a Lymphodepleting Chemotherapy and Reinfusion of Autologous Lymphocytes Depleted of T Regulatory Lymphocytes in Metastatic Melanoma|Terminated||Phase 2|58|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:41:09.571056|2017-02-18 16:41:09.571056
NCT00303823|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2015-04-14|2012-07-13||September 2005||2005-09-01|April 2013|2013-04-01|February 2011|Actual|2011-02-01|November 2010|Actual|2010-11-01||Interventional|||Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia|A Phase II Trial of Polyphenon E for Cervical Cancer Prevention|Completed||Phase 2|98|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 16:41:09.700067|2017-02-18 16:41:09.700067
NCT00303810|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2014-01-27|||January 2001||2001-01-01|July 2009|2009-07-01||||December 2013|Actual|2013-12-01||Interventional|||Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma|Multicenter Therapy Optimizing Study for Treatment of Children and Adolescents With Intracranial Medulloblastoma / PNET and Ependymoma|Completed||N/A|567|Actual|Universitätsklinikum Hamburg-Eppendorf|||||f||||||||||||||2017-02-18 16:41:10.160605|2017-02-18 16:41:10.160605
NCT00303797|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-03-18|||December 2005||2005-12-01|March 2013|2013-03-01||||May 2010|Actual|2010-05-01||Interventional|||Sorafenib and Bortezomib in Treating Patients With Advanced Cancer|A Phase I Study of the Raf Kinase/VEGFR Inhibitor BAY 43-9006 in Combination With the Proteasome Inhibitor PS-341 in Patients With Advanced Malignancies|Completed||Phase 1|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:41:10.263652|2017-02-18 16:41:10.263652
NCT00303784|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-10-26|||March 2006||2006-03-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|PATCH||Prostate Adenocarcinoma TransCutaneous Hormones|A Randomized-Controlled Trial of Transcutaneous Oestrogen Patches Versus LHRH Agonists in Prostate Cancer|Recruiting||Phase 3|2200|Anticipated|Imperial College London||2|||f||||||||||||||2017-02-18 16:41:10.379904|2017-02-18 16:41:10.379904
NCT00303771|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-05-27|||June 2003||2003-06-01|May 2016|2016-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Randomized Study of Classic vs Simplified Leucovorin Calcium and Fluorouracil With or Without Irinotecan in Patients Aged At Least 75 Years With Advanced Colorectal Cancer|Completed||Phase 3|282|Actual|Federation Francophone de Cancerologie Digestive||4|||f||||t||||||||||2017-02-18 16:41:13.190774|2017-02-18 16:41:13.190774
NCT00303758|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2014-03-03|||October 2005||2005-10-01|December 2006|2006-12-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery|Essai Randomise Comparant Deux Stategies De Chimiotherapie Dans Les Cancers Pancreatiques Avances: LV5FU2 Simplifie + Cisplatine Suivi de Gemcitabine, Versus Gemcitabine Suivi de LV5FU2 Simplifie + Cisplatine en Can de Progression|Completed||Phase 3|202|Actual|Federation Francophone de Cancerologie Digestive||2|||f||||||||||||||2017-02-18 16:41:13.383383|2017-02-18 16:41:13.383383
NCT00303745|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2008-07-23|||June 2006||2006-06-01|December 2006|2006-12-01||||||||Interventional|||Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Randomized Study of Second-Line Therapy Comprising Irinotecan With or Without Capecitabine in Patients Aged At Least 75 Years With Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|78|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:41:16.169308|2017-02-18 16:41:16.169308
NCT00303732|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-03-01|||December 2004||2004-12-01|March 2016|2016-03-01|August 2012|Actual|2012-08-01|August 2010|Actual|2010-08-01||Interventional|PTK/RAD||Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors|PTK787/ZK222584 and RAD001 for Patients With Advanced Solid Tumors|Completed||Phase 1|37|Actual|Duke University||1|||f||||t||||||||||2017-02-18 16:41:16.281302|2017-02-18 16:41:16.281302
NCT00303706|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2007-09-27|||April 2005||2005-04-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Study of Endoscopic Versus Open Harvest of the Radial Artery in Coronary Artery Bypass Surgery|A Prospective Randomized Trial of Endoscopic Versus Conventional Harvesting of the Radial Artery in Coronary Artery Bypass|Completed||Phase 2/Phase 3|119|Actual|Lawson Health Research Institute||1|||f||||||||||||||2017-02-18 16:41:16.549899|2017-02-18 16:41:16.549899
NCT00303667|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-08-10|2015-06-11||January 2005||2005-01-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant|Reduced Intensity Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Supplemented With Donor Natural Killer (NK) Cell Infusions in Patients With High Risk Myeloid Malignancies Who Are Unsuitable for Fully Myeloablative Transplantation|Completed||Phase 1/Phase 2|50|Actual|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-02-18 16:41:16.646413|2017-02-18 16:41:16.646413
NCT00303654|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2013-03-25|||August 2005||2005-08-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection|Quality Assessment of the Roei Loop Resectoscope for Transurethral Resection of Bladder Neoplasm and BPH|Completed||N/A|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:41:17.500012|2017-02-18 16:41:17.500012
NCT00303641|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2006-09-06|||November 2004||2004-11-01|September 2006|2006-09-01|February 2006||2006-02-01|||||Interventional|||Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients|A Prospective Randomized Study of the Safety and Effectiveness of the Medtronic Resting Heart System|Completed||Phase 1|60||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:41:17.600478|2017-02-18 16:41:17.600478
NCT00303628|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2016-07-13|2016-01-28||February 2006||2006-02-01|July 2016|2016-07-01|April 2019|Anticipated|2019-04-01|April 2015|Actual|2015-04-01||Interventional||All randomized patients (intent-to-treat population)|Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer|Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients With Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation|Terminated||Phase 3|355|Actual|Eastern Cooperative Oncology Group||2||The study was terminated before reaching its accrual goal due to slow accrual.|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-02-18 16:41:17.740092|2017-02-18 16:41:17.740092
NCT00303615|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2008-10-17|||June 2005||2005-06-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|June 2007|Anticipated|2007-06-01||Interventional|||Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer|Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer, Phase II Study|Terminated||Phase 2|5|Actual|Legacy Health System||||Low accrural|f||||||||||||||2017-02-18 16:41:19.659708|2017-02-18 16:41:19.659708
NCT00303602|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2009-06-05|2008-12-19||March 2006||2006-03-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)|BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS)|Completed||Phase 4|149|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 16:41:19.758034|2017-02-18 16:41:19.758034
NCT00303589|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-11-01|||December 2005||2005-12-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections|A Phase II Prospective, Open Label, Randomized, Active-controlled, Parallel Group, Multi-center 'Proof of Concept' Trial in Adult Patients With Complicated Skin or Skin Structure Infections Requiring Hospitalization.|Completed||Phase 2|313|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 16:41:21.614563|2017-02-18 16:41:21.614563
NCT00303576|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2006-07-28|||October 2005||2005-10-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel|A Phase I/II Double-Blind, Randomized Study of the Safety, Tolerability and Systemic Absorption of TMC120 Vaginal Microbicide Gel and Matching Placebo in Healthy HIV-Negative Women.|Completed||Phase 1/Phase 2|112||International Partnership for Microbicides, Inc.|||||f||||||||||||||2017-02-18 16:41:21.781005|2017-02-18 16:41:21.781005
NCT00303563|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-11-01|||April 2006||2006-04-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis|A Randomized, Double-blind Study to Compare the Effect of RO4402257 Monotherapy and Methotrexate Monotherapy on Disease Response in Patients With Active Rheumatoid Arthritis.|Completed||Phase 2|204|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 16:41:21.871814|2017-02-18 16:41:21.871814
NCT00303550|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2007-03-26|||March 2006||2006-03-01|March 2006|2006-03-01||||||||Interventional|||Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)|Phase 3, Randomized, Investigator-Blind, Multi-Center Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections (ASSIST-2)|Completed||Phase 3|||Arpida AG|||||||||||||||||||2017-02-18 16:41:22.024811|2017-02-18 16:41:22.024811
NCT00303537|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2007-06-29|||November 2004||2004-11-01|June 2007|2007-06-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Metformin in Non-Alcoholic Fatty Liver Disease|Double Blind, Randomized, Placebo Controlled Trial With Metformin in Non-Alcoholic Fatty Liver Disease (NAFLD)|Unknown status|Active, not recruiting|Phase 2/Phase 3|90|Anticipated|University Hospital, Aker||2|||f||||f||||||||||2017-02-18 16:41:22.205252|2017-02-18 16:41:22.205252
NCT00303524|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2009-12-20|||February 2006||2006-02-01|December 2009|2009-12-01|February 2009|Actual|2009-02-01|August 2007|Actual|2007-08-01||Interventional|||Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients|An Open-label, Randomized, Parallel Group, Multicentre Study to Compare Oestradiol Suppression Between ZOLADEX 10.8 mg Depot Given 3 Monthly and ZOLADEX 3.6 mg Depot Given Monthly in Pre-menopausal Patients With ER Positive Early Breast Cancer|Completed||Phase 2|170|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:41:22.302132|2017-02-18 16:41:22.302132
NCT00303511|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2014-07-16|2013-11-08||January 1996||1996-01-01|July 2014|2014-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Pacemaker Therapy in Adults With Congenital Heart Defects|Pacemaker Therapy in Adults With Congenital Heart Defects|Completed||N/A|10|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:41:22.419607|2017-02-18 16:41:22.419607
NCT00303498|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2012-10-08||2012-10-08|March 2006||2006-03-01|October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure|A Phase 2 Randomised, Double-Blind, Placebo-Controlled Exploratory Efficacy Study Of Sitaxsentan Sodium To Improve Impaired Exercise Tolerance In Subjects With Diastolic Heart Failure|Completed||Phase 2|192|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:41:22.655184|2017-02-18 16:41:22.655184
NCT00303485|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2016-03-30|2016-02-23||February 2006||2006-02-01|March 2016|2016-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional||The Intent-to-Treat (ITT) Population included all randomized participants who received at least 1 dose of study medication.|A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)|A Randomized, Double-blind, Placebo-controlled Study to Determine Time to Onset of Suppression of the Bone Resorption Marker sCTX With Once Monthly Ibandronate in the Treatment of Postmenopausal Osteoporosis|Completed||Phase 4|67|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:41:22.988071|2017-02-18 16:41:22.988071
NCT00303472|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2013-11-21|2010-10-22||February 2006||2006-02-01|November 2013|2013-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)|An Open Label, Sequential Cohort, Dose Escalation Study to Evaluate the Safety and Efficacy of AMG 531 in Thrombocytopenic Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)|Completed||Phase 2|72|Actual|Amgen||7|||f||||||||||||||2017-02-18 16:41:23.77038|2017-02-18 16:41:23.77038
NCT00303459|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-16|2015-10-16|2015-01-02||May 2006||2006-05-01|October 2015|2015-10-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|Compass-2|All randomized set|Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)|Effects of Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Morbidity and Mortality in Symptomatic Patients With Pulmonary Arterial Hypertension - A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Prospective, Event Driven Phase IV Study|Completed||Phase 4|334|Actual|Actelion||2|||f||||t||||||||||2017-02-18 16:41:27.029424|2017-02-18 16:41:27.029424
NCT00303446|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2011-01-25|2009-12-09||March 2006||2006-03-01|January 2011|2011-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)|Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients With Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)|Completed||Phase 2|57|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 16:41:28.975547|2017-02-18 16:41:28.975547
NCT00303433|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2015-06-02|||March 2006||2006-03-01|December 2009|2009-12-01|September 2006||2006-09-01|||||Interventional|||Namenda to Prevent Post-Operative Delirium|Namenda as Prevention for Post-Operative Delirium|Terminated||Phase 4|30||University of Rochester|||||f||||||||||||||2017-02-18 16:41:29.732803|2017-02-18 16:41:29.732803
NCT00303420|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2008-12-17|||September 2004||2004-09-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Alteplase for Blood Flow Restoration in Hemodialysis Catheters|Alteplase for Blood Flow Restoration in Hemodialysis Catheters: A Randomized Prospective Clinical Trial|Terminated||Phase 4|180|Anticipated|University of Manitoba||2||Unable to enrol enough people to achieve the full sample size|f||||t||||||||||2017-02-18 16:41:29.842041|2017-02-18 16:41:29.842041
NCT00303407|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2006-03-15|||January 2001||2001-01-01|December 2005|2005-12-01|July 2002||2002-07-01|||||Observational|||Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care||Terminated||Phase 4|||University Hospital, Geneva|||||f||||||||||||||2017-02-18 16:41:30.197125|2017-02-18 16:41:30.197125
NCT00303394|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2007-03-02|||April 2004||2004-04-01|March 2007|2007-03-01|March 2006||2006-03-01|||||Interventional|||Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist|Phase 2 Study of IL-1Ra in Patients With Type 2 Diabetes|Completed||Phase 2|72||University of Zurich|||||f||||||||||||||2017-02-18 16:41:30.284694|2017-02-18 16:41:30.284694
NCT00303381|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2013-08-04|||December 2001||2001-12-01|August 2013|2013-08-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis|A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-finding Phase II Study of Subcutaneously Administered IFN-beta-1a in the Treatment of Patients With Moderately Active Ulcerative Colitis|Completed||Phase 2|194|Actual|EMD Serono||3|||f||||||||||||||2017-02-18 16:41:30.382503|2017-02-18 16:41:30.382503
NCT00303368|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2008-05-20|||March 2004||2004-03-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|||||Observational|NF1TD||Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia|Multicenter Study of Tibial Dysplasia in Neurofibromatosis Type I (NF1) Patients|Unknown status|Recruiting|N/A|420|Anticipated|Shriners Hospitals for Children|||1||f||||t||||||Samples With DNA|"~     If the enrollee's private physician includes surgery in the management of his/her disorder,~     and if tissue is removed to be discarded, permission is obtained to store the specimen in a~     tissue repository for future research.~   "|||2017-02-18 16:41:30.513956|2017-02-18 16:41:30.513956
NCT00303355|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2013-09-04|||September 2002||2002-09-01|September 2013|2013-09-01|September 2004||2004-09-01|||||Observational|||Measurement of Jugular Venous Pulse in Critically Ill Patients.|An Evaluation of the Utility of Clinical Examination for the Measurement of Jugular Venous Pulse in Critically Ill Patients.|Terminated||N/A|36||University of Chicago||||Study completed|f||||||||||||||2017-02-18 16:41:30.605985|2017-02-18 16:41:30.605985
NCT00303342|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2010-01-12|||March 2006||2006-03-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia|Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia|Completed||Phase 2|60|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 16:41:30.692657|2017-02-18 16:41:30.692657
NCT00303329|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-04-15|2010-12-15||March 2004||2004-03-01|April 2011|2011-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients|Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Other Patients With Rare Chronic Anemia and Transfusional Iron Overload|Completed||Phase 2|184|Actual|Novartis||1|||f||||t||||||||||2017-02-18 16:41:30.820156|2017-02-18 16:41:30.820156
NCT00303108|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2016-09-15|2016-02-02||December 2005||2005-12-01|September 2016|2016-09-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional||ITT population|Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer|Phase II Study of Doxil and Carboplatin, Plus Herceptin in HER2+ Patients, in Metastatic Breast Cancer|Completed||Phase 2|136|Actual|US Oncology Research||1|||f||||||||||||||2017-02-18 16:41:35.264067|2017-02-18 16:41:35.264067
NCT00303316|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2013-01-18|2012-12-11||February 2006||2006-02-01|January 2013|2013-01-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|||Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants|Immunogenicity Study of the Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months of Age Following a Primary Series of DTaP-IPV-HB-PRP~T Combined Vaccine or of PENTAXIM™ and ENGERIX B® PEDIATRICO at 2, 4, and 6 Months of Age in Healthy Argentinean Infants|Completed||Phase 3|458|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:41:32.22416|2017-02-18 16:41:32.22416
NCT00303303|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2008-07-16|||April 2005||2005-04-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations|The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations|Terminated||Phase 4|25|Anticipated|Carolinas Healthcare System||3||Study terminated due to declining enrollment; data analysis proceeding.|f||||t||||||||||2017-02-18 16:41:32.788831|2017-02-18 16:41:32.788831
NCT00303290|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-15|2015-11-25|||January 2000||2000-01-01|November 2015|2015-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With SCH54031 (PEG Interferon Alpha 2B/PEG Intron) and Low-Dose Cytosine Arabinoside (Ara-C)|Completed||Phase 1|76|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:41:32.909044|2017-02-18 16:41:32.909044
NCT00303277|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2010-04-12|||August 2002||2002-08-01|April 2010|2010-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Do HMG CoA Reductase Inhibitors Affect Abeta Levels?|Do HMG CoA Reductase Inhibitors Affect Abeta Levels?|Completed||Phase 4|35|Actual|Seattle Institute for Biomedical and Clinical Research||2|||f||||t||||||||||2017-02-18 16:41:33.023093|2017-02-18 16:41:33.023093
NCT00303264|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2012-03-01|||May 2006||2006-05-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.|A Phase II Study to Investigate the Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.|Completed||Phase 2|48|Actual|Forest Laboratories|||||||||||||||||||2017-02-18 16:41:33.154728|2017-02-18 16:41:33.154728
NCT00303251|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2013-02-09||2013-02-09|April 2006||2006-04-01|February 2013|2013-02-01||||September 2009|Actual|2009-09-01||Interventional|||Safety of TKI258 in Advanced/Metastatic Melanoma Subjects|A Phase I/II Dose Escalating Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of TKI258 (CHIR-258) in Patients With Locally Advanced or Metastatic Melanoma|Completed||Phase 1/Phase 2|47|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:41:33.363457|2017-02-18 16:41:33.363457
NCT00303238|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-03-14|||October 2004||2004-10-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Interventional|||Study to Evaluate the Effect of Botanical Dietary Supplements on Inflammation in Healthy People|Double-Blind Trial to Evaluate the Effect of Botanical Dietary Supplements on C-Reactive Protein, Ex-Vivo IL-1 Production, and In-Vivo IL-1 Gene Expression in Healthy Human Subjects|Completed||N/A|200||Access Business Group|||||f||||||||||||||2017-02-18 16:41:33.460268|2017-02-18 16:41:33.460268
NCT00303225|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2017-01-24|||March 13, 2006||2006-03-13|August 4, 2006|2006-08-04|August 4, 2006||2006-08-04|||||Interventional|||SIGA-246 to Treat Smallpox|A Double-Blind, Randomized, Placebo-Controlled, Ascending Single-Dose, Phase I Trial of the Anti-Orthopoxvirus Compound SIGA-246 in Healthy Volunteers|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:41:33.557689|2017-02-18 16:41:33.557689
NCT00303212|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2010-09-16|||March 2006||2006-03-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|January 2010|Actual|2010-01-01||Interventional|||Tele-HF: Yale Heart Failure Telemonitoring Study|A Study of Telemonitoring to Improve Heart Failure Outcomes|Completed||N/A|1660|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:41:33.646656|2017-02-18 16:41:33.646656
NCT00303199|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2012-07-18|||January 2006||2006-01-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of ZIO-101 in Multiple Myeloma|A Phase I/II Trial of ZIO-101 in Advanced Multiple Myeloma|Completed||Phase 1/Phase 2|35|Actual|Ziopharm||1|||f||||||||||||||2017-02-18 16:41:33.78702|2017-02-18 16:41:33.78702
NCT00303186|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2012-06-25|2012-06-25||February 2005||2005-02-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy|An Observational Study to Evaluate the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy|Completed||N/A|107|Actual|Pfizer|Results were not summarized for Month 6, 18 and 24 due to insufficient data collected and small sample size achieved at the time points.||1||f||||f||||||||||2017-02-18 16:41:33.900749|2017-02-18 16:41:33.900749
NCT00303173|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2008-06-23|||August 2004||2004-08-01|June 2008|2008-06-01|February 2007|Actual|2007-02-01|December 2006|Actual|2006-12-01||Interventional|||The Relaxation and Blood Pressure in Pregnancy (REBIP) Study|A Randomized Controlled Trial of The Effectiveness of Guided Imagery on Blood Pressure in Hypertensive Pregnant Women: The Relaxation and Blood Pressure in Pregnancy (REBIP) Pilot Study|Completed||N/A|69|Actual|University of Toronto||1|||f||||f||||||||||2017-02-18 16:41:34.812497|2017-02-18 16:41:34.812497
NCT00303160|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2007-08-13|||March 2006||2006-03-01|August 2007|2007-08-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Effect of Helicobacter Pylori on the Availability of Vitamin E and C|Effect of Helicobacter Pylori on the Availability of Vitamin E and C|Unknown status|Active, not recruiting|Phase 4|72|Anticipated|University of Toronto||2|||f||||||||||||||2017-02-18 16:41:34.909436|2017-02-18 16:41:34.909436
NCT00303147|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-03-14|||May 2003||2003-05-01|March 2006|2006-03-01|July 2005||2005-07-01|||||Interventional|||Cognitive and Health Benefits of Expressive Writing for Family Caregivers Under Stress||Unknown status|Active, not recruiting|Phase 1|120||University of Toronto|||||f||||||||||||||2017-02-18 16:41:35.001628|2017-02-18 16:41:35.001628
NCT00303134|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2008-12-04|||August 2003||2003-08-01|September 2007|2007-09-01||||||||Interventional|||Islet Cell Transplants for Diabetes|Human Islet Cell Transplantation in Type 1 Diabetic Patients|Suspended||Phase 1|8|Anticipated|Weill Medical College of Cornell University|||||||||||||||||||2017-02-18 16:41:35.102982|2017-02-18 16:41:35.102982
NCT00303121|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-10-10|||November 2005||2005-11-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Observational|||Compliance and Administration Technique in Topical Drug Therapy of Glaucoma||Completed||N/A|120||University of Toronto|||||f||||||||||||||2017-02-18 16:41:35.188179|2017-02-18 16:41:35.188179
NCT00294671|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2013-05-12|||February 2006||2006-02-01|May 2013|2013-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||The Effect of Diflunisal on Familial Amyloidosis|The Effect of Diflunisal on Familial Amyloidosis|Completed||Phase 2/Phase 3|140|Actual|Boston University||2|||f||||t||||||||||2017-02-18 16:44:30.185932|2017-02-18 16:44:30.185932
NCT00303082|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2011-06-14|||January 2006||2006-01-01|October 2009|2009-10-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Interventional|||Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity|Clinical Trial for the Prevention of Premature Birth and Neonatal Related Morbidity|Terminated||Phase 3|645|Actual|Oswaldo Cruz Foundation||1||Limitation of funding|f||||t||||||||||2017-02-18 16:41:36.084023|2017-02-18 16:41:36.084023
NCT00303069|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2015-06-29|2010-09-23||November 2005||2005-11-01|June 2015|2015-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||V710 First-In-Man (FIM) Study (V710-001)|A Sequential-Panel, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine in Healthy Adults 18 to 55 Years of Age|Completed||Phase 1|124|Actual|Merck Sharp & Dohme Corp.||4|||f||||t||||||||||2017-02-18 16:41:36.199166|2017-02-18 16:41:36.199166
NCT00303056|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2012-02-15|||February 2006||2006-02-01|February 2012|2012-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis|Efficacy and Safety of Intra-articular Multiple Doses of 500 µg Icatibant Including 40 mg Triamcinolone as Calibrator in a Randomized, Double-blind, Parallel-group, Placebo-controlled 13-week Multi-centre Study in Patients With Symptomatic Knee Osteoarthritis|Completed||Phase 2|590|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:41:37.283937|2017-02-18 16:41:37.283937
NCT00303043|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2009-12-29|||March 2006||2006-03-01|March 2009|2009-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Hemodynamic Monitoring With Mixed Venous Saturation|Hemodynamic Monitoring. The Continuous Measurement of Mixed Venous Saturation Compared to Clinical Valuation: A Pilot Study|Completed||N/A|30|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-02-18 16:41:37.396267|2017-02-18 16:41:37.396267
NCT00303030|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2011-11-16|||May 2006||2006-05-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence|A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence.|Completed||Phase 1|126|Actual|University Hospital of North Norway||2|||f||||f||||||||||2017-02-18 16:41:37.50022|2017-02-18 16:41:37.50022
NCT00303017|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2015-10-19|||March 2006||2006-03-01|November 2008|2008-11-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study|Safety, Efficacy and Acceptability of Flavocoxid (Limbrel) Compared With Naproxen in Subjects With Osteoarthritis of the Knee. A Pilot Study|Completed||N/A|60|Actual|Primus Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:41:37.628122|2017-02-18 16:41:37.628122
NCT00303004|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2008-01-23|||March 2006||2006-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome|Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome|Completed||Phase 3|20|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 16:41:37.745167|2017-02-18 16:41:37.745167
NCT00302991|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2008-01-29|||March 2006||2006-03-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)|Quality of Life and Adverse Effects in Epilepsy Patients According to Treatment Group (EPIKA)|Completed||Phase 4|180||UCB Pharma|||||f||||f||||||||||2017-02-18 16:41:37.84405|2017-02-18 16:41:37.84405
NCT00302978|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2011-12-14|||March 2006||2006-03-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Changes in Brain Activity (Functional MRI Study) Before and After Behavioral Therapy of Height Phobia|The Effects of in Vivo Exposure Therapy on the Neural Correlates of Height Phobia: a Functional Magnetic Resonance Imaging Study Using a Fear Provocation Paradigm.|Completed||N/A|40||New York State Psychiatric Institute|||||f||||||||||||||2017-02-18 16:41:37.925292|2017-02-18 16:41:37.925292
NCT00302965|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-17|||April 2005||2005-04-01|October 2008|2008-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effectiveness of Plasma Transfusions in Critical Care Patients|Effectiveness of Fresh Frozen Plasma in Critical Care (EPICC) Trial|Completed||Phase 1/Phase 2|70|Anticipated|Ottawa Hospital Research Institute|||||f||||||||||||||2017-02-18 16:41:38.014056|2017-02-18 16:41:38.014056
NCT00302952|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2016-09-13|2013-12-18||August 2006||2006-08-01|September 2016|2016-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional||Completed Intent-to-Treat (ITT)|Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis|A Double Blind, Placebo Controlled, Phase II, Randomized Study of Lovastatin Therapy in the Treatment of Mildly Active Rheumatoid Arthritis|Completed||Phase 2|64|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Enrollment was slow and the full sample size was not obtained.|2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 16:41:38.114991|2017-02-18 16:41:38.114991
NCT00302939|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2010-04-21|||January 2006||2006-01-01|April 2010|2010-04-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Etiology of Anemia|Studies in the Etiology of Anemia in an Unselected Sequential Referral Population|Terminated||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||1||f||||||||||Samples Without DNA|"~     Bone marrow aspirate, urine, blood serum~   "|||2017-02-18 16:41:39.015332|2017-02-18 16:41:39.015332
NCT00302926|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-03-14|||September 2002||2002-09-01|March 2006|2006-03-01|June 2003||2003-06-01|||||Interventional|||B195: Effect of Diet-Induced Energy Deficit and Body Fat Reduction on Inflammatory Markers in Obese Subjects|B195: Effect of Diet-Induced Energy Deficit and Body Fat Reduction on Inflammatory Markers in Obese Subjects|Completed||N/A|50||University of Copenhagen|||||f||||||||||||||2017-02-18 16:41:39.111538|2017-02-18 16:41:39.111538
NCT00302913|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-06-29|||December 2005||2005-12-01|February 2006|2006-02-01|June 2006||2006-06-01|||||Interventional|||Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition|Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition After Elective Coronary Stenting|Completed||N/A|120||Heart Center Bad Krozingen|||||f||||||||||||||2017-02-18 16:41:39.21558|2017-02-18 16:41:39.21558
NCT00302900|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2016-10-04|||January 2006||2006-01-01|February 2009|2009-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations|Preventing Adverse Reactions in Novice Blood Donors|Completed||Phase 2|441|Actual|Ohio University||4|||f||||t||||||||Yes|Deidentified data is available upon request from the primary investigator.|2017-02-18 16:41:39.32775|2017-02-18 16:41:39.32775
NCT00302887|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-03-14|||August 2003||2003-08-01|March 2006|2006-03-01|December 2004||2004-12-01|||||Observational|||Connective Tissue Manipulation and Combined Ultrasound Therapy in Patients With Fibromyalgia|Short and Long Term Results of Connective Tissue Manipulation and Combined Ultrasound Therapy in Patients With Fibromyalgia|Completed||N/A|20||Hacettepe University|||||f||||||||||||||2017-02-18 16:41:39.453638|2017-02-18 16:41:39.453638
NCT00302874|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2007-03-23|||February 2003||2003-02-01|October 2002|2002-10-01|October 2004||2004-10-01|||||Interventional|||In-Hospital Hyperglycemia: Effects of Treatment on Glycemic Control and Clinical Outcome|In-Hospital Hyperglycemia: Effects of Treatment on Glycemic Control and Clinical Outcome|Completed||N/A|400||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:41:39.559873|2017-02-18 16:41:39.559873
NCT00302861|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2008-03-14|||March 2006||2006-03-01|March 2008|2008-03-01||||||||Interventional|||A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)|Phase 1/2 Study to Evaluate the Feasibility and Tolerability of Treatment of Previously Untreated B-CLL Chronic Lymphocytic Leukemia (B-CLL) Patients With Recombinant Idiotype Conjugated to KLH (Id-KLH) Administered With GM-CSF|Terminated||Phase 1/Phase 2|86||Genitope Corporation|||||||||||||||||||2017-02-18 16:41:39.662158|2017-02-18 16:41:39.662158
NCT00302848|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2009-11-06|2009-06-23||November 2000||2000-11-01|November 2009|2009-11-01|December 2005||2005-12-01|||||Observational|||European Active Surveillance Study (EURAS)|The European Active Surveillance Study on OC Prescribing Practice, Benefits and Safety (EURAS)|Completed||Phase 4|59510|Actual|Center for Epidemiology and Health Research, Germany|This is an observational study. The possibility of bias and residual confounding cannot be entirely eliminated.||3||f||||t||||||||||2017-02-18 16:41:39.748449|2017-02-18 16:41:39.748449
NCT00302835|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-04-21|||January 2001||2001-01-01|April 2006|2006-04-01|December 2004||2004-12-01|||||Observational|||Case-Control Study on Analgesics and Nephropathy (SAN)|Case-Control Study on Analgesics and Nephropathy (SAN)|Completed||N/A|4200||Center for Epidemiology and Health Research, Germany|||||f||||||||||||||2017-02-18 16:41:40.277156|2017-02-18 16:41:40.277156
NCT00302822|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2013-07-09|||April 2006||2006-04-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)|Enfuvirtide for the Initial Phase of Antiretroviral Therapy in HIV-infected Patients With High Risk of Clinical Progression : ANRS 130 APOLLO|Completed||Phase 3|195|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 16:41:40.375211|2017-02-18 16:41:40.375211
NCT00302809|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2009-06-16|||March 2006||2006-03-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|||||Interventional|||Blood Pressure Lowering Effects of Grape Juice|Effect of Concord Grape Juice on Blood Pressure and Vascular Function in Subjects With Pre-Hypertension and Stage 1 Hypertension|Completed||N/A|60|Anticipated|Boston University||1|||f||||f||||||||||2017-02-18 16:41:40.498634|2017-02-18 16:41:40.498634
NCT00302796|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2010-05-26|||March 2006||2006-03-01|July 2009|2009-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Antibiotic Treatment to Patients With Low Back Pain|Antibiotic Treatment to Patients With Low Back Pain Associated With Modic Changes Following Disc Herniation. A Randomized Clinical Controlled Trial|Completed||Phase 4|162|Actual|The Back Research Center, Denmark||4|||f||||t||||||||||2017-02-18 16:41:40.720782|2017-02-18 16:41:40.720782
NCT00302783|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-14|2006-03-14|||June 2004||2004-06-01|January 2006|2006-01-01|September 2005||2005-09-01|||||Interventional|||Randomized Controlled Trial of Multi-Source Feedback to Pediatric Residents|Randomized Controlled Trial of Multi-Source Feedback to Pediatric Residents: The Formative Value of an ACGME Competency-Based Assessment Tool.|Completed||N/A|36||Children's Hospital Medical Center, Cincinnati|||||f||||||||||||||2017-02-18 16:41:40.831618|2017-02-18 16:41:40.831618
NCT00302770|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2011-01-25|||June 2006||2006-06-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Efficacy of Quetiapine in Generalised Social Anxiety Disorder|Efficacy of Quetiapine in Generalised Social Anxiety Disorder, a Double-blind, Placebo-controlled Study|Terminated||Phase 3|50|Anticipated|AstraZeneca||||This study was terminated due to poor enrollment|f||||||||||||||2017-02-18 16:41:40.914825|2017-02-18 16:41:40.914825
NCT00302757|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2014-05-28|||March 2006||2006-03-01|May 2014|2014-05-01|July 2011|Actual|2011-07-01|||||Interventional|||Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma|Multicenter Phase I/II Study of Radioimmunotherapy With 90Y-ibritumomab Tiuxetan in a Nonmyeloablative Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation From HLA-identical Donors in Patients With Advanced Non-Hodgkin Lymphoma|Completed||Phase 1/Phase 2|60|Anticipated|University Hospital Tuebingen|||||f||||||||||||||2017-02-18 16:41:41.004628|2017-02-18 16:41:41.004628
NCT00302744|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2013-01-28|||April 2004||2004-04-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety|Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety|Completed||Phase 1|12|Actual|Los Angeles Biomedical Research Institute||1|||f||||t||||||||||2017-02-18 16:41:41.11816|2017-02-18 16:41:41.11816
NCT00302731|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2014-01-06|||February 2006||2006-02-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Bioidentical 'Natural' Hormone Evaluation in Early Menopause|Prospective Double Blind Evaluation of Bioidentical Hormones|Completed||Phase 2|40|Anticipated|University of Kansas Medical Center||4|||f||||t||||||||||2017-02-18 16:41:41.229875|2017-02-18 16:41:41.229875
NCT00302718|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2015-04-06|2014-11-21||February 2007||2007-02-01|October 2014|2014-10-01|September 2012|Actual|2012-09-01|October 2011|Actual|2011-10-01||Interventional||Distribution of Physician Characteristics Across Study Groups|Financial Incentives to Translate ALLHAT Into Practice: A Randomized Trial|RCT of Financial Incentives to Translate ALLHAT Into Practice|Completed||N/A|83|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 16:41:41.344581|2017-02-18 16:41:41.344581
NCT00302705|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2009-01-02|||January 2005||2005-01-01|January 2009|2009-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose|Prospective, Randomized, Open-Label Study in Patients With Mild-to-Moderate Essential Hypertension to Compare the Antihypertensive Efficacy Determined by Ambulatory Blood Pressure Monitoring of Valsartan and Enalapril After Missing One Dose|Completed||Phase 4|150|Actual|University of Vigo||2|||f||||t||||||||||2017-02-18 16:41:42.388663|2017-02-18 16:41:42.388663
NCT00294463|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-02-17|||February 2003||2003-02-01|February 2006|2006-02-01|March 2005||2005-03-01|||||Interventional|||Effects of Tibolone Treatment on the Endometrium|Effects of Tibolone Treatment on the Endometrium|Completed||Phase 4|35||Erasmus Medical Center|||||f||||||||||||||2017-02-18 16:44:35.503474|2017-02-18 16:44:35.503474
NCT00302692|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2007-05-09|||December 2005||2005-12-01|May 2007|2007-05-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Use of Beta Blockers in Elderly Trauma Patients|"Effects of Beta-Blockade on Cardiovascular Morbidity and Mortality in Elderly Trauma Patients: A Prospective Randomized Clinical Trial"|Unknown status|Recruiting|Phase 2|148|Anticipated|University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:41:42.51113|2017-02-18 16:41:42.51113
NCT00302679|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-12|2006-03-13|||January 2006||2006-01-01|February 2006|2006-02-01|June 2006||2006-06-01|||||Observational|||Comparison of Colonoscopy and Sigmoidoscopy in Terms of Pain, Acceptance and Procedure Time|Comparison of Colonoscopy and Sigmoidoscopy in Terms of Pain, Acceptance and Procedure Time|Unknown status|Recruiting|Phase 1|400||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:41:42.633303|2017-02-18 16:41:42.633303
NCT00302666|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2009-05-15|||June 2003||2003-06-01|May 2009|2009-05-01|February 2005|Actual|2005-02-01|||||Interventional|||Bleeding Pattern Study|Comparative, Prospective, Multi-Center, Open, Randomized Study to Investigate Bleeding Patterns, Metabolic Effects, Contraceptive Efficacy, Acceptance, and Safety of an Oral Contraceptive Containing 0.03 mg Ethinylestradiol and 2 mg Dienogest, in Two Different Regimens of Intake (Four Extended Cycles of 84 Days Each Versus the Conventional Regimen of 21 Days) in Healthy Volunteers|Completed||Phase 3|1315|Actual|Bayer||2|||f||||||||||||||2017-02-18 16:41:42.724418|2017-02-18 16:41:42.724418
NCT00302653|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2009-09-24|||February 2006||2006-02-01|September 2009|2009-09-01||||November 2006|Actual|2006-11-01||Interventional|||Rasburicase in Tumor Lysis Syndrome|Program of Rasburicase in the Treatment of Hyperuricemia in Children and Adolescent Patients With or at Risk of Tumor Lysis Syndrome.|Completed||Phase 4|33|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:41:42.903807|2017-02-18 16:41:42.903807
NCT00302640|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2012-05-30|||February 2005||2005-02-01|May 2012|2012-05-01|September 2005||2005-09-01|||||Interventional|||Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children|Multi-center, Double-blind, Placebo-controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children|Completed||Phase 2/Phase 3|50|Actual|Romark Laboratories L.C.||2|||f||||||||||||||2017-02-18 16:41:43.012185|2017-02-18 16:41:43.012185
NCT00302627|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2010-08-25|||January 1999||1999-01-01|December 2002|2002-12-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation|Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation|Completed||N/A|43|Actual|Providence Health & Services||1|||f||||f||||||||||2017-02-18 16:41:43.10611|2017-02-18 16:41:43.10611
NCT00302614|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-12|2006-03-12|||January 2006||2006-01-01|December 2005|2005-12-01|June 2006||2006-06-01|||||Observational|||The Role of Clinical Parameters in Predicting the Severity of Obstructive Sleep Apnea||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:41:43.236476|2017-02-18 16:41:43.236476
NCT00302601|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2016-04-15|||April 2006||2006-04-01|April 2016|2016-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of Diagnosis and Pathophysiology of Pulmonary Embolism (APE 1 Trial)|The Acute Pulmonary Embolism 1 (APE 1) Trial: Prospective Investigation of Scintigraphic Diagnosis and Pathophysiology of Right Heart Strain|Terminated||N/A|15|Actual|Odense University Hospital||1||Logistics failure and staff/scanner shortage|f||||f||||||||No||2017-02-18 16:41:43.325925|2017-02-18 16:41:43.325925
NCT00302588|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-12|2006-03-12|||January 2006||2006-01-01|December 2005|2005-12-01|February 2006||2006-02-01|||||Observational|||The Final Diagnosis and Treatment Result of Metastatic Cervical Carcinoma of Unknown Primary||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:41:43.434422|2017-02-18 16:41:43.434422
NCT00302575|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2017-01-10|||February 2005||2005-02-01|August 2006|2006-08-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees|Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees|Unknown status|Recruiting|N/A|420|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:41:43.521198|2017-02-18 16:41:43.521198
NCT00302562|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-12|2006-03-12|||August 2006||2006-08-01|December 2005|2005-12-01|July 2007||2007-07-01|||||Observational|||The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma||Unknown status|Not yet recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:41:43.617237|2017-02-18 16:41:43.617237
NCT00302549|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2010-05-25|||May 2004||2004-05-01|July 2008|2008-07-01|February 2006|Actual|2006-02-01|May 2005|Actual|2005-05-01||Interventional|||To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN|To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class|Completed||N/A|61|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 16:41:43.698972|2017-02-18 16:41:43.698972
NCT00302536|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2012-02-08|||March 2006||2006-03-01|September 2010|2010-09-01|September 2010|Anticipated|2010-09-01|May 2010|Anticipated|2010-05-01||Interventional|||Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis|Tacrolimus Treatment of Patients With Idiopathic Focal Segmental|Withdrawn||N/A|0|Actual|Nanjing University School of Medicine||1||There was less patients recruited.|f||||t||||||||||2017-02-18 16:41:43.808091|2017-02-18 16:41:43.808091
NCT00302523|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2012-02-02|||March 2006||2006-03-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy|Tacrolimus Treatment of Patients With Idiopathic|Completed||N/A|16|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 16:41:43.917307|2017-02-18 16:41:43.917307
NCT00302510|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2010-05-25|||January 2000||2000-01-01|July 2008|2008-07-01|August 2003|Actual|2003-08-01|March 2002|Actual|2002-03-01||Interventional|||Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy|Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein|Completed||N/A|20|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 16:41:44.028441|2017-02-18 16:41:44.028441
NCT00302497|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2007-04-11|||April 2007||2007-04-01|February 2006|2006-02-01|April 2008|Anticipated|2008-04-01|||||Interventional|||EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function|12 Month, Prospective, Randomised, Open-Label Comparative Study to Evaluate the Protection of Kidney Function by Basiliximab in a CNI-Free Regimen in Newly Kidney Transplanted Patients (Three Months Post-Transplant) Who Are Recipient of One Kidney From Expanded Donor Criteria (UNOS Criteria)|Unknown status|Not yet recruiting|Phase 3|50||McGill University Health Center|||||f||||||||||||||2017-02-18 16:41:44.127685|2017-02-18 16:41:44.127685
NCT00302484|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2006-07-25|||April 2002||2002-04-01|January 2006|2006-01-01||||||||Interventional|||Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation|Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation, a Prospective Randomised Study|Unknown status|Active, not recruiting|N/A|96||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:41:44.207676|2017-02-18 16:41:44.207676
NCT00302471|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2015-04-24|||March 2006||2006-03-01|April 2015|2015-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)|A Phase I, Randomized, Multicenter, Double-Blind Study of MK0429 in the Treatment of Men With Hormone Refractory Prostate Cancer and Metastatic Bone Disease|Completed||Phase 1|29|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 16:41:44.288912|2017-02-18 16:41:44.288912
NCT00302458|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2016-02-01|2013-11-18||January 2006||2006-01-01|February 2016|2016-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional||One subject was ineligible, one subject was lost to follow-up, one withdrew, and twenty six subjects completed the study.|A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults|A Double-blind, Randomized, Placebo-controlled, Crossover Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults|Completed||Phase 4|44|Actual|Massachusetts General Hospital||5|||f||||f||||||||||2017-02-18 16:41:44.39338|2017-02-18 16:41:44.39338
NCT00302445|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2007-07-12|||March 2006||2006-03-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis|An Open-Label Pilot Study to Evaluate the Efficacy and Safety of Raptiva (Efalizumab)in Combination With Narrow Band Phototherapy for the Treatment of Moderate to Severe Plaque Psoriasis.|Completed||Phase 4|20||Derm Research, PLLC|||||f||||t||||||||||2017-02-18 16:41:44.695527|2017-02-18 16:41:44.695527
NCT00302432|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2010-07-21|||March 2006||2006-03-01|July 2010|2010-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effect of Cigarette Holders, Plastic Menthol Cigarettes, and Cognitive Behavioral Therapy for Smoking Reduction Among Schizophrenia Inpatients: A Comparative Study|The Effect of Cigarette Holders, Plastic Menthol Cigarettes, and Cognitive Behavioral Therapy for Smoking Reduction Among Schizophrenia Inpatients: A Comparative Study|Completed||N/A|37|Actual|Lev-Hasharon Mental Healtlh Center||2|||f||||||||||||||2017-02-18 16:41:44.911956|2017-02-18 16:41:44.911956
NCT00302419|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2008-07-30|||October 2004||2004-10-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|February 2006|Actual|2006-02-01||Interventional|||Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction|Effect of Complementary Intracoronary Streptokinase Administration Immediately After Primary Percutaneous Coronary Intervention on Microvascular Perfusion and Late Term Infarct Size in Patients With Acute Myocardial Infarction|Completed||Phase 4|95|Actual|Istanbul University||2|||f||||||||||||||2017-02-18 16:41:45.023456|2017-02-18 16:41:45.023456
NCT00302406|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2011-07-11|||July 2003||2003-07-01|July 2011|2011-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate|Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate|Completed||Phase 4|50|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 16:41:45.149284|2017-02-18 16:41:45.149284
NCT00302393|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2013-10-21|||June 2006||2006-06-01|October 2013|2013-10-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults|A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy of Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults|Completed||Phase 3|20|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 16:41:45.245977|2017-02-18 16:41:45.245977
NCT00302380|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2011-06-27|||October 2000||2000-10-01|June 2011|2011-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD|An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD|Completed||Phase 1/Phase 2|300|Actual|Massachusetts General Hospital|||2||f||||t||||||Samples With DNA|"~     A sample of blood (2 tablespoons) will be drawn from all subjects.~   "|||2017-02-18 16:41:45.359243|2017-02-18 16:41:45.359243
NCT00302367|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2011-07-11|||January 2004||2004-01-01|July 2011|2011-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects|An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects|Completed||Phase 4|20||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 16:41:45.454196|2017-02-18 16:41:45.454196
NCT00302354|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2011-07-11|||December 2004||2004-12-01|July 2011|2011-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults|A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults|Completed||Phase 4|50||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 16:41:45.55432|2017-02-18 16:41:45.55432
NCT00302341|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2013-03-06|||May 2006||2006-05-01|March 2013|2013-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)|International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-sulfamethoxazole for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) in Patients With HIV/AIDS|Terminated||Phase 3|48|Actual|Immtech Pharmaceuticals, Inc||2||FDA Clinical Hold as of 12/21/07 due to safety concerns|f||||t||||||||||2017-02-18 16:41:45.648323|2017-02-18 16:41:45.648323
NCT00300937|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2007-11-21|||July 2004||2004-07-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Coenzyme Q10 Supplementation and Development of Preeclampsia|Coenzyme Q10 Supplementation in Pregnant Women as Strategy to Reduce Maternal Morbidity Due to Preeclampsia|Completed||Phase 3|235|Actual|Teran, Enrique, MD, PhD||1|||f||||f||||||||||2017-02-18 16:42:13.850696|2017-02-18 16:42:13.850696
NCT00302328|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2014-03-13|2012-10-04||August 2005||2005-08-01|March 2014|2014-03-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|||Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes|A Randomised Clinical Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes|Completed||N/A|78|Actual|Glostrup University Hospital, Copenhagen|non-closure of macular hole after surgical procedure in 18 patients led to re-operation. Data included in main published papers.|3|||f||||f||||||||||2017-02-18 16:41:45.770917|2017-02-18 16:41:45.770917
NCT00302315|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2006-03-13|||December 2004||2004-12-01|March 2006|2006-03-01|May 2005||2005-05-01|||||Interventional|||Effectiveness of Physiotherapy on Postcesarean Pain and Functional Activities|Effectiveness of Physiotherapy on Postcesarean Pain and Functional Activities|Completed||N/A|50||Hacettepe University|||||f||||||||||||||2017-02-18 16:41:46.49397|2017-02-18 16:41:46.49397
NCT00302302|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-02-25|||September 2005||2005-09-01|February 2014|2014-02-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||The Effects of L-arabinose on Intestinal Sucrase Activity in Man|The Effects of Increasing Doses of L-arabinose in a Sucrose Rich Meal on Intestinal Sucrase Activity in Man|Completed||Phase 1|15|Actual|University of Copenhagen||1|||f||||f||||||||||2017-02-18 16:41:46.588428|2017-02-18 16:41:46.588428
NCT00302289|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2006-03-13|||January 2000||2000-01-01|December 2000|2000-12-01|December 2000||2000-12-01|||||Interventional|||B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients|B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients|Completed||Phase 1|12||University of Copenhagen|||||f||||||||||||||2017-02-18 16:41:46.683521|2017-02-18 16:41:46.683521
NCT00302276|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2009-01-20|||January 2004||2004-01-01|November 2004|2004-11-01|July 2004||2004-07-01|||||Interventional|||Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)|Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)|Completed||Phase 2/Phase 3|80||University of Copenhagen|||||f||||||||||||||2017-02-18 16:41:46.780782|2017-02-18 16:41:46.780782
NCT00302263|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2006-03-13|||January 2005||2005-01-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)|B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)|Completed||Phase 2/Phase 3|22||University of Copenhagen|||||f||||||||||||||2017-02-18 16:41:46.863723|2017-02-18 16:41:46.863723
NCT00302250|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2006-03-21|||February 2006||2006-02-01|March 2006|2006-03-01|December 2006||2006-12-01|||||Interventional|||The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension|Study of The Effect of Vascular Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension Before and After Receiving Oral Alagebrium or Placebo for 8 Weeks (STRETCH)|Completed||Phase 2|70||Synvista Therapeutics, Inc|||||||||||||||||||2017-02-18 16:41:46.953878|2017-02-18 16:41:46.953878
NCT00302237|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2012-12-12|||March 2006||2006-03-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Observational|CAPTURE 2||CAPTURE 2 Post-Marketing Registry|"Second Phase of Carotid RX ACCULINK/RX ACCUNET Post-Approval Trial to Uncover Unanticipated or Rare Events"|Completed||Phase 4|6426|Actual|Abbott Vascular|||1||f||||f||||||||||2017-02-18 16:41:47.04905|2017-02-18 16:41:47.04905
NCT00302224|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2008-02-20|||February 2005||2005-02-01|February 2008|2008-02-01|August 2006||2006-08-01|||||Interventional|||A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus|A Phase 1/2a, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Study of Safety, Tolerability, Pharmacokinetics and Activity of 14 Days of Oral Dosing With the 2S,4R Enantiomer of Ketoconazole (DIO-902) in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|50||DiObex|||||||||||||||||||2017-02-18 16:41:47.148427|2017-02-18 16:41:47.148427
NCT00302211|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2011-05-12|2010-05-27||February 2006||2006-02-01|May 2011|2011-05-01|November 2009|Actual|2009-11-01|December 2007|Actual|2007-12-01||Interventional|VISION||"The VISION Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension"|A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of Inhaled Iloprost in Patients With Pulmonary Arterial Hypertension Receiving Oral Sildenafil|Terminated||Phase 3|67|Actual|Actelion|Primary purpose was to evaluate the efficacy of iloprost in PAH patients. Slow patient recruitment led to early study closure. In addition there were factors regarding the conduct of the study which preclude conclusions from this limited dataset.|3||Terminated due to slow enrollment|f||||||||||||||2017-02-18 16:41:47.254255|2017-02-18 16:41:47.254255
NCT00302198|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2010-03-01|||January 2006||2006-01-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org|Amyotrophic Lateral Sclerosis Web Based Patient Care Database|Completed||N/A|15000|Anticipated|Forbes Norris MDA/ALS Research Center|||1||f||||||||||||||2017-02-18 16:41:51.517769|2017-02-18 16:41:51.517769
NCT00302185|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-13|2010-10-19|||June 2007||2007-06-01|October 2010|2010-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Acupuncture in Palliative Cancer Care|A Feasibility Study in Acupuncture for Symptom Management in Palliative Care.|Completed||Phase 3|20|Actual|British Columbia Cancer Agency||2|||f||||f||||||||||2017-02-18 16:41:51.650024|2017-02-18 16:41:51.650024
NCT00302172|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2009-08-25|||January 2006||2006-01-01|August 2009|2009-08-01||||||||Interventional|||ARQ 197 in Subjects With Metastatic Solid Tumors|A Phase 1 Dose Escalation Study of ARQ 197 in Adult Patients With Metastatic Solid Tumors|Completed||Phase 1|78|Anticipated|ArQule||1|||f||||f||||||||||2017-02-18 16:41:51.750235|2017-02-18 16:41:51.750235
NCT00302159|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-11|2016-07-19|2014-05-22||March 2006||2006-03-01|July 2016|2016-07-01|November 2014|Actual|2014-11-01|June 2013|Actual|2013-06-01||Interventional|||Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors|A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas: Multi-Institutional Trial|Completed||Phase 2|43|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||Undecided||2017-02-18 16:41:51.852377|2017-02-18 16:41:51.852377
NCT00302146|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-11|2017-01-26|||March 7, 2006||2006-03-07|January 12, 2017|2017-01-12||||||||Observational|||Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations|Functional Imaging in Subjects With Glucocerebrosidase Mutations|Completed||N/A|64|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:41:52.378472|2017-02-18 16:41:52.378472
NCT00302133|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2016-04-16|2014-10-20||May 2006||2006-05-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|April 2013|Actual|2013-04-01||Interventional|||Optimizing Pharmacotherapy for Bipolar Alcoholics|Optimizing Pharmacotherapy for Bipolar Alcoholics|Completed||Phase 1/Phase 2|88|Actual|University of Miami|High early drop-out rate leading to small number of subjects analyzed.|2|||f||||f||||||||||2017-02-18 16:41:52.466693|2017-02-18 16:41:52.466693
NCT00302120|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2008-06-09|||February 2006||2006-02-01|June 2008|2008-06-01|March 2010|Anticipated|2010-03-01|March 2009|Anticipated|2009-03-01||Interventional|MONET||The MONET - Study: MR Mammography of Nonpalpable Breast Tumors|MR Mammography: Randomized Controlled Trial to Study Efficiency of MR Mammography in Reducing the Number of Invasive Interventions in Nonpalpable Suspicious Breast Lesions. The MONET - Study|Unknown status|Recruiting|Phase 4|440|Anticipated|UMC Utrecht||2|||f||||||||||||||2017-02-18 16:41:53.224806|2017-02-18 16:41:53.224806
NCT00302107|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2014-11-25|2014-01-03||April 2006||2006-04-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|May 2011|Actual|2011-05-01||Interventional||Seventy-three (94%) were male; mean age 38.1 +/- 9.5 (SD) years in placebo group and 37.7 +/- 10.3 (SD) in mirtazapine group.|A Placebo-Controlled Study of Mirtazapine for PTSD|A Placebo-Controlled Study of Mirtazapine for PTSD in OIF/OEF Veterans|Completed||Phase 4|78|Actual|VA Office of Research and Development|Small sample of predominantly male combat veterans limits generalizability of findings.|2|||f||||t||||||||||2017-02-18 16:41:53.316867|2017-02-18 16:41:53.316867
NCT00302094|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2012-11-29|||June 2006||2006-06-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Image Fusion PET, CT and 3D-ultrasound Examinations|Image Fusion PET, CT and 3D-ultrasound Examinations in Treatment of Anal Cancer|Completed||N/A|10|Actual|Rigshospitalet, Denmark|||1||f||||||||||||||2017-02-18 16:41:53.64508|2017-02-18 16:41:53.64508
NCT00302081|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2015-04-07|2009-04-29||August 2003||2003-08-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)|Comparison of Three Regimens of PEG-Intron and Ribavirin in the Treatment of Chronic Hepatitis C, Genotype 2 or 3, in Previously Untreated Patients|Completed||Phase 3|696|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 16:41:53.726322|2017-02-18 16:41:53.726322
NCT00302068|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2015-06-01|2012-11-01||July 2006||2006-07-01|May 2015|2015-05-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Interventional|UPBEAT||Exercise to Treat Depression in Individuals With Coronary Heart Disease|Understanding the Prognostic Benefits of Exercise and Anti-depressant Therapy (UPBEAT)|Completed||Phase 3|101|Actual|Duke University|Relatively small sample size. Participants had to be willing to accept the condition to which they were randomly assigned, and patients who were not interested in exercise or taking an antidepressant were unlikely to have volunteered.|3|||f||||t||||||||||2017-02-18 16:41:54.372385|2017-02-18 16:41:54.372385
NCT00302055|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2016-10-06|2014-12-10||March 2006||2006-03-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Feasibility of a Partnered Approach to Prevent Diabetes|Feasibility of a Partnered Approach to Prevent Diabetes|Completed||N/A|72|Actual|Northwestern University||2|||f||||f||||||||No||2017-02-18 16:41:55.016552|2017-02-18 16:41:55.016552
NCT00302042|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2014-08-05|2013-05-23||May 2005||2005-05-01|August 2014|2014-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Translating the DPP Into the Community|Translating the DPP Into the Community|Completed||Phase 2|92|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 16:41:55.367422|2017-02-18 16:41:55.367422
NCT00302029|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2011-11-10|||June 2006||2006-06-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||CMV Infection in Adolescent Males|Seroprevalence and Prospective Risk Factor Analysis of Cytomegalovirus (CMV) Infection in Adolescent Males|Terminated||N/A|411|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     Blood, urine and salvia samples.~   "|||2017-02-18 16:41:55.712606|2017-02-18 16:41:55.712606
NCT00302016|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2011-08-25|||January 2006||2006-01-01|August 2011|2011-08-01||||November 2008|Actual|2008-11-01||Expanded Access|||Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia|An Open-label, Multicenter, Expanded Access Study of Oral AMN107 in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase, or Chronic Phase.|No longer available||Phase 3|||Novartis|||||||||||||||||||2017-02-18 16:41:55.816906|2017-02-18 16:41:55.816906
NCT00302003|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2016-12-16|2016-06-29||February 2006||2006-02-01|August 2016|2016-08-01||||March 2012|Actual|2012-03-01||Interventional|||Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma|A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin Disease|Active, not recruiting||Phase 3|287|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 16:41:56.42948|2017-02-18 16:41:56.42948
NCT00301990|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2014-01-09|||September 2005||2005-09-01|April 2007|2007-04-01||||||||Interventional|||Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|A Phase II Study of Bevacizumab and Aldesleukin in Patients With Metastatic Renal Cell Carcinoma (RCC): A Cytokine Working Group (CWG) Study|Unknown status|Recruiting|Phase 2|65|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:41:56.920567|2017-02-18 16:41:56.920567
NCT00301964|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2014-11-19|2014-11-19||October 2007||2007-10-01|October 2013|2013-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional||Total number of eligible and evaluable participants|Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Bevacizumab (NCI-Supplied Agent: NSC# 704865, IND # 7921) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:41:57.036478|2017-02-18 16:41:57.036478
NCT00301951|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2015-06-30|||September 2004||2004-09-01|June 2015|2015-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer|Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients With Advanced Hematopoietic Malignancies|Completed||N/A|7|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:41:57.621433|2017-02-18 16:41:57.621433
NCT00301938|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-09-27|||December 2005||2005-12-01|September 2013|2013-09-01||||May 2012|Actual|2012-05-01||Interventional|||7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes|A Phase 1 Study of UCN-01 in Combination With Perifosine in Patients With Relapsed and Refractory Acute Leukemias and High Risk MDS|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:41:57.750184|2017-02-18 16:41:57.750184
NCT00300742|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2012-02-06|||March 2006||2006-03-01|February 2012|2012-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals|Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individual|Completed||Phase 2|5|Actual|University of Virginia||1|||f||||t||||||||||2017-02-18 16:42:18.083599|2017-02-18 16:42:18.083599
NCT00301925|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2010-11-25|||December 2005||2005-12-01|July 2009|2009-07-01||||September 2024|Anticipated|2024-09-01||Interventional|||Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery|Trial of Accelerated Adjuvant Chemotherapy With Capecitabine in Early Breast Cancer (TACT2)|Active, not recruiting||Phase 3|4400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:41:57.884967|2017-02-18 16:41:57.884967
NCT00301912|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2012-10-01|||January 2002||2002-01-01|October 2012|2012-10-01||||November 2007|Actual|2007-11-01||Interventional|||Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer|Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation|Withdrawn||Phase 2|0|Actual|University of California, San Francisco||1||Withdrawn because study never opened to accrual|f||||||||||||||2017-02-18 16:41:58.325919|2017-02-18 16:41:58.325919
NCT00301899|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2012-03-07|||December 2005||2005-12-01|March 2012|2012-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab|A Phase II Study to Evaluate the Efficacy and Safety Using Combined Monoclonal Antibodies, Trastuzumab and Pertuzumab in Subjects With Her-2 Overexpressed Locally Advanced and Metastatic Breast Cancer|Completed||Phase 2|37|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 16:41:58.462148|2017-02-18 16:41:58.462148
NCT00301886|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-11-11|||May 2006||2006-05-01|November 2013|2013-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone|A Phase III Randomized, Multicenter Non-Inferiority Trial Evaluating the Efficacy of Oral Ibandronate Versus Intravenous Zoledronate in the Reduction of Skeletal-Related Events in Patients With Metastatic Breast Cancer|Withdrawn||Phase 3|0|Actual|Southwest Oncology Group||2||withdrawn support for study|f||||t||||||||||2017-02-18 16:41:58.566436|2017-02-18 16:41:58.566436
NCT00301873|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-02-13|2012-10-15||May 2006||2006-05-01|February 2013|2013-02-01|September 2012|Actual|2012-09-01|February 2011|Actual|2011-02-01||Interventional|||Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma|Phase II Study of Zometa (Zoledronic Acid) to Prevent Osteoporosis in Patients With Brain Tumors|Completed||Phase 2|60|Actual|Duke University|Limitations include early pt termination leading to small numbers of subjects analyzed (eg no BMD study at 6 and/or 12 mos)secondary to the poor overall survival (eg median survival 3-9 mos)associated with recurrent glioblastoma multiforme(GBM) pts.|1|||f||||t||||||||||2017-02-18 16:41:58.671419|2017-02-18 16:41:58.671419
NCT00301860|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-07-11|||January 2003||2003-01-01|July 2013|2013-07-01|November 2007|Actual|2007-11-01|March 2007|Actual|2007-03-01||Interventional|||Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer|Feasibility of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions for Children at High Risk for Complications With Conventional Transplantation|Terminated||N/A|8|Actual|University of California, San Francisco||||lack of efficacy|f||||t||||||||||2017-02-18 16:41:59.007625|2017-02-18 16:41:59.007625
NCT00301847|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-02-08|||November 2005||2005-11-01|April 2006|2006-04-01||||June 2007|Actual|2007-06-01||Interventional|||Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain|A Phase 2 Study of Sorafenib (BAY 43-9006) in Metastatic Renal Cell Cancer to the Brain|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:41:59.109405|2017-02-18 16:41:59.109405
NCT00301834|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-05-15|2013-01-31||January 2005||2005-01-01|May 2013|2013-05-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||Thirty-five children undergoing allogeneic hemotopoietic stem cell transplants (HSCTs) for malignant and nonmalignant diseases; 12 with HLA-matched related donors (MRDs), 16 with 10 of 10 HLA allele-matched unrelated donors (MUDs), 7 with 9 of 10 allele MUDs.|Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders|Evaluation of Fludarabine, Busulfan and Alemtuzumab as a Reduced Toxicity Ablative Bone Marrow Stem Cell Transplant Regimen for Children With Stem Cell Defects, Marrow Failure Syndromes, or Myelodysplastic Syndrome (MDS)/Leukemia|Completed||Phase 2|35|Actual|University of California, San Francisco||1|||f||||||||||||||2017-02-18 16:41:59.22701|2017-02-18 16:41:59.22701
NCT00301821|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2016-07-01|2015-03-13||January 2006||2006-01-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|October 2008|Actual|2008-10-01||Interventional|||Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma|A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma|Completed||Phase 2|107|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 16:41:59.57066|2017-02-18 16:41:59.57066
NCT00301808|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2014-07-15|2014-04-12||November 2005||2005-11-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|||Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer|Phase II Study of Concurrent Cisplatin/Pemetrexed and RT Followed by Docetaxel in Stage III NSCLC (Non Small Cell Lung Cancer)|Completed||Phase 2|29|Actual|Barbara Ann Karmanos Cancer Institute|Study being a single institution, single arm study.|1|||f||||t||||||||||2017-02-18 16:42:00.240391|2017-02-18 16:42:00.240391
NCT00301795|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-01-04|||March 2006||2006-03-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma|A Phase II Trial of Rituximab + Oblimersen Sodium (GenasenseTM, G3139, NSC #683428, IND #58842) in Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma (NHL)|Terminated||Phase 2|52|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:42:00.73748|2017-02-18 16:42:00.73748
NCT00301782|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-08-23|||June 2005||2005-06-01|May 2007|2007-05-01|June 2010|Actual|2010-06-01|||||Interventional|||Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors|Randomized Phase II Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP Chemotherapy in Poor Prognosis Male Germ Cell Tumors|Completed||Phase 2|88|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:42:00.851903|2017-02-18 16:42:00.851903
NCT00301769|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-09-27|||December 2005||2005-12-01|September 2013|2013-09-01||||February 2009|Actual|2009-02-01||Interventional|||SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia|A Phase I Study of SJG-136 in Patients With Advanced Leukemia|Terminated||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:42:00.972272|2017-02-18 16:42:00.972272
NCT00301756|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2016-10-20|2015-04-01||September 2006||2006-09-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|August 2009|Actual|2009-08-01||Interventional|||Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors|A Phase 2 Study of PXD101 in Platinum Resistant Epithelial Ovarian Tumors and Micropapillary/Borderline (LMP) Ovarian Tumors|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:42:01.076594|2017-02-18 16:42:01.076594
NCT00301730|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2015-04-27|||October 2005||2005-10-01|April 2006|2006-04-01||||||||Interventional|||Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung|Adoptive Immunotherapy With Costimulated Tumor-Derived T Cells After Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 1|1|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:42:01.41615|2017-02-18 16:42:01.41615
NCT00301691|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-07-09|||September 2000||2000-09-01|May 2006|2006-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Nutrition Education for Low-Income Healthy Participants Who Eat an Unhealthy Diet|Tailoring Nutrition Education for Low-Income Audiences|Completed||N/A|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:42:01.512773|2017-02-18 16:42:01.512773
NCT00301678|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-09-16|||June 2001||2001-06-01|May 2007|2007-05-01||||||||Interventional|||Personalized Nutrition Education in Improving Eating Habits of Healthy Participants Who Eat an Unhealthy Diet|Innovative Video Tailoring for Dietary Change|Unknown status|Active, not recruiting|N/A|2520|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:42:01.601661|2017-02-18 16:42:01.601661
NCT00301665|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2007-09-12|||February 2003||2003-02-01|September 2007|2007-09-01|March 2005|Actual|2005-03-01|||||Interventional|||Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis|A Phase II, Multicentre, Randomised, Double-Blind, Parallel Groups, Placebo Controlled Clinical Study of Efficacy and Safety of Dysport® for Migraine Prophylaxis|Completed||Phase 2|120||Ipsen|||||f||||||||||||||2017-02-18 16:42:01.714919|2017-02-18 16:42:01.714919
NCT00301652|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2010-06-07|||June 2003||2003-06-01|March 2009|2009-03-01|December 2005|Actual|2005-12-01|April 2004|Actual|2004-04-01||Interventional|||MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis|Mycophenolate Mofetil Versus Cyclophosphamide in the Induction Treatment of ANCA Associated Vasculitis|Completed||N/A|60|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 16:42:01.823368|2017-02-18 16:42:01.823368
NCT00301639|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2011-07-11|||March 2005||2005-03-01|July 2011|2011-07-01|December 2005||2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults|A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults|Completed||Phase 3|40||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 16:42:01.942267|2017-02-18 16:42:01.942267
NCT00301626|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2008-10-23|||October 2000||2000-10-01|April 2005|2005-04-01|January 2005||2005-01-01|||||Interventional|||ROSCAP: Reduction of Smoking in Cardiac Patients Study||Completed||N/A|180||Minneapolis Veterans Affairs Medical Center|||||||||||||||||||2017-02-18 16:42:02.047623|2017-02-18 16:42:02.047623
NCT00301613|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2010-05-25|||January 2003||2003-01-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|May 2005|Actual|2005-05-01||Interventional|||Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN|MMF Versus Intravenous CTX Pulses in the Treatment of Adult Severe Henoch-Schonlein Purpura Nephritis|Completed||N/A|60|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 16:42:02.141563|2017-02-18 16:42:02.141563
NCT00301600|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2010-05-25|||January 2003||2003-01-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|May 2005|Actual|2005-05-01||Interventional|||Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy|Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy|Completed||N/A|40|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 16:42:02.268096|2017-02-18 16:42:02.268096
NCT00301587|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2016-09-19||||||July 2011|2011-07-01|December 2004|Anticipated|2004-12-01|||||Interventional|||A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives|A Randomized, Double-Blind, Two-Part, Parallel-Group, Comparative Study to Evaluate Blood Folate Levels in Women Taking an Oral Contraceptive With and Without Folic Acid|Withdrawn||Phase 3|0|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"Company decision to not fund further development of women's health new drug development~   programs."|||||f||||||||||2017-02-18 16:42:02.385409|2017-02-18 16:42:02.385409
NCT00301574|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2011-05-16|||April 2001||2001-04-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|||||Interventional|||An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.|Placebo-Controlled, Double-Blind Study of Galantamine (R113675) in the Treatment of Alzheimer's Disease.|Completed||Phase 3|398|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 16:42:02.488814|2017-02-18 16:42:02.488814
NCT00301561|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2016-07-20|||May 2006||2006-05-01|July 2016|2016-07-01|October 2010|Actual|2010-10-01|April 2010|Actual|2010-04-01||Interventional|||Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)|Expanded Access to Antiretroviral Therapy in Africa: Assessment of the Patients' Management in District Hospitals With a Simplified Follow-up Approach (ANRS 12110 STRATALL)|Completed||Phase 3|459|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 16:42:02.589255|2017-02-18 16:42:02.589255
NCT00301548|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2006-03-09|||February 2000||2000-02-01|January 2006|2006-01-01|June 2005||2005-06-01|||||Interventional|||Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer|Primary Chemotherapy Combined With Perioperative Chemotherapy In Operable Breast Cancer|Completed||Phase 2|172||European Institute of Oncology|||||f||||||||||||||2017-02-18 16:42:02.710875|2017-02-18 16:42:02.710875
NCT00301535|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2008-05-15|||February 2006||2006-02-01|May 2008|2008-05-01|September 2008|Anticipated|2008-09-01|July 2008|Anticipated|2008-07-01||Interventional|||A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery|Enhancement of Tissue Preservation During Cardiopulmonary Bypass With HBOC-201 (Registry Study)|Unknown status|Recruiting|Phase 2|60|Anticipated|Biopure Corporation||2|||f||||t||||||||||2017-02-18 16:42:02.79152|2017-02-18 16:42:02.79152
NCT00300352|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2008-08-06|||May 2004||2004-05-01|January 2007|2007-01-01||||May 2006|Actual|2006-05-01||Interventional|||Effect of Folic Acid Treatment in Coronary Artery Disease|Effect of Folic Acid Treatment in Coronary Artery Disease|Unknown status|Recruiting|Phase 2|60|Anticipated|University of Oxford|||||f||||||||||||||2017-02-18 16:42:29.308707|2017-02-18 16:42:29.308707
NCT00301522|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2010-08-05|||February 2003||2003-02-01|August 2010|2010-08-01|April 2009|Actual|2009-04-01|December 2004|Actual|2004-12-01||Interventional|||Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions|TAXUS V: De Novo Lesion: A Randomized, Double-blind Trial to Assess TAXUS Paclitaxel-Eluting Coronary Stents, SR Formulation, in the Treatment of De Novo Coronary Lesions|Completed||Phase 2/Phase 3|1108|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-02-18 16:42:02.90569|2017-02-18 16:42:02.90569
NCT00301509|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2006-03-10|||January 2002||2002-01-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis|Outcome of Decompensated Hepatitis C Virus-Related Cirrhotic Patients Treated With Peginterferon Alfa-2b and Ribavirin: Results of a Controlled Study|Completed||Phase 2/Phase 3|||Casa Sollievo della Sofferenza IRCCS|||||f||||||||||||||2017-02-18 16:42:03.08449|2017-02-18 16:42:03.08449
NCT00301496|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2007-10-10|||March 2006||2006-03-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Randomized Controlled 8-Week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers|Randomized Controlled Eight Week Cross-Over Clinical Evaluation of the 3M Coban 2-Layer Compression System to Evaluate the Product Performance in Patients With Venous Leg Ulcers|Completed||N/A|80||3M|||||f||||||||||||||2017-02-18 16:42:03.17266|2017-02-18 16:42:03.17266
NCT00301483|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2008-03-05|||July 2004||2004-07-01|February 2008|2008-02-01|December 2008|Anticipated|2008-12-01|September 2008|Anticipated|2008-09-01||Interventional|||A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects|A Single-Center, Study to Evaluate the Safety and Tolerability of Hemoglobin-Based Oxygen Carrier-201 (HBOC 201) in Trauma Subjects. (Phase II - Safety and Tolerability)|Unknown status|Recruiting|Phase 2|53|Anticipated|Biopure Corporation||2|||f||||t||||||||||2017-02-18 16:42:03.487341|2017-02-18 16:42:03.487341
NCT00301470|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-10|2011-07-21|||March 2006||2006-03-01|October 2006|2006-10-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Functional MR Urography|Interest of MR Urography in the Evaluation of Functional Consequences of Urinary Tract in Children and Adults|Completed||Phase 4|550|Actual|Central Hospital, Nancy, France||1|||f||||f||||||||||2017-02-18 16:42:03.729805|2017-02-18 16:42:03.729805
NCT00301457|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2017-02-14|||June 2006||2006-06-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|DATA||Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer|A Prospective Randomised, Open, Multicentre, Phase III Study to Assess Different Durations of Anastrozole Therapy After 2 to 3 Years Tamoxifen as Adjuvant Therapy in Postmenopausal Women With Breast Cancer.|Completed||Phase 3|1914|Actual|Maastricht University Medical Center||2|||f||||||||||||||2017-02-18 16:42:03.849293|2017-02-18 16:42:03.849293
NCT00301444|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2007-06-13|||March 2006||2006-03-01|April 2007|2007-04-01|June 2008|Anticipated|2008-06-01|||||Interventional|||A Study to Test the Effectiveness of Mirror-Box and Mental Visualization Treatments on Phantom Limb Pain|A Pilot Study to Assess the Efficacy of Mirror-Box and Mental Visualization Treatments on Phantom Limb Pain|Unknown status|Recruiting|N/A|48|Anticipated|Walter Reed Army Medical Center|||||f||||f||||||||||2017-02-18 16:42:04.021175|2017-02-18 16:42:04.021175
NCT00301431|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2007-12-03|||August 2006||2006-08-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Study Evaluating the Efficacy of DVS-233 in Fibromyalgia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive Design, Efficacy and Tolerability Study of 4 Fixed Doses of DVS-233 in Adult Outpatients With Fibromyalgia Syndrome|Terminated||Phase 2/Phase 3|1050||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:42:04.128013|2017-02-18 16:42:04.128013
NCT00301418|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2016-01-12|2016-01-12||March 2006||2006-03-01|January 2016|2016-01-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma|Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma|Completed||Phase 1/Phase 2|11|Actual|Northwell Health||1|||f||||f||||||||||2017-02-18 16:42:04.455138|2017-02-18 16:42:04.455138
NCT00301405|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2013-08-01|||March 2006||2006-03-01|August 2013|2013-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain|Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain|Terminated||Phase 2|9|Actual|William Beaumont Hospitals||1||Study closed. Difficult enrollment of patients with prostatitis.|f||||f||||||||||2017-02-18 16:42:04.712984|2017-02-18 16:42:04.712984
NCT00301392|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-05|2013-09-05|||April 2006||2006-04-01|September 2013|2013-09-01|June 2012|Actual|2012-06-01|March 2012|Actual|2012-03-01||Interventional|||Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)|Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)|Completed||Phase 4|1240|Actual|Tokyo University||1|||f||||f||||||||||2017-02-18 16:42:04.829236|2017-02-18 16:42:04.829236
NCT00301379|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2017-01-18|||August 2005||2005-08-01|January 2017|2017-01-01|April 2018|Anticipated|2018-04-01|June 2017|Anticipated|2017-06-01||Observational|||Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients|Prospective Registry Study of Neoadjuvant Chemoradiation in Conjunction With Liver Transplantation for Cholangiocarcinoma With Induction Gemcitabine, Followed by 3D Conformal Radiation With 5-FU as a Radiosensitizer, and Maintenance Xeloda Therapy Until Liver Transplantation|Recruiting||N/A|30|Anticipated|Washington University School of Medicine|||1||f||||f||||||||No||2017-02-18 16:42:04.950976|2017-02-18 16:42:04.950976
NCT00301366|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2014-07-30|2009-08-28||June 2006||2006-06-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|STAMP||The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency|Multi-center, Open-label Trial to Evaluate the Safety and Tolerability of Alpha-1 MP in Subjects With Alpha-1-antitrypsin (AAT) Deficiency|Completed||Phase 3|38|Actual|Grifols Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 16:42:05.092289|2017-02-18 16:42:05.092289
NCT00301353|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2015-05-20|||October 2002||2002-10-01|October 2002|2002-10-01|July 2004||2004-07-01|||||Interventional|||Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women|Effects of Phytoestrogen-rich Diets on Bone Turnover in Postmenopausal Women|Completed||N/A|300||TNO|||||f||||||||||||||2017-02-18 16:42:05.392072|2017-02-18 16:42:05.392072
NCT00301340|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2007-05-25|||March 2006||2006-03-01|May 2007|2007-05-01||||||||Interventional|||Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice|An Open Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice|Completed||Phase 3|200||Summers Laboratories|||||||||||||||||||2017-02-18 16:42:05.501121|2017-02-18 16:42:05.501121
NCT00301327|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2007-05-25|||January 2006||2006-01-01|May 2007|2007-05-01||||||||Interventional|||Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.|A Multi-Center, Randomized, Vehicle Controlled, Double Blind Clinical Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice.|Completed||Phase 3|120||Summers Laboratories|||||||||||||||||||2017-02-18 16:42:05.605675|2017-02-18 16:42:05.605675
NCT00301314|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2010-01-11||||||January 2010|2010-01-01||||||||Observational|||A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).||Completed||N/A|||Royal Marsden NHS Foundation Trust|||1||f||||||||||||||2017-02-18 16:42:05.708498|2017-02-18 16:42:05.708498
NCT00301301|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2010-01-11||||||January 2010|2010-01-01||||||||Observational|||A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)||Completed||N/A|39||Royal Marsden NHS Foundation Trust|||1||f||||||||||||||2017-02-18 16:42:05.790276|2017-02-18 16:42:05.790276
NCT00301288|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2010-01-11||||||January 2010|2010-01-01||||||||Observational|||A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL).||Completed||N/A|152||Royal Marsden NHS Foundation Trust|||1||f||||||||||||||2017-02-18 16:42:05.870262|2017-02-18 16:42:05.870262
NCT00301275|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-03-09|||June 2002||2002-06-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Observational|||Assessing Free Immunoglobulin Light Chains in Patients With Myeloma||Completed||Phase 2|||Royal Marsden NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:42:05.946205|2017-02-18 16:42:05.946205
NCT00301262|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2008-12-08|2008-11-12||November 2005||2005-11-01|December 2008|2008-12-01||||||||Interventional|||Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied|A Multi-Center, Parallel Group, Flexible Dose Trial With A Double-Blind, Randomized, Placebo-Controlled Phase Followed By An Open-Label Phase To Assess The Impact Of Viagra On The Sexual Satisfaction Of Men With Mild Erectile Dysfunction|Completed||Phase 4|183|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:42:06.047771|2017-02-18 16:42:06.047771
NCT00301249|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2010-01-12|||October 1999||1999-10-01|January 2010|2010-01-01|November 2005||2005-11-01|||||Observational|||Linkage Consortium for End-Stage Renal Disease|The Family Investigation of Nephropathy and Diabetes (FIND) Study|Completed||Phase 4|7000||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:42:08.012038|2017-02-18 16:42:08.012038
NCT00301236|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2007-12-17|||February 2006||2006-02-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder|A 5-Week Treatment, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of the Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules Administered Once Daily in Pediatric Children With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|252||Novartis|||||||||||||||||||2017-02-18 16:42:08.099691|2017-02-18 16:42:08.099691
NCT00301223|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2011-05-04|||February 2006||2006-02-01|May 2011|2011-05-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain|An 8-Week Multi-Center, Randomized, Double Blind, Placebo-Controlled Study To Evaluate The Efficacy, Safety And Tolerability Of Pregabalin (150mg-600mg/Day) Using A Flexible Dosing Schedule In The Treatment Of Subjects With Symptoms Of Neuropathic Pain|Completed||Phase 3|309|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:42:08.21071|2017-02-18 16:42:08.21071
NCT00301210|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2015-04-16|||January 2006||2006-01-01|April 2015|2015-04-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Assessment of Tramadol as a Treatment for Opioid Addiction|Assessment of the Level of Physical Dependence and Blockade Efficacy Produced by Tramadol|Completed||Phase 1/Phase 2|9|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 16:42:11.058537|2017-02-18 16:42:11.058537
NCT00301197|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-03-08|||August 1999||1999-08-01|March 2006|2006-03-01|April 2004||2004-04-01|||||Interventional|||Childhood Obesity Treatment: A Maintenance Approach|Childhood Obesity Treatment: A Maintenance Approach|Completed||N/A|216||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 16:42:11.163908|2017-02-18 16:42:11.163908
NCT00301184|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2013-05-30|||April 2006||2006-04-01|May 2013|2013-05-01|December 2008|Actual|2008-12-01|||||Interventional|||Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of pGA2/JS7 DNA Vaccine and Recombinant Modified Vaccinia Ankara/HIV62 Vaccine in Healthy, HIV-1-Uninfected Adult Participants|Completed||Phase 1|120|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:42:11.251332|2017-02-18 16:42:11.251332
NCT00301171|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2016-07-28|||September 2003||2003-09-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Treatment of Persistent Wheezing in Infants and Children|Respiratory Function in Infants With Persistent Wheezing|Completed||N/A|54|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:42:11.385151|2017-02-18 16:42:11.385151
NCT00301158|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2013-09-16|||September 2004||2004-09-01|June 2009|2009-06-01||||August 2008|Anticipated|2008-08-01||Interventional|||Promoting Physical Activity In After-School Programs for Urban Adolescents|Involving Adolescents in Physical Activity Promotion|Unknown status|Recruiting|N/A|420|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:42:11.475109|2017-02-18 16:42:11.475109
NCT00301145|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2013-12-18|||October 2005||2005-10-01|September 2007|2007-09-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|||Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking|Treatment of Nicotine Dependence in a Health Care Setting|Completed||N/A|1200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:42:11.562854|2017-02-18 16:42:11.562854
NCT00301119|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2016-10-05|||May 2000||2000-05-01|October 2016|2016-10-01|September 2018|Anticipated|2018-09-01|September 2017|Anticipated|2017-09-01||Observational|NYULCBC||Lung Cancer Biomarkers and Screening|NYU Lung Cancer Biomarker Center|Recruiting||N/A|6860|Anticipated|New York University School of Medicine|||2||f||||t||||||Samples With DNA|"~     blood serum, plasma, urine, sputum, BAL, lung tissue, buccal swab~   "|||2017-02-18 16:42:11.650938|2017-02-18 16:42:11.650938
NCT00298571|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2012-06-14|||February 2006||2006-02-01|February 2006|2006-02-01|October 2007|Actual|2007-10-01|||||Interventional|||Cesarean Delivery and Post-operative Pain Management With Local Anesthesia||Completed||Phase 2/Phase 3|100|Anticipated|University of South Florida|||||f||||||||||||||2017-02-18 16:43:01.650704|2017-02-18 16:43:01.650704
NCT00301106|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2017-01-31|||October 2005||2005-10-01|January 2017|2017-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver|Phase I Trial of Adenoviral Vector Delivery of the Human Interleukin-12 cDNA by Intratumoral Injection in Patients With Metastatic Breast Cancer to the Liver|Terminated||Phase 1|2|Actual|Icahn School of Medicine at Mount Sinai||1||"protocol underwent significant revisions, decision made to terminate study and open as new~   study listed NCT00849459"|f||||t||||||||||2017-02-18 16:42:11.761231|2017-02-18 16:42:11.761231
NCT00301093|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2016-12-23|||September 2005||2005-09-01|December 2016|2016-12-01||||May 2007|Actual|2007-05-01||Interventional|||Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia|Vaccination for CML Patients With Persistent Disease on Imatinib Mesylate|Active, not recruiting||Phase 1|30|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:42:11.887407|2017-02-18 16:42:11.887407
NCT00301080|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2013-11-25|2013-11-25||February 2006||2006-02-01|November 2013|2013-11-01|May 2008|Actual|2008-05-01|February 2007|Actual|2007-02-01||Interventional|||D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain|A Phase III Study of D-Cycloserine in the Management of Paclitaxel-Induced Peripheral Neuropathic Pain in Breast Cancer Patients|Terminated||Phase 3|7|Actual|Northwestern University|Early termination resulted from a change in funding source (which ultimately fell through) along with drug manufacturing delays. Data could not be analyzed based on only 7 patients, all of whom were enrolled under the original design version.|5||Funding for the study fell through.|f||||t||||||||||2017-02-18 16:42:12.24141|2017-02-18 16:42:12.24141
NCT00301067|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2016-11-16|||May 2005||2005-05-01|November 2016|2016-11-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma|A Phase I/II Study of High-Dose Calcitriol in Combination With Temozolomide for Patients With Metastatic Melanoma|Active, not recruiting||Phase 1/Phase 2|28|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 16:42:12.692215|2017-02-18 16:42:12.692215
NCT00301054|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2006-05-26|||June 2005||2005-06-01|July 2005|2005-07-01|April 2006||2006-04-01|||||Interventional|||Study on Preventing Anemia in Children in Ghana|Preventing Anemia in Children (6months-30months) in a Malaria Endemic Rural Area in Ghana - A Randomized Double Blind Study|Completed||N/A|872||Ghana Health Services|||||f||||||||||||||2017-02-18 16:42:12.804156|2017-02-18 16:42:12.804156
NCT00301041|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2013-08-19|||April 2004||2004-04-01|August 2013|2013-08-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Radiation Therapy in Treating Women With Invasive Breast Cancer|The Relationship Between Plasma Transforming Growth Factor-beta 1 (TGF-β) and Fractionation in Radiotherapy for Breast Cancer: A Randomized Study|Completed||Early Phase 1|20|Actual|University of California, San Francisco||1|||f||||||||||||||2017-02-18 16:42:12.913866|2017-02-18 16:42:12.913866
NCT00301028|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2013-02-26|2013-02-26||April 2006||2006-04-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer|Phase II Trial of Induction Therapy With Cetuximab (C225) and Carboplatin/Paclitaxel Chemotherapy in Previously Untreated Patients With Advanced (Stage IV) Head & Neck Squamous Cell Carcinoma|Completed||Phase 2|48|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:42:13.00505|2017-02-18 16:42:13.00505
NCT00301015|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2007-10-31|||March 2006||2006-03-01|October 2007|2007-10-01|August 2006|Actual|2006-08-01|||||Interventional|||Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers|Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers|Completed||Phase 4|3005|Actual|Karolinska University Hospital||2|||f||||||||||||||2017-02-18 16:42:13.264782|2017-02-18 16:42:13.264782
NCT00301002|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-11-21|||June 2005||2005-06-01|November 2006|2006-11-01|October 2006||2006-10-01|||||Interventional|||Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis|A Pilot Open-Label Study to Evaluate the Safety and Observe the Effectiveness of 16 Weeks of Alefacept in Palmar Plantar Pustulosis (IST 92)|Completed||Phase 2|15||The Guenther Dermatology Research Centre|||||f||||||||||||||2017-02-18 16:42:13.3544|2017-02-18 16:42:13.3544
NCT00300989|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2007-10-04|||December 2005||2005-12-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Inion OTPS Biodegradable Fixation System for the Ankle|A Double-Blind,Randomised,Prospective Clinical Investigation to Compare Post-Operative Fracture Healing Using the Inion OTPS Biodegradable Fixation System Versus Conventional Metal Screws and Plates in the Treatment of Ankle Fractures.|Completed||Phase 2|43|Actual|Inion Oy|||||f||||||||||||||2017-02-18 16:42:13.448306|2017-02-18 16:42:13.448306
NCT00300976|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2015-10-16|||May 2006||2006-05-01|October 2015|2015-10-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|J-DOIT3||The Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular Diseases|A Randomized Controlled Study of the Intensive Therapy and the Conventional Therapy for the Suppression of the Vascular Complications in the Type 2 Diabetic Patients|Active, not recruiting||N/A|2542|Actual|Japan Foundation for the Promotion of International Medical Research Cooperation||2|||f||||t||||||||||2017-02-18 16:42:13.521093|2017-02-18 16:42:13.521093
NCT00300963|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2013-02-13|||December 2004||2004-12-01|February 2013|2013-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients|A Multicenter, Double-Blind, Double-Dummy, Placebo-Controlled, Randomized, Parallel Group Evaluation of the Efficacy and Safety of a Fixed-Dose of Talnetant Versus Placebo Versus Risperidone in Subjects With Schizophrenia|Completed||Phase 2|275||GlaxoSmithKline|||||||||||||||||||2017-02-18 16:42:13.625268|2017-02-18 16:42:13.625268
NCT00300950|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2015-04-02|||January 2006||2006-01-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer|A Phase 2 Double-Blind, Placebo Controlled, Multi-center Adjuvant Trial of the Efficacy, Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing Mutant Ras Protein Combined With a Gemcitabine Regimen Versus a Gemcitabine Regimen With Placebo, in Patients With Post-resection R0/R1 Pancreatic Cancer With Tumor Sequence Confirmation of Ras Mutations.|Completed||Phase 2|176|Actual|GlobeImmune||2|||f||||||||||||||2017-02-18 16:42:13.728916|2017-02-18 16:42:13.728916
NCT00005464|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||February 1991||1991-02-01|May 2000|2000-05-01|January 1993|Actual|1993-01-01|||||Observational|||DISH Data Analysis Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.18023|2017-02-18 18:14:57.18023
NCT00300924|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2008-05-27|||March 2006||2006-03-01|May 2008|2008-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine|A Double-Blind, Double-Dummy, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Co-Administered With Acetaminophen for the Treatment of Acute Migraine.|Completed||Phase 3|200||Diamond Headache Clinic|||||f||||t||||||||||2017-02-18 16:42:14.188276|2017-02-18 16:42:14.188276
NCT00300911|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-09|2006-03-09|||December 2005||2005-12-01|November 2005|2005-11-01||||||||Interventional|||Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction|A Study of PPAR-Gamma Agonist-Rosiglitazone for Determining Cardiac Adverse Effects in Type 2 Diabetic Patients|Completed||Phase 4|45||Baskent University|||||f||||||||||||||2017-02-18 16:42:14.287359|2017-02-18 16:42:14.287359
NCT00300898|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-03-08|||July 2006||2006-07-01|September 2005|2005-09-01|July 2008||2008-07-01|||||Interventional|||Radiofrequency Nucleoplasty Vs Percutaneous Nucleotomy (Dekompressor) Vs Decompression Catheter for the Treatment of Painful Contained Lumbar Disc Herniation|Radiofrequency Nucleoplasty Vs Percutaneous Nucleotomy (Dekompressor) Vs Decompression Catheter for the Treatment of Painful Contained Lumbar Disc Herniation: A Prospective Randomized Controlled Study|Unknown status|Not yet recruiting|N/A|72||The Cleveland Clinic|||||f||||||||||||||2017-02-18 16:42:14.388332|2017-02-18 16:42:14.388332
NCT00300885|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2014-10-28|2009-11-04||February 2006||2006-02-01|October 2014|2014-10-01|February 2009|Actual|2009-02-01|October 2007|Actual|2007-10-01||Interventional|||A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)|A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 3|926|Actual|Bayer|Based on the results of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early. The planned biomarker analysis was suspended due to early termination.|2||"Based on the results of the interim analysis, it was determined that the study would not meet~   its primary efficacy endpoint and the study was terminated early."|f||||f||||||||||2017-02-18 16:42:14.499749|2017-02-18 16:42:14.499749
NCT00300872|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2011-06-22|||January 2005||2005-01-01|June 2011|2011-06-01|December 2013|Anticipated|2013-12-01|January 2013|Anticipated|2013-01-01||Interventional|||Effect of Nasal Continuous Positive Airway Pressure (CPAP) Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome|A Randomized, Placebo-controlled Study of the Medium-term Effect of Nasal CPAP on 24 Hour Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome|Unknown status|Recruiting|N/A|140|Anticipated|Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 16:42:16.217335|2017-02-18 16:42:16.217335
NCT00300859|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-03-09|||February 2006||2006-02-01|March 2006|2006-03-01|October 2006||2006-10-01|||||Interventional|||Brief Intervention to Increase Safety Belt Use Among ED Patients|Brief Intervention to Increase Safety Belt Use Among ED Patients|Unknown status|Not yet recruiting|Phase 4|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 16:42:16.321925|2017-02-18 16:42:16.321925
NCT00300846|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2013-11-07|||December 2005||2005-12-01|June 2008|2008-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients|A Multicenter, Comparative, Randomized, Double-Blind, Placebo Controlled Study on the Effect on Weight of Adjunctive Treatment With Aripiprazole in Patients With Schizophrenia.|Completed||Phase 4|200||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 16:42:16.395769|2017-02-18 16:42:16.395769
NCT00300833|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2011-08-10|||January 2006||2006-01-01|January 2009|2009-01-01||||January 2012|Anticipated|2012-01-01||Interventional|||Treating Acute MI Patients With Aggrastat on Their Way to Hospital||Unknown status|Recruiting|Phase 4|200|Anticipated|The Baruch Padeh Medical Center, Poriya||1|||f||||||||||||||2017-02-18 16:42:16.576999|2017-02-18 16:42:16.576999
NCT00300820|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2017-01-24|||March 2, 2006||2006-03-02|February 6, 2008|2008-02-06|February 6, 2008||2008-02-06|||||Observational|||Perspectives of Individuals With Bipolar Disorder and Siblings of Individuals With Bipolar Disorder; A Telephone Interview Study|Seeking Genetic Counseling: What Motivates Families At Risk For Psychiatric Illness?|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:42:16.670272|2017-02-18 16:42:16.670272
NCT00300807|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2007-03-06|||October 2005||2005-10-01|March 2007|2007-03-01|April 2007||2007-04-01|||||Interventional|||Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection|A Phase I, Randomized, Double Blind, Placebo-Controlled, Multi-Center Study of the Safety and Virologic Effects of Ascending Single (and Multiple) Doses of XTL6865 in Patients With Chronic Hepatitis C Virus Infection|Unknown status|Active, not recruiting|Phase 1|36||XTL Biopharmaceuticals|||||||||||||||||||2017-02-18 16:42:16.752245|2017-02-18 16:42:16.752245
NCT00300794|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2006-11-13|||February 2003||2003-02-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia||Completed||Phase 4|60||Vilnius University|||||f||||||||||||||2017-02-18 16:42:16.86666|2017-02-18 16:42:16.86666
NCT00300781|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2016-08-30||2011-02-17|August 2006||2006-08-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|April 2008|Actual|2008-04-01||Interventional|||Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer|Phase 2 Study of HKI-272 In Subjects With Advanced Breast Cancer|Active, not recruiting||Phase 2|137|Actual|Puma Biotechnology, Inc.||2|||f||||f||||||||||2017-02-18 16:42:16.948304|2017-02-18 16:42:16.948304
NCT00300768|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2012-02-13|||September 2006||2006-09-01|February 2012|2012-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection|A Randomized, Single-Ascending Dose, Ivermectin-Controlled, Double-Blind, Safety, Tolerability, Pharmacokinetic, and Efficacy Study Of Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection|Completed||Phase 2|172|Actual|World Health Organization||4|||f||||t||||||||||2017-02-18 16:42:17.100301|2017-02-18 16:42:17.100301
NCT00300755|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2010-04-14|2009-11-30||May 2006||2006-05-01|April 2010|2010-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)|A Multicenter, Randomized, Double-Blind Study of the Clinical Outcomes, Safety and Tolerability of Multiple Doses of Pantoprazole Sodium Enteric-Coated Spheroids in Children Ages 1 to 5 With Endoscopically Proven Symptomatic Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|60|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||f||||||||||2017-02-18 16:42:17.209337|2017-02-18 16:42:17.209337
NCT00300729|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2009-06-29|||May 2006||2006-05-01|June 2009|2009-06-01|September 2010|Anticipated|2010-09-01|May 2010|Anticipated|2010-05-01||Interventional|CYCLUS||Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy|Cox-2-Inhibitor and Chemotherapy in Non-Small Cell Lung Cancer. A Prospective Randomized Double-Blind Study|Unknown status|Active, not recruiting|Phase 3|319|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-02-18 16:42:18.215789|2017-02-18 16:42:18.215789
NCT00300716|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2009-08-27|||April 2004||2004-04-01|April 2007|2007-04-01||||||||Interventional|||Trial of Memantine for Cognitive Impairment in Multiple Sclerosis|Double Blind Placebo Controlled Pilot Trial of Memantine for Cognitive Impairment in Multiple Sclerosis|Unknown status|Recruiting|Phase 2/Phase 3|146|Anticipated|Oregon Health and Science University|||||f||||||||||||||2017-02-18 16:42:18.592747|2017-02-18 16:42:18.592747
NCT00300703|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-10-13|||January 2006||2006-01-01|October 2010|2010-10-01|September 2007|Actual|2007-09-01|||||Observational|||OPALS Cardiac Arrest Database (OCAD)|Ontario Prehospital Advanced Life Support (OPALS) Study Cardiac Arrest Database|Completed||N/A|1538|Actual|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 16:42:18.705337|2017-02-18 16:42:18.705337
NCT00300690|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-03-08|||October 1993||1993-10-01|March 2006|2006-03-01|January 1999||1999-01-01|||||Interventional|||Choice of Material for Above-Knee Femoro-Popliteal Bypass Prosthetic Graft (PopUp)|Choice of Material for Above-Knee Femoro-Popliteal Bypass Prosthetic Graft. Multicenter Randomized Study of an Impregnated Knitted Polyester Prosthesis Vs. PTFE (Uni-Graft Vs Gore-Tex).|Completed||Phase 4|400||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 16:42:18.807719|2017-02-18 16:42:18.807719
NCT00300677|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2009-10-05|2009-08-26||March 2007||2007-03-01|October 2009|2009-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days|Assessment Of Voriconazole Penetration Into The Brain By Fluorine-Magnetic Resonance Spectroscopy|Completed||Phase 4|12|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:42:18.91665|2017-02-18 16:42:18.91665
NCT00300664|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-10-12|||July 2002||2002-07-01|March 2006|2006-03-01|April 2005||2005-04-01|||||Interventional|||A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.||Completed||Phase 2/Phase 3|150||Royal Marsden NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:42:19.215028|2017-02-18 16:42:19.215028
NCT00300651|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-03-08|||March 2006||2006-03-01|March 2006|2006-03-01|August 2009||2009-08-01|||||Interventional|||Trial of Cognitive Behavioral Therapy for Schizophrenia|Phase 3 Randomized Controlled Trial of Cognitive Behavioural Therapy for Patients With Schizophrenia|Unknown status|Recruiting|Phase 3|70||Philipps University Marburg Medical Center|||||f||||||||||||||2017-02-18 16:42:19.282903|2017-02-18 16:42:19.282903
NCT00300638|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2012-11-08|||August 2001||2001-08-01|November 2012|2012-11-01|August 2014|Anticipated|2014-08-01|August 2014|Anticipated|2014-08-01||Observational|||Alcoholism: Emotion and Thinking|Affective and Conative Changes in Alcoholism|Unknown status|Recruiting|N/A|700|Anticipated|Boston University|||1||f||||||||||||||2017-02-18 16:42:19.379887|2017-02-18 16:42:19.379887
NCT00300625|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2009-02-17|||January 2005||2005-01-01|March 2006|2006-03-01||||||||Observational|||Validation of the San Francisco Syncope Rule|Validation of the San Francisco Syncope Rule|Completed||N/A|||Albert Einstein College of Medicine, Inc.|||||f||||||||||||||2017-02-18 16:42:19.488559|2017-02-18 16:42:19.488559
NCT00300612|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2015-05-29|||March 2006||2006-03-01|May 2015|2015-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Vaccine Treatment for Advanced Malignant Melanoma|A Phase I/II Study of Dorgenmeltucel-L (HyperAcute Melanoma) an Antitumor Vaccination Using Alpha(1,3)Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Refractory or Recurrent Malignant Melanoma|Completed||Phase 1/Phase 2|6|Actual|NewLink Genetics Corporation||1|||f||||f||||||||||2017-02-18 16:42:19.585834|2017-02-18 16:42:19.585834
NCT00300599|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2011-06-22|||January 2006||2006-01-01|June 2011|2011-06-01|December 2013|Anticipated|2013-12-01|February 2013|Anticipated|2013-02-01||Interventional|||Effect of Continuous Positive Airway Pressure (CPAP) on Systemic Blood Pressure, Coagulability and Carotid Intima-media Thickness in Patients With Sleep Apnea|A Randomized Controlled Study of the Long-term Effects of Nasal Continuous Positive Airway Pressure on Systemic Blood Pressure, Coagulability and Carotid Intima-media Thickness in Obstructive Sleep Apnea Syndrome|Unknown status|Recruiting|N/A|100|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 16:42:19.698138|2017-02-18 16:42:19.698138
NCT00300586|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2011-12-28|||June 2006||2006-06-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer|A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer Not Progressing on First Line Cisplatin-gemcitabine Chemotherapy Maintenance Chemotherapy With Gemcitabine or Sequential Treatment With Erlotinib|Completed||Phase 3|842|Actual|Hospices Civils de Lyon||3|||f||||t||||||||||2017-02-18 16:42:19.809722|2017-02-18 16:42:19.809722
NCT00300573|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2012-06-01|||April 2006||2006-04-01|June 2012|2012-06-01|April 2006|Actual|2006-04-01|||||Interventional|DECLARE||Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs|A Randomized, Double-Blind, Phase II Study Comparing the Anti-Retroviral Safety and Efficacy of Dexelvucitabine (DFC) 200 mg Once Daily to Lamivudine (3TC) 300 mg Once Daily in Addition to Optimized Background Therapy in HIV-1 Infected Subjects Who Have Failed and/or Harbor HIV With Resistance Mutations to NRTIs, PIs, and NNRTIs|Terminated||Phase 2|250|Actual|Incyte Corporation||2||"Development program ended due to inability to pair with other cytidine analogs and higher risk~   of hyperlipasemia when not used with 3TC/FTC."|f||||t||||||||||2017-02-18 16:42:19.922419|2017-02-18 16:42:19.922419
NCT00300560|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2006-05-19|||February 2006||2006-02-01|March 2006|2006-03-01|December 2006||2006-12-01|||||Interventional|||Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli|Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli|Unknown status|Recruiting|Phase 3|152||Mahidol University|||||f||||||||||||||2017-02-18 16:42:20.053288|2017-02-18 16:42:20.053288
NCT00300547|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2010-08-17|||March 2007||2007-03-01|March 2006|2006-03-01||||April 2008|Actual|2008-04-01||Interventional|||Preoperative Assessment for Synchronous Carcinoma or Polyps With Magnetic Resonance (MR) Colonography|Preoperative Assessment for Synchronous Carcinoma or Polyps With MR Colonography in Patients With Obstructing Cancer. A Prospective Study.|Completed||Phase 4|50|Actual|Herlev Hospital||1|||f||||||||||||||2017-02-18 16:42:20.143999|2017-02-18 16:42:20.143999
NCT00300534|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2012-09-06|||August 2002||2002-08-01|September 2012|2012-09-01|July 2009|Actual|2009-07-01|December 2005|Actual|2005-12-01||Interventional|||Multi-site Study of Rapid Diagnostic Syphilis Assays|Multi-site Study of Rapid Diagnostic Syphilis Assays of Persons Attending STD Clinics in High Syphilis Morbidity Areas|Completed||N/A|1000|Actual|Centers for Disease Control and Prevention||1|||f||||||||||||||2017-02-18 16:42:20.240167|2017-02-18 16:42:20.240167
NCT00300521|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2006-03-08|||September 2000||2000-09-01|September 2000|2000-09-01|November 2005||2005-11-01|||||Interventional|||Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma|Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 2|40||Beijing Chao Yang Hospital|||||f||||||||||||||2017-02-18 16:42:20.336684|2017-02-18 16:42:20.336684
NCT00300508|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2009-04-30|||January 1996||1996-01-01|April 2009|2009-04-01||||||||Interventional|||3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer|A Randomized, Open, Comparative Multicentre Trial of 3 Years Anastrozole Treatment vs. 3 Years no Treatment in Postmenopausal Patients With Breast Cancer Who Have Completed 5 Years Adjuvant Hormone Therapy.|Completed||Phase 3|856||AstraZeneca|||||f||||||||||||||2017-02-18 16:42:20.4321|2017-02-18 16:42:20.4321
NCT00300495|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-08|2008-05-05|||February 2006||2006-02-01|May 2008|2008-05-01|March 2011|Anticipated|2011-03-01|January 2011|Anticipated|2011-01-01||Interventional|||Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection|Phase III Study of Preoperative Amiodarone for Prevention of Atrial Fibrillation After Lung Resection|Unknown status|Recruiting|Phase 3|400|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||||||||||||2017-02-18 16:42:20.593221|2017-02-18 16:42:20.593221
NCT00300482|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2009-06-03|2009-01-14||March 2006||2006-03-01|June 2009|2009-06-01||||December 2006|Actual|2006-12-01||Interventional|||Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood|A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of Fenofibric Acid and Rosuvastatin Calcium Combination Therapy to Fenofibric Acid and Rosuvastatin Calcium Monotherapy in Subjects With Mixed Dyslipidemia|Completed||Phase 3|1445|Actual|Abbott||6|||f||||f||||||||||2017-02-18 16:42:20.716114|2017-02-18 16:42:20.716114
NCT00300469|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2009-06-01|2009-01-14||March 2006||2006-03-01|June 2009|2009-06-01||||February 2007|Actual|2007-02-01||Interventional|||Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood|A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of Fenofibric Acid and Atorvastatin Calcium Combination Therapy to Fenofibric Acid and Atorvastatin Calcium Monotherapy in Subjects With Mixed Dyslipidemia|Completed||Phase 3|613|Actual|Abbott||6|||f||||f||||||||||2017-02-18 16:42:22.05635|2017-02-18 16:42:22.05635
NCT00300456|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2009-05-29|2009-01-14||March 2006||2006-03-01|May 2009|2009-05-01||||March 2007|Actual|2007-03-01||Interventional|||Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood|A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of ABT-335 and Simvastatin Combination Therapy to ABT-335 and Simvastatin Monotherapy in Subjects With Mixed Dyslipidemia|Completed||Phase 3|657|Actual|Abbott||6|||f||||f||||||||||2017-02-18 16:42:23.583313|2017-02-18 16:42:23.583313
NCT00300443|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2011-05-27|||December 2005||2005-12-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 2/Phase 3|561|Actual|Allergan|||||f||||||||||||||2017-02-18 16:42:24.872963|2017-02-18 16:42:24.872963
NCT00300430|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2009-06-03|2009-03-10||September 2006||2006-09-01|June 2009|2009-06-01||||March 2008|Actual|2008-03-01||Interventional|||Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.|A Long-Term, Open-Label, Safety Extension Study of the Combination of Fenofibric Acid and Statin Therapy for Subjects With Mixed Dyslipidemia|Completed||Phase 3|1911|Actual|Abbott|This was an open-label study designed to assess the longer-term safety of the combination therapies. Evaluation of efficacy outcomes was a secondary objective.|3|||f||||f||||||||||2017-02-18 16:42:24.963358|2017-02-18 16:42:24.963358
NCT00300417|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2017-01-24|||March 3, 2006||2006-03-03|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Interventional|||Phase I Study of West Nile Virus Vaccine|A Phase I Study of the Safety and Immunogenicity of a West Nile Virus Recombinant DNA Plasmid Vaccine, VRC-WNVDNA020-00-VP, in Healthy Adult Subjects|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:42:26.126414|2017-02-18 16:42:26.126414
NCT00300404|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2006-05-19|||January 2002||2002-01-01|March 2006|2006-03-01|September 2005||2005-09-01|||||Interventional|||Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression|Effect of Add-on Anti-Toxoplasmosis Treatment on Parameters Defining Toxoplasma Gondii Infection and on Psychopathology in Patients With Schizophrenia or Major Depression Serologically Positive for Toxoplasma Gondii - Phase 3 Study|Completed||Phase 3|40||Zentrum für Integrative Psychiatrie|||||f||||||||||||||2017-02-18 16:42:26.214639|2017-02-18 16:42:26.214639
NCT00300391|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2016-05-10|||March 2006||2006-03-01|May 2016|2016-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium|ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium|Terminated||Phase 3|40|Actual|University of Pittsburgh||2||Insufficient recruitment to meet aims.|f||||t||||||||No||2017-02-18 16:42:26.292296|2017-02-18 16:42:26.292296
NCT00300378|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2007-12-03|||March 2006||2006-03-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (50 mg, 100 mg) of Desvenlafaxine Sustained-Release Tablets in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|480|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:42:26.40491|2017-02-18 16:42:26.40491
NCT00300365|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2006-05-19|||November 2005||2005-11-01|March 2006|2006-03-01||||||||Interventional|||Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL|A Randomized, Double Blind, Placebo Controlled Trial of Pioglitazone and Niacin Extended Release in Non-Diabetic Patients With Metabolic Syndrome|Unknown status|Recruiting|Phase 4|84||University of Pennsylvania|||||f||||||||||||||2017-02-18 16:42:26.525542|2017-02-18 16:42:26.525542
NCT00300339|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2008-12-18|||February 2006||2006-02-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|MASCOT||Mixed Antagonist of Serotonin for Claudication Optimal Therapy|Double-Blind, Double-Dummy, Randomized, Parallel Group Trial of SL650472 (Three Dose Regimens Versus Placebo and Cilostazol), for 24-Week Improvement of Walking Distance in Patients With Stage II Peripheral Arterial Disease Who Benefit From Optimal Prevention Strategy Including Clopidogrel|Completed||Phase 2|599|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:42:29.447414|2017-02-18 16:42:29.447414
NCT00300326|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2016-09-26|||January 2006||2006-01-01|April 2009|2009-04-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional|||Computer-assisted Total Knee Arthroplasty (TKA) With Zimmer LPS Flex Knee System|An Investigation of Total Knee Arthroplasty Kinematics on Patient Performance - The Zimmer Legacy® LPS Flex Knee System|Terminated||Phase 4|7|Actual|Queen's University||2||problems with planned computer|f||||t||||||||||2017-02-18 16:42:29.556823|2017-02-18 16:42:29.556823
NCT00300313|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2013-12-30|||June 2005||2005-06-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||PTSD Prevention Using Escitalopram||Completed||N/A|450|Anticipated|Sheba Medical Center||2|||f||||||||||||||2017-02-18 16:42:29.64999|2017-02-18 16:42:29.64999
NCT00300300|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2015-09-09|||September 2009||2009-09-01|September 2015|2015-09-01|January 2029|Anticipated|2029-01-01|January 2028|Anticipated|2028-01-01||Interventional|||Anterior Cruciate Ligament (ACL) Reconstruction Using Different Grafts and Surgical Techniques|Anterior Cruciate Ligament Reconstruction: Comparison of Patellar With Hamstring Tendon Using a Computer-assisted Versus a Conventional Surgical Technique.|Terminated||Phase 4|125|Actual|Queen's University||4||Study temporarily suspended until funding can be secured.|f||||f||||||||||2017-02-18 16:42:29.756839|2017-02-18 16:42:29.756839
NCT00300287|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2007-07-16|||February 2006||2006-02-01|July 2007|2007-07-01||||||||Interventional|||A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia|A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia|Completed||Phase 3|150||Novartis|||||f||||||||||||||2017-02-18 16:42:29.852444|2017-02-18 16:42:29.852444
NCT00300274|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2012-07-10|2012-07-06||January 2006||2006-01-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection|A 24-month, Multi-center, Randomized, Open-label, Non-inferiority Study of Efficacy and Safety Comparing Two Exposures of Concentration-controlled Everolimus With Reduced Cyclosporine Versus 3.0 g Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Heart Transplant Recipients|Completed||Phase 3|721|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:42:29.968009|2017-02-18 16:42:29.968009
NCT00300261|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2015-11-30|||September 2005||2005-09-01|March 2010|2010-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Testing the Effects of Telehealth Monitoring on Rehospitalization and Self Care for Heart Failure Patients in Home Care|Promoting Self Care Using Telehomecare: Impact on Outcomes|Completed||Phase 3|216|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 16:42:32.954636|2017-02-18 16:42:32.954636
NCT00300248|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2015-08-31|||October 2004||2004-10-01|August 2015|2015-08-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||Long-Term Results in Mechanically Ventilated Individuals With Acute Lung Injury/Acute Respiratory Distress Syndrome|The Improving Care of Acute Lung Injury Patients (ICAP) Study|Completed||N/A|520|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 16:42:33.059142|2017-02-18 16:42:33.059142
NCT00300235|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2015-12-22|2009-03-13||August 2005||2005-08-01|December 2015|2015-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence|The Epidemiology of Priapism (Sickle Cell Disease)|Completed||N/A|1464|Actual|University of Texas Southwestern Medical Center|||5||f||||t||||||||||2017-02-18 16:42:33.161111|2017-02-18 16:42:33.161111
NCT00300222|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2008-03-04|||March 2006||2006-03-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|A Multicenter Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|Completed||Phase 3|400||NeurogesX|||||f||||||||||||||2017-02-18 16:42:33.798013|2017-02-18 16:42:33.798013
NCT00300209|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2016-03-16|||September 1998||1998-09-01|March 2016|2016-03-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Observational|||Manhattan HIV/Hepatology Brain Bank|Manhattan HIV/Hepatology Brain Bank|Completed||N/A|187|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||||||||Samples Without DNA|"~     plasma and serum blood~   "|||2017-02-18 16:42:33.895086|2017-02-18 16:42:33.895086
NCT00300196|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2010-01-11|||March 2006||2006-03-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke|ASP II (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute Ischemic Stroke|Terminated||Phase 3|311|Actual|Neurobiological Technologies||2||Futility|f||||t||||||||||2017-02-18 16:42:34.037117|2017-02-18 16:42:34.037117
NCT00300183|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2006-03-31|||October 2003||2003-10-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Observational|||Evaluation of an HIV Outreach Program|Evaluation of an Outreach and Intervention Program to Reach HIV- Positive Persons Living in Bronx, NY Single Room Occupancy Hotels|Completed||N/A|150||Montefiore Medical Center|||||f||||||||||||||2017-02-18 16:42:34.415148|2017-02-18 16:42:34.415148
NCT00300170|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2006-03-31|||October 2004||2004-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Observational|||Engagement in HIV Primary Care Services|Determinants of Engagement in HIV Primary Care Services Among Black and Hispanic Single Room Occupancy Hotel Residents in New York City|Completed||N/A|500||Montefiore Medical Center|||||f||||||||||||||2017-02-18 16:42:34.498375|2017-02-18 16:42:34.498375
NCT00300157|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2011-01-03|||December 2005||2005-12-01|January 2011|2011-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent|French Multicenter Study Assessing Angioplasty With Taxus Drug Eluting Stent in Unprotected Left Main Coronary Artery Associated to Other Coronary Lesions or Not|Completed||Phase 3|155|Actual|French Cardiology Society||1|||f||||t||||||||||2017-02-18 16:42:34.576187|2017-02-18 16:42:34.576187
NCT00005463|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1991||1991-08-01|September 2002|2002-09-01|May 1993|Actual|1993-05-01|||||Observational|||Population-Based Modeling of Cholesterol Lowering in the United States||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.246696|2017-02-18 18:14:57.246696
NCT00300131|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2011-09-09|||March 2006||2006-03-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|ABSORB A||ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation|Bioabsorbable Vascular Solutions First in Man Clinical Investigation: A Clinical Evaluation of the Bioabsorbable Vascular Solutions Everolimus Eluting Coronary Stent System (BVS EECSS) in the Treatment of Patients With Single de Novo Native Coronary Artery Lesions|Completed||Phase 3|30|Actual|Abbott Vascular|||1||f||||t||||||||||2017-02-18 16:42:34.702035|2017-02-18 16:42:34.702035
NCT00300118|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2014-05-16|||September 2004||2004-09-01|May 2014|2014-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)|Double-blind, Double-dummy, Randomized, Multicentre Study to Compare the Efficacy and Safety of Oral Budesonide (9 mg) and Oral Mesalazine (4.5 g) in Moderately Active Crohn's Disease Patients|Completed||Phase 3|311|Actual|Dr. Falk Pharma GmbH||2|||f||||t||||||||||2017-02-18 16:42:34.836399|2017-02-18 16:42:34.836399
NCT00300105|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2008-03-14|||October 2005||2005-10-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|||||Interventional|||GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes|A Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar Therapy in Patients With Type 2 Diabetes|Terminated||Phase 3|400||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:42:34.953102|2017-02-18 16:42:34.953102
NCT00300092|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2015-04-16|||September 2000||2000-09-01|April 2015|2015-04-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Pediatric Fingertip Injuries:Are Antibiotics Required?|Pediatric Fingertip Injuries: Do Prophylactic Antibiotics Alter Infection Rates?|Completed||Phase 2|146|Actual|Children's Hospital Los Angeles||2|||f||||f||||||||||2017-02-18 16:42:35.100906|2017-02-18 16:42:35.100906
NCT00300079|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2016-11-17|||September 2006||2006-09-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension|A Multiple-Dose Study of the IOP-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% When Added to a PGA as Adjunctive Therapy Over a 24 Hour Period in Patients With Glaucoma or Ocular Hypertension|Completed||Phase 4|30|Anticipated|Alcon Research|||||f||||||||||||||2017-02-18 16:42:35.365706|2017-02-18 16:42:35.365706
NCT00300066|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2010-05-27|||March 2006||2006-03-01|May 2010|2010-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Assessment of Serum Cystatin C as a Marker of Kidney Function in Children|Prediction Equations for Glomerular Filtration Rate in Children Based on Serum Cystatin C and Body Cell Mass|Completed||Phase 2|200|Anticipated|Aalborg Universitetshospital|||1||f||||||||||||||2017-02-18 16:42:35.470114|2017-02-18 16:42:35.470114
NCT00300053|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2010-09-01||2009-10-28|March 2006||2006-03-01|September 2010|2010-09-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||ACT34-CMI -- Adult Autologous CD34+ Stem Cells|A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto--CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)|Completed||Phase 2|150|Anticipated|Baxter Healthcare Corporation||3|||f||||t||||||||||2017-02-18 16:42:35.574944|2017-02-18 16:42:35.574944
NCT00300040|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2008-05-15|||May 2006||2006-05-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia|Phase II, Multi-Center,Single-Blind,Placebo-Controlled Study,Evaluating Safety & Feasibility of HBOC-201 (Wound Healing Patients With Peripheral Vascular Disease & Undergoing Lower Limb Amputation Due to Critical Lower Limb Ischemia|Terminated||Phase 2|16|Actual|Biopure Corporation||2||Very slow enrollment.Study entry criteria not in line w/local standards of care|f||||f||||||||||2017-02-18 16:42:35.693059|2017-02-18 16:42:35.693059
NCT00300027|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2010-02-27||2010-02-27|April 2006||2006-04-01|September 2007|2007-09-01||||December 2006|Actual|2006-12-01||Interventional|||Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies|A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-582664 in Combination With 5-Fluorouracil/Leucovorin and Irinotecan or Oxaliplatin for Patients With Advanced or Metastatic Cancer|Terminated||Phase 1|50||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:42:35.810166|2017-02-18 16:42:35.810166
NCT00300014|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-07|2007-06-12|||January 2006||2006-01-01|June 2007|2007-06-01|May 2007||2007-05-01|||||Interventional|||Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage|Comparative,Randomized Study Between Intravitreal Triamcinolone Acetonide and Air-Fluid Exchange in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage|Unknown status|Recruiting|N/A|30|Anticipated|Asan Medical Center|||||f||||||||||||||2017-02-18 16:42:35.908597|2017-02-18 16:42:35.908597
NCT00300001|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2006-08-23|||March 2006||2006-03-01|August 2006|2006-08-01||||||||Observational|||Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes|Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes|Unknown status|Recruiting|N/A|300||Community Cancer Care|||||f||||||||||||||2017-02-18 16:42:36.020693|2017-02-18 16:42:36.020693
NCT00299988|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2010-11-08|||February 2006||2006-02-01|November 2010|2010-11-01|April 2010|Actual|2010-04-01|January 2009|Actual|2009-01-01||Interventional|||Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease|A Placebo-controlled, Randomized, Double-Blind Phase II Clinical Study of Gammagard Intravenous Immunoglobulin (IVIg) for Treatment of Mild to Moderate Alzheimer's Disease|Completed||Phase 2|24|Anticipated|Weill Medical College of Cornell University|||||f||||t||||||||||2017-02-18 16:42:36.112244|2017-02-18 16:42:36.112244
NCT00299975|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2015-04-08|2011-08-02||October 2006||2006-10-01|April 2015|2015-04-01|October 2007|Actual|2007-10-01|August 2007|Actual|2007-08-01||Interventional|||A Dose Determination Study of Chinese Herbal Medicine for Functional Constipation|A Randomized Controlled Trial of Chinese Herbal Medicine in Three-dose Regimen for the Treatment of Functional Constipation|Completed||Phase 2|97|Actual|Hong Kong Baptist University||3|||f||||t||||||||||2017-02-18 16:42:36.403914|2017-02-18 16:42:36.403914
NCT00299962|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2015-12-22|||March 2006||2006-03-01|December 2015|2015-12-01|April 2023|Anticipated|2023-04-01|April 2023|Anticipated|2023-04-01||Interventional|||Gene Therapy for Pleural Malignancies|A Phase I Clinical Trial of Repeated Dose Intrapleural Adenoviral-Mediated Interferon-beta (BG00001, Ad.hIFN-β for Pleural Malignancies|Active, not recruiting||Phase 1|18|Anticipated|University of Pennsylvania||5|||f||||f||||||||||2017-02-18 16:42:37.481164|2017-02-18 16:42:37.481164
NCT00299949|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2013-02-06|||October 2006||2006-10-01|February 2013|2013-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Thrombin Generation and Thromboelastography in Non-overt DIC|Use of Whole Blood and Cell-rich Coagulation Assays for the Detection of Non-Overt DIC in Sepsis|Terminated||N/A|2|Actual|The University of Texas Health Science Center, Houston|||1|Insufficient subject enrollment|f||||f||||||Samples Without DNA|"~     Samples will be discarded after the study is completed.~   "|||2017-02-18 16:42:37.596846|2017-02-18 16:42:37.596846
NCT00299936|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2006-03-03||||||March 2006|2006-03-01||||||||Interventional|||Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects|Comparison of PEG Interferon Alfa-2b Plus Ribavirin Given as a Fixed Dose or on a Weight Optimized Basis for Treatment of Chronic Hepatitis C in Previously Untreated Adult Subjects|Completed||Phase 3|5000||Weill Medical College of Cornell University|||||||||||||||||||2017-02-18 16:42:37.680494|2017-02-18 16:42:37.680494
NCT00299923|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2007-03-08|||November 2005||2005-11-01|March 2007|2007-03-01||||||||Interventional|||Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy|Randomized, Open-Label, Multicenter Study Examining the Effects of Duration of Treatment of PEGASYS® in Combination With Daily COPEGUS® + Amantadine in Patients With Chronic HCV After Relapse to Previous (Peg)IFN + Ribavirin Therapy.|Unknown status|Active, not recruiting|Phase 3|300||Universitätsklinikum Hamburg-Eppendorf|||||f||||||||||||||2017-02-18 16:42:37.766028|2017-02-18 16:42:37.766028
NCT00299910|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2008-05-20|||March 2005||2005-03-01|May 2008|2008-05-01||||||||Interventional|||Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing|Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing|Unknown status|Recruiting|Phase 4|50|Anticipated|Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:42:37.877315|2017-02-18 16:42:37.877315
NCT00299897|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2006-10-25|||March 2006||2006-03-01|October 2006|2006-10-01||||||||Interventional|||SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Orally Administered SP01A for 28 Days as Monotherapy Treatment in HIV-Infected Patients With Evidence of Resistance to Currently Available Antiretroviral Therapy|Unknown status|Active, not recruiting|Phase 2|60||Samaritan Pharmaceuticals, Inc|||||||||||||||||||2017-02-18 16:42:37.959401|2017-02-18 16:42:37.959401
NCT00299884|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-28|||January 2005||2005-01-01|March 2016|2016-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy|The Comparison of the Efficacy of Ezetimibe and Fenofibrate Versus Atorvastatin Alone in the Lowering of LDL Cholesterol|Completed||Phase 4|45|Actual|Queen's University|||2||f||||f||||||Samples Without DNA|"~     Apo-lipo B~   "|||2017-02-18 16:42:38.057026|2017-02-18 16:42:38.057026
NCT00299871|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2014-01-27|||February 2006||2006-02-01|January 2014|2014-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus|A 13-week Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose-Response Trial Assessing the Safety, Tolerability and Efficacy of AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|542|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:42:38.160274|2017-02-18 16:42:38.160274
NCT00299858|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2010-11-10|||October 2006||2006-10-01|November 2010|2010-11-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Theophylline in Chronic Obstructive Pulmonary Disease|Effect of Theophylline on Exercise Capacity and Lung Function in COPD Patients Receiving Long-acting Inhaled Bronchodilator Therapy|Completed||Phase 2/Phase 3|24|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 16:42:38.369301|2017-02-18 16:42:38.369301
NCT00299845|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2012-10-10||||||September 2006|2006-09-01||||||||Interventional|||Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children||Withdrawn||Phase 4|0|Actual|Osaka University|||||f||||||||||||||2017-02-18 16:42:38.478894|2017-02-18 16:42:38.478894
NCT00299832|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2016-11-16|||April 2006||2006-04-01|November 2016|2016-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction|A Multi-center, Open-label Study Assessing the Safety, Efficacy and Pharmacokinetics of 8 Week's Treatment of SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction|Completed||Phase 3|40|Actual|Novartis|||||f||||f||||||||||2017-02-18 16:42:38.565533|2017-02-18 16:42:38.565533
NCT00299819|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2007-12-17|||March 2006||2006-03-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)|A Phase I, Randomized, Double-Blind, Placebo Controlled, Dose-Escalation Study to Evaluate Safety and Tolerability of a Single IV Dose of MEDI-545, a Fully Human Monoclonal Antibody Directed Against Interferon Alpha Subtypes, in Patients With Systemic Lupus Erythematosus (SLE)|Completed||Phase 1|45|Actual|MedImmune LLC||5|||f||||||||||||||2017-02-18 16:42:38.662722|2017-02-18 16:42:38.662722
NCT00299806|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2016-11-16|||April 2006||2006-04-01|November 2016|2016-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension|A Multi-center, Open-label Study Assessing the Safety and Efficacy of 8 Week's Treatment of SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension|Completed||Phase 3|39|Actual|Novartis|||||f||||||||||||||2017-02-18 16:42:38.786513|2017-02-18 16:42:38.786513
NCT00299793|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2007-03-22|||October 2001||2001-10-01|March 2007|2007-03-01||||||||Observational|||Observational Study of Lamotrigine|Observational Study of Lamotrigine|Completed||Phase 4|60||Northwell Health|||||f||||||||||||||2017-02-18 16:42:38.877212|2017-02-18 16:42:38.877212
NCT00299780|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2007-04-23|||July 2004||2004-07-01|April 2007|2007-04-01|April 2007||2007-04-01|||||Interventional|||Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.|Phase I Study of Parathyroid Hormone in Combination With G-CSF in Patients Requiring Additional Stem Cell Mobilization|Completed||Phase 1|12||Massachusetts General Hospital|||||f||||t||||||||||2017-02-18 16:42:38.960129|2017-02-18 16:42:38.960129
NCT00299767|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2016-05-09|||May 2003||2003-05-01|May 2016|2016-05-01|May 2009|Actual|2009-05-01|May 2005|Actual|2005-05-01||Interventional|||Phase I Study of Sequential Cord Blood Transplants|Phase I Study of Sequential Cord Blood Transplants|Completed||Phase 1|21|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-02-18 16:42:39.05409|2017-02-18 16:42:39.05409
NCT00299754|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2006-03-06|||January 2003||2003-01-01|June 2005|2005-06-01|December 2004||2004-12-01|||||Interventional|||Trial Of Misoprostol And Dinoprostone Vaginal Pessaries for Cervical Priming (TROMAD Study)|The Randomised-Controlled Trial Of Misoprostol And Dinoprostone Vaginal Pessaries for Cervical Priming (TROMAD Study)|Completed||Phase 3|171||KK Women's and Children's Hospital|||||f||||||||||||||2017-02-18 16:42:39.149197|2017-02-18 16:42:39.149197
NCT00299741|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2012-12-14|2012-05-09||March 2006||2006-03-01|December 2012|2012-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of SU11248 in Men With Advanced Prostate Cancer|A Phase II Study of SU011248 in Men With Advanced Prostate Cancer|Completed||Phase 2|36|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 16:42:39.435197|2017-02-18 16:42:39.435197
NCT00299728|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2009-01-28|||March 2006||2006-03-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors|A Phase I Study Using Vaccination With NY-ESO-1 Recombinant Protein Mixed With CpG7909 and Montanide® ISA-51 in Patients With Cancers That Often Express NY-ESO-1.|Completed||Phase 1|20||Ludwig Institute for Cancer Research|||||||||||||||||||2017-02-18 16:42:39.710548|2017-02-18 16:42:39.710548
NCT00299715|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2011-06-02||2011-06-02|February 2006||2006-02-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Response, Multicenter Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone in the Treatment of Subjects With Acute Manic and Mixed Episodes Associated With Bipolar I Disorder|Completed||Phase 3|473|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:42:39.797759|2017-02-18 16:42:39.797759
NCT00299702|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2011-12-22|2010-01-26||February 2006||2006-02-01|December 2011|2011-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia|A 2-year, Prospective, Blinded-rater, Open-label, Active-controlled, Multicenter, Randomized Study of Long-term Efficacy and Effectiveness Comparing Risperdal® Consta® and Abilify® (Aripiprazole) in Adults With Schizophrenia|Completed||Phase 4|355|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|15% of subjects did not meet stability inclusion criteria; many received supplemental antipsychotics post-randomization; biweekly visits may have increased aripiprazole adherence; numerous early dropouts may have led to dependent censoring and bias.|2|||f||||t||||||||||2017-02-18 16:42:39.896999|2017-02-18 16:42:39.896999
NCT00299689|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2014-08-26|2014-08-26||March 2006||2006-03-01|May 2013|2013-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Phase II Trial of Ontak With Metastatic Melanoma|Phase II Trial of ONTAK With Metastatic Melanoma|Completed||Phase 2|69|Actual|James Graham Brown Cancer Center||1|||f||||t||||||||||2017-02-18 16:42:40.530511|2017-02-18 16:42:40.530511
NCT00299676|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2014-05-22|||May 2005||2005-05-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period|An Observational Study of Clinical Outcomes and Safety Profile of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period|Completed||Phase 4|61|Actual|Janssen-Cilag Pty Ltd|||1||f||||||||||||||2017-02-18 16:42:40.738259|2017-02-18 16:42:40.738259
NCT00299663|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-05|2012-01-15|||February 2006||2006-02-01|January 2012|2012-01-01|October 2011|Actual|2011-10-01|||||Observational|||Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract|Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract|Completed||N/A|61|Actual|Hadassah Medical Organization|||1||f||||t||||||||||2017-02-18 16:42:40.852757|2017-02-18 16:42:40.852757
NCT00299650|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2008-10-09|||March 2006||2006-03-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients|Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients|Completed||Phase 4|340|Anticipated|Assistance Publique Hopitaux De Marseille||2|||f||||t||||||||||2017-02-18 16:42:40.942329|2017-02-18 16:42:40.942329
NCT00299637|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-05|2006-11-29|||October 2006||2006-10-01|March 2006|2006-03-01|December 2007|Anticipated|2007-12-01|||||Observational|||Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis|Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis During Labor Comparing to Fetuses to Healthy Mothers.|Unknown status|Recruiting|Early Phase 1|34|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:42:41.06521|2017-02-18 16:42:41.06521
NCT00299624|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2010-09-13|||October 2005||2005-10-01|September 2010|2010-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Effect of Aging on Haemostasis Parameters|Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging|Completed||N/A|100|Anticipated|Hopital Lariboisière|||1||f||||t||||||||||2017-02-18 16:42:41.142996|2017-02-18 16:42:41.142996
NCT00299611|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-06|2013-04-09|||November 2005||2005-11-01|June 2010|2010-06-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder|A Double-Blind Augmentation Study of LEvetiracetam in Obsessive Compulsive Disorder|Terminated||Phase 2/Phase 3|12|Actual|Duke University||2||Sponsor decided to terminate the study due to budget consideration|f||||t||||||||||2017-02-18 16:42:41.220521|2017-02-18 16:42:41.220521
NCT00299598|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-05|2010-01-05|||September 2006||2006-09-01|October 2009|2009-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Clinical Study of Antibacterial Nanoparticles Incorporated in Composite Restorations|phase2 Safety and Efficacy of Antibacterial Nano Particles Incorporated in Dental Composite.|Completed||Phase 2|10|Actual|Hadassah Medical Organization|||1||f||||||||||||||2017-02-18 16:42:41.340021|2017-02-18 16:42:41.340021
NCT00299585|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-05|2010-01-05|||December 2007||2007-12-01|December 2007|2007-12-01|November 2008|Anticipated|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||A Clinical Study of the Use of Brushite as Primary Stabilizer in Immediate Dental Implantation|Phase 2 Clinical Study on the Efficacy of Injectable Brushite Bone Cement in Bone Augmentation and Dental Implant Stabilization|Suspended||Phase 2|40|Anticipated|Hadassah Medical Organization||1||manufacturer could not finance the study|f||||||||||||||2017-02-18 16:42:41.429019|2017-02-18 16:42:41.429019
NCT00299572|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-05|2006-03-05|||March 2006||2006-03-01|March 2006|2006-03-01|December 2006||2006-12-01|||||Interventional|||Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?|Can Alendronate Suppress Aortic and Coronary Artery Calcification and Improve Bone Mineral Density in Chronic Peritoneal Dialysis Patients?|Unknown status|Not yet recruiting|Phase 4|50||Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 16:42:41.526966|2017-02-18 16:42:41.526966
NCT00005462|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-11|||September 1991||1991-09-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Genetics of Atherosclerosis in Mexican Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.317945|2017-02-18 18:14:57.317945
NCT00299559|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2009-02-12|||March 2006||2006-03-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Kinetics of Etheric Oils, Smart Textiles vs. Ointment|An Open Clinical Cross-Over Trial to Compare the Kinetics of Etheric Oils Applied Onto the Skin or Via Smart Textiles|Completed||Phase 1|6|Actual|Technische Universität Dresden||1|||f||||f||||||||||2017-02-18 16:42:41.621043|2017-02-18 16:42:41.621043
NCT00299546|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2014-01-27|2009-05-21||February 2006||2006-02-01|January 2014|2014-01-01|May 2012|Actual|2012-05-01|August 2007|Actual|2007-08-01||Interventional|||A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis and Previously Treated With Biologic Anti- TNFa Agent(s)|Completed||Phase 3|461|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <= 5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|3|||f||||t||||||||||2017-02-18 16:42:41.735521|2017-02-18 16:42:41.735521
NCT00299533|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2013-08-14|||February 2004||2004-02-01|August 2013|2013-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Polyunsaturated Fatty Acids for Adjunctive Treatment of Refractory Epilepsy|A Randomized, Double-blind, Placebo-controlled, Prospective Study Evaluating the Usefulness of Polyunsaturated Fatty Acids (PUFA) in Patients Wtih Uncontrolled Epilepsy|Completed||Phase 3|40||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 16:42:43.374448|2017-02-18 16:42:43.374448
NCT00299520|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2008-04-02|||June 2005||2005-06-01|April 2008|2008-04-01|July 2006||2006-07-01|||||Interventional|||Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)|Phase 3, Randomized, Investigator-Blind, Multi-Center Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections.(ASSIST-1)|Completed||Phase 3|||Arpida AG|||||||||||||||||||2017-02-18 16:42:43.461195|2017-02-18 16:42:43.461195
NCT00299507|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2012-11-27||2012-11-27|March 2005||2005-03-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)|Anecortave Acetate 15 mg Administered Every 3 Months Versus Anecortave Acetate 15 mg Administered Every 6 Months Versus Anecortave Acetate 30 mg Administered Every 6 Months in Patients With Exudative Age-Related Macular Degeneration (AMD)|Completed||Phase 3|240|Actual|Alcon Research||4|||f||||t||||||||||2017-02-18 16:42:43.554109|2017-02-18 16:42:43.554109
NCT00299494|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2015-10-06||2015-07-21|May 2006||2006-05-01|October 2015|2015-10-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)|A Phase 1/2 Study Of CMC-544 Administered In Combination With Rituximab In Subjects With Follicular Or Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|119|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 16:42:43.964162|2017-02-18 16:42:43.964162
NCT00299481|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2008-06-26|||March 2006||2006-03-01|June 2008|2008-06-01|January 2011||2011-01-01|||||Observational|||Tissue Bank of Biological Specimens From Patients With Gynecologic Disease|Tissue and Data Acquisition Activity for the Study of Gynecological Disease|Unknown status|Recruiting|N/A|7000|Anticipated|Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 16:42:44.130281|2017-02-18 16:42:44.130281
NCT00299468|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2008-03-12|||April 2006||2006-04-01|May 2006|2006-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Effect of the Patient Activation Measure on Chronic Care|Using the Patient Activation Measure (PAM) to Improve Patient Self-Management of Hypertension|Completed||Phase 1|283|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 16:42:44.221182|2017-02-18 16:42:44.221182
NCT00299455|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2009-02-10|||March 2006||2006-03-01|February 2009|2009-02-01|March 2009|Anticipated|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Amoxicillin Clavulanate in Treatment of Acute Otitis Media|Phase 4 Efficacy Study of Antimicrobials in the Treatment of Acute Otitis Media in Young Children|Unknown status|Active, not recruiting|Phase 4|320|Anticipated|University of Turku||2|||f||||f||||||||||2017-02-18 16:42:44.323249|2017-02-18 16:42:44.323249
NCT00299442|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2009-03-10|||July 2007||2007-07-01|November 2008|2008-11-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|||Self-Help Parent Training for Conduct Problems in Children|Can Self−Help Parent Training Reduce Conduct Problems in Children on NHS Waiting Lists for Child Mental Health Services?|Unknown status|Recruiting|Phase 3|70|Anticipated|University of Oxford||2|||f||||||||||||||2017-02-18 16:42:44.429419|2017-02-18 16:42:44.429419
NCT00299429|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-07-07|||January 2003||2003-01-01|March 2007|2007-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||MIDCAB Versus DES in Proximal LAD Lesions|Randomised Comparison of Minimally Invasive Direct Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Proximal Stenosis of the Left Anterior Descending Coronary Artery|Completed||Phase 4|130|Actual|University of Leipzig||2|||f||||t||||||||||2017-02-18 16:42:44.548113|2017-02-18 16:42:44.548113
NCT00299416|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2011-04-05|2010-08-16||February 2003||2003-02-01|April 2011|2011-04-01|August 2009|Actual|2009-08-01|January 2009|Actual|2009-01-01||Interventional|||Caffeinol Hypothermia Protocol|Combined Neuroprotective Modalities Coupled With Thrombolysis in Acute Ischemic Stroke: A Pilot Study of Caffeinol and Mild Hypothermia|Completed||Phase 1/Phase 2|30|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-02-18 16:42:44.651558|2017-02-18 16:42:44.651558
NCT00299403|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2008-06-30|||May 2002||2002-05-01|June 2008|2008-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECT|The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to Electroconvulsive Therapy (ECT).An Open Randomized Noninferiority Trial.|Completed||Phase 2/Phase 3|60|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 16:42:44.920685|2017-02-18 16:42:44.920685
NCT00299390|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2015-12-30|||April 2006||2006-04-01|December 2015|2015-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer|Phase II Study to Investigate the Efficacy and Safety of ZK 219477 as First Line Therapy in Chemotherapy Naive Patients With Extensive Disease (ED) Stage Small Cell Lung Cancer (SCLC)|Terminated||Phase 2|10|Actual|Bayer||1||"Since only 1 of the first 10 subjects responded to the study treatment, it was decided to stop~   the trial due to lack of efficacy ."|f||||||||||||||2017-02-18 16:42:45.062328|2017-02-18 16:42:45.062328
NCT00299377|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2008-07-02|||January 2006||2006-01-01|June 2008|2008-06-01|February 2008|Actual|2008-02-01|November 2007||2007-11-01||Interventional|||Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI|Randomized Comparison of Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI and Effects on Infarct Size and Microvascular Obstruction|Completed||Phase 2/Phase 3|150||University of Leipzig|||||f||||||||||||||2017-02-18 16:42:45.195757|2017-02-18 16:42:45.195757
NCT00299364|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2006-03-02|||September 2004||2004-09-01|March 2006|2006-03-01|May 2005||2005-05-01|||||Interventional|||Comparison of the Efficacy and Tolerability of Black Cohosh Vs Tibolone in Patients With Menopausal Symptoms|Multi-Center, Randomized, Double-Blind, Parallel-Controlled Study on the Efficacy and Tolerability of Black Cohosh Vs Tibolone in Patients With Menopausal Symptoms|Completed||Phase 3|240||Schaper & Bruemmer GmbH & Co KG|||||f||||||||||||||2017-02-18 16:42:45.2999|2017-02-18 16:42:45.2999
NCT00299351|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2006-03-03||||||November 2005|2005-11-01||||||||Interventional|||A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.||Unknown status|Not yet recruiting|Phase 2|8||Royal Marsden NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:42:45.411853|2017-02-18 16:42:45.411853
NCT00299338|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2006-03-31|||September 1997||1997-09-01|March 2006|2006-03-01|September 2001||2001-09-01|||||Interventional|||A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients|A Pharmacokinetic and Safety Study of Procaine HCl in HIV-1 Infected Patients|Completed||Phase 1/Phase 2|24||Samaritan Pharmaceuticals, Inc|||||||||||||||||||2017-02-18 16:42:45.480015|2017-02-18 16:42:45.480015
NCT00299325|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2016-06-01||2016-04-21|February 2006||2006-02-01|June 2016|2016-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|VICTORIA||VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt|A Randomized, Double Blind, Two-arm Placebo Controlled, 12-Month Study of the Effects of Rimonabant 20mg Once Daily on the Amount and the Activity of Visceral Fat in Abdominally Obese Patients With Metabolic Syndrome.|Completed||Phase 3|254|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:42:45.589575|2017-02-18 16:42:45.589575
NCT00299312|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2015-11-06|||March 2006||2006-03-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Genetic and Physical Characteristics of Rett Syndrome|Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome|Completed||N/A|10|Actual|University of Alabama at Birmingham|||1||f||||t||||||||||2017-02-18 16:42:45.715913|2017-02-18 16:42:45.715913
NCT00299299|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2010-01-11|||June 2006||2006-06-01|January 2010|2010-01-01||||||||Observational|||Modelling Internal Hepatic Movement With an External Abdominal Marker|Modelling Internal Hepatic Movement With an External Abdominal Marker Block for Use With a Real Time Position Monitoring System for Respiratory Gating|Unknown status|Recruiting|N/A|10|Anticipated|Royal Marsden NHS Foundation Trust|||1||f||||||||||||||2017-02-18 16:42:45.830624|2017-02-18 16:42:45.830624
NCT00299286|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2012-08-03|||June 2007||2007-06-01|August 2012|2012-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|MAPLE||Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer|A Double Blind Short-Term Presurgical Study Assessing the Molecular Antiproliferative Predictors of Lapatinib's Effects in Breast Cancer|Completed||Phase 2|121|Actual|Institute of Cancer Research, United Kingdom||2|||f||||t||||||||||2017-02-18 16:42:45.913054|2017-02-18 16:42:45.913054
NCT00299273|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2015-06-04|||March 2006||2006-03-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||High Fat - High Protein Diet in the Treatment of Obesity|Exploratory Feasibility Study: High Fat/Protein Diet in the Treatment of Obesity|Terminated||N/A|8|Actual|Rockefeller University||1||PI left institution|f||||t||||||||||2017-02-18 16:42:46.027145|2017-02-18 16:42:46.027145
NCT00299260|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2010-04-16|||August 2006||2006-08-01|January 2008|2008-01-01|September 2011|Anticipated|2011-09-01|September 2009|Actual|2009-09-01||Interventional|||CMV Glycoprotein B Vaccine in Allograft Recipients|A Phase II Immunogenicity Trial of Cytomegalovirus Glycoprotein B Vaccine in Allograft Candidate Recipients|Unknown status|Active, not recruiting|Phase 2|140|Actual|University College, London||2|||f||||t||||||||||2017-02-18 16:42:46.244621|2017-02-18 16:42:46.244621
NCT00299247|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2010-08-26||||||January 2010|2010-01-01|December 2006|Anticipated|2006-12-01|December 2006|Anticipated|2006-12-01||Interventional|||SP Resistance and Falciparum Malaria Transmission|SP Resistance Markers and Falciparum Malaria Transmission|Withdrawn||Phase 3|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:42:46.357985|2017-02-18 16:42:46.357985
NCT00299234|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2012-04-25|||June 2006||2006-06-01|April 2007|2007-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL|Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for Acute Lymphocytic Leukemia|Terminated||Phase 4|1|Actual|Monarch Medical Research||2||Insufficient number of interested potentital subjects|f||||f||||||||||2017-02-18 16:42:46.450261|2017-02-18 16:42:46.450261
NCT00299221|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2015-05-26|2010-09-10||April 2004||2004-04-01|May 2015|2015-05-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|TICTAC||Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients|Tacrolimus In Combination, Tacrolimus Alone Compared (TICTAC Trial): A Prospective Randomized Trial Of Minimized Immunosuppression In Adult Heart Transplant Recipients|Completed||Phase 4|150|Actual|Newark Beth Israel Medical Center|This trial enrolled 150 patients, but cannot be used to generalize care to other patients without careful consideration of risks and benefits. All patients had corticosteorids weaned so this trial doesn't assess the risk of steroid weaning.|2|||f||||f||||||||||2017-02-18 16:42:46.578387|2017-02-18 16:42:46.578387
NCT00299208|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2010-08-26||||||March 2010|2010-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Azithromycin Combination Therapy for Malaria|Phase II, Open Label, Randomized Study of Azithromycin Combination Therapy for the Treatment of Acute, Uncomplicated Falciparum Malaria|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:42:47.048293|2017-02-18 16:42:47.048293
NCT00299195|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2016-06-06|||February 2006||2006-02-01|June 2016|2016-06-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||A Randomized Study of Sulindac in Oral Premalignant Lesions|A Pilot Multi-Center International Double-Blind Placebo Controlled Randomized Study of Sulindac, a Pan-Cox Inhibitor, in Oral Premalignant Lesions|Active, not recruiting||N/A|66|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 16:42:47.13457|2017-02-18 16:42:47.13457
NCT00299182|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2014-09-04|||March 2006||2006-03-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma|Phase 1/2 Study of AMG 531 to Evaluate the Safety, Efficacy, and Pharmacokinetics in Patients With Aggressive Non-Hodgkin's Lymphoma Receiving R-HyperCVAD Alternating With R-Ara-C/MTX|Completed||Phase 1/Phase 2|50|Actual|M.D. Anderson Cancer Center||7|||f||||f||||||||||2017-02-18 16:42:47.249077|2017-02-18 16:42:47.249077
NCT00299169|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2008-01-04|||September 2006||2006-09-01|September 2006|2006-09-01|November 2007|Actual|2007-11-01|||||Interventional|||Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes|Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes|Terminated||Phase 4|6|Actual|Lawson Health Research Institute||2||insufficient recruitment/enrollment|f||||f||||||||||2017-02-18 16:42:47.585369|2017-02-18 16:42:47.585369
NCT00299156|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2015-10-08|2015-08-19||March 2006||2006-03-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Oral Clofarabine Study in Patients With Myelodysplastic Syndrome|Phase II Study of Oral Clofarabine in Myelodysplastic Syndrome (MDS)|Completed||Phase 2|65|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:42:47.706616|2017-02-18 16:42:47.706616
NCT00299143|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2011-12-27|||June 2005||2005-06-01|December 2011|2011-12-01|June 2010|Actual|2010-06-01|September 2009|Actual|2009-09-01||Observational|REACS||Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes|Pilot Study on Shear-induced Platelet Aggregation in Acute Coronary Syndromes|Completed||N/A|97|Actual|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||t||||||Samples Without DNA|"~     serum, plasma, urines~   "|||2017-02-18 16:42:48.344331|2017-02-18 16:42:48.344331
NCT00299130|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2016-01-11|2013-02-21||October 2005||2005-10-01|January 2016|2016-01-01|July 2013|Actual|2013-07-01|June 2008|Actual|2008-06-01||Interventional|SERENE|Safety population included all randomized participants who received any part of an infusion.|A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis|A Randomized, Placebo Controlled, Double-blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate, Compared to Methotrexate Monotherapy, in Patients With Active Rheumatoid Arthritis|Completed||Phase 3|511|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 16:42:48.470625|2017-02-18 16:42:48.470625
NCT00299117|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2009-01-30|||April 2006||2006-04-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Brief Smoking Intervention for Women Undergoing Breast Cancer Surgery|Effect of a Brief Preoperative Smoking Intervention on Postoperative Complications in Women Undergoing Breast Cancer Surgery: A Randomised Clinical Trial|Completed||N/A|130|Actual|Herlev Hospital||1|||f||||t||||||||||2017-02-18 16:42:51.188093|2017-02-18 16:42:51.188093
NCT00299104|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2016-03-16|2009-11-16||January 2006||2006-01-01|March 2016|2016-03-01|July 2013|Actual|2013-07-01|September 2008|Actual|2008-09-01||Interventional|IMAGE||A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis|A Randomized, Phase 3, Controlled, Double-Blind, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate (MTX) Compared to MTX Alone, in Methotrexate-Naive Patients With Active Rheumatoid Arthritis|Completed||Phase 3|755|Actual|Genentech, Inc.||3|||f||||||||||||||2017-02-18 16:42:51.300917|2017-02-18 16:42:51.300917
NCT00299091|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2016-09-15|||September 2006||2006-09-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients|Open, Parallel and Randomised Pilot Clinical Trial to Evaluate the Utility of the Therapeutic Monitoring of Plasma Levels of Efavirenz in Hiv-Infected Patients Initiating an Antiretroviral Treatment Regimen With Sustiva|Completed||Phase 4|31|Actual|Germans Trias i Pujol Hospital||2|||f||||f||||||||||2017-02-18 16:42:56.367777|2017-02-18 16:42:56.367777
NCT00299065|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2007-09-24|||January 2006||2006-01-01|September 2007|2007-09-01|June 2006||2006-06-01|||||Interventional|||Safety Study of Zileuton Injection in Patients With Asthma|Assessment of Safety, Tolerability, and Pharmacokinetics of Zileuton Injection in Patients With Asthma|Completed||Phase 1/Phase 2|60||Critical Therapeutics|||||||||||||||||||2017-02-18 16:42:56.479746|2017-02-18 16:42:56.479746
NCT00299052|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2013-09-23|||March 2006||2006-03-01|September 2013|2013-09-01|September 2008|Actual|2008-09-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of DBM on Fractures of the Shinbone (Tibia)|The Efficacy of Demineralized Bone Matrix and Autogenous Bone Graft in Accelerated Fracture Healing in Closed Tibia Fracture|Completed||Phase 4|16|Actual|Emory University||2|||f||||f||||||||||2017-02-18 16:42:56.591665|2017-02-18 16:42:56.591665
NCT00299039|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2009-01-30|||May 2006||2006-05-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|T3AI||T3AI-Pain After Breast Surgery|A Randomized Controlled Trial Comparing Combination Therapy of Acetaminophen Plus Ibuprofen Versus Tylenol #3® for the Treatment of Pain After Breast Surgery.|Completed||Phase 3|150|Anticipated|Nova Scotia Health Authority||2|||f||||||||||||||2017-02-18 16:42:56.702113|2017-02-18 16:42:56.702113
NCT00299026|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-03|2008-08-28|||June 2001||2001-06-01|August 2008|2008-08-01|February 2007|Actual|2007-02-01|May 2003|Actual|2003-05-01||Interventional|||A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent|TAXUS II: A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent|Completed||Phase 2|532||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 16:42:56.816755|2017-02-18 16:42:56.816755
NCT00299013|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2008-04-24|||March 2006||2006-03-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis|A Multicentre, Randomised, Double Blind, Double Dummy, Active Comparator Controlled, Parallel Group Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis|Completed||Phase 3|796|Actual|Alizyme||4|||f||||f||||||||||2017-02-18 16:42:56.916504|2017-02-18 16:42:56.916504
NCT00299000|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2011-07-19|2010-05-07||May 2006||2006-05-01|July 2011|2011-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI|A Phase 4 Multi-center, Multi-national, Open-label, Randomized, Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With Maroteaux-Lamy Syndrome (MPS VI)|Completed||Phase 4|4|Actual|BioMarin Pharmaceutical|Given the small number of patients (4) represented in this study, the outcomes observed in this study may not reflect or predict outcomes observed by physicians in clinical practice.|2|||f||||f||||||||||2017-02-18 16:42:57.112098|2017-02-18 16:42:57.112098
NCT00298987|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2010-02-04||2010-02-04|February 2006||2006-02-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate|Study of Dasatinib (BMS-354825) in Subjects With Chronic Myelogenous Leukemia With Accelerated or Myeloid or Lymphoid Blast Phase or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Who Are Resistant to or Intolerant of Imatinib Mesylate|Completed||Phase 2|400|Anticipated|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 16:42:57.928955|2017-02-18 16:42:57.928955
NCT00298974|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2011-01-24|||February 2006||2006-02-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study of Pain Relief in Osteoarthritis|A Phase 3, Randomized, Multicenter, Double-blind Study Comparing the Analgesic Efficacy of Extended Release Hydrocodone/Acetaminophen Tablets (Vicodin CR) to Placebo in Subjects With Osteoarthritis|Completed||Phase 3|873|Actual|Abbott||2|||f||||f||||||||||2017-02-18 16:42:58.06955|2017-02-18 16:42:58.06955
NCT00298961|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2008-05-20|||May 2006||2006-05-01|May 2008|2008-05-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Psychiatric Consultation Through Videoconference in a Primary Care Setting|Telepsychiatry: Cost Analysis, Quality of Life, Satisfaction and Effectiveness of Psychiatric Consultation Through Videoconference in a Primary Care Setting|Unknown status|Not yet recruiting|N/A|160|Anticipated|Sha’ar Menashe Mental Health Center|||||f||||||||||||||2017-02-18 16:42:58.263065|2017-02-18 16:42:58.263065
NCT00298935|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2013-06-21|||July 2003||2003-07-01|June 2013|2013-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Study of the Effectiveness of Osteopathic Manipulative Treatment in Pregnant Women|Pilot Clinical Trial of Osteopathic Manipulative Treatment (OMT) in Pregnancy|Completed||Phase 2|146||University of North Texas Health Science Center|||||f||||||||||||||2017-02-18 16:42:58.355773|2017-02-18 16:42:58.355773
NCT00298922|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2009-07-30|||February 2006||2006-02-01|July 2009|2009-07-01|October 2009|Anticipated|2009-10-01|February 2009|Anticipated|2009-02-01||Interventional|||Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex|Phase II, Randomized, Double Blind, Placebo-Controlled Trial of Azithromycin in Patients With CF, Chronically Infected With Burkholderia Cepacia Complex|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|St. Michael's Hospital, Toronto||2|||f||||t||||||||||2017-02-18 16:42:58.449452|2017-02-18 16:42:58.449452
NCT00298909|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2012-07-29|||March 2006||2006-03-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)|Exercise Versus Extended-Release Niacin in Patients With Coronary Heart Disease and Low High-Density Lipoproteins (HDL) Cholesterol: Effect on Lipid Profile and Endothelial Function|Completed||Phase 4|48|Actual|University of Leipzig||3|||f||||||||||||||2017-02-18 16:42:58.553116|2017-02-18 16:42:58.553116
NCT00298896|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2009-03-05|||February 2006||2006-02-01|March 2009|2009-03-01|June 2008|Actual|2008-06-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer|Phase 2 Open-Label, Multicenter Clinical Study of the Safety and Efficacy of Intravenous Administration of SNS-595 in Patients With Advanced Small Cell Lung Cancer (SCLC)|Completed||Phase 2|80|Anticipated|Sunesis Pharmaceuticals|||||f||||||||||||||2017-02-18 16:42:58.662606|2017-02-18 16:42:58.662606
NCT00298883|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2012-07-24|||February 2006||2006-02-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Desensitization of Renal Transplant Candidates|Desensitization of Renal Transplant Candidates|Completed||Phase 1|9|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 16:42:58.773713|2017-02-18 16:42:58.773713
NCT00298870|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2012-10-17|||June 2005||2005-06-01|May 2011|2011-05-01||||||||Interventional|||Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)||Completed||Phase 4|172|Actual|Osaka University||2|||f||||t||||||||||2017-02-18 16:42:58.878189|2017-02-18 16:42:58.878189
NCT00298857|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2012-06-29|||March 2006||2006-03-01|June 2012|2012-06-01|March 2007|Actual|2007-03-01|||||Interventional|||A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights|An Open-label, Prospective Trial to Determine the Effect(s) of Obesity on the Pharmacokinetic Parameters of Valproic Acid|Terminated||Phase 4|22||Northwell Health||||Lack of funding|f||||||||||||||2017-02-18 16:42:58.983438|2017-02-18 16:42:58.983438
NCT00298844|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2007-03-22|||January 2006||2006-01-01|March 2007|2007-03-01|January 2010|Anticipated|2010-01-01|||||Observational|||Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus|Prevalence of Macrovascular Disease in Type 2 Diabetes Mellitus: Left Ventricular Diastolic Dysfunction, Myocardial Ischemia and Peripheral Vascular Insufficient|Unknown status|Recruiting|Phase 4|350||Odense University Hospital|||||f||||||||||||||2017-02-18 16:42:59.092521|2017-02-18 16:42:59.092521
NCT00298831|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2016-05-13|||October 2005||2005-10-01|May 2016|2016-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Use of Sugammadex at the End of Case in Routine Anesthesia (19.4.311)(P05943)|A Multicenter, Open Label, Phase IIIa Trial to Evaluate the Efficacy and Safety of Org 25969 When Used at the End of Surgical Procedure to Reverse the Neuromuscular Block Induced by Rocuronium Following Routine Anesthesia|Completed||Phase 3|224|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 16:42:59.166256|2017-02-18 16:42:59.166256
NCT00298818|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2008-05-19|||August 2002||2002-08-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|December 2005|Actual|2005-12-01||Observational|||Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation|Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation / Developmental Disabilities|Completed||Phase 4|25|Actual|Northwell Health|||1||f||||f||||||||||2017-02-18 16:42:59.252812|2017-02-18 16:42:59.252812
NCT00298805|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2013-08-08|||January 2006||2006-01-01|August 2013|2013-08-01|April 2013|Actual|2013-04-01|June 2009|Actual|2009-06-01||Observational|||A Quality of Life Study in Patients With Migraines|Dysphoric-like Disorder of Epilepsy, Is It Unique?|Terminated||N/A|52|Actual|Northwell Health|||1|Study terminated due to expiration of IRB approval|f||||f||||||||||2017-02-18 16:42:59.337076|2017-02-18 16:42:59.337076
NCT00298792|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2009-04-14|||January 2006||2006-01-01|April 2009|2009-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|IATP||Individualized Treatment Program for Alcohol Problems|Individualized Treatment Program for Alcohol Problems|Completed||Phase 1|110|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||2|||f||||f||||||||||2017-02-18 16:42:59.423812|2017-02-18 16:42:59.423812
NCT00298012|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2009-01-02|||March 2006||2006-03-01|January 2009|2009-01-01||||||||Interventional|||Methotrexate in the Treatment of Axial Spondyloarthritis|Methotrexate in the Treatment of Axial Spondyloarthritis. A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.|Withdrawn||Phase 4|120|Anticipated|Rheumatism Foundation Hospital|||||f||||||||||||||2017-02-18 16:43:12.034511|2017-02-18 16:43:12.034511
NCT00298779|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2008-06-04||||||June 2008|2008-06-01||||||||Interventional|||Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.|An Open-Label Study to Assess the Effect of Omeprazole Administration on the Pharmacokinetics of VELCADE in Subjects With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma|Completed||Phase 1|20|Anticipated|Millennium Pharmaceuticals, Inc.||2|||f||||||||||||||2017-02-18 16:42:59.534409|2017-02-18 16:42:59.534409
NCT00298766|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2012-06-19|2010-07-16||June 2005||2005-06-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis|An Open-Label Phase 1/2 Study of VELCADE for Injection in Subjects With Light-Chain (AL)-Amyloidosis|Completed||Phase 1/Phase 2|70|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||||||||||||2017-02-18 16:42:59.685737|2017-02-18 16:42:59.685737
NCT00298753|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2015-09-14|||May 2005||2005-05-01|September 2006|2006-09-01||||||||Interventional|||Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine|Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine|Withdrawn||Phase 4|0|Actual|Regional Hospital Holstebro||||no patients could be recruited|f||||||||||||||2017-02-18 16:43:00.28779|2017-02-18 16:43:00.28779
NCT00298740|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2006-03-01|||February 2003||2003-02-01|February 2006|2006-02-01|December 2011||2011-12-01|||||Interventional|||Medtronic MiniMed Implantable Insulin Pump|Reimplantation of Subjects With Implantable Insulin Pump Therapy|Unknown status|Active, not recruiting|Phase 2/Phase 3|||Johns Hopkins University|||||||||||||||||||2017-02-18 16:43:00.389584|2017-02-18 16:43:00.389584
NCT00298727|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2011-05-03|||January 2007||2007-01-01|May 2011|2011-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||The Effect and Mediators of Two Knowledge Translation Strategies|Defining the Effect and Mediators of Two Knowledge Translation Strategies Designed to Alter Knowledge, Intent and Clinical Utilization of Rehabilitation Outcome Measures|Completed||Phase 3|131|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 16:43:00.506884|2017-02-18 16:43:00.506884
NCT00298714|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2007-11-21|||March 2003||2003-03-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C|Effect of Long-Term Administration of Oral Losartan on Hepatic Fibrogenesis and Gene Expression in Chronic Hepatitis C With Significant Liver Fibrosis.|Completed||Phase 4|20||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 16:43:00.619023|2017-02-18 16:43:00.619023
NCT00298701|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2006-05-03|||February 2006||2006-02-01|May 2006|2006-05-01|April 2006||2006-04-01|||||Interventional|||Tolerability of Grazax-R in Children|A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Phase I Trial Investigating the Safety of GRAZAX-R in Children Aged 5-12 Years With Grass Pollen Induced Rhinoconjunctivitis (With/Without Asthma)|Completed||Phase 1|50||ALK-Abelló A/S|||||f||||||||||||||2017-02-18 16:43:00.698195|2017-02-18 16:43:00.698195
NCT00298688|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2008-06-11|||September 2004||2004-09-01|June 2008|2008-06-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer|Phase II Study of Iressa in Relapsed and Refractory Small Cell Lung Cancer|Completed||Phase 2|56||AstraZeneca|||||f||||||||||||||2017-02-18 16:43:00.781559|2017-02-18 16:43:00.781559
NCT00298675|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2012-08-01|||March 2006||2006-03-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|July 2010|Actual|2010-07-01||Interventional|||Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors|A Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors|Completed||Phase 1|59|Actual|Sanofi||2|||t||||||||||||||2017-02-18 16:43:00.879993|2017-02-18 16:43:00.879993
NCT00298662|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-02|2006-03-02|||February 2003||2003-02-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||Combination Therapy of Betaseron-Prograf in Multiple Sclerosis|A Pilot Safety and Tolerability Open-Label Study of Interferon Beta-1b in Combination With Tacrolimus in Patients Suffering From Multiple Sclerosis Who Have Failed Treatment With Approved Disease Modifying Agents|Unknown status|Active, not recruiting|Phase 2|30||Clinique de sclérose en plaques et neuromusculaire de l'Outaouais|||||f||||||||||||||2017-02-18 16:43:00.987561|2017-02-18 16:43:00.987561
NCT00298649|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2015-10-05|||July 2002||2002-07-01|March 2006|2006-03-01|October 2004||2004-10-01|||||Interventional|||Reducing Farmworkers Exposure to Agricultural Chemicals||Terminated||N/A|400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 16:43:01.091277|2017-02-18 16:43:01.091277
NCT00298636|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2006-08-01|||October 2005||2005-10-01|August 2006|2006-08-01||||||||Interventional|||Dose-Response of Adenosine for Perioperative Pain|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Escalating Dose-Response Trial of Intravenous Adenosine for Perioperative Analgesia in Females Undergoing Abdominal Hysterectomy or Myomectomy|Completed||Phase 2|160||Xsira Pharmaceuticals|||||||||||||||||||2017-02-18 16:43:01.182872|2017-02-18 16:43:01.182872
NCT00298623|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2013-05-10|||March 2006||2006-03-01|May 2011|2011-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of XP13512 in Patients With Restless Legs Syndrome.|Completed||Phase 3|222|Actual|XenoPort, Inc.||2|||f||||t||||||||||2017-02-18 16:43:01.282258|2017-02-18 16:43:01.282258
NCT00298610|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2008-09-02|||March 2006||2006-03-01|September 2008|2008-09-01||||October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy Study of IV Artesunate to Treat Malaria|A Phase II, Open Label, Study of the Safety, Tolerability, Efficacy and Pharmacokinetics of Intravenous Artesunate in Adults With Uncomplicated Malaria|Completed||Phase 2|30||Walter Reed Army Institute of Research (WRAIR)|||||||||||||||||||2017-02-18 16:43:01.37295|2017-02-18 16:43:01.37295
NCT00298597|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2009-04-22|||March 2006||2006-03-01|April 2007|2007-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Influence of G-CSF and EPO on Associative Learning and Motor Skills|Influence of G-CSF and EPO on Associative Learning and Motor Skills|Completed||Phase 2|180|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-02-18 16:43:01.466733|2017-02-18 16:43:01.466733
NCT00298584|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2007-02-22|||February 2006||2006-02-01|August 2006|2006-08-01||||||||Interventional|||Comparison of Infant Pain Responses Between Two Different Methods of Urine Collection|Comparison of Infant Pain Responses Between Two Different Methods of Urine Collection for Diagnosis of Infection: Suprapubic Aspiration and Urinary Catheterization|Unknown status|Recruiting|Phase 3|50||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 16:43:01.55851|2017-02-18 16:43:01.55851
NCT00298558|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2014-03-24|2013-04-24||March 1998||1998-03-01|January 2014|2014-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|ACTIVE|Of 2832 randomized subjects, 30 subjects were randomized inappropriately in violation of the protocol and excluded from the analysis. Therefore, 2802 subjects were used for the baseline analysis.|ACTIVE: Advanced Cognitive Training for Independent and Vital Elderly|Trial of a Cognitive Intervention for Older Adults|Completed||Phase 2/Phase 3|2832|Actual|New England Research Institutes||4|||f||||t||||||||||2017-02-18 16:43:01.767414|2017-02-18 16:43:01.767414
NCT00298545|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2011-11-17|||November 2005||2005-11-01|November 2011|2011-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Vitamin D and Calcium on Genes in the Colon|High vs. Low Calcium Intake in the Presence of High Vitamin D: Effect on Gene Expression in the Colon|Completed||Phase 1|10|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 16:43:02.624415|2017-02-18 16:43:02.624415
NCT00298532|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2010-10-13|||July 1992||1992-07-01|October 2010|2010-10-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||OPALS Pediatric Study|The Ontario Prehospital Advanced Life Support (OPALS) Study for Critically Ill and Injured Pediatric Patients|Completed||N/A|9000||Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-02-18 16:43:02.722769|2017-02-18 16:43:02.722769
NCT00298519|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2009-09-18|||June 2003||2003-06-01|September 2009|2009-09-01|February 2006|Actual|2006-02-01|||||Observational|||Maternal Ethnic Group,Diet,Breast Milk Fatty Acid and Potential Effect Development of Allergy in the Offspring|The Influence of Maternal Ethnic Group and Diet on Breast Milk Fatty Acid Content and Its Potential Effect on Development of Allergy in the Offspring.|Completed||N/A|300|Anticipated|National University Hospital, Singapore|||1||f||||||||||||||2017-02-18 16:43:02.826229|2017-02-18 16:43:02.826229
NCT00298506|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2011-09-28|||September 2005||2005-09-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)|An Open, Prospective Study to Assess the Efficacy and Safety of FK506 Combined MMF in the Treatment of Class III，IV，V + IV or V + III Lupus Nephritis|Completed||N/A|120|Actual|Nanjing University School of Medicine||1|||f||||t||||||||||2017-02-18 16:43:02.903581|2017-02-18 16:43:02.903581
NCT00298493|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2006-02-28|||February 2001||2001-02-01|February 2006|2006-02-01|September 2004||2004-09-01|||||Interventional|||Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol|A Randomized Trial of Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol - A Pilot Study|Completed||Phase 2|65||Mount Sinai Hospital, Canada|||||f||||||||||||||2017-02-18 16:43:03.011994|2017-02-18 16:43:03.011994
NCT00298480|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2007-04-18|||February 2005||2005-02-01|April 2007|2007-04-01|July 2007|Anticipated|2007-07-01|||||Observational|||Dynamic Cervical Change: Prediction of Preterm Labor in Symptomatic Patients||Unknown status|Recruiting|N/A|220||Memorial Health Services Research Council|||||f||||||||||||||2017-02-18 16:43:03.097495|2017-02-18 16:43:03.097495
NCT00298467|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2010-04-23|||February 2006||2006-02-01|April 2010|2010-04-01||||||||Interventional|||MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma|An Open-label, Fixed-dose, Multicenter, Phase II Study of MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma|Withdrawn||Phase 2|45|Anticipated|Bristol-Myers Squibb||||sponsor decision|||||||||||||||2017-02-18 16:43:03.246709|2017-02-18 16:43:03.246709
NCT00298454|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2007-04-18|||December 2005||2005-12-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients|Forced Diuresis Vs Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients (Fodorefh)|Terminated||Phase 3|72||Medical Centre Leeuwarden||||Number included has been reached|f||||||||||||||2017-02-18 16:43:03.536257|2017-02-18 16:43:03.536257
NCT00298441|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2008-05-08|||June 2005||2005-06-01|May 2008|2008-05-01|March 2007|Actual|2007-03-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy of Intravenous Iron Administration in Hemodialysis Patients|Effect of IVIR Frequency on Anemia Correction and Oxidative Stress Formation and in Hemodialysis Patients|Completed||Phase 4|50||Kumamoto University|||||f||||t||||||||||2017-02-18 16:43:03.647066|2017-02-18 16:43:03.647066
NCT00298428|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2011-09-23|||May 2006||2006-05-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|SPACE||Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE)|Biological Efficacy of Clopidogrel 600 mg Loading Dose Followed by 75 mg Maintenance Dose After Implantation of Drug-eluting Stents in Patients With Diabetes Mellitus or Metabolic Syndrome (SPACE)|Completed||N/A|159|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 16:43:03.759187|2017-02-18 16:43:03.759187
NCT00298415|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2013-10-24|||March 2006||2006-03-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)|Phase III Study of Monotherapy by Gemcitabine or Vinorelbine Comparing to Doublet by Carboplatin and Paclitaxel Among Elderly Patients With Stage IIIB/IV NSCLC (Obligatory Second-line by Erlotinib)|Completed||Phase 3|451|Actual|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||t||||||||||2017-02-18 16:43:03.883156|2017-02-18 16:43:03.883156
NCT00298402|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2015-05-27|||October 2005||2005-10-01|March 2006|2006-03-01|October 2007||2007-10-01|||||Observational|||Macrophages in Smokers' Lung|The Role of Macrophages in the Pathophysiology of Smokers' Lung|Withdrawn||N/A|0|Actual|Imperial College London|||1||f||||||||||||||2017-02-18 16:43:03.998309|2017-02-18 16:43:03.998309
NCT00298389|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2014-03-19|||October 2005||2005-10-01|March 2006|2006-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Macrophage Phagocytosis in COPD|Macrophage Phagocytosis in Chronic Obstructive Pulmonary Disease|Completed||N/A|90|Actual|Imperial College London|||1||f||||||||||||||2017-02-18 16:43:04.077746|2017-02-18 16:43:04.077746
NCT00298376|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2007-04-26|||March 2006||2006-03-01|April 2007|2007-04-01||||||||Observational|||Oral Tolerance in Cow’s Milk Allergy in the Infant|Oral Tolerance in Cow’s Milk Allergy in the Infant: Role of CD4+CD25+ T Cells and Intestinal Microflora|Unknown status|Recruiting|N/A|50||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:43:04.170372|2017-02-18 16:43:04.170372
NCT00298181|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2008-01-24|||October 2005||2005-10-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|November 2006|Actual|2006-11-01||Observational|||YSPSL for Prevention of Delayed Graft Function Part A|Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Efficacy of YSPSL for Prevention of Delayed Graft Function in Patients Undergoing Cadaveric Kidney Transplantation|Completed||Phase 1/Phase 2|15|Actual|Y's Therapeutics, Inc.|||4||f||||t||||||||||2017-02-18 16:43:10.333835|2017-02-18 16:43:10.333835
NCT00298363|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2013-04-19|2012-04-10||April 2006||2006-04-01|April 2013|2013-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.|A Phase 2, Double-Blind, Multi-center, Randomized Study Comparing Tenofovir Disoproxil Fumarate, Emtricitabine Plus Tenofovir Disoproxil Fumarate, and Entecavir in the Treatment of Chronic Hepatitis B Subjects With Decompensated Liver Disease and in the Prevention of Hepatitis B Recurrence Post-Transplantation|Completed||Phase 2|112|Actual|Gilead Sciences||3|||f||||t||||||||||2017-02-18 16:43:04.274445|2017-02-18 16:43:04.274445
NCT00298350|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2008-07-28|||February 2006||2006-02-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.|Phase 2 Study of the Treatment of Antiretroviral Treatment-Experienced Subjects Comparing Ritonavir-Boosted GS-9137 (GS-9137/r) vs. a Comparator Ritonavir-Boosted Protease Inhibitor (CPI/r) in Combination With Background ART.|Completed||Phase 2|278|Actual|Gilead Sciences||4|||f||||t||||||||||2017-02-18 16:43:07.292619|2017-02-18 16:43:07.292619
NCT00298337|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2006-10-17|||October 1999||1999-10-01|March 2006|2006-03-01|December 2007||2007-12-01|||||Interventional|||Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008||Unknown status|Active, not recruiting|Phase 2/Phase 3|||Helsinki University|||||f||||||||||||||2017-02-18 16:43:07.662542|2017-02-18 16:43:07.662542
NCT00298324|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2015-04-02|||September 2006||2006-09-01|April 2015|2015-04-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Interventional|||Myfortic - Treatment for Extensive cGvHD|A Randomized Double Blinded Placebo-Controlled Phase III Trial Comparing Cyclosporine Plus Steroids With or Without Myfortic as Primary Treatment for Extensive Chronic Graft Versus Host Disease|Terminated||Phase 3|34|Actual|European Group for Blood and Marrow Transplantation||2||Due to slow accrual|f||||t||||||||||2017-02-18 16:43:07.755054|2017-02-18 16:43:07.755054
NCT00298311|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2009-02-06|||November 2005||2005-11-01|February 2009|2009-02-01|July 2009|Anticipated|2009-07-01|February 2009|Actual|2009-02-01||Interventional|||Trial to Evaluate the Effect of Home-Based Peer Support on Maternal-Infant Interaction, Infant Health Outcomes, and Postpartum Depression (PPD)|An RCT to Evaluate the Effect of Home-Based Peer Support on Maternal-Infant Interaction, Infant Health Outcomes, and Postpartum Depression|Unknown status|Recruiting|N/A|104|Anticipated|Canadian Research Institute for Social Policy||1|||f||||f||||||||||2017-02-18 16:43:07.880371|2017-02-18 16:43:07.880371
NCT00298298|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2015-12-02|||January 2006||2006-01-01|December 2015|2015-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer|L-Vax: A Feasibility Study Using a DNP-Modified Autologous Tumor Cell Vaccine as Therapy in Patients With Resectable Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|6|Actual|AVAX Technologies||3||Suspended until capitalization is completed|f||||t||||||||||2017-02-18 16:43:07.977244|2017-02-18 16:43:07.977244
NCT00298285|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2007-11-07||||||January 2006|2006-01-01|October 2006||2006-10-01|||||Interventional|||ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement|ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement. A Pilot Study|Completed||Phase 4|100||The Cleveland Clinic|||||||||||||||||||2017-02-18 16:43:08.10034|2017-02-18 16:43:08.10034
NCT00298272|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2015-08-27|2010-04-20||May 2006||2006-05-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|April 2009|Actual|2009-04-01||Interventional||Safety Population|Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis|A Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Tolerability and Safety of Rituximab When Given in Combination With Methotrexate and Etanercept (Enbrel) or Methotrexate and Adalimumab (Humira) in Subjects With Active Rheumatoid Arthritis|Terminated||Phase 2|54|Actual|Biogen|Sponsor made a business decision to terminate study on 28 July 2011, after completion of the primary endpoint and during the long-term extension phase. One participant was still in extended safety follow-up and was referred for appropriate care.|2||Sponsor decided to end long term extension phase for business reasons unrelated to safety.|f||||f||||||||||2017-02-18 16:43:08.208071|2017-02-18 16:43:08.208071
NCT00298259|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2012-12-09|||January 2007||2007-01-01|December 2012|2012-12-01|March 2012|Actual|2012-03-01|January 2012|Actual|2012-01-01||Interventional|||Trial of Operative Fixation of Fractured Ribs in Patients With Flail Chest|Prospective Randomised Trial of Operative Fixation of Fractured Ribs in Patients With Flail Chest|Completed||Phase 2|48|Actual|The Alfred||2|||f||||f||||||||||2017-02-18 16:43:09.311079|2017-02-18 16:43:09.311079
NCT00298246|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2017-01-24|||February 22, 2006||2006-02-22|December 2, 2016|2016-12-02||||||||Observational|||Clinical and Immunological Investigations of Subtypes of Autism|Clinical and Immunological Investigations of Subtypes of Autism|Completed||N/A|557|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:43:09.409616|2017-02-18 16:43:09.409616
NCT00298233|ClinicalTrials.gov processed this data on February 17, 2017|2006-03-01|2014-05-26|2014-01-17||February 2006||2006-02-01|May 2014|2014-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||All participants that were randomized|High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza|High-Dose Versus Standard-Dose Oseltamivir for the Treatment of Severe Influenza and Avian Influenza: A Phase II Double-Blind, Randomized Clinical Trial|Completed||Phase 2|326|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 16:43:09.514793|2017-02-18 16:43:09.514793
NCT00298220|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2009-09-21|||July 2005||2005-07-01|August 2009|2009-08-01|April 2009|Actual|2009-04-01|May 2008|Actual|2008-05-01||Interventional|||Engaging General Practice in the Prevention of Patients With Alcohol Problems|Engaging General Practice in the Prevention of Patients With Alcohol Problems|Completed||N/A|77|Actual|Radboud University||2|||f||||||||||||||2017-02-18 16:43:10.021386|2017-02-18 16:43:10.021386
NCT00298207|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2006-02-27|||April 2001||2001-04-01|April 2001|2001-04-01|February 2004||2004-02-01|||||Interventional|||Walking Intervention in African American Adults With Newly Diagnosed Hypertension|Walking Intervention in African American Adults With Newly Diagnosed Hypertension|Completed||N/A|20||University of Illinois at Chicago|||||f||||||||||||||2017-02-18 16:43:10.143647|2017-02-18 16:43:10.143647
NCT00298194|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2009-01-12|||February 2006||2006-02-01|January 2009|2009-01-01||||July 2008|Actual|2008-07-01||Interventional|||The Effects of Z-338 in Subjects With and Without Functional Dyspepsia|The Effects of Z-338 on the Symptomatic Response to a Nutrient Challenge and Gastric Nutrient Distribution and Emptying in Subjects With and Without Functional Dyspepsia|Completed||Phase 2|52|Anticipated|Zeria Pharmaceutical|||||f||||f||||||||||2017-02-18 16:43:10.247763|2017-02-18 16:43:10.247763
NCT00298168|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2008-01-24|||May 2006||2006-05-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||YSPSL for Prevention of Delayed Graft Function Part B|Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Efficacy of YSPSL for Prevention of Delayed Graft Function in Patients Undergoing Cadaveric Kidney Transplantation|Completed||Phase 1/Phase 2|60|Actual|Y's Therapeutics, Inc.||3|||t||||t||||||||||2017-02-18 16:43:10.446343|2017-02-18 16:43:10.446343
NCT00298155|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2012-01-06|||July 2006||2006-07-01|January 2012|2012-01-01|February 2012|Anticipated|2012-02-01|June 2010|Actual|2010-06-01||Interventional|TAPS||Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer|Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|University of Washington||3|||f||||t||||||||||2017-02-18 16:43:10.580413|2017-02-18 16:43:10.580413
NCT00298142|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2009-10-05|||February 2006||2006-02-01|October 2009|2009-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Management of Headache Disorders: A Clinical Trial Screening for Prognostic Patient Characteristics|A Prospective Randomised Clinical Trial to Investigate the Management of Headache Disorders. Study to Identify Prognostic Patient Characteristics and to Investigate the Additional Value of Physio-/Manual Therapy|Terminated||N/A|120|Anticipated|Vrije Universiteit Brussel||||Insufficient enrollment|f||||||||||||||2017-02-18 16:43:10.690268|2017-02-18 16:43:10.690268
NCT00298129|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2007-05-08|||February 2004||2004-02-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Observational|||Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease|Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease|Completed||N/A|278|Actual|Yokohama City University Medical Center|||||f||||t||||||||||2017-02-18 16:43:10.793814|2017-02-18 16:43:10.793814
NCT00298116|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2014-12-05|||September 2000||2000-09-01|December 2014|2014-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Molecular Associations With Reproductive Failure|Molecular Associations With Reproductive Failure|Completed||N/A|475|Actual|University of Pittsburgh|||1||f||||||||||||||2017-02-18 16:43:10.957613|2017-02-18 16:43:10.957613
NCT00298103|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2015-12-16|||February 2006||2006-02-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Observational|||Antibiotic Resistant Community-Acquired E. Coli|Antibiotic Resistant Community-Acquired E. Coli|Completed||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:43:11.046947|2017-02-18 16:43:11.046947
NCT00298090|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2014-11-14|2012-05-04||January 2006||2006-01-01|November 2014|2014-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Evaluation of a Radial Arterial Line's Effect on StO2 Monitoring|An Evaluation of a Radial Arterial Line's Effect on StO2 Monitoring Using the InSpectra® Tissue Spectrometer|Completed||N/A|47|Actual|The University of Texas Health Science Center at San Antonio|Eighteen subjects were not included in final analysis due to incomplete data sets; unsuccessful arterial line placement, technical problems in applying StO2 device, unreliable data or partial data.||1||f||||f||||||||||2017-02-18 16:43:11.135866|2017-02-18 16:43:11.135866
NCT00298077|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2015-12-16|||August 2006||2006-08-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|November 2016|Anticipated|2016-11-01||Observational|||A Retrospective Review of Infections Usually Observed in Transplant Recipients|A Retrospective Review of Infections Usually Observed in Transplant Recipients|Active, not recruiting||N/A|500|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:43:11.358583|2017-02-18 16:43:11.358583
NCT00298064|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2016-05-10|||December 2005||2005-12-01|May 2016|2016-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer|Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer|Completed||N/A|300|Actual|University of New Mexico|||||f||||t||||||||||2017-02-18 16:43:11.447986|2017-02-18 16:43:11.447986
NCT00298051|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2013-09-26|||October 2003||2003-10-01|September 2013|2013-09-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Umbilical Cord Clamping and Infant Iron Status|Umbilical Cord Clamping and Infant Iron Status|Completed||N/A|476|Actual|University of California, Davis||2|||f||||||||||||||2017-02-18 16:43:11.533247|2017-02-18 16:43:11.533247
NCT00298038|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2011-07-17|||December 2005||2005-12-01|July 2011|2011-07-01|April 2009|Actual|2009-04-01|August 2008|Actual|2008-08-01||Interventional|||A 6-month Efficacy, Safety and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerability of Rifaximin 550 mg BID For 6 Months In Preventing Hepatic Encephalopathy|Completed||Phase 3|299|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||t||||||||||2017-02-18 16:43:11.821567|2017-02-18 16:43:11.821567
NCT00298025|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2014-03-24|||September 2003||2003-09-01|March 2014|2014-03-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation|A Phase IV, Multicenter, Open-label, Randomized Study to Compare the Safety and Efficacy of Cetrotide® 3 mg Versus Antagon™ in the Inhibition of a Premature LH Surge in a r-hFSH/hMG Stimulation Cycle With OCP Programming in Women Undergoing Ovarian Stimulation Prior to ART|Completed||Phase 4|185|Actual|EMD Serono||2|||f||||||||||||||2017-02-18 16:43:11.914323|2017-02-18 16:43:11.914323
NCT00297986|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2015-04-27|||June 2004||2004-06-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Observational|||Evaluation of Different Interfaces for Noninvasive Positive Pressure Ventilation (NPPV)|Evaluation of Different Interfaces for NPPV|Completed||N/A|10|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-02-18 16:43:12.144614|2017-02-18 16:43:12.144614
NCT00297973|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2009-03-27|||February 2006||2006-02-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|||||Interventional|RIGHT||Cardiovascular Risk Assessment in Patients Treated With Caduet|Cardiovascular Risk Assessment In Patients With Hypertension And At Least Three Other Risk Factors, Treated With Caduet Compared To Usual Care: The Right Study|Completed||Phase 4|1442|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:43:12.281396|2017-02-18 16:43:12.281396
NCT00297960|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2006-10-17|||April 2005||2005-04-01|October 2005|2005-10-01||||||||Interventional|||Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle|Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle|Completed||Phase 4|||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:43:12.799827|2017-02-18 16:43:12.799827
NCT00297947|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2015-04-16|||December 2004||2004-12-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|HDQ||High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder|A Randomized, Double-Blind, Parallel-Group, Fixed Dose, Clinical Trial of Quetiapine 600 mg/Day vs 1200 mg/Day for Patients With Treatment-Resistant Schizophrenia or Schizoaffective Disorder|Completed||Phase 2/Phase 3|60|Actual|Manhattan Psychiatric Center||2|||f||||t||||||||||2017-02-18 16:43:12.888319|2017-02-18 16:43:12.888319
NCT00297934|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2008-12-17|||March 2006||2006-03-01|October 2006|2006-10-01|March 2006||2006-03-01|||||Interventional|||Spinal Manipulative Therapy: Dual-Task Performance|Influence of Instrument-Applied Spinal Manipulative Therapy on Dual-Task Performance Involving Complex Postural and Cognitive Tasks|Completed||N/A|20||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:43:13.012341|2017-02-18 16:43:13.012341
NCT00297921|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2013-11-04||||||November 2013|2013-11-01||||||||Interventional|||A Phase 2 Study of Tandutinib in Patients With Newly Diagnosed Acute Myelogenous Leukemia Who Are Considered Ineligible For or Who Decline Treatment With Standard Induction Therapy||Withdrawn||Phase 1/Phase 2|0|Actual|Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 16:43:13.093788|2017-02-18 16:43:13.093788
NCT00297908|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2015-06-02|||February 2006||2006-02-01|February 2007|2007-02-01|February 2006||2006-02-01|||||Observational|||Alcohol Based Hand Sanitizer: Can Frequent Use Cause an Elevated Blood Alcohol Level?|Alcohol Based Hand Sanitizer: Can Frequent Use Cause an Elevated Blood Alcohol Level?|Completed||N/A|5||C.R.Darnall Army Medical Center|||||f||||||||||||||2017-02-18 16:43:13.163146|2017-02-18 16:43:13.163146
NCT00297895|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2017-02-03|||September 2004||2004-09-01|February 2017|2017-02-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Interventional|||Multicenter Selective Lymphadenectomy Trial II (MSLT-II)|A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node|Active, not recruiting||N/A|1925|Anticipated|John Wayne Cancer Institute||2|||f||||t|f|f||||||Undecided||2017-02-18 16:43:13.252478|2017-02-18 16:43:13.252478
NCT00297882|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2013-04-28|||July 2006||2006-07-01|April 2013|2013-04-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon|Phase III Clinical Trials of Artemisinin-based Combination Therapy in Cameroon|Completed||Phase 3|900|Actual|Gates Malaria Partnership||2|||f||||t||||||||||2017-02-18 16:43:13.419618|2017-02-18 16:43:13.419618
NCT00297869|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2016-10-04|||January 2005||2005-01-01|October 2016|2016-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Using Informatics to Enhance Care of Older Emergency Department Patients|Computer-Assisted Decision Support to Increase the Safety of Prescribing to Older Emergency Department Patients|Completed||N/A|1350|Actual|Indiana University||2|||f||||f||||||||||2017-02-18 16:43:13.608632|2017-02-18 16:43:13.608632
NCT00297856|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2014-01-09|||March 2006||2006-03-01|January 2014|2014-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine|Open, Prospective Study of the Safety of GSK Biologicals' Boostrix® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) Administered to a Cohort of Adolescents in a US Health Maintenance Organization (HMO)|Completed||N/A|10000|Actual|GlaxoSmithKline|||2||f||||||||||||||2017-02-18 16:43:13.699848|2017-02-18 16:43:13.699848
NCT00297843|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2007-06-18|||March 2006||2006-03-01|June 2007|2007-06-01|May 2006||2006-05-01|||||Observational|||A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions|A Pilot Monocenter Study to Assess the Reproducibility and Specificity of Cellular and Soluble Biomarkers in Nasal Secretions in Patients With Allergic Rhinitis and Healthy Volunteers Following Pollen Exposure in the Fraunhofer Environmental Challenge Chamber (ECC)|Completed||N/A|40||Fraunhofer-Institute of Toxicology and Experimental Medicine|||||f||||||||||||||2017-02-18 16:43:13.819422|2017-02-18 16:43:13.819422
NCT00297830|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2016-07-28|2013-02-15||November 2005||2005-11-01|July 2016|2016-07-01|January 2014|Actual|2014-01-01|April 2010|Actual|2010-04-01||Interventional|CTX|Based on preliminary data that total hip BMD would decrease by 1.5 ± 3.7% on alendronate and increase by 1.0 ± 3.7% on zoledronate, we estimated that 35 subjects per group would provide 80% power and 5% α to detect a 2.5 ± 3.7% difference between randomized groups. Anticipating a 20% dropout, 84 subjects were randomized.|Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation|Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation|Completed||Phase 2/Phase 3|111|Actual|Columbia University|Heart and liver transplant recipients differ in pretransplant bone disease and exposure to prednisone. Not powered to detect differences in fracture rates,an important clinical outcome,one that would require a large comparative effectiveness trial.|2|||f||||f||||||||Undecided||2017-02-18 16:43:13.894808|2017-02-18 16:43:13.894808
NCT00297817|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2016-11-30|||February 2006||2006-02-01|January 2012|2012-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents|A Phase 2, Single-Blind, Controlled, Randomized Study of the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine ± OMV When Administered at an 0-2-6-Month Schedule in Healthy Adolescents 11-18 Years of Age|Completed||Phase 2|203|Actual|Novartis||3|||||||f||||||||||2017-02-18 16:43:14.438476|2017-02-18 16:43:14.438476
NCT00297804|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2009-03-11|||May 2002||2002-05-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|October 2003|Actual|2003-10-01||Interventional|TAXUS VI||A Randomized, Double-Blind Study to Assess Paclitaxel-Eluting Stents in Treatment of Longer Lesions|TAXUS VI - A Randomized, Double-Blind Study to Assess Paclitaxel-Eluting Stents in Treatment of Longer Lesions|Completed||Phase 2/Phase 3|448|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 16:43:14.549319|2017-02-18 16:43:14.549319
NCT00297791|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2013-07-29|||June 2004||2004-06-01|July 2013|2013-07-01|October 2017|Anticipated|2017-10-01|April 2013|Actual|2013-04-01||Interventional|COLORII||COLOR II: Laparoscopic Versus Open Rectal Cancer Removal|A Randomized Clinical Trial Comparing Laparoscopic and Open Surgery for Rectal Cancer.|Active, not recruiting||Phase 3|1100|Anticipated|Nova Scotia Health Authority||1|||f||||t||||||||||2017-02-18 16:43:14.652486|2017-02-18 16:43:14.652486
NCT00297778|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2014-06-03|2009-05-22||March 2006||2006-03-01|April 2014|2014-04-01||||May 2008|Actual|2008-05-01||Interventional|||Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms|A Randomized, Double-blind, Placebo-controlled, Parallel Group Efficacy Study of Pramipexole and Placebo Administered Orally Over a 12 Week Treatment Phase in Parkinson's Disease Patients With Stable Motor Function and Depressive Symptoms|Completed||Phase 4|296|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 16:43:14.803326|2017-02-18 16:43:14.803326
NCT00297765|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2008-08-25|||January 2003||2003-01-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|OPTIMA||Optimizing Prograf® Therapy in Renal Transplant Patients|OPTIMA (Optimizing Prograf® Therapy in Renal Transplant Patients)|Completed||Phase 4|323|Actual|Astellas Pharma Inc||3|||f||||t||||||||||2017-02-18 16:43:20.877296|2017-02-18 16:43:20.877296
NCT00297752|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2009-08-07|||March 2006||2006-03-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|||||Interventional|||Treatment of Facial Burns With Flammacerium Compared to Flammazine and the Impact of Facial Burns on Psychosocial Wellbeing|A Randomised Multicentre Clinical Trial on the Efficacy of Flammacerium in the Treatment of Facial Burns and the Impact of Facial Burns on Psychosocial Wellbeing|Completed||Phase 4|180|Anticipated|Association of Dutch Burn Centres|||||f||||||||||||||2017-02-18 16:43:21.015142|2017-02-18 16:43:21.015142
NCT00297739|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-28|2006-03-15|||January 2003||2003-01-01|March 2006|2006-03-01|April 2005||2005-04-01|||||Interventional|||Risperidone Augmentation for Treatment-Resistant Aggression in ADHD|Risperidone Augmentation for Treatment-Resistant Aggression in ADHD|Completed||Phase 4|25||Armenteros, Jorge L., M.D., P.A.|||||f||||||||||||||2017-02-18 16:43:21.101467|2017-02-18 16:43:21.101467
NCT00297726|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2006-02-27|||October 2004||2004-10-01|February 2006|2006-02-01|April 2006||2006-04-01|||||Interventional|||A Study to Examine the Efficacy of the Arthritis Self Management Program|A Prospective Study to Examine the Efficacy of the Arthritis Self Management Program (ASMP) in Patients With Osteoarthritis (OA) in Alberta|Completed||N/A|64||Alberta Bone and Joint Health Institute|||||f||||||||||||||2017-02-18 16:43:21.191233|2017-02-18 16:43:21.191233
NCT00297713|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2006-12-11|||July 2005||2005-07-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety|A Phase II, Multi-Center, Multi-Dose, Randomized, Open-Label, Parallel Group Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety|Completed||Phase 2|12||Altus Pharmaceuticals|||||||||||||||||||2017-02-18 16:43:21.2738|2017-02-18 16:43:21.2738
NCT00297700|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2017-01-10|||May 2004||2004-05-01|July 2006|2006-07-01|April 2007||2007-04-01|||||Interventional|||Implementing Tobacco Control in Dental Practice|Implementing Tobacco Control in Dental Practice|Unknown status|Active, not recruiting|Phase 3|2800||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:43:21.34914|2017-02-18 16:43:21.34914
NCT00297687|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2007-12-03|||March 2006||2006-03-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults|A Randomized, Placebo-Controlled, Double Blind, Phase 1 Trial of the Safety, Immunogenicity, and Tolerability of Ascending Doses of Meningococcal Group B rLP2086 Vaccine in Healthy Adults|Completed||Phase 1|108||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:43:21.459878|2017-02-18 16:43:21.459878
NCT00297674|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2006-02-27|||June 2004||2004-06-01|July 2004|2004-07-01|December 2005||2005-12-01|||||Interventional|||Intravenous Clarithromycin in Septic Syndrome|Clarithromycin as Immunomodulatory Therapy for the Management of Septic Syndrome by Ventilator-Associated Pneumonia|Completed||Phase 4|200||University of Athens|||||f||||||||||||||2017-02-18 16:43:21.802889|2017-02-18 16:43:21.802889
NCT00297661|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2006-10-19|||April 2003||2003-04-01|February 2006|2006-02-01||||||||Interventional|||Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization|Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization: SIRTAX Trial|Completed||Phase 4|1012||University of Bern|||||f||||||||||||||2017-02-18 16:43:21.911762|2017-02-18 16:43:21.911762
NCT00297648|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2011-08-30|2009-12-10||February 2006||2006-02-01|February 2011|2011-02-01|December 2009|Actual|2009-12-01|January 2008|Actual|2008-01-01||Interventional|MUSIC||Mucosal Healing Study in Crohn's Disease (CD)|A Phase IIIB Multicentre Open Label 54 Weeks Clinical Trial Evaluating Certolizumab Pegol, a PEGylated Fab Fragment of Humanized Antibody to Tumor Necrosis Factor Alpha (TNFα) on Endoscopic and Mucosal Healing in Patients Suffering From Active Crohn's Disease.|Completed||Phase 3|89|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 16:43:22.032864|2017-02-18 16:43:22.032864
NCT00297635|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2017-01-11|||March 2006||2006-03-01|January 2017|2017-01-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Telemetric Glucose Data Acquisition During Initiation of Insulin Pump Therapy||Withdrawn||Phase 2|0|Actual|Thomas Jefferson University||||Decided not to participate in study per Leslie Padron-Massaro|f||||||||||||||2017-02-18 16:43:22.773843|2017-02-18 16:43:22.773843
NCT00297609|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2006-02-27|||January 2002||2002-01-01|February 2006|2006-02-01||||||||Observational|||Prevention of Errors in Resuscitation Medications Orders by Means of a Computerized Physician Order Entry|Prevention of Potential Errors in Resuscitation Medications Orders by Means of a Computerized Physician Order Entry With Clinical Decision Support System in Pediatric Critical Care – a Prospective Cohort Study.|Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:43:22.858502|2017-02-18 16:43:22.858502
NCT00297596|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2013-01-24|2012-11-15||February 2006||2006-02-01|January 2013|2013-01-01|October 2010|Actual|2010-10-01|October 2008|Actual|2008-10-01||Interventional|||Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer|A Phase II Trial of Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer|Completed||Phase 2|25|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:43:22.945232|2017-02-18 16:43:22.945232
NCT00297583|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2009-12-04|||April 2004||2004-04-01|December 2009|2009-12-01||||May 2004|Actual|2004-05-01||Interventional|||Insulin Glulisine in Type 1 Diabetes Mellitus|A Single-center, Randomized, Double-blind, 3-period Cross-over Trial to Compare the Effect of Insulin Glulisine, Insulin Lispro and Unmodified Human Insulin on the Endogenous Glucose Production in Type 1 Diabetic Patients.|Completed||Phase 1|||Sanofi|||||f||||||||||||||2017-02-18 16:43:23.461689|2017-02-18 16:43:23.461689
NCT00297570|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2007-10-07|||February 2006||2006-02-01|October 2007|2007-10-01||||||||Interventional|||Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy||Unknown status|Recruiting|Phase 3|90|Anticipated|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 16:43:23.546978|2017-02-18 16:43:23.546978
NCT00297557|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2006-10-10||||||January 2006|2006-01-01||||||||Observational|||Dual Time Point PET Imaging in Lymphoma||Unknown status|Not yet recruiting|N/A|||Royal Marsden NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:43:23.629319|2017-02-18 16:43:23.629319
NCT00297544|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2006-02-27|||October 2005||2005-10-01|November 2005|2005-11-01||||||||Interventional|||Effect of Sildenafil on Endothelial Function|Effect of Sildenafil on Endothelial Function|Unknown status|Recruiting|N/A|60||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:43:23.687429|2017-02-18 16:43:23.687429
NCT00297531|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2007-05-17|||April 2006||2006-04-01|May 2007|2007-05-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Study of Scaling and Root Planing With PerioWave Versus Scaling and Root Planing Alone in Chronic Periodontitis|Photodynamic Disinfection in Combination With Scaling and Root Planing in the Treatment of Chronic Periodontitis|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Ondine Research Laboratories||2|||f||||||||||||||2017-02-18 16:43:23.785795|2017-02-18 16:43:23.785795
NCT00297518|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2007-05-17|||March 2006||2006-03-01|May 2007|2007-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Study of Scaling and Root Planing (SRP) With PerioWave vs. SRP Alone in Chronic Periodontitis|A Multicenter, Randomized, Examiner Blinded Study of Photoactivated Disinfection With Scaling and Root Planing in the Treatment of Chronic Periodontitis|Completed||Phase 4|40|Actual|Ondine Research Laboratories||2|||f||||||||||||||2017-02-18 16:43:23.899387|2017-02-18 16:43:23.899387
NCT00297505|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2017-01-11|||April 2001||2001-04-01|February 2006|2006-02-01|November 2004||2004-11-01|||||Interventional|||Serotonin, Impulsivity, and Cocaine Dependence Treatment|Serotonin, Impulsivity, and Cocaine Dependence Treatment|Completed||Phase 2|120||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:43:24.006759|2017-02-18 16:43:24.006759
NCT00297492|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2013-09-17|2012-05-31||January 2006||2006-01-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Gradual vs. Abrupt Cessation Treatment for Smoking|Gradual vs. Abrupt Cessation Treatment for Smoking|Completed||Phase 2|750|Actual|University of Vermont|Our projected incidence of abstinence was higher than what was actually observed, leading to lower statistical power than expected.|3|||f||||f||||||||||2017-02-18 16:43:24.106773|2017-02-18 16:43:24.106773
NCT00297479|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2016-10-24|||April 2005||2005-04-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Interventional|||Group Therapy for Nicotine Dependence: Mindfulness and Smoking|Group Therapy for Nicotine Dependence|Completed||N/A|650|Actual|M.D. Anderson Cancer Center||3|||f||||t||||||||||2017-02-18 16:43:24.576215|2017-02-18 16:43:24.576215
NCT00297466|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2017-01-10|||January 2006||2006-01-01|February 2006|2006-02-01|May 2008|Actual|2008-05-01|April 2007|Actual|2007-04-01||Interventional|||Strategies to Help Adult ED Patients Quit Smoking|Strategies to Help Adult ED Patients Quit Smoking|Completed||N/A|336|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:43:24.690568|2017-02-18 16:43:24.690568
NCT00297453|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2012-06-25|||January 2006||2006-01-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Smoking Treatment in HIV Clinical Care Settings||Completed||Phase 3|207|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-02-18 16:43:24.775691|2017-02-18 16:43:24.775691
NCT00297440|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2010-07-22|||March 2006||2006-03-01|July 2010|2010-07-01|August 2011|Anticipated|2011-08-01|August 2009|Actual|2009-08-01||Interventional|||Exercise, Smoking Cessation and Adolescents|Exercise to Aid Smoking Cessation in Adolescent Girls|Unknown status|Active, not recruiting|Phase 1/Phase 2|80|Anticipated|Temple University||2|||f||||f||||||||||2017-02-18 16:43:24.882337|2017-02-18 16:43:24.882337
NCT00297427|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2016-08-31|2016-01-14||October 2005||2005-10-01|August 2016|2016-08-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Acupuncture for Urinary Incontinence|Efficacy of Acupuncture in Treating Urinary Incontinence|Completed||Phase 2|127|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 16:43:25.00246|2017-02-18 16:43:25.00246
NCT00297414|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2012-04-11|||June 2004||2004-06-01|April 2012|2012-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|||An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine|An Analysis of Mortality in Subjects Who Participated in Three Studies of Galantamine in Mild Cognitive Impairment|Completed||Phase 3|1083|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||f||||||||||2017-02-18 16:43:26.203106|2017-02-18 16:43:26.203106
NCT00297401|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2016-08-25||2009-01-30|March 2006||2006-03-01|August 2016|2016-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus|The Effect of Protein Kinase C Inhibition on Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus|Completed||Phase 3|20|Actual|Chromaderm, Inc.||2|||f||||f||||||||||2017-02-18 16:43:26.696859|2017-02-18 16:43:26.696859
NCT00297388|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2011-05-17||||||April 2010|2010-04-01|September 2004|Actual|2004-09-01|||||Interventional|||A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder|A 52-wk Prospective, Randomized, Double-blind, Multicenter Study of Relapse Following Transition From Oral Antipsychotic Medication to 2 Different Doses (25 or 50 mg Every 2 Wks) of Risperidone Long-acting Microspheres (Risperdal� CONSTA�) in Adults With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|40|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:43:26.811135|2017-02-18 16:43:26.811135
NCT00297375|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2011-06-08|||April 2003||2003-04-01|April 2010|2010-04-01|August 2003|Actual|2003-08-01|||||Interventional|||A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine Headache|A Comparison of the Efficacy and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Acute Treatment of Migraine Headache Pain|Completed||Phase 4|375|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 16:43:26.906109|2017-02-18 16:43:26.906109
NCT00297362|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2012-03-23|||June 2004||2004-06-01|March 2012|2012-03-01|October 2005|Actual|2005-10-01|||||Observational|||A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease|Open Observational Study of Galantamine Hydrobromide Administration for the Treatment of Patients With Mild to Moderate Dementia of the Alzheimer Type|Completed||Phase 4|344|Actual|Janssen Cilag Pharmaceutica S.A.C.I., Greece|||1||f||||||||||||||2017-02-18 16:43:27.001136|2017-02-18 16:43:27.001136
NCT00297349|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2010-04-26|||November 2003||2003-11-01|April 2010|2010-04-01|June 2005|Actual|2005-06-01|||||Observational|||A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures|An Open-label Observation Study of Topiramate Administration as Adjuvant Therapy for Focal Epilepsy, Lennox-Gastaut Syndrome Epileptic Seizures and Generalized Tonoclonic Seizures in Adults and Children Aged 2 Years and Older|Completed||N/A|153|Actual|Janssen Cilag Pharmaceutica S.A.C.I., Greece|||1||f||||||||||||||2017-02-18 16:43:27.102533|2017-02-18 16:43:27.102533
NCT00297336|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2010-04-26|||March 2005||2005-03-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|||||Observational|||An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine|An Open-label Observational Safety Study During Administration of Topiramate, for the Prophylaxis of Migraine|Completed||N/A|80|Actual|Janssen Cilag Pharmaceutica S.A.C.I., Greece|||1||f||||||||||||||2017-02-18 16:43:27.21679|2017-02-18 16:43:27.21679
NCT00297323|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2010-04-26|||June 2005||2005-06-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|||||Observational|||An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy|An Open Observational Safety Study During Administration of Topamac, as Monotherapy in Epileptic Patients With no Prior Treatment or Unsuccessfully Treated With Other Antiepileptic Drug|Completed||N/A|80|Actual|Janssen Cilag Pharmaceutica S.A.C.I., Greece|||1||f||||||||||||||2017-02-18 16:43:27.328806|2017-02-18 16:43:27.328806
NCT00297310|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2011-06-06||2011-06-06|May 2004||2004-05-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|October 2006|Actual|2006-10-01||Interventional|||Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation|Pre-transplant Pharmacokinetics as a Predictor of the Tacrolimus Dose Requirement Post Renal Transplantation|Completed||Phase 4|89|Actual|Janssen-Cilag Pty Ltd|||||f||||||||||||||2017-02-18 16:43:27.435783|2017-02-18 16:43:27.435783
NCT00297297|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2010-02-24|||December 2008||2008-12-01|October 2007|2007-10-01|March 2011|Anticipated|2011-03-01|||||Observational|||Improved Preoperative Selection of Cold Thyroid Nodules|Preoperative Selection of Solitary Solid Cold Thyroid Nodules - A Prospective Study on the Value of Sonography, Cytology, Immunostaining and Molecular Profiling|Unknown status|Enrolling by invitation|Phase 3|100|Anticipated|Herlev Hospital|||1||f||||||||||||||2017-02-18 16:43:27.51964|2017-02-18 16:43:27.51964
NCT00297284|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2009-01-27|||February 2006||2006-02-01|September 2006|2006-09-01|February 2007||2007-02-01|||||Interventional|||Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil|Pilot and Feasibility Study of Modafinil Treatment to Improve Cognitive Efficiency in SLE Patients|Terminated||N/A|20||Hospital for Special Surgery, New York|||||f||||||||||||||2017-02-18 16:43:27.61622|2017-02-18 16:43:27.61622
NCT00297271|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2013-11-28|||August 2005||2005-08-01|November 2013|2013-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Prospective Research in Memory Clinics (PRIME)|Prospective Research in Memory Clinics (PRIME)|Completed||Phase 4|970|Actual|Janssen-Cilag Pty Ltd|||1||f||||f||||||||||2017-02-18 16:43:27.718054|2017-02-18 16:43:27.718054
NCT00297258|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2016-01-04|2009-12-02||November 2005||2005-11-01|December 2015|2015-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|||Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma|Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma|Completed||Phase 2|148|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:43:27.846336|2017-02-18 16:43:27.846336
NCT00297245|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2006-02-27|||February 2006||2006-02-01|January 2006|2006-01-01|May 2006||2006-05-01|||||Interventional|||Gastrodin Prevents Cognitive Decline Related to Cardiopulmonary Bypass||Unknown status|Recruiting|Phase 4|200||Huazhong University of Science and Technology|||||f||||||||||||||2017-02-18 16:43:28.325947|2017-02-18 16:43:28.325947
NCT00297232|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2016-06-16|2015-04-21||March 2006||2006-03-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|STRATA||Natalizumab (Tysabri) Re-Initiation of Dosing|An Open-Label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of Natalizumab Following Re-Initiation of Dosing in Multiple Sclerosis Subjects Who Have Completed Study C-1801, C-1802, C-1803, or C-1808 and a Dosing Suspension Safety Evaluation|Terminated||Phase 3|1094|Actual|Biogen|Sponsor decided to terminate the study prior to all subjects reaching Week 480 as the primary objective was deemed to have been met and only approximately 45% of the original STRATA population remained in the study at the time of study termination.|1|||f||||f||||||||||2017-02-18 16:43:28.428652|2017-02-18 16:43:28.428652
NCT00297219|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2009-08-03|||November 2005||2005-11-01|August 2009|2009-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry|The Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry: Prospective, Randomized, Controlled Study|Completed||N/A|457|Actual|Ege University||2|||f||||t||||||||||2017-02-18 16:43:29.401263|2017-02-18 16:43:29.401263
NCT00297206|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2016-10-26|||January 2003||2003-01-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children|An Open-label, Single-dose, Multicenter, Pharmacokinetic, Safety and Tolerability Study of Valaciclovir Oral Suspension in Infants and Children.|Completed||Phase 1|36|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:43:29.518494|2017-02-18 16:43:29.518494
NCT00297193|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2013-08-29|||June 2006||2006-06-01|August 2013|2013-08-01|March 2017|Anticipated|2017-03-01|March 2013|Actual|2013-03-01||Interventional|||ASTIC Autologous Stem Cell Transplantation for Crohn's Disease|Autologous Stem Cell Transplantation for Crohn's Disease: ASTIC|Terminated||Phase 3|45|Actual|European Group for Blood and Marrow Transplantation||2||"For safety reasons the recruitment was halted prematurely. Patients on the trial continute to~   receive treatment and are being followed up as part the protocol."|f||||t||||||||||2017-02-18 16:43:29.629479|2017-02-18 16:43:29.629479
NCT00005461|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1991||1991-04-01|July 2004|2004-07-01|June 2002|Actual|2002-06-01|||||Observational|||Epidemiology of Symptom Perception in Childhood Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.427327|2017-02-18 18:14:57.427327
NCT00297180|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2015-04-14|||January 2006||2006-01-01|April 2015|2015-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks|A Double-Blind, Randomized, Placebo-controlled Study to Evaluate Weight Loss, Safety, Tolerability and Pharmacokinetics in Obese Subjects Following 12-Week Dosing of GW869682, an SGLT2 Inhibitor|Completed||Phase 2|136|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:43:29.768932|2017-02-18 16:43:29.768932
NCT00297167|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2014-02-24|2014-02-24||May 2006||2006-05-01|February 2014|2014-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional||Safety population included all participants who received at least 1 dose of study treatment.|Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency|A Randomized, Double-Blind, Placebo-Controlled, Two-Treatment, Crossover Study to Evaluate the Safety and Efficacy of Eurand Pancreatic Enzyme Product (PEP) in Patients With Cystic Fibrosis and Exocrine Pancreatic Insufficiency|Completed||Phase 3|34|Actual|Forest Laboratories||2|||f||||||||||||||2017-02-18 16:43:29.884328|2017-02-18 16:43:29.884328
NCT00297154|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2010-12-02|||March 2005||2005-03-01|December 2010|2010-12-01||||||||Interventional|||The Effect of Diet and Exercise in Heart Failure|Lifestyle Modification in the Treatment of Heart Failure|Unknown status|Recruiting|N/A|60|Anticipated|Baylor College of Medicine|||||f||||||||||||||2017-02-18 16:43:30.402919|2017-02-18 16:43:30.402919
NCT00297141|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2013-12-30|||October 2004||2004-10-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma|Preoperative Combined Radiochemotherapy for Patients With Newly Diagnosed, Primary Operable and Locally Advanced Rectal Carcinoma (cT3, Nx, M0) of the Lower and Middle Rectum|Completed||Phase 2|60|Actual|Austrian Breast & Colorectal Cancer Study Group||1|||f||||f||||||||||2017-02-18 16:43:30.493702|2017-02-18 16:43:30.493702
NCT00297128|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2011-12-29|||October 2005||2005-10-01|December 2011|2011-12-01|November 2011|Actual|2011-11-01|August 2011|Actual|2011-08-01||Interventional|||Preoperative Chemoradiation With Capecitabine and Cetuximab|Preoperative Chemoradiation With Capecitabine and Cetuximab Within a Multidisciplinary Therapeutic Approach in Patients With Operable T3-T4 Rectal Cancer: a Phase II Study|Completed||Phase 2|31|Actual|Austrian Breast & Colorectal Cancer Study Group||1|||f||||f||||||||||2017-02-18 16:43:30.625209|2017-02-18 16:43:30.625209
NCT00297115|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2016-10-03|2011-03-17||March 2006||2006-03-01|September 2016|2016-09-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)|Effect of Roflumilast on Exacerbation Rate in Patients With COPD. The HERMES Study|Completed||Phase 3|1568|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:43:30.78764|2017-02-18 16:43:30.78764
NCT00297102|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2016-11-29|2011-03-17||February 2006||2006-02-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)|Effect of Roflumilast on Exacerbation Rate in Patients With COPD. The AURA Study|Completed||Phase 3|1523|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 16:43:32.171011|2017-02-18 16:43:32.171011
NCT00297089|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-27|2013-01-29||2011-12-07|November 2006||2006-11-01|January 2013|2013-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer|A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT 751 in Combination With Pemetrexed Versus Pemetrexed Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|165|Actual|AbbVie||2|||f||||f||||||||||2017-02-18 16:43:33.153455|2017-02-18 16:43:33.153455
NCT00297076|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2009-05-15|||July 2005||2005-07-01|May 2009|2009-05-01|October 2007|Anticipated|2007-10-01|October 2007|Anticipated|2007-10-01||Interventional|||Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to Compare the Efficacy and Safety of GW873140 400mg BID in Combination With a Ritonavir-Containing Optimized Background Therapy (OBT) Regimen Versus Placebo Plus OBT Over 48 Weeks.|Terminated||Phase 3|406||GlaxoSmithKline||1|||||||||||||||||2017-02-18 16:43:33.549691|2017-02-18 16:43:33.549691
NCT00297063|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2017-01-16|||January 2006||2006-01-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|||||Interventional|||BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-|Clinical Evaluation of Rosiglitazone Malate (BRL49653C) in Patients With Type 2 Diabetes Mellitus (Monotherapy) - Double-Blind Comparative Study of Rosiglitazone Maleate vs. Pioglitazone Hydrochloride and Placebo -|Completed||Phase 3|350|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:43:33.661942|2017-02-18 16:43:33.661942
NCT00297050|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-25|2017-01-24|||February 23, 2006||2006-02-23|August 5, 2009|2009-08-05|November 14, 2006|Actual|2006-11-14|November 14, 2006|Actual|2006-11-14||Interventional|||Safety and Dose Study of Peramivir for Influenza Treatment|A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Intravenous Peramivir in Healthy Subjects|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:43:33.778965|2017-02-18 16:43:33.778965
NCT00297037|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-09-14|2011-03-01||August 2005||2005-08-01|June 2012|2012-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Pimecrolimus Cream for Oral Lichen Planus|A 6-week Randomized, Double-blind, Vehicle-controlled Pilot Study With a 6-week Open Label Extension to Assess the Efficacy and Safety of Pimecrolimus 1% Cream in the Treatment of Oral Lichen Planus|Completed||Phase 2|21|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 16:43:33.884255|2017-02-18 16:43:33.884255
NCT00297024|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2014-01-03|||February 2005||2005-02-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Radiotherapy - Cerebrovascular Reactivity (RT-CVR Study)|MRI Changes With Administered Oxygen and Carbon Dioxide in Patients With Brain Tumors Receiving Radiotherapy: A Pilot Study|Completed||Phase 2|14|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 16:43:34.301371|2017-02-18 16:43:34.301371
NCT00297011|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2008-04-30|||September 2004||2004-09-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|March 2007|Actual|2007-03-01||Interventional|||Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis|Valacyclovir+Temovate Gel for the Episodic Treatment of Herpes Labialis: A Patient-Initiated Double-Blind, Placebo-Controlled Study, Randomized Study.|Completed||Phase 2|300||University of Utah|||||f||||f||||||||||2017-02-18 16:43:34.401844|2017-02-18 16:43:34.401844
NCT00296985|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2013-11-25|||December 2001||2001-12-01|November 2013|2013-11-01|January 2007|Actual|2007-01-01|January 2005|Actual|2005-01-01||Interventional|||Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery|The Impact of Continuous Flow Cellsaver on Neurocognitive Decline After Cardiac Surgery|Completed||Phase 4|312||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:43:34.501427|2017-02-18 16:43:34.501427
NCT00296972|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2007-04-19|||July 2005||2005-07-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication|A Randomized, Multicenter, phaseIIIB, Two Arm Study Evaluating the Tolerability of Peginterferon Alfa-2a Plus Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection co-Infected With Human Immunodeficiency Virus Receiving HAART Versus Not Receiving HAART|Terminated||Phase 3|100||University Health Network, Toronto||||not funded|f||||||||||||||2017-02-18 16:43:34.58636|2017-02-18 16:43:34.58636
NCT00296959|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2007-09-19|||September 2004||2004-09-01|August 2007|2007-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease|Anti-Dyskinetic Properties of Topiramate: A Double-Blind, Placebo-Controlled Trial in Patients With Parkinson's Disease and Levodopa-Induced Dyskinesias|Terminated||Phase 2|20|Anticipated|University Health Network, Toronto||||early termination due to slow recruitment|f||||||||||||||2017-02-18 16:43:34.68759|2017-02-18 16:43:34.68759
NCT00296946|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2006-11-15|||November 2004||2004-11-01|October 2004|2004-10-01|June 2006||2006-06-01|||||Interventional|||Ipratropium Spray for Drooling Saliva in Parkinson's Disease|Phase II Clinical Trial of Ipratropium Bromide Spray as a Treatment for Sialorrhea in Patients With Parkinson's Disease|Completed||Phase 2|20||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:43:34.786673|2017-02-18 16:43:34.786673
NCT00296933|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2009-02-16|||December 2005||2005-12-01|February 2009|2009-02-01||||||||Interventional|||Memory Functioning and Antidepressant Treatment|Memory Functioning and Antidepressant Treatment: A Randomized Controlled Trial Comparing Escitalopram and Bupropion XL|Completed||Phase 3|60|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:43:34.89147|2017-02-18 16:43:34.89147
NCT00296920|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2009-02-16|||June 2002||2002-06-01|September 2005|2005-09-01||||November 2007|Actual|2007-11-01||Interventional|||Deep Brain Stimulation for Refractory Major Depression|Deep Brain Stimulation for Refractory Major Depression|Completed||Phase 3|10||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:43:35.001212|2017-02-18 16:43:35.001212
NCT00296907|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2012-07-27|||April 2006||2006-04-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Psychological Interventions in Siblings of Children With Cancer|Psychological Interventions in Siblings of Children With Cancer: a Randomized Controlled Study|Completed||N/A|30|Actual|University Children's Hospital, Zurich||1|||f||||||||||||||2017-02-18 16:43:35.105138|2017-02-18 16:43:35.105138
NCT00296894|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2009-02-06|||May 2006||2006-05-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints|TNF-Blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints: Randomized, Double Blind, Placebo-Controlled Cross-Over Study to Evaluate the Efficacy of Adalimumab 40 mg SC Every Other Week in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints|Completed||Phase 2|60|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 16:43:35.217815|2017-02-18 16:43:35.217815
NCT00296881|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2007-05-17|||April 2006||2006-04-01|May 2007|2007-05-01|December 2007|Anticipated|2007-12-01|||||Interventional|||SRP in Combination With PERIOWAVE in Comparison to SRP Alone in Chronic Periodontitis|Clinical Outcomes Following Non-Surgical Treatment of Chronic Periodontitis, Using Scaling and Root Planing (SRP) in Conjunction With PerioWave, Compared to SRP Alone|Unknown status|Active, not recruiting|Phase 4|80|Actual|Ondine Research Laboratories||2|||f||||||||||||||2017-02-18 16:43:35.329198|2017-02-18 16:43:35.329198
NCT00296868|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2006-02-24|||January 2001||2001-01-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Prophylactic Administration of Vitamin C in Wrist Fractures|Prophylactic Administration of Vitamin C in Wrist Fractures; a Randomized Placebo Controlled Multicentre Dose-Finding Study of the Incidence of Complex Regional Pain Syndrome|Completed||Phase 4|300||Stichting Achmea Slachtoffer en Samenleving|||||f||||||||||||||2017-02-18 16:43:35.440402|2017-02-18 16:43:35.440402
NCT00296855|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2010-04-22|||February 2006||2006-02-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease|Intra-individual Open-label Multicenter Comparison Study of Magnetic Resonance Angiography (MRA) With the Blood Pool Contrast Agent Vasovist® and a Conventional Extracellular Contrast Agent With Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients With Peripheral Artery Disease|Completed||Phase 3|261|Actual|Bayer||1|||f||||||||||||||2017-02-18 16:43:35.551715|2017-02-18 16:43:35.551715
NCT00296842|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2011-12-08|||November 2004||2004-11-01|December 2011|2011-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Prevention of Posttraumatic Stress Symptoms and Behavioral Problems in Children After Road Traffic Accidents: a Randomized Controlled Trial|Prevention of Posttraumatic Stress Symptoms and Behavioral Problems in Children and Adolescents After Road Traffic Accidents: a Randomized Controlled Trial|Completed||N/A|99|Actual|University Children's Hospital, Zurich||1|||f||||||||||||||2017-02-18 16:43:35.686903|2017-02-18 16:43:35.686903
NCT00296829|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2014-01-10|||January 2006||2006-01-01|January 2014|2014-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly||Completed||Phase 2|1080||Sanofi|||||f||||f||||||||||2017-02-18 16:43:35.78607|2017-02-18 16:43:35.78607
NCT00296816|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-07-20|2012-06-18||March 2006||2006-03-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|TEACO||TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary|A Pilot Phase II Study Evaluating the Combination of Oxaliplatin and Docetaxel With Bevacizumab as First Line Therapy in Patients With FIGO Stage IB-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Carcinoma|Completed||Phase 2|132|Actual|Sanofi|One site closed prematurely during the study. Every effort was made to collect, at minimum, any outstanding safety data for the participants at this site. As a result, participants from this site were included only in the safety analysis.|1|||f||||f||||||||||2017-02-18 16:43:35.90025|2017-02-18 16:43:35.90025
NCT00296803|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2011-01-10|||November 2005||2005-11-01|January 2011|2011-01-01|August 2006|Actual|2006-08-01|||||Interventional|||PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome|PROCLAIM: Pilot Study Examining Effects of Clopidogrel Compared to Placebo on Markers of Inflammation in Subjects With Metabolic Syndrome|Completed||Phase 4|216||Sanofi|||||f||||||||||||||2017-02-18 16:43:36.618359|2017-02-18 16:43:36.618359
NCT00296790|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2007-10-11|||February 2006||2006-02-01|October 2007|2007-10-01|February 2007||2007-02-01|||||Interventional|||Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)||Completed||Phase 4|372||Sanofi|||||f||||||||||||||2017-02-18 16:43:36.708214|2017-02-18 16:43:36.708214
NCT00296777|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-04-26|||December 2004||2004-12-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|May 2007|Actual|2007-05-01||Interventional|||Treatment of Depression Following Multiple Brain Tests|Medication Treatment Following Neuropsychologic, Dichotic and f-MRI Tests in Depressed Outpatients With Repeat f-MRI Following Treatment|Completed||Phase 4|28|Actual|New York State Psychiatric Institute||3|||f||||f||||||||||2017-02-18 16:43:36.788562|2017-02-18 16:43:36.788562
NCT00296764|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2016-11-29|||February 2006||2006-02-01|November 2016|2016-11-01|September 2020|Anticipated|2020-09-01|September 2020|Anticipated|2020-09-01||Observational|||Characterization of Angelman Syndrome|Angelman Syndrome Natural History Study|Active, not recruiting||N/A|400|Anticipated|University of California, San Diego|||1||f||||f||||||Samples With DNA|"~     Blood and cheek swab samples~   "|No||2017-02-18 16:43:36.915036|2017-02-18 16:43:36.915036
NCT00296751|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2010-06-30|||March 2006||2006-03-01|April 2008|2008-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Epidural Analgesia Versus IV Meperidine for Labor Pain Control|Epidural Analgesia Versus IV Meperidine for Labor Pain Control. Objective Evaluation of the Pain Intensity Influence on the Autonomic Nervous System.|Completed||N/A|60|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:43:37.079819|2017-02-18 16:43:37.079819
NCT00296738|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2011-08-17|||May 2007||2007-05-01|August 2011|2011-08-01|May 2010|Actual|2010-05-01|August 2009|Actual|2009-08-01||Observational|||123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation|Quantitative 123I-MIBG SPECT/CT Assessment of Cardiac Sympathetic Innervation|Completed||Early Phase 1|50|Actual|Rambam Health Care Campus|||1||f||||||||||||||2017-02-18 16:43:37.176967|2017-02-18 16:43:37.176967
NCT00296725|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2012-04-26|||April 1994||1994-04-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Dichotic Listening as a Predictor of Medication Response in Depression|Dichotic Listening as a Predictor of Placebo and Medication Response in Depression|Completed||Phase 4|130|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 16:43:37.27488|2017-02-18 16:43:37.27488
NCT00296712|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2012-04-26|||February 2005||2005-02-01|April 2012|2012-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Are Two Antidepressants a Good Initial Treatment for Depression?|Combined Escitalopram/Bupropion as First Line Treatment for Depression, a Replication.|Completed||Phase 4|55|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 16:43:37.394898|2017-02-18 16:43:37.394898
NCT00296699|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2008-01-14|||March 2005||2005-03-01|January 2008|2008-01-01||||June 2007|Actual|2007-06-01||Interventional|||A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression|A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression|Completed||Phase 4|20|Actual|New York State Psychiatric Institute||1|||f||||||||||||||2017-02-18 16:43:37.518586|2017-02-18 16:43:37.518586
NCT00296686|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-04-26|||September 2001||2001-09-01|April 2012|2012-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression|A Pilot Study of Treatment for Refractory Depression With Sequential Trials of Tranylcypromine, Tranylcypromine Plus Dextroamphetamine, Tranylcypromine Plus Triiodothyronine.|Terminated||Phase 4|31|Actual|New York State Psychiatric Institute||1||Study is no longer funded.|f||||f||||||||||2017-02-18 16:43:37.623063|2017-02-18 16:43:37.623063
NCT00296673|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2006-10-25||||||October 2006|2006-10-01|October 2006||2006-10-01|||||Interventional|||Reactive Neuromuscular Training Effects on Side Bridge Endurance Test||Completed||N/A|20||Logan College of Chiropractic|||||f||||||||||||||2017-02-18 16:43:37.738063|2017-02-18 16:43:37.738063
NCT00296660|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2013-11-18|||June 2006||2006-06-01|November 2013|2013-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Acute HIV Infection Observational Study|Acute HIV-1 Infection Prospective Cohort Study|Completed||N/A|1300|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||||||||||||2017-02-18 16:43:37.815809|2017-02-18 16:43:37.815809
NCT00296647|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2015-10-09|2011-10-21||September 2004||2004-09-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|July 2009|Actual|2009-07-01||Interventional|||Smoking Cessation Intervention: Effectiveness in Primary Care|Tobacco Dependence: Treatment and Outcomes; Pharmacotherapies: Effectiveness in Primary Care|Completed||Phase 4|1346|Actual|University of Wisconsin, Madison|The present study is limited to some extent by the fact that self-reported abstinence was not biochemically confirmed. However, there is evidence that self-reported abstinence rates are generally accurate in low-contact effectiveness studies.|5|||f||||f||||||||||2017-02-18 16:43:37.932728|2017-02-18 16:43:37.932728
NCT00296634|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2010-08-26|||March 2006||2006-03-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||H5 Vaccine Alone or With Adjuvant in Healthy Adults|A Phase I-II, Randomized, Controlled, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine Given Alone or With Aluminum Hydroxide to Healthy Adults|Completed||Phase 1/Phase 2|600|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:43:41.148914|2017-02-18 16:43:41.148914
NCT00296621|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2007-12-20|||February 2006||2006-02-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|February 2008|Anticipated|2008-02-01||Interventional|MDB-GLN||Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy|Efficacy Study of Oral Glutamine Supplementation in Duchenne Muscular Dystrophy|Completed||Phase 2|30|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 16:43:41.257892|2017-02-18 16:43:41.257892
NCT00296608|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2016-05-27|||April 1993||1993-04-01|May 2016|2016-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer|Preoperative Radiotherapy With or Without Concurrent Chemotherapy (5-Fluorouracil and Leucovorin) in T3-4 Rectal Cancers - Randomized Trial|Completed||Phase 3|762|Actual|Federation Francophone de Cancerologie Digestive||2|||f||||f||||||||||2017-02-18 16:43:41.373961|2017-02-18 16:43:41.373961
NCT00296595|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-09-21|||February 2006||2006-02-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of n-3 Polyunsaturated Fatty Acids and Antioxidants on Postprandial Hyperlipidemia and Vascular Function in Men|Physiological Mechanisms Underlying the Effects of PUFA and Antioxidants on Postprandial Lipemia, Oxidative Stress, Endothelial Dysfunction and Inflammation in Men|Completed||Phase 2/Phase 3|99|Actual|Laval University||4|||f||||||||||||||2017-02-18 16:43:41.482147|2017-02-18 16:43:41.482147
NCT00296582|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2011-05-20|||January 2006||2006-01-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Gastric Motor Function Measurement in Dyspepsia and Normal Subjects|Simultaneous Gastric Motor Function Measurement in Dyspepsia And Normal Subjects Ingesting a Solid-Liquid Meal|Completed||N/A|30|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 16:43:41.585878|2017-02-18 16:43:41.585878
NCT00296569|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2014-12-23|||September 2005||2005-09-01|December 2014|2014-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)|A 4-Week, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of MK0686 in Patients With Osteoarthritis of the Knee or Hip|Completed||Phase 2|150|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:43:41.675188|2017-02-18 16:43:41.675188
NCT00296556|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2009-04-27|||February 2006||2006-02-01|April 2009|2009-04-01|March 2008|Actual|2008-03-01|December 2007|Anticipated|2007-12-01||Interventional|||Therapeutic Study of ONO-4819CD for Ulcerative Colitis|A Randomized, Placebo-Controlled Trial of ONO-4819CD for Treatment of Mild to Moderate Ulcerative Colitis.|Terminated||Phase 2|7|Actual|Kyoto University, Graduate School of Medicine||1||terminated|f||||t||||||||||2017-02-18 16:43:41.761769|2017-02-18 16:43:41.761769
NCT00296543|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2011-06-17|||October 2005||2005-10-01|June 2011|2011-06-01|August 2008|Actual|2008-08-01|||||Observational|||T Wave Alternans in Hemodialysis|Pilot Study of a Noninvasive Predictor of Sudden Cardiac Death in Hemodialysis Patients|Completed||N/A|30|Anticipated|Indiana University|||1||f||||||||||||||2017-02-18 16:43:41.873444|2017-02-18 16:43:41.873444
NCT00296530|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2016-10-27|||September 2005||2005-09-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study Of Patients With Allergic Rhinitis And Asthma|A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg QD Versus Montelukast 10mg QD in Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Who Are Receiving ADVAIR DISKUS® 100/50mcg BID or Placebo BID|Completed||Phase 4|600|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:43:41.960897|2017-02-18 16:43:41.960897
NCT00296517|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2009-11-25|2009-03-19||January 2006||2006-01-01|November 2009|2009-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors|Clinical Evaluation of 323U66 SR in Patients With Depression - Placebo-controlled, Double-blind, Comparative Study in Patients With Depression Who Did Not Respond Sufficiently to Selective Serotonin Re-uptake Inhibitors|Completed||Phase 3|325|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:43:42.430197|2017-02-18 16:43:42.430197
NCT00296504|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2013-04-11|2011-09-30||November 2001||2001-11-01|June 2012|2012-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects|An Open-Label Phase III Study to Assess the Long Term Safety Profile of GW433908 Containing Regimens in HIV-1 Infected Subjects|Completed||Phase 3|753|Actual|ViiV Healthcare|||||||||f||||||||||2017-02-18 16:43:44.488203|2017-02-18 16:43:44.488203
NCT00296491|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2016-11-03|2008-10-31||September 2005||2005-09-01|November 2016|2016-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study Of Allergic Rhinitis In Patients Who Also Have Asthma|A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg QD Versus Montelukast 10mg QD in Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Who Are Receiving ADVAIR DISKUS® 100/50mcg BID or Placebo BID|Completed||Phase 4|725|Actual|GlaxoSmithKline||4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:43:49.936723|2017-02-18 16:43:49.936723
NCT00296478|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2011-05-18|||July 2005||2005-07-01|May 2011|2011-05-01|July 2006|Actual|2006-07-01|April 2006|Actual|2006-04-01||Interventional|||Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)|Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)|Completed||Phase 3|1211|Actual|Ferring Pharmaceuticals||3|||f||||||||||||||2017-02-18 16:43:51.337275|2017-02-18 16:43:51.337275
NCT00296465|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2011-05-18|||February 2005||2005-02-01|May 2011|2011-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Administered Intravenously or Subcutaneously (Via Portable Infusion Pump) Compared to Oral Treatment With Clomiphene Citrate in Anovulatory or Oligoovulatory Infertile Females|Completed||Phase 2/Phase 3|132|Actual|Ferring Pharmaceuticals||7|||t||||t||||||||||2017-02-18 16:43:51.434484|2017-02-18 16:43:51.434484
NCT00296452|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2006-02-23|||February 2006||2006-02-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Effect of a Nutritional Supplement on H&N Cancer Patients|The Effect of an Enhanced Nutritional Supplement on Head and Neck Cancer Patients|Unknown status|Recruiting|N/A|40||Edward Hines Jr. VA Hospital|||||f||||||||||||||2017-02-18 16:43:51.549339|2017-02-18 16:43:51.549339
NCT00296439|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2006-02-23|||February 2006||2006-02-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Nutrition Counseling to Lower Serum Phosphorus Levels|Comparison of Different Counseling Methods on Serum Phosphorus Levels in Renal Patients at Hines VA Hospital|Unknown status|Recruiting|N/A|44||Edward Hines Jr. VA Hospital|||||f||||||||||||||2017-02-18 16:43:51.635958|2017-02-18 16:43:51.635958
NCT00005460|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||January 1991||1991-01-01|May 2000|2000-05-01|December 1992|Actual|1992-12-01|||||Observational|||Predictors of Cardiovascular Disease in the Elderly||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.512241|2017-02-18 18:14:57.512241
NCT00296426|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2010-01-13|||May 2006||2006-05-01|January 2010|2010-01-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Interventional|||Implementation and Evaluation of a Medical Reconciliation Protocol at Brigham and Women's Hospital|Implementation and Evaluation of a Medical Reconciliation Protocol|Unknown status|Active, not recruiting|N/A|500|Anticipated|Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 16:43:51.714168|2017-02-18 16:43:51.714168
NCT00296413|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2010-03-15|||February 2006||2006-02-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||A Study to Look at Hormone Levels While on Lamictal or Depakote With or Without an Oral Contraceptive|Variation of Serum Valproate and Lamotrigine Levels in Relation to The Menstrual Cycle and Oral Contraceptive Use|Completed||N/A|48|Anticipated|Beth Israel Deaconess Medical Center|||4||f||||f||||||Samples Without DNA|"~     Serum Samples for hormone testing~   "|||2017-02-18 16:43:51.799062|2017-02-18 16:43:51.799062
NCT00296400|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2011-06-14|2010-03-22||February 2006||2006-02-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|PLANET II||Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease|Randomised, Double-blind, 52-wk, Parallel-grp Multicentre, PIIb Study to Evaluate Effects of Rosuvastatin 10mg, Rosuvastatin 40mg and Atorvastatin 80mg on Urinary Protein Excretion in Hypercholesterolaemic Non-diabetic Patients With Moderate Proteinuria|Completed||Phase 2|237|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:43:51.923267|2017-02-18 16:43:51.923267
NCT00296387|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2007-12-12|||January 2006||2006-01-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome|Comparison of the Effects Noted in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With acUte Coronary Syndrome - CENTAURUS|Completed||Phase 3|1160|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:43:54.739896|2017-02-18 16:43:54.739896
NCT00296374|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2011-08-30|2010-03-03||February 2006||2006-02-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|PLANET 1||Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease|Randomised, Double-blind, 52-wk, Parallel-grp, Multicentre, PIIb Study to Evaluate Effects of Rosuvastatin 10mg, Rosuvastatin 40mg and Atorvastatin 80mg on Urinary Protein Excretion in Hypercholesterolaemic Diabetic Patients With Moderate Proteinuria|Completed||Phase 2|353|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:43:54.956392|2017-02-18 16:43:54.956392
NCT00296361|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2014-08-28|||October 2004||2004-10-01|August 2014|2014-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|RESTORE||To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.|A Multicentre, Randomised, Open Clinical Study to Compare the Efficacy and Safety of a Combination Therapy of Tacrolimus With Sirolimus Versus Tacrolimus With Mycophenolate Mofetil in Kidney Transplantation.|Completed||Phase 3|634|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:43:57.940762|2017-02-18 16:43:57.940762
NCT00296348|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2015-06-25|||November 2005||2005-11-01|June 2015|2015-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|TWIST||Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation|An Open, Randomised, Multicentre Clinical Study to Investigate the Safety and Efficacy of Steroid Withdrawal With Tacrolimus, Mycophenolate Mofetil and Daclizumab Against Tacrolimus, Mycophenolate Mofetil and Steroids in Children After Kidney Transplantation|Completed||Phase 3|198|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:43:58.101253|2017-02-18 16:43:58.101253
NCT00296335|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2014-01-13|2013-11-12||February 2002||2002-02-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|November 2007|Actual|2007-11-01||Interventional||All enrolled patients were included in the analysis.|Trial of Adjuvant Chemotherapy for Gastric Cancer|A Phase III Randomized Controlled Trial of Adjuvant Chemotherapy for Advanced Gastric Adenocarcinoma|Completed||Phase 3|855|Actual|Asan Medical Center||2|||f||||t||||||||||2017-02-18 16:43:58.370236|2017-02-18 16:43:58.370236
NCT00296322|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-24|2013-08-07|2012-07-19||October 2001||2001-10-01|August 2013|2013-08-01|March 2010|Actual|2010-03-01|December 2007|Actual|2007-12-01||Interventional|||Trial of Adjuvant Chemotherapy for Gastric Cancer|A Phase III Randomized Controlled Trial of Adjuvant Chemotherapy for Gastric Adenocarcinoma: Mitomycin and Doxifluridine Versus Intraperitoneal Chemotherapy and Mitomycin, Doxifluridine, and Cisplatin|Completed||Phase 3|528|Actual|Asan Medical Center||2|||f||||f||||||||||2017-02-18 16:43:58.810191|2017-02-18 16:43:58.810191
NCT00296309|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2014-08-28|||October 2004||2004-10-01|August 2014|2014-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|SENIOR||Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.|A Multicentre, Randomised, Open Clinical Study to Compare the Efficacy and Safety of a Combination of Tacrolimus and Mycophenolate Mofetil Based Regimen With or Without Induction in Elderly Recipients Undergoing Kidney Transplantation|Completed||Phase 3|267|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:43:59.213374|2017-02-18 16:43:59.213374
NCT00296296|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2016-11-29|||June 2005||2005-06-01|November 2016|2016-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)|Randomized Open Label Study Comparing the Metabolic Control of Kidney Transplant Recipients With Type 2 Diabetes Receiving Either Prograf or Neoral as Part of a ATG Induction, Prednisone Free and Monitored MMF Immunosuppressive Regimen.|Completed||Phase 4|29|Actual|Stanford University||2|||f||||f||||||||No||2017-02-18 16:43:59.353739|2017-02-18 16:43:59.353739
NCT00296283|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2007-05-22|||August 2005||2005-08-01|May 2007|2007-05-01||||||||Interventional|||Family Workshops for Bipolar Disorder|An Acceptance Based Psychoeducation Intervention to Reduce Expressed Emotion in Family Members of Bipolar Patients|Completed||Phase 1|40|Anticipated|University of Miami|||||f||||||||||||||2017-02-18 16:43:59.480858|2017-02-18 16:43:59.480858
NCT00296270|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2006-02-23|||March 2005||2005-03-01|February 2006|2006-02-01|June 2005||2005-06-01|||||Interventional|||Memory for Flu Facts and Myths and Effects on Vaccine Intentions|"Myths and Facts About the Flu: Health Education Campaigns Can Reduce Vaccination Intentions"|Completed||N/A|175||University of Michigan|||||f||||||||||||||2017-02-18 16:43:59.583516|2017-02-18 16:43:59.583516
NCT00296049|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2017-01-18|||July 2005||2005-07-01|July 2012|2012-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy|An Open-Label, Pilot Study of Daptomycin vs. Vancomycin for Treatment of Gram-Positive Bacteremia in Neutropenic Cancer Patients|Withdrawn||N/A|0|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 16:44:05.784517|2017-02-18 16:44:05.784517
NCT00296257|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2009-03-12|||February 2006||2006-02-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|||||Interventional|||Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114|A Phase 2, Multi-Centre, Randomised, Double Blind, Placebo Controlled Study Evaluating the Efficacy, Safety and Pharmacokinetics of Two Doses of a Candidate Disease Modifying Anti-Rheumatic Drug (DMARD), (SMP-114 120 mg and 240 mg Once Daily), Administered in Combination With Ongoing Methotrexate Treatment in Patients With Active Rheumatoid Arthritis.|Terminated||Phase 2|312|Actual|Dainippon Sumitomo Pharma Europe LTd.|||||f||||t||||||||||2017-02-18 16:43:59.685311|2017-02-18 16:43:59.685311
NCT00296244|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-10-18|2011-07-21||February 2006||2006-02-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Steroid Free Immunosuppression in Liver Transplantation|Steroid Free Immunosuppression in Liver Transplantation|Completed||Phase 4|40|Actual|Thomas Jefferson University||2|||f||||f||||||||||2017-02-18 16:43:59.814652|2017-02-18 16:43:59.814652
NCT00296231|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2010-11-23|2010-10-29||February 2006||2006-02-01|November 2010|2010-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Nasal High Frequency Ventilation in Preterm Infants: A Pilot Study|Nasal High Frequency Ventilation in Preterm Infants: A Pilot Study|Completed||Phase 1|14|Actual|University of Iowa||1|||f||||||||||||||2017-02-18 16:44:03.077853|2017-02-18 16:44:03.077853
NCT00296218|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2009-10-14|||February 2006||2006-02-01|October 2009|2009-10-01||||March 2007|Actual|2007-03-01||Interventional|||ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation|Randomized Comparison of a Two-month Regimen of Irbesartan Versus Enalapril on Cardiovascular Markers in Patients With Acute Coronary Syndrome Without ST Segment Elevation.|Completed||Phase 3|440||Sanofi|||||f||||||||||||||2017-02-18 16:44:03.311539|2017-02-18 16:44:03.311539
NCT00296205|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2009-07-21|||October 2003||2003-10-01|October 2006|2006-10-01|February 2006|Anticipated|2006-02-01|||||Interventional|||Phase II High-Dose Cyclophosphamide for Multiple Sclerosis|Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis|Withdrawn||Phase 2|25|Anticipated|Stony Brook University||||I am changing locations to Johns Hopkins Medical Center|||||||||||||||2017-02-18 16:44:03.415451|2017-02-18 16:44:03.415451
NCT00296192|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2014-09-24|2009-07-30||February 2006||2006-02-01|February 2011|2011-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms|"A Double-Blind, Placebo-Controlled, Parallel-Group, Proof of Concept Trial to Assess the Tolerability, Safety, and Efficacy of Rotigotine Nasal Spray for the Acute Treatment of OFF Symptoms in Subjects With Advanced-Stage, Idiopathic Parkinson Disease"|Completed||Phase 2|82|Actual|UCB Pharma||5|||f||||f||||||||||2017-02-18 16:44:03.526455|2017-02-18 16:44:03.526455
NCT00296179|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2008-07-25|||February 2006||2006-02-01|July 2008|2008-07-01||||June 2007|Actual|2007-06-01||Interventional|||Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro|Comparison of Zolpidem Tartrate Extended-Release vs. Placebo in Treatment of Insomnia Associated With Newly Diagnosed Major Depressive Disorder(MDD) or Untreated MDD Relapse, When Used Concomitantly With Escitalopram|Completed||Phase 4|372||Sanofi|||||f||||||||||||||2017-02-18 16:44:04.940217|2017-02-18 16:44:04.940217
NCT00296166|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2010-09-01|||November 2006||2006-11-01|July 2007|2007-07-01|November 2010|Anticipated|2010-11-01|||||Interventional|||Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation|A Randomized Study That Will Show the Effects of Catheter Ablation Compared to the Effects of Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation.|Terminated||N/A|200|Anticipated|Rigshospitalet, Denmark||2||"Patients with permanent AF are seldomly symptomatic enough to justify intervention. We decided~   to stop inclusion due to low recruitment rate."|f||||t||||||||||2017-02-18 16:44:05.023007|2017-02-18 16:44:05.023007
NCT00296153|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2008-03-10|||February 2006||2006-02-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|November 2006|Actual|2006-11-01||Interventional|||Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment|Omacor; Omega-3-Acid Ethyl Ester 90 (n-3 PUFA) and Risk Factors in HIV Infected Patients Treated With HAART, With Special Focus on Lipids|Completed||Phase 4|51|Actual|Pronova BioPharma||2|||f||||f||||||||||2017-02-18 16:44:05.116|2017-02-18 16:44:05.116
NCT00296140|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2006-02-22||||||February 2006|2006-02-01||||||||Interventional|||Implementing Evidence in the Detection and Treatment of Post Stroke Depression||Unknown status|Not yet recruiting|N/A|||Richard L. Roudebush VA Medical Center|||||f||||||||||||||2017-02-18 16:44:05.228519|2017-02-18 16:44:05.228519
NCT00296127|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2007-02-01|||February 2006||2006-02-01|June 2006|2006-06-01|March 2006||2006-03-01|||||Interventional|||Study of Celecoxib Bioavailability in Healthy Subjects|A Relative Bioavailability Study Of Celecoxib Administered As Capsule Contents Sprinkled On Applesauce In Healthy Adult Volunteers|Completed||Phase 1|24||Pfizer|||||||||||||||||||2017-02-18 16:44:05.30842|2017-02-18 16:44:05.30842
NCT00296114|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2013-04-29|||February 2004||2004-02-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Pancreatic Cancer Serum and DNA Repository|Pancreatic Cancer Serum and DNA Repository|Completed||N/A|690|Actual|Pancreatic Cancer Research Team|||1||f||||||||||Samples With DNA|"~     Whole Blood and Serum Samples~   "|||2017-02-18 16:44:05.389334|2017-02-18 16:44:05.389334
NCT00296101|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2016-08-05|||February 2000||2000-02-01|February 2006|2006-02-01|May 2005|Actual|2005-05-01|||||Interventional|||School-Based Intervention to Increase Physical Activity Among Adolescent Females|Interventions to Increase Adolescent Physical Activity|Completed||N/A|300||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:44:05.500857|2017-02-18 16:44:05.500857
NCT00296088|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2013-07-29|||February 2006||2006-02-01|July 2013|2013-07-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Effects of Obesity on Care and Outcomes in Mechanically Ventilated Individuals in the Intensive Care Unit|A Prospective Observational Study of the Association Between Excess Body Weight and Outcome and Process Measures in Mechanically Ventilated Medical Intensive Care Unit Patients|Terminated||N/A|582|Actual|Ohio State University|||1|PI left institution|f||||||||||||||2017-02-18 16:44:05.587793|2017-02-18 16:44:05.587793
NCT00296062|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-01-13|||March 2006||2006-03-01|January 2012|2012-01-01|May 2011|Actual|2011-05-01|October 2009|Actual|2009-10-01||Interventional|||Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer|Dose-Dense and Dose-Intense Alternating Irinotecan/Capecitabine and Oxaliplatin/Capecitabine: Phase I in Solid Tumors and Phase II With Bevacizumab a First-Line Therapy of Advanced Colorectal Cancer|Terminated||Phase 1|12|Actual|Case Comprehensive Cancer Center||1||Trial did not move to Phase II portion due to poor tolerance of treatment|f||||t||||||||||2017-02-18 16:44:05.671123|2017-02-18 16:44:05.671123
NCT00296036|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2010-11-17|||June 2006||2006-06-01|January 2009|2009-01-01||||June 2010|Actual|2010-06-01||Interventional|||Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer|A Phase III Randomized, Placebo-controlled, Double-blind Trial to Determine the Effectiveness of a Urea/Lactic Acid-Based Topical Keratolytic Agent and Vitamin B-6 for Prevention of Capecitabine-Induced Hand and Foot Syndrome|Completed||Phase 3|132|Anticipated|National Cancer Institute (NCI)||6|||f||||||||||||||2017-02-18 16:44:05.906429|2017-02-18 16:44:05.906429
NCT00296023|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-10-02|||January 1999||1999-01-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer|Low-Dose Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Low Grade Hematologic Malignancies|Completed||N/A|25|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:44:06.635196|2017-02-18 16:44:06.635196
NCT00296010|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2015-08-25|||August 2005||2005-08-01|August 2015|2015-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|CASA||Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer|"Phase III Trial Evaluating the Role of Adjuvant Pegylated Liposomal Doxorubicin (PLD, Caelyx, Doxil) for Women (Age 66 Years or Older) With Endocrine Nonresponsive Breast Cancer Who Are Not Suitable for Being Offered a  Standard Chemotherapy Regimen"|Terminated||Phase 3|77|Actual|International Breast Cancer Study Group||4||Accrual rate was too low|f||||t||||||||||2017-02-18 16:44:06.764717|2017-02-18 16:44:06.764717
NCT00295997|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2014-01-03|||May 2005||2005-05-01|April 2007|2007-04-01||||||||Interventional|||Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia|Non-myeloablative Allogeneic Stem Cell Transplantation With Match Unrelated Donors for Treatment of Hematologic Malignancies and Renal Cell Carcinoma and Aplastic Anemia|Unknown status|Active, not recruiting|N/A|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:44:06.909035|2017-02-18 16:44:06.909035
NCT00295984|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2013-06-18|||March 2006||2006-03-01|August 2006|2006-08-01|August 2006|Actual|2006-08-01|||||Interventional|||Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma|Treatment of Classical Kaposi Sarcoma With Nicotine Dermal Patch: A Phase II Trial|Completed||Phase 2|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:44:07.015294|2017-02-18 16:44:07.015294
NCT00295971|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-11-08|||April 2005||2005-04-01|November 2012|2012-11-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease|Stem Cell Enriched, T Cell Depleted Haplocompatible Peripheral Blood Transplantation for Children With Myelodysplastic Disease, Leukemia, Marrow Failure Syndromes, or Severe Immunodeficiency Diseases|Completed||Phase 1|21|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:44:07.11207|2017-02-18 16:44:07.11207
NCT00295958|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-06-12|||December 2005||2005-12-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|June 2006|Actual|2006-06-01||Interventional|||LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery|Phase II Evaluation of Peptide Immunization and LMB-2 in Metastatic Melanoma|Completed||Phase 2|26|Actual|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 16:44:07.22955|2017-02-18 16:44:07.22955
NCT00295945|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2014-05-19|||March 2005||2005-03-01|May 2014|2014-05-01|December 2009|Actual|2009-12-01|April 2008|Actual|2008-04-01||Observational|||Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer|Outcomes of Perioperative Epidural Analgesia in Gynecologic Oncology Patients: A Parallel Prospective Cohort and Randomized Clinical Study|Completed||N/A|240|Actual|University of California, San Francisco|||2||f||||||||||||||2017-02-18 16:44:07.519156|2017-02-18 16:44:07.519156
NCT00295932|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2016-09-26|||December 2005||2005-12-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|A Phase II Study of the Novel Proteasome Inhibitor Bortezomib in Combination With Rituximab, Cyclophosphamide and Prednisone in Patients With Relapsed/Refractory Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)|Active, not recruiting||Phase 1/Phase 2|117|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 16:44:07.644758|2017-02-18 16:44:07.644758
NCT00295919|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2016-02-11|||December 2005||2005-12-01|February 2016|2016-02-01|May 2015|Actual|2015-05-01|March 2014|Actual|2014-03-01||Interventional|||N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma|Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder in Patients With Recurrent or Resistant Neuroblastoma|Completed||Phase 1|68|Anticipated|Children's Hospital Los Angeles||1|||f||||t||||||||||2017-02-18 16:44:07.780249|2017-02-18 16:44:07.780249
NCT00295906|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2013-12-17|||June 2004||2004-06-01|November 2008|2008-11-01||||January 2008|Anticipated|2008-01-01||Interventional|||Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control|Efficacy of Web-Based Instruction on Skin Cancer Triage|Unknown status|Recruiting|N/A|4550|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:44:07.908066|2017-02-18 16:44:07.908066
NCT00295893|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2017-02-10|||September 2005||2005-09-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer|Randomized Phase II Study of Docetaxel, Adriamycin, and Cytoxan (TAC) Versus Adriamycin/Cytoxan, Followed by Abraxane/Carboplatin (ACAC) +/- Trastuzumab as Neoadjuvant Therapy for Patients With Stage II-III Breast Cancer|Active, not recruiting||Phase 2|105|Anticipated|City of Hope Medical Center||3|||f||||t||||||||||2017-02-18 16:44:08.00708|2017-02-18 16:44:08.00708
NCT00295880|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-11-06|2009-03-25||June 2005||2005-06-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer|A Phase I/II Study of Double Unit Umbilical Cord Blood (UCB) Transplantation Utilizing Graft Administration Via Intra-Bone Marrow Injection (Companion Protocol to MT2000-25)|Terminated||Phase 1/Phase 2|12|Actual|Masonic Cancer Center, University of Minnesota|This study was terminated early based on interim statistical analysis that indicated time to engraftment will not be improved compared to historical controls. While safe, lack of faster marrow recovery supports early discontinuation.|1||Time to engraftment would not be improved compared to historical controls.|f||||t||||||||||2017-02-18 16:44:08.138651|2017-02-18 16:44:08.138651
NCT00295867|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2012-10-09|||December 2005||2005-12-01|October 2012|2012-10-01|December 2013|Anticipated|2013-12-01|June 2011|Actual|2011-06-01||Interventional|||Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer|Pilot Study to Evaluate the Effect of Zoledronic Acid (Zometa) on Occult Malignant Bone Marrow Cells in Patients With High Risk Early Stage Breast Cancer|Unknown status|Active, not recruiting|N/A|45|Anticipated|University of California, San Francisco||1|||f||||||||||||||2017-02-18 16:44:08.445594|2017-02-18 16:44:08.445594
NCT00295854|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2011-12-16|2011-02-16||May 2005||2005-05-01|December 2011|2011-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis|A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis|Completed||Phase 2|296|Actual|MediciNova||2|||f||||t||||||||||2017-02-18 16:44:08.554648|2017-02-18 16:44:08.554648
NCT00295841|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2015-09-22|||February 2005||2005-02-01|September 2015|2015-09-01||||November 2008|Actual|2008-11-01||Interventional|||Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|A Phase I Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 1|53|Actual|Wake Forest University Health Sciences||1|||f||||t||||||||||2017-02-18 16:44:09.057859|2017-02-18 16:44:09.057859
NCT00295828|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2008-09-03|||January 2006||2006-01-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Pilot Study for the Treatment of Iris Neovascularization With Macugen|A Pilot Study for the Treatment of Iris Neovascularization With Macugen|Completed||Phase 1|10|Actual|Hermann Eye Center||2|||f||||f||||||||||2017-02-18 16:44:09.273524|2017-02-18 16:44:09.273524
NCT00295815|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2016-11-21|||January 2006||2006-01-01|November 2016|2016-11-01|May 2014|Actual|2014-05-01|August 2007|Actual|2007-08-01||Interventional|||Enzastaurin Versus Lomustine in Glioblastoma|Randomized Phase 3 Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma|Completed||Phase 3|397|Actual|Eli Lilly and Company||2|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 16:44:09.392834|2017-02-18 16:44:09.392834
NCT00295802|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2014-02-06|||April 2006||2006-04-01|February 2014|2014-02-01|September 2014|Anticipated|2014-09-01|August 2012|Actual|2012-08-01||Interventional|||Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer|Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|141|Actual|EDAP TMS S.A.||2|||f||||f||||||||||2017-02-18 16:44:09.609468|2017-02-18 16:44:09.609468
NCT00295789|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2016-09-20|||February 2006||2006-02-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)|A Randomized Phase III Trial of Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Carboplatin in Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)|Completed||Phase 3|253|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 16:44:09.906062|2017-02-18 16:44:09.906062
NCT00295776|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2013-03-11|||February 2005||2005-02-01|February 2005|2005-02-01||||December 2007|Actual|2007-12-01||Interventional|||Lamictal in the Treatment of Post-Herpetic Neuralgia|Lamictal in the Treatment of Post-Herpetic Neuralgia-A Safety, Efficacy,Randomized, Double Blind, Placebo Controlled, Cross-Over Study|Terminated||Phase 2/Phase 3|||George Washington University||||enrollment difficult due to inclusion/exclusion criteria/protocol requirements|f||||||||||||||2017-02-18 16:44:10.055914|2017-02-18 16:44:10.055914
NCT00295763|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2015-03-17|||May 2006||2006-05-01|March 2015|2015-03-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.|Follow-up of Thyroid Cancer Patients From Study THYR-008-00 Who Received Thyroid Remnant Ablation Using Either the Hypothyroid or the Thyrogen Method.|Completed||Phase 3|61|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:44:10.148743|2017-02-18 16:44:10.148743
NCT00295750|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2012-12-17|2009-01-05||February 2006||2006-02-01|December 2012|2012-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer|An Open-label, Multi-Centre, Randomized, Parallel-group Study, Investigating the Efficacy and Safety of Degarelix One Month Dosing Regimens; 160 mg (40 mg/ml) and 80 mg (20mg/ml), in Comparison to LUPRON DEPOT® 7.5 mg in Patients With Prostate Cancer Requiring Androgen Ablation Therapy|Completed||Phase 3|620|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-02-18 16:44:10.276076|2017-02-18 16:44:10.276076
NCT00295737|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2008-01-15|||February 2006||2006-02-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma|05/04 IMHOTEP-1 FHG: Ex Vivo Effect of an Immunotoxin on Activated Human Macrophages From Atopics After Segmental Instillation of Allergen and Endotoxin|Terminated||N/A|8|Actual|Fraunhofer-Institute of Toxicology and Experimental Medicine||||proof of mechanism achieved with fewer subjects than anticipated|f||||||||||||||2017-02-18 16:44:12.034106|2017-02-18 16:44:12.034106
NCT00295724|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2007-01-26|||October 2005||2005-10-01|January 2007|2007-01-01||||||||Interventional|||Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain|A Multi-Center, Double-Blind, Placebo-Controlled Randomized Study of Bicifadine 200 mg BID in the Treatment of Chronic Low Back Pain|Completed||Phase 3|||DOV Pharmaceutical, Inc.|||||f||||||||||||||2017-02-18 16:44:12.115693|2017-02-18 16:44:12.115693
NCT00295711|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2006-06-22|||September 2004||2004-09-01|June 2006|2006-06-01||||||||Interventional|||Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain|A Multi-Center Double-Blind, Placebo-Controlled Randomized Study of Bicifadine 200 Mg BID, Bicifadine 300 Mg BID, and Bicifadine 400 Mg BID in the Treatment of Chronic Low Back Pain|Completed||Phase 3|532||DOV Pharmaceutical, Inc.|||||||||||||||||||2017-02-18 16:44:12.18734|2017-02-18 16:44:12.18734
NCT00295685|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2009-02-24|||October 2005||2005-10-01|February 2009|2009-02-01|December 2007||2007-12-01|||||Interventional|||Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD|Single Dose Nexium 40MG QAM vs Lansoprazole 30mg BID for Control of Symptomatic GERD-A Double Blind Cross-Over Study|Completed||Phase 4|50|Anticipated|Digestive & Liver Disease Specialists|||||||||||||||||||2017-02-18 16:44:12.448633|2017-02-18 16:44:12.448633
NCT00295672|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2009-07-24|||February 2006||2006-02-01|July 2009|2009-07-01|June 2007|Actual|2007-06-01|||||Interventional|VINCR||Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.|Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy With Cisplatin-docetaxel in Patients With Locally Advanced Non-small-cell Lung Cancer. A Multicenter Phase II Trial|Completed||Phase 2|60|Anticipated|University Hospital, Brest|||||f||||f||||||||||2017-02-18 16:44:12.534744|2017-02-18 16:44:12.534744
NCT00295659|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2006-10-17|||January 2001||2001-01-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Observational|||An RCT to Evaluate Incidence, Cost and Clinical Outcomes Using 75 vs 100g. Screening Methods for Gestational Diabetes|What is the Optimal Method for Screening and Diagnosis of Gestational Diabetes? An RCT to Evaluate Incidence, Cost-Effectiveness and Clinical Outcomes Using Three Methods|Completed||N/A|5800||Canadian Diabetes Association|||||f||||||||||||||2017-02-18 16:44:12.643961|2017-02-18 16:44:12.643961
NCT00295646|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2015-08-03|||June 1999||1999-06-01|August 2015|2015-08-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid|Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid, in Premenopausal, Hormone Receptor-positive Breast Cancer Patients (Stage I, II)|Active, not recruiting||Phase 3|1803|Actual|Austrian Breast & Colorectal Cancer Study Group||4|||f||||t||||||||||2017-02-18 16:44:12.752673|2017-02-18 16:44:12.752673
NCT00295633|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2015-03-18|2009-08-17||March 2006||2006-03-01|March 2015|2015-03-01|October 2008|Actual|2008-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone|A Multicenter, Randomized, Double Blind, Placebo Controlled, Phase III Trial to Evaluate the Efficacy and Safety of Saxagliptin (BMS477118) in Combination With Thiazolidinedione Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Thiazolidinedione Therapy Alone|Completed||Phase 3|565|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:44:13.11707|2017-02-18 16:44:13.11707
NCT00295620|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2016-12-12|||March 2004||2004-03-01|December 2016|2016-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|SALSA||Secondary Adjuvant Long Term Study With Arimidex|A Prospective, Randomized, Open, Multicentre Phase III-study to Assess the Efficacy of Secondary Adjuvant Endocrine Anastrozole Therapy for 2 Further Yrs vs 5 Further Yrs in Patients With HR +ve Breast Cancer After 5-yr Primary Adjuvant Endocrine Therapy|Active, not recruiting||Phase 3|3500|Anticipated|AstraZeneca||2|||f||||t||||||||||2017-02-18 16:44:13.983678|2017-02-18 16:44:13.983678
NCT00295607|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2013-04-09|||June 2005||2005-06-01|September 2011|2011-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|CHASE||Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients|Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in HCV Positive in Liver Transplantation|Completed||Phase 2|138|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:44:14.13774|2017-02-18 16:44:14.13774
NCT00295594|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2014-08-25|||March 2005||2005-03-01|August 2014|2014-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|MARSILEA||Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.|An Open, Randomised, Multicenter, Clinical Study to Compare the Safety and Efficacy of Tacrolimus and Minimal Steroids in Combination With Either a Monoclonal Anti-IL2R Antibody (Daclizumab) or Mycophenolate Mofetil in Liver Allograft Transplantation.|Completed||Phase 3|627|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:44:14.282927|2017-02-18 16:44:14.282927
NCT00295581|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2017-01-24|||March 7, 2005||2005-03-07|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Interventional|||PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria|Phase 1 Study of the Safety and Immunogenicity of PpPfs25/ISA51 and ScPvs25/ISA51: Transmission Blocking Vaccines for Plasmodium Falciparum and Plasmodium Vivax Malaria|Completed||Phase 1|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:44:14.43476|2017-02-18 16:44:14.43476
NCT00295568|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-23|2017-01-24|||February 17, 2006||2006-02-17|January 12, 2009|2009-01-12|January 12, 2009||2009-01-12|||||Observational|||Interaction of Right and Left Brain Hemispheres in Learning Precision Hand Movements|Contribution of Interhemispheric Inhibition to Motor Learning|Completed||N/A|46||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:44:14.521657|2017-02-18 16:44:14.521657
NCT00295555|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2007-05-08|||January 2004||2004-01-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy|Effects of Doxazosin on Ambulatory Blood Pressure and Sympathetic Nervous Activity in Hypertensive Patients With Diabetic Nephropathy|Completed||Phase 4|98|Actual|Yokohama City University Medical Center||1|||f||||t||||||||||2017-02-18 16:44:14.629887|2017-02-18 16:44:14.629887
NCT00295542|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2009-04-27|||March 2000||2000-03-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|MAPEC||Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy|Prognostic Value of Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy in Relation to Risk (the MAPEC Study).|Completed||Phase 4|3344|Actual|University of Vigo||2|||f||||t||||||||||2017-02-18 16:44:14.740894|2017-02-18 16:44:14.740894
NCT00295529|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2014-12-03|||April 2005||2005-04-01|December 2014|2014-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians|GenetiKiT: Evaluation of the Impact of a Multifaceted Intervention to Enhance the Delivery of Genetics Services by Family Physicians.|Completed||N/A|125|Actual|University of Toronto||2|||f||||f||||||||||2017-02-18 16:44:14.885124|2017-02-18 16:44:14.885124
NCT00295516|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2006-05-19|||October 2000||2000-10-01|February 2006|2006-02-01|August 2004||2004-08-01|||||Interventional|||Doppler or Amniocentesis to Predict Fetal Anemia|Minimally Invasive Management of Rh Alloimmunization: Can Amniotic Fluid DeltaOD450 Measurements Be Replaced by Doppler Studies?|Completed||Phase 3|157||University of Toronto|||||f||||||||||||||2017-02-18 16:44:15.037566|2017-02-18 16:44:15.037566
NCT00295503|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2016-11-04|2013-10-18||February 2006||2006-02-01|November 2016|2016-11-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional||one patient excluded due to ineligibility. That patient is included in the toxicity analysis|Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma|A Phase II Trial of Cisplatin, Pemetrexed and Bevacizumab in Untreated Malignant Mesothelioma|Completed||Phase 2|53|Actual|University of Texas Southwestern Medical Center||1|||f||||t||||||||||2017-02-18 16:44:15.307278|2017-02-18 16:44:15.307278
NCT00295490|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2011-09-09|2009-06-19||December 2004||2004-12-01|September 2011|2011-09-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Trial Evaluating Devil's Claw for the Treatment of Hip and Knee Osteoarthritis|A Randomized, Double-blind, Placebo-controlled, Dose-ranging Two- Centre Study to Evaluate the Efficacy and Safety of Devil's Claw in the Treatment of Knee and Hip Osteoarthritis|Terminated||Phase 2|67|Actual|University of Southampton||4||unexpected withdrawal of funding|f||||f||||||||||2017-02-18 16:44:15.607572|2017-02-18 16:44:15.607572
NCT00295477|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2016-08-17|||January 2006||2006-01-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|September 2020|Anticipated|2020-09-01||Interventional|||Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV|A Phase I/II, Open-label, Single Center Study to Evaluate the Tolerability, Trafficking and Therapeutic Effects of Repeated Doses of Autologous T Cells Transduced With VRX496 in HIV Infected Subjects|Active, not recruiting||Phase 1/Phase 2|25|Anticipated|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 16:44:16.362008|2017-02-18 16:44:16.362008
NCT00295464|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-05-01|||May 2001||2001-05-01|February 2006|2006-02-01||||||||Interventional|||Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth|Randomized Trial on Efficacy and Safety of the Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth (ACG Trial)|Terminated||Phase 4|440||University of Oulu|||||f||||||||||||||2017-02-18 16:44:16.463111|2017-02-18 16:44:16.463111
NCT00295438|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2016-09-14|||February 2006||2006-02-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Robot-based Tele-echography II - A Comparative Study|Robot-based Tele-echography II - A Comparative Study Using Two Echographic Modalities for Diagnosis of Thoracoabdominal Injuries at the Trauma Center of the Grenoble University Hospital.|Terminated||N/A|18|Actual|University Hospital, Grenoble||2||"No diagnosis of visceral lesion was placed on 18 included patients. The study is thus stopped~   prematurely for ethical reasons."|f||||t||||||||||2017-02-18 16:44:16.758399|2017-02-18 16:44:16.758399
NCT00295425|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2006-10-04|||May 2000||2000-05-01|October 2006|2006-10-01|October 2006||2006-10-01|||||Interventional|||CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.|Open, Multicenter, Randomized Clinical Trial in Patients With Moderate-Severe Psoriasis (PASI > 10) to Compare the Efficacy of Mycophenolate Mofetil Versus Cyclosporine A.|Unknown status|Active, not recruiting|Phase 2|50||University Hospital Muenster|||||f||||||||||||||2017-02-18 16:44:16.874486|2017-02-18 16:44:16.874486
NCT00295412|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-02-21||||||September 2005|2005-09-01||||||||Interventional|||The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients|The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients|Completed||Phase 4|||Université de Montréal|||||f||||||||||||||2017-02-18 16:44:16.982566|2017-02-18 16:44:16.982566
NCT00295399|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2008-08-11||||||August 2008|2008-08-01||||||||Interventional|||Telerehabilitation for the Hand and Arm After Stroke and Traumatic Brain Injury||Unknown status|Not yet recruiting|N/A|||Ono Academic College|||||f||||||||||||||2017-02-18 16:44:17.073427|2017-02-18 16:44:17.073427
NCT00295386|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2009-01-02|||January 2004||2004-01-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|January 2006|Actual|2006-01-01||Interventional|||Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the Elderly||Completed||Phase 4|||University of Bergen|||||f||||||||||||||2017-02-18 16:44:17.169385|2017-02-18 16:44:17.169385
NCT00295373|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2007-04-19|||February 2006||2006-02-01|April 2007|2007-04-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy?|Phase 4 Clinical Trial to Examine the Role of Rosuvastatin and Exercise Treatment in Modulating Inflammatory Response in Hypercholesterolemic Subjects|Unknown status|Active, not recruiting|Phase 4|48||Purdue University|||||f||||||||||||||2017-02-18 16:44:17.253249|2017-02-18 16:44:17.253249
NCT00295360|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-02-22|||June 2003||2003-06-01|March 2005|2005-03-01|August 2004||2004-08-01|||||Observational|||Expression of BCRP in Icteric Patients|Influence of Cholestasis on Intestinal BCRP Expression|Completed||N/A|40||University Hospital, Basel, Switzerland|||||f||||||||||||||2017-02-18 16:44:17.361521|2017-02-18 16:44:17.361521
NCT00295347|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2008-06-09|||December 2005||2005-12-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Mineralocorticoid Receptor in the Treatment of Severe Depression|Mineralocorticoid Receptor in the Treatment of Severe Depression: A Randomized, Double Blind, and Placebo Controlled Trial|Completed||N/A|65|Anticipated|Universitätsklinikum Hamburg-Eppendorf|||||f||||||||||||||2017-02-18 16:44:17.447737|2017-02-18 16:44:17.447737
NCT00295334|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-09-11|||February 2006||2006-02-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Moderate Alcohol Intake Among Patients With Type 2 Diabetes||Unknown status|Active, not recruiting|Phase 2|100||The S. Daniel Abraham International Center for Health and Nutrition|||||f||||||||||||||2017-02-18 16:44:17.540484|2017-02-18 16:44:17.540484
NCT00295308|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2017-01-24|||November 8, 2005||2005-11-08|September 17, 2014|2014-09-17|July 30, 2014|Actual|2014-07-30|||||Interventional|||Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients|Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients|Completed||Phase 1|300|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:44:17.630106|2017-02-18 16:44:17.630106
NCT00295295|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2013-06-19|||September 2004||2004-09-01|May 2013|2013-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Vibration Intervention to Improve Bone and Muscle in Children With Cerebral Palsy|Mechanical Intervention in Children With Cerebral Palsy|Completed||Phase 2|34||Children's Hospital Los Angeles||2|||f||||||||||||||2017-02-18 16:44:17.736269|2017-02-18 16:44:17.736269
NCT00295282|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2010-04-22|||January 2006||2006-01-01|April 2010|2010-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis|A Phase I, Multicenter, Dose-escalation Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Patients With Active Ulcerative Colitis|Completed||Phase 1|24|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 16:44:17.847845|2017-02-18 16:44:17.847845
NCT00005459|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||September 2000||2000-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.592951|2017-02-18 18:14:57.592951
NCT00295269|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-05-08|||March 1997||1997-03-01|April 2006|2006-04-01|September 2005||2005-09-01|||||Interventional|||Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome|Late Steroid Rescue Study (LaSRS): The Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome|Completed||Phase 3|200||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:44:17.967355|2017-02-18 16:44:17.967355
NCT00295256|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2006-09-13|||February 2006||2006-02-01|September 2006|2006-09-01|October 2007||2007-10-01|||||Interventional|||Randomized Trial to Evaluate the Effectiveness of Nurse Case Management|Randomized Trial to Evaluate the Effectiveness of Nurse Case Management on High-Risk Pregnancy Outcomes|Unknown status|Recruiting|N/A|100||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:44:18.069635|2017-02-18 16:44:18.069635
NCT00295243|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2011-01-12|||September 2004||2004-09-01|January 2011|2011-01-01|November 2006|Actual|2006-11-01|||||Interventional|||Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies|A Phase I Trial of the Dual Kinase Inhibitor GW572016 in Combination With Topotecan in Patients With Advanced Solid Malignancies|Completed||Phase 1|25|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 16:44:18.162199|2017-02-18 16:44:18.162199
NCT00295230|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2007-11-06|||February 2006||2006-02-01|November 2007|2007-11-01|September 2007|Anticipated|2007-09-01|||||Observational|||Effects of Volume Guarantee With Pressure Supported vs. Synchronized Intermittent Mandatory Ventilation in VLBW Infants|The Effects of Volume Guarantee Combined With Pressure Supported Ventilation (PSV+VG) Versus Synchronized Intermittent Mandatory Ventilation (SIMV+VG) in Very Low Birth Weight Infants|Suspended||Phase 1|16|Anticipated|Children's Hospitals and Clinics of Minnesota|||1|suboptimal enrollment after 18 months.|f||||||||||||||2017-02-18 16:44:18.260841|2017-02-18 16:44:18.260841
NCT00295217|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2009-01-13|||February 2006||2006-02-01|January 2009|2009-01-01|October 2006||2006-10-01|||||Interventional|||MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation|MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Clinical Study to Validate the Changes to ExAblate 2000 Device|Completed||Phase 3|15||InSightec|||||||||||||||||||2017-02-18 16:44:18.368713|2017-02-18 16:44:18.368713
NCT00295204|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-08-02|||April 2005||2005-04-01|February 2006|2006-02-01|October 2006||2006-10-01|||||Observational|||Evaluation of a Mobile Cardiac Outpatient Telemetry System Versus Standard Loop Event Monitor|Evaluation of a Mobile Cardiac Outpatient Telemetry System (CardioNet) Versus Standard Loop Event Monitor: A Multi-Center Randomized Study|Unknown status|Active, not recruiting|N/A|300||Cardionet|||||f||||||||||||||2017-02-18 16:44:18.479043|2017-02-18 16:44:18.479043
NCT00295191|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-22|2011-10-03|||November 2005||2005-11-01|October 2011|2011-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)|Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Prospective, Randomized, Controlled Study|Completed||Phase 4|704|Actual|Ege University||4|||f||||t||||||||||2017-02-18 16:44:18.570807|2017-02-18 16:44:18.570807
NCT00295178|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2016-10-10|||February 2006||2006-02-01|October 2016|2016-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas|A Multicenter, Randomized Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in the Treatment of Cellulitis or Erysipelas|Completed||Phase 4|80||Cubist Pharmaceuticals LLC|||||f||||||||||||||2017-02-18 16:44:18.687143|2017-02-18 16:44:18.687143
NCT00295165|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2013-12-02|||January 2006||2006-01-01|December 2013|2013-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease|Randomized, Double-Blind, Placebo-Controlled, Phase 3 Induction Study to Assess the Efficacy and Safety of 6µg Sargramostim (Leukine) Administered Subcutaneously Once Daily for 8 Weeks in Patients With Active Crohn's Disease|Terminated||Phase 3|33|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:44:18.780356|2017-02-18 16:44:18.780356
NCT00295152|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2011-11-16|||April 2001||2001-04-01|February 2006|2006-02-01|February 2005||2005-02-01|||||Interventional|||Effects of Community Occupational Therapy in Older Patients With Dementia and Their Caregivers.|Effects of Community Occupational Therapy on the Daily Performance of Older Patients With Mild to Moderate Dementia and on the Sense of Competence of Their Primary Caregivers.|Unknown status|Active, not recruiting|N/A|135||Radboud University|||||f||||||||||||||2017-02-18 16:44:19.105318|2017-02-18 16:44:19.105318
NCT00295139|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-19|2009-12-17|||January 2005||2005-01-01|December 2009|2009-12-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients|Behavioral Treatment of Drug Abuse in SPMI Patients|Unknown status|Active, not recruiting|Phase 2|307|Anticipated|University of Maryland||3|||f||||f||||||||||2017-02-18 16:44:19.206436|2017-02-18 16:44:19.206436
NCT00295126|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2008-03-11|||May 2003||2003-05-01|March 2008|2008-03-01|November 2007|Actual|2007-11-01|||||Interventional|||REPI : a Randomized Open Label Trial Evaluating the Use of APC in Pre-Implantation Reconstruction of Maxilla|Use of Autologous Platelet Concentrate in Pre-Implantation Reconstruction of Maxilla.|Terminated||Phase 2/Phase 3|20||University Hospital, Grenoble||1|||f||||f||||||||||2017-02-18 16:44:19.324218|2017-02-18 16:44:19.324218
NCT00295113|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-28|||November 2001||2001-11-01|November 2007|2007-11-01|June 2003||2003-06-01|||||Interventional|||Interest of a 30 Minutes' Intermittent Work Exercise Test in Patients With Chronic Obstructive Pulmonary Disease: Cardiac and Pulmonary Functions|Interest of a 30 Minutes' Intermittent Work Exercise Test in Patients With Chronic Obstructive Pulmonary Disease: Cardiac and Pulmonary Functions|Completed||N/A|10|Actual|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 16:44:19.418535|2017-02-18 16:44:19.418535
NCT00295100|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2007-06-20|||September 2000||2000-09-01|June 2007|2007-06-01|July 2006||2006-07-01|||||Interventional|||Tamoxifen-MRI Study|Cancer Risk and Biomarkers of Tamoxifen Chemoprevention|Completed||Phase 2|78||University of Pennsylvania|||||f||||||||||||||2017-02-18 16:44:19.513173|2017-02-18 16:44:19.513173
NCT00295087|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2014-12-05|||November 2005||2005-11-01|December 2014|2014-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||X-Chromosome Inactivation Status and Premature Ovarian Failure|X-Chromosome Inactivation Status and Premature Ovarian Failure|Completed||N/A|13|Actual|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     DNA that is extracted from the blood specimen~   "|||2017-02-18 16:44:19.625179|2017-02-18 16:44:19.625179
NCT00295061|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2014-08-28|2009-08-28||May 2006||2006-05-01|August 2014|2014-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|ChAMP||Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults|Multi-center, Randomized, Double-blind, Crossover Trial to Evaluate the Pharmacokinetic Comparability of Alpha-1 MP to Prolastin in Subjects With Alpha1-antitrypsin Deficiency.|Completed||Phase 3|24|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 16:44:19.808769|2017-02-18 16:44:19.808769
NCT00295048|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-19|2007-06-26|||November 2004||2004-11-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Cognitive Remediation for Schizophrenia|Cognitive Remediation for Schizophrenia|Completed||N/A|50|Actual|University of Maryland||2|||f||||f||||||||||2017-02-18 16:44:20.213233|2017-02-18 16:44:20.213233
NCT00295035|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-02-21|||March 2006||2006-03-01|February 2006|2006-02-01|March 2007||2007-03-01|||||Interventional|||Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer|Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer|Unknown status|Not yet recruiting|Phase 3|100||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 16:44:20.296937|2017-02-18 16:44:20.296937
NCT00295022|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2013-12-13|||August 2006||2006-08-01|September 2009|2009-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing SAR Symptoms in Ragweed Sensitive Subjects|Double-blind, 3 Parallel Randomized Groups, Therapeutic Confirmatory. Clinical Trial to Compare the Efficacy of Levocetirizine 5 mg and Montelukast 10 mg to Placebo in Reducing SAR Symptoms in Ragweed Sensitive Subjects in an EEU.|Completed||Phase 4|403||UCB Pharma|||||f||||||||||||||2017-02-18 16:44:20.381091|2017-02-18 16:44:20.381091
NCT00295009|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2014-07-31|2014-06-18||September 2001||2001-09-01|July 2014|2014-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|PDL|Enrolled and treated|Safety and Effectiveness Study of Prodisc to Spinal Fusion Surgery|A Multi-Center, Prospective, Randomized, Controlled Clinical Trial Comparing the Safety and Effectiveness of ProDisc to Spinal Fusion Surgery in the Treatment of Discogenic Pain Associated With DDD in the Lumbosacral Spine|Completed||N/A|852|Actual|Synthes USA HQ, Inc.||6|||f||||f||||||||||2017-02-18 16:44:20.480944|2017-02-18 16:44:20.480944
NCT00294996|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2009-03-30|||January 2006||2006-01-01|March 2009|2009-03-01||||||||Interventional|||Trial of Myocet in Metastatic Breast Cancer|A Phase III Randomized, Controlled Trial of Myocet, Trastuzumab and Paclitaxel Versus Trastuzumab and Paclitaxel for First-Line Therapy of Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 3|363|Actual|Sopherion Therapeutics|||||f||||||||||||||2017-02-18 16:44:24.04028|2017-02-18 16:44:24.04028
NCT00294983|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-19|2008-01-28||||||January 2008|2008-01-01||||||||Observational|||OCD Among Patients With Burns||Withdrawn||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:44:24.228122|2017-02-18 16:44:24.228122
NCT00294970|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-19|2010-01-31|||February 2006||2006-02-01|January 2010|2010-01-01|August 2006|Actual|2006-08-01|||||Observational|||Cognitive Characteristics of PTSD Patients With OCD|Cognitive Characteristics of PTSD Patients With OCD|Completed||N/A|76|Actual|Sheba Medical Center|||3||f||||f||||||||||2017-02-18 16:44:24.297317|2017-02-18 16:44:24.297317
NCT00294957|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-19|2008-01-28||||||January 2008|2008-01-01||||||||Observational|||Psychological and Physiological Status of Former Prisoners of War||Withdrawn||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:44:24.640517|2017-02-18 16:44:24.640517
NCT00294944|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-19|2008-01-28||||||January 2008|2008-01-01||||||||Interventional|||The Effectiveness of Idazoxan in Treating TRD||Withdrawn||Phase 3|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:44:24.707142|2017-02-18 16:44:24.707142
NCT00294931|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2010-06-24|||February 2006||2006-02-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|May 2007|Actual|2007-05-01||Interventional|||Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer|A Phase II Trial of Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|50|Anticipated|SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 16:44:24.786152|2017-02-18 16:44:24.786152
NCT00294918|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2014-03-24|||September 2001||2001-09-01|March 2014|2014-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome|Multicenter Open-label, Randomized, Dose-finding, Parallel-group, Safety and Efficacy Trial of Subcutaneous Administration of Serostim® (Mammalian Cell-derived Recombinant Human Growth Hormone, r-hGH) in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|Completed||Phase 2/Phase 3|142|Actual|EMD Serono||3|||f||||||||||||||2017-02-18 16:44:24.896557|2017-02-18 16:44:24.896557
NCT00294905|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2010-09-22|||March 2006||2006-03-01|February 2007|2007-02-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Implementation of an Evidence Based Smoking Cessation Strategy (SMOCC) for Patients With COPD in Primary Care|Implementation of an Evidence Based Smoking Cessation Strategy (SMOCC) for Patients With COPD in Primary Care|Terminated||N/A|2700|Anticipated|Radboud University||||recruitment of patients did not reach sufficient numbers|f||||||||||||||2017-02-18 16:44:25.002566|2017-02-18 16:44:25.002566
NCT00294892|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2012-05-30|||February 2006||2006-02-01|May 2012|2012-05-01|June 2010|Actual|2010-06-01|September 2009|Actual|2009-09-01||Interventional|||Pharmacokinetics Study on Nevirapine Resistance in Tanzania|The Effect of Single Dose Carbamazepine on the Pharmacokinetics of Single Dose Nevirapine (Viramune, NVP) and Development of NVP Resistance, PMTCT Program of Moshi, Tanzania (VITA1)|Completed||Phase 2|144|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 16:44:25.097593|2017-02-18 16:44:25.097593
NCT00294879|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2008-05-30|||February 2006||2006-02-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|||||Interventional|||Effects of Inspiration Rise Time on Work of Breathing and Comfort of Conscious Patients on Mechanical Ventilation||Completed||N/A|10|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 16:44:25.213701|2017-02-18 16:44:25.213701
NCT00294866|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2010-04-07|||March 2006||2006-03-01|April 2010|2010-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients|An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.|Completed||Phase 4|64|Actual|Fresenius Medical Care North America||2|||f||||f||||||||||2017-02-18 16:44:25.305485|2017-02-18 16:44:25.305485
NCT00005458|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||January 1991||1991-01-01|May 2000|2000-05-01|December 1991|Actual|1991-12-01|||||Observational|||Suppressed Anger, Blood Pressure and Mortality Follow-up||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.667535|2017-02-18 18:14:57.667535
NCT00294840|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2010-07-28|||August 2006||2006-08-01|May 2008|2008-05-01|April 2010|Actual|2010-04-01|September 2009|Actual|2009-09-01||Observational|||Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment|Dynamic FDG-PET in Aggressive Lymphoma and Pancreas Cancer|Completed||Early Phase 1|70|Anticipated|Rambam Health Care Campus|||1||f||||||||||||||2017-02-18 16:44:25.513844|2017-02-18 16:44:25.513844
NCT00294827|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2016-03-30|||February 2006||2006-02-01|March 2016|2016-03-01|May 2023|Anticipated|2023-05-01|May 2022|Anticipated|2022-05-01||Interventional|||Liver Transplantation and Metastatic Colo-rectal Cancer.|Liver Transplantation and Metastatic Colo-rectal Cancer.|Active, not recruiting||Phase 2|25|Anticipated|Oslo University Hospital||1|||f||||||||||||||2017-02-18 16:44:25.596681|2017-02-18 16:44:25.596681
NCT00294814|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2007-03-19||||||May 2006|2006-05-01||||||||Interventional|||TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique|Gas and Solid Brain Microembolization Detected by the EmbodopR TCD System During Proximal Coronary Graft Anastomosis Done With Aortic Cross Clamping, Partial Occlusion or the HeartstringR Device and Their Effect on Neurocognitive Performance After Coronary Bypass Operation|Unknown status|Recruiting|N/A|100||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:44:25.702372|2017-02-18 16:44:25.702372
NCT00294801|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-02-21|||January 2006||2006-01-01|February 2006|2006-02-01|December 2007||2007-12-01|||||Interventional|||Effect of Flex-a-New on Osteoarthritis of the Knee||Unknown status|Recruiting|Phase 4|80||Rabin Medical Center|||||f||||||||||||||2017-02-18 16:44:25.802137|2017-02-18 16:44:25.802137
NCT00294788|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2007-01-08|||March 2006||2006-03-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines|Phase I/II Placebo-Controlled Study of Consumption of a Probiotic on HAI Titre Following Influenza Vaccination of Healthy Adult Subjects|Unknown status|Active, not recruiting|Phase 1/Phase 2|300||Probiomics Ltd|||||f||||||||||||||2017-02-18 16:44:25.890103|2017-02-18 16:44:25.890103
NCT00294775|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2009-06-26|||February 2006||2006-02-01|June 2009|2009-06-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis|Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis - Effect of Blockade of the Angiotensin-II Receptor|Unknown status|Active, not recruiting|Phase 3|140|Anticipated|Odense University Hospital|||||f||||||||||||||2017-02-18 16:44:25.979644|2017-02-18 16:44:25.979644
NCT00294762|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2012-08-06|2010-10-05||January 2006||2006-01-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC|A Phase 2 Randomized Study of Tarceva (Erlotinib) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With Newly Diagnosed Advanced Non-small Cell Lung Cancer Who Have Tumors With EGFR Protein Overexpression and/or Increased EGFR Gene Copy Numbers|Completed||Phase 2|143|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:44:26.109609|2017-02-18 16:44:26.109609
NCT00294749|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-19|2009-01-26|||February 2006||2006-02-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy|Comparison Between Short and Long Schemes of Antibiotic Prophylaxis for Transrectal Prostate Biopsy. A Multicentre Prospective Randomised Study|Terminated||Phase 3|300|Anticipated|Poitiers University Hospital|||||f||||f||||||||||2017-02-18 16:44:27.213838|2017-02-18 16:44:27.213838
NCT00294736|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2012-08-06|||November 2005||2005-11-01|August 2012|2012-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens|A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva® (Erlotinib) in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue To Smoke After Failure of One or Two Prior Chemotherapy Regimens|Completed||Phase 1|57|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:44:27.318435|2017-02-18 16:44:27.318435
NCT00294723|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2014-06-25|2010-02-23||February 2006||2006-02-01|June 2014|2014-06-01|March 2010|Actual|2010-03-01|November 2008|Actual|2008-11-01||Interventional|LEAD-3||To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c|Liraglutide Effect and Action in Diabetes (LEAD-3): Effect on Glycemic Control of Liraglutide Versus Glimepiride in Type 2 Diabetes|Terminated||Phase 3|746|Actual|Novo Nordisk A/S|Trial terminated due to an insufficient number of subjects remaining to obtain reasonable statistical power. Efficacy data was not analysed after week 156. Safety data was collected through week 195. No data was available from week 195 to 260|4||"The trial was terminated at week 195 due to an insufficient number of subjects remaining to~   obtain reasonable statistical power"|f||||f||||||||||2017-02-18 16:44:27.455162|2017-02-18 16:44:27.455162
NCT00294710|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-18|2011-11-07|||March 2005||2005-03-01|November 2011|2011-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine|A Twenty Six-week, Dose Titration Study to Evaluate the Efficacy and Safety of Aliskiren Compared to HCTZ With the Optional Addition of Amlodipine, Followed by a Second Twenty Six Weeks of Blinded Treatment, in Patients With Essential Hypertension|Completed||Phase 3|976|Actual|Novartis|||||||||||||||||||2017-02-18 16:44:29.886697|2017-02-18 16:44:29.886697
NCT00294697|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2010-08-23|||August 2003||2003-08-01|August 2010|2010-08-01|October 2011|Anticipated|2011-10-01|||||Observational|||Genetic Variation and Immune Responses After Injury|Genetics of Innate Immune Response After Burn Trauma|Unknown status|Recruiting|N/A|2000|Anticipated|National Institute of General Medical Sciences (NIGMS)|||1||f||||t||||||Samples With DNA|"~     Blood, Tissue, Fluids~   "|||2017-02-18 16:44:29.971143|2017-02-18 16:44:29.971143
NCT00294684|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2014-02-26|||November 2005||2005-11-01|February 2014|2014-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy|A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy in Infants With Biliary Atresia|Completed||N/A|140|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 16:44:30.061354|2017-02-18 16:44:30.061354
NCT00005457|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||January 1991||1991-01-01|June 2000|2000-06-01|June 1994|Actual|1994-06-01|||||Observational|||Model-Free Time Curves for Longitudinal Data Analysis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.732227|2017-02-18 18:14:57.732227
NCT00294658|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2016-11-17|2016-09-19||June 2006||2006-06-01|November 2016|2016-11-01|December 2015|Actual|2015-12-01|November 2015|Actual|2015-11-01||Interventional|||Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy|A Multi-Center, Single-Blind, Randomized Study Comparing Thymectomy to No Thymectomy in Non-Thymomatous Myasthenia Gravis (MG) Patients Receiving Prednisone|Completed||Phase 3|126|Actual|University of Alabama at Birmingham|Potential weakness of this trial include the single-blinded and pill count methodology.|2|||f||||t||||||||Yes||2017-02-18 16:44:30.314113|2017-02-18 16:44:30.314113
NCT00294645|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2010-10-01|2009-04-01||April 2004||2004-04-01|October 2010|2010-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||PREFER (Pacemaker Remote Follow-Up Evaluation and Review)|Pacemaker Remote Follow-up Evaluation and Review|Completed||N/A|980|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||f||||||||||2017-02-18 16:44:32.479063|2017-02-18 16:44:32.479063
NCT00294632|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2016-02-03|||February 2006||2006-02-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma|Lenalidomide and Rituximab Treatment of Relapsed Mantle Cell Lymphoma and Diffuse Large B-Cell Non-Hodgkin's Lymphoma, Transformed Large Cell Lymphoma, and/or Grade 3 Follicular Lymphoma (Follicular Cleaved Large Cell Lymphoma or Follicular Non-Cleaved Large Cell Lymphoma (RV-LYM-PI-0056)|Completed||Phase 1/Phase 2|112|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:44:33.25054|2017-02-18 16:44:33.25054
NCT00294619|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2012-10-04|||April 2006||2006-04-01|October 2012|2012-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Treatment of Adults With Growth Hormone Deficiency|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess Efficacy and Safety of LB03002 Administered Weekly in Adults With Growth Hormone Deficiency.|Completed||Phase 3|147|Actual|LG Life Sciences||2|||f||||t||||||||||2017-02-18 16:44:33.368457|2017-02-18 16:44:33.368457
NCT00294606|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-02-17|||February 2006||2006-02-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Artery Surgery|Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Cross-Clamping During Carotid Endarterectomy Under General Anesthesia|Unknown status|Recruiting|N/A|86||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:44:33.464108|2017-02-18 16:44:33.464108
NCT00294593|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2009-12-16|||October 2000||2000-10-01|December 2009|2009-12-01|December 2003||2003-12-01|||||Interventional|||Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome|One-year Double-blind Placebo-controlled Phase 2-3 Study to Evaluate the Effect of Oral Folinic Acid Treatment (1mg/kg/d) on the Psychomotor Development of Young Down Syndrome Patients|Completed||Phase 2/Phase 3|120||Institut Jerome Lejeune|||||f||||||||||||||2017-02-18 16:44:33.548835|2017-02-18 16:44:33.548835
NCT00294580|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2015-05-27|||April 1982||1982-04-01|March 2006|2006-03-01|September 2001||2001-09-01|||||Interventional|||Early Childhood Malaria Prevention With Maloprim in The Gambia|Comparison of Two Strategies for Control of Malaria Within A Primary Health Care Programme in the Gambia|Completed||Phase 4|2253||Imperial College London|||||f||||||||||||||2017-02-18 16:44:33.642451|2017-02-18 16:44:33.642451
NCT00294567|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2011-06-02|||December 2005||2005-12-01|October 2008|2008-10-01|January 2011|Actual|2011-01-01|May 2009|Actual|2009-05-01||Interventional|||Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)|Azelnidipine and Amlodipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients Undergoing Coronary Intervention by Serial Volumetric Intravascular Ultrasound Analysis in Junten Medical University (ALPS-J)|Completed||Phase 4|200|Anticipated|Juntendo University Hospital||2|||f||||f||||||||||2017-02-18 16:44:33.742106|2017-02-18 16:44:33.742106
NCT00294554|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2012-04-02|||April 2005||2005-04-01|April 2008|2008-04-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia|Double-Blind Placebo-Controlled Trial of Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia|Completed||N/A|20|Actual|Johns Hopkins University||1|||f||||f||||||||||2017-02-18 16:44:33.847447|2017-02-18 16:44:33.847447
NCT00294541|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2007-09-10|||February 2006||2006-02-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy|An Open-Label Extension Study Evaluating the Long-Term Safety of ICA-17043 With or Without Hydroxyurea Therapy in Subjects With Sickle Cell Disease|Terminated||Phase 3|51|Actual|Icagen||1||Lack of efficacy demonstrated in study ICA-17043-10|f||||t||||||||||2017-02-18 16:44:33.948763|2017-02-18 16:44:33.948763
NCT00294528|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-02-21|||January 2004||2004-01-01|October 2003|2003-10-01|January 2010||2010-01-01|||||Interventional|||Comparing Clinical Outcome of 2 Different Total Knee Prostheses: Nexgen LPS-Flex Versus AGC|Comparing Clinical Outcome of 2 Different Total Knee Prostheses: Nexgen LPS-Flex and AGC|Unknown status|Recruiting|Phase 4|100||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 16:44:34.248651|2017-02-18 16:44:34.248651
NCT00294515|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2010-07-30|2010-06-02||March 2006||2006-03-01|July 2010|2010-07-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|IMPACT||IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Efficacy and Safety of up to 100 Days of Valganciclovir Versus up to 200 Days of Valganciclovir for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Kidney Allograft Recipients|Completed||Phase 3|326|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:44:34.368835|2017-02-18 16:44:34.368835
NCT00294502|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-02-21|||September 2003||2003-09-01|September 2003|2003-09-01|May 2004||2004-05-01|||||Interventional|||Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia||Completed||Phase 4|120||Henry Ford Health System|||||f||||||||||||||2017-02-18 16:44:35.217832|2017-02-18 16:44:35.217832
NCT00294489|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-02-21|||February 2006||2006-02-01|February 2006|2006-02-01|December 2006|Anticipated|2006-12-01|||||Observational|||Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT|Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT|Unknown status|Recruiting|Phase 3|500|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:44:35.306411|2017-02-18 16:44:35.306411
NCT00294476|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-19|2006-10-11|||July 2005||2005-07-01|September 2006|2006-09-01||||||||Interventional|||IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma|A One Arm, Open Label,Multi - Center Phase II Study to Evaluate the Safety and Efficacy of IVIG in the Treatment of Various Metastatic Solid Tumors for Which There is no Better Alternate Treatment|Unknown status|Recruiting|Phase 2|30||GammaCan|||||f||||||||||||||2017-02-18 16:44:35.395893|2017-02-18 16:44:35.395893
NCT00294450|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2012-01-31|||February 2006||2006-02-01|January 2012|2012-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Feasibility Study of a New Fistula Pouching System|Pouching of Fistula - a Non-comparative, Multi-center Investigation|Completed||Phase 2/Phase 3|22|Actual|Coloplast A/S||1|||f||||f||||||||||2017-02-18 16:44:35.612693|2017-02-18 16:44:35.612693
NCT00294437|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2012-04-30|||December 2003||2003-12-01|April 2012|2012-04-01|November 2007|Actual|2007-11-01|December 2003|Actual|2003-12-01||Interventional|||ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases|Randomised Open-label Multicenter Prosp. Clinical Study to Show the Efficacy of IV ZOMETA® 4mg for Prevention of Bone Metastases in Hormone-naïve High Risk Patients With Locally Advanced Prostate Cancer|Terminated||Phase 3|376|Actual|Central European Cooperative Oncology Group||2||underfunding|f||||f||||||||||2017-02-18 16:44:35.712678|2017-02-18 16:44:35.712678
NCT00294424|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-02-21|||September 2002||2002-09-01|January 2006|2006-01-01|April 2006||2006-04-01|||||Interventional|||Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements|A Prospective, Multi-Centre Study on Costs and Effects of Waiting Time in Patients Undergoing Total Hip and Knee Replacement Surgery. A Randomized Controlled Trial.|Unknown status|Active, not recruiting|N/A|833||Academy of Finland|||||f||||||||||||||2017-02-18 16:44:35.877994|2017-02-18 16:44:35.877994
NCT00294411|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2006-02-21|||December 2003||2003-12-01|February 2006|2006-02-01||||||||Interventional|||Vaginal Birth After Caesarean Section – Effect on Maternal Psychosocial Function||Completed||N/A|||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 16:44:35.978294|2017-02-18 16:44:35.978294
NCT00294398|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2015-04-23|2013-05-20||March 2006||2006-03-01|April 2015|2015-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma|Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma|Completed||N/A|152|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-02-18 16:44:36.043622|2017-02-18 16:44:36.043622
NCT00294385|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2011-06-22|||June 2002||2002-06-01|June 2011|2011-06-01|October 2005|Actual|2005-10-01|||||Interventional|||Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine|A Randomized Phase III Study Comparing Concomitant Docetaxel Plus Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine in Anthracycline-Pretreated Metastatic or Locally Recurrent Breast Cancer Patients|Completed||Phase 3|430|Actual|Central European Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 16:44:36.436476|2017-02-18 16:44:36.436476
NCT00294372|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-20|2013-11-13|||February 2006||2006-02-01|November 2013|2013-11-01||||September 2007|Actual|2007-09-01||Interventional|||Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients|Randomised, Double-blind, Placebo-controlled 7 Day Monotherapy Phase IIa Study to Evaluate the Antiviral Activity and Safety of Increasing Doses of Oral Administered RTV-boosted BILR 355 BS (75 mg and 150 mg Twice Daily) in HIV-1-infected, NNRTI-experienced Patients, Followed by 28 Day Combination Therapy With Tipranavir or Lopinavir Based HAART-regimen|Terminated||Phase 2|36||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:44:36.669301|2017-02-18 16:44:36.669301
NCT00294359|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2007-08-21|||June 2005||2005-06-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer|The MAX Study: A Randomised Phase II/III Study to Evaluate the Role of Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer|Completed||Phase 2/Phase 3|333|Anticipated|Australasian Gastro-Intestinal Trials Group|||||f||||||||||||||2017-02-18 16:44:36.781729|2017-02-18 16:44:36.781729
NCT00294346|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2008-02-15|||February 2006||2006-02-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder|A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Social Anxiety Disorder|Completed||Phase 2|180||Avera Pharmaceuticals|||||f||||||||||||||2017-02-18 16:44:36.913996|2017-02-18 16:44:36.913996
NCT00294320|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-21|2008-09-24|||February 2006||2006-02-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions|Pilot Study to Evaluate Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions (Clinical and Sub-Clinical), When Treated With Aldara 5% (Imiquimod) Cream|Completed||Phase 3|12|Actual|MEDA Pharma GmbH & Co. KG||2|||f||||||||||||||2017-02-18 16:44:37.003231|2017-02-18 16:44:37.003231
NCT00294307|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2016-01-13|||February 2006||2006-02-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|July 2010|Actual|2010-07-01||Observational|||Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers|Hospital to Home: Cognitively Impaired Elders/Caregivers|Completed||N/A|814|Actual|University of Pennsylvania|||3||f||||f||||||||||2017-02-18 16:44:37.107501|2017-02-18 16:44:37.107501
NCT00294294|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2013-02-20|||May 2005||2005-05-01|February 2013|2013-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa|A Randomized Controlled Open-Label Phase IV Multi Center Study to Assess the Effect of Antipyretic Prophylactic Treatment on the Rate of Febrile Reactions Following Concomitant Contralateral Administration of a 7-Valent Pneumococcal Conjugate Vaccine (Prevenar®) and DTPa-HBV-IPV+Hib Vaccine (Infanrix Hexa®) in Children at 2, 3, 4 and 11-14 Months of Age|Completed||Phase 4|300||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:44:37.415526|2017-02-18 16:44:37.415526
NCT00294281|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-09-19|||October 2006||2006-10-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||Vagus Nerve Stimulation for Treating Adults With Severe Fibromyalgia|A Pilot Study to Assess the Tolerability and Exploratory Efficacy of Vagus Nerve Stimulation (VNS) Using the VNS Therapy System in Patients With Refractory Fibromyalgia With and Without Major Depression|Completed||Phase 1|14|Actual|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-02-18 16:44:37.504691|2017-02-18 16:44:37.504691
NCT00294268|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2008-07-01|||March 2006||2006-03-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Cognitive Behavioural Therapy for Obesity|A Maintenance-Oriented Cognitive Behavioural Therapy in the Treatment of Obesity|Completed||Phase 2|24|Actual|University of Sydney||1|||f||||t||||||||||2017-02-18 16:44:37.621113|2017-02-18 16:44:37.621113
NCT00294255|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-02-27|||March 2003||2003-03-01|February 2013|2013-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania|Risperidone Plus Mood Stabilizer in the Treatment of Mixed Mania|Completed||Phase 4|45|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 16:44:37.731878|2017-02-18 16:44:37.731878
NCT00294242|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-02-17|||February 2006||2006-02-01|February 2006|2006-02-01||||||||Interventional|||Safety Study of Membrane Sweeping in Pregnancy|Does Routine Membrane Sweeping in Uncomplicated Term Pregnancies Increase the Rate of Prelabour Rupture of Membranes|Unknown status|Not yet recruiting|Phase 3|300||Tripler Army Medical Center|||||f||||||||||||||2017-02-18 16:44:37.84756|2017-02-18 16:44:37.84756
NCT00294229|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-09-30|||March 2003||2003-03-01|September 2011|2011-09-01|October 2006|Actual|2006-10-01|April 2006|Actual|2006-04-01||Interventional|||Spinal Manipulative Therapy for Low Back Pain|Spinal Manipulative Therapy for Low Back Pain: Randomised Controlled Trial|Completed||Phase 4|104|Actual|University of Bern|||||f||||f||||||||||2017-02-18 16:44:37.94867|2017-02-18 16:44:37.94867
NCT00294216|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-02-17|||August 2003||2003-08-01|February 2006|2006-02-01|July 2005||2005-07-01|||||Interventional|||Omacor and Placebo in Carotid Plaque Stability|A Double Blind Comparison of Omacor and Placebo in Patients Awaiting Endarterectomy to Investigate the Effect on Carotid Plaque Stability|Completed||Phase 3|121||Pronova BioPharma|||||f||||||||||||||2017-02-18 16:44:38.04599|2017-02-18 16:44:38.04599
NCT00294203|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2014-04-14|||February 2006||2006-02-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer|Placebo-Controlled Pilot Study to Assess the Post-Operative Administration of Epoetin Alfa on Patients Undergoing Abdominal or Pelvic Surgery for Malignancy|Completed||Phase 1|40|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 16:44:38.148924|2017-02-18 16:44:38.148924
NCT00294190|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2012-12-06|||February 2006||2006-02-01|May 2011|2011-05-01|July 2009|Actual|2009-07-01|September 2007|Actual|2007-09-01||Interventional|||Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer|A Phase II Study Of Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer|Completed||Phase 2|38|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:44:38.261445|2017-02-18 16:44:38.261445
NCT00294177|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-02-17|||August 2006||2006-08-01|February 2006|2006-02-01|July 2008||2008-07-01|||||Observational|||Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma|Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Persistent Gestational Trophoblastic Tumors Using Atomic Force Microscopy and Dual Polarisation Interferometry|Unknown status|Not yet recruiting|Phase 4|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:44:38.39453|2017-02-18 16:44:38.39453
NCT00294164|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2014-03-24|||March 2001||2001-03-01|March 2014|2014-03-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|Phase 2/3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding, Safety and Efficacy Trial of Subcutaneously Administered Serostim® (Mammalian Cell-derived Recombinant Human Growth Hormone, r-hGH) in the Treatment of Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|Completed||Phase 2/Phase 3|245|Actual|EMD Serono||3|||f||||||||||||||2017-02-18 16:44:38.507796|2017-02-18 16:44:38.507796
NCT00294151|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2007-07-12|||September 2005||2005-09-01|January 2006|2006-01-01||||||||Interventional|||Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer|Challenging the Paradigm in Pain Relief for Advanced Breast and Prostate Cancer Patients With Vertebral Metastasis: Vertebral Augmentation With Cement Plus Radiotherapy Versus Radiotherapy. A Randomized, Prospective, Double Blind Pilot Study|Unknown status|Recruiting|Phase 3|30|Anticipated|McGill University Health Center|||||f||||||||||||||2017-02-18 16:44:38.624602|2017-02-18 16:44:38.624602
NCT00294125|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2013-04-19|||February 2006||2006-02-01|April 2013|2013-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis|Flavocoxid: A Medical Food Therapy for Osteoarthritis|Completed||Phase 1|59|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-02-18 16:44:38.731887|2017-02-18 16:44:38.731887
NCT00294112|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2014-12-02|||February 2006||2006-02-01|December 2014|2014-12-01|September 2008|Actual|2008-09-01|August 2006|Actual|2006-08-01||Interventional|||Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease|A Phase II, Open-label, Randomized Study to Evaluate the Safety and Efficacy of PROCHYMAL™ IBD (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Treatment of Subjects Experiencing Moderate-to-severe Crohn's Disease That is Refractory to Steroids and Immune Suppressants|Completed||Phase 2|10|Actual|Mesoblast, Ltd.||2|||f||||f||||||||||2017-02-18 16:44:38.846816|2017-02-18 16:44:38.846816
NCT00294099|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2013-05-30|||March 2006||2006-03-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults|A Phase I-II, Randomized, Controlled, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine Given Alone or With Aluminum Hydroxide to Healthy Elderly Adults|Completed||Phase 1/Phase 2|600|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||||||||||||2017-02-18 16:44:38.963688|2017-02-18 16:44:38.963688
NCT00294086|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2011-06-07|||December 2005||2005-12-01|June 2011|2011-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure|A 12-Week Multicenter, 2-Arm Regimen, Exploratory Study to Evaluate the Tolerability and Safety of Valsartan Administered Once Daily vs Daily, in Patients With Stable, Chronic Heart Failure (NYHA Class Ll-lll)|Completed||Phase 2|160||Novartis|||||f||||||||||||||2017-02-18 16:44:39.090158|2017-02-18 16:44:39.090158
NCT00294073|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2007-06-18|||July 2005||2005-07-01|August 2005|2005-08-01||||||||Interventional|||Defining the Best Approach to Block the Pain After Knee Surgery|Defining the Best Approach to Block the Pain After Knee Surgery|Unknown status|Recruiting|Phase 3|60|Anticipated|McGill University Health Center|||||f||||||||||||||2017-02-18 16:44:39.183275|2017-02-18 16:44:39.183275
NCT00294060|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-04-06|2009-07-01||March 2004||2004-03-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||P3: Pacemaker Patient Profiling Study|Pacemaker Patient Profiling (P3) Study|Terminated||N/A|2013|Actual|Medtronic Cardiac Rhythm and Heart Failure|Characterization of objectives also encompassed 8 device features (Capture Management, MVP, APP, ARS, PMOP, Rate Response, Mode Switch, Sinus Preference) and 10 additional clinical outcomes. More information is available through the point of contact.||1|"Preliminary analysis determined there was sufficient data to support objectives and allow~   early completion. The last patient visit occurred on November 6, 2007."|f||||f||||||||||2017-02-18 16:44:39.293445|2017-02-18 16:44:39.293445
NCT00294047|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2016-09-22|2011-12-08||February 2006||2006-02-01|September 2016|2016-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older|A Study to Evaluate Safety, Immunogenicity and Efficacy of GSK Biologicals HPV-16/18 L1/AS04 Vaccine Administered Intramuscularly According to a Three-dose Schedule (0, 1, 6 Month) in Healthy Adult Female Subjects Aged 26 Years and Above|Completed||Phase 3|5752|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:44:39.739095|2017-02-18 16:44:39.739095
NCT00294034|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2007-03-26|||October 2002||2002-10-01|March 2007|2007-03-01|May 2006|Actual|2006-05-01|||||Observational|||VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies|VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies|Completed||N/A|950||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:44:45.793012|2017-02-18 16:44:45.793012
NCT00294021|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2012-09-25|||March 2006||2006-03-01|September 2012|2012-09-01|April 2008|Actual|2008-04-01|||||Observational|||Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage|Long-term Impact of the Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Colonization and Immune Correlates for Disease Protection|Completed||N/A|1000|Anticipated|Johns Hopkins Bloomberg School of Public Health|||1||f||||f||||||Samples Without DNA|"~     Nasopharyngeal specimens will be collected for isolation of pneumococcus; saliva and serum~     specimens will be collected for antibody assays~   "|||2017-02-18 16:44:45.907781|2017-02-18 16:44:45.907781
NCT00294008|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2014-04-02|||December 2004||2004-12-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)|Electronic Schizophrenia Treatment Adherence Registry(e-STAR): An Observational, International Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres|Completed||Phase 4|230|Actual|Janssen Korea, Ltd., Korea|||1||f||||f||||||||||2017-02-18 16:44:45.998847|2017-02-18 16:44:45.998847
NCT00293995|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-12-22||||||December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Minimal Access Repair of Contralateral Hernias (MARCH Trial)||Unknown status|Recruiting|N/A|360||Institute of Child Health|||||f||||||||||||||2017-02-18 16:44:46.113839|2017-02-18 16:44:46.113839
NCT00293982|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-02-17|||June 2004||2004-06-01|February 2005|2005-02-01|August 2005||2005-08-01|||||Interventional|||The Influence of Expectations on Patient Satisfaction in the Pediatric Emergency Department||Completed||N/A|948||Medical College of Wisconsin|||||f||||||||||||||2017-02-18 16:44:46.195777|2017-02-18 16:44:46.195777
NCT00293969|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2006-02-17|||March 2005||2005-03-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||A Trial Comparing Different Dosing Regimens of Morphine in Patients With Moderate to Severe Pain|A Randomized Clinical Trial Comparing Different Dosing Regimens of Intravenous Morphine in the Treatment of Adult Patients Presenting to the Emergency Department With Moderate to Severe Pain|Completed||N/A|280||Montefiore Medical Center|||||f||||||||||||||2017-02-18 16:44:46.280043|2017-02-18 16:44:46.280043
NCT00293956|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2008-01-16|||January 2006||2006-01-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Thyroid Function in Term Infants With Respiratory Distress|Thyroid Function in Term and Near Term Infants With Respiratory Distress and Its' Relation to Severity of Illness|Completed||N/A|20|Actual|Christiana Care Health Services|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum~   "|||2017-02-18 16:44:46.386428|2017-02-18 16:44:46.386428
NCT00293943|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2012-09-07|||February 2006||2006-02-01|September 2012|2012-09-01|August 2010|Actual|2010-08-01|March 2010|Actual|2010-03-01||Interventional|||Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrillation|A Randomized Trial to Investigate the Significance of Complete Versus Incomplete Electrical Isolation of Pulmonary Veins by Radiofrequency-induced Linear Lesions|Completed||N/A|232|Actual|German Atrial Fibrillation Network||1|||f||||||||||||||2017-02-18 16:44:46.497435|2017-02-18 16:44:46.497435
NCT00293930|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2007-12-19||||||December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis||Completed||Phase 3|645|Actual|Astellas Pharma Inc|||||||||||||||||||2017-02-18 16:44:46.608438|2017-02-18 16:44:46.608438
NCT00293917|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2008-02-11|||January 2006||2006-01-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis|A Phase 3, Long-Term, Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 0.1% in the Treatment of Psoriasis|Completed||Phase 3|658|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 16:44:46.733405|2017-02-18 16:44:46.733405
NCT00293904|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2007-09-19|||February 2006||2006-02-01|September 2007|2007-09-01|February 2007|Actual|2007-02-01|||||Interventional|||Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy|Safety, Immunogenicity and Clinical Efficacy of an Allergen Vaccine (CYT005-AllQbG10) in Subjects With Seasonal Rhinoconjunctivitis Due to Grass-Pollen Allergy|Completed||Phase 1/Phase 2|36|Anticipated|Cytos Biotechnology AG|||||f||||||||||||||2017-02-18 16:44:46.861198|2017-02-18 16:44:46.861198
NCT00293891|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2007-12-19||||||December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis||Completed||Phase 3|658|Actual|Astellas Pharma Inc|||||||||||||||||||2017-02-18 16:44:46.941093|2017-02-18 16:44:46.941093
NCT00293878|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2007-02-22|||November 2005||2005-11-01|February 2007|2007-02-01||||||||Interventional|||Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Effects on Lipids of 12 Weeks of 2 Doses of FM-VP4 in Subjects With Primary Hypercholesterolemia|Completed||Phase 2|150||Forbes Medi-Tech|||||||||||||||||||2017-02-18 16:44:47.292288|2017-02-18 16:44:47.292288
NCT00293865|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2016-04-18|||March 2006||2006-03-01|April 2016|2016-04-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|GATA||Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer|Prospective Multicentric Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer|Completed||N/A|203|Actual|Institut Cancerologie de l'Ouest||1|||f||||||||||||||2017-02-18 16:44:47.385173|2017-02-18 16:44:47.385173
NCT00293852|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2010-12-02|||February 2006||2006-02-01|December 2010|2010-12-01||||||||Interventional|||Collaborative Care for Heart Failure Patients With the Metabolic Syndrome|Collaborative Care for Heart Failure Patients With the Metabolic Syndrome|Unknown status|Recruiting|N/A|380|Anticipated|Baylor College of Medicine|||||f||||||||||||||2017-02-18 16:44:47.484076|2017-02-18 16:44:47.484076
NCT00293839|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2010-12-07||||||December 2010|2010-12-01|December 2002|Actual|2002-12-01|||||Interventional|||Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder|Comparison of the Efficacy and Tolerability of DITROPAN XL and DETROL LA in the Treatment of Overactive Bladder|Completed||Phase 3|790|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 16:44:47.576752|2017-02-18 16:44:47.576752
NCT00293826|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2010-03-04|||March 2006||2006-03-01|March 2010|2010-03-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|||A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis.|Completed||Phase 2|813|Actual|Amgen||4|||f||||||||||||||2017-02-18 16:44:47.67662|2017-02-18 16:44:47.67662
NCT00293813|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2014-07-18|2009-12-22||May 2006||2006-05-01|July 2014|2014-07-01|August 2008|Actual|2008-08-01|March 2008|Actual|2008-03-01||Interventional|||A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density|A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density|Completed||Phase 2|247|Actual|Amgen||3|||f||||||||||||||2017-02-18 16:44:47.791553|2017-02-18 16:44:47.791553
NCT00293800|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2012-02-11|||July 2004||2004-07-01|February 2012|2012-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 3|173|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:44:48.275129|2017-02-18 16:44:48.275129
NCT00293787|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2012-02-13|||June 2004||2004-06-01|February 2012|2012-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension|A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|156|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:44:48.369782|2017-02-18 16:44:48.369782
NCT00293774|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2016-07-18|||June 2004||2004-06-01|July 2016|2016-07-01|September 2020|Anticipated|2020-09-01|January 2011|Actual|2011-01-01||Observational|||Alberta Hip Improvement Project|A Provincial Initiative to Examine the Efficacy, Cost-effectiveness and Long-term Safety of Alternative Hip Bearing Surfaces Versus Conventional Therapy for Degenerative Joint Disease of the Hip|Active, not recruiting||Phase 4|1000|Anticipated|Alberta Bone and Joint Health Institute|||2||f||||t||||||Samples Without DNA|"~     Blood samples retained for cobalt and chromium metal ion level analysis on select cohort.~   "|||2017-02-18 16:44:48.468388|2017-02-18 16:44:48.468388
NCT00293761|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2016-11-17|||January 2006||2006-01-01|March 2012|2012-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 3|109|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 16:44:48.558145|2017-02-18 16:44:48.558145
NCT00293748|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-17|2017-01-24|||February 13, 2006||2006-02-13|December 15, 2008|2008-12-15|December 15, 2008||2008-12-15|||||Observational|||Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease|Dose-Response Study of Modulation of Gene Expression in Peripheral Blood Mononuclear Cells by Atorvastatin|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:44:48.652469|2017-02-18 16:44:48.652469
NCT00293735|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2017-01-12|||June 2015||2015-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|LAMPET||Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial|Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)|Withdrawn||Phase 2/Phase 3|0|Actual|Baylor College of Medicine||2||Lack of funding|f||||t||||||||||2017-02-18 16:44:48.737143|2017-02-18 16:44:48.737143
NCT00293722|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2014-01-10|2014-01-10||January 2006||2006-01-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational||Safety analysis set included all participants who were enrolled in this study and had safety data available. Out of a total of 1285 participants included in the safety analysis set, data for baseline measure (age) was available only for 1274 participants.|Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists|Prospective Post Marketing Surveillance to Evaluate the Safety and Efficacy of Etanercept Under Usual Care Settings in Patients With Psoriatic Arthritis (PsA) Treated by Rheumatologists|Completed||N/A|1308|Actual|Pfizer|Results for Psoriasis Area and Severity Index (PASI) was not reported since it was not to be analyzed by rheumatologists as part of this study, as per planned analysis.||1||f||||f||||||||||2017-02-18 16:44:48.871792|2017-02-18 16:44:48.871792
NCT00293709|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2014-01-10|2014-01-10||January 2006||2006-01-01|January 2014|2014-01-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational||Safety analysis set included all participants who were enrolled in this study. Out of a total of 149 participants, data for baseline measure (age) was available only for 146 participants.|Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists|Prospective Post Marketing Surveillance To Evaluate The Safety And Efficacy Of Etanercept Under Usual Care Settings In Patients With Psoriatic Arthritis (Psa) Treated By Dermatologists|Completed||N/A|129|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 16:44:49.586691|2017-02-18 16:44:49.586691
NCT00293696|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2007-05-07|||October 2004||2004-10-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Interventional|||Casodex/Zoladex Biomarkers in Localised Prostate Cancer|A Randomised Pilot Study to Evaluate the Effect(s) of Casodex 150 mg and Zoladex 3.6 mg on Pathological and Genomic Tumour Markers in Subjects Undergoing Radical Prostatectomy for Localised Prostate Carcinoma|Completed||Phase 4|30|Actual|University of Tampere|||||f||||||||||||||2017-02-18 16:44:50.250556|2017-02-18 16:44:50.250556
NCT00293683|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2014-07-28|||December 2004||2004-12-01|July 2014|2014-07-01|December 2014|Anticipated|2014-12-01|October 2014|Anticipated|2014-10-01||Interventional|||A Study Comparing Two Different Techniques for Closing the Skin After a Cesarean Delivery|Cesarean Delivery Skin Closure: A Randomized Controlled Trial of Standard Staples Versus Absorbable Staples|Unknown status|Active, not recruiting|N/A|120||Thomas Jefferson University|||||f||||t||||||||||2017-02-18 16:44:50.343205|2017-02-18 16:44:50.343205
NCT00293670|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2006-02-16|||May 1997||1997-05-01|February 2006|2006-02-01|April 2015||2015-04-01|||||Interventional|||FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer|Intermittent Vs Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer|Unknown status|Active, not recruiting|Phase 4|573||University of Tampere|||||f||||||||||||||2017-02-18 16:44:50.443314|2017-02-18 16:44:50.443314
NCT00293657|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2012-11-29|||December 2005||2005-12-01|November 2012|2012-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.|A Randomized, Double-Blind, Single-Dose Study, Placebo-Controlled Evaluation of the Safety and Efficacy of Intravenous Lornoxicam in the Acute Treatment of the Headache of Migraine.|Completed||Phase 2|150||POZEN|||||||||||||||||||2017-02-18 16:44:50.534597|2017-02-18 16:44:50.534597
NCT00293644|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2016-07-20|||February 2006||2006-02-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2012|Actual|2012-06-01||Interventional|||Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy|A Randomized, Open-Label, Study of Pre-emptive Diclectin® Treatment for Severe Nausea and Vomiting of Pregnancy|Completed||Phase 3|76|Actual|The Hospital for Sick Children||3|||f||||f||||||||No||2017-02-18 16:44:50.65319|2017-02-18 16:44:50.65319
NCT00293631|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2012-11-29|||November 2005||2005-11-01|November 2012|2012-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy|A Randomized, Parallel-Group, Double-Blind, Single-Dose Study Evaluating the Efficacy and Safety of Intravenous Lornoxicam (8 mg and 16 mg) Compared to Intravenous Placebo and Ketorolac 30 mg in Management of Acute Postoperative Pain Following Orthopedic Surgery (Bunionectomy).|Completed||Phase 2|100||POZEN|||||||||||||||||||2017-02-18 16:44:50.777678|2017-02-18 16:44:50.777678
NCT00293618|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2009-01-15|||March 2006||2006-03-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Implementation Study of the PostOperative Nausea and Vomiting Prediction Rule|IMplementation of a Prediction Rule in Anesthesia Practice to Improve Cost-Effectiveness of Treatment of Postoperative Nausea and Vomiting|Completed||N/A|11970|Actual|UMC Utrecht||2|||f||||f||||||||||2017-02-18 16:44:50.863313|2017-02-18 16:44:50.863313
NCT00293605|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-05-06|||January 2004||2004-01-01|May 2011|2011-05-01|April 2011|Actual|2011-04-01|November 2008|Actual|2008-11-01||Observational|||Effect of Cemented Stem Design on Periprosthetic Bone Mass Following Primary Total Hip Arthroplasty|Effect of Cemented Stem Design on Periprosthetic Bone Mass Following Primary Total Hip Arthroplasty|Completed||N/A|120|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||3||f||||f||||||Samples Without DNA|"~     Blood and Urine only~   "|||2017-02-18 16:44:50.972544|2017-02-18 16:44:50.972544
NCT00293592|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2015-04-18|||May 2006||2006-05-01|April 2015|2015-04-01|December 2012|Actual|2012-12-01|November 2011|Actual|2011-11-01||Interventional|||Dexamethasone for Cardiac Surgery Trial|Dexamethasone for Cardiac Surgery Trial|Completed||N/A|4500|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 16:44:51.071081|2017-02-18 16:44:51.071081
NCT00293579|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2016-02-11|2015-10-30||February 2006||2006-02-01|February 2016|2016-02-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer|A Phase II Study of Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer|Completed||Phase 2|5|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:44:51.18238|2017-02-18 16:44:51.18238
NCT00293553|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2010-03-17||||||March 2010|2010-03-01|December 2007|Actual|2007-12-01|||||Interventional|||Clinical Approaches to Ileal Pouch Dysfunction||Completed||Phase 3|64|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:44:51.451146|2017-02-18 16:44:51.451146
NCT00293540|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2016-06-28|2016-05-19||February 2006||2006-02-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|February 2014|Actual|2014-02-01||Interventional|||Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer|Phase III Randomized Study of Luteal Phase vs. Follicular Phase Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor-Positive Breast Cancer|Completed||Phase 3|249|Actual|International Breast Cancer Research Foundation||2|||f||||t||||||||||2017-02-18 16:44:51.533249|2017-02-18 16:44:51.533249
NCT00293527|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2013-05-22||||||May 2013|2013-05-01|November 2006||2006-11-01|||||Interventional|||Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma|A Phase II Dose Escalation Study of Continuous Daily Subcutaneous Administration of Interferon Alpha-2b in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|Ohio State University Comprehensive Cancer Center||1||Withdrawn in October 2006, no longer of interest|f||||t||||||||||2017-02-18 16:44:52.104439|2017-02-18 16:44:52.104439
NCT00293514|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2012-05-04|||February 2006||2006-02-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)|An Open, Randomised, Prospective, Multi-centre, Parallel-group Trial of TachoSil Versus Standard Surgical Treatment in Patients Undergoing Pulmonary Lobectomy for Lung Malignancy and Requiring Treatment for Air Leakage|Completed||Phase 3|||Nycomed|||||f||||t||||||||||2017-02-18 16:44:52.192316|2017-02-18 16:44:52.192316
NCT00293501|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2013-11-05|||December 2005||2005-12-01|February 2007|2007-02-01||||February 2007|Anticipated|2007-02-01||Interventional|||Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery|A Phase I/II Trial of Tinzaparin (Innohep), a Low Molecular Weight Heparin (LMWH) for Treatment of Advanced Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 16:44:52.285113|2017-02-18 16:44:52.285113
NCT00293488|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2016-06-21|||January 2006||2006-01-01|June 2016|2016-06-01||||September 2008|Actual|2008-09-01||Interventional|||SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma|An Open Label Phase I Study Evaluating Safety, Tolerability and Pharmacokinetics of SL-11047 in Patients With Refractory Lymphoma|Completed||Phase 1|20|Anticipated|Progen Pharmaceuticals|||||f||||||||||||||2017-02-18 16:44:52.382717|2017-02-18 16:44:52.382717
NCT00293475|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2016-11-07|||October 2005||2005-10-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma|A Phase I/II Study of Patients With Newly Diagnosed Primary Central Nervous System Lymphoma Treated With Methotrexate/BBBD, and Adding Rituximab (an Anti CD-20 Antibody) and Carboplatin, to the Treatment Regimen|Recruiting||Phase 1/Phase 2|81|Anticipated|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 16:44:52.490166|2017-02-18 16:44:52.490166
NCT00293098|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2012-02-08|||March 2006||2006-03-01|February 2012|2012-02-01||||||||Expanded Access|||Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease|Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease|Approved for marketing||N/A|||Children's Hospital of Philadelphia|||||||||||||||||||2017-02-18 16:45:03.553157|2017-02-18 16:45:03.553157
NCT00293462|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2013-05-14|2013-03-27||May 2005||2005-05-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer|Management of Mucositis With GM-CSF (Sargramostim) Mouthwash Study Protocol|Completed||N/A|91|Actual|University of California, San Francisco|Of 532 potential subjects that were screened, 374 were excluded as they did not meet the inclusion criteria, 45 refused to participate and 22 were no-shows (declined radiation therapy), thereby reducing our original target sample population to 91.|3|||f||||f||||||||||2017-02-18 16:44:52.663386|2017-02-18 16:44:52.663386
NCT00293436|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2012-09-13|||January 2005||2005-01-01|September 2012|2012-09-01||||||||Interventional|||Celecoxib and Erlotinib in Treating Patients With Liver Cancer|A Phase I/II Study of Celecoxib and Erlotinib Hydrochloride as Adjuvant Therapy for High Risk Patients With a History of Hepatocellular Carcinoma|Withdrawn||Phase 1/Phase 2|0|Actual|University of California, San Francisco|||||f||||||||||||||2017-02-18 16:44:53.561334|2017-02-18 16:44:53.561334
NCT00293423|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2014-11-12||2014-11-12|October 2005||2005-10-01|November 2014|2014-11-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma|Phase I/II Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine for Patients With Recurrent High Grade Glioma|Completed||Phase 1/Phase 2|41|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:44:53.654535|2017-02-18 16:44:53.654535
NCT00293410|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2010-05-05|||November 2005||2005-11-01|May 2010|2010-05-01||||April 2010|Actual|2010-04-01||Interventional|||Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders|Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Adults and Children With Relapsed or Refractory Acute Leukemias|Completed||Phase 1|70|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:44:53.763588|2017-02-18 16:44:53.763588
NCT00293397|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-07-19|||November 2005||2005-11-01|July 2011|2011-07-01||||April 2011|Actual|2011-04-01||Interventional|||Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery|Treatment of Patients With Hepatocellular Carcinoma Using Drug-Eluting Bead Embolization|Completed||Phase 2|20|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:44:53.852978|2017-02-18 16:44:53.852978
NCT00293384|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2016-02-12|2014-05-12||October 2004||2004-10-01|February 2016|2016-02-01|February 2012|Actual|2012-02-01|June 2009|Actual|2009-06-01||Interventional||Patients who received all doses of the study drug were considered evaluable patients.|Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant|Pilot Study Evaluating Aprepitant (MK-869) for Prevention of Nausea & Vomiting Secondary to High Dose Cyclophosphamide Administered to Patients Underging Undergoing Peripheral Hematopoietic Progenitor Cell Mobilization Prior to Autologous Transplantation|Completed||N/A|40|Actual|Barbara Ann Karmanos Cancer Institute|There were no other significant limitations except for the details provided.|1|||f||||t||||||||||2017-02-18 16:44:53.954515|2017-02-18 16:44:53.954515
NCT00293371|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2012-10-09|||February 2005||2005-02-01|October 2012|2012-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer|A Phase I/II Study of Docetaxel/Prednisone and PTK 787/ZK 222584 in Previously Untreated Metastatic Hormone Refractory Prostate Cancer|Terminated||Phase 1/Phase 2|6|Actual|University of California, San Francisco||||low accrual|f||||||||||||||2017-02-18 16:44:54.267479|2017-02-18 16:44:54.267479
NCT00293358|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2013-09-16|||January 1997||1997-01-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain|SIOP Intracranial Germ Cell Tumours Protocol|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:44:54.360172|2017-02-18 16:44:54.360172
NCT00293345|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2013-09-27|||June 2006||2006-06-01|September 2013|2013-09-01||||October 2012|Actual|2012-10-01||Interventional|||3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study of a Prolonged Infusion of Triapine in Combination With a Fixed Dose Rate of Gemcitabine in Patients With Advanced Solid Tumors and Lymphomas|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:44:54.715195|2017-02-18 16:44:54.715195
NCT00293332|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-02-08|||December 2005||2005-12-01|June 2007|2007-06-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery|A Phase II Study of Neoadjuvant Therapy With Docetaxel, Carboplatin, and Bevacizumab in Patients With Resectable Early Stage Non-Small Cell Lung Cancer|Terminated||Phase 2|1|Actual|University of California, San Francisco||1||Terminated due to low subject accrual|f||||t||||||||||2017-02-18 16:44:54.847688|2017-02-18 16:44:54.847688
NCT00293319|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2014-08-14|||April 2005||2005-04-01|August 2014|2014-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma|I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma, A Phase II Study|Completed||Phase 2|164|Actual|University of California, San Francisco||1|||f||||||||||||||2017-02-18 16:44:54.971616|2017-02-18 16:44:54.971616
NCT00293293|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2015-10-06|2011-08-22||May 2005||2005-05-01|October 2015|2015-10-01|January 2010|Actual|2010-01-01|April 2009|Actual|2009-04-01||Interventional|||Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine|Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine|Completed||N/A|43|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 16:44:55.086044|2017-02-18 16:44:55.086044
NCT00293280|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2013-05-03|||July 2005||2005-07-01|May 2013|2013-05-01||||July 2007|Actual|2007-07-01||Interventional|||Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of CCNU (Lomustine) in Patients With Advanced Non-Small Cell Lung Cancer and Aberrant Hypermethylation of the MGMT Gene|Completed||Phase 2|42|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:44:55.721937|2017-02-18 16:44:55.721937
NCT00293085|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-06-22|||December 2001||2001-12-01|June 2011|2011-06-01|September 2003|Actual|2003-09-01|||||Interventional|||An Open, Randomized, Multicentre, Phase II Pilot Study|An Open, Randomized, Multicentre, Phase II Pilot Study of Docetaxel and Cisplatin in the Adjuvant Treatment of Non-Small Cell Lung Cancer (NSCLC) Stage I-II|Completed||Phase 2|37|Actual|Central European Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 16:45:03.827638|2017-02-18 16:45:03.827638
NCT00293267|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2015-09-04|2009-08-18||February 2006||2006-02-01|September 2015|2015-09-01|May 2011|Actual|2011-05-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 in Combination With an Optimized Background Therapy (OBT), Versus Optimized Background Therapy Alone, in HIV-Infected Patients With Documented Resistance to at Least 1 Drug in Each of the 3 Classes of Licensed Oral Antiviral Therapies|Completed||Phase 3|352|Actual|Merck Sharp & Dohme Corp.|Adverse events are reported by original treatment group for the entire 240-week study, including double-blind, open-label, and OLPVF phases; 94 of 118 participants in the placebo group also received raltegravir in the open-label or OLPVF phase.|2|||f||||t||||||||||2017-02-18 16:44:55.850834|2017-02-18 16:44:55.850834
NCT00293254|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2015-07-16|2009-08-20||February 2006||2006-02-01|July 2015|2015-07-01|May 2011|Actual|2011-05-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 in Combination With an Optimized Background Therapy (OBT), Versus Optimized Background Therapy Alone, in HIV-Infected Patients With Documented Resistance to at Least 1 Drug in Each of the 3 Classes of Licensed Oral Antiretroviral Therapies|Completed||Phase 3|351|Actual|Merck Sharp & Dohme Corp.|Adverse events are reported by original treatment group for the entire 240-week study, including double-blind, open-label, and OLPVF phases; 83 of 119 participants in the placebo group also received raltegravir in the open-label or OLPVF phase.|2|||f||||||||||||||2017-02-18 16:44:57.288116|2017-02-18 16:44:57.288116
NCT00293241|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2016-05-23|2014-10-09||February 2006||2006-02-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||PreFER Managed Ventricular Pacing (MVP) For Elective Replacement|PreFER MVP for Elective Replacement|Completed||Phase 4|630|Actual|Medtronic Cardiac Rhythm and Heart Failure|Atrial pacing % was not collected at implant, device programming in the MVP off arm was more often non-compliant than in MVP on arm, and 25% of the case report forms were sent without device data, possibly influencing device data related objectives|2|||f||||t||||||||||2017-02-18 16:45:01.32315|2017-02-18 16:45:01.32315
NCT00293228|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2010-05-25|||February 2007||2007-02-01|May 2010|2010-05-01|June 2009|Actual|2009-06-01|March 2008|Actual|2008-03-01||Interventional|||Treatment of Latent Tuberculosis Infection With Isoniazid|Drugs for Treatment of Latent Tuberculosis Infection Objective 4: Identify Biomarkers for Clinical Trials of Drugs Active Against Latent TB|Completed||Phase 4|200|Anticipated|Instituto Nacional de Salud Publica, Mexico||4|||f||||t||||||||||2017-02-18 16:45:02.432365|2017-02-18 16:45:02.432365
NCT00293215|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2007-05-11|||February 2006||2006-02-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen|A Phase I Biodistribution Study of 111-Indium-CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen|Completed||Phase 1|9|Actual|Ludwig Institute for Cancer Research|||||||||||||||||||2017-02-18 16:45:02.555886|2017-02-18 16:45:02.555886
NCT00293202|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2012-04-04|||March 2005||2005-03-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients|The Effect of Etanercept in Suppression of the Systemic Inflammatory Response in Hemodialysis Patients|Terminated||Phase 2|10|Actual|Kaysen, George A., M.D., Ph.D.||2||We were unable to recruit sufficient patients within the confines of our budget|f||||||||||||||2017-02-18 16:45:02.644246|2017-02-18 16:45:02.644246
NCT00293189|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2006-05-19|||December 2005||2005-12-01|August 2005|2005-08-01||||||||Observational|||Gene-Polymorphies in the P2X7 Gene in Patients With Osteoporotic Fractures|Gene-Polymorphies in the P2X7 Gene in Patients With Osteoporotic Fractures|Unknown status|Recruiting|N/A|700||Kolding Sygehus|||||f||||||||||||||2017-02-18 16:45:02.765879|2017-02-18 16:45:02.765879
NCT00293176|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2011-03-31|||December 2003||2003-12-01|March 2011|2011-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)|A One-Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)|Completed||Phase 4|821|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:45:02.84755|2017-02-18 16:45:02.84755
NCT00293163|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2015-03-04|||February 2006||2006-02-01|March 2015|2015-03-01|October 2006|Actual|2006-10-01|||||Interventional|||A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.||Completed||Phase 4|120||Sanofi|||||f||||||||||||||2017-02-18 16:45:03.009327|2017-02-18 16:45:03.009327
NCT00293150|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2017-01-26|||September 2003||2003-09-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|PREDICT||Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure|Determine the Effectiveness of Eplerenone in Reversing Diastolic Dysfunction, Improving Endothelial Function, and Suppressing Natriuretic Peptides and Collagen Turnover in Patients With Diastolic Heart Failure ( PREDICT Study)|Terminated||Phase 4|11|Actual|The Cleveland Clinic||2||Lack of eligible patients|f||||f|t|f||||||No||2017-02-18 16:45:03.088704|2017-02-18 16:45:03.088704
NCT00293137|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2008-09-18|||February 2006||2006-02-01|September 2008|2008-09-01|August 2007|Actual|2007-08-01|||||Observational|NORDIC||NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy|Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy|Terminated||Phase 4|60|Anticipated|The Cleveland Clinic|||1|safety concerns regarding use of rosiglitazone|f||||||||||||||2017-02-18 16:45:03.189437|2017-02-18 16:45:03.189437
NCT00293124|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2015-08-11|||March 2004||2004-03-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|July 2006|Actual|2006-07-01||Interventional|||Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors|An Open-label Trial of Glivec in Patients With Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors Expressing C-kit.|Completed||Phase 3|125|Actual|Central European Cooperative Oncology Group||1|||f||||t||||||||||2017-02-18 16:45:03.282774|2017-02-18 16:45:03.282774
NCT00293111|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2014-05-08|||February 2002||2002-02-01|May 2014|2014-05-01||||October 2003|Actual|2003-10-01||Interventional|||Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)|An Open Label, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)|Terminated||Phase 2|30||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 16:45:03.396631|2017-02-18 16:45:03.396631
NCT00293072|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2006-02-16|||March 2002||2002-03-01|October 2005|2005-10-01|May 2005||2005-05-01|||||Interventional|||Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis|Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis Resistant to Conventional Therapy|Completed||Phase 2|20||Cambridge University Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:45:03.934276|2017-02-18 16:45:03.934276
NCT00293059|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2013-11-05|2011-02-23||December 2005||2005-12-01|November 2013|2013-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo- Controlled, 7 Cycle Duration (196 Days), Phase 3 Study of Oral Estradiol Valerate/Dienogest Tablets for the Treatment of Dysfunctional Uterine Bleeding.|Completed||Phase 3|190|Actual|Bayer||2|||f||||f||||||||||2017-02-18 16:45:04.038545|2017-02-18 16:45:04.038545
NCT00291967|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2006-12-07|||November 2002||2002-11-01|December 2006|2006-12-01||||||||Interventional|||Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants|Evaluate the Feasibility of GSK Biologicals’ Tritanrix™-HepB/Hib-MenAC Vaccine Administered as a 3 Dose Primary Vaccination Course at 6, 10 & 14 Weeks of Age|Completed||Phase 2|525||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:45:05.53511|2017-02-18 16:45:05.53511
NCT00291954|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2008-08-27|||March 2006||2006-03-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination|A Multicentric, Randomised Study Comparing the Immunogenicity and Safety of Henogen's Adjuvanted Hepatitis B Vaccine Given at 0, 1months to That of Aventis Pasteur MSD's Hepatitis B Given at 0, 1 Months in Pre-Dialysis, and Dialysis Patients Did Not Respond to Previous Hepatitis B Vaccination|Completed||Phase 3|257|Actual|Henogen||2|||f||||f||||||||||2017-02-18 16:45:05.633813|2017-02-18 16:45:05.633813
NCT00291941|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2008-08-27|||February 2006||2006-02-01|August 2008|2008-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.|A Multicentric, Randomised Study Comparing the Immunogenicity and Safety of Henogen's Adjuvanted Hepatitis B Vaccine Given at 0, 1, 6 Months to That of GSK Biologicals' Adjuvanted Hepatitis B Vaccine Given at 0, 1, 2, 6 Moths in Pre-Dialysis, and Dialysis Patients Who Are Hepatitis B Naive.|Completed||Phase 3|300|Actual|Henogen||2|||f||||f||||||||||2017-02-18 16:45:05.761954|2017-02-18 16:45:05.761954
NCT00291928|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2012-11-08|||February 2005||2005-02-01|November 2012|2012-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II|A Double-blind, Randomized, Placebo Controlled, Dose Escalation, Multi-centerphase I/II Trial of HuMax-CD20, a Fully Human Monoclonal Anti-CD20antibody, in Patients With Active Rheumatoid Arthritis Who Have Previously Failedone or More Disease Modifying Anti-rheumatic Drugs|Completed||Phase 2|201|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:45:05.884002|2017-02-18 16:45:05.884002
NCT00291915|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2006-02-14|||May 2004||2004-05-01|February 2006|2006-02-01|March 2007||2007-03-01|||||Interventional|||Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis|Methotrexate Alone Versus Methotrexate in Combination With Adalimumab in Early Arthritis|Unknown status|Recruiting|Phase 4|80||Goupe d'Etudes et de Recherche Clinique En Rhumatologie|||||f||||||||||||||2017-02-18 16:45:05.980356|2017-02-18 16:45:05.980356
NCT00291902|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2012-05-31|||March 2006||2006-03-01|September 2011|2011-09-01||||||||Interventional|||A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention|A 28-day, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Anti-inflammatory Effect and Steady-state Pharmacokinetics of SB-681323 (7.5 mg) in Subjects With Coronary Heart Disease (CHD) Undergoing Elective Percutaneous Coronary Interventions (PCI)|Completed||Phase 2|80||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:45:06.13731|2017-02-18 16:45:06.13731
NCT00291889|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2011-02-10|||July 2004||2004-07-01|February 2011|2011-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.|Evaluate the Safety, Reactogenicity & Immunogenicity of 2 Antigen Dose Levels of GSK Biologicals' Candidate Tuberculosis Vaccine, Mtb72F/AS02 to Healthy PPD-negative Volunteers Aged 18 to 45 Yrs|Completed||Phase 1|50|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:45:06.405245|2017-02-18 16:45:06.405245
NCT00291876|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2017-01-02|2009-12-10||January 2004||2004-01-01|December 2016|2016-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||In this study,107 subjects were enrolled at M138,117 subjects at M150,127 subjects at M162 and M174, 129 subjects at M186,135 subjects at M198,124 subjects at M210,114 subjects at M222,110 subjects at M234 and 116 subjects at M246. The highest enrollment has been mentioned to account for all subjects participating in this long-term follow-up study.|Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule|Double-blind Randomized Study to Evaluate the Immunogenicity and Reactogenicity of Two Different Lots of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Containing 1440 EL.U of Antigen Per mL and Injected According to a 0, 12 Month Schedule in Healthy Adult Volunteers|Completed||Phase 4|135|Actual|GlaxoSmithKline|For 5 subjects at Month 234, serum sample tubes were broken. Due to risk of contamination, anti-HAV concentrations analyses were not performed for these subjects, who were excluded in the LT-ATP cohort for immunogenicity analysis at Month 234.|1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:45:06.500921|2017-02-18 16:45:06.500921
NCT00291863|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2006-02-15|||February 2006||2006-02-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis|Simvastatin Effect on Endothelium Dependent Venodilation in Chronic Renal Failure Patients Treated by Peritoneal Dialysis|Unknown status|Recruiting|Phase 4|30||Federal University of São Paulo|||||f||||||||||||||2017-02-18 16:45:06.858373|2017-02-18 16:45:06.858373
NCT00292994|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2006-02-15|||April 2004||2004-04-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Study of How Exercise or Weight Loss Effects Metabolic Syndrome|Exercise and Diet With Weight Loss in Metabolic Syndrome|Unknown status|Active, not recruiting|N/A|130||Yankton Clinical Research Alliance|||||f||||||||||||||2017-02-18 16:45:08.905811|2017-02-18 16:45:08.905811
NCT00291850|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2012-04-30|||June 2005||2005-06-01|April 2012|2012-04-01||||||||Interventional|||Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC|Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA Non-Small Cell Lung Cancer|Terminated||Phase 2|50|Actual|Central European Cooperative Oncology Group||1||no patient recruitment|f||||f||||||||||2017-02-18 16:45:06.948684|2017-02-18 16:45:06.948684
NCT00291837|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2010-02-24|||November 2004||2004-11-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|June 2006|Actual|2006-06-01||Interventional|||CT-2106 for the Second Line Treatment of Ovarian Cancer|Phase II Open Label Study of CT-2106 as a Single Agent in Patients With Advanced Metastatic Ovarian Cancer Who Have Failed One Prior Platinum and Taxane Based Regimen|Completed||Phase 2|40||CTI BioPharma|||||||||||||||||||2017-02-18 16:45:07.052179|2017-02-18 16:45:07.052179
NCT00291824|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2006-02-13|||August 2004||2004-08-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care|A Randomized Controlled Trial of the Effects and Expense of a Primary and Secondary Cardiovascular Risk Reduction Clinic in Primary Care|Unknown status|Recruiting|Phase 1|670||Caroline Medical Group|||||f||||||||||||||2017-02-18 16:45:07.154121|2017-02-18 16:45:07.154121
NCT00291811|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2014-02-10|||October 2003||2003-10-01|February 2014|2014-02-01||||||||Expanded Access|CUP||Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization|Compassionate Use Protocol for the Use of AMD3100 to Mobilize Peripheral Blood Stem Cells for Collection and Transplantation|Approved for marketing||N/A|||Sanofi|||||||||||||||||||2017-02-18 16:45:07.25139|2017-02-18 16:45:07.25139
NCT00291798|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2006-09-18|||September 2000||2000-09-01|February 2006|2006-02-01|March 2009||2009-03-01|||||Interventional|||Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane|Neoadjuvant Endocrinotherapy of Mamma Carcinoma With Exemestane|Completed||Phase 2|98||Austrian Breast & Colorectal Cancer Study Group|||||f||||||||||||||2017-02-18 16:45:07.340637|2017-02-18 16:45:07.340637
NCT00291785|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2011-06-06|||January 2004||2004-01-01|June 2011|2011-06-01|September 2008|Actual|2008-09-01|August 2007|Actual|2007-08-01||Interventional|||Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer|Phase I/II Study of CT-2106 in Combination With Infusional 5-fluorouracil/Folinic Acid (5-FU/FA)(de Gramont Schedule) as Second Line in Patients With Metastatic Colorectal Cancer Failing an Oxaliplatin Plus 5-FU/FA Regimen|Completed||Phase 1/Phase 2|48|Actual|CTI BioPharma||1|||f||||f||||||||||2017-02-18 16:45:07.449426|2017-02-18 16:45:07.449426
NCT00291772|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2016-07-12|||January 2006||2006-01-01|July 2016|2016-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Continuous Subcutaneous Infusion of Pramlintide and Insulin|Continuous Subcutaneous Infusion of Pramlintide and Insulin: A Randomized, Crossover Design Study|Completed||Phase 4|13|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 16:45:07.539508|2017-02-18 16:45:07.539508
NCT00291759|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2013-01-29|||January 1996||1996-01-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.|Adjuvant Endocrine Therapy in Postmenopausal Patients With HR +ve BC With Good to Moderate Differentiation - ARNO (Arimidex + Nolvadex). Primary Treatment for 2 Years With Tamoxifen Thereafter Randomisation to: Tamoxifen 3 Years or Anastrozole 3 Years.|Completed||Phase 3|3858|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:45:07.648199|2017-02-18 16:45:07.648199
NCT00291746|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2009-03-11|||September 2005||2005-09-01|March 2009|2009-03-01|November 2006|Actual|2006-11-01|||||Interventional|||Validation of RDQ Questionnaire|A Single-Blind Single Arm Study to Validate the Reflux Disease Questionnaire (RDQ) for the Diagnosis of Reflux Disease in Primary Care in Patients Treated With Esomeprazole 40 mg o.d.|Completed||Phase 4|350||AstraZeneca|||||f||||||||||||||2017-02-18 16:45:07.786556|2017-02-18 16:45:07.786556
NCT00291733|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2007-11-14|||May 2006||2006-05-01|November 2007|2007-11-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease|Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease: A Double-Blind,Placebo-Controlled, Crossover Trial|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|1st Hospital of Social Security Services||4|||f||||||||||||||2017-02-18 16:45:07.914091|2017-02-18 16:45:07.914091
NCT00291720|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2008-05-20|||April 2005||2005-04-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?|Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?|Completed||Phase 2|120|Actual|University Hospital Birmingham||2|||f||||t||||||||||2017-02-18 16:45:08.027222|2017-02-18 16:45:08.027222
NCT00291707|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2013-05-02|||March 2006||2006-03-01|May 2013|2013-05-01|January 2009|Actual|2009-01-01|March 2008|Actual|2008-03-01||Interventional|||Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer|A Phase I Trial of Cetuximab (C225) and Pemetrexed With Concurrent Radiation in Head and Neck Cancer|Completed||Phase 1|40|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:45:08.153217|2017-02-18 16:45:08.153217
NCT00293046|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-16|2008-09-29|||February 2006||2006-02-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|September 2006|Actual|2006-09-01||Interventional|||Assessment of Grazax® Treatment Compliance|A Randomised, Parallel-Group, Open, Controlled Phase III Trial Assessing the Treatment Compliance With GRAZAX® in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis|Completed||Phase 3|500||ALK-Abelló A/S|||||f||||||||||||||2017-02-18 16:45:08.265293|2017-02-18 16:45:08.265293
NCT00293033|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2008-01-16|||February 2006||2006-02-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects|A Double-Blind, Placebo Controlled Evaluation of the Efficacy, Safety and Tolerability of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects|Completed||Phase 3|152|Actual|BioDelivery Sciences International||1|||f||||f||||||||||2017-02-18 16:45:08.362146|2017-02-18 16:45:08.362146
NCT00293020|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2012-09-06|2012-02-13||February 2006||2006-02-01|September 2012|2012-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy|An Open Label, Long-term Treatment Evaluation of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy|Completed||Phase 3|244|Actual|BioDelivery Sciences International||1|||f||||f||||||||||2017-02-18 16:45:08.45619|2017-02-18 16:45:08.45619
NCT00292981|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2015-04-20|2011-05-25||August 2005||2005-08-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)|Open-label Extension Study of CE1145 (Human Pasteurized C1 Esterase Inhibitor Concentrate) in Subjects With Congenital C1-INH Deficiency and Acute HAE Attacks|Completed||Phase 3|57|Actual|CSL Behring||1|||f||||||||||||||2017-02-18 16:45:08.998334|2017-02-18 16:45:08.998334
NCT00292968|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2012-07-18|||June 2006||2006-06-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|February 2007|Actual|2007-02-01||Interventional|||A Comprehensive Practice-Friendly Model for Promoting Healthy Behaviors|A Comprehensive Practice-Friendly Model for Promoting Healthy Behaviors|Completed||N/A|5670|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 16:45:09.553577|2017-02-18 16:45:09.553577
NCT00292955|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2011-05-26|||February 2006||2006-02-01|May 2011|2011-05-01||||February 2012|Anticipated|2012-02-01||Interventional|||Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma|An Exploratory Pharmacogenomic Study of Neoadjuvant Cetuximab Followed by Cisplatin, Radiotherapy, and Cetuximab in Women With Newly Diagnosed Locally Advanced or Metastatic Cervical Carcinoma|Unknown status|Recruiting|Phase 2|30|Anticipated|University of Virginia||1|||f||||||||||||||2017-02-18 16:45:09.66902|2017-02-18 16:45:09.66902
NCT00292942|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2016-10-25||||||March 2007|2007-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Study of the Safety of Intravenous Artesunate|A Phase 1 Double-Blind, Placebo-Controlled, Randomized Multiple Dose Escalation Study to Evaluate the Safety, Tolerance, and Pharmacokinetics/Pharmacodynamics of a New GMP Formulation of Intravenous Artesunate if Healthy Subjects|Completed||Phase 1|40||U.S. Army Medical Research and Materiel Command|||||||||t||||||||||2017-02-18 16:45:09.774628|2017-02-18 16:45:09.774628
NCT00292929|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2016-10-25||||||March 2007|2007-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Study of the Safety of Intravenous Artesunate|A Phase 1 Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Single Intravenous Doses of Artesunate Administered to Healthy Subjects|Completed||Phase 1|40||U.S. Army Medical Research and Materiel Command|||||||||||||||||||2017-02-18 16:45:09.864608|2017-02-18 16:45:09.864608
NCT00292916|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2015-05-27|||January 2006||2006-01-01|May 2015|2015-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Effect of Whole Body Vibration on Bone and Fall Related Parameters|Effect of Whole Body Vibration on Bone and Fall Related Parameters - the Erlangen Longitudinal Vibration Study (ELVIS)|Terminated||Phase 3|150||University of Erlangen-Nürnberg Medical School|||||f||||||||||||||2017-02-18 16:45:09.945774|2017-02-18 16:45:09.945774
NCT00292903|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2012-09-06|||March 2004||2004-03-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluating the Effectiveness of Brief Interpersonal Psychotherapy for Pregnant Women With Depression|Culturally Relevant Brief Interpersonal Psychotherapy (IPT-B) for Perinatal Depression|Completed||N/A|60|Anticipated|University of Pittsburgh||2|||f||||||||||||||2017-02-18 16:45:10.042025|2017-02-18 16:45:10.042025
NCT00292890|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2006-02-15|||January 2004||2004-01-01|January 2005|2005-01-01|October 2004||2004-10-01|||||Interventional|||Which Needle Length for Injecting Insulin||Completed||N/A|50||University Medical Center Groningen|||||f||||||||||||||2017-02-18 16:45:10.138747|2017-02-18 16:45:10.138747
NCT00292877|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2011-01-21|||January 2005||2005-01-01|January 2011|2011-01-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)|The Effects of a Humanized Anti-IL-5 Monoclonal Antibody (SB-240563) on Asthma Control, Airway Eosinophilia and the Degree to Which Corticosteroid Treatment Can be Reduced to Maintain Control|Completed||Phase 2|20||St. Joseph's Healthcare Hamilton|||||f||||f||||||||||2017-02-18 16:45:10.242132|2017-02-18 16:45:10.242132
NCT00292864|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2012-06-05|||January 2006||2006-01-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors|Phase 1 Open-Label, Multicenter, Dose-Escalation Clinical Study of the Safety and Tolerability of SNS-032, a Novel Cyclin-Dependent Kinase Inhibitor, Administered to Patients With Select Advanced Solid Tumors|Completed||Phase 1|25|Anticipated|Sunesis Pharmaceuticals|||||f||||||||||||||2017-02-18 16:45:10.348925|2017-02-18 16:45:10.348925
NCT00292851|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2011-07-19|||July 2004||2004-07-01|July 2011|2011-07-01|June 2005||2005-06-01|||||Observational|||Blown Nasal Secretion Measurements in Rhinosinusitis: Repeatability and Validity Compared to Nasal Lavage|Repeatability and Validity of Measurements in Blown Nasal Secretion in Patients With Rhinosinusitis|Completed||N/A|15||St. Joseph's Healthcare Hamilton|||1||f||||f||||||||||2017-02-18 16:45:10.450681|2017-02-18 16:45:10.450681
NCT00292838|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2011-07-19|||January 2001||2001-01-01|July 2011|2011-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Relative Potency of Inhaled Corticosteroids|Relative Potency of Inhaled Corticosteroids: Validation of a Clinical Model|Completed||Phase 4|40||St. Joseph's Healthcare Hamilton|||||f||||||||||||||2017-02-18 16:45:10.52533|2017-02-18 16:45:10.52533
NCT00292825|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2010-03-31|||February 2006||2006-02-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effect of Closed Loop Pacemaker Treatment on Recurrent Vasovagal Syncope|SCANdinavian Vasovagal SYNCope Pacemaker Investigation (SCANSYNC)|Completed||N/A|100|Anticipated|Aarhus University Hospital Skejby||1|||f||||||||||||||2017-02-18 16:45:10.618618|2017-02-18 16:45:10.618618
NCT00292812|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2007-10-22|||March 2006||2006-03-01|May 2007|2007-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Clinical Effects of a Nucleotides-Supplemented Infant Formula|The Clinical Effects of an Infant Formula Supplemented With Various Concentrations of Nucleotides|Completed||N/A|150|Anticipated|Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:45:10.720939|2017-02-18 16:45:10.720939
NCT00292799|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2008-07-15|||February 2006||2006-02-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||An RCT of Metformin Vs Orlistat in Obese Anovulatory Women|A Randomised Controlled Clinical Trial of Metformin Versus Orlistat for the Management of Obese Anovulatory Women.|Completed||N/A|36|Actual|Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:45:10.805518|2017-02-18 16:45:10.805518
NCT00292786|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2008-02-04|||June 2005||2005-06-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Effects of Electrical Stimulation Gait Training on Walking and Posture for Children With Cerebral Palsy|Electrical Stimulation Gait Training to Effect Improvements in Walking Function and Posture for Children With Cerebral Palsy|Completed||N/A|60|Anticipated|Shriners Hospitals for Children|||||f||||f||||||||||2017-02-18 16:45:10.893971|2017-02-18 16:45:10.893971
NCT00292773|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2011-07-19|||February 2006||2006-02-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|||||Observational|||Weight Reduction Surgery and Ovarian Function|The Effect of Weight Reduction Surgery on Ovarian Function in Obese Anovulatory Patients|Completed||N/A|30|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||1||f||||||||||||||2017-02-18 16:45:10.979496|2017-02-18 16:45:10.979496
NCT00292760|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2009-12-15||||||December 2009|2009-12-01||||||||Interventional|||A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion|A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion|Completed||Phase 2|||Royal Marsden NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:45:11.095118|2017-02-18 16:45:11.095118
NCT00292747|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2008-11-14|||May 2005||2005-05-01|November 2008|2008-11-01||||||||Interventional|||Drotaverine in Dysmenorrhoea Treatment|Comparison of the Efficacy and Tolerability of Drotaverine 80 mg, Ibuprofen 400 mg and Their Combination in a Calendar Packaging for the Treatment of Primary and Secondary Dysmenorrhoea|Terminated||Phase 4|480||Sanofi||2||early termination due to loss of interest and low enrollment of patient|f||||||||||||||2017-02-18 16:45:11.167298|2017-02-18 16:45:11.167298
NCT00292734|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2007-12-04|||January 2005||2005-01-01|December 2007|2007-12-01|June 2006||2006-06-01|||||Interventional|||STILDEP: Zolpidem in Depressive and Dysthimic Patients|Additive Beneficial Effect of Zolpidem Onto the Antidepressant Therapy in Depressive and Dysthimic Patients in the Acute Phase of the Disease|Completed||Phase 4|120||Sanofi|||||f||||||||||||||2017-02-18 16:45:11.263439|2017-02-18 16:45:11.263439
NCT00292721|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2011-07-20|||August 2004||2004-08-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effects of Celecoxib After Percutaneous Coronary Intervention|Effects of Celecoxib on Restenosis After Percutaneous Coronary Intervention and Evolution of Atherosclerosis (COREA) Trial|Completed||Phase 4|260|Anticipated|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 16:45:11.34632|2017-02-18 16:45:11.34632
NCT00292708|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2006-02-15|||May 2004||2004-05-01|February 2006|2006-02-01|July 2005||2005-07-01|||||Interventional|||Trial of Antibiotic Prophylaxis in Elective Colorectal Surgery|Randomized Multicenter Trial of Antibiotic Prophylaxis in Elective Colorectal Surgery: Single-Dose Vs. Three Doses of Second-Generation Cephalosporin|Completed||Phase 3|500||National Cancer Center, Japan|||||f||||||||||||||2017-02-18 16:45:11.441477|2017-02-18 16:45:11.441477
NCT00292695|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2013-10-28|||May 2006||2006-05-01|October 2013|2013-10-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||A Phase II Study of Nasal NK/T-cell Lymphoma|A Phase II Study of Concurrent Chemoradiation for The Localized Nasal NK/T-cell Lymphoma|Completed||Phase 2|33|Actual|National Health Research Institutes, Taiwan||1|||f||||t||||||||||2017-02-18 16:45:11.539974|2017-02-18 16:45:11.539974
NCT00292656|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2006-04-02|||December 2005||2005-12-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Importance of Hand Washing After Each NAET® Treatment|Importance of Hand Washing After Each NAET® Treatment|Completed||Phase 1/Phase 2|60||Nambudripad's Allergy Research Foundation|||||f||||||||||||||2017-02-18 16:45:11.647477|2017-02-18 16:45:11.647477
NCT00292591|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2016-08-09|2016-06-28||January 2004||2004-01-01|August 2016|2016-08-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Evaluation of Vitamin D Requirements During Pregnancy|Evaluation of Vitamin D Requirements During Pregnancy|Completed||Phase 3|501|Actual|Medical University of South Carolina||3|||f||||||||||||||2017-02-18 16:45:11.738391|2017-02-18 16:45:11.738391
NCT00292578|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2008-10-16|||January 2005||2005-01-01|October 2008|2008-10-01|January 2006||2006-01-01|||||Interventional|||NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar|NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar|Completed||Phase 1/Phase 2|75||Nambudripad's Allergy Research Foundation|||||f||||||||||||||2017-02-18 16:45:12.110792|2017-02-18 16:45:12.110792
NCT00292552|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2013-01-04|||December 2005||2005-12-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|ECLIPSE||Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints|A Multicentre 3 Year Longitudinal Prospective Study to Identify Novel Endpoints and Compare These With Forced Expiratory Volume in 1 Second (FEV1) for Their Ability to Measure and Predict COPD Severity and Its Progression Over Time|Completed||N/A|2747|Actual|GlaxoSmithKline|||3||f||||f||||||Samples With DNA|"~     Whole blood, serum, plasma, urine sputum~   "|||2017-02-18 16:45:12.205379|2017-02-18 16:45:12.205379
NCT00292539|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2009-04-22|||February 2006||2006-02-01|April 2009|2009-04-01|September 2006|Actual|2006-09-01|||||Observational|||Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class|Preserve Registry: Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class|Completed||N/A|600||Guidant Corporation|||1||f||||||||||||||2017-02-18 16:45:12.345816|2017-02-18 16:45:12.345816
NCT00292526|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2017-02-07|||November 2000|Actual|2000-11-01|February 2017|2017-02-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients|Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients|Completed||Phase 4|114|Actual|European Institute of Oncology||1|||f||||||||||||No||2017-02-18 16:45:12.426694|2017-02-18 16:45:12.426694
NCT00292513|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2006-02-15||||||May 2005|2005-05-01||||||||Interventional|||Clinical Trial Comparing Tissue Adhesive Vs. Absorbable Suture Vs. Non-Absorbable Suture|A Randomized Clinical Trial Comparing Tissue Adhesive (2-Octylcyanoacrylate) Vs. Absorbable Suture Vs. Non-Absorbable Suture for the Closure of Low Tension Facial and Neck Wounds in Children and Adolescents|Unknown status|Recruiting|N/A|||Rady Children's Hospital, San Diego|||||f||||||||||||||2017-02-18 16:45:12.527792|2017-02-18 16:45:12.527792
NCT00292500|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2013-08-19|||January 2006||2006-01-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy of Automated Distal Vascular Anastomosis in Coronary Surgery: Phase II|Efficacy of Automated Distal Vascular Anastomosis in Coronary Surgery: Phase II|Terminated||N/A|170|Actual|Cardica, Inc||1||Cardica has terminated the development of the product for Business Reason.|f||||f||||||||||2017-02-18 16:45:12.611325|2017-02-18 16:45:12.611325
NCT00292487|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2012-02-07|||November 2004||2004-11-01|August 2006|2006-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Patients With Renal Impairment Undergoing CT|Isovue and Visipaque in Renally Impaired Patients Undergoing CT|Completed||Phase 4|150||Bracco Diagnostics, Inc|||||f||||||||||||||2017-02-18 16:45:12.723833|2017-02-18 16:45:12.723833
NCT00291421|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2013-04-15|||July 2002||2002-07-01|April 2013|2013-04-01|May 2006|Actual|2006-05-01|||||Observational|||A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease|International Outcomes Survey In Dementia (IOSID)|Completed||N/A|2360|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 16:45:29.139953|2017-02-18 16:45:29.139953
NCT00292474|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2008-10-07|||March 2002||2002-03-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent|TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent|Completed||Phase 2/Phase 3|1326|Actual|Boston Scientific Corporation||2|||f||||||||||||||2017-02-18 16:45:12.802352|2017-02-18 16:45:12.802352
NCT00292461|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2013-05-13|2010-09-27||March 2006||2006-03-01|August 2009|2009-08-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures|A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures|Completed||Phase 3|64|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:45:12.912716|2017-02-18 16:45:12.912716
NCT00292448|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2013-10-28|||February 2006||2006-02-01|October 2013|2013-10-01|March 2007||2007-03-01|||||Interventional|||A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Double-dummy, Crossover Efficacy and Safety Comparison of 4-week Treatment Periods of Ba 679 BR Respimat® 5 μg and Tiotropium Inhalation Capsule 18 μg in Patients With COPD|Completed||Phase 2|157||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:45:13.447063|2017-02-18 16:45:13.447063
NCT00292435|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2013-10-28|||March 2006||2006-03-01|October 2013|2013-10-01||||October 2006|Actual|2006-10-01||Interventional|||Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI)|A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial to Evaluate Efficacy and Tolerability of Antistax Film-coated Tablets, 360 mg/Day Orally, in Male and Female Patients Suffering From Chronic Venous Insufficiency.|Completed||Phase 3|202||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:45:13.617078|2017-02-18 16:45:13.617078
NCT00292422|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-15|2007-12-26|||November 2005||2005-11-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis|A Randomized, Blinded, Placebo-Controlled, Multicenter, Dose-Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BG9924 When Given in Combination With Methotrexate to Subjects With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to DMARD Therapy|Completed||Phase 2|50|Actual|Biogen||6|||f||||||||||||||2017-02-18 16:45:13.895098|2017-02-18 16:45:13.895098
NCT00292409|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-07|||March 2005||2005-03-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices|A Prospective Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices|Completed||Phase 3|400|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-02-18 16:45:14.003703|2017-02-18 16:45:14.003703
NCT00292396|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2013-01-10||2011-08-22|November 2005||2005-11-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Subcutaneous Injections of ABT-874 vs. Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|180|Actual|AbbVie||6|||f||||t||||||||||2017-02-18 16:45:14.095464|2017-02-18 16:45:14.095464
NCT00292383|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2011-08-01||||||October 2007|2007-10-01|December 2008||2008-12-01|||||Interventional|||Ventricular Pacing Site Selection (V-PASS)|A Randomized, Prospective Multicenter Pilot Study to Determine the Influence of the Ventricular Pacing Site on the Incidence of Atrial Fibrillation and Heart Failure in Patients With Indication for Permanent Pacemaker Stimulation Therapy.|Unknown status|Recruiting|Phase 4|100|Anticipated|Medtronic BRC|||||f||||||||||||||2017-02-18 16:45:14.238662|2017-02-18 16:45:14.238662
NCT00292370|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2014-06-27|2014-02-14||January 2006||2006-01-01|June 2014|2014-06-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional||"Period 1 or Phase I, 124 patients enrolled in Arm 1/Open-Label Paroxetene for 8 weeks.~Period 2 or Phase II (intervention period), 50 patients enrolled from week 8 to week 16; 25 in Arm 2/OL paroxetene & DB Placebo, 25 in Arm 3/OL paroxetene & DB quetiapine."|Quetiapine Augmentation for Treatment-resistant PTSD|A Placebo-controlled Trial of Adjunctive Quetiapine for Refractory PTSD|Completed||Phase 4|124|Actual|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 16:45:14.372382|2017-02-18 16:45:14.372382
NCT00292357|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2010-01-15||||||April 2007|2007-04-01||||||||Interventional|||Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers||Unknown status|Recruiting|Phase 1|40|Anticipated|Heidelberg University|||||f||||||||||||||2017-02-18 16:45:15.151047|2017-02-18 16:45:15.151047
NCT00292344|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2009-04-17|||June 2004||2004-06-01|February 2006|2006-02-01|August 2005||2005-08-01|||||Interventional|||Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea|Rifaximin in Standard Three-Day Dosing With and Without the Antimotility Drug, Loperamide, in the Treatment of Travelers' Diarrhea|Completed||Phase 4|316||The University of Texas Health Science Center, Houston|||||||||||||||||||2017-02-18 16:45:15.238975|2017-02-18 16:45:15.238975
NCT00292331|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2006-02-14||||||February 2006|2006-02-01||||||||Interventional|||N-Butyl-2-Cyanoacrylate Injection Versus Band Ligation for Gastric Variceal Hemorrhage|A Randomized Trial of Endoscopic Treatment of Acute Gastric Variceal Hemorrhage: N-Butyl-2-Cyanoacrylate Injection Versus Band Ligation|Completed||Phase 3|120||Taipei Veterans General Hospital, Taiwan|||||f||||||||||||||2017-02-18 16:45:15.344045|2017-02-18 16:45:15.344045
NCT00292318|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2015-08-13|2015-08-13||January 2008||2008-01-01|August 2015|2015-08-01|September 2014|Actual|2014-09-01|September 2012|Actual|2012-09-01||Interventional|||Treatment of Patients With Fecal Incontinence|Biofeedback Therapy for Fecal Incontinence a Randomized Control Trial|Terminated||N/A|7|Actual|VA Office of Research and Development||2||"Unable to continue due to medical equipment necessary for research study was removed from~   facility."|f||||f||||||||||2017-02-18 16:45:15.44036|2017-02-18 16:45:15.44036
NCT00292305|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2016-09-23|||September 2005||2005-09-01|September 2016|2016-09-01|December 2012|Actual|2012-12-01|February 2007|Actual|2007-02-01||Interventional|BIF II||Nordic Bifurcation Stent Technique Study (BIF II)|Crush- or Culotte Stenting of Bifurcation Lesions Using Drug Eluting Stents? A Randomized Nordic Multicenter Study (BIF II)|Completed||Phase 4|425|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-02-18 16:45:15.870171|2017-02-18 16:45:15.870171
NCT00292292|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2013-08-31||2011-07-19|January 2005||2005-01-01|August 2013|2013-08-01|August 2013|Actual|2013-08-01|May 2009|Actual|2009-05-01||Interventional|||Kineflex Artificial Disc System to Treat Degenerative Disc Disease (DDD)|Clinical Study Protocol for the Investigation of the Kineflex Spinal System - a Pivotal Study in Continued Access Stage|Terminated||N/A|514|Actual|SpinalMotion||2||Economic and business reasons|f||||f||||||||||2017-02-18 16:45:15.985307|2017-02-18 16:45:15.985307
NCT00292279|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2008-05-12|||June 2002||2002-06-01|May 2008|2008-05-01|February 2004|Actual|2004-02-01|November 2003|Actual|2003-11-01||Interventional|||The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients|The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients: A Randomized, Double Blind, Controlled, Multi-Center Clinical Trial.|Completed||Phase 3|206|Actual|Sino-Swed Pharmaceutical Corporation||2|||f||||t||||||||||2017-02-18 16:45:16.110329|2017-02-18 16:45:16.110329
NCT00292266|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2013-08-02|||November 1999||1999-11-01|August 2013|2013-08-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)|An Open Label, Randomized, Multicenter, Comparative, Parallel Group Study of Rebif® 44 Mcg Administered Three Times Per Week by Subcutaneous Injection, Compared With Avonex® 30 Mcg Administered Once Per Week by Intramuscular Injection in the Treatment of Relapsing-remitting Multiple Sclerosis|Completed||Phase 3|677|Actual|EMD Serono||2|||||||||||||||||2017-02-18 16:45:16.223454|2017-02-18 16:45:16.223454
NCT00292253|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2013-08-04|||January 2001||2001-01-01|August 2013|2013-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects|A Randomized, Multicenter, Parallel Group, Open-label Study Comparing the Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing Remitting MS Patients|Completed||Phase 3|1883|Actual|EMD Serono||2|||f||||||||||||||2017-02-18 16:45:16.318114|2017-02-18 16:45:16.318114
NCT00292240|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2011-07-20|||October 2004||2004-10-01|July 2011|2011-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Brief Youth Substance Use Intervention for Primary Care||Completed||N/A|60||RAND|||||f||||||||||||||2017-02-18 16:45:16.415636|2017-02-18 16:45:16.415636
NCT00292227|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2014-10-17|2009-09-09||January 2006||2006-01-01|February 2011|2011-02-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease|Double-blind, Randomized, Placebo- and Positive-controlled, Parallel-group Trial to Assess the Potential Electrocardiographic Effects of Rotigotine Transdermal System up to 120 cm2/54.0 mg/Day in Subjects With Advanced-stage Idiopathic Parkinson's Disease: A Thorough QT/QTc Trial.|Completed||Phase 1|130|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 16:45:16.526899|2017-02-18 16:45:16.526899
NCT00292214|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2007-03-08|||October 2005||2005-10-01|February 2006|2006-02-01|October 2006||2006-10-01|||||Interventional|||Comparing Intravenous and Oral Paracetamol for Cholecystectomy|Comparative Pharmacokinetics of Intravenous and Oral Paracetamol in the Peri-Operative Period of Laparoscopic Cholecystectomy|Completed||Phase 4|30||Melbourne Health|||||f||||||||||||||2017-02-18 16:45:20.668188|2017-02-18 16:45:20.668188
NCT00292201|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2015-09-14|||February 2006||2006-02-01|September 2015|2015-09-01|June 2015|Actual|2015-06-01|June 2013|Actual|2013-06-01||Interventional|||Statin Treatment in Patients With Asthma|Pilot Study of Statin Treatment in Patients With Stable Moderate to Severe Asthma|Terminated||Phase 2|10|Actual|Queen's University||2||Lack of funding to complete subject recruitment and testing|f||||f||||||||||2017-02-18 16:45:20.763228|2017-02-18 16:45:20.763228
NCT00292188|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2011-04-22|2009-05-27||January 2006||2006-01-01|April 2011|2011-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|P4||P4 (Pregabalin for Peripheral Posttraumatic Pain)|A 9 Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Study Of Pregabalin (BID) In Subject With Posttraumatic Peripheral Neuropathic Pain|Completed||Phase 4|255|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:45:20.918384|2017-02-18 16:45:20.918384
NCT00292175|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2007-09-21|||February 2006||2006-02-01|September 2007|2007-09-01||||||||Interventional|||NBI With Magnification for Dysplasia Detection in Ulcerative Colitis|Randomised,Controlled Trial of Narrow Band Imaging With Magnification (NBI) Versus White Light Endoscopy for Dysplasia Detection in Ulcerative Colitis Surveillance|Unknown status|Recruiting|N/A|110|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 16:45:23.067321|2017-02-18 16:45:23.067321
NCT00292162|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2012-05-29|2011-08-01||January 2007||2007-01-01|May 2012|2012-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Curing Atrial Fibrillation in Heart Failure|Radiofrequency Ablation for Atrial Fibrillation in Advanced Chronic Heart Failure|Completed||N/A|41|Actual|NHS Greater Glasgow and Clyde||2|||f||||||||||||||2017-02-18 16:45:23.161946|2017-02-18 16:45:23.161946
NCT00292136|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2017-01-24|||August 15, 2003||2003-08-15|June 11, 2013|2013-06-11|June 11, 2013||2013-06-11|||||Observational|||Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study|Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study|Completed||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:45:23.557368|2017-02-18 16:45:23.557368
NCT00292123|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2017-01-11|||June 1999||1999-06-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|||Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse||Completed||Phase 1|200|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 16:45:23.850963|2017-02-18 16:45:23.850963
NCT00292110|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2017-01-24|||February 1, 2004||2004-02-01|August 9, 2013|2013-08-09|August 9, 2013|Actual|2013-08-09|August 9, 2013|Actual|2013-08-09||Interventional|||Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management|Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management|Completed||Phase 1|300|Anticipated|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-02-18 16:45:23.93404|2017-02-18 16:45:23.93404
NCT00292097|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2008-06-04|||February 2006||2006-02-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Prospective, Randomized Trial of Early Versus Late Tracheostomy in Trauma Patients With Severe Brain Injury|A Prospective, Randomized Trial of Early Versus Conventional Conversion From Endotracheal Intubation to Percutaneous Tracheostomy for Ventilatory Support of Trauma Patients With Severe Brain Injury|Terminated||N/A|5|Actual|Memorial Medical Center||2||Difficulty obtaining enrollment|f||||f||||||||||2017-02-18 16:45:24.052128|2017-02-18 16:45:24.052128
NCT00292084|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2008-01-17|||February 2006||2006-02-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|||||Interventional|||An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection|A Phase II, Multi-Center, Extension Study to Evaluate the Safety and Efficacy of Celgosivir in Combination With Peginterferon Alfa-2b, With or Without Ribavirin, for an Additional 36 Weeks|Completed||Phase 2|60||BioWest Therapeutics Inc|||||f||||||||||||||2017-02-18 16:45:24.159989|2017-02-18 16:45:24.159989
NCT00292071|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2015-11-09|||May 2004||2004-05-01|November 2015|2015-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)|A Multicenter, Open, Sequential Dose-Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 2 Separate Doses of Caspofungin Acetate in Children Between the Ages of 3 to 24 Months With New Onset Fever and Neutropenia|Completed||Phase 2|16|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:45:24.25436|2017-02-18 16:45:24.25436
NCT00292058|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2006-02-14|||August 2001||2001-08-01|February 2006|2006-02-01|August 2004||2004-08-01|||||Interventional|||Comparing Telepsychiatry and in-Person Outcomes|Comparing Patient Outcomes and Cost of Psychiatric Care Provided Through Videoconferencing With Psychiatric Care Provided in-Person.|Completed||N/A|495||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:45:24.356735|2017-02-18 16:45:24.356735
NCT00292045|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2009-06-19|||December 2004||2004-12-01|June 2009|2009-06-01|January 2006||2006-01-01|||||Interventional|||Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer|Phase 1 Study of Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With High-Risk Stage D1 or Advanced Prostate Cancer|Completed||Phase 1|12||Ludwig Institute for Cancer Research|||||||||||||||||||2017-02-18 16:45:24.444771|2017-02-18 16:45:24.444771
NCT00292032|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2016-05-16|||May 2004||2004-05-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Registry of Unexplained Cardiac Arrest|Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)|Recruiting||Phase 3|1500|Anticipated|University of British Columbia|||2||f||||t||||||Samples With DNA|"~     blood~   "|No||2017-02-18 16:45:24.539873|2017-02-18 16:45:24.539873
NCT00292019|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2009-07-07|||March 2004||2004-03-01|July 2009|2009-07-01|June 2011|Anticipated|2011-06-01|June 2011|Anticipated|2011-06-01||Observational|||Robotic Laparoscopic Radical Prostatectomy|Robotic Laparoscopic Radical Prostatectomy|Unknown status|Recruiting|N/A|20|Anticipated|Lawson Health Research Institute|||1||f||||f||||||||||2017-02-18 16:45:24.652703|2017-02-18 16:45:24.652703
NCT00292006|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2006-02-14|||February 2006||2006-02-01|February 2006|2006-02-01|January 2007||2007-01-01|||||Interventional|||Computerized Tomography to Help Diagnosis Pediatrics Scaphoid Fractures.|The Efficiency of Computerized Tomography to Aid in the Diagnosis of Pediatrics Scaphoid Fractures|Unknown status|Not yet recruiting|Phase 1|73||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 16:45:24.746676|2017-02-18 16:45:24.746676
NCT00291993|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2008-04-17|||January 2004||2004-01-01|April 2008|2008-04-01||||||||Observational|||Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls.||Completed||Phase 4|||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:45:24.84023|2017-02-18 16:45:24.84023
NCT00291980|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-14|2008-08-27|||March 2006||2006-03-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.|A Phase III, Multicentric, Multinational, Controlled, Randomised, Open Study Comparing the Immunogenicity, Reactogenicity and Safety of Henogen's New Adjuvanted Hepatitis B Vaccine, HB-AS02V, to That of Aventis Pasteur MSD's Hepatitis B Vaccine, HBVAXPRO® , Administered as a Booster Dose in Pre-Dialysis, Peritoneal Dialysis and Haemodialysis Subjects (³ 15 Years of Age) Who Previously Responded to Hepatitis B Primary Vaccination But Have Lost Antibody.|Completed||Phase 3|185|Actual|Henogen||2|||f||||f||||||||||2017-02-18 16:45:24.91761|2017-02-18 16:45:24.91761
NCT00291694|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-09-16|2013-06-24||April 2003||2003-04-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Protocol for Women at Increased Risk of Developing Breast Cancer|A Double-blinded Phase II Study of the Expression of Ki-67/MIB-1 in Women With Hyperplasia of the Breast Randomized to Receive Daily Celecoxib 400 mg BID or Placebo|Completed||Phase 2|72|Actual|University of Kansas Medical Center||2|||f||||f||||||||No||2017-02-18 16:45:25.056024|2017-02-18 16:45:25.056024
NCT00291681|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-12|2006-02-12|||September 2005||2005-09-01|January 2006|2006-01-01||||||||Observational|||Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Lineage Trees in Inflammatory Bowel Disease|Studying the Role of B Cells in Inflammatory Bowel Disease (IBD), Using a Combination of Experimental and Bioinformatical Techniques.|Unknown status|Active, not recruiting|N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:45:25.804844|2017-02-18 16:45:25.804844
NCT00291668|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2015-03-05|||March 2006||2006-03-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease|A Phase II, Multi-center, Double-blind, Placebo-controlled, Parallel-group, Dose-response Study to Assess the Safety and Efficacy of CDP870/Certolizumab Pegol, Dosed Subcutaneously in Patients With Active Crohn's Disease|Completed||Phase 2|94|Actual|UCB Pharma||3|||f||||f||||||||||2017-02-18 16:45:25.888658|2017-02-18 16:45:25.888658
NCT00291655|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2015-04-29|2009-08-25||June 2006||2006-06-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903).|A Multicenter, Open-label, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam, for Patients Suffering From Epilepsy and Coming From the Study N01175 (NCT00175903).|Completed||Phase 3|130|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 16:45:26.029025|2017-02-18 16:45:26.029025
NCT00291642|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2017-02-09|||January 2006||2006-01-01|February 2017|2017-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen|Five Parallel Groups, Exploratory Clinical Trial to Compare the Efficacy of Single Dose Levocetirizine 2.5 and 5 mg, Cetirizine 5 mg and 10 mg to Placebo in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen in a EEU.|Completed||Phase 2|541||UCB Pharma|||||f||||||||||||||2017-02-18 16:45:26.346623|2017-02-18 16:45:26.346623
NCT00291629|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2007-09-06|||March 2004||2004-03-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DES|Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DES (MAGIC Cell-3-DES)|Completed||Phase 2|96|Actual|Seoul National University Hospital||4|||f||||t||||||||||2017-02-18 16:45:26.439566|2017-02-18 16:45:26.439566
NCT00291616|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2011-07-20|||December 2005||2005-12-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B|A Multicenter, Randomized, Controlled Trial of Combination Therapy for HBeAg Positive Chronic Hepatitis B: Comparing Thymosin Alpha 1 and Pegylated Interferon-alpha2a With Pegylated Interferon-alpha2a Alone.|Completed||Phase 4|52|Actual|Seoul National University Hospital||2|||f||||t||||||||||2017-02-18 16:45:26.534151|2017-02-18 16:45:26.534151
NCT00291603|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2007-04-24|||February 2006||2006-02-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Short Term Effects of FX Dialysers on QOL and Inflammation|Short-Term Effects of the FX-Class of Haemodialyser on Quality of Life and Inflammatory Markers in Stable Dialysis Patients|Completed||Phase 4|50||Sir Charles Gairdner Hospital|||||f||||f||||||||||2017-02-18 16:45:26.642711|2017-02-18 16:45:26.642711
NCT00291590|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2006-02-13|||July 2001||2001-07-01|June 2005|2005-06-01|August 2003||2003-08-01|||||Interventional|||Diabetes Health Enhancement Program to Improve Health of People With Diabetes|Phase 3 Randomized Controlled Trial of the Diabetes Health Enhancement Program for Medicaid and Dual Eligibles in South King County, Washington|Completed||Phase 3|146||VA Puget Sound Health Care System|||||f||||||||||||||2017-02-18 16:45:26.736957|2017-02-18 16:45:26.736957
NCT00291577|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2009-11-19|2009-10-01||July 2006||2006-07-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer|Exploratory Evaluation Of A Sequential Administration Of Docetaxel And SU011248 In Women With Advanced Breast Cancer|Completed||Phase 1|22|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:45:26.837368|2017-02-18 16:45:26.837368
NCT00291564|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2007-12-17|||May 2004||2004-05-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Observational|||Ensure Cardiac Resynchronization Therapy Study|Ensure Cardiac Resynchronization Therapy Study|Completed||N/A|430||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:45:27.356621|2017-02-18 16:45:27.356621
NCT00291551|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2012-05-14|2011-04-14||January 2005||2005-01-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|April 2007|Actual|2007-04-01||Interventional|PEERLESS-HF||Paracor Ventricular Support System (PVSS) for Patients With Heart Failure|Paracor Ventricular Support System: United States Clinical Investigational Plan|Terminated||Phase 1|39|Actual|Paracor Medical, Inc|Insufficient resources to continue study follow-up.|1||Resources unavailable to continue study follow-up.|f||||t||||||||||2017-02-18 16:45:27.486253|2017-02-18 16:45:27.486253
NCT00291538|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2009-02-03|||February 2006||2006-02-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|June 2007|Actual|2007-06-01||Interventional|||Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma|Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma|Completed||Phase 1|20|Anticipated|Nantes University Hospital|||||f||||||||||||||2017-02-18 16:45:27.898324|2017-02-18 16:45:27.898324
NCT00291525|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2015-09-04|||July 2006||2006-07-01|September 2015|2015-09-01|March 2018|Anticipated|2018-03-01|March 2018|Anticipated|2018-03-01||Interventional|PROACT||Randomized On-X Anticoagulation Trial|Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT)|Recruiting||Phase 4|1200|Anticipated|On-X Life Technologies, Inc.||6|||f||||t||||||||||2017-02-18 16:45:27.985769|2017-02-18 16:45:27.985769
NCT00291512|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2011-10-12||||||November 2008|2008-11-01||||||||Interventional|||Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine|Promoting Safer Sex in HIV+ MSM Methamphetamine Users|Completed||Phase 2|||University of California, San Diego|||||f||||||||||||||2017-02-18 16:45:28.452797|2017-02-18 16:45:28.452797
NCT00291499|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2012-11-27|||June 2005||2005-06-01|November 2012|2012-11-01|August 2010|Actual|2010-08-01|December 2009|Actual|2009-12-01||Interventional|||Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand|Clinical Evaluation of Condrosulf 800 mg in the Treatment of Symptomatic OA of the Hand: a 6-month, Double-blind, Placebo Controlled Study|Completed||Phase 3|162|Actual|IBSA Institut Biochimique SA||2|||f||||||||||||||2017-02-18 16:45:28.542316|2017-02-18 16:45:28.542316
NCT00291486|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2009-03-02|||October 2003||2003-10-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer|Phase I Trial of Oral Capecitabine Combined With 131I-huA33 in Patients With Metastatic Colorectal Cancer|Completed||Phase 1|30|Anticipated|Ludwig Institute for Cancer Research||1|||f||||f||||||||||2017-02-18 16:45:28.66072|2017-02-18 16:45:28.66072
NCT00291473|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2009-03-02|||July 2005||2005-07-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers|Safety and Immunogenicity of Cholesterol-Bearing Hydrophobized Pullulan HER2 Protein 146 (CHP-HER2) and NY-ESO-1 Protein (CHP-NY-ESO-1) in Combination With OK-432 in HER2- and/or NY-ESO-1-Expressing Cancers|Completed||Phase 1|9|Anticipated|Ludwig Institute for Cancer Research|||||f||||||||||||||2017-02-18 16:45:28.766125|2017-02-18 16:45:28.766125
NCT00291460|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2006-08-18|||February 2006||2006-02-01|February 2006|2006-02-01|March 2008||2008-03-01|||||Interventional|||Inspiratory Muscle Training in Hypercapnic COPD|Randomized Controlled Trial of Inspiratory Muscle Training in Patients With Stable Hypercapnic Respiratory Failure Due to COPD|Unknown status|Recruiting|Phase 4|40||Krankenhaus Kloster Grafschaft|||||f||||||||||||||2017-02-18 16:45:28.854024|2017-02-18 16:45:28.854024
NCT00291447|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2006-08-11|||May 2005||2005-05-01|August 2006|2006-08-01|May 2006||2006-05-01|||||Interventional|||111-In-ch806 in Patients With Advanced Tumours Expressing the 806 Antigen|A Phase 1 Single Dose Escalation Trial of ch806 in Patients With Advanced Tumours Expressing the 806 Antigen|Completed||Phase 1|12||Ludwig Institute for Cancer Research|||||f||||||||||||||2017-02-18 16:45:28.951325|2017-02-18 16:45:28.951325
NCT00291434|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2006-05-03|||March 1999||1999-03-01|January 2005|2005-01-01|June 2005||2005-06-01|||||Observational|||Altered and Conventional Fractionated Radiotherapy in Patients With Head and Neck Cancer|Hyperfractionation and Accelerated Fractionation in Comparison With Conventional Fractionation in Definitive Radiotherapy of Squamous Cell Carcinoma of Larynx, Oropharynx and Hypopharynx|Completed||Phase 1|152||Institute of Radiotherapy and Oncology, Macedonia|||||f||||||||||||||2017-02-18 16:45:29.056802|2017-02-18 16:45:29.056802
NCT00291408|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2015-05-28|||April 2006||2006-04-01|April 2008|2008-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD|A Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Effect of Symbicort® and Pulmicort® on HAT and HDAC Expression and Activity in Induced Sputum Cells Obtained From COPD Patients.|Completed||Phase 4|48|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 16:45:29.219141|2017-02-18 16:45:29.219141
NCT00291395|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2006-10-25|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers||Terminated||Phase 1|12||Danish Headache Center|||||f||||||||||||||2017-02-18 16:45:29.341237|2017-02-18 16:45:29.341237
NCT00291382|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2017-01-19|||November 2005|Actual|2005-11-01|January 2017|2017-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product|A Multicentre, Stratified, Randomised, Double Blind, Parallel Group Trial to Evaluate Whether a Treatment Strategy Based on Aiming for Total Control Results in Better AHR Than a Treatment Strategy Based on Maintaining Well Control|Completed||Phase 4|150|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:45:29.424819|2017-02-18 16:45:29.424819
NCT00291369|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2006-02-15|||December 1999||1999-12-01|February 2006|2006-02-01|February 2005||2005-02-01|||||Interventional|||Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis|PERCY QUATTRO: Medroxyprogesterone, Interferon Alpha-2a, Interleukin 2 or Combination of Both Cytokines in Patients With Metastatic Renal Carcinoma of Intermediate Prognosis|Completed||Phase 3|456||Centre Leon Berard|||||f||||||||||||||2017-02-18 16:45:29.571477|2017-02-18 16:45:29.571477
NCT00291356|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2015-04-14|||January 2006||2006-01-01|April 2015|2015-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients|A Double-blind, Randomized, Placebo-controlled, Repeat Dose Study to Compare the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK189075 With GW869682 in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|45|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:45:29.677003|2017-02-18 16:45:29.677003
NCT00291343|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2016-10-27|||February 2006||2006-02-01|October 2016|2016-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study|Booster Vaccination Study to Assess Immunogenicity & Safety of a Dose of GSK Biologicals' Mencevax™ ACWY & 1/5th of a Dose of Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study|Completed||Phase 3|296|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:45:29.782982|2017-02-18 16:45:29.782982
NCT00291330|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2014-06-03|2010-11-18||February 2006||2006-02-01|April 2014|2014-04-01||||May 2009|Actual|2009-05-01||Interventional|RE-COVER I||Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism|A Phase III, Randomised, Double Blind, Parallel-group Study of the Efficacy and Safety of Oral Dabigatran Etexilate 150 mg Twice Daily Compared to Warfarin (INR 2.0-3.0) for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism (VTE), Following Initial Treatment (5-10 Days) With a Parenteral Anticoagulant Approved for This Indication.|Completed||Phase 3|2564|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 16:45:29.930855|2017-02-18 16:45:29.930855
NCT00291317|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2012-08-10|2011-06-21||January 2006||2006-01-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|September 2008|Actual|2008-09-01||Interventional|||The Effect of FES on Children With Spinal Cord Injury|The Effect of FES on Children With Spinal Cord Dysfunction|Completed||N/A|6|Actual|Children's Specialized Hospital|Difficulty for participants to attend sessions. Difficulties with recruitment.|1|||f||||f||||||||||2017-02-18 16:45:31.748506|2017-02-18 16:45:31.748506
NCT00291304|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-13|2016-02-23|||March 2006||2006-03-01|December 2011|2011-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma|Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma|Terminated||Phase 2|72|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 16:45:31.987703|2017-02-18 16:45:31.987703
NCT00291278|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-11|2017-01-24|||February 7, 2006||2006-02-07|February 10, 2009|2009-02-10|February 10, 2009||2009-02-10|||||Observational|||Effects of Endometriosis on Bone Mineral Density|The Effects of Endometriosis on Bone Mineral Density|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:45:32.086655|2017-02-18 16:45:32.086655
NCT00291265|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-11|2017-01-24|||February 9, 2006||2006-02-09|February 2, 2010|2010-02-02|February 2, 2010||2010-02-02|||||Observational|||Measures of Motor Impairment in Early Parkinson's Disease|Testing Objective Measures of Motor Impairment in Early Parkinson's Disease|Completed||N/A|10|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:45:32.172339|2017-02-18 16:45:32.172339
NCT00291239|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2009-04-02|||February 2006||2006-02-01|April 2009|2009-04-01|July 2009|Anticipated|2009-07-01|December 2008|Actual|2008-12-01||Interventional|||Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major Depression|Phase 4 Study on the Effect of Partial Sleep Deprivation on Cognition and the IL-6-gp130-System in Individuals With Major Depression|Unknown status|Active, not recruiting|Phase 4|40|Anticipated|Zentrum für Integrative Psychiatrie|||||f||||||||||||||2017-02-18 16:45:32.257836|2017-02-18 16:45:32.257836
NCT00291226|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-11-01|2016-09-06||March 2006||2006-03-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Glycine vs Placebo for the Schizophrenia Prodrome|Glycine vs Placebo for the Schizophrenia Prodrome|Completed||Phase 2/Phase 3|8|Actual|Yale University||2|||f||||t||||||||No||2017-02-18 16:45:32.345973|2017-02-18 16:45:32.345973
NCT00291213|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2014-06-05||||||June 2014|2014-06-01||||April 2006|Actual|2006-04-01||Interventional|||Levetiracetam Treatment of Tardive Dyskinesia||Completed||Phase 3|50|Actual|Yale University||2|||f||||||||||||||2017-02-18 16:45:32.670922|2017-02-18 16:45:32.670922
NCT00291200|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2014-06-09|||August 2003||2003-08-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Enhancing the Prospective Prediction of Psychosis|Enhancing the Prospective Prediction of Psychosis|Completed||N/A|268|Actual|Yale University|||2||f||||||||||Samples With DNA|"~     Blood samples for routine laboratory studies~   "|||2017-02-18 16:45:32.766017|2017-02-18 16:45:32.766017
NCT00005456|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||December 1990||1990-12-01|March 2005|2005-03-01|November 1995|Actual|1995-11-01|||||Observational|||Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.807321|2017-02-18 18:14:57.807321
NCT00291187|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2014-10-08|2014-02-28||February 2006||2006-02-01|October 2014|2014-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional||Modified Intent-to-Treat. A total of 411 subjects received treatment.|VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Investigate the Efficacy and Safety of VEC-162 and Matching Placebo in Healthy Male and Female Subjects With Induced Transient Insomnia|Completed||Phase 3|411|Actual|Vanda Pharmaceuticals||4|||f||||f||||||||||2017-02-18 16:45:32.936991|2017-02-18 16:45:32.936991
NCT00291174|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-08-15|||April 2006||2006-04-01|August 2016|2016-08-01|January 2008|Actual|2008-01-01|July 2006|Actual|2006-07-01||Observational|||Measuring Electrical Resistance of Different Tissues on the Outer Surface of the Heart|Impedance Measurement of Epicardial Substrate for Ventricular Arrhythmias: Case Control Series of Patients With and Without Myocardial Scarring|Terminated||N/A|8|Actual|University of Pennsylvania|||1|Unforeseen difficulty identifying and enrolling eligible subjects|f||||||||||||||2017-02-18 16:45:33.485533|2017-02-18 16:45:33.485533
NCT00291161|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-05-10|2015-03-18||December 2006||2006-12-01|May 2016|2016-05-01|February 2011|Actual|2011-02-01|September 2010|Actual|2010-09-01||Interventional|PDC||Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters|Partners in Dementia Care|Completed||N/A|994|Actual|VA Office of Research and Development||2|||f||||f||||||||Undecided||2017-02-18 16:45:33.587093|2017-02-18 16:45:33.587093
NCT00291148|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2012-07-26|||March 2006||2006-03-01|March 2011|2011-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain|A Comparative Single Center, Randomized Neuropathic Pain Assessment Study Involving Patients With Clinically Definite Multiple Sclerosis (MS) Receiving Treatment With Either Pregabalin or Paroxetine|Completed||Phase 3|75|Anticipated|University of Manitoba||2|||f||||||||||||||2017-02-18 16:45:36.957029|2017-02-18 16:45:36.957029
NCT00291135|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-05-11|2013-06-24||January 2003||2003-01-01|May 2016|2016-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Protocol for Women at Increased Risk of Developing Breast Cancer|Study of the Effect of Letrozole on Breast Biomarkers of High Risk Postmenopausal Women Receiving Hormone Replacement Therapy|Completed||Phase 2|42|Actual|University of Kansas Medical Center||1|||f||||f||||||||No|Global results will be published.|2017-02-18 16:45:37.057966|2017-02-18 16:45:37.057966
NCT00291122|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2008-09-15|||January 2003||2003-01-01|September 2008|2008-09-01|December 2005||2005-12-01|||||Observational|||An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer|Quantitative Real Time PCR in Formalin Fixed Breast Tissue From Biopsy and Re-Excision Specimens: An Ancillary Protocol to a Chemoprevention Trial of Celecoxib|Completed||Phase 1|100||University of Kansas Medical Center|||||f||||||||||||||2017-02-18 16:45:37.283951|2017-02-18 16:45:37.283951
NCT00291109|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2008-09-15|||January 2003||2003-01-01|September 2008|2008-09-01|July 2005||2005-07-01|||||Observational|||An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg|Quantitative Real Time PCR in Cytolytic Formalin Fixed Breast Cells Obtained by Periareolar Fine Needle Aspiration. An Ancillary Protocol to a Chemoprevention Trial of Letrozole|Completed||Phase 1/Phase 2|40||University of Kansas Medical Center|||||f||||||||||||||2017-02-18 16:45:37.369774|2017-02-18 16:45:37.369774
NCT00291096|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2017-01-04|||January 1989||1989-01-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Protocol for Women at Increased Risk of Developing Breast Cancer|High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer|Recruiting||N/A|3000|Anticipated|University of Kansas Medical Center|||1||f||||f||||||Samples Without DNA|"~     RPFNA specimens, serum, NAF~   "|No||2017-02-18 16:45:37.452209|2017-02-18 16:45:37.452209
NCT00291083|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2012-02-06|||October 2005||2005-10-01|February 2012|2012-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer|Study of Manual Nipple Fluid Aspiration IN Post-Menopausal Women|Completed||N/A|229|Actual|University of Kansas Medical Center|||1||f||||f||||||||||2017-02-18 16:45:37.542071|2017-02-18 16:45:37.542071
NCT00291070|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2008-04-28|||October 2005||2005-10-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effects of L-Theanine in Boys With ADHD|A Double Blind, Randomized Placebo Controlled Clinical Trial Examining the Effects of L-Theanine (Suntheanine®) in Male Child Subjects With Attention Deficit Hyperactivity Disorder|Completed||Phase 2|100|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 16:45:37.621177|2017-02-18 16:45:37.621177
NCT00291057|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2013-12-19|||February 2006||2006-02-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice|Phase II, Multi-center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis|Terminated||Phase 2|30|Anticipated|Taro Pharmaceuticals USA||1||Lack of enrollment|f||||f||||||||||2017-02-18 16:45:37.703997|2017-02-18 16:45:37.703997
NCT00291044|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2010-11-18|||September 2005||2005-09-01|November 2010|2010-11-01|September 2009|Actual|2009-09-01|||||Observational|||HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women|HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women|Completed||N/A|300|Actual|Stony Brook University|||1||f||||||||||||||2017-02-18 16:45:37.808429|2017-02-18 16:45:37.808429
NCT00291031|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2013-10-16|||February 2006||2006-02-01|October 2013|2013-10-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Study of the Effect of Imagery Rehearsal Therapy (IRT) of Nightmares|A Randomised Controlled Trial of Imagery Rehearsal Therapy (IRT) of Nightmares in a Psychiatric Population|Completed||Phase 1/Phase 2|112|Actual|GGZ Centraal||2|||f||||t||||||||||2017-02-18 16:45:38.15525|2017-02-18 16:45:38.15525
NCT00291018|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2015-08-04|||August 2003||2003-08-01|July 2014|2014-07-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Safety and Efficacy Study Comparing ProDisc-C to ACDF Surgery to Treat SCDD|A Multi-Center, Prospective, Randomized, Controlled Clinical Trial Comparing the Safety and Effectiveness of ProDisc-C to Anterior Cervical Discectomy and Fusion (ACDF) Surgery in the Treatment of Symptomatic Cervical Disc Disease (SCDD)|Completed||N/A|279|Actual|Synthes USA HQ, Inc.||2|||f||||f||||||||||2017-02-18 16:45:38.29126|2017-02-18 16:45:38.29126
NCT00291005|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2009-03-26|||August 2004||2004-08-01|March 2009|2009-03-01||||||||Interventional|||PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone|A Multicenter Phase II Open Label Non-Comparative Trial of RP56976 Administered Every Three Weeks in Combination With Daily Prednisolone for Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|42||Sanofi|||||f||||||||||||||2017-02-18 16:45:38.390151|2017-02-18 16:45:38.390151
NCT00290992|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2009-03-27|||June 2005||2005-06-01|March 2009|2009-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Rasburicase for Hyperuricemia|Open-Label, Multi-Center Study of SR29142 as Uricolytic Therapy/Prophylaxis for Hyperuricemia in Pediatric Patients With Newly Diagnosed Hematological Malignancies at High Risk for Tumor Lysis Syndrome|Completed||Phase 2|30|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:45:38.475666|2017-02-18 16:45:38.475666
NCT00290979|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2009-08-25|||December 2004||2004-12-01|March 2009|2009-03-01||||||||Interventional|||Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus|Evaluation of Efficacy and Safety of HMR1964 (Insulin Glulisine) in Subjects With Type 1 Diabetes Mellitus; Insulin Lispro Controlled, Open, Randomized, Parallel Group, Non-inferiority Study, for 28 Weeks|Completed||Phase 3|250||Sanofi|||||f||||||||||||||2017-02-18 16:45:38.56668|2017-02-18 16:45:38.56668
NCT00290966|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2009-04-28|||October 1998||1998-10-01|April 2009|2009-04-01|May 2003||2003-05-01|||||Interventional|||Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer|Open Label, Randomized Multicentre Phase II/III Study of Docetaxel in Combination With Cisplatin (CDDP) or Docetaxel in Combination With 5-Fluorouracil (5-FU) and CDDP Compared to the Combination of CDDP and 5-FU in Patients With Metastatic or Locally Recurrent Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease|Completed||Phase 2/Phase 3|610||Sanofi|||||f||||||||||||||2017-02-18 16:45:38.665654|2017-02-18 16:45:38.665654
NCT00290953|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2008-12-22|||October 2002||2002-10-01|December 2008|2008-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|SESAME||Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide|A Double Blind, Randomized, Phase II-III Maintenance Study of SR48692 Versus Placebo in Patients With Extensive Stage Small Cell Lung Cancer Following a First Line Chemotherapy With Cisplatin + Etoposide|Completed||Phase 2/Phase 3|432|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:45:38.753247|2017-02-18 16:45:38.753247
NCT00290940|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2007-09-10|||January 2006||2006-01-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of CS-917 as Monotherapy for Type 2 Diabetes|Completed||Phase 2|400|Anticipated|Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 16:45:38.87143|2017-02-18 16:45:38.87143
NCT00290927|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2009-08-25|||December 2003||2003-12-01|March 2009|2009-03-01||||||||Interventional|||Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus|Evaluation of Efficacy and Safety of HMR1964 Intensive Therapy in Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled With Oral Hypoglycemic Agents (OHA); OHA Therapy Controlled, Open, Randomized, Parallel Group, Comparative (Superiority), 16-week, Multinational, Multicenter Study|Completed||Phase 3|390||Sanofi|||||f||||||||||||||2017-02-18 16:45:39.032317|2017-02-18 16:45:39.032317
NCT00289848|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2015-05-20|2010-03-18||March 2006||2006-03-01|May 2015|2015-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of MK0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 3|530|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:45:39.121974|2017-02-18 16:45:39.121974
NCT00289835|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2011-11-23|||February 2006||2006-02-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|VELETI||Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial|Sealing Moderate Coronary Saphenous VEin Graft LEsions With the Paclitaxel-eluting Stent (Taxus) as a New Approach to Maintain Vein Graft Patency and Reduce Cardiac Events: a Pilot Intravascular Ultrasound Study.|Completed||Phase 4|57|Actual|Laval University||2|||f||||f||||||||||2017-02-18 16:45:39.605264|2017-02-18 16:45:39.605264
NCT00289822|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2006-11-29|||January 2002||2002-01-01|February 2006|2006-02-01|January 2005||2005-01-01|||||Interventional|||Cell Therapy for Coronary Heart Disease|Cell Therapy for Coronary Heart Disease: Infusion of Autologous Ex Vivo Cultivated Endothelial Progenitor Cells (EPCs)” and Autologous Bone Marrow Progenitor Cells in Crossover Design for Improvement of Vascularization and Cardiac Function|Terminated||Phase 2|75||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 16:45:39.711868|2017-02-18 16:45:39.711868
NCT00289809|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2009-12-17|||September 2006||2006-09-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients|A Perspective Phase I and II Trial of Liposome-encapsulated Doxorubicin (TLC D-99) in Combination With Ifosfamide in Patients With Metastatic Soft Tissue Sarcoma|Completed||Phase 1/Phase 2|36|Anticipated|Istituto Clinico Humanitas||1|||f||||f||||||||||2017-02-18 16:45:39.813507|2017-02-18 16:45:39.813507
NCT00289796|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2017-02-06|||July 2004||2004-07-01|February 2017|2017-02-01|December 2006|Actual|2006-12-01|April 2006|Actual|2006-04-01||Interventional|||Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine|Assess the Feasibility of an Investigational Vaccination Regimen, Compared to a 3-dose Primary Vaccination With GSK Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib Vaccine) Following Hepatitis B Vaccination at Birth. Primary Vaccination is Followed in the 2nd Year of Life by a Booster Dose of Infanrix-hexa|Completed||Phase 2|121|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:45:40.168143|2017-02-18 16:45:40.168143
NCT00289783|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-11-03|2012-06-15||February 2006||2006-02-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine|A Phase III, Randomized, Multinational Study, Double-blinded for the Immunogenicity and Consistency Evaluation of 3 Hib-MenCY-TT Vaccine Lots and Single-blinded and Controlled for the Evaluation of Safety and Immunogenicity of GSK Biologicals' Haemophilus Influenzae Type b and Neisseria Meningitidis Serogroups C and Y-tetanus Toxoid Conjugate Vaccine Combined (Hib-MenCY-TT) Compared to Monovalent Hib Vaccine in Healthy Infants at 2, 4, 6, and 12 to 15 Months of Age.|Completed||Phase 3|4441|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:45:40.370947|2017-02-18 16:45:40.370947
NCT00290680|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2012-04-26|||March 2005||2005-03-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors|Phase I Trial of Bortezomib (VELCADE™) and Celecoxib in Patients With Advanced Solid Tumors|Completed||Phase 1|36|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-02-18 16:45:50.060724|2017-02-18 16:45:50.060724
NCT00289770|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-09-20|2010-11-30||November 2004||2004-11-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults|A Double Blind Randomised, Comparative Study of the Immunogenicity and Reactogenicity of Three Different Lots of GlaxoSmithKline Biologicals' Combined Hepatitis A - Hepatitis B Vaccine When Administered in Healthy Adults|Completed||Phase 3|50|Actual|GlaxoSmithKline|A decrease in the specificity of the anti-HB ELISA assay had been observed in some studies for low levels of antibody (10-100 mIU/mL). The table shows updated results following complete retesting and reanalysis.|3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:45:43.20591|2017-02-18 16:45:43.20591
NCT00289757|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-09-06|2009-12-10||January 2004||2004-01-01|September 2016|2016-09-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule|Double-blind, Randomized Study to Evaluate the Immunogenicity and Reactogenicity of Three Different Lots of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Containing 1440 EL.U of Antigen Per mL and Injected According to a 0, 6 Month Schedule in Healthy Adult Subjects|Completed||Phase 4|78|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:45:43.57396|2017-02-18 16:45:43.57396
NCT00289744|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2014-10-02|2010-04-08||February 2004||2004-02-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule|Long-Term Follow-up Study to Evaluate the Immune Persistence of GSK Biologicals' Combined Hepatitis A / Hepatitis B Vaccine in Healthy Children|Completed||Phase 3|171|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 16:45:43.931599|2017-02-18 16:45:43.931599
NCT00289731|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-09-15|||November 2003||2003-11-01|September 2016|2016-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc|Evaluate the Effect of Several Risk Factors That Are Likely to Influence the Immunogenicity of GSK Biologicals' Combined Hepatitis A & B Vaccine, vs Separately Administered Monovalent Hepatitis A and Hepatitis B Vaccines|Completed||Phase 4|577|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:45:44.366429|2017-02-18 16:45:44.366429
NCT00289718|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2014-11-06|2010-01-11||November 2004||2004-11-01|November 2014|2014-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule|Long-Term Persistence Follow-up Study to Evaluate the Immune Persistence of GSK Biologicals' Combined Hepatitis A / Hepatitis B Vaccine in Healthy Adult Volunteers|Completed||Phase 3|51|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:45:44.497359|2017-02-18 16:45:44.497359
NCT00289705|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2017-02-01|||February 2006||2006-02-01|February 2017|2017-02-01|February 2018|Anticipated|2018-02-01|November 2017|Anticipated|2017-11-01||Interventional|||Surgical Intervention for Morbidly Obese Adolescents|Surgical Intervention With Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity in Adolescence - a Matched Control Study|Active, not recruiting||Phase 3|80|Anticipated|Göteborg University||2|||f||||t||||||||||2017-02-18 16:45:44.786329|2017-02-18 16:45:44.786329
NCT00288964|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2015-12-28|||November 2005||2005-11-01|December 2015|2015-12-01||||||||Interventional|||Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure|Compassionate Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure - A Clinical Trial|Withdrawn||Phase 3|0|Actual|Alung Technologies||1||Sponsor no longer pursuing regulatory approval of investigational device|f||||||||||||||2017-02-18 16:45:44.891116|2017-02-18 16:45:44.891116
NCT00288236|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-04-06|||January 2006||2006-01-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)|A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Fixed-Dose Study Evaluating the Effect of One Dose of Rimonabant (20 mg/Day) on Glycemic Control in Type 2 Diabetic Patients Inadequately Controlled With Insulin|Completed||Phase 3|368|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:45:44.988572|2017-02-18 16:45:44.988572
NCT00288223|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-12-08|||January 2006||2006-01-01|December 2009|2009-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Telithromycin in Acute Exacerbation of Chronic Bronchitis|Multicenter Non Comparative Phase IV Study on the Safety and Efficacy of Telithromycin 800 mg Per Day for 5 Days in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adults|Terminated||Phase 4|54|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:45:45.103855|2017-02-18 16:45:45.103855
NCT00288210|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2006-02-09|||March 2003||2003-03-01|February 2006|2006-02-01|March 2006||2006-03-01|||||Interventional|||Sirolimus Eluting Stenting in Acute Myocardial Infarction|Randomized Study Of Sirolimus Eluting Stent Vs Conventional Stent In Acute Myocardial Infarction Acronym SESAMI|Unknown status|Active, not recruiting|Phase 4|||San Camillo Hospital, Rome|||||f||||||||||||||2017-02-18 16:45:45.207726|2017-02-18 16:45:45.207726
NCT00290914|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2012-05-08||||||May 2012|2012-05-01||||||||Interventional|||Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder||Completed||Phase 2|||Pharmacology Research Institute|||||||||||||||||||2017-02-18 16:45:45.532073|2017-02-18 16:45:45.532073
NCT00290901|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2008-03-21|||March 2006||2006-03-01|March 2008|2008-03-01||||December 2006|Actual|2006-12-01||Interventional|||Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.|A Six Week Double-Blind, Randomized, Multicenter Comparison Study of the Analgesic Effectiveness of Celecoxib 200 mg BID Compared to Tramadol Hydrochloride 50 mg QID in Subjects With Chronic Low Back Pain|Completed||Phase 4|754||Pfizer|||||||||||||||||||2017-02-18 16:45:45.606911|2017-02-18 16:45:45.606911
NCT00290693|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-12-14|2013-02-20||June 2004||2004-06-01|December 2016|2016-12-01|June 2010|Actual|2010-06-01|August 2008|Actual|2008-08-01||Interventional|||Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer|"A Multicenter Phase II Study of Capecitabine and Docetaxel for Previously Treated Pancreatic Cancer Patients CapTere"|Completed||Phase 2|45|Actual|University of Miami|The results are for 24 evaluable patients enrolled before June 2007. The study has not been published.|1|||f||||t||||||||||2017-02-18 16:45:49.779436|2017-02-18 16:45:49.779436
NCT00290888|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2015-03-09|2014-03-05||April 2004||2004-04-01|March 2015|2015-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty|Arthroscopic Rotator Cuff Repair With and Without Arthroscopic Acromioplasty in the Treatment of Full Thickness Rotator Cuff|Completed||N/A|86|Actual|Panam Clinic|Variation in surgical technique and post-op rehabilitation. We do not have confirmation of cuff healing status as no imaging was carried out post-operatively. Assessment of AC morphology is subjective & based solely on pre-operative radiographs.|2|||f||||f||||||||||2017-02-18 16:45:45.747865|2017-02-18 16:45:45.747865
NCT00290875|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-04-20|||January 2003||2003-01-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Implementation of the Canadian C-Spine Rule|Implementation of the Canadian C-Spine Rule: Phase III|Completed||Phase 3|11824|Actual|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-02-18 16:45:46.15925|2017-02-18 16:45:46.15925
NCT00290862|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2008-10-13|||September 2004||2004-09-01|October 2008|2008-10-01|March 2009||2009-03-01|||||Interventional|||A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by Osteoporosis|A Randomized, Controlled Clinical Study to Evaluate the Safety and Effectiveness of CORTOSS® Synthetic Cortical Bone Void Filler in Vertebral Augmentation|Unknown status|Active, not recruiting|N/A|256|Actual|Orthovita d/b/a Stryker||2|||f||||||||||||||2017-02-18 16:45:46.264386|2017-02-18 16:45:46.264386
NCT00290849|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2012-05-04|||March 2005||2005-03-01|April 2010|2010-04-01|September 2007|Actual|2007-09-01|June 2006|Actual|2006-06-01||Observational|||ImproveR International (BI-001-IM)|European Registry of Consecutive Patients Undergoing PCI Evaluating the Use of the Thrombin-specific Anticoagulant Bivalirudin With Focus on Patient Selection, Convenience and Safety Aspects.|Completed||N/A|4000||Nycomed|||1||f||||t||||||||||2017-02-18 16:45:46.397589|2017-02-18 16:45:46.397589
NCT00290836|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2012-05-04|||May 2004||2004-05-01|May 2012|2012-05-01|August 2007|Actual|2007-08-01|||||Interventional|||Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)|An Open, Randomised, Prospective, Single-centre Phase IV Trial to Assess Efficacy and Safety of TachoComb H Versus Standard Surgical Treatment (i.e. Suture) in Patients Undergoing Prostatectomy|Completed||Phase 4|120||Nycomed|||||f||||t||||||||||2017-02-18 16:45:46.482881|2017-02-18 16:45:46.482881
NCT00290823|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2017-02-02|||April 2006||2006-04-01|February 2017|2017-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients|Treatment of Intraparenchymal Neurocysticercosis: Effect of Increased Dosing of Corticosteroids on Seizure Frequency|Completed||Phase 3|110|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:45:46.569234|2017-02-18 16:45:46.569234
NCT00290810|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2014-04-21|2013-03-22||December 2005||2005-12-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|October 2008|Actual|2008-10-01||Interventional|||Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|A Phase II Trial of Bevacizumab to Prevent or Delay Disease Progression in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:45:46.707746|2017-02-18 16:45:46.707746
NCT00290771|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2011-04-20|2010-12-20||February 2006||2006-02-01|April 2011|2011-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)|A Phase II, Open-label, Multicenter Study Evaluating the Efficacy of Imatinib Plus Hydroxyurea (HU) in Patients With Progressive Glioblastoma Multiforme (GBM) Receiving or Not Receiving Enzyme-inducing Anticonvulsant Drugs (EIACDs)|Terminated||Phase 2|231|Actual|Novartis||2||Lack of efficacy|f||||f||||||||||2017-02-18 16:45:47.009425|2017-02-18 16:45:47.009425
NCT00290758|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-12-14|2016-02-10||January 2006||2006-01-01|December 2016|2016-12-01|July 2009|Actual|2009-07-01|March 2009|Actual|2009-03-01||Interventional||Participants who had >4000 epithelial cells in the first and the second rFNA sample.|Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer|Phase IIB Trial of G-2535 (Unconjugated Isoflavones-100) in Women at High Risk for Breast Cancer|Completed||Phase 2|126|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||No||2017-02-18 16:45:47.855672|2017-02-18 16:45:47.855672
NCT00290745|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2014-03-28|||January 2004||2004-01-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|July 2009|Actual|2009-07-01||Interventional|||Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ|Primary Hormonal Therapy for Ductal Carcinoma in Situ: Exploration of a Novel Approach to the Clinical Management of Noninvasive Breast Cancer|Completed||N/A|56|Actual|University of California, San Francisco||1|||f||||||||||||||2017-02-18 16:45:48.724021|2017-02-18 16:45:48.724021
NCT00290732|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2013-10-07|2013-03-01||November 2005||2005-11-01|October 2013|2013-10-01|October 2011|Actual|2011-10-01|May 2011|Actual|2011-05-01||Interventional|||Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer|A Phase I Study Assessing the Feasibility and Safety of Intraductal Administration of Pegylated Liposomal Doxorubicin (Doxil) in Women With Breast Cancer|Completed||Phase 1|20|Actual|Sidney Kimmel Comprehensive Cancer Center|Duct cannulation was not successful in all participants; possibly due to extensive disease or prior excisional biopsy (2 subjects).|2|||f||||f||||||||||2017-02-18 16:45:48.831943|2017-02-18 16:45:48.831943
NCT00290719|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2014-05-07|||November 2005||2005-11-01|May 2014|2014-05-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery|A Phase I/II Study to Evaluate Safety and Efficacy in Patients Who Have Resectable Esophageal Cancer and Are Treated With Neoadjuvant Cisplatin, Irinotecan (CPT-11) ZD1839 (IRESSA), and Radiotherapy Followed by Surgical Resection|Terminated||Phase 1|6|Actual|University of California, San Francisco||1||low enrollment|f||||t||||||||||2017-02-18 16:45:49.299832|2017-02-18 16:45:49.299832
NCT00290706|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-08-11|||September 2005||2005-09-01|August 2016|2016-08-01|March 2019|Anticipated|2019-03-01|March 2018|Anticipated|2018-03-01||Interventional|||A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma|A Phase I/II Trial of Combination Bortezomib (VELCADE) and Gemcitabine Therapy for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|32|Actual|Northwestern University||1||"Closed per Data Monitoring Committee due to toxicity & incomplete treatment of patients~   resulting in poor data."|f||||t||||||||||2017-02-18 16:45:49.652004|2017-02-18 16:45:49.652004
NCT00290667|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-11-25|||February 2004||2004-02-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|December 2013|Actual|2013-12-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma|2-Weekly CHOP Chemotherapy With Dose-Dense Rituximab for the Treatment of Patients Aged 61 to 80 Years With Aggressive CD-20 Positive B-Cell Lymphomas: A Phase-II/Pharmacokinetic Study (CHOP-R-ESC)|Completed||Phase 2|586|Actual|German High-Grade Non-Hodgkin's Lymphoma Study Group||2|||f||||t||||||||||2017-02-18 16:45:50.173482|2017-02-18 16:45:50.173482
NCT00290654|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-06-16|2015-04-29||December 2002||2002-12-01|November 2012|2012-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ|Twin Cities Brachytherapy Study for Ductal Carcinoma in Situ A Phase II Trial|Terminated||Phase 2|45|Actual|Masonic Cancer Center, University of Minnesota||1||Unable to recruit further patients.|f||||t||||||||||2017-02-18 16:45:50.69451|2017-02-18 16:45:50.69451
NCT00290641|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2012-10-09|||April 2001||2001-04-01|October 2012|2012-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer|A Cyclophosphamide/Fludarabine/Total Body Irradiation Preparative Regimen for Patients With Hematological Malignancy Receiving Unrelated Donor Umbilical Cord Blood Transplantation|Completed||N/A|68|Actual|Masonic Cancer Center, University of Minnesota|||||f||||t||||||||||2017-02-18 16:45:50.984962|2017-02-18 16:45:50.984962
NCT00290628|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2012-10-09|||October 1999||1999-10-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer|Transplantation of Umbilical Cord Blood From Related and Unrelated Donors|Terminated||N/A|43|Actual|Masonic Cancer Center, University of Minnesota||||Replaced with another study|f||||t||||||||||2017-02-18 16:45:51.105041|2017-02-18 16:45:51.105041
NCT00290615|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2013-03-25|2013-02-12||January 2006||2006-01-01|March 2013|2013-03-01|January 2011|Actual|2011-01-01|January 2009|Actual|2009-01-01||Interventional|||Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery|Phase II Study of Oxaliplatin, Capecitabine, Cetuximab, and Bevacizumab in the Treatment of Metastatic Colorectal Cancer|Completed||Phase 2|30|Actual|Duke University||1|||f||||t||||||||||2017-02-18 16:45:51.222801|2017-02-18 16:45:51.222801
NCT00290602|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2007-01-16|||February 2004||2004-02-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome|Prospective Phase II Study of Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome (ARDS) After Thoracic Surgery (E-START)|Completed||Phase 2|40||National Cancer Center, Korea|||||f||||||||||||||2017-02-18 16:45:51.509025|2017-02-18 16:45:51.509025
NCT00290589|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2009-10-26|||June 2003||2003-06-01|October 2009|2009-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Trial of Corticosteroids for Low Back Pain|Utility of Intramuscular Corticosteroids for Radicular Low Back Pain|Completed||Phase 3|76|Anticipated|Montefiore Medical Center|||||f||||||||||||||2017-02-18 16:45:51.61881|2017-02-18 16:45:51.61881
NCT00290576|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2008-06-06|||April 2004||2004-04-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|April 2007|Actual|2007-04-01||Interventional|||Digestive and Nutritional Effects of Probiotics Supplementation in Premature Newborns|Digestive and Nutritional Effects of Probiotics (Bifidobacterium Longum and Lactobacillus GG) Supplementation in Premature Newborns|Completed||N/A|127|Actual|Nantes University Hospital|||||f||||||||||||||2017-02-18 16:45:51.731475|2017-02-18 16:45:51.731475
NCT00290563|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2009-12-14|||February 2006||2006-02-01|December 2009|2009-12-01||||August 2007|Actual|2007-08-01||Interventional|||A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase II Study of MK0594 in Patients With Overactive Bladder|A Multicenter, Double-Blind, Randomized, Placebo- and Active-Controlled, Parallel-Group, Dose-Ranging Study of MK0594 in Patients With Overactive Bladder|Completed||Phase 2|557|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:45:51.821614|2017-02-18 16:45:51.821614
NCT00290550|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-07-24|||June 2006||2006-06-01|July 2015|2015-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)|A Phase IIA Study Evaluating the Efficacy of MK0457 as a 5-Day Continuous Infusion in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|22|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 16:45:51.895487|2017-02-18 16:45:51.895487
NCT00290537|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-04-13|2009-03-18||January 2006||2006-01-01|August 2009|2009-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase II Study of ZD6474 in Advanced NSCLC|A Phase II Study of ZD6474 Alone and With Chemotherapy in Advanced NSCLC|Terminated||Phase 2|4|Actual|M.D. Anderson Cancer Center||3||Accrual was suboptimal and increasing the number of patients was not feasible.|f||||f||||||||||2017-02-18 16:45:52.044292|2017-02-18 16:45:52.044292
NCT00290524|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2006-04-06|||January 2006||2006-01-01|April 2006|2006-04-01||||||||Interventional|||Early Alimentation Following Colorectal Surgery|Prospective, Multicentric, Randomized Phase III Study Comparing Early Oral Alimentation to Nil Per Os Diet After Colorectal Surgery|Unknown status|Recruiting|Phase 3|800||Maisonneuve-Rosemont Hospital|||||f||||||||||||||2017-02-18 16:45:52.295716|2017-02-18 16:45:52.295716
NCT00290511|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-12-19|||June 2004||2004-06-01|December 2016|2016-12-01||||June 2018|Anticipated|2018-06-01||Interventional|||Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma|A Phase II Study of R-FND, Followed by Zevalin Radioimmunotherapy, and Subsequent Maintenance Rituximab for Advanced Stage Follicular Lymphoma With High-Risk Features|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:45:52.401628|2017-02-18 16:45:52.401628
NCT00290498|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-09-12|||August 2005||2005-08-01|September 2016|2016-09-01||||August 2018|Anticipated|2018-08-01||Interventional|||Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma|Rituximab-HCVAD Alternating Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger|Active, not recruiting||Phase 2|66|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:45:52.535041|2017-02-18 16:45:52.535041
NCT00290485|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2006-04-06|||August 2005||2005-08-01|April 2006|2006-04-01||||||||Interventional|||Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)|A Phase II Study on Preoperative Administration of Gleevec in Patients With Initially Non-Resectable Gastrointestinal Stromal Tumor|Unknown status|Recruiting|Phase 2|50||Maisonneuve-Rosemont Hospital|||||f||||||||||||||2017-02-18 16:45:52.770181|2017-02-18 16:45:52.770181
NCT00290472|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2014-05-07|2013-08-19||March 2004||2004-03-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|A Phase II Study of CCI-779 in B-cell Lymphoma and CLL|Completed||Phase 2|89|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:45:52.878112|2017-02-18 16:45:52.878112
NCT00290459|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-11-21|||December 2003||2003-12-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Prognostic Markers of Gynecologic Cancers|Prognostic Markers of Gynecologic Cancers|Recruiting||N/A|5000|Anticipated|James Graham Brown Cancer Center|||1||f||||||||||||||2017-02-18 16:45:55.956727|2017-02-18 16:45:55.956727
NCT00290433|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2015-07-13|||September 2003||2003-09-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma|A Phase II Study of the Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T Cell Lymphoma|Completed||Phase 2|55|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:45:56.055117|2017-02-18 16:45:56.055117
NCT00290420|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2013-05-21|||March 2006||2006-03-01|May 2013|2013-05-01|November 2007|Anticipated|2007-11-01|November 2007|Anticipated|2007-11-01||Interventional|||Prevention of P. Vivax Malaria During Pregnancy in Bolivia|Prevention of P. Vivax Malaria During Pregnancy: Effects on Mother and Child Health in Santa Cruz, Bolivia. Open, Multicentric, Randomized Clinical Trial, Comparing Prophylaxis Once a Week to Malaria Attack Treatment, Both by Chloroquine.|Withdrawn||Phase 4|0|Actual|Institut de Recherche pour le Developpement||2||important delays and malaria season missed, due to political changes|f||||f||||||||||2017-02-18 16:45:56.179168|2017-02-18 16:45:56.179168
NCT00290407|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2013-05-03|2013-05-03||March 2006||2006-03-01|May 2013|2013-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)|Phase II Study of Rituximab Plus B-Glucan in Patients With Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)|Terminated||Phase 2|2|Actual|James Graham Brown Cancer Center|Study terminated, results data not available|1||terminated due to lack of accrual|f||||t||||||||||2017-02-18 16:45:56.290736|2017-02-18 16:45:56.290736
NCT00290394|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2006-02-09|||March 2004||2004-03-01|March 2004|2004-03-01|August 2004||2004-08-01|||||Interventional|||Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients|Study of PPAR Gamma Agonist-Rosiglitazone in Normotensive Type 2 Diabetics With Ambulatory Blood Pressure Monitoring|Completed||Phase 4|25||Baskent University|||||f||||||||||||||2017-02-18 16:45:56.491433|2017-02-18 16:45:56.491433
NCT00290381|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2015-05-27|||February 2006||2006-02-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||The Effects of OC000459 on Nasal Mediators|The Effects of OC000459 on Nasal Th2 Cytokine Release, Eosinophil Responses, and Nasal Symptoms After Nasal Allergen Challenge (NAC) With Timothy Grass Pollen in Subjects With Allergic Rhinitis Out of Season|Completed||Phase 1|20||Imperial College London|||||f||||||||||||||2017-02-18 16:45:56.590913|2017-02-18 16:45:56.590913
NCT00290368|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2015-10-21|||February 2006||2006-02-01|September 2006|2006-09-01|May 2006||2006-05-01|||||Interventional|||Repeat Nasal Allergen Challenge|Assessment of Inflammatory Mediator and Cellular Changes Following Repeated Nasal Allergen Challenge in Subjects With Allergic Rhinitis Sensitive to Timothy Grass Pollen - a Validation Study|Completed||Phase 2|22||Imperial College London|||||f||||||||||||||2017-02-18 16:45:59.222146|2017-02-18 16:45:59.222146
NCT00290355|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2014-11-20||2011-05-13|May 2002||2002-05-01|November 2014|2014-11-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery|A Phase IIB Study to Assess the Efficacy of GSK 249553 as Adjuvant Therapy Given to MAGE-3-Positive Patients With Non-Small-Cell Lung Cancer in Stage IB (T2/N0) or II (T1/N1 or T2/N1 or T3/N0), Who Have Had Complete Surgical Resection|Completed||Phase 2|182|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:45:59.328883|2017-02-18 16:45:59.328883
NCT00290342|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-10-11|||January 2006||2006-01-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants|A Multicentric Study to Compare the Immunogenicity, Safety & Reactogenicity of GSK Biologicals' DTPa-IPV Vaccine vs. Co-administration of GSK's DTPa Vaccine & Sanofi-Pasteurs' IPV Vaccine at Different Injection Sites, to Healthy Children|Completed||Phase 3|452|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:45:59.502817|2017-02-18 16:45:59.502817
NCT00290329|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2012-11-01|||January 2006||2006-01-01|October 2012|2012-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years|Multicentric, Surveillance Study to Monitor Safety of GSK Biologicals' Purified Meningococcal Polysaccharide Vaccine of Serogroups ACWY in 3,000 Filipino Subjects Aged > 2 Yrs When Administered According to the Prescribing Information.|Completed||Phase 4|249|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:45:59.621336|2017-02-18 16:45:59.621336
NCT00290316|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2006-06-05|||July 2004||2004-07-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver|Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver – A Prospective Study|Unknown status|Active, not recruiting|Phase 2|||Central Texas Veterans Health Care System|||||f||||||||||||||2017-02-18 16:45:59.733337|2017-02-18 16:45:59.733337
NCT00290303|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-09-15|||May 2004||2004-05-01|September 2016|2016-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants|Study to Show Non-inferiority of Tritanrix™-HepB/Hib-MenAC (+/- Hepatitis B Vaccine at Birth) Versus Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vacc. at Birth for Antibody Response to All Vaccine Antigens Given in Healthy Infants|Completed||Phase 3|996|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:46:00.067887|2017-02-18 16:46:00.067887
NCT00290095|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2011-03-07|||January 2006||2006-01-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Quality of Life in Patients With Multiple Myeloma|Quality of Life in Patients With Multiple Myeloma|Completed||N/A|260|Actual|Oslo University Hospital|||1||f||||||||||||||2017-02-18 16:46:04.49664|2017-02-18 16:46:04.49664
NCT00290290|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2014-09-10|2012-11-15||September 2003||2003-09-01|September 2014|2014-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections|Chlorhexidine-Alcohol Versus Povidone-Iodine for Surgical-Site Antisepsis:A Prospective, Randomized, Multicenter Clinical Trial|Completed||Phase 3|849|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 16:46:00.18627|2017-02-18 16:46:00.18627
NCT00290277|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2016-09-27|||November 2005||2005-11-01|September 2016|2016-09-01|August 2006|Actual|2006-08-01|||||Interventional|||Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years|Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV-16/18 L1/AS04 Vaccine Administered Intramuscularly According to a 0,1,6 Mth Schedule in Healthy Female Subjects Aged 10-14 Yrs|Completed||Phase 3|300|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:46:00.599123|2017-02-18 16:46:00.599123
NCT00290264|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2011-01-21|||December 2004||2004-12-01|January 2011|2011-01-01|August 2006|Actual|2006-08-01|||||Interventional|||SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma|A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbohaler 160/4.5 μg, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults - a 26-week, Randomised, Open-label, Parallel-group, Multi-centre Study (SALTO)|Completed||Phase 3|1000||AstraZeneca|||||f||||||||||||||2017-02-18 16:46:00.723416|2017-02-18 16:46:00.723416
NCT00290251|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-10|2012-11-14|2011-10-28||February 2006||2006-02-01|November 2012|2012-11-01|August 2010|Actual|2010-08-01|July 2009|Actual|2009-07-01||Interventional|||Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914|Evaluation of Whether the Selective Progesterone Receptor Modulator CDB-2914 Can Shrink Leiomyomata|Completed||Phase 2|72|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||t||||||||||2017-02-18 16:46:01.259576|2017-02-18 16:46:01.259576
NCT00290238|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2009-05-08|2008-11-25||December 2005||2005-12-01|May 2009|2009-05-01|September 2008|Actual|2008-09-01|November 2007|Actual|2007-11-01||Interventional|||Percutaneous Neuromodulation Therapy (PNT) With Chronic Low Back Pain Patients|Percutaneous Neuromodulation Therapy With Chronic Low Back Pain Patients With or Without Lower Extremity Pain - A Randomized, Controlled, Parallel Groups Study|Terminated||Phase 4|122|Actual|RS Medical||2||Slow recruitment and high dropout rates|f||||f||||||||||2017-02-18 16:46:01.691662|2017-02-18 16:46:01.691662
NCT00290225|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2007-05-02|||June 2005||2005-06-01|May 2007|2007-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Yoga Breath Program and Client-Centered Exposure for Relief of PTSD in Tsunami Victims|Controlled Trial of Yoga Breath Based Group Intervention and Client-Centered Exposure Treatment for Relief of Traumatic Stress and Depression in Tsunami Victims|Completed||Phase 3|180|Actual|Victim Services Center, Miami||3|||f||||f||||||||||2017-02-18 16:46:02.149833|2017-02-18 16:46:02.149833
NCT00290212|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2008-01-23|||January 2006||2006-01-01|December 2006|2006-12-01|June 2007||2007-06-01|||||Interventional|||Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause|Phase II Study of Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause: a Randomised Double Blind Placebo-Controlled Trial|Completed||Phase 2|304|Actual|University Hospital of North Norway||1|||f||||||||||||||2017-02-18 16:46:02.243086|2017-02-18 16:46:02.243086
NCT00290199|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2012-09-29|2012-06-01||December 2005||2005-12-01|September 2012|2012-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture|A Randomized Controlled Trial of Foley Catheter for Labor Induction in Women With Term and Near Term Prelabor Rupture of Membranes (PROM)|Terminated||N/A|169|Actual|University of Alabama at Birmingham||2||Gathering information from the PI records to provide this response.|f||||t||||||||||2017-02-18 16:46:02.323481|2017-02-18 16:46:02.323481
NCT00290186|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2014-08-13|2014-02-27||August 2005||2005-08-01|August 2014|2014-08-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||An Evaluation of Hyperbaric Treatments for Children With Cerebral Palsy|An Evaluation of the Therapeutic Effectiveness of Hyperbaric Oxygen Treatments and Hyperbaric Air Treatments for Children With Cerebral Palsy|Terminated||N/A|49|Actual|Dayton Children's Hospital||2||Terminated for futility.|f||||t||||||||||2017-02-18 16:46:02.743792|2017-02-18 16:46:02.743792
NCT00290173|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2006-05-03||||||February 2006|2006-02-01|August 2005||2005-08-01|||||Interventional|||Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor|Ritodrine in Oral Maintenance of Tocolysis After Active Preterm Labor: Randomized Controlled Trial|Completed||N/A|||University of Zagreb|||||f||||||||||||||2017-02-18 16:46:03.844439|2017-02-18 16:46:03.844439
NCT00290160|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2012-12-06|||December 2002||2002-12-01|December 2012|2012-12-01|July 2007|Actual|2007-07-01|September 2005|Actual|2005-09-01||Interventional|||Early Protein Supplementation on Prevention of Hyperkalemia|The Effect of Early Protein Supplementation on Prevention of Hyperkalemia in Extremely Low Birth Weight Infants|Completed||N/A|62||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 16:46:03.948611|2017-02-18 16:46:03.948611
NCT00290147|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-10-24|||January 2006||2006-01-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|December 2006|Actual|2006-12-01||Interventional|||Safety Study of a Dengue Virus DNA Vaccine|Phase I Clinical Trial of a Dengue-1 DNA Vaccine|Completed||Phase 1|24||U.S. Army Medical Research and Materiel Command|||||||||||||||||||2017-02-18 16:46:04.051941|2017-02-18 16:46:04.051941
NCT00290134|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2008-02-29|||February 2006||2006-02-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|||||Interventional|||A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism|Preliminary Efficacy and Safety of Fispemifene in the Treatment of Hypogonadism: A 4 Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing Daily Oral Doses of 100, 200, and 300 mg Fispemifene and Placebo|Completed||Phase 2|100||QuatRx Pharmaceuticals Company|||||||||||||||||||2017-02-18 16:46:04.147845|2017-02-18 16:46:04.147845
NCT00290121|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2013-03-13|||September 2006||2006-09-01|October 2005|2005-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics|Cerebral Mechanism Involved in Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics (IIT)|Completed||Phase 4|25|Actual|Université de Montréal||1|||f||||||||||||||2017-02-18 16:46:04.259826|2017-02-18 16:46:04.259826
NCT00290108|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2006-02-09|||March 2003||2003-03-01|June 1998|1998-06-01|December 2003||2003-12-01|||||Interventional|||The Influence of Injection Rate on EEG Propofol Peak Effect as Measured by Bispectral Index|The Influence of Injection Rate on EEG Propofol Peak Effect as Measured by Bispectral Index|Completed||N/A|99||Technische Universität München|||||f||||||||||||||2017-02-18 16:46:04.398412|2017-02-18 16:46:04.398412
NCT00290082|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-03-10|||December 2005||2005-12-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients|Comparison Between Midazolam and Loxapine in the Treatment of Agitated Patients in the Emergency Department|Terminated||Phase 3|120|Anticipated|University Hospital, Rouen||2||2 complications with midazolam|f||||t||||||||||2017-02-18 16:46:04.579946|2017-02-18 16:46:04.579946
NCT00290069|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2007-05-14||||||February 2006|2006-02-01||||||||Interventional|||Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)|Comparative Study of Tacrolimus and Rapamycin to Evaluate the Renal Function in Patients Older Than 50 Years, Receptors of a Kidney From a Donor Older Than 55 Years in a Mycophenolate Mofetil and Daclizumab Immunosuppressor Regime|Unknown status|Not yet recruiting|Phase 4|94|Anticipated|Sociedad Andaluza de Trasplantes de Organos y Tejidos|||||f||||||||||||||2017-02-18 16:46:04.729133|2017-02-18 16:46:04.729133
NCT00290056|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2009-11-03|||November 2005||2005-11-01|November 2009|2009-11-01|June 2010|Anticipated|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial||Unknown status|Active, not recruiting|Phase 4|105|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 16:46:04.838572|2017-02-18 16:46:04.838572
NCT00290043|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2010-12-03|||December 2001||2001-12-01|December 2010|2010-12-01|March 2002||2002-03-01|||||Interventional|||Glulisine Pre- and Postmeal|Glucodynamic Response to Pre- and Postmeal Subcutaneous Injection of 0.15 IU/kg HMR1964 Insulin and RHI in Type 1 Diabetic Subjects in an Open, Randomized, Four-way Crossover Study|Completed||Phase 1|20||Sanofi|||||f||||||||||||||2017-02-18 16:46:04.941606|2017-02-18 16:46:04.941606
NCT00290030|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2009-03-10|||May 2001||2001-05-01|March 2009|2009-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH|A Double-Blind Randomized Parallel Group Study of Alfuzosin 10mg OD Versus Placebo in the Management of Acute Urinary Retention in Patients With a First Episode Due to Benign Prostatic Hyperplasia (BPH)|Completed||Phase 3|800|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:46:05.024903|2017-02-18 16:46:05.024903
NCT00290017|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2007-06-07|||February 2006||2006-02-01|June 2007|2007-06-01||||||||Interventional|||Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy|A Phase 3, Randomized, Double-Blind, Multicenter Study of Talabostat and Pemetrexed vs. Pemetrexed and Placebo in Patients With Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy|Terminated||Phase 3|400|Anticipated|Point Therapeutics||||FDA Hold May 2007|||||||||||||||2017-02-18 16:46:05.119779|2017-02-18 16:46:05.119779
NCT00290004|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2008-09-10|||November 2005||2005-11-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase I/II Trial of Weekly Motexafin Gadolinium (MGd) for Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Completed||Phase 1/Phase 2|35||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 16:46:05.305607|2017-02-18 16:46:05.305607
NCT00289991|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-10-16|2010-02-09||March 2006||2006-03-01|October 2015|2015-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|IMPROVIT||Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)|Prospective, Open-Label, Comparative, Multi-Center Study Of Voriconazole Compared To Itraconazole For The Primary Prophylaxis Of Invasive Fungal Infection (IFI) With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)|Completed||Phase 3|489|Actual|Pfizer|Data was excluded from 1 site due to Good Clinical Practices deviations.|2|||f||||t||||||||||2017-02-18 16:46:05.427411|2017-02-18 16:46:05.427411
NCT00289978|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2012-04-09|2011-01-04||January 2006||2006-01-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|FREEDOMS||Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis|A 24-month, Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of Fingolimod 1.25 mg and 0.5 mg Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis|Completed||Phase 3|1272|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:46:06.93057|2017-02-18 16:46:06.93057
NCT00289965|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2011-07-25|||September 2005||2005-09-01|July 2011|2011-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Substance Use Risk Education (SURE) Project|Brief Alcohol Interventions by Counselor vs Computer|Completed||Phase 2|703|Actual|Syracuse University||3|||f||||t||||||||||2017-02-18 16:46:08.477362|2017-02-18 16:46:08.477362
NCT00289952|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2009-03-30|||June 2006||2006-06-01|January 2008|2008-01-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Valproic Acid and Its Effects on HIV Latent Reservoirs|Use of Valproic Acid to Purge HIV From Resting CD4+ Memory Cells/ A Proof-of-Concept Study|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|McGill University Health Center||2|||f||||t||||||||||2017-02-18 16:46:08.600254|2017-02-18 16:46:08.600254
NCT00289939|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2006-02-27|||September 2000||2000-09-01|July 2005|2005-07-01|January 2005||2005-01-01|||||Interventional|||Reducing HIV & Domestic Violence Risk in Women Offenders|Reducing HIV & Domestic Violence Risk in Women Offenders|Completed||Phase 3|530||Multnomah County Health Department|||||f||||||||||||||2017-02-18 16:46:08.720301|2017-02-18 16:46:08.720301
NCT00289926|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-03-15|||February 2006||2006-02-01|March 2016|2016-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms|A Randomised, Double-blind, Placebo-controlled, Parallel-group, 52-week Study to Evaluate the Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms|Completed||Phase 3|240|Actual|Monash University||2|||f||||t||||||||No||2017-02-18 16:46:08.812405|2017-02-18 16:46:08.812405
NCT00289913|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2016-03-04|2011-06-09||April 2006||2006-04-01|March 2016|2016-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)|An Open, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of VAQTA™ Given Concomitantly With PedvaxHIB™ and Infanrix™ in Healthy Children 15 Months of Age|Completed||Phase 4|1274|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 16:46:08.931038|2017-02-18 16:46:08.931038
NCT00289900|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2015-12-17|2015-12-17||January 2006||2006-01-01|December 2015|2015-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)|A Multicenter, Randomized, Double-Blind, Parallel Group, 12 Week Study to Evaluate the Efficacy and Safety of MK0524B Versus Atorvastatin in Patients With Mixed Hyperlipidemia|Completed||Phase 3|2340|Actual|Merck Sharp & Dohme Corp.||6|||f||||||||||||||2017-02-18 16:46:09.759622|2017-02-18 16:46:09.759622
NCT00289887|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2015-07-21|2009-09-21||February 2006||2006-02-01|July 2015|2015-07-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Obese Hypertension Study (0954-315)|A Double-Blind, Randomized, Parallel, Efficacy Study Evaluating Losartan Potassium Alone or in Combination With Hydrochlorothiazide Versus Placebo in Obese Patients With Elevated Systolic and Diastolic Blood Pressure|Completed||Phase 3|261|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:46:11.683066|2017-02-18 16:46:11.683066
NCT00289874|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2016-01-20|2009-09-09||March 2006||2006-03-01|January 2016|2016-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)|A Multicenter, Double-Blind, Placebo Controlled, Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral Montelukast Versus Placebo in Persistent Asthma Which is Also Active During Allergy Seasons in Pediatric Patients With Seasonal Aeroallergen Sensitivity|Completed||Phase 3|421|Actual|Merck Sharp & Dohme Corp.|Safety is reported in the literature.|2|||f||||||||||||||2017-02-18 16:46:12.239211|2017-02-18 16:46:12.239211
NCT00289861|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2013-10-29|||February 2003||2003-02-01|October 2013|2013-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Risperidone Augmentation in Patients With Schizophrenia|Risperidone Augmentation in Patients With Schizophrenia Partially Responsive to Clozapine|Completed||Phase 4|24|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:46:12.609048|2017-02-18 16:46:12.609048
NCT00289679|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-03-17||||||July 2007|2007-07-01||||||||Interventional|||Cytokine Profile and Metal Ion Concentrations at Patients Undergoing a Revision THR||Unknown status|Recruiting|Phase 4|||Frederiksberg University Hospital|||||f||||||||||||||2017-02-18 16:46:12.723787|2017-02-18 16:46:12.723787
NCT00289666|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-07-07|||July 2003||2003-07-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|March 2007|Actual|2007-03-01||Observational|||The Effect of Positive Airway Pressure on Heart Rate Variability|A Prospective Study to Determine the Effect of Positive Airway Pressure on Heart Rate Variability in Individuals With Obstructive Sleep Apnea|Completed||N/A|38|Anticipated|Christiana Care Health Services|||1||f||||f||||||Samples Without DNA|"~     Serum, Plasma, Urine~   "|||2017-02-18 16:46:12.803303|2017-02-18 16:46:12.803303
NCT00289653|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2009-05-09|||September 2005||2005-09-01|May 2009|2009-05-01|June 2006||2006-06-01|||||Interventional|||Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation|Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation|Completed||N/A|60||Centre for Addiction and Mental Health|||||f||||||||||||||2017-02-18 16:46:12.893289|2017-02-18 16:46:12.893289
NCT00289640|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2010-02-27||2010-02-27|April 2006||2006-04-01|January 2009|2009-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma|A Randomized, Double-Blind, Multi-center, Phase II Fixed Dose Study of Multiple Doses of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma|Completed||Phase 2|210|Anticipated|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 16:46:12.996401|2017-02-18 16:46:12.996401
NCT00289627|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2016-09-27|||April 2006||2006-04-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma|A Multi-Center Single Arm Phase II Study of MDX-010 (BMS-734016) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma|Completed||Phase 2|155|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 16:46:13.169742|2017-02-18 16:46:13.169742
NCT00289614|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2008-01-03|||January 2006||2006-01-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)|Patients With Renal Impairment and Diabetes Undergoing Computed Tomography|Completed||Phase 4|350|Anticipated|Bracco Diagnostics, Inc|||||f||||||||||||||2017-02-18 16:46:13.326827|2017-02-18 16:46:13.326827
NCT00289601|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2007-07-19|||March 2006||2006-03-01|July 2007|2007-07-01|December 2007||2007-12-01|||||Interventional|||Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty|Research Evaluation to Study Individuals Who Show Thromboxane Or P2Y12 Receptor Resistance|Terminated||Phase 4|1200|Anticipated|Brigham and Women's Hospital||||Sponsor support withdrawn|f||||t||||||||||2017-02-18 16:46:13.413841|2017-02-18 16:46:13.413841
NCT00289588|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2006-02-13|||January 2005||2005-01-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers|An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus Infection in Soldiers: a Controlled Trial|Completed||N/A|3000||Brooke Army Medical Center|||||f||||||||||||||2017-02-18 16:46:13.518198|2017-02-18 16:46:13.518198
NCT00289575|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2007-03-01|||February 2006||2006-02-01|March 2007|2007-03-01|February 2008||2008-02-01|||||Interventional|||MBCP Safety and Performance in the Osteonecrosis of Femur Head|Evaluation of Safety and Performance of Macroporous Biphasic Calcium Phosphate Granules Combined With Cellulosic-Derived Gel, in Filling Bones Gap After Aseptic Osteonecrosis Biopsy of Femur Head.|Unknown status|Recruiting|Phase 2|12||Biomatlante|||||f||||f||||||||||2017-02-18 16:46:13.616668|2017-02-18 16:46:13.616668
NCT00289562|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2012-01-19|||September 2004||2004-09-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia|A Phase I/II, Multi-Center, Open-Label, Repeat-Dose Study of Forodesine Hydrochloride Infusion in Patients With B-Cell Acute Lymphoblastic Leukemia With an Option of Extended Use of Forodesine Hydrochloride|Completed||Phase 1/Phase 2|20||BioCryst Pharmaceuticals|||||f||||||||||||||2017-02-18 16:46:13.793245|2017-02-18 16:46:13.793245
NCT00289549|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2012-02-06||2012-01-19|June 2005||2005-06-01|February 2012|2012-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)|Phase II Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-Refractory Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|8|Actual|BioCryst Pharmaceuticals||1|||f||||||||||||||2017-02-18 16:46:13.877473|2017-02-18 16:46:13.877473
NCT00289536|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-06-26|2010-09-30||February 2006||2006-02-01|May 2011|2011-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A|Advate Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (ADVATE rAHF-PFM): A Phase 4 Study to Determine the Pharmacokinetic Response of Patients Diagnosed With Severe Hemophilia A to Different Doses of ADVATE rAHF-PFM|Completed||Phase 4|38|Actual|Baxalta US Inc.||3|||f||||t||||||||||2017-02-18 16:46:13.968863|2017-02-18 16:46:13.968863
NCT00289523|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2012-03-06|||January 2006||2006-01-01|April 2010|2010-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||EEG Biomarkers for Predicting Response to Antidepressant Therapy|Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD), a Prospective, Randomized, Multi-center Study to Determine the Efficacy of Selected EEG and Genotype Biomarkers for Predicting Response to Antidepressant Therapy With Escitalopram, Bupropion XL, or a Combination Treatment Regimen.|Completed||Phase 4|375|Actual|Medtronic - MITG|||3||f||||t||||||||||2017-02-18 16:46:14.802555|2017-02-18 16:46:14.802555
NCT00289510|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-09|2015-10-07|||January 2006||2006-01-01|October 2007|2007-10-01||||||||Interventional|||Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)|Single-Blind, Randomized, Controlled Phase I/II Study to Compare the Safety and Immunogenicity of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived) With a License Egg Derived Influenza Vaccine|Completed||Phase 1/Phase 2|423||Nanotherapeutics, Inc.|||||f||||||||||||||2017-02-18 16:46:14.923595|2017-02-18 16:46:14.923595
NCT00289497|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2006-02-08|||June 2000||2000-06-01|February 2006|2006-02-01|July 2003||2003-07-01|||||Interventional|||TempTouch IR Thermometry & Diabetic Patient Self-Care|Phase 2 Study for Infrared Thermometry Used by Diabetic Patients at Home|Completed||Phase 2/Phase 3|180||Diabetica Solutions Inc.|||||f||||||||||||||2017-02-18 16:46:15.005787|2017-02-18 16:46:15.005787
NCT00289484|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2006-09-11|||February 2006||2006-02-01|September 2006|2006-09-01||||||||Interventional|||A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression|A Randomised, Double-Blind, Placebo Controlled Trial of Omega-3 Polyunsaturated Fatty Acid as an Augmentor of Antidepressant Medication for Major Depression.|Unknown status|Recruiting|Phase 2|52||The University of New South Wales|||||f||||||||||||||2017-02-18 16:46:15.109439|2017-02-18 16:46:15.109439
NCT00289471|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2015-04-10|2014-08-11||October 2009||2009-10-01|April 2015|2015-04-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Observational|GEMS||Identifying Patients With Dementia in Primary Care|Dementia in Primary Care: Setting the Stage for Quality Improvement|Completed||N/A|630|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 16:46:15.227303|2017-02-18 16:46:15.227303
NCT00289458|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2010-07-06|2009-02-13||October 2005||2005-10-01|July 2010|2010-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Aquatic Exercise and Efficacy Enhancement to Decrease Fall Risk in Older Adults With Hip Osteoarthritis|The Effect of Aquatic Exercise and Aquatic Exercise Combined With Education and Efficacy Enhancement on Improving Indices of Fall Risk in Older Adults With Hip Osteoarthritis: a Randomized Controlled Clinical Trial|Completed||Phase 1|79|Actual|University of Saskatchewan||3|||f||||||||||||||2017-02-18 16:46:15.482617|2017-02-18 16:46:15.482617
NCT00289445|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2013-01-25|||September 1999||1999-09-01|January 2013|2013-01-01|March 2006||2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)|Open, Multi-center Phase I/II Trial With Mitomycin C in Combination With 5-Fluorouracil and Folinic Acid in Pretreated Patients With Metastatic Gastrointestinal Cancer|Completed||Phase 1/Phase 2|||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 16:46:16.078326|2017-02-18 16:46:16.078326
NCT00289432|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2015-04-29|||April 2006||2006-04-01|April 2015|2015-04-01|December 2014|Actual|2014-12-01|February 2009|Actual|2009-02-01||Interventional|||Hospital Based Group Intervention for Breast Cancer Patients.|Effects of Group Intervention on Anxiety, Depression and Quality of Life Among Women Operated for Breast Cancer. A Randomized, Prospective Study.|Completed||N/A|450|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 16:46:16.166466|2017-02-18 16:46:16.166466
NCT00289419|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2008-05-06|||February 2005||2005-02-01|May 2008|2008-05-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|||Intraarticular Analgesia After Total Hip Arthroplasty, a Randomised Study|Postoperative Analgesia After Total Hip Arthroplasty. A Comparison of Continuous Epidural Infusion and Wound Infiltration With Intraarticular Bolus Injection.|Completed||Phase 4|80|Actual|University of Aarhus||2|||f||||||||||||||2017-02-18 16:46:16.273502|2017-02-18 16:46:16.273502
NCT00289406|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2007-03-05|||January 2006||2006-01-01|September 2006|2006-09-01|February 2006||2006-02-01|||||Interventional|||Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension|An 8 Weeks, Multi-Center, Randomized, Double Blinded, Comparative Phase 3 Clinical Trial to Assess the Efficacy and Safety of S-Amlodipine Gentisate Compared to Amlodipine Besylate in Patients With Mild-to-Moderate Hypertension|Completed||Phase 3|110||SK Chemicals Co.,Ltd.|||||f||||||||||||||2017-02-18 16:46:16.381573|2017-02-18 16:46:16.381573
NCT00289393|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2006-09-11||||||September 2006|2006-09-01||||||||Observational|||Response Shift in Patient Expectations and Functional Outcome|Response Shift in Patient Expectations and Functional Outcome Following Posterior Lumbar Spinal Surgery for Degenerative Spinal Disorders|Unknown status|Recruiting|N/A|||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 16:46:16.467513|2017-02-18 16:46:16.467513
NCT00289380|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2014-02-11|||January 2005||2005-01-01|February 2014|2014-02-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk|1. Prevalence of Nutritional Risk-undernutrition-support in China-Euro-USA. 2. Impact of Nutrition Support on Outcome for Patient at Risk. 3. Impact of Nutrition Support on Outcome,Cost/Effectiveness for Patient at Risk.|Recruiting||N/A|2000|Anticipated|Peking Union Medical College|||2||f||||f||||||||||2017-02-18 16:46:16.538836|2017-02-18 16:46:16.538836
NCT00289367|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2008-05-19|||February 2006||2006-02-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|August 2006|Actual|2006-08-01||Interventional|||Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery|Randomized Prospective Study of T3 on the Incidence of Post-Operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery|Completed||Phase 1|280|Anticipated|Northwell Health||1|||f||||||||||||||2017-02-18 16:46:16.66876|2017-02-18 16:46:16.66876
NCT00288769|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2009-01-22|||March 2006||2006-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Oral Vitamin B12 as Potential Treatment of Recurrent Aphthous Stomatitis||Completed||N/A|||Soroka University Medical Center||1|||f||||||||||||||2017-02-18 16:46:30.401988|2017-02-18 16:46:30.401988
NCT00289354|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2006-02-07|||March 2003||2003-03-01|February 2006|2006-02-01|November 2005||2005-11-01|||||Interventional|||Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM|Randomized, Double Blinded, Placebo Controlled, Study to Evaluate Improvements in Glycemic Control, Lipid Levels, Quality of Life and Healthcare Costs After Daily Administration of Chromium Picolinate and Biotin in Patients With T2DM|Completed||N/A|600||Nutrition 21, Inc.|||||f||||||||||||||2017-02-18 16:46:16.753053|2017-02-18 16:46:16.753053
NCT00289341|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2013-01-11|2011-08-08||March 2002||2002-03-01|January 2013|2013-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.|A Phase I/II Study of Autologous Dendritic Cells Pulsed With Apoptotic Tumor Cells (DC/LNCaP) Administered Subcutaneously to Prostate Cancer Patients.|Completed||Phase 1/Phase 2|24|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 16:46:16.864713|2017-02-18 16:46:16.864713
NCT00289328|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2010-03-01|||November 2001||2001-11-01|March 2010|2010-03-01|April 2006|Actual|2006-04-01|||||Observational|||Glucocorticoid-induced Osteopenia in Children||Completed||N/A|550||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:46:17.40157|2017-02-18 16:46:17.40157
NCT00289315|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2014-09-23|||August 2005||2005-08-01|September 2014|2014-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||LA Health Project HIPTeens Project (a Secondary Prevention Program) and the Wise Mind Project (a Primary Prevention Program).|LA Health: A Prospective Study of Primary and Secondary Obesity Prevention in Children and Adolescents|Completed||N/A|2709|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 16:46:17.478698|2017-02-18 16:46:17.478698
NCT00289302|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2007-10-03|||January 2003||2003-01-01|September 2006|2006-09-01|December 2006|Actual|2006-12-01|||||Observational|||InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy|InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy|Completed||N/A|600||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:46:17.576466|2017-02-18 16:46:17.576466
NCT00289289|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2012-06-25|2011-12-21||February 2004||2004-02-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|November 2010|Actual|2010-11-01||Interventional|||Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)|Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)|Completed||N/A|400|Actual|Medtronic Cardiac Rhythm and Heart Failure|The effect of ON programming was not consistent across randomized study period, violating a key assumption of the cross-over study design.|3|||f||||f||||||||||2017-02-18 16:46:17.710213|2017-02-18 16:46:17.710213
NCT00289276|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2010-10-05|2009-04-01||November 2003||2003-11-01|October 2010|2010-10-01||||April 2008|Actual|2008-04-01||Interventional|||FAST (Fluid Accumulation Status Trial)|FAST (Fluid Accumulation Status Trial)|Completed||N/A|156|Actual|Medtronic Cardiac Rhythm and Heart Failure|This was a characterization study with no descriptive statistical analysis. The results reported were counts of subjects with impedance data available as applicable for each objective.|1|||f||||f||||||||||2017-02-18 16:46:18.316737|2017-02-18 16:46:18.316737
NCT00289263|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2006-02-08|||April 1998||1998-04-01|November 2003|2003-11-01|October 2003||2003-10-01|||||Interventional|||Maintenance Chemotherapy in Metastatic Breast Cancer|Maintenance Paclitaxel Vs Control After Anthracycline/Paclitaxel Combined First-Line Chemotherapy in Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 3|524||MANTA 1 Study Italian Collaborative Group|||||f||||||||||||||2017-02-18 16:46:19.035366|2017-02-18 16:46:19.035366
NCT00289250|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2006-02-28|||May 2001||2001-05-01|December 2002|2002-12-01|December 2001||2001-12-01|||||Interventional|||Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. Falciparum|Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. Falciparum: A Randomized Controlled Trial|Completed||Phase 3|360||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 16:46:19.320258|2017-02-18 16:46:19.320258
NCT00289237|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2012-10-02|||March 1999||1999-03-01|October 2012|2012-10-01|March 2011|Actual|2011-03-01|March 2006|Actual|2006-03-01||Interventional|||Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease|A Randomised Non-pharmacological Intervention Study for Prevention of Ischaemic Heart Disease Inter99|Completed||N/A|61301|Actual|Glostrup University Hospital, Copenhagen||3|||f||||||||||||||2017-02-18 16:46:19.43303|2017-02-18 16:46:19.43303
NCT00289224|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2014-07-30|||July 2006||2006-07-01|March 2012|2012-03-01|May 2013|Actual|2013-05-01|December 2011|Actual|2011-12-01||Interventional|||Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata|A Randomized Controlled Trial of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Eastern Kolkata, West Bengal, India|Completed||Phase 3|69329|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-02-18 16:46:19.574094|2017-02-18 16:46:19.574094
NCT00289211|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2014-03-19|2010-03-17||June 2005||2005-06-01|March 2014|2014-03-01|September 2007|Actual|2007-09-01|December 2006|Actual|2006-12-01||Interventional|||C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks|LEVP2005-1/Part A: A Double-blind, Placebo-Controlled, Clinical Study to Investigate the Efficacy and Safety of Purified C1 Esterase Inhibitor (Human) for the Treatment of HAE in Acute Attacks|Completed||Phase 3|83|Actual|Shire||2|||f||||t||||||||||2017-02-18 16:46:19.698803|2017-02-18 16:46:19.698803
NCT00289198|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2016-09-22|||February 2006||2006-02-01|September 2016|2016-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 6 Weeks in Adult and Adolescent Subjects 12 Years of Age and Older With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|301|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:46:20.270069|2017-02-18 16:46:20.270069
NCT00289185|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2014-07-03|2012-11-08||September 2006||2006-09-01|July 2014|2014-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants|A Phase IIb Randomized, Double-blind, Controlled Study of the Safety, Immunogenicity and Proof-of-concept of RTS,S/AS02D, a Candidate Malaria Vaccine, When Incorporated Into an Expanded Program on Immunization (EPI) Regimen That Includes DTPw/Hib in Infants Living in a Malaria-endemic Region.|Completed||Phase 2|340|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 16:46:20.448293|2017-02-18 16:46:20.448293
NCT00289172|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2010-10-14|||February 2006||2006-02-01|October 2010|2010-10-01|September 2006|Actual|2006-09-01|||||Interventional|||Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India|A Multicenter Study of the Immunogenicity & Safety of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus Vaccine (RIX4414) as Primary Dosing of Healthy Infants in India Aged Approximately 8 Wks at the Time of the First Dose|Completed||Phase 3|360||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:46:21.27058|2017-02-18 16:46:21.27058
NCT00289159|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2006-02-08||||||September 2005|2005-09-01||||||||Observational|||Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up|Follow Up by Multimodal MRI of a Cohort of Patients With Early Remitting Multiple Sclerosis (REPROMMS Study).|Unknown status|Active, not recruiting|Phase 4|||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-02-18 16:46:21.354428|2017-02-18 16:46:21.354428
NCT00289146|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2013-09-23|||November 2005||2005-11-01|September 2013|2013-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Comparison of Immune Response Following Surgical Management of Renal Tumors|Comparison of Immune Response Following Surgical Management of Renal Tumors|Terminated||N/A|50|Anticipated|Emory University|||1||f||||f||||||Samples Without DNA|"~     Blood samples~   "|||2017-02-18 16:46:21.415996|2017-02-18 16:46:21.415996
NCT00289133|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2016-05-31|2014-05-30||February 2005||2005-02-01|May 2016|2016-05-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional||Enrolled Subjects|Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study|Prospective, Comparative, Randomized Study of GVF Versus Cross-linked Polyethylene in Total Knee Arthroplasty|Completed||N/A|938|Actual|DePuy Orthopaedics|Serious adverse events were not collected in this study per the modern definition. All adverse events collected for this study will be reported in the 'Other Adverse Events' table. MedDRA was used to classify each AE into SOC, but not Preferred Term.|2|||f||||f||||||||||2017-02-18 16:46:21.513961|2017-02-18 16:46:21.513961
NCT00289120|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2016-05-05|2013-08-14||November 2003||2003-11-01|May 2016|2016-05-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional||Thirteen subjects, including 10 normal subjects and 3 calcium oxalate stone-formers were enrolled in this prospective cross-over study.|Effect of Cola on Urinary Stone Risk Factors|Effect of Cola on Urinary Stone Risk Factors|Completed||N/A|13|Actual|Emory University||2|||f||||f||||||||||2017-02-18 16:46:22.223798|2017-02-18 16:46:22.223798
NCT00289107|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2013-08-06|2010-09-29||April 2001||2001-04-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA|Multi-center, Prospective, Clinical Evaluation of the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting vs P.F.C.® Sigma™ Cruciate Substituting Knee Primary Cases|Completed||N/A|149|Actual|DePuy Orthopaedics||2|||f||||f||||||||||2017-02-18 16:46:22.593693|2017-02-18 16:46:22.593693
NCT00289094|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2013-08-06|2010-09-29||March 2001||2001-03-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA|Multi-center, Prospective, Clinical Evaluation of the PFC Sigma Rotating Platform Cruciate Retaining Versus PFC Sigma Cruciate Retaining Knee Primary Cases|Completed||N/A|99|Actual|DePuy Orthopaedics||2|||f||||f||||||||||2017-02-18 16:46:22.949157|2017-02-18 16:46:22.949157
NCT00289081|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2014-05-12|||February 2001||2001-02-01|May 2014|2014-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee Prostheses|Multi-center Prospective Clinical Evaluation of the P.F.C.® Sigma™ Rotating Platform Knee Primary Cases Cruciate Retaining Versus Cruciate Substituting|Terminated||N/A|399|Actual|DePuy Orthopaedics||2||Business reasons|f||||f||||||||||2017-02-18 16:46:23.268027|2017-02-18 16:46:23.268027
NCT00289068|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2011-07-08|||January 2006||2006-01-01|July 2011|2011-07-01|September 2007|Actual|2007-09-01|April 2006|Actual|2006-04-01||Observational|||Phacoemulsification Sleeves|Determination of Surgical Efficacy and Most Efficient Surgical Parameters for Use With the 2.2, 2.8, and 3.0mm Phacoemulsification Sleeves Used With the Alcon Infinity 1.1mm ABS Flared Tip|Completed||N/A|44|Actual|University of Oklahoma|||3||f||||t||||||||||2017-02-18 16:46:23.391273|2017-02-18 16:46:23.391273
NCT00289055|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2009-02-20|||November 2005||2005-11-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|DURAVEST||The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions.|A Clinical Investigation of the SMART™ Nitinol Self-Expandable Stent Versus Balloon Angioplasty for the Treatment of Superficial Femoral Artery Occlusions|Terminated||Phase 4|10|Actual|Cordis Corporation||2||lack of enrollment|f||||t||||||||||2017-02-18 16:46:23.506281|2017-02-18 16:46:23.506281
NCT00289042|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2007-01-30|||December 1999||1999-12-01|May 2005|2005-05-01|November 2004||2004-11-01|||||Interventional|||Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)|The Use of Enoxaparin Compared to Unfractionated Heparin for Short Term Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing TEE Guided Cardioversion: Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Randomized Multicenter Study|Completed||Phase 4|200||The Cleveland Clinic|||||||||||||||||||2017-02-18 16:46:23.613574|2017-02-18 16:46:23.613574
NCT00289029|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2006-08-17|||July 2005||2005-07-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Interventional|||A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography|Visipaque and Isovue in Cardiac Angiography in Renally Impaired Patients|Completed||Phase 4|400||Bracco Diagnostics, Inc|||||f||||||||||||||2017-02-18 16:46:26.477677|2017-02-18 16:46:26.477677
NCT00289016|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2015-11-12|2015-11-12||December 2005||2005-12-01|November 2015|2015-11-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma|A Phase II Study of the Efficacy, Safety and Immunogenicity of OncoVEX^GM-CSF in Patients With Stage IIIc and Stage IV Malignant Melanoma|Completed||Phase 2|50|Actual|BioVex Limited||1|||f||||t||||||||||2017-02-18 16:46:26.553071|2017-02-18 16:46:26.553071
NCT00289003|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2007-01-15|||October 2003||2003-10-01|May 2006|2006-05-01|July 2006||2006-07-01|||||Interventional|||The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients|An Exploratory, Randomised, Parallel Group Study, Comparing the Protective Effect of Soluble Beta-1,3/1,6-Glucan or Placebo in Oral Mucositis in Head and Neck Cancer Patients Receiving Radiation Therapy or Chemoradiotherapy|Completed||Phase 2|40||Biotec Pharmacon ASA|||||f||||||||||||||2017-02-18 16:46:26.92402|2017-02-18 16:46:26.92402
NCT00288756|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2006-09-11|||July 2006||2006-07-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Observational|||The V-Tachogram:Decreasing Ventricular Arrythmias When Injecting Contrast in the Left Ventricle||Unknown status|Active, not recruiting|Phase 1|156||Trillium Health Centre|||||f||||||||||||||2017-02-18 16:46:30.513062|2017-02-18 16:46:30.513062
NCT00288990|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2007-12-20|||January 2006||2006-01-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Observational|||A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis|Impact of Neutralizing Antibodies on Interferon Responsive Genes Highlights Biomarker Response.|Completed||Phase 4|300|Anticipated|Biogen|||3||f||||f||||||Samples With DNA|"~     whole blood and serum~   "|||2017-02-18 16:46:27.016821|2017-02-18 16:46:27.016821
NCT00288977|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2008-10-22|||September 2000||2000-09-01|September 2006|2006-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants|Islet Transplantation in Type 1 Diabetic Recipients of Renal Allografts, Using the Edmonton Protocol|Completed||Phase 2/Phase 3|40|Anticipated|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 16:46:27.36296|2017-02-18 16:46:27.36296
NCT00288951|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2012-08-16|||October 2004||2004-10-01|September 2009|2009-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients||Completed||Phase 3|690|Actual|Alcon Research|||||f||||||||||||||2017-02-18 16:46:27.462194|2017-02-18 16:46:27.462194
NCT00288938|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-08|2017-01-24|||February 3, 2006||2006-02-03|October 31, 2011|2011-10-31|October 31, 2011||2011-10-31|||||Observational|||Natural History Study of Moles and Suspicious Melanoma|Dermoscopic Diagnosis, Histopathological Correlation, and Cellular Immortalization of Melanocytic Nevi and Primary Cutaneous Melanoma|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:46:27.529513|2017-02-18 16:46:27.529513
NCT00288925|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-05-29|||September 2005||2005-09-01|May 2009|2009-05-01||||December 2007|Actual|2007-12-01||Interventional|||Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment|Phase Ib/IIa, to Evaluate the Safety and Pharmacokinetics of Z-360 in Subjects With Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment|Completed||Phase 1/Phase 2|30||Zeria Pharmaceutical|||||f||||||||||||||2017-02-18 16:46:27.606372|2017-02-18 16:46:27.606372
NCT00288912|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2015-04-06|2014-08-01||October 2006||2006-10-01|April 2015|2015-04-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|SeMOA|Among n=523 who consented and were randomized 8 were excluded from analyses because subsequent review of VA medical records revealed there was no documentation of radiographic evidence of knee or hip OA and therefore these participants did not meet initial eligibility requirements.|Self-Management of Osteoarthritis|Self-Management of Osteoarthritis: A Tailored, Telephone-based Intervention|Completed||N/A|523|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 16:46:27.695637|2017-02-18 16:46:27.695637
NCT00288899|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2015-04-06|||August 2006||2006-08-01|September 2014|2014-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Benefits of 'Repeat Back' Protocols Within A Computer-Based Informed Consent Program|Benefits of 'Repeat Back' Protocols Within A Computer-Based Informed Consent Program|Completed||Phase 1|575|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:46:28.308377|2017-02-18 16:46:28.308377
NCT00288886|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2015-04-06|2014-10-17||March 2007||2007-03-01|July 2014|2014-07-01|June 2011|Actual|2011-06-01|June 2009|Actual|2009-06-01||Interventional|||Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment|Reinforcement of Abstinence and Attendance in Substance Abuse Treatment|Completed||Phase 2|183|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:46:28.432684|2017-02-18 16:46:28.432684
NCT00288873|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2007-07-19|||February 2006||2006-02-01|July 2007|2007-07-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity|Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 16:46:28.879155|2017-02-18 16:46:28.879155
NCT00288860|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2016-03-22|2014-10-03||October 2006||2006-10-01|March 2016|2016-03-01|December 2011|Actual|2011-12-01|April 2011|Actual|2011-04-01||Interventional|TCM-PTSD|Veterans entering residential treatment for posttraumatic stress disorder.|Telephone Case Monitoring (TCM) for Veterans With Post-Traumatic Stress Disorder (PTSD)|Telephone Case Monitoring for Veterans With PTSD|Completed||N/A|837|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:46:28.970693|2017-02-18 16:46:28.970693
NCT00288847|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2015-09-21|||November 2005||2005-11-01|September 2015|2015-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Functional Surface Electromyogram of Knee Extensors in Healthy Humans and Patients With Patella-dislocation.|Functional Surface Electromyogram of Knee Extensors in Healthy Humans and Patients With Patella-dislocation.|Completed||N/A|15|Actual|University Hospital, Basel, Switzerland|||||f||||f||||||||||2017-02-18 16:46:29.806307|2017-02-18 16:46:29.806307
NCT00288834|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2006-02-06|||August 2001||2001-08-01|February 2006|2006-02-01|July 2006||2006-07-01|||||Interventional|||Outcomes of Swallowing Rehabilitation After Stroke|Outcomes of Swallowing Rehabilitation After Stroke|Completed||N/A|||University of Canterbury|||||f||||||||||||||2017-02-18 16:46:29.899719|2017-02-18 16:46:29.899719
NCT00288821|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2012-02-08|||February 2006||2006-02-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology|The Diagnostic Accuracy of Non-invasive Lymph Node Imaging in Gynaecologic Malignancies|Completed||N/A|84|Actual|UMC Utrecht|||1||f||||||||||||||2017-02-18 16:46:30.003346|2017-02-18 16:46:30.003346
NCT00288808|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2015-04-24|||October 2005||2005-10-01|April 2015|2015-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.|Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements for Pediatric Patients on Anticoagulation Therapy.|Terminated||Phase 1|200|Anticipated|University of Rochester||||insufficient enrollment|f||||||||||||||2017-02-18 16:46:30.096484|2017-02-18 16:46:30.096484
NCT00288795|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-11-30|||January 2006||2006-01-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Randomized Study of Polarity or Massage Therapy to Reduce Fatigue in Breast Cancer Patients During Radiation Therapy|A Randomized Study of Polarity or Massage Therapy to Reduce Fatigue in Breast Cancer Patients During Radiation Therapy|Completed||Phase 1/Phase 2|45|Actual|University of Rochester||3|||f||||||||||||||2017-02-18 16:46:30.190712|2017-02-18 16:46:30.190712
NCT00288782|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2007-04-18|||February 2006||2006-02-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||PET Neuroimaging of [11C]Mirtazapine|Receptor Occupancy Determined by PET Neuroimaging of [11C]Mirtazapine in Healthy Humans|Completed||Phase 4|24||University of Aarhus|||||f||||f||||||||||2017-02-18 16:46:30.29849|2017-02-18 16:46:30.29849
NCT00288743|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2007-12-19|||September 2002||2002-09-01|December 2007|2007-12-01|December 2002|Actual|2002-12-01|||||Interventional|||Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study|Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study|Completed||Phase 2|30||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:46:30.608109|2017-02-18 16:46:30.608109
NCT00288730|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-06-09|||October 1996||1996-10-01|June 2011|2011-06-01|August 1997|Actual|1997-08-01|||||Interventional|||A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest|A Randomized, Double-Blinded, Placebo-Controlled Study of Two Doses of NATRECOR hBNP (Nesiritide) Administered as a Continuous Infusion in Subjects With Decompensated CHF|Completed||Phase 3|127|Actual|Scios, Inc.||1|||f||||||||||||||2017-02-18 16:46:30.697883|2017-02-18 16:46:30.697883
NCT00288717|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2007-01-09|||February 2006||2006-02-01|January 2007|2007-01-01|September 2007||2007-09-01|||||Interventional|||Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients|A Randomized, Comparative Study of the Effects of Candesartan and Telmisartan on the Home Blood Pressure, Glucose and Lipid Metabolism in the Hypertensive Patients With the Accumulation of Visceral Fat by the Central Registration System|Unknown status|Recruiting|N/A|300||Saitama Medical University|||||f||||||||||||||2017-02-18 16:46:30.791532|2017-02-18 16:46:30.791532
NCT00288704|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-12-01|2009-09-30||December 2005||2005-12-01|December 2011|2011-12-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)|IL1T-AI-0505: A Multi-center, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, & Efficacy of Rilonacept in Subjects With Cryopyrin-Associated Periodic Syndromes (CAPS) Using Parallel Group & Randomized Withdrawal Designs|Completed||Phase 3|104|Actual|Regeneron Pharmaceuticals|Cryopyrin Associated Periodic Syndrome (CAPS) is a rare disease with only a few hundred cases in the US.|3|||f||||t||||||||||2017-02-18 16:46:30.892648|2017-02-18 16:46:30.892648
NCT00288691|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2014-12-29|||November 2001||2001-11-01|December 2014|2014-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Menorrhagia Study in Women With Treatment-resistant Menorrhagia|A Multi-center, Double-blind, Placebo-controlled, Randomized, Parallel Group Study to Evaluate the Effects of Different Doses of SH T 00127B in Women With Treatment-resistant Menorrhagia Aged 30 to 55 Years After Daily Oral Administration of Multiple Doses for 35 up to 50 Days|Completed||Phase 2|26|Actual|Bayer||4|||f||||f||||||||||2017-02-18 16:46:31.922161|2017-02-18 16:46:31.922161
NCT00288678|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2010-01-26|||July 2003||2003-07-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|DMIDS||A Prospective Study on Diabetes Management Through an Integrated Delivery System|A Prospective Study on Diabetes Management Through an Integrated Delivery System|Completed||Phase 3|1222|Actual|National Health Research Institutes, Taiwan||1|||f||||f||||||||||2017-02-18 16:46:32.034976|2017-02-18 16:46:32.034976
NCT00288665|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2006-02-06|||April 2004||2004-04-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Thrombectomy and Improvement of Left Ventricular Function in AMI|Thrombectomy Before Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Improves Left Ventricular Function at 3 Months|Completed||Phase 4|50||R&D Cardiologie|||||f||||||||||||||2017-02-18 16:46:32.146005|2017-02-18 16:46:32.146005
NCT00288652|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2011-06-07|||March 2006||2006-03-01|June 2011|2011-06-01|February 2007|Actual|2007-02-01|||||Interventional|||[S,S]-Reboxetine Dose-Range Finding Trial|[S,S]-Reboxetine Dose-Range Finding Trial: A 16-Week, Randomized, Double-Blind, Placebo And An Active Comparator Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN)|Completed||Phase 2|280||Pfizer|||||||||||||||||||2017-02-18 16:46:32.467248|2017-02-18 16:46:32.467248
NCT00288639|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2009-08-28|2008-12-16||December 2005||2005-12-01|August 2009|2009-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|LEADER||Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).|Lyrica (Pregabalin) Administered As An Add-On Therapy For Partial Seizures (LEADER) An Open-Label, Multicenter Add-On Therapy Trial|Completed||Phase 4|98|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:46:32.637968|2017-02-18 16:46:32.637968
NCT00288626|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2016-11-09|||July 2006||2006-07-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study|A Phase II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) and Thymoglobulin, and Autologous CD34+ Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis|Completed||Phase 2|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||Yes|Data access is provided to the public in the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools available to researchers.|2017-02-18 16:46:33.109472|2017-02-18 16:46:33.109472
NCT00288613|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2014-07-22|||January 2006||2006-01-01|July 2014|2014-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study|FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study|Completed||Phase 4|501|Actual|NxStage Medical|||1||f||||t||||||||||2017-02-18 16:46:33.241591|2017-02-18 16:46:33.241591
NCT00288600|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2015-12-02|2015-07-20||October 2006||2006-10-01|December 2015|2015-12-01|August 2010|Actual|2010-08-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease|Phase 4 Study of Use of High-dose Intravenous Immune Globulin for Prevent Hyperbilirubinemia Due Rh Hemolytic Disease in Newborns Infants|Completed||Phase 4|92|Actual|Oswaldo Cruz Foundation|We calculated the sample size using a expected rate of 30% reduction in exchange using incidence of exchange transfusion at our department and data from a meta-analysis (relative risk, 0.21; 95% CI 0.10-0.45).|2|||f||||t||||||||||2017-02-18 16:46:33.376403|2017-02-18 16:46:33.376403
NCT00288587|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2012-05-16|2012-05-16||October 2003||2003-10-01|May 2012|2012-05-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)|CP0007: Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)|Completed||Phase 4|36|Actual|NxStage Medical||2|||f||||||||||||||2017-02-18 16:46:33.735876|2017-02-18 16:46:33.735876
NCT00288158|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-04-25|||February 2006||2006-02-01|April 2011|2011-04-01||||||||Interventional|||Primary Prevention of Hypertension in Obese Adolescents||Completed||Phase 2|128|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:46:37.92296|2017-02-18 16:46:37.92296
NCT00288574|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2016-05-26|2015-09-08||January 2000||2000-01-01|March 2015|2015-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa|Fluoxetine After Weight Restoration in Anorexia Nervosa|Completed||Phase 4|93|Actual|New York State Psychiatric Institute||2|||f||||||||||||||2017-02-18 16:46:34.187585|2017-02-18 16:46:34.187585
NCT00288561|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2008-06-18|||November 2004||2004-11-01|June 2008|2008-06-01|July 2007|Actual|2007-07-01|||||Interventional|||Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration|Open-Label, Multicenter, Phase II Study Assessing the Safety of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Occult or Predominately Classic Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (ARMD)|Completed||Phase 2|||Novartis|||||f||||||||||||||2017-02-18 16:46:34.56623|2017-02-18 16:46:34.56623
NCT00288548|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2006-02-17|||February 2006||2006-02-01|February 2006|2006-02-01||||||||Interventional|||Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)|Pulmonary Effects of the Combination of Metoprolol and Formoterol in COPD|Unknown status|Recruiting|Phase 4|45||Martini Hospital Groningen|||||f||||||||||||||2017-02-18 16:46:34.652424|2017-02-18 16:46:34.652424
NCT00288535|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2007-09-17|||March 2005||2005-03-01|March 2005|2005-03-01|February 2007||2007-02-01|||||Interventional|||Treatment of Bifurcated Coronary Lesions With Cypher™-Stent|Prospective, Randomized, Single-Center Evaluation of the Cypher™ Sirolimus Eluting Coronary Stent System in the Treatment of Bifurcated Coronary Lesions|Unknown status|Recruiting|Phase 4|200|Anticipated|Heart Center Bad Krozingen||2|||f||||||||||||||2017-02-18 16:46:34.734719|2017-02-18 16:46:34.734719
NCT00288522|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2015-09-29|||January 2006||2006-01-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment|A Phase II, Single Centre, Randomized, Double-blind, Parallel and Placebo Controlled, Pilot Study to Evaluate the Efficacy and Safety of Somatuline Autogel 60mg in Patients With Active Thyroid-associated Ophthalmopathy of Moderate Intensity.|Terminated||Phase 2|20||Ipsen|||||f||||||||||||||2017-02-18 16:46:34.831731|2017-02-18 16:46:34.831731
NCT00288509|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2010-06-17|2010-01-06||February 2006||2006-02-01|June 2010|2010-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia|A Phase III, Prospective, Multicenter, Open-label Extension Study to Assess the Longer Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Cervical Dystonia|Completed||Phase 3|108|Actual|Ipsen||1|||f||||f||||||||||2017-02-18 16:46:34.916552|2017-02-18 16:46:34.916552
NCT00288496|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2006-02-07|||April 1998||1998-04-01|April 2000|2000-04-01|February 2004||2004-02-01|||||Interventional|||Mechanical Bowel Preparation for Elective Colorectal Surgery|Mechanical Bowel Preparation for Elective Colorectal Surgery. A Multicenter Randomized Study|Completed||N/A|1400||Ikazia Hospital, Rotterdam|||||f||||||||||||||2017-02-18 16:46:35.498104|2017-02-18 16:46:35.498104
NCT00288483|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2006-07-20|||September 2000||2000-09-01|November 2005|2005-11-01|July 2001||2001-07-01|||||Interventional|||Cholesterol-Lowering Effects of Policosanol|Placebo-Controlled, Randomised, Double-Blind, Multi-Centre Clinical Trial on Dose-Dependent Cholesterol-Lowering Effects of Policosanol in Patients With Hypercholesterolaemia With 10 to 80 Mg Policosanol for 12 Weeks|Terminated||Phase 3|||Drug Commission of the German Medical Association|||||f||||||||||||||2017-02-18 16:46:35.591838|2017-02-18 16:46:35.591838
NCT00288470|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2015-03-17|||June 2002||2002-06-01|March 2015|2015-03-01|August 2003||2003-08-01|||||Interventional|||A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.||Completed||N/A|||Sanofi|||||||||||||||||||2017-02-18 16:46:35.68299|2017-02-18 16:46:35.68299
NCT00288457|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-12-23|||February 2006||2006-02-01|December 2013|2013-12-01|October 2006|Actual|2006-10-01|||||Observational|||Ureteral Stent Length and Patient Symptoms||Terminated||N/A|1|Actual|Emory University|||1|Because no staff to consent or enroll subjects|f||||||||||||||2017-02-18 16:46:35.757025|2017-02-18 16:46:35.757025
NCT00288444|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2012-12-17|||January 2006||2006-01-01|December 2012|2012-12-01|March 2009|Actual|2009-03-01|May 2008|Actual|2008-05-01||Interventional|||Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer|Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies|Terminated||Phase 1|38|Actual|Emory University||4|||f||||||||||||||2017-02-18 16:46:35.84034|2017-02-18 16:46:35.84034
NCT00288431|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2015-07-21|||February 2006||2006-02-01|July 2015|2015-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)|A Phase 1B, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin|Completed||Phase 1|37|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 16:46:35.958091|2017-02-18 16:46:35.958091
NCT00288418|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-01-22|||December 2005||2005-12-01|January 2013|2013-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization|A Controlled, Randomized, Single-Blind, Multi-Center Pivotal Clinical Study Using Angiotech CVC to Prevent Bacterial Colonization on Short-Term Central Venous Catheters|Completed||Phase 3|960|Actual|Angiotech Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:46:36.074157|2017-02-18 16:46:36.074157
NCT00288405|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2012-04-30|||June 2004||2004-06-01|April 2012|2012-04-01|December 2005|Actual|2005-12-01|||||Interventional|||The ENTERPRISE Study - Study of the Enterprise Self-Expanding Stent System|Cordis Neurovascular Feasibility Study of the Enterprise Self-Expanding Stent System to Facilitate Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms|Completed||Phase 1|31|Actual|Codman & Shurtleff||1|||f||||t||||||||||2017-02-18 16:46:36.197895|2017-02-18 16:46:36.197895
NCT00288392|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2006-10-17|||June 2005||2005-06-01|May 2006|2006-05-01|September 2006||2006-09-01|||||Interventional|||Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients|A Double-Blind Therapeutic Exploratory Clinical Study to Evaluate the Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients|Completed||Phase 2|60||Biotec Pharmacon ASA|||||f||||||||||||||2017-02-18 16:46:36.290828|2017-02-18 16:46:36.290828
NCT00288145|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-04-30|||June 2006||2006-06-01|April 2013|2013-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Statewide (Rhode Island and Neighboring States) Partnerships for Worksite Weight Management|Statewide Partnerships for Worksite Weight Management|Completed||Phase 2|1700|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 16:46:38.017261|2017-02-18 16:46:38.017261
NCT00288379|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-07|2011-01-21|||October 2004||2004-10-01|January 2011|2011-01-01|May 2006|Actual|2006-05-01|||||Interventional|||SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma|A Comparative, Placebo-controlled, Double Blind, Double Dummy, Cross-over, Single Centre, Phase IIIb Study Between Formoterol Alone (Oxis® Turbuhaler® 4.5 µg) and the Fixed Combination of Formoterol and Budesonide (Symbicort® Turbuhaler®160/4.5 µg) on Airway Responsiveness and Airway Inflammation Induced by Repeated Low-dose Allergen Challenge in Allergic Patients With Mild Asthma|Completed||Phase 3|16||AstraZeneca|||||f||||||||||||||2017-02-18 16:46:36.392593|2017-02-18 16:46:36.392593
NCT00288366|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-01-23|||January 2006||2006-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome|Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome|Completed||N/A|250|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 16:46:36.478298|2017-02-18 16:46:36.478298
NCT00288353|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-01-23|||January 2006||2006-01-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes|Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes|Terminated||Phase 3|250|Anticipated|Vanderbilt University||2||unable to secure additional funding|f||||f||||||||||2017-02-18 16:46:36.588372|2017-02-18 16:46:36.588372
NCT00288340|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2008-08-12|||January 2006||2006-01-01|August 2008|2008-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging|Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging|Completed||N/A|60|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:46:36.699697|2017-02-18 16:46:36.699697
NCT00288327|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-03-12|||March 2003||2003-03-01|March 2009|2009-03-01|January 2005|Actual|2005-01-01|December 2004|Actual|2004-12-01||Interventional|||NC Enhanced WISEWOMAN Project|Testing Lifestyle Interventions for CVD Risk Reduction in Older, Underserved Women; Enhanced WISEWOMAN Project|Completed||N/A|258|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 16:46:36.818526|2017-02-18 16:46:36.818526
NCT00288314|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2010-03-16|||January 2007||2007-01-01|March 2010|2010-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|METRAPI||fMRI in Posttraumatic Stress Disorder (PTSD) During Working Memory Updating|Working Memory Updating in Posttraumatic Stress Disorder (PTSD): Study of Neural Correlates Using fMRI|Completed||N/A|34|Actual|University Hospital, Tours|||2||f||||t||||||||||2017-02-18 16:46:36.927451|2017-02-18 16:46:36.927451
NCT00288301|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2010-06-09|||February 2005||2005-02-01|June 2010|2010-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||North Carolina WISEWOMAN: Weight-Wise Pilot Study|North Carolina WISEWOMAN Study - Weight-Wise Program|Completed||N/A|151|Actual|University of North Carolina, Chapel Hill||2|||f||||f||||||||||2017-02-18 16:46:37.032047|2017-02-18 16:46:37.032047
NCT00288288|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2012-09-24|||March 2006||2006-03-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|||||Observational|||Prospective Registry of Epicardial LV Leads Placed During Cardiac Surgery Procedures|Prospective Registry of Epicardial LV Leads Placed During Cardiac Surgery Procedures|Completed||N/A|40|Actual|University of Kansas Medical Center|||2||f||||f||||||||||2017-02-18 16:46:37.144299|2017-02-18 16:46:37.144299
NCT00288275|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2012-10-04|||July 2004||2004-07-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|||||Observational|||Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer|A Non-Interventional Prospective Study of the Correlation of the Precision Therapeutics, Inc. Chemoresponse Assay With Progression-Free Survival in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer.|Terminated||N/A|256|Anticipated|Precision Therapeutics|||1||f||||||||||Samples With DNA|"~     Leftover tumor cells from the test, pathology slides, and blood samples will be collected~     and stored to look for potential genetic variations related to drug pathway genes to~     identify patterns associated with clinical outcome.~   "|||2017-02-18 16:46:37.241546|2017-02-18 16:46:37.241546
NCT00288262|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2006-02-06|||June 2004||2004-06-01|October 2005|2005-10-01|February 2005||2005-02-01|||||Interventional|||Melatonin Effects on Luteinizing Hormone|Melatonin Effects on Luteinizing Hormone|Terminated||Phase 1/Phase 2|20||Scripps Health|||||f||||||||||||||2017-02-18 16:46:37.375757|2017-02-18 16:46:37.375757
NCT00288249|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2014-11-27|||December 2005||2005-12-01|November 2014|2014-11-01|January 2009|Actual|2009-01-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer|Prospective, Multicenter, Randomized, Independent-group, Open-label Phase II Study to Investigate the Efficacy, Safety and Tolerability of 4 Regimen With 3 Doses of ZK 219477 (16 and 12 mg/m2 Body Surface Area as 3-hour Infusion or 22 mg/m2 Body Surface Area as 30-minute or 3-hour Infusion) in Patients With Metastatic Breast Cancer|Completed||Phase 2|82|Actual|Bayer||4|||f||||f||||||||||2017-02-18 16:46:37.480023|2017-02-18 16:46:37.480023
NCT00288197|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2008-06-10|||January 2006||2006-01-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections|An Open, Prospective, Uncontrolled, Multi-Center Study To Evaluate The Efficacy And Safety Of Voriconazole In Chinese Subjects With Proven Or Probable Serious Invasive Fungal Infections|Completed||Phase 4|77|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:46:37.62116|2017-02-18 16:46:37.62116
NCT00288184|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2010-01-12|||December 2003||2003-12-01|January 2010|2010-01-01|August 2007|Actual|2007-08-01|||||Interventional|||Uric Acid in Essential Hypertension in Children|Randomized Double-blinded, Placebo-controlled, Cross-over Trial of Allopurinol for the Treatment of Newly Diagnosed Essential Hypertension in Adolescents|Completed||Phase 2|30|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||f||||||||||2017-02-18 16:46:37.716947|2017-02-18 16:46:37.716947
NCT00288171|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-06-06|||February 2006||2006-02-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||Allopurinol for Renal Transplant Associated Hypertension in Children|Randomized Double-blinded, Placebo-controlled, Cross-over Trial of Allopurinol for the Treatment of Post-renal-transplant Hypertension in Children|Terminated||Phase 1/Phase 2|0|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1||insufficient number of eligible subjects|f||||f||||||||||2017-02-18 16:46:37.81483|2017-02-18 16:46:37.81483
NCT00288132|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-02-03|||August 2005||2005-08-01|February 2011|2011-02-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|DTC||The Diabetes TeleCare Study|Bridging Barriers to Diabetes Care With Telemedicine: The Diabetes TeleCare Study (DTC)|Unknown status|Active, not recruiting|N/A|165|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 16:46:38.131694|2017-02-18 16:46:38.131694
NCT00288119|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-01-15|||October 2005||2005-10-01|January 2013|2013-01-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|FBE||Familial Barrett's Esophagus|Familial Barrett's Esophagus|Recruiting||N/A|1000|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||Samples With DNA|"~     Blood Samples are required to be sent to our NIH approved Biorepository and this repository~     is designed to help all researchers performing studies on the genetic basis of diseases.~   "|||2017-02-18 16:46:38.238783|2017-02-18 16:46:38.238783
NCT00288106|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2015-09-28|||September 2005||2005-09-01|September 2015|2015-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT|Prostate Cancer Prevention Trial (PCPT) Companion Long Term Follow Up Study for Men Diagnosed With Prostate Cancer|Terminated||N/A|961|Actual|Southwest Oncology Group|||1|Poor accrual resulted in lack of feasibility to evaluate endpoints.|f||||t||||||||||2017-02-18 16:46:38.394132|2017-02-18 16:46:38.394132
NCT00288093|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2017-01-31|||December 2006||2006-12-01|November 2016|2016-11-01||||May 2011|Actual|2011-05-01||Interventional|||3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery|A Phase I Study of Triapine® in Combination With Radiation Therapy in Locally Advanced Pancreas Cancer|Active, not recruiting||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:46:38.551245|2017-02-18 16:46:38.551245
NCT00288080|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2016-11-28|2016-11-28||December 2005||2005-12-01|November 2016|2016-11-01||||April 2014|Actual|2014-04-01||Interventional||Eligible patients who have not withdrawn consent.|Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer|A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT Vs AS and 3DCTR/IMRT Followed by Chemotherapy With Docetaxel and Prednisone for Localized, High-Risk, Prostate Cancer|Active, not recruiting||Phase 3|612|Actual|Radiation Therapy Oncology Group|Due to insufficient number of events, local control analysis was not conducted.|2|||f||||t||||||||||2017-02-18 16:46:38.669576|2017-02-18 16:46:38.669576
NCT00288067|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2014-09-30|2014-01-08||October 2005||2005-10-01|January 2014|2014-01-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma|A Phase I-II Trial of Fenretinide (4-HPR) + Rituximab in Patients With B-cell Lymphoma|Terminated||Phase 1/Phase 2|32|Actual|National Cancer Institute (NCI)||1||NCI stopped supplying fenretinide in November of 2012.|f||||t||||||||||2017-02-18 16:46:40.014638|2017-02-18 16:46:40.014638
NCT00288054|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-01-02|2012-11-26||April 2006||2006-04-01|January 2013|2013-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Pilot (Phase I) Study of Weekly Docetaxel and Cetuximab Chemoradiation for Poor Risk Stage III Non-Small Cell Lung Cancer|Terminated||Phase 1|24|Actual|Southwest Oncology Group||2||Study closed early due to poor accrual.|f||||t||||||||||2017-02-18 16:46:40.339455|2017-02-18 16:46:40.339455
NCT00288041|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-03-04|||October 2005||2005-10-01|March 2013|2013-03-01||||September 2007|Actual|2007-09-01||Interventional|||Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma|A Phase II Trial of PS-341 in Combination With Paclitaxel and Carboplatin for the Treatment of Metastatic Melanoma|Completed||Phase 2|36|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:46:40.888488|2017-02-18 16:46:40.888488
NCT00288028|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-11-18|||July 2005||2005-07-01|November 2013|2013-11-01|June 2012|Actual|2012-06-01|November 2010|Actual|2010-11-01||Interventional|||Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant|A Phase I Study of Bortezomib During Maintenance Phase After High Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Multiple Myeloma|Completed||Phase 1|15|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-02-18 16:46:41.002892|2017-02-18 16:46:41.002892
NCT00288015|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2016-05-26|||October 2005||2005-10-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Bevacizumab in Treating Patients With Angiosarcoma|An Open Label Multicenter Phase II Study of Bevacizumab for the Treatment of Angiosarcoma|Active, not recruiting||Phase 2|30|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 16:46:41.111276|2017-02-18 16:46:41.111276
NCT00288002|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-08-23|||January 2005||2005-01-01|July 2009|2009-07-01||||||||Interventional|||Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer|A Randomized Phase III Study Exploring the Efficacy of Capecitabine Given Concomitantly or in Sequence to EC-Doc With or Without Trastuzumab as Neoadjuvant Treatment of Primary Breast Cancer|Completed||Phase 3|1500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:46:43.999454|2017-02-18 16:46:43.999454
NCT00287989|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2010-08-05|||November 2004||2004-11-01|August 2010|2010-08-01||||August 2007|Actual|2007-08-01||Interventional|||Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Randomized Phase II Trial Comparing Two Doses of Pulsed Erlotinib Prechemotherapy (PEP-C) in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Completed||Phase 2|58|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||||||||||||||||2017-02-18 16:46:44.109697|2017-02-18 16:46:44.109697
NCT00287976|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-09-16|||April 2003||2003-04-01|June 2009|2009-06-01||||December 2008|Anticipated|2008-12-01||Interventional|||Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma|Irinotecan Single-Drug Treatment For Children With Refractory or Recurrent Hepatoblastoma|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:46:44.224114|2017-02-18 16:46:44.224114
NCT00287963|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2012-04-26|||February 2004||2004-02-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer|A Phase I Study of Topotecan in Combination With Vinorelbine in Recurrent Lung Cancer|Completed||Phase 1|36|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-02-18 16:46:44.337504|2017-02-18 16:46:44.337504
NCT00287950|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-09-16|||September 1992||1992-09-01|December 2006|2006-12-01||||||||Interventional|||Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma|Protocol for Infants With Neuroblastoma Diagnosed Under the Age of One Year|Unknown status|Active, not recruiting|N/A|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:46:44.451834|2017-02-18 16:46:44.451834
NCT00287937|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-02-06|||July 2005||2005-07-01|February 2013|2013-02-01||||June 2007|Actual|2007-06-01||Interventional|||Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors|Phase I Study Of Suberoylanilide Hydroxamic Acid (SAHA) (NSC 701852) in Combination With Paclitaxel /Carboplatin for Advanced and Refractory Solid Malignancies|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:46:44.573928|2017-02-18 16:46:44.573928
NCT00287924|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-09-16|||March 2005||2005-03-01|June 2009|2009-06-01||||March 2010|Anticipated|2010-03-01||Interventional|||High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma|Phase II Study of High-Dose Methotrexate in Children With Residual Ependymoma|Unknown status|Active, not recruiting|Phase 2|29|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:46:44.754043|2017-02-18 16:46:44.754043
NCT00287911|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2012-11-06|||February 2005||2005-02-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer|A Phase I Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer|Completed||Phase 1|18|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:46:45.064064|2017-02-18 16:46:45.064064
NCT00287898|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2016-04-06|||May 2005||2005-05-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 Mutation|Telephone-Based Genetic Counseling; An Equivalence Trial|Active, not recruiting||Phase 3|600|Anticipated|Georgetown University||1|||f||||f||||||||||2017-02-18 16:46:45.20788|2017-02-18 16:46:45.20788
NCT00287885|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2012-11-06|||March 2004||2004-03-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer|Phase I Study of Metronomic Daily Dosing of Docetaxel in Women With Progressive or Recurrent Gynecologic Cancer|Completed||Phase 1|18|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:46:45.34105|2017-02-18 16:46:45.34105
NCT00287872|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2014-06-25|2014-06-25||September 2004||2004-09-01|June 2014|2014-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma|VELCADE (Bortezomib) and Thalidomide in Newly Diagnosed Patients With Multiple Myeloma|Completed||Phase 2|30|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:46:45.464551|2017-02-18 16:46:45.464551
NCT00287859|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2010-01-20|||August 2004||2004-08-01|January 2010|2010-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer|Phase I Study of Weekly Topotecan in Women With Progressive or Recurrent Ovarian Cancer and a Poor Performance Status|Terminated||Phase 1|5|Actual|Masonic Cancer Center, University of Minnesota||1||Withdrawn due to low accrual|f||||t||||||||||2017-02-18 16:46:45.730412|2017-02-18 16:46:45.730412
NCT00287846|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2016-08-29|||September 2004||2004-09-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|February 2006|Actual|2006-02-01||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis|Multicentric Phase I/II Study Evaluating the Efficacy and Toxicity of Imatinib in Adult Patients With Aggressive Fibromatosis That Cannot be Treated by Surgery or Curative Radiotherapy|Completed||Phase 1/Phase 2|40|Actual|UNICANCER||1|||f||||f||||||||No|Individual Participant data will not be shared at an individual level.|2017-02-18 16:46:45.844843|2017-02-18 16:46:45.844843
NCT00287833|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2013-05-01|||January 2006||2006-01-01|May 2013|2013-05-01||||April 2007|Actual|2007-04-01||Interventional|||Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men|Phase I Single Dose Safety and Pharmacokinetic Study of Bowman Birk Inhibitor Concentrate, Delivered as an Orange Juice Suspension to Healthy Male Volunteers Between 18 and 65 Years of Age|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:46:45.98312|2017-02-18 16:46:45.98312
NCT00287820|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-07-22|||February 2004||2004-02-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism|Independent Investigator Grant Study-Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism|Completed||Phase 4|46|Anticipated|Nathan Kline Institute for Psychiatric Research||2|||f||||f||||||||||2017-02-18 16:46:46.085031|2017-02-18 16:46:46.085031
NCT00287807|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2011-09-23|||February 2006||2006-02-01|September 2011|2011-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin|Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Who Are Not Using Insulin. A Randomized Controlled Trial|Completed||Phase 3|60|Anticipated|Medical Research Foundation, The Netherlands||1|||f||||||||||||||2017-02-18 16:46:46.209408|2017-02-18 16:46:46.209408
NCT00287794|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-03-13|||February 2006||2006-02-01|March 2009|2009-03-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Quality of Sleep in Patients With Rheumatoid Arthritis|Study on the Quality of Sleep in Patients With Rheumatoid Arthritis|Unknown status|Recruiting|Phase 1|1000|Anticipated|Kobe University|||1||f||||||||||Samples Without DNA|"~     Samples for Western blot for inflammatory cytokines and transcription factors responsible~     for arthritis.~   "|||2017-02-18 16:46:46.313586|2017-02-18 16:46:46.313586
NCT00287781|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2008-01-23|||January 2002||2002-01-01|January 2008|2008-01-01|April 2006||2006-04-01|||||Interventional|||A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache|A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache|Completed||N/A|150||Kern Medical Center|||||f||||||||||||||2017-02-18 16:46:46.420239|2017-02-18 16:46:46.420239
NCT00287768|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-06-27|||March 2006||2006-03-01|June 2011|2011-06-01|October 2010|Actual|2010-10-01|September 2008|Actual|2008-09-01||Interventional|||Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer|A Phase III Study of Docetaxel and S-1 Versus S-1 in the Treatment of Advanced Gastric Cancer|Completed||Phase 3|628|Anticipated|Japan Clinical Cancer Research Organization||2|||f||||t||||||||||2017-02-18 16:46:46.517594|2017-02-18 16:46:46.517594
NCT00287755|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-06-28|||March 2006||2006-03-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Clinical Trial of Chemosensitivity Test|Chemosensitivity Test to Evaluate the Effect of Adjuvant Cancer Chemotherapy (S-1) After Gastric Surgery|Completed||Phase 2|300|Anticipated|Japan Clinical Cancer Research Organization||1|||f||||t||||||||||2017-02-18 16:46:46.996413|2017-02-18 16:46:46.996413
NCT00287742|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-05-20|||March 2002||2002-03-01|November 2010|2010-11-01|March 2003|Actual|2003-03-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease|Double-blind, Placebo-controlled Clinical Trial of JK6476 (Risperidone) in Patients With Hallucinations and Delusions Associated With Alzheimer's Disease|Terminated||Phase 3|33|Actual|Janssen Pharmaceutical K.K.||||"A decision was made to discontinue the study due to a change in the strategic direction of the~   company."|f||||f||||||||||2017-02-18 16:46:47.139213|2017-02-18 16:46:47.139213
NCT00287729|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-05-12|2010-06-02||April 2006||2006-04-01|May 2011|2011-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis|A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 3|344|Actual|InterMune||2|||f||||t||||||||||2017-02-18 16:46:47.246655|2017-02-18 16:46:47.246655
NCT00287716|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-05-12|2010-06-02||June 2006||2006-06-01|May 2011|2011-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis|A Randomized, Double-Blind, Placebo Controlled, Phase 3, Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 3|435|Actual|InterMune||3|||f||||t||||||||||2017-02-18 16:46:48.105055|2017-02-18 16:46:48.105055
NCT00287703|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-05-28|||March 2006||2006-03-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of Depression|Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of Depression|Completed||Phase 3|50|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-02-18 16:46:49.667094|2017-02-18 16:46:49.667094
NCT00287690|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2015-10-21|||October 1999||1999-10-01|February 2006|2006-02-01|April 2003||2003-04-01|||||Interventional|||Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease|The Effect of Genistein (Supro®) on Coronary Artery Diameter and Blood Flow in Men and Women With Coronary Heart Disease|Completed||Phase 2/Phase 3|26|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 16:46:49.772468|2017-02-18 16:46:49.772468
NCT00287677|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-11-03|||January 2006||2006-01-01|November 2009|2009-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients|Double Strategy to Induce and Expand the T Cell Repertoire by the Administration of Growth Hormone and Vaccination in HIV-1 Infected Patients|Completed||Phase 4|33|Actual|Germans Trias i Pujol Hospital||4|||f||||f||||||||||2017-02-18 16:46:49.876772|2017-02-18 16:46:49.876772
NCT00287664|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2007-04-10|||February 2002||2002-02-01|April 2007|2007-04-01|September 2006||2006-09-01|||||Interventional|||Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin|Terlipressin as Treatment of Patients With Cirrhosis and Hepatorenal Syndrome. Effect on Survival and Renal Function. Multicenter, Randomized and Prospective Study|Suspended||Phase 4|100||Hospital Clinic of Barcelona||||"because in a preliminary analysis we would need 1000 patients per group to achieve~   significative differences in the main end point."|f||||||||||||||2017-02-18 16:46:49.992089|2017-02-18 16:46:49.992089
NCT00287651|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2016-08-08|||November 2005||2005-11-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus|Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy|Terminated||Phase 2/Phase 3|150|Actual|Florida Atlantic University||2||Administrative|f||||t||||||||||2017-02-18 16:46:50.096073|2017-02-18 16:46:50.096073
NCT00287638|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2010-01-21|||January 2006||2006-01-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Markers in Exhaled Breath Condensate in Obstructive Sleep Apnoea (OSA) Patients|To Assess the Differences in Chemokines and Oxidative Stress Markers in Exhaled Breath Condensate of Obstructive Sleep Apnoea Patients|Completed||N/A|60|Anticipated|Chinese University of Hong Kong||2|||f||||||||||||||2017-02-18 16:46:50.212319|2017-02-18 16:46:50.212319
NCT00287625|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-06-22|||January 2006||2006-01-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Early Pulmonary Rehabilitation for Hospitalized Patients With Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)|To Study the Effect of Early Pulmonary Rehabilitation on Exacerbations, Hospitalization Rates and Quality of Life in Patients Admitted to Hospital With Acute Exacerbation of Chronic Obstructive Pulmonary Disease.|Completed||N/A|60|Anticipated|Chinese University of Hong Kong||2|||f||||||||||||||2017-02-18 16:46:50.314814|2017-02-18 16:46:50.314814
NCT00287612|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-09-21|||February 2006||2006-02-01|March 2009|2009-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Necessity of Esophageal Dissection During Laparoscopic Fundoplication|Prospective Trial Comparing Utility of Esophageal Crural Dissection During Laparoscopic Fundoplication in Children|Completed||N/A|177|Actual|Children's Mercy Hospital Kansas City||2|||f||||t||||||||||2017-02-18 16:46:50.420858|2017-02-18 16:46:50.420858
NCT00287599|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2012-02-07|||October 2006||2006-10-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|September 2009|Actual|2009-09-01||Observational|||Rapid Identification of Key Pathogens in Wound Infection by Molecular Means|Rapid Identification of Key Pathogens in Wound Infection by Molecular Means|Completed||N/A|400|Actual|Brentwood Biomedical Research Institute|||1||f||||f||||||Samples With DNA|"~     Pus and tissue specimens~   "|||2017-02-18 16:46:50.529515|2017-02-18 16:46:50.529515
NCT00287586|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2012-03-06|||March 2003||2003-03-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|June 2012|Anticipated|2012-06-01||Interventional|||Testosterone Replacement in Older Men and Atherosclerosis Progression|Effects of Testosterone Replacement on Atherosclerosis Progression in Older Men With Low Testosterone Levels|Unknown status|Active, not recruiting|Phase 4|360|Anticipated|Boston University||1|||f||||t||||||||||2017-02-18 16:46:50.617306|2017-02-18 16:46:50.617306
NCT00287573|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2010-08-05|||June 2003||2003-06-01|August 2010|2010-08-01|January 2010|Actual|2010-01-01|December 2004|Actual|2004-12-01||Interventional|TAXUS V ISR||Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis|A Prospective, Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis|Completed||Phase 2/Phase 3|488|Actual|Boston Scientific Corporation||2|||f||||||||||||||2017-02-18 16:46:50.725652|2017-02-18 16:46:50.725652
NCT00287560|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2008-02-22|||August 2003||2003-08-01|February 2008|2008-02-01|February 2005||2005-02-01|||||Interventional|||Effect of a Modified Propofol Preparation on Injection Pain During Induction of Anesthesia in Children|A Comparison of Venous Tolerability and Injection Pain of a Modified Propofol Preparation and Standard Propofol in the Induction of Anesthesia in Children|Completed||Phase 3|64||B. Braun Melsungen AG|||||f||||||||||||||2017-02-18 16:46:50.884188|2017-02-18 16:46:50.884188
NCT00287547|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2011-04-11||2011-04-11|March 1997||1997-03-01|April 2011|2011-04-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris|Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris|Completed||Phase 2|144||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:46:50.957041|2017-02-18 16:46:50.957041
NCT00287534|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-06|2009-06-07|||November 1996||1996-11-01|June 2009|2009-06-01|September 2004|Actual|2004-09-01|||||Interventional|ARNO-95||Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.|A Prospective, Multi-Centre, Randomised, Open Parallel Group Study to Compare the Effectiveness and Compatibility of ARIMIDEX (ZD 1033) With NOLVADEX After a Prior 2 Years' Treatment With Tamoxifen in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.|Completed||Phase 2|1059|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 16:46:51.061976|2017-02-18 16:46:51.061976
NCT00287521|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2012-03-02|||November 2005||2005-11-01|March 2012|2012-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension||Completed||Phase 2|87|Actual|Alcon Research||4|||f||||||||||||||2017-02-18 16:46:51.282486|2017-02-18 16:46:51.282486
NCT00287508|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2008-10-16|||November 2005||2005-11-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)|Emboshield and Xact Post Approval Carotid Stent Trial Using the Emboshield® BareWire™ Rapid Exchange Embolic Protection System and Xact® Rapid Exchange Carotid Stent System|Completed||Phase 4|1500||Abbott Vascular|||||f||||||||||||||2017-02-18 16:46:51.393084|2017-02-18 16:46:51.393084
NCT00287495|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-04|2017-01-24|||February 1, 2006||2006-02-01|October 27, 2016|2016-10-27|January 30, 2013|Actual|2013-01-30|September 21, 2012|Actual|2012-09-21||Interventional|||BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma|Phase I and Pharmacokinetic Study of BAY 43-9006 (Sorafenib) in Patients With Kaposi's Sarcoma|Completed||Phase 1|10|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 16:46:51.477902|2017-02-18 16:46:51.477902
NCT00287482|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2007-02-08|||October 2005||2005-10-01|February 2007|2007-02-01|July 2007||2007-07-01|||||Interventional|||Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.|A Pilot Study of the Herbal Remedy Essiac (ESIAK ®) Versus Placebo in Improving the Quality of Life in Women Completing Adjuvant Treatment for Breast or Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers.|Terminated||N/A|20||Women and Infants Hospital of Rhode Island|||||f||||||||||||||2017-02-18 16:46:51.770349|2017-02-18 16:46:51.770349
NCT00287469|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2016-12-27|||February 2000||2000-02-01|December 2016|2016-12-01|January 2004||2004-01-01|||||Interventional|||A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.|A Phase II, Prospective, Randomized, Double-blind, Placebo Controlled, Field Efficacy Trial of a Candidate Hepatitis E Vaccine in Nepal.|Withdrawn||Phase 2|0|Actual|U.S. Army Medical Research and Materiel Command||||IND was inactivated|||||||||||||||2017-02-18 16:46:51.859655|2017-02-18 16:46:51.859655
NCT00287456|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2006-02-02||||||January 2006|2006-01-01||||||||Interventional|||Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.||Unknown status|Active, not recruiting|N/A|16||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:46:51.959745|2017-02-18 16:46:51.959745
NCT00287443|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2006-02-02||||||January 2006|2006-01-01||||||||Interventional|||Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis||Unknown status|Active, not recruiting|N/A|48||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:46:52.047603|2017-02-18 16:46:52.047603
NCT00287430|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2006-02-02||||||January 2006|2006-01-01||||||||Interventional|||Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis||Unknown status|Active, not recruiting|N/A|12||University of Texas Southwestern Medical Center|||||||||||||||||||2017-02-18 16:46:52.132895|2017-02-18 16:46:52.132895
NCT00287417|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-13|||July 2003||2003-07-01|May 2011|2011-05-01|February 2011|Actual|2011-02-01|||||Observational|||Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester|Nuchal Translucency Study - PAPP-A|Completed||N/A|20000|Actual|University Hospital, Strasbourg, France|||1||f||||||||||||||2017-02-18 16:46:52.218865|2017-02-18 16:46:52.218865
NCT00287404|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2007-12-19|||October 2005||2005-10-01|December 2007|2007-12-01|September 2006||2006-09-01|||||Observational|||Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes|A Comparison of NMR and Chemical Lipid Analysis in the Fasting and Postprandial State in Patients With Type 2 Diabetes|Completed||N/A|30||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 16:46:52.308235|2017-02-18 16:46:52.308235
NCT00287391|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2007-04-25|||September 2004||2004-09-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Sleep Disorders and Gastroesophageal Reflux Disease (GERD)|The Impact of Gastroesophageal Reflux Disease in Sleep Disorders: A Pilot Investigation of Rabeprazole, 20 mg Twice Daily for the Relief of GERD-Related Insomnia.|Completed||Phase 4|20||University of North Carolina, Chapel Hill|||||f||||f||||||||||2017-02-18 16:46:52.40009|2017-02-18 16:46:52.40009
NCT00287378|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2009-06-26|||March 2006||2006-03-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab|Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab|Terminated||N/A|1|Actual|University of North Carolina, Chapel Hill||1||lack of enrollment|f||||t||||||||||2017-02-18 16:46:52.49345|2017-02-18 16:46:52.49345
NCT00287365|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2016-04-07|||January 2006||2006-01-01|April 2016|2016-04-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|Glutoz||Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers|Glutathione S Transferase M1 (GSTM1) Genotype Associated Susceptibility to Airway Response to Ozone in Mild Asthmatic Volunteers.|Completed||N/A|52|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 16:46:52.602557|2017-02-18 16:46:52.602557
NCT00287352|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-04-29|||May 2005||2005-05-01|April 2011|2011-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of Amantadine for Weight Stabilization During Olanzapine Treatment|Double Blind Placebo Controlled Investigation of Amantadine for Retarding Weight Gain in First Episode Adlt Psychotic Subjects Beginning Therapy With Olanzapine.|Completed||Phase 1|40|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 16:46:52.706292|2017-02-18 16:46:52.706292
NCT00287339|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2012-01-06|2011-05-11||September 2005||2005-09-01|January 2012|2012-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||The Utility of Nexium in Chronic Cough and Reflux Disease|Chronic Cough and Reflux Disease: A Randomized, Double-Blinded, Placebo Controlled Trial of High Dose Proton Pump Inhibition|Completed||Phase 4|40|Actual|University of North Carolina, Chapel Hill|This study was performed at a single center, and participants were mostly female and white, which may limit generalizability. The number of subjects in some patient subgroups was small.|2|||f||||f||||||||||2017-02-18 16:46:52.812693|2017-02-18 16:46:52.812693
NCT00287326|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2016-04-15|||January 2006||2006-01-01|June 2009|2009-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Comparison of Low-dose Epidural With Intravenous Narcotic Versus Intravenous Narcotic Alone|Comparison of Epidural Bupivacaine-Clonidine With Intravenous Morphine Versus Intravenous Morphine Alone for Post-Operative Pain Relief in Pediatric Patients Undergoing Lower Extremity or Pelvic Osteotomy.|Terminated||Phase 3|40|Anticipated|University of North Carolina, Chapel Hill||||terminated by PI|f||||||||||||||2017-02-18 16:46:53.182983|2017-02-18 16:46:53.182983
NCT00287313|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2010-01-11|||October 2005||2005-10-01|January 2010|2010-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Daily Vitamin K in Patients on Warfarin With Unstable INRs|Use of Daily Vitamin K Supplementation in Patients on Warfarin With a History of Frequent Dose Changes or Variable INRs|Completed||N/A|15|Actual|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 16:46:53.276432|2017-02-18 16:46:53.276432
NCT00287300|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2006-02-03|||September 2003||2003-09-01|January 2006|2006-01-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety of Azithromycin and Artesunate in Pregnant Women|A Pilot Randomized Controlled Trial of Azithromycin or Artesunate Added to Sulphadoxine Pyrimethamine as Therapy for Malaria in Pregnancy|Completed||N/A|141||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 16:46:53.371306|2017-02-18 16:46:53.371306
NCT00287287|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2015-11-30|||February 2006||2006-02-01|November 2015|2015-11-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas|Phase II Trial of REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary & Follicular Thyroid Carcinomas|Active, not recruiting||Phase 2|25|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-02-18 16:46:53.472287|2017-02-18 16:46:53.472287
NCT00287274|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2007-12-19|||March 2004||2004-03-01|December 2007|2007-12-01|April 2004|Actual|2004-04-01|||||Interventional|||Impact of Computerized Physician Order Entry on Medication Prescription Errors in the Intensive Care Unit: a Controlled Cross-Sectional Trial.|Impact of Computerized Physician Order Entry on Medication Prescription Errors in the Intensive Care Unit: a Controlled Cross-Sectional Trial.|Completed||N/A|160||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:46:53.578904|2017-02-18 16:46:53.578904
NCT00287261|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2014-12-08|||February 2006||2006-02-01|December 2014|2014-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)|A Prospective Multicentre Phase II Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)|Completed||Phase 2|17|Actual|Universitaire Ziekenhuizen Leuven||1|||f||||f||||||||||2017-02-18 16:46:53.668674|2017-02-18 16:46:53.668674
NCT00287248|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2014-03-06|||February 2006||2006-02-01|March 2014|2014-03-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain|Evaluation of [123I] IMPY and SPECT as a Marker of Beta-amyloid Protein Deposition in the Brain of Healthy Subjects and Patients With Alzheimer Disease|Completed||Phase 1|38|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 16:46:53.793265|2017-02-18 16:46:53.793265
NCT00287235|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2014-06-19|||September 2000||2000-09-01|June 2014|2014-06-01|April 2004|Actual|2004-04-01|November 2003|Actual|2003-11-01||Interventional|||Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)|A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy|Completed||N/A|70|Actual|Gambro Renal Products, Inc.||2|||f||||t||||||||||2017-02-18 16:46:53.918674|2017-02-18 16:46:53.918674
NCT00287222|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-06-17|2011-03-22||February 2006||2006-02-01|June 2011|2011-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma|Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma|Completed||Phase 2|21|Actual|University of Arkansas|Two subjects withdrew consent.|1|||f||||f||||||||||2017-02-18 16:46:54.044194|2017-02-18 16:46:54.044194
NCT00287209|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2006-02-03|||January 2004||2004-01-01|February 2006|2006-02-01|August 2005||2005-08-01|||||Interventional|||Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)|Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)|Completed||Phase 4|250||University of Aarhus|||||f||||||||||||||2017-02-18 16:46:54.285353|2017-02-18 16:46:54.285353
NCT00287196|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2013-06-23|||March 2002||2002-03-01|September 2009|2009-09-01|December 2011|Actual|2011-12-01|November 2008|Actual|2008-11-01||Interventional|||Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes|Randomised Clinical Trial of Surgery Versus Surgery Plus Adjuvant Radiotherapy for Regional Control in Patients With Completely Resected Macroscopic Nodal Metastatic Melanoma|Completed||Phase 3|250|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-02-18 16:46:54.38099|2017-02-18 16:46:54.38099
NCT00287183|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2009-09-30|||February 2006||2006-02-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria|Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multicenter Study In Patients With Type 2 Diabetes And Persistent Albuminuria To Evaluate The Safety And Efficacy Of A Six Month Regimen Of Orally-Administered TTP488|Completed||Phase 2|110|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:46:54.513759|2017-02-18 16:46:54.513759
NCT00287170|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2008-07-03|||July 2006||2006-07-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|||||Interventional|||Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease|Pilot, Open-Label, Randomized, Parallel Group Study to Evaluate Clinical/ and Immunological Efficacy/Safety of Locally Delivered 6-MP or Calcitriol vs Purinethol in Non-Steroid Dependent Patients With Active CD|Completed||Phase 1/Phase 2|15|Actual|Teva GTC||3|||f||||||||||||||2017-02-18 16:46:54.639665|2017-02-18 16:46:54.639665
NCT00287157|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2009-01-20|||December 2006||2006-12-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)|A Double-Blind, Randomized, Two-Way Crossover, Comparative Study to Evaluate the Clinical Efficacy and Safety of Novel Sublingual Tizanidine HCl Versus Placebo in Children With Chronic Traumatic Brain Injury|Completed||Phase 1|5|Actual|Teva GTC|||||f||||||||||||||2017-02-18 16:46:54.728643|2017-02-18 16:46:54.728643
NCT00287144|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2006-02-02|||November 2002||2002-11-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Post Partum Thyroiditis 2: Long Term Observations|Observations of Leng Term Effects From Post Partum Thyroiditis.|Unknown status|Active, not recruiting|Phase 4|||Sykehuset Telemark|||||f||||||||||||||2017-02-18 16:46:54.815764|2017-02-18 16:46:54.815764
NCT00287131|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2012-03-28|||January 2006||2006-01-01|March 2012|2012-03-01|November 2013|Anticipated|2013-11-01|December 2012|Anticipated|2012-12-01||Interventional|||Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients|Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients|Unknown status|Recruiting|Phase 2|70|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 16:46:54.900739|2017-02-18 16:46:54.900739
NCT00287118|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2016-11-04|||October 2004||2004-10-01|February 2014|2014-02-01|October 2006|Actual|2006-10-01|May 2006|Actual|2006-05-01||Interventional|||A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Patients With Moderate to Severe Plaque Psoriasis||Completed||Phase 4|189|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 16:46:54.988475|2017-02-18 16:46:54.988475
NCT00287105|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2017-02-14|||December 2005|Actual|2005-12-01|February 2017|2017-02-01|December 31, 2016|Actual|2016-12-31|December 31, 2015|Actual|2015-12-31||Interventional|ESPHALL||Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children|An Open-label, Phase II Study to Explore the Safety and Efficacy of Imatinib With Chemotherapy in Pediatric Patients With Ph+ / BCR-ABL+ Acute Lymphoblastic Leukemia (Ph+ALL)|Completed||Phase 2|49|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-02-18 16:46:55.096232|2017-02-18 16:46:55.096232
NCT00287092|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2015-01-06|||February 2006||2006-02-01|January 2015|2015-01-01|September 2008|Actual|2008-09-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants|"A Randomised, Controlled, Double-Blind Study of the Immunogenicity and Safety of PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus Influenzae Type b Conjugate Vaccine (Adsorbed) Compared To Infanrix®-IPV+Hib When Both Vaccines Are Given to Infants Using a Three Dose Immunisation Schedule (Nordic Schedule 3-5-12 Months)"|Completed||Phase 3|807|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:46:55.311116|2017-02-18 16:46:55.311116
NCT00287079|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2013-12-02|2012-02-02||October 2005||2005-10-01|December 2013|2013-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|CIS-ON||A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome|A Prospective, Open Label, Multi-centre Study Exploring the Use of Subcutaneous (sc) 44 Microgram Interferon (IFN) Beta - 1a (Rebif®) Once a Week (qw) in Subjects With Clinically Isolated Syndrome (CIS)|Completed||Phase 3|35|Actual|Merck KGaA||2|||f||||||||||||||2017-02-18 16:46:55.613719|2017-02-18 16:46:55.613719
NCT00287066|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2008-02-20|||February 2006||2006-02-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition|Open-Label Randomized Two-Way Crossover Pilot Study To Estimate The Effects Of Inhaled Versus IV Infusion Of Human Insulin With Regards To Glucose Disposal In Subjects With Type 1 Diabetes Mellitus|Terminated||Phase 3|22||Pfizer||||See termination reason in detailed description.|||||||||||||||2017-02-18 16:46:55.999386|2017-02-18 16:46:55.999386
NCT00287053|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2016-01-15|2009-04-21||February 2006||2006-02-01|January 2016|2016-01-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|VPA||Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation|Phase IV Study of the Effects of Divalproex Sodium on Food Intake and Energy Expenditure.|Completed||Phase 4|57|Actual|Pennington Biomedical Research Center|This was a short-term study; the long-term effects of this compound on energy balance require further study.|2|||f||||f||||||||||2017-02-18 16:46:56.100417|2017-02-18 16:46:56.100417
NCT00287040|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2012-05-16|||September 2007||2007-09-01|August 2008|2008-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Breast Cancer Screening Via Computer V. Phone|Breast Cancer Screening Via Computer V. Phone|Completed||Phase 3|1686|Actual|Indiana University||3|||f||||t||||||||||2017-02-18 16:46:56.483339|2017-02-18 16:46:56.483339
NCT00287027|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2007-01-04|||February 2006||2006-02-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Observational|||Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication|Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication|Terminated||N/A|60||National Alliance on Mental Illness New Hampshire|||||f||||||||||||||2017-02-18 16:46:56.618401|2017-02-18 16:46:56.618401
NCT00287014|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2010-08-26|||March 2006||2006-03-01|October 2007|2007-10-01|April 2006||2006-04-01|||||Observational|||Rift Valley Fever in Kenya|Late Outcomes of Rift Valley Fever in Kenya: Ijara Clinical Survey|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:46:56.709895|2017-02-18 16:46:56.709895
NCT00286169|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2010-08-09|||April 2006||2006-04-01|August 2010|2010-08-01||||||||Interventional|||Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)|Randomized Phase III Trial of Amrubicin Versus Carboplatin Plus Etoposide in Elderly Patients With Extensive-disease Small-cell Lung Cancer|Terminated||Phase 3|130|Anticipated|Sumitomo Dainippon Pharma Co., Ltd.|||||f||||||||||||||2017-02-18 16:47:20.850757|2017-02-18 16:47:20.850757
NCT00287001|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2008-05-21|||December 2005||2005-12-01|February 2007|2007-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Effect of Cold Air Cooling on the Incidence of Post Inflammatory Hyperpigmentation Following Laser Treatment|Effect of Cold Air Cooling on the Incidence of Post Inflammatory Hyperpigmentation Following a Q-Switched Nd:YAG Laser Treatment of Acquired Bilateral Nevus of Ota-Like Macules|Completed||N/A|20|Actual|Mahidol University||1|||f||||f||||||||||2017-02-18 16:46:56.787951|2017-02-18 16:46:56.787951
NCT00286988|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2011-01-05|||March 2006||2006-03-01|April 2007|2007-04-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children|Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children|Terminated||Phase 4|12|Anticipated|Monarch Medical Research||||Insufficient potential subjects|f||||||||||||||2017-02-18 16:46:56.898774|2017-02-18 16:46:56.898774
NCT00286975|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2008-10-16||||||November 2005|2005-11-01||||||||Interventional|||Growing Future Physician Leaders: A Randomized Trial of an Educational Intervention in Postgraduate Trainees|Growing Future Physician Leaders: A Randomized, Controlled Trial of an Educational Intervention in Postgraduate Trainees|Completed||Phase 4|||McGill University Health Center|||||f||||||||||||||2017-02-18 16:46:57.010204|2017-02-18 16:46:57.010204
NCT00286962|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2008-04-10|||February 2006||2006-02-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus|A Randomized Cross-Over Single Centre Study Comparing the Effects of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus Patients|Completed||Phase 3|24|Actual|Medical Research Foundation, The Netherlands||2|||f||||||||||||||2017-02-18 16:46:57.089273|2017-02-18 16:46:57.089273
NCT00286949|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2006-07-25|||September 2004||2004-09-01|November 2005|2005-11-01|September 2006||2006-09-01|||||Interventional|||Treatment of Executive Dysfunction in Parkinson's Disease|Atomoxetine for the Treatment of Executive Dysfunction in Patients With Parkinson's Disease: A Pilot Open-Label Study|Unknown status|Active, not recruiting|N/A|12||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:46:57.191617|2017-02-18 16:46:57.191617
NCT00286936|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-08-29|||February 2004||2004-02-01|September 2006|2006-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo|Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics vs Placebo|Terminated||Phase 4|96|Anticipated|Hvidovre University Hospital||||Slow inclusion resulting in premature termination due to logistics|f||||||||||||||2017-02-18 16:46:57.292644|2017-02-18 16:46:57.292644
NCT00286923|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2006-02-13|||February 2006||2006-02-01|February 2006|2006-02-01|August 2006||2006-08-01|||||Observational|||Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers?|Modulation of the Excitability of the Occipital Cerebral Cortex Using Topiramate|Unknown status|Not yet recruiting|N/A|10||Emerald City Headache Organization|||||f||||||||||||||2017-02-18 16:46:57.390624|2017-02-18 16:46:57.390624
NCT00286910|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2010-03-17|||May 2005||2005-05-01|March 2010|2010-03-01||||||||Observational|||Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic Syndrome|Urinary Aquaporin 2 and Expression of the NPHS2 Gene in Adults Suffering From Nephrotic Syndrome|Completed||Phase 4|150|Anticipated|Regional Hospital Holstebro|||1||f||||||||||||||2017-02-18 16:46:57.484732|2017-02-18 16:46:57.484732
NCT00286897|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2015-11-02|||February 2006||2006-02-01|November 2015|2015-11-01|August 2007|Actual|2007-08-01|June 2007|Actual|2007-06-01||Interventional|||The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|Completed||Phase 3|702|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 16:46:57.57775|2017-02-18 16:46:57.57775
NCT00286884|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2006-09-08||||||September 2006|2006-09-01||||||||Observational|||Heart Rate Variability in White Coat Hypertension and Essential Hypertension||Completed||N/A|65||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:46:57.789935|2017-02-18 16:46:57.789935
NCT00286871|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2014-09-18|||February 2006||2006-02-01|February 2006|2006-02-01|February 2009||2009-02-01|||||Interventional|||Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen|Steroid Avoidance in Hep C OLT|Completed||Phase 1|40||Duke University|||||f||||||||||||||2017-02-18 16:46:57.8692|2017-02-18 16:46:57.8692
NCT00286858|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2016-01-05|||September 2006||2006-09-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|September 2009|Actual|2009-09-01||Observational|||Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing|Clinical Observations of Automatic Algorithms for Cardiac Pacing|Completed||Phase 4|903|Actual|Boston Scientific Corporation|||1||f||||f||||||||||2017-02-18 16:46:57.974744|2017-02-18 16:46:57.974744
NCT00286845|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2012-01-25|||January 2006||2006-01-01|January 2012|2012-01-01|December 2009|Actual|2009-12-01|||||Observational|||Use of the MiCK Assay for Apoptosis in AML|Use of the MiCK Assay for Apoptosis to Predict Complete Remission in Acute Myeloid Leukemia|Completed||Phase 1|50|Anticipated|DiaTech Oncology|||2||f||||f||||||||||2017-02-18 16:46:58.109209|2017-02-18 16:46:58.109209
NCT00286832|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-07-02|||August 2005||2005-08-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV|Evaluation of Response to Treatment Using 18F-FDG Positron Emission Tomography Imaging (PET) With Special Emphasize on the Prognostic Significance of Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV|Completed||Phase 3|100|Actual|Copenhagen University Hospital at Herlev|||1||f||||t||||||||||2017-02-18 16:46:58.220306|2017-02-18 16:46:58.220306
NCT00286819|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2012-05-15|||April 2005||2005-04-01|May 2012|2012-05-01|September 2006|Actual|2006-09-01|||||Interventional|||Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer|Randomized Phase II Study of Dose-Dense Fluorouracil Plus Epirubicin 75 Plus Cyclophosphamide (FEC75) and Fluorouracil Plus Epirubicin 90 Plus Cyclophosphamide (FEC90) as Adjuvant Therapy for Early Breast Cancer|Completed||Phase 2|50|Actual|Central European Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 16:46:58.331797|2017-02-18 16:46:58.331797
NCT00286806|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2010-08-20||2010-08-12|December 2005||2005-12-01|August 2010|2010-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer|An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer (HRPC) and Rising Prostate Specific Antigen (PSA) Levels Who Have Not Received Prior Chemotherapy|Completed||Phase 1/Phase 2|27||Ascenta Therapeutics|||||||||||||||||||2017-02-18 16:46:58.454325|2017-02-18 16:46:58.454325
NCT00286793|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2011-06-27||2011-06-27|February 2006||2006-02-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC|An Open-label, Multicenter, Phase I/II Study of AT-101 in Combination With Docetaxel and Prednisone in Men With Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 1/Phase 2|76|Actual|Ascenta Therapeutics||1|||f||||f||||||||||2017-02-18 16:46:58.540605|2017-02-18 16:46:58.540605
NCT00286780|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2010-08-12|||January 2006||2006-01-01|August 2010|2010-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia|A Phase 2, Open Label Study of AT-101 in Combination With Rituximab in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 2|19|Actual|Ascenta Therapeutics||1|||f||||f||||||||||2017-02-18 16:46:58.665958|2017-02-18 16:46:58.665958
NCT00286767|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-03|2017-01-24|||January 30, 2006||2006-01-30|December 7, 2016|2016-12-07||||||||Observational|||Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy|A Cohort Observational Study Evaluating Predictors, Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients With CD4 Count Less Than or Equal to 100 Cells/microL Who Are Initiating Antiretroviral Therapy|Active, not recruiting||N/A|225|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:46:58.762638|2017-02-18 16:46:58.762638
NCT00286754|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2015-05-08|2015-01-21||July 2006||2006-07-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|January 2010|Actual|2010-01-01||Interventional|||A Behavioral Intervention To Improve Hypertension Control In Veterans|A Behavioral Intervention to Improve Hypertension Control in Veterans|Completed||N/A|533|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 16:46:58.871276|2017-02-18 16:46:58.871276
NCT00286741|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2015-04-06|2014-07-31||June 2006||2006-06-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Can Group Visits Improve Outcomes of Veterans With Diabetes|Can Group Visits Improve Outcomes of Veterans With Diabetes|Completed||Phase 3|239|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:47:00.77802|2017-02-18 16:47:00.77802
NCT00286728|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2015-04-06|2014-09-15||April 2006||2006-04-01|August 2014|2014-08-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Dual Diagnosis Self-Help Referral|Dual Diagnosis Self-Help Group Referral: Outcomes and Services Use|Completed||N/A|287|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:47:01.35575|2017-02-18 16:47:01.35575
NCT00286702|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2006-02-01|||October 2002||2002-10-01|January 2006|2006-01-01|September 2004||2004-09-01|||||Interventional|||Does Splinting Prevent Contractures Following Stroke?||Completed||N/A|63||University of Western Sydney|||||f||||||||||||||2017-02-18 16:47:01.716351|2017-02-18 16:47:01.716351
NCT00286689|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2006-02-01||||||January 2006|2006-01-01||||||||Interventional|||Effects of Growth Hormone in Chronically Ill Children||Unknown status|Active, not recruiting|N/A|18||University of Texas Southwestern Medical Center|||||||||||||||||||2017-02-18 16:47:01.801641|2017-02-18 16:47:01.801641
NCT00286676|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2006-02-01||||||January 2006|2006-01-01||||||||Interventional|||The Use of Nutropin Depot in HIV-Infected Adult Males||Unknown status|Active, not recruiting|Phase 2/Phase 3|20||University of Texas Southwestern Medical Center|||||||||||||||||||2017-02-18 16:47:01.912306|2017-02-18 16:47:01.912306
NCT00286663|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2008-07-08|||January 2006||2006-01-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|||||Observational|||Autoimmune Hepatitis Study|Evaluation of the Cellular Immune Response in Patients With Anti-SLA/LP- or Anti-LKM-Positive Autoimmune Hepatitis|Terminated||Phase 1|100|Anticipated|University of Rochester||||Principal Investigator moving out of state, no other staff to lead research.|f||||||||||||||2017-02-18 16:47:02.022799|2017-02-18 16:47:02.022799
NCT00286650|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2006-02-02|||May 2005||2005-05-01|June 2004|2004-06-01|October 2005||2005-10-01|||||Interventional|||Comparison of Two Different Doses of Paracetamol for Post-Operative Pain Relief|Comparison of Two Different Doses of Paracetamol for Post-Operative Pain Relief|Completed||Phase 4|18||University of Otago|||||f||||||||||||||2017-02-18 16:47:02.12369|2017-02-18 16:47:02.12369
NCT00286637|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2017-01-11|||January 1995||1995-01-01|January 2017|2017-01-01|January 2020|Anticipated|2020-01-01|January 2018|Anticipated|2018-01-01||Observational|||Novel Diagnostics for Ocular Structure|Optical Coherence Tomography Domain Reflectometry & Optical Coherence Tomography Measurements of Intraocular Structure|Active, not recruiting||N/A|2767|Actual|New York University School of Medicine|||1||f||||t||||||||Undecided||2017-02-18 16:47:02.23331|2017-02-18 16:47:02.23331
NCT00286624|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2008-05-02|||March 2003||2003-03-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|NITA||Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation|A One-Year, Single-Center, Prospective, Open-Label Study of the Safety, Tolerability, and Preliminary Efficacy of Anti-Thymocyte Globulin, Cyclosporine, and RAD in Type 1 Diabetic Islet Transplant Recipients|Completed||Phase 1/Phase 2|6|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 16:47:02.332731|2017-02-18 16:47:02.332731
NCT00286611|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-06-09|||October 2004||2004-10-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|||||Observational|||Determination of Amifostine Levels During Radiation Therapy|Serial Blood and Salivary Sampling for Validation of Quantitative Amifostine Assays|Completed||N/A|13|Actual|University of Iowa|||1||f||||t||||||||||2017-02-18 16:47:02.453931|2017-02-18 16:47:02.453931
NCT00286598|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2016-10-04|||January 2005||2005-01-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Feet First: Promoting Physical Activity Among People With Diabetes Mellitus and Insensate Feet|Feet First: Increasing Activity Without Increasing the Risk of Foot Ulcers in People With Diabetes and Insensate Feet|Completed||Phase 1|79|Actual|University of Missouri-Columbia||2|||f||||t||||||||No||2017-02-18 16:47:02.548902|2017-02-18 16:47:02.548902
NCT00286585|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2012-08-24|||February 2006||2006-02-01|August 2012|2012-08-01|November 2011|Actual|2011-11-01|November 2010|Actual|2010-11-01||Interventional|||TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality|Multi-Center Trial on the Effect of Anesthetics on Morbidity and Mortality in Patients Undergoing Major Non-cardiac Surgery|Completed||Phase 4|385|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 16:47:02.659892|2017-02-18 16:47:02.659892
NCT00286572|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2015-03-09|||January 2004||2004-01-01|March 2015|2015-03-01|August 2010|Actual|2010-08-01|August 2009|Actual|2009-08-01||Observational|||Long-term Mortality in Diabetics Undergoing Major Surgery|Comparison in Survival in Patients With Insulin-dependent and Non-insulin-dependent Diabetes Mellitus With Known or Suspected Coronary Artery Disease Undergoing Major Non-cardiac Surgery|Completed||N/A|380|Actual|University Hospital, Basel, Switzerland|||1||f||||t||||||||||2017-02-18 16:47:02.786557|2017-02-18 16:47:02.786557
NCT00286559|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2015-03-24|||August 2006||2006-08-01|March 2015|2015-03-01|December 2008||2008-12-01|||||Interventional|||Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)|Feasibility and Accuracy of Transoesophageal Harmonic Contrast Echocardiography in Assessing Myocardial Blood Flow and Blood Flow Reserve|Withdrawn||Phase 1/Phase 2|0|Actual|University Hospital, Basel, Switzerland||||echo contrast agents no longer allowed in CAD patients.|f||||t||||||||||2017-02-18 16:47:02.869928|2017-02-18 16:47:02.869928
NCT00286546|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2006-09-08|||January 2001||2001-01-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Testosterone and Major Depression|The Role of Testosterone in Major Depression|Completed||Phase 4|100||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:47:02.956252|2017-02-18 16:47:02.956252
NCT00286533|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2014-12-04|||January 2006||2006-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Evaluation of Implants Placed in the Regular Dentist's Practice|Retrospective Evaluation of Implants Placed in the Regular Dentist's Practice. A Study to Evaluate Implant Success, Prosthetic Complications, Opinion of the Patient, and Quality of Care|Unknown status|Recruiting|N/A|500|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:47:03.040112|2017-02-18 16:47:03.040112
NCT00286520|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2006-02-02|||December 2003||2003-12-01|February 2006|2006-02-01|August 2005||2005-08-01|||||Interventional|||Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury|Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury - a Prospective, Randomized, Controlled, Multicentre Trial of Transanal Irrigation Vs. Conservative Bowel Management|Completed||Phase 4|80||University of Aarhus|||||f||||||||||||||2017-02-18 16:47:03.139206|2017-02-18 16:47:03.139206
NCT00286507|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2012-06-05|||July 2005||2005-07-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|September 2009|Actual|2009-09-01||Interventional|FILMS||Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study|Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study: Randomised Comparison of Macular Hole Surgery With or Without Internal Limiting Membrane Peeling|Completed||N/A|141|Actual|University of Aberdeen||2|||f||||||||||||||2017-02-18 16:47:03.234952|2017-02-18 16:47:03.234952
NCT00286494|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2012-02-01|2011-06-08||February 2006||2006-02-01|February 2012|2012-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With Pioglitazone in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|493|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:47:03.370547|2017-02-18 16:47:03.370547
NCT00286481|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2012-05-23|||March 2006||2006-03-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia|A Double-Blind, Randomized, Placebo-Controlled Factorial Study to Evaluate the Efficacy and Safety of Lapaquistat and Simvastatin Alone and in Combination in Subjects With Hypercholesterolemia|Completed||Phase 3|1362|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:47:08.625337|2017-02-18 16:47:08.625337
NCT00286468|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2012-02-01|2011-06-08||April 2006||2006-04-01|February 2012|2012-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With a Sulfonylurea in Subjects With Type 2 Diabetes|Completed||Phase 3|500|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:47:09.09525|2017-02-18 16:47:09.09525
NCT00286455|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2012-02-01|2011-06-08||February 2006||2006-02-01|February 2012|2012-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) Compared With Placebo in Subjects With Type 2 Diabetes|Completed||Phase 3|329|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:47:11.714396|2017-02-18 16:47:11.714396
NCT00286442|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2012-02-01|2011-06-08||March 2006||2006-03-01|February 2012|2012-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With Metformin in Subjects With Type 2 Diabetes|Completed||Phase 3|527|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:47:14.260517|2017-02-18 16:47:14.260517
NCT00286429|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2012-02-01|2011-06-08||February 2006||2006-02-01|February 2012|2012-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With Insulin in Subjects With Type 2 Diabetes|Completed||Phase 3|390|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:47:16.680707|2017-02-18 16:47:16.680707
NCT00286416|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2006-11-06|||January 2006||2006-01-01|January 2006|2006-01-01|July 2008||2008-07-01|||||Interventional|||Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma|Double Blind Study to Determine Effect of Omalizumab Treatment in Patients With the Co-Morbid Conditions of Aspirin Exacerbated Respiratory Disease(AERD) and Allergic Asthma and Rhinitis.|Unknown status|Recruiting|N/A|60||Scripps Health|||||f||||||||||||||2017-02-18 16:47:18.503255|2017-02-18 16:47:18.503255
NCT00286403|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2016-03-25|||August 2008||2008-08-01|March 2016|2016-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Vasodilators and Anti-Oxidant Therapy in Early ATN|Combination Fenoldopam Mesylate and Intravenous MESNA (2-mercaptoethane Sulphonate)in Early Acute Kidney Injury (AKD): A Randomized, Double-Blind Placebo Controlled Clinical Trial|Withdrawn||Phase 2/Phase 3|0|Actual|Southeast Renal Research Institute||||The study was terminated due to logistics at a local hospital.|f||||t||||||||||2017-02-18 16:47:18.606327|2017-02-18 16:47:18.606327
NCT00286390|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2007-09-04|||March 2005||2005-03-01|September 2007|2007-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Acupuncture for Acute and Chronic Pain in Air Force Personnel|Outcomes and Cost Assessment of Acupuncture in the Treatment (OCAT) of Pain Patients at Malcolm Grow USAF Medical Center|Completed||N/A|200||Samueli Institute for Information Biology|||||f||||||||||||||2017-02-18 16:47:18.718161|2017-02-18 16:47:18.718161
NCT00285961|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2009-05-11||||||February 2009|2009-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Evaluation of Cork Splint Materials Instead of Plaster Splint for Children|Evaluation of Cork Splint Materials Instead of Plaster Splint for Children|Completed||N/A|50|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:47:29.786854|2017-02-18 16:47:29.786854
NCT00286377|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2006-02-02|||September 2003||2003-09-01|January 2006|2006-01-01|December 2004||2004-12-01|||||Interventional|||Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of Prosaptide Over 6 Weeks of Treatment for the Relief of Neuropathic Pain Associated With HIV-1|Terminated||Phase 2|350||Savient Pharmaceuticals|||||||||||||||||||2017-02-18 16:47:18.815706|2017-02-18 16:47:18.815706
NCT00286364|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2007-04-20||||||April 2007|2007-04-01||||||||Interventional|||Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial||Completed||Phase 4|||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:47:18.898938|2017-02-18 16:47:18.898938
NCT00286351|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2007-04-20|||January 2005||2005-01-01|April 2007|2007-04-01||||||||Interventional|||Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis||Completed||Phase 4|20||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:47:18.985091|2017-02-18 16:47:18.985091
NCT00286338|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2009-01-13|||February 2006||2006-02-01|January 2009|2009-01-01|April 2006|Actual|2006-04-01|||||Observational|||Comparison of Monitors of Fluid Therapy|Comparison of Monitors of Fluid Therapy|Completed||Phase 4|12||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:47:19.06301|2017-02-18 16:47:19.06301
NCT00286325|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2013-04-09|2011-04-04||March 2005||2005-03-01|September 2012|2012-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Rituximab in the Treatment of Patients With Bullous Pemphigoid|Rituximab in the Treatment of Patients With Bullous Pemphigoid|Completed||Phase 1/Phase 2|8|Actual|Duke University|Open label trial of rituximab in the treatment of 7 patients with the autoimmune blistering disease bullous pemphigoid.|1|||f||||f||||||||||2017-02-18 16:47:19.143292|2017-02-18 16:47:19.143292
NCT00286312|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2008-05-20|||February 2006||2006-02-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Myocardial Infarction Size Reduction With Atorvastatin|Prevention of Reperfusion Damage and Late Left Ventricular Remodelling With Atorvastatin Administered Before Reperfusion Therapy. The REPERATOR Study|Completed||Phase 4|50|Anticipated|R&D Cardiologie|||||f||||f||||||||||2017-02-18 16:47:19.470319|2017-02-18 16:47:19.470319
NCT00286299|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2016-03-15|||October 2005||2005-10-01|March 2016|2016-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia|Physiological and Psychiatric Effects From Aerobic High Intensity Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia: A Controlled Clinical Trial.|Completed||Phase 2|33|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-02-18 16:47:19.570708|2017-02-18 16:47:19.570708
NCT00286286|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2007-01-09|||February 2006||2006-02-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Intraperitoneal Aerosolized Delivery of a Local Anesthetic for Post Operative Pain Management. A Double Blind, Randomised Controlled Clinical Trial.|Clinical Protocol for the Prospective Double Blind Randomised Controlled Trial for the Use of Intraperitoneal Aerosolized Local Anesthetic|Unknown status|Active, not recruiting|N/A|50||Northgate Technologies|||||f||||||||||||||2017-02-18 16:47:19.691651|2017-02-18 16:47:19.691651
NCT00286273|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2009-08-25|||March 2003||2003-03-01|August 2009|2009-08-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration|Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration, a Randomized Controlled Trial Comparing Anticoagulation With Citrate to the Low Molecular Weight Heparin Nadroparin|Completed||Phase 4|215|Actual|Onze Lieve Vrouwe Gasthuis||2|||f||||t||||||||||2017-02-18 16:47:19.806122|2017-02-18 16:47:19.806122
NCT00286260|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2009-12-17|||January 2006||2006-01-01|January 2006|2006-01-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Levetiracetam for Painful Polyneuropathy|Double-blind, Randomised, Placebo-controlled Trial of the Effect of Levetiracetam on Painful Polyneuropathy|Completed||Phase 4|40|Anticipated|Odense University Hospital||1|||f||||||||||||||2017-02-18 16:47:19.92867|2017-02-18 16:47:19.92867
NCT00286247|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2008-03-28||||||March 2008|2008-03-01||||||||Interventional|||Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer||Completed||Phase 2|60||Introgen Therapeutics|||||||||||||||||||2017-02-18 16:47:20.021435|2017-02-18 16:47:20.021435
NCT00286234|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2013-04-30|||October 2007||2007-10-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Niacin, N-3 Fatty Acids and Insulin Resistance|Niacin, N-3 Fatty Acids and Insulin Resistance|Completed||Phase 4|10|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||t||||||||||2017-02-18 16:47:20.095603|2017-02-18 16:47:20.095603
NCT00286221|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2006-02-01|||March 2006||2006-03-01|January 2006|2006-01-01||||||||Interventional|||IVPCA in the Management of Pain Following Major Intracranial Surgery|The Safety and Efficacy of IVPCA in the Management of Adult Postoperative Craniotomy Pain: A Prospective, Randomized Controlled Trial|Unknown status|Not yet recruiting|Phase 2/Phase 3|128||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:47:20.219838|2017-02-18 16:47:20.219838
NCT00286208|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2014-02-18|||August 2005||2005-08-01|February 2014|2014-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation|A Randomized Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation|Completed||N/A|1443|Actual|Gynuity Health Projects||2|||f||||||||||||||2017-02-18 16:47:20.301579|2017-02-18 16:47:20.301579
NCT00286195|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2015-05-12|||December 2004||2004-12-01|May 2015|2015-05-01|December 2006||2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Frontier Registry II Bifurcation Stent System Registry|The Abbott Vascular MULTI -LINK FRONTIER Coronary Bifurcation Stent System Registry II|Withdrawn||Phase 4|0|Actual|Abbott Vascular||1||Study was withdrawn due to a business decision.|f||||||||||||||2017-02-18 16:47:20.413676|2017-02-18 16:47:20.413676
NCT00286182|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2016-05-03|2015-08-17||July 2007||2007-07-01|May 2016|2016-05-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)|Efficacy of Treating Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) on Ventricular Function, Exercise Capacity and Health Status|Completed||Phase 2|56|Actual|Columbia University||2|||f||||t||||||||Undecided||2017-02-18 16:47:20.50977|2017-02-18 16:47:20.50977
NCT00286156|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2015-03-31|2015-03-31||October 2006||2006-10-01|March 2014|2014-03-01|December 2014|Actual|2014-12-01|March 2012|Actual|2012-03-01||Interventional|||Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)|Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease|Completed||Phase 1/Phase 2|30|Actual|The Cleveland Clinic||3|||f||||t||||||||||2017-02-18 16:47:20.962432|2017-02-18 16:47:20.962432
NCT00286143|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2009-09-14|||February 2005||2005-02-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates|Evaluation of Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates on Perioperative Outcome|Completed||Phase 3|32|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 16:47:21.719332|2017-02-18 16:47:21.719332
NCT00286130|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2012-04-30|||July 2005||2005-07-01|April 2012|2012-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer|A Randomised, Open-label Phase II Study Evaluating the Efficacy and Safety of Folfox6 + Cetuximab as First-line Therapy in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|150|Actual|Central European Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 16:47:21.821121|2017-02-18 16:47:21.821121
NCT00286117|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2009-04-30|||March 1998||1998-03-01|April 2009|2009-04-01|May 2006|Actual|2006-05-01|||||Interventional|||ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years|An Open Randomised Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ as Adjuvant Therapies in Post-Menopausal Women With Breast Cancer Already Being Treated With NOLVADEX for at Least Two Years|Completed||Phase 3|448|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:47:21.949806|2017-02-18 16:47:21.949806
NCT00286104|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2009-12-21|||April 2004||2004-04-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular Catheter|The Impact of Ventricular Catheter Impregnated With Antimicrobial Agents on Infection in Patients With Ventricular Catheter: A Prospective Randomized Study|Completed||Phase 3|184|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 16:47:22.149112|2017-02-18 16:47:22.149112
NCT00286091|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-02|2015-05-20|2015-03-25||February 2006||2006-02-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|July 2010|Actual|2010-07-01||Interventional|||Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer|Completed||Phase 3|1435|Actual|Amgen||2|||f||||t||||||||||2017-02-18 16:47:22.281441|2017-02-18 16:47:22.281441
NCT00286078|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2016-06-28|2016-04-06||February 2006||2006-02-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|April 2009|Actual|2009-04-01||Interventional||1 subject excluded from analysis because HIPAA authorization was not obtained; randomized to active group, received percutaneous trial only|Treatment for Migraines With an Implantable Device|Precision Implantable Stimulator for Migraine (PRISM) Study- Occipital Nerve Stimulation (ONS) for Migraine|Active, not recruiting||Phase 3|179|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-02-18 16:47:28.630385|2017-02-18 16:47:28.630385
NCT00286065|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2007-06-26|||January 2006||2006-01-01|June 2007|2007-06-01||||||||Interventional|||Study to Determine Efficacy and Safety of Inhaled AeroLEF in the Treatment of Acute Post-op Pain in Adult Patients Undergoing Elective Orthopedic Surgery|Multi-Centre Placebo-Controlled Randomized 2 Part Study to Determine Efficacy and Safety of Inhaled AeroLEF in the Treatment of Acute Post-Op Pain in Adult Patients Undergoing Elective Orthopedic Surgery|Completed||Phase 2|123||YM BioSciences|||||f||||||||||||||2017-02-18 16:47:29.023434|2017-02-18 16:47:29.023434
NCT00286052|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-01-31|||December 2002||2002-12-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Impact of Low Dose Naloxone on Fentanyl Requirements in Pediatric ICU Patients|The Impact of Concomitant Ultra Low Dose Infusion Naloxone and Therapeutic Infusion Opioid on Opioid Requirements in Pediatric ICU Patients|Completed||Phase 3|128||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:47:29.115601|2017-02-18 16:47:29.115601
NCT00286039|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2011-09-29|||August 2005||2005-08-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Plasma Citrulline Level in Relation to Absorptive Surface|Plasma Citrulline Level in Relation to Absorptive Surface|Completed||N/A|200|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:47:29.2009|2017-02-18 16:47:29.2009
NCT00286026|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2012-04-12|||June 2005||2005-06-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2007|Actual|2007-08-01||Interventional|||Azithromycin in Control of Trachoma II|Azithromycin in Control of Trachoma II|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||2||Prevalence of infection for screened population too low (<7%) to enroll anyone.|f||||f||||||||||2017-02-18 16:47:29.290224|2017-02-18 16:47:29.290224
NCT00286013|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2007-12-19|||May 2004||2004-05-01|December 2007|2007-12-01||||||||Interventional|||Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma|Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma|Suspended||Phase 2|30||University Hospital, Ghent||||Study suspended because of safety reasons|f||||f||||||||||2017-02-18 16:47:29.426477|2017-02-18 16:47:29.426477
NCT00286000|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2007-12-19|||June 2004||2004-06-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|||||Interventional|||High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study|High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study|Completed||Phase 2|106||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:29.513665|2017-02-18 16:47:29.513665
NCT00285987|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2007-12-19||||||December 2007|2007-12-01||||||||Interventional|||Quality of Life After an Ambulatory Reconstruction of the Cruciate Ligament|Quality of Life After an Ambulatory Reconstruction of the Cruciate Ligament|Withdrawn||N/A|500||University Hospital, Ghent||||Study has never started|f||||f||||||||||2017-02-18 16:47:29.598144|2017-02-18 16:47:29.598144
NCT00285974|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2014-12-04|||December 2003||2003-12-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Dosage of Metal Ions in the Blood of Different Metal-on-metal Prostheses, in Correlation With Physical Activity|Dosage of Metal Ions in the Blood of Different Metal-on-metal Prostheses, in Correlation With Physical Activity|Unknown status|Active, not recruiting|N/A|120|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:47:29.680282|2017-02-18 16:47:29.680282
NCT00284739|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-02-24|2013-12-16||February 2006||2006-02-01|February 2015|2015-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses|Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses|Completed||Phase 2|20|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-02-18 16:47:29.908683|2017-02-18 16:47:29.908683
NCT00285948|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2009-02-17|||November 1998||1998-11-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient|Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient|Completed||N/A|250|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:30.326262|2017-02-18 16:47:30.326262
NCT00285935|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2016-11-07|||December 2010||2010-12-01|November 2016|2016-11-01|February 2020|Anticipated|2020-02-01|February 2020|Anticipated|2020-02-01||Interventional|CAN-D||Cellular Aging and Neurobiology of Depression Study|Neurosteroid Metabolism and the Antidepressant Effects of Serotonin Specific Reuptake Inhibitors (SSRI's)|Recruiting||Phase 4|228|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 16:47:30.422407|2017-02-18 16:47:30.422407
NCT00285922|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-01-31|||August 2001||2001-08-01|July 2005|2005-07-01|December 2005||2005-12-01|||||Observational|||Novel Method to Diagnose Acute Myocardial Ischemia|Comparison of Estimated Body Surface Potential Mapping With Standard Electrocardiography in Patients Presenting to the Emergency Department With Chest Pain|Completed||N/A|1320||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:47:30.546154|2017-02-18 16:47:30.546154
NCT00285909|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-08-15|||March 2006||2006-03-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Interventional|||Moderate Alcohol Consumption, Risk of Cardiovascular Disease and Type 2 Diabetes: Influence of Alcohol Oxidation|Effect of Moderate Alcohol Consumption on PPAR-γ Activity and Risk Markers of Metabolic Disease: Influence of Genetic Variation in Alcohol Oxidation|Completed||N/A|36||TNO|||||f||||||||||||||2017-02-18 16:47:30.636994|2017-02-18 16:47:30.636994
NCT00285896|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2008-07-10|||December 2005||2005-12-01|July 2008|2008-07-01|May 2007|Actual|2007-05-01|October 2006|Actual|2006-10-01||Interventional|||GLP-1 Infusion and Long-Time Fasting|The Effect of 48 Hours of GLP-1 Infusion During Long-Time Fasting on Glycaemia and Counterregulatory Hormones|Completed||N/A|8|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 16:47:30.722825|2017-02-18 16:47:30.722825
NCT00285883|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-02-27|||April 2004||2004-04-01|January 2006|2006-01-01|May 2006||2006-05-01|||||Interventional|||Directly Observed Therapy in High Risk Populations in Newark, NJ|Directly Observed Therapy in High Risk Populations in Newark, NJ|Completed||Phase 3|30||Saint Michael's Medical Center|||||||||||||||||||2017-02-18 16:47:30.827488|2017-02-18 16:47:30.827488
NCT00285870|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2013-03-11|||January 2006||2006-01-01|March 2013|2013-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Quantification of Upper Extremity Hypertonia|Quantification of Upper Extremity Hypertonia|Completed||Phase 1/Phase 2|60|Actual|University of Southern California|||1||f||||||||||||||2017-02-18 16:47:30.915665|2017-02-18 16:47:30.915665
NCT00285857|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2014-06-05|||November 2005||2005-11-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||Phase II Trial - Breast Cancer Chemoprevention by Lovastatin|A Phase II Trial of Lovastatin for Modification of Abnormal Breast Duct Cytology and Risk-Associated Biomarkers in Women at High Inherited Risk of Breast Cancer|Terminated||Phase 2|30|Actual|Stanford University||1||Slow accrual|f||||t||||||||||2017-02-18 16:47:31.063417|2017-02-18 16:47:31.063417
NCT00285844|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2016-11-03|||October 2005||2005-10-01|November 2016|2016-11-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Integrating the Genetic and Metabolic Faces of Obesity|Integrating the Genetic and Metabolic Faces of Obesity|Completed||Phase 1|88|Actual|Stanford University||2|||f||||f||||||||No||2017-02-18 16:47:31.174087|2017-02-18 16:47:31.174087
NCT00285831|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-10-23|||December 2005||2005-12-01|October 2008|2008-10-01||||||||Observational|||Mild Depression 2 Week Observational Study|Dysphoric-Like Disorder of Epilepsy, Is it Unique?|Unknown status|Active, not recruiting|N/A|120||Stanford University|||||f||||||||||||||2017-02-18 16:47:31.459733|2017-02-18 16:47:31.459733
NCT00285818|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2016-12-23|2016-10-20||January 2003||2003-01-01|December 2016|2016-12-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT|A Double-blind, Placebo-controlled Study of Mifepristone in Patients With Non-psychotic Major Depressive Disorder Referred for Bilateral Electroconvulsive Therapy (ECT)|Completed||N/A|11|Actual|Stanford University||2|||f||||f||||||||No||2017-02-18 16:47:31.556129|2017-02-18 16:47:31.556129
NCT00285805|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2010-08-23|||February 2006||2006-02-01|October 2008|2008-10-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||The Influence of Rosiglitazone on the Diuretic Effect of Furosemide and Amiloride|The Influence of Rosiglitazone on the Diuretic Effect of Furosemide and Amiloride. A Double-blind Placebo Controlled Cross Over Study.|Completed||N/A|13|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 16:47:32.080637|2017-02-18 16:47:32.080637
NCT00285792|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-10-04|||December 2005||2005-12-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Stanford Preschool Physical Activity Project|Stanford Preschool Physical Activity Project|Completed||Phase 1/Phase 2|60||Stanford University|||||f||||||||||||||2017-02-18 16:47:32.20155|2017-02-18 16:47:32.20155
NCT00285779|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-02-16|2015-01-28||August 2006||2006-08-01|February 2015|2015-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus|A Double-Blind, Randomized, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Etanercept 50mg SC Twice Weekly in the Treatment of Moderate to Severe Lichen Planus|Terminated||Phase 2|27|Actual|Stanford University|Trial was terminated early due to low recruitment rates.|2||Slow recruitment|f||||t||||||||||2017-02-18 16:47:32.29222|2017-02-18 16:47:32.29222
NCT00285766|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-04-21|||August 2002||2002-08-01|April 2008|2008-04-01|July 2005||2005-07-01|||||Interventional|||Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression|A Phase III, Open-Label Study of the Safety, Tolerability and Efficacy of the Selegiline Transdermal System in Elderly Subjects With Major Depression|Completed||Phase 3|300||Somerset Pharmaceuticals|||||||||||||||||||2017-02-18 16:47:32.862072|2017-02-18 16:47:32.862072
NCT00285753|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2008-05-20|||November 2003||2003-11-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Support Groups for Patients With Mild Cognitive Impairment and Their Partners|Development and Evaluation of Support Groups for Patients With Mild Cognitive Impairment and Their Partners|Completed||Phase 2|110|Actual|Radboud University||1|||f||||t||||||||||2017-02-18 16:47:32.954854|2017-02-18 16:47:32.954854
NCT00285727|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-05-16|||January 2006||2006-01-01|May 2008|2008-05-01|October 2007||2007-10-01|||||Interventional|||Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression|Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression|Completed||N/A|60||Stanford University|||||||||||||||||||2017-02-18 16:47:33.147997|2017-02-18 16:47:33.147997
NCT00285714|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2007-07-26|||February 2006||2006-02-01|July 2007|2007-07-01|December 2010|Anticipated|2010-12-01|||||Interventional|||3D Imaging of Hard and Soft Tissue in Orthognathic Surgery|An Analysis of the Clinical Applicability of a Three-Dimensional Imaging Platform Used to Register the Influence of Orthognathic Surgery on Facial Hard and Soft Tissue in Patients With Congenital Maxillofacial Deformities.|Unknown status|Recruiting|N/A|450|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 16:47:33.244012|2017-02-18 16:47:33.244012
NCT00285701|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2010-01-14|||July 2006||2006-07-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Interventional|||Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study|Early Detection of Pre-malignant and Malignant Conditions in the Colon by Means of Fluorescence Endoscopy Using Local and Oral Sensitisation With Hexaminolevulinate (HAL) - a Dose Finding Study|Completed||Phase 1/Phase 2|38|Actual|Photocure|||||f||||||||||||||2017-02-18 16:47:33.342736|2017-02-18 16:47:33.342736
NCT00285688|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2008-08-02|||June 2006||2006-06-01|August 2008|2008-08-01|December 2008|Anticipated|2008-12-01|||||Observational|||Antibiotic Resistant Helicobacter Pylori in Rajavithi Hospital|Antibiotic Resistance Helicobacter Pylori and Clarithromycin Resistance Mutation in Helicobacter Pylori in Rajavithi Hospital|Unknown status|Recruiting|Phase 3|200|Anticipated|Rajavithi Hospital|||2||f||||t||||||Samples With DNA|"~     Gastric Biopsy tissue and H. pylori DNA~   "|||2017-02-18 16:47:33.427511|2017-02-18 16:47:33.427511
NCT00285675|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-05-30|||April 2006||2006-04-01|January 2006|2006-01-01|January 2008||2008-01-01|||||Interventional|||Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004|A Continuation Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004|Unknown status|Active, not recruiting|Phase 2|25||Novacea|||||||||||||||||||2017-02-18 16:47:33.531302|2017-02-18 16:47:33.531302
NCT00285662|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2011-07-22|||June 2006||2006-06-01|July 2011|2011-07-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants|Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants|Completed||N/A|1100|Anticipated|Papua New Guinea Institute of Medical Research||3|||f||||t||||||||||2017-02-18 16:47:33.630807|2017-02-18 16:47:33.630807
NCT00285649|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-08-31|||July 2004||2004-07-01|August 2009|2009-08-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Interventional|||Predicting Patients' Response to Spinal Manipulation|Predicting Patients' Response to Spinal Manipulation|Completed||Phase 2|240|Actual|Palmer College of Chiropractic||3|||f||||t||||||||||2017-02-18 16:47:33.743442|2017-02-18 16:47:33.743442
NCT00285636|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2013-05-06|||June 1992||1992-06-01|September 2009|2009-09-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Observational|||Long Term Follow-Up of Burn Injuries|Long Term Follow-Up of Burn Injuries|Completed||N/A|1000|Anticipated|National Institute of General Medical Sciences (NIGMS)|||1||f||||f||||||||||2017-02-18 16:47:33.852146|2017-02-18 16:47:33.852146
NCT00285623|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2012-05-04|||December 2005||2005-12-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Observational|||Observational Cohort Study of TachoSil (TC-018-IN)|An Non-interventional, Prospective, Non-controlled Study of the Use of TachoSil in Supportive Treatment in Surgery for Improvement of Haemostasis Where Standard Techniques Are Insufficient.|Completed||Phase 4|3000|Actual|Nycomed|||1||f||||t||||||||||2017-02-18 16:47:33.931377|2017-02-18 16:47:33.931377
NCT00285610|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2014-11-17|||November 2001||2001-11-01|November 2014|2014-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Early Exposure to Lead and Adult Antisocial Outcomes||Completed||N/A|225|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||||||||||||2017-02-18 16:47:34.015365|2017-02-18 16:47:34.015365
NCT00285597|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-10-08|||May 2004||2004-05-01|October 2009|2009-10-01|January 2006||2006-01-01|||||Interventional|||Ursodeoxycholic Acid in Chronic Heart Failure|Ursodeoxycholic Acid Therapy in Chronic Heart Failure: A Placebo-controlled Study Evaluating the Effects of Ursodeoxycholic Acid on Peripheral Blood Flow and Immune Function|Unknown status|Active, not recruiting|Phase 2|||National Heart and Lung Institute|||||f||||||||||||||2017-02-18 16:47:34.098978|2017-02-18 16:47:34.098978
NCT00285584|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2012-05-17|2012-03-13||September 2002||2002-09-01|May 2012|2012-05-01|September 2004|Actual|2004-09-01|March 2004|Actual|2004-03-01||Interventional|||Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)|Drug Abuse, Depression and Responses to HIV Counseling|Completed||Phase 1|41|Actual|New York University|We achieved substantially lower recruitment than needed to adequately test the study hypothesis. We also experienced substantial losses-to-follow-up.|2|||f||||t||||||||||2017-02-18 16:47:34.19066|2017-02-18 16:47:34.19066
NCT00285571|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2010-03-17|||September 2005||2005-09-01|March 2010|2010-03-01|September 2007|Actual|2007-09-01|||||Interventional|||Dietary Variety Versus Dietary Fat Effects in Energy Intake|Dietary Variety vs Dietary Fat Effects on Energy Intake|Completed||Phase 1/Phase 2|64|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:47:34.830437|2017-02-18 16:47:34.830437
NCT00285558|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2010-01-12|||March 2002||2002-03-01|January 2010|2010-01-01|April 2008||2008-04-01|||||Interventional|||Peer-enhanced Intervention to Support Teen Weight Loss|Peer-Enhanced Intervention to Support Teen Weight Loss|Completed||Phase 2|150||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:47:34.917029|2017-02-18 16:47:34.917029
NCT00285545|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2013-06-29|||January 2000||2000-01-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Biomagnetic Signals of Intestinal Ischemia|Biomagnetic Signals of Intestinal Ischemia II|Completed||Phase 1|60|Actual|University of South Alabama|||2||f||||f||||||||||2017-02-18 16:47:35.001044|2017-02-18 16:47:35.001044
NCT00285532|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2014-11-17|||October 2001||2001-10-01|November 2014|2014-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Identifying Residential Hazards Using Home Test Kits||Completed||N/A|150|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||||||||||||2017-02-18 16:47:35.088826|2017-02-18 16:47:35.088826
NCT00285519|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2006-02-01|||August 2003||2003-08-01|February 2006|2006-02-01|August 2005||2005-08-01|||||Interventional|||Japan Morning Surge-1 Study|The Effects of Controlling Morning Hypertension on Target Organ Damage With Adrenergic Blockers, Based on Self-Measured Morning Blood Pressure Readings|Completed||Phase 4|600||Japan Heart Foundation|||||f||||||||||||||2017-02-18 16:47:35.167155|2017-02-18 16:47:35.167155
NCT00285506|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-05-25|||January 2006||2006-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||The Effect of Contrast Media on Erythrocytes in Healthy Volunteers|The Effect of Low-Osmolar and Iso-Osmolar Contrast Media on Erythrocytes in Healthy Volunteers.|Completed||N/A|20||Medical University of South Carolina|||||f||||||||||||||2017-02-18 16:47:35.326302|2017-02-18 16:47:35.326302
NCT00285493|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2014-03-12|||January 2006||2006-01-01|June 2011|2011-06-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Low Back Pain and Antibiotic Treatment|Phase 1 Study of Antibiotic Treatment for Low Back Pain|Withdrawn||Phase 1|0|Actual|Loewenstein Hospital||||Withdrawn: study halted prematurely, prior to enrollment of first participant|f||||||||||||||2017-02-18 16:47:35.407358|2017-02-18 16:47:35.407358
NCT00285467|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2016-04-18|2012-03-27||January 2006||2006-01-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||47 subjects had at least one follow up visit after taking medications and were included in results.|Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease|Comparison of Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in CKD|Completed||N/A|55|Actual|Indiana University|Larger, long term studies are needed to demonstrate efficacy of mineral-related and non-mineral-related endpoints and safety.|2|||f||||t||||||||No||2017-02-18 16:47:35.497814|2017-02-18 16:47:35.497814
NCT00285454|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2015-03-30|||January 2006||2006-01-01|March 2015|2015-03-01|December 2008|Anticipated|2008-12-01|February 2006|Anticipated|2006-02-01||Interventional|||Cell Repair in Heart Failure|A Phase I/II, Randomised, Double-blind, Placebo Controlled, Single-centre Study of Bone Marrow Mononuclear Cells by Percutaneous Retrograde Coronary Venous Delivery to Patients With Ischaemic Heart Failure and no Standard Revascularisation Options.|Withdrawn||Phase 1/Phase 2|0|Actual|Imperial College London||||no funding|f||||||||||||||2017-02-18 16:47:36.001116|2017-02-18 16:47:36.001116
NCT00285441|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-02-27|||November 2005||2005-11-01|December 2005|2005-12-01|September 2008||2008-09-01|||||Observational|||Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis||Unknown status|Recruiting|N/A|60||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 16:47:36.09344|2017-02-18 16:47:36.09344
NCT00285428|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2012-02-02|||September 2004||2004-09-01|February 2012|2012-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma|A Phase I Study of Immunotherapy With hA20 Administered Once Weekly for 4 Consecutive Weeks in Patients With CD20+ Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|82|Actual|Immunomedics, Inc.||4|||f||||f||||||||||2017-02-18 16:47:36.184741|2017-02-18 16:47:36.184741
NCT00285415|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2013-10-24|||April 2005||2005-04-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation|A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Plus or Minus Para-Aortic Irradiation for Stage III/IV Endometrial Carcinoma|Completed||Phase 2|46|Actual|Carilion Clinic||1|||f||||||||||||||2017-02-18 16:47:36.29565|2017-02-18 16:47:36.29565
NCT00285402|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-02-06|||May 2007||2007-05-01|February 2008|2008-02-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine|Intranasal AST-726 Treatment for Prophylaxis of Migraine: A Placebo-Controlled Clinical Study|Unknown status|Active, not recruiting|Phase 2|198|Anticipated|Ariston Pharmaceuticals, Inc.||3|||f||||f||||||||||2017-02-18 16:47:36.406499|2017-02-18 16:47:36.406499
NCT00285389|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-02-11|||February 2002||2002-02-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2005|Actual|2005-12-01||Interventional|||Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years|Treatment in First Line of Mantle Cell Lymphoma for Patients Under 66 Years by the VAD-CHLORAMBUCIL -Rituximab Regimen Followed by Intensification and Autologous PBSC Transplantation After Marrow Purging With Rituximab|Completed||Phase 2|39|Actual|French Innovative Leukemia Organisation||1|||f||||t||||||||||2017-02-18 16:47:36.53376|2017-02-18 16:47:36.53376
NCT00285376|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-02-12|||February 2006||2006-02-01|February 2008|2008-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response|A Randomized, Double-Blind, Placebo Controlled Study Assessing the Efficacy and Safety of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder|Completed||Phase 3|410|Actual|Genaissance Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:47:36.669601|2017-02-18 16:47:36.669601
NCT00285363|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-01-31|||March 2005||2005-03-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Quality of Life Among Children and Adolescents With Cancer|Quality of Life Among Children and Adolescents With Cancer|Unknown status|Active, not recruiting|N/A|75||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 16:47:36.792744|2017-02-18 16:47:36.792744
NCT00285350|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-03-24|||September 2002||2002-09-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Mycophenolate Mofetil in Myasthenia Gravis|A Trial of Mycophenolate Mofetil in Myasthenia Gravis|Completed||Phase 3|80||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 16:47:36.864073|2017-02-18 16:47:36.864073
NCT00285337|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2015-11-23|||December 2005||2005-12-01|November 2015|2015-11-01|November 2007|Actual|2007-11-01|||||Interventional|CSM||Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy|An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy|Completed||Phase 4|321|Anticipated|AOSpine North America Research Network||1|||f||||f||||||||||2017-02-18 16:47:36.950164|2017-02-18 16:47:36.950164
NCT00285324|ClinicalTrials.gov processed this data on February 17, 2017|2006-02-01|2017-01-24|||January 27, 2006||2006-01-27|August 20, 2013|2013-08-20|August 20, 2013||2013-08-20|||||Observational|||Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation Necrosis|Two-Compartment Model of Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) for the Diagnosis of Glioma Tumor Recurrence Versus Radiation Necrosis|Completed||N/A|29|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:47:37.073194|2017-02-18 16:47:37.073194
NCT00285298|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2011-07-28|||January 2006||2006-01-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients|Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients: a Pilot Randomized, Placebo-controlled, Double-blind Trial.|Completed||Phase 3|39|Actual|Walter Reed Army Medical Center||2|||f||||||||||||||2017-02-18 16:47:37.157589|2017-02-18 16:47:37.157589
NCT00285285|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-01-31|||January 2004||2004-01-01|January 2006|2006-01-01|August 2004||2004-08-01|||||Interventional|||Point of Care Device Use in the Pediatric Emergency Department|A Randomized Trial to Assess the Efficacy of Point-of-Care Testing in Decreasing Length of Stay in a Pediatric Emergency Department|Completed||N/A|200||Yale University|||||f||||||||||||||2017-02-18 16:47:37.267894|2017-02-18 16:47:37.267894
NCT00285259|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2013-07-31||2013-07-31|January 2006||2006-01-01|July 2013|2013-07-01|November 2010|Actual|2010-11-01|November 2009|Actual|2009-11-01||Interventional|||Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)|A Phase 2 Clinical Trial to Evaluate the Safety, Immunogenicity, and Clinical Benefit of a CMV Immunotherapeutic Vaccine in Donors and CMV-Seropositive Recipients Undergoing Allogeneic, Matched Hematopoietic Cell Transplant (HCT)|Completed||Phase 2|108|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 16:47:37.353626|2017-02-18 16:47:37.353626
NCT00285246|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2015-04-23|2014-08-28||December 2005||2005-12-01|April 2015|2015-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational||All enrolled participants|Prospective Study of Veteran Health in Previously Deployed Soldiers|Prospective Study of Functional Status in Veterans at Risk for Unexplained Illnesses|Completed||N/A|838|Actual|VA Office of Research and Development|The sample was comprised of only Army National Guard and Reserve military personnel, and therefore results may not generalize to the broader population of military personnel from other Service branches or components.||1||f||||f||||||None Retained|"~     Saliva~   "|||2017-02-18 16:47:37.485684|2017-02-18 16:47:37.485684
NCT00285233|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-07-31|||September 2000||2000-09-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|September 2004|Actual|2004-09-01||Interventional|||Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes|An Open-label Pilot Study of Delayed Mycophenolate Mofetil Instead of Tacrolimus Combined With Anti-thymocyte Globulin, Daclizumab, Etanercept, and Sirolimus in Single-donor, Solitary Islet Allograft Recipients With Type 1 Diabetes|Completed||Phase 1/Phase 2|8|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 16:47:37.794753|2017-02-18 16:47:37.794753
NCT00285220|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-02-17|||September 2005||2005-09-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|||||Interventional|||Safety and Efficacy of Laparoscopic Truncal Vagotomy for the Treatment of Obesity|A Prospective, Multi-Center Study to Evaluate the Safety and Effectiveness of Laparoscopic Truncal Vagotomy for the Treatment of Obesity|Completed||N/A|30||University of Rochester|||||f||||t||||||||||2017-02-18 16:47:37.910881|2017-02-18 16:47:37.910881
NCT00285207|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2010-09-23|2010-08-30||January 2006||2006-01-01|September 2010|2010-09-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Trial of the Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix|Completed||Phase 2|147|Actual|Tigris Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:47:38.004384|2017-02-18 16:47:38.004384
NCT00285194|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-07-31|||April 2000||2000-04-01|July 2012|2012-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients|hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients|Completed||Phase 1/Phase 2|6||University of Minnesota - Clinical and Translational Science Institute|||||f||||t||||||||||2017-02-18 16:47:38.422252|2017-02-18 16:47:38.422252
NCT00285181|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2007-08-08|||November 2005||2005-11-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Effects of Statins on Pro- and Antioxidant Status : Link With Statin-Associated Myopathy.|Effects of Statins on Pro- and Antioxidant Status : Link With Statin-Associated Myopathy. A Randomized, Placebo-Controlled, Double-Blind Study.|Completed||N/A|24|Anticipated|University Hospital, Montpellier|||||f||||f||||||||||2017-02-18 16:47:38.529531|2017-02-18 16:47:38.529531
NCT00285168|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-07-18|||May 2005||2005-05-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|March 2008|Actual|2008-03-01||Observational|||A Randomized Controlled Trial of a Bone Density Decision Aide|A Randomized Controlled Trial of a Bone Density Decision Aide in the Pharmacological Management of Osteoporosis|Terminated||N/A|200|Actual|University of Manitoba|||2|Inadequate recruitment|f||||||||||||||2017-02-18 16:47:38.627599|2017-02-18 16:47:38.627599
NCT00285155|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2007-08-08|||November 2004||2004-11-01|August 2007|2007-08-01|February 2006|Actual|2006-02-01|||||Interventional|||Assessment of Bupropion on Cognitive Function and Behaviour in Healthy Volunteers|Assessment of Bupropion on Cognitive Function and Behaviour in Healthy Volunteers|Completed||N/A|12|Anticipated|University Hospital, Montpellier|||||f||||||||||||||2017-02-18 16:47:38.738663|2017-02-18 16:47:38.738663
NCT00285142|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-10-05|||June 2004||2004-06-01|January 2006|2006-01-01|November 2004||2004-11-01|||||Interventional|||Effect of Rosiglitazone|Assessment of the Effect of Rosiglitazone on Insulin Secretion in Healthy Volunteers|Completed||N/A|12||University Hospital, Montpellier|||||f||||||||||||||2017-02-18 16:47:38.832119|2017-02-18 16:47:38.832119
NCT00284245|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2011-06-24|||June 2004||2004-06-01|September 2006|2006-09-01||||||||Observational|||Evaluation of Pain Location, Pain Quality and Pain Patterns in Subjects With Chronic Pain|Internet-based Study of 10,000 Subjects With Chronic Pain, Including Subject-drawn Pain Diagrams, and Computer-generated Composite Images of Pain Patterns|Unknown status|Recruiting|N/A|1000|Anticipated|Taylor MicroTechnology|||1||f||||||||||||||2017-02-18 16:47:38.918537|2017-02-18 16:47:38.918537
NCT00284232|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2015-07-27|||October 2004||2004-10-01|July 2015|2015-07-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes|Randomized Controlled Trial Studying the Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes|Completed||Phase 4|140||Helse Stavanger HF|||||f||||f||||||||||2017-02-18 16:47:38.99531|2017-02-18 16:47:38.99531
NCT00284219|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2011-06-29|||July 2005||2005-07-01|June 2011|2011-06-01||||||||Interventional|||High-Frequency Repetitive Transcranial Magnetic Stimulation Assists In Smoking Cessation||Completed||N/A|50|Anticipated|Sheba Medical Center||2|||f||||||||||||||2017-02-18 16:47:39.086953|2017-02-18 16:47:39.086953
NCT00284206|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2008-01-03|||January 2006||2006-01-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence|An Open-Label Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence|Completed||Phase 2|20|Anticipated|Seattle Institute for Biomedical and Clinical Research|||||f||||||||||||||2017-02-18 16:47:39.182799|2017-02-18 16:47:39.182799
NCT00284193|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2012-07-26|||January 2005||2005-01-01|July 2012|2012-07-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional|||Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII|Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII|Completed||Phase 4|5|Actual|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 16:47:39.274604|2017-02-18 16:47:39.274604
NCT00284180|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2013-07-09|2013-03-25||January 2006||2006-01-01|July 2013|2013-07-01|November 2010|Actual|2010-11-01|February 2008|Actual|2008-02-01||Interventional|||Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer|Phase II Trial of Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer|Completed||Phase 2|32|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 16:47:39.375632|2017-02-18 16:47:39.375632
NCT00284167|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2011-07-25|||September 2003||2003-09-01|July 2011|2011-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Efficacy of a Web-based Tailored Weight Management Program|Efficacy of a Web-based Tailored Weight Management Program With and Without Tailored Nutrition and Goal Setting Support|Completed||Phase 2/Phase 3|1848||Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 16:47:39.848804|2017-02-18 16:47:39.848804
NCT00284154|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2013-02-08|2013-02-08||January 2006||2006-01-01|February 2013|2013-02-01|November 2009|Actual|2009-11-01|May 2009|Actual|2009-05-01||Interventional|||Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer|A Phase II Trial of VInflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer|Completed||Phase 2|51|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 16:47:40.018882|2017-02-18 16:47:40.018882
NCT00284141|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-11-12|2012-08-17||January 2006||2006-01-01|July 2011|2011-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma|A Multicenter, Open-label, Single-arm, Two-stage Study of the Efficacy and Safety of AVE0005 (VEGF Trap) Administered Intravenously Every 2 Weeks in Patients With Platinum- and Erlotinib-resistant Locally Advanced or Metastatic Non-small-cell Lung Adenocarcinoma|Completed||Phase 2|98|Actual|Sanofi||1|||f||||t||||||||||2017-02-18 16:47:40.567737|2017-02-18 16:47:40.567737
NCT00284128|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2016-04-19||2016-04-19|December 2005||2005-12-01|April 2016|2016-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|RAVEL-1||AVE7688 in Patients With Mild to Moderate Blood Pressure|Double-blind, Randomized, Parallel-group, Dose Ranging, Multicenter Study to Evaluate the Efficacy and Safety of 2.5, 10, 35 and 50 mg AVE 7688 Once Daily, Using 100 mg Losartan-potassium Once Daily as Calibrator, for 12 Months Treatment, in Patients With Mild to Moderate Hypertension|Completed||Phase 2/Phase 3|1940|Actual|Sanofi||5|||f||||f||||||||No||2017-02-18 16:47:41.187584|2017-02-18 16:47:41.187584
NCT00284115|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-07-03|||March 2006||2006-03-01|July 2012|2012-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Efficacy of a Mechanical Gait Repetitive Training Technique in Hemiparetic Stroke Patients (AVC)|Efficacy of a Mechanical Gait Repetitive Training Technique Compared With a Usual Rehabilitation Program on Gait Recovery in Hemiparetic Stroke Patients|Terminated||N/A|122|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-02-18 16:47:41.341048|2017-02-18 16:47:41.341048
NCT00284102|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2008-09-24|||January 2006||2006-01-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||PEEP Test and Gas Exchange in ALI/ARDS Patients|Positive End Expiratory Pressure (PEEP) Test and Gas Exchange in ALI/ARDS Patients|Completed||N/A|50|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 16:47:41.682853|2017-02-18 16:47:41.682853
NCT00284089|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2011-02-22|2011-01-20||April 2005||2005-04-01|February 2011|2011-02-01|January 2009|Actual|2009-01-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration|Open-label Multicenter, Phase I/II Study Assessing the Safety and Efficacy of Ranibizumab (RFB002) in Japanese Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)|Completed||Phase 1/Phase 2|88|Actual|Novartis||4|||f||||||||||||||2017-02-18 16:47:41.809139|2017-02-18 16:47:41.809139
NCT00284076|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2014-03-04|||February 2000||2000-02-01|March 2014|2014-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||L-Arginine in the Treatment of Peripheral Arterial Disease||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 16:47:42.991796|2017-02-18 16:47:42.991796
NCT00284063|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2015-04-14|||October 2005||2005-10-01|April 2015|2015-04-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Interventional|||Z-Joint Changes in Low Back Pain Following Adjusting|Z-Joint Changes in Low Back Pain Following Adjusting|Completed||N/A|112|Actual|National University of Health Sciences||4|||f||||t||||||||||2017-02-18 16:47:43.080842|2017-02-18 16:47:43.080842
NCT00285129|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2007-12-19|||January 2004||2004-01-01|December 2007|2007-12-01|December 2004|Actual|2004-12-01|||||Interventional|||Primary Ceramic-on-Ceramic Total Hip Replacement Versus Metal-on-Metal Hip Resurfacing in Young Active Patients|Primary Ceramic-on-Ceramic Total Hip Replacement Versus Metal-on-Metal Hip Resurfacing in Young Active Patients|Completed||N/A|400||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:43.19247|2017-02-18 16:47:43.19247
NCT00285116|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-05-18||||||February 2009|2009-02-01||||||||Interventional|||The Correlation Between Fasicitis Plantaris and Hallux Rigidus|The Correlation Between Fasicitis Plantaris and Hallux Rigidus|Withdrawn||N/A|60|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:43.271148|2017-02-18 16:47:43.271148
NCT00285103|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-01|||June 2005||2005-06-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|||||Interventional|||SPC2996 in Chronic Lymphocytic Leukaemia|An Open-labelled, International, Multicenter, Dose Escalating, Phase I/II Study of SPC2996,an LNA Antisense Molecule Against Bcl-2, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia|Completed||Phase 1/Phase 2|46|Anticipated|Santaris Pharma A/S||1|||f||||t||||||||||2017-02-18 16:47:43.416781|2017-02-18 16:47:43.416781
NCT00285090|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2011-12-19|||February 2005||2005-02-01|December 2011|2011-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Bone Mineral Density, Body Composition and Growth Following Severe Burn Injury|Bone Mineral Density, Body Composition and Growth Following Severe Burn Injury|Terminated||Phase 1|60|Anticipated|Shriners Hospitals for Children||4||Lack of volunteers|f||||||||||||||2017-02-18 16:47:43.517912|2017-02-18 16:47:43.517912
NCT00284895|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-06-25|||November 2005||2005-11-01|June 2008|2008-06-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Observational|||The Effect of Obesity on Lung Functioning|The Effect of Medical and Surgical Weight Loss on Pulmonary Physiology and Airway|Completed||N/A|40|Anticipated|National Jewish Health|||||f||||||||||||||2017-02-18 16:47:49.0436|2017-02-18 16:47:49.0436
NCT00285077|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-12-22|||March 2004||2004-03-01|December 2008|2008-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease|Long-Term Safety Extension of Phase II Study EFC5286 of SR57667B in Patients With Mild-to-Moderate Alzheimer's Disease|Completed||Phase 2|390|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:47:43.642023|2017-02-18 16:47:43.642023
NCT00285064|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2008-10-11|||January 2006||2006-01-01|February 2007|2007-02-01|May 2008|Actual|2008-05-01|August 2007|Actual|2007-08-01||Interventional|||Assessment of Myocardial Viability Using Multidetector Computed Tomography|Non-Invasive Assessment of Myocardial Viability Using Multidetector Computed Tomography Post Acute Myocardial Infarction|Completed||N/A|20|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:47:43.757984|2017-02-18 16:47:43.757984
NCT00285051|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2007-02-27|||November 2005||2005-11-01|February 2007|2007-02-01|November 2005||2005-11-01|||||Interventional|||Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy|Study to Compare the Safety and Efficacy of 2 Different Doses of Inhaled D8-THC to Standard Therapy With Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy|Suspended||Phase 2|108||Rafa Laboratories||||Study drug expiry date not extended|f||||||||||||||2017-02-18 16:47:43.851053|2017-02-18 16:47:43.851053
NCT00285038|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2010-12-13|||March 2006||2006-03-01|January 2006|2006-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Ultrasound (US)-Doppler for the Diagnosis of Asymptomatic Deep Vein Thrombosis (DVT) in Gynecologic Cancer Patients|US-Doppler for the Diagnosis of Asymptomatic DVT in Gynecologic Cancer Patients|Completed||Phase 2|100|Anticipated|Rambam Health Care Campus|||1||f||||||||||||||2017-02-18 16:47:43.948198|2017-02-18 16:47:43.948198
NCT00285025|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-01-31|||March 2005||2005-03-01|January 2006|2006-01-01|September 2005||2005-09-01|||||Interventional|||Study of the Effect of SR57667B in Patients With Alzheimer's Disease|A Phase II, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Safety and Tolerability Study of SR57667B in Patients With Mild-to-Moderate Alzheimer's Disease|Completed||Phase 2|500||Sanofi|||||f||||||||||||||2017-02-18 16:47:44.034052|2017-02-18 16:47:44.034052
NCT00285012|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2010-04-15|2009-10-30||May 2006||2006-05-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|July 2008|Actual|2008-07-01||Interventional|||Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial With 40-Week Follow-Up Evaluating The Safety And Efficacy Of Varenicline Tartrate For Smoking Cessation In Patients With Mild-To-Moderate Chronic Obstructive Pulmonary Disease|Completed||Phase 3|504|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:47:44.120248|2017-02-18 16:47:44.120248
NCT00284999|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-08-21||||||August 2006|2006-08-01|August 2006||2006-08-01|||||Interventional|||Soothe Versus Refresh||Completed||Phase 4|33||Pharmaceutical Research Network|||||f||||||||||||||2017-02-18 16:47:47.631176|2017-02-18 16:47:47.631176
NCT00284986|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2014-12-02|||November 2005||2005-11-01|December 2014|2014-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Patients|A Phase II Open Label Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Salvage of Treatment-Refractory Acute GVHD Patients|Completed||Phase 2|15|Actual|Mesoblast, Ltd.||1|||f||||f||||||||||2017-02-18 16:47:47.70754|2017-02-18 16:47:47.70754
NCT00284973|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2015-04-13|||January 2006||2006-01-01|April 2007|2007-04-01||||||||Interventional|||A Study of Safety and Immunogenicity of a Malaria Vaccine Candidate|Ph-1 Double-Blind Randomized Control Study-Evaluate Safety & Immunogenicity of Wanxing Bio-Pharmaceuticals AMA-1/MSP-1 Recombinant Malaria Vaccine (PfCP-2.9) Adj. w/ Montanide ISA 720 Compared to Montanide ISA 720 Alone in Adult Volunteers|Completed||Phase 1|70||PATH|||||f||||||||||||||2017-02-18 16:47:47.808371|2017-02-18 16:47:47.808371
NCT00284960|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-01-31|||July 2005||2005-07-01|June 2005|2005-06-01|June 2006||2006-06-01|||||Observational|||The Incidence and Treatment of Insulin Resistance Among Men With Erectile Dysfunction|The Incidence and Treatment of Insulin Resistance Among Men With Erectile|Unknown status|Recruiting|Phase 4|30||Penn State University|||||f||||||||||||||2017-02-18 16:47:48.139296|2017-02-18 16:47:48.139296
NCT00284947|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-05-07|||January 2006||2006-01-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids|REPLACE: Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids|Completed||Phase 4|7|Actual|Novartis||1|||f||||f||||||||||2017-02-18 16:47:48.230188|2017-02-18 16:47:48.230188
NCT00284934|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2011-03-31|2010-12-20||December 2005||2005-12-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|OLYMPE||Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients|A Multicenter, National, Open-label, Prospective, Randomized Study to Evaluate Efficacy and Tolerability of Enteric-coated Mycophenolate Sodium 1440 mg/Day With Tacrolimus Reduced Dose Versus Enteric-coated Mycophenolate Sodium 720 mg/Day With Tacrolimus Standard Dose, in Maintenance, Stable, Adult, Kidney Transplant Recipients|Completed||Phase 3|94|Actual|Novartis||2|||f||||f||||||||||2017-02-18 16:47:48.344579|2017-02-18 16:47:48.344579
NCT00284921|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2011-11-01|||April 2004||2004-04-01|November 2011|2011-11-01||||August 2006|Actual|2006-08-01||Interventional|||MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive|A Twelve-month, Randomized, Multicenter, Open-label, Exploratory Study to Investigate the Clinical Outcomes of an Immunosuppressive Regimen of Basiliximab, Cyclosporine Microemulsion (CsA-ME) and Enteric-coated Mycophenolate Sodium (EC-MPS) Free of Steroids Compared With a Regimen of EC-MPS With Standard Steroids in de Novo Kidney Recipients Who Are Hepatitis C Positive|Terminated||Phase 3|60||Novartis|||||f||||||||||||||2017-02-18 16:47:48.84847|2017-02-18 16:47:48.84847
NCT00284908|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-03-21|||September 2006||2006-09-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers|Pharmacodynamic Dose-Response of S-Tenatoprazole-Na (STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers|Completed||Phase 1|32|Actual|STEBA France||1|||f||||f||||||||||2017-02-18 16:47:48.931143|2017-02-18 16:47:48.931143
NCT00284674|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-03-17||||||September 2006|2006-09-01||||||||Interventional|||Prospective Clinical Evaluation of Three Prosthesis Re-cap, M2a-Magnum and C2a-taper.||Completed||Phase 4|||Frederiksberg University Hospital|||||f||||||||||||||2017-02-18 16:47:51.323783|2017-02-18 16:47:51.323783
NCT00284882|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2008-01-24|||January 2006||2006-01-01|October 2007|2007-10-01|November 2006||2006-11-01|||||Observational|||Incidence of Group A Strep Pharyngitis in School Children in Fiji|The Epidemiology of Group A Streptococcal Infections in Fiji (Fiji GrASP) Part 3: The Incidence of Group A Streptococcal Pharyngitis and the Prevalence of Pyoderma and Scabies in School Children in Fiji, and Establishing Immunologic Correlates of Protection for a J8 Vaccine|Completed||N/A|1000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:47:49.122557|2017-02-18 16:47:49.122557
NCT00284869|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-09-11|||January 2006||2006-01-01|September 2006|2006-09-01|April 2006||2006-04-01|||||Interventional|||Ethnic Differences in the Inflammatory Response in Systemic Inflammation|Ethnic Differences in the Inflammatory Response in Systemic Inflammation|Completed||Phase 1|32||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:47:49.204001|2017-02-18 16:47:49.204001
NCT00284856|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-03-27|2011-04-06||May 2006||2006-05-01|March 2015|2015-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Parallel-Group 6-Month Study to Evaluate the Efficacy and Safety of Oral Montelukast Sodium, Fluticasone Propionate and Placebo in Patients With Chronic Asthma Who Smoke Cigarettes|Completed||Phase 3|1640|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 16:47:49.299125|2017-02-18 16:47:49.299125
NCT00284843|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2008-01-24|||January 2006||2006-01-01|October 2007|2007-10-01|June 2007||2007-06-01|||||Observational|||Prevalence of RHD, Pyoderma and Scabies in Children in Fiji|The Epidemiology of Group A Streptococcal Infections in Fiji (Fiji GrASP) Part 1: The Prevalence of Rheumatic Heart Disease, Pyoderma and Scabies in School Children in Fiji|Completed||N/A|5200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:47:49.820081|2017-02-18 16:47:49.820081
NCT00284830|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-02-26|||January 2003||2003-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|December 2006|Actual|2006-12-01||Interventional|SAVEPACe||SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction|Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction (SAVE PACe)|Completed||N/A|1070|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||t||||||||||2017-02-18 16:47:49.908267|2017-02-18 16:47:49.908267
NCT00284817|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2008-05-27|||July 2001||2001-07-01|May 2008|2008-05-01|May 2005|Actual|2005-05-01|January 2005|Actual|2005-01-01||Interventional|||Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer|Phase I Study of MEDI522, a Humanized Monoclonal Antibody Directed Against the Human Alpha V Beta 3 Integrin, in Patients With Irinotecan-Refractory Advanced Colorectal Cancer or Other Solid Tumors Refractory to Standard Therapy|Completed||Phase 1/Phase 2|17|Actual|MedImmune LLC||5|||f||||||||||||||2017-02-18 16:47:50.323471|2017-02-18 16:47:50.323471
NCT00284804|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2015-09-23||2015-09-23|November 2005||2005-11-01|September 2015|2015-09-01|October 2009|Actual|2009-10-01|May 2008|Actual|2008-05-01||Interventional|||A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease|An Open-label, Randomized, Multicenter, Phase II Study of MDX-060 in Combination With Gemcitabine, MDX060 in Combination With Dexamethasone, and Gemcitabine Monotherapy in Patients With Relapsed or Refractory Hodgkin's Disease|Completed||Phase 2|74|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 16:47:50.434704|2017-02-18 16:47:50.434704
NCT00284791|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2006-03-29|||January 2006||2006-01-01|September 2005|2005-09-01||||||||Interventional|||Lamotrigine in Treatment Resistant Depression in Adolescents|Lamotrigine Use in Treatment Refractory Depression in Adolescents|Suspended||N/A|50||Maine Medical Center|||||f||||||||||||||2017-02-18 16:47:50.56303|2017-02-18 16:47:50.56303
NCT00284778|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2010-03-26|||February 2006||2006-02-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer|A Randomized Cost-minimization Trial Comparing Pemetrexed (Alimta®) Versus Docetaxel (Taxotere®) as Second Line Treatment in Advanced Non Small Cell Lung Cancer (NSCLC): Study 05-06 of Groupe Français de Pneumo-Cancérologie (GFPC).|Completed||Phase 3|150|Anticipated|University Hospital, Limoges|||||f||||||||||||||2017-02-18 16:47:50.655708|2017-02-18 16:47:50.655708
NCT00284765|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-03-10|||February 2006||2006-02-01|January 2006|2006-01-01|May 2006||2006-05-01|||||Interventional|||Management of the Sprained Ankle by Help of NSAID-Plaster|Optimation of Treatment of the Sprained Ankle by Help of NSAID-Plaster (Flector). A Questionnaire.|Unknown status|Recruiting|N/A|200||Kolding Sygehus|||||f||||||||||||||2017-02-18 16:47:50.774236|2017-02-18 16:47:50.774236
NCT00284752|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-09-28|||August 2005||2005-08-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|October 2007|Actual|2007-10-01||Interventional|||Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer|Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer|Completed||Phase 2|56|Actual|Kaiser Permanente||1|||f||||||||||||||2017-02-18 16:47:50.858111|2017-02-18 16:47:50.858111
NCT00284726|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-01-31|||December 2000||2000-12-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Interventional|||The Effect of Cold Storage Solutions on Ischemic Injury in Lung Transplantation|A Prospective, Controlled, Randomized Study on the Effect of Cold Storage Solutions on Complement Activation and Other Mediators of Ischemic Injury in Lung Transplantation|Unknown status|Active, not recruiting|Phase 3|||Johns Hopkins University|||||f||||||||||||||2017-02-18 16:47:50.971026|2017-02-18 16:47:50.971026
NCT00284713|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-02-17|||May 2004||2004-05-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Progenitor Cell Therapy in Dilative Cardiomyopathy|Transplantation Of Progenitor Cells And Recovery Of Left Ventricular Function In Patients With Nonischemic Dilatative Cardiomyopathy|Completed||Phase 1/Phase 2|30|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||f||||||||||2017-02-18 16:47:51.051518|2017-02-18 16:47:51.051518
NCT00284700|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2006-01-31|||December 1997||1997-12-01|January 2006|2006-01-01|May 2001||2001-05-01|||||Interventional|||Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?|Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?|Completed||N/A|260||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 16:47:51.134857|2017-02-18 16:47:51.134857
NCT00284687|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2010-06-09|||July 2006||2006-07-01|August 2009|2009-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients|Phase III Study Evaluating the Safety and Efficacy of Artesunate in Preemptive Treatment of Human Cytomegalovirus Disease in Stem Cell Transplant Recipients|Completed||Phase 3|20|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-02-18 16:47:51.229031|2017-02-18 16:47:51.229031
NCT00284661|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-11-26|||June 2005||2005-06-01|November 2015|2015-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Meniscal Repair: A Randomized Prospective Trial of FAST-FIX vs. Meniscal Suturing|Meniscal Repair: A Randomized Prospective Trial of FAST-FIX vs. Meniscal Suturing|Completed||N/A|132|Actual|Fowler Kennedy Sport Medicine Clinic||2|||f||||f||||||||||2017-02-18 16:47:51.401689|2017-02-18 16:47:51.401689
NCT00284648|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-11-26|||December 2000||2000-12-01|November 2015|2015-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Operative Versus Non-operative Treatment of Achilles Tendon Rupture|Operative Versus Non-operative Treatment of Achilles Tendon Rupture: A Multicentre, Prospective Randomized Study.|Completed||N/A|150||Fowler Kennedy Sport Medicine Clinic|||||f||||f||||||||||2017-02-18 16:47:51.5103|2017-02-18 16:47:51.5103
NCT00284635|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2007-07-03||||||July 2007|2007-07-01||||||||Interventional|||Fast-Track vs Conventional for UKA||Completed||Phase 4|||Frederiksberg University Hospital|||||f||||||||||||||2017-02-18 16:47:51.609079|2017-02-18 16:47:51.609079
NCT00284622|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-01-28|||December 2009||2009-12-01|January 2009|2009-01-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||HTO With and Without Arthroscopy|A Randomized Clinical Trial to Compare the Effectiveness of High Tibial Osteotomy With or Without Arthroscopy of the Knee Joint on Quality of Life, Functional Ability and Pain for Patients With Medical Compartment Osteoarthritis of the Knee|Unknown status|Not yet recruiting|Phase 2|98|Anticipated|Fowler Kennedy Sport Medicine Clinic||1|||f||||||||||||||2017-02-18 16:47:51.681409|2017-02-18 16:47:51.681409
NCT00284609|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2010-03-25|||August 2006||2006-08-01|January 2009|2009-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Rehabilitation of Type 2 Diabetes Patients.|"The Effect of Rehabilitation of Type 2 Diabetes Mellitus Versus Standard Outpatient Care. A Randomized Controlled Trial."|Completed||N/A|180|Anticipated|Bispebjerg Hospital||2|||f||||f||||||||||2017-02-18 16:47:51.778852|2017-02-18 16:47:51.778852
NCT00284596|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2009-01-28|||February 2005||2005-02-01|January 2009|2009-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Fixation Stability and Bony Healing Following Open Wedge High Tibial Osteotomy|Fixation Stability and Progress of Bony Healing Following Open-Wedge High- Tibial Osteotomy A 24-Subject Clinical Pilot Study Using Radio Stereometric Analysis|Completed||N/A|24|Actual|Fowler Kennedy Sport Medicine Clinic||1|||f||||f||||||||||2017-02-18 16:47:51.919727|2017-02-18 16:47:51.919727
NCT00284583|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2006-01-30|||May 2005||2005-05-01|January 2006|2006-01-01||||||||Interventional|||Comparison of Alcohol and Steroid Injection for Treating Morton's Neuroma|Comparison of Corticosteroid and Ethanol Injection Therapy in the Treatment of Morton's Neuroma|Unknown status|Recruiting|N/A|120||Brown University|||||f||||||||||||||2017-02-18 16:47:52.235665|2017-02-18 16:47:52.235665
NCT00284570|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2013-11-26|||January 2006||2006-01-01|November 2013|2013-11-01|March 2007|Actual|2007-03-01|||||Observational|||Pro-Calcitonin Levels Following Pediatric Cardiac Surgery|ProCalcitonin in the Pediatric Surgical Patient, Evaluation of a New Marker of Infection|Completed||N/A|49|Actual|Emory University|||1||f||||f||||||Samples With DNA|"~     Blood samples are collected in order to get the procalcitonin level.~   "|||2017-02-18 16:47:52.337228|2017-02-18 16:47:52.337228
NCT00284557|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-06-29|2012-05-25||January 2006||2006-01-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||A Primary Care Behavioral Approach for Addressing Childhood Overweight|Evaluation of a Primary Care-Based Behavioral Intervention for Improving Physical Activity and Nutrition Behaviors Among High-Risk African-American Youth|Completed||Phase 3|130|Actual|Emory University||2|||f||||f||||||||||2017-02-18 16:47:52.429223|2017-02-18 16:47:52.429223
NCT00284531|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2015-10-14|||October 2003||2003-10-01|October 2015|2015-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients|Use of Zenapax (Daclizumab) for the Prevention of Primary Acute Cardiac Rejection in Children and Adolescents. Ind Number: 10100|Terminated||Phase 1/Phase 2|1|Actual|Baylor College of Medicine||1||Slow enrollment|f||||f||||||||||2017-02-18 16:47:52.954164|2017-02-18 16:47:52.954164
NCT00284518|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-31|2012-11-16|2012-11-16||December 2005||2005-12-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia||Completed||Phase 2|380|Actual|Allergan||4|||f||||t||||||||||2017-02-18 16:47:53.046178|2017-02-18 16:47:53.046178
NCT00284505|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2008-12-04|||July 2005||2005-07-01|December 2008|2008-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Use of Thalidomide in Patients With Arachnoiditis|Prospective Study of the Use of Thalidomide in Patients With Arachnoiditis|Completed||Phase 2|3|Anticipated|Washington University School of Medicine|||||||||||||||||||2017-02-18 16:47:54.245355|2017-02-18 16:47:54.245355
NCT00284492|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-05-11|||February 2006||2006-02-01|May 2012|2012-05-01|May 2008|Actual|2008-05-01|May 2007|Actual|2007-05-01||Interventional|ACUFLASH||Acupuncture for Hot Flushes in Menopause|Effectiveness of Acupuncture-care for Treatment of Hot Flushes Among Postmenopausal Women|Completed||N/A|286|Actual|University Hospital of North Norway||2|||f||||||||||||||2017-02-18 16:47:54.334984|2017-02-18 16:47:54.334984
NCT00284479|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2006-07-20|||May 2002||2002-05-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Interventional|||The Effect of Walking on Cardiovascular Risk|The Effect of a Worksite Based Walking Programme on Cardiovascular Risk in Previously Sedentary Civil Servants|Completed||N/A|40||University of Ulster|||||f||||||||||||||2017-02-18 16:47:54.439459|2017-02-18 16:47:54.439459
NCT00284466|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2012-08-28|||January 2006||2006-01-01|August 2012|2012-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Comparing Angiography: Multislice CT Versus Invasive Heart Catheterization (CACTI)|Comparing Angiography: Multislice CT vs. Invasive Heart Catheterization (CACTI)|Completed||N/A|50|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 16:47:54.530151|2017-02-18 16:47:54.530151
NCT00284453|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2016-01-11|||October 2005||2005-10-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm|Gene Expression in ICD Patients With Electrical Storm|Active, not recruiting||N/A|75|Anticipated|University of Pittsburgh|||3||f||||f||||||Samples With DNA|"~     6 RNA samples are obtained and kept frozen on-site to be evalauted at a later date. A~     portion of this DNA will be used to analyze the structure of certain genes that are known to~     play a role in cardiac arrhythmias. We cannot at this time know exatly what genes will be~     tested.~   "|||2017-02-18 16:47:54.626651|2017-02-18 16:47:54.626651
NCT00284440|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2015-03-09|||March 2006||2006-03-01|March 2015|2015-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Choroidal Blood Flow Response to Hand-grip Test in Progressive Glaucoma|Relationship Between Visual Field Progression in Glaucoma and Choroidal Blood Flow Response to the Hand-grip Test|Withdrawn||N/A|0|Actual|University Hospital, Basel, Switzerland|||1|enrollment problems|f||||f||||||||||2017-02-18 16:47:54.737672|2017-02-18 16:47:54.737672
NCT00284427|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2016-02-09|||September 2005||2005-09-01|February 2016|2016-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety of Antioxidants During GYN Cancer Care|Safety of Oral Antioxidants and Intravenous Vitamin C During GYN Cancer Care|Completed||Phase 2|25|Actual|University of Kansas Medical Center||1|||f||||t||||||||||2017-02-18 16:47:54.83635|2017-02-18 16:47:54.83635
NCT00284050|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2011-02-22|2010-12-20||October 2005||2005-10-01|February 2011|2011-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|RESOLVE||Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement|A Randomized, Double-masked, Multi-center, Phase II Study Assessing the Safety and Efficacy of Two Concentrations of Ranibizumab (Intravitreal Injections) Compared With Non-treatment Control for the Treatment of Diabetic Macular Edema With Center Involvement|Completed||Phase 2|151|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:47:54.962409|2017-02-18 16:47:54.962409
NCT00284037|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2006-01-27||||||May 2005|2005-05-01||||||||Interventional|||Improvement in Baroreflex Sensitivity in OSAS||Unknown status|Recruiting|N/A|||Nagoya University|||||f||||||||||||||2017-02-18 16:47:55.535839|2017-02-18 16:47:55.535839
NCT00284024|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2007-10-11|||September 2006||2006-09-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||Effectiveness of Domperidone to Increase Breastmilk Supply in Mothers With Low Supply|Assessing the Feasibility of Testing Domperidone's Effect on Breastfeeding in Women With Insufficient Breast Milk: An RCT Pilot Study|Terminated||Phase 2|45|Anticipated|McMaster University||||Unable to recruit participants|f||||f||||||||||2017-02-18 16:47:55.621464|2017-02-18 16:47:55.621464
NCT00284011|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-01-04|||June 2005||2005-06-01|January 2012|2012-01-01|May 2006|Actual|2006-05-01|April 2006|Actual|2006-04-01||Interventional|||Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels|Effect of the Dietary Supplement S-Adenosyl-L-Methionine on Plasma Homocysteine Levels in Healthy Human Subjects|Completed||N/A|52|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:47:55.707865|2017-02-18 16:47:55.707865
NCT00283998|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2014-03-25|||January 2006||2006-01-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|October 2010|Actual|2010-10-01||Interventional|||Comparing Surgical to Conservative Management in the Treatment of Type II Odontoid Fractures Among the Elderly|Phase 4 Study Comparing Surigcal to Conservative Management of Type 2 Odontoid Fractures|Completed||Phase 4|166|Anticipated|AO Clinical Investigation and Documentation||1|||f||||f||||||||||2017-02-18 16:47:55.814325|2017-02-18 16:47:55.814325
NCT00283985|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2013-02-27|||February 2006||2006-02-01|February 2013|2013-02-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma|Phase II Study of an Association of L-asparaginase-Methotrexate-Dexamethasone for Relapsing and/or Refractory Nasal and Nasal-type NK-T-cell Lymphoma|Completed||Phase 2|40|Actual|University Hospital, Limoges||1|||f||||t||||||||||2017-02-18 16:47:55.906841|2017-02-18 16:47:55.906841
NCT00283972|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2006-01-30|||June 2005||2005-06-01|January 2006|2006-01-01|December 2006||2006-12-01|||||Observational|||LAP-BAND Observational Cohort|Health Outcome Study of LAP-BAND Adjustable Gastric Banding System|Unknown status|Active, not recruiting|Phase 4|240||Inamed|||||f||||||||||||||2017-02-18 16:47:56.024869|2017-02-18 16:47:56.024869
NCT00283959|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2015-03-25||2010-08-17|March 2006||2006-03-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A 12-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease|A Phase 2, Open-Label, Single Dose Level, 12-Week Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AT1001 in Patients With Fabry Disease|Completed||Phase 2|4|Actual|Amicus Therapeutics||1|||f||||||||||||||2017-02-18 16:47:56.10269|2017-02-18 16:47:56.10269
NCT00283946|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2014-08-19|||February 2006||2006-02-01|August 2014|2014-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia|FK199B (Zolpidem MR Tablet) Phase III Clinical Study -A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia -|Completed||Phase 3|876|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:47:56.204111|2017-02-18 16:47:56.204111
NCT00283933|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2015-04-08||2010-08-17|January 2006||2006-01-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A 24-Week Safety and Pharmacodynamic Study of AT1001 in Patients With Fabry Disease|A Phase 2, Open-Label, Single Dose Level, 24-Week Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AT1001 in Patients With Fabry Disease|Completed||Phase 2|5|Actual|Amicus Therapeutics||1|||f||||||||||||||2017-02-18 16:47:56.317124|2017-02-18 16:47:56.317124
NCT00284414|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2009-05-18||||||February 2009|2009-02-01||||||||Interventional|||Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?|Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?|Withdrawn||N/A|40|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:56.417514|2017-02-18 16:47:56.417514
NCT00284401|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2007-12-19|||February 2004||2004-02-01|December 2007|2007-12-01|July 2004|Actual|2004-07-01|||||Interventional|||Prosthetic Component Relationship of the Reversed Delta III Total Shoulder Prosthesis in the Transverse Plane of the Body|Prosthetic Component Relationship of the Reversed Delta III Total Shoulder Prosthesis in the Transverse Plane of the Body|Completed||N/A|50||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:56.738939|2017-02-18 16:47:56.738939
NCT00284388|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2009-02-13||||||February 2009|2009-02-01||||||||Interventional|||Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs|Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs|Withdrawn||N/A|20|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:47:56.818792|2017-02-18 16:47:56.818792
NCT00284375|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2014-12-04|||January 2005||2005-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Systematic Registration of All Big Toe Prostheses Placed in Ghent University Hospital|Systematic Registration of All Big Toe Prostheses Placed in Ghent University Hospital|Unknown status|Recruiting|N/A|500|Anticipated|University Hospital, Ghent|||1||f||||f||||||||||2017-02-18 16:47:56.900681|2017-02-18 16:47:56.900681
NCT00283920|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-29|2017-01-24|||January 26, 2006||2006-01-26|October 2, 2007|2007-10-02|October 2, 2007||2007-10-02|||||Interventional|||PET Imaging of Brain Peripheral Benzodiazepine Receptors|PET Imaging of Brain Peripheral Type Benzodiazepine Receptors|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:47:56.992231|2017-02-18 16:47:56.992231
NCT00283907|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-29|2017-01-24|||January 27, 2006||2006-01-27|December 16, 2008|2008-12-16|December 16, 2008||2008-12-16|||||Observational|||Brain Networks Responsible for Sense of Agency|Brain Networks Responsible for Sense of Agency: An EEG Study|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:47:57.074433|2017-02-18 16:47:57.074433
NCT00283894|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-29|2017-01-24|||January 20, 2006||2006-01-20|June 19, 2013|2013-06-19|June 19, 2013||2013-06-19|||||Observational|||Body Weight Regulation in Patients With Narcolepsy|The Role of the Orexin System in Body Weight Regulation: Patients With Narcolepsy|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:47:57.154095|2017-02-18 16:47:57.154095
NCT00283881|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-29|2017-01-24|||January 25, 2006||2006-01-25|October 7, 2009|2009-10-07||||October 7, 2009|Actual|2009-10-07||Observational|||Tactile Learning in Stroke Patients|Implicit Tactile Learning in Chronic Stroke Enhanced by Non-Invasive Brain Stimulation of the Somatosensory Cortex|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:47:57.241353|2017-02-18 16:47:57.241353
NCT00284362|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2009-05-18||||||February 2009|2009-02-01||||||||Interventional|||Prospective and Comparative Analysis of Arthroscopic and Open Surgery for Hallux Rigidus|Prospective and Comparative Analysis of Arthroscopic and Open Surgery for Hallux Rigidus|Withdrawn||N/A|60|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:57.322484|2017-02-18 16:47:57.322484
NCT00284349|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2009-05-18||||||April 2009|2009-04-01||||||||Interventional|||Study to Investigate the Added Value of a Rehabilitation Brace in the Treatment at Home After a Fracture of the Ankle|Study to Investigate the Added Value of a Rehabilitation Brace in the Treatment at Home After a Fracture of the Ankle|Withdrawn||N/A|100|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:57.411136|2017-02-18 16:47:57.411136
NCT00284336|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2014-12-08|||January 2006||2006-01-01|December 2014|2014-12-01|April 2007||2007-04-01|||||Interventional|||Caelyx Adjuvant in Elderly Breast Cancer|An Open Label Phase II Trial to Investigate the Cardiac Effects of Pegylated Liposomal Doxorubicine (Caelyx) in Elderly Breast Cancer Patients With New Imaging and Biochemical Techniques.|Completed||Phase 2|16||Universitaire Ziekenhuizen Leuven|||||f||||||||||||||2017-02-18 16:47:57.5063|2017-02-18 16:47:57.5063
NCT00284323|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2006-01-27|||January 2006||2006-01-01|January 2006|2006-01-01||||||||Interventional|||Salvage: Postconditioning With Adenosine for STEMI|Beneficial Effect of Intracoronary Adenosine on Microvascular and Myocardial Salvage in Patients With Acute Myocardial Infarction (SALVAGE)|Unknown status|Recruiting|Phase 2|100||University Hospital, Gasthuisberg|||||f||||||||||||||2017-02-18 16:47:57.616712|2017-02-18 16:47:57.616712
NCT00284310|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2014-12-04|||October 2005||2005-10-01|December 2014|2014-12-01|December 2020|Anticipated|2020-12-01|July 2015|Anticipated|2015-07-01||Interventional|||Follow-up of Patients After 4-row Arthrodesis or Proximal Row Carpectomy|Follow-up of Patients After 4-row Arthrodesis or Proximal Row Carpectomy|Recruiting||N/A|40|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:47:57.726803|2017-02-18 16:47:57.726803
NCT00284297|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2014-12-04|||September 2005||2005-09-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail|Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:47:57.838374|2017-02-18 16:47:57.838374
NCT00284284|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2009-05-11||||||April 2009|2009-04-01||||||||Interventional|||Investigation of the Added Value of a Big Toe Hinged Brace for the Treatment of Hallux Rigidus|Investigation of the Added Value of a Big Toe Hinged Brace for the Treatment of Hallux Rigidus|Withdrawn||N/A|50|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:47:57.922872|2017-02-18 16:47:57.922872
NCT00284271|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2011-07-28|||January 2004||2004-01-01|July 2011|2011-07-01||||December 2005|Actual|2005-12-01||Interventional|||Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma||Completed||Phase 2|65|Actual|University of Cologne||1|||f||||||||||||||2017-02-18 16:47:58.001802|2017-02-18 16:47:58.001802
NCT00284258|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-30|2012-11-01|||January 2006||2006-01-01|November 2012|2012-11-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer|Phase II/III Trial of CPT-11/5-FU/l-LV (FOLFIRI) Versus CPT-11/TS-1 (IRIS) as Second Line Chemotherapy of Unresectable Colorectal Cancer|Completed||Phase 2/Phase 3|426|Actual|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 16:47:58.094171|2017-02-18 16:47:58.094171
NCT00283868|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2015-06-02|2009-03-27||January 2004||2004-01-01|September 2009|2009-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|STRokE DOC||Stroke Team Remote Evaluation Using a Digital Observation Camera|A Prospective Study to Evaluate the Efficacy of a Remote Digital Observation Camera Protocol in the Evaluation and Thrombolytic Treatment of Acute Stroke Patients in the Remote Hospital Setting|Completed||N/A|234|Actual|University of California, San Diego|||2||f||||t||||||||||2017-02-18 16:47:58.202201|2017-02-18 16:47:58.202201
NCT00283855|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2016-09-29|||October 2003||2003-10-01|September 2016|2016-09-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||RAHelp.Org: An Online Self Management Program for Adults With Rheumatoid Arthritis|An Online Self Management Program for Adults With Rheumatoid Arthritis|Completed||N/A|200|Actual|University of Missouri-Columbia||2|||f||||f||||||||No||2017-02-18 16:47:58.63176|2017-02-18 16:47:58.63176
NCT00283842|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2011-10-20|2009-06-30||March 2006||2006-03-01|October 2011|2011-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy|A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, 13-Week, Adaptive-Design Study of 4 Fixed Oral Doses of DVS SR in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy|Terminated||Phase 3|408|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||5||business reasons|f||||f||||||||||2017-02-18 16:47:58.767424|2017-02-18 16:47:58.767424
NCT00283452|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2010-03-09|||September 2003||2003-09-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|January 2008|Actual|2008-01-01||Interventional|||Keep Active Minnesota|Maintaining Physical Activity in Older Adult MCO Members|Completed||N/A|1049|Actual|HealthPartners Institute||2|||f||||t||||||||||2017-02-18 16:48:07.033628|2017-02-18 16:48:07.033628
NCT00283829|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2007-11-28|||September 2002||2002-09-01|November 2007|2007-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer|Immunotherapy With Low Dose Interleukin-2 After Cytoreductive Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer: A Phase I/II Study|Completed||Phase 1/Phase 2|30|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 16:48:00.132308|2017-02-18 16:48:00.132308
NCT00283816|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2015-04-28|2011-04-08||January 2006||2006-01-01|April 2011|2011-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy|Metabolic Impact of Oral Contraceptives With or Without Metformin in Obese Adolescents With Polycystic Ovary Syndrome (PCOS)|Completed||Phase 3|36|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 16:48:00.252835|2017-02-18 16:48:00.252835
NCT00283803|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2008-02-20|||October 2001||2001-10-01|February 2008|2008-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||To Lengthen the Duration of the Off-Treatment of Intermittent Androgen Suppression|"Evaluation of the Effect of Exisulind on the Duration of the Off-Treatment Interval on Patients With Biochemical Relapse of Prostate Cancer Who Are Treated With Intermittent Androgen Suppression"|Unknown status|Active, not recruiting|Phase 2|32|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 16:48:00.682422|2017-02-18 16:48:00.682422
NCT00283790|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2008-04-01|||January 2006||2006-01-01|April 2008|2008-04-01|April 2006||2006-04-01|||||Interventional|||Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo|Investigation of Psycliomotor and Cognitive Residual Effects After Single Oral Doses of Zolpidem Tartrate Extended Release 12.5 mg and Eszopielone 3 mg Compared to Placebo in Healthy Young Volunteers, Using Plurazepam 30 mg As An External Comparator|Completed||Phase 4|36||Sanofi|||||f||||||||||||||2017-02-18 16:48:00.795625|2017-02-18 16:48:00.795625
NCT00283777|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2016-04-07|||August 1998||1998-08-01|April 2016|2016-04-01|April 2003|Actual|2003-04-01|January 2003|Actual|2003-01-01||Interventional|||Chromium and Insulin Action|Effect of Chromium Picolinate on Metabolic and Physiologic Parameters in Type 2 Diabetes|Completed||Phase 4|30||Pennington Biomedical Research Center|||||f||||||||||||||2017-02-18 16:48:01.131314|2017-02-18 16:48:01.131314
NCT00283764|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2015-03-04||||||March 2015|2015-03-01||||||||Interventional|||Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device|A Phase 3, 12-Week, Parallel-Design Study Comparing The Safety, Efficacy, and Ease Of Use Of Xalatan When Self-Administered By Subjects With Open-Angle Glaucoma Or Ocular Hypertension Using Either A Conventional Dropper Bottle Or A Forced-Flow Delivery Device|Withdrawn||Phase 3|0|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:48:01.234232|2017-02-18 16:48:01.234232
NCT00283751|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2017-01-26|||March 2003||2003-03-01|January 2017|2017-01-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes|Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine as Add-on to Current Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes|Completed||Phase 3|583|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:48:01.328064|2017-02-18 16:48:01.328064
NCT00283738|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2008-01-23|||February 2006||2006-02-01|January 2008|2008-01-01|March 2008|Anticipated|2008-03-01|||||Interventional|||MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant|A Prospective, Multi-Center, Double-Blinded, Placebo-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With the BioSTAR Septal Repair Implant to Reduce Refractory Migraine Headache With Aura.|Unknown status|Active, not recruiting|Phase 2/Phase 3|610|Anticipated|NMT Medical||2|||f||||t||||||||||2017-02-18 16:48:01.530279|2017-02-18 16:48:01.530279
NCT00283725|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2013-01-24|||June 2003||2003-06-01|January 2013|2013-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|REMIND||Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease|Review of Management Strategies in Dementia|Completed||Phase 4|573|Actual|Ortho-McNeil Neurologics, Inc.|||2||f||||f||||||||||2017-02-18 16:48:01.64202|2017-02-18 16:48:01.64202
NCT00283712|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2014-10-15|2012-12-21||March 2006||2006-03-01|October 2014|2014-10-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Use of Infliximab for the Treatment of Pemphigus Vulgaris|A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone|Completed||Phase 2|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:48:01.760069|2017-02-18 16:48:01.760069
NCT00283699|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2010-02-05|||February 2001||2001-02-01|March 2008|2008-03-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Pilot Study of Neurocysticercosis Treatment|A Pilot Study of Neurocysticercosis Treatment|Completed||Phase 3|178|Actual|National Institute of Neurological Disorders and Stroke (NINDS)||2|||f||||t||||||||||2017-02-18 16:48:02.941874|2017-02-18 16:48:02.941874
NCT00283686|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2015-03-18|2015-02-09||January 2006||2006-01-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||HALT Progression of Polycystic Kidney Disease (HALT PKD) Study A|Polycystic Kidney Disease-Treatment Network|Completed||Phase 3|558|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||t||||||||||2017-02-18 16:48:03.070838|2017-02-18 16:48:03.070838
NCT00283673|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2011-06-03|||September 1995||1995-09-01|June 2011|2011-06-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Effect of Exercise Intervention on Various Physiologic Factors That Change With Increasing Age|Impact of Aerobic Exercise Training on Age Related Changes in Insulin Sensitivity and Muscle Oxidative Capacity|Completed||N/A|102||Mayo Clinic|||||f||||||||||||||2017-02-18 16:48:04.773691|2017-02-18 16:48:04.773691
NCT00283660|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2015-11-16|||January 2006||2006-01-01|November 2015|2015-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Zinc, Mental Health, and School Performance in Guatemalan Schoolchildren|Zinc, Mental Health, and School Performance|Completed||N/A|750|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:48:04.867195|2017-02-18 16:48:04.867195
NCT00283647|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2015-04-13|||October 2002||2002-10-01|April 2015|2015-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||MR Assessment of Brain Function Altered by Lead Exposure|MR Assessment of Brain Function Altered by Lead Exposure|Completed||N/A|150||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 16:48:04.997127|2017-02-18 16:48:04.997127
NCT00282828|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2013-08-08|2013-04-22||March 2006||2006-03-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder|Improving Outcomes in Pharmacotherapy of Social Phobia|Completed||Phase 4|397|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-02-18 16:48:22.081883|2017-02-18 16:48:22.081883
NCT00283634|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2011-02-16|||August 2005||2005-08-01|February 2011|2011-02-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer|A Randomized, Non-comparative, Multicenter, Open-Label, Phase 2 Study of Tarceva™ (Erlotinib) Alone and of Tarceva Plus VELCADE* (Bortezomib) for Injection in Patients With Relapsed or Refractory, Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Terminated||Phase 2|||Millennium Pharmaceuticals, Inc.||||insufficient efficacy|||||||||||||||2017-02-18 16:48:05.076415|2017-02-18 16:48:05.076415
NCT00283621|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2012-07-31|||November 2002||2002-11-01|July 2012|2012-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide|A Pilot Study of Aranesp (Darbepoetin Alfa) and Pegfilgrastim (Neulasta) in Patients With Sarcoma Receiving Adriamycin and Ifosfamide|Completed||N/A|51|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:48:05.161942|2017-02-18 16:48:05.161942
NCT00283608|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2011-05-13|||July 2005||2005-07-01|May 2011|2011-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer|Pharmacogenetics of Aromatase Inhibitors|Completed||N/A|1000|Anticipated|Mayo Clinic|||2||f||||t||||||Samples With DNA|"~     Anastrozole treatment group samples will be used as described for this study, and then will~     be destroyed.~      Exemestane treatment group samples of blood will be stored at Mayo Clinic Rochester.~   "|||2017-02-18 16:48:05.295077|2017-02-18 16:48:05.295077
NCT00283595|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2012-09-15|2012-08-16||January 2006||2006-01-01|September 2012|2012-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa|Effect of Supraphysiological rhGH on Bone Metabolism in Patients With Anorexia Nervosa|Completed||Phase 2|21|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 16:48:05.433807|2017-02-18 16:48:05.433807
NCT00283582|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2012-02-22|||June 2001||2001-06-01|February 2012|2012-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy|Randomized Double-blind Placebo-controlled Trial of Primary Prophylaxis With Recombinant Human Thrombopoietin Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy|Completed||Phase 3|50|Actual|M.D. Anderson Cancer Center|||||f||||||||||||||2017-02-18 16:48:05.783609|2017-02-18 16:48:05.783609
NCT00283569|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2010-01-18|||May 2004||2004-05-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Genetic Epidemiology of Adult Onset Glioma|Genetic Epidemiology of Adult-Onset Glioma|Completed||N/A|100|Anticipated|Kentuckiana Cancer Institute|||1||f||||||||||Samples With DNA|"~     Saliva, Toe Nail Clippings~   "|||2017-02-18 16:48:06.113846|2017-02-18 16:48:06.113846
NCT00283556|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2010-01-18|||August 2001||2001-08-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma|Phase I/II Study of High Dose Irinotecan (Camptosar, CPT-11) in Patients With Recurrent Unresectable Malignant Glioma on Steroids/Anti-epileptics|Completed||Phase 1/Phase 2|30|Anticipated|Kentuckiana Cancer Institute||3|||f||||||||||||||2017-02-18 16:48:06.208297|2017-02-18 16:48:06.208297
NCT00283543|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2007-10-30|||September 2002||2002-09-01|October 2007|2007-10-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma|A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|Kentuckiana Cancer Institute|||||f||||||||||||||2017-02-18 16:48:06.317517|2017-02-18 16:48:06.317517
NCT00283530|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2010-01-18|||May 2003||2003-05-01|January 2010|2010-01-01|July 2009|Actual|2009-07-01|||||Observational|||Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer|Identification of Tumor Phenotypes and Correlation to Clinical Outcomes in Patients Diagnosed With Cancer|Terminated||N/A|1000|Anticipated|Kentuckiana Cancer Institute|||1|"The PI is no longer with Kentuckiana Cancer Institute. All current subjects completed. No~   further subjects will be enrolled. Terminated with IRB."|f||||||||||||||2017-02-18 16:48:06.423296|2017-02-18 16:48:06.423296
NCT00283517|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2010-04-26|||September 2003||2003-09-01|April 2010|2010-04-01|May 2006|Actual|2006-05-01|||||Observational|||A Registry of Treatment Adherence for Patients With Schizophrenia|Electronic Schizophrenia Treatment Adherence Registry, eSTAR|Completed||N/A|2046|Actual|Janssen-Cilag, S.A.|||1||f||||||||||||||2017-02-18 16:48:06.510771|2017-02-18 16:48:06.510771
NCT00283504|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2010-05-25|||January 2006||2006-01-01|January 2006|2006-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy|A Description of Inflammatory Cell Types in Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy (Xolair)|Completed||Phase 4|40|Anticipated|Children's Hospital of The King's Daughters|||||||||||||||||||2017-02-18 16:48:06.630137|2017-02-18 16:48:06.630137
NCT00283491|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2009-01-20|||October 2005||2005-10-01|October 2005|2005-10-01|November 2005|Actual|2005-11-01|||||Interventional|||The Effect of Lactobacillus Cultures on Iron Bioavailability.|The Effect of a Lactic Acid Fermented Oat Gruel on Iron Absorption in the Proximal and Distal Small Intestine From a Phytate Rich Meal in Healthy Women of Childbearing Age.|Completed||N/A|18|Actual|University of Copenhagen||2|||f||||||||||||||2017-02-18 16:48:06.722463|2017-02-18 16:48:06.722463
NCT00283478|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2007-10-30|||May 2004||2004-05-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer|Randomized Pilot Study of Supplemental Iscar in Combination With Gemcitabine vs. Gemcitabine Alone as Second Line Treatment for Advanced Non-Small Cell Lung Cancer.|Completed||N/A|20|Anticipated|Kentuckiana Cancer Institute|||||||||||||||||||2017-02-18 16:48:06.827301|2017-02-18 16:48:06.827301
NCT00283465|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2011-01-13|||November 1999||1999-11-01|January 2011|2011-01-01|April 2004|Actual|2004-04-01|||||Interventional|||A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy|An Open-label, Randomized Study to Evaluate the Effect of Early Treatment of Anemia With Epoetin Alfa on Hemoglobin, the Incidence of Blood Transfusions and Quality of Life in Patients Receiving Platinum-containing Chemotherapy|Completed||Phase 4|316|Actual|Janssen-Cilag B.V.|||||f||||||||||||||2017-02-18 16:48:06.93742|2017-02-18 16:48:06.93742
NCT00283439|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2011-06-16|2010-08-13||October 2005||2005-10-01|June 2011|2011-06-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma|An Open Label Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 for Treatment of Severe Thrombocytopenia Due to Multi-Cycle Chemotherapy in Adult Subjects With Lymphoma.|Completed||Phase 1/Phase 2|39|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:48:07.158679|2017-02-18 16:48:07.158679
NCT00283426|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2007-03-16|||January 2006||2006-01-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns|An Open Clinical Feasibility Study to Evaluate Efficacy and Safety of Soluble Beta-1,3/1,6-Glucan in Thermal Burns|Terminated||Phase 1|10||Biotec Pharmacon ASA||||Slow patient recruitment|f||||||||||||||2017-02-18 16:48:08.160303|2017-02-18 16:48:08.160303
NCT00283413|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-27|2009-10-30|||March 2002||2002-03-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|May 2004|Actual|2004-05-01||Interventional|||Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts|Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts|Completed||N/A|514|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 16:48:08.2708|2017-02-18 16:48:08.2708
NCT00283400|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2015-03-18|2013-02-05||January 2006||2006-01-01|March 2015|2015-03-01|April 2011|Actual|2011-04-01|January 2011|Actual|2011-01-01||Interventional|||Treatment of Subarachnoid Hemorrhage With Human Albumin|Treatment of Subarachnoid Hemorrhage With Human Albumin|Terminated||N/A|47|Actual|Baylor College of Medicine|Our study has several limitations. ALISAH is an early phase design and we do not have concurrent controls. In addition, the study was neither randomized nor powered to test for efficacy effects.|4||Study met safety endpoints|f||||t||||||||||2017-02-18 16:48:08.436173|2017-02-18 16:48:08.436173
NCT00283387|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2013-11-21|2012-11-01||February 2007||2007-02-01|November 2013|2013-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria|Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria|Completed||Phase 2|15|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 16:48:09.102855|2017-02-18 16:48:09.102855
NCT00283374|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2006-05-17|||October 2005||2005-10-01|May 2006|2006-05-01||||||||Observational|||Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric Syndrome|A Prospective, Longitudinal Multicenter, Nontreatment, Exploratory Biomarker Study of Metabolic Syndrome in Subjects Undergoing Laparoscopic Roux-En-Y Gastric Bypass Bariatric Syndrome|Terminated||N/A|120||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:48:09.407517|2017-02-18 16:48:09.407517
NCT00283361|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2007-02-27|||January 2006||2006-01-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure|A Phase II,Randomized, Double-Blind, Flexible Dose Study of ZP120 I.V. Infusion as Add-On Therapy in Patients With Acute or Sub-Acute Decompensated Chronic Heart Failure NYHA Class III-IV Treated With Furosemide|Terminated||Phase 2|130||Zealand Pharma|||||f||||||||||||||2017-02-18 16:48:09.503658|2017-02-18 16:48:09.503658
NCT00283348|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2009-03-19|||January 2006||2006-01-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|||||Observational|||New Strategies for Non-Invasive Detection of Chronic Allograft Nephropathy|New Strategies for Non-Invasive Detection of Chronic Allograft Nephropathy|Completed||N/A|121|Actual|Virginia Commonwealth University|||1||f||||f||||||Samples With DNA|"~     Blood, Urine~   "|||2017-02-18 16:48:09.676775|2017-02-18 16:48:09.676775
NCT00283335|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2015-10-20|||June 1991||1991-06-01|October 2015|2015-10-01|August 1999|Actual|1999-08-01|September 1998|Actual|1998-09-01||Interventional|HIT||The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol|CSP #363 - The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol|Completed||Phase 3|2531|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:48:09.767238|2017-02-18 16:48:09.767238
NCT00283322|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2007-12-03|||November 2004||2004-11-01|December 2007|2007-12-01|May 2006|Actual|2006-05-01|||||Observational|||Heparin Antibodies in Intensive Care Unit Patients (HAICU)|Heparin Antibodies in Intensive Care Unit Patients (HAICU)|Completed||N/A|185|Actual|The University of Texas Health Science Center, Houston|||3||f||||f||||||Samples Without DNA|"~     Plasma. Patients consented for use to look for heparin antibodies in this study only.~   "|||2017-02-18 16:48:09.874439|2017-02-18 16:48:09.874439
NCT00283309|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-04-19|||November 2005||2005-11-01|April 2013|2013-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes||Terminated||Phase 4|20|Actual|University of Texas Southwestern Medical Center||3||Study finished enrollment but data was never sent for publishing.|f||||||||||||||2017-02-18 16:48:09.989063|2017-02-18 16:48:09.989063
NCT00283296|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2014-12-23|2013-06-11||January 2004||2004-01-01|December 2014|2014-12-01|April 2011|Actual|2011-04-01|July 2008|Actual|2008-07-01||Interventional|||Development of a Collapsible Folding Manual Wheelchair|Development of a Collapsible Folding Manual Wheelchair|Completed||Phase 2|14|Actual|VA Pittsburgh Healthcare System|Limited number of Endeavor prototypes.|1|||f||||f||||||||||2017-02-18 16:48:10.099147|2017-02-18 16:48:10.099147
NCT00283283|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2015-06-05|||November 2004||2004-11-01|June 2015|2015-06-01|May 2006|Actual|2006-05-01|November 2004|Actual|2004-11-01||Interventional|||Half vs Full Dose Influenza Vaccine|Clinical Study to Compare the Immune Response of Half Dose Trivalent Inactivated Influenza Vaccine (TIV) to Full Dose|Completed||Phase 2|1316|Actual|U.S. Army Medical Research and Materiel Command||8|||f||||f||||||||||2017-02-18 16:48:10.353861|2017-02-18 16:48:10.353861
NCT00283270|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2006-01-26|||November 2002||2002-11-01|December 2005|2005-12-01|August 2005||2005-08-01|||||Interventional|||Effectiveness of Screening and Counselling for Elderly With Psychological Problems|A Randomised Controlled Trial on the Effectiveness of Screening and Brief Counselling for Elderly Patients With Psychological Problems in Primary Care.|Completed||Phase 4|450||The University of Hong Kong|||||f||||||||||||||2017-02-18 16:48:10.465961|2017-02-18 16:48:10.465961
NCT00283257|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2006-01-25|||February 2002||2002-02-01|January 2006|2006-01-01|June 2007||2007-06-01|||||Interventional|||Simultaneous Care: Linking Palliation to Clinical Trials|A Randomized Control Trial That Teaches Oncology Clinical Trial Patients and Their Caregivers Problem Solving Skills.|Unknown status|Recruiting|N/A|600||University of California, Davis|||||f||||||||||||||2017-02-18 16:48:10.546366|2017-02-18 16:48:10.546366
NCT00283244|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-07-01|||March 2006||2006-03-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|September 2014|Actual|2014-09-01||Interventional|||Gemcitabine and/or Erlotinib as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Randomized Phase II Study of First-Line Treatment With Gemcitabine vs. Erlotinib vs. Gemcitabine and Erlotinib in Elderly Patients With Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|147|Actual|UNC Lineberger Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 16:48:13.356346|2017-02-18 16:48:13.356346
NCT00283231|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2008-05-06|||October 2005||2005-10-01|July 2005|2005-07-01|February 2006||2006-02-01|||||Interventional|||RESPeRATE for Treatment of Hot Flashes|RESPeRATE (Paced Respiration) for Treatment of Hot Flashes and Menopausal Symptoms|Completed||N/A|12||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:48:13.520517|2017-02-18 16:48:13.520517
NCT00283218|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2006-08-07|||January 2006||2006-01-01|August 2006|2006-08-01|August 2006||2006-08-01|||||Interventional|||A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.|A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70. - A Randomised, Quadruple Cross-Over Trial|Completed||N/A|24||University of Aarhus|||||f||||||||||||||2017-02-18 16:48:13.613668|2017-02-18 16:48:13.613668
NCT00283205|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2006-01-25|||September 2005||2005-09-01|March 2005|2005-03-01|December 2005||2005-12-01|||||Interventional|||Yoga for Treatment of Hot Flashes|Yoga for Treatment of Hot Flashes and Menopausal Symptoms|Completed||N/A|12||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:48:13.708754|2017-02-18 16:48:13.708754
NCT00283192|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2006-08-02|||July 2003||2003-07-01|August 2005|2005-08-01|January 2006||2006-01-01|||||Interventional|||Flushes and Sertraline Trial|A Randomized, Double-Blinded, Placebo Controlled, Trial of the Effect of Sertraline Vs. Placebo in Reducing the Incidence and Severity of Hot Flashes in Healthy Women|Completed||N/A|100||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:48:13.798586|2017-02-18 16:48:13.798586
NCT00283179|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2008-05-14|||March 2004||2004-03-01|January 2006|2006-01-01|December 2004|Actual|2004-12-01|||||Interventional|||Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia|Efficacy and Safety of Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia or Schizoaffective Disorder With Risperidone as an Active Control|Completed||Phase 3|83|Actual|Taiwan Otsuka Pharm. Co., Ltd||2|||f||||||||||||||2017-02-18 16:48:13.886985|2017-02-18 16:48:13.886985
NCT00283166|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2011-12-06|||November 2006||2006-11-01|December 2011|2011-12-01|December 2011|Actual|2011-12-01|March 2009|Actual|2009-03-01||Interventional|||Coaching to Improve Care of Cancer Pain|Coaching to Improve Care of Cancer Pain|Completed||N/A|258|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 16:48:13.981903|2017-02-18 16:48:13.981903
NCT00283153|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2014-08-01|||October 2008||2008-10-01|August 2014|2014-08-01|August 2014|Actual|2014-08-01|September 2012|Actual|2012-09-01||Interventional|||Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)|Controlled Study of Affect Recognition Training for Individuals With Acquired Brain Injury|Completed||Phase 2/Phase 3|71|Actual|University at Buffalo||2|||f||||f||||||||||2017-02-18 16:48:14.085088|2017-02-18 16:48:14.085088
NCT00283127|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2010-03-02|||February 2006||2006-02-01|January 2009|2009-01-01|September 2006||2006-09-01|||||Interventional|||Home Sampling Versus Conventional Sampling for Screening of Urogenital Chlamydia Trachomatis in Young Men and Women.|Home Sampling Versus Conventional Sampling for Screening of Urogenital Chlamydia Trachomatis in Young Men and Women. - A Randomised Control Trial|Completed||N/A|41719||Norwegian Institute of Public Health|||||f||||||||||||||2017-02-18 16:48:14.201491|2017-02-18 16:48:14.201491
NCT00283114|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2014-12-17|||November 2005||2005-11-01|December 2014|2014-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome|A Phase 1, Multi-Dose Study of SGN-33 (Anti-huCD33 mAb; HuM195; Lintuzumab) in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome|Completed||Phase 1|82|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-02-18 16:48:14.301112|2017-02-18 16:48:14.301112
NCT00283101|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2014-12-17|||July 2005||2005-07-01|December 2014|2014-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Safety Study in Patients With Chronic Lymphocytic Leukemia|A Phase 1/2, Multi-Dose Study of SGN-40 (Anti-huCD40 mAb) in Patients With Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|12|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-02-18 16:48:14.661748|2017-02-18 16:48:14.661748
NCT00283088|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2011-01-11|||October 2003||2003-10-01|January 2009|2009-01-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|||Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke|Phase 1 Study of Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke|Completed||Phase 1|130|Anticipated|University of California, San Diego||6|||f||||t||||||||||2017-02-18 16:48:14.779944|2017-02-18 16:48:14.779944
NCT00283075|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2016-02-11|2015-10-26||January 2005||2005-01-01|February 2016|2016-02-01|February 2015|Actual|2015-02-01|December 2012|Actual|2012-12-01||Interventional|||Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer|Use of Mouse Renal Adenocarcinoma Cell-containing Agarose-agarose Macrobeads in the Treatment of Patients With End-stage, Treatment-resistant Epithelial-derived Cancer|Completed||Phase 1|56|Actual|The Rogosin Institute||1|||f||||t||||||||||2017-02-18 16:48:14.91224|2017-02-18 16:48:14.91224
NCT00283062|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2012-01-25|2011-12-16||December 2005||2005-12-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy|A Multicenter, Open-Label, Randomized, Phase III Trial Comparing Immediate Adjuvant Hormonal Therapy (ELIGARD®- Leuprolide Acetate) in Combination With TAXOTERE® (Docetaxel) Administered Every Three Weeks Versus Hormonal Therapy Alone Versus Deferred Therapy Followed by the Same Therapeutic Options in Patients With Prostate Cancer at High Risk of Relapse After Radical Prostatectomy|Completed||Phase 3|228|Actual|Sanofi|The study had difficulties in meeting enrollment goals within a reasonable time frame. The final sample size allowed for the safety analyses but was underpowered for drawing conclusions regarding efficacy and quality of life (QoL) endpoints.|4|||f||||||||||||||2017-02-18 16:48:15.311775|2017-02-18 16:48:15.311775
NCT00282841|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2009-09-10|||May 2005||2005-05-01|July 2008|2008-07-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||Visualization of the Cerebral Arterial Circulation Using Contrast-Enhanced Transcranial Ultrasound in Code Stroke Patients|Visualization of the Cerebral Arterial Circulation Using Contrast-Enhanced Transcranial Ultrasound in Code Stroke Patients|Unknown status|Active, not recruiting|N/A|403|Anticipated|University of California, San Diego||1|||f||||t||||||||||2017-02-18 16:48:21.962546|2017-02-18 16:48:21.962546
NCT00283049|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2011-01-07|2009-12-16||February 2006||2006-02-01|January 2011|2011-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control|Safety and Efficacy of Insulin Glargine Injection [rDNA Origin] Treatment in Place of the TZD or the Sulfonylurea or Metformin in Triple Agent Therapy for T2DM Adult Subjects With Unsatisfactory Control|Terminated||Phase 4|390|Actual|Sanofi|The study was terminated prematurely due to technical issues with electronic diary data. Consequently, some of the initially planned efficacy analyses, based directly or indirectly on the e-diary data, were not performed.|3||Due to technical issues relating to the Electronic diary data.|f||||||||||||||2017-02-18 16:48:17.310982|2017-02-18 16:48:17.310982
NCT00283036|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2008-04-01|||April 2005||2005-04-01|April 2008|2008-04-01||||||||Interventional|||APROVE : Irbesartan in Hypertension|Efficacy and Tolerability of Posology Adaptation of Irbesartan in Ambulatory Hypertensive Patients|Completed||Phase 4|200||Sanofi|||||f||||||||||||||2017-02-18 16:48:18.113042|2017-02-18 16:48:18.113042
NCT00283023|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2008-08-02|||December 2007||2007-12-01|August 2008|2008-08-01||||December 2010|Anticipated|2010-12-01||Interventional|||Oligodendrocyte Progenitor Cell Culture From Human Brain|Phase 1: Oligodendrocyte Progenitor Cell Culture From Human Brain|Unknown status|Recruiting|Phase 1|100|Anticipated|Rajavithi Hospital||1|||f||||t||||||||||2017-02-18 16:48:18.197081|2017-02-18 16:48:18.197081
NCT00283010|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2015-10-29|||January 2006||2006-01-01|October 2015|2015-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|IMPACT||Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)|Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)|Completed||N/A|487|Actual|Posit Science Corporation||2|||f||||||||||||||2017-02-18 16:48:18.297027|2017-02-18 16:48:18.297027
NCT00282997|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2008-03-21|||February 2006||2006-02-01|October 2007|2007-10-01|October 2006|Actual|2006-10-01|||||Interventional|||A Safety Study Of Pregabalin In Fibromyalgia|A 12-Week, Open-Label, Safety Trial Of Pregabalin In Patients With Fibromyalgia|Completed||Phase 3|500||Pfizer|||||||||||||||||||2017-02-18 16:48:18.402167|2017-02-18 16:48:18.402167
NCT00282984|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2009-08-27|2009-02-13||February 2006||2006-02-01|August 2009|2009-08-01|August 2008|Actual|2008-08-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking|A 12-Week, Double-Blind, Placebo-Controlled, Multicenter Study With A 40 Week Follow Up Evaluating the Safety and Efficacy of Varenicline Tartrate 1 Milligram (Mg) Twice Daily (BID) for Smoking Cessation in Subjects With Cardiovascular Disease|Completed||Phase 3|714|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:48:18.814442|2017-02-18 16:48:18.814442
NCT00282971|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2009-09-11|2009-02-11||March 2006||2006-03-01|July 2009|2009-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus|A Six Month, Open-Label Outpatient, Parallel Group Trial Assessing The Impact Of Inhaled Insulin (Exubera) On Glycemic Control In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On Two Oral Anti-Diabetic Agents.|Terminated||Phase 3|354|Actual|Pfizer|Study terminated prematurely since the sponsor stopped marketing and manufacturing of EXUBERA and withdrew Market Authorization in Europe in September 2008. No efficacy, safety, or quality reason was associated with the premature halt of this study.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 16:48:19.716672|2017-02-18 16:48:19.716672
NCT00282958|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2015-03-04|||February 2003||2003-02-01|March 2015|2015-03-01|July 2006||2006-07-01|||||Interventional|||The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain|The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain|Completed||N/A|||Palo Alto Veterans Institute for Research|||||f||||||||||||||2017-02-18 16:48:20.24736|2017-02-18 16:48:20.24736
NCT00282945|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2008-10-09|||January 2006||2006-01-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone|Analyzing Beta Cell Function Tests Over Time In Patients With Type 2 Diabetes Mellitus Randomized To Metformin Or Rosiglitazone|Terminated||N/A|29|Actual|Pfizer||||See statement in Detailed Description.|f||||||||||||||2017-02-18 16:48:20.519332|2017-02-18 16:48:20.519332
NCT00282932|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2007-09-05|||January 2006||2006-01-01|September 2007|2007-09-01||||||||Interventional|||Detrol LA In Men With Overactive Bladder.|"A Randomized, Double Blind, Placebo Controlled Detrol LA Add-On To Alpha-Blocker Study In Men With Persistent Overactive Bladder Symptoms Of Urinary Frequency And Urgency With/Without Urgency Incontinence After Previous Monotherapy With Alpha Blocker."|Completed||Phase 4|600||Pfizer|||||||||||||||||||2017-02-18 16:48:20.620763|2017-02-18 16:48:20.620763
NCT00282919|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2014-05-27|2014-05-27||March 2006||2006-03-01|May 2014|2014-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional||All treated population included participants who received at least 1 dose of study medication.|A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria|A Phase 2, Open Label, Non-Comparative Trial Of Azithromycin 2000 mg Plus Chloroquine 600 Mg Base Daily For Three Days For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 2|110|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 16:48:20.806837|2017-02-18 16:48:20.806837
NCT00282906|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2014-12-14|||October 2005||2005-10-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|January 2013|Actual|2013-01-01||Interventional|||FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer|[F-18]-Fluorodeoxyglucose (FDG) Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer|Completed||N/A|257|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 16:48:21.169002|2017-02-18 16:48:21.169002
NCT00282893|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2017-02-13|||October 2000||2000-10-01|March 2014|2014-03-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Balloon Prophylaxis of Aneurysmal Vasospasm|Balloon Prophylaxis of Aneurysmal Vasospasm|Completed||Phase 2|170|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 16:48:21.271128|2017-02-18 16:48:21.271128
NCT00282867|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2009-07-15|2009-07-14||May 2006||2006-05-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||Glucose Regulation in Acute Stroke Patients (GRASP) Study|Glucose Regulation in Acute Stroke Patients (GRASP) Study|Completed||Phase 2|74|Actual|University of Virginia||3|||f||||t||||||||||2017-02-18 16:48:21.392152|2017-02-18 16:48:21.392152
NCT00282854|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2011-12-05|||January 2005||2005-01-01|August 2011|2011-08-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||Genetics of Rolandic Epilepsy|Genetics of Rolandic Epilepsy|Unknown status|Recruiting|N/A|1000|Anticipated|King's College London|||2||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 16:48:21.874993|2017-02-18 16:48:21.874993
NCT00282815|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2013-01-31|2011-06-21||September 2004||2004-09-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Sleep Apnea Treatment After Stroke (SATS)|Treatment of Obstructive Sleep Apnea After Stroke|Terminated||Phase 2|32|Actual|University of Michigan|Attrition pre-randomization and while in randomized treatment led to small numbers.|2||Poor recruitment. Funding expired.|f||||f||||||||||2017-02-18 16:48:22.579302|2017-02-18 16:48:22.579302
NCT00282802|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2009-07-01|||April 2001||2001-04-01|July 2009|2009-07-01|July 2010|Anticipated|2010-07-01|||||Observational|||Twins and the Risk of Parkinson's Disease: A Clinical and Imaging Study|Twins and the Risk of PD: A Clinical and Imaging Study|Unknown status|Active, not recruiting|N/A|250|Anticipated|The Parkinson's Institute|||1||f||||f||||||||||2017-02-18 16:48:23.143237|2017-02-18 16:48:23.143237
NCT00281814|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2011-03-28|||February 2006||2006-02-01|March 2011|2011-03-01||||December 2008|Actual|2008-12-01||Observational|||Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant|Adjustment to Illness by Survival Rates in Allogeneic Bone Marrow Transplant (BMT): The Relative Importance of Lay Care-Partner Support|Unknown status|Active, not recruiting|N/A|36|Actual|The Cleveland Clinic|||1||f||||f||||||||||2017-02-18 16:48:23.242474|2017-02-18 16:48:23.242474
NCT00281801|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2012-03-13|||February 2006||2006-02-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|December 2008|Actual|2008-12-01||Observational|||Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation|Survival in Allogeneic Bone Marrow Transplantation: The Relative Importance of Inpatient Lay Care-Partner Support|Completed||N/A|168|Actual|Case Comprehensive Cancer Center|||1||f||||f||||||||||2017-02-18 16:48:23.353539|2017-02-18 16:48:23.353539
NCT00281788|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-03-20|||September 2003||2003-09-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer|A Phase I Study of Oral Capecitabine in Combination With Weekly IV Carboplatin/Paclitaxel and Radiation Therapy for Patients|Completed||Phase 1|13|Actual|Duke University|||||f||||||||||||||2017-02-18 16:48:23.475115|2017-02-18 16:48:23.475115
NCT00281762|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2008-05-06||||||May 2008|2008-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Urinary Aquaporin 2 Excretion After NSAID in Fasting Healthy Human|Urinary Aquaporin 2 Excretion After NSAID in Fasting Healthy Human|Completed||Phase 4|20||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:48:23.573742|2017-02-18 16:48:23.573742
NCT00281749|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2011-08-17||||||August 2011|2011-08-01|October 2006|Actual|2006-10-01|||||Interventional|||Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients||Completed||Phase 1|||Maimonides Medical Center|||||f||||||||||||||2017-02-18 16:48:23.653289|2017-02-18 16:48:23.653289
NCT00281736|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-12-31|||February 2004||2004-02-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|July 2007|Actual|2007-07-01||Interventional|||Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer|A Phase II Study of HPPH Photodynamic Therapy for Treatment of High Grade Dysplasia, Carcinoma In-Situ or Early Intramucosal Adenocarcinoma in Barrett's Esophagus. Randomization to Two PDT Treatment Regimens of HPPH (2-1 [Hexyloxyethyl]-2devinylpyropheophorbide-a) and Light|Completed||Phase 2|60|Anticipated|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-02-18 16:48:23.737733|2017-02-18 16:48:23.737733
NCT00281723|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2007-05-06||||||May 2007|2007-05-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Efficacy of Adhesive Tablets in Treating Oral Ulcers (Aphthous)|Phase 2 Study of Efficacy of Adhesive Tablets in Treating Oral Ulcers (Aphthous)|Suspended||Phase 2|50|Anticipated|Hadassah Medical Organization||||The company which holds the patent was not interested.|f||||f||||||||||2017-02-18 16:48:23.842751|2017-02-18 16:48:23.842751
NCT00281710|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2008-05-06|||October 2005||2005-10-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Urinary Aquaporin 2 Excretion After Methylprednisolone in Fasting Healthy Humans|Urinary Aquaporin 2 Excretion After Methylprednisolone in Fasting Healthy Humans|Completed||Phase 4|20||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:48:23.939189|2017-02-18 16:48:23.939189
NCT00281697|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2013-07-05|2012-08-23||February 2006||2006-02-01|July 2013|2013-07-01|September 2012|Actual|2012-09-01|March 2009|Actual|2009-03-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)|A Phase III, Multicenter, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy Regimens in Subjects With Previously Treated Metastatic Breast Cancer|Completed||Phase 3|684|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:48:24.041898|2017-02-18 16:48:24.041898
NCT00281684|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2011-03-10||2009-07-22|December 2005||2005-12-01|March 2011|2011-03-01||||||||Interventional|||SB-705498 Dental Pain Study After Tooth Extraction|A Multi-centre, Randomised, Single Blind, Placebo Controlled, Parallel Group Study to Examine the Effect of Single Doses of SB-705498, a TRPV1 Receptor Antagonist, on Pain Following Third Molar Tooth Extraction|Completed||Phase 2|137|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:48:24.998192|2017-02-18 16:48:24.998192
NCT00281671|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2009-01-28|||February 2006||2006-02-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Nesiritide Use Following Cardiac Surgery in Infants|Pilot Study of the Effects of Nesiritide on Hemodynamics and Urine Output Following Cardiopulmonary Bypass in Infants|Terminated||Phase 1/Phase 2|9|Actual|Boston Children’s Hospital||1||Slow patient enrollment.|f||||t||||||||||2017-02-18 16:48:25.100171|2017-02-18 16:48:25.100171
NCT00281658|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2016-07-28|2011-05-05||January 2006||2006-01-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|June 2010|Actual|2010-06-01||Interventional|||Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase III Study of Lapatinib (GW572016) in Combination With Paclitaxel Versus Paclitaxel Plus Placebo in Subjects With ErbB2 Amplified Metastatic Breast Cancer|Active, not recruiting||Phase 3|444|Actual|Novartis|Some participants (PAR) are captured as withdrawing from the study due to death. Per protocol, PAR who died were considered to be study completers and did not withdraw from the study; for the purposes of this report, they are classified as withdrawn.|3|||f||||t||||||||||2017-02-18 16:48:25.229653|2017-02-18 16:48:25.229653
NCT00281645|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2007-03-26|||December 2004||2004-12-01|March 2007|2007-03-01||||||||Interventional|||Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain|A Multicenter Standard of Care-Controlled Study to Evaluate the Long-Term Safety of Bicifadine for the Treatment of Chronic Low Back Pain|Completed||Phase 3|1250||DOV Pharmaceutical, Inc.|||||||||||||||||||2017-02-18 16:48:26.368553|2017-02-18 16:48:26.368553
NCT00281632|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2011-03-17|2009-11-25||March 2006||2006-03-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|April 2008|Actual|2008-04-01||Interventional|||A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer|This Study is a Non-randomized, Open-label, Multi-center Phase II Study of GW786034 to Evaluate the Administration of Oral GW786034 in Subjects With Ovarian Cancer.|Completed||Phase 2|35|Actual|GlaxoSmithKline||1|||t||||||||||||||2017-02-18 16:48:26.457191|2017-02-18 16:48:26.457191
NCT00281619|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2013-12-18|||January 2006||2006-01-01|December 2013|2013-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients|Development of Population Pharmacokinetic-Pharmacodynamic (PK-PD) Models of Mycophenolic Acid for Bayesian Dose Individualization in Pediatric Kidney Transplant Patients|Completed||Phase 1|29|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-02-18 16:48:27.135835|2017-02-18 16:48:27.135835
NCT00281606|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2013-09-10|||February 2006||2006-02-01|September 2013|2013-09-01||||October 2008|Actual|2008-10-01||Interventional|||A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules|A Phase IV, Randomized, Open-label Study of the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules|Completed||Phase 4|65|Actual|California Collaborative Treatment Group||2|||f||||||||||||||2017-02-18 16:48:27.246561|2017-02-18 16:48:27.246561
NCT00282789|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2006-01-27|||June 2000||2000-06-01|June 2000|2000-06-01||||||||Interventional|||BiPAP for Cardiomyopathy With Central Sleep Apnea||Completed||N/A|||Nagoya University|||||f||||||||||||||2017-02-18 16:48:27.535941|2017-02-18 16:48:27.535941
NCT00282776|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2013-09-30|||August 2006||2006-08-01|September 2013|2013-09-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Identification and Therapy of Postpartum Depression|Identification and Therapy of Postpartum Depression|Completed||Phase 3|628|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 16:48:27.618308|2017-02-18 16:48:27.618308
NCT00282763|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2015-11-20|||December 2005||2005-12-01|November 2015|2015-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)|Proprietary Information - Exploratory (Non-confirmatory) Trial|Terminated||Phase 2|12|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 16:48:27.730957|2017-02-18 16:48:27.730957
NCT00282750|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2010-01-13|||March 2006||2006-03-01|January 2010|2010-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Bar Coded Sponge Study|A Randomised Clinical Trial of a Bar-Coded Safety Sponge System|Completed||N/A|350||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 16:48:27.811171|2017-02-18 16:48:27.811171
NCT00282724|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2011-09-23|||January 2006||2006-01-01|September 2011|2011-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis|A Randomized, Double-blind, Placebo-controlled Phase II/III Trial to Evaluate the Efficacy and Safety of 2 Doses of Oral Liarozole (75 mg od and 150 mg od) Given During 12 Weeks in Lamellar Ichthyosis|Completed||Phase 2/Phase 3|98|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:48:27.911755|2017-02-18 16:48:27.911755
NCT00282711|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2012-07-31|||June 2004||2004-06-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Observational|||The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?|"The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?A Multi-Center, Prospective, Randomized Study to Establish the Optimal Method for Detection of CAD Risk in Women at an Intermediate-High Pre-Test Likelihood CAD"|Completed||N/A|824|Actual|Hartford Hospital|||2||f||||t||||||||||2017-02-18 16:48:28.04233|2017-02-18 16:48:28.04233
NCT00282698|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2011-05-20|||July 2004||2004-07-01|May 2011|2011-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients|Outcomes With Use Of Intensive Insulin Therapy In Intraoperative Management Of Hyperglycemia In Adult Patients Undergoing Cardiac Surgery|Completed||Phase 3|400||Mayo Clinic|||||f||||||||||||||2017-02-18 16:48:28.196951|2017-02-18 16:48:28.196951
NCT00282685|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2007-11-21|||October 2005||2005-10-01|November 2007|2007-11-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy|(Restoration of Nerve Functions by Intra-Arterial Transplantation of Bone Marrow Progenitor Cells in Patients With Diabetic Poly Neuropathy (PNP)|Unknown status|Recruiting|Phase 1|20|Anticipated|Johann Wolfgang Goethe University Hospital||1|||f||||f||||||||||2017-02-18 16:48:28.293703|2017-02-18 16:48:28.293703
NCT00282672|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2015-12-28|2015-09-11||February 2006||2006-02-01|December 2015|2015-12-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Ablation of Intestinal Metaplasia Containing Dysplasia|Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years|Completed||N/A|127|Actual|Medtronic - MITG||4|||f||||t||||||||||2017-02-18 16:48:28.409153|2017-02-18 16:48:28.409153
NCT00282659|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2007-11-02|||January 2006||2006-01-01|March 2007|2007-03-01|June 2008|Anticipated|2008-06-01|||||Interventional|||The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control|The Use of Magnesium to Improve Hemodynamics, Cholesterol, and Glucose Control: A Substudy of AdMag|Unknown status|Recruiting|Phase 4|240|Anticipated|Hartford Hospital|||||f||||||||||||||2017-02-18 16:48:29.310346|2017-02-18 16:48:29.310346
NCT00282646|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2011-08-23|||October 2005||2005-10-01|March 2011|2011-03-01|March 2011|Actual|2011-03-01|October 2010|Actual|2010-10-01||Interventional|||Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)|(Intraarterial Progenitor Cell Transplantation of Bone Marrow Mononuclear Cells for Induction of Neovascularization in Patients With Peripheral Arterial Occlusive Disease)|Completed||Phase 1/Phase 2|40|Anticipated|Johann Wolfgang Goethe University Hospital||2|||f||||f||||||||||2017-02-18 16:48:29.412944|2017-02-18 16:48:29.412944
NCT00282633|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2007-10-30|||November 2005||2005-11-01|October 2007|2007-10-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Wound Closure Techniques|A Comparison of Skin Closure Techniques After Primary Cesarean Delivery|Unknown status|Recruiting|N/A|120|Anticipated|Hartford Hospital|||||f||||||||||||||2017-02-18 16:48:29.525189|2017-02-18 16:48:29.525189
NCT00282620|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2007-11-16|||January 2006||2006-01-01|March 2007|2007-03-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.|The Adjuvant Magnesium Trial (AdMag): Assessment if the Impact of Oral Magnesium on ICD Firing and Quality of Life|Unknown status|Recruiting|Phase 4|240|Anticipated|Hartford Hospital|||||f||||||||||||||2017-02-18 16:48:29.617109|2017-02-18 16:48:29.617109
NCT00282607|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2007-02-27|||May 2005||2005-05-01|February 2007|2007-02-01|June 2006||2006-06-01|||||Interventional|||A Study of DA-8159 in Subjects With Erectile Dysfunction|A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Phase 2 Dose Ranging Trial To Assess The Safety and Efficacy of DA-8159 Tablets in Male Subjects With Erectile Dysfunction.|Completed||Phase 2|300||Dong-A PharmTech Co., Ltd.|||||f||||t||||||||||2017-02-18 16:48:29.703558|2017-02-18 16:48:29.703558
NCT00282594|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2006-01-26|||July 2003||2003-07-01|November 2005|2005-11-01|October 2005||2005-10-01|||||Interventional|||The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit|No Outcome Benefit for the Use of Intensive Insulin Therapy in the Critically Ill General and Vascular Surgical Patient. A Randomized Prospective Trial.|Completed||N/A|317||Genesys|||||f||||||||||||||2017-02-18 16:48:29.808328|2017-02-18 16:48:29.808328
NCT00282581|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-26|2014-01-17|||October 2006||2006-10-01|January 2014|2014-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive|A Phase 1, Double-Blind, Placebo-Controlled Study to Assess the Safety and Immunogenicity of MVA3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Vaccinia-Naive Human Immunodeficiency Virus (HIV)-Seropositive Subjects|Terminated||Phase 1|2|Actual|Sanofi||1||Senior managemnt decision|f||||t||||||||||2017-02-18 16:48:29.907091|2017-02-18 16:48:29.907091
NCT00282568|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2013-07-25|2013-07-25||August 2002||2002-08-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Pharmacokinetic evaluable set defined as all patients with all five complete pharmacokinetic profiles (two tacrolimus and three tacrolimus MR).|A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients|A Phase 2, Open-Label, Multi-center Study to Assess the Pharmacokinetics, Safety and Tolerability of Tacrolimus in Stable Kidney Transplant Patients Converted From a Prograf® Based Immunosuppression Regimen to a Modified Release (MR) Tacrolimus Based Immunosuppression Regimen|Completed||Phase 2|70|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|1|||f||||f||||||||||2017-02-18 16:48:30.044216|2017-02-18 16:48:30.044216
NCT00282555|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2008-03-18|||February 2006||2006-02-01|March 2008|2008-03-01||||||||Interventional|||Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis|Assessment of the Healing Rate of Erosive or Ulcerative Esophagitis After Two and Four Weeks of Treatment With S-Tenatoprazole-Na (STU-Na) 15 mg, 30 mg, 60 mg, 90 mg and Esomeprazole 40 mg. A Multicenter, Randomized, Double-Blind, Parallel Group Study.|Suspended||Phase 2|450||STEBA France|||||f||||||||||||||2017-02-18 16:48:30.930881|2017-02-18 16:48:30.930881
NCT00282542|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2017-01-30|||May 2000||2000-05-01|January 2017|2017-01-01|January 2006||2006-01-01|||||Interventional|||Hepatocyte Transplantation as a Life Support Bridge|The Use of Human Hepatocyte Transplantation as a Life Support Bridge in Terminal Liver Failure|Withdrawn||N/A|0|Actual|Virginia Commonwealth University|||||f||||||||||||||2017-02-18 16:48:31.218181|2017-02-18 16:48:31.218181
NCT00282529|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2017-01-23|||January 2006|Actual|2006-01-01|January 2017|2017-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study|Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study|Terminated||N/A|400|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:48:31.314897|2017-02-18 16:48:31.314897
NCT00282516|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2006-01-25|||April 2003||2003-04-01|January 2006|2006-01-01|February 2005||2005-02-01|||||Interventional|||Asthma In-Home Monitoring (AIM) Trial|“Internet-Based Home Monitoring and Education of Children With Asthma is Comparable to Ideal, Office-Based Care: Results of a One-Year, Asthma In-Home Monitoring (AIM) Trial”|Unknown status|Active, not recruiting|N/A|120||Tripler Army Medical Center|||||f||||||||||||||2017-02-18 16:48:31.425964|2017-02-18 16:48:31.425964
NCT00282503|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-10-18|||January 2006||2006-01-01|October 2016|2016-10-01||||June 2007|Actual|2007-06-01||Interventional|||Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease|A Randomized, Controlled, Parallel-Group, Multicenter Study of Extracorporeal Photoimmune Therapy With THERAKOS* UVADEX* for the Treatment of Patients With Newly Diagnosed Acute Graft Versus-Host Disease|Terminated||Phase 3|19|Actual|Mallinckrodt||2||Lack of recruitment|f||||||||||||||2017-02-18 16:48:31.515701|2017-02-18 16:48:31.515701
NCT00282490|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2008-06-13|||February 2006||2006-02-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Surface Nerve Stimulation Treatment for OAB in Children|Sacral Transcutaneous Nerve Stimulation Treatment for Functional Daytime Incontinence in Children With Over Active Bladder Syndrome|Completed||N/A|30|Anticipated|University of Aarhus||2|||f||||f||||||||||2017-02-18 16:48:31.670742|2017-02-18 16:48:31.670742
NCT00282477|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2007-08-06|||February 2006||2006-02-01|August 2007|2007-08-01||||||||Observational|||Trial to Evaluate Erectile Function, Fertility and Sperm Count in Male Cyclists Compared to Age Matched Controls|Prospective Controlled Trial to Evaluate Erectile Function, Fertility and Sperm Count in Male Cyclists Compared to Age Matched Controls|Unknown status|Recruiting|Phase 2|30|Anticipated|Sheba Medical Center|||||f||||||||||||||2017-02-18 16:48:31.770989|2017-02-18 16:48:31.770989
NCT00282464|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2009-06-01|2009-03-03||February 2006||2006-02-01|June 2009|2009-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Six-Week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.|A Six-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Flexible Doses of Oral Ziprasidone in Outpatients With Bipolar I Depression|Completed||Phase 3|392|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:48:31.872865|2017-02-18 16:48:31.872865
NCT00282451|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2016-10-27|||February 2006||2006-02-01|October 2016|2016-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes|Comparison of Biphasic Insulin Aspart 30 Twice Daily With Biphasic Insulin Aspart 30 Twice Daily Plus Lunchtime Injection of Insulin Aspart, in Combination With or Without Metformin (for Both Treatment Groups) in Subjects With Type 2 Diabetes. A Multi-center, Randomized, Open-labeled, Two-armed Parallel Group Trial in Subjects With Type 2 Diabetes Previously Treated With Conventional Biphasic Human Insulin 30/70|Completed||Phase 4|79|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:48:33.029531|2017-02-18 16:48:33.029531
NCT00005455|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-14|||January 1993||1993-01-01|November 2001|2001-11-01|December 1993|Actual|1993-12-01|||||Observational|||Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.880472|2017-02-18 18:14:57.880472
NCT00282438|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-03-21|||December 2003||2003-12-01|March 2016|2016-03-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis|Hematopoietic Stem Cell Transplant in Patients With Refractory Sarcoidosis: A Phase I/II Trial|Terminated||Phase 1/Phase 2|2|Actual|Northwestern University||2||No plan to continue enrollment|f||||f||||||||||2017-02-18 16:48:33.237501|2017-02-18 16:48:33.237501
NCT00282425|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2012-12-14|||May 2005||2005-05-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis|Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis|Terminated||Phase 1|8|Actual|Northwestern University||1||No subject enrolled since 2009|f||||t||||||||||2017-02-18 16:48:33.345593|2017-02-18 16:48:33.345593
NCT00282412|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-07-11|||September 2002||2002-09-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism|Rheumatoid Arthritis: Tolerance Induction by Mixed Chimerism|Terminated||Phase 1|4|Actual|Northwestern University||1||No participant enrolled for three years. No plan to continue study.|f||||t||||||||No||2017-02-18 16:48:33.436172|2017-02-18 16:48:33.436172
NCT00282399|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2015-10-27|||October 2006||2006-10-01|October 2015|2015-10-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome|Phase I/II Trial of Subcutaneous Decitabine Maximizing Genomic Demethylation in Patients With Myelodysplastic Syndrome.|Terminated||Phase 1|41|Actual|Eisai Inc.||3|||f||||f||||||||||2017-02-18 16:48:33.534224|2017-02-18 16:48:33.534224
NCT00282386|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2015-09-15|||December 1999||1999-12-01|September 2015|2015-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)|A Multicenter, Randomized, Parallel-Group, Placebo-Controlled, Double-Blind Study With In-House Blinding to Determine the Effect of 156 Weeks of Treatment With MK0966 on the Recurrence of Neoplastic Polyps of the Large Bowel in Patients With a History of Colorectal Adenomas|Completed||Phase 3|2586|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:48:33.641139|2017-02-18 16:48:33.641139
NCT00282373|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2007-09-10|||November 2004||2004-11-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Induction of Mild Hypothermia in Resuscitated Cardiac Arrest Patients|Randomized Controlled Pilot Study: Induction of Mild Hypothermia in Resuscitated Cardiac Arrest Patients Using Traditional Surface Cooling Techniques vs. the Medivance® Arctic Sun® System|Completed||Phase 2/Phase 3|64|Anticipated|Medivance, Inc.|||||f||||t||||||||||2017-02-18 16:48:33.726476|2017-02-18 16:48:33.726476
NCT00282360|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2006-01-24|||February 1999||1999-02-01|May 2004|2004-05-01|October 2003||2003-10-01|||||Interventional|||Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease|Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease|Completed||Phase 4|30||IRCCS San Raffaele|||||f||||||||||||||2017-02-18 16:48:33.823783|2017-02-18 16:48:33.823783
NCT00282347|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2015-01-06|2010-02-01||January 2006||2006-01-01|January 2015|2015-01-01|January 2013|Actual|2013-01-01|January 2009|Actual|2009-01-01||Interventional|LUNAR||A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With ISN/RPS Class III or IV Lupus Nephritis|Completed||Phase 3|144|Actual|Genentech, Inc.||2|||f||||f||||||||||2017-02-18 16:48:33.926913|2017-02-18 16:48:33.926913
NCT00282334|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2011-07-29|2010-02-18||May 2004||2004-05-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Comparison of Telemedical and Conventional Antihypertensive Treatment|A Comparison of Telemedical and Conventional Antihypertensive Treatment|Completed||Phase 4|236|Actual|Regional Hospital Holstebro|Technical difficulties with telemedical equipment,referral bias,unblinded study|2|||f||||f||||||||||2017-02-18 16:48:37.832448|2017-02-18 16:48:37.832448
NCT00282321|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2010-02-19|||May 2007||2007-05-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||High-protein and High-carbohydrate Diets' Effect on Urinary Concentrating Ability||Completed||Phase 4|20|Anticipated|Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:48:38.174388|2017-02-18 16:48:38.174388
NCT00282308|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-08-19|2013-06-05||January 2006||2006-01-01|August 2013|2013-08-01|February 2009|Actual|2009-02-01|January 2008|Actual|2008-01-01||Interventional|SIERRA|Safety population: All patients who received any amount of rituximab or any vaccine.|A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate|A Phase II, Randomized, Parallel-group, Open-label, Multicenter Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate|Completed||Phase 2|103|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:48:38.266446|2017-02-18 16:48:38.266446
NCT00282295|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2016-09-27|||January 2006||2006-01-01|September 2016|2016-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease|Safety & Immunogenicity of a Booster Dose of dTPa Vaccine (Boostrix®) Co-admnd. With Aventis Pasteur's Meningococcal (Serogroups A, C, Y and W-135) Polysaccharide Vaccine (Menactra™) vs Admn. of Either Vaccine Alone in Healthy Adolescents|Completed||Phase 4|1376|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:48:39.268665|2017-02-18 16:48:39.268665
NCT00282282|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2014-04-29|2013-01-11||January 2006||2006-01-01|March 2014|2014-03-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|||Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation|Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis After Allogeneic Non-myeloablative Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|31|Actual|Dana-Farber Cancer Institute|This study is a single-institution study, and as such the data are limited by the small study population.|1|||f||||t||||||||||2017-02-18 16:48:39.413145|2017-02-18 16:48:39.413145
NCT00282269|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-25|2010-06-18|||November 2006||2006-11-01|June 2009|2009-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Hypothermia in Traumatic Brain Injury in Children (HiTBIC)|Pilot Study of Early and Prolonged Hypothermia in Severe Traumatic Brain Injury in Children|Completed||Phase 2/Phase 3|50|Anticipated|Australia and New Zealand Intensive Care Society||1|||f||||t||||||||||2017-02-18 16:48:39.67145|2017-02-18 16:48:39.67145
NCT00282256|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-08-12|2013-08-12||January 2004||2004-01-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||The pharmacokinetic evaluable set was defined as all patients who completed both pharmacokinetic profiles: one for tacrolimus, and one for tacrolimus MR.|A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients|A Phase 2, Open-Label, Multi-center Study to Assess the Pharmacokinetics, Long-Term Safety and Tolerability of Tacrolimus in Stable Pediatric Liver Transplant Patients Converted From a Prograf® Based Immunosuppression Regimen to a Modified Release (MR) Tacrolimus Based Immunosuppression Regimen|Completed||Phase 2|19|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|1|||f||||f||||||||||2017-02-18 16:48:39.791187|2017-02-18 16:48:39.791187
NCT00282243|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-08-01|2013-08-01||February 2003||2003-02-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Pharmacokinetic evaluable set, defined as all patients with four complete pharmacokinetic profiles (two tacrolimus and two tacrolimus MR).|A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients|A Phase 2, Open-Label, Multi-Center Study to Assess the Pharmacokinetics, Long-term Safety and Tolerability of Tacrolimus in Stable Liver Transplant Patients Converted From a Prograf® Based Immunosuppression Regimen to a Modified Release (MR) Tacrolimus Based Immunosuppression Regimen|Completed||Phase 2|70|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 16:48:40.372475|2017-02-18 16:48:40.372475
NCT00282230|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2012-06-06|||November 2003||2003-11-01|June 2012|2012-06-01|October 2005|Actual|2005-10-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients|A Phase 2, Randomized, Open-Label, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Prograf®/FK778 and Prograf®/MMF in De Novo Kidney Transplant Recipients|Terminated||Phase 2|150||Astellas Pharma Inc|||||||||||||||||||2017-02-18 16:48:41.400351|2017-02-18 16:48:41.400351
NCT00282217|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2007-03-21|||August 2006||2006-08-01|March 2007|2007-03-01||||||||Interventional|||Study Evaluating Sirolimus in the Treatment of Kidney Transplant|Sirolimus in the Treatment of Histological Defined Chronic Allograft Nephropathy|Completed||Phase 4|100||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:48:41.516301|2017-02-18 16:48:41.516301
NCT00282204|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2012-06-28|||December 2005||2005-12-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Hypnosis Antenatal Training for Childbirth (HATCh): a Randomised Controlled Trial|Hypnosis Antenatal Training for Childbirth (HATCh): a Randomised Controlled Trial|Completed||Phase 2/Phase 3|448|Actual|Women's and Children's Hospital, Australia||3|||f||||t||||||||||2017-02-18 16:48:41.624306|2017-02-18 16:48:41.624306
NCT00282191|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2008-03-26|||August 2006||2006-08-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Prevalence of Spasticity in Adults With Mental Retardation Living in the Community|Prevalence of Spasticity in Adults With Mental Retardation Residing in a Community Setting|Completed||Phase 1|7|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 16:48:41.735887|2017-02-18 16:48:41.735887
NCT00282178|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2008-10-15|||April 2005||2005-04-01|June 2008|2008-06-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo|A 36 Week Three-Center Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo|Completed||Phase 2|26|Actual|Umeå University||3|||f||||f||||||||||2017-02-18 16:48:41.82158|2017-02-18 16:48:41.82158
NCT00282165|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2015-01-23|||November 2006||2006-11-01|January 2015|2015-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order|Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order|Terminated||Phase 4|8|Actual|UMC Utrecht||2||Required number of subjects to be included could not be accomplished|f||||f||||||||||2017-02-18 16:48:41.937089|2017-02-18 16:48:41.937089
NCT00282152|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2016-01-25||2014-12-11|March 2006||2006-03-01|January 2016|2016-01-01|October 2015|Actual|2015-10-01|January 2012|Actual|2012-01-01||Interventional|||Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD)|Safety and Tolerability of Neurostimulation in Early Stage Parkinson's Disease|Completed||N/A|30|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 16:48:42.044142|2017-02-18 16:48:42.044142
NCT00282139|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2011-10-04|||January 2004||2004-01-01|October 2011|2011-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Aripiprazole in the Treatment of Tourette's Syndrome|Aripiprazole in the Treatment of Tourette's Syndrome|Terminated||N/A|40|Anticipated|University of Florida|||||f||||||||||||||2017-02-18 16:48:42.139624|2017-02-18 16:48:42.139624
NCT00282126|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2014-08-08|||January 2006||2006-01-01|August 2014|2014-08-01||||January 2011|Actual|2011-01-01||Interventional|||Potassium Citrate to Prevent Age Related Bone Loss|Potassium Citrate to Prevent Age Related Bone Loss: Pilot Study|Completed||N/A|52|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-02-18 16:48:42.233053|2017-02-18 16:48:42.233053
NCT00282113|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2009-12-31|2009-11-19||October 2004||2004-10-01|December 2009|2009-12-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||Effects of Probiotic and Prebiotic Combinations on Premature Infants|Efficacy of a Prebiotic and Probiotic Combination in Preterm Infants|Completed||N/A|90|Actual|University of California, Davis|Smaller sample size than anticipated due to the number of infants enrolled who were discharged home prior to completing five weeks of treatment.|3|||f||||t||||||||||2017-02-18 16:48:42.344953|2017-02-18 16:48:42.344953
NCT00282100|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2008-12-16|||December 2005||2005-12-01|December 2008|2008-12-01|December 2012|Anticipated|2012-12-01|||||Interventional|||A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma||Unknown status|Active, not recruiting|Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:48:42.850203|2017-02-18 16:48:42.850203
NCT00282087|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2014-11-23|2013-07-19||January 2006||2006-01-01|November 2014|2014-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma|Adjuvant Treatment of High Risk Uterine Leiomyosarcoma With Gemcitabine/Docetaxel Followed by Doxorubicin: A Phase II Trial|Completed||Phase 2|47|Actual|Sarcoma Alliance for Research through Collaboration||1|||f||||t||||||||||2017-02-18 16:48:42.947778|2017-02-18 16:48:42.947778
NCT00282074|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2007-01-23|||January 2006||2006-01-01|January 2007|2007-01-01||||||||Interventional|||Evaluating Changes in Spermatogram Following Bilateral Laparoscopic Inguinal Hernia Repair in Fertile Males|Prospective Trial to Evaluate Changes in Spermatogram Following Bilateral Laparoscopic Inguinal Hernia Repair in Males in the Fertility Age|Terminated||Phase 2/Phase 3|30||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:48:43.402911|2017-02-18 16:48:43.402911
NCT00282061|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2006-12-14||||||January 2006|2006-01-01||||||||Interventional|||Synchronization and Desynchronization Between Circadian Rhythms in Patients With Delayed Sleep Phase Syndrome (DSPS)||Unknown status|Recruiting|Phase 1|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:48:43.654994|2017-02-18 16:48:43.654994
NCT00282048|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2012-07-23|2012-02-25||March 2006||2006-03-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer|Phase 2 Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer|Completed||Phase 2|62|Actual|Pfizer|Population pharmacokinetics was not presented, as the data was not available for the single study and data of other axitinib (AG-013736) Phase 2 studies would be pooled together in a separate report.|1|||f||||f||||||||||2017-02-18 16:48:43.753433|2017-02-18 16:48:43.753433
NCT00282035|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2016-09-26|||January 2006||2006-01-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|June 2020|Anticipated|2020-06-01||Interventional|||RAPID: Randomized Trial of Accelerated Partial Breast Irradiation|A Multi-centre Randomized Trial to Determine if Accelerated Partial Breast Irradiation, Utilizing 3D CRT, is as Effective as Whole Breast Irradiation Following Breast Conserving Surgery in Women With Ductal Carcinoma in Situ or Invasive Breast Cancer With Negative Axillary Lymph Nodes|Active, not recruiting||Phase 3|2128|Anticipated|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-02-18 16:48:44.412188|2017-02-18 16:48:44.412188
NCT00282022|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-11-05|||September 2005||2005-09-01|January 2009|2009-01-01||||May 2008|Actual|2008-05-01||Interventional|||VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer|A Phase II Trial of Cloretazine™ (VNP40101M) for Patients With Relapsed or Refractory Small Cell Lung Cancer|Completed||Phase 2|87|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 16:48:44.558554|2017-02-18 16:48:44.558554
NCT00282009|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-02-09|||August 2004||2004-08-01|August 2014|2014-08-01|December 2015|Actual|2015-12-01|October 2015|Actual|2015-10-01||Interventional|||Internet and Telephone Counseling for Smoking Cessation|Internet and Telephone Counseling for Smoking Cessation|Completed||N/A|2205|Actual|Georgetown University||3|||f||||t||||||||No||2017-02-18 16:48:44.656589|2017-02-18 16:48:44.656589
NCT00281996|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2011-08-24|||March 2005||2005-03-01|August 2011|2011-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer|Phase I/II Study of Gleevec (Imatinib Mesylate, Formerly Known as STI571) and Gemcitabine for Advanced Pancreas Cancer|Terminated||Phase 1|19|Actual|Northwestern University||1||Closed to accrual to allow enrollment on another more promising trial.|f||||t||||||||||2017-02-18 16:48:44.759335|2017-02-18 16:48:44.759335
NCT00281983|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-09-23|||June 2000||2000-06-01|April 2007|2007-04-01|July 2010|Actual|2010-07-01|||||Interventional|||Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia|Pilot Study on Allogeneic Stem Cell Transplantation Following Conditioning With Fludarabine and an Alkylating Agent in Patients With High-Risk Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|70|Anticipated|German CLL Study Group|||||f||||||||||||||2017-02-18 16:48:44.862573|2017-02-18 16:48:44.862573
NCT00281970|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2009-02-06|||August 2004||2004-08-01|July 2007|2007-07-01||||||||Interventional|||Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery|Phase II Trial of Weekly Docetaxel (Taxotere®) and Monthly Cisplatin Chemotherapy as Adjuvant Treatment for Patients With Completely Resected Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:48:45.001719|2017-02-18 16:48:45.001719
NCT00281957|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2014-05-02|2012-06-05||August 2007||2007-08-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|||Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery|A Randomized Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) With Either CCI-779 (Temsirolimus; NSC-683864) or R115777 (Tipifarnib; NSC-702818) in Metastatic Melanoma|Completed||Phase 2|109|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:48:45.14527|2017-02-18 16:48:45.14527
NCT00281944|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-05-01|||September 2005||2005-09-01|May 2013|2013-05-01||||May 2009|Actual|2009-05-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors|A Multi-Center Phase Ib Study of Oxaliplatin (NSC #266046) in Combination With Fluorouracil and Leucovorin in Pediatric Patients With Advanced Solid Tumors|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:48:46.224298|2017-02-18 16:48:46.224298
NCT00281931|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-09-23|||September 1999||1999-09-01|September 2016|2016-09-01|October 2006|Actual|2006-10-01|April 2006|Actual|2006-04-01||Interventional|||Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia|Phase II Trial of Combined Immunochemotherapy With Fludarabine, Cyclophosphamide and Rituximab in Patients With B-PLL|Terminated||Phase 2|21|Anticipated|German CLL Study Group|||||f||||||||||||No||2017-02-18 16:48:46.341611|2017-02-18 16:48:46.341611
NCT00281918|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-09-09|2009-12-21||July 2003||2003-07-01|September 2013|2013-09-01|October 2011|Actual|2011-10-01|July 2007|Actual|2007-07-01||Interventional|CLL-8||Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia|Phase III Trial of Combined Immunochemotherapy With Fludarabine, Cyclophosphamide and Rituximab (FCR) Versus Chemotherapy With Fludarabine and Cyclophosphamide (FC) Alone in Patients With Previously Untreated Chronic Lymphocytic Leukaemia|Completed||Phase 3|817|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:48:46.460521|2017-02-18 16:48:46.460521
NCT00281905|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-09-19|||June 1992||1992-06-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors|Management of Children Aged Less Than 3 Years With Brain Tumors|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:48:47.618682|2017-02-18 16:48:47.618682
NCT00005453|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1992||1992-09-01|September 2002|2002-09-01|June 1997|Actual|1997-06-01|||||Observational|||Adherence in Clinical Trials-Induction Strategies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.941871|2017-02-18 18:14:57.941871
NCT00281892|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-09-30|||September 2004||2004-09-01|September 2016|2016-09-01|October 2010|Actual|2010-10-01|May 2008|Actual|2008-05-01||Interventional|||Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia|Darbepoetin Alfa in Patients With Chronic Lymphocytic Leukemia and Comorbidity|Completed||Phase 3|97|Actual|German CLL Study Group||2|||f||||f||||||||No||2017-02-18 16:48:47.799143|2017-02-18 16:48:47.799143
NCT00281879|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2012-07-02|2012-05-17||February 2006||2006-02-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer|Transplantation of Unrelated Donor Hematopoietic Stem Cells for the Treatment of Hematological Malignancies|Terminated||Phase 2|200|Actual|OHSU Knight Cancer Institute|Early termination|8|||f||||t||||||||||2017-02-18 16:48:48.142315|2017-02-18 16:48:48.142315
NCT00281866|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-10-10|||July 2005||2005-07-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Interventional|||Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer|Genotypic-Based Pharmacodynamic Evaluation of Erlotinib (Erlotinib (Tarceva™, OSI Pharmaceuticals, Uniondale, NY) in Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|37|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:48:49.306559|2017-02-18 16:48:49.306559
NCT00281853|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2010-06-10|||March 2005||2005-03-01|June 2010|2010-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer|Characterization of Chemotherapy/Biotherapy-Induced Peripheral Neuropathy: Refinement of Clinical Measures|Completed||N/A|15|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||||||2017-02-18 16:48:49.447535|2017-02-18 16:48:49.447535
NCT00281840|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2015-05-19|2014-07-14||September 2005||2005-09-01|May 2015|2015-05-01|December 2012|Actual|2012-12-01|April 2012|Actual|2012-04-01||Interventional|||Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer|A Phase II Study of Bevacizumab in Combination With Docetaxel and Radiation in Locally Advanced Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|30|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:48:49.561105|2017-02-18 16:48:49.561105
NCT00281827|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2012-11-06|2009-06-23||May 2002||2002-05-01|November 2012|2012-11-01|July 2008|Actual|2008-07-01|March 2008|Actual|2008-03-01||Interventional|||Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer|Phase II Trial of Neoadjuvant Therapy With Carboplatin and Gemcitabine With Thalidomide in Patients With Stage II and IIIA Non-Small Cell Lung Cancer|Terminated||Phase 2|22|Actual|Masonic Cancer Center, University of Minnesota||1||Due to drug unavailability|f||||t||||||||||2017-02-18 16:48:49.976554|2017-02-18 16:48:49.976554
NCT00281593|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-10-31|||April 2006||2006-04-01|October 2013|2013-10-01||||April 2007|Actual|2007-04-01||Interventional|||Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension|A Randomized, Double-blind, Double-dummy, Placebo-controlled, 3x4 Factorial Design Trial to Evaluate Telmisartan 20 and 80 mg Tablets in Combination With Ramipril 1.25, 10, and 20 mg Capsules After Eight Weeks of Treatment in Patients With Stage I or II Hypertension, With an ABPM Sub-study|Completed||Phase 3|1354|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 16:48:50.347753|2017-02-18 16:48:50.347753
NCT00281580|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2014-02-10|2009-11-18||April 2006||2006-04-01|February 2014|2014-02-01||||March 2007|Actual|2007-03-01||Interventional||Treated set including all 1461 patients who were randomised to receive double-blind treatment and took at least one dose.|Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension|A Randomized, Double-blind, Double-dummy, Placebo-controlled, 4x4 Factorial Design Trial to Evaluate Telmisartan 20, 40 and 80 mg Tablets in Combination With Amlodipine 2.5, 5 and 10 mg Capsules After Eight Weeks of Treatment in Patients With Stage I or II Hypertension, With an ABPM Sub-study|Completed||Phase 3|1461|Actual|Boehringer Ingelheim||16|||f||||||||||||||2017-02-18 16:48:50.581345|2017-02-18 16:48:50.581345
NCT00281567|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2013-10-31|||August 2002||2002-08-01|October 2013|2013-10-01||||July 2003|Actual|2003-07-01||Interventional|||Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Crossover Efficacy and Safety Comparison of 4-week Treatment Periods of Two Doses [5 μg (2 Actuations of 2.5 μg) and 10 μg (2 Actuations of 5 μg)] of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler, Tiotropium Inhalation Powder Capsule (18μg) Delivered by the HandiHaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|76|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:48:55.038781|2017-02-18 16:48:55.038781
NCT00281554|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2008-04-01|||October 2005||2005-10-01|April 2008|2008-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|ACT 4||Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation|A Phase 3, Multi-Center, Open Label, Safety Study of RSD1235 in Subjects With Atrial Fibrillation|Completed||Phase 3|254|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 16:48:55.131584|2017-02-18 16:48:55.131584
NCT00281541|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2012-06-06|||November 2005||2005-11-01|June 2012|2012-06-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma|A Phase II, Multicenter, Open-Label Study of YM155 in Subjects With Unresectable Stage III or Metastatic (Stage IV) Melanoma|Completed||Phase 2|29|Anticipated|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 16:48:55.265999|2017-02-18 16:48:55.265999
NCT00281528|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2016-10-25|2012-02-17||February 2006||2006-02-01|October 2016|2016-10-01|March 2011|Actual|2011-03-01|July 2010|Actual|2010-07-01||Interventional|||Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer|A Phase II Study of Weekly Versus Every 2-week Versus Every 3-week Administration of ABI-007 (Abraxane) in Combination With Bevacizumab in Women With Metastatic Breast Cancer.|Terminated||Phase 2|208|Actual|Celgene Corporation||3||sufficient mature data to complete a final analysis|f||||f||||||||||2017-02-18 16:48:55.454594|2017-02-18 16:48:55.454594
NCT00281515|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-24|2012-06-28|||January 2006||2006-01-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer|An Open-label, Multicenter, Randomized Phase II Study to Compare the Effects of Paclitaxel/Carboplatin and Lonafarnib to Those of Paclitaxel/Carboplatin for First-line Treatment of Patients With Epithelial Ovarian Cancer FIGO Stages IIB-IV|Completed||Phase 2|105|Actual|AGO Study Group||2|||f||||||||||||||2017-02-18 16:48:57.396988|2017-02-18 16:48:57.396988
NCT00281502|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2010-11-04|||December 2005||2005-12-01|November 2010|2010-11-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy|The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy. Phase A: Breath Testing and Colonic Transit in Hepatic Encephalopathy. Phase B: A Randomized Double Blind, Placebo Controlled Trial of Rifaximin for Hepatic Encephalopathy|Unknown status|Recruiting|Phase 2|50|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 16:48:57.528066|2017-02-18 16:48:57.528066
NCT00281489|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2012-07-20|||August 2005||2005-08-01|July 2012|2012-07-01||||October 2006|Actual|2006-10-01||Interventional|||Study Evaluating Ways of Preventing Patients From Being Awake During High-Risk Surgery and Anesthesia|B-Unaware Study: Comparison of BIS-guided Anesthesia With End-Tidal Volatile-Guided Anesthesia to Decrease The Incidence of Awareness During High-Risk Surgery|Completed||Phase 2/Phase 3|2000|Actual|Washington University School of Medicine||2|||f||||||||||||||2017-02-18 16:48:57.654089|2017-02-18 16:48:57.654089
NCT00281476|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2011-10-31|||February 2006||2006-02-01|October 2011|2011-10-01|November 2007|Actual|2007-11-01|||||Interventional|||The Effect of High Dose Simvastatine on Multiple Myeloma|The Effect of High Dose Simvastatine on Multiple Myeloma|Completed||Phase 1/Phase 2|10|Anticipated|Vejle Hospital|||||f||||||||||||||2017-02-18 16:48:57.772616|2017-02-18 16:48:57.772616
NCT00281463|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2014-11-06|2014-11-06||November 2001||2001-11-01|November 2014|2014-11-01|January 2008|Actual|2008-01-01|March 2007|Actual|2007-03-01||Interventional|||Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia|Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia|Completed||N/A|45|Actual|VA Pittsburgh Healthcare System||1|||f||||f||||||||||2017-02-18 16:48:57.848746|2017-02-18 16:48:57.848746
NCT00281450|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2010-04-27|||January 2006||2006-01-01|December 2005|2005-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||An Intervention to Reduce Inappropriate Prescriptions for Elderly Patients in General Practice|A Cluster Randomized Educational Intervention to Reduce Inappropriate Prescription Patterns for Elderly Patients in General Practice|Completed||Phase 1/Phase 2|85836|Actual|University of Oslo||1|||f||||||||||||||2017-02-18 16:48:58.073509|2017-02-18 16:48:58.073509
NCT00281437|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2006-10-11||||||January 2006|2006-01-01||||||||Interventional|||Health First-Study 2|Health First: Health and Psychological Outcomes of Physical Activity- Study 2|Completed||Phase 2/Phase 3|200||University of Alberta, Physical Education|||||f||||||||||||||2017-02-18 16:48:58.140213|2017-02-18 16:48:58.140213
NCT00281424|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-10-26|||June 2005||2005-06-01|October 2016|2016-10-01|January 2009|Actual|2009-01-01|January 2008|Actual|2008-01-01||Interventional|||Increasing Walking Following Cardiac Rehabilitation|Increasing Walking Following Completion of Cardiac Rehabilitation|Completed||Phase 2/Phase 3|100|Actual|University of Alberta, Physical Education||2|||f||||f||||||||No||2017-02-18 16:48:58.217076|2017-02-18 16:48:58.217076
NCT00281411|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2008-11-17|||January 2006||2006-01-01|November 2008|2008-11-01|January 2009|Anticipated|2009-01-01|||||Observational|||Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial|Follow-up Study of Endovascular Abdominal Aortic Aneurysm Treatment|Unknown status|Active, not recruiting|N/A|30|Anticipated|UMC Utrecht|||1||f||||||||||||||2017-02-18 16:48:58.321197|2017-02-18 16:48:58.321197
NCT00281398|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2013-06-19|||August 2005||2005-08-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Attitudes of Medical Trainees Towards Homeless Persons Presenting for Care in the Emergency Department|Attitudes of Medical Trainees Towards Homeless Persons Presenting for Care in the Emergency Department|Completed||N/A|100|Anticipated|St. Michael's Hospital, Toronto|||||f||||t||||||||||2017-02-18 16:48:58.405651|2017-02-18 16:48:58.405651
NCT00281385|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2006-10-10||||||January 2006|2006-01-01||||||||Interventional|||Health and Psychological Outcomes of Lifestyle Versus Traditional Physical Activity|Health and Psychological Outcomes of Lifestyle Versus Traditional Physical Activity- Study 1|Completed||Phase 1/Phase 2|300||University of Alberta, Physical Education|||||f||||||||||||||2017-02-18 16:48:58.585171|2017-02-18 16:48:58.585171
NCT00281372|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2008-07-28|||February 2006||2006-02-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|||||Observational|||Sexual Dysfunction and Dental Care|Association Between Sexual Dysfunction in Adults and Behavioral Dysfunctions in Achieving Proper Dental Care|Completed||N/A|448|Actual|Sheba Medical Center|||1||f||||||||||||||2017-02-18 16:48:58.660268|2017-02-18 16:48:58.660268
NCT00281359|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2014-11-04|||April 2003||2003-04-01|November 2014|2014-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Comparative Study of the Effectiveness of Treatment of Contractures With Mechanically Applied Stretch and Heat.|A Comparative Study of the Effectiveness of Treatment of Contractures With Mechanically Applied Stretch and Heat.|Completed||N/A|20|Actual|Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust||2|||f||||f||||||||||2017-02-18 16:48:58.739923|2017-02-18 16:48:58.739923
NCT00281346|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2016-07-15|||December 2005||2005-12-01|July 2016|2016-07-01|August 2008|Actual|2008-08-01|January 2008|Actual|2008-01-01||Interventional|||Non-invasive Diagnosis of Coronary Artery Stenoses by Doppler Echocardiography|Non-invasive Evaluation of Coronary Pathology by Transthoracic Doppler Echocardiography. A Comparative Study to Coronary Angiography.|Completed||N/A|110|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 16:48:58.840238|2017-02-18 16:48:58.840238
NCT00281333|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2011-08-28||||||August 2011|2011-08-01|October 2006|Actual|2006-10-01|||||Interventional|||"The Influence of Karate on Bleeding in Hemophilic Patients."|"The Influence of Karate on Bleeding in Hemophilic Patients."|Terminated||N/A|12|Anticipated|Sheba Medical Center||||logistics|f||||f||||||||||2017-02-18 16:48:58.938511|2017-02-18 16:48:58.938511
NCT00281320|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2015-02-20|2010-08-12||February 2006||2006-02-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)|A Randomized, Parallel Group, Multiple Dose, 6-Week Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Asenapine in Elderly Subjects With Psychosis.|Completed||Phase 3|122|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 16:48:59.01125|2017-02-18 16:48:59.01125
NCT00281307|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2009-02-03|||January 2006||2006-01-01|February 2009|2009-02-01|October 2008|Anticipated|2008-10-01|March 2008|Anticipated|2008-03-01||Interventional|||Treatment of Rhinitis With Intranasal Vitamin E|DBPCR Clinical Trial for Treatment of Rhinitis With Intranasal Vitamin E|Suspended||N/A|149|Anticipated|Penn State University||1||"Due to a substantial response to placebo an interim analysis indicated the need for a larger~   than expected study population to achieve the level of significance"|f||||||||||||||2017-02-18 16:48:59.521647|2017-02-18 16:48:59.521647
NCT00281294|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2008-08-02|||December 2005||2005-12-01|August 2008|2008-08-01|December 2006||2006-12-01|||||Interventional|||A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis|A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis|Terminated||Phase 2|40||Facet Biotech||||Terminated early because the first phase didn't meet the endpoint.|||||||||||||||2017-02-18 16:48:59.628225|2017-02-18 16:48:59.628225
NCT00281281|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-22|2012-12-04|||December 2005||2005-12-01|December 2012|2012-12-01|April 2007||2007-04-01|||||Interventional|||Pharmacokinetics of Vancomycin in Adults Receiving ECMO|Pharmacokinetics and Posology of Vancomycin in Adults Receiving ECMO|Completed||Phase 4|24|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:48:59.746031|2017-02-18 16:48:59.746031
NCT00281268|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2008-01-18||||||January 2008|2008-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Fluids and Catheters Treatment Trial (FACTT) - ARDS Clinical Research Network||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:48:59.833311|2017-02-18 16:48:59.833311
NCT00281255|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2013-06-17|||June 2003||2003-06-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy|Allopurinol and Cardiac Function Pilot Study in Idiopathic Dilated Cardiomyopathy|Withdrawn||Phase 1/Phase 2|0|Actual|University of Pennsylvania||2||Infeasible|f||||f||||||||||2017-02-18 16:48:59.920843|2017-02-18 16:48:59.920843
NCT00281242|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-01-28|||September 2005||2005-09-01|January 2016|2016-01-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Observational|||Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Innate and Adaptive Immunity in COPD Exacerbations: Severe AE-COPD Clinical Course Study|Completed||N/A|37|Actual|University of Michigan|||1||f||||f||||||||||2017-02-18 16:49:00.033429|2017-02-18 16:49:00.033429
NCT00281229|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-01-28|||September 2005||2005-09-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|September 2014|Actual|2014-09-01||Observational|||T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease|Innate and Adaptive Immunity in COPD Exacerbations: Surgical Volunteers|Completed||N/A|481|Actual|University of Michigan|||1||f||||f||||||||||2017-02-18 16:49:00.181523|2017-02-18 16:49:00.181523
NCT00281216|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-01-28|||September 2005||2005-09-01|January 2016|2016-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations|Innate and Adaptive Immunity in COPD Exacerbations: Prospective Cohort Study|Completed||N/A|10|Actual|University of Michigan|||1||f||||f||||||Samples Without DNA|"~     serum, sputum~   "|||2017-02-18 16:49:00.282561|2017-02-18 16:49:00.282561
NCT00281203|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2013-07-15|||September 2005||2005-09-01|July 2013|2013-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD|Innate and Adaptive Immunity in COPD Exacerbations: Bronchoscopies on Healthy Volunteers|Completed||N/A|32|Actual|University of Michigan|||1||f||||f||||||||||2017-02-18 16:49:00.37663|2017-02-18 16:49:00.37663
NCT00281190|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2014-12-12|||September 2005||2005-09-01|December 2014|2014-12-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function|Innate and Adaptive Immunity in COPD Exacerbations: Clinically-Indicated Bronchoscopies|Completed||N/A|32|Actual|University of Michigan|||2||f||||f||||||||||2017-02-18 16:49:00.491424|2017-02-18 16:49:00.491424
NCT00281177|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-07-11|||September 2002||2002-09-01|June 2006|2006-06-01|August 2009|Actual|2009-08-01|||||Interventional|||Center for Reducing Asthma Disparities - Northwestern University/Cook County Hospital Centers|Center for Reducing Asthma Disparities - Northwestern University/Cook County Hospital Centers|Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:49:03.409408|2017-02-18 16:49:03.409408
NCT00281151|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2014-12-10|||September 2002||2002-09-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers|Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers|Completed||N/A|180|Actual|Vanderbilt University|||1||f||||t||||||||||2017-02-18 16:49:03.478106|2017-02-18 16:49:03.478106
NCT00281138|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2013-11-05|||September 2002||2002-09-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Center for Reducing Asthma Disparities - Rhode Island/Puerto Rico Centers|Pediatric Asthma Disparities: Perceptions and Management|Completed||N/A|983|Actual|Rhode Island Hospital|||1||f||||f||||||||||2017-02-18 16:49:03.566205|2017-02-18 16:49:03.566205
NCT00281125|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2012-03-15|||January 2006||2006-01-01|March 2012|2012-03-01|August 2008|Actual|2008-08-01|September 2006|Actual|2006-09-01||Interventional|||Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer|A Two-Cohort Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin in Patients With Advanced Non-Small Cell Lung Cancers and Malignant Pleural Mesotheliomas|Terminated||Phase 1/Phase 2|20||Nevada Cancer Institute||||"Suspended due to data issues revealed at DSMB meeting. Planned amendment but was never~   submitted. Study was then closed."|f||||t||||||||||2017-02-18 16:49:03.640833|2017-02-18 16:49:03.640833
NCT00281112|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-07-11|||September 2002||2002-09-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Center for Reducing Asthma Disparities - Howard/Hopkins Centers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:49:03.739336|2017-02-18 16:49:03.739336
NCT00281099|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2010-07-30|2009-06-30||October 2004||2004-10-01|July 2010|2010-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|MVP||"Managed Ventricular Pacing (MVP) Trial"|"MVP Trial (Managed Ventricular Pacing (MVP) Versus Backup Ventricular Pacing at a Rate of 40 Beats Per Minute (VVI 40) Pacing Trial)"|Terminated||N/A|1031|Actual|Medtronic Cardiac Rhythm and Heart Failure||2||Inability to reach statistical significance toward primary endpoint|f||||t||||||||||2017-02-18 16:49:03.830809|2017-02-18 16:49:03.830809
NCT00281086|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-07-28|||September 2002||2002-09-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Center for Reducing Asthma Disparities - Harvard University/Boston Area Community Health Centers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:49:06.01484|2017-02-18 16:49:06.01484
NCT00280878|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-22|2016-01-13|||January 2006||2006-01-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma|A Pilot Study of Rituximab in Combination With Out-patient Based VGF/F-GIV Salvage Therapies for Relapsed/Refractory CD20+ Lymphomas|Completed||Phase 2|12|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 16:49:08.581976|2017-02-18 16:49:08.581976
NCT00281073|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2011-05-09|||March 2005||2005-03-01|May 2011|2011-05-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|ICE-CHIP||Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study|A Sequential Phase I - Phase II Pilot Study to Compare Cardiac Imaging Capabilities of ICE With TEE Followed by a Randomized Comparison of ICE Guided Cardioversion With Conventional Cardioversion Strategy in Patients With Atrial Fibrillation|Completed||Phase 1/Phase 2|95|Actual|EP MedSystems||2|||f||||t||||||||||2017-02-18 16:49:06.097748|2017-02-18 16:49:06.097748
NCT00281060|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2006-07-26|||June 2003||2003-06-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Vienna Absolute Trial: Balloon Angioplasty Versus Stenting in the Superficial Femoral Artery|Balloon Angioplasty Versus Stenting With Nitinol Stents in the Superficial Femoral Artery|Completed||Phase 4|110||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:49:06.238509|2017-02-18 16:49:06.238509
NCT00281047|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2006-01-26|||January 2006||2006-01-01|January 2006|2006-01-01|May 2006||2006-05-01|||||Interventional|||The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy|The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin|Unknown status|Recruiting|Phase 2/Phase 3|138||Hamamatsu University|||||f||||||||||||||2017-02-18 16:49:06.338986|2017-02-18 16:49:06.338986
NCT00281034|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2012-04-10|||September 2005||2005-09-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|||||Observational|||OASIS STUDY Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)|Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS Study)|Completed||N/A|2069|Actual|Kyorin Pharmaceutical Co.,Ltd|||1||f||||t||||||||||2017-02-18 16:49:06.448236|2017-02-18 16:49:06.448236
NCT00281021|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2014-11-06|2013-04-12||February 2006||2006-02-01|November 2014|2014-11-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer|Phase II Trial of Second Line Erlotinib + Digoxin in Patients With Non-Small Cell Lung Cancer|Terminated||Phase 2|26|Actual|James Graham Brown Cancer Center||1||Interim analysis revealed that only 1 patient had a partial response.|f||||t||||||||||2017-02-18 16:49:06.544853|2017-02-18 16:49:06.544853
NCT00281008|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-08-01|||February 2006||2006-02-01|August 2016|2016-08-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy|A Phase 2, Double-Blind, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Efficacy, and Pharmacokinetics of ISIS 301012 as Add-on Therapy in Heterozygous Familial Hypercholesterolemia Subjects|Completed||Phase 2|44|Actual|Kastle Therapeutics, LLC||4|||f||||||||||||||2017-02-18 16:49:06.797407|2017-02-18 16:49:06.797407
NCT00280995|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-08-01|||January 2006||2006-01-01|August 2016|2016-08-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy|A Phase 2, Open-Label, Dose Escalation Study to Assess the Safety and Efficacy of ISIS 301012 as Add-on Therapy in Homozygous Familial Hypercholesterolemia Subjects|Completed||Phase 2|12|Actual|Kastle Therapeutics, LLC||4|||f||||||||||||||2017-02-18 16:49:06.914823|2017-02-18 16:49:06.914823
NCT00280982|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2010-11-15|||January 2006||2006-01-01|November 2010|2010-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Dendritic Cell-based Immunotherapy in Mesothelioma|Vaccination With Autologous Dendritic Cells Pulsed With Tumor Lysate for Treatment of Patients With Malignant Pleural Mesothelioma|Completed||Phase 1|10|Actual|Erasmus Medical Center||1|||f||||||||||||||2017-02-18 16:49:07.032898|2017-02-18 16:49:07.032898
NCT00280969|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-22|2015-03-27|||September 2005||2005-09-01|March 2015|2015-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment|Open-label Randomized Multicenter Study of Once Daily Antiretroviral Treatment Regimen Comparing Ritonavir Boosted Atazanavir to Efavirenz|Completed||Phase 3|71|Actual|International Medical Center of Japan||2|||f||||t||||||||||2017-02-18 16:49:07.14449|2017-02-18 16:49:07.14449
NCT00280956|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-21|2016-06-14|||July 2002||2002-07-01|March 2012|2012-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease|A Phase III, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Antegren™ (Natalizumab) in Crohn's Disease Subjects Who Have Previously Participated in Antegren Crohn's Disease Studies|Completed||Phase 4|2000|Anticipated|Biogen||1|||f||||||||||||||2017-02-18 16:49:07.25527|2017-02-18 16:49:07.25527
NCT00280943|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2007-10-16|||January 2005||2005-01-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Interventional|||Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities|Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities Written for FDA Approved Medications for Osteoporosis Treatment.|Completed||Phase 2/Phase 3|64||Duke University|||||f||||||||||||||2017-02-18 16:49:07.352292|2017-02-18 16:49:07.352292
NCT00280930|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2007-01-18|||October 2005||2005-10-01|January 2007|2007-01-01||||||||Interventional|||Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer|A Randomized Feasibility Study of Letrozole in Postmenopausal Women at Increased Risk for Development of Breast Cancer as Evidenced by High Breast Density|Unknown status|Active, not recruiting|Phase 2|60||Dana-Farber Cancer Institute|||||||||||||||||||2017-02-18 16:49:07.464268|2017-02-18 16:49:07.464268
NCT00280917|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-23|2015-03-10|2015-02-24||June 2006||2006-06-01|June 2011|2011-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Daily CF101 Administered Orally, When Added to Weekly Methotrexate, in Patients With Active Rheumatoid Arthritis|Completed||Phase 2|254|Actual|Can-Fite BioPharma|||||||||||||||||||2017-02-18 16:49:07.578104|2017-02-18 16:49:07.578104
NCT00280904|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2013-02-05|2010-11-17||January 2006||2006-01-01|February 2013|2013-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus|A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus|Completed||Phase 4|433|Actual|Codman & Shurtleff|||1||f||||f||||||||||2017-02-18 16:49:08.036103|2017-02-18 16:49:08.036103
NCT00280891|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2013-01-24|||January 2006||2006-01-01|July 2006|2006-07-01|June 2006|Actual|2006-06-01|||||Observational|||Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer|Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer|Completed||N/A|100|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 16:49:08.500571|2017-02-18 16:49:08.500571
NCT00280865|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2006-07-27|||April 2002||2002-04-01|July 2006|2006-07-01|June 2003||2003-06-01|||||Interventional|||GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes|Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes|Completed||Phase 2|500||AstraZeneca|||||||||||||||||||2017-02-18 16:49:08.697339|2017-02-18 16:49:08.697339
NCT00280176|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-02-12|||April 2003||2003-04-01|February 2012|2012-02-01|September 2010|Actual|2010-09-01|November 2008|Actual|2008-11-01||Interventional|||Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer|Phase I Study of PS-341 in Combination With 5-Fluorouracil and External Beam Radiotherapy For The Treatment Of Locally Advanced And Metastatic Rectal Cancer|Completed||Phase 1|11|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:49:08.89739|2017-02-18 16:49:08.89739
NCT00280163|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2016-02-11|||November 2005||2005-11-01|February 2016|2016-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Genomics and Postoperative Atrial Fibrillation|Genomics and Postoperative Atrial Fibrillation|Completed||N/A|336|Actual|University of Pittsburgh|||1||f||||||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 16:49:09.002609|2017-02-18 16:49:09.002609
NCT00280150|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2013-02-14|||January 2006||2006-01-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2012|Actual|2012-01-01||Interventional|||Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer|Phase I/II Trial of Induction Carboplatin/Paclitaxel With Bevacizumab Followed by Concurrent Thoracic Conformal Radiation Therapy With Carboplatin/Paclitaxel, Bevacizumab and Erlotinib in Stage IIIA/B Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|48|Actual|UNC Lineberger Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 16:49:09.082158|2017-02-18 16:49:09.082158
NCT00280137|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2016-04-08|||June 2004||2004-06-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|November 2012|Actual|2012-11-01||Observational|||Health-related Quality of Life Measure in Pediatric Lupus|Health-related Quality of Life Measure in Pediatric Lupus|Completed||N/A|31|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-02-18 16:49:09.210732|2017-02-18 16:49:09.210732
NCT00280111|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2008-07-01|||January 2005||2005-01-01|July 2008|2008-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants|Reactogenicity and Immunogenicity of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Healthy Non-Malnourished Infants 8-12 Weeks of Age|Completed||Phase 1|90|Actual|Society for Applied Studies||3|||f||||t||||||||||2017-02-18 16:49:09.323072|2017-02-18 16:49:09.323072
NCT00280098|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2009-12-04|||January 2006||2006-01-01|December 2009|2009-12-01||||October 2007|Actual|2007-10-01||Interventional|||Docetaxel in the Treatment of Hormone Refractory Prostate Cancer|Phase IV Study of Safety and Efficacy of Docetaxel in Combination With Prednisone in Advanced Hormone Refractory Prostate Cancer Treatment|Completed||Phase 4|30|Anticipated|Sanofi||1|||f||||||||||||||2017-02-18 16:49:09.446582|2017-02-18 16:49:09.446582
NCT00280085|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2009-08-06|||December 2005||2005-12-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|||||Interventional|||The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.|Pancreatic Beta-Cell Mass And Function Quantification By Means Of Perfusion Imaging|Terminated||N/A|29|Actual|Pfizer||||Explanation provided in detailed descriptiong section of record.|f||||||||||||||2017-02-18 16:49:09.547931|2017-02-18 16:49:09.547931
NCT00280072|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-11-29|||January 2006||2006-01-01|November 2012|2012-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study to Evaluate the Safety and Efficacy of the Renal Assist Device in Patients With Acute Renal Failure|A Multi-Center, Randomized, Controlled, Double-Blind, Phase II Study To Assess Safety and Efficacy With the Renal Assist Device (RAD) in Patients With Acute Renal Failure|Terminated||Phase 2|||RenaMed Biologics|||||||||||||||||||2017-02-18 16:49:09.651939|2017-02-18 16:49:09.651939
NCT00280059|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2015-03-04|2010-12-16||August 2006||2006-08-01|March 2015|2015-03-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy|A Randomized, Comparative, Double-Blind, Parallel-Group, Multicenter, Monotherapy, Study Of Pregabalin (Lyrica) And Lamotrigine (Lamictal) In Patients With Newly Diagnosed Partial Seizures|Completed||Phase 3|660|Actual|Pfizer|Cox proportional hazards model for time to event (TTE) analyses; three summary statistics were not generated as median TTE will not exist if survival function (Kaplan-Meier product limit estimates) does not fall below 0.5 (post-hoc analysis).|2|||f||||f||||||||||2017-02-18 16:49:09.775558|2017-02-18 16:49:09.775558
NCT00280046|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2017-01-05|||November 2003||2003-11-01|January 2017|2017-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Biphasic Insulin Aspart 30 on Glycaemic Control in Subjects With Type 2 Diabetes|Completed||Phase 3|307|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:49:11.358044|2017-02-18 16:49:11.358044
NCT00280033|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2013-09-12|||February 2006||2006-02-01|January 2009|2009-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||H5 Adult - Chiron Study of Bird Flu Vaccine|A Randomized, Placebo-Controlled, Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine Given Alone or Combined With Adjuvants in Healthy Adults|Completed||Phase 1/Phase 2|394|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||9|||f||||||||||||||2017-02-18 16:49:11.472574|2017-02-18 16:49:11.472574
NCT00280020|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-07-09|||April 2006||2006-04-01|July 2012|2012-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Behavioral Treatment of Insomnia in Aging|Aging: Cytokine Mechanisms and Treatment of Insomnia|Completed||N/A|123|Actual|University of California, Los Angeles||3|||f||||t||||||||||2017-02-18 16:49:11.600552|2017-02-18 16:49:11.600552
NCT00280007|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2010-04-21|||January 2006||2006-01-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma|AVATACE-1: Bevacizumab (Avastin®) as Inhibitor of Collateral Tumor Vessel Growth During Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma (HCC) a Pilot Trial|Terminated||Phase 2|32|Actual|Medical University of Vienna||2||Safety concerns in the treatment arm|f||||f||||||||||2017-02-18 16:49:11.726069|2017-02-18 16:49:11.726069
NCT00280722|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2006-01-20|||January 2006||2006-01-01|January 2006|2006-01-01|November 2006||2006-11-01|||||Interventional|||RAW Study Version 3.4|Does Increasing Research Awareness Impact on Accrual? A Feasibility Study. Protocol Version 3.4 Dated April 2005.|Unknown status|Not yet recruiting|N/A|400||Oxford University Hospitals NHS Trust|||||f||||||||||||||2017-02-18 16:49:14.674657|2017-02-18 16:49:14.674657
NCT00279994|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2008-05-06|||December 2005||2005-12-01|May 2008|2008-05-01|May 2009|Anticipated|2009-05-01|||||Interventional|EXITPAD||(Cost) Effectiveness Study of Exercise Therapy in Patients With Peripheral Arterial Disease|"Exercise Therapy in Patients With Peripheral Arterial Disease: the Costs and Effectiveness of Physiotherapeutic Supervision With or Without Therapy Feedback Versus a go Home and Walk Advice"|Unknown status|Active, not recruiting|N/A|300|Anticipated|Atrium Medical Center|||||f||||||||||||||2017-02-18 16:49:11.856989|2017-02-18 16:49:11.856989
NCT00279981|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2008-12-10|||November 2003||2003-11-01|December 2008|2008-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics|TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics|Completed||N/A|3100||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:49:11.98252|2017-02-18 16:49:11.98252
NCT00279968|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2007-12-26|||February 2004||2004-02-01|December 2007|2007-12-01|January 2006||2006-01-01|||||Observational|||INSIGHTS ICD Registry|Investigating Significant ICD Heart Therapies Registry Study (INSIGHTS ICD Registry)|Completed||N/A|1326||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:49:12.169883|2017-02-18 16:49:12.169883
NCT00279955|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-06-11|2011-07-20||June 2004||2004-06-01|June 2012|2012-06-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Observational|||PARTNERS HF: Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure|Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure|Completed||N/A|1024|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||||||||||||2017-02-18 16:49:12.298464|2017-02-18 16:49:12.298464
NCT00279942|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-01-04|||May 2006||2006-05-01|January 2012|2012-01-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Effect of Revival Soy on Fibromyalgia Pain|Effect of Revival Soy on Fibromyalgia Pain|Completed||N/A|50|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:49:13.185047|2017-02-18 16:49:13.185047
NCT00279929|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2011-05-20|||July 2002||2002-07-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||DHEA Replacement in Adrenalectomized/Hypoadrenal Patients|Assessing the Effects of Dehydroepiandrosterone Replacement on the Mood of Adrenalectomised/Hypoadrenal Subjects|Completed||N/A|32||Mayo Clinic|||||f||||||||||||||2017-02-18 16:49:13.309177|2017-02-18 16:49:13.309177
NCT00280852|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2011-11-18|||January 2006||2006-01-01|July 2011|2011-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Review of Multimodality Management of Anaplastic Thyroid Cancer|A Retrospective Review of Multimodality Management of Anaplastic Thyroid Cancer|Completed||N/A|5|Actual|AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 16:49:13.394438|2017-02-18 16:49:13.394438
NCT00280839|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-11||||||April 2012|2012-04-01||||||||Interventional|||Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation|A Double-Blind, Placebo-Controlled, 11-Week Trial of Topiramate as an Aid to Smoking Cessation|Completed||Phase 3|87|Actual|Lindner Center of HOPE||2|||f||||||||||||||2017-02-18 16:49:13.472892|2017-02-18 16:49:13.472892
NCT00280826|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-21|2011-01-28|2010-07-15||January 2006||2006-01-01|January 2011|2011-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efalizumab to Treat Uveitis|Treatment of Non-Infectious Intermediate and Posterior Uveitis Associated Macular Edema With Humanized Anti-CD11a Antibody Therapy|Completed||Phase 1|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 16:49:13.578218|2017-02-18 16:49:13.578218
NCT00280813|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2008-10-24|||March 2004||2004-03-01|October 2008|2008-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Alcohol Use Disorders in Schizophrenia|Treatment of Alcohol Use Disorders in Schizophrenia|Completed||N/A|54|Actual|University of Maryland||1|||f||||f||||||||||2017-02-18 16:49:13.869857|2017-02-18 16:49:13.869857
NCT00280800|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2014-05-14|||January 2006||2006-01-01|May 2014|2014-05-01|March 2014|Actual|2014-03-01|December 2013|Actual|2013-12-01||Interventional|||Effectiveness of Auto-adjusted Continuous Positive Airway Pressure for Long-term Treatment of Sleep Apnea|Effectiveness of Auto-adjusted Continuous Positive Airway Pressure for Long-term Treatment of Obstructive Sleep Apnea Syndrome|Completed||N/A|208|Actual|University of Zurich||2|||f||||f||||||||||2017-02-18 16:49:13.989733|2017-02-18 16:49:13.989733
NCT00280787|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2013-02-01|||November 2003||2003-11-01|February 2013|2013-02-01|October 2010|Actual|2010-10-01|January 2006|Actual|2006-01-01||Interventional|||Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim|LCCC 0215: Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim Support Followed by Conformal Radiotherapy and Paclitaxel/Carboplatin/ZD1839 in Locally Advanced Unresectable Stage IIIA/B Non-Small Cell Carcinoma of the Lung|Completed||Phase 2|24|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:49:14.110148|2017-02-18 16:49:14.110148
NCT00280774|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2008-01-23|||March 2006||2006-03-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|||||Interventional|||Memantine for Corticosteroid-Induced Mood and Declarative Memory Changes|Memantine for Corticosteroid-Induced Mood and Declarative Memory Changes: A Pilot Study|Completed||Phase 4|20||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 16:49:14.220983|2017-02-18 16:49:14.220983
NCT00280761|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2016-07-01|||December 2003||2003-12-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy|A Biologic Study of Global Gene Expression, NF-Kappa B and p53 in Adenocarcinoma of the Rectum.|Recruiting||N/A|60|Anticipated|UNC Lineberger Comprehensive Cancer Center|||1||f||||t||||||Samples With DNA|"~     Adenocarcinoma of the Rectum~   "|||2017-02-18 16:49:14.316625|2017-02-18 16:49:14.316625
NCT00280748|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2016-01-20|||May 2005||2005-05-01|January 2016|2016-01-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|NRR||Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer|A Phase II Study of Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Concurrent Whole Brain Radiation Therapy and Pemetrexed|Completed||Phase 2|10|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:49:14.442769|2017-02-18 16:49:14.442769
NCT00280735|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2016-01-20|||May 2004||2004-05-01|January 2016|2016-01-01||||July 2011|Actual|2011-07-01||Interventional|NRR||Carboplatin and Docetaxel After Surgery in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Phase II Trial Exploring the Feasibility of Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA Non-Small Cell Lung Cancer|Completed||Phase 2|75|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:49:14.555472|2017-02-18 16:49:14.555472
NCT00280709|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2011-08-09|||January 2006||2006-01-01|December 2010|2010-12-01|August 2010|Actual|2010-08-01|October 2008|Actual|2008-10-01||Interventional|||Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction|Covered Versus Uncovered Metal Stents for Management of Distal Malignant Biliary Obstruction? Results of a Randomized Prospective Study.|Completed||Phase 4|400|Actual|University Hospital, Linkoeping||2|||f||||t||||||||||2017-02-18 16:49:14.776097|2017-02-18 16:49:14.776097
NCT00280696|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2015-02-10|||November 2005||2005-11-01|February 2015|2015-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures|A Double-blind, Randomized, Placebo-controlled 5 Parallel Groups, Confirmatory Trial on the Efficacy and Safety of Levetiracetam Used as add-on Therapy at Doses of 0.5 to 3 g/Day in Patients From 16 to 65 Years With Epilepsy With Partial Onset Seizures Under Treatment With 1 to 3 Anti-epileptic Drug(s)|Completed||Phase 3|352|Actual|UCB Pharma||5|||f||||f||||||||||2017-02-18 16:49:14.88205|2017-02-18 16:49:14.88205
NCT00280683|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2013-04-26|2012-12-06||December 2004||2004-12-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma|Phase 2 Study: GCRC: Effects of L-arginine Supplementation on Exhaled Nitric Oxide and Clinical Exacerbations in Adults With Moderate to Severe Asthma|Completed||Phase 2|20|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 16:49:15.042497|2017-02-18 16:49:15.042497
NCT00280670|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2012-03-28|||January 2005||2005-01-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|BIACA||CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS||Completed||Phase 2|20|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 16:49:15.456389|2017-02-18 16:49:15.456389
NCT00280657|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2014-12-17|||March 2004||2004-03-01|December 2014|2014-12-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa|Multicenter, Double-blind, Double-dummy, Randomized Parallel Group Study to Evaluate the Safety and Efficacy of SH D 00659 E for 6 Treatment Cycles in Female Patients With Acne Papulopustulosa in Comparison to SH D 00659 G and Placebo.|Completed||Phase 3|1326|Actual|Bayer||3|||f||||f||||||||||2017-02-18 16:49:15.571457|2017-02-18 16:49:15.571457
NCT00280644|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2011-01-10|||April 2004||2004-04-01|January 2011|2011-01-01||||||||Interventional|||Leflunomide in Rheumatoid Arthritis|Efficacy of Leflunomide on Joint Inflammation and Destruction of Joint Integrity in Active Rheumatoid Arthritis (RA) Patients|Completed||Phase 4|60||Sanofi|||||f||||f||||||||||2017-02-18 16:49:15.740874|2017-02-18 16:49:15.740874
NCT00280631|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2012-05-30|||February 2006||2006-02-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)|Phase 1-2a Dose-Ranging Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)|Completed||Phase 1/Phase 2|49|Actual|Telik||1|||f||||f||||||||||2017-02-18 16:49:15.822925|2017-02-18 16:49:15.822925
NCT00280618|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2009-09-14|||July 2004||2004-07-01|September 2009|2009-09-01||||November 2006|Actual|2006-11-01||Interventional|||Oxaliplatin in Unresectable Hepatocellular Carcinoma|Phase II Study of Eloxatin + 5-Fluorouracil/Leucovorin in Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|||Sanofi|||||f||||||||||||||2017-02-18 16:49:15.924121|2017-02-18 16:49:15.924121
NCT00280605|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2010-08-30|||August 2005||2005-08-01|August 2010|2010-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||ALF-ONE : ALFuzosin ONcE Daily|Study of the Outcome of Patients With Lower Urinary Symptoms Suggestive of Benign Prostatic Hyperplasia and Treated With Alfuzosin 10 mg Once Daily for 3 Months in China|Completed||Phase 4|200||Sanofi|||||f||||||||||||||2017-02-18 16:49:15.99889|2017-02-18 16:49:15.99889
NCT00280592|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2012-05-18|||January 2006||2006-01-01|May 2008|2008-05-01|October 2008|Actual|2008-10-01|March 2008|Actual|2008-03-01||Interventional|CANNEBERGE||Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients|Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.|Completed||Phase 3|171|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-02-18 16:49:16.086576|2017-02-18 16:49:16.086576
NCT00280579|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2014-11-06|||January 2006||2006-01-01|November 2014|2014-11-01|January 2007||2007-01-01|||||Observational|||Cyanide Poisoning in Fire Victims||Withdrawn||N/A|0|Actual|Rigshospitalet, Denmark|||1|Not sufficient time to conduct the study|f||||||||||||||2017-02-18 16:49:16.202884|2017-02-18 16:49:16.202884
NCT00280566|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2010-01-05|2009-05-06||December 2005||2005-12-01|January 2010|2010-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)|A Phase 3, Randomized, 6-Month, Double-Blind Trial in Subjects With Bipolar I Disorder to Evaluate the Continued Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer (vs Placebo Plus a Mood Stabilizer) Following a Minimum of 2 Months of Response to Open-Label Treatment With Both Agents|Completed||Phase 3|584|Actual|Pfizer|This is a maintenance of effect design using a survival analysis methodology. In such a design it may be difficult to interpret timepoint by timepoint treatment group comparisons in MRS, CGI-S, CGI-I, MADRS, and PANSS.|2|||f||||f||||||||||2017-02-18 16:49:16.300245|2017-02-18 16:49:16.300245
NCT00280553|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2012-05-14|||April 2005||2005-04-01|May 2012|2012-05-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||A Pilot Study of Bupivacaine Infusion in Abdominal Surgery|A Pilot Study of Bupivacaine Infusion in Abdominal Surgery|Unknown status|Recruiting|Phase 2|60|Anticipated|McMaster University||3|||f||||||||||||||2017-02-18 16:49:17.56637|2017-02-18 16:49:17.56637
NCT00280540|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2010-11-05|||December 2005||2005-12-01|March 2008|2008-03-01||||August 2006|Actual|2006-08-01||Interventional|||Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension|A 6-week Treatment Regimen Study to Evaluate the Efficacy of Initial High Dose Valsartan Monotherapy (160 mg) or Combo Therapy (Valsartan + Hydrochlorothiazide, 160/12.5 mg) to Conventional Low-dose Valsartan Monotherapy (80 mg) in Managing Patients With Hypertension|Completed||Phase 4|648||Novartis|||||||||||||||||||2017-02-18 16:49:17.678869|2017-02-18 16:49:17.678869
NCT00280527|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2011-12-16|||September 2006||2006-09-01|December 2011|2011-12-01|September 2008|Actual|2008-09-01|||||Observational|||Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients.|Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients.|Completed||N/A|43|Actual|Northwestern University|||1||f||||f||||||||||2017-02-18 16:49:17.767359|2017-02-18 16:49:17.767359
NCT00280514|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2010-08-03|||January 2006||2006-01-01|November 2005|2005-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration|Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration|Completed||Phase 4|20|Anticipated|Medical University of Vienna|||||f||||f||||||||||2017-02-18 16:49:17.853442|2017-02-18 16:49:17.853442
NCT00280501|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2008-07-08|||August 2005||2005-08-01|July 2008|2008-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions|Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions|Completed||N/A|21|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-02-18 16:49:17.976117|2017-02-18 16:49:17.976117
NCT00280488|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2010-06-24|||May 2005||2005-05-01|June 2010|2010-06-01|April 2011|Anticipated|2011-04-01|April 2011|Anticipated|2011-04-01||Interventional|||Enhanced Motivational Interviewing With Alcohol Positive Trauma Patients|Enhanced MI With Alcohol Positive Trauma Patients|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|Brown University||3|||f||||t||||||||||2017-02-18 16:49:18.086986|2017-02-18 16:49:18.086986
NCT00280475|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-09-20|||January 2006||2006-01-01|September 2016|2016-09-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis|Randomized Phase III Trial of Postoperative Whole Brain Radiation Therapy Compared With Salvage Stereotactic Radiosurgery in Patients With One to Four Brain Metastasis: Japan Clinical Oncology Group Study (JCOG 0504)|Completed||Phase 3|270|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 16:49:18.198865|2017-02-18 16:49:18.198865
NCT00280462|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2008-07-08|||August 2005||2005-08-01|July 2008|2008-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade|Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade|Completed||N/A|21|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-02-18 16:49:18.322732|2017-02-18 16:49:18.322732
NCT00280449|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2006-01-20|||March 2006||2006-03-01|November 2005|2005-11-01|February 2007||2007-02-01|||||Interventional|||Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDS|Two Approaches to Providing HIV/AIDS Services in the Community to People Living With HIV/AIDS (PHAs): The Comparative Impact on Quality of Life, Access to and Expenditures for All Health and Social Services|Unknown status|Not yet recruiting|Phase 1|120||McMaster University|||||f||||||||||||||2017-02-18 16:49:18.424053|2017-02-18 16:49:18.424053
NCT00280436|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2015-04-14|||January 2006||2006-01-01|April 2015|2015-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia|A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia|Completed||Phase 2|122|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 16:49:18.510573|2017-02-18 16:49:18.510573
NCT00280423|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2015-04-14|||January 2006||2006-01-01|April 2015|2015-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia|A 28 Day, Polysomnographic and Subjective Assessment of GW679769 for the Treatment of Primary Insomnia: A Randomized, Double-blind, Parallel-Group, Placebo-Controlled Trial.|Completed||Phase 2|342|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 16:49:18.693547|2017-02-18 16:49:18.693547
NCT00280410|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2010-01-28|||February 2006||2006-02-01|January 2010|2010-01-01||||October 2006|Actual|2006-10-01||Interventional|||Study Investigating the Effect of E7337 on Tumor Like Lesions in Computed Tomography (CT) of the Liver|Multicenter, Randomized, Open-Label Study Investigating The Superiority Of The Contrast Enhancement Effect Of E7337 On Tumor Like Lesion In The Dynamic CT Of The Liver Of Patients With Tumor Like Lesions In The Liver|Completed||Phase 2/Phase 3|192||Eisai Inc.|||||f||||||||||||||2017-02-18 16:49:18.854207|2017-02-18 16:49:18.854207
NCT00280397|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2016-08-29|2015-02-21||January 2006||2006-01-01|August 2016|2016-08-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors|An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors|Completed||Phase 1|27|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 16:49:18.941595|2017-02-18 16:49:18.941595
NCT00280384|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2013-04-23|2013-03-12||January 2006||2006-01-01|April 2013|2013-04-01||||August 2006|Actual|2006-08-01||Interventional|||An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects|An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects|Completed||Phase 2|48|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:49:21.998702|2017-02-18 16:49:21.998702
NCT00280371|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2010-11-09|||January 2006||2006-01-01|February 2008|2008-02-01|May 2007|Actual|2007-05-01|July 2006|Actual|2006-07-01||Interventional|||A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD|A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg/0.5 mL Delivered by OMRON MicroAir NE-U22V Nebulizer in the Treatment of Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|345||Dey|||||||||||||||||||2017-02-18 16:49:22.814525|2017-02-18 16:49:22.814525
NCT00280358|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2008-03-05||||||March 2008|2008-03-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.||Completed||Phase 1|30||Dey|||||||||||||||||||2017-02-18 16:49:23.20735|2017-02-18 16:49:23.20735
NCT00280345|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2011-07-08|||February 2006||2006-02-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|September 2007|Actual|2007-09-01||Interventional|||Autoimmune Dysregulation in Pigmentary Glaucoma|Autoimmune Dysregulation in Pigmentary Glaucoma|Completed||N/A|23|Actual|University of Oklahoma||1|||f||||t||||||||||2017-02-18 16:49:23.302051|2017-02-18 16:49:23.302051
NCT00280332|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2008-05-09|||March 2006||2006-03-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening Colonoscopy|A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening Colonoscopy|Completed||N/A|560|Actual|Chinese University of Hong Kong|||2||f||||f||||||||||2017-02-18 16:49:23.398922|2017-02-18 16:49:23.398922
NCT00280319|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-20|2006-01-20|||July 2005||2005-07-01|January 2006|2006-01-01|February 2006||2006-02-01|||||Interventional|||Study of Treatments for Depression Among Displaced Adolescents in Northern Uganda.|Randomized Controlled Study of Non-Pharmacologic Treatments for Depression Among Displaced Adolescents in Northern Uganda.|Unknown status|Active, not recruiting|N/A|600||Boston University|||||f||||||||||||||2017-02-18 16:49:23.522793|2017-02-18 16:49:23.522793
NCT00280306|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-06-02|||November 2005||2005-11-01|June 2015|2015-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||White Matter Fiber Tracking and Assessment of White Matter Integrity in the Cervical Spinal Cord|White Matter Fiber Tracking and Assessment of White Matter Integrity in the Cervical Spinal Cord - Pilot Study|Completed||N/A|35|Actual|Weill Medical College of Cornell University|||1||f||||||||||||||2017-02-18 16:49:23.606994|2017-02-18 16:49:23.606994
NCT00280293|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2013-07-30|2013-05-13||March 2006||2006-03-01|July 2013|2013-07-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency|A Randomized, Double-blind, Placebo-controlled, Trial of Lamotrigine add-on Therapy in Outpatients With Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence|Completed||Phase 4|112|Actual|University of Texas Southwestern Medical Center|The weekly UDS (rather than thrice weekly as is customary in cocaine trials) design feature decreased our number of observations and statistical power, and did not provide us with a complete picture of cocaine use between weekly visits.|2|||f||||f||||||||||2017-02-18 16:49:23.701985|2017-02-18 16:49:23.701985
NCT00280280|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-01-19|||February 2006||2006-02-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Botox vs. Baclofen for Upper Limb Spasticity|Double-blind Comparison of Botox Versus Baclofen for the Treatment of Subjects With Upper Limb Spasticity - Pilot Study|Terminated||Phase 1|8|Actual|Vanderbilt University||1||low patient accrual|f||||f||||||||||2017-02-18 16:49:24.186461|2017-02-18 16:49:24.186461
NCT00280267|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2009-02-03|||August 2004||2004-08-01|February 2009|2009-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Testosterone Therapy After Hip Fracture in Elderly Women|Testosterone Therapy After Hip Fracture in Elderly Women|Completed||Phase 2|15|Actual|Washington University School of Medicine||2|||||||t||||||||||2017-02-18 16:49:24.298599|2017-02-18 16:49:24.298599
NCT00280254|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2006-01-19|||November 1999||1999-11-01|January 2006|2006-01-01|December 2004||2004-12-01|||||Interventional|||A Hemodynamically Oriented Echocardiography-Based Strategy in the Treatment of Congestive Heart Failure|A Hemodynamically Oriented Echocardiography-Based Strategy in the Treatment of Congestive Heart Failure|Terminated||Phase 2|102||Federal University of Rio Grande do Sul|||||f||||||||||||||2017-02-18 16:49:24.407769|2017-02-18 16:49:24.407769
NCT00280241|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2016-01-05|2016-01-05||June 2004||2004-06-01|January 2016|2016-01-01|January 2013|Actual|2013-01-01|February 2008|Actual|2008-02-01||Interventional|||Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia|Phase II Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia|Completed||Phase 2|65|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:49:24.493804|2017-02-18 16:49:24.493804
NCT00280228|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2011-05-25|||January 2006||2006-01-01|May 2011|2011-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Home Based Treatment for Drug Use in Early Adolescents|Home-based Behavioral Therapy (HBT): Psychosocial Intervention Project for Early Adolescents With Pre- or Early Substance Use Disorder: Phase II|Completed||Phase 2|36|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 16:49:24.803616|2017-02-18 16:49:24.803616
NCT00280215|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2015-04-06|||December 2007||2007-12-01|April 2015|2015-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria|Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria|Withdrawn||Phase 3|0|Actual|Mayo Clinic||2||Inadequate number of patients, lack of funding|f||||f||||||||||2017-02-18 16:49:24.910877|2017-02-18 16:49:24.910877
NCT00280202|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2015-12-01|||June 1996||1996-06-01|December 2015|2015-12-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|||Detection of Genetic Markers of Lung Cancer|Detection of Genetic Markers of Lung Cancer Initiation and Progression|Recruiting||N/A|4000|Anticipated|University of Pittsburgh|||1||f||||||||||Samples With DNA|"~     Blood, tissue, and lymph nodes~   "|||2017-02-18 16:49:25.033117|2017-02-18 16:49:25.033117
NCT00280189|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2015-04-03|||September 2003||2003-09-01|February 2014|2014-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Study of Outcomes of Radiofrequency Ablation of Lung Tumors|A Prospective Study of Outcomes of Radiofrequency Ablation of Lung Tumors|Suspended||N/A|72|Anticipated|University of Pittsburgh|||1||f||||||||||||||2017-02-18 16:49:25.409444|2017-02-18 16:49:25.409444
NCT00279916|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2011-07-20|2011-07-20||September 2005||2005-09-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays|Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays: a Randomized Placebo-controlled Study|Completed||Phase 3|146|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:49:25.519348|2017-02-18 16:49:25.519348
NCT00279903|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-11-06|||November 2005||2005-11-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Is Botox Effective in Relieving Pain From Knee Osteoarthritis?|Intra-articular Botulinum Toxin Type-A in Knee Osteoarthritis - a Randomized, Cortisone Controlled, Double Blind Study.|Completed||Phase 1|62|Actual|Mayo Clinic||3|||f||||t||||||||||2017-02-18 16:49:25.959729|2017-02-18 16:49:25.959729
NCT00279890|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2011-05-20|||July 2005||2005-07-01|May 2011|2011-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Topical Agent for Treatment of Red Skin|Proof of Concept Trial:SR-01 for the Treatment of Rosacea|Completed||Phase 1|20||Mayo Clinic|||||f||||||||||||||2017-02-18 16:49:26.070796|2017-02-18 16:49:26.070796
NCT00279877|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2016-08-17|||May 2005||2005-05-01|August 2016|2016-08-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Cost Effectiveness and Efficacy of Kyphoplasty and Vertebroplasty Trial|Cost Effectiveness and Efficacy of Kypho and Vertebro Plasty Trial|Completed||Phase 3|112|Actual|University of Virginia||2|||f||||||||||||||2017-02-18 16:49:26.153293|2017-02-18 16:49:26.153293
NCT00279864|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2015-04-29|||September 2005||2005-09-01|April 2015|2015-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection|Prolonged Oral Levofloxacin-Rifampin for Staphylococcus Aureus Prosthetic Joint Infection (PJI) Treated With Debridement And Retention Of Components: A Prospective Observational Cohort Study. Mayo PJI Study Group (MPSG)*|Completed||N/A|15|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 16:49:26.248794|2017-02-18 16:49:26.248794
NCT00279851|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2006-09-06|||February 2006||2006-02-01|September 2006|2006-09-01|August 2007||2007-08-01|||||Observational|||Blood Sugars in Children With Idiopathic Seizures.|Prevalence of Hypoglycemia and/or Hyperinsulinism/Hyperammonemia Syndrome in Patients With Idiopathic Seizures.|Unknown status|Recruiting|N/A|225||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 16:49:26.333601|2017-02-18 16:49:26.333601
NCT00279838|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2011-03-22|||June 2004||2004-06-01|March 2011|2011-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Computer Assisted Total Knee Replacement|Computer Assisted Navigation in Total Knee Arthroplasty|Completed||Phase 4|200|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 16:49:26.425585|2017-02-18 16:49:26.425585
NCT00279825|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2017-01-31|||January 2006||2006-01-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Compare IPX054 200 mg and 250 mg to CD-LD IR 200 (2x100) mg Tablets and CD-LD CR 200 mg Tablet in Subjects With Parkinson's Disease|Completed||Phase 2|16|Actual|IMPAX Laboratories, Inc.||4|||f||||f||||||||No||2017-02-18 16:49:26.514965|2017-02-18 16:49:26.514965
NCT00279812|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2011-03-18|||April 2005||2005-04-01|March 2011|2011-03-01|August 2008|Actual|2008-08-01|||||Interventional|||Selenium and Immune Function|Selenium and Immune Function|Completed||N/A|144|Anticipated|Institute of Food Research|||||f||||||||||||||2017-02-18 16:49:26.647552|2017-02-18 16:49:26.647552
NCT00279799|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2013-11-18|||February 2005||2005-02-01|September 2013|2013-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||HIV Prevention for African American Teens|HIV Prevention Maintenance for African American Teens|Completed||Phase 3|701|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:49:26.742626|2017-02-18 16:49:26.742626
NCT00279786|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2009-07-27|||December 2005||2005-12-01|July 2009|2009-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||B2-Adrenergic Receptor Polymorphisms|B2-Adrenergic Receptor Polymorphisms: Implications For The Treatment Of Status Asthmaticus In Children|Completed||Phase 4|126|Actual|Connecticut Children's Medical Center|||1||f||||f||||||||||2017-02-18 16:49:26.876998|2017-02-18 16:49:26.876998
NCT00279773|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2010-06-29|||September 2004||2004-09-01|June 2010|2010-06-01||||October 2007|Actual|2007-10-01||Interventional|||Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia|A Phase I Dose Escalating Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia|Terminated||Phase 1|34|Actual|Novartis||2||Study was stopped due to time dependent drug accumulation|f||||||||||||||2017-02-18 16:49:26.980853|2017-02-18 16:49:26.980853
NCT00279760|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2016-09-15||||||September 2016|2016-09-01||||March 2002|Actual|2002-03-01||Interventional|||Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis|A Pilot, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Preliminary Clinical Activity and Immunogenicity of Multiple Doses of LEA29Y and CTLA4Ig Administered Intravenously to Subjects With Rheumatoid Arthritis|Completed||Phase 1/Phase 2|210||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 16:49:27.083685|2017-02-18 16:49:27.083685
NCT00279747|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2013-10-31|||September 2000||2000-09-01|October 2013|2013-10-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)|A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension 0.25mg/kg and 0.125 mg/kg Administered Once Daily in Comparison to Naproxen Oral Suspension 5mg/kg Administered Twice Daily in Children With Juvenile Rheumatoid Arthritis.|Completed||Phase 3|226||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:49:27.238058|2017-02-18 16:49:27.238058
NCT00279734|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-19|2011-04-11|||August 2004||2004-08-01|April 2011|2011-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers|An Exploratory Study to Evaluate the Effect of Abatacept (BMS-188667) on the Antibody Response Following Tetanus Toxoid and 23-Valent Pneumococcal Vaccinations in Healthy Subjects|Completed||Phase 1|80|Anticipated|Bristol-Myers Squibb||4|||f||||||||||||||2017-02-18 16:49:27.373815|2017-02-18 16:49:27.373815
NCT00279721|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-01-18|||January 2006||2006-01-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.|Phase II Study of Intensity-modulated Radiation (IMRT)With Simultaneous Integrated Boost (SIB) as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.|Completed||Phase 2|40|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 16:49:27.489649|2017-02-18 16:49:27.489649
NCT00279708|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2016-06-30|2016-06-30||January 2006||2006-01-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Atorvastatin to Treat Pulmonary Sarcoidosis|Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|56|Actual|National Institutes of Health Clinical Center (CC)|The recruitment goal of 96 subjects was not met due to slow accrual. The primary endpoint analysis was based on the available subject data.|2|||f||||t||||||||No||2017-02-18 16:49:27.57804|2017-02-18 16:49:27.57804
NCT00279695|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2010-01-19|||January 1996||1996-01-01|January 2010|2010-01-01|June 2010|Anticipated|2010-06-01|||||Observational|||Ultrasonic Evaluation of Ocular Tissues|Ultrasonic Evaluation of Ocular Tissues|Unknown status|Active, not recruiting|N/A|150|Anticipated|Weill Medical College of Cornell University|||4||f||||f||||||||||2017-02-18 16:49:28.267522|2017-02-18 16:49:28.267522
NCT00279682|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-01-17|||May 1999||1999-05-01|January 2006|2006-01-01|August 2003||2003-08-01|||||Interventional|||Prevention of Suicide in Primary Care Elderly: Collaborative Trial (PROSPECT)|Prevention of Suicide in Primary Care Elderly: Collaborative Trial|Completed||Phase 4|1200||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 16:49:28.399281|2017-02-18 16:49:28.399281
NCT00279669|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2008-05-07|||December 2004||2004-12-01|May 2008|2008-05-01|July 2008|Anticipated|2008-07-01|||||Observational|||Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity|Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity|Suspended||N/A|30|Anticipated|Weill Medical College of Cornell University|||1|Studies are suspended until a new ultrasound scanner is acquired.|f||||f||||||||||2017-02-18 16:49:28.510786|2017-02-18 16:49:28.510786
NCT00279656|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-01-17|||November 2003||2003-11-01|June 2004|2004-06-01|June 2005||2005-06-01|||||Interventional|||Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients|Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients - Randomized Controlled Trial|Completed||Phase 4|180||Université Catholique de Louvain|||||f||||||||||||||2017-02-18 16:49:28.623446|2017-02-18 16:49:28.623446
NCT00279643|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-04-29|||January 2005||2005-01-01|April 2015|2015-04-01|June 2006|Actual|2006-06-01|||||Interventional|||The Effect of Laser Hair Removal on Permanent Hair Reduction|The Effect of Laser Hair Removal on Markers of Follicular Stem Cells|Completed||Phase 1/Phase 2|60||University of Michigan|||||f||||f||||||||||2017-02-18 16:49:28.719645|2017-02-18 16:49:28.719645
NCT00279630|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2014-12-02|||June 2002||2002-06-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Exercise and Shoe Orthoses in Treatment of Posterior Tibial Tendon Dysfunction|Phase 1 Study on Effectiveness of Exercise on Function, Quality of Life and Disability in Patients With Posterior Tibial Tendon Dysfunction|Completed||Phase 1|45|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 16:49:28.811496|2017-02-18 16:49:28.811496
NCT00279617|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2011-12-12|||January 2006||2006-01-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks|Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks|Completed||Phase 3|15|Actual|Lindner Center of HOPE||1|||f||||||||||||||2017-02-18 16:49:28.915965|2017-02-18 16:49:28.915965
NCT00279604|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2007-04-19|||July 2005||2005-07-01|April 2007|2007-04-01|October 2007|Anticipated|2007-10-01|||||Interventional|||INCA - Intervention and Neuropsychology in Cannabis Abuse|Targeted Interventions in Cannabis Abuse: Focus on Decision Making (INCA)|Unknown status|Recruiting|N/A|160||University Hospital, Bonn|||||f||||||||||||||2017-02-18 16:49:29.02549|2017-02-18 16:49:29.02549
NCT00279591|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2012-04-03|2011-03-28||June 2006||2006-06-01|April 2012|2012-04-01|January 2008|Actual|2008-01-01|June 2007|Actual|2007-06-01||Interventional|||Near-Continuous, Noninvasive Blood Pressure Monitoring to Improve Outcomes in Pediatric Transport|Near-Continuous, Noninvasive Blood Pressure Monitoring to Improve Outcomes in Pediatric Transport|Terminated||N/A|94|Actual|University of Arkansas|Small Sample Size. Halted prior to projected enrollment secondary to lack of technical support and supplies for near continuous BP measuring device.|2||Lack of technical support and supplies|f||||f||||||||||2017-02-18 16:49:29.115692|2017-02-18 16:49:29.115692
NCT00279578|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-11-15|||January 2006||2006-01-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||Clot Formation and Clot Stability in Patients With Severe Haemophilia A|Clot Formation and Clot Stability in Patients With Severe Haemophilia A - Effect of Recombinant Factor VIII and Tranexamic Acid|Completed||N/A|8||University of Aarhus|||||f||||||||||||||2017-02-18 16:49:29.575459|2017-02-18 16:49:29.575459
NCT00279565|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2012-11-21|||August 2005||2005-08-01|February 2007|2007-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)|Randomized, Controlled Study of Buprenorphine and Methadone in Hepatitis C Patients in Need of Treatment|Terminated||Phase 4|128||Indivior Inc.||||The trial was terminated because of deviations from the protocol.|f||||f||||||||||2017-02-18 16:49:29.670936|2017-02-18 16:49:29.670936
NCT00279552|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-01-17|||April 2004||2004-04-01|January 2006|2006-01-01|December 2004||2004-12-01|||||Interventional|||Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?|Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?|Completed||Phase 2|37||University of Aarhus|||||f||||||||||||||2017-02-18 16:49:29.750791|2017-02-18 16:49:29.750791
NCT00279539|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-03-30|||July 2008||2008-07-01|June 2009|2009-06-01||||||||Interventional|||Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure|phVEGF165 GENE TRANSFER TO PROMOTE ANGIOGENESIS IN PATIENTS WITH ISCHEMIC HEART FAILURE|Withdrawn||Phase 1|0|Actual|Losordo, Douglas, M.D.||||Study never started.|||||f||||||||||2017-02-18 16:49:29.840093|2017-02-18 16:49:29.840093
NCT00279526|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2007-05-24|||April 2006||2006-04-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Observational|||Depression and Increased Health Services Utilization Among Elderly Primary Care Patients||Completed||N/A|450||Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:49:29.924473|2017-02-18 16:49:29.924473
NCT00279513|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2011-04-03|||September 2006||2006-09-01|April 2011|2011-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||TRAUMEEL S in Reducing Pain After Correction of Hallux Valgus-Clinical Trial|A Randomised, Double- Blind, Placebo Controlled, Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Reducing Pain After Surgical Correction of Hallux Valgus|Completed||Phase 3|||Shaare Zedek Medical Center|||||f||||||||||||||2017-02-18 16:49:30.023406|2017-02-18 16:49:30.023406
NCT00279500|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2016-04-12|||February 2002||2002-02-01|April 2016|2016-04-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa|Chronic Retinal Electrodes to Provide Electrical Stimulation of the Retina to Elicit Visual Percepts in Blind Subjects|Completed||Phase 1/Phase 2|6|Actual|Second Sight Medical Products||1|||f||||f||||||||No||2017-02-18 16:49:30.119967|2017-02-18 16:49:30.119967
NCT00279487|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2016-10-24||||||October 2016|2016-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Preanalgesic Effect of Gabapentin in Total Knee Repair|Preanalgesic Effect of Gabapentin in Total Knee Repair|Completed||N/A|24|Actual|Texas Health Resources||2|||f||||f||||||||No||2017-02-18 16:49:30.215641|2017-02-18 16:49:30.215641
NCT00279474|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-01-17|||July 2004||2004-07-01|October 2005|2005-10-01|December 2005||2005-12-01|||||Interventional|||The Effect of Cognitive Behavior Intervention on Psychological Distress of Cancer Patients and Their Family Members|Evaluation of the Effect of Cognitive Behavior Intervention on Psychological Distress of Cancer Patients and Their Family Members|Unknown status|Recruiting|N/A|320||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 16:49:30.319905|2017-02-18 16:49:30.319905
NCT00279461|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-07-31|||May 2009||2009-05-01|July 2015|2015-07-01|May 2011|Anticipated|2011-05-01|May 2011|Anticipated|2011-05-01||Interventional|||Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis|Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis: Clinical Trial and Investigations on Dendritic Cells|Withdrawn||Phase 2|0|Actual|Indiana University||2||"Dr. Levy terminated from IU in December 2009. Indiana University has no record that this study~   was initiated prior to his termination."|f||||f||||||||||2017-02-18 16:49:30.405819|2017-02-18 16:49:30.405819
NCT00279448|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2011-12-22|||January 2002||2002-01-01|December 2011|2011-12-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|TEAM||Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer|Multicenter, Randomized, Open-Label Study To Compare The Efficacy, Tolerance And Quality Of Life Of 5 Years Of Adjuvant Exemestane (Aromasin) Therapy With 2.5 To 3 Years Of Adjuvant Tamoxifen Therapy, Followed By 2 To 2.5 Years Of Exemestane For A Total Duration Of 5 Years To Treat HR+ Post-Menopausal Patients With Non-Metastatic Breast Cancer|Completed||Phase 3|9779|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:49:30.532357|2017-02-18 16:49:30.532357
NCT00279435|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2012-03-08|||August 2006||2006-08-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study|A Randomized, Double-blind, Multicenter Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study|Terminated||Phase 2/Phase 3|25|Actual|Facet Biotech||2||company decision based on other studies|f||||t||||||||||2017-02-18 16:49:30.696673|2017-02-18 16:49:30.696673
NCT00279422|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2012-03-08|||February 2006||2006-02-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis|A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis|Terminated||Phase 2/Phase 3|127|Actual|Facet Biotech||2||DMC recommendation, no efficacy|f||||t||||||||||2017-02-18 16:49:30.842383|2017-02-18 16:49:30.842383
NCT00279409|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2013-09-20|||July 2006||2006-07-01|September 2013|2013-09-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|TREAT||Treatment of Children With ADHD Who do Not Fully Respond to Stimulants|"Developing More Efficacious Treatments for Children With ADHD Who Are Partial or Non-responders to Stimulants"|Terminated||Phase 2|10|Actual|New York State Psychiatric Institute||2||Recruitment Rate too slow|f||||t||||||||||2017-02-18 16:49:30.993443|2017-02-18 16:49:30.993443
NCT00279383|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2012-05-04|||August 2005||2005-08-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||OSHES - Observational Study on Hemostasis in Surgery (TC-022-IT)|OSHES (Observational Study on Hemostasis in Surgery ). A Non Interventional Study on the Hemostasis Supportive Methods in Surgery|Completed||Phase 4|800|Anticipated|Nycomed|||1||f||||t||||||||||2017-02-18 16:49:31.350573|2017-02-18 16:49:31.350573
NCT00279370|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2013-09-30|||September 1999||1999-09-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Antidepressant Use During Pregnancy|Antidepressant Use During Pregnancy|Completed||N/A|283|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 16:49:31.432981|2017-02-18 16:49:31.432981
NCT00279357|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2007-06-28|||January 2006||2006-01-01|June 2007|2007-06-01||||||||Interventional|||Randomised Trial of NBI for Adenoma Detection|Randomised, Controlled Trial of Narrow Band Imaging (NBI) Versus Standard Endoscopy for Adenoma Detection|Unknown status|Recruiting|N/A|214|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 16:49:31.52642|2017-02-18 16:49:31.52642
NCT00279344|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2012-05-04|||September 2004||2004-09-01|May 2012|2012-05-01|August 2007|Actual|2007-08-01|||||Interventional|||Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)|A Randomised, Open, Parallel-group, Multi-centre Trial to Investigate Analgesic Efficacy and Safety of Transdermal Fentanyl (FITpatch) Compared to Standard Opioid Treatment in Cancer Pain.|Completed||Phase 3|220||Nycomed|||||f||||f||||||||||2017-02-18 16:49:31.616946|2017-02-18 16:49:31.616946
NCT00279331|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2013-09-20||||||September 2013|2013-09-01|November 2006|Actual|2006-11-01|||||Observational|||Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador|Implementation of a Third Generation Sentinel Surveillance Approach Among Men Who Have Sex With Men at High Risk for HIV, Type-1 Acquisition in the Andean Region|Completed||N/A|2608|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:49:31.696674|2017-02-18 16:49:31.696674
NCT00279318|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2016-12-05|||September 2004||2004-09-01|December 2016|2016-12-01|September 2025|Anticipated|2025-09-01|September 2025|Anticipated|2025-09-01||Observational|||TEDDY - The Environmental Determinants of Diabetes in the Young|Consortium for Identification of Environmental Triggers of Type 1 Diabetes|Active, not recruiting||N/A|8668|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||Samples With DNA|"~     Serum, plasma, PBMCs, stool, urine, saliva, nasal swabs, nail clippings, water~   "|||2017-02-18 16:49:31.809134|2017-02-18 16:49:31.809134
NCT00279305|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2016-09-27|2016-05-12||August 2005||2005-08-01|September 2016|2016-09-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|||Rituximab in New Onset Type 1 Diabetes|Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects|Completed||Phase 2|87|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||Yes||2017-02-18 16:49:31.936472|2017-02-18 16:49:31.936472
NCT00279292|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-10-13|||August 2004||2004-08-01|October 2015|2015-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Randomized Trial of EUS Neurolysis in Pancreas Cancer|Phase III Randomized Placebo Controlled Trial of EUS Guided Celiac Plexus Neurolysis for Pancreatic Cancer Pain|Completed||Phase 3|26|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:49:32.373698|2017-02-18 16:49:32.373698
NCT00279279|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-10-25|||October 2003||2003-10-01|October 2006|2006-10-01|May 2006||2006-05-01|||||Interventional|||PREPARE - Primary Prevention Parameters Evaluation|PREPARE - Primary Prevention Parameters Evaluation|Completed||N/A|700||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:49:32.478|2017-02-18 16:49:32.478
NCT00279266|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2015-05-11|||January 2006||2006-01-01|May 2015|2015-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy|A Randomized Double Blinded Pilot Study of Oral Thiamine in the Symptomatic Treatment of Painful Diabetic Peripheral Neuropathy|Withdrawn||N/A|0|Actual|Loma Linda University||||inadequate recruitment|f||||t||||||||||2017-02-18 16:49:32.598128|2017-02-18 16:49:32.598128
NCT00279253|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2006-01-18|||March 2004||2004-03-01|January 2006|2006-01-01|January 2005||2005-01-01|||||Interventional|||Effects of Intravenous Clonidine on Ocular Blood Flow and Intraocular Pressure||Completed||Phase 4|12||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:49:32.704925|2017-02-18 16:49:32.704925
NCT00279240|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2006-01-23|||March 2001||2001-03-01|July 2002|2002-07-01|December 2004||2004-12-01|||||Interventional|||Life Style Modifications Prevents Type 2 Diabetes in Asian Indians|The Indian Diabetes Prevention Programme Shows That Lifestyle Modification and Metformin Prevent Type 2 Diabetes in Asian Indian Subjects With Impaired Glucose Tolerance (IDPP1)|Completed||Phase 1|||M.V. Hospital for Diabetes|||||f||||||||||||||2017-02-18 16:49:32.77679|2017-02-18 16:49:32.77679
NCT00279227|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-08-09|||January 2006||2006-01-01|January 2006|2006-01-01|December 2006||2006-12-01|||||Observational|||Role of Epicardial Adipose Tissue in Coronary Artery Disease|Role of Epicardial Adipose Tissue in Coronary Artery Disease|Unknown status|Recruiting|N/A|50||McMaster University|||||f||||||||||||||2017-02-18 16:49:32.869812|2017-02-18 16:49:32.869812
NCT00279214|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2009-08-26|2008-10-31||November 2005||2005-11-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|||||Interventional|||Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock|An Evaluation of Vasopressor Requirement, Hemodynamic Response and Measures of Tissue Perfusion With the Administration of Drotrecogin Alfa (Activated) as Part of Physician-Directed Therapy in Patients With Septic Shock|Completed||Phase 4|43|Actual|Eli Lilly and Company|||||||||||||||||||2017-02-18 16:49:32.956718|2017-02-18 16:49:32.956718
NCT00279201|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2011-01-24|2010-11-11||December 2005||2005-12-01|January 2011|2011-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|IOOV||The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)|The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine When Added to Existing Oral Therapy in Patients With Type 2 Diabetes and Inadequate Glycemic Control|Completed||Phase 4|2091|Actual|Eli Lilly and Company||6|||f||||t||||||||||2017-02-18 16:49:33.901541|2017-02-18 16:49:33.901541
NCT00279188|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-01-17|||May 1992||1992-05-01|September 2004|2004-09-01|September 2008||2008-09-01|||||Interventional|||Asthma Management Project University Leiden|Asthma Management Project University Leiden|Completed||N/A|75||Leiden University Medical Center|||||f||||||||||||||2017-02-18 16:49:42.936221|2017-02-18 16:49:42.936221
NCT00279175|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2012-09-19|||April 2004||2004-04-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|October 2005|Actual|2005-10-01||Interventional|||REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI)|Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute Myocardial Infarction (REPAIR - AMI)|Completed||Phase 3|204|Actual|Johann Wolfgang Goethe University Hospital||2|||f||||||||||||||2017-02-18 16:49:43.036222|2017-02-18 16:49:43.036222
NCT00279162|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-03-25|||December 2005||2005-12-01|March 2015|2015-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis|Calcipotriene Plus Betamethasone Dipropionate Gel Compared to the Gel Vehicle in Scalp Psoriasis, in Patients Receiving Calcipotriene Plus Betamethasone Dipropionate Ointment for Psoriasis Vulgaris of Trunk/Limbs|Completed||Phase 3|160|Anticipated|LEO Pharma|||||||||||||||||||2017-02-18 16:49:43.160339|2017-02-18 16:49:43.160339
NCT00279149|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2011-02-16|||March 2006||2006-03-01|February 2007|2007-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||TRUST-tPA: Therapeutic Trial Evaluating Efficacy of Telemedicine (TELESTROKE) of Patients With Acute Stroke|Therapeutic Trial Evaluating Efficacy of Telemedicine (TELESTROKE) in the Management of Patient With Acute Stroke Within 3-hour After Their Symptom Onset Who Are Admitted to a Remote Hospital With no Stroke Unit Facility|Completed||Phase 4|400|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:49:43.242904|2017-02-18 16:49:43.242904
NCT00279136|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-01-17|||September 2004||2004-09-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Observational|||Towards Restoring the Physiological Inhibition of Airway Narrowing in Asthma|Towards Restoring the Physiological Inhibition of Airway Narrowing in Asthma|Unknown status|Recruiting|N/A|36||Leiden University Medical Center|||||f||||||||||||||2017-02-18 16:49:43.352888|2017-02-18 16:49:43.352888
NCT00279123|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-01-17|||January 2002||2002-01-01|January 2006|2006-01-01||||||||Interventional|||Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers||Completed||Phase 4|||Kwong Wah Hospital|||||f||||||||||||||2017-02-18 16:49:43.437534|2017-02-18 16:49:43.437534
NCT00279110|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-04-14|||April 2006||2006-04-01|May 2011|2011-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Directly Administered HIV Therapy in Methadone Clinics|Directly Administered vs. Self-administered Antiretroviral Therapy in Methadone Clinics|Completed||Phase 2/Phase 3|107|Actual|Johns Hopkins University||2|||f||||||||||||||2017-02-18 16:49:43.787524|2017-02-18 16:49:43.787524
NCT00279097|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-11-15|||January 2006||2006-01-01|November 2006|2006-11-01|September 2006||2006-09-01|||||Interventional|||Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation|A Safety Study to Evaluate Intracranial Pressure With the Utilization of High Frequency Chest Wall Oscillation (HFCWO) Using the Vest™ on Mechanically Ventilated Neurosurgical Patients|Terminated||N/A|20||Hill-Rom|||||f||||||||||||||2017-02-18 16:49:43.908178|2017-02-18 16:49:43.908178
NCT00279084|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2007-10-03|||January 2004||2004-01-01|October 2007|2007-10-01||||||||Interventional|||NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels|Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels (110- 129 g/L and 130 - 149 g/L) on Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes and With Chronic Kidney Disease|Unknown status|Active, not recruiting|N/A|204||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:49:43.994045|2017-02-18 16:49:43.994045
NCT00279071|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2008-07-01|||October 2002||2002-10-01|July 2008|2008-07-01|March 2007|Actual|2007-03-01|||||Interventional|||Use of Acupuncture for Stimulation of Labour|Use of Acupuncture for Stimulation of Labour|Terminated||Phase 2|100|Actual|Herning Hospital||1||exhausted personel after a long recruiting period|f||||f||||||||||2017-02-18 16:49:44.087766|2017-02-18 16:49:44.087766
NCT00279058|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-04-19|||December 2005||2005-12-01|April 2007|2007-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2|The Role of Autologous Dendritic Cells Pulsed by Melanoma Associated Peptides to Augment the Therapeutic Effect of Interleukin-2|Completed||Phase 1/Phase 2|24|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:49:44.175243|2017-02-18 16:49:44.175243
NCT00279045|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2016-09-22|||January 2000||2000-01-01|September 2016|2016-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide|A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus|Completed||Phase 3|4426|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:49:44.273534|2017-02-18 16:49:44.273534
NCT00279032|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2009-02-19|||September 2003||2003-09-01|February 2009|2009-02-01||||||||Interventional|||GW406381 In Patients With Peripheral Nerve Injury|A Randomised, Placebo-Controlled, Double-Blind, Parallel Group Study to Investigate the Effects of Chronic Dose Oral GW406381 on Pain and Areas of Hyperalgesia and Allodynia in Patients With Peripheral Nerve Injury as a Result of Trauma or Surgery.|Completed||Phase 1|40||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:49:45.21936|2017-02-18 16:49:45.21936
NCT00279019|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2016-09-22|||December 2005||2005-12-01|September 2016|2016-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease|A Randomised, Double Blind, Placebo-controlled, Double Dummy, 4-way Cross-over, Dose Ascending Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Inhaled Doses of GSK233705 and Tiotropium Bromide (18µg) Via DPI in COPD Patients|Completed||Phase 1|31|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:49:45.318251|2017-02-18 16:49:45.318251
NCT00279006|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2006-01-17|||January 2006||2006-01-01|January 2006|2006-01-01|March 2007||2007-03-01|||||Interventional|||Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison|Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison|Unknown status|Not yet recruiting|N/A|150||Foundation for Cardiovascular Research, Zurich|||||f||||||||||||||2017-02-18 16:49:45.410644|2017-02-18 16:49:45.410644
NCT00278993|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2014-06-30|2011-12-22||January 2006||2006-01-01|April 2012|2012-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy|A Phase II, Multicenter, Open Label, Two Stage Design Study Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy|Completed||Phase 2|108|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 16:49:45.489896|2017-02-18 16:49:45.489896
NCT00278980|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2006-01-12|||October 2003||2003-10-01|January 2006|2006-01-01|December 2004||2004-12-01|||||Interventional|||Effect of C-Peptide on Diabetic Peripheral Neuropathy|Effect of C-Peptide on Diabetic Peripheral Neuropathy, a 6 Months Randomized Double-Blind, Placebo Controlled, Dose-Finding, Multicenter Study, With Parallel Groups|Completed||Phase 2|180||Creative Peptides Sweden Inc.|||||f||||||||||||||2017-02-18 16:49:45.988974|2017-02-18 16:49:45.988974
NCT00278967|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2006-10-18|||February 2006||2006-02-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects|An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects|Completed||Phase 4|450||Braintree Laboratories|||||||||||||||||||2017-02-18 16:49:46.076296|2017-02-18 16:49:46.076296
NCT00278954|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2013-01-23|2009-05-29||January 2006||2006-01-01|January 2013|2013-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.|A Phase III, Multicenter, Open-Label Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of Gammaplex® in Primary Immunodeficiency Diseases|Completed||Phase 3|50|Actual|Bio Products Laboratory||1|||f||||f||||||||||2017-02-18 16:49:46.174536|2017-02-18 16:49:46.174536
NCT00278941|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2009-03-24|||December 2005||2005-12-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|||||Interventional|AMETHYST||Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder|A Multi-Centre, Double-Blind, Randomised-Withdrawal, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR™) As Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|3000||AstraZeneca|||||f||||||||||||||2017-02-18 16:49:46.50682|2017-02-18 16:49:46.50682
NCT00278928|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-18|2007-05-16|||January 2006||2006-01-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic|Prospective, Randomized Study of Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic Containers.|Terminated||N/A|82|Anticipated|Beth Israel Deaconess Medical Center||||Manufacturing change in one of the two lipid emulsion products being studied.|f||||||||||||||2017-02-18 16:49:46.957493|2017-02-18 16:49:46.957493
NCT00278915|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2016-11-07|2010-12-06||January 2006||2006-01-01|November 2016|2016-11-01|July 2023|Anticipated|2023-07-01|December 2009|Actual|2009-12-01||Interventional|FMAS||Faslodex in McCune Albright Syndrome|An Open-label, Non-Comparative Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Faslodex (Fulvestrant) in Girls With Progressive Precocious Puberty Associated With McCune-Albright Syndrome|Active, not recruiting||Phase 2|34|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 16:49:47.055694|2017-02-18 16:49:47.055694
NCT00278902|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2012-09-28|||January 2006||2006-01-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study of ARRY-334543 in Patients With Advanced Cancer||Completed||Phase 1|96|Actual|Array BioPharma||1|||f||||||||||||||2017-02-18 16:49:47.641907|2017-02-18 16:49:47.641907
NCT00278889|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2012-09-24|2012-07-26||January 2006||2006-01-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|November 2007|Actual|2007-11-01||Interventional|HORIZON I||Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)|A Study to Compare the Efficacy of AZD2171 in Combination With 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) and the Efficacy of Bevacizumab in Combination With FOLFOX in the Second-line Treatment of Patients With Metastatic Colorectal Cancer|Completed||Phase 2|215|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:49:47.748121|2017-02-18 16:49:47.748121
NCT00278876|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2015-06-30|2013-11-19||April 2005||2005-04-01|June 2015|2015-06-01|March 2011|Actual|2011-03-01|August 2007|Actual|2007-08-01||Interventional||All enrolled patients were included for baseline analysis.|Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation|Phase II Study of Imatinib Mesylate as Adjuvant Treatment in High-relapse Risk Localized Gastrointestinal Stromal Tumors With C-kit Mutation|Completed||Phase 2|47|Actual|Asan Medical Center||1|||f||||f||||||||||2017-02-18 16:49:48.752315|2017-02-18 16:49:48.752315
NCT00278863|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2014-01-13|2014-01-13||November 2004||2004-11-01|January 2014|2014-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial|Randomized Multicenter Phase II Trial of Capecitabine Versus S-1 as First-line Treatment in Elderly Patients With Advanced or Recurrent Unresectable Gastric Cancer|Completed||Phase 2|96|Actual|Asan Medical Center||2|||f||||f||||||||||2017-02-18 16:49:49.004666|2017-02-18 16:49:49.004666
NCT00278850|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2015-06-11|||January 2006||2006-01-01|June 2015|2015-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||"Vestibulitis Educational Seminar Trial Study"|"Vestibulitis Educational Seminar Trial Study"|Completed||N/A|500|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 16:49:49.542728|2017-02-18 16:49:49.542728
NCT00005452|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1991||1991-09-01|June 2000|2000-06-01|April 1996|Actual|1996-04-01|||||Observational|||Ti PC Software for Analyzing Longitudinal Data||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.007032|2017-02-18 18:14:58.007032
NCT00278837|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2008-04-22|||May 2003||2003-05-01|April 2008|2008-04-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Avon Foundation Program to Improve Quality of Life in Breast Cancer Survivors|Contemplative Self-Healing to Improve Quality of Life in Breast Cancer Survivors: the Avon Foundation Program to Reach Medically Underserved Populations|Unknown status|Active, not recruiting|N/A|160|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 16:49:49.648708|2017-02-18 16:49:49.648708
NCT00278824|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2012-06-04|||January 2006||2006-01-01|June 2012|2012-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain|A Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate the Efficacy of CHADD™ Applied Over a Transdermal Fentanyl Patch for the Treatment of Breakthrough Pain in Patients With Moderate to Severe Non-malignant Chronic Pain|Terminated||Phase 2|109|Actual|ZARS Pharma Inc.||2||Difficulty identifying and enrolling eligible patients|f||||f||||||||||2017-02-18 16:49:49.764559|2017-02-18 16:49:49.764559
NCT00278811|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2015-10-20|||April 2003||2003-04-01|October 2015|2015-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Emergency Linkage to Outpatient Psychiatric Services|Emergency Linkage to Outpatient Psychiatric Services|Completed||Phase 1|120|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 16:49:49.898414|2017-02-18 16:49:49.898414
NCT00278798|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2012-07-10|||January 2006||2006-01-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|July 2011|Actual|2011-07-01||Observational|||TRAIL-CC: Trachelectomy, Radical Hysterectomy, and Intimate Life After Cervical Cancer Study||Completed||N/A|33|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 16:49:50.011791|2017-02-18 16:49:50.011791
NCT00278785|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2012-10-26|||March 2006||2006-03-01|October 2012|2012-10-01|June 2013|Anticipated|2013-06-01|June 2013|Anticipated|2013-06-01||Interventional|||Brief Intervention for Alcohol Use Among Injured Patients|Brief Intervention for Alcohol Use Among Injured Patients: A Prospective, Randomized Trial|Unknown status|Active, not recruiting|N/A|830|Actual|University of California, Davis||2|||f||||f||||||||||2017-02-18 16:49:50.123205|2017-02-18 16:49:50.123205
NCT00278772|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2010-05-24|||August 2003||2003-08-01|May 2010|2010-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania|"A Randomized, Double-Blind, Placebo-Controlled Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania"|Completed||Phase 3|62|Actual|Lindner Center of HOPE||2|||f||||||||||||||2017-02-18 16:49:50.259025|2017-02-18 16:49:50.259025
NCT00278759|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2009-02-17|||December 2005||2005-12-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Unclogging the Pediatric Emergency Room: Impact of Rapid Viral Diagnostics|Unclogging the Pediatric Emergency Room: Impact of Rapid Viral Diagnostics. A Randomized Controlled Trial of Decision Making Based Upon Early (at Triage) Rapid Diagnosis of Respiratory Viral Infections (VIRAP) in Children 3-36 Months of Age Presenting to the Emergency Department (ED) With a Flu-Like Illness.|Completed||N/A|275|Anticipated|University of British Columbia|||||f||||f||||||||||2017-02-18 16:49:50.370757|2017-02-18 16:49:50.370757
NCT00278746|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2015-06-15|||January 2005||2005-01-01|June 2015|2015-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting|An Effectiveness Trial Examining the Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting.|Completed||N/A|20032|Actual|Society for Applied Studies||2|||f||||f||||||||||2017-02-18 16:49:50.479069|2017-02-18 16:49:50.479069
NCT00278733|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2007-03-07|||February 2006||2006-02-01|March 2007|2007-03-01|May 2008||2008-05-01|||||Interventional|||Campus Health Intervention Projects UBC Site|Campus Health Intervention Projects to Reduce High Risk Drinking Among University Students by Means of Brief Physician Advice|Completed||N/A|150||University of British Columbia|||||f||||||||||||||2017-02-18 16:49:50.593091|2017-02-18 16:49:50.593091
NCT00278707|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2006-08-11|||January 2006||2006-01-01|August 2006|2006-08-01|July 2006||2006-07-01|||||Interventional|||GTA-Glyceryltriacetate for Canavan Disease|Phase 1 Treatment With GTA in Two Infant With Canavan Disease|Unknown status|Active, not recruiting|Phase 1|5||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:49:50.679107|2017-02-18 16:49:50.679107
NCT00278694|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2016-09-28|||September 2005||2005-09-01|September 2016|2016-09-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|LARC-RRP||Oxaliplatin and 5-FU Based Preoperative Chemoradiation|Oxaliplatin and 5-FU Based Preoperative Chemoradiation|Completed||Phase 2|109|Actual|Oslo University Hospital||1|||f||||||||||||||2017-02-18 16:49:50.791407|2017-02-18 16:49:50.791407
NCT00278681|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2008-07-01|||August 2003||2003-08-01|July 2008|2008-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Effectiveness of Adding Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting|An Effectiveness Trial Examining the Addition of Zinc to the Current Case Management Package of Diarrhoea in a Primary Health Care Setting. Phase I|Completed||Phase 1|2364|Actual|Society for Applied Studies||1|||f||||f||||||||||2017-02-18 16:49:50.903399|2017-02-18 16:49:50.903399
NCT00278668|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2008-05-20|||October 2006||2006-10-01|May 2008|2008-05-01|October 2006|Anticipated|2006-10-01|||||Observational|||ECT Schizophrenia Serotonin Study|Serotonin Uptake to Lymphocytes and Citalopram Platelets Binding of Treatment-Resistant Schizophrenia Patients Before and After Electroconvulsive Therapy|Unknown status|Not yet recruiting|Phase 1|15|Anticipated|Sha’ar Menashe Mental Health Center|||||f||||||||||||||2017-02-18 16:49:51.011629|2017-02-18 16:49:51.011629
NCT00278655|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2014-03-31|2013-04-09||June 2003||2003-06-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis|Hematopoietic Stem Cell Therapy for Patients With Inflammatory Multiple Sclerosis Failing Interferon Therapy: A Phase II Multi-Center Trial|Terminated||Phase 1/Phase 2|21|Actual|Northwestern University|The study had following limitations: small number of enrolled participants and no randomization.|1|||f||||f||||||||||2017-02-18 16:49:51.079542|2017-02-18 16:49:51.079542
NCT00278642|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-04-04|||September 2002||2002-09-01|April 2013|2013-04-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders|High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders: A Phase I Trial|Terminated||Phase 1|1|Actual|Northwestern University||1||sponsor stopped the study because of lack of elligible participants|f||||f||||||||||2017-02-18 16:49:51.297589|2017-02-18 16:49:51.297589
NCT00278629|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2016-09-15|||March 2005||2005-03-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy|Non-myeloablative Autologous Hematopoietic Stem Cell Transplantation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Phase II Trial|Active, not recruiting||Phase 2|80|Actual|Northwestern University||1|||f||||f||||||||No||2017-02-18 16:49:51.38364|2017-02-18 16:49:51.38364
NCT00278616|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2012-04-09|||August 2005||2005-08-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome|High Dose Cyclophosphamide & CAMPATH-1H With Hematopoietic Stem Cell Transplantation in Patients With Refractory Antiphospholipid Syndrome (APS): A Phase I Trial|Withdrawn||Phase 1|0|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 16:49:51.47893|2017-02-18 16:49:51.47893
NCT00278603|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2012-04-09|||October 2004||2004-10-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Interventional|||Stem Cell Injection for Peripheral Vascular Disease|Hematopoietic Stem Cell Injection for Peripheral Vascular Disease: Induction of Neoangiogenesis. A Phase I Study|Completed||Phase 1|10|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 16:49:51.569687|2017-02-18 16:49:51.569687
NCT00278590|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2017-01-12|||July 2004||2004-07-01|January 2017|2017-01-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus|Allogeneic Stem Cell Transplantation in Patients With Systemic Lupus Erythematosus|Withdrawn||Phase 1|0|Actual|Northwestern University||1||No participants enrolled|f||||f||||||||||2017-02-18 16:49:51.645899|2017-02-18 16:49:51.645899
NCT00278577|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2014-02-04|||April 2001||2001-04-01|April 2013|2013-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease|Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease|Terminated||Phase 1|25|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 16:49:51.740478|2017-02-18 16:49:51.740478
NCT00278564|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2016-07-13|||September 2005||2005-09-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases|High Dose Cyclophosphamide & ATG With Hematopoietic Stem Cell Transplantation in Patients With Refractory Idiopathic Inflammatory Myopathy Diseases: A Phase I Trial|Terminated||Phase 1|7|Actual|Northwestern University||1||high relapse rate|f||||f||||||||No||2017-02-18 16:49:51.83001|2017-02-18 16:49:51.83001
NCT00278551|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2013-04-04|||June 1997||1997-06-01|April 2013|2013-04-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Stem Cell Support in Patients With Rheumatoid Arthritis|Immune Ablation and Hematopoietic Stem Cell Support in Patients With Rheumatoid Arthritis and High Risk Factors|Terminated||Phase 1|10|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 16:49:52.03033|2017-02-18 16:49:52.03033
NCT00278538|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2017-01-12|||August 2005||2005-08-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus|Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus: Phase II Trial|Active, not recruiting||Phase 2|33|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 16:49:52.129056|2017-02-18 16:49:52.129056
NCT00278525|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2014-03-28|2013-04-09||September 2005||2005-09-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|September 2011|Actual|2011-09-01||Interventional|||Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma|Trial of High Dose Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG) With Hematopoietic Stem Cell Support in Patients With Systemic Scleroderma: A Randomized Trial|Completed||Phase 2|19|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 16:49:52.229016|2017-02-18 16:49:52.229016
NCT00278512|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2016-07-11|||August 2003||2003-08-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Interventional|||Hematopoietic Stem Cell Support in Vasculitis|High Dose Immune Suppression With Hematopoietic Stem Cell Support in Refractory Vasculitis, Necrotizing Vasculitis, Neurovascular Behcet's Disease, and Sjogren's Syndrome|Terminated||Phase 1|7|Actual|Northwestern University||2||No participant enrolled over five years. No plan to continue the study.|f||||f||||||||No||2017-02-18 16:49:52.611937|2017-02-18 16:49:52.611937
NCT00278499|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2011-01-12|||March 2006||2006-03-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Prevalence of HIV and Other Sexually Transmitted Infections Among Female Sex Workers and Miners in Honghe Prefecture, Yunnan Province, China|Epidemiology of HIV-1 and Other Sexually Transmitted Infections in Honghe Prefecture, Yunnan Province, China|Completed||N/A|3800|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||||||2017-02-18 16:49:52.723724|2017-02-18 16:49:52.723724
NCT00278486|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2013-04-04|||August 2004||2004-08-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)|Immune Ablation and Hematopoietic Stem Cell Transplantation in Patients With Autoimmune-Related Retinopathy and Optic Neuropathy (ARRON) Syndrome (Not Associated With Cancer)|Terminated||Phase 1|2|Actual|Northwestern University||1||"First subject over five years after the transplant. The second subject is not in compliance~   with follow ups. We do not plan to enroll more subjects."|f||||f||||||||||2017-02-18 16:49:52.830465|2017-02-18 16:49:52.830465
NCT00278473|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2008-12-30|||May 2005||2005-05-01|November 2008|2008-11-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults|Treatment of Meta-Cognitive Deficits in Adults With ADHD|Unknown status|Active, not recruiting|N/A|84|Anticipated|National Institute of Mental Health (NIMH)||2|||f||||f||||||||||2017-02-18 16:49:52.918251|2017-02-18 16:49:52.918251
NCT00278460|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2017-01-18|||November 2000||2000-11-01|July 2012|2012-07-01|September 2007|Actual|2007-09-01|February 2006|Actual|2006-02-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of Taxotere and Gemcitabine for Stages III-B and IV Non-Small Cell Lung Cancer|Completed||Phase 2|49|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 16:49:53.025641|2017-02-18 16:49:53.025641
NCT00278447|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2014-10-01|||April 2006||2006-04-01|October 2012|2012-10-01|April 2012|Actual|2012-04-01|January 2010|Actual|2010-01-01||Interventional|||Addiction Health Evaluation And Disease Management (AHEAD) Study|Linkage of Alcohol Abusers to Primary Care|Completed||Phase 3|569|Actual|Boston Medical Center||2|||f||||f||||||||||2017-02-18 16:49:53.118116|2017-02-18 16:49:53.118116
NCT00278434|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-08-02|||April 2005||2005-04-01|August 2013|2013-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3|An Exploratory Clinical Trial of Zoledronic Acid in Women With CIN 2/3 or 3|Terminated||Phase 2|12|Actual|University of California, San Francisco||2||Accrual was insufficient to meet study endpoints|f||||t||||||||||2017-02-18 16:49:53.245115|2017-02-18 16:49:53.245115
NCT00278421|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2016-10-25|||November 2005||2005-11-01|November 2015|2015-11-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma|Randomized Study Comparing 4 and 6 Cycles of Chemotherapy With CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) at 21-day Intervals, Both With 6 Cycles of Immunotherapy With the Monoclonal Anti-CD20-Positive B-Cell Lymphoma Aged 18-60 Years Having no Risk Factor (Age-Adjusted IPI=0) and No Large Tumor Mass (Diameter <7,5cm) [FLYER 6-6-6-4 Study]|Completed||Phase 3|592|Actual|German High-Grade Non-Hodgkin's Lymphoma Study Group||2|||f||||t||||||||||2017-02-18 16:49:53.360498|2017-02-18 16:49:53.360498
NCT00278408|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2016-01-20|||November 2005||2005-11-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma|Randomized Study Comparing an Immuno-Chemotherapy With 6 Cycles of the Monoclonal Anti-CD20 Antibody Rituximab in Combination With 6 Cycles of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) at 21-day Intervals or 14-day Intervals, Both With or Without Consolidating Radiotherapy or Large Tumour Masses (≥7.5 cm) and/or Extranodal Involvement in Patients With Aggressive CD20 B-Cell Lymphoma Aged 18 to 60 Years With Age-Adjusted IPI=1 (All) or IPI=0 With a Large Tumour Mass (≥7.5 cm) [UNFOLDER 21/14 Study]|Completed||Phase 3|700|Actual|German High-Grade Non-Hodgkin's Lymphoma Study Group||4|||f||||f||||||||||2017-02-18 16:49:53.549988|2017-02-18 16:49:53.549988
NCT00278395|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2015-06-03|2012-12-07||October 2005||2005-10-01|December 2013|2013-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Vorinostat in Treating Patients With Kidney Cancer|A Phase II, Pharmacokinetic and Biologic Correlative Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Renal Cell Carcinoma (RCC)|Completed||Phase 2|14|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:49:56.536721|2017-02-18 16:49:56.536721
NCT00278382|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-02-06|||October 2005||2005-10-01|February 2013|2013-02-01||||December 2007|Actual|2007-12-01||Interventional|||Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma|A Phase 2 Study of BAY 43-9006 (IND 69896) in Chemosensitive Relapsed Aggressive Non-Hodgkin's Lymphomas|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:49:56.771741|2017-02-18 16:49:56.771741
NCT00278369|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-05-20|||April 2005||2005-04-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|||Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer|A Pilot Study of Denileukin Diftitox in Combination With High-Dose IL-2 for Patients With Metastatic Renal Cell Carcinoma|Completed||Early Phase 1|20|Actual|Northwestern University||3|||f||||t||||||||||2017-02-18 16:49:56.878418|2017-02-18 16:49:56.878418
NCT00278343|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2014-08-05|||April 2006||2006-04-01|August 2014|2014-08-01||||June 2010|Actual|2010-06-01||Interventional|||Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer|A Phase 2 Study of AZD2171 in Recurrent or Persistent Ovarian, Peritoneal, or Fallopian Tube Cancer|Unknown status|Active, not recruiting|Phase 2|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:49:56.997573|2017-02-18 16:49:56.997573
NCT00278330|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-04-01|||January 2006||2006-01-01|April 2013|2013-04-01||||October 2009|Actual|2009-10-01||Interventional|||Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia|Phase I Trial of Vorinostat (SAHA) in Combination With Alvocidib (Flavopiridol) in Patients With Relapsed, Refractory, or (Selected) Poor Prognosis Acute Leukemia or Refractory Anemia With Excess Blasts-2|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:49:57.379557|2017-02-18 16:49:57.379557
NCT00278304|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-06-18|||September 2005||2005-09-01|April 2006|2006-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Radiation Therapy in Treating Patients With Cervical Cancer|A Pilot Study of MR-Guided High Dose Rate Brachytherapy With MR Image Acquisition for Patients With Cervical Cancer|Completed||Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:49:57.492117|2017-02-18 16:49:57.492117
NCT00278278|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-12-18|||September 2003||2003-09-01|November 2008|2008-11-01||||March 2010|Anticipated|2010-03-01||Interventional|||Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas|Treatment of Children and Adolescents With Diffuse Intrinsic Pontine Glioma and High Grade Glioma|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:49:57.591247|2017-02-18 16:49:57.591247
NCT00278265|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2016-09-30|||June 2005||2005-06-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia|First Line Therapy With Methotrexate (MTX) and Second Line Therapy With Fludarabine of Patients With T-Cell Large Granular Lymphocyte Leukemia (T-LGL)|Terminated||Phase 2|12|Actual|German CLL Study Group||1||slow recruitment|f||||f||||||||No||2017-02-18 16:49:57.716243|2017-02-18 16:49:57.716243
NCT00278252|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-08-06|||July 2001||2001-07-01|June 2009|2009-06-01||||July 2010|Anticipated|2010-07-01||Interventional|||Etoposide in Treating Young Patients With Relapsed Ependymoma|Phase II Study of Intravenous Etoposide in Patients With Relapsed Ependymoma|Unknown status|Recruiting|Phase 2|14|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:49:57.837036|2017-02-18 16:49:57.837036
NCT00278239|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-09-19|||June 2002||2002-06-01|April 2006|2006-04-01||||||||Observational|||Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors|Study of Outcome of Children Previously Enrolled in European Trials of Treatment for Primitive Neuroectodermal Tumour (PNET)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:49:57.938692|2017-02-18 16:49:57.938692
NCT00278226|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2010-03-23|||June 2001||2001-06-01|March 2010|2010-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Motivational Program for Smokers Enrolled in a Methadone Maintenance Program|Smoking Cessation Among Methadone Maintained Patients|Completed||N/A|398|Actual|Butler Hospital||2|||f||||f||||||||||2017-02-18 16:49:58.056941|2017-02-18 16:49:58.056941
NCT00278213|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2016-09-30|||September 2002||2002-09-01|September 2016|2016-09-01|December 2009|Actual|2009-12-01|February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia|Consolidation With Campath-1H After FMC Induction in Patients With T-cell Chronic Lymphocytic Leukemia|Completed||Phase 2|17|Anticipated|German CLL Study Group|||||f||||||||||||No||2017-02-18 16:49:58.162098|2017-02-18 16:49:58.162098
NCT00278200|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2015-10-30|||September 2002||2002-09-01|October 2015|2015-10-01|December 2022||2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Vaccine Therapy in Treating Patients Who Are Being Considered For a Solid Organ Transplant and Are at Risk For Post-Transplant Lymphoproliferative Disorder|Vaccination of Patients at High Risk for Post-Transplant Lymphoproliferative Disorder With a Photochemically Inactivated EBV-Infected B-Cell Vaccine|Active, not recruiting||Phase 1|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:49:58.276332|2017-02-18 16:49:58.276332
NCT00278187|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-12-18|||July 2005||2005-07-01|February 2006|2006-02-01||||||||Interventional|||Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Open-Label Study of Volociximab (M200) in Combination With Erlotinib (Tarceva™) in Previously Treated Patients With Locally Advanced (Stage IIIb) or Metastatic (Stage IV) Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:49:58.384733|2017-02-18 16:49:58.384733
NCT00278174|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2011-05-02|||February 2005||2005-02-01|May 2011|2011-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer|A Phase II Trial of Interferon Alpha-1b (IFN Alpha-1b) in Patients With Metastatic Clear Cell Renal Carcinoma|Completed||Phase 2|7|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:49:58.496222|2017-02-18 16:49:58.496222
NCT00278161|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2014-04-16|||January 2005||2005-01-01|April 2014|2014-04-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|||Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma|Phase II Study of High Dose Cyclophosphamide and Rituximab in Low Grade and Mantle Cell Lymphoma|Completed||Phase 2|82|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:49:58.59231|2017-02-18 16:49:58.59231
NCT00278148|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2012-02-08|||October 2005||2005-10-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|February 2011|Actual|2011-02-01||Interventional|||Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer|A Phase I/II Trial of Neoadjuvant Paclitaxel, Carboplatin and OSI-774 (Tarceva) With Concurrent Accelerated Hyperfractionation Radiation Followed by Maintenance Therapy With OSI-774 for Stage III Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|32|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:49:58.704039|2017-02-18 16:49:58.704039
NCT00278135|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2014-05-16|||December 2005||2005-12-01|May 2014|2014-05-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|MIDAS||Memory Improvement With Docosahexaenoic Acid Study (MIDAS)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly|Completed||N/A|485|Actual|DSM Nutritional Products, Inc.||2|||f||||f||||||||||2017-02-18 16:49:58.813246|2017-02-18 16:49:58.813246
NCT00278122|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2013-12-09|||July 2005||2005-07-01|December 2013|2013-12-01||||December 2015|Anticipated|2015-12-01||Interventional|||Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery|Evaluation of the Clinical Efficacy of Leukine® Administered in Conjunction With Paclitaxel in Patients With Advanced Melanoma|Suspended||Phase 2|42|Anticipated|University of Virginia||1|||||||||||||||||2017-02-18 16:49:59.170719|2017-02-18 16:49:59.170719
NCT00278109|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2014-03-28|||July 2004||2004-07-01|March 2014|2014-03-01||||May 2015|Anticipated|2015-05-01||Interventional|||Radiation Therapy, Cyclophosphamide, and Doxorubicin in Treating Women With Stage I or Stage II Breast Cancer Who Have Undergone Surgery|Phase I/II Partial Breast Irradiation With Concurrent Chemotherapy|Unknown status|Active, not recruiting|Phase 1/Phase 2|42|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:49:59.278967|2017-02-18 16:49:59.278967
NCT00278096|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2006-01-13|||March 2000||2000-03-01|January 2006|2006-01-01|May 2004||2004-05-01|||||Interventional|||Randomised Controlled Trial of Unsolicited Occupational Therapy in Community-Dwelling Elderly|Randomised Controlled Trial of Unsolicited Occupational Therapy in Community-Dwelling Elderly|Completed||N/A|400||Leiden University Medical Center|||||f||||||||||||||2017-02-18 16:49:59.390165|2017-02-18 16:49:59.390165
NCT00278083|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2016-02-23|||October 2001||2001-10-01|January 2006|2006-01-01|April 2004||2004-04-01|||||Interventional|||TNF-alpha Directed Therapy in Asthma|A Randomised, Double Blind, Placebo-controlled, Parallel Group Pilot Study to Determine the Effect of REMICADE on Safety, Efficacy and Biomarkers of Inflammation in Patients With Asthma Receiving Inhaled Corticosteroids|Completed||Phase 2|40||Imperial College London|||||f||||||||||||||2017-02-18 16:49:59.474529|2017-02-18 16:49:59.474529
NCT00278070|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2008-02-27|||January 2006||2006-01-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|||||Interventional|||Metronomic Oral Vinorelbine in Patients With Metastatic Tumors|Metronomic Vinorelbine in Patients With Metastatic Tumors: Phase II Translational Study|Completed||Phase 2|||Hellenic Cooperative Oncology Group||3|||f||||t||||||||||2017-02-18 16:49:59.578673|2017-02-18 16:49:59.578673
NCT00278057|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2006-01-16|||May 2003||2003-05-01|January 2006|2006-01-01|May 2003||2003-05-01|||||Interventional|||STUDY OF GLUCOSE IN DIALYSIS WATER WITH REGARD TO BLOOD PRESSURE AND QUALITY OF LIFE|PHASE 4 STUDY OT THE EFFECT OF GLUCOSE ADDED TO THE DIALYSIS FLUID ON BLOOD PRESSURE, BLOOD GLUCOSE AND QUALITY OF LIFE IN HEMODIALYSIS PATIENTS.|Completed||Phase 4|55||Regional Hospital Holstebro|||||f||||||||||||||2017-02-18 16:49:59.725777|2017-02-18 16:49:59.725777
NCT00278044|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2009-02-06|||January 2006||2006-01-01|January 2006|2006-01-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children|Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children|Unknown status|Recruiting|N/A|20|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 16:49:59.808233|2017-02-18 16:49:59.808233
NCT00278031|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-17|2016-10-01|||March 2006||2006-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|||Quality of Life in Children Cured of Retinoblastoma|Quality of Life in Children Cured of Retinoblastoma|Recruiting||N/A|35|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||Yes||2017-02-18 16:49:59.885203|2017-02-18 16:49:59.885203
NCT00278018|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2015-04-19|||December 2005||2005-12-01|April 2007|2007-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors|Peritumoral Injection of Immature Dendritic Cels to Irradiated Metastases of Solid Tumors|Terminated||Phase 1/Phase 2|20|Anticipated|Hadassah Medical Organization||||Because there were no responses|f||||||||||||||2017-02-18 16:49:59.981156|2017-02-18 16:49:59.981156
NCT00278005|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2012-03-14|||January 1998||1998-01-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Infection in DiGeorge Following CHD Surgery|Incidence of Infection in the Patient With DiGeorge Syndrome Following Surgery for Congenital Heart Disease|Terminated||N/A|400|Actual|Children's Healthcare of Atlanta|||1|completed|f||||f||||||||||2017-02-18 16:50:00.068705|2017-02-18 16:50:00.068705
NCT00277992|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2007-05-22|||January 2001||2001-01-01|May 2007|2007-05-01||||||||Observational|||Growth in Children With HLHS|Growth in Children With HLHS|Terminated||N/A|100||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:50:00.176378|2017-02-18 16:50:00.176378
NCT00277979|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2012-03-14|||January 2005||2005-01-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||3D Echocardiography Managing Infantile Pompe's Disease|Utilization of 3D Echocardiography in the Management of Infantile Pompe's Disease: Two Case Reports|Terminated||N/A|2|Actual|Children's Healthcare of Atlanta|||1|project withdrawn|f||||f||||||||||2017-02-18 16:50:00.255496|2017-02-18 16:50:00.255496
NCT00277966|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2016-08-05|||January 2004||2004-01-01|August 2016|2016-08-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Observational|||Cath Lab Performance Improvement|Cardiac Catheterization Laboratory Radiology Performance Improvement|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta||||No enrollment as this was a retrospective review, not a clinical trial.|f||||||||||||||2017-02-18 16:50:00.332021|2017-02-18 16:50:00.332021
NCT00277953|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2007-05-02||||||May 2007|2007-05-01||||||||Observational|||MRI Review of Tracheal Dimensions|A Review of Tracheal Dimensions in the Pediatric Population Using MRI|Terminated||N/A|75||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:50:00.409075|2017-02-18 16:50:00.409075
NCT00277940|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2011-07-05||||||May 2007|2007-05-01||||||||Observational|||Aortic Arch Reconstruction|Neoaortic Elastic Properties After Aortic Arch Reconstruction|Terminated||N/A|36|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 16:50:00.489393|2017-02-18 16:50:00.489393
NCT00277927|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2011-07-05|||January 1984||1984-01-01|November 2007|2007-11-01|December 2007|Actual|2007-12-01|||||Observational|||Mild Valvar Pulmonary Stenosis|Clinical Management of Children With Mild Valvar Pulmonary Stenosis|Terminated||N/A|146|Actual|Children's Healthcare of Atlanta|||1|sufficient data collected for significant study results|f||||f||||||||||2017-02-18 16:50:00.578736|2017-02-18 16:50:00.578736
NCT00277914|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-16|2012-03-14|||January 2006||2006-01-01|March 2012|2012-03-01||||July 2007|Actual|2007-07-01||Interventional|||Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women|12-month Sustained Efficacy of Flibanserin v Placebo n Younger Women With HSDD in NA|Completed||Phase 3|749|Actual|Sprout Pharmaceuticals, Inc||1|||f||||||||||||||2017-02-18 16:50:00.672675|2017-02-18 16:50:00.672675
NCT00277901|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2014-11-26|||March 2002||2002-03-01|November 2014|2014-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||MRI Assessment of RV Function: Patients With TOF or Aortic Coarctation|MRI Assessment of Two Congenital Heart Disease States: Assessment of Right Ventricular Function: Predictor of Optimal Timing of Pulmonary Valve Replacement in Patients With TOF; Assessment of Flow Dynamics in Patients With Aortic Coarctation|Completed||N/A|390|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 16:50:00.827734|2017-02-18 16:50:00.827734
NCT00277888|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2014-11-13|||April 2004||2004-04-01|November 2014|2014-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|CATHEDIA||Comparison of Femoral Versus Jugular Routes for Temporary Hemodialysis in Seriously Ill Patients|Complications of Jugular and Femoral Venous Catheterization in Critically Ill Patients Requiring Hemodialysis: A Randomized Controlled Trial|Completed||N/A|750|Actual|University Hospital, Caen||2|||f||||||||||||||2017-02-18 16:50:00.917161|2017-02-18 16:50:00.917161
NCT00277875|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2009-08-26|||February 2004||2004-02-01|January 2006|2006-01-01|January 2006|Actual|2006-01-01|December 2004|Actual|2004-12-01||Interventional|||STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH|The Effect of Vascular Distensibility on Endothelial-Dependent Vasoreactivity in Patients With Systolic Hypertension Before and After Receiving Oral Alagebrium for 8 Weeks.|Completed||Phase 2|25||Synvista Therapeutics, Inc|||||f||||f||||||||||2017-02-18 16:50:01.027481|2017-02-18 16:50:01.027481
NCT00277862|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-15|2008-02-25|||April 2002||2002-04-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|||Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4|Role of Rapid Virologic Response in Determining Treatment Duration of Peginterferon Alfa-2b/Ribavirin in Chronic Hepatitis C Genotype 4|Completed||Phase 4|280|Actual|Ain Shams University||4|||f||||t||||||||||2017-02-18 16:50:01.126182|2017-02-18 16:50:01.126182
NCT00277849|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-14|2017-01-24|||January 11, 2006||2006-01-11|July 20, 2010|2010-07-20|July 20, 2010||2010-07-20|||||Observational|||Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research|Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research|Completed||N/A|130|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:50:01.251206|2017-02-18 16:50:01.251206
NCT00277836|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2006-12-07||||||December 2006|2006-12-01||||||||Interventional|||Study Evaluating MST-997 in Advanced Malignant Solid Tumors|A Phase 1 Dose-Escalation Study of Intravenous MST-997 Formulated in Polysorbate 80 Diluent Administered Weekly in Subjects With Advanced Malignant Solid Tumors|Terminated||Phase 1|60||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:50:01.343942|2017-02-18 16:50:01.343942
NCT00277823|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2007-12-19|||February 2006||2006-02-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Fixed Doses (50 mg, 100 mg) of Desvenlafaxine Sustained-Release Tablets in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|480||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:50:01.430891|2017-02-18 16:50:01.430891
NCT00277199|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2011-04-11|||September 2002||2002-09-01|April 2011|2011-04-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Comparability DE vs CD-CHO1|Study to Compare the Pharmacokinetics of CD-CHO1 Process BMS-188667 to DE Process BMS188667 in Healthy Subjects|Completed||Phase 1|30||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 16:50:10.393318|2017-02-18 16:50:10.393318
NCT00277810|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-02-14||2013-02-14|March 2006||2006-03-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease|A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability, and Efficacy Study of 3 Doses of Lecozotan (SRA-333) SR in Outpatients With Mild to Moderate Alzheimer's Disease Treated With a Cholinesterase Inhibitor|Completed||Phase 2/Phase 3|250|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||t||||||||||2017-02-18 16:50:01.791115|2017-02-18 16:50:01.791115
NCT00277797|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-06-13|||February 2001||2001-02-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|March 2006|Actual|2006-03-01||Interventional|||"Non-Invasive Targeted Electronic Pain Control Device (Biowave System) Versus Transcutaneous Electrical Nerve Stimulation (TENS) for the Symptomatic Treatment of Chronic Low Back Pain"|"A Randomized, Single-Blinded, Comparative Crossover Trial of the Safety and Efficacy of a Non-Invasive Targeted Electronic Pain Control Device (Biowave System) Versus Transcutaneous Electrical Nerve Stimulation (TENS) for the Symptomatic Treatment of Chronic Low Back Pain."|Completed||Phase 3|50|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 16:50:01.983506|2017-02-18 16:50:01.983506
NCT00277784|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2008-03-04|||July 2005||2005-07-01|March 2008|2008-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular Degeneration|High-Resolution Ultrasound Imaging of the Retina and Choroid|Completed||N/A|40|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 16:50:02.103832|2017-02-18 16:50:02.103832
NCT00277771|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2015-07-02|||February 2006||2006-02-01|July 2015|2015-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Improving Self-Monitoring in Weight Loss With Technology|Improving Self-Monitoring in Weight Loss With Technology|Completed||N/A|210|Actual|University of Pittsburgh||1|||f||||f||||||||||2017-02-18 16:50:02.218816|2017-02-18 16:50:02.218816
NCT00277758|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2008-03-06|||March 2004||2004-03-01|March 2008|2008-03-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I|A Phase I Study of Low Dose Interleukin 2 (IL-2)Monotherapy, Followed by IL-2 Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I Infection|Terminated||Phase 1|18|Actual|Weill Medical College of Cornell University||2||Insufficient rate of volunteer accrual.|f||||t||||||||||2017-02-18 16:50:02.322925|2017-02-18 16:50:02.322925
NCT00277745|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2015-12-11|||June 2005||2005-06-01|December 2015|2015-12-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Observational|||Integrated Microfluidic System for Oral Diagnostics|Integrated Microfluidic System for Oral Diagnostics|Completed||Phase 1|100|Actual|University of Michigan|||1||f||||t||||||Samples Without DNA|"~     Saliva, serum, dental plaque and gingival crevicular fluid~   "|||2017-02-18 16:50:02.464596|2017-02-18 16:50:02.464596
NCT00277732|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2007-12-19|||January 2006||2006-01-01|December 2007|2007-12-01|November 2006||2006-11-01|||||Interventional|||Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial|Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial|Completed||N/A|288|Actual|University Ghent||1|||f||||f||||||||||2017-02-18 16:50:02.571078|2017-02-18 16:50:02.571078
NCT00277706|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2009-10-06|||August 2004||2004-08-01|October 2009|2009-10-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Impact of Parathyroid Hormone (PTH) on Osseous Cavity|Impact of Parathyroid Hormone (1-34) on Osseous Regeneration in the Oral Cavity|Completed||Phase 1|40|Anticipated|University of Michigan||2|||||||||||||||||2017-02-18 16:50:02.660435|2017-02-18 16:50:02.660435
NCT00277693|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2006-01-12||||||December 2005|2005-12-01||||||||Interventional|||Cardiovascular Protective Effect of Spironolactone in Hemodialysis|Protective Mechanisms of Aldosterone Antagonists and Their Effects on Cardiovascular Damage in Chronic Renal Failure: Clinical and Experimental Studies|Unknown status|Recruiting|Phase 4|||Universidad Los Andes, Chile|||||f||||||||||||||2017-02-18 16:50:02.769885|2017-02-18 16:50:02.769885
NCT00277680|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2011-07-03|||December 2000||2000-12-01|January 2006|2006-01-01|April 2010||2010-04-01|||||Interventional|||Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine Fibroids|A Randomized Trial Comparing Laparoscopic Bilateral Occlusion of Uterine Vessels to Uterine Fibroid Embolization for the Treatment of Symptomatic Uterine Fibroids|Unknown status|Active, not recruiting|N/A|60||Oslo University Hospital|||||f||||||||||||||2017-02-18 16:50:02.858322|2017-02-18 16:50:02.858322
NCT00277667|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2009-03-12|||February 2004||2004-02-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms|A Randomized, Double-Blind, Placebo-Controlled Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms|Completed||Phase 3|40|Anticipated|Lindner Center of HOPE||1|||f||||||||||||||2017-02-18 16:50:02.971265|2017-02-18 16:50:02.971265
NCT00277654|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2011-12-12|||February 2004||2004-02-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder|A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder|Completed||Phase 3|111|Actual|Lindner Center of HOPE||2|||f||||||||||||||2017-02-18 16:50:03.082578|2017-02-18 16:50:03.082578
NCT00277641|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2011-06-21|||March 2006||2006-03-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity|Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity: A Single-Center, Double-Blind, Placebo-Controlled, Flexible-Dose Study in Outpatients|Completed||Phase 3|70|Anticipated|Lindner Center of HOPE||2|||f||||||||||||||2017-02-18 16:50:03.203336|2017-02-18 16:50:03.203336
NCT00277615|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2012-01-20|||October 2005||2005-10-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|||||Observational|||Evaluation Study of Ultrasound Bladder Scanner for Monitoring Bladder Function|Clinical Evaluation of a Portable Ultrasound Bladder Scanner for Continuous Monitoring of Bladder Function in Children.|Unknown status|Active, not recruiting|N/A|30|Anticipated|University of Aarhus|||1||f||||f||||||||||2017-02-18 16:50:03.31867|2017-02-18 16:50:03.31867
NCT00271206|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2012-07-24|||September 2004||2004-09-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Progesterone on Smoking Behavior in Male and Female Smokers|Progesterone and the Effects of Nicotine|Completed||Phase 1|65|Actual|Yale University||2|||f||||t||||||||||2017-02-18 16:51:59.445047|2017-02-18 16:51:59.445047
NCT00277602|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2012-02-15|||November 1999||1999-11-01|February 2012|2012-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Riluzole in Huntington's Disease|A Phase III Multicenter, Double-Blind, Parallel-Group, Placebo Controlled Study to Measure the Effect of Riluzole 50 mg b.i.d. Over a Period of Three Years on the Progression of Huntington's Disease|Completed||Phase 3|537|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:50:03.403305|2017-02-18 16:50:03.403305
NCT00277589|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2009-12-03|||May 2004||2004-05-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||LISA-study : Levothyroxin in Nodular Goiter|TSH-adapted Therapy in a Large Randomized, Observer-blind, Placebo-controlled, Prospective Treatment Study of Patients With Nodular Goiter|Completed||Phase 4|1024|Actual|Sanofi||4|||f||||||||||||||2017-02-18 16:50:03.483851|2017-02-18 16:50:03.483851
NCT00277576|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2008-11-20|||January 2006||2006-01-01|November 2008|2008-11-01|December 2007|Actual|2007-12-01|||||Interventional|||Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection|Phase I, Multi-Centre, Randomised, Placebo-Controlled, Dose Escalation Study to Assess Local & Systemic Tolerability of Therapeutic DNA Plasmid pdpSC18 Vaccine Administered by Particle Mediated Epidermal Delivery Using PowderJect ND10 Delivery System in Subjects With Chronic Hepatitis B Infection|Completed||Phase 1|48|Anticipated|PowderMed|||||||||||||||||||2017-02-18 16:50:03.586775|2017-02-18 16:50:03.586775
NCT00277563|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2007-09-20|||June 2004||2004-06-01|September 2007|2007-09-01|July 2005||2005-07-01|||||Interventional|||Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome|Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome (Cts): A Randomized, Placebo-Controlled Trial With Secondary Bayesian Modification|Completed||Phase 4|50||Weintraub, Michael I., MD, FACP, FAAN|||||f||||||||||||||2017-02-18 16:50:03.69229|2017-02-18 16:50:03.69229
NCT00277550|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2016-03-02||||||March 2016|2016-03-01||||||||Interventional|||The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia|A Randomized, Double-blind, Placebo-controlled Evaluation of the Effects of Tegaserod (6 mg b.i.d) on Whole Gut Transit Time in Patients With Chronic Idiopathic Constipation and Dyspepsia|Withdrawn||Phase 4|0|Actual|Novartis|||||||||||||||||||2017-02-18 16:50:03.793105|2017-02-18 16:50:03.793105
NCT00277537|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2008-08-27|||March 2006||2006-03-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy of Bronchitol in Bronchiectasis|A Phase III Multicenter, Randomised, Parallel, Placebo-Controlled, Double-Blind Study to Investigate the Safety and Efficacy of Treatment With Bronchitol (Dry Powder Mannitol) in the Symptomatic Treatment of Bronchiectasis.|Completed||Phase 3|354|Anticipated|Pharmaxis||2|||f||||t||||||||||2017-02-18 16:50:03.884905|2017-02-18 16:50:03.884905
NCT00277524|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-05-21|2012-07-13||August 2005||2005-08-01|May 2013|2013-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|OMNI|Subjects implanted with an IPG, ICD or CRT-D and age 18 years or older were eligible for the OMNI study. Clinical data and device programming at baseline from all subjects was summarized for categorical and continuous variables using descriptive statistics.|OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.|OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.|Terminated||N/A|3032|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1|Ended follow-up after four years|f||||f||||||||||2017-02-18 16:50:04.037687|2017-02-18 16:50:04.037687
NCT00277511|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2007-10-11|||March 2003||2003-03-01|October 2007|2007-10-01||||||||Interventional|||Levofloxacin, Chronic Bacterial Prostatitis|Prospective, Multinational, Multicenter, Non-Comparative, Open Study With a 6 Months Follow-up Period to Demonstrate the Efficacy and Safety of Oral Levofloxacin 500 mg Once Daily in the Treatment of Chronic Bacterial Prostatitis (CBP)|Completed||Phase 3|120||Sanofi|||||f||||||||||||||2017-02-18 16:50:05.069287|2017-02-18 16:50:05.069287
NCT00277498|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2011-03-15|||December 2005||2005-12-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|||||Interventional|||A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma|A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Xalacom Given In The Evening, Xalatan Given In The Evening, And Timolol Given In The Morning In Patients With Open Angle Glaucoma Or Ocular Hypertension In The United States.|Completed||Phase 3|528||Pfizer|||||f||||||||||||||2017-02-18 16:50:05.161397|2017-02-18 16:50:05.161397
NCT00277472|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2011-06-06|||November 2005||2005-11-01|March 2008|2008-03-01||||November 2005|Actual|2005-11-01||Interventional|||Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension|A 28-week, Multicenter Study to Evaluate the Effects of Valsartan/Hydrochlorothiazide (160/12.5 mg) in Comparison With Hydrochlorothiazide (25 mg) Monotherapy, for the Treatment of Patients With Hypertension, Uncontrolled by Hydrochlorothiazide (12.5 mg) Monotherapy|Completed||Phase 4|300|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:50:05.33982|2017-02-18 16:50:05.33982
NCT00277446|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2011-02-23|2011-01-14||January 2006||2006-01-01|February 2011|2011-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Dietary Supplementation With Soy Isoflavones in Asthma|Dietary Supplementation With Soy Isoflavones in Asthma|Completed||N/A|13|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 16:50:05.453809|2017-02-18 16:50:05.453809
NCT00277433|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-04-28|||June 2004||2004-06-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|||||Observational|||Histamine Pharmacogenetics in Children With Atopic Dermatitis|Histamine Pharmacogenetics in Children With Atopic Dermatitis|Completed||N/A|751|Actual|Virginia Commonwealth University|||2||f||||f||||||Samples With DNA|"~     buccal-derived DNA~   "|||2017-02-18 16:50:05.707594|2017-02-18 16:50:05.707594
NCT00277420|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2015-08-21|||August 2005||2005-08-01|August 2015|2015-08-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Trial of a Culturally-Appropriate Weight Loss Intervention for Overweight Latino Children|A Randomized Controlled Trial of a Culturally-Appropriate Weight Loss Intervention for Overweight Latino Children|Withdrawn||N/A|0|Actual|Medical College of Wisconsin||||PI has left institution after losing funding for this PI-initiated study|f||||||||||||||2017-02-18 16:50:05.824161|2017-02-18 16:50:05.824161
NCT00277407|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2007-05-04|||June 2006||2006-06-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Treatment of Autistic Children Using NAET Procedures|An Investigation Into the Outcome of NAET Treatment on Children With Allergy-Related Autism Spectrum Disorders in a Multi-Clinical Setting.|Completed||N/A|48|Actual|Nambudripad's Allergy Research Foundation||1|||f||||t||||||||||2017-02-18 16:50:05.906499|2017-02-18 16:50:05.906499
NCT00005451|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|July 2000|2000-07-01|July 1999||1999-07-01|||||Observational|||WINCATI Software Tool for Survey Research||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.064703|2017-02-18 18:14:58.064703
NCT00277394|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2015-03-25|2010-11-23||December 2005||2005-12-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis|Safety Profile of Innohep Versus Subcutaneous Unfractionated Heparin in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis|Completed||Phase 4|541|Actual|LEO Pharma||2|||f||||t||||||||||2017-02-18 16:50:06.011994|2017-02-18 16:50:06.011994
NCT00277381|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2013-02-27|||July 2006||2006-07-01|February 2013|2013-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Improving Adherence in Patients With Hypertension - A Novel Use of Communication Technology|Improving Adherence in Patients With Hypertension - A Novel Use of Communication Technology|Completed||N/A|84|Actual|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 16:50:06.861342|2017-02-18 16:50:06.861342
NCT00277368|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2010-04-26|||July 2005||2005-07-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Observational|||A Study of the Prevalence of Headache in Epileptic Patients|Headache in Epileptic Patients|Completed||N/A|719|Actual|Janssen Korea, Ltd., Korea|||1||f||||||||||||||2017-02-18 16:50:06.949067|2017-02-18 16:50:06.949067
NCT00277355|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-04-17|2013-03-07||April 2006||2006-04-01|April 2013|2013-04-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Pilot Study of Minocycline in Huntington's Disease|A Multi-Center, Double-Blind, Pilot Study of Minocycline in Huntington's Disease|Completed||Phase 2/Phase 3|114|Actual|Huntington Study Group||2|||f||||t||||||||||2017-02-18 16:50:07.041987|2017-02-18 16:50:07.041987
NCT00277342|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2012-05-03|||January 2006||2006-01-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Potential Association of a Common L-FABP Polymorphism With Lipid-induced Hepatic Insulin Resistance||Completed||N/A|18||German Institute of Human Nutrition|||||f||||||||||||||2017-02-18 16:50:07.555947|2017-02-18 16:50:07.555947
NCT00277329|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-02-18|||December 2005||2005-12-01|February 2010|2010-02-01|July 2008|Actual|2008-07-01|August 2007|Actual|2007-08-01||Interventional|||Study of XL999 in Patients With Non-small Cell Lung Cancer|A Phase 2 Study of XL999 Administered Intravenously to Subjects With Non-Small-Cell Lung Cancer|Terminated||Phase 2|9|Actual|Symphony Evolution, Inc.||1||Study was terminated due to cardiac toxicities in the subejcts|f||||t||||||||||2017-02-18 16:50:07.90446|2017-02-18 16:50:07.90446
NCT00277316|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-02-18|||December 2005||2005-12-01|February 2010|2010-02-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|||Study of XL999 in Patients With Metastatic Renal Cell Carcinoma|A Phase 2 Study of XL999 Administered Intravenously to Subjects With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|11|Actual|Symphony Evolution, Inc.||1||Development of XL999 was stopped due to cardiac toxicities in the subjects|f||||t||||||||||2017-02-18 16:50:07.999645|2017-02-18 16:50:07.999645
NCT00277303|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-02-18|||December 2005||2005-12-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Interventional|||Study of XL999 in Patients With Metastatic Colorectal Cancer|A Phase 2 Study of XL999 Administered Intravenously to Subjects With Metastatic Colorectal Cancer|Terminated||Phase 2|17|Actual|Symphony Evolution, Inc.||1||Study was terminated due to cardiac toxicities in the subjects|f||||t||||||||||2017-02-18 16:50:08.09522|2017-02-18 16:50:08.09522
NCT00277290|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-02-18|||January 2006||2006-01-01|February 2010|2010-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study of XL999 in Patients With Previously Treated Ovarian Cancer|A Phase 2 Study of XL999 Administered Intravenously to Subjects With Recurrent Ovarian Cancer|Terminated||Phase 2|24|Actual|Symphony Evolution, Inc.||1||Study was terminated due to cardiac toxicities in the subjects|t||||t||||||||||2017-02-18 16:50:08.191128|2017-02-18 16:50:08.191128
NCT00277277|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2007-10-29|||August 2004||2004-08-01|October 2007|2007-10-01|September 2005||2005-09-01|||||Interventional|||In-Home Weight Loss Program for Adults With Type 2 Diabetes Delivered by Interactive Cable Television Technology|Telehealth Delivery of a Weight Loss Program in Diabetes|Completed||N/A|19||Bastyr University|||||f||||||||||||||2017-02-18 16:50:08.295075|2017-02-18 16:50:08.295075
NCT00277264|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-11-05|||January 2002||2002-01-01|November 2013|2013-11-01|May 2004||2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Spiriva® Assessment of FEV1 (SAFE)|Spiriva® Assessment of FEV1 (SAFE). The Effect of Inhaled Tiotropium Bromide (18 Mcg Once Daily) on the Change in FEV1 During Long-term Treatment in Patients With COPD. A One-year Parallel Group, Double-blind, Randomised, Placebo-controlled Study|Completed||Phase 3|914||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:50:08.403054|2017-02-18 16:50:08.403054
NCT00277251|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2006-01-13|||March 2003||2003-03-01|January 2006|2006-01-01||||||||Interventional|||Alendronate Osteoporosis Study|Double-Blinded Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid- Associated Osteopenia and Osteoporosis|Unknown status|Active, not recruiting|Phase 2/Phase 3|20||Boston Children’s Hospital|||||||||||||||||||2017-02-18 16:50:08.599331|2017-02-18 16:50:08.599331
NCT00277238|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2011-04-21||2011-01-03|February 2006||2006-02-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects|CPG 10101 Combination Therapy for the Treatment of Hepatitis C: A Phase II Randomized, Open Label, Multi-Center, Parallel Arm, Controlled Trial of CPG 10101 at Two Different Dose Levels With Pegylated-Interferon-Alpha 2B (PEG-IFN) Plus Ribavirin (RBV) or PEG-IFN Plus RBV Without CPG 10101 in the Treatment of Non-Responder (Null and Partial Responder) HCV Genotype 1 Infected Subjects|Completed||Phase 2|113|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 16:50:08.688781|2017-02-18 16:50:08.688781
NCT00277225|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2011-04-11|||November 1995||1995-11-01|April 2011|2011-04-01|June 1996|Actual|1996-06-01|June 1996|Actual|1996-06-01||Interventional|||A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris|A Phase I,Randomized, Double Blind, Placebo Controlled Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris|Completed||Phase 1|32||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 16:50:08.816424|2017-02-18 16:50:08.816424
NCT00277212|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2013-11-07|2010-09-20||December 2005||2005-12-01|November 2010|2010-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode|A Multicenter, Double-blind, Study of the Efficacy and Safety of Aripiprazole in Combination With Lamotrigine in the Long-term Maintenance Treatment of Patients With Bipolar I Disorder With a Recent Manic or Mixed Episode|Completed||Phase 4|1169|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-02-18 16:50:08.923192|2017-02-18 16:50:08.923192
NCT00277186|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2008-07-28|||April 2005||2005-04-01|July 2008|2008-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Alberta Hip and Knee Replacement Project|A Randomized Controlled Prospective Study to Examine the Effectiveness of a New Evidence Based Arthroplasty Care Model for Patients With Severe Degenerative Joint Disease (DJD) of the Hip or Knee in Alberta|Completed||N/A|3434|Actual|Alberta Bone and Joint Health Institute||2|||f||||t||||||||||2017-02-18 16:50:10.476488|2017-02-18 16:50:10.476488
NCT00277173|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-13|2006-01-13|||January 2006||2006-01-01|January 2006|2006-01-01||||||||Interventional|||Improving Geriatric Drug Safety in Underserved Practices|Improving Geriatric Drug Safety in Underserved Practices|Unknown status|Recruiting|N/A|4800||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 16:50:10.58741|2017-02-18 16:50:10.58741
NCT00277160|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-10-07|||June 2002||2002-06-01|October 2010|2010-10-01|January 2005|Actual|2005-01-01|November 2004|Actual|2004-11-01||Interventional|||A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer|A Randomized, Open Label, Multicenter Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis as an Adjunct to Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer|Completed||Phase 4|852|Actual|Amgen||2|||f||||||||||||||2017-02-18 16:50:10.846934|2017-02-18 16:50:10.846934
NCT00277147|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2017-01-24|||January 9, 2006||2006-01-09|September 17, 2008|2008-09-17|September 17, 2008||2008-09-17|||||Interventional|||Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine|Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine, Phase 1 Trial in Adults at NIH CC|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:50:10.949501|2017-02-18 16:50:10.949501
NCT00277121|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2006-01-12|||January 2006||2006-01-01|January 2006|2006-01-01||||||||Observational|||Genetic Origin of Lipid Disorders|Genetic Origin of Lipid Disorders|Unknown status|Not yet recruiting|Phase 1|||University of Oslo|||||f||||||||||||||2017-02-18 16:50:11.06915|2017-02-18 16:50:11.06915
NCT00277108|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2008-11-05|||February 2004||2004-02-01|November 2008|2008-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Lexapro in the Treatment of Patients With Postpartum Depression|Open Label Variable Dose Escitalopram (Lexapro) in the Treatment of Patients With Postpartum Major Depression: A Pilot Study|Completed||N/A|20|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 16:50:11.161497|2017-02-18 16:50:11.161497
NCT00277095|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2016-01-04|2013-01-30||August 2005||2005-08-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|February 2009|Actual|2009-02-01||Interventional|ProACT||ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males|Clinical Investigation of the ProACT Adjustable Continence Therapy for Treatment of Post-Prostatectomy Stress Urinary Incontinence|Active, not recruiting||Phase 2/Phase 3|123|Actual|Uromedica||1|||f||||f||||||||||2017-02-18 16:50:11.267656|2017-02-18 16:50:11.267656
NCT00277082|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-01-06|||August 2003||2003-08-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|||||Observational|||Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung|Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung (NSCLC)|Completed||N/A|24|Actual|University of New Mexico|||1||f||||t||||||Samples Without DNA|"~     Blood, lung tissue, lung cancer tissue.~   "|||2017-02-18 16:50:11.569064|2017-02-18 16:50:11.569064
NCT00277069|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-01-06|||May 2000||2000-05-01|October 2008|2008-10-01|March 2006|Actual|2006-03-01|March 2005|Actual|2005-03-01||Interventional|||Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer|INST: Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|33|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:50:11.672747|2017-02-18 16:50:11.672747
NCT00277056|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2010-01-06|||May 2002||2002-05-01|April 2008|2008-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||Dysregulated Tyrosine Kinase Signaling in Leukemia|Dysregulated Tyrosine Kinase Signaling in Leukemia|Completed||N/A|30|Actual|University of New Mexico|||1||f||||t||||||Samples With DNA|"~     blood bone marrow~   "|||2017-02-18 16:50:11.785545|2017-02-18 16:50:11.785545
NCT00277043|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2011-09-23|||June 2002||2002-06-01|December 2009|2009-12-01|September 2005|Actual|2005-09-01|July 2004|Actual|2004-07-01||Interventional|||A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes|A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes|Completed||Phase 3|200|Actual|New Mexico Cancer Care Alliance||2|||f||||t||||||||||2017-02-18 16:50:11.884003|2017-02-18 16:50:11.884003
NCT00277030|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2006-08-22|||January 2006||2006-01-01|December 2005|2005-12-01||||||||Interventional|||Two Strategies of RDS Treatment in Newborns With Birth Weight > 1500 Grams|Comparative Trial of Two Strategies of RDS Treatment in Newborns With Birth Weight > 1500 Grams|Unknown status|Recruiting|Phase 4|110||Pontificia Universidad Catolica de Chile|||||f||||||||||||||2017-02-18 16:50:12.002636|2017-02-18 16:50:12.002636
NCT00277017|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2011-09-23|||September 2000||2000-09-01|December 2009|2009-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma|A Phase I/II Trial of Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, and Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma.|Completed||Phase 1/Phase 2|15|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-02-18 16:50:12.12843|2017-02-18 16:50:12.12843
NCT00277004|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2010-01-06|||February 1999||1999-02-01|March 2008|2008-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Observational|||Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.|Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.|Completed||N/A|22|Actual|University of New Mexico|||1||f||||t||||||||||2017-02-18 16:50:12.255979|2017-02-18 16:50:12.255979
NCT00276991|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2015-11-02|||November 2007||2007-11-01|November 2015|2015-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Traditional CAM Therapy in the Treatment of HIV/AIDS|Modest Phase 1 and Phase II Clinical Studies on Traditional CAM Therapy in the Treatment of HIV/AIDS|Terminated||Phase 1/Phase 2|40|Actual|Traditional Alternative Medicine Research, India||1||Lack of funding prevented the recruitment of 1000 HIV Patients all over India|f||||t||||||||||2017-02-18 16:50:12.342229|2017-02-18 16:50:12.342229
NCT00276978|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2016-05-12|||June 2005||2005-06-01|May 2016|2016-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Aripiprazole Augmentation Therapy in Treatment-resistant Depression|Aripiprazole Augmentation Therapy in Treatment-resistant Depression|Terminated||Phase 3|20|Actual|University Hospital Freiburg||1|||f||||f||||||||||2017-02-18 16:50:12.48112|2017-02-18 16:50:12.48112
NCT00276965|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-05-08|||September 2006||2006-09-01|May 2013|2013-05-01|July 2012|Actual|2012-07-01|March 2012|Actual|2012-03-01||Interventional|||Bipolar II Depression: Lithium, SSRI, or the Combination|Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression|Completed||Phase 3|139|Actual|Lindner Center of HOPE||3|||f||||t||||||||||2017-02-18 16:50:12.596002|2017-02-18 16:50:12.596002
NCT00276952|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2006-01-12|||September 2004||2004-09-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Gonyautoxin in the Treatment of Chronic Tension-Type Headache|Phase 2 Study of Treatment of Chronic Tension-Type Headache Using Gonyautoxins|Terminated||Phase 2|27||University of Chile|||||f||||||||||||||2017-02-18 16:50:12.71748|2017-02-18 16:50:12.71748
NCT00276939|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2012-08-06|||September 2003||2003-09-01|August 2012|2012-08-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Plant-Based Dietary Intervention in Type 2 Diabetes|Plant-Based Dietary Intervention in Type 2 Diabetes|Completed||N/A|99|Actual|Physicians Committee for Responsible Medicine||2|||f||||t||||||||||2017-02-18 16:50:12.816321|2017-02-18 16:50:12.816321
NCT00276926|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2009-09-14|||March 2003||2003-03-01|September 2009|2009-09-01||||||||Interventional|||Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias|Open Label Pilot Phase II Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias|Unknown status|Recruiting|Phase 2|||University of Bologna|||||f||||||||||||||2017-02-18 16:50:12.929178|2017-02-18 16:50:12.929178
NCT00276913|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2014-01-31|||June 2004||2004-06-01|January 2014|2014-01-01||||||||Interventional|||A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors|A Phase I Study of STA-5312 Administered Weekly in Subjects With Advanced or Metastatic Solid Tumors|Completed||Phase 1|30||Synta Pharmaceuticals Corp.|||||f||||||||||||||2017-02-18 16:50:13.037585|2017-02-18 16:50:13.037585
NCT00276900|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2013-09-30|||December 2003||2003-12-01|September 2013|2013-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Sertraline for the Prevention of Recurrent Postpartum Depression|Prevention of Recurrent Postpartum Depression|Completed||Phase 3|300||University of Pittsburgh|||||f||||f||||||||||2017-02-18 16:50:13.115811|2017-02-18 16:50:13.115811
NCT00276887|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2014-02-19|||September 1999||1999-09-01|February 2014|2014-02-01|April 2004|Actual|2004-04-01|April 2003|Actual|2003-04-01||Interventional|||Cognitive Behavior Therapy for Somatization Disorder|Cognitive Behavior Therapy for Somatization Disorder|Completed||Phase 2|84|Actual|Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-02-18 16:50:13.21508|2017-02-18 16:50:13.21508
NCT00276874|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2016-11-16|||January 2006||2006-01-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Aripiprazole to Reduce Cocaine Relapse|Preventing Cocaine Relapse: Developing Pharmacotherapies|Completed||Phase 1|41|Actual|University of Kentucky||2|||f||||t||||||||||2017-02-18 16:50:13.30752|2017-02-18 16:50:13.30752
NCT00276861|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2016-12-14|2013-01-22||September 2005||2005-09-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|September 2006|Actual|2006-09-01||Interventional|||Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer|Phase II Study of Oxaliplatin And Fixed Rate Infusion Gemcitabine as Second Line Therapy for Patients With Metastatic Colon Cancer|Terminated||Phase 2|10|Actual|University of Miami|Protocol closed prematurely due to low accrual. Only 10 of 27 anticipated patients were enrolled.|1||Low Accrual|f||||t||||||||||2017-02-18 16:50:13.422171|2017-02-18 16:50:13.422171
NCT00276848|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2016-09-23|||July 1999||1999-07-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|July 2003|Actual|2003-07-01||Interventional|||Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia|Fludarabine Versus Fludarabine Plus Cyclophosphamide in First Line Therapy of Younger Patients (Up to 65 Years) With Advanced Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 3|375|Actual|German CLL Study Group||2|||f||||f||||||||No||2017-02-18 16:50:13.789444|2017-02-18 16:50:13.789444
NCT00276835|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2015-04-08|||November 2005||2005-11-01|April 2015|2015-04-01|January 2014|Actual|2014-01-01|July 2007|Actual|2007-07-01||Interventional|||Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer|A Pilot Study of the Effect of Genistein in Combination With High-Dose Interleukin-2 on Cell Expansion and Gene Expression in Patients With Metastatic Melanoma or Renal Cell Carcinoma|Completed||Early Phase 1|15|Actual|Northwestern University||1|||f||||||||||||||2017-02-18 16:50:14.044479|2017-02-18 16:50:14.044479
NCT00276822|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2012-06-08|||October 2005||2005-10-01|June 2012|2012-06-01||||November 2006|Actual|2006-11-01||Interventional|||Improving Communication With Patients With Breast Cancer|Facilitating Caring Communication for People With Cancer: The Case of Breast Cancer|Terminated||N/A|30|Actual|Northwestern University||1||Preliminary findings did not support purpose.|f||||||||||||||2017-02-18 16:50:14.159964|2017-02-18 16:50:14.159964
NCT00276809|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2016-09-23|||June 2001||2001-06-01|September 2016|2016-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia|Campath 1H (Alemtuzumab) Combined With High-Dose Therapy and Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia|Completed||Phase 2|30|Anticipated|German CLL Study Group|||||f||||||||||||||2017-02-18 16:50:14.270192|2017-02-18 16:50:14.270192
NCT00276796|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-05-24||||||February 2009|2009-02-01||||January 2007|Actual|2007-01-01||Interventional|||Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer|A Limited Access Phase II Trial of Weekly Topotecan (NSC #609699), Paclitaxel (NSC #673089), and Cisplatin (NSC #119875) in the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix|Completed||Phase 2|66|Anticipated|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 16:50:14.39183|2017-02-18 16:50:14.39183
NCT00276783|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2016-05-26|||November 2005||2005-11-01|May 2016|2016-05-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases|A Phase II Trial of Alimta (Pemetrexed) in Patients With Recurrent Malignant Gliomas, Primary Central Nervous System Lymphoma, and Brain Metastases|Active, not recruiting||Phase 2|31|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 16:50:14.479657|2017-02-18 16:50:14.479657
NCT00276549|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-01-24|2012-04-26||October 2005||2005-10-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer|Phase II Trial of Gemcitabine And Docetaxel In Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|35|Actual|Case Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 16:50:19.478373|2017-02-18 16:50:19.478373
NCT00276770|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2012-12-12|||February 2006||2006-02-01|December 2012|2012-12-01||||May 2007|Actual|2007-05-01||Interventional|||Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas|NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy Using [F18] Fluorothymidine (FLT) As a Marker of Proliferation in Patients With Primary Brain Tumors|Completed||N/A|12|Actual|University of Washington||1|||f||||||||||||||2017-02-18 16:50:14.604028|2017-02-18 16:50:14.604028
NCT00276757|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2014-01-09|||April 2001||2001-04-01|May 2007|2007-05-01|June 2013|Actual|2013-06-01|||||Interventional|||Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis|Treatment Protocol of the Third International Study For Langerhans Cell Histiocytosis|Completed||N/A|376|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:14.692634|2017-02-18 16:50:14.692634
NCT00276744|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2012-06-06|||October 2005||2005-10-01|June 2012|2012-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Individualized Drug Treatment Selection Process for Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery|A Feasibility Study for Individualized Treatment of Patients With Advanced Pancreatic Cancer|Completed||Phase 2|85|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:50:17.59221|2017-02-18 16:50:17.59221
NCT00276731|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-09-16|||March 1995||1995-03-01|January 2006|2006-01-01||||||||Interventional|||Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma|Randomized Study of Radiotherapy in Patients With Stage 2B/3 (INSS) Neuroblastoma in Children Over 1 Year of Age|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:17.694803|2017-02-18 16:50:17.694803
NCT00276718|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-09-16|||April 1989||1989-04-01|February 2006|2006-02-01||||||||Interventional|||Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors|Germ Cell Tumour Study II|Unknown status|Active, not recruiting|N/A|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:17.813505|2017-02-18 16:50:17.813505
NCT00276705|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-09-16|||June 2005||2005-06-01|June 2009|2009-06-01||||April 2009|Anticipated|2009-04-01||Interventional|||Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer|Hepatocellular Carcinoma Family of Tumours In Children / Adolescents and Young Adults|Unknown status|Active, not recruiting|Phase 2|47|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:17.924284|2017-02-18 16:50:17.924284
NCT00276692|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-06-25|||August 2003||2003-08-01|June 2009|2009-06-01|July 2009|Actual|2009-07-01|September 2008|Actual|2008-09-01||Interventional|||Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma|Phase II Study of Irinotecan (CPT-11) in Children and Adolescents With High Risk Ewing's Sarcoma|Completed||Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:18.039101|2017-02-18 16:50:18.039101
NCT00276679|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-09-16|||April 2003||2003-04-01|January 2006|2006-01-01|November 2006|Actual|2006-11-01|||||Interventional|||Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma|Phase II Study of Temozolomide (Temodal) in Children Over 1 Year of Age With Relapsed or Refractory High Risk Neuroblastoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:18.398082|2017-02-18 16:50:18.398082
NCT00276666|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-09-16|||November 2001||2001-11-01|June 2009|2009-06-01||||March 2010|Anticipated|2010-03-01||Interventional|||Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery|Hyperfractionated Accelerated Radiotherapy (HART) With Chemotherapy (Cisplatin, CCNU, Vincristine) for Metastatic (M1-3) Medulloblastoma|Unknown status|Active, not recruiting|Phase 2|29|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:18.526754|2017-02-18 16:50:18.526754
NCT00276640|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2016-10-14|||April 2004||2004-04-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|SIOP-LGG-2004||Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas|Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma|Active, not recruiting||N/A|3000|Anticipated|Societe Internationale d'Oncologie Pediatrique||4|||f||||t||||||||||2017-02-18 16:50:18.663356|2017-02-18 16:50:18.663356
NCT00276627|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2014-02-05|||February 2003||2003-02-01|February 2014|2014-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer|Enhancing Patient-Oncologist Communication|Completed||N/A|800|Actual|Duke University||2|||f||||f||||||||||2017-02-18 16:50:18.798661|2017-02-18 16:50:18.798661
NCT00276614|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2015-10-28|2012-03-27||April 2006||2006-04-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Bortezomib in Treating Patients With Metastatic Kidney Cancer|A Phase II Study of Bortezomib (Velcade ) Administered as a Single Agent in Metastatic Non-Clear Cell Renal Cell Carcinoma (RCC) Patients|Completed||Phase 2|4|Actual|Jonsson Comprehensive Cancer Center|Approval of several agents for management of renal cell carcinoma rendered accrual to this trial quite difficult.|1|||f||||t||||||||||2017-02-18 16:50:18.905962|2017-02-18 16:50:18.905962
NCT00276601|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2014-04-16|||October 2004||2004-10-01|April 2014|2014-04-01|June 2013|Actual|2013-06-01|December 2007|Actual|2007-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia|A Pilot Study of Arsenic Trioxide-Based Consolidation Therapy for the Primary Treatment of Acute Promyelocytic Leukemia|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:50:19.158054|2017-02-18 16:50:19.158054
NCT00276588|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2010-08-05|||July 2005||2005-07-01|August 2010|2010-08-01||||March 2007|Actual|2007-03-01||Interventional|||Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Trial of Gemcitabine/Paraplatin® (Carboplatin) Followed by Taxol® (Paclitaxel) in Patients With Performance Status = 2,3 or Other Significant Co-Morbidity (HIV Infection or s/p Organ Transplantation) in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|46|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:50:19.264626|2017-02-18 16:50:19.264626
NCT00276575|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2014-11-18|||March 2005||2005-03-01|November 2014|2014-11-01|September 2014|Actual|2014-09-01|October 2012|Actual|2012-10-01||Interventional|||Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors|Phase I Study of Bevacizumab in Combination With Everolimus and Erlotinib in Advanced Cancer|Completed||Phase 1|65|Actual|Duke University||1|||f||||||||||||||2017-02-18 16:50:19.367572|2017-02-18 16:50:19.367572
NCT00276536|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2015-10-11|||January 2001||2001-01-01|October 2015|2015-10-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|IFNa||Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma|Phase I Evaluation of Interferon-alpha-1b in Solid Tumors, Lymphoma or Myeloma|Completed||Phase 1|35|Actual|The Cleveland Clinic||1|||f||||t||||||||||2017-02-18 16:50:19.721851|2017-02-18 16:50:19.721851
NCT00276523|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2012-10-29|||February 2004||2004-02-01|October 2012|2012-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery|A Randomized Phase II Study of SCH 54031 in Surgically Resectable Squamous Cell Tumors of the Head and Neck|Completed||Phase 2|3|Actual|M.D. Anderson Cancer Center||4|||f||||f||||||||||2017-02-18 16:50:19.835844|2017-02-18 16:50:19.835844
NCT00276510|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2009-12-14|||February 2002||2002-02-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints|Efficacy and Tolerance of EGb 761® 120mg Two Times a Day on Dementia of Alzheimer Type's Onset in Patients Suffering From Memory Complaints. A Randomised, Double-blind, Multicentre, Parallel Groups, Placebo Controlled Phase IIIb/IV Study in Elderly Over 70|Completed||Phase 4|2878|Actual|Ipsen||2|||f||||||||||||||2017-02-18 16:50:20.230024|2017-02-18 16:50:20.230024
NCT00276497|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2009-04-03|||October 2003||2003-10-01|April 2009|2009-04-01|May 2008||2008-05-01|||||Interventional|||Role of Pioglitazone in Preventing Diabetes||Completed||Phase 1|||M.V. Hospital for Diabetes|||||f||||t||||||||||2017-02-18 16:50:21.320324|2017-02-18 16:50:21.320324
NCT00276484|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2015-02-20|2009-02-06||February 2006||2006-02-01|February 2015|2015-02-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)|A Multicenter, Rand., Double-Blind, Titration Study to Evaluate & Compare the Efficacy & Safety of Ezetimibe Plus Atorvastatin Vs Atorvastatin in Hypercholesterolemic Pts. at High Risk for CHD Not Adequately Controlled on Atorvastatin 40 Mg|Completed||Phase 3|579|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:50:21.41789|2017-02-18 16:50:21.41789
NCT00276471|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2012-01-31|||December 2005||2005-12-01|January 2012|2012-01-01|June 2007|Actual|2007-06-01|January 2007|Actual|2007-01-01||Interventional|||Evaluation of the Tantalus System in Type 2 Diabetic Subjects|Evaluation of the Tantalus System in Type 2 Diabetic Subjects|Completed||Phase 1|18|Anticipated|Metacure|||||f||||||||||||||2017-02-18 16:50:22.539142|2017-02-18 16:50:22.539142
NCT00276458|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-09-02|2008-12-18||February 2006||2006-02-01|September 2015|2015-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)|A Multicenter., Rand., Double-Blind, Titration Study to Evaluate & Compare the Efficacy & Safety of Ezetimibe Plus Atorvastatin Vs Atorvastatin in Hypercholesterolemic Pts. at Moderately High Risk for CHD Not Adequately Controlled on Atorvastatin 20 Mg|Completed||Phase 3|196|Actual|Merck Sharp & Dohme Corp.|194 out of 196 randomized patients took at least one dose of blinded study therapy and were included in the safety analysis|2|||f||||||||||||||2017-02-18 16:50:22.62806|2017-02-18 16:50:22.62806
NCT00276445|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2006-11-06|||January 2004||2004-01-01|January 2004|2004-01-01|June 2004||2004-06-01|||||Interventional|||Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan|Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan - A Double-Blind Randomized Study|Terminated||Phase 4|60||Meiji University of Oriental Medicine|||||f||||||||||||||2017-02-18 16:50:23.788739|2017-02-18 16:50:23.788739
NCT00276432|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2010-01-27|||November 2005||2005-11-01|January 2010|2010-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome.|Diagnosis and Treatment of Acute Coronary Syndrome in the Emergency Department- The Impact of Rapid Bedside cTnl on Outcome.|Completed||Phase 4|350|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:50:23.894108|2017-02-18 16:50:23.894108
NCT00276419|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2012-12-13|2012-11-16||June 2005||2005-06-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin|Topical Diclofenac for the Treatment of Noncyclic Breast Pain|Terminated||Phase 2/Phase 3|25|Actual|Mayo Clinic|This study was terminated early due to lack of funds; the FDA approved a topical form of diclofenac during study, therefore there was no need to continue study of pharmacy-compounded drug.|2||"Lack of funds; FDA approved a topical form of diclofenac during study, no need to continue~   study of pharmacy-compounded drug."|f||||f||||||||||2017-02-18 16:50:23.980462|2017-02-18 16:50:23.980462
NCT00276406|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2012-11-02|2012-11-02||May 2006||2006-05-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Use of Pyridostigmine for Constipation in Diabetics|Pyridostigmine in Diabetics With Constipation: Randomized, Placebo-controlled, Double-blind Trial|Completed||Phase 1/Phase 2|30|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:50:24.375634|2017-02-18 16:50:24.375634
NCT00276393|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2011-05-20|||July 2002||2002-07-01|May 2011|2011-05-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes|Randomized Trial Comparing Insulin Glargine to Ultra-Lente Insulin in Type I Diabetes|Completed||Phase 4|22||Mayo Clinic|||||f||||||||||||||2017-02-18 16:50:25.064381|2017-02-18 16:50:25.064381
NCT00276380|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2017-01-17|||February 2003||2003-02-01|January 2017|2017-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke|A Phase III, Multicentre, Randomised, Double-blinded, Parallel Group, Placebo Controlled Clinical Study for Evaluating the Efficacy of EGb 761® (Tanakan®) (240mg) in the Recovery of Neurological Impairment Following Ischemic Stroke|Completed||Phase 3|204|Actual|Ipsen||2|||f||||f||||||||No||2017-02-18 16:50:25.160734|2017-02-18 16:50:25.160734
NCT00276367|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2015-05-11|||October 2006||2006-10-01|May 2015|2015-05-01||||||||Observational|||The Impact of Post Discharge One-Time Home Visit: Bridging the Gap Between Hospital and Home.||Withdrawn||N/A|0|Actual|Maimonides Medical Center|||1|is involved in NIH study|f||||||||||||||2017-02-18 16:50:25.29578|2017-02-18 16:50:25.29578
NCT00276354|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2006-05-15|||December 1999||1999-12-01|May 2006|2006-05-01||||||||Interventional|||Study of Long-Term Use of Forlax® in Elderly Patients With Chronic Constipation|Tolerance of Long Term Administration of Forlax® 10g in Elderly Ambulatory or Institutionalized Patients Suffering From Chronic Constipation. Single Blind Randomised Lactulose-Controlled Study With Individual Expected Benefit.|Completed||Phase 4|240||Ipsen|||||f||||||||||||||2017-02-18 16:50:25.372368|2017-02-18 16:50:25.372368
NCT00276341|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2006-05-15|||August 2003||2003-08-01|May 2006|2006-05-01||||||||Interventional|||Study on the Effectiveness of EGb 761® Vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis|Efficacy of EGb 761® 120mg Twice a Day Versus Placebo on Cognitive Impairment in Patients With Multiple Sclerosis. A Randomised, Double-Blind, Multicentre, Parallel Groups Placebo Controlled Phase III Study.|Completed||Phase 3|240||Ipsen|||||f||||||||||||||2017-02-18 16:50:25.84271|2017-02-18 16:50:25.84271
NCT00276328|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2007-01-16|||January 2005||2005-01-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults|Efficacy of Diosmectite (Smecta®) in the Treatment of Acute Diarrhoea in Adults. A Multicentre, Randomised, Double Blind, Placebo Controlled, Parallel Groups Study.|Completed||Phase 4|280||Ipsen|||||f||||||||||||||2017-02-18 16:50:25.958802|2017-02-18 16:50:25.958802
NCT00276315|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2007-07-23|||December 2005||2005-12-01|July 2007|2007-07-01|January 2007|Actual|2007-01-01|||||Interventional|||Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm|A Phase III, Multicentre, Randomised, Assessor-Blind, Parallel Groups, Reference Drug Controlled Study to Assess the Efficacy and Safety of a Single Administration, by Subcutaneous Injection of Dysport® for the Treatment of Hemifacial Spasm|Completed||Phase 3|348||Ipsen|||||f||||||||||||||2017-02-18 16:50:26.088057|2017-02-18 16:50:26.088057
NCT00276302|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2011-01-05|||December 2005||2005-12-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)|A Phase 1, Safety Assessment and Pharmacokinetic Study of IPI-504 in Patients With Either Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) or Advanced or Metastatic Soft Tissue Sarcomas (STS)|Completed||Phase 1|63|Actual|Infinity Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 16:50:26.179037|2017-02-18 16:50:26.179037
NCT00276289|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2009-12-02|||January 2006||2006-01-01|December 2009|2009-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics|Spironolactone to Decrease Potassium Wasting in Hypercalciuric Patients Treated With Thiazide Diuretics|Completed||N/A|10|Anticipated|Indiana University|||||f||||||||||||||2017-02-18 16:50:26.288583|2017-02-18 16:50:26.288583
NCT00276276|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2013-04-11|||November 2000||2000-11-01|November 2012|2012-11-01||||||||Interventional|||Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer|An Open-Label, Multicentre, Randomised, Phase III Comparator Study of Active Symptom Control Alone or in Combination With Oral Topotecan in Patients With Relapsed Resistant SCLC|Completed||Phase 3|141||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:50:26.388133|2017-02-18 16:50:26.388133
NCT00276263|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2014-06-03|||August 2006||2006-08-01|June 2014|2014-06-01|June 2009||2009-06-01|||||Interventional|||Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia|Sarcosine (N-methylglycine) Trial for Individuals At Risk for Developing Schizophrenia and Related Disorders|Withdrawn||Phase 2|0|Actual|Herzog Hospital||1||lack of participants|f||||t||||||||||2017-02-18 16:50:26.516897|2017-02-18 16:50:26.516897
NCT00276250|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2016-06-16|2016-04-25||December 2005||2005-12-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Islet Transplantation Using Abatacept|Development of Immunosuppression Regimens to Facilitate Single Donor Islet Transplantation Using Abatacept|Completed||Phase 2|5|Actual|Emory University|Enrollment in this study was limited by the removal of Efalizumab from the market in 2009 after patients (external to this study) being treated for plaque psoriasis were diagnosed with Progressive Multifocal Leukoencephalopathy (PML).|3|||f||||t||||||||||2017-02-18 16:50:26.644014|2017-02-18 16:50:26.644014
NCT00276237|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2013-11-25|||July 2005||2005-07-01|November 2013|2013-11-01|November 2005|Actual|2005-11-01|||||Observational|||Outcomes Following Pulmonary Valve Replacement in Adults|Review of Outcomes Following Pulmonary Valve Replacement for Congenital Heart Disease in Adults|Completed||N/A|300||Emory University|||||f||||||||||||||2017-02-18 16:50:27.304778|2017-02-18 16:50:27.304778
NCT00276224|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2007-10-30|||September 2005||2005-09-01|October 2007|2007-10-01|April 2006||2006-04-01|||||Interventional|||Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia|Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia|Completed||N/A|480||DBL -Institute for Health Research and Development|||||f||||||||||||||2017-02-18 16:50:27.38146|2017-02-18 16:50:27.38146
NCT00276211|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2009-01-27|||January 2006||2006-01-01|January 2006|2006-01-01|December 2006|Actual|2006-12-01|||||Observational|||Diffusion Weighted MRI for Lymphnodes in the Axilla|Diffusionsvægtet MR Skanning Med Henblik på axillære Lymfeknudemetastaser Hos Patienter Med primær Mammacancer - et Pilotstudie|Completed||N/A|10|Anticipated|Copenhagen University Hospital at Herlev|||1||f||||||||||||||2017-02-18 16:50:27.470344|2017-02-18 16:50:27.470344
NCT00276198|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2008-04-15|||July 2005||2005-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy Trial to Examine Efficacy of Multimicronutrient Home Supplementation in Infants|Controlled Clinical Trial to Assess the Effect of Multiple Micronutrient Supplementation (Iron, Vitamins A, C, D, Folic Acid and Zinc) on Nutritional and Health Indicators in Infants in Southern Israel.|Completed||Phase 3|771|Anticipated|Soroka University Medical Center||3|||f||||f||||||||||2017-02-18 16:50:27.543367|2017-02-18 16:50:27.543367
NCT00276185|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-12|2011-01-18|||December 2005||2005-12-01|January 2011|2011-01-01|December 2009|Anticipated|2009-12-01|January 2009|Anticipated|2009-01-01||Interventional|||HEMITOX : Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After Stroke|Effect of Botulinum Toxin Injections on Motor and Functional Ability of Upper Limb in Adults at Earlier Phases of Spastic Hemiplegia After Stroke|Unknown status|Recruiting|Phase 3|180|Anticipated|University Hospital, Clermont-Ferrand||1|||f||||||||||||||2017-02-18 16:50:27.660739|2017-02-18 16:50:27.660739
NCT00276172|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2009-06-19|||December 2003||2003-12-01|June 2009|2009-06-01|January 2006|Actual|2006-01-01|October 2005|Actual|2005-10-01||Interventional|||Open-Label Natalizumab Safety Extension Study|An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Natalizumab in Subjects With Multiple Sclerosis Who Have Completed Studies C-1801, C-1802, or C-1803|Completed||Phase 3|1615|Actual|Biogen||1|||f||||f||||||||||2017-02-18 16:50:27.767044|2017-02-18 16:50:27.767044
NCT00275483|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2008-05-27|||May 2005||2005-05-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|October 2005|Actual|2005-10-01||Interventional|||Prevention of Postoperative Nausea and Vomiting (PONV) by Acupressure|Prevention of PONV by Acupressure. A Study of the Effect of a Recently Generated Danish Bracelet Vital-Band(R) Which Stimulates the Acupressure Point P6|Completed||Phase 4|132|Actual|Herlev Hospital||2|||f||||||||||||||2017-02-18 16:50:39.999696|2017-02-18 16:50:39.999696
NCT00276159|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2010-07-07|2010-03-02||January 2006||2006-01-01|July 2010|2010-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Immune Response Modifier in the Treatment of Hematologic Malignancies|Phase II Study of 852A Administered Subcutaneously in Patients With Hematologic Malignancies Not Responding to Standard Treatment|Terminated||Phase 2|6|Actual|Masonic Cancer Center, University of Minnesota||1||Drug was not available.|f||||t||||||||||2017-02-18 16:50:27.87295|2017-02-18 16:50:27.87295
NCT00276146|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2013-08-05|||May 2005||2005-05-01|August 2013|2013-08-01||||||||Interventional|||Dipyridamole/Magnesium To Improve Sickle Cell Hydration|Dipyridamole/Magnesium To Improve Sickle Cell Hydration|Withdrawn||Phase 2|0|Actual|Children's Hospital Medical Center, Cincinnati||||The NHLBI BSMB recommended closure due to poor enrollment.|f||||t||||||||||2017-02-18 16:50:28.160293|2017-02-18 16:50:28.160293
NCT00276133|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2007-05-08|||January 2004||2004-01-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Effects of Atorvastatin Versus Probucol on Small Dense LDL|Effects of Atorvastatin Versus Probucol on Low-Density Lipoprotein Subtype Distribution and Renal Function in Hyperlipidemic Patients With Non-Diabetic Nephropathy|Completed||Phase 4|24|Actual|Yokohama City University Medical Center||1|||f||||t||||||||||2017-02-18 16:50:28.27313|2017-02-18 16:50:28.27313
NCT00276120|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-03-09|||March 2005||2005-03-01|March 2011|2011-03-01|January 2015|Anticipated|2015-01-01|||||Observational|||Young Women's Breast Cancer Research Program|Identification of Novel Genetic Risk Factors That Contribute to the Risk for Breast Cancer|Unknown status|Recruiting|N/A|5000|Anticipated|Washington University School of Medicine|||1||f||||t||||||Samples With DNA|"~     Blood specimens.~   "|||2017-02-18 16:50:28.370728|2017-02-18 16:50:28.370728
NCT00276107|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2009-07-28|||December 2004||2004-12-01|July 2009|2009-07-01|December 2005||2005-12-01|||||Interventional|||Study Evaluating Prevenar Vaccine in Healthy Infants|An Open-Label Trial of the Immunogenicity and Safety of Prevenar (Pneumococcal 7-Valent Conjugate Vaccine [Diphteria CRM197 Protein Conjugate]) in Healthy Infants at 2, 4 and 6 Months of Age|Completed||Phase 4|200||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:50:28.474484|2017-02-18 16:50:28.474484
NCT00276094|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-05-21|2013-03-20||January 2006||2006-01-01|March 2013|2013-03-01|December 2007|Actual|2007-12-01|||||Interventional|||A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women|Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women: A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing Oral Ospemifene 30 and 60 Mg Daily Doses With Placebo|Completed||Phase 3|826|Actual|Shionogi Inc.||3|||||||||||||||||2017-02-18 16:50:28.562008|2017-02-18 16:50:28.562008
NCT00276081|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2006-11-27|||May 2002||2002-05-01|January 2006|2006-01-01|September 2004||2004-09-01|||||Interventional|||Gabapentin Versus Estrogen for the Treatment of Hot Flashes|A Randomized Trial of Gabapentin, Estrogen and Placebo for the Treatment of Postmenopausal Hot Flashes|Completed||Phase 4|60||University of Rochester|||||||||||||||||||2017-02-18 16:50:30.95858|2017-02-18 16:50:30.95858
NCT00276068|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2007-11-12|||August 2002||2002-08-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Vulvar Vestibulitis Clinical Trial: Desipramine-Lidocaine|Vulvar Vestibulitis Trial: Desipramine-Lidocaine|Completed||N/A|128|Anticipated|University of Rochester|||||f||||t||||||||||2017-02-18 16:50:31.068685|2017-02-18 16:50:31.068685
NCT00276055|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2015-06-17|||November 2005||2005-11-01|June 2015|2015-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma|Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma|Completed||Phase 1|38|Actual|New Mexico Cancer Care Alliance||3|||f||||t||||||||||2017-02-18 16:50:31.167922|2017-02-18 16:50:31.167922
NCT00276042|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2008-02-01|||January 2006||2006-01-01|February 2008|2008-02-01||||January 2007|Actual|2007-01-01||Interventional|||A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media|Prospective, Randomized, Investigator-Blind Trial to Evaluate the Bacteriologic Eradication, Safety and Tolerability, and Pharmacokinetics of Different Dosages of Faropenem Medoxomil BID for 10 Days in the Treatment of Acute Otitis Media|Completed||Phase 2|328|Actual|Replidyne|||||f||||f||||||||||2017-02-18 16:50:31.289904|2017-02-18 16:50:31.289904
NCT00276029|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2006-05-03|||December 2003||2003-12-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Interventional|||TNF Alpha in Refractory Asthma|The Efficacy of a Soluble Ligand Binding Tumour Necrosis Factor Receptor, Etanercept, in Severe, Steroid Dependant Asthma: a Randomised Controlled Study|Completed||N/A|10||University Hospitals, Leicester|||||f||||||||||||||2017-02-18 16:50:31.38596|2017-02-18 16:50:31.38596
NCT00276016|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2015-09-25|2010-04-01||January 2006||2006-01-01|September 2015|2015-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR)(P04579)|Crossover Study of the Decongestant Effect of Phenylephrine Compared With Placebo and Pseudoephedrine as Active Control in SAR Subjects Exposed to Pollen in the Vienna Challenge Chamber|Completed||Phase 3|39|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 16:50:31.496501|2017-02-18 16:50:31.496501
NCT00276003|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2010-01-06|||August 2002||2002-08-01|December 2009|2009-12-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.|INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.|Completed||Phase 2|22|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:50:32.057631|2017-02-18 16:50:32.057631
NCT00275990|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2014-10-08|||December 2005||2005-12-01|October 2014|2014-10-01|August 2010|Actual|2010-08-01|October 2009|Actual|2009-10-01||Interventional|||AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction|AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients Undergoing Primary PCI for Acute Myocardial Infarction: [JETSTENT] Study|Completed||Phase 4|501|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 16:50:32.167118|2017-02-18 16:50:32.167118
NCT00275977|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-07-22|||February 2006||2006-02-01|January 2006|2006-01-01|March 2007||2007-03-01|||||Interventional|||Treatment of Myocardial Infarction With Bone Marrow Derived Stem Cells|Treatment of Myocardial Infarction With Autologous Bone Marrow Derived Stem Cells|Unknown status|Recruiting|Phase 1|10|Anticipated|Odense University Hospital|||||f||||||||||||||2017-02-18 16:50:32.291115|2017-02-18 16:50:32.291115
NCT00275964|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2008-10-23|||February 2004||2004-02-01|June 2005|2005-06-01|September 2004||2004-09-01|||||Observational|||Development of Active Safety Surveillance System for Traditional Chinese Medicine||Completed||Phase 4|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:50:32.400917|2017-02-18 16:50:32.400917
NCT00275951|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2012-11-15|||December 2005||2005-12-01|November 2012|2012-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|FLAG||Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer|Phase II Study of Cetuximab Plus P-HDFL(Cisplatin and Weekly 24-Hour Infusion of High-dose 5-Fluorouracil and Leucovorin)for the First-line Treatment of Advanced Gastric Cancer|Completed||Phase 2|39|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 16:50:32.464342|2017-02-18 16:50:32.464342
NCT00275938|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2006-01-11|||October 1998||1998-10-01|January 2006|2006-01-01|June 2001||2001-06-01|||||Interventional|||Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B|A Pilot Study Of Interferon Alpha 2b Plus Ribavirin In The Treatment Of Patients With Chronic Hepatitis B|Completed||Phase 2/Phase 3|120||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:50:32.577131|2017-02-18 16:50:32.577131
NCT00275925|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2007-11-29|||December 2005||2005-12-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures|A 24-Week Prospective, Open-Label, Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Adult Patients With Partial Seizures|Completed||Phase 4|80||Novartis|||||f||||||||||||||2017-02-18 16:50:32.665892|2017-02-18 16:50:32.665892
NCT00275912|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2017-02-07|||December 2005||2005-12-01|February 2017|2017-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures|A 24-week Prospective Open-label Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures|Completed||Phase 4|60|Actual|Novartis|||||f||||f||||||||||2017-02-18 16:50:32.763599|2017-02-18 16:50:32.763599
NCT00275899|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2006-01-11|||January 2006||2006-01-01|December 2005|2005-12-01|December 2007||2007-12-01|||||Observational|||Role of DcR3 in T Cell Activation in SLE and RA|Role of DcR3 in T Cell Activation in SLE and RA|Unknown status|Recruiting|N/A|450||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:50:32.856894|2017-02-18 16:50:32.856894
NCT00275886|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2006-01-11|||January 2006||2006-01-01|December 2005|2005-12-01|December 2008||2008-12-01|||||Observational|||Activation and Recruitment of GIL During Hp Infection|Activation and Recruitment of Gastric Infiltrating Lymphocytes During H. Pylori Infection|Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:50:32.94699|2017-02-18 16:50:32.94699
NCT00275834|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-11-15|2012-12-10||January 2006||2006-01-01|November 2016|2016-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Zonisamide for Weight Reduction in Obese Adults|Zonisamide for Weight Reduction in Obese Adults|Completed||N/A|225|Actual|Duke University||3|||f||||t||||||||||2017-02-18 16:50:33.026786|2017-02-18 16:50:33.026786
NCT00275821|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2011-02-22|2010-12-20||December 2005||2005-12-01|February 2011|2011-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|EXCITE||Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)|A Randomized, Double-masked, Active-controlled, Multi-center Study Comparing the Efficacy and Safety of Ranibizumab Administered as Two Dosing Regimens in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration|Completed||Phase 3|353|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:50:33.695388|2017-02-18 16:50:33.695388
NCT00275795|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2006-10-31|||July 2005||2005-07-01|April 2006|2006-04-01|January 2006||2006-01-01|||||Observational|||NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®|Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST-NAET®|Completed||Phase 1/Phase 2|42||Nambudripad's Allergy Research Foundation|||||f||||||||||||||2017-02-18 16:50:34.528632|2017-02-18 16:50:34.528632
NCT00275769|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2008-12-10|||March 2004||2004-03-01|December 2008|2008-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse|Complete Automatic Pacing Threshold Utilization Recorded by EnPulse|Completed||N/A|860||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:50:34.631974|2017-02-18 16:50:34.631974
NCT00275756|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2014-11-20|||September 2008||2008-09-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans|Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans|Withdrawn||N/A|0|Actual|Medical University of Vienna||3|||f||||t||||||||||2017-02-18 16:50:34.7742|2017-02-18 16:50:34.7742
NCT00275743|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2009-04-27|||October 2005||2005-10-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Use of MRI for Assessing Stomach Relaxation in Response to a Meal|Dynamic MRI - A Novel Approach for Measuring Gastric Accommodation|Completed||Phase 1|50|Anticipated|Mayo Clinic||1|||f||||||||||||||2017-02-18 16:50:34.887522|2017-02-18 16:50:34.887522
NCT00275730|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2007-02-09|||January 2006||2006-01-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers|Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers|Completed||N/A|12||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:50:34.967762|2017-02-18 16:50:34.967762
NCT00275717|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-12-20|||March 2005||2005-03-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.|The Effects of Thymoglobulin on Antibody Screening Cells.|Completed||Phase 1|60|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 16:50:35.058232|2017-02-18 16:50:35.058232
NCT00275704|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-06-09|||May 2005||2005-05-01|June 2011|2011-06-01||||June 2006|Actual|2006-06-01||Interventional|||Flaxseed for the Treatment of Hot Flashes|Phase II Evaluation of Flaxseed for the Treatment of Hot Flashes|Completed||Phase 2|30||Mayo Clinic|||||f||||||||||||||2017-02-18 16:50:35.142693|2017-02-18 16:50:35.142693
NCT00275691|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-01-15|||October 2005||2005-10-01|January 2010|2010-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR|Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR|Completed||Phase 2/Phase 3|867|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 16:50:35.229709|2017-02-18 16:50:35.229709
NCT00275678|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-06-02|||November 2003||2003-11-01|June 2010|2010-06-01||||September 2009|Actual|2009-09-01||Interventional|||Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies|A Phase III Randomized, Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell With Marrow Transplantation From HLA Compatible Unrelated Donors.|Completed||Phase 3|15|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 16:50:38.070902|2017-02-18 16:50:38.070902
NCT00275665|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-12-16|||November 2001||2001-11-01|December 2011|2011-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.|A Phase III Multicenter Study of Valganciclovir for the Prevention of Late Cytomegalovirus Infection After Allogenic Hematopoietic Stem Cell Transplantation.|Completed||Phase 3|20|Actual|Mayo Clinic|||||||||||||||||||2017-02-18 16:50:38.160775|2017-02-18 16:50:38.160775
NCT00275652|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-03-22|||June 2004||2004-06-01|March 2011|2011-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.|A Randomized, Double-Blind Trial of Telbivudine (LdT) Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.|Completed||Phase 3|6||Mayo Clinic|||||||||||||||||||2017-02-18 16:50:38.249586|2017-02-18 16:50:38.249586
NCT00275639|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2012-01-04|||December 2004||2004-12-01|January 2012|2012-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant|A Randomized, Double-blinded, Placebo-controlled Study of Angiotensin II Receptor Blockade to Prevent Renal Dysfunction Following Liver Transplantation.|Completed||Phase 4|62|Anticipated|Mayo Clinic|||||||||||||||||||2017-02-18 16:50:38.334113|2017-02-18 16:50:38.334113
NCT00275613|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-01-15|||November 2005||2005-11-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis|Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis|Completed||Phase 1|10|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 16:50:38.415944|2017-02-18 16:50:38.415944
NCT00275600|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2009-11-25|||January 2003||2003-01-01|November 2009|2009-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Randomized Clinical Trial of Vitamin E and Evening Oil of Primrose for the Managment of Breast Pain|Randomized Clinical Trial of Vitamin E and Evening Oil of Primrose for the Managment of Cyclical Breast Pain|Completed||Phase 2/Phase 3|82|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:50:38.522375|2017-02-18 16:50:38.522375
NCT00275587|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-03-21|||January 2005||2005-01-01|March 2011|2011-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Development of a Hospital Service That Uses Critical Pathway (Protocolized) Care Plans to Provide High-Quality, High-Reliability, Evidence-Based Medical Care|Development of Critical Pathway Care for Hospitalized Patients Using Principles of Patient-Centered Quality Care, Evidence-Based Medicine, and High Reliability Organizational Structure|Completed||N/A|348|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 16:50:38.614001|2017-02-18 16:50:38.614001
NCT00275574|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-12-30|||April 2003||2003-04-01|December 2015|2015-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Acupuncture for Non-cyclical Breast Pain|Acupuncture for the Treatment of Non-Cyclical Breast Pain|Completed||N/A|30|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 16:50:38.686214|2017-02-18 16:50:38.686214
NCT00275561|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2012-05-01|2011-11-03||November 2005||2005-11-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Topical Steroid Treatment for Eosinophilic Esophagitis|A Randomized Placebo-controlled Trial of Swallowed Fluticasone in Treatment of Eosinophilic Esophagitis|Completed||Phase 2|42|Actual|Mayo Clinic|The relatively small sample size; unexpected high dropout rate in the placebo group; study commenced before the consensus definition of EoE advising exclusion of gastroesophageal reflux disease (GERD) was established.|2|||f||||f||||||||||2017-02-18 16:50:38.773752|2017-02-18 16:50:38.773752
NCT00275548|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-11-09|||July 2004||2004-07-01|November 2011|2011-11-01|April 2009|Actual|2009-04-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C|A Prospective, Randomized, Multi-center, Open-label, Comparative Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon Alfa-2a(Pegasys) Plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C.|Completed||Phase 4|12|Actual|Mayo Clinic||2|||f||||||||||||||2017-02-18 16:50:39.446585|2017-02-18 16:50:39.446585
NCT00275535|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-12-06|||April 2001||2001-04-01|December 2011|2011-12-01|December 2008|Actual|2008-12-01|November 2007|Actual|2007-11-01||Interventional|||The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients|A Prospective, Randomized Trial of Calcineurin-Inhibitor Withdrawal in Renal Allograft Recipients|Completed||Phase 4|165|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:50:39.560687|2017-02-18 16:50:39.560687
NCT00275522|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-01-19|||December 2005||2005-12-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.|A Randomized Open-label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients.|Completed||Phase 4|16|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:50:39.696214|2017-02-18 16:50:39.696214
NCT00275509|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2008-05-07|||January 2006||2006-01-01|May 2008|2008-05-01|January 2010|Anticipated|2010-01-01|||||Interventional|||Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch|Open Label Randomized Study of Thymoglobulin Versus Daclizumab Induction Therapies for the Reduction of Acute Rejection in Live Donor Kidney Transplant Recipients With a Positive Crossmatch|Unknown status|Recruiting|Phase 3|110|Anticipated|Johns Hopkins University|||||f||||||||||||||2017-02-18 16:50:39.789723|2017-02-18 16:50:39.789723
NCT00275496|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-09-01|||November 1993||1993-11-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Multicenter Selective Lymphadenectomy Trial (MSLT)|A Clinical Study of Wide Excision Alone Versus Wide Excision With Intraoperative Lymphatic Mapping and Selective Lymph Node Dissection in the Treatment of Patients With Cutaneous Invasive Melanoma.|Completed||Phase 3|2001|Actual|John Wayne Cancer Institute||3|||f||||t||||||||||2017-02-18 16:50:39.888373|2017-02-18 16:50:39.888373
NCT00275288|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-11-01|||January 2005||2005-01-01|November 2010|2010-11-01|June 2007|Actual|2007-06-01|||||Observational|||MRI Imaging in Borderline Personality Disorder|"Brain Correlates Of Affect Regulation In BPD"|Completed||N/A|20|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-02-18 16:50:42.431223|2017-02-18 16:50:42.431223
NCT00275457|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-11|2013-10-30|||October 2002||2002-10-01|October 2013|2013-10-01|April 2004||2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients|A Randomised, Double-blind, Placebo-controlled Dose Titration Trial With 0.125-0.75 mg Pramipexole (Sifrol®) Orally to Investigate the Safety and Efficacy in Out-patients With Idiopathic Restless Legs Syndrome for 6 Weeks Followed by 46 Weeks Open-label or Double-blind Treatment Period|Completed||Phase 3|346||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:50:40.094297|2017-02-18 16:50:40.094297
NCT00275444|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-11-04|||March 2002||2002-03-01|November 2013|2013-11-01||||January 2003|Actual|2003-01-01||Interventional|||3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study|Double-blind, Randomized, Dose Optimization Trial of Three Doses of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) in Multiple Antiretroviral Drug-experienced Subjects|Completed||Phase 2|216|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:50:40.226246|2017-02-18 16:50:40.226246
NCT00275431|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-06-24||2010-08-12|November 2005||2005-11-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies|A Phase II, Open Label, Multicenter Study of Single-Agent AT-101 in Patients With Relapsed or Refractory B-Cell Malignancies (Follicular Lymphoma, Mantle Cell Lymphoma, Diffuse Large Cell Lymphoma, or Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia)|Completed||Phase 2|50|Actual|Ascenta Therapeutics||1|||f||||||||||||||2017-02-18 16:50:40.380248|2017-02-18 16:50:40.380248
NCT00275418|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2006-01-10|||July 2002||2002-07-01|January 2006|2006-01-01||||||||Interventional|||Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease|Double-Blind Randomized Prospective Trial of Treatment With Natural Beta Carotene Vs. Placebo for Patients With Crohn's Disease in Remission|Unknown status|Recruiting|Phase 3|300||Bnai Zion Medical Center|||||f||||||||||||||2017-02-18 16:50:40.491277|2017-02-18 16:50:40.491277
NCT00275405|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2007-03-19|||April 2006||2006-04-01|March 2007|2007-03-01|March 2007|Anticipated|2007-03-01|||||Interventional|||Effect of Garlic on Inflammatory Mediators|Effect of Garlic Oil Macerate on Inflammatory Mediators in Healthy Normal Weight and Obese Subjects.|Suspended||Phase 4|34||Albany Medical College||||Results inconclusive|f||||||||||||||2017-02-18 16:50:40.583311|2017-02-18 16:50:40.583311
NCT00275392|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2014-12-05|2014-09-17||April 2006||2006-04-01|December 2014|2014-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Vestibular Rehabilitation and Dizziness in Geriatric Patients|Vestibular Rehabilitation and Dizziness in Geriatric Patients|Completed||N/A|39|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:50:40.672523|2017-02-18 16:50:40.672523
NCT00275379|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2007-03-14|||August 2006||2006-08-01|March 2007|2007-03-01||||||||Interventional|||Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Exploratory Study of Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis|Terminated||N/A|60||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:50:41.2913|2017-02-18 16:50:41.2913
NCT00275366|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2008-03-10|||July 2005||2005-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Arm Robotics in Musculoskeletal Rehabilitation|Upper Extremity Robotics in Musculoskeletal Rehabilitation|Completed||N/A|20|Anticipated|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 16:50:41.394685|2017-02-18 16:50:41.394685
NCT00275353|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2006-05-25|||July 2003||2003-07-01|January 2006|2006-01-01|February 2006||2006-02-01|||||Interventional|||Effectiveness of an Individualized Symptom Education Program (ISEP)|Effectiveness of an Individualized Symptom Education Program (ISEP) on the Symptom Distress of Women Receiving Radiation for Gynecological Cancer.|Completed||Phase 2|144||University of Toronto|||||f||||||||||||||2017-02-18 16:50:41.49471|2017-02-18 16:50:41.49471
NCT00275340|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2009-06-05|2009-01-28||February 2006||2006-02-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Cardiac Home Education and Support Trial (CHEST): A Pilot Study|A Pilot Trial of a Home-Based Peer Support Program After Coronary Artery Bypass Graft Surgery|Completed||Phase 1|101|Actual|University of Toronto|||||f||||f||||||||||2017-02-18 16:50:41.584851|2017-02-18 16:50:41.584851
NCT00275327|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2015-12-16|||January 2006||2006-01-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria|Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria|Completed||N/A|300|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 16:50:42.152467|2017-02-18 16:50:42.152467
NCT00275314|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2015-12-16|||February 2006||2006-02-01|December 2015|2015-12-01|April 2006||2006-04-01|||||Interventional|||WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients|WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients, Sponsor Protocol Dated 8/11/2005 and Investigator Brochure Version August 2005|Terminated||Phase 3|5||University of Pittsburgh||||Study never started at our site Funding issue|||||||||||||||2017-02-18 16:50:42.237694|2017-02-18 16:50:42.237694
NCT00275301|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-08-25|||December 2005||2005-12-01|August 2011|2011-08-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||PET Imaging and Olanzapine Treatment in Borderline Personality Disorder|Brain Correlates of Olanzapine Treatment Response in BPD|Completed||N/A|15|Anticipated|University of Minnesota - Clinical and Translational Science Institute||1|||f||||f||||||||||2017-02-18 16:50:42.331836|2017-02-18 16:50:42.331836
NCT00005450|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||May 1991||1991-05-01|July 2000|2000-07-01|November 1991|Actual|1991-11-01|||||Observational|||Health Promotion in the Elderly--Prevention of Cardiovascular Disorders||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.133628|2017-02-18 18:14:58.133628
NCT00275275|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2012-07-21|2012-05-02||January 2006||2006-01-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Pramipexole Conversion to Ropinirole Controlled Release (CR)|An Open Label Conversion Study of Pramipexole to Ropinirole Controlled Release (CR) in Patients With Parkinson's Disease.|Completed||Phase 3|61|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-02-18 16:50:42.532368|2017-02-18 16:50:42.532368
NCT00275262|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2010-04-09|2010-02-05||February 2006||2006-02-01|April 2010|2010-04-01||||February 2009|Actual|2009-02-01||Interventional|||A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation|Leuprolide Acetate to Enhance Immune Function Post-Autologous Stem Cell Transplantation|Terminated||Phase 2|25|Actual|Abbott|The study was terminated early because of slow enrollment. For the primary endpoint, changes from baseline within each treatment group were analyzed. Between treatment group comparisons were not performed because the sample size was too small.|2|||f||||f||||||||||2017-02-18 16:50:42.957734|2017-02-18 16:50:42.957734
NCT00275249|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2011-04-12|||March 2001||2001-03-01|March 2011|2011-03-01|December 2005|Actual|2005-12-01|October 2004|Actual|2004-10-01||Interventional|||Evolution of Analgesic Tolerance With Opioids|Evolution of Analgesic Tolerance During Long Term Treatment of Chronic Pain With Opioids|Completed||N/A|60||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:50:43.513699|2017-02-18 16:50:43.513699
NCT00275236|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2014-09-24|||November 2005||2005-11-01|September 2009|2009-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|A Multi-center, Double-blind, Randomized, Placebo-controlled, Two-arm, Parallel-group, Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|Completed||Phase 3|60||UCB Pharma|||||f||||||||||||||2017-02-18 16:50:43.596387|2017-02-18 16:50:43.596387
NCT00275223|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-03-17|||September 2004||2004-09-01|March 2010|2010-03-01||||||||Observational|||Insulin Resistance in Severely Obese Patients|Insulin Resistance in Severely Obese Patients|Completed||N/A|48|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:50:43.687953|2017-02-18 16:50:43.687953
NCT00275210|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2009-04-17|||October 1998||1998-10-01|April 2009|2009-04-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer|Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer|Completed||Phase 3|2246|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:50:43.768441|2017-02-18 16:50:43.768441
NCT00275197|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2008-10-30|||December 2005||2005-12-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|||||Interventional|||A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)|An Eight-Week, Double-Blind, Group-Sequential Design, Placebo Controlled Trial To Evaluate The Safety And Efficacy Of The Co- Administration Of Sertraline And Elzasonan (CP-448,187) In Outpatients With Major Depressive Disorder|Completed||Phase 2|262|Actual|Pfizer|||||||||||||||||||2017-02-18 16:50:44.13777|2017-02-18 16:50:44.13777
NCT00275184|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2007-09-21|||January 2006||2006-01-01|September 2007|2007-09-01||||||||Interventional|||Bowel Preparation and Prokinetics in Capsule Endoscopy|A Randomised Study of the Optimal Bowel Preparation for Routine Capsule Endoscopy Using Citramag and Senna or Metoclopramide|Unknown status|Recruiting|Phase 3|150|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 16:50:44.258459|2017-02-18 16:50:44.258459
NCT00275171|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-12-03|||February 2006||2006-02-01|December 2013|2013-12-01|September 2009|Actual|2009-09-01|April 2009|Actual|2009-04-01||Interventional|||rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter|The Effect of 0.1 mg Recombinant Human Thyrotropin (rhTSH) on Thyroid Radioiodine-uptake and the Degree of Goiter Reduction Following 131I-therapy, in Patients With Benign Non-toxic Nodular Goiter. A Randomized, Double-blind, Placebo-controlled Trial.|Completed||Phase 2|90|Actual|Odense University Hospital||2|||f||||t||||||||||2017-02-18 16:50:44.360297|2017-02-18 16:50:44.360297
NCT00275158|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-01-12|||January 2000||2000-01-01|January 2010|2010-01-01|December 2003|Actual|2003-12-01|||||Interventional|||Glomerular Injury of Preeclampsia|Effect of L-Arginine Therapy on the Glomerular Injury of Pre-Eclampsia: A Randomized Controlled Trial|Completed||N/A|45||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||||||||||||2017-02-18 16:50:44.471581|2017-02-18 16:50:44.471581
NCT00275145|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-05-23|||May 2004||2004-05-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|STRRIDE2||Effects of Resistance and Aerobic Exercise on Cardiovascular Health|Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE II)|Completed||Phase 2|261|Actual|Duke University||4|||f||||f||||||||||2017-02-18 16:50:44.562545|2017-02-18 16:50:44.562545
NCT00275132|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2014-12-01|||April 2005||2005-04-01|December 2011|2011-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|TOPICAL||Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Randomised, Placebo-Controlled Trial of Erlotinib in Patients With Advanced NSCLC Unsuitable for Chemotherapy|Completed||Phase 3|670|Actual|University College, London||2|||f||||t||||||||||2017-02-18 16:50:44.664629|2017-02-18 16:50:44.664629
NCT00275119|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2009-02-06|||November 2003||2003-11-01|January 2006|2006-01-01||||||||Interventional|||Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery|Protocole de Phase II: Etude de Faisabilite de L'Oxaliplatine en Association Chimio-Radiotherapie Concomitante Dans le Traitement Des Cancers du Pancreas Localement Avances Non Resecables|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:44.806771|2017-02-18 16:50:44.806771
NCT00275106|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-07-09|||September 2004||2004-09-01|April 2008|2008-04-01|August 2012|Actual|2012-08-01|December 2009|Actual|2009-12-01||Interventional|||Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma|Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL)|Terminated||Phase 3|600|Anticipated|National Cancer Institute (NCI)||||Withdrawn due to an excess of toxic deaths|f||||||||||||||2017-02-18 16:50:44.924674|2017-02-18 16:50:44.924674
NCT00271700|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2010-05-03|||May 2010||2010-05-01|May 2010|2010-05-01|March 2011|Anticipated|2011-03-01|March 2011|Anticipated|2011-03-01||Interventional|||Improving Glycemic Control on GMS: A Quality Improvement Study|Improving Glycemic Control on GMS: A Quality Improvement Study|Unknown status|Not yet recruiting|N/A|1100|Anticipated|Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 16:51:36.659076|2017-02-18 16:51:36.659076
NCT00275093|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-01-29|||December 2005||2005-12-01|January 2013|2013-01-01||||March 2008|Actual|2008-03-01||Interventional|||Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function|A Phase I Pharmacokinetic and Pharmacodynamic Study of Temsirolimus (CCI-779) in Patients With Advanced Malignancies and Normal and Impaired Liver Function: An NCI Organ Dysfunction Working Group Study|Completed||Phase 1|130|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:50:45.073452|2017-02-18 16:50:45.073452
NCT00275080|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2014-08-26|||February 2006||2006-02-01|June 2014|2014-06-01|August 2014|Actual|2014-08-01|November 2009|Actual|2009-11-01||Interventional|||Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia|A Phase 1 Study of Vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in Combination With Decitabine in Patients With Advanced Solid Tumors, Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia in Blast Crisis|Completed||Phase 1|80|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:50:45.19796|2017-02-18 16:50:45.19796
NCT00275067|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2017-01-10|||May 2005||2005-05-01|January 2017|2017-01-01|May 2019|Anticipated|2019-05-01|May 2018|Anticipated|2018-05-01||Interventional|||Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery|A Phase I/II Trial of Arsenic Trioxide and Temozolomide in Combination With Radiation Therapy for Patients With Malignant Gliomas|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 16:50:45.329336|2017-02-18 16:50:45.329336
NCT00275054|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-09-30|||October 2005||2005-10-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|July 2007|Actual|2007-07-01||Interventional|||Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia|Randomized Phase III Trial Comparing Early Treatment With Fludarabine/Cyclophosphamide + Rituximab Versus Deferred Treatment in Untreated Binet Stage A Patients With CLL and High Risk of Progression|Completed||Phase 3|825|Actual|German CLL Study Group||3|||f||||||||||||No||2017-02-18 16:50:45.462439|2017-02-18 16:50:45.462439
NCT00275041|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-12-09|||February 2006||2006-02-01|December 2016|2016-12-01|February 2009|Actual|2009-02-01|February 2007|Actual|2007-02-01||Interventional|||Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer|Phase II Trial of Concurrent Irinotecan Plus Cetuximab in Patients With Advanced Breast Cancer With Prior Anthracycline and/or Taxane-Containing Therapy|Completed||Phase 2|21|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 16:50:45.67064|2017-02-18 16:50:45.67064
NCT00275028|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-10-09|2015-04-21||October 2005||2005-10-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|March 2010|Actual|2010-03-01||Interventional||The number of patients analyzed reflects the intent-to-treat population.|AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer|A Phase 2 Study of AZD2171 in Patients With Recurrent Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer|Completed||Phase 2|47|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:50:45.784001|2017-02-18 16:50:45.784001
NCT00275015|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-11-05|||January 1998||1998-01-01|April 2007|2007-04-01|April 2012|Actual|2012-04-01|||||Interventional|||Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia|Pivotal Study for High Dose Therapy and Autologous Stem Cell Transplantation in Early Stages of CLL|Completed||Phase 2|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:46.224616|2017-02-18 16:50:46.224616
NCT00275002|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2014-07-25|2011-07-13||February 2006||2006-02-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors|A Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas and Recurrent or Progressive Brainstem Tumors|Completed||Phase 2|41|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:50:46.624954|2017-02-18 16:50:46.624954
NCT00274989|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-09-30|||November 2005||2005-11-01|September 2016|2016-09-01|March 2011|Actual|2011-03-01|March 2008|Actual|2008-03-01||Interventional|||Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia|Multicentre Phase II Trial of Bendamustine in Combination With Rituximab for Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia. CLL2M Protocol of the German CLL-Study Group (GCLLSG)|Completed||Phase 2|195|Actual|German CLL Study Group||1|||f||||f||||||||No||2017-02-18 16:50:47.180334|2017-02-18 16:50:47.180334
NCT00274976|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-11-05|||September 2002||2002-09-01|May 2006|2006-05-01|August 2009|Actual|2009-08-01|||||Interventional|||Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine|Subcutaneous Campath-1H in Fludarabine-Refractory CLL|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:47.362196|2017-02-18 16:50:47.362196
NCT00274963|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-09-30|||October 2004||2004-10-01|September 2016|2016-09-01|October 2009|Actual|2009-10-01|November 2007|Actual|2007-11-01||Interventional|||Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Treatment of Relapsed / Refractory Chronic Lymphocytic Leukemia (CLL) WITH Bendamustine / Mitoxantrone (BM)|Completed||Phase 2|60|Anticipated|German CLL Study Group|||||f||||||||||||||2017-02-18 16:50:47.495421|2017-02-18 16:50:47.495421
NCT00274950|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-09-16|||May 2005||2005-05-01|June 2009|2009-06-01||||May 2010|Anticipated|2010-05-01||Interventional|||Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors|Protocol for the Treatment of Extracranial Germ Cell Tumours in Children and Adolescents (GC III)|Unknown status|Active, not recruiting|Phase 3|105|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:47.615251|2017-02-18 16:50:47.615251
NCT00274937|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-11-23|2016-10-24||February 2006||2006-02-01|November 2016|2016-11-01||||March 2016|Actual|2016-03-01||Interventional|||Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer|Treatment of Childhood Nasopharyngeal Carcinoma With Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy: A Groupwide Phase III Study|Active, not recruiting||Phase 3|111|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 16:50:47.755939|2017-02-18 16:50:47.755939
NCT00271622|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-31|2017-01-24|||December 29, 2005||2005-12-29|December 5, 2016|2016-12-05||||||||Observational|||Screening for Studies on Autism Spectrum Disorders|Screening Protocol for Studies of the Pediatrics and Developmental Neuroscience Branch|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:51:49.409611|2017-02-18 16:51:49.409611
NCT00274924|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-10-06|2014-01-09||April 2006||2006-04-01|October 2015|2015-10-01|March 2019|Anticipated|2019-03-01|June 2013|Actual|2013-06-01||Interventional||Eligible and treated patients|Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Response-Adapted Therapy for Aggressive Non-Hodgkin's Lymphomas Based on Early [18F] FDG-PET Scanning|Active, not recruiting||Phase 2|100|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 16:50:48.353149|2017-02-18 16:50:48.353149
NCT00274911|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-08-01|||February 2004||2004-02-01|June 2009|2009-06-01||||March 2010|Anticipated|2010-03-01||Interventional|||Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors|Hyperfractionated Accelerated Radiotherapy (HART) With Chemotherapy (Cisplatin, CCNU, Vincristine) for Non-Pineal Supratentorial Primitive Neuroectodermal Tumours|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:49.508738|2017-02-18 16:50:49.508738
NCT00274898|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2009-02-06|||May 2004||2004-05-01|September 2006|2006-09-01||||||||Interventional|||Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer|Phase II Randomized Study Evaluting the Effect of Celecoxib as Maintenance Treatment of Stage IIIb Non-Small Cell Lung Cancer That Reponded or is Stable After Radiochemotherapy|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:49.63578|2017-02-18 16:50:49.63578
NCT00274885|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-12-02|||October 2005||2005-10-01|May 2007|2007-05-01||||||||Interventional|||Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer|Study of the Relationship Between the Rate of Residual Platinum in the Blood and the Incidence of Persistent Neurotoxicity in Patients Treated for Gastrointestinal Cancer With Oxaliplatin|Unknown status|Recruiting|Phase 4|58|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:49.768548|2017-02-18 16:50:49.768548
NCT00274872|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-01-29|||January 2004||2004-01-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Phase II-III Study of an Optimized LV-5FU-Oxaliplatin Strategy in Metastatic Colorectal Cancer. Optimox2 Study. C02-2|Unknown status|Active, not recruiting|Phase 2/Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:49.903417|2017-02-18 16:50:49.903417
NCT00274859|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2008-07-23|||August 2005||2005-08-01|May 2007|2007-05-01||||||||Interventional|||Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer|Multicenter Phase II Study Evaluating Gemcitabine and Oxaliplatin in the Treatment of Patients Suffering From Metastatic Breast Cancer Who Are Not Candidates For Treatment With Antracyclines and Taxanes|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:50:50.022453|2017-02-18 16:50:50.022453
NCT00274846|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2012-11-06|2009-07-24||March 2005||2005-03-01|November 2012|2012-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia|Allogeneic Natural Killer Cells in Patients With Relapsed Acute Myelogenous Leukemia|Completed||Phase 2|21|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:50:50.139683|2017-02-18 16:50:50.139683
NCT00274833|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2012-12-05|||October 2005||2005-10-01|December 2012|2012-12-01|September 2012|Actual|2012-09-01|October 2007|Actual|2007-10-01||Interventional|||Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase II Trial of Erlotinib With Temozolomide and Concurrent Radiation Therapy Post-Operatively in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|27|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:50:50.426573|2017-02-18 16:50:50.426573
NCT00274820|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2012-09-26|||October 2005||2005-10-01|September 2012|2012-09-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder|A Phase II Trial of Combination Therapy With Thalidomide, Arsenic Trioxide, Dexamethasone, and Ascorbic Acid (TADA) in Patients With Chronic Idiopathic Myelofibrosis or Overlap Myelodysplastic/Myeloproliferative Disorders|Completed||Phase 2|15|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:50:50.54406|2017-02-18 16:50:50.54406
NCT00274807|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-02-09|||June 2001||2001-06-01|February 2011|2011-02-01|May 2008|Actual|2008-05-01|April 2007|Actual|2007-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|Intensive Induction for Newly Diagnosed Acute Myelogenous Leukemia|Completed||Phase 2|40|Actual|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 16:50:50.649143|2017-02-18 16:50:50.649143
NCT00274794|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2011-03-28|||February 2000||2000-02-01|March 2011|2011-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL|A Prospective Randomized Trial of VP-16 Plus G-CSF Plus Rituximab vs VP-16 Plus G-CSF Alone for Peripheral Blood Progenitor Cell Mobilization Prior to Autologous Stem Cell Transplantation for B Cell Lymphoid Malignancies|Completed||N/A|55|Actual|The Cleveland Clinic||2|||f||||f||||||||||2017-02-18 16:50:50.737549|2017-02-18 16:50:50.737549
NCT00274781|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-07-06|2015-06-03||February 2004||2004-02-01|July 2015|2015-07-01|November 2010|Actual|2010-11-01|December 2008|Actual|2008-12-01||Interventional|||Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes|A Phase II Trial of Combination Therapy With Arsenic Trioxide (Trisenox) and Gemtuzumab Ozogamicin (Mylotarg) for the Treatment of Adult Patients With Advanced Myelodysplastic Syndrome|Completed||Phase 2|30|Actual|The Cleveland Clinic||1|||f||||f||||||||||2017-02-18 16:50:50.930594|2017-02-18 16:50:50.930594
NCT00274768|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-10-09|2012-11-21||April 2004||2004-04-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|December 2009|Actual|2009-12-01||Interventional|||Capecitabine in Treating Patients With Metastatic Breast Cancer|Phase II Study of Fixed-Dose Capecitabine in Metastatic Breast Cancer|Completed||Phase 2|26|Actual|Sidney Kimmel Comprehensive Cancer Center|The small sample size limited a number of the secondary objectives.|1|||f||||f||||||||||2017-02-18 16:50:51.227224|2017-02-18 16:50:51.227224
NCT00274755|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2014-05-19|||November 2003||2003-11-01|May 2014|2014-05-01||||April 2007|Actual|2007-04-01||Interventional|||Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas|Improved Characterization of Brain Tumors By MRI and MRS|Completed||Phase 2|250|Anticipated|University of California, San Francisco|||||f||||||||||||||2017-02-18 16:50:51.46474|2017-02-18 16:50:51.46474
NCT00274742|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-01-15|2014-12-23||June 2004||2004-06-01|January 2015|2015-01-01|April 2012|Actual|2012-04-01|August 2011|Actual|2011-08-01||Interventional|||Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL|An Open-label, Multi-center Phase I Study to Investigate the Tolerability and Safety of a Continuous Infusion of the Bispecific T-cell Engager MT103 in Patients With Relapsed Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 1|76|Actual|Amgen Research (Munich) GmbH||1|||f||||t||||||||||2017-02-18 16:50:51.592763|2017-02-18 16:50:51.592763
NCT00274729|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2010-03-24|||January 2004||2004-01-01|January 2006|2006-01-01|June 2008||2008-06-01|||||Interventional|||Mono Unsaturated Fatty Acids in Obesity - Weight Maintenance and Prevention of Lifestyle Diseases in Obese Subjects.|MUFObes: MonoUnsaturated Fatty Acids in Obesity - a Comparison Between 3 Different Diets in Weight Maintenance and the Prevention of Lifestyle Diseases in Obese Subjects. A Randomised, Long-term Intervention Study.|Completed||N/A|125||University of Copenhagen|||||f||||||||||||||2017-02-18 16:50:57.067814|2017-02-18 16:50:57.067814
NCT00274716|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-06-08|2013-12-23||November 2005||2005-11-01|June 2015|2015-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)(0736-003)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of MK0736 and MK0916 in Hypertensive Patients|Completed||Phase 2|249|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 16:50:57.204333|2017-02-18 16:50:57.204333
NCT00274703|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-12-02|||December 2005||2005-12-01|December 2016|2016-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients|A Randomised, Double-Blind, Placebo-Controlled, Single-Centre Study to Provide a Preliminary Evaluation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Intravenous Anti-human Interleukin-5 (Mepolizumab, 750mg and 1500mg) in the Treatment of Eosinophilic Oesophagitis in Adults|Completed||Phase 2|10|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:50:58.899352|2017-02-18 16:50:58.899352
NCT00274690|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2017-01-19|||February 2005||2005-02-01|January 2017|2017-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Post-Operative Nausea And Vomiting Study In Female Patients|A Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing With GW679769 (50 mg or 150 mg) for Three Consecutive Days When Administered With a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting and Post-discharge Nausea and Vomiting in Female Subjects With Known Risk Factors for Post-operative Nausea and Vomiting Who Are Undergoing Laparoscopic/Laparotomic Surgical Procedures Associated With an Increased Emetogenic Risk|Completed||Phase 2|435|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:50:58.995679|2017-02-18 16:50:58.995679
NCT00274677|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2016-09-13|||November 2003||2003-11-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Depression And Bipolar Disorder|A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose, 8-Week Evaluation of the Efficacy and Safety of Lamotrigine in the Treatment of Depression in Patients With Type II Bipolar Disorder|Completed||Phase 3|221|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:50:59.14718|2017-02-18 16:50:59.14718
NCT00274664|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2006-01-09|||February 2002||2002-02-01|December 2005|2005-12-01|May 2005||2005-05-01|||||Interventional|||Patching for Lazy Eye: Trial to Evaluate Daily Patching Amounts|Randomised Occlusion Treatment of Amblyopia Study (ROTAS): Trial of Maximal Vs Substantial Doses of Occlusion to Evaluate Visual Outcome for Children With Amblyopia|Completed||Phase 1|100||City, University of London|||||f||||||||||||||2017-02-18 16:50:59.275093|2017-02-18 16:50:59.275093
NCT00274651|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2015-07-07|2014-06-30||January 2006||2006-01-01|July 2015|2015-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|PXD101-CLN-6|Patients received PXD101, 1000 mg/m2/day over 30 minutes days 1-5 of a 21-day cycle. Patients with OR or stable disease were permitted to continue with PXD101 for up to 8 cycles or until progressive disease. Patients with PR or SD could continue therapy beyond 8 cycles until progression in consultation with Investigators and Sponsor.|A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas|A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas|Terminated||Phase 2|53|Actual|Onxeo||2||"Enrollment stopped prior to reaching expected number of patients, study had accumulated~   sufficient data to allow a registration study in PTCL (PXD101-CLN-19)"|f||||f||||||||||2017-02-18 16:50:59.376081|2017-02-18 16:50:59.376081
NCT00274638|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-12-06|||July 2002||2002-07-01|December 2013|2013-12-01||||July 2003|Actual|2003-07-01||Interventional|||PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)|A Prospective, Randomised, Open-Label, Blinded-Endpoint, Parallel Group 6-week Treatment Study Comparing Telmisartan Combined With Hydrochlorothiazide (40 mg/12.5 mg or 80 mg/12.5 mg) Tablets With Losartan Combined With Hydrochlorothiazide (50 mg/12.5 mg) Tablets Using Ambulatory Blood Pressure Monitoring in Patients With Mild-to-Moderate Hypertension|Completed||Phase 4|805|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 16:51:00.140194|2017-02-18 16:51:00.140194
NCT00274625|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2014-11-10|2014-10-24||August 2005||2005-08-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional||14 patients in Surgisis Gold group and 8 patients in Suture Closure group were excluded from the analysis, because prior to procedure, either they were found not to meet the inclusion/exclusion criteria, or they chose not to participate.|Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery||Completed||N/A|402|Actual|Cook||2|||f||||f||||||||||2017-02-18 16:51:00.297529|2017-02-18 16:51:00.297529
NCT00274612|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-10-31|||October 2002||2002-10-01|October 2013|2013-10-01|November 2003||2003-11-01|November 2003|Actual|2003-11-01||Interventional|PRISMA||Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM|A Prospective Randomised Open- Label Blinded-Endpoint (PROBE) Trial Comparing Telmisartan (MICARDIS®) (40-80-80mg QD) and Ramipril (2.5-5--10mg QD) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring. PRISMA = Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM|Completed||Phase 4|801||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:00.860027|2017-02-18 16:51:00.860027
NCT00274599|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-11-07|||October 2002||2002-10-01|November 2013|2013-11-01||||December 2003|Actual|2003-12-01||Interventional|||PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN|A Prospective, Randomised, Open-Label, Blinded-Endpoint, Parallel Group, Multicentre, Forced-Titration, 14-Week Treatment Study Comparing MICARDIS® (Telmisartan 40-80-80 mg, QD) and ALTACE® (Ramipril 2.5-5-10 mg, QD) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring|Completed||Phase 4|812|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:01.021233|2017-02-18 16:51:01.021233
NCT00274586|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2013-10-30|||September 2002||2002-09-01|October 2013|2013-10-01|April 2003||2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Headache Study to Compare Aggrenox Full Dose and Reduced Dose|Tolerability of a Four Weeks Treatment With Aggrenox® Modified Release Capsules b.i.d, Compared to Reduced Dose During the First Two Weeks of Treatment in a Double-Blind, Randomized Controlled Parallel Group Comparison Trial Among Taiwanese Patients With Previous TIAs or Ischemic Stroke|Completed||Phase 3|100||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:01.191217|2017-02-18 16:51:01.191217
NCT00274573|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-11-20|||March 2002||2002-03-01|November 2013|2013-11-01||||October 2002|Actual|2002-10-01||Interventional|||Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity|Acute and Long-term Effects of Once Daily Oral Inhalation of Tiotropium 18 Mcg Dry Powder Inhalation Capsules in a Placebo Controlled Parallel Group Design Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity|Completed||Phase 3|1639|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:01.292842|2017-02-18 16:51:01.292842
NCT00274560|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-11-08|||May 2002||2002-05-01|November 2013|2013-11-01||||March 2003|Actual|2003-03-01||Interventional|||A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.|A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol in a 12 Week, Randomized, Double-Blind, Double-Dummy Parallel Group Study in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|653|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 16:51:01.914752|2017-02-18 16:51:01.914752
NCT00274547|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||September 2001||2001-09-01|October 2013|2013-10-01||||February 2003|Actual|2003-02-01||Interventional|||Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Proportion of Patients Experiencing an Exacerbation and Proportion of Patients Hospitalized for an Exacerbation Over 6 Months During Treatment With Tiotropium 18 Mcg Capsule Once Daily in Patients With COPD in a Veterans Affairs Setting|Completed||Phase 3|1829|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 16:51:02.064644|2017-02-18 16:51:02.064644
NCT00274534|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-11-04|||December 2000||2000-12-01|November 2013|2013-11-01|July 2003||2003-07-01|||||Interventional|||A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.|A Comparison of the Effects of Tiotropium (18 Mcg) Inhalation Capsule q.d. and Salmeterol (50 Mcg) Inhalation Aerosol b.i.d. on Arterial Blood Gases in a Double-blind, Double-dummy, 4-week Crossover Study in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|36||Boehringer Ingelheim|||||||||||||||||||2017-02-18 16:51:02.184267|2017-02-18 16:51:02.184267
NCT00274521|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||May 2001||2001-05-01|October 2013|2013-10-01||||February 2003|Actual|2003-02-01||Interventional|||Tiotropium (Spiriva) Rehabilitation Study|A Randomized, Double-blind, Placebo Controlled 25-week Trial to Compare the Effect of Tiotropium Inhalation Capsuled (18 Mcg) Once Daily on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 8 Weeks of Pulmonary Rehabilitation.|Completed||Phase 3|108||Boehringer Ingelheim|||||||||||||||||||2017-02-18 16:51:02.278106|2017-02-18 16:51:02.278106
NCT00274508|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||October 2000||2000-10-01|October 2013|2013-10-01||||January 2003|Actual|2003-01-01||Interventional|||Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients|Effect of Tiotropium on Exercise Tolerance and Static and Dynamic Lung Volumes in COPD Patients (A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study)|Completed||Phase 3|261|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:02.388429|2017-02-18 16:51:02.388429
NCT00274495|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2007-10-31|||January 2006||2006-01-01|January 2006|2006-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver|Randomized Placebo-Control Pilot Study Evaluating the Efficacy and Safety of Rosiglitazone Combined With Pegylated Interferon Plus Ribavirin Versus Pegylated Interferon Plus Ribavirin Alone in Genotype 1 Hepatitis C With Steatosis|Terminated||Phase 4|30|Anticipated|Beth Israel Medical Center|||||||||||||||||||2017-02-18 16:51:02.506802|2017-02-18 16:51:02.506802
NCT00274469|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-11-10|2009-01-27||February 2006||2006-02-01|November 2016|2016-11-01|December 2017|Anticipated|2017-12-01|January 2008|Actual|2008-01-01||Interventional|FIRST||A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer|A Randomized, Open-Label, Parallel-Group, Multicentre, Phase II Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 500 mg With Anastrozole (ARIMIDEX™) 1 mg as First Line Hormonal Treatment for Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer|Active, not recruiting||Phase 2|233|Actual|AstraZeneca|One patient in the ITT population was randomized to Fulvestrant 500 but did not receive drug and was excluded from the safety population. Hence, the safety population for Fulvestrant contained 101 patients.|2|||f||||||||||||||2017-02-18 16:51:02.603522|2017-02-18 16:51:02.603522
NCT00274456|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-12-14|2011-02-07||November 2005||2005-11-01|December 2016|2016-12-01|July 2011|Actual|2011-07-01|March 2008|Actual|2008-03-01||Interventional|||Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer|A Randomized Phase II Study of Weekly or Every 3 Weeks ABI-007 Versus Every 3 Weeks Taxotere as First Line Therapy of Stage IV (Metastatic) Breast Cancer|Completed||Phase 2|302|Actual|Celgene Corporation||4|||f||||f||||||||||2017-02-18 16:51:03.236206|2017-02-18 16:51:03.236206
NCT00274443|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-10|2016-11-16|||March 2005||2005-03-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin|An Open -Label, Phase II Trial of Increasing Doses of ABI-007 and Carboplatin in Patients With Advanced Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|250|Actual|Celgene Corporation||1|||f||||f||||||||||2017-02-18 16:51:05.940768|2017-02-18 16:51:05.940768
NCT00005449|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-07|||August 1996||1996-08-01|January 2016|2016-01-01|June 2001||2001-06-01|||||Observational|||Social Support and Myocardial Ischemia||Completed||N/A|||University of Florida|||||f||||||||||||||2017-02-18 18:14:58.199912|2017-02-18 18:14:58.199912
NCT00274430|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2006-11-30|||July 2003||2003-07-01|December 2003|2003-12-01|September 2003||2003-09-01|||||Interventional|||Prevention of High Altitude Pulmonary Edema|A Randomized Controlled Trial of the Effects of Tadalafil and Dexamethasone Versus Placebo on Pulmonary Edema Formation and Cerebral Blood Flow Autoregulation in High Altitude Newcomers With a Previous History of High Altitude Pulmonary Edema|Completed||Phase 1/Phase 2|30||University of Zurich|||||f||||||||||||||2017-02-18 16:51:06.053111|2017-02-18 16:51:06.053111
NCT00274417|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2007-04-17|||January 2006||2006-01-01|April 2007|2007-04-01|May 2009|Anticipated|2009-05-01|||||Interventional|||Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)|A Randomized, Placebo-Controlled, Double-Blind Study of the Use of Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP Study)|Unknown status|Active, not recruiting|N/A|60||Urology of Virginia|||||f||||||||||||||2017-02-18 16:51:06.133294|2017-02-18 16:51:06.133294
NCT00274404|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2011-10-26|||February 2004||2004-02-01|October 2011|2011-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Controlled Trial of Valacyclovir in Infectious Mononucleosis|Randomized Study Assessing the Antiviral Activity and Safety of Valacyclovir in Primary Infectious Mononucleosis|Completed||Phase 1/Phase 2|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||t||||||||||2017-02-18 16:51:06.227367|2017-02-18 16:51:06.227367
NCT00274391|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2006-01-09|||July 2001||2001-07-01|December 2005|2005-12-01|April 2004||2004-04-01|||||Interventional|||Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis|Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis|Completed||Phase 2|24||University of North Carolina, Chapel Hill|||||||||||||||||||2017-02-18 16:51:06.338821|2017-02-18 16:51:06.338821
NCT00274378|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2009-07-29|||June 2005||2005-06-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Allomatrix Injectable Putty in Distal Radius Fractures|Allomatrix Injectable Putty in Distal Radius Fractures. Protocol for a Randomised, Controlled Clinical Study in Unstable Fractures of the Distal Radius|Completed||Phase 4|50|Anticipated|Université Catholique de Louvain|||||f||||||||||||||2017-02-18 16:51:06.424004|2017-02-18 16:51:06.424004
NCT00274365|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2009-01-28|||November 2005||2005-11-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Consultations in Psychiatry Through Videoconference|Consultations in Psychiatry Given to GP's Through Videoconference|Completed||N/A|250||Sha’ar Menashe Mental Health Center|||||f||||||||||||||2017-02-18 16:51:06.526524|2017-02-18 16:51:06.526524
NCT00274352|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2013-05-20|||September 2006||2006-09-01|May 2013|2013-05-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Study of Adalimumab to Treat Sarcoidosis of the Skin|A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous Sarcoidosis|Completed||Phase 2|16|Actual|Pariser, Robert J., M.D.||1|||f||||f||||||||||2017-02-18 16:51:06.61316|2017-02-18 16:51:06.61316
NCT00274339|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2007-06-22|||December 2005||2005-12-01|June 2007|2007-06-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Prevacid vs Lifestyle Modifications for the Treatment of LPR|A Comparison of Prevacid 30mg BID Plus Lifestyle Modifications Versus Lifestyle Modifications Alone for the Treatment of Laryngopharyngeal Reflux (LPR) in Adults|Unknown status|Recruiting|N/A|135|Anticipated|Hodge, Kenneth M., M.D.||2|||f||||f||||||||||2017-02-18 16:51:06.708574|2017-02-18 16:51:06.708574
NCT00274326|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2008-09-12|||May 2005||2005-05-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||DILIPO (DILutIonal HyPOnatremia)|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of a Vasopressin V2 Receptor Antagonist (SR121463B) on Serum Sodium in Patients With Dilutional Hyponatremia|Completed||Phase 3|150||Sanofi|||||f||||||||||||||2017-02-18 16:51:06.836273|2017-02-18 16:51:06.836273
NCT00274313|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2009-01-12|||January 2006||2006-01-01|January 2009|2009-01-01|August 2006||2006-08-01|||||Interventional|||Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients|A Study of the Safety and Pharmacokinetics of 552-02 Following 14 Days of Dosing By Inhalation in Patients With Cystic Fibrosis|Completed||Phase 1/Phase 2|40||Parion Sciences|||||f||||||||||||||2017-02-18 16:51:06.946505|2017-02-18 16:51:06.946505
NCT00274300|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2007-01-25|||August 2004||2004-08-01|January 2006|2006-01-01|July 2005||2005-07-01|||||Interventional|||Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2|A Phase I, Two-Center, Open-Label, Dose-Escalating Study to Investigate the Safety, Tolerability and Immunogenicity of pPJV7630, a Therapeutic DNA Vaccine for Herpes Simplex Virus Type 2 (HSV-2), in Patients With Recurrent Genital Herpes Caused by HSV-2|Completed||Phase 1|36||PowderMed|||||||||||||||||||2017-02-18 16:51:07.034127|2017-02-18 16:51:07.034127
NCT00274287|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2014-06-19|2011-10-06||January 2006||2006-01-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere|A Phase II Pilot Study Investigating the Efficacy and Activity of Single Agent GM-CSF (Leukine) Maintenance Approach in Androgen-independent Prostate Cancer (AIPC) Patients Responding to Taxotere Chemotherapy|Completed||Phase 2|15|Actual|Oncology Specialists, S.C.||1|||f||||f||||||||||2017-02-18 16:51:07.12802|2017-02-18 16:51:07.12802
NCT00274274|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2014-11-20|||September 2005||2005-09-01|November 2014|2014-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes|Efficacy and Safety of Insulin Aspart in a Fixed or Flexible Supplementary Insulin Therapy Regimen, With or Without Insulin Detemir in Type 2 Diabetes|Completed||Phase 4|373|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:51:07.526756|2017-02-18 16:51:07.526756
NCT00274261|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2016-08-17|2012-12-14||June 2004||2004-06-01|August 2016|2016-08-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®|A Phase II/III Multicenter, Randomized, Double-masked, Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®|Completed||Phase 3|1565|Actual|Health Decisions||2|||f||||t||||||||||2017-02-18 16:51:07.625298|2017-02-18 16:51:07.625298
NCT00274248|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2008-02-07|||March 2005||2005-03-01|February 2008|2008-02-01||||May 2007|Actual|2007-05-01||Interventional|||MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia|A Phase 1 Study of MLN518 Given in Combination With Standard Induction Chemotherapy for the Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia|Completed||Phase 1|||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 16:51:08.093402|2017-02-18 16:51:08.093402
NCT00271219|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2015-07-30|2013-03-11||July 2005||2005-07-01|July 2015|2015-07-01|June 2010|Actual|2010-06-01|August 2009|Actual|2009-08-01||Interventional|||RCT Comparing Methadone and Buprenorphine in Pregnant Women|Maternal Opioid Treatment: Human Experimental Research|Completed||Phase 3|175|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:51:58.74667|2017-02-18 16:51:58.74667
NCT00274235|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2008-10-30|||July 2005||2005-07-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Intermittent Preventive Treatment During Pregnancy in Benin|Intermittent Preventive Treatment During Pregnancy in Benin: a Randomized, Open, and Equivalent Trial Comparing Sulfadoxine-Pyrimethamine With Mefloquine|Completed||Phase 3|1600|Anticipated|Institut de Recherche pour le Developpement|||||f||||t||||||||||2017-02-18 16:51:08.161682|2017-02-18 16:51:08.161682
NCT00274222|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2006-01-09|||January 2003||2003-01-01|January 2006|2006-01-01|October 2005||2005-10-01|||||Observational|||The Role of Nebulized Budesonide in the Treatment of Acute Exacerbations of COPD||Terminated||N/A|120||Inonu University|||||f||||||||||||||2017-02-18 16:51:08.442717|2017-02-18 16:51:08.442717
NCT00274209|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2011-11-21|||December 2005||2005-12-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Chromoendoscopy for Ulcerative Colitis Surveillance|Impact of Chromoendoscopy on the Detection of Neoplasia in Ulcerative Colitis|Completed||N/A|100|Actual|Indiana University|||1||f||||t||||||Samples Without DNA|"~     endoscopic biopsies~   "|||2017-02-18 16:51:08.520213|2017-02-18 16:51:08.520213
NCT00274196|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2007-11-12|||February 2006||2006-02-01|November 2007|2007-11-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Ultrasound as a Diagnostic Tool for Occult Hip Fractures|A Prospective Study of the Specificity and Sensitivity of Ultrasound in Diagnosing Occult Hip Fractures|Unknown status|Recruiting|N/A|30|Anticipated|Hadassah Medical Organization||1|||f||||f||||||||||2017-02-18 16:51:08.631772|2017-02-18 16:51:08.631772
NCT00274183|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2015-10-12|||January 2006||2006-01-01|September 2015|2015-09-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Observational|||Nonalcoholic Fatty Liver Disease in Taiwanese Children|Prevalence, Clinicopathological Characteristics, Biomarkers and Genetics of Nonalcoholic Steatohepatitis in Taiwanese Children|Recruiting||N/A|800|Anticipated|Far Eastern Memorial Hospital|||1||f||||t||||||Samples With DNA|"~     Serum, WBC DNA~   "|||2017-02-18 16:51:08.72144|2017-02-18 16:51:08.72144
NCT00274170|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2007-02-27|||January 2006||2006-01-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache|Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache|Unknown status|Recruiting|Phase 1/Phase 2|56||C.R.Darnall Army Medical Center|||||f||||||||||||||2017-02-18 16:51:08.810587|2017-02-18 16:51:08.810587
NCT00274157|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2008-06-26|||March 2007||2007-03-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||FIRE-PAD: Functional Improvement Through Revascularization of the Extremities for Peripheral Arterial Disease|Functional Improvement Through Revascularization of the Extremities for Peripheral Arterial Disease (FIRE-PAD). Effects of Catheter-Based Revascularization on Functional Capacity, Quality of Life, and the Cardiovascular Risk Profile of Patients With Intermittent Claudication|Terminated||Phase 2|37|Anticipated|The Cleveland Clinic||||Low enrollment|f||||||||||||||2017-02-18 16:51:08.902355|2017-02-18 16:51:08.902355
NCT00274144|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||December 2001||2001-12-01|October 2013|2013-10-01|May 2004||2004-05-01|March 2004|Actual|2004-03-01||Interventional|||Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism|Pilot Study: Inflammation and Coronary Artery Disease. Role of AT1 Receptor Antagonism|Completed||Phase 4|42||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:08.991337|2017-02-18 16:51:08.991337
NCT00274131|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2012-05-18|||December 1998||1998-12-01|May 2012|2012-05-01|February 2004||2004-02-01|||||Interventional|||Long-term Administration Study of SND 919 Tablets in Parkinson's Disease|Long-term Administration Study of SND 919 Tablets in Parkinson's Disease|Completed||Phase 3|170||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:09.084207|2017-02-18 16:51:09.084207
NCT00274118|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||July 1997||1997-07-01|October 2013|2013-10-01|January 2004||2004-01-01|January 2004|Actual|2004-01-01||Interventional|||DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril|DETAIL = Diabetics Exposed to Telmisartan And enalapIL: A Randomised, Double-blind, Parallel-group Comparison of the Renal and Antihypertensive Effects of Telmisartan and Enalapril in Subjects With Mild to Moderate Hypertension and Concurrent Type II Diabetes Mellitus and Diabetic Nephropathy|Completed||Phase 3|250||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:09.169479|2017-02-18 16:51:09.169479
NCT00274105|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||March 2001||2001-03-01|October 2013|2013-10-01|October 2004||2004-10-01|October 2004|Actual|2004-10-01||Interventional|||SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients|A Double Blind, 2:1 Randomised Monocentre Study to Investigate the Efficacy and Safety of Telmisartan (80 mg qd) Concerning the Amelioration of Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients (SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients)|Terminated||Phase 4|22||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:09.297418|2017-02-18 16:51:09.297418
NCT00274092|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-11-04|||September 2002||2002-09-01|November 2013|2013-11-01|October 2003||2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Comparison of 18 Mcg of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (2 Puffs of 20 Mcg) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|132|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:09.409502|2017-02-18 16:51:09.409502
NCT00274079|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||October 2002||2002-10-01|October 2013|2013-10-01|October 2003||2003-10-01|October 2003|Actual|2003-10-01||Interventional|||SPIRIVA in Ususal Care|A Randomised, Double-blind, Parallel Group, 12 Week Study, Comparing the Effect of Once Daily Tiotropium Lactose Capsule With Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD), naïve to Anticholinergic Agents in Addition to Receiving Their Usual COPD Care|Completed||Phase 4|395||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:09.504646|2017-02-18 16:51:09.504646
NCT00274066|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||October 2002||2002-10-01|October 2013|2013-10-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva|The Acute Bronchodilator Effects of a Single Dose (2 Puffs) of the Shortacting Anticholinergic Ipratropium Bromide (40μg) and the Short-acting Beta-adrenergic Fenoterol (200μg) in Comparison to Placebo on Top of Pharmacodynamic Steady State of Once Daily Tiotropium (18μg) Inhalation Capsule in Patients With Chronic Pulmonary Disease (COPD)|Completed||Phase 3|65||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:09.827828|2017-02-18 16:51:09.827828
NCT00005448|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-09-07|||July 1996||1996-07-01|August 2016|2016-08-01|June 2002|Anticipated|2002-06-01|June 2002|Anticipated|2002-06-01||Observational|||Adverse Events With Magnesium Sulfate||Withdrawn||N/A|0|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||||||2017-02-18 18:14:58.26794|2017-02-18 18:14:58.26794
NCT00274053|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||April 2002||2002-04-01|October 2013|2013-10-01|April 2004||2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD|Effect of a 9-month Treatment of SPIRIVA® on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease. Validation of a New HRQoL Questionnaire Appropriate to Common Daily Practice. (TIPHON Study)|Completed||Phase 3|555|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:09.939734|2017-02-18 16:51:09.939734
NCT00274040|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||July 2002||2002-07-01|October 2013|2013-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD|A Comparison of 18 μg of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (2 Puffs of 20 μg, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|141||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:10.072377|2017-02-18 16:51:10.072377
NCT00274027|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||January 2001||2001-01-01|October 2013|2013-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)|Randomised, Double-Blind, Placebo-Controlled, Cross-Over Study to Examine the Effects of Tiotropium on Lung Hyperinflation, Respiratory Mechanics and Dyspnea During Exercise in Patients With COPD|Completed||Phase 3|19|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:10.193081|2017-02-18 16:51:10.193081
NCT00274014|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||October 2000||2000-10-01|October 2013|2013-10-01|October 2003||2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders|Effects of Inhaled Tiotropium Bromide on Severity of Airflow Obstruction During Long-term Treatment in Patients With Moderately Severe Copd. Impact on Severity and Incidence of Exacerbations.|Completed||Phase 3|1000||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:10.295625|2017-02-18 16:51:10.295625
NCT00274001|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-31|||September 2001||2001-09-01|October 2013|2013-10-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients|An Open, Randomised, Multicentre, Comparative Trial, to Evaluate the Benefit of Switching From a PI-based Regimen to a Nevirapine-based Regimen on the Quality of Life, Patient Adherence, Patient's Perception of Fat Redistribution and Metabolic Changes, in HIV+ Patients Suffering From Fat Abnormalities|Completed||Phase 4|158|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:10.640804|2017-02-18 16:51:10.640804
NCT00273988|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-30|||April 2002||2002-04-01|October 2013|2013-10-01|October 2003||2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults|A Pharmacokinetic Study to Evaluate the Interaction Between Nevirapine (Viramune®) and Methadone in HIV-1 Infected, Opioid-dependent Adults on Stable Methadone Maintenance Therapy|Completed||Phase 4|10||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:10.769189|2017-02-18 16:51:10.769189
NCT00273975|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-30|||January 2002||2002-01-01|October 2013|2013-10-01|December 2004||2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients|A Randomised Open Label Multi-centre Trial to Evaluate the Pharmacokinetic, Efficacy and Safety Parameters of Nevirapine 150mg/m2 and Nevirapine 4 or 7 mg/kg When Administered in Combination With AZT and 3TC for 48 Weeks in Antiretroviral naïve Paediatric Patients.|Completed||Phase 2|123||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:10.872566|2017-02-18 16:51:10.872566
NCT00273962|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2013-10-28|||May 2002||2002-05-01|October 2013|2013-10-01|November 2003||2003-11-01|November 2003|Actual|2003-11-01||Interventional|||A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)|A Comparison of Combivent® UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) in a Double-Blind Efficacy and Safety Study in Asthmatic Children With Severe Acute Exacerbation|Completed||Phase 4|500|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:51:10.987017|2017-02-18 16:51:10.987017
NCT00273949|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-09|2008-02-05|||January 2006||2006-01-01|September 2005|2005-09-01|January 2007||2007-01-01|||||Interventional|||Lactulose for the Prevention of Nosocomial Infections in Children|Lactulose for the Prevention of Nosocomial Infections in Children|Unknown status|Active, not recruiting|N/A|100||Bnai Zion Medical Center|||||f||||f||||||||||2017-02-18 16:51:11.088821|2017-02-18 16:51:11.088821
NCT00273936|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2011-08-02|||January 2006||2006-01-01|August 2011|2011-08-01||||||||Interventional|||Trial of AVN-944 in Patients With Advanced Hematologic Malignancies|A Phase I Trial of AVN-944 in Patients With Advanced Hematologic Malignancies|Completed||Phase 1|72|Anticipated|Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-02-18 16:51:11.200172|2017-02-18 16:51:11.200172
NCT00273910|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-07|2012-10-17|2012-03-30||January 2006||2006-01-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma|Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High Risk Melanoma|Completed||Phase 2|104|Actual|National Institutes of Health Clinical Center (CC)||6|||f||||f||||||||||2017-02-18 16:51:11.293951|2017-02-18 16:51:11.293951
NCT00273897|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-07|2017-01-24|||December 30, 2005||2005-12-30|December 16, 2008|2008-12-16||||December 11, 2007|Actual|2007-12-11||Interventional|||Electrical Polarization of the Brain in Corticobasal Syndrome|Direct Current Brain Polarization for Apraxia in Corticobasal Syndrome|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:51:12.449661|2017-02-18 16:51:12.449661
NCT00273884|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2007-02-16|||August 2005||2005-08-01|February 2007|2007-02-01|April 2009||2009-04-01|||||Interventional|||Amonafide in Combination With Cytarabine in Secondary AML|Phase 2 Open-Label Study of Amonafide L-Malate in Combination With Cytarabine in Subjects With Secondary Acute Myeloid Leukemia (AML)|Completed||Phase 2|80||Xanthus Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:51:12.55269|2017-02-18 16:51:12.55269
NCT00273871|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2011-03-07|||January 2002||2002-01-01|May 2007|2007-05-01|September 2006|Actual|2006-09-01|||||Interventional|||Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients|A Multi-centre, Randomized, Open-label, Study to Compare Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients on Maintenance Therapy With Mild to Moderate Renal Insufficiency.|Completed||Phase 3|190||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:51:12.662915|2017-02-18 16:51:12.662915
NCT00273858|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2011-09-08|2011-06-30||March 2006||2006-03-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis|Open Label Study To Evaluate The Safety Profile And The Quality Of Life In Patients Receiving Etanercept For The Treatment Of Rheumatoid Arthritis, Ankylosing Spondylitis And Psoriatic Arthritis|Terminated||N/A|880|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1|"The study was terminated because at least one year follow-up was achieved for each patient and~   the achievement of 965 exposure years to the drug."|f||||f||||||||||2017-02-18 16:51:12.748702|2017-02-18 16:51:12.748702
NCT00273845|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2009-02-23|||May 2003||2003-05-01|February 2009|2009-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|RBP||Reducing Barriers to Drug Abuse Treatment Services|Reducing Barriers to Drug Abuse Treatment Services|Completed||Phase 2/Phase 3|678|Actual|Wright State University||2|||f||||t||||||||||2017-02-18 16:51:13.395329|2017-02-18 16:51:13.395329
NCT00273832|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-01-04|||March 2005||2005-03-01|December 2005|2005-12-01|November 2005||2005-11-01|||||Interventional|||Study of Coronary Artery Computed Tomography to Diagnose Emergency Chest Pain|Randomized Controlled Trial of Multi-Slice Coronary Computed Tomography for Evaluation of Acute Chest Pain|Completed||Phase 2|200||William Beaumont Hospitals|||||f||||||||||||||2017-02-18 16:51:13.500342|2017-02-18 16:51:13.500342
NCT00273819|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2009-01-24|||October 2005||2005-10-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of Coronary Artery Disease by Two Types of Angiography|Non-Invasive Detection of Revascularizable Cardiomyopathy|Completed||N/A|30|Anticipated|VA Connecticut Healthcare System|||||f||||||||||||||2017-02-18 16:51:13.611524|2017-02-18 16:51:13.611524
NCT00273806|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2008-08-26|||December 2005||2005-12-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Medical Assistant-Based Program to Promote Healthy Behaviors in Primary Care|Engaging the Team: A Multilevel Program to Promote Healthy Behaviors|Completed||N/A|864|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||||||||||||2017-02-18 16:51:13.704183|2017-02-18 16:51:13.704183
NCT00273793|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2012-06-14|2012-03-09||June 2005||2005-06-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|June 2010|Actual|2010-06-01||Interventional|||Increasing Contingency Management Success in Smoking Cessation|Increasing Contingency Management Success Using Shaping|Completed||N/A|328|Actual|The University of Texas Health Science Center at San Antonio|The study was conducted largely as planned. However the study was not designed to adequately test post-treatment outcomes, as this would not be justifiable unless during treatment differences were observed.|6|||f||||||||||||||2017-02-18 16:51:13.992664|2017-02-18 16:51:13.992664
NCT00273780|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2012-08-23|||May 2006||2006-05-01|August 2012|2012-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Highly Active Antiretroviral Therapy (HAART) Adherence Interventions|HAART Adherence Interventions in Africa: An RCT|Completed||N/A|400|Actual|University of Washington||4|||f||||t||||||||||2017-02-18 16:51:14.719967|2017-02-18 16:51:14.719967
NCT00273767|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2009-12-04|||January 2006||2006-01-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|July 2009|Actual|2009-07-01||Interventional|EPOetCEC||Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB|Double-blind Phase II Pilot Monocentric Randomized Clinical Trial Evaluating the Effect of a Preliminary Administration of Erythropoietin on Different Markers of Cardiac Ischemia Induced by Cardiopulmonary Bypass|Completed||Phase 2|50|Actual|University Hospital, Grenoble||2|||f||||t||||||||||2017-02-18 16:51:14.830943|2017-02-18 16:51:14.830943
NCT00273754|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2016-05-12|2009-06-05||September 2003||2003-09-01|May 2016|2016-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|OSA||The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).|A Pilot Study to Evaluate if Caffeine Helps Children With Obstructive Sleep Apnea Recover Faster From Anesthesia, and With Less Complications After General Anesthesia for Tonsillectomy and Adenoidectomy.|Completed||Phase 2|74|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 16:51:14.947038|2017-02-18 16:51:14.947038
NCT00273741|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2009-12-04|||January 2007||2007-01-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|Ritaline||Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients|Randomized Study Evaluating the Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients|Terminated||Phase 3|39|Actual|University Hospital, Grenoble||2||difficulty of recrutement|f||||t||||||||||2017-02-18 16:51:15.410105|2017-02-18 16:51:15.410105
NCT00273728|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2011-08-11|||May 2005||2005-05-01|August 2011|2011-08-01|May 2011|Actual|2011-05-01|June 2010|Actual|2010-06-01||Interventional|BaSES||BaSES Trial: Basel Starch Evaluation in Sepsis|Basel Study for Evaluation of Starch (130;0.4) Infusion in Septic Patients: BaSES (130;0.4) Trial|Completed||Phase 4|231|Actual|University Hospital, Basel, Switzerland||1|||f||||f||||||||||2017-02-18 16:51:15.538737|2017-02-18 16:51:15.538737
NCT00273715|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2013-07-30|||December 2005||2005-12-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Study of Sutures Versus Staples for Skin Closure After Surgical Procedures of Hip|A Comparative Randomized Efficacy Study of Sutures Versus Staples in Hip Surgical Procedures|Completed||Phase 4|93|Actual|University of Kentucky||1|||f||||f||||||||||2017-02-18 16:51:15.649587|2017-02-18 16:51:15.649587
NCT00273702|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2007-04-27|||January 2006||2006-01-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling|An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling|Completed||Phase 1|36|Actual|University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 16:51:15.748695|2017-02-18 16:51:15.748695
NCT00273689|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2008-05-01|||December 2005||2005-12-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Exercise Induced Bronchospasm in Children|"Pretreatment With Albuterol vs. Montelukast in Exercise Induced Bronchospasm in Children."|Completed||Phase 4|13|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:51:15.844449|2017-02-18 16:51:15.844449
NCT00273676|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2006-01-05|||July 2000||2000-07-01|January 2006|2006-01-01|March 2004||2004-03-01|||||Interventional|||Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia|Costs and Effects of Early Switch of Intravenous to Oral Antibiotics in Severe Community-Acquired Pneumonia: a Multicenter Randomized Trial|Completed||Phase 4|500||UMC Utrecht|||||f||||||||||||||2017-02-18 16:51:15.953669|2017-02-18 16:51:15.953669
NCT00005447|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1995||1995-08-01|April 2002|2002-04-01|July 2001|Actual|2001-07-01|||||Observational|||Physical Activity and Cardiovascular Disease Prevention||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.357979|2017-02-18 18:14:58.357979
NCT00273663|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2007-06-28|||January 2006||2006-01-01|June 2007|2007-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Transcranial Electrical Stimulation (TCES) / Cerebral Blood Flow (CBF) / Xenon Under Computerized Tomography (Xe/CT)|The Effects of Transcranial Electrical Stimulation (TCES) on Cerebral Blood Flow (CBF) With Xenon Under Computerized Tomography (Xe/CT)|Completed||N/A|44|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 16:51:16.078962|2017-02-18 16:51:16.078962
NCT00273650|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2012-10-30|||July 2005||2005-07-01|October 2012|2012-10-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism|Double-Blind Placebo Controlled, Cross-over Trial of Subcutaneous B12 on Behavioral and Metabolic Measures in Children With Autism.|Completed||Phase 2/Phase 3|35|Actual|University of California, Davis||2|||f||||t||||||||||2017-02-18 16:51:16.164096|2017-02-18 16:51:16.164096
NCT00273637|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2006-05-25|||October 2005||2005-10-01|October 2005|2005-10-01|January 2006||2006-01-01|||||Observational|||Registry and Survey of Women With Pregnancy Related Cardiomyopathy|Pregnancy Related Cardiomyopathy Enrollment and Lessons in Web-Based Recruitment (PRiCELESS)|Unknown status|Recruiting|N/A|175||St. Vincent's Medical Center|||||f||||||||||||||2017-02-18 16:51:16.286054|2017-02-18 16:51:16.286054
NCT00273624|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2016-05-12|||June 2005||2005-06-01|May 2016|2016-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial|Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial|Terminated||Phase 3|60|Actual|University Hospital Freiburg||2|||f||||f||||||||||2017-02-18 16:51:16.386324|2017-02-18 16:51:16.386324
NCT00273611|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2013-11-18|||December 2005||2005-12-01|November 2013|2013-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Vitamin D Levels and Vitamin D Education in Geriatric Patients|Characterization of Vitamin D Levels and Affect of Pharmacist-initiated Vitamin D Education in Geriatric Outpatients.|Completed||N/A|80|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 16:51:16.495788|2017-02-18 16:51:16.495788
NCT00273598|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2013-12-02|||September 1997||1997-09-01|December 2013|2013-12-01|September 2002||2002-09-01|||||Interventional|||Comparing Two Instrumentation Systems for the Treatment of Adolescent Scoliosis|Comparing the Moss Miami and Universal Spinal Instrumentation Systems for the Treatment of Adolescent Idiopathic Scoliosis|Completed||Phase 2|126||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 16:51:16.6063|2017-02-18 16:51:16.6063
NCT00273585|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2006-09-06|||August 2005||2005-08-01|September 2006|2006-09-01|February 2006||2006-02-01|||||Interventional|||Study of Using Computerized Education to Increase Patients' Confidence in Their Ability to Be Screened for Colon Cancer|Randomized Controlled Trial of Software-Based Enhancement of Colorectal Cancer Screening Self-Efficacy|Completed||Phase 3|100||University of California, Davis|||||f||||||||||||||2017-02-18 16:51:16.69857|2017-02-18 16:51:16.69857
NCT00273572|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2008-10-27|||December 2004||2004-12-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Lifestyle Intervention in Obese Arab Women|The Effect of a Lifestyle Intervention Program on Parameters of the Metabolic Syndrome Among Non-Diabetic Obese Arab Women|Completed||N/A|200|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 16:51:16.797856|2017-02-18 16:51:16.797856
NCT00273559|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2008-05-08|||January 2006||2006-01-01|November 2007|2007-11-01|December 2008|Anticipated|2008-12-01|||||Observational|||A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids|A Single Center, Open Label, Comparative, Controlled Trial to Assess the Risks and Benefits of Steroid Elimination vs. Steroid Therapy After Renal Transplantation|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Florida Hospital Transplant Center|||2||f||||t||||||||||2017-02-18 16:51:16.903186|2017-02-18 16:51:16.903186
NCT00273546|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2009-04-28|||May 1999||1999-05-01|April 2009|2009-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer|A Randomized Phase III Multicenter Trial of Neoadjuvant Docetaxel (Taxotere®) Plus Cisplatin and 5-Fluorouracil (TPF) Versus Neoadjuvant Cisplatin Plus 5-Fluorouracil Followed by Concomitant Chemoradiotherapy to Improve the Overall Survival and Progression Free Survival in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|500|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:51:17.00777|2017-02-18 16:51:17.00777
NCT00273533|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2008-07-21|||June 2004||2004-06-01|October 2006|2006-10-01|July 2006||2006-07-01|||||Interventional|||Ramipril in Rheumatoid Arthritis|Effects of Ramipril on Endothelial Function in Patients With Rheumatoid Arthritis|Completed||Phase 2/Phase 3|13|Actual|University of Zurich||2|||f||||||||||||||2017-02-18 16:51:17.115781|2017-02-18 16:51:17.115781
NCT00273520|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2009-09-14|||January 2003||2003-01-01|September 2009|2009-09-01|May 2004|Actual|2004-05-01|April 2004|Actual|2004-04-01||Interventional|||TELICAST : Telithromycin in Acute Exacerbations of Asthma|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Telithromycin 800 mg (Once Daily for 10 Days) as a Supplement to the Standard of Care for Patients With Acute Exacerbations of Asthma|Completed||Phase 3|||Sanofi|||||f||||f||||||||||2017-02-18 16:51:17.196608|2017-02-18 16:51:17.196608
NCT00273507|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2009-09-17|||January 1998||1998-01-01|September 2009|2009-09-01|January 2006||2006-01-01|||||Interventional|||Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3|Neoadjuvant Chemotherapy in Resectable NSCLC Stages IB, IIA, IIB, and IIIA/T3 But Not IIIA/N2|Terminated||Phase 3|270||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:51:17.385761|2017-02-18 16:51:17.385761
NCT00273494|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2008-05-21|||January 1998||1998-01-01|May 2008|2008-05-01|January 2008||2008-01-01|||||Interventional|||Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2|Scandinavian Neoadjuvant Phase III Study of Induction Chemotherapy Followed by Irradiation Alone or Surgery Plus Irradiation in NSCLC Stage IIIA/N2 (T1N2, T2N2, T3/N2).|Unknown status|Recruiting|Phase 3|406|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:51:17.470898|2017-02-18 16:51:17.470898
NCT00273481|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2008-11-18|||September 2005||2005-09-01|November 2008|2008-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Cosopt Versus Xalacom||Completed||Phase 4|33||Pharmaceutical Research Network|||||f||||||||||||||2017-02-18 16:51:17.564338|2017-02-18 16:51:17.564338
NCT00273273|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2016-02-29|||February 2006||2006-02-01|February 2016|2016-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir|Pharmacokinetics of Once Daily Antiretroviral Therapy Regimens Containing Tenofovir and Atazanavir/Ritonavir in Adolescents and Young Adults With HIV Infection|Completed||Phase 4|30||Westat|||||f||||f||||||||||2017-02-18 16:51:19.727092|2017-02-18 16:51:19.727092
NCT00273468|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2008-05-02|||January 2006||2006-01-01|May 2008|2008-05-01|October 2006|Actual|2006-10-01|||||Interventional|||To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)|A Randomised, Active Control, Double-Blind, Double-Dummy, Parallel-Group, Multi-National Study to Assess the Efficacy, Tolerability and Safety of the Granisetron Transdermal Delivery System in Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With the Administration of Moderately or Highly Emetogenic Multi-Day Chemotherapy|Completed||Phase 3|630||Prostrakan Pharmaceuticals|||||f||||||||||||||2017-02-18 16:51:17.649901|2017-02-18 16:51:17.649901
NCT00273455|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2008-11-18|||January 2006||2006-01-01|November 2008|2008-11-01|May 2007|Actual|2007-05-01|||||Interventional|||Lumigan Versus Cosopt||Completed||Phase 4|34||Pharmaceutical Research Network|||||f||||||||||||||2017-02-18 16:51:17.731565|2017-02-18 16:51:17.731565
NCT00273442|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2008-11-18|||November 2005||2005-11-01|November 2008|2008-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Assessing Cosopt Switch Patients||Completed||Phase 4|60||Pharmaceutical Research Network|||||f||||||||||||||2017-02-18 16:51:17.809439|2017-02-18 16:51:17.809439
NCT00273429|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2007-01-08|||April 2005||2005-04-01|January 2007|2007-01-01|December 2005||2005-12-01|||||Interventional|||Cosopt Versus Xalatan||Completed||Phase 4|||Pharmaceutical Research Network|||||f||||||||||||||2017-02-18 16:51:17.897942|2017-02-18 16:51:17.897942
NCT00273416|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-08-23|||January 2006||2006-01-01|August 2006|2006-08-01||||||||Interventional|||A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses|A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses Of PF-00592379 On Erectile Function, Using 100mg Sildenafil As A Positive Control|Completed||Phase 2|32||Pfizer|||||f||||||||||||||2017-02-18 16:51:17.983819|2017-02-18 16:51:17.983819
NCT00273403|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-09-21|||November 1999||1999-11-01|September 2006|2006-09-01|November 2006||2006-11-01|||||Interventional|||Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA|Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA|Unknown status|Recruiting|N/A|5100||The New York Academy of Medicine|||||f||||||||||||||2017-02-18 16:51:18.07525|2017-02-18 16:51:18.07525
NCT00273390|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2011-07-01|||August 2001||2001-08-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Clinical Trial of Infliximab for Uveitis|The Use of Remicade (Infliximab) in the Management of Vision-threatening Uveitis That is Refractory to Other Modes of Systemic Immunosuppression|Completed||N/A|32||Oregon Health and Science University|||||f||||||||||||||2017-02-18 16:51:18.364194|2017-02-18 16:51:18.364194
NCT00273377|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2016-06-27|||May 2002||2002-05-01|June 2016|2016-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection|The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection|Completed||Phase 3|2000|Anticipated|The Cleveland Clinic||2|||f||||t||||||||||2017-02-18 16:51:18.440739|2017-02-18 16:51:18.440739
NCT00273364|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2016-12-05|||January 2006||2006-01-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study|Hematopoietic Stem Cell Therapy for Patients With Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy: A Randomized Study|Recruiting||Phase 3|110|Anticipated|Northwestern University||2|||f||||t||||||||||2017-02-18 16:51:18.546093|2017-02-18 16:51:18.546093
NCT00273351|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2014-04-21||2014-04-21|January 2006||2006-01-01|April 2014|2014-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families|Assessment of Pre-symptomatic and Symptomatic Patients With Parkinson Disease to Identify and Characterize Genetic and Phenotypic Biomarkers for Disease Onset and Progression.|Completed||Phase 2|62|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 16:51:18.67973|2017-02-18 16:51:18.67973
NCT00273338|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2007-11-02|||January 2006||2006-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])|A Phase 3, Randomized, Open-Label Study Evaluating DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (ASCENT-2)|Terminated||Phase 3|1200|Anticipated|Novacea||||DSMB|||||||||||||||2017-02-18 16:51:18.796981|2017-02-18 16:51:18.796981
NCT00273325|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-06-16|||July 2004||2004-07-01|June 2015|2015-06-01|March 2009|Actual|2009-03-01|July 2007|Actual|2007-07-01||Observational|PCV-7||Immunogenicity of PCV-7 Vaccine in VLBW Infants|Observational Study of the Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine in Very-low-birth-weight Infants|Completed||Phase 4|368|Actual|NICHD Neonatal Research Network|||1||f||||t||||||Samples With DNA|"~     Serum was separated from blood samples. After all study assays were completed on all~     subjects, if a subject's parents asked that his/her serum not be stored, the serum was~     destroyed. For subjects whose parents permit it, leftover serum was re-labeled with a new,~     randomly-generated unique de-identifier, linked only to the subject's gestational age, birth~     weight, and chronologic age at the time of sampling. The link to any other subject~     identifiers will then be destroyed. The serum will be stored indefinitely at the University~     of Rochester for other, non-genetic-testing-related research.~   "|||2017-02-18 16:51:19.296771|2017-02-18 16:51:19.296771
NCT00273312|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2017-02-03|||January 2006||2006-01-01|February 2017|2017-02-01||||October 2006|Actual|2006-10-01||Interventional|||Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma|An Open-label, Phase II Trial of Patupilone (EPO906) as Monotherapy to Evaluate Activity of Patupilone in Patients With Advanced Unresectable and/or Metastatic Hepatocellular Carcinoma (HCC)|Completed||Phase 2|25|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:51:19.416395|2017-02-18 16:51:19.416395
NCT00273299|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2011-11-07|||November 2005||2005-11-01|November 2011|2011-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension|A 6-Week Study to Evaluate the Combination of Valsartan/HCTZ (160/12.5mg With Forced Titration to Maximum Dose of 320/25mg) Compared to Valsartan Monotherapy (160mg With Forced Titration to 320mg) as Initial Therapy in Patients With Severe Hypertension|Completed||Phase 3|607|Actual|Novartis|||||||||||||||||||2017-02-18 16:51:19.531627|2017-02-18 16:51:19.531627
NCT00273286|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2011-05-11|||January 2006||2006-01-01|April 2011|2011-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Family Management of Type 1 Diabetes in Children|Family Management of Childhood Diabetes Study|Completed||Phase 2|422|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||t||||||||||2017-02-18 16:51:19.619189|2017-02-18 16:51:19.619189
NCT00273260|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2006-05-08|||January 2000||2000-01-01|January 2006|2006-01-01|December 2002||2002-12-01|||||Interventional|||The Effectiveness of Individualised Bone Density Feedback and Osteoporosis Education in Premenopausal Women|The Effect on Behavior and Bone Mineral Density of Individualized Bone Mineral Density Feedback and Educational Interventions in Premenopausal Women: a Randomized Controlled Trial.|Completed||Phase 2|400||Menzies Institute for Medical Research|||||f||||||||||||||2017-02-18 16:51:19.83838|2017-02-18 16:51:19.83838
NCT00273247|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2006-01-05|||June 1998||1998-06-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis|Adjuvant α-Interferon Treatment After Resection of Hepatocellular Carcinoma in HCV-Related Cirrhosis: a Randomized Trial on Prevention of Cancer Recurrence|Completed||Phase 3|150||National Cancer Institute, Milan|||||f||||||||||||||2017-02-18 16:51:20.10499|2017-02-18 16:51:20.10499
NCT00273234|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2007-03-04|||January 2006||2006-01-01|March 2007|2007-03-01|November 2006||2006-11-01|||||Interventional|||Clinical Effectiveness of Topical Autologous Platelet Gel for the Treatment of Venous Ulcers|Clinical Evaluation of the Safety and Effectiveness of Topical Autologous Platelet Gel (APG) for the Treatment of Lower Extremity Chronic Venous Insufficiency Ulcers. A Multicenter, Randomized, Controlled Clinical Trial|Withdrawn||Phase 3|70||National Healing Corporation||||Lack of financial support. Study criteria severly limited enrollment.|||||||||||||||2017-02-18 16:51:20.199942|2017-02-18 16:51:20.199942
NCT00273221|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2008-05-21|||July 2005||2005-07-01|May 2008|2008-05-01|July 2006|Anticipated|2006-07-01|||||Interventional|||Combined Phacotube vs Phacotrabeculectomy:A Randomized Controlled Trial|Combined Phacoemulsification and Glaucoma Implant Surgery Versus Combined Phacoemulsification and Trabeculectomy: A Randomized Controlled Trial|Unknown status|Recruiting|Phase 4|50|Anticipated|National University Hospital, Singapore|||||f||||||||||||||2017-02-18 16:51:20.304937|2017-02-18 16:51:20.304937
NCT00273208|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2007-08-01|||September 2005||2005-09-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||An Intervention to Decrease Fatigue Among Breast Cancer Survivors|Being Well, Staying Healthy: An Integrated Mind-Body Medicine Intervention to Decrease Fatigue Among Breast Cancer Survivors, PILOT STUDY|Completed||N/A|25||Mercy Medical Center|||||f||||f||||||||||2017-02-18 16:51:20.399037|2017-02-18 16:51:20.399037
NCT00273195|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-10-11|||April 2004||2004-04-01|October 2006|2006-10-01|June 2005||2005-06-01|||||Interventional|||Clinical Investigation of the Medtronic EnTrust™ Implantable Cardioverter Defibrillator (ICD), Model D153ATG|Clinical Investigation of the Medtronic EnTrust™ Implantable Cardioverter Defibrillator (ICD), Model D153ATG|Completed||N/A|500||Medtronic Cardiac Rhythm and Heart Failure|||||||||||||||||||2017-02-18 16:51:20.495482|2017-02-18 16:51:20.495482
NCT00273182|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2013-07-01|2012-04-13||March 2002||2002-03-01|July 2013|2013-07-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry|InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Systems for Cardiac Resynchronization Therapy (CRT) - InSync Registry|Completed||N/A|1999|Actual|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-02-18 16:51:20.625357|2017-02-18 16:51:20.625357
NCT00273169|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2010-01-14|||July 2005||2005-07-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Use of the PSA 4000 Monitor in the Post-Operative Period in Patients Undergoing Major Surgery|Use of the PSA 4000 Monitor in the Post-Operative Period in Patients Undergoing Major Surgery|Completed||N/A|50|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 16:51:21.023516|2017-02-18 16:51:21.023516
NCT00273156|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2013-04-22|||February 2005||2005-02-01|April 2013|2013-04-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Interventional|||A Brief Dental Office Intervention With Tobacco Quitline|A Brief Dental Office Intervention With Tobacco Quitline|Completed||Phase 3|90|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 16:51:21.097349|2017-02-18 16:51:21.097349
NCT00273143|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2011-05-20|||May 2005||2005-05-01|May 2011|2011-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.|Kinetics of Cytomegalovirus (CMV) Replication and CMV-specific Immune Reconstitution After Hematopoietic Stem Cell Transplantation.|Completed||Phase 1|50||Mayo Clinic|||1||f||||||||||||||2017-02-18 16:51:21.178258|2017-02-18 16:51:21.178258
NCT00273130|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2006-09-11|||March 1999||1999-03-01|December 2003|2003-12-01|August 2002||2002-08-01|||||Interventional|||Stress Response Using Thin and Standard Size Endoscopy.|Randomised Evaluation of Neuroendocrine Stress Response During Upper Gastrointestinal Endoscopy With Standard or Ultrathin Endoscope.|Terminated||Phase 2/Phase 3|60||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 16:51:21.258826|2017-02-18 16:51:21.258826
NCT00273117|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2006-01-06|||February 2002||2002-02-01|January 2006|2006-01-01|August 2003||2003-08-01|||||Observational|||Transnasal and Oral Gastroscopy.|Transnasal and Conventional Oral Diagnostic Gastroscopy. A Prospective Randomised Study.|Terminated||Phase 3|100||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 16:51:21.355582|2017-02-18 16:51:21.355582
NCT00273104|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2015-02-17|||December 2005||2005-12-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|December 2009|Actual|2009-12-01||Interventional|||The Effect of Lifestyle Intervention Versus Gastric Bypass on Various Comorbidities in Morbidly Obese Subjects|The Effect of Lifestyle Intervention vs Gastric Bypass on Various Comorbidities|Completed||N/A|180|Actual|The Hospital of Vestfold||2|||f||||f||||||||||2017-02-18 16:51:21.436554|2017-02-18 16:51:21.436554
NCT00273091|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2015-03-09|||August 2003||2003-08-01|April 2009|2009-04-01|May 2007|Actual|2007-05-01|||||Observational|||MODULA Modul 5 BEAT-HF|MODULA-Study: Modul 5 / BEAT HF: Detektion and Registration of Atrial Tachyarrhythmias at Patients With Heart Failure|Completed||Phase 4|100|Anticipated|Guidant Corporation|||1||f||||||||||||||2017-02-18 16:51:21.535875|2017-02-18 16:51:21.535875
NCT00273078|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2007-04-26|||January 2006||2006-01-01|April 2007|2007-04-01||||||||Observational|||Tongue Pressure Recording During Speech|Experimental Study About Tongue Interactions With Teeth and Palate During Speech, Using Strain Gauge Transducer and Complete Denture. Comparison of Adaptation Phenomenon’s Between Patients With New Complete Denture.|Unknown status|Recruiting|N/A|20||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 16:51:21.626367|2017-02-18 16:51:21.626367
NCT00273065|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2007-02-16|||May 2005||2005-05-01|February 2007|2007-02-01|September 2005||2005-09-01|||||Interventional|||Local Anesthetic Properties of Neosaxitoxin|Phase 1 Study of Local Infiltration of Neosaxitoxin as a Local Anesthetic|Completed||Phase 1|10||University of Chile|||||f||||||||||||||2017-02-18 16:51:21.690906|2017-02-18 16:51:21.690906
NCT00005446|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-30|||April 1994||1994-04-01|December 2015|2015-12-01||||March 1999|Actual|1999-03-01||Observational|||Endogenous Estrogen and Coronary Heart Disease in Women||Completed||N/A|||New York University School of Medicine|||2||f||||||||||||||2017-02-18 18:14:58.420474|2017-02-18 18:14:58.420474
NCT00273052|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2016-12-02|2008-12-19||January 2006||2006-01-01|December 2016|2016-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension|A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Phosphate Modified Release Formulation (COREG- MR) With Metoprolol Succinate (TOPROL XL) on the Lipid Profile in Normolipidemic, or Mildly Dyslipidemic Hypertensive Patients|Completed||Phase 3|514|Actual|GlaxoSmithKline||2|||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:51:21.928832|2017-02-18 16:51:21.928832
NCT00273039|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2016-10-24|||August 2005||2005-08-01|October 2016|2016-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder|Completed||Phase 2|242|Actual|GlaxoSmithKline|||||||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:51:22.905583|2017-02-18 16:51:22.905583
NCT00273026|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2012-11-21|||November 2004||2004-11-01|November 2012|2012-11-01||||||||Interventional|||Study In Asthma Control|An Open-label, Multi-centre, Randomized, Parallel Group Clinical Effectiveness Study to Determine the Level of Asthma Control in Adolescent and Adult Patients With ADVAIR Versus Usual Care for 24 Weeks.|Terminated||Phase 4|680||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:51:23.041797|2017-02-18 16:51:23.041797
NCT00273013|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2012-05-31|||November 2004||2004-11-01|February 2011|2011-02-01||||||||Interventional|||Study With GW274150 In Patients With Mild Asthma|A Two-centre, Randomised, Double-blind, Double-dummy, Placebo-controlled, 3-period Cross-over Study to Evaluate the Effect of Treatment With Repeat Doses of GW274150 on the Allergen-induced Late Asthmatic Response in Subjects With Mild Asthma.|Completed||Phase 1|28||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:51:23.268754|2017-02-18 16:51:23.268754
NCT00273000|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2006-09-07|||January 2006||2006-01-01|October 2005|2005-10-01||||||||Interventional|||The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans|The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans|Unknown status|Recruiting|N/A|10||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 16:51:23.366926|2017-02-18 16:51:23.366926
NCT00272987|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2016-07-27|2014-07-28||December 2005||2005-12-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|July 2009|Actual|2009-07-01||Interventional|||ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib|A Randomized, Double Blind, Placebo-Controlled, Multicenter, Phase III Study Comparing the Activity of Paclitaxel Plus Trastuzumab Plus Lapatinib to Paclitaxel Plus Trastuzumab Plus Placebo in Women With ErbB2 Overexpressing Metastatic Breast Cancer|Active, not recruiting||Phase 3|63|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:51:23.476382|2017-02-18 16:51:23.476382
NCT00272974|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-01-04|||February 2001||2001-02-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Madagascar Female Condom Study|Measuring the Impact of Male and Female Condom Promotion Among Commercial Sex Workers in Madagascar|Completed||Phase 3|1000||FHI 360|||||f||||||||||||||2017-02-18 16:51:26.22189|2017-02-18 16:51:26.22189
NCT00272961|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2013-01-28|2013-01-28||January 2006||2006-01-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.|A Phase 2 Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Dose Ranging Study Of TBC3711 In Subjects With Resistant Hypertension|Terminated||Phase 2|60|Actual|Pfizer|Results for ‘change from standing to sitting SBP and DBP’ and ‘change from pre-dose to post-dose SBP and DBP’ are reported only at Week 10 as per changes in planned analysis because of early termination of the study and clinical development program.|5||See termination reason in detailed description.|f||||f||||||||||2017-02-18 16:51:26.432674|2017-02-18 16:51:26.432674
NCT00272948|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2011-06-08|||December 2005||2005-12-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|VOD-DF||Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide|Prospective Randomized Study of the Incidence and Outcome of Veno-Occlusive Disease (VOD) With the Prophylactic Use of Defibrotide (DF) in Pediatric Stem Cell Transplantation|Completed||Phase 2/Phase 3|360|Anticipated|European Group for Blood and Marrow Transplantation||2|||f||||t||||||||||2017-02-18 16:51:27.904487|2017-02-18 16:51:27.904487
NCT00272935|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2012-06-29|||December 2005||2005-12-01|July 2009|2009-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes|A Randomized, Multicenter, Double-blind, Placebo-controlled Trial to Demonstrate the Safety and Efficacy of Daily 0.3 mg Synthetic Conjugated Estrogens, A (Cenestin) for the Treatment of Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 3|400|Anticipated|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 16:51:30.832562|2017-02-18 16:51:30.832562
NCT00272922|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2007-10-17|||July 2002||2002-07-01|October 2007|2007-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Randomized, Prospective Controlled Trial of Paraesophageal Hernia Repair With Small Intestinal Submucosa (SIS)|Randomized, Prospective Controlled Trial of Paraesophageal Hernia Repair With Small Intestinal Submucosa (SIS)|Completed||N/A|150||Cook|||||f||||||||||||||2017-02-18 16:51:31.000144|2017-02-18 16:51:31.000144
NCT00272909|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2015-10-19|||September 2004||2004-09-01|October 2015|2015-10-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)|A Phase IIb Randomized, Double-blind, Placebo-Controlled, Group-Sequential, Multicenter, Dose Finding Study of the Safety and Efficacy of SUN N4057 (Piclozotan) Administered for 72 Hours by Continuous Intravenous Infusion in Subjects With Acute Ischemic Stroke and Measurable Penumbra on MRI|Terminated||Phase 2|43|Actual|Daiichi Sankyo Inc.||3|||f||||t||||||||||2017-02-18 16:51:31.08134|2017-02-18 16:51:31.08134
NCT00272896|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-01-04|||October 2004||2004-10-01|October 2004|2004-10-01|September 2005||2005-09-01|||||Interventional|||Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs|Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide (VIP) in Migraineurs|Completed||N/A|12||Danish Headache Center|||||f||||||||||||||2017-02-18 16:51:31.471289|2017-02-18 16:51:31.471289
NCT00272883|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2016-12-08|||August 2003||2003-08-01|December 2016|2016-12-01|January 2050|Anticipated|2050-01-01|January 2050|Anticipated|2050-01-01||Observational|||Molecular and Genetic Studies of Congenital Myopathies|Molecular Analysis of Neuromuscular Disease|Recruiting||N/A|4000|Anticipated|Boston Children’s Hospital|||1||f||||f||||||Samples With DNA|"~     The primary biospecimens retained are blood, saliva and muscle tissue samples. Other~     specimens are retained on a case-by-case basis.~   "|||2017-02-18 16:51:31.569236|2017-02-18 16:51:31.569236
NCT00272870|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2012-08-28|||December 2005||2005-12-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|December 2008|Actual|2008-12-01||Interventional|||Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy|A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection|Terminated||Phase 1|1|Actual|Children's Hospital Medical Center, Cincinnati||1||Slow accrual; drug availability|f||||t||||||||||2017-02-18 16:51:31.687535|2017-02-18 16:51:31.687535
NCT00272857|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2014-09-18|||August 2004||2004-08-01|September 2014|2014-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia|Gene Transfer From Patients With Fanconi Anemia, Genotype A: A Pilot Study|Completed||Phase 1|3|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 16:51:31.791402|2017-02-18 16:51:31.791402
NCT00272844|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2011-07-13|||January 1998||1998-01-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome|Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome|Completed||Phase 1/Phase 2|23|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 16:51:31.898797|2017-02-18 16:51:31.898797
NCT00272831|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2009-05-21|||December 2005||2005-12-01|May 2009|2009-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Use of Cilostazol in Patients With Diabetic Nephropathy|A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100 mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese|Completed||Phase 4|62|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 16:51:32.003793|2017-02-18 16:51:32.003793
NCT00272818|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2016-01-26|||September 2004||2004-09-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Observational|||Study to Identify Non-Invasive Markers of Gastrointestinal Allergy|Non Invasive Markers in the Diagnosis and Interval Assessment of Children and Adults With Known or Suspected Allergic Disease|Completed||Phase 1|110|Actual|Boston Children’s Hospital|||1||f||||||||||||||2017-02-18 16:51:32.124645|2017-02-18 16:51:32.124645
NCT00272805|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2013-02-15|||October 2005||2005-10-01|February 2013|2013-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg|Prospective, Randomized, Controlled Assessment of Once-Daily Controlled Release COREG CR vs Twice-Daily COREG Immediate Release(IR)on Measures of Compliance and Quality of Life in Patients With Heart Failure and Left Ventricular Systolic Dysfunction|Completed||Phase 3|400||Cardiovascular Clinical Studies|||||f||||||||||||||2017-02-18 16:51:32.221356|2017-02-18 16:51:32.221356
NCT00272792|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2015-07-23|2009-01-29||February 2006||2006-02-01|July 2015|2015-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet|A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet|Completed||Phase 3|45|Actual|BioMarin Pharmaceutical||2|||||||||||||||||2017-02-18 16:51:32.368945|2017-02-18 16:51:32.368945
NCT00272779|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2011-04-07|2010-12-03||November 2005||2005-11-01|April 2011|2011-04-01|October 2008|Actual|2008-10-01|June 2007|Actual|2007-06-01||Interventional|||BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada|A 96 Week Study Comparing the Antiviral Efficacy and Safety of Atazanavir/Ritonavir With Lopinavir/Ritonavir, Each in Combination With Fixed Dose Tenofovir-Emtricitabine in HIV-1 Infected Treatment in Naive Subjects|Completed||Phase 3|1057|Actual|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 16:51:33.055793|2017-02-18 16:51:33.055793
NCT00272766|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-10-25|||February 2006||2006-02-01|October 2006|2006-10-01|May 2007||2007-05-01|||||Interventional|||Macugen for Histoplasmosis|Macugen for Histoplasmosis-An Open-Label, Single-Site, Comparative, Prospective Case Series|Terminated||N/A|24||Barnes Retina Institute|||||||||||||||||||2017-02-18 16:51:36.199311|2017-02-18 16:51:36.199311
NCT00272753|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2011-05-31|||April 2004||2004-04-01|May 2011|2011-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations|A Randomized Double Blind Comparison Between Single Doses of Symbicort Turbuhaler (Budesonide/Formoterol Combination), Formoterol, Salbutamol and Placebo in Repeated AMP-challenges in Patients With Mild - to Moderate Asthma. Investigating the Supplementary Value of the Budesonide Component Within Symbicort When Tested in a Model of Slow Onset Acute Asthma|Completed||Phase 4|20||AstraZeneca|||||f||||f||||||||||2017-02-18 16:51:36.285068|2017-02-18 16:51:36.285068
NCT00272740|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2007-02-08|||March 2000||2000-03-01|February 2007|2007-02-01||||||||Interventional|||SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer|An Open, Multicenter Phase II Trial Evaluating the Antitumour Efficacy of Faslodex® (Fulvestrant) in Postmenopausal Women With Advanced Breast Cancer Failing Non-Steroidal or Steroidal Aromatase Inhibitors|Completed||Phase 2|93||AstraZeneca|||||f||||||||||||||2017-02-18 16:51:36.366851|2017-02-18 16:51:36.366851
NCT00271726|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2007-04-25|||November 2005||2005-11-01|April 2007|2007-04-01||||||||Interventional|||Operative Treatment of Extraarticular Colles' Fractures of the Distal Radius (OTEC)|Prospective, Randomized, Multi-Center Pilot Study on the Treatment of Unstable, Extraarticular Colles Fractures of the Distal Radius by Palmar Locking Plate, External Fixator or Kirschner Wires|Unknown status|Recruiting|N/A|90||Heinrich-Heine University, Duesseldorf|||||f||||||||||||||2017-02-18 16:51:36.466703|2017-02-18 16:51:36.466703
NCT00271713|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2009-01-27|||March 2006||2006-03-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)|Randomized Double-Blind Placebo-Controlled and Parallel Group Study to Evaluate the Impact of One Year Therapy With Monthly Oral Ibandronate 150 mg on Structural Properties of Bone in Postmenopausal Osteoporosis Without Vertebral Fractures|Completed||Phase 4|70|Actual|Charite University, Berlin, Germany||2|||f||||f||||||||||2017-02-18 16:51:36.551753|2017-02-18 16:51:36.551753
NCT00271687|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2016-02-24|||February 2006||2006-02-01|March 2012|2012-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer|A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer|Completed||Phase 2|30|Anticipated|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 16:51:36.995166|2017-02-18 16:51:36.995166
NCT00270699|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2012-12-31|||June 2006||2006-06-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of rDEN4delta30-200,201, a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 4|Completed||Phase 1|56|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 16:51:37.086753|2017-02-18 16:51:37.086753
NCT00272727|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2011-01-21|||February 2006||2006-02-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and Caregiver|Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and Caregiver|Completed||N/A|100||AstraZeneca|||||f||||||||||||||2017-02-18 16:51:37.2168|2017-02-18 16:51:37.2168
NCT00272714|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2013-07-11|||March 2003||2003-03-01|July 2013|2013-07-01|April 2005|Actual|2005-04-01|March 2004|Actual|2004-03-01||Interventional|||Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women|A Phase II, Randomized, Double-Blind, Two-Dose, Placebo-Controlled Multicentre Study of 4-Hydroxy Tamoxifen Gel for Cyclical Mastalgia in Otherwise Healthy Pre-Menopausal Women With Regular Menstrual Cycles.|Completed||Phase 2|146|Actual|ASCEND Therapeutics|||||f||||f||||||||||2017-02-18 16:51:37.299623|2017-02-18 16:51:37.299623
NCT00272701|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2009-03-05|||December 2005||2005-12-01|August 2007|2007-08-01|February 2007|Actual|2007-02-01|||||Interventional|||Esomeprazole in PPI Failures - IMPROVE|A Randomised, Open, Phase IV, Parallel Group Multicentre Study to Evaluate a Change of Management in Gastroesophageal Reflux Disease (GERD) Patients by Treatment With Esomeprazole 40 mg or Any Other Proton Pump Inhibitor (PPI), After Initial Treatment Failure, in Ordinary Clinical Practice During 4 Weeks.|Completed||Phase 4|450|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:51:37.390027|2017-02-18 16:51:37.390027
NCT00272688|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2015-12-29|||January 2006||2006-01-01|December 2015|2015-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit|Continuous Delivery of Levodopa/Carbidopa (Duodopa) in Patients With Advanced Idiopathic Parkinsons Disease - a Health Economic Evaluation|Completed||Phase 4|10|Actual|University Hospital, Akershus||1|||f||||||||||||||2017-02-18 16:51:37.523081|2017-02-18 16:51:37.523081
NCT00272675|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-01-06|||August 2003||2003-08-01|January 2006|2006-01-01|September 2005||2005-09-01|||||Interventional|||Prevention of Nosocomial Infection by Decontamination of the Naso- and Oropharynx With Chlorhexidine (NONI Trial)|Prevention of Nosocomial Infection in Cardiac Surgery by Decontamination of the Naso- and Oropharynx With Chlorhexidine. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.|Completed||Phase 2/Phase 3|1000||Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||||f||||||||||||||2017-02-18 16:51:37.614528|2017-02-18 16:51:37.614528
NCT00272662|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2012-12-19|||January 2006||2006-01-01|December 2012|2012-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy|A Phase 2, Open-Label, Multi-Center Dose Escalation Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy|Completed||Phase 2|60|Actual|Affymax||4|||f||||f||||||||||2017-02-18 16:51:37.716659|2017-02-18 16:51:37.716659
NCT00272649|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-06|2013-03-06||2013-03-06|January 2006||2006-01-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer|A Phase I/II Study Testing the Biologic Activity and Safety of AGS-003 as an Immunotherapeutic in Subjects With Newly Diagnosed Stage IV Renal Cell Carcinoma|Completed||Phase 1/Phase 2|22|Actual|Argos Therapeutics||1|||f||||t||||||||||2017-02-18 16:51:37.855688|2017-02-18 16:51:37.855688
NCT00272636|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2015-06-02|||November 2002||2002-11-01|January 2006|2006-01-01|February 2005||2005-02-01|||||Interventional|||Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation|Randomized Comparison of Radiofrequency Catheter Ablation vs. Antiarrhythmic Therapy With Amiodarone for Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation|Completed||N/A|140||University of Michigan|||||f||||||||||||||2017-02-18 16:51:38.057339|2017-02-18 16:51:38.057339
NCT00272623|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2009-06-02|||January 2006||2006-01-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Seldinger Technique Versus Venous Cut-Down for Placement of Totally Implantable Venous Access Ports|A Prospective, Randomized Trial Comparing Seldinger Technique Versus Venous Cut-Down for Placement of Totally Implantable Venous Access Ports|Completed||N/A|152|Actual|University of Zurich||2|||f||||||||||||||2017-02-18 16:51:38.151728|2017-02-18 16:51:38.151728
NCT00272610|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2015-06-23|||September 2000||2000-09-01|September 2006|2006-09-01|February 2002||2002-02-01|||||Interventional|||Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin|Topical Vitamin A (All-trans Retinol) Versus Vehicle Cream in the Treatment of Aged Skin|Completed||Phase 2|50||University of Michigan|||||f||||||||||||||2017-02-18 16:51:38.242664|2017-02-18 16:51:38.242664
NCT00272597|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2011-04-12|||September 2005||2005-09-01|April 2011|2011-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Risperidone LA Study|Risperidone Long Acting: A Healthcare Resource Utilization Pilot Study|Completed||Phase 4|30|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:51:38.339546|2017-02-18 16:51:38.339546
NCT00272584|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2006-05-05|||June 2001||2001-06-01|January 2006|2006-01-01|January 2004||2004-01-01|||||Interventional|||CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia|International Study of Improving Treatment for the Most Severely Ill With Schizophrenia|Completed||Phase 4|100||University of British Columbia|||||f||||||||||||||2017-02-18 16:51:38.445115|2017-02-18 16:51:38.445115
NCT00272571|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-01-29|||August 2004||2004-08-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||The Effects of External Counter Pulsation Therapy on Circulating Endothelial Progenitor Cells|The Effects of External Counter Pulsation Therapy (ECPT) on the Number and Function of Circulating Endothelial Progenitor Cells in Patients With Angina Pectoris|Completed||N/A|25||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:51:38.554357|2017-02-18 16:51:38.554357
NCT00272558|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2009-09-17|||September 2004||2004-09-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma|Phase II Study of Carboplatin and Vinorelbine i.v. (Day 1) and Orally (Day 8) for Malignant Pleural Mesothelioma|Completed||Phase 2|40|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:51:38.644481|2017-02-18 16:51:38.644481
NCT00272545|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2013-09-04|||January 2006||2006-01-01|September 2013|2013-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effectiveness of a Normalization of Eating Intervention Program for Treating Women With Eating Disorders|Adaptation of a CBT Intervention for Eating Disorders|Completed||N/A|280|Actual|Drexel University||2|||f||||||||||||||2017-02-18 16:51:38.742512|2017-02-18 16:51:38.742512
NCT00272532|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2008-02-18|||April 2005||2005-04-01|February 2008|2008-02-01||||||||Interventional|||EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes|The Efficacy of Topical Thiocolchicoside in Cervical Myofascial Pain Syndrome: Triple-Arm, Single-Blind, Randomized, Prospective, Phase IV Clinical Study|Completed||Phase 4|65||Sanofi|||||f||||||||||||||2017-02-18 16:51:38.986149|2017-02-18 16:51:38.986149
NCT00272519|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2016-02-29|||June 2006||2006-06-01|February 2016|2016-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Life Skills Intervention for Adolescents Perinatally Infected With HIV|Life Skills Intervention for Young Adolescents Perinatally Infected With HIV and Their Caregivers|Completed||N/A|16|Actual|Westat||1|||f||||f||||||||||2017-02-18 16:51:39.075577|2017-02-18 16:51:39.075577
NCT00272506|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2016-07-11|||August 2002||2002-08-01|January 2006|2006-01-01|September 2004|Actual|2004-09-01|||||Interventional|||Pediatric Asthma Controller Trial (PACT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:51:39.18684|2017-02-18 16:51:39.18684
NCT00272493|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2012-05-17||2009-09-08||||May 2012|2012-05-01|September 2008|Actual|2008-09-01|November 2007|Actual|2007-11-01||Interventional|||Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals|Improving Immune Response to Hepatitis B Vaccine in HIV-positive Subjects Using Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as a Vaccine Adjuvant: A Phase II Open-Label Pilot Study|Completed||Phase 2|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:51:39.263805|2017-02-18 16:51:39.263805
NCT00272480|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2015-05-27|||November 1999||1999-11-01|January 2006|2006-01-01|November 2001||2001-11-01|||||Interventional|||Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial|Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial|Completed||Phase 2/Phase 3|24||Imperial College London|||||f||||||||||||||2017-02-18 16:51:39.405372|2017-02-18 16:51:39.405372
NCT00272467|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2015-04-27|||July 2005||2005-07-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy|A Comparative Study on the Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy|Completed||Phase 4|132|Actual|Korea Otsuka International Asia Arab||2|||f||||t||||||||||2017-02-18 16:51:39.502988|2017-02-18 16:51:39.502988
NCT00272454|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2009-12-15|||January 2006||2006-01-01|December 2009|2009-12-01|September 2008|Actual|2008-09-01|||||Interventional|||Cilostazol in Acute Ischemic Stroke Treatment (CAIST)|The Double-Blind, Randomized, Multi-Center, and Active Controlled Trial for Efficacy and Safety of Cilostazol in Acute Ischemic Stroke|Completed||Phase 4|468|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.|||||f||||||||||||||2017-02-18 16:51:39.627139|2017-02-18 16:51:39.627139
NCT00272441|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2016-07-11|||January 2001||2001-01-01|January 2008|2008-01-01|September 2004|Actual|2004-09-01|||||Interventional|||Prevention of Early Asthma in Kids (PEAK)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:51:39.736223|2017-02-18 16:51:39.736223
NCT00272428|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2009-12-16|||October 1994||1994-10-01|October 2007|2007-10-01|September 2005|Actual|2005-09-01|||||Interventional|||Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.|The SU.VI.MAX Study. A Randomized, Placebo-controlled Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.|Completed||Phase 3|13000||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||t||||||||||2017-02-18 16:51:39.991093|2017-02-18 16:51:39.991093
NCT00272415|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2009-03-09|||October 2005||2005-10-01|November 2007|2007-11-01||||||||Interventional|||A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma|A Phase Ib, Open-Label, Multicenter Trial of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate the Tolerability, Safety, and Pharmacokinetics in Subjects With Newly-Diagnosed or Recurrent Unresectable Stage III or Stage IV Melanoma|Terminated||Phase 1|39|Anticipated|Genentech, Inc.||1|||f||||||||||||||2017-02-18 16:51:40.095435|2017-02-18 16:51:40.095435
NCT00272402|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2012-09-04|||February 2006||2006-02-01|September 2012|2012-09-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Reducing Clinical Inertia in Diabetes Care|Reducing Clinical Inertia in Diabetes Care|Completed||N/A|61|Actual|HealthPartners Institute||3|||f||||t||||||||||2017-02-18 16:51:40.19929|2017-02-18 16:51:40.19929
NCT00272389|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-01-04|||March 2006||2006-03-01|January 2006|2006-01-01|May 2006|Anticipated|2006-05-01|||||Observational|||Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile|Prediction of Response to PEGINTERFERON and RIBAVIRIN Treatment in Patients With Chronic HCV Infection by Genetic Profile|Unknown status|Not yet recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:51:40.307485|2017-02-18 16:51:40.307485
NCT00272376|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2017-01-24|||December 21, 2005||2005-12-21|July 29, 2016|2016-07-29|July 29, 2016||2016-07-29|||||Observational|||Clinical and Genetic Studies in Families With Myopia and Related Diseases|Clinical and Molecular Studies in Families With Myopia and Related Diseases|Completed||N/A|9|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:51:40.388396|2017-02-18 16:51:40.388396
NCT00272363|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2017-01-24|||December 29, 2005||2005-12-29|July 29, 2016|2016-07-29|July 29, 2016||2016-07-29|||||Observational|||Clinical and Molecular Studies in Families With Glaucoma and Related Diseases|Clinical and Molecular Studies in Families With Glaucoma and Related Diseases|Completed||N/A|1|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:51:40.476636|2017-02-18 16:51:40.476636
NCT00272350|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-05|2017-01-24|||December 29, 2005||2005-12-29|February 27, 2014|2014-02-27|February 27, 2014|Actual|2014-02-27|February 27, 2014|Actual|2014-02-27||Interventional|||ZD6474 to Treat Advanced Brain Cancer in Patients|A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas|Completed||Phase 1|83|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:51:40.579732|2017-02-18 16:51:40.579732
NCT00272337|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2012-06-20|2012-05-16||October 2006||2006-10-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TAD||Aspirin Dose and Atherosclerosis in Patients With Heart Disease|A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation & Endothelial Function in Secondary Prevention (Pts w/Chronic Stable Coronary Disease)|Completed||Phase 4|37|Actual|Florida Atlantic University||5|||f||||t||||||||||2017-02-18 16:51:40.681391|2017-02-18 16:51:40.681391
NCT00272324|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2006-01-03|||February 1992||1992-02-01|November 2005|2005-11-01|January 2007||2007-01-01|||||Interventional|||Aspirin/Folate Prevention of Large Bowel Polyps|Aspirin/Folate Prevention of Large Bowel Polyps|Completed||Phase 2/Phase 3|1121||Dartmouth-Hitchcock Medical Center|||||||||||||||||||2017-02-18 16:51:41.353316|2017-02-18 16:51:41.353316
NCT00272311|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2012-06-20|2012-05-16||October 2006||2006-10-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|PAD||Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome|A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation in High Risk Primary Prevention (Patients With Metabolic Syndrome)|Completed||Phase 4|70|Actual|Florida Atlantic University||5|||f||||t||||||||||2017-02-18 16:51:41.468996|2017-02-18 16:51:41.468996
NCT00272285|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2008-04-24|||January 2006||2006-01-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea|A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron Plus Dexamethasone Injection for the Prevention of Chemotherapy-Induced Vomiting and Nausea|Completed||Phase 3|287|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 16:51:42.106263|2017-02-18 16:51:42.106263
NCT00272272|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2016-01-26|||December 2005||2005-12-01|January 2016|2016-01-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Interventional|||Fall Prevention in a Geriatric Nursing Home Setting Using the Music of Nolwenn Leroy|The Nolwenn Effect in a Geriatric Nursing Home Setting|Completed||N/A|200|Actual|Carrick Institute for Graduate Studies||1|||f||||f||||||||No||2017-02-18 16:51:42.20755|2017-02-18 16:51:42.20755
NCT00272259|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2007-01-04||||||January 2007|2007-01-01||||||||Interventional|||Robots for Stroke Survivors||Terminated||Phase 1|||Carnegie Mellon University|||||f||||||||||||||2017-02-18 16:51:42.299461|2017-02-18 16:51:42.299461
NCT00272246|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-04|2006-01-04|||February 2005||2005-02-01|January 2006|2006-01-01|December 2007||2007-12-01|||||Interventional|||Bilateral Internal Pallidum Stimulation in Primary Generalized Dystonia||Unknown status|Recruiting|Phase 2/Phase 3|24||Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||||f||||||||||||||2017-02-18 16:51:42.366885|2017-02-18 16:51:42.366885
NCT00272233|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2007-03-19|||December 2004||2004-12-01|January 2006|2006-01-01|June 2005||2005-06-01|||||Observational|||Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents|Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents|Completed||Phase 1|22||Yale University|||||f||||||||||||||2017-02-18 16:51:42.46965|2017-02-18 16:51:42.46965
NCT00272220|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2007-11-06|||October 2004||2004-10-01|November 2007|2007-11-01|June 2006|Actual|2006-06-01|||||Interventional|||Longitudinal Study of HAART, Social Networks, & Adherence|Longitudinal Randomized Controlled Study of Modified Directly Observed HAART in Mozambique|Completed||N/A|350|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:51:42.550381|2017-02-18 16:51:42.550381
NCT00272207|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2011-08-24|||April 2006||2006-04-01|August 2011|2011-08-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia|A Randomized Double-blinded Placebo Controlled Trial Assessing the Effect of the Oral Cannabinoid Nabilone on Pain and Quality of Life in Patients With Fibromyalgia|Completed||Phase 2|40|Actual|Winnipeg Regional Health Authority||1|||f||||f||||||||||2017-02-18 16:51:42.648196|2017-02-18 16:51:42.648196
NCT00272194|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2016-03-22|||December 2005||2005-12-01|March 2016|2016-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Ambu® Laryngeal Mask as an Intubation Conduit|The Ambu® Laryngeal Mask as an Intubation Conduit For Patients Undergoing Routine General Anesthesia|Completed||Phase 4|160||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 16:51:42.750179|2017-02-18 16:51:42.750179
NCT00272181|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2015-12-22|||January 2006||2006-01-01|December 2015|2015-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer|A Phase II, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Proxinium in Patients With Advanced SCCHN Who Have Received at Least One Anti-Cancer Treatment Regimen for Advanced Disease|Terminated||Phase 2|15|Actual|Viventia Bio||1||Slow accrual in North America|f||||f||||||||||2017-02-18 16:51:42.842799|2017-02-18 16:51:42.842799
NCT00272168|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2016-05-10|2015-11-13||October 2005||2005-10-01|May 2016|2016-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|MPROVE||The Use of Skills Training to Augment Compensated Work Therapy (CWT)/VI for Veterans With SMI|The Use of Skills Training to Augment CWT/VI for Veterans With SMI|Completed||N/A|88|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:51:43.071107|2017-02-18 16:51:43.071107
NCT00272155|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2010-04-26|||January 2006||2006-01-01|December 2005|2005-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice|Can Antibiotic Prescriptions in Respiratory Tract Infections be Improved? A Cluster Randomized Educational Intervention in General Practice|Completed||Phase 1/Phase 2|118621|Actual|University of Oslo||1|||f||||||||||||||2017-02-18 16:51:43.472879|2017-02-18 16:51:43.472879
NCT00272142|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2009-09-02|||January 2005||2005-01-01|September 2009|2009-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Impact of Zinc Supplementation in Low Birth Weight Infants on Severe Morbidity, Mortality and Zinc Status: A Randomized Controlled Trial|Impact of Zinc Supplementation in Low Birth Weight Infants on Severe Morbidity, Mortality and Zinc Status: A Randomized Controlled Trial|Completed||N/A|2000|Anticipated|Society for Applied Studies||2|||f||||f||||||||||2017-02-18 16:51:43.559516|2017-02-18 16:51:43.559516
NCT00272116|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2012-04-02|||February 1998||1998-02-01|April 2012|2012-04-01|September 2000|Actual|2000-09-01|February 2000|Actual|2000-02-01||Interventional|||Effect of Zinc and Vitamin A Supplementation on Diarrhea, Physical Growth and Immune Response in Malnourished Children|Effect of Zinc and Vitamin A Supplementation on Diarrhea, Physical Growth and Immune Response in Malnourished Children|Completed||N/A|2482|Actual|Society for Applied Studies||2|||f||||f||||||||||2017-02-18 16:51:43.657875|2017-02-18 16:51:43.657875
NCT00272103|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2006-05-03|||December 2000||2000-12-01|November 2005|2005-11-01|January 2002||2002-01-01|||||Interventional|||Itopride in Functional Dyspepsia:a Dose Finding Study|A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Dose Finding Study in 4 Parallel Groups to Establish the Efficacy and Safety of an Eight Week Treatment With Itopride Three Times Daily Compared to Placebo in Patients Suffering From Functional Dyspepsia|Completed||Phase 2/Phase 3|500||Royal Adelaide Hospital|||||f||||||||||||||2017-02-18 16:51:43.765484|2017-02-18 16:51:43.765484
NCT00272090|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2011-06-07|||November 2002||2002-11-01|June 2011|2011-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Insulin Glargine in Type 1 Diabetes Mellitus|Italian Experience Trial for the Implementation of the Use of Lantus in Basal - Bolus Regimen in Type I Diabetes Mellitus Patients.|Completed||Phase 3|489|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:51:43.850316|2017-02-18 16:51:43.850316
NCT00272077|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2009-12-04|||April 2005||2005-04-01|December 2009|2009-12-01||||May 2006|Actual|2006-05-01||Interventional|||Insulin Glargine in Type 2 Diabetes Mellitus|Pilot Study on Glycaemic Variability in Type 2 Diabetes Mellitus Patients With Basal Insulin and Fixed Combo Oral Antidiabetic Treatment.|Completed||Phase 4|||Sanofi|||||f||||||||||||||2017-02-18 16:51:43.928671|2017-02-18 16:51:43.928671
NCT00272064|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2009-12-04|||October 2005||2005-10-01|December 2009|2009-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.|Optimisation of Insulin Treatment of Type 2 Diabetes Mellitus by Telecare Assistance for Self Monitoring of Blood Glucose (SMBG).|Completed||Phase 3|352|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:51:44.011271|2017-02-18 16:51:44.011271
NCT00272051|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2006-09-11|||July 2002||2002-07-01|September 2006|2006-09-01|May 2004||2004-05-01|||||Interventional|||XENOX – Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy|A Multicenter Randomized Dble-Blind Placebo Controlled Phase III Study of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin and 5-FU/LV Combination in First-Line Treatment of Patients With Metastatic Colorectal Carcinoma(MCRC)|Completed||Phase 3|620||Sanofi|||||f||||||||||||||2017-02-18 16:51:44.293408|2017-02-18 16:51:44.293408
NCT00272038|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2013-08-12|2013-05-06||December 2005||2005-12-01|August 2013|2013-08-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer|Phase II Study Investigating the Efficacy and Activity of Single Agent Erlotinib in Chemotherapy-Naive Androgen Independent Prostate Cancer|Completed||Phase 2|29|Actual|Oncology Specialists, S.C.||1|||f||||f||||||||||2017-02-18 16:51:44.372758|2017-02-18 16:51:44.372758
NCT00272025|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2015-12-14|||October 2006||2006-10-01|December 2015|2015-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Treatment Resistant Bipolar Depression|Six Week Double Blind, Randomized Trial of Escitalopram Add On for Treatment Resistant Bipolar Depression|Terminated||Phase 1|1|Actual|Queen's University||2||Lundbeck withdrew committment - expiring patents and prolonged inactivity|f||||f||||||||||2017-02-18 16:51:44.685546|2017-02-18 16:51:44.685546
NCT00272012|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2009-12-04|||July 2004||2004-07-01|December 2009|2009-12-01||||September 2006|Actual|2006-09-01||Interventional|||OPAL - Insulin Glulisine, Diabetes Mellitus|Efficacy and Safety of Insulin Glulisine Given as a Single Injection at Breakfast + Insulin Glargine+OAD (Oral Antidiabetic Drug) vs Insulin Glulisine Given as a Single Injection at Main Meal+Insulin Glargine+OAD in Type 2 Diabetic Patients for Which Glycemic Control is Suboptimal Using Insulin Glargine+ OAD Alone|Completed||Phase 3|396|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:51:44.797716|2017-02-18 16:51:44.797716
NCT00271999|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2010-03-02|||January 2006||2006-01-01|March 2010|2010-03-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Frequent Hemodialysis Network: Nocturnal Trial|Frequent Hemodialysis Network: Nocturnal Trial|Unknown status|Active, not recruiting|Phase 2/Phase 3|150|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 16:51:44.892456|2017-02-18 16:51:44.892456
NCT00271986|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2011-07-20|||January 2006||2006-01-01|May 2008|2008-05-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Observational|||Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection (LAR) for Recto-sigmoid Cancer|Intraperitoneal Microdialysis Monitoring of Patients During the Early Postoperative Period After LAR With Reference to Early Diagnosis of Anastomotic Leakage|Completed||N/A|60|Actual|Odense University Hospital|||1||f||||f||||||||||2017-02-18 16:51:45.009759|2017-02-18 16:51:45.009759
NCT00271973|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2007-01-29|||February 2006||2006-02-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models|The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models|Completed||Phase 4|32||Odense University Hospital|||||f||||||||||||||2017-02-18 16:51:45.098672|2017-02-18 16:51:45.098672
NCT00271960|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2016-07-25|||April 2001||2001-04-01|July 2016|2016-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women|Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women|Completed||Phase 3|1047|Actual|Yale University||3|||f||||f||||||||||2017-02-18 16:51:45.190105|2017-02-18 16:51:45.190105
NCT00271947|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2014-02-10|2013-05-08||April 2005||2005-04-01|February 2014|2014-02-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Interventional|||Crohn's Disease Stem Cell Transplantation|Crohn's Disease Non-myeloablative Autologous Hematopoietic Stem Cell Transplantation (CDNST) Versus Standard Therapy|Terminated||Phase 2|1|Actual|Northwestern University|Potential participants refused to be randomized. Just one participant was enrolled on study, the study is terminated early.|1||The PI, who was sponsor got retired|f||||t||||||||||2017-02-18 16:51:45.313821|2017-02-18 16:51:45.313821
NCT00271934|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-02|2012-04-09|||September 2002||2002-09-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|November 2007|Actual|2007-11-01||Interventional|||Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study|Immune Ablation and Hematopoietic Stem Cell Support in Patients With Poor Prognostic Indicators and Systemic Lupus Erythematosus:A Phase II Study|Completed||Phase 2|52|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 16:51:45.518524|2017-02-18 16:51:45.518524
NCT00271921|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2012-12-17|||September 2005||2005-09-01|December 2012|2012-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Does Metabolic Syndrome Exist in Anorexia Nervosa?|Does Metabolic Syndrome Exist in Anorexia Nervosa?|Completed||N/A|50|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||f||||||||||2017-02-18 16:51:45.619431|2017-02-18 16:51:45.619431
NCT00005445|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-05|||April 1994||1994-04-01|January 2016|2016-01-01|February 1999||1999-02-01|||||Observational|||Epidemiology of Pediatric Asthma Hospitalization||Completed||N/A|||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 18:14:58.486779|2017-02-18 18:14:58.486779
NCT00271908|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2016-03-01|||February 2007||2007-02-01|March 2016|2016-03-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||C2P (With Venues): Connect to Protect® Partnerships For Youth Prevention Interventions|Connect to Protect® Partnerships for Youth Prevention Interventions Phase III: Full Evaluation|Completed||N/A|4472|Actual|Westat|||2||f||||t||||||||||2017-02-18 16:51:45.717929|2017-02-18 16:51:45.717929
NCT00271882|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2016-02-29|||March 2006||2006-03-01|February 2016|2016-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||PTSD and Risk Behavior in HIV Positive Female Adolescents|PTSD and Risk Behavior in HIV Positive Female Adolescents|Completed||N/A|40|Actual|Westat|||1||f||||f||||||||||2017-02-18 16:51:45.841777|2017-02-18 16:51:45.841777
NCT00271869|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2006-01-03|||December 2005||2005-12-01|December 2005|2005-12-01||||||||Interventional|||Treatment of Chronic GVHD of Liver or Lungs by ECP|Phase II Study for Treatment of Chronic Graft-Versus-Host Disease of the Liver or Lungs With Adjunct Extracorporeal Photoimmunotherapy|Unknown status|Recruiting|Phase 2|20||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:51:45.945199|2017-02-18 16:51:45.945199
NCT00271856|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2012-04-11|2011-08-03||May 2005||2005-05-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV|Mindfulness-Based Stress Reduction (MBSR), Stress Arousal and Immune Response in Early HIV|Completed||Phase 2|177|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 16:51:46.045437|2017-02-18 16:51:46.045437
NCT00271843|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2017-01-10|||October 2005||2005-10-01|December 2008|2008-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Smoking and Alcohol Initiation|Predicting Tobacco and Alcohol Initiation|Completed||Phase 1|2600|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:51:46.541291|2017-02-18 16:51:46.541291
NCT00271830|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2007-12-10|||January 2006||2006-01-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Observational|||Sexual Function in Male Renal Transplant Patients|Sexual Function in Male Renal Transplant Patients|Terminated||N/A|110|Anticipated|Montefiore Medical Center|||||f||||||||||||||2017-02-18 16:51:46.617939|2017-02-18 16:51:46.617939
NCT00271817|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2015-09-02|2009-02-13||December 2005||2005-12-01|September 2015|2015-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)|Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) Co-Administered in Patients With Type IIa or Type IIb Hyperlipidemia|Completed||Phase 3|1220|Actual|Merck Sharp & Dohme Corp.|Part 1 population is all patients enrolled in Part 1 of the study. Part 2 is those patients who received either niacin, ezetimibe/simvastatin, or ezetimibe/simvastatin + niacin during Part 1 until they finished the study at week 64 or discontinued.|5|||f||||||||||||||2017-02-18 16:51:46.700785|2017-02-18 16:51:46.700785
NCT00271804|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2008-03-07|||June 2005||2005-06-01|March 2008|2008-03-01|April 2007||2007-04-01|||||Interventional|||Study of Velcade and Thalidomide in Patients With Myelodysplasia|Phase I Dose Escalation Trial of Bortezomib in Combination With Thalidomide in Patients With Myelodysplasia|Terminated||Phase 1|28||Massachusetts General Hospital||1||New study with lenalidomide pending|f||||||||||||||2017-02-18 16:51:48.096909|2017-02-18 16:51:48.096909
NCT00271791|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-01|2007-11-04|||September 2005||2005-09-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Prednisone Treatment for Vestibular Neuronitis|Prednisone Treatment for Vestibular Neuronitis|Completed||Phase 2|17|Actual|Carmel Medical Center||2|||f||||f||||||||||2017-02-18 16:51:48.196919|2017-02-18 16:51:48.196919
NCT00271778|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2006-01-03|||July 2003||2003-07-01|December 2005|2005-12-01|June 2006||2006-06-01|||||Interventional|||A Comparative Study of the Outcomes of 2 Surgical Procedures for Safe Type of Chronic Otitis Media|A Randomized Control Study of the Outcomes of Mastoidotympanoplasty Versus Tympanoplasty in Quiescent Tubotympanic Otitis Media|Unknown status|Active, not recruiting|Phase 3|60||Karnataka Institute of Medical Sciences|||||f||||||||||||||2017-02-18 16:51:48.307387|2017-02-18 16:51:48.307387
NCT00271765|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2006-11-27|||January 2004||2004-01-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||A Study of INO-1001, an Intravenous PARP (Poly [ADP Ribose] Polymerase) Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention|A Phase II Randomized, Placebo-Controlled, Single-Blind, Multi-Center Dose-Escalation Study to Evaluate Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Administration of INO-1001 in Subjects With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention|Completed||Phase 2|40||Inotek Pharmaceuticals Corporation|||||f||||||||||||||2017-02-18 16:51:48.391722|2017-02-18 16:51:48.391722
NCT00271752|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-01|2010-03-03|||January 2006||2006-01-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|PASS||The Procalcitonin and Survival Study|The Procalcitonin and Survival Study - A Multicentre Single Blinded Randomized Controlled Trial to Investigate if Treatment Guided by Daily Procalcitonin Measurements Can Reduce Mortality in the Intensive Care Unit|Completed||N/A|1200|Actual|Danish Procalcitonin Study Group||2|||f||||t||||||||||2017-02-18 16:51:48.49795|2017-02-18 16:51:48.49795
NCT00271739|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2012-11-19|2011-02-28||December 2000||2000-12-01|November 2012|2012-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|IDEATel||Randomized Trial of Telemedicine for Diabetes Care|Informatics for Diabetes Education and Telemedicine (IDEATel)|Completed||N/A|1665|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 16:51:48.61123|2017-02-18 16:51:48.61123
NCT00271674|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2008-06-02|||January 2006||2006-01-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|||||Interventional|||YAG Laser Versus Punch Biopsy for the Treatment of Tattoo Skin Markers||Completed||N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:51:49.126138|2017-02-18 16:51:49.126138
NCT00271661|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2011-12-08|||August 2005||2005-08-01|December 2011|2011-12-01|May 2006||2006-05-01|||||Observational|||Presbyopia in Breast Cancer Survivors|Presbyopia in Breast Cancer Survivors|Withdrawn||N/A|0|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 16:51:49.201653|2017-02-18 16:51:49.201653
NCT00271635|ClinicalTrials.gov processed this data on February 17, 2017|2006-01-03|2008-07-02|||January 2006||2006-01-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|AATIC||Ascorbic Acid Treatment in CMT1A Trial (AATIC)|Phase 2 Study of Ascorbic Acid Treatment in Charcot-Marie-Tooth Type 1A|Completed||Phase 2|13|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2|||f||||t||||||||||2017-02-18 16:51:49.285231|2017-02-18 16:51:49.285231
NCT00005444|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1995||1995-08-01|July 2004|2004-07-01|July 2001|Actual|2001-07-01|||||Observational|||Hypertension in Families of African Origin||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.552739|2017-02-18 18:14:58.552739
NCT00271609|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-31|2014-04-13|2012-04-30||December 2005||2005-12-01|April 2014|2014-04-01|February 2014|Actual|2014-02-01|March 2011|Actual|2011-03-01||Interventional|||Bevacizumab for Recurrent Malignant Glioma|A Phase II Trial of Bevacizumab for Patients With Recurrent High-Grade Gliomas|Completed||Phase 2|88|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 16:51:49.524332|2017-02-18 16:51:49.524332
NCT00271596|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2013-02-08|2012-12-19||November 2005||2005-11-01|February 2013|2013-02-01|November 2011|Actual|2011-11-01|April 2011|Actual|2011-04-01||Interventional|CIT-HD||Citalopram to Enhance Cognition in HD|A Randomized, Placebo-Controlled Pilot Study in Huntington's Disease (CIT-HD)|Completed||Phase 2|33|Actual|University of Iowa|Statistical power was limited.|2|||f||||t||||||||||2017-02-18 16:51:50.518997|2017-02-18 16:51:50.518997
NCT00271583|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2007-12-13|||September 1999||1999-09-01|December 2007|2007-12-01|September 2001|Actual|2001-09-01|||||Interventional|||Efficacy Trial of CDB 2914 for Emergency Contraception|A Prospective, Randomized, Double Blind, Multicenter Study to Compare the Efficacy, Safety and Tolerance of CDB-2914 With Levonorgestrel as Emergency Contraception|Completed||Phase 2/Phase 3|1672|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 16:51:51.043182|2017-02-18 16:51:51.043182
NCT00271570|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2010-06-11|2009-05-01||April 2004||2004-04-01|November 2009|2009-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Infliximab (Remicade) for Patients With Acute Kawasaki Disease|Infliximab (Remicade) for Patients With Acute Kawasaki Disease Who Fail to Become Afebrile After Intravenous Gamma Globulin Therapy|Completed||Phase 1|24|Actual|University of California, San Diego||2|||f||||t||||||||||2017-02-18 16:51:51.154098|2017-02-18 16:51:51.154098
NCT00271557|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2011-03-03|||January 1997||1997-01-01|March 2011|2011-03-01|December 1997|Actual|1997-12-01|||||Interventional|||A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels|A Randomized, Open-Label, Active-Controlled, Multicenter Phase III Safety Study of Two Doses of NATRECOR hBNP (Nesiritide) Administered as a Continuous Infusion in the Treatment of Decompensated CHF|Completed||Phase 3|305|Actual|Scios, Inc.|||||||||||||||||||2017-02-18 16:51:51.717417|2017-02-18 16:51:51.717417
NCT00271544|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2009-09-24|2009-04-30||February 2007||2007-02-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|August 2007|Actual|2007-08-01||Interventional|||Attain Model 4196 Left Ventricular (LV) Lead|Attain Model 4196 Left Ventricular (LV) Lead|Completed||N/A|190|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||f||||f||||||||||2017-02-18 16:51:51.824969|2017-02-18 16:51:51.824969
NCT00271531|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2011-08-11|||April 2006||2006-04-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Bacterial Pulmonary Infection in PICU|Derivation of a Clinical Prediction Rule for Bacterial Pulmonary Infection in Mechanically Ventilated Children|Completed||N/A|21|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Nasal aspirate, tracheal aspirate, and non bronchoscopic bronchoalveolar lavage.~   "|||2017-02-18 16:51:52.373574|2017-02-18 16:51:52.373574
NCT00271518|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2010-03-16|||September 2005||2005-09-01|March 2010|2010-03-01||||December 2013|Anticipated|2013-12-01||Interventional|BPLG-004||Treatment of Children With Insufficient Secretion of Growth Hormone|A Phase III, Multi-centre, Randomised, Parallel Group Study of Safety and Efficacy of the LB03002 a New Sustained Release Formulation of Human Recombinant Growth Hormone as Compared to Standard Daily Therapy in Treatment Naive Children With Growth Failure Due to Insufficient Secretion of Endogenous Growth Hormone|Unknown status|Active, not recruiting|Phase 3|144|Anticipated|LG Life Sciences||1|||t||||t||||||||||2017-02-18 16:51:52.485612|2017-02-18 16:51:52.485612
NCT00271505|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2016-04-25|||December 2005||2005-12-01|April 2016|2016-04-01||||December 2017|Anticipated|2017-12-01||Interventional|||Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer|A Phase II Evaluation of Avastin in Combination With Docetaxel and Carboplatin as Chemotherapy in Patients With Metastatic Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:51:52.580983|2017-02-18 16:51:52.580983
NCT00271492|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2010-04-28|||July 2001||2001-07-01|April 2010|2010-04-01|January 2008|Actual|2008-01-01|June 2006|Actual|2006-06-01||Interventional|||Correlation of Endothelial Function and Early Coronary Artery Disease in Humans|Endothelin in the Coronary Circulation in Early Atherosclerosis in Humans|Completed||Phase 3|200|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:51:52.706016|2017-02-18 16:51:52.706016
NCT00271479|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2006-12-21|||June 2004||2004-06-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Interventional|||Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine|Assay of the Immunogenicity of Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine in Africa|Completed||Phase 4|720||Epicentre|||||f||||||||||||||2017-02-18 16:51:52.815781|2017-02-18 16:51:52.815781
NCT00271466|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2011-05-17|||February 2000||2000-02-01|April 2010|2010-04-01|April 2002|Actual|2002-04-01|||||Interventional|||A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy|A Study to Assess the Safety, Dose Conversion and Titration of DURAGESIC® (Fentanyl Transdermal System) in Pediatric Subjects With Chronic Pain Requiring Opioid Therapy|Completed||Phase 3|199|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 16:51:52.926421|2017-02-18 16:51:52.926421
NCT00271453|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2011-05-17|||February 1996||1996-02-01|April 2010|2010-04-01|October 1998|Actual|1998-10-01|||||Interventional|||A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy|A Study to Assess the Safety, Efficacy and Pharmacokinetics of Durogesic (Fentanyl Transdermal Drug Delivery System) in the Treatment of Pediatric Patients With Chronic Pain Requiring Long-term Opioid Therapy|Completed||Phase 3|41|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:51:53.017988|2017-02-18 16:51:53.017988
NCT00271440|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2010-04-02|||January 2006||2006-01-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|NNIPS-SFS||Effect of Chlorhexidine Cleansing on Skin Flora of Newborns in Nepal|Effect of Chlorhexidine Cleansing on Skin Flora of Newborns in Nepal|Completed||Phase 1/Phase 2|286|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||f||||||||||2017-02-18 16:51:53.112097|2017-02-18 16:51:53.112097
NCT00271427|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2006-08-22|||December 2004||2004-12-01|December 2004|2004-12-01|August 2005||2005-08-01|||||Interventional|||Selenium Treatment in Autoimmune Thyroiditis (AIT)|Selenium Treatment in Autoimmune Thyroiditis: Long Term Follow-Up With Variable Doses|Completed||N/A|100||Ege University|||||f||||||||||||||2017-02-18 16:51:53.41241|2017-02-18 16:51:53.41241
NCT00271414|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2011-05-16|||March 1999||1999-03-01|April 2010|2010-04-01|March 2001|Actual|2001-03-01|||||Interventional|||A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy|A 15-day Trial to Document the Safety, Clinical Utility and Pharmacokinetics of Duragesic (TTS Fentanyl) in the Treatment of Pediatric Subjects With Continuous Pain Requiring Opioid Therapy|Completed||Phase 3|53|Actual|Janssen Pharmaceutica N.V., Belgium|||||||||||||||||||2017-02-18 16:51:53.502106|2017-02-18 16:51:53.502106
NCT00271401|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-30|2015-05-22|||July 1996||1996-07-01|May 2015|2015-05-01|September 1997|Actual|1997-09-01|September 1997|Actual|1997-09-01||Interventional|||A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab|A Multicenter, Randomized Trial Evaluating 30-day and 6-month Clinical Outcomes With Three Different Treatment Strategies (Coronary Angioplasty + Abciximab, Intracoronary Stent + Abciximab, and Intracoronary Stent + Placebo) in Patients Undergoing Percutaneous Coronary Intervention|Completed||Phase 3|2399|Actual|Centocor, Inc.||3|||f||||f||||||||||2017-02-18 16:51:53.59255|2017-02-18 16:51:53.59255
NCT00271388|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2014-10-01|||January 2006||2006-01-01|October 2014|2014-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Vestibular Stimulation to Treat Hemispatial Neglect|Noise Enhanced Galvanic Vestibular Stimulation in Hemispatial Neglect|Completed||N/A|2|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 16:51:53.68774|2017-02-18 16:51:53.68774
NCT00271375|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2016-04-22|2014-10-16||October 2005||2005-10-01|April 2016|2016-04-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Evaluating the Carter Institute Caregiver Education Program at the VA|Evaluating the Carter Institute Caregiver Education Program at the VA|Completed||N/A|254|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 16:51:56.563732|2017-02-18 16:51:56.563732
NCT00271362|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2010-11-04|||January 2006||2006-01-01|November 2010|2010-11-01|December 2010|Anticipated|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Bone Physiology & Mechanics in Osteomyoplasty Amputation Rehabilitation|Bone Physiology & Mechanics in Osteomyoplasty Amputation Rehabilitation|Terminated||N/A|95|Anticipated|VA Office of Research and Development||1||This project is no longer active with DVA.|f||||f||||||||||2017-02-18 16:51:57.405543|2017-02-18 16:51:57.405543
NCT00271349|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2015-05-21|||December 2005||2005-12-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|BEE||Budesonide for Eosinophilic Esophagitis|Budesonide for Eosinophilic Esophagitis: a Randomized, Placebo-controlled, Double-blind Treatment Study|Completed||Phase 2|28|Actual|Swiss EE Study Group|||||f||||||||||||||2017-02-18 16:51:57.508479|2017-02-18 16:51:57.508479
NCT00271336|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2008-05-22|||January 2005||2005-01-01|December 2005|2005-12-01|March 2010|Anticipated|2010-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Pentoxifylline in the Treatment of NEC in Premature Neonates|Pentoxifylline in the Treatment of Necrotizing Enterocolitis in Premature Neonates|Unknown status|Recruiting|Phase 2|50|Anticipated|Shaare Zedek Medical Center||2|||f||||t||||||||||2017-02-18 16:51:57.600861|2017-02-18 16:51:57.600861
NCT00271323|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2009-12-21|||May 2005||2005-05-01|December 2009|2009-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients|A Two Arm Phase II Study Assessing Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in Patients With Locally Advanced Unresectable NSCLC (Stage IIIA-multiple cN2 or IIIB)|Terminated||Phase 2|14|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:51:57.702606|2017-02-18 16:51:57.702606
NCT00271310|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2006-10-06|||September 2000||2000-09-01|October 2006|2006-10-01|November 2003||2003-11-01|||||Interventional|||The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis|The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis|Completed||Phase 3|164||Royal Prince Alfred Hospital, Sydney, Australia|||||f||||||||||||||2017-02-18 16:51:58.038835|2017-02-18 16:51:58.038835
NCT00271297|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2009-09-18|||December 2005||2005-12-01|September 2009|2009-09-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Pelvic Floor Muscle Training (PFMT) in Treatment and Prevention of POP (POP Study)|Effect of Pelvic Floor Muscle Training (PFMT) in Prevention and Treatment of Female Pelvic Organ Prolapse (POP).|Completed||N/A|168|Anticipated|Norwegian School of Sport Sciences|||||f||||||||||||||2017-02-18 16:51:58.134836|2017-02-18 16:51:58.134836
NCT00271284|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2009-12-04|||October 2005||2005-10-01|December 2009|2009-12-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|VARIABILITE||Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients|A Crossover, Multicentre, Randomised Trial Comparing the Effect on the Control of Blood Glucose Concentration of Insulin Glargine and Insulin Detemir, Combined With Insulin Glulisine, Used as a Bolus, in Type 1 Diabetic Patients|Completed||Phase 3|88|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:51:58.22933|2017-02-18 16:51:58.22933
NCT00271271|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2009-12-04|||June 2003||2003-06-01|December 2009|2009-12-01|October 2006|Actual|2006-10-01|||||Interventional|GON||Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients|Phase II Clinical Trial With the Combination Gemcitabine, Oxaliplatin and Vinorelbine as First Line Treatment in Patients With Non-small Cell Bronchopulmonary Cancer|Completed||Phase 2|40||Sanofi|||||f||||f||||||||||2017-02-18 16:51:58.336702|2017-02-18 16:51:58.336702
NCT00271258|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2011-01-10|||January 2005||2005-01-01|January 2011|2011-01-01|January 2007|Actual|2007-01-01|||||Interventional|ADOKOT||Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents|STUDY OF THE TOLERANCE OF SODIUM DIVALPROATE (DEPAKOTE) IN ADOLESCENTS IN MANIC, MIXED OR HYPOMANIC EPISODES OF BIPOLAR DISORDER|Completed||Phase 3|200||Sanofi|||||f||||f||||||||||2017-02-18 16:51:58.428381|2017-02-18 16:51:58.428381
NCT00271245|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2012-03-06|||February 2006||2006-02-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Selenium Supplementation of Patients With Cirrhosis|Selenium Supplementation of Patients With Cirrhosis|Terminated||N/A|99|Actual|Vanderbilt University||4||Insufficient funds to complete study.|f||||t||||||||||2017-02-18 16:51:58.512303|2017-02-18 16:51:58.512303
NCT00271232|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2007-12-20|||March 2003||2003-03-01|December 2007|2007-12-01|April 2005||2005-04-01|||||Interventional|||InSync III Marquis Model 7279 Cardioverter Defibrillator Cardiac Resynchronization System|InSync III Marquis Model 7279 Cardioverter Defibrillator Cardiac Resynchronization System|Completed||N/A|238||Medtronic Cardiac Rhythm and Heart Failure|||||||||||||||||||2017-02-18 16:51:58.624316|2017-02-18 16:51:58.624316
NCT00271193|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2015-05-27|||September 2005||2005-09-01|May 2015|2015-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Primary Care Intervention for Weight Management|A Primary Care Intervention for Weight Management|Completed||Phase 3|50|Actual|University of Colorado, Denver||2|||f||||||||||||||2017-02-18 16:51:59.551689|2017-02-18 16:51:59.551689
NCT00271180|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2014-09-12|||January 1983||1983-01-01|September 2014|2014-09-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Observational|PPR||Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products|Medtronic CRDM Product Performance Report|Recruiting||N/A|15000|Anticipated|Medtronic Cardiac Rhythm and Heart Failure|||1||f||||f||||||||||2017-02-18 16:51:59.641066|2017-02-18 16:51:59.641066
NCT00271167|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2015-03-23|||October 2005||2005-10-01|March 2015|2015-03-01|June 2006|Actual|2006-06-01|||||Interventional|||A Trial of INO-1001 in Patients Undergoing Heart Surgery That Involves Heart-lung Bypass|A Phase II Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Tolerability, Safety, Pharmacokinetics and Efficacy of Intravenous INO-1001 in High Risk Subjects Undergoing Cardiopulmonary Bypass for Coronary Revascularization and/or Valve Surgery.|Terminated||Phase 2|162||Inotek Pharmaceuticals Corporation||||"It was determined that the study was not appropriate for demonstrating therapeutic benefit in~   the cardiopulmonary bypass patient population."|f||||||||||||||2017-02-18 16:51:59.98292|2017-02-18 16:51:59.98292
NCT00271154|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2012-01-26|2008-12-24||September 2004||2004-09-01|January 2012|2012-01-01|November 2011|Actual|2011-11-01|October 2007|Actual|2007-10-01||Interventional|||REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)|REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)|Completed||N/A|684|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||t||||||||||2017-02-18 16:52:00.124165|2017-02-18 16:52:00.124165
NCT00271141|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2005-12-29|||May 2005||2005-05-01|December 2005|2005-12-01|December 2015||2015-12-01|||||Observational|||Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease|Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease|Unknown status|Recruiting|N/A|500||Hillel Yaffe Medical Center|||||f||||||||||||||2017-02-18 16:52:01.821305|2017-02-18 16:52:01.821305
NCT00271128|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2008-03-19|||October 2005||2005-10-01|December 2005|2005-12-01|September 2007|Anticipated|2007-09-01|||||Observational|||NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward|NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward (BNP4EVER)|Unknown status|Active, not recruiting|N/A|500|Anticipated|Hillel Yaffe Medical Center|||||f||||||||||||||2017-02-18 16:52:01.927054|2017-02-18 16:52:01.927054
NCT00271115|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2012-02-16|||September 2005||2005-09-01|February 2012|2012-02-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||Kangaroo Holding and Maternal Stress|The Effect of Kangaroo Holding on Maternal Stress Levels|Completed||N/A|20|Actual|Christiana Care Health Services||1|||f||||f||||||||||2017-02-18 16:52:02.013934|2017-02-18 16:52:02.013934
NCT00271102|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2010-07-09|||December 2005||2005-12-01|July 2010|2010-07-01|February 2012|Anticipated|2012-02-01|February 2010|Actual|2010-02-01||Interventional|||Surgical Study Comparing 2 Procedures for the Treatment of a Dropped Bladder|Randomized Trial Comparing Anterior Colporrhaphy to Paravaginal Defect Repair for Anterior Vaginal Wall Prolapse|Unknown status|Active, not recruiting|N/A|70|Anticipated|Geisinger Clinic||2|||f||||f||||||||||2017-02-18 16:52:02.123647|2017-02-18 16:52:02.123647
NCT00271089|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2016-07-11|||August 2004||2004-08-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Blood Cell Collection for Future Use in Individuals With Fanconi Anemia|Collection of Hematopoietic Cells From Patients With Fanconi Anemia (FA) for Future Autologous Reinfusion and Research|Completed||N/A|40|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||||||||||||||||||2017-02-18 16:52:02.221372|2017-02-18 16:52:02.221372
NCT00271076|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2007-10-24|||January 2006||2006-01-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||CAPITAL: Carotid Artery Plaque Intravascular Ultrasound Evaluation|Carotid Artery Plaque Intravascular Ultrasound Evaluation|Completed||Phase 1|31|Actual|Arizona Heart Institute|||||||||||||||||||2017-02-18 16:52:02.567868|2017-02-18 16:52:02.567868
NCT00271063|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-29|2007-12-17|||October 2005||2005-10-01|December 2007|2007-12-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia|Phase I/II Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia|Unknown status|Recruiting|Phase 1/Phase 2|34|Anticipated|Callisto Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:52:02.677695|2017-02-18 16:52:02.677695
NCT00271050|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2010-12-20|||December 2005||2005-12-01|December 2010|2010-12-01|June 2010|Actual|2010-06-01|December 2007|Actual|2007-12-01||Interventional|||External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma|The Role of Conformal External Beam Radiotherapy in the Management of Patients With Bulky Disease Undergoing Y90-Ibritumomab Tiuxetan (Zevalin) Radio-immunotherapy for Indolent B-cell Non-Hodgkin's Lymphoma|Completed||Phase 1|12|Anticipated|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 16:52:02.789862|2017-02-18 16:52:02.789862
NCT00271037|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2011-01-09|||July 2004||2004-07-01|October 2010|2010-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Colpocleisis for Advanced Pelvic Organ Prolapse|Pelvic Symptoms and Patient Satisfaction After Colpocleisis for Advanced Pelvic Organ Prolapse|Completed||N/A|152|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||t||||||||||2017-02-18 16:52:02.920579|2017-02-18 16:52:02.920579
NCT00271024|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2013-03-13|2012-12-19||December 2005||2005-12-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of Naltrexone in Women's Smoking Cessation|Efficacy of Naltrexone in Women's Smoking Cessation|Completed||Phase 2|333|Actual|University of Chicago||4|||f||||f||||||||||2017-02-18 16:52:03.041791|2017-02-18 16:52:03.041791
NCT00271011|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2015-11-04|2014-06-04||December 2005||2005-12-01|November 2015|2015-11-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of Mitomycin C, Irinotecan, and Cetuximab|A Phase II Study of Mitomycin C, Irinotecan and Cetuximab in Patients With Previously Treated, Metastatic Colorectal Cancer|Terminated||Phase 2|13|Actual|University of Michigan Cancer Center|The study was discontinued and not completed due to the death of a co-investigator and a second co-investigator leaving the institution.|1||"The study was discontinued due to the death of a co-investigator and a second co-investigator~   leaving the institution."|f||||t||||||||||2017-02-18 16:52:04.126678|2017-02-18 16:52:04.126678
NCT00005443|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||January 1994||1994-01-01|July 2000|2000-07-01|December 1997|Actual|1997-12-01|||||Observational|||Race, Class, and Gender--Studies of Health Effects||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.621837|2017-02-18 18:14:58.621837
NCT00270998|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2013-09-27|||June 2005||2005-06-01|September 2013|2013-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||ATLAS: Ambulatory Treatments for Leakage Associated With Stress|ATLAS: Ambulatory Treatments for Leakage Associated With Stress, A Randomized Trial of Pelvic Muscle Exercise Versus Incontinence Pessary Versus Both for Women With Stress or Mixed Urinary Incontinence|Completed||Phase 3|450|Actual|NICHD Pelvic Floor Disorders Network||3|||f||||t||||||||||2017-02-18 16:52:04.358822|2017-02-18 16:52:04.358822
NCT00270985|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2016-06-20|||January 2006||2006-01-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|May 2007|Actual|2007-05-01||Interventional|||The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes|The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes|Completed||Phase 1|66|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||No|No plan to make individual participant data (IPD) available.|2017-02-18 16:52:04.484104|2017-02-18 16:52:04.484104
NCT00270972|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2006-06-02|||September 2005||2005-09-01|June 2006|2006-06-01||||||||Interventional|||The Evaluation of OrCel for the Treatment of Venous Ulcers|A Confirmatory Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (ORCEL) for the Treatment of Venous Ulcers|Unknown status|Active, not recruiting|N/A|60||Ortec International|||||||||||||||||||2017-02-18 16:52:04.597825|2017-02-18 16:52:04.597825
NCT00270959|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2012-06-19|||June 2006||2006-06-01|June 2012|2012-06-01|December 2015|Anticipated|2015-12-01|September 2010|Actual|2010-09-01||Interventional|||Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury|Early Combined Intervention After Traumatic Injury|Unknown status|Active, not recruiting|Phase 1|300|Anticipated|University of Washington||2|||f||||t||||||||||2017-02-18 16:52:04.704691|2017-02-18 16:52:04.704691
NCT00270946|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2005-12-28|||April 2002||2002-04-01|December 2005|2005-12-01|December 2003||2003-12-01|||||Interventional|||Evaluation of Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers|A Pivotal Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers|Completed||N/A|130||Ortec International|||||||||||||||||||2017-02-18 16:52:04.830547|2017-02-18 16:52:04.830547
NCT00270933|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2007-12-26|||January 2004||2004-01-01|December 2007|2007-12-01|December 2005||2005-12-01|||||Observational|||MAVRIC VR ICD Registry|Marquis/Maximo VR ICD Programming Practices Registry (MAVRIC VR ICD Registry)|Completed||N/A|742||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:52:04.916596|2017-02-18 16:52:04.916596
NCT00270920|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2008-07-10|||February 2004||2004-02-01|July 2008|2008-07-01|March 2006||2006-03-01|||||Interventional|||A Randomised Controlled Trial to Compare Antenatal Preparation and Postnatal Counseling|A Randomised Controlled Trial to Compare Antenatal Preparation and Postnatal Counseling Strategies for Improving Breastfeeding Rates|Completed||N/A|450||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 16:52:05.080286|2017-02-18 16:52:05.080286
NCT00270907|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2013-02-11|||December 2005||2005-12-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer|A Phase I Study of CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer|Completed||Phase 1|13|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:52:05.246838|2017-02-18 16:52:05.246838
NCT00270894|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2012-03-15|2011-11-18||November 2005||2005-11-01|March 2012|2012-03-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients|Pilot Trial of Sequential Dose-Dense Neoadjuvant Chemotherapy Plus Herceptin in HER2 Positive Stage II-III Breast Cancer Patients|Completed||Phase 2|30|Actual|Accelerated Community Oncology Research Network||1|||f||||f||||||||||2017-02-18 16:52:05.365643|2017-02-18 16:52:05.365643
NCT00270881|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-28|2012-04-05|||January 2006||2006-01-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies|Phase 1/2 Study of Cord Blood Transplantation From Unrelated Donor for Adult Patients With Hematologic Malignancies Using Myeloablative Conditioning Regimen|Completed||Phase 1/Phase 2|33|Actual|Keio University||1|||f||||t||||||||||2017-02-18 16:52:05.968841|2017-02-18 16:52:05.968841
NCT00270868|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2006-10-17|||November 2004||2004-11-01|October 2006|2006-10-01|November 2006||2006-11-01|||||Interventional|||Efficacy of Double Wire Technique in Difficult Cases of Common Bile Duct Cannulation in ERCP (UDOGUIA-04)|Double Guide Wire Placement Compared With Conventional Method in Cases of Difficult Common Bile Duct Cannulation in Endoscopic Retrograde Cholangiopancreatography Procedures. A Controlled Multicentred Randomized Trial.|Unknown status|Active, not recruiting|N/A|1050||Puerta de Hierro University Hospital|||||f||||||||||||||2017-02-18 16:52:06.073131|2017-02-18 16:52:06.073131
NCT00270855|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2012-05-21|||May 2008||2008-05-01|May 2012|2012-05-01|December 2011|Actual|2011-12-01|June 2011|Actual|2011-06-01||Interventional|||Exercise to Reduce Obesity in Spinal Cord Injury|Exercise to Reduce Obesity in Spinal Cord Injury|Completed||N/A|24|Anticipated|VA Office of Research and Development||2|||f||||||||||||||2017-02-18 16:52:06.174459|2017-02-18 16:52:06.174459
NCT00270842|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2015-04-07|2014-10-14||January 2006||2006-01-01|April 2015|2015-04-01|September 2012|Actual|2012-09-01|January 2009|Actual|2009-01-01||Interventional||101 subjects were enrolled, however, 2 subjects dropped after completion of baseline assessments. Only 99 are included in the data.|Effect of Exercise on Gait and Balance in Peripheral Neuropathy|Effect of Exercise on Gait and Balance in Peripheral Neuropathy|Completed||N/A|101|Actual|VA Office of Research and Development|Due to the large number of drop outs following the 10 week data point, maintenance of gait and balance changes is uncertain.|3|||f||||f||||||||||2017-02-18 16:52:06.280311|2017-02-18 16:52:06.280311
NCT00270829|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2008-02-08|||December 2005||2005-12-01|February 2008|2008-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Renal Effects of Intrarenal Nesiritide|Renal Effects of Intrarenal Nesiritide|Terminated||Phase 4|2|Actual|University of Maryland||2||Funding not available|f||||||||||||||2017-02-18 16:52:06.643822|2017-02-18 16:52:06.643822
NCT00270816|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2014-02-10|||November 2005||2005-11-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|February 2011|Actual|2011-02-01||Interventional|||Interferon ß-1b Treatment by Cyclical Administration|Effect of Cyclical Administration of Interferon β-1b in Multiple Sclerosis - Comparison With Normal Dose.|Completed||Phase 2/Phase 3|60|Actual|S. Andrea Hospital||2|||f||||t||||||||||2017-02-18 16:52:06.751139|2017-02-18 16:52:06.751139
NCT00269763|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-18|||October 1987||1987-10-01|April 2010|2010-04-01|April 1988||1988-04-01|||||Interventional|||Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer|The Clinical Use and Safety of TTS (Fentanyl) in the Management of Pain in Patients With Cancer|Completed||Phase 3|32||Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:52:22.967324|2017-02-18 16:52:22.967324
NCT00270803|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-25|2008-05-06|||July 2004||2004-07-01|December 2005|2005-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana|The Effects of Marijuana on Orientation and Motor Coordination and Brain Metabolism in Regular Smokers of Marijuana.|Completed||N/A|12|Actual|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 16:52:06.865949|2017-02-18 16:52:06.865949
NCT00270790|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2016-12-05|2015-12-11||May 2002||2002-05-01|December 2016|2016-12-01|February 2009|Actual|2009-02-01|December 2005|Actual|2005-12-01||Interventional|||EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202)|A SINGLE SITE EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CONCURRENT CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH ADVANCED LOCOREGIONAL SQUAMOUS CELL CARCINOMAS OF THE HEAD AND NECK.|Completed||Phase 2|21|Actual|University of Maryland||1|||f||||t||||||||No||2017-02-18 16:52:06.983304|2017-02-18 16:52:06.983304
NCT00270777|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2008-06-04|||March 2005||2005-03-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Improving Safety of Antivenom in People Bitten by Snakes|Low Dose Adrenaline, Promethazine, & Hydrocortisone (Alone and in Combination) to Prevent Acute Adverse Reactions to Antivenom in People Bitten by Snakes: Randomised, Double Blind, Placebo-Controlled Trial|Completed||Phase 4|1000|Anticipated|University of Kelaniya|||||f||||t||||||||||2017-02-18 16:52:07.242592|2017-02-18 16:52:07.242592
NCT00270764|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2013-11-19|||July 2005||2005-07-01|November 2013|2013-11-01|September 2013|Actual|2013-09-01|June 2011|Actual|2011-06-01||Observational|||Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults|Economic Outcomes of HIV/AIDS Care and Treatment in South Africa|Completed||N/A|1065|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||||||2017-02-18 16:52:07.336991|2017-02-18 16:52:07.336991
NCT00270751|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-26|2006-08-04|||April 2005||2005-04-01|August 2006|2006-08-01|May 2009||2009-05-01|||||Interventional|||Pleural Abrasion Plus Minocycline Versus Apical Pleurectomy for Primary Spontaneous Pneumothorax|Comparison of Pleural Abrasion Plus Minocycline Pleurodesis Versus Apical Pleurectomy After Thoracoscopic Bullectomy for High Recurrent Risk Patients With Primary Spontaneous Pneumothorax: A Prospective Randomized Trial.|Unknown status|Recruiting|Phase 2/Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:52:07.447464|2017-02-18 16:52:07.447464
NCT00270738|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-26|2012-12-04|||December 2005||2005-12-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|December 2006|Actual|2006-12-01||Interventional|||Treatment for Female Stress Urinary Incontinence|Treatment for Stress Urinary Incontinence—Indirect Training of Pelvic Floor Muscle Via Transversus Abdominis Muscle Contraction|Completed||N/A|168|Actual|National Taiwan University Hospital||3|||f||||t||||||||||2017-02-18 16:52:07.557868|2017-02-18 16:52:07.557868
NCT00270725|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2011-03-29|||July 2005||2005-07-01|March 2011|2011-03-01|July 2005|Actual|2005-07-01|||||Observational|||Impact of Anti-HIV Treatment on Labor Productivity and Costs in South Africa|The Effectiveness of Antiretroviral Therapy in Reducing the Costs of HIV/AIDS|Terminated||N/A|120||Boston University|||1|Enrollment never initiated, study withdrawn.|f||||||||||||||2017-02-18 16:52:07.672276|2017-02-18 16:52:07.672276
NCT00270712|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2017-01-19|||October 2005||2005-10-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|DeKAF||A Study of Factors That Affect Long-Term Kidney Transplant Function|Study of Long-term Deterioration of Kidney Allograft Function (DeKAF)|Active, not recruiting||N/A|3175|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||Samples With DNA|"~     Blood and urine specimens.~   "|||2017-02-18 16:52:07.76818|2017-02-18 16:52:07.76818
NCT00270686|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2017-01-24|||January 21, 2003||2003-01-21|January 2, 2015|2015-01-02|January 2, 2015||2015-01-02|||||Observational|||Studies of Heritable Disorders of Connective Tissue|Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue|Completed||N/A|1335|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:52:07.867267|2017-02-18 16:52:07.867267
NCT00270673|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2008-04-24|||February 2006||2006-02-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Early Lactate-Directed Therapy in the Intensive Care Unit (ICU)|Early Lactate-Directed Therapy on the ICU: A Randomized Controlled Trial|Completed||Phase 3|350|Anticipated|Erasmus Medical Center|||||f||||t||||||||||2017-02-18 16:52:07.968397|2017-02-18 16:52:07.968397
NCT00270660|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2006-11-29|||July 2003||2003-07-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||A Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis Media|A Cross Sectional Study of Clinicopathologic Behaviour of Primary, Secondary and Mixed Types of Atticoantral Chronic Otitis Media|Unknown status|Active, not recruiting|Phase 3|192||Karnataka Institute of Medical Sciences|||||f||||||||||||||2017-02-18 16:52:08.081199|2017-02-18 16:52:08.081199
NCT00270647|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-27|2012-07-17|||July 1997||1997-07-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|PHS II||Physicians' Health Study II|Physicians' Health Study II: Trial of Vitamins in the Chemoprevention of Cancer, CVD, and Eye Disease|Completed||N/A|14641|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-02-18 16:52:08.167628|2017-02-18 16:52:08.167628
NCT00270634|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2013-02-11|2012-10-10||January 2006||2006-01-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|PROMISE||Study of ISA247 (Voclosporin) in De Novo Renal Transplantation|A Phase IIb, Randomized, Multicenter, Open-Label, Concentration Controlled, Safety Study of ISA247 (Voclosporin) and Tacrolimus (Prograf®) in De Novo Renal Transplant Patients|Completed||Phase 2|334|Actual|Aurinia Pharmaceuticals Inc.|By limiting access to patients at relatively low risk for rejection and no delayed graft function, the results observed may not be applicable to all renal transplant recipients.|4|||f||||t||||||||||2017-02-18 16:52:08.30848|2017-02-18 16:52:08.30848
NCT00270621|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2016-09-01|||June 2003||2003-06-01|September 2016|2016-09-01|April 2008|Actual|2008-04-01|October 2006|Actual|2006-10-01||Interventional|||Family Help Program: Nighttime Enuresis Treatment Program|Family Help Program: Primary Care Delivery by Telephone for Psychological and Behavioural Problems (Pediatric Enuresis)|Completed||Phase 2|56|Actual|IWK Health Centre||2|||f||||f||||||||No|Aggregate summary data would be made available but not individual data.|2017-02-18 16:52:09.870442|2017-02-18 16:52:09.870442
NCT00269386|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2009-01-06|||April 2000||2000-04-01|January 2009|2009-01-01|May 2007|Actual|2007-05-01|December 2006|Actual|2006-12-01||Interventional|||Clarithromycin in Active Crohn's Disease|Randomised Controlled Trial of Clarithromycin in Active Crohn's Disease|Completed||Phase 3|44|Actual|Royal Liverpool University Hospital||2|||f||||t||||||||||2017-02-18 16:52:27.736746|2017-02-18 16:52:27.736746
NCT00270608|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-26|2007-11-25|||March 2007||2007-03-01|November 2007|2007-11-01|November 2008|Anticipated|2008-11-01|||||Observational|||How Does Early Age Life Style Affect Bone Strength and General Health Parameters at Middle Age?|How Does Early Age Life Style Affect Bone Strength and General Health at Middle Age? Twenty-Five Year Follow-up Health Status Comparison of a Sedentary Versus Extremely Physically Active Population From an Early Age|Unknown status|Recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||t||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 16:52:09.979817|2017-02-18 16:52:09.979817
NCT00270582|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-26|2009-02-06|||November 2005||2005-11-01|September 2005|2005-09-01||||||||Interventional|||A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer|A Randomized Phase II Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|58|Anticipated|Far Eastern Memorial Hospital||2|||f||||||||||||||2017-02-18 16:52:10.248132|2017-02-18 16:52:10.248132
NCT00270569|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-26|2009-02-06|||October 2005||2005-10-01|August 2005|2005-08-01||||February 2007|Actual|2007-02-01||Interventional|||An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancer|A Phase II Study of Weekly Low-Dose Paclitaxel Plus 24-Hour Infusion of Cisplatin as First-Line Chemotherapy for Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|43|Anticipated|Far Eastern Memorial Hospital||1|||f||||||||||||||2017-02-18 16:52:10.351797|2017-02-18 16:52:10.351797
NCT00270556|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2008-04-07|||January 2003||2003-01-01|April 2008|2008-04-01|October 2004||2004-10-01|||||Interventional|||Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.|Phase II, Open-Label,Randomised, Comparator Study of Substitution w/Tenofovir or Abacavir in HIV-1 Infected Individuals, w/Viral Load Less 50 Copies/mL, Receiving a Thymidine Analogue (Zidovudine or Stavudine) as Part of HAART.|Completed||Phase 2|100||Gilead Sciences|||||f||||||||||||||2017-02-18 16:52:10.443297|2017-02-18 16:52:10.443297
NCT00270543|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-26|2009-02-06||||||September 2004|2004-09-01||||||||Interventional|||An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer|A Phase II Study of Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin(HDFL)for Inoperable Advanced or Metastatic Gastric Cancer|Unknown status|Not yet recruiting|Phase 2|54|Anticipated|Far Eastern Memorial Hospital||1|||f||||||||||||||2017-02-18 16:52:10.525138|2017-02-18 16:52:10.525138
NCT00270530|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2006-01-30|||November 2002||2002-11-01|November 2004|2004-11-01|October 2004||2004-10-01|||||Interventional|||Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia|Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia|Completed||Phase 4|454||Center for International Health and Development|||||f||||||||||||||2017-02-18 16:52:10.629468|2017-02-18 16:52:10.629468
NCT00270517|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2006-09-18|||December 2005||2005-12-01|September 2006|2006-09-01|July 2007||2007-07-01|||||Interventional|||Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia|A Randomized, Double-Blinded, Parallel Group, Multicenter Study of EDP-420 Versus Telithromycin for the Treatment of Community Acquired Pneumonia|Unknown status|Recruiting|Phase 2|250||Enanta Pharmaceuticals|||||||||||||||||||2017-02-18 16:52:10.732997|2017-02-18 16:52:10.732997
NCT00270504|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2009-11-17|||December 2002||2002-12-01|December 2008|2008-12-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Memokath® 044TW Stent for Treatment of Urethral Stricture|Prospective, Randomized, Controlled, Multicenter Trial of the Memokath® 044TW Thermo-Expandable Stent for Maintaining Urethral Patency in Patients After Dilation or Internal Urethrotomy of Recurrent Stricture of the Bulbar Urethra|Completed||Phase 3|92|Actual|Pnn Medical DK||1|||f||||f||||||||||2017-02-18 16:52:10.823509|2017-02-18 16:52:10.823509
NCT00270491|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-26|2011-02-24|||December 2005||2005-12-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|October 2009|Actual|2009-10-01||Interventional|||Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.|A Multicenter Randomized Phase II Study Evaluating Tolerance and Efficacy of Capecitabine 5/7 Days With Weekly Paclitaxel Versus the Recommended Treatment Plan of Weekly Paclitaxel-capecitabine, in Patients With Metastatic Breast Cancer.|Completed||Phase 2|130|Anticipated|ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-02-18 16:52:10.938563|2017-02-18 16:52:10.938563
NCT00270478|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-25|2017-01-24|||December 21, 2005||2005-12-21|January 27, 2016|2016-01-27|August 31, 2009|Actual|2009-08-31|August 31, 2009|Actual|2009-08-31||Interventional|||Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia|Evaluation of Synergy of Combining Hydroxyurea With Recombinant Human Erythropoietin Glycoform Alpha (Rhu Erythropoietin-alpha) on Fetal Hemoglobin Synthesis in Patients With Sickle Cell Anemia|Completed||Phase 1|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:52:11.043755|2017-02-18 16:52:11.043755
NCT00270465|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-24|2017-01-24|||December 21, 2005||2005-12-21|June 25, 2009|2009-06-25|June 25, 2009|Actual|2009-06-25|June 25, 2009|Actual|2009-06-25||Interventional|||Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients|VRC101: A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Prime-Boost HIV-1 Vaccination Schedule of a 6-Plasmid Multiclade HIV-1 DNA Vaccine, VRC-HIVDNA016-00-VP, Followed by a Recombinant Multiclade Adenoviral Vector HIV Vaccine|Completed||Phase 1|17||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:52:11.150517|2017-02-18 16:52:11.150517
NCT00270452|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-24|2017-01-24|||December 22, 2005||2005-12-22|February 9, 2012|2012-02-09|October 26, 2007|Actual|2007-10-26|October 26, 2007|Actual|2007-10-26||Interventional|||Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome|Safety of WT1 and PR1 Peptide Vaccination for Patients With Myeloid Malignancies|Completed||Phase 1|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:52:11.242273|2017-02-18 16:52:11.242273
NCT00270439|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2009-09-10|||January 2006||2006-01-01|September 2009|2009-09-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Omentectomy for the Treatment of Diabetes Mellitus Type 2|Omentectomy for Treatment of Diabetes Mellitus Type 2|Completed||Phase 1|10|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 16:52:11.349681|2017-02-18 16:52:11.349681
NCT00270426|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2006-05-04||||||March 1999|1999-03-01||||||||Interventional|||Benazepril for Advanced Chronic Renal Insufficiency||Terminated||N/A|||Southern Medical University, China|||||f||||||||||||||2017-02-18 16:52:11.466405|2017-02-18 16:52:11.466405
NCT00005442|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||June 1994||1994-06-01|March 2005|2005-03-01|May 2000|Actual|2000-05-01|||||Observational|||Re-evaluating Triglycerides in Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.69228|2017-02-18 18:14:58.69228
NCT00270413|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2014-12-08|||January 2006||2006-01-01|December 2014|2014-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer|A Belgian Multicenter Phase II Randomized Trial in her2 Negative Metastatic Breast Cancer Evaluating Consolidation Antiangiogenic Therapy With SU11248 After Response to Taxane Chemotherapy Induction|Completed||Phase 2|55|Actual|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-02-18 16:52:11.552186|2017-02-18 16:52:11.552186
NCT00270400|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-09|||August 1998||1998-08-01|June 2011|2011-06-01|February 1999|Actual|1999-02-01|||||Interventional|||A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure|Natrecor (Nesiritide) Versus Dobutamine Therapy for Symptomatic, Decompensated CHF: A Safety Study Using 24-Hour Holter Monitoring - The PRECEDENT Trial: Prospective, Randomized Evaluation of Cardiac Ectopy With Dobutamine or Natrecor Therapy|Completed||Phase 3|255|Actual|Scios, Inc.||1|||f||||||||||||||2017-02-18 16:52:11.684058|2017-02-18 16:52:11.684058
NCT00270387|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2012-12-12|||January 2001||2001-01-01|December 2012|2012-12-01|January 2002|Actual|2002-01-01|||||Interventional|||A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy|Prospective Randomized Outcomes Study of Acutely Decompensated Congestive Heart Failure Treated Initially in Outpatients With Natrecor (Nesiritide) - The PROACTION Trial|Completed||Phase 3|250|Actual|Scios, Inc.||1|||f||||||||||||||2017-02-18 16:52:11.787237|2017-02-18 16:52:11.787237
NCT00270374|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-09|||October 1999||1999-10-01|June 2011|2011-06-01|August 2000|Actual|2000-08-01|||||Interventional|||A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Hemodynamic and Clinical Effects of Natrecor (Nesiritide) Compared With Nitroglycerin Therapy for Symptomatic Decompensated CHF, The VMAC Trial: Vasodilation in the Management of Acute Congestive Heart Failure|Completed||Phase 3|498|Actual|Scios, Inc.||1|||f||||||||||||||2017-02-18 16:52:12.105633|2017-02-18 16:52:12.105633
NCT00270361|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-07-25|||December 2001||2001-12-01|July 2011|2011-07-01|January 2003|Actual|2003-01-01|||||Interventional|||FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.|Management of Patients With CHF After Hospitalization-Follow up Serial Infusions of NATRECOR (Nesiritide) - FUSION I, A Pilot Study|Completed||Phase 3|214|Actual|Scios, Inc.||3|||f||||||||||||||2017-02-18 16:52:12.216274|2017-02-18 16:52:12.216274
NCT00270348|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2005-12-27|||December 2000||2000-12-01|December 2005|2005-12-01|September 2004||2004-09-01|||||Interventional|||Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma|A Phase III, Multicenter, Double-Blind, Placebo Controlled, Non-Inferiority Study Assessing the Effects of Ciclesonide Metered Dose Inhaler 50 Mg/Day and 200 Mg/Day (Ex-Valve) Administered Once Daily on Growth in Children With Mild Persistent Asthma|Completed||Phase 3|450||Sanofi|||||||||||||||||||2017-02-18 16:52:12.325465|2017-02-18 16:52:12.325465
NCT00270335|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2009-10-15|||January 2006||2006-01-01|October 2009|2009-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Optimizing Propofol in Obese Patients|Optimizing Propofol in Obese Patients|Completed||Phase 4|38|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 16:52:12.41106|2017-02-18 16:52:12.41106
NCT00270322|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2007-04-10|||January 2006||2006-01-01|May 2006|2006-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Pain Treatment After Total Knee Replacement - Continuous Epidural Versus Intravenous Patient Controlled Analgesia With Morphine|Pain Treatment After Total Knee Replacement - Continuous Epidural Versus Intravenous Patient Controlled Analgesia With Morphine|Terminated||Phase 4|80||Rambam Health Care Campus||||"We believe regional anesth better for TKR,90% patients got epidural. Last year we started~   spinal morphine one shot, and found it very promissing."|f||||||||||||||2017-02-18 16:52:12.523887|2017-02-18 16:52:12.523887
NCT00270309|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2015-05-05|||January 2004||2004-01-01|December 2005|2005-12-01|October 2006|Actual|2006-10-01|April 2004|Actual|2004-04-01||Interventional|||Self-management for Men With Uncomplicated Lower Urinary Tract Symptoms|Self-management for Men With Uncomplicated Lower Urinary Tract Symptoms. A Randomised Controlled Trial Against Standard Therapy|Completed||Phase 3|168||The Royal College of Surgeons of England|||||f||||||||||||||2017-02-18 16:52:12.635382|2017-02-18 16:52:12.635382
NCT00270296|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2015-06-09||2010-03-26|June 2006||2006-06-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|March 2009|Actual|2009-03-01||Interventional|||Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV|Lopinavir/Ritonavir/Combivir vs. Abacavir/Zidovudine/Lamivudine for Virologic Efficacy and the Prevention of Mother-to-Child HIV Transmission Among Breastfeeding Women With CD4 Counts Greater Than or Equal to 200 Cells/mm3 in Botswana|Completed||Phase 2|730|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 16:52:12.748135|2017-02-18 16:52:12.748135
NCT00270283|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||July 1988||1988-07-01|July 2009|2009-07-01|April 1990|Actual|1990-04-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||Phase 2|102|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:12.883322|2017-02-18 16:52:12.883322
NCT00270270|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17||||||April 2010|2010-04-01|July 1989|Actual|1989-07-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||Phase 2|63|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:12.969856|2017-02-18 16:52:12.969856
NCT00269373|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2012-02-20|||December 2005||2005-12-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|||Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors|PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors|Completed||N/A|136|Actual|Rigshospitalet, Denmark|||1||f||||f||||||||||2017-02-18 16:52:27.855448|2017-02-18 16:52:27.855448
NCT00270257|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2016-12-08|2015-11-05||May 2008||2008-05-01|December 2016|2016-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users|A Phase III Randomized Controlled Trial to Evaluate the Efficacy of Drug Treatment in Prevention of HIV Infection and Death Among Opiate Dependent Injectors|Terminated||Phase 3|1251|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2||"DSMB halted the study due to futility as a result of lower than anticipated HIV incidence~   rates"|f||||t||||||||No||2017-02-18 16:52:13.065152|2017-02-18 16:52:13.065152
NCT00270244|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2011-12-27|||December 2005||2005-12-01|December 2011|2011-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Group Interpersonal Psychotherapy for Depressed Adolescents in School-based Clinics|Group Interpersonal Psychotherapy for Depressed Adolescents (IPT-AG) in School-based Clinics|Completed||Phase 2|16|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 16:52:13.702639|2017-02-18 16:52:13.702639
NCT00270231|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2013-11-12|2009-02-18||March 2004||2004-03-01|November 2013|2013-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effects of Naltrexone on Nicotine Reinforcement|Pharmacogenetic Investigation of Naltrexone|Completed||Phase 2|64|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 16:52:13.895425|2017-02-18 16:52:13.895425
NCT00270218|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2015-03-03|||February 2006||2006-02-01|March 2015|2015-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults|A Phase I Clinical Trial to Evaluate Immune Response Kinetics and Safety of Two Different Primes, Adenoviral Vector Vaccine (VRC-HIVADV014-00-VP) and DNA Vaccine (VRC-HIVDNA009-00-VP), Each Followed by Adenoviral Vector Boost in Healthy, HIV-1 Uninfected Adults|Completed||Phase 1|66|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 16:52:14.167834|2017-02-18 16:52:14.167834
NCT00270205|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2014-03-05|2011-09-07||January 2006||2006-01-01|March 2014|2014-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART|A Phase I/II, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of LC002, a DermaVir Vaccine, in HIV-1-Infected Subjects Currently Under Treatment With Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1/Phase 2|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|This is a Phase I/II small sample study that was not powered for the secondary efficacy endpoints.|6|||f||||t||||||||||2017-02-18 16:52:14.316126|2017-02-18 16:52:14.316126
NCT00270192|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2006-10-23|||May 2002||2002-05-01|December 2005|2005-12-01|December 2004||2004-12-01|||||Interventional|||Antenatal Educational Intervention for Improvement of Breastfeeding|The Effects Of Antenatal Breast Preparation On The Successful Initiation And Continuation Of Breastfeeding In Singaporean Mothers|Completed||Phase 3|450||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 16:52:18.828561|2017-02-18 16:52:18.828561
NCT00270179|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17||||||April 2010|2010-04-01|May 1988|Actual|1988-05-01|||||Interventional|||A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.|A Double-Blind, Placebo-Controlled Study to Determine Whether R-huEPO Can Facilitate Presurgical Autologous Blood Donation and to Determine Its Safety for This Purpose|Completed||Phase 3|17|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:18.919095|2017-02-18 16:52:18.919095
NCT00270166|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||February 1995||1995-02-01|February 2011|2011-02-01|May 1998|Actual|1998-05-01|||||Interventional|||The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy|A Placebo-Controlled Study on the Effect of Epoetin Alfa in Patients With Malignancy Receiving Chemotherapy|Completed||Phase 3|201|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:52:19.001699|2017-02-18 16:52:19.001699
NCT00270153|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-23|2011-09-15|||September 2004||2004-09-01|November 2009|2009-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Use of ACE Inhibitors in the Early Renal Post-transplant Period|The Use of ACE Inhibitors in the Early Renal Post-transplant Period|Completed||N/A|110|Anticipated|Montefiore Medical Center||1|||f||||f||||||||||2017-02-18 16:52:19.085223|2017-02-18 16:52:19.085223
NCT00270140|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||September 1989||1989-09-01|February 2011|2011-02-01|August 1991|Actual|1991-08-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee.|A Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of Multiple Doses of R-HuEPO in Facilitating Presurgical Autologous Blood Donation|Completed||Phase 3|17|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:19.191674|2017-02-18 16:52:19.191674
NCT00270127|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||August 1996||1996-08-01|January 2011|2011-01-01|September 1998|Actual|1998-09-01|||||Interventional|||Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy|Double-Blind, Placebo-Controlled Study to Assess the Effect of Early Intervention and/or Treatment With Epoetin Alfa on Anemia in Cancer Patients Receiving Non-Platinum-Containing Chemotherapy|Completed||Phase 3|375|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:52:19.274779|2017-02-18 16:52:19.274779
NCT00270114|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17||||||April 2010|2010-04-01|March 1991|Actual|1991-03-01|||||Interventional|||A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)|Recombinant Human Erythropoietin (r-HuEPO) in Patients With Low Hematocrit Levels to Facilitate Presurgical Autologous Blood Donation in Patients Undergoing Orthopedic Surgery (An Open-label Dose Finding Study)|Completed||Phase 2/Phase 3|55|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:52:19.361426|2017-02-18 16:52:19.361426
NCT00270101|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||January 1995||1995-01-01|January 2011|2011-01-01|September 1996|Actual|1996-09-01|||||Interventional|||The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma|A Placebo-Controlled Study on the Effect of r-huEPO in Patients With Multiple Myeloma Followed by an Open-Label Extension|Completed||Phase 3|156|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:52:19.448356|2017-02-18 16:52:19.448356
NCT00269360|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2007-11-19|||March 2001||2001-03-01|November 2007|2007-11-01|February 2005|Actual|2005-02-01|||||Interventional|||Manipulation, Exercise, and Self-Care for Neck Pain|Manipulation, Exercise, and Self-Care for Neck Pain|Completed||Phase 2|270|Actual|Northwestern Health Sciences University||3|||f||||||||||||||2017-02-18 16:52:27.94463|2017-02-18 16:52:27.94463
NCT00270088|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||April 1993||1993-04-01|February 2011|2011-02-01|August 1994|Actual|1994-08-01|||||Interventional|||A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery.|A Double-Blind, Placebo-Controlled Study to Determine Whether Procrit� (Epoetin Alfa) Can Reduce Peri-Operative Transfusion Requirements in Subjects Undergoing Major Orthopedic Surgery|Completed||Phase 3|316|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:19.772308|2017-02-18 16:52:19.772308
NCT00270075|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||January 1990||1990-01-01|February 2011|2011-02-01|May 1992|Actual|1992-05-01|||||Interventional|||A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery|Recombinant Human Erythropoietin (R-HuEPO) in Non-Anemic Patients Scheduled for Orthopedic or Cardiovascular Surgery, to Facilitate Presurgical Autologous Blood Donation (A Double-blind, Randomized, Dose Finding Study)|Completed||Phase 2/Phase 3|80|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:52:19.856289|2017-02-18 16:52:19.856289
NCT00270062|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||May 1989||1989-05-01|February 2011|2011-02-01|July 1991|Actual|1991-07-01|||||Interventional|||A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.|A Double-Blind, Placebo-Controlled Study to Determine Whether R-HuEPO Can Facilitate Presurgical Autologous Blood Donation in Patients With Low Hematocrit Levels|Completed||Phase 3|77|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:19.939283|2017-02-18 16:52:19.939283
NCT00270049|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||November 1990||1990-11-01|January 2011|2011-01-01|January 1994|Actual|1994-01-01|||||Interventional|||Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia|The Effect of Subcutaneous r-HuEPO in Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|195|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:20.02202|2017-02-18 16:52:20.02202
NCT00270036|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17|||April 1991||1991-04-01|November 2010|2010-11-01|October 1991|Actual|1991-10-01|||||Interventional|||A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery.|A Double-Blind, Placebo-Controlled Study to Determine the Safety of r-HuEPO and Whether r-HuEPO Can Reduce Post-Operative Transfusion Requirements in Subjects Undergoing Major Orthopedic Surgery|Completed||Phase 2|1|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:20.11903|2017-02-18 16:52:20.11903
NCT00270023|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17||||||April 2010|2010-04-01|November 1991|Actual|1991-11-01|||||Interventional|||A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.|Recombinant Human Erythropoietin (R-HuEPO) in Non-Anemic Patients Scheduled for Selective Orthopedic and Vascular Surgery or Reductive Mammoplasty to Facilitate Presurgical Autologous Blood Donation Combined With Normo-Volemic Hemodilution (NVHD)|Completed||Phase 2/Phase 3|112|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:52:20.208236|2017-02-18 16:52:20.208236
NCT00270010|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17||||||April 2010|2010-04-01|August 1989|Actual|1989-08-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||Phase 2|72|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:20.300276|2017-02-18 16:52:20.300276
NCT00269997|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17||||||April 2010|2010-04-01|July 1990|Actual|1990-07-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug|The Effect of Subcutaneous r-HuEPO in Patients With Chronic Anemia Secondary to Cisplatin Chemotherapy|Completed||Phase 2|72|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:20.395813|2017-02-18 16:52:20.395813
NCT00269984|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-06||||||April 2010|2010-04-01|June 1990|Actual|1990-06-01|||||Interventional|||A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Efficacy of r-HuEPO, Administered Subcutaneously, in Chronic Anemia Induced by Advanced Cancer|Completed||Phase 2|56|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:20.479372|2017-02-18 16:52:20.479372
NCT00269971|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2016-09-19|||May 1996||1996-05-01|September 2011|2011-09-01|April 1999|Actual|1999-04-01|||||Interventional|||A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.|A Parallel Group Placebo-Controlled Study to Determine an Effective Dose Regimen for EPREX� (Epoetin Alfa) Sterile Solution to Reduce Transfusion Requirements in Patients Undergoing Major Elective Orthopedic Surgery|Withdrawn||Phase 3|0|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 16:52:20.586857|2017-02-18 16:52:20.586857
NCT00269958|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-16||||||April 2010|2010-04-01|December 1991|Actual|1991-12-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery|A Double-Blind, Phase II, Placebo-Controlled Study to Determine the Safety and Efficacy of r-HuEPO in Reducing Transfusion Requirements in Patients Undergoing Total Hip Joint Replacement Surgery|Completed||Phase 2|208|Actual|Janssen-Ortho Inc., Canada|||||||||||||||||||2017-02-18 16:52:20.679499|2017-02-18 16:52:20.679499
NCT00269945|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-17||||||April 2010|2010-04-01|January 1989|Actual|1989-01-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||Phase 2|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:20.766891|2017-02-18 16:52:20.766891
NCT00269932|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-08|||August 1993||1993-08-01|February 2011|2011-02-01|May 1994|Actual|1994-05-01|||||Interventional|||A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment of Adults With Persistent Bronchitis Experiencing Rapid Onset of Severe Worsening of Symptoms Caused by Bacteria|A Multicenter, Randomized Study to Compare the Safety and Efficacy of Oral Levofloxacin With That of Cefuroxime Axetil in the Treatment of Acute Bacterial Exacerbation of Chronic Bronchitis in Adults|Completed||Phase 3|485|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:52:20.854884|2017-02-18 16:52:20.854884
NCT00269919|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2014-03-25|2013-03-29||August 2005||2005-08-01|March 2014|2014-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia|Effect on Efficacy, Safety and Quality of Life by Long-Term Treatment of Long-Acting Risperidone Microspheres in Patients With Schizophrenia|Completed||Phase 4|40|Actual|Janssen Korea, Ltd., Korea|There is limitation in the study that selection or observer bias may occur because this clinical trial was an open, non-comparative, single-arm study and precaution would be necessary for interpreting change in various scales observed in this study.|1|||f||||f||||||||||2017-02-18 16:52:20.950994|2017-02-18 16:52:20.950994
NCT00269906|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2015-05-22|||May 1993||1993-05-01|May 2015|2015-05-01|December 1995|Actual|1995-12-01|December 1995|Actual|1995-12-01||Interventional|||A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty|Chimeric Anti-Platelet Therapy (Abciximab) in Unstable Angina Refractory to Standard Medical Therapy Trial (CAPTURE)|Completed||Phase 3|1265|Actual|Centocor, Inc.||2|||f||||||||||||||2017-02-18 16:52:21.349644|2017-02-18 16:52:21.349644
NCT00269893|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2015-06-01|||November 1991||1991-11-01|June 2015|2015-06-01|November 1992|Actual|1992-11-01|November 1992|Actual|1992-11-01||Interventional|||A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty|A Phase III Double-Blind, Placebo-Controlled Multicenter Study of Abciximab In Patients Undergoing High Risk Coronary Angioplasty (EPIC)|Completed||Phase 3|2038|Actual|Centocor, Inc.||3|||f||||t||||||||||2017-02-18 16:52:21.462164|2017-02-18 16:52:21.462164
NCT00269880|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2015-05-22|||February 1995||1995-02-01|May 2015|2015-05-01|December 1995|Actual|1995-12-01|December 1995|Actual|1995-12-01||Interventional|||A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Clinical Outcomes Following Percutaneous Coronary Intervention in Patients Treated With an Abciximab Bolus Plus 12-Hour Infusion Given With Either Standard-Dose Weight-Adjusted Heparin or Low-Dose Weight-Adjusted Heparin|Completed||Phase 3|2792|Actual|Centocor, Inc.||3|||f||||||||||||||2017-02-18 16:52:21.574068|2017-02-18 16:52:21.574068
NCT00269867|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2014-11-03|||March 1997||1997-03-01|November 2014|2014-11-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis|A Placebo-Controlled, Double-Blinded, Randomized Clinical Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Treatment|Completed||Phase 3|428|Actual|Centocor, Inc.||5|||f||||f||||||||||2017-02-18 16:52:21.685604|2017-02-18 16:52:21.685604
NCT00269854|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2014-11-03|||June 1995||1995-06-01|November 2014|2014-11-01|October 1996|Actual|1996-10-01|October 1996|Actual|1996-10-01||Interventional|||An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease|A Placebo-Controlled, Dose-Ranging Study Followed by a Placebo-Controlled, Repeated-Dose Extension of Anti-TNF Chimeric Monoclonal Antibody (cA2) in the Treatment of Patients With Active Crohn's Disease|Completed||Phase 2/Phase 3|108|Actual|Centocor, Inc.||4|||f||||f||||||||||2017-02-18 16:52:22.03765|2017-02-18 16:52:22.03765
NCT00269841|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2014-11-03|||May 1996||1996-05-01|November 2014|2014-11-01|February 1998|Actual|1998-02-01|February 1998|Actual|1998-02-01||Interventional|||An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease|A Placebo-Controlled, Repeated-Dose Study of Anti-TNF Chimeric Monoclonal Antibody (cA2) in the Treatment of Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease|Completed||Phase 3|94|Actual|Centocor, Inc.||3|||f||||f||||||||||2017-02-18 16:52:22.161433|2017-02-18 16:52:22.161433
NCT00269828|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2007-02-13|||December 2005||2005-12-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.|Paclitaxel Poliglumex (CT-2103) vs. Paclitaxel for the Treatment of Women With Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer (NSCLC) Who Are Performance Status 2.|Terminated||Phase 3|600||CTI BioPharma|||||f||||||||||||||2017-02-18 16:52:22.279134|2017-02-18 16:52:22.279134
NCT00269815|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-13||||||June 2011|2011-06-01|December 1999|Actual|1999-12-01|||||Interventional|||Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder|Long-term Safety and Effectiveness of OROS (Methylphenidate HCl) in Children With ADHD|Completed||Phase 3|||Alza Corporation, DE, USA||1|||f||||||||||||||2017-02-18 16:52:22.524258|2017-02-18 16:52:22.524258
NCT00269802|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-09||||||June 2011|2011-06-01|February 1999|Actual|1999-02-01|||||Interventional|||A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder|Multicenter Study Comparing the Efficacy and Safety of OROS (Methylphenidate HCl), Ritalin, and Placebo in Children With ADHD|Completed||Phase 3|||Alza Corporation, DE, USA||3|||f||||||||||||||2017-02-18 16:52:22.625491|2017-02-18 16:52:22.625491
NCT00269789|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-09|||March 1998||1998-03-01|June 2011|2011-06-01|May 1998|Actual|1998-05-01|||||Interventional|||A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children|Comparative Crossover Study of OROS (Methylphenidate HCl), Ritalin, and Placebo in Children With ADHD|Completed||Phase 3|||Alza Corporation, DE, USA||3|||f||||||||||||||2017-02-18 16:52:22.736669|2017-02-18 16:52:22.736669
NCT00269776|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-07-08|||November 1998||1998-11-01|July 2011|2011-07-01|January 1999|Actual|1999-01-01|||||Interventional|||An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder|Screening, Efficacy, and Safety Study Evaluating OROS (Methylphenidate HCl), Ritalin and Placebo in Children With ADHD|Completed||Phase 3|||Alza Corporation, DE, USA||3|||f||||||||||||||2017-02-18 16:52:22.847354|2017-02-18 16:52:22.847354
NCT00269750|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-18|||July 1996||1996-07-01|April 2010|2010-04-01|February 1997||1997-02-01|||||Interventional|||A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.|The Maximum Tolerated Dose and Minimum Effective Dose of OROS® Oxybutynin Compared to Ditropan® (Immediate-release Oxybutynin) in the Treatment of Patients With Urge or Mixed Urinary Incontinence|Completed||Phase 3|100||Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 16:52:23.068936|2017-02-18 16:52:23.068936
NCT00269737|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-18|||May 1986||1986-05-01|April 2010|2010-04-01|February 1988||1988-02-01|||||Interventional|||Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer|Efficacy of TTS Fentanyl in the Management of Pain in Patients With Malignancy - Study III|Completed||Phase 3|7||Alza Corporation, DE, USA|||||f||||||||||||||2017-02-18 16:52:23.162949|2017-02-18 16:52:23.162949
NCT00269724|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-05-18|||March 1997||1997-03-01|April 2010|2010-04-01|September 1997||1997-09-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence|Open-Label Safety And Dose Conversion/Determination Study of OROS® Oxybutynin Chloride for Urge Urinary Incontinence|Completed||Phase 3|250||Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 16:52:23.252985|2017-02-18 16:52:23.252985
NCT00269685|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2006-05-26|||July 2000||2000-07-01|August 2005|2005-08-01||||||||Interventional|||Comparison of Vasopressin and Other Pressors in Septic Shock|Comparative Prospective Study of Vasopressin and Catecholamine in Septic Shock|Completed||Phase 2/Phase 3|20||Université de Sherbrooke|||||f||||||||||||||2017-02-18 16:52:23.338201|2017-02-18 16:52:23.338201
NCT00269672|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2010-08-04|||September 2005||2005-09-01|August 2010|2010-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects|A Randomized, Open Label, Controlled Phase II Study to Evaluate Safety, Tolerability and Immunogenicity After Two Different 13-Valent Pneumococcal Conjugate Vaccine Formulations in Elderly Subjects Aged 65 Years and Older Who Are Naive to Previous 23vPS Immunization|Completed||Phase 2|915|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:52:23.423119|2017-02-18 16:52:23.423119
NCT00269659|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2009-02-23|||January 2004||2004-01-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Evaluating Effects of a Left Bundle Branch Block|Serial Evaluation of Left Bundle Branch Block; Role of New Imaging Techniques. Three-Dimensional Echocardiography, Tissue Doppler Imaging, and Magnetic Resonance Imaging|Completed||Phase 3|100|Anticipated|VU University Medical Center|||||f||||f||||||||||2017-02-18 16:52:23.498|2017-02-18 16:52:23.498
NCT00269646|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2009-02-16|||November 2004||2004-11-01|February 2009|2009-02-01|August 2009|Anticipated|2009-08-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Two Different Diets on Health Outcomes|Effect of a Low-Carbohydrate and High-Carbohydrate, High-Fiber Diet on Insulin Sensitivity and Risk Markers for Cardiovascular Disease in Men and Women With the Metabolic Syndrome|Unknown status|Active, not recruiting|N/A|24|Anticipated|University of Virginia||1|||f||||f||||||||||2017-02-18 16:52:23.589942|2017-02-18 16:52:23.589942
NCT00269633|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2016-03-02|2015-05-18||November 2006||2006-11-01|March 2016|2016-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Research Study of Treatment for Winter Depression With Different Colors of Light|Optimizing Light Wavelength for Treatment of Seasonal Affective Disorder|Completed||Phase 2|9|Actual|Thomas Jefferson University||2|||f||||t||||||||No||2017-02-18 16:52:23.706274|2017-02-18 16:52:23.706274
NCT00269620|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-20|||June 2005||2005-06-01|October 2008|2008-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|PARIS||PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra|An Open-Label, Randomized, Multicenter Trial to Evaluate Continuation Rates, Side Effects and Acceptability of NuvaRing Versus OrthoEvra|Completed||Phase 4|500|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 16:52:24.069386|2017-02-18 16:52:24.069386
NCT00269607|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2013-12-10|||May 2005||2005-05-01|December 2005|2005-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Naltrexone Implants as Relapse Prevention|Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction.|Terminated||Phase 2/Phase 3|12|Actual|University of Oslo||1||Recruitment difficulties. Reframed as pilot study|f||||||||||||||2017-02-18 16:52:24.19037|2017-02-18 16:52:24.19037
NCT00269594|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2007-04-27|||January 2006||2006-01-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||An Open-Label Study Of Lamictal In Neurotic Excoriation|An Open-Label Study of Lamictal In Neurotic Excoriation|Completed||Phase 2|25|Actual|University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 16:52:24.272127|2017-02-18 16:52:24.272127
NCT00269581|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2012-09-24|||August 2004||2004-08-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Interventional|||Headstrong Intervention for Pediatric Headache|Headstrong Intervention for Recurrent Pediatric Headache|Completed||Phase 3|35|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 16:52:24.362793|2017-02-18 16:52:24.362793
NCT00269568|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-28|||June 2004||2004-06-01|January 2016|2016-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|MAST||Mifepristone at Same Time Multicenter Study|A Multicenter, Randomized Comparison of Mifepristone and Misoprostol Administered Simultaneously Versus 24 Hours Apart for Abortion Through 63 Days|Completed||Phase 4|1128|Actual|University of Pittsburgh||2|||f||||f||||||||No||2017-02-18 16:52:24.472447|2017-02-18 16:52:24.472447
NCT00269555|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2010-06-25|||May 2004||2004-05-01|June 2010|2010-06-01|September 2006|Actual|2006-09-01|January 2006|Actual|2006-01-01||Interventional|||Effects of GCP on Prostate Cancer.|Effects of a Genistein Combined Polysaccharide (GCP) on Patients With a Diagnosis of Prostate Cancer on Active Surveillance.|Completed||N/A|62||University of California, Davis|||||f||||||||||||||2017-02-18 16:52:24.82166|2017-02-18 16:52:24.82166
NCT00269542|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2008-06-30|||February 2002||2002-02-01|June 2008|2008-06-01|August 2003|Actual|2003-08-01|March 2003|Actual|2003-03-01||Interventional|||Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months|Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months|Completed||N/A|94359|Actual|Society for Applied Studies||2|||f||||t||||||||||2017-02-18 16:52:24.919846|2017-02-18 16:52:24.919846
NCT00269529|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2006-10-12|||February 2005||2005-02-01|October 2006|2006-10-01|March 2006||2006-03-01|||||Interventional|||Intraarticular Analgesia After Total Knee Arthroplasty, a Randomised Study|Postoperative Analgesia After Total Knee Arthroplasty. A Comparison of Continuous Femoral Block and Extensive Intraoperative Infiltration With Local Anesthetic Supplemented With Intraarticular Bolus the Following Day.|Completed||N/A|80||University of Aarhus|||||f||||||||||||||2017-02-18 16:52:25.027251|2017-02-18 16:52:25.027251
NCT00269516|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2008-08-28|||June 2006||2006-06-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||SLV308 for Treatment of Patients With Early Parkinson's Disease|A Randomized, Double Blind, Placebo Controlled Parallel-Group Fixed and Flexible SLV308 Dose Arm Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients With Early Stage Parkinson's Disease|Completed||Phase 3|468|Actual|Solvay Pharmaceuticals||4|||f||||t||||||||||2017-02-18 16:52:25.117631|2017-02-18 16:52:25.117631
NCT00269503|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2008-05-07|||March 2006||2006-03-01|May 2008|2008-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Chiropractic Prone Distraction for Lower Back Pain|A Pilot Study of Chiropractic Prone Distraction for Subacute Back Pain With Sciatica|Terminated||N/A|60|Anticipated|Samueli Institute for Information Biology||4|||f||||||||||||||2017-02-18 16:52:25.356624|2017-02-18 16:52:25.356624
NCT00269490|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2008-01-24|||December 2005||2005-12-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|October 2006|Actual|2006-10-01||Observational|||Yoga as a Therapy for Traumatic Experiences|Yoga as an Adjunctive Therapy for Post-Traumatic Stress Disorder: A Feasibility Study|Completed||N/A|7|Actual|Samueli Institute for Information Biology|||||f||||||||||||||2017-02-18 16:52:25.439209|2017-02-18 16:52:25.439209
NCT00269477|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2016-04-12|2009-11-10||December 2005||2005-12-01|April 2016|2016-04-01|December 2007|Actual|2007-12-01|February 2007|Actual|2007-02-01||Interventional|||Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®|Persistence of Bactericidal Antibodies in Adolescents and Adults Aged 15 to 23 Years Who Received a Single Dose of Menactra® or Menomune®-A/C/Y/W-135 Five Years Earlier|Completed||Phase 2|145|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 16:52:25.528221|2017-02-18 16:52:25.528221
NCT00268684|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2006-02-27|||May 2005||2005-05-01|December 2005|2005-12-01||||||||Interventional|||Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC|A Phase III Trial Comparing Whole Brain Radiation (WBRT) and Stereotactic Radiosurgery (SRS) Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases|Unknown status|Recruiting|Phase 3|381||Tel-Aviv Sourasky Medical Center|||||||||||||||||||2017-02-18 16:52:26.279418|2017-02-18 16:52:26.279418
NCT00268671|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2009-12-04|||August 2003||2003-08-01|December 2009|2009-12-01|April 2006||2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)|Phase I/II Trial of Weekly Docetaxel and Cisplatin for Locoregional Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 1/Phase 2|45||Sanofi|||||f||||||||||||||2017-02-18 16:52:26.35566|2017-02-18 16:52:26.35566
NCT00268658|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2007-02-26||||||November 2005|2005-11-01||||||||Interventional|||Clinical Use of Andante SmartStep System in Gait Rehabilitation|Clinical Use of Andante SmartStep System in Gait Rehabilitation|Unknown status|Not yet recruiting|N/A|60||Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:52:26.434185|2017-02-18 16:52:26.434185
NCT00268645|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2011-01-10|||September 2004||2004-09-01|January 2011|2011-01-01||||||||Interventional|||Insulin Glargine in Type 2 Diabetes|Open Trial of the Safety and Efficacy of Lantus for Insulin Naive Type 2 Diabetes Mellitus Patients or Patients Who Use Insulin Combined With 1 or More Oral Antidiabetic Drugs and Don't Have Good Glycemic Control.|Completed||Phase 4|534||Sanofi|||||f||||||||||||||2017-02-18 16:52:26.530809|2017-02-18 16:52:26.530809
NCT00268632|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2011-01-10|||August 1999||1999-08-01|January 2011|2011-01-01||||February 2002|Actual|2002-02-01||Interventional|||"IMPACT Study (Improving Measurements of Persistence on ACtonel Treatment)"|A Multicenter Prospective Study to Assess the Impact of Physician's Reinforcement on the Subject's Compliance and Persistence on Treatment Using Feedback on Bone Markers in Previously Undiagnosed Postmenopausal Osteoporotic Women Treated With Risedronate.|Completed||Phase 3|||Sanofi|||||f||||||||||||||2017-02-18 16:52:26.615668|2017-02-18 16:52:26.615668
NCT00268619|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2011-01-10|||June 2004||2004-06-01|January 2011|2011-01-01||||July 2005|Actual|2005-07-01||Interventional|||FOCUS:Focus On Coronary Unstable Syndromes|A Placebo-controlled, Double-blind, Randomized, Multicenter Study of Ramipril 5 and 10 mg Capsules and Insulin Infusion in Subjects With Unstable Coronary Syndromes|Completed||Phase 3|||Sanofi|||||f||||||||||||||2017-02-18 16:52:26.705799|2017-02-18 16:52:26.705799
NCT00269464|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2007-12-18||||||December 2007|2007-12-01|March 2007||2007-03-01|||||Observational|||Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:52:26.779244|2017-02-18 16:52:26.779244
NCT00269451|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2005-12-22||||||December 2005|2005-12-01||||||||Observational|||Assessing PTSD After Earthquake in Turkey||Unknown status|Active, not recruiting|N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:52:26.842337|2017-02-18 16:52:26.842337
NCT00269438|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2009-12-21|||December 2005||2005-12-01|December 2009|2009-12-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis|Phase 3 Study to Establish the Efficacy and Safety of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium Dosed Twice Daily in Achieving Clinical Improvement in Subjects With Mildly to Moderately Active Ulcerative Colitis After 8 Weeks of Therapy|Completed||Phase 3|225||Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:52:26.91201|2017-02-18 16:52:26.91201
NCT00269425|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2010-08-23|||October 2000||2000-10-01|December 2005|2005-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Heart Institute of Spokane Diet Study|The Heart Institute of Spokane Diet Intervention and Evaluation Trial (THIS DIET)|Completed||Phase 3|202|Actual|Providence Health & Services||3|||f||||f||||||||||2017-02-18 16:52:27.055953|2017-02-18 16:52:27.055953
NCT00269412|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2009-12-21|||December 2005||2005-12-01|December 2009|2009-12-01|September 2008|Actual|2008-09-01|August 2007|Actual|2007-08-01||Interventional|||Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome|Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess The Efficacy and Safety of Three Different Doses (275, 550 AND 1100 MG) of Rifaximin Administered BID For Either Two or Four Weeks in The Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome|Completed||Phase 2|525|Anticipated|Valeant Pharmaceuticals International, Inc.|||||||||||||||||||2017-02-18 16:52:27.180227|2017-02-18 16:52:27.180227
NCT00269399|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-07-17|||December 2005||2005-12-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)|A Double-Blind, Randomized, Controlled Trial of Rifaximin Compared to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)|Completed||Phase 3|300|Anticipated|Valeant Pharmaceuticals International, Inc.|||||f||||||||||||||2017-02-18 16:52:27.575528|2017-02-18 16:52:27.575528
NCT00269334|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2005-12-22|||December 2005||2005-12-01|December 2005|2005-12-01|November 2007||2007-11-01|||||Interventional|||Clinical Pharmacogenomics of Antidepressant Response|Phase 4 Study of Clinical Pharmacogenomics of Antidepressant Response|Unknown status|Not yet recruiting|Phase 4|400||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 16:52:28.184876|2017-02-18 16:52:28.184876
NCT00269321|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2013-06-27|||October 2003||2003-10-01|June 2013|2013-06-01|March 2008|Actual|2008-03-01|||||Interventional|||Chiropractic and Exercise for Seniors With Low Back Pain|Randomized Clinical Trial of Chiropractic Manual Therapy Plus Home Exercise, Supervised Exercise Plus Home Exercise and Home Exercise Alone For Individuals 65 and Over With Chronic Mechanical Low Back Pain|Completed||Phase 2|240|Actual|Northwestern Health Sciences University||3|||f||||||||||||||2017-02-18 16:52:28.297673|2017-02-18 16:52:28.297673
NCT00269308|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2011-08-22|||October 2003||2003-10-01|August 2011|2011-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Chiropractic and Exercise for Seniors With Neck Pain|Randomized Clinical Trial of Chiropractic Manual Therapy Plus Home Exercise, Supervised Exercise Plus Home Exercise and Home Exercise Alone For Individual 65 and Over With Chronic Mechanical Neck Pain|Completed||Phase 2|241|Actual|Northwestern Health Sciences University||3|||f||||||||||||||2017-02-18 16:52:28.413303|2017-02-18 16:52:28.413303
NCT00269295|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-09|||February 2006||2006-02-01|February 2010|2010-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||TY800 Dose Escalation (Typhoid)|A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation, In-Patient Phase I/II Study to Determine the Safety and Immunogenicity of Ty800 in Healthy Adult Subjects|Completed||Phase 1/Phase 2|47|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-02-18 16:52:28.533216|2017-02-18 16:52:28.533216
NCT00269282|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2013-01-11|||May 2006||2006-05-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Increasing Adherence to Asthma Medication in Urban Teens|Motivating Asthma Adherence in Urban Teens|Completed||N/A|207|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 16:52:28.642654|2017-02-18 16:52:28.642654
NCT00269269|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2016-02-17|||September 2002||2002-09-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Conditioned Placebo Effects and Treatment of Hypertension||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:52:28.747792|2017-02-18 16:52:28.747792
NCT00269256|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2016-02-02|||September 2005||2005-09-01|February 2016|2016-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Stress, Environment, and Genetics in Urban Children With Asthma|Stress, Environment, and Genetics in Urban Asthma|Completed||N/A|959|Actual|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"~     Maternal DNA Child DNA~   "|Undecided||2017-02-18 16:52:28.827742|2017-02-18 16:52:28.827742
NCT00269243|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2006-02-06|||November 1999||1999-11-01|December 2005|2005-12-01|May 2005||2005-05-01|||||Interventional|||Management With Accupril Post Bypass Graft|The Ischemia Management With Accupril Post Bypass Graft Via Inhibition of the coNverting Enzyme (IMAGINE) Trial|Completed||Phase 4|||Montreal Heart Institute|||||f||||||||||||||2017-02-18 16:52:28.913525|2017-02-18 16:52:28.913525
NCT00269230|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2008-11-18|||July 2004||2004-07-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Attain StarFix™ Model 4195 Left Ventricular Lead|Attain StarFix™ Model 4195 Left Ventricular Lead|Completed||N/A|441|Actual|Medtronic Cardiac Rhythm and Heart Failure||1|||t||||f||||||||||2017-02-18 16:52:28.985262|2017-02-18 16:52:28.985262
NCT00269217|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2016-01-21|||January 2006||2006-01-01|January 2016|2016-01-01||||January 2007|Actual|2007-01-01||Interventional|||Lipid Efficacy Study (0524B-022)(COMPLETED)|"A Multicenter, Randomized, Double-Blind, Factorial Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Coadministered MK0524B Tablets in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia"|Completed||Phase 3|1400|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:52:29.096034|2017-02-18 16:52:29.096034
NCT00269204|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2015-07-24|||December 2005||2005-12-01|July 2015|2015-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Lipid Efficacy/Tolerability Study (0524A-020)|A Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Evaluate the Lipid-Altering Efficacy, Safety and Tolerability of MK0524A in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia|Completed||Phase 3|1620|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:52:29.19759|2017-02-18 16:52:29.19759
NCT00269191|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2015-02-24|||February 2003||2003-02-01|February 2015|2015-02-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)|A 12-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Ibuprofen 2400 mg in Patients With Osteoarthritis (Study 1)|Completed||Phase 3|528|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:52:29.302997|2017-02-18 16:52:29.302997
NCT00269178|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2017-02-16|||August 2003||2003-08-01|March 2003|2003-03-01|October 2004|Actual|2004-10-01|||||Interventional|||Cluster Randomized Trial of Peer Health Education in Malaria in The Gambia|Cluster Randomized Trial of the Impact of a Peer-health Education Programme on Malaria Knowledge Attitudes and Practice in Students and Their Families|Completed||Phase 3|960||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 16:52:29.397496|2017-02-18 16:52:29.397496
NCT00269165|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2010-05-28|||November 2005||2005-11-01|May 2010|2010-05-01||||||||Interventional|||Adjuvant Radiation in Aortic Valvuloplasty - ARAVA||Terminated||Phase 3|60||Medstar Health Research Institute|||||f||||||||||||||2017-02-18 16:52:29.491838|2017-02-18 16:52:29.491838
NCT00269152|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2015-07-28|2008-11-12||December 2005||2005-12-01|July 2015|2015-07-01|July 2013|Actual|2013-07-01|November 2007|Actual|2007-11-01||Interventional|||Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer|A Randomized Phase 2 Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Chemotherapy in Patients With Completely Resected Stage Ib or II Non-Small Cell Lung Cancer|Completed||Phase 2|122|Actual|Eli Lilly and Company|A protocol amendment was approved after the trial original completed to allow for collection of additional overall survival data due to number of participants surviving at 3 years.|2|||f||||f||||||||||2017-02-18 16:52:29.569913|2017-02-18 16:52:29.569913
NCT00269139|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2006-02-17||||||December 2005|2005-12-01||||||||Interventional|||Outcome of Crisis Intervention for Subjects With Borderline Personality Disorder or Post-Traumatic Stress Disorder|Study of Outcome With an Intervention From the Cape Cod Model of Psychotherapy for Subjects in a Behavioral Crisis and With the Diagnosis of Borderline Personality Disorder (BPD) or Post-Traumatic Stress Disorder (PTSD)|Unknown status|Not yet recruiting|Phase 1|40||Laddis, Andreas, M.D.|||||f||||||||||||||2017-02-18 16:52:30.569183|2017-02-18 16:52:30.569183
NCT00269126|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2013-04-11|||February 2005||2005-02-01|May 2012|2012-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)|See Detailed Description|Completed||Phase 3|150|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:52:30.673132|2017-02-18 16:52:30.673132
NCT00269113|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2015-07-21|2014-05-20||September 1998||1998-09-01|July 2015|2015-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional||Intent to Treat (ITT) Population: all participants included in the study, who began a therapy and received at least 1 therapy cycle.|A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma|A Randomized, Open-label Study of the Effect of MabThera Plus Chemotherapy Versus Chemotherapy Alone on Clinical Response in Patients With Indolent Non-Hodgkin's and Mantle Cell Lymphoma|Completed||Phase 3|360|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 16:52:30.78305|2017-02-18 16:52:30.78305
NCT00268606|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2008-05-20|||December 2003||2003-12-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk|Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial|Completed||N/A|400|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 16:52:31.607176|2017-02-18 16:52:31.607176
NCT00268593|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2011-06-13|||August 2005||2005-08-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer|A Randomised Phase II Study of Two Dose Schedules of PI-88 in Combination With Docetaxel in Patients With Androgen-independent Prostate Cancer|Completed||Phase 2|48|Actual|Progen Pharmaceuticals||2|||f||||||||||||||2017-02-18 16:52:31.718247|2017-02-18 16:52:31.718247
NCT00268580|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2016-03-28|||January 2006||2006-01-01|March 2016|2016-03-01|June 2006|Actual|2006-06-01|January 2006|Actual|2006-01-01||Interventional|||Evaluation of the Emergency Department Asthma Care Project|Evaluation of the Emergency Department Asthma Care Project|Completed||N/A|300|Anticipated|Queen's University||2|||f||||f||||||||||2017-02-18 16:52:31.848408|2017-02-18 16:52:31.848408
NCT00268567|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2005-12-21|||October 2002||2002-10-01|October 2004|2004-10-01||||||||Interventional|||Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone|Phase 3 Study of Leflunomide Combined With Prednisone Treatment of Proliferative Lupus Nephritis as Induction Therapy|Completed||Phase 2/Phase 3|||Peking University|||||f||||||||||||||2017-02-18 16:52:31.973699|2017-02-18 16:52:31.973699
NCT00268554|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2008-03-27|||December 2005||2005-12-01|March 2008|2008-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole|Enhancement of Postocclusive Reactive Hyperaemia|Completed||N/A|12|Anticipated|Radboud University|||||f||||t||||||||||2017-02-18 16:52:32.072748|2017-02-18 16:52:32.072748
NCT00268541|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2007-04-19|||September 2004||2004-09-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Physical Activity, Insulin Resistance and Function of Fat Tissue in the Offspring of Patients With Type 2 Diabetes|Physical Activity, Insulin Resistance and Adipose Tissue Gene Expression in the Offspring of Patients With Type 2 Diabetes|Completed||N/A|80||NHS Greater Glasgow and Clyde|||||f||||||||||||||2017-02-18 16:52:32.180152|2017-02-18 16:52:32.180152
NCT00268528|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2017-02-07|||May 2005||2005-05-01|February 2017|2017-02-01|March 5, 2012|Actual|2012-03-05|March 5, 2012|Actual|2012-03-05||Interventional|||Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission|Understanding the Ethnic and Racial Differences in Survival in Children With Acute Lymphoblastic Leukemia|Completed||N/A|755|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 16:52:32.279169|2017-02-18 16:52:32.279169
NCT00268515|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2016-05-12|||April 1998||1998-04-01|December 2005|2005-12-01|March 2003|Actual|2003-03-01|||||Interventional|||Aerosol Cyclosporine for Prevention of Lung Rejection||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:52:32.520706|2017-02-18 16:52:32.520706
NCT00268502|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2015-11-12|||December 2005||2005-12-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|November 2007|Actual|2007-11-01||Observational|||Quality of Life in African-American or Caucasian Female Breast Cancer Survivors|Survey of the Quality of Life of Women|Completed||N/A|195|Anticipated|Indiana University|||||f||||f||||||||||2017-02-18 16:52:32.635174|2017-02-18 16:52:32.635174
NCT00268489|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2016-07-01|||May 2006||2006-05-01|July 2016|2016-07-01|April 2010|Actual|2010-04-01|May 2007|Actual|2007-05-01||Interventional|||Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of Pemetrexed Disodium (ALIMTA®) Plus Bevacizumab in Patients With Stage IIIB Pleural Effusion or Stage IV Non-Small Cell Lung Cancer (Second-Line Treatment)|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 16:52:32.741946|2017-02-18 16:52:32.741946
NCT00268476|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2014-07-24|||September 2005||2005-09-01|July 2014|2014-07-01||||September 2017|Anticipated|2017-09-01||Interventional|STAMPEDE||STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial|STAMPEDE: Systemic Therapy in Advanced or Metastatic Prostate Cancer: Evaluation of Drug Efficacy - Androgen Suppression-Based Therapy Alone or Combined With Zoledronic Acid, Docetaxel, Prednisolone, Celecoxib, Abiraterone, Enzalutamide and/or Radiotherapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer|Recruiting||Phase 2/Phase 3|8100|Anticipated|Medical Research Council||9|||f||||t||||||||||2017-02-18 16:52:33.17317|2017-02-18 16:52:33.17317
NCT00269100|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2007-04-19||||||April 2007|2007-04-01||||||||Observational|||Prevention of Bacteremia Induced by Debridement of Pressure Ulcer||Terminated||Phase 1/Phase 2|60||Herzog Hospital|||||f||||||||||||||2017-02-18 16:52:36.183859|2017-02-18 16:52:36.183859
NCT00269087|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2017-02-06|||January 2005||2005-01-01|February 2017|2017-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)|"Clinical Evaluation of GW815SF for Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) A Long-term Treatment Study of GW815SF50/500µg in Chronic Obstructive Pulmonary Disease -"|Completed||Phase 3|122|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:52:36.269835|2017-02-18 16:52:36.269835
NCT00269074|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2009-03-19|||January 2006||2006-01-01|March 2009|2009-03-01|July 2006||2006-07-01|||||Interventional|||Effect of IDEA-070 on Pain and Inflammation Induced by PDT|Safety and Efficacy of IDEA-070 for the Treatment of Pain and Inflammation Induced by Photodynamic Therapy of Actinic Keratosis|Completed||Phase 2|24||IDEA AG|||||f||||||||||||||2017-02-18 16:52:36.37807|2017-02-18 16:52:36.37807
NCT00269061|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2008-10-15|||January 2006||2006-01-01|October 2008|2008-10-01||||||||Interventional|||Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin|An Exploratory MRI Study in Type 2 Diabetic Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Measurement of Fluid Volumes by MRI in the Lower Extremities of Subjects Receiving Pioglitazone|Completed||Phase 1|32||GlaxoSmithKline|||||||||||||||||||2017-02-18 16:52:36.449798|2017-02-18 16:52:36.449798
NCT00269048|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2016-08-05|||November 2005||2005-11-01|August 2016|2016-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||SB-480848 In Subjects With Coronary Heart Disease|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study of SB-480848, an Oral Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Inhibitor, in Subjects With Stable Coronary Heart Disease (CHD) or CHD-risk Equivalent to Examine Chronic Inhibition of Lp-PLA2 Effects on Circulating Biomarkers Associated With Cardiovascular Risk, Safety and Tolerability Over 12 Weeks|Completed||Phase 2|969|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 16:52:36.54506|2017-02-18 16:52:36.54506
NCT00269035|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2012-09-13|||June 2005||2005-06-01|September 2012|2012-09-01||||||||Interventional|||SPECT Study With SB-773812 In Schizophrenic Patients|A Parallel Study to Investigate Dopaminergic D2 and Serotoninergic 5HT2A Receptor Occupancy at Stable Plasma Concentrations of SB-773812 After Repeated Doses in Schizophrenic Patients. Relationship With Pharmacokinetics and Efficacy Readouts.|Completed||Phase 1|95|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:52:37.03015|2017-02-18 16:52:37.03015
NCT00269022|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2009-05-15|||January 2006||2006-01-01|May 2009|2009-05-01||||||||Interventional|||Use Of SB-705498 In The Acute Treatment Of Migraine|A Single Blind, Placebo Controlled, Multi-Centre Study to Investigate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of the TRPV1 Antagonist SB-705498 Against the Pain of Acute Migraine.|Completed||Phase 2|70||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:52:37.125118|2017-02-18 16:52:37.125118
NCT00269009|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2007-01-10|||January 2006||2006-01-01|September 2006|2006-09-01|February 2007||2007-02-01|||||Interventional|||CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change|CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change|Unknown status|Recruiting|Phase 1|||Great Lakes Research Into Practice Network|||||f||||||||||||||2017-02-18 16:52:37.217832|2017-02-18 16:52:37.217832
NCT00268996|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2009-05-15|||November 2005||2005-11-01|May 2009|2009-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Integrated Biomarker And Imaging Study - 2|See Detailed Description|Completed||Phase 2|300||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:52:37.317119|2017-02-18 16:52:37.317119
NCT00268983|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2016-11-18|2010-06-29||October 2004||2004-10-01|November 2016|2016-11-01|June 2013|Actual|2013-06-01|September 2009|Actual|2009-09-01||Interventional|||Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma|A Multi-Center, Randomized, Phase 3 Study of Rituximab Versus Iodine I 131 Tositumomab Therapeutic Regimen For Patients With Relapsed Follicular Non-Hodgkins Lymphoma|Completed||Phase 3|14|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:52:37.447729|2017-02-18 16:52:37.447729
NCT00268970|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2012-04-27|||December 2005||2005-12-01|April 2012|2012-04-01|September 2009|Actual|2009-09-01|April 2007|Actual|2007-04-01||Interventional|||Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer|Phase 2 Trial of First-Line Therapy With Satraplatin and Paclitaxel in Patients With Unresectable Stage III or IV Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|40|Actual|Agennix||1|||f||||||||||||||2017-02-18 16:52:38.525669|2017-02-18 16:52:38.525669
NCT00268957|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2014-03-17|||January 2006||2006-01-01|March 2014|2014-03-01|May 2007|Actual|2007-05-01|March 2007|Actual|2007-03-01||Interventional|||Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis|A Randomized, Parallel, Open-Label Study to Compare Once Per Day Sevelamer Carbonate Powder Dosing With Three Times Per Day Sevelamer Hydrochloride Tablet Dosing in Chronic Kidney Disease Patients on Hemodialysis|Completed||Phase 3|217|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:52:38.617687|2017-02-18 16:52:38.617687
NCT00268944|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2014-02-04|||December 2005||2005-12-01|February 2014|2014-02-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory Support|Prospective, Open-label, Single-arm, Exploratory Study of the Effect and Safety of rhGAA in Patients With Advanced Late-onset Pompe Disease Who Are Receiving Respiratory Support|Completed||Phase 3|5|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:52:38.751465|2017-02-18 16:52:38.751465
NCT00268931|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2013-04-12|||August 2004||2004-08-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Development Training in Babies Born Preterm|Enhanced Developmental Training Experiences in Babies Born Preterm|Completed||N/A|32|Actual|Christiana Care Health Services||3|||f||||f||||||||||2017-02-18 16:52:38.860859|2017-02-18 16:52:38.860859
NCT00268918|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2016-05-05|||September 2005||2005-09-01|May 2016|2016-05-01|January 2011|Actual|2011-01-01|January 2007|Actual|2007-01-01||Interventional|||Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients|A Phase I Trial of Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Recurrent or Refractory Gynecological Cancer Patients|Completed||Phase 1|24|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:52:39.194528|2017-02-18 16:52:39.194528
NCT00268905|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2013-02-06|2012-12-20||October 2006||2006-10-01|February 2013|2013-02-01||||November 2011|Actual|2011-11-01||Interventional|||A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors|A Phase Ib Open-Label, Two-Arm, Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors|Completed||Phase 1|64|Actual|Eisai Inc.||3|||f||||||||||||||2017-02-18 16:52:39.330692|2017-02-18 16:52:39.330692
NCT00268892|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2010-12-08|2010-11-17||January 2006||2006-01-01|December 2010|2010-12-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer|An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Different Three-Month Degarelix Dosing Regimens in Patients With Prostate Cancer|Completed||Phase 2/Phase 3|278|Actual|Ferring Pharmaceuticals||3|||f||||f||||||||||2017-02-18 16:52:40.369937|2017-02-18 16:52:40.369937
NCT00005441|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-04|||April 1993||1993-04-01|February 2016|2016-02-01|March 1998|Actual|1998-03-01|October 1997|Actual|1997-10-01||Observational|||Lifestyle Management for Women With CHD and NIDDM||Completed||N/A|||Oregon Research Institute|||||f||||f||||||||Undecided||2017-02-18 18:14:58.768786|2017-02-18 18:14:58.768786
NCT00268879|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2008-02-13|||December 2005||2005-12-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)|A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (c-IBS)|Completed||Phase 3|1821|Actual|Alizyme||3|||f||||t||||||||||2017-02-18 16:52:42.007513|2017-02-18 16:52:42.007513
NCT00268866|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2008-04-15||||||April 2008|2008-04-01|January 2007||2007-01-01|||||Observational|||Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics|Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics|Completed||Phase 4|1820||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:52:42.117648|2017-02-18 16:52:42.117648
NCT00268853|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2015-01-15|||November 2005||2005-11-01|July 2012|2012-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|RAPID||A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin|Cyclophosphamide, Doxorubicin, Vincristine, Prednisone Plus Rituximab (CHOP-R) and Cyclophosphamide, Pixantrone, Vincristine, Prednisone Plus Rituximab (CPOP-R) in Patients With Diffuse Large-B-cell Lymphoma: A Phase II, Randomized, Multicenter, Comparative Trial|Completed||Phase 2|124|Actual|CTI BioPharma||2|||f||||t||||||||||2017-02-18 16:52:42.200751|2017-02-18 16:52:42.200751
NCT00268840|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2011-06-29|||August 2001||2001-08-01|June 2011|2011-06-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer|National Trial Phase II to Study the Combination of Gemcitabine and Docetaxel in Patients With Locally Advanced or Metastatic Pancreatic or Biliary Adenocarcinoma That Cannot be Removed by Surgery|Completed||Phase 2|45|Actual|ARCAGY/ GINECO GROUP||1|||f||||f||||||||||2017-02-18 16:52:42.382633|2017-02-18 16:52:42.382633
NCT00268827|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-22|2007-04-04|||December 2005||2005-12-01|April 2007|2007-04-01|February 2006|Actual|2006-02-01|||||Interventional|||A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort|A Comparison of Adverse Events and Quality of Life Before and After Switching From Kaletra Soft-Gel Capsules (SGC) to Kaletra Tablets in an African American Cohort|Completed||Phase 4|120||AIDS Arms Inc.|||||f||||t||||||||||2017-02-18 16:52:42.489111|2017-02-18 16:52:42.489111
NCT00268814|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2015-09-07|||March 2002||2002-03-01|September 2015|2015-09-01|December 2007|Actual|2007-12-01|December 2003|Actual|2003-12-01||Interventional|||The German Project of Heroin Assisted Treatment of Opiate Dependent Patients|Phase III Study of Maintenance Treatment for Opiate Dependence With Heroin (Diamorphine) Compared to Methadone|Completed||Phase 3|1015|Actual|Universitätsklinikum Hamburg-Eppendorf||8|||f||||t||||||||||2017-02-18 16:52:42.581004|2017-02-18 16:52:42.581004
NCT00268788|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2008-02-19|||August 2005||2005-08-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy|A Controlled Cross-Over Trial of Subcutaneous Versus Intravenous Immunoglobulin for Multifocal Motor Neuropathy|Completed||Phase 2|10|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 16:52:42.710884|2017-02-18 16:52:42.710884
NCT00268775|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2009-08-17|||November 2005||2005-11-01|August 2009|2009-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Implementation Strategies for a Simple Intervention to Reduce Longterm Benzodiazepine Use in Dutch Community Pharmacies|Implementation Strategies Aimed at a Simple Patient-directed Intervention to Reduce Long-term Use of Benzodiazepines in Dutch Community Pharmacies|Completed||N/A|20000||Radboud University|||||f||||||||||||||2017-02-18 16:52:42.829485|2017-02-18 16:52:42.829485
NCT00268762|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2014-11-03|2012-08-20||February 2003||2003-02-01|November 2014|2014-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Argatroban Stroke Treatment - A Pilot Safety Study|A Pilot Study To Determine The Safety Of Argatroban Injection In Combination With Tissue Plasmingen Activator (TPA) In Patients With Acute Ischemic Stroke|Completed||Phase 1/Phase 2|65|Actual|The University of Texas Health Science Center, Houston|Possible selection bias and investigators unblinded to treatment. In addition, although 60/65 patients had 24 hour recanalization data, only 47 were available at 2 hours.|1|||f||||t||||||||||2017-02-18 16:52:43.093697|2017-02-18 16:52:43.093697
NCT00268749|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-03-28|||July 2002||2002-07-01|March 2012|2012-03-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Glycine Treatment of Prodromal Symptoms|Glycine Treatment of Prodromal Symptoms|Completed||Phase 2|10|Actual|Yale University||1|||f||||||||||||||2017-02-18 16:52:43.594542|2017-02-18 16:52:43.594542
NCT00268723|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-02-21|||December 2005||2005-12-01|February 2012|2012-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB|An Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Versus Placebo in Prevention of EIB in Subjects 18 Years of Age and Older With EIB|Completed||Phase 3|15|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 16:52:43.688657|2017-02-18 16:52:43.688657
NCT00268710|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2009-12-04|||February 2004||2004-02-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]|Multicenter Phase II Study of Taxotere (Docetaxel) Administered Weekly or Every Three Weeks in Combination With Prednisone as Second Line Chemotherapy in Patients With Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 2|||Sanofi|||||f||||||||||||||2017-02-18 16:52:43.800364|2017-02-18 16:52:43.800364
NCT00268697|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-05-23|||October 2005||2005-10-01|May 2012|2012-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.|A Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 100 mg and Lapaquistat Acetate 100 mg Administered in Combination With Ezetimibe 10 mg vs Ezetimibe 10 mg in Subjects With Primary Dyslipidemia|Completed||Phase 3|1267|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:52:43.879092|2017-02-18 16:52:43.879092
NCT00268463|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2013-05-10|2013-02-05||January 2006||2006-01-01|May 2013|2013-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer|A Phase III Clinical Trial Comparing Oxaliplatin, Capecitabine and Hepatic Arterial Infusion of Floxuridine to Oxaliplatin and Capecitabine in Patients With Resected or Ablated Liver Metastases From Colorectal Cancer|Terminated||Phase 3|22|Actual|NSABP Foundation Inc||2||The study was terminated due to low accrual.|f||||t||||||||||2017-02-18 16:52:44.028851|2017-02-18 16:52:44.028851
NCT00268450|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-04-26|||September 2005||2005-09-01|April 2012|2012-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery|A Phase II Study of Neo-Adjuvant Cisplatin, Gemcitabine & Bevacizumab, Followed by Radical Cystectomy for Patients With Muscle Invasive, Resectable, Non-Metastatic Transitional Cell Carcinoma (TCC) of the Bladder|Completed||Phase 2|25|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-02-18 16:52:44.42524|2017-02-18 16:52:44.42524
NCT00268437|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2016-07-01|2015-03-09||April 2006||2006-04-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|January 2008|Actual|2008-01-01||Interventional|||Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery|A Phase II Trial of Preoperative Radiation and Chemotherapy (Pemetrexed and Carboplatin) for Locally Advanced Esophageal Cancer|Terminated||Phase 2|27|Actual|Alliance for Clinical Trials in Oncology||1||Trial closed early because, during an interim analysis, the primary endpoint fell short.|f||||t||||||||||2017-02-18 16:52:44.535133|2017-02-18 16:52:44.535133
NCT00268411|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2008-05-23|||September 2004||2004-09-01|May 2007|2007-05-01||||||||Interventional|||Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer|Phase II Randomisee Dans Les Adenocarcinomes Metastatiques Du Pancreas: Gemox Et Gemox Simplifie. [GEMOX]|Unknown status|Active, not recruiting|Phase 3|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:52:44.963885|2017-02-18 16:52:44.963885
NCT00268398|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-05-21|||July 2002||2002-07-01|May 2012|2012-05-01||||December 2011|Actual|2011-12-01||Interventional|MIROX||Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases|Essai De Phase III De Chimiotherapie Par FOLFOX 4 Ou Par Une Succession FOLFOX 7 - FOLFIRI Chez Des Patients Ayant Des Metastases Resecables D'Origine Colorectale - MIROX|Completed||Phase 3|284|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2|||f||||||||||||||2017-02-18 16:52:45.096144|2017-02-18 16:52:45.096144
NCT00268385|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2017-01-31|||December 2005||2005-12-01|October 2016|2016-10-01||||October 2011|Actual|2011-10-01||Interventional|||Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas|A Phase I Study of Vorinostat (Suberoylanilide Hydroxamic Acid [SAHA]) in Combination With Temozolomide in Patients With Malignant Gliomas|Active, not recruiting||Phase 1|83|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 16:52:45.250563|2017-02-18 16:52:45.250563
NCT00268372|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2012-10-03|||December 2005||2005-12-01|October 2012|2012-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx|A Phase III Trial of Standard Fractionation Radiation and Concurrent Single Agent Cisplatin, With and Without Docetaxel, Cisplatin, and 5-Fluorouracil Induction Chemotherapy, in Patients With Advanced Oropharyngeal Squamous Cell Cancer|Terminated||Phase 3|6|Actual|Southwest Oncology Group||2||SWOG eliminated its head and neck committee|f||||t||||||||||2017-02-18 16:52:45.403516|2017-02-18 16:52:45.403516
NCT00268359|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2014-07-18|||May 2005||2005-05-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|August 2006|Actual|2006-08-01||Interventional|||Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas|Bevacizumab in Combination With Irinotecan for Malignant Gliomas|Completed||Phase 2|68|Anticipated|Duke University|||||f||||||||||||||2017-02-18 16:52:45.694543|2017-02-18 16:52:45.694543
NCT00268346|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2015-12-04|2011-10-27||October 2005||2005-10-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer|A Phase II Trial of ZD1839 (IRESSA®) for Patients With Recurrent or Metastatic Cancer of the Esophagus or Gastroesophageal Junction|Completed||Phase 2|58|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:52:45.806145|2017-02-18 16:52:45.806145
NCT00268333|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2009-02-06|||August 2005||2005-08-01|May 2007|2007-05-01||||January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer|Phase II Study of Recurrent Ganglionic Colorectal Cancer Not Accessible By Surgery Treated Using Chemotherapy With Simplified FOLFOX7 Followed By Radiotherapy Combined With 5FU and Oxaliplatin|Completed||Phase 2|39|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:52:46.134182|2017-02-18 16:52:46.134182
NCT00268320|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2008-09-22|||January 2006||2006-01-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Clinical Investigation of the Medtronic Concerto™ Device|Clinical Investigation of the Medtronic Concerto™ Cardiac Resynchronization Therapy (CRT) and Implantable Cardioverter Defibrillator (ICD) Therapies (CRT+ICD Device)|Completed||N/A|270||Medtronic Cardiac Rhythm and Heart Failure|||||||||||||||||||2017-02-18 16:52:46.421664|2017-02-18 16:52:46.421664
NCT00268307|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2013-12-03|||December 2005||2005-12-01|December 2013|2013-12-01|September 2010|Actual|2010-09-01|January 2010|Actual|2010-01-01||Interventional|||Bone Marrow Stem Cell Infusion Following a Heart Attack|Cellular Transplantation of Autologous Bone Marrow-Derived Stem Cells Following Myocardial Infarction|Completed||Phase 1|41|Actual|Minneapolis Heart Institute Foundation||1|||f||||f||||||||||2017-02-18 16:52:46.571726|2017-02-18 16:52:46.571726
NCT00268294|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2008-12-16|||May 2003||2003-05-01|December 2008|2008-12-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Restoring Sinus Rhythm With Cardiac Resynchronization in Patients With Atrial Fibrillation (ReSync AF)|Restoring Sinus Rhythm With Cardiac Resynchronization in Patients With Atrial Fibrillation|Completed||N/A|20||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:52:46.685044|2017-02-18 16:52:46.685044
NCT00268281|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2006-10-11|||December 2004||2004-12-01|October 2006|2006-10-01|July 2005||2005-07-01|||||Interventional|||Left Ventricular Capture Management (LVCM) Software Download Clinical Trial|Left Ventricular Capture Management (LVCM) Software Download Clinical Trial|Completed||N/A|107||Medtronic Cardiac Rhythm and Heart Failure|||||||||||||||||||2017-02-18 16:52:46.770111|2017-02-18 16:52:46.770111
NCT00268255|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2013-04-12||||||April 2013|2013-04-01||||||||Interventional|||Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer|Phase I/II Study of Induction Gefitinib and Concurrent Radiotherapy in Patients With Previously Untreated, Medically Inoperable Stage I or II Non-Small Cell Lung Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|Barbara Ann Karmanos Cancer Institute||1||Study never moved forward with accrual.|f||||t||||||||||2017-02-18 16:52:46.866913|2017-02-18 16:52:46.866913
NCT00005440|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1992||1992-09-01|May 2000|2000-05-01|January 1997|Actual|1997-01-01|||||Observational|||Disability Among Adults With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.836255|2017-02-18 18:14:58.836255
NCT00268242|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2015-08-30|2015-06-03||January 2006||2006-01-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|||Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia|A Phase II Study of Gemcitabine/ Mitoxantrone in Patients With Acute Myeloid Leukemia in First Relapse|Terminated||Phase 2|24|Actual|The Cleveland Clinic|If </= 5 of 1st 18 pts had a CR, study would stop (otherwise, another 22 pts would be accrued). Study would stop if >4 of 1st 10 or 10 of 1st 25 pts had unacceptable toxicity per protocol & Common Toxicity Criteria for Adverse Effects (CTCAE) v3.0|1||"If </= 5 of the initial 18 patients had a CR, the study would be stopped. Only 5 patients~   (21%) of 24 enrolled patients had a CR so the study was terminated."|f||||f||||||||||2017-02-18 16:52:46.966517|2017-02-18 16:52:46.966517
NCT00268229|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2013-02-12|||July 2003||2003-07-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia|A Phase I Trial of Imatinib Mesylate (Gleevec, Formerly Known as STI571) in Combination With Daunorubicin and Cytarabine for C-kit Positive Relapsed AML|Completed||Phase 1|21|Actual|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 16:52:47.244429|2017-02-18 16:52:47.244429
NCT00268216|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2017-01-19|||September 2000||2000-09-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)|A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Long-term Effects of Salmeterol/Fluticasone Propionate (Seretide tm) 50/500mcg BD, Salmeterol 50mcg BD and Fluticasone Propionate 500mcg BD, All Delivered Via the Diskus tm/Accuhaler tm Inhaler, on Mortality and Morbidity of Subjects With Chronic Obstructive Pulmonary Disease (COPD) Over 3 Years of Treatment|Completed||Phase 3|6228|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:52:47.360965|2017-02-18 16:52:47.360965
NCT00268203|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2016-11-18|2013-10-10||September 1998||1998-09-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|March 2000|Actual|2000-03-01||Interventional|||Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma|Expanded Access Study of Iodine I 131 Tositumomab for Relapsed/Refractory Low-Grade and Transformed Low-Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|765|Actual|GlaxoSmithKline|||||||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:52:48.058798|2017-02-18 16:52:48.058798
NCT00268177|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2016-09-13|||October 2002||2002-10-01|September 2016|2016-09-01|December 2003|Actual|2003-12-01|||||Interventional|||Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease|A 13-week, Double-blind, Parallel Group, Multi-centre Study to Compare the Bronchial Anti-inflammatory Activity of the Combination of Salmeterol/Fluticasone Propionate 50/500mcg Twice Daily Compared With Placebo Twice Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|130||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:52:49.174604|2017-02-18 16:52:49.174604
NCT00268164|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2015-05-05|||June 2004||2004-06-01|September 2006|2006-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis|Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis|Terminated||Phase 2|48||Hvidovre University Hospital||||Inclusion was difficult and to slow|f||||||||||||||2017-02-18 16:52:49.302167|2017-02-18 16:52:49.302167
NCT00268151|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2013-05-02|||February 2005||2005-02-01|May 2013|2013-05-01||||February 2007|Actual|2007-02-01||Interventional|||Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer|Phase I Study of Oxaliplatin (Eloxatin) and Capecitabine (Xeloda) and Concurrent Radiation Therapy (XELOX-RT) in Non-Small Cell Lung Cancer|Terminated||Phase 1|24||James Graham Brown Cancer Center||||Study was terminated due to lack of funding.|f||||||||||||||2017-02-18 16:52:49.385944|2017-02-18 16:52:49.385944
NCT00268138|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2009-02-17|||April 2006||2006-04-01|December 2005|2005-12-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Elmex Gel Efficacy in Preventing White Spot Lesions|Phase 4 Study Prevention of Incipient Carious Lesions (White Spot Lesions) in Patients With Fixed Orthodontic Appliances Following the Application of Elmex Gel|Unknown status|Recruiting|Phase 4|314|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 16:52:49.486302|2017-02-18 16:52:49.486302
NCT00268125|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2009-03-17|||February 2006||2006-02-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.|Evaluation of Acupression's Bracelets Associated to an Educational Step Versus Education Only in Nausea and Vomiting's Mastering Induced by FEC100 Chemotherapy's Sort.|Completed||Phase 3|347|Anticipated|Institut Claudius Regaud|||||f||||||||||||||2017-02-18 16:52:49.581694|2017-02-18 16:52:49.581694
NCT00268112|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-03-14|||January 2004||2004-01-01|December 2006|2006-12-01|December 2006|Actual|2006-12-01|||||Observational|||Resynchronization of Left Ventricular Contraction After Reimplantation of Anomalous Left Coronary Artery|Resynchronization of Left Ventricular Contraction After Re-implantation of Anomalous Left Coronary Artery From the Pulmonary Artery (ALCAPA) Evaluated by Tissue Doppler Imaging|Terminated||N/A|3|Actual|Children's Healthcare of Atlanta|||1|sufficient data collected for analysis|f||||f||||||||||2017-02-18 16:52:49.673418|2017-02-18 16:52:49.673418
NCT00268099|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-03-15|||May 2005||2005-05-01|June 2007|2007-06-01|November 2006|Actual|2006-11-01|||||Observational|||Optimal Timing for Repair of Right-to-Left Shunt Lesions|Optimal Timing for Repair of Right-to-Left Shunt Lesions|Terminated||N/A|75|Anticipated|Children's Healthcare of Atlanta|||1|study not started|f||||f||||||||||2017-02-18 16:52:49.748461|2017-02-18 16:52:49.748461
NCT00268086|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2007-06-12||||||June 2007|2007-06-01||||||||Observational|||Constrictive Pericarditis in the Adult Congenital Cardiac Population|Constrictive Pericarditis in the Adult Congenital Cardiac Population|Terminated||N/A|15||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:52:49.932979|2017-02-18 16:52:49.932979
NCT00268073|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2007-05-03|||January 2002||2002-01-01|May 2007|2007-05-01||||||||Observational|||Incidence of Neo-Aortic Insufficiency|Comparison of the Incidence of Neo-Aortic Insufficiency After Classic Norwood I and Norwood I-Sano Procedures|Terminated||N/A|||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:52:50.014704|2017-02-18 16:52:50.014704
NCT00268047|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2011-07-05||||||July 2011|2011-07-01||||||||Observational|||Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation|Retrospective Assessment of Pulmonary Vascular Resistance in Fontan Patients Who Have Undergone Orthotopic Heart Transplantation|Terminated||N/A|50|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 16:52:50.186466|2017-02-18 16:52:50.186466
NCT00268034|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2007-05-03|||June 2002||2002-06-01|May 2007|2007-05-01||||||||Observational|||Left Ventricular Aneurysms in Children|Left Ventricular Aneurysms in Children|Terminated||N/A|5||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:52:50.262821|2017-02-18 16:52:50.262821
NCT00268021|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2014-11-26|||January 1998||1998-01-01|November 2014|2014-11-01||||||||Observational|||Automated Cardioverter Defibrillator in Children|The Use of Automated Cardioverter Defibrillator in Children (AICD)|Completed||N/A|34|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 16:52:50.346191|2017-02-18 16:52:50.346191
NCT00268008|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2007-05-03|||January 1976||1976-01-01|May 2007|2007-05-01||||||||Observational|||Children and Adolescents Receiving Mechanical and Prosthetic Valves|Retrospective Review of Children and Adolescents Receiving Mechanical and Prosthetic Valves in the Aortic and Mitral Position 1976-2002|Terminated||N/A|300||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:52:50.42555|2017-02-18 16:52:50.42555
NCT00267995|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2011-07-05|||December 1994||1994-12-01|May 2007|2007-05-01||||||||Observational|||Ross Aortic Valve Replacement Patients|Proposal for Retrospective Review of Ross Aortic Valve Replacement Patients|Terminated||N/A|75|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 16:52:50.497941|2017-02-18 16:52:50.497941
NCT00267982|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2011-07-05|||August 1992||1992-08-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|August 2003|Actual|2003-08-01||Observational|||Radiofrequency Ablation of Ectopic Atrial Tachycardia|A Retrospective Review of Outcomes Related to Radiofrequency Ablation of Ectopic Atrial Tachycardia|Terminated||N/A|25|Actual|Children's Healthcare of Atlanta|||1|significant conclusive data has been collected|f||||f||||||||||2017-02-18 16:52:50.575185|2017-02-18 16:52:50.575185
NCT00267969|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2013-06-10|2009-10-23||December 2005||2005-12-01|June 2013|2013-06-01|May 2011|Actual|2011-05-01|July 2006|Actual|2006-07-01||Interventional|PHOENIX1||A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis|A Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Trial Evaluating the Efficacy and Safety of Ustekinumab (CNTO 1275) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis|Completed||Phase 3|766|Actual|Centocor Research & Development, Inc.|The count of patients with any nonserious adverse event (NAE) excludes patients who only had NAE that occured in <=5% of patients. This information may vary from existing approved labeling and publications due to the requirements of this website.|3|||f||||t||||||||||2017-02-18 16:52:50.6876|2017-02-18 16:52:50.6876
NCT00267956|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2013-05-30|2009-10-23||December 2005||2005-12-01|May 2013|2013-05-01|September 2007|Actual|2007-09-01|March 2007|Actual|2007-03-01||Interventional|||An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of CNTO 1275, a Fully Human Anti-IL-12 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis|Completed||Phase 2|146|Actual|Centocor, Inc.|The count of patients with any nonserious adverse event (NAE) excludes patients who only had NAE that occured in <= 5% of patients. This information may vary from existing approved labeling and publications due to the requirements of this website.|2|||f||||t||||||||||2017-02-18 16:52:55.115787|2017-02-18 16:52:55.115787
NCT00267943|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2013-11-12|||January 2006||2006-01-01|November 2013|2013-11-01|January 2007||2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients|An Open-label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Fixed Dose Combination of Telmisartan 80 mg + Hydrochlorothiazide 25 mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension.|Completed||Phase 3|639||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:52:55.903319|2017-02-18 16:52:55.903319
NCT00267930|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2008-12-17|||December 2005||2005-12-01|December 2008|2008-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence|A Pilot Phase II, Randomised, Double-Blind, Placebo-Controlled, Multi-Centred Safety, Tolerability and Preliminary Efficacy Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter (AF/AFL) Recurrence in Subjects Post-Conversion Form AF|Completed||Phase 2|221|Actual|Cardiome Pharma||3|||f||||f||||||||||2017-02-18 16:52:56.075783|2017-02-18 16:52:56.075783
NCT00267917|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2013-10-28|||January 2006||2006-01-01|October 2013|2013-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.|A Randomised Open Label, Four Way, Cross-over Scintigraphic Evaluation of the Respimat Inhaler vs. a Metered Dose Inhaler (HFA-MDI) Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Poor MDI Technique.|Completed||Phase 4|13||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:52:56.201445|2017-02-18 16:52:56.201445
NCT00267904|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2017-01-24|||December 14, 2005||2005-12-14|October 6, 2016|2016-10-06||||||||Observational|||Reference Values for Plasma Catechols|Reference Values for Plasma Catechols|Recruiting||N/A|53|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:52:56.292002|2017-02-18 16:52:56.292002
NCT00267891|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2017-01-24|||December 14, 2005||2005-12-14|August 12, 2010|2010-08-12|August 12, 2010||2010-08-12|||||Observational|||Brain Changes in Adolescents While Imagining and Observing Aggressive Behavior|Changes in Activation Patterns in the Ventro-Medial Prefrontal Cortex of Healthy Adolescents During the Imagination and Observation of Aggressive Behavior|Completed||N/A|88|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:52:56.387418|2017-02-18 16:52:56.387418
NCT00267865|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-21|2017-01-24|||December 15, 2005||2005-12-15|September 26, 2016|2016-09-26|July 31, 2021|Anticipated|2021-07-31|July 31, 2018|Anticipated|2018-07-31||Interventional|||Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma|AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy|Recruiting||Phase 2|28|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:52:56.474616|2017-02-18 16:52:56.474616
NCT00267449|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-09-10|||November 2005||2005-11-01|September 2007|2007-09-01||||||||Observational|||Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System|Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System|Unknown status|Recruiting|Phase 3|950|Anticipated|ART Advanced Research Technologies Inc.|||||f||||||||||||||2017-02-18 16:53:03.039074|2017-02-18 16:53:03.039074
NCT00267852|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2011-09-14|||April 2006||2006-04-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|ARPA||Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis|An Observational Study To Evaluate The Clinical Remission In Early Aggressive Rheumatoid Arthritis (Artrite Reumatoide Precoce Aggressiva Italian Study)|Completed||Phase 4|152|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||t||||||||||2017-02-18 16:52:56.701675|2017-02-18 16:52:56.701675
NCT00267839|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2015-05-29|||January 2006||2006-01-01|May 2015|2015-05-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Exercise on Risk-factors of Elderly Women|Effects of Exercise on Multiple Risk Factors and Health Costs in Community Living Elderly Women. The Senior Fitness and Prevention Study (SEFIP)|Terminated||Phase 3|246|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||||||||||||2017-02-18 16:52:56.83057|2017-02-18 16:52:56.83057
NCT00267826|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2008-06-16|||December 2005||2005-12-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Interventional|||Immunopharmacological Effects of Rituximab in Atopic Dermatitis|Open-Label, Single Center Study to Evaluate the Immunopharmacological Effects of Rituximab in Patients With Atopic Dermatitis|Completed||N/A|6|Actual|University of Bern||1|||f||||f||||||||||2017-02-18 16:52:56.942159|2017-02-18 16:52:56.942159
NCT00267813|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2008-05-06|||July 2004||2004-07-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers|The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers.|Completed||N/A|24|Actual|Tel-Aviv Sourasky Medical Center||1|||f||||f||||||||||2017-02-18 16:52:57.054522|2017-02-18 16:52:57.054522
NCT00267800|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2008-08-07|||January 2006||2006-01-01|December 2005|2005-12-01||||||||Observational|||Database of Interstitial Lung Diseases|Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD)|Unknown status|Active, not recruiting|N/A|100000||St. Antonius Hospital|||||f||||||||||||||2017-02-18 16:52:57.144901|2017-02-18 16:52:57.144901
NCT00267787|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2012-07-05|||September 2004||2004-09-01|July 2012|2012-07-01|December 2013|Anticipated|2013-12-01|December 2012|Anticipated|2012-12-01||Observational|||Molecular Genetic and Pathological Studies of Anal Tumors|Molecular Genetic and Pathological Studies of Anal Tumors|Unknown status|Recruiting|N/A|300|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 16:52:57.224987|2017-02-18 16:52:57.224987
NCT00267774|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2016-06-17|2016-06-17||January 2006||2006-01-01|June 2016|2016-06-01|September 2015|Actual|2015-09-01|September 2008|Actual|2008-09-01||Interventional|||Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)||Completed||N/A|1005|Actual|Stanford University||2|||f||||||||||||||2017-02-18 16:52:57.503499|2017-02-18 16:52:57.503499
NCT00267748|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2011-08-03|2011-06-23||December 2005||2005-12-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)|A Randomized Phase II Study Of The Efficacy And Safety Of Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (Renal EFFECT Trial)|Completed||Phase 2|317|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 16:52:57.800906|2017-02-18 16:52:57.800906
NCT00267735|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2006-09-08|||January 2006||2006-01-01|December 2005|2005-12-01||||||||Interventional|||Measuring Preferences for Childbirth After Cesarean|Measuring Preferences for Childbirth After Cesarean|Unknown status|Recruiting|N/A|120||Oregon Health and Science University|||||f||||||||||||||2017-02-18 16:52:59.037091|2017-02-18 16:52:59.037091
NCT00267722|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2012-03-06|||February 2005||2005-02-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease|A Phase 2a, Open-label Study of Visilizumab in Patients With Moderate-to-Severe Inflammatory, Nonstricturing, Nonpenetrating Forms of Crohn's Disease|Completed||Phase 2|18||Facet Biotech|||||f||||||||||||||2017-02-18 16:52:59.120049|2017-02-18 16:52:59.120049
NCT00267709|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2012-03-06|||February 2005||2005-02-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease|A Phase 2a, Open-label Study of Visilizumab for Treatment of Perianal Fistulas in Patients With Crohn's Disease|Completed||Phase 2|18||Facet Biotech|||||f||||||||||||||2017-02-18 16:52:59.214112|2017-02-18 16:52:59.214112
NCT00267696|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2015-04-28|2015-02-09||November 2005||2005-11-01|April 2015|2015-04-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer|A Phase II Study of Gemcitabine/Carboplatin/Bevacizumab in Platinum Sensitive Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients.|Completed||Phase 2|45|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:52:59.305971|2017-02-18 16:52:59.305971
NCT00267683|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2016-03-03|||December 2005||2005-12-01|March 2016|2016-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes|A Clinical Trial to Study the Efficacy and Safety of Insulin Aspart Three Times Per Day Compared to Glibenclamide Once or Twice Daily in Type 2 Diabetes by Comparison of Ability to Control Blood Glucose|Terminated||Phase 3|9|Actual|Novo Nordisk A/S||||This trial was terminated due to low recruitment|f||||f||||||||||2017-02-18 16:52:59.891768|2017-02-18 16:52:59.891768
NCT00267670|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2014-08-27|2011-01-13||March 2005||2005-03-01|August 2014|2014-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH|The Effect of Pentoxifylline on Nonalcoholic Steatohepatitis (NASH)|Completed||Phase 2/Phase 3|26|Actual|Northwestern University|The most significant limitation of this study is the small sample size, thus the lack of statistical significance may be due to low power.|2|||f||||f||||||||||2017-02-18 16:52:59.989094|2017-02-18 16:52:59.989094
NCT00267657|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2017-01-10|||January 2004||2004-01-01|December 2005|2005-12-01|November 2004||2004-11-01|||||Interventional|||A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1|Assessment of Interactions Between IV Methamphetamine and Reserpine|Unknown status|Active, not recruiting|Phase 1|30||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 16:53:00.508228|2017-02-18 16:53:00.508228
NCT00265590|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2017-01-24|||December 7, 2005||2005-12-07|October 3, 2008|2008-10-03|October 3, 2008||2008-10-03|||||Observational|||Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia|Phenotype-Genotype Correlation in Aniridia|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:53:54.891823|2017-02-18 16:53:54.891823
NCT00267644|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2013-04-18|2013-02-27||December 2005||2005-12-01|April 2013|2013-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Ultrasound of the Inferior Vena Cava (IVC) and Dehydration Status in Pediatric Emergency Patients|Ultrasound of the Inferior Vena Cava (IVC) and Dehydration Status in Pediatric Emergency Patients|Completed||Phase 2|76|Actual|Maimonides Medical Center|||2||f||||t||||||||||2017-02-18 16:53:00.600618|2017-02-18 16:53:00.600618
NCT00267631|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2013-07-29|2013-02-27||April 2005||2005-04-01|July 2013|2013-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Impact of Body Weight on the Immediate Health of the Pediatric Population|The Influence of Childhood Obesity on Presentation to a Pediatric Emergency Department|Completed||Early Phase 1|5392|Actual|Maimonides Medical Center|||2||f||||f||||||||||2017-02-18 16:53:00.987407|2017-02-18 16:53:00.987407
NCT00267618|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2015-06-15|||June 2004||2004-06-01|June 2015|2015-06-01|April 2008|Actual|2008-04-01|June 2007|Actual|2007-06-01||Interventional|||Family Help Program: Pediatric Recurrent Headache and Abdominal Pain|Family Help Program: Primary Care Delivery by Telephone for Psychological and Behavioural Problems (Pediatric Recurrent Headache and Abdominal Pain)|Completed||Phase 2|10|Actual|IWK Health Centre||2|||f||||f||||||||||2017-02-18 16:53:01.34816|2017-02-18 16:53:01.34816
NCT00267605|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2013-03-27|||June 2003||2003-06-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|June 2006|Actual|2006-06-01||Interventional|FHPADHD||Strongest Families (Formerly Family Help Program): Pediatric Attention Deficit/Hyperactivity Disorder|Strongest Families (Formerly Family Help Program): Primary Care Delivery by Telephone for Psychological and Behavioural Problems (Pediatric Attention Deficit/Hyperactivity Disorder)|Completed||Phase 2|72|Actual|IWK Health Centre||2|||f||||f||||||||||2017-02-18 16:53:01.46802|2017-02-18 16:53:01.46802
NCT00267592|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2016-04-20||2011-08-16|December 2005||2005-12-01|April 2016|2016-04-01|February 2011|Actual|2011-02-01|September 2008|Actual|2008-09-01||Interventional|||Safety and Efficacy of Talampanel in Glioblastoma Multiforme|A Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Concurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|72|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 16:53:01.588098|2017-02-18 16:53:01.588098
NCT00267579|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2013-03-27|||October 2003||2003-10-01|March 2013|2013-03-01|April 2008|Actual|2008-04-01|September 2006|Actual|2006-09-01||Interventional|||Strongest Families (Formerly Family Help Program): Pediatric Disruptive Behaviour Disorder|Strongest Families (Formerly Family Help Program):Primary Care Delivery by Telephone for Psychological and Behavioural Problems (Pediatric Disruptive Behaviour Disorder)|Completed||Phase 2|80|Actual|IWK Health Centre||2|||f||||f||||||||||2017-02-18 16:53:01.682068|2017-02-18 16:53:01.682068
NCT00267566|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2013-09-11|||August 2003||2003-08-01|September 2013|2013-09-01|April 2008|Actual|2008-04-01|September 2007|Actual|2007-09-01||Interventional|FHP-ANX||Strongest Families (Formerly Family Help Program): Pediatric Anxiety|Strongest Families (Formerly Family Help Program): Primary Care Delivery by Telephone for Psychological and Behavioural Problems (Pediatric Anxiety)|Completed||Phase 2|91|Actual|IWK Health Centre||2|||f||||f||||||||||2017-02-18 16:53:01.792183|2017-02-18 16:53:01.792183
NCT00267553|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2007-09-07|||November 2005||2005-11-01|September 2007|2007-09-01|June 2006|Actual|2006-06-01|||||Interventional|||Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer|Open Label Treatment and Survival Continuation Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer|Terminated||Phase 3|200||Intarcia Therapeutics||||This was a follow-on study to Biomed 777-CLP-029 which did not meet superiority endpoint|||||||||||||||2017-02-18 16:53:01.909096|2017-02-18 16:53:01.909096
NCT00267540|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2008-01-29|||January 2001||2001-01-01|January 2008|2008-01-01|December 2003||2003-12-01|||||Interventional|||The Effect of Vitamin D on Bone Accretion and Turn-Over in Young Girls|Adolescent Girls-Impact of Vitamin D on Bone Accretion Work Package 1 (Danish Part) of OPTIFORD (Towards A Strategy for Optimal Vitamin D Fortification)|Completed||N/A|225||University of Copenhagen|||||f||||||||||||||2017-02-18 16:53:02.051857|2017-02-18 16:53:02.051857
NCT00267527|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2006-10-12|||December 2005||2005-12-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity|A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study to Evaluate the Efficacy and Safety of CJC 1295 Administered for 12 Weeks in HIV Infected Patients With HIV Associated Visceral Obesity|Terminated||Phase 2|120||ConjuChem|||||||||||||||||||2017-02-18 16:53:02.14662|2017-02-18 16:53:02.14662
NCT00267514|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2015-03-17|||January 2006||2006-01-01|March 2015|2015-03-01|May 2007|Actual|2007-05-01|March 2007|Actual|2007-03-01||Interventional|||Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients|A Randomized, Cross-over Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Haemodialysis Patients|Completed||Phase 3|31|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:53:02.218456|2017-02-18 16:53:02.218456
NCT00267501|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2015-11-10|||May 2005||2005-05-01|September 2014|2014-09-01|January 2050|Anticipated|2050-01-01|January 2050|Anticipated|2050-01-01||Observational|||Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders|Eosinophils and Inflammation, an Expanded Study|Recruiting||N/A|5000|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-02-18 16:53:02.323479|2017-02-18 16:53:02.323479
NCT00267488|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-06-28|2008-12-05||October 2005||2005-10-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer|An Open-label, Phase II, Multicenter Study of Intravenous Weekly Topotecan in Subjects With Recurrent or Persistent Endometrial Cancer|Completed||Phase 2|70|Actual|GlaxoSmithKline|As there was only 1 responder, time to response, and duration of response were not calculated.||||||||f||||||||||2017-02-18 16:53:02.424255|2017-02-18 16:53:02.424255
NCT00267475|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2013-09-17|||May 2001||2001-05-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Data Bank for Eosinophilic Disorders|Clinical and Immunological Evaluation of Eosinophil Associated Gastrointestinal Disorders (EGID)|Completed||N/A|500|Anticipated|Children's Hospital Medical Center, Cincinnati|||1||f||||||||||||||2017-02-18 16:53:02.877711|2017-02-18 16:53:02.877711
NCT00267462|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-05-03|||January 1996||1996-01-01|May 2007|2007-05-01||||||||Observational|||Hypertrophic Myopathy in Children|Retrospective Review of Hypertrophic Myopathy in Children|Terminated||N/A|75||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:53:02.959546|2017-02-18 16:53:02.959546
NCT00005439|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1992||1992-04-01|May 2000|2000-05-01|March 1997|Actual|1997-03-01|||||Observational|||Evaluation of Childhood Blood Pressure and Lipid Screening||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:58.897599|2017-02-18 18:14:58.897599
NCT00267436|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-04-12|||July 2006||2006-07-01|April 2012|2012-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS|Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE Positives Leading and Utilizing Strategies (ADAPT CP PLUS)|Completed||Phase 1/Phase 2|574|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-02-18 16:53:03.133101|2017-02-18 16:53:03.133101
NCT00267423|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-05-02|||January 2002||2002-01-01|May 2007|2007-05-01||||||||Observational|||Biventricular Pacing in the Pediatric Population|A Single Center, Retrospective Study of the Safety and Feasibility of Epicardial Biventricular Pacing in the Pediatric Population|Terminated||N/A|12||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 16:53:03.228279|2017-02-18 16:53:03.228279
NCT00267410|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-20|2012-09-10|||November 2005||2005-11-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center|Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center|Completed||N/A|33|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-02-18 16:53:03.315416|2017-02-18 16:53:03.315416
NCT00267397|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-05-02|||January 1967||1967-01-01|May 2007|2007-05-01|December 2006||2006-12-01|||||Observational|||Prevalence and Clinical Spectrum of the 22q11 Deletion|Prevalence and Clincial Spectrum of the 22q11 Deletion: A Population Based Study of Children and Congenital Heart Defects|Terminated||N/A|||Children's Healthcare of Atlanta||||sufficient data collected|f||||f||||||||||2017-02-18 16:53:03.410577|2017-02-18 16:53:03.410577
NCT00267384|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2012-06-19|||March 2006||2006-03-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|May 2008|Actual|2008-05-01||Interventional|||N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity||Completed||Phase 2/Phase 3|||Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:53:03.661294|2017-02-18 16:53:03.661294
NCT00267371|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2016-08-23||2014-03-31|November 2005||2005-11-01|August 2016|2016-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||ESCAPE Migraine Trial|Effect of Septal Closure of Atrial PFO on Events of Migraine With Premere: ESCAPE Migraine Trial|Terminated||Phase 3|168|Actual|St. Jude Medical||2||Insufficient enrollment|f||||t||||||||||2017-02-18 16:53:03.756628|2017-02-18 16:53:03.756628
NCT00267358|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2013-08-30|||November 2005||2005-11-01|August 2013|2013-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.||Completed||Phase 2|||Helsinn Therapeutics (U.S.), Inc||2|||||||||||||||||2017-02-18 16:53:03.90475|2017-02-18 16:53:03.90475
NCT00265070|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2013-02-04|||January 2003||2003-01-01|February 2013|2013-02-01|August 2011|Actual|2011-08-01|||||Interventional|||Trial of Iressa in Prostate Cancer Patients|An Open-Label, Phase II Trial Of 250 mg ZD1839 (IRESSA™) In Prostate Cancer Patients With Early Biochemical Failure Post Prostatectomy|Completed||Phase 2|80|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:53:04.013671|2017-02-18 16:53:04.013671
NCT00265057|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2010-12-27|||June 2005||2005-06-01|December 2010|2010-12-01|January 2008|Actual|2008-01-01|||||Interventional|||Study of ADH-1 Given Intravenously to Patients With Solid Tumors|Dose Finding, Safety, Pharmacokinetic and Pharmacodynamic Study of the Vascular Targeting Agent Exherin™ (ADH-1) Administered Once Weekly in 3 Week Cycles by Intravenous Infusion in Patients With N-Cadherin Expressing, Incurable, Solid Tumors (Adherex Protocol Number AHX-01-004)|Completed||Phase 1/Phase 2|||Adherex Technologies, Inc.|||||||||||||||||||2017-02-18 16:53:04.116635|2017-02-18 16:53:04.116635
NCT00265044|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2015-04-06|||January 2004||2004-01-01|May 2006|2006-05-01|December 2004|Actual|2004-12-01|||||Interventional|||Improving Practice Patterns for the Treatment of Hypertension|Innovations to Implementing Evidence-based Clinical Practice|Completed||N/A|1300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 16:53:04.208012|2017-02-18 16:53:04.208012
NCT00265031|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2012-06-22|||January 1999||1999-01-01|August 2007|2007-08-01||||||||Interventional|||HD12 for Advanced Stages||Completed||Phase 3|||University of Cologne|||||f||||||||||||||2017-02-18 16:53:04.319205|2017-02-18 16:53:04.319205
NCT00265018|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2011-07-28|||May 1998||1998-05-01|July 2011|2011-07-01||||January 2003|Actual|2003-01-01||Interventional|||HD10 for Early Stages||Completed||Phase 3|1370|Actual|University of Cologne||4|||f||||||||||||||2017-02-18 16:53:04.406059|2017-02-18 16:53:04.406059
NCT00265005|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2016-03-08|||June 2005||2005-06-01|December 2015|2015-12-01|December 2012|Actual|2012-12-01|December 2009|Actual|2009-12-01||Interventional|||Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants|Dose-Ranging, Safety And Efficacy Of Cathflo(TM) Activase(R) (Alteplase) For The Treatment Of Central Catheter Occlusion In Neonates And Infants; Phase I|Terminated||Phase 1|12|Actual|University of Louisville||1||difficulty in recruiting subjects|f||||t||||||||||2017-02-18 16:53:04.510551|2017-02-18 16:53:04.510551
NCT00264992|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-05-27|||January 2006||2006-01-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Implantation and Cytokine Expression|The Cytokine Paired Footprint of Successful Implantation|Completed||N/A|160||UMC Utrecht|||||f||||||||||||||2017-02-18 16:53:04.629808|2017-02-18 16:53:04.629808
NCT00264979|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2017-02-14|||December 2005||2005-12-01|February 2017|2017-02-01|December 2019|Anticipated|2019-12-01|June 2017|Anticipated|2017-06-01||Interventional|METASYNC||Evaluation of 2 Resection Strategies of Synchronous Colorectal Cancer Metastases|Prospective Randomized Study Comparing the Morbidity and Mortality After Liver Resection for Synchronous Colorectal Cancer Metastases When Performed Either During or 12 to 14 Weeks After the Primary Resection|Recruiting||N/A|222|Anticipated|Rennes University Hospital||2|||f||||t||||||||||2017-02-18 16:53:04.719229|2017-02-18 16:53:04.719229
NCT00264966|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2012-11-30|||December 2005||2005-12-01|November 2012|2012-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Multiple Dose ASM8 in Mild Asthmatics|A Double-blind, Placebo-controled, Crossover Study To Evaluate the Efficacy, Safety and Tolerability of Inhaled ASM8-003 in Subjects With Mild Allergic Asthma.|Completed||Phase 1/Phase 2|15||Pharmaxis|||||f||||f||||||||||2017-02-18 16:53:04.891807|2017-02-18 16:53:04.891807
NCT00264953|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2011-08-03|||May 1998||1998-05-01|July 2011|2011-07-01||||January 2003|Actual|2003-01-01||Interventional|||HD11 for Intermediate Stages||Completed||Phase 3|1395|Actual|University of Cologne||4|||f||||||||||||||2017-02-18 16:53:04.98869|2017-02-18 16:53:04.98869
NCT00264940|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2005-12-12||||||December 2005|2005-12-01||||||||Observational|||Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index.||Unknown status|Not yet recruiting|N/A|||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 16:53:05.099064|2017-02-18 16:53:05.099064
NCT00264927|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2008-12-09|||May 2004||2004-05-01|December 2008|2008-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|SIADH||Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion|A Randomized, Double-Blind, Placebo-Group, Multicenter Study Evaluating the Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion|Completed||Phase 3|77|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:53:05.165758|2017-02-18 16:53:05.165758
NCT00264914|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2009-01-19|||July 2005||2005-07-01|January 2009|2009-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|SIADH Safety||Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion|An Open-Label, Multicenter Study Evaluating the Long-Term Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion|Completed||Phase 3|57|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:53:05.272247|2017-02-18 16:53:05.272247
NCT00264901|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2017-01-30|||October 2005||2005-10-01|January 2017|2017-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|PREDICTIVE™||Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes|Impact of a Self-Adjusted Titration Guideline in Subjects With Type 2 Diabetes Mellitus: A Treat-to-Target of the Efficacy and Safety of Levemir® (Insulin Detemir [rDNA Origin] Injection) (PREDICTIVE™ 303)|Completed||Phase 4|5652|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:53:05.384358|2017-02-18 16:53:05.384358
NCT00264888|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2009-01-09|||December 2005||2005-12-01|January 2009|2009-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy|A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy|Completed||Phase 2|38||PTC Therapeutics|||||f||||||||||||||2017-02-18 16:53:05.490706|2017-02-18 16:53:05.490706
NCT00264875|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2009-03-20|2009-02-20||February 2006||2006-02-01|March 2009|2009-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy|An Open-Label, Extension Safety And Efficacy Trial Of Pregabalin In Subjects With Neuropathic Pain Associated With Human Immunodeficiency Virus (HIV) Neuropathy|Completed||Phase 3|220|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:53:05.583088|2017-02-18 16:53:05.583088
NCT00267345|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-02-28|||March 2005||2005-03-01|January 2006|2006-01-01|October 2007||2007-10-01|||||Observational|||Measurement of Hormonal Concentration in Chylothorax Fluid in Infants With Congenital Chylothorax||Unknown status|Recruiting|N/A|15||Sheba Medical Center|||||f||||t||||||||||2017-02-18 16:53:05.844165|2017-02-18 16:53:05.844165
NCT00267332|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2007-04-23|||January 2006||2006-01-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Modafinil in Opioid Induced Sedation|A Randomized Double-Blinded, Placebo Controlled, Crossover Trial Examining the Effectiveness of Modafinil in Opioid Induced Sedation|Terminated||Phase 3|90||Sidney Kimmel Comprehensive Cancer Center||||Low accrual|f||||||||||||||2017-02-18 16:53:05.923551|2017-02-18 16:53:05.923551
NCT00267319|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2009-12-04|||June 2003||2003-06-01|December 2009|2009-12-01||||October 2006|Actual|2006-10-01||Interventional|||FOCUS Fatigue Outcome in Copaxone USers|Fatigue Outcomes of Copaxone Users in Relapsing-remitting Multiple Sclerosis|Completed||Phase 4|111|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:53:06.010992|2017-02-18 16:53:06.010992
NCT00267306|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2012-03-08|||January 2004||2004-01-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis|A Phase 1/2, Partially Randomized, Open-Label Study of Visilizumab in Patients With Severe Ulcerative Colitis Refractory to Intravenous Corticosteroids|Completed||Phase 1/Phase 2|144||Facet Biotech|||||f||||||||||||||2017-02-18 16:53:06.109021|2017-02-18 16:53:06.109021
NCT00267293|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2012-05-08|2011-07-22||January 2006||2006-01-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever|Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever|Completed||Phase 4|60|Actual|Penn State University|Relatively small sample size. Underpowered to evaluate effect oon discomfort and pain. The 6 hour observation allowed for evaluation of single cycle of drug. Did not evaluate the effect of multiple doses over a longer observation period.|3|||f||||f||||||||||2017-02-18 16:53:06.219425|2017-02-18 16:53:06.219425
NCT00267280|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2012-02-15||2012-02-15|January 2006||2006-01-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).|A Phase 3, Open-Label, Multisite, Randomized, Parallel Group Study of the Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin Administered Once Daily (QD) Compared to Simvastatin for 6 Weeks in Subjects With Hypercholesterolemia (A5091031)|Terminated||Phase 3|640||Pfizer|||||f||||||||||||||2017-02-18 16:53:06.665551|2017-02-18 16:53:06.665551
NCT00267267|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-12-06|||January 2006||2006-01-01|December 2006|2006-12-01|January 2007|Actual|2007-01-01|||||Interventional|||A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.|Phase 3, Open-Label, Multi-Center, Double-Blind, Randomized, Parallel Group Study Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin, Administered Once Daily (QD) Compared to Fixed Combination Ezetimibe/Simvastatin for 6 Weeks in Subjects With Dyslipidemia.|Terminated||Phase 3|1784||Pfizer|||||||||||||||||||2017-02-18 16:53:06.913242|2017-02-18 16:53:06.913242
NCT00267254|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-11-20|||January 2006||2006-01-01|April 2007|2007-04-01|August 2006|Actual|2006-08-01|||||Interventional|||A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.|A Phase 3, Open-Label, Multisite, Randomized, Parallel Group Study of the Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin Administered Once Daily (QD) Compared to Simvastatin for 6 Weeks in Subjects With Hypercholesterolemia (A5091030)|Completed||Phase 3|640||Pfizer|||||||||||||||||||2017-02-18 16:53:07.340043|2017-02-18 16:53:07.340043
NCT00267241|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2015-04-27|||December 2005||2005-12-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Effects of Different Assisted Mechanical Ventilation in Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS) Patients|Effects of Different Assisted Mechanical Ventilation in ALI/ARDS Patients|Completed||N/A|20|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 16:53:07.502104|2017-02-18 16:53:07.502104
NCT00267228|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-03-22|||February 2006||2006-02-01|March 2007|2007-03-01||||||||Observational|||Funen Anorexia Nervosa Study - Retrospective Cohort Study and 10 Year Follow-up Study||Unknown status|Active, not recruiting|Phase 1|||Odense University Hospital|||||f||||f||||||||||2017-02-18 16:53:07.609616|2017-02-18 16:53:07.609616
NCT00267215|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2012-05-18|||November 2000||2000-11-01|May 2012|2012-05-01||||February 2001|Actual|2001-02-01||Interventional|||Efficacy and Safety of Lumiracoxib|A One-week Multicenter, Multiple-dose, Randomized, Double-blind, Double-dummy, Parallel-group Comparison of the Analgesic Efficacy and Safety of Lumiracoxib (COX189), Celecoxib, and Placebo in the Treatment of Osteoarthritis of the Knee|Completed||Phase 3|330||Novartis|||||||||||||||||||2017-02-18 16:53:07.690691|2017-02-18 16:53:07.690691
NCT00267202|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2016-08-02|2010-11-22||December 2005||2005-12-01|October 2011|2011-10-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma|A 26-week, Randomized, Double-blind, Parallel-group, Placebo-controlled,Multi-center Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids|Completed||Phase 4|275|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:53:07.787748|2017-02-18 16:53:07.787748
NCT00267189|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2011-04-11|2010-12-20||November 2005||2005-11-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency|A 6-month, Multicenter, Randomized, Open-label Study of Safety and Efficacy of Everolimus-based Regimen Versus Calcineurin Inhibitor (CNI)-Based Regimen in Maintenance Liver Transplant Recipients|Completed||Phase 3|145|Actual|Novartis||2|||f||||t||||||||||2017-02-18 16:53:08.394167|2017-02-18 16:53:08.394167
NCT00267176|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2017-02-03|||November 2005||2005-11-01|February 2017|2017-02-01||||September 2006|Actual|2006-09-01||Interventional|||Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension|A 4-week, Multicentre, Randomized, Double-blind, Double-dummy, Parallel Group Ambulatory Blood Pressure Monitoring Study to Investigate Whether Treatment With Lumiracoxib 100 mg Once Daily Results in an Improved 24-hour Blood Pressure Profile Compared to Ibuprofen 600 mg Three Times a Day in Osteoarthritis Patients With Controlled Hypertension|Completed||Phase 4|1020||Novartis|||||||||||||||||||2017-02-18 16:53:08.948481|2017-02-18 16:53:08.948481
NCT00267163|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2008-08-28|||September 2000||2000-09-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Brain Imaging and Mental Disorders of Aging Intervention|Brain Imaging and Mental Disorders of Aging Intervention|Completed||Phase 4|64|Actual|National Institute on Aging (NIA)||2|||f||||||||||||||2017-02-18 16:53:09.047059|2017-02-18 16:53:09.047059
NCT00267150|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2011-05-17|2010-12-09||November 2005||2005-11-01|May 2011|2011-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants|Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients|Completed||Phase 3|31|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:53:09.158886|2017-02-18 16:53:09.158886
NCT00267137|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2006-05-19|||September 2002||2002-09-01|May 2006|2006-05-01||||||||Interventional|||Study for Atrial Fibrillation Reduction (SAFARI)|Study for Atrial Fibrillation Reduction (SAFARI)|Completed||N/A|540||Medtronic Cardiac Rhythm and Heart Failure|||||||||||||||||||2017-02-18 16:53:09.44947|2017-02-18 16:53:09.44947
NCT00267124|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2009-04-28|||November 2004||2004-11-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Observational|||Brain Aging Project--Kansas University|KU Brain Aging Project|Unknown status|Active, not recruiting|N/A|120|Anticipated|National Institute on Aging (NIA)|||2||f||||||||||Samples With DNA|"~     Blood samples are collected analyzed and banked as whole blood, serum, white blood cells~   "|||2017-02-18 16:53:09.571658|2017-02-18 16:53:09.571658
NCT00267111|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2012-03-28|2011-08-10||July 2003||2003-07-01|March 2012|2012-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Topical Amethocaine Gel for Intramuscular Injection in Term Neonates|Local Anaesthesia [Topical Amethocaine Gel (Ametop)] for Intramuscular Injection in Term Neonates: A Randomized Controlled Trial.|Completed||Phase 2|110|Actual|Mount Sinai Hospital, Canada||2|||f||||f||||||||||2017-02-18 16:53:09.661931|2017-02-18 16:53:09.661931
NCT00267098|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2014-02-20|2013-12-18||December 2003||2003-12-01|February 2014|2014-02-01|March 2013|Actual|2013-03-01|December 2012|Actual|2012-12-01||Interventional|BLOCK HF||Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)|Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)|Completed||N/A|918|Actual|Medtronic Cardiac Rhythm and Heart Failure||2|||f||||t||||||||||2017-02-18 16:53:10.101733|2017-02-18 16:53:10.101733
NCT00267085|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2012-08-01|2009-09-24||December 2005||2005-12-01|August 2012|2012-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease|A Pilot Phase II Trial of a Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients With Chronic Myeloid Leukemia (CML) and Minimal Residual Disease|Completed||Phase 2|11|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 16:53:17.26899|2017-02-18 16:53:17.26899
NCT00267072|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2013-04-22|||June 2001||2001-06-01|April 2013|2013-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Ovarian Screening Study|The University of Louisville Ovarian Screening Study|Completed||N/A|5000|Anticipated|James Graham Brown Cancer Center|||1||f||||t||||||||||2017-02-18 16:53:17.532962|2017-02-18 16:53:17.532962
NCT00267059|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2012-08-01|2009-09-24||December 2005||2005-12-01|August 2012|2012-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)|Lenalidomide (Revlimid) in Patients With Previously Treated Chronic Lymphocytic Leukemia|Completed||Phase 2|45|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:53:17.632031|2017-02-18 16:53:17.632031
NCT00267046|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2012-04-17|2012-01-18||December 2005||2005-12-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma|A Phase II Study to Evaluate the Pharmacokinetics, Safety, and Obtain a Preliminary Efficacy Assessment of Palifermin in Patients With Sarcoma Receiving Multicycle Chemotherapy With Doxorubicin and Ifosfamide|Completed||Phase 2|49|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:53:17.911493|2017-02-18 16:53:17.911493
NCT00267033|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2008-12-01|||November 2005||2005-11-01|March 2007|2007-03-01|August 2008|Actual|2008-08-01|February 2008|Actual|2008-02-01||Interventional|||Evaluation of Vertebroplasty Associated With Radiotherapy for Spine Metastases (EVAR)|Randomized Trial of Vertebroplasty and Radiotherapy Versus Radiotherapy Alone for Osseous Spine Metastases|Completed||Phase 3|186|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:53:18.650277|2017-02-18 16:53:18.650277
NCT00267020|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2009-10-05||2009-06-10|December 2005||2005-12-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Patients With Advanced or Metastatic Pancreatic Cancer|A Randomized, Open-Label Phase 2 Study of 2 Regimens, Gemcitabine Plus Enzastaurin and Single-Agent Gemcitabine, in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|130|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 16:53:18.761584|2017-02-18 16:53:18.761584
NCT00267007|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2014-05-21|2009-07-31||June 2006||2006-06-01|May 2014|2014-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 18 Week Pilot Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) on the Development of Peripheral Neuropathy in Patients Receiving Combination Taxane and Platinum-Based Chemotherapy for Cancer|Terminated||Phase 2|32|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|No formal analysis was conducted due to early termination|2||Slow enrollment|f||||t||||||||||2017-02-18 16:53:18.87755|2017-02-18 16:53:18.87755
NCT00266994|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2013-02-20|||December 2005||2005-12-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Observational|||HTRS TE Registry (ThromboEmbolism Registry)|HTRS TE Registry (ThromboEmbolism Registry): Prospective Registry of Demographic and Clinical Data for Patients With Thromboembolic Disease|Completed||N/A|2760|Actual|Nationwide Children's Hospital|||1||f||||||||||||||2017-02-18 16:53:19.519552|2017-02-18 16:53:19.519552
NCT00266981|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2005-12-19|||March 2006||2006-03-01|December 2005|2005-12-01|December 2006|Anticipated|2006-12-01|||||Interventional|||Treatment of Whiplash Associated Disorders by APOS Kit|A Randomized Controlled Trial Which Compare the Effectiveness of an APOS Kit With Short Waves Therapy for Treating Whiplash Associated Disorders|Unknown status|Not yet recruiting|N/A|132|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:53:19.608838|2017-02-18 16:53:19.608838
NCT00266968|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2014-11-26|||January 2000||2000-01-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Outcomes of Children With Congenital Single Ventricle Heart|Assessment of the Outcomes of Children With Congenital Single Ventricle Heart|Completed||N/A|200|Actual|Children's Healthcare of Atlanta|||1||f||||t||||||||||2017-02-18 16:53:19.688301|2017-02-18 16:53:19.688301
NCT00266955|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2011-07-05|||January 1999||1999-01-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Observational|||Retrospective of Children With ADHD and Cardiac Symptoms|A Retrospective Study of Children With ADHD and Cardiac Symptoms|Terminated||N/A|10|Actual|Children's Healthcare of Atlanta|||1|insufficient number of eligible subjects|f||||||||||||||2017-02-18 16:53:19.770468|2017-02-18 16:53:19.770468
NCT00266942|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-05-22|||January 1990||1990-01-01|May 2007|2007-05-01|January 2007||2007-01-01|||||Observational|||Intra-Atrial vs. Extra-Cardiac Technique During Fontan Operation|The Determination of Differences Between Intr-Atrial vs. Extra-Cardiac Technique During the Fontan Operation: A Retrospective Review|Terminated||N/A|400||Children's Healthcare of Atlanta||||data collection ended|f||||f||||||||||2017-02-18 16:53:19.847659|2017-02-18 16:53:19.847659
NCT00266929|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2015-05-19|||December 2005||2005-12-01|April 2015|2015-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Treatment of Type II Odontoid Fractures Among the Elderly|Comparing Surgical to Conservative Management in the Treatment of Type II Odontoid Fractures Among the Elderly|Completed||N/A|159|Actual|AOSpine North America Research Network|||2||f||||f||||||||||2017-02-18 16:53:19.921643|2017-02-18 16:53:19.921643
NCT00266916|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2007-05-22|||January 1996||1996-01-01|May 2007|2007-05-01|August 2006||2006-08-01|||||Observational|||Percutaneous Interventions in Adults With CHD|Percutaneous Interventions in Adults With Complex Cyanotic Congenital Heart Disease|Terminated||N/A|9||Children's Healthcare of Atlanta||||data collection sufficient|f||||||||||||||2017-02-18 16:53:20.051108|2017-02-18 16:53:20.051108
NCT00266903|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-19|2014-11-26|||January 1996||1996-01-01|November 2014|2014-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Eisenmenger's Syndrome in Adults With CHD|Treatment of Eisenmenger's Syndrome in Adults With Congenital Heart Disease With Pulmonary Arterial Vasodilators|Completed||N/A|48|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 16:53:20.124179|2017-02-18 16:53:20.124179
NCT00266877|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2012-05-10||2009-02-26|December 2005||2005-12-01|May 2012|2012-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer|A Phase 2 Study of HKI-272 In Subjects With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|172|Actual|Puma Biotechnology, Inc.||3|||f||||f||||||||||2017-02-18 16:53:20.212503|2017-02-18 16:53:20.212503
NCT00266864|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2014-04-08|2013-12-19||August 2003||2003-08-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|August 2012|Actual|2012-08-01||Interventional|||Testosterone Replacement Therapy in Chronic Spinal Cord Injury|Testosterone Replacement Therapy in Chronic Spinal Cord Injury|Completed||Phase 2/Phase 3|31|Actual|VA Office of Research and Development|Compared to similar trials our trial was relatively small. Although there was statistical and clinical changes associated with testosterone replacement therapy, the translation of these findings with regard to functional gain was not addressed.|2|||f||||f||||||||||2017-02-18 16:53:20.497034|2017-02-18 16:53:20.497034
NCT00266851|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2013-12-11|||January 2006||2006-01-01|December 2013|2013-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||AZMATICS: AZithroMycin/Asthma Trial In Community Settings|AZMATICS: Azithromycin Asthma Trial In Community Settings|Completed||Phase 3|97|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 16:53:20.939735|2017-02-18 16:53:20.939735
NCT00266838|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2010-06-24|||July 2006||2006-07-01|December 2005|2005-12-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Prevention of Docetaxel Induced Dacryostenosis|A Double Blind Interventional Study of the Efficacy of Topical Eye Treatment in the Prevention of Docetaxel Induced Dacryostenosis|Completed||Phase 1|20|Anticipated|Universitaire Ziekenhuizen Leuven||2|||f||||f||||||||||2017-02-18 16:53:21.075289|2017-02-18 16:53:21.075289
NCT00266825|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2016-02-11|2015-06-30||January 2006||2006-01-01|February 2016|2016-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||DHA Supplementation and Pregnancy Outcome|Kansas University DHA Outcome Study (KUDOS)|Completed||Phase 3|350|Actual|University of Kansas Medical Center||2|||f||||t||||||||Undecided||2017-02-18 16:53:21.191004|2017-02-18 16:53:21.191004
NCT00265564|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2014-11-06|||July 2006||2006-07-01|November 2014|2014-11-01|July 2011|Actual|2011-07-01|April 2011|Actual|2011-04-01||Interventional|||SUPER Study (Substance Use and PTSD Treatment Effectiveness Research Study)|Effectiveness of Screening and Treatment for PTSD in SUD Patients|Completed||N/A|125|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 16:53:54.981231|2017-02-18 16:53:54.981231
NCT00266812|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2015-04-29|2009-07-29||March 2005||2005-03-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)|Randomized Phase II Study: Temozolomide (TMZ) Concomitant to Radiotherapy Followed by Sequential TMZ in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Central Nervous System (CNS) Metastasis Versus Radiotherapy Alone|Terminated||Phase 2|35|Actual|Merck Sharp & Dohme Corp.||2||Patient target could not be reached within the planned timeframe.|f||||f||||||||||2017-02-18 16:53:22.028975|2017-02-18 16:53:22.028975
NCT00266799|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2015-02-06|2011-10-10||January 2006||2006-01-01|February 2015|2015-02-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071)|A Randomized, Open-Label Trial Comparing Treatment With Either Pegylated Liposomal Doxorubicin or Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (PELICAN Trial)|Completed||Phase 3|210|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:53:22.457545|2017-02-18 16:53:22.457545
NCT00266786|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2017-02-06|||December 2005||2005-12-01|February 2017|2017-02-01||||February 2007|Actual|2007-02-01||Interventional|||Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery|A Phase 3, Double-Blind, Randomized Study of the Safety, Tolerability, and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain Following Major Abdominal Surgery|Completed||Phase 3|321|Actual|Egalet Ltd||2|||f||||||||||||||2017-02-18 16:53:23.343851|2017-02-18 16:53:23.343851
NCT00266773|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2013-02-15|||November 2005||2005-11-01|February 2013|2013-02-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||A Telephone Feedback System for Prevention of Chronic Pain Relapse|Therapeutic Interactive Voice Response (IVR) for Relapse Prevention in Chronic Pain|Completed||N/A|158|Actual|University of Vermont||3|||f||||t||||||||||2017-02-18 16:53:23.446267|2017-02-18 16:53:23.446267
NCT00266760|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2010-07-14|||May 2006||2006-05-01|July 2010|2010-07-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Observational|||Characteristics of Episodic Ataxia Syndrome|Episodic Ataxia Syndrome: Genotype-phenotype Correlation and Longitudinal Study|Unknown status|Active, not recruiting|N/A|125|Anticipated|Office of Rare Diseases (ORD)|||1||f||||||||||Samples With DNA|"~     Blood~   "|||2017-02-18 16:53:23.562651|2017-02-18 16:53:23.562651
NCT00266747|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2009-03-10|||December 2005||2005-12-01|March 2009|2009-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|AQUARIUS||An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder|An Eight-Week,Dble-Blind,Placebo-Controlled, Multicenter Study With Paroxetine (20 mg q24) as Positive Control, Evaluating the Efficacy, Safety and Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Outpatients With Generalized Anxiety Disorder|Completed||Phase 3|366|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:53:23.664716|2017-02-18 16:53:23.664716
NCT00266734|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2010-02-09|||December 2004||2004-12-01|February 2010|2010-02-01|September 2005||2005-09-01|||||Interventional|||Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears|A Prospective Blinded Multi-center Clinical Trial to Evaluate the Efficacy of the Recently FDA Approved RPS Adeno Detector for Detecting Adenoviral Conjunctivitis|Completed||N/A|186||Rapid Pathogen Screening|||||f||||f||||||||||2017-02-18 16:53:23.776629|2017-02-18 16:53:23.776629
NCT00266721|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2005-12-15|||January 2000||2000-01-01|December 2000|2000-12-01|October 2000||2000-10-01|||||Interventional|||Efficacy of Pancrelipase on Postprandial Belching and Bloating.||Completed||Phase 3|45||Minneapolis Veterans Affairs Medical Center|||||f||||||||||||||2017-02-18 16:53:23.965932|2017-02-18 16:53:23.965932
NCT00266708|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2012-10-22|||October 2002||2002-10-01|October 2012|2012-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.|Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant|Completed||N/A|60|Actual|Montefiore Medical Center||2|||f||||||||||||||2017-02-18 16:53:24.096441|2017-02-18 16:53:24.096441
NCT00266695|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2016-08-25|2015-12-22||January 2006||2006-01-01|August 2016|2016-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional||All enrolled participants.|Treatment for Completers of the Study B7A-MC-MBCM|Open-Label Treatment for Patients Completing Study B7A-MC-MBCM|Completed||Phase 3|203|Actual|Chromaderm, Inc.|A participant could have one or both eyes meet the criteria for a diabetic retinopathy (DR) study eye as defined in study B7A-MC-MBCM.|1|||f||||f||||||||||2017-02-18 16:53:24.217649|2017-02-18 16:53:24.217649
NCT00266682|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2006-10-11|||August 2002||2002-08-01|October 2006|2006-10-01|August 2005||2005-08-01|||||Interventional|||Clinical Investigation of the SelectSecure Pacing Lead|Clinical Investigation of the SelectSecure Pacing Lead|Completed||N/A|365||Medtronic Cardiac Rhythm and Heart Failure|||||||||||||||||||2017-02-18 16:53:24.956114|2017-02-18 16:53:24.956114
NCT00266669|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2007-08-06|||December 2005||2005-12-01|August 2007|2007-08-01|May 2006||2006-05-01|||||Interventional|||Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon|"Phase III in-Life Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, and Matching Placebo Gel in the Treatment and Prevention of Raynaud's Phenomenon"|Completed||Phase 3|200||MediQuest Therapeutics|||||||||||||||||||2017-02-18 16:53:25.074257|2017-02-18 16:53:25.074257
NCT00266656|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2016-07-13|2016-07-13||December 2005||2005-12-01|July 2016|2016-07-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional||All enrolled/started participants.|Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome|Effect of Early Growth Hormone Treatment on Long-term Growth and Skeletal Maturation in Girls With Turner Syndrome|Completed||Phase 4|69|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 16:53:25.189382|2017-02-18 16:53:25.189382
NCT00266643|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2007-08-01|||December 2005||2005-12-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain|A Comparison of Strategies for Switching Patients From Amitriptyline to Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain|Completed||Phase 4|205||Eli Lilly and Company|||||||||||||||||||2017-02-18 16:53:26.083607|2017-02-18 16:53:26.083607
NCT00266630|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2010-12-10|2010-05-26||November 2005||2005-11-01|December 2010|2010-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder|Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder|Completed||Phase 3|139|Actual|Eli Lilly and Company|Identified errors were corrected.|2|||f||||||||||||||2017-02-18 16:53:26.204424|2017-02-18 16:53:26.204424
NCT00266617|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2011-05-17||||||April 2010|2010-04-01|June 1990|Actual|1990-06-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy|The Effect of Subcutaneous r-HuEPO in Patients With Chronic Anemia Secondary to Chemotherapy|Completed||Phase 2|86|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:53:27.237903|2017-02-18 16:53:27.237903
NCT00266604|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2011-06-08|||December 2005||2005-12-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy|TOPAMAX� (Topiramate) Initiated as Monotherapy in Epilepsy (TIME): A Multicenter, Outpatient, Open-Label, Study to Evaluate the Dosing, Effectiveness and Safety of TOPAMAX� as Monotherapy in the Treatment of Epilepsy in Clinical Practice|Completed||Phase 4|409|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:53:27.331286|2017-02-18 16:53:27.331286
NCT00266591|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2011-06-06|||October 1992||1992-10-01|January 2011|2011-01-01|April 1997|Actual|1997-04-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy|Single Center TOPAMAX� (Topiramate) Monotherapy Trial in Subjects With Refractory Partial Onset Seizures|Completed||Phase 3|51|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:53:27.442687|2017-02-18 16:53:27.442687
NCT00266578|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2013-04-10|||October 2002||2002-10-01|April 2013|2013-04-01|October 2012|Actual|2012-10-01|November 2006|Actual|2006-11-01||Interventional|||A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders|Effect of Swallowed Fluticasone Propionate on Eosinophilic Esophagitis; A Prospective, Randomized, Placebo-Controlled Trial|Completed||Phase 3|30|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||||||||||||2017-02-18 16:53:27.53234|2017-02-18 16:53:27.53234
NCT00266565|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2017-01-20|||December 2001||2001-12-01|January 2017|2017-01-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome|A Phase I/II Study of the Effect of Intravenous Anti-IL-5 (Mepolizumab) SB 240563 on the Outcome and Management of Hypereosinophilic Syndromes|Completed||Phase 1/Phase 2|24|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 16:53:27.617485|2017-02-18 16:53:27.617485
NCT00266552|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2011-01-20||||||January 2011|2011-01-01|October 1998|Actual|1998-10-01|||||Interventional|||A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation|The Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder and Other Disruptive Behavior Disorders In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years|Completed||Phase 3|118|Actual|Janssen Pharmaceutica N.V., Belgium|||||||||||||||||||2017-02-18 16:53:27.714076|2017-02-18 16:53:27.714076
NCT00266539|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2011-05-18|||April 2004||2004-04-01|April 2010|2010-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Scheduled Abdominal or Pelvic Surgery: The Fentanyl Transdermal System Versus the Morphine Intravenous Pump|Comparison of the Safety and Efficacy of Patient Controlled Analgesia Delivered by Fentanyl HCl Transdermal System Versus Morphine IV Pump for Pain Management After Non-emergent Abdominal or Pelvic Surgery|Completed||Phase 3|506|Actual|Alza Corporation, DE, USA||1|||||||||||||||||2017-02-18 16:53:27.804072|2017-02-18 16:53:27.804072
NCT00266526|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2013-03-01|||July 2003||2003-07-01|March 2013|2013-03-01|July 2005|Actual|2005-07-01|July 2004|Actual|2004-07-01||Interventional|||Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV|A Bicentre Open Label Randomised Pilot Study for Proof of Safety and Efficacy of Immunotherapy With an Aluminium Hydroxide-adsorbed Recombinant Hypoallergenic Derivative of the Major Birch Pollen Allergen Bet v 1-FV Versus a Depot Extract of Natural Birch Allergen|Completed||Phase 2|||Allergopharma GmbH & Co. KG|||||f||||||||||||||2017-02-18 16:53:27.896597|2017-02-18 16:53:27.896597
NCT00266513|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2017-01-24|||December 14, 2005||2005-12-14|July 11, 2013|2013-07-11|July 11, 2013||2013-07-11|||||Observational|||Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States|Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States|Terminated||N/A|119|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:53:28.112874|2017-02-18 16:53:28.112874
NCT00266500|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-16|2017-01-24|||December 12, 2005||2005-12-12|October 28, 2014|2014-10-28|October 28, 2014||2014-10-28|||||Observational|||Body Heat Content and Dissipation in Obese and Normal Weight Adults|Body Heat Content and Dissipation in Obese and Normal Weight Adults|Completed||N/A|80|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:53:28.205277|2017-02-18 16:53:28.205277
NCT00266487|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2006-05-03|||December 1998||1998-12-01|August 2005|2005-08-01|March 2004||2004-03-01|||||Interventional|||The Norwegian Vitamin Trial (NORVIT)|Randomized Trial of Homocysteine-Lowering With B Vitamins for Secondary Prevention of Cardiovascular Disease After Acute Myocardial Infarction. The Norwegian Vitamin Trial (NORVIT)|Completed||N/A|3750||University of Tromso|||||f||||||||||||||2017-02-18 16:53:28.292357|2017-02-18 16:53:28.292357
NCT00266474|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2014-12-03|||December 2005||2005-12-01|December 2014|2014-12-01|September 2007|Actual|2007-09-01|||||Observational|||Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis|Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis|Completed||N/A|187|Actual|University of Jena|||1||f||||||||||Samples With DNA|"~     Pseudomonas aeruginosa and Staphylococcus aureus cultures (SNPS)~   "|||2017-02-18 16:53:28.404483|2017-02-18 16:53:28.404483
NCT00266461|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2013-07-11||2013-07-11|December 2005||2005-12-01|June 2012|2012-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Tolerability and Efficacy Study of TU-100 For The Treatment of Postoperative Ileus|A Randomized, Controlled, Open-Label Tolerability And Efficacy Study Of TU-100 For The Treatment Of Postoperative Ileus In Patients Undergoing Laparotomy For Large Bowel Resection|Completed||Phase 2|24|Actual|Tsumura USA||3|||f||||f||||||||||2017-02-18 16:53:28.517681|2017-02-18 16:53:28.517681
NCT00266448|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2005-12-15|||January 2001||2001-01-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||Whole Body Washing With Chlorhexidine for the Eradication of MRSA|The Value of Whole Body Washing With Chlorhexidine for the Eradication of MRSA – a Randomized, Placebo-Controlled, Double-Blinded Clinical Trial|Completed||Phase 2|100||Heidelberg University|||||f||||||||||||||2017-02-18 16:53:28.6273|2017-02-18 16:53:28.6273
NCT00266435|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2008-03-25|||November 2005||2005-11-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||The Usefulness of the HyperQ Stress System in Routine Annual Screening Testing|The Usefulness of the HyperQ Stress System in Routine Annual Screening Testing|Completed||Phase 1|371|Actual|Sheba Medical Center|||1||f||||||||||||||2017-02-18 16:53:28.728144|2017-02-18 16:53:28.728144
NCT00264862|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2014-02-27|||December 2005||2005-12-01|February 2014|2014-02-01|March 2007|Actual|2007-03-01|||||Interventional|||DynaCT Imaging in EVAR: Comparing Clinical Benefit of DynaCT to Multidetector CT as the Current Gold Standard.|Use of DynaCT in Endovascular Treatment of Abdominal Aortic Aneurysm. Evaluation of Image Quality.|Completed||N/A|20|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 16:53:28.808173|2017-02-18 16:53:28.808173
NCT00264849|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2011-06-24|2010-12-03||November 2005||2005-11-01|June 2011|2011-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma|A Randomized, Open Label, Parallel-group, International, Multicenter Study Evaluating Persistency of Response to Omalizumab During 32 Weeks Treatment Given as Add on to Optimized Asthma Therapy in Adult and Adolescent Patients With Severe Persistent Allergic Asthma, Who Remain Inadequately Controlled Despite GINA (2004) Step 4 Therapy|Completed||Phase 4|406|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:53:28.914756|2017-02-18 16:53:28.914756
NCT00264823|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-10-03|||June 2003||2003-06-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI)|Nursing Intervention for HIV Regimen Adherence Among Serious Mental Illness (SMI)|Completed||Phase 2|273|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-02-18 16:53:30.203591|2017-02-18 16:53:30.203591
NCT00264810|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2013-08-23|2013-08-23||December 2005||2005-12-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|October 2009|Actual|2009-10-01||Interventional||Baseline characteristics and primary endpoints were calculated using the Intent-to-Treat population, which includes all subjects that underwent RNS® System implantation (191 subjects). Individuals that did not undergo initial implant (49 subjects) were withdrawn from the study and are considered screen failures.|RNS® System Pivotal Study|RNS® System Pivotal-A Clinical Investigation|Completed||Phase 3|240|Actual|NeuroPace||2|||f||||t||||||||||2017-02-18 16:53:30.324816|2017-02-18 16:53:30.324816
NCT00266422|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2006-01-28|||January 2005||2005-01-01|January 2006|2006-01-01|December 2005||2005-12-01|||||Observational|||Neurological Outcome of VLBW Infants With Early Hypotension||Completed||N/A|250||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:53:31.579726|2017-02-18 16:53:31.579726
NCT00266409|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2014-10-17|2009-05-05||October 2005||2005-10-01|December 2009|2009-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder|A Multicenter, Randomized, Open-label, Parallel Design Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder|Completed||Phase 4|418|Actual|UCB Pharma|Originally it was planned to enrol and randomize 848 subjects. The smaller than planned sample size was a result of an unusually high rate of screening failure (results published in Psychiatry 2006, Vol. 3, Issue 12 , pages 39 - 59).|4|||f||||||||||||||2017-02-18 16:53:31.674095|2017-02-18 16:53:31.674095
NCT00266396|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2016-04-04|||January 2002||2002-01-01|April 2016|2016-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Weight-bearing Recommendation After Replacement of the Hip or Knee Joint|A Randomized Trial of Weight-bearing Recommendations After Total Hip or Total Knee Arthroplasty|Completed||Phase 1/Phase 2|352||Verein zur Förderung der Rehabilitationsforschung in Schleswig-Holstein||1|||f||||t||||||||No||2017-02-18 16:53:38.604351|2017-02-18 16:53:38.604351
NCT00266383|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2005-12-16|||January 2005||2005-01-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population|The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population|Completed||N/A|250||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 16:53:38.701216|2017-02-18 16:53:38.701216
NCT00266370|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2005-12-16|||January 2005||2005-01-01|December 2005|2005-12-01|December 2009||2009-12-01|||||Observational|||A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma|A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma|Unknown status|Recruiting|N/A|100||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 16:53:38.767553|2017-02-18 16:53:38.767553
NCT00266357|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2015-01-13|||November 2005||2005-11-01|January 2015|2015-01-01||||March 2007|Actual|2007-03-01||Interventional|||Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)|MK0928 Phase II Sleep Laboratory Study - Primary Insomnia|Terminated||Phase 2|50||H. Lundbeck A/S|||||f||||||||||||||2017-02-18 16:53:38.846408|2017-02-18 16:53:38.846408
NCT00266344|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2015-01-13|||November 2005||2005-11-01|January 2015|2015-01-01|October 2006|Actual|2006-10-01|||||Interventional|||MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)|MK0928 Phase IIb Dose-range Finding Study -Primary Insomnia|Completed||Phase 2|520||H. Lundbeck A/S|||||f||||||||||||||2017-02-18 16:53:38.917824|2017-02-18 16:53:38.917824
NCT00266331|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2013-08-27|||October 2004||2004-10-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||RayGel-An Alternative for Skin Care During External Beam Radiation|Prospective Blinded Randomized Study; RayGel Versus Placebo-an Alternative for Skin Care During External Beam Radiation.|Completed||Phase 2|150|Actual|Legacy Health System||2|||f||||t||||||||||2017-02-18 16:53:39.250071|2017-02-18 16:53:39.250071
NCT00266318|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2008-04-16|||December 2005||2005-12-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy|A Phase 4 Open-Label Pilot Study of the Safety and Tolerability of High Dosage of CIFN Plus RBV Administered Daily for 48 Weeks in HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Pegylated Interferon Alfa Plus RBV Therapy|Completed||Phase 4|40||Beth Israel Medical Center|||||||||||||||||||2017-02-18 16:53:39.36023|2017-02-18 16:53:39.36023
NCT00266305|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2008-08-12|||December 1998||1998-12-01|August 2008|2008-08-01|January 2007||2007-01-01|||||Interventional|||Fish Oil Supplementation in Lactation||Completed||N/A|150||University of Copenhagen||3|||f||||||||||||||2017-02-18 16:53:39.471146|2017-02-18 16:53:39.471146
NCT00266292|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2010-05-27|||September 2005||2005-09-01|December 2005|2005-12-01|April 2006||2006-04-01|||||Interventional|||The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors||Unknown status|Active, not recruiting|N/A|60||University of Copenhagen|||||f||||||||||||||2017-02-18 16:53:39.593378|2017-02-18 16:53:39.593378
NCT00266279|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2016-11-21|2013-05-03||April 2005||2005-04-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies|Phase II Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies|Completed||Phase 2|17|Actual|James Graham Brown Cancer Center|Results data not available, PI not longer at institution|1|||f||||t||||||||||2017-02-18 16:53:39.697074|2017-02-18 16:53:39.697074
NCT00266266|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2013-05-03|||January 2004||2004-01-01|May 2013|2013-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|HPV||Human Papilloma Virus DNA Self-Test|Human Papilloma Virus DNA Self-Test|Completed||N/A|171|Actual|James Graham Brown Cancer Center|||1||f||||t||||||||||2017-02-18 16:53:39.91534|2017-02-18 16:53:39.91534
NCT00266253|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2016-11-01|||November 2005||2005-11-01|November 2016|2016-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin|A Randomized Double-blind Study to Determine the Effect of GK Activator (2) on Efficacy (HbA1c), Safety, Tolerability and Pharmacokinetics in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin.|Completed||Phase 2|220|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-02-18 16:53:40.010536|2017-02-18 16:53:40.010536
NCT00266240|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2016-11-01|||November 2005||2005-11-01|November 2016|2016-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus|A Randomized, Double-blind Study to Determine the Effect of GK Activator (2) on Efficacy (HbA1c), Safety, Tolerability and Pharmacokinetics in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|267|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-02-18 16:53:40.156371|2017-02-18 16:53:40.156371
NCT00266227|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2013-09-20|2008-10-24||January 2006||2006-01-01|September 2013|2013-09-01||||October 2007|Actual|2007-10-01||Interventional|SUNRISE||A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Retreatment With Rituximab in Subjects With Rheumatoid Arthritis Receiving Background Methotrexate|Completed||Phase 3|559|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:53:40.311055|2017-02-18 16:53:40.311055
NCT00266214|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2011-06-13|||November 2005||2005-11-01|June 2011|2011-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome|A Randomized, Double-Blind Study Comparing the Safety and Efficacy of the Lidocaine Patch 5% With Placebo in Patients With Pain From Carpal Tunnel Syndrome|Terminated||Phase 3|210|Actual|Endo Pharmaceuticals||2||Sponsor decision|f||||||||||||||2017-02-18 16:53:41.59856|2017-02-18 16:53:41.59856
NCT00266201|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2011-08-17|||June 2003||2003-06-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Observational|||Right Ventricular Failure in Congenital Heart Defects|Evaluation of Biochemical Markers of Neurohumoral Activity and Correlation With Clinically Significant Parameters in Patients With Right Ventricular Failure and Congenital Heart Defects|Completed||N/A|150||Competence Network for Congenital Heart Defects|||1||f||||f||||||||||2017-02-18 16:53:41.721305|2017-02-18 16:53:41.721305
NCT00266188|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2011-09-20|||January 2005||2005-01-01|September 2011|2011-09-01|June 2008|Actual|2008-06-01|||||Observational|||Follow up of Post-repair Tetralogy of Fallot|Non-invasive Imaging and Exercise Tolerance Tests in Post-repair Tetralogy of Fallot - Intervention and Course in Patients Over 8 Years Old|Completed||N/A|406|Actual|Competence Network for Congenital Heart Defects|||1||f||||f||||||||||2017-02-18 16:53:41.812288|2017-02-18 16:53:41.812288
NCT00266175|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2008-10-14|||May 2005||2005-05-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|||||Observational|||Pulmonary Arteriopathy-Diagnostics and Therapy|Pulmonary Arteriopathy; Evaluation of Invasive Treatments of Peripheral Pulmonary Stenosis in Terms of Right Ventricular Function and Patient Exercise Tolerance|Completed||N/A|53|Actual|Competence Network for Congenital Heart Defects|||||f||||f||||||||||2017-02-18 16:53:41.91678|2017-02-18 16:53:41.91678
NCT00266162|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-15|2008-05-06|||August 2004||2004-08-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Bosentan in Treatment of Pulmonary Arterial Hypertension|Therapy of Pulmonary Arterial Hypertension (PAH) With Bosentan in Patients With Eisenmenger Syndrome|Completed||Phase 4|60||Competence Network for Congenital Heart Defects|||||f||||f||||||||||2017-02-18 16:53:42.020828|2017-02-18 16:53:42.020828
NCT00266149|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2008-04-23|||June 2003||2003-06-01|December 2005|2005-12-01|May 2005||2005-05-01|||||Interventional|||Lamotrigine and Oral Contraceptives|Phase 3: Metabolism of Lamotrigine During Treatment With Oral Contraceptives|Terminated||Phase 3|10||University of Aarhus|||||f||||||||||||||2017-02-18 16:53:42.133516|2017-02-18 16:53:42.133516
NCT00266136|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2012-10-25|||June 1999||1999-06-01|October 2012|2012-10-01|October 2012|Actual|2012-10-01|January 2007|Actual|2007-01-01||Interventional|||Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)|Risk-stratified Therapy for Primary and Secondary AML and MDS. A Randomized Study by AMLCG in Relation to Cytogenetically Defined Prognostic Factors (1) on the Role of High-dose AraC as Part of Double Induction, (2) on G-CSF Priming, and (3) on High-dose Chemotherapy With Stem Cell Transplantation|Completed||Phase 3|3500|Actual|University Hospital Muenster||1|||f||||||||||||||2017-02-18 16:53:42.232424|2017-02-18 16:53:42.232424
NCT00266123|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2007-12-18|||March 2004||2004-03-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients|A Randomized Open-Label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients|Completed||Phase 4|420||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:53:42.333972|2017-02-18 16:53:42.333972
NCT00266110|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2016-01-17|||December 2005||2005-12-01|January 2016|2016-01-01|May 2019|Anticipated|2019-05-01|December 2018|Anticipated|2018-12-01||Interventional|||Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer|Phase II Trial Evaluating the Toxicity and Efficacy of a Multiepitope Dendritic Cell Vaccine Given With Trastuzumab and Vinorelbine Ditartrate for the Treatment of Women With Metastatic Breast Cancer That Express HLA-A0201 and Whose Tumors Overexpress HER-2/NEU|Active, not recruiting||Phase 2|26|Anticipated|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:53:42.423131|2017-02-18 16:53:42.423131
NCT00261066|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2016-08-04|||September 2001||2001-09-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Outcome Following Orthopaedic Surgery|A Prospective Database for Orthopaedic Surgery|Recruiting||N/A|5000|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 16:55:59.580665|2017-02-18 16:55:59.580665
NCT00266097|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2012-03-05|||August 2004||2004-08-01|March 2012|2012-03-01|September 2011|Actual|2011-09-01|March 2009|Actual|2009-03-01||Interventional|||Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer|A Two-Part Phase I Study of the Addition of Oxaliplatin to Gemcitabine, and Then Erlotinib Plus Oxaliplatin to Gemcitabine as Radiosensitizers for Pancreatic and Biliary Adenocarcinoma|Completed||Phase 1|23|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 16:53:42.542696|2017-02-18 16:53:42.542696
NCT00266084|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-05-10|||August 1999||1999-08-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix|Double-Blinded Multicenter Clinical Study Assessing the Equivalence of the InPath Cervical Cell Collector to the Standard Endocervical Brush and Spatula in Patients Seeking Primary Pap Screening or Follow-up Screening|Completed||Phase 1/Phase 2|85||University Hospitals Cleveland Medical Center|||1||f||||||||||||||2017-02-18 16:53:42.657825|2017-02-18 16:53:42.657825
NCT00264797|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-10|2013-05-02|2013-01-18||February 2006||2006-02-01|May 2013|2013-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)|Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)|Completed||Phase 3|303|Actual|University of Cincinnati||2|||f||||t||||||||||2017-02-18 16:53:42.735182|2017-02-18 16:53:42.735182
NCT00264784|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2007-12-19|||December 2005||2005-12-01|October 2007|2007-10-01|May 2006||2006-05-01|||||Observational|||GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine|The Epidemiology of Group A Streptococcal Infections in Fiji (Fiji GrASP) - Part 5: Establishing Natural Age-Related Titers of Antibodies to the J8 Group A Streptococcal Epitope in Fiji|Completed||N/A|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:53:43.207288|2017-02-18 16:53:43.207288
NCT00264771|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-05-01|||December 2005||2005-12-01|October 2007|2007-10-01|December 2007||2007-12-01|||||Observational|||Hospital Based Incidence of Group A Streptococcal Disease in Fiji|The Hospital Based Incidence of Acute Rheumatic Fever and Rheumatic Heart Disease, Acute Post Streptococcal Glomerulonephritis and Invasive Group A Streptococcal Disease in Fiji|Completed||N/A|550||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:53:43.279219|2017-02-18 16:53:43.279219
NCT00264758|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2014-07-02|||January 2006||2006-01-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Frequent Hemodialysis Network: Daily Trial|Frequent Hemodialysis Network: Daily Trial|Completed||Phase 2/Phase 3|245|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 16:53:43.354399|2017-02-18 16:53:43.354399
NCT00264745|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2011-01-11|||June 2004||2004-06-01|October 2008|2008-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Telephone Assessment and Skill-Building Kit (TASK): A New Program for Family Caregivers of Stroke Survivors|Caregiver Telephone Assessment and Skill-Building Kit|Completed||Phase 1|50|Actual|Indiana University||2|||f||||||||||||||2017-02-18 16:53:43.468561|2017-02-18 16:53:43.468561
NCT00264732|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2013-05-21||2013-05-21|July 2005||2005-07-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Amolimogene (ZYC101a) in the Treatment of High-Grade Cervical Intraepithelial Lesions (CIN 2/3) of the Uterine Cervix|Completed||Phase 2/Phase 3|251|Actual|Eisai Inc.||3|||f||||||||||||||2017-02-18 16:53:43.577324|2017-02-18 16:53:43.577324
NCT00266071|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2005-12-14|||December 2005||2005-12-01|December 2005|2005-12-01||||||||Observational|||Study of the Cutaneous Microcirculation in Elderly People||Unknown status|Not yet recruiting|N/A|||University Hospital, Angers|||||f||||||||||||||2017-02-18 16:53:43.817846|2017-02-18 16:53:43.817846
NCT00266058|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2013-06-04|||December 2005||2005-12-01|May 2013|2013-05-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Drug Interaction Study Between Antimalarial and Anti-HIV Medications|Pharmacokinetic Interactions Between Antiretroviral Agents, Lopinavir/Ritonavir and Efavirenz and Antimalarial Drug Combination, Artemether/Lumefantrine|Completed||Phase 1|33|Actual|University of California, San Francisco||2|||f||||||||||||||2017-02-18 16:53:43.897113|2017-02-18 16:53:43.897113
NCT00266045|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2012-08-31|||August 2005||2005-08-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Observational|||D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence|A Multicentre, Prospective, Observational Study on the Predictive Role for Recurrence of D-dimer Levels Measured During and After Anticoagulation in Patients With a First Venous Thromboembolism Episode (the PROLONG-II Study)|Completed||Phase 4|355|Actual|St. Orsola Hospital|||1||f||||||||||Samples Without DNA|"~     Plasma samples for D-dimer assays or other coagulation tests~   "|||2017-02-18 16:53:44.005969|2017-02-18 16:53:44.005969
NCT00266032|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2014-10-27|2009-10-28||December 2005||2005-12-01|October 2014|2014-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles|A Multicenter, Open, Randomized, Parallel Group Comparison to Assess the Safety and Efficacy of the Oral Contraceptive SH T00186D (0.02 mg Ethinylestradiol as Betadex Clathrate and 3 mg Drospirenone) in Two Variations of an Extended Regimen vs. a Standard Regimen (24 + 4 Days) in 1122 Healthy Female Volunteers for One Year, Followed by a One Year Safety Extension|Completed||Phase 3|1166|Actual|Bayer|Data for center no. 1148 was included in “all randomized” set of subjects, but not in FAS, as during medical monitoring of laboratory data a suspicion of potential misconduct was found. An audit was made, but the suspicion could not be resolved.|3|||f||||f||||||||||2017-02-18 16:53:44.104762|2017-02-18 16:53:44.104762
NCT00266019|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2010-01-12|||January 2005||2005-01-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Weight Management in Nonalcoholic Steatohepatitis|Weight Management in Nonalcoholic Steatohepatitis (NASH)|Completed||Phase 2|30|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:53:45.101801|2017-02-18 16:53:45.101801
NCT00266006|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-11-16|||January 2006||2006-01-01|November 2016|2016-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Factor VIIa in Acute Intracerebral Haemorrhage|Safety of Eptacog Alfa (Activated) (Genetical Recombination) on Adverse Events and Serious Adverse Events in Patients With Acute Intracerebral Haemorrhage.|Completed||Phase 2|90|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:53:45.213052|2017-02-18 16:53:45.213052
NCT00265993|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2010-02-02|||December 2004||2004-12-01|February 2010|2010-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Enoxaparin in Acute Venous Thromboembolic Disease|The Efficacy of Subcutaneous Enoxaparin Once Daily in the Treatment of Acute Venous Thromboembolic Disease: an Open-labelled, Non-comparative, Multicentric, Phase IV Trial|Completed||Phase 4|251|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:53:45.303499|2017-02-18 16:53:45.303499
NCT00265980|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2015-03-30|||July 2002||2002-07-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|September 2015|Anticipated|2015-09-01||Interventional|||Leptin in Human Energy and Neuroendocrine Homeostasis|Leptin in Human Energy and Neuroendocrine Homeostasis|Active, not recruiting||N/A|60|Anticipated|Columbia University||5|||f||||t||||||||||2017-02-18 16:53:45.399208|2017-02-18 16:53:45.399208
NCT00265967|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2009-12-04|||September 2005||2005-09-01|December 2009|2009-12-01||||February 2007|Actual|2007-02-01||Interventional|||Irbesartan in Hypertension|Missed Dose Effect of Irbesartan in Hypertensive Patients and Cardiovascular Risk Profile Monitoring Under Irbesartan Treatment|Completed||Phase 4|88|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:53:45.51649|2017-02-18 16:53:45.51649
NCT00265954|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2010-01-21|||February 2006||2006-02-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|iReach||Internet Assisted Obesity Treatment|A Randomized Trial of an Internet Versus In-person Behavioral Weight Loss Treatment Program.|Completed||Phase 3|488|Anticipated|University of Vermont||3|||f||||||||||||||2017-02-18 16:53:45.610336|2017-02-18 16:53:45.610336
NCT00265941|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-10-11|||November 2005||2005-11-01|October 2016|2016-10-01||||January 2011|Actual|2011-01-01||Interventional|||Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer|A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin Versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas|Active, not recruiting||Phase 3|720|Anticipated|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 16:53:45.73188|2017-02-18 16:53:45.73188
NCT00265928|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2008-01-24||||||January 2007|2007-01-01||||||||Interventional|||Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma|VELCADE (Bortezomib) for Injection - Phase II Study of Bortezomib and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma|Terminated||Phase 2|46|Anticipated|National Cancer Institute (NCI)||||Withdrawn for poor accrual|f||||||||||||||2017-02-18 16:53:46.508|2017-02-18 16:53:46.508
NCT00265915|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2014-08-11|||July 2005||2005-07-01|August 2014|2014-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia|A CRC Trial of Rituximab in Combination With Sargramostim (GM-CSF) in Patients With Chronic Lymphocytic Leukemia|Terminated||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:53:46.603436|2017-02-18 16:53:46.603436
NCT00265902|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2009-02-06|||November 2004||2004-11-01|June 2006|2006-06-01||||||||Interventional|||Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's Sarcoma|Ultra-Sensitive, Infra-Red Thermographic Analysis of Kaposi's Sarcoma Skin Lesions|Unknown status|Active, not recruiting|N/A|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:53:46.700765|2017-02-18 16:53:46.700765
NCT00265889|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2013-10-28|2013-06-10||February 2002||2002-02-01|October 2013|2013-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma|Tandem Autologous Stem Cell Transplantation for Patients With Primary Progressive or Poor Risk Recurrent Hodgkin's Disease|Completed||Phase 2|42|Actual|Case Comprehensive Cancer Center||2|||f||||f||||||||||2017-02-18 16:53:46.802232|2017-02-18 16:53:46.802232
NCT00265876|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-11-25|||September 2005||2005-09-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||AZD0530 and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery|A Phase I/II Study of AZD0530 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|34|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 16:53:47.153726|2017-02-18 16:53:47.153726
NCT00265863|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2012-11-06|||August 2004||2004-08-01|November 2012|2012-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites|Phase II Study of Laparoscopic Hyperthermic Peritoneal Chemotherapy for Malignant Ascites|Terminated||Phase 2|1|Actual|Masonic Cancer Center, University of Minnesota||1||Withdrawn due to slow accrual|f||||t||||||||||2017-02-18 16:53:47.271731|2017-02-18 16:53:47.271731
NCT00265850|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-12-09|||November 2005||2005-11-01|December 2016|2016-12-01||||February 2015|Actual|2015-02-01||Interventional|||Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer|A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination of Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum|Active, not recruiting||Phase 3|2334|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-02-18 16:53:47.435219|2017-02-18 16:53:47.435219
NCT00265837|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2014-04-16|||December 2002||2002-12-01|April 2014|2014-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer|Phase III Trial of T Lymphocyte Depletion by Elutriation and CD34 Add-Back for Allogeneic Bone Marrow Transplantation|Completed||Phase 3|72|Actual|Sidney Kimmel Comprehensive Cancer Center|||||||||||||||||||2017-02-18 16:53:51.370241|2017-02-18 16:53:51.370241
NCT00265824|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2015-12-10|||May 2005||2005-05-01|March 2014|2014-03-01||||March 2012|Actual|2012-03-01||Interventional|DREAM||Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)|Phase III Study of an Optimized Chemotherapy Followed by Maintenance With Bevacizumab Strategy With or Without Erlotinib in Unresectable Metastatic Colorectal Cancer. DREAM OPTIMOX 3. C04-2|Completed||Phase 3|700|Actual|Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)||2|||f||||f||||||||||2017-02-18 16:53:51.478703|2017-02-18 16:53:51.478703
NCT00265811|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-05-26|||November 2005||2005-11-01|December 2006|2006-12-01||||November 2009|Actual|2009-11-01||Interventional|||Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery|Adjuvant Treatment of Fully Resected Stage III Colon Cancer With FOLFOX-4 Versus FOLFOX-4 Plus Cetuximab|Completed||Phase 3|2559|Actual|Federation Francophone de Cancerologie Digestive||2|||f||||t||||||||||2017-02-18 16:53:51.626487|2017-02-18 16:53:51.626487
NCT00265798|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-12-28|2013-12-06||September 2005||2005-09-01|December 2016|2016-12-01||||February 2010|Actual|2010-02-01||Interventional|||Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate|A Phase 2 Study of BAY 43-9006 for Imatinib- and Sunitinib Resistant Gastrointestinal Stromal Tumor|Active, not recruiting||Phase 2|38|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:53:51.740883|2017-02-18 16:53:51.740883
NCT00265785|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2012-10-03|2012-07-12||July 2006||2006-07-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Trial of Pemetrexed in Patients With Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)|Terminated||Phase 2|27|Actual|Southwest Oncology Group||1||Closed due to poor accrual|f||||t||||||||||2017-02-18 16:53:52.26732|2017-02-18 16:53:52.26732
NCT00265772|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2005-12-14|||November 2005||2005-11-01|November 2005|2005-11-01|April 2008||2008-04-01|||||Interventional|||Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis|Phase IV Study Comparing a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis|Unknown status|Recruiting|Phase 4|24||Hôpital Necker-Enfants Malades|||||f||||||||||||||2017-02-18 16:53:52.908914|2017-02-18 16:53:52.908914
NCT00265759|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-08-11|||January 2006||2006-01-01|August 2016|2016-08-01||||August 2012|Actual|2012-08-01||Interventional|||Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer|A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane (25 mg Daily), Letrozole (2.5 mg), or Anastrozole (1 mg) in Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer|Active, not recruiting||Phase 3|610|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-02-18 16:53:53.012484|2017-02-18 16:53:53.012484
NCT00265746|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2006-02-27|||November 2005||2005-11-01|December 2005|2005-12-01||||||||Interventional|||Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes|Program for the Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes. Evaluation of the Efficacy of the Life-Style Modification and the Life-Style Modification in Conjunction With Metformin, in the Prevention of Diabetes Mellitus Development in a Population of Women Who Had Expired a Gestational Diabetes - a Multicenter, Randomized, Double Blind Study.|Unknown status|Recruiting|Phase 4|300||Medical Universtity of Lodz|||||f||||||||||||||2017-02-18 16:53:53.150115|2017-02-18 16:53:53.150115
NCT00265733|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2016-12-02|||February 2006||2006-02-01|December 2016|2016-12-01|May 2013|Actual|2013-05-01|August 2007|Actual|2007-08-01||Interventional|||Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer|Phase II Trial of CT-2103 (Xyotax™) With Capecitabine as First-Line Chemotherapy for Patients With Metastatic Breast Cancer|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 16:53:53.243547|2017-02-18 16:53:53.243547
NCT00265720|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2009-02-03|||March 2003||2003-03-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Colorectal Cancer Screening Intervention Trial|Research on Community Cancer Control: Study of Colorectal Cancer Screening in the African American Population|Completed||N/A|360|Actual|Morehouse School of Medicine||4|||f||||f||||||||||2017-02-18 16:53:53.353466|2017-02-18 16:53:53.353466
NCT00265707|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2006-10-06|||September 2005||2005-09-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Evaluation of a New Blood Pressure Measuring Device.|A Study to Evaluate the Safety and Effectiveness (Overall Performance) of the Press-O-Sense Non-Invasive Blood Pressure Measuring Device.|Unknown status|Recruiting|N/A|120||Maaynei Hayesha Medical Center|||||f||||||||||||||2017-02-18 16:53:53.460614|2017-02-18 16:53:53.460614
NCT00265694|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2005-12-14||||||June 2005|2005-06-01||||||||Interventional|||Random Trial for Elderly Patients With NSCLC|A Randomized Phase III Trial of Vinorelbine Versus Gemcitabine and Carboplatin for Elderly Patients With Advanced Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 3|||Inje University|||||f||||||||||||||2017-02-18 16:53:53.548601|2017-02-18 16:53:53.548601
NCT00265681|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2007-04-03|||November 2004||2004-11-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Telephone Counseling for Snuff Users|Proactive Telephone Counseling With Rural Smokeless Tobacco Users|Completed||N/A|400||HealthPartners Institute|||||f||||f||||||||||2017-02-18 16:53:53.625983|2017-02-18 16:53:53.625983
NCT00265655|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2012-03-22||2012-03-21|November 2005||2005-11-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Satraplatin for Patients With Metastatic Breast Cancer (MBC)|Phase II of Oral Satraplatin in Patients With Metastatic Breast Cancer (MBC)|Completed||Phase 2|40|Actual|Agennix||1|||f||||||||||||||2017-02-18 16:53:53.716464|2017-02-18 16:53:53.716464
NCT00265642|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2014-02-06|||October 2006||2006-10-01|July 2012|2012-07-01|November 2013|Actual|2013-11-01|April 2013|Actual|2013-04-01||Interventional|Fibrosar||Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C|Study of the Effects of a Sartan on Hepatic Fibrosis Progression in Chronic Viral Hepatitis C|Completed||Phase 3|166|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 16:53:54.046023|2017-02-18 16:53:54.046023
NCT00265629|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2013-06-18|||August 2005||2005-08-01|June 2013|2013-06-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||RF Ablation of Atrial Fibrillation|A Clinical Investigation of Radiofrequency Ablation for the Treatment of Atrial Fibrillation Using the High Density Mesh Bard Ablation System|Completed||Phase 1|20|Actual|C. R. Bard||1|||f||||f||||||||||2017-02-18 16:53:54.157417|2017-02-18 16:53:54.157417
NCT00265616|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2013-04-02|2010-10-27||May 2006||2006-05-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Treatment of Refractory Status Epilepticus|A Randomized Clinical Trial for the Treatment of Refractory Status Epilepticus|Terminated||Phase 3|23|Actual|Brigham and Women's Hospital||2||Insufficient recruitment|f||||t||||||||||2017-02-18 16:53:54.269993|2017-02-18 16:53:54.269993
NCT00265603|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-14|2014-01-15|||October 2004||2004-10-01|January 2014|2014-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer|Phase 1 Toxicity/Feasibility Study: Combined Modality Treatment With Transimmunization for Non-Small Cell Lung Cancer|Terminated||Phase 1|16|Anticipated|Atlantic Health System||1|||f||||t||||||||||2017-02-18 16:53:54.780854|2017-02-18 16:53:54.780854
NCT00005438|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||February 1993||1993-02-01|November 2001|2001-11-01|January 1998|Actual|1998-01-01|||||Observational|||Neuropsychological Studies of Children With Sickle Cell||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.224765|2017-02-18 18:14:59.224765
NCT00265551|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2007-12-07|||January 2006||2006-01-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Olanzapine-Referenced, Parallel Group Safety, Efficacy, and Tolerability Study of SCA-136 in Subjects With Acute Exacerbations of Schizophrenia|Completed||Phase 2|300||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:53:55.098511|2017-02-18 16:53:55.098511
NCT00265538|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2014-08-06|||July 2006||2006-07-01|August 2014|2014-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Implementing Evidence Based Treatment of Hypertension|Implementing Evidence-based Treatment of Hypertension|Completed||N/A|900|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 16:53:55.225066|2017-02-18 16:53:55.225066
NCT00265525|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2015-04-07|||November 2004||2004-11-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|June 2007|Actual|2007-06-01||Interventional|||Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease.|Evaluation of a Web-Based Intervention to Promote Physical Activity in Patients With Heart Disease: A Randomize Control Trial|Completed||Phase 3|223|Actual|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-02-18 16:53:55.337529|2017-02-18 16:53:55.337529
NCT00265512|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2015-04-06|2014-10-02||November 2006||2006-11-01|July 2014|2014-07-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||LINK: Aftercare Monitoring Project|Improving Longterm SUD Outcomes With Telephone Case Monitoring|Completed||N/A|667|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:53:55.45728|2017-02-18 16:53:55.45728
NCT00265499|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2005-12-13||||||November 2005|2005-11-01||||||||Interventional|||The Internal Thoracic Artery Skeletonization Study: A Paired, Within-Patient Comparison|Skeletonized Versus Non-Skeletonized Internal Thoracic Artery Harvest for Coronary Artery Bypass Grafting|Completed||N/A|48||University of Ottawa|||||f||||||||||||||2017-02-18 16:53:55.777287|2017-02-18 16:53:55.777287
NCT00265486|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2012-05-23|||August 2005||2005-08-01|August 2005|2005-08-01|July 2012|Anticipated|2012-07-01|June 2012|Anticipated|2012-06-01||Observational|||Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?|Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?|Unknown status|Recruiting|N/A|12|Anticipated|Rigshospitalet, Denmark|||1||f||||||||||||||2017-02-18 16:53:55.87516|2017-02-18 16:53:55.87516
NCT00265473|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2015-08-11|2011-04-01||November 2005||2005-11-01|August 2015|2015-08-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||MGA031, Sirolimus and Tacrolimus in Islet Transplantation|hOKT3γ1 (Ala-Ala), Sirolimus and Low Dose Tacrolimus Therapy in Type 1 Diabetic Islet Allograft Recipients|Completed||Phase 1/Phase 2|5|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 16:53:55.971556|2017-02-18 16:53:55.971556
NCT00265460|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2009-09-14|||March 2005||2005-03-01|September 2009|2009-09-01|November 2006|Actual|2006-11-01|||||Interventional|||Smoking Cessation in Groups and With Tobacco Pastils|Phase 2 Study of Smoke Free Tobacco and Group Support for Smoking Cessation|Completed||Phase 2|240||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 16:53:56.236153|2017-02-18 16:53:56.236153
NCT00265447|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2016-09-26|||December 2005||2005-12-01|September 2016|2016-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Exercise and Physical Fitness for Persons With Knee Osteoarthritis|Exercise and Physical Fitness for Persons With Knee Osteoarthritis: Does One Size Fit All|Completed||Phase 3|55|Actual|University of Missouri-Columbia||3|||f||||||||||||||2017-02-18 16:53:56.412427|2017-02-18 16:53:56.412427
NCT00265434|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2014-12-03|||December 2005||2005-12-01|December 2014|2014-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis|Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis|Completed||Phase 3|5|Actual|University of Jena||2|||f||||t||||||||||2017-02-18 16:53:56.518401|2017-02-18 16:53:56.518401
NCT00265421|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2009-09-29|||August 2004||2004-08-01|September 2009|2009-09-01|April 2006||2006-04-01|||||Interventional|||Study of Different Suturing Techniques for Perineal Repair After Delivery|The Danish Suture Trial: a Randomized Trial on Perineal Sutures Following Vaginal Birth.|Completed||N/A|400||University of Aarhus|||||f||||t||||||||||2017-02-18 16:53:56.61786|2017-02-18 16:53:56.61786
NCT00265408|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2014-12-05|||December 2005||2005-12-01|March 2007|2007-03-01|March 2007|Anticipated|2007-03-01|||||Interventional|||Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection|Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection|Withdrawn||Phase 1|0|Actual|University of California, San Diego||2|||f||||||||||||||2017-02-18 16:53:56.705565|2017-02-18 16:53:56.705565
NCT00265395|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2015-10-07|2009-05-15||December 2004||2004-12-01|October 2015|2015-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)|A Study to Assess Treatment With PEG-Intron® and Rebetol® in Naïve Patients With Genotype 1 Chronic Hepatitis C and Slow Virological Response|Completed||Phase 3|1428|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:53:56.807005|2017-02-18 16:53:56.807005
NCT00265382|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2011-12-02|2010-04-16||June 2006||2006-06-01|December 2011|2011-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia|26-Week Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Adolescent Subjects With Schizophrenia|Terminated||Phase 3|221|Actual|Pfizer|The AE tables were amended to incorporate previously unreported AEs that were found during an independent audit and verified by the investigators.|1||Please see Detailed Description for termination reason.|f||||t||||||||||2017-02-18 16:53:57.535531|2017-02-18 16:53:57.535531
NCT00265369|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-01-10|||May 2004||2004-05-01|January 2011|2011-01-01||||||||Interventional|||TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in Children|Comparative Efficacy and Safety of a Bacillus Clausii Probiotic Strain Versus Placebo in the Treatment of Acute Diarrhoea in Children|Completed||Phase 3|420||Sanofi|||||f||||||||||||||2017-02-18 16:53:58.295046|2017-02-18 16:53:58.295046
NCT00265356|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2013-10-18|||November 2005||2005-11-01|October 2013|2013-10-01|April 2013|Actual|2013-04-01|April 2010|Actual|2010-04-01||Interventional|PETCAM||Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases|The Impact of Positron Emission Tomography (PET) Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases: A Prospective, Multicentre Randomized Clinical Trial|Completed||Phase 3|404|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-02-18 16:53:58.377336|2017-02-18 16:53:58.377336
NCT00265343|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2015-02-20|2010-02-17||December 2005||2005-12-01|February 2015|2015-02-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)|A Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the Safety and Efficacy of Asenapine With Olanzapine in Subjects Who Completed the Protocol 25543 (NCT 00212836; P05817)|Completed||Phase 3|306|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 16:53:58.503678|2017-02-18 16:53:58.503678
NCT00265330|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2011-12-02|2009-01-22||March 2006||2006-03-01|December 2011|2011-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)|26-Week Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)|Completed||Phase 3|169|Actual|Pfizer|The AE tables were amended to incorporate previously unreported AEs that were found during an independent audit and verified by the investigators.|1|||f||||t||||||||||2017-02-18 16:53:58.833371|2017-02-18 16:53:58.833371
NCT00265317|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2013-01-31|2011-01-21||June 2006||2006-06-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|January 2010|Actual|2010-01-01||Interventional|SUN1058||A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone|Randomized, Double-Blind, Phase 2 Study Of Erlotinib With Or Without SU011248 In The Treatment Of Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|162|Actual|Pfizer|Due to rounding some percentages will not equal 100%|2|||f||||f||||||||||2017-02-18 16:53:59.736751|2017-02-18 16:53:59.736751
NCT00265304|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2009-03-19|||July 2005||2005-07-01|March 2009|2009-03-01||||July 2007|Actual|2007-07-01||Interventional|||A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee|A Double-Blind, Long-Term Evaluation of the Safety of IDEA-033 in Comparison to Oral Naproxen for the Treatment of the Signs and Symptoms of Osteoarthritis of the Knee|Completed||Phase 2|550||IDEA AG|||||f||||||||||||||2017-02-18 16:54:07.716343|2017-02-18 16:54:07.716343
NCT00265291|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2008-10-09|||November 1999||1999-11-01|September 2008|2008-09-01|October 2008|Actual|2008-10-01|May 2006|Actual|2006-05-01||Interventional|||Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group||Completed||Phase 2|700|Actual|National Institute of General Medical Sciences (NIGMS)||1|||f||||t||||||||||2017-02-18 16:54:08.188216|2017-02-18 16:54:08.188216
NCT00265278|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2017-01-10|||March 2005||2005-03-01|December 2005|2005-12-01|March 2006||2006-03-01|||||Interventional|||Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1|Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 16:54:08.300265|2017-02-18 16:54:08.300265
NCT00265265|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2017-01-11|||August 2005||2005-08-01|August 2016|2016-08-01||||September 2006|Actual|2006-09-01||Interventional|||Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1|Phase 1, Double-Blind, Placebo-Controlled Multiple Dose Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine|Completed||Phase 1|16||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:54:08.394794|2017-02-18 16:54:08.394794
NCT00265252|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2008-02-26|||June 2005||2005-06-01|April 2007|2007-04-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis|Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis|Unknown status|Active, not recruiting|Phase 4|60||Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||||||||||||2017-02-18 16:54:08.498327|2017-02-18 16:54:08.498327
NCT00265239|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2014-09-12|2014-05-19||April 2001||2001-04-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Pilot Study of Edaravone to Treat Acute Myocardial Infarction|Effects of Edaravone in Patients With Acute Myocardial Infarction|Completed||Phase 4|104|Actual|Kumamoto University||2|||f||||||||||||||2017-02-18 16:54:08.602522|2017-02-18 16:54:08.602522
NCT00265226|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2014-01-03|||March 2005||2005-03-01|July 2011|2011-07-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients|Efficacy and Safety Study of Immunomodulator (Mycobacterium w) as an Adjunct Therapy in Category-II Pulmonary Tuberculosis Along With Assessment of Immunological Parameters|Completed||Phase 3|1020|Actual|Ministry of Science and Technology, India||2|||f||||t||||||||||2017-02-18 16:54:08.961455|2017-02-18 16:54:08.961455
NCT00265213|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2008-02-26|||May 2005||2005-05-01|December 2005|2005-12-01|February 2006|Anticipated|2006-02-01|||||Observational|||How Breast Conservative Surgery (BCS) Affects Women's Daily Activities On Post-Operation 2 Days?||Unknown status|Recruiting|N/A|30|Anticipated|Kaohsiung Medical University Chung-Ho Memorial Hospital|||||f||||||||||||||2017-02-18 16:54:09.097587|2017-02-18 16:54:09.097587
NCT00265200|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2013-04-05|||February 2005||2005-02-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|August 2009|Actual|2009-08-01||Interventional|||Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer|Bone Metabolic Markers, TRAP, and Zometa's Effect on Bone Metastasis Due to Lung Cancer|Terminated||Phase 2|28|Actual|James Graham Brown Cancer Center||1||funding discontinued by sponsor|f||||t||||||||||2017-02-18 16:54:09.182487|2017-02-18 16:54:09.182487
NCT00265187|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2013-01-02|||December 2005||2005-12-01|August 2006|2006-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis.|The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis in Northern Israel.|Completed||N/A|200|Actual|HaEmek Medical Center, Israel|||1||f||||f||||||||||2017-02-18 16:54:09.309917|2017-02-18 16:54:09.309917
NCT00265174|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2005-12-13|||January 2006||2006-01-01|November 2005|2005-11-01||||||||Observational|||Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer.|Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer.|Unknown status|Not yet recruiting|N/A|60|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:54:09.40282|2017-02-18 16:54:09.40282
NCT00265161|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2007-05-31|||December 2005||2005-12-01|August 2006|2006-08-01|March 2007|Actual|2007-03-01|||||Observational|||The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.||Completed||N/A|40||HaEmek Medical Center, Israel|||||f||||f||||||||||2017-02-18 16:54:09.485639|2017-02-18 16:54:09.485639
NCT00259415|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2015-07-06|||September 2000||2000-09-01|July 2015|2015-07-01||||||||Interventional|||Telesupport: Evaluation of Professionally Led Support Groups for Caregivers|Evaluation of Professionally Led Support Groups for Caregivers|Completed||Phase 1|||Thomas Jefferson University|||||f||||||||||||||2017-02-18 16:56:22.607326|2017-02-18 16:56:22.607326
NCT00265148|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2016-11-15||2010-10-13|May 2004||2004-05-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease|A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD)|Completed||Phase 2|80|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:54:09.568358|2017-02-18 16:54:09.568358
NCT00265135|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2014-07-01|||August 2003||2003-08-01|July 2014|2014-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma|A Phase I/II Study of a Chimeric Antibody Against Interleukin-6 (CNTO 328) in Subjects With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|68|Actual|Centocor, Inc.||3|||f||||t||||||||||2017-02-18 16:54:09.786025|2017-02-18 16:54:09.786025
NCT00265122|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-13|2014-01-20|2009-10-23||April 2004||2004-04-01|January 2014|2014-01-01|October 2006|Actual|2006-10-01|November 2005|Actual|2005-11-01||Interventional|||A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease|A Multicenter, Randomized, Phase 2a Study of Human Monoclonal Antibody to IL-12p40 (CNTO 1275) in Subjects With Moderately to Severely Active Crohn's Disease|Completed||Phase 2|131|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <=5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|6|||f||||f||||||||||2017-02-18 16:54:09.938211|2017-02-18 16:54:09.938211
NCT00265109|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2010-11-16|2010-10-18||December 2004||2004-12-01|November 2010|2010-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder|Open-Label Study of Levetiracetam in Body Dysmorphic Disorder|Completed||Phase 4|17|Actual|Butler Hospital||1|||f||||||||||||||2017-02-18 16:54:11.38671|2017-02-18 16:54:11.38671
NCT00265096|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2013-07-12|2009-05-21||December 2005||2005-12-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|May 2007|Actual|2007-05-01||Interventional|GO-REVEAL||A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa MonoclonalAntibody, Administered Subcutaneously in Subjects With Active Psoriatic Arthritis|Completed||Phase 3|407|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <=5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|3|||f||||t||||||||||2017-02-18 16:54:11.637893|2017-02-18 16:54:11.637893
NCT00265083|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2013-07-12|2009-05-21||December 2005||2005-12-01|July 2013|2013-07-01|January 2012|Actual|2012-01-01|March 2007|Actual|2007-03-01||Interventional|||A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalpha MonoclonalAntibody, Administered Subcutaneously, in Subjects With Active Ankylosing Spondylitis|Completed||Phase 3|356|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <= 5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|3|||f||||t||||||||||2017-02-18 16:54:12.937337|2017-02-18 16:54:12.937337
NCT00264719|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-11|2009-09-18|||January 2006||2006-01-01|September 2009|2009-09-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Metoclopramide to Aid Establishment of Breastfeeding:a Randomised Controlled Trial|Metoclopramide to Aid Establishment of Breastfeeding After Delivery: a Randomized Controlled Trial|Completed||N/A|160|Anticipated|National University Hospital, Singapore||4|||f||||t||||||||||2017-02-18 16:54:14.098514|2017-02-18 16:54:14.098514
NCT00264706|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-11|2016-09-07|||March 2005||2005-03-01|September 2016|2016-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||PolyArginine Treated vEiN grafTs (PATENT)|PolyArginine Treated vEiN grafTs (PATENT)|Terminated||Phase 1/Phase 2|25|Actual|Lumen Therapeutics||1||Reformulation of test compound|f||||||||||||||2017-02-18 16:54:14.215628|2017-02-18 16:54:14.215628
NCT00264693|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-11|2010-01-25|||January 2006||2006-01-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function|Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function|Completed||Phase 4|96|Actual|Luzerner Kantonsspital|||8||f||||||||||||||2017-02-18 16:54:14.315333|2017-02-18 16:54:14.315333
NCT00264680|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2011-05-05|||October 2003||2003-10-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy|Validation Of Qolie-10 For Epilepsy, Comparison Of Quality Of Life In Patients Treated With Lamotrigine Or Valproic Acid|Completed||Phase 4|155|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:54:14.40795|2017-02-18 16:54:14.40795
NCT00264667|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2016-10-26|||December 2005||2005-12-01|October 2016|2016-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Study In Patients With Dyslipidaemia|A Randomised,Double-blind, Parallel Group, Placebo-controlled, Multicentre Study to Evaluate the Safety, Tolerability and Efficacy of Oral GW677954 Capsules 2.5mg, 5mg, 10mg and 20mg a Day for 24 Weeks in Overweight Dyslipidaemic Subjects|Completed||Phase 2|290||GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:54:14.523935|2017-02-18 16:54:14.523935
NCT00264654|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2013-04-11|||October 2005||2005-10-01|May 2012|2012-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|SAD||Long-term Study Of Paroxetine in Women and Men|Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Social Phobia/Social Anxiety Disorder (SAD) -A Open-Label, Uncontrolled, Long-term Study- <Phase III Study>|Completed||Phase 3|50|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:54:14.74204|2017-02-18 16:54:14.74204
NCT00264641|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2006-03-27|||January 2006||2006-01-01|March 2006|2006-03-01|December 2006||2006-12-01|||||Observational|||The Impact of Renin-Angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study|The Impact of Renin-Angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study|Unknown status|Active, not recruiting|N/A|20||Hypoglycaemia Research Group|||||f||||||||||||||2017-02-18 16:54:14.83453|2017-02-18 16:54:14.83453
NCT00005437|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||February 1992||1992-02-01|August 2004|2004-08-01|January 1998||1998-01-01|||||Observational|||Physical Activity and Cardiovascular Risk in Black Girls||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.28743|2017-02-18 18:14:59.28743
NCT00264628|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2015-04-15|||October 2005||2005-10-01|April 2015|2015-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||GW679769 In Fibromyalgia|An Outpatient, Randomised, Double-blind, Placebo Controlled, Parallel Group Exploratory Study to Evaluate Safety, Tolerability and Efficacy of GW679769 in Patients With Fibromyalgia Syndrome Comorbid With Depression.|Completed||N/A|8|Actual|GlaxoSmithKline|||1||f||||||||||||||2017-02-18 16:54:14.92835|2017-02-18 16:54:14.92835
NCT00264615|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2016-09-22|||October 2005||2005-10-01|September 2016|2016-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa|An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa|Completed||Phase 3|45||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:54:15.190449|2017-02-18 16:54:15.190449
NCT00264602|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2017-02-02|||January 2009||2009-01-01|February 2017|2017-02-01|January 2019|Anticipated|2019-01-01|January 2019|Anticipated|2019-01-01||Interventional|||Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer|Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer|Recruiting||Phase 1|114|Anticipated|Dana-Farber Cancer Institute||1|||f||||f||||||||No||2017-02-18 16:54:15.301524|2017-02-18 16:54:15.301524
NCT00264589|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2015-03-26|||December 2005||2005-12-01|March 2015|2015-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Exercise Training and Cardiovascular Function in Obesity and in Type 2 Diabetes|Effects of an Individualized Training Program on Cardiovascular Function at Rest and During Exercise in Obese and in Type 2 Diabetic Subjects|Completed||Phase 4|59|Actual|Centre Hospitalier Universitaire de Nīmes||1|||f||||f||||||||||2017-02-18 16:54:15.415612|2017-02-18 16:54:15.415612
NCT00264576|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2012-12-20|2012-12-20||October 2005||2005-10-01|December 2012|2012-12-01|May 2006|Actual|2006-05-01|December 2005|Actual|2005-12-01||Interventional|||Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults|A Phase 2, Observer-Blinded, Randomized, Multicenter Study in Healthy Adults to Evaluate Safety and Tolerability and to Compare Immunogenicity of a Single Dose of Either an Investigational Trivalent Inactivated Influenza Vaccine Produced in Mammalian Cell Culture or a US-licensed Trivalent Inactivated Influenza Vaccine (Fluvirin®) Produced in Embryonated Hen Eggs|Completed||Phase 2|613|Actual|Novartis||2|||||||f||||||||||2017-02-18 16:54:15.52833|2017-02-18 16:54:15.52833
NCT00264563|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2011-06-16|||November 2005||2005-11-01|August 2005|2005-08-01|April 2006||2006-04-01|||||Observational|||"Iatrogenesis Imperfecta- Extent and Characteristic in NICU in Israel."||Completed||Phase 1|750|Anticipated|Bnai Zion Medical Center|||1||f||||||||||||||2017-02-18 16:54:16.159889|2017-02-18 16:54:16.159889
NCT00264550|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-11|2014-04-14|2009-05-21||December 2005||2005-12-01|April 2014|2014-04-01|May 2012|Actual|2012-05-01|September 2007|Actual|2007-09-01||Interventional|GO-FORWARD||An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy|A Multicenter, Randomized, Double-blind, Placebo-controlledTrial of Golimumab, a Fully Human Anti-TNFa MonoclonalAntibody, Administered Subcutaneously, in Subjects With ActiveRheumatoid Arthritis Despite Methotrexate Therapy|Completed||Phase 3|444|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <= 5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|4|||f||||t||||||||||2017-02-18 16:54:16.284743|2017-02-18 16:54:16.284743
NCT00264537|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-11|2014-08-27|2009-05-21||December 2005||2005-12-01|August 2014|2014-08-01|June 2012|Actual|2012-06-01|April 2008|Actual|2008-04-01||Interventional|||A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive|A Multicenter, Randomized, Double-blind, Placebo-controlledTrial of Golimumab, a Fully Human Anti-TNFa MonoclonalAntibody, Administered Subcutaneously, in Methotrexate-naive Subjects With Active Rheumatoid Arthritis|Completed||Phase 3|637|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in less than or equal to 5% of patients. This information may vary from existing approved labeling and publications.|4|||f||||t||||||||||2017-02-18 16:54:17.792339|2017-02-18 16:54:17.792339
NCT00264524|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2010-11-26|||January 2004||2004-01-01|January 2004|2004-01-01|July 2005||2005-07-01|||||Interventional|||DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease||Completed||N/A|||China Medical University Hospital|||||f||||||||||||||2017-02-18 16:54:19.59248|2017-02-18 16:54:19.59248
NCT00264511|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2016-01-13|||February 2006||2006-02-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|August 2014|Actual|2014-08-01||Interventional|||Hyperbaric Oxygen in Lower Leg Trauma|Does Hyperbaric Oxygen Reduce Complications and Improve Outcomes After Open Tibial Fractures With Severe Soft Tissue Injury? An International Multi-centre Randomized Controlled Trial.|Active, not recruiting||Phase 2/Phase 3|120|Anticipated|Bayside Health||2|||f||||t||||||||||2017-02-18 16:54:19.67475|2017-02-18 16:54:19.67475
NCT00264498|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2009-06-11|2009-06-11||October 2004||2004-10-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|||||Interventional|||Phase II Iressa & Carbo/Gem in NSCLC|A Randomized, Open-Label Phase II Study Of ZD1839 (IRESSA™) Versus Gemcitabine And Carboplatin In Chemotherapy-Naive Patients With Advanced (Stage IIIB OR IV) Non-Small Cell Lung Cancer And ECOG Performance Status 2|Completed||Phase 2|38|Actual|AstraZeneca|"No analysis of the efficacy results was performed as the study was prematurely terminated with only 35 out of the planned 122 subjects randomized.~Serious and Other adverse event data for Periods 1 and 2 were combined by treatment for this report."|2|||f||||||||||||||2017-02-18 16:54:19.802156|2017-02-18 16:54:19.802156
NCT00264485|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2011-05-18|||March 2004||2004-03-01|April 2010|2010-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Total Hip Replacement: The E-TRANS Fentanyl Transdermal System Versus the Morphine Intravenous Pump|Comparison of the Safety and Efficacy of Patient Controlled Analgesia Delivered by the E-TRANS Fentanyl HCl Transdermal System Versus Morphine IV Pump for Pain Management After Primary Unilateral Total Hip Replacement|Completed||Phase 3|799|Actual|Alza Corporation, DE, USA||1|||||||||||||||||2017-02-18 16:54:20.266782|2017-02-18 16:54:20.266782
NCT00264290|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2013-11-07|2013-08-13||August 2006||2006-08-01|November 2013|2013-11-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Valganciclovir to Reduce T Cell Activation in HIV Infection|Valganciclovir to Reduce T Cell Activation in HIV Infection|Completed||Phase 4|30|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 16:54:22.929316|2017-02-18 16:54:22.929316
NCT00264472|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2008-12-12|||January 2006||2006-01-01|December 2008|2008-12-01||||June 2009|Anticipated|2009-06-01||Interventional|||A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors|A 2-Part Phase 1 Study Evaluating the Safety and Anti-Tumor Activity of ADH300004 (Eniluracil) Administered With 5-Fluorouracil (5-FU), and the Pharmacokinetics of 5-FU Given as: 5.0 mg ADH300004 With Escalating Doses of 5-FU Administered Orally 3 Weeks Out of 4 in Subjects With Refractory Solid Tumors (Part 1); or 5.0 mg ADH300004 With 5 FU Administered Orally as a Split Dose for 3 Weeks Out of 4 in Subjects With Hepatocellular Carcinoma, Non-Small Cell Lung Carcinoma, Gastric Cancer, Cervical Cancer, Prostate Cancer, or Breast Cancer (Part 2) (Adherex Protocol Number AHX-03-104)|Suspended||Phase 1|60|Anticipated|Adherex Technologies, Inc.||1||Lack of funds|f||||||||||||||2017-02-18 16:54:20.360574|2017-02-18 16:54:20.360574
NCT00264459|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2014-01-23|||February 2003||2003-02-01|January 2014|2014-01-01|September 2011|Actual|2011-09-01|August 2008|Actual|2008-08-01||Interventional|||Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture|A Multicentre, Placebo-controlled, Double-blind Study to Evaluate Efficacy and Safety of a Perennial Sublingual Specific Immunotherapy With a Liquid Formulation of an Extract of a Six Grass Pollen-mixture in Patients With Clinically Relevant Grass Pollen Sensitivity.|Completed||Phase 3|160|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 16:54:20.460411|2017-02-18 16:54:20.460411
NCT00264446|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2007-08-03||||||August 2007|2007-08-01||||||||Interventional|||A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection|Phase 1 Study of the Evaluation of Dihydropyrimidine Dehydrogenase (DPD), Uridine Phosphorylase (UP), Orotate Phosphoribosyl Transferase (OPRT), and Thymidine Phosphorylase (TP) Activity in Tissue Resected From Subjects Undergoing Planned Resection of Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection, Following Administration of Oral ADH300004 (Adherex Protocol Number AHX-03-101)|Completed||Phase 1|||Adherex Technologies, Inc.|||||||||||||||||||2017-02-18 16:54:20.57177|2017-02-18 16:54:20.57177
NCT00264433|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-12|2007-08-03||||||August 2007|2007-08-01||||||||Interventional|||A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent|An Open-Label Phase 2a Study in Subjects With N-Cadherin Positive, Advanced or Recurrent Solid Tumors to Investigate the Safety and Efficacy of ADH-1 Administered Intravenously as a Single Agent (Adherex Protocol Number AHX-01-201)|Completed||Phase 2|||Adherex Technologies, Inc.|||||||||||||||||||2017-02-18 16:54:20.654119|2017-02-18 16:54:20.654119
NCT00264420|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2010-12-20|||December 2005||2005-12-01|December 2010|2010-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation|A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer|Completed||Phase 1|4|Actual|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 16:54:20.74035|2017-02-18 16:54:20.74035
NCT00264407|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2005-12-08|||January 2001||2001-01-01|December 2005|2005-12-01|February 2005||2005-02-01|||||Observational|||Neural Changes in the Aging Auditory System|Age-Related Hearing Loss: Presbycusis & Its Neural Bases|Completed||Phase 1|126||University of Rochester|||||f||||||||||||||2017-02-18 16:54:20.878179|2017-02-18 16:54:20.878179
NCT00264394|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2015-05-27|||July 2006||2006-07-01|May 2015|2015-05-01|February 2010|Actual|2010-02-01|October 2008|Actual|2008-10-01||Interventional|||Cardiovascular Risk Factor Management in HIV Infection|Efficacy of a Computerised Physician Reminder System to Control Cardiovascular Risk Factors in HIV-infected Patients Receiving Antiretroviral Therapy: A Nested Randomised Controlled Cluster Trial Within the Swiss HIV Cohort Study|Completed||Phase 4|4097|Actual|University Hospital, Basel, Switzerland||2|||f||||t||||||||||2017-02-18 16:54:20.977231|2017-02-18 16:54:20.977231
NCT00264381|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2013-11-14|2013-11-14||October 2002||2002-10-01|November 2013|2013-11-01|September 2011|Actual|2011-09-01|September 2009|Actual|2009-09-01||Interventional|||Management of Superficial Thrombophlebitis|Management of Superficial Thrombophlebitis|Completed||Phase 4|72|Actual|University of Oklahoma||1|||f||||f||||||||||2017-02-18 16:54:21.115637|2017-02-18 16:54:21.115637
NCT00264368|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2007-06-27|||December 2005||2005-12-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy|Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy|Terminated||Phase 4|6|Anticipated|University of Oslo School of Pharmacy|||||f||||||||||||||2017-02-18 16:54:21.51542|2017-02-18 16:54:21.51542
NCT00264355|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2007-09-05|||December 2005||2005-12-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Metabolic Pattern of Cyclosporine A and Acute Renal Failure|Metabolic Pattern of Cyclosporine A - Association of Secondary- and Cyclic Metabolites With Acute Renal Failure in Heart Transplant Recipients|Completed||Phase 4|30|Anticipated|University of Oslo School of Pharmacy|||||f||||||||||||||2017-02-18 16:54:21.619416|2017-02-18 16:54:21.619416
NCT00264342|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2013-05-21|||July 2005||2005-07-01|May 2013|2013-05-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Observational|||Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction|Safety of Nicotine Reduction Strategy|Completed||N/A|135|Actual|University of California, San Francisco|||1||f||||t||||||Samples Without DNA|"~     Tissue (blood) and urine~   "|||2017-02-18 16:54:21.708959|2017-02-18 16:54:21.708959
NCT00264329|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2016-11-16|||November 2004||2004-11-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|April 2006|Actual|2006-04-01||Interventional|||Transitional Case Management Study|Transitional Case Management Study|Completed||Phase 3|812|Actual|University of California, Los Angeles||1|||f||||||||||||||2017-02-18 16:54:21.889619|2017-02-18 16:54:21.889619
NCT00264316|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2013-01-16|||May 2003||2003-05-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Bone Marrow-Derived Stem Cell Transfer in Acute Myocardial Infarctions|A Double-blind, Randomised, Controlled Study of Autologous Bone Marrow-Derived Stem Cell Transfer In Patients With ST-Segment Elevation Myocardial Infarction.|Completed||Phase 2|68||Universitaire Ziekenhuizen Leuven|||||f||||||||||||||2017-02-18 16:54:21.980518|2017-02-18 16:54:21.980518
NCT00264303|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2011-08-30|2009-05-18||December 2005||2005-12-01|June 2011|2011-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||CUTE (Chronic Urticaria Treatment Evaluation)|A Comparative Study on Clinical Efficacy and Safety of Levocetirizine 5 mg Oral Capsules Once Daily in the Morning vs. Desloratadine 5 mg Oral Capsules Once Daily in the Morning in Patients Suffering From Chronic Idiopathic Urticaria (CIU)|Completed||Phase 4|886|Actual|UCB Pharma||2|||f||||||||||||||2017-02-18 16:54:22.077433|2017-02-18 16:54:22.077433
NCT00264277|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2016-11-22|||September 2002||2002-09-01|November 2016|2016-11-01|September 2005||2005-09-01|December 2004|Actual|2004-12-01||Interventional|||D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism|"D-dimer Test to Establish Duration of Anticoagulation After a First Idiopathic Episode of Venous Thromboembolism; the Prospective Randomized Prolong Study"|Completed||Phase 4|600||St. Orsola Hospital|||||f||||||||||||||2017-02-18 16:54:23.335684|2017-02-18 16:54:23.335684
NCT00264264|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2013-05-15|||July 2006||2006-07-01|May 2013|2013-05-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Arterial Closure vs Direct Compression for Hemostasis After PCI - The ACDC Trial|Arterial Closure vs Direct Compression for Hemostasis After Percutaneous Coronary Interventions|Completed||N/A|572|Actual|St. Michael's Hospital, Toronto||2|||f||||||||||||||2017-02-18 16:54:23.443217|2017-02-18 16:54:23.443217
NCT00264251|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2007-10-26|||July 2005||2005-07-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance|Effect of Diet, Exercise and Rosiglitazone on Regional Fat and Insulin Resistance in HIV-Infected and Uninfected Men and Women|Completed||N/A|48|Anticipated|St. Luke's-Roosevelt Hospital Center|||||f||||t||||||||||2017-02-18 16:54:23.557448|2017-02-18 16:54:23.557448
NCT00264238|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2009-04-08|||January 2006||2006-01-01|April 2009|2009-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Memantine Augmentation in Obsessive-Compulsive Disorder|An Open-Label Trial of Memantine to Augment Response in the Treatment of Obsessive-Compulsive Disorder|Completed||N/A|15|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 16:54:23.654108|2017-02-18 16:54:23.654108
NCT00264225|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-02-15|||December 2005||2005-12-01|February 2008|2008-02-01||||||||Interventional|||Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)|A Randomized, Double-Blind, Comparative Parallel Group Study of Analgesic Effectiveness and Safety of Three Different Doses of Lamaline® New Formulation vs Dafalgan® Codeine, After 10 Days Administration in Subjects With Painful Gonarthrosis.|Completed||Phase 3|||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 16:54:23.759589|2017-02-18 16:54:23.759589
NCT00264212|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2007-12-17|||August 2004||2004-08-01|December 2007|2007-12-01||||||||Interventional|||AMISH : Aprovel for Management of Isolated Systolic Hypertension|A Multicentre Prospective Randomized Open-Label 12-Week Study With Blinded Evaluation Comparing the Efficacy and Safety of Irbesartan and Irbesartan-Hydrochlorothiazide Fixed Combination With Amlodipine and Amlodipine Plus Hydrochlorothiazide in Elderly Patients With Isolated Systolic Hypertension|Completed||Phase 4|436||Sanofi|||||f||||||||||||||2017-02-18 16:54:24.230122|2017-02-18 16:54:24.230122
NCT00264199|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2007-12-18|||December 2005||2005-12-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure|The Effect of 48 Hours GLP-1 Infusion on Left Ventricular Function, Exercise Capacity, Insulin Sensitivity and Substrate Metabolism in Patients With Chronic Heart Failure|Completed||N/A|20|Actual|Aarhus University Hospital Skejby||2|||f||||f||||||||||2017-02-18 16:54:24.329155|2017-02-18 16:54:24.329155
NCT00264186|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-05-21|||June 2005||2005-06-01|May 2008|2008-05-01||||||||Interventional|||Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity|Impact of rhCu/Zn SOD on Inflammation-Induced Impairment of Vascular Reactivity|Completed||Phase 1|43||Medical University of Vienna|||||f||||f||||||||||2017-02-18 16:54:24.441569|2017-02-18 16:54:24.441569
NCT00264173|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2007-11-15|||February 2004||2004-02-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||VALID : VAlproate Versus LIthium in Bipolar Disorders|A Twelve-Week, Open, Randomized Trial Comparing Valproate to Lithium in Bipolar I Patients Suffering From a Manic Episode|Completed||Phase 4|270||Sanofi|||||f||||||||||||||2017-02-18 16:54:24.533555|2017-02-18 16:54:24.533555
NCT00264160|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2012-08-06|||May 2006||2006-05-01|August 2012|2012-08-01|August 2009|Actual|2009-08-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy|Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy|Completed||Phase 2/Phase 3|36|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:54:24.800343|2017-02-18 16:54:24.800343
NCT00264147|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2015-01-29|2009-03-19||January 2006||2006-01-01|January 2015|2015-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)|A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel-Group, 12-Week Study to Assess the Clinically Effective Dose Range of Etoricoxib and to Assess Its Safety and Tolerability in Patients With Rheumatoid Arthritis|Completed||Phase 2|761|Actual|Merck Sharp & Dohme Corp.||7|||f||||||||||||||2017-02-18 16:54:24.923773|2017-02-18 16:54:24.923773
NCT00264134|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2010-01-18|||June 2003||2003-06-01|January 2010|2010-01-01|October 2005||2005-10-01|||||Interventional|||Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer|A Phase I/II Trial: Docetaxel, Irinotecan, and Carboplatin in the Treatment of Extensive Stage Small Cell Lung Carcinoma|Terminated||Phase 1/Phase 2|40||Kentuckiana Cancer Institute|||||f||||||||||||||2017-02-18 16:54:27.230313|2017-02-18 16:54:27.230313
NCT00264121|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-05-21|||June 2005||2005-06-01|May 2008|2008-05-01|June 2008||2008-06-01|||||Observational|||The Incidence of Congenital Undescended Testis Among Dutch Infants|The Incidence of Congenital Undescended Testis Among Dutch Infants in the Medical Centre Alkmaar|Unknown status|Recruiting|N/A|3000|Anticipated|Medical Center Alkmaar|||||f||||||||||||||2017-02-18 16:54:27.318812|2017-02-18 16:54:27.318812
NCT00264108|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2014-05-06|||June 2005||2005-06-01|May 2014|2014-05-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia|EPREX (Epoetin Alfa) Versus ARANESP (Darbepoetin Alfa): Looking at Outcome of Anemia Treatment and Comparing Cost-effectiveness (EVALUATE).|Completed||Phase 4|492|Actual|Janssen-Cilag B.V.|||2||f||||||||||||||2017-02-18 16:54:27.429066|2017-02-18 16:54:27.429066
NCT00264095|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2014-04-25|||July 2004||2004-07-01|April 2014|2014-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||An Observational Study of Blood Management Techniques in Oncology Surgical Treatment|Blood Management Observation in Oncology Surgical Treatment (BOOST)|Completed||Phase 4|488|Actual|Janssen-Cilag B.V.|||1||f||||||||||||||2017-02-18 16:54:27.671593|2017-02-18 16:54:27.671593
NCT00263536|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2017-01-24|||December 5, 2005||2005-12-05|August 16, 2016|2016-08-16|August 16, 2016|Actual|2016-08-16|August 16, 2016|Actual|2016-08-16||Interventional|||Pilot Program for Targeted Prevention of Child or Adolescent Weight Gain|Pilot Program for Targeted Prevention of Child or Adolescent Weight Gain|Completed||Phase 1|147|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:54:35.240715|2017-02-18 16:54:35.240715
NCT00264082|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2013-04-08|||September 2004||2004-09-01|April 2013|2013-04-01||||May 2006|Actual|2006-05-01||Observational|||Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis|"Tartrate-Resistant Acid Phosphatase as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis During Zometa Treatment: A Pilot Study"|Completed||Phase 2|30|Anticipated|James Graham Brown Cancer Center|||||f||||||||||||||2017-02-18 16:54:27.783176|2017-02-18 16:54:27.783176
NCT00264069|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2011-05-18|||June 2005||2005-06-01|April 2010|2010-04-01|June 2006|Actual|2006-06-01|||||Observational|||ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry|"Study ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: Mental Health Registry"|Completed||N/A|2622|Actual|Janssen-Cilag, S.A.|||2||f||||||||||||||2017-02-18 16:54:27.863113|2017-02-18 16:54:27.863113
NCT00264056|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2005-12-08|||December 2005||2005-12-01|November 2005|2005-11-01|June 2007||2007-06-01|||||Interventional|||Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases|Evaluation of the Safety and Efficacy of Systemic Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Locally Inoperable Progressive Soft Tissue Metastases|Unknown status|Recruiting|N/A|26||Fachklinik Hornheide an der Universität Münster|||||f||||||||||||||2017-02-18 16:54:27.964679|2017-02-18 16:54:27.964679
NCT00264043|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-08-05|||May 2000||2000-05-01|August 2008|2008-08-01|June 2002|Actual|2002-06-01|February 2002|Actual|2002-02-01||Interventional|DISCOVER||The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.|Distal Protection Combined With Velocity in Coronary Arteries and SVBG Registry.|Completed||Phase 2/Phase 3|100|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 16:54:28.045836|2017-02-18 16:54:28.045836
NCT00264030|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-01-04|||March 2002||2002-03-01|January 2008|2008-01-01|August 2004|Actual|2004-08-01|||||Interventional|DIPLOMAT||Distal Protection Combined With PTCA in AMI Patients|Distal Protection Combined With PTCA in AMI Patients -- The DIPLOMAT Study.|Completed||Phase 2|56|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 16:54:28.156853|2017-02-18 16:54:28.156853
NCT00264017|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2005-12-06|||November 2005||2005-11-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy Analysis|Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs Twice Daily Dosing of Flomax-A 3 Month Retrospective Efficacy Analysis|Completed||N/A|60||Dattoli Cancer Center and Brachytherapy Research Institute|||||f||||||||||||||2017-02-18 16:54:28.266876|2017-02-18 16:54:28.266876
NCT00264004|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2012-07-26|2012-07-26||November 2005||2005-11-01|July 2012|2012-07-01|April 2011|Actual|2011-04-01|January 2007|Actual|2007-01-01||Interventional|||Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours|A Phase II, Randomised, Factorial, Double-blind Study to Investigate the Management of AZD2171-induced Hypertension and Efficacy of AZD2171 at Doses of 30 mg and 45 mg in Patients With Advanced Solid Tumours|Completed||Phase 2|119|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:54:28.345868|2017-02-18 16:54:28.345868
NCT00263991|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2005-12-09||||||August 2005|2005-08-01||||||||Observational|||Cortical Reorganisation in Patients With Primary Headache Disorders|Cortical Reorganisation in Patients With Primary Headache Disorders|Unknown status|Active, not recruiting|N/A|||Danish Headache Center|||||f||||||||||||||2017-02-18 16:54:29.551337|2017-02-18 16:54:29.551337
NCT00263978|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2014-06-27|||November 2005||2005-11-01|June 2014|2014-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Expanded Access|||Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver|Defibrotide Compassionate Use Protocol for Patients With Life Threatening Veno-Occlusive Disease of the Liver|No longer available||N/A|||Emory University||||poor enrollment|f||||f||||||||||2017-02-18 16:54:29.629152|2017-02-18 16:54:29.629152
NCT00263965|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2008-03-14|||August 2005||2005-08-01|March 2008|2008-03-01|July 2006|Actual|2006-07-01|||||Interventional|||ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity|A 16-Week Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo- and Active- (Metformin) Controlled Study to Evaluate the Effect on Whole Body Insulin Sensitivity of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes|Terminated||Phase 2|105||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:54:29.724391|2017-02-18 16:54:29.724391
NCT00263952|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2013-03-01|||March 2003||2003-03-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|January 2005|Actual|2005-01-01||Interventional|||Efficacy and Safety of a Purified Standardised Bee Venom Preparation|Immunotherapy of Bee Venom Allergy: Evaluation of a New Purified Bee Venom Preparation in Comparison With Already Published Studies.|Completed||Phase 3|||Allergopharma GmbH & Co. KG|||||f||||f||||||||||2017-02-18 16:54:29.823341|2017-02-18 16:54:29.823341
NCT00263939|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2010-10-04|||July 2004||2004-07-01|February 2010|2010-02-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Homing in on Health: Study of a Home Delivered Chronic Disease Self Management Program|A Randomized Trial of Home Self-Efficacy Enhancement|Completed||N/A|415|Actual|Agency for Healthcare Research and Quality (AHRQ)||3|||f||||t||||||||||2017-02-18 16:54:29.909845|2017-02-18 16:54:29.909845
NCT00263926|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-09|2013-03-08|||March 2001||2001-03-01|March 2013|2013-03-01|November 2010|Actual|2010-11-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety of a Purified Standardised Wasp Venom Preparation|Immunotherapy of Wasp Venom Allergy: Comparison of a Purified Preparation to Conventional Aqueous Wasp Venom in an Open Controlled Study|Completed||Phase 3|||Allergopharma GmbH & Co. KG|||||f||||||||||||||2017-02-18 16:54:30.029252|2017-02-18 16:54:30.029252
NCT00263900|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2011-04-20|||December 2005||2005-12-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|||TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit|Exploratory Study of the Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit and Their Impact on the Assumption of Responsibility of the Suspect Children of a Viral Infection|Completed||N/A|377|Actual|University Hospital, Rouen||1|||f||||f||||||||||2017-02-18 16:54:30.110294|2017-02-18 16:54:30.110294
NCT00263887|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-08-05|2009-09-24||December 2003||2003-12-01|August 2014|2014-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)|Multi-center, Randomized Trial With I.V. Prolastin® to Evaluate Frequency of Exacerbations and Progression of Emphysema by Means of Multi-slice CT Scans in Patients With Congenital Alpha-1-antitrypsin Deficiency.|Completed||Phase 2|77|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 16:54:30.202266|2017-02-18 16:54:30.202266
NCT00263874|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2007-07-20|||November 2005||2005-11-01|July 2007|2007-07-01|September 2006||2006-09-01|||||Interventional|||Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD|A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of UK-500,001 Dry Powder For Inhalation (DPI) In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).|Terminated||Phase 2|324||Pfizer||||"The decision to terminate was completely related to efficacy and there were no safety~   concerns."|f||||||||||||||2017-02-18 16:54:30.905188|2017-02-18 16:54:30.905188
NCT00263861|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2010-06-10|||March 2005||2005-03-01|June 2010|2010-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid Tumors|Impact of Treatment With Taxane or Platinum-Containing Regimens on Peripheral Nerve Functioning in Older Cancer Patients With Diabetes: An Exploratory Study|Completed||N/A|14|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:54:31.011125|2017-02-18 16:54:31.011125
NCT00263835|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2010-03-01|||October 2004||2004-10-01|March 2010|2010-03-01|May 2006||2006-05-01|||||Interventional|||A Self-care Intervention for Latino Adults With Diabetes|A Self-care Intervention for Latino Adults With Diabetes|Completed||Phase 2|300||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:54:31.112579|2017-02-18 16:54:31.112579
NCT00263822|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2013-08-26|||September 2005||2005-09-01|August 2013|2013-08-01||||February 2008|Actual|2008-02-01||Interventional|||Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer|A Randomized, Multicenter, Phase III Study of Erlotinib Versus Observation in Patients With no Evidence of Disease Progression After First Line, Platinum-Based Chemotherapy For High-Risk Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|Completed||Phase 3|835|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 16:54:31.189137|2017-02-18 16:54:31.189137
NCT00263809|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2009-10-06|||December 2005||2005-12-01|October 2009|2009-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products|Evaluation of the Safety and Performance of Platelet Transfusion Products Treated With MIRASOL® Pathogen Reduction Technology. A Study in Human Thrombocytopenic Subjects.|Completed||Early Phase 1|118|Actual|Terumo BCTbio||2|||f||||||||||||||2017-02-18 16:54:31.484764|2017-02-18 16:54:31.484764
NCT00263796|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2014-04-28|||March 2006||2006-03-01|April 2014|2014-04-01|September 2012|Actual|2012-09-01|October 2010|Actual|2010-10-01||Interventional|||An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism|An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism|Completed||Phase 1|16|Actual|Anagnostou, Evdokia, M.D.||2|||f||||t||||||||||2017-02-18 16:54:31.603377|2017-02-18 16:54:31.603377
NCT00263783|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2009-01-28|||March 2001||2001-03-01|January 2009|2009-01-01|June 2002|Actual|2002-06-01|April 2002|Actual|2002-04-01||Interventional|||Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors|Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors|Completed||Phase 1|24||MedImmune LLC||1|||f||||||||||||||2017-02-18 16:54:31.704552|2017-02-18 16:54:31.704552
NCT00263770|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2011-05-18|||December 2005||2005-12-01|May 2011|2011-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Treatment Study of Soft Palatal Implants in Obstructive Sleep Apnea|A Randomized, Controlled Treatment Trial of Soft Palatal Implants and Positive Airway Pressure in Mild to Moderate Obstructive Sleep Apnea and Snoring|Completed||N/A|64|Actual|Mayo Clinic||3|||f||||f||||||||||2017-02-18 16:54:31.788691|2017-02-18 16:54:31.788691
NCT00263757|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2014-07-07|2014-05-30||October 2009||2009-10-01|July 2014|2014-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Atrial Fibrillation Recurrence in Sleep Apnea|A Randomized Trial of Positive Airway Pressure Therapy In Atrial Fibrillation Recurrence In Sleep Apnea|Completed||N/A|25|Actual|Mayo Clinic|The primary barrier to enrollment was the high rate of subjects who were previously diagnosed with sleep apnea and were already prescribed treatment.|2|||f||||t||||||||||2017-02-18 16:54:31.897574|2017-02-18 16:54:31.897574
NCT00263744|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2009-01-07|||November 1999||1999-11-01|January 2009|2009-01-01|June 2001|Actual|2001-06-01|April 2001|Actual|2001-04-01||Interventional|||Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive|A Phase I/II Study to Evaluate the Safety and Immunogenicity of MEDI-517, a Virus-Like Particle Vaccine Against Human Papillomavirus (HPV) Types 16 and 18, in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive|Completed||Phase 1/Phase 2|60|Actual|MedImmune LLC||2|||f||||||||||||||2017-02-18 16:54:32.469139|2017-02-18 16:54:32.469139
NCT00263731|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2016-11-21|||December 2005||2005-12-01|November 2016|2016-11-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Metabolomic Analysis of Lung Cancer|Preoperative Metabolomic Analysis of Primary Lung Cancer: A Translational Clinical Trial of the Brown Cancer Center|Recruiting||Phase 1|750|Anticipated|James Graham Brown Cancer Center|||3||f||||t||||||||||2017-02-18 16:54:32.567321|2017-02-18 16:54:32.567321
NCT00263718|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2015-03-25|||December 2005||2005-12-01|March 2015|2015-03-01|May 2006||2006-05-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris|Calcipotriol Plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle Alone in Psoriasis Vulgaris|Completed||Phase 2|360||LEO Pharma|||||f||||||||||||||2017-02-18 16:54:32.689246|2017-02-18 16:54:32.689246
NCT00263705|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-23|||January 2003||2003-01-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study|Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study|Completed||Phase 2|43|Actual|Jules Bordet Institute||1|||f||||f||||||||||2017-02-18 16:54:32.788895|2017-02-18 16:54:32.788895
NCT00263549|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2013-02-08|||September 2002||2002-09-01|February 2013|2013-02-01|February 2006|Actual|2006-02-01|February 2005|Actual|2005-02-01||Interventional|||Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis|Multicenter Study for Evaluation of Efficacy and Safety of Perennial Specific Immunotherapy With a Depot House Dust Mite Allergen Extract (D. Pteronyssinus 100%) in Patients With House Dust Mite Sensitivity|Completed||Phase 4|||Allergopharma GmbH & Co. KG|||||f||||f||||||||||2017-02-18 16:54:35.148812|2017-02-18 16:54:35.148812
NCT00263523|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2017-01-24|||December 5, 2005||2005-12-05|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY|PET Imaging of Brain 5-HT1A Receptors Using [11C](-)-RWAY|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:54:35.332564|2017-02-18 16:54:35.332564
NCT00263692|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2016-09-14|||November 2002||2002-11-01|September 2016|2016-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety|Open, Randomized, Phase II, Clinical Trial to Compare the Immunogenicity and Safety of a Booster Dose of GSK Biologicals' DTaP-IPV Vaccine (Infanrix®-IPV) Co-administered With a Booster Dose of Merck and Company's M-M-R®II, to That of Separate Injections of GSK Biologicals' DTaP Vaccine (Infanrix®), Aventis Pasteur's IPV (IPOL®) and M-M-R®II Administered as Booster Doses to Healthy Children 4 to 6 Years of Age.|Completed||Phase 2|401|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:54:32.901443|2017-02-18 16:54:32.901443
NCT00263679|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2016-09-14|||November 2003||2003-11-01|September 2016|2016-09-01|October 2004|Actual|2004-10-01|May 2004|Actual|2004-05-01||Interventional|||Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.|A Phase III, Double-blinded, Randomized, Multicenter, Clinical Study to Assess the Safety and Immunogenicity of GSK Biologicals' Tdap 0.3 mg Candidate Vaccine When Given as a Booster Dose to Healthy School Children and Adolescents (9-13 Years of Age), Previously Vaccinated With a 5th Consecutive Dose of Acellular Pertussis-containing Vaccine, in Studies APV-118 or APV-120|Completed||Phase 3|321|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:54:33.016474|2017-02-18 16:54:33.016474
NCT00263666|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2016-11-09|2009-02-13||March 2005||2005-03-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa|A Phase II, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Reactogenicity and Immunogenicity of Three Doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine|Completed||Phase 2|100|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:54:33.146557|2017-02-18 16:54:33.146557
NCT00263653|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2016-09-20|||March 2005||2005-03-01|September 2016|2016-09-01|September 2005|Actual|2005-09-01|March 2005|Actual|2005-03-01||Interventional|||Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197|Study to Evaluate the Safety, Reactogenicity & Immunogenicity of a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™, vs Hib-MenC or Priorix™ Only, in Toddlers (13-14 m) Primed With 3 Doses of Hib (as Part of a DTPa -Containing Vaccine) & MenC-CRM197 Conjugate Vaccines.|Completed||Phase 3|297|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:54:34.078005|2017-02-18 16:54:34.078005
NCT00263640|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2015-01-14|||May 2005||2005-05-01|January 2015|2015-01-01|August 2012|Actual|2012-08-01|April 2009|Actual|2009-04-01||Interventional|||Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma|A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Specific Immunotherapy With an Alum.-Adsorbed Allergoid Preparation of House Dust Mite (D. Pteronyssinus) in Patients With Allergic Bronchial Asthma, Rhinitis, Rhinoconjunctivitis|Completed||Phase 3|130|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 16:54:34.188332|2017-02-18 16:54:34.188332
NCT00263627|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2014-07-02|||June 2005||2005-06-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens|A Multicentre Randomised Placebo-controlled Double-blind Clinical Trial for Evaluation of Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens|Completed||Phase 3|253|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 16:54:34.308658|2017-02-18 16:54:34.308658
NCT00263614|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2009-01-30|||December 2005||2005-12-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|||||Observational|||Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.|A Cross Sectional and Retrospective Evaluation in HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B (CHB)Patients With Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases(The MELT Study).|Completed||Phase 4|100|Anticipated|Gilead Sciences|||||f||||||||||||||2017-02-18 16:54:34.423934|2017-02-18 16:54:34.423934
NCT00263601|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2014-06-04|||November 2001||2001-11-01|June 2014|2014-06-01|August 2010|Actual|2010-08-01|May 2004|Actual|2004-05-01||Interventional|||Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis|A Multicentre, Placebo Controlled, Double-Blind Study for Evaluation of Safety and Efficacy of Preseasonal Specific Immunotherapy With an Allergoid Preparation of an Extract of a 6 Grass Pollen Mixture in Patients With Clinically Relevant Grass Pollen Sensitivity|Completed||Phase 3|154|Actual|Allergopharma GmbH & Co. KG||2|||f||||f||||||||||2017-02-18 16:54:34.499471|2017-02-18 16:54:34.499471
NCT00263588|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2016-08-07|||December 2005||2005-12-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|September 2007|Actual|2007-09-01||Interventional|||Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer|A Phase II Study of Lapatinib for Brain Metastases in Subjects With ErbB2-Positive Breast Cancer Following Trastuzumab-based Systemic Therapy and Cranial Radiotherapy|Active, not recruiting||Phase 2|244|Actual|Novartis||1|||f||||f||||||||||2017-02-18 16:54:34.615122|2017-02-18 16:54:34.615122
NCT00263575|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2013-01-31|||January 2005||2005-01-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients|A Multiple-Dose, Non-Randomized, Open-Label, Multicenter Study to Evaluate the Long-Term Safety and Effectiveness of EN3267 in the Treatment of Breakthrough Pain in Cancer Patients|Completed||Phase 3|97|Actual|Prostrakan Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:54:34.927116|2017-02-18 16:54:34.927116
NCT00263562|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-08|2010-11-30|||December 2005||2005-12-01|November 2010|2010-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Steroid Treatment for Sickle Cell Pain Crisis|Randomized Trial of High-dose Intravenous Methylprednisolone and Steroid Taper for Vaso-occlusive Crises in Sickle Cell Disease|Completed||Phase 3|80|Anticipated|Baylor College of Medicine|||||f||||||||||||||2017-02-18 16:54:35.042268|2017-02-18 16:54:35.042268
NCT00263497|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2012-05-11|||March 2006||2006-03-01|May 2012|2012-05-01|December 2012|Anticipated|2012-12-01|October 2012|Anticipated|2012-10-01||Interventional|||Temporary Prosthesis in Traumatic Below-knee Amputation|Immediate Temporary Prosthesis Fitting in Traumatic Trans-tibial Amputation: a Controlled Clinical Study in Rural Cambodia|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital of North Norway||1|||f||||t||||||||||2017-02-18 16:54:35.412996|2017-02-18 16:54:35.412996
NCT00263484|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2011-07-19|||December 2005||2005-12-01|July 2011|2011-07-01|October 2010|Actual|2010-10-01|October 2008|Actual|2008-10-01||Interventional|dtZ||Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma|An International, Multicenter, Non-Randomized, Open-Labeled Study to Evaluate the Efficacy of Lower Dose Dexamethasone/Thalidomide and Higher Frequency ZOMETA(TM) in the Treatment of Previously Untreated Patients With Multiple Myeloma|Completed||Phase 2|56|Actual|Gleneagles Hospital||1|||f||||t||||||||||2017-02-18 16:54:35.499649|2017-02-18 16:54:35.499649
NCT00263471|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2005-12-13|||October 2003||2003-10-01|October 2003|2003-10-01|March 2006||2006-03-01|||||Interventional|||Myopia Progression and the Effect of 7-Methylxanthine|Phase 2 Study of the Effect of 7-Methylxanthine on the Progression of Childhood Myopia|Unknown status|Active, not recruiting|Phase 2|90||Trier Research Laboratories|||||f||||||||||||||2017-02-18 16:54:35.815974|2017-02-18 16:54:35.815974
NCT00263458|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2011-09-08|||December 2005||2005-12-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|BHIVES-SF||Integrating Buprenorphine Into the SFGH AIDS Program|Integrating Buprenorphine Into the SFGH AIDS Program (Patient Evaluation Study)|Completed||Phase 4|37|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 16:54:35.895422|2017-02-18 16:54:35.895422
NCT00263445|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2014-12-01|||August 2004||2004-08-01|December 2014|2014-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Constructing an Insulin-Like Growth Factor-based Prediction Model|Constructing an Insulin-Like Growth Factor-based Prediction Model|Terminated||Phase 1/Phase 2|30|Actual|University of California, Los Angeles|||1|Insufficient recruitment|f||||||||||||||2017-02-18 16:54:36.02191|2017-02-18 16:54:36.02191
NCT00263432|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2014-12-04|||August 2011||2011-08-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes|Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes|Unknown status|Recruiting|N/A|10|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 16:54:36.110989|2017-02-18 16:54:36.110989
NCT00263419|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2011-10-26|||January 2005||2005-01-01|October 2011|2011-10-01|June 2012|Anticipated|2012-06-01|March 2012|Anticipated|2012-03-01||Interventional|HEIDIS||Stress-relief Management for Treatment of Late Complications in Type 2 Diabetes|Psychosoziale Intervention Zur Reduktion Diabetischer Spätschäden Bei Diabetes Mellitus Typ 2|Unknown status|Active, not recruiting|N/A|110|Actual|Heidelberg University||1|||f||||||||||||||2017-02-18 16:54:36.201988|2017-02-18 16:54:36.201988
NCT00263406|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2007-12-19|||December 2002||2002-12-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation|Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation|Completed||Phase 2|40||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:54:36.298104|2017-02-18 16:54:36.298104
NCT00263393|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-06-21|||December 2005||2005-12-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|RAPCAPS||Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)|Evaluation of a Primary Health Care Intervention for the Prevention of Cardiovascular Disease in Rural Andhra Pradesh|Completed||Phase 4|3712|Actual|The George Institute||2|||f||||||||||||||2017-02-18 16:54:36.384333|2017-02-18 16:54:36.384333
NCT00263380|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2006-09-08|||October 2005||2005-10-01|July 2005|2005-07-01||||||||Observational|||Investigation on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients|Experimental Study on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients|Unknown status|Recruiting|N/A|90||St. Antonius Hospital|||||f||||||||||||||2017-02-18 16:54:36.504457|2017-02-18 16:54:36.504457
NCT00263367|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2011-06-21|||October 2005||2005-10-01|June 2011|2011-06-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism|Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism: A Pilot Study|Completed||N/A|10|Actual|The International Child Development Resource Center||1|||f||||t||||||||||2017-02-18 16:54:36.581589|2017-02-18 16:54:36.581589
NCT00263354|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2010-11-05|||October 2003||2003-10-01|August 2010|2010-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Oxaliplatin in Gastric Cancer|Oxaliplatin Phase II Trial in Association With 5FU and Folinic Acid in the Treatment of Advanced Unresectable or Metastatic Gastric Cancer.|Completed||Phase 2|20||Sanofi|||||f||||||||||||||2017-02-18 16:54:36.704811|2017-02-18 16:54:36.704811
NCT00263341|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-09-25||2012-07-10|December 2005||2005-12-01|September 2012|2012-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol|A Multicenter, Open-label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150 ug of Nestorone® and 15 ug of Ethinyl Estradiol|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|Population Council||1|||f||||||||||||||2017-02-18 16:54:36.792525|2017-02-18 16:54:36.792525
NCT00263328|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2015-06-16|2015-04-02||December 2005||2005-12-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|January 2014|Actual|2014-01-01||Interventional||Safety population: all participants who received at least 1 dose of study medication in the study.|Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient|A Multicenter, Phase 2, Open-label, Controlled, Extension Study For Stage 1 Subjects Of Study A3921009 To Evaluate The Long-term Safety And Efficacy Of Cp-690,550 Versus Tacrolimus, When Co-administered With Mycophenolate Mofetil In Renal Allograft Recipients|Completed||Phase 2|46|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 16:54:36.97191|2017-02-18 16:54:36.97191
NCT00263315|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2006-08-17|||January 2000||2000-01-01|August 2006|2006-08-01|May 2006||2006-05-01|||||Interventional|||Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis|Nebulized Liposomal Amphotericin B (Ambisome) Versus Nebulized Placebo for the Prophylaxis of Invasive Pulmonary Aspergillosis in Haematological Patients With Prolonged Neutropenia. A Randomized Clinical Trial.|Completed||Phase 2/Phase 3|320||Erasmus Medical Center|||||f||||||||||||||2017-02-18 16:54:42.370002|2017-02-18 16:54:42.370002
NCT00263289|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2005-12-07|||January 2006||2006-01-01|December 2005|2005-12-01||||||||Observational|||Preprocedural Fasting and Nitrous Oxide -Oxygen Inhalation Analgesia for Dental Treatment of Children|The Effect of Preprocedural Fasting on Vomiting Frequency in Children Administered Nitrous Oxide -Oxygen Inhalation Analgesia for Dental Treatment|Unknown status|Not yet recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:54:42.583155|2017-02-18 16:54:42.583155
NCT00263276|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2016-11-16|||December 2005||2005-12-01|November 2016|2016-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Evaluate the Safety and Efficacy of BMS-512148 as Monotherapy in Subjects With Type 2 Diabetes Mellitus Who Are Treatment Naive And Have Inadequate Glycemic Control on Diet and Exercise|Completed||Phase 2|389|Actual|AstraZeneca||7|||f||||f||||||||||2017-02-18 16:54:45.524203|2017-02-18 16:54:45.524203
NCT00263263|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2007-03-12|||September 2003||2003-09-01|March 2007|2007-03-01|December 2005||2005-12-01|||||Interventional|||RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.|Phase 2 Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Degenerated Saphenous Vein Grafts|Completed||Phase 2|75||Antwerp Cardiovascular Institute Middelheim|||||f||||t||||||||||2017-02-18 16:54:46.032426|2017-02-18 16:54:46.032426
NCT00263250|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2013-06-28|||February 1999||1999-02-01|June 2013|2013-06-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men|Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men|Completed||N/A|724||Creighton University|||||f||||f||||||||||2017-02-18 16:54:46.125421|2017-02-18 16:54:46.125421
NCT00263237|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-07|2017-01-24|||December 2, 2005||2005-12-02|July 23, 2008|2008-07-23|July 23, 2008||2008-07-23|||||Interventional|||STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency|A Pilot Study of Safety and Efficacy of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:54:46.228361|2017-02-18 16:54:46.228361
NCT00263211|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2013-08-09|||January 2006||2006-01-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients|The Impact Of Platelet Function Inhibition On Circulating Cancer Cells In Metastatic Breast Cancer Patients|Completed||Phase 2|48|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 16:54:46.321206|2017-02-18 16:54:46.321206
NCT00263198|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2013-05-06|||March 2006||2006-03-01|May 2013|2013-05-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer|Phase II Study of the Combination of PTK787/ZK222584 and Letrozole in Postmenopausal Women With Advanced Hormone Receptor Positive Breast Cancer|Terminated||Phase 2|4|Actual|Washington University School of Medicine||1||unacceptable toxicity|f||||||||||||||2017-02-18 16:54:46.448572|2017-02-18 16:54:46.448572
NCT00263185|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2014-09-18|||November 2005||2005-11-01|September 2014|2014-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status|A Double-Blind, Randomized, Placebo Controlled Trial of High Dose Vitamin D Therapy On Musculoskeletal Symptoms and Bone Mineral Density in Anastrozole-Treated Early Stage Breast Cancer Patients With Marginal Vitamin D Status|Completed||Early Phase 1|63|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-02-18 16:54:46.558586|2017-02-18 16:54:46.558586
NCT00263172|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2010-01-21|||February 2003||2003-02-01|December 2005|2005-12-01|March 2005||2005-03-01|||||Interventional|||Weight Loss on the Web: A Pilot Study Comparing a Commercial Website to a Structured Behavioral Intervention||Completed||N/A|||University of Vermont|||||f||||||||||||||2017-02-18 16:54:46.678296|2017-02-18 16:54:46.678296
NCT00263159|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2007-12-19|||January 2006||2006-01-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study|Pharmaceutical Care for Asthma Control Improvement|Completed||N/A|221|Actual|University Ghent||1|||f||||f||||||||||2017-02-18 16:54:46.763743|2017-02-18 16:54:46.763743
NCT00263146|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2017-01-13|||September 2005||2005-09-01|February 2010|2010-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Recruitment Maneuvers in ARDS: Effects on Respiratory Function and Inflammatory Markers.|Recruitment Maneuvers in ARDS: Effects on Respiratory Function and Inflammatory (ARAMIS: Apport d'un Recrutement Alveolaire Sur Les Marqueurs de l'Inflammation Dans le SDRA)|Terminated||N/A|30|Anticipated|University Hospital, Tours||||Lack of inclusion due to changed medical practice|f||||t||||||||||2017-02-18 16:54:46.85391|2017-02-18 16:54:46.85391
NCT00263133|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2007-06-01|||December 2005||2005-12-01|May 2007|2007-05-01|January 2006||2006-01-01|||||Interventional|||Modulation of Visually Evoked Potentials by an Antidepressant|Modulation of Visually Evoked Potentials by an Antidepressant|Completed||N/A|12||University Hospital Freiburg|||||f||||||||||||||2017-02-18 16:54:46.93459|2017-02-18 16:54:46.93459
NCT00263120|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2016-08-23|||March 2006||2006-03-01|August 2016|2016-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Effects of Thymectomy During Cardiothoracic Surgery||Completed||N/A|124|Actual|University of California, Los Angeles|||1||f||||f||||||||No||2017-02-18 16:54:47.02285|2017-02-18 16:54:47.02285
NCT00263107|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2006-05-30|||August 2004||2004-08-01|December 2005|2005-12-01|June 2005||2005-06-01|||||Observational|||Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction.|Remote Post-Operative Rounding and the Physician Ability to Identify Morbidity|Completed||N/A|270||University of California, Davis|||||f||||||||||||||2017-02-18 16:54:47.106473|2017-02-18 16:54:47.106473
NCT00263094|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2006-01-25|||September 2004||2004-09-01|January 2006|2006-01-01|November 2004||2004-11-01|||||Interventional|||An End to the Yom Kippur (and Ramadan) Headache|: An End to the Yom Kippur (and Ramadan) Headache: A Double Blind Placebo Controlled Trial of Prophylactic Rofecoxib in Preventing Ritual Fasting Headache.|Completed||N/A|220||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:54:47.189255|2017-02-18 16:54:47.189255
NCT00262886|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2013-06-05|||August 2001||2001-08-01|June 2013|2013-06-01||||July 2007|Actual|2007-07-01||Interventional|||Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer|Non-Myeloablative HLA-Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma|Completed||Phase 2|35|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 16:54:50.866924|2017-02-18 16:54:50.866924
NCT00263081|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-05-23|||November 2005||2005-11-01|May 2012|2012-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia|A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 or Placebo When Co-administered With Current Lipid-lowering Therapy in Subjects With Homozygous Familial Hypercholesterolemia.|Terminated||Phase 3|44|Actual|Takeda||2||"Overall profile of the compound does not offer significant clinical advantage to patients over~   currently available lipid lowering agents"|f||||f||||||||||2017-02-18 16:54:47.28153|2017-02-18 16:54:47.28153
NCT00263068|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2014-09-24|||December 2005||2005-12-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome|An Open-Label Extension Trial to Investigate the Safety and Tolerability of Long-Term Treatment With Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|Completed||Phase 3|279|Actual|UCB Pharma||1|||f||||||||||||||2017-02-18 16:54:47.412788|2017-02-18 16:54:47.412788
NCT00263055|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2009-09-14|||August 2004||2004-08-01|September 2009|2009-09-01||||June 2005|Actual|2005-06-01||Interventional|||MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV|Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV|Completed||Phase 4|||Sanofi|||||f||||||||||||||2017-02-18 16:54:47.509899|2017-02-18 16:54:47.509899
NCT00263042|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2016-04-21||2016-04-21|December 2005||2005-12-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|CRESCENDO||Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes|Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20 mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients With Clustering Risk Factors|Terminated||Phase 3|18695|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 16:54:47.673078|2017-02-18 16:54:47.673078
NCT00263029|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2009-09-17|||June 2002||2002-06-01|September 2008|2008-09-01||||March 2007|Actual|2007-03-01||Interventional|PROCTFUL||Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer|Pre-operative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer (PROCTFUL)|Completed||Phase 2|18|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:54:48.018915|2017-02-18 16:54:48.018915
NCT00263016|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2008-03-18|||May 2005||2005-05-01|March 2008|2008-03-01||||||||Interventional|||Docetaxel in Non Small Cell Lung Cancer (NSCLC)|A Phase II Pilot Study of Combination of Irinotecan and Cisplatin in Docetaxel/Cisplatin-Responsive Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|50|Anticipated|Sanofi||||Slow recruitment|f||||||||||||||2017-02-18 16:54:48.106561|2017-02-18 16:54:48.106561
NCT00263003|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2007-12-06|||June 2005||2005-06-01|December 2007|2007-12-01||||||||Interventional|||Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension|A Randomized, Open Label Comparative Study of Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension|Completed||Phase 3|40||Sanofi|||||f||||||||||||||2017-02-18 16:54:48.195188|2017-02-18 16:54:48.195188
NCT00262990|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-05-02||2012-05-01|November 2005||2005-11-01|May 2012|2012-05-01||||February 2010|Actual|2010-02-01||Interventional|||Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer|A Randomized, Parallel Group, Open-label, Active Controlled, Multicenter Phase III Trial of Patupilone (EPO906) Versus Pegylated Liposomal Doxorubicin in Taxane/Platinum Refractory/Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian or Primary Peritoneal Cancer|Completed||Phase 3|829|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:54:48.286994|2017-02-18 16:54:48.286994
NCT00262977|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2010-07-21|||September 2004||2004-09-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Improving Aspirin Use in Diabetes: A Cluster Randomized Trial|Improving Appropriate Aspirin Use Among Adults With Diabetes in a Primary Care Setting: Using an Electronic Medical Record to Target a Physician-supervised Nurse Practitioner Intervention|Completed||N/A|300||Northwestern University|||||f||||||||||||||2017-02-18 16:54:48.55817|2017-02-18 16:54:48.55817
NCT00262964|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2010-07-02|2010-03-15||October 2004||2004-10-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Obesity and Nonalcoholic Fatty Liver Disease|Obesity and Nonalcoholic Fatty Liver Disease|Completed||N/A|51|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-02-18 16:54:48.658521|2017-02-18 16:54:48.658521
NCT00262951|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-01-03|2011-11-14||January 2005||2005-01-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|April 2011|Actual|2011-04-01||Interventional|||Chemoradiation in Locally Advanced Pancreatic Cancer|A Phase II Pilot Study of Multi-Agent Neo-Adjuvant Chemoradiation in Patients With Locally Advanced Pancreatic Adenocarcinoma|Terminated||Phase 2|23|Actual|Masonic Cancer Center, University of Minnesota||1||Closed at a planned interim analysis by meeting a predefined toxicity endpoint|f||||t||||||||||2017-02-18 16:54:49.516702|2017-02-18 16:54:49.516702
NCT00262938|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-01-17|||February 2005||2005-02-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|January 2006|Actual|2006-01-01||Interventional|||Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission|Lifestyle Change and Quality of Life in Obese Endometrial Cancer Survivors|Completed||N/A|47|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 16:54:50.026312|2017-02-18 16:54:50.026312
NCT00262925|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2015-04-14|2014-04-25||June 2006||2006-06-01|October 2013|2013-10-01|February 2013|Actual|2013-02-01|October 2012|Actual|2012-10-01||Interventional||All enrolled patients, and 7 were entered to the first step with 5mg Campath dose, 5 entered to the second step with 10mg Campath dose|Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|A Phase II Study of MOAD (Methotrexate, Vincristine, L-asparaginase and Dexamethasone) With Subcutaneous Campath for Adults With Relapsed or Refractory Acute Leukemia (ALL)|Terminated||Phase 2|12|Actual|National Cancer Institute (NCI)||1||slow accrual|f||||f||||||||||2017-02-18 16:54:50.143847|2017-02-18 16:54:50.143847
NCT00262899|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2013-01-04|||August 2005||2005-08-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|July 2010|Actual|2010-07-01||Interventional|||Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions|Genetic Counseling for Newly Diagnosed Breast Cancer Patients|Completed||Phase 3|331|Actual|Georgetown University||2|||f||||f||||||||||2017-02-18 16:54:50.751625|2017-02-18 16:54:50.751625
NCT00262873|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2016-04-04|2016-02-29||May 2005||2005-05-01|April 2016|2016-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Bortezomib in Treating Patients With Myelodysplastic Syndromes|A Phase II Pilot Study of VELCADE in Patients With MDS|Completed||Phase 2|8|Actual|University of Rochester|All study visits were completed and the trial concluded normally for the limited number of enrolled participants; therefore, the study was considered to have been completed. However, the study is under-powered.|1|||f||||t||||||||||2017-02-18 16:54:50.972891|2017-02-18 16:54:50.972891
NCT00262860|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2016-03-30|2016-02-25||April 2005||2005-04-01|March 2016|2016-03-01||||May 2008|Actual|2008-05-01||Interventional|||Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|Phase II Pilot Study of Bortezomib (VELCADE®) and Gemcitabine for Patients With Relapsed or Refractory Hodgkin's Lymphoma|Completed||Phase 2|18|Actual|University of Rochester|Trial was stopped early by the Data Safety Monitoring Committee due to unexpected toxicity with no improvement in the response rate compared with gemcitabine alone. Trial was prespecified to be stopped early if these criteria were met.|1|||f||||t||||||||||2017-02-18 16:54:51.30393|2017-02-18 16:54:51.30393
NCT00262847|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2015-08-18|2013-07-09||September 2005||2005-09-01|February 2015|2015-02-01|July 2015|Actual|2015-07-01|November 2010|Actual|2010-11-01||Interventional|||Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase III Trial of Carboplatin and Paclitaxel Plus Placebo Versus Carboplatin and Paclitaxel Plus Concurrent Bevacizumab (NSC # 704865) Followed by Placebo, Versus Carboplatin and Paclitaxel Plus Concurrent and Extended Bevacizumab, in Women With Newly Diagnosed, Previously Untreated, Stage III or IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer|Completed||Phase 3|1873|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 16:54:51.608748|2017-02-18 16:54:51.608748
NCT00262834|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2014-08-28|2013-07-10||October 2005||2005-10-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|October 2008|Actual|2008-10-01||Interventional|||Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer|A Pilot Study Evaluating Surrogates of Response to Short Term Oral Suberoylanilide Hydroxamic Acid (SAHA) in Women With Newly Diagnosed Breast Cancer|Completed||N/A|54|Actual|National Cancer Institute (NCI)|The main limitation of the trial is the unexpectedly low proportion of matched evaluable samples available for the biomarkers studied, ranging from 44% to 92%.|1|||f||||||||||||||2017-02-18 16:54:55.043747|2017-02-18 16:54:55.043747
NCT00262821|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2014-06-18|||February 2006||2006-02-01|June 2014|2014-06-01||||August 2010|Actual|2010-08-01||Interventional|||Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer|A Phase III, Randomized Trial of Weekly Cisplatin and Radiation Versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIIB and IVA Cervical Carcinoma Limited to the Pelvis|Completed||Phase 3|402|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:54:55.461936|2017-02-18 16:54:55.461936
NCT00262808|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2013-10-14|||March 2004||2004-03-01|October 2013|2013-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer|A PHASE II Study of GM-CSF As Pre- And Post-operative Adjuvant Therapy For Stage II And III Colon Cancer|Completed||Phase 2|50|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 16:54:56.052324|2017-02-18 16:54:56.052324
NCT00262795|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2016-09-28|||September 2003||2003-09-01|September 2016|2016-09-01|October 2005|Actual|2005-10-01|January 2005|Actual|2005-01-01||Interventional|||Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia|Fludarabine Versus Chlorambucil in First Line Therapy of Elderly Patients (More Than 65 Years) With Advanced Chronic Lymphocytic Leukemia|Completed||Phase 3|206|Actual|German CLL Study Group||2|||f||||||||||||||2017-02-18 16:54:56.159721|2017-02-18 16:54:56.159721
NCT00262782|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2016-09-30|||April 1997||1997-04-01|September 2016|2016-09-01|June 2010|Actual|2010-06-01|December 2004|Actual|2004-12-01||Interventional|||Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia|Prognostic Factors and Risk-Adapted Therapy in Patients With Early Stage Chronic Lymphocytic Leukemia|Completed||Phase 3|877|Actual|German CLL Study Group||2|||f||||||||||||No||2017-02-18 16:54:56.364116|2017-02-18 16:54:56.364116
NCT00262769|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-07-16|||May 2005||2005-05-01|July 2012|2012-07-01||||August 2008|Actual|2008-08-01||Interventional|ABC-02||Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors|Gemcitabine, Alone or in Combination With Cisplatin, in Patients With Advanced or Metastatic Cholangiocarcinomas and Other Biliary Tract Tumors: A Multicentre, Randomized Phase III Study|Completed||Phase 3|324|Actual|University College, London||2|||f||||t||||||||||2017-02-18 16:54:56.745589|2017-02-18 16:54:56.745589
NCT00262743|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2013-05-03|2011-12-07||August 2005||2005-08-01|May 2013|2013-05-01|August 2012|Actual|2012-08-01|May 2010|Actual|2010-05-01||Interventional|||Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia|A Phase I/II Study of Daily Oral Polyphenon E in Asymptomatic, Rai Stage 0-II Patients With Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|73|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 16:54:56.891277|2017-02-18 16:54:56.891277
NCT00262730|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2014-06-16|2013-03-22||January 2006||2006-01-01|June 2014|2014-06-01|April 2010|Actual|2010-04-01|August 2009|Actual|2009-08-01||Interventional|||Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase II Trial of Radiation Plus Temozolomide Followed by Adjuvant Temozolomide and Poly-ICLC in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|97|Actual|Sidney Kimmel Comprehensive Cancer Center|"Other Adverse Events not reported for this study. Only serious(grade 3/4)related to either TMZ and/or Poly were reported. Subjects may have experienced grade 1 and grade 2 other adverse event but they have no bearing on clinical outcome of agent"|1|||f||||t||||||||||2017-02-18 16:54:57.909253|2017-02-18 16:54:57.909253
NCT00262717|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2006-06-08|||March 2001||2001-03-01|June 2006|2006-06-01|August 2002||2002-08-01|||||Interventional|||Can Resistance Enhance Selection of Treatment? (CREST)|A Randomised Comparator Study to Assess the Relative Efficacy of Genotypic Versus Virtual Phenotypic Resistance Tests in Treatment Experienced Patients With HIV Infection for Whom a Change in Therapy is Indicated|Completed||Phase 4|300||Kirby Institute|||||f||||||||||||||2017-02-18 16:54:58.274207|2017-02-18 16:54:58.274207
NCT00262704|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2014-08-20|||December 2001||2001-12-01|August 2014|2014-08-01|September 2002|Actual|2002-09-01|August 2002|Actual|2002-08-01||Interventional|||SimCare: Physician Intervention to Improve Diabetes Care|SimCare: Physician Intervention to Improve Diabetes Care|Completed||N/A|2020|Actual|HealthPartners Institute||3|||f||||f||||||||||2017-02-18 16:54:58.38622|2017-02-18 16:54:58.38622
NCT00262691|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2007-09-20|||May 2005||2005-05-01|September 2007|2007-09-01||||||||Observational|||Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort Study|Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort Study, the Kitanagoya Genome (KING) Study for the Local Residents of Kitanagoya, Japan|Unknown status|Recruiting|N/A|7000|Anticipated|Nagoya University|||||f||||f||||||||||2017-02-18 16:54:58.489929|2017-02-18 16:54:58.489929
NCT00262678|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2009-06-02|||December 2005||2005-12-01|June 2009|2009-06-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of EN3267 for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients.|Completed||Phase 3|||Prostrakan Pharmaceuticals|||||f||||||||||||||2017-02-18 16:54:58.563724|2017-02-18 16:54:58.563724
NCT00262665|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-12-10|||March 2005||2005-03-01|December 2012|2012-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder|Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder|Withdrawn||Phase 2|0|Actual|Icahn School of Medicine at Mount Sinai||2||protocol cancelled|f||||t||||||||||2017-02-18 16:54:58.637424|2017-02-18 16:54:58.637424
NCT00262652|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2011-06-24|||January 2006||2006-01-01|November 2005|2005-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics|Sodium Pyruvate Bronchodilation in Asthmatics|Terminated||Phase 1/Phase 2|20|Actual|Emphycorp||1||Patients did not respond to therapy|f||||t||||||||||2017-02-18 16:54:58.735513|2017-02-18 16:54:58.735513
NCT00262639|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2009-12-09|2009-07-06||December 2005||2005-12-01|December 2009|2009-12-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Prometa Protocol for Alcohol Dependence|A Double Blind Evaluation of Flumazenil and Gabapentin for the Treatment of Alcohol Withdrawal and Relapse Prevention|Completed||Phase 2/Phase 3|60|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 16:54:58.831473|2017-02-18 16:54:58.831473
NCT00262626|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2005-12-05|||February 1995||1995-02-01|June 2003|2003-06-01|June 1995||1995-06-01|||||Interventional|||The Canadian Glaucoma Study|A Multicentre Study on the Risk Factors for the Progression of Open-Angle Glaucoma|Terminated||N/A|430||Dalhousie University|||||f||||||||||||||2017-02-18 16:54:59.421368|2017-02-18 16:54:59.421368
NCT00262613|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2006-05-25|||September 2004||2004-09-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Sodium Pyruvate Therapy in COPD Patients|Long-Term Use of Inhaled Sodium Pyruvate for the Treatment of Chronic Obstructive Pulmonary Disease|Completed||Phase 2|60||Emphycorp|||||||||||||||||||2017-02-18 16:54:59.51275|2017-02-18 16:54:59.51275
NCT00262600|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2014-11-05|2010-11-18||November 2005||2005-11-01|April 2014|2014-04-01||||April 2009|Actual|2009-04-01||Interventional|||Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate|Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate With Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation: Prospective, Multi-centre, Parallel-group, Non-inferiority Trial (RE-LY Study)|Completed||Phase 3|18113|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 16:54:59.680778|2017-02-18 16:54:59.680778
NCT00262587|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2012-05-15|||September 2005||2005-09-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Elite Sport and Development of Asthma|Elite Sport and Development of Asthma|Completed||Phase 4|18|Actual|Bispebjerg Hospital||2|||f||||||||||||||2017-02-18 16:55:10.80014|2017-02-18 16:55:10.80014
NCT00262574|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2011-08-08|||July 2005||2005-07-01|December 2010|2010-12-01|June 2013|Anticipated|2013-06-01|April 2012|Anticipated|2012-04-01||Interventional|||Effect of BNP (Brain Natriuretic Peptides) on Endothelial Dysfunction Induced by Coronary Angioplasty|Phase 4 Study of Patients Receiving BNP or NTG (IV) During Angioplasty, Re-examined 24 Hours Later Using the Flow-mediated Brachial Artery Dilation Study, and Blood Assays for Pro BNP and ET1|Unknown status|Recruiting|Phase 4|500|Anticipated|The Baruch Padeh Medical Center, Poriya||1|||f||||f||||||||||2017-02-18 16:55:10.910288|2017-02-18 16:55:10.910288
NCT00262561|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-06|2014-01-25|||January 2006||2006-01-01|January 2014|2014-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Resistance to Aspirin and/or Clopidogrel Among Patients With PAD.|Prevalence of Resistance to Aspirin and/or Clopidogrel Among Patients With PAD. Prognostic Significance of Resistance to Aspirin|Completed||Phase 4|263|Actual|Aalborg Universitetshospital||1|||f||||t||||||||||2017-02-18 16:55:10.99886|2017-02-18 16:55:10.99886
NCT00262548|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-08-24|||October 2005||2005-10-01|August 2007|2007-08-01||||||||Interventional|||C-Reactive Protein (CRP) in Obese Diabetic Women|Interventions Study for the Control of Diabetes Mellitus Type 2 in Obese Women|Completed||Phase 4|100|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:55:11.110787|2017-02-18 16:55:11.110787
NCT00262522|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2012-02-03|2009-07-09||November 2005||2005-11-01|February 2012|2012-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects|A Phase 3, Randomized, Open-label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects|Completed||Phase 3|664|Actual|Abbott||4|||f||||f||||||||||2017-02-18 16:55:11.211006|2017-02-18 16:55:11.211006
NCT00262509|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2014-01-14|2013-09-17||September 2008||2008-09-01|January 2014|2014-01-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional||Includes groups randomized to do either baseline tests first or Intervention tests first|Emergency Egress and Information System for Persons With Vision Loss|Emergency Egress and Information System for Persons With Vision Loss|Terminated||N/A|17|Actual|VA Office of Research and Development|Trials were terminated early with just 17 Participants of the planned 24, as the intervention was NOT providing measurable benefit.|2||Intervention worsened performance for first 17 of 24 planned participants.|f||||f||||||||||2017-02-18 16:55:12.621936|2017-02-18 16:55:12.621936
NCT00262496|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2015-06-25||||||June 2015|2015-06-01||||||||Interventional|||Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.|Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.|Withdrawn||Phase 2|0|Actual|VA Office of Research and Development|||||||||||||||||||2017-02-18 16:55:12.988642|2017-02-18 16:55:12.988642
NCT00262483|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2007-12-17|||December 2005||2005-12-01|December 2007|2007-12-01|April 2006|Actual|2006-04-01|||||Interventional|||Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C|A Phase 2 Study of VX-950 in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects With Hepatitis C|Completed||Phase 2|12||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-02-18 16:55:13.092294|2017-02-18 16:55:13.092294
NCT00262470|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2016-08-15|||April 1997||1997-04-01|August 2016|2016-08-01||||January 2018|Anticipated|2018-01-01||Interventional|||Treatment of Orthostatic Intolerance|Treatment of Orthostatic Intolerance|Active, not recruiting||Phase 1/Phase 2|150|Anticipated|Vanderbilt University||20|||f||||f||||||||||2017-02-18 16:55:13.19299|2017-02-18 16:55:13.19299
NCT00262457|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2013-09-16|||April 2004||2004-04-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||BIONs, for Improved Tissue Health and Pressure Sore Prevention|BIONs, for Improved Tissue Health and Pressure Sore Prevention|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||It was found that the devices were not suitable for the application.|f||||f||||||||||2017-02-18 16:55:13.349822|2017-02-18 16:55:13.349822
NCT00262444|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2007-12-19|||September 2003||2003-09-01|December 2007|2007-12-01|May 2005|Actual|2005-05-01|||||Interventional|||Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial|Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial|Completed||N/A|500|Actual|University Ghent||1|||f||||f||||||||||2017-02-18 16:55:13.456625|2017-02-18 16:55:13.456625
NCT00262431|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2012-06-07|||June 2004||2004-06-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of Early Tracheostomy to Reduce Incidence of Ventilator Acquired Pneumonia (VAP)||Completed||Phase 3|320|Actual|University of Turin, Italy||2|||f||||||||||||||2017-02-18 16:55:13.559445|2017-02-18 16:55:13.559445
NCT00262418|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2007-12-19|||July 2004||2004-07-01|December 2007|2007-12-01|May 2005|Actual|2005-05-01|||||Interventional|||Comparison of the Efficacy and Safety of Ivermectin to Permethrin|A Randomised, Double Blind, Double Dummy Study to Compare the Efficacy and Safety of a Single Administration of Ivermectin to a Single Administration of Permethrin for the Treatment of Scabies|Completed||Phase 2|160|Actual|University Ghent||1|||f||||f||||||||||2017-02-18 16:55:13.848518|2017-02-18 16:55:13.848518
NCT00262405|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-02|||January 2001||2001-01-01|December 2015|2015-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis|Phase II Trial of Zileuton Compared to Azathioprine/Prednisone for the Treatment of Idiopathic Pulmonary Fibrosis|Completed||Phase 2|44|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 16:55:13.947965|2017-02-18 16:55:13.947965
NCT00262392|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2015-03-09|||June 2005||2005-06-01|March 2015|2015-03-01|June 2010|Anticipated|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Pamidronate for the Prevention of Heterotopic Ossification|Study Into the Effect of Pamidronate for the Prevention of Heterotopic Ossification in High-risk Patients: A Randomized Controlled Trial|Withdrawn||N/A|0|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 16:55:14.050165|2017-02-18 16:55:14.050165
NCT00262379|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2014-12-11|||December 2005||2005-12-01|December 2014|2014-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C|Multicenter Study, Randomized and Pragmatic, Comparing Two Therapeutic Strategies : Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C and Treated by Combination Therapy Peginterferon Alfa-2a Plus Ribavirin|Completed||Phase 3|229|Actual|University Hospital, Angers||2|||f||||t||||||||||2017-02-18 16:55:14.15758|2017-02-18 16:55:14.15758
NCT00262366|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2007-12-19|||May 2005||2005-05-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Comparison of Automatic CPAP to Fixed CPAP for OSAS Following a Prediction Formula|Titration Efficacy of Automatic CPAP Versus Fixed CPAP, Following a Prediction Formula in Patients With OSAS|Completed||N/A|45||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:55:14.309735|2017-02-18 16:55:14.309735
NCT00262353|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2010-06-28||||||June 2010|2010-06-01||||||||Interventional|||Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis|Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis|Suspended||N/A|10|Anticipated|University Hospital, Ghent||||study never started because of safety alerts in literature regarding the topic to be examined|f||||f||||||||||2017-02-18 16:55:14.394784|2017-02-18 16:55:14.394784
NCT00262340|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2015-10-28|||December 2005||2005-12-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma|Prospective, Randomised Controlled Trial of the Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma|Completed||N/A|55|Actual|Royal Brompton & Harefield NHS Foundation Trust||2|||f||||f||||||||||2017-02-18 16:55:14.491008|2017-02-18 16:55:14.491008
NCT00262327|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2006-06-15|||May 2005||2005-05-01|December 2005|2005-12-01|February 2006||2006-02-01|||||Interventional|||Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor|Phase I Trial of Intratumoral Injection of an Adenovirus Encoding Human Endostatin for Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|20||Sun Yat-sen University|||||f||||||||||||||2017-02-18 16:55:14.598571|2017-02-18 16:55:14.598571
NCT00262314|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2013-10-21|2010-05-21||October 2000||2000-10-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Observational|RENEW||Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients|Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients|Completed||Phase 4|509|Actual|EMD Serono|||1||f||||||||||||||2017-02-18 16:55:14.692082|2017-02-18 16:55:14.692082
NCT00262301|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2012-09-27|2012-07-27||June 2004||2004-06-01|September 2012|2012-09-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|A Randomized, Placebo-controlled, Double-blind Phase III Study of the Efficacy and Safety of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|Completed||Phase 3|75|Actual|Pharming Technologies B.V.||2|||f||||t||||||||||2017-02-18 16:55:15.151348|2017-02-18 16:55:15.151348
NCT00262288|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2013-02-21|||April 2004||2004-04-01|February 2013|2013-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|A Phase II/III Study of the Efficacy and Safety of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|Completed||Phase 2/Phase 3|14|Actual|Pharming Technologies B.V.||1|||f||||||||||||||2017-02-18 16:55:15.736131|2017-02-18 16:55:15.736131
NCT00262275|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2016-01-21|||July 2002||2002-07-01|January 2016|2016-01-01||||July 2004|Actual|2004-07-01||Interventional|||Optimum Platelet Inhibition After Coronary Bypass Surgery|Optimum Platelet Inhibition After Coronary Artery Bypass Surgery: A Randomised Trial Comparing Platelet Aggregation Using Low, Medium Dose Aspirin and Clopidogrel|Completed||N/A|||Papworth Hospital NHS Foundation Trust|||||f||||||||||||||2017-02-18 16:55:15.83066|2017-02-18 16:55:15.83066
NCT00262262|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2007-11-21|||March 2004||2004-03-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||The Effect of Levetiracetam on the Postmastectomy Pain Syndrome|The Effect of Levetiracetam on the Postmastectomy Pain Syndrome|Completed||N/A|25|Actual|Odense University Hospital||1|||f||||f||||||||||2017-02-18 16:55:15.917004|2017-02-18 16:55:15.917004
NCT00262249|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2017-01-17|||August 2000||2000-08-01|January 2017|2017-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Effect of Growth Hormone in Children With Growth Hormone Deficiency|Effect of Growth Hormone in Children With Growth Hormone Deficiency and Idiopathic Short Stature|Completed||Phase 3|173|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:55:16.009892|2017-02-18 16:55:16.009892
NCT00262236|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2016-11-16|||November 2005||2005-11-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension|A Twelve-week, Randomized, Double-blind, Parallel-group, Multicenter, Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination With Atenolol in Patients With Essential Hypertension|Completed||Phase 3|693|Actual|Novartis|||||||||||||||||||2017-02-18 16:55:16.149825|2017-02-18 16:55:16.149825
NCT00262223|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2014-09-03|2014-08-14||May 2006||2006-05-01|November 2013|2013-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Combined Treatment for Alcohol-Dependent Individuals With PTSD|Combined Treatment for Alcohol-Dependent Individuals With PTSD|Completed||Phase 2|69|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 16:55:16.255951|2017-02-18 16:55:16.255951
NCT00262210|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2005-12-05|||June 1995||1995-06-01|December 2005|2005-12-01|December 1999||1999-12-01|||||Interventional|||A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers|A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers|Completed||Phase 2|50||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 16:55:16.793051|2017-02-18 16:55:16.793051
NCT00262197|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2012-09-04|||December 2001||2001-12-01|September 2012|2012-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Patient Based Strategy to Reduce Errors in Diabetes Care|Patient Based Strategy to Reduce Errors in Diabetes Care|Completed||N/A|10000||HealthPartners Institute|||||f||||f||||||||||2017-02-18 16:55:16.885425|2017-02-18 16:55:16.885425
NCT00262184|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2005-12-05|||December 2004||2004-12-01|December 2005|2005-12-01|December 2007||2007-12-01|||||Interventional|||A Taiwan Isoflavone Multicenter Study (TIMS)|A Taiwan Isoflavone Multicenter Study (TIMS)|Unknown status|Recruiting|N/A|420||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 16:55:16.97404|2017-02-18 16:55:16.97404
NCT00262171|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2016-04-05|||May 2002||2002-05-01|March 2016|2016-03-01|August 2016|Anticipated|2016-08-01|August 2016|Anticipated|2016-08-01||Observational|||Hereditary Nonpolyposis Colorectal Cancer in Taiwan－Related Genetic Study and Clinical Applications|Hereditary Nonpolyposis Colorectal Cancer in Taiwan－Related Genetic Study and Clinical Applications|Active, not recruiting||N/A|1014|Actual|National Health Research Institutes, Taiwan|||1||f||||f||||||||Undecided||2017-02-18 16:55:17.067353|2017-02-18 16:55:17.067353
NCT00262158|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2005-12-05|||August 2004||2004-08-01|December 2005|2005-12-01|September 2004||2004-09-01|||||Observational|||Analysis of 'Tobacco and Alcohol Tax Law' and Its Impact on Cigarette Consumption|The Survey of Cigarette Consumption|Completed||N/A|4000||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 16:55:17.147317|2017-02-18 16:55:17.147317
NCT00262145|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2005-12-05|||October 2005||2005-10-01|October 2005|2005-10-01|November 2005||2005-11-01|||||Interventional|||Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption|Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Uptake in Human|Completed||Phase 1|20||NatureGen|||||f||||||||||||||2017-02-18 16:55:17.216232|2017-02-18 16:55:17.216232
NCT00262132|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2007-01-04|||September 2003||2003-09-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Mycophenolate for Pulmonary Sarcoidosis|Mycophenolate for Pulmonary Sarcoidosis|Terminated||Phase 3|20||Medical University of South Carolina|||||||||||||||||||2017-02-18 16:55:17.307468|2017-02-18 16:55:17.307468
NCT00262119|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2016-03-23|2014-05-09||February 2006||2006-02-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2012|Actual|2012-04-01||Interventional|||MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure|MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure|Completed||Phase 4|1300|Actual|Medtronic Bakken Research Center||3|||f||||||||||||||2017-02-18 16:55:17.392721|2017-02-18 16:55:17.392721
NCT00262106|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2012-09-05||2012-02-08|October 2005||2005-10-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|August 2008|Actual|2008-08-01||Interventional|||Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection|An International Multi-centre, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 0.5% and 2% PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection|Completed||Phase 3|9404|Actual|Endo Pharmaceuticals||2|||f||||t||||||||||2017-02-18 16:55:18.40578|2017-02-18 16:55:18.40578
NCT00262093|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2007-03-19|||November 2005||2005-11-01|November 2005|2005-11-01||||||||Observational|||Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence|Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence|Unknown status|Recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:55:18.527831|2017-02-18 16:55:18.527831
NCT00262080|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2016-08-01|2009-12-30||December 2005||2005-12-01|August 2016|2016-08-01|February 2007|Actual|2007-02-01|December 2005|Actual|2005-12-01||Interventional|||Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)|A Double-blind, Placebo-controlled Study (72 Patients, Randomized 1:1) Followed by a Repeat-dosing Phase to Assess the Efficacy and Safety of DX-88 (Ecallantide; Recombinant Plasma Kallikrein Inhibitor) for the Treatment of Acute Attacks of Hereditary Angioedema|Completed||Phase 3|91|Actual|Shire||2|||f||||t||||||||||2017-02-18 16:55:18.622801|2017-02-18 16:55:18.622801
NCT00261898|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-04|2015-11-03|||November 2005||2005-11-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity|Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity|Terminated||Phase 2|239|Actual|National Institutes of Health Clinical Center (CC)||1||"This study has been terminated. (Interim analysis of preliminary results indicated the need~   for protocol re-design)."|f||||||||||||||2017-02-18 16:55:28.466806|2017-02-18 16:55:28.466806
NCT00262067|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2013-11-18|2013-08-20||December 2005||2005-12-01|November 2013|2013-11-01|December 2013|Anticipated|2013-12-01|July 2008|Actual|2008-07-01||Interventional||Intent-to-treat population: All randomized patients, regardless of whether they received any study drug or completed the full course of treatment.|A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)|A Multicenter, Phase III, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy Regimens in Subjects With Previously Untreated Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 3|1237|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:55:19.170768|2017-02-18 16:55:19.170768
NCT00262054|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2010-03-12|||November 2005||2005-11-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)|Prospective, Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Bivalirudin and Un-fractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions. ISAR-REACT-3|Completed||Phase 4|4570|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 16:55:21.314048|2017-02-18 16:55:21.314048
NCT00262041|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2016-09-23|2013-09-09||October 2004||2004-10-01|September 2016|2016-09-01|March 2006||2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents|A Phase 2, Randomized, Single-blind, Controlled, Multicenter Study to Compare the Safety and Immune Response of One Dose of Novartis Meningococcal ACWY Conjugate Vaccine With the Safety and Immune Response of One Dose of Licensed Meningococcal ACWY Polysaccharide Vaccine Administered to Healthy Adolescents 11 to 17 Years of Age|Completed||Phase 2|524|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:55:21.470747|2017-02-18 16:55:21.470747
NCT00262028|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2016-01-12|2013-08-30||April 2005||2005-04-01|January 2016|2016-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children|A Phase 2, Randomized, Single-blind, Controlled, Single-Center Study to Compare the Safety and Immunogenicity of One Dose of Chiron Meningococcal ACWY Conjugate Vaccine With One Dose of Licensed Meningococcal ACWY Polysaccharide Vaccine Administered to Healthy Children 2-10 Years of Age and an Open-label Study to Assess the Safety and Immunogenicity of One Dose of Chiron Meningococcal ACWY Conjugate Vaccine Administered to Healthy Toddlers 12-23 Months of Age|Completed||Phase 2|910|Actual|Novartis||5|||f||||f||||||||||2017-02-18 16:55:22.117075|2017-02-18 16:55:22.117075
NCT00262015|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2005-12-02|||September 2003||2003-09-01|December 2005|2005-12-01||||||||Interventional|||Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine|A Phase IV, Single Center, Open-Label, Controlled, Randomized Study to Evaluate the Memory Response of Children Previously Vaccinated With Chiron Meningococcal C Conjugate Vaccine, Menjugate® and Describe the Kinetic of the Antibody Response and Maturation on Days 2-7 and 28 After Challenge With Pasteur Merieux Meningococcal A/C Polysaccharide Vaccine or Menjugate®|Unknown status|Active, not recruiting|Phase 4|264||Chiron Corporation|||||f||||||||||||||2017-02-18 16:55:24.21159|2017-02-18 16:55:24.21159
NCT00262002|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2014-06-16|2013-09-02||September 2004||2004-09-01|June 2014|2014-06-01|October 2006|Actual|2006-10-01|July 2005|Actual|2005-07-01||Interventional|||Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants|A Phase II, Randomized, Open Label, Controlled, Multicenter Study to Evaluate the Safety, Immunogenicity and Induction of Immunological Memory After Two or Three Doses of Novartis (Formerly Chiron) Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infants at 2, 3, 4 or 2, 4, 6 Months of Age|Completed||Phase 2|601|Actual|Novartis||7|||f||||||||||||||2017-02-18 16:55:24.317857|2017-02-18 16:55:24.317857
NCT00261989|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-07-05|||November 2005||2005-11-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Observational|||Pulse Oximetry Readings and Hourly Variation in Oximetry Readings With CHD|The Retrospective Analysis of Presenting Pulse Oximetry Readings and Hourly Variation in Oximetry Readings in Patients With Known Congenital Heart Disease|Terminated||N/A|1000|Actual|Children's Healthcare of Atlanta|||1|data insignificant, study terminated|f||||f||||||||||2017-02-18 16:55:26.843289|2017-02-18 16:55:26.843289
NCT00261976|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2014-03-15|||February 2002||2002-02-01|March 2014|2014-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||A Long-term Safety Study of Infliximab (Remicade)|Long-term Safety Follow-up of REMICADE (RESULTS)|Completed||Phase 4|2971|Actual|Centocor, Inc.|||1||f||||t||||||||||2017-02-18 16:55:26.930386|2017-02-18 16:55:26.930386
NCT00261963|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2007-06-04|||February 2004||2004-02-01|June 2007|2007-06-01|August 2006||2006-08-01|||||Interventional|||The Effect of UV-Irradiation on Cutaneous Cicatrices|The Effect of UV-Irradiation on Cutaneous Cicatrices -A Randomised, Controlled Study With Clinical, Skin Reflectance, Histological and Biochemical Evaluations|Completed||N/A|15||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:55:27.457964|2017-02-18 16:55:27.457964
NCT00261950|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2014-06-24|2013-10-07||May 2006||2006-05-01|June 2014|2014-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|BONAFIDE||Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease|Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease|Completed||Phase 2|110|Actual|Amgen||1|||f||||f||||||||||2017-02-18 16:55:27.547449|2017-02-18 16:55:27.547449
NCT00261937|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2013-02-05|||December 2005||2005-12-01|December 2005|2005-12-01|April 2006|Actual|2006-04-01|||||Interventional|||Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants|Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants|Completed||Phase 1|||Bnai Zion Medical Center|||||f||||||||||||||2017-02-18 16:55:28.180402|2017-02-18 16:55:28.180402
NCT00261924|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-05|2010-04-13|||October 2005||2005-10-01|December 2005|2005-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|TESSI||Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days|Clinical Trial to Evaluate the Therapeutic Efficacy and Safety of INTERCEPT Platelets Stored for up to Seven Days After Collection|Completed||Phase 3|211|Actual|Cerus Corporation||2|||f||||t||||||||||2017-02-18 16:55:28.281777|2017-02-18 16:55:28.281777
NCT00261911|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2007-08-30|||July 2000||2000-07-01|August 2007|2007-08-01|February 2002||2002-02-01|||||Interventional|||A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.|A 12 Month Study to Assess Safety and Efficacy of Meridia (Sibutramine Hydrochloride Monohydrate) 10 and 15 mg in Obese Adolescents|Completed||Phase 3|498|Actual|Abbott||2|||f||||f||||||||||2017-02-18 16:55:28.384217|2017-02-18 16:55:28.384217
NCT00261872|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-03|2017-01-24|||December 1, 2005||2005-12-01|April 9, 2007|2007-04-09|April 9, 2007||2007-04-09|||||Interventional|||Treatment of Patients With Alcoholism and Attention Deficit Disorder|Treatment of Patients With Alcoholism and Attention Deficit Disorder|Completed||Phase 4|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:55:28.558349|2017-02-18 16:55:28.558349
NCT00261859|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2016-08-04|||October 2005||2005-10-01|August 2016|2016-08-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Enhancing Emergency Practitioner (EP)-Performed Alcohol Interventions in the Emergency Department (ED)|Enhancing EP-Performed Alcohol Interventions in the ED|Completed||Phase 2/Phase 3|900|Actual|Yale University||4|||f||||f||||||||||2017-02-18 16:55:28.65365|2017-02-18 16:55:28.65365
NCT00261846|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2015-10-27|2012-10-04||March 2006||2006-03-01|October 2015|2015-10-01|July 2015|Actual|2015-07-01|September 2009|Actual|2009-09-01||Interventional|||Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias|A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias|Completed||Phase 1/Phase 2|571|Actual|Pfizer|Analyses of progression free survival and overall survival was based on all-treated population, instead of evaluable population which was the primary efficacy population as per planned analyses.|1|||f||||f||||||||||2017-02-18 16:55:28.807892|2017-02-18 16:55:28.807892
NCT00261833|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2015-01-11|2014-11-02||March 2006||2006-03-01|January 2015|2015-01-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency|A Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase III/IV Study to Compare the Efficacy and Safety of 60mg/kg Body Weight of Zemaira® Weekly I.V. Administration With Placebo Weekly I.V. Administration in Chronic Augmentation and Maintenance Therapy in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency|Completed||Phase 4|180|Actual|CSL Behring||2|||f||||t||||||||||2017-02-18 16:55:39.077794|2017-02-18 16:55:39.077794
NCT00261820|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2006-05-17||||||May 2006|2006-05-01|January 2005||2005-01-01|||||Interventional|||Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients|A Randomized Study To Compare The Safety And Efficacy Of Two Immunosuppressive Regimens In De Novo Renal Allograft Recipients:Sirolimus Plus Mycophenolate Mofetil Plus Corticosteroids Following A Rabbit Anti-Human Thymocyte Globulin Induction (RATG) Vs Tacrolimus Plus Mycophenolate Mofetil Plus Corticosteroids|Completed||Phase 4|160||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:55:40.042062|2017-02-18 16:55:40.042062
NCT00261807|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2008-05-30|||June 2005||2005-06-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections|Open Label, Single Center Study to Evaluate Higher Doses of Daptomycin in the Treatment of Patients With Severe Necrotizing Skin and Soft Tissue Infections.|Completed||N/A|25|Anticipated|University of Maryland|||||||||||||||||||2017-02-18 16:55:40.130655|2017-02-18 16:55:40.130655
NCT00261794|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2010-01-05|||November 2004||2004-11-01|January 2010|2010-01-01|September 2007|Actual|2007-09-01|June 2007|Actual|2007-06-01||Interventional|||Cognitive Remediation for Schizophrenia|Computer Assisted Cognitive Remediation for Schizophrenia|Completed||N/A|90|Actual|VA Office of Research and Development||2|||f||||||||||||||2017-02-18 16:55:40.234132|2017-02-18 16:55:40.234132
NCT00261781|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2015-05-27|||May 2005||2005-05-01|May 2015|2015-05-01|September 2012|Actual|2012-09-01|December 2006|Actual|2006-12-01||Interventional|||Walking Capacity in Parkinson's Disease (PD-Walk)|Does Home-based Treadmill Training Improve Walking Capacity and Quality of Life in People With Early to Mid-stage Parkinson's Disease?|Terminated||N/A|20|Actual|University of Sydney||2||20 subjects completed for a pilot, further funding required to continue study|f||||f||||||||||2017-02-18 16:55:40.357183|2017-02-18 16:55:40.357183
NCT00261768|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2010-03-19|||June 2004||2004-06-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial|Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial|Completed||N/A|288|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 16:55:40.675821|2017-02-18 16:55:40.675821
NCT00261755|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2008-05-06|||March 2001||2001-03-01|May 2008|2008-05-01|May 2004|Actual|2004-05-01|February 2004|Actual|2004-02-01||Interventional|||Acupuncture as Pain Relief and Relaxation During Childbirth|Acupuncture as Pain Relief and Relaxation During Childbirth. A Randomized Controlled Study|Completed||Phase 1/Phase 2|607|Actual|University of Aarhus||3|||f||||f||||||||||2017-02-18 16:55:40.78581|2017-02-18 16:55:40.78581
NCT00261742|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2007-01-16|||October 2005||2005-10-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis|Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Dermatitis - an Open, Randomized, Controlled Trial|Terminated||Phase 4|194||University Children's Hospital Basel|||||f||||||||||||||2017-02-18 16:55:40.898372|2017-02-18 16:55:40.898372
NCT00261729|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2009-12-02|||July 2004||2004-07-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|August 2007|Actual|2007-08-01||Interventional|||Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees|Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees|Completed||N/A|210|Anticipated|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 16:55:40.993808|2017-02-18 16:55:40.993808
NCT00261716|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2016-06-17|2016-03-17||January 2005||2005-01-01|June 2016|2016-06-01|February 2010|Actual|2010-02-01|September 2008|Actual|2008-09-01||Interventional|||Motivational Interviewing to Improve Work Outcomes in Schizophrenia|Motivational Interviewing to Improve Work Outcomes in Schizophrenia|Completed||Phase 3|38|Actual|VA Office of Research and Development|Small sample size reflecting recruitment challenges|2|||f||||f||||||||Yes|Contact PI for access to data|2017-02-18 16:55:41.198574|2017-02-18 16:55:41.198574
NCT00261703|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2012-05-10|||December 2002||2002-12-01|May 2012|2012-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Docetaxel in Head and Neck Cancer|Randomized Phase III Trial Comparing Induction Chemotherapy With Cisplatin/5-fluorouracil (PF) or Docetaxel/Cisplatin/5-fluorouracil (TPF) Plus Chemoradiotherapy (CRT) Versus CRT Alone as First-line Treatment or Unresectable Locally Advanced Head and Neck Cancer (LAHNC).|Completed||Phase 2/Phase 3|439|Actual|Sanofi||3|||f||||||||||||||2017-02-18 16:55:42.018155|2017-02-18 16:55:42.018155
NCT00261690|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2013-04-17|||February 2002||2002-02-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|VRPT/H2O/RT||Virtual Reality Pain Control During Burn Wound Care|Use of Virtual Reality for Adjunctive Treatment of Burn Pain|Completed||Phase 2/Phase 3|184|Actual|National Institute of General Medical Sciences (NIGMS)||1|||f||||f||||||||||2017-02-18 16:55:42.124612|2017-02-18 16:55:42.124612
NCT00261677|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-05-19|||August 2000||2000-08-01|April 2010|2010-04-01|October 2003|Actual|2003-10-01|||||Interventional|||A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) on Anemia and Quality of Life in Children With Cancer Undergoing Myelosuppressive Chemotherapy|Completed||Phase 3|224|Actual|Ortho Biotech Products, L.P.|||||f||||||||||||||2017-02-18 16:55:42.227348|2017-02-18 16:55:42.227348
NCT00261664|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-07-25|||September 2003||2003-09-01|July 2011|2011-07-01|July 2005|Actual|2005-07-01|||||Interventional|||Empowering Elders Through Technology|Empowering Elders Through Technology|Completed||Phase 1/Phase 2|290||Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 16:55:42.318019|2017-02-18 16:55:42.318019
NCT00261638|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2005-12-02|||October 2005||2005-10-01|October 2005|2005-10-01|May 2006||2006-05-01|||||Observational|||A Study of the Effect of Mental Health Promotion on Mental Health Index|A Study of the Effect of Mental Health Promotion on Mental Health Index|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:55:42.406331|2017-02-18 16:55:42.406331
NCT00261625|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2009-01-02|||August 2005||2005-08-01|December 2008|2008-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?|Can Alendronate Suppress Aortic and Coronary Artery Calcification and Improve Bone Mineral Density in Chronic Peritoneal Dialysis Patients?|Completed||Phase 4|50|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:55:42.473141|2017-02-18 16:55:42.473141
NCT00261612|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2006-10-17|||January 2005||2005-01-01|October 2006|2006-10-01|January 2007||2007-01-01|||||Interventional|||Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma||Unknown status|Active, not recruiting|Phase 2|16||Medical University of Vienna|||||f||||||||||||||2017-02-18 16:55:42.571443|2017-02-18 16:55:42.571443
NCT00261599|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2008-11-06|||March 2006||2006-03-01|November 2008|2008-11-01|October 2006|Actual|2006-10-01|||||Interventional|||An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy|A Phase 3, Randomized, Double-Blind, Dose-Controlled Study to Assess the Efficacy and Safety of AQUAVAN® (Fospropofol Disodium) Injection for Minimal to Moderate Sedation in Patients Undergoing Colonoscopy|Completed||Phase 3|300||Eisai Inc.|||||||||||||||||||2017-02-18 16:55:42.678126|2017-02-18 16:55:42.678126
NCT00261586|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-06-28||||||June 2011|2011-06-01|March 2004|Actual|2004-03-01|||||Interventional|||A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach|Effect of Analgesics on the Irreversible Inactivation of Cyclooxygenase-1 Activity by Low Dose Aspirin and Endoscopic Evaluation of the Gastric Mucosal Effect|Completed||Phase 4|92|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|||||f||||||||||||||2017-02-18 16:55:42.800006|2017-02-18 16:55:42.800006
NCT00261573|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-05-17|||December 1998||1998-12-01|November 2010|2010-11-01|December 2000|Actual|2000-12-01|||||Interventional|||A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia|The Safety and Efficacy of Galantamine in the Treatment of Vascular and Mixed Dementia|Completed||Phase 3|593|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:55:42.890345|2017-02-18 16:55:42.890345
NCT00261560|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-06-28||||||June 2011|2011-06-01|February 2004|Actual|2004-02-01|||||Interventional|||A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.|A Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Effectiveness of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Ankle Sprains.|Completed||Phase 4|260|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|||||||||||||||||||2017-02-18 16:55:43.001423|2017-02-18 16:55:43.001423
NCT00261547|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2008-02-15|||December 2005||2005-12-01|February 2008|2008-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients|Pilot Study of Rituximab Treatment to Inhibit HLA Antibodies in Renal Allograft Recipients|Completed||Phase 1/Phase 2|0|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 16:55:43.092947|2017-02-18 16:55:43.092947
NCT00261534|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2006-09-13|||January 2006||2006-01-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Observational|||Cancer Related Fatigue in Patients Receiving Chemotherapy|Outcomes Research on the Course of Cancer Related Fatigue Throughout Five Chemotherapy Treatments|Unknown status|Active, not recruiting|N/A|90||Medical Center Alkmaar|||||f||||||||||||||2017-02-18 16:55:43.211933|2017-02-18 16:55:43.211933
NCT00261521|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2010-12-02|||February 2000||2000-02-01|December 2010|2010-12-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients|Double-blind Study to Assess the Impact of Normalization of Hemoglobin Compared to Partial Correction of Hemoglobin With EPREX�/ERYPO� on Left Ventricular Structure in Early Hemodialysis Patients (RWJ-22512)|Completed||Phase 3|596|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:55:43.302075|2017-02-18 16:55:43.302075
NCT00261508|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-01-20|||August 1999||1999-08-01|January 2011|2011-01-01|December 2001|Actual|2001-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)|Efficacy And Safety Of Risperidone In The Treatment Of Children With Autistic Disorder And Other Pervasive Developmental Disorders: A Canadian, Multicenter, Double-Blind, Placebo-Controlled Study|Completed||Phase 3|80|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 16:55:43.413529|2017-02-18 16:55:43.413529
NCT00261495|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2014-05-21|2012-11-20||March 2006||2006-03-01|May 2014|2014-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.|Randomized, Open-Label, Comparative Parallel Group Study to Assess Efficacy and Safety on Flexible Dosages of OROS Hydromorphone Once-Daily Compared to Sustained Release Oxycodone Twice Daily in Subjects With Chronic Non-malignant Pain Requiring Continuous Opioid Therapy.|Completed||Phase 3|504|Actual|Janssen Pharmaceutica N.V., Belgium||2|||f||||f||||||||||2017-02-18 16:55:43.561332|2017-02-18 16:55:43.561332
NCT00261092|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2008-04-14|||October 2005||2005-10-01|April 2008|2008-04-01||||||||Interventional|||GEMOX: Oxaliplatin in Pancreatic Cancer|Phase II Multicenter, Open Label Study of Oxaliplatin Combined With Gemcitabine(GEMOX) in Advanced and Metastatic Pancreatic Cancer|Completed||Phase 2|48||Sanofi|||||f||||||||||||||2017-02-18 16:55:59.414261|2017-02-18 16:55:59.414261
NCT00261482|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2010-11-15|||July 2003||2003-07-01|November 2010|2010-11-01|December 2004|Actual|2004-12-01|||||Interventional|||Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.|An Open Label, Multicentre Study of the EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch in Europe: Evaluation of Women's Experience With EVRA� and Comparison With Previously Used Methods of Contraception.|Completed||Phase 4|778|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 16:55:46.456631|2017-02-18 16:55:46.456631
NCT00261469|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-05-16|||April 2003||2003-04-01|January 2011|2011-01-01|November 2004|Actual|2004-11-01|||||Interventional|||An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans|Efficacy of Topiramate Prophylaxis as add-on to Triptan Therapy for Migraine|Completed||Phase 2|38|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 16:55:46.544088|2017-02-18 16:55:46.544088
NCT00261456|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2016-08-31|||October 2005||2005-10-01|August 2016|2016-08-01|December 2021|Anticipated|2021-12-01|December 2019|Anticipated|2019-12-01||Observational|||The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer|The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer: Targeted Screening in BRCA1/2 Mutation Carriers & Controls|Recruiting||N/A|1700|Anticipated|Institute of Cancer Research, United Kingdom|||2||f||||t||||||Samples With DNA|"~     Whole blood, Serum, Plasma, Urine, Prostate tissue.~   "|Yes|Anonymised data can be applied for via the Data Access Committee|2017-02-18 16:55:46.632426|2017-02-18 16:55:46.632426
NCT00261443|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2013-11-07|2011-01-28||September 2005||2005-09-01|April 2011|2011-04-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania|Efficacy of Aripiprazole in Combination With Lithium or Valproate in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients Partially Nonresponsive to Lithium or Valproate Monotherapy|Completed||Phase 4|1270|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-02-18 16:55:47.06274|2017-02-18 16:55:47.06274
NCT00261430|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-05-16||||||April 2010|2010-04-01|October 2004|Actual|2004-10-01|||||Interventional|||A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.|"Schizophrenia Treatment Acceptance Response Trial: a 20-week, Open-label, Multicenter, Randomized Study Comparing the Effect of the GAIN Acceptance Approach Verses the Approach-as-usual in Supporting Patient Acceptance of Long-acting Risperidone (Risperdal� CONSTA�) in Adults With Schizophrenia"|Completed||Phase 4|650|Actual|Janssen, LP|||||f||||||||||||||2017-02-18 16:55:53.491928|2017-02-18 16:55:53.491928
NCT00261417|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2009-04-21|||May 2004||2004-05-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Dose Response Study in Japanese Patients|A Randomized, Double-Blind, Multicentre, Placebo-Controlled Study to Evaluate the Efficacy, Dose-Response and Safety of Tesaglitazar Therapy in Japanese Subjects With Type 2 Diabetes|Terminated||Phase 2|250||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:55:53.584226|2017-02-18 16:55:53.584226
NCT00261404|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-05-11||||||May 2011|2011-05-01||||||||Interventional|||TNFerade™ Biologic Plus Radiation for Metastatic Melanoma|"A Phase II, Open Label, Single Arm, Proof of Concept Study of TNFerade™ Plus Radiation in Patients With Metastatic Melanoma"|Completed||Phase 2|||GenVec|||||||||||||||||||2017-02-18 16:55:53.675643|2017-02-18 16:55:53.675643
NCT00261391|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2008-01-08|||October 2000||2000-10-01|May 2005|2005-05-01|October 2007||2007-10-01|||||Interventional|||Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.|Phase I Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Marimastat in Patients With Disabling Malformations and No Other Treatment Options|Completed||Phase 1|9||Boston Children’s Hospital|||||||||||||||||||2017-02-18 16:55:53.75083|2017-02-18 16:55:53.75083
NCT00261378|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2010-06-14|||November 2005||2005-11-01|June 2010|2010-06-01|January 2008|Actual|2008-01-01|||||Interventional|PRECISIONV||Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation|Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation (PRECISION V)|Completed||Phase 2|212|Actual|Biocompatibles UK Ltd||2|||f||||||||||||||2017-02-18 16:55:53.833294|2017-02-18 16:55:53.833294
NCT00261365|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2016-09-27|||November 2005||2005-11-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)|An Exploratory Study to Determine Potential Predictive Markers of Response and/or Toxicity in Patients With Unresectable Stage III or IV Malignant Melanoma Randomized and Treated With Ipilimumab (MDX-010/BMS-734016) at Two Dose Levels|Completed||Phase 1/Phase 2|80|Anticipated|Bristol-Myers Squibb||2|||f||||t||||||||||2017-02-18 16:55:53.938001|2017-02-18 16:55:53.938001
NCT00261352|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2009-04-21|||March 2005||2005-03-01|April 2009|2009-04-01|December 2006|Actual|2006-12-01|||||Interventional|||GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate|A 24-Week Randomised, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin or Metformin Combined With Fenofibrate) Study to Evaluate the Lipid Metabolic Effects, Safety and Tolerability of Tesaglitazar Therapy in Patients With Type 2 Diabetes and Low HDL-Cholesterol on a Fixed Background Therapy With a Statin|Terminated||Phase 3|1000||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:55:54.063251|2017-02-18 16:55:54.063251
NCT00261339|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2012-05-04|||August 2005||2005-08-01|December 2006|2006-12-01||||||||Interventional|||Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)|PRISM: Determination of the Performance Characteristics of ReQuest (TradeMark) in Practice in the Stepped Down Management of GORD|Completed||Phase 4|300||Takeda|||||f||||||||||||||2017-02-18 16:55:57.072972|2017-02-18 16:55:57.072972
NCT00261326|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2011-01-07|||September 2006||2006-09-01|March 2009|2009-03-01|May 2011|Anticipated|2011-05-01|January 2010|Anticipated|2010-01-01||Interventional|||Simvastatin Treatment of Patients With Acute Optic Neuritis|Simvastatin Treatment of Patients With Acut Optic Neuritis. A Doubleblind, Randomized and Placebo Controlled Fase III Trial|Unknown status|Active, not recruiting|Phase 3|64|Anticipated|Glostrup University Hospital, Copenhagen||2|||f||||t||||||||||2017-02-18 16:55:57.264411|2017-02-18 16:55:57.264411
NCT00261079|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2007-11-05|||April 2005||2005-04-01|November 2007|2007-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Fexofenadine in Pruritic Skin Disease|The Evaluation of Efficacy and Safety of Fexofenadine 180mg Tablets for 7 Days in the Treatment of Pruritic Skin Disease|Completed||Phase 4|435|Actual|Handok Pharmaceuticals Co., Ltd.|||||f||||f||||||||||2017-02-18 16:55:59.498091|2017-02-18 16:55:59.498091
NCT00261313|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2010-02-25|||December 2005||2005-12-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer|An Open Label Phase 2 Study of Doxorubicin and Cyclophosphamide Followed by Paclitaxel Delivered Every 14 Days With Pegfilgrastim and Darbepoetin Alfa Support for the Adjuvant Treatment of Women With Breast Cancer|Completed||Phase 2|80|Actual|Amgen||2|||f||||||||||||||2017-02-18 16:55:57.557476|2017-02-18 16:55:57.557476
NCT00261300|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2012-05-04|||October 2000||2000-10-01|December 2008|2008-12-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)|Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints|Completed||Phase 3|100|Anticipated|Takeda||1|||f||||||||||||||2017-02-18 16:55:57.661838|2017-02-18 16:55:57.661838
NCT00261287|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-02|2016-11-29|||November 2005||2005-11-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Clinical Trial Designed to Assess the Safety and Tolerability of Ciclesonide (200 mcg Once Daily), Applied as a Nasal Spray for Twelve Weeks, in the Treatment of Perennial Allergic Rhinitis (PAR) in Pediatric Patients 2-5 Years of Age|Completed||Phase 3|102||AstraZeneca|||||f||||||||||||||2017-02-18 16:55:57.762981|2017-02-18 16:55:57.762981
NCT00261274|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2009-05-22|||November 2005||2005-11-01|May 2009|2009-05-01||||||||Interventional|||Safety Study of ECO Conversion System For Red Blood Cells.|Evaluation of the Safety of Repeated Autologous Infusions of Enzyme-Converted A-to-O (A-ECO) Red Cells Into Group A Volunteers.|Completed||Phase 1|60||Velico Medical|||||f||||t||||||||||2017-02-18 16:55:57.85419|2017-02-18 16:55:57.85419
NCT00261261|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2005-11-30|||January 2001||2001-01-01|November 2005|2005-11-01|December 2004||2004-12-01|||||Interventional|||Family-Centered Behavioral Preparation for Surgery|Study of the ADVANCE Behavioral Preparation Program for Children and Their Parents|Completed||N/A|400||Yale University|||||f||||||||||||||2017-02-18 16:55:57.960646|2017-02-18 16:55:57.960646
NCT00261248|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2015-10-01|||November 1996||1996-11-01|September 2003|2003-09-01|December 2003||2003-12-01|||||Interventional|||Vaccine for Recurrent Urinary Tract Infections in Women|Phase 2 Clinical Trial of Vaginal Mucosal Immunization for Recurrent Urinary Tract Infections|Completed||Phase 2|75||University of Wisconsin, Madison|||||||||||||||||||2017-02-18 16:55:58.056052|2017-02-18 16:55:58.056052
NCT00261235|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2009-01-24|||March 2005||2005-03-01|January 2009|2009-01-01|January 2007|Actual|2007-01-01|January 2006|Actual|2006-01-01||Interventional|||Trial of Supported Employment Versus USES Supported Employment|A Randomized Trial of Supported Employment Versus USES Enhanced Supported Employment in Veterans With Serious Mental Illness|Completed||N/A|300|Anticipated|VA Connecticut Healthcare System|||||f||||||||||||||2017-02-18 16:55:58.1614|2017-02-18 16:55:58.1614
NCT00261222|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2010-02-02|||September 2005||2005-09-01|October 2006|2006-10-01|November 2005||2005-11-01|||||Interventional|||Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso|Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso|Completed||Phase 2|120||Heidelberg University|||||f||||||||||||||2017-02-18 16:55:58.253854|2017-02-18 16:55:58.253854
NCT00261209|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2016-04-20|||January 2005||2005-01-01|April 2016|2016-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand|Study of Collagenase Injection Therapy for Treatment of Zone II Flexor Tendon Adhesions in the Hand|Completed||Phase 1/Phase 2|3|Actual|Stony Brook University||1|||f||||f||||||||No||2017-02-18 16:55:58.344247|2017-02-18 16:55:58.344247
NCT00261196|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2011-08-11|||January 2006||2006-01-01|August 2011|2011-08-01|January 2007|Anticipated|2007-01-01|||||Interventional|||Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder)||Withdrawn||Phase 2|58|Anticipated|Stony Brook University||||IND moved to sponsor.|||||||||||||||2017-02-18 16:55:58.442784|2017-02-18 16:55:58.442784
NCT00261183|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2005-12-01|||December 2004||2004-12-01|November 2005|2005-11-01|December 2006||2006-12-01|||||Interventional|||The Contribution of Melatonin Vs. Placebo in Benzodiazepine Withdrawal in Methadone Maintenance Treatment Patients||Unknown status|Recruiting|Phase 3|100||Tel-Aviv Sourasky Medical Center|||||f||||||||||||||2017-02-18 16:55:58.528763|2017-02-18 16:55:58.528763
NCT00261170|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2008-05-22|||July 2003||2003-07-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Interventional|||Bupropion for Hospital-Based Smoking Cessation|Bupropion for Hospital-Based Smoking Cessation|Completed||Phase 3|85|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 16:55:58.607884|2017-02-18 16:55:58.607884
NCT00261157|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2005-11-30|||April 2004||2004-04-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Use of Robotic Telerounding After Operative Procedures|Use of Robotic Telerounding After Operative Procedures: Does It Affect Patient Outcomes?|Completed||N/A|72||University of California, Davis|||||f||||||||||||||2017-02-18 16:55:58.717965|2017-02-18 16:55:58.717965
NCT00261144|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2012-12-11|||February 2013||2013-02-01|December 2012|2012-12-01|March 2014|Anticipated|2014-03-01|February 2014|Anticipated|2014-02-01||Interventional|||Collagenase in the Treatment of Cellulite|Collagenase in the Treatment of Cellulite|Unknown status|Not yet recruiting|Phase 2|20|Anticipated|Stony Brook University||1|||f||||f||||||||||2017-02-18 16:55:58.796126|2017-02-18 16:55:58.796126
NCT00261131|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2009-02-04|||March 2006||2006-03-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|||||Interventional|||Efficacy and Functional Outcomes of Botulinum Toxin A Injections to Hamstrings in Flexed Knee Gait in Cerebral Palsy|Efficacy and Functional Outcomes of Botulinum Toxin A Injections to Hamstrings in Flexed Knee Gait in Cerebral Palsy: A Double-Blind, Randomized, Placebo-Controlled Trial|Completed||Phase 3|250|Anticipated|Shriners Hospitals for Children|||||f||||||||||||||2017-02-18 16:55:58.883038|2017-02-18 16:55:58.883038
NCT00261118|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2014-11-05|||April 2004||2004-04-01|November 2014|2014-11-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Rituximab in Active Ulcerative Colitis|Phase 3: Randomised Controlled Trial of Rituximab in Active Ulcerative Colitis|Completed||Phase 2/Phase 3|24|Actual|Royal Liverpool University Hospital||2|||f||||t||||||||||2017-02-18 16:55:58.971122|2017-02-18 16:55:58.971122
NCT00261105|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2009-09-24|||February 2005||2005-02-01|September 2009|2009-09-01|December 2005|Actual|2005-12-01|October 2005|Actual|2005-10-01||Interventional|||Telithromycin in Respiratory Tract Infections|An Open, Multicenter, Non-comparative, Phase IV Trial of Efficacy and Safety of Ketek(Telithromycin) 800mg|Completed||Phase 4|||Sanofi|||||f||||||||||||||2017-02-18 16:55:59.094524|2017-02-18 16:55:59.094524
NCT00261053|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2013-04-24|||June 2003||2003-06-01|April 2013|2013-04-01|December 2005|Actual|2005-12-01|September 2005|Actual|2005-09-01||Interventional|||Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|A Phase II Exploratory, Open-label Study of the Safety and Efficacy of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|Completed||Phase 2|14|Actual|Pharming Technologies B.V.||1|||f||||t||||||||||2017-02-18 16:55:59.671338|2017-02-18 16:55:59.671338
NCT00261040|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2011-10-24|||June 2003||2003-06-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|December 2010|Actual|2010-12-01||Interventional|||Minimally Invasive Surgery of the Hip Versus Standard Approach|Minimally Invasive Surgery of the Hip: A Randomized Study|Completed||N/A|40|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 16:55:59.758778|2017-02-18 16:55:59.758778
NCT00261027|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2010-03-01|||January 2003||2003-01-01|March 2010|2010-03-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer|A Pilot, Phase II, Single Center, Non-comparative, Open-label Study of Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer|Completed||Phase 2|30|Anticipated|Ottawa Hospital Research Institute|||||f||||f||||||||||2017-02-18 16:55:59.859325|2017-02-18 16:55:59.859325
NCT00261014|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2015-11-17|||October 2002||2002-10-01|November 2015|2015-11-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Observational|||Understanding Risk Factors Involved in Developing a Second Blood Clot.|REcurrent VEnous Thromboembolism Risk Stratification Evaluation A Study to Develop a Clinical Prediction Rule to Predict Low Recurrence Risk in Patients With Idiopathic Venous Thromboembolism.|Active, not recruiting||N/A|800|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 16:55:59.954015|2017-02-18 16:55:59.954015
NCT00261001|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2009-11-24|||October 2005||2005-10-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|February 2006|Actual|2006-02-01||Interventional|MANON-05||Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route|A Randomized Comparative Phase I Study to Evaluate and to Compare the Safety and Immunogenicity of a Transcutaneous Mode of Administration of a Licensed Tetanus/Influenza Vaccine to the Conventional Intramuscular Route of Vaccine Administration in Healthy Volunteers and HIV-infected Patients|Completed||Phase 1|38|Actual|Objectif Recherche Vaccins SIDA||2|||f||||f||||||||||2017-02-18 16:56:00.057476|2017-02-18 16:56:00.057476
NCT00260988|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2014-09-08|||October 2003||2003-10-01|July 2009|2009-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery|Tinzaparin Versus Dalteparin for Perioperative Thromboembolic Prophylaxis in Patients With Dialysis Dependent Renal Disease- A Canadian Multicentre Trial|Completed||Phase 2/Phase 3|29|Actual|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 16:56:00.193908|2017-02-18 16:56:00.193908
NCT00260975|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2010-08-23|||June 2001||2001-06-01|August 2010|2010-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer|A Prospective, Longitudinal Investigation of the Neuropsychological and Psychosocial Effects of Cancer Therapy|Completed||N/A|150||Ottawa Hospital Research Institute|||3||f||||f||||||||||2017-02-18 16:56:00.323112|2017-02-18 16:56:00.323112
NCT00260962|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2009-09-30|||September 2000||2000-09-01|September 2009|2009-09-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Olanzapine in the Treatment of Patients With Anorexia Nervosa|Olanzapine in the Treatment of Low Weight and Obsessional Thinking Among Those With Anorexia Nervosa: A Double Blind Placebo Controlled Study|Completed||Phase 2|28|Actual|Ottawa Hospital Research Institute||1|||f||||||||||||||2017-02-18 16:56:00.413256|2017-02-18 16:56:00.413256
NCT00260949|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2011-10-24|||November 2004||2004-11-01|October 2011|2011-10-01|September 2011|Actual|2011-09-01|August 2011|Actual|2011-08-01||Interventional|||Outcome Following Surgery to Repair Rotator Cuff Tears|Functional and Anatomical Results Following Arthroscopic Cuff Repair|Completed||Phase 4|30|Anticipated|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-02-18 16:56:00.53211|2017-02-18 16:56:00.53211
NCT00260936|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2016-02-29|||March 2006||2006-03-01|February 2016|2016-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Metabolic Abnormalities - HIV Infected and Uninfected Males|Prevalence of Morphologic and Metabolic Anormalities in HIV Infected and Uninfected Young Men|Completed||N/A|250|Actual|Westat|||4||f||||f||||||||||2017-02-18 16:56:00.641061|2017-02-18 16:56:00.641061
NCT00260923|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2011-11-07|||November 2005||2005-11-01|November 2011|2011-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study Comparing an Eight-week Treatment of Aliskiren 75 mg, 150 mg and 300 mg to Placebo in Patients With Essential Hypertension|Completed||Phase 3|641|Actual|Novartis|||||f||||||||||||||2017-02-18 16:56:00.751808|2017-02-18 16:56:00.751808
NCT00260910|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2016-04-05|||May 2001||2001-05-01|August 2009|2009-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Progression Evaluation and Genetic Determinants of Hypertension in Chinese - A Follow-up Study of Taiwan SAPPHIRe|Progression Evaluation and Genetic Determinants of Hypertension in Chinese - A Follow-up Study of Taiwan SAPPHIRe|Completed||N/A|1246|Actual|National Health Research Institutes, Taiwan|||1||f||||f||||||Samples With DNA|"~     Plasma, serum, urine, and buffy coat~   "|Undecided||2017-02-18 16:56:00.955097|2017-02-18 16:56:00.955097
NCT00260897|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2007-05-07|||May 2003||2003-05-01|May 2007|2007-05-01|April 2008|Anticipated|2008-04-01|||||Observational|||Molecular Genetic Study of Avascular Necrosis of the Femoral Head|Molecular Genetic Study of Avascular Necrosis of the Femoral Head-Revealing ANFH Pathogenesis Mechanism by Cell and Animal Models|Unknown status|Recruiting|N/A|500|Anticipated|National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 16:56:01.042503|2017-02-18 16:56:01.042503
NCT00260884|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2005-12-01|||October 1993||1993-10-01|December 2005|2005-12-01|August 2004||2004-08-01|||||Interventional|||Phase III Study OF the Gastric Surgery on Advanced Stage Gastric Cancer|Phase III Study of the Effect of Radical Gastric Surgery Versus Conventional Surgery on Recurrence and Survival in Patients With Advanced Stage Gastric Cancer.|Completed||Phase 3|220||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 16:56:01.138095|2017-02-18 16:56:01.138095
NCT00254345|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2007-12-10|||September 2006||2006-09-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Effect of Provisional-Crown Surface Coating on Biofilm Formation|Effect of Provisional-Crown Surface Coating on Biofilm Formation|Completed||Phase 1|1||Hadassah Medical Organization|||||f||||f||||||||||2017-02-18 16:58:05.255602|2017-02-18 16:58:05.255602
NCT00260871|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2011-07-27|||May 2002||2002-05-01|July 2011|2011-07-01||||||||Observational|||Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications|Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications-focusing on Female Lung Adenocarcinoma (GEFLAC)|Unknown status|Active, not recruiting|N/A|1500|Anticipated|National Health Research Institutes, Taiwan|||1||f||||t||||||||||2017-02-18 16:56:01.226095|2017-02-18 16:56:01.226095
NCT00260858|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2006-06-07|||November 2005||2005-11-01|June 2006|2006-06-01|April 2006||2006-04-01|||||Interventional|||GI Interlab 2 Study: Measuring the Glycaemic Index (GI) of Foods|Measuring the Glycaemic Index of Foods: Interlaboratory Study #2|Completed||N/A|280||Glycaemic Index Testing, Inc.|||||f||||||||||||||2017-02-18 16:56:01.327857|2017-02-18 16:56:01.327857
NCT00260832|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2011-09-20|2011-04-13||November 2005||2005-11-01|September 2011|2011-09-01|December 2010|Actual|2010-12-01|October 2009|Actual|2009-10-01||Interventional|||Trial of Decitabine in Patients With Acute Myeloid Leukemia|Randomized Phase 3 Trial of Decitabine Versus Patient's Choice With Physician's Advice of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 3|485|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 16:56:01.452516|2017-02-18 16:56:01.452516
NCT00260819|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2008-10-16|||January 2006||2006-01-01|March 2007|2007-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia|Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia|Completed||Phase 1|20|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 16:56:02.302971|2017-02-18 16:56:02.302971
NCT00260806|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2014-03-17|||August 2004||2004-08-01|March 2014|2014-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children|HAART Associated Cardiotoxicity in HIV-Infected Children|Completed||N/A|71|Actual|University of Miami|||2||f||||t||||||Samples With DNA|"~     Peripheral blood mononuclear cells (PBMCs) were collected from the WITS cohort to~     investigate the presence of mitochondrial DNA (mtDNA) mutations.~   "|||2017-02-18 16:56:02.433284|2017-02-18 16:56:02.433284
NCT00260793|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2006-02-02|||November 2005||2005-11-01|November 2005|2005-11-01||||||||Interventional|||Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease|Open Label Prospective Study of High Dose Ropinirole for Motor Fluctuations and Dyskinesias in Advanced Parkinson's Disease|Unknown status|Recruiting|Phase 3|20||Colorado Neurology|||||f||||||||||||||2017-02-18 16:56:02.531319|2017-02-18 16:56:02.531319
NCT00260780|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2005-12-01|||June 2001||2001-06-01|December 2005|2005-12-01|June 2004||2004-06-01|||||Interventional|||An STD Prevention Intervention for Men Newly Released From Jail|The MISTERS Project: An STD Prevention Intervention for Men Newly Released From Jail|Completed||N/A|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 16:56:02.61808|2017-02-18 16:56:02.61808
NCT00260767|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2005-11-30||||||November 2005|2005-11-01||||||||Interventional|||Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution|An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution|Unknown status|Not yet recruiting|Phase 1|6||Biosyn|||||f||||||||||||||2017-02-18 16:56:02.706055|2017-02-18 16:56:02.706055
NCT00260754|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2006-05-30|||October 2002||2002-10-01|December 2005|2005-12-01|July 2005||2005-07-01|||||Interventional|||Utilization of the Community Popular Opinion Leader (C-POL) Model in Alabama|Utilization of the Community Popular Opinion Leader (C-POL) Model to Achieve Syphilis Elimination in Alabama|Completed||N/A|600||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 16:56:02.787305|2017-02-18 16:56:02.787305
NCT00260741|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2007-04-03|||March 2003||2003-03-01|April 2007|2007-04-01|January 2006|Actual|2006-01-01|||||Interventional|||Cannabis for Spasticity in Multiple Sclerosis|Cannabis for Spasticity in Multiple Sclerosis: A Placebo-Controlled Study|Terminated||Phase 1/Phase 2|60||Center for Medicinal Cannabis Research||||Discontinued due to non-enrollment.|||||||||||||||2017-02-18 16:56:02.879664|2017-02-18 16:56:02.879664
NCT00260728|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2012-06-26|||December 2005||2005-12-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|May 2007|Actual|2007-05-01||Interventional|ACCESS||The Boston Scientific ACCESS Trial|ACCESS: Prospective, Multi-center Trial of the Fusion Vascular Access Graft for Patients Who Require Early Vascular Access for Hemodialysis|Terminated||Phase 2/Phase 3|149|Actual|Maquet Cardiovascular||1|||f||||||||||||||2017-02-18 16:56:02.978653|2017-02-18 16:56:02.978653
NCT00260715|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2005-12-01|||October 2002||2002-10-01|December 2005|2005-12-01|July 2005||2005-07-01|||||Interventional|||A Community-Based Intervention With Popular Opinion Leaders (C-POL) in Texas|A Community-Based Intervention With Popular Opinion Leaders (C-POL) in Texas to Achieve Syphilis Elimination|Completed||N/A|1200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 16:56:03.089517|2017-02-18 16:56:03.089517
NCT00260702|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2017-01-24|||November 24, 2005||2005-11-24|March 15, 2010|2010-03-15|March 19, 2010|Actual|2010-03-19|March 19, 2010|Actual|2010-03-19||Interventional|||Omalizumab to Treat Hyper-IgE (Job's) Syndrome|Pilot Study of Omalizumab (Xolair) in Hyper IgE (Job's) Syndrome|Completed||Phase 1|1|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:56:03.187257|2017-02-18 16:56:03.187257
NCT00260689|ClinicalTrials.gov processed this data on February 17, 2017|2005-12-01|2017-01-24|||November 28, 2005||2005-11-28|August 15, 2016|2016-08-15|May 4, 2016|Actual|2016-05-04|May 4, 2016|Actual|2016-05-04||Interventional|||Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia|A Randomized Study of Three Immunosuppressive Regimens in Treatment Naive Patients With Severe Aplastic Anemia: Horse ATG/CsA Taper vs Rabbit-ATG/CsA vs Alemtuzumab|Completed||Phase 2|136|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 16:56:03.2871|2017-02-18 16:56:03.2871
NCT00260676|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2009-06-16|||September 2004||2004-09-01|June 2009|2009-06-01|January 2010|Anticipated|2010-01-01|September 2009|Anticipated|2009-09-01||Interventional|||Protective Ventilatory Strategy in Potential Organ Donors|a Randomised Control Trial on Protective Ventilatory Strategy in Potential Organ Donors|Unknown status|Recruiting|Phase 3|200|Anticipated|University of Turin, Italy||1|||f||||||||||||||2017-02-18 16:56:03.420628|2017-02-18 16:56:03.420628
NCT00260663|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2015-04-06|||February 2006||2006-02-01|January 2008|2008-01-01|June 2008|Actual|2008-06-01|October 2007|Actual|2007-10-01||Interventional|||The Hearing Aid Effectiveness After Aural Rehabilitation (HEAR) Trial|The Hearing Aid Effectiveness After Aural Rehabilitation (HEAR) Trial|Completed||N/A|660|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 16:56:03.532229|2017-02-18 16:56:03.532229
NCT00005436|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1991||1991-09-01|May 2000|2000-05-01|August 1996|Actual|1996-08-01|||||Observational|||Lupus Cohort--Thrombotic Events and Coronary Artery Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.365961|2017-02-18 18:14:59.365961
NCT00260650|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2014-09-29|||September 2006||2006-09-01|September 2014|2014-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|Heart PACT||Patient Activation in High-Risk Patients With Heart Failure|Heart PACT: Patient Activation in High-Risk Patients With Heart Failure|Completed||N/A|84|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:56:03.645926|2017-02-18 16:56:03.645926
NCT00260637|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2006-10-25|||February 2004||2004-02-01|November 2005|2005-11-01|August 2005||2005-08-01|||||Interventional|||Efficacy Study of Acupuncture to Relieve Symptoms of Chronic Prostatitis|A Double Blind, Sham Controlled Trial Evaluating the Efficacy of Acupuncture in Relieving Symptoms of Chronic Prostatitis/ Chronic Pelvic Pain Syndrome|Completed||Phase 2/Phase 3|86||University of Science Malaysia|||||f||||||||||||||2017-02-18 16:56:03.757706|2017-02-18 16:56:03.757706
NCT00260624|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2012-02-23|||February 2003||2003-02-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Escitalopram Treatment of Patients With Agitated Dementia|Escitalopram in the Treatment of Patients With Agitated Dementia|Completed||Phase 4|20|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 16:56:03.84933|2017-02-18 16:56:03.84933
NCT00260611|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2015-03-24|||November 2004||2004-11-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of Oxaliplatin and Taxotere in Prostate Cancer|Study of Oxaliplatin and Taxotere in Androgen Independent Prostate Cancer|Completed||Phase 2|34|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:56:03.951184|2017-02-18 16:56:03.951184
NCT00260598|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2015-04-06|||August 1998||1998-08-01|April 2015|2015-04-01||||January 2010|Actual|2010-01-01||Interventional|||LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer|LIFE-Lung Fluorescence Endoscopic Surveillance in Patients at High Risk For Developing Lung Cancer|Terminated||Phase 2|142|Actual|University of Pittsburgh||1||LIFE Bronchoscopy equipment no longer functioning and cannot be repaired.|f||||||||||||||2017-02-18 16:56:04.066444|2017-02-18 16:56:04.066444
NCT00260585|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2015-12-01|||June 1999||1999-06-01|December 2015|2015-12-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|||Esophageal Cancer Risk Registry|Esophageal Cancer Risk Registry|Recruiting||N/A|4500|Anticipated|University of Pittsburgh|||1||f||||||||||Samples With DNA|"~     blood, tissue, lymph nodes~   "|||2017-02-18 16:56:04.174602|2017-02-18 16:56:04.174602
NCT00260572|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2015-12-01|||April 1999||1999-04-01|December 2015|2015-12-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|||Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease|Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease|Recruiting||N/A|1500|Anticipated|University of Pittsburgh|||1||f||||||||||||||2017-02-18 16:56:04.298186|2017-02-18 16:56:04.298186
NCT00260559|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2015-12-01|||May 1999||1999-05-01|December 2015|2015-12-01|December 2050|Anticipated|2050-12-01|December 2050|Anticipated|2050-12-01||Observational|||Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life|Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life|Recruiting||N/A|1200|Anticipated|University of Pittsburgh|||1||f||||||||||||||2017-02-18 16:56:04.408297|2017-02-18 16:56:04.408297
NCT00260546|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2011-09-29|||May 2006||2006-05-01|September 2011|2011-09-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||An-Art Study: Atrioventricular (AV) Node Ablation in Cardiac Resynchronisation Therapy|An-Art Study: AV-Node Ablation in Cardiac Resynchronisation Therapy|Withdrawn||Early Phase 1|0|Actual|University Hospital, Basel, Switzerland||1||No patients enrolled for 6 months.|f||||f||||||||||2017-02-18 16:56:04.513973|2017-02-18 16:56:04.513973
NCT00260533|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2016-05-19|2012-06-13||November 2005||2005-11-01|May 2016|2016-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder|Double Blind Placebo Controlled Parallel Group Comparison of Atomoxetine (Strattera) for Generalized Social Anxiety Disorder (GSAD)|Completed||Phase 2/Phase 3|27|Actual|University of California, San Diego|Small study, with possibility of Type II error. Nonetheless, response rates in both arms were very low, making it unlikely that the failure to see a response to atomoxetine was due to low power compared to placebo.|2|||f||||f||||||||||2017-02-18 16:56:04.590873|2017-02-18 16:56:04.590873
NCT00260520|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2006-03-03|||January 2002||2002-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||LMWH to Prevent Preeclampsia and Fetal Growth Restriction|Low Molecular Weight Heparin Vs No Treatment in Pregnant Women With Previous Preeclampsia or Fetal Growth Restriction Who Were Heterozygote for Factor V Leiden or Prothrombin Gene G20210A Mutation|Terminated||Phase 4|||University of Florence|||||f||||||||||||||2017-02-18 16:56:04.937918|2017-02-18 16:56:04.937918
NCT00260507|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2013-11-26|||August 2006||2006-08-01|November 2013|2013-11-01|May 2014|Anticipated|2014-05-01|June 2010|Actual|2010-06-01||Interventional|VocRehab||The Impact of Vocational Rehabilitation for Mentally Ill Veterans|The Impact of Vocational Rehabilitation on Mentally Ill Veterans|Unknown status|Active, not recruiting|N/A|100|Actual|Tuscaloosa Research & Education Advancement Corporation||1|||f||||f||||||||||2017-02-18 16:56:05.017595|2017-02-18 16:56:05.017595
NCT00260494|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2013-07-22|||March 2005||2005-03-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Acupuncture and Post-Surgical Wound Healing|Acupuncture and Post-Surgical Wound Healing in Coronary Artery Bypass Graft Patients Undergoing Open Saphenous Vein Graft Harvest|Terminated||N/A|65|Actual|University of California, San Francisco||3||No difference in primary outcomes at interim analysis.|f||||t||||||||||2017-02-18 16:56:05.125586|2017-02-18 16:56:05.125586
NCT00260481|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2016-01-20|||January 2006||2006-01-01|January 2016|2016-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Prometa Pharmacotherapy for Methamphetamine Dependence|Double-Blind, Placebo Controlled Trial of Prometa Pharmacotherapy for the Treatment of Methamphetamine Abuse|Completed||Phase 2/Phase 3|120|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 16:56:05.268323|2017-02-18 16:56:05.268323
NCT00260468|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2009-10-21|||November 2005||2005-11-01|October 2009|2009-10-01|December 2008|Actual|2008-12-01|||||Observational|||Brain Abnormalities in Late-Onset Major Depression|Structural and Functional Cerebral Findings in Late-Onset Major Depression|Completed||N/A|44|Actual|University of Aarhus|||1||f||||f||||||Samples With DNA|"~     Apolipoprotein~   "|||2017-02-18 16:56:05.377892|2017-02-18 16:56:05.377892
NCT00260442|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2015-11-04|||November 2005||2005-11-01|November 2015|2015-11-01|May 2017|Anticipated|2017-05-01|May 2008|Actual|2008-05-01||Interventional|||Egg Cholesterol Consumption, Blood Cholesterol and Skeletal Muscle Hypertrophy|Egg Cholesterol Consumption, Blood Cholesterol and Skeletal Muscle Hypertrophy|Active, not recruiting||Phase 2|36|Actual|Texas A&M University||3|||f||||||||||||||2017-02-18 16:56:05.474643|2017-02-18 16:56:05.474643
NCT00260429|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2010-11-05|2010-11-05||June 2003||2003-06-01|November 2010|2010-11-01|April 2008|Actual|2008-04-01|August 2005|Actual|2005-08-01||Interventional|||Collagenase in the Treatment of Dupuytrens Disease|Double-blind, Randomized Placebo Controlled Study of the Relative Safety and Efficacy of Collagenase Therapy in the Treatment of Residual-type Dupuytren's Disease.|Completed||Phase 3|38|Actual|Stony Brook University||2|||f||||f||||||||||2017-02-18 16:56:05.824713|2017-02-18 16:56:05.824713
NCT00260416|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2008-05-21|||May 2005||2005-05-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours|Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours|Completed||Phase 2|60|Anticipated|Aarhus University Hospital Skejby|||||f||||||||||||||2017-02-18 16:56:06.260123|2017-02-18 16:56:06.260123
NCT00260403|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2006-02-02|||June 2003||2003-06-01|June 2004|2004-06-01|January 2008||2008-01-01|||||Interventional|||TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration|Transpupillary Thermotherapy Versus Photodynamic Therapy Treatment of Occult and Minimally Classic Choroidal Neovascularization in Age-Related Macular Degeneration.|Unknown status|Recruiting|Phase 2/Phase 3|140||St. Erik Eye Hospital|||||f||||||||||||||2017-02-18 16:56:06.360767|2017-02-18 16:56:06.360767
NCT00260390|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2006-10-03|||September 2004||2004-09-01|October 2006|2006-10-01||||||||Interventional|||Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial|The Efficacy of Testosterone Replacement in Treating Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial|Unknown status|Recruiting|Phase 4|||Sheba Medical Center|||||f||||||||||||||2017-02-18 16:56:06.4663|2017-02-18 16:56:06.4663
NCT00260377|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2008-09-08|||January 2005||2005-01-01|September 2008|2008-09-01|December 2006||2006-12-01|June 2006||2006-06-01||Interventional|||Aspirin Resistance Following Coronary Bypass Surgery||Terminated||N/A|||Sheba Medical Center||||The researcher had left the hospital and the project was stopped|f||||f||||||||||2017-02-18 16:56:06.570774|2017-02-18 16:56:06.570774
NCT00260364|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2016-10-13|||November 2005||2005-11-01|January 2010|2010-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|TARGET||Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer|A Phase I-II Dose Finding and Early Efficacy Study of Combination Therapy With Erlotinib (Tarceva), Gemcitabine, Bevacizumab (Avastin), and Capecitabine in Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|44|Actual|Royal Marsden NHS Foundation Trust||1|||f||||t||||||||||2017-02-18 16:56:06.673538|2017-02-18 16:56:06.673538
NCT00260351|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2014-01-10|||December 2004||2004-12-01|January 2014|2014-01-01|October 2008|Actual|2008-10-01|August 2008|Actual|2008-08-01||Interventional|||Immunogenicity and Safety of Verorab™ in Indian Population|Immunogenicity and Safety of Purified Vero Cell Rabies Vaccine (PVRV, Verorab™) Administered for Rabies Post-exposure Treatment. Comparison of Essen-IM, Zagreb-IM, and Thai Red Cross (TRC)-ID Regimens in the Indian Population.|Completed||Phase 4|405|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 16:56:06.78479|2017-02-18 16:56:06.78479
NCT00260338|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2013-05-30|||December 2005||2005-12-01|May 2013|2013-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia|Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia|Completed||Phase 1/Phase 2|31|Actual|Rigshospitalet, Denmark||1|||f||||||||||||||2017-02-18 16:56:06.912603|2017-02-18 16:56:06.912603
NCT00260325|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2007-05-29|||August 2004||2004-08-01|May 2007|2007-05-01|December 2004||2004-12-01|||||Interventional|||Effect of Valdecoxib Pretreatment on Pain and Secondary Hyperalgesia in Healthy Volunteers|Effect of Valdecoxib Pretreatment on Pain and Secondary Hyperalgesia: a Randomized Controlled Trial in Healthy Volunteers|Completed||Phase 4|20||Penn State University|||||f||||||||||||||2017-02-18 16:56:07.020362|2017-02-18 16:56:07.020362
NCT00260312|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2005-11-29|||August 2001||2001-08-01|January 2004|2004-01-01|January 2003||2003-01-01|||||Interventional|||Study of Inactivated Poliovirus Vaccine Given at an Earlier Schedule With Shorter Intervals|Randomized Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba|Completed||N/A|300||Pan American Health Organization|||||f||||||||||||||2017-02-18 16:56:07.119316|2017-02-18 16:56:07.119316
NCT00260299|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2012-03-21|||February 2005||2005-02-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|||||Observational|||Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency|Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency|Unknown status|Recruiting|N/A|15|Anticipated|Oregon Health and Science University|||1||f||||t||||||Samples With DNA|"~     blood samples, cells (fibroblasts) from skin biopsy tissue, DNA, urine and stool~   "|||2017-02-18 16:56:07.202045|2017-02-18 16:56:07.202045
NCT00260286|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2005-12-02|||August 2001||2001-08-01|November 2005|2005-11-01|May 2004||2004-05-01|||||Interventional|||Effects of Gynecological Age on LH Sensitivity to Energy Availability|Dietary Energy Requirements in Physically Active Men and Women, Objective 4B: Effects of Gynecological Age on LH Sensitivity to Energy Availability|Completed||N/A|18||Ohio University|||||f||||||||||||||2017-02-18 16:56:07.303532|2017-02-18 16:56:07.303532
NCT00260273|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2007-11-07|||August 2004||2004-08-01|October 2007|2007-10-01|August 2008|Anticipated|2008-08-01|||||Interventional|||Access, Detection and Psychological Treatments|Access, Detection and Psychological Treatments|Unknown status|Active, not recruiting|N/A|56|Actual|Ontario Mental Health Foundation||2|||f||||f||||||||||2017-02-18 16:56:07.415808|2017-02-18 16:56:07.415808
NCT00260260|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2008-01-03|||June 2005||2005-06-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||OXY-1: The Pharmacogenetics of Oxycodone Analgesia in Postoperative Pain|The Pharmacogenetics of Oxycodone Analgesia in Postoperative Pain|Completed||Phase 4|300|Anticipated|Odense University Hospital|||||f||||||||||||||2017-02-18 16:56:07.512994|2017-02-18 16:56:07.512994
NCT00260247|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2015-04-21|||April 2005||2005-04-01|March 2005|2005-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.|Induction of Drug Metabolism: A Comparative, Pharmacokinetic in Vivo Study of the Effect of Carbamazepine and Oxcarbazepine on CYP3A4.|Completed||Phase 4|10|Actual|Odense University Hospital|||||f||||||||||||||2017-02-18 16:56:07.613256|2017-02-18 16:56:07.613256
NCT00260234|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2014-09-08|||November 2005||2005-11-01|September 2014|2014-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients|A Single-Center Phase I/II Study Of Peg-Encapsulated Islet Allografts Implanted In Patients With Type I Diabetes|Terminated||Phase 1/Phase 2|12||Novocell||1||Stopped in December 2007|f||||||||||||||2017-02-18 16:56:07.704639|2017-02-18 16:56:07.704639
NCT00260221|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2013-05-06|||January 2002||2002-01-01|March 2011|2011-03-01|November 2011|Actual|2011-11-01|January 2011|Actual|2011-01-01||Interventional|VRH||VRH Pain Reduction During Burn Wound Care and Physical Therapy|Testing Interactions to Adjunctive Pain Control Techniques|Completed||N/A|77|Actual|National Institute of General Medical Sciences (NIGMS)||3|||f||||f||||||||||2017-02-18 16:56:07.8357|2017-02-18 16:56:07.8357
NCT00260208|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2011-12-02|2011-09-14||January 2006||2006-01-01|December 2011|2011-12-01||||September 2010|Actual|2010-09-01||Interventional|||Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus|A Multicenter, Randomized, Open-label Study to Compare the Development of Liver Fibrosis at 12 Months After Transplantation for Hepatitis C Cirrhosis in Patients Receiving Either Cyclosporine Microemulsion or Tacrolimus|Terminated||Phase 4|361|Actual|Novartis|This study was prematurely discontinued due to poor recruitment. Since only a small patient group could be analyzed for primary outcome measure, robust conclusions on the effect of the two calcineurin inhibitors on the fibrosis score cannot be drawn.|2||Study was prematurely terminated due to poor recruitment.|f||||||||||||||2017-02-18 16:56:07.957637|2017-02-18 16:56:07.957637
NCT00260195|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2014-04-28|2013-11-27||July 2005||2005-07-01|April 2014|2014-04-01|July 2009|Actual|2009-07-01|July 2007|Actual|2007-07-01||Interventional|||A School Program for Children Exposed to Violence|A School Program for Children Exposed to Violence|Completed||Phase 2|78|Actual|RAND||2|||f||||f||||||||||2017-02-18 16:56:09.145502|2017-02-18 16:56:09.145502
NCT00260182|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2011-01-03|||October 2005||2005-10-01|May 2009|2009-05-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Observational|||Genetics of Recurrent Early Onset Major Depression|Genetics of Recurrent Early Onset Major Depression|Unknown status|Active, not recruiting|N/A|1500|Anticipated|National Institute of Mental Health (NIMH)|||1||f||||||||||Samples With DNA|"~     Blood samples with DNA~   "|||2017-02-18 16:56:09.58629|2017-02-18 16:56:09.58629
NCT00260169|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2013-12-09|||November 2005||2005-11-01|December 2013|2013-12-01|January 2009|Actual|2009-01-01|October 2007|Actual|2007-10-01||Interventional|||Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care Settings|Patient-Centered Depression Care in the Public Sector|Completed||N/A|432|Actual|University of Southern California||2|||f||||||||||||||2017-02-18 16:56:09.68864|2017-02-18 16:56:09.68864
NCT00260156|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2013-01-02||2013-01-02|November 2005||2005-11-01|January 2013|2013-01-01||||December 2008|Actual|2008-12-01||Interventional|||A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes|A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|59|Actual|Novartis||2|||f||||||||||||||2017-02-18 16:56:10.031234|2017-02-18 16:56:10.031234
NCT00260143|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2010-01-14|||May 2003||2003-05-01|January 2010|2010-01-01||||||||Interventional|||Testosterone and Physical Function in HIV+ Men|Testosterone and Physical Function in HIV Associate Weight Loss|Completed||Phase 2|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:56:10.135921|2017-02-18 16:56:10.135921
NCT00260130|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2013-05-28|||February 2005||2005-02-01|May 2013|2013-05-01|July 2009|Actual|2009-07-01|December 2007|Actual|2007-12-01||Interventional|||Food Rheology and Feeding in Lean and Obese Humans|Study 1: Viscosity Study Study 2: Meal Timing Study Study 3:Chronic Fluid and Solid Food Intake in Lean and Overweight Individuals|Completed||N/A|34|Anticipated|Purdue University||2|||f||||||||||||||2017-02-18 16:56:10.226778|2017-02-18 16:56:10.226778
NCT00260117|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2010-02-24|||January 2005||2005-01-01|February 2010|2010-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Long-Term Exercise Maintenance Via Internet Support|Long-Term Exercise Maintenance Via Internet Support|Completed||Phase 1/Phase 2|16000|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 16:56:10.358068|2017-02-18 16:56:10.358068
NCT00260104|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2008-05-23|||November 2005||2005-11-01|May 2008|2008-05-01||||||||Observational|||Risk Factors of Individuals With Coronary Artery Disease||Unknown status|Recruiting|N/A|||Nanjing Medical University|||||f||||||||||||||2017-02-18 16:56:10.447109|2017-02-18 16:56:10.447109
NCT00260091|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2013-11-15|||August 1999||1999-08-01|January 2009|2009-01-01|April 2006|Actual|2006-04-01|August 2005|Actual|2005-08-01||Interventional|FASTT||Conventional Infertility Treatment vs. Fast Track to IVF|Conventional Infertility Therapy vs. Fast Track to IVF|Completed||N/A|503|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 16:56:10.529759|2017-02-18 16:56:10.529759
NCT00260078|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2016-07-26||2010-01-20|February 2006||2006-02-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children|Intensive Pharmacokinetic Studies of Antiretroviral Drug Combinations in Children|Completed||Phase 1/Phase 2|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 16:56:10.659416|2017-02-18 16:56:10.659416
NCT00260065|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2013-05-13|2009-04-13||May 2005||2005-05-01|June 2010|2010-06-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes|A Phase 2 Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Advanced-Stage Myelodysplastic Syndromes|Completed||Phase 2|99|Actual|Eisai Inc.|Not Specified|1|||f||||||||||||||2017-02-18 16:56:10.841365|2017-02-18 16:56:10.841365
NCT00260052|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2015-08-21|||July 2003||2003-07-01|August 2015|2015-08-01|January 2010|Actual|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Erythropoietin Effects After Traumatic Brain Injury|Phase II Study of the Effects of Erythropoietin on Neuronal Cell Death in Traumatic Brain Injury Patients|Withdrawn||Phase 2/Phase 3|0|Actual|Medical College of Wisconsin||1||PI has left institution|f||||||||||||||2017-02-18 16:56:11.280173|2017-02-18 16:56:11.280173
NCT00260039|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2015-06-05|||December 2005||2005-12-01|June 2015|2015-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)|A Randomized, International, Double-Blinded (With In-House Blinding), GARDASIL-Controlled, Dose-Ranging Study of Octavalent Human Papillomavirus (HPV) L1 Virus-like Particle (VLP) Vaccine Administered to 16- to 23- Year-Old Women|Completed||Phase 2|680|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 16:56:11.38593|2017-02-18 16:56:11.38593
NCT00260026|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2007-01-25|||November 2004||2004-11-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer|Safety and Pharmacokinetic Study of Jin Fu Kang In Combination With Docetaxel for Patients With Previously Treated Non-Small Cell Lung Cancer|Completed||Phase 2|20||Memorial Sloan Kettering Cancer Center|||||||||||||||||||2017-02-18 16:56:11.496322|2017-02-18 16:56:11.496322
NCT00260013|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2010-03-22|||January 2005||2005-01-01|March 2010|2010-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Transition Into Primary-care Psychiatry (TIPP)|Transition Into Primary-care Psychiatry (TIPP): A Mental Health Demonstration Project.|Completed||Phase 2/Phase 3|40|Actual|Lawson Health Research Institute|||||f||||f||||||||||2017-02-18 16:56:11.593209|2017-02-18 16:56:11.593209
NCT00260000|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2006-04-12|||April 2005||2005-04-01|April 2006|2006-04-01|December 2005||2005-12-01|||||Interventional|||Study of BH4, a New and Simple Treatment of Mild PKU|Study of the Response of Tetrahydrobiopterin on S-Phenylalanine in Patients With PKU Housing the Y414C Mutation|Completed||Phase 2|15||The Kennedy Institute-National Eye Clinic|||||f||||||||||||||2017-02-18 16:56:11.702267|2017-02-18 16:56:11.702267
NCT00259987|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2009-05-15|||November 2005||2005-11-01|May 2009|2009-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus|A Phase II, Open-Label Study Evaluating Clinical Efficacy, Safety, Pharmacokinetic and Pharmacodynamic Effects of Lapatinib (GW572016) in Patients With Relapsed Adenocarcinoma of the Esophagus, Including Tumors of the Gastroesophageal Junction and Gastric Cardia|Completed||Phase 2|24|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 16:56:11.795375|2017-02-18 16:56:11.795375
NCT00259974|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2011-05-05|||April 2006||2006-04-01|March 2007|2007-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy|Double-blind Randomized Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy|Completed||Phase 3|60|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:56:11.895359|2017-02-18 16:56:11.895359
NCT00259961|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2006-12-22||||||December 2006|2006-12-01|December 2006||2006-12-01|||||Observational|||Clinical Outcome of Laparoscopic Versus Open Nissen Fundoplication in Children: 3−Year Follow-up Study of Randomized Controlled Trial.||Completed||N/A|||Institute of Child Health|||||f||||||||||||||2017-02-18 16:56:12.007958|2017-02-18 16:56:12.007958
NCT00259948|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2005-11-30|||January 2006||2006-01-01|October 2005|2005-10-01||||||||Interventional|||Aerobic Exercise Training & the Autonomic System In Patients After Myocardial Infarction or Stroke|The Effect of Aerobic Exercise Training On the Function of the Autonomic System In Patients That Have Suffered Myocardial Infarction or Stroke|Unknown status|Not yet recruiting|Phase 1|230|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:56:12.079001|2017-02-18 16:56:12.079001
NCT00259935|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2011-03-17|||October 2004||2004-10-01|March 2011|2011-03-01||||||||Interventional|||A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors|A Study to Determine the Bioequivalence of an Oral Formulation of Topotecan Containing the Drug Substance Manufactured by New Process Relative to the Current Study Formulation of Topotecan in Patients With Advanced Solid Tumors|Completed||Phase 1|106||GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:56:12.166642|2017-02-18 16:56:12.166642
NCT00259922|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2015-09-01|||August 2005||2005-08-01|September 2009|2009-09-01||||June 2006|Actual|2006-06-01||Interventional|||Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain|Completed||Phase 3|485|Actual|Cubist Pharmaceuticals LLC||3|||||||||||||||||2017-02-18 16:56:12.280345|2017-02-18 16:56:12.280345
NCT00259909|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2008-10-15|||November 2005||2005-11-01|October 2008|2008-10-01||||||||Observational|||Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Prospective Observational Study for the Psychometric Validation of a Patient-Reported Questionnaire in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD).|Completed||N/A|740||GlaxoSmithKline|||||f||||||||||||||2017-02-18 16:56:12.68868|2017-02-18 16:56:12.68868
NCT00259896|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2012-05-31|||October 2005||2005-10-01|January 2011|2011-01-01||||||||Interventional|||In-patient Study in Patients With Type 2 Diabetes Mellitus|A Randomized, Open-label, Placebo-controlled, Repeat-dose Study to Assess the Pharmacokinetics and Pharmacodynamics of 5 Micrograms Exenatide Administered Subcutaneously Twice Daily for 7 Days in Healthy Normal Volunteers and in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|30||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:56:12.858829|2017-02-18 16:56:12.858829
NCT00259883|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2017-01-16|||June 2005||2005-06-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Combination Of PAXIL Tablet And Benzodiazepines|Post-marketing Clinical Study on PAXIL Tablet in Patients With Depression or Depressive Mood - A Study on Combination of PAXIL Tablet and Benzodiazepines|Completed||Phase 4|150|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 16:56:13.121089|2017-02-18 16:56:13.121089
NCT00259870|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2012-11-21|||September 2005||2005-09-01|November 2012|2012-11-01|June 2007|Actual|2007-06-01|||||Interventional|||SB-773812 Administered In Adults With Schizophrenia|A Multi Centre, Double-Blind, Double-Dummy, Placebo-Controlled, Randomised, Adaptive, Dose-Range Study To Evaluate the Safety and Efficacy of SB-773812 Administered Once Daily for 12 Weeks in Adults With Schizophrenia|Completed||Phase 2|338|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 16:56:13.229247|2017-02-18 16:56:13.229247
NCT00259857|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2010-12-29|2010-11-09||October 2003||2003-10-01|December 2010|2010-12-01|August 2009|Actual|2009-08-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis|A Randomized, Double-Blind, Placebo-Controlled, Prospective, Cross-Over Phase II Clinical Trial to Determine the Safety and Efficacy of Alendronate (Fosamax) in Juvenile Osteoporosis (IND#60,017)|Completed||Phase 2|22|Actual|Medical University of South Carolina||2|||f||||t||||||||||2017-02-18 16:56:13.392442|2017-02-18 16:56:13.392442
NCT00259844|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2006-07-17|||June 2004||2004-06-01|November 2005|2005-11-01|December 2006||2006-12-01|||||Interventional|||Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed|A Phase 2 Study Immunologically Evaluating 5T4-MVA (TroVax) in Patients Undergoing Surgical Resection of Colorectal Liver Metastases|Completed||Phase 2|20||Cancer Research UK|||||f||||||||||||||2017-02-18 16:56:13.903549|2017-02-18 16:56:13.903549
NCT00259831|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2009-06-04|||December 2005||2005-12-01|June 2009|2009-06-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults|Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adult Employees in Continuing Care Facilities|Completed||Phase 3|500||Afexa Life Sciences Inc|||||f||||||||||||||2017-02-18 16:56:13.992918|2017-02-18 16:56:13.992918
NCT00259818|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2008-01-23|||December 2005||2005-12-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|||||Interventional|||Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors|An Open-Label Phase I Dose Escalation Study of Intravenous Infusion of Tetra-O-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Refractory Malignant Tumors|Completed||Phase 1|30|Anticipated|Erimos Pharmaceuticals|||||||||||||||||||2017-02-18 16:56:14.088601|2017-02-18 16:56:14.088601
NCT00259805|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2013-03-20|||January 2005||2005-01-01|March 2008|2008-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis|A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis|Completed||Phase 1|10|Actual|California Pacific Medical Center Research Institute||1|||f||||f||||||||||2017-02-18 16:56:14.17299|2017-02-18 16:56:14.17299
NCT00259792|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2011-01-21|||September 2004||2004-09-01|January 2011|2011-01-01|January 2006|Actual|2006-01-01|||||Interventional|||SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults|A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults - a 26-week, Randomised, Open, Parallel Group Multicentre Study|Completed||Phase 3|1000||AstraZeneca|||||f||||||||||||||2017-02-18 16:56:14.297303|2017-02-18 16:56:14.297303
NCT00259779|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2011-01-21|||September 2005||2005-09-01|January 2011|2011-01-01|July 2007|Actual|2007-07-01|||||Interventional|SPACE||Comparison Between Symbicort® and Prednisolone in COPD|A Randomised, Double Blind, Double Dummy, Multicentre Phase III Study Comparing the Efficacy of Budesonide/Formoterol (Symbicort® Forte Turbuhaler®) and Oral Prednisolone + Formoterol (Oxis® Turbuhaler) During Two Weeks, in COPD Patients With an Acute Exacerbation, Followed by Twelve Weeks Open Follow up Period With Budesonide/Formoterol (Symbicort Forte Turbuhaler)|Completed||Phase 3|120|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:56:14.477886|2017-02-18 16:56:14.477886
NCT00259766|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2011-01-21|||April 2004||2004-04-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|||||Interventional|||SHARE - Symbicort and Health Economics in a Real Life Evaluation|Symbicort and Health Economics in a Real Life Evaluation - SHARE - A Randomised, Open-Label, Parallel-Group, Multicentre Study to Assess the Asthma-Related Health-Care Costs, in Ordinary Clinical Practice During 12 Months|Completed||Phase 3|1970||AstraZeneca|||||f||||||||||||||2017-02-18 16:56:14.631526|2017-02-18 16:56:14.631526
NCT00259753|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-30|2008-08-04|||July 2005||2005-07-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration|A Phase II, Randomized, Double-Masked, Controlled, Dose Comparison Study of Cand5 for Intravitreal Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated With Wet Age-Related Macular Degeneration|Completed||Phase 2|120|Actual|OPKO Health, Inc.||3|||f||||t||||||||||2017-02-18 16:56:14.944581|2017-02-18 16:56:14.944581
NCT00259740|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-29|2014-09-12|2010-12-09||November 2005||2005-11-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|August 2007|Actual|2007-08-01||Interventional|||Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab|An Open-Label, Multi-Center Phase 2 Trial of Denosumab in the Treatment of Relapsed or Plateau-Phase Multiple Myeloma|Completed||Phase 2|96|Actual|Amgen||1|||f||||f||||||||||2017-02-18 16:56:15.084864|2017-02-18 16:56:15.084864
NCT00259727|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-09-28|||January 2006||2006-01-01|March 2009|2009-03-01|September 2008|Actual|2008-09-01|||||Observational|||The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism|The Effects of HIV Protease Inhibitors on Glucose Metabolism|Completed||N/A|80|Anticipated|VA Office of Research and Development|||1||f||||||||||||||2017-02-18 16:56:15.655202|2017-02-18 16:56:15.655202
NCT00259714|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2016-07-21|||March 2006||2006-03-01|July 2016|2016-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Dialysate Sodium Individualization in Hemodialysis|Hemodynamic and Hormonal Responses to Dialysate Sodium Individualization in Hemodialysis Patients|Terminated||Phase 1|1|Actual|Yale University||2||Protocol was not feasible - only 1 of 18 enrollees completed procedures.|f||||f||||||||||2017-02-18 16:56:15.760049|2017-02-18 16:56:15.760049
NCT00259701|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2006-10-05|||June 2005||2005-06-01|November 2005|2005-11-01|September 2005||2005-09-01|||||Observational|||Microvascular Reactivity.|Transdermal Application of Acetylcholine and Nitroglycerin Without Iontophoresis.|Completed||N/A|20||Yale University|||||f||||||||||||||2017-02-18 16:56:15.868456|2017-02-18 16:56:15.868456
NCT00259688|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2010-01-07|||February 2006||2006-02-01|January 2010|2010-01-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Prevalence Study of Sleep Apnea in Women With Preeclampsia|Sleep Disordered Breathing and Preeclampsia|Completed||Phase 2|60|Anticipated|University of Saskatchewan||3|||f||||||||||||||2017-02-18 16:56:15.951495|2017-02-18 16:56:15.951495
NCT00259675|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2007-11-10|||May 2004||2004-05-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC|Treatment of Stages IIIB and IV, Non Small Cell Lung Cancer With Alternating Cycles of Carboplatin/Taxol and Carboplatin/Gemcitabine.|Completed||Phase 2|100|Anticipated|University of Saskatchewan|||||f||||||||||||||2017-02-18 16:56:16.059672|2017-02-18 16:56:16.059672
NCT00259662|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2016-11-30|||November 2005||2005-11-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||High-dose Periop Statins for Prevention of DVT|High-dose Statin Therapy in the Perioperative Period and DVT Prevention.|Completed||N/A|29|Actual|Yale University|||||f||||||||||||||2017-02-18 16:56:16.156864|2017-02-18 16:56:16.156864
NCT00259649|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-26|2011-07-01|2011-05-26||August 2004||2004-08-01|June 2011|2011-06-01||||August 2008|Actual|2008-08-01||Interventional|||Prospective Survey of Menstrual Migraine & Prevention With Eletriptan|Assessment and Prevention of Menstrual Migraine: Phase 1-prospective Survey of Self-identified Menstrual Migraine. Phase 2-prevention of Menstrual Migraine With Relpax|Completed||Phase 4|71|Actual|University of Pittsburgh|Relatively small sample size and open-label treatment limit Menstrual regulation by hormonal therapy might have affected treatment response;|1|||f||||||||||||||2017-02-18 16:56:16.241846|2017-02-18 16:56:16.241846
NCT00259636|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-26|2011-05-31|||August 2004||2004-08-01|May 2011|2011-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Zonisamide for Fibromyalgia & Migraine|Zonisamide for Fibromyalgia & Migraine|Withdrawn||Phase 4|0|Actual|University of Pittsburgh||1||Logistical problems prevented enrollment|f||||t||||||||||2017-02-18 16:56:16.453155|2017-02-18 16:56:16.453155
NCT00254332|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-03-24|||November 2005||2005-11-01|December 2007|2007-12-01|September 2007||2007-09-01|||||Observational|||Effect of Denileukin Diftitox on Immune System in CTCL Patients|Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients|Completed||N/A|10|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 16:58:05.366731|2017-02-18 16:58:05.366731
NCT00259623|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2009-07-16|||December 2005||2005-12-01|July 2009|2009-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cardiac Surgical Treatment by Radiofrequency Ablation on Valvular Patients: Efficacy at 3 Months|Efficacy at 3 Months on Permanent Atrial Fibrillation in Patients Candidates to Cardiac Surgical Treatment by Epicardial, or Possibly Endocardial, Radiofrequency Ablation|Completed||N/A|13|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 16:56:16.548939|2017-02-18 16:56:16.548939
NCT00259610|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2014-07-16|2012-05-31||May 2004||2004-05-01|October 2013|2013-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TEAR||Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)|Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)|Completed||Phase 4|755|Actual|University of Alabama at Birmingham||4|||f||||t||||||||||2017-02-18 16:56:19.417194|2017-02-18 16:56:19.417194
NCT00259597|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2012-12-19|||June 2004||2004-06-01|November 2008|2008-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Nuclear Morphology of Breast Cells in Ductal Lavage|Morphometry of Breast Cells in Ductal Lavage|Completed||N/A|57|Actual|University of Michigan|||1||f||||t||||||||||2017-02-18 16:56:21.06688|2017-02-18 16:56:21.06688
NCT00259584|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2010-08-12|||October 2001||2001-10-01|August 2010|2010-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Superior Vena Caval Obstruction (SVCO) - Management and Outcome|A Prospective Longitudinal Study of the Management and Outcome of Superior Vena Caval Obstruction (SVCO)|Completed||Phase 1/Phase 2|20|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:56:21.159478|2017-02-18 16:56:21.159478
NCT00259571|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2013-12-12||||||November 2005|2005-11-01|March 2010||2010-03-01|||||Interventional|||Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.|"Prospektive, Randomisierte, Doppelblinde, Mesalazin-kontrollierte (Double-dummy Verfahren) Multizenter-Studie Zur Beurteilung Der Annahme Der äquivalenten Wirkung Von Intestinal Retardiert Freigesetztem Phosphatidylcholin gegenüber Mesalazin (Non-inferiority Study) in Der Remissionserhaltung Der Colitis Ulcerosa."|Withdrawn||Phase 2/Phase 3|0|Actual|Heidelberg University||||Missing financial sponsorship|f||||||||||||||2017-02-18 16:56:21.233205|2017-02-18 16:56:21.233205
NCT00259558|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2007-02-07|||April 2003||2003-04-01|February 2007|2007-02-01|March 2006||2006-03-01|||||Interventional|||Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis|Prospektive, Randomisierte Doppelblinde Studie Zur Dosisfindung Von Intestinal Redardiert Freigesetztem Phosphatidylcholin Bei Chronisch Aktiver Pancolitis Ulcerosa|Completed||Phase 2|60||Heidelberg University|||||f||||||||||||||2017-02-18 16:56:21.325966|2017-02-18 16:56:21.325966
NCT00259545|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2008-06-04|||February 2003||2003-02-01|June 2008|2008-06-01|February 2006||2006-02-01|||||Interventional|||Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis|Prospektive, Randomisierte Doppelblinde Studie Zur Wirksamkeit Von Intestinal Retardiert Freigesetztem Phosphatidylcholine Bei therapierefraktärer Colitis Ulcerosa Mit Chronisch Aktivem Verlauf Unter Corticosteroiden|Completed||Phase 2|60||Heidelberg University|||||f||||f||||||||||2017-02-18 16:56:21.41518|2017-02-18 16:56:21.41518
NCT00259532|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2009-02-25|||February 2005||2005-02-01|February 2009|2009-02-01|January 2009||2009-01-01|||||Interventional|||Three New Methods for Diagnosing Pancreas Cancer|Ultrasound With Contrast Agent, 64-Slice-CT and Tumormarkers for Diagnosing, Evaluation of Operability and Treatment Control of Pancreas Cancer|Unknown status|Recruiting|N/A|80|Anticipated|University of Copenhagen|||||f||||||||||||||2017-02-18 16:56:21.505773|2017-02-18 16:56:21.505773
NCT00259519|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2010-04-05|||January 2006||2006-01-01|April 2010|2010-04-01|September 2011|Anticipated|2011-09-01|March 2010|Actual|2010-03-01||Interventional|||Safety and Efficacy Study of Intentional Delivery in Women With Preterm and Prelabour Rupture of the Membranes|Effects of Intentional Delivery After Preterm and Prelabor Rupture of Membranes Between 32 and 35 Weeks of Gestation: A Multicentre Randomized and Controlled Trial|Terminated||N/A|152|Actual|University of Alberta||2||The DSMB supported termination of the trial due to slow recruitment.|f||||t||||||||||2017-02-18 16:56:21.578656|2017-02-18 16:56:21.578656
NCT00259506|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-06-02|||March 2006||2006-03-01|June 2009|2009-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||"Implementation and Evaluation of Mindfulness-Based Cognitive Therapy in a Health Care Region in Flanders: a Randomized Clinical Trial"|"Implementation and Evaluation of Mindfulness-Based Cognitive Therapy in a Health Care Region in Flanders: a Randomized Clinical Trial"|Completed||N/A|405|Anticipated|University Hospital, Ghent|||||f||||f||||||||||2017-02-18 16:56:21.692831|2017-02-18 16:56:21.692831
NCT00259493|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2006-09-07|||December 2005||2005-12-01|September 2005|2005-09-01|October 2007||2007-10-01|||||Interventional|||Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT|Graft Patency Following Off-Pump CABG Vs. On-Pump CABG Using 64 MDCT Bypass Graft CT Angiography|Unknown status|Recruiting|N/A|350||Trillium Health Centre|||||f||||||||||||||2017-02-18 16:56:21.78212|2017-02-18 16:56:21.78212
NCT00259480|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2015-05-12|||August 2001||2001-08-01|May 2015|2015-05-01|March 2015|Actual|2015-03-01|March 2014|Actual|2014-03-01||Interventional|||Project ACT: Advancing Caregiving Techniques|Reducing Family Caregiver Upset With Disruptive Behavior|Completed||Phase 3|272|Actual|Thomas Jefferson University||1|||f||||||||||||||2017-02-18 16:56:21.869254|2017-02-18 16:56:21.869254
NCT00259467|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2010-08-24|||February 2004||2004-02-01|August 2010|2010-08-01|January 2007||2007-01-01|||||Interventional|||Project TAP: Tailored Activities Project|Tailored Activity to Improve Affect in Dementia|Completed||Phase 1|60||Thomas Jefferson University|||||f||||f||||||||||2017-02-18 16:56:22.188213|2017-02-18 16:56:22.188213
NCT00259454|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2010-03-15|||June 2005||2005-06-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||Project COPE:Managing Dementia at Home|Managing Problem Behaviors of Alzheimer's Disease|Completed||Phase 3|278|Anticipated|Thomas Jefferson University||1|||f||||t||||||||||2017-02-18 16:56:22.277705|2017-02-18 16:56:22.277705
NCT00259441|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2007-07-10|||February 2005||2005-02-01|July 2007|2007-07-01|March 2006||2006-03-01|||||Interventional|||PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography|Prevention of Radiocontrast Media Induced Nephropathy by Short-Term High-Dose Statin in Renal Insufficiency Undergoing Coronary Angiography (PROMISS)|Completed||Phase 4|320||Seoul National University Hospital|||||f||||||||||||||2017-02-18 16:56:22.377227|2017-02-18 16:56:22.377227
NCT00259428|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2010-02-08|||November 2001||2001-11-01|February 2010|2010-02-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|EURIDIS||EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)|EURopean Trial In Atrial Fibrillation or Flutter Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)|Completed||Phase 3|615|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:56:22.475804|2017-02-18 16:56:22.475804
NCT00259402|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-12-04|||February 2000||2000-02-01|December 2009|2009-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Oxaliplatin in Esophagus Cancer (Advanced) 1st Line|Phase II Open-label Single Arm Study of Oxaliplatin Combined With Cisplatin and 5FU in Advanced Esophagus Cancer Patients|Completed||Phase 2|41|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:56:22.688127|2017-02-18 16:56:22.688127
NCT00259389|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2012-09-17|||April 2006||2006-04-01|September 2012|2012-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Directly Observed Therapy for HIV Infected Adolescents|Directly Observed Therapy (DOT) in HIV-1 Infected Adolescents|Completed||N/A|24|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:56:22.785036|2017-02-18 16:56:22.785036
NCT00259376|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2010-02-12|||November 2001||2001-11-01|February 2010|2010-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|ADONIS||American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm|American-Australian-African Trial With Dronedarone in Atrial Fibrillation or Flutter Patients for the Maintenance of Sinus Rhythm (ADONIS)|Completed||Phase 3|629|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:56:22.895543|2017-02-18 16:56:22.895543
NCT00259363|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-12-04|||October 2002||2002-10-01|December 2009|2009-12-01||||June 2006|Actual|2006-06-01||Interventional|||Oxaliplatin in Rectal Cancer|Phase I-II Study of Preoperative Oxaliplatin-FU and Radiotherapy for Patients With Rectal Cancer|Terminated||Phase 1/Phase 2|46|Actual|Sanofi||||Study cancelled because recruitment rate was too slow|f||||||||||||||2017-02-18 16:56:23.011709|2017-02-18 16:56:23.011709
NCT00259350|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-27|2009-01-26|||May 2004||2004-05-01|January 2009|2009-01-01|April 2006||2006-04-01|||||Interventional|||Chlorhexidine vs Povidone Iodine in Alcoholic Solutions for Prevention of Central Venous Catheter Infection|Prevention of Central Venous Catheter Infections : Comparison of the Efficacy of Skin Disinfection With 5% Povidone Iodine in Alcoholic Solution Versus 0.25% Chlorhexidine, 0.025 Benzalkonium and 4% Benzylic Alcohol|Completed||Phase 4|520||Poitiers University Hospital|||||f||||||||||||||2017-02-18 16:56:23.099973|2017-02-18 16:56:23.099973
NCT00259337|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2012-04-13|||February 2006||2006-02-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|||Immunogenicity and Safety of Pentaxim™ in an Indian Population|Immunogenicity and Safety of the Sanofi Pasteur DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM™) Given as a Three-Dose Primary Vaccination at 6, 10, and 14 Weeks of Age and Followed by a Booster Dose at 18-19 Months of Age in Healthy Infants in India.|Completed||Phase 3|226|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:56:23.188728|2017-02-18 16:56:23.188728
NCT00259324|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2012-04-19|||September 2005||2005-09-01|December 2007|2007-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Childhood Obesity Treatment Targeting Specific Behaviors|Childhood Obesity Treatment Targeting Specific Behaviors|Completed||N/A|81|Actual|The Miriam Hospital||3|||f||||||||||||||2017-02-18 16:56:23.301241|2017-02-18 16:56:23.301241
NCT00259311|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2007-01-24|||November 2005||2005-11-01|January 2007|2007-01-01|November 2006||2006-11-01|||||Interventional|||Efficacy Study of LY2422347 to Treat Insomnia|A Randomized, Double-Blind Comparison of 5 mg of LY2422347, 15 mg of LY2422347, and Placebo in the Treatment of Patients With Primary Insomnia|Completed||Phase 2|400||Eli Lilly and Company|||||||||||||||||||2017-02-18 16:56:23.402681|2017-02-18 16:56:23.402681
NCT00259298|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2010-07-14|2010-07-14||November 2005||2005-11-01|July 2010|2010-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis|The Use of Nuclear Scintigraphy to Evaluate the Anabolic Effects of Teriparatide on the Skeleton in Postmenopausal Women With Osteoporosis|Completed||Phase 4|12|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 16:56:23.644269|2017-02-18 16:56:23.644269
NCT00259285|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-04-07|2008-12-19||November 2005||2005-11-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer|Alimta (Pemetrexed) and Cisplatin Treatment as Neoadjuvant Therapy in Non Small Cell Lung Cancer|Terminated||Phase 2|10|Actual|Eli Lilly and Company|Trial was stopped early due to low enrollment and the relapse-free survival outcome measure was not analyzed.|1||Trial was stopped early due to low enrollment.|f||||f||||||||||2017-02-18 16:56:24.605915|2017-02-18 16:56:24.605915
NCT00259272|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-04-30|2009-04-30||November 2005||2005-11-01|April 2009|2009-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine|Phase IIIb, Multicenter, Single-Arm Open-Label Study, Supporting the Development and the Validation of the MATHYS Scale (Multidimensional Assessment of THYmic States) in a Population of Bipolar Patients Treated With Olanzapine, Either in-Label (Manic and Mixed Patients) and Off-Label (Hypomanic and Bipolar Depression)|Completed||Phase 3|141|Actual|Eli Lilly and Company|Fewer patients than planned were enrolled in the study. Not all the analyses (Principal Component Analysis, scree plot to define the structure) could be provided due to the specific formatting of the clinicaltrials.gov databank.|1|||f||||f||||||||||2017-02-18 16:56:24.986108|2017-02-18 16:56:24.986108
NCT00259259|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-01-20|||October 2005||2005-10-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Functional Lipids and Appetite Regulation|The Effect of Functional Lipids on Appetite Regulation in Man|Completed||N/A|22||University of Copenhagen|||||f||||||||||||||2017-02-18 16:56:27.722402|2017-02-18 16:56:27.722402
NCT00259246|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2009-01-20|||June 2004||2004-06-01|April 2005|2005-04-01|November 2005||2005-11-01|||||Interventional|||The Role of Peptide YY (PYY)Infusions in Inhibiting Food Intake.|Fasting and Postprandial Response After Infusion of Saline, PYY1-36 and PYY3-36 and Effects on Appetite, Energy Intake and Energy Expenditure in Overweight/Obese Compared to Normalweight Subjects|Completed||N/A|24||University of Copenhagen|||||f||||||||||||||2017-02-18 16:56:27.811619|2017-02-18 16:56:27.811619
NCT00259233|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2009-01-20|||March 2005||2005-03-01|April 2007|2007-04-01|May 2005||2005-05-01|||||Interventional|||The Role of Peptide YY (PYY)in Inhibiting Food Intake.|The Effects of Peripheral Administration of Saline, PYY1-36 and PYY3-36 on ad Libitum Energy Intake and Appetite.|Completed||N/A|24||University of Copenhagen|||||f||||||||||||||2017-02-18 16:56:27.884798|2017-02-18 16:56:27.884798
NCT00259220|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2008-09-30|||December 2005||2005-12-01|March 2007|2007-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||HDUPE 2004: Gastro-Oesophageal Haemorrhage in Emergency : Gastric Préparation to Endoscopy|In Urgency Hight Digestive Haemorrhage : Gastric Preparation for Endoscopy|Completed||Phase 3|270|Actual|Assistance Publique - Hôpitaux de Paris||3|||f||||t||||||||||2017-02-18 16:56:27.949195|2017-02-18 16:56:27.949195
NCT00259207|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-09-29|||December 2005||2005-12-01|March 2007|2007-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Pulmonary Valve Replacement in Large Right Ventricular Outflow Tract|Pulmonary Valve Replacement : Study of Comparison Between a Standard Surgical Approach With Extracorporeal Circulation and an Off-pump Hybrid Strategy.|Completed||Phase 3|8|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 16:56:28.231244|2017-02-18 16:56:28.231244
NCT00259194|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-06-08|||December 2005||2005-12-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|OPKAT||Observation and Prediction of Complications After Coronary Angiography|Observation and Prediction of Complications After Coronary Angiography|Completed||N/A|1000|Anticipated|Herning Hospital||2|||f||||f||||||||||2017-02-18 16:56:28.344115|2017-02-18 16:56:28.344115
NCT00259181|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2010-01-05|||January 2005||2005-01-01|December 2007|2007-12-01||||||||Interventional|||A Protocol for the Use of Chlorhexidine Gluconate Saturation for the Reduction of Dental Biofilm Formation on Polymethylmethacrylate Restoration|Examination of the Immersion of Provisional Crown Material in Chlorhexidine Gluconate on Dental Plaque Formation in Vivo|Completed||Phase 1|12||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:56:28.444079|2017-02-18 16:56:28.444079
NCT00259168|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2005-11-28|||June 2003||2003-06-01|November 2005|2005-11-01||||||||Interventional|||Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?|Insulin Resistance and Postprandial Endothelial Function: Does Early Intervention Make a Difference?|Unknown status|Recruiting|Phase 4|70||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:56:28.528287|2017-02-18 16:56:28.528287
NCT00259155|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2008-03-17|||July 2003||2003-07-01|July 2003|2003-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Rifaximin for the Treatment of Irritable Bowel Syndrome|Rifaximin in the Treatment of Small Intestinal Bacterial Overgrowth and IBS: Double Blind Randomized Controlled Trial (Multicenter Trial)|Completed||Phase 2|92||Cedars-Sinai Medical Center|||||||||||||||||||2017-02-18 16:56:28.62272|2017-02-18 16:56:28.62272
NCT00259142|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2015-05-12|||November 2005||2005-11-01|May 2015|2015-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Acceptability and Cost Effectiveness of Home Based Management of Fever: Different Strategies|Community Acceptability and Cost-effectiveness of Two Drug Distribution Methods for Home Based Management of Fevr in Kayunga District, Uganda|Terminated||N/A|1314|Anticipated|DBL -Institute for Health Research and Development||||Study never started|f||||||||||||||2017-02-18 16:56:28.713724|2017-02-18 16:56:28.713724
NCT00259129|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2014-11-11|||August 2005||2005-08-01|November 2014|2014-11-01|March 2008|Actual|2008-03-01|February 2007|Actual|2007-02-01||Interventional|||Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients|Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients|Completed||Phase 1|53|Actual|Bayer||1|||f||||f||||||||||2017-02-18 16:56:28.81854|2017-02-18 16:56:28.81854
NCT00259116|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2009-04-13|||November 2005||2005-11-01|April 2009|2009-04-01||||||||Interventional|||A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure|A Pilot Safety and Dose-Finding Trial of Intravenous Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure|Completed||Phase 2|18||Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies|||||f||||||||||||||2017-02-18 16:56:28.930331|2017-02-18 16:56:28.930331
NCT00259103|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2014-05-06|||November 2005||2005-11-01|May 2014|2014-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor|A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety, Pharmacokinetics and Efficacy of Intravenous Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labour|Completed||Phase 2|72|Actual|Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies||4|||f||||||||||||||2017-02-18 16:56:29.029383|2017-02-18 16:56:29.029383
NCT00259090|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2012-07-09|2009-11-03||April 2004||2004-04-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer|A Double-blind, Randomized, Multicentre Trial to Compare the Anti-tumour Effects and Tolerability of a 500 mg Dose of Faslodex (Fulvestrant) Plus Arimidex (Anastrozole) With a 500 mg Dose of Faslodex(Fulvestrant) Alone and With Arimidex(Anastrozole) Alone, in Postmenopausal Women Prior to Surgery for Primary Breast Cancer|Completed||Phase 2|120|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:56:29.139005|2017-02-18 16:56:29.139005
NCT00259077|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2011-01-21|||October 2003||2003-10-01|January 2011|2011-01-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population|A Double-blind, Randomised, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy of Omeprazole 20mg and 10mg od for the Four-week Treatment of Non-erosive Reflux Disease (NERD) With That of Placebo od and to Investigate Safety|Completed||Phase 3|270||AstraZeneca|||||f||||||||||||||2017-02-18 16:56:29.689323|2017-02-18 16:56:29.689323
NCT00259064|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2016-06-01|||September 2004||2004-09-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|February 2007|Actual|2007-02-01||Interventional|INSTEP||Iressa v BSC (Best Supportive Care) in First Line NSCLC|A Phase II Multicentre Randomised, Parallel Group, Double-Blind, Placebo-Controlled Study of ZD1839 (IRESSATM) (250MG Tablet) Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Chemotherapy-Naive Patients With Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC) and Poor Performance Status|Completed||Phase 2/Phase 3|216|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:56:29.800767|2017-02-18 16:56:29.800767
NCT00259051|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2011-01-21|||January 2004||2004-01-01|January 2011|2011-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population|A Double-blind, Randomised, Parallel-group, Multicentre, Phase III Study to Investigate the Pharmacodynamic Effect by Assessment of the 24 Hours Intraesophageal pH Level, the Efficacy and Safety of Omeprazole 10mg and 20mg od in Patients With Non-erosive Reflux Disease (NERD).|Completed||Phase 3|40||AstraZeneca|||||f||||||||||||||2017-02-18 16:56:29.933511|2017-02-18 16:56:29.933511
NCT00259038|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-28|2016-11-04|||January 2004||2004-01-01|November 2016|2016-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure|A Phase II, Dose Escalation Evaluation of the Pharmacokinetic and Hemodynamic Effects of Carperitide in Subjects With Congestive Heart Failure|Completed||Phase 2|162|Actual|Daiichi Sankyo Inc.||2|||f||||||||||||||2017-02-18 16:56:30.046375|2017-02-18 16:56:30.046375
NCT00259025|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2008-08-08|||September 2006||2006-09-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients|The Effect of Intravenous n-3 Polyunsaturated Fatty Acids on Risk Markers for Sudden Cardiac Death in Hemodialysis Patients|Completed||Phase 2|60|Actual|Aalborg Universitetshospital||2|||f||||||||||||||2017-02-18 16:56:30.169034|2017-02-18 16:56:30.169034
NCT00259012|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2010-04-19|2009-11-30||November 2005||2005-11-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD|A Multicenter, Randomized, Open Label, Single and Multiple Dose Study of the Pharmacokinetics and Pharmacodynamics of 2 Dose Levels of Pantoprazole Sodium Enteric-Coated Spheroid Suspension in Infants Aged 1 Through 11 Months With Presumed GERD|Completed||Phase 3|67|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 16:56:30.414457|2017-02-18 16:56:30.414457
NCT00258999|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2015-10-01|||October 2005||2005-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study|Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study|Completed||N/A|600||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 16:56:31.092287|2017-02-18 16:56:31.092287
NCT00258986|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2006-01-31|||March 2004||2004-03-01|November 2005|2005-11-01|December 2006||2006-12-01|||||Interventional|||Efficacy Study Comparing Hand-Assisted Laparoscopic and Mini-Incision Muscle Splitting Incision Living Donor Nephrectomy||Unknown status|Recruiting|Phase 3|50||University Medical Center Groningen|||||f||||||||||||||2017-02-18 16:56:31.360295|2017-02-18 16:56:31.360295
NCT00258973|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2015-12-01|||April 2006||2006-04-01|December 2015|2015-12-01|September 2007|Actual|2007-09-01|||||Observational|||Office Practice Assessment of Carotid Atherosclerosis Using Handheld Ultrasound (OPACA) Study|Office Practice Assessment of Carotid Atherosclerosis Using Handheld Ultrasound (OPACA) Study|Completed||N/A|375|Actual|University of Wisconsin, Madison|||1||f||||||||||||||2017-02-18 16:56:31.446956|2017-02-18 16:56:31.446956
NCT00258960|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2009-09-25|||February 2006||2006-02-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|||||Interventional|||Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer|Phase IV.II, Clinical Trial, With the Combination of Pegylated Liposomal Doxorubicin (Caelyx), Cyclophosphamide and Trastuzumab (Herceptin) in Patients With Metastatic Breast Cancer With Overexpression of HER2/Neu|Completed||Phase 2|49|Anticipated|Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 16:56:31.535899|2017-02-18 16:56:31.535899
NCT00258947|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2012-01-30|||September 2005||2005-09-01|January 2012|2012-01-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults|Take Evaluation and Safety of Smallpox Vaccine (LISTER Strain) in Naïve Healthy Adults.|Completed||Phase 2|230|Actual|Sanofi|||||f||||f||||||||||2017-02-18 16:56:31.631319|2017-02-18 16:56:31.631319
NCT00258934|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2014-01-10|||September 2005||2005-09-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|||Immunogenicity Study of the Influenza Vaccine in Adults||Completed||Phase 2|978|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:56:31.72711|2017-02-18 16:56:31.72711
NCT00258921|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2007-11-21|||March 2004||2004-03-01|November 2007|2007-11-01|July 2006|Actual|2006-07-01|||||Observational|RIAT||RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment|An International Registry in Essential Hypertension|Completed||N/A|31870||Sanofi|||||f||||||||||||||2017-02-18 16:56:31.836001|2017-02-18 16:56:31.836001
NCT00258908|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2016-04-12|2009-04-07||November 2005||2005-11-01|April 2016|2016-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan|Immunogenicity and Safety of ADACEL™ (TdcP Vaccine) as Fifth Dose in Children 6-8 Years of Age.|Completed||Phase 3|115|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:56:31.910212|2017-02-18 16:56:31.910212
NCT00258895|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2016-04-12|2009-08-18||March 2005||2005-03-01|April 2016|2016-04-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®|Safety and Immunogenicity of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With DAPTACEL® or Pentacel®|Completed||Phase 3|649|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:56:32.201226|2017-02-18 16:56:32.201226
NCT00258882|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2016-03-10|2015-11-13||January 2006||2006-01-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|July 2011|Actual|2011-07-01||Observational||Participants who received Adacel vaccine during the study period and age matched participants who received Td vaccine but no live virus vaccine, during the year prior to initiation of study during the same month as the Adacel vaccine recipient, 1 year earlier.|Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine|Post-licensure Safety Surveillance Study of Routine Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®)|Completed||N/A|327293|Actual|Sanofi|As a result of screening using The Risk Interval and The Historic Cohort methods incident rates for 1030 outcomes were flagged as elevated. In post-hoc manual review no safety signals were identified. Details highlighted in the manuscript.||1||f||||f||||||||||2017-02-18 16:56:32.822637|2017-02-18 16:56:32.822637
NCT00258869|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2010-11-05|||December 2005||2005-12-01|January 2009|2009-01-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|||Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests|Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP|Unknown status|Recruiting|N/A|1200|Anticipated|National Center for Genome Resources|||1||f||||t||||||Samples With DNA|"~     PaxGene whole blood tubes (RNA and DNA), EDTA plasma, serum (subset), microbiologic isolates~   "|||2017-02-18 16:56:33.402006|2017-02-18 16:56:33.402006
NCT00258856|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2014-01-21|2009-10-19||January 2006||2006-01-01|January 2014|2014-01-01|November 2007|Actual|2007-11-01|March 2007|Actual|2007-03-01||Interventional|||Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®|Persistence of Bactericidal Antibodies in Children Aged 7 to 15 Years Who Received a Single Dose of Menactra® or Menomune®-A/C/Y/W-135 Five Years Earlier|Completed||Phase 2|234|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 16:56:33.547418|2017-02-18 16:56:33.547418
NCT00258843|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2014-01-20|||November 2005||2005-11-01|January 2014|2014-01-01|April 2006|Actual|2006-04-01|February 2006|Actual|2006-02-01||Interventional|||Safety of Imovax Polio in Chinese Infants and Children|Clinical Safety Evaluation Study of the Sanofi Pasteur's Inactivated Poliomyelitis Vaccine (IMOVAX Polio™) Administered as a Single Booster Dose at 18 Months of Age in Healthy Chinese Children, and as the First Dose of Primary Vaccination at 2 Months of Age in Healthy Chinese Infants.|Completed||Phase 3|40|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:56:34.244703|2017-02-18 16:56:34.244703
NCT00258830|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2016-04-12|2009-03-05||September 2005||2005-09-01|April 2016|2016-04-01|March 2007|Actual|2007-03-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine|Annual Study of Safety and Immunogenicity of Fluzone® Influenza Virus Vaccine (2005-2006 Formulation)|Completed||Phase 4|120|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:56:34.351836|2017-02-18 16:56:34.351836
NCT00258817|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2016-04-12|2009-01-21||October 2005||2005-10-01|April 2016|2016-04-01|August 2007|Actual|2007-08-01|March 2006|Actual|2006-03-01||Interventional|||Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine|Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2005-2006 Formulation)|Completed||Phase 4|30|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:56:34.814766|2017-02-18 16:56:34.814766
NCT00258804|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2011-06-07|||May 2005||2005-05-01|June 2011|2011-06-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Insulin Glargine During and After the Period of Fasting in Ramadan|Evaluation (Safety and Efficacy) of Treatment With Insulin Glargine and Glimepiride in Patients With Type 2 Diabetes Before, During and After the Period of Fasting in Ramadan|Completed||Phase 4|450||Sanofi|||||f||||||||||||||2017-02-18 16:56:35.463522|2017-02-18 16:56:35.463522
NCT00258791|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2012-09-21|||January 2012||2012-01-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache|Effects of Pretreatment With Ibuprofen in Post- ECT Headache|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||1||first postponed then cancelled as national drug authority changed requirements|f||||f||||||||||2017-02-18 16:56:35.553432|2017-02-18 16:56:35.553432
NCT00258778|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2006-12-04|||November 2005||2005-11-01|December 2006|2006-12-01|January 2006||2006-01-01|||||Interventional|||Phase I Single Dose-Escalation Safety Study of Human Glucocerebrosidase (prGCD)|A Phase I, Non-Randomized, Open Label, Single Dose-Escalation Safety Study of Recombinant Human Glucocerebrosidase (prGCD) in Healthy Volunteers|Completed||Phase 1|6||Protalix|||||||||||||||||||2017-02-18 16:56:35.647067|2017-02-18 16:56:35.647067
NCT00258765|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2010-04-23|||May 2006||2006-05-01|April 2010|2010-04-01||||November 2006|Actual|2006-11-01||Interventional|||Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.|A Phase IIb Randomised Clinical Trial of the Tolerability, Safety and Efficacy of Adjuvant Docetaxel-Zoledronic Acid After Prostatectomy for High-risk Early Prostate Cancer (AD-ZAP).|Terminated||Phase 2|1|Actual|Novartis||2||Poor recruitment & not feasible to continue|f||||t||||||||||2017-02-18 16:56:35.733855|2017-02-18 16:56:35.733855
NCT00258752|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2013-04-11|||November 2005||2005-11-01|April 2013|2013-04-01|June 2009|Actual|2009-06-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Three Therapy-Based Interventions for Preventing Depression in Adolescents|Prevention of Depression in Adolescents|Completed||N/A|57|Actual|Rutgers University||3|||f||||f||||||||||2017-02-18 16:56:35.846609|2017-02-18 16:56:35.846609
NCT00258739|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2009-12-04|||October 2001||2001-10-01|December 2009|2009-12-01||||September 2007|Actual|2007-09-01||Interventional|||Docetaxel in Non Small Cell Lung Cancer (NSCLC)|A Phase II, Randomized Study With Docetaxel-gemcitabine Followed by Radiotherapy vs Concomitant Treatment (Radiotherapy and Carboplatine-docetaxel) Followed by Docetaxel-gemcitabine Versus Docetaxel-gemcitabine Followed by Concomitant Treatment (Radiotherapy and Carboplatine-docetaxel) in Stage III NSCLC|Completed||Phase 2|140|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:56:35.97838|2017-02-18 16:56:35.97838
NCT00258726|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2010-08-26|||October 2005||2005-10-01|April 2010|2010-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Immune Responses to Two Dose Varivax +/- MMR-II|Immunogenicity and Safety of Live Attenuated Varicella Vaccine in 12 and 18 Month-old Children, With and Without Concomitant Administration of Measles-Mumps-Rubella Vaccine|Terminated||Phase 1/Phase 2|105||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 16:56:36.08846|2017-02-18 16:56:36.08846
NCT00258713|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2008-09-24|||September 2005||2005-09-01|September 2008|2008-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|SPIRIT||A 36-Week Extension to Protocol ISA04-03|A 36-Week Extension to Protocol ISA04-03 to Evaluate the Safety and Efficacy of ISA247 in Patients With Plaque Psoriasis|Completed||Phase 3|309|Actual|Aurinia Pharmaceuticals Inc.||3|||f||||t||||||||||2017-02-18 16:56:36.183794|2017-02-18 16:56:36.183794
NCT00258700|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2016-09-20|||February 2005||2005-02-01|September 2016|2016-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine|Demonstrate Non-inferiority of Men-C Immune Response of Hib-MenC With Infanrix™-IPV Versus a Licensed Men-C Vaccine With Pediacel™ When Given at 2, 3, 4 Months and the Immunogenicity of Hib-MenC When Given as a Booster Dose at 12-15 Months|Completed||Phase 3|478|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:56:36.33439|2017-02-18 16:56:36.33439
NCT00258687|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|July 2006|Actual|2006-07-01||Interventional|||Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma|A Phase I Trial of Vaccination With Autologous, Lethally Irradiated Tumor Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Colony Stimulating Factor in Pediatric and Adult Patients|Active, not recruiting||Phase 1|12|Actual|Dana-Farber Cancer Institute||2|||f||||||||||||||2017-02-18 16:56:36.459221|2017-02-18 16:56:36.459221
NCT00258674|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2013-07-22|2011-10-21||January 2000||2000-01-01|July 2013|2013-07-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Improving Diabetes Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource Nurse|A Randomized Trial of Strategies to Improve Diabetes Care: Effectiveness and Costs of Physician Profiling and Care Coordination by a Diabetes Resource Nurse|Completed||N/A|1891|Actual|Baylor Research Institute|"All participating practices belonged to the same network of fee-for-service practices, which may reduce generalizability.~Neither physicians nor patients could be blinded; but data were collected by individuals blinded to study arm assignments."|3|||f||||t||||||||||2017-02-18 16:56:36.590721|2017-02-18 16:56:36.590721
NCT00258661|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2011-07-22|||March 2004||2004-03-01|July 2011|2011-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|MOPSE||Is Osteopathic Manipulative Treatment (OMT) Beneficial for Elderly Patients Hospitalized With Pneumonia?|Multicenter Osteopathic Pneumonia Study in the Elderly (MOPSE)|Completed||N/A|406|Actual|A.T. Still University of Health Sciences||3|||f||||t||||||||||2017-02-18 16:56:37.965009|2017-02-18 16:56:37.965009
NCT00258635|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-25|2010-06-16|||November 2005||2005-11-01|June 2010|2010-06-01||||||||Interventional|||Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test|A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Ragweed Allergoid With MPL® With a Single-Blind Portion to Evaluate the Residual Allergenicity in Skin Test in Patients Sensitized to Ragweed Pollen.|Completed||Phase 2|69|Actual|Allergy Therapeutics|||||f||||||||||||||2017-02-18 16:56:38.087091|2017-02-18 16:56:38.087091
NCT00258622|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-24|2007-11-15|||November 2005||2005-11-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|||||Interventional|||NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain|NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain: a Randomized, Double-Blind, Placebo-Controlled, Crossover Study|Completed||Phase 2|18|Actual|Danish Pain Research Center||3|||f||||||||||||||2017-02-18 16:56:38.177221|2017-02-18 16:56:38.177221
NCT00258609|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2005-12-22|||February 2003||2003-02-01|December 2005|2005-12-01|June 2004||2004-06-01|||||Interventional|||Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study|A 12-Week Prospective, Double-Blinded, Randomized, Multicenter Study of Low Dose and Medium Dose Botulinum Toxin Type A (Dysport® ) Injection for Migraine Prophylaxis.|Completed||Phase 3|128||Rajavithi Hospital|||||f||||||||||||||2017-02-18 16:56:38.391695|2017-02-18 16:56:38.391695
NCT00258596|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2007-03-05|||January 2003||2003-01-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions|Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions: A Randomized Comparison of Bare Metal Stent Implantation With Sirolimus-Eluting Stent Implantation for the Treatment of Chronic Total Coronary Occlusions (PRISON II)|Completed||Phase 3|200||R&D Cardiologie|||||f||||||||||||||2017-02-18 16:56:38.501097|2017-02-18 16:56:38.501097
NCT00258583|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2016-01-04|||October 2003||2003-10-01|December 2015|2015-12-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|ILDRR||UPMC Simmons Center for Interstitial Lung Disease Pennsylvania Statewide Research Registry|UPMC Simmons Center for Interstitial Lung Disease Pennsylvania Statewide Research Registry|Recruiting||N/A|5000|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 16:56:38.608742|2017-02-18 16:56:38.608742
NCT00258570|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2016-01-04|||January 2003||2003-01-01|January 2016|2016-01-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|GP||Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)|Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis|Recruiting||N/A|2000|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     Blood samples retained for multitude of testing. Consent allows for unrestricted use of~     samples.~   "|||2017-02-18 16:56:38.715765|2017-02-18 16:56:38.715765
NCT00258557|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-06-25|||September 2005||2005-09-01|June 2013|2013-06-01|May 2012|Actual|2012-05-01|June 2007|Actual|2007-06-01||Interventional|||"TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir (TMC114/r) in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications."|Phase III Randomized, Controlled, Open-label Trial to Investigate the Antiviral Activity, Tolerability and Safety of TMC114/r in Treatment- Naive HIV-1 Infected Patients.|Completed||Phase 3|692|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-02-18 16:56:38.82576|2017-02-18 16:56:38.82576
NCT00258544|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2016-01-04|||October 2001||2001-10-01|December 2015|2015-12-01|July 2020|Anticipated|2020-07-01|July 2020|Anticipated|2020-07-01||Observational|MAA||Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)|Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis|Recruiting||N/A|150|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples With DNA|"~     Lung Tissue from a Lung Biopsy ordered by the patients physician. Also, a blood sample may~     be collected at the researchers discretion as listed in the addendum consent form.~   "|||2017-02-18 16:56:39.026717|2017-02-18 16:56:39.026717
NCT00258531|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2006-07-27|||June 2003||2003-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Evaluation of 3-Dimensional Magnetic Imaging During Colonoscopy|Evaluation of 3-Dimensional Magnetic Imaging During Colonoscopy for Visualisation of Endoscope Localisation|Completed||Phase 4|360||Sykehuset Telemark|||||f||||||||||||||2017-02-18 16:56:39.134833|2017-02-18 16:56:39.134833
NCT00258518|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2012-03-07|||November 2005||2005-11-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Respiratory Mechanics and Pleural Effusion|Estimation of Respiratory Mechanics (Respiratory System, Chest Wall and Lung Elastance) and Pleural Effusion at the Bedside With CT Scan.|Completed||N/A|60|Actual|Policlinico Hospital|||1||f||||f||||||||||2017-02-18 16:56:39.220096|2017-02-18 16:56:39.220096
NCT00258505|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2007-07-31||||||October 2005|2005-10-01|September 2007||2007-09-01|||||Observational|||Monitoring Brain Activity in Human Brain Injury|Incidence, Nature and Consequences of Cortical Depolarizations in Human Brain Injury From Trauma and Ischemia: The COSBID Study|Unknown status|Not yet recruiting|N/A|100|Anticipated|Soroka University Medical Center|||||f||||||||||||||2017-02-18 16:56:39.332401|2017-02-18 16:56:39.332401
NCT00258492|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2007-01-25|||December 2005||2005-12-01|July 2006|2006-07-01|January 2007||2007-01-01|||||Interventional|||Restless Legs Syndrome Exercise Intervention|The Prevalence and Outcomes of Restless Legs Syndrome Among Veterans - Exercise Intervention|Unknown status|Active, not recruiting|Phase 1/Phase 2|30||Northeastern Ohio Universities College of Medicine|||||f||||||||||||||2017-02-18 16:56:39.44395|2017-02-18 16:56:39.44395
NCT00258479|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2012-03-12|||June 2003||2003-06-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents|Modafinil and Nicotine in Adolescents: Phase I Trial|Completed||Phase 1|24|Actual|University of Kentucky||3|||f||||t||||||||||2017-02-18 16:56:39.535479|2017-02-18 16:56:39.535479
NCT00258466|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2013-04-05|||May 2005||2005-05-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer|Phase III Trial of Neutron + Photon Radiation Versus Photon + Hypofractionated Intensity Modulated Radiation Therapy in Localized Prostate Cancer|Withdrawn||Phase 3|0|Actual|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 16:56:39.666036|2017-02-18 16:56:39.666036
NCT00258453|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-08-01|||May 2001||2001-05-01|October 2007|2007-10-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Interventional|||Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma|Prospective, Multi-Center Survey Study of Children and Adolescents With Craniopharyngioma|Completed||N/A|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:56:39.757107|2017-02-18 16:56:39.757107
NCT00258440|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2015-03-26|2010-06-10||May 2003||2003-05-01|March 2015|2015-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer|A Pilot Trial of Extended Interval Dosing of Epoetin Alfa (Procrit®) for the Treatment of Anemia in Oncology Patients|Terminated||N/A|7|Actual|OHSU Knight Cancer Institute|Due to low accruals the sponsor decided to discontinue the study early. A full analysis was not completed.|3||Sponsor discontinued funding of the study|f||||t||||||||||2017-02-18 16:56:42.720387|2017-02-18 16:56:42.720387
NCT00258427|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2016-08-15|||March 2002||2002-03-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia|Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia MT2002-02|Recruiting||Phase 2|25|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:56:43.444256|2017-02-18 16:56:43.444256
NCT00258401|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-01-11|||May 2005||2005-05-01|January 2011|2011-01-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.|The Effectiveness of a Low-Residue Diet on Diarrhea in Cancer Patients Receiving Pelvic Radiation Therapy|Completed||N/A|11|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 16:56:43.583547|2017-02-18 16:56:43.583547
NCT00258388|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-09-27|||June 2005||2005-06-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|October 2007|Actual|2007-10-01||Interventional|||Docetaxel and Prednisone With or Without OGX-011 in Treating Patients With Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy|A Randomized Phase II Study of OGX-011 in Combination With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Patients With Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|82|Actual|Canadian Cancer Trials Group||2|||f||||f||||||||||2017-02-18 16:56:43.699938|2017-02-18 16:56:43.699938
NCT00258375|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2010-11-07|||June 2005||2005-06-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer|A Phase II Study of a Second Generation Clusterin Antisense Oligonucleotide (OGX-011) in Combination With Docetaxel in Advanced Breast Cancer|Completed||Phase 2|42|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 16:56:43.829423|2017-02-18 16:56:43.829423
NCT00258362|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2012-11-06|2010-08-20||July 2005||2005-07-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer|A Phase II Trial of Induction Carboplatin and Docetaxel Followed by Radiotherapy Then Consolidation Chemotherapy With Carboplatin and Docetaxel in Stage III, IV and Recurrent Endometrial Cancer|Completed||Phase 2|41|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 16:56:43.938024|2017-02-18 16:56:43.938024
NCT00258349|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2014-05-29|2012-08-28||August 2006||2006-08-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|August 2010|Actual|2010-08-01||Interventional|||Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer|A Phase I/II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Trastuzumab (Herceptin) in Patients With Advanced Metastatic and/or Local Chest Wall Recurrent Her-2 Amplified Breast Cancer|Completed||Phase 1/Phase 2|16|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:56:44.288063|2017-02-18 16:56:44.288063
NCT00258336|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2014-01-09|||August 2004||2004-08-01|August 2008|2008-08-01||||November 2009|Anticipated|2009-11-01||Interventional|||Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma|Phase II Trial of Maintenance Rituximab Plus FavId® and GM-CSF Immunotherapy in Patients With Treatment-Naive Indolent B-Cell Lymphoma|Unknown status|Recruiting|Phase 2|56|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:56:44.585111|2017-02-18 16:56:44.585111
NCT00258323|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2015-09-29|||October 2005||2005-10-01|September 2015|2015-09-01|February 2010|Actual|2010-02-01|July 2007|Actual|2007-07-01||Interventional|||Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer|A Phase II Trial of Pre- and Postoperative Chemoradiotherapy and ZD1839 (IRESSA) Followed by Maintenance ZD1839 in Patients With Locoregionally Advanced Esophageal and Gastroesophageal Junction Carcinoma|Completed||Phase 2|80|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:56:44.679803|2017-02-18 16:56:44.679803
NCT00258310|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2015-01-15|2014-11-20||December 2003||2003-12-01|January 2015|2015-01-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Ph II Study Examining Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation &/or Chemotherapy|A Phase II Study Examining the Feasibility of Long Term and Low Dose Oral Capecitabine (Xeloda®) in Newly Diagnosed Head and Neck Squamous Cell Carcinoma (HNSCC) After Surgery, Radiation and/or Chemotherapy|Completed||Phase 2|35|Actual|Barbara Ann Karmanos Cancer Institute|There were no significant limitations.|1|||f||||t||||||||||2017-02-18 16:56:44.79158|2017-02-18 16:56:44.79158
NCT00258297|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-10-14|||April 2004||2004-04-01|October 2013|2013-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery|A Phase II Safety, Efficacy, and Feasibility Study of Neoadjuvant ZD1839 (IRESSA) in Resectable Esophageal Cancer|Terminated||Phase 2|30|Anticipated|University of Rochester||||Withdrawn for lack of funding and accrual|f||||t||||||||||2017-02-18 16:56:45.257475|2017-02-18 16:56:45.257475
NCT00258284|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2014-03-05|||August 2003||2003-08-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer|Phase II Trial of Capecitabine (Xeloda) and Weekly Docetaxel (Taxotere) in Metastatic Androgen Independent Prostate Carcinoma|Completed||Phase 2|30|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 16:56:45.356982|2017-02-18 16:56:45.356982
NCT00258271|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-10-14|||March 2005||2005-03-01|October 2013|2013-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia|A Phase I Study of CLAG Regimen in Combination With Imatinib Mesylate (Gleevec) in Refractory or Relapsed Leukemias|Completed||Phase 1|18|Anticipated|University of Rochester|||||f||||t||||||||||2017-02-18 16:56:45.464553|2017-02-18 16:56:45.464553
NCT00255450|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2008-11-10|||January 2005||2005-01-01|October 2007|2007-10-01|August 2006|Actual|2006-08-01|||||Interventional|||A Crossover Safety Study of Ferumoxytol Versus Placebo|A Double Blind, Placebo Controlled, Crossover Design, Multicenter Study of Intravenous Ferumoxytol Compared With Placebo|Completed||Phase 3|750||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:57:38.493832|2017-02-18 16:57:38.493832
NCT00258258|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-01-31|||August 2005||2005-08-01|January 2013|2013-01-01||||March 2009|Actual|2009-03-01||Interventional|||Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders|An Open Label Dose Escalation Study of Intravenous Paricalcitol (ZEMPLAR™) [19-NOR-1 ALPHA, 25 - (OH)D] With Zoledronic Acid (Zometa™) in Patients With Multiple Myeloma|Terminated||Phase 1|7|Actual|Roswell Park Cancer Institute||||Withdrawn due to low accrual|f||||f||||||||||2017-02-18 16:56:45.571459|2017-02-18 16:56:45.571459
NCT00258245|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-04-25|||May 2005||2005-05-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia|A Phase I Study of Arsenic Trioxide and Ascorbic Acid (ATO/AA) in Combination With Low Dose Velcade-Thalidomide-Dexamethasone (VTD) in Relapsed/Refractory Multiple Myeloma (MM)|Completed||Phase 1|5|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 16:56:45.667413|2017-02-18 16:56:45.667413
NCT00258232|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-04-05|||January 2002||2002-01-01|April 2013|2013-04-01|August 2007|Actual|2007-08-01|March 2007|Actual|2007-03-01||Interventional|||Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer|Phase II Study of Celecoxib, Capecitabine, and Irinotecan in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 16:56:45.806288|2017-02-18 16:56:45.806288
NCT00258206|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2015-06-10|2015-05-28||December 2004||2004-12-01|June 2015|2015-06-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma|Phase II Study of High Dose Cyclophosphamide and Rituximab in Multiple Myeloma|Completed||Phase 2|21|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:56:45.91517|2017-02-18 16:56:45.91517
NCT00258193|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2006-10-19|||January 2006||2006-01-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS|A Phase 2 Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of the Pharmacodynamic Effects of Orally Administered 100ug and 1000ug QD MD-1100 Acetate on Gastrointestinal Transit in Patients With Constipation Predominant Irritable Bowel Syndrome (C-IBS)|Completed||Phase 2|36||Ironwood Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:56:46.210916|2017-02-18 16:56:46.210916
NCT00258180|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2012-06-13|||June 2005||2005-06-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy|High-Dose Cyclophosphamide for the Treatment of Severe Autoimmune Enteropathy|Completed||Phase 2|3|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:56:46.303279|2017-02-18 16:56:46.303279
NCT00258167|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2008-06-10|||November 2005||2005-11-01|June 2008|2008-06-01|November 2008|Anticipated|2008-11-01|November 2008|Anticipated|2008-11-01||Interventional|||Family Involvement in The Treatment Of a Mentally Ill Relative|Family Involvement in The Treatment Of a Mentally Ill Relative|Unknown status|Recruiting|N/A|50|Anticipated|Lev-Hasharon Mental Healtlh Center||1|||f||||||||||||||2017-02-18 16:56:46.405185|2017-02-18 16:56:46.405185
NCT00258154|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-10-05|2009-08-10||February 2006||2006-02-01|October 2015|2015-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)|Safety and Immunogenicity of Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants|Completed||Phase 3|403|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:56:46.519525|2017-02-18 16:56:46.519525
NCT00258141|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2005-11-23||||||November 2005|2005-11-01||||||||Interventional|||Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects|A Placebo-Controlled, Double-Blind, Cross-Over Study With Rupatadine 10 Mg in 30 Mosquito-Bite Allergic Adult Subjects|Unknown status|Not yet recruiting|Phase 4|30||J. Uriach and Company|||||f||||||||||||||2017-02-18 16:56:47.55231|2017-02-18 16:56:47.55231
NCT00258128|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2008-11-26|||January 2000||2000-01-01|November 2008|2008-11-01||||||||Interventional|||Effect of Salicylate on Glucose Metabolism in Insulin Resistance States|Effect of Salicylate on Glucose Metabolism in Insulin Resistance States|Completed||Phase 2/Phase 3|20||Joslin Diabetes Center|||||f||||||||||||||2017-02-18 16:56:47.64716|2017-02-18 16:56:47.64716
NCT00258115|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2012-09-21|||December 2003||2003-12-01|September 2012|2012-09-01||||October 2007|Actual|2007-10-01||Interventional|||The Study of Inflammation on Blood Glucose Levels in Obese People|The Study of Inhibition of Inflammation in the Dysmetabolic Syndrome of Obesity|Completed||Phase 2|20|Actual|Joslin Diabetes Center||2|||f||||f||||||||||2017-02-18 16:56:47.72133|2017-02-18 16:56:47.72133
NCT00258102|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-06-08|||January 1993||1993-01-01|January 2011|2011-01-01|January 1995|Actual|1995-01-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections|A Multicenter, Randomized Study To Compare The Safety And Efficacy Of Oral Levofloxacin With That Of Lomefloxacin HCl In The Treatment Of Complicated Urinary Tract Infections In Adults|Completed||Phase 3|603|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:56:48.06009|2017-02-18 16:56:48.06009
NCT00258089|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-05-19|||June 1993||1993-06-01|November 2010|2010-11-01|January 1995|Actual|1995-01-01|||||Interventional|||A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections|A Multicenter, Double-Blind, Randomized Study To Compare The Safety And Efficacy Of Oral Levofloxacin With That Of Ciprofloxacin HCl In The Treatment Of Complicated Urinary Tract Infections In Adults|Completed||Phase 3|578|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:56:48.15245|2017-02-18 16:56:48.15245
NCT00258076|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2012-12-11|||April 2004||2004-04-01|December 2012|2012-12-01|September 2004|Actual|2004-09-01|||||Interventional|||A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)|Open-Label, Randomized, Partially Balanced, Incomplete Block Design Sudy to Evaluate the Hormone Exposure From Commercial ORTHO EVRA�|Completed||Phase 1|53|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 16:56:48.244747|2017-02-18 16:56:48.244747
NCT00257881|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2007-12-06|||November 2005||2005-11-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors|Phase 1 Dose-Escalation Study of Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors|Terminated||Phase 1|46||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:56:51.217972|2017-02-18 16:56:51.217972
NCT00258063|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-06-06|||May 2004||2004-05-01|January 2011|2011-01-01|September 2004|Actual|2004-09-01|||||Interventional|||A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)|Open-Label, Randomized, Partially Balanced, Incomplete Block Design Study to Evaluate the Hormone Exposure From Commercial EVRA (Manufactured by LOHMANN Therapie-Systeme) and an Oral Contraceptive|Completed||Phase 1|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:56:48.34195|2017-02-18 16:56:48.34195
NCT00258050|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2008-10-09|||November 2005||2005-11-01|October 2008|2008-10-01||||||||Interventional|||To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients|A Four-Way Cross-Over Study to Examine the Effects of Lapatinib on the Pharmacokinetics of Orally and Intravenously Administered Midazolam in Cancer Patients|Completed||Phase 1|16||GlaxoSmithKline|||||||||||||||||||2017-02-18 16:56:48.431362|2017-02-18 16:56:48.431362
NCT00258037|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2010-05-25|||January 1999||1999-01-01|March 2000|2000-03-01|September 2001||2001-09-01|||||Interventional|||Effect of Pelvic Floor Muscle Training in Stroke|Six Months Follow-Up of Pelvic Floor Muscle Training in Women With Urinary Incontinence After Stroke|Terminated||Phase 2|60||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 16:56:48.524396|2017-02-18 16:56:48.524396
NCT00258024|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2008-02-19|||November 2005||2005-11-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment|Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment Through Community Involvement in Rural Ghana|Completed||N/A|420|Anticipated|DBL -Institute for Health Research and Development|||||f||||||||||||||2017-02-18 16:56:48.626477|2017-02-18 16:56:48.626477
NCT00258011|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2014-02-04|2009-01-13||December 2005||2005-12-01|February 2014|2014-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease|A Safety Confirmatory Study of JC0498 (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients|Completed||Phase 3|3|Actual|Sanofi|Due to the rarity of the disease, this study is limited by its small sample size, lack of a control group and patients had variable treatment durations.|1|||f||||||||||||||2017-02-18 16:56:48.722833|2017-02-18 16:56:48.722833
NCT00257998|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2007-10-31|||November 2005||2005-11-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Effectiveness of Three Manual Physical Therapy Techniques in a Subgroup of Patients With Low Back Pain|Comparison of the Effectiveness of Three Manual Physical Therapy Techniques in a Subgroup of Patients With Low Back Pain Who Satisfy a Clinical Prediction Rule: A Randomized Clinical Trial.|Completed||Phase 1|240|Anticipated|Franklin Pierce University||1|||f||||||||||||||2017-02-18 16:56:49.001074|2017-02-18 16:56:49.001074
NCT00257985|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2006-07-31|||April 2005||2005-04-01|November 2005|2005-11-01|March 2006||2006-03-01|||||Interventional|||Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2|Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2|Completed||N/A|30||Danish Headache Center|||||f||||||||||||||2017-02-18 16:56:49.09168|2017-02-18 16:56:49.09168
NCT00257972|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-23|2013-11-07|||October 2004||2004-10-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Aripiprazole in Patients With Bipolar I Disorder|Efficacy of Aripiprazole in Combination With Valproate or Lithium in the Treatment of Mania in Patients With Bipolar I Disorder Partially Nonresponsive to Valproate or Lithium Monotherapy|Completed||Phase 3|400||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||f||||||||||||||2017-02-18 16:56:49.187975|2017-02-18 16:56:49.187975
NCT00257959|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2006-07-26|||January 2001||2001-01-01|November 2005|2005-11-01|October 2004||2004-10-01|||||Interventional|||Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)||Completed||Phase 4|400||Connolly, Stuart, M.D.|||||f||||||||||||||2017-02-18 16:56:49.377126|2017-02-18 16:56:49.377126
NCT00257946|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-12-14|||December 2005||2005-12-01|December 2011|2011-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Type of Material in Repair of Congenital Diaphragmatic Hernia|Prospective Randomized Trial Comparing Type of Material in Repair of Congenital Diaphragmatic Hernia|Terminated||Phase 3|50||Children's Mercy Hospital Kansas City||||poor accrual|f||||f||||||||||2017-02-18 16:56:49.475421|2017-02-18 16:56:49.475421
NCT00257933|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2010-12-23|2010-07-14||February 2006||2006-02-01|December 2010|2010-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Oral Prednisolone Dosing in Children Hospitalized With Asthma|Oral Prednisolone Dosing in Children Hospitalized With Asthma|Completed||Phase 4|152|Actual|Children's Hospital of Philadelphia|"Limited ability to measure pulmonary function in hospitalized children with asthma did not allow measurement of this outcome.~Some protocol violations occurred~Single center study"|2|||f||||f||||||||||2017-02-18 16:56:49.587599|2017-02-18 16:56:49.587599
NCT00257920|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2009-12-22|2009-01-26||June 2006||2006-06-01|December 2009|2009-12-01||||January 2008|Actual|2008-01-01||Interventional|||A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease|A Phase 4, Single-Center, Open-Label, Randomized, Active-Controlled, Cross-over Pilot Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in CKD Stage 5 Subjects on Hemodialysis|Completed||Phase 4|41|Actual|Abbott|The null hypothesis was not tested appropriately as a result of measurable differences in parathyroid hormone (PTH) suppression indicating dose exposure was different. Therefore, differences in calcium absorption could not be determined.|2|||f||||||||||||||2017-02-18 16:56:49.984543|2017-02-18 16:56:49.984543
NCT00257907|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2017-01-24|||November 18, 2005||2005-11-18|February 24, 2016|2016-02-24|February 24, 2016||2016-02-24|||||Observational|||Immune Response to Mycobacterium Tuberculosis Infection|Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells With Induration Measured in the Tuberculin Skin Test (TST)|Completed||N/A|32|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:56:50.697339|2017-02-18 16:56:50.697339
NCT00257894|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2015-10-05|2014-01-28||December 2005||2005-12-01|October 2015|2015-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Baclofen Effects on Smoking Urge and Withdrawal|Baclofen Effects on Smoking Urge and Withdrawal|Terminated||Phase 2|41|Actual|VA Office of Research and Development||2||Enrollment was completed with insufficient sample size for publishable results|f||||f||||||||||2017-02-18 16:56:50.783347|2017-02-18 16:56:50.783347
NCT00005435|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1991||1991-07-01|June 2000|2000-06-01|June 1997|Actual|1997-06-01|||||Observational|||Hostility and Pathogenic Mechanisms of Coronary Heart Disease in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.442032|2017-02-18 18:14:59.442032
NCT00257868|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2007-07-30|||January 2006||2006-01-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery|Rivastigmine for the Prevention of Postoperative Delirium After Cardiac Surgery|Completed||Phase 3|120|Actual|University Hospital, Basel, Switzerland||2|||f||||||||||||||2017-02-18 16:56:51.288941|2017-02-18 16:56:51.288941
NCT00257855|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2010-02-05|||November 2005||2005-11-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis|A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis: Single Centre, Phase 2 Trial|Completed||Phase 2|120||University College London Hospitals|||||f||||t||||||||||2017-02-18 16:56:51.376292|2017-02-18 16:56:51.376292
NCT00257842|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2014-09-16||||||September 2014|2014-09-01||||||||Interventional|||Randomized Controlled Trial of Biofeedback Therapy for Dyssynergic Defecation||Terminated||N/A|||Augusta University|||||f||||||||||||||2017-02-18 16:56:51.476929|2017-02-18 16:56:51.476929
NCT00257829|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2008-02-27|||July 2004||2004-07-01|February 2008|2008-02-01||||||||Interventional|||Improving Tumor Oxygenation in Cervical Cancer|Improving Tumor Oxygenation in Cervical Cancer With Methazolamide|Withdrawn||Phase 2|18||University of California, Irvine||||This study was closed due to lack of funding.|f||||t||||||||||2017-02-18 16:56:51.784288|2017-02-18 16:56:51.784288
NCT00257816|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2008-03-26|||April 2004||2004-04-01|March 2008|2008-03-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma|Feasibility Study of Weekly IV Topotecan and Cisplatin With Concurrent Pelvic Radiation in the Treatment of Stages IB2 - IVA Cervical Carcinoma|Unknown status|Recruiting|Phase 2|12|Anticipated|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:56:51.866449|2017-02-18 16:56:51.866449
NCT00257803|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2014-03-14|||November 2005||2005-11-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|October 2006|Actual|2006-10-01||Interventional|||Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?|A Randomized Double-blind Comparison of a 5 Unit Intravenous Oxytocin Bolus Versus Placebo as a Strategy to Prevent Uterine Atony at Cesarean Section in Women Who Are at Increased Risk of Post-Partum Hemorrhage|Completed||N/A|150|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 16:56:51.972735|2017-02-18 16:56:51.972735
NCT00257790|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-07-03|||September 2001||2001-09-01|November 2005|2005-11-01|March 2005||2005-03-01|||||Interventional|||The Tobramycin Study|Tobramycin én Gang Daglig Mot Tre Ganger Daglig, Gitt Med Benzylpenicillin, Til Pasienter Med nøytropen Feber|Completed||Phase 4|210||Oslo University Hospital|||||f||||||||||||||2017-02-18 16:56:52.088106|2017-02-18 16:56:52.088106
NCT00257777|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-07-03|||November 2003||2003-11-01|November 2005|2005-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Intermittent Cold Blood vs Crystalloid Cardioplegia in Aortic Valve Surgery|Intermittent Cold Blood vs Crystalloid Cardioplegia in Aortic Valve Surgery|Completed||N/A|350|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-02-18 16:56:52.184008|2017-02-18 16:56:52.184008
NCT00257764|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2006-05-04|||May 1996||1996-05-01|June 1999|1999-06-01|May 1999||1999-05-01|||||Interventional|||Behavioural Intervention for Dysphagia in Acute Stroke|A Randomised Controlled Trial of Dysphagia Therapies for Swallowing Disorders Following Stroke.|Completed||Phase 2/Phase 3|300||Royal Perth Hospital|||||f||||||||||||||2017-02-18 16:56:52.273142|2017-02-18 16:56:52.273142
NCT00257751|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2011-07-03|||March 2004||2004-03-01|March 2009|2009-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Different Regimen of Aprotinine(Trasylol) Administration in Patients Receiving Antiplatelet Therapy With Clopidogrel (Plavix)|Different Regimen of Aprotinine(Trasylol) Administration in Patients Receiving|Completed||N/A|400|Anticipated|Oslo University Hospital|||||f||||f||||||||||2017-02-18 16:56:52.374733|2017-02-18 16:56:52.374733
NCT00257738|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2009-12-10|||November 2005||2005-11-01|December 2009|2009-12-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck|A Phase 1 Open Label, Dose Escalation Study to Evaluate the Effect of Four Doses of MAGE-A3/HPV 16 Trojan Peptides 0001 and 0002 Administered Subcutaneously in Combination With Montanide and GM-CSF on Immunological Response, Safety, Tolerability, and Preliminary Efficacy in Patients With Squamous Cell Carcinoma of the Head and Neck|Unknown status|Recruiting|Phase 1|90|Anticipated|University of Maryland||2|||f||||t||||||||||2017-02-18 16:56:52.469672|2017-02-18 16:56:52.469672
NCT00257725|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2009-02-04|||March 2005||2005-03-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Long Duration Stimulant Treatment Study of Preschoolers With ADHD-Feasibility Study||Completed||Phase 4|10|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 16:56:52.570951|2017-02-18 16:56:52.570951
NCT00257712|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-12-17|||February 2006||2006-02-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||SMART: Somatotrophics, Memory, and Aging Research Trial|GHRH: Cognition in Aging and MCI|Completed||Phase 2|151|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 16:56:52.655681|2017-02-18 16:56:52.655681
NCT00257699|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2008-08-11|||May 2006||2006-05-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study of Antibiotics in the Treatment of Colonic Crohn's Disease|Metronidazole and Ciprofloxacin in the Treatment of Colonic Crohn's Disease: The MACINTOCC Trial.|Terminated||Phase 2|12|Actual|Mount Sinai Hospital, Canada||2||Inadequate recruitment to meet completion date|f||||||||||||||2017-02-18 16:56:52.768775|2017-02-18 16:56:52.768775
NCT00257686|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2010-03-09|2009-08-26||September 2005||2005-09-01|March 2010|2010-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients|Study Of Pitavastatin 1 Mg Vs. Pravastatin 10 Mg, Pitavastatin 2 Mg Vs. Pravastatin 20 Mg And Pitavastatin 4 Mg Vs. Pravastatin 40 Mg (Following Up-Titration) In Elderly Patients With Primary Hypercholesterolemia Or Combined Dyslipidemia|Completed||Phase 3|962|Actual|Kowa Research Europe||6|||f||||f||||||||||2017-02-18 16:56:52.884064|2017-02-18 16:56:52.884064
NCT00257673|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2008-05-05|||November 2005||2005-11-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of MEM 1003 in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|183|Actual|Memory Pharmaceuticals||3|||f||||f||||||||||2017-02-18 16:56:53.76588|2017-02-18 16:56:53.76588
NCT00257660|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2010-06-17|2010-01-06||October 2005||2005-10-01|June 2010|2010-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia|A Phase III Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia|Completed||Phase 3|116|Actual|Ipsen||2|||f||||f||||||||||2017-02-18 16:56:53.921746|2017-02-18 16:56:53.921746
NCT00257647|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2009-02-17|||September 2005||2005-09-01|April 2007|2007-04-01|November 2007|Actual|2007-11-01|||||Observational|||Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)|Use of SV40 siRNA Vectors to Treat CML|Completed||N/A|25|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 16:56:54.631625|2017-02-18 16:56:54.631625
NCT00257634|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2007-04-26|||December 2004||2004-12-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis|Dexamethasone Delivery for Treatment of Lateral Epicondylitis (IRB #3260)|Completed||Phase 3|80||Henry Ford Health System|||||f||||||||||||||2017-02-18 16:56:54.728587|2017-02-18 16:56:54.728587
NCT00257621|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-04-01|||October 2004||2004-10-01|April 2013|2013-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults|A Pilot, Phase II, Open-label, Single Arm Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GW640385 When Administered With Ritonavir in Combination With NRTIs for 48 Weeks in HIV-1 Infected Adults|Completed||Phase 2|30|Actual|ViiV Healthcare|||||||||f||||||||||2017-02-18 16:56:54.827375|2017-02-18 16:56:54.827375
NCT00257608|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2016-03-18|2015-11-09||January 2006||2006-01-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)|A Randomized, Double-Blind, Placebo-Controlled, Phase IIIb Trial Comparing Bevacizumab Therapy With or Without Erlotinib After Completion of Chemotherapy With Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|1145|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 16:56:54.944885|2017-02-18 16:56:54.944885
NCT00257595|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-05-03|||August 2005||2005-08-01|May 2013|2013-05-01||||||||Interventional|||Perennial Allergic Rhinitis In Pediatric Subjects|Long-term Study of Cetirizine Dry Syrup in Children. Suffering From Perennial Allergic Rhinitis.|Completed||Phase 3|30||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:56:56.61597|2017-02-18 16:56:56.61597
NCT00257582|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-05-03|||August 2005||2005-08-01|May 2013|2013-05-01||||||||Interventional|||Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics|Long-term Study of Cetirizine Dry Syrup in Children Suffering From Various Type of Cutaneous Disease Accompanied With Pruritus.|Completed||Phase 3|60||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:56:56.709633|2017-02-18 16:56:56.709633
NCT00257569|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-05-03|||August 2005||2005-08-01|May 2013|2013-05-01||||||||Interventional|||Study Of Atopic Dermatitis In Pediatrics|Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup in Children -Suffering From Atopic Dermatitis-|Completed||Phase 3|278||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:56:56.798966|2017-02-18 16:56:56.798966
NCT00257556|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2010-02-12|2010-01-08||October 2005||2005-10-01|February 2010|2010-02-01|April 2009|Actual|2009-04-01|July 2008|Actual|2008-07-01||Interventional|||A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa|A Prospective, Open Label, Randomised, Parallel Group, Comparative Pilot Study to Study the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant FSH (Follitropin Alfa) Administered Subcutaneously to Subfertile Female Patients Undergoing IVF Using Antagonist Downregulation|Completed||Phase 4|80|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 16:56:56.892986|2017-02-18 16:56:56.892986
NCT00257543|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-09-16|||January 2006||2006-01-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease|SALT - Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease|Terminated||Early Phase 1|3|Actual|Emory University||1||lack of enrollment|f||||t||||||||||2017-02-18 16:56:57.784257|2017-02-18 16:56:57.784257
NCT00257530|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2008-06-11|||December 2005||2005-12-01|June 2008|2008-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis|Randomized Double Blind Clinical Trial of Imiquimod (Aldara) Versus Placebo Used in Combination With Pentavalent Antimony (Glucantime) in Peruvian Cutaneous Leishmaniasis Patients|Completed||Phase 3|80||Drugs for Neglected Diseases|||||f||||||||||||||2017-02-18 16:56:57.8854|2017-02-18 16:56:57.8854
NCT00257517|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2014-02-11|||October 2005||2005-10-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Observational|||Multisite Feeding Study: Home Surveillance and Feeding Strategies in Infants With Complex Single Ventricle|Home Surveillance and Feeding Strategies in Infants With Complex Single Ventricle|Completed||N/A|20|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:56:57.966858|2017-02-18 16:56:57.966858
NCT00257504|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2006-09-11|||November 2005||2005-11-01|September 2006|2006-09-01|May 2006||2006-05-01|||||Observational|||Central Blood Volume in Hypotensive Dialysis Patients|Registration of Central Blood Volume in Hypotensive Dialysis Patients - a Comparison of Thoracic Impedance and Central Venous Saturation Monitoring|Completed||N/A|20||Danish State Hospital|||||f||||||||||||||2017-02-18 16:56:58.045616|2017-02-18 16:56:58.045616
NCT00257491|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2013-11-08|||November 2005||2005-11-01|November 2013|2013-11-01|August 2006||2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension|An Open-label Study to Evaluate the Trough and Peak Effect of Once Daily Micardis Plus (Telmisartan 80mg / Hydrochlorothiazide 12.5 mg) by 24 ABPM in Patients With Mild to Moderate Essential Hypertension|Completed||Phase 3|29|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:56:58.115052|2017-02-18 16:56:58.115052
NCT00257478|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2012-06-06||||||June 2012|2012-06-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy||Completed||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-02-18 16:56:58.203784|2017-02-18 16:56:58.203784
NCT00256880|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2017-01-16|||January 2005||2005-01-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma|A Phase II, Open-Label Study of Pazopanib (GW786034) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|100|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:57:11.939431|2017-02-18 16:57:11.939431
NCT00257465|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-22|2015-12-02|||June 2005||2005-06-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma|M-Vax: A Feasibility and Bio-Equivalence Study Using a DNP-Modified Autologous Melanoma Tumor Cell Vaccine as Therapy in Patients With Stage III or IV Melanoma|Completed||Phase 1/Phase 2|82|Actual|AVAX Technologies||4|||f||||t||||||||||2017-02-18 16:57:01.109562|2017-02-18 16:57:01.109562
NCT00257452|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-10-31|||October 2004||2004-10-01|October 2013|2013-10-01|July 2005||2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Double-blind, Randomised Study to Assess the Influence of Tiotropium (Spiriva®)|A Double-blind, Randomised, Placebo Controlled, Three-way Cross-over Study With an Open Label Positive Control (Moxifloxacin) to Assess the Influence of Inhaled Tiotropium Once Daily Over Twelve Days on the QTC Interval of the ECG in Healthy Male and Female Volunteers|Completed||Phase 1|56||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 16:57:01.264763|2017-02-18 16:57:01.264763
NCT00257439|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2012-09-24|||December 2005||2005-12-01|September 2012|2012-09-01||||||||Observational|||Vitamin Metabolism in Kidney Disease|Vitamin Metabolism in Kidney Disease|Unknown status|Recruiting|N/A|100|Anticipated|Aalborg Universitetshospital|||2||f||||f||||||||||2017-02-18 16:57:01.363763|2017-02-18 16:57:01.363763
NCT00257426|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2012-02-12|||July 2005||2005-07-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|February 2007|Actual|2007-02-01||Interventional|||Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer|A Phase II Study of Octreotide Acetate for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|31|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 16:57:01.461764|2017-02-18 16:57:01.461764
NCT00257413|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2005-11-21||||||December 2003|2003-12-01||||||||Interventional|||Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension||Completed||N/A|||Zhejiang University|||||f||||||||||||||2017-02-18 16:57:01.569811|2017-02-18 16:57:01.569811
NCT00257400|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-12-31|||May 2003||2003-05-01|December 2013|2013-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Comparison of Two Psychotherapy Treatments for Depressed Women With a History of Sexual Abuse|Interpersonal Psychotherapy for Depressed Women With Sexual Abuse Histories|Completed||Phase 1/Phase 2|70|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 16:57:01.654102|2017-02-18 16:57:01.654102
NCT00257387|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-02-01|||June 2004||2004-06-01|June 2007|2007-06-01|August 2006|Actual|2006-08-01|||||Interventional|||Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants|A Nonrandomized, Open-label, Multicenter, Sequential Phase Study to Evaluate the Safety and Efficacy of Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese De Novo Renal Allograft Recipients Receiving Rapamune|Completed||Phase 1/Phase 2|120||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:57:01.767511|2017-02-18 16:57:01.767511
NCT00257374|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2014-01-08||||||January 2014|2014-01-01||||||||Interventional|||Pedialyte or Gatorade for Viral Gastroenteritis in Adults: a Randomized, Controlled Trial||Completed||N/A|||Augusta University|||||f||||||||||||||2017-02-18 16:57:01.846111|2017-02-18 16:57:01.846111
NCT00257361|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2013-09-27|||July 2005||2005-07-01|August 2011|2011-08-01||||||||Interventional|||D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder|D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder|Withdrawn||Phase 2|0|Actual|University of Florida||||PI left the university|f||||f||||||||||2017-02-18 16:57:01.929357|2017-02-18 16:57:01.929357
NCT00257348|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-02-06|||March 2004||2004-03-01|February 2013|2013-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer|A Phase II Trial of Capecitabine and Docetaxel in the Treatment of Advanced and Recurrent Cervical Cancer|Completed||Phase 2|5|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:02.029643|2017-02-18 16:57:02.029643
NCT00257335|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2008-02-27|||October 2004||2004-10-01|February 2008|2008-02-01||||||||Interventional|||Intensity-Modulated Radiotherapy for Recurrent Head and Neck Cancer|A Phase II Protocol of Intensity-Modulated Radiotherapy for Treatment of Previously Irradiated Recurrent Head and Neck Cancer|Withdrawn||Phase 2|40|Anticipated|University of California, Irvine||||Due to no patient enrollment this study was withdrawn/closed|f||||||||||||||2017-02-18 16:57:02.132118|2017-02-18 16:57:02.132118
NCT00257322|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-03-23|2009-06-26||April 2003||2003-04-01|March 2016|2016-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Cellular Immune Augmentation in Colon and Rectal Cancer|A Pilot Study of Cellular Immune Augmentation in Colon and Rectal Cancer Therapy|Completed||Phase 2|20|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:02.478801|2017-02-18 16:57:02.478801
NCT00257309|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-11-22|2016-10-02||April 2005||2005-04-01|November 2016|2016-11-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|TRIANA||Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients|TRIANA: A Randomized Trial to Compare the Efficay and Safety of Thrombolysis With Primary Angioplasty as Initial Reperfusion Therapy in Older Patients (>= 75 Years Old) With Acute Myocardial Infarction|Terminated||Phase 4|266|Actual|Spanish Society of Cardiology||2||Slow recruitment|f||||t||||||||||2017-02-18 16:57:02.730892|2017-02-18 16:57:02.730892
NCT00257296|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2005-11-21||||||November 2005|2005-11-01||||||||Interventional|||Evaluation of an Intimate Partner Violence Screening-Intervention|Evaluation of an Intimate Partner Violence Screening-Intervention|Suspended||N/A|2000||University at Albany|||||f||||||||||||||2017-02-18 16:57:03.183212|2017-02-18 16:57:03.183212
NCT00257283|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2008-03-10|||November 2002||2002-11-01|March 2008|2008-03-01|June 2005||2005-06-01|||||Interventional|||Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis|A Double Blind Comparison of Omacor and Placebo as Secondary Prevention Against Cardiovascular Events in Patients Undergoing Chronic Hemodialysis|Completed||Phase 4|200||Pronova BioPharma|||||f||||||||||||||2017-02-18 16:57:03.255798|2017-02-18 16:57:03.255798
NCT00257270|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2005-11-18|||August 2003||2003-08-01|June 2005|2005-06-01|January 2005||2005-01-01|||||Interventional|||The Effect of Gabapentin on the Sensation and Impact of Tinnitus|The Effect of Gabapentin on the Sensation and Impact of Tinnitus|Completed||Phase 2|40||Tinnitus Research Consortium|||||f||||||||||||||2017-02-18 16:57:03.355055|2017-02-18 16:57:03.355055
NCT00257257|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2009-04-17|||March 2005||2005-03-01|April 2009|2009-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|SERENADE||Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose (Rimonabant 20 mg) Multicenter Study of Long-Term Glycemic Control With Rimonabant in Treatment-naïve Patients With Type 2 Diabetes|Completed||Phase 3|281|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:57:03.445524|2017-02-18 16:57:03.445524
NCT00257244|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-11-08|||April 2004||2004-04-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2013|Actual|2013-09-01||Observational|||Inflammation and the Host Response to Injury (Burns)|Inflammation and the Host Response to Injury|Active, not recruiting||N/A|280|Anticipated|Massachusetts General Hospital|||1||f||||t||||||Samples Without DNA|"~     Plasma, blood leukocyte nucleic acids (RNA), solid tissue nucleic acids (only RNA, no DNA)~   "|Yes|Curated and validated data are available to Consortium Members|2017-02-18 16:57:03.551512|2017-02-18 16:57:03.551512
NCT00257231|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-11-08|||November 2003||2003-11-01|November 2016|2016-11-01|September 2018|Anticipated|2018-09-01|September 2013|Actual|2013-09-01||Observational|||Inflammation and the Host Response to Injury (Trauma)|Inflammation and the Host Response to Injury|Active, not recruiting||N/A|610|Anticipated|Massachusetts General Hospital|||1||f||||t||||||Samples Without DNA|"~     Plasma, blood leukocyte nucleic acids (only RNA, no DNA)~   "|Yes|Curated and validated data are available to Consortium Members|2017-02-18 16:57:03.658308|2017-02-18 16:57:03.658308
NCT00257218|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2005-11-21|||January 2006||2006-01-01|November 2005|2005-11-01||||||||Interventional|||A Study on Effect of Health Promotion for Prevention NIDDM in People With Prediabetes||Unknown status|Not yet recruiting|N/A|1000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:57:03.774539|2017-02-18 16:57:03.774539
NCT00257205|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2012-06-25||2011-01-03|March 2006||2006-03-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy|A Phase 3, Open Label, Randomized, Comparative Study Of CP-675,206 And Either Dacarbazine Or Temozolomide In Patients With Advanced Melanoma|Completed||Phase 3|655|Actual|AstraZeneca||2|||f||||t||||||||||2017-02-18 16:57:03.878416|2017-02-18 16:57:03.878416
NCT00257192|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2011-12-02|2010-03-23||April 2006||2006-04-01|December 2011|2011-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia|Six Week, Double-Blind, Placebo Controlled Phase III Trial Evaluating The Efficacy, Safety And Pharmacokinetics Of Flexible Doses Of Oral Ziprasidone In Adolescent Subjects With Schizophrenia|Terminated||Phase 3|284|Actual|Pfizer|The AE tables were amended to incorporate previously unreported AEs that were found during an independent audit and verified by the investigators.|2||Please see Detailed Description for termination reason.|f||||t||||||||||2017-02-18 16:57:04.391671|2017-02-18 16:57:04.391671
NCT00257179|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2006-03-13|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor||Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:57:06.769395|2017-02-18 16:57:06.769395
NCT00257166|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2013-07-24|2013-05-24||January 2006||2006-01-01|July 2013|2013-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)|Four Week, Double-Blind, Placebo Controlled Phase III Trial Evaluating The Efficacy, Safety And Pharmacokinetics Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)|Completed||Phase 3|238|Actual|Pfizer||2|||f||||||||||||||2017-02-18 16:57:06.857967|2017-02-18 16:57:06.857967
NCT00257153|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2006-12-01|||March 2004||2004-03-01|June 2005|2005-06-01|September 2005||2005-09-01|||||Interventional|||Thrombus Aspiration Before Standard Primary Angioplasty Improves Myocardial Reperfusion in Acute Myocardial Infarction.||Completed||Phase 4|160||Niguarda Hospital|||||f||||||||||||||2017-02-18 16:57:07.449693|2017-02-18 16:57:07.449693
NCT00257140|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2011-06-08|||June 1931||1931-06-01|January 2011|2011-01-01|July 1994|Actual|1994-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria|A Multicenter, Active-Controlled, Randomized Study to Evaluate the Safety and Efficacy of Oral Levofloxacin Versus Cefaclor in the Treatment of Acute Bacterial Exacerbation of Chronic Bronchitis in Adults|Completed||Phase 2/Phase 3|367|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:57:07.554018|2017-02-18 16:57:07.554018
NCT00257127|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2014-11-10|||February 2006||2006-02-01|November 2014|2014-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs|Evaluation of Immunologic Memory Following Pneumococcal, Hepatitis B, and Measles Vaccination in HIV Infected Children Treated With Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|101|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 16:57:07.651047|2017-02-18 16:57:07.651047
NCT00257114|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2008-02-07||||||February 2008|2008-02-01||||March 2007|Actual|2007-03-01||Interventional|||Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability|Evaluation of VELCADE (Botezomib) for Injection Employed as Re-Treatment for Efficacy, Safety, and Tolerability|Completed||Phase 4|||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 16:57:07.809218|2017-02-18 16:57:07.809218
NCT00257101|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-02-17|||September 2001||2001-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Stepped Intervention for Meds Adherence and Blood Pressure Control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 16:57:07.892424|2017-02-18 16:57:07.892424
NCT00257088|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2008-02-13|||September 2003||2003-09-01|August 2005|2005-08-01||||||||Interventional|||The Whole Day First Grade Program|Prevention Services in Schools for Early Drug Abuse Risk|Completed||Phase 4|2000||American Institutes for Research|||||f||||||||||||||2017-02-18 16:57:07.962763|2017-02-18 16:57:07.962763
NCT00257075|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2011-01-13|||December 2000||2000-12-01|January 2011|2011-01-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder|The Efficacy And Safety Of Flexible Dosage Ranges Of Risperidone Versus Placebo In The Treatment Of Manic Episodes Associated With Bipolar I Disorder.|Completed||Phase 3|267|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:57:08.067776|2017-02-18 16:57:08.067776
NCT00257062|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2011-06-08|||January 1993||1993-01-01|April 2010|2010-04-01|April 1994|Actual|1994-04-01|||||Interventional|||A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin|A Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Oral Levofloxacin With That of Ciprofloxacin HCl in the Treatment of Uncomplicated Skin and Skin Structure Infections in Adults|Completed||Phase 3|361|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:57:08.160578|2017-02-18 16:57:08.160578
NCT00257049|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2011-06-08|||January 1984||1984-01-01|November 2010|2010-11-01|January 1995|Actual|1995-01-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared With Ceftriaxone Sodium or Cefuroxime Axetil in the Treatment of Adults With Pneumonia|A Multicenter, Active-Controlled, Randomized Study To Evaluate The Safety And Efficacy Of Levofloxacin Versus Ceftriaxone Sodium Or Cefuroxime Axetil In The Treatment Of Community-Acquired Pneumonia In Adults|Completed||Phase 2/Phase 3|604|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:57:08.255719|2017-02-18 16:57:08.255719
NCT00257036|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2011-06-08|||July 1991||1991-07-01|January 2011|2011-01-01|February 1993|Actual|1993-02-01|||||Interventional|||A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin|A Multicenter, Active-Controlled, Randomized Study to Evaluate the Safety and Efficacy of Levofloxacin Versus Ciprofloxacin HCl in the Treatment of Mild to Moderate Skin and Skin Structure Infections in Adults|Completed||Phase 2/Phase 3|431|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:57:08.358728|2017-02-18 16:57:08.358728
NCT00257023|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2011-05-16|||February 2005||2005-02-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|||||Interventional|||An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia|Exploratory Study of Paliperidone in Patients With Schizophrenia to Investigate the Safety and Efficacy|Completed||Phase 2|52|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 16:57:08.447693|2017-02-18 16:57:08.447693
NCT00257010|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2014-01-23|2013-10-11||December 2005||2005-12-01|January 2014|2014-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches|Long-Term, Open-Label Safety Study of Oral Almotriptan Malate 12.5 mg in the Treatment of Migraine in Adolescents|Completed||Phase 3|447|Actual|Janssen-Ortho LLC||1|||f||||f||||||||||2017-02-18 16:57:08.560605|2017-02-18 16:57:08.560605
NCT00256997|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2013-11-12|2013-02-27||January 2006||2006-01-01|November 2013|2013-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional||Out of a total of 167 participants, Baseline data was available for only 165 participants who were included in intent to treat (ITT) population.|A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication|Pragmatic Randomized Trial of Risperdal Consta Versus Oral Atypical Antipsychotics in Poorly Adherent Subjects With Schizophrenia in a Routine Care Setting|Terminated||Phase 4|167|Actual|Janssen-Ortho Inc., Canada|The study was terminated due to futility.|2||Inability to recruit number of planned patients|f||||f||||||||||2017-02-18 16:57:09.331553|2017-02-18 16:57:09.331553
NCT00256984|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2011-03-07|2009-10-27||October 2005||2005-10-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)|A Multi-center Study to Assess the Outcomes of Stapled Trans-Anal Rectal Resection (STARR) in the Treatment of Obstructed Defecation Syndrome (ODS)|Completed||Phase 4|75|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-02-18 16:57:10.455908|2017-02-18 16:57:10.455908
NCT00256971|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-20|2008-05-12|||November 2005||2005-11-01|November 2005|2005-11-01|January 2008|Anticipated|2008-01-01|||||Observational|||Balance in Patients After Surgery for Torn Meniscus|Functioning Balance in Patients After Surgery for Torn Meniscus: Meniscectomy vs Meniscal Repair; A Prospective Study|Unknown status|Recruiting|Phase 1|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:57:10.790114|2017-02-18 16:57:10.790114
NCT00256958|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-20|2008-05-12|||November 2005||2005-11-01|November 2005|2005-11-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Static and Dynamic Balance in Correlation With Quality of Life, in Primary Total Knee Replacement|Static and Dynamic Balance During Standing and Walking in Correlation With Quality of Life, in Primary Total Knee Replacement|Unknown status|Recruiting|Phase 1/Phase 2|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:57:10.862763|2017-02-18 16:57:10.862763
NCT00256945|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-20|2010-01-05|||January 2005||2005-01-01|December 2007|2007-12-01|August 2006||2006-08-01|||||Interventional|||Surface Roughness of a Dental Restorative Material and Biofilm Formation|In Vivo Study of the Relationship Between Surface Roughness of a Dental Restorative Material and Biofilm Formation|Completed||Phase 1|12||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:57:10.94827|2017-02-18 16:57:10.94827
NCT00256932|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2015-09-01|||August 2005||2005-08-01|December 2011|2011-12-01|May 2006|Actual|2006-05-01|||||Interventional|||Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain|Completed||Phase 3|518|Actual|Cubist Pharmaceuticals LLC||3|||||||||||||||||2017-02-18 16:57:11.047432|2017-02-18 16:57:11.047432
NCT00256919|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2012-11-01|||November 2005||2005-11-01|October 2012|2012-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)|A Randomised, Placebo-controlled, Parallel Group Single Dose Study of GW856553 in Patients With Active RA to Investigate the C-Reactive Protein (CRP) Dose Response Relationship|Completed||Phase 2|51|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:57:11.594082|2017-02-18 16:57:11.594082
NCT00256906|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-20|2008-05-12|||January 2006||2006-01-01|June 2007|2007-06-01|January 2012|Anticipated|2012-01-01|December 2010|Anticipated|2010-12-01||Observational|||Isolated Mild Fetal Ventriculomegaly and Neurodevelopmental Outcome|Isolated Mild Fetal Ventriculomegaly and Neurodevelopmental Outcome|Unknown status|Active, not recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||f||||||||||2017-02-18 16:57:11.704459|2017-02-18 16:57:11.704459
NCT00256893|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2016-09-13|||November 2004||2004-11-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|||||Interventional|||Fibromyalgia Study In Adults|A Randomised, Double Blind, Placebo-controlled, Parallel Group Study to Investigate the Safety and Efficacy of Controlled-release Ropinirole (CR) (1-24 mg) Administered Once Daily for 12 Weeks in Subjects With Fibromyalgia|Completed||Phase 2|164||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:57:11.817404|2017-02-18 16:57:11.817404
NCT00005434|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1992||1992-04-01|May 2000|2000-05-01|March 1997|Actual|1997-03-01|||||Observational|||Opioid Compromise in Hypertension--Modulating Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.513306|2017-02-18 18:14:59.513306
NCT00256867|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-10-24|||August 2005||2005-08-01|October 2016|2016-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Study In Patients With Type 2 Diabetes Mellitus|A 16 Week Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of a New Medication (GSK523338) to Lower LDL-c and HbA1c in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|360|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:57:12.044613|2017-02-18 16:57:12.044613
NCT00256854|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2016-09-22|||November 2005||2005-11-01|September 2016|2016-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)|A 4-Week, Randomized, Double-Blind, Cohort Study to Evaluate the Safety and Tolerability of Converting From Ropinirole Immediate Release (IR) to Ropinirole Extended Release (XR) Formulation in Patients With Restless Legs Syndrome (RLS)|Completed||Phase 3|135|Actual|GlaxoSmithKline|||||||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:57:12.222436|2017-02-18 16:57:12.222436
NCT00256841|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2014-01-27|||September 2005||2005-09-01|January 2014|2014-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy|Dose Escalation of Xeloda or 5FU Continuous Infusion in Combination With Taxotere and Concurrent Once Weekly, Hypofractionated Chest Radiotherapy for Advanced Non Small Cell Lung Cancer: A Phase I/II Study|Withdrawn||Phase 1/Phase 2|0|Actual|Clinical Oncology Research Associates||1||Lack of funding|f||||||||||||||2017-02-18 16:57:12.349301|2017-02-18 16:57:12.349301
NCT00256828|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2007-10-15|||June 2004||2004-06-01|November 2005|2005-11-01|November 2006||2006-11-01|||||Interventional|||Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV|A Multicenter, Randomized, Open Label, Clinical Trial Comparing a QD Regimen of Didanosine, Lamivudine and Efavirenz With a Standard BID Regimen of Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of Human Immunodeficiency Virus Infection (GESIDA 39/03)|Completed||Phase 4|360||Clinical Trial Agency of HIV Study Group|||||f||||||||||||||2017-02-18 16:57:12.466939|2017-02-18 16:57:12.466939
NCT00256815|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2014-02-10|||March 2003||2003-03-01|September 2005|2005-09-01|September 2005|Actual|2005-09-01|||||Interventional|||Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study||Completed||Phase 1/Phase 2|35||Clinical Oncology Research Associates|||||||||||||||||||2017-02-18 16:57:12.750361|2017-02-18 16:57:12.750361
NCT00256802|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2009-03-30|||June 2004||2004-06-01|May 2004|2004-05-01|January 2005||2005-01-01|||||Interventional|||The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography|The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography (MRA) Under Provocation With Glyceryl Trinitrate in Healthy Volunteers.|Completed||N/A|12||Danish Headache Center|||||f||||||||||||||2017-02-18 16:57:12.852896|2017-02-18 16:57:12.852896
NCT00256789|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2014-02-10|||September 2002||2002-09-01|November 2005|2005-11-01|December 2004|Actual|2004-12-01|December 2003|Actual|2003-12-01||Interventional|||Once Weekly Radiation for Lung Cancer With Chemotherapy|Combination of Weekly Radiation and Docetaxel for Locally Advanced Non Small Cell Lung Cancer: A Feasibility Study|Completed||N/A|26|Actual|Clinical Oncology Research Associates|||||f||||||||||||||2017-02-18 16:57:12.940195|2017-02-18 16:57:12.940195
NCT00256776|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-21|2012-08-06|||July 2005||2005-07-01|August 2012|2012-08-01|June 2013|Anticipated|2013-06-01|||||Interventional|||MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation|A Randomized Controlled Study of Velcade (Bortezomib) Plus Thalidomide Plus Dexamethasone Compared to Thalidomide Plus Dexamethasone for the Treatment of Myeloma Patients Progressing or Relapsing After Autologous Transplantation|Unknown status|Active, not recruiting|Phase 3|269|Actual|European Group for Blood and Marrow Transplantation||2|||f||||t||||||||||2017-02-18 16:57:13.037129|2017-02-18 16:57:13.037129
NCT00256750|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2016-07-12|2016-05-24||March 2005||2005-03-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|June 2008|Actual|2008-06-01||Interventional|BENEFIT|Baseline characteristics of transplant recipients: All randomized and transplanted participants, intent to treat (ITT) population|Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)|Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)|Completed||Phase 3|738|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-02-18 16:57:13.468554|2017-02-18 16:57:13.468554
NCT00256737|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-20|2011-01-21|||January 1998||1998-01-01|January 2011|2011-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Sopran - Omeprazole Treatment Versus Surgery|Omeprazole Versus Anti-reflux Surgery in the Long-term Management of Peptic Esophagitis - a 10 Year Follow up Study of Patients Previously Studied for 5 Years - A Nordic Multicentre Study|Completed||Phase 3|219||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:21.607457|2017-02-18 16:57:21.607457
NCT00256724|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2013-07-24|2013-05-24||June 2005||2005-06-01|July 2013|2013-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy Study of a Facemask Device to Treat Hypotension|Evaluation of an Inspiratory Impedance Threshold Device (ITD) in the Emergency Department for the Treatment of Hypotension|Completed||Phase 2|47|Actual|Advanced Circulatory Systems||2|||f||||f||||||||||2017-02-18 16:57:21.722961|2017-02-18 16:57:21.722961
NCT00256711|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-20|2009-04-22|||July 2004||2004-07-01|April 2009|2009-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Phase II Iressa Versus Vinorelbine (INVITE)|A Randomised, Open Label, Parallel Group, Multi-Centre, Phase II Study of Progression Free Survival Comparing ZD1839 (IRESSA™) (250 MG Tablet) Versus Vinorelbine (30 MG/M2 Infusion) in Chemonaive, Elderly Patients With Locally Advanced (Stage IIIB) or Metastatic (Stage IV) NSCLC|Completed||Phase 2|192||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:22.139475|2017-02-18 16:57:22.139475
NCT00256698|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-20|2012-07-27|2010-04-29||January 2004||2004-01-01|July 2012|2012-07-01|February 2012|Actual|2012-02-01|April 2009|Actual|2009-04-01||Interventional|FACT||Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy|FACT: Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy; an Open Randomized, Comparative, Phase III Multicentre Study in Postmenopausal Women With Hormone Receptor Positive Breast Cancer in First Relapse After Primary Treatment of Localized Tumor.|Completed||Phase 3|514|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:57:22.549352|2017-02-18 16:57:22.549352
NCT00256685|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2006-05-17|||September 2004||2004-09-01|May 2006|2006-05-01|July 2005||2005-07-01|||||Interventional|||Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause|A Double-Blind, Randomized, Placebo-Controlled Efficacy and Safety Study of DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|568||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:57:23.401028|2017-02-18 16:57:23.401028
NCT00256672|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2008-06-11|||June 2005||2005-06-01|June 2008|2008-06-01|December 2012|Anticipated|2012-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Effectiveness of Bracing in Preventing Scoliosis in Children With Spinal Cord Injury|Effectiveness of Full-Time Prophylactic Bracing at Preventing or Delaying Curve Progression in Paralytic Scoliosis Secondary to Spinal Cord Injury in the Growing Child: Randomized Trial|Unknown status|Active, not recruiting|N/A|88|Anticipated|Shriners Hospitals for Children||2|||f||||||||||||||2017-02-18 16:57:23.50546|2017-02-18 16:57:23.50546
NCT00256659|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2008-03-31|||September 1998||1998-09-01|March 2008|2008-03-01|April 1999||1999-04-01|||||Interventional|||Hospital Outcomes: Intervention in Moderately III Patients|Hospital Outcomes: Intervention in Moderately III Patients|Completed||N/A|444||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 16:57:23.64135|2017-02-18 16:57:23.64135
NCT00256646|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2014-05-21|||June 2007||2007-06-01|May 2014|2014-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Markers and Mechanisms of Vascular Disease in Type II Diabetes|CSP #465D - Markers And Mechanisms of Vascular Disease in Type II Diabetes|Completed||N/A|298|Actual|VA Office of Research and Development|||1||f||||f||||||Samples Without DNA|"~     samples without DNA~   "|||2017-02-18 16:57:23.746315|2017-02-18 16:57:23.746315
NCT00256633|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2014-05-21|||April 2007||2007-04-01|May 2014|2014-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal|CSP #465C - Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal|Completed||N/A|874|Actual|VA Office of Research and Development|||1||f||||t||||||Samples With DNA|"~     Blood draws of DNA samples.~   "|||2017-02-18 16:57:23.874359|2017-02-18 16:57:23.874359
NCT00256620|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2008-03-31|||December 1996||1996-12-01|March 2008|2008-03-01|December 1999||1999-12-01|||||Interventional|||Improving Outcomes and Quality of Life After CABG|Improving Outcomes and Quality of Life After CABG|Completed||N/A|412||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 16:57:24.166863|2017-02-18 16:57:24.166863
NCT00256607|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2014-06-26|||June 2007||2007-06-01|June 2014|2014-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Non-traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes|CSP #465A - Non-Traditional Cardiovascular Risk Factors And Atherosclerosis In Type 2 Diabetes|Completed||N/A|301|Actual|VA Office of Research and Development|||1||f||||t||||||||||2017-02-18 16:57:24.26978|2017-02-18 16:57:24.26978
NCT00256594|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2011-12-14|||August 2005||2005-08-01|December 2011|2011-12-01|January 2011|Actual|2011-01-01|February 2010|Actual|2010-02-01||Interventional|||Evaluation of an Outpatient Modified Prescription Form|Evaluation of an Outpatient Modified Paper Prescription Form in 4 Rural States to Address the Public Health Problem of Prescribing Error|Completed||N/A|84|Actual|University of Vermont||1|||f||||f||||||||||2017-02-18 16:57:24.381217|2017-02-18 16:57:24.381217
NCT00256581|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2012-08-28|||November 2005||2005-11-01|August 2012|2012-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Imaging Studies With GE C-Hawk Gamma Camera Compared to Routine Clinical Exam|Imaging Studies With GE C-Hawk Gamma Camera Compared to Routine Clinical Exam|Completed||N/A|34|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 16:57:24.479768|2017-02-18 16:57:24.479768
NCT00256568|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2011-12-14|||September 2003||2003-09-01|December 2011|2011-12-01|August 2008|Actual|2008-08-01|||||Observational|||Outpatient Prescription Errors: Detection, Analysis, and Impact on Safety|Outpatient Prescription Errors: Detection, Analysis, and Impact on Safety|Completed||N/A|103|Actual|University of Vermont|||1||f||||f||||||||||2017-02-18 16:57:24.575823|2017-02-18 16:57:24.575823
NCT00256555|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2005-11-17|||February 2000||2000-02-01|November 2005|2005-11-01||||||||Interventional|||Growth Hormone Treatment Study in Children With Cystic Fibrosis|GROWTH HORMONE USE IN CYSTIC FIBROSIS - A MULTICENTER STUDY|Unknown status|Active, not recruiting|Phase 2/Phase 3|60||University of Texas Southwestern Medical Center|||||||||||||||||||2017-02-18 16:57:24.686873|2017-02-18 16:57:24.686873
NCT00256542|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2006-09-28|||January 2006||2006-01-01|August 2006|2006-08-01|September 2006||2006-09-01|||||Interventional|||Study of U101 for Bladder Pain and/or Urgency|A Phase II Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravesical Alkalinized Lidocaine-Heparin for the Symptoms of Pelvic Pain and/or Urgency of Bladder Origin|Completed||Phase 2|90||Urigen|||||||||||||||||||2017-02-18 16:57:24.773877|2017-02-18 16:57:24.773877
NCT00256529|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2014-12-12|||November 2005||2005-11-01|December 2014|2014-12-01|February 2012|Actual|2012-02-01|July 2011|Actual|2011-07-01||Observational|||Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia|Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia|Completed||N/A|483|Actual|University of Utah|||1||f||||f||||||Samples Without DNA|"~     4 quadrant distal and proximal biopsies of the esophagus~   "|||2017-02-18 16:57:24.883648|2017-02-18 16:57:24.883648
NCT00256516|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2013-05-17|||April 2005||2005-04-01|May 2013|2013-05-01|December 2006||2006-12-01|||||Interventional|||"Low Carbohydrate Portfolio or Eco-Atkins Diet"|"Low Carbohydrate Portfolio or Eco-Atkins Diet"|Completed||Phase 2|30||University of Toronto||2|||f||||||||||||||2017-02-18 16:57:24.996599|2017-02-18 16:57:24.996599
NCT00256503|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2016-01-11|||December 2005||2005-12-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Sleep Homeostasis in Primary Insomnia|Sleep Homeostasis in Primary Insomnia Following Behavioral Treatment|Completed||N/A|18|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 16:57:25.111812|2017-02-18 16:57:25.111812
NCT00256490|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2005-11-17|||November 2005||2005-11-01|November 2005|2005-11-01|November 2009||2009-11-01|||||Interventional|||Early Evaluation of the Response of Large B Cell Non Hodgkin’s Lymphoma to Chemotherapy by PET/CT|Early Evaluation of the Response of Large B Cell Non Hodgkin’s Lymphoma to Chemotherapy by Positron Emission Tomography Coupled With Computed Tomography (PET/CT)|Unknown status|Recruiting|N/A|82||Université de Sherbrooke|||||f||||||||||||||2017-02-18 16:57:25.222608|2017-02-18 16:57:25.222608
NCT00256477|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2005-11-16|||March 2005||2005-03-01|March 2005|2005-03-01|October 2005||2005-10-01|||||Interventional|||A Controlled Breathing Course for Social & Emotional Health for Vietnam Veterans With Chronic PTSD-RCT|A Controlled Breathing Course Promoting Social and Emotional Health for Vietnam Veterans With Chronic Posttraumatic Stress Disorder - A Randomised Controlled Trial|Completed||Phase 1|30||The University of Queensland|||||f||||||||||||||2017-02-18 16:57:25.309344|2017-02-18 16:57:25.309344
NCT00256464|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2006-09-07|||June 2007||2007-06-01|August 2005|2005-08-01|January 2008||2008-01-01|||||Interventional|||Evaluation of a MCYI as Adjunct to Psychiatric Treatment for Vietnam Veterans With PTSD - RCT|Evaluation of a Multi-Component Yoga Intervention as Adjunct to Psychiatric Treatment for Vietnam Veterans With Posttraumatic Stress Disorder (PTSD): A Randomized Controlled Trial (RCT).|Unknown status|Not yet recruiting|Phase 1|30||The University of Queensland|||||f||||||||||||||2017-02-18 16:57:25.403138|2017-02-18 16:57:25.403138
NCT00256451|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2016-12-01|||November 2005||2005-11-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|DEFINE||Endophenotype for Alcohol Misuse in Healthy Minority Populations|Defining an Endophenotype for Alcohol Misuse: A Focus On Minority Populations|Completed||Phase 4|38|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-02-18 16:57:25.496772|2017-02-18 16:57:25.496772
NCT00256438|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2006-07-06|||February 2006||2006-02-01|July 2006|2006-07-01||||||||Interventional|||Depression and Transcranial Direct Current Stimulation (tDCS)|The Treatment of Depression Using Transcranial Direct Current Stimulation (tDCS): a Pilot Study.|Unknown status|Recruiting|Phase 1/Phase 2|20||The University of New South Wales|||||f||||||||||||||2017-02-18 16:57:25.611721|2017-02-18 16:57:25.611721
NCT00256425|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2008-03-20|||October 2003||2003-10-01|July 2007|2007-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Cognitive Rehabilitation of Glioma Patients|Cognitive Rehabilitation of Glioma Patients: a Prospective, Randomized Study|Unknown status|Active, not recruiting|Phase 3|140|Actual|UMC Utrecht||2|||f||||f||||||||||2017-02-18 16:57:25.707456|2017-02-18 16:57:25.707456
NCT00256412|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2008-06-03|||October 2005||2005-10-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Essential Fatty Acids for Major Depression|Essential Fatty Acids in Management of MDD - A Pilot Study|Completed||N/A|24|Actual|University of Iowa||3|||f||||f||||||||||2017-02-18 16:57:25.814024|2017-02-18 16:57:25.814024
NCT00256399|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2007-11-26|||November 2005||2005-11-01|November 2005|2005-11-01||||||||Interventional|||Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)|A Prospective, Open Label, Study to Assess the Efficacy of Alfuzosin 10 mg Tablet Once a Day in Male Subjects Suffering From Benign Prostate Hypertrophy Associated Lower Urinary Tract Symptoms and Erectile Dysfunction|Unknown status|Recruiting|N/A|100|Anticipated|University Hospitals Cleveland Medical Center|||||||||||||||||||2017-02-18 16:57:25.91809|2017-02-18 16:57:25.91809
NCT00256386|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2006-11-29|||January 2004||2004-01-01|November 2005|2005-11-01|March 2005||2005-03-01|||||Interventional|||LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring|LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Medication Safety|Completed||N/A|800||Kaiser Permanente|||||f||||||||||||||2017-02-18 16:57:26.013076|2017-02-18 16:57:26.013076
NCT00256373|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2006-04-18|||January 2001||2001-01-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||Treatment of Chronic Low Back Pain: A Trial Comparing Traditional Back School and Individual Therapist-Assisted Exercise||Unknown status|Active, not recruiting|Phase 3|||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 16:57:26.236723|2017-02-18 16:57:26.236723
NCT00256360|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2014-12-08|||September 2005||2005-09-01|December 2014|2014-12-01|May 2006||2006-05-01|||||Interventional|||Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer|A Randomized Phase II Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer|Completed||Phase 2|117||Universitaire Ziekenhuizen Leuven|||||f||||||||||||||2017-02-18 16:57:26.332849|2017-02-18 16:57:26.332849
NCT00256347|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2011-04-12|||March 2005||2005-03-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine|Development of Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine Using the Brief Thermal Sensitization Model in Healthy Volunteers|Completed||N/A|30||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:57:26.434357|2017-02-18 16:57:26.434357
NCT00256334|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2014-06-18|||July 2005||2005-07-01|June 2014|2014-06-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Resveratrol for Patients With Colon Cancer|Resveratrol for Patients With Colon Cancer|Completed||Phase 1|11|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:26.518903|2017-02-18 16:57:26.518903
NCT00256321|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2008-02-27|||October 2004||2004-10-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|||||Interventional|||Celecoxib/Oxaliplatin/Capecitabine for Gastric/GE Junction Carcinoma|A Phase II Study of Celecoxib/Oxaliplatin/Capecitabine Combination Chemotherapy for Unresectable,Recurrent, or Metastatic Gastric/Gastroesophageal Junction Carcinoma|Completed||Phase 2|20||University of California, Irvine|||||f||||||||||||||2017-02-18 16:57:26.631254|2017-02-18 16:57:26.631254
NCT00256308|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2010-05-06|||April 2005||2005-04-01|May 2010|2010-05-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer|A Phase II Study of Adjuvant Chemoradiation With Weekly Oxaliplatin in Patients With High Risk Resected Squamous Cell Carcinoma of the Head and Neck Region|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:26.718033|2017-02-18 16:57:26.718033
NCT00256295|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2016-12-02|2013-06-21||April 2005||2005-04-01|December 2016|2016-12-01|October 2011|Actual|2011-10-01|February 2008|Actual|2008-02-01||Interventional|||Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer|A Phase II Study of Weekly Oxaliplatin and Gemcitabine Combination Chemotherapy for Recurrent or Metastatic Head and Neck Cancer|Terminated||Phase 2|8|Actual|University of California, Irvine||1||Low accrual|f||||t||||||||||2017-02-18 16:57:26.809312|2017-02-18 16:57:26.809312
NCT00256282|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2013-03-19|||April 2003||2003-04-01|March 2013|2013-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma|A Phase II Evaluation of Docetaxel and Vinorelbine Plus Sargramostim in Patients With Metastatic Malignant Melanoma|Completed||Phase 2|82|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:27.126684|2017-02-18 16:57:27.126684
NCT00256269|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2011-08-15|||June 2005||2005-06-01|August 2011|2011-08-01|April 2011|Actual|2011-04-01|February 2008|Actual|2008-02-01||Interventional|||Weekly Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal Carcinoma|A Phase II Study of Weekly Oxaliplatin and Irinotecan in the Treatment of Recurrent or Metastatic Esophageal Carcinoma|Completed||Phase 2|4|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:27.224488|2017-02-18 16:57:27.224488
NCT00256256|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2007-10-29|||November 2005||2005-11-01|October 2007|2007-10-01|January 2007|Actual|2007-01-01|||||Interventional|||The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men|The Effect of GLP-1 on Glucose Uptake in the CNS and Heart in Healthy Subjects During Normoglycaemia Assessed by Positron Emission Tomografi|Completed||N/A|10|Actual|University of Aarhus||1|||f||||||||||||||2017-02-18 16:57:27.49983|2017-02-18 16:57:27.49983
NCT00256243|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2014-01-28|2009-08-28||April 2004||2004-04-01|January 2014|2014-01-01|July 2012|Actual|2012-07-01|March 2011|Actual|2011-03-01||Interventional|||Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer|A Pilot Study of Neoadjuvant Biweekly Doxorubicin and Cyclophosphamide (AC) With GMCSF Followed by Weekly Carboplatin/Paclitaxel With Plus or Minus Trastuzumab (TC ± H) in the Treatment of Breast Cancer|Completed||Phase 2|48|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:27.604567|2017-02-18 16:57:27.604567
NCT00256230|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2016-12-06|||January 2002||2002-01-01|December 2011|2011-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Disulfiram in Patients With Metastatic Melanoma|Evaluation of Disulfiram in Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy, Phase I/II|Completed||Phase 1/Phase 2|7|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:27.839545|2017-02-18 16:57:27.839545
NCT00256217|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2014-01-30|||September 2004||2004-09-01|January 2014|2014-01-01|December 2018|Anticipated|2018-12-01|August 2012|Actual|2012-08-01||Interventional|||Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women|Phase II Chemoprevention Trial - Anastrozole in the DCIS and Early Invasive Breast Cancer in Postmenopausal Women|Active, not recruiting||Phase 2|42|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:27.940989|2017-02-18 16:57:27.940989
NCT00256204|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2012-01-10|2010-03-08||November 2005||2005-11-01|January 2012|2012-01-01|June 2009|Actual|2009-06-01|April 2008|Actual|2008-04-01||Interventional|ADAGIO||A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease|A Multi Center, Double Blind, Randomized Start, Placebo-Controlled, Parallel-Group Study to Assess Rasagiline as a Disease Modifying Therapy in Early Parkinson's Disease Subjects|Completed||Phase 3|1174|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-02-18 16:57:28.056161|2017-02-18 16:57:28.056161
NCT00256191|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2007-10-11|||November 2005||2005-11-01|November 2005|2005-11-01|February 2007|Actual|2007-02-01|||||Interventional|||Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies|A Phase 1, Open-Label, Q21 Day Dose Escalation, Multi-Center Study of TPI 287 in Patients With Advanced Malignancies|Completed||Phase 1|45||Cortice Biosciences, Inc.|||||t||||f||||||||||2017-02-18 16:57:29.492764|2017-02-18 16:57:29.492764
NCT00256178|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2012-05-23|||October 2005||2005-10-01|May 2012|2012-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.|A Placebo-controlled, Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 50 mg and 100 mg Versus Placebo, When Co-administered With Simvastatin 20 mg or 40 mg in Subjects With Primary Dyslipidemia.|Completed||Phase 3|411|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:57:29.588363|2017-02-18 16:57:29.588363
NCT00256165|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2009-03-30|||January 2006||2006-01-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||REST Study: Left Ventricular Regression European Study|Left Ventricular Regression European Study|Completed||Phase 4|150|Anticipated|St. Jude Medical||1|||f||||f||||||||||2017-02-18 16:57:29.883003|2017-02-18 16:57:29.883003
NCT00256152|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2012-07-27|||September 2004||2004-09-01|July 2012|2012-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial|Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial|Completed||Phase 4|2580|Actual|St. Jude Medical||2|||f||||||||||||||2017-02-18 16:57:29.9745|2017-02-18 16:57:29.9745
NCT00256139|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2017-01-13|||March 2003||2003-03-01|January 2017|2017-01-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||CLEAR Study: Clinical Experience Acquired With Raptiva Study||Completed||Phase 3|793|Actual|Merck KGaA|||||f||||||||||||||2017-02-18 16:57:30.095585|2017-02-18 16:57:30.095585
NCT00256126|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2014-03-26|||May 2005||2005-05-01|March 2014|2014-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Predictive Markers in GHD and TS Children Treated With SAIZEN®|A Phase IV Open-label Study of Predictive Markers in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children Treated With SAIZEN®|Completed||Phase 4|318|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 16:57:30.181176|2017-02-18 16:57:30.181176
NCT00256113|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2008-12-22|||December 2004||2004-12-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression|An Eight-Week, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder|Completed||Phase 3|467|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:57:30.306816|2017-02-18 16:57:30.306816
NCT00256100|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-04-23|||June 2004||2004-06-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.|Assessment of the Safety and Efficacy of Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Renal Failure.|Terminated||N/A|20|Actual|Melbourne Health||2||Teh Priincipal investigator responsible for the trial no longer employed at the study site.|f||||f||||||||||2017-02-18 16:57:30.418338|2017-02-18 16:57:30.418338
NCT00256087|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-11-18|||January 2005||2005-01-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||The Effect of Prophylactic Probiotic Lactobacilli in Enteral Feeding on Nosocomial Pneumonia Rates in Critically Ill Patients|The Effect of Prophylactic Probiotic Lactobacilli in Enteral Feeding on Nosocomial Pneumonia Rates in Critically Ill Patients|Completed||N/A|57|Actual|Melbourne Health||3|||f||||||||||||||2017-02-18 16:57:30.533477|2017-02-18 16:57:30.533477
NCT00256074|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-04-23|||June 2004||2004-06-01|April 2015|2015-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||The Effects of Nutritional Support of Critically Ill Patients Requiring Mechanical Ventilation|The Effects of Nutritional Support of Critically Ill Patients Requiring Mechanical Ventilation|Terminated||N/A|30|Anticipated|Melbourne Health||2||"Decision was made to terminate the project due to slower than anticipated recruitment and many~   of the investigators no longer being available."|f||||f||||||||||2017-02-18 16:57:30.649794|2017-02-18 16:57:30.649794
NCT00256061|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-04-23|||February 2003||2003-02-01|April 2015|2015-04-01|February 2004||2004-02-01|||||Observational|||Assessment of Electrolyte Values in the Intensive Care Unit:Comparison Between Arterial and Venous Blood Gas Analysis and Formal Laboratory Testing|Assessment of Electrolyte Values in the Intensive Care Unit:Comparison Between Arterial and Venous Blood Gas Analysis and Formal Laboratory Testing|Withdrawn||N/A|0|Actual|Melbourne Health||||"Due to the publication of significant literature in this area since commencement of the~   project which has now rendered the project unnecessary."|f||||f||||||||||2017-02-18 16:57:30.753164|2017-02-18 16:57:30.753164
NCT00256048|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-04-23|||May 2003||2003-05-01|April 2015|2015-04-01|July 2005|Actual|2005-07-01|||||Interventional|||Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.|Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.|Completed||N/A|50|Actual|Melbourne Health||2|||f||||f||||||||||2017-02-18 16:57:30.818124|2017-02-18 16:57:30.818124
NCT00256035|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-04-23||||||April 2015|2015-04-01||||||||Interventional|||Interleukin-4 (IL-4) as a Marker of Atherosclerosis|IL-4 as a Marker of Atherosclerosis|Withdrawn||N/A|0|Actual|Melbourne Health||4|||f||||f||||||||||2017-02-18 16:57:31.102064|2017-02-18 16:57:31.102064
NCT00256022|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-11-18|||July 2007||2007-07-01|April 2015|2015-04-01|December 2007|Anticipated|2007-12-01|||||Interventional|||The Effect of Prophylactic Pre Operative Probiotic Therapy on Endotoxin Levels in Cardiac Surgery Patients|The Effect of Prophylactic Pre Operative Probiotic Therapy on Peri Operative Endotoxin Levels in Cardiac Surgery Patients.|Withdrawn||N/A|0|Actual|Melbourne Health||4||Due to delays with logistics and protocol revision not viable to continue.|f||||f||||||||||2017-02-18 16:57:31.208024|2017-02-18 16:57:31.208024
NCT00256009|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2006-05-31||||||November 2005|2005-11-01|January 2009||2009-01-01|||||Interventional|||Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment|Evacuatio Uteri or Conservtive Treatment After Late Abortion. A Randomize Trial.|Unknown status|Not yet recruiting|Phase 4|200||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 16:57:31.295675|2017-02-18 16:57:31.295675
NCT00255996|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2009-07-13|||May 2006||2006-05-01|July 2009|2009-07-01|January 2007|Actual|2007-01-01|||||Interventional|||Evaluation Of Linezolid Pk Profile In Burns Patients|An Open Label Parallel Group Study To Investigate The Pharmacokinetics Of Intravenous Linezolid, An Oxazolidinone, Administered To Healthy Volunteers And Patients With Major Thermal Injuries|Completed||Phase 1|16|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:57:31.390162|2017-02-18 16:57:31.390162
NCT00255983|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2008-05-30|||December 2005||2005-12-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis|Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 5 Days Versus Placebo In the Treatment of Acute Exacerbation of Chronic Bronchitis|Terminated||Phase 3|491|Actual|Replidyne||2||financial reasons|f||||t||||||||||2017-02-18 16:57:31.497078|2017-02-18 16:57:31.497078
NCT00255970|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2011-08-08|2009-06-09||January 2006||2006-01-01|August 2011|2011-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects|Regenerative Therapy for Vertical Defects Comparing Demineralized Freeze Dried Bone Allograft (DFDBA) and Regenafil|Completed||Phase 2/Phase 3|40|Actual|RTI Surgical||2|||f||||f||||||||||2017-02-18 16:57:31.611118|2017-02-18 16:57:31.611118
NCT00255957|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2006-04-17|||October 2005||2005-10-01|November 2005|2005-11-01|March 2006||2006-03-01|||||Interventional|||Influence of Hydroxyehtyl Starch (HES) on Hemorehology, Coagulation and Elimination Kinetics|Clinical Trial to Study the Effects of HES on Coagulation, Hemorehology and Kinetics Comparing Two Different Products.|Completed||N/A|20||Nizam's Institute of Medical Sciences University, India|||||f||||||||||||||2017-02-18 16:57:32.141692|2017-02-18 16:57:32.141692
NCT00255944|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2013-11-26|||October 2005||2005-10-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|Youthnet suppl||Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults|Internet-based Efficacy Trial of an HIV Prevention Program|Completed||Phase 1/Phase 2|1860|Actual|University of Colorado, Denver||2|||f||||||||||||||2017-02-18 16:57:32.224334|2017-02-18 16:57:32.224334
NCT00255931|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2012-06-02|||July 2004||2004-07-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Impact of a Psychological Biofeedback-Relaxation Intervention on Clinical, Physical and Psychological Outcomes in Patients With Heart Failure|Biobehavioral Intervention in Heart Failure|Completed||Phase 2|380|Actual|University of Kentucky||3|||f||||f||||||||||2017-02-18 16:57:32.33089|2017-02-18 16:57:32.33089
NCT00255918|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2015-06-30|||March 2004||2004-03-01|June 2015|2015-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients|Phase 1 Trial of 3-2,4 Dimethoxbenzylidene Anabaseine in Schizophrenia|Completed||Phase 1|12|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-02-18 16:57:32.440396|2017-02-18 16:57:32.440396
NCT00255905|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2013-06-27|||July 2004||2004-07-01|June 2013|2013-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Cognitive Behavioral Therapy for the Treatment of Depression-Related Insomnia|Is Insomnia a Modifiable Risk Factor for Major Depressive Disorder|Completed||N/A|45|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 16:57:32.553718|2017-02-18 16:57:32.553718
NCT00255892|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2016-02-29|||February 2006||2006-02-01|February 2016|2016-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Intervention Development for Newly Diagnosed Youth With HIV|Intervention Development for Newly Diagnosed Youth With HIV|Completed||N/A|48|Actual|Westat|||2||f||||f||||||||||2017-02-18 16:57:32.652565|2017-02-18 16:57:32.652565
NCT00255879|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2013-06-05|||January 1999||1999-01-01|November 2005|2005-11-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Movement Disorders Caused by Antipsychotic Drugs in Older Patients|Neuroleptic Induced Movement Disorders in Older Patients|Completed||Phase 1|250||University of California, San Diego|||||f||||||||||||||2017-02-18 16:57:32.757271|2017-02-18 16:57:32.757271
NCT00255866|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2015-11-30|||January 2004||2004-01-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers|Improving Affect and Behavior in Assisted Living Residents|Completed||Phase 2/Phase 3|90||University of Washington|||||f||||||||||||||2017-02-18 16:57:32.867566|2017-02-18 16:57:32.867566
NCT00255242|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2009-07-31|||July 2004||2004-07-01|January 2008|2008-01-01|May 2009|Actual|2009-05-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Simvastatin on CF Airway Inflammation|Effect of Simvastatin on CF Airway Inflammation|Completed||Phase 1|40|Anticipated|Akron Children's Hospital||1|||f||||f||||||||||2017-02-18 16:57:40.077084|2017-02-18 16:57:40.077084
NCT00255840|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2011-06-17|2011-03-02||July 2006||2006-07-01|June 2011|2011-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities|"Safeguard the Household - A Study of HIV Antiretroviral Therapy Treatment Strategies Appropriate for a Resource Poor Country"|Completed||N/A|812|Actual|CIPRA SA|The study design did not address nurse-initiated ART because the prescription of ART in South Africa is restricted to doctors. We noted a high rate of loss to follow-up, but this rate was similar to other resource-constrained settings.|2|||f||||f||||||||||2017-02-18 16:57:32.969955|2017-02-18 16:57:32.969955
NCT00255827|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2015-05-29|||November 2005||2005-11-01|May 2015|2015-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Vaccine Treatment for Surgically Resected Pancreatic Cancer|A Phase I/II Study of Algenpantucel-L (HyperAcute Pancreas) an Antitumor Vaccination Using Alpha(1,3)Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Pancreatic Cancer|Completed||Phase 1/Phase 2|7|Actual|NewLink Genetics Corporation||1|||f||||t||||||||||2017-02-18 16:57:33.612553|2017-02-18 16:57:33.612553
NCT00255814|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2015-11-14|||November 2005||2005-11-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|September 2011|Actual|2011-09-01||Interventional|||Radiation Therapy in Treating Patients With Liver Metastases|A Phase I Trial of Highly Conformal Radiation Therapy for Patients With Liver Metastases|Completed||Phase 1|26|Actual|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-02-18 16:57:33.714638|2017-02-18 16:57:33.714638
NCT00255801|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-03-28|||November 2005||2005-11-01|March 2016|2016-03-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Interventional|||Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma|Phase II Trial of Doxorubicin HCl Liposome Injection (Doxil®) in Advanced Stage Cutaneous T-Cell Lymphoma Followed by Bexarotene (Targretin®)|Active, not recruiting||Phase 2|37|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:57:33.827135|2017-02-18 16:57:33.827135
NCT00255788|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-11-25|||January 2005||2005-01-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer|A Randomized Phase II Study of Two Different Schedules of RAD001C in Patients With Recurrent/Metastatic Breast Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 16:57:33.941421|2017-02-18 16:57:33.941421
NCT00255775|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2010-08-05|||January 2005||2005-01-01|August 2010|2010-08-01||||May 2009|Actual|2009-05-01||Interventional|||Broccoli Sprout Extract in Preventing Lung Cancer in Smokers|Evaluation of the Biological Effects of Broccoli Sprout Extract in Smokers|Completed||N/A|70|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:57:34.042641|2017-02-18 16:57:34.042641
NCT00255762|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2013-10-25|||December 2005||2005-12-01|October 2013|2013-10-01||||December 2006|Actual|2006-12-01||Interventional|||Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery|Phase II Trial of Carboplatin, Weekly Paclitaxel and Biweekly Bevacizumab in Patients With Unresectable Stage IV Melanoma|Completed||Phase 2|47|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:57:34.13444|2017-02-18 16:57:34.13444
NCT00255749|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2012-10-03|||August 2005||2005-08-01|October 2012|2012-10-01||||April 2007|Actual|2007-04-01||Interventional|||Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer|Assessment of Early and Standard Intervention With Procrit® (Epoetin Alfa) 120,000 Units Once Every Three Weeks (Q3W) in Patients With Cancer Receiving Chemotherapy|Completed||Phase 2|89|Actual|Jonsson Comprehensive Cancer Center||2|||f||||||||||||||2017-02-18 16:57:34.249177|2017-02-18 16:57:34.249177
NCT00255723|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2015-12-22|2015-12-22||April 2004||2004-04-01|December 2015|2015-12-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma|Risk-Adapted High Dose Chemoradiotherapy and Autologous Stem Cell Transplantation for Patients With Relapsed and Primary Refractory Hodgkin's Lymphoma|Completed||Phase 2|98|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 16:57:34.484875|2017-02-18 16:57:34.484875
NCT00255710|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2010-03-16|||July 2002||2002-07-01|March 2010|2010-03-01||||||||Interventional|||Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer|Nonmyeloablative Bone Marrow Transplants in Hematologic Malignancies: Dose Finding Study for Post-Transplant Immunosuppression|Completed||Phase 1|60|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 16:57:34.897333|2017-02-18 16:57:34.897333
NCT00255697|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2015-10-08|||July 2005||2005-07-01|October 2015|2015-10-01|December 2012|Actual|2012-12-01|March 2012|Actual|2012-03-01||Observational|||Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers|Quality of Life Study Registry for Persons With Cancer and Family Caregivers|Completed||N/A|863|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||||||2017-02-18 16:57:35.006728|2017-02-18 16:57:35.006728
NCT00255684|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2016-09-28|2016-05-18||December 2003||2003-12-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|March 2013|Actual|2013-03-01||Interventional|||Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer|Non-Myeloablative Conditioning and Unrelated Umbilical Cord Blood Transplantation for Children and Adults With Serious Oncohematologic Diseases|Terminated||N/A|16|Actual|University of Rochester||1||low accrual|f||||t||||||||||2017-02-18 16:57:35.099593|2017-02-18 16:57:35.099593
NCT00255671|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2015-10-01|||May 2005||2005-05-01|October 2015|2015-10-01|May 2012|Actual|2012-05-01|April 2008|Actual|2008-04-01||Observational|||Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders|Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery|Completed||N/A|76|Actual|Case Comprehensive Cancer Center|||1||f||||t||||||None Retained|"~     Determine the incidence and types of acute complications in patients undergoing stereotactic~     radiosurgery for brain tumors or other brain disorders.~   "|||2017-02-18 16:57:35.350264|2017-02-18 16:57:35.350264
NCT00255658|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2015-04-14|||September 2005||2005-09-01|December 2013|2013-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors|Phase I, Pharmacokinetic and Pharmacodynamic Study of BAY 43-9006 (Sorafenib) in Combination With CCI-779 (Temsirolimus) in Advanced Solid Malignancies|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:57:35.447833|2017-02-18 16:57:35.447833
NCT00255645|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2008-03-14|||September 2005||2005-09-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|||||Observational|||G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)|A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.|Terminated||Phase 3|4500||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:57:35.750992|2017-02-18 16:57:35.750992
NCT00255619|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2006-10-25|||May 2002||2002-05-01|November 2005|2005-11-01|May 2004||2004-05-01|||||Interventional|||Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.|A Randomized, Multi-Center, Open Label Trial to Establish the Equivalence Between ANDY-Disc® (Fresenius Medical Care) and Ultrabag® (Baxter) in Patients on CAPD. [CAPD-2 Trial]|Completed||Phase 4|264||Ministry of Health, Malaysia|||||f||||||||||||||2017-02-18 16:57:36.791504|2017-02-18 16:57:36.791504
NCT00255606|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2013-06-25|||August 2005||2005-08-01|September 2010|2010-09-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Interventional|||Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer|A Phase III Trial Comparing Docetaxel Every Third Week to Biweekly Docetaxel Monotherapy in Metastatic Hormone Refractory Prostate Cancer Patients - PROSTY Trial|Completed||Phase 3|360|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 16:57:36.903795|2017-02-18 16:57:36.903795
NCT00255593|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-18|2007-11-29|||November 2005||2005-11-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety and Efficacy Study of Rituximab in Renal Transplantation|A Prospective, Randomised, Placebo Controlled, Multicenter Study of the Efficacy and Safety of Rituximab as Induction Therapy Together With Tacrolimus, Mycophenolate Mofetil and Steroids for Patients Undergoing Renal Transplantation|Completed||Phase 1|140|Anticipated|Karolinska University Hospital|||||f||||||||||||||2017-02-18 16:57:37.021636|2017-02-18 16:57:37.021636
NCT00255580|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2008-02-20|||September 2001||2001-09-01|February 2008|2008-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Medicinal Cannabis for Painful HIV Neuropathy|Placebo-Controlled, Double Blind Trial of Medicinal Cannabis in Painful HIV Neuropathy|Completed||Phase 1/Phase 2|28|Actual|Center for Medicinal Cannabis Research||2|||f||||t||||||||||2017-02-18 16:57:37.107315|2017-02-18 16:57:37.107315
NCT00255567|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2016-03-21|||November 2004||2004-11-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis|A Multicentre Comparative Trial of Efficacy and Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) Versus Combination of SSG and PM as the First Line Treatment for Visceral Leishmaniasis in Ethiopia, Kenya and Sudan|Completed||Phase 3|1142|Actual|Drugs for Neglected Diseases||3|||f||||t||||||||||2017-02-18 16:57:37.211181|2017-02-18 16:57:37.211181
NCT00255554|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2005-11-17||||||November 2005|2005-11-01||||||||Interventional|||DBT and Escitalopram in Borderline Personality Disorder|Effects of Dialectical Behavioral Therapy and Escitalopram on Impulsive Aggression, Affective Instability and Cognitive Processing in Borderline Personality Disorder|Unknown status|Recruiting|N/A|||Bronx VA Medical Center|||||f||||||||||||||2017-02-18 16:57:37.323794|2017-02-18 16:57:37.323794
NCT00255541|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2008-03-14|||September 2004||2004-09-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|||||Interventional|||GALLANT 4 Tesaglitazar vs. Glibenclamide|A 52-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes|Terminated||Phase 3|580||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:57:37.419003|2017-02-18 16:57:37.419003
NCT00255528|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2007-03-19|||July 2002||2002-07-01|March 2007|2007-03-01||||||||Interventional|307A||Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects|Dose Ranging, Safety and Tolerability of TOPROL-XL® (Metoprolol Succinate) Extended-Release Tablets (Metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study|Completed||Phase 3|144||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:37.667105|2017-02-18 16:57:37.667105
NCT00255515|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2009-03-24|||September 2005||2005-09-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|SCORE||Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia|An Open, Randomised, Parallel, Three Treatment Groups, Multicentre, Phase IV Study - in Real Life - to Compare the Change in Social Outcome of Quetiapine Fumarate (Seroquel®) Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia.|Completed||Phase 4|85|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 16:57:37.779111|2017-02-18 16:57:37.779111
NCT00255502|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2006-11-20|||July 2002||2002-07-01|November 2006|2006-11-01||||||||Interventional|||307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects|A Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® (Metoprolol Succinate) Extended-Release Tablets (Metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Open-Label Extension of Protocol 307A|Completed||Phase 3|100||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:37.910431|2017-02-18 16:57:37.910431
NCT00255489|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2011-01-24|||May 2004||2004-05-01|January 2011|2011-01-01|June 2006|Actual|2006-06-01|||||Interventional|||A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer|A Phase I Study of ZD1839 (Iressa) and Palliative Thoracic Radiotherapy in Patients With Non-small Cell Lung Cancer|Completed||Phase 1|36||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:38.023795|2017-02-18 16:57:38.023795
NCT00255476|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2009-04-22|||February 2004||2004-02-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|||||Interventional|||The IRESSA Novel Head and Neck Chemotherapy Evaluation Study|A Randomised Phase II Study to Investigate the Feasibility and Benefits of Combining ZD1839 and Cisplatin/5FU, as Induction Therapy, in Patients With Locally and Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|64||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:38.28464|2017-02-18 16:57:38.28464
NCT00255463|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2009-04-22|||January 2004||2004-01-01|April 2009|2009-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study|Phase II, Placebo Controlled, Parallel Group, Double Blind, Randomised, Multicentre Trial Comparing the Anastrozole (Arimidex®) Placebo Combination to the Anastrozole - ZD1839 (Iressa™) Combination as Neoadjuvant Treatment in Postmenopausal Women With Stage I-IIIB Breast Cancer and Oestrogen Receptor (ER) and/or Progesterone (PgR) Positive Tumours|Completed||Phase 2|185||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:38.371037|2017-02-18 16:57:38.371037
NCT00255437|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-01-07|||June 2004||2004-06-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients|A Phase III Study of the Safety and Efficacy of Ferumoxytol (Compared With Oral Iron) as an Iron Replacement Therapy in Chronic Kidney Disease Patients Not on Dialysis|Completed||Phase 3|304||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:57:38.627736|2017-02-18 16:57:38.627736
NCT00255424|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2015-01-07|||May 2004||2004-05-01|October 2008|2008-10-01|August 2006|Actual|2006-08-01|||||Interventional|||Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients|A Phase III Study of the Safety and Efficacy of Ferumoxytol (Compared With Oral Iron) as an Iron Replacement Therapy in Chronic Kidney Disease Patients Not on Dialysis|Completed||Phase 3|304||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:57:38.733789|2017-02-18 16:57:38.733789
NCT00255411|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2017-01-24|||November 9, 2005||2005-11-09|February 24, 2009|2009-02-24|February 24, 2009||2009-02-24|||||Observational|||Psychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure|Neuropsychiatric Correlates of Psychogenic Movement Disorder and Non-Epileptic Seizure|Completed||N/A|190||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:57:38.839841|2017-02-18 16:57:38.839841
NCT00255398|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2017-01-24|||November 10, 2005||2005-11-10|December 3, 2014|2014-12-03|December 3, 2014||2014-12-03|||||Observational|||Kidney Disease Biomarkers|Kidney Disease Biomarkers|Completed||N/A|25|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:57:38.923609|2017-02-18 16:57:38.923609
NCT00255385|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2005-11-16|||April 2002||2002-04-01|April 2005|2005-04-01|April 2004||2004-04-01|||||Interventional|||Efficacy of Bifidus DR10 and Oligo Saccharides / Micronutrient Fortification of Milk|Evaluating Efficacy of Milk Fortified With Bifidus DR10-Oligosaccharides, Zinc and Iron in Reducing Morbidity Due to Diarrhea, Pneumonia and Improving Growth and Development in Children Ages 13-36 Months|Completed||Phase 3|1200||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 16:57:39.015692|2017-02-18 16:57:39.015692
NCT00255372|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2008-06-03|||April 2005||2005-04-01|June 2008|2008-06-01||||May 2008|Actual|2008-05-01||Interventional|||To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.|Polyethylene Glycol Laxative (Macrogol 4000;Forlax®) for Treatment of Chronic Constipation in Children : A Phase III, Bicentric, Randomized, Double-Blind, Lactulose Controlled Study.|Completed||Phase 3|84|Anticipated|Ipsen||2|||f||||||||||||||2017-02-18 16:57:39.124072|2017-02-18 16:57:39.124072
NCT00255359|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2007-11-05|||February 2006||2006-02-01|November 2007|2007-11-01|November 2007||2007-11-01|||||Interventional|||Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers|A Multicenter, Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study of the Safety and Efficacy of XTL 2125 in Adult HCV-Infected Patients With Compensated Liver Disease, Who Are Interferon-Alpha Non-Responders or Have Relapsed From Interferon-Alpha Therapy|Withdrawn||Phase 1|60|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:57:39.223938|2017-02-18 16:57:39.223938
NCT00255346|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2016-10-24|||November 2005||2005-11-01|October 2016|2016-10-01|November 2018|Anticipated|2018-11-01|December 2007|Actual|2007-12-01||Interventional|||Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)|Therapy of Myeloid Metaplasia-Myelofibrosis, Atypical Chronic Myeloid or Myelomonocytic Leukemia, C-Kit Positive Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (AML-MDS), Hypereosinophilic Syndrome, Polycythemia Vera, and Mastocytosis With Dasatinib (BMS-354825)|Active, not recruiting||Phase 2|145|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:57:39.322853|2017-02-18 16:57:39.322853
NCT00255333|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2007-05-11|||November 2005||2005-11-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||INNO-105 in Patients With Solid Tumors|A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Weekly Intravenous INNO-105 in Adult Patients With Advanced Solid Malignancies|Terminated||Phase 1|24||Innovive Pharmaceuticals||||Development of this compound was discontinued.|||||||||||||||2017-02-18 16:57:39.437284|2017-02-18 16:57:39.437284
NCT00255320|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2005-12-07|||December 2003||2003-12-01|December 2003|2003-12-01|June 2004||2004-06-01|||||Interventional|||Experimental Headache Induced by Vasoactive Intestinal Polypeptide|Experimental Headache Induced by Vasoactive Intestinal Polypeptide|Completed||N/A|12||Danish Headache Center|||||f||||||||||||||2017-02-18 16:57:39.510674|2017-02-18 16:57:39.510674
NCT00255307|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2007-06-14|||November 2005||2005-11-01|June 2007|2007-06-01|April 2006|Actual|2006-04-01|||||Interventional|||Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.|A Pilot Evaluation of Two Dosing Schedules of American Ginseng Extract in Pediatric Upper Respiratory Tract Infection.|Completed||Phase 2|75|Actual|Afexa Life Sciences Inc||3|||f||||||||||||||2017-02-18 16:57:39.598488|2017-02-18 16:57:39.598488
NCT00255294|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2005-11-17|||January 2005||2005-01-01|November 2005|2005-11-01|October 2005||2005-10-01|||||Interventional|||Contraceptive Effectiveness Trial of Cellulose Sulfate Gel|Non-Comparative Contraceptive Effectiveness Trial of Cellulose Sulfate (CS) Gel|Completed||Phase 2|200||CONRAD|||||||||||||||||||2017-02-18 16:57:39.699446|2017-02-18 16:57:39.699446
NCT00255281|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2007-12-04|||September 2005||2005-09-01|December 2007|2007-12-01|May 2006|Actual|2006-05-01|||||Interventional|||Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation|A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre, Phase II Study to Assess the Efficacy of AZD7009 (AR H065522XX) Given Intravenously (Infusion for 15 or 30 Minutes) to Patients for Conversion of Atrial Fibrillation|Completed||Phase 2|160|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:57:39.784095|2017-02-18 16:57:39.784095
NCT00255268|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-08-24|||August 2004||2004-08-01|August 2007|2007-08-01||||||||Interventional|||CMAB vs IMAB in Metastatic Prostate Cancer|Longitudinal, Randomized, Open and Prospective Clinical Trial to Evaluate the Efficacy of Continuous vs Intermittent Maximum Androgen Blockade (CMAB vs IMAB) With Goserelin-Bicalutamide Combination in the Treatment of Hormonal naïve With Metastatic Prostate Cancer|Withdrawn||Phase 4|15|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:57:39.890382|2017-02-18 16:57:39.890382
NCT00255255|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-17|2011-01-21|||November 2005||2005-11-01|January 2011|2011-01-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma|An Open, Phase III, Multicentre, 52-week Study, Evaluating the Safety and Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma|Completed||Phase 3|120||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:39.972743|2017-02-18 16:57:39.972743
NCT00255229|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2016-02-24|||December 2002||2002-12-01|January 2012|2012-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea|Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea|Completed||Phase 2|130|Actual|AHS Cancer Control Alberta||2|||f||||t||||||||||2017-02-18 16:57:40.172212|2017-02-18 16:57:40.172212
NCT00255216|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2005-11-17|||January 2005||2005-01-01|October 2005|2005-10-01|August 2005||2005-08-01|||||Interventional|||Policosanol for the Treatment of Hypercholesterolemia|Policosanol for the Treatment of Hypercholesterolemia|Completed||N/A|40||Carolinas Healthcare System|||||f||||||||||||||2017-02-18 16:57:40.386107|2017-02-18 16:57:40.386107
NCT00255190|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2016-06-27|2009-06-24||January 2006||2006-01-01|April 2011|2011-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn|A Phase 3, Open-Label Study to Assess the Long-Term Safety of Dexlansoprazole MR (60 mg QD and 90 mg QD)|Completed||Phase 3|591|Actual|Takeda|The incidence of adverse events was considered one of the primary outcome measures of this study. These results are presented in the Adverse Events Section and are not reposted as a separate primary endpoint.|2|||f||||f||||||||||2017-02-18 16:57:40.500409|2017-02-18 16:57:40.500409
NCT00255177|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2009-10-30|2009-04-22||November 2005||2005-11-01|October 2009|2009-10-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Interventional|||Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients|A Randomized, Open-label Phase II Trial of the Anti-HCV Activity and Safety of VGX-410 (Mifepristone) at 3 Dose Levels in HCV Infected Patients|Completed||Phase 2|44|Actual|VGX Pharmaceuticals, LLC||4|||f||||f||||||||||2017-02-18 16:57:42.162601|2017-02-18 16:57:42.162601
NCT00255164|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2012-02-01|2009-02-20||January 2006||2006-01-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis|A Phase 3 Study to Evaluate the Safety and Efficacy of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis|Completed||Phase 3|451|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:57:42.707548|2017-02-18 16:57:42.707548
NCT00255151|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2012-02-01|2009-02-20||January 2006||2006-01-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis|A Phase 3 Study to Evaluate the Safety and Efficacy of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis|Completed||Phase 3|451|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:57:43.882514|2017-02-18 16:57:43.882514
NCT00255138|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2008-10-28|||November 2005||2005-11-01|October 2008|2008-10-01||||||||Interventional|||Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects|Efficacy of Atomoxetine Therapy Versus Placebo For Ameliorating Cognitive Late Effects Among Survivors of Childhood Cancers|Withdrawn||Phase 3|60||Temple University|||||f||||||||||||||2017-02-18 16:57:45.169817|2017-02-18 16:57:45.169817
NCT00255125|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-06-12|2013-12-24||September 2005||2005-09-01|June 2015|2015-06-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional||Prostate cancer patient, randomized between to study groups; all patients with early stage prostate cancer.|Role of Soy Supplementation in Prostate Cancer Development|Role of Soy Isoflavones in Prostate Cancer Prevention|Completed||Phase 3|86|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:57:45.266493|2017-02-18 16:57:45.266493
NCT00255112|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2015-06-10|||June 2004||2004-06-01|June 2015|2015-06-01||||December 2009|Actual|2009-12-01||Interventional|||TAFF-Psychological Treatment of Separation Anxiety Disorder|Psychological Treatment of Separation Anxiety Disorder|Completed||N/A|64|Actual|University Hospital, Basel, Switzerland||2|||f||||f||||||||||2017-02-18 16:57:45.758771|2017-02-18 16:57:45.758771
NCT00255099|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2011-06-02||2011-06-02|December 2005||2005-12-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|January 2007|Actual|2007-01-01||Interventional|||TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.|A Phase III Randomized, Double-blinded, Placebo-controlled Trial to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an ART Regimen, Including TMC114/RTV and an Investigator-selected OBR, in HIV-1 Infected Patients With Limited Treatment to no Treatment Options.|Completed||Phase 3|593|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||||||||||||2017-02-18 16:57:45.869818|2017-02-18 16:57:45.869818
NCT00255086|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2010-10-14|||May 2005||2005-05-01|October 2010|2010-10-01|February 2010|Actual|2010-02-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients|The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients: A Randomized, Placebo-Controlled, 52-Week Clinical Trial|Completed||Phase 3|17|Actual|Stanford University||2|||f||||||||||||||2017-02-18 16:57:45.977319|2017-02-18 16:57:45.977319
NCT00255073|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2014-05-21|||January 2005||2005-01-01|May 2014|2014-05-01|April 2006||2006-04-01|||||Interventional|||Does Reducing Spasticity Permit an Increase in Strength?|Does Reducing Spasticity Permit an Increase in Strength?|Completed||Phase 2|10||University of Southern California|||||f||||f||||||||||2017-02-18 16:57:46.077463|2017-02-18 16:57:46.077463
NCT00255060|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2010-07-16|||November 2001||2001-11-01|July 2010|2010-07-01|June 2007|Actual|2007-06-01|July 2006|Actual|2006-07-01||Observational|||Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer|Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer|Completed||N/A|100|Anticipated|Stanford University|||1||f||||||||||||||2017-02-18 16:57:46.177056|2017-02-18 16:57:46.177056
NCT00255047|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2014-01-21|2010-09-14||November 2005||2005-11-01|January 2014|2014-01-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Immune Response of Different Pediatric Combination Vaccines.|Comparative Immunogenicity of Different Multivalent Component Pertussis Vaccine Formulations Based on a 5 Component Acellular Pertussis Vaccine in Infants and Toddlers|Completed||Phase 3|2167|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 16:57:46.272029|2017-02-18 16:57:46.272029
NCT00254852|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2013-11-20|||October 2005||2005-10-01|November 2013|2013-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft|A Single Blind, Multi-Center, Randomized, Prospective Clinical Study Comparing Optecure™ Autograft Extender to Autograft Only in Fusion of the Lumbar Spine|Terminated||N/A|94|Actual|Exactech||2||Slow enrollment|f||||f||||||||||2017-02-18 16:57:51.517744|2017-02-18 16:57:51.517744
NCT00255034|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-03-30|2009-06-04||February 2005||2005-02-01|March 2015|2015-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)|Phase IV Study of Tailored Therapy With Peg Interferon Alfa 2b and Ribavirin for Patients With Genotype 3 and High Viral Load. Genotype 3 Extended Treatment for HCV (GET-C Study)|Terminated||Phase 4|146|Actual|Merck Sharp & Dohme Corp.|No formal comparisons could be made and no conclusions drawn because of small numbers in the treatment groups; a result of an inability to fulfill the recruitment target.|2||Recruitment targets were unachievable in the currently available population.|f||||f||||||||||2017-02-18 16:57:47.306764|2017-02-18 16:57:47.306764
NCT00255021|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2012-04-13|||December 2005||2005-12-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|September 2007|Actual|2007-09-01||Interventional|||Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand||Completed||Phase 4|186|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:57:47.739754|2017-02-18 16:57:47.739754
NCT00255008|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-02-04|2008-12-05||March 2005||2005-03-01|February 2015|2015-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)|SEASON South East Asian Study Of Novel Genotypes in Hepatitis C Infection: Pegylated-Interferon and Ribavirin Therapy (PEGATRON REDIPEN Combination Therapy (PEG-Intron® REDIPEN Plus REBETOL®)) in Treatment Naive Patients With Genotypes 1, 6, 7, 8, 9: A Comparison of Race and Genotype on Treatment Outcome.|Terminated||Phase 4|121|Actual|Merck Sharp & Dohme Corp.||4||Slow enrollment|f||||f||||||||||2017-02-18 16:57:47.855986|2017-02-18 16:57:47.855986
NCT00254995|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2016-04-15|2014-09-04||July 2005||2005-07-01|April 2016|2016-04-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational||Subjects who received Menactra vaccine during the study period from the Kaiser Permanente databases.|Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine|Post-licensure Safety Surveillance Study of Routine Use of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra ™)|Completed||Phase 4|62626|Actual|Sanofi|||2||f||||f||||||||||2017-02-18 16:57:48.645499|2017-02-18 16:57:48.645499
NCT00254982|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-10-09|2010-05-27||August 2005||2005-08-01|October 2015|2015-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)|"An Open-Label Study to Determine Equivalence in Efficacy, Organ Safety and Systemic Tolerability Between Infliximab in GROUP I (High Need) and GROUP II (Low Need) Patients Suffering From Chronic Plaque Psoriasis (Psoriasis Vulgaris)"|Completed||Phase 3|593|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 16:57:49.776157|2017-02-18 16:57:49.776157
NCT00254969|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2012-04-16|||October 2005||2005-10-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|May 2008|Actual|2008-05-01||Interventional|||Immunogenicity and Safety of Pentaxim in South African Infants||Completed||Phase 3|212|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 16:57:50.264055|2017-02-18 16:57:50.264055
NCT00254956|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2009-04-07|||January 2004||2004-01-01|April 2009|2009-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma|A Multi-Center, Multinational, Randomized, Double-Blind, Parallel Group Study of the Effects of Ciclesonide Hfa-Mdi 640 μg/Day and Beclomethasone Hfa-Mdi 640 μg/Day on Lens Opacification in Adult Subjects With Moderate to Severe Persistent Asthma|Completed||Phase 3|1568|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:57:50.369094|2017-02-18 16:57:50.369094
NCT00254930|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2011-05-18|||September 2003||2003-09-01|March 2010|2010-03-01|June 2006|Actual|2006-06-01|||||Interventional|||A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children|Prospective Trial of Risperdal (Risperidone) Following Psychological Therapy for Challenging Behaviour in Learning Disabled Children|Completed||Phase 3|19|Actual|Janssen-Cilag Ltd.|||||f||||||||||||||2017-02-18 16:57:50.475775|2017-02-18 16:57:50.475775
NCT00254917|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2012-04-13|||October 2003||2003-10-01|April 2012|2012-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines||Completed||Phase 4|387|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:57:50.56604|2017-02-18 16:57:50.56604
NCT00254904|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-03-10||2009-03-20|November 2005||2005-11-01|March 2015|2015-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC|International, Randomized, Open-Label, Phase 3 Trial of Gemcitabine/Cisplatin Plus PF-3512676 Versus Gemcitabine/Cisplatin Alone as First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 3|839|Actual|Pfizer||2||See Termination Reason in Detailed Description|f||||t||||||||||2017-02-18 16:57:50.688192|2017-02-18 16:57:50.688192
NCT00254891|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-03-10||2009-03-20|November 2005||2005-11-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer|International, Randomized, Open-Label, Phase 3 Trial of Paclitaxel/Carboplatin Plus PF-3512676 Versus Paclitaxel/Carboplatin Alone as First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 3|828|Actual|Pfizer||2||See Termination Reason in Detailed Description|f||||t||||||||||2017-02-18 16:57:50.935757|2017-02-18 16:57:50.935757
NCT00254878|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2007-12-17|||October 2005||2005-10-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14|A 7 Week Multicenter, Double-Blind, Randomized, Placebo-Controlled Cross-Over Evaluation of the Efficacy and Safety of Two Different Brands of Modified-Release Oral Dosage Forms of Methylphenidate-HCl (20 mg, q.d.) in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14|Completed||Phase 3|130||Novartis|||||f||||||||||||||2017-02-18 16:57:51.326964|2017-02-18 16:57:51.326964
NCT00254865|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2011-06-06|||August 2002||2002-08-01|January 2011|2011-01-01|March 2003|Actual|2003-03-01|||||Interventional|||A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers|A Comparative Pharmacokinetic Study of EVRA and CILEST in Healthy Female Volunteers|Completed||Phase 1|34|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:57:51.424479|2017-02-18 16:57:51.424479
NCT00253864|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2016-10-25|||November 2004||2004-11-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Functional Outcomes Following Shoulder Surgery: A Prospective Database|Functional Outcome Following Shoulder Surgery: A Prospective Database|Recruiting||N/A|2500|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 16:57:51.64816|2017-02-18 16:57:51.64816
NCT00253851|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2012-04-13|||July 2003||2003-07-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery|Multi-centre, Double-blind, Randomized, Controlled Trial Comparing Intra-operative Regional Heparinization to Placebo for the Prevention of Deep Vein Thrombosis Following Total Knee Arthroplasty|Completed||Phase 4|30|Actual|Ottawa Hospital Research Institute||1|||f||||||||||||||2017-02-18 16:57:51.741322|2017-02-18 16:57:51.741322
NCT00253838|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2015-10-21|||October 2001||2001-10-01|October 2011|2011-10-01|February 2016|Anticipated|2016-02-01|December 2015|Anticipated|2015-12-01||Interventional|||A Comparison of Two Type of Stems in Revision Hip Arthroplasty|A Randomized Controlled Trial Comparing a Titanium to a Cobalt Chrome Femoral Stem in Revision Hip Arthroplasty: A Pilot Study|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Ottawa Hospital Research Institute||2|||f||||f||||||||||2017-02-18 16:57:51.843576|2017-02-18 16:57:51.843576
NCT00253825|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2005-12-20|||November 2005||2005-11-01|August 2005|2005-08-01|July 2006||2006-07-01|||||Interventional|||mCIMT and Eye Patching for Neglect Rehabilitation Post Stroke: A Longitudinal Study of Separate and Combined Effects|Modified Constraint-Induced Movement Therapy and Eye Patching for Neglect Rehabilitation Post Stroke: A Longitudinal Study of Separate and Combined Effects|Unknown status|Recruiting|Phase 1/Phase 2|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 16:57:51.95986|2017-02-18 16:57:51.95986
NCT00253812|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2007-09-21|||November 2005||2005-11-01|September 2007|2007-09-01||||||||Interventional|||Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy|Adenoma Detection Rate in Rectal Remnants of Familial Polyposis (FAP) Patients Using Standard (White Light), Auto-Fluorescence (AFI), Narrow Band Imaging (NBI) and Chromoscopic Endoscopy|Unknown status|Recruiting|N/A|60|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 16:57:52.034985|2017-02-18 16:57:52.034985
NCT00253799|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2007-06-21|||December 2005||2005-12-01|June 2007|2007-06-01||||||||Interventional|||A Safety Study of Hylan GF-20 to Treat Shoulder Osteoarthritis|Prospective, Single Arm, Pilot Study Evaluating the Safety and Efficacy of Hyaluronan (Hylan GF-20) in Patients With Painful Shoulder Osteoarthritis|Unknown status|Active, not recruiting|Phase 4|35|Anticipated|Northwestern Ophthalmic Institute S.C.||1|||f||||t||||||||||2017-02-18 16:57:52.120754|2017-02-18 16:57:52.120754
NCT00253786|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2007-01-15|||July 2005||2005-07-01|January 2007|2007-01-01|June 2011||2011-06-01|||||Interventional|||Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy|Study for the Effectiveness of Intensive Therapy for Diabetic Nephropathy in Unblinded, Randomized Intergroup Comparison Study.|Unknown status|Recruiting|N/A|600||Okayama University|||||f||||||||||||||2017-02-18 16:57:52.189239|2017-02-18 16:57:52.189239
NCT00253773|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2010-01-12|||January 2005||2005-01-01|January 2010|2010-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Metabolic Effects of Chemical Interactions in Toxicity|Metabolic Effects of Chemical Interactions in Toxicity|Completed||N/A|15|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:57:52.281464|2017-02-18 16:57:52.281464
NCT00253760|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2010-03-17|||February 2004||2004-02-01|March 2010|2010-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Metabolic Analysis in Human Sulfur Amino Acid Deficiency||Completed||N/A|15|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:57:52.365376|2017-02-18 16:57:52.365376
NCT00253747|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-13|2012-08-17|2012-07-16||November 2005||2005-11-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)|A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers With ADHD|Completed||Phase 3|255|Actual|University of Cincinnati||2|||f||||t||||||||||2017-02-18 16:57:52.45702|2017-02-18 16:57:52.45702
NCT00253734|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2013-05-30|||November 2005||2005-11-01|July 2008|2008-07-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||Immunogenicity and Safety of Different Doses of Fluzone® Influenza|Immunogenicity and Safety of a Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route Compared to an Intramuscular Vaccination With Fluzone® in Healthy Adults|Completed||Phase 2|217|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-02-18 16:57:55.740081|2017-02-18 16:57:55.740081
NCT00253721|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2016-08-03|||May 1998||1998-05-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Melphalan With BBBD in Treating Patients With Brain Malignancies|Intra-Arterial Melphalan (L-Phenylalanine Mustard) Administered in Conjunction With Osmotic Blood-Brain Barrier Disruption in Patients With Brain Malignancies: A Phase I Study|Terminated||Phase 1|21|Actual|OHSU Knight Cancer Institute||1||Other competing clinical trials affecting enrollment|f||||t||||||||||2017-02-18 16:57:55.845983|2017-02-18 16:57:55.845983
NCT00253708|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2017-01-30|||December 1, 2004|Actual|2004-12-01|January 2017|2017-01-01|January 1, 2013|Actual|2013-01-01|January 1, 2013|Actual|2013-01-01||Interventional|||Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer|Body-Based Complementary Therapies for Patients With Cancer|Completed||N/A|42|Actual|Beth Israel Deaconess Medical Center||3|||f||||f|f|f||||||No||2017-02-18 16:57:55.951166|2017-02-18 16:57:55.951166
NCT00253695|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2013-03-26|||July 2004||2004-07-01|March 2013|2013-03-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents|Sleep Studies in HIV+ Older Children/Adolescents|Completed||N/A|90|Actual|Baylor College of Medicine|||1||f||||f||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 16:57:56.067166|2017-02-18 16:57:56.067166
NCT00253682|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2014-03-17|||September 2002||2002-09-01|March 2014|2014-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|CHAART-1||Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers|Cardiac Status of HAART Exposed Infants of HIV-Infected Mothers (CHAART I)|Completed||N/A|167|Actual|University of Miami|||2||f||||t||||||Samples Without DNA|"~     Blood samples were collected for analysis of cardiac biomarkers high sensitivity C REactive~     PRotein (hsCRP) and N-terminal Pro-Brain Natriuretic Peptide (NT-proBNP).~   "|||2017-02-18 16:57:56.162236|2017-02-18 16:57:56.162236
NCT00253669|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2012-05-24|||April 2005||2005-04-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas|Pilot Study of Thrombophilic States in Newly Diagnosed Patients With High-Grade Gliomas|Completed||N/A|110|Actual|Sidney Kimmel Comprehensive Cancer Center|||1||f||||||||||||||2017-02-18 16:57:56.261245|2017-02-18 16:57:56.261245
NCT00253643|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2015-02-17|2014-12-19||July 2005||2005-07-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|September 2013|Actual|2013-09-01||Interventional|||Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer|Catechins and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prostate: A Randomized Controlled Trial|Completed||N/A|89|Actual|OHSU Knight Cancer Institute||4|||f||||t||||||||||2017-02-18 16:57:56.611286|2017-02-18 16:57:56.611286
NCT00253630|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2016-11-15|||September 2005||2005-09-01|November 2016|2016-11-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma|A Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Indolent Non-Hodgkin's Lymphoma|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:57:57.312616|2017-02-18 16:57:57.312616
NCT00253617|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2013-04-02||||||December 2006|2006-12-01||||||||Interventional|||Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery|Phase III Randomized Study of Double Plastic Endoprosthesis Insertion With Versus Without Adjuvant Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Patients With Unresectable Stage III-IV Cholangiocarcinoma|Withdrawn||Phase 3|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:57:57.434807|2017-02-18 16:57:57.434807
NCT00253591|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2013-12-18|||June 2005||2005-06-01|July 2007|2007-07-01|December 2009|Actual|2009-12-01|December 2007|Actual|2007-12-01||Interventional|||Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Randomised Phase II/III Trial of Induction Chemotherapy Followed by Continuous Hyperfractionated Accelerated Radiotherapy (CHART) Versus CHART Alone in Patients With Inoperable Non-Small Cell Lung Cancer|Completed||Phase 2/Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:57:57.529324|2017-02-18 16:57:57.529324
NCT00253578|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2013-01-04|||March 2006||2006-03-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Trial of BAY 43-9006 (Sorafenib) (NSC-724772) in Patients With Relapsing or Resistant Multiple Myeloma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:57:57.654078|2017-02-18 16:57:57.654078
NCT00254839|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-16|2006-09-14|||December 2005||2005-12-01|November 2005|2005-11-01||||||||Observational|||Association Between Dental Implants Properties and Malodor Production|Bacterial Accumulation and Malodor Production in Various Types of Dental Implants|Completed||N/A|60||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:57:57.758471|2017-02-18 16:57:57.758471
NCT00254826|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2013-12-03|||June 2006||2006-06-01|December 2013|2013-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Yellow Fever Virus Vaccine and Immune Globulin Study|Randomized Controlled Double-Blind Trial of the Comparative Viremia, Immunogenicity and Safety of a 17-D Live Attenuated Yellow Fever Vaccine (YF-VAX)Given Alone or in Combination With Human Immune Globulin (Gama STAN S/D)|Completed||Phase 1|80|Actual|Emory University||2|||f||||f||||||||||2017-02-18 16:57:57.830804|2017-02-18 16:57:57.830804
NCT00254813|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2011-01-25|||October 2004||2004-10-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|||||Interventional|||Fast Titration Of Quetiapine Versus Currently Approved Titration|Fast Titration Of Quetiapine Versus Currently Approved Titration: A Randomised, Multicentre, Parallel Group Open Trial In Schizophrenia And Schizoaffective Disorder|Completed||Phase 3|150||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:57.946184|2017-02-18 16:57:57.946184
NCT00254800|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-08-17|||November 2005||2005-11-01|August 2015|2015-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females|The Effect of Exenatide on Single and Multiple Doses Oral Contraceptive Pharmacokinetics in Healthy Female Subjects|Completed||Phase 1|38|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 16:57:58.043844|2017-02-18 16:57:58.043844
NCT00254787|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2009-06-09|||June 2005||2005-06-01|June 2009|2009-06-01|January 2006|Actual|2006-01-01|||||Interventional|||Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients|Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in the Treatment of Patients With Acute Schizophrenia - a Multicentre, Double-Blind, Parallel Group, Randomized Study|Completed||Phase 2|30||AstraZeneca|||||f||||||||||||||2017-02-18 16:57:58.15437|2017-02-18 16:57:58.15437
NCT00254774|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2007-12-14|||January 2002||2002-01-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling|Pilot Study of the Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling: an Open Trial|Completed||Phase 3|44|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:57:58.241111|2017-02-18 16:57:58.241111
NCT00254761|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2008-02-27|||November 2003||2003-11-01|February 2008|2008-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Effects of Smoked Marijuana on Neuropathic Pain|A Double Blind, Active Placebo Controlled Crossover Trial of the Antinociceptive Effect of Smoked Marijuana on Subjects With Neuropathic Pain; Correlation With Changes in Mood, Cognition, and Psychomotor Performance|Completed||Phase 1/Phase 2|28|Actual|Center for Medicinal Cannabis Research||3|||f||||t||||||||||2017-02-18 16:57:58.323595|2017-02-18 16:57:58.323595
NCT00254748|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2009-06-09|||June 2004||2004-06-01|June 2009|2009-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients|The Effect of Quetiapine on Psychotic-Like Symptoms in Borderline Personality Disordered Patients: A Randomised Placebo-Controlled Trial|Completed||Phase 2|40|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 16:57:58.423973|2017-02-18 16:57:58.423973
NCT00254735|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2007-12-14|||April 2002||2002-04-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Quetiapine Augmentation in Severe Obsessive Compulsive Disorder|Quetiapine Augmentation in Severe Obsessive Compulsive Disorder (OCD) - Pilot Study|Completed||Phase 3|44|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:57:58.519123|2017-02-18 16:57:58.519123
NCT00254722|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2010-01-04|||April 2006||2006-04-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|November 2008|Actual|2008-11-01||Interventional|||Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children|Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children|Completed||Phase 1|10|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-02-18 16:57:58.860231|2017-02-18 16:57:58.860231
NCT00254709|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2012-01-26|||October 2002||2002-10-01|January 2012|2012-01-01|September 2005|Actual|2005-09-01|||||Interventional|||Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients|Open, Pilot, Comparative Study to Evaluate the Efficacy and Safety of Two Immunosuppressor Regimens, Anti Il-2, Sirolimus Mycophenolate, Mophetyl and Steroids Versus Sirolimus, Cyclosporine, and Withdrawal of Cyclosporine Since the Third Month and Steroids in Elderly Population|Completed||Phase 4|66|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:57:58.961908|2017-02-18 16:57:58.961908
NCT00254696|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2011-04-13|||June 2004||2004-06-01|April 2011|2011-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)|Association of Antibiotic Utilization Measures and Control of Extended-spectrum-lactamases (ESBLs)|Completed||Phase 4|710|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:57:59.042968|2017-02-18 16:57:59.042968
NCT00254683|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2009-04-13|||September 2005||2005-09-01|April 2009|2009-04-01|September 2015|Anticipated|2015-09-01|August 2010|Anticipated|2010-08-01||Interventional|||Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer|Study of the Value of the PET/CT in Evaluating the Response of Distal Rectal Cancer to Neoadjuvant Chemoradiation Therapy|Unknown status|Recruiting|Phase 2|100|Anticipated|University of Sao Paulo||1|||f||||f||||||||||2017-02-18 16:57:59.132385|2017-02-18 16:57:59.132385
NCT00254670|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2011-04-12|||February 2005||2005-02-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|December 2005|Actual|2005-12-01||Interventional|||Naltrexone Effects on Alcohol Intake|Naltrexone Effects on Alcohol Intake Using a Laboratory Bar in Asp40 Positive and Negative Alcohol Users Characterized by fMRI and Genetic Screening|Completed||N/A|||University of California, San Francisco|||||f||||||||||||||2017-02-18 16:57:59.245694|2017-02-18 16:57:59.245694
NCT00254657|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2013-05-10|||March 2004||2004-03-01|May 2013|2013-05-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|||Levetiracetam for Treatment of Pain Associated With Fibromyalgia|A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Treatment of Pain Associated With Fibromyalgia|Completed||N/A|66|Actual|University of California, San Francisco||2|||f||||||||||||||2017-02-18 16:57:59.336676|2017-02-18 16:57:59.336676
NCT00254644|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2017-01-13|||February 2007||2007-02-01|May 2011|2011-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|PHR04-CH/DYS||Morphofunctional Imaging and Developmental Dyslexia|Morphofunctional Imaging and Developmental Dyslexia|Completed||N/A|32|Actual|University Hospital, Tours|||2||f||||f||||||||||2017-02-18 16:57:59.446739|2017-02-18 16:57:59.446739
NCT00254631|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2015-02-04|||April 2007||2007-04-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures|Preemptive Analgesia With OxyContin Versus Placebo Before Surgery for Long Bone Fractures|Completed||Phase 4|65|Actual|Rambam Health Care Campus||2|||f||||||||||||||2017-02-18 16:57:59.540446|2017-02-18 16:57:59.540446
NCT00254618|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2013-04-15|||October 2005||2005-10-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.|Study to Determine the Pharmacokinetics of Mesalamine Following Administration of 30, 60, and 90 mg/kg/Day as 400 mg Delayed-release Tablets Given Every 12 Hours for 28 Days to Children/Adolescents With Active Ulcerative Colitis.|Terminated||Phase 1|34|Actual|Warner Chilcott||3||Slow enrollment.|f||||f||||||||||2017-02-18 16:57:59.650881|2017-02-18 16:57:59.650881
NCT00254605|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2016-10-24|||November 2005||2005-11-01|October 2016|2016-10-01|November 2019|Anticipated|2019-11-01|October 2017|Anticipated|2017-10-01||Observational|||Retinal Imaging in Patients With Inherited Retinal Degenerations|High Resolution Retinal Imaging in Patients With Inherited Retinal Degenerations|Recruiting||Phase 1|400|Anticipated|University of California, San Francisco|||1||f||||t||||||||||2017-02-18 16:57:59.783049|2017-02-18 16:57:59.783049
NCT00254592|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2016-11-15|2009-08-28||October 2005||2005-10-01|November 2016|2016-11-01|January 2017|Anticipated|2017-01-01|July 2013|Actual|2013-07-01||Interventional|||Neoadjuvant Treatment of Breast Cancer|Neoadjuvant Biweekly Doxorubicin and Cyclophosphamide With GMCSF Followed by Weekly Carboplatin/Nab-paclitaxel Plus or Minus Trastuzumab and Plus or Minus Bevacizumab in Treatment of Large or Inflammatory Breast Cancer-a Phase II Study|Active, not recruiting||Phase 2|43|Actual|University of California, Irvine||1|||f||||t||||||||||2017-02-18 16:57:59.886399|2017-02-18 16:57:59.886399
NCT00254579|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2012-06-05||2009-05-09|December 2005||2005-12-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Study of CP-675,206 in Refractory Melanoma|A Phase 2, Open Label, Single Arm Study To Evaluate The Efficacy, Safety, Tolerability And Pharmacokinetics Of CP-675,206 In Patients With Advanced Refractory And/Or Relapsed Melanoma|Completed||Phase 2|251|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 16:58:00.15637|2017-02-18 16:58:00.15637
NCT00254566|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2009-11-03|2009-07-22||February 2006||2006-02-01|November 2009|2009-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)|A Phase 3B Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial To Evaluate The Efficacy and Safety Of Azithromycin SR (Microspheres Formulation) Versus Moxifloxacin For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB).|Completed||Phase 3|398|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 16:58:00.341303|2017-02-18 16:58:00.341303
NCT00254553|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2015-12-11|||July 2005||2005-07-01|December 2015|2015-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two Period Cross Over Trial to Validate Patient-Reported Outcome Measures for Use in Men With Late Onset Hypogonadism|Terminated||Phase 2|150|Actual|Merck Sharp & Dohme Corp.||2||Recruitment issues|f||||f||||||||||2017-02-18 16:58:00.921382|2017-02-18 16:58:00.921382
NCT00005433|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||April 1996||1996-04-01|April 2002|2002-04-01|March 1998||1998-03-01|||||Observational|||Correlates of Angiographic Changes and Coronary Events||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.592969|2017-02-18 18:14:59.592969
NCT00254540|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2010-02-17|2010-01-15||December 2005||2005-12-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of SU011248 in Patients With Advanced Kidney Cancer|Phase II Study Of Single-Agent SU011248 In The Treatment Of Patients With Renal Cell Carcinoma|Completed||Phase 2|51|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 16:58:01.025561|2017-02-18 16:58:01.025561
NCT00254527|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2007-04-30|||January 2005||2005-01-01|November 2005|2005-11-01|April 2007|Actual|2007-04-01|||||Observational|||Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.|Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.|Completed||N/A|477|Actual|Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 16:58:02.163425|2017-02-18 16:58:02.163425
NCT00254514|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2017-01-20|||August 2001||2001-08-01|January 2017|2017-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures|A Multi-centre, Randomised, Double-blind, Placebocontrolled, Parallel-group Trial Investigating the Efficacy and Safety of Norditropin® SimpleXx® in Tibia Fractures|Completed||Phase 2|407|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 16:58:02.266379|2017-02-18 16:58:02.266379
NCT00254501|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2016-07-20|2016-07-14||November 2005||2005-11-01|July 2016|2016-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Empowering Patients to Better Manage Diabetes Through Self-Care|Empowering Patients to Better Manage Diabetes Through Self-Care|Completed||Phase 3|69|Actual|Oregon State University||2|||f||||f||||||||No||2017-02-18 16:58:02.411123|2017-02-18 16:58:02.411123
NCT00254488|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2013-07-24|||November 2005||2005-11-01|July 2013|2013-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|GERI-BD||Treatment of Bipolar Mania in Older Adults|Acute Pharmacotherapy of Late-Life Mania (GERI-BD)|Completed||Phase 4|224|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 16:58:03.546419|2017-02-18 16:58:03.546419
NCT00254475|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2014-08-18|||November 2005||2005-11-01|August 2014|2014-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia|A Study to Evaluate the Efficacy of the Valsartan/Simvastatin Combinations 160/20mg up Titrated to 320/20mg Versus 160/40mg up Titrated to 320/40mg in Patients With Both Essential Hypertension and Hypercholesterolemia|Completed||Phase 3|871|Actual|Novartis|||||f||||||||||||||2017-02-18 16:58:03.662382|2017-02-18 16:58:03.662382
NCT00254462|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2015-12-16|2011-10-03||October 2005||2005-10-01|December 2015|2015-12-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children|Pharmacological Treatment of ADHD in Young Children|Completed||Phase 4|93|Actual|University of Nebraska|Study design does not allow differentiation between placebo response and psychoeducational treatment effect. Eight-week duration does not allow for examination of long-term effectiveness or assessment of adverse effects over time.|2|||f||||t||||||||||2017-02-18 16:58:03.76108|2017-02-18 16:58:03.76108
NCT00254449|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2009-02-12|||November 2005||2005-11-01|September 2007|2007-09-01|May 2006||2006-05-01|||||Interventional|||Effect of NGX-4010 on ENFD and Sensory Function|A Randomized, Controlled, Open-Label Study to Investigate the Effect of NGX-4010 on Epidermal Nerve Fiber Density and Sensory Function in Healthy Volunteers|Completed||Phase 1|36||NeurogesX|||||||||||||||||||2017-02-18 16:58:04.161439|2017-02-18 16:58:04.161439
NCT00254436|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2012-07-27|||December 2002||2002-12-01|July 2012|2012-07-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing Preoperative Chemoradiation Followed by Surgery|Terminated||Phase 3|50|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 16:58:04.254307|2017-02-18 16:58:04.254307
NCT00254423|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2016-12-19|||November 2005||2005-11-01|December 2016|2016-12-01||||November 2018|Anticipated|2018-11-01||Interventional|||Study of Dasatinib in Patients With Chronic Myelogenous Leukemia|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib (BMS-354825)|Active, not recruiting||Phase 2|150|Anticipated|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 16:58:04.364913|2017-02-18 16:58:04.364913
NCT00254410|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2016-02-18|||March 2005||2005-03-01|February 2016|2016-02-01||||March 2018|Anticipated|2018-03-01||Interventional|||FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years|Phase 2 Study of the Activity and Safety of Fludarabine, Cyclophosphamide, and Mitoxantrone Plus Rituximab (FCM-R) With Pegfilgrastim (Neulasta) as Frontline Therapy for Patients < 70 Years With Chronic Lymphocytic Leukemia|Active, not recruiting||Phase 2|30|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:58:04.478581|2017-02-18 16:58:04.478581
NCT00254397|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2013-02-12|||November 2005||2005-11-01|February 2013|2013-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Melanoma Vaccine With Peptides and Leuprolide|Study of the Modulatory Activity of an LHRH-Agonist (Leuprolide) on Melanoma Peptide Vaccines as Adjuvant Therapy in Melanoma Patients|Completed||Phase 2|98|Actual|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 16:58:04.834692|2017-02-18 16:58:04.834692
NCT00254384|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2016-10-14|||October 2005||2005-10-01|October 2016|2016-10-01||||October 2018|Anticipated|2018-10-01||Interventional|||Neoadjuvant, Tarceva, Surgery for Non-Small Cell Lung Cancer (NSCLC)|Neoadjuvant Chemotherapy With Docetaxel, Cisplatin Followed by Maintenance Therapy With the EGFR Inhibitor Erlotinib (Tarceva) in Patients With Stage I, II and III Non-Small Cell Lung Cancer Following Definitive Surgical Resection|Active, not recruiting||N/A|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 16:58:04.959079|2017-02-18 16:58:04.959079
NCT00254371|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2011-05-20|||July 1998||1998-07-01|May 2011|2011-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||DHEA and Testosterone Replacement in Elderly|Pathogenesis of Sarcopenia and Metabolic Changes in Aging|Completed||N/A|150||Mayo Clinic|||||f||||||||||||||2017-02-18 16:58:05.083609|2017-02-18 16:58:05.083609
NCT00254358|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2008-07-03|||April 2007||2007-04-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|||||Observational|||A Brain Imaging Study of Nicotine Release in Cigarette Smokers|A Brain Imaging Study of Nicotine Release in Cigarette Smokers|Terminated||N/A|0|Actual|Hadassah Medical Organization|||1|It was decided to use a different protocol with a different radioligand|f||||t||||||||||2017-02-18 16:58:05.168413|2017-02-18 16:58:05.168413
NCT00254319|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2005-11-14||||||November 2005|2005-11-01||||||||Interventional|||Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)|Phase II Trial of Bevacizumab (Avastin) Plus Pemetrexed (Alimta) and Carboplatin in Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 2|||The Cooper Health System|||||||||||||||||||2017-02-18 16:58:05.450666|2017-02-18 16:58:05.450666
NCT00254306|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2011-07-06|||January 2006||2006-01-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Functional Brain Imaging in Recreational Users of Ecstasy|Functional Brain Imaging in Recreational Users of Ecstasy|Completed||N/A|18|Actual|Hadassah Medical Organization|||2||f||||t||||||||||2017-02-18 16:58:05.528946|2017-02-18 16:58:05.528946
NCT00254293|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2014-03-03|2013-08-20||January 2006||2006-01-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|May 2007|Actual|2007-05-01||Interventional||Baseline includes all participants enrolled and treated. Baseline parameters are presented for each arm but the total value for baseline mean age and standard deviation (SD) includes all participants in LTE. Data are presented by treatment the participant actually received, not to what they were randomized to receive.|Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)|A Study to Assess the Steady-State Trough Serum Concentration, Safety, and Immunogenicity of Abatacept (BMS-188667) Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis Who Are Receiving Disease Modifying Ant-Rheumatic Drugs (DMARDs)|Completed||Phase 1/Phase 2|87|Actual|Bristol-Myers Squibb|Error resulted in 4 participants being treated with study drug they were not randomized to receive. ST data were summarized by study drug participants actually received while LT data were summarized by what participants were randomized to receive.|6|||f||||||||||||||2017-02-18 16:58:05.632497|2017-02-18 16:58:05.632497
NCT00254280|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-15|2008-05-30|||November 2005||2005-11-01|May 2008|2008-05-01|September 2008||2008-09-01|||||Interventional|||Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial|Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light and Paring Versus Paring Alone - a Randomized Controlled Trial With Blinded Response Evaluation|Unknown status|Active, not recruiting|N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:58:07.875257|2017-02-18 16:58:07.875257
NCT00254267|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2014-02-26|||November 2005||2005-11-01|February 2014|2014-02-01|December 2012|Actual|2012-12-01|February 2007|Actual|2007-02-01||Interventional|||Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors|An Open-label Phase 2 Study of AMG 706 in Japanese Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) Who Developed Progressive Disease or Relapsed While on Imatinib Mesylate|Completed||Phase 2|35|Actual|Amgen||1|||f||||t||||||||||2017-02-18 16:58:07.959868|2017-02-18 16:58:07.959868
NCT00254254|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2015-02-19|||February 2006||2006-02-01|January 2015|2015-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus|A Randomized, Single-Blind, Dose-Rising, Placebo-Controlled, Crossover Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|13|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 16:58:08.057239|2017-02-18 16:58:08.057239
NCT00254241|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2009-06-09|||May 2002||2002-05-01|June 2009|2009-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Safety and Efficacy of Seroquel in First Episode Schizophrenia|Safety and Efficacy of Seroquel in First Episode Schizophrenia|Completed||Phase 4|80||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:08.166713|2017-02-18 16:58:08.166713
NCT00254228|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2008-10-08|||November 2005||2005-11-01|October 2008|2008-10-01|December 2007||2007-12-01|||||Interventional|||Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction|A Clinical Study to Evaluate the Safety and Efficacy of the BrainPort™ Balance Device When Used to Improve Postural Control in Subjects With Bilateral Vestibular Disorders|Terminated||N/A|60||Wicab||||Terminated due to slow recruitment|f||||||||||||||2017-02-18 16:58:08.249865|2017-02-18 16:58:08.249865
NCT00254215|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-13|2006-11-27|||March 2002||2002-03-01|July 2005|2005-07-01|October 2004||2004-10-01|||||Interventional|||Glycemic Load, Weight Loss and Cardiovascular Disease Risk|The Effect of 4 Diets Varying in Glycemic Index, Glycemic Load, Carbohydrate and Protein, on Weight, Body Composition and Cardio-Vascular Risk Factors|Completed||Phase 1|120||University of Sydney|||||f||||||||||||||2017-02-18 16:58:08.357305|2017-02-18 16:58:08.357305
NCT00254202|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2012-07-18|||November 2005||2005-11-01|July 2012|2012-07-01|March 2007||2007-03-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia|A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Iloperidone in Schizophrenic Patients in Acute Exacerbation Followed by a Long-term Treatment Phase.|Completed||Phase 3|600||Vanda Pharmaceuticals|||||||||||||||||||2017-02-18 16:58:08.691937|2017-02-18 16:58:08.691937
NCT00254189|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2006-05-17|||December 2002||2002-12-01|May 2006|2006-05-01|October 2004||2004-10-01|||||Interventional|||Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation|A Single Center, Open-Label Study to Evaluate the Effects on Ovulation of Levonorgestrel 90mg and Ethinyl Estradiol 20mg in a Daily, Continuous, Oral Regimen.|Completed||Phase 2|60||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 16:58:08.820425|2017-02-18 16:58:08.820425
NCT00254176|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2010-02-25|||September 2006||2006-09-01|February 2010|2010-02-01|July 2011|Anticipated|2011-07-01|March 2011|Anticipated|2011-03-01||Interventional|||Cysteine Supplementation in Critically Ill Neonates|Effect of Cysteine Supplementation on Glutathione Production in Critically Ill Neonates|Unknown status|Active, not recruiting|Phase 2/Phase 3|108|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 16:58:08.913472|2017-02-18 16:58:08.913472
NCT00254163|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2016-09-15|2016-02-02||December 2003||2003-12-01|September 2016|2016-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional||ITT population|Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients|A Prospective, Randomized, Open Label, Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab vs. Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-cell Chronic Lymphocytic Leukemia|Completed||Phase 3|184|Actual|US Oncology Research||2|||f||||f||||||||||2017-02-18 16:58:09.043468|2017-02-18 16:58:09.043468
NCT00251199|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2007-12-17|||October 2005||2005-10-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||VX-950 and Peginterferon for Hepatitis C|A Phase 1b Viral Kinetic Study of VX-950 and Peginterferon in Hepatitis C|Completed||Phase 1|20||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-02-18 16:59:11.239534|2017-02-18 16:59:11.239534
NCT00254150|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2005-11-14|||May 1995||1995-05-01|April 1995|1995-04-01|December 1996||1996-12-01|||||Interventional|||A Therapy to Reduce Morbidity and Hospital Length of Stay of High-Risk Surgical Patients|Goal-Directed Intraoperative Therapy Reduces Morbidity and Length of Hospital Stay in High Risk Surgical Patients|Completed||Phase 2|130||Università Politecnica delle Marche|||||f||||||||||||||2017-02-18 16:58:09.759439|2017-02-18 16:58:09.759439
NCT00254137|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2010-10-27|||September 2004||2004-09-01|September 2004|2004-09-01|November 2006||2006-11-01|||||Interventional|||Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.|A Randomized Phase II-study to Evaluate the Safety and Efficacy of Capecitabine Plus Irinotecan Plus Cetuximab Compared to Capecitabine Plus Oxaliplatin Plus Cetuximab in First-line Treatment of Patients With Metastatic Colorectal Cancer.|Completed||Phase 2|92||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 16:58:09.856182|2017-02-18 16:58:09.856182
NCT00254124|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2005-11-14|||April 2004||2004-04-01|November 2005|2005-11-01|December 2004||2004-12-01|||||Interventional|||Use of a Portion Control Food Tool to Induce Weight Loss in Obese Type 2 Diabetics.|Efficacy of a Food Portion Control Tool to Induce Weight Loss and Decrease Hypoglycemic Medication Requirements Amongst Obese Type 2 Diabetics.|Completed||N/A|130||University of Calgary|||||f||||||||||||||2017-02-18 16:58:09.942465|2017-02-18 16:58:09.942465
NCT00254111|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2005-11-14|||July 2005||2005-07-01|November 2005|2005-11-01|July 2006||2006-07-01|||||Interventional|||Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.|Ultra Probe Laser System Osteoarthritis of the Hand Clinical Study.|Unknown status|Recruiting|N/A|100||TriTech Manufacturing|||||f||||||||||||||2017-02-18 16:58:10.046585|2017-02-18 16:58:10.046585
NCT00254085|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2005-11-14|||March 2005||2005-03-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Interventional|||Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.|Multiple Substitution of First Phase Insulin Response With a Rapid Action Insuli Analogue in Patient With Newly Diagnosed Type 2 Diabtes.|Unknown status|Recruiting|Phase 4|20||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 16:58:10.147466|2017-02-18 16:58:10.147466
NCT00254072|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2010-02-11|2009-11-05||January 2007||2007-01-01|February 2010|2010-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|EEA-LGB||Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)|Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)a Prospective Randomized Comparison of the 3.5 mm vs 4.8 mm Circular Stapler for Creation of the Gastrojejunostomy in Prevention of Staple Line Hemorrhage During Laparoscopic Gastric Bypass|Completed||N/A|355|Actual|University of California, Irvine|"Difficulty discerning GI bleeding attributed to the gastrojejunostomy vs gastric pouch staple-line~Technological differences between 3.5mm vs 4.8 mm stapler~Operative techniques varying between study sites~Study size may be underpowered"|2|||f||||f||||||||||2017-02-18 16:58:10.248061|2017-02-18 16:58:10.248061
NCT00254059|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2005-11-10||||||November 2005|2005-11-01|December 2004||2004-12-01|||||Interventional|||A Randomized Study to Compare Polysomnography With Overnight Home Oximetry and Auto – CPAP for Sleep Apnea|A Randomized Study to Compare Polysomnography With Overnight Home Oximetry and Auto – CPAP for Diagnosis and Nasal CPAP Titration in Patients With a High Probability of Obstructive Sleep Apnea.|Completed||N/A|60||University of British Columbia|||||f||||||||||||||2017-02-18 16:58:10.669481|2017-02-18 16:58:10.669481
NCT00254046|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2014-06-19|||November 2005||2005-11-01|June 2014|2014-06-01|July 2008|Actual|2008-07-01|February 2007|Actual|2007-02-01||Interventional|||TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.|A Phase III Randomized, Double-blinded, Placebo-controlled Trial to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an ART Regimen, Including TMC114/RTV and an Investigator-selected OBR, in HIV-1 Infected Patients With Limited Treatment to no Treatment Options.|Completed||Phase 3|616|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-02-18 16:58:10.759786|2017-02-18 16:58:10.759786
NCT00254033|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2008-05-21|||October 2003||2003-10-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Apathy Associated With Alzheimer's Disease|The Role of the Dopaminergic Brain Reward System in Apathy Associated With Alzheimer's Disease|Completed||Phase 4|40||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 16:58:10.914943|2017-02-18 16:58:10.914943
NCT00254020|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2014-11-17|||June 2005||2005-06-01|November 2014|2014-11-01|December 2013|Actual|2013-12-01|January 2011|Actual|2011-01-01||Interventional|||The Role of Cytokine-Serotonin Interactions in Post-Stroke Depression|The Role of Cytokine-Serotonin Interactions in Post-Stroke Depression|Completed||Phase 4|138|Actual|Sunnybrook Health Sciences Centre||1|||f||||f||||||||||2017-02-18 16:58:11.018903|2017-02-18 16:58:11.018903
NCT00254007|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2011-02-28|||July 2003||2003-07-01|September 2006|2006-09-01|May 2010|Actual|2010-05-01|December 2005|Actual|2005-12-01||Interventional|||Depression and Traumatic Brain Injury|The Serotonin Transporter Gene Polymorphism and Major Depression Following Traumatic Brain Injury|Completed||Phase 4|200|Anticipated|Sunnybrook Health Sciences Centre||1|||f||||||||||||||2017-02-18 16:58:11.263903|2017-02-18 16:58:11.263903
NCT00253994|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2007-09-04|||August 2003||2003-08-01|September 2007|2007-09-01|December 2004|Actual|2004-12-01|||||Interventional|||Auricular Acupuncture for Acute Pain|Auricular Acupuncture in the Treatment of Acute Pain Syndromes (AATAPS) Pilot|Completed||N/A|100||Samueli Institute for Information Biology|||||f||||||||||||||2017-02-18 16:58:11.355382|2017-02-18 16:58:11.355382
NCT00253981|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2016-05-10|2013-08-28||November 2005||2005-11-01|May 2016|2016-05-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|MilCAM||Light Therapy in the Treatment of Leg Pain|Monochromatic Near-Infrared Light Energy (MIRE) in the Treatment of Tibial Stress Reaction|Terminated||N/A|30|Actual|Samueli Institute for Information Biology||2||Enrollment not achieved succesfully|f||||t||||||||||2017-02-18 16:58:11.443194|2017-02-18 16:58:11.443194
NCT00253968|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2016-02-02||2016-02-02|November 2005||2005-11-01|February 2016|2016-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|GEMS||Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia|Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 3|967|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 16:58:11.770457|2017-02-18 16:58:11.770457
NCT00253474|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2012-03-28|||September 2005||2005-09-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|||||Interventional|||PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma|A Phase I Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas|Completed||Phase 1|36|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:58:14.359988|2017-02-18 16:58:14.359988
NCT00253955|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2008-11-07|||June 2003||2003-06-01|November 2008|2008-11-01|November 2007|Actual|2007-11-01|May 2007|Actual|2007-05-01||Interventional|||Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia|An Open-Label, Multicenter, Multinational, Centrally Randomized, Two-Arm Parallel-Group Study to Demonstrate the Non-Inferiority in Clinical Efficacy of Levofloxacin 750mg od in Comparison With Piperacillin/Tazobactam 4g/500mg Every 8 Hours in the Treatment of Mild to Moderate Hospital-Acquired Pneumonia Adult Patients in Both General Wards and ICU (Intensive Care Unit)|Completed||Phase 3|460|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:58:11.890446|2017-02-18 16:58:11.890446
NCT00253942|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2005-11-14|||November 2005||2005-11-01|October 2005|2005-10-01||||||||Interventional|||Safety and Efficacy Study of Bee Venom to Treat Knee Osteoarthritis|A Randomized, Double-Blind, Histamine-Controlled, Phase 3 Study to Determine the Safety and Efficacy of Bee Venom in the Treatment of Knee Osteoarthritis|Unknown status|Recruiting|Phase 3|40||Rheumatology Therapeutics Medical Center|||||f||||||||||||||2017-02-18 16:58:12.015819|2017-02-18 16:58:12.015819
NCT00253929|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2007-04-04|||November 2005||2005-11-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia|The Influence of the 1976T>C Polymorphism in the Adenosine A2A Receptor Gene on Adenosine-Induced Vasodilation and the Influence of the 34C>T Polymorphism in the AMP Deaminase Gene on Post-Occlusive Reactive Hyperemia.|Completed||N/A|100||Radboud University|||||f||||||||||||||2017-02-18 16:58:12.097776|2017-02-18 16:58:12.097776
NCT00253916|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2015-11-23|||June 2002||2002-06-01|November 2015|2015-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Exercise in Men Receiving Radiation Therapy for Prostate Cancer.|Exercise in Men Receiving Radiation Therapy for Prostate Cancer: Effects on Fatigue, Toxicity, Body Composition, Muscular Fitness, Cardiorespiratory Fitness and Quality of Life.|Completed||Phase 3|121|Actual|Ottawa Hospital Research Institute||3|||f||||||||||||||2017-02-18 16:58:12.20035|2017-02-18 16:58:12.20035
NCT00253903|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2010-11-29|||November 2005||2005-11-01|November 2010|2010-11-01|September 2008|Actual|2008-09-01|November 2007|Actual|2007-11-01||Interventional|EPLILONG||Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year|Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia: a 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study Followed by an Open Treatment Phase Extension With Eplivanserin for a 40-week Period|Completed||Phase 3|1155|Actual|Sanofi||2|||f||||||||||||||2017-02-18 16:58:12.487665|2017-02-18 16:58:12.487665
NCT00253890|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2013-10-22|2012-08-01||October 2005||2005-10-01|October 2013|2013-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Insomnia and Drug Relapse Risk|Insomnia and Drug Relapse Risk|Completed||Phase 3|137|Actual|Butler Hospital||2|||f||||t||||||||||2017-02-18 16:58:12.614406|2017-02-18 16:58:12.614406
NCT00253877|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2010-08-19|||July 2003||2003-07-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Comparison of a Resurfacing Hip System to Standard Total Hip Arthroplasty|A Prospective, Multi-Centre, Historical Control Trial Comparing the Conserve® Plus Resurfacing Hip System to Standard Total Hip Arthroplasty.|Completed||Phase 4|200|Actual|Ottawa Hospital Research Institute||1|||f||||f||||||||||2017-02-18 16:58:13.235949|2017-02-18 16:58:13.235949
NCT00253565|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2013-04-04|||August 2003||2003-08-01|April 2013|2013-04-01|July 2010|Actual|2010-07-01|July 2006|Actual|2006-07-01||Interventional|||Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors|A Phase I Dose Escalation Study of Imatinib Mesylate (Gleevec/STI571) Plus Capecitabine (Xeloda) in Advanced Solid Tumor Malignancies|Completed||Phase 1|25|Actual|Duke University|||||f||||||||||||||2017-02-18 16:58:13.345265|2017-02-18 16:58:13.345265
NCT00253552|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2012-05-24|||May 2004||2004-05-01|June 2010|2010-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders|A Pilot Study of Using Filgrastim-Primed Bone Marrow in Human Leukocyte Antigen (HLA) Matched Related Donor Allogenetic Bone Marrow Transplantation for Patients With Hematologic Malignancies and Non-Malignancies|Terminated||N/A|4|Actual|OHSU Knight Cancer Institute||||Terminated at request of PI as study was outdated.|f||||||||||||||2017-02-18 16:58:13.441848|2017-02-18 16:58:13.441848
NCT00253539|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2011-04-11|||January 2002||2002-01-01|April 2011|2011-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer|A Phase II Study of a Selective Estrogen Receptor Modulator (LY353381) vs. Tamoxifen vs. Placebo in Premenopausal Women With and Increased Risk for Breast Cancer|Completed||Phase 2|3|Actual|The Cleveland Clinic||3|||f||||t||||||||||2017-02-18 16:58:13.5666|2017-02-18 16:58:13.5666
NCT00253526|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2015-04-27||||||December 2006|2006-12-01||||||||Interventional|||Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer|Phase II Randomized Study of Surgical Resection and Adjuvant Gemcitabine Hydrochloride With Versus Without Bevacizumab in Patients With Adenocarcinoma of the Pancreas|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:58:13.678039|2017-02-18 16:58:13.678039
NCT00253513|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2012-05-24|2010-11-16||June 2005||2005-06-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome|A Study of a Reduced-Intensity Conditioning Regimen With Treosulfan and Fludarabine for Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Leukemia|Completed||Phase 1/Phase 2|60|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 16:58:13.768028|2017-02-18 16:58:13.768028
NCT00253500|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2013-01-02|||June 2002||2002-06-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|September 2005|Actual|2005-09-01||Interventional|||Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer|Prediction of Response or Resistance to Dose Intensified Pre-Operative Epirubicin Therapy of Operable Breast Cancer|Completed||Phase 2|15|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:58:14.155209|2017-02-18 16:58:14.155209
NCT00253487|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2014-01-03|||August 2005||2005-08-01|January 2006|2006-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas|A Pilot Study of Temozolomide and O-Benzylguanine for Treatment of High-Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:58:14.273074|2017-02-18 16:58:14.273074
NCT00253461|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2012-03-16|||December 2004||2004-12-01|March 2012|2012-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||11C Topotecan PET Imaging|Positron Emission Tomography Using 11C Topotecan in Predicting Response to Treatment in Patients With Brain Metastases Due to Ovarian, Small Cell Lung, or Other Cancer|Terminated||Early Phase 1|7|Actual|Case Comprehensive Cancer Center||||Drugs unavailable:unable to make radioactive topotecan|f||||t||||||||||2017-02-18 16:58:14.4565|2017-02-18 16:58:14.4565
NCT00253448|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2011-08-25|2011-06-29||December 2002||2002-12-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|||Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme|Phase II Trial of Conventional Radiotherapy With Stereotactic Radiosurgery to High Risk Tumor Regions as Determined by Functional Imaging in Patients With Glioblastoma Multiforme|Completed||Phase 2|35|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:58:14.563544|2017-02-18 16:58:14.563544
NCT00253435|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2016-08-23|2014-08-25||September 2005||2005-09-01|August 2016|2016-08-01|December 2013|Actual|2013-12-01|December 2012|Actual|2012-12-01||Interventional||Number of patients who signed the consent form and started treatment.|N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma|I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma|Completed||Phase 2|50|Actual|Children's Hospital Los Angeles||1|||f||||t||||||||||2017-02-18 16:58:14.809025|2017-02-18 16:58:14.809025
NCT00253422|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2011-05-14|||March 2004||2004-03-01|May 2011|2011-05-01||||May 2016|Anticipated|2016-05-01||Interventional|||Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer|A Partially-Blind Phase III Randomized Trial of Fulvestrant (Faslodex™) With or Without Concomitant Anastrozole (Arimidex™) Compared With Exemestane in Postmenopausal Women With ER+ve Locally Advanced/Metastatic Breast Cancer Following Progression on Non-Steroidal Aromatase Inhibitors|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:58:15.826343|2017-02-18 16:58:15.826343
NCT00253409|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2009-07-11|||May 2005||2005-05-01|July 2009|2009-07-01||||June 2011|Anticipated|2011-06-01||Interventional|||Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery|Mesothelioma and Radical Surgery Trial|Unknown status|Active, not recruiting|N/A|670|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:58:15.92352|2017-02-18 16:58:15.92352
NCT00253396|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2009-03-09|||October 2005||2005-10-01|May 2007|2007-05-01|January 2007||2007-01-01|||||Interventional|||Patients Preference With Self-Injection: The PRISM Study|THE PRISM Study-Low-Molecular-Weight Heparin Versus Unfractionated Heparin for Perioperative Bridging Anticoagulation: the Patient Preference for Self-Injection Study and Related Measurements|Completed||Phase 4|100|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 16:58:16.026442|2017-02-18 16:58:16.026442
NCT00253383|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2014-12-18|||January 2003||2003-01-01|December 2014|2014-12-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients|Improving Palliative Care for Patients With Cancer|Completed||N/A|329|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 16:58:16.120559|2017-02-18 16:58:16.120559
NCT00253370|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2014-11-19|2014-05-21||October 2005||2005-10-01|December 2013|2013-12-01|September 2010|Actual|2010-09-01|May 2008|Actual|2008-05-01||Interventional||All 44 patients started treatment and were considered eligible and hence were included in the analysis.|Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer|A Phase II Study to Evaluate Overall Response Rate of BAY 43-9006 (Sorafenib) Combined With Docetaxel and Cisplatin or Oxaliplatin in the Treatment of Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 16:58:16.240332|2017-02-18 16:58:16.240332
NCT00253357|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-13|2007-12-17|||March 2004||2004-03-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Observational|||PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy|Predictors of Response to Cardiac Re-Synchronization Therapy|Completed||N/A|450||Medtronic Cardiac Rhythm and Heart Failure|||||f||||||||||||||2017-02-18 16:58:16.70118|2017-02-18 16:58:16.70118
NCT00253344|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2010-06-10|||June 2005||2005-06-01|June 2010|2010-06-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors|Phase I Trial of Daily Lenalidomide (CC-5013, Revlimid™) and Docetaxel Given Every Three Weeks in Patients With Advanced Solid Tumors|Completed||Phase 1|33|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 16:58:16.797571|2017-02-18 16:58:16.797571
NCT00253331|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-13|2007-05-29|||November 2004||2004-11-01|May 2007|2007-05-01|September 2005||2005-09-01|||||Interventional|||Lab Study of MQX-503 in Treatment of Raynaud's|Phase III Laboratory Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, in the Treatment of Raynaud’s Phenomenon|Completed||Phase 2/Phase 3|36||MediQuest Therapeutics|||||||||||||||||||2017-02-18 16:58:16.893882|2017-02-18 16:58:16.893882
NCT00253318|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2013-04-04|||November 2005||2005-11-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer|Phase I, Open Label, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of the Combination RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer|Terminated||Phase 1|15|Actual|M.D. Anderson Cancer Center||1||Toxicity and Lack of Efficacy|f||||f||||||||||2017-02-18 16:58:16.999624|2017-02-18 16:58:16.999624
NCT00253305|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-13|2007-05-29|||September 2005||2005-09-01|May 2007|2007-05-01||||||||Interventional|||Topical Gel Anti-Fungal Agent for Tinea Unguium|Phase IIB Efficacy and Safety Study of Four Topical Gel Formulations of Anti-Fungal Agents, MQX-5858, MQX-5859, MQX-5866, and MQX-5867, Versus Vehicle in the Treatment of Tinea Unguium.|Completed||Phase 2|75||MediQuest Therapeutics|||||||||||||||||||2017-02-18 16:58:17.116654|2017-02-18 16:58:17.116654
NCT00253292|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2011-07-27|||January 1997||1997-01-01|July 2011|2011-07-01|December 2007|Actual|2007-12-01|||||Observational|||Psychometric Study of Outcomes Instruments|Psychometric Study of Outcomes Instruments|Terminated||N/A|40|Actual|Massachusetts General Hospital|||1|Unable to recruit necessary sample size|f||||f||||||||||2017-02-18 16:58:17.383839|2017-02-18 16:58:17.383839
NCT00251043|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2012-03-23|||September 2005||2005-09-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Site|Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Sites|Completed||Phase 4|142|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 16:58:54.135542|2017-02-18 16:58:54.135542
NCT00253279|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2009-08-12|||November 2009||2009-11-01|August 2009|2009-08-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans|A Quantitative Study of the Metabolic Alterations in Protein Synthesis Rate That Occur in Burn Patients Over the Time Course of Their Injury Using Positron Emission Tomography.|Unknown status|Not yet recruiting|Phase 1|64|Anticipated|National Institute of General Medical Sciences (NIGMS)|||2||f||||t||||||||||2017-02-18 16:58:17.468754|2017-02-18 16:58:17.468754
NCT00253266|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2015-04-07|||April 2008||2008-04-01|April 2015|2015-04-01|August 2014|Actual|2014-08-01|April 2014|Actual|2014-04-01||Interventional|||Venlafaxine Augmentation in Treatment Resistant Depression|Comparison of Venlafaxine Augmentation With Quetiapine v.s. Placebo in Treatment Resistant Depression|Completed||Phase 4|126|Actual|Max-Planck-Institute of Psychiatry||2|||f||||t||||||||||2017-02-18 16:58:17.581263|2017-02-18 16:58:17.581263
NCT00253253|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2008-05-21|||August 2006||2006-08-01|May 2008|2008-05-01|January 2007||2007-01-01|||||Observational|||Long-Term Outcome in Congenital Undescended Testis After Surgical Treatment by Orchidopexy|Long-Term Outcome in Congenital Undescended Testis After Surgical Treatment by Orchidopexy|Completed||N/A|181|Actual|Medical Center Alkmaar|||||f||||||||||||||2017-02-18 16:58:17.699169|2017-02-18 16:58:17.699169
NCT00253240|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2007-07-20|||September 2004||2004-09-01|July 2007|2007-07-01|September 2005|Actual|2005-09-01|||||Observational|||Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population|Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population - An Evaluation Project|Completed||Phase 3|75|Actual|Lawson Health Research Institute|||||f||||f||||||||||2017-02-18 16:58:17.777723|2017-02-18 16:58:17.777723
NCT00253227|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2011-05-17|||July 1997||1997-07-01|November 2010|2010-11-01|December 1998|Actual|1998-12-01|||||Interventional|||A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|Galantamine in the Treatment of Alzheimer's Disease: Flexible Dose Range Trial|Completed||Phase 3|387|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:58:17.866339|2017-02-18 16:58:17.866339
NCT00253214|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2011-05-19|||March 2001||2001-03-01|November 2010|2010-11-01|July 2002|Actual|2002-07-01|||||Interventional|||Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation|Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation|Completed||Phase 3|973|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:58:17.959832|2017-02-18 16:58:17.959832
NCT00253201|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2011-05-17||||||November 2010|2010-11-01|October 1997|Actual|1997-10-01|||||Interventional|||A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|Efficacy, Tolerability and Safety of Galantamine in the Treatment of Alzheimer's Disease|Completed||Phase 3|636|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:58:18.053758|2017-02-18 16:58:18.053758
NCT00253188|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2011-05-17|||February 1997||1997-02-01|November 2010|2010-11-01|December 1998|Actual|1998-12-01|||||Interventional|||A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|Efficacy, Tolerability and Safety of Galantamine in the Treatment of Alzheimer's Disease|Completed||Phase 3|653|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:58:18.148752|2017-02-18 16:58:18.148752
NCT00253175|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2010-04-26|||October 2000||2000-10-01|April 2010|2010-04-01|December 2001|Actual|2001-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine|A Comparison Of The Efficacy And Safety Of Topamax® (Topiramate) Tablets Versus Placebo For The Prophylaxis Of Migraine|Completed||Phase 3|211|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 16:58:18.245633|2017-02-18 16:58:18.245633
NCT00253162|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2011-01-27|||March 2001||2001-03-01|January 2011|2011-01-01|September 2002|Actual|2002-09-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol|The Efficacy And Safety Of Flexible Dose Ranges Of Risperidone Versus Placebo Or Haloperidol In The Treatment Of Manic Episodes Associated With Bipolar I Disorder.|Completed||Phase 3|439|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 16:58:18.34961|2017-02-18 16:58:18.34961
NCT00253149|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2011-01-20||||||January 2011|2011-01-01|April 1999|Actual|1999-04-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder|The Safety And Efficacy Of Risperdal� (Risperidone) Versus Placebo Versus Haloperidol As Add-On Therapy To Mood Stabilizers In The Treatment Of The Manic Phase Of Bipolar Disorder|Completed||Phase 3|158|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:58:18.442705|2017-02-18 16:58:18.442705
NCT00253136|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2010-12-02|||November 1999||1999-11-01|December 2010|2010-12-01|December 2000|Actual|2000-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia|Risperidone Depot (Microspheres) vs. Placebo in the Treatment of Subjects With Schizophrenia|Completed||Phase 3|458|Actual|Janssen, LP|||||||||||||||||||2017-02-18 16:58:18.527974|2017-02-18 16:58:18.527974
NCT00253123|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2010-12-02||||||December 2010|2010-12-01|March 1997|Actual|1997-03-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia|A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia|Completed||Phase 3|626|Actual|Janssen, LP|||||||||||||||||||2017-02-18 16:58:18.619091|2017-02-18 16:58:18.619091
NCT00253110|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2012-08-03|||May 1996||1996-05-01|August 2012|2012-08-01|September 1998|Actual|1998-09-01|||||Interventional|||A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder|A Comparison of Risperidone and Haloperidol for Prevention of Relapse in Subjects With Schizophrenia and Schizoaffective Disorders|Completed||Phase 4|396|Actual|Janssen, LP||2|||||||||||||||||2017-02-18 16:58:18.711878|2017-02-18 16:58:18.711878
NCT00251030|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2009-02-13|||November 2005||2005-11-01|February 2009|2009-02-01|January 2006|Actual|2006-01-01|||||Interventional|||A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects|A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects|Completed||Phase 4|20|Actual|Pfizer|||||f||||||||||||||2017-02-18 16:58:54.24496|2017-02-18 16:58:54.24496
NCT00253097|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2009-08-10|||December 2005||2005-12-01|July 2009|2009-07-01|October 2009|Anticipated|2009-10-01|October 2009|Anticipated|2009-10-01||Interventional|PREVENT||The Post Stroke Preventive Trial (PREVENT). A RCT Nested in a Cohort Study|The Post Stroke Preventive Trial (PREVENT) A Randomised Controlled Trial Nested in a Cohort (RIALTO) Study|Unknown status|Active, not recruiting|N/A|353|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 16:58:18.814137|2017-02-18 16:58:18.814137
NCT00253084|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2017-01-31|||November 2005||2005-11-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease|A Randomized, Double-Blind, Cross-Over Study to Compare IPX054 to Carbidopa-Levodopa Immediate-Release Tablets in Subjects With Parkinson's Disease|Completed||Phase 2|12|Actual|IMPAX Laboratories, Inc.||2|||f||||f||||||||No||2017-02-18 16:58:18.919223|2017-02-18 16:58:18.919223
NCT00253071|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2015-03-18|||December 2005||2005-12-01|March 2015|2015-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Early Integrated Intervention in Severe Affective Disorders|Early Integrated Intervention in Severe Affective Disorders - a Randomized Controlled Trial.|Completed||N/A|426|Actual|Hovedstadens Sygehusfaelesskab||2|||f||||f||||||||||2017-02-18 16:58:19.033035|2017-02-18 16:58:19.033035
NCT00253058|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2013-05-03|||July 2005||2005-07-01|May 2013|2013-05-01||||||||Interventional|||Study Of Perennial Allergic Rhinitis In Pediatrics|Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup in Children -Suffering From Perennial Allergic Rhinitis-|Completed||Phase 3|286||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 16:58:19.14201|2017-02-18 16:58:19.14201
NCT00253045|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2013-09-13|||August 2004||2004-08-01|September 2013|2013-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|KHARMA||Motivating HIV+ Women: Risk Reduction and ART Adherence|Motivating HIV+ Women: Risk Reduction and ART Adherence|Completed||N/A|207|Actual|Emory University||1|||f||||t||||||||||2017-02-18 16:58:19.242609|2017-02-18 16:58:19.242609
NCT00253032|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2006-03-02||||||March 2006|2006-03-01||||||||Interventional|||Pain Relief Investigation of NeuroModulation Therapy in Adult Humans|PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial.|Terminated||Phase 3|||Fralex Therapeutics|||||||||||||||||||2017-02-18 16:58:19.358016|2017-02-18 16:58:19.358016
NCT00253019|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2013-08-10|2013-04-09||October 2004||2004-10-01|August 2013|2013-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods|A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods (Oral Contraceptive Pills, Depo Provera and Ortho Evra) Among Women Seeking First Trimester Abortion.|Completed||N/A|321|Actual|Emory University|||1||f||||f||||||||||2017-02-18 16:58:19.423229|2017-02-18 16:58:19.423229
NCT00253006|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2006-10-06|||January 2006||2006-01-01|October 2006|2006-10-01|January 2008||2008-01-01|||||Observational|||Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium|A Quantitative Analysis of Protein- and mRNA-Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium|Terminated||N/A|60||Copenhagen University Hospital at Herlev|||||f||||||||||||||2017-02-18 16:58:19.858677|2017-02-18 16:58:19.858677
NCT00252993|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2007-10-10|||November 2005||2005-11-01|October 2007|2007-10-01|March 2006||2006-03-01|||||Interventional|||12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DDP225 in Patients With Chronic Functional Vomiting|Terminated||Phase 2|30||Dynogen Pharmaceuticals|||||||||||||||||||2017-02-18 16:58:19.945057|2017-02-18 16:58:19.945057
NCT00252980|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2007-01-15|||January 2006||2006-01-01|January 2007|2007-01-01|March 2007||2007-03-01|||||Interventional|||CANDIS - Targeted Treatment for Cannabis Disorders|CANDIS -Targeted Treatment for Cannabis Disorders|Unknown status|Active, not recruiting|Phase 2|210||Technische Universität Dresden|||||f||||||||||||||2017-02-18 16:58:20.025314|2017-02-18 16:58:20.025314
NCT00252967|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2014-08-21|2014-04-21||October 2005||2005-10-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|November 2008|Actual|2008-11-01||Interventional|||Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)|Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)|Terminated||Phase 3|64|Actual|Emory University|Limited enrollment; recurrence rate of AF was slightly higher than other trials indicated that the study sample may be a high-risk population.|2||Insufficient power to show therapy difference at interim analysis.|f||||t||||||||||2017-02-18 16:58:20.116226|2017-02-18 16:58:20.116226
NCT00252954|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2009-08-19|||November 2005||2005-11-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury|Effects of Levetiracetam on Chronic Neuropathic Pain Following Spinal Cord Injury: a Randomized, Double-blind, Placebo-controlled, Cross-over, Multi-center Study|Completed||Phase 4|36|Actual|Danish Pain Research Center||1|||f||||t||||||||||2017-02-18 16:58:20.569086|2017-02-18 16:58:20.569086
NCT00252941|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2010-12-20|||November 2005||2005-11-01|December 2010|2010-12-01|November 2006|Actual|2006-11-01|April 2006|Actual|2006-04-01||Interventional|||Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma|The Role Of Prophylactic Urethral Stenting With Memokath® 028SW in Patients Undergoing Prostate 125I Seed Implants For Prostate Carcinoma: A Phase I/II Study|Completed||Phase 1/Phase 2|20||The Cleveland Clinic|||||||||||||||||||2017-02-18 16:58:20.680755|2017-02-18 16:58:20.680755
NCT00252928|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2007-10-29|||July 2006||2006-07-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Health Impact Study of Aquatabs in Tamale, Ghana|Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana|Completed||N/A|240|Actual|Centers for Disease Control and Prevention||2|||f||||||||||||||2017-02-18 16:58:20.882025|2017-02-18 16:58:20.882025
NCT00252915|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2011-05-24|||November 2005||2005-11-01|July 2009|2009-07-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock|Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock: a Prospective, Randomised, Double-blind, Placebo-controlled Study|Completed||Phase 2|38|Actual|Charite University, Berlin, Germany||1|||f||||f||||||||||2017-02-18 16:58:21.002522|2017-02-18 16:58:21.002522
NCT00252902|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2017-01-10|||December 2005||2005-12-01|October 2013|2013-10-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Emergency Department Initiated Tobacco Treatment (EDITT)|Emergency Department Initiated Tobacco Treatment (EDITT)|Completed||Phase 1/Phase 2|75|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:58:21.105267|2017-02-18 16:58:21.105267
NCT00252889|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2009-01-26|||May 2004||2004-05-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|March 2006|Actual|2006-03-01||Interventional|||Doxil Topotecan Doublet Cancer Study|GSK - Doublet: A Phase I Study of Pegylated Liposomal Doxorubicin (Doxil) and Weekly Intravenous Topotecan in Patients With Advanced Solid Tumors|Completed||Phase 1|20|Actual|Christiana Care Health Services||1|||f||||t||||||||||2017-02-18 16:58:21.198441|2017-02-18 16:58:21.198441
NCT00252876|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2008-03-14|||March 2005||2005-03-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|||||Interventional|||GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes|An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.|Terminated||Phase 3|2000||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:58:21.320159|2017-02-18 16:58:21.320159
NCT00252863|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2009-03-16|||December 2004||2004-12-01|March 2009|2009-03-01|May 2006|Actual|2006-05-01|||||Interventional|||DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults|A Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbuhaler 160/4.5 µg, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults - a 26-Week, Randomised, Open-Label, Parallel-Group, Multicentre Study|Completed||Phase 3|1600||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:24.287708|2017-02-18 16:58:24.287708
NCT00252850|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2016-09-02|||June 2005||2005-06-01|September 2016|2016-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease|A Phase I, Open-Label Study of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin[NTN] to Assess the Safety and Tolerability of Intrastriatal Delivery to Subjects With Idiopathic Parkinson's Disease|Completed||Phase 1|12||Sangamo Therapeutics|||||f||||t||||||||||2017-02-18 16:58:27.162699|2017-02-18 16:58:27.162699
NCT00252837|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2008-03-14|||April 2005||2005-04-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|||||Interventional|||GALLANT 22 Tesaglitazar vs. Placebo|A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Administered as Monotherapy to Drug-Naïve Patients With Type 2 Diabetes|Terminated||Phase 3|475||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:58:27.252546|2017-02-18 16:58:27.252546
NCT00252824|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2011-01-21|||July 2005||2005-07-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|||||Interventional|||STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma|A Comparison of the Efficacy of Symbicort® Single Inhaler Therapy (Symbicort Turbuhaler® 160/4.5 mg 1 Inhalation b.i.d. Plus As-needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults - a 26 Weeks, Randomised, Open-label, Parallel-group, Multicentre Study|Completed||Phase 3|1000|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:58:27.688424|2017-02-18 16:58:27.688424
NCT00252811|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2011-01-27|||February 2004||2004-02-01|January 2011|2011-01-01||||||||Interventional|||A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer|A Phase II, Randomised, Double-Blind, Placebocontrolled Study To Investigate The Effects Of ZD1839 (IRESSA™) On Cell Proliferation In Oestrogen And Progesterone Receptor Negative Breast Cancer Prior To Surgery|Withdrawn||Phase 2|60||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:27.847578|2017-02-18 16:58:27.847578
NCT00252798|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2007-12-16|||July 2002||2002-07-01|December 2007|2007-12-01|October 2005|Actual|2005-10-01|||||Interventional|||ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer|A Phase I Trial to Evaluate ZD1839(Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer|Completed||Phase 1|44||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:27.945615|2017-02-18 16:58:27.945615
NCT00252785|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-11|2011-01-21|||October 2005||2005-10-01|January 2011|2011-01-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients|An 8-week, Randomised, Double Blind, Parallel-group, Multi-centre, Phase III Study Comparing the Efficacy and Safety of Symbicort® Turbuhaler® 160/4.5 µg Twice Daily and Pulmicort® Turbuhaler® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Patients With Asthma|Completed||Phase 3|340||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:28.040113|2017-02-18 16:58:28.040113
NCT00252772|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-04-21|||September 2004||2004-09-01|April 2009|2009-04-01|November 2006|Actual|2006-11-01|||||Interventional|||GALLANT 2 Tesaglitazar vs. Placebo|A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Administered as Monotherapy to Drug-Naïve Patients With Type 2 Diabetes|Terminated||Phase 3|80||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:58:28.179602|2017-02-18 16:58:28.179602
NCT00252759|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2011-01-27|||November 2003||2003-11-01|January 2011|2011-01-01|February 2006|Actual|2006-02-01|||||Observational|||Iressa Case Control Study in Japan|A Nested Case-control Study to Determine the Relative Risk of and Risk Factors for Interstitial Lung Disease in a Cohort of NSCLC Patients Treated With and Without Gefitinib|Completed||Phase 4|6000|Anticipated|AstraZeneca|||1||f||||||||||||||2017-02-18 16:58:28.282722|2017-02-18 16:58:28.282722
NCT00252746|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2016-08-24|||December 2004||2004-12-01|August 2016|2016-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ZD6474 Phase IIa Dose Finding Multicentre Study|A Randomised, Double-blind, Parallel-group, Dose Finding Study to Assess the Efficacy and Safety of ZD6474 in Patients With Advanced, Metastatic, or Recurrent NSCLC Who Have Failed Previous Chemotherapy Regimens, at Least One of Which Contained Platinum [Title Abbreviated]|Completed||Phase 2|53|Actual|Sanofi||3|||f||||||||||||||2017-02-18 16:58:28.658987|2017-02-18 16:58:28.658987
NCT00252733|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2014-05-09|2009-03-31||June 2001||2001-06-01|April 2014|2014-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|DIRECT||Diabetic Retinopathy Candesartan Trials|Effects of Candesartan Cilexetil (Candesartan) on Diabetic Retinopathy in Type 1 Diabetic Patients Without Retinopathy.|Completed||Phase 3|5238|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:58:28.790246|2017-02-18 16:58:28.790246
NCT00252720|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2014-05-09|2012-03-19||August 2001||2001-08-01|April 2014|2014-04-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|DIRECT||DIabetic Retinopathy Candesartan Trials.|DIRECT: DIabetic Retinopathy Candesartan Trials. Effects of Candesartan Cilexetil (Candesartan) on Diabetic Retinopathy in Type 1 Diabetic Patients With Retinopathy.|Completed||Phase 3|1850|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:58:29.540711|2017-02-18 16:58:29.540711
NCT00252707|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-14|2007-12-14|||September 2003||2003-09-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Iressa 2nd Line Phase III Study in Japan|A Multicentre, Randomised, Open-Label, Parallel-Group, Phase III Post-Marketing Clinical Study to Compare the Overall Survival Between Gefitinib and Docetaxel in Patients With Advanced or Metastatic (Stage IIIB/IV), or Recurrent Non-Small Cell Lung Cancer, Who Have Failed One or Two Chemotherapy Regimens|Completed||Phase 3|484|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 16:58:30.864356|2017-02-18 16:58:30.864356
NCT00252694|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2014-05-09|2012-03-22||August 2001||2001-08-01|April 2014|2014-04-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|DIRECT||DIabetic Retinopathy Candesartan Trials|Effects of Candesartan Cilexetil (Candesartan) on Diabetic Retinopathy in Type 2 Diabetic Patients With Retinopathy.|Completed||Phase 3|4717|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:58:31.013429|2017-02-18 16:58:31.013429
NCT00252681|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2006-07-20|||July 1999||1999-07-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Comparison of Two Surgical Treatments for Necrotizing Enterocolitis in Human Infants|Surgery for Necrotizing Enterocolitis in Human Infants: A Randomized Trial|Completed||N/A|130||Yale University|||||f||||||||||||||2017-02-18 16:58:32.370048|2017-02-18 16:58:32.370048
NCT00252668|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2011-05-17|||June 2004||2004-06-01|May 2011|2011-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects|An Open-Label, Multicentre, Extension Study of the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects|Completed||Phase 4|300||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:58:32.464811|2017-02-18 16:58:32.464811
NCT00252655|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2007-04-18|||January 2004||2004-01-01|April 2007|2007-04-01|June 2009||2009-06-01|||||Interventional|||Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients|Use of Sirolimus Vs. Tacrolimus As The Primary Agent In Immunosuppressive Regimen For African-American Renal Allograft Recipients With Immediate Graft Function: A Pilot Study|Unknown status|Active, not recruiting|Phase 4|40||Wayne State University|||||f||||||||||||||2017-02-18 16:58:32.548701|2017-02-18 16:58:32.548701
NCT00252642|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2007-12-14|||November 2005||2005-11-01|August 2006|2006-08-01|September 2007|Actual|2007-09-01|||||Interventional|||Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C|The Impact of Peginterferon Alpha-2a Maintenance Therapy on Portal Hypertension in Patients With Chronic Hepatitis C Virus Infection and Advanced Fibrosis and Cirrhosis Enrolled in the HALT-C Trial|Completed||N/A|60|Actual|Virginia Commonwealth University||2|||f||||t||||||||||2017-02-18 16:58:32.700918|2017-02-18 16:58:32.700918
NCT00252629|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2014-12-10|2014-11-14||November 2005||2005-11-01|December 2014|2014-12-01|November 2010|Actual|2010-11-01|October 2008|Actual|2008-10-01||Interventional|||Sleep Disordered Breathing in Gulf War Illness and the Effect of Nasal CPAP Treatment|Inspiratory Flow Dynamics During Sleep in Gulf War Syndrome (GWS) and the Effect of Continuous Positive Airway Pressure (CPAP)|Completed||N/A|29|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:58:32.999715|2017-02-18 16:58:32.999715
NCT00252616|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2013-12-16|||September 2003||2003-09-01|December 2013|2013-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Timing of Target Enteral Feeding in the Mechanically Ventilated Patient|Phase III Study of Early vs. Delayed Goal Enteral Nutrition in Mechanically Ventilated Patients|Completed||Phase 2/Phase 3|200|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-02-18 16:58:33.427932|2017-02-18 16:58:33.427932
NCT00252603|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2007-01-25|||April 2004||2004-04-01|January 2007|2007-01-01|April 2007||2007-04-01|||||Interventional|||Galantamine Versus Placebo in Childhood Autism|Galantamine Versus Placebo in Childhood Autism|Completed||Phase 3|20||Rutgers, The State University of New Jersey|||||||||||||||||||2017-02-18 16:58:33.52578|2017-02-18 16:58:33.52578
NCT00252590|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2016-02-19|2015-06-25||November 2005||2005-11-01|February 2016|2016-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Health Focused Motivational Treatment for Alcohol Dependent Veterans|Health Focused Motivational Treatment for Alcohol Dependent Veterans|Completed||N/A|99|Actual|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 16:58:33.635877|2017-02-18 16:58:33.635877
NCT00252577|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2016-07-26|||October 2005||2005-10-01|July 2016|2016-07-01|May 2016|Actual|2016-05-01|March 2016|Actual|2016-03-01||Observational|||Genetic Predictors of Lithium Response in Bipolar Disorder|Genetic Studies of Psychiatric Illness|Completed||N/A|130|Anticipated|VA Office of Research and Development|||1||f||||t||||||Samples With DNA|"~     DNA from patients with bipolar disorder~   "|Undecided||2017-02-18 16:58:34.113129|2017-02-18 16:58:34.113129
NCT00252564|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2011-02-15|2011-02-15||September 2005||2005-09-01|February 2011|2011-02-01|June 2009|Actual|2009-06-01|June 2007|Actual|2007-06-01||Interventional|||Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer|Randomized PhIII Trial of Cetuximab, Bevacizumab & Biweekly Infusional 5FU/Leucovorin (FOLF-CB) vs. Oxaliplatin, Bevacizumab, & Biweekly Infusional 5FU/Leucovorin (Bev-FOLFOX) in First Line Treatment of Metastatic Colorectal Cancer|Completed||Phase 3|247|Actual|US Oncology Research||2|||f||||f||||||||||2017-02-18 16:58:34.324915|2017-02-18 16:58:34.324915
NCT00252551|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2015-03-15|||March 2005||2005-03-01|March 2015|2015-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|CLEOS||Vertebral Osteosynthesis in Degenerative Lumbar Stenosis With Spondylolisthesis|Vertebral Osteosynthesis in Degenerative Lumbar Stenosis With Spondylolisthesis - CLEOS Study|Terminated||N/A|11|Actual|University Hospital, Toulouse||2||Insufficient recruitment|f||||f||||||||||2017-02-18 16:58:35.262301|2017-02-18 16:58:35.262301
NCT00252538|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2014-12-03|2014-11-17||April 2006||2006-04-01|December 2014|2014-12-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Genetic and Biochemical Markers of Interferon-Induced Depression.|Genetic and Biochemical Markers of Interferon-Induced Depression.|Completed||N/A|133|Actual|VA Office of Research and Development|Limitations include that there are numerous polymorphism in various genes that may influence certain symptoms of depression. The risk for side effects during interferon-alpha treatment likely influenced by many genetic polymorphisms.||1||f||||||||||Samples With DNA|"~     Blood samples are being collected to determine the variability in the development of~     depressive symptoms induced by interferon. Thus, we plan to measure specific genetic~     polymorphisms [i.e., in the serotonin (5-HT) transporter gene-linked polymorphic region~     (5-HTTLPR), in the promoter of the 5-HT1A receptor subtype, and an intronic tryptophan~     hydroxylase polymorphism]. Tryptophan, 5-HT, and cortisol blood levels will also be~     measured.~   "|||2017-02-18 16:58:35.402787|2017-02-18 16:58:35.402787
NCT00005432|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||May 1995||1995-05-01|November 2001|2001-11-01|December 1997|Actual|1997-12-01|||||Observational|||Impact of Surfactant's Availability on Newborns||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.663486|2017-02-18 18:14:59.663486
NCT00252525|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2014-06-26|||June 2007||2007-06-01|June 2014|2014-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Correlation of Plasma Endothelial Cell Activity With Cardiovascular Events in Patients With Diabetes Mellitus Type 2|CSP #465B - Correlation of Plasma Endothelial Cell (Basic Fibroblast Growth Factor) Activity With Cardiovascular Events In Patients With Diabetes Mellitus Type 2|Completed||N/A|400|Actual|VA Office of Research and Development|||1||f||||t||||||None Retained|"~     The cohort consisted of patients that participated in the 465 main study.~   "|||2017-02-18 16:58:35.660603|2017-02-18 16:58:35.660603
NCT00252512|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2015-04-06|2014-08-18||May 2007||2007-05-01|July 2014|2014-07-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|REAP||The Effect of a Contingency Management Intervention on Substance Use|Effectiveness of Contingency Management in VA Addictions Treatment|Completed||N/A|332|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 16:58:35.772865|2017-02-18 16:58:35.772865
NCT00252499|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2014-08-18|2013-11-12||October 2005||2005-10-01|August 2014|2014-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Insulin Resistance in Non-alcoholic Fatty Liver Disease|Insulin Resistance in Non-alcoholic Fatty Liver Disease|Terminated||N/A|13|Actual|VA Office of Research and Development|Due to recruitment difficulties and concerns about the safety of thiazolidinediones, recruitment was stopped without achieving adequate sample size (16/arm). Thus, no definitive conclusions can be made about the study medications.|3||Protocol drug change required new clinicaltrails.gov entry|f||||f||||||||||2017-02-18 16:58:36.31713|2017-02-18 16:58:36.31713
NCT00252486|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2013-06-17|||November 2001||2001-11-01|June 2013|2013-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder|A Comparison of Omega-3 Fatty Acids vs. Placebo in Children and Adolescents With Bipolar Disorder|Completed||N/A|65|Actual|University of Rochester||1|||f||||t||||||||||2017-02-18 16:58:36.901502|2017-02-18 16:58:36.901502
NCT00252473|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2010-08-12|||January 2005||2005-01-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer|Evaluation of Setup Accuracy in Med Tec S-Frame Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer|Completed||Phase 2|30|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:58:37.006737|2017-02-18 16:58:37.006737
NCT00252460|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2016-03-24|||November 2003||2003-11-01|March 2016|2016-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||CT/MRI Co-registration Prostate Cancer|Evaluation of Planning Computed Tomography Scan and Magnetic Resonance Imaging Simulator Scan Co-Registration for Delineation of Gross Tumour Volume in Radiotherapy Treatment of Localized Prostate Cancer|Completed||Phase 1|31|Actual|University Health Network, Toronto|||1||f||||||||||||||2017-02-18 16:58:37.097222|2017-02-18 16:58:37.097222
NCT00252447|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2010-08-10|||May 2000||2000-05-01|August 2010|2010-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Preop Conformal Radiotherapy - Prostate|A Pilot Study of Pre-Operative Conformal Radiotherapy in Patients With Radical Prostatectomy|Completed||Phase 1/Phase 2|15||University Health Network, Toronto|||||f||||||||||||||2017-02-18 16:58:37.414009|2017-02-18 16:58:37.414009
NCT00252434|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2016-01-26|||August 2004||2004-08-01|January 2016|2016-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Behavioral Therapy Development for Methamphetamine Abuse|Behavioral Therapy Development for Methamphetamine Abuse|Terminated||Phase 1|||University of California, Los Angeles||||Slow enrollment|f||||f||||||||||2017-02-18 16:58:37.495567|2017-02-18 16:58:37.495567
NCT00252421|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2014-05-20|||October 2005||2005-10-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||The Nitrate and Bone Study: Effects of Nitrates on Osteoporosis|The Effects of Organic Nitrates on Osteoporosis: Part 2|Completed||Phase 3|243|Actual|University of Toronto||2|||f||||t||||||||||2017-02-18 16:58:37.595552|2017-02-18 16:58:37.595552
NCT00252408|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-09-03|||October 1990||1990-10-01|September 2009|2009-09-01|December 2003||2003-12-01|||||Interventional|||Danish Osteoporosis Prevention Study|Danish Osteoporosis Prevention Study|Completed||Phase 4|2000||University of Aarhus|||||f||||||||||||||2017-02-18 16:58:37.710634|2017-02-18 16:58:37.710634
NCT00252395|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2005-11-09|||August 2005||2005-08-01|November 2005|2005-11-01|August 2006||2006-08-01|||||Interventional|||Evaluation of Electronic Prescribing in Hospital Ambulatory Care Clinics|Effects of Electronic Prescribing on Safety and Quality in Hospital-Based Ambulatory Are: a Randomised Controlled Trial|Completed||Phase 4|40||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 16:58:37.815238|2017-02-18 16:58:37.815238
NCT00252382|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2007-05-09|||November 2005||2005-11-01|January 2007|2007-01-01|April 2007||2007-04-01|||||Interventional|||Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC|Phase 2 Open-Label, Multicenter Clinical Study of the Safety and Efficacy of the Intravenous Administration of SNS-595 as Second-Line Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|50||Sunesis Pharmaceuticals|||||||||||||||||||2017-02-18 16:58:37.899138|2017-02-18 16:58:37.899138
NCT00252369|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-04-23||||||April 2009|2009-04-01||||||||Interventional|||Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.|Instillation of Fibrin Glue After Induction of Local Conditions Using Infliximab, in the Treatment of Perianal Crohn's Disease.|Terminated||N/A|||Sheba Medical Center||||Low accrual rate|f||||f||||||||||2017-02-18 16:58:37.993897|2017-02-18 16:58:37.993897
NCT00252356|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-03-10|||September 2005||2005-09-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|January 2007|Actual|2007-01-01||Interventional|ORION||Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder|An Eight-Week, Double-Blind, Placebo Controlled, Multicenter Study With Escitalopram (10 mg qd) as Positive Control, Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Outpatients With MDD|Completed||Phase 3|468|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:58:38.086987|2017-02-18 16:58:38.086987
NCT00252343|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-03-10|||September 2005||2005-09-01|March 2009|2009-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|LIBRA||Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder|An Eight-Week, Double-Blind, Placebo-Controlled, Multicenter Study With Escitalopram (10mg qd) as Positive Control, Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Outpatients With Generalized Anxiety Disorder|Completed||Phase 3|360|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:58:38.189063|2017-02-18 16:58:38.189063
NCT00249561|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-07-19|||September 2001||2001-09-01|July 2011|2011-07-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||Colorado Women's TC Project|Women's Prison TC: Outcomes, Process & Economic Analysis|Completed||Phase 1/Phase 2|610|Actual|National Development and Research Institutes, Inc.||2|||f||||t||||||||||2017-02-18 16:59:37.807409|2017-02-18 16:59:37.807409
NCT00252330|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-03-10|||September 2005||2005-09-01|March 2009|2009-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|PHOENIX||Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder|An Eight-Week, Double-Blind, Placebo Controlled, Multicenter Study With Escitalopram (10 mg qd) as Positive Control, Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Outpatients With MDD|Completed||Phase 3|476|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:58:38.296015|2017-02-18 16:58:38.296015
NCT00252317|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2008-09-02|||November 2005||2005-11-01|November 2007|2007-11-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis|Acute Haemodynamic Effects of Treatment With ACE-Inhibitors in Patients With Symptomatic Aortic Stenosis (ACCESS)|Unknown status|Recruiting|Phase 4|64|Anticipated|Rigshospitalet, Denmark||2|||f||||t||||||||||2017-02-18 16:58:38.406235|2017-02-18 16:58:38.406235
NCT00252304|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-10-02|||January 2006||2006-01-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Therapeutic Zinc in Childhood Pneumonia|Efficacy of Zinc as Adjuvant Therapy in the Treatment of Severe Pneumonia in Nepalese Children at the Kanti Children's Hospital|Completed||Phase 2/Phase 3|641|Actual|Centre For International Health||2|||f||||f||||||||||2017-02-18 16:58:38.520624|2017-02-18 16:58:38.520624
NCT00252291|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-11-29|||November 2005||2005-11-01|November 2009|2009-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics|A Phase III Multicenter Study to Demonstrate the Sensitivity and Specificity of Aridol (Mannitol) Challenge to Predict Bronchial Hyperresponsiveness as Manifested by a Positive Exercise Challenge in Subjects Presenting With Signs and Symptoms Suggestive of Asthma But Without a Definitive Diagnosis|Completed||Phase 3|240||Pharmaxis|||||||||||||||||||2017-02-18 16:58:38.651617|2017-02-18 16:58:38.651617
NCT00252278|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2006-07-05|||November 2005||2005-11-01|November 2005|2005-11-01||||||||Interventional|||Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents|The Effect of a Once Daily Evening Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents|Unknown status|Recruiting|Phase 4|36||Rhode Island Hospital|||||f||||||||||||||2017-02-18 16:58:38.746059|2017-02-18 16:58:38.746059
NCT00252252|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2008-06-20|||November 2005||2005-11-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation|Crossover Trial of VPAP (Variable Positive Airway Pressure) Ventilation Versus AutoVPAP in Neuromuscular and Chest Wall Disease: Effects on Nocturnal Hypoventilation, Sleep Quality and Tolerance|Completed||Phase 1|20|Actual|ResMed||2|||f||||||||||||||2017-02-18 16:58:38.829575|2017-02-18 16:58:38.829575
NCT00252239|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2015-02-26|2015-01-12||November 2005||2005-11-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)|Phase 2B Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)|Terminated||Phase 2|112|Actual|University of Virginia|Premature termination limits any conclusions from the trial.|2||Slow enrollment|f||||t||||||||||2017-02-18 16:58:38.915678|2017-02-18 16:58:38.915678
NCT00252226|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2008-06-02|||June 2004||2004-06-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders|Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders: An Open Prospective Longitudinal Study of the Effectiveness of Quetiapine Monotherapy in Preventing Relapse and Minimizing Neurocognitive Dysfunction Among Adolescents Manifesting Bipolar Spectrum Disorders|Completed||Phase 3|100|Anticipated|Mood Disorders Center of Ottawa|||||f||||||||||||||2017-02-18 16:58:39.848977|2017-02-18 16:58:39.848977
NCT00252213|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-12-09|||August 2002||2002-08-01|December 2009|2009-12-01|January 2006||2006-01-01|||||Interventional|||BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling|B-Type Natriuretic Peptide (Nesiritide) and Post Myocardial Infarction Left Ventricular Remodeling: Pilot Study Assessing Safety|Terminated||Phase 1|24||Mayo Clinic||||recruitment of subjects was halted prematurely. recruiting subjects halted prematurely|||||||||||||||2017-02-18 16:58:39.947278|2017-02-18 16:58:39.947278
NCT00252200|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2009-09-22|||March 2003||2003-03-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.|Low Dose Continuous Infusion of BNP (Nesiritide) in the Prevention of Renal Insufficiency Post Cardiopulmonary Bypass Cardiac Surgery.|Completed||Phase 1/Phase 2|40|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 16:58:40.040142|2017-02-18 16:58:40.040142
NCT00252187|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2012-12-19|2012-11-20||January 2000||2000-01-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|July 2008|Actual|2008-07-01||Interventional|SubqBNP||Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure|Cardiac Hormone Replacement With BNP in Heart Failure: A Novel Therapeutic Strategy|Completed||Phase 1/Phase 2|45|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 16:58:40.149225|2017-02-18 16:58:40.149225
NCT00252174|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2010-07-22|||February 2007||2007-02-01|July 2010|2010-07-01|March 2011|Anticipated|2011-03-01|December 2010|Anticipated|2010-12-01||Interventional|||MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer|Phase II Dose-response Pilot Study of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Anxiety Associated With Advanced-stage Cancer.|Unknown status|Recruiting|Phase 2|12|Anticipated|Brigham and Women's Hospital||3|||f||||t||||||||||2017-02-18 16:58:41.202896|2017-02-18 16:58:41.202896
NCT00252161|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2016-09-20|||November 2005||2005-11-01|September 2016|2016-09-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer|Randomized Phase III Trial of Surgery Plus Neoadjuvant TS-1 and Cisplatin Compared With Surgery Alone for Type 4 and Large Type 3 Gastric Cancer: Japan Clinical Oncology Group Study (JCOG 0501)|Completed||Phase 3|316|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 16:58:41.326251|2017-02-18 16:58:41.326251
NCT00252148|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2013-02-08|||January 2005||2005-01-01|June 2010|2010-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults|Randomized, Placebo-Controlled, Dose-Escalating, Double-Blinded Phase 1 Safety and Immunogenicity Study of a Modified Vaccinia Ankara (MVA) Vectored HIV-1 (ADMVA) Vaccine Administered Intramuscularly to HIV-Uninfected, Healthy Volunteers|Completed||Phase 1|48|Anticipated|International AIDS Vaccine Initiative||2|||f||||t||||||||||2017-02-18 16:58:41.480622|2017-02-18 16:58:41.480622
NCT00252135|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2011-11-23|||June 2004||2004-06-01|November 2011|2011-11-01||||||||Observational|||A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma|An Epidemiologic Study of Xolair (Omalizumab): Evaluating Clinical Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma (EXCELS)|Completed||Phase 4|8023|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 16:58:41.600445|2017-02-18 16:58:41.600445
NCT00252122|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2009-03-12|||June 2004||2004-06-01|March 2009|2009-03-01|January 2007|Actual|2007-01-01|November 2005|Actual|2005-11-01||Interventional|||Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease|A Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease|Terminated||Phase 4|3|Actual|Children's Hospital of Philadelphia||1||Recruitment was very slow.|f||||f||||||||||2017-02-18 16:58:41.68499|2017-02-18 16:58:41.68499
NCT00252109|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2012-08-15|||July 2004||2004-07-01|August 2012|2012-08-01|January 2009|Actual|2009-01-01|September 2007|Actual|2007-09-01||Observational|||ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader|New Orleans AIDS Task Force Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT) With Popular Opinion Leader (POL)|Completed||N/A|27|Actual|Centers for Disease Control and Prevention|||1||f||||t||||||||||2017-02-18 16:58:41.797349|2017-02-18 16:58:41.797349
NCT00252096|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2012-09-26|||June 2003||2003-06-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|January 2006|Actual|2006-01-01||Interventional|||Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections|Nucleic Acid Amplification Tests for the Diagnosis of Pharyngeal and Rectal Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections|Completed||N/A|3900|Anticipated|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 16:58:41.896026|2017-02-18 16:58:41.896026
NCT00252083|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2012-04-04|||July 2004||2004-07-01|April 2012|2012-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||ADAPT-POL: Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques|Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques With Popular Opinion Leader (ADAPT-POL)|Completed||N/A|41|Actual|Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-02-18 16:58:41.992829|2017-02-18 16:58:41.992829
NCT00252070|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2007-09-06|||November 2005||2005-11-01|September 2007|2007-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Fitness and Exercise for People With Arthritis|Fitness and Functional Exercise for People With Arthritis|Completed||Phase 2/Phase 3|154|Actual|Centers for Disease Control and Prevention||1|||f||||||||||||||2017-02-18 16:58:42.078627|2017-02-18 16:58:42.078627
NCT00252057|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2016-01-14|2009-02-10||December 2005||2005-12-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Testing the Re-Engineered Hospital Discharge|Testing the Re-Engineered Hospital Discharge|Completed||Phase 2|749|Actual|Boston University||2|||f||||f||||||||||2017-02-18 16:58:42.167032|2017-02-18 16:58:42.167032
NCT00252044|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2005-11-17|||October 2000||2000-10-01|November 2005|2005-11-01||||||||Interventional|||Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder|The Dopaminergic System in Schizotypal Personality Disorder: Pergolide for Cognitive Symptoms in Schizotypal Personality Disorder|Unknown status|Recruiting|N/A|||Bronx VA Medical Center|||||f||||||||||||||2017-02-18 16:58:42.511174|2017-02-18 16:58:42.511174
NCT00252031|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2005-11-17||||||November 2005|2005-11-01||||||||Interventional|||DBT in Borderline Personality Disorder|Dialectical Behavioral Therapy for Patients With Borderline Personality Disorder|Unknown status|Recruiting|N/A|||Bronx VA Medical Center|||||f||||||||||||||2017-02-18 16:58:42.590647|2017-02-18 16:58:42.590647
NCT00252018|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2008-05-13|||January 2006||2006-01-01|May 2008|2008-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Effect of Broccoli Sprouts as a Nutritional Supplement in the Prevention of Cardiovascular Disease|The Effect of Broccoli Sprouts as a Nutritional Supplement in the Prevention of Cardiovascular Disease.|Completed||N/A|160|Anticipated|Bispebjerg Hospital|||||f||||||||||||||2017-02-18 16:58:42.734199|2017-02-18 16:58:42.734199
NCT00252005|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2010-02-27||2010-02-27|November 2005||2005-11-01|August 2008|2008-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study|Protocol CV185017: A Phase 2 Randomized, Parallel-Arm Study of Oral Direct Factor Xa-Inhibitor Apixaban and Low Molecular Weight Heparin or Fondaparinux With A Vitamin K Antagonist In Subjects With Acute Symptomatic Deep-Vein Thrombosis|Completed||Phase 2|520||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 16:58:43.017087|2017-02-18 16:58:43.017087
NCT00251992|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2011-01-21|||December 2002||2002-12-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Nexium Dyspepsia/AST|Supportive Test for Acid-Related Symptoms (STARS II) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Uninvestigated Subjects With Upper Gastrointestinal Symptoms.|Completed||Phase 3|1200||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:43.204515|2017-02-18 16:58:43.204515
NCT00251979|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2011-05-18|2008-12-12||October 2005||2005-10-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer|A Randomised, Double-blind, Parallel-group, Placebo Controlled Study of Esomeprazole i.v. (Bolus Infusion of 80 mg Followed by a Continuous Infusion of 8 mg Per Hour) Administered for 72 Hours to Assess Prevention of Rebleeding in Subjects That Have Undergone Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer - the PUB Study.|Completed||Phase 3|1312|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 16:58:43.523003|2017-02-18 16:58:43.523003
NCT00251966|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2009-03-11|||May 2004||2004-05-01|March 2009|2009-03-01|September 2005|Actual|2005-09-01|||||Interventional|||ASTERIX: Low Dose ASA and Nexium|A Randomized Double-Blind Placebo-Controlled Study to Assess the Prevention of Low-Dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 mg Once Daily for 26 Weeks.|Completed||Phase 3|960||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:44.369429|2017-02-18 16:58:44.369429
NCT00251953|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2009-04-21|||July 2004||2004-07-01|April 2009|2009-04-01|March 2006|Actual|2006-03-01|||||Interventional|||GALLANT 8 Tesaglitazar Add-on to Metformin|A 24-Week Randomised, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Added to the Therapy of Patients With Type 2 Diabetes Poorly Controlled on Metformin Alone|Terminated||Phase 3|555||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:58:44.541483|2017-02-18 16:58:44.541483
NCT00251940|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2008-03-14|||July 2004||2004-07-01|March 2008|2008-03-01|March 2006|Actual|2006-03-01|||||Interventional|||GALLANT 7 Tesaglitazar Add-on to Sulphonylurea|A 24-Week Randomised, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Added to the Therapy of Patients With Type 2 Diabetes Poorly Controlled on Sulphonylurea Alone|Terminated||Phase 3|555||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 16:58:44.795146|2017-02-18 16:58:44.795146
NCT00251927|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2012-08-07|2010-07-08||October 2001||2001-10-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|LOTUS||Esomeprazole (NEXIUM) vs. Surgery|An Open, Randomized, Multicenter, Phase IIIB Study During 5 Years to Assess Long-term Efficacy and Tolerability of Esomeprazole Compared to Laparoscopic Anti-reflux Surgery in Adult Subjects With Gastroesophageal Reflux Disease - LOTUS.|Completed||Phase 3|626|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 16:58:47.627028|2017-02-18 16:58:47.627028
NCT00251914|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2011-01-21|||December 2002||2002-12-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Nexium Dyspepsia/AST|Supportive Test for Acid-Related Symptoms (STARS I) With Esomeprazole and a Following 7-week, Double-blind, Randomized, Placebo Controlled Treatment Period in Subjects With Upper Gastrointestinal Symptoms and With Normal Findings at Esophagogastroduodenoscopy.|Completed||Phase 3|1500||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:51.226635|2017-02-18 16:58:51.226635
NCT00251901|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2011-01-21|||May 2004||2004-05-01|January 2011|2011-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Chest Pain Pilot Study|A Randomized Double-Blind Placebo-Controlled Multi-Centre Pilot Study to Assess Symptom Response in Subjects With Pain or Discomfort in the Chest Receiving Oral Treatment With Esomeprazole 40 mg Bid for 4 Weeks.|Completed||Phase 3|600||AstraZeneca|||||f||||||||||||||2017-02-18 16:58:51.769427|2017-02-18 16:58:51.769427
NCT00251888|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-10|2017-01-24|||November 2002||2002-11-01|February 2011|2011-02-01|November 2005|Actual|2005-11-01|||||Interventional|||CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto|Etude de Recherche de Dose de l'Association Irinotecan (Campto(R)) - Cisplatine (Cisplatyl(R)) Avec la radiothérapie Pelvienne Dans Les Cancers avancés du Col de l'utérus.|Completed||Phase 1|15||ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-02-18 16:58:52.021824|2017-02-18 16:58:52.021824
NCT00251875|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2005-11-09|||July 2005||2005-07-01|November 2005|2005-11-01|September 2007||2007-09-01|||||Interventional|||Shared Online Health Records for Patient Safety and Care|Shared Online Health Records for Patient Safety and Care|Unknown status|Recruiting|N/A|5400||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 16:58:52.29861|2017-02-18 16:58:52.29861
NCT00251862|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2013-12-02|2013-07-23||January 2005||2005-01-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Shared Decision-Making for Colorectal Cancer Screening|Shared Decision-Making for Colorectal Cancer Screening|Completed||N/A|825|Actual|Agency for Healthcare Research and Quality (AHRQ)||3|||f||||f||||||||||2017-02-18 16:58:52.407296|2017-02-18 16:58:52.407296
NCT00251849|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2008-08-20|||November 2005||2005-11-01|October 2006|2006-10-01|December 2007||2007-12-01|||||Interventional|||PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients|Prospective Evaluation of Rifalazil Effect On Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia Seropositive Patients|Unknown status|Active, not recruiting|Phase 3|274||ActivBiotics|||||||||||||||||||2017-02-18 16:58:53.202694|2017-02-18 16:58:53.202694
NCT00251836|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2016-12-28|||January 2007||2007-01-01|December 2016|2016-12-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||Adrenal Function After Living Kidney Donation|Prospective Evaluation of Adrenal Function After Living Donor Nephrectomy With or Without Ligation of the Adrenal Vein|Completed||N/A|30|Actual|University of Zurich|||2||f||||f||||||||No||2017-02-18 16:58:53.337424|2017-02-18 16:58:53.337424
NCT00251823|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2008-09-03|||July 2005||2005-07-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|||||Interventional|||Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI)|The Safety and Efficacy of Eptifibatide-Facilitated Percutaneous Coronary Angioplasty Versus Primary Percutaneous Coronary Angioplasty Alone|Completed||Phase 3|400|Anticipated|Ottawa Heart Institute Research Corporation|||||f||||||||||||||2017-02-18 16:58:53.450408|2017-02-18 16:58:53.450408
NCT00251810|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2011-08-15|||November 2004||2004-11-01|August 2011|2011-08-01||||||||Observational|||Can CSM Monitor Depth of Anaesthesia Just as Good as BIS?|Can CSM Monitor Depth of Anaesthesia Just as Good as BIS?|Unknown status|Active, not recruiting|N/A|60|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-02-18 16:58:53.542878|2017-02-18 16:58:53.542878
NCT00251797|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2010-01-06|||March 2000||2000-03-01|October 2008|2008-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors|A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors.|Completed||Phase 1|10|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:58:53.638521|2017-02-18 16:58:53.638521
NCT00251082|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2008-03-11|||December 2005||2005-12-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination|A Randomized, Placebo-Controlled, Double-Blind, Multi-National Study to Demonstrate Efficacy of Continuous Combined 0.5 mg Estradiol and 2.5 mg Dydrogesterone in the Treatment of Vasomotor Symptoms in Postmenopausal Women in Comparison to Placebo Over 3 Months, and to Investigate the Bleeding Pattern Over a Double-Blind Treatment Period of One Year Compared With Continuous Combined 1 mg Estradiol and 5 mg Dydrogesterone|Completed||Phase 3|391|Actual|Solvay Pharmaceuticals||3|||f||||f||||||||||2017-02-18 16:58:53.744891|2017-02-18 16:58:53.744891
NCT00251069|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2005-11-07|||April 2005||2005-04-01|July 2005|2005-07-01|August 2005||2005-08-01|||||Interventional|||Glucosamine Sulphate and Increased Level of Blood Cholesterol|Glucosamine Sulphate and Hypercholesterolaemia|Completed||Phase 4|66||Slidgigtinstituttet|||||f||||||||||||||2017-02-18 16:58:53.862231|2017-02-18 16:58:53.862231
NCT00251056|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-08-27|||October 2005||2005-10-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Mannitol Dose Response Study in Cystic Fibrosis|A Phase IIa Randomised, Open Label, Dose Response Study to Determine the Optimum Dose of Dry Powder Mannitol Required to Generate Clinical Improvement In Patients With Cystic Fibrosis|Completed||Phase 2|48|Actual|Pharmaxis||4|||f||||t||||||||||2017-02-18 16:58:53.945551|2017-02-18 16:58:53.945551
NCT00249548|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2017-01-11|||August 2004||2004-08-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Low-Cost Contingency Management for Hispanic Outpatients - 3|Low-Cost Contingency Management for Hispanic Outpatients|Completed||N/A|30|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 16:59:40.676726|2017-02-18 16:59:40.676726
NCT00251017|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-12-25|||July 2005||2005-07-01|December 2012|2012-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs|Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs|Completed||N/A|34|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 16:58:54.327326|2017-02-18 16:58:54.327326
NCT00251004|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2011-04-07|2010-12-17||October 2005||2005-10-01|April 2011|2011-04-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients|Efficacy and Safety Study Comparing Concentration-controlled Everolimus in Two Doses (1.5 and 3.0 mg/Day Starting Doses) With Reduced Cyclosporine Versus 1.44 g Mycophenolic Acid (as Sodium Salt) With Standard Dose Cyclosporine in de Novo Renal Transplant Recipients|Completed||Phase 3|833|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:58:54.629576|2017-02-18 16:58:54.629576
NCT00250991|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2009-05-07|||July 2003||2003-07-01|May 2009|2009-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial|Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial|Completed||Phase 1/Phase 2|94|Actual|University of Cincinnati|||||f||||t||||||||||2017-02-18 16:58:57.001552|2017-02-18 16:58:57.001552
NCT00250978|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2008-04-29|||November 2005||2005-11-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC|Phase I of Bevacizumab Plus Chemotherapy in Patients With Malignant Pleural Effusion Due to Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|15|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 16:58:57.115379|2017-02-18 16:58:57.115379
NCT00250965|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2010-11-03|||July 2004||2004-07-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||MPAACS: Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery|Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery|Terminated||Phase 3|927|Actual|University of British Columbia||1||Terminated by DSMB; futility analysis showing Mg treatment not efficacious|f||||f||||||||||2017-02-18 16:58:57.212007|2017-02-18 16:58:57.212007
NCT00250952|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2005-11-08|||February 2005||2005-02-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Study to Determine If the Volume Used to Dilute BOTOX Cosmetic™ for Injection Affects Its Overall Effect and Duration.|A Randomized, Evaluator-Blinded, Two Centre Study of the Safety and Effect of Volume on the Diffusion and Efficacy of BOTOX Cosmetic™ (Botulinum Toxin Type A) in the Treatment of Lateral Orbital Rhytides.|Completed||N/A|20||Carruthers Dermatology Centre|||||f||||||||||||||2017-02-18 16:58:57.312318|2017-02-18 16:58:57.312318
NCT00250939|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2014-02-04|||February 2005||2005-02-01|February 2014|2014-02-01|November 2006|Actual|2006-11-01|July 2006|Actual|2006-07-01||Interventional|||A Study of rhGAA in Patients With Late-Onset Pompe Disease|Single-center, Open-label Study of Safety, Pharmacokinetics and Efficacy of rhGAA in Patients With Late-Onset Pompe Disease|Completed||Phase 2|5|Actual|Sanofi||1|||f||||||||||||||2017-02-18 16:58:57.402699|2017-02-18 16:58:57.402699
NCT00250926|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2016-03-10|2012-12-19||October 2005||2005-10-01|March 2016|2016-03-01|February 2009|Actual|2009-02-01|March 2007|Actual|2007-03-01||Interventional|||Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia|A Phase II Study of the Combination Bortezomib (Velcade, PS-341), Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia|Completed||Phase 2|23|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:58:57.513907|2017-02-18 16:58:57.513907
NCT00250913|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2010-11-05|||August 2005||2005-08-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI)|Efficacy and Cost-Effectiveness of Behavioral Counseling For Exercise Behavior in Men and Women Following AMI and PCI|Completed||Phase 1|304|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||||||||||||2017-02-18 16:58:57.817741|2017-02-18 16:58:57.817741
NCT00250900|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2006-11-29|||July 2004||2004-07-01|November 2005|2005-11-01|August 2005||2005-08-01|||||Interventional|||Wait and See Antibiotic Prescription for Acute Otitis Media: A Randomized Controlled Trial|Wait and See Antibiotic Prescription for Acute Otitis Media: A Randomized Controlled Trial|Completed||N/A|240||Yale University|||||f||||||||||||||2017-02-18 16:58:57.928398|2017-02-18 16:58:57.928398
NCT00250887|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2007-10-22|||July 2005||2005-07-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research|A Phase II Open Label Study of the Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research|Completed||Phase 2|22|Actual|University of Zurich||1|||f||||f||||||||||2017-02-18 16:58:58.033205|2017-02-18 16:58:58.033205
NCT00250874|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2005-11-07|||December 2003||2003-12-01|November 2005|2005-11-01||||||||Interventional|||Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer|Phase I-II Study of Liposomal Doxorubicin (Myocet®), Docetaxel and Trastuzumab as First-Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|45||Zeneus Pharma|||||f||||||||||||||2017-02-18 16:58:58.122264|2017-02-18 16:58:58.122264
NCT00250861|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2008-04-17|||October 2005||2005-10-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma|A Randomized Phase II Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for CD20 Positive Aggressive Non-Hodgkin's Lymphoma Following High Dose Therapy With Autologous PBSC Rescue|Terminated||Phase 2|110||US Oncology Research||||Study terminated due to lack of enrollment.|f||||||||||||||2017-02-18 16:58:58.211981|2017-02-18 16:58:58.211981
NCT00250848|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-06-09|||March 2004||2004-03-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2015|Actual|2015-06-01||Observational|||Lung Cancer Case Registry and Tissue Resource|Lung Cancer Case Registry and Tissue Resource|Completed||N/A|750|Actual|University of New Mexico|||1||f||||f||||||Samples With DNA|"~     Blood samples, and sputum (phlegm) samples.~   "|||2017-02-18 16:58:58.317032|2017-02-18 16:58:58.317032
NCT00251407|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-08-07|||September 1999||1999-09-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|January 2003|Actual|2003-01-01||Interventional|||Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies|Phase I Study of Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies|Completed||Phase 1|46|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:59:08.769406|2017-02-18 16:59:08.769406
NCT00250835|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2015-08-03|2015-06-19||April 2005||2005-04-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|December 2012|Actual|2012-12-01||Interventional|||Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer|A Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Patients With Newly Diagnosed Resectable Rectal Cancer|Terminated||Phase 2|38|Actual|New Mexico Cancer Care Alliance||1||Low accrual|f||||t||||||||||2017-02-18 16:58:58.414498|2017-02-18 16:58:58.414498
NCT00251784|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2005-11-09|||February 2002||2002-02-01|December 2003|2003-12-01|June 2003||2003-06-01|||||Interventional|||Healthy Volunteer Study of Sildenafil Effects Upon Vision|A Double-Blind, Randomised, Placebo Controlled Healthy Volunteer Study to Investigate the Nature and Origin of the Disturbance of Vision Induced by Single Oral Doses of Sildenafil|Completed||Phase 4|||University of Cambridge|||||f||||||||||||||2017-02-18 16:58:58.812477|2017-02-18 16:58:58.812477
NCT00251771|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2015-04-29|||January 2006||2006-01-01|November 2014|2014-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|CaVenT||Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis|Catheter-directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis, an Open Randomized, Controlled, Clinical Trial|Completed||N/A|209|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 16:58:58.882702|2017-02-18 16:58:58.882702
NCT00251758|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2010-05-12|2009-02-26||December 2005||2005-12-01|May 2010|2010-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn|A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|908|Actual|Takeda||3|||t||||f||||||||||2017-02-18 16:58:59.188897|2017-02-18 16:58:59.188897
NCT00251745|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2011-04-25|2009-02-26||December 2005||2005-12-01|April 2011|2011-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn|A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (60 mg Once-Daily (QD) and 90 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD)|Completed||Phase 3|908|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:59:00.402806|2017-02-18 16:59:00.402806
NCT00251732|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2010-08-18|||March 2005||2005-03-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)|Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI.|Completed||Phase 4|150|Actual|Southern Arizona VA Health Care System||3|||f||||f||||||||||2017-02-18 16:59:01.78094|2017-02-18 16:59:01.78094
NCT00251719|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-02-01|2009-02-20||December 2005||2005-12-01|February 2012|2012-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis|A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg Once-daily [QD] and 90 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis|Completed||Phase 3|2054|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:59:01.926483|2017-02-18 16:59:01.926483
NCT00251706|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2006-05-04|||February 1999||1999-02-01|November 2005|2005-11-01|September 2004||2004-09-01|||||Interventional|||Amiodarone to Prevent Post-Operative Arrhythmias|Prophylactic Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair - PAPABEAR|Completed||Phase 3|600||University of Calgary|||||f||||||||||||||2017-02-18 16:59:03.322922|2017-02-18 16:59:03.322922
NCT00251693|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-02-01|2009-02-20||December 2005||2005-12-01|February 2012|2012-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis|A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-390MR (60 mg Once- Daily [QD] and 90 mg QD) and an Active Comparator, Lansoprazole (30 mg QD) on Healing of Erosive Esophagitis|Completed||Phase 3|2038|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:59:03.434575|2017-02-18 16:59:03.434575
NCT00251680|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-05-23|||October 2005||2005-10-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.|A Placebo-Controlled, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 100 mg in Subjects With Type 2 Diabetes Currently Treated With Lipid-Lowering Therapy|Completed||Phase 3|400|Actual|Takeda||2|||f||||f||||||||||2017-02-18 16:59:04.927783|2017-02-18 16:59:04.927783
NCT00251654|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2009-09-30|||January 2002||2002-01-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia|Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia Results of Investigations on 3,491 Catheters|Completed||Phase 4|9000|Actual|Rechbergklinik Bretten|||1||f||||f||||||||||2017-02-18 16:59:05.133704|2017-02-18 16:59:05.133704
NCT00251641|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2015-01-22|2009-05-21||September 2005||2005-09-01|January 2015|2015-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)|An Open-Label, Randomized Efficacy and Safety Study of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis|Completed||Phase 3|868|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 16:59:05.245693|2017-02-18 16:59:05.245693
NCT00251628|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-06-07|||June 2000||2000-06-01|June 2012|2012-06-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Home Care Management of Pediatric Pain|Home Care Management of Pediatric Pain|Completed||Phase 4|211|Actual|University of California, San Francisco||3|||f||||f||||||||||2017-02-18 16:59:05.889004|2017-02-18 16:59:05.889004
NCT00251615|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-08-03|||August 2012||2012-08-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging|Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging|Completed||N/A|18|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||||||||Samples With DNA|"~     Vascular tissue obtained from the surgical site that would have otherwise been discarded and~     Blood Serum~   "|||2017-02-18 16:59:05.999618|2017-02-18 16:59:05.999618
NCT00251602|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-08-03|||March 2003||2003-03-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Analysis of Atropine and Propranolol Induced Changes|Wavelet Transform and Pharmacodynamic Analysis of Atropine and Propranolol Induced Changes in Human Heart Rate Variability|Completed||Phase 1|24|Actual|National Institutes of Health Clinical Center (CC)||6|||f||||||||||||||2017-02-18 16:59:06.083879|2017-02-18 16:59:06.083879
NCT00251589|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2015-02-17|2008-10-27||January 2006||2006-01-01|February 2015|2015-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)|A Phase I/II Clinical Trial of Oral Vorinostat (MK0683) in Combination With Erlotinib in Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer|Terminated||Phase 1/Phase 2|23|Actual|Merck Sharp & Dohme Corp.|Due to the slow pace of patient accrual, failure to observe meaningful efficacy in treated patients, and overall intolerance of the combination regimen, the study was terminated prematurely on 12-Oct-2007.|4||"This trial is being closed based on lack of substantive efficacy, slow accrual and overall~   tolerance in patients treated to date."|f||||f||||||||||2017-02-18 16:59:06.321824|2017-02-18 16:59:06.321824
NCT00251576|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2015-02-02|||November 1999||1999-11-01|February 2015|2015-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)|A Multicenter, Randomized, Controlled, Double-Blind Trial to Investigate the Clinical Efficacy and Tolerability of Early Treatment With Simvastatin 40 mg Daily for 30 Days, Followed by Simvastatin 80 mg Daily Thereafter in Tirofiban-Treated Acute Coronary Syndrome Patients Who Have Been Randomized to Receive Enoxaparin or Unfractionated Heparin in Conjunction With Aspirin|Completed||Phase 3|4497|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:59:07.339447|2017-02-18 16:59:07.339447
NCT00251563|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2006-10-12|||August 2005||2005-08-01|November 2005|2005-11-01||||||||Observational|||Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer.||Unknown status|Recruiting|N/A|||Nanjing Medical University|||||f||||||||||||||2017-02-18 16:59:07.599067|2017-02-18 16:59:07.599067
NCT00251550|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2007-11-05|||October 2005||2005-10-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|||||Interventional|||Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma|Phase I/II Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma|Completed||Phase 1/Phase 2|12||Eli Lilly and Company|||||f||||||||||||||2017-02-18 16:59:07.679575|2017-02-18 16:59:07.679575
NCT00251537|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2006-07-07|||November 2005||2005-11-01|July 2006|2006-07-01|August 2006||2006-08-01|||||Interventional|||A Pilot Study of LTB4 in HIV-1 Infected Adults|A Pilot Study Assessing Safety and Antiretroviral Activity of Intravenously Administered LTB4 in HIV-1 Infected Adults With a CD4 Count Greater Than 250 Cells/mm3 and a Viral Load Greater Than 5,000 Copies/mL, and Who Have Not Received Antiretroviral Therapy Within Two Months|Completed||Phase 2|40||LTB4 Sweden AB|||||f||||||||||||||2017-02-18 16:59:07.780496|2017-02-18 16:59:07.780496
NCT00251524|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-05-09|||November 2005||2005-11-01|May 2012|2012-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC|A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC|Completed||Phase 2|69|Actual|Veeda Oncology||1|||f||||f||||||||||2017-02-18 16:59:07.884713|2017-02-18 16:59:07.884713
NCT00251511|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-05-09|||August 2004||2004-08-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|January 2006|Actual|2006-01-01||Interventional|||A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome|A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome|Terminated||Phase 2|60|Actual|Veeda Oncology||1||Sponsor terminated trial|f||||f||||||||||2017-02-18 16:59:07.994018|2017-02-18 16:59:07.994018
NCT00251498|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2008-08-20||||||August 2008|2008-08-01|October 2007|Actual|2007-10-01|||||Interventional|||Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer|Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|82|Actual|Veeda Oncology||1|||f||||||||||||||2017-02-18 16:59:08.085732|2017-02-18 16:59:08.085732
NCT00251485|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2008-08-20|||March 2004||2004-03-01|August 2008|2008-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer|A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer|Completed||Phase 2|82|Actual|Veeda Oncology||1|||f||||f||||||||||2017-02-18 16:59:08.174754|2017-02-18 16:59:08.174754
NCT00251472|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-05-09|||March 2005||2005-03-01|May 2012|2012-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer|A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer|Completed||Phase 2|72|Actual|Veeda Oncology||1|||f||||f||||||||||2017-02-18 16:59:08.266342|2017-02-18 16:59:08.266342
NCT00251459|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2014-03-06|||November 2005||2005-11-01|March 2014|2014-03-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)|A Phase IIIb, Single-Masked, Multicenter, Randomized Study to Evaluate the Safety and Tolerability of Ranibizumab in Naive and Previously Treated Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)|Completed||Phase 3|5000||Genentech, Inc.|||||||||||||||||||2017-02-18 16:59:08.364755|2017-02-18 16:59:08.364755
NCT00251446|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-05-09|||October 2005||2005-10-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer|A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|70|Actual|Veeda Oncology||1|||f||||f||||||||||2017-02-18 16:59:08.4563|2017-02-18 16:59:08.4563
NCT00251433|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2017-01-25|||September 26, 2005||2005-09-26|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|June 10, 2010|Actual|2010-06-10||Interventional|||GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer|An Open-label, Multicenter, Phase I/II Dose Escalation Study of Oral GW572016 in Combination With Docetaxel (Taxotere) Plus Trastuzumab (Herceptin) in Subjects Previously Untreated for ErbB2-overexpressing Metastatic Breast Cancer|Active, not recruiting||Phase 1|53|Actual|Novartis||3|||f||||||||||||||2017-02-18 16:59:08.559258|2017-02-18 16:59:08.559258
NCT00251420|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2009-05-06|||December 2005||2005-12-01|May 2009|2009-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Writing About Disease: Effect on Rehabilitation?|Writing About Disease: Effect on Rehabilitation?|Completed||N/A|180|Anticipated|LHL Helse||1|||f||||f||||||||||2017-02-18 16:59:08.677269|2017-02-18 16:59:08.677269
NCT00005356|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1994||1994-07-01|March 2005|2005-03-01|May 1998|Actual|1998-05-01|||||Observational|||Novel Hemostatic Cardiac Risk Factors in Framingham||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.724613|2017-02-18 18:14:59.724613
NCT00251394|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2010-01-28|||July 2004||2004-07-01|July 2009|2009-07-01|July 2009|Actual|2009-07-01|December 2006|Actual|2006-12-01||Interventional|||Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma|A Phase 2, Open-Label Study of the Efficacy, Safety, and Tolerability of Dynavax's Immunostimulatory Phosphorothiolate Oligodeoxyribonucleotide, 1018 ISS, Following Rituxan (Rituximab) Treatment in Patients With CD20+, B-Cell Follicular Non-Hodgkin's Lymphoma.|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 16:59:08.884567|2017-02-18 16:59:08.884567
NCT00251381|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2006-10-25|||November 2005||2005-11-01|October 2006|2006-10-01|November 2009||2009-11-01|||||Interventional|||Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.|Open Label Randomized Phase II, Multicentre, Pilot Study to Evaluate Safety and Efficacy of the Combination of Cetuximab and Concomitant-Boost Accelerated Radiotherapy Followed or Not by a Complementary Treatment With Cetuximab in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.|Unknown status|Recruiting|Phase 2|90||Trial Form Support S.L.|||||f||||||||||||||2017-02-18 16:59:08.992469|2017-02-18 16:59:08.992469
NCT00251368|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2011-03-09|||January 1995||1995-01-01|March 2011|2011-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia|Multicenter Study of 9-AC in Refractory Leukemia|Completed||Phase 1|52|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:59:09.101562|2017-02-18 16:59:09.101562
NCT00251355|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2016-12-19|||January 1998||1998-01-01|December 2016|2016-12-01|August 2008|Actual|2008-08-01|June 2007|Actual|2007-06-01||Interventional|||Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer|A Phase I Study of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Locally Unresectable Non-Metastatic Pancreatic Cancer|Completed||Phase 1|40|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 16:59:09.194738|2017-02-18 16:59:09.194738
NCT00251342|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2007-04-04|||October 2005||2005-10-01|April 2007|2007-04-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale|Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale|Unknown status|Recruiting|Phase 2/Phase 3|460||Chinese University of Hong Kong|||||f||||f||||||||||2017-02-18 16:59:09.304661|2017-02-18 16:59:09.304661
NCT00251329|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2007-04-03|||May 2003||2003-05-01|April 2007|2007-04-01||||||||Interventional|||Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery|Phase II Neoadjuvant Trial of Docetaxel (Taxotere), Carboplatin, and Capecitabine (Xeloda) in the Treatment of Early Stage Locally Advanced and Inflammatory Breast Cancer|Unknown status|Active, not recruiting|Phase 2|48||Cancer Research Network|||||f||||||||||||||2017-02-18 16:59:09.396335|2017-02-18 16:59:09.396335
NCT00251316|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2013-01-29|2012-11-20||November 2005||2005-11-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer|The Effects of Lithium Carbonate on Low Dose Radioiodine Ablation in Early Thyroid Cancer Treatment|Completed||Phase 2|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 16:59:09.499567|2017-02-18 16:59:09.499567
NCT00251303|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-09|2014-07-14|2013-05-16||August 2005||2005-08-01|July 2014|2014-07-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||These data apply only to double-blind phase.|Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders|An Investigation of the Efficacy in Childhood Obsessive-Compulsive Disorder of Riluzole: An Antiglutamatergic Agent|Completed||Phase 2|78|Actual|National Institutes of Health Clinical Center (CC)|Only treatment-refractory subjects were eligible for study participation. This may have decreased treatment response. Further, 98% were taking psychotropic drugs at baseline, which may have reduced between-group differences.|2|||f||||f||||||||||2017-02-18 16:59:09.902697|2017-02-18 16:59:09.902697
NCT00251290|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2009-03-02|||November 2004||2004-11-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack|Diagnosis and Treatment of Sleep-Disordered Breathing in the Homes of Patients With Transient Ischemic Attack|Completed||Phase 2|62|Actual|Yale University||1|||f||||||||||||||2017-02-18 16:59:10.355025|2017-02-18 16:59:10.355025
NCT00251277|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2012-11-14|||November 2005||2005-11-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura|Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura|Withdrawn||Phase 1/Phase 2|0|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 16:59:10.446346|2017-02-18 16:59:10.446346
NCT00251264|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2015-07-09|||November 2001||2001-11-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2010|Actual|2010-12-01||Interventional|||Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability|Arthroscopic Versus Open Stabilization of Traumatic Unidirectional Anterior Shoulder Instability: A Randomized Clinical Trial|Completed||N/A|194|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 16:59:10.550251|2017-02-18 16:59:10.550251
NCT00251251|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2012-06-15|||April 2003||2003-04-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|September 2010|Actual|2010-09-01||Interventional|RAFT||Resynchronization/Defibrillation for Ambulatory Heart Failure Trial|Resynchronization/Defibrillation for Ambulatory Heart Failure Trial|Completed||N/A|1798|Actual|Ottawa Heart Institute Research Corporation||2|||f||||t||||||||||2017-02-18 16:59:10.668946|2017-02-18 16:59:10.668946
NCT00251238|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2006-02-17|||November 2005||2005-11-01|September 2005|2005-09-01|April 2006||2006-04-01|||||Interventional|||Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon|Efficacy and Tolerability of Ginkgo Biloba Extract EGb 761® in Patients With Raynaud´s Phenomenon|Unknown status|Active, not recruiting|Phase 2|45||VSM Geneesmiddelen b.v.|||||f||||||||||||||2017-02-18 16:59:10.803415|2017-02-18 16:59:10.803415
NCT00251225|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2015-05-28|||August 2005||2005-08-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Imatinib and Docetaxel in Prostate Cancer|A Phase II Study of Imatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer|Completed||Phase 2|49|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 16:59:10.893226|2017-02-18 16:59:10.893226
NCT00251212|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2014-04-09|||September 2006||2006-09-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2010|Actual|2010-10-01||Interventional|||Tailored Teen Alcohol and Violence Prevention in the Emergency Room (ER)|Tailored Teen Alcohol and Violence Prevention in the ER|Completed||N/A|3694|Actual|University of Michigan||3|||f||||f||||||||||2017-02-18 16:59:11.124906|2017-02-18 16:59:11.124906
NCT00251186|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2010-01-25|||April 2006||2006-04-01|January 2010|2010-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients|Phase II Study of First-Line Capecitabine and Cetuximab for Treatment of Metastatic Colorectal Cancer in Elderly Patients and/or Those With Multiple Comorbidities Unable to Receive Chemotherapy Doublets|Terminated||Phase 2|18||Rutgers, The State University of New Jersey||||Funding unavailable|f||||||||||||||2017-02-18 16:59:11.323261|2017-02-18 16:59:11.323261
NCT00251173|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2016-04-07|||November 2005||2005-11-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Project Health Link: Connecting Patients With Services|Services Interventions for Injured ED Substance Abusers|Completed||N/A|755|Actual|University of Michigan||3|||f||||f||||||||No||2017-02-18 16:59:11.41131|2017-02-18 16:59:11.41131
NCT00251160|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2015-07-09|||December 1999||1999-12-01|July 2015|2015-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Electrothermal Arthroscopic Capsulorrhaphy (ETAC) and Open Inferior Capsular Shift in Patients With Shoulder Instability|Arthroscopic Electrothermal Capsulorrhaphy, ETAC, Versus Open Inferior Capsular Shift, ICS in Patients With Shoulder Instability: A Multicentre Randomized Clinical Trial|Completed||N/A|58|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 16:59:11.506372|2017-02-18 16:59:11.506372
NCT00251147|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2008-01-14|||March 1999||1999-03-01|January 2008|2008-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Randomized Clinical Trial Comparing Open to Mini-Open Rotator Cuff Repair for Full-Thickness Rotator Cuff Tears.|Prospective Randomized Study Comparing Open Acromioplasty and Rotator Cuff Repair Versus Arthroscopic Acromioplasty and Mini-Open Rotator Cuff Repair.|Completed||N/A|73|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 16:59:11.627437|2017-02-18 16:59:11.627437
NCT00251134|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2008-09-11|||October 2003||2003-10-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|June 2008|Actual|2008-06-01||Interventional|OMEGA||OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction|OMEGA: A Prospective, Randomised, Double-Blind, Placebo-Controlled Multicentre Study in Patients Who Survived Acute Myocardial Infarction to Investigate the Efficacy and Safety of 1 Gram Ω-3-Fatty Acid Ethyl Esters (Ω-3FAE) Daily Versus Placebo to Reduce the Risk of Sudden Cardiac Death.|Completed||Phase 3|3800|Actual|Stiftung Institut fuer Herzinfarktforschung||2|||f||||t||||||||||2017-02-18 16:59:11.736991|2017-02-18 16:59:11.736991
NCT00251121|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2012-02-08|||November 2005||2005-11-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG|Mini-invasive Electrophysiology Study as a Routine Examination for Patients Complaining of Tachycardia, But With a Negative Holter ECG.|Completed||N/A|51|Actual|Sykehuset Telemark||1|||f||||f||||||||||2017-02-18 16:59:11.853146|2017-02-18 16:59:11.853146
NCT00251108|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2007-02-28|||October 2003||2003-10-01|February 2007|2007-02-01|March 2007||2007-03-01|||||Interventional|||Fitness Training After Traumatic Brain Injury|The Efficacy of a Supervised Fitness Centre-Based Exercise Programme Compared to an Unsupervised Home-Based Exercise Programme on Improving Fitness and Psychosocial Outcomes in a Traumatic Brain Injured Population|Completed||N/A|60||Sydney South West Area Health Service|||||f||||||||||||||2017-02-18 16:59:11.957728|2017-02-18 16:59:11.957728
NCT00251095|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-08|2009-06-02|||September 2005||2005-09-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer|A Multicenter Phase 3, Randomized Comparison of the Safety and Efficacy of Weekly TOCOSOL(R) Paclitaxel vs. Weekly Paclitaxel Injection in the Treatment of Metastatic Breast Cancer|Terminated||Phase 3|821|Actual|OncoGenex Technologies||2||Failed primary endpoint|f||||||||||||||2017-02-18 16:59:12.262815|2017-02-18 16:59:12.262815
NCT00250822|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-09-23||2011-07-19|October 2005||2005-10-01|September 2011|2011-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter|Single Arm, Non Randomized Phase II Trial of Gemcitabine and Oxaliplatin (GEM-OX) for Hepatocellular Carcinoma (HCC) Patients With Platelet Counts Greater Than 100,000 Per Microliter.|Completed||Phase 2|11|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-02-18 16:59:12.393599|2017-02-18 16:59:12.393599
NCT00250809|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-01-06|||March 1994||1994-03-01|March 2009|2009-03-01|March 2006|Actual|2006-03-01|December 2005|Actual|2005-12-01||Interventional|||Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study|CVC Pros and Cons of Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study|Completed||N/A|15|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:59:12.497989|2017-02-18 16:59:12.497989
NCT00250796|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-01-06|||September 2000||2000-09-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma|Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|12|Actual|University of New Mexico||2|||f||||t||||||||||2017-02-18 16:59:12.586081|2017-02-18 16:59:12.586081
NCT00250783|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-01-06|||July 2002||2002-07-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|||||Observational|||Pre-Clinical Models in Gynecological Tumors A Tissue Repository|Pre-Clinical Models in Gynecological Tumors: A Tissue Repository|Completed||N/A|26|Actual|University of New Mexico|||1||f||||t||||||Samples Without DNA|"~     Tumor and normal tissues, ascites, and/or serum, and/or urine from women with malignant or~     premalignant gynecological conditions for which they are undergoing medically-indicated~     surgery, and normal tissues from women without malignancy who volunteer to donate serum~     and/or tissue at the time of medically indicated surgery~   "|||2017-02-18 16:59:12.703832|2017-02-18 16:59:12.703832
NCT00250770|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-05-10|||January 1998||1998-01-01|May 2016|2016-05-01|January 2022|Anticipated|2022-01-01|January 2022|Anticipated|2022-01-01||Observational|||Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis|CSF-1 and Other Cytokines in Human Endometrial Carcinogenesis|Recruiting||N/A|750|Anticipated|University of New Mexico|||1||f||||t||||||Samples Without DNA|"~     We have collected serum and ascites from approximately 200 patients with endometrial~     carcinoma and 200 controls. We have long term follow-up serum from approximately 60 of these~     patients. Approximately 10% of endometrial carcinoma patients recur. Our goal will be to~     eventually have follow-up serum from up to 60 patients with recurrent endometrial carcinoma~     in our tissue bank, so that we can determine the role of these assays in predicting~     recurrence.~   "|||2017-02-18 16:59:12.795006|2017-02-18 16:59:12.795006
NCT00250757|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-01-06|||October 2005||2005-10-01|January 2016|2016-01-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational|||Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions|Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions|Terminated||N/A|101|Actual|New Mexico Cancer Care Alliance|||1|Study was not renewed timely with IRB of record.|f||||t||||||Samples Without DNA|"~     Semen samples or Prostatic secretions (via prostate massage).~   "|||2017-02-18 16:59:12.908841|2017-02-18 16:59:12.908841
NCT00250744|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-09-23|||December 2004||2004-12-01|December 2009|2009-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting|Comparison of Aprepitant vs. Gabapentin in the Prevention of Delayed Nausea and Vomiting|Completed||Phase 2|200|Actual|New Mexico Cancer Care Alliance||2|||f||||t||||||||||2017-02-18 16:59:13.002343|2017-02-18 16:59:13.002343
NCT00250731|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2009-06-15|||January 2006||2006-01-01|June 2009|2009-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Improving Diabetes Outcomes: a Couples Intervention|Improving Diabetes Outcomes: a Couples Intervention|Completed||Phase 1|45|Anticipated|State University of New York - Upstate Medical University||3|||f||||t||||||||||2017-02-18 16:59:13.115648|2017-02-18 16:59:13.115648
NCT00250718|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2015-07-06|2015-06-13||October 2004||2004-10-01|July 2015|2015-07-01|May 2014|Actual|2014-05-01|November 2008|Actual|2008-11-01||Interventional|||Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach|Phase II Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-angiogenic Approach|Terminated||Phase 2|17|Actual|New Mexico Cancer Care Alliance||1||Low rate of accrual|f||||t||||||||||2017-02-18 16:59:13.25192|2017-02-18 16:59:13.25192
NCT00250705|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-01-14|||May 2004||2004-05-01|January 2010|2010-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Trial of Aripiprazole in the Treatment of CD in Adolescents|Open Label Trial of Aripiprazole in the Treatment of CD in Adolescents|Completed||Phase 4|12|Actual|University of Iowa||1|||f||||f||||||||||2017-02-18 16:59:13.565986|2017-02-18 16:59:13.565986
NCT00250692|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2017-02-15||||||February 2017|2017-02-01||||||||Interventional|||A Study to Test the Pain-relieving Effect of Laughing Gas in Infants|Analgesic Effect of Nitrous Oxide in Neonates Undergoing Heel Stick|Withdrawn||Phase 3|0|Actual|University of California, Los Angeles||||unknown - no record of study conduct in departmental archive|f||||||||||||||2017-02-18 16:59:13.668438|2017-02-18 16:59:13.668438
NCT00250679|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2012-05-29|2008-10-03||October 2005||2005-10-01|May 2012|2012-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease|Multicenter, Double-Blind, Double-Dummy, Randomized, Active-Controlled, Parallel Group Long-Term Safety Study of 15 μg and 25 μg Arformoterol Tartrate Inhalation Solution BID in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|443|Actual|Sunovion|Please see dropout rate in participant group. Sunovion is unaware of any other limitations or caveats associated with this study.|3|||f||||t||||||||||2017-02-18 16:59:13.777615|2017-02-18 16:59:13.777615
NCT00250666|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2008-07-07|||January 2006||2006-01-01|July 2008|2008-07-01|May 2007|Actual|2007-05-01|May 2007||2007-05-01||Interventional|||Procalcitonin-Guided Antimicrobial Discontinuation|Procalcitonin-Guided Antimicrobial Discontinuation Strategy in Critically Ill Patients With Suspected or Confirmed Bacterial Sepsis|Completed||Phase 4|70|Anticipated|University Hospital, Geneva|||||f||||||||||||||2017-02-18 16:59:16.191481|2017-02-18 16:59:16.191481
NCT00250653|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2012-02-15|||May 2005||2005-05-01|February 2012|2012-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression|A Fifty-two-week, Multicenter, Open-label Study Evaluating the Long-term Safety and Tolerability of Saredutant in Adult and Elderly Patients With Major Depressive Disorder|Completed||Phase 3|365|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:59:16.281139|2017-02-18 16:59:16.281139
NCT00250640|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2015-01-30|||April 2005||2005-04-01|January 2015|2015-01-01|July 2012|Actual|2012-07-01|April 2012|Actual|2012-04-01||Observational|||Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years|Open-label, Uncontrolled, Prospective Long-term Observation of Ventavis Inhalation Therapy in the Treatment of Patients With Primary Pulmonary Hypertension up to 4 Years|Completed||N/A|106|Actual|Bayer|||1||f||||f||||||None Retained|"~     n.a~   "|||2017-02-18 16:59:16.392753|2017-02-18 16:59:16.392753
NCT00250627|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2008-12-22|||December 2004||2004-12-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression|An Eight-Week, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder|Completed||Phase 3|465|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:59:16.538531|2017-02-18 16:59:16.538531
NCT00250614|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2010-06-08|||April 2005||2005-04-01|June 2010|2010-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression|An Eight-Week, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder.|Completed||Phase 3|452|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:59:16.637284|2017-02-18 16:59:16.637284
NCT00250601|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2012-02-15|||April 2005||2005-04-01|February 2012|2012-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression|An Eight-Week, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety, and Tolerability of One Fixed 100 mg Dose of Saredutant in Patients With Major Depressive Disorder.|Completed||Phase 3|460|Actual|Sanofi|||||f||||||||||||||2017-02-18 16:59:16.744929|2017-02-18 16:59:16.744929
NCT00250588|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2013-04-25|2012-12-11||October 2003||2003-10-01|April 2013|2013-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Problem-Solving Skills Training to Improve Care for Children With Asthma|Reducing Barriers to Care for Vulnerable Children With Asthma|Completed||N/A|252|Actual|RAND|Substantial dropout, particularly from CC+PST, is a limitation. Our sample size was not large enough, nor was there sufficient variability in our secondary outcomes, to detect differences in health care utilization despite the odds ratios.|3|||f||||f||||||||||2017-02-18 16:59:16.841478|2017-02-18 16:59:16.841478
NCT00005355|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-29|||February 1993||1993-02-01|February 2016|2016-02-01|January 1996||1996-01-01|||||Observational|||Gender Differences in Familial Risk||Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-02-18 18:14:59.79774|2017-02-18 18:14:59.79774
NCT00250575|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2016-04-20|||November 2005||2005-11-01|April 2016|2016-04-01||||December 2009|Actual|2009-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia|A 24-week, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia|Completed||Phase 3|43|Actual|Novartis||1|||f||||||||||||||2017-02-18 16:59:20.176669|2017-02-18 16:59:20.176669
NCT00250562|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-06|2016-11-16|||October 2005||2005-10-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.|A Multicenter, Double-blind, Randomized, Active Controlled, Parallel Group Trial Comparing the Combinations of Valsartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Valsartan 80 mg in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Valsartan 80mg|Completed||Phase 3|1171|Actual|Novartis|||||f||||||||||||||2017-02-18 16:59:20.304441|2017-02-18 16:59:20.304441
NCT00250549|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2014-12-09|||May 2005||2005-05-01|December 2014|2014-12-01|March 2006|Actual|2006-03-01|October 2005|Actual|2005-10-01||Interventional|||A Theory Based HIV Prevention Video For Rapid HIV Testing: A Randomized Trial|A Randomized Control Trial Evaluating the Educational Effectiveness of a Rapid HIV Post-Test Counseling Video.|Completed||N/A|128|Actual|North Bronx Healthcare Network||2|||f||||f||||||||||2017-02-18 16:59:20.398941|2017-02-18 16:59:20.398941
NCT00250536|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2010-01-12|||March 2000||2000-03-01|January 2010|2010-01-01|October 2004||2004-10-01|||||Interventional|||Anabolic Steroids and Exercise in Hemodialysis Patients|Anabolic Steroids and Exercise in Hemodialysis Patients|Completed||N/A|80||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:59:20.50894|2017-02-18 16:59:20.50894
NCT00250523|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2010-07-22|||February 2003||2003-02-01|July 2010|2010-07-01|July 2014|Anticipated|2014-07-01|July 2014|Anticipated|2014-07-01||Observational|||Mathematical Modeling of the Acute Inflammatory Response Following Injury|Host Response to Injury|Unknown status|Recruiting|N/A|520|Anticipated|National Institute of General Medical Sciences (NIGMS)|||2||f||||t||||||Samples With DNA|"~     For trauma injury cohort: The maximum blood volume collected over the 28 day period, if all~     samples are obtained, is approximately 90 cc. All standard precautions will be undertaken to~     assure minimal risk.~      Blood samples will be obtained for genetic analysis of inflammatory gene polymorphisms. We~     will collect whole blood, serum and white cells.~   "|||2017-02-18 16:59:20.588245|2017-02-18 16:59:20.588245
NCT00250510|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2010-03-17|||June 2004||2004-06-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Reimbursement Effects on Enrollment in Obesity Treatment|A Prospective Study to Determine the Effects of a Reimbursement Incentive on Enrollment and Outcomes in a Community Weight Control Program.|Completed||N/A|401|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 16:59:20.674148|2017-02-18 16:59:20.674148
NCT00250497|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2015-07-06|2012-07-12||September 2005||2005-09-01|July 2015|2015-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||New Moves - Obesity Prevention Among Adolescent Girls|New Moves: Obesity Prevention Among Adolescent Girls|Completed||N/A|356|Actual|University of Minnesota - Clinical and Translational Science Institute|Control group also had all-girls PE. Some girls missing body composition data.|2|||f||||t||||||||||2017-02-18 16:59:20.784972|2017-02-18 16:59:20.784972
NCT00250484|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2016-08-30|2015-07-20||November 2004||2004-11-01|August 2016|2016-08-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||TMS Treatment for Pain in Chronic Pancreatitis|The Effect of 10-Day Treatment of Repetitive Transcranial Magnetic Stimulation on Abdominal Pain in Patients With Chronic Pancreatitis|Completed||Phase 2|23|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||No|No plan in protocol to share individual data|2017-02-18 16:59:21.486775|2017-02-18 16:59:21.486775
NCT00250471|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2005-11-07|||May 2003||2003-05-01|November 2005|2005-11-01|September 2004||2004-09-01|||||Interventional|||PROTECT-TIMI 30 Trial|A Randomized Trial to Evaluate the Relative Protection Against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia Among Anti-Platelet and Anti-Thrombotic Agents|Completed||Phase 3|900||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 16:59:21.890954|2017-02-18 16:59:21.890954
NCT00250458|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2015-10-30|2009-09-21||March 2006||2006-03-01|October 2015|2015-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Elimination of Migraine-Associated Nausea in Migraine Patients Treated With Rizatriptan Orally Disintegrating Tablet (ODT)|Completed||Phase 3|346|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:59:22.003086|2017-02-18 16:59:22.003086
NCT00250445|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2015-07-29|||January 2003||2003-01-01|July 2015|2015-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)|A Randomized, Double-Blind, Active-Comparator-Controlled, Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients With Osteoarthritis or Rheumatoid Arthritis|Completed||Phase 3|23498|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:59:22.406175|2017-02-18 16:59:22.406175
NCT00250432|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2015-09-24|2009-01-13||January 2006||2006-01-01|September 2015|2015-09-01|March 2008|Actual|2008-03-01|January 2008|Actual|2008-01-01||Interventional|||A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of Caspofungin in the Treatment of Invasive Candidiasis in Adults|Completed||Phase 3|204|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 16:59:22.51221|2017-02-18 16:59:22.51221
NCT00250419|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2015-02-09|||September 2005||2005-09-01|February 2015|2015-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||V930 First in Man (FIM) Study (V930-002)(COMPLETED)|A Phase I Study to Evaluate the Safety/Tolerability and Immunogenicity of V-930 in Patients With Cancers Expressing HER-2 and/or CEA|Completed||Phase 1|26|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 16:59:23.466427|2017-02-18 16:59:23.466427
NCT00250406|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2013-12-19|||November 2005||2005-11-01|December 2013|2013-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation|Assessment of Bacterial Adherence and Biofilm Formation on a Triclosan Loaded Ureteral Stent: A Phase II Study|Completed||Phase 2|20|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 16:59:23.81004|2017-02-18 16:59:23.81004
NCT00250393|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2012-08-28|||November 2005||2005-11-01|August 2012|2012-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease|Placebo-Controlled , Crossover , Double-Blind Study of KW-6002(Istradefylline) in the Treatment of Parkinson's Disease. [Monotherapy]|Completed||Phase 2|64||Kyowa Hakko Kirin Co., Ltd|||||f||||f||||||||||2017-02-18 16:59:23.929461|2017-02-18 16:59:23.929461
NCT00250380|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2011-12-12|||November 2005||2005-11-01|December 2011|2011-12-01|March 2011|Actual|2011-03-01|June 2010|Actual|2010-06-01||Observational|||The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)|The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)－A Prospective Multicenter Cohort Study-|Completed||Phase 4|583|Actual|Ministry of Health, Labour and Welfare, Japan|||1||f||||t||||||Samples With DNA|"~     whole blood, serum, urine~   "|||2017-02-18 16:59:24.032572|2017-02-18 16:59:24.032572
NCT00250367|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-11-24|||October 1997||1997-10-01|November 2010|2010-11-01|November 1999|Actual|1999-11-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.|The Safety And Efficacy Of Risperdal� (Risperidone) Versus Placebo As Add-On Therapy To Mood Stabilizers In The Treatment Of The Manic Phase Of Bipolar Disorder|Completed||Phase 3|151|Actual|Janssen Pharmaceutica N.V., Belgium|||||||||||||||||||2017-02-18 16:59:24.165046|2017-02-18 16:59:24.165046
NCT00250354|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-01-20|||September 1997||1997-09-01|January 2011|2011-01-01|August 1999|Actual|1999-08-01|||||Interventional|||A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation|The Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years|Completed||Phase 3|110|Actual|Janssen Pharmaceutica N.V., Belgium|||||||||||||||||||2017-02-18 16:59:24.255049|2017-02-18 16:59:24.255049
NCT00250341|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2015-03-19|||September 2005||2005-09-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Non-invasive Measures of Distal Lung Disease in Asthmatics|Non-Invasive Measures of Distal Lung Disease in Asthmatics Before and After Therapy Directed at the Proximal vs. Distal Lung|Completed||Phase 4|34|Anticipated|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 16:59:24.349399|2017-02-18 16:59:24.349399
NCT00250328|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-06|2005-11-06|||January 2006||2006-01-01|November 2005|2005-11-01||||||||Interventional|||Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy|Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy|Unknown status|Not yet recruiting|Phase 1|40|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:59:24.457972|2017-02-18 16:59:24.457972
NCT00250315|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2007-10-31|||November 2005||2005-11-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Observational|||DOCICAR: Cardiac Dysfunction in Cirrhosis|Cardiac Dysfunction in Cirrhosis: Cirrhotic Cardiomyopathy Evaluated by Dobutamin MRI.|Completed||Phase 3|||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 16:59:24.543103|2017-02-18 16:59:24.543103
NCT00250302|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-06|2011-04-27|||April 2009||2009-04-01|October 2010|2010-10-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures|Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures|Completed||Phase 1/Phase 2|24|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:59:24.617585|2017-02-18 16:59:24.617585
NCT00250289|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-06|2010-01-05|||March 2006||2006-03-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|January 2008|Actual|2008-01-01||Interventional|||Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula|Invivo Study of the Efficacy of an Innovative Herbal Formula and Delivery System on Oral Malodor|Completed||Phase 1|15|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:59:24.70013|2017-02-18 16:59:24.70013
NCT00250276|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2016-10-26|||October 2005||2005-10-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.|Assess Lot-to-lot Consistency of GSK Biologicals' HPV-16/18 L1/AS04 Vaccine Following Manufacturing Adjustments Administered Intramuscularly According to a 0,1,6-mth Schedule in Healthy Female Subjects (18-25 y)|Completed||Phase 3|798|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 16:59:24.805499|2017-02-18 16:59:24.805499
NCT00250263|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-06|2013-02-11|||November 2005||2005-11-01|November 2005|2005-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy|A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy|Completed||Phase 4|30|Actual|Bayside Health||2|||f||||||||||||||2017-02-18 16:59:24.901003|2017-02-18 16:59:24.901003
NCT00250250|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2011-05-19|||October 2005||2005-10-01|May 2011|2011-05-01|August 2006|Actual|2006-08-01|March 2006|Actual|2006-03-01||Interventional|||An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG|An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG (Recombinant Somatropin) Administered by ZomaJet Vision X|Completed||Phase 3|27|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-02-18 16:59:25.01151|2017-02-18 16:59:25.01151
NCT00250237|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2009-08-06|||November 2005||2005-11-01|August 2009|2009-08-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery|Randomised Double-blind Placebo-controlled Study of Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery|Completed||Phase 3|220|Actual|Bronovo Hospital||2|||f||||t||||||||||2017-02-18 16:59:25.115353|2017-02-18 16:59:25.115353
NCT00250224|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-07|2015-06-25|||January 2006||2006-01-01|September 2005|2005-09-01|May 2014|Actual|2014-05-01|May 2009|Actual|2009-05-01||Interventional|||Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II|Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II|Completed||Phase 1|100|Actual|Aalborg Universitetshospital||1|||f||||t||||||||||2017-02-18 16:59:25.221521|2017-02-18 16:59:25.221521
NCT00249574|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2017-01-13|||June 2003||2003-06-01|December 2008|2008-12-01|June 2006|Actual|2006-06-01|March 2004|Actual|2004-03-01||Interventional|||Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1|HCV Treatment of IDUs After Buprenorphine Stabilization|Completed||N/A|10|Anticipated|National Institute on Drug Abuse (NIDA)||1|||t||||t||||||||||2017-02-18 16:59:37.699668|2017-02-18 16:59:37.699668
NCT00250211|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-02-23|||March 2005||2005-03-01|October 2011|2011-10-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|||Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide|Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide|Completed||Phase 1/Phase 2|26|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 16:59:25.327693|2017-02-18 16:59:25.327693
NCT00250198|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-05|2017-01-24|||November 3, 2005||2005-11-03|September 5, 2006|2006-09-05|September 5, 2006||2006-09-05|||||Interventional|||The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease|A Randomized, Double-blind, Pilot Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, to Investigate Peripheral Blood and Mucosal Mononuclear Cell Phenotype and Cytokine Responses in Patients With Crohn's Disease|Completed||Phase 2|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:59:25.42307|2017-02-18 16:59:25.42307
NCT00250185|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-05|2017-01-24|||November 1, 2005||2005-11-01|August 22, 2008|2008-08-22|June 9, 2007|Actual|2007-06-09|June 9, 2007|Actual|2007-06-09||Interventional|||The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress|The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic Stress|Completed||Phase 1|135||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:59:25.50921|2017-02-18 16:59:25.50921
NCT00250172|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-05|2017-01-24|||October 31, 2005||2005-10-31|September 15, 2014|2014-09-15|February 5, 2009|Actual|2009-02-05|February 5, 2009|Actual|2009-02-05||Interventional|||PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram|PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram|Completed||Phase 1|26|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 16:59:25.608515|2017-02-18 16:59:25.608515
NCT00250159|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-05|2017-01-24|||October 27, 2005||2005-10-27|November 21, 2016|2016-11-21||||||||Observational|||Natural History Study of Patients With Excess Androgen|Natural History Study of Patients With Excess Androgen|Enrolling by invitation||N/A|711|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 16:59:25.718485|2017-02-18 16:59:25.718485
NCT00250146|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2005-11-03|||February 2001||2001-02-01|April 2005|2005-04-01|March 2005||2005-03-01|||||Interventional|||Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease||Terminated||N/A|39||Università Politecnica delle Marche|||||f||||||||||||||2017-02-18 16:59:25.825545|2017-02-18 16:59:25.825545
NCT00250133|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2007-08-31||||||August 2007|2007-08-01||||||||Observational|||Microbiologic Effect of Selective Decontamination of the Digestive Tract With Colistin, Gentamicin and Nystatin|Microbiologic Effect of Selective Decontamination of the Digestive Tract With Colistin, Gentamicin and Nystatin|Terminated||Phase 3|40||University of Pittsburgh||||Unable to obtain funding to complete study never started study|f||||||||||||||2017-02-18 16:59:25.918247|2017-02-18 16:59:25.918247
NCT00250120|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-05-10|||April 2003||2003-04-01|May 2016|2016-05-01|August 2007|Actual|2007-08-01|March 2007|Actual|2007-03-01||Interventional|||Pharmacology Study of Aerosolized Liposomal|Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S) - Camptothecin (L9NC)|Withdrawn||Phase 2|0|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:59:26.006981|2017-02-18 16:59:26.006981
NCT00250094|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-09-02|||May 2004||2004-05-01|September 2011|2011-09-01|March 2006|Actual|2006-03-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Benefit of Topoisomerase Downregulation|Clinical Benefit of Topoisomerase Downregulation: A Phase I Pilot Study|Completed||Phase 1|15|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-02-18 16:59:26.108935|2017-02-18 16:59:26.108935
NCT00250081|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2014-11-18|||February 2005||2005-02-01|November 2014|2014-11-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|UECP||Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy|Multi Center Project: Comparison of Functional Outcomes of Tendon Transfer Surgery, Botulinum Toxin Injections and Regular Ongoing Treatment in Hemiplegic Upper Extremity Cerebral Palsy|Terminated||N/A|38|Actual|Shriners Hospitals for Children||3||Accrual is complete.|f||||t||||||||||2017-02-18 16:59:26.204434|2017-02-18 16:59:26.204434
NCT00250068|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2010-05-18|||April 2003||2003-04-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)|Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)|Completed||Phase 2|8|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:59:26.34722|2017-02-18 16:59:26.34722
NCT00250055|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-05-10|||April 2004||2004-04-01|May 2016|2016-05-01|January 2010|Actual|2010-01-01|December 2007|Actual|2007-12-01||Interventional|||Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue|Non-Invasive, Real-time Technology for Diagnosis of Cervical Tissue|Completed||N/A|100|Anticipated|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:59:26.443609|2017-02-18 16:59:26.443609
NCT00250042|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-09-18|||April 2004||2004-04-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|April 2005|Actual|2005-04-01||Interventional|||A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec|A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail to Achieve a Complete Response to Initial Gleevec Treatment|Completed||Phase 2|6|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-02-18 16:59:26.597688|2017-02-18 16:59:26.597688
NCT00250029|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-09-23|||April 2004||2004-04-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|September 2005|Actual|2005-09-01||Interventional|||Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen|Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy|Completed||N/A|30|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-02-18 16:59:26.861476|2017-02-18 16:59:26.861476
NCT00250016|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2010-01-06|||August 2003||2003-08-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Observational|||Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)|1102C-T. Pharmacology Study of Aerosolized Liposomal-Nitro-20 (S)-Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium. Tissue Submission for Patients With Endometrial Cancer.|Completed||N/A|6|Actual|University of New Mexico|||1||f||||t||||||Samples Without DNA|"~     Blood sample, tumor endometrial tissue, and normal endometrial tissue.~   "|||2017-02-18 16:59:26.970004|2017-02-18 16:59:26.970004
NCT00250003|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2005-11-22|||February 2000||2000-02-01|September 2005|2005-09-01|December 2001||2001-12-01|||||Interventional|||Preventive Home Visits for Healthy Pensioners- a Randomized Controlled Trial|Preventive Home Visits for Healthy Pensioners- a Randomized Controlled Trial in Nordmaling|Completed||Phase 1|||Umeå University|||||f||||||||||||||2017-02-18 16:59:27.072132|2017-02-18 16:59:27.072132
NCT00249990|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2010-01-06|||April 2003||2003-04-01|October 2008|2008-10-01|September 2007|Actual|2007-09-01|July 2006|Actual|2006-07-01||Interventional|||Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)|Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium|Completed||Phase 2|39|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:59:27.161698|2017-02-18 16:59:27.161698
NCT00249977|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2010-01-06|||April 2003||2003-04-01|October 2009|2009-10-01|January 2009|Actual|2009-01-01|August 2007|Actual|2007-08-01||Interventional|||Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan|Phase I Study Of Capecitabine in Combination With Cisplatin and Irinotecan in Patients With Advanced Malignancies.|Completed||Phase 1|21|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 16:59:27.264309|2017-02-18 16:59:27.264309
NCT00249964|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-01-15|||November 2003||2003-11-01|January 2016|2016-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Combination Paclitaxel, Carboplatin and Temozolomide|Phase I Dose Finding Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide for Subjects With Solid Tumor Malignancies.|Completed||Phase 1|15|Actual|New Mexico Cancer Care Alliance||1|||f||||t||||||||||2017-02-18 16:59:27.356072|2017-02-18 16:59:27.356072
NCT00249951|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2012-06-29|||November 2005||2005-11-01|June 2012|2012-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants||Completed||Phase 3|80|Actual|University of Cologne||1|||f||||t||||||||||2017-02-18 16:59:27.487339|2017-02-18 16:59:27.487339
NCT00249938|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2015-08-10|||March 2005||2005-03-01|August 2015|2015-08-01|August 2006||2006-08-01|||||Interventional|||Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.|Evaluation of Plant Sterol and Placebo on Low-density Lipoprotein Concentrations in Hyperlipidemic Patients Treated With Combination Statin and Colesevelam Therapy.|Completed||Phase 4|60||University of Colorado, Denver|||||f||||||||||||||2017-02-18 16:59:27.597264|2017-02-18 16:59:27.597264
NCT00249925|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-04-25|||January 2000||2000-01-01|April 2016|2016-04-01|January 2005|Actual|2005-01-01|June 2004|Actual|2004-06-01||Interventional|||Project ABLE:Advancing Better Living for Elders|Enhancing Function of Frail Elders At Home|Completed||Phase 3|319||Thomas Jefferson University|||||f||||t||||||||||2017-02-18 16:59:27.707533|2017-02-18 16:59:27.707533
NCT00249912|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2012-05-23|||October 2005||2005-10-01|May 2012|2012-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia|A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg, 100 mg or Placebo When Coadministered With Rosuvastatin 10 mg or 20 mg in Subjects With Primary Hypercholesterolemia|Completed||Phase 3|415|Actual|Takeda||3|||f||||f||||||||||2017-02-18 16:59:27.804402|2017-02-18 16:59:27.804402
NCT00249899|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2012-05-23|||November 2005||2005-11-01|May 2012|2012-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia|A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia|Terminated||Phase 3|649|Actual|Takeda||2||"Overall profile of the compound does not offer significant clinical advantage to patients over~   currently available lipid lowering agents"|f||||f||||||||||2017-02-18 16:59:28.02149|2017-02-18 16:59:28.02149
NCT00249886|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2006-09-18|||September 2002||2002-09-01|November 2005|2005-11-01|November 2006||2006-11-01|||||Interventional|||Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents||Withdrawn||Phase 3|60||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 16:59:28.162971|2017-02-18 16:59:28.162971
NCT00249873|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2015-05-20|2010-03-08||June 2003||2003-06-01|May 2015|2015-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)|A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation|Completed||Phase 3|7554|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:59:28.289308|2017-02-18 16:59:28.289308
NCT00249860|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2013-08-04|||September 2002||2002-09-01|August 2013|2013-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects|A Multicentre Phase III Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects|Completed||Phase 3|257|Actual|EMD Serono||2|||f||||||||||||||2017-02-18 16:59:31.184654|2017-02-18 16:59:31.184654
NCT00249847|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2014-10-01|||October 2005||2005-10-01|October 2014|2014-10-01|April 2008|Actual|2008-04-01|July 2007|Actual|2007-07-01||Interventional|||Study of PET Scans and Serotonin in Hot Flashes Treatment|A Feasibility Study of Positron Emission Tomography (PET) of the Serotonin Transporter (SERT) Before and After Treatment With Conjugated Equine Estrogen or Paroxetine for Hot Flashes|Terminated||N/A|5|Actual|Sidney Kimmel Comprehensive Cancer Center||2||Unable to complete accrual; elected to close the study in April 2008.|f||||t||||||||||2017-02-18 16:59:31.287112|2017-02-18 16:59:31.287112
NCT00249834|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-11-04|||September 2004||2004-09-01|February 2014|2014-02-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|CONSORT||Safety and Efficacy of a Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing IVF|A Phase IIIB/IV, Open Label Study to Assess the Efficacy and Safety of a Pre-defined, Fixed Dose of Gonal-f® (Filled-by-Mass in a Prefilled Pen) Based on Subject Baseline Characteristics, for Ovarian Stimulation in Subjects Undergoing in Vitro Fertilization (IVF)|Completed||Phase 4|172|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 16:59:31.392021|2017-02-18 16:59:31.392021
NCT00249821|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2013-12-02|2012-06-28||February 2005||2005-02-01|December 2013|2013-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|SGA OPTIMIS||Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age|Optimization of the Dosage Regimen With Growth Hormone Therapy in Children Born Small for Gestational Age. An Open Label, Randomized, Pilot Study, Comparing in Children Treated for 3 Years, the Efficacy of a Saizen® Treatment at the Same Dose Versus a Lower Maintenance Dose Prolonged During 1 Additional Year.|Completed||Phase 3|22|Actual|Merck KGaA|Participants’ inclusion period was extended but due to remaining low recruitment rate, it was finally decided to stop enrollment even if only 22 participants were enrolled.|2|||f||||f||||||||||2017-02-18 16:59:31.487601|2017-02-18 16:59:31.487601
NCT00005354|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-03-26|||April 1992||1992-04-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Computed Tomography (CT)--An Epidemiologic Study in the Young||Completed||N/A|||University of Iowa|||||f||||||||||||||2017-02-18 18:14:59.865361|2017-02-18 18:14:59.865361
NCT00249808|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-11-18|||December 2004||2004-12-01|March 2009|2009-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Efalizumab in Patients With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies|A Multicentre, Open Label Phase IIIb Study of Subcutaneously Admin. Efalizumab (Adult Patients) With Moderate to Severe Chronic Psoriasis Failed to Respond to, or Have a Contraindication to, or Are Intolerant of Other Systemic Therapies Incl. Cyclosporine, Methotrexate and PUVA.|Completed||Phase 4|1266|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 16:59:31.933828|2017-02-18 16:59:31.933828
NCT00249795|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-09-29|2010-08-24||June 2003||2003-06-01|September 2010|2010-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|ACTIVE I||Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)|A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation|Completed||Phase 3|9016|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 16:59:32.312405|2017-02-18 16:59:32.312405
NCT00249782|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-05-27|||November 2005||2005-11-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.|A Phase II, Randomized, Partial-Blind, Parallel-Group, Active- and Vehicle-Controlled, Multicenter Study of the Safety and Efficacy of ACZONE™ (Dapsone) Gel, 5% in Subjects With Papulopustular Rosacea|Completed||Phase 2|400|Actual|Allergan|||||||||||||||||||2017-02-18 16:59:35.815162|2017-02-18 16:59:35.815162
NCT00249769|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-05-05|||November 2005||2005-11-01|May 2007|2007-05-01|May 2006||2006-05-01|||||Interventional|||Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine|Assessment of the Non-Inferiority of the Concurrent Administration of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Measles Vaccine Given Alone|Completed||Phase 3|600||PATH|||||f||||||||||||||2017-02-18 16:59:35.941653|2017-02-18 16:59:35.941653
NCT00249756|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-08-29|||August 2005||2005-08-01|August 2013|2013-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Re-Entry MTC for Offenders With MICA Disorders|Re-Entry MTC for Offenders With MICA Disorders|Completed||N/A|610|Actual|National Development and Research Institutes, Inc.||2|||f||||t||||||||||2017-02-18 16:59:36.035452|2017-02-18 16:59:36.035452
NCT00249743|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2006-05-25|||December 2004||2004-12-01|May 2006|2006-05-01|July 2005||2005-07-01|||||Interventional|||Clinical Evaluation of a Wireless Monitoring Device to Reduce Falls in the Elderly and Others at High Risk of Falling|NIH-NIA SBIR Phase I/II Study: Clinical Evaluation of a Device to Reduce Patient Falls|Completed||Phase 1/Phase 2|50||NOCwatch International|||||f||||||||||||||2017-02-18 16:59:36.145011|2017-02-18 16:59:36.145011
NCT00249730|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2006-12-18|||October 2005||2005-10-01|December 2006|2006-12-01||||||||Interventional|||Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.|A Prospective Multicenter, Parallel Group Study With A Single Blind Phase And A Double Blind Randomised Phase, To Evaluate The Efficacy And Satisfaction Of Viagra (Sildenafil Citrate) High Dose (100mg) Titration Compared With 50mg Dose, In Men With Erectile Dysfunction|Completed||Phase 4|510||Pfizer|||||f||||||||||||||2017-02-18 16:59:36.238025|2017-02-18 16:59:36.238025
NCT00249717|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-11-17|||May 2005||2005-05-01|November 2011|2011-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Group-Based Contingency Management for Substance Abuse Treatment - 1|Group-Based Contingency Management for Substance Abuse Treatment|Completed||N/A|312|Actual|UConn Health||1|||f||||f||||||||||2017-02-18 16:59:36.355403|2017-02-18 16:59:36.355403
NCT00249704|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2009-01-07|||October 2005||2005-10-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|||||Interventional|||Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects|Evaluation of the Effect of a 4-Month Intervention of Exercise and/or Vitamin D on Mobility Function and Strength in Frail Elderly Subjects|Terminated||Phase 1|64|Actual|Pfizer||4||See termination reason in detailed description.|f||||f||||||||||2017-02-18 16:59:36.435805|2017-02-18 16:59:36.435805
NCT00249691|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2012-03-06|||October 2005||2005-10-01|March 2012|2012-03-01|October 2012|Anticipated|2012-10-01|October 2011|Actual|2011-10-01||Interventional|||Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1|Medication Development for Cocaine Dependence|Unknown status|Active, not recruiting|Phase 3|180|Anticipated|University of Virginia||2|||f||||t||||||||||2017-02-18 16:59:36.54014|2017-02-18 16:59:36.54014
NCT00249678|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-05-31|||September 2004||2004-09-01|May 2013|2013-05-01|May 2007||2007-05-01|||||Interventional|||Behavioral Therapy Development for Methamphetamine Abusers|Behavioral Therapy Development for Methamphetamine Abuse|Suspended||Phase 2|50||University of California, Los Angeles|||||f||||||||||||||2017-02-18 16:59:36.661057|2017-02-18 16:59:36.661057
NCT00249652|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2015-04-13|||September 2003||2003-09-01|April 2015|2015-04-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Transplant and Addiction Project (TAP) - 1|Drug Treatment for Transplant Candidates|Completed||Phase 1/Phase 2|41|Actual|St. Luke's-Roosevelt Hospital Center||2|||f||||t||||||||||2017-02-18 16:59:36.829729|2017-02-18 16:59:36.829729
NCT00249639|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2017-01-11|||January 2004||2004-01-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Contingency Management for Attendance - 2|Contingency Management for Attendance|Completed||N/A|300|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 16:59:36.946756|2017-02-18 16:59:36.946756
NCT00249626|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-11-17|||January 2004||2004-01-01|November 2011|2011-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Therapists to Administer Contingency Management-Therapist Phase - 1|Therapists to Administer Contingency Management-Therapist Phase|Completed||N/A|42|Actual|UConn Health||1|||f||||f||||||||||2017-02-18 16:59:37.033846|2017-02-18 16:59:37.033846
NCT00249613|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2014-03-07|2013-04-10||June 2005||2005-06-01|March 2014|2014-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Gender-Responsive Treatment for Women Offenders - 1|Gender-Responsive Treatment for Women Offenders|Completed||N/A|291|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 16:59:37.13998|2017-02-18 16:59:37.13998
NCT00249600|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-11-17|||March 2003||2003-03-01|November 2011|2011-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Lower-Cost Contingency Management in a Group Setting - 1|Lower-Cost Contingency Management in a Group Setting|Completed||N/A|172|Actual|UConn Health||1|||f||||f||||||||||2017-02-18 16:59:37.49888|2017-02-18 16:59:37.49888
NCT00249587|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2017-01-09|||September 2000||2000-09-01|September 2008|2008-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Medication Adherence Therapy for Opioid Abusing Pain Patients|Medication Adherence Therapy for Opioid Abusing Pain Patients|Completed||Phase 1/Phase 2|36|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 16:59:37.585261|2017-02-18 16:59:37.585261
NCT00249535|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2012-03-29|||March 2005||2005-03-01|March 2012|2012-03-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2|Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients|Completed||N/A|240|Actual|UConn Health||3|||f||||f||||||||||2017-02-18 16:59:40.778155|2017-02-18 16:59:40.778155
NCT00249522|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2017-01-11|||August 2003||2003-08-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Vouchers vs. Prizes for Methadone Patients - 1|Vouchers vs. Prizes for Methadone Patients|Completed||N/A|76|Actual|National Institute on Drug Abuse (NIDA)|||||f||||f||||||||||2017-02-18 16:59:40.887293|2017-02-18 16:59:40.887293
NCT00249509|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2017-01-13|||September 2000||2000-09-01|March 2011|2011-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals|Marijuana Pharmacotherapies: Controlled Clinical Trials With Nefazodone and Bupropion|Completed||Phase 2|132||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:59:40.981054|2017-02-18 16:59:40.981054
NCT00249496|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-10-25|2016-08-31||October 2003||2003-10-01|October 2016|2016-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1|Therapeutic Workplace Maintenance Study|Completed||N/A|128|Actual|Johns Hopkins University||2|||f||||f||||||||No|The results were published in a peer-reviewed journal.|2017-02-18 16:59:41.095228|2017-02-18 16:59:41.095228
NCT00249483|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-10-31|||October 1999||1999-10-01|October 2013|2013-10-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals|Placebo-Controlled Venlafaxine Treatment for Depressed Cocaine Abusers|Completed||Phase 2|150|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 16:59:41.566549|2017-02-18 16:59:41.566549
NCT00249470|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-10-25|2016-09-02||April 2003||2003-04-01|October 2016|2016-10-01|October 2004|Actual|2004-10-01|May 2004|Actual|2004-05-01||Interventional|||The Therapeutic Workplace Initiation Study|The Therapeutic Workplace Initiation Study|Completed||N/A|117|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 16:59:41.676062|2017-02-18 16:59:41.676062
NCT00249457|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-09-06|||October 1996||1996-10-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2|A Therapeutic Workplace for Drug Abusers|Completed||N/A|40|Actual|Johns Hopkins University||2|||f||||f||||||||No|The data for this study have been published in a peer-reviewed journal.|2017-02-18 16:59:42.283134|2017-02-18 16:59:42.283134
NCT00249444|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-10-29|||May 2006||2006-05-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression|A Placebo Controlled Trial of Mirtazapine for Patients With Depression and Cocaine Dependence|Completed||Phase 2|107|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 16:59:42.404381|2017-02-18 16:59:42.404381
NCT00249431|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-12-10|||December 2001||2001-12-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1|A Pilot Study of Sertraline Plus Relapse Prevention Therapy (RP) for the Treatment of Pathological Gambling With Comorbid Abuse or Dependence|Terminated||Phase 2|9|Actual|New York State Psychiatric Institute||2||Terminated by the IRB for non-continuation|f||||||||||||||2017-02-18 16:59:42.530156|2017-02-18 16:59:42.530156
NCT00249418|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-11-17|||January 2004||2004-01-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Training Therapists to Administer Contingency Management-Patient Phase - 3|Training Therapists to Administer Contingency Management-Patient Phase|Completed||N/A|180|Actual|UConn Health||1|||f||||f||||||||||2017-02-18 16:59:42.641618|2017-02-18 16:59:42.641618
NCT00249405|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-11-02|||February 2005||2005-02-01|November 2010|2010-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)|Predicting Alcoholics' Treatment Responses to an SSRI|Completed||Phase 2|200|Anticipated|University of Cincinnati||2|||f||||t||||||||||2017-02-18 16:59:42.754246|2017-02-18 16:59:42.754246
NCT00249392|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2008-05-22|||October 2004||2004-10-01|May 2008|2008-05-01||||||||Observational|||Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Ocular Diseases||Unknown status|Active, not recruiting|N/A|800|Anticipated|Nanjing Medical University|||||f||||||||||||||2017-02-18 16:59:42.881666|2017-02-18 16:59:42.881666
NCT00249379|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-04-29|2012-01-03||June 2005||2005-06-01|April 2016|2016-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees|The Use of Acamprosate for Preventing Alcohol Relapse Among Alcohol Dependent Drug Treatment Court Participants|Terminated||Phase 4|26|Actual|Virginia Commonwealth University|Small numbers of subjects, significant number withdrew or were lost to follow-up|2||Not enough sugjects enrolled before funding ran out|f||||f||||||||||2017-02-18 16:59:42.967042|2017-02-18 16:59:42.967042
NCT00249366|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-04-08|||April 2001||2001-04-01|April 2016|2016-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Treatment of Alcohol Withdrawal in Hospital Patients|Acute Drug Withdrawal in a General Medical Setting|Completed||Phase 4|183|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-02-18 16:59:43.425613|2017-02-18 16:59:43.425613
NCT00249353|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-04-26|||March 2002||2002-03-01|April 2010|2010-04-01|October 2002|Actual|2002-10-01|||||Interventional|||An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder|An Evaluation of the Safety and Effectiveness of CONCERTA® (Methylphenidate Hydrochloride), up to 72 mg Daily, in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|220|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.||1|||||||||||||||||2017-02-18 16:59:43.549527|2017-02-18 16:59:43.549527
NCT00249340|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2007-04-10|||November 2005||2005-11-01|August 2005|2005-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Brief Behavioral Weight Loss Treatment vs. Weight Watchers|Comparison of a Brief Behavioral Weight Loss Intervention With the Weight Watchers Program|Completed||N/A|60||The Miriam Hospital|||||f||||||||||||||2017-02-18 16:59:43.655467|2017-02-18 16:59:43.655467
NCT00249327|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2007-04-18|||October 2005||2005-10-01|April 2007|2007-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Online HIV Prevention Vignette Evaluation|Online HIV Prevention Vignette Evaluation|Completed||N/A|1000||Public Health Solutions|||||f||||||||||||||2017-02-18 16:59:43.75709|2017-02-18 16:59:43.75709
NCT00249314|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2007-04-18|||November 2005||2005-11-01|April 2007|2007-04-01|December 2007|Anticipated|2007-12-01|||||Observational|||(Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups|A Prospective, Cross-Sectional, Case-Control, Molecular Study of Health Assessment and Risk in Ethnic Groups|Unknown status|Recruiting|N/A|120||McMaster University|||||f||||||||||||||2017-02-18 16:59:43.853874|2017-02-18 16:59:43.853874
NCT00249301|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2008-03-28|||October 2005||2005-10-01|March 2008|2008-03-01||||January 2008|Actual|2008-01-01||Interventional|||A Study of MLN8054 in Patients With Advanced Solid Tumors|An Open-Label, Dose Escalation Phase 1 Study of MLN8054, a Novel Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors|Terminated||Phase 1|63|Actual|Millennium Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 16:59:43.941487|2017-02-18 16:59:43.941487
NCT00249288|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2014-07-14|2014-06-11||December 2003||2003-12-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Folate Supplementation in Schizophrenia|Folate Supplementation in Schizophrenia|Completed||Phase 4|46|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 16:59:44.048342|2017-02-18 16:59:44.048342
NCT00249275|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2005-11-03|||January 2004||2004-01-01|January 2004|2004-01-01|August 2004||2004-08-01|||||Interventional|||Effectiveness of Alternative Approaches to Providing Spectacles in Tanzanian Secondary School Students|Evaluation of the Effectiveness of Alternative Approaches to Providing Spectacles in Secondary School Students in Dar Es Salaam, Tanzania|Completed||N/A|250||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 16:59:44.451541|2017-02-18 16:59:44.451541
NCT00249262|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2009-01-14|||October 2005||2005-10-01|January 2009|2009-01-01|April 2007||2007-04-01|||||Interventional|||Taxoprexin Treatment for Advanced Skin Melanoma|Phase II Open-Label Study of Weekly Taxoprexin (DHA-Paclitaxel) Injection as First Line Treatment of Patients With Metastatic Non-Choroidal Melanoma|Completed||Phase 2|30||Luitpold Pharmaceuticals|||||||||||||||||||2017-02-18 16:59:44.544843|2017-02-18 16:59:44.544843
NCT00249249|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-01-07|2009-08-26||October 2005||2005-10-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|||||Interventional|||Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels|Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia|Completed||Phase 3|830|Actual|Kowa Research Europe|||||f||||||||||||||2017-02-18 16:59:44.899936|2017-02-18 16:59:44.899936
NCT00249236|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-01-13|||March 2001||2001-03-01|January 2011|2011-01-01|December 2001|Actual|2001-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder|The Efficacy And Safety Of Flexible Dosage Ranges Of Risperidone Versus Placebo In The Treatment Of Manic Or Mixed Episodes Associated With Bipolar I Disorder|Completed||Phase 3|291|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:59:46.073574|2017-02-18 16:59:46.073574
NCT00249223|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-01-13|||January 2000||2000-01-01|January 2011|2011-01-01|December 2000|Actual|2000-12-01|||||Interventional|||A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia|Risperidone Depot (Microspheres) vs. Risperidone Tablets - a Non-inferiority, Efficacy Trial in Subjects With Schizophrenia|Completed||Phase 3|641|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 16:59:46.170299|2017-02-18 16:59:46.170299
NCT00249210|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-06-08|||August 1993||1993-08-01|February 2011|2011-02-01|July 1994|Actual|1994-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses|A Multicenter, Randomized Study to Compare the Safety and Efficacy of Oral Levofloxacin With Amoxicillin/Clavulanate Potassium in the Treatment of Acute Sinusitis in Adults|Completed||Phase 3|614|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:59:46.270144|2017-02-18 16:59:46.270144
NCT00249197|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-06-08|||January 1997||1997-01-01|January 2011|2011-01-01|July 1998|Actual|1998-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections|A Multicenter, Randomized, Open-Label Study to Compare the Safety and Efficacy of i.v. And/Or Oral Levofloxacin With That of Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Bacterial Skin and Skin Structure Infections|Completed||Phase 3|413|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 16:59:46.367723|2017-02-18 16:59:46.367723
NCT00249171|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-01-13|||June 2001||2001-06-01|January 2011|2011-01-01|February 2003|Actual|2003-02-01|||||Interventional|||A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients|Comparison of Oral Risperdal in Combination With Oral Lorazepam vs Standard Care Including Initial Conventional Neuroleptic IM Treatment, in Acute Schizophrenic Patients|Completed||Phase 4|226|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 16:59:46.468285|2017-02-18 16:59:46.468285
NCT00249158|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2010-11-18|||March 1998||1998-03-01|November 2010|2010-11-01|February 2001|Actual|2001-02-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia|Risperidone in the Treatment of Behavioural and Psychological Signs and Symptoms in Dementia (BPSSD): a Multicentre, Double-blind, Placebo-controlled Parallel-group Trial|Completed||Phase 3|344|Actual|Janssen-Cilag Pty Ltd|||||f||||||||||||||2017-02-18 16:59:46.55443|2017-02-18 16:59:46.55443
NCT00249145|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-01-13|||April 1995||1995-04-01|January 2011|2011-01-01|December 1996|Actual|1996-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia|Risperidone in the Treatment of Behavioral Disturbances in Demented Patients: an International, Multicenter, Placebo-controlled, Double-blind, Parallel-group Trial Using Haloperidol as Internal Reference|Completed||Phase 3|349|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 16:59:46.656092|2017-02-18 16:59:46.656092
NCT00249132|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-02-10||||||February 2011|2011-02-01|July 1991|Actual|1991-07-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia|Risperidone Versus Haloperidol Versus Placebo in the Treatment of Chronic Schizophrenia|Completed||Phase 3|523|Actual|Janssen, LP|||||f||||||||||||||2017-02-18 16:59:46.767469|2017-02-18 16:59:46.767469
NCT00005353|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||June 1992||1992-06-01|May 2000|2000-05-01|May 1995|Actual|1995-05-01|||||Observational|||Cardiac Autonomic Control in Children of HIV Positive Mothers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:59.940879|2017-02-18 18:14:59.940879
NCT00249119|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2011-02-10||||||February 2011|2011-02-01|December 1991|Actual|1991-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia|Risperidone in the Treatment of Chronic Schizophrenic Patients: an International Multicentre Double-blind Parallel-group Comparative Study Versus Haloperidol.|Completed||Phase 3|1579|Actual|Janssen, LP|||||f||||||||||||||2017-02-18 16:59:46.86843|2017-02-18 16:59:46.86843
NCT00249106|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-02-08|||December 2003||2003-12-01|September 2011|2011-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|C001||Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults|Randomized, Placebo-Controlled, Dose-Escalating, Double-Blinded Phase 1 Safety and Immunogenicity Study of Clade C DNA Vaccine ADVAX e/g + ADVAX p/N-t (ADVAX) Administered Intramuscularly to HIV-Uninfected, Healthy Volunteers.|Completed||Phase 1|45|Actual|International AIDS Vaccine Initiative||2|||f||||t||||||||||2017-02-18 16:59:46.957397|2017-02-18 16:59:46.957397
NCT00248066|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2007-02-06|||September 2005||2005-09-01|February 2007|2007-02-01||||||||Interventional|||Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries|APPRAISAL Trial: A Phase IIa Study to Evaluate the Safety and Preliminary Efficacy of RESTEN-MP® When Used in Conjunction With a Bare Metal Stent in de Novo Native Coronary Artery Lesions|Completed||Phase 2|50||Sarepta Therapeutics|||||f||||||||||||||2017-02-18 16:59:47.072702|2017-02-18 16:59:47.072702
NCT00248053|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2012-09-18|||November 2005||2005-11-01|September 2012|2012-09-01||||June 2008|Actual|2008-06-01||Interventional|||Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients|Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis (FAP) Patients|Withdrawn||Phase 2|0|Actual|Johns Hopkins University||1||"Subsequent data generated by our collaborators have shown efficacy with curcumin and quercetin~   in 5 patients in a non placebo controlled trial."|f||||f||||||||||2017-02-18 16:59:47.170271|2017-02-18 16:59:47.170271
NCT00248040|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2011-06-07|||October 2005||2005-10-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation|A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients|Completed||Phase 2|80|Actual|Dompé Farmaceutici S.p.A||3|||||||||||||||||2017-02-18 16:59:47.51724|2017-02-18 16:59:47.51724
NCT00248027|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2006-09-12|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Observational|||Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic|Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic|Terminated||Phase 1|||McMaster University|||||f||||||||||||||2017-02-18 16:59:47.635044|2017-02-18 16:59:47.635044
NCT00248014|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2012-01-18|||October 2005||2005-10-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||Response of Individuals With Class II Malocclusion|Cephalometric Indicators of Biological Responsiveness to Orthodontic Treatment of Class II/I in Growing Patients|Completed||Phase 2|63|Actual|Aristotle University Of Thessaloniki||1|||f||||t||||||||||2017-02-18 16:59:47.716773|2017-02-18 16:59:47.716773
NCT00247988|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2007-04-20|||October 2003||2003-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers|Phase II Study of Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers|Terminated||Phase 2|38||University of Saskatchewan||||"Regulatory issues(trial temporarily suspended December 28, 2005. Permanently suspended January~   19, 2007. Institutional Reveiw Board informed April 18, 2007"|f||||||||||||||2017-02-18 16:59:47.817172|2017-02-18 16:59:47.817172
NCT00247975|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2012-02-06|||March 2006||2006-03-01|February 2012|2012-02-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy|Primary Prevention of Anthracycline-Induced Cardiotoxicity With L-Carnitine in Patients With Breast Cancer (PPACC)-Pilot Study|Completed||Phase 2/Phase 3|144|Anticipated|Ottawa Heart Institute Research Corporation||1|||f||||t||||||||||2017-02-18 16:59:47.912226|2017-02-18 16:59:47.912226
NCT00247962|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2012-10-09|2009-01-30||December 2005||2005-12-01|October 2012|2012-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis|A Randomized, Double-Blind Study Evaluating the Safety and Efficacy of Etanercept and Sulphasalazine in Subjects With Ankylosing Spondylitis|Completed||Phase 4|566|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 16:59:48.023156|2017-02-18 16:59:48.023156
NCT00247949|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2009-11-09|||July 2004||2004-07-01|November 2009|2009-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Accuracy of Non-invasive Continuous CO2-Monitoring|The Accuracy of Non-invasive Continuous Carbon Dioxide Monitoring by the Sentec V-Sign Digital Monitor System|Terminated||Phase 4|150|Actual|University Hospital, Basel, Switzerland|||1|We had got enough data, therefore we stopped the study and published the data.|f||||t||||||||||2017-02-18 16:59:49.007532|2017-02-18 16:59:49.007532
NCT00247936|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2009-11-04|||May 2004||2004-05-01|November 2009|2009-11-01|April 2010|Anticipated|2010-04-01|April 2010|Anticipated|2010-04-01||Interventional|||Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial.|Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial.|Withdrawn||N/A|40|Anticipated|University of California, Irvine||2||Prior to recruitment, study terminated lack of recruitment interest.|f||||f||||||||||2017-02-18 16:59:49.089915|2017-02-18 16:59:49.089915
NCT00247923|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2011-07-03|||October 2005||2005-10-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|||||Interventional|||Endometrial Polyps: Pathophysiology and Clinical Consequences|Endometrial Polyps. Pathophysiology and Clinical Consequences.|Completed||N/A|1186|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-02-18 16:59:49.218274|2017-02-18 16:59:49.218274
NCT00247910|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2011-09-16|||October 2001||2001-10-01|September 2011|2011-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Behavioural Treatment of Hypertension|Behavioural Treatment of Hypertension|Completed||N/A|150|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:59:49.330007|2017-02-18 16:59:49.330007
NCT00248976|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-03-28|||April 1999||1999-04-01|March 2008|2008-03-01|March 2004||2004-03-01|||||Interventional|||Improving Health Behavior and Outcomes After Angioplasty|Improving Health Behavior and Outcomes After Angioplasty|Completed||N/A|660|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 16:59:51.52887|2017-02-18 16:59:51.52887
NCT00247897|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2011-04-11|||November 2005||2005-11-01|April 2011|2011-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Comparing Skin Disinfectants Before Labour Epidural Analgesia|What is the Best Skin Preparation Solution for Labour Epidural Analgesia? A Randomized Prospective Trial Comparing ChloraprepTM, DuraprepTM, and Chlorhexidine 0.5% in 70% Alcohol.|Completed||N/A|195|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 16:59:49.428593|2017-02-18 16:59:49.428593
NCT00247884|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2009-10-09|||June 2005||2005-06-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|||||Observational|||Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV|Directly Observed Therapy for the Treatment of Hepatitis C Virus Infection in Injection Drug Users|Completed||Phase 4|50|Anticipated|University of British Columbia|||1||f||||||||||||||2017-02-18 16:59:49.514451|2017-02-18 16:59:49.514451
NCT00247871|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2011-09-28|||October 2005||2005-10-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|||||Observational|||Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside|The Prevalence of Panton Valentine Leukocidin, Exfoliative Toxin and Agr Genotypes in Staphylococcus Aureus Nasal Colonization in Vancouver's Eastside Community|Unknown status|Active, not recruiting|N/A|600|Anticipated|University of British Columbia|||1||f||||||||||||||2017-02-18 16:59:49.602193|2017-02-18 16:59:49.602193
NCT00247858|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2011-09-28|||January 2005||2005-01-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Observational|||Analysis of Methicillin Resistant Staphylococcus Aureus (MRSA) Obtained Through the Emergency Department in a Tertiary Care Hospital in Vancouver Canada From 2001-2005|Analysis of Methicillin Resistant Staphylococcus Aureus (MRSA) Obtained Through the Emergency Department in a Tertiary Care Hospital in Vancouver Canada From 2001-2005|Unknown status|Active, not recruiting|N/A|97|Anticipated|University of British Columbia|||1||f||||||||||||||2017-02-18 16:59:49.684014|2017-02-18 16:59:49.684014
NCT00247845|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2014-08-20|||July 2004||2004-07-01|August 2014|2014-08-01|September 2007|Actual|2007-09-01|||||Observational|||Evaluation of Atazanavir Substitution Intervention (EASI) Study|Evaluation of Atazanavir Substitution Intervention (EASI) Study: An Observational Phase IV Study to Evaluate the Impact of Atazanavir Substitution on the Quality of Life and Maintenance of Virologic Suppression in HIV-Infected Patients Intolerant to Current Successful HAART|Completed||Phase 4|100|Anticipated|University of British Columbia|||1||f||||||||||||||2017-02-18 16:59:49.776719|2017-02-18 16:59:49.776719
NCT00247832|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2011-11-15|||October 2005||2005-10-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Readiness for Discharge Following Lobectomy|Readiness for Discharge Following Lobectomy: Effects of the Thoracic Risk Intervention and Management (T.R.I.M.) Protocol|Unknown status|Recruiting|N/A|99|Anticipated|University of British Columbia||3|||f||||f||||||||||2017-02-18 16:59:49.872236|2017-02-18 16:59:49.872236
NCT00247819|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2017-01-11|||August 1992||1992-08-01|October 2005|2005-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||The Genetic Basis for Vulnerability to Substance Abuse|Allelic Linkage in Substance Abuse|Completed||N/A|8000|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 16:59:49.9769|2017-02-18 16:59:49.9769
NCT00247806|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2008-09-24|||October 2008||2008-10-01|October 2005|2005-10-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Prevalence of Lactose Intolerance Following Stem Cell Transplantation|Prevalence of Lactose Intolerance Following Stem Cell Transplantation in Pediatric Patients.|Terminated||Phase 1|20|Anticipated|University of British Columbia||||Too few patients completed the study once enrolled.|f||||||||||||||2017-02-18 16:59:50.072201|2017-02-18 16:59:50.072201
NCT00249093|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2007-04-12|||October 2005||2005-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT||Completed||N/A|20||LHL Helse|||||f||||f||||||||||2017-02-18 16:59:50.149745|2017-02-18 16:59:50.149745
NCT00249080|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2009-08-21|||June 2005||2005-06-01|August 2009|2009-08-01|August 2007|Actual|2007-08-01|||||Observational|||Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease|High Field MRI of Brain Iron in Neurodegenerative Disease|Completed||N/A|182|Actual|Albany Medical College|||1||f||||t||||||||||2017-02-18 16:59:50.221904|2017-02-18 16:59:50.221904
NCT00249067|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2007-06-12|||October 2005||2005-10-01|June 2007|2007-06-01|October 2005||2005-10-01|||||Observational|||Retrospective Evaluation of Carvedilol Versus Captopril in CHF Patients|The Retrospective Evaluation of Carvedilol Versus Captopril and Digoxin/Lasix Therapy in Congestive Heart Failure Due to Left-to-Right Shunt Lesions|Terminated||N/A|50||Children's Healthcare of Atlanta||||data collection completed|f||||f||||||||||2017-02-18 16:59:50.311997|2017-02-18 16:59:50.311997
NCT00249054|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2007-07-03||||||July 2007|2007-07-01||||||||Interventional|||Prospective Clinical Evaluation of ASR Resurfacing Arthroplasty||Unknown status|Active, not recruiting|Phase 4|||Frederiksberg University Hospital|||||f||||||||||||||2017-02-18 16:59:50.416962|2017-02-18 16:59:50.416962
NCT00249041|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2010-07-29|||October 2005||2005-10-01|July 2010|2010-07-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Enbrel Liquid Immunogenicity Protocol|Open-label Study to Assess the Antibody Response to Etanercept Liquid in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 3|447|Actual|Amgen||1|||f||||||||||||||2017-02-18 16:59:50.482995|2017-02-18 16:59:50.482995
NCT00249015|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-04|2016-07-14|||January 2008||2008-01-01|June 2014|2014-06-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors|Randomized Controlled Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors. The CARE Trial.|Completed||Phase 3|301|Actual|AHS Cancer Control Alberta||3|||f||||t||||||||||2017-02-18 16:59:50.593961|2017-02-18 16:59:50.593961
NCT00249002|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-03-30|2012-02-21||November 2005||2005-11-01|March 2016|2016-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis|A Pilot Phase II Trial Of ABI-007 (A Cremophor El-Free, Protein Stabilized, Nanoparticle Paclitaxel) For The Prevention Of Vascular Access Graft Failure In Patients Undergoing Hemodialysis|Terminated||Phase 2|9|Actual|Celgene Corporation||1||Terminated due to pipeline prioritization|f||||f||||||||||2017-02-18 16:59:50.70305|2017-02-18 16:59:50.70305
NCT00248989|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2006-09-06|||November 2004||2004-11-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Effect of DHEA on Skin Aging in Postmenopausal Women|Placebo-Controlled and Randomized Phase III Study in Postmenopausal Women.|Unknown status|Active, not recruiting|Phase 3|150||Centre Hospitalier Universitaire de Québec, CHU de Québec|||||f||||||||||||||2017-02-18 16:59:51.397217|2017-02-18 16:59:51.397217
NCT00248963|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2006-05-17||||||May 2006|2006-05-01|October 2004||2004-10-01|||||Interventional|||Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception|A Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Levonorgestrel 90 Mg and Ethinyl Estradiol 20 Mg in a Continuous 28-Day Regimen for Oral Contraception Versus a Cyclic 21-Day Regimen Oral Contraceptive|Completed||Phase 3|600||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:59:51.637946|2017-02-18 16:59:51.637946
NCT00248950|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-04-01|||February 2004||2004-02-01|April 2008|2008-04-01|June 2004||2004-06-01|||||Interventional|||A Pilot Study: Changing Multiple Behaviors in Post-Angioplasty Patients|A Pilot Study: Changing Multiple Behaviors in Post-Angioplasty Patients|Completed||N/A|40||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 16:59:51.710389|2017-02-18 16:59:51.710389
NCT00248937|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-04-01|||February 2004||2004-02-01|April 2008|2008-04-01|June 2004||2004-06-01|||||Interventional|||A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients|A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients|Completed||N/A|40||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 16:59:51.805957|2017-02-18 16:59:51.805957
NCT00248924|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-03-31|||April 2001||2001-04-01|March 2008|2008-03-01|February 2003||2003-02-01|||||Observational|||Outcomes Of Social Service Programs For Homebound Older Adults|Outcomes Of Social Service Programs For Homebound Older Adults|Completed||N/A|56||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 16:59:51.897064|2017-02-18 16:59:51.897064
NCT00248911|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-04-10|||May 2003||2003-05-01|April 2008|2008-04-01|March 2010|Anticipated|2010-03-01|March 2010|Anticipated|2010-03-01||Interventional|||The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers|The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers:Avon Program for Meditation and Healing|Unknown status|Active, not recruiting|N/A|200|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 16:59:52.007635|2017-02-18 16:59:52.007635
NCT00248898|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2017-01-18|||March 2005||2005-03-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Quality of Life After Open Heart Surgery in Older Patients|Quality of Life After Open Heart Surgery in Older Patients|Completed||N/A|49|Actual|Weill Medical College of Cornell University|||1||f||||f||||||||Yes|Investigators may contact the PI for access to the data, with their planned analyses|2017-02-18 16:59:52.119402|2017-02-18 16:59:52.119402
NCT00248885|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-04-10|||September 1991||1991-09-01|April 2008|2008-04-01|September 1994|Actual|1994-09-01|||||Interventional|||Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)|Peri-Operative Morbidity and Quality of Life After CABG|Completed||N/A|248|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 16:59:52.20941|2017-02-18 16:59:52.20941
NCT00248872|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-04-01|||October 2004||2004-10-01|April 2008|2008-04-01|July 2008|Anticipated|2008-07-01|September 2006|Actual|2006-09-01||Interventional|||A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients|A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients|Unknown status|Active, not recruiting|N/A|262|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 16:59:52.315293|2017-02-18 16:59:52.315293
NCT00248859|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2010-11-04|||August 2004||2004-08-01|November 2010|2010-11-01|August 2009|Anticipated|2009-08-01|||||Observational|||Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease|Determinants of Cardiac Risk Factors Modification|Unknown status|Recruiting|N/A|213|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 16:59:52.420158|2017-02-18 16:59:52.420158
NCT00248846|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-04-01|||October 2004||2004-10-01|April 2008|2008-04-01|July 2008|Anticipated|2008-07-01|January 2008|Actual|2008-01-01||Interventional|||A Randomized Trial: Changing Behavior in Post-Angioplasty Patients|A Randomized Trial: Changing Behavior in Post-Angioplasty Patients|Unknown status|Active, not recruiting|N/A|246|Anticipated|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 16:59:52.512917|2017-02-18 16:59:52.512917
NCT00248833|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2016-10-25|||December 2005||2005-12-01|April 2010|2010-04-01|December 2007|Actual|2007-12-01|||||Interventional|||Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.|Phase 1 Dose Esc Study of Safety and Immun of 3 Injections, Given at 0, 6 and 24 Wks, of Grp B Meningococcal 44/76 MOS NOMV 5D Vaccine Admin to Healthy Subjs IM With and Without Adjuvant|Completed||Phase 1|30||U.S. Army Medical Research and Materiel Command|||||||||||||||||||2017-02-18 16:59:52.617804|2017-02-18 16:59:52.617804
NCT00248820|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2007-11-21|||September 2002||2002-09-01|November 2007|2007-11-01|February 2009|Anticipated|2009-02-01|||||Interventional|||Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses|Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Tours||1|||f||||f||||||||||2017-02-18 16:59:52.709991|2017-02-18 16:59:52.709991
NCT00248807|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2014-05-21|2013-09-12||October 2005||2005-10-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|May 2009|Actual|2009-05-01||Interventional|||A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.|Systemic Hemodynamics and Cerebral Blood Flow in Persons With Tetraplegia|Completed||N/A|30|Actual|VA Office of Research and Development|Did not assess carbon dioxide levels or the severity of spinal cord injury, which may have contributed to the results.|4|||f||||||||||||||2017-02-18 16:59:52.822247|2017-02-18 16:59:52.822247
NCT00248794|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2016-04-25|2015-09-02||June 2004||2004-06-01|April 2016|2016-04-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|||Cognitive Rehabilitation in Schizophrenia|The Effects of Cognitive Rehabilitation on Function in Schizophrenia|Completed||N/A|59|Actual|VA Office of Research and Development||3|||f||||f||||||||No|Data to be written up in peer review journal and possibly presented at regional and national conferences, but there is no plan to de-identify and share|2017-02-18 16:59:53.329583|2017-02-18 16:59:53.329583
NCT00248781|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2013-12-10|2013-09-24||September 2003||2003-09-01|December 2013|2013-12-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|||Home-based Exercise Via a Telecommunications System|Home-based Exercise Via a Telecommunications System|Completed||Phase 3|103|Actual|VA Office of Research and Development||2|||f||||||||||||||2017-02-18 16:59:53.8646|2017-02-18 16:59:53.8646
NCT00248768|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2014-09-18|||February 2005||2005-02-01|September 2014|2014-09-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|ATMS||Accelerated Transcranial Magnetic Stimulation (TMS) for Depression|Accelerated Transcranial Magnetic Stimulation for Depression|Completed||Phase 1|20|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 16:59:54.382352|2017-02-18 16:59:54.382352
NCT00248755|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2007-12-17|||November 2005||2005-11-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway|Pilot Study of a New Technique for Assessing Mucociliary Clearance and Airway Surface Liquid Volume in Cystic Fibrosis|Completed||N/A|14||University of Pittsburgh|||||f||||||||||||||2017-02-18 16:59:54.483373|2017-02-18 16:59:54.483373
NCT00248742|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-07-03|||February 2001||2001-02-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|INSPIRE||Psychobiology in Inflammatory Bowel Disease(IBD)|The Impact of Psychobiological Factors in Inflammatory Bowel Disease|Completed||N/A|114|Actual|Oslo University Hospital||1|||f||||f||||||||||2017-02-18 16:59:54.575386|2017-02-18 16:59:54.575386
NCT00248729|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2006-08-28|||October 2002||2002-10-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Effectiveness and Safety Study of Etomidate Versus Midazolam to Help Place a Breathing Tube Outside of the Hospital.|Etomidate Versus Midazolam for Pre-Hospital Intubation: A Prospective, Randomized Trial|Completed||Phase 2|||St. Luke's Hospital, Pennsylvania|||||f||||||||||||||2017-02-18 16:59:54.683395|2017-02-18 16:59:54.683395
NCT00248716|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-04-29|||February 2007||2007-02-01|April 2008|2008-04-01||||April 2009|Anticipated|2009-04-01||Interventional|||Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations.||Unknown status|Recruiting|Phase 4|200|Anticipated|Soroka University Medical Center||1|||f||||||||||||||2017-02-18 16:59:54.764998|2017-02-18 16:59:54.764998
NCT00248703|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2012-11-20|||October 2003||2003-10-01|November 2012|2012-11-01|November 2013|Anticipated|2013-11-01|November 2012|Actual|2012-11-01||Interventional|||Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow|Secondary Adjuvant (Rescue) Treatment With Docetaxel (Taxotere) and Detection of Isolated Tumor Cells in Bone Marrow as a Surrogate Marker for Effect in Node Positive and High Risk Node Negative Breast Cancer After Standard Adjuvant Epirubicin-containing Treatment|Unknown status|Active, not recruiting|Phase 2|1128|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-02-18 16:59:54.853213|2017-02-18 16:59:54.853213
NCT00248690|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-01-17|||November 2005||2005-11-01|January 2008|2008-01-01|June 2009|Actual|2009-06-01|February 2009|Actual|2009-02-01||Interventional|||ICP Versus Intracranial Compliance Guided Management in SAH|Intracranial Pressure (ICP) Versus Intracranial Compliance (ICC) Guided Management in Subarachnoid Hemorrhage; - a Prospective, Randomized Trial.|Completed||N/A|100|Actual|Oslo University Hospital||1|||f||||||||||||||2017-02-18 16:59:54.964618|2017-02-18 16:59:54.964618
NCT00248677|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-12-09|||September 2005||2005-09-01|February 2011|2011-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Sensible Treatment of Obesity in Rural Youth . . .|Sensible Treatment of Obesity in Rural Youth|Completed||Early Phase 1|93|Actual|University of Florida||3|||f||||||||||||||2017-02-18 16:59:55.061606|2017-02-18 16:59:55.061606
NCT00248664|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2010-03-02|||March 2004||2004-03-01|March 2010|2010-03-01|November 2008|Actual|2008-11-01|||||Observational|EPIC||Events Preceding Interstitial Cystitis (EPIC)|A Case Control Study of Interstitial Cystitis|Completed||N/A|400|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:59:55.168304|2017-02-18 16:59:55.168304
NCT00248651|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2014-06-26|2014-06-26||October 2006||2006-10-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|FDTT||Functional Dyspepsia Treatment Trial|Antidepressant Therapy for Functional Dyspepsia|Completed||Phase 2/Phase 3|292|Actual|Mayo Clinic||3|||f||||t||||||||||2017-02-18 16:59:55.252163|2017-02-18 16:59:55.252163
NCT00248638|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2015-08-04|2013-12-19||September 2006||2006-09-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|GLND|Adults following CABG, cardiac valve, vascular (non-neurosurgical), or small bowel and/or colonic surgery who are deemed likely to require PN for ≥ 7 subsequent days by the attending physicians and investigators are eligible. Potentially eligible subjects admitted to the SICU and deemed to require PN.|Efficacy and Mechanisms of GLN Dipeptide in the SICU|Phase III Study on the Efficacy of Glutamine Dipeptide-Supplemented Parenteral Nutrition in Surgical ICU Patients|Completed||Phase 3|150|Actual|Emory University||2|||f||||t||||||||||2017-02-18 16:59:56.132357|2017-02-18 16:59:56.132357
NCT00248625|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-06-16|2016-02-19||January 2000||2000-01-01|June 2016|2016-06-01|October 2010|Actual|2010-10-01|September 2009|Actual|2009-09-01||Interventional||All participants who were randomized were included in the baseline analysis.|N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure|A Multi-center Study of the Safety and Efficacy of N-acetylcysteine in the Treatment of Acute Liver Failure in Pediatric Patients Not Caused by Acetaminophen.|Completed||Phase 3|184|Actual|University of Pittsburgh||2|||f||||t||||||||No||2017-02-18 16:59:56.535244|2017-02-18 16:59:56.535244
NCT00248612|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2011-06-21|||September 2003||2003-09-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Psychosocial and Medication Treatment for Anxiety in Alcoholism|CBT And Venlafaxine Treatments For Anxiety In Alcoholism|Completed||Phase 2/Phase 3|180|Anticipated|Boston University||4|||f||||||||||||||2017-02-18 16:59:57.372479|2017-02-18 16:59:57.372479
NCT00248586|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2010-03-17||||||March 2010|2010-03-01||||||||Interventional|||Development of Limited Contact CBT Treatment for IBS|Development of Limited Contact CBT Treatment for IBS|Completed||Phase 1/Phase 2|85|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 16:59:57.479962|2017-02-18 16:59:57.479962
NCT00248573|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-12-16|||October 2004||2004-10-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|September 2012|Actual|2012-09-01||Observational|||Mechanisms of Adaptation in Human Short Bowel Syndrome||Completed||Phase 1/Phase 2|32|Actual|Emory University|||1||f||||||||||Samples With DNA|"~     Intestinal biopsy samples~   "|||2017-02-18 16:59:57.558674|2017-02-18 16:59:57.558674
NCT00248560|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2014-09-24|2014-08-18||January 2005||2005-01-01|September 2014|2014-09-01|June 2012|Actual|2012-06-01|December 2009|Actual|2009-12-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer|Phase II Study of Gemcitabine and Docetaxel (GEMDOC) Combination in Patients With Previously Treated Recurrent or Metatstatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|36|Actual|Barbara Ann Karmanos Cancer Institute|The trial design was changed during accrual to allow for study continuation although response rate was lower than predicted. The trial was completed but it did not meet the specified end points.|1|||f||||t||||||||||2017-02-18 16:59:57.646896|2017-02-18 16:59:57.646896
NCT00247663|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2012-04-18|||December 1999||1999-12-01|April 2012|2012-04-01||||December 2005|Actual|2005-12-01||Interventional|||Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer|Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer|Completed||Phase 2|17|Actual|Novartis||1|||f||||f||||||||||2017-02-18 17:00:10.052566|2017-02-18 17:00:10.052566
NCT00248547|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-12-20|2011-11-21||May 2004||2004-05-01|December 2011|2011-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant|A Pilot Study of Aprepitant vs. Placebo Combined With Standard Antiemetics for the Control of Nausea and Vomiting During Hematopoietic Cell Transplatation(HCT)|Completed||N/A|40|Actual|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-02-18 16:59:57.920651|2017-02-18 16:59:57.920651
NCT00248534|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2012-10-11|||September 2005||2005-09-01|October 2008|2008-10-01||||September 2012|Actual|2012-09-01||Interventional|||Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma|A Phase II Study of Rituximab and Temozolomide in Recurrent Primary CNS Lymphoma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 16:59:58.324867|2017-02-18 16:59:58.324867
NCT00248521|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-08-01|||October 2005||2005-10-01|March 2008|2008-03-01||||January 2007|Anticipated|2007-01-01||Interventional|||17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery|A Cancer Research UK Phase I Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of 17-Dimethylaminoethyl-amino-17-Demethoxygeldanamycin (17-DMAG) Given as a Once Weekly Infusion in Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 16:59:58.435532|2017-02-18 16:59:58.435532
NCT00248495|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-09-09|||June 2005||2005-06-01|September 2016|2016-09-01||||April 2012|Actual|2012-04-01||Interventional|||Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Molecular and Genetic Changes in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) Following Neoadjuvant Chemotherapy With Cisplatin and Alimta - Phase II Study|Active, not recruiting||Phase 2|38|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 16:59:58.523528|2017-02-18 16:59:58.523528
NCT00248482|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2013-04-25|||February 2002||2002-02-01|April 2013|2013-04-01|January 2008|Actual|2008-01-01|April 2005|Actual|2005-04-01||Interventional|||Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Imatinib Mesylate Maintenance Therapy in Patients With C-Kit (+) Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|6|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 16:59:58.633739|2017-02-18 16:59:58.633739
NCT00248469|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2006-10-19|||July 1998||1998-07-01|November 2005|2005-11-01|April 2002||2002-04-01|||||Interventional|||MEMA Kwa Vijana Trial: Impact of an Adolescent Sexual and Reproductive Health Intervention in Mwanza, Tanzania|Strategies for the Prevention of HIV Infection and the Enhancement of Reproductive Health Among Adolescents in Rural Tanzania: MEMA Kwa Vijana Trial|Completed||Phase 3|10000||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 16:59:58.747513|2017-02-18 16:59:58.747513
NCT00248456|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2008-02-20|||October 2005||2005-10-01|February 2008|2008-02-01|February 2006||2006-02-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris|A Randomised, Double-Blind, Active-Controlled, Parallel, Multi-Center Study to Investigate the Efficacy and Safety of Daivobet® Ointment in Patients With Psoriasis Vulgaris|Completed||Phase 4|320||LEO Pharma|||||f||||||||||||||2017-02-18 16:59:58.850067|2017-02-18 16:59:58.850067
NCT00248443|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2011-02-17|||August 2005||2005-08-01|March 2007|2007-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage|Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage. A Multicentric Randomized Controlled Trial|Completed||Phase 3|206|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 16:59:58.938553|2017-02-18 16:59:58.938553
NCT00248430|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2010-09-20|||August 2003||2003-08-01|September 2010|2010-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer|A Phase I-II Trial of Adoptive Immunotherapy Using Haploidentical, Related Donor-Lymphocyte Infusions and IL-2 After Autologous Stem Cell Transplantation for Advanced Lymphoid Malignancies|Completed||Phase 1/Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 16:59:59.044629|2017-02-18 16:59:59.044629
NCT00248404|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2012-09-26|||September 2005||2005-09-01|January 2008|2008-01-01||||||||Interventional|||NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)|A Phase I/II Study of NB1011 Administered Intravenously by Continuous Infusion in an Every Second Week Regimen With Open-label Continuation in Cancers That Overexpress the Enzyme Thymidylate Synthase|Completed||Phase 1/Phase 2|155|Anticipated|Kiadis Pharma|||||f||||||||||||||2017-02-18 16:59:59.148007|2017-02-18 16:59:59.148007
NCT00248391|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2007-10-25||||||October 2006|2006-10-01|January 2008|Anticipated|2008-01-01|||||Interventional|||The Influence of Feeding Position on Pulmonary Morbidity in Young Children|The Influence of Feeding Position on Pulmonary Morbidity in Young Children|Unknown status|Not yet recruiting|N/A|2000|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 16:59:59.232|2017-02-18 16:59:59.232
NCT00248378|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2006-06-21|||September 2001||2001-09-01|June 2006|2006-06-01|March 2005||2005-03-01|||||Interventional|||Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis|Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis|Completed||Phase 1/Phase 2|30||Center for Medicinal Cannabis Research|||||||||||||||||||2017-02-18 16:59:59.321007|2017-02-18 16:59:59.321007
NCT00248365|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-03|2016-02-24|||November 2005||2005-11-01|February 2016|2016-02-01|August 2007|Actual|2007-08-01|||||Interventional|||Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD)|Safety, Biological and Clinical Efficacy of Two Intensity Levels of Theralux Extracorporeal Photochemotherapy in Subjects With Extensive Chronic GvHD Refractory or Intolerant to Standard Therapy: A Randomized, Open-label Phase I/II Clinical Trial|Completed||Phase 1/Phase 2|20|Actual|Kiadis Pharma||2|||||||||||||||||2017-02-18 16:59:59.407693|2017-02-18 16:59:59.407693
NCT00248352|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2007-10-25|||February 2005||2005-02-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease|GLUCOSE : Glucose Lowering by Usual Care Or Specialized Endocrinology Team|Completed||N/A|212|Anticipated|Ottawa Heart Institute Research Corporation|||||f||||||||||||||2017-02-18 16:59:59.50874|2017-02-18 16:59:59.50874
NCT00248339|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2007-12-14|||May 2002||2002-05-01|November 2005|2005-11-01|July 2005|Actual|2005-07-01|||||Interventional|||Trial of Peg-Interferon Plus Epoetin-Alfa for Treatment of Chronic Hepatitis C Virus Infection|An Open-Label, Randomized Pilot Study to Compare the Effectiveness of Peginterferon-Alfa-2b Plus Ribavirin to Peginterferon-Alfa-2b Plus Epoetin-Alfa and Two Doses of Ribavirin in the Treatment of Chronic Hepatitis C Virus Infection|Completed||Phase 3|150|Actual|Virginia Commonwealth University||3|||f||||t||||||||||2017-02-18 16:59:59.617001|2017-02-18 16:59:59.617001
NCT00248326|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2016-01-04|||January 2005||2005-01-01|January 2016|2016-01-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||The Genetic Basis of Atrial Fibrillation (AF)|The Genetic Basis of Atrial Fibrillation|Completed||N/A|50|Actual|University of Pittsburgh|||2||f||||t||||||||||2017-02-18 16:59:59.738524|2017-02-18 16:59:59.738524
NCT00248313|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2010-03-09|||July 2000||2000-07-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus|A Randomized, Open-label Study to Compare the Safety and Efficacy of Cyclosporin Dose Reduction With Cyclosporin Elimination in de Novo Renal Allograft Recipients Receiving Rapamune|Completed||Phase 3|470||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 16:59:59.837496|2017-02-18 16:59:59.837496
NCT00248300|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2015-11-09|||August 2005||2005-08-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP|A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP|Completed||Phase 4|156|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-02-18 16:59:59.91251|2017-02-18 16:59:59.91251
NCT00248287|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2016-09-15|2016-02-02||July 2005||2005-07-01|September 2016|2016-09-01|December 2016|Anticipated|2016-12-01|May 2014|Actual|2014-05-01||Interventional|CA225200|ITT population|PhII ICb With/Without Erbitux in MBC Pts|Randomized Phase II Study of Weekly Irinotecan/Carboplatin (ICb) With or Without Cetuximab (Erbitux) in Patients With Metastatic Breast Cancer|Active, not recruiting||Phase 2|154|Actual|US Oncology Research||2|||f||||||||||||||2017-02-18 17:00:00.288662|2017-02-18 17:00:00.288662
NCT00248274|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2011-11-21|||January 2005||2005-01-01|November 2011|2011-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Atrial Tissue Banking: Atrial Tissue Obtained From Patients Undergoing Heart Surgery|Assessment of Atrial Tissue Obtained From Patients Undergoing Heart Surgery|Terminated||N/A|300|Actual|University of Pittsburgh|||1|Staffing and departmental changes at our site made it difficult to enroll subjects.|f||||t||||||Samples With DNA|"~     1. myocardial tissue~        2. DNA~   "|||2017-02-18 17:00:00.962929|2017-02-18 17:00:00.962929
NCT00248261|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2013-12-12|||November 2005||2005-11-01|December 2013|2013-12-01|June 2010|Actual|2010-06-01|August 2009|Actual|2009-08-01||Observational|||Ziprasidone and Sertraline in PTSD|Effects of Ziprasidone vs. Placebo During the First Four Weeks of Eight Weeks Sertraline Treatment in Patients With Post-traumatic Stress Disorder (PTSD)|Terminated||Phase 2|7|Actual|Universitätsklinikum Hamburg-Eppendorf|||1|High rate of early drop-outs|f||||||||||||||2017-02-18 17:00:01.05838|2017-02-18 17:00:01.05838
NCT00248248|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2011-10-07|||October 2005||2005-10-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||DOXIL for Consolidation Therapy in Ovarian Cancer.|A Phase II Non-randomized Study of DOXIL Consolidation Treatment for Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneal Carcinoma.|Completed||Phase 2|45|Anticipated|Southeastern Gynecologic Oncology||1|||f||||f||||||||||2017-02-18 17:00:01.171317|2017-02-18 17:00:01.171317
NCT00248235|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2016-05-10|||September 2005||2005-09-01|May 2016|2016-05-01|January 2009|Actual|2009-01-01|May 2008|Actual|2008-05-01||Interventional|||Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer|Randomized Controlled Trial of Progressive Resistance Exercise Training for Spinal Accessory Neurapraxia/ Neurectomy in Head and Neck Cancer Survivors|Completed||Phase 2/Phase 3|64|Actual|University of Alberta, Physical Education||2|||f||||||||||||||2017-02-18 17:00:01.297692|2017-02-18 17:00:01.297692
NCT00248222|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2009-10-26|||October 2005||2005-10-01|October 2009|2009-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Early Aerobic Training Program After Ischemic Stroke||Completed||Phase 2|||Sheba Medical Center|||||f||||f||||||||||2017-02-18 17:00:01.431038|2017-02-18 17:00:01.431038
NCT00248209|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2011-07-19|||May 2004||2004-05-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Female Orgasmic Disorder (FOD) and Wellbutrin XL|A Multi-center, Double-blind, Placebo-controlled Study of Bupropion XL in Females With Orgasmic Disorder|Completed||Phase 2/Phase 3|48|Actual|Segraves, R., T., M.D., Ph.D.||1|||f||||f||||||||||2017-02-18 17:00:01.549636|2017-02-18 17:00:01.549636
NCT00248196|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2008-03-20|||October 2005||2005-10-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||COOL MI II: Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction|COOL MI II: Cooling as an Adjunctive Therapy to Percutaneous Intervention in Patients With Acute Myocardial Infarction|Terminated||Phase 2/Phase 3|225|Anticipated|Radiant Medical|||||||||||||||||||2017-02-18 17:00:01.686236|2017-02-18 17:00:01.686236
NCT00248183|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2008-04-02|||August 2005||2005-08-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)|A Randomized, Double Blind, Placebo Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Tolerability Of PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)|Completed||Phase 3|310||Epix Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 17:00:01.786191|2017-02-18 17:00:01.786191
NCT00248170|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2016-03-20|2015-09-08||December 2005||2005-12-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|FACE||Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer|Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer|Completed||Phase 3|4172|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:00:01.946138|2017-02-18 17:00:01.946138
NCT00248157|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2012-04-30|||November 2005||2005-11-01|April 2012|2012-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy|An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Octreotide Acetate in Microspheres in the Therapy of Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR)|Terminated||Phase 3|105|Actual|Novartis||||Inconsistent treatment benefit|f||||||||||||||2017-02-18 17:00:07.371767|2017-02-18 17:00:07.371767
NCT00248144|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2007-12-07|||October 2003||2003-10-01|August 2006|2006-08-01|July 2007|Actual|2007-07-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis|A Randomized, Multicenter, Double-Blinded Controlled Study to Compare the Effectiveness of a Single Dose (1500 mg) of Famciclovir, One Day (750 mg q12) of Famciclovir and Placebo in Patient-Initiated Episodic Treatment of Recurrent Herpes Labialis|Completed||Phase 4|||Novartis|||||||||||||||||||2017-02-18 17:00:07.45671|2017-02-18 17:00:07.45671
NCT00248131|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-02|2012-04-08|||November 2005||2005-11-01|April 2012|2012-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy|An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Octreotide Acetate in Microspheres in the Therapy of Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR)|Terminated||Phase 3|260||Novartis|||||f||||||||||||||2017-02-18 17:00:07.536609|2017-02-18 17:00:07.536609
NCT00248118|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2016-09-22|||January 2005||2005-01-01|September 2016|2016-09-01|May 2008|Actual|2008-05-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking|Neurocognitive and Affective Correlates of Tobacco Dependence in Adolescent Smokers and Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking|Terminated||Phase 2/Phase 3|72|Actual|National Institutes of Health Clinical Center (CC)||2||PI left NIH|f||||t||||||||||2017-02-18 17:00:07.632041|2017-02-18 17:00:07.632041
NCT00248105|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2013-10-31|||September 2005||2005-09-01|October 2013|2013-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|IMPAACT||Improving Motivation for Physical Activity in Arthritis Clinical Trial|Physical Activity in Persons With Arthritis|Completed||N/A|889|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 17:00:07.757132|2017-02-18 17:00:07.757132
NCT00248092|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2007-11-01|||January 2006||2006-01-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse|A Double-Blind, Randomized, Placebo and Active-Controlled, Six-Period Crossover Study to Evaluate the Likeability, Safety, and Abuse Liability of NRP104 in Healthy Adult Volunteers With Histories of Stimulant Abuse|Completed||Phase 1/Phase 2|36||New River Pharmaceuticals|||||||||||||||||||2017-02-18 17:00:07.869175|2017-02-18 17:00:07.869175
NCT00248079|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2011-10-18|||November 2005||2005-11-01|October 2011|2011-10-01|October 2011|Actual|2011-10-01|June 2007|Actual|2007-06-01||Interventional|||The Medtronic RESOLUTE Clinical Trial|The Clinical Response Evaluation of the Medtronic Endeavor CR ABT-578 Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Completed||Phase 1/Phase 2|139|Actual|Medtronic Vascular||1|||f||||t||||||||||2017-02-18 17:00:07.969348|2017-02-18 17:00:07.969348
NCT00247793|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2005-11-01|||July 1996||1996-07-01|November 2005|2005-11-01|December 1998||1998-12-01|||||Interventional|||Immunonutrition in Cardiac Surgery|The Effect of Pre- and Postoperative Supplemental Enteral Nutrition in High-Risk Patients Undergoing Elective Cardiac Surgery. A Prospective Double Blind Study.|Completed||N/A|||Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||||f||||||||||||||2017-02-18 17:00:08.079513|2017-02-18 17:00:08.079513
NCT00247780|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2008-02-13|||November 2004||2004-11-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation|Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation|Completed||Phase 4|149|Actual|University of Aarhus||2|||f||||||||||||||2017-02-18 17:00:08.191922|2017-02-18 17:00:08.191922
NCT00247754|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2005-10-31|||November 2002||2002-11-01|October 2005|2005-10-01|June 2005||2005-06-01|||||Interventional|||VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children)|VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children)|Completed||N/A|281||University of British Columbia|||||f||||||||||||||2017-02-18 17:00:08.308617|2017-02-18 17:00:08.308617
NCT00247741|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2013-12-18|||November 2005||2005-11-01|October 2005|2005-10-01|May 2006||2006-05-01|||||Interventional|||Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery.|Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery: A Double Blind Randomized Clinical Trial.|Completed||Phase 3|80||St. Antonius Hospital||2|||f||||f||||||||||2017-02-18 17:00:08.639821|2017-02-18 17:00:08.639821
NCT00247728|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2007-10-16|||June 2004||2004-06-01|October 2007|2007-10-01|June 2008||2008-06-01|||||Interventional|||PI-88 in Hepatocellular Carcinoma After Hepatectomy|A Randomized, Multi-Centre, Efficacy Evaluation of PI-88 in Patients With Hepatocellular Carcinoma After Hepatectomy - A Phase II Study|Completed||Phase 2|343||Progen Pharmaceuticals|||||||||||||||||||2017-02-18 17:00:08.758316|2017-02-18 17:00:08.758316
NCT00247715|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2007-08-28|||October 2003||2003-10-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||"Comparison of a Step-Up Versus a Step-Down Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)"|Comparison of an Antacid/H2-Receptor Antagonist/Proton Pump Inhibitor Versus a Proton Pump Inhibitor/H2-Receptor Antagonist/Antacid Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)|Completed||N/A|664|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 17:00:08.86761|2017-02-18 17:00:08.86761
NCT00247702|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2005-11-01|||July 2005||2005-07-01|July 2005|2005-07-01|June 2006||2006-06-01|||||Interventional|||The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR|Study of the Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR|Unknown status|Recruiting|N/A|120||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:00:09.000232|2017-02-18 17:00:09.000232
NCT00247689|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2017-01-24|||December 22, 2004||2004-12-22|February 27, 2015|2015-02-27|February 27, 2015||2015-02-27|||||Observational|||Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics|Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics|Terminated||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:00:09.089585|2017-02-18 17:00:09.089585
NCT00247676|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2010-02-04|2010-01-06||February 2006||2006-02-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer|An Open Label International Multi-Center Phase 2 Activity And Safety Study Of SU011248 In Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|37|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:00:09.208643|2017-02-18 17:00:09.208643
NCT00247650|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2009-11-20|||September 2005||2005-09-01|November 2009|2009-11-01||||March 2007|Actual|2007-03-01||Interventional|||Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy|Randomized Multi-Center Study Comparing Prolonged Primary Systemic Endocrine Therapy With Letrozole Alone or in Combination With Zoledronic Acid in Early Breast Cancer (NEOadjuvant Study in CANada)|Completed||Phase 2|190|Anticipated|Novartis|||||f||||||||||||||2017-02-18 17:00:10.166717|2017-02-18 17:00:10.166717
NCT00247637|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2013-07-01|||May 2003||2003-05-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia|The Genetics of Endophenotypes and Schizophrenia|Completed||N/A|2025|Actual|University of California, San Diego|||1||f||||||||||Samples With DNA|"~     Whole blood was sent to the Cell Repository at Rutgers toestablish cell lines.~   "|||2017-02-18 17:00:10.266116|2017-02-18 17:00:10.266116
NCT00247624|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2010-11-29|||October 2005||2005-10-01|March 2009|2009-03-01|December 2008|Anticipated|2008-12-01|October 2008|Anticipated|2008-10-01||Interventional|||Improving Sleep and Psychological Functioning in People With Depression and Insomnia|Hypnotics in the Treatment of Psychiatric Disorders|Unknown status|Active, not recruiting|Phase 4|96|Anticipated|Wake Forest University Health Sciences||2|||f||||||||||||||2017-02-18 17:00:10.358905|2017-02-18 17:00:10.358905
NCT00247611|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2013-11-26|2013-08-01||October 2005||2005-10-01|November 2013|2013-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||Baseline characteristics provided for randomized sample. Analyses were conducted on those with >=2 adherence assessments for ITT.|Improving Treatment Adherence in HIV-Infected Individuals|Changing ART Adherence Behavior: The Lifewindows Project|Completed||Phase 2|594|Actual|University of Connecticut|"The only empirical demonstration of LifeWindows outcomes to date~OP sample was defined a posteriori~Under-powered to detect changes in Viral Load"|2|||f||||t||||||||||2017-02-18 17:00:10.483314|2017-02-18 17:00:10.483314
NCT00247585|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2006-12-04|||September 2003||2003-09-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Hangover, Congeners, Sleep and Occupational Performance|Hangover, Congeners, Sleep and Occupational Performance|Completed||Phase 2|140||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 17:00:11.410716|2017-02-18 17:00:11.410716
NCT00247572|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2007-11-01|||September 2005||2005-09-01|November 2007|2007-11-01|November 2005|Actual|2005-11-01|||||Interventional|||Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories|A Double-Blind Placebo- and Active-Controlled, Single-Dose Crossover PD and PK Study to Evaluate the Safety, Tolerability and Abuse Liability of IV Administered NRP104 25 mg and 50 mg in Adult Volunteers With Histories of Stimulant Abuse|Completed||Phase 2|12||New River Pharmaceuticals|||||||||||||||||||2017-02-18 17:00:11.507311|2017-02-18 17:00:11.507311
NCT00247559|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2006-05-15|||May 2004||2004-05-01|May 2006|2006-05-01|May 2005||2005-05-01|||||Interventional|||Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)|A Phase II, Multi-Centre, Randomised, Double-Blind, Dose-Ranging Study Comparing the Efficacy and Safety of a Single Treatment With 15 U, 30 U or 45 U of Botulinum Type A Toxin to Placebo in the Symptomatic Treatment of Lateral Canthal Lines (Crow’s Feet)|Completed||Phase 2|220||Ipsen|||||f||||||||||||||2017-02-18 17:00:11.621104|2017-02-18 17:00:11.621104
NCT00247546|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2006-10-17|||March 2003||2003-03-01|September 2006|2006-09-01|March 2005||2005-03-01|||||Interventional|||Prevention of Falls and Injurious Falls Among Elderly People||Completed||N/A|592||The Hospital District of Satakunta|||||f||||||||||||||2017-02-18 17:00:11.718712|2017-02-18 17:00:11.718712
NCT00247533|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2009-02-06|||October 2005||2005-10-01|August 2005|2005-08-01|August 2007|Anticipated|2007-08-01|||||Interventional|||Cerebral Artery Stenosis, Coronary Artery Disease and Arrhythmia|The Early Diagnosis and Prevention of Ischemic Stroke and Cognition Decline Associated With Coronary Artery Disease Combined With Cerebral Artery Stenosis or Arrhythmia by 24-Hour Simultaneous Recorder of Electrocardiograph and Electroencephalography|Unknown status|Recruiting|Phase 4|30|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 17:00:11.820808|2017-02-18 17:00:11.820808
NCT00247520|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2005-11-01|||May 2005||2005-05-01|November 2005|2005-11-01|August 2005||2005-08-01|||||Interventional|||Safety and Efficacy Study of rEV131 in Allergic Rhinitis|Two Center Evaluation of the Safety and Efficacy of Topical Nasal rEV131 Versus rEV131 Vehicle (Placebo)in the Prevention of the Signs and Symptoms of Allergic Rhinitis Induced by Nasal Allergen Challenge|Unknown status|Active, not recruiting|Phase 1/Phase 2|112||Evolutec Group|||||||||||||||||||2017-02-18 17:00:11.919977|2017-02-18 17:00:11.919977
NCT00247507|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2006-10-17|||September 2005||2005-09-01|October 2005|2005-10-01|December 2005||2005-12-01|||||Interventional|||The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients||Unknown status|Active, not recruiting|Phase 4|||Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 17:00:12.024617|2017-02-18 17:00:12.024617
NCT00247494|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2009-07-21|||April 2005||2005-04-01|November 2005|2005-11-01||||||||Interventional|||Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients|Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients|Unknown status|Recruiting|Phase 4|90|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||||f||||t||||||||||2017-02-18 17:00:12.129524|2017-02-18 17:00:12.129524
NCT00247481|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2009-04-22|||September 2002||2002-09-01|April 2009|2009-04-01|June 2005|Actual|2005-06-01|||||Interventional|||ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer|A Multicentre, Randomised, Double-Blind, Non-Comparative Phase II Trial Of ZD1839 (Iressa™) And Placebo In Combination With Chemotherapy With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer|Completed||Phase 2|77||AstraZeneca|||||f||||||||||||||2017-02-18 17:00:12.226789|2017-02-18 17:00:12.226789
NCT00247468|ClinicalTrials.gov processed this data on February 17, 2017|2005-11-01|2017-01-19|||December 2004|Actual|2004-12-01|January 2017|2017-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Strict Glucose Control of Pediatric Intensive Care Unit (ICU) Patients|Strict Glucose Control of Pediatric ICU Patients to Reduce Mortality and Morbidity|Withdrawn||N/A|0|Actual|Children's Hospital of Philadelphia||||Never received IRB approval|f||||f|f|f||||||No||2017-02-18 17:00:12.324687|2017-02-18 17:00:12.324687
NCT00247455|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-06-20|||March 2002||2002-03-01|August 2007|2007-08-01|August 2005|Actual|2005-08-01|||||Interventional|||Fibre and Appetite Regulation Trial (FART)|Long-term Effect of Cereal Fibre on Abdominal Fat in Insulin Resistant Subjects|Completed||N/A|32||University of Toronto|||||f||||f||||||||||2017-02-18 17:00:12.411949|2017-02-18 17:00:12.411949
NCT00247442|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-30|2006-09-27|||January 2006||2006-01-01|June 2005|2005-06-01|April 2006||2006-04-01|||||Interventional|||Australian Screening Mammography Decision Aid Trial (ASMDAT)|An Evaluation of a Decision Aid for Women Aged Over 70 Considering Whether to Stop or Continue Having Mammography Screening.|Completed||N/A|670||University of Sydney|||||f||||||||||||||2017-02-18 17:00:12.502814|2017-02-18 17:00:12.502814
NCT00247429|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2009-08-31|||July 2004||2004-07-01|August 2009|2009-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients|Vandral Retard (Venlafaxine Extended Release) in Depressive Syndrome With Anxiety and Painful Symptoms in Elderly Patients. Observational Study in Primary Care|Completed||Phase 4|59|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||None Retained|"~     No specimen retained~   "|||2017-02-18 17:00:12.593307|2017-02-18 17:00:12.593307
NCT00247416|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2014-01-16|2013-08-02||August 2005||2005-08-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer|Randomized Phase II Trail of Carboplatin and Gemcitabine Untreated Stage IIIB-pleural Effusion and Stage IV Lung Cancer|Completed||Phase 2|60|Actual|University of Kentucky||2|||f||||t||||||||||2017-02-18 17:00:12.674732|2017-02-18 17:00:12.674732
NCT00247403|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2015-04-09|||October 2005||2005-10-01|April 2015|2015-04-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Interventional|||Safety Study of 2DG With Stereotactic Radiosurgery|Phase I Clinical Trial: 2DG + Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases|Withdrawn||Phase 1|0|Actual|University of Iowa||1||Pharmaceutical company no longer manufactures drug|f||||t||||||||||2017-02-18 17:00:13.290948|2017-02-18 17:00:13.290948
NCT00247390|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2010-06-02|||July 2005||2005-07-01|June 2010|2010-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.|A Randomised, Double-blind, Placebo-controlled Study to Determine the Long-term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.|Completed||Phase 3|451|Actual|Takeda||2|||f||||f||||||||||2017-02-18 17:00:13.532177|2017-02-18 17:00:13.532177
NCT00247377|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2010-05-11|2010-01-19||October 2002||2002-10-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity|A Prospective Randomized Trial of Laparoscopic Gastric Bypass vs Laparoscopic Adjustable Gastric Banding (LAP-BAND) for Treatment of Morbid Obesity|Completed||N/A|197|Actual|University of California, Irvine||2|||f||||f||||||||||2017-02-18 17:00:13.714222|2017-02-18 17:00:13.714222
NCT00247364|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2005-10-28|||November 2003||2003-11-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)|A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)|Completed||Phase 2|20||Sleep Health Centers|||||f||||||||||||||2017-02-18 17:00:14.507787|2017-02-18 17:00:14.507787
NCT00247351|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2006-10-18|||September 2003||2003-09-01|September 2003|2003-09-01|June 2005||2005-06-01|||||Interventional|||Prevention of Atrial Tachycardia After a Right Atriotomy|Prevention of Atrial Tachycardia After a Right Atriotomy|Completed||N/A|15||Aarhus University Hospital Skejby|||||f||||||||||||||2017-02-18 17:00:14.599493|2017-02-18 17:00:14.599493
NCT00247338|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2008-05-09|||April 2005||2005-04-01|May 2008|2008-05-01|May 2006|Actual|2006-05-01|April 2006|Actual|2006-04-01||Interventional|||The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients|Comparing With Traditional Nitrogen Calorie Parenteral Nutrition Support, the Impact of Low Calorie and Low Nitrogen Intake on the Clinical Outcome of Gastrointestinal Postoperative Patients, Multicentre Post-Marketing Clinical Study|Completed||Phase 4|120|Anticipated|Sino-Swed Pharmaceutical Corporation|||||f||||||||||||||2017-02-18 17:00:14.690692|2017-02-18 17:00:14.690692
NCT00247325|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2006-11-29|||January 2004||2004-01-01|January 2005|2005-01-01|December 2004||2004-12-01|||||Interventional|||RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography|Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study, A Randomized Controlled Trial|Completed||Phase 4|||Seoul National University Hospital|||||f||||||||||||||2017-02-18 17:00:14.795955|2017-02-18 17:00:14.795955
NCT00247312|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2015-11-16|||October 2005||2005-10-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial|Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial|Completed||Phase 3|319|Actual|Schiffler Cancer Center||2|||f||||t||||||||||2017-02-18 17:00:14.894052|2017-02-18 17:00:14.894052
NCT00247299|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-30|2005-10-30|||May 2005||2005-05-01|October 2005|2005-10-01||||||||Interventional|||Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform|Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform|Unknown status|Active, not recruiting|N/A|30||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:00:15.008557|2017-02-18 17:00:15.008557
NCT00247286|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2016-01-25|||September 2001||2001-09-01|January 2016|2016-01-01|October 2007|Actual|2007-10-01|January 2007|Actual|2007-01-01||Interventional|||Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.|A Randomised, Single-Blind Comparison of Pelvic Floor Muscle Exercises With Biofeedback Versus Weighted Vaginal Cones in the Management of Genuine Stress Incontinence : A Pilot Study|Terminated||Phase 4|36|Actual|Queen's University||2||slow recruitment|f||||f||||||||Undecided||2017-02-18 17:00:15.108042|2017-02-18 17:00:15.108042
NCT00247273|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2013-04-15|2011-03-04||October 2005||2005-10-01|April 2013|2013-04-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Monthly Risedronate for Osteoporosis|A Phase III, Multicenter, Double-blind, Randomized, Active-controlled, Parallel Group, Non-inferiority Study Comparing 150 mg Risedronate Monthly With 5 mg Risedronate Daily in the Treatment of Postmenopausal Osteoporosis (PMO)|Completed||Phase 3|1294|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 17:00:15.232451|2017-02-18 17:00:15.232451
NCT00247260|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2007-03-13|||October 2005||2005-10-01|October 2005|2005-10-01|February 2007||2007-02-01|||||Interventional|||Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma|A Study of the Safety Profile of Three Escalating Radioactivity Levels of 32P BioSilicon Delivered With the SIMPL Needle as Intratumoural Implantations in Patients With Unresectable Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 2|50||pSiVida Limited|||||f||||||||||||||2017-02-18 17:00:16.75218|2017-02-18 17:00:16.75218
NCT00247247|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2007-06-22|||December 2002||2002-12-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.|Efficacy and Tolerability of Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing-Off Phenomenon|Completed||Phase 4|300||Orion Corporation, Orion Pharma||2|||f||||||||||||||2017-02-18 17:00:16.855123|2017-02-18 17:00:16.855123
NCT00247234|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2015-05-12|||September 2004||2004-09-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|June 2011|Actual|2011-06-01||Interventional|||Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders|Effectiveness of Group Based Schema Therapy in the Treatment of Borderline Personality Disorder and Avoidant Personality Disorder|Completed||Phase 2|90|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:00:16.93873|2017-02-18 17:00:16.93873
NCT00247221|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2012-07-28|||October 2002||2002-10-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Brief Intervention for Families of Teens Treated in the Emergency Department for an Alcohol-Related Event|Family Motivational Interviews for ETOH+ Teens in the ER|Completed||Phase 1|208|Actual|Brown University||2|||f||||t||||||||||2017-02-18 17:00:17.024552|2017-02-18 17:00:17.024552
NCT00247208|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2012-04-25|||May 2005||2005-05-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|October 2008|Actual|2008-10-01||Interventional|||The SOS (Stenting Of Saphenous Vein Grafts) Trial|The SOS (Stenting Of Saphenous Vein Grafts) Randomized-controlled Trial of a Paclitaxel-eluting Stent vs. a Bare Metal Stent in Saphenous Vein Graft Lesions|Completed||Phase 3|80|Actual|North Texas Veterans Healthcare System||2|||f||||t||||||||||2017-02-18 17:00:17.126555|2017-02-18 17:00:17.126555
NCT00247195|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2012-10-24|||November 2005||2005-11-01|October 2012|2012-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder|Culturally Congruent Care for Hispanic Outpatients With Major Depressive Disorder (MDD)|Completed||N/A|113|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 17:00:17.251165|2017-02-18 17:00:17.251165
NCT00247182|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2016-09-20|||October 2006||2006-10-01|September 2016|2016-09-01|June 2011|Actual|2011-06-01|April 2010|Actual|2010-04-01||Interventional|||Stepped Care for Mandated College Students|Stepped Care for Mandated College Students|Completed||Phase 1|598|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||3|||f||||t||||||||||2017-02-18 17:00:17.36427|2017-02-18 17:00:17.36427
NCT00247169|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2012-03-08|||August 2004||2004-08-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II|Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II: A Phase II Trial|Completed||Phase 2|40|Actual|Medical University of Vienna||1|||f||||||||||||||2017-02-18 17:00:17.594118|2017-02-18 17:00:17.594118
NCT00247156|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2008-06-25|||November 2004||2004-11-01|April 2006|2006-04-01|November 2005||2005-11-01|||||Interventional|||An Autism Study Using Nambudripad's Food Allergy Elimination Treatments|An Investigation Into the Effectiveness of NAET on Autism Spectrum Disorders|Completed||Phase 1/Phase 2|60||Nambudripad's Allergy Research Foundation|||||f||||||||||||||2017-02-18 17:00:17.6952|2017-02-18 17:00:17.6952
NCT00247143|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2006-09-18|||October 2005||2005-10-01|September 2006|2006-09-01||||||||Interventional|||High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease|Prospective Open Label Non-Comparative Study of the Safety, Efficacy and Tolerability of High Dose Ritonavir/Lopinavir Liquid in Salvage Therapy for PI Resistant HIV & a PK Equivalence Sub-Study of High Dose Ritonavir/Lopinavir Capsules|Unknown status|Recruiting|N/A|20||Lampiris, Harry W., M.D.|||||f||||||||||||||2017-02-18 17:00:17.794609|2017-02-18 17:00:17.794609
NCT00247130|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2015-03-31|||October 2005||2005-10-01|March 2015|2015-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer|A Prospective, Randomized Trial Comparing the Effect of Intravenous Omeprazole to That of Intravenous Ranitidine on the Maintenance of Hemostasis After Successful Endoscopic Treatment of Bleeding Peptic Ulcer|Withdrawn||Phase 4|0|Actual|Keio University||2||Superiority of iv omeprazole to ranitidine has already been proven by others.|f||||f||||||||||2017-02-18 17:00:17.884965|2017-02-18 17:00:17.884965
NCT00247117|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2006-10-06|||January 2004||2004-01-01|October 2003|2003-10-01|August 2005||2005-08-01|||||Interventional|||Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)|Study of the Effect of Metformin in Patients With Non-Alcoholic Fatty Liver Disease|Unknown status|Recruiting|N/A|15||Kaplan Medical Center|||||f||||||||||||||2017-02-18 17:00:17.991043|2017-02-18 17:00:17.991043
NCT00247104|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2007-04-10|||May 2007||2007-05-01|March 2006|2006-03-01|February 2008|Anticipated|2008-02-01|||||Interventional|||The Use of Cranberries in Women With Preterm Premature Rupture of Membranes|The Use of Cranberries in Women With Preterm Premature Rupture of Membranes|Unknown status|Not yet recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:00:18.081257|2017-02-18 17:00:18.081257
NCT00247091|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2005-10-28|||May 2000||2000-05-01|October 2005|2005-10-01|September 2004||2004-09-01|||||Observational|||Impact of HIV on Measles and Measles Immunisation|Impact of HIV on Measles and Measles Immunisation|Completed||N/A|700||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:00:18.180749|2017-02-18 17:00:18.180749
NCT00247078|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2016-03-18|||October 2005||2005-10-01|March 2016|2016-03-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism|The Efficacy and Safety of Aracmyn® [Antivenin Latrodectus (Black Widow)Equine Immune F(ab)2], in Patients With Systemic Latrodectism: A Phase II, Multi-center, Randomized, Double-Blind Trial|Completed||Phase 2|24|Actual|Instituto Bioclon S.A. de C.V.||2|||f||||t||||||||||2017-02-18 17:00:18.269162|2017-02-18 17:00:18.269162
NCT00247052|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2009-07-31|||March 2006||2006-03-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|December 2008|Actual|2008-12-01||Interventional|||Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion|the Post Operative Pericardial Effusion (POPE) Treatment Study|Completed||Phase 4|200|Anticipated|French Cardiology Society||2|||f||||||||||||||2017-02-18 17:00:18.374553|2017-02-18 17:00:18.374553
NCT00247039|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2013-07-04|||June 2006||2006-06-01|July 2013|2013-07-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Garlic in Patients With Febrile Neutropenia|A Controlled Study to Determine The Clinical Efficacy Of Garlic Compounds In Patients With Chemotherapy Related Febrile Neutropenia|Unknown status|Recruiting|Phase 1/Phase 2|120|Anticipated|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 17:00:18.487782|2017-02-18 17:00:18.487782
NCT00247026|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2007-04-10|||April 2007||2007-04-01|April 2007|2007-04-01||||||||Interventional|||The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes|A Pilot Study to Determine the Clinical Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes|Withdrawn||Phase 1/Phase 2|50||Hadassah Medical Organization||||No funding|f||||||||||||||2017-02-18 17:00:18.781841|2017-02-18 17:00:18.781841
NCT00247013|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2016-02-19|||January 1996||1996-01-01|September 2010|2010-09-01|January 2006||2006-01-01|||||Interventional|||Automated Tele Counseling for Screening Mammography|Automated Tele Counseling for Screening Mammography|Completed||Phase 1|2120||Boston Medical Center|||||f||||||||||||||2017-02-18 17:00:18.878977|2017-02-18 17:00:18.878977
NCT00247000|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-30|2007-06-27|||September 2007||2007-09-01|February 2006|2006-02-01|November 2007||2007-11-01|||||Interventional|||A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)|A Strategy of Home Telehealth for Management of Congestive Heart Failure: STARTEL|Unknown status|Not yet recruiting|Phase 4|150|Anticipated|Nova Scotia Health Authority|||||f||||||||||||||2017-02-18 17:00:18.978855|2017-02-18 17:00:18.978855
NCT00246987|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2012-04-26|||June 2003||2003-06-01|April 2012|2012-04-01|April 2004|Actual|2004-04-01|||||Interventional|||A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|Completed||Phase 3|341||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:00:19.096958|2017-02-18 17:00:19.096958
NCT00246974|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2008-10-14|||May 2003||2003-05-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT|An Open Randomised Phase II Study Of Gemcitabine Plus Cisplatin +/- Concomitant or Sequential ZD1839 in Patients With Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|125|Anticipated|AstraZeneca||2|||f||||||||||||||2017-02-18 17:00:19.34855|2017-02-18 17:00:19.34855
NCT00246961|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2007-10-11|||July 2004||2004-07-01|June 2007|2007-06-01||||||||Observational|ARREST||Arimidex Observational: Reason for and Effect of Change From Tamoxifen|Arimidex: Reason for and Effect of Change From Tamoxifen|Completed||Phase 4|200||AstraZeneca|||||f||||f||||||||||2017-02-18 17:00:19.4901|2017-02-18 17:00:19.4901
NCT00246948|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2008-10-16|||November 2001||2001-11-01|October 2005|2005-10-01|August 2003||2003-08-01|||||Interventional|||The Efficacy of Active Conservative Treatment for Patients With Severe Sciatica. A Randomized Clinical Controlled Trial|The Efficacy of Active Conservative Treatment for Patients With Severe Sciatica. A Randomized Clinical Controlled Trial|Completed||N/A|181||The Back Research Center, Denmark|||||f||||||||||||||2017-02-18 17:00:19.607702|2017-02-18 17:00:19.607702
NCT00246935|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2016-10-24|||May 2005||2005-05-01|September 2016|2016-09-01|October 2007|Actual|2007-10-01|January 2007|Actual|2007-01-01||Interventional|||Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)|A Long-term Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|150||AstraZeneca|||||f||||||||||||||2017-02-18 17:00:19.696101|2017-02-18 17:00:19.696101
NCT00246922|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2016-12-01|||December 2004||2004-12-01|September 2016|2016-09-01|October 2007|Actual|2007-10-01|January 2007|Actual|2007-01-01||Interventional|||Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)|A Long-term Study of APTA-2217 in Adult Patients With Bronchial Asthma|Completed||Phase 3|150||AstraZeneca|||||f||||||||||||||2017-02-18 17:00:19.784913|2017-02-18 17:00:19.784913
NCT00246909|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-31|2012-05-04|||November 2005||2005-11-01|June 2011|2011-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)|Determination of the Minimal Clinically Important Difference (MCID) of the Patient Orientated Self Assessment Scale ReQuest TradeMark in Patients Suffering From Endoscopically Confirmed Gastroesophageal Reflux Disease (GERD), Grade A-D According to Los Angeles Classification Treated With Pantoprazole 40 mg o.d. or Placebo o.d. Over One Week.|Completed||Phase 4|600||Takeda|||||f||||||||||||||2017-02-18 17:00:19.885338|2017-02-18 17:00:19.885338
NCT00246896|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2006-07-26|||August 2001||2001-08-01|October 2005|2005-10-01|August 2005||2005-08-01|||||Interventional|||Care Management for Patients With Alzheimer Disease and Their Family Caregivers|A Program of Collaborative Care for Alzheimer Disease|Completed||N/A|220||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:00:20.040138|2017-02-18 17:00:20.040138
NCT00246883|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-29|2017-01-24|||October 26, 2005||2005-10-26|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Interventional|||Effect of Regular Exercise on Vascular Function and Cardiovascular Risk in a Sedentary Work Force|"Effect of Regular Exercise on Vascular Function and Cardiovascular Risk in a Sedentary Work Force: The NHLBI Keep the Beat Program"|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:00:20.139268|2017-02-18 17:00:20.139268
NCT00246870|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-29|2017-01-24|||October 24, 2005||2005-10-24|October 19, 2010|2010-10-19|October 19, 2010||2010-10-19|||||Observational|||PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency|PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase Deficiency|Completed||N/A|42|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:00:20.229025|2017-02-18 17:00:20.229025
NCT00246857|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-29|2017-01-24|||October 26, 2005||2005-10-26|December 19, 2016|2016-12-19||||||||Observational|||Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death|Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:00:20.310004|2017-02-18 17:00:20.310004
NCT00246844|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-29|2017-01-24|||October 26, 2005||2005-10-26|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Observational|||Assessment of Insulin Production From Native Pancreas in Patients With Pancreas Transplants|Assessing Arginine-Stimulated Native Pancreas Insulin Production Via Selective Venous Sampling in Patients With Long-Functioning Pancreas Allografts|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:00:20.415554|2017-02-18 17:00:20.415554
NCT00246831|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-29|2017-01-24|||October 27, 2005||2005-10-27|October 28, 2008|2008-10-28|October 28, 2008||2008-10-28|||||Observational|||Brain Networks Responsible for Self-Agency|Brain Networks Responsible for Self-Agency: An fMRI Study|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:00:20.490169|2017-02-18 17:00:20.490169
NCT00246818|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-29|2017-01-24|||October 26, 2005||2005-10-26|February 25, 2011|2011-02-25|February 25, 2011|Actual|2011-02-25|July 31, 2007|Actual|2007-07-31||Interventional|||Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer Survivors|A Randomized Study of the Effect of Tai Chi Chuan Compared to a Structured Exercise Program on Parameters of Physical Fitness and Stress in Adult Cancer Survivors|Completed||Phase 2|76|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:00:20.570798|2017-02-18 17:00:20.570798
NCT00246805|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-08-23|2009-11-06||January 2006||2006-01-01|March 2010|2010-03-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|RARE-PEARL||Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study|Post Marketing Study on Heart Rate Regularization in Patients With Permanent Atrial Fibrillation|Completed||Phase 4|67|Actual|Medtronic BRC||2|||f||||t||||||||||2017-02-18 17:00:20.660156|2017-02-18 17:00:20.660156
NCT00246792|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2006-02-16|||September 2004||2004-09-01|November 2005|2005-11-01|December 2006||2006-12-01|||||Interventional|||Enhancing Self-Understanding and Social Integration of Middle School Students With Learning Disabilities|Enhancing Self-Understanding and Social Integration of Middle School Students With Learning Disabilities|Unknown status|Recruiting|Phase 2/Phase 3|||University of Toronto|||||f||||||||||||||2017-02-18 17:00:21.190717|2017-02-18 17:00:21.190717
NCT00246779|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2007-10-26|||November 2005||2005-11-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Surgery|Transfusion Reduction and Modified Ultrafiltration After Cardiopulmonary Bypass (TRAM Trial) - A Pilot Feasibility Trial|Completed||Phase 1|78|Anticipated|Ottawa Heart Institute Research Corporation|||||f||||||||||||||2017-02-18 17:00:21.291739|2017-02-18 17:00:21.291739
NCT00246766|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2007-11-21|||March 2005||2005-03-01|November 2007|2007-11-01|June 2010|Anticipated|2010-06-01|||||Observational|||Study of Fetal Movements Using Multichannel Ultrasound Pulsed Doppler in Normal and Pathologic Pregnancy|Qualitative and Quantitative Study of Fetal Movements Using Multichannel Ultrasound Pulsed Doppler in Normal and Pathologic Pregnancy|Unknown status|Recruiting|N/A|90|Anticipated|University Hospital, Tours|||1||f||||f||||||||||2017-02-18 17:00:21.389715|2017-02-18 17:00:21.389715
NCT00246753|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2016-01-20|||October 2005||2005-10-01|January 2016|2016-01-01|May 2013|Actual|2013-05-01|July 2012|Actual|2012-07-01||Interventional|NRR||Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Study of Oral Once Daily GW572016 (Lapatinib) In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|35|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:00:21.473613|2017-02-18 17:00:21.473613
NCT00246740|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2010-01-11|||October 2005||2005-10-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting|Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting: A Pilot Study|Completed||N/A|40|Anticipated|University of Alberta||1|||f||||f||||||||||2017-02-18 17:00:21.585013|2017-02-18 17:00:21.585013
NCT00246727|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2011-10-28|||December 2005||2005-12-01|October 2011|2011-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer|Study 1: Effects of a Dietary Supplement (SV) on Advanced NSCLC Treated With Chemotherapy: A Randomized Double Blind Placebo Controlled Study; Study 2: Effects of a Dietary Supplement (SV) on Advanced NSCLC Treated With Best Supportive Care: A Randomized Double Blind Placebo Controlled Study|Unknown status|Recruiting|Phase 3|300|Anticipated|Sun Farm Corporation||2|||f||||t||||||||||2017-02-18 17:00:21.674679|2017-02-18 17:00:21.674679
NCT00246714|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2008-04-14|||October 2005||2005-10-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans|Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans|Completed||Phase 1|16|Anticipated|Radboud University||2|||f||||f||||||||||2017-02-18 17:00:21.774273|2017-02-18 17:00:21.774273
NCT00246701|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2009-12-10|||November 2005||2005-11-01|December 2009|2009-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|COMBOS||Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Combined Omacor and Simvastatin Therapy in Hypertriglyceridemic Subjects|Completed||Phase 3|256|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 17:00:21.88178|2017-02-18 17:00:21.88178
NCT00246688|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2015-12-30|||November 2005||2005-11-01|December 2015|2015-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer|Randomized, Multicenter, Prospective Two-arm, Open-label Phase II Study to Investigate the Efficacy and Safety of Two ZK219477 i.v. Infusions (3-hour Infusion of 16mg/m2 Versus 0.5-hour Infusion of 16 mg/m2) in Patients With Recurrent Ovarian Cancer Progressing During, or Within 6 Months of the End of Platinum-based Chemotherapy|Completed||Phase 2|63|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:00:21.98304|2017-02-18 17:00:21.98304
NCT00246675|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2015-04-23||||||April 2015|2015-04-01||||||||Interventional|||Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.|Frusemide Infusion for the Prevention of Deterioration of Renal Function in Post Cardiac Surgery|Withdrawn||N/A|0|Actual|Melbourne Health||2||"The study has ceased recruiting as Ethics approval has lapsed and the investigator~   availability reduced."|f||||f||||||||||2017-02-18 17:00:22.093997|2017-02-18 17:00:22.093997
NCT00246662|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2017-02-06|||November 2005||2005-11-01|May 2016|2016-05-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies|Phase 1b Open-Label, Multicenter Clinical Study of the Safety and Activity of Intravenous Administration of SNS-595 in Patients With Advanced Hematologic Malignancies|Completed||Phase 1|75|Actual|Sunesis Pharmaceuticals||2|||f||||f||||||||No|Aggregate data of participants experiencing Adverse Events|2017-02-18 17:00:22.199362|2017-02-18 17:00:22.199362
NCT00246649|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2008-12-16|||September 2005||2005-09-01|December 2008|2008-12-01||||||||Interventional|||Stem Cell Transplant With Specially Treated Cells in Treating Patients With Acute Leukemia|Pilot Study of Ex Vivo Expansion of Mafosfamide-Purged CD34-Positive Cells for Autologous Peripheral Blood Stem Cell or Bone Marrow Transplantation in Patients With Acute Leukemia|Completed||N/A|25|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||||||||||||||||2017-02-18 17:00:22.316895|2017-02-18 17:00:22.316895
NCT00005352|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1992||1992-09-01|August 2004|2004-08-01|August 1996|Actual|1996-08-01|||||Observational|||Chronic Stress as a Risk Factor in the Etiology of Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.009224|2017-02-18 18:15:00.009224
NCT00246636|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2009-12-10|||October 2005||2005-10-01|December 2009|2009-12-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Omacor Therapy in Hypertriglyceridemic Subjects Treated With Antara, Followed by an 8-week Extension|Completed||Phase 4|167|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 17:00:22.405398|2017-02-18 17:00:22.405398
NCT00246623|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2008-02-06|||November 2005||2005-11-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||US Inhaled Insulin Dose Titration Study|A Randomized, Open-Label, Multicenter Study Assessing the Effects of Forced Exubera Dose Titration on Glycemic Control in Patients With Suboptimally Controlled Type 2 Diabetes on Two or More Oral Antidiabetic Agents|Completed||Phase 3|120||Pfizer|||||||||||||||||||2017-02-18 17:00:22.51562|2017-02-18 17:00:22.51562
NCT00246610|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-04-26|||March 2006||2006-03-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy|A Phase IV, Non-Randomized, Open-Label Trial Evaluating The Safety Of 625 mg Formulation Of VIRACEPT When Administered To HIV-Infected Women During Pregnancy|Completed||Phase 4|16|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 17:00:22.627621|2017-02-18 17:00:22.627621
NCT00246597|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-05-17|||December 2002||2002-12-01|March 2010|2010-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer|A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer|Terminated||Phase 3|37|Actual|Ortho Biotech Products, L.P.||||"Study stopped to avoid treating enrolled subjects to hemoglobin levels higher than those~   specified in current labeling."|f||||f||||||||||2017-02-18 17:00:22.739019|2017-02-18 17:00:22.739019
NCT00246584|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2006-07-27|||October 2004||2004-10-01|July 2006|2006-07-01||||||||Interventional|||A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)|Long-Term Treatment, Multicenter, Open-Label Study With SPP100 in Patients With Essential Hypertension|Completed||Phase 2|300||Novartis|||||f||||||||||||||2017-02-18 17:00:22.821826|2017-02-18 17:00:22.821826
NCT00246571|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2012-07-02|2011-05-31||January 2006||2006-01-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer|A Randomized Phase 2 Study Of SU011248 Versus Standard-Of-Care For Patients With Previously Treated, Advanced, Triple Receptor Negative (ER, PR, HER2) Breast Cancer|Completed||Phase 2|217|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 17:00:22.920746|2017-02-18 17:00:22.920746
NCT00246558|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2014-04-02|||November 2005||2005-11-01|April 2014|2014-04-01|November 2005||2005-11-01|||||Observational|||Tight Achilles Tendon, Hyperpronation and Anterior Knee Pains|Is There a Connection Between a Tight Achilles Tendon, Hyperpronation of the Foot and Pain in the Anterior Part of the Knee|Withdrawn||N/A|0|Actual|Northern Orthopaedic Division, Denmark||||The study stopped due to unforeseen circumstances.|f||||||||||||||2017-02-18 17:00:30.061951|2017-02-18 17:00:30.061951
NCT00246545|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-08-25|||October 2005||2005-10-01|August 2011|2011-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effect Evaluation of Early Exercise Training After Myocardial Infarction|Effect Evaluation of Early Exercise Training After Myocardial Infarction|Completed||Phase 2|39|Actual|Norwegian University of Science and Technology|||||f||||f||||||||||2017-02-18 17:00:30.162636|2017-02-18 17:00:30.162636
NCT00246532|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2012-04-26|||October 2005||2005-10-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||Opiate-Induced Tolerance & Hyperalgesia in Pain Patients|Opiate-Induced Tolerance & Hyperalgesia in Pain Patients|Completed||Phase 4|139|Actual|National Institute of General Medical Sciences (NIGMS)||2|||f||||t||||||||||2017-02-18 17:00:30.262376|2017-02-18 17:00:30.262376
NCT00246519|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2015-05-20|2013-05-20||October 2005||2005-10-01|May 2015|2015-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Pharmacogenomic Evaluation of Antihypertensive Responses|Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)|Completed||Phase 4|1701|Actual|University of Florida|The trial has limited number of hypertensive patients of African ancestry, therefore power is limited to those patients.|2|||f||||t||||||||||2017-02-18 17:00:30.373871|2017-02-18 17:00:30.373871
NCT00246506|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2013-01-14|||July 2003||2003-07-01|December 2012|2012-12-01|April 2013|Anticipated|2013-04-01|April 2012|Actual|2012-04-01||Interventional|FORT-T||Infertility Therapy for Women Age Thirty-eight and Older|Optimal Infertility Therapy RCT: Women 40 and Older|Unknown status|Active, not recruiting|N/A|450|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||t||||||||||2017-02-18 17:00:30.80193|2017-02-18 17:00:30.80193
NCT00246493|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2017-02-14|||June 22, 2004||2004-06-22|January 26, 2017|2017-01-26||||||||Observational|||Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)|Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)|Active, not recruiting||N/A|510|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:00:30.918295|2017-02-18 17:00:30.918295
NCT00246480|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2010-08-26|||October 2005||2005-10-01|April 2008|2008-04-01|October 2009||2009-10-01|||||Observational|||RSV Disease in the Elderly|Pathogenesis of RSV Disease in the Elderly|Unknown status|Recruiting|N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:00:31.016943|2017-02-18 17:00:31.016943
NCT00246467|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2008-09-12|||October 2005||2005-10-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)|A Phase 1b, Multi-Centre, Parallel Group, Single Blind Study to Evaluate the Safety, Tolerability and Immunogenicity of a Recombinant Plague Vaccine (rF1 and rV Antigens) in Healthy Subjects|Completed||Phase 1|123|Actual|PharmAthene UK Limited|||||f||||t||||||||||2017-02-18 17:00:31.095918|2017-02-18 17:00:31.095918
NCT00246454|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2016-09-22|||September 2003||2003-09-01|September 2016|2016-09-01|September 2017|Anticipated|2017-09-01|September 2017|Anticipated|2017-09-01||Observational|||Circadian Rhythms and Sleep in Familial DSPS and ASPS|Circadian Rhythms and Sleep in Familial Delayed Sleep Phase Syndrome (DSPS) and Advanced Sleep Phase Syndrome (ASPS)|Recruiting||N/A|156|Anticipated|Northwestern University|||3||f||||f||||||Samples Without DNA|"~     plasma~   "|No||2017-02-18 17:00:31.457566|2017-02-18 17:00:31.457566
NCT00246441|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2016-12-01|||March 2002||2002-03-01|November 2009|2009-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism|Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism|Completed||Phase 4|42|Actual|Medical University of South Carolina||2|||f||||f||||||||No||2017-02-18 17:00:31.575247|2017-02-18 17:00:31.575247
NCT00246428|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2007-12-06|||January 2000||2000-01-01|December 2007|2007-12-01|July 2003|Anticipated|2003-07-01|||||Interventional|||Motivational Interviewing for Alcohol-Positive Teens in the Emergency Room|Motivational Interviewing (MI) for ETOH+ Teens in the ER|Unknown status|Active, not recruiting|Phase 3|198|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||||||||||||2017-02-18 17:00:31.687431|2017-02-18 17:00:31.687431
NCT00246415|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2008-10-07|||November 2002||2002-11-01|October 2008|2008-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Placebo-Controlled Trial of Memantine for Alcohol Dependence|Medications Development for Alcohol Abuse: NMDA Agents -- A Placebo-Controlled Trial of Memantine for Alcohol Dependence|Completed||Phase 2|90||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 17:00:31.806347|2017-02-18 17:00:31.806347
NCT00246402|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2014-05-14|||September 2002||2002-09-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV|Anti-Lipolytic Strategy for HIV Lipodystrophy|Completed||N/A|30||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:00:31.907398|2017-02-18 17:00:31.907398
NCT00246389|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-02-17||||||February 2011|2011-02-01|July 2004|Actual|2004-07-01|||||Interventional|||An Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm|Flexeril� (Cyclobenzaprine Hydrochloride) Community Based Study - An Evaluation of Cyclobenzaprine HCl Monotherapy and in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm|Completed||Phase 4|1000|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||f||||||||||||||2017-02-18 17:00:32.00628|2017-02-18 17:00:32.00628
NCT00246376|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2016-02-25|2015-10-20||January 2004||2004-01-01|February 2016|2016-02-01|February 2012|Actual|2012-02-01|September 2009|Actual|2009-09-01||Interventional|HeartPositive||Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia|Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy|Completed||N/A|221|Actual|Baylor College of Medicine|High dropout rate, especially by loss to follow-up (with no explanation). Flushing was common among patients taking niacin, and this (with transportation and socio-economc problems) could have contributed to the high drop-out rate.|5|||f||||t||||||||||2017-02-18 17:00:32.099744|2017-02-18 17:00:32.099744
NCT00246363|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2011-09-14|||January 2005||2005-01-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C|A Pilot Randomized Placebo-Controlled Trial Designed to Determine the Tolerability and Efficacy of Silymarin (Milk Thistle) vs. Placebo for the Treatment of Chronic Hepatitis C in HIV Infected Patients|Completed||Phase 1/Phase 2|40|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 17:00:33.070159|2017-02-18 17:00:33.070159
NCT00246350|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-19|||September 2004||2004-09-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Spinal Manipulation for Treatment of Chronic Headaches|Dose-Response of Manipulation for Chronic Headache|Completed||Phase 2|80|Actual|University of Western States||4|||f||||f||||||||||2017-02-18 17:00:33.20133|2017-02-18 17:00:33.20133
NCT00246337|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2015-10-30|2010-07-19||November 2005||2005-11-01|October 2015|2015-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)|A Multicenter, Double-Blind, Placebo and Active-Controlled, Dose-Finding Study of MK0974 in the Treatment of Acute Migraine|Completed||Phase 2|420|Actual|Merck Sharp & Dohme Corp.||9|||f||||||||||||||2017-02-18 17:00:33.325884|2017-02-18 17:00:33.325884
NCT00246324|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2012-04-13|2011-05-05||December 2003||2003-12-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis|An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)|Completed||Phase 4|16|Actual|Louisiana State University Health Sciences Center Shreveport||1|||f||||f||||||||||2017-02-18 17:00:34.991268|2017-02-18 17:00:34.991268
NCT00246298|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-06-08|||October 2005||2005-10-01|March 2010|2010-03-01|September 2006|Actual|2006-09-01|||||Interventional|||A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients|A Randomized, Open-Label Study Assessing the Efficacy of Initiating PROCRIT (Epoetin Alfa) Dosing at Q2W vs. PROCRIT Dosing at QW in Anemic HIV-infected Subjects|Terminated||Phase 2|31|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||OBI business decision not to complete any additional research in HIV.|||||f||||||||||2017-02-18 17:00:35.233979|2017-02-18 17:00:35.233979
NCT00246285|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-06-06|||April 2001||2001-04-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia|The Efficacy And Safety Of Risperidone In The Treatment Of Adolescents With Schizophrenia: A Six-Month Open-Label Study.|Completed||Phase 3|381|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:00:35.3217|2017-02-18 17:00:35.3217
NCT00246272|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2010-04-26|||October 2004||2004-10-01|April 2010|2010-04-01|May 2006|Actual|2006-05-01|||||Interventional|||An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone|An Open-label Study Evaluating the Maintenance of Clinical Effect in Adults With Schizophrenia Switched From RISPERDAL® Tablets (Risperidone) to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone|Completed||Phase 3|82|Actual|Janssen-Ortho Inc., Canada||1|||f||||||||||||||2017-02-18 17:00:35.433147|2017-02-18 17:00:35.433147
NCT00246259|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2013-11-15|2013-03-20||October 2004||2004-10-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||Analysis was based on the Intent-to-treat (ITT) population.|A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis|An Open-Label Randomized Trial Comparing Risperdal Consta With Oral Antipsychotic Care in the Treatment of Early Psychosis|Completed||Phase 4|77|Actual|Janssen-Ortho Inc., Canada||2|||f||||f||||||||||2017-02-18 17:00:35.587671|2017-02-18 17:00:35.587671
NCT00246246|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-02-10|||January 2004||2004-01-01|February 2011|2011-02-01|April 2006|Actual|2006-04-01|||||Interventional|||A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder|A Randomized, Open-label Trial of RISPERDAL® CONSTA™ Versus Oral Antipsychotic Care in Subjects With Bipolar Disorder|Completed||Phase 3|48|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 17:00:36.517972|2017-02-18 17:00:36.517972
NCT00246233|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-05-16|||June 2005||2005-06-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|||||Interventional|||CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.|A Double-blind, Placebo-controlled, Randomized Trial to Evaluate the Safety, Tolerability and Efficacy of CONCERTA® (Methylphenidate Hydrochloride) Augmentation of SSRI/SNRI Monotherapy in Adult Patients With Major Depressive Disorder.|Completed||Phase 3|145|Actual|Janssen-Ortho Inc., Canada|||||f||||||||||||||2017-02-18 17:00:36.605035|2017-02-18 17:00:36.605035
NCT00246220|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-05-16|||March 2005||2005-03-01|April 2010|2010-04-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder.|A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study To Evaluate the Safety And Efficacy Of Prolonged Release OROS Methylphenidate Hydrochloride (18, 36 and 72 mg/Day), With Open-Label Extension, In Adults With Attention Deficit/Hyperactivity Disorder|Completed||Phase 3|402|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 17:00:36.703072|2017-02-18 17:00:36.703072
NCT00246207|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2012-02-09|||March 2005||2005-03-01|February 2012|2012-02-01|December 2005|Actual|2005-12-01|||||Interventional|||CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults|An Open-label Study Evaluating the Safety and Effectiveness of OROS Methylphenidate Hydrochloride (CONCERTA) in Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 3|32|Actual|Janssen-Ortho Inc., Canada||1|||f||||||||||||||2017-02-18 17:00:36.808652|2017-02-18 17:00:36.808652
NCT00246194|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2014-04-02|||September 2004||2004-09-01|April 2014|2014-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|SOURCE||Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)|The SOURCE Study: Schizophrenia Outcomes-utilization, Relapse, and Clinical Evaluation: a Prospective 2-year Observational Study of Patients With Schizophrenia Who Initiate Treatment With Injectable Risperidone Long-acting Microspheres (RISPERDAL CONSTA)|Completed||Phase 4|532|Actual|Janssen, LP|||1||f||||f||||||||||2017-02-18 17:00:36.920614|2017-02-18 17:00:36.920614
NCT00246181|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2014-01-10|||December 1999||1999-12-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|SBF-NSCLC||Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC|Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC|Completed||Phase 1/Phase 2|117|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 17:00:37.039307|2017-02-18 17:00:37.039307
NCT00246168|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2010-11-29||||||November 2010|2010-11-01|June 2005|Actual|2005-06-01|||||Interventional|||ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.|ULTRACET (Tramadol Hydrochloride and Acetaminophen) add-on Therapy for the Treatment of the Pain of Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled Study|Completed||Phase 4|277|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-02-18 17:00:37.12857|2017-02-18 17:00:37.12857
NCT00246155|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2006-10-10|||January 2005||2005-01-01|October 2006|2006-10-01||||||||Interventional|||Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain|A Prospective Study to Evaluate the Potential Effects on Function and Size in Back Muscle After Injection of Botulinum Toxin Type A (Dysport®) in the Treatment of Chronic Low Back Pain|Completed||Phase 3|35||Ipsen|||||f||||||||||||||2017-02-18 17:00:37.222514|2017-02-18 17:00:37.222514
NCT00246142|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2007-10-11|||April 2005||2005-04-01|October 2007|2007-10-01||||||||Interventional|||A Study of the Combination of Electrical Stimulation and Dysport® in Myofascial Pain Syndrome.|A 16-Week Prospective Randomised Double-Blind Study on Facilitation of DYSPORT® Effect on Myofascial Pain Syndrome (MPS) by Electrical Stimulation.|Completed||Phase 3|68||Ipsen|||||f||||||||||||||2017-02-18 17:00:37.308841|2017-02-18 17:00:37.308841
NCT00246129|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2008-05-09|||October 2005||2005-10-01|May 2008|2008-05-01|April 2011|Anticipated|2011-04-01|April 2009|Anticipated|2009-04-01||Interventional|||Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation|A Randomised Controlled Comparison of Campath−Tacrolimus vs IL2R MoAb−Tacrolimus/MMMF in Kidney Transplantation|Unknown status|Active, not recruiting|Phase 4|120|Anticipated|Hammersmith Hospitals NHS Trust||2|||f||||t||||||||||2017-02-18 17:00:37.403081|2017-02-18 17:00:37.403081
NCT00246116|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2017-01-27|||February 2002||2002-02-01|January 2017|2017-01-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|SBF Companion||Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer|Functional Imaging of Treatment Effects: A Companion Protocol to a Phase II Study of Extracranial Stereotactic Radioablation (a.k.a. Stereotactic Body Radiotherapy) in Early Stage Non-Small Cell Lung Cancer.|Completed||N/A|15|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 17:00:37.52376|2017-02-18 17:00:37.52376
NCT00246103|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2013-11-21|||March 2004||2004-03-01|January 2009|2009-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies|Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies|Completed||Phase 1|65|Anticipated|H. Lee Moffitt Cancer Center and Research Institute|||||f||||||||||||||2017-02-18 17:00:37.604668|2017-02-18 17:00:37.604668
NCT00246090|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2014-06-30|2011-12-22||October 2005||2005-10-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine|A Phase II Open Label Single-Arm Study of E7389 in Patients With Locally Advanced or Metastatic Breast Cancer, Previously Treated With Anthracycline, Taxane, and Capecitabine Therapy, Refractory to the Last Prior Therapy for Their Disease|Completed||Phase 2|298|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 17:00:37.710088|2017-02-18 17:00:37.710088
NCT00246077|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2007-04-10|||October 2005||2005-10-01|November 2005|2005-11-01|December 2005|Actual|2005-12-01|||||Observational|||Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport|Quality of Life of Children With Sickle Cell Disease Who Are Receiving Chronic Transfusion Therapy With a Lifeport Device|Completed||N/A|5||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 17:00:38.251709|2017-02-18 17:00:38.251709
NCT00246064|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2011-05-18|||December 2001||2001-12-01|January 2011|2011-01-01|November 2003|Actual|2003-11-01|||||Interventional|||The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol|The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol. Tapering Methotrexate in Patients With Rheumatoid Arthritis Beginning Therapy With Infliximab|Completed||Phase 4|210|Actual|Centocor Ortho Biotech Services, L.L.C.|||||f||||||||||||||2017-02-18 17:00:38.339227|2017-02-18 17:00:38.339227
NCT00246051|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-13|||November 2005||2005-11-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Comprehensive Police Fatigue Management Program|Testing the Effectiveness of a Comprehensive Fatigue Management for the Police|Completed||N/A|683|Actual|Brigham and Women's Hospital||3|||f||||||||||||||2017-02-18 17:00:38.439902|2017-02-18 17:00:38.439902
NCT00246038|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2015-08-27||||||August 2015|2015-08-01||||||||Interventional|||The Boston Scientific ENOVUS Trial|A Phase II Evaluation of the Safety and Efficacy of the Boston Scientific ENOVUS AAA Endograft in the Treatment of Abdominal Aortic Aneurysms|Withdrawn||Phase 2|0|Actual|Boston Scientific Corporation||||Sponsor cancelled the development program, and never conducted the study.|f||||f||||||||||2017-02-18 17:00:38.551007|2017-02-18 17:00:38.551007
NCT00246025|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2014-06-03|2010-11-18||October 2005||2005-10-01|February 2014|2014-02-01||||June 2007|Actual|2007-06-01||Interventional|||A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.|A Randomised, Parallel-group, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Knee Replacement Surgery|Completed||Phase 2|512|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 17:00:38.646594|2017-02-18 17:00:38.646594
NCT00246012|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-28|2013-07-17|2013-05-01||May 2005||2005-05-01|July 2013|2013-07-01|February 2009|Actual|2009-02-01|June 2008|Actual|2008-06-01||Interventional|||A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma|A Phase 1/2, Multi-Center, Blinded, Randomized, Controlled Study of the Safety and Efficacy of the Human Monoclonal Antibody to Human α ν Integrins (CNTO 95), Alone and in Combination With Dacarbazine, in Subjects With Stage IV Melanoma|Completed||Phase 1/Phase 2|144|Actual|Centocor, Inc.||9|||f||||t||||||||||2017-02-18 17:00:39.771663|2017-02-18 17:00:39.771663
NCT00245986|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2017-01-24|||October 18, 2005||2005-10-18|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Interventional|||Effect of Genetics on Metabolism of Efavirenz|Pharmacogenetics of Efavirenz Metabolism: Association of CYP2B6 Genotype and Prolonged Drug Exposure|Completed||Phase 4|350||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:00:42.322075|2017-02-18 17:00:42.322075
NCT00245973|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2007-12-03|||June 2005||2005-06-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Evaluating Bifeprunox in Bipolar Depression|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder|Completed||Phase 3|380||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:00:42.410264|2017-02-18 17:00:42.410264
NCT00245960|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2009-03-31|2009-03-31||December 2005||2005-12-01|March 2009|2009-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis|A Randomized, Double-Blind, Two-Period Study to Evaluate the Safety and Efficacy of Etanercept on Skin and Joint Disease in Psoriasis Subjects With Psoriatic Arthritis.|Completed||Phase 4|752|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 17:00:42.529796|2017-02-18 17:00:42.529796
NCT00245947|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2009-09-09|||April 2004||2004-04-01|September 2009|2009-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study Evaluating ERB-041 in Active Crohn's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel- Design, Exploratory Pharmacogenomic, Safety and Activity Study of Orally Administered ERB-041 in Subjects With Inflammation Associated With Active Crohn's Disease|Completed||Phase 1|22|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:00:43.239534|2017-02-18 17:00:43.239534
NCT00245934|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-12-12|||June 2003||2003-06-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|||||Observational|||Study Evaluating Enbrel in Patients With Rheumatoid Arthritis|Observational Study With Enbrel in Patients With Rheumatoid Arthritis|Completed||N/A|1500||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:00:43.312927|2017-02-18 17:00:43.312927
NCT00245921|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2013-02-07|||February 2003||2003-02-01|May 2006|2006-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception|A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg in a Continuous Daily Regimen for Oral Contraception|Completed||Phase 3|2000||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:00:43.383023|2017-02-18 17:00:43.383023
NCT00245908|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2005-10-27|||September 1999||1999-09-01|January 2002|2002-01-01|September 2002||2002-09-01|||||Interventional|||ASTHMA (AntibioticS To Help Manage Asthma) Pilot Study||Completed||Phase 3|100||Wisconsin Research Network|||||f||||||||||||||2017-02-18 17:00:43.460948|2017-02-18 17:00:43.460948
NCT00245895|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-11-27|||April 2003||2003-04-01|November 2007|2007-11-01|February 2005|Actual|2005-02-01|||||Interventional|||Study of Aranesp to Treat Anemia in Prostate Cancer Patients.|Phase II Study of Aranesp (Darbepoetin Alfa) to Treat Anemia in Prostate Cancer Patients.|Completed||Phase 2|20|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 17:00:43.549805|2017-02-18 17:00:43.549805
NCT00245882|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2012-09-17|||October 2005||2005-10-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|DiaTel||The Diabetes Telemonitoring (DiaTel) Study|The Diabetes Telemonitoring (DiaTel) Study|Completed||N/A|150|Actual|VA Pittsburgh Healthcare System||2|||f||||f||||||||||2017-02-18 17:00:43.676461|2017-02-18 17:00:43.676461
NCT00245869|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-02-19|||March 2004||2004-03-01|July 2006|2006-07-01|February 2007||2007-02-01|||||Interventional|||Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response|Contrast-Enhanced Ultrasound and Neoadjuvant Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response|Completed||N/A|30||University Hospital, Tours|||||f||||||||||||||2017-02-18 17:00:43.786466|2017-02-18 17:00:43.786466
NCT00245856|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2013-02-15|2013-02-01||September 2002||2002-09-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|March 2009|Actual|2009-03-01||Interventional|||Treatment of Upper Extremity Deep-Vein Thrombosis|Treatment of Upper Extremity Deep-Vein Thrombosis|Completed||Phase 4|67|Actual|University of Oklahoma||1|||f||||||||||||||2017-02-18 17:00:43.901057|2017-02-18 17:00:43.901057
NCT00245843|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2009-03-31|||January 2005||2005-01-01|March 2009|2009-03-01|February 2010|Anticipated|2010-02-01|February 2008|Actual|2008-02-01||Interventional|||Vermont Intervention: Effect on Joint Attention Skills Between Parents and Moderate/Late Preterm Infants in the First Year of Life|Vermont Intervention: Effect on Joint Attention Skills Between Parents and Moderate/Late Preterm Infants Int the First Year of Life|Unknown status|Active, not recruiting|N/A|170|Actual|Ullevaal University Hospital||1|||f||||t||||||||||2017-02-18 17:00:44.198632|2017-02-18 17:00:44.198632
NCT00245830|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2015-01-16|||October 2003||2003-10-01|January 2015|2015-01-01|March 2007|Actual|2007-03-01|July 2006|Actual|2006-07-01||Interventional|||Ischemic Preconditioning of Liver in Cadaver Donors|Ischemic Preconditioning of Liver in Cadaver Donors|Completed||N/A|100|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 17:00:44.292422|2017-02-18 17:00:44.292422
NCT00245817|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2011-03-10|||August 2003||2003-08-01|December 2010|2010-12-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||HINCAB-study. Home Based Intervention in Nursing for Coronary Artery Bypass Patients|Coronary Artery Bypass Grafting (CABG) Patients in the Rehabilitation Phase. A Randomised Controlled Trial.|Completed||N/A|203|Actual|Oslo University Hospital||1|||f||||t||||||||||2017-02-18 17:00:44.401847|2017-02-18 17:00:44.401847
NCT00245804|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2010-06-29|||March 2003||2003-03-01|January 2005|2005-01-01|February 2005||2005-02-01|||||Observational|DYS-AUT||Developmental Dyslexia and Functional Maturation of Auditory Cortex||Completed||N/A|60||University Hospital, Tours|||4||f||||t||||||||||2017-02-18 17:00:44.508434|2017-02-18 17:00:44.508434
NCT00245791|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2015-06-02|||October 2004||2004-10-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time|TREATMENT OF COMPLICATED URINARY INFECTION WITH FIVE DAY HIGH DOSE LEVOFLOXACIN|Terminated||Phase 4|30||University of Manitoba|||||f||||||||||||||2017-02-18 17:00:44.60407|2017-02-18 17:00:44.60407
NCT00245778|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-05-25|||March 2004||2004-03-01|May 2007|2007-05-01|February 2007|Actual|2007-02-01|||||Observational|||fMRI Study of Grasping in Autistic Patients|fMRI Study of Grasping in Autistic Patients|Terminated||N/A|30|Actual|University Hospital, Tours||||All the patients were included|f||||||||||||||2017-02-18 17:00:44.697449|2017-02-18 17:00:44.697449
NCT00245765|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2013-09-06|||October 2005||2005-10-01|September 2009|2009-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy|Multicenter, Dose Response, Randomized, Double Blind, Parallel, Placebo Controlled Clinical Trial to Evaluate the Efficacy and the Safety of Subcutaneous CDP870 in Subjects Suffering From Moderate-to-severe Chronic Plaque Psoriasis Who Are Candidates for Systemic Therapy and/or Phototherapy and/or Photochemotherapy|Completed||Phase 2|176|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:00:44.766317|2017-02-18 17:00:44.766317
NCT00245752|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2009-02-04|||November 2005||2005-11-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Can Acupuncture be Used as Preparation for Induction of Labour|Randomised Study of the Effect of Acupuncture as Induction of Labour|Completed||Phase 2|125|Actual|Aarhus University Hospital Skejby||2|||f||||f||||||||||2017-02-18 17:00:44.884309|2017-02-18 17:00:44.884309
NCT00245739|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2014-04-10||||||April 2014|2014-04-01||||||||Expanded Access|||TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.|Early Access of TMC114 in Combination With Low-dose Ritonavir (TMC/r)) and Other Antiretrovirals (ARVs) in Highly Treatment Experienced HIV-1 Infected Patients With Limited to no Treatment Options.|Approved for marketing||Phase 3|||Tibotec Pharmaceuticals, Ireland|||||||||f||||||||||2017-02-18 17:00:45.001215|2017-02-18 17:00:45.001215
NCT00245726|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2009-01-29|||March 2004||2004-03-01|January 2009|2009-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Functional Electrical Stimulation (FES) Cycling for Children With Spinal Cord Injuries (SCI)|Lower Extremity Cycling With Functional Electrical Stimulation to Improve the Health and Fitness of Children With Spinal Cord Injuries|Completed||N/A|30|Actual|Shriners Hospitals for Children||3|||f||||f||||||||||2017-02-18 17:00:45.847102|2017-02-18 17:00:45.847102
NCT00245713|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2013-11-25|||March 2003||2003-03-01|September 2009|2009-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.|9-11 Week Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Determine Effects of Adjunctive Levetiracetam on Sleep Architecture of Adults With Partial Onset Epilepsy Receiving a First Generation Anti-epileptic Drug.|Completed||Phase 4|40||UCB Pharma|||||f||||||||||||||2017-02-18 17:00:45.952979|2017-02-18 17:00:45.952979
NCT00245700|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2008-05-22|||April 2005||2005-04-01|May 2008|2008-05-01|July 2006|Actual|2006-07-01|||||Observational|||Adherence of Stalevo, Entacapone and Levodopa|Study of Adherence of Stalevo, Entacapone and Levodopa|Completed||N/A|14||South Glasgow University Hospitals NHS Trust|||||f||||||||||||||2017-02-18 17:00:46.039751|2017-02-18 17:00:46.039751
NCT00245687|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2014-03-13|||June 2005||2005-06-01|March 2014|2014-03-01|June 2007|Actual|2007-06-01|||||Interventional|||A Research Study to Test (2) Two Different Types of Feeding Tubes Used in the Intensive Care Unit|A Comparative Study of the Tiger Tube Frictional Nasal Jejunal Feeding Tube and the Dubhoff Tube|Completed||N/A|60|Anticipated|Thomas Jefferson University|||||f||||||||||||||2017-02-18 17:00:46.122599|2017-02-18 17:00:46.122599
NCT00245674|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2008-04-08|||June 2005||2005-06-01|April 2008|2008-04-01||||||||Interventional|||SOLIACS: Solian Solution in the Acute Setting|Solian Solution to Treat Schizophrenic Patients During an Acute Episode|Completed||Phase 4|300||Sanofi|||||f||||||||||||||2017-02-18 17:00:46.20825|2017-02-18 17:00:46.20825
NCT00245661|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2007-10-31|||October 2005||2005-10-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Effects of Temazepam in Patients With Chronic Pulmonary Obstructive Disease|Effects of Temazepam on Dyspnea, Gas Exchange and Sleep Quality in Chronic Obstructive Pulmonary Disease.|Completed||Phase 3|14|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-02-18 17:00:46.301757|2017-02-18 17:00:46.301757
NCT00245648|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2012-10-03|||June 2001||2001-06-01|October 2012|2012-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI|Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI; Results of the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries - V Trial|Completed||Phase 3|||New York University School of Medicine|||||f||||||||||||||2017-02-18 17:00:46.41174|2017-02-18 17:00:46.41174
NCT00245635|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2015-07-06|2015-04-21||November 2004||2004-11-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|FDA BDD||Fluoxetine in Pediatric Body Dysmorphic Disorder|Fluoxetine in Pediatric Body Dysmorphic Disorder|Completed||Phase 4|43|Actual|Montefiore Medical Center||2|||f||||t||||||||||2017-02-18 17:00:46.522503|2017-02-18 17:00:46.522503
NCT00245622|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2014-02-06||2011-06-27|May 2006||2006-05-01|February 2014|2014-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|TERMS||Autologous T Cell Vaccine (TCV) for Multiple Sclerosis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Tovaxin in Subjects With CIS or RR-MS|Completed||Phase 2|150|Actual|Opexa Therapeutics, Inc.||2|||f||||t||||||||||2017-02-18 17:00:46.934396|2017-02-18 17:00:46.934396
NCT00245609|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2008-03-19|||January 2006||2006-01-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial Of The Anxiolytic Efficacy Of Pregabalin And Alprazolam IR In Subjects With Anxiety Prior To Dental Procedure|Completed||Phase 2|90||Pfizer|||||f||||||||||||||2017-02-18 17:00:47.085063|2017-02-18 17:00:47.085063
NCT00245596|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2008-02-22|||October 2005||2005-10-01|February 2008|2008-02-01||||||||Interventional|||Evaluation of the Index of Sexual Life Questionnaire|An Open Label, Multicenter Study to Measure Treatment Responsiveness of Quality of Sexual Life Questionnaire in the Female Partner of Men With Erectile Dysfunction Treated With Viagra (Sildenafil Citrate)|Completed||Phase 4|120||Pfizer|||||f||||||||||||||2017-02-18 17:00:47.181128|2017-02-18 17:00:47.181128
NCT00245583|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2010-05-19||||||May 2008|2008-05-01||||||||Interventional|||Topiramate in the Treatment of Pathological Gambling|Topiramate in the Treatment of Pathological Gambling: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study|Unknown status|Active, not recruiting|Phase 4|120||Icahn School of Medicine at Mount Sinai|||||f||||||||||||||2017-02-18 17:00:47.28949|2017-02-18 17:00:47.28949
NCT00245570|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2015-06-22|2009-09-25||December 2005||2005-12-01|June 2015|2015-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)|A Double-Blind, Randomized Multicenter, 3-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast Compared With Placebo and Salmeterol on Exercise-Induced Bronchoconstriction|Completed||Phase 3|47|Actual|Merck Sharp & Dohme Corp.||6|||f||||f||||||||||2017-02-18 17:00:47.406429|2017-02-18 17:00:47.406429
NCT00245557|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2015-04-06|2009-09-16||November 2004||2004-11-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Magnetic Resonance Imaging Study of Geriatric Depression|Nuclear Magnetic Resonance Imaging Study of Treatment With Sertraline in Geriatric Depression|Completed||N/A|43|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 17:00:48.038915|2017-02-18 17:00:48.038915
NCT00245544|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2015-05-20|||November 2005||2005-11-01|May 2015|2015-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)|A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover Study to Explore the Safety and Preliminary Efficacy of Oral MK0759 in the Treatment of Postherpetic Neuralgia|Terminated||Phase 2|20|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:00:48.416202|2017-02-18 17:00:48.416202
NCT00245531|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-03-30|||August 2004||2004-08-01|March 2015|2015-03-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Observational|||Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs|Effects of Endocrine Health on the Cognitive Function of Men and Women Using Drugs: A Cross-sectional Investigation|Completed||N/A|300|Anticipated|Johns Hopkins University|||2||f||||t||||||||||2017-02-18 17:00:48.489201|2017-02-18 17:00:48.489201
NCT00245518|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2009-01-27|||June 2005||2005-06-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy|Effect of Isoflavones on Cognition, Quality of Life and Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy|Completed||Phase 4|50|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 17:00:48.687278|2017-02-18 17:00:48.687278
NCT00245505|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2012-03-09|||February 2009||2009-02-01|March 2012|2012-03-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||"The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active Drug: Crohn's Disease"|The Effect on Mucosal Healing With Pentasa Sachet 4g in Mild to Moderate Active Small Bowel Crohn´s Disease, Evaluated by Video Capsule Endoscopy After 6 and 12 Weeks Treatment. A Pilot Study|Terminated||Phase 3|3|Actual|Ferring Pharmaceuticals||1||Study terminated due to lack of eligible patients|f||||f||||||||||2017-02-18 17:00:48.792504|2017-02-18 17:00:48.792504
NCT00245492|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2009-01-27|||May 2006||2006-05-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.|Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.|Completed||N/A|792|Anticipated|Indiana University||1|||f||||||||||||||2017-02-18 17:00:48.884147|2017-02-18 17:00:48.884147
NCT00245479|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-18|||April 2002||2002-04-01|May 2011|2011-05-01|November 2006|Actual|2006-11-01|September 2005|Actual|2005-09-01||Interventional|DRIP||A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis|An Open Label, Multi-national Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis|Completed||Phase 4|802|Actual|Ferring Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:00:48.982871|2017-02-18 17:00:48.982871
NCT00245466|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2011-05-18|2009-01-22||October 2001||2001-10-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients|An Open-Label, Multi-Centre, Extension Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients.|Terminated||Phase 2|88|Actual|Ferring Pharmaceuticals||3||The maintenance doses were too low to maintain testosterone suppression|f||||f||||||||||2017-02-18 17:00:49.094379|2017-02-18 17:00:49.094379
NCT00245453|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2015-07-27|||October 2005||2005-10-01|July 2015|2015-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Outpatient Registry Trial of Respiratory Tract Infections in Adults|Randomized Aseptic Pharmacokinetic Pharmacodynamic Outpatient Registry Trial of Respiratory Tract Infections in Adults (RAPPORT)|Withdrawn||Phase 4|0|Actual|CPL Associates||3||Terminated by sponsor|f||||||||||||||2017-02-18 17:00:50.632796|2017-02-18 17:00:50.632796
NCT00245440|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-10-29|||December 2005||2005-12-01|October 2007|2007-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis|Influence of Oral Telithromycin vs. Azithromycin on the Endogenous Microflora in Adults With Acute Sinusitis|Terminated||Phase 4|192|Actual|CPL Associates||2||Sponsor Terminated|f||||||||||||||2017-02-18 17:00:50.762761|2017-02-18 17:00:50.762761
NCT00245427|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-10-29|||December 2005||2005-12-01|October 2007|2007-10-01|March 2006|Actual|2006-03-01|||||Interventional|||Outcomes of Patients Not Responding to Antibiotics in the Community|Outcomes of Patients Not Responding to Outpatient Macrolide or b-Lactam Therapy for the Treatment of Community Acquired Pneumonia: Expansion to Include Acute Exacerbations of Chronic Bronchitis and Acute Sinusitis|Completed||N/A|200|Actual|CPL Associates||2|||f||||||||||||||2017-02-18 17:00:50.875218|2017-02-18 17:00:50.875218
NCT00245414|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2010-11-16|||October 2005||2005-10-01|November 2010|2010-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Trial of Pegasys® in Patients With Chronic Hepatitis C|Post-marketing Clinical Trial of Pegasys® 180μg for Subcutaneous Injection in Patients With Chronic Hepatitis C. General Clinical Study in Interferon (IFN)-Treated and IFN-untreated Chronic Hepatitis C Patients, Except for Those Infected With High Viral Load of Genotype 1b|Completed||Phase 4|108|Actual|Chugai Pharmaceutical||4|||f||||f||||||||||2017-02-18 17:00:50.986083|2017-02-18 17:00:50.986083
NCT00245401|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-04-03|||August 2003||2003-08-01|April 2007|2007-04-01|December 2004|Actual|2004-12-01|||||Interventional|||CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)|CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)|Completed||Phase 4|2070||Cordis Corporation|||||f||||t||||||||||2017-02-18 17:00:51.09614|2017-02-18 17:00:51.09614
NCT00245388|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2012-04-20|||April 2002||2002-04-01|April 2012|2012-04-01|July 2002|Actual|2002-07-01|||||Interventional|||Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia|A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Trial to Determine the Lipid-Lowering Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia|Completed||Phase 2/Phase 3|330||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:00:51.178177|2017-02-18 17:00:51.178177
NCT00245375|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2008-03-28|||January 2005||2005-01-01|March 2008|2008-03-01|December 2005|Actual|2005-12-01|||||Interventional|||A Trial Comparing Combination Therapy of Acetaminophen Plus Ibuprofen Versus Tylenol #3 for the Treatment of Pain After Outpatient Surgery|A Randomized Controlled Trial Comparing Combination Therapy of Acetaminophen Plus Ibuprofen Versus Tylenol #3 for the Treatment of Pain After Outpatient Surgery|Completed||N/A|150||Nova Scotia Health Authority|||||f||||||||||||||2017-02-18 17:00:51.331165|2017-02-18 17:00:51.331165
NCT00245362|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-27|2005-10-27|||June 2002||2002-06-01|October 2005|2005-10-01|June 2004||2004-06-01|||||Interventional|||A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer|A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer|Completed||Phase 2|50||Cell Genesys|||||||||||||||||||2017-02-18 17:00:51.431457|2017-02-18 17:00:51.431457
NCT00245349|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2008-06-09|||October 2005||2005-10-01|June 2008|2008-06-01|April 2008|Actual|2008-04-01|||||Observational|||Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer|Biodistribution and Radiation Dosimetry of F-18 Fluorothymidine (FLT) Imaged With Positron Emission Tomography (PET) in Patients With Head and Neck Cancer: A Radioactive Drug Research Committee (RDRC) Study|Completed||Phase 1|9|Actual|University of Iowa|||1||f||||t||||||Samples With DNA|"~     Tumor biopsy, blood samples~   "|||2017-02-18 17:00:51.517867|2017-02-18 17:00:51.517867
NCT00245336|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2009-03-06|||October 2005||2005-10-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Study of Recombinant Human Thrombin for Bleeding During Surgery|A Phase 3, Randomized, Double-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Recombinant Human Thrombin (rhThrombin) and Thrombin-JMI (Bovine Thrombin) in Surgical Hemostasis|Completed||Phase 3|401|Actual|ZymoGenetics||2|||f||||t||||||||||2017-02-18 17:00:51.615898|2017-02-18 17:00:51.615898
NCT00245323|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2005-10-25|||November 2003||2003-11-01|October 2005|2005-10-01|August 2004||2004-08-01|||||Interventional|||Checking Smoking Status as a Routine Vital Sign: A Cluster-Randomized Trial of Its Effect on Cessation Counseling|Does Checking Smoking Status as a Vital Sign Increase Physician Counseling? A Practice-Level Randomized Controlled Trial|Completed||N/A|2000||Virginia Commonwealth University|||||f||||||||||||||2017-02-18 17:00:51.767251|2017-02-18 17:00:51.767251
NCT00245310|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2010-10-08|||October 2005||2005-10-01|November 2008|2008-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Indocyangreen Elimination in Cirrhosis and Acute Liver Failure|Evaluation of the Indocyangreen Elimination as a Prognostic Marker in Decompensated Cirrhosis and Acute Liver Failure|Completed||N/A|40|Anticipated|Heidelberg University|||1||f||||||||||||||2017-02-18 17:00:51.850145|2017-02-18 17:00:51.850145
NCT00245297|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2007-10-15|||October 2005||2005-10-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.|A Patient-Blinded, Randomized, Comparative, Multicenter, Crossover, (Liposome) Dose Finding Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.|Completed||Phase 2|16|Actual|Recoly N.V.|||||f||||f||||||||||2017-02-18 17:00:51.935059|2017-02-18 17:00:51.935059
NCT00245284|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2006-06-05|||September 2005||2005-09-01|June 2006|2006-06-01|May 2006||2006-05-01|||||Observational|||Predictor of Advanced Subclinical Atherosclerosis||Completed||N/A|600||PreMD|||||f||||||||||||||2017-02-18 17:00:52.037505|2017-02-18 17:00:52.037505
NCT00245271|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2011-06-17||2011-06-17|October 2004||2004-10-01|June 2011|2011-06-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction|Double-Blind, Multicenter Study Evaluating the Safety of OMS103HP and Vehicle in Subjects Undergoing Anterior Cruciate Ligament Reconstruction With an Open-Label Phase Containing a PK Analysis in a Subset of Subjects|Completed||Phase 3|480|Anticipated|Omeros Corporation||2|||f||||f||||||||||2017-02-18 17:00:52.123123|2017-02-18 17:00:52.123123
NCT00245258|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2006-10-05|||November 2005||2005-11-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction|A Multicenter, Double-Blind Placebo Controlled, Fixed Dose Study With An Open-Label, Flexible Dose Phase To Assess The Efficacy Of Sildenafil Citrate In Providing A Better Sexual Experience Including Quality Of Erections And Satisfaction In Men With Erectile Dysfunction|Completed||Phase 4|312||Pfizer|||||f||||||||||||||2017-02-18 17:00:52.343748|2017-02-18 17:00:52.343748
NCT00245245|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2007-10-02|||May 2005||2005-05-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII|An Open-Label Study of the Hemostatic Activity, Pharmacokinetics and Safety of OBI-1 (B-Domain Deleted Recombinant Porcine FVIII), When Administered by Intravenous Injection, to Control Non-Life and Non-Limb Threatening Bleeding Episodes in Congenital Hemophilia A Patients With an Inhibitor to Human FVIII|Completed||Phase 2|12|Anticipated|Octagen Corporation|||||||||||||||||||2017-02-18 17:00:52.453199|2017-02-18 17:00:52.453199
NCT00245232|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-03-30|||August 2000||2000-08-01|March 2015|2015-03-01|April 2005||2005-04-01|||||Interventional|||Cognitive Processing Therapy Versus Its Individual Components in the Treatment of Post-Traumatic Stress Disorder and Depression in Women Who Have Been Sexually Abused|Cognitive Processes in PTSD: Treatment|Completed||N/A|228||University of Missouri, St. Louis|||||f||||||||||||||2017-02-18 17:00:52.548676|2017-02-18 17:00:52.548676
NCT00245219|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2016-02-03|2015-08-25||September 1999||1999-09-01|December 2015|2015-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Understanding Shared Psychobiological Pathways|Understanding Shared Psychobiological Pathways--Project 4. Psychobiological Pathways: Breast Cancer Interventions|Completed||N/A|245|Actual|Carnegie Mellon University|The study was originally planned as a 2(early stage, late stage) X 3(education intervention, peer support intervention, control condition) design; however, the education condition for the late stage cancer group was dropped, due to slow recruitment.|3|||f||||t||||||||||2017-02-18 17:00:52.647934|2017-02-18 17:00:52.647934
NCT00245206|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-06-11|||August 2005||2005-08-01|April 2009|2009-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Side Effects of Newer Antipsychotics in Older Adults|Metabolic Effects of Newer Antipsychotics in Older Patients|Completed||Phase 4|406|Actual|Veterans Medical Research Foundation||3|||f||||t||||||||||2017-02-18 17:00:53.191241|2017-02-18 17:00:53.191241
NCT00245193|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-06-21|||April 2003||2003-04-01|June 2013|2013-06-01|March 2006|Actual|2006-03-01|||||Interventional|||Motivationally-Enhanced Brief Interpersonal Psychotherapy for Depressed Mothers of Ill Children|Motivationally-Enhanced Brief Interpersonal Psychotherapy for Depressed Mothers of Ill Children (MI-IPT-B-II)|Completed||Phase 4|50||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:00:53.309448|2017-02-18 17:00:53.309448
NCT00245180|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2014-03-10|||May 2006||2006-05-01|April 2006|2006-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Preventing American Indian Children From Becoming Overweight|Primordial Prevention of Overweight in American Indian Children|Completed||N/A|577|Actual|Kaiser Permanente||1|||f||||f||||||||||2017-02-18 17:00:53.398673|2017-02-18 17:00:53.398673
NCT00245167|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2016-07-28|||January 2002||2002-01-01|March 2008|2008-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung Disease|TLR's, Nitric Oxide and Chronic Lung Disease: Any Connections?|Completed||N/A|120||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:00:53.48698|2017-02-18 17:00:53.48698
NCT00245154|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2016-11-25|||September 2005||2005-09-01|November 2012|2012-11-01|January 2013|Actual|2013-01-01|February 2008|Actual|2008-02-01||Interventional|||Paclitaxel and Carboplatin With or Without Cediranib Maleate in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II/III Double Blind Randomized Trial of AZD2171 Versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2/Phase 3|296|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 17:00:53.566736|2017-02-18 17:00:53.566736
NCT00245141|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-08-09|||May 2004||2004-05-01|July 2009|2009-07-01||||April 2011|Anticipated|2011-04-01||Interventional|||Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma|Phase II Trial of Short VAC1.2 Therapy for Low-Risk A Group Patients With Rhabdomyosarcoma|Unknown status|Recruiting|Phase 2|32|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:00:53.70259|2017-02-18 17:00:53.70259
NCT00245128|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-12-01|2011-10-25||August 2005||2005-08-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|March 2007|Actual|2007-03-01||Interventional|||Imatinib Mesylate in Treating Patients With Myelofibrosis|A Phase II Pilot Study to Determine the Safety and Preliminary Efficacy of Imatinib Mesylate (Gleevec) in Patients With Myelofibrosis With Myeloid Metaplasia|Terminated||Phase 2|10|Actual|OHSU Knight Cancer Institute|Early termination/results were never analyzed due to negative study results from other similar studies.|1||"Per PI, results from another similar study were published prior to study analysis. Negative~   study results were published therefore analysis was not completed"|f||||t||||||||||2017-02-18 17:00:56.698622|2017-02-18 17:00:56.698622
NCT00245115|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2016-10-14|||October 2005||2005-10-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|December 2007|Actual|2007-12-01||Interventional|||Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia|Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia|Active, not recruiting||N/A|25|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 17:00:56.9798|2017-02-18 17:00:56.9798
NCT00245102|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2014-05-07|2013-11-19||September 2005||2005-09-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma|A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas|Completed||Phase 2|147|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:00:57.088316|2017-02-18 17:00:57.088316
NCT00245089|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-08-09|||May 2004||2004-05-01|July 2009|2009-07-01||||April 2011|Anticipated|2011-04-01||Interventional|||Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma|Phase II Trial of VAC2.2/VA Therapy for Low-Risk B Group Patients With Rhabdomyosarcoma|Unknown status|Recruiting|Phase 2|41|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:00:58.598949|2017-02-18 17:00:58.598949
NCT00245076|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-04-30|||April 2005||2005-04-01|April 2006|2006-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking|Evaluation of the Impact of a Bulletin Board on a Web-Based Smoking Cessation Intervention|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:00:58.735609|2017-02-18 17:00:58.735609
NCT00244894|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-08-29|||September 2002||2002-09-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer|Acupuncture for Hot Flashes in Prostate Cancer Patients|Terminated||N/A|22|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 17:01:01.725199|2017-02-18 17:01:01.725199
NCT00245063|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2014-10-01|2014-07-21||March 2006||2006-03-01|June 2013|2013-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer|Phase II Study of AZD2171 in Patients With Recurrent Small Cell Lung Cancer|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)|The 45 mg PO dose on arm 1 was deemed undeliverable since 7 of 12 patients were unable to complete one cycle due to treatment intolerance. Study was ammended and re-started at 30 mg (arm 2) after discussions with coinvestigators at CTEP.|1|||f||||||||||||||2017-02-18 17:00:58.82058|2017-02-18 17:00:58.82058
NCT00245050|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-12-28|2010-10-26||April 2004||2004-04-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|April 2008|Actual|2008-04-01||Interventional|||Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer|A Double-Blind Randomized Trial of Pyridoxine Versus Placebo for the Prevention of Doxil-Related Palmar-Plantar Erythrodysesthesia (Hand-Foot Syndrome)|Completed||Phase 3|34|Actual|Case Comprehensive Cancer Center|Interim analysis was conducted after 30 patients were enrolled and had evaluable PPE assessment data. Due to decreased accrual and similar PPE rates between groups, the trial was closed for enrollment after the interim analyses was completed.|2|||f||||t||||||||||2017-02-18 17:00:59.301738|2017-02-18 17:00:59.301738
NCT00245037|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2016-11-28||2016-11-28|June 2005||2005-06-01|November 2016|2016-11-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|Bu Flu TBI||Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer|A Phase I/II Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients With Hematologic Malignancies Using Busulfan, Fludarabine and Total Body Irradiation|Completed||Phase 1/Phase 2|204|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 17:01:00.005548|2017-02-18 17:01:00.005548
NCT00245024|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-05-01|||November 2005||2005-11-01|October 2011|2011-10-01|January 2010|Actual|2010-01-01|August 2007|Actual|2007-08-01||Interventional|||Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer|Phase IB Sulindac Study for Women at High Risk for Breast Cancer|Completed||Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:01:00.159001|2017-02-18 17:01:00.159001
NCT00245011|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2016-07-26|2015-02-03||October 2004||2004-10-01|July 2016|2016-07-01|March 2009|Actual|2009-03-01|October 2008|Actual|2008-10-01||Interventional|||Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma|High Dose Samarium-153 With Peripheral Blood Stem Cell Support in High Risk Osteogenic Sarcoma|Completed||Phase 2|11|Actual|Sidney Kimmel Comprehensive Cancer Center|"Future work will focus on better understanding the factors that contribute to drug delivery and improving efficacy be combination with chemotherapy, biologics, or external beam radiotherapy. (See Publication section of this entry)."|1|||f||||t||||||||||2017-02-18 17:01:00.276145|2017-02-18 17:01:00.276145
NCT00244998|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-03-07|||September 2005||2005-09-01|March 2013|2013-03-01|June 2012|Actual|2012-06-01|October 2006|Actual|2006-10-01||Interventional|||Fulvestrant in Treating Patients With Advanced Prostate Cancer|Phase II Study of Fulvestrant (Faslodex®) in Androgen Independent Prostate Cancer|Completed||Phase 2|20|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:01:00.561675|2017-02-18 17:01:00.561675
NCT00244985|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-11-20|||September 2005||2005-09-01|November 2015|2015-11-01||||August 2008|Actual|2008-08-01||Interventional|||Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I/II Pilot Study of the Safety and Efficacy of Rituxan (Chimeric Anti-CD20 Antibody) in Combination With Doxil (Liposomal Doxorubicin) Chemotherapy in Patients With Relapsing or Refractory Indolent or Aggressive B-Cell Lymphoma|Completed||Phase 1/Phase 2|42|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:01:00.670074|2017-02-18 17:01:00.670074
NCT00244972|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2017-01-31|||October 2005||2005-10-01|October 2016|2016-10-01||||March 2017|Anticipated|2017-03-01||Interventional|||Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer|Phase I Study of Tipifarnib (R115777) and Sorafenib (BAY 43-9006) in Patients With Biopsiable Advanced Cancers|Active, not recruiting||Phase 1|56|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:01:00.786099|2017-02-18 17:01:00.786099
NCT00244959|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-03-18|||January 2004||2004-01-01|March 2013|2013-03-01|November 2011|Actual|2011-11-01|September 2007|Actual|2007-09-01||Interventional|||Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer|Surrogate Markers of Response: A Phase II Study of Changes in Breast Density Among Postmenopausal Women Receiving Adjuvant Anastrozole Therapy|Completed||Phase 2|54|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 17:01:00.902812|2017-02-18 17:01:00.902812
NCT00244946|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-03-25|||March 2004||2004-03-01|March 2015|2015-03-01|March 2013|Actual|2013-03-01|January 2010|Actual|2010-01-01||Interventional|||Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma|Immune Consolidation With Activated T Cells Armed With OKT3 x Rituxan (Anti-CD3 x Anti-CD20) Bispecific Antibody (CD20Bi) After Peripheral Blood Stem Cell Transplant for High Risk CD20+ Non-Hodgkin's Lymphomas|Completed||Phase 1|15|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-02-18 17:01:01.026223|2017-02-18 17:01:01.026223
NCT00244933|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-02-05|2015-01-12||February 2004||2004-02-01|February 2015|2015-02-01|October 2009|Actual|2009-10-01|November 2008|Actual|2008-11-01||Interventional|||Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer|Phase II Trial of Gemcitabine and Genistein in Metastatic Breast Cancer Patients With Biomarker Assays|Completed||Phase 2|19|Actual|Barbara Ann Karmanos Cancer Institute|Although the study is designed to accrue 18 response evaluable participants in the first stage, the decision was made to close the study after 17 patients because of lack of efficacy.|1|||f||||t||||||||||2017-02-18 17:01:01.16722|2017-02-18 17:01:01.16722
NCT00244920|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2012-05-24|||January 2002||2002-01-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer|An Open Label Randomized Phase 2 Study To Evaluate The Activity, Tolerability, And Toxicity Of Combined Neoadjuvant Anti-angiogenesis and Androgen Ablation Therapy in Men Undergoing Radical Prostatectomy|Withdrawn||Phase 2|0|Actual|OHSU Knight Cancer Institute||||Sponsor withdrew drug.|f||||f||||||||||2017-02-18 17:01:01.478838|2017-02-18 17:01:01.478838
NCT00244907|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2014-02-07|||January 2006||2006-01-01|February 2014|2014-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women|Metabolism and Bone Health|Completed||Phase 1|23|Actual|Purdue University||2|||f||||t||||||||||2017-02-18 17:01:01.588398|2017-02-18 17:01:01.588398
NCT00244881|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-12-03|2013-11-04||September 2005||2005-09-01|November 2013|2013-11-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)|A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)|Completed||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:01:01.835704|2017-02-18 17:01:01.835704
NCT00244868|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-01-28|||July 2003||2003-07-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer|Facilitating Decision Making in Advanced Cancer Patients|Completed||Phase 3|720|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 17:01:02.147514|2017-02-18 17:01:02.147514
NCT00244855|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-08-11|||May 2004||2004-05-01|August 2011|2011-08-01||||December 2008|Actual|2008-12-01||Interventional|||Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma|Rituximab and Dexamethasone in CD20 Positive Low Grade and Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|55|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 17:01:02.255351|2017-02-18 17:01:02.255351
NCT00244842|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2008-09-24|||December 2004||2004-12-01|September 2008|2008-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|SPIRIT||Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis|A Phase III, Randomized, Multicentre, Double-Blind, Placebo-Controlled Study of ISA247 in Plaque Psoriasis Patients|Completed||Phase 3|451|Actual|Aurinia Pharmaceuticals Inc.||4|||f||||t||||||||||2017-02-18 17:01:02.633327|2017-02-18 17:01:02.633327
NCT00244829|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-11-28|||January 2004||2004-01-01|November 2011|2011-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia|A Multicenter Pilot Study Evaluating the Safety and Efficacy of Imatinib as Post-Transplant Therapy for High- Risk Philadelphia Chromosome-Positive Leukemias|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:01:02.786301|2017-02-18 17:01:02.786301
NCT00244816|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2009-01-14|||October 2005||2005-10-01|January 2009|2009-01-01|April 2007||2007-04-01|||||Interventional|||Taxoprexin® Treatment for Advanced Eye Melanoma|Phase II Open-Label Study of Weekly Taxoprexin® (DHA-Paclitaxel) Injection as Treatment of Patients With Metastatic Uveal (Choroidal) Malignant Melanoma|Completed||Phase 2|30||Luitpold Pharmaceuticals|||||||||||||||||||2017-02-18 17:01:02.892343|2017-02-18 17:01:02.892343
NCT00244803|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2016-08-30|||January 2005||2005-01-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)|Redistribution and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)|Completed||N/A|101|Actual|Johns Hopkins University|||1||f||||t||||||||||2017-02-18 17:01:03.001812|2017-02-18 17:01:03.001812
NCT00244790|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-08-26|||April 2004||2004-04-01|August 2015|2015-08-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||The Effects of Obesity and Protein Intake on the Kidney|The Effects of Obesity and Protein Intake on the Kidney|Completed||N/A|50|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 17:01:03.091461|2017-02-18 17:01:03.091461
NCT00244777|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2015-06-11|||December 2002||2002-12-01|October 2005|2005-10-01|February 2004||2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Introduction of Hypo-osmolar ORS for Routine Use|Introduction of New Hypo-osmolar ORS Into Routine Use in the Management of Diarrhoeal Disease: a Phase IV Clinical Surveillance.|Completed||Phase 4|75000||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 17:01:03.196217|2017-02-18 17:01:03.196217
NCT00244764|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-09-24|2009-11-19||October 2005||2005-10-01|August 2014|2014-08-01|September 2013|Actual|2013-09-01|March 2008|Actual|2008-03-01||Interventional|||GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma|A Phase II Study of GW786034 Using a Randomised Discontinuation Design in Subjects With Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma|Completed||Phase 2|225|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 17:01:03.292984|2017-02-18 17:01:03.292984
NCT00244751|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2016-04-28||2009-07-22|November 2005||2005-11-01|April 2016|2016-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects|A Double-Blind, Randomized, Placebo-Controlled Multi-Center, Phase II Parallel Dose-Ranging Study to Assess the Antifibrotic Activity of GI262570 in Chronic Hepatitis C Subjects With Hepatic Fibrosis Who Have Failed Prior Antiviral Therapy|Completed||Phase 2|225|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:01:03.828658|2017-02-18 17:01:03.828658
NCT00244738|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2012-03-18|||February 2006||2006-02-01|November 2005|2005-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||The Use of Castor Oil as a Labor Initiator in Post-date Pregnancies|The Use of Castor Oil as a Labor Initiator in Post-date Pregnancies|Completed||N/A|82|Actual|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 17:01:04.061185|2017-02-18 17:01:04.061185
NCT00244725|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-04-14|||September 2005||2005-09-01|April 2015|2015-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Odiparcil For The Prevention Of Venous Thromboembolism|A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery|Completed||Phase 2|961|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:01:04.178933|2017-02-18 17:01:04.178933
NCT00244712|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2010-06-03|2009-04-23||July 2005||2005-07-01|June 2010|2010-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|HEAT||Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV|A 96-Week, Phase IV, Randomized, Double-Blind, Multicenter Study of the Safety and Efficacy of EPZICOM Versus TRUVADA Administered in Combination With KALETRA in Antiretroviral-Naive HIV-1 Infected Subjects|Completed||Phase 4|688|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 17:01:04.620265|2017-02-18 17:01:04.620265
NCT00244699|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2009-05-09|||October 2005||2005-10-01|May 2009|2009-05-01|April 2007||2007-04-01|||||Interventional|||Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth|A Mindfulness-Based Intervention for Youth With Concurrent Disorders|Completed||N/A|40||Centre for Addiction and Mental Health|||||f||||||||||||||2017-02-18 17:01:06.225878|2017-02-18 17:01:06.225878
NCT00244686|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2017-02-02|||August 2005||2005-08-01|February 2017|2017-02-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Interventional|||An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES|An Open-Label Compassionate Use Access and Long-Term Access Study of Anti IL-5 (Mepolizumab) Treatment in Subjects With Hypereosinophilic Syndrome|Recruiting||Phase 3|300|Anticipated|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 17:01:06.330262|2017-02-18 17:01:06.330262
NCT00244673|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2012-02-25|||October 2005||2005-10-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination|Diphteria-tetanus-pertussis (DTP) Vaccination and Child Survival: Randomized Study of Not Providing DTP Vaccination Together With or After Measles Vaccination|Completed||Phase 4|6534|Actual|Bandim Health Project||1|||f||||||||||||||2017-02-18 17:01:06.626772|2017-02-18 17:01:06.626772
NCT00244660|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2008-01-17|||November 2005||2005-11-01|January 2008|2008-01-01|June 2007||2007-06-01|||||Interventional|||Blood Pressure Reduction in Danish General Practice (BRIDGE)|Blood Pressure Reduction in Danish General Practice (BRIDGE)|Completed||Phase 4|1000||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:01:06.962809|2017-02-18 17:01:06.962809
NCT00244647|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2008-04-09|||August 2003||2003-08-01|April 2008|2008-04-01||||||||Interventional|||A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis|A Phase 1b, Randomized, Single Blind Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis|Terminated||Phase 1|40||Sarepta Therapeutics|||||f||||||||||||||2017-02-18 17:01:07.04107|2017-02-18 17:01:07.04107
NCT00244634|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2007-12-17|||September 2003||2003-09-01|December 2007|2007-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age|A Dose-Ranging and Safety Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 6 to <17 Years of Age: A 4-Week, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study|Completed||Phase 3|238||AstraZeneca|||||||||||||||||||2017-02-18 17:01:07.132233|2017-02-18 17:01:07.132233
NCT00244621|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-08-29|2009-08-07||November 2004||2004-11-01|August 2011|2011-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age|A Dose-ranging Safety and Pharmacokinetics Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 1 to Less That 6 Years of Age: A 4-week, Multicenter, Randomized, Double-blind Study With a 1-year, Open-label, Follow-up Period.|Completed||Phase 3|95|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 17:01:07.261324|2017-02-18 17:01:07.261324
NCT00244608|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-01-21|||May 2005||2005-05-01|January 2011|2011-01-01|March 2007|Actual|2007-03-01|||||Interventional|||A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®|A Comparison of the Inflammatory Control of Asthma Provided by One Inhalation of Symbicort® Turbuhaler® 160/4.5 µg/Inhalation b.i.d. Plus As-needed Versus One Inhalation of Symbicort® Turbuhaler® 320/9 µg/Inhalation b.i.d. + One Inhalation of Pulmicort® Turbuhaler® 400 µg/Dose b.i.d. Plus Terbutaline Turbuhaler® 0.4 mg/Inhalation As-needed. A 12-month, Randomised, Double-blind, Parallel-group, Active Controlled, Multinational, Phase IIIB Study in Adult Patients With Asthma, EOS|Completed||Phase 3|100||AstraZeneca|||||f||||||||||||||2017-02-18 17:01:07.832987|2017-02-18 17:01:07.832987
NCT00244595|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2009-12-08|||September 2003||2003-09-01|December 2009|2009-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age|A Multicenter, Multinational, Open-Label Study of the Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age|Completed||Phase 3|235||AstraZeneca|||||||||||||||||||2017-02-18 17:01:07.947542|2017-02-18 17:01:07.947542
NCT00244582|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-26|2017-01-24|||October 22, 2005||2005-10-22|November 3, 2006|2006-11-03|November 3, 2006||2006-11-03|||||Observational|||Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease|Direct Convection-Enhanced Delivery of Glucocerebrosidase for the Treatment of Type 2 (Acute Neuronopathic) Gaucher Disease|Completed||N/A|1||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:01:08.077786|2017-02-18 17:01:08.077786
NCT00244569|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2007-12-14|||September 2005||2005-09-01|August 2006|2006-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Development of a Breath Test for Monitoring Patients With Liver Disease|Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis|Completed||Phase 3|120|Anticipated|Virginia Commonwealth University|||||f||||||||||||||2017-02-18 17:01:08.158246|2017-02-18 17:01:08.158246
NCT00244556|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2013-02-20|||March 2003||2003-03-01|February 2013|2013-02-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy|A Randomized Comparison of the Safety and Efficacy of Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Patients With Active Rheumatoid Arthritis Despite Current Methotrexate Therapy|Completed||Phase 4|300||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:01:08.267478|2017-02-18 17:01:08.267478
NCT00244543|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-09-26|||October 2005||2005-10-01|September 2011|2011-09-01||||November 2005|Actual|2005-11-01||Interventional|||Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis|A Single-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of R89674 0.25% Ophthalmic Solution in Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis|Completed||Phase 3|110||Vistakon Pharmaceuticals|||||f||||||||||||||2017-02-18 17:01:08.349975|2017-02-18 17:01:08.349975
NCT00244530|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2006-12-20|||June 2001||2001-06-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery|Postoperative Renal Function After Open-Heart Surgery in Patients With Impaired Renal Function Preoperatively. A Study of the Calcium Channel Blocker Nifedipine's Prophylactic Effect on Further Decline in Renal Function.|Completed||Phase 4|20||University of Oslo School of Pharmacy|||||f||||||||||||||2017-02-18 17:01:08.435827|2017-02-18 17:01:08.435827
NCT00244517|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2010-06-30|||June 2004||2004-06-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||DIAFAX I+II-Effects of Inhalative Anesthetics on Left Ventricular Diastolic Function|The Effects of Remifentanil, Sevoflurane, Isoflurane and Desflurane on Left Ventricular Diastolic Function in Humans|Terminated||Phase 4|60|Actual|University Hospital, Basel, Switzerland||3||"Part II was not performed as we could not include enough patients fulfilling the inclusion~   criteria."|f||||t||||||||||2017-02-18 17:01:08.526548|2017-02-18 17:01:08.526548
NCT00244504|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2009-11-09|||November 2002||2002-11-01|November 2009|2009-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Moxonidine in Patients Undergoing Vascular Surgery|The Effects of Small Doses of Moxonidine in Patients Undergoing Vascular Surgery|Terminated||Phase 3|141|Actual|University Hospital, Basel, Switzerland||2||Study was stopped after pre-definied interim analysis because of no effects|f||||t||||||||||2017-02-18 17:01:08.640197|2017-02-18 17:01:08.640197
NCT00244478|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-09-23|||October 2005||2005-10-01|September 2015|2015-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Soy, Bone and Health in College Females|Influence of Soy on Bone Turnover and Body Composition in College Females|Completed||N/A|120|Actual|University of Georgia||2|||f||||t||||||||||2017-02-18 17:01:08.837324|2017-02-18 17:01:08.837324
NCT00244465|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2016-09-05|||May 2006||2006-05-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|September 2016|Actual|2016-09-01||Observational|||Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription|Post Marketing Non-interventional Surveillance Pharmacoepidemiology Study (PMSS) to Evaluate Long-term Safety, Tolerability and Compliance in Administration of Xyrem® (Sodium Oxybate) Oral Solution in Patients Who Receive Treatment With This Medication in Regular Clinical Practice.|Completed||Phase 4|750|Actual|UCB Pharma|||1||f||||f||||||||||2017-02-18 17:01:08.939805|2017-02-18 17:01:08.939805
NCT00244452|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2008-03-28|||November 2005||2005-11-01|March 2008|2008-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis|A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis|Completed||Phase 2|||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 17:01:09.180799|2017-02-18 17:01:09.180799
NCT00244439|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2013-12-19|||December 2005||2005-12-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice|A Multi-Center Phase III Study to Evaluate MALG, a Novel Malathion 0.05%Formulation, for the Control of Head Lice in Pediatric and Adult Subjects With Pediculosis Capitis|Completed||Phase 3|360|Actual|Taro Pharmaceuticals USA||3|||f||||f||||||||||2017-02-18 17:01:09.324482|2017-02-18 17:01:09.324482
NCT00244426|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2009-10-29|||December 2000||2000-12-01|October 2009|2009-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|SIFA||S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation|II Italian Study on Atrial Fibrillation (S.I.F.A. II): Prevention of Thromboembolic Events in Patients With Non Valvular Atrial Fibrillation.|Completed||Phase 3|1372|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:01:09.43677|2017-02-18 17:01:09.43677
NCT00244413|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2013-03-05|||February 2006||2006-02-01|March 2013|2013-03-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Characteristics of Nondystrophic Myotonias|Nondystrophic Myotonias: Genotype-phenotype Correlation and Longitudinal Study|Completed||N/A|94|Actual|University of Kansas Medical Center|||1||f||||||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 17:01:09.846825|2017-02-18 17:01:09.846825
NCT00244400|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2006-10-16|||November 2002||2002-11-01|October 2006|2006-10-01|January 2006||2006-01-01|||||Observational|||Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis||Completed||N/A|200||Osaka City University|||||f||||||||||||||2017-02-18 17:01:09.949554|2017-02-18 17:01:09.949554
NCT00244387|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2014-09-24|||March 2004||2004-03-01|February 2010|2010-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa|A Multi-centre, Multi-national, Phase 3, Randomized, Double-blind, Double-dummy, 3- Arm Parallel Group, Placebo- and Pramipexole- Controlled Trial of the Efficacy and Safety of Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa|Completed||Phase 3|506|Actual|UCB Pharma|||||||||||||||||||2017-02-18 17:01:10.044312|2017-02-18 17:01:10.044312
NCT00244374|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2013-07-25|2013-04-25||August 2004||2004-08-01|July 2013|2013-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|UFO VAX||A Randomized Trial of Vaccine Adherence in Young Injection Drug Users|A Randomized Trial of Vaccine Adherence in Young IDU|Completed||N/A|546|Actual|University of California, San Francisco||4|||f||||f||||||||||2017-02-18 17:01:10.147954|2017-02-18 17:01:10.147954
NCT00244361|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2011-05-06|||June 2005||2005-06-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Effectiveness of Rituximab in Pediatric OMS Patients.|A Phase I Clinical Trial of Rituximab for Pediatric Opsoclonus-Myoclonus Syndrome|Completed||Phase 1/Phase 2|25|Actual|National Pediatric Myoclonus Center|||||f||||t||||||||||2017-02-18 17:01:10.739455|2017-02-18 17:01:10.739455
NCT00244348|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-08-26|||October 2005||2005-10-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Hepatic Artery Infusion With Oxaliplatin|Hepatic Arterial Infusion of Oxaliplatin Clinical Trial|Withdrawn||Phase 1/Phase 2|0|Actual|Medical College of Wisconsin||||Investigator has left institution|f||||||||||||||2017-02-18 17:01:10.843482|2017-02-18 17:01:10.843482
NCT00244335|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2017-01-09|||October 2000||2000-10-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|February 2006|Actual|2006-02-01||Observational|||Examining the Role of Negative Emotional States on Sedative Drug Use in Individuals With Post-Traumatic Stress Disorder|Emotional Control of Sedative Self-Medication in Post-Traumatic Stress Disorder|Completed||Phase 1/Phase 2|39|Actual|National Institute on Drug Abuse (NIDA)|||2||f||||t||||||||||2017-02-18 17:01:10.93451|2017-02-18 17:01:10.93451
NCT00244322|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2007-05-24|||October 2005||2005-10-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease|LY450139: Tolerability and Biomarker Assessment in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|45||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:01:11.054303|2017-02-18 17:01:11.054303
NCT00244309|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2011-05-03|||November 2005||2005-11-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer|A Randomized Trial of Tamsulosin and/or Dutasteride Versus Placebo to Relieve Urinary Symptoms After Brachytherapy for the Treatment of Localized Prostate Cancer|Completed||Phase 3|348|Anticipated|Case Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 17:01:11.141551|2017-02-18 17:01:11.141551
NCT00244101|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2012-08-16|2012-08-16||August 2003||2003-08-01|August 2012|2012-08-01|June 2011|Actual|2011-06-01|June 2009|Actual|2009-06-01||Interventional|||Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome|Delivery Room Management of Premature Infants at High Risk of Respiratory Distress Syndrome|Completed||Phase 3|648|Actual|Vermont Oxford Network||3|||f||||t||||||||||2017-02-18 17:01:13.185262|2017-02-18 17:01:13.185262
NCT00244296|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2007-01-24|||October 2005||2005-10-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms|A Double-Blind, Stratified, Randomised, Parallel, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy and Safety of Duloxetine (20 mg Bid for 2 Weeks Escalating to 40 mg Bid) for up to 12 Weeks, Compared to Placebo, in Community-Dwelling Elderly Women > or = 65 Years of Age With Symptoms of Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence.|Completed||Phase 4|276||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:01:11.249505|2017-02-18 17:01:11.249505
NCT00244283|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2005-10-24|||January 2006||2006-01-01|October 2005|2005-10-01|January 2008||2008-01-01|||||Interventional|||A Comparison of Two Anaesthetic Methods of Protecting Heart Tissue During Cardiac Surgery|A Comparison of Myocardial Protection Using Preconditioning With Sevoflurane Against High Thoracic Epidural Analgesia for CABG Surgery|Unknown status|Not yet recruiting|Phase 4|150||Golden Jubilee National Hospital|||||f||||||||||||||2017-02-18 17:01:11.37159|2017-02-18 17:01:11.37159
NCT00244270|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2011-08-26|||December 2005||2005-12-01|September 2005|2005-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|RITHM||Cystic Fibrosis and Totally Implantable Vascular Access Devices|Cystic Fibrosis and Totally Implantable Vascular Access Devices: Evaluation of the Incidence of Venous Thrombosis Related to the Catheter and Study of the Genetic and Acquired Risk Factors|Completed||Phase 4|97|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 17:01:11.470402|2017-02-18 17:01:11.470402
NCT00244257|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2015-04-08|||August 2005||2005-08-01|April 2015|2015-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)|Phase I, Open-Label, Multi-center, Single-Dose, Dose-Escalating, Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamic Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)|Terminated||Phase 1|10|Actual|Sanofi||5||Study terminated due to low enrollment.|f||||t||||||||||2017-02-18 17:01:11.563555|2017-02-18 17:01:11.563555
NCT00244244|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2012-02-08|||October 2005||2005-10-01|February 2012|2012-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS|A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 2|80||CytRx|||||f||||||||||||||2017-02-18 17:01:11.675048|2017-02-18 17:01:11.675048
NCT00244231|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2007-02-27|||October 2003||2003-10-01|February 2007|2007-02-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia|A Placebo-Controlled, Double Blind Study to Evaluate the Efficacy and Safety of Nidadd in the Management of Hyperlipidemia|Completed||Phase 3|70||Genovate Biotechnology Co., Ltd.,|||||f||||f||||||||||2017-02-18 17:01:11.771388|2017-02-18 17:01:11.771388
NCT00244218|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2009-01-15|||April 2005||2005-04-01|January 2009|2009-01-01||||March 2009|Anticipated|2009-03-01||Interventional|||Response to Phenylketonuria to Tetrahydrobiopterin (BH4)|Response to Phenylketonuria to Tetrahydrobiopterin (BH4)|Unknown status|Recruiting|Phase 1|36|Anticipated|FDA Office of Orphan Products Development||1|||f||||||||||||||2017-02-18 17:01:11.851747|2017-02-18 17:01:11.851747
NCT00244205|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2005-11-14|||November 2005||2005-11-01|November 2005|2005-11-01||||||||Observational|||Identifying Methylation Biomarkers for Monitoring Bladder Tumors|Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.|Unknown status|Recruiting|N/A|120||Copenhagen University Hospital at Herlev|||||f||||||||||||||2017-02-18 17:01:11.940789|2017-02-18 17:01:11.940789
NCT00244192|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2005-12-08|||October 2003||2003-10-01|October 2005|2005-10-01|December 2005||2005-12-01|||||Interventional|||Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia|Completed||Phase 2|16||Center for Integrated Rehabilitation and Organ Failure Horn|||||f||||||||||||||2017-02-18 17:01:12.013776|2017-02-18 17:01:12.013776
NCT00244179|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2006-09-07|||January 2003||2003-01-01|September 2006|2006-09-01||||||||Interventional|||New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis|New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis: Immunostimulation Plus Antibiotic Versus Immunosuppression Plus Antibiotic Versus Conventional Standardtherapy|Unknown status|Recruiting|Phase 2|40||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:01:12.115978|2017-02-18 17:01:12.115978
NCT00244166|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2006-09-07|||May 2002||2002-05-01|September 2006|2006-09-01|August 2008||2008-08-01|||||Interventional|||Prednisolone in Active Ankylosing Spondylitis (AS)|Threecenter Placebo Controlled Three Arm Trial in Patients With Active Ankylosing Spondylitis With Prednisolone|Unknown status|Recruiting|Phase 2/Phase 3|75||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:01:12.215067|2017-02-18 17:01:12.215067
NCT00244153|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-25|2006-09-07|||June 2004||2004-06-01|February 2004|2004-02-01|August 2007||2007-08-01|||||Interventional|||Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis|Intraarticular Application of Opioids Versus Glucocorticosteroids Versus Placebo in Rheumatoid Arthritis|Unknown status|Recruiting|Phase 1/Phase 2|120||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:01:12.326044|2017-02-18 17:01:12.326044
NCT00244140|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2014-01-28|2009-05-29||October 2005||2005-10-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Ultravist: Safety and Efficacy in Computed Tomography of Head and Body|Ultravist 370 Milligrams of Iodine Per Milliliter (mg I/mL): Safety and Efficacy in Computed Tomography of Head and Body|Completed||Phase 3|435|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:01:12.426922|2017-02-18 17:01:12.426922
NCT00244127|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2005-10-26|||October 2002||2002-10-01|October 2005|2005-10-01||||||||Interventional|||Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.|Cyclophosphamide, Oncovin, Myocet, Prednisone and Rituximab (R-COMP) in the Treatment of Elderly Patients With Aggressive NHL.|Unknown status|Active, not recruiting|Phase 2|75||Zeneus Pharma|||||f||||||||||||||2017-02-18 17:01:12.995977|2017-02-18 17:01:12.995977
NCT00244114|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2013-02-14|||February 2006||2006-02-01|February 2013|2013-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients|In Vitro Evaluation Of Allergic Reactions In Hemophilia B Subjects Who Have Exhibited A Systemic Allergic Response After Exposure To BeneFIX (Nonacog Alfa; Recombinant Factor IX)|Completed||Phase 4|20|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||2||f||||f||||||||||2017-02-18 17:01:13.091806|2017-02-18 17:01:13.091806
NCT00244088|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2009-08-31|||April 2004||2004-04-01|August 2009|2009-08-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Study Evaluating the Etiology of Intra-Abdominal Infections|Study of the Etiology of Intra-Abdominal Infections|Completed||N/A|340||Wyeth is now a wholly owned subsidiary of Pfizer|||2||f||||||||||Samples Without DNA|"~     Intra-abdominal fluid~   "|||2017-02-18 17:01:13.85328|2017-02-18 17:01:13.85328
NCT00244075|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2015-05-22|||July 1998||1998-07-01|May 2015|2015-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients|Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients|Completed||Phase 2|46|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:01:13.926508|2017-02-18 17:01:13.926508
NCT00244062|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2015-10-01|||April 2001||2001-04-01|April 2011|2011-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Healthy Moms Alcohol Intervention|"Brief Alcohol Intervention: The Healthy Moms Project."|Completed||N/A|250||University of Wisconsin, Madison|||||f||||f||||||||||2017-02-18 17:01:14.037083|2017-02-18 17:01:14.037083
NCT00244049|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2014-12-05|||May 2004||2004-05-01|December 2014|2014-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||CHIPs or College Health Intervention Projects|"Primary Care Alcohol Intervention in College Students"|Completed||Phase 3|1000|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 17:01:14.120783|2017-02-18 17:01:14.120783
NCT00244023|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-23|2008-08-22|||October 2005||2005-10-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone|Double-Blind, Placebo Controlled Randomized Study of Co-Administering Testosterone With PDE5 Inhibitors in Patients Non-Responders to PDE5 Inhibitors Alone|Completed||Phase 3|173|Actual|SELARL du Dr Jacques BUVAT||2|||f||||t||||||||||2017-02-18 17:01:14.227992|2017-02-18 17:01:14.227992
NCT00244010|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2012-05-01|2012-02-02||October 2005||2005-10-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias|Hematopoietic Stem Cell Transplantation (HSCT) From Partially Matched Family Donors for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias: A Pilot Study|Completed||N/A|4|Actual|St. Jude Children's Research Hospital|This study has terminated due to the PI leaving the institution. An insufficient number of subjects were enrolled to answer the primary objective.|1|||f||||f||||||||||2017-02-18 17:01:14.367917|2017-02-18 17:01:14.367917
NCT00243997|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2008-10-13|||February 2002||2002-02-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Evaluation of the Efficacy of the Becoming Parents Program|Study of the Effects of the Becoming Parents Program on Couples Becoming Parents for the First Time|Completed||N/A|940|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:01:14.752062|2017-02-18 17:01:14.752062
NCT00243984|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2007-12-07|||March 2005||2005-03-01|December 2007|2007-12-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome|Suspended||Phase 3|90|Anticipated|Northeastern Ohio Universities College of Medicine||||Study was discontinued because of high drop out rate.|f||||||||||||||2017-02-18 17:01:14.866028|2017-02-18 17:01:14.866028
NCT00243971|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2014-09-24|||November 2004||2004-11-01|September 2009|2009-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease|A Phase 3, Randomized, Open-Label, Two-Arm, Parallel-Group, Multicenter, Multinational Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-02-18 17:01:14.977807|2017-02-18 17:01:14.977807
NCT00243958|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-23|2005-10-23|||October 2005||2005-10-01|October 2005|2005-10-01||||||||Observational|||Aluminum and Auditory Function in ESRD||Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:01:15.071443|2017-02-18 17:01:15.071443
NCT00243945|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2014-09-24|||December 2004||2004-12-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease|A Phase 3b, Open-Label, Multicenter, Multinational Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders in Patients With Idiopathic Parkinson's Disease|Completed||Phase 3|58|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:01:15.154453|2017-02-18 17:01:15.154453
NCT00243932|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2014-01-28|2010-03-29||April 2005||2005-04-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Clinical Trial of High Dose CoQ10 in ALS|Clinical Trial of High Dose CoQ10 in ALS|Completed||Phase 2|185|Actual|Columbia University||3|||f||||t||||||||||2017-02-18 17:01:15.259598|2017-02-18 17:01:15.259598
NCT00243919|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2014-07-09|2011-03-29||April 2006||2006-04-01|December 2012|2012-12-01|June 2012|Actual|2012-06-01|April 2010|Actual|2010-04-01||Interventional|LEAPS||Locomotor Experience Applied Post Stroke Trial|Locomotor Experience Applied Post Stroke (LEAPS) Trial|Completed||Phase 3|408|Actual|Duke University||3|||f||||||||||||||2017-02-18 17:01:15.858879|2017-02-18 17:01:15.858879
NCT00243906|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2012-07-18||2012-07-18|January 2003||2003-01-01|July 2012|2012-07-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||Interventional Management of Stroke (IMS) II Study|Interventional Management of Stroke (IMS) II Study|Completed||Phase 2|81|Actual|University of Cincinnati||1|||f||||t||||||||||2017-02-18 17:01:17.626057|2017-02-18 17:01:17.626057
NCT00243893|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2013-10-08|||July 2004||2004-07-01|October 2013|2013-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms|Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms|Completed||Phase 1|26|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 17:01:17.725793|2017-02-18 17:01:17.725793
NCT00243880|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2016-05-05|||September 2005||2005-09-01|May 2016|2016-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|Neu-START||Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START)|SPOTRIAS: Neuroprotection With Statin Therapy for Acute Recovery Trial|Completed||Phase 1|33|Actual|Columbia University||1|||f||||t||||||||Undecided||2017-02-18 17:01:17.835842|2017-02-18 17:01:17.835842
NCT00243867|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2015-07-22|||November 2005||2005-11-01|July 2015|2015-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer|A Phase III, Randomized, Study of Weekly Taxoprexin Plus Carboplatin Versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|519|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:01:17.946596|2017-02-18 17:01:17.946596
NCT00243854|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2014-03-17|||November 2005||2005-11-01|March 2014|2014-03-01|October 2011|Actual|2011-10-01|August 2010|Actual|2010-08-01||Interventional|||Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer|Pilot Study Using Neoadjuvant Chemo-Radiotherapy and EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer|Completed||Phase 1|8|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 17:01:18.053286|2017-02-18 17:01:18.053286
NCT00243841|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2015-12-17|||May 2004||2004-05-01|December 2015|2015-12-01|December 2018|Anticipated|2018-12-01|December 2016|Anticipated|2016-12-01||Interventional|SBF-HCC||Dose Escalation Study for Primary Hepatocellular Carcinoma|Multi-institution Phase I/II Dose Escalation Study of Hypofractionated Stereotactic Body Radiation Therapy for Primary Hepatocellular Carcinoma|Active, not recruiting||Phase 1/Phase 2|60|Anticipated|Indiana University||2|||f||||t||||||||||2017-02-18 17:01:18.148761|2017-02-18 17:01:18.148761
NCT00243828|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2015-09-14|||November 2005||2005-11-01|March 2007|2007-03-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Assessment of the Effectivity of Total-face Mask for Noninvasive Ventilation During Acute Respiratory Failure|Assessment of the Effectivity of Total-face Mask for Noninvasive Ventilation During Acute Respiratory Failure: a Randomized Controlled Trial.|Terminated||Phase 4|300||Corporacion Parc Tauli||||Very low rate of recruitment anticipated futility of pursuing the study|f||||f||||||||||2017-02-18 17:01:18.244255|2017-02-18 17:01:18.244255
NCT00243815|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2006-10-16|||June 2002||2002-06-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Interventional|||Use of Ibuprofen to Prevent IUD Site Effects|Prophylactic Ibuprofen: Effect on IUD Continuation Rates|Completed||Phase 3|2019||FHI 360|||||f||||||||||||||2017-02-18 17:01:18.337988|2017-02-18 17:01:18.337988
NCT00243802|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2013-09-26|||May 2005||2005-05-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation|Comparison of Markers of Oxidative Stress Present in Left Atrial Appendage Tissue From Subjects With and Without Atrial Fibrillation|Terminated||Phase 2|23|Actual|Emory University|||1|Terminated.|f||||f||||||||||2017-02-18 17:01:18.423851|2017-02-18 17:01:18.423851
NCT00243789|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2011-10-26|||September 2005||2005-09-01|October 2011|2011-10-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy|A Double-Blinded Randomized Placebo Controlled Study of Daily Pentoxifylline as a Rescue Treatment in DMD|Completed||Phase 1/Phase 2|64|Actual|Cooperative International Neuromuscular Research Group||2|||f||||t||||||||||2017-02-18 17:01:18.516389|2017-02-18 17:01:18.516389
NCT00243776|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2016-08-03|||April 2005||2005-04-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Calcium Current in Human Heart Cells|Calcium Current in Human Atrial Myocytes|Recruiting||N/A|600|Anticipated|Emory University|||1||f||||f||||||Samples Without DNA|"~     tissue obtained from surgical waste tissue~   "|||2017-02-18 17:01:18.646859|2017-02-18 17:01:18.646859
NCT00243763|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2009-11-20||||||November 2009|2009-11-01||||||||Interventional|||TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma|Phase 1 Dose Escalating Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma|Terminated||Phase 1|64|Anticipated|Novartis|||||||||||||||||||2017-02-18 17:01:18.743223|2017-02-18 17:01:18.743223
NCT00243750|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2005-12-08|||September 2003||2003-09-01|August 2003|2003-08-01|November 2005||2005-11-01|||||Interventional|||Methotrexate in Ankylosing Spondylitis (MTX in AS)|Open Study for the Evaluation of the Efficacy of Methotrexate 20mg Given Subcutaneously in Patients With Active Ankylosing Spondylitis|Unknown status|Active, not recruiting|Phase 2|20||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:01:18.829323|2017-02-18 17:01:18.829323
NCT00243737|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2013-01-23|||October 2005||2005-10-01|January 2013|2013-01-01|April 2006||2006-04-01|||||Interventional|||Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria|Open-label, Stratified Study on the Efficacy, Safety and Pharmacokinetic Characteristics of Two Paediatric Formulations of ArtequinTM in Children With Acute Uncomplicated P. Falciparum Malaria|Completed||Phase 2|70||Albert Schweitzer Hospital|||||f||||||||||||||2017-02-18 17:01:18.919922|2017-02-18 17:01:18.919922
NCT00243724|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-24|2009-03-25|||April 2005||2005-04-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease|An Open-Label, Parallel-Group, Multi-Centre Study to Determine the Effect of Treatment With Esomeprazole for Six Months on Histological Markers of Esophageal Epithelial Acid-Related Disease in Patients With Upper GI Symptoms.|Completed||Phase 3|350|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 17:01:19.012275|2017-02-18 17:01:19.012275
NCT00243711|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2011-05-27|||September 2005||2005-09-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop||Completed||Phase 2/Phase 3|286|Actual|Allergan|||||f||||||||||||||2017-02-18 17:01:19.103495|2017-02-18 17:01:19.103495
NCT00243698|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2007-11-21|||May 2004||2004-05-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions|A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions|Completed||N/A|59|Actual|University Hospital, Tours|||||f||||f||||||||||2017-02-18 17:01:19.179666|2017-02-18 17:01:19.179666
NCT00243685|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2012-01-25|||September 2006||2006-09-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|||||Interventional|||Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis|Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Drug Testing Sensitivity of Solid Tumors|Completed||Phase 2/Phase 3|150|Anticipated|DiaTech Oncology||1|||f||||f||||||||||2017-02-18 17:01:22.078235|2017-02-18 17:01:22.078235
NCT00243672|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2007-11-16|||October 2005||2005-10-01|November 2007|2007-11-01|October 2007||2007-10-01|||||Interventional|||Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques|Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques: a Randomised Microarray-Study on Endarterectomy Specimens of Human Carotid Arteries|Withdrawn||Phase 4|100|Anticipated|University Hospital Muenster||||The study chair changed his employment, the realization of the study was not possible|f||||||||||||||2017-02-18 17:01:22.199006|2017-02-18 17:01:22.199006
NCT00243659|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2011-06-02|2009-05-29||April 2006||2006-04-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery|An Open Label Multi-center Study to Assess the Efficacy and Safety of B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery|Completed||Phase 3|30|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 17:01:22.28311|2017-02-18 17:01:22.28311
NCT00243646|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2016-04-12|||August 2004||2004-08-01|April 2016|2016-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial|Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial|Terminated||Phase 3|6|Actual|Schiffler Cancer Center||2||poor accrual|f||||t||||||||||2017-02-18 17:01:22.766934|2017-02-18 17:01:22.766934
NCT00243633|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2008-03-18|||April 2005||2005-04-01|March 2008|2008-03-01|August 2007|Actual|2007-08-01|December 2006|Actual|2006-12-01||Interventional|||Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)|Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)|Completed||N/A|878|Actual|University Hospital, Tours||1|||f||||f||||||||||2017-02-18 17:01:22.896162|2017-02-18 17:01:22.896162
NCT00243620|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2017-01-12|||May 2001||2001-05-01|May 2001|2001-05-01|May 2004||2004-05-01|||||Interventional|||A Randomised Controlled Trial Comparing Vacuum Assisted Closure (V.A.C.®) With Modern Wound Dressings|State-of-the Art Treatment of Chronic Leg Ulcers: a Randomised Controlled Trial Comparing Vacuum Assisted Closure (V.A.C.®) With Modern Wound Dressings|Completed||N/A|60||Maastricht University Medical Center|||||f||||||||||||||2017-02-18 17:01:23.261803|2017-02-18 17:01:23.261803
NCT00243607|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2009-06-19|||May 2006||2006-05-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Hydrotherapy Against Menopausal Symptoms in Breast Cancer Survivors|Prospective Randomized Feasibility Study on the Self Application of Hydrotherapy to Treat Menopausal Symptoms Caused by Breast Cancer Therapy|Completed||N/A|45|Actual|Heidelberg University||2|||f||||f||||||||||2017-02-18 17:01:23.359559|2017-02-18 17:01:23.359559
NCT00243594|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2009-02-18|||September 1999||1999-09-01|February 2009|2009-02-01||||January 2009|Actual|2009-01-01||Interventional|||Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection|Active Immunization of Patients With Stage III and IV Melanoma in Whom a Regional Lymph Node Dissection is Planned, With Peptide-Pulsed Dendritic Cells: Evaluation of in Vivo Immune and Clinical Response and Migration|Completed||Phase 1/Phase 2|40|Anticipated|Radboud University||1|||f||||f||||||||||2017-02-18 17:01:23.675534|2017-02-18 17:01:23.675534
NCT00243581|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2005-10-28|||August 2000||2000-08-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||The Effects of an Intensive Lifestyle Modification Program on Carotid Artery Intima-Media Thickness|The Effects of an Intensive Lifestyle Modification Program on Carotid Artery Intima-Media Thickness|Completed||Phase 4|||SwedishAmerican Health System|||||f||||||||||||||2017-02-18 17:01:23.783618|2017-02-18 17:01:23.783618
NCT00243568|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2009-10-21||2009-06-09|September 2005||2005-09-01|October 2009|2009-10-01||||||||Interventional|||Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285)(TERMINATED)|Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E2)|Terminated||Phase 3|500||Schering-Plough|||||f||||||||||||||2017-02-18 17:01:23.852669|2017-02-18 17:01:23.852669
NCT00243555|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2007-01-31|||September 2002||2002-09-01|September 2006|2006-09-01||||||||Observational|||Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut|Molecular Analysis of Immuno-Regulatory Genes Expressed by Mononuclear Cells From Peanut Skin Test Positive Individuals With and Without a History of Peanut Ingestion|Unknown status|Recruiting|N/A|60||McMaster University|||||f||||||||||||||2017-02-18 17:01:23.946224|2017-02-18 17:01:23.946224
NCT00243542|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2011-05-27|||November 2005||2005-11-01|May 2011|2011-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency|ACZ ACN 01. A Phase 4, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Cross-Over Study to Further Evaluate the Risk of Hematological Adverse Events in G6PD-Deficient Subjects With Acne Vulgaris Treated With ACZONE™ (Dapsone) Gel, 5%.|Completed||Phase 4|64|Actual|Allergan|||||||||||||||||||2017-02-18 17:01:24.046033|2017-02-18 17:01:24.046033
NCT00243529|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2009-09-28|||April 2004||2004-04-01|February 2009|2009-02-01||||February 2009|Actual|2009-02-01||Interventional|||Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients|In Vivo Responses of DC Vaccines Presenting HLA Class I and II Restricted Tumor Epitopes Either by Peptide-pulsing or mRNA Transfection in Melanoma Patients|Completed||Phase 1/Phase 2|64|Actual|Radboud University||3|||f||||f||||||||||2017-02-18 17:01:24.179944|2017-02-18 17:01:24.179944
NCT00243516|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2007-11-08|||October 2005||2005-10-01|September 2006|2006-09-01|October 2007||2007-10-01|||||Interventional|||Trial for the Use of Pretest Probability to Reduce Unnecessary Testing for Low-Risk Patients With Chest Pain|Randomized, Controlled Trial for the Use of Pretest Probability to Reduce Unnecessary Testing for Low-Risk Patients With Chest Pain|Unknown status|Recruiting|Phase 3|400|Anticipated|PREtest Consult|||||f||||||||||||||2017-02-18 17:01:24.299717|2017-02-18 17:01:24.299717
NCT00243503|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2011-07-20|2010-04-20||February 2006||2006-02-01|July 2011|2011-07-01|July 2010|Actual|2010-07-01|April 2009|Actual|2009-04-01||Interventional|||Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer|A Phase 2 Efficacy And Safety Study Of SU011248 In Combination With Trastuzumab As Treatment For Metastatic Disease In Patients With Breast Cancer|Completed||Phase 2|60|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:01:24.41443|2017-02-18 17:01:24.41443
NCT00243490|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2010-01-11||||||January 2010|2010-01-01|January 2009||2009-01-01|||||Interventional|||Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors|Prospective, Open-labeled, Clinical Trial in Compassionate Use to Evaluate the Efficacy and Safety of Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors|Withdrawn||Phase 2|5|Anticipated|National Taiwan University Hospital||||"The Trial could not get permit from Department of Health, Taiwan; Furthermore, no research~   fund could support the expensive (photosensitizer) photosan"|f||||||||||||||2017-02-18 17:01:25.287953|2017-02-18 17:01:25.287953
NCT00242190|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2010-11-10|||June 2004||2004-06-01|November 2010|2010-11-01|February 2010|Actual|2010-02-01|March 2006|Actual|2006-03-01||Interventional|||Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer|Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer|Completed||Phase 1/Phase 2|40||University of Michigan Cancer Center|||||f||||||||||||||2017-02-18 17:01:51.062525|2017-02-18 17:01:51.062525
NCT00243477|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2012-03-16|||January 2006||2006-01-01|March 2012|2012-03-01|February 2012|Actual|2012-02-01|February 2011|Actual|2011-02-01||Interventional|||MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting|MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting|Completed||Phase 4|368|Actual|Hopital Jean Minjoz||2|||f||||t||||||||||2017-02-18 17:01:25.379802|2017-02-18 17:01:25.379802
NCT00243464|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2015-03-25|||September 2005||2005-09-01|March 2015|2015-03-01|May 2006||2006-05-01|||||Interventional|||Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis|Calcipotriol Plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients With Scalp Psoriasis|Completed||Phase 3|300||LEO Pharma|||||f||||||||||||||2017-02-18 17:01:25.491859|2017-02-18 17:01:25.491859
NCT00243451|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-09-02|||September 2003||2003-09-01|September 2011|2011-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Early Detection of Mild Cognitive Impairment in Individual Patients|Early Detection of Mild Cognitive Impairment in Individual Patients|Completed||N/A|34|Anticipated|Louisiana State University Health Sciences Center Shreveport|||1||f||||f||||||||||2017-02-18 17:01:25.588951|2017-02-18 17:01:25.588951
NCT00243438|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2009-01-27|||July 2003||2003-07-01|January 2009|2009-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Observational|||DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)|Distinctly Access Vision In Coronary Interventions|Completed||Phase 4|1300||Abbott Vascular|||1||f||||t||||||||||2017-02-18 17:01:25.682917|2017-02-18 17:01:25.682917
NCT00243425|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2005-10-21|||March 2004||2004-03-01|October 2005|2005-10-01|March 2007||2007-03-01|||||Interventional|||Patient-Centered Depression Care for African Americans|Patient-Centered Depression Care for African Americans|Unknown status|Recruiting|N/A|250||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:01:25.781661|2017-02-18 17:01:25.781661
NCT00243412|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2011-09-06|2011-03-24||August 2005||2005-08-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|RUMBA||A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate|A Double-Blind, Randomized, Multicenter, Phase II Study of the Safety and Efficacy of Two Rituximab Regimens in Subjects With Moderate to Severe Active Rheumatoid Arthritis Receiving Stable Doses of Methotrexate|Completed||Phase 2|42|Actual|Genentech, Inc.|Because of the limited sample size, interpretation of these results should be made with caution and therefore definitive conclusions cannot be made regarding differences between the two retreatment regimens studied.|2|||f||||||||||||||2017-02-18 17:01:25.897858|2017-02-18 17:01:25.897858
NCT00243399|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2011-07-14|||July 2004||2004-07-01|July 2011|2011-07-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia|A Pilot Trial of Oxandrolone for the Treatment of Bone Marrow Aplasia in Patients With Fanconi Anemia|Completed||Phase 1|10|Anticipated|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 17:01:26.527321|2017-02-18 17:01:26.527321
NCT00243386|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2015-06-26|2012-03-14||January 2006||2006-01-01|October 2012|2012-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A|Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (ADVATE rAHF-PFM): A Phase 4 Study Comparing Two Prophylactic Regimens in Subjects With Severe or Moderately Severe Hemophilia A|Completed||Phase 4|82|Actual|Baxalta US Inc.||2|||f||||t||||||||||2017-02-18 17:01:26.652215|2017-02-18 17:01:26.652215
NCT00243373|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2012-01-18|||April 2005||2005-04-01|January 2012|2012-01-01|March 2008|Actual|2008-03-01|December 2005|Actual|2005-12-01||Interventional|||Using Barcode Technology to Improve Medication Safety|Using Barcode Technology to Improve Medication Safety|Completed||N/A|6700|Anticipated|Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:01:28.007136|2017-02-18 17:01:28.007136
NCT00243360|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2005-10-21|||January 2001||2001-01-01|October 2005|2005-10-01|July 2003||2003-07-01|||||Interventional|||Optimizing Antibiotic Use in Long Term Care|Optimizing Antibiotic Use in Long Term Care|Completed||N/A|||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:01:28.109768|2017-02-18 17:01:28.109768
NCT00243347|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2013-08-09|2013-03-22||December 2005||2005-12-01|August 2013|2013-08-01|July 2009|Actual|2009-07-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer|An Exploratory, Open-Lael Study to Assess the Effects of AZD2171 on Tumors and Biomarkers in Patients With Previously Untreated or Recurrent Non-small Cell Lung Cancer (NSCLC) or Patients With Metastatic or Recurrent Head and Neck Cancer (HNC)|Completed||Phase 1|19|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 17:01:28.228315|2017-02-18 17:01:28.228315
NCT00243334|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-21|2013-02-14|||July 2007||2007-07-01|February 2013|2013-02-01|June 2013|Anticipated|2013-06-01|December 2009|Actual|2009-12-01||Interventional|||Improving Safety and Quality With Outpatient Order Entry|Improving Safety and Quality With Outpatient Order Entry|Unknown status|Active, not recruiting|N/A|800|Anticipated|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 17:01:28.526896|2017-02-18 17:01:28.526896
NCT00243321|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2013-04-23|||February 2003||2003-02-01|April 2013|2013-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate Cancer|Phase I Examination of Combination High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Therapy for the Comprehensive Local Treatment of Patients With Locally Confined Adenocarcinoma of the Prostate|Completed||Phase 1|27|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 17:01:28.63801|2017-02-18 17:01:28.63801
NCT00243308|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2009-02-05|||October 2005||2005-10-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Serp-1 for the Treatment of Acute Coronary Syndrome|A Phase 2, Multicentre, Double-Blind, Placebo-Controlled, Dose Escalating Trial of the Safety, Pharmacokinetics, and Biological Activity of 3 Consecutive Daily Doses of Serp-1 When Added to Conventional Therapy in Patients With Acute Coronary Syndromes (Non ST-Elevation Myocardial Infarction and/or Unstable Angina)|Terminated||Phase 2|72|Anticipated|Viron Therapeutics Inc||||Third dose group not recruited due to slow enrollment.|||||||||||||||2017-02-18 17:01:28.753167|2017-02-18 17:01:28.753167
NCT00243295|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2006-10-05|||November 2003||2003-11-01|October 2006|2006-10-01|March 2005||2005-03-01|||||Interventional|||Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies|A Pilot Study to Validate the Feasibility of Injecting and Monitoring Recombinant Human Bone Morphogenetic Protein-2/Calcium Phosphate Matrix (rhBMP-2/CPM) in Subjects With Open Wedge Osteotomies|Completed||Phase 1|6||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:01:28.862024|2017-02-18 17:01:28.862024
NCT00243282|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2009-01-20|||October 2005||2005-10-01|March 2008|2008-03-01|October 2006||2006-10-01|||||Interventional|||Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life|Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life|Completed||N/A|120||VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:01:28.941574|2017-02-18 17:01:28.941574
NCT00243269|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2015-05-21|2010-03-22||November 2005||2005-11-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|May 2009|Actual|2009-05-01||Interventional|||Acupressure and Relaxation for Nausea Control|Acupressure and Relaxation for Nausea Control|Completed||Phase 1/Phase 2|83|Actual|University of Rochester|Limitations include a small sample size and the fact that we ceased recruitment to two of the treatment arms and changed our planned primary analysis mid-study based upon an interim analysis that was not specified at the time the study began.|4|||f||||t||||||||||2017-02-18 17:01:29.045115|2017-02-18 17:01:29.045115
NCT00243256|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2008-05-08|||November 2005||2005-11-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Treatment of Obesity With Vitamin D (40.000 IE Per Week for 1 Year)||Completed||Phase 2|450|Anticipated|University of Tromso|||||f||||||||||||||2017-02-18 17:01:29.643647|2017-02-18 17:01:29.643647
NCT00243243|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2016-04-26|2012-08-28||January 2006||2006-01-01|April 2016|2016-04-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|||Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn|Effect of Recombinant Coagulation Factor VIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn Excision and Grafting|Completed||Phase 3|20|Actual|United States Army Institute of Surgical Research||2|||f||||f||||||||No||2017-02-18 17:01:29.739465|2017-02-18 17:01:29.739465
NCT00243230|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2015-09-24|||September 2005||2005-09-01|September 2015|2015-09-01|March 2011|Actual|2011-03-01|October 2007|Actual|2007-10-01||Interventional|||Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1) (Study P03672AM6)|Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1)|Completed||Phase 2|120|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:01:30.150514|2017-02-18 17:01:30.150514
NCT00243217|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2014-09-24|||April 2003||2003-04-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Rotigotine Restless Legs Syndrome Dose Finding Trial|Multi-center, Double-blind, Randomized, Placebo-controlled, Six-arm, Parallel-group, Dose-finding Trial to Determine Efficacy, Safety and Tolerability of Five Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome|Completed||Phase 2|341|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:01:30.253911|2017-02-18 17:01:30.253911
NCT00243204|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2007-06-07|||January 2006||2006-01-01|June 2007|2007-06-01||||||||Interventional|||Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy||Terminated||Phase 3|400|Anticipated|Point Therapeutics||||FDA Hold May 2007|||||||||||||||2017-02-18 17:01:30.347817|2017-02-18 17:01:30.347817
NCT00243191|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2012-02-14|2011-03-14||May 2006||2006-05-01|February 2012|2012-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans|Study of a Short Course of Neoadjuvant Gleevec (Imatinib Mesylate) in Dermatofibrosarcoma Protuberans|Completed||Phase 2|18|Actual|Sarcoma Alliance for Research through Collaboration|Dermatofibrosarcoma protuberans (DFSP)is a rare tumor type. During the the trial the drug manufacturer obtained approval for DSFP indication.The other limitation is limited funding; SARC is actively seeking funding for secondary outcome goal 12/2012.|1|||f||||t||||||||||2017-02-18 17:01:30.75932|2017-02-18 17:01:30.75932
NCT00243178|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2009-10-16|||July 2003||2003-07-01|October 2009|2009-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)|A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation|Terminated||Phase 3|6706|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:01:30.995805|2017-02-18 17:01:30.995805
NCT00243165|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2009-12-04|||November 2005||2005-11-01|October 2005|2005-10-01||||||||Interventional|||Lifemel Honey to Reduce Leucopenia During Chemotherapy|Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia|Unknown status|Not yet recruiting|Phase 2|60|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:01:31.128442|2017-02-18 17:01:31.128442
NCT00243152|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2012-11-29|||October 2005||2005-10-01|November 2012|2012-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI|Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI|Completed||N/A|6|Actual|Pain and Analgesia Imaging and Neuroscience Group||1|||f||||f||||||||||2017-02-18 17:01:31.205703|2017-02-18 17:01:31.205703
NCT00243139|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2006-09-14|||July 1999||1999-07-01|September 2006|2006-09-01|February 2004||2004-02-01|||||Interventional|||Mandibular Advancement Device for Obstructive Sleep Apnea|A Randomized Controlled Trial of a Mandibular Advancement Device for Obstructive Sleep Apnea|Completed||Phase 2/Phase 3|90||Nykøbing Falster County Hospital|||||f||||||||||||||2017-02-18 17:01:31.330317|2017-02-18 17:01:31.330317
NCT00243126|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2016-02-29|||November 2005||2005-11-01|February 2016|2016-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Family-based HIV Prevention for Adolescent Girls|Family-based HIV Prevention for Adolescent Females|Completed||N/A|168|Actual|Westat||2|||f||||f||||||||||2017-02-18 17:01:31.416181|2017-02-18 17:01:31.416181
NCT00243113|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2013-03-25|||June 2004||2004-06-01|March 2008|2008-03-01|November 2008|Actual|2008-11-01|March 2008|Actual|2008-03-01||Interventional|||Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx|Multi-Institutional Phase II Study of Weekly Docetaxel and Concurrent Radiotherapy for Laryngeal and Hypopharyngeal Cancer in the Group of Elderly and/or Patients With Medical Illness|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:01:31.526291|2017-02-18 17:01:31.526291
NCT00243100|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2013-12-13|||November 2005||2005-11-01|December 2013|2013-12-01||||August 2011|Actual|2011-08-01||Interventional|||Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase 1 Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Gemcitabine in Patients With Epithelial Tumors|Completed||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:01:31.632471|2017-02-18 17:01:31.632471
NCT00005351|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1991||1991-08-01|September 2002|2002-09-01|July 1994|Actual|1994-07-01|||||Observational|||Incidence and Outcomes of Venous Thromboembolism||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.092586|2017-02-18 18:15:00.092586
NCT00243087|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2013-10-31|||July 2005||2005-07-01|October 2013|2013-10-01||||August 2008|Actual|2008-08-01||Interventional|||Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)|An Open Phase I Single Dose Escalation Study of BI 2536 Administered Intravenously in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 1|41|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:01:31.738107|2017-02-18 17:01:31.738107
NCT00243074|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2015-09-21|2012-10-30||November 2005||2005-11-01|February 2014|2014-02-01|December 2011|Actual|2011-12-01|April 2010|Actual|2010-04-01||Interventional||Only eligible patients who received protocol treatment are included in the analysis. Of the 54 patients enrolled, 6 were ineligible and 1 addtional patients refused protocol treatment.|S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery|A Phase II Trial of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma|Completed||Phase 2|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:01:31.850252|2017-02-18 17:01:31.850252
NCT00243061|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2015-06-01|2014-07-09||January 2006||2006-01-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma|A Phase II Study of AZD2171 in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma|Completed||Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:01:32.343023|2017-02-18 17:01:32.343023
NCT00243048|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2013-04-03|||May 2002||2002-05-01|April 2013|2013-04-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer|Phase II Randomized Study of Soy Isoflavones in Patients With Localized Prostate Cancer Treated With Radiation Therapy|Completed||Phase 2|70|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 17:01:32.673997|2017-02-18 17:01:32.673997
NCT00243035|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2013-10-07|||August 2005||2005-08-01|October 2013|2013-10-01||||February 2007|Actual|2007-02-01||Interventional|||Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma|A Dose Escalation Study of R115777 (Zarnestra) Combined With Velcade® (PS-341) in Patients With Relapsed Multiple Myeloma.|Terminated||Phase 1/Phase 2|64|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:01:32.78259|2017-02-18 17:01:32.78259
NCT00243022|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2013-06-21|2012-10-11||September 2004||2004-09-01|June 2013|2013-06-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme|Phase II Randomized Evaluation of 5-Lipoxygenase Inhibition by Herbal Complementary and Alternative Medicine Approach Compared to Control as an Adjuvant Therapy in Newly Diagnosed and Recurrent High-grade Gliomas|Terminated||Phase 2|12|Actual|Case Comprehensive Cancer Center|Certain outcome analysis not done due to low patient accrual.|2||Slow accrual|f||||t||||||||||2017-02-18 17:01:32.900985|2017-02-18 17:01:32.900985
NCT00243009|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2012-05-24|||June 2005||2005-06-01|June 2010|2010-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery|Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Metastatic Renal Cell Carcinoma|Terminated||Phase 2|1|Actual|OHSU Knight Cancer Institute||1||Due to a lack of a referal base, study was terminated.|f||||t||||||||||2017-02-18 17:01:33.680144|2017-02-18 17:01:33.680144
NCT00242996|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2016-10-14|||March 2004||2004-03-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|||Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma|Phase II Trial of Rituximab and Autologous Stem Cell Transplantation for Refractory B Cell Large Cell Lymphoma|Active, not recruiting||Phase 2|44|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 17:01:33.786905|2017-02-18 17:01:33.786905
NCT00242983|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2013-12-17|||April 2004||2004-04-01|December 2005|2005-12-01||||||||Observational|||Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer|"Assessment of Quality of Life (QOL) in Patients Registered With Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer (JMTO LC00-03)"|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:01:33.890966|2017-02-18 17:01:33.890966
NCT00242970|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2015-03-31|||October 2005||2005-10-01|March 2015|2015-03-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Observational|||Hypertrophic Scarring After Facial Burn|Hypertrophic Scarring After Facial Burn: A Pilot, Observational Study of Static and Dynamic Measurements of Facial Scars With the 3-D Scanner Through the Scar Maturation Process|Completed||Phase 2|15|Actual|Legacy Health System|||1||f||||f||||||||||2017-02-18 17:01:34.002189|2017-02-18 17:01:34.002189
NCT00242957|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2009-02-05|||June 2001||2001-06-01|December 2008|2008-12-01|April 2005||2005-04-01|||||Interventional|||The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) Study||Completed||N/A|||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:01:34.088722|2017-02-18 17:01:34.088722
NCT00242944|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2009-12-16|||November 2005||2005-11-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)|Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome|Completed||Phase 4|307|Actual|Kyoto University||2|||f||||t||||||||||2017-02-18 17:01:34.176288|2017-02-18 17:01:34.176288
NCT00242931|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2012-05-31|||January 2005||2005-01-01|September 2010|2010-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy|Pilot Trial of Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Hormone-Refractory Prostate Cancer|Withdrawn||Phase 2|0|Actual|OHSU Knight Cancer Institute||1||Unable to successfully recruit subjects to this study.|f||||t||||||||||2017-02-18 17:01:34.528679|2017-02-18 17:01:34.528679
NCT00242918|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2012-02-03|||May 2003||2003-05-01|June 2006|2006-06-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer|Phase II Trial of Neoadjuvant Docetaxel and ZD 1839 (Iressa) Followed by Radical Prostatectomy in Patients With High Risk, Locally Advanced Prostate Cancer|Completed||Phase 2|29||Benaroya Research Institute|||||||||||||||||||2017-02-18 17:01:34.639122|2017-02-18 17:01:34.639122
NCT00242905|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2011-04-29|||October 2005||2005-10-01|March 2007|2007-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Functional Magnetic Resonance Imaging (fMRI) Study of Memory in Children|Anatomical and Functional MRI Study of Episodic Memory in Epileptic Compared to Normal Children|Completed||N/A|52|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||||||2017-02-18 17:01:34.748054|2017-02-18 17:01:34.748054
NCT00242892|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2011-11-25|||November 2001||2001-11-01|March 2007|2007-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||FROST 4: Study of the Optimal Spreading of a Coronary Stent Guided With Pressure Into the Coronary Arteries|Prospective Study Randomized Multicentric On the Optimization Of the Installation Of Stent By Measurement Of the Intra-Coronary Pressure|Completed||N/A|800|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:01:34.846724|2017-02-18 17:01:34.846724
NCT00242879|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2017-01-18|||August 2005||2005-08-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults|Phase IIB, Randomized, Multicenter, Parallel Group, Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effect of Four Blinded Dosing Regimens of GW640385X/Ritonavir Compared to Open-label Current PI Therapy in HIV-1 Infected, Protease Inhibitor Experienced Adults for 2 Weeks With Long-term Assessment (>48 Weeks) of Safety, Pharmacokinetic and Antiviral Activity of Selected 385/RTV Dosing Regimen(s) vs. a Ritonavir-boosted, Protease Inhibitor Containing Regimen|Terminated||Phase 2|130|Actual|ViiV Healthcare|||||f||||||||||||||2017-02-18 17:01:34.953343|2017-02-18 17:01:34.953343
NCT00242866|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2016-05-05|||October 2005||2005-10-01|September 2015|2015-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Use Of GW274150 In The Prophylactic Treatment Of Migraine|A Multicentre, Two-part, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Tolerability and Pharmacokinetics of the iNOS Inhibitor GW274150 Administered up to 120mg Daily for 12 Weeks in the Prophylactic Treatment of Migraine.|Completed||Phase 2|430|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 17:01:35.161271|2017-02-18 17:01:35.161271
NCT00242853|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2008-10-09|||October 2004||2004-10-01|October 2008|2008-10-01||||||||Observational|||A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis|An Enabling Study to Investigate the Correlation of Biomarkers of the Activity of Inducible Nitric Oxide Synthase (iNOS) With Disease Activity and Treatment Response in Patients With Rheumatoid Arthritis(RA)|Completed||N/A|48||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:01:35.349474|2017-02-18 17:01:35.349474
NCT00242840|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2013-04-01|||June 2003||2003-06-01|April 2013|2013-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)|A 24 Week Phase IIIb/IV Single Arm Open Label Observational Study to Explore the Efficacy of Protease Inhibitors Given in Combination With Reverse Transcriptase Inhibitors to HIV-1 Infected Subjects With Protease Mutations Selected During Therapy With GW433908 Containing Antiretroviral Therapy|Completed||Phase 3|20|Actual|ViiV Healthcare|||||f||||||||||||||2017-02-18 17:01:35.446345|2017-02-18 17:01:35.446345
NCT00242827|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-08-22|||April 2006||2006-04-01|September 2006|2006-09-01|May 2007||2007-05-01|||||Interventional|||Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma|An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma|Terminated||Phase 2|||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:01:35.546959|2017-02-18 17:01:35.546959
NCT00242814|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2012-05-18|||October 2005||2005-10-01|May 2012|2012-05-01||||March 2007|Actual|2007-03-01||Interventional|||Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities|A Phase IV Study, Prospective, Randomised, Open Label, Blinded Endpoint, Parallel Group, 9 Weeks of Comparison Between Oral Administration of Telmisartan Tablet (80mg Once Daily) and Amlodipine Tablet (10 mg Once Daily) on Biological PPAR Gamma Activities in Non Controlled Hypertensive Male Patients With Metabolic Syndrome|Completed||Phase 4|100|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:01:35.63334|2017-02-18 17:01:35.63334
NCT00242801|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2009-04-22|||July 2003||2003-07-01|April 2009|2009-04-01|April 2005|Actual|2005-04-01|||||Interventional|||Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study|A Double Blind,Placebo Controlled,Parallel Group,Multicentre,Randomised,Phase Iii Survival Study Comparing ZD1839 (IRESSA™)(250mg Tablet) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients With Advanced NSCLC Who Have Received One Or Two Prior Chemotherapy Regimens And Are Refractory Or Intolerant To Their Most Recent Regimen|Completed||Phase 3|1692||AstraZeneca|||||||||||||||||||2017-02-18 17:01:35.76705|2017-02-18 17:01:35.76705
NCT00242788|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2009-04-22|||February 2004||2004-02-01|April 2009|2009-04-01|November 2005|Actual|2005-11-01|||||Interventional|||IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure|A Phase I/II, Multicentre Clinical Study Of ZD1839 (Iressa™) In Combination With Capecitabine (Xeloda™) In Subjects With Advanced Colorectal Carcinoma After Failure Of First-Line Chemotherapy|Completed||Phase 1/Phase 2|40||AstraZeneca|||||f||||||||||||||2017-02-18 17:01:36.057541|2017-02-18 17:01:36.057541
NCT00242775|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2011-01-21|||May 2005||2005-05-01|January 2011|2011-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg|Efficacy and Safety of Symbicort ®Turbuhaler® 160/4.5 µg/Inhalation, Two Inhalations Twice Daily Plus As-needed Compared With Seretide™ Diskus™ 50/500 µg/Inhalation, One Inhalation Twice Daily Plus Terbutaline Turbuhaler 0.4 mg/Inhalation As-needed - a 6-month, Randomised, Double-blind, Parallel-group, Active Controlled, Multinational Phase IIIB Study in Adult and Adolescent Patients With Persistent Asthma (AHEAD).|Completed||Phase 3|2100||AstraZeneca|||||f||||||||||||||2017-02-18 17:01:36.224805|2017-02-18 17:01:36.224805
NCT00242762|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2011-01-25|||July 2003||2003-07-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer|A Phase II Study to Evaluate the Safety and Efficacy of the Combination of ZD1839 (IRESSA™), Docetaxel and Cisplatin in Subjects With Recurrent and/or Metastatic Head and Neck Cancer|Completed||Phase 2|36||AstraZeneca|||||f||||||||||||||2017-02-18 17:01:39.266392|2017-02-18 17:01:39.266392
NCT00242177|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2005-10-24|||October 2003||2003-10-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability|Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability|Completed||Phase 1|30||University of Illinois at Chicago|||||f||||||||||||||2017-02-18 17:01:51.146371|2017-02-18 17:01:51.146371
NCT00242749|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2009-04-22|||December 2002||2002-12-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|||||Interventional|||IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma|A Phase 2 Trial to Evaluate ZD1839 (IRESSA) in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma (Unresectable &Inoperable)|Completed||Phase 2|47||AstraZeneca|||||f||||||||||||||2017-02-18 17:01:39.36838|2017-02-18 17:01:39.36838
NCT00242736|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2009-03-05|||October 2005||2005-10-01|March 2009|2009-03-01|January 2006|Actual|2006-01-01|||||Interventional|||An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)|An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) to Investigate the Relationship Between the Presence of Erosive Esophagitis (EE) at Baseline and Heartburn Resolution After 4 Weeks of Treatment|Completed||Phase 4|350||AstraZeneca|||||||||||||||||||2017-02-18 17:01:39.458897|2017-02-18 17:01:39.458897
NCT00242723|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-20|2017-01-24|||October 17, 2005||2005-10-17|September 26, 2016|2016-09-26||||||||Observational|||Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining|Prospective Evaluation of Epigenetic Alterations in Patients With Thoracic Malignancies|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:01:39.564176|2017-02-18 17:01:39.564176
NCT00242710|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2013-10-30|2013-10-30||September 2005||2005-09-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Safety analysis set included all randomly assigned participants who took at least 1 dose of test article.|Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women|A Double-Blind, Randomized, Placebo- And Active-Controlled Efficacy And Safety Study Of Bazedoxifene/Conjugated Estrogens Combinations For Prevention Of Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women|Completed||Phase 3|1083|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 17:01:39.696303|2017-02-18 17:01:39.696303
NCT00242697|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2005-10-19|||April 2002||2002-04-01|October 2005|2005-10-01|July 2003||2003-07-01|||||Interventional|||Double-Blind Comparison of Combined General-Spinal Anesthesia to General Anesthesia for Coronary Artery Surgery|A Randomized Double-Blind Comparison of Combined General-Spinal Anesthesia to General Anesthesia for Coronary Artery Surgery|Completed||Phase 3|63||University of Calgary|||||f||||||||||||||2017-02-18 17:01:41.852154|2017-02-18 17:01:41.852154
NCT00242684|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2015-04-06|2014-11-24||March 2006||2006-03-01|September 2014|2014-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Observational||Elderly patients admitted to TCU|PEU in Elderly TCU Residents|Manifestations, Causes, and Consequences of PEU in Elderly TCU Residents|Completed||N/A|446|Actual|VA Office of Research and Development|This was an observational study designed to develop a better understanding of the interrelationships among nutrient intake, weight change, serum concentration of albumins, illness severity, and mortality. For more details, see cited references.||1||f||||f||||||Samples Without DNA|"~     serum and plasma samples~   "|||2017-02-18 17:01:41.956103|2017-02-18 17:01:41.956103
NCT00242671|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2010-08-03|||October 2005||2005-10-01|September 2006|2006-09-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||The Efficacy of Isocapnic Hyperpnoea to Accelerate Recovery After General Anesthesia With Sevoflurane|The Efficacy of Isocapnic Hyperpnoea to Accelerate Recovery After General Anesthesia With Sevoflurane.|Completed||Phase 3|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:42.231078|2017-02-18 17:01:42.231078
NCT00242658|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2012-11-07|2010-12-16||May 2005||2005-05-01|November 2012|2012-11-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Computerized Health Education to Promote Physical Activity|Computerized Physical Activity Promotion in Primary Care|Completed||Phase 1|394|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-02-18 17:01:42.318073|2017-02-18 17:01:42.318073
NCT00242645|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2010-08-24|||June 2004||2004-06-01|August 2010|2010-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Computer-Assisted Cancer Risk Behavior Counseling|Computer-Assisted Cancer Risk Behavior Counseling|Terminated||Phase 1|200|Actual|Thomas Jefferson University||||Administratively terminated.|f||||f||||||||||2017-02-18 17:01:42.723159|2017-02-18 17:01:42.723159
NCT00242632|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2012-12-13|||June 2004||2004-06-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Treatment With Namenda in Women at Risk for Cognitive Decline||Completed||N/A|30|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:01:42.827711|2017-02-18 17:01:42.827711
NCT00242619|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2016-12-20|2016-10-10||July 2007||2007-07-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Insulin Resistance in Patients With Mood Disorder|Rosiglitazone Add-On in Treatment of Depressed Patients With Insulin Resistance: a Pilot Study|Completed||N/A|12|Actual|Stanford University||1|||f||||f||||||||No||2017-02-18 17:01:42.916232|2017-02-18 17:01:42.916232
NCT00242606|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2012-05-08|||March 2005||2005-03-01|May 2012|2012-05-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy|Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy: An Open, Prospective, Multicenter, Randomized Phase III Study|Completed||Phase 3|409|Actual|Philipps University Marburg Medical Center||2|||f||||t||||||||||2017-02-18 17:01:43.29937|2017-02-18 17:01:43.29937
NCT00242593|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2011-08-04|||June 2006||2006-06-01|August 2011|2011-08-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|RECALL||Rosiglitazone Effects on Cognition for Adults in Later Life|The Effects of Rosiglitazone on Cognition in Patients With MCI|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|University of Washington||2|||f||||t||||||||||2017-02-18 17:01:43.415981|2017-02-18 17:01:43.415981
NCT00242580|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2016-03-03|2011-01-24||September 2005||2005-09-01|March 2016|2016-03-01||||January 2008|Actual|2008-01-01||Interventional|VERITAS||A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib|A 24-month Randomized, Double-masked, Sham Controlled, Multicenter, Phase IIIB Study Comparing Photodynamic Therapy With Verteporfin (Visudyne®) Plus Two Different Dose Regimens of Intravitreal Triamcinolone Acetonide (1 mg and 4 mg) Versus Visudyne® Plus Intravitreal Pegaptanib(Macugen®) in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration|Completed||Phase 3|111|Actual|Novartis|Secondary outcome measures were to be assessed at Month 6 and at 24 months. However, this study was not completed but terminated after all patients completed 12 months. Original safety was COSTART now mapped to SOC MedDRA.|3|||f||||||||||||||2017-02-18 17:01:43.558031|2017-02-18 17:01:43.558031
NCT00242567|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2014-04-14|2013-01-29||December 2005||2005-12-01|April 2014|2014-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer|A Phase III, Parallel Group, Randomized, Open-label, Multi-centre Clinical Trial of Zoledronic Acid in Males Receiving Androgen Deprivation Therapy for Advanced Prostate Cancer.|Completed||Phase 3|522|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:01:44.571459|2017-02-18 17:01:44.571459
NCT00242554|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2012-04-27|||October 2002||2002-10-01|April 2012|2012-04-01||||July 2007|Actual|2007-07-01||Interventional|||Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases|Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases|Completed||Phase 4|150||Novartis|||||f||||||||||||||2017-02-18 17:01:46.880673|2017-02-18 17:01:46.880673
NCT00242541|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2012-04-25|||March 2003||2003-03-01|April 2012|2012-04-01||||August 2005|Actual|2005-08-01||Interventional|||Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas|Open Label Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas|Terminated||Phase 4|50|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:01:46.962194|2017-02-18 17:01:46.962194
NCT00242528|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2015-04-13|||April 2004||2004-04-01|April 2015|2015-04-01||||||||Interventional|||Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.|Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.|Withdrawn||Phase 4|0|Actual|Novartis|||||f||||||||||||||2017-02-18 17:01:47.074813|2017-02-18 17:01:47.074813
NCT00242515|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2014-01-07|||March 2005||2005-03-01|January 2014|2014-01-01|March 2008||2008-03-01|||||Interventional|||T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)|Preemptive CD8+ T-cell Depleted Donor Lymphocyte Infusion (DLI) Following Nonmyeloablative Stem Cell Transplantation (NMT) for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)|Unknown status|Recruiting|Phase 1/Phase 2|16|Anticipated|National University Hospital, Singapore|||||f||||||||||||||2017-02-18 17:01:47.144843|2017-02-18 17:01:47.144843
NCT00242502|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2013-03-25|2013-02-19||October 2005||2005-10-01|March 2013|2013-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery|A Phase II Study of the Combination of Bevacizumab and Erlotinib in Patients With Unresectable Hepatocellular Carcinoma|Completed||Phase 2|62|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:01:47.233994|2017-02-18 17:01:47.233994
NCT00242489|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2015-02-24|||June 1998||1998-06-01|February 2015|2015-02-01|July 2002|Actual|2002-07-01|February 1999|Actual|1999-02-01||Interventional|||Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)|A Placebo-Controlled, Parallel-Group, Double-Blind Study to Assess Safety and to Define the Clinically Effective Dose Range of MK0663 in Patients With Osteoarthritis of the Knee, Followed by a Double-Blind, Active-Comparator-Controlled Extension.|Completed||Phase 2|1167|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:01:47.486182|2017-02-18 17:01:47.486182
NCT00242476|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2015-05-13|||September 2005||2005-09-01|May 2015|2015-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Study to Assess the Effect of Vitamin D3 8400IU Once Weekly on Body Sway and Neuromuscular Function in Men and Women Aged 70 Years or Older|Completed||Phase 2|216|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:01:47.575657|2017-02-18 17:01:47.575657
NCT00242463|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2011-01-04|||October 2005||2005-10-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients|The Efficacy of Anabolic Steroids for the Nutritional Rehabilitation of Critically Ill Patients|Terminated||Phase 2|20|Anticipated|Lawson Health Research Institute||2||drug no longer available in canada|f||||f||||||||||2017-02-18 17:01:47.659404|2017-02-18 17:01:47.659404
NCT00242450|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2005-12-14|||March 2002||2002-03-01|May 2005|2005-05-01|July 2005||2005-07-01|||||Interventional|||Metoclopramide Use in Very Low Birth Weight Newborns|The Effect of Metoclopramide on Feeding in Very Low Birthweight Newborns : a Randomized, Double Blind, Placebo Controlled Pilot Study and a Proposal for a Multicentre Trial|Completed||Phase 4|30||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 17:01:47.771509|2017-02-18 17:01:47.771509
NCT00242437|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2006-07-11|||October 2005||2005-10-01|July 2006|2006-07-01|February 2006||2006-02-01|||||Interventional|||Hemostatic Matrix in Endoscopic Sinus Surgery|A Prospective, Multicenter Study to Evaluate Hemostatic Matrix With Bovine Thrombin in Achieving Hemostasis in Patients Undergoing Endoscopic Sinus Surgery|Completed||Phase 4|30||Ethicon, Inc.|||||f||||||||||||||2017-02-18 17:01:47.881286|2017-02-18 17:01:47.881286
NCT00242424|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2009-01-27|||September 2005||2005-09-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|GRC28||Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age|Safety and Immunogenicity of Fluzone Influenza Virus Vaccine (2005-2006 Formulation) Among Healthy Children 6 to 12 Weeks of Age|Completed||Phase 2/Phase 3|1375|Actual|Seattle Children's Hospital||2|||f||||f||||||||||2017-02-18 17:01:47.967441|2017-02-18 17:01:47.967441
NCT00242411|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2011-01-21|||September 2004||2004-09-01|January 2011|2011-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults|A Comparison of the Efficacy of Symbicort® Single Inhaler Therapy (Symbicort Turbuhaler® 160/4.5 mg 1 Inhalation b.i.d. Plus As-needed) and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults. A Randomized, Open, Parallel-group, Multicentre 26-weeks Study|Completed||Phase 4|1900||AstraZeneca|||||f||||||||||||||2017-02-18 17:01:48.083305|2017-02-18 17:01:48.083305
NCT00242398|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2007-10-02|||October 2005||2005-10-01|October 2007|2007-10-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Hemodialysis Without Anticoagulation in Intensive Care Unit|Heparin Free Hemodialysis for Patients With Bleeding High Risk in ICU. Randomized Study: Heparin Free Dialysis With Intermittent Saline Flushes Versus Heparin Free Dialysis With Nephral 400ST (AN69ST, Hospal, France)|Unknown status|Recruiting|Phase 3|120|Anticipated|Centre Hospitalier Départemental||2|||f||||t||||||||||2017-02-18 17:01:48.47586|2017-02-18 17:01:48.47586
NCT00242385|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2015-06-26|2011-02-15||December 2005||2005-12-01|July 2011|2011-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Pharmacokinetic Study of ARALAST (Human Alpha1- PI)|Single-Dose, Double-Blind, Crossover Study to Evaluate the Pharmacokinetic Comparability of ARALAST Fraction IV-1 Alpha1-Proteinase Inhibitor (ARALAST Fr. IV-1) and ARALAST|Completed||Phase 1|25|Actual|Baxalta US Inc.||2|||f||||||||||||||2017-02-18 17:01:48.573541|2017-02-18 17:01:48.573541
NCT00242372|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2009-04-21|||August 2004||2004-08-01|April 2009|2009-04-01|March 2006|Actual|2006-03-01|||||Interventional|||GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin|A 24-Week Randomised, Double-Blind, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Added to the Therapy of Patients With Type 2 Diabetes Poorly Controlled on Insulin|Terminated||Phase 3|370||AstraZeneca||||The development program has been terminated|||||||||||||||2017-02-18 17:01:49.182049|2017-02-18 17:01:49.182049
NCT00242359|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2009-01-27|||November 2005||2005-11-01|January 2009|2009-01-01||||||||Interventional|||A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma|A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma|Withdrawn||Phase 4|16|Anticipated|Bernstein Clinical Research Center||||could not find subject population|||||f||||||||||2017-02-18 17:01:49.34608|2017-02-18 17:01:49.34608
NCT00242346|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2007-12-17|||April 2003||2003-04-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||High Doses of Candesartan Cilexetil on the Reduction of Proteinuria|A Double-Blind, Randomised, Dose Ranging, Multi-Centre, Phase IIIb Study to Evaluate the Efficacy and Safety of High Doses of Candesartan Cilexetil (Atacand®) on the Reduction of Proteinuria in the Treatment of Subjects With Hypertension and Moderate to Severe Proteinuria|Completed||Phase 3|270||AstraZeneca|||||f||||||||||||||2017-02-18 17:01:49.426557|2017-02-18 17:01:49.426557
NCT00242333|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2006-05-15|||October 2005||2005-10-01|May 2006|2006-05-01||||||||Interventional|||A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD|A Multi-Center Randomized, Double-Blind, Parallel Group, Placebo Controlled Study, Including an Additional Open Label Tiotropium Group, to Assess the Efficacy, Safety and Tolerability of 4 Doses of AD 237 Inhaled Once Daily for 28 Days in Subjects With COPD.|Completed||Phase 2|300||Sosei|||||f||||||||||||||2017-02-18 17:01:49.549465|2017-02-18 17:01:49.549465
NCT00242320|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2016-12-01|||August 2005||2005-08-01|September 2016|2016-09-01|August 2007|Actual|2007-08-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)|The JADE Study: A 12-week, Double-blind, Randomized Study to Investigate the Effect of 500 mcg Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|551|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:01:49.674324|2017-02-18 17:01:49.674324
NCT00242307|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2016-10-31|||May 2004||2004-05-01|September 2016|2016-09-01|June 2007|Actual|2007-06-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)|A Confirmatory Study of APTA-2217 in Adult Patients With Bronchial Asthma (A Placebo-controlled Double-blind Comparative Study)|Completed||Phase 2/Phase 3|450|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 17:01:49.817229|2017-02-18 17:01:49.817229
NCT00242294|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2016-10-24|||November 2004||2004-11-01|September 2016|2016-09-01|March 2007|Actual|2007-03-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)|A Confirmatory Study of APTA-2217 in Patients With Chronic Obstructive Pulmonary Disease (A Placebo-controlled Double-blind Comparative Study)|Completed||Phase 2/Phase 3|570||AstraZeneca|||||f||||||||||||||2017-02-18 17:01:49.912377|2017-02-18 17:01:49.912377
NCT00242281|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2006-10-23|||November 2005||2005-11-01|January 2006|2006-01-01|July 2006||2006-07-01|||||Interventional|||APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat|A Phase III, Multicenter Study to Evaluate the Safety/Efficacy of APC-111 MP Tablet QD vs. Penicillin VK QID Both for 10 Days Treatment of Pharyngitis Secondary to S.Pyogenes in Adolescents/Adults|Completed||Phase 3|600||Advancis Pharmaceutical Corporation|||||||||||||||||||2017-02-18 17:01:50.005176|2017-02-18 17:01:50.005176
NCT00242268|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2005-12-06|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis||Unknown status|Recruiting|Phase 3|30||Alabama Neurology Associates, PC|||||f||||||||||||||2017-02-18 17:01:50.141157|2017-02-18 17:01:50.141157
NCT00242255|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2017-01-24|||October 14, 2005||2005-10-14|May 9, 2016|2016-05-09||||||||Observational|||Epigenetics in the Aging Process|Remodeling of Chromatin-Based Epigenetic Structures in Development and Aging|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:01:50.237717|2017-02-18 17:01:50.237717
NCT00242242|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-19|2017-01-24|||October 17, 2005||2005-10-17|July 23, 2013|2013-07-23|July 23, 2013||2013-07-23|||||Observational|||Moving a Paralyzed Hand Through Use of a Brain-Computer Interface|Moving a Paralyzed Hand Through a Brain-Computer Interface Controlled by the Affected Hemisphere After Stroke or Traumatic Brain Injury|Terminated||N/A|110|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:01:50.335961|2017-02-18 17:01:50.335961
NCT00242229|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2009-08-18|||October 2004||2004-10-01|August 2009|2009-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder|A 6 Month, Open-Label Evaluation of the Long-Term Safety of DVS-233 SR in Elderly Outpatients With Major Depressive Disorder (MDD)|Completed||N/A|52|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:01:50.429664|2017-02-18 17:01:50.429664
NCT00242216|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2013-12-12|2013-05-02||May 2004||2004-05-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||"The Once A Day Protease Inhibitor Regimens"|"PIQD: The Once a Day Protease Inhibitor Regimens. Ritonavir Boosted Atazanavir vs. Ritonavir Boosted Fosamprenavir Used in Combination With Tenofovir and Emtricitabine in HIV-1 Infected Antiretroviral Treatment-Naïve Patients."|Completed||Phase 4|76|Actual|The University of Texas Health Science Center, Houston|High porportion of subject did not complete the study.|2|||f||||f||||||||||2017-02-18 17:01:50.503145|2017-02-18 17:01:50.503145
NCT00242203|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-08-09|||October 2002||2002-10-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|August 2007|Actual|2007-08-01||Interventional|||Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer|Impact of Neoadjuvant Chemotherapy With or Without Zometa on Occult Micrometastases and Bone Density in Women With Locally Advanced Breast Cancer|Completed||Phase 2|120|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 17:01:50.935941|2017-02-18 17:01:50.935941
NCT00242164|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2014-12-08|||November 2005||2005-11-01|July 2005|2005-07-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Interventional|||Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis|Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis|Completed||Phase 2|25|Anticipated|University of Michigan|||||f||||||||||||||2017-02-18 17:01:51.244721|2017-02-18 17:01:51.244721
NCT00242151|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2006-10-11||||||September 2006|2006-09-01||||||||Observational|||Prevalence of Delirium in Patients Undergoing Cardiac Surgery|Prevalence of Delirium in Patients Undergoing Cardiac Surgery|Unknown status|Recruiting|N/A|100||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:51.479263|2017-02-18 17:01:51.479263
NCT00242138|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2016-02-08|||March 2000||2000-03-01|February 2016|2016-02-01|April 2004||2004-04-01|||||Interventional|||Erectile Dysfunction/Prostate/RT/Androgen|A Cross-Sectional Study of Erectile Dysfunction in Patients With Locally Advanced Prostate Cancer Who Have Undergone Radiotherapy and Prolonged Pharmacological Androgen Ablation|Completed||Phase 2|50||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:51.55093|2017-02-18 17:01:51.55093
NCT00242125|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2006-01-13|||October 2005||2005-10-01|October 2005|2005-10-01||||||||Observational|||Family Studies in Primary Biliary Cirrhosis (PBC)|Family Studies in Primary Biliary Cirrhosis|Unknown status|Recruiting|N/A|3000||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:51.631797|2017-02-18 17:01:51.631797
NCT00242112|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2015-02-12|||June 2005||2005-06-01|February 2015|2015-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI|Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI|Completed||N/A|31|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:01:51.714069|2017-02-18 17:01:51.714069
NCT00242099|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2008-04-15|||February 2005||2005-02-01|February 2005|2005-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant|The Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant: A Randomized Trial|Completed||Phase 4|160||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:51.8071|2017-02-18 17:01:51.8071
NCT00242086|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2016-05-31|||October 2004||2004-10-01|May 2016|2016-05-01||||March 2010|Actual|2010-03-01||Interventional|||Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases|Comparison of Triphasic CT, CT/PET and MR Defined Gross Tumour With Pathological Findings in Patients With Colorectal Cancer Liver Metastases|Completed||N/A|7|Actual|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:51.885339|2017-02-18 17:01:51.885339
NCT00242073|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2014-07-03|||October 2001||2001-10-01|August 2008|2008-08-01|October 2005||2005-10-01|||||Interventional|||The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer|The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer|Unknown status|Recruiting|N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:51.967739|2017-02-18 17:01:51.967739
NCT00242060|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2010-07-14|||November 2002||2002-11-01|July 2010|2010-07-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|||Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy|The Utility of Functional and Morphologic MRI in the Detection of Prostate Cancer for Patients With Elevated PSA and Prior Negative Biopsy|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:52.047745|2017-02-18 17:01:52.047745
NCT00242047|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2005-10-18|||March 2001||2001-03-01|November 2004|2004-11-01|August 2006||2006-08-01|||||Interventional|||Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.|Randomized, Controlled Trial Comparing Efficacy of Percutaneous and Intradermal Vaccination With Japanese (Tokyo) 172 BCG in the Prevention of Tuberculosis In Infants Vaccinated at Birth|Unknown status|Active, not recruiting|Phase 4|12000||University of Cape Town|||||f||||||||||||||2017-02-18 17:01:52.124465|2017-02-18 17:01:52.124465
NCT00242034|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2008-09-02||||||August 2008|2008-08-01||||||||Interventional|||Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques|Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques|Completed||N/A|60|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:01:52.220463|2017-02-18 17:01:52.220463
NCT00242021|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2009-10-13|||October 2005||2005-10-01|October 2009|2009-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Fatty Acid Composition on Energy Intake and Satiety|Fatty Acid Composition of a Fat Supplement on Energy Intake, Satiety and Fat Metabolism in Lean and Obese Men|Completed||N/A|20||TNO|||||f||||||||||||||2017-02-18 17:01:52.297732|2017-02-18 17:01:52.297732
NCT00242008|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2014-09-24|||December 2004||2004-12-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease|A Phase 3b, Open-Label, Multicenter, Multinational Trial To Assess The Tolerability Of Switching Subjects From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System And Its Effect On Symptoms In Subjects With Idiopathic Parkinson's Disease|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-02-18 17:01:52.386547|2017-02-18 17:01:52.386547
NCT00241995|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2006-10-17||||||October 2005|2005-10-01||||||||Interventional|||Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome||Completed||N/A|||St. Petersburg State Pavlov Medical University|||||f||||||||||||||2017-02-18 17:01:52.658491|2017-02-18 17:01:52.658491
NCT00241982|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2008-05-28|||October 2005||2005-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis|Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis|Completed||Phase 2|22|Actual|Radboud University||1|||f||||f||||||||||2017-02-18 17:01:52.728046|2017-02-18 17:01:52.728046
NCT00241969|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2016-08-31|||January 2006||2006-01-01|August 2016|2016-08-01|June 2015|Actual|2015-06-01|June 2012|Actual|2012-06-01||Interventional|||Behavioral & Nutritional Treatment to Help CF Preschoolers Grow|A Multi-Site Randomized Clinical Trial of Behavioral and Nutrition Treatment Designed to Help Preschoolers With Cystic Fibrosis Optimize Growth|Completed||Phase 3|102|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||No||2017-02-18 17:01:52.843961|2017-02-18 17:01:52.843961
NCT00241956|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2011-07-19|||October 2005||2005-10-01|July 2011|2011-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Impact of Diabetes and Glucose Control During Rehabilitation After Stroke|Impact of Diabetes and Glucose Control During Rehabilitation After Stroke|Terminated||N/A|20|Actual|Melbourne Health|||1|poor data collection|f||||f||||||||||2017-02-18 17:01:52.973857|2017-02-18 17:01:52.973857
NCT00241943|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2008-12-08|||November 2005||2005-11-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Video-Based HCV Curriculum for Active Injection Drug Users|Cooperative Agreement to Develop, Implement, and Evaluate Viral Hepatitis and Training|Completed||N/A|103|Actual|Organization to Achieve Solutions in Substance Abuse (OASIS)|||||f||||f||||||||||2017-02-18 17:01:53.059185|2017-02-18 17:01:53.059185
NCT00241930|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2005-10-24|||September 2005||2005-09-01|August 2005|2005-08-01|February 2009||2009-02-01|||||Interventional|||Integrating Buprenorphine Into HIV Treatment|SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model|Unknown status|Recruiting|Phase 4|60||Organization to Achieve Solutions in Substance Abuse (OASIS)|||||f||||||||||||||2017-02-18 17:01:53.158534|2017-02-18 17:01:53.158534
NCT00241917|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2008-12-05|||November 2005||2005-11-01|December 2008|2008-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Video-Based HCV Curriculum for Drug Users|Cooperative Agreement to Develop, Implement, and Evaluate Viral Hepatitis and Training|Completed||N/A|450|Actual|Organization to Achieve Solutions in Substance Abuse (OASIS)||2|||f||||f||||||||||2017-02-18 17:01:53.258162|2017-02-18 17:01:53.258162
NCT00241904|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2014-02-24|||May 2006||2006-05-01|February 2014|2014-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|COACH||Reducing Total Cardiovascular Risk in an Urban Community|Reducing Total Cardiovascular Risk in an Urban Community|Completed||N/A|525|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 17:01:53.374972|2017-02-18 17:01:53.374972
NCT00241891|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2015-04-06|||July 2006||2006-07-01|April 2015|2015-04-01|February 2015|Actual|2015-02-01|May 2011|Actual|2011-05-01||Interventional|||Behavior Change Family Counseling to Reduce Rate of Weight Gain in At-Risk Children|Primary Care Obesity Prevention: One or Multiple Targets|Completed||N/A|158|Actual|Children's Hospital of Philadelphia||3|||f||||f||||||||||2017-02-18 17:01:53.50885|2017-02-18 17:01:53.50885
NCT00241878|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2016-05-04|||September 2006||2006-09-01|December 2007|2007-12-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Preschool Based Obesity Prevention Effectiveness Trial|Preschool Based Obesity Prevention Effectiveness Trial|Completed||N/A|648|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||||||||||||2017-02-18 17:01:53.625719|2017-02-18 17:01:53.625719
NCT00241852|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2014-01-09|||May 2005||2005-05-01|January 2014|2014-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Family Approach to Managing Asthma in Early Teens|Family Approach to Managing Asthma in Early Teens|Completed||Phase 3|392|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-02-18 17:01:53.735142|2017-02-18 17:01:53.735142
NCT00241839|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-07-18|2013-03-28||August 2005||2005-08-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional||African Americans with borderline high Blood Pressure|Uric Acid and Hypertension in African Americans|Uric Acid and Hypertension in African Americans|Completed||Phase 3|150|Actual|University of Florida|For all 4 outcomes analyzed, patients required to have data at both baseline and 8-10 weeks on that field to be included. Thus, the numbers of subjects varies slightly from analysis to analysis.|2|||f||||t||||||||||2017-02-18 17:01:53.856802|2017-02-18 17:01:53.856802
NCT00241826|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-08-19|||April 2006||2006-04-01|July 2009|2009-07-01|April 2009||2009-04-01|September 2008|Actual|2008-09-01||Observational|||Prospective Investigation of Pulmonary Embolism Diagnosis III|Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III)|Completed||N/A|1256|Anticipated|George Washington University|||1||f||||||||||||||2017-02-18 17:01:54.347283|2017-02-18 17:01:54.347283
NCT00241813|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2012-12-13|||January 2005||2005-01-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Behavioral Stress Reduction Programs on Blood Pressure in African American Youth|Stress Reduction: Impact on Blood Pressure in African American Youth|Completed||N/A|283|Actual|Medical University of South Carolina||4|||f||||f||||||||||2017-02-18 17:01:54.4582|2017-02-18 17:01:54.4582
NCT00241800|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2012-04-26|||September 2005||2005-09-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|||||Observational|||Medications and the Risk of Sudden Cardiac Death||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:01:54.569266|2017-02-18 17:01:54.569266
NCT00241787|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2015-11-30|||September 2005||2005-09-01|November 2015|2015-11-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Progression of Sub-Clinical Atherosclerosis||Completed||N/A|2900|Actual|Tufts Medical Center|||1||f||||||||||||||2017-02-18 17:01:54.635527|2017-02-18 17:01:54.635527
NCT00241774|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2016-02-04|||August 2005||2005-08-01|February 2016|2016-02-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Observational|||Coronary Heart Disease Incidence: Depression & Inflammation Risk|Coronary Heart Disease Incidence: Depression & Inflammation Risk|Completed||N/A|3227|Actual|Columbia University|||1||f||||f||||||Samples With DNA|"~     In 1995, our study participants enrolled in the Nova Scotia Health Study (NSHS95). At the~     time of enrollment, epidemiologic data as well as blood samples were obtained. The~     participants have since been followed prospectively for a variety of health outcomes. We~     plan to assay stored blood samples collected in 1995 for markers of inflammation and link~     these results to existing epidemiologic and outcomes data, specifically the 7-year incidence~     of CAD events. Buffy coats were also obtained from the blood samples of the SAME~     participants for future DNA analysis.~   "|||2017-02-18 17:01:54.710973|2017-02-18 17:01:54.710973
NCT00241761|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2016-08-05|||September 2005||2005-09-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|||||Observational|||Epidemiology of Depression and Heart Failure in Aging||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:01:54.802537|2017-02-18 17:01:54.802537
NCT00241748|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2012-01-04|||September 2005||2005-09-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event|Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event|Completed||N/A|187|Actual|University of Washington|||3||f||||f||||||Samples With DNA|"~     DNA is extracted from swish and spit samples. DNA is retained.~   "|||2017-02-18 17:01:54.88468|2017-02-18 17:01:54.88468
NCT00241735|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2009-05-01|||September 2005||2005-09-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Soy Food and Coronary Heart Disease in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:01:54.973844|2017-02-18 17:01:54.973844
NCT00241722|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2015-09-01|||August 2005||2005-08-01|September 2009|2009-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain|Completed||Phase 3|805|Actual|Cubist Pharmaceuticals LLC||2|||||||||||||||||2017-02-18 17:01:55.151003|2017-02-18 17:01:55.151003
NCT00241709|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-03-08|||August 2005||2005-08-01|March 2013|2013-03-01||||June 2010|Actual|2010-06-01||Observational|GALA 1||Optimal Approach for Analysis of Case-Control Genetic Association Studies|Case-Control Association Studies and Genetic Confounding|Completed||N/A|800|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     Retrospective genetic analysis of DNA; samples collected between 1998-2001~   "|||2017-02-18 17:01:55.481092|2017-02-18 17:01:55.481092
NCT00241696|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2016-08-05|||August 2005||2005-08-01|April 2012|2012-04-01|June 2010|Actual|2010-06-01|||||Observational|||Air Pollution, Inflammation, and New Onset Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:01:55.557112|2017-02-18 17:01:55.557112
NCT00241683|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-01-18|||August 2005||2005-08-01|January 2013|2013-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Fetal Growth Restriction & Maternal Cardiovascular Risk|Fetal Growth Restriction & Maternal Cardiovascular Risk|Completed||N/A|704|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-02-18 17:01:55.626732|2017-02-18 17:01:55.626732
NCT00241670|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2012-04-25|||October 1999||1999-10-01|April 2012|2012-04-01||||July 2004|Actual|2004-07-01||Interventional|||Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid|Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection|Completed||Phase 3|415|Actual|medac GmbH||2|||f||||||||||||||2017-02-18 17:01:55.703375|2017-02-18 17:01:55.703375
NCT00241657|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2005-12-14||||||December 2002|2002-12-01||||||||Interventional|||Immune Responses to BCG Vaccination in Malawi and the UK||Completed||Phase 2|||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:01:55.794257|2017-02-18 17:01:55.794257
NCT00241644|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2016-10-27|2009-06-18||October 2005||2005-10-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants|Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants|Completed||Phase 3|2089|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:01:58.660422|2017-02-18 17:01:58.660422
NCT00241631|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2015-05-27|||April 2006||2006-04-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Enhancement of in−Vitro GC Function in Patients With COPD|Enhancement of In-vitro GC Function in Patients With COPD. A Randomised, Double Blind, Placebo Controlled, Parallel-group Study to Investigate the Effect of Theophylline and Fluticasone on Induced Sputum Cells Obtained Form COPD Patients|Completed||Phase 2|31|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 17:02:00.537681|2017-02-18 17:02:00.537681
NCT00241618|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2006-09-07|||January 2002||2002-01-01|September 2006|2006-09-01|January 2006||2006-01-01|||||Interventional|||Timing and Duration of Acute Hepatitis C Treatment|Phase IV Study of Treatment of Acute Hepatitis C With Pegylated Interferon|Completed||Phase 4|180||Ain Shams University|||||f||||||||||||||2017-02-18 17:02:00.636017|2017-02-18 17:02:00.636017
NCT00241605|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-07-11|||June 2003||2003-06-01|July 2012|2012-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus|AVANDAMET Compared to Metformin Evaluation Trial (ACME): A 48-week Randomized, Open-label, Multicenter Study to Compare the Efficacy and Tolerability of AVANDAMET to Metformin Monotherapy in Subjects With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Control on Submaximal Metformin.|Completed||Phase 4|600||GlaxoSmithKline|||||f||||f||||||||||2017-02-18 17:02:00.738126|2017-02-18 17:02:00.738126
NCT00241592|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2007-06-12|||August 2004||2004-08-01|June 2007|2007-06-01|May 2005||2005-05-01|||||Interventional|||Vaporization as a Smokeless Cannabis Delivery System|Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study|Completed||Phase 1|18||Center for Medicinal Cannabis Research|||||||||||||||||||2017-02-18 17:02:00.821132|2017-02-18 17:02:00.821132
NCT00241579|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2006-06-21|||February 2002||2002-02-01|June 2006|2006-06-01|January 2004||2004-01-01|||||Interventional|||Analgesic Efficacy of Smoked Cannabis|Analgesic Efficacy of Smoked Cannabis|Completed||Phase 1/Phase 2|15||Center for Medicinal Cannabis Research|||||||||||||||||||2017-02-18 17:02:00.931026|2017-02-18 17:02:00.931026
NCT00241566|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2010-01-19|||August 2003||2003-08-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation|Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation|Completed||Phase 4|200|Anticipated|University Hospital, Clermont-Ferrand|||||f||||||||||||||2017-02-18 17:02:01.041853|2017-02-18 17:02:01.041853
NCT00241553|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2011-01-21|||April 2001||2001-04-01|January 2011|2011-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs|Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo or Esomeprazole 20 mg Once Daily Versus Placebo in Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs|Completed||Phase 3|276||AstraZeneca|||||||||||||||||||2017-02-18 17:02:01.129285|2017-02-18 17:02:01.129285
NCT00241540|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2011-01-21|||January 2001||2001-01-01|January 2011|2011-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs|Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo & Esomeprazole 20 mg Once Daily Versus Placebo in Treatment for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs|Completed||Phase 3|808||AstraZeneca|||||||||||||||||||2017-02-18 17:02:01.606305|2017-02-18 17:02:01.606305
NCT00240604|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2011-09-13|||April 2005||2005-04-01|September 2011|2011-09-01|October 2015|Anticipated|2015-10-01|December 2013|Anticipated|2013-12-01||Interventional|||Prevention of Corticosteroid-induced Glucose Intolerance|Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids|Unknown status|Recruiting|Phase 3|100|Anticipated|Hadassah Medical Organization||1|||f||||||||||||||2017-02-18 17:02:11.757806|2017-02-18 17:02:11.757806
NCT00241527|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2011-01-21|||December 2000||2000-12-01|January 2011|2011-01-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs|Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo and Esomeprazole 20 mg Once Daily Versus Placebo in Treatment for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs|Completed||Phase 3|556||AstraZeneca|||||||||||||||||||2017-02-18 17:02:01.82696|2017-02-18 17:02:01.82696
NCT00241514|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2011-01-20|||February 2001||2001-02-01|January 2011|2011-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs|Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo or Esomeprazole 20 mg Once Daily Versus Placebo in Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs|Completed||Phase 3|334||AstraZeneca|||||||||||||||||||2017-02-18 17:02:02.177343|2017-02-18 17:02:02.177343
NCT00241501|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2010-11-18|||February 2004||2004-02-01|November 2010|2010-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients|A Phase III, Multicentre, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety of Once Daily Esomeprazole for the Treatment of Clinically Diagnosed Gastroesophageal Reflux Disease (GERD) in Pediatric and Adolescent Patients 12 to 17 Years of Age, Inclusive.|Completed||Phase 3|140||AstraZeneca|||||||||||||||||||2017-02-18 17:02:02.58475|2017-02-18 17:02:02.58475
NCT00241488|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2008-02-05|||June 2003||2003-06-01|February 2008|2008-02-01|February 2007|Actual|2007-02-01|December 2005|Actual|2005-12-01||Interventional|||DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia|: An Open-Label, Randomised, Multi-Centre, Phase IIIb/IV, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects With Type IIa and IIb Hypercholesterolaemia (DISCOVERY)|Completed||Phase 3|1362|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 17:02:02.717231|2017-02-18 17:02:02.717231
NCT00241475|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2009-04-22|||December 2003||2003-12-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy|An Open Label, Non-Comparative, Phase II Study of ZD1839 (Iressa) as First-Line Treatment in Subjects With Relapsed Prostate Cancer Following Radical Prostatectomy or Radiotherapy|Completed||Phase 2|30||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:02.837492|2017-02-18 17:02:02.837492
NCT00241462|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-18|2009-04-21|||June 2005||2005-06-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|||||Observational|FORUM||Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients|Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients|Terminated||Phase 4|150|Anticipated|AstraZeneca|||1|Due to poor patient enrollment|f||||||||||||||2017-02-18 17:02:02.939697|2017-02-18 17:02:02.939697
NCT00241449|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2012-06-05|||November 1998||1998-11-01|June 2012|2012-06-01|January 2012|Actual|2012-01-01|March 2007|Actual|2007-03-01||Interventional|||A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer|A Double-blind, Randomized, Multicentre Trial Comparing the Efficacy and Tolerability of 250mg of Faslodex (Long Acting ICI 182,780) With 20mg of Nolvadex (Tamoxifen) in Postmenopausal Women With Advanced Breast Cancer|Completed||Phase 3|51|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:02:03.055192|2017-02-18 17:02:03.055192
NCT00241436|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2011-01-25|||June 2005||2005-06-01|January 2011|2011-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Open Label Arimidex in Gynecomastia|An Open-Label Pharmacokinetic and Pharmacodynamic Study of Anastrozole (Arimidex™) Used to Treat Pubertal Boys With Gynecomastia of Recent Onset|Completed||Phase 2|35||AstraZeneca|||||||||||||||||||2017-02-18 17:02:03.42718|2017-02-18 17:02:03.42718
NCT00241423|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2015-02-20|||October 2005||2005-10-01|January 2015|2015-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes|Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes Using Metformin or Metformin Plus a Thiazolidinedione|Completed||Phase 2|30|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:02:03.509597|2017-02-18 17:02:03.509597
NCT00241410|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2010-06-16|||December 2005||2005-12-01|September 2009|2009-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen|Investigation of the Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen|Completed||Phase 1|86|Actual|Allergy Therapeutics||2|||f||||f||||||||||2017-02-18 17:02:03.613128|2017-02-18 17:02:03.613128
NCT00241397|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2007-03-14|||November 2005||2005-11-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety|An Observational Study on the Presence of Depression and/or Anxiety Disorder in Patients Consulting the General Practitioner With Painful Physical Symptoms in Belgium and Luxemburg.|Completed||N/A|2560||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:02:03.722743|2017-02-18 17:02:03.722743
NCT00241384|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-11-16|||January 2005||2005-01-01|November 2015|2015-11-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|||Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer|Low Dose Supplemental External Radiation With PD-103 Versus PD-103 Alone For Prostate Cancer|Completed||Phase 3|396|Actual|Schiffler Cancer Center||2|||f||||t||||||||||2017-02-18 17:02:04.068098|2017-02-18 17:02:04.068098
NCT00241371|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-08-09|||March 2005||2005-03-01|August 2013|2013-08-01|December 2007|Actual|2007-12-01|November 2005|Actual|2005-11-01||Interventional|||A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma|Terminated||Phase 2|8|Actual|Washington University School of Medicine||1||No response seen in patients|f||||||||||||||2017-02-18 17:02:04.191011|2017-02-18 17:02:04.191011
NCT00241358|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-08-09|||May 2004||2004-05-01|August 2013|2013-08-01|February 2010|Actual|2010-02-01|December 2009|Actual|2009-12-01||Interventional|||Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies|A Phase I/II Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies|Completed||Phase 1/Phase 2|92|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 17:02:04.302718|2017-02-18 17:02:04.302718
NCT00241345|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2013-07-22|||June 2004||2004-06-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant|Randomized Trial of Preemptive Treatment With Oral Valganciclovir Compared With IV Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant|Terminated||Phase 3|39|Actual|Washington University School of Medicine||2||Due to low accrual|f||||||||||||||2017-02-18 17:02:04.432736|2017-02-18 17:02:04.432736
NCT00241332|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2011-07-03|||October 2005||2005-10-01|September 2005|2005-09-01|July 2006|Actual|2006-07-01|||||Interventional|||Postoperative Pain After Orthopedic Surgery: Does it Help to Give Fentanyl Before Start of Remifentanil Based Anesthesia?|Prophylaxis Against Postoperative Pain After Orthopedic Surgery: Does it Help to Give Fentanyl Before Start of Remifentanil/Propofol Based Anesthesia?|Completed||Phase 3|100||Oslo University Hospital|||||f||||||||||||||2017-02-18 17:02:04.547874|2017-02-18 17:02:04.547874
NCT00241319|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-09-26|||October 2005||2005-10-01|September 2011|2011-09-01||||December 2005|Actual|2005-12-01||Interventional|||Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis|A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Evaluation of the Onset and Duration of Action of R89674 0.25% Ophthalmic Solution in Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis|Completed||Phase 3|150||Vistakon Pharmaceuticals|||||f||||||||||||||2017-02-18 17:02:04.645006|2017-02-18 17:02:04.645006
NCT00241306|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2005-10-14||||||July 2005|2005-07-01||||||||Observational|||Variations of Hemispheric Lateralisation of Language Depending of Gender and Age.|Variations of Hemispheric Lateralisation of Language Depending of Gender and Age.|Unknown status|Active, not recruiting|N/A|||University Hospital, Tours|||||f||||||||||||||2017-02-18 17:02:04.742861|2017-02-18 17:02:04.742861
NCT00241293|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2005-10-14||||||July 2005|2005-07-01||||||||Observational|||Influence of Age on Hemispheric Lateralization of Language : a Longitudinal Study||Completed||N/A|||University Hospital, Tours|||||f||||||||||||||2017-02-18 17:02:04.818101|2017-02-18 17:02:04.818101
NCT00241280|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-02-24|2015-12-04||September 2005||2005-09-01|February 2016|2016-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional||The baseline population consists of subjects that were randomized to receive either the Test or Control lens.|Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).||Completed||N/A|504|Actual|Johnson & Johnson Vision Care, Inc.||2|||f||||||||||||||2017-02-18 17:02:04.902067|2017-02-18 17:02:04.902067
NCT00241267|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2006-10-05|||March 2005||2005-03-01|May 2006|2006-05-01|March 2006||2006-03-01|||||Observational|||Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease|Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease|Terminated||N/A|20||University Hospital, Tours|||||f||||||||||||||2017-02-18 17:02:05.377109|2017-02-18 17:02:05.377109
NCT00241254|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2012-03-14|||December 2005||2005-12-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2010|Actual|2010-03-01||Interventional|PROMESS||Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis|A Double-blind, Two-arm, Multicenter, Randomized Trial to Evaluate Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Recent Secondary Progressive Multiple Sclerosis: P.R.OM.E.S.S Study|Completed||Phase 3|138|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 17:02:05.465678|2017-02-18 17:02:05.465678
NCT00241241|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2015-10-20|||September 2004||2004-09-01|October 2015|2015-10-01|January 2008|Actual|2008-01-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera|Multicenter Phase 2 Study of Efficacy and Safety of Pegylated Interferon-alfa 2a in Polycythemia Vera Patients|Completed||Phase 2|40||PV-Nord|||||f||||||||||||||2017-02-18 17:02:05.600232|2017-02-18 17:02:05.600232
NCT00241228|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2010-10-12|||October 2005||2005-10-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|IVOIRE||Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)|Impact of High-volume Veno-venous Continuous Hemofiltration in the Early Management of Septic Shock Patients With Acute Renal Failure|Completed||N/A|139|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 17:02:05.701986|2017-02-18 17:02:05.701986
NCT00241215|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2016-06-19|||June 2003||2003-06-01|June 2016|2016-06-01||||November 2005|Actual|2005-11-01||Interventional|||Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome|Probe Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome|Completed||Phase 4|132|Actual|University of California, Los Angeles|||||f||||||||||||||2017-02-18 17:02:05.819782|2017-02-18 17:02:05.819782
NCT00241202|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2008-01-14|||October 2005||2005-10-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||The Efficacy of the HIV/AIDS Symptom Management Manual|The Efficacy of the HIV/AIDS Symptom Management Manual|Completed||N/A|775|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 17:02:05.918038|2017-02-18 17:02:05.918038
NCT00241189|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-04-08|||August 2002||2002-08-01|April 2016|2016-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Rapamycin vs Methotrexate in Diffuse SSc|A 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral Rapamycin Versus Methotrexate in Systemic Sclerosis (Scleroderma)|Completed||Phase 1/Phase 2|17|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 17:02:06.141336|2017-02-18 17:02:06.141336
NCT00241176|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-10-26|2012-06-07||September 2005||2005-09-01|October 2016|2016-10-01|February 2010|Actual|2010-02-01|August 2008|Actual|2008-08-01||Interventional|||Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder|Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder|Completed||Phase 4|11|Actual|New York University School of Medicine|All subjects failed to respond to previous tic medications so could have unique tic symptoms, small sample size, and this was an open-label study, so we did not have a comparison group nor were we blinded to treatment.|1|||f||||t||||||||||2017-02-18 17:02:06.265109|2017-02-18 17:02:06.265109
NCT00241163|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2012-08-01||||||May 2012|2012-05-01||||||||Interventional|||TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)|An Open, Randomised, Prospective, Multicentre, Parallel-group Trial to Compare Efficacy and Safety of TachoComb S Versus Standard Surgical Treatment in Patients Undergoing Surgical Resection of Superficial Renal Tumour.|Completed||Phase 3|170||Takeda|||||f||||t||||||||||2017-02-18 17:02:06.537022|2017-02-18 17:02:06.537022
NCT00005350|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-21|||April 1991||1991-04-01|December 2015|2015-12-01|January 1993||1993-01-01|||||Observational|||Evaluating Strategies to Control Hypercholesterolemia||Completed||N/A|||National Bureau of Economic Research, Inc.|||||f||||||||||||||2017-02-18 18:15:00.166449|2017-02-18 18:15:00.166449
NCT00241150|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-11-07|||November 2002||2002-11-01|June 2006|2006-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome|A Multicenter, Double Blind, Randomized Study With Two Parallel Groups Comparing The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome|Completed||Phase 4|80|Actual|Novartis|||||||||||||||||||2017-02-18 17:02:06.630457|2017-02-18 17:02:06.630457
NCT00241137|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-11-22|||September 2003||2003-09-01|June 2006|2006-06-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg|A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg|Completed||Phase 3|3790|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:06.71638|2017-02-18 17:02:06.71638
NCT00241124|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-11-22|||April 2004||2004-04-01|November 2011|2011-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes|A Randomized, Double Blind, Double Dummy, Parallel Group, Active-Controlled Study To Evaluate The Effectiveness Of Morning Versus Evening Doses Of 320 Mg Valsartan Versus 40 Mg Lisinopril On The 24 Hour Blood Pressure Profile In Patients With Hypertension And Non-Insulin Dependent Diabetes|Completed||Phase 4|1099|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:06.808328|2017-02-18 17:02:06.808328
NCT00241111|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2010-04-07|||September 2003||2003-09-01|April 2010|2010-04-01||||January 2006|Actual|2006-01-01||Interventional|||Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis|Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis|Completed||Phase 4|148|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:02:06.89899|2017-02-18 17:02:06.89899
NCT00241098|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-11-07|||May 2003||2003-05-01|February 2006|2006-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure|A Randomized, Double Blind, Parallel Group Study to Evaluate the Effects of Valsartan Versus Placebo in Patients With Early Stage Heart Failure Due to Diastolic Dysfunction Already Evidenced by an Elevated B-type Natriuretic Peptide Level: the VALIDATE Study|Completed||Phase 4|37|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:06.992583|2017-02-18 17:02:06.992583
NCT00241085|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-11-07|||November 2002||2002-11-01|June 2006|2006-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus|A Multi-center, Double Blind, Randomized, Parallel Group Study to Evaluate the Effects of Valsartan on Proteinuria in Hypertensive Subjects With Type 2 Diabetes Mellitus|Completed||Phase 4|392|Actual|Novartis|||||||||||||||||||2017-02-18 17:02:07.075423|2017-02-18 17:02:07.075423
NCT00241072|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2012-05-03|||September 2002||2002-09-01|May 2012|2012-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance|A Single Center, Open Label, Single Arm Trial To Evaluate The Effect Of Twenty Four Weeks Of Treatment With 80 Mg To 320 Mg Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance (Igt)|Completed||Phase 4|27|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:02:07.340654|2017-02-18 17:02:07.340654
NCT00241059|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-01-28|||August 2002||2002-08-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients|A Prospective, Open-label, Multicenter, International Follow-up Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients|Completed||Phase 4|183|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:02:07.429427|2017-02-18 17:02:07.429427
NCT00241046|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2012-04-18|||April 2002||2002-04-01|April 2012|2012-04-01||||March 2005|Actual|2005-03-01||Interventional|||Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment|Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment|Terminated||Phase 4|13|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:02:07.520328|2017-02-18 17:02:07.520328
NCT00241020|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-04-11|||June 2002||2002-06-01|April 2016|2016-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma|Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 3|270|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:02:07.60135|2017-02-18 17:02:07.60135
NCT00241007|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-11-07|||December 2003||2003-12-01|October 2005|2005-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension|A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension|Completed||Phase 3|836|Actual|Novartis|||||||||||||||||||2017-02-18 17:02:07.699587|2017-02-18 17:02:07.699587
NCT00240994|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-11-15|2012-09-13||January 2005||2005-01-01|November 2016|2016-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients|A Phase II Exploratory Study to Determine the Safety and Study the Immunomodulatory Functions of Induction Therapy With Campath, Combined With Chronic Immunosuppression With Mycophenolate Mofetil and Sirolimus|Completed||Phase 2|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 17:02:07.802419|2017-02-18 17:02:07.802419
NCT00240981|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2012-11-20|||January 2005||2005-01-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||TOM: Testosterone in Older Men With Sarcopenia|Testosterone Replacement for Older Men With Sarcopenia|Completed||Phase 4|209|Actual|Boston Medical Center||2|||f||||t||||||||||2017-02-18 17:02:08.224999|2017-02-18 17:02:08.224999
NCT00240968|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-08-15|||October 2005||2005-10-01|July 2008|2008-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||H5 Booster After a Two Dose Schedule|Evaluation of a Booster Dose of A/Vietnam/1203/04 (H5N1) Vaccine Administered at 6 Months to Healthy Adult Subjects After a Two Dose Schedule at 0 and 1 Months|Completed||Phase 2|337|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:02:08.351104|2017-02-18 17:02:08.351104
NCT00240955|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-01-28|||March 2004||2004-03-01|January 2011|2011-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients|Efficacy and Safety of Two Immunosuppressive Regimens Mycophenolate Sodium (EC-MPS) With Short-term Steroid Use or Free of Steroids Compared With a Regimen of EC-MPS With Standard Steroids in de Novo Kidney Recipients|Completed||Phase 4|79|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:08.460258|2017-02-18 17:02:08.460258
NCT00240942|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2012-04-25|||October 2002||2002-10-01|April 2012|2012-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Letrozole in the Treatment of Severe and Recurrent Endometriosis|Letrozole in the Treatment of Severe and Recurrent Endometriosis|Completed||Phase 2|40||Novartis|||||f||||||||||||||2017-02-18 17:02:08.545824|2017-02-18 17:02:08.545824
NCT00240929|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2010-11-12|||September 2002||2002-09-01|November 2010|2010-11-01|April 2003|Actual|2003-04-01|||||Interventional|||A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)|A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis), A Humanized Respiratory Syncytial Virus Monoclonal Antibody, in Children With a History of Prematurity|Completed||Phase 2|150|Actual|MedImmune LLC||1|||f||||||||||||||2017-02-18 17:02:08.635872|2017-02-18 17:02:08.635872
NCT00240916|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2009-11-05|||July 1993||1993-07-01|November 2009|2009-11-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|||Ontogeny of Measles Immunity in Infants|Ontogeny of Vaccine-Induced Measles Immunity Child Participant-6 and 9 Months|Unknown status|Recruiting|N/A|555|Anticipated|Stanford University|||4||f||||||||||Samples With DNA|"~     white cells, serum~   "|||2017-02-18 17:02:08.737578|2017-02-18 17:02:08.737578
NCT00240903|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-08-11|||October 2005||2005-10-01|March 2007|2007-03-01|March 2006||2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine|Revaccination of Healthy Subjects With Intramuscular Inactivated Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine Representing a Drifted Variant|Completed||Phase 1|37|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:02:09.045282|2017-02-18 17:02:09.045282
NCT00240877|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2008-11-19|||August 2002||2002-08-01|November 2008|2008-11-01|April 2004|Actual|2004-04-01|August 2003|Actual|2003-08-01||Interventional|||Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)|Completed||Phase 3|330|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 17:02:09.145688|2017-02-18 17:02:09.145688
NCT00240864|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|February 2004|Actual|2004-02-01|||||Interventional|||An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain|A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain|Completed||Phase 4|224|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||||||||||||2017-02-18 17:02:09.243762|2017-02-18 17:02:09.243762
NCT00240851|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|February 2004|Actual|2004-02-01|||||Interventional|||An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in Treating Muscle Aches and Soreness That Occur After a Marathon Race|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release Caplets (3900 mg/Day) in the Treatment of Post-Race Muscle Aching and Pain (Soreness)|Completed||Phase 4|665|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||||||||||||2017-02-18 17:02:09.345761|2017-02-18 17:02:09.345761
NCT00240838|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-06-28|||May 2003||2003-05-01|June 2011|2011-06-01|June 2003|Actual|2003-06-01|||||Interventional|||An Effectiveness and Safety Study Comparing Acetaminophen (3900 mg/Day) to Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.|A Randomized, Double-Blind Study Evaluating Acetaminophen Extended Release Caplets (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Post-Race Muscle Soreness.|Completed||Phase 4|483|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|||||||||||||||||||2017-02-18 17:02:09.442213|2017-02-18 17:02:09.442213
NCT00240825|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|February 2004|Actual|2004-02-01|||||Interventional|||An Effectiveness and Safety Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain.|A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain|Completed||Phase 4|222|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||3|||f||||||||||||||2017-02-18 17:02:09.535033|2017-02-18 17:02:09.535033
NCT00240812|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-06-28||||||June 2011|2011-06-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting|A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children|Completed||Phase 2|318|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|||||||||||||||||||2017-02-18 17:02:09.634602|2017-02-18 17:02:09.634602
NCT00240799|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|October 2004|Actual|2004-10-01|||||Interventional|||An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release (3900 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee.|Completed||Phase 3|542|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||||||||||||2017-02-18 17:02:09.719785|2017-02-18 17:02:09.719785
NCT00240786|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-06-28|||April 2002||2002-04-01|June 2011|2011-06-01|March 2003|Actual|2003-03-01|||||Interventional|||An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee|A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release (1950 mg/Day or 3900 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee|Completed||Phase 3|483|Actual|Johnson & Johnson Consumer and Personal Products Worldwide|||||||||||||||||||2017-02-18 17:02:09.8222|2017-02-18 17:02:09.8222
NCT00239889|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2006-11-29|||March 2002||2002-03-01|March 2006|2006-03-01||||||||Interventional|||Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women|Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women|Completed||Phase 4|300||Novartis|||||f||||||||||||||2017-02-18 17:02:28.862801|2017-02-18 17:02:28.862801
NCT00240773|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-06-18||||||June 2015|2015-06-01|June 2003|Actual|2003-06-01|||||Interventional|||A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee|A Randomized, Double-Blind, Long-Term Comparative Study Evaluating the Safety and Efficacy of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee|Completed||Phase 3|581|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||4|||f||||||||||||||2017-02-18 17:02:09.91146|2017-02-18 17:02:09.91146
NCT00240760|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2006-02-17|||October 2005||2005-10-01|October 2005|2005-10-01||||||||Interventional|||Memantine and Down's Syndrome|Efficacy and Safety of Memantine Hydrochloride, a Low Affinity Antagonist to N-Methyl-D-Aspartate (NMDA) Type Receptors, in the Prevention of Cognitive Decline and Disease Progression in Down’s Syndrome|Unknown status|Recruiting|N/A|180||King's College London|||||f||||||||||||||2017-02-18 17:02:10.017499|2017-02-18 17:02:10.017499
NCT00240747|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2012-05-24|||June 2000||2000-06-01|May 2012|2012-05-01|January 2005||2005-01-01|||||Interventional|||Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients||Terminated||Phase 3|||Pfizer|||||||||||||||||||2017-02-18 17:02:10.118191|2017-02-18 17:02:10.118191
NCT00240734|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-06-08|||March 2005||2005-03-01|March 2010|2010-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Treatment of Anemia in Diabetic Subjects With CKD|A Randomized, Double-blind, Placebo-Controlled Study Evaluating Weekly Epoetin Alfa (PROCRIT�) Administration on Hemoglobin Response and Safety in Diabetic Subjects With the Anemia of Chronic Kidney Disease (CKD)|Terminated||Phase 2|11|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"This study was stopped for slow enrollment after enrolling only 11 of 180 patients in six~   months time."|||||f||||||||||2017-02-18 17:02:10.207154|2017-02-18 17:02:10.207154
NCT00240721|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-06-06|||October 2000||2000-10-01|November 2010|2010-11-01|September 2002|Actual|2002-09-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder|A Randomized, Double-Blind, Multicenter, Placebo-Controlled 12-Week Study Of The Safety And Efficacy Of Two Doses Of Topiramate For The Treatment Of Acute Manic Or Mixed Episodes In Subjects With Bipolar I Disorder With An Optional Open-Label Extension|Completed||Phase 3|363|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:02:10.300878|2017-02-18 17:02:10.300878
NCT00240708|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-05-16|||June 2004||2004-06-01|March 2010|2010-03-01|April 2006|Actual|2006-04-01|||||Interventional|||A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia|A Parallel-Group Comparative Open-Label Study of Long-Acting Injectible Risperidone Versus Risperidone Tablets in Patients With Schizophrenia.|Completed||Phase 3|205|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 17:02:10.3959|2017-02-18 17:02:10.3959
NCT00240695|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-05-17|||May 2003||2003-05-01|April 2010|2010-04-01|May 2004|Actual|2004-05-01|||||Interventional|||A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment|An Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Galantamine HBr in the Treatment of Mild Cognitive Impairment|Completed||Phase 3|724|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:02:10.488982|2017-02-18 17:02:10.488982
NCT00240682|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2012-02-18|||October 2005||2005-10-01|August 2009|2009-08-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|CTXSCC||Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR|Phase II Study of Cetuximab as Monotherapy and First Line Treatment in Patients With Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin Expressing EGFR.|Completed||Phase 2|37|Actual|Centre Hospitalier of Chartres||1|||f||||t||||||||||2017-02-18 17:02:10.573449|2017-02-18 17:02:10.573449
NCT00240669|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2007-04-26|||November 2005||2005-11-01|April 2007|2007-04-01||||||||Interventional|||RESTIT : Evaluation of Resorbable Osteosynthesis Devices Versus Titanium in Maxillofacial Surgery|RESTIT : Evaluation of Resorbable Osteosynthesis Devices Versus Titanium in Maxillofacial Surgery – A Prospective Randomized Trial in Therapeutic Strategy|Unknown status|Recruiting|N/A|308||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:02:10.695699|2017-02-18 17:02:10.695699
NCT00240656|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2008-06-27|||October 2005||2005-10-01|October 2005|2005-10-01|May 2006||2006-05-01|||||Interventional|||Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension|Official Title: Spironolactone Combined With Captopril and Carvedilol for the Treatment of Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease—Focus on Pulmonary Artery Remodeling|Completed||Phase 1|||Hebei Medical University|||||f||||||||||||||2017-02-18 17:02:10.771766|2017-02-18 17:02:10.771766
NCT00240643|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2017-01-13|||November 2005||2005-11-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke|A Randomized, Double Blind, Double Dummy, Parallel Group, Placebo Controlled Study to Evaluate the Pharmacodynamic and Pharmacokinetic Response and Safety and Tolerability of SB424323 (250mg, 375mg and 500 mg) Administered Twice Daily for 16 Weeks, on Top of Asprin (325mg, qd) in Men and Women With Non Valvular Atrial Fibrillation at a Low or Intermediate Risk for Stroke|Completed||Phase 2|640|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:02:10.998506|2017-02-18 17:02:10.998506
NCT00240630|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-04-15|||October 2005||2005-10-01|April 2015|2015-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks|A Randomized, Double-blind, Multi-center, Placebo-controlled, Cross-over Study to Determine the Consistency of Response for Trexima (Sumatriptan 85mg/Naproxen Sodium 500mg) Administered During the Mild Pain Phase for the Acute Treatment of Multiple Migraine Attacks|Completed||Phase 3|646|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 17:02:11.216826|2017-02-18 17:02:11.216826
NCT00240617|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-10-24|||October 2005||2005-10-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks|A Randomized, Double-blind, Multi-center, Placebo-controlled, Cross-over Study to Determine the Consistency of Response for Trexima* (Sumatriptan 85mg/Naproxen Sodium 500mg) Administered During the Mild Pain Phase for the Acute Treatment of Multiple Migraine Attacks (*Treximet)|Completed||Phase 3|623|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:02:11.573475|2017-02-18 17:02:11.573475
NCT00240591|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-11-09|||October 2003||2003-10-01|November 2015|2015-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational|||Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab|A MULTI-CENTER LONG-TERM FOLLOW-UP STUDY OF PATIENTS WITH LOW-GRADE NON-HODGKIN'S LYMPHOMA PREVIOUSLY TREATED WITH TOSITUMOMAB AND/OR IODINE I 131 TOSITUMOMAB IN STUDIES RIT-I-000, RIT-II-001, RIT-II-002, RIT-II-004, or CP-97-012|Completed||N/A|150|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 17:02:11.864685|2017-02-18 17:02:11.864685
NCT00240578|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-01-28|||November 2003||2003-11-01|January 2016|2016-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab|A MULTI-CENTER LONG-TERM FOLLOW-UP STUDY OF PATIENTS WITH LOW-GRADE NON-HODGKIN'S LYMPHOMA PREVIOUSLY TREATED WITH IODINE I 131 TOSITUMOMAB IN STUDIES CP-97-011, CP-98-025, CP-99-032, or CP-99-036|Completed||N/A|88|Actual|GlaxoSmithKline|||1||f||||f||||||||||2017-02-18 17:02:11.951422|2017-02-18 17:02:11.951422
NCT00240565|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2012-08-09|||April 2004||2004-04-01|August 2012|2012-08-01|September 2011|Actual|2011-09-01|February 2007|Actual|2007-02-01||Interventional|||Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma|A Single Arm, Open-label, Multicentre, Phase II Study of Tositumomab and Iodine 131-Tositumomab in Subjects With Indolent Non-Hodgkin's Lymphoma Who Have Previously Received Rituximab.|Completed||Phase 2|93|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 17:02:12.035781|2017-02-18 17:02:12.035781
NCT00240552|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-09-09|||July 2003||2003-07-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Fosamprenavir Expanded Access|An Open-label Phase III Study to Provide Access to Fosamprenavir and to Assess the Long Term Safety and Tolerability of Fosamprenavir Containing Regimens in HIV Infected Patients With Limited Treatment Options|Completed||Phase 4|85|Actual|ViiV Healthcare|||||f||||||||||||||2017-02-18 17:02:12.169141|2017-02-18 17:02:12.169141
NCT00240539|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-10-26|2009-07-16||October 2003||2003-10-01|October 2016|2016-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)|Long-term Follow-Up Studies at Years 16-20, to Evaluate the Persistence of Immune Response of GSK Biologicals' Hepatitis B Vaccine in Newborns of HBeAg+ and HBsAg+ Mothers in Comparison With a Historical Control Group|Completed||Phase 4|36|Actual|GlaxoSmithKline|No safety data were collected during this long-term follow-up study.|4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:02:12.288516|2017-02-18 17:02:12.288516
NCT00240526|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-10-14|2010-06-14||October 2003||2003-10-01|October 2016|2016-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers|Comparative Study of the Immunogenicity and Protective Efficacy of GlaxoSmithKline Biologicals' Rec-DNA Hepatitis B Vaccine With or Without Hepatitis B Immunoglobulins (HBIg) in Newborns of HBeAg+ Mothers.|Completed||Phase 4|79|Actual|GlaxoSmithKline|A decrease in the specificity of the anti-HB ELISA assay had been observed in some studies for low levels of antibody (10-100 mIU/mL). Additional tables have been generated following partial retesting and reanalysis of the results at Years 19 and 20.|4|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:02:12.9479|2017-02-18 17:02:12.9479
NCT00240513|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2012-02-22|||August 2004||2004-08-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin|A Randomized Study to Compare the Acne Relapse Rate After a 3-mo Course of Oral Minocycline, to a 3-mo Course of Oral Minocycline in Combination With a Daily Dose of Topical Tretinoin 0.01% Followed by 3 mo of Topical Tretinoin Alone|Terminated||Phase 4|38|Actual|Derm Research @ 888 Inc.||2||Too much difficulty recruiting and retaining patients, PI decided to stop.|f||||f||||||||||2017-02-18 17:02:13.736849|2017-02-18 17:02:13.736849
NCT00240500|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-11-03|2008-10-30||October 2003||2003-10-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers|Long-Term Follow Up Study at Years 16-20, to Evaluate the Persistence of Immune Response of GlaxoSmithKline Biologicals' Hepatitis B Vaccine in Newborns of HBeAg+ and HBsAg+ Mothers|Completed||Phase 4|109|Actual|GlaxoSmithKline||6|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:02:13.864015|2017-02-18 17:02:13.864015
NCT00240487|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-04-23|2013-01-10||September 2000||2000-09-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Nitric Oxide Administration for Acute Respiratory Distress Syndrome|Nitric Oxide Administration for Acute Respiratory Distress Syndrome|Completed||Phase 3|52|Actual|Children's Hospital of Philadelphia|There may be some confounding of effects of lung recruitment from high mean airway pressures over the duration of the observation period.|2|||f||||f||||||||||2017-02-18 17:02:14.72911|2017-02-18 17:02:14.72911
NCT00240474|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-10-31|||December 2002||2002-12-01|October 2013|2013-10-01|March 2004||2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)|A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-label, Blinded End-point Evaluation. (ATHOS Study)|Completed||Phase 4|1000||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:15.110299|2017-02-18 17:02:15.110299
NCT00240461|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-07-06|||September 2005||2005-09-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors|Efficacy and Safety of COLD-fX in the Prevention of Respiratory Infections in Community-dwelling Seniors: a Multi-center, Randomized, Double-blind, Placebo-controlled Trial|Completed||Phase 3|780|Actual|Capital Health, Canada||3|||f||||f||||||||||2017-02-18 17:02:15.267839|2017-02-18 17:02:15.267839
NCT00230906|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2007-12-19|||January 2001||2001-01-01|December 2007|2007-12-01|April 2002|Actual|2002-04-01|||||Interventional|||Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane|Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane|Completed||N/A|12||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:05:13.99259|2017-02-18 17:05:13.99259
NCT00240448|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-11-04|||September 2003||2003-09-01|November 2013|2013-11-01||||June 2004|Actual|2004-06-01||Interventional|||A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients|A Randomised, Double-blind, Double-dummy, Placebo-controlled, Forced-titration, Comparison of MICARDIS® HCT (Telmisartan 80 mg / Hydrochlorothiazide 25 mg) Versus DIOVAN® HCT (Valsartan 160 mg / Hydrochlorothiazide 25 mg) Using Seated Trough Cuff Blood Pressure in Patients With Stage 1 and Stage 2 Hypertension|Completed||Phase 4|1109|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:02:15.38607|2017-02-18 17:02:15.38607
NCT00240435|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-10-31|||November 2002||2002-11-01|October 2013|2013-10-01||||December 2003|Actual|2003-12-01||Interventional|||12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD|A Randomized, Double-blind, Double-dummy, Placebo- and Active-controlled, Parallel Group Efficacy and Safety Comparison of 12-week Treatment of Two Doses (5 Mcg and 10 Mcg) of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler, Placebo and Ipratropium Bromide Inhalation Aerosol (MDI) i|Completed||Phase 3|491||Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:02:18.332967|2017-02-18 17:02:18.332967
NCT00240422|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-11-07|||February 2003||2003-02-01|November 2013|2013-11-01|July 2004||2004-07-01|||||Interventional|||Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes|A Prospective, Randomized, Double-blind, Double-dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes|Completed||Phase 4|96|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:18.439208|2017-02-18 17:02:18.439208
NCT00240409|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-11-01|||July 2003||2003-07-01|November 2013|2013-11-01|August 2004||2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease|A Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole Tablets and Bromocriptine Tablets in Patients With Parkinson's Disease.|Completed||Phase 3|208|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:18.548901|2017-02-18 17:02:18.548901
NCT00240396|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2005-11-16|||October 2005||2005-10-01|November 2005|2005-11-01|December 2005||2005-12-01|||||Interventional|||Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture|Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture|Unknown status|Recruiting|N/A|150||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:02:18.643607|2017-02-18 17:02:18.643607
NCT00240383|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2010-09-10||2010-09-10|May 2002||2002-05-01|June 2008|2008-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Dose Ranging Study With LT, Monotherapy, PPAR|A Randomized, Double-Blind, Dose Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects With Type 2 Diabetes|Completed||Phase 2/Phase 3|1260||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:02:18.751916|2017-02-18 17:02:18.751916
NCT00240370|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-17|2010-09-10||2010-09-10|October 2003||2003-10-01|June 2008|2008-06-01||||March 2005|Actual|2005-03-01||Interventional|||A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics|A Phase 3, Randomized, Double-Blind, Active-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Metformin Compared to Pioglitazone in Combination With Metformin in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone|Completed||Phase 3|1159||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:02:19.35482|2017-02-18 17:02:19.35482
NCT00240357|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2009-03-25|||February 2003||2003-02-01|March 2009|2009-03-01||||||||Interventional|||Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia|Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement of LDL Goals. - Denmark|Withdrawn||Phase 4|1175||AstraZeneca||||Study cancelled prior to FSI|f||||||||||||||2017-02-18 17:02:19.76934|2017-02-18 17:02:19.76934
NCT00240344|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2011-08-29|||September 2004||2004-09-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal|REALISTIC: Protocol for an Observational Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New EAS LDL-C Target Goal|Completed||Phase 4|2650|Actual|AstraZeneca|||1||f||||||||||||||2017-02-18 17:02:19.977339|2017-02-18 17:02:19.977339
NCT00240331|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2011-05-17|2009-09-29||January 2003||2003-01-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)|A Study to Evaluate the Use of Rosuvastatin in Subjects On Regular Haemodialysis: an Assessment of Survival and Cardiovascular Events (AURORA). A Double Blind, Randomised, Phase 3b, Parallel-group Study to Compare the Effects of Rosuvastatin With Placebo on Assessment of Survival & Cardiovascular Events When Given to Subjects With End-stage Renal Failure on Chronic Haemodialysis Treatment|Completed||Phase 3|2776|Actual|AstraZeneca|The endpoints were originally intended to be time to event endpoints, however we are unable to report the data as intended due to the nature of time to event endpoints. Therefore we have reported the number of participants who reached the event.|2|||f||||||||||||||2017-02-18 17:02:20.173712|2017-02-18 17:02:20.173712
NCT00240318|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2010-11-18|||November 2002||2002-11-01|November 2010|2010-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)|A 104-Week, Open-label, Multi-centre, Phase IIIb Study Evaluating the Effect of Treatment With Rosuvastatin 40 mg on Atherosclerotic Disease as Measured by Intravascular Ultrasound and Quantitative Coronary Angiography in Subjects Undergoing Coronary Angiography Who Have Coronary Artery Disease|Completed||Phase 3|450||AstraZeneca|||||||||||||||||||2017-02-18 17:02:23.427017|2017-02-18 17:02:23.427017
NCT00240305|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2009-03-13|||April 2004||2004-04-01|March 2009|2009-03-01|May 2006|Actual|2006-05-01|||||Interventional|||A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome|A Randomised, Double-Blind, Placebo Controlled, Crossover Dose-Ranging Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome|Completed||Phase 3|15||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:23.594736|2017-02-18 17:02:23.594736
NCT00229983|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2016-10-06|||June 2004||2004-06-01|October 2016|2016-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Medical Office Intervention for Adolescent Drug Use|Medical Office Intervention for Adolescent Drug Use|Completed||Phase 2|170|Actual|Boston Children’s Hospital||2|||f||||t||||||||No||2017-02-18 17:05:28.70882|2017-02-18 17:05:28.70882
NCT00240292|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2010-11-18|||February 2003||2003-02-01|November 2010|2010-11-01||||||||Interventional|||Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines|A Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre, Phase III Study to Assess the Impact of Rosuvastatin Treatment for 26 Weeks (Titrated to a Maximum Dose of 40mg Once Daily) on Left Ventricular Function, Cytokines and Lipid Parameters in Patients With Established Systolic Chronic Heart Failure.|Completed||Phase 3|160||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:23.688032|2017-02-18 17:02:23.688032
NCT00240279|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2010-11-18|||January 2003||2003-01-01|November 2010|2010-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study|The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study|Completed||Phase 3|10||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:24.026115|2017-02-18 17:02:24.026115
NCT00240266|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-16|2010-11-18|||August 2003||2003-08-01|November 2010|2010-11-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)|A Randomised, Double-blind, Placebo-controlled, Crossover Pilot Study to Define the High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)|Completed||Phase 3|15||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:24.114396|2017-02-18 17:02:24.114396
NCT00240253|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2015-03-26|||October 2005||2005-10-01|March 2015|2015-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes Who Are Not Achieving Glycemic Targets|Completed||Phase 4|200|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 17:02:24.209626|2017-02-18 17:02:24.209626
NCT00240227|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-03-11|2013-11-25||April 2004||2004-04-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Prazosin for ETOH or Cocaine Craving|The Role of the Alpha 1-adrenergic Antagonist, Prazosin, in the Reduction of Craving and Relapse in Alcohol and Cocaine-dependent Individuals: a Double-blind, Randomized, Controlled Clinical Trial|Terminated||N/A|8|Actual|VA Office of Research and Development|The study procedure intended to induce substance craving failed to induce craving. Thus, any difference between placebo and active medication conditions could not be measured and so the study was terminated.|2||"Experimental procedure did not induce sufficient craving to determine any possible effect of~   medication."|f||||f||||||||||2017-02-18 17:02:24.337141|2017-02-18 17:02:24.337141
NCT00240214|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2008-03-13|||April 2001||2001-04-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Study Evaluating Rapamune in Patients After Kidney Transplantation|An Open Label Post Marketing Surveillance Assessment to Evaluate the Effectiveness and Safety of Rapamune in Patients After Kidney Transplantation Receiving a Rapamune Containing Regime|Terminated||N/A|500|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 17:02:24.600703|2017-02-18 17:02:24.600703
NCT00240188|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2010-09-15|||February 2004||2004-02-01|September 2010|2010-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study to Compare Ventral Incisional Hernia by Laparoscopic vs Open Repair With Mesh|Ventral Incisional Hernia Repair: Comparison Of Laparoscopic and Open Repair With Mesh|Completed||N/A|110|Anticipated|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 17:02:24.707953|2017-02-18 17:02:24.707953
NCT00240175|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2012-02-29|||August 2005||2005-08-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Evaluating the Effects of Foot Orthotics on Plantar Pressures in the Diabetic Population|Evaluating the Effects of Foot Orthotics on Plantar Pressures in the Diabetic Population|Completed||Phase 1|65|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||||||||||||2017-02-18 17:02:24.819746|2017-02-18 17:02:24.819746
NCT00240162|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2014-09-05|2014-08-22||September 2005||2005-09-01|September 2014|2014-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma|A Phase II Study of PTK787/ZK 222584, a Novel, Oral Angiogenesis Inhibitor as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma Following High Dose Chemotherapy and Autologous Stem Cell Transplant|Terminated||Phase 2|21|Actual|Washington University School of Medicine|In November 2008, it was reported that the drug might have carcinogenic potential in animal models. At that time, the remaining three patients were taken off study.|1||"investigator letter from drug manufacturer stating animal studies showed increased risk of~   cancer which was an unknown adverse event"|f||||||||||||||2017-02-18 17:02:24.914004|2017-02-18 17:02:24.914004
NCT00240149|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2007-12-19|||October 2005||2005-10-01|November 2007|2007-11-01|March 2006||2006-03-01|||||Interventional|||Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit|Pilot Study Evaluating Use of Insulin-Glucose Algorithm and Glucose Monitoring Techniques to Control Hyperglycemia in the Pediatric Intensive Care Unit|Completed||N/A|0||Stanford University|||||f||||||||||||||2017-02-18 17:02:25.379198|2017-02-18 17:02:25.379198
NCT00240136|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-02-17|||January 1993||1993-01-01|February 2016|2016-02-01|July 2023|Anticipated|2023-07-01|December 2022|Anticipated|2022-12-01||Observational|||Long-term Observation of Patients With Early Rheumatoid Arthritis|Long-term Observation of Patients With Early Rheumatoid Arthritis|Active, not recruiting||N/A|372|Actual|University of California, Los Angeles|||1||f||||t||||||||||2017-02-18 17:02:25.49032|2017-02-18 17:02:25.49032
NCT00240123|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-16|||July 2005||2005-07-01|September 2015|2015-09-01|July 2007||2007-07-01|||||Interventional|||Effect of Benadryl Sedation During ERCP or EUS|Effect of Diphenhydramine Sedation During Endoscopic Retrograde Cholangio-pancreatography (ERCP) or Endoscopic Ultrasound (EUS)|Withdrawn||Phase 1|0|Actual|University of Rochester|||||f||||||||||||||2017-02-18 17:02:25.601033|2017-02-18 17:02:25.601033
NCT00240110|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-08-24|2015-06-30||March 2006||2006-03-01|August 2016|2016-08-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Valproate Efficacy in Cocaine-Bipolar Comorbidity|Valproate Efficacy in Cocaine-Bipolar Comorbidity|Completed||Phase 1/Phase 2|152|Actual|University of Miami||2|||f||||t||||||||No||2017-02-18 17:02:25.701263|2017-02-18 17:02:25.701263
NCT00239707|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2013-11-27|||February 2003||2003-02-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GIP: Glucose-dependent Insulinotropic Peptide|Effect of GIP / GIP Analog in Type 2 Diabetes After a Meal|Completed||Phase 1|41|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-02-18 17:02:31.102409|2017-02-18 17:02:31.102409
NCT00240097|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2014-11-26|2012-06-08||June 2005||2005-06-01|November 2014|2014-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)|Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin-Etoposide/Carboplatin in Extensive SCLC|Completed||Phase 2|30|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 17:02:26.301701|2017-02-18 17:02:26.301701
NCT00240084|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2013-06-17|||July 2003||2003-07-01|June 2013|2013-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Nesiritide and Vo2 Max in Heart Failure Patients|Nesiritide and Vo2 Max in Heart Failure Patients|Completed||Phase 2|20|Actual|University of Rochester||1|||f||||f||||||||||2017-02-18 17:02:26.640491|2017-02-18 17:02:26.640491
NCT00240071|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-08-21|2011-04-20||October 2005||2005-10-01|August 2011|2011-08-01|April 2011|Actual|2011-04-01|March 2009|Actual|2009-03-01||Interventional|||Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.|The Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy: A Phase II Trial|Completed||Phase 2|30|Actual|University of Alabama at Birmingham|A Phase II trial.|1|||f||||t||||||||||2017-02-18 17:02:26.752756|2017-02-18 17:02:26.752756
NCT00240058|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-08-30|||July 2005||2005-07-01|August 2016|2016-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity|Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity|Completed||N/A|22|Actual|University of Michigan||1|||f||||||||||||||2017-02-18 17:02:27.023137|2017-02-18 17:02:27.023137
NCT00240045|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2007-12-03|||October 2005||2005-10-01|October 2005|2005-10-01|July 2007|Actual|2007-07-01|||||Interventional|||The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction|The Use of Midodrine, Octreotide and Albumin in Refractory Ascites|Completed||Phase 2/Phase 3|9|Actual|University of Alberta||1|||f||||f||||||||||2017-02-18 17:02:27.127964|2017-02-18 17:02:27.127964
NCT00240032|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-04-07|||October 2004||2004-10-01|April 2011|2011-04-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.|A Double-Blind, Randomized, Placebo Controlled Study of An Oral Antihistamine on Local Injection Site Reactions Among Persons With Multiple Sclerosis Who Perform Daily Injections of Copaxone® Using Autoject® 2 for Glass Syringe.|Completed||Phase 4|80|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:02:27.331584|2017-02-18 17:02:27.331584
NCT00240019|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2006-10-16|||December 2003||2003-12-01|June 2006|2006-06-01|April 2006||2006-04-01|||||Interventional|||Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.|Maximizing the Benefit of RAS Blockade in Diabetic Nephropathy|Completed||N/A|30||Stanford University|||||f||||||||||||||2017-02-18 17:02:27.432007|2017-02-18 17:02:27.432007
NCT00240006|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-04-08|||January 2006||2006-01-01|April 2011|2011-04-01|September 2007|Actual|2007-09-01|January 2007|Actual|2007-01-01||Interventional|||A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone|An Open Label, Prospective Parallel Cohort Study Comparing A 90-day Copaxone® Adherence Enhancement Program Among Persons With Multiple Sclerosis Who Participate in Shared Solutions® Alone or in Partnership With Their MS Center|Completed||Phase 4|307|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:02:27.510669|2017-02-18 17:02:27.510669
NCT00239993|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2017-02-02|||August 2005||2005-08-01|February 2017|2017-02-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®|An Open-Label, Randomized, Single Cross-over Study of Warm Compress Versus Usual Injection Site Preparation on Local Injection Site Reactions Among Persons With MS Who Perform Daily Injections of Copaxone®.|Completed||Phase 4|50|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:02:27.610551|2017-02-18 17:02:27.610551
NCT00239980|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2010-02-02|||October 2005||2005-10-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)|A Phase II Randomized Study of Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)|Completed||Phase 2|77|Actual|Ontario Clinical Oncology Group (OCOG)||3|||f||||t||||||||||2017-02-18 17:02:27.725825|2017-02-18 17:02:27.725825
NCT00239967|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2009-04-06|||May 2005||2005-05-01|April 2009|2009-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|ADAGIO-lipids||An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients|A Randomized, Double-Blind, Two-Arm Placebo-Controlled, Parallel-Group, Multicenter Study of Rimonabant 20 mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdominally Obese Patients|Completed||Phase 3|803|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:02:27.839712|2017-02-18 17:02:27.839712
NCT00239954|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2012-05-08|||March 2005||2005-03-01|May 2012|2012-05-01||||||||Interventional|||Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder|Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder|Unknown status|Active, not recruiting|Phase 3|||Pharmacology Research Institute|||||||||||||||||||2017-02-18 17:02:27.96718|2017-02-18 17:02:27.96718
NCT00239928|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-05-11|2009-11-04||September 2005||2005-09-01|May 2011|2011-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration|Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration (Extension Study From A5751010)|Completed||Phase 2|61|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:02:28.067929|2017-02-18 17:02:28.067929
NCT00239915|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2012-05-08|||April 2005||2005-04-01|May 2012|2012-05-01|December 2006||2006-12-01|||||Interventional|||Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)|An 8-week, Double-Blind, Randomized, Multicenter, Flexible-Dose, Placebo-Controlled Pilot Study of Pagoclone in Patients With Persistent Developmental Stuttering Followed by a 52-week Open-Label Extension.|Completed||Phase 2|||Pharmacology Research Institute|||||||||||||||||||2017-02-18 17:02:28.68588|2017-02-18 17:02:28.68588
NCT00239902|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-11-01|||May 2002||2002-05-01|November 2011|2011-11-01||||November 2004|Actual|2004-11-01||Interventional|||Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|Two-year Extension of a One-year, Multicenter, Randomized, Partially-blinded Study of the Safety and Efficacy of FTY720 Combined With Corticosteroids and Full or Reduced-dose Cyclosporine, USP [Modified] (Novartis Brand) in de Novo Adult Renal Transplant Recipients|Completed||Phase 2|396||Novartis|||||||||||||||||||2017-02-18 17:02:28.770777|2017-02-18 17:02:28.770777
NCT00239876|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-11-01|||May 2005||2005-05-01|November 2011|2011-11-01||||December 2005|Actual|2005-12-01||Interventional|||Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|A Two-year Extension to a One-year, Multicenter, Open-label, Randomised Study to Evaluate the Safety and Efficacy of FTY720 Combined With Tacrolimus and Steroids Versus Mycophenolate Mofetyl Combined With Tacrolimus and Steroids, in de Novo Adult Renal Transplant Recipients|Completed||Phase 3|140||Novartis|||||||||||||||||||2017-02-18 17:02:28.961651|2017-02-18 17:02:28.961651
NCT00239863|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-11-01|||May 2004||2004-05-01|November 2011|2011-11-01||||May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients|A Two-year Extension to a One-year, Multicenter, Partially Blinded, Double-dummy, Randomized Study to Evaluate the Efficacy and Safety of FTY720 Combined With Reduced-dose or Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids Versus Mycophenolate Mofetil Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids, in de Novo Adult Renal Transplant Recipients.|Completed||Phase 3|684||Novartis|||||||||||||||||||2017-02-18 17:02:29.045923|2017-02-18 17:02:29.045923
NCT00239850|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2015-02-05|||August 2005||2005-08-01|February 2015|2015-02-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Morbid Obesity: Effects of Conservative Treatments and Gastric Bypass Surgery|Morbid Obesity: Effects of Conservative Treatments and Gastric Bypass Surgery|Completed||N/A|240|Anticipated|Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 17:02:29.133155|2017-02-18 17:02:29.133155
NCT00239837|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2015-12-04|2013-05-06||December 2003||2003-12-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|December 2009|Actual|2009-12-01||Interventional|||Prevention Program for Problem Behaviors in Girls in Foster Care|Preventing Problems for Girls in Foster Care|Completed||Phase 1|100|Actual|Oregon Social Learning Center|Sample is relatively small in size, and limited to girls in foster care in two Oregon Counties|2|||f||||f||||||||||2017-02-18 17:02:29.243237|2017-02-18 17:02:29.243237
NCT00239824|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2016-07-15|||October 2005||2005-10-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Pelvic Floor Muscle Training to Treat Urinary Incontinence After Radical Prostatectomy|Urinary Incontinence After Radical Prostatectomy. - Effect of Pelvic Floor Muscle Training. A Randomised Controlled Trial|Completed||N/A|80|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:02:29.805962|2017-02-18 17:02:29.805962
NCT00239811|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-11-01|||April 2004||2004-04-01|November 2011|2011-11-01||||May 2006|Actual|2006-05-01||Interventional|||Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|A Two-year Extension to a One-year, Multicenter, Partially Blinded, Double Dummy, Randomized Study to Evaluate the Efficacy and Safety of FTY720 Combined With Reduced-dose or Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids Versus Mycophenolate Mofetil Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids, in de Novo Adult Renal Transplant Recipients|Completed||Phase 3|684||Novartis|||||f||||||||||||||2017-02-18 17:02:29.921916|2017-02-18 17:02:29.921916
NCT00239798|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-11-01|||November 2004||2004-11-01|November 2011|2011-11-01||||November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|A 24-month Extension of a One-year, Multicenter, Double Blinded Double Dummy, Randomized Study to Evaluate the Safety and Efficacy of Two Doses of FTY720 Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Steroids Versus Mycophenolate Mofetil Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Steroids, in Adult de Novo Renal Transplant Recipients|Completed||Phase 2|255||Novartis|||||||||||||||||||2017-02-18 17:02:30.001766|2017-02-18 17:02:30.001766
NCT00239785|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-11-01|||April 2003||2003-04-01|November 2011|2011-11-01||||April 2005|Actual|2005-04-01||Interventional|||Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients|A One-year, Multicenter, Partially Blinded, Double-dummy, Randomized Study to Evaluate the Efficacy and Safety of FTY720 Combined With Reduced-dose or Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids Versus Mycophenolate Mofetil Combined With Full-dose Cyclosporine, USP [Modified] (Novartis Brand) and Corticosteroids, in de Novo Adult Renal Transplant Recipients|Completed||Phase 3|684||Novartis|||||f||||||||||||||2017-02-18 17:02:30.081857|2017-02-18 17:02:30.081857
NCT00239772|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2014-06-04|||May 1994||1994-05-01|June 2014|2014-06-01||||||||Interventional|||Cognitive Processing Therapy Versus Prolonged Exposure for Treating Women With Post-Traumatic Stress Disorder Brought on by Sexual Assault|Cognitive Processes in PTSD: Treatment|Completed||N/A|120||University of Missouri, St. Louis|||||f||||||||||||||2017-02-18 17:02:30.159318|2017-02-18 17:02:30.159318
NCT00239759|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2009-02-24|||September 2002||2002-09-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|||||Observational|||MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology|Genetic Epidemiological Studies of Apolipoprotein E and Alzheimer's Disease|Completed||N/A|2000|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:02:30.256478|2017-02-18 17:02:30.256478
NCT00239746|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2009-04-28|||October 2005||2005-10-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|August 2009|Anticipated|2009-08-01||Interventional|||BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories|Biomarkers of Nonsteroidal Anti-Inflammatories|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 17:02:30.359073|2017-02-18 17:02:30.359073
NCT00239733|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2008-09-25|||March 2005||2005-03-01|September 2008|2008-09-01|March 2010|Anticipated|2010-03-01|March 2009|Anticipated|2009-03-01||Interventional|||Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection|The Safety and Efficacy of Intravenous Anti-D for the Treatment of Thrombocytopenia in Patients With HCV Infection Prior to or During Treatment With Pegylated-Interferon and Ribavirin|Unknown status|Recruiting|N/A|20|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:02:30.470218|2017-02-18 17:02:30.470218
NCT00239720|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2012-02-15|2012-02-15||March 2006||2006-03-01|February 2012|2012-02-01|June 2008|Actual|2008-06-01|December 2006|Actual|2006-12-01||Interventional|PART||hOKT3gamma1 (Ala-Ala) for the Treatment of Psoriatic Arthritis|Treatment of Psoriatic Arthritis With hOKT3gamma1 (Ala-Ala)|Terminated||Phase 2|4|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|This study was put on voluntary clinical hold after a serious adverse event occurred. After a review of the data, the team decided to close the study to further enrollment. Due to limited participants, no formal statistical analyses were performed|2||FDA Clinical Hold|f||||t||||||||||2017-02-18 17:02:30.589158|2017-02-18 17:02:30.589158
NCT00239694|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2015-07-14||2015-07-14|April 2001||2001-04-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||PPV: Pneumococcal Polysaccharide Vaccine in Older Adults|Immunogenicity of Pneumococcal Vaccination and Revaccination in Older Adults|Completed||Phase 4|100|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 17:02:31.22022|2017-02-18 17:02:31.22022
NCT00239681|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2014-02-06|2009-08-20||February 2003||2003-02-01|February 2014|2014-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events|A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase 3 Study of Rosuvastatin (CRESTOR®) 20 mg in the Prevention of Cardiovascular Events Among Subjects With Low Levels of Low Density Lipoprotein(LDL) Cholesterol & Elevated Levels of C-Reactive Protein|Terminated||Phase 3|17802|Actual|AstraZeneca||2||See detailed description for reason.|f||||t||||||||||2017-02-18 17:02:31.390245|2017-02-18 17:02:31.390245
NCT00239668|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2012-05-02|||March 2000||2000-03-01|May 2012|2012-05-01|January 2013|Anticipated|2013-01-01|January 2013|Anticipated|2013-01-01||Observational|||Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors|Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors|Unknown status|Recruiting|N/A|3000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||||||2017-02-18 17:02:38.498307|2017-02-18 17:02:38.498307
NCT00239655|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-07-29|||August 2004||2004-08-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)|A Randomized, Double-Blind Placebo Controlled, Parallel Groups Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by MRI|Terminated||Phase 2|120|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:02:38.590605|2017-02-18 17:02:38.590605
NCT00239642|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2012-10-22|2011-12-05||July 2005||2005-07-01|October 2012|2012-10-01|April 2010|Actual|2010-04-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Efficacy of Iron Sucrose in Children|Comparison of the Safety and Efficacy of Three Iron Sucrose Maintenance Regimens in Pediatric Chronic Kidney Disease (CKD) Patients|Completed||Phase 4|141|Actual|Luitpold Pharmaceuticals||3|||f||||||||||||||2017-02-18 17:02:38.683497|2017-02-18 17:02:38.683497
NCT00239629|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2007-06-11|||September 2005||2005-09-01|June 2007|2007-06-01|January 2007|Actual|2007-01-01|||||Interventional|||Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial|Differential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women With Osteoporosis|Completed||Phase 4|73||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:02:39.437914|2017-02-18 17:02:39.437914
NCT00239616|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-03-16|||June 2002||2002-06-01|March 2011|2011-03-01|November 2003||2003-11-01|||||Interventional|||Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin|Open-label Multicenter, Pharmacokinetic Study of a Single Dose of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin|Completed||Phase 4|8||Luitpold Pharmaceuticals|||||||||||||||||||2017-02-18 17:02:39.532694|2017-02-18 17:02:39.532694
NCT00239603|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2007-04-16|||October 2005||2005-10-01|April 2007|2007-04-01|June 2007||2007-06-01|||||Observational|||Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.|Clinical Investigation of the OV-Watch™ Personal Fertility Monitor for Women Undergoing Ovulation Induction With Clomiphene Citrate.|Completed||Phase 4|40||Emory University|||||f||||||||||||||2017-02-18 17:02:39.613621|2017-02-18 17:02:39.613621
NCT00239590|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2015-03-25|||June 2001||2001-06-01|October 2005|2005-10-01|April 2004||2004-04-01|||||Interventional|||Testosterone and Myocardial Perfusion in CHD|Effects of Chronic Testosterone on Myocardial Ischaemia and Endothelial Function in Men With Documented Coronary Heart Disease|Completed||Phase 2|||Imperial College London|||||f||||f||||||||||2017-02-18 17:02:39.698183|2017-02-18 17:02:39.698183
NCT00239577|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2008-10-09|||April 2006||2006-04-01|October 2008|2008-10-01||||June 2007|Actual|2007-06-01||Interventional|||A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults|Observer-Blind, Single Center, Controlled Study of 2 Doses of Various Formulations of the WRAIR Live Attenuated Tetravalent Dengue Vaccine Compared to a Placebo Control, Administered on a 0-6-Mth Schedule, to Healthy Adults|Completed||Phase 2|132||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:02:39.797756|2017-02-18 17:02:39.797756
NCT00239564|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2017-01-31|||October 2005||2005-10-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease|An Open-Label Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease|Completed||Phase 1/Phase 2|12|Actual|IMPAX Laboratories, Inc.||1|||f||||f|t|f||||||No||2017-02-18 17:02:39.903612|2017-02-18 17:02:39.903612
NCT00239551|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2013-07-29|||October 2005||2005-10-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|October 2006|Actual|2006-10-01||Interventional|||Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer|Effect of Prevacid on Prostaglandin Levels in the Gastric Mucosa of Patients With Stress Ulcer|Completed||Phase 4|30|Actual|Emory University||1|||f||||t||||||||||2017-02-18 17:02:40.022562|2017-02-18 17:02:40.022562
NCT00239538|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-11-07|||January 2003||2003-01-01|November 2013|2013-11-01|December 2004||2004-12-01|December 2004|Actual|2004-12-01||Interventional|||SMOOTH - Blood Pressure Control in Diabetic/Obese Patients|Prospective, Randomized, Open-label, Blinded Endpoint, Forced Titration Study to Compare Telmisartan Combined With HCTZ (80mg/12.5mg), to Valsartan Combined With HCTZ (160mg/12.5mg), for the Control of Mild-to-moderate Hypertension in Obese Patients With Type 2 Diabetes Mellitus Using ABPM.|Completed||Phase 4|840|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:40.142802|2017-02-18 17:02:40.142802
NCT00239525|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2014-04-09|||May 2006||2006-05-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|April 2007|Actual|2007-04-01||Interventional|Definity||3-D Transcranial Ultrasound Analysis Study|3-D Transcranial Ultrasound Analysis Using Definity Injectable Suspension|Completed||N/A|28|Actual|Duke University||1|||f||||t||||||||||2017-02-18 17:02:40.587474|2017-02-18 17:02:40.587474
NCT00239512|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2006-06-23|||March 2005||2005-03-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||New Management Strategy of PDA for VLBW Preterm Infants|New Management Strategy of PDA for VLBW Preterm--Comparison of Indomethacin and Ibuprofen|Terminated||N/A|60||China Medical University Hospital|||||f||||||||||||||2017-02-18 17:02:40.689125|2017-02-18 17:02:40.689125
NCT00239499|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-11-08|||September 2003||2003-09-01|November 2013|2013-11-01|August 2004||2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)|A Six-Week, Randomised, Double-Blind, Triple-Dummy, Parallel Group, Multiple Dose, Pilot Study Comparing Tiotropium Inhalation Capsules to Salmeterol Inhalation Aerosol Combined With Fluticasone Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 4|107||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:40.782693|2017-02-18 17:02:40.782693
NCT00239486|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-10-31|||October 2002||2002-10-01|October 2013|2013-10-01|April 2004||2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)|Evaluation of the Effect of Different Doses of Pramipexole on Subjective and Objective Symptoms of Idiopathic Restless Legs Syndrome (RLS).|Completed||Phase 2|109||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:40.881308|2017-02-18 17:02:40.881308
NCT00239473|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-10-31|||November 2002||2002-11-01|October 2013|2013-10-01||||December 2003|Actual|2003-12-01||Interventional|||12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD|A Randomised, Double-Blind, Double-Dummy, Placebo- and Active-Controlled, Parallel Group Efficacy and Safety Comparison of 12-Week Treatment of Two Doses [5 μg (2 Actuations of 2.5 μg) and 10 μg (2 Actuations of 5 μg)] of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler, Placebo and Ipratropium Bromide Inhalation Aerosol (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|429||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:40.961665|2017-02-18 17:02:40.961665
NCT00239460|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-10-31|||July 2003||2003-07-01|October 2013|2013-10-01||||March 2004|Actual|2004-03-01||Interventional|||Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD|Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With Chronic Obstructive Pulmonary Disease (a 12-week, Parallel Group, Randomized, Placebo-cotrolled, Double-blind Study).|Completed||Phase 3|196||Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:02:41.285673|2017-02-18 17:02:41.285673
NCT00239447|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-10-31|||November 2002||2002-11-01|October 2013|2013-10-01|April 2004||2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD|Efficacy and Safety Comparison of 4-week Treatment Periods of Two Doses [5 μg (2 Actuations of 2.5 μg) and 10 μg (2 Actuations of 5 μg)] of Tiotropium Inhalation Solution Delivered by the Respimat Inhaler, Tiotropium Inhalation Powder Capsule (18μg) Delivered by the HandiHaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|131||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:41.377704|2017-02-18 17:02:41.377704
NCT00239434|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2012-05-11|||June 2003||2003-06-01|May 2012|2012-05-01|March 2004||2004-03-01|||||Interventional|||A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)|Comparison of 18 mg of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20 mg, Four Times Daily) in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|200||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:41.475387|2017-02-18 17:02:41.475387
NCT00239421|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-10-31|||November 2003||2003-11-01|October 2013|2013-10-01|September 2004||2004-09-01|September 2004|Actual|2004-09-01||Interventional|||A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)|A Six-Week, Randomized, Double-Blind, Quadruple-Dummy Parallel Group Multiple Dose Study Comparing the Efficacy and Safety of Tiotropium Inhalation Capsules Plus Formoterol Inhalation Capsules to Salmeterol Inhalation Aerosol Plus Fluticasone Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|605||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:41.573392|2017-02-18 17:02:41.573392
NCT00239408|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2013-10-31|||December 2002||2002-12-01|October 2013|2013-10-01|April 2004||2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).|Spiriva Assessment of FEV1 - (SAFE-Portugal). The Effect of Inhaled Tiotropium Bromide (18 Mcg Once Daily) on the Change in FEV1 During Treatment in Patients With COPD. A Three-month Parallel Group, Double-blind, Randomised, Placebo-controlled Study.|Completed||Phase 4|311||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:41.909748|2017-02-18 17:02:41.909748
NCT00239395|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2013-10-31|||July 2004||2004-07-01|October 2013|2013-10-01|December 2004||2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis|A Randomised, Open-labelled Study to Compare the Efficacy and Safety of Meloxicam 7.5 mg IM Ampoules Once Daily and Meloxicam 7.5 mg Tablets Administered Orally Once Daily Over a Period of 7 Days in Patients With Osteoarthritis (OA)|Completed||Phase 3|168||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:42.049767|2017-02-18 17:02:42.049767
NCT00239382|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2012-05-11|||July 2004||2004-07-01|May 2012|2012-05-01|December 2004||2004-12-01|||||Interventional|||A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis|A Randomized, Open-labelled Study to Compare the Efficacy and Safety of Meloxicam 15 mg IM Ampoules Once Daily and Meloxicam 15 mg Tablets Administered Orally Once Daily Over a Period of 7 Days in Patients With RA.|Completed||Phase 3|150||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:42.152674|2017-02-18 17:02:42.152674
NCT00239369|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2013-10-31|||October 2005||2005-10-01|October 2013|2013-10-01|August 2006||2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5|A Prospective Randomised Study to Compare a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 25 mg With a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg in Patients With Uncontrolled Hypertension Who Fail to Respond Adequately to Treatment With a Fixed Dose Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg|Completed||Phase 3|713||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:02:42.260281|2017-02-18 17:02:42.260281
NCT00239356|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2014-12-04|2013-11-05||March 2003||2003-03-01|December 2014|2014-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||All treated participants.|Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials|Aripiprazole (BMS-337039) for Outpatients With Schizophrenia Completing Aripiprazole Clinical Trials: A Non-Comparative Rollover Protocol|Completed||Phase 3|119|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-02-18 17:02:42.455909|2017-02-18 17:02:42.455909
NCT00239343|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-14|2011-01-25|||October 2004||2004-10-01|January 2011|2011-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer|Randomised Placebo-controlled Phase II Trial of Preoperative Therapy With Gefitinib (Iressa®/ZD1839) and Epirubicin-Cyclophosphamide in Patients With Primary Operable (T2-T3) Oestrogen Receptor Negative Breast Cancer|Completed||Phase 2|160|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 17:02:43.438137|2017-02-18 17:02:43.438137
NCT00239330|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2010-11-18|||June 2003||2003-06-01|November 2010|2010-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy|An Open-label, Randomised, Multi-centre, Phase IIIb, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects With Type IIa and IIb Hypercholesterolaemia|Completed||Phase 3|824||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:43.529904|2017-02-18 17:02:43.529904
NCT00239317|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-10-18||||||October 2007|2007-10-01||||||||Interventional|||Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:02:43.646248|2017-02-18 17:02:43.646248
NCT00239304|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2007-12-14|||June 2003||2003-06-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer|A Phase I/II Trial of ZD1839 (Iressa) Given Concurrently With Cisplatin and Radiotherapy in Patients With Locally Advanced Head and Neck Cancer|Completed||Phase 1/Phase 2|40||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:43.731773|2017-02-18 17:02:43.731773
NCT00239291|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2009-04-22|||January 2003||2003-01-01|April 2009|2009-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer|A Phase I/II Study of ZD1839 (Iressa) Given Concurrently With Radiotherapy in Patients With Non-Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|42|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 17:02:43.8319|2017-02-18 17:02:43.8319
NCT00239278|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2011-01-21|||January 2001||2001-01-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|||||Interventional|||Budesonide / Formoterol in Treatment of Exacerbations of COPD|Effects of High Dose Inhaled Budesonide+ Formoterol Versus Placebo and Oral Prednisolone on Biomarkers of Airway Inflammation in the Treatment of Exacerbations in Non-hospitalised Patients With Mild to Moderate COPD.|Completed||Phase 2|120||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:43.908884|2017-02-18 17:02:43.908884
NCT00239265|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-18||||||October 2007|2007-10-01||||||||Interventional|||Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:02:44.004574|2017-02-18 17:02:44.004574
NCT00239252|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-08-25||||||August 2014|2014-08-01||||||||Interventional|||Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:02:44.086883|2017-02-18 17:02:44.086883
NCT00239239|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2010-03-04|||August 2005||2005-08-01|March 2010|2010-03-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies|An Open-label, Single-arm Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Darbepoetin Alfa Administered Three Times Per Week for the Treatment of Anemia in Subjects With Non-myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 2|44|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:02:44.364961|2017-02-18 17:02:44.364961
NCT00239226|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2013-09-20|2009-11-06||November 2005||2005-11-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|EPASS||Electrophysiologically Guided PAcing Site Selection Study|Investigational New Drug Application/ Investigational Device Exemption Information|Completed||Phase 4|102|Actual|Medtronic BRC||4|||f||||t||||||||||2017-02-18 17:02:44.468439|2017-02-18 17:02:44.468439
NCT00239213|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2006-10-28|||November 2005||2005-11-01|October 2006|2006-10-01|April 2006||2006-04-01|||||Interventional|||Catechin Gargling for Influenza Infection|A Randomized Clinical Study of Catechin Gargling Effects on the Prevention of Influenza Infection|Completed||N/A|400||University of Shizuoka|||||f||||||||||||||2017-02-18 17:02:45.097257|2017-02-18 17:02:45.097257
NCT00239200|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2008-07-28|||October 2005||2005-10-01|July 2008|2008-07-01|September 2007|Actual|2007-09-01|June 2006|Actual|2006-06-01||Interventional|||Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus|Lapatinib (GW572016) a Dual Inhibitor of EGFR and ErbB2, for Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus|Terminated||Phase 2|29|Anticipated|University of Michigan Cancer Center||||notification from sponsor|f||||||||||||||2017-02-18 17:02:45.198884|2017-02-18 17:02:45.198884
NCT00239187|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2008-07-17|||September 2005||2005-09-01|July 2006|2006-07-01|January 2007|Actual|2007-01-01|||||Interventional|||A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1|A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Response of Repeated Subcutaneous Doses of E1 in Combination With G1 in Patients With Type 2 Diabetes|Completed||Phase 1|30||Transition Therapeutics|||||||||||||||||||2017-02-18 17:02:45.281046|2017-02-18 17:02:45.281046
NCT00239174|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2008-12-09|||November 2004||2004-11-01|December 2008|2008-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study Evaluating the Efficacy and Safety of Four Doses of SR147778 in Obese Patients|Completed||Phase 2|394|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:02:45.385832|2017-02-18 17:02:45.385832
NCT00239161|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2005-10-12|||September 2004||2004-09-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin|TREATMENT OF ACUTE UNCOMPLICATED PYELONEPHRITIS WITH SHORT COURSE LEVOFLOXACIN A Pilot Study|Terminated||Phase 4|30||University of Manitoba|||||f||||||||||||||2017-02-18 17:02:45.479386|2017-02-18 17:02:45.479386
NCT00239148|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2009-05-25|||June 2005||2005-06-01|July 2006|2006-07-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1|A Randomized, Double-Blind, Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Effects of Repeated Subcutaneous Doses of E1 in Combination With G1 in Type 1 Diabetes|Completed||Phase 1|20||Transition Therapeutics|||||||||||||||||||2017-02-18 17:02:45.573191|2017-02-18 17:02:45.573191
NCT00239135|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2015-03-24|||September 2005||2005-09-01|March 2015|2015-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel|An Open-label, Dose Escalation, Cohort Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel When Applied on Day 1 and Day 2 to Actinic Keratoses on the Shoulders, Chest, Back or Arms Followed by a Post-Treatment Follow-up Period Lasting at Four Weeks|Completed||Phase 2|34||Peplin|||||||||||||||||||2017-02-18 17:02:45.671561|2017-02-18 17:02:45.671561
NCT00239122|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2005-10-12|||June 2000||2000-06-01|October 2005|2005-10-01|February 2004||2004-02-01|||||Interventional|||Recovery Therapy Trial|Applicability of CBT to Unselected Mental Health Service Clients With Psychotic Disorders|Completed||N/A|94||Melbourne Health|||||f||||||||||||||2017-02-18 17:02:45.770507|2017-02-18 17:02:45.770507
NCT00239109|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2008-03-17|||April 2003||2003-04-01|March 2008|2008-03-01|February 2007||2007-02-01|||||Interventional|||Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.|Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia: A Six Months, Double Blind Randomized, Parallel Group Study.|Completed||Phase 4|112||Pfizer|||||f||||||||||||||2017-02-18 17:02:45.870941|2017-02-18 17:02:45.870941
NCT00239096|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2005-10-13|||September 2005||2005-09-01|October 2005|2005-10-01|September 2011||2011-09-01|||||Interventional|||Prevention of Decompensation in Liver Cirrhosis|Losartan in the Prevention of Sodium Retention and Ascites in Liver Cirrhosis – a Prospective Randomized Long-Term Study|Unknown status|Recruiting|Phase 4|100||Odense University Hospital|||||f||||||||||||||2017-02-18 17:02:45.972162|2017-02-18 17:02:45.972162
NCT00239083|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2009-10-30|||January 2005||2005-01-01|October 2009|2009-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients|Phase IV Study of Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Kidney Transplant Patients|Completed||Phase 4|40|Anticipated|Novartis||1|||f||||||||||||||2017-02-18 17:02:46.07481|2017-02-18 17:02:46.07481
NCT00239070|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-01-28|||April 2003||2003-04-01|January 2011|2011-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients|A Prospective, Open-label, Multicenter, International Follow-up Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients|Completed||Phase 3|69|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:46.173662|2017-02-18 17:02:46.173662
NCT00239057|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-01-28|||May 2002||2002-05-01|January 2011|2011-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,|Enteric-Coated Mycophenolate Sodium (EC-MPS) Administration in Maintenance Renal Transplant Patients Receiving Cyclosporine Microemulsion (CsA-ME) and Steroids, for the Withdrawal of Concomitant Steroid Therapy: a Prospective, Open-label, Exploratory Study|Completed||Phase 3|23|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:46.257378|2017-02-18 17:02:46.257378
NCT00239044|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-11-01|||December 2002||2002-12-01|November 2011|2011-11-01||||July 2005|Actual|2005-07-01||Interventional|||An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients|An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients|Completed||Phase 3|40||Novartis|||||f||||||||||||||2017-02-18 17:02:46.335587|2017-02-18 17:02:46.335587
NCT00239031|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-01-28|||March 2002||2002-03-01|January 2011|2011-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids|Multicentre, Controlled, Prospective, Randomized, Open-label Clinical Trial to Compare Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced Dose Cyclosporine Microemulsion (CsA-ME) Vs EC-MPS Plus Standard Dose CsA-ME in Elderly de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids|Completed||Phase 3|117|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:02:46.414534|2017-02-18 17:02:46.414534
NCT00239018|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-01-28|||April 2003||2003-04-01|January 2011|2011-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients|A Prospective, Open-label, Multicenter, Follow-up Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients|Completed||Phase 4|144|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:46.502877|2017-02-18 17:02:46.502877
NCT00239005|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-02-23|2010-12-08||September 2005||2005-09-01|February 2011|2011-02-01||||March 2008|Actual|2008-03-01||Interventional|||Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation|A Study of the Effect of Conversion to Enteric-Coated Mycophenolate Sodium (EC-MPS) on Quality of Life in Patients With Gastrointestinal (GI) Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation (MYQOL)|Completed||Phase 4|134|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:02:46.582023|2017-02-18 17:02:46.582023
NCT00238992|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-11-01|||December 2002||2002-12-01|November 2011|2011-11-01||||July 2005|Actual|2005-07-01||Interventional|||Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.|A Prospective, Randomized, Open Label, Multicenter Trial of EC-MPS With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen for the Prevention of Acute Rejection Episodes in de Novo Renal Transplant Recipients.|Completed||Phase 3|144||Novartis|||||f||||||||||||||2017-02-18 17:02:47.09449|2017-02-18 17:02:47.09449
NCT00238979|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-11-01|||January 2003||2003-01-01|November 2011|2011-11-01||||February 2005|Actual|2005-02-01||Interventional|||A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)|A 6-month, 1-arm, Open-label Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)|Completed||Phase 4|50||Novartis|||||f||||||||||||||2017-02-18 17:02:47.173077|2017-02-18 17:02:47.173077
NCT00238966|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-01-28|||November 2002||2002-11-01|January 2011|2011-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil|A One Arm, Open-label Study to Investigate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Recipients Who Received Mycophenolate Mofetil (MMF)|Completed||Phase 4|187|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:47.256706|2017-02-18 17:02:47.256706
NCT00238953|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2009-10-30|||February 2005||2005-02-01|October 2009|2009-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients|A Prospective, Open Label Protocol to Assess the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients|Completed||Phase 4|30|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:02:47.33427|2017-02-18 17:02:47.33427
NCT00238940|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-01-28|||February 2003||2003-02-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants|A One-year, Randomized, Open Label, Parallel Group Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Either Full Dose or Reduced Dose Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients|Completed||Phase 3|55|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:47.428334|2017-02-18 17:02:47.428334
NCT00238927|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2014-03-25|||November 1999||1999-11-01|March 2014|2014-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma|Multicenter Randomised Controlled Trial of Episodic Fluticasone Versus Placebo in Viral-induced Asthma in Children|Completed||Phase 4|150||McGill University Health Center|||||f||||f||||||||||2017-02-18 17:02:47.509313|2017-02-18 17:02:47.509313
NCT00238914|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2012-01-12|||August 1999||1999-08-01|January 2012|2012-01-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1|Opiate Dependence: Combined Naltrexone/Behavior Therapy|Completed||Phase 2|12|Actual|New York State Psychiatric Institute||2|||t||||t||||||||||2017-02-18 17:02:47.621809|2017-02-18 17:02:47.621809
NCT00238901|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2010-08-31|||December 2002||2002-12-01|August 2010|2010-08-01||||July 2005|Actual|2005-07-01||Interventional|||Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation|Efficacy and Safety of Basiliximab in HCV+ Patients Undergoing Liver Transplantation, as Compared With Steroids, Both Given in Combination With Cyclosporine and Mycophenolate Mofetil (MMF)|Completed||Phase 3|194|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:02:47.732578|2017-02-18 17:02:47.732578
NCT00238888|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2010-11-26|||August 2002||2002-08-01|November 2010|2010-11-01||||April 2006|Actual|2006-04-01||Interventional|||Randomised Controlled Trial of a Multi-faceted Community-based Intervention to Improve Asthma in Children|Randomised Controlled Trial of a Multi-faceted Community-based Intervention to Improve Pediatric Morbidity: a PRIISME Project (Program to Integrate Information Service and Manage Education)|Completed||N/A|298|Actual|McGill University Health Center|||||f||||||||||||||2017-02-18 17:02:47.808801|2017-02-18 17:02:47.808801
NCT00238875|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-13|2016-09-21|||July 2004||2004-07-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)|A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)|Completed||Phase 2|167|Actual|Japan Clinical Oncology Group||1|||f||||t||||||||||2017-02-18 17:02:47.900957|2017-02-18 17:02:47.900957
NCT00238862|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2007-03-05|||October 2005||2005-10-01|March 2007|2007-03-01|September 2006||2006-09-01|||||Interventional|||Treatment of PED With AMT and Autologous Serum|Efficacy of Amniotic Membrane Transplantation and Autologous Serum in Treatment of Persistent Epithelial Defects|Completed||N/A|180||King Khaled Eye Specialist Hospital|||||f||||t||||||||||2017-02-18 17:02:48.22327|2017-02-18 17:02:48.22327
NCT00238849|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2005-10-13||||||October 2005|2005-10-01||||||||Interventional|||Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.|Phase II Study of Oxaliplatin in Combination With Navelbine for the Second-Line Treatment of Advanced and Metastatic Non-Small Cell Lung Cancer|Unknown status|Not yet recruiting|Phase 2|40||Integrated Community Oncology Network|||||f||||||||||||||2017-02-18 17:02:48.307773|2017-02-18 17:02:48.307773
NCT00238836|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2006-10-12||||||June 2005|2005-06-01|March 2006||2006-03-01|||||Interventional|||Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health Networks||Unknown status|Active, not recruiting|Phase 2/Phase 3|240||C. T. Lamont Primary Care Research Centre|||||f||||||||||||||2017-02-18 17:02:48.405806|2017-02-18 17:02:48.405806
NCT00238823|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2007-05-22|||January 2004||2004-01-01|May 2007|2007-05-01|December 2004||2004-12-01|||||Observational|||Cryoablation Versus Radiofrequency Ablation|A Review and Comparison of Cryoablation and Radiofrequency Ablation in Children|Terminated||N/A|50||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 17:02:48.487115|2017-02-18 17:02:48.487115
NCT00238810|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2014-11-26|||April 2005||2005-04-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome|Retrospective Evaluation of Serum B-type Natriuretic Peptide Hormone Levels in Post-operative Patients and the Relationship of BNP Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome|Completed||N/A|20|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 17:02:48.55848|2017-02-18 17:02:48.55848
NCT00238797|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-01-20|||February 2003||2003-02-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|||||Interventional|||A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme|A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa™) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme|Completed||Phase 2|36||AstraZeneca|||||f||||||||||||||2017-02-18 17:02:48.65002|2017-02-18 17:02:48.65002
NCT00238784|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2008-01-11|||May 2004||2004-05-01|January 2008|2008-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults|A Comparison of Symbicort® Single Inhaler Therapy (Symbicort® 200 Turbuhaler® 1 Inhalation b.i.d. Plus as Needed) & Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents & Adults-a 26-Week, Randomised, Open-Label, Parallel Group, Multicentre Study|Completed||Phase 3|1300||AstraZeneca|||||||||||||||||||2017-02-18 17:02:48.744079|2017-02-18 17:02:48.744079
NCT00238758|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2006-09-11|||October 2005||2005-10-01|September 2006|2006-09-01||||||||Interventional|||A Study of Omega-3 as a Treatment for Major Depression|A Randomised, Double-Blind, Placebo Controlled Trial of Omega-3 Polyunsaturated Fatty Acids as a Monotherapy for Major Depression|Unknown status|Recruiting|Phase 2|128||The University of New South Wales|||||f||||||||||||||2017-02-18 17:02:48.836881|2017-02-18 17:02:48.836881
NCT00238745|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2007-12-17|||August 2003||2003-08-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.|Bone Mineral Density Increase and Safety of TSE-424 Compared to Placebo in Osteoporotic Postmenopausal Women|Completed||Phase 2|375||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:02:48.936906|2017-02-18 17:02:48.936906
NCT00238732|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2007-12-19|||October 2005||2005-10-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause|A Double-Blind, Randomized, Placebo-and Active-Controlled Efficacy and Safety Study of Bazedoxifene/Conjugated Estrogens Combinations for Treatment of Moderate to Severe Vulvar/Vaginal Atrophy in Postmenopausal Women|Completed||Phase 3|650||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:02:49.022915|2017-02-18 17:02:49.022915
NCT00238719|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2006-05-17|||December 1999||1999-12-01|May 2006|2006-05-01|June 2003||2003-06-01|||||Interventional|||Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder|A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine ER In Children and Adolescent Outpatients With Social Anxiety Disorder|Completed||Phase 3|293||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:02:49.168006|2017-02-18 17:02:49.168006
NCT00238706|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2006-05-04|||December 2001||2001-12-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Interventional|||Use of Radiofrequency Ablation to Eliminate Continuous Atrial Fibrillation in Patients Undergoing Mitral Valve Surgery|Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation: A Prospective Randomized Clinical Trial|Completed||N/A|||University Hospitals, Leicester|||||f||||||||||||||2017-02-18 17:02:49.24739|2017-02-18 17:02:49.24739
NCT00238693|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2016-07-20|||April 2003||2003-04-01|July 2016|2016-07-01|January 2025|Anticipated|2025-01-01|January 2025|Anticipated|2025-01-01||Observational|||Transplant Patient Registry of Liver, Kidney and/or Pancreas|Transplant Registry: Patients Who May Require Transplantation and Those Who Have Undergone Transplantation of Liver, Kidney and/or Pancreas|Recruiting||N/A|15000|Anticipated|Virginia Commonwealth University|||1||f||||f||||||||||2017-02-18 17:02:49.331641|2017-02-18 17:02:49.331641
NCT00238680|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2008-06-13|||March 2005||2005-03-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|September 2006|Actual|2006-09-01||Interventional|||Programmable Timer in the Bladder Rehabilitation Treatment of OAB|The Effect of Programmable Timer in Bladder Rehabilitation Treatment of Idiopathic Overactive Bladder in Children|Completed||N/A|100||University of Aarhus|||||f||||||||||||||2017-02-18 17:02:49.427484|2017-02-18 17:02:49.427484
NCT00238667|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2015-05-19|||November 2005||2005-11-01|September 2005|2005-09-01|May 2014|Actual|2014-05-01|||||Interventional|CADISS||To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection|Cervical Artery Dissection in Stroke Study|Completed||Phase 3|250|Actual|St George's, University of London||2|||f||||||||||||||2017-02-18 17:02:49.525759|2017-02-18 17:02:49.525759
NCT00238654|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-04-08|||May 2003||2003-05-01|April 2011|2011-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy|"A Multicenter, Open-Label, Two-Arm Prospective Study to Evaluate the Impact of Patient Readiness to Self-Inject on Outcomes When Using the Copaxone® Prefilled Syringes [The READY Trial]"|Completed||Phase 4|257|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-02-18 17:02:49.639101|2017-02-18 17:02:49.639101
NCT00238641|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2005-10-11|||January 2002||2002-01-01|October 2005|2005-10-01|May 2005||2005-05-01|||||Interventional|||“DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?”|“DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?”|Completed||Phase 1/Phase 2|10||Stanford University|||||f||||||||||||||2017-02-18 17:02:49.717343|2017-02-18 17:02:49.717343
NCT00238628|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2010-07-16|||April 2004||2004-04-01|July 2010|2010-07-01|December 2005|Actual|2005-12-01|April 2005|Actual|2005-04-01||Interventional|||A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer|A Phase I/II Study of Bexarotene in Combination With ZD 1839 (IRESSA) in the Third Line Treatment of Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|12|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:02:49.805834|2017-02-18 17:02:49.805834
NCT00238615|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2015-04-21|2012-09-24||March 2003||2003-03-01|April 2015|2015-04-01|November 2014|Actual|2014-11-01|September 2009|Actual|2009-09-01||Interventional|||Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC|A Phase II Trial of Concurrent Docetaxel (Taxotere) / Carboplatin / Radiotherapy Followed by Surgical Resection Followed by Consolidation Taxotere / Carboplatin in Stage III Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|13|Actual|Stanford University|Accrual was very slow. The study was halted with accrual of only 13 patients. These results were published.|1||low accrual|f||||t||||||||||2017-02-18 17:02:49.896691|2017-02-18 17:02:49.896691
NCT00238602|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2012-07-12|||March 2000||2000-03-01|July 2012|2012-07-01|June 2012|Actual|2012-06-01|June 2007|Actual|2007-06-01||Interventional|||Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer|Evaluation of the Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Tumors - A Phase I/II Study|Completed||Phase 1/Phase 2|48|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:02:50.198183|2017-02-18 17:02:50.198183
NCT00238576|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2016-04-19|||May 2008||2008-05-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Observational|||Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age|Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age|Completed||N/A|30|Actual|Stanford University|||1||f||||||||||||||2017-02-18 17:02:50.280349|2017-02-18 17:02:50.280349
NCT00238563|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2008-02-22||||||August 2007|2007-08-01||||||||Interventional|||Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery|Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery|Unknown status|Recruiting|N/A|200||Stanford University|||||f||||||||||||||2017-02-18 17:02:50.362756|2017-02-18 17:02:50.362756
NCT00005431|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1994||1994-09-01|April 2001|2001-04-01|February 1996|Actual|1996-02-01|||||Observational|||Coronary Heart Disease Risk Factors in Blacks Vs Whites||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.262314|2017-02-18 18:15:00.262314
NCT00238550|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-07-19|||October 2003||2003-10-01|October 2005|2005-10-01|March 2006||2006-03-01|||||Interventional|||Study of CBME in the Relief of Painful Diabetic Neuropathy|Randomised Control Trial Studying the Addition of CBME to Conventional Treatment for the Relief of Painful Diabetic Neuropathy|Completed||Phase 2|36|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:02:50.444796|2017-02-18 17:02:50.444796
NCT00238537|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2013-05-28|||August 2001||2001-08-01|May 2009|2009-05-01|April 2007||2007-04-01|||||Interventional|||Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)|Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) in Acute Stroke|Completed||Phase 2|100||Melbourne Health|||||f||||||||||||||2017-02-18 17:02:50.535445|2017-02-18 17:02:50.535445
NCT00238524|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2014-09-19|||December 2003||2003-12-01|April 2010|2010-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy|A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 400mg/Day and 600mg/Day SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy|Completed||Phase 3|357|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:02:50.644102|2017-02-18 17:02:50.644102
NCT00238511|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2014-09-19|||November 2002||2002-11-01|September 2009|2009-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)|An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)|Completed||Phase 2|||UCB Pharma|||||f||||||||||||||2017-02-18 17:02:50.751838|2017-02-18 17:02:50.751838
NCT00238498|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2012-04-30|||July 2004||2004-07-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes|A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes|Completed||Phase 2|291|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:50.829987|2017-02-18 17:02:50.829987
NCT00238485|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-11-22|||January 2005||2005-01-01|November 2011|2011-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder|A 52-week, Open Label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750 - 2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder.|Completed||Phase 3|251|Actual|Novartis|||||f||||||||||||||2017-02-18 17:02:50.904096|2017-02-18 17:02:50.904096
NCT00238472|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2012-04-25|||May 2003||2003-05-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion|A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion|Completed||Phase 4|24||Novartis|||||||||||||||||||2017-02-18 17:02:50.979736|2017-02-18 17:02:50.979736
NCT00238459|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2013-11-19|||July 2005||2005-07-01|November 2013|2013-11-01|October 2013|Actual|2013-10-01|March 2011|Actual|2011-03-01||Observational|||Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised|Immunopathogenesis of Acute and Early HIV Infection and the Role of HIV-Specific CD4 T Cell Responses and the Effect of Their Enhancement by Potent Antiretroviral Drugs and an HIV Vaccine Adequate Vaccine Was Not Provided.|Completed||Phase 1|58|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||t||||||Samples Without DNA|"~     Sequential samples from patients with acute and recent HIV infection~   "|||2017-02-18 17:02:51.060059|2017-02-18 17:02:51.060059
NCT00238446|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2011-11-01|||April 2003||2003-04-01|November 2011|2011-11-01||||June 2006|Actual|2006-06-01||Interventional|||Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients|A Prospective, Open-label, Multicenter Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Heart Transplant Recipients|Completed||Phase 3|||Novartis|||||||||||||||||||2017-02-18 17:02:51.192967|2017-02-18 17:02:51.192967
NCT00238433|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2017-01-06||2016-11-28|March 2005||2005-03-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2015|Actual|2015-08-01||Interventional|||Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma|A Phase II Study to Evaluate the Safety and Efficacy of IV Busulfan, Melphalan, and Thiotepa (BuMelTT) Followed By Autologous PBSC Infusion for Patients With Hodgkin's Disease and Non-Hodgkin's Lymphoma|Completed||Phase 2|37|Actual|OHSU Knight Cancer Institute||1|||f||||||||||||||2017-02-18 17:02:51.388667|2017-02-18 17:02:51.388667
NCT00238420|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2016-04-15|2015-12-10||July 2005||2005-07-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|October 2013|Actual|2013-10-01||Interventional||Eligible patients who started protocol treatment.|Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer|A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer|Completed||Phase 1/Phase 2|70|Actual|National Cancer Institute (NCI)|Accrual of patients with her2/neu overexpression stopped early due to unmet targeted accrual goals, with 22 subject accrued out of 40 planned.|2|||f||||||||||||||2017-02-18 17:02:51.522364|2017-02-18 17:02:51.522364
NCT00238407|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2012-06-04|||March 2004||2004-03-01|June 2012|2012-06-01|August 2010|Actual|2010-08-01|February 2008|Actual|2008-02-01||Interventional|||Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery|Docetaxel and Cisplatin Chemotherapy Followed by Radiochemotherapy in Patients With Inoperable, Locally Advanced Esophageal Cancer, A Multicenter Phase II Trial|Completed||Phase 2|21|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 17:02:52.442695|2017-02-18 17:02:52.442695
NCT00238394|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2013-06-04|||December 2005||2005-12-01|June 2013|2013-06-01||||March 2007|Actual|2007-03-01||Interventional|||Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer|A Phase II Study of AZD2171 in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:02:52.570515|2017-02-18 17:02:52.570515
NCT00238199|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2015-04-22|||June 2002||2002-06-01|April 2015|2015-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer|Phase II Study of Calcitriol-Enhanced Docetaxel in Patients With Previously Untreated Metastatic or Locally Advanced Pancreatic Cancer|Completed||Phase 2|25|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 17:02:59.597988|2017-02-18 17:02:59.597988
NCT00238381|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2016-08-11|||July 2005||2005-07-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|May 2014|Actual|2014-05-01||Interventional|||Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer|Clinical Function After Total Mesorectal Excision and Rectal Replacement. A Prospective Randomized Trial Comparing Side-to-End Anastomosis, Colon-J-Pouch and Straight Coloanal Anastomosis|Completed||Phase 3|336|Actual|Swiss Group for Clinical Cancer Research||3|||f||||t||||||||||2017-02-18 17:02:52.679794|2017-02-18 17:02:52.679794
NCT00238368|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2014-04-16|||February 2004||2004-02-01|April 2014|2014-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant|Autologous Blood or Marrow Transplantation for Aggressive Non-Hodgkin's Lymphoma Based on Early [18F] FDG-PET Scanning|Completed||Phase 2|59|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:02:52.811698|2017-02-18 17:02:52.811698
NCT00238355|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-12-12|2011-11-07||August 2003||2003-08-01|December 2011|2011-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems|Phase II Trial of Voriconazole Plus Caspofungin for the Initial Treatment of Invasive Fungal Infections|Terminated||Phase 2|13|Actual|OHSU Knight Cancer Institute||1||competing study at site|f||||t||||||||||2017-02-18 17:02:52.925465|2017-02-18 17:02:52.925465
NCT00238342|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2010-02-06|||October 2005||2005-10-01|April 2007|2007-04-01||||October 2007|Anticipated|2007-10-01||Interventional|||Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass|Pelvic Mass Study to Develop Serum Proteomic Profiles (SIGNATURES) for Epithelial Ovarian Cancer Diagnosis and Prognosis|Unknown status|Active, not recruiting|N/A|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:02:53.166766|2017-02-18 17:02:53.166766
NCT00238329|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2013-04-05|||January 2001||2001-01-01|April 2013|2013-04-01|June 2007||2007-06-01|December 2005|Actual|2005-12-01||Interventional|||PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma|Phase II Study of Pegylated Interferon and Thalidomide in Pretreated Metastatic Malignant Melanoma|Completed||Phase 2|32|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 17:02:53.473395|2017-02-18 17:02:53.473395
NCT00238316|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2013-05-30|||December 2000||2000-12-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|April 2006|Actual|2006-04-01||Interventional|||Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density|A Randomized Feasibility Study of Letrozole in Postmenopausal Women at Increased Risk for Development of Breast Cancer as Evidenced by High Breast Density|Completed||Phase 2|68|Actual|Canadian Cancer Trials Group||2|||f||||||||||||||2017-02-18 17:02:53.575593|2017-02-18 17:02:53.575593
NCT00238303|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2014-05-07|2012-12-11||September 2005||2005-09-01|October 2011|2011-10-01|March 2010|Actual|2010-03-01|July 2008|Actual|2008-07-01||Interventional|||Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme|Phase II Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Recurrent Glioblastoma|Completed||Phase 2|103|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:02:53.697165|2017-02-18 17:02:53.697165
NCT00238290|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2012-06-04|||May 2005||2005-05-01|June 2012|2012-06-01|April 2011|Actual|2011-04-01|January 2010|Actual|2010-01-01||Interventional|||Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer|Trastuzumab Monotherapy Followed By the Combination of Trastuzumab and Letrozole in Post-Menopausal Women With ER-Positive, HER-2 Positive Advanced Breast Cancer Resistant to a Nonsteroidal Aromatase Inhibitor: A Multicenter Two-Step Phase II Trial|Completed||Phase 2|13|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 17:02:54.524461|2017-02-18 17:02:54.524461
NCT00238277|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2008-01-30|||March 2005||2005-03-01|December 2007|2007-12-01||||December 2007|Actual|2007-12-01||Interventional|||Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme|Phase II Study of Temozolomide and Radiation in Newly Diagnosed GBM Patients After Resection and Insertion of Gliadel® Wafers|Terminated||Phase 2|72||National Cancer Institute (NCI)||||Withdrawn - due to lack of accrual|f||||||||||||||2017-02-18 17:02:54.646515|2017-02-18 17:02:54.646515
NCT00238264|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2016-11-23|||November 2006||2006-11-01|November 2016|2016-11-01||||December 2013|Actual|2013-12-01||Interventional|||Radiation Therapy in Treating Young Patients With Gliomas|A Phase II Study of Conformal Radiotherapy In Patients With Low-Grade Gliomas|Active, not recruiting||Phase 2|92|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:02:54.73972|2017-02-18 17:02:54.73972
NCT00238251|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2012-06-04|||May 2005||2005-05-01|June 2012|2012-06-01|November 2010|Actual|2010-11-01|April 2009|Actual|2009-04-01||Interventional|||Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases|Whole Brain Radiotherapy in Combination With Gefitinib (Iressa) or Temozolomide (Temodal) for Brain Metastases From Non-Small Lung Cancer (NSCLC) A Randomized Phase II Trial|Completed||Phase 2|59|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 17:02:57.77189|2017-02-18 17:02:57.77189
NCT00238238|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2016-12-15|2016-12-15||March 2006||2006-03-01|December 2016|2016-12-01|August 2015|Actual|2015-08-01|June 2012|Actual|2012-06-01||Interventional||Three participants assigned to the lenalidomide arm alone arm never began treatment, and the rituximab arm was discontinued early.|Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab|A Randomized Phase II Trial of Rituximab Versus Lenalidomide (REVLIMID™, Cc-5013) (IND#73034) Versus Rituximab + Lenalidomide in Recurrent Follicular Non-Hodgkin Lymphoma (NHL) That is Not Rituximab-Refractory|Completed||Phase 2|180|Actual|Alliance for Clinical Trials in Oncology||3|||f||||f||||||||||2017-02-18 17:02:57.907575|2017-02-18 17:02:57.907575
NCT00238225|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2013-01-30|||November 2004||2004-11-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Oral Calcitriol in Combination With Ketoconazole in Refractory Advanced Malignancies|Completed||Phase 1|15|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 17:02:59.39658|2017-02-18 17:02:59.39658
NCT00238212|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2013-01-11|||October 2005||2005-10-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma|Phase II Study of BAY 43-9006 (NSC #724772) as Single Agent in Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:02:59.486794|2017-02-18 17:02:59.486794
NCT00238173|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-09-22|||December 2004||2004-12-01|March 2011|2011-03-01||||February 2006|Actual|2006-02-01||Interventional|||Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors|Phase I Dose Escalation Study of N-Acetylcysteine Administered in Conjunction With Carboplatin, Cyclophosphamide, and Etoposide Phosphate BBBD, in Children With Malignant Brain Tumors|Suspended||Phase 1|30|Anticipated|OHSU Knight Cancer Institute||||OHSU IRB closed study to further enrollment 2/17/2006|f||||t||||||||||2017-02-18 17:02:59.933833|2017-02-18 17:02:59.933833
NCT00238160|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2013-05-29||||||July 2006|2006-07-01||||||||Interventional|||Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer|Phase III Randomized Study of Surgical Resection With Versus Without Postoperative Hepatic Arterial Chemotherapy in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus|Withdrawn||Phase 3|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:03:00.050466|2017-02-18 17:03:00.050466
NCT00238147|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2013-05-15|||September 2004||2004-09-01|May 2013|2013-05-01|August 2008|Actual|2008-08-01|||||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer|Phase I Trial With Weekly Docetaxel, Capecitabine and Carboplatin as Induction Chemotherapy Followed by Concomitant Capecitabine and Radiotherapy in Patients With Locally Advanced Esophageal Cancer|Completed||Phase 1|18|Anticipated|University of Washington|||||f||||||||||||||2017-02-18 17:03:00.15498|2017-02-18 17:03:00.15498
NCT00238121|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2015-11-17|2013-12-23||February 2005||2005-02-01|January 2014|2014-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer|A Phase II Study of BAY 43-9006 in Advanced/Recurrent Uterine Carcinoma/Carcinosarcoma|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:03:00.268276|2017-02-18 17:03:00.268276
NCT00238108|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2012-08-24|2012-06-18||October 2005||2005-10-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Melatonin Supplements for Improving Sleep in Individuals With Hypertension|Melatonin Supplementation in Hypertensive Patients|Completed||Phase 2|16|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 17:03:00.90457|2017-02-18 17:03:00.90457
NCT00238082|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2014-09-24|||November 1999||1999-11-01|September 2014|2014-09-01|February 2005||2005-02-01|||||Interventional|||The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease|The Effect of HFA-beclomethasone Dipropionate on Static Lung Volumes in COPD|Terminated||N/A|20||National Jewish Health|||||f||||||||||||||2017-02-18 17:03:01.504187|2017-02-18 17:03:01.504187
NCT00238069|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2014-09-24|||December 2004||2004-12-01|September 2014|2014-09-01|August 2005||2005-08-01|||||Interventional|||Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep Apnea|Effect of CPAP (Continuous Positive Airway Pressure) on Airway Inflammation in Asthmatics With Sleep-Disordered Breathing: A Pilot Study|Completed||N/A|20||National Jewish Health|||||f||||||||||||||2017-02-18 17:03:01.60519|2017-02-18 17:03:01.60519
NCT00238056|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2015-01-26||||||October 2005|2005-10-01||||||||Interventional|||Effect of Domperidone on QT Interval in Premature Infants|Effect of Domperidone on QT Interval in Premature Infants|Completed||Phase 2|||Nantes University Hospital|||||f||||||||||||||2017-02-18 17:03:01.694581|2017-02-18 17:03:01.694581
NCT00238043|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2008-06-12|||August 2005||2005-08-01|October 2005|2005-10-01|April 2011|Anticipated|2011-04-01|||||Interventional|||Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia||Unknown status|Active, not recruiting|Phase 3|2000|Anticipated|Ministry of Health, Malaysia|||||f||||f||||||||||2017-02-18 17:03:01.780365|2017-02-18 17:03:01.780365
NCT00238030|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2011-01-04|||December 2004||2004-12-01|January 2011|2011-01-01|October 2010|Actual|2010-10-01|May 2009|Actual|2009-05-01||Interventional|||Thyroxine Replacement in Organ Donors|Efficacy and Pharmacokinetics of Oral Thyroid Replacement Therapy in Organ Donors|Completed||Phase 1/Phase 2|34|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 17:03:01.912001|2017-02-18 17:03:01.912001
NCT00238017|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2006-02-01|||October 2005||2005-10-01|July 2005|2005-07-01|December 2005||2005-12-01|||||Interventional|||Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate|A Randomized, Double Blind Trial on the Efficacy and Safety of Amodiaquine-Artesunate and Amodiaquine Alone in the Treatment of Children With Uncomplicated Falciparum Malaria|Unknown status|Active, not recruiting|Phase 4|400||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:03:02.033383|2017-02-18 17:03:02.033383
NCT00238004|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2006-09-11|||November 2005||2005-11-01|September 2006|2006-09-01||||||||Interventional|||The Low HDL On Six Weeks Statin Therapy (LOW) Study|The Low HDL On Six Weeks Statin Therapy (LOW) Study|Unknown status|Active, not recruiting|Phase 4|60||Craigavon Area Hospital|||||f||||||||||||||2017-02-18 17:03:02.147754|2017-02-18 17:03:02.147754
NCT00237991|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2008-10-15|||June 2005||2005-06-01|October 2008|2008-10-01||||||||Observational|||Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population|A Multicentric, Post-Marketing Surveillance to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals Hepatitis A Vaccine Administered in Korean Population.|Completed||N/A|600||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:03:02.248731|2017-02-18 17:03:02.248731
NCT00237978|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2009-05-13|||September 2006||2006-09-01|May 2008|2008-05-01|September 2009|Anticipated|2009-09-01|June 2009|Anticipated|2009-06-01||Interventional|||Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)|Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)|Unknown status|Recruiting|Phase 4|60|Anticipated|Technische Universität Dresden||3|||f||||f||||||||||2017-02-18 17:03:02.329139|2017-02-18 17:03:02.329139
NCT00237965|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2005-10-11||||||May 2004|2004-05-01||||||||Interventional|||The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy|The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy|Completed||N/A|||Brown University|||||f||||||||||||||2017-02-18 17:03:02.42194|2017-02-18 17:03:02.42194
NCT00237952|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2009-06-21|||August 2005||2005-08-01|June 2009|2009-06-01||||||||Interventional|||Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy|Environmental Lead Exposure and Progressive Renal Insufficiency in Patients With Type II Diabetes and Diabetic Nephropathy|Completed||N/A|||Chang Gung Memorial Hospital|||||f||||||||||||||2017-02-18 17:03:02.499514|2017-02-18 17:03:02.499514
NCT00237718|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2012-01-09|2011-09-01||April 2006||2006-04-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Provision of Antioxidant Therapy in Hemodialysis (PATH) Study|Provision of Antioxidant Therapy in Hemodialysis (PATH) Study|Completed||Phase 2|385|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 17:03:05.665956|2017-02-18 17:03:05.665956
NCT00237939|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2013-11-07|||September 2002||2002-09-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices|A Prospective, Multicenter, Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices (Broad Effectiveness Trial With Aripiprazole- BETA)|Completed||Phase 3|1200||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||f||||||||||||||2017-02-18 17:03:02.584837|2017-02-18 17:03:02.584837
NCT00237926|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2008-07-29|||November 2005||2005-11-01|July 2008|2008-07-01||||March 2008|Actual|2008-03-01||Interventional|||Comparing Aerobic to Resistance Training in Recovery From Cancer|Comparing Aerobic to Resistance Training in Recovery From Cancer|Completed||N/A|58|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-02-18 17:03:02.762712|2017-02-18 17:03:02.762712
NCT00237913|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2013-11-07|||July 2004||2004-07-01|July 2008|2008-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Schizophrenia Trial of Aripiprazole|A Multicenter, Randomized, Naturalistic, Open-Label Study Between Aripiprazole and Standard of Care in the Management of Community-Treated Schizophrenic Patients (Schizophrenia Trial of Aripiprazole - STAR)|Completed||Phase 3|700||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 17:03:02.8549|2017-02-18 17:03:02.8549
NCT00237900|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-12|2009-04-22|||July 2003||2003-07-01|April 2009|2009-04-01|February 2004|Actual|2004-02-01|||||Interventional|||Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer|An Open, Single.Centre, Phase I/II Study of ZD1839 (Iressa) in Combination With 5-Fluorouracil, Leucovorin and Radiotherapy in Subjects With Resectable Gastric Cancer|Terminated||Phase 1/Phase 2|34||AstraZeneca|||||f||||||||||||||2017-02-18 17:03:03.181032|2017-02-18 17:03:03.181032
NCT00237887|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2007-08-28|||December 2004||2004-12-01|August 2007|2007-08-01||||||||Interventional|||Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase III, Multicenter Study of the Efficacy and Safety of Adalimumab Treatment in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|1212|Actual|Abbott|||||f||||f||||||||||2017-02-18 17:03:03.267636|2017-02-18 17:03:03.267636
NCT00237874|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-06-05|||February 2004||2004-02-01|June 2014|2014-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Aripiprazole Treatment of Prodromal Patients|Aripiprazole Treatment of Prodromal Patients|Completed||Phase 2/Phase 3|15|Actual|Yale University|||||f||||||||||||||2017-02-18 17:03:03.347628|2017-02-18 17:03:03.347628
NCT00237861|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-06-05||||||June 2014|2014-06-01||||December 2002|Actual|2002-12-01||Interventional|||Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia|Effectiveness of Atypical Vs Conventional Antipsychotics|Completed||Phase 4|||Yale University|||||f||||||||||||||2017-02-18 17:03:03.452719|2017-02-18 17:03:03.452719
NCT00237848|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-15|||February 2005||2005-02-01|April 2008|2008-04-01||||||||Interventional|||D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia|D-Serine Augmentation of Cognitive Retraining in Schizophrenia|Completed||Phase 3|72|Anticipated|Yale University|||||f||||||||||||||2017-02-18 17:03:03.54142|2017-02-18 17:03:03.54142
NCT00237822|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2006-03-02|||September 2003||2003-09-01|October 2005|2005-10-01|December 2007||2007-12-01|||||Interventional|||Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders|Increasing Treatment Adherence in Co-Occurring Disorders|Unknown status|Recruiting|Phase 2|75||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:03:03.647509|2017-02-18 17:03:03.647509
NCT00237809|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-30|||September 2002||2002-09-01|August 2010|2010-08-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia|D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia|Unknown status|Recruiting|Phase 3|72|Anticipated|Yale University||4|||f||||||||||||||2017-02-18 17:03:03.738793|2017-02-18 17:03:03.738793
NCT00237796|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2015-03-23|2014-11-19||February 2005||2005-02-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional||Participants numbers reported include at least one baseline and at least 1 ILSS assesssment|Functional Rehabilitation of Older Patients With Schizophrenia|Functional Rehabilitation of Older Patients With Schizophrenia|Completed||N/A|116|Actual|VA Office of Research and Development|"Randomization of treatment groups were not matched on the primary outcome (ILSS) at baseline but this was controlled using baseline ILSS as a covariate.~Participant dropout varied across assessments"|2|||f||||t||||||||||2017-02-18 17:03:03.85784|2017-02-18 17:03:03.85784
NCT00237783|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2016-07-25|||October 2005||2005-10-01|July 2016|2016-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension|Hemodynamic Changes During Dialysate Sodium Individualization in Hemodialysis Patients|Terminated||Phase 1|4|Actual|Yale University||2||Unable to recruit enough subjects|f||||f||||||||||2017-02-18 17:03:04.397091|2017-02-18 17:03:04.397091
NCT00237770|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-04-23|2013-09-24||June 2003||2003-06-01|April 2014|2014-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Prevention of Low Blood Pressure in Persons With Tetraplegia|Prevention of Low Blood Pressure in Persons With Tetraplegia|Completed||Phase 2/Phase 3|16|Actual|VA Office of Research and Development|The small sample of subjects tested and the heterogeneity of spinal lesions.|1|||f||||f||||||||||2017-02-18 17:03:04.525488|2017-02-18 17:03:04.525488
NCT00237757|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2013-07-02|||January 2002||2002-01-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|January 2004|Actual|2004-01-01||Interventional|||Rehabilitation Team Functioning and Patient Outcomes|Rehabilitation Team Functioning and Patient Outcomes|Completed||N/A|31|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:03:04.964479|2017-02-18 17:03:04.964479
NCT00237744|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-10-03|2013-11-08||April 2005||2005-04-01|October 2014|2014-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Brain and Coordination Changes Induced By Robotics and FES Treatment Following Stroke|CNS Plasticity Induced By Motor Learning Technologies Following Stroke|Completed||N/A|40|Actual|VA Office of Research and Development||3|||f||||||||||||||2017-02-18 17:03:05.072179|2017-02-18 17:03:05.072179
NCT00237731|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-02-25|||September 2005||2005-09-01|February 2010|2010-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg|Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg|Completed||Phase 4|106|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 17:03:05.547514|2017-02-18 17:03:05.547514
NCT00005430|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|November 2001|2001-11-01|September 1995|Actual|1995-09-01|||||Observational|||Low Cholesterol and Mortality in Blacks and Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.332691|2017-02-18 18:15:00.332691
NCT00237692|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2015-04-06|2014-08-29||May 2006||2006-05-01|August 2014|2014-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional||All data except blood pressure, age, gender were patient-reported.|Hypertension Intervention Nurse Telemedicine Study (HINTS)|Behavioral/Pharmacological Telemedicine Interventions for BP Control|Completed||N/A|591|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 17:03:06.266034|2017-02-18 17:03:06.266034
NCT00237679|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2015-10-13|||January 2004||2004-01-01|October 2015|2015-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Quantifying Effects of Treatment of Pediatric Dysphonia|Quantifying Effects of Treatment of Pediatric Dysphonia|Terminated||N/A|31|Actual|University of Wisconsin, Madison||2||Terminated due to funding loss.|f||||t||||||||||2017-02-18 17:03:07.427027|2017-02-18 17:03:07.427027
NCT00237666|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2013-05-09|2012-11-20||February 2005||2005-02-01|May 2013|2013-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression|An Open-Label, Flexible-Dose Trial of the Safety and Efficacy of Geodon in Non-Rapid-Cycling Bipolar II Patients With Major Depression|Completed||Phase 4|30|Actual|The Medical Research Network||1|||f||||t||||||||||2017-02-18 17:03:07.532644|2017-02-18 17:03:07.532644
NCT00237653|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2009-04-02|||February 2004||2004-02-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|||||Interventional|||MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus|Relevance of Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus|Terminated||Phase 3|40|Anticipated|University Hospital, Grenoble||||difficulty to include patients|f||||||||||||||2017-02-18 17:03:07.857808|2017-02-18 17:03:07.857808
NCT00237640|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2008-09-19|||March 2005||2005-03-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus|Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus|Completed||Phase 2|85|Actual|University of Oklahoma||2|||f||||f||||||||||2017-02-18 17:03:07.969151|2017-02-18 17:03:07.969151
NCT00237627|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2012-05-16|||May 2001||2001-05-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|December 2006|Actual|2006-12-01||Interventional|||Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer|A Phase I Evaluation of the Combination of Pegylated Liposomal Doxorubicin (Doxil®) With PS-341 in Patients With Refractory Hematologic and Solid Malignancies|Completed||Phase 1/Phase 2|107|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:03:08.084717|2017-02-18 17:03:08.084717
NCT00237614|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2006-07-17|||February 2003||2003-02-01|July 2005|2005-07-01|May 2005||2005-05-01|||||Interventional|||Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction||Completed||Phase 2/Phase 3|300||University of Milan|||||f||||||||||||||2017-02-18 17:03:08.221653|2017-02-18 17:03:08.221653
NCT00237601|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-04-01|||January 2006||2006-01-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Observational|||Home or Home-like Hospital Birth|Home or Home-like Hospital Birth for Low-risk Nulliparae: Does it Matter?|Completed||Phase 3|500|Actual|Maastricht University Medical Center|||2||f||||f||||||||||2017-02-18 17:03:08.309587|2017-02-18 17:03:08.309587
NCT00237588|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2011-07-03|||December 2004||2004-12-01|October 2005|2005-10-01|July 2005||2005-07-01|||||Interventional|||Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)|Glucose Optimisation With Angiotensin II Antagonist Losartan in Patients With Hypertension and Other Risk Factors for Metabolic Syndrome (GOAAL)|Completed||Phase 4|25||Oslo University Hospital|||||f||||||||||||||2017-02-18 17:03:08.398086|2017-02-18 17:03:08.398086
NCT00237575|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2012-05-22|||November 2005||2005-11-01|May 2012|2012-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer|A Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin and Gemcitabine for Regionally Advanced or Metastatic Urothelial Cancer|Terminated||Phase 3|100||University of Kentucky|||||f||||||||||||||2017-02-18 17:03:08.504942|2017-02-18 17:03:08.504942
NCT00237562|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2006-05-04|||July 1999||1999-07-01|October 2005|2005-10-01||||||||Interventional|||Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit|Single Visit Cervical Cancer Prevention Program|Completed||Phase 3|||University of California, Irvine|||||f||||||||||||||2017-02-18 17:03:08.611682|2017-02-18 17:03:08.611682
NCT00237549|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2013-12-19|||January 2001||2001-01-01|August 2012|2012-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ADDTION||The ADDITION Study. Intensive Treatment in People With Screen Detected Diabetes in Primary Care.|The ADDITION Study. Anglo-Danish-Dutch Study of Intensive Treatment In PeOple With screeN Detected Diabetes in Primary Care|Completed||N/A|3057|Actual|University of Aarhus||1|||f||||t||||||||||2017-02-18 17:03:08.695344|2017-02-18 17:03:08.695344
NCT00237536|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2009-04-28|||June 2005||2005-06-01|April 2009|2009-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia|A Randomized, Double-Blind, Placebo-Controlled, Dose Comparison Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia|Terminated||Phase 2|240||Threshold Pharmaceuticals|||||||||||||||||||2017-02-18 17:03:08.819047|2017-02-18 17:03:08.819047
NCT00237523|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2007-06-15|||July 2005||2005-07-01|June 2007|2007-06-01|March 2008|Anticipated|2008-03-01|||||Interventional|||"Study for Treatment of Moderate or Severe, Periodic, Cyclic, Breast Pain"|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of IoGen™ for the Treatment of Moderate or Severe, Periodic Breast Pain Associated With Symptomatic Fibrocystic Breast Disease|Unknown status|Active, not recruiting|Phase 3|175|Anticipated|Symbollon Pharmaceuticals|||||f||||f||||||||||2017-02-18 17:03:08.947544|2017-02-18 17:03:08.947544
NCT00237510|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2014-03-04|||May 2005||2005-05-01|March 2014|2014-03-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating|A Pilot Study of the Efficacy and Tolerability of Terazosin for the Treatment of Antidepressant-Induced Excessive Sweating|Completed||N/A|15|Anticipated|Thomas Jefferson University|||||f||||t||||||||||2017-02-18 17:03:09.089243|2017-02-18 17:03:09.089243
NCT00237497|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2012-01-31|||July 2005||2005-07-01|January 2012|2012-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia|A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ramelteon Compared to Placebo With Zopiclone as a Reference Arm in Adults With Chronic Insomnia|Completed||Phase 3|275|Actual|Takeda||3|||f||||f||||||||||2017-02-18 17:03:09.201477|2017-02-18 17:03:09.201477
NCT00237484|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2015-10-01|||July 2005||2005-07-01|October 2015|2015-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|Pegade||Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)|Effect of Infliximab in Hepatitis-C Genotype 1 Naïve Patients With High TNF-alpha on the Efficacy of Pegylated Interferon Alfa-2b/Ribavirin Therapy|Completed||Phase 3|89|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:03:09.336587|2017-02-18 17:03:09.336587
NCT00237471|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2011-07-19|||October 2005||2005-10-01|July 2011|2011-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Impact of Tight Glycaemic Control in Acute Myocardial Infarction|Impact of Tight Glycaemic Control With Insulin on Novel Vascular Disease Risk Factors and Myocardial Function and Perfusion in Acute Myocardial Infarction Patients With Hyperglycaemia|Terminated||Phase 4|40||Melbourne Health||||difficulty recruiting patients|f||||||||||||||2017-02-18 17:03:09.441674|2017-02-18 17:03:09.441674
NCT00237458|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2014-09-19|2012-03-07||May 2001||2001-05-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain|An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain|Completed||Phase 2|7|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:03:09.547097|2017-02-18 17:03:09.547097
NCT00237445|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2011-01-10|||November 2005||2005-11-01|January 2011|2011-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|COBRA II||Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days|A Multinational, Multicenter, Randomized, Double-blind, Study in Areas of High Pneumococcal Resistance Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Ketek® Telithromycin Once Daily for 7 Days, or Zithromax® Azithromycin Once Daily for 5 Days|Terminated||Phase 4|110|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:03:09.967894|2017-02-18 17:03:09.967894
NCT00237432|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2010-12-09|||April 2003||2003-04-01|December 2010|2010-12-01|February 2008|Actual|2008-02-01|||||Observational|||Study of the Immune Response to Hepatitis C Virus|HCV Pathogenesis and Dendritic Cell Immunobiology|Completed||N/A|11|Actual|Rockefeller University|||1||f||||f||||||Samples With DNA|"~     White blood cells~   "|||2017-02-18 17:03:10.064636|2017-02-18 17:03:10.064636
NCT00237419|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2008-05-30|||December 2005||2005-12-01|May 2008|2008-05-01|April 2011|Anticipated|2011-04-01|November 2010|Anticipated|2010-11-01||Interventional|||Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis|An Open Label Extension, Investigator Initiated Trial to Examine Radiographic Progression , Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis. EASIC (European Ankylosing Spondylitis Infliximab Cohort)|Unknown status|Recruiting|N/A|149|Anticipated|Rheumazentrum Ruhrgebiet||1|||f||||||||||||||2017-02-18 17:03:10.147986|2017-02-18 17:03:10.147986
NCT00237406|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2010-03-24|||January 2006||2006-01-01|March 2010|2010-03-01|October 2006|Actual|2006-10-01|||||Observational|||Interactive Voice Response (IVR) for Methadone Patients|Interactive Voice Response for Methadone Patients|Completed||Phase 3|50||Butler Hospital|||2||f||||||||||||||2017-02-18 17:03:10.25925|2017-02-18 17:03:10.25925
NCT00237393|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2008-02-20|||August 2003||2003-08-01|October 2005|2005-10-01|December 2007|Actual|2007-12-01|||||Interventional|PTSD||Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)|A Randomized, Placebo-Controlled Trial of Quetiapine (Seroquel) Monotherapy in the Treatment of PTSD|Completed||Phase 4|80|Actual|Ralph H. Johnson VA Medical Center||2|||f||||f||||||||||2017-02-18 17:03:10.350317|2017-02-18 17:03:10.350317
NCT00237380|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2009-01-09|||November 2005||2005-11-01|January 2009|2009-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of PTC124 for Cystic Fibrosis|A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis|Completed||Phase 2|24||PTC Therapeutics|||||f||||||||||||||2017-02-18 17:03:10.54396|2017-02-18 17:03:10.54396
NCT00237367|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-04-26||||||April 2010|2010-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn|A Randomized, Two-way Crossover Study of the Effects of a Single Dose of Rabeprazole or Pantoprazole on 24-hour Intragastric Acidity and Esophageal Acid Exposure in GERD Patients With a History of Nocturnal Heartburn|Completed||Phase 4|52|Actual|PriCara, Unit of Ortho-McNeil, Inc.|||||f||||||||||||||2017-02-18 17:03:10.630476|2017-02-18 17:03:10.630476
NCT00237354|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2008-10-22|||October 2005||2005-10-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||PV-10 Chemoablation of Recurrent Breast Carcinoma|A Phase 1 Safety and Tolerability Study of PV-10 Chemoablation of Recurrent Breast Carcinoma|Completed||Phase 1|15|Anticipated|Provectus Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:03:10.712311|2017-02-18 17:03:10.712311
NCT00237341|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2013-11-19|||June 2002||2002-06-01|November 2013|2013-11-01|January 2004|Actual|2004-01-01|||||Interventional|||Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain|Assessing Functionality Changes Associated With Patients Who Were Taking Short Acting Opioids Chronically and Who Initiated Treatment With Duragesic® (Fentanyl Transdermal System) for the Management of Chronic Low Back Pain.|Completed||Phase 4|358|Actual|PriCara, Unit of Ortho-McNeil, Inc.|||||f||||||||||||||2017-02-18 17:03:11.001049|2017-02-18 17:03:11.001049
NCT00237328|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2013-02-22|||June 2006||2006-06-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|March 2009|Actual|2009-03-01||Observational|HIT||Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery|The Incidence of Thromboembolic Events in Patients With Antibodies to Heparin-PF4 After Cardiac Bypass|Completed||N/A|1015|Actual|Duke University|||1||f||||f||||||||||2017-02-18 17:03:11.106085|2017-02-18 17:03:11.106085
NCT00237315|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2016-07-25|||February 2006||2006-02-01|July 2016|2016-07-01|December 2019|Anticipated|2019-12-01|July 2019|Anticipated|2019-07-01||Observational|||Longitudinal Study of Urea Cycle Disorders|Longitudinal Study of Urea Cycle Disorders|Recruiting||Phase 2|1100|Anticipated|Children's Research Institute|||1||f||||t||||||||||2017-02-18 17:03:11.224586|2017-02-18 17:03:11.224586
NCT00237302|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-05-17|||July 2001||2001-07-01|April 2010|2010-04-01|September 2003|Actual|2003-09-01|||||Interventional|||A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children|A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Migraine in Pediatric Subjects|Completed||Phase 3|162|Actual|Ortho-McNeil Neurologics, Inc.||1|||f||||||||||||||2017-02-18 17:03:11.400194|2017-02-18 17:03:11.400194
NCT00237289|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-05-17|||October 2001||2001-10-01|April 2010|2010-04-01|October 2003|Actual|2003-10-01|||||Interventional|||Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting|Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient Setting|Completed||Phase 3|287|Actual|Ortho-McNeil Neurologics, Inc.||1|||f||||||||||||||2017-02-18 17:03:11.48949|2017-02-18 17:03:11.48949
NCT00237276|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2007-09-21|||October 2005||2005-10-01|September 2007|2007-09-01||||||||Interventional|||Experience and Enhancement: Improving Colonoscopic Polyp Detection|Evaluation of Effect of Colonoscopist Experience and Addition of of Mucosal Enhancement Techniques on Detection of Colonic Polyps When Viewing Videotaped Colonoscopic Withdrawals|Unknown status|Recruiting|N/A|30|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 17:03:11.586575|2017-02-18 17:03:11.586575
NCT00237263|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-11-22|||February 2003||2003-02-01|November 2011|2011-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States|An Extension Study to Phase IIb Dose-finding Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off|Completed||Phase 2|285|Actual|Novartis|||||f||||||||||||||2017-02-18 17:03:11.676991|2017-02-18 17:03:11.676991
NCT00237250|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2012-05-04|||October 2005||2005-10-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance|Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance|Completed||Phase 3|171|Actual|Novartis|||||f||||||||||||||2017-02-18 17:03:11.777497|2017-02-18 17:03:11.777497
NCT00237237|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2017-02-03|||October 2005||2005-10-01|February 2017|2017-02-01||||February 2007|Actual|2007-02-01||Interventional|||Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes|Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|588||Novartis|||||||||||||||||||2017-02-18 17:03:11.875457|2017-02-18 17:03:11.875457
NCT00237224|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2009-11-18|||February 2003||2003-02-01|November 2009|2009-11-01||||February 2007|Actual|2007-02-01||Interventional|||Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole|Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole|Completed||Phase 4|40|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:03:12.000245|2017-02-18 17:03:12.000245
NCT00237211|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2012-05-09|||June 2001||2001-06-01|May 2012|2012-05-01||||October 2006|Actual|2006-10-01||Interventional|||Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer|Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer|Completed||Phase 2|31|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:03:12.111118|2017-02-18 17:03:12.111118
NCT00237198|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2012-08-15|||March 2004||2004-03-01|August 2012|2012-08-01||||July 2006|Actual|2006-07-01||Interventional|||Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment|Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment|Completed||Phase 2|47|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:03:12.233916|2017-02-18 17:03:12.233916
NCT00237185|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2014-08-14|2014-06-13||June 2000||2000-06-01|August 2014|2014-08-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene|Open, Randomized, Phase II Study of Glivec in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Plus 10 Year Extension Study|Completed||Phase 2|148|Actual|Novartis|No safety data was collected in the extension.|2|||f||||f||||||||||2017-02-18 17:03:12.380221|2017-02-18 17:03:12.380221
NCT00237172|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2012-04-29|||September 2002||2002-09-01|April 2012|2012-04-01||||July 2005|Actual|2005-07-01||Interventional|||Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)|Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)|Completed||Phase 2|72|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:03:13.264616|2017-02-18 17:03:13.264616
NCT00237159|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2011-03-21|||October 2002||2002-10-01|March 2011|2011-03-01||||December 2005|Actual|2005-12-01||Interventional|||Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis|Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis|Completed||Phase 4|284|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:03:13.433533|2017-02-18 17:03:13.433533
NCT00237146|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2013-02-11|||November 2003||2003-11-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy|Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy.|Completed||Phase 4|38|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:03:13.594957|2017-02-18 17:03:13.594957
NCT00237133|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-09|2012-08-06|||March 2003||2003-03-01|August 2012|2012-08-01||||January 2009|Actual|2009-01-01||Interventional|PREDICT||Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women|PREDICT TRIAL- Neoadjuvant Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women Expressing Hormonal Receptors ( ER and PR)|Completed||Phase 4|112|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:03:13.694948|2017-02-18 17:03:13.694948
NCT00237120|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2009-11-20|||November 2002||2002-11-01|November 2009|2009-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)|Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)|Completed||Phase 3|100||Novartis|||||f||||||||||||||2017-02-18 17:03:13.805757|2017-02-18 17:03:13.805757
NCT00237107|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2016-07-18|||April 2002||2002-04-01|July 2016|2016-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment.|Relation of Basal Cell Carcinoma Tumour Thickness, Histologically Estimated, in Punch Biopsies Performed Before and After Curretage.|Completed||N/A|36|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||No||2017-02-18 17:03:13.897539|2017-02-18 17:03:13.897539
NCT00237068|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2011-03-15|||March 2006||2006-03-01|March 2011|2011-03-01|December 2010|Anticipated|2010-12-01|December 2009|Anticipated|2009-12-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.|A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma|Unknown status|Active, not recruiting|Phase 4|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 17:03:14.146726|2017-02-18 17:03:14.146726
NCT00237055|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2010-03-17|||August 2004||2004-08-01|March 2010|2010-03-01|September 2006||2006-09-01|||||Observational|||Infectious Agents in Pediatric Crohn's|Infectious Agents in Pediatric Crohn's Disease|Completed||N/A|500|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:03:14.251855|2017-02-18 17:03:14.251855
NCT00237042|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-10|2011-05-02||October 2005||2005-10-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Managing Temporomandibular Disorder (TMD) Symptoms|Hormonal Cycles in Women: Effects on TMD Pain & Symptoms|Completed||N/A|252|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 17:03:14.346379|2017-02-18 17:03:14.346379
NCT00237016|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2008-10-23|||April 2002||2002-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever|Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever|Completed||Phase 2/Phase 3|140||Medical Corps, Israel Defense Force|||||f||||||||||||||2017-02-18 17:03:14.930868|2017-02-18 17:03:14.930868
NCT00237003|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2010-05-10|||September 2003||2003-09-01|May 2010|2010-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Brief Alcohol Intervention for Incarcerated Women|A Brief Alcohol Intervention for Incarcerated Women|Completed||Phase 3|326|Anticipated|Butler Hospital||1|||f||||||||||||||2017-02-18 17:03:15.015704|2017-02-18 17:03:15.015704
NCT00236990|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-30||||||June 2011|2011-06-01|September 2005|Actual|2005-09-01|||||Interventional|||An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland|A Double-Blind, Randomized, Placebo-Controlled Trial of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Prostatitis|Completed||Phase 2|283|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.||1|||f||||||||||||||2017-02-18 17:03:17.882236|2017-02-18 17:03:17.882236
NCT00236977|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2015-04-27|2009-01-14||August 2003||2003-08-01|April 2015|2015-04-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia|Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia|Completed||Phase 3|182|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:03:17.983941|2017-02-18 17:03:17.983941
NCT00236964|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2005-10-13|||February 2001||2001-02-01|October 2005|2005-10-01|May 2002||2002-05-01|||||Interventional|||Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis|Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis|Completed||Phase 3|78||Luitpold Pharmaceuticals|||||||||||||||||||2017-02-18 17:03:18.477124|2017-02-18 17:03:18.477124
NCT00236951|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2010-05-06|2009-06-24||February 2003||2003-02-01|May 2010|2010-05-01|December 2005||2005-12-01|October 2005|Actual|2005-10-01||Interventional|||Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy|A Phase III Randomized Controlled Study Comparing Iron Sucrose Intravenously to No Iron Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy|Completed||Phase 3|224|Actual|Luitpold Pharmaceuticals||4|||f||||||||||||||2017-02-18 17:03:18.580398|2017-02-18 17:03:18.580398
NCT00236938|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2015-05-11|2009-01-14||July 2002||2002-07-01|May 2015|2015-05-01|October 2004|Actual|2004-10-01|September 2004|Actual|2004-09-01||Interventional|||Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis|Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis|Completed||Phase 3|121|Actual|Luitpold Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:03:19.68306|2017-02-18 17:03:19.68306
NCT00236925|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2015-03-30|||May 2003||2003-05-01|March 2015|2015-03-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Efficacy Study of Low-Dose Hydrocortisone Treatment for Fibromyalgia|A Double-Blind Crossover Within Subject Study on Low-Dose Hydrocortisone for Fibromyalgia|Completed||Early Phase 1|30|Actual|Ludwig-Maximilians - University of Munich||2|||f||||t||||||||||2017-02-18 17:03:20.126652|2017-02-18 17:03:20.126652
NCT00236912|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||July 2003||2003-07-01|April 2010|2010-04-01|September 2004|Actual|2004-09-01|||||Interventional|||A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus Piperacillin/Tazobactam in Treating Complicated Appendicitis|A Multi-center, Open-label, Randomized Study to Compare the Safety and Efficacy of Once Daily Levofloxacin Along With Once Daily Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Appendicitis|Terminated||Phase 4|139|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1||This study was terminated due to low enrollment.|||||f||||||||||2017-02-18 17:03:20.24441|2017-02-18 17:03:20.24441
NCT00236899|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-08-22|2011-07-25||September 2005||2005-09-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC|A Randomized Phase III Trial of Gemcitabine and Docetaxel Versus Gemcitabine and Paclitaxel in Patients With Metastatic Breast Cancer: A Comparison of Different Schedules|Completed||Phase 3|241|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 17:03:20.346092|2017-02-18 17:03:20.346092
NCT00236886|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-04-26|||May 1998||1998-05-01|April 2010|2010-04-01|June 2000|Actual|2000-06-01|||||Interventional|||Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients|Prospective Pilot Study on Metabolism and Weight Changes in Subjects With Diagnosed Partial Onset Epilepsy, With or Without Secondarily Generalized Seizures and Treated With Topiramate.|Completed||Phase 3|49|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:03:22.395803|2017-02-18 17:03:22.395803
NCT00236873|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||October 1989||1989-10-01|April 2010|2010-04-01|May 1993|Actual|1993-05-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.|Double-Blind Parallel Comparison of Topiramate 200 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy|Completed||Phase 2|47|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:22.4996|2017-02-18 17:03:22.4996
NCT00236860|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||May 1989||1989-05-01|April 2010|2010-04-01|February 1992|Actual|1992-02-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures|Double-Blind Parallel Comparison of Topiramate 400 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy|Completed||Phase 2|56|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:22.590976|2017-02-18 17:03:22.590976
NCT00236847|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||December 1989||1989-12-01|April 2010|2010-04-01|July 1993|Actual|1993-07-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.|Double-Blind, Parallel Comparison of Topiramate 300 mg Twice Daily to Placebo in Patients With Refractory Partial Epilepsy|Completed||Phase 2|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:22.682206|2017-02-18 17:03:22.682206
NCT00236834|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||December 1997||1997-12-01|April 2010|2010-04-01|June 2001|Actual|2001-06-01|||||Interventional|||A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization|A Multicenter, Randomized, Open Label Study to Compare the Safety and Efficacy of Levofloxacin With That of Imipenem/Cilastatin in the Treatment of Nosocomial Pneumonia|Completed||Phase 3|438|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:03:22.769839|2017-02-18 17:03:22.769839
NCT00236821|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||March 2001||2001-03-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia|Multicenter, Double-Blind Randomized Study to Compare the Safety and Efficacy of Levofloxacin 750 mg Once Daily for Five Days vs. Levofloxacin 500 mg Once Daily for 10 Days in the Treatment of Mild to Severe Community-Acquired Pneumonia in Adults|Completed||Phase 3|530|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:03:22.859001|2017-02-18 17:03:22.859001
NCT00236808|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||May 2000||2000-05-01|April 2010|2010-04-01|November 2001|Actual|2001-11-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis|A Multicenter, Double-Blind Study to Compare the Safety and Efficacy of Levofloxacin to That of Ciprofloxacin in the Treatment of Chronic Prostatitis|Completed||Phase 3|383|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:03:22.950236|2017-02-18 17:03:22.950236
NCT00236795|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||January 1997||1997-01-01|November 2010|2010-11-01|March 1999|Actual|1999-03-01|||||Interventional|||A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.|An Open-label Study to Evaluate the Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17-deacetylnorgestimate and Ethinyl Estradiol With the Oral Contraceptive Triphasil.|Completed||Phase 3|1494|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.061059|2017-02-18 17:03:23.061059
NCT00236782|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||October 1997||1997-10-01|November 2010|2010-11-01|March 1999|Actual|1999-03-01|||||Interventional|||A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.|An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17dNorgestimate and Ethinyl Estradiol With the Oral Contraceptive Mercilon.|Completed||Phase 3|1517|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.17855|2017-02-18 17:03:23.17855
NCT00236769|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-11-15|||November 1997||1997-11-01|November 2010|2010-11-01|October 1999|Actual|1999-10-01|||||Interventional|||A Study of Efficacy and Safety With the Transdermal Contraceptive System.|An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17deacetyl-norgestimate and Ethinyl Estradiol.|Completed||Phase 3|1751|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.269197|2017-02-18 17:03:23.269197
NCT00236756|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-02|||August 1993||1993-08-01|January 2011|2011-01-01|February 2001|Actual|2001-02-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome|A Double-Blind Trial of Topiramate in Subjects With Lennox-Gastaut Syndrome.|Completed||Phase 3|100|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.357824|2017-02-18 17:03:23.357824
NCT00236743|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||June 1994||1994-06-01|January 2011|2011-01-01|October 2000|Actual|2000-10-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy|Topiramate (RWJ 17021-000) Clinical Trial In Children With Partial Onset Seizures|Completed||Phase 3|90|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.451745|2017-02-18 17:03:23.451745
NCT00236730|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||June 1988||1988-06-01|January 2011|2011-01-01|December 1990|Actual|1990-12-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy|Double-Blind Parallel Comparison of Three Doses of Topiramate and Placebo in Refractory Partial Epilepsy|Completed||Phase 2|178|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.542044|2017-02-18 17:03:23.542044
NCT00236717|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||September 1997||1997-09-01|January 2011|2011-01-01|November 2000|Actual|2000-11-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy|TOPAMAX (Topiramate) Monotherapy Comparison Trial to Standard Monotherapy in the Treatment of Newly Diagnosed Epilepsy (RWJ-17021-000); Phase IIIB|Completed||Phase 3|865|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.632043|2017-02-18 17:03:23.632043
NCT00236704|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||March 1994||1994-03-01|January 2011|2011-01-01|December 1999|Actual|1999-12-01|||||Interventional|||"A Study of the Efficacy and Safety of Topiramate as Add on Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures"|Topiramate Clinical Trial in Primary Generalized Tonic-Clonic Seizures|Completed||Phase 3|80|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.731016|2017-02-18 17:03:23.731016
NCT00236691|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||July 1988||1988-07-01|January 2011|2011-01-01|December 1990|Actual|1990-12-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.|Double-Blind, Parallel Comparison of Three Doses of Topiramate and Placebo in Refractory Partial Epilepsy|Completed||Phase 2|188|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:23.82418|2017-02-18 17:03:23.82418
NCT00236678|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||July 2004||2004-07-01|March 2010|2010-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT|A Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With Anemia of Chronic Disease (ACD) Due to Rheumatoid Arthritis Receiving PROCRIT� (Epoetin Alfa)|Terminated||Phase 2|29|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"This study was terminated due to slow enrollment, despite protocol amendments to change the~   entrance criteria."|||||t||||||||||2017-02-18 17:03:23.905015|2017-02-18 17:03:23.905015
NCT00236665|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-04-26|||March 2001||2001-03-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension|Completed||Phase 3|531|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:03:24.001825|2017-02-18 17:03:24.001825
NCT00236652|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||November 2003||2003-11-01|April 2010|2010-04-01|June 2005|Actual|2005-06-01|||||Interventional|||A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.|An Open-label, Multi-center, Non-comparative Sinus Puncture Study of 750 mg, Short-course Levofloxacin in the Treatment of Acute Maxillary Sinusitis|Completed||Phase 3|18|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:03:24.33466|2017-02-18 17:03:24.33466
NCT00236639|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-04-26|||July 2000||2000-07-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Dose-Response Study to Assess the Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity|Completed||Phase 3|1293|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:03:24.423011|2017-02-18 17:03:24.423011
NCT00236626|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||April 2000||2000-04-01|April 2010|2010-04-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes|A 9 Month, Double-Blind, Placebo-Controlled Study With a Blinded Crossover Transition to Open-Label Extension, Evaluating the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Type 2 Diabetes Patients|Completed||Phase 2|38|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:03:24.516431|2017-02-18 17:03:24.516431
NCT00236613|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-12-02|||September 2000||2000-09-01|December 2010|2010-12-01|July 2001|Actual|2001-07-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Dose-Response Study to Assess the Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity|Completed||Phase 2|385|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:24.606021|2017-02-18 17:03:24.606021
NCT00236600|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-04-26|||August 2000||2000-08-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Efficacy and Safety of Topiramate in Weight Loss Maintenance in Obese Patients Following Participation in an Intensive, Non-Pharmacologic Weight Loss Program|Completed||Phase 3|561|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:03:24.695501|2017-02-18 17:03:24.695501
NCT00236587|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||November 2001||2001-11-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|||||Interventional|||A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia|An Open Label, Long Term Trial of Risperidone Long Acting Microspheres in the Treatment of Patients Diagnosed With Schizophrenia|Completed||Phase 3|100|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:24.788348|2017-02-18 17:03:24.788348
NCT00236574|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||May 2001||2001-05-01|November 2010|2010-11-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment|A Randomized Double Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer's Disease.|Completed||Phase 3|974|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:24.888994|2017-02-18 17:03:24.888994
NCT00236561|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-11-18|||April 2001||2001-04-01|November 2010|2010-11-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine|A Randomized, Double-Blind, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prophylaxis of Migraine|Completed||Phase 3|786|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:24.984112|2017-02-18 17:03:24.984112
NCT00236548|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-05-17||||||March 2011|2011-03-01|January 2003|Actual|2003-01-01|||||Interventional|||Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection|An Open-label Evaluation of the Utility of the RISPERDAL CONSTA Treatment Guidebook During Transition of Adult Patients With Schizophrenia or Schizoaffective Disorder to RISPERDAL CONSTA (Risperidone) Treatment Over Three Months in the Community Mental Health Center (CMHC) Setting|Completed||Phase 3|1|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:25.081557|2017-02-18 17:03:25.081557
NCT00236535|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||December 2003||2003-12-01|April 2010|2010-04-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study of the Efficacy and Safety of Tramadol HCl/Acetaminophen, Hydrocodone Bitartrate/Acetaminophen and Placebo in Patients With Pain From an Ankle Sprain With a Partial Torn Ligament|A Comparison of the Efficacy and Safety of Tramadol HCl/Acetaminophen Versus Hydrocodone Bitartrate/Acetaminophen Versus Placebo in Subjects With Acute Musculoskeletal Pain|Completed||Phase 3|603|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:03:25.172912|2017-02-18 17:03:25.172912
NCT00236522|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||October 2002||2002-10-01|April 2010|2010-04-01|April 2004|Actual|2004-04-01|||||Interventional|||A Comparison of the Safety and Efficacy of Two Different Regimens of Levofloxacin in the Treatment of Acute Bacterial Sinusitis(Sinus Infection) in Adults.|A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Levofloxacin 750 mg Once Daily for 5 Days Versus Levofloxacin 500 mg Once Daily for 10 Days in the Treatment of Acute Bacterial Sinusitis in Adults.|Completed||Phase 3|784|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:03:25.267688|2017-02-18 17:03:25.267688
NCT00236509|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-11-15|||February 2001||2001-02-01|November 2010|2010-11-01|September 2002|Actual|2002-09-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine|Completed||Phase 3|763|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:25.351957|2017-02-18 17:03:25.351957
NCT00236496|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||October 2001||2001-10-01|April 2010|2010-04-01|February 2004|Actual|2004-02-01|||||Interventional|||A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.|A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in the Treatment of Essential Tremor|Completed||Phase 3|223|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:03:25.442765|2017-02-18 17:03:25.442765
NCT00236483|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||November 2002||2002-11-01|April 2010|2010-04-01|February 2003|Actual|2003-02-01|||||Interventional|||A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery|A Comparison of the Efficacy and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus ULTRAM® (Tramadol HCl) Versus Placebo in Subjects With Pain Following Oral Surgery|Completed||Phase 4|456|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:03:25.531558|2017-02-18 17:03:25.531558
NCT00236470|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||January 2002||2002-01-01|January 2011|2011-01-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders|Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders - an Open Label Follow-up Trial of CR002020|Completed||Phase 3|232|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:03:25.626135|2017-02-18 17:03:25.626135
NCT00236457|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||November 2000||2000-11-01|November 2010|2010-11-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder|Randomized, Multi-center, Open Label Trial Comparing Risperidone Depot (Microspheres) and Olanzapine Tablets in Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|629|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:03:25.714604|2017-02-18 17:03:25.714604
NCT00236444|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||December 2001||2001-12-01|November 2010|2010-11-01|September 2003|Actual|2003-09-01|||||Interventional|||A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders|Risperidone in the Prevention of Relapse: a Randomized, Double-blind, Placebo-controlled Trial in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders.|Completed||Phase 3|375|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:25.799957|2017-02-18 17:03:25.799957
NCT00236431|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||May 2001||2001-05-01|November 2010|2010-11-01|December 2003|Actual|2003-12-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment|A Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer's Disease|Completed||Phase 3|1063|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:25.88765|2017-02-18 17:03:25.88765
NCT00236418|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-06|||December 1994||1994-12-01|April 2010|2010-04-01|December 1996|Actual|1996-12-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures|Topiramate Clinical Trial in Primary Generalized Tonic-Clonic Seizures|Completed||Phase 3|80|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:03:25.974986|2017-02-18 17:03:25.974986
NCT00236405|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-06-08|||March 2005||2005-03-01|March 2010|2010-03-01|October 2005|Actual|2005-10-01|||||Interventional|||PROCRIT and Short-Term Outcomes in Orthopedic Surgery|A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of of PROCRIT� (Epoetin Alfa) on Short-Term Outcomes in Orthopedic Subjects Undergoing Primary Unilateral Knee Arthroplasty|Terminated||Phase 2|6|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||The study was terminated due to poor enrollment.|||||f||||||||||2017-02-18 17:03:26.069455|2017-02-18 17:03:26.069455
NCT00236392|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-11-29|||October 2001||2001-10-01|November 2010|2010-11-01|October 2002|Actual|2002-10-01|||||Interventional|||"A Study of Efficacy and Safety of On-demand Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)"|"Double-Blind Placebo-Controlled Randomized Withdrawal Trial Assessing the Efficacy and Tolerability of On-Demand Maintenance Therapy With 10mg o.d. Rabeprazole for 6 Months in Non-Erosive Reflux Disease Patients With Complete Symptom Relief After 4 Week Open Acute Phase"|Completed||Phase 3|422|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 17:03:26.153673|2017-02-18 17:03:26.153673
NCT00236379|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-05-16||||||March 2011|2011-03-01|August 2003|Actual|2003-08-01|||||Interventional|||A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder|A Six-month, Double-blind, Randomized, International, Multicenter Trial to Evaluate the Glucoregulatory Effects of Risperidone and Olanzapine in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|59|Actual|Janssen, LP||2|||f||||||||||||||2017-02-18 17:03:26.240079|2017-02-18 17:03:26.240079
NCT00236158|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2009-02-20|||March 1999||1999-03-01|February 2009|2009-02-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Interventional|||The Danish Multicenter Randomised Study on AAI Versus DDD Pacing in Sick Sinus Syndrome|The Danish Multicenter Randomised Study on AAI Versus DDD Pacing in Sick Sinus Syndrome|Terminated||Phase 2/Phase 3|1415|Actual|The DANPACE Investigator Group||2||Not able to recruit the estimated number of patients|f||||t||||||||||2017-02-18 17:03:28.826684|2017-02-18 17:03:28.826684
NCT00236366|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-05-16|||June 2002||2002-06-01|December 2010|2010-12-01|April 2004|Actual|2004-04-01|||||Interventional|||A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With Osteoarthritis|Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Trial To Investigate Durogesic™ In Comparison To Placebo In Subjects With Moderate To Severe Pain Induced By Osteoarthritis Of The Hip Or The Knee, Who Are In Need Of And Waiting For Hip Or Knee Replacement.|Completed||Phase 4|418|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 17:03:26.340044|2017-02-18 17:03:26.340044
NCT00236353|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-05-16|||May 2002||2002-05-01|March 2011|2011-03-01|December 2003|Actual|2003-12-01|||||Interventional|||Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder|An Open-label Study of the Efficacy and Safety of RISPERDAL Long-acting Microspheres (RISPERDAL CONSTA) Administered Once Monthly in Adults With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|86|Actual|Janssen, LP|||||f||||||||||||||2017-02-18 17:03:26.420544|2017-02-18 17:03:26.420544
NCT00236340|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2007-04-18|||January 2002||2002-01-01|October 2005|2005-10-01|February 2005|Actual|2005-02-01|||||Interventional|||Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.|Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.|Completed||Phase 3|80||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||t||||||||||2017-02-18 17:03:26.514787|2017-02-18 17:03:26.514787
NCT00236327|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-05-16|||June 2003||2003-06-01|April 2010|2010-04-01|May 2004|Actual|2004-05-01|||||Interventional|||Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain|Evaluation of the Efficacy and Safety of Transdermal Fentanyl in Patients Suffering From Chronic Cancer Pain in an Ambulatory Setting|Terminated||Phase 4|34|Actual|Janssen Cilag S.A.S.||||"Sponsor discontinued the study following the discovery of a number of incompletely sealed~   batches that were unusable."|f||||f||||||||||2017-02-18 17:03:26.607938|2017-02-18 17:03:26.607938
NCT00236301|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2008-01-16|||March 2004||2004-03-01|October 2005|2005-10-01|January 2007|Actual|2007-01-01|June 2006|Actual|2006-06-01||Interventional|THS||Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers|Pro-Inflammatory Effects of Two Different Doses of 17 Beta Estradiol in Menopausal Women|Terminated||Phase 3|99|Actual|Assistance Publique - Hôpitaux de Paris||3||terminated|f||||f||||||||||2017-02-18 17:03:26.694492|2017-02-18 17:03:26.694492
NCT00236288|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2007-10-29|||October 2005||2005-10-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||A Feasibility Study of Smoking Cessation Program in Radiation Oncology|A Feasibility Study of Smoking Cessation Program in Radiation Oncology|Completed||N/A|36|Anticipated|Indiana University||1|||f||||||||||||||2017-02-18 17:03:26.812851|2017-02-18 17:03:26.812851
NCT00236275|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2011-04-29|||May 2004||2004-05-01|March 2007|2007-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer|PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer|Completed||Phase 3|60|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:03:26.90524|2017-02-18 17:03:26.90524
NCT00236262|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2007-03-23|||October 2005||2005-10-01|March 2007|2007-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress Syndrome|Effect of the Positive Expiratory Pressure on the Right Ventricular Function in Patient With Adult Respiratory Distress Syndrome Ventilated With Limited Plateau Pressure|Completed||N/A|15||Assistance Publique - Hôpitaux de Paris|||||f||||t||||||||||2017-02-18 17:03:27.024657|2017-02-18 17:03:27.024657
NCT00236249|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2011-02-17|||May 2005||2005-05-01|March 2007|2007-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety and Efficacy Study of Intravenous Lidocaine After Colorectal Surgery: LIDOREHAB|Evaluation of Lidocaine Continuous Intravenous Administration for Postoperative Recovery After Colorectal Surgery|Completed||Phase 3|110|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:03:27.119296|2017-02-18 17:03:27.119296
NCT00236236|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-11-13|||February 2003||2003-02-01|October 2005|2005-10-01|May 2005||2005-05-01|||||Observational|||The HF-HRV Registry|CONTAK RENEWAL® Heart Failure Heart Rate Variability Registry|Completed||Phase 4|1400||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:03:27.221278|2017-02-18 17:03:27.221278
NCT00236223|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2008-05-14|||October 2005||2005-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery|The Effect of Gabapentin, Low Dose Ketamine, Paracetamol, NSAID and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Primary Total Hip Replacement|Terminated||Phase 4|48|Actual|Glostrup University Hospital, Copenhagen||2||Structural changes that stopped the type of operations used in the study|f||||t||||||||||2017-02-18 17:03:27.2852|2017-02-18 17:03:27.2852
NCT00236210|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2009-07-31|||August 2004||2004-08-01|July 2009|2009-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program|The Vascular Intervention Project (VIP): a Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program in the Algoma District of Northern Ontario|Completed||N/A|422|Actual|Group Health Centre||2|||f||||f||||||||||2017-02-18 17:03:27.394302|2017-02-18 17:03:27.394302
NCT00236197|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2009-11-04|2009-08-25||October 2005||2005-10-01|November 2009|2009-11-01|June 2008|Actual|2008-06-01|March 2006|Actual|2006-03-01||Interventional|||E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers|E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers|Completed||Phase 3|619|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:03:27.498137|2017-02-18 17:03:27.498137
NCT00236184|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2010-03-30|2009-08-26||October 2005||2005-10-01|March 2010|2010-03-01|June 2008|Actual|2008-06-01|March 2006|Actual|2006-03-01||Interventional|||E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers|E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers|Completed||Phase 3|629|Actual|Eisai Inc.||2|||f||||t||||||||||2017-02-18 17:03:27.957494|2017-02-18 17:03:27.957494
NCT00236171|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2010-06-07|||September 2004||2004-09-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|April 2006|Actual|2006-04-01||Interventional|||Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test|Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test|Completed||N/A|14|Actual|Technische Universität Dresden||1|||f||||f||||||||||2017-02-18 17:03:28.736058|2017-02-18 17:03:28.736058
NCT00236145|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2013-01-28|||June 2004||2004-06-01|October 2005|2005-10-01||||August 2005|Actual|2005-08-01||Interventional|||Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain|A Randomised, Open-label, Parallel-group Study to Evaluate the Efficacy and Safety of ACTIQ (Oral Transmucosal Fentanyl Citrate) Titrated According to 2 Regimens in Patients With Cancer and Breakthrough Pain|Completed||Phase 3|||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:03:28.924805|2017-02-18 17:03:28.924805
NCT00236132|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2007-10-11|||August 2001||2001-08-01|October 2007|2007-10-01|December 2008|Anticipated|2008-12-01|||||Observational|||"A Multicenter Study Comparing the Clinical Outcomes of the Nuss and Ravitch Procedures for Repair Of Pediatric Pectus Excavatum"|" A Multicenter Study Comparing the Clinical Outcomes of the Nuss and Ravitch Procedures for Repair of Pediatric Pectus Excavatum"|Unknown status|Active, not recruiting|N/A|360|Anticipated|Children's Health System, Inc.|||||f||||||||||||||2017-02-18 17:03:29.005999|2017-02-18 17:03:29.005999
NCT00236119|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2012-08-22|||June 2005||2005-06-01|August 2012|2012-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis|A 12-Week, Exploratory, Open-Label, Nonrandomized, Dose-Escalation Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe, Recalcitrant, Plaque Type Psoriasis|Completed||Phase 2|46|Actual|Teva Pharmaceutical Industries||4|||f||||||||||||||2017-02-18 17:03:29.093789|2017-02-18 17:03:29.093789
NCT00236106|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2005-12-08|||February 2005||2005-02-01|March 2005|2005-03-01|June 2005||2005-06-01|||||Interventional|||Short Term Growth in Children With Atopic Dermatitis||Completed||Phase 4|20||Children´s Clinic, Randers|||||f||||||||||||||2017-02-18 17:03:29.20351|2017-02-18 17:03:29.20351
NCT00236093|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-05-08|||October 2006||2006-10-01|May 2014|2014-05-01||||December 2006|Actual|2006-12-01||Interventional|||Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain|A 4-week, Open-Label Extension Study of ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC]) Treatment for Opioid-Tolerant Children and Adolescents With Breakthrough Pain|Completed||Phase 2|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:03:29.279713|2017-02-18 17:03:29.279713
NCT00236080|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2013-07-12|2009-06-01||August 2005||2005-08-01|July 2013|2013-07-01|December 2005||2005-12-01|||||Interventional|||Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil (150, 200, and 250 mg) and PROVIGIL® (200 mg) in Patients With Chronic Shift Work Sleep Disorder|Completed||Phase 3|136|Actual|Teva Pharmaceutical Industries|In analyzing the PVT data, it was discovered that data transfer errors had occurred at certain study centers. The ability to interpret the efficacy results from this study is limited, and the findings should be considered inconclusive.|5|||||||||||||||||2017-02-18 17:03:29.406901|2017-02-18 17:03:29.406901
NCT00236067|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-05-08|||October 2004||2004-10-01|May 2014|2014-05-01|March 2006||2006-03-01|||||Interventional|||A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder|A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Gabitril(up to 16 mg/Day) in the Treatment of Adults With Generalized Anxiety Disorder|Completed||Phase 3|440||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:03:30.140425|2017-02-18 17:03:30.140425
NCT00236054|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-05-08|||October 2004||2004-10-01|May 2014|2014-05-01|December 2005||2005-12-01|||||Interventional|||A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder|A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Gabitril (up to 16 mg/Day) in the Treatment of Adults With Generalized Anxiety Disorder|Completed||Phase 3|440||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:03:30.23682|2017-02-18 17:03:30.23682
NCT00236041|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-05-08|||April 2004||2004-04-01|May 2014|2014-05-01|August 2006||2006-08-01|||||Interventional|||Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)|A Double-Blind, Placebo-Comparison Study to Evaluate the Efficacy and Safety of ACTIQ® (Oral Transmucosal Fentanyl Citrate [OTFC®]) Treatment for Opioid-Tolerant Children and Adolescents With Breakthrough Pain|Completed||Phase 2|38||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:03:30.342388|2017-02-18 17:03:30.342388
NCT00236028|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-05-18||||||March 2010|2010-03-01|April 2003|Actual|2003-04-01|||||Interventional|||A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis|A Randomized, Double-blind, Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate Compared With Methotrexate Alone for the Treatment of Patients With Early Rheumatoid Arthritis|Completed||Phase 3|607|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:03:30.471911|2017-02-18 17:03:30.471911
NCT00236015|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2014-05-08|||November 2004||2004-11-01|May 2014|2014-05-01|March 2006||2006-03-01|||||Interventional|||A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder|A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Gabitril at 4, 8, and 12 mg/Day in the Treatment of Adults With Generalized Anxiety Disorder.|Completed||Phase 3|880||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:03:30.566394|2017-02-18 17:03:30.566394
NCT00236002|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-11|2009-08-11|||July 2005||2005-07-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|November 2007|Actual|2007-11-01||Interventional|||Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )|A Phase III, Double-blind, Randomized, Parallel Group, Placebo-controlled Study of Oral Fosamax, 70 mg Once a Week, for the Prevention of Androgen Deprivation Bone Loss in Non-metastatic Prostate Cancer|Terminated||Phase 3|182|Actual|Canadian Urology Research Consortium||1||Slow accrual than anticipated.|f||||f||||||||||2017-02-18 17:03:30.697431|2017-02-18 17:03:30.697431
NCT00235989|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2014-04-25|2009-01-30||June 2003||2003-06-01|April 2014|2014-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis|An Open-label Extension Study of the Double-blind, Randomized, Parallel Group, Multicenter Phase 2 Study 307000A to Further Evaluate the Safety and Tolerability of Betaseron® 500 mcg Subcutaneously Every Other Day and Betaseron® 250 mcg Subcutaneously Every Other Day in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)|Completed||Phase 2|63|Actual|Bayer|The 40 patients in the NAb frequency summaries are the total number of patients with NAb titers at week 234. Official HARTS-to-MedDRA Mapping was used.|4|||f||||f||||||||||2017-02-18 17:03:30.811828|2017-02-18 17:03:30.811828
NCT00235976|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2006-07-20|||May 2005||2005-05-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General Anesthesia|A Multicenter, Randomized, Controlled, Observer-Blinded, Dose-Response Study to Evaluate the Efficacy in Tracheal Intubation and Safety of Gantacurium Chloride for Injection in Healthy Adult Patients Undergoing Surgery With General Anesthesia|Completed||Phase 1/Phase 2|200||Avera Pharmaceuticals|||||f||||||||||||||2017-02-18 17:03:32.583113|2017-02-18 17:03:32.583113
NCT00235963|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2008-10-14|||December 2002||2002-12-01|October 2008|2008-10-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm|A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm|Completed||Phase 1/Phase 2|104||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:03:32.674932|2017-02-18 17:03:32.674932
NCT00235950|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2010-11-18|||January 2004||2004-01-01|November 2010|2010-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease|A Multicentre Study Comparing the Efficacy of Rosuvastatin With Atorvastatin When Given for a Period of 16 Wks to Subjects With Coronary Heart Disease & a Previously Performed Percutaneous Coronary Intervention|Completed||Phase 4|255||AstraZeneca|||||f||||||||||||||2017-02-18 17:03:32.767467|2017-02-18 17:03:32.767467
NCT00235937|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2011-01-20|||December 2001||2001-12-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|||||Interventional|||Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex|An Open, Phase II Trial Assessing the Objective Response Rate After Combination of Arimidex® 1mg Per os/Day and Zoladex® 3.6 mg Sub Cut/Monthly as 1st Treatment for Premenopausal Receptor Positive Advanced or Metastatic Breast Cancer|Completed||Phase 2|45|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 17:03:32.883333|2017-02-18 17:03:32.883333
NCT00235924|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2005-12-07|||June 2004||2004-06-01|October 2005|2005-10-01||||||||Interventional|||Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women|Study Assessing the Effects on Endometrium and Breast of a Standardized Isoflavone Extract(Phytosoya) in Post Menopausal Women.|Unknown status|Active, not recruiting|Phase 3|300||Laboratoires Arkopharma|||||f||||||||||||||2017-02-18 17:03:32.978455|2017-02-18 17:03:32.978455
NCT00235911|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-01-21|||September 2003||2003-09-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting|Effects of Symbicort Single Inhaler Therapy on Bronchial Hyper Responsiveness, Asthma Control and Safety in Mild to Moderate Asthmatics in General Practice, Compared to Usual Care Therapy|Completed||Phase 3|100||AstraZeneca|||||f||||||||||||||2017-02-18 17:03:33.060359|2017-02-18 17:03:33.060359
NCT00235898|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2008-08-22|||May 2005||2005-05-01|August 2008|2008-08-01||||March 2008|Actual|2008-03-01||Interventional|||Clinical Trial in Patients With Metastatic Colorectal Cancer|A Multi-Center, Open Label, Parallel Group, Randomised, Phase IIB Clinical Trial to Evaluate the Safety and Efficacy of CoFactor and 5-FU Versus Leucovorin and 5-FU in Subjects With Metastatic Colorectal Carcinoma|Completed||Phase 2|300|Actual|Mast Therapeutics, Inc.||2|||f||||t||||||||||2017-02-18 17:03:33.148523|2017-02-18 17:03:33.148523
NCT00235885|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2007-08-28|||July 2005||2005-07-01|August 2007|2007-08-01||||||||Interventional|STEREO||Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)|Safety and Efficacy of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) - An Open-Label, Multinational Study to Evaluate the Response to Every-Other Week Adalimumab When Added to Insufficient Standard Therapy, Including Patients Who Failed Prior Treatment With Other TNF-Inhibitors (STEREO)|Completed||Phase 3|445||Abbott|||||f||||||||||||||2017-02-18 17:03:33.282673|2017-02-18 17:03:33.282673
NCT00235872|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-04-07|2009-12-09||August 2004||2004-08-01|April 2011|2011-04-01||||July 2006|Actual|2006-07-01||Interventional|||Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis|Open-Label Continuous Administration Study With Adalimumab (D2E7) in Subjects With Rheumatoid Arthritis|Completed||Phase 3|309|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:03:33.393132|2017-02-18 17:03:33.393132
NCT00235859|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2007-08-28|||July 2003||2003-07-01|August 2007|2007-08-01||||||||Interventional|||Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate|A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Human Anti-TNF Antibody Adalimumab Administered as Subcutaneous Injections in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate|Completed||Phase 3|128|Actual|Abbott|||||f||||f||||||||||2017-02-18 17:03:37.159196|2017-02-18 17:03:37.159196
NCT00235846|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-10|2015-04-13|||December 2004||2004-12-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Endoscopic Vessel Harvesting During Coronary Bypass Surgery|Endoscopic Vessel Harvesting During Coronary Bypass Surgery|Completed||N/A|132|Actual|Aalborg Universitetshospital||2|||f||||f||||||||||2017-02-18 17:03:37.253872|2017-02-18 17:03:37.253872
NCT00235833|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2011-04-07|2009-10-12||June 2003||2003-06-01|April 2011|2011-04-01||||October 2004|Actual|2004-10-01||Interventional|||Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis|Long-term Continuously Repeated Dose Study of Adalimumab (D2E7) in Patients With Rheumatoid Arthritis|Completed||Phase 2|25|Actual|Abbott|Due to the small population, statistical tests were not performed.|1|||f||||f||||||||||2017-02-18 17:03:37.381484|2017-02-18 17:03:37.381484
NCT00235820|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2008-07-15|||July 2005||2005-07-01|June 2008|2008-06-01||||May 2006|Actual|2006-05-01||Interventional|CHAMPION||Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Phase 3, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study Comparing the Safety and Efficacy of Adalimumab to Methotrexate in Subjects With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 3|271|Actual|Abbott||3|||f||||f||||||||||2017-02-18 17:03:38.379496|2017-02-18 17:03:38.379496
NCT00235807|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2011-03-23|||June 2004||2004-06-01|March 2011|2011-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Multi-Site Randomized Clinical Study of Tinnitus Treatment Methods|Multi-Site Randomized Clinical Study of Tinnitus Treatment Methods|Completed||N/A|144|Anticipated|VA Office of Research and Development||3|||f||||||||||||||2017-02-18 17:03:38.489476|2017-02-18 17:03:38.489476
NCT00235794|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2007-12-18|||January 2004||2004-01-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients|An Open Label Study of Exploratory Pharmacogenomics and Pharmacologic Effects of Neoadjuvant Oral Temsirolimus in Newly Diagnosed Prostate Cancer Patients Undergoing Radical Prostatectomy Who Have a High Risk of Relapse|Completed||N/A|50|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:03:38.599258|2017-02-18 17:03:38.599258
NCT00235781|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2006-10-13|||January 2006||2006-01-01|October 2006|2006-10-01|February 2006||2006-02-01|||||Interventional|||Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients|Non-Phased Study of the Use of a Single Dose of Thymoglobulin for Immunosuppressive Induction in Renal Transplant Recipients as Compared to a Standard Four Dose Regimen|Terminated||N/A|90||Washington University School of Medicine|||||f||||||||||||||2017-02-18 17:03:38.681806|2017-02-18 17:03:38.681806
NCT00235768|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2005-10-06|||April 2002||2002-04-01|October 2004|2004-10-01|July 2005||2005-07-01|||||Observational|||The NeXT Study; The Netherlands XTC Toxicity Study|Neurotoxicity of Ecstasy: Causality, Course and Clinical Relevance|Completed||Phase 1|225||UMC Utrecht|||||f||||||||||||||2017-02-18 17:03:38.763893|2017-02-18 17:03:38.763893
NCT00235755|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2015-04-08|2011-07-07||December 2005||2005-12-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|RESTORE2||Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy|Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study - Determine Efficacy and Safety of Two Doses of Retigabine (900 Mg/Day and 600 Mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients With Partial-Onset Seizures|Completed||Phase 3|539|Actual|GlaxoSmithKline||3|||f||||f||||||||||2017-02-18 17:03:38.863845|2017-02-18 17:03:38.863845
NCT00235729|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2009-03-19|||June 2006||2006-06-01|March 2009|2009-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Lofexidine for Inpatient Opiate Detox|CSP #1024 - A Phase III, Randomized, Multi-Center, Double Blind, Placebo-Controlled Study of Safety and Efficacy of Lofexidine for Relief of Symptoms in Subjects Undergoing Inpatient Opiate Detoxification.|Completed||Phase 3|264|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:03:40.756598|2017-02-18 17:03:40.756598
NCT00235716|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2014-07-14|2013-12-06||August 2007||2007-08-01|July 2014|2014-07-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional|TEAM-AD||A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease|CSP #546 - A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease (TEAM-AD)|Completed||Phase 3|613|Actual|VA Office of Research and Development||4|||f||||t||||||||||2017-02-18 17:03:40.905721|2017-02-18 17:03:40.905721
NCT00235703|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2006-05-04|||October 2001||2001-10-01|October 2005|2005-10-01|September 2005||2005-09-01|||||Observational|||Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)|Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)|Completed||N/A|13000||University of Utah|||||f||||||||||||||2017-02-18 17:03:45.498159|2017-02-18 17:03:45.498159
NCT00235690|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2015-12-16|||June 2008||2008-06-01|December 2015|2015-12-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)|Pharmacokinetics and Pharmacodynamics of Intravenous Colistin- Pilot Study|Completed||N/A|10|Anticipated|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 17:03:45.575247|2017-02-18 17:03:45.575247
NCT00235677|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2005-10-06|||August 2003||2003-08-01|July 2005|2005-07-01|August 2005||2005-08-01|||||Interventional|||Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study|A Blinded, Randomized, Sham-Controlled Trial of Endoscopic Gastroplication for the Treatment of Gastroesophageal Reflux Disease|Completed||Phase 3|60||UMC Utrecht|||||f||||||||||||||2017-02-18 17:03:45.683265|2017-02-18 17:03:45.683265
NCT00235664|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2008-12-16|||October 2005||2005-10-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Observational|||Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients|Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients|Completed||N/A|200|Anticipated|University of Pittsburgh|||1||f||||||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 17:03:45.789595|2017-02-18 17:03:45.789595
NCT00235651|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2008-12-16|||October 2005||2005-10-01|December 2008|2008-12-01|April 2006|Actual|2006-04-01|||||Interventional|||Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients|Pharmacokinetic and Deposition Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet®) in Lung Transplant Recipients (Radiotagging Protocol)|Terminated||Phase 3|12||University of Pittsburgh||||study completed|f||||||||||||||2017-02-18 17:03:45.883594|2017-02-18 17:03:45.883594
NCT00235625|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2007-12-12|||October 2005||2005-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris|A Phase II Open Label Study of the Safety and Efficacy of Curcuminoids C3 Complex® in Patients With Chronic Psoriasis Vulgaris.|Completed||Phase 2|12|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 17:03:45.98121|2017-02-18 17:03:45.98121
NCT00235599|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2007-05-15|||September 2005||2005-09-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Observational|||The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.|The Insulin-Like Growth Factor Binding Protein-3 Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.|Completed||N/A|10|Actual|University of Massachusetts, Worcester|||||f||||f||||||||||2017-02-18 17:03:46.075483|2017-02-18 17:03:46.075483
NCT00235586|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2007-09-18|||April 2004||2004-04-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Vitamin D Deficiency: Bone Loss and Vascular Dysfunction|Vitamin D Deficiency: Bone Loss and Vascular Dysfunction|Completed||N/A|40||University of Kansas Medical Center|||||f||||f||||||||||2017-02-18 17:03:46.16528|2017-02-18 17:03:46.16528
NCT00235573|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2011-12-15|2011-09-30||October 2005||2005-10-01|December 2011|2011-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption|Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption|Completed||N/A|21|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 17:03:46.269867|2017-02-18 17:03:46.269867
NCT00234780|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2007-08-15|||October 1997||1997-10-01|October 2005|2005-10-01|August 2000||2000-08-01|||||Interventional|||In Home Hospital Care Program|In Home Hospital Care Program|Completed||N/A|200||University of Rochester|||||f||||||||||||||2017-02-18 17:04:09.091973|2017-02-18 17:04:09.091973
NCT00235560|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-06-19|||June 2005||2005-06-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|LAM-RAPA||Rapamycin in Combination With Low-Dose Aracytin in Elderly Acute Myeloid Leukemia Patients|Rapamycin in Combination With Low-Dose Aracytin in Elderly Acute Myeloid Leukemia Patients. A Study From the Groupe Ouest Est d'étude Des Leucémies Aiguës Myéloïdes (GOELAMS)|Completed||Phase 2|50|Actual|University Hospital, Toulouse||1|||f||||f||||||||||2017-02-18 17:03:46.509302|2017-02-18 17:03:46.509302
NCT00235547|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2013-07-01|||August 2005||2005-08-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|May 2006|Actual|2006-05-01||Interventional|||Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion|Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion: A Randomized Trial|Completed||N/A|300|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 17:03:46.623097|2017-02-18 17:03:46.623097
NCT00235534|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2012-11-16|||October 2005||2005-10-01|November 2012|2012-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Trial of Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Abortion|Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Therapeutic Abortion - A Randomized Trial|Completed||N/A|300|Actual|University of California, San Francisco||2|||f||||||||||||||2017-02-18 17:03:46.728273|2017-02-18 17:03:46.728273
NCT00235521|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2012-12-11|||May 2005||2005-05-01|December 2012|2012-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery|Comparison of Inhaled Nitric Oxide With Aerosolized Iloprost (Ventavis®) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery|Completed||N/A|15|Actual|Heidelberg University|||||f||||t||||||||||2017-02-18 17:03:46.832371|2017-02-18 17:03:46.832371
NCT00235508|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2012-02-21|||June 2005||2005-06-01|February 2012|2012-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder|The Efficacy of Eszopiclone 3 mg as Adjunctive Therapy in Subjects With Insomnia Related to Generalized Anxiety Disorder.|Completed||Phase 4|420|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 17:03:46.933892|2017-02-18 17:03:46.933892
NCT00235495|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-11-14|||June 2006||2006-06-01|November 2012|2012-11-01|June 2014|Anticipated|2014-06-01|February 2013|Anticipated|2013-02-01||Interventional|ALIAS||Albumin in Acute Ischemic Stroke Trial|A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke|Terminated||Phase 3|843|Actual|University of Miami||2||Recruitment halted by DSMB following interim analysis.|f||||t||||||||||2017-02-18 17:03:47.339984|2017-02-18 17:03:47.339984
NCT00235482|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2007-09-12|||August 2005||2005-08-01|September 2007|2007-09-01||||||||Interventional|||Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma|Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma|Completed||Phase 1|3||Viralytics|||||f||||||||||||||2017-02-18 17:03:47.485491|2017-02-18 17:03:47.485491
NCT00235469|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2014-09-19|||April 2004||2004-04-01|February 2010|2010-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Efficacy and Safety OF 200, 400, AND 600 mg/Day SPM 927 in Subjects With Painful Distal Diabetic Neuropathy|Completed||Phase 2/Phase 3|496|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:03:47.582642|2017-02-18 17:03:47.582642
NCT00235456|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2016-12-18|2016-06-20||March 2003||2003-03-01|December 2016|2016-12-01|January 2005|Actual|2005-01-01|October 2004|Actual|2004-10-01||Interventional|||Supplemental Oxygen Reduces Surgical Infection|Supplemental Perioperative Oxygen Reduces the Risk of Surgical Wound Infection: A Randomized, Double-blind Trial|Completed||N/A|300|Actual|The Cleveland Clinic||2|||f||||t||||||||No||2017-02-18 17:03:47.679931|2017-02-18 17:03:47.679931
NCT00235443|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2014-09-19|2009-08-31||September 2004||2004-09-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy|A Multi-Center, Open-Label, Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy|Completed||Phase 2/Phase 3|451|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:03:48.108117|2017-02-18 17:03:48.108117
NCT00235417|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2007-06-07|||October 2005||2005-10-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Stem Cell Therapy in Chronic Ischemic Heart Failure||Completed||Phase 2|35|Anticipated|Odense University Hospital|||||f||||||||||||||2017-02-18 17:03:51.368331|2017-02-18 17:03:51.368331
NCT00235404|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2016-07-28|||September 2003||2003-09-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|||||Interventional|||Randomized Controlled Trial of Health Care to Elderly Patients.|Specialized Treatment and Care Intervention at a Primary Level in a Nursing Home Compared to Conventional Treatment at a Hospital: a Randomized Controlled Trial.|Completed||N/A|142|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:03:51.502128|2017-02-18 17:03:51.502128
NCT00235391|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2011-06-03|2010-12-17||October 2005||2005-10-01|June 2011|2011-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload|A Study to Provide Expanded Access of (Exjade®) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators|Completed||Phase 3|1683|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:03:51.620105|2017-02-18 17:03:51.620105
NCT00235378|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2015-10-13|||July 1996||1996-07-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Observational|||Genetic Study of Lupus Patients and Their Families|Gene Mapping in Women With SLE|Completed||N/A|2356|Actual|Oklahoma Medical Research Foundation|||3||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 17:03:53.4737|2017-02-18 17:03:53.4737
NCT00235365|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2012-11-21|||August 2009||2009-08-01|November 2012|2012-11-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Metacognitive Therapy for Comorbid Insomnia|Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia.|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||2||problems recruiting patients|f||||f||||||||||2017-02-18 17:03:53.57386|2017-02-18 17:03:53.57386
NCT00234390|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2011-01-21|||November 1998||1998-11-01|January 2011|2011-01-01|December 2004|Actual|2004-12-01|||||Interventional|||PreAsthmaControl (PAC)|Prevention of Asthma in Infants/Young Children - PAC|Completed||Phase 4|400||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:12.84504|2017-02-18 17:04:12.84504
NCT00235352|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2009-02-25|||February 2002||2002-02-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|April 2005|Actual|2005-04-01||Interventional|CX516||Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia|A Placebo-Controlled Trial of CX516 (Ampakine) Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia|Completed||Phase 2/Phase 3|105|Actual|North Suffolk Mental Health Association||1|||f||||t||||||||||2017-02-18 17:03:53.669725|2017-02-18 17:03:53.669725
NCT00235339|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-07|2012-05-11|||October 2005||2005-10-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|February 2008|Actual|2008-02-01||Interventional|||Effect of Standard Care Rehabilitation Versus Interval Treadmill Training After Myocardial Infarction|Comparative Study of Training Modality After Myocardial Infarction; Standard Care Rehabilitation Training or Interval Treadmill Training|Completed||N/A|89|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:03:53.768926|2017-02-18 17:03:53.768926
NCT00235326|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2009-03-16|2009-02-05||January 2002||2002-01-01|March 2009|2009-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario|Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario|Completed||N/A|4561|Actual|McMaster University|||2||f||||f||||||||||2017-02-18 17:03:53.883139|2017-02-18 17:03:53.883139
NCT00235313|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2008-03-28|||October 2005||2005-10-01|March 2007|2007-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|ADONIS||Adjustment of DOses of NIcotine in Smoking Cessation (ADONIS)|Does Dose Adjustment of Nicotine Replacement Therapies According to Saliva Cotinine Increase Efficacy of These Treatments of Assistance To the Nicotinic Weaning Of the High-Risk Patients?|Completed||Phase 4|300|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:03:54.225033|2017-02-18 17:03:54.225033
NCT00235300|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2015-03-17|||May 2000||2000-05-01|March 2015|2015-03-01|June 2005|Actual|2005-06-01|April 2003|Actual|2003-04-01||Interventional|||An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.|An Open-Label Prospective, Randomized, Multicenter Phase II Comparative Trial of Thymoglobulin® Versus Simulect® for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients|Completed||Phase 2|240|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:03:54.336294|2017-02-18 17:03:54.336294
NCT00235287|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2009-01-16|||September 2005||2005-09-01|January 2009|2009-01-01||||||||Interventional|||Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease|Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease: An Interventional and Methodological Study|Unknown status|Recruiting|Phase 4|60|Anticipated|Herlev Hospital||4|||f||||t||||||||||2017-02-18 17:03:54.477996|2017-02-18 17:03:54.477996
NCT00235274|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2006-07-18|||November 2005||2005-11-01|July 2006|2006-07-01|August 2006||2006-08-01|||||Interventional|||Effects of RG1068 (Secretin) on Information Processing in Schizophrenia|Effects of RG1068 (Secretin) on Information Processing in Schizophrenia|Completed||Phase 2|30||Indiana University|||||||||||||||||||2017-02-18 17:03:54.58052|2017-02-18 17:03:54.58052
NCT00235261|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2007-08-16|||October 2005||2005-10-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients After Hip Operations|Effect of Paracetamol Versus Paracetamol Combined With Pregabalin Versus Paracetamol Combined With Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for a Primary Total Hip Replacement|Completed||Phase 4|120|Anticipated|Glostrup University Hospital, Copenhagen|||||f||||t||||||||||2017-02-18 17:03:54.668067|2017-02-18 17:03:54.668067
NCT00235248|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2012-07-06|||February 2002||2002-02-01|July 2012|2012-07-01|July 2012|Actual|2012-07-01|December 2010|Actual|2010-12-01||Interventional|ARCH||Aortic Arch Related Cerebral Hazard Trial (ARCH)|Prevention of New Vascular Events in Patients With Brain Infarction or Peripheral Embolism and Thoracic Aortic Plaques ≥ 4 mm in Thickness in the Aortic Arch or Descending Aortic Upstream to the Embolized Artery|Completed||Phase 3|350|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:03:54.761127|2017-02-18 17:03:54.761127
NCT00235235|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2015-12-08|||September 2005||2005-09-01|December 2015|2015-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer|Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study: Hoosier Oncology Group COE-01|Terminated||N/A|80|Actual|Hoosier Cancer Research Network|||4|Funding terminated|f||||t||||||Samples With DNA|"~     core biopsy, serum, urine~   "|||2017-02-18 17:03:55.035445|2017-02-18 17:03:55.035445
NCT00235222|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2005-10-24|||June 2004||2004-06-01|October 2005|2005-10-01|March 2006||2006-03-01|||||Interventional|||Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY|Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY|Unknown status|Active, not recruiting|Phase 4|57||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-02-18 17:03:55.16469|2017-02-18 17:03:55.16469
NCT00235209|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2011-06-08|||November 2004||2004-11-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers|A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers|Completed||Phase 4|48||Ethicon, Inc.|||||f||||||||||||||2017-02-18 17:03:55.251879|2017-02-18 17:03:55.251879
NCT00235196|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2006-10-12|||July 2004||2004-07-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers|A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers|Completed||Phase 4|48||Ethicon, Inc.|||||f||||||||||||||2017-02-18 17:03:55.330307|2017-02-18 17:03:55.330307
NCT00235183|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2014-02-14|||June 2005||2005-06-01|February 2014|2014-02-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Plasma Transfusion in Liver Transplantation|Plasma Transfusion in Liver Transplantation : a Randomized, Double Blind, Multicenter Trial of Methylene Blue, Solvent/Detergent and Quarantined Plasma.|Completed||Phase 4|300|Anticipated|Etablissement Français du Sang||3|||f||||||||||||||2017-02-18 17:03:55.41473|2017-02-18 17:03:55.41473
NCT00235170|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2009-05-04|||February 2003||2003-02-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|December 2004|Actual|2004-12-01||Interventional|ARTS II||The Arterial Revascularization Therapies Study Part II.|ARTS II: Arterial Revascularization Therapies Study Part II of the Sirolimus-Eluting Bx VELOCITY™ Balloon Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions.|Completed||Phase 3|607|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 17:03:55.526254|2017-02-18 17:03:55.526254
NCT00235157|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2008-08-05|||November 2001||2001-11-01|August 2008|2008-08-01|July 2005|Actual|2005-07-01|November 2002|Actual|2002-11-01||Interventional|GREAT||A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.|Palmaz Genesis Peripheral Stainless Steel Balloon Expandable Stent, Comparing a Sirolimus Coated Versus an Uncoated Stent in REnal Artery Treatment.|Completed||Phase 2|105|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 17:03:55.643596|2017-02-18 17:03:55.643596
NCT00235144|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2009-05-08|||March 2001||2001-03-01|May 2009|2009-05-01|September 2008|Actual|2008-09-01|October 2002|Actual|2002-10-01||Interventional|E-SIRIUS||The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.|E-Sirius Study: a European, Multi-Center, Randomized, Double-Blind Study of the Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions|Completed||Phase 3|353|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:03:55.75125|2017-02-18 17:03:55.75125
NCT00235131|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2010-02-03|||May 2005||2005-05-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|March 2008|Actual|2008-03-01||Interventional|SUPER SL||The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent|A Clinical Investigation of the Cordis S.M.A.R.T. ™ CONTROL ™ Nitinol Stent System Versus the Bard® Luminexx™ 6F Vascular Stent for the Treatment of TASC C & D Superficial Femoral Artery Long Lesions|Completed||Phase 4|200|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:03:55.863479|2017-02-18 17:03:55.863479
NCT00235118|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2005-12-08|||December 1999||1999-12-01|October 2005|2005-10-01|February 2006||2006-02-01|||||Interventional|||Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)|An Evaluation of the Safety and Effectiveness of the Cordis Bilateral AAA Device Compared to Open Surgical Repair for the Treatment of Abdominal Aortic Aneurysm|Completed||Phase 1/Phase 2|29||Cordis Corporation|||||||||||||||||||2017-02-18 17:03:56.158758|2017-02-18 17:03:56.158758
NCT00235105|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2005-12-08|||March 2005||2005-03-01|October 2005|2005-10-01|June 2007||2007-06-01|||||Interventional|||D2E7-Early AS|Adalimumab in Early Axial Spondyloarthritis (Without Radiological Sacroiliitis): Placebo Controlled Phase Over 3 Months Followed by a 9 Months Open Extension Phase|Unknown status|Active, not recruiting|Phase 2/Phase 3|46||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:03:56.247964|2017-02-18 17:03:56.247964
NCT00235092|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-04-25|||August 2003||2003-08-01|April 2007|2007-04-01|March 2006||2006-03-01|||||Interventional|||The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus|A Prospective, Randomized, Multi-Center Comparison of the Cypher Sirolimus-Eluting and the Taxus Paclitaxel-Eluting Stent Systems.|Completed||Phase 4|1335||Cordis Corporation|||||f||||t||||||||||2017-02-18 17:03:56.350098|2017-02-18 17:03:56.350098
NCT00235079|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2013-08-06|||November 2005||2005-11-01|August 2013|2013-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|CORP 2||Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.|Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis.|Completed||Phase 4|240|Actual|Azienda Sanitaria Locale 3, Torino||2|||f||||t||||||||||2017-02-18 17:03:56.449307|2017-02-18 17:03:56.449307
NCT00235066|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2008-09-15|||November 2002||2002-11-01|September 2008|2008-09-01|April 2006|Actual|2006-04-01|November 2003|Actual|2003-11-01||Interventional|SVELTE||The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.|A Multicenter, Nonrandomized, Historical Controlled Study In Patients With De Novo Coronary Artery Lesions In Small VessELs Treated With The CYPHER™ STEnt|Completed||Phase 4|100|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 17:03:56.569062|2017-02-18 17:03:56.569062
NCT00235053|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2006-01-30|||August 2005||2005-08-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID|A Pilot Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID as Assessed by the Development of Laryngitis and Oropharyngeal Candidiasis in Adults With Mild Persistent Asthma|Unknown status|Active, not recruiting|Phase 4|13||Allergy & Asthma Medical Group & Research Center|||||f||||||||||||||2017-02-18 17:03:56.674454|2017-02-18 17:03:56.674454
NCT00235040|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2012-01-24|||November 2005||2005-11-01|January 2012|2012-01-01|August 2007|Actual|2007-08-01|May 2006|Actual|2006-05-01||Interventional|||Evaluating the Effectiveness of the Acute Respiratory Infection Smart Form|Evaluating Smart Forms and Quality Dashboards in an EHR: Effectiveness of the Acute Respiratory Infection Smart Form|Completed||N/A|18257|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-02-18 17:03:56.774834|2017-02-18 17:03:56.774834
NCT00235027|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2015-07-20|||August 2000||2000-08-01|July 2015|2015-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Improving Safety By Computerizing Outpatient Prescribing|Improving Safety By Computerizing Outpatient Prescribing|Completed||N/A|701|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||||||||||||2017-02-18 17:03:56.872385|2017-02-18 17:03:56.872385
NCT00235014|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-11|||March 1997||1997-03-01|June 2008|2008-06-01||||January 2006|Actual|2006-01-01||Interventional|BENEDICT||A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)|A Two-Phase Study for Primary and Secondary Prevention of Diabetic Nephropathy by Combined ACE Inhibition and Calcium Channel Blockade (BENEDICT)|Completed||Phase 4|1204|Actual|Abbott||4|||f||||f||||||||||2017-02-18 17:03:56.985127|2017-02-18 17:03:56.985127
NCT00235001|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-09|||June 2004||2004-06-01|July 2008|2008-07-01||||November 2006|Actual|2006-11-01||Interventional|||Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension|A Multicenter, Open, Phase IV, 24-Hour Ambulatory Blood Pressure Monitoring Study of the Efficacy and Safety of Tarka in Patients With Arterial Hypertension|Completed||Phase 4|120|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:03:57.095793|2017-02-18 17:03:57.095793
NCT00234988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-11|||June 2004||2004-06-01|July 2008|2008-07-01||||January 2006|Actual|2006-01-01||Interventional|||A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.|Safety and Weight Reduction of Sibutramine in the Treatment of Thai Obese and Overweight Subjects|Completed||Phase 4|93|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:03:57.208377|2017-02-18 17:03:57.208377
NCT00234975|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-02|||October 2002||2002-10-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score|Evaluation of Clinical Response and Safety in HIV Positive Subjects Co-infected With Hepatitis C Treated With a Kaletra Containing HAART Regimen|Completed||Phase 4|86|Actual|AbbVie||2|||f||||f||||||||||2017-02-18 17:03:57.320255|2017-02-18 17:03:57.320255
NCT00234962|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-11-19|||August 2002||2002-08-01|November 2008|2008-11-01|February 2007|Actual|2007-02-01|||||Interventional|||Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy|Factors Associated With Adherence in a Cohort of HIV Positive Subjects on a First Time PI Containing HAART Regimen: Observational Study of the Impact of Adherence on Viral Load for a HAART Regimen Containing Kaletra vs Other Selected PI Containing HAART.|Terminated||Phase 4|200||Abbott|||||f||||||||||||||2017-02-18 17:03:57.439162|2017-02-18 17:03:57.439162
NCT00234949|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-23|||March 2005||2005-03-01|October 2007|2007-10-01||||||||Interventional|||A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections|A Comparative Study of the Safety, Tolerability, and Efficacy of Cefdinir and Cephalexin for the Treatment of Subjects With Mild to Moderate Uncomplicated Skin and Skin Structure Infections|Completed||Phase 4|380||Abbott|||||f||||||||||||||2017-02-18 17:03:57.523267|2017-02-18 17:03:57.523267
NCT00234936|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-10-02|||December 2003||2003-12-01|October 2007|2007-10-01||||||||Interventional|||Quality of Life Study With Adalimumab in Rheumatoid Arthritis|Quality of Life Study With Adalimumab in Rheumatoid Arthritis|Completed||Phase 3|200|Actual|Abbott|||||f||||||||||||||2017-02-18 17:03:57.606084|2017-02-18 17:03:57.606084
NCT00234923|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-01|||August 2003||2003-08-01|April 2008|2008-04-01||||February 2007|Actual|2007-02-01||Interventional|MONARK||Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients|A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen Versus Lopinavir/Ritonavir in Combination With Lamivudine/Zidovudine in Antiretroviral Naïve Patients|Completed||Phase 3|138|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:03:57.687476|2017-02-18 17:03:57.687476
NCT00234910|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-09|||January 2005||2005-01-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|KALEAD||Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients|A Phase III, Open Label, Randomized, Comparative Study of the Antiviral Efficacy of ARV Therapy With Lopinavir/Ritonavir (LPV/r-Kaletra) in Combination With Tenofovir (TDF) Versus Standard of Care (Kaletra in Combination With 2 Nucleoside RTIs) in naïve-HIV-1 Positive Patients|Completed||Phase 3|152|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:03:57.789318|2017-02-18 17:03:57.789318
NCT00234897|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-28|||August 2004||2004-08-01|August 2007|2007-08-01||||||||Interventional|HERO||Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis|Humira Efficacy Response Optimization Study in Subjects With Active Rheumatoid Arthritis (HERO)|Completed||Phase 4|1938|Actual|Abbott|||||f||||f||||||||||2017-02-18 17:03:57.896856|2017-02-18 17:03:57.896856
NCT00234884|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-08-25|2011-07-15||September 2003||2003-09-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|ReAlise||Post-marketing Observational Study in Subjects With Rheumatoid Arthritis|A Five-year, Post-marketing Observational Study to Follow-up Patients With Rheumatoid Arthritis Formerly Treated in Study M02-497 (ReAct) and Subsequently Prescribed Humira|Completed||Phase 4|3435|Actual|Abbott|||1||f||||f||||||||||2017-02-18 17:03:58.016465|2017-02-18 17:03:58.016465
NCT00234871|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-11|||January 2004||2004-01-01|July 2008|2008-07-01||||March 2005|Actual|2005-03-01||Interventional|TANDEM||Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)|A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka® and Lotrel® on Albuminuria in Hypertensive, Type 2 Diabetic Subjects With Diabetic Nephropathy|Completed||Phase 4|357|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:03:59.785285|2017-02-18 17:03:59.785285
NCT00234858|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-11|||March 2004||2004-03-01|June 2008|2008-06-01||||April 2006|Actual|2006-04-01||Interventional|STAR||Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)|A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka® and Hyzaar® on Glucose Tolerance in Subjects With Metabolic Syndrome|Completed||Phase 4|280|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:03:59.894769|2017-02-18 17:03:59.894769
NCT00234845|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-28|||March 2003||2003-03-01|August 2007|2007-08-01||||||||Interventional|||Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis|A Multi-Centre Randomized, Double-Blind Study Comparing Adalimumab (D2E7) Plus Methotrexate With Placebo Plus Methotrexate on Work Disability in Subjects With Early Rheumatoid Arthritis|Completed||Phase 3|148|Actual|Abbott|||||f||||f||||||||||2017-02-18 17:03:59.98978|2017-02-18 17:03:59.98978
NCT00234832|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-06|2010-03-26||January 2003||2003-01-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|March 2009|Actual|2009-03-01||Interventional|SCOUT||A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients|Sibutramine Cardiovascular Morbidity/Mortality Outcomes Study in Overweight or Obese Subjects at Risk of a Cardiovascular Event|Completed||Phase 3|10777|Actual|Abbott|Most subjects not indicated for sibutramine (sbt) due to CV disease. Long-term sbt use (6 yrs) regardless of weight loss, is inconsistent with label (limits use to 1-2 yrs & 5% weight loss). Trial lacked true placebo; all received Lead-in Period sbt.|3|||f||||t||||||||||2017-02-18 17:04:00.133639|2017-02-18 17:04:00.133639
NCT00234819|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2007-12-19|||October 2005||2005-10-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause|A Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Bazedoxifene/Conjugated Estrogen Combinations for Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|325||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:04:08.810784|2017-02-18 17:04:08.810784
NCT00234806|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2015-10-21|||December 2000||2000-12-01|October 2015|2015-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Health-e-Access Telemedicine in Primary Pediatric Care|Health-e-Access: A Study of Telemedicine in Primary Pediatric Care in Rochester, NY|Completed||N/A|2000|Actual|University of Rochester||2|||f||||||||||||||2017-02-18 17:04:08.898155|2017-02-18 17:04:08.898155
NCT00234793|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-11|||May 2003||2003-05-01|June 2015|2015-06-01|April 2010||2010-04-01|||||Interventional|||Maternal Problem-Solving in Childhood Cancer|Maternal Problem-Solving in Childhood Cancer|Completed||Phase 3|433|Actual|University of Rochester|||||f||||||||||||||2017-02-18 17:04:08.996174|2017-02-18 17:04:08.996174
NCT00234767|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2008-11-05|||September 2001||2001-09-01|November 2008|2008-11-01||||August 2007|Actual|2007-08-01||Observational|||Study of the Economics of Pulmonary Artery Catheter Use in Patients With Acute Respiratory Distress Syndrome (ARDS)|Economic Analysis of Pulmonary Artery Catheter Use (EA-PAC)|Completed||Phase 3|650||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:04:09.179233|2017-02-18 17:04:09.179233
NCT00234754|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2016-08-29|||September 2005||2005-09-01|August 2016|2016-08-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in Women|Surgical Management of Stress Urinary Incontinence in Women: A Randomized Clinical Trial (RCT) of TOT vs TVT|Completed||N/A|199|Actual|University of Calgary||2|||f||||f||||||||Undecided|Decision to share will depend on review of IPD protocol|2017-02-18 17:04:09.261231|2017-02-18 17:04:09.261231
NCT00234741|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2008-12-03|||November 2005||2005-11-01|December 2008|2008-12-01||||||||Interventional|||Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease|A Randomized, Double-Blind, Pilot Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, to Investigate Peripheral Blood and Mucosal Mononuclear Cell Phenotype and Cytokine Responses in Patients With Crohn's Disease|Completed||Phase 2|12||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-02-18 17:04:09.374214|2017-02-18 17:04:09.374214
NCT00234728|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2008-06-30|||September 2005||2005-09-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of a New Dressing for Use With Topical Medications|An Open-Label, Bilaterally-Controlled Single Center Study to Compare the Efficacy of Occlusion of Topical Agents With a Hydrophilic Occlusive Dressing to Treatment With Occlusive Dressing Without the Addition of Topical Agents|Completed||N/A|120|Anticipated|Teikoku Pharma USA|||||f||||||||||||||2017-02-18 17:04:09.457829|2017-02-18 17:04:09.457829
NCT00234715|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2007-11-13|||October 2005||2005-10-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|||||Observational|||Psychosocial Study on Breast Cancer Risk Assessment|A Pilot Study: Psychosocial and Socio-Demographic Determinants of Accepting Breast Cancer Risk Assessment|Completed||N/A|62|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 17:04:09.54117|2017-02-18 17:04:09.54117
NCT00234702|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2010-04-29|||October 2005||2005-10-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease|A Phase II, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy and Safety of Lanthanum Carbonate for the Reduction of Serum Phosphorus in Subjects With Stage 3 and 4 Chronic Kidney Disease Who Have Elevated Serum Phosphorus Levels|Completed||Phase 2|84|Anticipated|Shire||2|||f||||||||||||||2017-02-18 17:04:09.62845|2017-02-18 17:04:09.62845
NCT00234689|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2008-01-28|||January 2002||2002-01-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:04:09.739524|2017-02-18 17:04:09.739524
NCT00234676|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2007-12-24|||October 2003||2003-10-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease|A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study for the Safety, Tolerability and Efficacy of Estrogen Replacement Therapy (Conjugated Equine Estrogens 0.625 mg Daily) in Post Menopausal Women With Parkinson's Disease|Completed||Phase 2|23|Actual|The Parkinson Study Group||1|||f||||||||||||||2017-02-18 17:04:09.820086|2017-02-18 17:04:09.820086
NCT00234663|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-01-09|||September 2005||2005-09-01|January 2009|2009-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||PTC124 for Cystic Fibrosis|A Phase 2 Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis|Completed||Phase 2|24||PTC Therapeutics|||||||||||||||||||2017-02-18 17:04:09.935021|2017-02-18 17:04:09.935021
NCT00234650|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-04-01|||October 2005||2005-10-01|December 2008|2008-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Adenoma Detection Rate With Position Change at Colonoscopy|Evaluation of the Effect of Position Change During the Withdrawal Phase of Colonoscopy on Adenoma Detection Rate|Completed||N/A|130|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 17:04:10.033685|2017-02-18 17:04:10.033685
NCT00234637|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2011-11-16|||November 2003||2003-11-01|November 2011|2011-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment|An Open-label Study to Evaluate the Efficacy and Safety of add-on Memantine [5-10 mg b.i.d (10-20 mg/Day)] to Rivastigmine [1.5-6 mg b.i.d. (3-12 mg/Day)] Treatment in Patients With Alzheimer's Disease Who Continued With Rivastigmine Treatment After a Previous Decline While on Donepezil or Galantamine Treatment|Completed||Phase 4|204|Actual|Novartis|||||f||||||||||||||2017-02-18 17:04:10.11866|2017-02-18 17:04:10.11866
NCT00234624|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2005-10-05|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Observational|||Hepatic Hemodynamic Changes and Simulation in Living-Related Liver Transplantation|Hepatic Hemodynamic Changes and Simulation Before /After Living-Related Liver Transplantation in Donors/Recipients|Unknown status|Recruiting|N/A|10||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:04:10.20858|2017-02-18 17:04:10.20858
NCT00234611|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2006-11-02|||September 2005||2005-09-01|November 2006|2006-11-01|April 2007||2007-04-01|||||Interventional|||Localization of CRT According to Echocardiography: LOCATE-Pilot Study|Localization of CRT According to Echocardiography: LOCATE-Pilot Study|Unknown status|Active, not recruiting|N/A|60||Michigan Heart, PC|||||f||||||||||||||2017-02-18 17:04:10.275784|2017-02-18 17:04:10.275784
NCT00234598|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2015-12-04|||March 2002||2002-03-01|December 2015|2015-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Strategies to Prevent Pneumonia (SToP Pneumonia)|Oral Care Intervention in Mechanically Ventilated Adults|Completed||Phase 2|547|Actual|Virginia Commonwealth University||4|||f||||f||||||||||2017-02-18 17:04:10.367381|2017-02-18 17:04:10.367381
NCT00234585|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2014-12-09|||August 2002||2002-08-01|December 2014|2014-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection|A Prospective Randomized Multicenter Study Comparing the Safety and Efficacy of Renal Artery Stenting With/Without Distal Protection Device (AngioGuard) and With/Without the Use of a Platelet Aggregator Inhibitor (Abciximab-Reopro) (RESIST)|Completed||Phase 2|100||University of Toledo Health Science Campus|||||f||||||||||||||2017-02-18 17:04:10.477981|2017-02-18 17:04:10.477981
NCT00234572|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2009-11-16|||May 2000||2000-05-01|November 2009|2009-11-01|January 2003||2003-01-01|||||Interventional|||Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly|Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.|Completed||Phase 2/Phase 3|96||Ipsen|||||||||||||||||||2017-02-18 17:04:10.596761|2017-02-18 17:04:10.596761
NCT00234559|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2013-08-19|||September 2005||2005-09-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis|A Randomized Controlled Study Comparing Vacuum Assisted Closure® Therapy to Moist Wound Therapy in Angiogenesis|Withdrawn||N/A|0|Actual|KCI USA, Inc.||||Study terminated due to no subject enrollment.|f||||||||||||||2017-02-18 17:04:10.789089|2017-02-18 17:04:10.789089
NCT00234546|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-06|2012-06-18|||February 2003||2003-02-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|||||Interventional|||Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity|A 24-week Prospective, Multicentre, Randomised, Double-blind, Placebo Controlled Study of Dysport® Injection for the Treatment of Upper Limb Spasticity in Early Stroke.|Completed||Phase 4|162|Actual|Ipsen||2|||f||||||||||||||2017-02-18 17:04:10.864734|2017-02-18 17:04:10.864734
NCT00234533|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-05-14|||June 2004||2004-06-01|May 2009|2009-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|OPTIMA||Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq|Phase IIIB, International, Single Group, Open Study to Define an Optimal Monitoring of IGF-1 in Children Treated With NutropinAq, Using a Novel Capillary Blood Collection Method|Completed||Phase 3|250|Actual|Ipsen||1|||f||||f||||||||||2017-02-18 17:04:10.973327|2017-02-18 17:04:10.973327
NCT00234520|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2008-06-26|||May 2003||2003-05-01|June 2008|2008-06-01||||||||Observational|||A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide|A Multicentre Prospective Controlled Observer Blinded Cohort Study in Patients With Acromegaly to Evaluate the Risk of Cardiac Valvular Regurgitation in Patients Treated With Lanreotide Relative to Patients Treated With Octreotide|Completed||Phase 4|200||Ipsen|||||||||||||||||||2017-02-18 17:04:11.311305|2017-02-18 17:04:11.311305
NCT00234507|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2006-04-12|||January 2003||2003-01-01|April 2006|2006-04-01|May 2004||2004-05-01|||||Interventional|||Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm|Phase II, Multi-Centre, Randomised, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Efficacy and Safety of a Single Administration, by Subcutaneous Injection, of Three Doses of Dysport (40 Units/Eye, 80 Units/Eye, and 120 Units/Eye) for the Treatment of Benign Essential Blepharospasm|Completed||Phase 2|120||Ipsen|||||||||||||||||||2017-02-18 17:04:11.453977|2017-02-18 17:04:11.453977
NCT00234494|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2016-02-16|2016-01-19||November 2005||2005-11-01|February 2016|2016-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer|A Phase II Trial of Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer: Hoosier Oncology Group GU04-75|Completed||Phase 2|45|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-02-18 17:04:11.570194|2017-02-18 17:04:11.570194
NCT00234481|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2008-06-02||||||June 2008|2008-06-01||||||||Interventional|||Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia|A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL844 Administered Orally to Subjects With Chronic Lymphocytic Leukemia|Terminated||Phase 1|||Exelixis||||Study closed due to slow enrollment|||||||||||||||2017-02-18 17:04:12.17263|2017-02-18 17:04:12.17263
NCT00234468|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2011-05-19|||January 2004||2004-01-01|May 2011|2011-05-01|August 2007|Actual|2007-08-01|||||Interventional|||Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC|A Phase III, Double-Blind, Randomised Study Comparing ZD1839 (IressaTM) Versus Placebo As Maintenance Therapy In Subjects With Locally Advanced Stage III Non-Small Cell Lung Cancer (NSCLC) After Combined Modality Therapy|Terminated||Phase 3|490|Anticipated|AstraZeneca||||Closed due to insufficient recruitment|f||||||||||||||2017-02-18 17:04:12.25394|2017-02-18 17:04:12.25394
NCT00234455|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2008-04-28|||June 2001||2001-06-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|October 2002|Actual|2002-10-01||Interventional|BIFURCATION||A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.|An Evaluation of the Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With Bifurcation Lesions.|Completed||Phase 2|86|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:12.372814|2017-02-18 17:04:12.372814
NCT00234442|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-06-29|||July 2004||2004-07-01|June 2009|2009-06-01|February 2006||2006-02-01|||||Interventional|||Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer|A Phase II, Multicentre, Non-Comparative, Open-Label Study To Evaluate The Efficacy And Tolerability Of ZD1839 (Iressa™) In Asymptomatic Radio-Naive Patients With Brain Metastases From Non-Small Cell Lung Carcinoma (NSCLC) Who Have Relapsed Following Prior Chemotherapy|Terminated||Phase 2|47||AstraZeneca||||Closed due to insufficient recruitment.|f||||||||||||||2017-02-18 17:04:12.476137|2017-02-18 17:04:12.476137
NCT00234429|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2007-12-14|||November 2003||2003-11-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma|A Randomized, Placebo-Controlled, Double-Blind Phase 2b Study of Raltitrexed (Tomudex) and ZD1839 (Iressa) Versus Raltitrexed Alone as Second Line Chemotherapy in Subjects With Colorectal Carcinoma|Completed||Phase 2/Phase 3|74||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:12.565524|2017-02-18 17:04:12.565524
NCT00234416|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-04-22|||August 2002||2002-08-01|April 2009|2009-04-01|March 2005|Actual|2005-03-01|||||Interventional|||IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer|A Trial to Evaluate ZD1839 (IRESSA) in Combination With Radiotherapy & Gemcitabine as First-Line Treatment in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|45||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:12.66074|2017-02-18 17:04:12.66074
NCT00234403|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-04-22|||May 2004||2004-05-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|||||Interventional|||A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer|A Phase II Trial to Evaluate the Combination of ZD1839 (Iressa) and Fulvestrant (Faslodex®) in Patients With Advanced or Metastatic Breast Cancer|Completed||Phase 2|60||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:12.748143|2017-02-18 17:04:12.748143
NCT00234377|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2013-01-03|||November 2004||2004-11-01|January 2013|2013-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia|A 12-week International, Multicenter, Open Label, Non-comparative Study to Evaluate the Feasibility of Switching Any Antipsychotic Treatment to Sustained-release Quetiapine Fumarate (SEROQUEL®) in Patients With Schizophrenia|Completed||Phase 3|550||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:12.934935|2017-02-18 17:04:12.934935
NCT00234364|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-09-19|||March 2005||2005-03-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Observational|||Pergolide Treatment and Valvular Heart Disease||Completed||N/A|155|Actual|Århus Amt|||||f||||f||||||||||2017-02-18 17:04:13.132407|2017-02-18 17:04:13.132407
NCT00233610|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2011-01-25|||December 2003||2003-12-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer|A Comparative Trial of the Efficacy of Two Different Nolvadex (NDX) Dosing and Scheduling Regimens in Preventing Gynecomastia Induced by Casodex (CDX) 150 Monotherapy in Prostate Cancer Patients. An Open, Multicenter, Phase III Trial.|Completed||Phase 3|180||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:13.218028|2017-02-18 17:04:13.218028
NCT00233597|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2009-02-26|||August 2004||2004-08-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Interventional|||Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients|A Phase III Study of the Safety and Efficacy of Ferumoxytol (Compared With Oral Iron) as an Iron Replacement Therapy in Hemodialysis Patients Who Are Receiving Supplemental EPO Therapy|Completed||Phase 3|230||AMAG Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:04:13.313784|2017-02-18 17:04:13.313784
NCT00233584|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-01-11|||July 2001||2001-07-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Pulmicort Asthma Prevention (Post-PAC)|A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC)|Completed||N/A|400||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:13.471429|2017-02-18 17:04:13.471429
NCT00233571|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-21|||June 2000||2000-06-01|November 2011|2011-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis|A Multi-Centre Open Label Continuation Study With Subcutaneous D2E7 (Adalimumab) for Patients With Rheumatoid Arthritis Who Completed a Preceding Clinical Study With D2E7 (Adalimumab)|Completed||Phase 3|796|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:04:13.566432|2017-02-18 17:04:13.566432
NCT00233558|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-23|||June 2005||2005-06-01|April 2007|2007-04-01||||||||Interventional|||Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis|Multicentre, Randomised, Open Label Study Comparing a “Scheduled Steroid Reduction Strategy” Versus a Free Steroid Reduction Strategy (Physician’s Usual Practice for Reducing Steroids) in Patients With Active RA Treated With Humira 40 mg Eow + MTX During 9 Months|Terminated||Phase 4|160||Abbott||||Study terminated due to low subject enrollment. Safety results consistent with product label.|f||||||||||||||2017-02-18 17:04:13.66442|2017-02-18 17:04:13.66442
NCT00233545|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-05-29|||September 2005||2005-09-01|May 2010|2010-05-01|September 2007||2007-09-01|||||Interventional|||Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia|Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia|Completed||Phase 2|80||AB Foundation|||||f||||||||||||||2017-02-18 17:04:13.74637|2017-02-18 17:04:13.74637
NCT00233532|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-18|||March 2004||2004-03-01|July 2008|2008-07-01||||June 2005|Actual|2005-06-01||Interventional|TRAIL||Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)|A Prospective, Open-Label Study to Evaluate the Effect of an Escalating Dose Regimen of Trandolapril on Blood Pressure in Treatment-Naïve and Concurrently Treated Hypertensive Patients (TRAIL)|Completed||Phase 4|2000|Actual|Abbott||3|||f||||f||||||||||2017-02-18 17:04:13.827158|2017-02-18 17:04:13.827158
NCT00233519|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2012-06-20|2009-08-13||November 2005||2005-11-01|June 2012|2012-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)|Effects of SomatoKine (Iplex) (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)|Completed||Phase 1/Phase 2|17|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 17:04:13.926818|2017-02-18 17:04:13.926818
NCT00233506|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2017-02-02|||July 2004||2004-07-01|February 2017|2017-02-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated|A Dose-Finding Study of CpG 7909 in Previously Treated Chronic Lymphocytic Leukemia|Completed||Phase 1|41|Actual|University of Iowa||2|||f||||||||||||||2017-02-18 17:04:14.358068|2017-02-18 17:04:14.358068
NCT00233493|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2005-10-03|||March 2005||2005-03-01|November 2004|2004-11-01|February 2006||2006-02-01|||||Observational|||Spread of Dermatophytes Among Families|Demonstration of the Spread of Dermatophytes Through Casual Contact Among Family Household Members|Unknown status|Recruiting|N/A|150||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-02-18 17:04:14.468598|2017-02-18 17:04:14.468598
NCT00233480|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2012-03-29|||August 2005||2005-08-01|March 2012|2012-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Statin Therapy in Heart Failure: Potential Mechanisms of Benefit|A Double-blind Randomized, Placebo-Controlled, Single-Center Study to Assess the Impact of Statins on the Autonomic Nervous System and Cardiac Structure/Function in Non-Ischemic Heart Failure|Completed||Phase 4|27|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 17:04:14.55222|2017-02-18 17:04:14.55222
NCT00233467|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2006-09-20|||September 2005||2005-09-01|September 2006|2006-09-01|September 2005||2005-09-01|||||Observational|||Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade|Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade|Completed||N/A|30||Tuscaloosa Research & Education Advancement Corporation|||||f||||||||||||||2017-02-18 17:04:17.539406|2017-02-18 17:04:17.539406
NCT00233454|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2015-06-16|2015-06-16||March 2005||2005-03-01|June 2015|2015-06-01|December 2017|Anticipated|2017-12-01|May 2011|Actual|2011-05-01||Interventional|||Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia|A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of Twice Daily Oral Dosing of PKC412 <Midostaurin> Administered to Patients With Aggressive Systemic Mastocytosis (ASM) and Mast Cell Leukemia (MCL)|Active, not recruiting||Phase 2|26|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 17:04:17.662429|2017-02-18 17:04:17.662429
NCT00233441|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2012-05-07|||December 2004||2004-12-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|MAIA||Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter|Placebo Controlled Double Blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200, or 300 mg OD, With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter|Completed||Phase 2/Phase 3|673|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:04:18.050558|2017-02-18 17:04:18.050558
NCT00233428|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2015-05-11|||May 2005||2005-05-01|May 2015|2015-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Study to Determine Racial and Gender Differences in Platelet Aggregation|Phase 1 Study to Determine Racial and Gender Differences in Platelet Aggregation|Completed||Phase 1|60||Texas Tech University Health Sciences Center|||||f||||||||||||||2017-02-18 17:04:18.168577|2017-02-18 17:04:18.168577
NCT00233415|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2010-06-01|||July 2003||2003-07-01|June 2010|2010-06-01|May 2007|Actual|2007-05-01|March 2006|Actual|2006-03-01||Interventional|||Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer|Phase II Study to Evaluate the Efficacy of Conventional Chemoradiotherapy Followed by Stereotactic Radiosurgery for Locally Advanced Pancreatic Cancer|Completed||Phase 2|100|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:04:18.483078|2017-02-18 17:04:18.483078
NCT00233402|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2013-08-05|2013-08-05||January 2005||2005-01-01|August 2013|2013-08-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy|A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer|Completed||Phase 3|789|Actual|Photocure||2|||f||||t||||||||||2017-02-18 17:04:18.58605|2017-02-18 17:04:18.58605
NCT00233389|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-05-25|||January 2004||2004-01-01|May 2007|2007-05-01|September 2005||2005-09-01|||||Interventional|||Post-Marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer|A Post-Marketing Clinical Study of Rebamipide to Investigate the Gastric Ulcer Healing Effect of Continued Dosing Following Helicobacter Pylori Eradication Therapy|Completed||Phase 4|300||Otsuka Pharmaceutical Co., Ltd.|||||f||||||||||||||2017-02-18 17:04:19.189895|2017-02-18 17:04:19.189895
NCT00234338|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-12-07|||October 2005||2005-10-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Observational|||Study Evaluating Prevenar in High-Risk Children|Prospective Post-Marketing Surveillance Study of Prevenar in High-Risk Children Aged 2 to 5 Years|Completed||N/A|5000|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:04:19.271496|2017-02-18 17:04:19.271496
NCT00234312|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2006-09-07|||September 2005||2005-09-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Interventional|||Medications for the Treatment of Dysthymic Disorder and Double Depression|Escitalopram Vs. Sertraline in the Treatment of Dysthymic Disorder and Double Depression|Unknown status|Active, not recruiting|Phase 4|40||Oregon Health and Science University|||||f||||||||||||||2017-02-18 17:04:19.34784|2017-02-18 17:04:19.34784
NCT00234299|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2016-05-24|||December 2005||2005-12-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Effects of ASA on Prostate Tissue|In Vivo Molecular Effects of Aspirin on Prostate Tissue|Completed||N/A|60|Anticipated|University of Washington||2|||f||||t||||||||||2017-02-18 17:04:19.434946|2017-02-18 17:04:19.434946
NCT00234286|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2015-04-23|2015-01-13||August 2005||2005-08-01|April 2015|2015-04-01|September 2013|Actual|2013-09-01|March 2011|Actual|2011-03-01||Interventional|BEACON|Deceased veterans|Intervention to Improve Care at Life's End|Intervention to Improve Care at Life's End in VA Medical Centers|Completed||N/A|78|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:04:19.540128|2017-02-18 17:04:19.540128
NCT00234273|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2013-06-18|||November 2004||2004-11-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||APAD2: Effects of Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics|Effects Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics Persons|Terminated||Phase 2|10|Actual|University Hospital, Grenoble||2||recrutment|f||||f||||||||||2017-02-18 17:04:20.35395|2017-02-18 17:04:20.35395
NCT00234260|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-07-15|||April 1995||1995-04-01|October 2005|2005-10-01||||||||Observational|||Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)|Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)|Terminated||N/A|||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 17:04:20.479636|2017-02-18 17:04:20.479636
NCT00234247|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2016-05-12|||December 2002||2002-12-01|May 2016|2016-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Prolonged Outcomes After Nitric Oxide (PrONOx)|Study of the Long-term Outcomes of Nitric Oxide for Ventilated Premature Babies|Completed||Phase 3|652|Actual|University of Pittsburgh|||1||f||||t||||||||No||2017-02-18 17:04:20.569618|2017-02-18 17:04:20.569618
NCT00234234|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2012-02-08|||January 2006||2006-01-01|February 2012|2012-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Predictors of the Response to Adalimumab in Rheumatoid Arthritis|Predictors of the Response to Adalimumab in Rheumatoid Arthritis|Completed||Phase 4|200|Actual|University Hospital, Rouen||1|||f||||||||||||||2017-02-18 17:04:20.670607|2017-02-18 17:04:20.670607
NCT00234221|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2016-04-11|||November 2005||2005-11-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Project Health Link: Connecting Patients With Services|Services Interventions for Injured ED Problem Drinkers|Completed||N/A|686|Actual|University of Michigan||3|||f||||f||||||||No||2017-02-18 17:04:20.759034|2017-02-18 17:04:20.759034
NCT00234208|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2016-05-23|||October 2005||2005-10-01|May 2016|2016-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Early Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusion and Pleural Empyema|A Randomized Controlled Study of Early Mini-invasive Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusions or Pleural Empyema - ESMITE (European Study on Mini-invasive Thoracoscopy in Empyema)|Terminated||Phase 3|2|Actual|University Hospital, Basel, Switzerland||2||insufficient enrollment|f||||f||||||||||2017-02-18 17:04:20.857576|2017-02-18 17:04:20.857576
NCT00234195|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-04-16|||September 2005||2005-09-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Wellbutrin XL, Major Depressive Disorder and Breast Cancer|A Pilot Study of the Efficacy and Tolerability of Bupropion Extended Release (Wellbutrin XL) for the Treatment of Major Depressive Disorder in Women With Breast Cancer|Completed||Phase 4|25||Thomas Jefferson University|||||f||||f||||||||||2017-02-18 17:04:20.973606|2017-02-18 17:04:20.973606
NCT00234182|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2005-11-29|||January 2000||2000-01-01|October 2005|2005-10-01|December 2004||2004-12-01|||||Interventional|||Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC|Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of Hepatocellular Carcinoma: a Randomized Controlled Trial|Completed||Phase 1/Phase 2|84||The University of Hong Kong|||||f||||||||||||||2017-02-18 17:04:21.067655|2017-02-18 17:04:21.067655
NCT00234169|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2012-05-09|||October 2005||2005-10-01|May 2012|2012-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone|A Phase I/II Study of Peripheral Blood Progenitor Cells Mobilisation With VTP195183 Plus G-CSF Compared to Mobilisation With G-CSF Alone in Patients With Multiple Myeloma and Lymphoma.|Completed||Phase 1/Phase 2|30|Actual|Peter MacCallum Cancer Centre, Australia||1|||f||||t||||||||||2017-02-18 17:04:21.155133|2017-02-18 17:04:21.155133
NCT00234156|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2012-01-10|||September 2004||2004-09-01|January 2012|2012-01-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers|Sensitivity to Fructose-Induced Palmitate Synthesis in End-Stage Renal Disease|Completed||N/A|30|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 17:04:21.260452|2017-02-18 17:04:21.260452
NCT00234143|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-03-11|||October 2004||2004-10-01|March 2009|2009-03-01||||||||Interventional|||Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)|A Randomised Controlled Trial of Prolonged Treatment With Darbepoetin Alpha With or Without Recombinant Human Granulocyte Colony Stimulating Factor (G-CSF) Versus Best Supportive Care in Patients With Low-Risk Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2/Phase 3|360|Anticipated|St. Bartholomew's Hospital||3|||f||||t||||||||||2017-02-18 17:04:21.371973|2017-02-18 17:04:21.371973
NCT00234130|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-06-02|||July 2002||2002-07-01|June 2009|2009-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure|A Comparison of the Effects of Conventional and Nocturnal Hemodialysis on the Inflammatory Response of Chronic Renal Failure|Terminated||N/A|20||Rockefeller University||||The patient population was not enough to complete enrollment|f||||f||||||||||2017-02-18 17:04:21.484112|2017-02-18 17:04:21.484112
NCT00234117|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2011-07-20|||July 2005||2005-07-01|October 2005|2005-10-01||||||||Interventional|||Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression|Overall Assessment of Improvement in Bronchial Asthma Patients With Extraesophageal Reflux After Effective Acid Suppression|Completed||N/A|40|Anticipated|Ponce Gastroenterology Research|||||f||||||||||||||2017-02-18 17:04:21.581241|2017-02-18 17:04:21.581241
NCT00234104|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2013-11-06|2013-11-01||August 2004||2004-08-01|November 2013|2013-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional||1 Subject of each arm were excluded form the analysis set because emergency codes were lost.|A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Dose Response of OPC-41061 in Congestive Heart Failure Patients With Extracellular Volume Expansion|Completed||Phase 2|122|Actual|Otsuka Pharmaceutical Co., Ltd.|||||f||||f||||||||||2017-02-18 17:04:21.690446|2017-02-18 17:04:21.690446
NCT00234091|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2013-12-02|||April 2006||2006-04-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)|An Open Label, Randomized Study to Compare Antiretroviral Therapy (ART) Initiation When CD4 is Between 15% to 24% to ART Initiation When CD4 Falls Below 15% in Children With HIV Infection and Moderate Immune Suppression|Completed||Phase 3|300|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:04:22.339364|2017-02-18 17:04:22.339364
NCT00234078|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2014-01-20|2014-01-20||January 2005||2005-01-01|January 2014|2014-01-01|March 2007|Actual|2007-03-01|April 2006|Actual|2006-04-01||Interventional|||Dose-response Study of OPC-12759 Ophthalmic Suspension|Dose-response Study of OPC-12759 Ophthalmic Suspension|Completed||Phase 2|290|Actual|Otsuka Pharmaceutical Co., Ltd.||4|||f||||f||||||||||2017-02-18 17:04:22.494052|2017-02-18 17:04:22.494052
NCT00234065|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2011-06-09|2011-04-19||December 2003||2003-12-01|June 2011|2011-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)|Post-marketing Study of Cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison With Aspirin|Completed||Phase 4|2800|Actual|Otsuka Pharmaceutical Co., Ltd.||2|||f||||t||||||||||2017-02-18 17:04:23.193551|2017-02-18 17:04:23.193551
NCT00234052|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2015-08-10|||June 2005||2005-06-01|August 2015|2015-08-01|May 2017|Anticipated|2017-05-01|May 2016|Anticipated|2016-05-01||Interventional|||Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer|Active, not recruiting||Phase 2|50|Actual|Northwestern University||1|||f||||||||||||||2017-02-18 17:04:24.778788|2017-02-18 17:04:24.778788
NCT00234039|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2015-12-08|2012-11-19||November 2006||2006-11-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|November 2011|Actual|2011-11-01||Interventional|||S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin|Phase II Study of Intravesical Gemcitabine in Patients With Superficial Bladder Cancer Who Have Progressed Despite Intravesical BCG|Completed||Phase 2|58|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 17:04:24.907406|2017-02-18 17:04:24.907406
NCT00234026|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma|Master Protocol for Mantle Cell Lymphoma A Multicenter Phase II Trial Testing Gemcitabine for the Treatment of Patients With Newly Diagnosed, Relapsed or Chemotherapy Resistant Mantle Cell Lymphoma|Completed||Phase 2|||Swiss Group for Clinical Cancer Research|||||f||||t||||||||||2017-02-18 17:04:25.310051|2017-02-18 17:04:25.310051
NCT00234000|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2015-09-30|||February 2007||2007-02-01|August 2012|2012-08-01||||February 2009|Actual|2009-02-01||Interventional|||Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes|A Phase I Multicenter Study of Arsenic Trioxide and Azacitidine in Patients With Myelodysplastic Syndromes|Terminated||Phase 1|1|Actual|Jonsson Comprehensive Cancer Center||1||The study was closed due to poor enrollment|f||||t||||||||||2017-02-18 17:04:25.422656|2017-02-18 17:04:25.422656
NCT00233987|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2016-10-13|2013-01-02||October 2005||2005-10-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|November 2014|Actual|2014-11-01||Interventional|||S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma|Tandem Autologous Stem Cell Transplantation for Patients With Primary Progressive or Recurrent Hodgkin's Disease (A BMT Study), Phase II|Active, not recruiting||Phase 2|98|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:04:25.778358|2017-02-18 17:04:25.778358
NCT00233974|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2012-03-05|||May 2002||2002-05-01|March 2012|2012-03-01|March 2006|Actual|2006-03-01|February 2005|Actual|2005-02-01||Interventional|||Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery|Axillary Lymph Nodes and PET (Positron Emission Tomography) Probe-Guided Surgical Resection in Locally Advanced Breast Cancer Patients: Molecular Marker Profile and Response to Neoadjuvant Chemotherapy|Completed||Phase 2|15|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:04:26.328079|2017-02-18 17:04:26.328079
NCT00233961|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2013-02-01|||January 2005||2005-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission|Peripheral Blood Stem Cell Mobilization With Filgrastim in Patients With Chronic Myeloid Leukemia in Cytogenetic Response|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:04:26.438289|2017-02-18 17:04:26.438289
NCT00233948|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2015-03-30|2015-02-02||March 2006||2006-03-01|March 2015|2015-03-01||||July 2013|Actual|2013-07-01||Interventional|||Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma|A Phase I/II Study of Nelfinavir in Liposarcoma|Terminated||Phase 1/Phase 2|29|Actual|City of Hope Medical Center|After 12 patients were accrued to the Phase II portion, the study was terminated…protocol objectives for the Phase II portion not met. Closed prematurely due to drug availability issues.|1||Drug availability issues|f||||t||||||||||2017-02-18 17:04:26.539579|2017-02-18 17:04:26.539579
NCT00233935|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2014-09-10|||November 2005||2005-11-01|April 2013|2013-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus|Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients With Barrett's Esophagus|Completed||Phase 1|55|Actual|National Cancer Institute (NCI)||4|||f||||f||||||||||2017-02-18 17:04:27.63631|2017-02-18 17:04:27.63631
NCT00233922|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2008-05-12|||July 2004||2004-07-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant|Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant|Completed||Phase 2|80|Anticipated|National University Hospital, Singapore|||||f||||||||||||||2017-02-18 17:04:27.764763|2017-02-18 17:04:27.764763
NCT00233909|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-03-28|||October 2005||2005-10-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia|An Open-Label, Phase I/II Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|55|Anticipated|Kanisa Pharmaceuticals|||||||||||||||||||2017-02-18 17:04:27.86196|2017-02-18 17:04:27.86196
NCT00233896|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2005-10-04|||July 2001||2001-07-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD|A Randomized, Placebo-Controlled, Multi-Center Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal Graft Vs. Host Disease|Completed||Phase 3|130||Enteron Pharmaceuticals|||||||||||||||||||2017-02-18 17:04:27.938938|2017-02-18 17:04:27.938938
NCT00233883|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2015-11-02|||August 2005||2005-08-01|November 2015|2015-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.|An Open-label Study of the Tolerability of a Subcutaneous Needle-free Injection Device Used to Administer Fuzeon, Compared With the Standard Needle/Syringe Supplied With Commercial Fuzeon in HIV-1 Infected, ARV Treatment-experienced Adults|Completed||Phase 4|58|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:04:28.039783|2017-02-18 17:04:28.039783
NCT00233870|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2015-05-07|||June 2004||2004-06-01|May 2015|2015-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.|Special Survey in Long-Term Use of Fabrazyme|Completed||Phase 4|405|Actual|Sanofi|||1||f||||||||||||||2017-02-18 17:04:28.147696|2017-02-18 17:04:28.147696
NCT00233857|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2011-02-25|||August 2003||2003-08-01|February 2011|2011-02-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||Auricular Acupuncture for Pain Relief After Ambulatory Knee Arthroscopy|Auricular Acupuncture Versus Placebo (Sham Acupuncture) for Postoperative Pain Relief After Ambulatory Knee Arthroscopy - a Randomized Controlled Trial|Completed||Phase 2/Phase 3|120||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:04:28.237575|2017-02-18 17:04:28.237575
NCT00233844|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2005-10-05|||February 2004||2004-02-01|October 2005|2005-10-01||||||||Interventional|||"Studying the Analgesic Mechanism of the Cough-Trick"|"Studying the Analgesic Mechanism of the Cough-Trick - Randomized Crossover Volunteer Study"|Completed||Phase 2|21||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:04:28.317877|2017-02-18 17:04:28.317877
NCT00233831|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2011-02-25|||March 2004||2004-03-01|February 2011|2011-02-01|October 2007|Actual|2007-10-01|October 2006|Actual|2006-10-01||Interventional|||Millimeter Wave Therapy (MWT) for Analgesia After Total Knee Replacement|Millimeter Wave Therapy (MWT) Versus Placebo for Analgesia and Wound Healing After Elective Total Knee Arthroplasty - a Randomized Controlled Trial|Completed||Phase 2/Phase 3|80||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:04:28.394935|2017-02-18 17:04:28.394935
NCT00233818|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-10-11|||February 2000||2000-02-01|October 2007|2007-10-01|June 2005|Actual|2005-06-01|||||Interventional|||FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent|An Evaluation of Sirolimus-Coated Modified BX VELOCITY Balloon-Expandable Stents for the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 1/Phase 2|15|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 17:04:28.481203|2017-02-18 17:04:28.481203
NCT00005429|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|November 2001|2001-11-01|March 1996|Actual|1996-03-01|||||Observational|||Clinical Cardiovascular Outcomes of African-Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.397914|2017-02-18 18:15:00.397914
NCT00233805|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-08-05|||August 2000||2000-08-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|||||Interventional|RAVEL||The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.|A Randomized Study With the Sirolimus Coated Modified BX Velocity Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 2|220|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:28.576472|2017-02-18 17:04:28.576472
NCT00233792|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-10-11|||December 1999||1999-12-01|October 2007|2007-10-01|March 2005|Actual|2005-03-01|||||Interventional|||FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent|An Evaluation of the Sirolimus Coated Modified BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo or Restenotic Native Coronary Artery Lesions.|Completed||Phase 1/Phase 2|30|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:28.918153|2017-02-18 17:04:28.918153
NCT00233779|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-06-26|||October 2003||2003-10-01|June 2007|2007-06-01|December 2004|Actual|2004-12-01|||||Interventional|||Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)|Sirolimus-Eluting, Heparin-Coated Cobalt Chromium Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions in Small Vessels (EVOLUTION)|Completed||Phase 2|52|Actual|Cordis Corporation||1|||f||||f||||||||||2017-02-18 17:04:29.01944|2017-02-18 17:04:29.01944
NCT00233766|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-04-17|||September 2002||2002-09-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)|An Evaluation of Two Reduced Sirolimus Doses on the BX VELOCITY Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions(REDOX)|Completed||Phase 1/Phase 2|60||Cordis Corporation|||||f||||f||||||||||2017-02-18 17:04:29.105706|2017-02-18 17:04:29.105706
NCT00233753|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-01-05|||January 2004||2004-01-01|January 2009|2009-01-01|December 2005||2005-12-01|||||Interventional|||Study of the Enterprise Self-Expanding Stent System With Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms|Cordis Neurovascular Feasibility Study of the Enterprise Self-Expanding Stent System to Facilitate Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms|Completed||Phase 1|30||Codman & Shurtleff|||||||||||||||||||2017-02-18 17:04:29.206443|2017-02-18 17:04:29.206443
NCT00233740|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-08-04|||September 2003||2003-09-01|August 2008|2008-08-01|May 2005|Actual|2005-05-01|||||Interventional|||Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)|The Cordis Protection From Pulmonary Embolism With the Permanent OptEase™ Filter - A Post Marketing Surveillance Study (PROOF Study)|Completed||Phase 4|150||Cordis Corporation|||||f||||f||||||||||2017-02-18 17:04:29.269012|2017-02-18 17:04:29.269012
NCT00233727|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2015-07-07|||January 2000||2000-01-01|July 2015|2015-07-01|May 2013|Actual|2013-05-01|April 2006|Actual|2006-04-01||Interventional|SAT||Screen and Treat for Cervical Cancer Prevention|Safety and Efficacy of Two Screen-and-Treat Approaches for the Prevention of Cervical Cancer|Terminated||Phase 3|7123|Actual|Columbia University||3||PI left University|f||||f||||||||||2017-02-18 17:04:29.352625|2017-02-18 17:04:29.352625
NCT00233714|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2009-11-17|||May 2003||2003-05-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|July 2004|Actual|2004-07-01||Interventional|3D||Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions|A Randomized Feasibility Study of the Double Dose or Single Dose Sirolimus-Eluting BX VELOCITY Balloon-Expandable Stent for the Treatment of Diabetic Patients With de Novo Native Coronary Artery Lesions(3D)|Completed||Phase 1/Phase 2|56|Actual|Cordis Corporation||2|||f||||f||||||||||2017-02-18 17:04:29.46691|2017-02-18 17:04:29.46691
NCT00233701|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2010-02-05|||October 2004||2004-10-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Normal Pressure Hydrocephalus (NPH) Registry|Normal Pressure Hydrocephalus (NPH) Registry|Completed||Phase 4|343|Actual|Codman & Shurtleff|||1||f||||f||||||||||2017-02-18 17:04:29.579342|2017-02-18 17:04:29.579342
NCT00233688|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2009-04-30|||November 2001||2001-11-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|December 2004|Actual|2004-12-01||Interventional|||Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)|A Prospective, Multicenter Study of the Cordis Endovascular QUANTUM LP™ Stent Graft System for the Treatment of Abdominal Aortic Aneurysms (AAA)-FORTRON|Completed||Phase 3|300|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:29.700432|2017-02-18 17:04:29.700432
NCT00233675|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2014-05-08|||August 2003||2003-08-01|May 2014|2014-05-01||||February 2005|Actual|2005-02-01||Interventional|||Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder|A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety of GABITRIL at Dosages up to 16mg/Day in Adults With Generalized Anxiety Disorder|Completed||Phase 3|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:04:29.800284|2017-02-18 17:04:29.800284
NCT00233662|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2005-10-04|||December 2002||2002-12-01|October 2005|2005-10-01|June 2005||2005-06-01|||||Interventional|||Safety and Tolerability of Repeat Courses of IM Alefacept|An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Repeat Courses of Intramuscular Administration of Alefacept (LFA-3/IgG1 Fusion Protein) in Patients With Chronic Plaque Psoriasis|Completed||Phase 3|400||Biogen|||||||||||||||||||2017-02-18 17:04:29.915342|2017-02-18 17:04:29.915342
NCT00233649|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-05|2010-11-18|||May 2004||2004-05-01|November 2010|2010-11-01||||||||Observational|||DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines|DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines|Completed||Phase 4|2500||AstraZeneca|||1||f||||||||||||||2017-02-18 17:04:30.061307|2017-02-18 17:04:30.061307
NCT00233636|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2011-01-25|||July 2003||2003-07-01|January 2011|2011-01-01||||||||Interventional|||Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck|A 2 Part Phase 2 Trial to Evaluate ZD1839 (Iressa™) & Radiotherapy in Patients w/Locally Advanced Inoperable Squamous Cell Carcinoma of the Head & Neck|Withdrawn||Phase 2|28||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:30.488962|2017-02-18 17:04:30.488962
NCT00233623|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2011-01-25|||July 2004||2004-07-01|January 2011|2011-01-01|January 2006|Anticipated|2006-01-01|January 2006|Anticipated|2006-01-01||Interventional|||Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer|A Randomised, Non-Comparative, Multicentre, Phase II, Parallel-Group Trial Of ZD1839 (Iressa™) In Combination With 5 Fluorouracil, Leucovorin And Cpt-11 (Irinotecan) In Patients With Metastatic Colorectal Cancer|Withdrawn||Phase 2|190||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:30.577381|2017-02-18 17:04:30.577381
NCT00233376|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2006-07-17|||May 2004||2004-05-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Interventional|||Computerized Decision Support System for Antibiotic Treatment|Improving Empirical Antibiotic Treatment Using TREAT,a Computerized Decision Support System. Cluster Randomized Trial|Completed||Phase 3|1500||Rabin Medical Center|||||f||||||||||||||2017-02-18 17:04:30.672804|2017-02-18 17:04:30.672804
NCT00233363|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-05-25|||March 2005||2005-03-01|May 2007|2007-05-01|January 2006||2006-01-01|||||Interventional|||Exploratory Study for Dry Mouth in Patients With Sjögren’s Syndrome|An Exploratory Study of Rebamipide to Evaluate Efficacy and Safety in the Treatment of Dry Mouth in Patients With Sjögren’s Syndrome|Completed||Phase 2|100||Otsuka Pharmaceutical Co., Ltd.|||||f||||||||||||||2017-02-18 17:04:30.957965|2017-02-18 17:04:30.957965
NCT00233350|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2015-09-30|||January 2007||2007-01-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study|Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study|Completed||N/A|142|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 17:04:31.054755|2017-02-18 17:04:31.054755
NCT00233337|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2012-04-25|||May 2001||2001-05-01|April 2012|2012-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers|Open-label, Multi-center, Non-comparative Efficacy, Safety, and Tolerability Study of Co-artemether in the Treatment of Acute Uncomplicated Malaria in Non-immune Patients|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 17:04:31.150673|2017-02-18 17:04:31.150673
NCT00233324|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2015-07-21|2014-11-16||February 2005||2005-02-01|July 2015|2015-07-01|April 2016|Anticipated|2016-04-01|February 2009|Actual|2009-02-01||Interventional|SUPPORT||Surfactant Positive Airway Pressure and Pulse Oximetry Trial|Surfactant Positive Airway Pressure and Pulse Oximetry Trial (SUPPORT) in Extremely Low Birth Weight Infants|Active, not recruiting||Phase 3|1316|Actual|NICHD Neonatal Research Network||4|||f||||t||||||||||2017-02-18 17:04:31.242167|2017-02-18 17:04:31.242167
NCT00233311|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2012-08-03|||March 2004||2004-03-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers|Assessment of the Postprandial Effects of a Fast-food on Inflammatory Markers|Completed||N/A|61|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||f||||||Samples With DNA|"~     Serum, Whole Blood~   "|||2017-02-18 17:04:31.881133|2017-02-18 17:04:31.881133
NCT00233298|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2017-01-24|||May 26, 2005||2005-05-26|January 2, 2015|2015-01-02|January 2, 2015||2015-01-02|||||Observational|||A Study of the Function of Hormones Present In Taste Buds|A Study of the Function of Hormones Present In Taste Buds|Completed||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:04:31.978621|2017-02-18 17:04:31.978621
NCT00233285|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2016-07-11|||September 1999||1999-09-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Factors in Childhood Lung Susceptibility to Pollution||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:04:32.090254|2017-02-18 17:04:32.090254
NCT00233272|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2017-01-26|||January 21, 2003||2003-01-21|January 12, 2017|2017-01-12||||||||Observational|||Baltimore Longitudinal Study of Aging|Longitudinal Studies of Human Physiology, Biochemistry, and Psychology (The Baltimore Longitudinal Syudy of Aging - BLSA)|Recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:04:32.165609|2017-02-18 17:04:32.165609
NCT00233259|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-10-24|||March 2006||2006-03-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes|CHD Lifestyle Modification for Latinas With Diabetes|Completed||N/A|273|Actual|Oregon Research Institute||2|||f||||t||||||||||2017-02-18 17:04:32.271931|2017-02-18 17:04:32.271931
NCT00233246|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2014-06-05|||March 2006||2006-03-01|June 2014|2014-06-01||||||||Interventional|||Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures|Study of Hemostasis and Invasive Procedures (SHIP: A TMH CTN Study)|Withdrawn||Phase 3|0|Actual|Massachusetts General Hospital||||Study never activated|f||||||||||||||2017-02-18 17:04:32.384758|2017-02-18 17:04:32.384758
NCT00233233|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2015-09-15|||August 2002||2002-08-01|September 2015|2015-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy Adherence|Assessment Mode and Validity of Self-Reports in Adults|Completed||N/A|139|Actual|Johns Hopkins University|||||f||||||||||||||2017-02-18 17:04:32.501157|2017-02-18 17:04:32.501157
NCT00233220|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2014-02-12|||September 2004||2004-09-01|February 2014|2014-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Blood Pressure Control in African Americans|Multi-site Randomized Controlled Trial for Blood Pressure Control in Hypertensive African Americans|Completed||N/A|1039|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-02-18 17:04:32.592641|2017-02-18 17:04:32.592641
NCT00233207|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2007-12-13|||September 2005||2005-09-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||IC14 Antibodies to Treat Individuals With Acute Lung Injury|Acute Lung Injury Clinical Trials Incubator Unit|Terminated||Phase 2|13|Actual|National Heart, Lung, and Blood Institute (NHLBI)||||Unable to meet enrollment number to complete study, study stopped June 30, 2007|f||||||||||||||2017-02-18 17:04:32.694612|2017-02-18 17:04:32.694612
NCT00233194|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2016-12-03|||January 2005||2005-01-01|December 2016|2016-12-01|July 2011|Actual|2011-07-01|November 2009|Actual|2009-11-01||Observational|||Identification of Sleep-Disordered Breathing in Children|Identification of Sleep-Disordered Breathing in Children|Completed||N/A|160|Actual|University of Michigan|||1||f||||f||||||||||2017-02-18 17:04:32.776392|2017-02-18 17:04:32.776392
NCT00233181|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2016-02-17|||April 2000||2000-04-01|December 2005|2005-12-01|March 2005|Actual|2005-03-01|||||Interventional|||Adherence Intervention for Minority Children With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:04:32.885631|2017-02-18 17:04:32.885631
NCT00233168|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2014-06-24|||September 2003||2003-09-01|June 2014|2014-06-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|||Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents|Promoting Adherence to TB Regimens in High Risk Youth|Completed||N/A|263|Actual|San Diego State University||2|||f||||t||||||||||2017-02-18 17:04:32.955101|2017-02-18 17:04:32.955101
NCT00233155|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2008-03-04|||August 2005||2005-08-01|March 2008|2008-03-01|December 2006||2006-12-01|||||Interventional|||Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)|A Multicenter, Open-Label, Phase 2 Study of NGX-4010 for the Treatment of Neuropathic Pain in Patients With Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)|Completed||Phase 2|100||NeurogesX|||||||||||||||||||2017-02-18 17:04:33.053797|2017-02-18 17:04:33.053797
NCT00233142|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-04-13|||September 2005||2005-09-01|November 2009|2009-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients|Expressive Writing: Complementary Treatment for Diabetes|Completed||Phase 2|187|Actual|Syracuse University||2|||f||||t||||||||||2017-02-18 17:04:33.140446|2017-02-18 17:04:33.140446
NCT00233129|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2013-09-23|||October 2005||2005-10-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||"Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the Executive Plus Program"|"Improving Executive Functions After TBI: A Randomized Clinical Trial of the Executive Plus Program"|Completed||N/A|77|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 17:04:33.243811|2017-02-18 17:04:33.243811
NCT00233103|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2015-10-14|2013-07-29||June 2003||2003-06-01|October 2015|2015-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Post-Traumatic Brain Injury (TBI) Depression|Treatment of Post-TBI Depression|Completed||Phase 2|52|Actual|Icahn School of Medicine at Mount Sinai|"Sample size was small - those who dropped out could have reduced the differential effect.~Sample was heterogeneous for severity and time since injury."|2|||f||||t||||||||||2017-02-18 17:04:33.360992|2017-02-18 17:04:33.360992
NCT00233090|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2016-03-16|2013-08-07||July 2005||2005-07-01|March 2016|2016-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment|Post-TBI Fatigue and Its Treatment|Terminated||Phase 2|21|Actual|Icahn School of Medicine at Mount Sinai|Study was terminated due to insufficient recruitment. Data analysis not available.|2||Insufficient recruitment|f||||||||||||||2017-02-18 17:04:33.801269|2017-02-18 17:04:33.801269
NCT00233077|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2013-12-02|||October 2006||2006-10-01|December 2013|2013-12-01|January 2011|Actual|2011-01-01|June 2010|Actual|2010-06-01||Interventional|||Patient Centered Randomized Controlled Trial|Patient Assistance to Reduce Breast Cancer Disparities|Completed||N/A|374|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 17:04:34.217901|2017-02-18 17:04:34.217901
NCT00233064|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2010-01-07|2008-10-02||October 2005||2005-10-01|January 2010|2010-01-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)|A Phase IV, Randomized, Double-Blind Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) in Children at High Risk for the Development of Serious RSV Disease|Completed||Phase 4|417|Actual|MedImmune LLC|Only serious adverse events were collected as part of the safety evaluation. One death (asphyxia) occurred in the Lyophilized Palivizumab group; this event was judged not related to study drug.|2|||f||||f||||||||||2017-02-18 17:04:34.32837|2017-02-18 17:04:34.32837
NCT00233051|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2014-09-24|||April 2003||2003-04-01|September 2014|2014-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Evaluating Genes in Sputum to Measure Drug Response in COPD|Expression of Inflammatory Mediators in Induced Sputum: A Potential Biomarker of Drug Response in COPD|Terminated||N/A|20||National Jewish Health|||||f||||||||||||||2017-02-18 17:04:35.191425|2017-02-18 17:04:35.191425
NCT00233038|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2013-10-28|||January 2005||2005-01-01|October 2013|2013-10-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial|EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial|Completed||Phase 2/Phase 3|50|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 17:04:35.284653|2017-02-18 17:04:35.284653
NCT00233025|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2007-08-22|||September 2005||2005-09-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Duloxetine Versus Placebo in the Treatment of FMS|Duloxetine 60/120mg Versus Placebo in the Treatment of Fibromyalgia Syndrome|Completed||Phase 3|320||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:04:35.389389|2017-02-18 17:04:35.389389
NCT00233012|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2010-05-24|||June 2005||2005-06-01|May 2010|2010-05-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures|A Randomized, Open-label (OL), Multicenter Study With OL Extension of the Pharmacokinetics and Safety of Topiramate Administered as Oral Liquid and Sprinkle Formulations as an Adjunct to Concurrent Anticonvulsant Therapy in Infants (Aged 1-24 Months, Inclusive) With Refractory Partial-onset Seizures|Completed||Phase 1|16|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:04:35.519366|2017-02-18 17:04:35.519366
NCT00232999|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2012-07-03|||October 2005||2005-10-01|September 2008|2008-09-01|January 2006|Actual|2006-01-01|December 2005|Actual|2005-12-01||Interventional|||Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma||Completed||Phase 2|15|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 17:04:35.602268|2017-02-18 17:04:35.602268
NCT00232986|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2005-10-03|||September 2004||2004-09-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Observational|||A Comparison of Survey Methodologies to Elicit Sensitive Information From Adolescents in Urban India|A Comparison of Survey Methodologies to Elicit Information on Sexual and Reproductive Health From Adolescents in Urban India|Completed||N/A|960||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:04:35.691124|2017-02-18 17:04:35.691124
NCT00232973|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-02-04|||July 2005||2005-07-01|February 2008|2008-02-01||||||||Interventional|||Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers|A Prospective, Multi-Centre, Double Blind, Randomized, Placebo Controlled Trial to Evaluate the Safety and Efficacy of ICXP007 in a Phase III Trial With Four-Layer Therapeutic Compression, for the Treatment of Non-Infected Skin Leg Ulcers, Due to Venous-Insufficiency|Unknown status|Recruiting|Phase 3|396|Anticipated|Intercytex||3|||f||||t||||||||||2017-02-18 17:04:35.766133|2017-02-18 17:04:35.766133
NCT00232960|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2012-03-27|||October 2005||2005-10-01|March 2012|2012-03-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Interventional|||Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC|Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Early Stages Oral and Oropharyngeal Squamous Cell Carcinomas: A Prospective Study|Unknown status|Active, not recruiting|N/A|310|Actual|Gustave Roussy, Cancer Campus, Grand Paris||1|||f||||||||||||||2017-02-18 17:04:35.911138|2017-02-18 17:04:35.911138
NCT00232947|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2007-01-19|||October 2005||2005-10-01|October 2005|2005-10-01|February 2006||2006-02-01|||||Interventional|||Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over|A Non-Inferiority Comparison of Fluviral™ Influenza Vaccine to a U.S. Licensed Inactivated Split-Virion Vaccine (Fluzone®) in Adults ≥ 50 Years Old Living in the Community|Completed||Phase 3|900||ID Biomedical Corporation, Quebec|||||||||||||||||||2017-02-18 17:04:36.003192|2017-02-18 17:04:36.003192
NCT00232934|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2005-10-04|||January 2002||2002-01-01|October 2005|2005-10-01|May 2010||2010-05-01|||||Interventional|||Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients|Phase III, Prospective, Open Label, Multicenter, Randomized Trial of Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone as First Line Therapy in Myeloma Patients Aged >65.|Completed||Phase 3|400||Gruppo Italiano per lo Studio del Mieloma Multiplo|||||f||||||||||||||2017-02-18 17:04:36.107169|2017-02-18 17:04:36.107169
NCT00232921|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2006-12-22||||||December 2006|2006-12-01|February 2003||2003-02-01|||||Interventional|||The Effect of Caudal Volumes on the Anatomical Spread of Caudals in Children||Completed||Phase 1|||Institute of Child Health|||||f||||||||||||||2017-02-18 17:04:36.214566|2017-02-18 17:04:36.214566
NCT00232908|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2016-11-01|||June 2004||2004-06-01|November 2016|2016-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection|An Open-label Study of a HAART (Highly Active Antiretroviral Therapy) Regimen Containing Subcutaneous Injection of Fuzeon on Quality of Life in Clinically Stable, Treatment-experienced Patients With HIV-1 Infection|Completed||Phase 4|361|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 17:04:36.300082|2017-02-18 17:04:36.300082
NCT00232895|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-03-27||||||March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years||Completed||N/A|||Institute of Child Health|||||f||||||||||||||2017-02-18 17:04:36.496236|2017-02-18 17:04:36.496236
NCT00232882|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2013-08-30|||December 2003||2003-12-01|August 2013|2013-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.|Neurohumoral and Oxidative Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Essential Hypertensive Patients.|Completed||Phase 4|86|Actual|Institut de Recherches Cliniques de Montreal||3|||f||||f||||||||||2017-02-18 17:04:36.582017|2017-02-18 17:04:36.582017
NCT00232869|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2010-02-03|||February 2001||2001-02-01|February 2010|2010-02-01|May 2009|Actual|2009-05-01|June 2003|Actual|2003-06-01||Interventional|SIROCCO||A Study of the SMART Stent in the Treatment SFA Disease.|A Clinical Investigation of the SIROlimus Coated Cordis SMART™ Nitinol Selfexpandable Stent for the Treatment of Obstructive Superficial Femoral Artery Disease.|Completed||Phase 2|93|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:36.7096|2017-02-18 17:04:36.7096
NCT00232856|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-04-29|||December 2002||2002-12-01|April 2008|2008-04-01|August 2006|Actual|2006-08-01|December 2003|Actual|2003-12-01||Interventional|TROPICAL||A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.|A Multi-Center, Non-Randomised Study of the CYPHER™ Sirolimus-Eluting Stent in the Treatment of Patient With an in-Stent Restenotic Native Coronary Artery Lesion|Completed||Phase 4|162|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 17:04:36.816435|2017-02-18 17:04:36.816435
NCT00232843|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2009-06-02|||March 2005||2005-03-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|SUPER UK||The Study to Treat Superficial Femoral Artery Occlusions.|A Clinical Investigation of the SMART™ Nitinol Self-Expandable Stent Versus Balloon Angioplasty Only for the Treatment of SUPERficial Femoral Artery Occlusions|Completed||Phase 4|150|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:36.931864|2017-02-18 17:04:36.931864
NCT00232830|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2009-09-15|||October 2003||2003-10-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|TYPHOON||The Study to Assess AMI Treated With Balloon Angioplasty.|Trial to Assess the Use of the Cypher TM Stent in Acute Myocardial Infarction Treated With Balloon Angioplasty|Completed||Phase 3|715|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:37.042072|2017-02-18 17:04:37.042072
NCT00232817|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-01-12|||July 2003||2003-07-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|July 2005|Actual|2005-07-01||Interventional|||Anesthesia and Postoperative Pain|Intranasal Nicotine for Postoperative Pain Treatment: A Comparison of Its Effects in the Context of Isoflurane-induced Anesthesia Versus Propofol Anesthesia|Completed||Phase 4|80|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 17:04:37.143877|2017-02-18 17:04:37.143877
NCT00232804|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-10-08|||June 2002||2002-06-01|October 2007|2007-10-01|February 2004|Actual|2004-02-01|||||Interventional|||The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent|Safety and Efficacy Registry of Bx Cypher Stent in the Revascularisation of Patients With Significant Risk of Restenosis|Completed||Phase 4|639|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 17:04:37.252373|2017-02-18 17:04:37.252373
NCT00232791|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2008-08-05|||January 2004||2004-01-01|August 2008|2008-08-01|March 2005|Actual|2005-03-01|August 2004|Actual|2004-08-01||Interventional|DOMINO||The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.|A Randomized Study With the CYPHER SELECT™ Sirolimus-Eluting Balloon-Expandable Coronary Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions.|Completed||Phase 2/Phase 3|102|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:37.473643|2017-02-18 17:04:37.473643
NCT00232778|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2008-04-17|||May 2000||2000-05-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|||||Interventional|||A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)|A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)|Completed||Phase 1/Phase 2|579||Cordis Corporation|||||f||||||||||||||2017-02-18 17:04:37.590056|2017-02-18 17:04:37.590056
NCT00232765|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2009-09-15|||February 2001||2001-02-01|September 2009|2009-09-01|November 2008|Actual|2008-11-01|May 2002|Actual|2002-05-01||Interventional|||Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)|A Multicenter, Randomized, Double-Blind Study of the Sirolimus-Coated BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions|Completed||Phase 3|1058|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:04:37.659466|2017-02-18 17:04:37.659466
NCT00232752|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2009-12-01||2009-11-16|September 2003||2003-09-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|January 2005|Actual|2005-01-01||Interventional|||Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions|A Multicenter, Non-Randomized Study of the 4.0mm Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 3|100|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 17:04:37.777864|2017-02-18 17:04:37.777864
NCT00232544|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-04-06|2013-11-04||October 2004||2004-10-01|October 2013|2013-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Telecommunications System in Sleep Apnea|RCT of a Telecommunications System in Sleep Apnea|Completed||N/A|250|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:04:41.954056|2017-02-18 17:04:41.954056
NCT00232739|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2010-03-11|2009-10-19||September 2003||2003-09-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|November 2004|Actual|2004-11-01||Interventional|||Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions|A Multicenter, Non-Randomized Study of the 2.25mm Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 3|100|Actual|Cordis Corporation||1|||f||||t||||||||||2017-02-18 17:04:37.882362|2017-02-18 17:04:37.882362
NCT00232726|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2007-07-09|||September 2005||2005-09-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Clinical Study of Previously Untreated Patients With Malignant Melanoma|A Non-Randomised, Multicentre, Phase II Clinical Study of CP-4055 in Chemotherapy-Naïve Patients With Metastatic Malignant Melanoma|Completed||Phase 2|42|Anticipated|Clavis Pharma|||||f||||t||||||||||2017-02-18 17:04:38.318415|2017-02-18 17:04:38.318415
NCT00232713|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2006-08-29|||December 2005||2005-12-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Observational|||Uterine Fibroid Pregnancy Registry||Terminated||Phase 4|2360||INC Research|||||f||||||||||||||2017-02-18 17:04:38.599101|2017-02-18 17:04:38.599101
NCT00232700|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2011-06-22|||September 2005||2005-09-01|September 2007|2007-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Investigation of a Combination Treatment of Escitalopram and rTMS|Investigation of Efficacy and Response Speed of a Combination Treatment of Escitalopram and Repetitive Transcranial Magnetic Stimulation|Completed||N/A|42|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:04:38.680444|2017-02-18 17:04:38.680444
NCT00232687|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2013-11-07|||June 2005||2005-06-01|February 2012|2012-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Switch Study of BMS-337039 in Schizophrenic Out-patients|A Comparative, Randomized, Open-Label, Multicenter Study on the Efficacy and Safety of Switch Treatment With Aripiprazole in Schizophrenic Out-patients Who Are Experiencing Insufficient Efficacy With Risperidone and/or Safety and Tolerability Issues, While on Risperidone|Completed||Phase 4|450|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 17:04:38.786931|2017-02-18 17:04:38.786931
NCT00232674|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2011-01-21|||July 1999||1999-07-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|||||Interventional|||Efficacy Study of the Effect of Budesonide on Emphysema|The Effect of Inhaled Corticosteroids on the Development of Emphysema in Smokers Assessed by Computed Tomography (CT).|Completed||Phase 4|240||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:39.004522|2017-02-18 17:04:39.004522
NCT00232661|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2010-02-02|||August 2000||2000-08-01|February 2010|2010-02-01|December 2007|Actual|2007-12-01|January 2003|Actual|2003-01-01||Interventional|||PROACT - Pre-Operative Arimidex Compared To Tamoxifen|A Randomised, Double-blind, Study Comparing ARIMIDEX™ With NOLVADEX™ as Neo-adjuvant and Adjuvant Treatment in Post-menopausal Women With Large Operable (T2 (≥3cm), T3, N0-2, M0) or Potentially-operable, Locally Advanced (T4b, N0-2, M0), ER+ and/or PR+ Breast Cancer.|Completed||Phase 3|452|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:04:39.098679|2017-02-18 17:04:39.098679
NCT00232648|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2009-03-24|||January 2004||2004-01-01|March 2009|2009-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma|Investigation of Safety and Efficacy of Budesonide Inhalation Suspension in the Long-Term Use in Japanese Children With Bronchial Asthma (Open Long-Term Extension Study Following Study SD-004-0765|Completed||Phase 3|54||AstraZeneca|||||f||||||||||||||2017-02-18 17:04:39.314289|2017-02-18 17:04:39.314289
NCT00232635|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-04|2010-02-11|||September 2005||2005-09-01|February 2010|2010-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT|A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Safety and Efficacy of A-60444 in Adults With RSV Infection Following Stem Cell Transplantation|Completed||Phase 2|27|Actual|Arrow Therapeutics||2|||f||||t||||||||||2017-02-18 17:04:39.41507|2017-02-18 17:04:39.41507
NCT00232622|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2013-10-23|||November 2004||2004-11-01|October 2013|2013-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|RAFT-PVT||A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots|A Prospective Randomized Trial of a Rapid Fibrinolytic Protocol for Left-sided Prosthetic Valve Thrombosis|Completed||Phase 3|120|Actual|All India Institute of Medical Sciences, New Delhi||2|||f||||f||||||||||2017-02-18 17:04:39.518464|2017-02-18 17:04:39.518464
NCT00232609|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2012-09-17|||August 2005||2005-08-01|September 2012|2012-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Development of the GameCycle Exercise System: Phase II|Development of the GameCycle Exercise System: Phase II|Completed||Phase 2|14|Actual|VA Pittsburgh Healthcare System|||||f||||f||||||||||2017-02-18 17:04:39.645896|2017-02-18 17:04:39.645896
NCT00232596|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2016-10-26|2011-07-07||September 2005||2005-09-01|October 2016|2016-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|RESTORE1||Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study to Determine the Efficacy and Safety of Retigabine (1200 mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients With Partial-Onset Seizures|Completed||Phase 3|306|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:04:39.757516|2017-02-18 17:04:39.757516
NCT00232583|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-05-26|2013-10-15||November 2003||2003-11-01|October 2013|2013-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Preservation of Beta-cell Function in Type 2 Diabetes Mellitus|Preservation of Beta-cell Function in Type 2 Diabetes Mellitus|Completed||N/A|58|Actual|University of Texas Southwestern Medical Center|Relatively small trial, but longest (6-year) follow-up.|2|||f||||f||||||||||2017-02-18 17:04:41.150896|2017-02-18 17:04:41.150896
NCT00232570|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2009-05-04|||November 2005||2005-11-01|May 2009|2009-05-01|January 2010|Anticipated|2010-01-01|December 2009|Anticipated|2009-12-01||Interventional|||Quetiapine for the Treatment of Insomnia in Alzheimer's Disease|Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease|Unknown status|Recruiting|N/A|18|Anticipated|University of Vermont||1|||||||||||||||||2017-02-18 17:04:41.545219|2017-02-18 17:04:41.545219
NCT00232557|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-04-06|2013-11-27||August 2004||2004-08-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional||Subject with baseline examination|Telecommunications System in Asthma|Effectiveness of a Telecommunications System in Asthma Management|Completed||Phase 3|136|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:04:41.641671|2017-02-18 17:04:41.641671
NCT00232531|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2007-01-26|||September 2004||2004-09-01|September 2006|2006-09-01|February 2009||2009-02-01|||||Interventional|||Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function|Cardiovascular Magnetic Resonance Evaluation of the Effects of Niaspan on Regression of Atherosclerosis and Restoration of Endothelial Function|Unknown status|Active, not recruiting|N/A|70||University of Oxford|||||f||||||||||||||2017-02-18 17:04:42.277705|2017-02-18 17:04:42.277705
NCT00232518|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2007-05-04|||September 2005||2005-09-01|April 2005|2005-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis|Randomised Controlled Clinical Trial of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis|Completed||N/A|30||University of Nottingham|||||f||||||||||||||2017-02-18 17:04:42.364198|2017-02-18 17:04:42.364198
NCT00232505|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2016-01-17|||November 2005||2005-11-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Cetuximab With or Without Carboplatin in Treating Women With Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer|Phase II Trial of Cetuximab Alone and in Combination With Carboplatin in ER-Negative, PR-Negative, HER-2 Nonoverexpressing Metastatic Breast Cancer|Active, not recruiting||Phase 2|112|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:04:42.45856|2017-02-18 17:04:42.45856
NCT00232492|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-07-03|||January 2005||2005-01-01|April 2008|2008-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Ketamine on Acute Pain in Females and Males|Effect of Racemic Ketamine on Pain in Females and Males After Surgical Removal of Third Molars|Completed||Phase 4|128|Actual|Oslo University Hospital||8|||f||||f||||||||||2017-02-18 17:04:42.57358|2017-02-18 17:04:42.57358
NCT00232479|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2012-07-16|2012-06-12||September 2005||2005-09-01|July 2012|2012-07-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer|Phase II Study of Dose Dense Carboplatin and Taxotere With Herceptin As Primary Systemic Therapy in Breast Cancer|Completed||Phase 2|48|Actual|University of Miami||1|||f||||t||||||||||2017-02-18 17:04:45.535059|2017-02-18 17:04:45.535059
NCT00232466|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2008-06-24|||October 2005||2005-10-01|June 2008|2008-06-01|May 2010|Anticipated|2010-05-01|May 2009|Anticipated|2009-05-01||Interventional|||VERTOS-II. Percutaneous Vertebroplasty Versus Conservative Therapy|VERTOS II. Percutaneous Vertebroplasty Versus Conservative Therapy in Patients With Osteoporotic Vertebral Fractures|Unknown status|Active, not recruiting|N/A|200|Actual|UMC Utrecht||2|||f||||||||||||||2017-02-18 17:04:45.781615|2017-02-18 17:04:45.781615
NCT00232453|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-02-11|||March 2001||2001-03-01|February 2011|2011-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Preoperative Combined Radiation and Chemotherapy - Rectal Cancer|A Phase II Protocol of Preoperative Combined Radiation and Chemotherapy for Resectable Primary Rectal Cancer|Completed||Phase 2|34||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:04:45.886323|2017-02-18 17:04:45.886323
NCT00232440|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2010-08-10|||January 2003||2003-01-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma|A Study to Examine the Reproducibility of an Immobilization Device (BodyFIX ) to Deliver High Precision Radiation Therapy for Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|20||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:04:45.966045|2017-02-18 17:04:45.966045
NCT00232427|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2007-10-02|||August 2005||2005-08-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||PiCCO Guided Therapy in Liver Cirrhosis|Optimized Therapy of Decompensated Liver Cirrhosis by Hemodynamic Monitoring Using the PiCCO System|Completed||N/A|20|Actual|Heidelberg University|||||f||||||||||||||2017-02-18 17:04:46.046762|2017-02-18 17:04:46.046762
NCT00232414|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2013-12-09|||October 2005||2005-10-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder|A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder|Completed||Phase 3|30|Anticipated|University of Cincinnati|||||f||||t||||||||||2017-02-18 17:04:46.134331|2017-02-18 17:04:46.134331
NCT00232401|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2009-02-13|||October 2005||2005-10-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|||||Observational|||The Circadian Rhythm of Urine Output in Healthy Infants|The Circadian Rhythm of Urine Output in Healthy Infants|Completed||N/A|60|Anticipated|University of Aarhus|||||f||||||||||||||2017-02-18 17:04:46.230921|2017-02-18 17:04:46.230921
NCT00232388|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2015-10-06|||September 2005||2005-09-01|October 2015|2015-10-01|September 2007|Actual|2007-09-01|||||Observational|||Association of PICP Serum Marker in Patients With LVSD|Phase 1 Study of PICP Serum Marker of Myocardial Fibrosis and Diastolic Function in Patients With Systolic Dysfunction|Terminated||Phase 1|45|Actual|Texas Tech University Health Sciences Center|||1|PI left institution; Data collected from 45 participants, but no results are available.|f||||f||||||None Retained|"~     PLEASE NOTE THAT THE INVESTIGATOR LEFT THE INSTITUION WITHOUT PROVIDING ANY INFORMATION~     REGARDING THIS PROJECT. NO FORWARDING INFORMATION IS AVAILABLE FROM THE INVESTIGATOR.~   "|||2017-02-18 17:04:46.312102|2017-02-18 17:04:46.312102
NCT00232375|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2005-09-30|||January 1996||1996-01-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes||Completed||N/A|42||Tokyo Study Group|||||f||||||||||||||2017-02-18 17:04:46.409045|2017-02-18 17:04:46.409045
NCT00232362|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-04-09|||June 2007||2007-06-01|April 2015|2015-04-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus|Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus|Withdrawn||Phase 1|0|Actual|Texas Tech University Health Sciences Center||||This study was not conducted as the Principal Investigator left the institution|f||||||||||||||2017-02-18 17:04:46.498761|2017-02-18 17:04:46.498761
NCT00232349|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2008-07-30|||February 2005||2005-02-01|July 2008|2008-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy of Galantamine to Treat Schizophrenia|An Open-Label Trial of Adjunctive Galantamine Maintenance Therapy to Treat Functional Impairments in Chronic Outpatients With Schizophrenia|Terminated||Phase 4|21|Actual|Seattle Institute for Biomedical and Clinical Research||1||Study terminated due to no apparent benefit.|f||||t||||||||||2017-02-18 17:04:46.829333|2017-02-18 17:04:46.829333
NCT00231348|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2013-11-08||||||November 2013|2013-11-01|April 2000|Actual|2000-04-01|||||Interventional|||Nefazodone in the Treatment of Social Phobia|Nefazodone in the Treatment of Social Phobia: Functional Brain Imaging and Neuroendocrine Correlates|Completed||Phase 4|24||Emory University|||||f||||||||||||||2017-02-18 17:05:04.609434|2017-02-18 17:05:04.609434
NCT00232336|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2008-07-29|||October 2003||2003-10-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|||||Interventional|||Quetiapine for Cocaine Use and Cravings|Efficacy of Quetiapine in the Reduction of Cocaine Use and Cravings in Individuals With Cocaine Dependence|Completed||Phase 4|42|Actual|Seattle Institute for Biomedical and Clinical Research||1|||f||||f||||||||||2017-02-18 17:04:46.946417|2017-02-18 17:04:46.946417
NCT00232323|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-02|2007-01-23|||January 2006||2006-01-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Simulation Training as a Tool to Decrease Occupational Stress in ICU Personnel|Experimental Like Study of Stress Reduction in Intensive Care Teams by Use of Simulation Training|Suspended||N/A|40||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:04:47.045594|2017-02-18 17:04:47.045594
NCT00232310|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2012-05-07|||October 2005||2005-10-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|CORYFEE||Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr|Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744C 300 or 600 mg for the Conversion of Atrial Fibrillation / Flutter|Completed||Phase 2|150|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:04:47.128961|2017-02-18 17:04:47.128961
NCT00232297|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2012-05-07|||June 2005||2005-06-01|May 2012|2012-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|ICARIOS||Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS|Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744C 100 OR 300 mg for the Prevention of Ventricular Arrhythmia-Triggered ICD Interventions|Completed||Phase 2|153|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:04:47.238729|2017-02-18 17:04:47.238729
NCT00232284|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-02|2015-06-24|||September 2004||2004-09-01|June 2015|2015-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Treatment of Comorbid Depression and Substance Abuse in Young People|An Integrated Pharmacological and Psychological Approach to Young People With Comorbid Depression and Substance Abuse|Completed||Phase 2|60|Actual|Melbourne Health||2|||f||||f||||||||||2017-02-18 17:04:47.341702|2017-02-18 17:04:47.341702
NCT00232271|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-02|2013-05-28|||August 2005||2005-08-01|October 2005|2005-10-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.|The Effect of Enoxaparin Sodium (Clexane) on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.|Terminated||Phase 4|35|Actual|Melbourne Health||2||Slow recruitment|f||||||||||||||2017-02-18 17:04:47.451337|2017-02-18 17:04:47.451337
NCT00232258|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2008-12-09|||April 2005||2005-04-01|December 2008|2008-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|NICE||Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study|Nolpitantium Besylate in Patients With Mild to Moderate Ulcerative Colitis, a Double-Blind, Placebo Controlled Efficacy and Safety, 8 Week Study|Completed||Phase 2|307|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:04:47.541823|2017-02-18 17:04:47.541823
NCT00232245|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-02|2013-05-28|||December 2003||2003-12-01|February 2013|2013-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.||Completed||Phase 4|80|Actual|Melbourne Health||2|||f||||t||||||||||2017-02-18 17:04:47.657081|2017-02-18 17:04:47.657081
NCT00232232|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-02|2015-05-08|||September 2003||2003-09-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|July 2013|Actual|2013-07-01||Interventional|||Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia||Completed||Phase 4|100|Anticipated|Melbourne Health||2|||f||||||||||||||2017-02-18 17:04:47.747481|2017-02-18 17:04:47.747481
NCT00232219|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-02|2015-05-04|||January 2003||2003-01-01|May 2015|2015-05-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion|Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.|Completed||Phase 4|200|Actual|Melbourne Health||2|||f||||||||||||||2017-02-18 17:04:47.844852|2017-02-18 17:04:47.844852
NCT00232206|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-05-17|||May 2005||2005-05-01|May 2011|2011-05-01|November 2007||2007-11-01|April 2007|Actual|2007-04-01||Interventional|||Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer|A Phase II Study of Cisplatin Plus Docetaxel as Neoadjuvant Therapy for Stages IB Through Selected IIIA NSCLC|Terminated||Phase 2|40|Anticipated|Providence Health & Services||||study terminated due to slow accrual|f||||||||||||||2017-02-18 17:04:47.936377|2017-02-18 17:04:47.936377
NCT00232193|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-07-20|||December 2003||2003-12-01|July 2011|2011-07-01|August 2010|Actual|2010-08-01|December 2008|Actual|2008-12-01||Observational|||Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS|Steroid Adjunctive Treatment at Initiation of Avonex Therapy for Patients With Mono-Symptomatic or Relapsing-Remitting Multiple Sclerosis|Completed||Phase 4|40|Actual|Providence Multiple Sclerosis Center|||2||f||||f||||||||||2017-02-18 17:04:48.041281|2017-02-18 17:04:48.041281
NCT00232180|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2013-03-28|2011-05-20||March 2006||2006-03-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|May 2010|Actual|2010-05-01||Interventional|EMPHASIS-HF||A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines|The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality And Heart Failure Hospitalization In Subjects With NYHA Class II Chronic Systolic Heart Failure|Completed||Phase 3|2743|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 17:04:48.200372|2017-02-18 17:04:48.200372
NCT00232167|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2007-10-01|||November 2005||2005-11-01|October 2007|2007-10-01|April 2006||2006-04-01|||||Interventional|||Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression|Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Tolerability Of Indiplon Therapy Initiated With Sertraline Versus Sertraline Monotherapy In Subjects With Insomnia And Co-Existing Major Depressive Disorder|Terminated||Phase 3|380||Neurocrine Biosciences||||Please see Detailed Description below for termination reason.|||||f||||||||||2017-02-18 17:04:53.730923|2017-02-18 17:04:53.730923
NCT00232154|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-04-20|||November 2005||2005-11-01|April 2011|2011-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To|An Open-Label Study Of Azithromycin Pharmacokinetics In Sinus Mucosal Tissue And Plasma In Subjects With Chronic Rhinosinusitis Following A Single 2g Dose Of Azithromycin Extended Release For Oral Suspension Or Azithromycin 500mg Tablet Formulation Once Daily For A Maximum Of Three Days|Completed||Phase 2|72|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:04:53.812101|2017-02-18 17:04:53.812101
NCT00232141|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2009-06-22|2008-11-25||October 2005||2005-10-01|June 2009|2009-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Pregabalin Versus Placebo in the Treatment of Neuropathic Pain Associated With HIV Neuropathy.|Completed||Phase 3|302|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:04:53.93915|2017-02-18 17:04:53.93915
NCT00232128|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2007-01-11|||June 2003||2003-06-01|May 2006|2006-05-01||||||||Interventional|||Protocol for Radiofrequency Ablation of Pulmonary Neoplasms|Protocol for Radiofrequency Ablation of Pulmonary Neoplasms|Terminated||N/A|||Oncology Specialties, Alabama|||||f||||||||||||||2017-02-18 17:04:56.465872|2017-02-18 17:04:56.465872
NCT00232115|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2008-01-15|||September 2005||2005-09-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|||||Interventional|||Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis|Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis|Completed||Phase 3|124|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:04:56.537937|2017-02-18 17:04:56.537937
NCT00232102|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-01-31|||September 2004||2004-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia|Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia|Completed||Phase 3|423||Novartis|||||||||||||||||||2017-02-18 17:04:56.640195|2017-02-18 17:04:56.640195
NCT00232089|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-11-16|||May 2004||2004-05-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia|Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia|Completed||Phase 3|1296||Novartis|||||||||||||||||||2017-02-18 17:04:56.726418|2017-02-18 17:04:56.726418
NCT00232076|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-11-01|||May 2004||2004-05-01|November 2011|2011-11-01||||March 2005|Actual|2005-03-01||Interventional|||Verification Study of Ciclosporin for Atopic Dermatitis|Verification Study of Ciclosporin for Atopic Dermatitis|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-02-18 17:04:56.82049|2017-02-18 17:04:56.82049
NCT00232063|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-11-01|||May 2004||2004-05-01|November 2011|2011-11-01||||November 2005|Actual|2005-11-01||Interventional|||Long-term Study of Ciclosporin for Atopic Dermatitis|Long-term Study of Ciclosporin for Atopic Dermatitis|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-02-18 17:04:56.904845|2017-02-18 17:04:56.904845
NCT00232050|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-10-24|||October 2002||2002-10-01|October 2011|2011-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study of Omalizumab in Moderate to Severe Bronchial Asthma|Study of Omalizumab in Moderate to Severe Bronchial Asthma|Completed||Phase 3|327|Actual|Novartis|||||f||||||||||||||2017-02-18 17:04:56.986403|2017-02-18 17:04:56.986403
NCT00232037|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-01-31|||September 2004||2004-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia|Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia|Completed||Phase 3|359||Novartis|||||||||||||||||||2017-02-18 17:04:57.061649|2017-02-18 17:04:57.061649
NCT00232024|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-01-31|||January 2004||2004-01-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia|Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia|Completed||Phase 3|1296||Novartis|||||||||||||||||||2017-02-18 17:04:57.148101|2017-02-18 17:04:57.148101
NCT00232011|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2007-12-13|||May 2004||2004-05-01|December 2007|2007-12-01|May 2005|Actual|2005-05-01|||||Interventional|||Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis|A Clinical Study Continued From the Confirmatory Study to Assess the Efficacy and Safety of ASM981 Cream in Adult Atopic Dermatitis Patients|Completed||Phase 3|160||Novartis||1|||f||||||||||||||2017-02-18 17:04:57.247581|2017-02-18 17:04:57.247581
NCT00231998|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2007-12-13|||May 2004||2004-05-01|December 2007|2007-12-01|June 2005|Actual|2005-06-01|||||Interventional|||Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis|A Clinical Study Continued From the Confirmatory Study to Validate the Efficacy and Safety of Pimecrolimus Cream in Pediatric Atopic Dermatitis Patients|Completed||Phase 3|240||Novartis||1|||f||||||||||||||2017-02-18 17:04:57.450434|2017-02-18 17:04:57.450434
NCT00231985|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2012-02-08|||October 2005||2005-10-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder|Behavior Therapy and Psychosocial Treatment for Tourette Syndrome and Chronic Tic Disorder|Completed||Phase 2|122|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 17:04:57.551345|2017-02-18 17:04:57.551345
NCT00231972|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-04-07|||December 2003||2003-12-01|February 2011|2011-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|Enhance||Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected Men|Enhancing HIV Prevention Among HIV Infected Men|Completed||N/A|201|Actual|Fenway Community Health||2|||f||||f||||||||||2017-02-18 17:04:57.66657|2017-02-18 17:04:57.66657
NCT00231959|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2012-04-25|||September 2003||2003-09-01|April 2012|2012-04-01|April 2008|Actual|2008-04-01|September 2007|Actual|2007-09-01||Interventional|||Effectiveness of Pramipexole for Treatment-Resistant Depression|A Double-Blind Placebo-Controlled Trial of Adjunctive Pramipexole, a Dopamine Receptor Agonist, for Treatment Resistant Major Depressive Episodes|Completed||Phase 4|65|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:04:57.778607|2017-02-18 17:04:57.778607
NCT00231946|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2007-09-18|||September 2005||2005-09-01|September 2007|2007-09-01||||||||Interventional|||ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)|A Double-Blind Placebo-Controlled Study of VP4896 For the Treatment of Mild-to-Moderate Alzheimer's Disease|Completed||Phase 3|555||National Institute on Aging (NIA)|||||||||||||||||||2017-02-18 17:04:57.886873|2017-02-18 17:04:57.886873
NCT00231933|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2012-04-09|||October 2005||2005-10-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Culturally Responsive Person-Centered Care for Psychosis|Culturally-responsive, Person-centered Care for Psychosis|Completed||Phase 1|290|Actual|Yale University||3|||f||||f||||||||||2017-02-18 17:04:58.043131|2017-02-18 17:04:58.043131
NCT00231920|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-08-11|||October 2004||2004-10-01|November 2006|2006-11-01|October 2006||2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age|Prospective Pilot Safety Study Administering Two Doses of Inactivated Influenza Vaccine to Infants 10-22 Weeks of Age|Completed||Phase 1|23|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:04:58.344644|2017-02-18 17:04:58.344644
NCT00231907|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2010-08-26|||September 2005||2005-09-01|February 2010|2010-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist|Influenza Vaccines: Mix and Match of Trivalent Inactivated Influenza (TIV) and Live Attenuated Influenza Vaccine (LAIV), a Phase I Safety, Immunogenicity, and Viral Shedding Study|Completed||Phase 1|56|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:04:58.430601|2017-02-18 17:04:58.430601
NCT00231894|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-07-22|||May 2005||2005-05-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia|Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia Treated With Antipsychotic Medication And Potential Effects on Cognitive Function|Completed||N/A|40|Anticipated|Nathan Kline Institute for Psychiatric Research||2|||f||||f||||||||||2017-02-18 17:04:58.54223|2017-02-18 17:04:58.54223
NCT00231881|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2007-04-27||||||April 2007|2007-04-01||||||||Observational|||Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux|Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux|Unknown status|Recruiting|N/A|60|Anticipated|Nantes University Hospital|||||f||||||||||||||2017-02-18 17:04:58.661497|2017-02-18 17:04:58.661497
NCT00231868|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2012-04-22|||December 2001||2001-12-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma|"A Pilot Phase II Trial of Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma"|Completed||Phase 2|81|Actual|Montefiore Medical Center||1|||f||||t||||||||||2017-02-18 17:04:58.743792|2017-02-18 17:04:58.743792
NCT00231855|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2012-04-22|||November 2004||2004-11-01|April 2012|2012-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers|Phase II Trial- Weekly Taxotere and Topotecan for Recurrent Ovarian, Primary Peritoneal, Endometrial and Uterine Cancers|Completed||Phase 2|31||Montefiore Medical Center|||||f||||t||||||||||2017-02-18 17:04:58.86172|2017-02-18 17:04:58.86172
NCT00231842|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2012-04-22|||February 2003||2003-02-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus|"A Pilot Phase II Trial of Adjuvant Radiation Therapy Sandwiched Between Ifosfamide in Patients With Mixed Mesodermal Tumors"|Completed||Phase 2|27|Actual|Montefiore Medical Center||1|||f||||t||||||||||2017-02-18 17:04:58.976794|2017-02-18 17:04:58.976794
NCT00231829|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2012-04-22|||April 2003||2003-04-01|April 2012|2012-04-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers|A Pilot Phase II Trial of Celecoxib in Patients With Grade 2 or 3 Endometrioid-type, Clear Cell, and Papillary Serous Uterine Cancers|Terminated||Phase 2|23||Montefiore Medical Center||||Due to reported toxicity of Celecoxib at high doses|f||||t||||||||||2017-02-18 17:04:59.094087|2017-02-18 17:04:59.094087
NCT00231816|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-09-02|2010-05-12||September 2005||2005-09-01|September 2015|2015-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)|A Double-Blind, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of V211 Administered Concomitantly Versus Nonconcomitantly With Influenza Virus Vaccine (Inactivated)|Completed||Phase 3|763|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:04:59.200516|2017-02-18 17:04:59.200516
NCT00231803|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2005-10-06|||April 2005||2005-04-01|October 2005|2005-10-01|December 2007||2007-12-01|||||Interventional|||The Canadian Prevention of Renal and Cardiovascular Endpoints Trial|Canadian Collaborative Group for the Prevention of Illness in Chronic Renal Disease. The Canadian Prevention of Renal and Cardiovascular Endpoints Trial|Unknown status|Recruiting|Phase 4|500||Memorial University of Newfoundland|||||f||||||||||||||2017-02-18 17:04:59.788213|2017-02-18 17:04:59.788213
NCT00231790|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-12-16|||August 2005||2005-08-01|December 2015|2015-12-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of MK0634 in Postmenopausal Women With Overactive Bladder|Completed||Phase 2|848|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 17:04:59.893453|2017-02-18 17:04:59.893453
NCT00231777|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-08-18|2010-05-10||July 2005||2005-07-01|August 2015|2015-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)|A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study Conducted Under In-House Blinding Conditions, to Examine the Safety and Tolerability of IV MK0517 for the Prevention of Postoperative Nausea and Vomiting (PONV)|Completed||Phase 3|216|Actual|Merck Sharp & Dohme Corp.|The formulation of MK0517 used in this study was a non polysorbate (PS80) formulation which was not further developed and is not available for use.|2|||f||||f||||||||||2017-02-18 17:05:00.009541|2017-02-18 17:05:00.009541
NCT00231764|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2008-04-22|||November 2002||2002-11-01|April 2008|2008-04-01|February 2008|Actual|2008-02-01|May 2006|Actual|2006-05-01||Interventional|||MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients|Evaluating Safety and Efficacy of MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Combination With Low-Dose CsA, Tac or Sir in Comparison to Current Standard Immunosuppression (MMF, CsA and Corticosteroids) in Renal Tx|Completed||Phase 4|1760||Ekberg, Henrik, M.D.|||||f||||||||||||||2017-02-18 17:05:00.682095|2017-02-18 17:05:00.682095
NCT00231751|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2005-09-30|||November 2002||2002-11-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Observational|||The Malmö International Brother Study (MIBS)|The Malmö International Brother Study (MIBS)|Completed||N/A|||Skane University Hospital|||||f||||||||||||||2017-02-18 17:05:00.780059|2017-02-18 17:05:00.780059
NCT00231738|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2015-11-19|||November 1996||1996-11-01|October 2005|2005-10-01|November 2004||2004-11-01|||||Interventional|||Protective Effect of EPA on Cardiovascular Events|Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS)|Completed||Phase 4|18000||Kobe University|||||f||||||||||||||2017-02-18 17:05:00.870749|2017-02-18 17:05:00.870749
NCT00005428|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||August 1993||1993-08-01|May 2000|2000-05-01|July 1995|Actual|1995-07-01|||||Observational|||Familial Aggregation of Stress Response||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.467168|2017-02-18 18:15:00.467168
NCT00231725|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2007-06-26|||September 2005||2005-09-01|June 2007|2007-06-01|April 2006|Actual|2006-04-01|||||Interventional|||Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin|Complaints Associated With Use of Pre-Filled Pen B When Used by Patients With Type 2 Diabetes on Twice-Daily Insulin Therapy|Completed||Phase 3|370||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:05:00.971171|2017-02-18 17:05:00.971171
NCT00231712|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2006-08-22|||March 2005||2005-03-01|September 2005|2005-09-01|February 2009||2009-02-01|||||Observational|||Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant|Prospective Analysis of the Patterns of Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Autologous/Allogeneic Stem Cell Transplant|Unknown status|Recruiting|N/A|50||Julius-Maximilians University|||||f||||||||||||||2017-02-18 17:05:01.060156|2017-02-18 17:05:01.060156
NCT00231699|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2005-10-03|||January 2004||2004-01-01|October 2005|2005-10-01|December 2004||2004-12-01|||||Interventional|||A Comparison of Prevention of Hypothermia in Pediatric Patient Between Wrapping With Cotton and Plastic.|A Comparison of Prevention of Hypothermia in Pediatric Patient Between Wrapping With Cotton (Webril) and Plastic (Mwrap).|Completed||N/A|42||Khon Kaen University|||||f||||||||||||||2017-02-18 17:05:01.143003|2017-02-18 17:05:01.143003
NCT00231686|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2005-09-30|||November 2000||2000-11-01|September 2005|2005-09-01|May 2003||2003-05-01|||||Interventional|||Effects of a 6-Months Physical Conditioning Program in Patients With Cystic Fibrosis|Effects of a 6-Months Physical Conditioning Program on Health Status and Physical Activity in Youths and Young Adults With Cystic Fibrosis - MUKOTRAIN|Completed||Phase 2/Phase 3|80||Julius-Maximilians University|||||f||||||||||||||2017-02-18 17:05:01.227129|2017-02-18 17:05:01.227129
NCT00231673|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-06|||July 2001||2001-07-01|April 2011|2011-04-01|January 2003|Actual|2003-01-01|||||Interventional|||A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy|A Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Topiramate on Electrophysiological Parameters in Subjects With Diabetic Peripheral Polyneuropathy|Completed||Phase 2|72|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||||||||||||2017-02-18 17:05:01.454905|2017-02-18 17:05:01.454905
NCT00231660|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-06|||October 2000||2000-10-01|January 2011|2011-01-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Treated With Metformin|Completed||Phase 3|211|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:05:01.57754|2017-02-18 17:05:01.57754
NCT00231647|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-06|||February 2004||2004-02-01|January 2011|2011-01-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Assess the Efficacy and Safety of Topiramate OROS Controlled-Release in the Treatment of Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin|Completed||Phase 2|113|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:05:01.692674|2017-02-18 17:05:01.692674
NCT00231634|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-06|||May 2001||2001-05-01|January 2011|2011-01-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy|Terminated||Phase 3|31|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||Program discontinued|f||||f||||||||||2017-02-18 17:05:01.801241|2017-02-18 17:05:01.801241
NCT00231621|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-06|||May 2001||2001-05-01|April 2010|2010-04-01|June 2002|Actual|2002-06-01|||||Interventional|||A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, One-year Study of the Efficacy and Safety of Topiramate in the Treatment of Obese Subjects With Dyslipidemia|Terminated||Phase 3|179|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"The study was terminated prior to completion to focus on the development of a controlled~   release formulation."|f||||f||||||||||2017-02-18 17:05:01.90379|2017-02-18 17:05:01.90379
NCT00231608|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-06|||December 1998||1998-12-01|April 2010|2010-04-01|January 2002|Actual|2002-01-01|||||Interventional|||A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity|The Safety and Efficacy of Topiramate in Male Patients With Abdominal Obesity: A 6-Month Double-Blind, Randomized, Placebo-Controlled Study With a 6-Month Open-Label Extension|Completed||Phase 2|68|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:05:02.013639|2017-02-18 17:05:02.013639
NCT00231595|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2010-11-18|||March 2001||2001-03-01|November 2010|2010-11-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine|Completed||Phase 3|768|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:05:02.11378|2017-02-18 17:05:02.11378
NCT00231582|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-02-24|||September 2004||2004-09-01|March 2007|2007-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II|Sequential High-Dose Chemotherapy Combining Two Mobilization and Cyto-Reductive Treatments Followed by Three High-Dose Chemotherapy Regimens Supported by Autologous Stem Cell Transplantation|Completed||Phase 2|50|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:05:02.208092|2017-02-18 17:05:02.208092
NCT00231569|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2016-08-01|||September 2005||2005-09-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Dose-escalating Safety Study in Subjects on Stable Statin Therapy|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Dose‑Escalation Study to Assess the Safety and Pharmacodynamics of ISIS 301012 in Hypercholesterolemic Subjects on Stable Statin Therapy|Completed||Phase 2|74|Actual|Kastle Therapeutics, LLC||7|||f||||t||||||||||2017-02-18 17:05:02.332228|2017-02-18 17:05:02.332228
NCT00229398|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2008-01-28|||November 1998||1998-11-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression Disorder||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:13.924683|2017-02-18 17:05:13.924683
NCT00231556|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-06|||July 1999||1999-07-01|January 2010|2010-01-01|September 2003|Actual|2003-09-01|||||Interventional|||A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy|A Randomized, Double-Blind, Parallel-Group, Monotherapy Study to Compare the Safety and Efficacy of Two Doses of Topiramate in the Treatment of Newly Diagnosed or Recurrent Epilepsy|Completed||Phase 3|750|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:05:02.446603|2017-02-18 17:05:02.446603
NCT00231543|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2006-10-11||||||October 2005|2005-10-01||||||||Interventional|||Laparoscopy in Children: Does it Decrease the Metabolic, Endocrine and Inflammatory Stress Response to Surgery||Completed||N/A|||Institute of Child Health|||||f||||||||||||||2017-02-18 17:05:02.539221|2017-02-18 17:05:02.539221
NCT00231530|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-06|||January 2001||2001-01-01|April 2010|2010-04-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients on a Controlled Diet|Completed||Phase 3|541|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:05:02.807076|2017-02-18 17:05:02.807076
NCT00231517|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2006-10-11||||||October 2005|2005-10-01||||||||Interventional|||Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa||Completed||Phase 4|||Institute of Child Health|||||f||||||||||||||2017-02-18 17:05:02.89951|2017-02-18 17:05:02.89951
NCT00231504|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2010-01-05|||October 2005||2005-10-01|March 2007|2007-03-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Observational|||Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count|Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count|Completed||Phase 1|82|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"~     DNA~   "|||2017-02-18 17:05:02.983882|2017-02-18 17:05:02.983882
NCT00231491|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2011-02-16|||November 2005||2005-11-01|March 2007|2007-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.|Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder (OAB). A Multicenter Phase II, Randomized, Double-blind, Placebo Controlled 6 Month Study . VESITOX|Completed||Phase 2|160|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:05:03.077687|2017-02-18 17:05:03.077687
NCT00231478|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-05-16|2011-03-30||April 2007||2007-04-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy|A Randomized, Double-blind Study of 2 Dose Levels of Kytril on the Prevention of Post-operative Nausea and Vomiting in Pediatric Patients Undergoing Surgery With General Anesthesia|Completed||Phase 4|171|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:05:03.195613|2017-02-18 17:05:03.195613
NCT00231465|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2012-12-03|2012-11-01||July 2003||2003-07-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer|Phase II Study of Taxotere® (Docetaxel) + ZD1839 (IRESSA®) in Previously Untreated Elderly Patients (≥70 Years Old) With Stage III-b (With Malignant Pleural Effusion [MPE+]) or Stage IV Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|44|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 17:05:03.585855|2017-02-18 17:05:03.585855
NCT00231452|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-10-27|||September 2005||2005-09-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Age of Exposure and Immunity to Malaria in Infants|Age of Exposure and Immunity to Malaria in Infants|Completed||N/A|349|Actual|Hospital Clinic of Barcelona||3|||f||||t||||||||||2017-02-18 17:05:03.895926|2017-02-18 17:05:03.895926
NCT00231439|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2005-12-12|||August 2003||2003-08-01|July 2003|2003-07-01|July 2004||2004-07-01|||||Interventional|||Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)|Post-Polio Syndrome Treated With Intravenous Immunoglobulin (IvIg)|Completed||Phase 2/Phase 3|40||Haukeland University Hospital|||||f||||||||||||||2017-02-18 17:05:04.001598|2017-02-18 17:05:04.001598
NCT00231426|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2006-11-20|||June 2003||2003-06-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations|Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICDs Study|Completed||Phase 4|||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:05:04.08658|2017-02-18 17:05:04.08658
NCT00231413|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2016-09-22|||March 2005||2005-03-01|September 2016|2016-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.|A Dose-range Study to Assess the Safety and Immunogenicity of a Novel HPV Vaccine When Administered Intramuscularly According to a 3-dose Schedule (0,1,6-month) in Healthy Adult Females (18-25 Years of Age)|Completed||Phase 2|383|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:05:04.177017|2017-02-18 17:05:04.177017
NCT00231400|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2016-04-29|||September 2004||2004-09-01|April 2016|2016-04-01|September 2022|Anticipated|2022-09-01|September 2022|Anticipated|2022-09-01||Observational|||Pompe Disease Registry|Pompe Disease Registry|Recruiting||N/A|2000|Anticipated|Sanofi|||1||f||||f||||||||||2017-02-18 17:05:04.288247|2017-02-18 17:05:04.288247
NCT00231387|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2017-01-20|||September 2002|Actual|2002-09-01|January 2017|2017-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus|Rosiglitazone and Plaque Study: A 12 Month Randomised, Double-blind, Placebo-controlled, Magnetic Resonance Imaging Study to Evaluate the Effect of Rosiglitazone on the Structure and Composition of Carotid Atherosclerotic Plaques in Subjects With Type 2 Diabetes Mellitus and Coexisting Vascular Disease or Hypertension|Completed||Phase 3|60||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:05:04.418417|2017-02-18 17:05:04.418417
NCT00231374|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2014-01-08|||September 2005||2005-09-01|January 2014|2014-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning|In Vivo Analysis of Intradural Pressure Variation With Patient Positioning|Withdrawn||N/A|0|Actual|Emory University||||Difficulty in recruiting patients for the study.|f||||||||||||||2017-02-18 17:05:04.510429|2017-02-18 17:05:04.510429
NCT00231335|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2010-12-06|||March 2006||2006-03-01|March 2006|2006-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia|The Efficacy and Safety of Escitalopram Augmentation of Risperidone and Olanzapine in Treatment Resistant Schizophrenia: a Double Blind Placebo Controlled Pilot Study|Completed||Phase 4|30|Anticipated|Emory University|||||f||||||||||||||2017-02-18 17:05:04.699687|2017-02-18 17:05:04.699687
NCT00231322|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2007-04-19|||March 2004||2004-03-01|April 2007|2007-04-01|March 2006||2006-03-01|||||Interventional|||Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique|The Influence of Transmission Season on Outcome of Schistosoma Haematobium Infection Treatment Among School Children in Urban and Peri-Urban Areas of Maputo and Matola, Mozambique|Completed||N/A|520||DBL -Institute for Health Research and Development|||||f||||||||||||||2017-02-18 17:05:04.790516|2017-02-18 17:05:04.790516
NCT00231309|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2014-08-19|2013-08-14||July 2003||2003-07-01|August 2014|2014-08-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)|Pilot Study of Using Granulocyte Colony Stimulating Factor-Primed Bone Marrow in Histocompatible Sibling Allogeneic Bone Marrow Transplantation for Patients With Hematologic Malignancies and Non-Malignancies|Completed||N/A|10|Actual|Emory University|Our study is also limited by its small patient population and short follow-up time.|1|||f||||t||||||||||2017-02-18 17:05:04.885025|2017-02-18 17:05:04.885025
NCT00231296|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2017-02-02|||November 2004||2004-11-01|February 2017|2017-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Safety and Efficacy of CryoCor™ Cryoablation for PAF|A Clinical Study to Evaluate the Safety and Efficacy of the CryoCor(TM)Cardiac Cryoablation System for the Treatment of Paroxysmal Atrial Fibrillation|Completed||Phase 3|174|Actual|Boston Scientific Corporation||2|||f||||f||||||||||2017-02-18 17:05:05.235371|2017-02-18 17:05:05.235371
NCT00231283|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2010-04-13|2008-11-18||April 2004||2004-04-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions|A Multicenter, Non-Randomized Study of the CYPHER NxT Sirolimus-Eluting Coronary Stent on BX SONIC OVER-THE-WIRE (OTW) Stent Delivery System(SDS)for the Treatment of de Novo Native Coronary Artery Lesions|Completed||Phase 3|100|Actual|Cordis Corporation||1|||f||||f||||||||||2017-02-18 17:05:05.372521|2017-02-18 17:05:05.372521
NCT00231270|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2008-04-17|||August 2000||2000-08-01|July 2007|2007-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)|Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy|Completed||Phase 3|1300||Cordis Corporation|||||f||||t||||||||||2017-02-18 17:05:05.658953|2017-02-18 17:05:05.658953
NCT00231257|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2009-11-17||2009-11-17|February 2003||2003-02-01|November 2009|2009-11-01|September 2009|Actual|2009-09-01|January 2005|Actual|2005-01-01||Interventional|||Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)|A Multicenter, Randomized Study of the Sirolimus-Eluting Bx VELOCITY® BALLOON Expandable Stent vs. Intravascular Brachytherapy in the Treatment of Patients With In-Stent Restenotic Coronary Artery Lesions|Completed||Phase 3|384|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:05:05.740635|2017-02-18 17:05:05.740635
NCT00231244|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2009-12-04|||March 2002||2002-03-01|December 2009|2009-12-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)|Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry|Completed||Phase 3|252|Actual|Cordis Corporation||1|||f||||f||||||||||2017-02-18 17:05:05.850156|2017-02-18 17:05:05.850156
NCT00231231|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2007-07-19|||September 2004||2004-09-01|July 2007|2007-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)|Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)|Completed||Phase 3|1500||Cordis Corporation|||||f||||t||||||||||2017-02-18 17:05:05.966687|2017-02-18 17:05:05.966687
NCT00231218|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2006-12-13|||January 2006||2006-01-01|December 2006|2006-12-01|March 2006||2006-03-01|||||Interventional|||Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers|the Effectiveness of Echinacea, Propolis and Vitamin C in the Prevention of Respiratory Tract Infections and Gastroenteritis in Preschool Age Children: a Prospective Study|Completed||Phase 3|104||The Cleveland Clinic|||||f||||||||||||||2017-02-18 17:05:06.045865|2017-02-18 17:05:06.045865
NCT00231205|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2005-09-30|||January 2005||2005-01-01|September 2005|2005-09-01|December 2009||2009-12-01|||||Observational|||TDI Preejection Velocities and Myocardial Viability|TDI-Derived Myocardial Preejection Velocities in Patients With Chronic Ischemic Left Ventricular Dysfunction Undergoing Surgical Revascularization|Unknown status|Recruiting|N/A|200||Charles University, Czech Republic|||||f||||||||||||||2017-02-18 17:05:06.138767|2017-02-18 17:05:06.138767
NCT00231192|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2015-03-11|||October 2005||2005-10-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes|Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes|Withdrawn||N/A|0|Actual|Children's Hospital of Philadelphia||1||Unable to recruit any subjects|f||||t||||||||||2017-02-18 17:05:06.22498|2017-02-18 17:05:06.22498
NCT00231179|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-10-26|2010-03-01||February 2004||2004-02-01|October 2015|2015-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|MOM Program||The MOM Program: 5 Year Follow-up Study of a Home Visiting Program at The Children's Hospital of Philadelphia|The MOM Program Continuation - 5 Year Follow-up|Completed||Phase 3|302|Actual|Children's Hospital of Philadelphia|The initial high rate of refusal to participate in the study may affect the generalizability of our results. Those who refused study participation were older and did not elaborate on their lack of interest.|2|||f||||f||||||||||2017-02-18 17:05:06.325895|2017-02-18 17:05:06.325895
NCT00231166|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2015-11-07|||September 2005||2005-09-01|November 2015|2015-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma|A Phase I, Dose-finding Trial of HCD122, an Anti-CD40 Monoclonal Antibody, in Patients With Multiple Myeloma That is Relapsed or Has Not Responded to Prior Therapy (CHIR1212-C12101)|Completed||Phase 2|33|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:05:06.710937|2017-02-18 17:05:06.710937
NCT00231153|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2009-06-30|2009-06-30||August 2005||2005-08-01|June 2009|2009-06-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters|A Phase 3, Multicenter, Randomized, Evaluation Committee-Blinded Study to Assess the Efficacy of Topical Omiganan 1% Gel in Preventing Local Catheter Site Infections/Colonization in Patients Undergoing Central Venous Catheterization|Completed||Phase 3|1859|Actual|Mallinckrodt||2|||f||||f||||||||||2017-02-18 17:05:06.821114|2017-02-18 17:05:06.821114
NCT00231140|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2007-01-18|||December 2005||2005-12-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)|Randomized, Open, Parallel Group Study for the Evaluation of an Oral Dose of 100 mg Thalidomide and Subsequent Dose Escalation of 400 mg Thalidomide in Combination With Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)|Terminated||Phase 2|40||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:05:10.038112|2017-02-18 17:05:10.038112
NCT00231127|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-03|2009-11-09|||April 2005||2005-04-01|November 2009|2009-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)|Osteoporosis and COPD (Making of a Database)|Completed||N/A|250|Anticipated|Catharina Ziekenhuis Eindhoven|||1||f||||f||||||||||2017-02-18 17:05:10.132402|2017-02-18 17:05:10.132402
NCT00231114|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2014-03-28|2010-08-31||September 2005||2005-09-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|August 2008|Actual|2008-08-01||Interventional|||Asthma Intervention Research 2 (AIR2) Trial|Safety and Effectiveness of the Alair® System for the Treatment of Asthma: A Multicenter Randomized Clinical Trial(Asthma Intervention Research (AIR2) Trial)|Completed||N/A|297|Actual|Asthmatx, Inc.||2|||f||||t||||||||||2017-02-18 17:05:10.222214|2017-02-18 17:05:10.222214
NCT00231101|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2006-10-16|||January 2004||2004-01-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia|Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia|Unknown status|Recruiting|N/A|40||Arthur P. Noyes Research Foundation|||||f||||||||||||||2017-02-18 17:05:11.420488|2017-02-18 17:05:11.420488
NCT00231075|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2005-11-02|||January 2001||2001-01-01|September 2005|2005-09-01|May 2007||2007-05-01|||||Interventional|||Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV|National, Phase II Study Designed to Evaluate the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III and IV. FAG-2|Completed||Phase 2|75||ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-02-18 17:05:11.516732|2017-02-18 17:05:11.516732
NCT00231062|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-10|2011-04-29||April 2005||2005-04-01|June 2011|2011-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)|Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)|Completed||Phase 3|115|Actual|Acclarent||1|||f||||t||||||||||2017-02-18 17:05:11.618338|2017-02-18 17:05:11.618338
NCT00231049|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2008-10-24|||March 2006||2006-03-01|October 2008|2008-10-01||||||||Interventional|||Trial Evaluating Safety, Tolerability and Immune Response of AG-707|A Phase 1 Trial Evaluating Safety, Tolerability and Immune Response of AG-707 Compared to Placebo in HSV-2 Seropositive Patients|Completed||Phase 1|35|Actual|Agenus Inc.|||||f||||||||||||||2017-02-18 17:05:11.864488|2017-02-18 17:05:11.864488
NCT00231023|ClinicalTrials.gov processed this data on February 17, 2017|2005-10-02|2008-03-03|||September 2005||2005-09-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema|Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:05:11.958484|2017-02-18 17:05:11.958484
NCT00231010|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2017-01-24|||September 26, 2005||2005-09-26|June 23, 2016|2016-06-23|June 23, 2016||2016-06-23|||||Observational|||Molecular Genetics of Retinal Degenerations|Molecular Genetics of Retinal Degenerations|Completed||N/A|119|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:05:12.051904|2017-02-18 17:05:12.051904
NCT00230997|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2005-12-15|||December 2002||2002-12-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies|An Open Label 24-Week, Flexible Dose Trial to Assess the Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies|Completed||Phase 3|50||Neurological Research Center|||||f||||||||||||||2017-02-18 17:05:12.151105|2017-02-18 17:05:12.151105
NCT00230984|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2009-07-07|||April 2003||2003-04-01|July 2006|2006-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||IRAD2 : Patients With Respiratory Failure at Home|Effects of Home Pulmonary Rehabilitation in Patients With Chronic Respiratory Failure and Nutritional Depletion.|Completed||Phase 3|200||University Hospital, Grenoble||2|||f||||||||||||||2017-02-18 17:05:12.260617|2017-02-18 17:05:12.260617
NCT00230971|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2013-02-20|2009-09-30||October 2005||2005-10-01|February 2013|2013-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)|A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection|Completed||Phase 4|473|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 17:05:12.624845|2017-02-18 17:05:12.624845
NCT00230958|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2012-06-21|||December 2003||2003-12-01|June 2012|2012-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive|Randomized, Double-Blind, Multicenter Study to Compare the Safety and Efficacy of Viramidine to Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C|Completed||Phase 3|900||Valeant Pharmaceuticals International, Inc.|||||f||||||||||||||2017-02-18 17:05:13.321305|2017-02-18 17:05:13.321305
NCT00230945|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2008-03-27|||January 2000||2000-01-01|March 2008|2008-03-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Couples-Oriented Psychosocial Intervention for Osteoarthritis|Psychobiological Pathways: Osteoarthritis Interventions|Completed||N/A|543|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:05:13.414308|2017-02-18 17:05:13.414308
NCT00230932|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2015-04-06|||October 2005||2005-10-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|June 2007|Actual|2007-06-01||Observational|HELP-Vets||Help Veterans Experience Less Pain Study (HELP-Vets)|Validation of Pain as a Vital Sign Among Veterans With Advanced Illness|Completed||N/A|654|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:05:13.513168|2017-02-18 17:05:13.513168
NCT00230919|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-30|2011-06-30|||April 2004||2004-04-01|February 2004|2004-02-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Interventional|||Weight Loss and Changes in Cardiovascular Risk Markers With a Low Glycemic Diet Compared With a Standard Diet|Weight Loss and Changes in Cardiovascular Risk Markers With a Low Glycemic Load Diet Compared With a Standard National Nutrition Council-recommended Diet: a Randomized Trial|Completed||N/A|200||Oslo University Hospital|||||f||||f||||||||||2017-02-18 17:05:13.825773|2017-02-18 17:05:13.825773
NCT00230893|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2006-09-20|||July 2005||2005-07-01|September 2006|2006-09-01|September 2005||2005-09-01|||||Observational|||Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years|Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years|Completed||N/A|99||Tuscaloosa Research & Education Advancement Corporation|||||f||||||||||||||2017-02-18 17:05:14.0797|2017-02-18 17:05:14.0797
NCT00230880|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2012-12-03|||July 2005||2005-07-01|December 2012|2012-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|REACH||The Young Woman's Reach Project: Trial of an Intervention to Impact Contraceptive Behavior, Unintended Pregnancy, and Sexually Transmitted Infections (STIs) Among Adolescent Females|Randomized Trial of an Intervention to Impact Contraceptive Behavior, Unintended Pregnancy, and STIs Among Adolescent Females Receiving Family Planning Clinic Services|Completed||N/A|800|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 17:05:14.171564|2017-02-18 17:05:14.171564
NCT00230867|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2006-06-30|||April 2005||2005-04-01|June 2006|2006-06-01|December 2005||2005-12-01|||||Interventional|||Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis|A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of a Single Topical Iontophoretic Application of Acyclovir 5% Cream With an Open Label Conventional Therapy Treatment Arm, and a Blinded Evaluator, for the Treatment of Recurrent Herpes Labialis|Completed||Phase 2|1800||Transport Pharmaceuticals|||||||||||||||||||2017-02-18 17:05:14.28154|2017-02-18 17:05:14.28154
NCT00230854|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2013-06-04|||August 2005||2005-08-01|June 2013|2013-06-01|July 2007||2007-07-01|||||Interventional|||Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin|An Open Label, Dose Escalation Study of EMZ702 in Combination With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Non-responsive to Prior Therapy With Pegylated Interferon and Ribavirin|Completed||Phase 1|28||Transition Therapeutics|||||f||||||||||||||2017-02-18 17:05:14.409747|2017-02-18 17:05:14.409747
NCT00230841|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2013-07-31|||September 2001||2001-09-01|July 2013|2013-07-01|April 2004||2004-04-01|||||Interventional|||Comparing Different Ways of Delivering Humidity to Children With Croup|Efficacy of Optimal Versus 'Traditional' Delivery of Humidity in Children With Croup|Completed||Phase 2|129||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:05:14.504086|2017-02-18 17:05:14.504086
NCT00230828|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-11|||May 2005||2005-05-01|September 2007|2007-09-01||||January 2006|Actual|2006-01-01||Interventional|||Patient-reported Outcomes in the Treatment of Schizophrenia|Patient-reported Outcomes With Bifeprunox or Olanzapine in the Treatment of Schizophrenia. A Pharmacoeconomic Study Carried Out in Connection With the S1543003 And S1543004 Clinical Trials|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:05:14.600469|2017-02-18 17:05:14.600469
NCT00230815|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2013-11-27|||July 2004||2004-07-01|November 2013|2013-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction|A Phase IIIb, Prospective, Multicenter Trial to Evaluate Subject Satisfaction With Follitropin Alfa Injection Applied by Pen Device Compared With Other Injectable Gonadotropins in Oligoanovulatory Infertile Women Undergoing Ovulation Induction|Completed||Phase 3|62|Actual|EMD Serono||1|||f||||||||||||||2017-02-18 17:05:14.680083|2017-02-18 17:05:14.680083
NCT00230802|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2016-10-31|2012-05-29||July 2005||2005-07-01|October 2016|2016-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Thyroid Hormone Dose Adjustment in Pregnancy|Thyroid Hormone Dose Adjustments During Pregnancy in Women With Primary Hypothyroidism.|Completed||N/A|48|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 17:05:14.792943|2017-02-18 17:05:14.792943
NCT00230789|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2013-04-09|||October 2005||2005-10-01|April 2013|2013-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.|A Multicenter, Multiphase, Single Arm, Open Label Study To Evaluate The Effects Of Tolterodine ER In Conjunction With Behavioral Intervention On Subject Satisfaction And Over- Active Bladder Symptoms (Urgency Urinary Incontinence (UUI), Urgency, Frequency) In Overactive Bladder Subjects Who Were Dissatisfied With Their Most Recent Antimuscarinic OAB Medication Therapy.|Completed||Phase 4|417||Pfizer|||||||||||||||||||2017-02-18 17:05:15.471986|2017-02-18 17:05:15.471986
NCT00230776|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2012-10-08|||October 2005||2005-10-01|October 2012|2012-10-01|July 2006|Actual|2006-07-01|||||Interventional|||A Controlled Pregabalin Trial In Fibromyalgia|A 14-Week, Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin Twice Daily In Patients With Fibromyalgia|Completed||Phase 3|740||Pfizer|||||||||||||||||||2017-02-18 17:05:15.633173|2017-02-18 17:05:15.633173
NCT00230763|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2015-03-04|||September 2005||2005-09-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|PREDICOM||Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure|Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure After A 12-Week Treatment With Latanoprost 0.005% / Timolol 0.5% Fixed Combination (Xalacom) In Previously Treated Patients With Open Angle Glaucoma Or Ocular Hypertension|Completed||Phase 3|396|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:05:15.818342|2017-02-18 17:05:15.818342
NCT00230750|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2013-08-22|||October 2005||2005-10-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Inactivated Influenza A/H5N1 Vaccine in the Elderly|A Randomized, Double-Blinded, Placebo-Controlled Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Elderly Adults|Completed||Phase 1/Phase 2|261|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 17:05:16.032075|2017-02-18 17:05:16.032075
NCT00230737|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-12|||October 2004||2004-10-01|January 2010|2010-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Melatonin on Insomnia Symptoms in Older Adults|Melatonin Randomized Trial for Insomnia in the Elderly|Completed||Phase 2|190|Anticipated|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 17:05:16.13412|2017-02-18 17:05:16.13412
NCT00230724|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2005-09-29|||April 2005||2005-04-01|September 2005|2005-09-01|April 2007||2007-04-01|||||Interventional|||Maintaining Exercise After Cardiac Rehabilitation|Maintaining Exercise After Cardiac Rehabilitation|Unknown status|Recruiting|Phase 3|180||The Miriam Hospital|||||f||||||||||||||2017-02-18 17:05:16.242043|2017-02-18 17:05:16.242043
NCT00230711|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2012-11-29|||April 2004||2004-04-01|September 2005|2005-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Physical Activity Promotion in Cancer Follow-Up Care|Physical Activity Promotion In Cancer Follow-up Care|Completed||Phase 3|300|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-02-18 17:05:16.329375|2017-02-18 17:05:16.329375
NCT00230698|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2010-11-12|||November 1995||1995-11-01|November 2010|2010-11-01|August 2002|Actual|2002-08-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure|Topiramate (RWJ-17021-000) Monotherapy Clinical Trial in Patients With Recently Diagnosed Partial-Onset Seizures|Completed||Phase 3|451|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:05:16.430987|2017-02-18 17:05:16.430987
NCT00230685|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2015-05-28|||January 2000||2000-01-01|August 2008|2008-08-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia|Hammersmith Hospital Patients With Pulmonary Arteriovenous Malformations (PAVMs) and Hereditary Haemorrhagic Telangiectasia|Recruiting||N/A|500|Anticipated|Imperial College London|||1||f||||||||||||||2017-02-18 17:05:16.540787|2017-02-18 17:05:16.540787
NCT00230672|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2008-08-12|||March 2005||2005-03-01|August 2008|2008-08-01||||||||Observational|||Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs|Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients|Unknown status|Recruiting|N/A|70|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:05:16.646729|2017-02-18 17:05:16.646729
NCT00230659|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2015-05-28|||August 2004||2004-08-01|September 2005|2005-09-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Observational|||Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia|Investigation of Coagulation Parameters in Hereditary Haemorrhagic|Completed||Phase 4|100||Imperial College London|||2||f||||||||||||||2017-02-18 17:05:16.734724|2017-02-18 17:05:16.734724
NCT00230646|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2010-10-04|||July 2005||2005-07-01|September 2005|2005-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Promoting Physical Activity After Colorectal Cancer|Promoting Physical Activity After Colorectal Cancer|Completed||Phase 3|46|Actual|The Miriam Hospital|||||f||||||||||||||2017-02-18 17:05:16.829397|2017-02-18 17:05:16.829397
NCT00230633|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2008-08-12|||April 2002||2002-04-01|August 2008|2008-08-01||||||||Observational|||Studies of White Blood Cells Derived From HHT Patients|Studies of White Blood Cells Derived From HHT Patients|Unknown status|Recruiting|N/A|200|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:05:16.918947|2017-02-18 17:05:16.918947
NCT00230620|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2015-05-28|||December 1998||1998-12-01|August 2008|2008-08-01|November 2020|Anticipated|2020-11-01|November 2018|Anticipated|2018-11-01||Observational|||Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families|Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families With Pulmonary Arteriovenous Malformations|Recruiting||N/A|250|Anticipated|Imperial College London|||1||f||||||||||||||2017-02-18 17:05:16.989263|2017-02-18 17:05:16.989263
NCT00230607|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2016-06-22|||August 2006||2006-08-01|June 2016|2016-06-01|January 2020|Anticipated|2020-01-01|December 2019|Anticipated|2019-12-01||Interventional|||A Study of the Effects of Fabrazyme (Agalsidase Beta) on Mother's Lactation and on the Growth, Development and Immunologic Response of Their Infants|A Multicenter, Multinational Study of the Effects of Fabrazyme (Agalsidase Beta) Treatment on Lactation and Infants|Recruiting||Phase 4|10|Anticipated|Sanofi||3|||f||||f||||||||||2017-02-18 17:05:17.075168|2017-02-18 17:05:17.075168
NCT00230594|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2011-05-18|||July 2004||2004-07-01|May 2011|2011-05-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|DRY||Desmopressin Response in the Young|Desmopressin Response in the Young: A Double-blind, Randomised, Placebo-controlled, Dose-titration Study With Three Different Doses (120 Mcg, 240 Mcg and 360 Mcg) of Desmopressin Administered as a New Melt Tablet in Children and Adolescents With Primary Nocturnal Enuresis (PNE).|Completed||Phase 3|132|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:05:17.190075|2017-02-18 17:05:17.190075
NCT00230581|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2007-10-12|||September 2005||2005-09-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS|A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Doses and Dose Levels of DDP225 in Female Patients With Irritable Bowel Syndrome With Diarrhea|Completed||Phase 2|88|Anticipated|Dynogen Pharmaceuticals|||||f||||||||||||||2017-02-18 17:05:17.312271|2017-02-18 17:05:17.312271
NCT00230568|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2011-03-31|||December 2005||2005-12-01|March 2011|2011-03-01|December 2007|Actual|2007-12-01|April 2007|Actual|2007-04-01||Interventional|||EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)|A 12-Week, Multicenter, Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept) in Hispanic Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 4|100|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:05:17.658863|2017-02-18 17:05:17.658863
NCT00230555|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2005-09-29|||July 2001||2001-07-01|April 2005|2005-04-01|November 2004||2004-11-01|||||Interventional|||The MOM Program at the Children's Hospital of Philadelphia|The MOM Program at the Children's Hospital of Philadelphia|Completed||Phase 3|300||Children's Hospital of Philadelphia|||||f||||||||||||||2017-02-18 17:05:17.7849|2017-02-18 17:05:17.7849
NCT00230542|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2016-03-29|||September 2005||2005-09-01|January 2016|2016-01-01|April 2011|Actual|2011-04-01|July 2007|Actual|2007-07-01||Interventional|||Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer|Phase II Study of Carboplatin and Pemetrexed in Patients With Recurrent Platinum Sensitive Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Completed||Phase 2|44|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:05:17.871625|2017-02-18 17:05:17.871625
NCT00230529|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2011-06-08||||||August 2010|2010-08-01|January 2003|Actual|2003-01-01|||||Interventional|||A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis|A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of Infliximab (REMICADE�) Induction Therapy in Patients With Plaque-type Psoriasis|Completed||Phase 2|249|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:05:17.98814|2017-02-18 17:05:17.98814
NCT00230516|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2013-01-03|||September 2005||2005-09-01|January 2013|2013-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects|A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects on Days 1 and 5 of Intravenous Treatment|Completed||Phase 4|100||AstraZeneca|||||||||||||||||||2017-02-18 17:05:18.293839|2017-02-18 17:05:18.293839
NCT00230503|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2012-06-21|||June 2004||2004-06-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B|Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B|Completed||Phase 2|220||Valeant Pharmaceuticals International, Inc.|||||f||||||||||||||2017-02-18 17:05:18.384972|2017-02-18 17:05:18.384972
NCT00230490|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2012-06-21|||June 2005||2005-06-01|June 2012|2012-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201|Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201|Terminated||Phase 2|150||Valeant Pharmaceuticals International, Inc.||||Adverse findings from nonclinical carcinogenicity studies.|f||||||||||||||2017-02-18 17:05:18.477432|2017-02-18 17:05:18.477432
NCT00230477|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-14|||April 2003||2003-04-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT|Efficacy of Adefovir Dipivoxil Versus Adefovir Dipivoxil Plus Lamivudine for the Treatment of Chronic Hepatitis B in Patients With Normal Baseline ALT|Completed||Phase 4|19|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:05:18.590715|2017-02-18 17:05:18.590715
NCT00230464|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2006-01-03|||November 2004||2004-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Acute Metabolic Effects of LAF 237 in Type 2 Diabetics|A Double-Blind, Placebo-Controlled, Randomized, Crossover Study to Explore the Acute Effects of LAF 237 on the Rate of Appearance and Disappearance of Glucose During the Overnight Post-Absorptive Period in Type 2 Diabetics|Completed||Phase 3|16||The University of Texas Health Science Center at San Antonio|||||||||||||||||||2017-02-18 17:05:18.701469|2017-02-18 17:05:18.701469
NCT00230451|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-01-14|||November 1997||1997-11-01|January 2010|2010-01-01|July 2008|Actual|2008-07-01|December 1999|Actual|1999-12-01||Interventional|||Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma|A Phase II Trial of Preoperative Chemotherapy and Radiation Therapy Followed by Adjuvant Combination Chemotherapy for Patients With Loco-Regional Esophageal Carcinoma|Completed||Phase 2|||University of Michigan Cancer Center|||||f||||t||||||||||2017-02-18 17:05:18.793877|2017-02-18 17:05:18.793877
NCT00230438|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2014-01-03|||January 2005||2005-01-01|January 2014|2014-01-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||External Beam Radiation Therapy - Target Volume|A Pilot Study to Develop a Technique for External Beam Radiotherapy After Radical Prostatectomy Based on MRI-Delineation of the Clinical Target Volume|Completed||Phase 2|27|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:05:18.885879|2017-02-18 17:05:18.885879
NCT00230425|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2006-10-10|||February 2003||2003-02-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Observational|||The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.|The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.|Completed||N/A|30||University of Saskatchewan|||||f||||||||||||||2017-02-18 17:05:18.982959|2017-02-18 17:05:18.982959
NCT00230412|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-02-01|||October 2005||2005-10-01|January 2010|2010-01-01|December 2010|Anticipated|2010-12-01|||||Observational|HSP||Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study)|Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study)|Unknown status|Recruiting|N/A|120|Anticipated|University of Munich Children's Clinic|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum and urine.~   "|||2017-02-18 17:05:19.072967|2017-02-18 17:05:19.072967
NCT00230399|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-04-20|||June 2003||2003-06-01|April 2015|2015-04-01|March 2008||2008-03-01|January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer|C-2424: Phase II Study of Celecoxib, Capecitabine, and Irinotecan in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|15||University of Michigan Cancer Center|||||f||||||||||||||2017-02-18 17:05:19.181506|2017-02-18 17:05:19.181506
NCT00230386|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2009-07-10|||May 2003||2003-05-01|September 2005|2005-09-01||||||||Interventional|||Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma|The Role of MRI Perfusion to Detect Locally Recurrent or Persistent Disease in Prostate Carcinoma Treated With Radiation Therapy - A Pilot Study|Completed||Phase 1/Phase 2|50|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:05:19.265362|2017-02-18 17:05:19.265362
NCT00230373|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2015-04-22|||November 2005||2005-11-01|April 2015|2015-04-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study|Evaluation of the Efficacy and Safety of Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study|Withdrawn||Phase 3|0|Actual|University of Alberta||||Study never started.|f||||t||||||||||2017-02-18 17:05:19.345399|2017-02-18 17:05:19.345399
NCT00230360|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2007-02-01|||June 2005||2005-06-01|February 2007|2007-02-01|April 2006||2006-04-01|||||Observational|||Diagnosis of Functional Defecation Disorders in Childhood|Diagnosis of Functional Defecation Disorders in Childhood|Completed||N/A|90||University of Aarhus|||||f||||||||||||||2017-02-18 17:05:19.439541|2017-02-18 17:05:19.439541
NCT00230347|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-03-30|||October 2003||2003-10-01|March 2010|2010-03-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Evaluation of Stereotactic Radiosurgery For Liver Malignancies|Dose Escalation Study Evaluating Stereotactic Radiosurgery for Liver Malignancies|Completed||Phase 1|20|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:05:19.532151|2017-02-18 17:05:19.532151
NCT00230334|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2011-04-11|||June 2003||2003-06-01|April 2011|2011-04-01||||||||Interventional|||Phase II Gleevec Idiopathic Hypereosinophilic Syndrome|Phase II Study of Gleevec (Imatinib Mesylate) in Patients With Idiopathic Hypereosinophilic Syndrome (HES)|Withdrawn||Phase 2|25||Stanford University||||Withdrawn by PI due to insufficient accrual|||||||||||||||2017-02-18 17:05:19.616984|2017-02-18 17:05:19.616984
NCT00230321|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2013-01-31|||February 2002||2002-02-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)|A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)|Completed||Phase 1/Phase 2|21|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:05:19.695032|2017-02-18 17:05:19.695032
NCT00230308|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2016-11-08|||April 2002||2002-04-01|November 2016|2016-11-01|December 2024|Anticipated|2024-12-01|December 2019|Anticipated|2019-12-01||Observational|||Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer|Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer|Recruiting||N/A|500|Anticipated|Stanford University|||1||f||||t||||||Samples With DNA|"~     At the time of biospy or surgery, a small amount of tumor tissue (approximately 1 cc) will~     be taken from the main tumor specimen and stored until analysis.~   "|||2017-02-18 17:05:19.791323|2017-02-18 17:05:19.791323
NCT00230295|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-07-23|||February 2003||2003-02-01|July 2010|2010-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast|Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast|Completed||N/A|20|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:05:19.884498|2017-02-18 17:05:19.884498
NCT00230282|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2014-09-25|2014-08-27||July 2004||2004-07-01|September 2014|2014-09-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Interventional|||Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia|A Multi-Center Phase 2 Efficacy and Pharmacokinetic Study Evaluating Fludarabine, Cyclophosphamide, and Subcutaneous Campath (FCCam, Alemtuzumab) for Previously Untreated B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|25|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 17:05:19.967043|2017-02-18 17:05:19.967043
NCT00230269|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2012-07-10|||May 2003||2003-05-01|July 2012|2012-07-01|November 2007|Actual|2007-11-01|June 2006|Actual|2006-06-01||Observational|||The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers|The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers|Completed||N/A|5|Actual|Stanford University|||1||f||||||||||||||2017-02-18 17:05:20.22356|2017-02-18 17:05:20.22356
NCT00229385|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2013-12-30|||January 2006||2006-01-01|December 2013|2013-12-01|April 2010|Actual|2010-04-01|April 2008|Actual|2008-04-01||Interventional|||Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)|Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)|Completed||N/A|45|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 17:05:20.296002|2017-02-18 17:05:20.296002
NCT00228488|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2007-12-16|||June 2004||2004-06-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|||||Interventional|||Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma|Phase II Study of Iressa With/Without Concurrent Chemoradiotherapy in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma and to Study the Effect of Iressa™ (ZD1839) on Tumour Gene Expression Profiles ®|Completed||Phase 2|60||AstraZeneca|||||f||||||||||||||2017-02-18 17:05:20.390591|2017-02-18 17:05:20.390591
NCT00228475|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2011-01-21|||September 2004||2004-09-01|January 2011|2011-01-01|October 2005|Actual|2005-10-01|||||Interventional|||A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women|An Open Single Centre Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women on Maintenance Treatment w/Pulmicort ® Turbuhaler ® at the Dose Levels 200/400 µg Bid|Completed||Phase 4|8||AstraZeneca|||||f||||||||||||||2017-02-18 17:05:20.489275|2017-02-18 17:05:20.489275
NCT00228462|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2013-01-03|||March 2005||2005-03-01|January 2013|2013-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo|A 1-year, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Phase 3 Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Sustained-release Quetiapine Fumarate (SEROQUEL) or Placebo (Abbreviated)|Completed||Phase 3|197|Actual|AstraZeneca|||||||||||||||||||2017-02-18 17:05:20.579492|2017-02-18 17:05:20.579492
NCT00228449|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-12-19|||July 2005||2005-07-01|December 2012|2012-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Peginesatide for Anemia in Chronic Hemodialysis Patients|A Phase 2, Open-label, Multi-center, Sequential, Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Peginesatide Administered Intravenously for the Maintenance Treatment of Anemia in Chronic Hemodialysis Patients|Completed||Phase 2|165|Actual|Affymax||8|||f||||f||||||||||2017-02-18 17:05:20.669757|2017-02-18 17:05:20.669757
NCT00230256|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2012-07-11|||April 2003||2003-04-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers|Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers|Completed||N/A|61|Actual|Stanford University|||1||f||||t||||||||||2017-02-18 17:05:20.796517|2017-02-18 17:05:20.796517
NCT00230243|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2015-09-09|||March 1997||1997-03-01|September 2015|2015-09-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Observational|||Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)|A Retrospective Study to Establish an Historical Database on the Efficacy of Standard Antifungal Therapy in Patients With Invasive Fungal Infections|Completed||N/A|330||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:05:20.866384|2017-02-18 17:05:20.866384
NCT00230230|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2015-09-15|||October 2005||2005-10-01|September 2015|2015-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED)|SCH 486757 vs Codeine and Placebo in Subjects With Persistent Postviral Cough|Completed||Phase 2|91|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:05:20.94959|2017-02-18 17:05:20.94959
NCT00230217|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2009-03-27|||March 2004||2004-03-01|March 2009|2009-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy|Evaluation of Single Agent Rasburicase in Treatment/Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Adult and Pediatric Patients With Lymphoma/Leukemia/Solid Tumor Malignancies at Their First Relapse or Refractory Disease|Completed||Phase 4|94|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:05:21.032694|2017-02-18 17:05:21.032694
NCT00230204|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2006-02-15|||September 2005||2005-09-01|January 2006|2006-01-01|April 2006||2006-04-01|||||Interventional|||Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis|Antibodies Screening in Multiple Sclerosis as a Part of an International Survey in Autoimmune Diseases.|Unknown status|Recruiting|Phase 1|100||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:21.133344|2017-02-18 17:05:21.133344
NCT00230191|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2007-01-12|||January 2003||2003-01-01|October 2005|2005-10-01|December 2005||2005-12-01|||||Interventional|||Safety and Efficacy of RK0202 in Oral Mucositis|Phase II, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of the Effects of RK-0202 on Oral Mucositis in Patients Receiving Radiation Therapy for Tumors of the Oral Cavity, Oropharynx, Nasopharynx, Salivary Glands or Supraglottic Region|Completed||Phase 2|110||RxKinetix|||||||||||||||||||2017-02-18 17:05:21.226819|2017-02-18 17:05:21.226819
NCT00230178|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-01-08|2009-07-22||April 2004||2004-04-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome|Evaluation of Single Agent Rasburicase for 5 Days Versus Sequential Treatment With Rasburicase From Day 1 Through 3 Followed by Oral Allopurinol From Day 3 Through 5 (Overlap on Day 3) Versus Single Agent Oral Allopurinol for 5 Days in the Management of Plasma Uric Acid in Adult Patients With Leukemia, Lymphoma, and Solid Tumor Malignancies at Risk for Hyperuricemia and Tumor Lysis Syndrome|Completed||Phase 3|280|Actual|Sanofi||3|||f||||||||||||||2017-02-18 17:05:21.335469|2017-02-18 17:05:21.335469
NCT00230165|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2016-08-18|||September 2005||2005-09-01|August 2016|2016-08-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Observational|||The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.|Studies of Interactions Among Normal and Abnormal Blood Cells, and the Vessel Wall, and Studies of Genetic and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell and Coagulation Disorders|Recruiting||N/A|60|Anticipated|Rockefeller University|||2||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 17:05:22.739984|2017-02-18 17:05:22.739984
NCT00230152|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2010-10-21|||February 2006||2006-02-01|September 2005|2005-09-01|March 2009|Actual|2009-03-01|April 2007|Actual|2007-04-01||Interventional|||Hybrid Imaging Modalities for the Evaluation of Infection|Nuclear Medicine for the Evaluation of Infection-the Added Value of Hybrid Imaging Modalities|Completed||N/A|300|Actual|Rambam Health Care Campus||1|||f||||f||||||||||2017-02-18 17:05:22.849445|2017-02-18 17:05:22.849445
NCT00230139|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2008-10-11|||January 2002||2002-01-01|September 2005|2005-09-01|January 2006|Actual|2006-01-01|January 2004|Actual|2004-01-01||Interventional|||SPECT/CT in Endocrine and Neuroendocrine Tumors|The Added Value of SPECT/CT in the Evaluation of Endocrine and Neuroendocrine Tumors|Completed||N/A|200|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:05:22.947855|2017-02-18 17:05:22.947855
NCT00230126|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2014-11-04|2014-04-15||October 2005||2005-10-01|November 2014|2014-11-01|July 2013|Actual|2013-07-01|September 2011|Actual|2011-09-01||Interventional||Fifty-eight patients . 31 men, 24 women.|OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer|A Phase II Randomized Study of OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|57|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:05:23.048474|2017-02-18 17:05:23.048474
NCT00230113|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2013-07-09|||September 2005||2005-09-01|July 2013|2013-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effect of Omega-3 PUFA Supplementation in NAFLD Patients|A Randomized, Masked, Controlled Study of Omega-3 Polyunsaturated Fatty Acid vs Monounsaturated Fatty Acid Diet Supplementation for the Treatment of Nonalcoholic Fatty Liver Disease|Completed||Phase 2|30|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 17:05:23.398841|2017-02-18 17:05:23.398841
NCT00230100|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2016-12-16|2014-09-15||March 2003||2003-03-01|December 2016|2016-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||The Women's Recovery Group Study: Stage I Trial|Recovery Group for Women With Substance Use Disorders - Stage I|Completed||Phase 1|46|Actual|Mclean Hospital|"small sample~small proportion had drug dependence; majority had alcohol dependence (questionable generalizability)~sample was almost all white and well-educated (questionable generalizability)~therapists not blind to study"|2|||f||||f||||||||No||2017-02-18 17:05:23.519055|2017-02-18 17:05:23.519055
NCT00230087|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2012-11-06|||September 2005||2005-09-01|November 2012|2012-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Iron Depletion Therapy for Type 2 DM and NAFLD|Iron Depletion Therapy for Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease|Completed||Phase 2|15|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 17:05:24.222531|2017-02-18 17:05:24.222531
NCT00230074|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2011-11-22|||November 2004||2004-11-01|November 2011|2011-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)|A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)|Completed||Phase 2|350|Actual|Novartis|||||f||||||||||||||2017-02-18 17:05:24.320276|2017-02-18 17:05:24.320276
NCT00230061|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-06-01|||April 2004||2004-04-01|June 2010|2010-06-01|February 2010|Actual|2010-02-01|May 2008|Actual|2008-05-01||Interventional|||Hepatitis B Vaccination in HIV-infected Persons|Randomised Open Label Clinical Trial of the Immune Response to Hepatitis B Vaccination in HIV-infected Persons.|Completed||Phase 4|800|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-02-18 17:05:24.408144|2017-02-18 17:05:24.408144
NCT00230048|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2012-10-29|2011-10-12||September 2001||2001-09-01|October 2012|2012-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Interactive Motivational Media for Perinatal Drug Abuse - 3|Interactive Motivational Media for Perinatal Drug Abuse|Completed||Phase 2|107|Actual|Wayne State University|Generalizability limited by relatively small sample, attrition of 29%, and restriction to low-income mothers. Second, power limitations prevented verification of effects on the dichotomous outcomes, despite effects in the small-moderate range.|2|||f||||f||||||||||2017-02-18 17:05:24.523206|2017-02-18 17:05:24.523206
NCT00230035|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2013-01-31|||September 2005||2005-09-01|January 2013|2013-01-01||||||||Interventional|||Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)|A Randomized, Open Label, Phase II Multicenter Study of Non-Myeloablative Autologous Transplantation With Auto-CD34+HPC Versus Currently Available Immunosuppressive/Immunomodulatory Therapy for Treatment of Systemic Lupus Erythematosus|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2||Recommended by DSMB due to lack of accrual|f||||t||||||||||2017-02-18 17:05:24.902175|2017-02-18 17:05:24.902175
NCT00230022|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2013-06-10|2011-10-12||October 2004||2004-10-01|June 2013|2013-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Pilot Clinical Trial of Computer-based Motivational Intervention - 1|Pilot Clinical Trial of Computer-based Motivational Intervention|Completed||Phase 1|30|Actual|Wayne State University|Small sample size in the pilot clinical trial. Because of this lack of power, a statistically significant difference between groups was not demonstrated, and the 95% Confidence Interval (CI) for the effect size estimate included zero.|2|||f||||f||||||||||2017-02-18 17:05:25.044368|2017-02-18 17:05:25.044368
NCT00230009|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2013-08-06|2013-03-19||April 2004||2004-04-01|August 2013|2013-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Brief Intervention in At-Risk First-time Mothers|Brief Intervention in At-Risk First-time Mothers|Completed||Phase 1/Phase 2|100|Actual|Wayne State University|This study is limited by the relatively small sample size and the restriction to low-income, urban women, thus limiting generalizability to other populations.|2|||f||||f||||||||||2017-02-18 17:05:28.182177|2017-02-18 17:05:28.182177
NCT00229996|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2014-01-23|||July 2004||2004-07-01|January 2014|2014-01-01||||||||Interventional|||Medical Treatment of Endometriosis-Associated Pelvic Pain|Oral Contraceptives Versus Depot-Leuprolide Taken After Surgery for Endometriosis-Associated Pelvic Pain|Completed||Phase 3|194|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:05:28.609923|2017-02-18 17:05:28.609923
NCT00229970|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2015-05-05|2009-05-22||September 2005||2005-09-01|May 2015|2015-05-01|June 2007|Actual|2007-06-01|October 2006|Actual|2006-10-01||Interventional|||MK0476 Study in Adult Patients With Acute Asthma (0476-322)|MK0476 Phase II/III Placebo Controlled Double Blind Study|Completed||Phase 3|225|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 17:05:28.825378|2017-02-18 17:05:28.825378
NCT00229957|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-07-13|2009-05-18||June 2004||2004-06-01|September 2009|2009-09-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness|Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness|Completed||N/A|303|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 17:05:29.35428|2017-02-18 17:05:29.35428
NCT00229944|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2006-07-20|||December 2002||2002-12-01|September 2005|2005-09-01|May 2004||2004-05-01|||||Interventional|||Single Dose Azithromycin in the Treatment of Adult Cholera|Randomized, Double-Blind, Controlled Clinical Trial to Compare Efficacy of a Single Dose of Azithromycin Versus a Single Dose of Ciprofloxacin in the Treatment of Adults With Clinically Severe Cholera Due to V. Cholerae O1 or O139|Completed||Phase 3|220||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 17:05:30.143337|2017-02-18 17:05:30.143337
NCT00229931|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2014-12-02|||November 2005||2005-11-01|December 2014|2014-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|IVTA||Triamcinolone vs. Laser for Diabetic Macular Edema|The Role of Triamcinolone Injection During Cataract Extraction for Diabetic Patients With Pre-Operative Macular Edema|Completed||N/A|11|Actual|University of Oklahoma||2|||f||||t||||||||||2017-02-18 17:05:30.253817|2017-02-18 17:05:30.253817
NCT00229918|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2005-09-28|||September 2005||2005-09-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||PST/Laser v. Laser Alone for CSME|Combined Posterior Sub-Tenon Injection of Triamcinolone Acetonide and Laser Photocoagulation for the Treatment of Clinically Significant Macular Edema|Unknown status|Recruiting|Phase 2|60||Edward Hines Jr. VA Hospital|||||f||||||||||||||2017-02-18 17:05:30.373863|2017-02-18 17:05:30.373863
NCT00229905|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-14|||March 2005||2005-03-01|May 2007|2007-05-01|November 2006|Actual|2006-11-01|||||Observational|||Child With Anomalous Drainage of IVC to Left Atrium|A Case Report of a Child With Anomalous Drainage of the Inferior Vena Cava to the Left Atrium|Terminated||N/A|1|Actual|Children's Healthcare of Atlanta|||1|sufficient data|f||||f||||||||||2017-02-18 17:05:30.462962|2017-02-18 17:05:30.462962
NCT00229892|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-16|||February 2005||2005-02-01|May 2007|2007-05-01|September 2006|Actual|2006-09-01|||||Observational|||Incisions for Cardiac Surgery|Small Incisions for Cardiac Surgery|Terminated||N/A|90|Actual|Children's Healthcare of Atlanta|||1|after 90 charts reviewed, insufficient data to support conclusion|f||||f||||||||||2017-02-18 17:05:30.543971|2017-02-18 17:05:30.543971
NCT00229879|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-14|||December 2004||2004-12-01|May 2007|2007-05-01|September 2006|Actual|2006-09-01|||||Observational|||Rare Tumor Case Review|Rare Tumor Case Review|Terminated||N/A|||Children's Healthcare of Atlanta|||1|sufficient data gathered to support conclusion|f||||f||||||||||2017-02-18 17:05:30.630429|2017-02-18 17:05:30.630429
NCT00229866|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-05|||August 2005||2005-08-01|July 2011|2011-07-01|June 2006|Actual|2006-06-01|||||Observational|||Feeding After Neonate Surgery Review|Feeding After Neonatal Surgery Chart Review|Terminated||N/A|90|Actual|Children's Healthcare of Atlanta|||1|sufficient data gathered for study conclusion|f||||f||||||||||2017-02-18 17:05:30.721798|2017-02-18 17:05:30.721798
NCT00229853|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-05|||August 2004||2004-08-01|July 2011|2011-07-01|July 2007|Actual|2007-07-01|||||Observational|||Thoracoscopic Vascular Rings Chart Review|Thoracoscopic Vascular Rings Chart Review|Terminated||N/A|47|Actual|Children's Healthcare of Atlanta|||1|sufficient data gathered to support hypothesis|f||||f||||||||||2017-02-18 17:05:30.808292|2017-02-18 17:05:30.808292
NCT00229840|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-24|||February 2006||2006-02-01|June 2011|2011-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Evaluation of Functional MRI and DTI (Imaging Techniques) in Children With Epilepsy and Focal Brain Lesions|Advanced MR Imaging Evaluation Of Neurosurgical Candidates With Focal Abnormalities|Completed||N/A|30|Actual|Children's Healthcare of Atlanta||1|||f||||f||||||||||2017-02-18 17:05:30.883221|2017-02-18 17:05:30.883221
NCT00229827|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-14|||May 2005||2005-05-01|May 2007|2007-05-01|August 2007|Actual|2007-08-01|||||Observational|||Optimal Timing for Repair of Left to Right Shunt Lesions|Optimal Timing for Repair of Left-to-Right Shunt Lesions|Terminated||N/A|200||Children's Healthcare of Atlanta|||1|sufficient data was collected|f||||||||||||||2017-02-18 17:05:30.967792|2017-02-18 17:05:30.967792
NCT00229814|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-09-20|||August 2005||2005-08-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Study of Brain Tumors (Tectal Tumors) Using Magnetic Resonance Imaging|Magnetic Resonance Spectroscopic Analysis of Pediatric Tectal Tumors: Insight Into Pathology and Behavior|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta|||1|There were technical difficulties and the study was terminated in 2008|f||||||||||||||2017-02-18 17:05:31.052478|2017-02-18 17:05:31.052478
NCT00229801|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-20|||June 2004||2004-06-01|September 2012|2012-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Kidney Function in Children With Brain Tumors|Evaluation of Renal Function in Children With Brain Tumors|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta||1||No funds available, hard to enroll patients-Terminated in 2008|f||||||||||||||2017-02-18 17:05:31.128588|2017-02-18 17:05:31.128588
NCT00229788|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-12|||March 2005||2005-03-01|June 2007|2007-06-01||||||||Observational|||Impact of Race and Re-Transplantation|Impact of Race and Re-Transplantation in Childhood: Analysis of Data From the United Network of Organ Sharing|Terminated||N/A|||Children's Healthcare of Atlanta|||||f||||||||||||||2017-02-18 17:05:31.214721|2017-02-18 17:05:31.214721
NCT00229775|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2012-09-10|||July 2003||2003-07-01|September 2012|2012-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines|Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines|Completed||N/A|560|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:05:31.287511|2017-02-18 17:05:31.287511
NCT00229762|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2005-09-28|||March 2004||2004-03-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Racial Disparities in Pneumococcal Vaccination in Managed Care|Racial Disparities in Pneumococcal Vaccination in Managed Care: the Effects of Randomized Telephone Outreach|Completed||N/A|7000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:05:31.387783|2017-02-18 17:05:31.387783
NCT00229749|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2008-04-09|||September 2005||2005-09-01|April 2008|2008-04-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients|Exploratory Study of AVI-4065 Injection to Design Therapeutic Dosing for Chronic Active HCV Patients|Terminated||Phase 1/Phase 2|80|Anticipated|Sarepta Therapeutics||1||Limited viral load reduction in HCV subjects|f||||||||||||||2017-02-18 17:05:31.480465|2017-02-18 17:05:31.480465
NCT00229736|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2013-12-02|||November 2004||2004-11-01|December 2013|2013-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease|A Phase1 Open Label Safety Study of Intrastriatal Infusion of Adeno-Associated Virus Encoding Human Aromatic L-Amino Acid Decarboxylase (AAV-hAADC-2) in Subjects With Parkinson's Disease [AAV-hAADC-2-003]|Completed||Phase 1|10|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 17:05:31.56482|2017-02-18 17:05:31.56482
NCT00229723|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2009-06-17|2009-06-17||November 2004||2004-11-01|June 2009|2009-06-01|June 2008|Actual|2008-06-01|||||Interventional|||IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma|A Phase 2 Randomised, Double-Blind, Placebo-Controlled, Multicentre Comparative Study of Gefitinib 250 mg or 500 mg (IRESSA™) Given Either Continuously or Concomitantly With Cisplatin Plus Radiotherapy for the Treatment of Patients With Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma|Completed||Phase 2|224|Actual|AstraZeneca||7|||f||||||||||||||2017-02-18 17:05:31.696875|2017-02-18 17:05:31.696875
NCT00229710|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2010-11-18|||February 2005||2005-02-01|November 2010|2010-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes|An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 0.5mg When Added to Insulin Therapy in Patients With Type 2 Diabetes Mellitus (GALLEX 9)|Terminated||Phase 3|270||AstraZeneca||||The development program has been terminated|||||||||||||||2017-02-18 17:05:34.970951|2017-02-18 17:05:34.970951
NCT00229697|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2015-10-02|||October 2003||2003-10-01|October 2015|2015-10-01|June 2015|Actual|2015-06-01|December 2006|Actual|2006-12-01||Interventional|||Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study|A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours|Completed||Phase 2|317|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:05:35.377903|2017-02-18 17:05:35.377903
NCT00229684|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2011-08-29|||September 2004||2004-09-01|August 2011|2011-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)|A 24-week, Randomised, Parallel-Group, Multi-Centre, Open-Label Study of the Renal Effects of Tesaglitazar in Patients With Type 2 Diabetes Mellitus|Terminated||Phase 2|100||AstraZeneca||||The development program has been terminated|||||||||||||||2017-02-18 17:05:35.552114|2017-02-18 17:05:35.552114
NCT00229671|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2005-09-28|||September 2001||2001-09-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics|Ambulatory Medication Errors and Adverse Drug Events (ADEs) in Pediatrics|Unknown status|Recruiting|N/A|30000||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:05:35.673704|2017-02-18 17:05:35.673704
NCT00229658|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2015-03-05|2009-05-05||September 2005||2005-09-01|February 2015|2015-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes|A Prospective, Open-Label, Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes Following SYMLIN Introduction Into the Marketplace|Completed||N/A|1297|Actual|AstraZeneca|||2||f||||f||||||||||2017-02-18 17:05:35.764869|2017-02-18 17:05:35.764869
NCT00229645|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2016-07-11|||November 2003||2003-11-01|July 2016|2016-07-01|April 2005||2005-04-01|||||Interventional|||A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety|A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and Tolerability of Immediate-Release Formulation of Quetiapine Fumarate as Potentiation of Selective Serotonin Reuptake Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors Treatment in Major Depression With Comorbid Anxiety Symptoms|Completed||Phase 4|60||Dr Alexander McIntyre Inc.|||||f||||||||||||||2017-02-18 17:05:36.736988|2017-02-18 17:05:36.736988
NCT00229632|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2017-01-24|||September 23, 2005||2005-09-23|April 28, 2016|2016-04-28|December 17, 2007|Actual|2007-12-17|December 17, 2007|Actual|2007-12-17||Interventional|||Idebenone to Treat Friedreich's Ataxia|A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients With Friedreich's Ataxia|Completed||Phase 2|51|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:05:36.828612|2017-02-18 17:05:36.828612
NCT00229619|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-29|2014-07-01|2013-01-28||September 2005||2005-09-01|July 2014|2014-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia|A Pilot Study of Recombinant Humanized Anti- Cluster of Differentiation Antigen 20 (Anti-CD20) Antibody (Rituximab) in Patients With Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 17:05:36.936039|2017-02-18 17:05:36.936039
NCT00229593|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2014-12-03|||September 2005||2005-09-01|December 2014|2014-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|NES-1||NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel|A Randomized, Open Label Clinical Trial to Evaluate if Nestorone Gel Has Gonadotropin Suppressive Activity and if Nestorone in Combination With Testosterone Will Have an Additive Effect on Gonadotropin Suppression When Applied Transdermally in Healthy Men|Completed||Phase 1|140|Actual|University of Washington||7|||f||||t||||||||||2017-02-18 17:05:37.39055|2017-02-18 17:05:37.39055
NCT00229580|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2007-11-28|||December 2003||2003-12-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Health Behavior Feedback Study for Veterans With Hepatitis C|Health Behavior Feedback Study for Veterans With Hepatitis C|Completed||Phase 1|12|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:05:37.527817|2017-02-18 17:05:37.527817
NCT00229567|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2007-04-18|||September 2005||2005-09-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel Function|A Randomised Controlled Trial of Lidocaine Infusion Plus Ketamine Injection Versus Placebo to Decrease Postoperative Ileus|Terminated||N/A|60||University of Saskatchewan||||"insufficient numbers of eligible patients as laparscopic surgery increased and open surgery~   decreased."|f||||||||||||||2017-02-18 17:05:37.633206|2017-02-18 17:05:37.633206
NCT00229554|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2015-04-06|||March 2006||2006-03-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|May 2007|Actual|2007-05-01||Observational|SCREEN||Survey of ColoRectal Cancer Education and Environment Needs|Assessing and Addressing Patient Colorectal Cancer Screening Barriers|Completed||N/A|4644|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:05:37.729152|2017-02-18 17:05:37.729152
NCT00229541|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2007-10-26|||October 2003||2003-10-01|October 2007|2007-10-01|March 2006|Actual|2006-03-01|||||Interventional|||Medical In-Patient Rehabilitation in Rheumatoid Arthritis|Medical In-Patient Rehabilitation in Rheumatoid Arthritis: Acceptance and Outcomes in Insurants of Compulsory Health Insurances and Statutory Pension Insurances (VERA)|Completed||Phase 3|129|Actual|University of Luebeck||2|||f||||t||||||||||2017-02-18 17:05:37.83168|2017-02-18 17:05:37.83168
NCT00229528|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2008-09-19|||March 2004||2004-03-01|September 2008|2008-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease|Dose Ranging Study of the Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease|Completed||Phase 4|25||University of Oklahoma|||||f||||||||||||||2017-02-18 17:05:37.944234|2017-02-18 17:05:37.944234
NCT00229515|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2011-10-26|||November 2004||2004-11-01|October 2011|2011-10-01|March 2012|Anticipated|2012-03-01|April 2007|Actual|2007-04-01||Interventional|||Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI|Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Administered With the Single High-Dose Bolus Versus Abciximab and Sirolimus Eluting Stent Versus Bare Metal Stent in Acute Myocardial Infarction - MULTI-STRATEGY Trial|Unknown status|Active, not recruiting|Phase 4|744|Actual|Università degli Studi di Ferrara||4|||f||||t||||||||||2017-02-18 17:05:38.037739|2017-02-18 17:05:38.037739
NCT00229502|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-03-21|||September 2005||2005-09-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|September 2011|Actual|2011-09-01||Observational|||Cognitive Effects of Immunomodulatory Drugs in MS|Comparison of the Cognitive Effects of Three Immunomodulatory Drugs in Relapsing-Remitting Multiple Sclerosis: A Longitudinal Study|Completed||N/A|96|Actual|University of Kansas Medical Center|||4||f||||f||||||||||2017-02-18 17:05:38.168248|2017-02-18 17:05:38.168248
NCT00229476|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2016-11-03|||December 2003||2003-12-01|November 2016|2016-11-01||||March 2006|Actual|2006-03-01||Interventional|||Study of Medication and Placebo Response in Major Depression||Completed||Phase 4|60||University of California, Los Angeles|||||f||||||||||||||2017-02-18 17:05:38.260197|2017-02-18 17:05:38.260197
NCT00229463|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2016-11-16|||January 2002||2002-01-01|October 2016|2016-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|Genetics||Study of Genetic Differences in People With Depression|Study of Genetic Differences in People With Depression|Completed||N/A|200|Anticipated|University of California, Los Angeles|||1||f||||f||||||||||2017-02-18 17:05:38.356638|2017-02-18 17:05:38.356638
NCT00229450|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2008-06-02|||October 2004||2004-10-01|June 2008|2008-06-01||||||||Interventional|||Estrogen and Perimenopausal Depression|Dose Response Effects of Estrogen Augmentation in Mood & Memory in Perimenopausal Depression|Unknown status|Recruiting|Phase 4|20|Anticipated|University of California, Los Angeles|||||f||||||||||||||2017-02-18 17:05:38.438275|2017-02-18 17:05:38.438275
NCT00229437|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-02-27|||March 2005||2005-03-01|February 2012|2012-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy|A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Three Doses of TAK-128 in Subjects With Mild to Moderate Diabetic Peripheral Neuropathy|Completed||Phase 2|343|Actual|Takeda||4|||f||||f||||||||||2017-02-18 17:05:38.534959|2017-02-18 17:05:38.534959
NCT00229424|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2011-07-06|||April 2005||2005-04-01|July 2011|2011-07-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -|Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -|Completed||Phase 3|325||Taiho Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-02-18 17:05:38.705415|2017-02-18 17:05:38.705415
NCT00229411|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2007-01-23|||January 2006||2006-01-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Simulation Training as a Tool for Teamwork Improvement in Multidisciplinary Intensive Care Team|Experimental Like Observational Study of Teamwork Improvement in Multidisciplinary Intensive Care Team Before and After Simulation Training.|Withdrawn||N/A|40||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:38.816205|2017-02-18 17:05:38.816205
NCT00228865|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-08-08|||June 2003||2003-06-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1|Effects of Pulsatile IV Insulin on Cognitive Deficits in Diabetic Patients|Terminated||Phase 2/Phase 3|75|Actual|Florida Atlantic University||1||Administrative|f||||t||||||||||2017-02-18 17:05:38.904003|2017-02-18 17:05:38.904003
NCT00228852|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2009-06-29||||||September 2005|2005-09-01|November 2006|Actual|2006-11-01|||||Interventional|||IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency|Phase I/II Trial of De-Escalation of Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency|Completed||Phase 1/Phase 2|||Emory University|||||f||||||||||||||2017-02-18 17:05:39.021356|2017-02-18 17:05:39.021356
NCT00228839|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2009-06-29||||||December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease|A Pediatric Phase I Pharmacokinetic Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease|Completed||Phase 1|||Emory University|||||f||||f||||||||||2017-02-18 17:05:39.098855|2017-02-18 17:05:39.098855
NCT00228579|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2015-03-17|||June 2003||2003-06-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Assessment of Changes in Abdominal Fat|Assessment of Changes in Abdominal Fat and Metabolic and Tissue Biomarkers During a Bariatric Surgery Weight Loss Intervention Program|Active, not recruiting||N/A|60|Anticipated|Purdue University|||1||f||||f||||||||||2017-02-18 17:05:41.107087|2017-02-18 17:05:41.107087
NCT00228813|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-05-25|2016-03-23||April 2004||2004-04-01|May 2016|2016-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|G-CSF PMRD||G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome|Feasibility Study of Using G-CSF Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome With Partially Mismatched Related Donors|Terminated||N/A|8|Actual|Emory University|There was a small number of participants and a short follow up time period for this trial.|1||lack of enrollment|f||||t||||||||||2017-02-18 17:05:39.299578|2017-02-18 17:05:39.299578
NCT00228696|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2013-11-23|||September 2005||2005-09-01|November 2013|2013-11-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Interventional|||National Wilm's Tumor Study Late Effects|National Wilm's Tumor Study Late Effects|Withdrawn||N/A|0|Actual|Emory University||1||national study, local site not responsible for results/analysis|f||||t||||||||||2017-02-18 17:05:39.548208|2017-02-18 17:05:39.548208
NCT00228683|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2013-11-23|||September 2005||2005-09-01|November 2013|2013-11-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Hepatoblastoma Biology Study and Tissue Bank|Hepatoblastoma Biology Study and Tissue Bank|Withdrawn||N/A|0|Actual|Emory University||1||national study, local site not responsible for any analysis/results/etc|f||||t||||||||||2017-02-18 17:05:39.645831|2017-02-18 17:05:39.645831
NCT00228670|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2013-12-24|||July 2005||2005-07-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Herpesvirus in Idiopathic Pulmonary Fibrosis|Herpesvirus in Idiopathic Pulmonary Fibrosis|Completed||N/A|41|Actual|Emory University|||4||f||||f||||||Samples Without DNA|"~     Lung tissue at the time of lung transplantation. Saliva, induced sputum, and blood at clinic~     visitis~   "|||2017-02-18 17:05:39.731636|2017-02-18 17:05:39.731636
NCT00228657|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2013-11-25|||July 2002||2002-07-01|September 2005|2005-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride|The Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium Chloride Administration (Substudy of SAFE Protocol 153711)|Completed||Phase 1/Phase 2|1100||Bayside Health|||||f||||f||||||||||2017-02-18 17:05:39.82969|2017-02-18 17:05:39.82969
NCT00228644|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2009-01-29|||July 2005||2005-07-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|||||Observational|||Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione|Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione and Cysteine.|Completed||N/A|15|Anticipated|Emory University|||1||f||||||||||||||2017-02-18 17:05:39.932405|2017-02-18 17:05:39.932405
NCT00228631|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2014-05-23|||September 2005||2005-09-01|May 2014|2014-05-01|July 2012|Actual|2012-07-01|August 2011|Actual|2011-08-01||Observational|||Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD|Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease (ImmuneReconstSCD)|Completed||N/A|7|Actual|Emory University|||1||f||||t||||||||||2017-02-18 17:05:40.022694|2017-02-18 17:05:40.022694
NCT00229372|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2008-01-28|||November 2006||2006-11-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Prolonged Exposure Versus Treatment as Usual in Chronic Posttraumatic Stress Disorder Combat and Terror Related Patients||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:40.121489|2017-02-18 17:05:40.121489
NCT00229359|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2007-12-18|||January 2000||2000-01-01|December 2007|2007-12-01|December 2002||2002-12-01|||||Observational|||Characteristics of Post-Traumatic Stress Disorder (PTSD) and Non-PTSD Subjects|Risk Factors for PTSD|Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:40.206673|2017-02-18 17:05:40.206673
NCT00229346|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2007-12-18|||October 2004||2004-10-01|December 2007|2007-12-01|January 2006||2006-01-01|||||Observational|||Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:40.275216|2017-02-18 17:05:40.275216
NCT00229333|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2006-08-28|||December 2004||2004-12-01|August 2006|2006-08-01||||||||Interventional|||Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia|Exploratory Study to Assess the Efficacy of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia and Mixed Vascular and Alzheimer’s Dementia|Unknown status|Recruiting|Phase 4|40||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:40.522|2017-02-18 17:05:40.522
NCT00229320|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2008-01-28|||February 2005||2005-02-01|January 2008|2008-01-01|November 2005||2005-11-01|||||Interventional|||Short Term Group Therapy for OCD||Completed||N/A|||Sheba Medical Center|||||f||||f||||||||||2017-02-18 17:05:40.60754|2017-02-18 17:05:40.60754
NCT00229307|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2013-01-26|||December 2005||2005-12-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Prolonged Exposure (PE) Treatment for Post Traumatic Stress Disorder (PTSD) 20 Minutes Versus 40 Minutes||Completed||N/A|39|Actual|Sheba Medical Center||2|||f||||f||||||||||2017-02-18 17:05:40.682063|2017-02-18 17:05:40.682063
NCT00228618|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2009-01-29|||January 2005||2005-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|||||Observational|||Dietary Effects of Sulfur Amino Acids|Dietary Effects of Sulfur Amino Acid Depletion and Repletion on Glutathione and Cysteine Pools.|Completed||N/A|20|Anticipated|Emory University|||1||f||||||||||||||2017-02-18 17:05:40.786317|2017-02-18 17:05:40.786317
NCT00228605|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2014-05-08|||March 2005||2005-03-01|May 2014|2014-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain|An Open-Label 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of OraVescent Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Noncancer Pain|Completed||Phase 3|500||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:05:40.870896|2017-02-18 17:05:40.870896
NCT00228592|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2007-02-12||||||February 2007|2007-02-01|August 2005||2005-08-01|||||Interventional|||HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection|A Phase II, Multicenter, Randomized, Open-Label, Dose-Ranging, Parallel Group Study to Compare the Anti-Viral Effects, Pharmacokinetics and Safety of HepeX-Bä, a Mixture of Two Monoclonal Antibodies, as Compared to Hepatitis B Immune Globulin in Patients Who Have Received Hepatic Allografts for Treatment of End-Stage Liver Disease Due to Hepatitis B Virus Infection|Terminated||Phase 2|||Cubist Pharmaceuticals LLC|||||||||||||||||||2017-02-18 17:05:40.996228|2017-02-18 17:05:40.996228
NCT00228566|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2013-07-12|2009-06-01||October 2005||2005-10-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|A Short-term (8 Week) Open-Label Study, Followed by a Long Term Evaluation, to Assess Patient-Reported Outcomes With Armodafinil Treatment (150 to 250 mg/Day) for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|247|Actual|Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:05:41.204701|2017-02-18 17:05:41.204701
NCT00228553|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2013-07-12|2009-06-01||May 2004||2004-05-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness|A 12-Month, Open-Label, Flexible-Dosage (100 to 250 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil (CEP-10953) in the Treatment of Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (With an Open-Ended Extension Period)|Completed||Phase 3|743|Actual|Teva Pharmaceutical Industries||1|||||||||||||||||2017-02-18 17:05:41.542153|2017-02-18 17:05:41.542153
NCT00228540|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2014-05-08|||September 2005||2005-09-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|||||Interventional|||Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD|An 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)|Completed||Phase 3|||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:05:42.041266|2017-02-18 17:05:42.041266
NCT00228527|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2010-11-18|||October 2004||2004-10-01|November 2009|2009-11-01|October 2005|Actual|2005-10-01|||||Interventional|||Esomeprazole for Treatment of GERD in Pediatric Patients|A Phase III, Multicentre, Randomized, Double-blind Parallel-group Study to Evaluate the Safety and Clinical Outcome of Once Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients 1 to 11 Years of Age, Inclusive.|Completed||Phase 4|100||AstraZeneca|||||f||||||||||||||2017-02-18 17:05:42.167857|2017-02-18 17:05:42.167857
NCT00228514|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2010-11-11|||February 2004||2004-02-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study|Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) PET Sub Study|Completed||Phase 3|40||AstraZeneca|||||f||||||||||||||2017-02-18 17:05:42.3998|2017-02-18 17:05:42.3998
NCT00229294|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2007-12-18|||March 2004||2004-03-01|December 2007|2007-12-01|March 2005||2005-03-01|||||Observational|||Fibromyalgia in Men Suffering From PTSD||Completed||N/A|||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:42.502567|2017-02-18 17:05:42.502567
NCT00229281|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2007-12-18|||February 2004||2004-02-01|December 2007|2007-12-01||||||||Interventional|||Short Term Group Therapy for Anxiety Disorder||Completed||N/A|30||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:42.574104|2017-02-18 17:05:42.574104
NCT00229268|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-05-31|||September 2005||2005-09-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|||||Observational|||Research on the Nature, Diagnosis, and Treatment of Obesity and Diabetes|FOXA2 Expression in Adipose Tissue of Human Subjects With Obesity/Insulin-Resistance|Completed||N/A|14|Anticipated|Rockefeller University|||1||f||||t||||||||||2017-02-18 17:05:42.652708|2017-02-18 17:05:42.652708
NCT00229255|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-05-31|||March 2005||2005-03-01|May 2012|2012-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Relation of Obesity With Frequency of Meals (MST 0557)|Relation of Obesity With Frequency of Meals (MST 0557)|Completed||N/A|22|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 17:05:42.740869|2017-02-18 17:05:42.740869
NCT00229242|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-12-11|||November 2003||2003-11-01|December 2009|2009-12-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures|Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures|Completed||N/A|38|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 17:05:42.847481|2017-02-18 17:05:42.847481
NCT00229229|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-27|||September 2004||2004-09-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Comparison of 4 Diets in the Management of Overweight Patients With Vascular Disease|Comparison of a Low Glycemic Load Diet With a Canada Food Guide Diet in the Management of Overweight Patients With Cardiovascular Disease|Terminated||Phase 4|90|Actual|Queen's University||4||Lack of funding|f||||t||||||||||2017-02-18 17:05:42.968276|2017-02-18 17:05:42.968276
NCT00229216|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2007-06-18|||January 2005||2005-01-01|June 2007|2007-06-01||||||||Interventional|||Treatment of Bacterial Vaginosis With Oral Tinidazole|A Phase III Randomized, Multi-Center, Double-Blind, Double-Dummy, Placebo-Controlled Treatment Trial of Bacterial Vaginosis With Tinidazole Oral Tablets.|Completed||Phase 3|200||Mission Pharmacal|||||||||||||||||||2017-02-18 17:05:43.07907|2017-02-18 17:05:43.07907
NCT00229203|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2009-12-14|2009-08-31||February 2005||2005-02-01|December 2009|2009-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma|"Phase II Multicenter, Open-Label, Clinical and Pharmacokinetic Study of Aplidin® As A 3-Hour Infusion Every 2 Weeks Alone or in Combination With Dexamethasone, in Pre-Treated Patients With Relapsing or Refractory Multiple Myeloma."|Completed||Phase 2|51|Actual|PharmaMar|32 patients were treated with plitidepsin as single agent;afterwards 19 of them were treated with plitidepsin+dexamethasone combination.Therefore 32+19=51 is the no. patients at risk for plitidepsin and 19 is no. of patients at risk for dexamethasone|1|||f||||f||||||||||2017-02-18 17:05:43.180599|2017-02-18 17:05:43.180599
NCT00229190|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2007-04-23|||September 2004||2004-09-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Interventional|||Nasal Lavage Study: Comparing Single Versus Multi Sample Lavages|Reproducibility of Cell Counts in Nasal Lavage: A Comparison of Pooled Versus Non-Pooled Nasal Lavage Samples|Completed||N/A|21||McMaster University|||||f||||f||||||||||2017-02-18 17:05:44.075196|2017-02-18 17:05:44.075196
NCT00229177|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-06-12|||September 2005||2005-09-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study of ONO-2506 in Patients With Acute Ischemic Stroke|Controlled Study of ONO-2506 in Patients With Acute Ischemic Stroke|Completed||Phase 2/Phase 3|757|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||||||||||||2017-02-18 17:05:44.184264|2017-02-18 17:05:44.184264
NCT00228969|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-08-01|||February 2005||2005-02-01|August 2012|2012-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy||Completed||Phase 2|||SK Life Science|||||f||||||||||||||2017-02-18 17:05:45.915488|2017-02-18 17:05:45.915488
NCT00229164|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-12-26|||October 2005||2005-10-01|November 2012|2012-11-01|January 2006||2006-01-01|||||Interventional|||The Effect of Transcutaneous Electric Nerve Stimulation on Primary Dysmenorrhea-a Randomized Control Study|The Effect of Transcutaneous Electric Nerve Stimulation on Primary Dysmenorrhea-a Randomized Control Study|Completed||Phase 1/Phase 2|20|Anticipated|National Taiwan University Hospital|||||f||||f||||||||||2017-02-18 17:05:44.305665|2017-02-18 17:05:44.305665
NCT00229151|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-04-06|||October 2005||2005-10-01|April 2012|2012-04-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression.|Sleep Deprivation and Three Days Sleep Phase Advancement as Treatment for Bipolar Depression.|Terminated||N/A|5|Actual|Norwegian University of Science and Technology||2||recruiting problems|f||||f||||||||||2017-02-18 17:05:44.390128|2017-02-18 17:05:44.390128
NCT00229138|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2017-02-03|||September 2005||2005-09-01|February 2017|2017-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients|A Six-month, Prospective, Multicenter, Open Label, Parallel, Randomized Study of the Safety, Tolerability and Efficacy of EC-MPS With Basiliximab, Corticosteroids and Two Different Levels of Tacrolimus in de Novo Renal Transplant Recipients|Completed||Phase 4|291|Actual|Novartis||2|||||||||||||||||2017-02-18 17:05:44.491116|2017-02-18 17:05:44.491116
NCT00229125|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2005-09-27|||July 2001||2001-07-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam|Gabapentin Vs. Lorazepam in Alcohol Withdrawal|Completed||Phase 2|160||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 17:05:44.605484|2017-02-18 17:05:44.605484
NCT00229112|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2017-02-16|||April 2001||2001-04-01|February 2017|2017-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)|A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability, of Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in Adults.|Completed||Phase 3|400||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:05:44.720009|2017-02-18 17:05:44.720009
NCT00229099|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-28|2006-10-25|||April 2005||2005-04-01|December 2005|2005-12-01|November 2005||2005-11-01|||||Interventional|||Efficacy and Safety Study of GerEPO|A Randomized, Multi-Center, Open Label Trial to Establish the Therapeutic Equivalence Between GerEpo and Eprex® and to Determine the Long Term Safety Profile of GerEpo in Patients on Hemodialysis.|Completed||Phase 3|270||Ministry of Health, Malaysia|||||f||||||||||||||2017-02-18 17:05:44.804042|2017-02-18 17:05:44.804042
NCT00229086|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2008-07-24||||||July 2008|2008-07-01||||||||Observational|||Gatekeeper European 005|Long Term Follow-up European Gatekeeper Study 005|Terminated||N/A|55||MedtronicNeuro|||||f||||||||||||||2017-02-18 17:05:44.919738|2017-02-18 17:05:44.919738
NCT00229073|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2011-06-06|||December 2004||2004-12-01|March 2010|2010-03-01|October 2006|Actual|2006-10-01|||||Interventional|||A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation|A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study Of The Efficacy And Safety Of Dapoxetine In The Treatment Of Subjects With Premature Ejaculation|Completed||Phase 3|1116|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:05:44.996393|2017-02-18 17:05:44.996393
NCT00229060|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2011-06-08|||March 2004||2004-03-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Doripenem in the Treatment of Complicated Intra-Abdominal Infections|A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Versus Comparator Antibiotic in the Treatment of Complicated Intra-Abdominal Infections|Completed||Phase 3|483|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:05:45.10763|2017-02-18 17:05:45.10763
NCT00229047|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2008-12-18|||April 2005||2005-04-01|December 2008|2008-12-01|December 2011|Anticipated|2011-12-01|December 2010|Anticipated|2010-12-01||Observational|||Ischemia and Reperfusion Injury in the Human: An Observational Study|Ischemia and Reperfusion Injury in the Human: An Observational Study|Unknown status|Recruiting|N/A|20|Anticipated|Lawson Health Research Institute|||1||f||||t||||||||||2017-02-18 17:05:45.204068|2017-02-18 17:05:45.204068
NCT00229034|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2008-12-19|||September 2005||2005-09-01|December 2008|2008-12-01|September 2011|Anticipated|2011-09-01|December 2010|Anticipated|2010-12-01||Observational|||Effect of APC and Epo on the Inflammatory Response During Sepsis|Effect of Activated Protein C and Erythropoietin on the Microvascular Inflammatory Response During Severe Sepsis.|Unknown status|Recruiting|N/A|40|Anticipated|Lawson Health Research Institute|||1||f||||t||||||||||2017-02-18 17:05:45.409094|2017-02-18 17:05:45.409094
NCT00229021|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2011-06-08|||December 2003||2003-12-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis|A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Verus a Comparator Antibiotic in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis|Completed||Phase 3|741|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:05:45.501368|2017-02-18 17:05:45.501368
NCT00229008|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-08-27||2011-06-02|November 2005||2005-11-01|August 2012|2012-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Ceftobiprole in Hospital Acquired Pneumonia|A Phase 3 Randomized Double-Blind Study Of Ceftobiprole Medocaril Versus Linezolid Plus Ceftazidime In The Treatment Of Nosocomial Pneumonia|Completed||Phase 3|106|Actual|Basilea Pharmaceutica||2|||f||||t||||||||||2017-02-18 17:05:45.594244|2017-02-18 17:05:45.594244
NCT00228995|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2011-06-08|||June 2004||2004-06-01|April 2010|2010-04-01|September 2005|Actual|2005-09-01|||||Interventional|||A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia|A Randomized, Double-blind, Placebo-controlled, Study to Assess Changes in Physical Function in Elderly Patients With Idiopathic Anemia of Aging (IAA) Receiving Epoetin Alfa (PROCRIT�)|Terminated||Phase 2|9|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"This study was stopped due to slow enrollment after enrolling only 9 of 80 patients over 14~   months time."|||||t||||||||||2017-02-18 17:05:45.706597|2017-02-18 17:05:45.706597
NCT00228982|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-07-25|||October 2004||2004-10-01|July 2012|2012-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections|A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections|Completed||Phase 3|784|Actual|Basilea Pharmaceutica||2|||||||f||||||||||2017-02-18 17:05:45.802844|2017-02-18 17:05:45.802844
NCT00228956|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2008-09-24|||January 2005||2005-01-01|September 2005|2005-09-01|February 2009|Anticipated|2009-02-01|||||Observational|||Aromatase Inhibitor Clinical Trial|A Multi-Center Randomized Clinical Trial Correlating the Effects of 24 Months of Exemestane or Letrozole on Surrogate Markers of Response With Aromatase Polymorphism|Unknown status|Recruiting|Phase 4|500|Anticipated|National Institute of General Medical Sciences (NIGMS)|||1||f||||||||||Samples With DNA|"~     Whole blood Serum and Plasma Urine~   "|||2017-02-18 17:05:46.061102|2017-02-18 17:05:46.061102
NCT00228943|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-03-24|2008-11-13||July 2005||2005-07-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|October 2007|Actual|2007-10-01||Interventional|||The Role of Serotonin in Hot Flashes After Breast Cancer|The Role of Serotonin in Hot Flashes After Breast Cancer|Completed||N/A|28|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 17:05:46.158304|2017-02-18 17:05:46.158304
NCT00228930|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2008-09-24|||September 2002||2002-09-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Observational|||Tamoxifen Pharmacogenetics and Clinical Effects|A Pilot Trial Correlating Metabolic Profile of Tamoxifen With Pharmacogenetic Predictors and Clinical Effects|Completed||Phase 4|297|Actual|National Institute of General Medical Sciences (NIGMS)|||1||f||||||||||Samples With DNA|"~     Whole Blood Serum Plasma~   "|||2017-02-18 17:05:46.435474|2017-02-18 17:05:46.435474
NCT00228917|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-09-20|||June 2005||2005-06-01|September 2016|2016-09-01|September 2006|Actual|2006-09-01|January 2006|Actual|2006-01-01||Interventional|||Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children|Assess Reactogenicity & Safety of a Booster of Either Tritanrix™-HepB/Hib-MenAC or Tritanrix™-HepB/Hiberix™ Given (Single-blind) at 15-18 (Philippines)/15-24 Mths (Thailand) & a Dose of Mencevax™ ACWY at 24-30 Mths (Open Label)|Completed||Phase 3|798|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:05:46.547065|2017-02-18 17:05:46.547065
NCT00228904|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-08-08|||February 2005||2005-02-01|August 2016|2016-08-01|October 2011|Anticipated|2011-10-01|May 2011|Anticipated|2011-05-01||Interventional|||Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes|Effects of Pulsatile IV Insulin Delivery on Peripheral Diabetic Neuropathy|Withdrawn||Phase 2/Phase 3|0|Actual|Florida Atlantic University||2||Administrative|f||||t||||||||||2017-02-18 17:05:46.657817|2017-02-18 17:05:46.657817
NCT00228891|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-08-08|||February 2004||2004-02-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus|Effects of Pulsatile Insulin Delivery on Peripheral Diabetic Neuropathy|Terminated||Phase 2/Phase 3|152|Actual|Florida Atlantic University||2||Administrative|f||||t||||||||||2017-02-18 17:05:46.771717|2017-02-18 17:05:46.771717
NCT00228878|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-08-08|||March 2003||2003-03-01|August 2016|2016-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Effect Pulsatile IV Insulin Therapy on the Quality of Life in Patients With Types 1 and 2 Diabetes|Quality of Life With and Without Pulsatile IV Insulin Therapy in Diabetes.|Terminated||Phase 2/Phase 3|152|Actual|Florida Atlantic University||1||Administrative|f||||t||||||||||2017-02-18 17:05:46.888624|2017-02-18 17:05:46.888624
NCT00228436|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2012-12-19|||September 2005||2005-09-01|December 2012|2012-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients|A Phase 2, Open-label, Multi-center, Sequential Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Multiple Doses of Subcutaneously Administered Peginesatide in Chronic Kidney Disease Patients Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment|Completed||Phase 2|139|Actual|Affymax||8|||f||||f||||||||||2017-02-18 17:05:47.006109|2017-02-18 17:05:47.006109
NCT00228423|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-11-02|||May 2006||2006-05-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|||Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)|Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial): Does Clopidogrel Prevent Saphenous Vein Graft Disease After Coronary Bypass?|Completed||Phase 2|91|Actual|Ottawa Heart Institute Research Corporation||2|||f||||||||||||||2017-02-18 17:05:47.133585|2017-02-18 17:05:47.133585
NCT00228410|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-02-07|||November 2002||2002-11-01|February 2013|2013-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections|A Multicenter, Randomized, Double-Blind Comparison of the Safety and Efficacy of Tigecycline With Those of Vancomycin With Aztreonam to Treat Complicated Skin and Skin Structure Infections in Hospitalized Patients.|Completed||Phase 3|503|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:05:50.102005|2017-02-18 17:05:50.102005
NCT00228397|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-02-11|||November 2003||2003-11-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Evaluating CCI-779 in Relapsing Multiple Sclerosis|A Multicenter, Randomized, Double-blind, Long-term Extension Study to Determine the Safety, Tolerability, and Preliminary Efficacy of CCI-779 in Subjects With Relapsing Multiple Sclerosis.|Completed||Phase 2|221|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:05:50.183853|2017-02-18 17:05:50.183853
NCT00228384|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2012-05-25|2012-01-27||September 2005||2005-09-01|May 2012|2012-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study|GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease|Completed||Phase 4|148|Actual|W.L.Gore & Associates||2|||f||||f||||||||||2017-02-18 17:05:50.275766|2017-02-18 17:05:50.275766
NCT00228371|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2015-05-27|||September 2005||2005-09-01|May 2015|2015-05-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy|Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy Associated With Dopaminergic Metabolism Deficit. A Randomized, Double Blind, Controlled Trial.|Terminated||Phase 2/Phase 3|4|Actual|University Hospital, Grenoble||2||insufficent enrolement|f||||t||||||||||2017-02-18 17:05:51.34917|2017-02-18 17:05:51.34917
NCT00228358|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-11-07|||June 2003||2003-06-01|November 2014|2014-11-01||||May 2011|Actual|2011-05-01||Interventional|||Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine|A Phase I Study of Infusion of HER-2/Neu Specific T Cells in Patients With Advanced Stage HER-2/Neu Expressing Cancers Who Have Received a HER-2/Neu Vaccine|Completed||Phase 1|8|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:05:51.473151|2017-02-18 17:05:51.473151
NCT00228345|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-09-04|||January 2004||2004-01-01|September 2013|2013-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy|The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy|Terminated||Phase 1|40||University of Chicago||||Study Completed|f||||||||||||||2017-02-18 17:05:51.594284|2017-02-18 17:05:51.594284
NCT00228332|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-19|||April 2004||2004-04-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|||||Interventional|||A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares|A Double-Blind, Placebo-Controlled Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares|Completed||Phase 2|70||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:05:51.701439|2017-02-18 17:05:51.701439
NCT00228319|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2016-02-09|||October 2002||2002-10-01|February 2016|2016-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants|Antioxidant Effects on the Outcome of Ovarian Cancer|Completed||Phase 1/Phase 2|27|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 17:05:51.79013|2017-02-18 17:05:51.79013
NCT00228306|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2012-04-27|||September 2005||2005-09-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effect of Aerobic Exercise on Learning After Stroke|Effect of Cardiovascular Fitness on Motor Learning and Executive Function in Individuals After Stroke|Completed||Phase 1|38|Actual|University of Kansas Medical Center||2|||f||||t||||||||||2017-02-18 17:05:51.908174|2017-02-18 17:05:51.908174
NCT00228293|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2013-09-20|||December 2002||2002-12-01|September 2013|2013-09-01|September 2005||2005-09-01|||||Interventional|||Assessing CPR Quality During In-Hospital Cardiac Arrest|Assessment of Cardiopulmonary Resuscitation Quality During In-Hospital Cardiac Arrest|Terminated||Phase 2/Phase 3|200||University of Chicago|||||||||||||||||||2017-02-18 17:05:52.005209|2017-02-18 17:05:52.005209
NCT00228280|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-12-03|||January 2005||2005-01-01|December 2008|2008-12-01|September 2008|Anticipated|2008-09-01|||||Interventional|||Periapical Bone Healing After Apicectomy With and Without Retrograde Root Filling|Periapical Bone Healing After Apicectomy With and Without Retrograde Root Filling|Unknown status|Active, not recruiting|Phase 1/Phase 2|54|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:05:52.099916|2017-02-18 17:05:52.099916
NCT00228267|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2007-11-05|||September 2004||2004-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Propofol Injection for Daily Headache|The Effect of Single-Dose Propofol Injection on Pain and Quality of Life in Chronic Daily Headache: a Randomized Double-Blind Controlled Trial|Completed||Phase 2|28|Anticipated|University of Alberta|||||f||||||||||||||2017-02-18 17:05:52.20078|2017-02-18 17:05:52.20078
NCT00228254|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2005-09-23|||January 2000||2000-01-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Interventional|||Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study|Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study|Completed||Phase 4|2582||Tufts University|||||f||||||||||||||2017-02-18 17:05:52.310272|2017-02-18 17:05:52.310272
NCT00228241|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2006-10-25|||September 2003||2003-09-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Interventional|||Left Ventricular Function and Remodelling During Permanent Pacing|Left Ventricular Function and Remodelling During Permanent Pacing|Unknown status|Active, not recruiting|N/A|100||Aarhus University Hospital Skejby|||||f||||||||||||||2017-02-18 17:05:52.407339|2017-02-18 17:05:52.407339
NCT00228228|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2006-08-27|||May 2002||2002-05-01|August 2006|2006-08-01|December 2006||2006-12-01|||||Interventional|||TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis|T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis|Unknown status|Recruiting|Phase 3|80||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:52.493455|2017-02-18 17:05:52.493455
NCT00228215|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2014-11-18|||September 2005||2005-09-01|November 2014|2014-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Tips for Infant and Parent Sleep (TIPS)|Tips for Infant and Parent Sleep (TIPS) Pilot Study|Completed||N/A|30|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 17:05:52.588809|2017-02-18 17:05:52.588809
NCT00228202|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2006-08-17|||September 2005||2005-09-01|January 2006|2006-01-01||||||||Observational|||Genotyping of Cytomegalovirus From Patients in Israel|Cytomegalovirus Glycoprotein B Genotypes in Israeli Patients: Relationship Between CMV Genotype, Clinical and Demographic Factors|Unknown status|Recruiting|N/A|100||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:05:52.692495|2017-02-18 17:05:52.692495
NCT00228189|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2010-11-26|||December 2003||2003-12-01|November 2010|2010-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients|Induction of Specific T Cell Responses in Colorectal Cancer Patients With Liver Metastases Upon Vaccination With Autologous Dendritic Cells Pulsed With CEA-peptide or Electroporated With CEA-RNA: Evaluation of in Vivo Immune Response.|Completed||Phase 1/Phase 2|30|Anticipated|Radboud University||3|||f||||||||||||||2017-02-18 17:05:52.783539|2017-02-18 17:05:52.783539
NCT00228176|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-04-21||2016-04-21|August 2005||2005-08-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|AUDITOR||Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant|Randomized, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20-mg od, for Inhibition of Atherosclerosis Progression Assessed by Carotid Artery Intima-media Thickness (CIMT), in Overweight Patients With Additional Risk Factors|Terminated||Phase 3|661|Actual|Sanofi||2||Company decision taken in light of demands by certain national health authorities|f||||t||||||||||2017-02-18 17:05:52.895055|2017-02-18 17:05:52.895055
NCT00228163|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2015-03-24|||January 2002||2002-01-01|March 2015|2015-03-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses|Extension of Protocol HMR1726D/2001, A Phase II Study of the Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses|Completed||Phase 2|147|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 17:05:53.251609|2017-02-18 17:05:53.251609
NCT00228150|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2008-12-22|||July 2003||2003-07-01|December 2008|2008-12-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease|A Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy, Safety and Tolerability Study of SR57667B in Outpatients With Early Parkinson's Disease|Completed||Phase 2|564|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:05:53.370245|2017-02-18 17:05:53.370245
NCT00005427|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||March 1993||1993-03-01|January 2016|2016-01-01|February 1995||1995-02-01|||||Observational|||Cohort Study of Respiratory Illness in Early Childhood||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-02-18 18:15:00.536885|2017-02-18 18:15:00.536885
NCT00228137|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-08|||November 2002||2002-11-01|August 2007|2007-08-01|November 2012|Anticipated|2012-11-01|||||Observational|||Randomised Controlled Trial PFC Versus CKS Total Knee Prostheses|A Prospective Randomized Double-Blind Study to Assess the Functional Differences Between the PFC and CKS Knee Prostheses|Unknown status|Active, not recruiting|N/A|90||Radboud University|||||f||||||||||||||2017-02-18 17:05:53.47786|2017-02-18 17:05:53.47786
NCT00228124|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2006-01-25|||April 2004||2004-04-01|September 2005|2005-09-01|April 2008||2008-04-01|||||Observational|||PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition|Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition in a Phase III Randomized Trial|Unknown status|Recruiting|Phase 3|300||Ontario Cancer Research Network|||||f||||||||||||||2017-02-18 17:05:53.548216|2017-02-18 17:05:53.548216
NCT00228111|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2009-09-23|||June 2005||2005-06-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Observational|||TRACT Study: Evaluation of the Value of Routine Thoraco-abdominal CT in Blunt Trauma Patients|Prospective Evaluation of the Additional Value of Routine Thoraco-abdominal CT in Patients That Suffered Severe Blunt Trauma of the Abdomen/Thorax|Completed||N/A|1000|Anticipated|Radboud University|||1||f||||f||||||||||2017-02-18 17:05:53.640634|2017-02-18 17:05:53.640634
NCT00228098|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2005-09-27|||February 2005||2005-02-01|September 2005|2005-09-01|February 2007||2007-02-01|||||Interventional|||Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack.|Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack. A Randomised Controlled Trial|Unknown status|Recruiting|N/A|300||Odense University Hospital|||||f||||||||||||||2017-02-18 17:05:53.733207|2017-02-18 17:05:53.733207
NCT00228085|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2005-09-26|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Observational|||Changes of Parameters of Transcranial Magnetic Stimulation in Patients With Spinal Cord Injury|Reorganization of Cortical Motor Activation in Patients With Spinal Cord Injury: a Study of Motor Evoked Potential|Unknown status|Not yet recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:05:53.817665|2017-02-18 17:05:53.817665
NCT00228072|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2008-05-28||||||May 2008|2008-05-01||||February 2008|Actual|2008-02-01||Interventional|||Liposuction as Treatment for Excessive Axillary Sweat|Suction-Curettage vs. Standard Excision in Axillary Hyperhidrosis|Completed||Phase 2/Phase 3|50|Anticipated|Odense University Hospital|||||f||||||||||||||2017-02-18 17:05:53.897499|2017-02-18 17:05:53.897499
NCT00228059|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2011-11-22|||January 2005||2005-01-01|November 2011|2011-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.|A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750- 2000 mg/Day in the Treatment of Manic Episodes of Bipolar I Disorder|Completed||Phase 3|132|Actual|Novartis|||||f||||||||||||||2017-02-18 17:05:53.985882|2017-02-18 17:05:53.985882
NCT00228046|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-10-29|||January 2004||2004-01-01|October 2013|2013-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder|Double-Blind, Placebo-Controlled Trial of Flexible Dose Divalproex Sodium Adjunctive to Stimulant Treatment for Aggressive Children With Attention-Deficit Hyperactivity Disorder|Completed||Phase 4|40|Anticipated|Stony Brook University|||||f||||||||||||||2017-02-18 17:05:54.080373|2017-02-18 17:05:54.080373
NCT00228033|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2014-03-19|||April 2002||2002-04-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|December 2005|Actual|2005-12-01||Interventional|||Effectiveness of Supplemental Calcium in Preventing Postpartum Depression|Calcium for the Prevention of Postpartum Depression|Completed||Phase 4|238||Oregon Health and Science University|||||f||||||||||||||2017-02-18 17:05:54.180259|2017-02-18 17:05:54.180259
NCT00228020|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2010-08-24|||May 2001||2001-05-01|August 2010|2010-08-01||||January 2006|Actual|2006-01-01||Interventional|||Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients|A Randomized, Placebo-controlled, Double-blind, Multicenter Study Investigating Basiliximab in Combination With MMF, Cyclosporine Microemulsion and Prednisone in the Prevention of Acute Rejection in Pediatric Renal Allograft Recipients|Completed||Phase 3|212|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:05:54.281433|2017-02-18 17:05:54.281433
NCT00228007|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-08-20|||September 2000||2000-09-01|August 2013|2013-08-01|September 2004|Actual|2004-09-01|||||Interventional|||Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users|Maintaining HIV Risk Reduction Among Needle Exchangers|Completed||Phase 3|265||Butler Hospital|||||f||||||||||||||2017-02-18 17:05:54.368557|2017-02-18 17:05:54.368557
NCT00227994|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-10-30|2016-05-02||April 2003||2003-04-01|October 2016|2016-10-01|March 2005|Actual|2005-03-01|January 2005|Actual|2005-01-01||Interventional|||Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke|Donepezil/ Galantamine in the Treatment of Post-stroke Cognitively Impaired Rehabilitating Elderly|Completed||Phase 4|40|Actual|University of Pittsburgh||2|||f||||f||||||||Yes|study has small sample size and is unlikely to be useful for data sharing efforts; however, interested researchers can contact the first author via email.|2017-02-18 17:05:54.474681|2017-02-18 17:05:54.474681
NCT00227981|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-06-21|||March 1995||1995-03-01|June 2013|2013-06-01|March 2001||2001-03-01|||||Interventional|||Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression|Maintenance Psychotherapies in Recurrent Depression: Study II|Completed||N/A|93||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:05:54.887002|2017-02-18 17:05:54.887002
NCT00227968|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-06-21|||March 1995||1995-03-01|June 2013|2013-06-01|April 2002||2002-04-01|||||Interventional|||Psychosocial Therapy Plus Maintenance Pharmacotherapy for Treating Bipolar Disorder|Maintenance Therapies in Bipolar Disorder|Completed||Phase 4|181||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:05:54.983615|2017-02-18 17:05:54.983615
NCT00227955|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-06-21|||December 1987||1987-12-01|June 2013|2013-06-01|December 1993||1993-12-01|||||Interventional|||Comparing Various Treatments for Achieving and Maintaining Remission of Depression|Maintenance Therapies in Recurrent Depression-Study I|Completed||Phase 4|200||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:05:55.077529|2017-02-18 17:05:55.077529
NCT00227942|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2014-05-23|||August 2003||2003-08-01|May 2014|2014-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia|Understanding the Role That Hot Flashes and Sleep Disruption Play in the Effect of Estrogen Replacement Therapy on Mood in Perimenopausal and Postmenopausal Women|Completed||Phase 4|86|Actual|Massachusetts General Hospital||3|||f||||f||||||||||2017-02-18 17:05:55.166622|2017-02-18 17:05:55.166622
NCT00227929|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-12-09|||July 2003||2003-07-01|December 2013|2013-12-01|June 2008|Actual|2008-06-01|September 2007|Actual|2007-09-01||Interventional|||Culturally Sensitive Collaborative Treatment for Depressed Chinese Americans|Effectiveness of Culturally Sensitive Collaborative Treatment (CSCT) of Depressed Chinese Americans in Primary Care|Completed||N/A|120|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:05:55.282624|2017-02-18 17:05:55.282624
NCT00227916|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2014-09-24|||November 2000||2000-11-01|September 2014|2014-09-01|July 2004|Actual|2004-07-01|May 2004|Actual|2004-05-01||Interventional|||Motivational Interviews for Incarcerated Teens - 1|Motivational Interviews for Incarcerated Teens|Completed||N/A|200|Anticipated|Brown University|||||f||||||||||||||2017-02-18 17:05:55.366084|2017-02-18 17:05:55.366084
NCT00227903|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-11-22|2013-06-14||September 2004||2004-09-01|September 2016|2016-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|PRIDE-P|Analysis excluded women with no follow-up assessments.|Therapeutic Substance Abuse Treatment in Pregnancy - 1|Psychosocial Research to Improve Drug Treatment in Pregnancy (PRIDE-P)|Completed||Phase 2|168|Actual|Yale University|Did not acheive desired sample size; results were averaged across substances; women were not seeking substance abuse treatment (i.e. they were attending for prenatal care); treatment was brief|2|||f||||t||||||||No|only aggregate de-identified data|2017-02-18 17:05:55.476789|2017-02-18 17:05:55.476789
NCT00227890|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-12-28|||March 2005||2005-03-01|December 2016|2016-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Skills and Motivation at the Rhode Island Training School (Project SMART) - 1|Motivation and Skills for THC/ETOH+ Teens in Jail|Completed||Phase 2|205|Actual|University of Rhode Island||1|||f||||||||||||||2017-02-18 17:05:57.518597|2017-02-18 17:05:57.518597
NCT00227877|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2016-10-06|||September 2004||2004-09-01|October 2016|2016-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Screening and Brief Advice to Reduce Teen Substance Use|Screening and Brief Advice to Reduce Teen Substance Use|Completed||Phase 2|2145|Actual|Boston Children’s Hospital||2|||f||||t||||||||No||2017-02-18 17:05:57.622888|2017-02-18 17:05:57.622888
NCT00227864|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2015-11-10|||September 2004||2004-09-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Brief Marijuana Intervention for Adolescent Women - 1|A Brief Marijuana Intervention for Adolescent Women|Completed||Phase 3|326|Actual|Butler Hospital||2|||f||||||||||||||2017-02-18 17:05:57.74572|2017-02-18 17:05:57.74572
NCT00227838|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2017-01-11|||July 2003||2003-07-01|September 2005|2005-09-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Modifying Group Therapy for Bipolar Substance Abusers - 1|Modifying Group Therapy for Bipolar Abusers|Completed||N/A|60|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:05:57.848624|2017-02-18 17:05:57.848624
NCT00227825|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2017-01-10|||January 2002||2002-01-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1|Motivational Enhancement Therapy to Reduce Risk Behaviors in HIV Infected Youth|Unknown status|Not yet recruiting|Phase 2|60||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||No||2017-02-18 17:05:57.941966|2017-02-18 17:05:57.941966
NCT00227812|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2017-01-11|||April 2001||2001-04-01|January 2009|2009-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Integrated Treatment for Cocaine and Mood Disorders - 1|ERP-8654 - Integrated Treatment for Cocaine and Mood Disorders|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:05:58.031993|2017-02-18 17:05:58.031993
NCT00227786|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-08-15|||January 2003||2003-01-01|November 2005|2005-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Primary Care Physicians' Use of Stop-Smoking Plans to Help Patients Who Are Smokers|Using Electronic Medical Records to Measure and Improve Adherence to Tobacco Treatment Guidelines in Primary Care|Completed||N/A|344|Actual|Kaiser Permanente||1|||f||||f||||||||||2017-02-18 17:05:58.124575|2017-02-18 17:05:58.124575
NCT00227773|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2015-10-06||||||October 2015|2015-10-01||||||||Interventional|||Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors|Phase II Study of Vatalanib and Octreotide in Patients With Progressive Low-Grade Neuroendocrine Tumors|Withdrawn||Phase 2|0|Actual|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 17:05:58.226653|2017-02-18 17:05:58.226653
NCT00227760|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-01-29|2016-01-29||December 2005||2005-12-01|December 2013|2013-12-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery|A Phase 2 Study of AZD2171 in Progressive Unresectable, Recurrent or Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:05:58.319976|2017-02-18 17:05:58.319976
NCT00227747|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2010-04-14|||July 2005||2005-07-01|December 2006|2006-12-01||||||||Interventional|||Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer|Randomized Phase III Trial Comparing in a Preoperative Schedule the Result of Two Concurrent Chemoradiation Schemes (45 Gy + Capecitabine vs 50 Gy + Capecitabine - Oxaliplatin) on the Rate of Sterilization of the Operative Specimen in Resectable Rectal Carcinomas T3-4 No-2 Mo|Unknown status|Active, not recruiting|Phase 3|590|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:05:58.605903|2017-02-18 17:05:58.605903
NCT00227734|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2012-06-04|||June 2004||2004-06-01|June 2012|2012-06-01|February 2006|Actual|2006-02-01|October 2005|Actual|2005-10-01||Interventional|||Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Capecitabine and Oxaliplatin Alone or in Combination With Cetuximab as First-Line Treatment for Metastatic EGFR-Positive Colorectal Cancer, A Randomized Multicenter Phase II Trial|Completed||Phase 2|74|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 17:05:58.768262|2017-02-18 17:05:58.768262
NCT00227721|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-02-16|2014-11-18||February 2004||2004-02-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|June 2011|Actual|2011-06-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer|Phase II Trial of Weekly Gemcitabine and Docetaxel Combination Therapy for Relapsed Ovarian or Peritoneal Cancer|Active, not recruiting||Phase 2|30|Actual|Barbara Ann Karmanos Cancer Institute|Small sample size|1|||f||||t||||||||||2017-02-18 17:05:58.900637|2017-02-18 17:05:58.900637
NCT00227071|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2006-01-03|||September 1999||1999-09-01|September 2005|2005-09-01|June 2002||2002-06-01|||||Interventional|||Aquatic Verses Land Exercise to Decrease Fall Risk|The Effect of Water Verses Land Exercise to Decrease Fall Risk in Older Women With Osteoporosis|Completed||N/A|73||University of Saskatchewan|||||f||||||||||||||2017-02-18 17:06:10.534226|2017-02-18 17:06:10.534226
NCT00227708|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2009-08-19|||June 2005||2005-06-01|December 2006|2006-12-01||||||||Interventional|||Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy Regimen With Bi-Weekly Docetaxel in the Treatment of Metastatic or Locally Advanced Non-Small Cell Lung Cancer in Patients Over the Age of 70|Unknown status|Active, not recruiting|Phase 2|58|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:05:59.173365|2017-02-18 17:05:59.173365
NCT00227695|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-05-24|||June 2004||2004-06-01|May 2016|2016-05-01|September 2017|Anticipated|2017-09-01|September 2013|Actual|2013-09-01||Interventional|||Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma|Comparing Two Schedules of Rituximab Maintenance in Rituximab-Responding Patients With Untreated, Chemotherapy Resistant or Relapsed Follicular Lymphoma: A Randomized Phase III Trial|Active, not recruiting||Phase 3|270|Anticipated|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||No||2017-02-18 17:05:59.284789|2017-02-18 17:05:59.284789
NCT00227682|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2012-05-24|||June 2004||2004-06-01|June 2010|2010-06-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Study of Arsenic Trioxide in Combination With Thalidomide, Dexamethasone, and Ascorbic Acid|Terminated||Phase 2|2|Actual|OHSU Knight Cancer Institute||1||Terminated early due to funding suspension by grant sponsor.|f||||||||||||||2017-02-18 17:05:59.672034|2017-02-18 17:05:59.672034
NCT00227669|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-08-29|||October 2005||2005-10-01|August 2016|2016-08-01|August 2012|Actual|2012-08-01|February 2010|Actual|2010-02-01||Interventional|||Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma|Randomized Phase II Study Evaluating the Efficacy of Gemcitabine Versus the Gemcitabine/Docetaxel Combination as Second Line Treatment in Metastatic or Relapsed and Inoperable Uterine or Soft Tissue Leiomyosarcomas|Completed||Phase 2|90|Actual|UNICANCER||2|||f||||f||||||||No|Individual participant data will not be shared at an individual level.|2017-02-18 17:05:59.98926|2017-02-18 17:05:59.98926
NCT00227656|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2012-12-10|||September 2005||2005-09-01|December 2012|2012-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer|Phase II Trial of Capecitabine (Xeloda®) and Pegylated Interferon Alfa-2A(Pegasys®) for Recurrent or Progressive Brain Metastasis From Breast Carcinoma|Terminated||Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Study slow to accrue.|f||||f||||||||||2017-02-18 17:06:00.155037|2017-02-18 17:06:00.155037
NCT00227630|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2012-07-17|||July 2005||2005-07-01|July 2012|2012-07-01||||August 2007|Actual|2007-08-01||Interventional|||Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma|A Phase II Feasibility Trial of Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Postoperative Radiotherapy in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|59|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:06:00.290171|2017-02-18 17:06:00.290171
NCT00227617|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2015-04-07|||June 2005||2005-06-01|April 2015|2015-04-01|June 2016|Anticipated|2016-06-01|January 2012|Actual|2012-01-01||Interventional|||Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors|A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors|Active, not recruiting||Phase 2/Phase 3|70|Anticipated|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 17:06:00.412384|2017-02-18 17:06:00.412384
NCT00227591|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2014-05-02|2012-10-11||December 2005||2005-12-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Lenalidomide and Prednisone in Treating Patients With Myelofibrosis|A Phase II Study of Lenalidomide (CC-5013) in Combination With Prednisone for the Treatment of Myelofibrosis With Myeloid Metaplasia|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:06:00.545322|2017-02-18 17:06:00.545322
NCT00227565|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-07-01|||February 2006||2006-02-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|December 2007|Actual|2007-12-01||Interventional|||Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|50|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:06:00.852588|2017-02-18 17:06:00.852588
NCT00227539|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2014-01-06|||July 2005||2005-07-01|January 2014|2014-01-01||||March 2010|Actual|2010-03-01||Interventional|||Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Early Positron Emission Tomography as a Predictor of Response in Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer|Completed||Phase 2|25|Actual|University of Washington||1|||f||||||||||||||2017-02-18 17:06:01.12767|2017-02-18 17:06:01.12767
NCT00227526|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2010-09-02|||February 2005||2005-02-01|September 2010|2010-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Enhancing Outcomes After Colon Surgery|Enhancing Outcomes After Colon Surgery: Role of Prehabilitation Facilitating the Recovery Process.|Completed||Phase 2|200|Anticipated|McGill University||2|||f||||f||||||||||2017-02-18 17:06:01.246074|2017-02-18 17:06:01.246074
NCT00227513|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2014-02-21|||July 2005||2005-07-01|April 2013|2013-04-01||||June 2010|Actual|2010-06-01||Interventional|||Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Bortezomib in Patients With Advanced Malignancies|Completed||Phase 1|66|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:06:01.347131|2017-02-18 17:06:01.347131
NCT00227500|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2006-06-08|||July 2001||2001-07-01|June 2006|2006-06-01|October 2004||2004-10-01|||||Interventional|||Pravastatin for Hyperlipidaemia in HIV.|A Randomised, Double-Blind Study of Pravastatin for the Treatment of Hyperlipidaemia in Patients With HIV|Completed||Phase 4|40||Kirby Institute|||||f||||||||||||||2017-02-18 17:06:01.462124|2017-02-18 17:06:01.462124
NCT00227487|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-09-28|||October 2005||2005-10-01|September 2016|2016-09-01|December 2017|Anticipated|2017-12-01|May 2011|Actual|2011-05-01||Interventional|||Intestinal Inflammation and Carbohydrate Digestion in Autistic Children|The Evaluation of Intestinal Inflammation and Carbohydrate Digestion in Children With Autistic Spectrum Disorders|Active, not recruiting||N/A|115|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 17:06:01.574132|2017-02-18 17:06:01.574132
NCT00227474|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-01-23||||||January 2013|2013-01-01||||||||Interventional|||S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission|S0348: A Phase II Study of 5T4-Modified Vaccinia Ankara (MVA) Vaccine (TROVAX) in Patients With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||||SWOG has decided to not pursue this trial|f||||t||||||||||2017-02-18 17:06:01.684348|2017-02-18 17:06:01.684348
NCT00227461|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2015-03-31|||September 2005||2005-09-01|March 2015|2015-03-01|December 2016|Anticipated|2016-12-01|June 2016|Anticipated|2016-06-01||Interventional|||Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.|Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.|Active, not recruiting||Phase 1|50|Anticipated|Kessler Foundation||2|||f||||t||||||||||2017-02-18 17:06:01.770202|2017-02-18 17:06:01.770202
NCT00227448|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2008-04-01|||June 2003||2003-06-01|April 2008|2008-04-01|April 2005||2005-04-01|||||Interventional|||Induced Hypertension for Acute Ischemic Stroke|Induced Hypertension for Acute Ischemic Stroke|Completed||Phase 2|60||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:06:01.887248|2017-02-18 17:06:01.887248
NCT00227435|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-04-25|||February 2003||2003-02-01|April 2016|2016-04-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C|A Phase I/II Double-Blind, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Val-mCyd (NM283) in Adults With Chronic Hepatitis C|Completed||Phase 1/Phase 2|||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:06:01.987297|2017-02-18 17:06:01.987297
NCT00227422|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2016-09-20|||June 2005||2005-06-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs|A Phase IV, Partially Double-blind Study to Demonstrate Non-inferiority of GSK Biologicals' Mencevax™ ACWY (New Process) Versus Mencevax™ ACWY (Current Process) When Administered as a Single Dose to Subjects Aged 2-30 Yrs|Completed||Phase 4|324||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:06:02.080951|2017-02-18 17:06:02.080951
NCT00227409|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2006-10-17|||November 2001||2001-11-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency|Long-Term Repeated Lead Chelation Therapy in Non-Diabetic Patients With Chronic Renal Insufficiency and High-Normal Body Lead Burden|Completed||N/A|||Chang Gung Memorial Hospital|||||f||||||||||||||2017-02-18 17:06:02.18023|2017-02-18 17:06:02.18023
NCT00227383|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2007-01-19||||||September 2005|2005-09-01||||||||Interventional|||Effect of Electroacupuncture in Diabetic Patients With Gastroparesis||Unknown status|Not yet recruiting|Phase 3|30||China Medical University Hospital|||||f||||||||||||||2017-02-18 17:06:02.274624|2017-02-18 17:06:02.274624
NCT00227370|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-04-25|2013-01-24||July 2003||2003-07-01|April 2013|2013-04-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|Valgan||Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation|A Phase III, Randomized, Double-Blind Comparison of Oral Valganciclovir and Placebo for Prevention of CMV After Lung Transplantation|Completed||Phase 3|136|Actual|Duke University||2|||f||||||||||||||2017-02-18 17:06:02.367188|2017-02-18 17:06:02.367188
NCT00227357|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2010-06-04|||July 2005||2005-07-01|September 2005|2005-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|BUP||The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration|SPNS - An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Abuse Treatment in HIV Primary Care|Completed||N/A|101|Actual|Ruth M. Rothstein CORE Center|||2||f||||f||||||||||2017-02-18 17:06:03.320786|2017-02-18 17:06:03.320786
NCT00227344|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-03-10|2014-05-27||December 2004||2004-12-01|March 2016|2016-03-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|CACAF-2||CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation|Catheter Ablation for Cure of Atrial Fibrillation|Terminated||Phase 4|129|Actual|Biosense Webster, Inc.|The study was terminated early due to randomization imbalance. The relatively small number of subjects enrolled limited the amount of data available for analysis. Because the study did not reach its targeted enrollment, the study is underpowered.|2||Study prematurely terminated due to randomization imbalance.|f||||f||||||||||2017-02-18 17:06:03.670312|2017-02-18 17:06:03.670312
NCT00227331|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2006-05-02|||January 1998||1998-01-01|September 2005|2005-09-01|January 2000||2000-01-01|||||Interventional|||Equivalency Of Oral Amoxicillin Vs Injectable Penicillin In Children With Severe Pneumonia|A Randomized Multicentre Equivalency Study Of Oral Amoxicillin Versus Injectable Penicillin In Children Aged 3 To 59 Months With Severe Pneumonia|Completed||N/A|||Boston Medical Center|||||f||||||||||||||2017-02-18 17:06:04.22615|2017-02-18 17:06:04.22615
NCT00227318|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2011-08-29|||July 1998||1998-07-01|August 2011|2011-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial|A Randomized, Double-blind, Placebo-controlled, Multicenter, Long-term Trial of Preventing Hypertension Using Candesartan Cilexetil 16 mg in Patients With High Normal Blood Pressure (TROPHY)|Completed||Phase 3|1000||AstraZeneca|||||f||||||||||||||2017-02-18 17:06:04.326577|2017-02-18 17:06:04.326577
NCT00227305|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-27|2013-01-03|2008-12-22||August 2004||2004-08-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ANCHOR 150||Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder|A 26-week, Multicenter, Open-label Phase 3b Study of the Safety and Tolerability of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in Daily Doses of 400 mg to 800 mg in Children and Adolescents With Bipolar I Disorder and Adolescents With Schizophrenia (Abbreviated)|Completed||Phase 3|381|Actual|AstraZeneca|No comparator group, open label treatment, duration only 26 weeks - not long enough to assess full impact on growth and development|1|||f||||||||||||||2017-02-18 17:06:04.484171|2017-02-18 17:06:04.484171
NCT00227292|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2014-06-15|||November 2007||2007-11-01|June 2014|2014-06-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain|Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain|Withdrawn||Phase 4|0|Actual|Martin-Luther-Universität Halle-Wittenberg||2||Mutual agreement between Sponsor and Investigator.|f||||f||||||||||2017-02-18 17:06:04.959153|2017-02-18 17:06:04.959153
NCT00224965|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2017-01-11||||||September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Early Tobacco Abstinence - 5|Early Tobacco Abstinence in High Risk Smokers|Terminated||Phase 1|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:06:36.3294|2017-02-18 17:06:36.3294
NCT00227279|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-01-28|||October 2004||2004-10-01|January 2013|2013-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||A Trial of the ALK Grass Tablet in Subjects With Hayfever|A Randomized, Parallel-group, Double-blind, Placebo-controlled Phase III Trial Assessing the Efficacy and Safety of ALK Grass Tablet in Subjects With Seasonal Grass Pollen Induced Rhinoconjunctivitis|Completed||Phase 3|634|Actual|ALK-Abelló A/S||2|||f||||||||||||||2017-02-18 17:06:05.085013|2017-02-18 17:06:05.085013
NCT00227266|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2011-09-22|2010-03-19||September 2005||2005-09-01|September 2011|2011-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy|Multi-center Phase II Trial of Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (SMA CARNI-VAL Trial)|Completed||Phase 2|94|Actual|University of Utah||3|||f||||t||||||||||2017-02-18 17:06:05.192561|2017-02-18 17:06:05.192561
NCT00227253|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-09-26|||September 1993||1993-09-01|September 2016|2016-09-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|Chromosome18||Chromosome 18 Clinical Research Center|The Chromosome 18 Clinical Research Center|Recruiting||N/A|1000|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples With DNA|"~     blood specimens are collected from study participant and both biological parents if~     available and are processed for DNA and to establish cell lines~   "|||2017-02-18 17:06:06.283008|2017-02-18 17:06:06.283008
NCT00227240|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-20|||April 2005||2005-04-01|March 2012|2012-03-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis|Observational Study With Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis|Completed||N/A|753|Actual|Pfizer|||1||f||||||||||||||2017-02-18 17:06:06.482119|2017-02-18 17:06:06.482119
NCT00227227|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-07|||May 2004||2004-05-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Observational|||Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis|Observational Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis|Completed||N/A|750|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:06:06.571455|2017-02-18 17:06:06.571455
NCT00227214|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-24|||January 2004||2004-01-01|June 2010|2010-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.|Prevalence of Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.|Completed||N/A|160|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 17:06:06.649197|2017-02-18 17:06:06.649197
NCT00227201|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-04-23|||June 2003||2003-06-01|April 2008|2008-04-01|May 2005||2005-05-01|||||Observational|||The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans|The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans|Completed||N/A|60||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:06:06.758036|2017-02-18 17:06:06.758036
NCT00227188|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-28|||May 2003||2003-05-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.|Effectiveness of Prevnar in the Prevention on IPD in the Paediatric Population in Spain|Completed||N/A|408|Actual|Pfizer|||1||f||||f||||||Samples Without DNA|"~     Samples without DNA~   "|||2017-02-18 17:06:06.852931|2017-02-18 17:06:06.852931
NCT00227175|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-03-31|||April 2003||2003-04-01|March 2008|2008-03-01|September 2003||2003-09-01|||||Observational|||Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study|Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study|Completed||N/A|60||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 17:06:06.947759|2017-02-18 17:06:06.947759
NCT00227162|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-04-09|||February 2004||2004-02-01|April 2008|2008-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Pilot Study of Changing Exercise and Physical Activity Behavior in Asthma Patients|Pilot Study of Changing Exercise and Physical Activity Behavior in Asthma Patients|Completed||N/A|40|Actual|Weill Medical College of Cornell University||4|||f||||t||||||||||2017-02-18 17:06:07.039493|2017-02-18 17:06:07.039493
NCT00227149|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2009-02-03|||July 2005||2005-07-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|||||Observational|||Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C|Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C Infection and a Former (Peg)Interferon Alfa-2b-Based Therapy|Completed||N/A|197|Actual|University of Wuerzburg|||1||f||||f||||||||||2017-02-18 17:06:07.150311|2017-02-18 17:06:07.150311
NCT00227136|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2006-07-11|||May 2005||2005-05-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion|Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion|Terminated||Phase 3|8||University of Western Ontario, Canada|||||f||||||||||||||2017-02-18 17:06:07.241848|2017-02-18 17:06:07.241848
NCT00227123|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-01-03|||October 2002||2002-10-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence|A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder Outpatients With Current Stimulant Dependence|Completed||N/A|96|Actual|University of Texas Southwestern Medical Center||1|||f||||f||||||||||2017-02-18 17:06:10.104278|2017-02-18 17:06:10.104278
NCT00227110|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2009-10-12|||October 2002||2002-10-01|October 2009|2009-10-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)|Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)|Completed||Phase 4|55|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-02-18 17:06:10.231334|2017-02-18 17:06:10.231334
NCT00227097|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2006-07-06|||December 2002||2002-12-01|July 2006|2006-07-01|December 2004||2004-12-01|||||Observational|||Educ'Avk: Recommendations for the Antivitamin K's Gestion|Implication of Patient in the Making Ready of Recommendations for the Antivitamin K's Gestion in Case of Thrombosis Embolic Venous's Illness. Randomised Study for Clinical Validation.|Terminated||Phase 3|300||University Hospital, Grenoble|||||f||||||||||||||2017-02-18 17:06:10.352055|2017-02-18 17:06:10.352055
NCT00227084|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2007-08-24|||September 2005||2005-09-01|August 2007|2007-08-01|October 2006|Actual|2006-10-01|||||Interventional|||Effect of Arista Powder on Bleeding in Reductive Mammary Surgery|Effect of Arista AH-Haemostatic Powder in Plastic Surgery. A Prospective, Consecutive Randomized Study in 30 Women Undergoing Reduction of Both Mamma|Completed||Phase 2|30||University of Oslo|||||f||||t||||||||||2017-02-18 17:06:10.444279|2017-02-18 17:06:10.444279
NCT00227058|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2007-01-24|||January 2005||2005-01-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis|Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic|Completed||N/A|100||University of Mississippi Medical Center|||||f||||||||||||||2017-02-18 17:06:10.628239|2017-02-18 17:06:10.628239
NCT00227045|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2007-04-19|||October 2003||2003-10-01|April 2007|2007-04-01||||||||Observational|||CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients|The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction: A Two Phase Pharmacokinetic Study in Renal Allograft Recipients at the University of Michigan Transplant Program|Completed||N/A|20||University of Michigan|||||f||||||||||||||2017-02-18 17:06:10.723373|2017-02-18 17:06:10.723373
NCT00227032|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2012-03-05|||September 2005||2005-09-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme|Phase I Study of Erlotinib Administered Every 72 Hours in Patients With Glioblastoma Multiforme With Pharmacokinetic/Pharmacodynamic Correlates|Terminated||Phase 1|10|Actual|UNC Lineberger Comprehensive Cancer Center||2||Loss of funding|f||||t||||||||||2017-02-18 17:06:10.825971|2017-02-18 17:06:10.825971
NCT00227019|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-21|||March 2006||2006-03-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Phase II Trial of Bevacizumab in Combination With Pemetrexed as 2nd Line Therapy in Patients With Stable Brain Metastases From Non-small Cell Lung Cancer|Phase II Trial of Bevacizumab in Combination With Pemetrexed as Second Line Therapy in Patients With Stable Brain Metastases From Non-small Cell Lung Cancer (NSCLC)(Excluding Squamous Cell Carcinoma)|Active, not recruiting||Phase 2|40|Anticipated|Stanford University||1|||f||||t||||||||||2017-02-18 17:06:10.937425|2017-02-18 17:06:10.937425
NCT00227006|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-18|||January 1999||1999-01-01|May 2015|2015-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Promoting Long-term Behavior Change to Reduce CVD Risk|Promoting Long-term Dietary Change to Reduce CVD Risk|Completed||N/A|163|Actual|Stanford University||3|||f||||||||||||||2017-02-18 17:06:11.05908|2017-02-18 17:06:11.05908
NCT00226993|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-29|||March 2005||2005-03-01|November 2016|2016-11-01||||December 2006|Anticipated|2006-12-01||Interventional|||Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.|Phase I/II Study of Intratumoral Injection of CPG 7909, A TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides|Withdrawn||Phase 1/Phase 2|0|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:06:11.172215|2017-02-18 17:06:11.172215
NCT00226980|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-10|||October 2002||2002-10-01|April 2009|2009-04-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma|A Phase II Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma|Completed||Phase 2|30|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:06:11.496977|2017-02-18 17:06:11.496977
NCT00226967|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-09|||September 2002||2002-09-01|November 2012|2012-11-01|December 2012|Anticipated|2012-12-01|November 2004|Actual|2004-11-01||Observational|||Stress, Diurnal Cortisol, and Breast Cancer Survival|Stress, Diurnal Cortisol, and Breast Cancer Survival|Unknown status|Active, not recruiting|N/A|115|Anticipated|Stanford University|||1||f||||t||||||Samples Without DNA|"~     Saliva~   "|||2017-02-18 17:06:11.604823|2017-02-18 17:06:11.604823
NCT00226954|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-07-27|||March 2003||2003-03-01|July 2009|2009-07-01|February 2009|Actual|2009-02-01|November 2007|Actual|2007-11-01||Interventional|||Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer|Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer|Completed||Phase 2|30|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:06:11.716575|2017-02-18 17:06:11.716575
NCT00226941|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-11-06|||June 2004||2004-06-01|July 2010|2010-07-01|February 2009|Actual|2009-02-01|March 2008|Actual|2008-03-01||Interventional|||Safety Study of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer|A Phase I/II Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgical Resection for Locally-Advanced Rectal Cancer|Completed||Phase 1/Phase 2|23|Actual|Stanford University||4|||f||||||||||||||2017-02-18 17:06:11.829285|2017-02-18 17:06:11.829285
NCT00226928|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-02||||||December 2013|2013-12-01|July 2005|Actual|2005-07-01|||||Interventional|||Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer|Psychosocial Treatment Effects on Cancer Survival|Completed||N/A|125|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 17:06:11.949963|2017-02-18 17:06:11.949963
NCT00226915|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2012-04-02|||April 2003||2003-04-01|April 2012|2012-04-01|June 2012|Anticipated|2012-06-01|June 2012|Anticipated|2012-06-01||Interventional|||Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma|Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense Weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma|Unknown status|Active, not recruiting|Phase 3|637|Actual|Japanese Gynecologic Oncology Group||2|||f||||t||||||||||2017-02-18 17:06:12.049661|2017-02-18 17:06:12.049661
NCT00226902|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2015-05-04|||September 2006||2006-09-01|May 2015|2015-05-01|September 2013|Actual|2013-09-01|August 2013|Actual|2013-08-01||Interventional|||Vascular Reactivity in Kidney Disease Patients|Integrated Studies in Vascular Reactivity and Anaemia Correction Therapy in Endstage Kidney Disease Patients|Completed||N/A|15||Melbourne Health|||||f||||f||||||||||2017-02-18 17:06:12.190428|2017-02-18 17:06:12.190428
NCT00226889|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2009-06-11|||January 2005||2005-01-01|March 2006|2006-03-01|June 2009||2009-06-01|January 2009||2009-01-01||Interventional|TRANOS||Treatment of Early Systemic Sclerosis by Bosentan||Terminated||Phase 1/Phase 2|30|Anticipated|Rikshospitalet University Hospital||||failure of recruiting a sufficient number of patients|f||||||||||||||2017-02-18 17:06:12.281656|2017-02-18 17:06:12.281656
NCT00226876|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2013-05-28|||February 2005||2005-02-01|September 2005|2005-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||Dreaming During Anaesthesia and Anaesthetic Depth|Dreaming During Anaesthesia and Anaesthetic Depth|Completed||N/A|300|Actual|Melbourne Health|||1||f||||f||||||||||2017-02-18 17:06:12.386341|2017-02-18 17:06:12.386341
NCT00226863|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-23||||||September 2005|2005-09-01||||||||Interventional|||Meditation and Hypnosis for Chronic Depressed Mood||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-02-18 17:06:12.477631|2017-02-18 17:06:12.477631
NCT00226850|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-23||||||September 2005|2005-09-01||||||||Interventional|||Using Hypnosis to Help Children Undergoing a Difficult Medical Procedure||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-02-18 17:06:12.543267|2017-02-18 17:06:12.543267
NCT00226837|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2009-02-03|||August 2004||2004-08-01|February 2009|2009-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Quantifying Nitrous Oxide Effect on Depth of Anaesthesia Using Theoretically Based Time Series Modelling|Quantifying Nitrous Oxide Effect on Depth of Anaesthesia Using Theoretically Based Time Series Modelling|Completed||Phase 4|60|Actual|Melbourne Health||3|||f||||f||||||||||2017-02-18 17:06:12.632382|2017-02-18 17:06:12.632382
NCT00226824|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2009-08-21|||September 2005||2005-09-01|August 2009|2009-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety Study of Galantamine in Tic Disorders|Pilot Examination of Galantamine in the Management of Tic Disorders|Terminated||Phase 4|1|Actual|Parkinson's Disease and Movement Disorders Center||1||Unable to recruit subjects into the trial.|f||||||||||||||2017-02-18 17:06:12.740155|2017-02-18 17:06:12.740155
NCT00226811|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2015-03-10|2009-05-14||January 2006||2006-01-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy|An Open Label International Multi-Center Phase 2 Activity And Safety Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Progressing Or Recurring After One Prior Chemotherapy|Completed||Phase 2|78|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:06:12.840797|2017-02-18 17:06:12.840797
NCT00226798|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2005-12-31|||December 2003||2003-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Immunochemotherapy for Metastatic Renal Cell Carcinoma|Interleukin-2, Interferon Alpha,Capecitabine and Vinblastin for Treatment of Metastatic Renal Cell Carcinoma: A Multicenter Study|Unknown status|Recruiting|Phase 2|45||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:06:13.490957|2017-02-18 17:06:13.490957
NCT00226785|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2006-11-10|||October 2005||2005-10-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||Dexmedetomidine for Continuous Sedation|A Prospective, Multi-Centre, Randomised, Double-Blind Comparison of Intravenous Dexmedetomidine With Propofol/Midazolam for Continuous Sedation (24 Hours to 14 Days) of Ventilated Patients in Intensive Care Unit|Terminated||Phase 3|900||Orion Corporation, Orion Pharma|||||f||||||||||||||2017-02-18 17:06:13.587314|2017-02-18 17:06:13.587314
NCT00226772|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2012-10-10||2012-10-10|June 2005||2005-06-01|October 2012|2012-10-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction|Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Autograft ACL Reconstruction|Completed||Phase 3|326|Actual|Omeros Corporation||2|||f||||f||||||||||2017-02-18 17:06:13.684364|2017-02-18 17:06:13.684364
NCT00226759|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2012-10-10||2012-10-10|November 2004||2004-11-01|October 2012|2012-10-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Interventional|||Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction|Double-Blind, Multicenter Phase 3 Study Comparing the Efficacy and Safety of OMS103HP With Vehicle in Patients Undergoing Allograft ACL Reconstruction|Completed||Phase 3|321|Actual|Omeros Corporation||2|||f||||f||||||||||2017-02-18 17:06:13.82361|2017-02-18 17:06:13.82361
NCT00226746|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2007-03-20|||March 2003||2003-03-01|September 2006|2006-09-01|December 2010||2010-12-01|||||Interventional|||Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer|A Multicenter Phase II Trial of Weekly Gemcitabine, Paclitaxel, and Hyperfractionated External Irradiation (63.80 GY) for Locally Advanced Pancreatic Cancer|Unknown status|Recruiting|Phase 2|70||New York Methodist Hospital|||||f||||||||||||||2017-02-18 17:06:13.94903|2017-02-18 17:06:13.94903
NCT00226733|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-05-17|||March 2004||2004-03-01|April 2008|2008-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Training Intensity After Coronary Bypass Grafting|Training Intensity After Coronary Bypass Grafting|Terminated||Phase 2|60||Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:06:14.054761|2017-02-18 17:06:14.054761
NCT00226720|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-05-05|||September 2002||2002-09-01|April 2007|2007-04-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Outpatient Versus Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence: The IN/OUT Study|Comparison of Efficacy of an Outpatient vs Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence. A Prospective Randomized Clinical Trial.|Completed||N/A|500|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 17:06:14.166773|2017-02-18 17:06:14.166773
NCT00226707|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-26|2008-02-13|||July 2004||2004-07-01|February 2008|2008-02-01|March 2005|Actual|2005-03-01|||||Interventional|||Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis|A 6-Week Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Pimecrolimus Cream 1% in Patients With Mild-to-Moderate Chronic Hand Dermatitis Followed by a 6-Week Open-Label Phase to Assess the Safety of Pimecrolimus Cream 1%|Completed||Phase 3|652||Novartis|||||||||||||||||||2017-02-18 17:06:14.291866|2017-02-18 17:06:14.291866
NCT00226694|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2014-01-03|||September 2003||2003-09-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|||Alcohol and Gender Effects on Stress Circuit Function|Alcohol and Gender Effects on Stress Circuit Function|Completed||N/A|96|Actual|University of Cincinnati||2|||f||||||||||||||2017-02-18 17:06:14.384802|2017-02-18 17:06:14.384802
NCT00226681|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-09-09|||September 1999||1999-09-01|September 2008|2008-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Nurses Helping Sudden Cardiac Arrest Survivors Recover After Getting An Implantable Cardioverter Defibrillator (ICD)|Nursing Interventions Following Sudden Cardiac Arrest|Completed||Phase 1|150|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-02-18 17:06:14.50745|2017-02-18 17:06:14.50745
NCT00226668|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2007-12-27|||January 2006||2006-01-01|December 2007|2007-12-01|January 2008|Anticipated|2008-01-01|||||Interventional|||XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema|A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Primary Malignant Glioma|Withdrawn||Phase 3|120|Anticipated|Celtic Pharma Development Services||2||Alternate study projected to assess imaging endpoints versus clinical endpoints.|f||||t||||||||||2017-02-18 17:06:14.624684|2017-02-18 17:06:14.624684
NCT00226655|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2012-07-31|2012-07-31||July 2005||2005-07-01|July 2012|2012-07-01|April 2009|Actual|2009-04-01|March 2009|Actual|2009-03-01||Interventional|||An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies|An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302, NTI 0303, or Other Designated Studies|Completed||Phase 3|112|Actual|Celtic Pharma Development Services||1|||f||||t||||||||||2017-02-18 17:06:14.785464|2017-02-18 17:06:14.785464
NCT00226642|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2005-09-23||||||February 2002|2002-02-01||||||||Interventional|||Treatment of Mild and Subthreshold Depressive Disorders|"Behandlung Von Leichten Und Unterschwelligen Depressionen. Eine Randomisierte, Kontrollierte Studie Zum Wirksamkeitsnachweis Eines Serotonin-Wiederaufnahme-Hemmers (SSRI), Einer Kognitiven Verhaltenstherapie Und Einer Freien Therapiewahl (Treatment of Mild and Subthreshold Depressive Disorders. A Randomized, Controlled Trial on the Efficacy of a Serotonin-Reuptake-Inhibitor (SSRI), a Cognitive-Behavioral Therapy and of Free Choice Between SSRI and CBT)"|Unknown status|Active, not recruiting|Phase 4|369||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 17:06:15.266064|2017-02-18 17:06:15.266064
NCT00226629|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2006-04-24|||August 2003||2003-08-01|April 2006|2006-04-01|August 2007||2007-08-01|||||Interventional|||Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC|Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC|Completed||N/A|130||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 17:06:15.359034|2017-02-18 17:06:15.359034
NCT00226616|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-25|2005-10-19|||November 2000||2000-11-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Interventional|||Zinc Supplementation in Cholera Patients|Clinical Trial of Zinc Supplementation in Cholera Patients|Completed||Phase 3|||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 17:06:15.429227|2017-02-18 17:06:15.429227
NCT00226603|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2005-09-26|||September 1997||1997-09-01|June 1998|1998-06-01|June 1998||1998-06-01|||||Interventional|||Lyske Trial (Danish) Groin Trial|Prevention of Groin Injuries in Football Players|Unknown status|Active, not recruiting|Phase 2/Phase 3|1600||Hölmich, Per, M.D.|||||f||||||||||||||2017-02-18 17:06:15.535304|2017-02-18 17:06:15.535304
NCT00226590|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2013-12-13|2011-03-11||April 2003||2003-04-01|May 2011|2011-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC|Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Paclitaxel and Carboplatin With Concurrent Thoracic Radiation for Patients With Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer|Completed||Phase 2|39|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 17:06:15.621621|2017-02-18 17:06:15.621621
NCT00226577|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2013-12-13|2010-10-26||February 2004||2004-02-01|January 2011|2011-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.|Phase II Study of Neoadjuvant Chemotherapy With Gemcitabine and Pemetrexed in Resectable Non-Small-Cell Lung Cancer (NSCLC) With Pharmacogenomic Correlates.|Completed||Phase 2|52|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 17:06:16.112639|2017-02-18 17:06:16.112639
NCT00226564|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-28|||August 1997||1997-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of Opioids Analgesia|The Effect of mu Opioid Receptor Polymorphism on the Response to Alfentanil During Lithotripsy|Completed||N/A|100||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:06:16.408805|2017-02-18 17:06:16.408805
NCT00226551|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-28|||August 1999||1999-08-01|October 2008|2008-10-01||||||||Interventional|||Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms|ß2 Adrenergic Receptor Polymorphisms and Vasodilation of Internal Mammary Artery Induced by Isoproterenol|Completed||N/A|100||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:06:16.493732|2017-02-18 17:06:16.493732
NCT00226538|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-28|||August 1999||1999-08-01|October 2008|2008-10-01||||||||Interventional|||Prediction of Drug Interactions With CYP2C9 Substrates|Prediction of Potential Drug Interaction With CYP2C9 Substrate by Using Phenytoin Metabolic Ratio as a Marker of Its Activity in-Vivo.|Completed||N/A|16||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:06:16.598168|2017-02-18 17:06:16.598168
NCT00225823|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2016-09-13|||May 2005||2005-05-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study In Adults And Adolescents With Seasonal Allergic Rhinitis.|A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Two Week Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis in Europe|Completed||Phase 3|288|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:06:16.680631|2017-02-18 17:06:16.680631
NCT00225810|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2011-05-18|||October 2005||2005-10-01|May 2011|2011-05-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease|Multicentre, Controlled, Randomised, Open, Cross-over Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tbl. 500 mg in Children With Crohn´s Disease|Completed||Phase 4|50|Actual|Ferring Pharmaceuticals|||||f||||f||||||||||2017-02-18 17:06:16.810413|2017-02-18 17:06:16.810413
NCT00225797|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2010-02-12|||November 2004||2004-11-01|February 2010|2010-02-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain|An Open-Label Titration Followed by a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Tolerability, and Safety of Oxymorphone Extended Release Tablets in Opioid-Naïve Patients With Chronic Low Back Pain|Completed||Phase 3|160||Endo Pharmaceuticals|||||||||||||||||||2017-02-18 17:06:16.902812|2017-02-18 17:06:16.902812
NCT00225784|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2014-07-10|2012-08-22||February 2005||2005-02-01|October 2011|2011-10-01|September 2012|Actual|2012-09-01|February 2010|Actual|2010-02-01||Interventional|||Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer|A Phase II Trial of Cetuximab, Radiotherapy and Twice Weekly Gemcitabine in Patients With Adenocarcinoma of the Pancreas|Completed||Phase 2|37|Actual|Dartmouth-Hitchcock Medical Center|Our study suffers limitations common to single institution trials, namely small patient numbers and selection bias. Our cohort of subjects is too small to adequately assess the effect of tumor EGFR and KRAS status on outcome.|1|||f||||t||||||||||2017-02-18 17:06:17.043431|2017-02-18 17:06:17.043431
NCT00225758|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2015-01-12|||January 2006||2006-01-01|August 2013|2013-08-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy|Lapatinib in Endocrine-Resistant Metastatic Breast Cancer|Terminated||Phase 2|27|Actual|Dartmouth-Hitchcock Medical Center||1||slow accrual|f||||t||||||||||2017-02-18 17:06:17.344569|2017-02-18 17:06:17.344569
NCT00225745|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2015-10-12|||April 2004||2004-04-01|August 2015|2015-08-01|September 2015|Actual|2015-09-01|October 2013|Actual|2013-10-01||Observational|||Ghrelin Levels in Pancreatic Cancer Patients|Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer|Completed||N/A|72|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||t||||||Samples Without DNA|"~     Whole Blood~   "|||2017-02-18 17:06:17.465769|2017-02-18 17:06:17.465769
NCT00225732|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2016-05-17|2011-04-01||January 2005||2005-01-01|May 2016|2016-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Injection (IVIb) for Treatment of Pain in the Post-Operative Adult Patients|Completed||Phase 3|319|Actual|Cumberland Pharmaceuticals||2|||f||||t||||||||||2017-02-18 17:06:17.571012|2017-02-18 17:06:17.571012
NCT00225719|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-11-06|||July 2005||2005-07-01|November 2008|2008-11-01||||||||Interventional|||Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL|Regression of Coronary Atherosclerotic Lesions After rHDL Infusions in Acute Coronary Syndrome Patients as Assessed by Intravascular Ultrasound.|Completed||Phase 2|180|Anticipated|CSL Limited|||||f||||||||||||||2017-02-18 17:06:18.096763|2017-02-18 17:06:18.096763
NCT00225706|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2010-04-08|||October 2005||2005-10-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of Caldolor in Hospitalized Febrile Pediatric Patients|Efficacy and Safety Study of Caldolor in Hospitalized Febrile Pediatric Patients|Completed||Phase 3|||Cumberland Pharmaceuticals|||||||||||||||||||2017-02-18 17:06:18.184202|2017-02-18 17:06:18.184202
NCT00225693|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-01-30|||October 2003||2003-10-01|January 2012|2012-01-01|July 2005||2005-07-01|||||Interventional|ELUTES III||V-Flex Plus PTX Drug Eluting Coronary Stent|ELUTES III - V-Flex Plus PTX Drug Eluting Coronary Stent|Completed||N/A|150||Cook|||||f||||||||||||||2017-02-18 17:06:18.270388|2017-02-18 17:06:18.270388
NCT00226525|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-10|2006-11-06|||February 2005||2005-02-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Effect of Metal Skin Sensitivity on Restenosis After Stent Implantation|Rate of Metal Skin Allergy in Cohorts of Patients With and Without Coronary Stent Restenosis|Unknown status|Active, not recruiting|N/A|150||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:06:18.372402|2017-02-18 17:06:18.372402
NCT00226512|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-07|||July 2004||2004-07-01|September 2005|2005-09-01||||||||Interventional|||To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning|Phase III Trial of a Non-myeloablative Preparative Regimen With Fludarabine and Busulfan With or Without Anti-lymphocyte Antibodies (Campath-1H or ATG) for Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation From an HLA Compatible Donor|Withdrawn||Phase 3|203|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-02-18 17:06:18.45181|2017-02-18 17:06:18.45181
NCT00226499|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2015-01-12||2014-11-24|September 2005||2005-09-01|January 2015|2015-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox|Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine|Completed||Phase 3|5735|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 17:06:18.540834|2017-02-18 17:06:18.540834
NCT00226486|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-08-20|||September 2005||2005-09-01|August 2008|2008-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Examination and Treatment of Elderly After a Fall|Examination and Treatment of Elderly After a Fall- an Analysis in a Medical Technology Evaluation Perspective|Completed||N/A|392|Actual|Glostrup University Hospital, Copenhagen||2|||f||||||||||||||2017-02-18 17:06:18.792891|2017-02-18 17:06:18.792891
NCT00226473|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-25|2006-06-20|||September 2001||2001-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma|Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy (CVD-Protocol) in the Second-Line Therapy of Distant Metastasized Malignant Melanoma|Unknown status|Recruiting|Phase 4|200||Dermatologic Cooperative Oncology Group|||||f||||||||||||||2017-02-18 17:06:18.884811|2017-02-18 17:06:18.884811
NCT00226460|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2015-03-17|||August 1997||1997-08-01|March 2015|2015-03-01|January 2001||2001-01-01|||||Interventional|||Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.||Completed||Phase 2|||Sanofi|||||||||||||||||||2017-02-18 17:06:19.229318|2017-02-18 17:06:19.229318
NCT00226447|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-10-23|||December 2002||2002-12-01|October 2008|2008-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients|A Study on the Viral Kinetics of Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in HBeAg Positive Chronic Hepatitis B|Completed||Phase 2|30||Chinese University of Hong Kong||3|||f||||||||||||||2017-02-18 17:06:19.311991|2017-02-18 17:06:19.311991
NCT00226434|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2012-03-15|||January 2006||2006-01-01|March 2012|2012-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)|Early vs Late Introduction of Antiretroviral Therapy in Naive HIV-infected Patients With Tuberculosis in Cambodia|Completed||Phase 3|661|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 17:06:19.419888|2017-02-18 17:06:19.419888
NCT00226421|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2010-02-12|||October 2004||2004-10-01|February 2010|2010-02-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain|An Open-Label Titration Followed by a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Tolerability, and Safety of Oxymorphone Extended Release Tablets in Opioid-Experienced Patients With Chronic Low Back Pain|Completed||Phase 3|120||Endo Pharmaceuticals|||||||||||||||||||2017-02-18 17:06:19.5419|2017-02-18 17:06:19.5419
NCT00226408|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-25|2006-06-20|||November 2003||2003-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon|Randomized, Multicenter Study for Adjuvant Treatment of Stage III Malignant Melanoma: Intermittent, High-Dose Intravenous Interferon Alpha-2b Versus Standard High-Dose Interferon Alpha-2b Therapy|Unknown status|Recruiting|Phase 3|600||Dermatologic Cooperative Oncology Group|||||f||||||||||||||2017-02-18 17:06:19.667768|2017-02-18 17:06:19.667768
NCT00226395|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2010-02-12|||September 2004||2004-09-01|February 2010|2010-02-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain|Randomized, Double-Blind, Placebo- and Active-Control, Single- and Multiple-Dose Evaluation of the Analgesic Efficacy and Safety of Oxymorphone Immediate Release (IR) Tablets in Patients With Moderate/Severe Pain Following Abdominal Surgery|Completed||Phase 3|320||Endo Pharmaceuticals|||||||||||||||||||2017-02-18 17:06:19.783996|2017-02-18 17:06:19.783996
NCT00226382|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2010-06-10|||January 2005||2005-01-01|October 2008|2008-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment|Treatment With Peginterferon Alfa-2a (40 KD) (PEGASYS®) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment. A Pilot Study.|Completed||Phase 4|50|Actual|Chinese University of Hong Kong||1|||f||||f||||||||||2017-02-18 17:06:19.904742|2017-02-18 17:06:19.904742
NCT00226369|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2010-02-11|||December 1997||1997-12-01|September 2005|2005-09-01|June 2001||2001-06-01|||||Interventional|||Cylexin for Reduction of Reperfusion Injury in Infant Heart Surgery|Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy/Safety of CY-1503 (Cylexin) in Prevention of Reperfusion Injury in Neonates/Infants Undergoing Hypothermic Cardiopulmonary Bypass|Completed||Phase 2/Phase 3|242||Boston Children’s Hospital|||||||||||||||||||2017-02-18 17:06:20.013556|2017-02-18 17:06:20.013556
NCT00226356|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-19|||December 2004||2004-12-01|October 2006|2006-10-01|September 2005||2005-09-01|||||Interventional|||Natural Supplements for Unipolar Depression|Phase 4 Study: An Open Study of the Efficacy and Tolerability in Unipolar Depression of Augmentation of the One-Carbon Cycle With L-Methionine, Betaine and Folate|Unknown status|Recruiting|Phase 4|20||Cambridge Health Alliance|||||f||||||||||||||2017-02-18 17:06:20.102656|2017-02-18 17:06:20.102656
NCT00226343|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-04-13|||August 2003||2003-08-01|April 2006|2006-04-01|September 2005||2005-09-01|||||Interventional|||Depakote-ER for Depressive and Bipolar Depression|Phase 4 Study: Double-Blind Placebo-Controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-Refractory Bipolar Depression|Unknown status|Active, not recruiting|Phase 4|25||Cambridge Health Alliance|||||||||||||||||||2017-02-18 17:06:20.197315|2017-02-18 17:06:20.197315
NCT00226330|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2010-11-18|||March 2005||2005-03-01|November 2010|2010-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus|A Double-Blind, Multi-Centre, Active-Controlled (15, 30, and 45 mg Pioglitazone) Long-Term Extension Study to Evaluate the Safety and Tolerability of Tesaglitazar (0.5 and 1 mg) in Patients With Type 2 Diabetes Mellitus (GALLEX 6)|Terminated||Phase 3|1100||AstraZeneca||||The development program has been terminated|||||||||||||||2017-02-18 17:06:20.293786|2017-02-18 17:06:20.293786
NCT00226317|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-17|||April 2004||2004-04-01|June 2008|2008-06-01|March 2007||2007-03-01|||||Interventional|||Aripiprazole in the Treatment of Bipolar Depression|Phase 4 Study: An Open Prospective Study of the Safety and Effectiveness of Aripiprazole in the Treatment of Bipolar Depression|Unknown status|Active, not recruiting|N/A|20||Cambridge Health Alliance|||||||||||||||||||2017-02-18 17:06:20.567362|2017-02-18 17:06:20.567362
NCT00226304|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2017-01-24|||September 20, 2005||2005-09-20|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Observational|||Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma|The Evaluation of Focal Contrast-Enhancing Brain Lesions in HIV-Infected Patients|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:06:20.665754|2017-02-18 17:06:20.665754
NCT00226291|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2014-05-27|||August 2004||2004-08-01|May 2014|2014-05-01|May 2007|Actual|2007-05-01|February 2006|Actual|2006-02-01||Interventional|||The Clinical Informationist: Does the Model Work|The Clinical Informationist: Does the Model Work|Completed||N/A|299|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:06:20.746515|2017-02-18 17:06:20.746515
NCT00226278|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2008-03-28|||September 2004||2004-09-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety Study of ORG 34517 for Major Depression With Psychotic Features|"Prospective, Double Blind, Randomized, Placebo-Controlled Dose Finding Study of the Efficacy and Safety of 2 Target Doses of Org 34517 Used as Adjunct"|Completed||Phase 2|25|Anticipated|Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:06:20.861685|2017-02-18 17:06:20.861685
NCT00226265|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-03-31|||January 2000||2000-01-01|March 2008|2008-03-01|September 2007|Anticipated|2007-09-01|||||Observational|||The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients|The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients|Unknown status|Active, not recruiting|N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 17:06:20.941814|2017-02-18 17:06:20.941814
NCT00226252|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2013-03-11|||December 2003||2003-12-01|March 2013|2013-03-01|November 2012|Actual|2012-11-01|March 2008|Actual|2008-03-01||Interventional|||Manual Wheelchair Propulsion Training|Manual Wheelchair Propulsion Training|Completed||N/A|28|Actual|VA Pittsburgh Healthcare System||3|||f||||f||||||||||2017-02-18 17:06:21.030718|2017-02-18 17:06:21.030718
NCT00226239|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2013-07-23|||October 2005||2005-10-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer|A Phase II Trial of Docetaxel, Cetuximab (C225), and Cisplatin Followed by Radiation, Cetuximab, and Cisplatin in Locally Advanced Head and Neck Cancer|Completed||Phase 2|39|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 17:06:21.142973|2017-02-18 17:06:21.142973
NCT00226226|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2008-02-10|||June 2006||2006-06-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|||||Interventional|||Peripherally Inserted Central Catheter Placement by IV Team Nurses Using the Sonic Flashlight|Peripherally Inserted Central Catheter Placement by IV Team Nurses Using the Sonic Flashlight|Completed||Phase 1|230|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:06:21.256489|2017-02-18 17:06:21.256489
NCT00226213|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2007-12-11|||February 2005||2005-02-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Peripherally Inserted Central Catheter Placement by Interventional Radiologists Using the Sonic Flashlight|Peripherally Inserted Central Catheter Placement by Interventional Radiologists Using the Sonic Flashlight|Completed||Phase 1|20|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:06:21.347289|2017-02-18 17:06:21.347289
NCT00226200|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2008-11-26|||November 2004||2004-11-01|November 2008|2008-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Soluble CD23 Expression in Asthma Patients Treated With OMA|Soluble CD23 Expression as a Marker of Immunomodulation and CLinical Response in Asthma Patients Treated With Omalizumab|Terminated||N/A|80||University of Mississippi Medical Center||||Completed|||||t||||||||||2017-02-18 17:06:21.432159|2017-02-18 17:06:21.432159
NCT00226187|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2007-02-14|||December 2003||2003-12-01|September 2005|2005-09-01||||||||Interventional|||A Randomized Clinical Trial on Supplementation of DHA and AA to Preterm Infants||Completed||N/A|140||University of Oslo|||||f||||||||||||||2017-02-18 17:06:21.531179|2017-02-18 17:06:21.531179
NCT00226174|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2005-09-22|||February 2003||2003-02-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||A Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Curcuminoids in Oral Lichen Planus|A Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Curcuminoids in Oral Lichen Planus|Terminated||Phase 2|||University of California, San Francisco|||||||||||||||||||2017-02-18 17:06:21.616581|2017-02-18 17:06:21.616581
NCT00226161|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2013-01-25|||September 2005||2005-09-01|September 2005|2005-09-01|September 2013||2013-09-01|September 2013||2013-09-01||Interventional|||Chronic Pain After Inguinal Herniorrhaphy||Terminated||N/A|||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 17:06:21.705805|2017-02-18 17:06:21.705805
NCT00226148|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2009-09-08|||September 2005||2005-09-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Immediate Implant Placement in the Molar Regions|Immediate Implant Placement in the Molar Regions|Completed||Early Phase 1|92|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:06:21.789922|2017-02-18 17:06:21.789922
NCT00226135|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2007-04-04|||March 2001||2001-03-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder|Lamotrigine Versus Lithium in Subjects With Bipolar Affective Disorders - a Randomised Study of Prophylactic Effect|Completed||Phase 3|150||University of Aarhus|||||f||||f||||||||||2017-02-18 17:06:21.885489|2017-02-18 17:06:21.885489
NCT00226122|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2010-06-24|||January 2003||2003-01-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal|The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal|Completed||Phase 4|56|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:06:21.982045|2017-02-18 17:06:21.982045
NCT00226109|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2010-10-19|||April 2004||2004-04-01|October 2010|2010-10-01|December 2011|Anticipated|2011-12-01|August 2011|Anticipated|2011-08-01||Interventional|SPICA||Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics|Effect of Spironolactone Treatment on Heart- and Skeletal Muscle in Chronic Alcoholics|Suspended||Phase 4|40|Anticipated|University of Aarhus||1||Problems recruting patients|f||||t||||||||||2017-02-18 17:06:22.086309|2017-02-18 17:06:22.086309
NCT00226096|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2008-06-25|||November 2005||2005-11-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage|A Randomised Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients With Stroke Due to Acute Intracerebral Haemorrhage|Completed||N/A|404|Actual|The George Institute||1|||f||||t||||||||||2017-02-18 17:06:22.204798|2017-02-18 17:06:22.204798
NCT00226083|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2015-06-05|||August 2005||2005-08-01|June 2015|2015-06-01|September 2007|Anticipated|2007-09-01|September 2007|Anticipated|2007-09-01||Observational|||Study of Blood Platelets in Sickle Cell Disease|Studies of Large Platelets in Patients With Sickle Cell Disease|Withdrawn||N/A|0|Actual|Rockefeller University|||1|PI returned to India|f||||f||||||||||2017-02-18 17:06:22.329265|2017-02-18 17:06:22.329265
NCT00226070|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2006-12-18|||September 2004||2004-09-01|December 2006|2006-12-01|September 2005||2005-09-01|||||Interventional|||Rehabilitation to Patients Over 65 Years Undergoing THA|Cross-Section Study Among Patients Waiting for or Already Undergoing THA Followed by a RCT|Unknown status|Recruiting|Phase 1/Phase 2|160||University of Aarhus|||||f||||||||||||||2017-02-18 17:06:22.409644|2017-02-18 17:06:22.409644
NCT00226057|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2005-09-22|||June 2005||2005-06-01|August 2005|2005-08-01|November 2005||2005-11-01|||||Interventional|||Efalizumab for Moderate to Severe Atopic Dermatitis|Efalizumab for Moderate to Severe Atopic Dermatitis - A Phase I Pilot Study in Adults|Completed||Phase 1|10||Oregon Health and Science University|||||||||||||||||||2017-02-18 17:06:22.501308|2017-02-18 17:06:22.501308
NCT00226044|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2013-04-25|||September 2005||2005-09-01|April 2013|2013-04-01|December 2007||2007-12-01|||||Interventional|||Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.|Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study.|Unknown status|Recruiting|Phase 3|20|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-02-18 17:06:22.836907|2017-02-18 17:06:22.836907
NCT00226031|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2015-03-10|||September 2003||2003-09-01|March 2015|2015-03-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||Optimal Management of Women With Wrist Fractures|Optimal Management of Older Women With Distal Forearm Fractures|Completed||N/A|270|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 17:06:22.952038|2017-02-18 17:06:22.952038
NCT00226018|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2008-04-16|||March 2005||2005-03-01|April 2008|2008-04-01|October 2006||2006-10-01|||||Interventional|||Performance of Acceleromyography With and Without Preload|Performance of Acceleromyography With and Without Preload During Neuromuscular Blockade|Completed||Phase 4|60||Rigshospitalet, Denmark||4|||f||||f||||||||||2017-02-18 17:06:23.067211|2017-02-18 17:06:23.067211
NCT00226005|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2012-05-08|||December 2005||2005-12-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|December 2008|Actual|2008-12-01||Interventional|||PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma|Phase II Trial of PTK787/ZK222584 in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Who Failed First-Line Gemcitabine Therapy.|Completed||Phase 2|67|Actual|Pancreatic Cancer Research Team||1|||f||||t||||||||||2017-02-18 17:06:23.178093|2017-02-18 17:06:23.178093
NCT00225992|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2012-10-10|||February 2004||2004-02-01|October 2012|2012-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)|A Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)|Terminated||Phase 2|||Oncology Specialties, Alabama||||terminated due to lack of accrual.|f||||f||||||||||2017-02-18 17:06:23.320027|2017-02-18 17:06:23.320027
NCT00225979|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-23|2012-04-10|||November 2002||2002-11-01|April 2012|2012-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly|Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly|Completed||Phase 3|100|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:06:23.414299|2017-02-18 17:06:23.414299
NCT00225966|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-14|||August 2004||2004-08-01|November 2013|2013-11-01|October 2007||2007-10-01|||||Interventional|||Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control|Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control|Terminated||N/A|153||MedtronicNeuro||||Study design was changed and is now InSite trial #1634 - See NCT00547378|f||||||||||||||2017-02-18 17:06:23.524222|2017-02-18 17:06:23.524222
NCT00225927|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-02-28|||June 2004||2004-06-01|March 2010|2010-03-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|||Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers|A Prospective, Randomized, Controlled Trial of Radioguided Seed Localization Versus Standard Needle Localization of Nonpalpable Breast Cancers|Completed||N/A|333|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 17:06:23.625967|2017-02-18 17:06:23.625967
NCT00225914|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2010-11-23|||September 2004||2004-09-01|November 2010|2010-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Study of Paxil Use in Menopausal Women|Paroxetine Controlled Release in the Treatment of Symptomatic Menopausal Women Following Discontinuation of Hormone Therapy|Completed||Phase 4|64|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 17:06:23.737922|2017-02-18 17:06:23.737922
NCT00225901|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-09-22|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure|Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant and Late-Onset Hepatic Failure|Unknown status|Recruiting|Phase 1/Phase 2|16||Kyoto University, Graduate School of Medicine|||||f||||||||||||||2017-02-18 17:06:23.875421|2017-02-18 17:06:23.875421
NCT00225888|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2008-02-19|||October 2004||2004-10-01|February 2008|2008-02-01|October 2005|Actual|2005-10-01|October 2005|Anticipated|2005-10-01||Interventional|||Feasibility Study of Digital Photography and Group Discussion for People With Diabetes|Digital Photography and Group Discussion as a Means of Affecting Dietary Change Among People With Type 2 Diabetes: Feasibility Project|Completed||N/A|36|Anticipated|Joslin Diabetes Center||1|||f||||||||||||||2017-02-18 17:06:23.970857|2017-02-18 17:06:23.970857
NCT00225875|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-10-25|||September 2003||2003-09-01|March 2005|2005-03-01|July 2007||2007-07-01|||||Interventional|||Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy|Evaluation De l’Efficacité Du Rituximab (Mabthéra) Chez l'Adulte Atteint d'Un Purpura thrombopénique Auto-Immun Chronique Et sévère Et Candidat à La splénectomie|Terminated||Phase 2|65||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:06:24.073779|2017-02-18 17:06:24.073779
NCT00225862|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-09-13|||January 2005||2005-01-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|||||Interventional|||A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)|A 12-week, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Intermittent Dosing of Ropinirole in Patients With Restless Legs Syndrome (RLS)|Completed||Phase 3|140|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:06:24.183445|2017-02-18 17:06:24.183445
NCT00225849|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2005-09-22|||March 2005||2005-03-01|September 2005|2005-09-01|September 2010||2010-09-01|||||Interventional|||Japanese Primary Prevention Project With Aspirin|Japanese Primary Prevention Project With Aspirin in the Elderly With One or More Risk Factors of Vascular Events: JPPP|Unknown status|Recruiting|Phase 4|10000||Ministry of Health, Labour and Welfare, Japan|||||f||||||||||||||2017-02-18 17:06:24.334697|2017-02-18 17:06:24.334697
NCT00225836|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2007-01-12|||September 2005||2005-09-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Treatment of Dysmenorrhoea With the OVA TENS Apparatus|Treatment of Dysmenorrhoea With the OVA TENS Apparatus|Completed||N/A|20||The Hospital of Vestfold|||||f||||||||||||||2017-02-18 17:06:24.430246|2017-02-18 17:06:24.430246
NCT00225680|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-01-30|||April 2002||2002-04-01|January 2012|2012-01-01|August 2005||2005-08-01|||||Interventional|ELUTES II||In Stent ELUTES Study|ELUTES II - In Stent ELUTES Study|Completed||N/A|124||Cook|||||f||||||||||||||2017-02-18 17:06:24.521366|2017-02-18 17:06:24.521366
NCT00225667|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-22|||December 2005||2005-12-01|November 2005|2005-11-01|July 2007||2007-07-01|||||Interventional|||Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers|Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension, Permanent Pacemakers and Risk Factors for Developing Atrial Fibrillation|Unknown status|Not yet recruiting|Phase 3|200||Connolly, Stuart, M.D.|||||f||||||||||||||2017-02-18 17:06:24.609507|2017-02-18 17:06:24.609507
NCT00225654|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-01-30|||January 2000||2000-01-01|January 2012|2012-01-01|November 2001||2001-11-01|||||Interventional|ELUTES I||The ELUTES Clinical Trial|The ELUTES Clinical Trial (European Evaluation of Paclitaxel Eluting Stent)|Completed||N/A|192||Cook|||||f||||||||||||||2017-02-18 17:06:24.723149|2017-02-18 17:06:24.723149
NCT00225641|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2015-12-21|||March 2006||2006-03-01|December 2015|2015-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer|COLOFOL - A Pragmatic Study to Assess the Frequency of Surveillance Tests After Curative Resection in Patients With Stage II and III Colorectal Cancer - a Randomised Multicentre Trial|Active, not recruiting||N/A|2500|Anticipated|Bispebjerg Hospital||2|||f||||t||||||||||2017-02-18 17:06:24.81141|2017-02-18 17:06:24.81141
NCT00225628|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2005-09-23|||September 2000||2000-09-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Improving Quality With Outpatient Decision Support|Improving Quality With Outpatient Decision Support|Completed||N/A|3000||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:06:24.928559|2017-02-18 17:06:24.928559
NCT00225615|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2009-08-18|||November 2005||2005-11-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|||||Interventional|||A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels|A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels|Completed||Phase 3|100||BioMarin Pharmaceutical|||||||||||||||||||2017-02-18 17:06:25.03409|2017-02-18 17:06:25.03409
NCT00225602|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2005-09-22|||January 2004||2004-01-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Interventional|||Assertive Community Treatment in Copenhagen|Quasi-Experimental Trial of the Effect of Assertive Community Treatment Among Those With Severe Mental Disorder|Unknown status|Active, not recruiting|N/A|400||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 17:06:25.148926|2017-02-18 17:06:25.148926
NCT00225589|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2010-11-18|||August 2002||2002-08-01|November 2010|2010-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)|A Randomized, Double-blind, Placebo-controlled, Multicenter Parallel Group Phase III Study Measuring Effects on Intima Media Thickness: an Evaluation Of Rosuvastatin 40 mg (METEOR)|Completed||Phase 3|840||AstraZeneca|||||||||||||||||||2017-02-18 17:06:25.246241|2017-02-18 17:06:25.246241
NCT00225576|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2014-01-23|||September 2005||2005-09-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|November 2007|Actual|2007-11-01||Interventional|||Statewide Implementation of Electronic Health Records|Statewide Implementation of Electronic Health Records|Completed||Phase 2|2030|Anticipated|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-02-18 17:06:25.410437|2017-02-18 17:06:25.410437
NCT00225563|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2007-06-12|||October 2004||2004-10-01|September 2005|2005-09-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Taconic Health Information Network and Community (THINC)|Transforming Healthcare Quality Through I.T.|Unknown status|Recruiting|N/A|9000|Anticipated|Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:06:25.578566|2017-02-18 17:06:25.578566
NCT00225550|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2007-08-03||||||August 2007|2007-08-01||||||||Interventional|||A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors|Dose Finding, Safety, Pharmacokinetic and Pharmacodynamic Study of the Vascular Targeting Agent Exherin™ (ADH-1) Administered Once Daily for 5 Consecutive Days by Intravenous Infusion in Subjects With N-Cadherin Expressing, Incurable, Solid Tumors (Adherex Protocol Number AHX 01 003)|Terminated||Phase 1/Phase 2|||Adherex Technologies, Inc.|||||||||||||||||||2017-02-18 17:06:25.663048|2017-02-18 17:06:25.663048
NCT00225537|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2006-09-07|||September 2005||2005-09-01|April 2006|2006-04-01|August 2007||2007-08-01|||||Interventional|||4-Methylumbelliferone as a Treatment for Chronic HBV/HCV|Evaluation of 4-Methylumbelliferone for Treatment of Chronic Hepatitis B (HBV) and Chronic Hepatitis C (HCV)|Unknown status|Active, not recruiting|Phase 2|160||MTmedical Institute of Health|||||f||||||||||||||2017-02-18 17:06:25.744306|2017-02-18 17:06:25.744306
NCT00225524|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-22|||September 2004||2004-09-01|May 2007|2007-05-01||||||||Interventional|||Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.|Phase III Long-Term Administration Study of Effexor XR for the Treatment of Depression|Completed||Phase 3|150|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:06:25.85899|2017-02-18 17:06:25.85899
NCT00225511|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-22|||June 2004||2004-06-01|May 2007|2007-05-01||||||||Interventional|||Study Evaluating Effexor XR for Major Depression.|Phase III Multi-Center, Double-Blind, Comparative Study of Effexor XR for the Treatment of Depression|Completed||Phase 3|590|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:06:26.012577|2017-02-18 17:06:26.012577
NCT00225498|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2015-09-02|2012-12-12||June 2002||2002-06-01|September 2015|2015-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||Baseline characteristics for all participants prior to randomization are reported because treatment assignment information is not available. That information was not preserved when the orginally planned analyses were not conducted because the enrollment was insufficient for statistically valid results.|Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade|Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade|Completed||N/A|35|Actual|Northwell Health|This is a small sample.|2|||f||||f||||||||||2017-02-18 17:06:28.931179|2017-02-18 17:06:28.931179
NCT00225485|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-25|||December 2003||2003-12-01|May 2007|2007-05-01||||||||Interventional|||Study Evaluating Effexor XR in Elderly Patients With Major Depression.|Phase III Study of Effexor XR for the Treatment of Elderly Patients With Depression|Completed||Phase 3|100||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:06:29.154931|2017-02-18 17:06:29.154931
NCT00225472|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-10|||June 2004||2004-06-01|May 2016|2016-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Organ Preservation Media Investigation|Organ Preservation Media Investigation|Completed||Phase 1|20|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:06:29.51115|2017-02-18 17:06:29.51115
NCT00225459|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2011-10-04|||June 2005||2005-06-01|October 2011|2011-10-01|December 2008|Actual|2008-12-01|||||Observational|||Does Spiritual/Religious Commitment Mediate the Relationship Between Mood Variability and Suicidal Ideation.|Does Spiritual/Religious Commitment Mediate the Relationship Between Mood Variability and Suicidal Ideation.|Completed||N/A|200|Anticipated|University of Saskatchewan|||1||f||||||||||||||2017-02-18 17:06:29.588237|2017-02-18 17:06:29.588237
NCT00225446|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2008-06-03|||February 2006||2006-02-01|June 2008|2008-06-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Micron Tracker: Computer-Assisted Orthognathic Surgery With a Third Generation Optic Repositioning System|Computer-Assisted Orthognathic Surgery With a Third Generation Optic Repositioning System.|Suspended||Phase 1/Phase 2|20|Anticipated|University Hospital, Grenoble||1|||f||||||||||||||2017-02-18 17:06:29.675455|2017-02-18 17:06:29.675455
NCT00225433|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2015-12-01|||September 2005||2005-09-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|December 2006|Actual|2006-12-01||Interventional|||Luteal Phase FSH in the IVF Poor Responder|Luteal Phase Recombinant FSH vs. Follicular Phase Recombinant FSH for IVF Stimulation in the Poor Responder|Completed||Phase 4|20|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 17:06:29.782312|2017-02-18 17:06:29.782312
NCT00225420|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-01-20|||August 2005||2005-08-01|January 2016|2016-01-01|August 2012|Actual|2012-08-01|June 2010|Actual|2010-06-01||Interventional|NRR||Docetaxel, Androgen Ablation Therapy, and External-Beam Radiation Therapy in Treating Patients With High-Risk Localized Prostate Cancer|A Phase I/II Study of Concurrent Weekly Docetaxel (Taxotere®), Androgen Ablation, and Adaptive External Beam Radiotherapy for Localized High-Risk Adenocarcinoma of the Prostate|Completed||Phase 1/Phase 2|23|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:06:29.89307|2017-02-18 17:06:29.89307
NCT00225407|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-09-21|||July 2005||2005-07-01|March 2005|2005-03-01|December 2005||2005-12-01|||||Interventional|||Processing and Effects of Cannabis|A Double-Blind, Randomised, Placebo-Controlled, Cross-Over Study on the Pharmacokinetics and Effects of Cannabis|Unknown status|Recruiting|Phase 1|27||UMC Utrecht|||||f||||||||||||||2017-02-18 17:06:30.009136|2017-02-18 17:06:30.009136
NCT00225394|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-09-21|||October 2003||2003-10-01|August 2005|2005-08-01|July 2006||2006-07-01|||||Observational|||Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients|Long-Term Valcyte Therapy in Transplant Patients and the Development of Ganciclovir Resistant CMV|Completed||Phase 4|100||University of Massachusetts, Worcester|||||||||||||||||||2017-02-18 17:06:30.115787|2017-02-18 17:06:30.115787
NCT00225381|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2011-02-10|||August 2005||2005-08-01|February 2011|2011-02-01|December 2011|Anticipated|2011-12-01|||||Observational|||Gas Kinetics and Metabolism in Anesthesia During Non Steady State|Gas Kinetics and Metabolism in Anesthesia During Non Steady State|Unknown status|Recruiting|Phase 1|100|Anticipated|University of California, Irvine|||7||f||||f||||||||||2017-02-18 17:06:30.211246|2017-02-18 17:06:30.211246
NCT00225368|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2010-02-05||||||September 2005|2005-09-01||||||||Interventional|||Effects of Insecticide Treated Bednets on Child Morbidity and Mortality|Long Term Effects of Insecticide Treated Bednets on the Morbidity and Mortality Caused by Malaria and on the Overall Mortality in Young Children of a Rural Population in Burkina Faso|Completed||N/A|||Heidelberg University|||||f||||||||||||||2017-02-18 17:06:30.342385|2017-02-18 17:06:30.342385
NCT00225355|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2009-02-18|||February 2006||2006-02-01|February 2009|2009-02-01|November 2006|Anticipated|2006-11-01|||||Interventional|||Rosiglitazone Versus Placebo in Chronic Stable Angina|Insulin Sensitisation as a Novel Mechanism to Lessen Ischaemic Burden in Overweight Non-Diabetic Patients With Chronic Stable Angina: A Pilot Study|Terminated||Phase 4|80|Anticipated|University of Glasgow|||||f||||||||||||||2017-02-18 17:06:30.433726|2017-02-18 17:06:30.433726
NCT00225342|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2006-09-07||||||September 2005|2005-09-01||||||||Interventional|||Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina|Effects of Rosiglitazone and Sulphonylureas on Ischaemic Burden, Blood Pressure and Novel Risk Markers Inclusive of Vascular Function in Patients With Chronic Stable Angina and Type 2 Diabetes Mellitus: A Randomised, Double-Blinded Study.|Withdrawn||Phase 4|60||University of Glasgow|||||f||||||||||||||2017-02-18 17:06:30.528084|2017-02-18 17:06:30.528084
NCT00225329|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-09-21|||September 2001||2001-09-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Early Labour Assessment and Support at Home|Early Labour Support at Home: RCT of Nurse Visits and Telephone Triage|Completed||N/A|1466||University of British Columbia|||||f||||||||||||||2017-02-18 17:06:30.620286|2017-02-18 17:06:30.620286
NCT00225316|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2011-05-13|||August 2005||2005-08-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Maternal Acupuncture for Substance Abuse|Can Maternal Acupuncture for Chemically Dependent Pregnant Women Reduce the Severity of Neonatal Abstinence Syndrome? - A Randomized Controlled Trial|Completed||Phase 3|89|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:06:30.702094|2017-02-18 17:06:30.702094
NCT00225303|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-18|||March 2005||2005-03-01|October 2010|2010-10-01|June 2006|Actual|2006-06-01|||||Interventional|||TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use|A Phase II, Randomized, Active Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-na�ve and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use.|Completed||Phase 2|116|Actual|Tibotec Pharmaceuticals, Ireland|||||f||||||||||||||2017-02-18 17:06:30.794959|2017-02-18 17:06:30.794959
NCT00225290|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2011-10-07|||February 2003||2003-02-01|September 2005|2005-09-01||||||||Interventional|||Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve|Double-blind, Placebo-controlled, Randomized Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve|Terminated||Phase 3|230|Anticipated|TTY Biopharm||||slowly recruitment rate|f||||||||||||||2017-02-18 17:06:30.897018|2017-02-18 17:06:30.897018
NCT00225277|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2012-02-27|2008-10-17||July 2003||2003-07-01|February 2012|2012-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|PERISCOPE||Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus|A Double-Blind, Randomized, Comparator-Controlled Study In Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus Glimepiride on the Rate of Progression of Coronary Atherosclerotic Disease as Measured by Intravascular Ultrasound|Completed||Phase 3|547|Actual|Takeda|Composite Endpoints A,B,C include cardiovascular mortality, nonfatal MI and nonfatal stroke. In addition, B: coronary revascularization, carotid endarterectomy/stenting, unstable angina hosp. or CHF; C: hospitalization for unstable angina or CHF.|2|||f||||f||||||||||2017-02-18 17:06:30.987522|2017-02-18 17:06:30.987522
NCT00225264|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2012-02-27|||October 2003||2003-10-01|February 2012|2012-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|CHICAGO||Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.|A Double-Blind, Randomized, Comparator-Controlled Study in Subjects With Type 2 Diabetes Mellitus Comparing the Effects of Pioglitazone HCl Versus Glimepiride on the Rate of Progression of Atherosclerotic Disease as Measured by Carotid Intima-Media Thickness|Completed||Phase 3|458|Actual|Takeda||2|||f||||f||||||||||2017-02-18 17:06:32.358691|2017-02-18 17:06:32.358691
NCT00225251|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2015-10-29|2014-05-13||November 2004||2004-11-01|October 2014|2014-10-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional||adults with dysthymic disorder, males and females|Wellbutrin XL for Dysthymic Disorder|Double-Blind Treatment of Outpatients With Dysthymic Disorder With Wellbutrin XL|Completed||Phase 4|18|Actual|St. Luke's-Roosevelt Hospital Center|Early termination led to small numbers of subjects analyzed|2|||f||||f||||||||||2017-02-18 17:06:32.48315|2017-02-18 17:06:32.48315
NCT00225238|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep|The Effect of Esomeprazole (Nexium) on the Incidence and Severity of Gastrointestinal Adverse Events Associated With a Colonoscopy Purgative|Completed||Phase 4|500|Actual|Thomas Jefferson University||1|||f||||f||||||||||2017-02-18 17:06:33.000818|2017-02-18 17:06:33.000818
NCT00225225|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-10-18|||October 2002||2002-10-01|October 2016|2016-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Rosiglitazone-Induced Weight Gain|Rosiglitazone-Induced Weight Gain|Terminated||N/A|45|Actual|Stanford University||2||due to published data on Rosiglitazone|f||||||||||||||2017-02-18 17:06:33.090249|2017-02-18 17:06:33.090249
NCT00225212|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-09-04|2014-08-26||November 1997||1997-11-01|September 2014|2014-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma|Clinical Trial Of C2B8 Monoclonal Antibody Following High Dose Therapy And Autografting In B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|35|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 17:06:33.193543|2017-02-18 17:06:33.193543
NCT00225199|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2010-04-22|||March 2004||2004-03-01|April 2010|2010-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Efficacy and Safety of SH T00660AA in Treatment of Endometriosis|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Daily Oral Administration of SH T00660AA for the Treatment of Endometriosis Over 12 Weeks|Completed||Phase 3|198|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:06:33.465824|2017-02-18 17:06:33.465824
NCT00225186|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2014-01-08|||July 2004||2004-07-01|January 2014|2014-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety and Efficacy of SH T00660AA in Treatment of Endometriosis|A Multi-center, Open, One-arm Study to Investigate the Safety and Efficacy of Daily Oral Administration of T00660AA for the Treatment of Endometriosis Over 52 Weeks (Follow-up to Study 307041)|Completed||Phase 3|168|Actual|Bayer||1|||f||||f||||||||||2017-02-18 17:06:33.574271|2017-02-18 17:06:33.574271
NCT00225173|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-08-26|||October 2001||2001-10-01|September 2005|2005-09-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease|A Phase II Trial of Stanford VI ± Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease With 3+ Risk Factors: the G6 Study|Terminated||Phase 2|45|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:06:33.952348|2017-02-18 17:06:33.952348
NCT00225160|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2008-09-17|||November 2003||2003-11-01|September 2008|2008-09-01||||||||Interventional|||ALCAR Prophylaxis Study|A Randomised Double Blinded Placebo Controlled Pilot Study to Evaluate the Safety and Efficacy of Acetyl L Carnitine in Combination With Antiretroviral Therapy for the Prevention of Distal Symmetric Polyneuropathy and Lipid Abnormalities in Treatment naïve HIV Infected Subjects|Unknown status|Active, not recruiting|Phase 2|50||Royal Free Hampstead NHS Trust|||||f||||||||||||||2017-02-18 17:06:34.084727|2017-02-18 17:06:34.084727
NCT00225147|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-02-20|2012-02-22||July 2005||2005-07-01|February 2013|2013-02-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|A Randomized, Placebo-controlled, Double Blind Phase II/III Study of the Safety and Efficacy of Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema|Completed||Phase 2/Phase 3|77|Actual|Pharming Technologies B.V.||3|||f||||t||||||||||2017-02-18 17:06:34.180294|2017-02-18 17:06:34.180294
NCT00225121|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2012-04-06|||October 2005||2005-10-01|April 2012|2012-04-01|September 2010|Actual|2010-09-01|April 2007|Actual|2007-04-01||Interventional|||Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors|A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of 2 Dosing Schedules Of PF-00299804 In Patients With Advanced Malignant Solid Tumors|Completed||Phase 1|121|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:06:34.785287|2017-02-18 17:06:34.785287
NCT00225108|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2006-09-23|||July 2002||2002-07-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section|The Cesarean Section Thromboprophylaxis Pilot Study:A Randomized Open-Label Controlled Pilot Study of Prophylactic Low Molecular Weight Heparin in High Risk Postpartum Women Following Cesarean Section|Completed||Phase 2/Phase 3|30||Ottawa Hospital Research Institute|||||f||||||||||||||2017-02-18 17:06:34.877979|2017-02-18 17:06:34.877979
NCT00225095|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-12-02|||September 2005||2005-09-01|December 2014|2014-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy|A Phase I/II, Randomized, Controlled, Double Blind, Study of Chondrogen - Adult Universal Cell Delivered by Intra-Articular Injection Following Meniscectomy in Patients 18-60 Years|Completed||Phase 1/Phase 2|55|Actual|Mesoblast, Ltd.||3|||f||||||||||||||2017-02-18 17:06:34.967997|2017-02-18 17:06:34.967997
NCT00225082|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2010-10-04|||November 2004||2004-11-01|October 2010|2010-10-01|October 2007|Actual|2007-10-01|December 2006|Actual|2006-12-01||Observational|||SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function|SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial|Completed||N/A|12|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"~     adipose tissue, blood~   "|||2017-02-18 17:06:35.09509|2017-02-18 17:06:35.09509
NCT00225069|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2012-08-22|||September 2005||2005-09-01|August 2012|2012-08-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Thoracoscopic Sympathectomy for Blushing|Thoracoscopic Sympathectomy for Blushing. A Prospective Randomised Trial.|Completed||Phase 4|100|Actual|Odense University Hospital||2|||f||||||||||||||2017-02-18 17:06:35.183183|2017-02-18 17:06:35.183183
NCT00225056|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2007-04-18|||October 2003||2003-10-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma|Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma|Terminated||Phase 2|43||Oncology Specialties, Alabama||||Terminated due to lack of accrual|f||||||||||||||2017-02-18 17:06:35.276085|2017-02-18 17:06:35.276085
NCT00225043|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2008-05-30|||June 2005||2005-06-01|May 2008|2008-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Randomized, Double-Blind, Trial Comparing Epinephrine Versus Phenylephrine as a Vasoconstrictor in Regional Anesthesia for Upper Extremity Surgery||Completed||N/A|60|Actual|New York Methodist Hospital|||||f||||||||||||||2017-02-18 17:06:35.361585|2017-02-18 17:06:35.361585
NCT00225030|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 1970||1970-01-01|July 2004|2004-07-01|July 2004||2004-07-01|||||Observational|||Observational Study of the Prognosis in Treated Arterial Hypertension|Observational Study of the Prognosis in Treated Arterial Hypertension|Completed||N/A|1000||Odense University Hospital|||||f||||||||||||||2017-02-18 17:06:35.454628|2017-02-18 17:06:35.454628
NCT00225017|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2012-06-29|2010-10-04||June 2005||2005-06-01|June 2012|2012-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|SABAR||Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study|Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study: Endothelial Function in HIV-Infected Subjects Switched to an Atazanavir Regimen|Completed||Phase 3|50|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 17:06:35.540417|2017-02-18 17:06:35.540417
NCT00225004|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-04-02|||July 2004||2004-07-01|April 2014|2014-04-01||||||||Observational|||Osteoporosis and Colles Fracture|Low-energy Fracture of the Wrist (Colles Fracture) and Osteoporosis. A Ten Year Follow-up and a Prospective Study|Terminated||N/A|||Northern Orthopaedic Division, Denmark|||1|Recruiting problems|f||||||||||||||2017-02-18 17:06:36.04855|2017-02-18 17:06:36.04855
NCT00224991|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-04-02|||June 1999||1999-06-01|April 2014|2014-04-01|June 2005||2005-06-01|||||Interventional|||Osteoporosis School|Effect of Training in Prevention of Falls, Compliance to Treatment and Quality of Life: A Randomized, Prospective Investigation.|Completed||N/A|350||Northern Orthopaedic Division, Denmark|||||f||||f||||||||||2017-02-18 17:06:36.143495|2017-02-18 17:06:36.143495
NCT00224978|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2009-11-17|||January 2005||2005-01-01|November 2009|2009-11-01|August 2005||2005-08-01|||||Interventional|||Chloroquine for Treatment of Glioblastoma Multiforme|Chloroquine as Adjuvant to the Treatment of Glioblastoma Multiforme, A Randomized Trial|Completed||Phase 3|||National Institute of Neurology and Neurosurgery, Mexico|||||f||||||||||||||2017-02-18 17:06:36.236703|2017-02-18 17:06:36.236703
NCT00224952|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2013-04-29|||July 2002||2002-07-01|April 2013|2013-04-01||||March 2010|Actual|2010-03-01||Observational|||Pathogenesis of Adverse Drug Reactions|The Role of Drug Metabolizing Enzymes in the Pathogenesis Adverse Drug Reactions in Children|Completed||N/A|98|Actual|Children's Mercy Hospital Kansas City|||2||f||||f||||||Samples With DNA|"~     Urine DNA (source: blood or saliva)~   "|||2017-02-18 17:06:36.430483|2017-02-18 17:06:36.430483
NCT00224939|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2010-01-12|||July 2002||2002-07-01|January 2010|2010-01-01|December 2006|Actual|2006-12-01|||||Interventional|||Pre-ESRD Syndrome in High Risk African Americans|Pre-ESRD Syndrome in High Risk African American Young Adults|Terminated||N/A|144|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||||"Only apx 1/3 of enrolled subjects (signed consent) participated. Futility analysis to show~   primary endpoint"|f||||||||||||||2017-02-18 17:06:36.545466|2017-02-18 17:06:36.545466
NCT00224926|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2011-09-16|||September 2003||2003-09-01|September 2011|2011-09-01|September 2005|Actual|2005-09-01|||||Observational|||The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation|The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation|Completed||N/A|446|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"~     fungal scalp cultures~   "|||2017-02-18 17:06:36.622901|2017-02-18 17:06:36.622901
NCT00224913|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-10-11|||March 2002||2002-03-01|October 2005|2005-10-01||||||||Interventional|||Electrical Stimulation After Total Knee Arthroplasty|NMES for Older Individuals After Total Knee Arthroplasty|Unknown status|Recruiting|Phase 1|200||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:06:36.713245|2017-02-18 17:06:36.713245
NCT00224900|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-02-29|||September 2005||2005-09-01|February 2016|2016-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers|Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers Part A: Focus Group And Measurement Evaluation|Terminated||N/A|10|Actual|Westat|||1||f||||f||||||||||2017-02-18 17:06:36.802508|2017-02-18 17:06:36.802508
NCT00224887|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2008-07-23|||September 2003||2003-09-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Family-Based Nutrition Intervention for Latino Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:06:36.891419|2017-02-18 17:06:36.891419
NCT00224874|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-05-12|2010-01-29||September 2005||2005-09-01|April 2016|2016-04-01|June 2012|Actual|2012-06-01|January 2009|Actual|2009-01-01||Interventional|||Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)|Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (ONTAK), and Pentostatin in Combination With Corticosteroids (BMT CTN #0302)|Completed||Phase 2|180|Actual|National Heart, Lung, and Blood Institute (NHLBI)||4|||f||||t||||||||Yes|Findings will be published in a manuscript|2017-02-18 17:06:36.967026|2017-02-18 17:06:36.967026
NCT00224861|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2013-03-21|||September 2004||2004-09-01|March 2013|2013-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Hypertension Telemanagement in African Americans|Hypertension Telemanagement in African Americans|Completed||N/A|||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:06:38.859175|2017-02-18 17:06:38.859175
NCT00224848|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-11-04|||July 2002||2002-07-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|September 2007|Actual|2007-09-01||Interventional|GLAD Heart||Guideline Adherence for Heart Health||Completed||Phase 2|61|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||f||||||||||2017-02-18 17:06:38.9456|2017-02-18 17:06:38.9456
NCT00224835|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-05-12|||May 2003||2003-05-01|May 2016|2016-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Mindfulness-Based Stress Reduction and Myocardial Ischemia|Mindfulness-Based Stress Reduction and Myocardial Ischemia|Completed||N/A|150|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 17:06:39.044872|2017-02-18 17:06:39.044872
NCT00224822|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2010-03-23|||March 2004||2004-03-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||The Effects of Aripiprazole on Patients With Metabolic Syndrome|"The Effects of Aripiprazole on Patients With Metabolic Syndrome: An Open-Label Trial"|Completed||Phase 4|27|Actual|New Mexico VA Healthcare System|||||f||||t||||||||||2017-02-18 17:06:39.151372|2017-02-18 17:06:39.151372
NCT00224809|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-02-18|||September 2002||2002-09-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation|Functional Mitral Regurgitation in STICH|Completed||N/A|250|Anticipated|Baylor Research Institute|||||f||||||||||||||2017-02-18 17:06:39.259121|2017-02-18 17:06:39.259121
NCT00224796|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2006-07-19|||May 2002||2002-05-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Trial of Vacuum Assisted Closure® Therapy in Amputation Wounds of the Diabetic Foot|A Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure® Therapy in the Treatment and Blinded Evaluation of Amputation Wounds of the Diabetic Foot|Completed||Phase 4|146||KCI USA, Inc.|||||f||||||||||||||2017-02-18 17:06:39.567437|2017-02-18 17:06:39.567437
NCT00224783|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-01-25|||August 2002||2002-08-01|January 2012|2012-01-01|September 2002|Actual|2002-09-01|||||Interventional|||Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults|Placebo-controlled Double-blind Controlled Trial of Single Intranasal Inoculation of CAIV-T Liquid Formulation in Healthy Japanese Male Adults|Completed||Phase 1|45|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 17:06:39.651924|2017-02-18 17:06:39.651924
NCT00224770|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2015-06-17|2014-09-21||August 2005||2005-08-01|June 2015|2015-06-01|April 2013|Actual|2013-04-01|August 2012|Actual|2012-08-01||Interventional|MISTIE|The decision was made to exclude the pilot patients from the analysis...|Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation|Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation|Completed||Phase 2|141|Actual|Johns Hopkins University||3|||f||||t||||||||||2017-02-18 17:06:39.758306|2017-02-18 17:06:39.758306
NCT00224757|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2011-09-05|||September 2005||2005-09-01|September 2011|2011-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|TIARA||Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study|Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation|Completed||N/A|227|Actual|The Interuniversity Cardiology Institute of the Netherlands||2|||f||||t||||||||||2017-02-18 17:06:40.811172|2017-02-18 17:06:40.811172
NCT00224536|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-09-21|||January 2002||2002-01-01|September 2005|2005-09-01|October 2003||2003-10-01|||||Interventional|||Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration|Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration-1|Completed||Phase 1|60||Hannover Medical School|||||f||||||||||||||2017-02-18 17:06:42.751865|2017-02-18 17:06:42.751865
NCT00224744|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-22|2014-09-11|||November 2005||2005-11-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage|Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage.|Completed||Phase 3|73|Actual|Institut Claudius Regaud||2|||f||||||||||||||2017-02-18 17:06:40.92207|2017-02-18 17:06:40.92207
NCT00224731|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2006-10-25|||December 2003||2003-12-01|September 2005|2005-09-01||||||||Observational|||Sleep Disorders in Children With ADHD|Sleep Disorders in Children With ADHD|Unknown status|Recruiting|N/A|100||Hvolby, Allan, M.D.|||||f||||||||||||||2017-02-18 17:06:41.019553|2017-02-18 17:06:41.019553
NCT00224718|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-03-31|||January 2003||2003-01-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|ACE||Elective Abdominal Aortic Aneurism - Open Versus Endovascular Repair|"ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal  Surgery Versus Endoprosthesis "|Completed||N/A|306|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:06:41.095312|2017-02-18 17:06:41.095312
NCT00224705|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2011-02-16|||August 2004||2004-08-01|July 2007|2007-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure|Efficacy and Safety of the Albumin Dialysis MARS® Therapy in Patients With Fulminant and Subfulminant Hepatic Failure|Completed||Phase 3|110|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:06:41.216705|2017-02-18 17:06:41.216705
NCT00224692|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2006-10-25|||February 2003||2003-02-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine|MK III Trial: Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine|Terminated||Phase 3|50||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:06:41.315186|2017-02-18 17:06:41.315186
NCT00224679|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2012-06-04|||March 1997||1997-03-01|September 2006|2006-09-01|March 1999||1999-03-01|||||Interventional|||APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence|Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence|Terminated||Phase 3|300||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:06:41.406902|2017-02-18 17:06:41.406902
NCT00224666|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-01-09|||March 2001||2001-03-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Efficacy of Cortex Stimulation in Neuropathic Pain|Evaluation of the Effectiveness of Stimulation Cortex Sensorimotor for the Treatment of Rebel Neuropathic Pains|Terminated||Phase 2|16||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:06:41.517073|2017-02-18 17:06:41.517073
NCT00224653|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2006-04-12|||January 2005||2005-01-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Comparison Between Volume Controlled Ventilation and Pressure Controlled Ventilation||Completed||N/A|36||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:06:41.607374|2017-02-18 17:06:41.607374
NCT00224640|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-03-03|||March 2005||2005-03-01|March 2007|2007-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Iron-Chelating Therapy and Friedreich Ataxia|Effect of Iron-Chelating Therapy in Friedreich Ataxia. Study Phase I/II|Completed||Phase 1/Phase 2|15|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:06:41.696395|2017-02-18 17:06:41.696395
NCT00224627|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-03-23|||March 2002||2002-03-01|March 2007|2007-03-01|June 2005|Actual|2005-06-01|||||Interventional|||Capsule Endoscopy vs. Push Enteroscopy in Occult Gastrointestinal Bleeding OGIB|Efficiency of Capsule Endoscopy and Push Enteroscopy in Obscure Gastrointestinal Bleeding. A Prospective Randomized Study.|Completed||Phase 3|45||Assistance Publique - Hôpitaux de Paris|||||f||||t||||||||||2017-02-18 17:06:41.813683|2017-02-18 17:06:41.813683
NCT00224614|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-12-13|||July 2005||2005-07-01|June 2005|2005-06-01|July 2009||2009-07-01|||||Interventional|||Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia|Randomised Prospective Comparison of the nonmyélo-Ablative Allograft and the Traditional Allograft in Acute Myeloid Leukaemia in Complete Remission of the Adult|Unknown status|Recruiting|Phase 3|100||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:06:42.14383|2017-02-18 17:06:42.14383
NCT00224601|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-02-17|||July 2005||2005-07-01|July 2007|2007-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome|Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Syndrome: Assessment of Coloscopy With Chromoscopy Benefit|Completed||Phase 2|80|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 17:06:42.244237|2017-02-18 17:06:42.244237
NCT00224588|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2006-04-12|||January 2003||2003-01-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||KETOR: Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain|Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain|Completed||Phase 3|80||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:06:42.342155|2017-02-18 17:06:42.342155
NCT00224575|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-07|||November 2004||2004-11-01|March 2016|2016-03-01|November 2006|Actual|2006-11-01|November 2005|Actual|2005-11-01||Interventional|IRIDIA||Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly|Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly|Terminated||N/A|260|Actual|Assistance Publique - Hôpitaux de Paris||1||End of recruitment period|f||||f||||||||||2017-02-18 17:06:42.444599|2017-02-18 17:06:42.444599
NCT00224562|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-10-25|||February 2004||2004-02-01|February 2004|2004-02-01||||||||Observational|||The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists|The RATIO Registry: French Registry on Opportunistic and Severe Bacterial Infections and Lymphoma in Patients Treated With TNF-a Antagonists|Unknown status|Recruiting|N/A|||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:06:42.555159|2017-02-18 17:06:42.555159
NCT00224549|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-02-25|||April 2005||2005-04-01|March 2007|2007-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||PHARES Study: Management of Resistant Hypertension|Management of Resistant Hypertension -Pharmacokinetic Assessment of Different Antihypertensive Regimen -Comparison of Two Treatment Strategies: Increase Sodium Depletion or Combined Blockage of Renin-angiotensin System (RAS)|Completed||Phase 4|180|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:06:42.641167|2017-02-18 17:06:42.641167
NCT00005426|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||May 1993||1993-05-01|December 2000|2000-12-01|December 1994|Actual|1994-12-01|||||Observational|||Effects of CHD Prevention on Lipoprotein Subclasses||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.610496|2017-02-18 18:15:00.610496
NCT00224523|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2016-10-27|||September 2005||2005-09-01|October 2016|2016-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Long Term Safety Of GW685698X Via Nasal Biopsy|A Randomized, Open Label, Active Controlled (Mometasone Furoate Aqueous Nasal Spray [Nasonex®] 200mcg QD), Parallel Group, Multi-Center, 52-Week Study to Assess the Long Term Safety of GW685698X Aqueous Nasal Spray 100mcg QD Via Nasal Biopsy in Subjects 18 Years of Age With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|125|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:06:42.850673|2017-02-18 17:06:42.850673
NCT00224510|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2017-01-19|||August 2002|Actual|2002-08-01|January 2017|2017-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium|A Mulitcentre, Double-blind, Randomised, Fixed-dose Evaluation of the Safety and Efficacy of Lamictal (Lamotrigine) Compared to Placebo as an add-on Therapy to Lithium or Another Mood Stabiliser in the Treatment of Bipolar Depression, Followed by Long-term Prevention of Relapse and Recurrence of Depression and/or Mania in Patients With Bipolar Disorder|Completed||Phase 3|120|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 17:06:42.994982|2017-02-18 17:06:42.994982
NCT00224497|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2009-12-23|||September 2005||2005-09-01|December 2009|2009-12-01||||||||Interventional|||A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease|A Phase IIa/b Double-blind, Randomised, Placebo-controlled, Linear Trend Design Dose-ranging Study to Investigate the Effects of 24 Weeks of Monotherapy With SB-742457 on Cognition in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|380||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 17:06:43.141848|2017-02-18 17:06:43.141848
NCT00224484|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2017-02-16|||April 2004||2004-04-01|February 2017|2017-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old|A Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Herpes Simplex Candidate Vaccine (gD2‑AS04) in Healthy HSV Seronegative and Seropositive Female Subjects Aged 10-17 Years.|Completed||Phase 3|5960|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:06:43.296694|2017-02-18 17:06:43.296694
NCT00224471|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-09-20|||December 2003||2003-12-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|September 2005|Actual|2005-09-01||Interventional|||Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine|A Phase III, Double-blind, Randomized, Study to Compare: 1) the Immunogenicity and Safety of 3 Commercial Scale Consistency Lots of GlaxoSmithKline (GSK) Biologicals' Herpes Simplex Candidate Vaccine in Healthy HSV-1 and -2 Seronegative (HSV 1-/2-) Female Subjects Aged 10 - 17 Years, and 2) Vaccine Immunogenicity in Healthy HSV 1-/2- Females Aged 10 - 17 Years With Healthy HSV 1-/2- Adult Females|Completed||Phase 3|671|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:06:43.749474|2017-02-18 17:06:43.749474
NCT00224458|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2008-04-07|||September 2004||2004-09-01|February 2008|2008-02-01|February 2006|Actual|2006-02-01|||||Interventional|||Combination of Efavirenz and Truvada - COMET Study|Combination of Efavirenz & Truvada (COMET Study): Phase 4 Evaluation of Switching Twice Daily Combivir to Once-Daily Regimen Co-Formulated Truvada in Virologically Suppressed HIV Infected Patients Taking Efavirenz.|Completed||Phase 4|400||Gilead Sciences||1|||f||||||||||||||2017-02-18 17:06:43.876006|2017-02-18 17:06:43.876006
NCT00224445|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-01-08|||September 2005||2005-09-01|January 2013|2013-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Boosted Atazanavir and Truvada Given Once-Daily - BATON Study|Boosted Atazanavir and Truvada Given Once-Daily (BATON Study): A Phase 4 Study of Safety, Efficacy & Adherence in HIV Infected, Antiretroviral Naïve Subjects Treated With a Simple Once-Daily Regimen|Completed||Phase 4|100|Actual|Gilead Sciences||1|||f||||||||||||||2017-02-18 17:06:43.963072|2017-02-18 17:06:43.963072
NCT00224432|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-26|||March 2001||2001-03-01|September 2006|2006-09-01|September 2002||2002-09-01|||||Interventional|||Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis|Double-Blind, Parallel, Randomised Study to Investigate the Clinical and Immunological Effects of Oral Administration of Probiotic Bacteria in Infants With Atopic Dermatitis With and Without Cow’s Milk Allergy.|Completed||N/A|45||Groningen Research Institute for Asthma and COPD|||||f||||||||||||||2017-02-18 17:06:44.074637|2017-02-18 17:06:44.074637
NCT00224419|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-07-18|||June 2003||2003-06-01|April 2009|2009-04-01||||August 2006|Actual|2006-08-01||Interventional|||Testing Pharmacological Therapies for Pregnant Smokers|Testing Pharmacological Therapies for Pregnant Smokers|Terminated||Phase 4|181|Actual|Duke University||2||was terminated due to meeting a priori stopping rule set by DSMB|f||||t||||||||||2017-02-18 17:06:44.182128|2017-02-18 17:06:44.182128
NCT00224406|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2008-11-26|||May 2005||2005-05-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|September 2007|Actual|2007-09-01||Interventional|||Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation|A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Repertaxin in the Prevention of Primary Graft Dysfunction After Lung Transplantation|Completed||Phase 2|100||Dompé Farmaceutici S.p.A|||||||||||||||||||2017-02-18 17:06:44.299493|2017-02-18 17:06:44.299493
NCT00224393|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-09-21|||February 2001||2001-02-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis||Suspended||Phase 2|60||The Cleveland Clinic|||||f||||||||||||||2017-02-18 17:06:44.396699|2017-02-18 17:06:44.396699
NCT00224380|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-09-22|||July 2003||2003-07-01|September 2009|2009-09-01|February 2005||2005-02-01|||||Interventional|||Medication Adherence in Older Adults With Serious Mental Illness|Medication Adherence in Older Adults|Completed||N/A|72||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 17:06:44.485853|2017-02-18 17:06:44.485853
NCT00224367|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-09-21|||February 2004||2004-02-01|February 2005|2005-02-01|December 2004||2004-12-01|||||Interventional|||Does Early Ambulation After Hip Fracture Surgery Accelerate Recovery?|Does Early Ambulation After Hip Fracture Surgery Accelerate Recovery?: A Randomised Controlled Trial|Completed||N/A|60||Bayside Health|||||f||||||||||||||2017-02-18 17:06:44.764479|2017-02-18 17:06:44.764479
NCT00219323|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2011-10-24|||November 2003||2003-11-01|October 2011|2011-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.|Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma|Completed||Phase 3|133|Actual|Novartis|||||f||||||||||||||2017-02-18 17:07:51.41848|2017-02-18 17:07:51.41848
NCT00224354|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2012-05-18|||September 2005||2005-09-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|CLONTAK||Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells|Treatment of Chronic Lymphocytic B-Leukemia (B-CLL) With Human IL-2 Gene Modified and Human CD40 Ligand-Expressing Autologous Tumor Cells After Depletion of Regulatory T Cells|Withdrawn||Phase 1|0|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:06:44.859595|2017-02-18 17:06:44.859595
NCT00224341|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2006-10-17|||November 2003||2003-11-01|September 2005|2005-09-01|November 2006||2006-11-01|||||Interventional|||Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation||Unknown status|Recruiting|Phase 4|360||Vitatron France|||||f||||||||||||||2017-02-18 17:06:44.968047|2017-02-18 17:06:44.968047
NCT00224328|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-11|||August 2005||2005-08-01|September 2007|2007-09-01|January 2007|Actual|2007-01-01|||||Observational|||Measurement of Tissue Oxygen Saturation in Chronic Critical Limb Ischemia|Measurement of Tissue Oxygen Saturation in Chronic Critical Limb Ischemia: A Phase Iia, Non-Randomized Study Using the ODISsey Tissue Oximeter to Evaluate the Correlation Between Tissue Oxygen Saturation and Symptom Resolution in Patients With Chronic Critical Limb Ischemia Undergoing Treatment Interventions|Terminated||Phase 2|100|Anticipated|ViOptix Canada||||The results were not able to be consistantly reproduced. Thus the trial was terminated|f||||||||||||||2017-02-18 17:06:45.126268|2017-02-18 17:06:45.126268
NCT00224315|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-06-02|||November 2003||2003-11-01|June 2008|2008-06-01|September 2006||2006-09-01|||||Interventional|||Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial|Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial|Completed||Phase 4|24||Central Institute of Mental Health, Mannheim|||||f||||||||||||||2017-02-18 17:06:45.215818|2017-02-18 17:06:45.215818
NCT00224302|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-06-03|||August 2005||2005-08-01|September 2005|2005-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine|Treatment of Major Depressive Episodes During the Course of Psychotic Disorders With Duloxetine|Completed||Phase 4|20|Anticipated|Central Institute of Mental Health, Mannheim|||||f||||||||||||||2017-02-18 17:06:45.308264|2017-02-18 17:06:45.308264
NCT00224289|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-11-09|2012-11-09||March 2005||2005-03-01|November 2012|2012-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Effect of Age on Latanoprost 0.005% in Patients With Glaucoma|Effect of Age on Efficacy and Response Time of Latanoprost 0.005% in Patients With Glaucoma|Completed||Phase 4|17|Actual|Yale University||1|||f||||f||||||||||2017-02-18 17:06:45.411643|2017-02-18 17:06:45.411643
NCT00224276|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16||||||September 2005|2005-09-01||||||||Observational|||Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics|Prevalence and Incidence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics|Completed||Phase 4|100||Yale University|||||f||||||||||||||2017-02-18 17:06:45.634211|2017-02-18 17:06:45.634211
NCT00224263|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2011-08-15|||September 2005||2005-09-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|||||Interventional|||Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease Receiving Stable L-dopa/DCI|Completed||Phase 2|360||Xuanwu Hospital, Beijing|||||f||||t||||||||||2017-02-18 17:06:45.707893|2017-02-18 17:06:45.707893
NCT00224250|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-12-07|||January 2005||2005-01-01|December 2006|2006-12-01||||||||Interventional|||Ultrasound Study of the Uterine Healing Process After Cesarean Delivery|Ultrasonographic Assessment of the Uterine Scarring Process Following Closure of the Uterus in One Versus Two Layer Technique.|Completed||N/A|30||Yale University|||||f||||||||||||||2017-02-18 17:06:45.823012|2017-02-18 17:06:45.823012
NCT00224237|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-11-04|||December 2005||2005-12-01|November 2010|2010-11-01|October 2007|Anticipated|2007-10-01|||||Observational|||Exploring Folk Health Practices in Latinos With Chronic Medical Conditions|Exploring Folk Health Practices in Latinos With Chronic Medical Conditions|Unknown status|Active, not recruiting|N/A|60|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 17:06:45.909175|2017-02-18 17:06:45.909175
NCT00224224|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-04-02|||January 1995||1995-01-01|March 2008|2008-03-01|January 2005||2005-01-01|||||Observational|||A Comparison of Primary Care and Traditional Internal Medicine Residents|A Comparison of Primary Care and Traditional Internal Medicine Residents|Completed||N/A|||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 17:06:45.999776|2017-02-18 17:06:45.999776
NCT00224211|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-03-12|||June 2005||2005-06-01|September 2005|2005-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Music's Effects on Premature Babies.|Effects of Homophonic Sounds on Preterm Infants|Completed||N/A|50|Actual|Weill Medical College of Cornell University|||1||f||||t||||||||||2017-02-18 17:06:46.094006|2017-02-18 17:06:46.094006
NCT00224198|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2016-04-29|||January 2004||2004-01-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Evaluation of the Lungs of Individuals With Lung Disease|Evaluation of the Lungs of Individuals With Lung Disease With Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing and Bronchial Wall Biopsy|Completed||N/A|196|Actual|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"~     Specimens will be retained from both a blood draw and a bronchoscopy procedure.~   "|Undecided||2017-02-18 17:06:46.195727|2017-02-18 17:06:46.195727
NCT00224185|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2016-04-29|||January 2004||2004-01-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Observational|||Evaluation of Lungs of Normal Individuals by Lung Lavage, Brushing and Bronchial Wall Biopsy|Evaluation of the Lungs of Normal Individuals With Segmental Bronchopulmonary Lung Lavage, Bronchial Brushing and Bronchial Wall Biopsy|Completed||N/A|196|Actual|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"~     Specimens will be retained from both a blood draw and a bronchial wall biopsy which obtains~     tissue to a depth of 2-3 mm and includes epithelial and subepithelial tissue.~   "|Undecided||2017-02-18 17:06:46.30782|2017-02-18 17:06:46.30782
NCT00224172|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-03-27|||January 2001||2001-01-01|March 2008|2008-03-01|December 2001||2001-12-01|||||Observational|||Ambulatory Care Characteristics as Predictors of Mortality and Re-Admission|Ambulatory Care Characteristics as Predictors of Mortality and Re-Admission|Completed||N/A|302||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 17:06:46.418743|2017-02-18 17:06:46.418743
NCT00224159|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2011-02-18|||February 2005||2005-02-01|February 2011|2011-02-01|June 2006||2006-06-01|||||Observational|||Does Statin Initiation Undermine Dietary Behavior?|Does Statin Initiation Undermine Dietary Behavior?|Completed||N/A|100||Weill Medical College of Cornell University|||1||f||||||||||||||2017-02-18 17:06:46.505425|2017-02-18 17:06:46.505425
NCT00224146|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-11-29|||May 2004||2004-05-01|November 2011|2011-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|MATRIX||Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder|Multicenter Assessment of Transdermal Therapy in Overactive Bladder With Oxybutynin TDS (MATRIX)|Completed||Phase 4|2878|Actual|Watson Pharmaceuticals|||||f||||||||||||||2017-02-18 17:06:46.599431|2017-02-18 17:06:46.599431
NCT00224133|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-04-06|2009-12-23||September 2005||2005-09-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months|A Multi-Center, Open-Label Evaluation of the Safety of a New Drug in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|661|Actual|Watson Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:06:46.712439|2017-02-18 17:06:46.712439
NCT00224120|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-12-11|2009-09-08||May 2005||2005-05-01|December 2009|2009-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo|A Multi-Center, Randomized, Double-Blind, Placebo Controlled, Parallel Evaluation of the Efficacy and Safety of a New Drug in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|462|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:06:47.184007|2017-02-18 17:06:47.184007
NCT00224107|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-07-05|2009-09-08||May 2005||2005-05-01|July 2011|2011-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo|A Multi-Center, Randomized, Double-Blind, Placebo Controlled, Parallel Evaluation of the Efficacy and Safety of a New Drug in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia|Completed||Phase 3|461|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:06:47.661197|2017-02-18 17:06:47.661197
NCT00224094|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-10-11|||January 2002||2002-01-01|October 2012|2012-10-01||||May 2003|Actual|2003-05-01||Interventional|||A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women|A Comparison of Transdermal vs. Oral Estrogen Replacement Therapy on Androgen Levels and Thyroid Function in Naturally Menopausal Women|Completed||Phase 4|27|Actual|Watson Pharmaceuticals||2|||f||||||||||||||2017-02-18 17:06:48.343734|2017-02-18 17:06:48.343734
NCT00224081|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-08|||September 2004||2004-09-01|December 2015|2015-12-01||||May 2006|Actual|2006-05-01||Interventional|DRIVE||DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)|Dialysis Patients' Response to IV Iron With Elevated Ferritin|Completed||Phase 4|134|Actual|Watson Pharmaceuticals||2|||f||||||||||||||2017-02-18 17:06:48.450207|2017-02-18 17:06:48.450207
NCT00224068|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-29|||May 2002||2002-05-01|February 2012|2012-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy|A Multicenter, Randomized, Controlled Prospective Trial of the Safety and Efficacy of Ferrlecit® in Anemic Cancer Patients Who Are Receiving Acute Chemotherapy and Epoetin as Compared to Oral Iron and No Treatment|Completed||Phase 4|180||Watson Pharmaceuticals|||||f||||f||||||||||2017-02-18 17:06:48.595875|2017-02-18 17:06:48.595875
NCT00224055|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-29|2012-02-29||April 2003||2003-04-01|February 2012|2012-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients|A Randomized, Controlled, Open-label Study of the Safety and Efficacy of Ferrlecit® vs Oral Iron in Iron Deficient Patients With Chronic Kidney Disease|Completed||Phase 4|89|Actual|Watson Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:06:48.745883|2017-02-18 17:06:48.745883
NCT00224042|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-29|2009-12-23||April 2003||2003-04-01|February 2012|2012-02-01||||May 2005|Actual|2005-05-01||Interventional|||Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents|A Randomized, Controlled, Open-label Study of the Safety and Efficacy of Ferrlecit® vs Oral Iron in Iron Deficient Patients With Chronic Kidney Disease Being Treated With Erythropoietic Therapy|Completed||Phase 4|52|Actual|Watson Pharmaceuticals||2|||f||||||||||||||2017-02-18 17:06:49.269468|2017-02-18 17:06:49.269468
NCT00224029|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-07|2009-11-13||December 2004||2004-12-01|April 2010|2010-04-01|May 2008|Actual|2008-05-01|December 2005|Actual|2005-12-01||Interventional|||A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition|A Multi-center, Open-label, Dose-titration Pilot Study Evaluating the Efficacy and Safety of Oxybutynin Transdermal Systems in Patients With Neurogenic Bladder Resulting From Spinal Cord Injury|Completed||Phase 4|24|Actual|Watson Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:06:49.755095|2017-02-18 17:06:49.755095
NCT00224016|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-07|2009-11-13||December 2004||2004-12-01|February 2012|2012-02-01|September 2008|Actual|2008-09-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition|A Multi-Center, Open-Label (OL), Active-Controlled, Dose-Titration Study Evaluating the Safety, Efficacy and PK of Oxybutynin Transdermal Systems in the Treatment of Detrusor Overactivity in Pediatric Patients|Completed||Phase 4|57|Actual|Watson Pharmaceuticals|The transdermal groups included more males and younger subjects. The study was not designed to compare the transdermal and oral groups. Advserse event data reported for the titration and maintenance periods.|2|||f||||f||||||||||2017-02-18 17:06:50.002662|2017-02-18 17:06:50.002662
NCT00224003|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-08-18|2009-08-18||April 2003||2003-04-01|August 2009|2009-08-01|February 2005|Actual|2005-02-01|March 2004|Actual|2004-03-01||Interventional|||Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients|Open-Label, Multi-Center Study of the Safety and Efficacy of Ferrlecit® in the Maintenance of Iron Stores in Pediatric Hemodialysis Patients Receiving Epoetin|Completed||Phase 4|23|Actual|Watson Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:06:50.581452|2017-02-18 17:06:50.581452
NCT00223990|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-02-01|||March 2005||2005-03-01|February 2013|2013-02-01|April 2006||2006-04-01|||||Interventional|||Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine|A Dbl-blind,Randomized,Controlled,Phase IIb Field Trial in 12-47 Month-old Children in Western Kenya to Eval the Efficacy,Safety and Immunogenicity of the FMP1/AS02A Malaria Vaccine vs Rabies Vaccine|Completed||Phase 2|400||U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-02-18 17:06:50.805466|2017-02-18 17:06:50.805466
NCT00223782|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-03-21|||May 2004||2004-05-01|March 2008|2008-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy|Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy|Completed||N/A|150|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 17:06:57.499805|2017-02-18 17:06:57.499805
NCT00223977|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-17|2009-08-19||December 2003||2003-12-01|May 2013|2013-05-01|February 2008|Actual|2008-02-01|November 2004|Actual|2004-11-01||Interventional|||2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.|A Multi-center, Randomized, Open Label Study of the Efficacy and Safety of Two Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peroneal Dialysis Patients Receiving Erythropoietin.|Completed||Phase 2/Phase 3|146|Actual|Watson Pharmaceuticals|Primary endpoint for the 250 mg dose was 4 weeks earlier than the endpoint for the 125 mg dose, which may have contributed to lower Hbg increase with the 250 mg dose at endpoint.|3|||f||||f||||||||||2017-02-18 17:06:50.914997|2017-02-18 17:06:50.914997
NCT00223964|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-10|||June 2003||2003-06-01|August 2012|2012-08-01||||October 2003|Actual|2003-10-01||Interventional|||Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients|Randomized Double-Blind Parallel Group MultiCenter Study of the Efficacy of Two Doses of Ferrlecit® in Treatment of Iron Deficiency in Pediatric Hemodialysis Patients Receiving Epoetin.|Completed||Phase 4|59|Actual|Watson Pharmaceuticals||2|||f||||||||||||||2017-02-18 17:06:51.789372|2017-02-18 17:06:51.789372
NCT00223951|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-02-19|||September 2005||2005-09-01|February 2015|2015-02-01||||December 2005|Actual|2005-12-01||Interventional|||Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers|A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of R89674 0.25% Ophthalmic Solution in Healthy, Normal Volunteers|Completed||Phase 3|900||Vistakon Pharmaceuticals|||||f||||||||||||||2017-02-18 17:06:51.910637|2017-02-18 17:06:51.910637
NCT00223938|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-18|||May 2004||2004-05-01|February 2008|2008-02-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Interventional|||Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.|A Multi-Center, Open-Label, Randomized, Parallel Group Study of the Efficacy and Safety of Ferrlecit in the Maintenance of Iron Stores and Serum Hemoglobin Concentration in Hemodialysis Patients Receiving Erythropoietin.|Unknown status|Active, not recruiting|Phase 4|291|Anticipated|Watson Pharmaceuticals||3|||f||||f||||||||||2017-02-18 17:06:52.014585|2017-02-18 17:06:52.014585
NCT00223925|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-25|||October 2004||2004-10-01|March 2014|2014-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Maribavir for Prevention of CMV After Stem Cell Transplants|A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Assess the Safety, Tolerability, and Prophylactic Anti-cytomegalovirus Activity of Maribavir in Recipients of Allogeneic Stem Cell Transplants|Completed||Phase 2|111|Actual|Shire||4|||||||||||||||||2017-02-18 17:06:54.990966|2017-02-18 17:06:54.990966
NCT00223912|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-09-15|||November 2003||2003-11-01|September 2010|2010-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|FES||Effect of Exercise on Blood Coagulation in Persons With Chronic Spinal Cord Injury|Effect of FES- Exercise on Hemostasis in Persons With Chronic Spinal Cord Injury|Completed||N/A|12|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:06:55.106615|2017-02-18 17:06:55.106615
NCT00223899|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-05|||July 2005||2005-07-01|July 2011|2011-07-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Interventional|||A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma|A Phase 1, Multi-Center, Open-Label, Dose-Escalation Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma|Completed||Phase 1|26|Actual|Vical||1|||f||||f||||||||||2017-02-18 17:06:55.212696|2017-02-18 17:06:55.212696
NCT00223873|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-20|||November 2002||2002-11-01|May 2006|2006-05-01|July 2006|Actual|2006-07-01|||||Interventional|||The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury|The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury|Completed||N/A|30||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:06:55.319245|2017-02-18 17:06:55.319245
NCT00223860|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-03-05|||July 2001||2001-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.|Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury|Completed||N/A|100|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:06:55.416114|2017-02-18 17:06:55.416114
NCT00223847|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-12-31|||August 2002||2002-08-01|December 2008|2008-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||An Investigation of Constraint Induced Language Therapy for Aphasia|An Investigation of Constraint Induced Language Therapy for Aphasia|Completed||N/A|48|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 17:06:55.526973|2017-02-18 17:06:55.526973
NCT00223834|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-03-11|||March 2005||2005-03-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|January 2007|Actual|2007-01-01||Interventional|||Pathways to Vocational Rehabilitation: Enhancing Entry and Retention|Pathways to Vocational Rehabilitation: Enhancing Entry and Retention|Completed||N/A|200|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:06:55.622992|2017-02-18 17:06:55.622992
NCT00223821|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-10-29|2013-10-11||September 2003||2003-09-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|November 2008|Actual|2008-11-01||Interventional|COMBO||Enhancing Conservative Treatment for Urge Incontinence|Enhancing Conservative Treatment for Urge Incontinence|Completed||N/A|166|Actual|VA Office of Research and Development|Secondary objectives could not be achieved because, based on a conditional power calculation, the trial was stopped early for futility.|2|||f||||f||||||||||2017-02-18 17:06:55.720043|2017-02-18 17:06:55.720043
NCT00223808|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-01-03|2013-10-09||January 2002||2002-01-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical Trial|Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical Trial|Completed||Phase 3|71|Actual|VA Office of Research and Development|Limitations include the relatively small number of subjects in each group and the variation in severity level across subjects. Subjects at the Houston site were enrolled earlier after stroke than in the LA site and the Palo Alto site.|3|||f||||f||||||||||2017-02-18 17:06:56.666429|2017-02-18 17:06:56.666429
NCT00223795|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-05|2013-09-24||July 2006||2006-07-01|May 2014|2014-05-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Walking Aids in the Management of Knee Osteoarthritis|Walking Aids in the Management of Obesity-Related Knee Osteoarthritis|Completed||N/A|53|Actual|VA Office of Research and Development|Had high drop out rate leading to small numbers of subjects analyzed.|2|||f||||f||||||||||2017-02-18 17:06:57.220262|2017-02-18 17:06:57.220262
NCT00223769|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-12|||January 2004||2004-01-01|May 2006|2006-05-01|May 2006|Actual|2006-05-01|||||Interventional|||The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury|The Use of Oxandrolone to Improve Function in Persons With Chronic Spinal Cord Injury|Completed||N/A|40||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:06:57.612658|2017-02-18 17:06:57.612658
NCT00223756|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-06|||November 2004||2004-11-01|January 2016|2016-01-01|August 2007|Actual|2007-08-01|July 2006|Actual|2006-07-01||Interventional|LOVIT||VA Low Vision Intervention Trial|VA Low Vision Intervention Trial|Completed||N/A|61|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:06:57.724624|2017-02-18 17:06:57.724624
NCT00223743|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-06-20|||November 2004||2004-11-01|June 2012|2012-06-01||||September 2008|Actual|2008-09-01||Interventional|||A Safety/Efficacy Trial of Zonisamide for Essential Tremor|Novel Therapies for Essential Tremor - Zonisamide Pilot Study|Completed||Phase 2|25|Actual|VA Greater Los Angeles Healthcare System||1|||f||||||||||||||2017-02-18 17:06:57.83869|2017-02-18 17:06:57.83869
NCT00223730|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-11-01|||October 2001||2001-10-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Chemotherapy Toxicity Reduction Via Urea Cycle Support|Chemotherapy Toxicity Reduction Via Urea Cycle Support|Completed||Phase 2|100|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 17:06:57.953387|2017-02-18 17:06:57.953387
NCT00223717|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2017-01-16|||June 2001||2001-06-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Treatment of Supine Hypertension in Autonomic Failure|The Pathophysiology and Treatment of Supine Hypertension in Patients With Autonomic Failure|Completed||Phase 1|152|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-02-18 17:06:58.064313|2017-02-18 17:06:58.064313
NCT00223704|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-10-15|2013-07-29||May 2006||2006-05-01|October 2013|2013-10-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|BRAC||Bradykinin Receptor Antagonism During Cardiopulmonary Bypass|Bradykinin Receptor Antagonism During Cardiopulmonary Bypass|Completed||Phase 2/Phase 3|150|Actual|Vanderbilt University|This study was conducted in a population that predominantly underwent valve-only surgery. We cannot exclude the possibility that our results may have been different if we studied only coronary artery bypass graft surgery patients.|3|||f||||t||||||||||2017-02-18 17:06:58.228714|2017-02-18 17:06:58.228714
NCT00223691|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2017-01-16|||March 2002||2002-03-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||Treatment of Orthostatic Hypotension in Autonomic Failure|Evaluation and Treatment of Autonomic Failure.|Completed||Phase 1|389|Actual|Vanderbilt University Medical Center||2|||f||||f||||||||||2017-02-18 17:06:59.118189|2017-02-18 17:06:59.118189
NCT00223678|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2008-02-21|||June 2000||2000-06-01|February 2008|2008-02-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure|Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:06:59.298028|2017-02-18 17:06:59.298028
NCT00223665|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-01-19|||January 1997||1997-01-01|January 2011|2011-01-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy|A Prospective Study of Intermittent Androgen Suppression in Men With Localized Prostate Cancer Who Have Biochemical Relapse After Radiation Therapy or Radical Prostatectomy|Unknown status|Recruiting|Phase 2|100|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 17:06:59.406705|2017-02-18 17:06:59.406705
NCT00223652|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-04-06|2014-09-09||March 2006||2006-03-01|August 2014|2014-08-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas|Tele-Mental Health Intervention to Improve Depression Outcomes in Community Based Outpatient Clinics (CBOCs)|Completed||Phase 2|85|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:06:59.522724|2017-02-18 17:06:59.522724
NCT00223639|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2012-02-03|||September 2005||2005-09-01|February 2012|2012-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||New Medications to Treat Alcohol Dependence|New Medications to Treat Alcohol Dependence|Completed||Phase 2|29|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 17:07:00.152298|2017-02-18 17:07:00.152298
NCT00223626|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-17|||January 2007||2007-01-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||Topiramate to Reduce Cocaine Dependence|Lab Trials to Develop Medication for Cocaine Dependence|Completed||Phase 2|25|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 17:07:00.280948|2017-02-18 17:07:00.280948
NCT00223613|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-18|||August 1997||1997-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Intranasal Insulin for Prevention of Type 1 Diabetes|Intranasal Insulin for Prevention of Type 1 Diabetes in Children Carrying Increased HLA-Conferred Genetic Risk|Unknown status|Recruiting|Phase 3|240||University of Turku|||||f||||||||||||||2017-02-18 17:07:00.412747|2017-02-18 17:07:00.412747
NCT00223600|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-18|||May 1990||1990-05-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Special Turku Atherosclerosis Risk Factor Intervention Project for Children (STRIP)|Special Turku Atherosclerosis Risk Factor Intervention Project for Children (STRIP)|Unknown status|Active, not recruiting|Phase 3|1062||University of Turku|||||f||||||||||||||2017-02-18 17:07:00.522598|2017-02-18 17:07:00.522598
NCT00223587|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-11|||September 2004||2004-09-01|April 2008|2008-04-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Seasonal Allergic Rhinitis and Driving Ability|Study to Investigate the Effects of Seasonal Allergic Rhinitis on Over-the-Road Driving Performance and Memory Functioning|Terminated||Phase 4|22|Actual|Utrecht Institute for Pharmaceutical Sciences||1||slow recruitment rate|f||||f||||||||||2017-02-18 17:07:00.633851|2017-02-18 17:07:00.633851
NCT00223574|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-09-21|||January 2002||2002-01-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Canadian Trial of Dietary Carbohydrates in Diabetes|Long-Term Effect of Altering the Source or Amount of Dietary Carbohydrate in Type 2 Diabetes|Completed||N/A|168||University of Toronto|||||f||||||||||||||2017-02-18 17:07:00.744898|2017-02-18 17:07:00.744898
NCT00223353|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-15|||November 1998||1998-11-01|February 2012|2012-02-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Quantitative Gait Analysis for Clinical Decision Making|Quantitative Gait Analysis for Clinical Decision Making|Completed||N/A|100|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||||||||||||2017-02-18 17:07:02.722417|2017-02-18 17:07:02.722417
NCT00223561|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-02-28|||February 2003||2003-02-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder|A Double Blind, Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder|Completed||Phase 4|18||Utrecht Institute for Pharmaceutical Sciences|||||f||||||||||||||2017-02-18 17:07:00.841268|2017-02-18 17:07:00.841268
NCT00223548|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||October 2002||2002-10-01|September 2002|2002-09-01|December 2004||2004-12-01|||||Interventional|||MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application|MESNA Zur Prophylaxe Der Kontrastmittel-Induzierten Nephropathie|Completed||Phase 2|106||University of Ulm|||||f||||||||||||||2017-02-18 17:07:00.932545|2017-02-18 17:07:00.932545
NCT00223535|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||February 2003||2003-02-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Cognitive Remediation and Social Skills Training in Schizophrenia|Cognitive Remediation and Social Skills Training in Schizophrenia|Completed||N/A|40||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 17:07:01.028643|2017-02-18 17:07:01.028643
NCT00223522|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||April 2004||2004-04-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Observational|||Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?|Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?|Completed||N/A|50||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 17:07:01.118861|2017-02-18 17:07:01.118861
NCT00223509|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-19|||August 2005||2005-08-01|June 2012|2012-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Lamictal As Add on Treatment in Mixed States of Bipolar Disorder|Lamictal As Add on Treatment in Mixed States of Bipolar Disorder|Completed||Phase 4|28|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 17:07:01.202875|2017-02-18 17:07:01.202875
NCT00223496|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-04-09|2013-02-27||September 2004||2004-09-01|April 2013|2013-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||32 subjects consented, 19 subjects were baselined|12- Week Open Label Treatment of Refractory Bipolar Depression|12- Week Open Label Treatment of Refractory Bipolar Depression (BD) With Combination of Depakote ER (DEP) and Aripiprazole (AZP)|Completed||Phase 4|32|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 17:07:01.306123|2017-02-18 17:07:01.306123
NCT00223483|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-12-19|||March 2005||2005-03-01|December 2016|2016-12-01|December 2019|Anticipated|2019-12-01|August 2017|Anticipated|2017-08-01||Observational|||Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers|Identification and Analysis of Immunomodulatory Molecules From Leukocytes in Patients With Hematologic Disorders and Healthy Volunteers|Active, not recruiting||N/A|1000|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, white cells~   "|||2017-02-18 17:07:01.805804|2017-02-18 17:07:01.805804
NCT00223470|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-07|||October 2002||2002-10-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Cytokine Regulation of Periradicular Pain in Humans|Cytokine Regulation of Periradicular Pain in Humans|Completed||N/A|9|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples Without DNA|"~     Sterile paper points are placed in the canal for 30 seconds~   "|||2017-02-18 17:07:01.91304|2017-02-18 17:07:01.91304
NCT00223457|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2007-01-23|||April 2004||2004-04-01|April 2005|2005-04-01|September 2005||2005-09-01|||||Observational|||Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis|Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis|Completed||N/A|1040||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 17:07:02.007756|2017-02-18 17:07:02.007756
NCT00223444|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-30|||August 2002||2002-08-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|GABA-Alcohol||Clinical-Genetic Variation in GABA/Alcohol Sensitivity|Clinical-Genetic Variation in GABA/Alcohol Sensitivity|Completed||Phase 1/Phase 2|23|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||f||||||Samples With DNA|"~     Specifically, we will determine whether the subject's gene for a brain protein called~     GABA-alpha-6 is of the Pro type or Ser type.~   "|||2017-02-18 17:07:02.111381|2017-02-18 17:07:02.111381
NCT00223431|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||February 1998||1998-02-01|September 2005|2005-09-01|May 2004||2004-05-01|||||Interventional|||Clinical Performance of 3-Unit FPDs|Clinical Performance of Three-Unit Fixed Partial Dentures (FPDs) Made From a Hot-Pressed Ceramic (Five-Year Study)|Completed||Phase 2|30||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 17:07:02.209559|2017-02-18 17:07:02.209559
NCT00223418|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-04-05|||January 2004||2004-01-01|April 2013|2013-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills|Do Patients Taking Aripiprazole Learn More in Vocational Skills Training Than Patients Taking Olanzapine?|Completed||N/A|43|Actual|The University of Texas Health Science Center at San Antonio|||||f||||f||||||||||2017-02-18 17:07:02.310663|2017-02-18 17:07:02.310663
NCT00223405|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-18|||April 2003||2003-04-01|April 2013|2013-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Analysis of Enamel Wear Against Ceramic Restorations|Analysis of Clinical Wear Patterns of Tooth Enamel and Ceramic Restorations as a Function of Particle Size, Inter-Particle Spacing and Fracture Toughness of Ceramic Crystals|Completed||Phase 2|36|Actual|The University of Texas Health Science Center at San Antonio|||2||f||||||||||||||2017-02-18 17:07:02.423263|2017-02-18 17:07:02.423263
NCT00223379|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-06|||December 2002||2002-12-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Longitudinal Endodontic Study of Apical Preparation Size|Longitudinal Endodontic Study of Apical Preparation Size|Completed||N/A|36|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||||2017-02-18 17:07:02.534562|2017-02-18 17:07:02.534562
NCT00223366|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-09|||October 2001||2001-10-01|February 2017|2017-02-01|August 2019|Anticipated|2019-08-01|August 2019|Anticipated|2019-08-01||Observational|||In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors|Studies on Normal and Inflamed Dental Pulp, NPY Regulation of Peripheral Human Nociceptors, Peripheral Mechanisms of Opioid Analgesia, Cannabinoid-induced Desensitization of TRPV1 Receptors Adrenergic Modulation of Trigeminal Nociceptors|Active, not recruiting||N/A|2000|Anticipated|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum, sputum, oral mucosa tissue, teeth~   "|||2017-02-18 17:07:02.630991|2017-02-18 17:07:02.630991
NCT00223340|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-28|||March 2005||2005-03-01|June 2012|2012-06-01|June 2007||2007-06-01|June 2007|Actual|2007-06-01||Interventional|||The ABC Planning Study: Diabetes and Cardiovascular Risks in Primary Care|Diabetes and Cardiovascular Risks in Primary Care|Completed||N/A|400||The University of Texas Health Science Center at San Antonio|||||f||||f||||||||||2017-02-18 17:07:02.832576|2017-02-18 17:07:02.832576
NCT00223327|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-07|||March 2005||2005-03-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Measurement of Bite Force in Humans|Measurement of Bite Force in Humans|Completed||Early Phase 1|89|Actual|The University of Texas Health Science Center at San Antonio|||1||f||||f||||||||||2017-02-18 17:07:02.934321|2017-02-18 17:07:02.934321
NCT00223314|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-12-20|||November 2000||2000-11-01|December 2007|2007-12-01|February 2004|Actual|2004-02-01|||||Interventional|||Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program|HIV Prevention Among Alternative School Youth|Completed||N/A|1000|Actual|The University of Texas Health Science Center, Houston||1|||f||||f||||||||||2017-02-18 17:07:03.02577|2017-02-18 17:07:03.02577
NCT00223301|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-04-18|||July 2004||2004-07-01|April 2013|2013-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis|A One-Year Prospective, Randomized, Placebo-Controlled, Double-Blind, Phase II/III Safety Trial of Combination Therapy With IFN Beta-1a (Avonex) and Mycophenolate Mofetil (Cellcept) in Early Multiple Sclerosis|Completed||Phase 2/Phase 3|24||University of Texas Southwestern Medical Center|||||f||||f||||||||||2017-02-18 17:07:03.138797|2017-02-18 17:07:03.138797
NCT00223288|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-08-02|||March 2003||2003-03-01|August 2011|2011-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Impact of Caregiver Depression on Asthma in the Child|Caregiver Psychiatric Symptomatology and it's Relationship to Service Utilization by Children With Asthma|Completed||Phase 4|175||University of Texas Southwestern Medical Center|||1||f||||||||||||||2017-02-18 17:07:03.243171|2017-02-18 17:07:03.243171
NCT00223275|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-05-23|||May 2005||2005-05-01|May 2011|2011-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Naltrexone for Bipolar Disorder and Alcohol Dependence|Naltrexone for Bipolar Disorder and Alcohol Dependence|Completed||Phase 4|50|Anticipated|University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 17:07:03.339732|2017-02-18 17:07:03.339732
NCT00223262|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-08-02|||August 2002||2002-08-01|January 2010|2010-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients||Completed||Phase 4|||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 17:07:03.440917|2017-02-18 17:07:03.440917
NCT00223249|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-04-01|||November 2002||2002-11-01|April 2016|2016-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence|A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Alcohol Abuse/ Dependence.|Completed||Phase 4|115|Actual|University of Texas Southwestern Medical Center||2|||f||||f||||||||||2017-02-18 17:07:03.525028|2017-02-18 17:07:03.525028
NCT00223236|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-08-07|2013-07-08||July 2010||2010-07-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional||Number of paticipants who completed baseline assessment|Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence|A Double-blind, Placebo-controlled Trial of Citicoline add-on Therapy in Patients With a History of Mania or Hypomania and Cocaine Abuse/Dependence|Completed||Phase 3|44|Actual|University of Texas Southwestern Medical Center|Low retention rate in the end of study (12 weeks) leading to a potential underestimation of treatment effectiveness.|2|||f||||f||||||||||2017-02-18 17:07:03.630806|2017-02-18 17:07:03.630806
NCT00223223|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-08-02|||February 2005||2005-02-01|September 2005|2005-09-01|November 2005||2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study|Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study|Completed||Phase 4|30||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 17:07:04.21651|2017-02-18 17:07:04.21651
NCT00223210|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-08-16|||November 2005||2005-11-01|August 2012|2012-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence|A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence|Completed||Phase 4|100|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 17:07:04.304569|2017-02-18 17:07:04.304569
NCT00223197|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-04-02|||February 2004||2004-02-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse|A Double-blind Placebo Controlled Trial of Pregnenolone for Depression in Patients With Bipolar Disorders or Recurrent Major Depressive Disorder and a History of Substance Abuse|Completed||Phase 4|75||University of Texas Southwestern Medical Center|||||f||||||||||||||2017-02-18 17:07:04.418997|2017-02-18 17:07:04.418997
NCT00223184|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-29|||March 2003||2003-03-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Observational|||Genetic Characterisation of High-grade Paediatric Osteosarcomas|Study of Prognostic Value by Molecular Analysis in Paediatric Osteosarcomas of the Chromosomal Regions Containing Rb, p16, p53, Cycline D1, APC, erbB2 and C-met Genes|Completed||N/A|||University Hospital, Strasbourg, France|||1||f||||||||||||||2017-02-18 17:07:04.516074|2017-02-18 17:07:04.516074
NCT00223171|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-01-22|||October 2000||2000-10-01|January 2015|2015-01-01|December 2016|Anticipated|2016-12-01|January 2016|Anticipated|2016-01-01||Interventional|PCS IV||Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers|Randomized, Multicentre, Phase III Study: Assessment of the Duration of Androgen Blockade Combined With Pelvic Irradiation in High-risk Prostate Cancers|Unknown status|Active, not recruiting|Phase 3|650|Anticipated|Université de Sherbrooke||2|||f||||f||||||||||2017-02-18 17:07:04.59634|2017-02-18 17:07:04.59634
NCT00223158|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2014-04-08|||September 2003||2003-09-01|July 2005|2005-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer|L-T3 Preparation for I131 Whole Body Scintigraphy: A Randomized Controlled Trial|Completed||N/A|70|Anticipated|Université de Sherbrooke|||||f||||||||||||||2017-02-18 17:07:04.702432|2017-02-18 17:07:04.702432
NCT00222937|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2016-01-21|||October 2005||2005-10-01|January 2016|2016-01-01|August 2010|Actual|2010-08-01|June 2009|Actual|2009-06-01||Interventional|||Voice Therapy for Teachers With Voice Problems|Efficacy of Voice Therapy for Phonotrauma in Teachers|Completed||Phase 3|105|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 17:07:06.479785|2017-02-18 17:07:06.479785
NCT00223145|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-01-22|||December 2000||2000-12-01|January 2015|2015-01-01|December 2018|Anticipated|2018-12-01|January 2018|Anticipated|2018-01-01||Interventional|PCS III||Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone|Randomized, Multicentre, Phase III Study in Patients With Intermediate-risk T1 T2 Prostate Adenocarcinomas, to Verify the Role of Six Months of Total Androgen Blockade for Two Dosage Levels of Prostate Radiation Therapy (70 Gy and 76 Gy) Versus Prostate Radiation Therapy Alone at 76 Gy|Active, not recruiting||Phase 3|600|Actual|Université de Sherbrooke||3|||f||||f||||||||||2017-02-18 17:07:04.805109|2017-02-18 17:07:04.805109
NCT00223132|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-24|||February 2005||2005-02-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Suture Granuloma in Body Contouring Surgery||Completed||Phase 4|||Medtronic - MITG|||||f||||||||||||||2017-02-18 17:07:04.908967|2017-02-18 17:07:04.908967
NCT00223119|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-24|||January 2004||2004-01-01|October 2012|2012-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Comparison of Absorbable Sutures in Perineal Laceration Repair||Terminated||Phase 4|||Medtronic - MITG||||Study recruitment very slow.|f||||||||||||||2017-02-18 17:07:04.998577|2017-02-18 17:07:04.998577
NCT00223106|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-07-23|||March 2004||2004-03-01|July 2015|2015-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault Prolapse|A Prospective Multicenter Clinical Study on a New Approach in Treating Stress and Mixed Incontinence and Vaginal Vault Prolapse|Completed||N/A|467|Actual|Medtronic - MITG|||||f||||||||||||||2017-02-18 17:07:05.078037|2017-02-18 17:07:05.078037
NCT00223093|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-10-27|||February 2004||2004-02-01|April 2003|2003-04-01|August 2005||2005-08-01|||||Interventional|||TAIZ -Monocytes for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)|A Single-Center Open-Labelled Study of the Administration of Transplant-Acceptance Inducing Cells (TAIZ) for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)|Unknown status|Active, not recruiting|Phase 1|10||University of Schleswig-Holstein|||||f||||||||||||||2017-02-18 17:07:05.166416|2017-02-18 17:07:05.166416
NCT00223080|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-04|||October 2003||2003-10-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|July 2006|Actual|2006-07-01||Interventional|||HIV Vaccine Trial in Thai Adults|A Phase III Trial of Aventis Pasteur Live Recombinant ALVAC-HIV (vCP1521) Priming With VaxGen gp120 B/E (AIDSVAX B/E) Boosting in HIV-uninfected Thai Adults|Completed||Phase 3|16402|Actual|U.S. Army Medical Research and Materiel Command||2|||f||||t||||||||||2017-02-18 17:07:05.238467|2017-02-18 17:07:05.238467
NCT00223067|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-10-27|||March 2005||2005-03-01|April 2004|2004-04-01|May 2006||2006-05-01|||||Interventional|||Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes|A Multi-Center Open-Labeled Study of the Administration of Allogenic and Autologous Regulatory Cells for the Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor)|Unknown status|Recruiting|Phase 1|10||University of Schleswig-Holstein|||||f||||||||||||||2017-02-18 17:07:05.357467|2017-02-18 17:07:05.357467
NCT00223054|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-08-03|||March 2005||2005-03-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Observational|||Polymorphism of the Cytochrome P450-system in Renal Transplants|Polymorphism of the Cytochrome P450-system and the MDR-system in Renal Transplants Receiving the Immunosuppressive Drugs Tacrolimus, Sirolimus, Everolimus or Cyclosporine A|Completed||Phase 4|200|Actual|University of Schleswig-Holstein|||1||f||||t||||||Samples With DNA|"~     DNA samples to analyze polymorphisms~   "|||2017-02-18 17:07:05.43595|2017-02-18 17:07:05.43595
NCT00223041|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-08-04|||April 2003||2003-04-01|May 2006|2006-05-01|December 2010|Actual|2010-12-01|November 2009|Actual|2009-11-01||Interventional|||Cranoc Lipid Study in Renal Transplantation|Cardiovascular Events in Renal Transplant Recipients With Low LDL-cholesterol Receiving Tacrolimus in Combination With the Statin Fluvastatin|Terminated||Phase 2/Phase 3|200|Anticipated|University of Schleswig-Holstein||2||No possibilty to receive all plened patients for this study|f||||t||||||||||2017-02-18 17:07:05.525896|2017-02-18 17:07:05.525896
NCT00223028|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-10-27|||April 2005||2005-04-01|July 2004|2004-07-01|July 2005||2005-07-01|||||Interventional|||Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation|Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation|Completed||Phase 4|15||University of Schleswig-Holstein|||||f||||||||||||||2017-02-18 17:07:05.625965|2017-02-18 17:07:05.625965
NCT00223015|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-10-19|||May 2004||2004-05-01|May 2004|2004-05-01|April 2005||2005-04-01|||||Interventional|||Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation||Completed||Phase 4|15||University of Schleswig-Holstein|||||f||||||||||||||2017-02-18 17:07:05.696089|2017-02-18 17:07:05.696089
NCT00223002|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-02-12|||November 2004||2004-11-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||Chlorhexidine Versus Povidone-Iodine for Prevention of Epidural Needle Contamination in the Parturient|Chlorhexidine Versus Povidone-Iodine for Prevention of Epidural Needle Contamination in the Parturient|Completed||N/A|400|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-02-18 17:07:06.011821|2017-02-18 17:07:06.011821
NCT00222989|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-09-13|||October 2003||2003-10-01|September 2006|2006-09-01||||||||Interventional|||PPI Versus Placebo in Severe Functional Heartburn|PPI Versus Placebo in Severe Functional Heartburn|Unknown status|Recruiting|N/A|60||University of Southern California|||||f||||||||||||||2017-02-18 17:07:06.117986|2017-02-18 17:07:06.117986
NCT00222976|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-11-13|||September 2006||2006-09-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||Oral vs Rectal Admin of Naproxen for Post-Vag Perineal Pain Control|Oral vs Rectal Administration of Naproxen for Post-Vaginal Perineal Pain Control: A Randomized Clinical Trial|Completed||Phase 4|60|Anticipated|University of Saskatchewan||2|||f||||f||||||||||2017-02-18 17:07:06.20427|2017-02-18 17:07:06.20427
NCT00222963|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-02-12|||September 2004||2004-09-01|September 2006|2006-09-01||||||||Observational|||Pilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and Adolescents|Pilot Study to Assess the Effectiveness of Tonsil and Adenoidectomy (T+A) in Overweight Children and Adolescents|Completed||N/A|250|Actual|University of Rochester|||1||f||||f||||||||||2017-02-18 17:07:06.311943|2017-02-18 17:07:06.311943
NCT00222950|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-14|||September 2003||2003-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Concentration of Plant Sterols in Serum and Aortic Valve Cusps|Concentrations of Plant Sterols in Serum and Aortic Valve Cusps: a Prospectiv Observational Study|Unknown status|Recruiting|N/A|100||University Hospital, Saarland|||||f||||||||||||||2017-02-18 17:07:06.40015|2017-02-18 17:07:06.40015
NCT00222911|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-05-19|||August 2005||2005-08-01|May 2008|2008-05-01|November 2006|Actual|2006-11-01|||||Interventional|||Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports|Conservative Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports: a Prospective Randomized Study|Completed||Phase 4|75|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:06.678686|2017-02-18 17:07:06.678686
NCT00222898|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2007-02-16|||June 2004||2004-06-01|February 2007|2007-02-01||||||||Observational|||Cancer Detection in Pancreatic Cysts|Pancreatic Cyst DNA Analysis|Completed||N/A|300||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:06.771124|2017-02-18 17:07:06.771124
NCT00222885|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2007-12-14|||December 2002||2002-12-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Observational|||Multi-Tracer PET Quantitation of Insulin Action in Muscle (Phase 1, Phase 2, Phase 3, Phase 4)|Three-Tracer PET Quantitation of Insulin Action in Muscle|Completed||N/A|50||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:06.870088|2017-02-18 17:07:06.870088
NCT00222872|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-04-25|||July 2005||2005-07-01|April 2014|2014-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women|A Three Week Dose Escalation Study of PTHrP(1-36) in Postmenopausal Women|Completed||Phase 1|61|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 17:07:06.9673|2017-02-18 17:07:06.9673
NCT00222859|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-29|||March 2005||2005-03-01|July 2013|2013-07-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting|Reasons for Nontreatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting|Completed||N/A|300|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 17:07:07.089522|2017-02-18 17:07:07.089522
NCT00222846|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-05-14|||May 2004||2004-05-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|ENHANCE||Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study|Enhancing Adherence in Type 2 Diabetics|Completed||N/A|288|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 17:07:07.18064|2017-02-18 17:07:07.18064
NCT00222833|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-01-08|||October 2004||2004-10-01|January 2008|2008-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia|The Effect of Switching to Aripiprazole on Indices of Cardiovascular Health in Overweight and Obese Patients With Schizophrenia|Completed||Phase 4|30||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:07.286801|2017-02-18 17:07:07.286801
NCT00222820|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-19|||April 2002||2002-04-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study|Depression: The Search for Treatment-Relevant Phenotypes|Completed||Phase 4|35||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:07.389555|2017-02-18 17:07:07.389555
NCT00222807|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-16|||August 2003||2003-08-01|February 2011|2011-02-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Observational|||Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus|Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus|Unknown status|Recruiting|N/A|200|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     blood samples are collected, stored at minus 70 degree C and analyzed in batches.~   "|||2017-02-18 17:07:07.485226|2017-02-18 17:07:07.485226
NCT00222794|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-08-30|||November 2003||2003-11-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|||||Interventional|||A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia|A Randomized, Parallel Group, Double Blind, Placebo Controlled, Clinical Trial of Augmentation With Atomoxetine for the Treatment of Negative Symptoms in Patients With Schizophrenia and Schizoaffective Disorder|Completed||Phase 4|66||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:07.579872|2017-02-18 17:07:07.579872
NCT00222781|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-12-14|||January 2004||2004-01-01|December 2007|2007-12-01|December 2006||2006-12-01|||||Observational|||Multi-Tracer PET Quantitation of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus|Three-Tracer PET Quantitation of Insulin Action in Muscle|Completed||N/A|24||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:07.688057|2017-02-18 17:07:07.688057
NCT00222768|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2008-02-15|||April 2005||2005-04-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|||||Observational|||PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans|Three-Tracer PET Quantitation of Insulin Action in Muscle|Completed||N/A|20||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:07.790656|2017-02-18 17:07:07.790656
NCT00222755|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2008-01-03|||January 2006||2006-01-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|CIVIC-2||Improving Care for Patients With Bipolar Disorder|Improving Care for Veterans With Bipolar Disorder|Completed||N/A|60|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 17:07:07.87272|2017-02-18 17:07:07.87272
NCT00222742|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-07-10|||November 2007||2007-11-01|July 2012|2012-07-01|March 2012|Actual|2012-03-01|May 2011|Actual|2011-05-01||Interventional|||Hypothermia in Children After Trauma|Pediatric Traumatic Brain Injury Consortium: Hypothermia|Terminated||Phase 3|90|Actual|Phoenix Children's Hospital||1||Futility|f||||t||||||||||2017-02-18 17:07:07.978106|2017-02-18 17:07:07.978106
NCT00222729|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-01-15|2016-01-15||November 2005||2005-11-01|January 2016|2016-01-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer|Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer|Completed||Phase 2|42|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 17:07:08.12829|2017-02-18 17:07:08.12829
NCT00222716|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-03-26|||January 2004||2004-01-01|March 2008|2008-03-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Managing Medications|Improving Adherence to Antiretroviral Therapy|Unknown status|Active, not recruiting|N/A|300|Anticipated|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 17:07:08.435493|2017-02-18 17:07:08.435493
NCT00222703|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||May 2002||2002-05-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Enhancing Tobacco Abstinence Following Hospitalization|Enhancing Tobacco Abstinence Following Hospitalization|Completed||N/A|80||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:08.542312|2017-02-18 17:07:08.542312
NCT00222209|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-08-02|||September 2005||2005-09-01|September 2005|2005-09-01|November 2007||2007-11-01|||||Interventional|||Clinical Study on Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain|Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain Syndromes|Unknown status|Recruiting|N/A|64||Universitätsmedizin Mannheim|||||f||||||||||||||2017-02-18 17:07:12.67921|2017-02-18 17:07:12.67921
NCT00222690|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-05-26|||June 2005||2005-06-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Observational|||Living With Fibromyalgia: Triggers,Subgroups, and a Cognitive-Behavioral and Interactive Technology-Based Intervention|Living With Fibromyalgia (FM): Triggers,Clinical Subgroups, and the Effects Of A Self-Monitored Cognitive-Behavioral and Interactive Technology-Based Intervention on Clinical Subgroups|Completed||N/A|30||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:07:08.635882|2017-02-18 17:07:08.635882
NCT00222677|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-21|||May 2004||2004-05-01|August 2011|2011-08-01||||January 2012|Anticipated|2012-01-01||Interventional|||Aspirin for the Prevention of Recurrent Venous Thromboembolism|Aspirin After Six Months or One Year of Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism in Patients With Idiopathic Venous Thromboembolism. The WARFASA Study.|Unknown status|Active, not recruiting|Phase 2/Phase 3|70|Anticipated|University Of Perugia|||||f||||||||||||||2017-02-18 17:07:08.722023|2017-02-18 17:07:08.722023
NCT00222664|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 1983||1983-09-01|August 2005|2005-08-01|December 2004||2004-12-01|||||Interventional|||Qidong Hepatitis B Intervention Study||Completed||Phase 4|80000||University of Oxford|||||f||||||||||||||2017-02-18 17:07:08.8451|2017-02-18 17:07:08.8451
NCT00222651|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2008-04-29|||July 2004||2004-07-01|April 2008|2008-04-01|July 2006|Anticipated|2006-07-01|||||Interventional|||Tenecteplase Pulmonary Embolism Italian Study|A Phase II Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of Single Bolus i.v. Tenecteplase Versus Placebo in Normotensive Patients With Pulmonary Embolism and Right Ventricular Dysfunction|Terminated||Phase 2|180|Anticipated|University Of Perugia||2||competitor study about to start|f||||||||||||||2017-02-18 17:07:08.937254|2017-02-18 17:07:08.937254
NCT00222638|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 2004||2004-10-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Interventional|||Influenza Vaccination and Oral Anticoagulant Therapy|Randomized Blinded Cross-Over Clinical Trial Investigate the Interactions Between Influenza Vaccination and Oral Anticoagulant Therapy|Completed||Phase 4|100||University Of Perugia|||||f||||||||||||||2017-02-18 17:07:09.064242|2017-02-18 17:07:09.064242
NCT00222625|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-19|||September 2005||2005-09-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets|Randomized, Open, Prospective, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII in Acute Intracerebral Haemorrhage in Patients Treated With Oral Anticoagulants or Antiplatelets Agents.|Unknown status|Recruiting|Phase 2|32||University Of Perugia|||||f||||||||||||||2017-02-18 17:07:09.16284|2017-02-18 17:07:09.16284
NCT00222612|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-02|||October 2003||2003-10-01|February 2010|2010-02-01|August 2013|Anticipated|2013-08-01|August 2013|Anticipated|2013-08-01||Interventional|||Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003|Medical Research Council Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003|Unknown status|Recruiting|Phase 4|2100|Anticipated|University of Oxford||3|||f||||t||||||||||2017-02-18 17:07:09.269835|2017-02-18 17:07:09.269835
NCT00222573|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-05-04|||July 1999||1999-07-01|March 2005|2005-03-01|February 2005||2005-02-01|||||Interventional|||Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial Infarction|Clopidogrel Or Metoprolol in Myocardial Infarction Trial|Completed||Phase 4|46000||University of Oxford|||||f||||||||||||||2017-02-18 17:07:09.397598|2017-02-18 17:07:09.397598
NCT00222560|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-04-27|||May 2005||2005-05-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|PAC||The PAC Project: Integrating a Physical Activity Counsellor in the Primary Health Care Team|The PAC Project: Integrating a Physical Activity Counsellor in the Primary Health Care Team: A Randomized Controlled Trial|Completed||Phase 2|120|Actual|University of Ottawa||2|||f||||f||||||||||2017-02-18 17:07:09.508849|2017-02-18 17:07:09.508849
NCT00222547|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-10-27|||January 1999||1999-01-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Deworming and Enhanced Vitamin A Every 6 Month in Rural Indian Children Aged 1-6|Deworming and Enhanced Vitamin A Supplementation DEVTA Project|Completed||Phase 4|720000||University of Oxford|||||f||||||||||||||2017-02-18 17:07:09.607983|2017-02-18 17:07:09.607983
NCT00222534|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-01-17|||January 2002||2002-01-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis|Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis|Completed||Phase 4|70|Actual|University of Oslo School of Pharmacy||2|||f||||||||||||||2017-02-18 17:07:09.696925|2017-02-18 17:07:09.696925
NCT00222521|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||April 2003||2003-04-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Insulin Glargine Vs Standard Insulin Therapy|Comparison of Insulin Glargine Vs Standard Insulin Therapy in CFRD Without Fasting Hyperglycemia|Completed||Phase 3|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 17:07:09.818437|2017-02-18 17:07:09.818437
NCT00222508|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-07-31|||April 2001||2001-04-01|July 2012|2012-07-01|July 2005||2005-07-01|||||Observational|||The Microvascular Complications Study|Microvascular Complications of Cystic Fibrosis Related Diabetes|Completed||Phase 3|150|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||||||2017-02-18 17:07:09.920331|2017-02-18 17:07:09.920331
NCT00222495|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2006-09-07|||August 2002||2002-08-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||A Comparative Study of New Medications for Psychosis in Adolescents|A Comparative Study of New Medications for Psychosis in Adolescents|Completed||N/A|30||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 17:07:10.023943|2017-02-18 17:07:10.023943
NCT00222482|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-08-08|||March 2003||2003-03-01|August 2007|2007-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Depakote ER in Borderline Personality Disorder|A Double-Blind and Placebo Controlled Assessment of Depakote ER in Borderline Personality Disorder|Completed||N/A|15||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-02-18 17:07:10.135015|2017-02-18 17:07:10.135015
NCT00222469|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-07-08|||August 2005||2005-08-01|July 2008|2008-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer|A Phase II Trial of Bevacizumab Plus Gemcitabine™ and Oxaliplatin™ as First Line Therapy in Metastatic or Locally Advanced (Unresectable) Pancreatic Cancer|Completed||Phase 2|50|Actual|University of Oklahoma||1|||f||||||||||||||2017-02-18 17:07:10.248709|2017-02-18 17:07:10.248709
NCT00222456|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2005-09-15|||March 1999||1999-03-01|September 2005|2005-09-01|September 2008||2008-09-01|||||Interventional|||Project Early Intervention 2000|Can Early Intervention Prevent Developmental Disturbances/Delays and Improve the Health of Children Born Prematurely|Completed||N/A|210||University Hospital of North Norway|||||f||||||||||||||2017-02-18 17:07:10.613891|2017-02-18 17:07:10.613891
NCT00222443|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-09-19|||September 2004||2004-09-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy|Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy|Completed||Phase 1|40||University of Oklahoma|||||f||||||||||||||2017-02-18 17:07:10.720136|2017-02-18 17:07:10.720136
NCT00222430|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-03-27|||March 2005||2005-03-01|March 2012|2012-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Fluoroscopy Guided Femoral Arterial Access|Fluoroscopy Guided Femoral Arterial Access and the Use of Closure Devices: A Randomized Controlled Trial.|Completed||N/A|990|Actual|University of Oklahoma||2|||f||||f||||||||||2017-02-18 17:07:10.819379|2017-02-18 17:07:10.819379
NCT00222417|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-20|||September 2002||2002-09-01|June 2012|2012-06-01|December 2014|Anticipated|2014-12-01|||||Observational|||Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease|Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease|Unknown status|Active, not recruiting|Phase 2/Phase 3|44|Actual|University Hospital of North Norway|||2||f||||f||||||||||2017-02-18 17:07:10.945757|2017-02-18 17:07:10.945757
NCT00222404|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-11-04|||July 2005||2005-07-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|||||Observational|Pharmacogenos||"Pharmacogenomic Study Realized on Non-small Cell Lung Carcinoma"|"Pharmacogenomic Study Realized Within the Framework of the Common Care to Non-small Cell Lung Carcinoma at Any Stages Treated by Chemotherapy."|Completed||N/A|556|Actual|University Hospital, Grenoble|||1||f||||||||||||||2017-02-18 17:07:11.06702|2017-02-18 17:07:11.06702
NCT00222391|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2009-01-06|||April 2004||2004-04-01|March 2006|2006-03-01|January 2006||2006-01-01|||||Observational|||Influence of Thoracic Epidural Anesthesia on Skin Sympathetic Activity and Heart Rate Variability|Influence of Thoracic Epidural Anesthesia on Skin Sympathetic Activity and Heart Rate Variability in Surgical Patients|Completed||N/A|40||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:07:11.170955|2017-02-18 17:07:11.170955
NCT00222378|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2015-07-28|||April 2005||2005-04-01|May 2015|2015-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease|Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease|Completed||N/A|129|Actual|University of Miami|||1||f||||t||||||Samples With DNA|"~     Specimens will be discarded upon study completion~   "|||2017-02-18 17:07:11.256991|2017-02-18 17:07:11.256991
NCT00222365|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-11-09|||December 2003||2003-12-01|July 2006|2006-07-01|May 2006||2006-05-01|||||Interventional|||Homeopathy Assessment in Terms of the Consumption of Analgesics After Knee Ligamentoplasty|Homeopathy Assessment in Terms of the Consumption of Analgesics After Knee Ligamentoplasty|Terminated||Phase 3|165||University Hospital, Grenoble|||||f||||||||||||||2017-02-18 17:07:11.369488|2017-02-18 17:07:11.369488
NCT00222352|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-02-27|||December 2004||2004-12-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Observational|||Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes|Diagnosis and Treatment of Acute Coronary Syndromes in the Emergency Department: The Impact of Rapid Bedside cTnI Testing on Outcomes|Unknown status|Active, not recruiting|Phase 4|2000||University Emergency Physicians|||||f||||f||||||||||2017-02-18 17:07:11.480165|2017-02-18 17:07:11.480165
NCT00222339|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||February 2002||2002-02-01|December 2001|2001-12-01|June 2004||2004-06-01|||||Interventional|||Task-Related Training of Arm Use After Stroke|Task-Related Training of Arm Use After Stroke: a Randomised Controlled Trial|Completed||N/A|30||University of Melbourne|||||f||||||||||||||2017-02-18 17:07:11.591423|2017-02-18 17:07:11.591423
NCT00222326|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-17|||July 2002||2002-07-01|February 2009|2009-02-01|April 2007|Actual|2007-04-01|April 2006|Actual|2006-04-01||Interventional|||The Effect of Physiotherapy Treatment Following Gynaecological Surgery|The Effect of a Physiotherapy Treatment Program on Pelvic Function Following Gynaecological Surgery|Completed||N/A|50|Actual|University of Melbourne||1|||f||||f||||||||||2017-02-18 17:07:11.704051|2017-02-18 17:07:11.704051
NCT00222300|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-08-07|||May 2003||2003-05-01|October 2003|2003-10-01|December 2005||2005-12-01|||||Interventional|||A Targeted Strengthening Program Following Total Hip Replacement.|A Targeted Strengthening Program Following Total Hip Replacement.|Completed||N/A|30||University of Melbourne|||||f||||||||||||||2017-02-18 17:07:11.822378|2017-02-18 17:07:11.822378
NCT00222287|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-21|||September 2004||2004-09-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||The Effect of Feldenkrais Lessons on Walking and Balance|The Effect of Feldenkrais Lessons on Walking and Balance|Unknown status|Active, not recruiting|Phase 1|60||University of Melbourne|||||f||||||||||||||2017-02-18 17:07:12.014487|2017-02-18 17:07:12.014487
NCT00222274|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-02-06|||July 2004||2004-07-01|February 2015|2015-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||HRV Biofeedback in Fibromyalgia|A Pilot Study of the Efficacy of Biofeedback in Patients With Fibromyalgia Syndrome.|Completed||N/A|80|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 17:07:12.113659|2017-02-18 17:07:12.113659
NCT00222261|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-22|||April 2003||2003-04-01|March 2011|2011-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|ASCET||Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.|Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.|Completed||Phase 4|1001|Actual|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 17:07:12.236024|2017-02-18 17:07:12.236024
NCT00222248|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-08-07|||March 2003||2003-03-01|June 2003|2003-06-01|March 2006||2006-03-01|||||Interventional|||Pelvic Floor Muscle Training for Incontinence in Older Women.|The Effect of Pelvic Floor Muscle Training for the Management of Incontinence in Older Women: a Single Blind Randomised Controlled Trial.|Unknown status|Active, not recruiting|N/A|90||University of Melbourne|||||f||||||||||||||2017-02-18 17:07:12.375001|2017-02-18 17:07:12.375001
NCT00222235|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-21|||January 2000||2000-01-01|June 2013|2013-06-01|June 2004||2004-06-01|||||Interventional|||Adjunctive Treatment for Decreasing Symptoms of Schizophrenia|Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST)|Completed||Phase 2/Phase 3|240||University of Maryland|||||||||||||||||||2017-02-18 17:07:12.472965|2017-02-18 17:07:12.472965
NCT00222222|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-14|||March 2003||2003-03-01|February 2012|2012-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis|Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis|Completed||N/A|105|Actual|Universitätsmedizin Mannheim||1|||f||||f||||||||||2017-02-18 17:07:12.580079|2017-02-18 17:07:12.580079
NCT00222183|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-04-05|||June 2003||2003-06-01|February 2007|2007-02-01||||||||Interventional|||Cutaneous Lupus Erythematosus and Elidel|Evaluation of the Therapeutic Effect and Local Tolerability of Elidel® Cream 1% (Pimecrolimus) in Chronic Discoid Lupus Erythematosus (dLE) or Subacute Cutaneous Lupus Erythematosus (scLE)|Unknown status|Recruiting|N/A|25||University of Leipzig|||||f||||||||||||||2017-02-18 17:07:12.85332|2017-02-18 17:07:12.85332
NCT00222170|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-05-07|||May 2005||2005-05-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)|Esophagoprotection by Rabeprazole Mediated by Restoration of an Impairment in Esophageal Mucin Production: Its Potential Therapeutic Benefit in Patients With Gastroesophageal Reflux Disease (GERD)|Completed||Phase 2|24|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 17:07:12.95685|2017-02-18 17:07:12.95685
NCT00222144|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-06|||September 2004||2004-09-01|August 2012|2012-08-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer|Phase II Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|23|Actual|University of Kansas Medical Center||1|||f||||f||||||||||2017-02-18 17:07:13.045809|2017-02-18 17:07:13.045809
NCT00222131|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-01|||October 2003||2003-10-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients|Inhibition of Gastric Acid Is the Key To Satisfactory Relief of Symptoms and Restoration of the Quality of Life in Patients With Epigastric Pain Related to Non-Ulcer Dyspepsia During Therapy With Esomeprazole|Completed||Phase 2|77|Actual|University of Kansas Medical Center||2|||f||||f||||||||||2017-02-18 17:07:13.157551|2017-02-18 17:07:13.157551
NCT00222118|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-08|||October 2003||2003-10-01|November 2012|2012-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Kansas University Teen Mothers Project|Promoting and Supporting Breastfeeding in Adolescents|Completed||N/A|390|Actual|University of Kansas Medical Center||3|||f||||f||||||||||2017-02-18 17:07:13.267543|2017-02-18 17:07:13.267543
NCT00222105|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-16|||November 2002||2002-11-01|February 2011|2011-02-01|July 2009|Anticipated|2009-07-01|April 2009|Anticipated|2009-04-01||Interventional|||A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life|Doxil® (Pegylated Liposomal Doxorubicin), Dexamethasone Plus Thalidomide (Ddt) in Previously Untreated Multiple Myeloma: A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life|Withdrawn||Phase 2|25|Actual|University of Kansas Medical Center||1||PI left institution, study closed September 2009|f||||t||||||||||2017-02-18 17:07:13.379647|2017-02-18 17:07:13.379647
NCT00222092|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-23|||September 2005||2005-09-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Observational|||Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers|Effect of Octreotide, Somatostatin, Pentoxyfilline or Placebo in the Prevention and the Course of Post-ERCP Pancreatitis and Study of Molecular Markers in Post-ERCP Pancreatitis|Completed||Phase 4|300||University of Ioannina|||1||f||||||||||||||2017-02-18 17:07:13.49068|2017-02-18 17:07:13.49068
NCT00222079|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2008-07-21|||November 2004||2004-11-01|August 2005|2005-08-01|August 2005|Anticipated|2005-08-01|||||Interventional|||Evaluation of Esomeprazole in Treating Gastro-Esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy|Pilot Study to Evaluate Esomeprazole (Nexium) in Treating Gastro-Esophageal Reflux in Patients With Head and Neck Cancer With Prior External Beam Radiation Therapy: a Randomized, Prospective, Placebo-Controlled, Double-Blind Study.|Unknown status|Recruiting|N/A|46|Anticipated|University of Iowa|||||f||||||||||||||2017-02-18 17:07:13.566821|2017-02-18 17:07:13.566821
NCT00222066|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2010-02-02|||June 2001||2001-06-01|September 2006|2006-09-01|September 2007|Actual|2007-09-01|January 2007|Actual|2007-01-01||Interventional|||Effect of Fetal Ovarian Cyst Aspiration to Prevent Torsion|Comparison Between Abstention and Intrauterine Aspiration in the Treatment of Anechoic Fetal Ovarian Cysts to Prevent Ovarian Torsion|Completed||N/A|61|Actual|University Hospital, Tours||2|||f||||t||||||||||2017-02-18 17:07:13.645554|2017-02-18 17:07:13.645554
NCT00222053|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2010-04-01|||April 2000||2000-04-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||IFM 99-02 Thalidomide in Myeloma||Completed||Phase 3|800|Actual|University Hospital, Toulouse||3|||f||||f||||||||||2017-02-18 17:07:13.747588|2017-02-18 17:07:13.747588
NCT00222040|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2010-04-29|||June 2004||2004-06-01|June 2008|2008-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Microbubbles and Ultrasound in Stroke Trial: MUST Study||Terminated||Phase 2|20|Actual|University Hospital, Toulouse||2|||f||||f||||||||||2017-02-18 17:07:13.86221|2017-02-18 17:07:13.86221
NCT00222027|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-06|||November 2003||2003-11-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|GRAALL2003||Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial|GRAALL 2003 Trial (ALL 15-59 Years). Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial|Completed||Phase 2|300||University Hospital, Toulouse|||||f||||f||||||||||2017-02-18 17:07:14.051327|2017-02-18 17:07:14.051327
NCT00222014|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-22|||May 2005||2005-05-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2012|Actual|2012-12-01||Interventional|||TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis|TIPS (With Coated Stents) OR PARACENTESIS + ALBUMIN ADMINISTRATION FOR THE TREATMENT OF REFRACTORY ASCITES IN PATIENTS WITH CIRRHOSIS : A RANDOMIZED TRIAL COMPARING SURVIVAL, QUALITY OF LIFE AND NUTRITIONAL STATUS|Completed||N/A|55|Actual|University Hospital, Toulouse||2|||f||||t||||||||||2017-02-18 17:07:14.14253|2017-02-18 17:07:14.14253
NCT00222001|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-01-27|||December 2002||2002-12-01|January 2015|2015-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Telephone Triage Study|Outcome Evaluation of Triage for Health Maintenance Organization (HMO) Patients Performed by Doctors in a Medical Telemedicine Center|Completed||N/A|100|Actual|University Hospital, Basel, Switzerland|||1||f||||f||||||||||2017-02-18 17:07:14.248322|2017-02-18 17:07:14.248322
NCT00221988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||March 2004||2004-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers|A Randomized, Double-Blind, Cross-Over Study of the Cognitive and Mood Effects of KEPPRA (Levetiracetam) Tablets in Healthy Older Adults.|Unknown status|Recruiting|N/A|40||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-02-18 17:07:14.328196|2017-02-18 17:07:14.328196
NCT00005425|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1992||1992-09-01|April 2001|2001-04-01|February 1995|Actual|1995-02-01|||||Observational|||Statistical Analysis of Vlagtwedde-Vlaardingen Data Set||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.682212|2017-02-18 18:15:00.682212
NCT00221975|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-01|||July 2002||2002-07-01|December 2014|2014-12-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling|Combination Therapy in Dual Diagnosis Rapid Cycling Bipolar Disorder|Completed||Phase 3|98|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-02-18 17:07:14.426995|2017-02-18 17:07:14.426995
NCT00221962|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2014-12-12|||April 2005||2005-04-01|June 2013|2013-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)|The Cognitive Effects of Aripiprazole in Children|Completed||Phase 4|23|Actual|University Hospitals Cleveland Medical Center||1|||f||||t||||||||||2017-02-18 17:07:14.528285|2017-02-18 17:07:14.528285
NCT00221949|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-12-04||||||August 2005|2005-08-01||||||||Observational|||Visualizing Peripheral Nerves Using Ultrasound-Guided Approach|Development of a Comprehensive Study of the Peripheral Nerves in the Lower Arm and Lower Leg Using an Ultrasound Guided Approach|Completed||N/A|16|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:07:14.633245|2017-02-18 17:07:14.633245
NCT00221936|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-12-04|||July 2004||2004-07-01|July 2005|2005-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Patient Controlled Oral Analgesia for Postoperative Pain Management After Total Knee Replacement|Patient Controlled Oral Analgesia (PCOA) for Postoperative Pain Management After Total Knee Replacement-A Pilot Study|Completed||N/A|50|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:07:14.702988|2017-02-18 17:07:14.702988
NCT00221923|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-08-29|||September 2002||2002-09-01|August 2011|2011-08-01|February 2015|Anticipated|2015-02-01|||||Observational|ADAGES||African Descent and Glaucoma Evaluation Study|African Descent and Glaucoma Evaluation Study (Formerly African Americans With Glaucoma Study)|Unknown status|Active, not recruiting|N/A|1540|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-02-18 17:07:14.785202|2017-02-18 17:07:14.785202
NCT00221910|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-12-04|||February 2003||2003-02-01|March 2005|2005-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Use of Ultrasound in Lower Extremity Blocks.|Does Ultrasound Guidance Improve the Success of Sciatic Nerve Block at the Popliteal Fossa? A Prospective, Randomized, Controlled Trial.|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:07:14.894197|2017-02-18 17:07:14.894197
NCT00221897|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-08-29|||April 1995||1995-04-01|August 2011|2011-08-01|July 2016|Anticipated|2016-07-01|||||Observational|DIGS||Diagnostic Innovations in Glaucoma Study|Diagnostic Innovations in Glaucoma Study|Unknown status|Recruiting|N/A|3000|Anticipated|University of California, San Diego|||2||f||||f||||||||||2017-02-18 17:07:17.794361|2017-02-18 17:07:17.794361
NCT00221884|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-12-04|||August 2002||2002-08-01|September 2005|2005-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Use of Ultrasound in Upper Extremity Blocks.|Does Ultrasound Guidance Improve the Success of Brachial Plexus Block? A Prospective, Randomized, Controlled Trial.|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:07:17.910211|2017-02-18 17:07:17.910211
NCT00221871|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2006-10-10|||January 2004||2004-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Proper Dosage of Ketamine in Intravenous Regional Anesthesia|Proper Dosage of Intravenous Ketamine When Used as an Adjuvant to Lidocaine in Intravenous Regional Anesthesia (IVRA).|Unknown status|Recruiting|N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:07:17.984222|2017-02-18 17:07:17.984222
NCT00221858|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-09-20|||August 2002||2002-08-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Observational|||Regional Anesthesia Database|Regional Anesthesia Database|Completed||N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:07:18.058301|2017-02-18 17:07:18.058301
NCT00221845|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2010-01-11|||January 1998||1998-01-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|July 2007|Actual|2007-07-01||Interventional|ESCAPE||Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients|Molecular Mechanisms of Disease Progression and Renoprotective Pharmacotherapy in Children With Chronic Renal Failure|Completed||Phase 3|400|Actual|Heidelberg University||2|||f||||t||||||||||2017-02-18 17:07:18.128179|2017-02-18 17:07:18.128179
NCT00221832|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-01-12|||October 2003||2003-10-01|October 2003|2003-10-01|December 2011|Anticipated|2011-12-01|||||Observational|||Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases|Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases|Unknown status|Recruiting|N/A|300|Anticipated|Heidelberg University|||1||f||||f||||||Samples With DNA|"~     no biospecimens are to be retained.~   "|||2017-02-18 17:07:18.282563|2017-02-18 17:07:18.282563
NCT00221819|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-05-07|||June 2004||2004-06-01|May 2013|2013-05-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Gases Humidification During Noninvasive Ventilation : Heat and Moisture Exchanger or Heated Humidifier ?|Prospective Study of the Influence of the Humidification Mode on Ventilation Parameters and Arterial Blood Gases in Non Invasive Ventilation|Terminated||N/A|||University Hospital, Bordeaux|||||f||||||||||||||2017-02-18 17:07:18.379834|2017-02-18 17:07:18.379834
NCT00221806|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2004||2004-06-01|September 2005|2005-09-01|June 2012||2012-06-01|||||Interventional|||Comparison of Two Under Knee Lower Limb Bypass Types:Endothelialised Prosthesis Versus Autologous Vein Graft|Randomised Study Comparing Endothelialised Prosthesis and Autologous Vein for Under Knee Revascularisation With Femoro Popliteal Bypass. ePTFE|Unknown status|Recruiting|Phase 2|40||University Hospital, Bordeaux|||||f||||||||||||||2017-02-18 17:07:18.475642|2017-02-18 17:07:18.475642
NCT00221793|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-17|||December 2002||2002-12-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation|Study of Ponderal Load in Parkinsonian Patients After Deep Brain Stimulation of the Subthalamic Nucleus|Completed||N/A|20|Actual|University Hospital, Bordeaux||2|||f||||f||||||||||2017-02-18 17:07:18.560343|2017-02-18 17:07:18.560343
NCT00221780|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-28|||November 2003||2003-11-01|June 2007|2007-06-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Role of Left Ventricular Pacing Site|Importance of Left Ventricular Pacing Site in Biventricular Resynchronization Therapy for Severe Heart Failure|Unknown status|Recruiting|N/A|33|Anticipated|University Hospital, Bordeaux|||||f||||f||||||||||2017-02-18 17:07:18.918942|2017-02-18 17:07:18.918942
NCT00221767|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-13|||June 2005||2005-06-01|June 2012|2012-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|BRINDLEY||Medico-economical Impact of the Brindley Neurosurgical Technique in France|Prospective Comparative Multicenter Study on the Medico-economical Impact of the Brindley Technique in the Management of Neurogenic Bladder in Patients With Injured Spinal Cord|Completed||N/A|53|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 17:07:19.013775|2017-02-18 17:07:19.013775
NCT00221754|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-12|||March 2003||2003-03-01|June 2007|2007-06-01|March 2004|Actual|2004-03-01|||||Interventional|||Pravastatin and Protease Inhibitors in HIV-Infected Patients|Pravastatin in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy|Completed||Phase 2|21|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 17:07:19.129664|2017-02-18 17:07:19.129664
NCT00221741|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-17|||February 2004||2004-02-01|March 2015|2015-03-01|March 2006|Actual|2006-03-01|||||Observational|PLASMACARD||Fresh Frozen Plasma in Cardiac Surgery: Descriptive and Prognostic Study|PLASMACARD - Fresh Frozen Plasma in Cardiac Surgery: Descriptive and Prognostic Study|Completed||N/A|1497|Actual|University Hospital, Bordeaux|||||f||||f||||||||||2017-02-18 17:07:19.23006|2017-02-18 17:07:19.23006
NCT00221728|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-27|||April 2005||2005-04-01|May 2010|2010-05-01|January 2008|Anticipated|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors|Treatment of Renal Tumors With Radiofrequency: Efficacy Evaluation in Comparison With Conservative Surgery (Multicentric Randomized Trial)|Terminated||Phase 2/Phase 3|160|Anticipated|University Hospital, Bordeaux||2||lack of patients|f||||t||||||||||2017-02-18 17:07:19.327328|2017-02-18 17:07:19.327328
NCT00221715|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-07|||July 2002||2002-07-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|REVA||Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous Vein|Randomised Study Comparing Prosthesis and Autologous Vein for Revascularisation With Above Knee Femoropopliteal Bypass.|Completed||N/A|100|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 17:07:19.421125|2017-02-18 17:07:19.421125
NCT00221702|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-10-12|||June 2003||2003-06-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|EADO||PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)|Randomized, Multicenter Phase III Trial Comparing Adjuvant Treatment With PegIntron Over 36 Months Versus Reference Treatment With IntronA Over 18 Months in Cutaneous Melanoma Patients AJCC Stage II (>=1.5 mm Clinically Node Negative)|Completed||Phase 3|898|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 17:07:19.527478|2017-02-18 17:07:19.527478
NCT00221689|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-12|||March 2003||2003-03-01|June 2007|2007-06-01|February 2004|Actual|2004-02-01|||||Interventional|||Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients|Early Treatment of Paroxysmal Dysautonomia and Hypertonia for Severe Brain Injured Patients by Intrathecal Baclofen Therapy|Terminated||Phase 2|4|Actual|University Hospital, Bordeaux||2||very slow recruitment and treatments beyond expiry date|f||||t||||||||||2017-02-18 17:07:19.643157|2017-02-18 17:07:19.643157
NCT00221676|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-27|||July 2002||2002-07-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Interventional|||Effectiveness of Influenza Vaccination Among General Practitioners|Effectiveness of Influenza Vaccination (Alfarix)in Preventing Clinical Influenza Cases Among General Practitioners: Non-Randomized Clinical Trial.|Completed||Phase 4|300||University Hospital, Antwerp|||||f||||||||||||||2017-02-18 17:07:19.746846|2017-02-18 17:07:19.746846
NCT00221663|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-08-14|||January 2002||2002-01-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|January 2002|Actual|2002-01-01||Interventional|||Conventional Versus Mini-Sternotomy for Aortic Valve Surgery|Clinical Trial Comparing a Conventional Median Sternotomy Versus a Minimally Invasive Technique for Aortic Valvular Replacement in Adults|Terminated||Phase 2/Phase 3|78|Actual|University Hospital, Bordeaux||2||slow recruitment|f||||t||||||||||2017-02-18 17:07:19.837338|2017-02-18 17:07:19.837338
NCT00221650|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-12|||April 2002||2002-04-01|June 2007|2007-06-01|June 2004|Actual|2004-06-01|||||Interventional|ROCO2||Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients|Efficacy and Safety of Peginterferon alfa2a and Ribavirin for the Second Line Treatment of Chronic Hepatitis C in HIV Infected Patients Previously Non Responders to a First Anti-HCV Treatment|Completed||Phase 2|17|Actual|University Hospital, Bordeaux||1|||f||||t||||||||||2017-02-18 17:07:19.931834|2017-02-18 17:07:19.931834
NCT00221637|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-12|||March 2002||2002-03-01|June 2007|2007-06-01|July 2005|Actual|2005-07-01|||||Interventional|||Efficacy of Valproate in Peripheral Neuropathic Pain|Efficacy of a Therapeutic Strategy in Peripheral Neuropathic Pain: Intravenous Sodium Valproate Followed by Oral Route Treatment Versus Placebo (Clinical and Neurophysiologic Evaluation)|Terminated||Phase 2/Phase 3|40|Actual|University Hospital, Bordeaux||2||slow recruitment and treatments beyond expiry date|f||||t||||||||||2017-02-18 17:07:20.026032|2017-02-18 17:07:20.026032
NCT00221624|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-12|||November 2001||2001-11-01|June 2007|2007-06-01|April 2004|Actual|2004-04-01|||||Interventional|PEGARI||Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients|Randomized Placebo-Controlled Trial of a Triple Therapy Combining Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine Versus Peginterferon Alfa-2a Plus Ribavirin Plus Placebo in Hepatitis C-Infected Patients Non Responders to a First-Line Therapy of Interferon and Ribavirin|Completed||Phase 3|131|Actual|University Hospital, Bordeaux||2|||f||||t||||||||||2017-02-18 17:07:20.12177|2017-02-18 17:07:20.12177
NCT00221611|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-19|||January 2000||2000-01-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity|Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity|Completed||Phase 2|80||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:07:20.223877|2017-02-18 17:07:20.223877
NCT00221598|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-04|||June 2005||2005-06-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency|Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency|Unknown status|Recruiting|N/A|40|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 17:07:20.305669|2017-02-18 17:07:20.305669
NCT00221585|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2006-11-06|||October 1997||1997-10-01|July 1997|1997-07-01|July 2005||2005-07-01|||||Observational|||The National Danish Schizophrenia Project||Unknown status|Active, not recruiting|N/A|||University of Copenhagen|||||f||||||||||||||2017-02-18 17:07:20.414822|2017-02-18 17:07:20.414822
NCT00221572|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-12-04|||July 2005||2005-07-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Observational|||Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis|Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis|Unknown status|Recruiting|N/A|100|Anticipated|University Hospital, Ghent|||1||f||||f||||||||||2017-02-18 17:07:20.504165|2017-02-18 17:07:20.504165
NCT00005424|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1993||1993-09-01|November 2001|2001-11-01|February 1996|Actual|1996-02-01|||||Observational|||Prospective Analysis of the Effect of Widowhood on CVD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.752726|2017-02-18 18:15:00.752726
NCT00221559|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-05-07|||September 2004||2004-09-01|May 2006|2006-05-01||||||||Observational|||Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group|Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group|Completed||N/A|0||University Hospital, Ghent|||||f||||||||||||||2017-02-18 17:07:20.587381|2017-02-18 17:07:20.587381
NCT00221546|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-27|||September 2007||2007-09-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis|Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis|Completed||Phase 2|17|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 17:07:20.676819|2017-02-18 17:07:20.676819
NCT00221533|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-19|||March 2004||2004-03-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Observational|||Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients|Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant Recipients|Completed||N/A|250||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:07:20.777619|2017-02-18 17:07:20.777619
NCT00221520|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2007-01-09|||February 2003||2003-02-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Sedation in the Intensive Care Unit|Trial on The Efficacy of Sedation in Mechanically Ventilated Critically Ill Patients|Unknown status|Active, not recruiting|Phase 3|126||University Hospital, Geneva|||||f||||||||||||||2017-02-18 17:07:20.859463|2017-02-18 17:07:20.859463
NCT00221507|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-07-17|||February 2004||2004-02-01|January 2007|2007-01-01|June 2007||2007-06-01|||||Interventional|||Increasing Infant Preventive Health Service Delivery in an Inner City Population|Increasing Infant Preventive Health Service Delivery in an Inner City Population|Unknown status|Recruiting|N/A|800|Anticipated|University of Colorado, Denver|||||f||||||||||||||2017-02-18 17:07:21.196792|2017-02-18 17:07:21.196792
NCT00221494|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-29|||January 2004||2004-01-01|June 2006|2006-06-01||||June 2006|Actual|2006-06-01||Interventional|||Can Additional Drug Therapy Accelerate Response Time to Antidepressants|Can Additional Drug Therapy Accelerate Response Time to Antidepressants: A Double-blind, Placebo-controlled Randomization Research Study for Major Depression|Withdrawn||Phase 4|0|Actual|Mayo Clinic||||PI move|f||||t||||||||||2017-02-18 17:07:21.286246|2017-02-18 17:07:21.286246
NCT00221481|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-29||||||February 2009|2009-02-01|March 2006||2006-03-01|||||Interventional|||An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder|An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder|Withdrawn||Phase 4|0|Actual|Mayo Clinic||||Lack of recruitment|f||||||||||||||2017-02-18 17:07:21.390797|2017-02-18 17:07:21.390797
NCT00221468|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-07-17|||June 2003||2003-06-01|March 2007|2007-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents|A Single-Blind Prospective Study of Quetiapine for the Treatment of Mood Disorders in Adolescents|Completed||Phase 3|20|Actual|University of Cincinnati||1|||f||||||||||||||2017-02-18 17:07:21.483636|2017-02-18 17:07:21.483636
NCT00221455|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-07-25|||September 2004||2004-09-01|July 2011|2011-07-01|September 2007|Actual|2007-09-01|||||Interventional|||The Potential of Technology to Improve Chronic Disease Management and Quality of Care|The Potential of Technology to Improve Chronic Disease Management and Quality of Care|Completed||Phase 1|1000|Anticipated|Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 17:07:21.594359|2017-02-18 17:07:21.594359
NCT00221442|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-06-21|||August 2005||2005-08-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity|Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity: A Single Center, Double-Blind, Placebo-controlled, Flexible-Dose Study in Outpatients|Completed||Phase 3|60|Actual|Lindner Center of HOPE||2|||f||||||||||||||2017-02-18 17:07:21.699435|2017-02-18 17:07:21.699435
NCT00221429|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-02-22|||March 2001||2001-03-01|November 2002|2002-11-01||||||||Interventional|||Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder|Pediatric Bipolar Collaborative Mood Stabilizer Trial|Unknown status|Active, not recruiting|Phase 3|154||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 17:07:21.809993|2017-02-18 17:07:21.809993
NCT00221416|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-06-26|||June 2005||2005-06-01|June 2013|2013-06-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder|An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder|Completed||Phase 3|30|Anticipated|University of Cincinnati||1|||f||||f||||||||||2017-02-18 17:07:21.900444|2017-02-18 17:07:21.900444
NCT00221403|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-06-24|||September 2004||2004-09-01|June 2011|2011-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders|Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders|Completed||Phase 3|46|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 17:07:22.006315|2017-02-18 17:07:22.006315
NCT00221390|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-10-28|||October 2003||2003-10-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|February 2007|Actual|2007-02-01||Interventional|||Trial of Ropinirole in Motor Recovery After Stroke|Randomized, Placebo-controlled, Double-blind Pilot Trial to Evaluate the Safety and Efficacy of Ropinirole in Motor Recovery After Stroke|Completed||Phase 2|52|Anticipated|University of California, Irvine||2|||f||||f||||||||||2017-02-18 17:07:22.101419|2017-02-18 17:07:22.101419
NCT00221377|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-16|||April 2005||2005-04-01|December 2011|2011-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||"Cuffed Versus Uncuffed Tracheal Tubes in Small Children"|"Cuffed Versus Uncuffed Tracheal Tubes in Small Children"|Completed||N/A|4000|Anticipated|University Children's Hospital, Zurich|||||f||||||||||||||2017-02-18 17:07:22.20917|2017-02-18 17:07:22.20917
NCT00221364|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-07-13|||March 2003||2003-03-01|July 2015|2015-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|TEF||Trachoma Elimination Follow-up|Trachoma Elimination With Repeated Mass Azithromycin Treatments|Completed||Phase 4|20000|Anticipated|University of California, San Francisco|||||f||||t||||||||||2017-02-18 17:07:22.329776|2017-02-18 17:07:22.329776
NCT00221351|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2011-05-20|||October 2005||2005-10-01|May 2011|2011-05-01|July 2006|Actual|2006-07-01|March 2006|Actual|2006-03-01||Interventional|||C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough|A Randomized, Controlled Trial of a C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough Illness in the Emergency Department|Completed||N/A|139|Actual|University of California, San Francisco|||||f||||||||||||||2017-02-18 17:07:22.433941|2017-02-18 17:07:22.433941
NCT00221338|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2015-07-14|||January 2006||2006-01-01|July 2015|2015-07-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Clinical Trial of Gabapentin to Improve Postoperative Pain in Surgical Patients|Clinical Trial of Gabapentin to Improve Postoperative Pain in Surgical Patients|Completed||Phase 3|750|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 17:07:22.533202|2017-02-18 17:07:22.533202
NCT00221325|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-02-12|||April 2007||2007-04-01|February 2015|2015-02-01|March 2013|Actual|2013-03-01|January 2012|Actual|2012-01-01||Interventional|||A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma|Phase I Study of Intraventricular Administration of Rituximab in Combination With Methotrexate in the Treatment of Recurrent CNS and Intraocular Lymphoma|Completed||Phase 1|14|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 17:07:22.652011|2017-02-18 17:07:22.652011
NCT00221312|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2008-05-05|||May 2002||2002-05-01|May 2005|2005-05-01|July 2007|Actual|2007-07-01|||||Observational|||Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss|Alendronate to Prevent Perimenopausal Transition Bone Loss|Completed||N/A|48|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 17:07:22.765819|2017-02-18 17:07:22.765819
NCT00221299|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-06-02|2014-01-23||September 2005||2005-09-01|June 2015|2015-06-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional||Study subjects were men and women, greater than 18 years of age with a history of glucocorticoid therapy with prednisone >= 7.5gm a day for 6 months and currently on prednisone or equivalent >= 5mg/day.|Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use|Can Risedronate and Parathyroid Hormone Reverse Glucocorticoid Induced Osteoporosis?|Completed||Phase 4|60|Actual|University of California, Davis||4|||f||||f||||||||||2017-02-18 17:07:22.853042|2017-02-18 17:07:22.853042
NCT00221286|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-02-17|||September 2004||2004-09-01|February 2009|2009-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients|Pegylated Interferon Alfa-2a Versus Emtricitabine / Tenofovir +/- Pegylated Interferon Alfa-2a for the Treatment of Chronic HBe-Ag Positive Hepatitis B Infection in HIV-Coinfected Patients - the PEGPLUS Trial|Terminated||Phase 3|2|Actual|University Hospital, Bonn||3||Lack of accrual|f||||f||||||||||2017-02-18 17:07:23.236218|2017-02-18 17:07:23.236218
NCT00221273|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2011-04-26|||December 2010||2010-12-01|April 2011|2011-04-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Use of Graft Tensioner Device in ACL (Knee) Repair|Randomized Clinical Trial to Assess the Clinical Effectiveness of a Measured Objective Tensioning in Hamstring ACL Reconstruction|Unknown status|Active, not recruiting|N/A|130|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:07:23.333897|2017-02-18 17:07:23.333897
NCT00221260|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2008-09-24|||September 2005||2005-09-01|September 2008|2008-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Perioperative Epidural Trial (POET) Pilot Study|Perioperative Epidural Trial (POET) Pilot Study|Completed||N/A|250|Anticipated|University of British Columbia||1|||f||||||||||||||2017-02-18 17:07:23.400585|2017-02-18 17:07:23.400585
NCT00221247|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-13|||October 2004||2004-10-01|May 2016|2016-05-01|October 2008|Actual|2008-10-01|March 2008|Actual|2008-03-01||Interventional|||Acupuncture as Complementary Therapy for Cerebral Palsy|Acupuncture as Complementary Therapy for Cerebral Palsy|Completed||Phase 2|75|Actual|University of Arizona||2|||f||||f||||||||||2017-02-18 17:07:23.489804|2017-02-18 17:07:23.489804
NCT00221234|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-13|||September 2005||2005-09-01|March 2009|2009-03-01|July 2007|Actual|2007-07-01|||||Interventional|||Alberta Diabetes and Physical Activity Trial|The Development and Evaluation of Physical Activity Behavioural Strategies for Adults With Type 2 Diabetes: A Population Based Approach|Completed||Phase 2|300|Anticipated|University of Alberta, Physical Education|||||f||||||||||||||2017-02-18 17:07:23.592071|2017-02-18 17:07:23.592071
NCT00221221|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-02|||July 2005||2005-07-01|May 2007|2007-05-01|March 2006||2006-03-01|||||Interventional|||Physical Activity Promotion in Breast Cancer Survivors|Physical Activity Promotion in Breast Cancer Survivors: A Population Based Randomized Controlled Trial|Completed||Phase 2/Phase 3|300||University of Alberta, Physical Education|||||f||||||||||||||2017-02-18 17:07:23.677614|2017-02-18 17:07:23.677614
NCT00221208|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-16|||April 2005||2005-04-01|March 2009|2009-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Home Based Resistance Training For Type 2 Diabetes|A Home Based Resistance Training Program for Obese Adults With Type 2 Diabetes|Completed||Phase 1|54||University of Alberta, Physical Education|||||f||||||||||||||2017-02-18 17:07:23.761676|2017-02-18 17:07:23.761676
NCT00221195|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-12-12|2016-12-12||June 2003||2003-06-01|December 2016|2016-12-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|ProFEIBA||Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors|A Prospective, Randomized, Cross-over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients With Hemophilia A and Inhibitors|Completed||Phase 2/Phase 3|34|Actual|Tulane University|One limitation was the relatively short duration; in addition, due to the small number of children enrolled, it is not possible to draw conclusions regarding the relationship of age and the benefits of prophylaxis.|2|||f||||||||||||||2017-02-18 17:07:23.84976|2017-02-18 17:07:23.84976
NCT00221182|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-21|||September 2005||2005-09-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Stem Cell Study for Patients With Heart Disease|Phase I / II Clinical Trial Regarding Vascular Regeneration Therapy by Transplantation of Autologous Peripheral Blood Endothelial Progenitor Cells (CD34+ Cells) in No-Option Patients With Chronic Myocardial Ischemia|Terminated||Phase 1/Phase 2|1|Actual|Foundation for Biomedical Research and Innovation||1||slow recruitment of the study subjects|f||||||||||||||2017-02-18 17:07:24.581855|2017-02-18 17:07:24.581855
NCT00221169|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-04|||October 2005||2005-10-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer|Can PET CT Coregistration Imaging Adequately Determine the Gross Tumor Volume and Microscopic Extension in Non-Small Cell Lung Cancer Patients for Radical Radiation Therapy?|Completed||Early Phase 1|31|Actual|Toronto Sunnybrook Regional Cancer Centre||1|||f||||f||||||||||2017-02-18 17:07:24.684279|2017-02-18 17:07:24.684279
NCT00221156|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-23|||May 2005||2005-05-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|||||Interventional|||Acarbose and Secondary Prevention After Coronary Stenting|Effects of Acarbose Long-Term Therapy on Prevention of Cardiovascular Events in Abnormal Glucose Tolerance With Coronary Artery Disease (ALERT Study)|Completed||Phase 3|300|Anticipated|Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||||||||||||2017-02-18 17:07:24.786861|2017-02-18 17:07:24.786861
NCT00221143|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-06|||November 2003||2003-11-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|||||Interventional|||Stem Cell Study for Patients With Leg Ulcer/Gangrene|Phase I / II Clinical Trial Regarding Vascular Regeneration Therapy by Transplantation of Autologous Peripheral Blood Endothelial Progenitor Cells (CD34+ Cells) in No-Option Patients With Chronic Critical Limb Ischemia|Completed||Phase 1/Phase 2|15|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||t||||||||||2017-02-18 17:07:24.885751|2017-02-18 17:07:24.885751
NCT00221130|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-06|||July 2004||2004-07-01|February 2009|2009-02-01|December 2005||2005-12-01|||||Interventional|||Clinical Trials of Regeneration for Periodontal Tissue|Clinical Trial of Regenerative Periodontal Tissue by Transplanting Mesenchymal Stem Cells and Osteoblast Cells - I, II Phase-|Completed||Phase 1/Phase 2|10||Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||||||||||||2017-02-18 17:07:24.992643|2017-02-18 17:07:24.992643
NCT00221117|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-09-28|||August 2005||2005-08-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Benefits of Applying Neuroprosthesis to Improve Grasping and Reaching in Spinal Cord Injury Patients|Neuroprosthesis for Improving Grasping Function in Spinal Cord Injured Patients|Completed||Phase 2|40|Actual|Toronto Rehabilitation Institute||1|||f||||t||||||||||2017-02-18 17:07:25.090424|2017-02-18 17:07:25.090424
NCT00221104|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-04-22|||March 2004||2004-03-01|March 2015|2015-03-01||||July 2014|Actual|2014-07-01||Interventional|||Japan Statin Treatment Against Recurrent Stroke (J-STARS)|Secondary Prevention With HMG-CoA Reductase Inhibitor Against Stroke|Completed||Phase 3|1578|Actual|Translational Research Informatics Center, Kobe, Hyogo, Japan||2|||f||||||||||||||2017-02-18 17:07:25.199444|2017-02-18 17:07:25.199444
NCT00221091|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-06|||September 2004||2004-09-01|February 2009|2009-02-01|October 2005||2005-10-01|||||Interventional|||Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus|Clinical Study of Idiopathic Normal Pressure Hydrocephalus for Neurological Improvement|Completed||Phase 2|110||Translational Research Informatics Center, Kobe, Hyogo, Japan|||||f||||||||||||||2017-02-18 17:07:25.309638|2017-02-18 17:07:25.309638
NCT00221078|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-02-04|||April 2003||2003-04-01|February 2009|2009-02-01|December 2005|Actual|2005-12-01|June 2005|Actual|2005-06-01||Interventional|||Benefits of Applying Neuroprosthesis for Improving Reaching and Grasping Functions in Stroke Patients|Restoration of Reaching and Grasping Functions in Stroke Patients Using Functional Electrical Stimulation.|Completed||Phase 3|40|Actual|Toronto Rehabilitation Institute||1|||f||||t||||||||||2017-02-18 17:07:25.407152|2017-02-18 17:07:25.407152
NCT00221065|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-04|||June 2005||2005-06-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effect of Continuous Positive Airway Pressure (CPAP) on Cognitive and Functional Performance in Stroke Patients With Obstructive Sleep Apnea|Influence of CPAP on Cognitive Function and Outcome of Stroke Patients With Obstructive Apnea|Completed||Phase 3|60|Anticipated|Toronto Rehabilitation Institute||2|||f||||f||||||||||2017-02-18 17:07:25.516577|2017-02-18 17:07:25.516577
NCT00221052|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-10|||June 2005||2005-06-01|October 2006|2006-10-01|July 2005||2005-07-01|||||Interventional|||Effect of Reduction of Inflammatory Status on Glucose Metabolism in Overweight Men|Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men|Completed||N/A|20||TNO|||||f||||||||||||||2017-02-18 17:07:25.628591|2017-02-18 17:07:25.628591
NCT00221039|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-23|||September 2004||2004-09-01|May 2016|2016-05-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A|UVADEX Sterile Solution in Conjunction With the UVAR XTS Photopheresis System as an Interventional Therapy for the Treatment Of CTCL (Mycosis Fungoides) in Patients With TMN Classification Stage 1A, 1B, 2A|Completed||Phase 4|19|Actual|Mallinckrodt||1|||f||||f||||||||||2017-02-18 17:07:25.70903|2017-02-18 17:07:25.70903
NCT00221026|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-18|||December 2004||2004-12-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease|A Multicenter, Open-Label, Study of Extracorporeal Photoimmune Therapy With UVADEX in the Treatment of Patients With Moderately Active Crohn's Disease Who Are Refractory or Intolerant to Immunosuppressants and/or Anti-TNF Agents|Completed||Phase 2|25|Actual|Mallinckrodt||1|||f||||f||||||||||2017-02-18 17:07:25.834011|2017-02-18 17:07:25.834011
NCT00221013|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-02-25|||November 2005||2005-11-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).|Multicentre, Unblinded, Open Label, Randomised, Controlled Trial to Assess the Effect of Augmented Vs. Normal Continuous Renal Replacement Therapy (CRRT) on 90-Day All-Cause Mortality of Intensive Care Unit Patients With Severe Acute Renal Failure (ARF).|Completed||Phase 4|1508|Actual|The George Institute||2|||f||||t||||||||||2017-02-18 17:07:25.948826|2017-02-18 17:07:25.948826
NCT00221000|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-18|||August 2003||2003-08-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|RA-1||Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis|"A Phase II, Multicenter, Randomized, Double-blind, Sham Pheresis-controlled, Study of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis in Patients Who Have an Inadequate Response to Disease Modifying Antirheumatic Drugs and Biological Agents"|Completed||Phase 2|86|Actual|Mallinckrodt||3|||f||||f||||||||||2017-02-18 17:07:26.085494|2017-02-18 17:07:26.085494
NCT00220987|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-27|||April 2005||2005-04-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE - SUGAR STUDY)|A Multi-Center, Open Label Randomized Stratified Controlled Trial of the Effects of Blood Glucose Management on 90-Day All-Cause Mortality in a Heterogenous Population of Intensive Care Unit (ICU) Patients.|Completed||Phase 4|6104|Actual|The George Institute||2|||f||||t||||||||||2017-02-18 17:07:26.226515|2017-02-18 17:07:26.226515
NCT00220974|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-11|||October 2004||2004-10-01|February 2009|2009-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study to Assess if Internet-Based Tailored Advice Could Modify Behaviour to Improve Health|Internet-Based Cholesterol Assessment Trial|Completed||N/A|3708|Anticipated|The George Institute|||||f||||||||||||||2017-02-18 17:07:26.350979|2017-02-18 17:07:26.350979
NCT00220961|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-06-29|2016-02-17||January 2004||2004-01-01|June 2016|2016-06-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Actos Now for Prevention of Diabetes (ACT NOW)|Actos Now for Prevention of Diabetes (ACT NOW)|Completed||Phase 3|602|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||||||||||||2017-02-18 17:07:26.445643|2017-02-18 17:07:26.445643
NCT00220935|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-04|||January 2003||2003-01-01|July 2005|2005-07-01|July 2006||2006-07-01|||||Interventional|||A Randomized, Controlled Trial of Treatment for Disc Herniation With Radiating Leg Pain|Orthotrac Pneumatic Vest: A Randomized, Controlled Trial of Treatment for Disc Herniation With Radiating Leg Pain|Completed||N/A|150||Texas Back Institute|||||f||||||||||||||2017-02-18 17:07:27.010082|2017-02-18 17:07:27.010082
NCT00220922|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2011-04-07|||August 2004||2004-08-01|April 2011|2011-04-01|February 2006|Actual|2006-02-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.|An Open-Label, Randomized, Single Cross-Over Study of Isopropyl Alcohol Wipes Versus No Injection Site Preparation on Local Injection Site Reactions Among Persons With Multiple Sclerosis Who Perform Daily Injections of Copaxone®|Completed||Phase 4|50|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:07:27.094227|2017-02-18 17:07:27.094227
NCT00220909|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-01-02|||September 2005||2005-09-01|January 2008|2008-01-01|January 2006|Actual|2006-01-01|||||Interventional|||Lansoprazole Preventing Gastroduodenal Stress Ulcerations|A Prospective, Randomized, Double-Blind Protocol to Compare the Efficacy of Lansoprazole to Ranitidine in Healing Pre-Existing and/or Preventing the Development of Gastroduodenal Stress Ulceration and Postoperative Bleeding in Patients Undergoing Elective Coronary Artery Bypass Graft or Cardiac Valve Replacement Surgery|Terminated||Phase 4|40|Anticipated|Temple University||||Recruitment slow|||||||||||||||2017-02-18 17:07:27.200675|2017-02-18 17:07:27.200675
NCT00220896|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-09-13|||January 2006||2006-01-01|September 2011|2011-09-01|March 2009|Actual|2009-03-01|||||Interventional|||Prevention of Postoperative Delirium With Donepezil||Completed||Phase 4|37|Actual|Technische Universität München|||||f||||||||||||||2017-02-18 17:07:27.299464|2017-02-18 17:07:27.299464
NCT00220883|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2006-02-06|||August 2005||2005-08-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Observational|||Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients|Reproducibility and Inter-Reader Reliability of Electrogastrographic Readings in Normal Subjects and Dyspeptic Patients|Unknown status|Recruiting|N/A|40||Temple University|||||f||||||||||||||2017-02-18 17:07:27.385887|2017-02-18 17:07:27.385887
NCT00220870|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2010-04-07|||January 2003||2003-01-01|April 2010|2010-04-01|August 2005||2005-08-01|||||Interventional|||Shared Decision Making for Schizophrenia|Shared Decision Making in the Therapy of Schizophrenia|Completed||N/A|||Technische Universität München|||||f||||||||||||||2017-02-18 17:07:27.459171|2017-02-18 17:07:27.459171
NCT00220857|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-01-02|||September 2005||2005-09-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Rabeprazole Protection of Aspirin Induced Gastric Damage.|Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-Induced Damage by Rabeprazole|Completed||Phase 4|30|Anticipated|Temple University|||||f||||||||||||||2017-02-18 17:07:27.546331|2017-02-18 17:07:27.546331
NCT00220844|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2006-02-08|||September 2005||2005-09-01|September 2005|2005-09-01|September 2007||2007-09-01|||||Interventional|||Tricyclic Antidepressants (TCAs) on Gastric Emptying|Effect of Tricyclic Antidepressant Agents on Gastric Accommodation and Emptying|Unknown status|Recruiting|N/A|60||Temple University|||||f||||||||||||||2017-02-18 17:07:27.635615|2017-02-18 17:07:27.635615
NCT00220831|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-02-28|||April 2005||2005-04-01|February 2007|2007-02-01|December 2009||2009-12-01|||||Interventional|||Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment|Prevention of Diabetic Cardiovascular Complications With Vitamin E 400 IU Treatment to High Risk Patients by Haptoglobin Phenotype (I CARE – Israel Cardiovascular Atherosclerosis Risk and Vitamin E)|Terminated||Phase 2/Phase 3|2000||Technion, Israel Institute of Technology||||interim analysis showed significant differences between two treatment groups|f||||||||||||||2017-02-18 17:07:27.724904|2017-02-18 17:07:27.724904
NCT00220818|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-07-20|||January 2005||2005-01-01|July 2010|2010-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.|A Phase 1, Single- and Repeated-Dose, Randomized, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Lansoprazole in Infants With Clinically-Evident Gastroesophageal Reflux Disease.|Completed||Phase 1|24|Actual|Takeda||2|||f||||f||||||||||2017-02-18 17:07:27.828243|2017-02-18 17:07:27.828243
NCT00220805|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-02-22|2009-09-24||January 2004||2004-01-01|February 2016|2016-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional||The intent to treat (ITT) population, which was defined as the primary analysis population, comprised 29 subjects treated with IGIV-C 10% and 24 subjects treated with placebo. A total of 4 subjects were excluded from the ITT population: 1 from IGIV-C 10% and 3 from Placebo.|Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration|Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of IGIV-C, 10% Treatment in Subjects With Pure Occult Choroidal Neovascularization Due to Age Related Macular Degeneration|Completed||Phase 2|96|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 17:07:27.940484|2017-02-18 17:07:27.940484
NCT00220792|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2005-09-15|||June 1993||1993-06-01|September 2005|2005-09-01|June 1998||1998-06-01|||||Interventional|||Group Therapy for Primary Breast Cancer|A Multicenter Trial of Group Therapy for Breast Cancer|Completed||Phase 3|480||Stanford University|||||f||||||||||||||2017-02-18 17:07:28.771805|2017-02-18 17:07:28.771805
NCT00220779|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-28|2009-09-24||December 2002||2002-12-01|March 2016|2016-03-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|PRIVIG||Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis|Randomized, Double-Blind, Placebo-Controlled Study to Compare the Effects of Different Dose Regimens of IGIV Chromatography (IGIV-C), 10% Treatment on Relapses in Patients With Relapsing Remitting Multiple Sclerosis|Completed||Phase 2|128|Actual|Grifols Therapeutics Inc.||3|||f||||f||||||||||2017-02-18 17:07:28.884404|2017-02-18 17:07:28.884404
NCT00220766|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-09-24|||August 2002||2002-08-01|September 2009|2009-09-01|March 2004|Actual|2004-03-01|August 2002|Actual|2002-08-01||Interventional|||Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients|IGIV-C 10% Rapid Infusion Trial in Primary Immune Deficient Patients|Completed||Phase 3|100|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 17:07:29.724401|2017-02-18 17:07:29.724401
NCT00220753|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-07-21|||September 2005||2005-09-01|July 2009|2009-07-01|April 2006|Actual|2006-04-01|February 2006|Actual|2006-02-01||Interventional|||Air Cleaners for Children and Adolescents With Asthma and Dog Allergy|Air Cleaners for Children and Adolescents With Asthma and Dog Allergy|Completed||N/A|22|Actual|Sykehuset Innlandet HF||2|||f||||t||||||||||2017-02-18 17:07:29.852949|2017-02-18 17:07:29.852949
NCT00220740|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-02-23|2009-09-24||April 2004||2004-04-01|February 2016|2016-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|ICE||Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)|Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of IGIV-Chromatography (IGIV-C), 10% Treatment in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy|Completed||Phase 3|117|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 17:07:29.975375|2017-02-18 17:07:29.975375
NCT00220727|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-28|2009-09-24||July 2003||2003-07-01|March 2016|2016-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP|Randomized, Controlled, Open Study Investigating IGIV-C, 10% Given at Different Infusion Rates on Intravascular Hemolysis in Patients With Idiopathic (Immune) Thrombocytopenic Purpura (ITP)|Completed||Phase 2|8|Actual|Grifols Therapeutics Inc.||2|||f||||f||||||||||2017-02-18 17:07:30.787902|2017-02-18 17:07:30.787902
NCT00220714|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-03-28|||November 2004||2004-11-01|March 2008|2008-03-01|December 2007|Anticipated|2007-12-01|||||Interventional|||PREvent First Episode Relapse (PREFER)|Effectiveness of Long-Acting Risperidone in the Maintenance Treatment of First-Episode Schizophrenia|Unknown status|Active, not recruiting|Phase 4|80||State University of New York - Downstate Medical Center|||||f||||||||||||||2017-02-18 17:07:31.28176|2017-02-18 17:07:31.28176
NCT00220701|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2015-10-13|2014-11-19||June 2002||2002-06-01|November 2007|2007-11-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|||Escitalopram in the Treatment of Dysthymic Disorder, Double Blind|Double-Blind Placebo-Controlled Study of Escitalopram in the Treatment of Dysthymic Disorder|Completed||Phase 4|36|Actual|St. Luke's-Roosevelt Hospital Center|Small double blinded study with limited power.|2|||f||||f||||||||||2017-02-18 17:07:31.388881|2017-02-18 17:07:31.388881
NCT00220688|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-10-13|||September 2005||2005-09-01|March 2007|2007-03-01|October 2006||2006-10-01|||||Interventional|||Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients?|Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients?|Completed||N/A|10||Gloucestershire Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:07:31.83354|2017-02-18 17:07:31.83354
NCT00220675|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-05-21|||August 2005||2005-08-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Erythropoietin Spinal Cord Compression Randomized Trial|Recombinant Human Erythropoietin (r-HuEPO) in the Prevention of Neurologic Sequelae From Malignant Spinal Cord Compression: a Multi-Center, Placebo-Controlled, Phase 2 Randomized Study|Terminated||Phase 2/Phase 3|7|Actual|Sunnybrook Health Sciences Centre||2||Insufficient accrual|f||||t||||||||||2017-02-18 17:07:31.934408|2017-02-18 17:07:31.934408
NCT00220662|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||June 2000||2000-06-01|July 2004|2004-07-01|June 2006||2006-06-01|||||Interventional|||The Efficacy of Readiness and Motivation Therapy in Individuals With Anorexia Nervosa and Bulimia Nervosa|The Efficacy of Readiness and Motivation Therapy in Individuals With Anorexia Nervosa and Bulimia Nervosa|Unknown status|Active, not recruiting|Phase 3|100||St. Paul's Hospital, Canada|||||f||||||||||||||2017-02-18 17:07:32.05782|2017-02-18 17:07:32.05782
NCT00220649|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-08-14|||March 2004||2004-03-01|August 2009|2009-08-01||||||||Interventional|||Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas|Phase I Study to Determine the Safety, Maximum Tolerated Dose, and Efficacy of Biweekly Oxaliplatin (Eloxatin) in Combination With Gemcitabine, Irinotecan, and 5-FU/Leucovorin (G-Flie) in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Exocrine Pancreas|Completed||Phase 1|25|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||t||||||||||2017-02-18 17:07:32.15533|2017-02-18 17:07:32.15533
NCT00220636|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2016-04-26|2009-04-15||March 2005||2005-03-01|October 2014|2014-10-01|January 2008|Actual|2008-01-01|March 2007|Actual|2007-03-01||Interventional|||Abilify as an Adjunctive Treatment for Refractory Depression|Abilify (Aripiprazole) as an Adjunctive Treatment for Refractory Unipolar Depression|Completed||Phase 4|15|Actual|St. Luke's-Roosevelt Hospital Center|Open label study without comparison group.|1|||f||||f||||||||||2017-02-18 17:07:32.260247|2017-02-18 17:07:32.260247
NCT00220623|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||August 2004||2004-08-01|September 2005|2005-09-01||||||||Interventional|||Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major Depression|Efficacy and Cost-Effectiveness of 18-Months of Antidepressive Medication Plus Either Cognitive-Behavior Therapy or Dynamic Psychotherapy Compared to Supportive Clinical Management for Recurrent Major Depression: a Pilot Study|Unknown status|Recruiting|Phase 3|30||Sir Mortimer B. Davis - Jewish General Hospital|||||f||||||||||||||2017-02-18 17:07:32.558827|2017-02-18 17:07:32.558827
NCT00220610|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 2004||2004-05-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN the Treatment of DEPRESSION|Right Parietal Inhibition With rTMS in the Treatment of Depression|Unknown status|Recruiting|Phase 2|40||St. Lucas Andreas Ziekenhuis Hospital|||||f||||||||||||||2017-02-18 17:07:32.672425|2017-02-18 17:07:32.672425
NCT00220597|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-12-02|||September 1999||1999-09-01|December 2013|2013-12-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse|Group Interventions to Prevent HIV in High Risk Women|Completed||N/A|171|Actual|Stanford University|||||f||||f||||||||||2017-02-18 17:07:32.997398|2017-02-18 17:07:32.997398
NCT00220584|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-12-11|||July 2005||2005-07-01|December 2012|2012-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||An Open-Label Trial of Donepezil in Fragile X Syndrome|An Open-Label Trial of Donepezil in Fragile X Syndrome|Completed||Phase 1|10|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 17:07:33.095592|2017-02-18 17:07:33.095592
NCT00220571|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-02|||May 2003||2003-05-01|September 2005|2005-09-01|March 2007|Actual|2007-03-01|||||Interventional|||CARESS in Acute Myocardial Infarction|Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction|Completed||Phase 3|600|Actual|Società Italiana di Cardiologia Invasiva||2|||f||||t||||||||||2017-02-18 17:07:33.211337|2017-02-18 17:07:33.211337
NCT00220558|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-12-03|||May 2005||2005-05-01|May 2009|2009-05-01|February 2010|Anticipated|2010-02-01|October 2007|Actual|2007-10-01||Interventional|||GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions|A Randomized Comparison of Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions: The Gruppo Italiano di Studio Sullo Stent Nelle Occlusioni Coronariche. The GISSOC II Study.|Unknown status|Active, not recruiting|Phase 4|150|Actual|Società Italiana di Cardiologia Invasiva||1|||f||||f||||||||||2017-02-18 17:07:33.403101|2017-02-18 17:07:33.403101
NCT00220545|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-10-22|||March 2002||2002-03-01|October 2007|2007-10-01|March 2006||2006-03-01|||||Interventional|||Comparison Between Laparoscopic Ovarian Diathermy and Clomiphene Citrate in Women With Anovulatory PCOS|A Prospective Randomized Controlled Trial to Compare Laparoscopic Ovarian Diathermy With Clomiphene Citrate as a First Line Treatment of Anovulatory Infertility in Patients With Polycystic Ovarian Syndrome|Completed||N/A|72|Anticipated|Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:07:33.529921|2017-02-18 17:07:33.529921
NCT00220532|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-11|||July 2005||2005-07-01|September 2006|2006-09-01|May 2007||2007-05-01|||||Interventional|||Folate and Protection Against Cervical Cancer|A Randomised Placebo-Controlled Trial to Evaluate Interactions Between Riboflavin and Folate Intake and Genotype in Reducing Risk of Cervical Cancer|Terminated||Phase 1/Phase 2|180||Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:07:33.631723|2017-02-18 17:07:33.631723
NCT00220519|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-12-21|||October 2004||2004-10-01|September 2005|2005-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Lactobacillus GG Supplementation During Pediatric Burn Injuries|Lactobacillus GG Supplementation During Pediatric Burn Injuries|Terminated||N/A|3|Actual|Shriners Hospitals for Children||1||Study stopped due to low enrollment|f||||t||||||||||2017-02-18 17:07:33.733664|2017-02-18 17:07:33.733664
NCT00220506|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-02-16|||September 2005||2005-09-01|February 2006|2006-02-01|December 2006||2006-12-01|||||Interventional|||Fatigue Treatment Using Provigil|Fatigue Treatment Using Provigil in Patients With Relapsing Remitting Multiple Sclerosis|Unknown status|Recruiting|N/A|50||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:07:33.823971|2017-02-18 17:07:33.823971
NCT00220493|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-01-04|||June 2003||2003-06-01|January 2007|2007-01-01|June 2005||2005-06-01|||||Interventional|||Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients|Clinical Study Protocol: Evaluation of the Efficiency of Ritalin in Multiple Sclerosis Patients|Unknown status|Recruiting|Phase 1|80||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:07:33.918813|2017-02-18 17:07:33.918813
NCT00220480|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-02-07|||February 2005||2005-02-01|February 2010|2010-02-01||||June 2011|Anticipated|2011-06-01||Interventional|||A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression||Unknown status|Recruiting|N/A|60|Anticipated|Sheba Medical Center||1|||f||||f||||||||||2017-02-18 17:07:34.011465|2017-02-18 17:07:34.011465
NCT00220467|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2008-07-29|||January 2005||2005-01-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Cognitive Effects of Aerobic Exercise for MCI Adults|Cognitive Effects of Aerobic Exercise for Adults With Mild Cognitive Impairment: A Controlled Trial|Completed||Phase 2|40|Anticipated|Seattle Institute for Biomedical and Clinical Research|||||f||||f||||||||||2017-02-18 17:07:34.096656|2017-02-18 17:07:34.096656
NCT00220454|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-02-26|||December 2002||2002-12-01|February 2007|2007-02-01|March 2005||2005-03-01|||||Interventional|||Effect of Estrogen & Stress for Postmenopausal Women|Effect of Estrogen on the Stress Response for Postmenopausal Women|Completed||Phase 2|40||Seattle Institute for Biomedical and Clinical Research|||||f||||f||||||||||2017-02-18 17:07:34.185011|2017-02-18 17:07:34.185011
NCT00220441|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2008-07-29|||July 2004||2004-07-01|July 2008|2008-07-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Cognitive Effects of Aerobic Exercise for IGT Adults|Cognitive Effects of Aerobic Exercise for Adults With Impaired Glucose Tolerance: A Controlled Trial|Completed||Phase 2|40||Seattle Institute for Biomedical and Clinical Research|||||f||||f||||||||||2017-02-18 17:07:34.271297|2017-02-18 17:07:34.271297
NCT00220428|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-01-23|||July 1998||1998-07-01|January 2007|2007-01-01|December 2007||2007-12-01|||||Interventional|||T-Cell Vaccination in Multiple Sclerosis (MS)|The Effect of T-Cell Vaccination in Multiple Sclerosis - Phase I/II Safety and Efficacy Trial|Unknown status|Recruiting|Phase 1/Phase 2|20||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:07:34.356251|2017-02-18 17:07:34.356251
NCT00220415|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2014-09-19|||May 2004||2004-05-01|February 2010|2010-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-02-18 17:07:34.454593|2017-02-18 17:07:34.454593
NCT00220402|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-11-21|||July 2004||2004-07-01|November 2008|2008-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome|Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 17:07:34.541172|2017-02-18 17:07:34.541172
NCT00220389|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-10-15|||June 2003||2003-06-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase|Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder(OAB): a Double-Blind Phase Followed by an Open-Label Extension Phase|Completed||Phase 2|||Pfizer|||||||||||||||||||2017-02-18 17:07:34.619078|2017-02-18 17:07:34.619078
NCT00220376|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-11-21|||April 2004||2004-04-01|November 2008|2008-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome|Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome|Completed||Phase 3|||Pfizer|||||||||||||||||||2017-02-18 17:07:34.697888|2017-02-18 17:07:34.697888
NCT00220363|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-04-29|||January 2004||2004-01-01|April 2008|2008-04-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome|A Phase 3, Parallel Group, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled Multicenter Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 17:07:34.779644|2017-02-18 17:07:34.779644
NCT00005423|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1992||1992-07-01|April 2002|2002-04-01|December 1994|Actual|1994-12-01|||||Observational|||Dietary Quality and Subsequent Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.821741|2017-02-18 18:15:00.821741
NCT00220337|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-09-19|||December 2004||2004-12-01|September 2009|2009-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy|A Multicenter, Open-label Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy|Completed||Phase 3|371|Actual|UCB Pharma||1|||f||||||||||||||2017-02-18 17:07:34.956222|2017-02-18 17:07:34.956222
NCT00220324|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-04-02|||February 2004||2004-02-01|April 2015|2015-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Pearl Index Study With Low Dose Combined Oral Contraceptive|Prospective, Multicenter, Open-label, Uncontrolled Study to Investigate the Contraceptive Efficacy, Bleeding Patterns, and Safety of an Oral Contraceptive Containing 0.03 mg Ethinylestradiol and 0.125 mg Levonorgestrel (SH D00342A) Applied for 13 Cycles to Healthy Female Volunteers|Completed||Phase 3|840|Actual|Bayer||1|||f||||f||||||||||2017-02-18 17:07:35.063239|2017-02-18 17:07:35.063239
NCT00220311|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2013-12-02|||November 2000||2000-11-01|December 2013|2013-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia|A Multicenter Study to Confirm the Efficacy and Safety of Fludara i.v. (Fludarabine Phosphate, SH L 573), Administered in 6 Treatment Cycles (1 Treatment Cycle: 5-consecutive Day Dosing, Followed by an Observation Period of 23 Days) in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia|Completed||Phase 4|10|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 17:07:35.19522|2017-02-18 17:07:35.19522
NCT00220298|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2014-12-29|||February 2003||2003-02-01|December 2014|2014-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism|Open One-arm Study to Investigate Safety and Efficacy of Intramuscular Injections of 1000 mg Testosterone Undecanoate (TU) in Hypogonadal Men at Variable Intervals During a 136-week to 192-week Treatment Including Pharmacokinetics|Completed||Phase 3|96|Actual|Bayer||1|||f||||f||||||||||2017-02-18 17:07:35.302484|2017-02-18 17:07:35.302484
NCT00220285|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2014-12-29|||August 2004||2004-08-01|December 2014|2014-12-01|October 2005|Actual|2005-10-01|||||Interventional|||Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma|A Phase II Open-label Study of SH L 749 in Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphomas|Completed||Phase 2|45|Actual|Bayer||2|||f||||t||||||||||2017-02-18 17:07:35.428426|2017-02-18 17:07:35.428426
NCT00220272|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2008-12-22|||January 2004||2004-01-01|December 2008|2008-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease|A Phase II, Randomized, Multicenter, Multinational, Double-Blind, Placebo-Controlled, Study of the Effect of SR57667B on Dopaminergic Nigro-Striatal Function Assessed by 18F-Dopa PET Imaging in Outpatients With Early Parkinson's Disease|Completed||Phase 2|183|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:07:35.667967|2017-02-18 17:07:35.667967
NCT00220259|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-11-07|||May 2001||2001-05-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)|Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)|Completed||N/A|240||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:07:35.772472|2017-02-18 17:07:35.772472
NCT00220246|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2007-02-28|||March 2004||2004-03-01|February 2007|2007-02-01|September 2008||2008-09-01|||||Observational|||Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer||Unknown status|Active, not recruiting|N/A|130||Radboud University|||||f||||||||||||||2017-02-18 17:07:35.865959|2017-02-18 17:07:35.865959
NCT00220233|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-12-12|||April 2005||2005-04-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Olmesartan as an Add-on to Amlodipine in Hypertension|Add-on Study of Olmesartan Medoxomil in Patients With Moderate to Severe Hypertension Not Achieving Target Blood Pressure on Amlodipine 5 mg Alone|Completed||Phase 3|632||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:07:35.950453|2017-02-18 17:07:35.950453
NCT00220220|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-10-10|||April 2005||2005-04-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Amlodipine as Add-on to Olmesartan in Hypertension|Efficacy and Safety of Amlodipine Used as Add-on Therapy in Moderately to Severely Hypertensive Patients Not Adequately Controlled by Olmesartan Medoxomil 20 mg Monotherapy|Completed||Phase 3|429|Anticipated|Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:07:36.041222|2017-02-18 17:07:36.041222
NCT00220207|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2007-07-31|||September 2003||2003-09-01|July 2007|2007-07-01|February 2007||2007-02-01|||||Interventional|||Determining the Effect on Patients of Internet-Based Diabetes Disease Management|A Randomized Controlled Trial of Diabetes Disease Management Over the Internet|Completed||N/A|63||Robert Wood Johnson Foundation|||||f||||f||||||||||2017-02-18 17:07:36.127107|2017-02-18 17:07:36.127107
NCT00220194|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-17|2016-10-13|||April 2003||2003-04-01|October 2016|2016-10-01|June 2005||2005-06-01|||||Interventional|||A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer|A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer|Completed||Phase 4|100||San Bernardino Urological Associates Medical Group Inc|||||f||||||||||||||2017-02-18 17:07:36.216792|2017-02-18 17:07:36.216792
NCT00220181|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2005-09-21|||April 2003||2003-04-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Prospective Study in Pelvic Radiotherapy Patients|A Prospective Study to Identify Changes in Nutritional Status and Bowel Symptoms in Patients Receiving a Course of Radical Radiotherapy to the Pelvis for Treatment of Gynaecological, Urological or Rectal Cancer.|Completed||N/A|100||Royal Marsden NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:07:36.289287|2017-02-18 17:07:36.289287
NCT00220168|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-12-15|||January 2003||2003-01-01|December 2009|2009-12-01||||||||Interventional|||Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours|A Phase II Trial Evaluating Irinotecan and Capecitabine in Patients With Relapsed/Refractory Upper Gastrointestinal Tumours|Completed||Phase 4|33|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 17:07:36.357753|2017-02-18 17:07:36.357753
NCT00220155|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2009-12-15|||May 2004||2004-05-01|December 2009|2009-12-01||||||||Interventional|||Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer|A Phase II Trial of Fixed Dose Rate Gemcitabine in Patients With Advanced or Metastatic Colorectal Cancer.|Completed||Phase 2|16|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 17:07:36.453607|2017-02-18 17:07:36.453607
NCT00220129|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-12-15|||November 2002||2002-11-01|December 2009|2009-12-01||||||||Interventional|||Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus|Neoadjuvant Epirubicin, Cisplatin and Capecitabine (Xeloda) [ECX] Followed by Definitive Chemoradiation With or Without Surgery for Patients With Newly Diagnosed Localized Squamous Cell Carcinoma of the Oesophagus|Completed||Phase 2|16|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 17:07:36.806185|2017-02-18 17:07:36.806185
NCT00220116|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2010-01-05|||August 2002||2002-08-01|January 2010|2010-01-01||||||||Interventional|||Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer|A Phase II Trial Assessing the Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer.|Completed||Phase 2|172|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 17:07:36.903117|2017-02-18 17:07:36.903117
NCT00220103|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-12-15|||November 2002||2002-11-01|December 2009|2009-12-01||||||||Interventional|||Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma|Pre-operative Epirubicin, Capecitabine (Xeloda) and Cisplatin in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma|Completed||Phase 2|80|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 17:07:37.00291|2017-02-18 17:07:37.00291
NCT00220090|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-13|||July 2003||2003-07-01|May 2008|2008-05-01||||September 2006|Actual|2006-09-01||Interventional|||DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)|A 24-wk, Prospective, d/b, Placebo Controlled, Parallel Group, Multicenter, Randomized/Withdrawal Efficacy and Safety Study of Dexloxiglumide for the Relief of Symptoms in Patients With Constipation-Predominant Irritable Bowel Syndrome|Completed||Phase 3|||Rottapharm|||||f||||||||||||||2017-02-18 17:07:37.105208|2017-02-18 17:07:37.105208
NCT00220077|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2015-11-23|||June 2002||2002-06-01|November 2015|2015-11-01||||||||Interventional|||Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer|Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer|Recruiting||N/A|400|Anticipated|Royal Marsden NHS Foundation Trust||1|||f||||||||||||||2017-02-18 17:07:37.293176|2017-02-18 17:07:37.293176
NCT00220064|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-05-30|||July 2000||2000-07-01|May 2013|2013-05-01|November 2005|Actual|2005-11-01|||||Interventional|||A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours|A Phase II Trial Evaluating Irinotecan With 5_fluorouracil Plus Leucovorin in Patients With Relapsed/Refractory Upper Gastrointestinal Tumours|Completed||Phase 2|65|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 17:07:37.404283|2017-02-18 17:07:37.404283
NCT00220051|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-05-30|||November 2001||2001-11-01|May 2013|2013-05-01||||||||Interventional|||A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer|A Phase II Study of Oxaliplatin (Eloxatin) Capecitabine (Xeloda) and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer.|Completed||Phase 2|109|Actual|Royal Marsden NHS Foundation Trust||1|||f||||f||||||||||2017-02-18 17:07:37.496685|2017-02-18 17:07:37.496685
NCT00220038|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2012-01-10|||May 2004||2004-05-01|January 2012|2012-01-01|May 2010|Actual|2010-05-01|January 2007|Actual|2007-01-01||Observational|||Experiments to Test How and Why the Sense of Smell Differs Between People|Genetic Basis of Specific Anosmias|Completed||N/A|500|Actual|Rockefeller University|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 17:07:37.581914|2017-02-18 17:07:37.581914
NCT00220025|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-10-24|||June 1999||1999-06-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.|A Study To Determine the Efficacy of Whole Body Narrowband UVB Phototherapy in People With Darker Skin Types|Completed||Phase 1|70|Actual|Rockefeller University||1|||f||||t||||||||||2017-02-18 17:07:37.675916|2017-02-18 17:07:37.675916
NCT00220012|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-11-14|||June 2003||2003-06-01|November 2013|2013-11-01|September 2008|Actual|2008-09-01|||||Interventional|||Effect of Folate on Colon and Blood Cells|Effect of Folate on Colonic and Blood Cells|Completed||Phase 1|20||Rockefeller University|||||f||||||||||||||2017-02-18 17:07:37.77254|2017-02-18 17:07:37.77254
NCT00219999|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-08-06|||September 2001||2001-09-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Hepatitis C Virus and the Humoral Immune System|Hepatitis C Virus and the Humoral Immune System|Completed||N/A|161|Actual|Rockefeller University|||5||f||||t||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 17:07:37.871326|2017-02-18 17:07:37.871326
NCT00219986|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-16|||October 2003||2003-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Phase I/II, Open-Label Trial of Three Monoclonal Antibodies|A Phase I/II Single Site Open Label Trial of the Safety and Antiviral Activity of C2F5, C2G12, and C4E10 Monoclonal Antibody Infusions in Well-Suppressed HAART-Treated Individuals Treated During Acute and Early HIV-1 Infection|Completed||Phase 1/Phase 2|12||Rockefeller University|||||||||||||||||||2017-02-18 17:07:37.975795|2017-02-18 17:07:37.975795
NCT00219973|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2010-04-27|||May 2005||2005-05-01|April 2010|2010-04-01|April 2009|Actual|2009-04-01|||||Interventional|||CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)|Multicentric, Rand., D-b, Pbo Controlled Clinical Trial to Evaluate the Efficacy and the Safety of the Thromboprophylaxis With Bemiparin 3,500 IU/d for 28 Days Compared to 8 Days, in Patients Undergoing Oncological Abdominal/ Pelvic Surgery|Completed||Phase 3|526|Anticipated|Rovi Pharmaceuticals Laboratories|||||f||||t||||||||||2017-02-18 17:07:38.079361|2017-02-18 17:07:38.079361
NCT00219960|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||April 2001||2001-04-01|June 2004|2004-06-01|October 2003||2003-10-01|||||Interventional|||The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension|The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension|Completed||Phase 3|52||Risk Factor Modification Centre|||||f||||||||||||||2017-02-18 17:07:38.188587|2017-02-18 17:07:38.188587
NCT00219947|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-01-17|||July 2000||2000-07-01|January 2017|2017-01-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Viral and Host Factors in the Transmission and Pathogenesis of HIV|Viral and Host Factors in the Transmission and Pathogenesis of HIV|Recruiting||N/A|600|Anticipated|Rockefeller University|||2||f||||f||||||Samples With DNA|"~     whole blood~   "|No||2017-02-18 17:07:38.286364|2017-02-18 17:07:38.286364
NCT00005422|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1992||1992-04-01|June 2000|2000-06-01|March 1995|Actual|1995-03-01|||||Observational|||Longitudinal Analysis of Spirometry in Black Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.888389|2017-02-18 18:15:00.888389
NCT00219934|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-02-15|||February 2002||2002-02-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Observational Study of Treated and Untreated Acute and Early HIV-1 Infection|Observational Study of Treated and Untreated Acute and Early HIV-1 Infection|Completed||N/A|399|Actual|Rockefeller University|||2||f||||t||||||Samples With DNA|"~     PLASMA AND PERIPHERAL BLOOD MONONUCLEAR CELLS~   "|||2017-02-18 17:07:38.4938|2017-02-18 17:07:38.4938
NCT00219921|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-03-29|||September 2005||2005-09-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Postoperative Analgesia After Total Hip Replacement|Postoperative Analgesia After Total Hip Replacement|Completed||Phase 3|120||Rijnstate Hospital|||||f||||||||||||||2017-02-18 17:07:38.60401|2017-02-18 17:07:38.60401
NCT00219908|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-12-21|||July 1999||1999-07-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis|Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis: Induction Treatment With Mitoxantrone Followed by Long-Term Treatment With Interferon-beta1b|Terminated||Phase 2|124||Rennes University Hospital|||||f||||||||||||||2017-02-18 17:07:38.687834|2017-02-18 17:07:38.687834
NCT00219895|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-12-18|||August 2004||2004-08-01|August 2006|2006-08-01|March 2006|Actual|2006-03-01|||||Interventional|||Assessment of Inflammatory Mediators (AIM)|Assessment of Induced Sputum as a Tool to Evaluate Anti-Inflammatory Agents in Patients With Cystic Fibrosis|Completed||N/A|120||Ramsey, Bonnie, MD|||||f||||||||||||||2017-02-18 17:07:38.796811|2017-02-18 17:07:38.796811
NCT00219882|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-12-18|||April 2005||2005-04-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|SEER||Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis|A Phase I Safety and Dose Finding Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis Who Are Homozygous for Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (ΔF508 CFTR) Mutation|Completed||Phase 1|11|Actual|Ramsey, Bonnie, MD||1|||f||||t||||||||||2017-02-18 17:07:38.90263|2017-02-18 17:07:38.90263
NCT00219869|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||July 2005||2005-07-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Galantamine in the Treatment of Post-Traumatic Headache|Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache|Unknown status|Recruiting|Phase 4|30||Rapoport, Alan, M.D.|||||f||||||||||||||2017-02-18 17:07:39.00899|2017-02-18 17:07:39.00899
NCT00219856|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-25|||August 2004||2004-08-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Effects of Propofol on Oxidative Stress and Liver Regeneration After Partial Hepatectomy|Prospective, Randomized, Simple Blind Study Comparing the Effects of an Anaesthesia With Propofol to an Anaesthesia With Desflurane on Oxydative Stress and Liver Function Recovery After Hepatectomy|Completed||Phase 3|34|Actual|Rennes University Hospital||2|||f||||f||||||||||2017-02-18 17:07:39.106998|2017-02-18 17:07:39.106998
NCT00219843|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-08-22|||August 2005||2005-08-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Intralesional PV-10 Chemoablation of Metastatic Melanoma|A Phase 1 Safety and Tolerability Study of Intralesional PV-10 Chemoablation in Subjects With Metastatic Melanoma|Completed||Phase 1|20||Provectus Pharmaceuticals|||||f||||f||||||||||2017-02-18 17:07:39.304232|2017-02-18 17:07:39.304232
NCT00219830|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-02-18|||January 2005||2005-01-01|February 2009|2009-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|CRU-SHAL||A Trial of a Home Based Walking Program as an Alternate Program for Non Attenders at Cardiac Rehabilitation|Health and Social Inequalities in the Uptake of Cardiac Rehabilitation in Northern Ireland: an Alternative Program for Non-Attenders: (2) a Randomised Controlled Trial.|Completed||N/A|432|Actual|Queen's University, Belfast|||2||f||||f||||||||||2017-02-18 17:07:39.39257|2017-02-18 17:07:39.39257
NCT00219817|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-08-30|||June 2005||2005-06-01|August 2013|2013-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss||Completed||Phase 2|80||Helsinn Therapeutics (U.S.), Inc|||||||||||||||||||2017-02-18 17:07:39.497167|2017-02-18 17:07:39.497167
NCT00219804|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14||||||September 2005|2005-09-01||||||||Interventional|||Efficacy and Safety of Tetrabenazine in Chorea|A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea|Completed||Phase 3|||Prestwick Pharmaceuticals|||||||||||||||||||2017-02-18 17:07:39.581484|2017-02-18 17:07:39.581484
NCT00219791|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-09-10|||January 2000||2000-01-01|September 2014|2014-09-01|June 2003||2003-06-01|||||Interventional|||Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance|Study of Recombinant Carboxypeptidase G2 (CPG2) for the Management of Patients With Delayed Methotrexate (MTX) Clearance or Intrathecal MTX Overdosage|Completed||Phase 2|||BTG International Inc.|||||f||||||||||||||2017-02-18 17:07:39.648638|2017-02-18 17:07:39.648638
NCT00219778|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-04-04|||December 2004||2004-12-01|March 2010|2010-03-01|February 2010|Actual|2010-02-01|||||Interventional|||A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas|A Placebo Controlled Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas|Terminated||Phase 2|20|Anticipated|Poitiers University Hospital|||||f||||||||||||||2017-02-18 17:07:39.731599|2017-02-18 17:07:39.731599
NCT00219765|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-11-25|||May 2001||2001-05-01|September 2005|2005-09-01|January 2006||2006-01-01|||||Interventional|||Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients|Phase I/II Trial to Study the Dose, Tolerability and the Effectiveness of Imatinib in Combination With Daunorubicine and Cytarabine for Patients With Chronic Myelogenous Leukemia in Myeloid Acute Phase|Terminated||Phase 1/Phase 2|30||Poitiers University Hospital|||||f||||||||||||||2017-02-18 17:07:39.813801|2017-02-18 17:07:39.813801
NCT00219752|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-21|||May 2002||2002-05-01|September 2005|2005-09-01|May 2007||2007-05-01|||||Interventional|||Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years|Phase II Trial to Study the Tolerability and the Effectiveness of Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase With Age More Than 70, Diagnosis of CML is Being Performed Within 1 Year|Completed||Phase 2|30||Poitiers University Hospital|||||f||||||||||||||2017-02-18 17:07:39.912905|2017-02-18 17:07:39.912905
NCT00219739|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-10|||September 2003||2003-09-01|June 2016|2016-06-01||||December 2014|Actual|2014-12-01||Interventional|SPIRIT||STI571 ProspectIve RandomIzed Trial: SPIRIT|A Phase III Prospective Randomized Comparison of Imatinib at a Dose of 400mg in Combination With Peg-Interferon-alpha2a (Peg-IFNa2a) or Cytarabine (Ara-C)Versus Imatinib at a Dose of 600mg Versus Imatinib a Dose of 400mg for Previously Untreated Chronic Myelogenous Leukemia (CML) in Chronic Phase|Completed||Phase 3|789|Actual|Poitiers University Hospital||4|||f||||||||||||||2017-02-18 17:07:40.016138|2017-02-18 17:07:40.016138
NCT00219726|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-28|||May 2002||2002-05-01|September 2005|2005-09-01|July 2007||2007-07-01|||||Interventional|||Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation|Phase II Trial to Study the Tolerability and the Effectiveness of Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase in Relapse After Allogeneic Stem Cell Transplantation|Completed||Phase 2|30|Anticipated|Poitiers University Hospital|||||f||||||||||||||2017-02-18 17:07:40.135403|2017-02-18 17:07:40.135403
NCT00219713|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||March 2000||2000-03-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Evaluation of Pain Intensity During Bone Marrow Biopsy Performed With Inhalation of Pre-Mixed 50 Per Cent Nitrous Oxide and Oxygen Mixture.|A Randomized Placebo-Controlled Double Blind Trial Comparing Pre-Mixed 50 Per Cent Nitrous Oxide and Oxygen Mixture in Combination With Local Local 1% Xylocaine Anesthetic Versus Placebo in Order to Evaluate Pain Intensity During Bone Marrow Biopsy.|Terminated||Phase 3|280||Poitiers University Hospital|||||f||||||||||||||2017-02-18 17:07:40.233621|2017-02-18 17:07:40.233621
NCT00219700|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-11-25|||January 2005||2005-01-01|November 2008|2008-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial|Phase II, Randomized, Blinded Study of Ibuprofen-PC and Ibuprofen in Patients With Osteoarthritis to Investigate Efficacy and Gastrointestinal Toxicity|Completed||Phase 2|125||PLx Pharma|||||f||||f||||||||||2017-02-18 17:07:40.329925|2017-02-18 17:07:40.329925
NCT00219687|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-10-28|||June 2004||2004-06-01|October 2014|2014-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Dispatcher-Assisted Resuscitation Trial (DART)|Randomized Trial of Dispatcher-Assisted CPR:Chest Compression Alone Versus Chest Compression Plus Ventilation|Completed||Phase 3|5494|Actual|Public Health - Seattle and King County||2|||f||||t||||||||||2017-02-18 17:07:40.42174|2017-02-18 17:07:40.42174
NCT00219674|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-10-28|||July 2004||2004-07-01|October 2014|2014-10-01|March 2011|Actual|2011-03-01|March 2009|Actual|2009-03-01||Interventional|||At-Home Automated External Defibrillator (AED) Training Study|Home Automatic External Defibrillator Training for High-Risk Patients|Completed||Phase 2|305|Actual|Public Health - Seattle and King County||4|||f||||t||||||||||2017-02-18 17:07:40.533507|2017-02-18 17:07:40.533507
NCT00219661|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-20|||June 2003||2003-06-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Effect of Drainage of Subglottic Secretions on Pneumonia Acquired Under Mechanical Ventilation|Impact of Drainage of Subglottic Secretions on Ventilator-Associated Pneumonia:a Randomised Multicentre Trial|Completed||Phase 3|440||Poissy-Saint Germain Hospital|||||f||||f||||||||||2017-02-18 17:07:40.646012|2017-02-18 17:07:40.646012
NCT00219648|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-09-20|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose- Finding, Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Unknown status|Recruiting|Phase 2|||PharmaEngine|||||||||||||||||||2017-02-18 17:07:40.733034|2017-02-18 17:07:40.733034
NCT00219635|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-11-05|||January 2005||2005-01-01|November 2012|2012-11-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation|A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study To Assess The Efficacy and Safety Of Oral UK-390,957 In Men With Premature Ejaculation|Completed||Phase 2/Phase 3|138||Pfizer|||||||||||||||||||2017-02-18 17:07:40.801268|2017-02-18 17:07:40.801268
NCT00219622|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2012-11-05|||May 2004||2004-05-01|November 2012|2012-11-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease|Phase 2, Randomized, Double-Blind, Placebo-Controlled, Six Week Study Of The Efficacy And Safety Of Tofimilast Dry Powder For Inhalation In Adults Diagnosed With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|300||Pfizer|||||f||||||||||||||2017-02-18 17:07:40.907331|2017-02-18 17:07:40.907331
NCT00219609|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-11-05|||January 2005||2005-01-01|November 2012|2012-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Assessment Of Safety Of UK-390,957|A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation|Completed||Phase 2/Phase 3|1058||Pfizer|||||||||||||||||||2017-02-18 17:07:43.827352|2017-02-18 17:07:43.827352
NCT00219596|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-13|||June 2005||2005-06-01|November 2006|2006-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension|An 8-Week, Randomized, Open-Label, Parallel Group Study Comparing The Efficacy And Safety Of Xalacom With The Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension|Completed||Phase 3|240||Pfizer|||||f||||||||||||||2017-02-18 17:07:43.979428|2017-02-18 17:07:43.979428
NCT00219583|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-11-05|||August 2004||2004-08-01|November 2012|2012-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation|A Phase 2b, Multi-Centre, Double-Blind, Placebo-Controlled, Parallel Group Dose Response Study To Assess The Efficacy and Safety Of Oral UK390,957 In Men With Premature Ejaculation|Completed||Phase 2/Phase 3|460||Pfizer|||||||||||||||||||2017-02-18 17:07:44.07161|2017-02-18 17:07:44.07161
NCT00219570|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-09|||January 2005||2005-01-01|May 2011|2011-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Dalacin-T Gel Post Approval Study|Phase IV Clinical Study Of Clindamycin Phosphate Topical Gel In The Treatment Of Acne Vulgaris|Completed||Phase 4|134|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:07:44.462824|2017-02-18 17:07:44.462824
NCT00219557|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-23|2012-02-25||July 2005||2005-07-01|July 2012|2012-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer|A Randomized Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Combination With Gemcitabine In Patients With Chemotherapy Naive Advanced Pancreatic Cancer Preceded By A Phase 1 Portion|Completed||Phase 2|111|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:07:44.61094|2017-02-18 17:07:44.61094
NCT00219544|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-22|2009-02-13||November 2005||2005-11-01|April 2011|2011-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.|A Randomized, Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Peripheral Neuropathic Pain|Completed||Phase 3|158|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 17:07:48.646053|2017-02-18 17:07:48.646053
NCT00219531|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-06-01|||March 1999||1999-03-01|September 2009|2009-09-01||||||||Observational|||Effect of Menstrual Cycle on CNS Processing of Gut Stimuli in IBS and Control|Effect of Menstrual Cycle and Irritable Bowel Syndrome on the Central Nervous System Processing of Gut Stimuli|Terminated||N/A|50|Anticipated|Penn State University|||2|inadequate number of patients, study completed with normal subjects|f||||f||||||||||2017-02-18 17:07:49.383655|2017-02-18 17:07:49.383655
NCT00219518|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-06-01|||February 2006||2006-02-01|September 2009|2009-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|||Mechano-physiological Approach to Anorectal Function|Mechano-physiological Approach to Normal Anorectal Function and the Classification of Defecatory Disorders|Terminated||N/A|17|Actual|Penn State University|||1|inadequate no of constip patients|f||||||||||||||2017-02-18 17:07:49.486086|2017-02-18 17:07:49.486086
NCT00219505|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-06-01|||August 2001||2001-08-01|September 2006|2006-09-01|January 2004||2004-01-01|||||Interventional|||Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBS|Effect of Acupuncture on Symptoms of Diarrhea and Pain in Diarrhea Predominant Irritable Bowel Syndrome (IBS) and Effect on Plasma Beta-endorphin and Serotonin Levels.|Terminated||N/A|36||Penn State University||||no eligible subjects identified during recruitment|f||||||||||||||2017-02-18 17:07:49.584088|2017-02-18 17:07:49.584088
NCT00219492|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||September 2005||2005-09-01|September 2005|2005-09-01|September 2008||2008-09-01|||||Observational|||Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)|Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)|Unknown status|Recruiting|N/A|90||Penn State University|||||f||||||||||||||2017-02-18 17:07:49.74713|2017-02-18 17:07:49.74713
NCT00219479|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-06-13|||August 1997||1997-08-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study|Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study|Terminated||Phase 4|3|Actual|Penn State University||1||Difficulty recruiting subjects|f||||f||||||||||2017-02-18 17:07:49.834589|2017-02-18 17:07:49.834589
NCT00219466|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-19|||June 2005||2005-06-01|August 2011|2011-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash|A Parallel, Evaluator-Blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Two Marketed Topical Skin Protectants Containing Zinc Oxide in Children With Diaper Rash|Completed||Phase 4|112|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-02-18 17:07:49.930334|2017-02-18 17:07:49.930334
NCT00219453|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-18|||October 2004||2004-10-01|April 2007|2007-04-01|January 2006||2006-01-01|||||Interventional|||Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination|A Pilot Safety Study to Determine the Presence of Hepatitis B Virus in Downstream Injection Samples Using the HSI-500 Jet Injector With Protector Cap|Completed||Phase 1|17||PATH|||||f||||||||||||||2017-02-18 17:07:50.038226|2017-02-18 17:07:50.038226
NCT00219440|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-01-22|||February 2003||2003-02-01|January 2016|2016-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|TAKE II||A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS|A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS|Completed||Phase 4|60|Anticipated|Pennington Biomedical Research Center||3|||f||||t||||||||||2017-02-18 17:07:50.134774|2017-02-18 17:07:50.134774
NCT00219427|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-05-20|||January 2005||2005-01-01|May 2008|2008-05-01|December 2005|Actual|2005-12-01|November 2005|Actual|2005-11-01||Observational|||Retina Projection System Trials for Low Vision People|Multicenter Clinical Trials of Retina Projection System|Completed||N/A|58|Actual|Osaka City University|||1||f||||t||||||||||2017-02-18 17:07:50.244999|2017-02-18 17:07:50.244999
NCT00219414|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-09-26|||June 2005||2005-06-01|September 2007|2007-09-01|June 2006||2006-06-01|||||Interventional|||Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)||Completed||Phase 4|42||Otsuka Frankfurt Research Institute GmbH|||||f||||||||||||||2017-02-18 17:07:50.516314|2017-02-18 17:07:50.516314
NCT00219401|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-07-10|||May 2005||2005-05-01|July 2011|2011-07-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea|Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea|Completed||Phase 2|318|Actual|Papua New Guinea Institute of Medical Research||3|||f||||t||||||||||2017-02-18 17:07:50.596452|2017-02-18 17:07:50.596452
NCT00219388|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-21|||November 2002||2002-11-01|September 2005|2005-09-01|April 2005||2005-04-01|||||Interventional|||Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.|Efficacy and Safety of Short-Term Intravenous Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients Treated With Beta-Receptor Blocking Agents.|Completed||Phase 4|60||Orion Corporation, Orion Pharma|||||f||||||||||||||2017-02-18 17:07:50.708818|2017-02-18 17:07:50.708818
NCT00219375|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-21|||June 2004||2004-06-01|June 2012|2012-06-01||||July 2007|Actual|2007-07-01||Interventional|||Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan|Efficacy and Safety of Sivelestat Sodium Hydrate in Acute Lung Injury Associated With Systemic Inflammatory Response Syndrome, Compared With the Conventional Treatment in Japan|Completed||Phase 4|649|Actual|Ono Pharmaceutical Co. Ltd||3|||f||||||||||||||2017-02-18 17:07:50.815895|2017-02-18 17:07:50.815895
NCT00219362|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-11-24|||April 2004||2004-04-01|November 2009|2009-11-01|September 2006|Actual|2006-09-01|November 2005|Actual|2005-11-01||Interventional|MANON 02||Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients|A Phase II, Randomized, Placebo-controlled Study to Evaluate the Immunogenicity and the Safety of 2 Schedules of an Homologous Prime-boost With the ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients|Completed||Phase 2|65|Actual|Objectif Recherche Vaccins SIDA||4|||f||||f||||||||||2017-02-18 17:07:50.927346|2017-02-18 17:07:50.927346
NCT00219349|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-04-11|2012-02-29||January 2005||2005-01-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)|Cognitive-Behavioral Therapy and Pharmacotherapy Augmentation for Generalized Anxiety Disorder: A Pilot Investigation|Completed||Phase 4|25|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 17:07:51.048505|2017-02-18 17:07:51.048505
NCT00219336|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-09-29|||November 2005||2005-11-01|September 2016|2016-09-01|March 2009|Actual|2009-03-01|July 2008|Actual|2008-07-01||Interventional|||A Media Based Motivational Intervention to Prevent Alcohol Exposed Pregnancies (AEPs)|A Media Based Motivational Intervention to Reduce Alcohol Exposed Pregnancies (AEPs)|Completed||Phase 2|354|Actual|Nova Southeastern University||2|||f||||f||||||||No||2017-02-18 17:07:51.302656|2017-02-18 17:07:51.302656
NCT00219310|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2012-04-26|||June 2003||2003-06-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir|A Study to Determine the Safety and Efficacy of Famciclovir in the Episodic and Suppressive Treatment of Recurrent Genital Herpes (RGH). The Study Will Also Evaluate Quality of Life and Patient Satisfaction|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 17:07:51.512678|2017-02-18 17:07:51.512678
NCT00219297|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2013-03-14||2012-05-01|November 2005||2005-11-01|March 2013|2013-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer|An Open-label, Multi-center, Phase II Study to Evaluate the Activity of Patupilone (EPO906), in the Treatment of Recurrent or Progressive Brain Metastases in Patients With Non-small Cell Lung Cancer.|Completed||Phase 2|62|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:07:51.600995|2017-02-18 17:07:51.600995
NCT00219284|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-02-16|2010-12-07||January 2005||2005-01-01|February 2011|2011-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease|A Prospective, Multi-center, Randomized, Open-label Study With Blinded Raters to Evaluate the Effects of Immediate Versus Delayed Switch to Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease With End-of-dose Wearing Off|Completed||Phase 4|359|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:07:51.716405|2017-02-18 17:07:51.716405
NCT00219271|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-21|||September 2003||2003-09-01|May 2013|2013-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer|Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer|Completed||Phase 4|60|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:07:52.448077|2017-02-18 17:07:52.448077
NCT00219258|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-20|||July 2005||2005-07-01|November 2009|2009-11-01||||||||Interventional|||Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma|A Randomized, Double-blind, Multi-centre Study to Evaluate the Fficacy and Safety of Zometa as a Treatment in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma|Completed||Phase 3|240||Novartis|||||f||||||||||||||2017-02-18 17:07:52.535164|2017-02-18 17:07:52.535164
NCT00219245|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-11-16|||November 2002||2002-11-01|November 2011|2011-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits|A 26-Week Open-Label Extension to Protocol No. CENA713BUS11: A 12-Week, Prospective, Double-blind, Placebo-controlled, Multi-center Study Evaluating the Efficacy and Safety of Rivastigmine 3 to 6 mg/Day in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits|Completed||Phase 4|157|Actual|Novartis|||||f||||||||||||||2017-02-18 17:07:52.619491|2017-02-18 17:07:52.619491
NCT00219232|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-11-16|||February 2003||2003-02-01|November 2016|2016-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease|An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease|Completed||Phase 3|868|Actual|Novartis|||||f||||||||||||||2017-02-18 17:07:52.700351|2017-02-18 17:07:52.700351
NCT00219219|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-04-13|||September 2003||2003-09-01|April 2015|2015-04-01|October 2006||2006-10-01|||||Interventional|||Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases|Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 17:07:52.795796|2017-02-18 17:07:52.795796
NCT00219193|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-02-03|||October 2005||2005-10-01|February 2017|2017-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients|An Eight Week, Multicenter Study to Evaluate Efficacy and Safety of the Triple Combo of Aliskiren /Valsartan/HCTZ (300/320/25 mg), Compared to the Double Combos of Aliskiren/HCTZ (300/25 mg) or Valsartan/HCTZ (320/25 mg) in Patients With Essential Hypertension Not Adequately Responsive to HCTZ 25 mg|Completed||Phase 3|641|Actual|Novartis|||||f||||||||||||||2017-02-18 17:07:53.06656|2017-02-18 17:07:53.06656
NCT00219180|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||June 2005||2005-06-01|November 2011|2011-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure|An 8-week Multi-center, Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren (150 mg and 300 mg) Administered Alone and in Combination With Valsartan (160 mg and 320 mg) in Patients With Hypertension|Completed||Phase 3|1797|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:53.169148|2017-02-18 17:07:53.169148
NCT00219167|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-16|||April 2005||2005-04-01|November 2016|2016-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure|An 8-week, Randomized, Double-blind, Parallel-group, Multicenter Study Assessing the Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Patients With at Least 65 Years of Age With Essential Hypertension, Using 24-hour ABPM, With Lisinopril 10 mg as a Reference|Completed||Phase 3|355|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:53.26034|2017-02-18 17:07:53.26034
NCT00219154|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||March 2005||2005-03-01|November 2011|2011-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine|A Twenty Six-week, Randomized, Double-blind, Parallel Group, Multicenter, Active Controlled, Dose Titration Study to Evaluate the Efficacy and Safety of Aliskiren Compared to HCTZ With the Optional Addition of Amlodipine, Followed by a Second Twenty Six Weeks of Blinded Treatment, in Patients With Essential Hypertension|Completed||Phase 3|1125|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:53.364554|2017-02-18 17:07:53.364554
NCT00218985|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-02-14|||January 2005|Actual|2005-01-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Exercise-training Before Coronary Artery Bypass Graft (CABG)|Exercise-training Before Coronary Artery Bypass Graft (CABG)|Completed||N/A|40|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:07:55.427191|2017-02-18 17:07:55.427191
NCT00219141|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-20|2011-01-11||October 2005||2005-10-01|May 2011|2011-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|ALLAY||Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension|A 36-week, Randomized, Double-blind, Multi-center, Parallel Group Study Comparing the Efficacy and Safety of Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension|Completed||Phase 3|460|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:07:53.466072|2017-02-18 17:07:53.466072
NCT00219128|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||November 2004||2004-11-01|June 2006|2006-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.|An Eight-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study Comparing Aliskiren 150 mg, 300 mg, and 600 mg to Placebo in Patients With Essential Hypertension|Completed||Phase 3|671|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:54.294568|2017-02-18 17:07:54.294568
NCT00219115|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-02-03|||January 2005||2005-01-01|February 2017|2017-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg|A 12-week Randomized Double-blind Parallel Group Study to Evaluate the Efficacy and Safety of the Combination Aliskiren With HCTZ Compared to Irbesartan or Amlodipine With HCTZ or HCTZ Alone in Hypertensive Patients With BMI ≥ 30 kg/m2 Not Adequately Responsive to HCTZ 25 mg|Completed||Phase 3|493|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:54.394913|2017-02-18 17:07:54.394913
NCT00219102|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-24|||June 2005||2005-06-01|February 2011|2011-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients|A 12-week, Randomized, Double-blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy & Safety of Aliskiren in Patients With Diabetes & Hypertension Not Adequately Responsive to the Combination of Valsartan 160 mg & Hydrochlorothiazide 25 mg|Completed||Phase 3|336||Novartis|||||f||||||||||||||2017-02-18 17:07:54.50672|2017-02-18 17:07:54.50672
NCT00219089|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||November 2004||2004-11-01|June 2006|2006-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.|An Eight-week, Randomized, Double-blind, Parallel Group, Multicenter, Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination With Ramipril in Patients With Hypertension and Diabetes Mellitus|Completed||Phase 3|839|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:54.600117|2017-02-18 17:07:54.600117
NCT00219076|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-25|||February 2005||2005-02-01|September 2008|2008-09-01||||October 2005|Actual|2005-10-01||Interventional|||A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients|A Six-Week, Randomized, Double-Blind, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren 150 mg and Amlodipine 5 mg Compared to Amlodipine 5 mg and 10 mg in Hypertensive Patients Not Adequately Responsive to Amlodipine 5 mg|Completed||Phase 3|504||Novartis|||||f||||||||||||||2017-02-18 17:07:54.691559|2017-02-18 17:07:54.691559
NCT00219063|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-16|||February 2005||2005-02-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.|A 26 Week, Double-blind, Randomized, Multicenter, Parallel Group, Active-controlled Study Comparing Aliskiren to Ramipril With Optional Addition of Hydrochlorothiazide, Followed by a 4 Week Double-blind, Randomized, Placebo-controlled Withdrawal in Patients With Essential Hypertension|Completed||Phase 3|844|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:54.773835|2017-02-18 17:07:54.773835
NCT00219050|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-24|||February 2005||2005-02-01|February 2011|2011-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension|An Eight-week, Randomized, Double-blind, Multi-center, Active-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of an Aliskiren-based Regimen Compared to a Lisinopril-based Regimen in Patients With Uncomplicated Severe Hypertension|Completed||Phase 3|180||Novartis|||||f||||||||||||||2017-02-18 17:07:54.866988|2017-02-18 17:07:54.866988
NCT00219037|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||June 2004||2004-06-01|June 2006|2006-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension|A 12 Month, Randomized, Open-label, Multicenter, Study to Assess the Long Term Safety of Aliskiren 150 mg Alone and 300 mg Alone or With the Optional Addition of Hydrochlorothiazide (12.5 mg or 25 mg) in Patients With Essential Hypertension.|Completed||Phase 3|1955|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:54.954254|2017-02-18 17:07:54.954254
NCT00219024|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||August 2004||2004-08-01|June 2006|2006-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.|An 8 Week Double-blind, Multicenter, Randomized, Multifactorial, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension|Completed||Phase 3|2775|Actual|Novartis|||||||||||||||||||2017-02-18 17:07:55.043302|2017-02-18 17:07:55.043302
NCT00219011|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||May 2005||2005-05-01|November 2011|2011-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||"ALOFT - Aliskiren Observation of Heart Failure Treatment: Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure"|A Twelve-week, Randomized, Double-blind, Multi-center, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Aliskiren 150 mg When Added to Standard Therapy in Hypertensive Patients With Stable Heart Failure|Completed||Phase 3|280||Novartis|||||f||||||||||||||2017-02-18 17:07:55.261033|2017-02-18 17:07:55.261033
NCT00218998|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-08-25|||January 2004||2004-01-01|September 2005|2005-09-01||||||||Interventional|||Effective Endurance Training in Metabolic Syndrome|Effective Endurance Training in Metabolic Syndrome|Completed||Phase 2|30||Norwegian University of Science and Technology|||||f||||f||||||||||2017-02-18 17:07:55.347747|2017-02-18 17:07:55.347747
NCT00218972|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-12-05|||February 2005||2005-02-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Physical Exercise in Hypertension, Randomised Clinical Trial|Physical Exercise in Hypertension, Randomised Clinical Trial|Completed||N/A|88|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-02-18 17:07:55.523227|2017-02-18 17:07:55.523227
NCT00218959|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-01-25|||September 2005||2005-09-01|January 2017|2017-01-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Randomized Controlled Trial of Narrative Exposure Therapy Compared to Treatment as Usual for Traumatized Refugees|Randomized Controlled Trial of Narrative Exposure Therapy Compared to Treatment as Usual for Traumatized Refugees and Asylum Seekers in Mid-Norway|Completed||N/A|81|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:07:55.637993|2017-02-18 17:07:55.637993
NCT00218946|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-04-07|||January 2005||2005-01-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Nasogastric Tube in Premature Babies - Pain and Treatment|Nasogastric Tube in Premature Babies - Pain and Treatment. A Randomised, Partly Blinded, Placebo-controlled Factorial Clinical Trial of Sucrose and Pacifier|Completed||Phase 2|24|Actual|Norwegian University of Science and Technology||6|||f||||f||||||||||2017-02-18 17:07:55.762616|2017-02-18 17:07:55.762616
NCT00218933|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-02-07|||October 2001|Actual|2001-10-01|February 2017|2017-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||High-intensity Exercise Training in Patients With Post-infarction Heart Failure|Anti-remodeling Effect of High-intensity Interval Training in Patients With Post-infarction Heart Failure on Optimal Treatment|Completed||N/A|27|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-02-18 17:07:55.881762|2017-02-18 17:07:55.881762
NCT00218920|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-08-25|||September 2005||2005-09-01|August 2008|2008-08-01|January 2008||2008-01-01|||||Interventional|||Effective Training in Overweight and Obese People|Effective Training in Overweight and Obesity|Completed||Phase 1|60|Anticipated|Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 17:07:55.990798|2017-02-18 17:07:55.990798
NCT00218907|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2005-10-21|||June 2003||2003-06-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||An Educational HIV Pre-Test Counseling Video Program for Off Hours Testing in the ED: A Randomized Control Trial|An Educational HIV Pre-Test Counseling Video Program for Off Hours Testing in the ED: A Randomized Control Trial|Terminated||N/A|130||North Bronx Healthcare Network|||||f||||||||||||||2017-02-18 17:07:56.075707|2017-02-18 17:07:56.075707
NCT00218894|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-01-16|||January 2004||2004-01-01|January 2017|2017-01-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Observational|||The Influence of Vision on Balance, Gait and Falls|The Effect of Cataract Surgery on Gait, Balance and Falls in Older Persons|Completed||N/A|148|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 17:07:56.16522|2017-02-18 17:07:56.16522
NCT00218881|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2005-10-21|||October 2003||2003-10-01|September 2005|2005-09-01|July 2004||2004-07-01|||||Interventional|||An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized Trial|An Effective Alternative to the Standard Referral System for HIV Testing in the ED|Completed||N/A|408||North Bronx Healthcare Network|||||f||||||||||||||2017-02-18 17:07:56.275376|2017-02-18 17:07:56.275376
NCT00218868|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-02-09|||January 2000||2000-01-01|February 2012|2012-02-01|November 2007|Actual|2007-11-01|February 2006|Actual|2006-02-01||Observational|||Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear|Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunvald-giemsa Stained Cutaneous Tissue Smear in Relation to Photodynamic Therapy|Completed||N/A|66|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 17:07:56.554284|2017-02-18 17:07:56.554284
NCT00218855|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-03-06|||January 2002||2002-01-01|March 2014|2014-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Thalidomide to Patients With Previously Untreated Multiple Myeloma|A Phase 3 Study With Randomization to Melphalan/Prednisone/Thalidomide Versus Melphalan/Prednisone/Placebo to Patients With Previously Untreated Multiple Myeloma|Completed||Phase 3|363|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:07:56.668257|2017-02-18 17:07:56.668257
NCT00218842|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-03-06|||October 2005||2005-10-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Interventional|||The Effect on Function of Increasing Activity for Nursing Home Residents|Physical and Daily Activity for Residents in a Nursing Home Setting. -A Nordic Multi-Centre Study|Completed||N/A|125|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:07:56.790892|2017-02-18 17:07:56.790892
NCT00218829|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2006-05-16|||September 1997||1997-09-01|September 2005|2005-09-01||||||||Observational|||DMSO-PDT of BCC - A 6 Year Follow Up|Dimethylsulphoxide-Supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curretage - A 6 Year Clinical and Histological Evaluation.|Completed||N/A|48||Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 17:07:56.89515|2017-02-18 17:07:56.89515
NCT00218816|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-09-03|||August 2000||2000-08-01|September 2008|2008-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Nebulizer Intervention for Minority Children With Asthma|Nebulizer Intervention for Minority Children With Asthma|Completed||Phase 3|221|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-02-18 17:07:56.966697|2017-02-18 17:07:56.966697
NCT00218803|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-09-03|||August 2000||2000-08-01|September 2008|2008-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Teaching Children With Asthma and Who Live in a Rural Setting How to Self-Manage Their Asthma|A+ Asthma Rural Partnership|Completed||Phase 3|220|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-02-18 17:07:57.078079|2017-02-18 17:07:57.078079
NCT00218790|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2014-02-10|||April 2003||2003-04-01|September 2005|2005-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||"The Effects of Cool Dialysate on the Sleep/Wake Cycle in Patients on Chronic Hemodialysis - The Sleep Cool Study"|The Effects of Hemodialysis on the Sleep/Wake Cycle|Completed||N/A|58|Actual|Emory University||2|||f||||t||||||||||2017-02-18 17:07:57.190134|2017-02-18 17:07:57.190134
NCT00218777|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2015-12-10|||December 2004||2004-12-01|December 2015|2015-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|CBIT||Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children|Behavior Therapy for Children With Chronic Tic Disorders|Completed||Phase 2/Phase 3|120|Anticipated|Tourette Association of America|||||f||||||||||||||2017-02-18 17:07:57.303839|2017-02-18 17:07:57.303839
NCT00218764|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2008-10-21|||December 2003||2003-12-01|October 2008|2008-10-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Cognitive Therapy Versus Medication Treatment for Preventing Depression Relapse|Are CT's Effects Durable?|Unknown status|Active, not recruiting|N/A|500|Anticipated|National Institute of Mental Health (NIMH)||3|||f||||t||||||||||2017-02-18 17:07:57.414268|2017-02-18 17:07:57.414268
NCT00218751|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-09-23|||March 2000||2000-03-01|February 2008|2008-02-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Early Home Visitation Program to Promote Good Health and Development in Children at Risk for Abuse|Promoting Child Mental Health: RCT of Home Visiting|Completed||Phase 2/Phase 3|1122||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:07:57.538836|2017-02-18 17:07:57.538836
NCT00218725|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2015-09-28|||May 2005||2005-05-01|September 2015|2015-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder|Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder|Completed||Phase 1|2|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 17:07:57.639809|2017-02-18 17:07:57.639809
NCT00218712|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-04-30|||September 2005||2005-09-01|April 2012|2012-04-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men|Reducing HIV Transmission Risk Behavior: a Trial of a Two Session Risk-Reduction Intervention With HIV-Positive Men Who Have Sex With Men|Completed||N/A|488|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 17:07:57.753954|2017-02-18 17:07:57.753954
NCT00218699|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-08-02|||August 2002||2002-08-01|August 2013|2013-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV Infected|Changing Sexual Behavior in Gay Male Repeat HIV Testers: A Randomized Trial of a Single Session Counseling Intervention|Completed||N/A|300|Actual|University of California, San Francisco|||||f||||f||||||||||2017-02-18 17:07:57.862743|2017-02-18 17:07:57.862743
NCT00218686|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-08-31|||January 2003||2003-01-01|August 2015|2015-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Network Intervention for Prevention of HIV Infection in Chennai, India - 1|Supplement to the Long-term Impact of a Network Outreach Intervention|Withdrawn||Phase 2|0|Actual|Johns Hopkins Bloomberg School of Public Health||2||In ability to obtain Indian governmental approval from the study from NACO|f||||f||||||||||2017-02-18 17:07:57.957878|2017-02-18 17:07:57.957878
NCT00218673|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-05-11|||October 2003||2003-10-01|May 2016|2016-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||RCT of Russian IDU Peer Network HIV Prevention Intervention - 1|Randomized Controlled Trial of Russian IDU Peer Network HIV Prevention Intervention|Completed||Phase 3|400|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||||||||||||2017-02-18 17:07:58.060605|2017-02-18 17:07:58.060605
NCT00218660|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-10-21|||April 1998||1998-04-01|June 2010|2010-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1|Naltrexone and Psychosocial Treatments for the Treatment of Cocaine Dependence Complicated by Alcohol Dependence|Completed||Phase 3|164|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-02-18 17:07:58.162448|2017-02-18 17:07:58.162448
NCT00218634|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-06-22|2012-01-03||February 2005||2005-02-01|June 2012|2012-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1|CBT for Depression & Adherence in HIV Methadone Patients|Completed||N/A|89|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 17:07:58.28288|2017-02-18 17:07:58.28288
NCT00218621|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-02-20|||September 2005||2005-09-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1|Maternal Buprenorphine Administration and Fetal/Infant Neurobehavior|Completed||Phase 2|20|Actual|Johns Hopkins University|||1||f||||t||||||||||2017-02-18 17:07:58.996249|2017-02-18 17:07:58.996249
NCT00218608|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-01-26|||April 2001||2001-04-01|January 2012|2012-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone|Disulfiram for Cocaine Abuse in Methadone- Patients|Completed||Phase 2|158|Actual|University of Arkansas||4|||f||||t||||||||||2017-02-18 17:07:59.101129|2017-02-18 17:07:59.101129
NCT00218595|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-07-31|||August 2004||2004-08-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||DBT Compared to I/GDC for the Treatment of Opiate Addiction in Emotionally Dysregulated Patients. - 1|Evaluation of Dialectical Behavior Therapy in Treatment of Opioid Addiction and Emotional Problems|Completed||N/A|39|Actual|Duke University||2|||f||||t||||||||||2017-02-18 17:07:59.210965|2017-02-18 17:07:59.210965
NCT00218582|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-01-11|||March 2003||2003-03-01|October 2008|2008-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effectiveness of Self-Help for Dually-Diagnosed Persons - 1|Effectiveness of Self-Help for Dually-Diagnosed Persons|Completed||Phase 1/Phase 2|229|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 17:07:59.310819|2017-02-18 17:07:59.310819
NCT00218569|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2016-01-25|||April 2003||2003-04-01|January 2016|2016-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Combined Treatment for Cocaine-Alcohol Dependence - 1|Combined Treatment for Cocaine-Alcohol Dependence|Completed||Phase 2|87|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-02-18 17:07:59.421542|2017-02-18 17:07:59.421542
NCT00218556|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-01-11|||January 2004||2004-01-01|October 2015|2015-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1|Preventing Depression in MMT Patients on Interferon|Completed||N/A|42|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-02-18 17:07:59.54123|2017-02-18 17:07:59.54123
NCT00218543|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-06-25|2012-01-12||June 2004||2004-06-01|June 2012|2012-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|Atom||Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)|Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial|Completed||Phase 2|20|Actual|New York State Psychiatric Institute|Clearly, there are limitations of this study including the high drop-out rate, small sample size, and lack of a control group.|1|||f||||t||||||||||2017-02-18 17:07:59.653028|2017-02-18 17:07:59.653028
NCT00218530|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||March 2003||2003-03-01|October 2016|2016-10-01|September 2004||2004-09-01|||||Interventional|||Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1|Naltrexone and Lofexidine in Detoxified Heroin Addicts|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:07:59.9007|2017-02-18 17:07:59.9007
NCT00218517|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||March 2005||2005-03-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1|Selegiline for Treatment of Cannabis Dependence|Completed||Phase 2|19|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 17:07:59.988935|2017-02-18 17:07:59.988935
NCT00218504|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-06-01|||December 2005||2005-12-01|June 2012|2012-06-01|October 2009|Actual|2009-10-01|||||Observational|||Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2|Cue Reactivity Model for Assessing Pharmacologic Intervention in Treatment of Cannabis Use Disorders (Study 2)|Completed||Phase 1|20|Anticipated|Wayne State University|||1||f||||||||||||||2017-02-18 17:08:00.105182|2017-02-18 17:08:00.105182
NCT00218491|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-11-07|||November 2005||2005-11-01|September 2010|2010-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|NAC||Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1|A Controlled Trial of N-Acetylcysteine (NAC) for Cocaine Dependence|Completed||Phase 2|235|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-02-18 17:08:00.20497|2017-02-18 17:08:00.20497
NCT00218478|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-06-01|||September 2004||2004-09-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|||||Observational|||Evaluating Responses to Drug-Related Cues Versus Neutral Cues to Understand the Effects of Marijuana Craving - 1|Cue Reactivity Model for Assessing Pharmacologic Intervention in Treatment of Cannabis Use Disorders (Study 1)|Completed||Phase 1|15|Anticipated|Wayne State University|||1||f||||||||||||||2017-02-18 17:08:00.429807|2017-02-18 17:08:00.429807
NCT00218465|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2014-01-14|2010-08-02||August 2006||2006-08-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking|A Double-Blind, Placebo-Controlled Trial of the NMDA Glycine Site Antagonist, GW468816, for Prevention of Relapse to Smoking|Completed||Phase 2|264|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:08:00.518942|2017-02-18 17:08:00.518942
NCT00218452|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-04-06|||September 2005||2005-09-01|April 2015|2015-04-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Smoking Cessation for Young Adults Who Binge Drink - 1|Smoking Cessation for Young Adults Who Binge Drink|Completed||Early Phase 1|41|Actual|Mayo Clinic||1|||f||||f||||||||||2017-02-18 17:08:00.958181|2017-02-18 17:08:00.958181
NCT00218439|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-07-28|2013-10-29||October 2005||2005-10-01|July 2015|2015-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional||Includes subjects who completed both laboratory sessions (n=62). One additional subject completed both laboratory sessions but did not have usable measures in the primary outcomes (cardiovascular measures) and was excluded|Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1|Smoking, Antidepressants, and Response to Mental Stress|Completed||N/A|105|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||||||||||||2017-02-18 17:08:01.062648|2017-02-18 17:08:01.062648
NCT00218426|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-07-03|||July 2006||2006-07-01|January 2012|2012-01-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||Addiction Treatment in Russia: Oral vs. Naltrexone Implant|Addiction Treatment in Russia: Oral and Depot Naltrexone|Completed||Phase 2/Phase 3|306|Actual|University of Pennsylvania||3|||f||||t||||||||||2017-02-18 17:08:01.56722|2017-02-18 17:08:01.56722
NCT00218413|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||October 2004||2004-10-01|November 2008|2008-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals|A Phase 2 Study to Assess Safety and Immunogenicity of Five Doses of 3'-Aminomethylnicotine-P. Aeruginosa r-Exoprotein A Conjugate Vaccine (NicVAX) Administered to Smokers|Completed||Phase 2|51|Actual|National Institute on Drug Abuse (NIDA)||5|||f||||f||||||||||2017-02-18 17:08:01.868426|2017-02-18 17:08:01.868426
NCT00218387|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-11-07|||April 2004||2004-04-01|September 2010|2010-09-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1|CBT and Modafinil for Cocaine Addiction|Completed||Phase 2|326|Actual|Medical University of South Carolina||3|||f||||t||||||||||2017-02-18 17:08:01.999356|2017-02-18 17:08:01.999356
NCT00218374|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||October 2006||2006-10-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia|Hyperalgesia in Methadone Patients: Can it be Treated?|Completed||N/A|60|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-02-18 17:08:02.121951|2017-02-18 17:08:02.121951
NCT00218361|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-06-01|||August 2005||2005-08-01|June 2012|2012-06-01||||||||Observational|||Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals|Biobehavioral Study of Opioid Drug Seeking Behavior: Study 2|Completed||Phase 1|16|Anticipated|Wayne State University|||1||f||||||||||Samples With DNA|"~     Whole Blood~   "|||2017-02-18 17:08:02.234591|2017-02-18 17:08:02.234591
NCT00218348|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-01-07|||September 2003||2003-09-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo|Pharmacotherapy for Cocaine Dependence - 1|Completed||Phase 2|140|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:08:02.340297|2017-02-18 17:08:02.340297
NCT00218335|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-03-07|2013-01-25||June 2003||2003-06-01|March 2013|2013-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Network & Dyad HIV Prevention Intervention for IDU's - 1|A Network & Dyad HIV Prevention Intervention for IDU's|Completed||Phase 2|1024|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-02-18 17:08:02.453902|2017-02-18 17:08:02.453902
NCT00218322|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-11-06|||September 2004||2004-09-01|November 2012|2012-11-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Effectiveness of ATMX in Treating Adolescents With ADHD and SUD|Atomoxetine in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD)|Completed||Phase 4|108|Anticipated|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:08:03.459967|2017-02-18 17:08:03.459967
NCT00218309|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||September 2003||2003-09-01|May 2006|2006-05-01|July 2005||2005-07-01|||||Observational|||Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals|Biobehavioral Studies of Opioid Drug Seeking Behavior: Study 1|Completed||Phase 2|16||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:08:03.563431|2017-02-18 17:08:03.563431
NCT00218296|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2014-10-03|2013-10-29||November 2006||2006-11-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use|Treatment of Smokeless Tobacco Users|Completed||Phase 2|332|Actual|University of Minnesota - Clinical and Translational Science Institute|Sample size was limited.|2|||f||||t||||||||||2017-02-18 17:08:03.652165|2017-02-18 17:08:03.652165
NCT00218283|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-09|||January 2005||2005-01-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Nicotine Lozenge to Reduce Smokeless Tobacco Use|Treatment of Smokeless Tobacco Users|Completed||Phase 2|100|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 17:08:04.153415|2017-02-18 17:08:04.153415
NCT00218270|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-09|||December 2002||2002-12-01|June 2008|2008-06-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use|Treatment of Smokeless Tobacco Users|Completed||Phase 2|138|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 17:08:04.264089|2017-02-18 17:08:04.264089
NCT00218257|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-11-16|||July 2002||2002-07-01|November 2015|2015-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Progesterone for the Treatment of Cocaine Dependence - 1|Interactions Between Progesterone and Cocaine in Women|Completed||N/A|36|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 17:08:04.365228|2017-02-18 17:08:04.365228
NCT00218244|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-09|||August 2001||2001-08-01|June 2008|2008-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|Brandswitch||Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use|Treatment of Smokeless Tobacco Users: Use of Nicotine Replacement Products to Reduce Smokeless Tobacco Use|Completed||Phase 1/Phase 2|56|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 17:08:04.470869|2017-02-18 17:08:04.470869
NCT00218231|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||January 2004||2004-01-01|August 2008|2008-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia|Transdermal Nicotine and Bupropion-SR in Schizophrenics (Study 2)|Completed||Phase 2|48|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 17:08:04.69517|2017-02-18 17:08:04.69517
NCT00218218|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||June 2002||2002-06-01|August 2008|2008-08-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia|Transdermal Nicotine and Bupropion for Smoking in Schizophrenics (Study 1)|Completed||Phase 2|48|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||f||||||||||2017-02-18 17:08:04.805047|2017-02-18 17:08:04.805047
NCT00218205|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-09-20|||July 2002||2002-07-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer|A Phase II Trial of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Hormone Resistant Prostate Cancer (HRPC)|Unknown status|Recruiting|Phase 2|28||Department of Veterans Affairs, New Jersey|||||||||||||||||||2017-02-18 17:08:04.923844|2017-02-18 17:08:04.923844
NCT00218192|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-05-21|||September 2000||2000-09-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Trial to Reduce Hepatitis C Among Injection Drug Users - 1|A Trial to Reduce Hepatitis C Among Injection Drug Users|Completed||Phase 3|277|Actual|Butler Hospital|||||f||||f||||||||||2017-02-18 17:08:05.016294|2017-02-18 17:08:05.016294
NCT00218179|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-19|||September 2005||2005-09-01|January 2017|2017-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1|Prostate, Lung, Colon, and Ovarian Cancer (PLCO) Screen Trial|Completed||N/A|200|Actual|University of Minnesota - Clinical and Translational Science Institute|||2||f||||f||||||||||2017-02-18 17:08:05.108565|2017-02-18 17:08:05.108565
NCT00218166|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-10|||August 2001||2001-08-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine|GABA Agonists as Pharmacotherapies for Cocaine Abuse|Completed||Phase 2|78|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 17:08:05.220918|2017-02-18 17:08:05.220918
NCT00218153|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||November 2000||2000-11-01|September 2005|2005-09-01|April 2004||2004-04-01|||||Interventional|||Naltrexone Augmentation of Nicotine Patch Therapy - 1|Naltrexone Augmentation of Nicotine Patch Therapy|Completed||Phase 3|200||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:08:05.333144|2017-02-18 17:08:05.333144
NCT00218140|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11||||||October 2016|2016-10-01|April 2005||2005-04-01|||||Interventional|||Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1|Effects of Nicotine Patch in Men and Women|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:08:05.421847|2017-02-18 17:08:05.421847
NCT00218127|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||November 2001||2001-11-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens|Opioid Maintenance: Optimum Stabilization and Withdrawal|Completed||Phase 2|142|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 17:08:05.526474|2017-02-18 17:08:05.526474
NCT00218114|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2014-03-06|||February 2000||2000-02-01|December 2012|2012-12-01|January 2015|Anticipated|2015-01-01|January 2015|Anticipated|2015-01-01||Interventional|||Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults|Parallel Groups Study of Divalproex Sodium (Depakote) for Irritable, Explosive Adults & Adolescents|Unknown status|Active, not recruiting|Phase 3|75|Anticipated|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 17:08:05.639075|2017-02-18 17:08:05.639075
NCT00218101|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||May 2004||2004-05-01|October 2016|2016-10-01|March 2005||2005-03-01|||||Interventional|||Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids|Dose Reduction Strategies in Oral Opioid Dependence Subsequent to Pain Management: An Exploratory Study|Completed||Phase 2|10||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:08:05.746597|2017-02-18 17:08:05.746597
NCT00218075|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-01-04|||March 2000||2000-03-01|January 2016|2016-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence|Behavioral Strategies to Maximize the Efficacy of Pharmacotherapy for Cocaine Dependence: Relapse Prevention With Contingency Management Procedures|Completed||Phase 2|200||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 17:08:05.839252|2017-02-18 17:08:05.839252
NCT00218062|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-03-02|||March 2006||2006-03-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals|Pharmacotherapy Dosing Regimen (Cocaine Dependence Population)|Completed||Phase 2|73|Actual|The University of Texas Health Science Center, Houston||4|||f||||t||||||||||2017-02-18 17:08:05.936513|2017-02-18 17:08:05.936513
NCT00218049|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||December 2004||2004-12-01|August 2008|2008-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals|Phase 1, Double-blind, Placebo-controlled Assessment of Interactions Between 2 Doses of Cocaine and Three Doses of Escalating Vanoxerine (GBR 12909) in Cocaine Using Volunteers|Terminated||Phase 1|3|Actual|National Institute on Drug Abuse (NIDA)||3||Issue of priority of resources|f||||t||||||||||2017-02-18 17:08:06.043432|2017-02-18 17:08:06.043432
NCT00218036|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-12-11|||July 2006||2006-07-01|December 2009|2009-12-01|July 2011|Anticipated|2011-07-01|July 2010|Anticipated|2010-07-01||Interventional|||Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8|Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals|Unknown status|Recruiting|Phase 2|200|Anticipated|National Institute on Drug Abuse (NIDA)||5|||f||||t||||||||||2017-02-18 17:08:06.145848|2017-02-18 17:08:06.145848
NCT00218023|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-12-11|||March 2006||2006-03-01|December 2009|2009-12-01|March 2011|Anticipated|2011-03-01|March 2010|Anticipated|2010-03-01||Interventional|||Medications for Stopping Cocaine Dependence and Preventing Relapse|Screening Medications for Cocaine Cessation and Relapse Prevention|Unknown status|Recruiting|Phase 2|200|Anticipated|National Institute on Drug Abuse (NIDA)||4|||f||||t||||||||||2017-02-18 17:08:06.259192|2017-02-18 17:08:06.259192
NCT00218010|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||November 2000||2000-11-01|April 2015|2015-04-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Observational|||Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2|Breastfeeding Among Methadone Maintained Women|Completed||N/A|25|Actual|National Institute on Drug Abuse (NIDA)|||1||f||||f||||||||||2017-02-18 17:08:06.366239|2017-02-18 17:08:06.366239
NCT00217997|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-05-03|||September 2005||2005-09-01|May 2013|2013-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals|Impulsivity, Brain Function and Substance Abuse Treatment|Completed||Phase 2|192|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-02-18 17:08:06.46919|2017-02-18 17:08:06.46919
NCT00217984|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-06-25|||July 2006||2006-07-01|June 2012|2012-06-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Intensive Intervention for Smokers - 6|Intensive Intervention for Smokers in Alcohol Treatment|Completed||Phase 2/Phase 3|162|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 17:08:06.55991|2017-02-18 17:08:06.55991
NCT00217971|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-04-06|2011-09-13||March 2005||2005-03-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|MARINOL||Dronabinol Treatment for Marijuana Addiction|A Randomized, Double-Blind, Placebo-Controlled Study of Dronabinol in the Treatment of Marijuana Addiction|Completed||Phase 2|156|Actual|New York State Psychiatric Institute|Consequences of use are often long-term and more subtle. Thus, trying to initiate change over a relatively short period (i.e. patients in the present trial were maintained on the maximum dronabinol dose for only 6 weeks), may have been inadequate.|2|||f||||t||||||||||2017-02-18 17:08:06.665012|2017-02-18 17:08:06.665012
NCT00217958|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2014-10-27|||May 2002||2002-05-01|October 2014|2014-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Better Asthma Outcomes: Lowering Tobacco Smoke Exposure||Completed||N/A|||Palo Alto Medical Foundation|||||f||||||||||||||2017-02-18 17:08:09.821726|2017-02-18 17:08:09.821726
NCT00217945|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Does Shared Decision-Making Improve Adherence in Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:08:09.898461|2017-02-18 17:08:09.898461
NCT00217932|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-11|||September 2000||2000-09-01|April 2006|2006-04-01|August 2005||2005-08-01|||||Interventional|||Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings|Double-Blind, Placebo-Controlled Study of Depakote (Divalproex Sodium) in Children With Temper Outbursts and Severe Mood Swings|Completed||Phase 2|15||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:08:09.967088|2017-02-18 17:08:09.967088
NCT00217919|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2014-04-07|||February 2006||2006-02-01|April 2014|2014-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Reducing Risk Factors in Peripheral Arterial Disease|Reducing Risk Factors in Peripheral Arterial Disease|Completed||N/A|355|Actual|Northwestern University||2|||f||||t||||||||||2017-02-18 17:08:10.051679|2017-02-18 17:08:10.051679
NCT00217906|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-02-17|||October 1999||1999-10-01|December 2005|2005-12-01|March 2004|Actual|2004-03-01|||||Interventional|||A+ Asthma Early Intervention in Asthma Management||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:08:10.155791|2017-02-18 17:08:10.155791
NCT00217893|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-10-22|||February 2003||2003-02-01|October 2013|2013-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Environmental Tobacco Smoke Exposure Reduction in High-Risk Preteens|ETS Reduction in High-Risk Preteens: A Controlled Trial|Completed||N/A|203|Actual|San Diego State University||2|||f||||t||||||||||2017-02-18 17:08:10.236932|2017-02-18 17:08:10.236932
NCT00217880|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-08-16|||July 2004||2004-07-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease|Prognostic Significance of Biological Markers in Patients With ALI/ARDS|Completed||N/A|40|Actual|University of Michigan||1|||f||||t||||||||||2017-02-18 17:08:10.34036|2017-02-18 17:08:10.34036
NCT00217867|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-06-01|||October 2008||2008-10-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|April 2012|Actual|2012-04-01||Interventional|||Educational and Supportive Interventions to Prevent Cardiopulmonary Rehospitalization|A RCT to Reduce Cardiopulmonary Rehospitalization|Completed||N/A|832|Actual|Boston Medical Center||2|||f||||t||||||||||2017-02-18 17:08:10.43355|2017-02-18 17:08:10.43355
NCT00217854|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2015-06-30|||September 2001||2001-09-01|June 2015|2015-06-01|February 2011|Actual|2011-02-01|February 2009|Actual|2009-02-01||Interventional|||Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity|Mechanisms of Airway Inflammation: Natural Exacerbation of Asthma Induced by Glucocorticoid Withdrawal|Completed||N/A|27|Actual|Washington University School of Medicine||1|||f||||||||||||||2017-02-18 17:08:10.749939|2017-02-18 17:08:10.749939
NCT00217841|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-09-18|||January 2004||2004-01-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Aurograb and Vancomycin in MRSA Infection|A Multi Centre, Double-Blind, Randomised, Placebo Controlled Prospective Study on the Safety and Efficacy of Aurograb in Patients With Severe, Deep-Seated Staphylococcal Infections Receiving Vancomycin|Completed||Phase 3|180||NeuTec Pharma|||||f||||||||||||||2017-02-18 17:08:10.891556|2017-02-18 17:08:10.891556
NCT00217828|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2014-06-10|||March 2002||2002-03-01|June 2014|2014-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Effects of Citalopram on Hostility and CHD Risk||Completed||N/A|||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:08:10.988779|2017-02-18 17:08:10.988779
NCT00217815|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-07-14|||September 2005||2005-09-01|July 2008|2008-07-01|October 2006||2006-10-01|||||Interventional|||Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer|A Phase Ib, Pharmacokinetic, Multiple Center, Open Label Study Evaluating the Safety and Efficacy of Mycograb Administered IV in Combination With Docetaxel in Metastatic or Recurrent Breast Cancer Patients|Completed||Phase 1/Phase 2|20||NeuTec Pharma|||||f||||||||||||||2017-02-18 17:08:11.31142|2017-02-18 17:08:11.31142
NCT00217802|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-07-28|||March 2000||2000-03-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||The Effect of Self-regulatory Education on Women With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:08:11.409273|2017-02-18 17:08:11.409273
NCT00217789|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-12-23|||July 2004||2004-07-01|December 2013|2013-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Pathogen Specific Immunity in Patients With Sarcoidosis|Pathogen Specific Immunity in Sarcoidosis|Completed||N/A|5|Actual|Rutgers, The State University of New Jersey|||1||f||||||||||||||2017-02-18 17:08:11.496399|2017-02-18 17:08:11.496399
NCT00217776|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-01-16|||February 2003||2003-02-01|January 2013|2013-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|DMSP||School-based Approaches to Help Pre-teens Manage Asthma||Completed||N/A|1292|Actual|University of Michigan||3|||f||||||||||||||2017-02-18 17:08:11.592358|2017-02-18 17:08:11.592358
NCT00217763|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-12-07|||September 2005||2005-09-01|December 2007|2007-12-01|December 2007|Anticipated|2007-12-01|||||Interventional|||European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients|A Phase III Study of the Efficacy and Safety of 3APS as Add-on Therapy in Mild to Moderate Alzheimer's Disease|Unknown status|Active, not recruiting|Phase 3|930|Anticipated|Bellus Health Inc|||||||||||||||||||2017-02-18 17:08:11.697575|2017-02-18 17:08:11.697575
NCT00217737|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2016-12-30|||August 2005||2005-08-01|December 2016|2016-12-01||||December 2016|Anticipated|2016-12-01||Interventional|||Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer|A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers|Active, not recruiting||Phase 3|3610|Anticipated|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 17:08:11.908703|2017-02-18 17:08:11.908703
NCT00217724|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-12-10|2010-06-10||July 1999||1999-07-01|December 2015|2015-12-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer|A Double-blinded Pilot Study of Glutamine for the Prevention of Paclitaxel-Induced Myalgias and Arthralgias|Terminated||N/A|18|Actual|OHSU Knight Cancer Institute|We were able to only accrue 18 of the 40 patient target. This, plus confounded results and limited funds, the remaining research funds were returned to the sponsor and no evaluation of serum or dietary glutamine levels was done.|2||Only able to accrue just 18 of the 40 target & funds were limited.|f||||t||||||||||2017-02-18 17:08:13.479273|2017-02-18 17:08:13.479273
NCT00217711|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-06-02|||May 2005||2005-05-01|June 2012|2012-06-01|October 2011|Actual|2011-10-01|August 2007|Actual|2007-08-01||Interventional|||Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery|Oxaliplatin, Irinotecan, and Capecitabine as a Combination Regimen for First-Line Treatment of Advanced or Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|23|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 17:08:13.810299|2017-02-18 17:08:13.810299
NCT00217698|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-06-02|||November 2003||2003-11-01|June 2012|2012-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Multicenter Phase II Trial of Gefitinib (Iressa™) First Line Therapy Followed by Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|63|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 17:08:13.922212|2017-02-18 17:08:13.922212
NCT00217672|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2016-02-25|2015-09-21||May 2005||2005-05-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|December 2008|Actual|2008-12-01||Interventional|||Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer|A Randomized Phase II Trial of Docetaxel With or Without Bevacizumab as First-Line Therapy for Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer|Completed||Phase 2|76|Actual|Translational Oncology Research International|Small sample size and that it was changed from a 2-arm study to a single arm study. This was necessary with public release of E2100 results(improved progression free survival) and subsequent availability of bevacizumab outside of clinical trial.|2|||f||||t||||||||||2017-02-18 17:08:14.03516|2017-02-18 17:08:14.03516
NCT00217659|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-01-02|||September 2005||2005-09-01|January 2013|2013-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer|A Phase II Study of Goserelin Plus Anastrozole for the Treatment of Male Patients With Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||||poor accrual|f||||t||||||||||2017-02-18 17:08:14.677663|2017-02-18 17:08:14.677663
NCT00217646|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-04-27|||October 2005||2005-10-01|February 2013|2013-02-01||||December 2010|Actual|2010-12-01||Interventional|||Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia|Phase I Study of BAY 43-9006 (NSC 724772) in Patients With Acute Leukemias, Myelodysplastic Syndromes and Chronic Myeloid Leukemia in Blast Phase|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:08:14.855316|2017-02-18 17:08:14.855316
NCT00217074|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-02-01|||January 2004||2004-01-01|February 2010|2010-02-01|October 2005|Actual|2005-10-01|January 2004|Actual|2004-01-01||Interventional|||Acupuncture and Hot Flashes|Acupuncture for Hot Flashes: A Randomized Sham Controlled Clinical Study|Terminated||Phase 3|103|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 17:08:22.197327|2017-02-18 17:08:22.197327
NCT00217633|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-05-27|||January 2006||2006-01-01|May 2015|2015-05-01||||January 2013|Actual|2013-01-01||Interventional|||Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer|Prospective Evaluation of Pelvic Exenteration in Patients With Recurrent Cervical Cancer|Completed||Phase 2|38|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:08:14.972898|2017-02-18 17:08:14.972898
NCT00217620|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-05-05|2012-10-03||March 2006||2006-03-01|January 2013|2013-01-01|September 2012|Actual|2012-09-01|April 2008|Actual|2008-04-01||Interventional|||S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas|Phase II Trial of BAY-9006 (NSC #724772) in Advanced Soft Tissue Sarcomas|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 17:08:15.131573|2017-02-18 17:08:15.131573
NCT00217607|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2016-08-29|||February 2005||2005-02-01|August 2016|2016-08-01|January 2012|Actual|2012-01-01|April 2008|Actual|2008-04-01||Interventional|||Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery|Multicentric Phase II Study Evaluating the Efficacy and Toxicity of Weekly Paclitaxel in Locally Advanced or Metastatic Soft Tissue Angiosarcomas That Cannot be Treated by Surgery|Completed||Phase 2|30|Actual|UNICANCER||1|||f||||f||||||||No|Individual participant data will not be shared at an individual level.|2017-02-18 17:08:15.862717|2017-02-18 17:08:15.862717
NCT00217594|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-02-07|||July 20, 2005||2005-07-20|February 6, 2017|2017-02-06|February 6, 2017|Actual|2017-02-06|February 6, 2017|Actual|2017-02-06||Interventional|||A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome|A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome (MDS)|Completed||Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:08:16.005738|2017-02-18 17:08:16.005738
NCT00217581|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-06-05|2014-06-05||October 2004||2004-10-01|June 2014|2014-06-01|January 2013|Actual|2013-01-01|November 2012|Actual|2012-11-01||Interventional|||Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer|Phase II Trial of Bevacizumab, Docetaxel, and Oxaliplatin in Gastric and Gastroesophageal Junction Cancer|Completed||Phase 2|39|Actual|Barbara Ann Karmanos Cancer Institute|The trial completed its planned accrual. There were no significant limitations.|1|||f||||t||||||||||2017-02-18 17:08:16.11697|2017-02-18 17:08:16.11697
NCT00217568|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-09-20|||May 2005||2005-05-01|September 2010|2010-09-01||||March 2006|Actual|2006-03-01||Interventional|||Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer|A Phase II Trial of Docetaxel and Carboplatin for First Relapsed Platinum-Sensitive Stage III and IV Advanced Ovarian Cancer or Peritoneal Carcinoma|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:08:16.568885|2017-02-18 17:08:16.568885
NCT00217555|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-09-20|||July 2002||2002-07-01|September 2010|2010-09-01||||February 2006|Actual|2006-02-01||Interventional|||Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer|Phase II Trial for the Treatment of Recurrent or Persistent Platinum-Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With Gemcitabine and Topotecan|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:08:16.671223|2017-02-18 17:08:16.671223
NCT00217542|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-05-01|||July 2005||2005-07-01|May 2013|2013-05-01||||July 2008|Actual|2008-07-01||Interventional|||Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery|A Phase 1 Study of 5-azacitidine in Combination With Interferon-Alfa 2B in Unresectable or Metastatic Melanoma and Renal Cell Carcinoma|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:08:16.776151|2017-02-18 17:08:16.776151
NCT00217529|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-09-20|||June 2004||2004-06-01|September 2010|2010-09-01||||November 2005|Actual|2005-11-01||Interventional|||Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer|A Phase I-II Study of OSI-774 (Tarceva, Erlotinib) With Docetaxel/Carboplatin Followed by Maintenance Therapy With Tarceva as Treatment for Newly Diagnosed Stage III/IV Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:08:16.900357|2017-02-18 17:08:16.900357
NCT00217516|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-02-08|||March 2005||2005-03-01|September 2010|2010-09-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Interventional|||Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer|Supplementation of L-Selenomethionine in Patients With Prostate Cancer Prior to Brachytherapy. Selenium Brachytherapy Trial: Phase I/Pilot Study|Completed||Phase 1|18|Actual|Roswell Park Cancer Institute||2|||f||||t||||||||||2017-02-18 17:08:17.006702|2017-02-18 17:08:17.006702
NCT00217503|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-06-18|||July 2005||2005-07-01|April 2007|2007-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma|Primary Effusion Lymphoma: A Pilot Trial of Bevacizumab and Modified Dose-Adjusted Infusional CDE Chemotherapy Preceded by a Brief Pre-Phase Assessment of Targeted Oncolytic Virotherapy With Bortezomib, Zidovudine and Valganciclovir|Completed||Phase 2|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:08:17.118681|2017-02-18 17:08:17.118681
NCT00217490|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2009-03-07|||March 2005||2005-03-01|April 2006|2006-04-01||||||||Interventional|||Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet|Helping Women Adopt a Cancer Prevention Diet|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:08:17.222016|2017-02-18 17:08:17.222016
NCT00217477|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-12-08|||August 2004||2004-08-01|December 2014|2014-12-01|September 2014|Actual|2014-09-01|May 2013|Actual|2013-05-01||Interventional|||Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer|An Open Label, Dose Escalation Study of Paricalcitol (Zemplar™) [19-NOR-1 ALPHA, 25-(OH) D] in Combination With Gemcitabine [2', 2' -Difluorodeoxycytidine] in Patients With Advanced Malignancies|Completed||Phase 1|34|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:08:17.314219|2017-02-18 17:08:17.314219
NCT00217464|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-03-31|2015-03-17||June 2004||2004-06-01|March 2015|2015-03-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional||All treated and eligible patients|Fulvestrant in Treating Patients With Recurrent Prostate Cancer|Multicenter Study of Fulvestrant (Faslodex®) in Early, Recurrent Prostate Cancer Following Local Therapy: A Phase II Trial|Terminated||Phase 2|17|Actual|Roswell Park Cancer Institute||1||Closed for futility|f||||t||||||||||2017-02-18 17:08:17.427383|2017-02-18 17:08:17.427383
NCT00217451|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-19|||June 2002||2002-06-01|September 2005|2005-09-01|March 2003||2003-03-01|||||Interventional|||Treatment of Malaria in Gabon With Fosmidomycin-Clindamycin|Evaluation of Fosmidomycin in Combination With Clindamycin in Children With Acute Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 2|51||Albert Schweitzer Hospital|||||f||||||||||||||2017-02-18 17:08:17.706625|2017-02-18 17:08:17.706625
NCT00217438|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-08-04|2013-11-01||July 2005||2005-07-01|August 2015|2015-08-01||||October 2012|Actual|2012-10-01||Interventional|||Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma|A Multi-Center Phase III Study of Autologous Transplantation for Patients With Multiple Myeloma Comparing Melphalan 280 mg/m2 + Amifostine With Melphalan 200 mg/m2 + Amifostine|Completed||Phase 3|130|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 17:08:17.830002|2017-02-18 17:08:17.830002
NCT00217425|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-04-08|2014-02-20||July 2006||2006-07-01|April 2014|2014-04-01|March 2014|Actual|2014-03-01|April 2012|Actual|2012-04-01||Interventional||Eligible and treated|Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms|Bevacizumab and CHOP (A-CHOP) in Combination for Patients With Peripheral T-Cell or Natural Killer Cell Neoplasms|Completed||Phase 2|46|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 17:08:18.259748|2017-02-18 17:08:18.259748
NCT00217412|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-06-16|||August 2005||2005-08-01|April 2013|2013-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia|A Phase 1 Study of SAHA (NSC# 701852) in Pediatric Patients With Recurrent or Refractory Solid Tumors (Including Lymphomas) and Leukemia Followed by a Phase I Study of SAHA in Combination With 13-Cis-Retinoic Acid for Patients With Selected Recurrent/Refractory Solid Tumors|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 17:08:18.806298|2017-02-18 17:08:18.806298
NCT00217399|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-05-12|2011-03-23||June 2005||2005-06-01|December 2012|2012-12-01|January 2013|Actual|2013-01-01|July 2009|Actual|2009-07-01||Interventional|||Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer|A Phase I/II Trial of BAY 43-9006 (Sorafenib) in Combination With Anastrozole in Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:08:18.929405|2017-02-18 17:08:18.929405
NCT00217386|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-09-13|||March 2004||2004-03-01|September 2010|2010-09-01||||December 2007|Actual|2007-12-01||Interventional|||Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes|Therapy of Early Stage Myelodysplastic Syndrome (MDS) With ATG and Etanercept|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 17:08:19.218055|2017-02-18 17:08:19.218055
NCT00217373|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-04-17|||June 2005||2005-06-01|December 2014|2014-12-01|March 2015|Actual|2015-03-01|January 2013|Actual|2013-01-01||Interventional|||Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)|A Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-Tricom (B7.1/ICAM/LFA3) and Vaccinia-CEA (6D)-Tricom, in Combination With GM-CSF and Interferon-Alfa-2B in Patients With CEA-Expressing Carcinomas|Completed||Phase 1|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:08:19.32737|2017-02-18 17:08:19.32737
NCT00217360|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2006-10-03|||December 2002||2002-12-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||RCT to Reduce Further Falls and Injuries for Older Fallers Presenting to an Emergency Department|RCT to Evaluate the Effectiveness of a Targeted and Personalised Multifactorial Program to Reduce Further Falls and Injuries for Community-Dwelling Older Fallers Presenting to and Being Discharged Directly From an Emergency Department.|Unknown status|Recruiting|N/A|700||National Ageing Research Institute, Australia|||||f||||||||||||||2017-02-18 17:08:19.442399|2017-02-18 17:08:19.442399
NCT00217347|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-06-04|||September 2005||2005-09-01|June 2008|2008-06-01|July 2006|Actual|2006-07-01|||||Interventional|||Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy||Completed||N/A|150|Anticipated|Nantes University Hospital|||||f||||||||||||||2017-02-18 17:08:19.527942|2017-02-18 17:08:19.527942
NCT00217334|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2005-09-19|||November 2002||2002-11-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Community Hypertension Assessment Trial (CHAT)|A Pragmatic Trial of Community Pharmacy Blood Pressure Clinics Linked With Family Medicine Practices to Improve the Monitoring and Management of High Blood Pressure Among Older Adults|Completed||N/A|28||McMaster University|||||f||||||||||||||2017-02-18 17:08:19.807511|2017-02-18 17:08:19.807511
NCT00217321|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2010-07-20|||November 2003||2003-11-01|September 2006|2006-09-01|December 2015|Anticipated|2015-12-01|||||Observational|||Parkinson's Disease Registry of the Muhammad Ali Parkinson Center|Parkinson's Disease Registry|Unknown status|Active, not recruiting|N/A|20000|Anticipated|Muhammad Ali Parkinson Research Center|||1||f||||||||||||||2017-02-18 17:08:19.90915|2017-02-18 17:08:19.90915
NCT00217308|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-08-23|||February 2005||2005-02-01|August 2007|2007-08-01||||||||Interventional|||Effect of Probiotic Lactobacilli on Vaginal Flora of Pregnant Women at High Risk for Preterm Delivery|Effect of Probiotic Lactobacilli on Vaginal Flora of Pregnant Women at High Risk for Preterm Delivery|Suspended||Phase 1|160|Anticipated|Mount Sinai Hospital, Canada||||Tightly defined inclusion criteria were making recruitment very slow.|f||||f||||||||||2017-02-18 17:08:19.997|2017-02-18 17:08:19.997
NCT00217295|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||April 2004||2004-04-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis|A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis.|Unknown status|Recruiting|Phase 2|30||Multiple Sclerosis Institute|||||f||||||||||||||2017-02-18 17:08:20.086741|2017-02-18 17:08:20.086741
NCT00217282|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-05-20|||June 2004||2004-06-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|June 2007|Actual|2007-06-01||Interventional|||Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer|Phase II Trial OF Oxaliplatin and Gemcitabine With Bevacizumab in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|45|Actual|Mt. Sinai Medical Center, Miami||1|||f||||f||||||||||2017-02-18 17:08:20.189159|2017-02-18 17:08:20.189159
NCT00216879|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-03-25|||February 2005||2005-02-01|March 2015|2015-03-01|July 2006||2006-07-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis|Long-term Treatment of Scalp Psoriasis With Calcipotriol Plus Betamethasone Dipropionate Gel|Completed||Phase 3|800||LEO Pharma|||||||||||||||||||2017-02-18 17:08:24.072994|2017-02-18 17:08:24.072994
NCT00217269|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-04-19|||April 2005||2005-04-01|April 2012|2012-04-01|July 2011|Actual|2011-07-01|March 2007|Actual|2007-03-01||Interventional|ENDEAVOR IV||The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions|A Randomized, Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Completed||N/A|1548|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-02-18 17:08:20.287693|2017-02-18 17:08:20.287693
NCT00217256|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-06-22|||February 2004||2004-02-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|May 2005|Actual|2005-05-01||Interventional|ENDEAVOR III||The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial|A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions|Completed||N/A|436|Actual|Medtronic Vascular||2|||f||||t||||||||||2017-02-18 17:08:20.410739|2017-02-18 17:08:20.410739
NCT00217243|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-09-17|||June 2005||2005-06-01|September 2009|2009-09-01|June 2007|Actual|2007-06-01|||||Observational|||Evoked Fields After Median and Ulnar Stimulation|Evoked (Magnetic) Cortical Fields for the Comparative Study of Mechanisms Underlying Chronic Non-malignant Pain in Peripheral Nerve Injury (CRPS II) and CRPS I (Chronic Regional Pain Syndrome I)|Completed||N/A|60|Actual|Medical Center Alkmaar|||1||f||||f||||||||||2017-02-18 17:08:20.521898|2017-02-18 17:08:20.521898
NCT00217230|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-02|||April 2001||2001-04-01|October 2006|2006-10-01|November 2001||2001-11-01|||||Interventional|||Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older|A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older CAIV-T, Liquid Formulation|Completed||Phase 3|3000||MedImmune LLC|||||||||||||||||||2017-02-18 17:08:20.638533|2017-02-18 17:08:20.638533
NCT00217217|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-03-13|||September 2004||2004-09-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|December 2011|Actual|2011-12-01||Interventional|||Low Field Magnetic Stimulation Treatment for Bipolar Depression|Low Field Magnetic Stimulation in Bipolar Depression|Terminated||Phase 3|13|Actual|Mclean Hospital||2||Study was terminated for lack of recruitment.|f||||t||||||||||2017-02-18 17:08:20.720373|2017-02-18 17:08:20.720373
NCT00217204|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-17|||July 2005||2005-07-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption|A Phase II, Randomized, Investigator-Blinded, Parallel-Group, Pilot Study Evaluating the Safety, Palatability and Effectiveness of Four Doses of Pancrelipase Microtablets in the Treatment of Infants and Toddlers With Cystic Fibrosis-Related Pancreatic Insufficiency and Fat Malabsorption|Completed||Phase 2|18|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||f||||||||||||||2017-02-18 17:08:20.841599|2017-02-18 17:08:20.841599
NCT00217191|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-09-18|||September 2004||2004-09-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Ibuprofen and Renal Function in Premature Infants|Ibuprofen and Renal Function in Premature Infants|Completed||Phase 4|120||Maternite Regionale Universitaire|||||f||||||||||||||2017-02-18 17:08:20.940315|2017-02-18 17:08:20.940315
NCT00217178|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||January 2000||2000-01-01|October 2004|2004-10-01|October 2005||2005-10-01|||||Interventional|||Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)|Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)|Unknown status|Active, not recruiting|Phase 4|900||McMaster University|||||f||||||||||||||2017-02-18 17:08:21.048376|2017-02-18 17:08:21.048376
NCT00217165|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-06-02|||April 2005||2005-04-01|June 2014|2014-06-01|December 2011|Actual|2011-12-01|January 2010|Actual|2010-01-01||Interventional|||Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study|Taurine as an Anti-manic Agent: a Double-blind Placebo-controlled Study.|Completed||Phase 2|60|Actual|Mclean Hospital||1|||f||||f||||||||||2017-02-18 17:08:21.142045|2017-02-18 17:08:21.142045
NCT00217152|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2011-12-16|||March 2005||2005-03-01|December 2011|2011-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors|An Open Label, Prospective, Randomized, Controlled, Multicenter Study Assessing Fixed Dose vs. Concentration Controlled CellCept Regimens for Patients Following a Single Organ Renal Transplantation in Combination With Full Dose and Reduced Dose Calcineurin Inhibitors|Terminated||Phase 4|12|Actual|Mayo Clinic||||Roche decided to prematurely terminate study.|f||||||||||||||2017-02-18 17:08:21.257619|2017-02-18 17:08:21.257619
NCT00217139|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-27|||September 2005||2005-09-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection|A Phase II, Randomized, Active-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Celgosivir in Combination With Peginterferon Alfa-2b, With and Without Ribavirin, for 12 Weeks in Patients With Chronic Hepatitis C Infection (Genotype 1) Who Failed to Respond to Pegylated α Interferon-Based Therapy|Completed||Phase 2|60||BioWest Therapeutics Inc|||||f||||||||||||||2017-02-18 17:08:21.355916|2017-02-18 17:08:21.355916
NCT00217126|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-01-02|||October 2005||2005-10-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||The Study of Long-term Deterioration of Kidney Transplants.|Long-term Kidney Function (2 Arms-Prospective and Retrospective)|Completed||Phase 4|870|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 17:08:21.457314|2017-02-18 17:08:21.457314
NCT00217113|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2010-01-20|||September 2005||2005-09-01|January 2010|2010-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly|An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly|Completed||N/A|100|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 17:08:21.541596|2017-02-18 17:08:21.541596
NCT00217100|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-04-23|||October 2004||2004-10-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||A Multivitamin Comparison Study in Kidney Transplant Recipients.|Folic Acid for Vascular Outcome Reduction in Transplantation.|Completed||Phase 3|200|Actual|Mayo Clinic||2|||f||||||||||||||2017-02-18 17:08:21.628188|2017-02-18 17:08:21.628188
NCT00217087|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-11-23|2015-03-02||September 2005||2005-09-01|November 2015|2015-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Endoscopic Therapy of Early Cancer in Barretts Esophagus|Endoscopic Therapy of Early Cancer in Barretts Esophagus|Completed||Phase 2|73|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 17:08:21.723456|2017-02-18 17:08:21.723456
NCT00217061|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-05-20|||April 2005||2005-04-01|May 2011|2011-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus|The Statin Choice Decision Aid and Its Effects on Statin Decisions in Patients With Type 2 Diabetes Mellitus. A Clustered Randomized Trial|Completed||Phase 3|98||Mayo Clinic|||||f||||||||||||||2017-02-18 17:08:22.274758|2017-02-18 17:08:22.274758
NCT00217048|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-04-27|||June 2005||2005-06-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effect of Yohimbine on Colon Transit|Effect of Oral Yohimbine on Colonic Transit: Randomized, Placebo-Controlled Trial|Completed||Phase 1/Phase 2|30|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 17:08:22.372146|2017-02-18 17:08:22.372146
NCT00217035|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2017-01-12|||August 1997||1997-08-01|January 2017|2017-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients|Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients.|Withdrawn||N/A|0|Actual|National Institute of General Medical Sciences (NIGMS)||||"State of Mass. tightened regulations for making intravenous solutions for research subjects.~   Study was withdrawn and no participants were enrolled."|f||||t||||||||||2017-02-18 17:08:22.455517|2017-02-18 17:08:22.455517
NCT00217022|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-03-16|2011-07-15||June 2003||2003-06-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis|A Randomized, Double-Blind, Placebo Controlled Trial of Budesonide for the Treatment of Active Lymphocytic Colitis|Terminated||Phase 2/Phase 3|16|Actual|Mayo Clinic|Study closed early, because of low enrollment. Primary physician for patients with lymphocytic colitis would prescribe Budesonide off label for them. Subjects not interested in placebo trial.|2||Study closed early, because of low enrollment.|f||||f||||||||||2017-02-18 17:08:22.562887|2017-02-18 17:08:22.562887
NCT00217009|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-05-18|||March 2005||2005-03-01|May 2015|2015-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.|A Randomized Controlled Trial of Narrowband Ultraviolet B vs Topical Psoralen Plus Ultraviolet A Photochemotherapy for Hand and Foot Dermatoses|Terminated||Early Phase 1|3|Actual|Mayo Clinic||2||"Unfortunately we had unforeseen difficulty recruiting to this study. Therefore we have decided~   to halt the study and not publish the results."|f||||||||||||||2017-02-18 17:08:22.95509|2017-02-18 17:08:22.95509
NCT00216996|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2016-11-15||||||November 2016|2016-11-01||||||||Observational|||Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Burns|Study on the Effect of Glutamine Supplemented Nutrition Support on Protein and Glutamine Metabolism in Severely Burned Patients|Withdrawn||N/A|0|Actual|Massachusetts General Hospital|||1|This study was withdrawn (see NCT00181753).|f||||t||||||||Yes|Published data will be shared in our publications and directly with an individual researcher when requested.|2017-02-18 17:08:23.046782|2017-02-18 17:08:23.046782
NCT00216983|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2017-01-12|||September 1997||1997-09-01|January 2017|2017-01-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding|Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding.|Withdrawn||N/A|0|Actual|National Institute of General Medical Sciences (NIGMS)|||3|"State of Mass. tightened regulations for making intravenous solutions for research subjects.~   Study was withdrawn and no participants were enrolled."|f||||t||||||||||2017-02-18 17:08:23.199463|2017-02-18 17:08:23.199463
NCT00216970|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-08-12|||August 1997||1997-08-01|August 2009|2009-08-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients|Study of Arginine Metabolism and Nitric Oxide Formation in Relation to Glutamine Supply in Severely Burned Patients|Unknown status|Recruiting|N/A|16|Anticipated|National Institute of General Medical Sciences (NIGMS)||2|||f||||t||||||||||2017-02-18 17:08:23.298335|2017-02-18 17:08:23.298335
NCT00216957|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2005-09-19|||October 1998||1998-10-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Interventional|||Randomized Clinical Trial Comparing Coronary Bypass Grafting With or Without Cardiopulmonary Bypass|Randomized Clinical Trial Comparing Coronary Bypass Grafting With or Without Cardiopulmonary Bypass|Completed||Phase 3|300||Maritime Heart Centre|||||f||||||||||||||2017-02-18 17:08:23.415557|2017-02-18 17:08:23.415557
NCT00216944|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2010-02-12|||August 2005||2005-08-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Balanced Anesthesia for Intubation of Premature Infants|Balanced Anesthesia for Intubation of Newborn Premature Infants - a Randomized Intervention Study|Completed||Phase 4|40|Anticipated|Lund University Hospital||2|||f||||||||||||||2017-02-18 17:08:23.513891|2017-02-18 17:08:23.513891
NCT00216931|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-02-03|||May 2006||2006-05-01|February 2009|2009-02-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost|Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost|Withdrawn||N/A|40|Anticipated|Lund University Hospital||||No patients enrolled after three years|f||||||||||||||2017-02-18 17:08:23.732587|2017-02-18 17:08:23.732587
NCT00216918|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2007-01-24|||September 2005||2005-09-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.|An Open-Label Pilot Study of Atomoxetine Hydrochloride to Evaluate Neuropsychological Function in Children Ages 6 to 10 Years With Attention-Deficit/Hyperactivity Disorder.|Completed||Phase 4|40||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:08:23.817404|2017-02-18 17:08:23.817404
NCT00216905|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2010-06-01|||October 2004||2004-10-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Simultaneous Measurement of Electroencephalography (EEG) and Functional Magnetic Resonance Imaging (fMRI) in Patients With Alcoholism|Neurobiological Correlates of Disturbed Cognitive Function in Patients With Alcoholism - Simultaneous Measurement With EEG and fMRI|Completed||N/A|25|Actual|Ludwig-Maximilians - University of Munich|||1||f||||||||||||||2017-02-18 17:08:23.902167|2017-02-18 17:08:23.902167
NCT00216892|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-03-25|||April 2005||2005-04-01|March 2015|2015-03-01|December 2005||2005-12-01|||||Interventional|||Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris|Different Treatment Regimens of Calcipotriol Cream and Combination (Calcipotriol/Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris|Completed||Phase 4|1032||LEO Pharma|||||f||||||||||||||2017-02-18 17:08:23.976281|2017-02-18 17:08:23.976281
NCT00216866|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2006-09-06|||September 2002||2002-09-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis|A Pilot Study of Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis of the Upper Extremity|Completed||Phase 2|70||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 17:08:24.164175|2017-02-18 17:08:24.164175
NCT00216853|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-04-15|||September 2003||2003-09-01|April 2009|2009-04-01|March 2007|Actual|2007-03-01|June 2006|Actual|2006-06-01||Observational|||A Study of Vaginal MicroFlora and Immune Profiles of Patients With Recurrent Urinary Tract Infection|A Study of Vaginal MicroFlora and Immune Profiles of Patients With Recurrent Urinary Tract Infection|Completed||N/A|44|Actual|Lawson Health Research Institute|||2||f||||f||||||||||2017-02-18 17:08:24.266041|2017-02-18 17:08:24.266041
NCT00216840|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-03-25|||December 2004||2004-12-01|March 2015|2015-03-01|September 2005||2005-09-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis|Calcipotriol Plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle and Calcipotriol in the Gel Vehicle in Scalp Psoriasis|Completed||Phase 3|1350||LEO Pharma|||||||||||||||||||2017-02-18 17:08:24.355385|2017-02-18 17:08:24.355385
NCT00216827|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-03-25|||November 2004||2004-11-01|March 2015|2015-03-01|September 2005||2005-09-01|||||Interventional|||Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis|Calcipotriol Plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle, and the Gel Vehicle Alone in Scalp Psoriasis|Completed||Phase 3|1485||LEO Pharma|||||||||||||||||||2017-02-18 17:08:24.459311|2017-02-18 17:08:24.459311
NCT00216814|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2008-04-18|||October 2003||2003-10-01|January 2008|2008-01-01|September 2007|Actual|2007-09-01|||||Observational|||Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors|Intravesically Administered BCG May Have Antiangiogenic Effects on Urinary Concentrations of Basic Fibroblast Growth Factor ( bFGF), Vascular Endothelial Growth Factor (VEGF) and Interleukin (IL-8)|Terminated||N/A|220|Actual|Lawson Health Research Institute|||1|No funding and data was not appropriate to consider continuing.|f||||||||||||||2017-02-18 17:08:24.744926|2017-02-18 17:08:24.744926
NCT00216801|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-01-20|||September 2005||2005-09-01|January 2009|2009-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Relationship of Ochratoxin A to Upper Urologic Cancers|The Relationship of Ochratoxin A to Upper Tract TCC Malignancies, Testicular Cancer, and Renal Cell Cancer|Completed||N/A|60|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-02-18 17:08:24.832011|2017-02-18 17:08:24.832011
NCT00216788|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2010-03-15|||January 2006||2006-01-01|November 2005|2005-11-01|January 2006|Anticipated|2006-01-01|||||Interventional|||The Effect of Nexium on Transmucosal Esophageal Leak|The Effect of Proton Pump Inhibitors on Transmucosal Esophageal Leak|Unknown status|Not yet recruiting|Phase 1|35|Anticipated|Main Line Health|||||f||||||||||||||2017-02-18 17:08:24.927763|2017-02-18 17:08:24.927763
NCT00216775|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2015-09-01|||December 2004||2004-12-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C||Completed||Phase 4|50|Actual|Kyoto University|||1||f||||||||||||||2017-02-18 17:08:25.035658|2017-02-18 17:08:25.035658
NCT00216762|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-08-31|||January 2006||2006-01-01|August 2015|2015-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Safety Study of Rituximab (Rituxan®) in Chronic Urticaria|"Phase I/II Open Label Evaluation of the Safety and Efficacy of Rituximab in Patients With Chronic Urticaria (The Rituximab Urticaria Study - RUSTY)"|Terminated||Phase 1/Phase 2|15|Anticipated|Johns Hopkins University||1||Full Clinical Hold|f||||t||||||||||2017-02-18 17:08:25.137445|2017-02-18 17:08:25.137445
NCT00216749|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-12-15|||December 2003||2003-12-01|December 2009|2009-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Efficacy and Safety of Cilostazol for the Indication of CSPS|Post Marketing Surveillance of Efficacy and Safety of Cilostazol for the Indication of CSPS|Completed||Phase 4|650|Actual|Korea Otsuka Pharmaceutical Co., Ltd.|||1||f||||f||||||||||2017-02-18 17:08:25.248164|2017-02-18 17:08:25.248164
NCT00216736|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-04-13|2009-05-28||April 2005||2005-04-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|December 2006|Actual|2006-12-01||Interventional|||Oral Dexamethasone for Treatment of Migraine|Does a Single Oral Dose of Dexamethasone After Successful Emergency Treatment of Migraine Reduce the Incidence or Severity of Rebound Headache Within 48 Hours?|Completed||Phase 4|63|Actual|The Joseph Epstein Centre for Emergency Medicine Research||2|||f||||f||||||||||2017-02-18 17:08:25.35664|2017-02-18 17:08:25.35664
NCT00216723|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-10-22|||April 2004||2004-04-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|||||Observational|||Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder|Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder|Completed||Phase 4|3000|Anticipated|Korea Otsuka Pharmaceutical Co., Ltd.|||1||f||||||||||||||2017-02-18 17:08:25.8488|2017-02-18 17:08:25.8488
NCT00216710|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||July 1999||1999-07-01|January 2005|2005-01-01|February 2004||2004-02-01|||||Interventional|||Evaluation of the Healthy Families Alaska Program|Evaluation of the Healthy Families Alaska Program|Completed||Phase 2/Phase 3|380||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:08:25.962676|2017-02-18 17:08:25.962676
NCT00216697|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-16|||March 2005||2005-03-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|||||Interventional|||An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy|An Extension or Re-Treatment Study of Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|13|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 17:08:26.069843|2017-02-18 17:08:26.069843
NCT00216684|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-31|||May 2005||2005-05-01|January 2011|2011-01-01|September 2006|Actual|2006-09-01|||||Interventional|||Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics|An Open Label Study to Confirm the Effectiveness, and Safety of Fentanyl Transdermal Matrix Patch in Japanese Patients With Chronic Intractable Pain Who Has Prior Therapy of Codeine, Morphine Hydrochloride, or Fentanyl Injectable Preparations.|Completed||Phase 3|139|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 17:08:26.177056|2017-02-18 17:08:26.177056
NCT00005421|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1992||1992-09-01|March 2005|2005-03-01|March 1995|Actual|1995-03-01|||||Observational|||Blood Pressure Tracking--Childhood to Young Adulthood||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:00.951158|2017-02-18 18:15:00.951158
NCT00216671|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-12|2011-01-07||November 2005||2005-11-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode|Early Versus Late Initiation of Treatment With Risperdal Consta in Subjects With Schizophrenia After an Acute Episode|Completed||Phase 4|220|Actual|Janssen Pharmaceutica N.V., Belgium|Due to the substantial number of protocol deviations (mainly due to prohibited medication), the study did not have the required power to demonstrate non-inferiority in the per protocol population|2|||f||||f||||||||||2017-02-18 17:08:26.294898|2017-02-18 17:08:26.294898
NCT00216658|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-20|||December 2004||2004-12-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|||||Interventional|||Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -|Open Label Study to Confirm Effectiveness, Safety and Pharmacokinetics of Fentanyl Transdermal Matrix Patch, in Japanese Patients With Cancer Pain Who Have Had a Minimum Amount of Morphine Therapy, Such as Equal to Less Than 45 mg/Day of Oral Morphine or Oxycodone Equal to Less Than 30 mg/Day.|Completed||Phase 2|87|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 17:08:26.883833|2017-02-18 17:08:26.883833
NCT00216645|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-16|||January 2005||2005-01-01|March 2010|2010-03-01|November 2006|Actual|2006-11-01|||||Interventional|||Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy|Open-label Study to Verify Effectiveness, Safety of Pegylated Liposomal Doxorubicin 50 mg/m2 Administered Every 4 Weeks to Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Who Have Undergone Prior Platinum-based Chemotherapy.|Completed||Phase 2|74|Actual|Janssen Pharmaceutical K.K.|||||f||||||||||||||2017-02-18 17:08:26.971821|2017-02-18 17:08:26.971821
NCT00216632|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-12-06|||March 2005||2005-03-01|December 2012|2012-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)|Treatment Success in Patients Requiring Treatment Change From Olanzapine to Risperidone Long Acting Injectable (TRESOR)|Completed||Phase 4|99|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 17:08:27.066257|2017-02-18 17:08:27.066257
NCT00216619|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-07-01|||November 2003||2003-11-01|July 2014|2014-07-01|August 2006|Actual|2006-08-01|||||Interventional|PROMPT||The Prolonged Use of Topiramate for Preventing Migraine Headaches|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Investigate the Efficacy and Tolerability of Topiramate in Prolonged Migraine Prevention|Completed||Phase 3|834|Actual|Janssen Pharmaceutica N.V., Belgium||2|||f||||f||||||||||2017-02-18 17:08:27.158184|2017-02-18 17:08:27.158184
NCT00216606|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-31|||December 2003||2003-12-01|January 2011|2011-01-01|July 2005|Actual|2005-07-01|||||Interventional|||The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine|A Randomized Double-Blind Placebo Controlled Trial to Investigate the Efficacy and Tolerability of Topiramate in the Prophylaxis of Chronic Migraine|Completed||Phase 3|59|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 17:08:27.442718|2017-02-18 17:08:27.442718
NCT00216593|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-07||2011-06-07|December 2003||2003-12-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|||Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study|Treatment of Severe Alzheimer's Disease in a Residential Home, Nursing Home, or Geriatric Residential Setting: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Randomised, Doubleblind, Placebo-Controlled Study.|Completed||Phase 3|415|Actual|Janssen Pharmaceutica N.V., Belgium|||||f||||||||||||||2017-02-18 17:08:27.530409|2017-02-18 17:08:27.530409
NCT00216580|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-22|||February 2004||2004-02-01|March 2013|2013-03-01|December 2006|Actual|2006-12-01|||||Interventional|||A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis|An Open-label Trial of Risperidone Long-acting Injectable in the Treatment of Subjects With Recent Onset Psychosis|Completed||Phase 3|50|Actual|Janssen Pharmaceutica N.V., Belgium||1|||f||||f||||||||||2017-02-18 17:08:27.624658|2017-02-18 17:08:27.624658
NCT00216567|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-31|||December 2002||2002-12-01|January 2011|2011-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy|A Randomized, Open Label, Comparative, Multi-center Clinical Trial to Determine the Efficacy and Safety of Topiramate Comparing With Carbamazepine in Benign Rolandic Epilepsy.|Completed||Phase 4|114|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-02-18 17:08:27.73636|2017-02-18 17:08:27.73636
NCT00216554|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-20|||September 2004||2004-09-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|||||Interventional|||The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania|A Multicenter, Open-Label Study to Evaluate Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania|Completed||Phase 4|118|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-02-18 17:08:27.81981|2017-02-18 17:08:27.81981
NCT00216541|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-18|||August 2003||2003-08-01|June 2010|2010-06-01|September 2006|Actual|2006-09-01|||||Interventional|||A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy|Randomised Study to Evaluate the Effect of Early Intervention to Treat Anemia With Epoetin Alfa Versus Standard Use on Hemoglobin Levels and the Incidence of Blood Transfusions in Cancer Patients Receiving Chemotherapy|Completed||Phase 4|110|Actual|Janssen-Cilag B.V.|||||f||||||||||||||2017-02-18 17:08:27.902827|2017-02-18 17:08:27.902827
NCT00216528|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-26|||July 2005||2005-07-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres|A Prospective, Open-Label Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres (Risperdal Consta)|Completed||Phase 4|527|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-02-18 17:08:27.994952|2017-02-18 17:08:27.994952
NCT00216515|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-20|||March 2004||2004-03-01|January 2011|2011-01-01|November 2005|Actual|2005-11-01|||||Interventional|||The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type|A Prospective, Open-labeled, Multicenter Study of Galantamine on the Attention and Frontal Function of the Patients With Dementia of Alzheimer Type|Completed||Phase 4|102|Actual|Janssen Korea, Ltd., Korea|||||f||||||||||||||2017-02-18 17:08:28.079633|2017-02-18 17:08:28.079633
NCT00216502|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-20|||August 2001||2001-08-01|January 2011|2011-01-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease|Long Term Treatment With Galantamine In Dementia|Completed||Phase 3|254|Actual|Janssen-Cilag S.p.A.|||||f||||||||||||||2017-02-18 17:08:28.162186|2017-02-18 17:08:28.162186
NCT00216489|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-22|||March 2003||2003-03-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)|A Non Interventional Post Authorization Safety Study (PASS) On The Rabeprazole's Administration To Adults With Gastro-Oesophageal Reflux Disease (GORD)|Completed||Phase 4|191|Actual|Janssen Cilag Pharmaceutica S.A.C.I., Greece|||||f||||||||||||||2017-02-18 17:08:28.261521|2017-02-18 17:08:28.261521
NCT00216476|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-25|2010-07-08||October 2004||2004-10-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder|CONSTATRE: Risperdal Consta Trial Of Relapse Prevention And Effectiveness|Completed||Phase 3|753|Actual|Janssen-Cilag International NV||3|||f||||f||||||||||2017-02-18 17:08:28.35537|2017-02-18 17:08:28.35537
NCT00216463|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-08-01|||August 2005||2005-08-01|August 2016|2016-08-01|August 2007|Actual|2007-08-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Tolerability of Varying Load and Dose of ISIS 301012 in People With Elevated LDL-cholesterol Levels|A Phase 2, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Varying Loading and Maintenance Dosing Regimens of ISIS 301012 Administered to Hypercholesterolemic Subjects|Completed||Phase 2|50|Actual|Kastle Therapeutics, LLC||5|||f||||||||||||||2017-02-18 17:08:32.166844|2017-02-18 17:08:32.166844
NCT00216450|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-22|||October 2004||2004-10-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.|An Open Observational Study For The Rabeprazole Administration In Adult Subjects With Helicobacter Pylori (H. Pylori) Infection|Completed||Phase 4|80|Actual|Janssen Cilag Pharmaceutica S.A.C.I., Greece|||||f||||||||||||||2017-02-18 17:08:32.278964|2017-02-18 17:08:32.278964
NCT00216437|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2007-11-09|||December 2004||2004-12-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma|A Phase I Dose Escalation Study to Assess the Maximum Tolerated Dose and Feasibility of Combining Oral Capecitabine (Xeloda) and Conformal Radiotherapy (CRT) for Patients With Unresectable Hepatocellular Carcinoma, Multiple Hepatic Metastases or Cholangiocarcinoma|Terminated||Phase 1|30|Anticipated|James A. Haley Veterans Administration Hospital||||lack of accrual|f||||||||||||||2017-02-18 17:08:32.368028|2017-02-18 17:08:32.368028
NCT00216424|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2007-11-09|||February 2005||2005-02-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma|An Open Label, Phase II Study of Capecitabine (Xeloda) Plus Conformal Radiotherapy for Patients With Locally Advanced, Non-Metastatic Rectosigmoid Carcinoma|Terminated||Phase 4|40|Anticipated|James A. Haley Veterans Administration Hospital||||lack of accrual|f||||||||||||||2017-02-18 17:08:32.695656|2017-02-18 17:08:32.695656
NCT00216411|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-11|||November 2004||2004-11-01|October 2007|2007-10-01|October 2006||2006-10-01|||||Interventional|||Effects on Quality of Life Following Dysport Treatment in Post-Stroke Spasticity of the Arm|A Prospective Phase IV, Multicentre, Placebo-Controlled Study to Demonstrate Changes in the Quality of Life Following DYSPORT Intramuscular Injection in the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients|Completed||Phase 4|102||Ipsen|||||f||||||||||||||2017-02-18 17:08:32.791059|2017-02-18 17:08:32.791059
NCT00216398|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-11|||June 2004||2004-06-01|October 2007|2007-10-01|December 2006||2006-12-01|||||Interventional|||Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR|A Phase IV, Multicentre, Open-Label, Single Group Study to Evaluate the Dosing, Efficacy and Safety of Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR|Completed||Phase 4|8||Ipsen|||||f||||||||||||||2017-02-18 17:08:32.880052|2017-02-18 17:08:32.880052
NCT00216385|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-20|||January 2005||2005-01-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Interventional|||A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis|A Randomised Open-Label Controlled Trial of a 4-Month Gatifloxacin-Containing Regimen Versus Standard Regimen for the Treatment of Adult Patients With Pulmonary Tuberculosis|Unknown status|Recruiting|Phase 3|2070||Institut de Recherche pour le Developpement|||||f||||||||||||||2017-02-18 17:08:32.976073|2017-02-18 17:08:32.976073
NCT00216372|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-05-28|||September 2003||2003-09-01|May 2009|2009-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis|Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Assess the Efficacy and Safety of Lanreotide 30 mg Versus Placebo as a Palliative Treatment of Clinical Symptoms Associated With Intestinal Obstruction Due to Peritoneal Carcinomatosis in Inoperable Patients.|Completed||Phase 3|80|Actual|Ipsen||2|||f||||||||||||||2017-02-18 17:08:33.090195|2017-02-18 17:08:33.090195
NCT00216359|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-10-21|||May 2003||2003-05-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Observational|||Cohort Study for Patients Using Fuzeon (Enfuvirtide)|The Radata-Fuzeon Cohort - An Observational Cohort-Study in HIV-Infected Patients Using Fuzeon (Enfuvirtide) as Part of Their Antiretroviral Combination Therapy|Unknown status|Active, not recruiting|N/A|200||Institute for Interdisciplinary Infectiology|||||f||||||||||||||2017-02-18 17:08:33.257804|2017-02-18 17:08:33.257804
NCT00216346|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-10-02|||June 2003||2003-06-01|October 2014|2014-10-01|November 2004||2004-11-01|||||Interventional|||Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis|A Phase 3 Multicenter, Randomized, Controlled, Clinical Trial to Assess the Safety and Efficacy of Injectable Paromomycin in Patients With Visceral Leishmaniasis|Completed||Phase 3|667||PATH|||||f||||||||||||||2017-02-18 17:08:33.352245|2017-02-18 17:08:33.352245
NCT00216333|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2006-09-12|||December 2003||2003-12-01|September 2006|2006-09-01|June 2007||2007-06-01|||||Interventional|||Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis|International Multicenter Trial for the Evaluation of a Four-Drug Fixed Dose Combined Tablet Daily in the Initial Intensive Phase of Chemotherapy Followed by a Two-Drug Fixed Dose Combined Tablet Three Times a Week in the Continuation Phase for the Treatment of Pulmonary Tuberculosis|Unknown status|Recruiting|Phase 4|1500||International Union Against Tuberculosis and Lung Diseases|||||f||||||||||||||2017-02-18 17:08:33.443968|2017-02-18 17:08:33.443968
NCT00216320|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-04-18|2013-04-18||September 2005||2005-09-01|April 2013|2013-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy of the WalkAide and AFOs for CVA|A Three-Arm, Randomized Crossover Study Comparing the Innovative Neurotronics WalkAide™ System to Ankle-Foot Orthosis [AFO]|Completed||N/A|121|Actual|Innovative Neurotronics||3|||f||||f||||||||||2017-02-18 17:08:33.548676|2017-02-18 17:08:33.548676
NCT00216294|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-07-14|||February 2005||2005-02-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder|An Open-Label, Dose Escalation, Pilot Study to Assess the Safety and Efficacy of Subcutaneous RG1068 (Synthetic Human Secretin) in Patients With Obsessive Compulsive Disorder (OCD)|Completed||Phase 2|16||Indiana University|||||||||||||||||||2017-02-18 17:08:34.095871|2017-02-18 17:08:34.095871
NCT00216281|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-03-25|||September 2005||2005-09-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia|Correlation of Phenotype, Genotype and Clinical Efficacy/Toxicity of Clozapine Augmented by Atomoxetine for Treatment Refractory Schizophrenia (CAPG Study)|Terminated||Phase 3|126|Actual|Indiana University||2|||f||||f||||||||||2017-02-18 17:08:34.193652|2017-02-18 17:08:34.193652
NCT00216268|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2006-02-08|||July 2005||2005-07-01|September 2005|2005-09-01|May 2008||2008-05-01|||||Interventional|||Treatment of Japanese Encephalitis|Treatment of Japanese Encephalitis - a Double Blind Placebo Controlled Trial|Unknown status|Recruiting|Phase 2|200||Indian Council of Medical Research|||||f||||||||||||||2017-02-18 17:08:34.301313|2017-02-18 17:08:34.301313
NCT00216255|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-08-27||2012-08-20|April 2005||2005-04-01|August 2012|2012-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study|An 8-week, Double-blind, Randomized, Multicenter, Flexible-dose, Placebo Controlled Pilot Study of Pagoclone in Patients With PDS Followed by a 52-week Open-label Extension|Completed||Phase 2|120|Actual|Endo Pharmaceuticals||2|||f||||t||||||||||2017-02-18 17:08:34.631724|2017-02-18 17:08:34.631724
NCT00216242|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2006-12-08|||September 2005||2005-09-01|December 2006|2006-12-01|May 2007||2007-05-01|||||Interventional|||Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.|A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Fluviral™ Influenza Vaccine in Healthy Adults 18 to 49 Years of Age|Unknown status|Active, not recruiting|Phase 3|7400||ID Biomedical Corporation, Quebec|||||f||||||||||||||2017-02-18 17:08:34.754844|2017-02-18 17:08:34.754844
NCT00216229|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-13|||September 2004||2004-09-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Twinrix Alternative Schedule Study|A Study Comparing the Effectiveness of Two Different Vaccination Schedules of the Combined Hepatitis A and B Vaccine(Twinrix Adult1440/20)|Unknown status|Active, not recruiting|Phase 4|400||IDEWE Occupational Health Services|||||f||||||||||||||2017-02-18 17:08:34.902235|2017-02-18 17:08:34.902235
NCT00216216|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-28|||January 2005||2005-01-01|April 2011|2011-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer|Pemetrexed (Alimta) in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study (LUN04-78)|Terminated||Phase 2|43|Actual|Hoosier Cancer Research Network||1||The results from the interim analysis were not favorable to continue this trial.|f||||t||||||||||2017-02-18 17:08:34.994072|2017-02-18 17:08:34.994072
NCT00216203|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-22|2016-04-27||May 2005||2005-05-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||33 of 36 consented participants received treatment.|Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer|A Phase I-IIa Dose-Ranging Study of Pemetrexed (Alimta) Plus Cetuximab (Erbitux) in Patients With Recurrent Non-Small Cell Lung Cancer (NSCLC): Hoosier Oncology Group LUN04-79|Completed||Phase 1/Phase 2|36|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-02-18 17:08:35.130827|2017-02-18 17:08:35.130827
NCT00216190|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-07-22|||March 2005||2005-03-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|||||Interventional|||A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation|A Phase 4, Randomized, Double-Blind, Multi-Center, Comparator Study Evaluating the Safety and Efficacy of Dexmedetomidine Compared to IV Midazolam in ICU Subjects Requiring Greater Than Twenty-Four Hours of Continuous Sedation|Completed||Phase 4|420|Actual|Hospira, Inc.||2|||f||||f||||||||||2017-02-18 17:08:35.708921|2017-02-18 17:08:35.708921
NCT00216177|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2009-08-17|||September 2005||2005-09-01|August 2009|2009-08-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis|Randomised, Multicenter, Open-label, Parallel-group Study Comparing Adalimumab 40 mg s.c. Eow Versus Infliximab 3 mg/kg i.v. Every 6 Weeks in Rheumatoid Arthritis Patients With Unsustainable Clinical Response to Infliximab 3 mg/kg Every 8 Weeks|Unknown status|Recruiting|Phase 4|112|Anticipated|Hvidovre University Hospital||1|||f||||t||||||||||2017-02-18 17:08:35.904729|2017-02-18 17:08:35.904729
NCT00216164|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-28|||April 2005||2005-04-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Phase II Study of Rituximab and Gemcitabine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Hoosier Oncology Group LYM03-64|Terminated||Phase 2|8|Actual|Hoosier Cancer Research Network||1||Study terminated due to lack of response at the first efficacy analysis|f||||t||||||||||2017-02-18 17:08:36.004186|2017-02-18 17:08:36.004186
NCT00216151|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-28|||June 2005||2005-06-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma|A Randomized Phase II Study of Bisphosphonate: Zoledronic Acid (Zometa) in the Management of Asymptomatic/Early Stage Multiple Myeloma: Hoosier Oncology Group MM02-35|Terminated||Phase 2|3|Actual|Hoosier Cancer Research Network||2||Study terminated due to low patient enrollment.|f||||t||||||||||2017-02-18 17:08:36.132171|2017-02-18 17:08:36.132171
NCT00216138|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-28|||March 2004||2004-03-01|April 2011|2011-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck|A Single Arm Phase II Trial of Docetaxel and Capecitabine for the First Line Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): Hoosier Oncology Group HN02-40|Terminated||Phase 2|19|Actual|Hoosier Cancer Research Network||1||Interim analysis results did not meet criteria for second stage of trial|f||||t||||||||||2017-02-18 17:08:36.497998|2017-02-18 17:08:36.497998
NCT00216125|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-17|2015-11-23||February 2002||2002-02-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|June 2006|Actual|2006-06-01||Interventional|||Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer|A Phase III Trial of Cisplatin/Etoposide/Radiotherapy With or Without Consolidation Docetaxel in Patients With Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer (NSCLC): Hoosier Oncology Group LUN01-24|Completed||Phase 3|243|Actual|Hoosier Cancer Research Network||3|||f||||t||||||||No||2017-02-18 17:08:36.646703|2017-02-18 17:08:36.646703
NCT00216112|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-17|||December 2003||2003-12-01|February 2016|2016-02-01|July 2007|Actual|2007-07-01|October 2005|Actual|2005-10-01||Interventional|||Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer|Imatinib Mesylate (Gleevec®, STI571) in Combination With Docetaxel (Taxotere) for the Treatment of Advanced, Platinum-Refractory Ovarian Cancer and Primary Peritoneal Carcinomatosis: Hoosier Oncology Group GYN03-62|Completed||Phase 2|23|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-02-18 17:08:37.482554|2017-02-18 17:08:37.482554
NCT00216099|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-06-18|2015-12-17||February 2005||2005-02-01|June 2016|2016-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer|A Phase II Study of Pemetrexed (Alimta) as Second-Line Therapy for Hormone Refractory Prostate Cancer: Hoosier Oncology Group GU03-67|Completed||Phase 2|49|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||No||2017-02-18 17:08:37.623826|2017-02-18 17:08:37.623826
NCT00216086|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-04-27|2016-01-05||May 2005||2005-05-01|April 2016|2016-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer|A Phase II Trial of Preoperative Capecitabine Plus Irinotecan Followed by Combined Modality Capecitabine and Radiation for Locally Advanced Rectal Cancer: Hoosier Oncology Group GI03-53|Terminated||Phase 2|22|Actual|Hoosier Cancer Research Network||1||Funding withdrawn|f||||t||||||||No||2017-02-18 17:08:38.153239|2017-02-18 17:08:38.153239
NCT00216073|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-29|||March 2004||2004-03-01|April 2011|2011-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer|A Phase II Trial of Capecitabine, Oxaliplatin and Trastuzumab (CAPOX-T) in Patients With HER-2 Positive Metastatic Breast Cancer: Hoosier Oncology Group BRE03-61|Terminated||Phase 2|11|Actual|Hoosier Cancer Research Network||1||Lack of patient accrual|f||||t||||||||||2017-02-18 17:08:38.819086|2017-02-18 17:08:38.819086
NCT00216060|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-25|2016-01-05||October 2003||2003-10-01|May 2016|2016-05-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Ability of Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy: Hoosier Oncology Group GU02-41|Terminated||Phase 3|63|Actual|Hoosier Cancer Research Network||2||Terminated due to low accrual|f||||t||||||||No||2017-02-18 17:08:38.961196|2017-02-18 17:08:38.961196
NCT00216047|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-08|||January 2005||2005-01-01|December 2015|2015-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer|A Phase I/II Study of PTK787 in Combination With Trastuzumab in Patients With Newly Diagnosed HER2 Overexpressing Locally Recurrent or Metastatic Breast Cancer: Hoosier Oncology Group Trial BRE04-80|Terminated||Phase 1/Phase 2|7|Actual|Hoosier Cancer Research Network||1||Low patient enrollment; toxicities|f||||t||||||||||2017-02-18 17:08:39.990431|2017-02-18 17:08:39.990431
NCT00216034|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2016-06-06|||March 2005||2005-03-01|June 2016|2016-06-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK|Randomized Multicenter Controlled Phase III Study of Postoperative Adjuvant Therapy for Stage II/IIIA Gastric Cancer Using TS-1 Alone or TS-1+PSK Combined Therapy|Completed||Phase 3|255|Actual|Hokuriku-Kinki Immunochemotherapy Study Group||2|||f||||t||||||||||2017-02-18 17:08:40.123557|2017-02-18 17:08:40.123557
NCT00216021|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-12-08|||March 2004||2004-03-01|December 2015|2015-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer|A Phase II Trial of Capecitabine and Oxaliplatin (CAPOX) in Patients With Metastatic Breast Cancer: Hoosier Oncology Group BRE03-60|Completed||Phase 2|25|Actual|Hoosier Cancer Research Network||1|||f||||t||||||||||2017-02-18 17:08:40.290873|2017-02-18 17:08:40.290873
NCT00216008|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-11-21|||July 2005||2005-07-01|July 2009|2009-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.|Phase II Pharmacogenomic Study of Neoadjuvant Pre-irradiation Docetaxel and Cisplatin, Followed by Neoadjuvant Concomitant Docetaxel, Cisplatin and Irradiation, Followed by Surgery (CD-CDR-S) in Adult Patients With Operable Adenocarcinomas of the Esophagus or Gastroesophageal Junction|Terminated||Phase 2|42||H. Lee Moffitt Cancer Center and Research Institute||||IRB Closure|f||||||||||||||2017-02-18 17:08:40.416542|2017-02-18 17:08:40.416542
NCT00215995|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2012-01-12|||July 2003||2003-07-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas|A Phase II Study of Cisplatin and Irinotecan Induction Chemotherapy, Followed by ZD 1839 (IRESSA) in Adult Patients With Surgically Unresectable and/or Metastatic Esophageal or Gastric Carcinomas|Completed||Phase 2|21|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 17:08:40.512714|2017-02-18 17:08:40.512714
NCT00215982|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-11-21|||December 2004||2004-12-01|September 2010|2010-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer|A Phase II Study of Capecitabine in Combination With Irinotecan and Oxaliplatin (Eloxatin) in Adult Patients With Advanced Colorectal Cancer|Completed||Phase 2|24|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 17:08:40.638353|2017-02-18 17:08:40.638353
NCT00215969|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-02-01|||January 2004||2004-01-01|September 2005|2005-09-01|October 2007||2007-10-01|||||Observational|||Prospective Study in Pregnant Women With Hypercoagulopathy|Prospective Study of Hypercoagulation in Pregnant Women|Unknown status|Recruiting|N/A|600||Hillerod Hospital, Denmark|||||f||||||||||||||2017-02-18 17:08:40.767342|2017-02-18 17:08:40.767342
NCT00005420|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-13|||April 1992||1992-04-01|January 2016|2016-01-01|March 1995||1995-03-01|||||Observational|||Prediction of Quality of Life in Cardiovascular Disease||Completed||N/A|||University of Texas at Austin|||||f||||||||||||||2017-02-18 18:15:01.022634|2017-02-18 18:15:01.022634
NCT00215956|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-12-20|||November 2001||2001-11-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma|A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma|Completed||Phase 1|31|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||||||||||||2017-02-18 17:08:40.84504|2017-02-18 17:08:40.84504
NCT00215943|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-04-01|2013-08-21||June 2003||2003-06-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)|Phase III Randomized Trial of Thalidomide/Dexamethasone vs VAD as Induction Chemotherapy for Newly Diagnosed Myeloma Patients and Evaluation of the Effects of Zoledronate on Chemotherapy Induced Apoptosis and Antigen Presentation.|Terminated||Phase 3|90|Actual|H. Lee Moffitt Cancer Center and Research Institute|Target accrual for planned analysis (176) was not met. Principal Investigator (PI) determined study must close due to changes in the management of newly diagnosed myeloma (emergence of new drugs, more effective regimens).|2||"Poor accrual, changes in management of newly diagnosed myeloma patients, new drugs/more~   effective regimens."|f||||t||||||||||2017-02-18 17:08:40.958654|2017-02-18 17:08:40.958654
NCT00215930|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-12-13|2010-10-08||February 2004||2004-02-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer|Phase II Study on the Use of Molecular Analyses-Based Customized Chemotherapy in Patients With Stage IV/IIIB (Malignant Pleural Effusion) Non-Small-Cell Lung Cancer (NSCLC)|Completed||Phase 2|53|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||t||||||||||2017-02-18 17:08:41.498853|2017-02-18 17:08:41.498853
NCT00215917|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2006-05-01||||||May 2006|2006-05-01||||||||Interventional|||D-Serine Monotherapy for Schizophrenia||Unknown status|Recruiting|Phase 1/Phase 2|40||Herzog Hospital|||||f||||||||||||||2017-02-18 17:08:42.050113|2017-02-18 17:08:42.050113
NCT00215904|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2012-07-05|||August 2003||2003-08-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||D-serine Adjuvant Treatment for Parkinson's Disease|D-serine Adjuvant Treatment for Parkinson's Disease|Completed||Phase 4|13|Actual|Herzog Hospital||2|||f||||t||||||||||2017-02-18 17:08:42.129666|2017-02-18 17:08:42.129666
NCT00215891|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-10-24||||||September 2005|2005-09-01||||||||Interventional|||PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon|PEG-Interferon a-2b + Ribavirin for Treatment of Chronic Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon|Completed||Phase 3|300||Hepatitis Resource Network|||||||||||||||||||2017-02-18 17:08:42.233244|2017-02-18 17:08:42.233244
NCT00215878|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2012-07-05|||August 2003||2003-08-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||D-serine for Posttraumatic Stress Disorder Treatment|D-serine for Posttraumatic Stress Disorder Treatment|Completed||Phase 2|22|Actual|Herzog Hospital||2|||f||||t||||||||||2017-02-18 17:08:42.337059|2017-02-18 17:08:42.337059
NCT00215865|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-09-20||||||September 2005|2005-09-01||||||||Interventional|||PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy|HRN 003PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy|Completed||Phase 3|600||Hepatitis Resource Network|||||||||||||||||||2017-02-18 17:08:42.444209|2017-02-18 17:08:42.444209
NCT00215852|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-08-27||2013-08-27|July 2005||2005-07-01|August 2013|2013-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects|A Randomized, Dose-Ranging Study of Alferon® LDO [Low Dose Interferon Alfa-n3 (Human Leukocyte Derived)] in Asymptomatic HIV+ Subjects|Terminated||Phase 2|17|Actual|Hemispherx Biopharma||3|||f||||f||||||||||2017-02-18 17:08:42.539936|2017-02-18 17:08:42.539936
NCT00215839|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-10-24||||||September 2005|2005-09-01||||||||Interventional|||HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy|A Multi-Center, Randomized, Open-Label, Phase IIIb Study Investigating the Safety and Efficacy of Peginterferon a-2a Plus Ribavirin for the Treatment of Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy|Unknown status|Active, not recruiting|Phase 3|||Hepatitis Resource Network|||||||||||||||||||2017-02-18 17:08:42.667919|2017-02-18 17:08:42.667919
NCT00215826|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-04-16|||November 2004||2004-11-01|April 2013|2013-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers|A Randomized, Dose-ranging Study of Alferon® LDO {Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)} in Normal Volunteers and/or Asymptomatic Subjects With Exposure to a Person Known to Have SARS or Possible SARS|Completed||Phase 2|10|Actual|Hemispherx Biopharma||2|||f||||f||||||||||2017-02-18 17:08:42.763894|2017-02-18 17:08:42.763894
NCT00215813|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-08-03|||March 1997||1997-03-01|August 2016|2016-08-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||Ampligen in Chronic Fatigue Syndrome|An Open-Label Study Of Poly I:Poly C12U (AMPLIGEN®) in Patients With Severely Debilitating Chronic Fatigue Syndrome (CFS)|Active, not recruiting||Phase 3|100|Anticipated|Hemispherx Biopharma||1|||f||||f||||||||No||2017-02-18 17:08:42.880156|2017-02-18 17:08:42.880156
NCT00215800|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-04-16|||December 1998||1998-12-01|April 2013|2013-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome|A Multi-center, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Poly I:Poly C12U (Ampligen®) 400 mg IV Twice Weekly Versus Placebo in Patients With Severely Debilitating Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME)|Completed||Phase 3|234||Hemispherx Biopharma|||||f||||f||||||||||2017-02-18 17:08:43.005039|2017-02-18 17:08:43.005039
NCT00215787|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2010-09-21|2010-08-10||September 2005||2005-09-01|September 2010|2010-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease|Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease|Completed||N/A|20|Actual|Head and Neck Surgery Associates||1|||f||||t||||||||||2017-02-18 17:08:43.09361|2017-02-18 17:08:43.09361
NCT00215774|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-09-10|||March 2005||2005-03-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|October 2009|Actual|2009-10-01||Interventional|||Flecainide-Short Long Study (Flec-SL)|Targeted Pharmacological Reversal of Electrical Remodeling After Cardioversion.|Completed||N/A|760|Actual|German Atrial Fibrillation Network||3|||f||||t||||||||||2017-02-18 17:08:43.563809|2017-02-18 17:08:43.563809
NCT00215761|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-09-07|||January 2005||2005-01-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Observational|||Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug Therapy|A Multicenter Study to Investigate Preventive Pacing in Combination With Antiarrhythmic Beta-Blocker Oder AT-I-/ACE-inhibitor Therapy on the Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers|Completed||N/A|263|Actual|German Atrial Fibrillation Network|||1||f||||||||||||||2017-02-18 17:08:43.684362|2017-02-18 17:08:43.684362
NCT00215748|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-11-15|||August 2004||2004-08-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel|Feasibility of A Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Treated With Weekly Docetaxel|Terminated||Phase 2|40|Anticipated|Geriatric Oncology Consortium||||slow accrual|f||||||||||||||2017-02-18 17:08:43.785699|2017-02-18 17:08:43.785699
NCT00215735|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-03-16|||June 2004||2004-06-01|March 2012|2012-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Effect of Platelet Concentrate in Treatment of Diabetic Ulcers|Clinical Evaluation of the Safety and Effectiveness of Harvest Autologous Platelet Concentrate and Autologous Thrombin for Treatment of Lower Extremity Chronic Diabetic Ulcers|Terminated||N/A|||Harvest Technologies||1||inconclusive results, market feasiblity|f||||||||||||||2017-02-18 17:08:43.897393|2017-02-18 17:08:43.897393
NCT00215722|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2007-04-05|||July 2005||2005-07-01|April 2007|2007-04-01|July 2008|Anticipated|2008-07-01|||||Interventional|||XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer||Unknown status|Active, not recruiting|Phase 2|45||Grupo de Investigacao do Cancro Digestivo|||||f||||||||||||||2017-02-18 17:08:44.009791|2017-02-18 17:08:44.009791
NCT00215709|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-11-15|||July 2004||2004-07-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer|A Pilot Study of Docetaxel on a Bi-Weekly Schedule in the Treatment of Elderly Men With Hormone-Refractory Prostate Cancer (HRPC)|Completed||Phase 1|17|Actual|Geriatric Oncology Consortium||1|||f||||||||||||||2017-02-18 17:08:44.120447|2017-02-18 17:08:44.120447
NCT00215696|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-05-12|||April 2005||2005-04-01|May 2011|2011-05-01||||||||Interventional|||A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies|"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of BIOBYPASS® (ADGVVEGF121.10NH) Delivered by NOGA™-GUIDED/MYOSTAR™ Catheter in No Option Patients With Class II-IV Stable Angina"|Completed||Phase 2|129||GenVec|||||f||||||||||||||2017-02-18 17:08:44.218794|2017-02-18 17:08:44.218794
NCT00215683|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2015-03-12|2010-11-12||February 2005||2005-02-01|March 2015|2015-03-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer|An Open-Label, Multi-Centre, Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Patients With Prostate Cancer.|Completed||Phase 2/Phase 3|137|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-02-18 17:08:44.313055|2017-02-18 17:08:44.313055
NCT00215670|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-05-02|||November 2002||2002-11-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)|A Randomized, Double-Masked, Multi-Center Trial of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Intravitreal Injections of Pegaptanib Sodium (Anti-Vegf Pegylated Aptamer) Given Every 6 Weeks for 54 Weeks, in Patients With Exudative Age-Related Macular Degeneration (AMD)|Completed||Phase 2/Phase 3|125||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 17:08:45.819829|2017-02-18 17:08:45.819829
NCT00215657|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2011-05-18|2009-01-22||March 2003||2003-03-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients|An Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients|Terminated||Phase 2|131|Actual|Ferring Pharmaceuticals||8||The doses were not effective in maintaining testosterone suppression|f||||f||||||||||2017-02-18 17:08:45.912011|2017-02-18 17:08:45.912011
NCT00215644|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-11-04|||August 2005||2005-08-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||MATRIX EG (Matuzumab Treatment With ECX in Esophago-Gastric Cancer)|Randomized Phase II Open-label Controlled Study of EMD 72000 (Matuzumab), in Combination With the Chemotherapy Regimen ECX or the Chemotherapy Regimen ECX Alone as First-line Treatment in Subjects With Metastatic Esophago-gastric Adenocarcinoma|Completed||Phase 2|72|Actual|Merck KGaA||2|||f||||f||||||||||2017-02-18 17:08:49.07453|2017-02-18 17:08:49.07453
NCT00215631|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2015-09-14|||October 2005||2005-10-01|April 2007|2007-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?|Can Tadalafil (Cialis)® Maintain Erectile Function In Patients Treated With External-beam Radiotherapy For Prostate Cancer? A Randomized, Double-blind, Placebo-controlled Study|Terminated||Phase 3|100||Erasmus Medical Center||||slow recruitment|f||||||||||||||2017-02-18 17:08:49.204128|2017-02-18 17:08:49.204128
NCT00215618|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2009-01-13|||March 2003||2003-03-01|January 2009|2009-01-01|September 2008|Actual|2008-09-01|August 2006|Actual|2006-08-01||Interventional|||Uterine Balloon Treatment for Heavy Period Bleeding.|Clinical Evaluation of Uterine Balloon Therapy System for Menorrhagia|Completed||Phase 3|250|Actual|Ethicon, Inc.||2|||f||||f||||||||||2017-02-18 17:08:49.292817|2017-02-18 17:08:49.292817
NCT00215605|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-02-26|||September 2005||2005-09-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|April 2011|Actual|2011-04-01||Interventional|||Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL184 Administered Orally to Subjects With Advanced Malignancies|Completed||Phase 1|85|Actual|Exelixis||1|||f||||||||||||||2017-02-18 17:08:49.391775|2017-02-18 17:08:49.391775
NCT00215592|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-01-06|||October 2005||2005-10-01|November 2015|2015-11-01||||July 2007|Actual|2007-07-01||Interventional|||Open Label, Zonegran (Zonisamide) In Partial Onset Seizures|An Open Label Study Of Zonegran (Zonisamide) In Patients With Partial Onset Seizures|Completed||Phase 4|1000|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:08:49.491698|2017-02-18 17:08:49.491698
NCT00215566|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-05-25|||September 2005||2005-09-01|March 2006|2006-03-01||||||||Interventional|||A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Doses and Dose Levels of DDP733 in Patients With Irritable Bowel Syndrome With Constipation|Completed||Phase 2|90||Dynogen Pharmaceuticals|||||f||||||||||||||2017-02-18 17:08:49.696716|2017-02-18 17:08:49.696716
NCT00215553|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-04-02|2012-04-02||May 2001||2001-05-01|April 2012|2012-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||KL₄Surfactant Treatment in Patients With ARDS|A Multicenter, Randomized, Controlled Trial Comparing the Safety and Effectiveness of SURFAXIN® (Lucinactant) Delivered Via Bronchopulmonary Segmental Lavage to Standard of Care in Patients With Acute Respiratory Distress Syndrome (ARDS).|Terminated||Phase 2|124|Actual|Windtree Therapeutics||7||Slow enrollment and administrative reasons|f||||t||||||||||2017-02-18 17:08:49.870652|2017-02-18 17:08:49.870652
NCT00215540|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-05-11|2012-04-02||February 2005||2005-02-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.|A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Efficacy of SURFAXIN® (Lucinactant), in Very Low Birth Weight (VLBW) Infants at Risk for Developing Bronchopulmonary Dysplasia|Terminated||Phase 2|136|Actual|Windtree Therapeutics||3||Concerns related to availability of drug product|f||||t||||||||||2017-02-18 17:08:54.235992|2017-02-18 17:08:54.235992
NCT00215527|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-02-20|||November 2005||2005-11-01|February 2013|2013-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I|A Study of Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis I|Terminated||Phase 1|4|Actual|Dickson, Patricia I., M.D.||1||Due to slow enrolment.|f||||t||||||||||2017-02-18 17:08:55.614007|2017-02-18 17:08:55.614007
NCT00215514|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-07-28|||September 2000||2000-09-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|November 2003|Actual|2003-11-01||Interventional|||Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma|A Pilot Study of Adjuvant Chemoradiation After Resection of Gastric Or Gastroesophageal Junction Adenocarcinoma|Completed||Early Phase 1|25|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:08:55.737701|2017-02-18 17:08:55.737701
NCT00215501|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-07-08|||November 2001||2001-11-01|July 2016|2016-07-01|September 2016|Anticipated|2016-09-01|September 2005|Actual|2005-09-01||Interventional|||Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies|A Phase I Trial of Capecitabine or Continuous Infusion 5-Fluorouracil in Combination With Weekly Irinotecan and Cisplatin in Patients With Advanced Solid Tumor Malignancies|Active, not recruiting||Phase 1|68|Anticipated|Dana-Farber Cancer Institute||2|||f||||||||||||||2017-02-18 17:08:55.849705|2017-02-18 17:08:55.849705
NCT00215462|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-04-27|||June 2000||2000-06-01|April 2009|2009-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma|A Phase II Study of Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma|Completed||Phase 2|32||Dana-Farber Cancer Institute|||||f||||t||||||||||2017-02-18 17:08:55.961375|2017-02-18 17:08:55.961375
NCT00215449|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10||||||January 2009|2009-01-01|April 2006|Actual|2006-04-01|December 2005|Actual|2005-12-01||Interventional|||Study in Patients With COPD||Completed||Phase 3|690||Dey|||||||||||||||||||2017-02-18 17:08:56.063938|2017-02-18 17:08:56.063938
NCT00215436|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-09|||March 2005||2005-03-01|April 2008|2008-04-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD|A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg in the Treatment of Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|345||Dey|||||||||||||||||||2017-02-18 17:08:56.238355|2017-02-18 17:08:56.238355
NCT00215423|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10||||||August 2008|2008-08-01|September 2005|Actual|2005-09-01|December 2003|Actual|2003-12-01||Interventional|||Study in Patients With COPD||Completed||Phase 2|49||Dey|||||||||||||||||||2017-02-18 17:08:56.378165|2017-02-18 17:08:56.378165
NCT00215410|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10||||||February 2008|2008-02-01|October 2005|Actual|2005-10-01|October 2003|Actual|2003-10-01||Interventional|||Study in Patients With Asthma||Completed||Phase 2|36||Dey|||||||||||||||||||2017-02-18 17:08:56.474616|2017-02-18 17:08:56.474616
NCT00215397|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10||||||February 2008|2008-02-01|December 2005|Actual|2005-12-01|February 2003|Actual|2003-02-01||Interventional|||Study in Patients With Asthma||Completed||Phase 2|16||Dey|||||||||||||||||||2017-02-18 17:08:56.652141|2017-02-18 17:08:56.652141
NCT00215384|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10||||||February 2008|2008-02-01|October 2005|Actual|2005-10-01|April 2003|Actual|2003-04-01||Interventional|||Study in Patients With COPD||Completed||Phase 2|35||Dey|||||||||||||||||||2017-02-18 17:08:56.932542|2017-02-18 17:08:56.932542
NCT00215371|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10|||July 2002||2002-07-01|February 2008|2008-02-01|November 2005|Actual|2005-11-01|October 2002|Actual|2002-10-01||Interventional|||Study in Patients With Asthma||Completed||Phase 2|32||Dey|||||||||||||||||||2017-02-18 17:08:57.032928|2017-02-18 17:08:57.032928
NCT00215358|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10|||July 2002||2002-07-01|February 2008|2008-02-01|December 2005|Actual|2005-12-01|October 2002|Actual|2002-10-01||Interventional|||Study in Patients With Asthma||Completed||Phase 2|32||Dey|||||||||||||||||||2017-02-18 17:08:57.120461|2017-02-18 17:08:57.120461
NCT00215345|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2005-09-20|||August 2002||2002-08-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer|A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer|Unknown status|Recruiting|Phase 2|66||Department of Veterans Affairs, New Jersey|||||||||||||||||||2017-02-18 17:08:57.211946|2017-02-18 17:08:57.211946
NCT00215332|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-04-10|||March 2005||2005-03-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|||||Observational|||CHARITE™ vs. ALIF 5-Year Follow-up|Five-year Follow-up of the CHARITÉ™ Artificial Disc Compared to Anterior Lumbar Interbody Fusion With the BAK Cage.|Completed||Phase 4|367|Anticipated|DePuy Spine|||3||f||||f||||||||||2017-02-18 17:08:57.326263|2017-02-18 17:08:57.326263
NCT00215319|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-22|||December 2000||2000-12-01|May 2014|2014-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Titanium Surgical Mesh and MOSS-Miami Screws for Lumbar Fusion.|A Multi-center Study to Evaluate the Safety and Efficacy of DePuy AcroMed Titanium Surgical Mesh and MOSS-Miami Spinal Fixation System Pedicle Screws for Intradiscal Fusion in the Lumbar Spine|Completed||Phase 3|139|Actual|DePuy Spine||1|||f||||f||||||||||2017-02-18 17:08:57.436586|2017-02-18 17:08:57.436586
NCT00215306|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-22|||March 2000||2000-03-01|May 2014|2014-05-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||CHARITÉ™ Artificial Disc Compared to Anterior Interbody Fusion for Treatment of Degenerative Disc Disease|Clinical Investigation of the SB Charite III Intervertebral Disc Spacer.|Completed||Phase 3|304|Actual|DePuy Spine||2|||f||||||||||||||2017-02-18 17:08:57.549848|2017-02-18 17:08:57.549848
NCT00215293|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-22|||August 2000||2000-08-01|May 2014|2014-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cervical I/F Cage for Anterior Cervical Fusion|A Randomized Multi-Center Study to Evaluate the Safety and Efficacy of the Cervical I/F Cage for Anterior Cervical Fusion|Completed||Phase 3|240|Actual|DePuy Spine||2|||f||||f||||||||||2017-02-18 17:08:57.663385|2017-02-18 17:08:57.663385
NCT00215280|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2007-04-19|||November 2005||2005-11-01|April 2007|2007-04-01|February 2006||2006-02-01|||||Interventional|||Epidemiology and Control of Mansonella Perstans Infection in Uganda|Studies on the Epidemiology and Control of Mansonella Perstans Infection in Uganda|Completed||N/A|1000||DBL -Institute for Health Research and Development|||||f||||||||||||||2017-02-18 17:08:57.757721|2017-02-18 17:08:57.757721
NCT00215267|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-02-19|||September 2005||2005-09-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda|The Effect of One Versus Two Praziquantel Treatments on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria in Uganda|Completed||N/A|540|Anticipated|DBL -Institute for Health Research and Development|||||f||||||||||||||2017-02-18 17:08:57.860117|2017-02-18 17:08:57.860117
NCT00215254|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2006-12-18|||March 2004||2004-03-01|March 2006|2006-03-01|February 2006||2006-02-01|||||Interventional|||Quetiapine in Social Anxiety Disorder|A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Quetiapine in Social Anxiety Disorder|Completed||Phase 2/Phase 3|15||Duke University|||||f||||||||||||||2017-02-18 17:08:57.961854|2017-02-18 17:08:57.961854
NCT00215241|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-09-18|||April 2004||2004-04-01|June 2006|2006-06-01|July 2006||2006-07-01|||||Interventional|||Risperidone Augmentation for PTSD|Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD|Completed||Phase 2/Phase 3|80||Duke University|||||f||||||||||||||2017-02-18 17:08:58.064607|2017-02-18 17:08:58.064607
NCT00215228|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-07-18|||July 2005||2005-07-01|September 2007|2007-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression|Effects of Escitalopram vs. Duloxetine on Heart Rate Variability and Autonomic Cardiovascular Control|Completed||Phase 2/Phase 3|26|Anticipated|Duke University|||||f||||||||||||||2017-02-18 17:08:58.162207|2017-02-18 17:08:58.162207
NCT00215215|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2006-02-20|||February 2005||2005-02-01|February 2006|2006-02-01|November 2007||2007-11-01|||||Interventional|||Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures|Post Marketing Study; Randomized, Parallel-Group Comparison of Treatment With Pharmacotherapy or Adjunctive Vagus Nerve Stimulation Therapy for Pharmacoresistant Partial Seizures: A Large Simple Effectiveness Trial|Terminated||Phase 4|360||Cyberonics, Inc.|||||f||||||||||||||2017-02-18 17:08:58.262571|2017-02-18 17:08:58.262571
NCT00215202|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-08-13|||August 2004||2004-08-01|August 2008|2008-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)|A Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)|Completed||Phase 2|33|Anticipated|Dartmouth-Hitchcock Medical Center|||||f||||t||||||||||2017-02-18 17:08:58.391458|2017-02-18 17:08:58.391458
NCT00215189|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-09-22|||August 2004||2004-08-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Evaluation of a Health Promotion Intervention for Persons With Mental Illness|Evaluation of a Health Promotion Intervention for Persons With Mental Illness|Completed||N/A|145|Actual|Dartmouth-Hitchcock Medical Center|||2||f||||t||||||||||2017-02-18 17:08:58.492457|2017-02-18 17:08:58.492457
NCT00215176|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-06-17|||February 2003||2003-02-01|September 2005|2005-09-01|April 2005||2005-04-01|||||Interventional|||Modafinil for Atypical Depression|A Study of Modafinil for Atypical Depression|Completed||Phase 2/Phase 3|65||Duke University|||||f||||||||||||||2017-02-18 17:08:58.578377|2017-02-18 17:08:58.578377
NCT00215163|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2013-05-29|||December 2002||2002-12-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy|Randomized Trial of Paroxetine-CR for the Treatment of Patients With Post-Traumatic Stress Disorder (PTSD) Remaining Symptomatic After Initial Exposure Therapy|Completed||Phase 2/Phase 3|17|Actual|Duke University|||||f||||||||||||||2017-02-18 17:08:58.672337|2017-02-18 17:08:58.672337
NCT00215150|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-10-23|2012-12-13||November 2004||2004-11-01|April 2013|2013-04-01|July 2009|Actual|2009-07-01|December 2008|Actual|2008-12-01||Interventional|SAD|This is the intent to treat population consisting of subjects completing at least one post baseline visit.|Geodon for the Treatment of Refractory Social Anxiety Disorder|Ziprasidone for the Treatment of Refractory Social Anxiety Disorder|Completed||Phase 2|51|Actual|Duke University||3|||f||||f||||||||||2017-02-18 17:08:58.787614|2017-02-18 17:08:58.787614
NCT00215137|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2014-07-14|2013-04-15||October 2004||2004-10-01|August 2013|2013-08-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional||Only the open label treatment phase is being reported per reviewer's instructions. The other arms are for the second phase of the study.|Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder|Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder|Completed||Phase 2|14|Actual|Duke University||3|||f||||f||||||||||2017-02-18 17:08:59.118544|2017-02-18 17:08:59.118544
NCT00215124|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-09-17||||||September 2008|2008-09-01|February 2007|Actual|2007-02-01|||||Interventional|||A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction|Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction|Completed||Phase 1/Phase 2|||The Cleveland Clinic|||||f||||t||||||||||2017-02-18 17:08:59.45041|2017-02-18 17:08:59.45041
NCT00215111|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-02-04|||March 2005||2005-03-01|February 2015|2015-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Role of Carbohydrate Modification in Weight Management Among Obese Children|Role of Carbohydrate Modification in Weight Management Among Obese Children|Completed||N/A|102|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||||||||||||2017-02-18 17:08:59.533432|2017-02-18 17:08:59.533432
NCT00215098|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-03-14|||May 2005||2005-05-01|June 2007|2007-06-01|November 2006|Actual|2006-11-01|||||Observational|||Chylothorax Following Heart Surgery|Chylothorax in Children Following Congenital Heart Surgery|Terminated||N/A|70|Anticipated|Children's Healthcare of Atlanta|||1|insufficient data|f||||f||||||||||2017-02-18 17:08:59.638331|2017-02-18 17:08:59.638331
NCT00215072|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-03-14|||July 2005||2005-07-01|May 2007|2007-05-01|February 2007|Actual|2007-02-01|||||Observational|||Death Following Congenital Heart Surgery|Death Following Congenital Heart Surgery|Terminated||N/A|40|Anticipated|Children's Healthcare of Atlanta|||1|insufficient number of patient charts to support hypothesis|f||||f||||||||||2017-02-18 17:08:59.796856|2017-02-18 17:08:59.796856
NCT00215059|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-08-01|||August 2000||2000-08-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis|Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Multivessel Pulmonary Vein Stenosis|Terminated||N/A|50|Anticipated|Boston Children’s Hospital|||1|Lack of funding|f||||f||||||||||2017-02-18 17:08:59.935956|2017-02-18 17:08:59.935956
NCT00215046|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-06-22|||March 2000||2000-03-01|June 2011|2011-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis|Vinblastine and Methotrexate in Children With Multivessel Pulmonary Vein Stenosis-A Phase II Study|Completed||Phase 2|28|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 17:09:00.215801|2017-02-18 17:09:00.215801
NCT00215033|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2012-03-14|||April 2005||2005-04-01|May 2007|2007-05-01|May 2006|Actual|2006-05-01|||||Observational|||Relationship Between EBV and PTLD|Relationship Between Quantitative Epstein-Bar Viral(EBV) Titres and Post-Transplant Lymphoproliferative Disease|Terminated||N/A|160|Actual|Children's Healthcare of Atlanta|||1|sufficient data gathered to support conclusion|f||||f||||||||||2017-02-18 17:09:00.344615|2017-02-18 17:09:00.344615
NCT00215020|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-01-26|||September 2003||2003-09-01|January 2016|2016-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease|Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease|Completed||Phase 1|150|Actual|Boston Children’s Hospital|||1||f||||f||||||Samples Without DNA|"~     Specimens stored at -80 in the Center for IBD at Boston Children's Hospital.~   "|No||2017-02-18 17:09:00.429985|2017-02-18 17:09:00.429985
NCT00214279|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-06-22|||May 2002||2002-05-01|June 2012|2012-06-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal|MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal|Completed||N/A|32|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-02-18 17:09:00.518514|2017-02-18 17:09:00.518514
NCT00214266|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-22|||January 2005||2005-01-01|June 2012|2012-06-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation|A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation|Completed||Phase 2|31|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 17:09:00.6111|2017-02-18 17:09:00.6111
NCT00214253|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-10-09|||February 2002||2002-02-01|October 2015|2015-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Islet Transplantation in Type 1 Diabetic Patients|Islet Transplantation in Type 1 Diabetic Patients Using a Steroid-free Immunosuppression Protocol and Thiazolidinedione Insulin Sensitizers|Completed||N/A|14|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-02-18 17:09:00.704015|2017-02-18 17:09:00.704015
NCT00214240|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-25|||January 2000||2000-01-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease|The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease|Completed||N/A|28|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:09:00.795446|2017-02-18 17:09:00.795446
NCT00214227|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-18|||December 2007||2007-12-01|June 2013|2013-06-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||ATM Variants in Radiotherapy Patients|ATM Variants in Radiotherapy|Completed||N/A|60|Actual|University of Wisconsin, Madison|||1||f||||||||||Samples With DNA|"~     direct sequence analysis of all exons and intron-exon junctions of the ATM gene. DNA will be~     isolated from lympocytes using the PAX blood DNA system.~   "|||2017-02-18 17:09:00.903226|2017-02-18 17:09:00.903226
NCT00214214|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-06|||October 2005||2005-10-01|October 2015|2015-10-01||||||||Interventional|||A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus|A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus|Withdrawn||Phase 1|0|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:00.98371|2017-02-18 17:09:00.98371
NCT00214201|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-21|2012-08-13||May 2003||2003-05-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation|Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation|Completed||N/A|40|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:09:01.075078|2017-02-18 17:09:01.075078
NCT00214175|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-22|||June 2004||2004-06-01|February 2012|2012-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Observational|||Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy|Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy|Completed||N/A|44|Actual|University of Wisconsin, Madison|||2||f||||f||||||||||2017-02-18 17:09:01.561432|2017-02-18 17:09:01.561432
NCT00214162|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-16|||August 2004||2004-08-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer|Web-based Support for Informal Caregivers in Cancer|Completed||N/A|235|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 17:09:01.649784|2017-02-18 17:09:01.649784
NCT00215007|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2007-11-29||||||February 2004|2004-02-01||||||||Interventional|||Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)|Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial With Levofloxacin as Prophylaxis for Bacterial Infections in Immunocompromised Patients After Allogeneic Transplantation of Hematopoietic Stem Cells|Unknown status|Recruiting|Phase 2/Phase 3|||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:09:01.752458|2017-02-18 17:09:01.752458
NCT00214994|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-05-08|||January 2005||2005-01-01|May 2014|2014-05-01|December 2006||2006-12-01|||||Interventional|||Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.|A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment (up to 16 mg/Day) in Adults With Generalized Anxiety Disorder.|Completed||Phase 3|||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:09:01.839269|2017-02-18 17:09:01.839269
NCT00214981|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-07-25|||September 2003||2003-09-01|July 2012|2012-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD|A 1-Year, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Continued Efficacy of Modafinil (Film-coated Tablet Formulation) in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (Followed by an Open-Ended Extension Period)|Completed||Phase 3|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:09:02.025807|2017-02-18 17:09:02.025807
NCT00214968|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-05-23||2012-05-23|January 2005||2005-01-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness|A 6-Month Open Label, Flexible-Dosage Study to Assess the Safety and Effectiveness of PROVIGIL (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|92|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 17:09:02.170263|2017-02-18 17:09:02.170263
NCT00214955|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-05-08|||September 2005||2005-09-01|May 2014|2014-05-01||||May 2006|Actual|2006-05-01||Interventional|||Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Neuropathic Pain|Completed||Phase 3|120||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:09:02.267322|2017-02-18 17:09:02.267322
NCT00214942|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-05-08|||September 2005||2005-09-01|May 2014|2014-05-01||||March 2006|Actual|2006-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Low Back Pain|Completed||Phase 3|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:09:02.369972|2017-02-18 17:09:02.369972
NCT00214929|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-12-08|||December 2004||2004-12-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Home Treatment of Pulmonary Embolism|Cooperative Investigation Plan for Home Treatment of Pulmonary Embolism|Unknown status|Active, not recruiting|Phase 4|||Carlos III Health Institute|||||f||||||||||||||2017-02-18 17:09:02.470715|2017-02-18 17:09:02.470715
NCT00214916|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2011-08-24|||October 2004||2004-10-01|August 2011|2011-08-01|February 2012|Anticipated|2012-02-01|February 2008|Actual|2008-02-01||Interventional|||Tight Glycemic Control With Intensive Insulin Therapy in PICU|KULeuven Intensive Insulin Study in Pediatric Intensive Care Patients|Unknown status|Active, not recruiting|Phase 2|700|Actual|Katholieke Universiteit Leuven||2|||f||||t||||||||||2017-02-18 17:09:02.581609|2017-02-18 17:09:02.581609
NCT00214903|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2014-11-13|2014-11-06||November 2004||2004-11-01|November 2014|2014-11-01|November 2011|Actual|2011-11-01|May 2011|Actual|2011-05-01||Observational||At baseline, 33% of women were using DRSP/E2, 44% were using ooccHRT, 13% were using ooHRT, and 10% ‘Non-oral HRT’. These proportions only partially reflect the overall exposure in each cohort (AT population) because market authorization for DRSP/E2 was delayed by more than 1.5 years.|European Active Surveillance Study of Women Taking Hormone Replacement Therapy (HRT)|European Active Surveillance Study of Women Taking HRT|Completed||Phase 4|30597|Actual|Center for Epidemiology and Health Research, Germany|In non-experimental studies like EURAS-HRT the possibility of bias and residual confounding can never be entirely eliminated. The findings may exclude large, but not small relative risks.||2||f||||t||||||||||2017-02-18 17:09:02.696059|2017-02-18 17:09:02.696059
NCT00214890|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2011-08-02|||April 2005||2005-04-01|August 2011|2011-08-01||||February 2009|Actual|2009-02-01||Interventional|||Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir|CCTG584: Viral Dynamics and Pharmacokinetics of Tenofovir and Abacavir Monotherapy Versus the Combination Therapy of TDF-ABC in HIV-Infected Treatment Naive Patients|Completed||Phase 2|20|Anticipated|California Collaborative Treatment Group||2|||f||||||||||||||2017-02-18 17:09:03.278835|2017-02-18 17:09:03.278835
NCT00214877|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2008-03-28|||November 2003||2003-11-01|March 2008|2008-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Methylene Blue for Cognitive Dysfunction in Bipolar Disorder|Double-Blind Trial of Methylene Blue for Cognitive Dysfunction in Bipolar Disorder|Completed||Phase 3|40|Anticipated|Nova Scotia Health Authority|||||f||||f||||||||||2017-02-18 17:09:03.59383|2017-02-18 17:09:03.59383
NCT00214864|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-02-13|||December 2002||2002-12-01|February 2012|2012-02-01||||January 2006|Actual|2006-01-01||Interventional|||A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer|A Pilot Study of Taxotere (Docetaxel) Combined With Xeloda (Capecitabine) in the Treatment of Metastatic Breast Cancer|Completed||Phase 2|18|Actual|Cancer Research Network||1|||f||||t||||||||||2017-02-18 17:09:03.698817|2017-02-18 17:09:03.698817
NCT00214851|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2008-05-30|||September 2005||2005-09-01|May 2008|2008-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria|The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria|Completed||Phase 1|8|Anticipated|Nova Scotia Health Authority||1|||f||||f||||||||||2017-02-18 17:09:03.797949|2017-02-18 17:09:03.797949
NCT00214838|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-12-01|||March 2005||2005-03-01|December 2006|2006-12-01|March 2007||2007-03-01|||||Interventional|||An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer|An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|61||Callisto Pharmaceuticals|||||f||||||||||||||2017-02-18 17:09:03.891838|2017-02-18 17:09:03.891838
NCT00214825|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2007-12-28|||August 2003||2003-08-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Aldosterone and Vascular Disease in Diabetes Mellitus|Aldosterone and Vascular Disease in Diabetes Mellitus|Completed||N/A|46|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-02-18 17:09:03.992135|2017-02-18 17:09:03.992135
NCT00214812|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-10-24|||June 2005||2005-06-01|September 2005|2005-09-01||||||||Interventional|||An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots|An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots|Unknown status|Recruiting|Phase 1|6||Biosyn|||||f||||||||||||||2017-02-18 17:09:04.105796|2017-02-18 17:09:04.105796
NCT00214786|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-05-15|2013-02-11||April 2005||2005-04-01|May 2014|2014-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Pancreatic Islet Cell Transplantation|Pancreatic Islet Cell Transplantation - A Novel Approach to Immunosuppression and Validation of Remote Site Islet Cell Processing, Islet Cell Culture and Two-Layer Preservation|Completed||Phase 1|4|Actual|Baylor Research Institute|Three of the four patients voluntarily withdrew from the study.|1|||f||||t||||||||||2017-02-18 17:09:04.196164|2017-02-18 17:09:04.196164
NCT00214773|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-14|||July 2005||2005-07-01|November 2016|2016-11-01|December 2020|Anticipated|2020-12-01|July 2020|Anticipated|2020-07-01||Observational|||Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)|MPS VI Clinical Surveillance Program (CSP)|Recruiting||Phase 4|200|Anticipated|BioMarin Pharmaceutical|||1||f||||f||||||Samples Without DNA|"~     Urine and serum~   "|No||2017-02-18 17:09:04.550907|2017-02-18 17:09:04.550907
NCT00214760|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2010-01-29|||May 2005||2005-05-01|November 2009|2009-11-01|September 2011|Anticipated|2011-09-01|August 2008|Actual|2008-08-01||Interventional|||Polymethyl Methacrylate and (PEGT/PBT) Centralizer by the Uncemented BIHAPRO THP|Phase 3 Randomised, Prospective Study Comparing the PMMA and the Resorbable PEGT/PBT Centralizer by the Uncemented BIHAPRO Total Hip Prosthesis|Terminated||Phase 3|70|Actual|Biomet Nederland BV||2||On of the liners has been taken from the market|f||||f||||||||||2017-02-18 17:09:04.770473|2017-02-18 17:09:04.770473
NCT00214747|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-10-24|||March 2005||2005-03-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina|An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina: Candidate Formulations|Unknown status|Active, not recruiting|Phase 1|6||Biosyn|||||f||||||||||||||2017-02-18 17:09:04.886231|2017-02-18 17:09:04.886231
NCT00214734|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-06-26|||August 2004||2004-08-01|April 2009|2009-04-01|January 2007||2007-01-01|||||Observational|||ADVATE Post Authorization Safety Surveillance|Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study|Completed||N/A|450|Anticipated|Baxalta US Inc.|||1||f||||||||||||||2017-02-18 17:09:04.976885|2017-02-18 17:09:04.976885
NCT00214721|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-11-28|||February 2005||2005-02-01|November 2007|2007-11-01|July 2006||2006-07-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis|A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis|Completed||Phase 3|120||Baxter Healthcare Corporation|||||f||||||||||||||2017-02-18 17:09:05.103745|2017-02-18 17:09:05.103745
NCT00214708|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||January 2002||2002-01-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Observational|||Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?|Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis? A Cluster Randomised Controlled Trial in an East London Primary Care Trust|Unknown status|Active, not recruiting|Phase 4|200||Barts & The London NHS Trust|||||f||||||||||||||2017-02-18 17:09:05.188215|2017-02-18 17:09:05.188215
NCT00214695|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-11-20|||May 2005||2005-05-01|November 2006|2006-11-01|July 2006||2006-07-01|||||Interventional|||A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis|A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis|Completed||N/A|20||Baxter Healthcare Corporation|||||f||||||||||||||2017-02-18 17:09:05.278413|2017-02-18 17:09:05.278413
NCT00214682|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-09-12|||October 2005||2005-10-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Beyond Ageing Project: A Study for the Prevention of Depression|Beyond Ageing Project: A RCT to Assess the Benefit of Improving Mental Health Literacy as Well as the Effect of Folate and B12, and Physical Activity, in Preventing Major Depression and Cognitive Decline Among Older Australians|Completed||Phase 2|909|Actual|Australian National University||6|||f||||t||||||||||2017-02-18 17:09:05.357064|2017-02-18 17:09:05.357064
NCT00214669|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-06-03|||November 2005||2005-11-01|May 2009|2009-05-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|OEDIPUS||Can Education for South Asians With Asthma and Their Clinicians Reduce Unscheduled Care? A Randomised Trial|Can Education for South Asians With Asthma and Their Clinicians Reduce Unscheduled Care? A Cluster Randomised Trial|Completed||Phase 1|375|Actual|Barts & The London NHS Trust||2|||f||||||||||||||2017-02-18 17:09:05.488852|2017-02-18 17:09:05.488852
NCT00214656|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||June 2005||2005-06-01|September 2005|2005-09-01|June 2008||2008-06-01|||||Interventional|||"Salvage Use of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery"|"Salvage Use of Recombinant Activated Factor VII After Inadequate Haemostatic Response to Conventional Therapy in Complex Cardiac Surgery - a Randomised Placebo Controlled Trial"|Unknown status|Recruiting|Phase 3|40||Austin Health|||||f||||||||||||||2017-02-18 17:09:05.602375|2017-02-18 17:09:05.602375
NCT00214643|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2009-02-03|||June 2005||2005-06-01|February 2009|2009-02-01|July 2006||2006-07-01|||||Interventional|||Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children|A Comparative Assessment of the Efficacy of Fosmidomycin-Clindamycin Versus Sulfadoxine-Pyrimethamine for the Treatment of Children With Uncomplicated Plasmodium Falciparum Malaria|Completed||Phase 3|160||Albert Schweitzer Hospital|||||f||||||||||||||2017-02-18 17:09:05.707856|2017-02-18 17:09:05.707856
NCT00214630|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2010-11-18|||December 2003||2003-12-01|November 2010|2010-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes|A 12-week Randomized, Open-label 3-arm, Parallel Group, Multicenter Phase IIIb Study Comparing Efficacy and Safety of Rosuvastatin 20mg and 40mg With That of Atorvastatin 80 mg in Subjects With Acute Coronary Syndromes|Completed||Phase 3|825|Actual|AstraZeneca|||||||||||||||||||2017-02-18 17:09:05.821686|2017-02-18 17:09:05.821686
NCT00214617|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2006-09-22|||January 2005||2005-01-01|September 2006|2006-09-01|February 2006||2006-02-01|||||Interventional|||Effect of Crestor on Lipoprotein Metabolism in Humans|Effect of Crestor on the Kinetics of Plasma Apolipoproteins: Dose-Response Study|Completed||Phase 4|8||Atlanta Research and Education Foundation|||||f||||||||||||||2017-02-18 17:09:05.974202|2017-02-18 17:09:05.974202
NCT00214604|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-21|2010-11-18|||February 2005||2005-02-01|November 2010|2010-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Type III Dysbetalipoproteinemia|An 18-week, Randomized, Multicenter, Phase 3b, Double-blind, Crossover Study, Followed by an 18-week Open-Label Period to Evaluate the Efficacy & Safety of the Lipid-Regulating Agents, Rosuvastatin & Pravastatin in the Treatment of Subjects With Dysbetalipoproteinemia (Frederickson Type III Hyperlipoproteinemia)|Completed||Phase 3|30||AstraZeneca|||||||||||||||||||2017-02-18 17:09:06.068652|2017-02-18 17:09:06.068652
NCT00214591|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-11-18|||August 2004||2004-08-01|November 2010|2010-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||GALLANT 5 Tesaglitazar Versus Metformin|A 52-wk Randomised, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin) Study to Evaluate the Efficacy, Safety & Tolerability of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes|Terminated||Phase 3|580||AstraZeneca||||The development program has been terminated|f||||||||||||||2017-02-18 17:09:06.166335|2017-02-18 17:09:06.166335
NCT00214578|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-01-03|||April 2004||2004-04-01|January 2013|2013-01-01|October 2005|Actual|2005-10-01|||||Interventional|||Seroquel on Glucose Metabolism|Seroquel on Glucose Metabolism|Completed||Phase 4|572||AstraZeneca|||||f||||||||||||||2017-02-18 17:09:06.381161|2017-02-18 17:09:06.381161
NCT00214565|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-11-17|||August 2004||2004-08-01|November 2010|2010-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||GALLANT 6 Tesaglitazar vs. Pioglitazone|A 24-Wk Randomised, Double-Blind, Multi-Centre, Active-Controlled (Pioglitazone) Study to Evaluate the Efficacy, Safety & Tolerability of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes|Terminated||Phase 3|1450||AstraZeneca||||The development program has been terminated|||||||||||||||2017-02-18 17:09:06.801825|2017-02-18 17:09:06.801825
NCT00214552|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-06-22|||September 2002||2002-09-01|June 2011|2011-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.|A Double-blind Placebo Controlled Clinical Trial to Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.|Completed||Phase 3|80|Anticipated|Associated Scientists to Help Minimize Allergies||1|||f||||f||||||||||2017-02-18 17:09:07.004389|2017-02-18 17:09:07.004389
NCT00214539|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-09-30|2010-09-08||April 2004||2004-04-01|September 2011|2011-09-01|August 2006|Actual|2006-08-01|February 2006|Actual|2006-02-01||Interventional|||Research in Severe Asthma (RISA) Trial|Multicenter Randomized Clinical Trial of Bronchial Thermoplasty With the Alair System for the Treatment of Severe Asthma|Completed||N/A|34|Actual|Asthmatx, Inc.||2|||f||||t||||||||||2017-02-18 17:09:07.128707|2017-02-18 17:09:07.128707
NCT00214526|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-08-21|2010-09-08||November 2002||2002-11-01|August 2015|2015-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Asthma Intervention Research (AIR) Trial|Multicenter Randomized Clinical Trial of the Alair System for the Bronchial Thermoplasty Treatment of Asthma|Completed||N/A|112|Actual|Asthmatx, Inc.||2|||f||||t||||||||||2017-02-18 17:09:08.288374|2017-02-18 17:09:08.288374
NCT00214513|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-05-16|||June 2004||2004-06-01|May 2007|2007-05-01|July 2006|Actual|2006-07-01|||||Interventional|||A Randomized Trial of Effect of Low-Cost Maintenance Training on Exercise Capacity, Quality of Life and Morbidity|Maintain. A Randomized Trial of Effect of Low-Cost Maintenance Training on Exercise Capacity, Quality of Life and Morbidity|Completed||Phase 3|160|Anticipated|Amager Hospital|||||f||||||||||||||2017-02-18 17:09:09.10375|2017-02-18 17:09:09.10375
NCT00214500|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-05||2010-08-17|September 2005||2005-09-01|May 2015|2015-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of AT1001 in Patients With Fabry Disease|A Phase 2, Open-Label, Multicenter, Ascending-Dose, 12-Week Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AT1001 in Patients With Fabry Disease|Completed||Phase 2|14|Actual|Amicus Therapeutics||4|||f||||||||||||||2017-02-18 17:09:09.215656|2017-02-18 17:09:09.215656
NCT00214487|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-06-23|2014-06-23||October 2003||2003-10-01|June 2014|2014-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional||Numbers reflect those subjects screened, enrolled, randomized with at least one follow up examination.|Bifocal Soft Contact Lenses and Their Effect on Myopia Progression in Children and Adolescents.|Bifocal Soft Contact Lenses - Do They Slow Progression of Myopia Relative to Single Vision Soft Contact Lenses in Children and Adolescents?|Completed||N/A|78|Actual|Aller, Thomas A., OD||2|||f||||f||||||||||2017-02-18 17:09:09.329618|2017-02-18 17:09:09.329618
NCT00214474|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2013-02-12|||November 2002||2002-11-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Improving Diabetes Efforts Across Language and Literacy (IDEALL)|Improving Diabetes Efforts Across Language and Literacy (IDEALL)|Completed||N/A|339|Actual|Agency for Healthcare Research and Quality (AHRQ)||3|||f||||f||||||||||2017-02-18 17:09:09.676183|2017-02-18 17:09:09.676183
NCT00214461|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-04-09|2012-03-13||November 2005||2005-11-01|April 2012|2012-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers|A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of the Safety, Tolerability and Immunogenicity of a Clostridium Difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Elderly Volunteers (> or =65 Years)|Completed||Phase 1|48|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 17:09:09.800231|2017-02-18 17:09:09.800231
NCT00214448|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2006-07-13||||||September 2005|2005-09-01||||||||Observational|||Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples|Reproducibility of the GeneTrait™ CGH Microarray System DX Using Whole Blood Samples|Unknown status|Not yet recruiting|N/A|4||Abbott Molecular|||||||||||||||||||2017-02-18 17:09:13.494049|2017-02-18 17:09:13.494049
NCT00214435|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-10-21|||May 2004||2004-05-01|September 2005|2005-09-01||||||||Interventional|||Once Daily 3TC, Efavirenz and ddI for HIV Infection|A Randomised, Multi-Centre, Open-Label Study in Well-Controlled Treatment-Experienced HIV-Infected Patients to Assess Compliance With a Once-Daily Regimen of Lamivudine, Efavirenz and Didanosine Versus Continuation of Current Anti-Retroviral Regimen Delivered at Least Twice Daily|Unknown status|Recruiting|Phase 4|120||407 Doctors|||||f||||||||||||||2017-02-18 17:09:13.550145|2017-02-18 17:09:13.550145
NCT00214422|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||September 15, 2005||2005-09-15|September 26, 2016|2016-09-26|May 27, 2014|Actual|2014-05-27|May 27, 2014|Actual|2014-05-27||Interventional|||Intensity Modulated Radiation Therapy for Prostate Cancer|A Pilot Study of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Therapy (IMRT) in Prostate Cancer|Completed||Phase 1|19|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 17:09:13.652649|2017-02-18 17:09:13.652649
NCT00214383|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-16|2012-04-04||May 2004||2004-05-01|January 2013|2013-01-01|May 2009|Actual|2009-05-01|August 2007|Actual|2007-08-01||Interventional|CHESS||Internet Telehealth for Pediatric Asthma Case Management|Internet Telehealth for Pediatric Asthma Case Management|Completed||N/A|301|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:09:13.761417|2017-02-18 17:09:13.761417
NCT00214019|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-06-24|2011-08-17||November 2003||2003-11-01|June 2016|2016-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||The Effect of Salmeterol on Eosinophil (EOS) Function|The Effect of Salmeterol on Eosinophil (EOS) Function|Completed||N/A|36|Actual|University of Wisconsin, Madison||4|||f||||f||||||||Yes||2017-02-18 17:09:15.994445|2017-02-18 17:09:15.994445
NCT00214370|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-10-01|||July 2004||2004-07-01|July 2007|2007-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma|Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma|Completed||N/A|40|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:14.138489|2017-02-18 17:09:14.138489
NCT00214357|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-10-01|||October 2004||2004-10-01|November 2008|2008-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||The Effects of Mindfulness Training on School Staff|The Effects of Mindfulness Training on School Staff Emotions, Attention, and Stress|Completed||N/A|19||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:14.228317|2017-02-18 17:09:14.228317
NCT00214344|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-10-01|||October 2003||2003-10-01|September 2005|2005-09-01|February 2007|Actual|2007-02-01|||||Interventional|||Family Preparation Study For Withdrawal of Mechanical Ventilation From Their Family Member|Evaluating the Usefulness of Preparing Families For Withdrawal of Mechanical Ventilation From Their Family Member: A Pilot Study|Completed||Phase 2|20||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:14.556784|2017-02-18 17:09:14.556784
NCT00214331|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-10-25|||April 2003||2003-04-01|October 2016|2016-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy|Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy|Completed||Phase 4|150|Actual|University of Wisconsin, Madison|||3||f||||t||||||||||2017-02-18 17:09:14.658818|2017-02-18 17:09:14.658818
NCT00214318|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-10-06|||January 2005||2005-01-01|October 2015|2015-10-01|February 2007|Actual|2007-02-01|||||Interventional|||Beta-2 Polymorphisms and Beta Receptor Selectivity|The Effects of ß2 Polymorphisms on Beta Selectivity After ß-adrenergic Blockade in Patients With Heart Failure|Completed||N/A|25||University of Wisconsin, Madison|||||f||||f||||||||||2017-02-18 17:09:14.745749|2017-02-18 17:09:14.745749
NCT00214305|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-30|||August 2005||2005-08-01|September 2015|2015-09-01||||||||Interventional|||Effects of Swallowing Therapy in Head and Neck Cancer|Effects of Swallowing Therapy in Head and Neck Cancer|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison||2||low accrual|f||||t||||||||||2017-02-18 17:09:14.831363|2017-02-18 17:09:14.831363
NCT00214292|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-01-28|||May 2005||2005-05-01|January 2016|2016-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy|A Pilot Study of Intraoperative Margin Assessment Comparing Optical Spectroscopy and Frozen Section Analysis for Ductal Carcinoma In Situ of the Breast|Completed||N/A|20|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:14.934824|2017-02-18 17:09:14.934824
NCT00214149|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||October 2004||2004-10-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|April 2008|Actual|2008-04-01||Interventional|||Multi-catheter High Dose Rate (HDR) Breast Brachytherapy|A UW Phase II Trial of Multi-catheter HDR Brachytherapy Following Lumpectomy for Early Stage Breast Breast Cancer|Terminated||Phase 2|127|Actual|University of Wisconsin, Madison||1||lost funding|f||||t||||||||||2017-02-18 17:09:15.020002|2017-02-18 17:09:15.020002
NCT00214136|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-18|||March 2005||2005-03-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes|A Phase II Prostate Cancer Trial Treating Pelvic Lymph Nodes to High Dose Using Intensity Modulated Radiation Therapy|Completed||Phase 2|30|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 17:09:15.111764|2017-02-18 17:09:15.111764
NCT00214123|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-22|||June 2004||2004-06-01|July 2015|2015-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Hypofractionated Radiotherapy for Lung Cancer|The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer|Completed||Phase 1|79|Actual|University of Wisconsin, Madison||5|||f||||t||||||||||2017-02-18 17:09:15.218997|2017-02-18 17:09:15.218997
NCT00214110|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||January 2001||2001-01-01|August 2008|2008-08-01|January 2005|Actual|2005-01-01|||||Interventional|||Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]|Phase 2 Randomized Single-blind Escalating Dose Response Clinical Trial of Tamoxifen Therapy on Mean Percent Predicted Isometric Strength in Amyotrophic Lateral Sclerosis [ALS]|Completed||Phase 2|100||University of Wisconsin, Madison|||||f||||t||||||||||2017-02-18 17:09:15.318753|2017-02-18 17:09:15.318753
NCT00214097|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-06-17|||August 2002||2002-08-01|June 2016|2016-06-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Phase I/II Hypofractionated Radiotherapy for Prostate Cancer|Phase I/II Trial Examining Dose-per-Fraction Escalation Using Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|309|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 17:09:15.407068|2017-02-18 17:09:15.407068
NCT00214084|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-06||||||October 2015|2015-10-01||||||||Interventional|||Vascular Pathophysiology in Obstructive Sleep Apnea|Influence of Xanthine Oxidase Inhibition on Vascular Function in Obstructive Sleep Apnea|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:15.500361|2017-02-18 17:09:15.500361
NCT00214071|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||October 2004||2004-10-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Immunological Consequences of Obstructive Sleep Apnea|Influence of Obstructive Sleep Apnea on Humoral and Cell-Mediated Vaccine Responses|Completed||N/A|30||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:15.610536|2017-02-18 17:09:15.610536
NCT00214058|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-30|||August 2002||2002-08-01|June 2008|2008-06-01|February 2006|Actual|2006-02-01|||||Interventional|||Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer|Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma|Completed||Phase 2|36||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:15.693966|2017-02-18 17:09:15.693966
NCT00214045|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-19|||July 2004||2004-07-01|October 2012|2012-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Rigid Versus Flexible Cystoscopy in Women|Rigid Versus Flexible Cystoscopy in Women in Outpatient Clinic|Completed||N/A|36|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 17:09:15.776869|2017-02-18 17:09:15.776869
NCT00214032|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||May 2002||2002-05-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|November 2006|Actual|2006-11-01||Interventional|||Pycnogenol for the Treatment of Lymphedema|Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo|Completed||Phase 2|2|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-02-18 17:09:15.879798|2017-02-18 17:09:15.879798
NCT00213993|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||May 2005||2005-05-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Topical Antiperspirant for Hand-Foot Syndrome|Topical Antiperspirant for Prevention of Palmar-Plantar Erythrodysesthesia (Hand-Foot Syndrome) Associated With Capecitabine|Completed||Phase 2|14|Actual|University of Wisconsin, Madison||1|||f||||||||||||||2017-02-18 17:09:16.347418|2017-02-18 17:09:16.347418
NCT00213980|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-16|||January 2000||2000-01-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer|Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer|Completed||Phase 2|74|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:09:16.44017|2017-02-18 17:09:16.44017
NCT00213967|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||October 2005||2005-10-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection|The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection|Completed||N/A|80|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:09:16.552956|2017-02-18 17:09:16.552956
NCT00213954|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-24|||May 2005||2005-05-01|February 2009|2009-02-01|September 2009|Anticipated|2009-09-01|March 2009|Anticipated|2009-03-01||Interventional|||Ultrasound Guidance in Nerve Block Anaesthesia|Ultrasound Guidance in Nerve Block Anaesthesia: Classic Nerve Stimulation Technique Versus Ultrasound-Neurostimulation Combination in Four Blocks: Interscalene, Humeral, Parasacral and Lumbar Blocks|Unknown status|Active, not recruiting|N/A|1002|Anticipated|University Hospital, Strasbourg, France||4|||f||||f||||||||||2017-02-18 17:09:16.641732|2017-02-18 17:09:16.641732
NCT00213941|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-02|||November 2004||2004-11-01|October 2006|2006-10-01||||||||Interventional|||Study Protocol Evaluating Transient Tachypnoea of the Newborn in Term and Near Term Neonates|Study Protocol Evaluating Transient Tachypnoea of the Newborn in Term and Near Term Neonates|Unknown status|Recruiting|N/A|100||University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 17:09:16.975643|2017-02-18 17:09:16.975643
NCT00213928|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-29|||May 2002||2002-05-01|July 2011|2011-07-01|September 2008|Actual|2008-09-01|September 2004|Actual|2004-09-01||Interventional|||Horse Chestnut Seed Extract for Lymphedema|A Single-blind, Randomized Trial of Horse Chestnut Seed Extract for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors|Completed||Phase 2|56|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 17:09:17.061394|2017-02-18 17:09:17.061394
NCT00213915|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-28|||February 2004||2004-02-01|November 2007|2007-11-01|December 2004||2004-12-01|||||Interventional|||L-Arginine Supplementation and Exercise; L-Arginine Supplementation and Renal Function|Effects of Oral Chronic L-Arginine Supplementation on Exercise and Renal Function of Heart Transplant Recipients|Completed||Phase 4|30||University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 17:09:17.162185|2017-02-18 17:09:17.162185
NCT00213902|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-28|||April 2004||2004-04-01|November 2007|2007-11-01||||||||Observational|||Clonidine and Left Ventricular Dysfunction|Evaluation of Effects of Central Sympathetic Inhibition in Elderly With Left Ventricular Diastolic Dysfunction and Preserved Ejection Fraction: A Proof-of-Concept Trial With Clonidine|Withdrawn||Phase 2|70|Anticipated|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 17:09:17.244838|2017-02-18 17:09:17.244838
NCT00213889|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-26|||February 2003||2003-02-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||TWIST Human Gene and Cleft Lips and Palates|TWIST Human Gene and Cleft Lips and Palates|Terminated||N/A|45|Actual|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-02-18 17:09:17.314165|2017-02-18 17:09:17.314165
NCT00213876|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-29|||February 2004||2004-02-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Observational|||Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours|Research of Molecular and Metabolic Diagnostic Markers in Oligodendrogliomas A and B Comparatively.|Completed||N/A|189|Actual|University Hospital, Strasbourg, France|||1||f||||||||||||||2017-02-18 17:09:17.418299|2017-02-18 17:09:17.418299
NCT00213863|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-28|||December 2010||2010-12-01|June 2012|2012-06-01|November 2016|Anticipated|2016-11-01|May 2016|Anticipated|2016-05-01||Interventional|||Implantation of Porous Titanium Prosthesis in Laryngeal Surgery|Implantation of Porous Titanium Prosthesis in Laryngeal Surgery|Unknown status|Recruiting|Phase 2|10|Anticipated|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-02-18 17:09:17.490097|2017-02-18 17:09:17.490097
NCT00213850|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-28|||January 2002||2002-01-01|November 2007|2007-11-01|September 2006||2006-09-01|||||Interventional|||Reference Values for Respiratory Resistance Measured by the Interrupter Technique in Adults|Reference Values for Respiratory Resistance Measured by the Interrupter Technique in Adults|Completed||N/A|122|Actual|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 17:09:17.580163|2017-02-18 17:09:17.580163
NCT00213837|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-24|||October 2003||2003-10-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Reconstruction Implant Bone After Removal Using Porous Titanium Prosthesis|Reconstruction Implant Bone (Anterior Mandibular Arch) After Removing Using Porous Titanium Prosthesis in ENT Surgery|Completed||Phase 2|7|Actual|University Hospital, Strasbourg, France||1|||f||||f||||||||||2017-02-18 17:09:17.656251|2017-02-18 17:09:17.656251
NCT00213824|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-26|||February 2004||2004-02-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Observational|||A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis|A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis|Terminated||N/A|79|Actual|University Hospital, Strasbourg, France|||1||f||||||||||None Retained|"~     tissue (skeletal muscle)~   "|||2017-02-18 17:09:17.750752|2017-02-18 17:09:17.750752
NCT00213811|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-08-07|||June 2003||2003-06-01|August 2008|2008-08-01||||||||Observational|||Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults|Bardet-Biedl Syndrome: Clinical and Genetic Epidemiology Study in the Adults|Completed||N/A|40||University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 17:09:17.830336|2017-02-18 17:09:17.830336
NCT00213798|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-29|||December 2003||2003-12-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Interventional|||Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients|Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.|Completed||N/A|200|Anticipated|University Hospital, Strasbourg, France||1|||f||||||||||||||2017-02-18 17:09:17.922616|2017-02-18 17:09:17.922616
NCT00005419|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-08|||March 1992||1992-03-01|January 2016|2016-01-01|February 1994||1994-02-01|||||Observational|||Physical Activity, Hypertension, Diabetes, and Coronary Heart Disease||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 18:15:01.091024|2017-02-18 18:15:01.091024
NCT00213785|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-28|||November 2001||2001-11-01|November 2007|2007-11-01|March 2004||2004-03-01|||||Observational|||A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.|A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.|Completed||N/A|14|Actual|University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 17:09:18.010256|2017-02-18 17:09:18.010256
NCT00213772|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 1999||1999-05-01|September 2005|2005-09-01||||||||Observational|||Risk Factors of Porphyria Cutanea Tarda (PCT)|“Factors Associated With Porphyria Cutanea Tarda in Patients Infected With Hepatitis C Virus”|Completed||N/A|280||University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 17:09:18.088422|2017-02-18 17:09:18.088422
NCT00213759|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-28|||March 2002||2002-03-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|||||Interventional|||Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF|Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF|Completed||Phase 3|200|Actual|University Hospital, Strasbourg, France||2|||f||||||||||||||2017-02-18 17:09:18.151516|2017-02-18 17:09:18.151516
NCT00213746|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||October 2003||2003-10-01|June 2013|2013-06-01|December 2005||2005-12-01|||||Observational|||Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)|Prediction of Left Ventricular Function Changes Using Low Dose Dobutamine Gated SPECT in Patients Referred for Viability Assessment: The DOGS (DObutamine Gated Spect)Study.|Completed||N/A|75||University Hospital, Rouen|||||f||||f||||||||||2017-02-18 17:09:18.255263|2017-02-18 17:09:18.255263
NCT00213733|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-29|||June 2004||2004-06-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|||||Observational|||Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer|Research of Molecular Markers for Diagnosis and/or Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer|Completed||N/A|150|Anticipated|University Hospital, Strasbourg, France|||1||f||||||||||||||2017-02-18 17:09:18.353393|2017-02-18 17:09:18.353393
NCT00213720|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-19|||August 2005||2005-08-01|November 2007|2007-11-01||||||||Observational|||Treatment of Subclinical Hyperthyroidism|Place de l'Iode RadioActif Dans l'HyperThyroïdiE Sub-clinique (PIRHATES)/ Evaluation of the Interest of Subclinical Hyperthyroidism Treatment|Unknown status|Recruiting|Phase 4|300|Anticipated|University Hospital, Strasbourg, France|||1||f||||||||||Samples Without DNA|"~     serum~   "|||2017-02-18 17:09:18.438419|2017-02-18 17:09:18.438419
NCT00213707|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-24|||May 2003||2003-05-01|February 2009|2009-02-01|May 2011|Anticipated|2011-05-01|May 2010|Anticipated|2010-05-01||Observational|||Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.|Liver Transplanted Patients for HCV Related End Stage Liver Disease.Functional Role of Blood Circulating Dendritic Cells in the Pathogenesis of Hepatitis C Virus Infection During Liver Transplantation.|Unknown status|Active, not recruiting|N/A|30|Anticipated|University Hospital, Strasbourg, France|||1||f||||f||||||Samples With DNA|"~     Serum peripheral blood mononuclear cells~   "|||2017-02-18 17:09:18.550837|2017-02-18 17:09:18.550837
NCT00213304|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-08-15|||June 1999||1999-06-01|August 2013|2013-08-01||||||||Interventional|||The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation|Safety and Immunogenicity of Live Attenuated Oka/Merck Varicella Vaccine in Children Listed to Undergo Solid Organ Transplantation|Unknown status|Active, not recruiting|Phase 3|150||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:09:18.639341|2017-02-18 17:09:18.639341
NCT00213291|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-23|||April 2005||2005-04-01|August 2013|2013-08-01|October 2005||2005-10-01|September 2005|Actual|2005-09-01||Interventional|||Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure|Extended Dosing of Darbepoetin Alfa (Aranesp) for the Management of Anemia in Children With Chronic Renal Failure|Completed||Phase 3|40|Anticipated|The Hospital for Sick Children||1|||f||||f||||||||||2017-02-18 17:09:18.729373|2017-02-18 17:09:18.729373
NCT00213278|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-11-19|||January 2002||2002-01-01|November 2014|2014-11-01|September 2012|Actual|2012-09-01|September 2011|Actual|2011-09-01||Interventional|||Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma|A Phase 2 Study of Vinblastine Sulphate Injection in Children With Recurrent or Refractory Low Grade Glioma|Completed||Phase 2|50|Actual|The Hospital for Sick Children||1|||f||||t||||||||||2017-02-18 17:09:18.838226|2017-02-18 17:09:18.838226
NCT00213265|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-15|||July 2002||2002-07-01|August 2013|2013-08-01||||||||Interventional|||Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants|Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Among Solid Organ Transplant Recipients: Protocol 1A and 1B|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 17:09:18.938031|2017-02-18 17:09:18.938031
NCT00213252|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-12|||September 2005||2005-09-01|May 2014|2014-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma|Can Montelukast Shorten Corticosteroid Therapy In Children With Mild To Moderate Acute Asthma?|Completed||Phase 2|130|Actual|The Hospital for Sick Children||2|||f||||t||||||||||2017-02-18 17:09:19.048059|2017-02-18 17:09:19.048059
NCT00213239|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-19|||September 2005||2005-09-01|August 2013|2013-08-01|January 2008|Actual|2008-01-01|September 2007|Actual|2007-09-01||Interventional|||A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children|The Minimum Effective Dose of Remifentanil When Co-administered With Propofol for Lumbar Puncture in Children: A Dose-finding Study|Completed||Phase 1/Phase 2|64|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 17:09:19.159571|2017-02-18 17:09:19.159571
NCT00213226|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-12|||December 2001||2001-12-01|May 2014|2014-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Single Dose Versus Multiple Doses of Dexamethasone in Children With Acute Bronchiolitis|Efficacy of Single Dose Versus Multiple Doses of Dexamethasone in Outpatients With Acute Bronchiolitis|Completed||Phase 3|120|Anticipated|The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:09:19.27486|2017-02-18 17:09:19.27486
NCT00213213|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-11|||July 2003||2003-07-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Using Sugar Water to Relieve Pain in Infants|Effectiveness of Sucrose Analgesia in Reducing Pain Responses in Infants Born to Diabetic and Non-diabetic Mothers: A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|240||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:09:19.36552|2017-02-18 17:09:19.36552
NCT00213200|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-10|||July 2003||2003-07-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Intravenous and Topical Analgesics for Procedural Pain in Neonates|Systemic Analgesia and Local Anaesthesia for Percutaneous Venous Catheter Placement in Preterm Neonates|Completed||Phase 3|108||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:09:19.459542|2017-02-18 17:09:19.459542
NCT00213187|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-17|||August 2002||2002-08-01|December 2013|2013-12-01|November 2005||2005-11-01|||||Interventional|||PEAK Study (Physical Exercise and Activity in Kids)|The Effect of Vigorous Exercise on Motor Function and Functional Fitness in Juvenile Arthritis|Completed||Phase 2|80||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:09:19.54699|2017-02-18 17:09:19.54699
NCT00213174|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-14|||January 2005||2005-01-01|August 2013|2013-08-01||||||||Interventional|||Study of Sand Versus Wood Chip Surfaces on School Playgrounds to Minimize Injury in School Children|School Playground Surfacing - A Randomized Prospective Comparison of Injury Rates on Sand Versus Wood Chip Surfaces|Unknown status|Recruiting|Phase 3|34|Anticipated|The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:09:19.643853|2017-02-18 17:09:19.643853
NCT00213161|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-10|||August 2004||2004-08-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in India|Establishing an Iron Supplementation Strategy to Reduce the Prevalence of Iron Deficiency Anemia Among Infants and Young Children in India.|Completed||N/A|425||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:09:19.975282|2017-02-18 17:09:19.975282
NCT00213148|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-08-05|||March 2005||2005-03-01|August 2014|2014-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction|A Phase II, Prospective, Randomized, Double-Blind, Multicenter, Dose Finding, Comparative Study for the Evaluation of the Aromatase Inhibitor Anastrozole (Multiple-Dose) Versus Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction|Completed||Phase 2|271|Actual|EMD Serono||4|||f||||||||||||||2017-02-18 17:09:20.081689|2017-02-18 17:09:20.081689
NCT00213135|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-01-10|2013-09-30||April 2005||2005-04-01|January 2014|2014-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|CLARITY||A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)|A Phase III, Randomized, Double-blind, Three-arm, Placebo-controlled, Multi-center Study to Evaluate the Safety and Efficacy of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)|Completed||Phase 3|1326|Actual|EMD Serono||3|||f||||||||||||||2017-02-18 17:09:20.201063|2017-02-18 17:09:20.201063
NCT00211302|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-09-02|||August 2003||2003-08-01|September 2011|2011-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)|Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia. (BMS)|Terminated||N/A|8|Actual|Louisiana State University Health Sciences Center Shreveport||1||Enrollment too difficult|f||||f||||||||||2017-02-18 17:09:21.20693|2017-02-18 17:09:21.20693
NCT00211289|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-14|||July 2002||2002-07-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||Trial of Education and Compliance in Heart Dysfunction (TEACH)|Trial of Education and Compliance in Heart Dysfunction. A Study Measuring the Impact of Multi-Disciplinary Education as an Intervention to Increase Patient Concordance and the Cost Effectiveness of Treatment in Patients With Heart Dysfunction|Unknown status|Recruiting|Phase 3|383|Anticipated|London Health Sciences Centre|||||f||||||||||||||2017-02-18 17:09:21.31583|2017-02-18 17:09:21.31583
NCT00213694|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-04|||November 2003||2003-11-01|March 2013|2013-03-01|June 2006||2006-06-01|||||Observational|||PROSTACOX : Metastatic Prostate Chemotherapy|Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer|Completed||Phase 2|52||University Hospital, Rouen|||||f||||||||||||||2017-02-18 17:09:21.414628|2017-02-18 17:09:21.414628
NCT00213681|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-06-17|||November 2002||2002-11-01|June 2013|2013-06-01|March 2005||2005-03-01|||||Interventional|||CPAP Versus Bilevel Pressure Support Ventilation in Cardiogenic Pulmonary Edema|CPAP Boussignac Versus Bilevel Pressure Support Ventilation in Severe Acute Cardiogenic Pulmonary Edema|Completed||Phase 3|||University Hospital, Rouen|||||f||||||||||||||2017-02-18 17:09:21.496577|2017-02-18 17:09:21.496577
NCT00213668|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||April 2002||2002-04-01|June 2013|2013-06-01||||||||Interventional|||Effect of Glutamine on Gastric Emptying and Length of Parenteral Nutrition in Premature Neonates|Effect of Glutamine on Gastric Emptying and Length of Parenteral Nutrition in Premature Neonates|Completed||Phase 4|||University Hospital, Rouen|||||f||||||||||||||2017-02-18 17:09:21.582416|2017-02-18 17:09:21.582416
NCT00213655|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-07-30|||June 2004||2004-06-01|July 2014|2014-07-01|December 2013|Actual|2013-12-01|May 2013|Actual|2013-05-01||Observational|||URO-BCG-4 : Bladder Tumors Immunotherapy|Clinical Evaluation of Maintenance BCG Immunotherapy in Superficial Bladder Tumors|Completed||Phase 3|146|Actual|University Hospital, Rouen|||2||f||||f||||||||||2017-02-18 17:09:21.669504|2017-02-18 17:09:21.669504
NCT00213642|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||July 2001||2001-07-01|June 2013|2013-06-01|August 2004||2004-08-01|||||Observational|||Tc-99m Renography and Cisplatin-induced Nephrotoxicity|Value of Tc-99m Renography for Early Diagnosis of Cisplatin-induced Renal Toxicity|Terminated||N/A|20||University Hospital, Rouen|||||f||||f||||||||||2017-02-18 17:09:21.762725|2017-02-18 17:09:21.762725
NCT00213629|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-14|||November 2004||2004-11-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|MYOARRAY||myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies|Transcriptome Analysis Through a Dedicated Macro-array and TcLandscape Repertoire Analysis for Diagnosis of Myositis.|Completed||N/A|100|Actual|University Hospital, Rouen||1|||f||||t||||||||||2017-02-18 17:09:21.836083|2017-02-18 17:09:21.836083
NCT00213616|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||March 2004||2004-03-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Bilateral Laryngeal Paralysis Reinnervation|Bilateral Laryngeal Paralysis Reinnervation. Speech and Ventilatory Results Analysis|Completed||N/A|10|Actual|University Hospital, Rouen||1|||f||||t||||||||||2017-02-18 17:09:21.938123|2017-02-18 17:09:21.938123
NCT00213603|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-17|||April 2002||2002-04-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Observational|||Follow-up Modalities of Low Grade Precancerous Bronchial Lesions|Endoscopic Follow-up of Low Grade Precancerous Bronchial Lesions in High Risk Patients (SELEPREBB1)|Completed||N/A|365|Actual|University Hospital, Rouen|||1||f||||t||||||Samples Without DNA|"~     bronchial biopsies (fixed samples)~   "|||2017-02-18 17:09:22.029045|2017-02-18 17:09:22.029045
NCT00213590|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-14|||April 2000||2000-04-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|DICAM||Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients|A Multicentric, Randomized, Opened Study to Evaluate Efficacy on Renal Function of an Immunosuppressant Regimen Based on Cyclosporine A Dose Reduction in Combination With Mycophenolate Mofetil, From the Second Year of Renal Transplantation|Completed||Phase 3|208|Actual|University Hospital, Rouen||2|||f||||t||||||||||2017-02-18 17:09:22.113939|2017-02-18 17:09:22.113939
NCT00213577|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-23|||December 2003||2003-12-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder|Evaluation of the Efficacy and Tolerance of 2 Dosages of Type A Botulinic Toxin in Neurogenic Areactive Bladder Resistant to Oral Medical Treatment|Terminated||Phase 2|80|Actual|University Hospital, Rouen||1||the study has concluded normally;|f||||t||||||||||2017-02-18 17:09:22.21159|2017-02-18 17:09:22.21159
NCT00213564|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-25|||April 2003||2003-04-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|May 2004|Actual|2004-05-01||Observational|||Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis|Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis|Completed||Phase 4|40|Anticipated|University Hospital, Rouen|||||f||||f||||||||||2017-02-18 17:09:22.300941|2017-02-18 17:09:22.300941
NCT00213551|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||April 2004||2004-04-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|||||Interventional|||Glutamine and Intestinal Protein Metabolism|Comparative Effects of Glutamine and Glucose on Intestinal Protein Metabolism in Healthy Humans|Completed||Phase 1|30|Anticipated|University Hospital, Rouen|||||f||||||||||||||2017-02-18 17:09:22.381288|2017-02-18 17:09:22.381288
NCT00213538|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-22|||June 2003||2003-06-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis|Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis|Active, not recruiting||Phase 4|341|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-02-18 17:09:22.460221|2017-02-18 17:09:22.460221
NCT00213525|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-02-04|||October 2004||2004-10-01|February 2015|2015-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls|Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Healthy Controls|Completed||N/A|300|Actual|University Hospital, Rouen|||2||f||||f||||||||||2017-02-18 17:09:22.540125|2017-02-18 17:09:22.540125
NCT00213512|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||June 2003||2003-06-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|June 2006|Actual|2006-06-01||Interventional|||Effect of Anti CD20 in Pemphigus Desease|Traitment of Patients Presenting Pemphigus With Anti CD20 (Mabthera).|Completed||Phase 2/Phase 3|22||University Hospital, Rouen|||||f||||f||||||||||2017-02-18 17:09:22.633343|2017-02-18 17:09:22.633343
NCT00213499|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-14|||January 2002||2002-01-01|February 2012|2012-02-01|September 2008|Actual|2008-09-01|April 2006|Actual|2006-04-01||Interventional|VENISE||Non Invasive Ventilation and Weaning : VENISE Trial|Randomized Prospective Multicenter Study of Non Invasive Ventilation Assessment for Weaning From Mechanical Ventilation in Patients With Chronic Respiratory Failure. NIV and Weaning (VENISE)Trial.|Completed||N/A|205||University Hospital, Rouen|||||f||||t||||||||||2017-02-18 17:09:22.959761|2017-02-18 17:09:22.959761
NCT00213486|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-10-27|||June 2002||2002-06-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial|Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial|Completed||Phase 2|43||University Hospital, Rouen|||||f||||||||||||||2017-02-18 17:09:23.049925|2017-02-18 17:09:23.049925
NCT00213473|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||June 2001||2001-06-01|June 2013|2013-06-01|May 2006||2006-05-01|||||Observational|||Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study|Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study|Completed||N/A|81|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-02-18 17:09:23.152129|2017-02-18 17:09:23.152129
NCT00213460|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-04-15|||August 2001||2001-08-01|April 2013|2013-04-01|July 2003|Actual|2003-07-01|||||Observational|||Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up|Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-up|Completed||N/A|||University Hospital, Rouen|||||f||||||||||||||2017-02-18 17:09:23.232785|2017-02-18 17:09:23.232785
NCT00213447|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||November 2002||2002-11-01|June 2013|2013-06-01|December 2005||2005-12-01|||||Observational|||T Cell Response in Hypersensitivity Syndrome|Characterization of T Cell Response in Hypersensitivity Syndrome|Completed||N/A|40|Anticipated|University Hospital, Rouen|||1||f||||f||||||||||2017-02-18 17:09:23.307415|2017-02-18 17:09:23.307415
NCT00213434|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-25|||November 2001||2001-11-01|June 2013|2013-06-01|June 2006|Actual|2006-06-01|December 2004|Actual|2004-12-01||Interventional|||Evaluation of a Mandibular Advancement Device in the Treatment of Obstructive Sleep Apnea Syndrome|Prospective Evaluation of Mandibular Advancement by Herbst Device in the Treatment of Moderate Obstructive Sleep Apnea Syndrome|Completed||N/A|||University Hospital, Rouen|||||f||||||||||||||2017-02-18 17:09:23.37794|2017-02-18 17:09:23.37794
NCT00213421|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||August 2001||2001-08-01|June 2013|2013-06-01|November 2008|Actual|2008-11-01|October 2004|Actual|2004-10-01||Observational|||Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus||Completed||Phase 4|330|Actual|University Hospital, Rouen|||2||f||||||||||||||2017-02-18 17:09:23.466856|2017-02-18 17:09:23.466856
NCT00213408|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||June 2001||2001-06-01|June 2013|2013-06-01|January 2007|Actual|2007-01-01|||||Interventional|||Catheter Ablation as the First Line Therapy for Typical Atrial Flutter|Catheter Ablation as the First Line Therapy for Symptomatic Typical Atrial Flutter: A Multicenter Randomized Study of Cost/Effectiveness|Terminated||Phase 4|120||University Hospital, Rouen||||end of the follow-up period|f||||||||||||||2017-02-18 17:09:23.550998|2017-02-18 17:09:23.550998
NCT00213395|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-14|||October 2004||2004-10-01|February 2012|2012-02-01|February 2006||2006-02-01|||||Interventional|||Clinical Efficacy of a Cephalic Mask for Noninvasive Ventilation During Acute Hypercapnic Respiratory Failure||Terminated||N/A|||University Hospital, Rouen|||||f||||||||||||||2017-02-18 17:09:23.638209|2017-02-18 17:09:23.638209
NCT00213382|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-23|||February 2005||2005-02-01|February 2011|2011-02-01||||||||Observational|||Cortical Pharyngeal Area: Excitability, Facilitation and Plasticity in Healthy Subjects|Cortical Pharyngeal Area: Excitability, Facilitation and Plasticity in Healthy Subjects|Completed||N/A|10|Anticipated|University Hospital, Rouen|||1||f||||||||||||||2017-02-18 17:09:23.720977|2017-02-18 17:09:23.720977
NCT00213356|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||April 2003||2003-04-01|June 2013|2013-06-01|March 2004||2004-03-01|||||Observational|||Study of the Nervous Control of the Anal Sphincter|Evoked Responses of External Anal Sphincter After Cortical and Lombo-sacral Magnetic Stimulations|Withdrawn||N/A|0|Actual|University Hospital, Rouen|||1|patients with neurological disease not included|f||||f||||||||||2017-02-18 17:09:23.867951|2017-02-18 17:09:23.867951
NCT00213343|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||May 2005||2005-05-01|June 2013|2013-06-01|July 2005|Actual|2005-07-01|June 2005|Actual|2005-06-01||Observational|||Effects of Phrenic Nerve Stimulation During Swallowing : Experimental Model of Aspiration|Effects of Phrenic Nerve Stimulation During Swallowing : Experimental Model of Aspiration|Terminated||N/A|30|Actual|University Hospital, Rouen|||1|dyspnea|f||||f||||||||||2017-02-18 17:09:23.947476|2017-02-18 17:09:23.947476
NCT00213330|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-20|||April 2003||2003-04-01|April 2012|2012-04-01|February 2006||2006-02-01|||||Observational|||Cerebral Resonance Magnetic Imaging During Rectal Distention|Cerebral Activity During Rectal Pain in Patients With Irritable Bowel Syndrome or Inflammatory Bowel Disease:Resonance Magnetic Imaging Study.|Withdrawn||N/A|0|Actual|University Hospital, Rouen|||1|patients with inflammatory colitis not included|f||||||||||||||2017-02-18 17:09:24.033284|2017-02-18 17:09:24.033284
NCT00213317|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-14|||April 2005||2005-04-01|February 2012|2012-02-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Observational|||Effect of Lumbo-sacral Magnetic Stimulation on Colonic Motility|Could Lumbo-sacral Magnetic Stimulation Modify Recto-colonic Motility?|Completed||N/A|30|Actual|University Hospital, Rouen|||1||f||||f||||||||||2017-02-18 17:09:24.119673|2017-02-18 17:09:24.119673
NCT00213122|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-25||||||September 2006|2006-09-01||||||||Interventional|||Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 17:09:24.19455|2017-02-18 17:09:24.19455
NCT00213109|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-20||||||September 2006|2006-09-01||||||||Interventional|||Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 17:09:24.281444|2017-02-18 17:09:24.281444
NCT00213096|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-05-30|||March 2003||2003-03-01|May 2006|2006-05-01|February 2004||2004-02-01|||||Interventional|||Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral Contraceptive|A Randomized, Open-Label Study Comparing the Effect of a Contraceptive Vaginal Ring Delivering Daily Doses of 150 Micrograms Nestorone and 15 Micrograms Ethinyl Estradiol to an Oral Contraceptive Containing 150 Micrograms of Levonorgestrel and 30 Micrograms of Ethinyl Estradiol Per Tablet on Hepatic Factors Including Coagulation Factors|Completed||Phase 2|50||Population Council|||||||||||||||||||2017-02-18 17:09:24.380044|2017-02-18 17:09:24.380044
NCT00213083|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-14|||April 2004||2004-04-01|May 2012|2012-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission|Phase 3 Study of the Efficacy and Safety of the Microbicide Carraguard® in Preventing HIV Seroconversion in Women|Completed||Phase 3|6203||Population Council|||||f||||||||||||||2017-02-18 17:09:24.471601|2017-02-18 17:09:24.471601
NCT00213070|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-20||||||September 2006|2006-09-01||||||||Interventional|||Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment||Completed||Phase 3|||Sanwa Kagaku Kenkyusho Co., Ltd.|||||f||||||||||||||2017-02-18 17:09:24.582436|2017-02-18 17:09:24.582436
NCT00213057|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-21|||June 2001||2001-06-01|September 2002|2002-09-01|June 2002||2002-06-01|||||Interventional|||Safety and Acceptability of Carraguard™ Among HIV-Negative Couples in Thailand|A Randomized, Placebo-Controlled, Double-Blind Trial to Assess Expanded Safety and Acceptability of Carraguard™ (PC-515) Vaginal Gel Among Heterosexual Couples in Chiang Rai|Completed||Phase 1|110||Population Council|||||||||||||||||||2017-02-18 17:09:24.678214|2017-02-18 17:09:24.678214
NCT00213044|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-27|||March 2003||2003-03-01|May 2016|2016-05-01|June 2004||2004-06-01|||||Interventional|||A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women|A Randomized, Controlled, Double-Blind, Cross-Over Trial of Safety, Effect on Genital Tract HIV Shedding, and Acceptability of Vaginal Use of Carraguard by HIV-Infected Women|Completed||Phase 1|60||Population Council|||||||||||||||||||2017-02-18 17:09:24.772517|2017-02-18 17:09:24.772517
NCT00213031|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-05-10|||February 2000||2000-02-01|September 2002|2002-09-01|December 2001||2001-12-01|||||Interventional|||Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide|A Randomized, Placebo-Controlled, Double-Blind Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of PC-515 (Lambda Carrageenan) for Vaginal Use as a Possible Microbicide|Completed||Phase 2|165||Population Council|||||||||||||||||||2017-02-18 17:09:24.866026|2017-02-18 17:09:24.866026
NCT00213018|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-10-21|||October 1999||1999-10-01|September 2004|2004-09-01|January 2002||2002-01-01|||||Interventional|||Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission|A Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing STI/HIV Transmission|Completed||Phase 2|400||Population Council|||||||||||||||||||2017-02-18 17:09:24.965592|2017-02-18 17:09:24.965592
NCT00213005|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-21|||June 2002||2002-06-01|February 2005|2005-02-01|August 2003||2003-08-01|||||Interventional|||Safety and Acceptability of Carraguard® in HIV Positive Women and Men|A Phase 1 Safety and Acceptability Study of Carraguard® Among HIV Positive Women and Men in Durban, South Africa|Completed||Phase 1|60||Population Council|||||||||||||||||||2017-02-18 17:09:25.187127|2017-02-18 17:09:25.187127
NCT00212992|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-23|||March 2001|Actual|2001-03-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|September 2005|Actual|2005-09-01||Interventional|||Biphasic Defibrillation Study: Trial to Compare Fixed Versus Escalating Energy|A Pilot Randomized Controlled Trial to Compare Fixed Versus Escalating Energy Regimens for Biphasic Waveform Defibrillation|Completed||Phase 3|200||Ottawa Hospital Research Institute|||||f|||||f|f||||||No||2017-02-18 17:09:25.276659|2017-02-18 17:09:25.276659
NCT00212979|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-29|||April 2004||2004-04-01|February 2009|2009-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Measuring Kidney Function in Kidney Transplantation|The Accurate Prediction of Renal Function in Kidney Transplant Recipients|Completed||N/A|250|Anticipated|Ottawa Hospital Research Institute|||1||f||||||||||||||2017-02-18 17:09:25.377534|2017-02-18 17:09:25.377534
NCT00211588|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-04|||June 2004||2004-06-01|May 2007|2007-05-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Galantamine Executive Function in Parkinson's Disease|Investigator Initiated Study: Galantamine CR Potential Enhancement of Attentional and Executive Function in Non-Demented Patients With Parkinson's Disease|Unknown status|Active, not recruiting|N/A|90|Anticipated|Memorial Hospital of Rhode Island||1|||f||||t||||||||||2017-02-18 17:09:25.468306|2017-02-18 17:09:25.468306
NCT00211575|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-01-02|||May 2003||2003-05-01|January 2015|2015-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Instrument Utility for Suspected Asthma (0000-042)(COMPLETED)|Clinical Utility of an Instrument in the Evaluation of Young Children With Suspected Asthma|Completed||N/A|400|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:09:25.55821|2017-02-18 17:09:25.55821
NCT00211562|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-23|||October 2005||2005-10-01|October 2012|2012-10-01||||January 2006|Actual|2006-01-01||Interventional|||Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids|Reduction of Body Weight in Olanzapine Treated Schizophrenia Patients by Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids|Terminated||Phase 3|20|Actual|Augusta University||3|||f||||||||||||||2017-02-18 17:09:25.629642|2017-02-18 17:09:25.629642
NCT00211549|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-19|||June 2005||2005-06-01|March 2009|2009-03-01||||||||Interventional|||An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee|A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Doses of IDEA-033 in Comparison to Oral Naproxen for the Treatment of the Signs and Symptoms of Osteoarthritis of the Knee|Completed||Phase 2|875||IDEA AG|||||||||||||||||||2017-02-18 17:09:25.747773|2017-02-18 17:09:25.747773
NCT00211536|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-09-19|2011-04-25||June 2002||2002-06-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|August 2004|Actual|2004-08-01||Interventional|MIP310||Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration|A Randomized, Active Control, Multi-Center Study Comparing the Effect of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration on Glycemic Control and the Frequency of Severe Hypoglycemia|Completed||Phase 3|107|Actual|Medtronic Diabetes||2|||f||||f||||||||||2017-02-18 17:09:26.114969|2017-02-18 17:09:26.114969
NCT00211523|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 2000||2000-10-01|September 2005|2005-09-01|September 2001||2001-09-01|||||Interventional|||Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne|Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of MBI 226 2.5% and 5.0% Acne Solutions Applied Topically for 6 Weeks to Subjects With Acne Vulgaris|Completed||Phase 2|75||BioWest Therapeutics Inc|||||||||||||||||||2017-02-18 17:09:26.616939|2017-02-18 17:09:26.616939
NCT00211510|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-28|2011-04-01||June 2005||2005-06-01|April 2011|2011-04-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Interventional|STAR1||Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes|Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes: A Multi-center, Randomized Controlled Trial|Completed||Phase 3|146|Actual|Medtronic Diabetes||2|||f||||f||||||||||2017-02-18 17:09:26.704022|2017-02-18 17:09:26.704022
NCT00211497|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2003||2003-01-01|September 2005|2005-09-01|September 2003||2003-09-01|||||Interventional|||Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne|A Phase II, Randomized, Vehicle-Controlled, Double-Blind, Multi-Center Study to Evaluate Safety and Efficacy of MBI 226 1.25% and 2.5% Acne Solutions Applied Topically for 12 Weeks to Subjects With Acne Vulgaris|Completed||Phase 2|255||BioWest Therapeutics Inc|||||||||||||||||||2017-02-18 17:09:27.197386|2017-02-18 17:09:27.197386
NCT00211484|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-04|||May 2003||2003-05-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.||Completed||Phase 2|5|Actual|Manhattan Eye, Ear & Throat Hospital|||||t||||f||||||||||2017-02-18 17:09:27.286031|2017-02-18 17:09:27.286031
NCT00211471|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-04|||March 2002||2002-03-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).|Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension (15mg.).|Terminated||Phase 2|0|Actual|Manhattan Eye, Ear & Throat Hospital||||poor enrollment|t||||f||||||||||2017-02-18 17:09:27.37357|2017-02-18 17:09:27.37357
NCT00211458|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-24|||September 2005||2005-09-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Treatment of Age-Related Macular Degeneration With Anecortave Acetate|Treatment of Age-Related Macular Degeneration With Open-label Anecortave Acetate Sterile Suspension (15mg) Following Failed Treatment With Photodynamic Therapy With Visudyne|Completed||Phase 2|||Manhattan Eye, Ear & Throat Hospital|||||f||||f||||||||||2017-02-18 17:09:27.466428|2017-02-18 17:09:27.466428
NCT00211445|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-27|||July 2002||2002-07-01|September 2007|2007-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)||Completed||Phase 2|11|Actual|Manhattan Eye, Ear & Throat Hospital|||||f||||f||||||||||2017-02-18 17:09:27.553336|2017-02-18 17:09:27.553336
NCT00211432|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-24|||April 2008||2008-04-01|October 2012|2012-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)||Completed||Phase 2|4|Actual|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-02-18 17:09:27.646846|2017-02-18 17:09:27.646846
NCT00211419|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-23||||||September 2005|2005-09-01||||||||Interventional|||Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)|Pilot Study of the Combination of Anecortave Acetate 15mg Delivered by Posterior Juxtascleral Injection and Triamcinolone Acetonide 4mg Delivered by Intravitreal Injection for the Treatment of Exudative Age-Related Macular Degeneration (AMD)|Completed||Phase 1|||Manhattan Eye, Ear & Throat Hospital|||||||||||||||||||2017-02-18 17:09:27.740037|2017-02-18 17:09:27.740037
NCT00211406|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-06||||||May 2007|2007-05-01||||||||Interventional|||Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)||Terminated||Phase 1|||Manhattan Eye, Ear & Throat Hospital|||||f||||f||||||||||2017-02-18 17:09:27.81763|2017-02-18 17:09:27.81763
NCT00211393|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-24|||May 2005||2005-05-01|October 2012|2012-10-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|CSC/Keto||A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole|A Pilot Study of The Treatment of Central Serous Chorioretinopathy With Ketoconazole.|Completed||Phase 2|5|Actual|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-02-18 17:09:27.89452|2017-02-18 17:09:27.89452
NCT00211380|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-09-02|||August 2003||2003-08-01|September 2011|2011-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)|Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia, (SFBRI).|Terminated||N/A|8|Actual|Louisiana State University Health Sciences Center Shreveport||1||Recruitment was too difficult|f||||f||||||||||2017-02-18 17:09:27.992657|2017-02-18 17:09:27.992657
NCT00211354|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-03|||March 2002||2002-03-01|February 2009|2009-02-01|April 2007|Anticipated|2007-04-01|March 2007|Anticipated|2007-03-01||Interventional|||Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)||Withdrawn||Phase 2|0|Actual|Manhattan Eye, Ear & Throat Hospital||1||No subjects enrolled|t||||f||||||||||2017-02-18 17:09:28.18701|2017-02-18 17:09:28.18701
NCT00212966|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-19|||July 2004||2004-07-01|August 2010|2010-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Shared Mental Health Care Linking Mental Health Services With Family Medicine Groups|Shared Mental Health Care Linking General Hospital Acute Care Mental Health Services With Two Comprehensive Family Medicine Groups|Completed||N/A|350|Anticipated|Ottawa Hospital Research Institute|||1||f||||f||||||||||2017-02-18 17:09:28.290401|2017-02-18 17:09:28.290401
NCT00212953|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-10-13|||March 1997||1997-03-01|October 2010|2010-10-01|May 1999|Actual|1999-05-01|||||Interventional|||OPALS Critical Care Sub-Studies|Ontario Prehospital Advanced Life Support (OPALS) Study Phase III Cardiac Arrest and Critical Care Sub-Studies - Chest Pain Sub-Study, Respiratory Sub-Study, and Major Trauma Sub-Study|Completed||N/A|21000||Ottawa Hospital Research Institute|||||f||||f||||||||||2017-02-18 17:09:28.361778|2017-02-18 17:09:28.361778
NCT00212940|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-25|||October 2000||2000-10-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Supportive Therapy for Adherence to ART(STAART)|Increasing Patient Adherence to HIV Medications: A Prospective Intervention Study|Completed||N/A|112|Anticipated|Ottawa Hospital Research Institute|||||f||||||||||||||2017-02-18 17:09:28.451474|2017-02-18 17:09:28.451474
NCT00212927|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-08-31|||October 2002||2002-10-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Observational|||Continuity of Care and Outcomes After Discharge From Hospital|The Association of Provider Continuity and Information Continuity With Patient Outcomes After Discharge From Hospital|Completed||N/A|5900|Anticipated|Ottawa Hospital Research Institute|||||f||||f||||||||||2017-02-18 17:09:28.539703|2017-02-18 17:09:28.539703
NCT00212914|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-08|||May 2002||2002-05-01|September 2008|2008-09-01|January 2006||2006-01-01|||||Interventional|||Increasing Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes.|Mailing Recommendations to the Individual or Physician to Increase Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes: Clinical Trial.|Completed||N/A|268||Ottawa Hospital Research Institute|||||f||||||||||||||2017-02-18 17:09:28.610127|2017-02-18 17:09:28.610127
NCT00212901|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-25|||August 2004||2004-08-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|||High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy|Addition of Angiotensin Receptor Blockade to ACE Inhibition Versus High Dose ACE Inhibition for Reduction of Proteinuria in Patients With Diabetic Nephropathy|Completed||N/A|30|Anticipated|Ottawa Hospital Research Institute|||||f||||||||||||||2017-02-18 17:09:28.800453|2017-02-18 17:09:28.800453
NCT00212888|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-22|||April 2004||2004-04-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|July 2010|Actual|2010-07-01||Interventional|||Combination Vaccination Before HIV Treatment Interruption|A Pilot Study to Determine the Impact of Therapeutic HIV Vaccination Followed by a Scheduled Interruption of Antiretroviral Therapy on HIV-Specific Immune Function and Virologic Rebound in Patients With Prolonged Viral Suppression|Completed||Phase 1/Phase 2|60|Actual|Ottawa Hospital Research Institute||1|||f||||t||||||||||2017-02-18 17:09:28.889466|2017-02-18 17:09:28.889466
NCT00212875|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-05-19|||September 2005||2005-09-01|March 2010|2010-03-01|February 2007|Actual|2007-02-01|||||Interventional|||A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.|An Open-Label, Randomized, Multicenter Study of the Initiation of Four Dosing Regimens of PROCRIT (Epoetin Alfa) for the Treatment of Anemia of Chronic Kidney Disease (CKD). Protocol Addendum: Due to Space Constraints, See Detailed Description for Full Title of Addendum.|Completed||Phase 2|267|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:29.004676|2017-02-18 17:09:29.004676
NCT00212862|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-27|||December 2003||2003-12-01|June 2014|2014-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|DOSE||Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia|Dosing and Outcomes Study of Erythropoietic Stimulating Therapies|Completed||Phase 4|2130|Actual|Ortho Biotech Products, L.P.|||1||f||||f||||||||||2017-02-18 17:09:29.096934|2017-02-18 17:09:29.096934
NCT00212849|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|December 2004|2004-12-01|August 2005||2005-08-01|||||Observational|||Autologous Chondrocyte Implantation in the Patellofemoral Joint|Autologous Chondrocyte Implantation in the Patellofemoral Joint|Completed||Phase 4|35||Orthopaedic Research Foundation|||||f||||||||||||||2017-02-18 17:09:29.191328|2017-02-18 17:09:29.191328
NCT00212836|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-15|||May 2005||2005-05-01|May 2014|2014-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)|A Multicenter, Double-Blind, Flexible -Dose, 6-Month Trial Comparing the Efficacy Safety of Asenapine With Olanzapine in Stable Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia|Completed||Phase 3|444|Anticipated|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:09:29.272156|2017-02-18 17:09:29.272156
NCT00212823|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-17|||June 2004||2004-06-01|April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain|AXERT® 12.5mg Time vs Intensity Migraine Study (AIMS): An Open-label Multicenter Trial to Evaluate the Efficacy of Almotriptan Malate (AXERT®) 12.5 Milligram Intervention at Onset of Migraine Pain|Completed||Phase 4|1450|Actual|Ortho-McNeil Neurologics, Inc.||1|||f||||||||||||||2017-02-18 17:09:29.382475|2017-02-18 17:09:29.382475
NCT00212810|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-17|||September 2005||2005-09-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.|TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study|Completed||Phase 4|385|Actual|Ortho-McNeil Neurologics, Inc.|||||f||||||||||||||2017-02-18 17:09:29.478501|2017-02-18 17:09:29.478501
NCT00212589|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||December 2002||2002-12-01|May 2004|2004-05-01|April 2004||2004-04-01|||||Interventional|||Patients Preference for Oral or i.v. Therapy|A Randomized Crossover Trial Comparing Oral Capecitabine and Intravenous Fluorouracil + Folinic Acid (Nordic FU/FA Regimen) for Patient Preference in Colorectal Cancer|Completed||Phase 3|60||Odense University Hospital|||||f||||||||||||||2017-02-18 17:09:31.541015|2017-02-18 17:09:31.541015
NCT00212797|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-11-25|||July 2004||2004-07-01|November 2015|2015-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|Hermes||A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)|Prospective, Double-Blind, Randomized, Placebo-Controlled Dose Finding Study of the Efficacy and Safety of 2 Target Doses of Org 34517 Used as Adjunctive Therapy in Subjects With Psychotic Major Depression (Major Depressive Episode, Severe, With Psychotic Features).|Completed||Phase 2|273|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:09:29.575769|2017-02-18 17:09:29.575769
NCT00212784|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-18|||September 2003||2003-09-01|June 2014|2014-06-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)|A Phase III, Double-Blind, Randomized, Active-Controlled, Two-Armed, Multicenter, Efficacy and Safety Assessment (ACTAMESA) of Org 5222 and Olanzapine in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|1225|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:09:29.671152|2017-02-18 17:09:29.671152
NCT00212771|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-22|||September 2004||2004-09-01|December 2014|2014-12-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|ACTAMESA||Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)|Long-Term Efficacy and Safety Evaluation of Asenapine (10-20 mg/Day) in With Schizophrenia or Schizoaffective Disorder, in a Multicenter Trial Using (10-20 mg/Day) as a Control|Completed||Phase 3|440|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:09:29.774684|2017-02-18 17:09:29.774684
NCT00212758|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-10-22|2011-07-22||January 2005||2005-01-01|October 2011|2011-10-01|May 2010|Actual|2010-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood|IGF-1 Generation Test in Children With Chronic Kidney Disease|Completed||Phase 4|17|Actual|Oregon Health and Science University|Slow enrollment and the small number of participants in the study is the main limitation.|2|||f||||f||||||||||2017-02-18 17:09:30.066896|2017-02-18 17:09:30.066896
NCT00212745|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-09-22|||February 2004||2004-02-01|September 2009|2009-09-01|March 2010|Anticipated|2010-03-01|March 2009|Actual|2009-03-01||Interventional|||Pilot Trial of a Behavioral Treatment for Epilepsy|Nonrandomized Pilot Trial of the Andrews/Reiter Behavioral Treatment for Epilepsy|Unknown status|Active, not recruiting|Phase 1/Phase 2|8|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 17:09:30.365451|2017-02-18 17:09:30.365451
NCT00212732|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-10|||October 2003||2003-10-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan|Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan|Completed||Phase 3|750||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:30.469996|2017-02-18 17:09:30.469996
NCT00212719|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-10|||May 2003||2003-05-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Completed||Phase 3|250||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:30.543507|2017-02-18 17:09:30.543507
NCT00212706|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-11|||October 2001||2001-10-01|October 2012|2012-10-01||||November 2002|Actual|2002-11-01||Interventional|||Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan|Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan|Completed||Phase 2|400||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:30.629038|2017-02-18 17:09:30.629038
NCT00212693|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-10|||January 2004||2004-01-01|October 2012|2012-10-01||||September 2005|Actual|2005-09-01||Interventional|||Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan|Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan|Completed||Phase 2|165||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:30.715848|2017-02-18 17:09:30.715848
NCT00212680|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-10|||December 1996||1996-12-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan|Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan|Completed||Phase 2|100||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:30.794759|2017-02-18 17:09:30.794759
NCT00212667|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-10|||August 2002||2002-08-01|October 2012|2012-10-01||||September 2006|Actual|2006-09-01||Interventional|||Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Completed||Phase 3|650||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:30.873743|2017-02-18 17:09:30.873743
NCT00212654|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-10|||June 2001||2001-06-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan|Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan|Completed||Phase 2/Phase 3|165||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:30.96609|2017-02-18 17:09:30.96609
NCT00212641|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-10|||June 2005||2005-06-01|October 2012|2012-10-01||||October 2007|Actual|2007-10-01||Interventional|||A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus|Randomized Double-Blind Placebo-Controlled Pharmacodynamic Evaluation of ONO-5129 in Patients With Treatment Naive Type 2 Diabetes Mellitus|Completed||Phase 2|105||Ono Pharmaceutical Co. Ltd|||||||||||||||||||2017-02-18 17:09:31.057358|2017-02-18 17:09:31.057358
NCT00212628|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-12|||June 2004||2004-06-01|June 2012|2012-06-01||||||||Interventional|||Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan|Completed||Phase 3|444|Actual|Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:31.217985|2017-02-18 17:09:31.217985
NCT00212615|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-10-16|||February 2004||2004-02-01|October 2009|2009-10-01|October 2008||2008-10-01|||||Interventional|||XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer|XELOX III. Capecitabine (Xeloda) in Combination With Oxaliplatin (Eloxatin) as First-line Treatment of Patients With Advanced or Metastatic Colorectal Cancer. A Randomized Phase II Study|Unknown status|Active, not recruiting|Phase 2/Phase 3|116||Odense University Hospital|||||f||||||||||||||2017-02-18 17:09:31.31682|2017-02-18 17:09:31.31682
NCT00212602|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-12|||August 2005||2005-08-01|June 2012|2012-06-01||||||||Interventional|||ONO-7436 Phase II Study in Japan|ONO-7436 Phase II Study - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of ONO-7436 for the Prevention of Cancer Chemotherapy-Induced Nausea and Vomiting in Japan|Completed||Phase 2|420||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:09:31.428736|2017-02-18 17:09:31.428736
NCT00212576|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-06-21|||November 2005||2005-11-01|June 2016|2016-06-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Promoting Early School Readiness in Primary Health Care|Promoting Early School Readiness in Primary Health Care|Active, not recruiting||N/A|675|Actual|New York University School of Medicine||5|||f||||t||||||||||2017-02-18 17:09:31.635452|2017-02-18 17:09:31.635452
NCT00212550|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-29|||January 2006||2006-01-01|March 2016|2016-03-01|January 2012|Actual|2012-01-01|February 2010|Actual|2010-02-01||Observational|||Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb|Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb|Completed||N/A|10|Actual|New York University School of Medicine|||1||f||||t||||||||Undecided||2017-02-18 17:09:31.750381|2017-02-18 17:09:31.750381
NCT00212537|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2017-02-01|||April 2002||2002-04-01|February 2017|2017-02-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Disease Modifying Genes in Severe Asthma|Disease Modifying Genes in Severe Asthma|Active, not recruiting||N/A|2000|Anticipated|New York University School of Medicine|||1||f||||||||||Samples With DNA|"~     The total amount of blood drawn is approximately 5 tablespoons (75 ml). The blood sample~     will be processed to isolate genetic material (mainly DNA, RNA and protein). This genetic~     material will be used to try to identify the genetic factors or genes that a person~     inherits that make him or her more likely to develop asthma. The blood is used to test for~     allergies to weeds, trees, insects and molds (RAST) and a complete blood count.~   "|||2017-02-18 17:09:31.85603|2017-02-18 17:09:31.85603
NCT00212511|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-31|||November 2004||2004-11-01|March 2016|2016-03-01|January 2018|Anticipated|2018-01-01|January 2018|Anticipated|2018-01-01||Observational|||Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry|Prospective Evaluation of Patients With Idiopathic Pulmonary Fibrosis Through an IPF Registry|Active, not recruiting||N/A|20|Anticipated|New York University School of Medicine|||1||f||||t||||||||Yes|Data has not been analyzed yet.|2017-02-18 17:09:31.93743|2017-02-18 17:09:31.93743
NCT00212498|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-07|||November 2006||2006-11-01|December 2015|2015-12-01||||January 2012|Actual|2012-01-01||Observational|||Tuberculosis Research Blood Bank||Withdrawn||N/A|0|Actual|New York University School of Medicine|||1||f||||||||||||||2017-02-18 17:09:32.015935|2017-02-18 17:09:32.015935
NCT00212485|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-30|||September 2005||2005-09-01|June 2010|2010-06-01|May 2009|Actual|2009-05-01|April 2008|Actual|2008-04-01||Interventional|||Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint Disease|Evaluation of the Role of Power Doppler Sonography in the Diagnosis of Hemophilic Joint Disease|Completed||N/A|43|Actual|New York Presbyterian Hospital||1|||f||||f||||||||||2017-02-18 17:09:32.114357|2017-02-18 17:09:32.114357
NCT00212472|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-12-04|||July 2002||2002-07-01|October 2009|2009-10-01|December 2012|Anticipated|2012-12-01|December 2010|Anticipated|2010-12-01||Interventional|||International Immune Tolerance Study|An International Randomised Controlled Trial Of Immune Tolerance Induction|Terminated||N/A|134|Actual|New York Presbyterian Hospital||2||The DSMB recommended stopping the study due to safety concerns.|f||||t||||||||||2017-02-18 17:09:32.215367|2017-02-18 17:09:32.215367
NCT00212459|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-26|||May 2005||2005-05-01|May 2008|2008-05-01|April 2008|Actual|2008-04-01|February 2006|Actual|2006-02-01||Interventional|||The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs|A Prospective Randomized Pilot Study on the Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs|Completed||N/A|14|Actual|New York Presbyterian Hospital||2|||f||||f||||||||||2017-02-18 17:09:32.396197|2017-02-18 17:09:32.396197
NCT00212446|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-19|||September 2014||2014-09-01|October 2015|2015-10-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|||Pilot Study to Evaluate a Prototype Electronic Uterine Inhibitor to Prevent Preterm Contractions|Pilot Study to Evaluate a Prototype Electronic Uterine Inhibitor to Prevent Preterm Contractions|Completed||N/A|8|Actual|St. Luke's-Roosevelt Hospital Center||1|||f||||f||||||||||2017-02-18 17:09:32.506387|2017-02-18 17:09:32.506387
NCT00212433|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-20|||July 2004||2004-07-01|December 2005|2005-12-01|February 2006||2006-02-01|||||Interventional|||Optimisation and Performance of Reduced Preparation CT Colography|Multidetector-Row CT Colonography: Optimisation of Reduced Bowel Preparation Regimes and Diagnostic Performance in Comparison to Colonoscopy|Completed||Phase 4|120||London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 17:09:32.619307|2017-02-18 17:09:32.619307
NCT00212420|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-21|||December 2004||2004-12-01|September 2007|2007-09-01||||||||Interventional|||Nutritional Management of Acute and Chronic Enterocutaneous Fistulae|Nutritional Management of Acute and Chronic Enterocutaneous Fistulae|Unknown status|Recruiting|N/A|150|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 17:09:32.711806|2017-02-18 17:09:32.711806
NCT00212407|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-24|||February 1993||1993-02-01|March 2016|2016-03-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||New York Blood Center National Cord Blood Program|New York Blood Center National Cord Blood Program|Recruiting||Early Phase 1|5000|Anticipated|New York Blood Center||1|||f||||f||||||||||2017-02-18 17:09:32.808047|2017-02-18 17:09:32.808047
NCT00212394|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-06-22|||January 2005||2005-01-01|June 2006|2006-06-01|September 2005||2005-09-01|||||Observational|||Tourniquet Complications in Orthopaedic Surgery|A Prospective, Epidemiological Study of the Incidence and Nature of Tourniquet Complications in Norway|Completed||Phase 4|10||Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 17:09:32.928615|2017-02-18 17:09:32.928615
NCT00212381|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 2000||2000-09-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia|Diindolylmethane (DIM) Dietary Supplementation: A Nonsurgical Treatment for Cervical Intraepithelial Neoplasia (CIN)|Unknown status|Recruiting|Phase 3|62||New York Presbyterian Hospital|||||f||||||||||||||2017-02-18 17:09:33.013205|2017-02-18 17:09:33.013205
NCT00212368|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-09-09|||October 2004||2004-10-01|September 2010|2010-09-01|December 2005|Actual|2005-12-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.|Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.|Completed||Phase 3|||Nobelpharma|||||f||||||||||||||2017-02-18 17:09:33.104168|2017-02-18 17:09:33.104168
NCT00212355|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-10|2014-04-09||March 2005||2005-03-01|April 2014|2014-04-01|January 2009|Actual|2009-01-01|April 2008|Actual|2008-04-01||Interventional||Analysis was performed subjects comprised 37 patients who were found to have Wilson disease through clnical and biochemical tests.|Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.|Phase3, Open-Label, Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.|Completed||Phase 3|37|Actual|Nobelpharma||1|||f||||f||||||||||2017-02-18 17:09:33.173749|2017-02-18 17:09:33.173749
NCT00212342|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-09-06|||December 2004||2004-12-01|September 2010|2010-09-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea|Phase 3,Placebo Controlled,Randomized,Double-Blinded,NSAID-Add-on,Clinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis.|Completed||Phase 3|100|Actual|Nobelpharma||2|||f||||||||||||||2017-02-18 17:09:33.530333|2017-02-18 17:09:33.530333
NCT00212329|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-12|||September 2005||2005-09-01|May 2016|2016-05-01|September 2007|Actual|2007-09-01|||||Observational|||T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus|A Comparative Study Between the Cytokine Elispot, Tetramer, Immunoblot, and T Cell Proliferation Assays Using Fresh Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus|Completed||N/A|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:09:33.617856|2017-02-18 17:09:33.617856
NCT00212316|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2012-08-14|||August 2005||2005-08-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)|Phenylbutyrate Development for Huntington's Disease (PHEND-HD): A Multi-Center, Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Tolerability of Phenylbutyrate in Subjects With Huntington's Disease|Completed||Phase 2|60||University of Rochester|||||||||||||||||||2017-02-18 17:09:33.721119|2017-02-18 17:09:33.721119
NCT00212303|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-18|||May 2004||2004-05-01|January 2013|2013-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|SHAPE2||Exercise Training in Type 2 Diabetes and Hypertension|Exercise Training in Type 2 Diabetes and Hypertension|Completed||Phase 4|115|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 17:09:33.828294|2017-02-18 17:09:33.828294
NCT00212290|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-02-12|||November 2002||2002-11-01|February 2010|2010-02-01|December 2006|Actual|2006-12-01|||||Interventional|||Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes||Completed||Phase 4|140|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:09:33.935054|2017-02-18 17:09:33.935054
NCT00211341|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-17|||December 2000||2000-12-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|ObaapaVitA||Trial of the Impact of Vitamin A on Maternal Mortality|Randomised Double-blind Placebo-controlled Trial to Evaluate the Impact of Vitamin A on Maternal Mortality in Ghana|Completed||Phase 3|100000|Anticipated|London School of Hygiene and Tropical Medicine||1|||f||||t||||||||||2017-02-18 17:09:34.031953|2017-02-18 17:09:34.031953
NCT00211328|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-03|||March 2002||2002-03-01|February 2009|2009-02-01|March 2007|Actual|2007-03-01|||||Interventional|||Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).||Completed||Phase 2|5|Actual|Manhattan Eye, Ear & Throat Hospital||1|||t||||f||||||||||2017-02-18 17:09:34.329276|2017-02-18 17:09:34.329276
NCT00211315|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-23|||March 2002||2002-03-01|October 2012|2012-10-01|March 2007||2007-03-01|||||Interventional|||Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)||Completed||Phase 2|4|Actual|Manhattan Eye, Ear & Throat Hospital||1|||f||||f||||||||||2017-02-18 17:09:34.432748|2017-02-18 17:09:34.432748
NCT00212277|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-09-09|||February 2005||2005-02-01|September 2010|2010-09-01|February 2007|Actual|2007-02-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.|Phase3,Open-label,Long-term,NSAID-Add-on,Clinical Trial of Mono-phase Low-dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis.|Completed||Phase 3|||Nobelpharma|||||f||||||||||||||2017-02-18 17:09:34.529375|2017-02-18 17:09:34.529375
NCT00212264|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-21|2014-10-07||August 2003||2003-08-01|March 2016|2016-03-01|August 2011|Actual|2011-08-01|September 2008|Actual|2008-09-01||Interventional|||Conservative Treatment of Postprostatectomy Incontinence|Conservative Treatment of Postprostatectomy Incontinence|Completed||N/A|208|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||f||||||||||2017-02-18 17:09:34.60651|2017-02-18 17:09:34.60651
NCT00212251|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2014-07-14|||August 2004||2004-08-01|January 2010|2010-01-01|April 2008||2008-04-01|||||Interventional|||Promoting Postpartum Weight Loss in Overweight Women|Promoting Postpartum Weight Loss in Overweight Women|Completed||N/A|450||Duke University||1|||f||||||||||||||2017-02-18 17:09:35.235911|2017-02-18 17:09:35.235911
NCT00212238|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2010-03-17|||September 2003||2003-09-01|March 2010|2010-03-01|October 2006||2006-10-01|||||Interventional|||Enhanced Internet Behavior Therapy for Treating Obesity|Enhanced Internet Behavior Therapy for Treating Obesity|Completed||N/A|100||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:09:35.355774|2017-02-18 17:09:35.355774
NCT00212225|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-20|2010-01-12|||October 1997||1997-10-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Observational|||Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)|Risk Factors for Gastric Disease in Pediatric H. Pylori|Completed||N/A|755|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:09:35.454296|2017-02-18 17:09:35.454296
NCT00212212|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2012-03-06|||March 2006||2006-03-01|March 2012|2012-03-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Selenium Supplementation of Patients With Cirrhosis|Human Selenium Nutritional Requirement and Biomarkers in Health and Disease|Terminated||N/A|99|Actual|Vanderbilt University||4||Insufficient funds to complete study.|f||||t||||||||||2017-02-18 17:09:35.540779|2017-02-18 17:09:35.540779
NCT00212199|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-17|||January 2002||2002-01-01|March 2010|2010-03-01|August 2004|Actual|2004-08-01|||||Interventional|||Effectiveness of Brief Counseling for Weight Management|Effectiveness of Brief Counseling for Weight Management|Completed||Phase 4|246||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:09:35.65307|2017-02-18 17:09:35.65307
NCT00212186|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2012-03-06|||October 1998||1998-10-01|March 2012|2012-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Selenium Supplementation of Patients With Cirrhosis||Completed||N/A|48|Actual|Vanderbilt University|||||f||||||||||||||2017-02-18 17:09:35.747713|2017-02-18 17:09:35.747713
NCT00212173|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-16||||||April 2015|2015-04-01|August 2007|Actual|2007-08-01|||||Interventional|||Adolescent Weight Management Study|Behavioral & Pharmacologic Therapy of Adolescent Obesity|Completed||N/A|120||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 17:09:35.839269|2017-02-18 17:09:35.839269
NCT00005418|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||April 1992||1992-04-01|September 2001|2001-09-01|March 1994|Actual|1994-03-01|||||Observational|||Epidemiology of Cardiotoxicity in Children With Cancer||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.156313|2017-02-18 18:15:01.156313
NCT00212160|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-30|||January 2005|Actual|2005-01-01|January 2017|2017-01-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||The Role of the Omentum in the Treatment of Morbid Obesity|The Role of the Omentum in the Treatment of Morbid Obesity|Completed||N/A|66|Actual|Vanderbilt University Medical Center||4|||f||||t||||||||||2017-02-18 17:09:35.920748|2017-02-18 17:09:35.920748
NCT00212147|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-06|||September 2003||2003-09-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly|Subtle Disturbances of Cobalamin Status|Completed||N/A|444|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||f||||||||||2017-02-18 17:09:36.035322|2017-02-18 17:09:36.035322
NCT00212134|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-07-27|2013-07-15||December 2004||2004-12-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|IATS||Infant Aphakia Treatment Study (IATS)|Infant Aphakia Treatment Study (IATS)|Completed||Phase 3|114|Actual|Emory University||2|||f||||t||||||||||2017-02-18 17:09:36.152267|2017-02-18 17:09:36.152267
NCT00212121|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-25|||July 2004||2004-07-01|June 2016|2016-06-01|December 2018|Anticipated|2018-12-01|December 2015|Actual|2015-12-01||Interventional|||Radiation Dose Intensity Study in Breast Cancer in Young Women|Radiation Dose Intensity Study in Breast Cancer in Young Women: a Randomized Phase III Trial of Additional Dose to the Tumor Bed|Active, not recruiting||Phase 3|2400|Anticipated|The Netherlands Cancer Institute||2|||f||||f||||||||||2017-02-18 17:09:37.20016|2017-02-18 17:09:37.20016
NCT00212108|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-29|||November 2003||2003-11-01|March 2012|2012-03-01|January 2009|Actual|2009-01-01|March 2007|Actual|2007-03-01||Interventional|||A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839|A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839|Completed||Phase 1/Phase 2|22|Actual|National University Hospital, Singapore||1|||f||||||||||||||2017-02-18 17:09:37.421821|2017-02-18 17:09:37.421821
NCT00212095|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-31|||June 2005||2005-06-01|October 2012|2012-10-01|June 2012|Actual|2012-06-01|April 2007|Actual|2007-04-01||Interventional|||Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer|Phase II Study of Docetaxel Combined With Ketoconazole in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor|Completed||Phase 2|30|Actual|National University Hospital, Singapore||1|||f||||t||||||||||2017-02-18 17:09:37.521881|2017-02-18 17:09:37.521881
NCT00212082|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-06-11|||April 2002||2002-04-01|June 2008|2008-06-01||||||||Interventional|||Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer|Gene Expression Profiles of Breast Cancer Treated With Sequential Adriamycin and Docetaxel in Relation to Tumor Responses|Completed||Phase 2|100||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 17:09:37.623582|2017-02-18 17:09:37.623582
NCT00212069|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-10|||March 2004||2004-03-01|December 2013|2013-12-01|April 2013|Actual|2013-04-01|March 2013|Actual|2013-03-01||Interventional|||Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer|Serum Protein Profiling as a Predictor of Gemcitabine Sensitivity in Breast Cancer With Prior Exposure to Anthracyclines and Taxanes|Completed||Phase 2|30|Anticipated|National University Hospital, Singapore|||||f||||||||||||||2017-02-18 17:09:37.713189|2017-02-18 17:09:37.713189
NCT00212056|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-31|||October 2001||2001-10-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by ANP|Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by ANP|Completed||N/A|600|Anticipated|National Cerebral and Cardiovascular Center||2|||f||||||||||||||2017-02-18 17:09:37.807086|2017-02-18 17:09:37.807086
NCT00212043|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-10-07|||July 2000||2000-07-01|May 2008|2008-05-01|February 2004||2004-02-01|||||Interventional|||Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma|Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma|Completed||Phase 2|74||National University Hospital, Singapore|||||f||||||||||||||2017-02-18 17:09:37.911054|2017-02-18 17:09:37.911054
NCT00212030|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-31|||October 2001||2001-10-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP|Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP|Completed||N/A|600|Anticipated|National Cerebral and Cardiovascular Center||2|||f||||||||||||||2017-02-18 17:09:38.001722|2017-02-18 17:09:38.001722
NCT00212017|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-07|||April 2005||2005-04-01|November 2007|2007-11-01|April 2009|Anticipated|2009-04-01|||||Interventional|||Assessment of an Alpha-Glucosidase Inhibitor to Block Cardiac Events in Patients With Myocardial Infarction and IGT (ABC Study)|The Japan Working Group for the Assessment That the Alpha-Glucosidase Inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT|Unknown status|Recruiting|N/A|3000|Anticipated|National Cerebral and Cardiovascular Center|||||f||||||||||||||2017-02-18 17:09:38.111295|2017-02-18 17:09:38.111295
NCT00212004|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||April 2005||2005-04-01|November 2004|2004-11-01|April 2009||2009-04-01|||||Interventional|||Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study)|The Japan Working Group for the Assessment That the Pioglitazone Protects DM Patients Against Re-Infarction|Unknown status|Recruiting|N/A|3000||National Cerebral and Cardiovascular Center|||||f||||||||||||||2017-02-18 17:09:38.21123|2017-02-18 17:09:38.21123
NCT00211991|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-10|||April 2005||2005-04-01|May 2012|2012-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Evaluation of Consistency of StaphVAX Manufacturing Lots|A Phase 3, Multicenter, Double-Blinded, Randomized, Study to Compare Immunogenicity and Safety Between Three Commercial Lots of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Normal, Healthy, Adult Volunteers|Completed||Phase 3|354||Nabi Biopharmaceuticals|||||f||||||||||||||2017-02-18 17:09:38.303278|2017-02-18 17:09:38.303278
NCT00211978|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-26|||May 2005||2005-05-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Interventional|||EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)|EPIC (Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease): A Prospective, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel Arm, Study of PhosLo on Phosphorus Levels in Subjects With Chronic Kidney Disease|Completed||Phase 3|110|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-02-18 17:09:38.381766|2017-02-18 17:09:38.381766
NCT00211757|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-15|||September 2002||2002-09-01|April 2011|2011-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism|Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism|Completed||Phase 2|55|Anticipated|Montefiore Medical Center||2|||f||||||||||||||2017-02-18 17:09:43.611006|2017-02-18 17:09:43.611006
NCT00211965|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-26|||April 2005||2005-04-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|May 2006|Actual|2006-05-01||Interventional|||StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery|A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Safety and Immunogenicity of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adult Patients Receiving an Orthopedic Prosthetic Implant|Completed||Phase 3|67|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-02-18 17:09:38.495029|2017-02-18 17:09:38.495029
NCT00211952|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||March 2004||2004-03-01|September 2005|2005-09-01||||||||Interventional|||Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients|A Randomized, Double Blind, Placebo Controlled Phase III Trial Evaluating the Role of Adjuvant Celecoxib in Completely Resected, High-Risk (pN1-2) Non-Small Cell Lung Cancer (NSCLC) Patients|Suspended||Phase 3|542||Medical University of Gdansk|||||f||||||||||||||2017-02-18 17:09:38.596315|2017-02-18 17:09:38.596315
NCT00211939|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-26|||January 2005||2005-01-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients|CARE-2 (Calcium Acetate (PhosLo®)/Sevelamer(Renagel®) Evaluation Study 2)|Completed||Phase 4|203|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-02-18 17:09:38.690215|2017-02-18 17:09:38.690215
NCT00211926|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-21|||December 2004||2004-12-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Interventional|||StaphVAX Immunogenicity in Orthopedic Implant Patients|A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Safety and Immunogenicity of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine, in Adult Patients Receiving an Orthopaedic Prosthetic Implant|Completed||Phase 3|120|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-02-18 17:09:38.806629|2017-02-18 17:09:38.806629
NCT00211913|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-26|||June 2004||2004-06-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|October 2005|Actual|2005-10-01||Interventional|||StaphVAX in Cardiovascular Surgery Patients|A Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Safety and Immunogenicity of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine, in Adult Patients Undergoing Cardiovascular Surgery|Completed||Phase 3|120|Actual|Nabi Biopharmaceuticals||2|||f||||f||||||||||2017-02-18 17:09:38.89891|2017-02-18 17:09:38.89891
NCT00211900|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-26|||March 2005||2005-03-01|December 2007|2007-12-01|November 2005|Actual|2005-11-01|August 2005|Actual|2005-08-01||Interventional|||Evaluation of Manufacturing Lot of StaphVAX|A Phase 3, Multicenter, Open-Label, Historical Comparative Study to Evaluate Immunogenicity and Safety of a Commercial Lot of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adults on Hemodialysis|Completed||Phase 3|65|Actual|Nabi Biopharmaceuticals||1|||f||||f||||||||||2017-02-18 17:09:38.993808|2017-02-18 17:09:38.993808
NCT00211887|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-06|2013-06-25||January 2005||2005-01-01|March 2014|2014-03-01|March 2013|Actual|2013-03-01|April 2012|Actual|2012-04-01||Interventional|||Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx|A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Patients With Relapsing-Remitting Multiple Sclerosis (CombiRx)|Completed||Phase 3|1008|Actual|Icahn School of Medicine at Mount Sinai|absence of a comparative randomized placebo only group|3|||f||||t||||||||||2017-02-18 17:09:39.095647|2017-02-18 17:09:39.095647
NCT00211874|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-10-09|||September 2000||2000-09-01|October 2015|2015-10-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Improving Heart Failure Care in Minority Communities|Improving Heart Failure Care in Minority Communities|Completed||N/A|406|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 17:09:42.515522|2017-02-18 17:09:42.515522
NCT00211848|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-26|||June 2000||2000-06-01|April 2007|2007-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers|Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers|Completed||Phase 2|207|Anticipated|Icahn School of Medicine at Mount Sinai||2|||||||||||||||||2017-02-18 17:09:42.633246|2017-02-18 17:09:42.633246
NCT00211835|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-09-20|||November 2005||2005-11-01|September 2013|2013-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Post-TBI Depression|Treatment of Post-TBI Depression - A Randomized Clinical Trial|Completed||N/A|75|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 17:09:42.735901|2017-02-18 17:09:42.735901
NCT00211822|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-13|||November 2004||2004-11-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)|fMRI Studies in Pathological Gambling and Obsessive-Compulsive Disorder|Terminated||N/A|57|Actual|Icahn School of Medicine at Mount Sinai|||3|Enrollments closed after former PI Eric Hollander left institution. There are no results.|f||||f||||||||||2017-02-18 17:09:42.844229|2017-02-18 17:09:42.844229
NCT00211809|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-23||||||May 2008|2008-05-01||||||||Interventional|||CBT as an Adjunct to SRIs in the Treatment of BDD|A Controlled Trial of Cognitive-Behavioral Therapy as an Adjunct to Serotonin Reuptake Inhibitors in Body Dysmorphic Disorder|Unknown status|Active, not recruiting|Phase 4|80|Anticipated|Icahn School of Medicine at Mount Sinai|||||f||||||||||||||2017-02-18 17:09:43.194609|2017-02-18 17:09:43.194609
NCT00211796|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-17|||April 2005||2005-04-01|April 2007|2007-04-01||||||||Interventional|||Divalproex Sodium ER in Adult Autism|Divalproex Sodium ER in Adult Autism|Unknown status|Recruiting|Phase 4|10||Icahn School of Medicine at Mount Sinai|||||||||||||||||||2017-02-18 17:09:43.302372|2017-02-18 17:09:43.302372
NCT00211783|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-26|||November 2004||2004-11-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|November 2011|Actual|2011-11-01||Observational|||Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism|fMRI for the Study of Response Inhibition, and Face and Linguistic Processing in Autism|Completed||N/A|71|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||||||2017-02-18 17:09:43.402522|2017-02-18 17:09:43.402522
NCT00211770|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-11|||February 2005||2005-02-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|December 2005|Actual|2005-12-01||Observational|||Use of Functional Behavioral Assessments to Evaluate Stereotypy and Repetitive Behaviors in a Double-blind, Placebo Controlled Trials of Various Medications Used to Treat Children With Autism.|Use of Functional Behavioral Assessments to Evaluate Stereotypy and Repetitive Behaviors in a Double-blind, Placebo Controlled Trials of Various Medications Used to Treat Children With Autism.|Completed||N/A|144|Actual|Icahn School of Medicine at Mount Sinai|||1||f||||f||||||||||2017-02-18 17:09:43.507936|2017-02-18 17:09:43.507936
NCT00211744|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-05|||August 2004||2004-08-01|December 2005|2005-12-01|August 2006|Anticipated|2006-08-01|||||Interventional|||Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder|Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder|Unknown status|Recruiting|Phase 4|24|Anticipated|Icahn School of Medicine at Mount Sinai|||||||||||||||||||2017-02-18 17:09:43.730716|2017-02-18 17:09:43.730716
NCT00211731|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-11-10|||September 2002||2002-09-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Preventing Recurrent Stroke in Minority Populations|Improving the Delivery of Effective Care to Minorities|Completed||N/A|87|Actual|Icahn School of Medicine at Mount Sinai|||||f||||||||||||||2017-02-18 17:09:43.841541|2017-02-18 17:09:43.841541
NCT00211718|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-11-02|||July 2004||2004-07-01|August 2005|2005-08-01|June 2007||2007-06-01|||||Interventional|||Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain|Intra-Articular Injection of Botulinum Toxin Type A for the Treatment of Shoulder Pain: A Randomized, Double Blinded, Placebo Controlled Trial|Unknown status|Recruiting|Phase 3|40||Minneapolis Veterans Affairs Medical Center|||||||||||||||||||2017-02-18 17:09:43.928578|2017-02-18 17:09:43.928578
NCT00211705|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-30|||February 1994||1994-02-01|June 2005|2005-06-01|March 2004||2004-03-01|||||Interventional|||Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)|Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)|Completed||Phase 4|8000||Mitsukoshi Health and Welfare Foundation|||||f||||||||||||||2017-02-18 17:09:44.024302|2017-02-18 17:09:44.024302
NCT00211692|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-11-20|2011-08-01||July 2005||2005-07-01|November 2014|2014-11-01|September 2009|Actual|2009-09-01|July 2008|Actual|2008-07-01||Interventional|||Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial|Prospective Randomized Pilot Study of Daily Consensus Interferon (CIFN) and Ribavirin for 52 Wks vs Extended Duration 72 Wks Based on Virologic Response for the Initial Treatment of Difficult-to-treat Patients With Chronic HCV Genotype 1|Completed||Phase 3|64|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||t||||||||||2017-02-18 17:09:44.12004|2017-02-18 17:09:44.12004
NCT00211679|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2004||2004-06-01|July 2005|2005-07-01|June 2007||2007-06-01|||||Interventional|||Intra-articularInjection of Botulinum Toxin Type|Intra-articularInjection of Botulinum Toxin Type a for the Treatment of Chronic Knee Pain: A Randomized, Placebo Controlled, Double Blind Study|Unknown status|Recruiting|Phase 2|40||Minneapolis Veterans Affairs Medical Center|||||||||||||||||||2017-02-18 17:09:44.64581|2017-02-18 17:09:44.64581
NCT00211666|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 2002||2002-09-01|September 2005|2005-09-01|August 2006||2006-08-01|||||Interventional|||Improving Hypertension Control in East and Central Harlem|Improving the Delivery of Effective Care to Minorities|Completed||N/A|480||Icahn School of Medicine at Mount Sinai|||||f||||||||||||||2017-02-18 17:09:44.74582|2017-02-18 17:09:44.74582
NCT00211653|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-18|||April 2003||2003-04-01|September 2007|2007-09-01|November 2006|Actual|2006-11-01|||||Interventional|||Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery|Single Center Randomized Clinical Trial of the Effects of Acetylcysteine in the Prevention of Postoperative Renal Failure|Completed||Phase 1/Phase 2|102|Actual|Minneapolis Veterans Affairs Medical Center||2|||f||||f||||||||||2017-02-18 17:09:44.841672|2017-02-18 17:09:44.841672
NCT00211640|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13||||||August 2005|2005-08-01||||||||Observational|||Identification and Treatment of Men With BPH in the Primary Care Setting|A Proactive Approach to the Identification and Treatment of Men With BPH Inthe Primary Care Setting|Completed||N/A|1100||Mid Michigan Health Centers|||||f||||||||||||||2017-02-18 17:09:44.933906|2017-02-18 17:09:44.933906
NCT00211627|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2004||2004-06-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.|Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.|Unknown status|Recruiting|Phase 1|30||Miller, Chipp St. Kevin, M.D.|||||f||||||||||||||2017-02-18 17:09:44.992774|2017-02-18 17:09:44.992774
NCT00211614|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-20|||July 2006||2006-07-01|February 2007|2007-02-01|July 2007||2007-07-01|||||Interventional|||Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea|Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea|Terminated||N/A|50||MetroHealth Medical Center|||||f||||||||||||||2017-02-18 17:09:45.078962|2017-02-18 17:09:45.078962
NCT00211601|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-30|||August 2004||2004-08-01|April 2015|2015-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|C-PHONE||Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)|Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis|Completed||N/A|1500||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:09:45.179121|2017-02-18 17:09:45.179121
NCT00211276|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-13|||March 2005||2005-03-01|March 2011|2011-03-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma|A Phase II Multicenter Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non-Hodgkins Lymphoma.|Completed||Phase 2|50|Anticipated|Eisai Inc.|||||f||||||||||||||2017-02-18 17:09:45.254977|2017-02-18 17:09:45.254977
NCT00211263|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-07|||November 2003||2003-11-01|June 2005|2005-06-01|February 2007||2007-02-01|||||Interventional|||Bipolar Disorder Research Study for Ages 12 and Older|Bipolar Disorder Center for Pennsylvanians (BDCP) Research Study|Completed||N/A|750||Kupfer, David J., M.D.||2|||||||||||||||||2017-02-18 17:09:45.401648|2017-02-18 17:09:45.401648
NCT00211250|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-27|||July 2005||2005-07-01|January 2009|2009-01-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER|An Exploratory Study Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar I and II Patients From Valproic Acid to Depakote ER|Completed||Phase 4|20|Anticipated|Joliet Center for Clinical Research||1|||f||||t||||||||||2017-02-18 17:09:45.691026|2017-02-18 17:09:45.691026
NCT00211237|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-16|2010-03-31||May 2005||2005-05-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|April 2009|Actual|2009-04-01||Interventional|CAFE||CAFE Study - Cancer Patient Fracture Evaluation|A Multicenter, Prospective, Randomized, Controlled Study to Compare Balloon Kyphoplasty to Non-surgical Fracture Management in the Treatment of Painful, Acute Vertebral Body Compression Fractures in Cancer Patients|Completed||Phase 4|134|Actual|Medtronic Spine LLC||2|||f||||t||||||||||2017-02-18 17:09:45.801581|2017-02-18 17:09:45.801581
NCT00211224|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-14|||April 2000||2000-04-01|September 2005|2005-09-01|November 2004||2004-11-01|||||Interventional|||Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)|Phase 3 Study of Riluzole in Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) (Parkinson's Plus Syndromes)|Terminated||Phase 3|800||King's College London|||||f||||||||||||||2017-02-18 17:09:46.253591|2017-02-18 17:09:46.253591
NCT00211211|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-18|||February 2003||2003-02-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||FREE Study - Fracture Reduction Evaluation|An International Multicentric, Multidisciplinary Prospective and Randomized Study to Compare Minimally Invasive Reduction and Fixation Using the KyphX System and Radiopaque PMMA Cement to Medical Therapy Alone for the Treatment of Painful, Acute Osteopenic Vertebral Body Compression Fractures|Completed||Phase 4|300||Medtronic Spine LLC|||||f||||||||||||||2017-02-18 17:09:46.349652|2017-02-18 17:09:46.349652
NCT00211198|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-29|||May 2001||2001-05-01|February 2008|2008-02-01|January 2006|Actual|2006-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)|Open Label Study of ONTAK® (Denileukin Diftitox, DAB389IL-2) to Estimate Response in Cutaneous T-Cell Lymphoma (CTCL) According to CD25 Status|Completed||Phase 4|60||Eisai Inc.|||||f||||t||||||||||2017-02-18 17:09:46.452037|2017-02-18 17:09:46.452037
NCT00211185|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-08-27|||March 2004||2004-03-01|March 2008|2008-03-01||||August 2008|Anticipated|2008-08-01||Interventional|||A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma|A Pilot Phase II Study to Determine the Safety and Efficacy of the Combination of ONTAK With CHOP in Peripheral T-Cell Lymphoma.|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|Eisai Inc.||1|||f||||t||||||||||2017-02-18 17:09:46.565642|2017-02-18 17:09:46.565642
NCT00211172|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-10-07|2009-08-05||October 2003||2003-10-01|July 2011|2011-07-01|May 2009|Actual|2009-05-01|December 2005|Actual|2005-12-01||Interventional|||HMO Research Network CERT: Acute Myocardial Infarction|The HMO Research Network CERT: Acute Myocardial Infarction|Completed||N/A|836|Actual|Kaiser Permanente||2|||f||||f||||||||||2017-02-18 17:09:46.727804|2017-02-18 17:09:46.727804
NCT00211159|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-02-07|||December 2000||2000-12-01|April 2005|2005-04-01||||||||Interventional|||OmegAD (Omega-3 and Alzheimer's Disease)|Omega-3 Fatty Acid Treatment of 174 Patients With Mild to Moderate Alzheimer's Disease (OmegAD): a Randomized Double-Blind Trial|Completed||N/A|204||Karolinska University Hospital|||||f||||||||||||||2017-02-18 17:09:47.092379|2017-02-18 17:09:47.092379
NCT00211146|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||April 1998||1998-04-01|April 2010|2010-04-01|May 2006|Actual|2006-05-01|||||Interventional|||A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)|An Open-Label, Randomized, Parallel-Group Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Subjects Undergoing Major Elective Spinal Surgery|Completed||Phase 3|680|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:47.192283|2017-02-18 17:09:47.192283
NCT00211133|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-29|||June 2000||2000-06-01|November 2010|2010-11-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy|A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Impact of Maintaining Hemoglobin Using Eprex (Epoetin Alfa) in Metastatic Breast Carcinoma Subjects Receiving Chemotherapy|Completed||Phase 3|939|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:09:47.295045|2017-02-18 17:09:47.295045
NCT00211120|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-17|||March 2002||2002-03-01|March 2010|2010-03-01|August 2005|Actual|2005-08-01|||||Interventional|||Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)|Correction of Hemoglobin and Outcomes In Renal Insufficiency|Terminated||Phase 4|1432|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"Stopped by the DSMB due to a trend toward more adverse events in the higher hemoglobin (Hb)~   arm and <5% chance that the study would show benefit for higher Hb."|f||||t||||||||||2017-02-18 17:09:47.384958|2017-02-18 17:09:47.384958
NCT00211107|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-05-18|||June 2003||2003-06-01|March 2010|2010-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.|A Placebo-Controlled, Double-Blind, Randomized, Parallel Study Of The Efficacy And Safety Of Dapoxetine HCl In The Treatment Of Rapid Ejaculation|Completed||Phase 3|1294|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 17:09:47.475705|2017-02-18 17:09:47.475705
NCT00211094|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-02-10||||||February 2011|2011-02-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation|A Placebo-Controlled, Double-blind, Randomized, Parallel Study of the Efficacy and Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation|Completed||Phase 3|1320|Actual|Alza Corporation, DE, USA|||||||||||||||||||2017-02-18 17:09:47.559978|2017-02-18 17:09:47.559978
NCT00211081|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-08|2014-12-08||November 2004||2004-11-01|December 2014|2014-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Spironolactone in Patients With Single Ventricle Heart|Impact of Spironolactone on Endothelial Function in Patients With Single Ventricle Heart|Completed||N/A|12|Actual|Emory University||1|||f||||f||||||||||2017-02-18 17:09:47.645244|2017-02-18 17:09:47.645244
NCT00211068|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-04-29|||March 2004||2004-03-01|April 2013|2013-04-01|March 2006|Actual|2006-03-01|||||Observational|||A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa|Retrospective Case-control Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa|Completed||Phase 4|124|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||t||||||Samples With DNA|"~     Blood sample collected for pharmacogenomic analysis~   "|||2017-02-18 17:09:47.880702|2017-02-18 17:09:47.880702
NCT00211055|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-04-15|||September 2004||2004-09-01|April 2013|2013-04-01|March 2005|Actual|2005-03-01|||||Observational|||A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children|A Multicenter, Epidemiological, Observational Study of the Management of Anemia in Critically Ill Pediatric Patients|Completed||N/A|1201|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:09:48.253948|2017-02-18 17:09:48.253948
NCT00211042|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-04-29|||February 2004||2004-02-01|April 2013|2013-04-01|December 2006|Actual|2006-12-01|||||Observational|||A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment|Observational, Multicenter Study of Subjects With Pure Red Cell Aplasia Associated With r-HuEPO Treatment|Completed||Phase 4|52|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||t||||||||||2017-02-18 17:09:48.328839|2017-02-18 17:09:48.328839
NCT00209365|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-13|||September 2005||2005-09-01|February 2017|2017-02-01|December 2005|Actual|2005-12-01|||||Interventional|||The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit||Completed||N/A|24||Fraunhofer-Institute of Toxicology and Experimental Medicine|||||f||||||||||||||2017-02-18 17:10:07.425685|2017-02-18 17:10:07.425685
NCT00211029|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-30|||January 2003||2003-01-01|July 2015|2015-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins|An Active Safety Surveillance Plan to Prospectively Monitor the Incidence of Pure Red Cell Aplasia (PRCA) Among Patients Receiving Epoetin Alfa Therapy or Other Recombinant Erythropoietins|Completed||Phase 4|4670|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||f||||||||||2017-02-18 17:09:48.46385|2017-02-18 17:09:48.46385
NCT00211016|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||August 2004||2004-08-01|March 2010|2010-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Doripenem in the Treatment of Ventilator-Associated Pneumonia|A Multicenter, Randomized, Open-Label, Phase 3 Study of Doripenem Versus a Comparator Antibiotic in the Treatment of Ventilator-Associated Pneumonia|Completed||Phase 3|318|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:48.563972|2017-02-18 17:09:48.563972
NCT00211003|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||May 2004||2004-05-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Doripenem in the Treatment of Hospital-Acquired Pneumonia|A Multicenter, Randomized, Open-Label, Phase 3 Study to Compare the Safety and Effectiveness of Doripenem Versus a Comparator Antibiotic in Hospital-Acquired Pneumonia|Completed||Phase 3|240|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:48.654142|2017-02-18 17:09:48.654142
NCT00210990|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||March 2004||2004-03-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|||||Interventional|||Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis|A Multicenter, Phase 3 Study of the Safety and Effectiveness of Doripenem in Complicated Lower Urinary Tract Infection or Pyelonephritis|Completed||Phase 3|403|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:48.743706|2017-02-18 17:09:48.743706
NCT00210977|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-29|||December 2005||2005-12-01|August 2013|2013-08-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Observational|||A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies|An Observational Study of Subjects Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies|Withdrawn||Phase 4|0|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1|The study never started due to zero enrolment|f||||t||||||Samples With DNA|"~     Blood samples will be collected for pharmacogenomic analysis.~   "|||2017-02-18 17:09:48.834425|2017-02-18 17:09:48.834425
NCT00210964|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-27||2011-06-02|April 2005||2005-04-01|August 2012|2012-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Ceftobiprole in Hospital Acquired Pneumonia|A Phase III Randomized Double-Blind Study Of Ceftobiprole Versus Linezolid Plus Ceftazidime In The Treatment Of Nosocomial Pneumonia|Completed||Phase 3|781|Actual|Basilea Pharmaceutica||2|||f||||t||||||||||2017-02-18 17:09:48.942149|2017-02-18 17:09:48.942149
NCT00210951|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-23|||May 2003||2003-05-01|March 2015|2015-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin|An Active Safety Surveillance Plan to Conduct Serologic Testing for Anti-erythropoietin Antibodies and Prospectively Monitor the Incidence of Pure Red Cell Aplasia (PRCA) Among Patients Receiving Epoetin Alfa or Another Erythropoietin|Completed||Phase 4|4761|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||1||f||||f||||||||||2017-02-18 17:09:49.077835|2017-02-18 17:09:49.077835
NCT00210938|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||March 2004||2004-03-01|April 2010|2010-04-01|January 2006|Actual|2006-01-01|||||Interventional|||Doripenem in the Treatment of Complicated Intra-Abdominal Infections|A Multicenter, Double-Blind, Randomized, Phase 3 Study of Doripenem Versus Comparator Antibiotic in the Treatment of Complicated Intra-Abdominal Infections|Completed||Phase 3|478|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:49.192461|2017-02-18 17:09:49.192461
NCT00210925|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-06|||March 2004||2004-03-01|April 2010|2010-04-01|August 2006|Actual|2006-08-01|||||Interventional|||An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Alcohol Dependence|Completed||Phase 2|371|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:49.283498|2017-02-18 17:09:49.283498
NCT00210912|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||September 2003||2003-09-01|April 2010|2010-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches|A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Chronic Migraine|Completed||Phase 3|328|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:09:49.377833|2017-02-18 17:09:49.377833
NCT00210899|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-25|||September 2005||2005-09-01|July 2012|2012-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections|A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections|Completed||Phase 3|828|Actual|Basilea Pharmaceutica||2|||f||||f||||||||||2017-02-18 17:09:49.470449|2017-02-18 17:09:49.470449
NCT00210886|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||October 2004||2004-10-01|April 2010|2010-04-01|April 2006|Actual|2006-04-01|||||Interventional|||A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.|A Multicenter, Double-blind, Randomized Study to Compare the Efficacy and Safety of Levofloxacin 750 mg Once Daily for Five Days Versus Ciprofloxacin Twice Daily for Ten Days in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis.|Completed||Phase 3|1109|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:49.607525|2017-02-18 17:09:49.607525
NCT00210873|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||February 2004||2004-02-01|May 2010|2010-05-01|August 2005|Actual|2005-08-01|||||Interventional|||An Open Label Extension of a Study of Topiramate in Chronic Migraine.|An Open-label Study of the Safety and Efficacy of Topiramate for the Prophylaxis of Chronic Migraine: Extension Study to CAPSS-276|Completed||Phase 3|200|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:49.706108|2017-02-18 17:09:49.706108
NCT00208962|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-08-11|||September 1998||1998-09-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|September 2007|Actual|2007-09-01||Interventional|||Allogeneic Cell Therapy for Adults With Hematologic Malignancies|Allogeneic Cell Therapy for Adults With Hematologic Malignancies|Completed||Phase 2|32|Actual|Emory University||1|||f||||t||||||||||2017-02-18 17:10:13.777264|2017-02-18 17:10:13.777264
NCT00210860|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||September 2004||2004-09-01|April 2010|2010-04-01|March 2006|Actual|2006-03-01|||||Interventional|||An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.|An Open-label Study of the Safety and Efficacy of Topiramate for Migraine Prophylaxis: Extension Study to CAPSS-277|Completed||Phase 3|142|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:09:49.798274|2017-02-18 17:09:49.798274
NCT00210847|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||December 2003||2003-12-01|April 2010|2010-04-01|May 2005|Actual|2005-05-01|||||Interventional|||A Study Comparing the Effectiveness and Safety of Tramadol HCl/Acetaminophen Versus Placebo for the Treatment of Painful Neuropathy in Diabetic Patients|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Tramadol HCl/Acetaminophen for the Treatment of Painful Diabetic Neuropathy|Completed||Phase 3|313|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:09:49.88677|2017-02-18 17:09:49.88677
NCT00210834|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||May 2004||2004-05-01|May 2010|2010-05-01|September 2005|Actual|2005-09-01|||||Interventional|||An Efficacy and Safety Study of Epoetin Alfa (PROCRIT) Initiated at 40,000 Units Every Week Versus 80,000 Units Every Two Weeks in Anemic Patients With Cancer Receiving Chemotherapy.|A Randomized, Open-Label Study Of Epoetin Alfa (PROCRIT) Initiated At 40,000 Units Every Week Versus 80,000 Units Every Two Weeks In Anemic Patients With Cancer Receiving Chemotherapy|Completed||Phase 2|310|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:49.987963|2017-02-18 17:09:49.987963
NCT00210821|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||February 2004||2004-02-01|May 2010|2010-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches|A Comparison of Topiramate Versus Amitriptyline in Migraine Prophylaxis|Completed||Phase 3|347|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:50.076162|2017-02-18 17:09:50.076162
NCT00210808|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||September 2003||2003-09-01|April 2010|2010-04-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity|A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity|Completed||Phase 2/Phase 3|407|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:09:50.165149|2017-02-18 17:09:50.165149
NCT00210795|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||June 2004||2004-06-01|April 2010|2010-04-01|October 2005|Actual|2005-10-01|||||Interventional|||A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia|A Randomized, Double-blind, Placebo-controlled, Study to Assess Changes in Physical Function in Elderly Patients With Anemia of Chronic Disease (ACD) Receiving Epoetin Alfa (PROCRIT�)|Terminated||Phase 2|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||"This study was stopped due to slow enrollment after enrolling only 12 of 80 patients over 14~   months time."|||||t||||||||||2017-02-18 17:09:50.256246|2017-02-18 17:09:50.256246
NCT00210782|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||June 2004||2004-06-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment|A Double-blind Trial Comparing the Efficacy, Tolerability and Safety of Monotherapy Topiramate Versus Phenytoin in Subjects With Seizures Indicative of New Onset Epilepsy|Completed||Phase 3|262|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:50.347761|2017-02-18 17:09:50.347761
NCT00210769|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-17|||January 2004||2004-01-01|April 2010|2010-04-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia|Open-label Extension of A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of 2 Fixed Dosages of Extended Release OROS� Paliperidone (6 and 12 mg/Day) and Olanzapine (10 mg/Day), in Patients With Schizophrenia|Completed||Phase 3|203|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:50.438638|2017-02-18 17:09:50.438638
NCT00210756|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||February 2004||2004-02-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.|Comparative Pharmacokinetic and Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Anemic Critically Ill Patients Randomized to One of Six Dose Regimens for 15 Days|Completed||Phase 2|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:50.530405|2017-02-18 17:09:50.530405
NCT00210743|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-19|||May 2004||2004-05-01|April 2010|2010-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.|An Open-Label, Clinical Evaluation of the Initiation of Every 2 Week Epoetin Alfa (PROCRIT)in the Treatment of Subjects With the Anemia of Chronic Kidney Disease (CKD)|Completed||Phase 2|67|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:50.635737|2017-02-18 17:09:50.635737
NCT00210730|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||June 2004||2004-06-01|March 2010|2010-03-01|July 2005|Actual|2005-07-01|||||Interventional|||The Duration Study|An Open Label Randomized Study To Evaluate The Response Rate Of Epoetin Alfa (PROCRIT�) Versus No/Delayed PROCRIT Treatment In Patients With Cancer And Persistent Chemotherapy-Induced Myelosuppression (Anemia)|Terminated||Phase 3|2|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||This study was stopped early due to slow enrollment.|||||f||||||||||2017-02-18 17:09:50.728326|2017-02-18 17:09:50.728326
NCT00210717|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-06|||February 2005||2005-02-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia|A Randomized, Double-Blind, Parallel Group, Comparative Study of Flexibly Dosed Paliperidone Palmitate (25, 50, 75, or 100 mg eq.) Administered Every 4 Weeks and Flexibly Dosed RISPERDAL CONSTA (25, 37.5, or 50 mg) Administered Every 2 Weeks in Subjects With Schizophrenia|Completed||Phase 3|748|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:09:50.817753|2017-02-18 17:09:50.817753
NCT00208520|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-11|||July 2003||2003-07-01|September 2006|2006-09-01|June 2007||2007-06-01|||||Interventional|||Second-Line Treatment Choice for Epilepsy|Second-Line Treatment Choice for Epilepsy|Unknown status|Active, not recruiting|N/A|60||Dutch Epilepsy Clinics Foundation|||||f||||||||||||||2017-02-18 17:10:18.059445|2017-02-18 17:10:18.059445
NCT00210704|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-06|||March 2005||2005-03-01|March 2010|2010-03-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation|A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation|Completed||Phase 3|1067|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||f||||||||||||||2017-02-18 17:09:50.911236|2017-02-18 17:09:50.911236
NCT00210691|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-18|||December 1999||1999-12-01|November 2010|2010-11-01|February 2004|Actual|2004-02-01|||||Interventional|||A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder|Risperidone Depot (Microspheres) in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|273|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:51.001151|2017-02-18 17:09:51.001151
NCT00210678|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-09|||March 2005||2005-03-01|October 2012|2012-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation|An Observational Study to Evaluate Intravaginal Ejaculatory Latency Time and Patient-Reported Outcomes in Men With and Without Premature Ejaculation|Completed||Phase 3|1115|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||2||f||||f||||||||||2017-02-18 17:09:51.089618|2017-02-18 17:09:51.089618
NCT00210665|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-07||||||November 2016|2016-11-01||||||||Expanded Access|||A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment|A Multicenter, Open-Label, Single-Arm Study of YONDELIS (Trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment|No longer available||Phase 3|||Janssen Research & Development, LLC|||||||||||||||||||2017-02-18 17:09:51.191399|2017-02-18 17:09:51.191399
NCT00210652|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-15||2013-01-15|July 2004||2004-07-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy|A Double-Blind, Placebo-Controlled, Dose-Titration Study to Determine Safety, Tolerability and Preliminary Efficacy of RWJ-333369 as Adjunctive Therapy in Subjects With Treatment-Resistant Partial Seizures (With or Without Secondary Generalization) or Primarily Generalized Tonic-Clonic Seizures|Completed||Phase 2|47|Actual|SK Life Science||1|||f||||||||||||||2017-02-18 17:09:51.313575|2017-02-18 17:09:51.313575
NCT00210639|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-02|2011-04-26||August 2002||2002-08-01|April 2014|2014-04-01|May 2010|Actual|2010-05-01|April 2010|Actual|2010-04-01||Observational|||A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection|A Multicenter, Long-Term, Active-Surveillance Study of Musculoskeletal Disorders That Occur After Initiating a Course of Levofloxacin (RWJ-25213-097) or Non-Fluoroquinolone Therapy for Acute Infectious Diseases in Children Who Were Enrolled in Phase 3 Clinical Trials Involving Levofloxacin Therapy|Completed||Phase 3|2233|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|This was an observational safety study with no efficacy endpoints. Adverse event data is entered into the appropriate section within this submission.||2||f||||f||||||||||2017-02-18 17:09:51.416873|2017-02-18 17:09:51.416873
NCT00210626|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-02|2009-06-26||August 2005||2005-08-01|April 2014|2014-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effect of Recombinant Human Erythropoietin (Epoetin Alfa (PROCRIT®)) on Functional Outcomes in Anemic, Critically Ill, Trauma Subjects|Terminated||Phase 2|192|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|The study was stopped early due to slow enrollment. Four subjects were randomized but withdrew prior to hospital entry and no data were collected|2|||f||||t||||||||||2017-02-18 17:09:52.47066|2017-02-18 17:09:52.47066
NCT00210613|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-06|||November 2004||2004-11-01|December 2010|2010-12-01|August 2005|Actual|2005-08-01|||||Interventional|||A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation|A Placebo-Controlled, Double-Blind, Randomized, Parallel Study of the Withdrawal Effects of Chronic Daily and As-Needed Dosing With Dapoxetine in the Treatment of Premature Ejaculation|Completed||Phase 3|199|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:53.052027|2017-02-18 17:09:53.052027
NCT00210600|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||May 2005||2005-05-01|April 2010|2010-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy|Assessment of Early and Standard Intervention With PROCRIT (Epoetin Alfa) 120,000 Units Once Every Three Weeks (Q3W) in Patients With Cancer Receiving Chemotherapy.|Completed||Phase 2|186|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:53.148214|2017-02-18 17:09:53.148214
NCT00210587|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||February 2005||2005-02-01|May 2010|2010-05-01|December 2005|Actual|2005-12-01|||||Interventional|||An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation|A Pilot Study to Evaluate the Response Rate of Epoetin Alfa (PROCRIT) at 80,000 Units Every Three Weeks in Anemic Patients With Cancer Not Receiving Chemotherapy or Radiation Therapy|Completed||Phase 3|51|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:53.248434|2017-02-18 17:09:53.248434
NCT00210574|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||March 2005||2005-03-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|||||Interventional|||A Pilot Study of Topiramate in Childhood Absence Epilepsy|A Pilot Study of Topiramate in Childhood Absence Epilepsy|Completed||Phase 2|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:53.336803|2017-02-18 17:09:53.336803
NCT00210561|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||March 2005||2005-03-01|April 2010|2010-04-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back Pain|A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) for the Treatment of Acute Low Back Pain|Terminated||Phase 4|22|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1||"Study was stopped shortly after initiation due to change in strategic direction of the~   company; no safety concerns were observed that impacted this decision."|||||f||||||||||2017-02-18 17:09:53.429231|2017-02-18 17:09:53.429231
NCT00210548|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-06|||April 2005||2005-04-01|April 2010|2010-04-01|June 2006|Actual|2006-06-01|||||Interventional|||A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (50 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Subjects With Schizophrenia|Completed||Phase 3|366|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:53.521302|2017-02-18 17:09:53.521302
NCT00210535|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-06|||June 2005||2005-06-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for the Prophylaxis of Migraine in Pediatric Subjects 12 to 17 Years of Age|Completed||Phase 3|110|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:09:53.610928|2017-02-18 17:09:53.610928
NCT00210522|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-15||2013-01-15|May 2005||2005-05-01|January 2013|2013-01-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy|A Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects With Refractory Partial Seizures (Protocol 333369-EPY-2003 [Double-blind] and Protocol 333369-EPY-2006 [Open-label Extension])|Completed||Phase 2|421|Actual|SK Life Science||1|||f||||||||||||||2017-02-18 17:09:53.702886|2017-02-18 17:09:53.702886
NCT00210509|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-16|||November 2004||2004-11-01|April 2010|2010-04-01|June 2005|Actual|2005-06-01|||||Interventional|||A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache|AXERT® Early miGraine Intervention Study (AEGIS): Efficacy and Safety of Almotriptan Malate (AXERT®) Versus Placebo for the Acute Treatment of Migraine Headache|Completed||Phase 4|378|Actual|Janssen-Ortho LLC||1|||||||||||||||||2017-02-18 17:09:53.803022|2017-02-18 17:09:53.803022
NCT00210496|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-16|||June 2005||2005-06-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine|Efficacy of AXERT (Almotriptan Malate) in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy With TOPAMAX (Topiramate)|Completed||Phase 4|406|Actual|Janssen-Ortho LLC|||||||||||||||||||2017-02-18 17:09:53.909026|2017-02-18 17:09:53.909026
NCT00210483|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-16|||July 2003||2003-07-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents|A Randomized, Double-blind, Placebo-controlled Study of Oral Almotriptan Malate (AXERT®) 6.25 mg, 12.5 mg, and 25 mg in the Acute Treatment of Migraine in Adolescents|Completed||Phase 3|866|Actual|Janssen-Ortho LLC||1|||||||||||||||||2017-02-18 17:09:53.999341|2017-02-18 17:09:53.999341
NCT00210470|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-22|2012-01-06||July 2005||2005-07-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer|A Phase 2, Open-label Trial of the Safety and Biological Effect of Subcutaneous IRX-2 (With Cyclophosphamide, Indomethacin, and Zinc) in Patients With Resectable Cancer of the Head and Neck|Completed||Phase 2|27|Actual|IRX Therapeutics||1|||f||||f||||||||||2017-02-18 17:09:54.102405|2017-02-18 17:09:54.102405
NCT00210457|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2008-06-26|||September 2000||2000-09-01|June 2008|2008-06-01||||||||Interventional|||Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients|Phase III, Multicentre, Open Study to Assess the Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients Previously Treated or Not by Somatostatin Analogues.|Completed||Phase 3|60||Ipsen|||||f||||||||||||||2017-02-18 17:09:54.418173|2017-02-18 17:09:54.418173
NCT00210444|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2007-09-12|||June 2003||2003-06-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy Study of Dysport® in the Treatment of Anal Fissure.|A Phase II, Multicentre, Open, Randomised, Parallel Group, Dose Ranging Study to Define the Efficacy of Dysport® in the Treatment of Anal Fissure.|Completed||Phase 2|152||Ipsen|||||f||||||||||||||2017-02-18 17:09:54.526373|2017-02-18 17:09:54.526373
NCT00210431|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-29|||October 2004||2004-10-01|September 2007|2007-09-01|June 2006|Actual|2006-06-01|||||Observational|||Post Marketing Surveillance Study of Dysport|A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research.|Completed||Phase 4|800||Ipsen|||1||f||||||||||||||2017-02-18 17:09:54.615312|2017-02-18 17:09:54.615312
NCT00210418|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-29|||May 2002||2002-05-01|August 2012|2012-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Effectiveness of Targeting Food Aid to Malnourished Children Compared to Targeting All Children Under Two Years|Prevention or Cure: A Comparison of the Effectiveness of Targeting Food Supplements to Malnourished Children Compared to Universal Targeting of Children Under Two in Haiti|Completed||N/A|1500||International Food Policy Research Institute||2|||f||||||||||||||2017-02-18 17:09:54.742434|2017-02-18 17:09:54.742434
NCT00210405|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-29|||March 2005||2005-03-01|August 2012|2012-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Feasibility and Effectiveness of Distributing Micronutrient Sprinkles to Reduce Prevalence of Anemia|Assessing the Feasibility and Effectiveness of Distributing Micronutrient Sprinkles Within a Title II Food Aid and Maternal and Child Health Program in Rural Haiti|Completed||N/A|450|Actual|International Food Policy Research Institute||2|||f||||||||||||||2017-02-18 17:09:54.856669|2017-02-18 17:09:54.856669
NCT00210392|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-27|||July 2005||2005-07-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy|Phase II Study of VELCADE in Patients With Extranodal Marginal Zone B-Cell Lymphoma of MALT-Type Pretreated With More Than One Prior Systemic Therapy Regimen (X05142)|Terminated||Phase 2|12|Actual|International Extranodal Lymphoma Study Group (IELSG)||1||"After IELSG25A study amendment, patients subject of the present study were eligible for~   inclusion in the IELSG25A study"|f||||t||||||||||2017-02-18 17:09:54.973189|2017-02-18 17:09:54.973189
NCT00210379|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-07-21|||November 2000||2000-11-01|July 2009|2009-07-01|March 2007|Actual|2007-03-01|November 2004|Actual|2004-11-01||Interventional|||Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma|A Phase II Study of CHOP + Rituximab, With Intrathecal Methotrexate Followed by Radiotherapy in Patients With Primary Testicular Non-Hodgkin's Lymphoma|Completed||Phase 2|64|Actual|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||||||||||||2017-02-18 17:09:55.07454|2017-02-18 17:09:55.07454
NCT00210366|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-07-29|||November 2004||2004-11-01|July 2010|2010-07-01||||July 2010|Actual|2010-07-01||Interventional|||Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma|Salvage Therapy With Idarubicin in Immunocompetent Patients With Relapsed or Refractory Primary Central Nervous System Lymphomas|Terminated||Phase 2|25|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||||due to slow accrual|f||||||||||||||2017-02-18 17:09:55.172701|2017-02-18 17:09:55.172701
NCT00210353|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-07-26|||January 2003||2003-01-01|July 2016|2016-07-01|April 2020|Anticipated|2020-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma|Multicenter Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)|Active, not recruiting||Phase 3|450|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||3|||f||||t||||||||||2017-02-18 17:09:55.27411|2017-02-18 17:09:55.27411
NCT00210340|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-27||||||March 2015|2015-03-01||||||||Interventional|||A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis|A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis|Withdrawn||Phase 1|0|Actual|International Extranodal Lymphoma Study Group (IELSG)||1||lack of accrual|f||||||||||||||2017-02-18 17:09:55.453076|2017-02-18 17:09:55.453076
NCT00210327|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-07-21|||July 2005||2005-07-01|July 2009|2009-07-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy|Phase II Study of VELCADE in Patients With Extranodal Marginal Zone B-cell Lymphoma of MALT-type Pretreated With Prior Systemic Therapy Regimen (X05142)|Completed||Phase 2|33|Anticipated|International Extranodal Lymphoma Study Group (IELSG)||1|||f||||t||||||||||2017-02-18 17:09:55.534149|2017-02-18 17:09:55.534149
NCT00210314|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-27|||July 2003||2003-07-01|March 2015|2015-03-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma|Randomized Phase II Trial on Primary Chemotherapy With High-dose Methotrexate, Alone or Associated With High-dose Cytarabine, Followed by Response- and Age-tailored Radiotherapy for Immunocompetent Patients With Newly Diagnosed Primary Central Nervous System Lymphoma|Completed||Phase 2|79|Actual|International Extranodal Lymphoma Study Group (IELSG)||2|||f||||||||||||||2017-02-18 17:09:55.629302|2017-02-18 17:09:55.629302
NCT00210301|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-06|||January 2003||2003-01-01|August 2005|2005-08-01||||||||Interventional|||Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS|Combination Therapy (Provigil + Avonex) in the Treatment of Attention Problems in Patients With Relapsing-Remitting MS|Unknown status|Recruiting|N/A|60||Institute for Clinical Research|||||f||||||||||||||2017-02-18 17:09:55.740228|2017-02-18 17:09:55.740228
NCT00210288|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-11|||May 2005||2005-05-01|March 2010|2010-03-01|April 2007|Actual|2007-04-01|September 2006|Actual|2006-09-01||Interventional|||Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine|A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 10^5 and 10^7 CFU of SC599 Oral Vaccine, a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers|Completed||Phase 2|111|Anticipated|Institut Pasteur|||||f||||||||||||||2017-02-18 17:09:55.83471|2017-02-18 17:09:55.83471
NCT00210275|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-25|||July 2005||2005-07-01|March 2015|2015-03-01|July 2016|Anticipated|2016-07-01|July 2015|Anticipated|2015-07-01||Interventional|OPEMS||Ontario Printed Educational Materials (PEMs) for Physician Behaviour Change|The Ontario Printed Educational Message (OPEM) Trial to Narrow the Evidence-practice Gap With Respect to Prescribing Practices of General and Family Physicians: a Cluster Randomized Controlled Trial|Active, not recruiting||N/A|5000|Anticipated|Institute for Clinical Evaluative Sciences||4|||f||||f||||||||||2017-02-18 17:09:55.932019|2017-02-18 17:09:55.932019
NCT00210262|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2005-09-15|||October 2002||2002-10-01|November 2003|2003-11-01|January 2005||2005-01-01|||||Interventional|||Promoting Blood Pressure Control and Cholesterol Reduction to Prevent Major Complications in Persons With Diabetes|Promoting Blood Pressure Control and Cholesterol Reduction to Prevent Major Complications in Persons With Diabetes|Completed||N/A|||Institute for Clinical Evaluative Sciences|||||f||||||||||||||2017-02-18 17:09:56.024855|2017-02-18 17:09:56.024855
NCT00210249|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-25|||September 2002||2002-09-01|September 2005|2005-09-01|June 2006|Actual|2006-06-01|||||Observational|ONCOGERIATRIE||Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment|Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment . Geriatric Oncology Protocol in Aquitaine Country.|Completed||N/A|360|Actual|Institut Bergonié|||1||f||||||||||||||2017-02-18 17:09:56.109691|2017-02-18 17:09:56.109691
NCT00210236|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-25|||September 1995||1995-09-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|AXIL95||Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer|Surgical Resection With or Without Axillary Lymph Node Excision in Treating Menopausal Women With Infiltrative Breast Cancer Smaller Than 10 mm|Terminated||Phase 3|592|Actual|Institut Bergonié|||||f||||||||||||||2017-02-18 17:09:56.455428|2017-02-18 17:09:56.455428
NCT00210223|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-25|||April 2004||2004-04-01|October 2007|2007-10-01|July 2006|Actual|2006-07-01|||||Interventional|RF SEIN||Radiofrequency of Breast Cancers in Non Surgical Patients|Radiofrequency of Breast Cancers : Pilot Study in Non Surgical Patients|Completed||N/A|15|Actual|Institut Bergonié|||||f||||||||||||||2017-02-18 17:09:56.565459|2017-02-18 17:09:56.565459
NCT00210210|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-25|||February 2004||2004-02-01|October 2007|2007-10-01|December 2005|Actual|2005-12-01|||||Interventional|KETAMINE||Administration of Ketamine to Prevent the Post-operative Pain|Effect of Ketamine, at the Induction and Its Maintenance to Prevent the Post-operative Pain: Clinical Trial in Cancerology|Completed||Phase 3|230|Actual|Institut Bergonié|||||f||||||||||||||2017-02-18 17:09:56.660544|2017-02-18 17:09:56.660544
NCT00210197|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-25|||January 2005||2005-01-01|October 2007|2007-10-01|January 2006|Actual|2006-01-01|||||Observational|EHC||Hypercoagulability After Breast Cancer Surgery|Plasma Coagulation Parameters and Hypercoagulability After Breast Cancer Surgery|Completed||N/A|48|Actual|Institut Bergonié|||1||f||||||||||||||2017-02-18 17:09:56.744627|2017-02-18 17:09:56.744627
NCT00210184|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-12-29|||July 2004||2004-07-01|October 2007|2007-10-01|July 2009||2009-07-01|||||Interventional|CEPAFIRI||Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer|Multicentric Phase II Trial: Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years Old and More Presenting Gastric Cancer Locally Advanced or Metastatic|Completed||Phase 2|43|Anticipated|Institut Bergonié|||||f||||||||||||||2017-02-18 17:09:56.83198|2017-02-18 17:09:56.83198
NCT00210171|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-25|||May 2004||2004-05-01|October 2007|2007-10-01|March 2007|Actual|2007-03-01|||||Interventional|BIB 01||Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer|Multicentric Phase II Study of Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-radiotherapy by Weekly Cisplatin - Docetaxel- Consolidation Chemotherapy by Docetaxel|Terminated||Phase 2|3|Actual|Institut Bergonié|||||f||||||||||||||2017-02-18 17:09:56.929045|2017-02-18 17:09:56.929045
NCT00210158|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-25|||January 2005||2005-01-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|PROTOX||Intraoperative Nitrous Oxide and Postoperative Pain for Patients With Current Opioid Treatment|Effects of Intraoperative Nitrous Oxide on Postoperative Pain for Patients With Current Opioid Treatment After Vertebroplasty.|Completed||N/A|36|Actual|Institut Bergonié|||||f||||||||||||||2017-02-18 17:09:57.028052|2017-02-18 17:09:57.028052
NCT00210145|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-12-29|||October 2003||2003-10-01|October 2007|2007-10-01|June 2006|Actual|2006-06-01|||||Observational|ASE K SEIN||Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer.|Impact of a Socio-aesthetic Intervention on Body Image and Quality of Life in Patients With Mastectomy or Tumorectomy for Breast Cancer.|Completed||N/A|100|Anticipated|Institut Bergonié|||1||f||||||||||||||2017-02-18 17:09:57.121062|2017-02-18 17:09:57.121062
NCT00210132|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-25|||October 2003||2003-10-01|November 2015|2015-11-01|February 2008|Actual|2008-02-01|June 2006|Actual|2006-06-01||Interventional|ROPAL 1||Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery|Randomized Trial to Evaluate the Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery|Completed||Phase 2|90|Actual|Institut Bergonié||1|||f||||||||||||||2017-02-18 17:09:57.206712|2017-02-18 17:09:57.206712
NCT00210119|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-25|||September 2005||2005-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|AFR22||Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response|Multicentric Phase II Study to Evaluate Feasibility and Efficacy of Association of Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response After One Year of Imatinib Mesylate Monotherapy|Terminated||Phase 2|17|Actual|Institut Bergonié|||||f||||||||||||||2017-02-18 17:09:57.312382|2017-02-18 17:09:57.312382
NCT00210106|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-03|||June 2003||2003-06-01|March 2015|2015-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|ARF2003||Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.|Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. A Phase 2 Study.|Completed||Phase 2|53|Anticipated|Institut Bergonié|||||f||||f||||||||||2017-02-18 17:09:57.41631|2017-02-18 17:09:57.41631
NCT00210093|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-15|||April 2003||2003-04-01|October 2015|2015-10-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||A Pharmacokinetic Evaluation Study in Healthy Volunteers|A Single-Center, Randomized, Crossover Pharmacokinetic Evaluation of the Effect of Single Doses of Intravenous INS37217, Nasally Inhaled INS37217 and Orally Inhaled INS37217 Solution in Healthy Volunteers|Completed||Phase 1|12|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:09:57.52898|2017-02-18 17:09:57.52898
NCT00210080|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-03|||April 2001||2001-04-01|September 2015|2015-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)|A Double-Blind, Placebo-Controlled, Parallel Group Study of Uridine 5'-Triphosphate (UTP) Solution for Inhalation as an Adjunct in the Diagnosis of Lung Cancer by Sputum Cytology|Completed||Phase 3|700||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:09:57.601874|2017-02-18 17:09:57.601874
NCT00210067|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-08|||May 2001||2001-05-01|October 2015|2015-10-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||A Study in Subjects With Retinal Detachment|A Double-Masked, Randomized, Dose-Ranging Study of a Single Intravitreal (IVT) Injection of INS37217 Intravitreal Injection in Subjects With Retinal Detachment|Completed||Phase 1|14|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:09:57.68307|2017-02-18 17:09:57.68307
NCT00210054|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-09|||November 2002||2002-11-01|October 2015|2015-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Pharmacokinetic Evaluation Study in Healthy Volunteers|Pilot Single-Dose Intravenous Pharmacokinetic Evaluation of INS37217 Solution in Healthy Volunteers|Completed||Phase 1|4|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:09:57.763904|2017-02-18 17:09:57.763904
NCT00210041|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-03-26|||February 2004||2004-02-01|March 2015|2015-03-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma|Phase 2 Study for Treatment of Penis Epidermoid Carcinoma Loco-regionally Advanced or Metastatic by Association Gemcitabine-Cisplatin|Completed||Phase 2|50|Anticipated|Institut Claudius Regaud||1|||f||||||||||||||2017-02-18 17:09:57.84457|2017-02-18 17:09:57.84457
NCT00210028|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-10|||August 2003||2003-08-01|November 2006|2006-11-01|August 2008||2008-08-01|||||Interventional|||Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer|Open, Single-Arm Phase II Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer Expressing the Estrogen and/or Progesterone Receptor|Terminated||Phase 2|40||Institut Claudius Regaud|||||f||||||||||||||2017-02-18 17:09:57.964556|2017-02-18 17:09:57.964556
NCT00210015|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-22|||December 2002||2002-12-01|January 2016|2016-01-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||A Study in Subjects With Perennial Allergic Rhinitis|A Multi-Center, Randomized, Parallel-Group, Double-Blind, Efficacy and Safety Study of INS37217 Nasal Spray Versus Placebo in Subjects With Perennial Allergic Rhinitis|Completed||Phase 2|630||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:09:58.068073|2017-02-18 17:09:58.068073
NCT00210002|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-13|||November 2003||2003-11-01|November 2006|2006-11-01|April 2006||2006-04-01|||||Interventional|||Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced|Evaluation of Systematic Intravenous Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced.|Terminated||Phase 2|55||Institut Claudius Regaud|||||f||||||||||||||2017-02-18 17:09:58.149796|2017-02-18 17:09:58.149796
NCT00208507|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-18|2011-01-21||April 2003||2003-04-01|December 2013|2013-12-01|December 2010|Actual|2010-12-01|March 2008|Actual|2008-03-01||Interventional|||28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study|Delta Ceramax™ Ceramic-on-Ceramic Acetabular Cup Prosthesis Study (28mm)|Completed||N/A|264|Actual|DePuy Orthopaedics||2|||f||||f||||||||||2017-02-18 17:10:18.166263|2017-02-18 17:10:18.166263
NCT00209989|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-23|||October 2005||2005-10-01|November 2011|2011-11-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme|Phase I/II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme|Completed||Phase 2|27|Actual|Institut Claudius Regaud||1|||f||||||||||||||2017-02-18 17:09:58.247301|2017-02-18 17:09:58.247301
NCT00209963|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-03-29|||June 2003||2003-06-01|March 2007|2007-03-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of Gaboxadol in Primary Insomnia|A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia|Completed||Phase 3|600||H. Lundbeck A/S|||||f||||f||||||||||2017-02-18 17:09:58.343732|2017-02-18 17:09:58.343732
NCT00209950|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-03-29|||July 2004||2004-07-01|March 2007|2007-03-01|September 2005|Actual|2005-09-01|||||Interventional|||A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia|A Prospective Open-Label Extension Study (to Study 99784) of Gaboxadol in Primary Insomnia|Completed||Phase 3|200||H. Lundbeck A/S|||||f||||f||||||||||2017-02-18 17:09:58.419091|2017-02-18 17:09:58.419091
NCT00209937|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-03-29|||January 2003||2003-01-01|March 2007|2007-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia|A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Active-Reference Study of Gaboxadol in Primary Insomnia|Completed||Phase 3|675||H. Lundbeck A/S|||||f||||f||||||||||2017-02-18 17:09:58.518004|2017-02-18 17:09:58.518004
NCT00209924|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-03-29|||April 2004||2004-04-01|March 2007|2007-03-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of Gaboxadol in Primary Insomnia|A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia|Completed||Phase 3|505||H. Lundbeck A/S|||||f||||f||||||||||2017-02-18 17:09:58.604932|2017-02-18 17:09:58.604932
NCT00209911|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2001||2001-01-01|January 2001|2001-01-01|January 2003||2003-01-01|||||Observational|||Study of the Effect of Cardioversion on Cardiac Volume in Patients With Persistent Atrial Fibrillation|Atrial and Ventricular Volume and Function In Atrial Fibrillation - A Magnetic Resonance Imaging Study|Terminated||N/A|60||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:09:58.694039|2017-02-18 17:09:58.694039
NCT00209898|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-19|||August 2003||2003-08-01|June 2003|2003-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|PEGPRI||Hepatitis C Treatment of Inmates|Hepatitis C Treatment of Inmates. A Randomized, Open-label Study Evaluating the Feasibility, Safety and Efficacy of Treatment With Peginterferon Alfa-2a in Combination With Ribavirin in Inmate Patients With Chronic Hepatitis C|Terminated||Phase 4|42|Anticipated|Haukeland University Hospital||2||Low inclusion rate|f||||f||||||||||2017-02-18 17:09:58.769429|2017-02-18 17:09:58.769429
NCT00209885|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy||Unknown status|Not yet recruiting|Phase 4|60||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:09:58.871805|2017-02-18 17:09:58.871805
NCT00209872|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-11-06|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||Optimal Multimodal Analgesia in Abdominal Hysterectomy||Unknown status|Not yet recruiting|Phase 4|60|Anticipated|Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:09:58.967269|2017-02-18 17:09:58.967269
NCT00209859|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16|||October 1998||1998-10-01|September 2005|2005-09-01|November 2007||2007-11-01|||||Interventional|||Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis|Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis.|Completed||Phase 4|160||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:09:59.060103|2017-02-18 17:09:59.060103
NCT00209846|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-03-29|||June 2004||2004-06-01|March 2007|2007-03-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study of Gaboxadol in Primary Insomnia|A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia|Completed||Phase 3|320||H. Lundbeck A/S|||||f||||f||||||||||2017-02-18 17:09:59.151351|2017-02-18 17:09:59.151351
NCT00209833|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-11-17|||January 1999||1999-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T|Protocol for the Treatment of Adults Aged </= 60 Years With De Novo Acute Myeloblastic Leukaemia or Secondary AML or RAEB-T (AML 01/99 Trial)|Unknown status|Active, not recruiting|Phase 2/Phase 3|200||Hannover Medical School|||||f||||||||||||||2017-02-18 17:09:59.243899|2017-02-18 17:09:59.243899
NCT00209820|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-10|||September 2005||2005-09-01|September 2005|2005-09-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Nordic Walking and Chronic Low Back Pain||Unknown status|Recruiting|N/A|150||Human Locomotion Science|||||f||||||||||||||2017-02-18 17:09:59.408778|2017-02-18 17:09:59.408778
NCT00209807|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-26|||September 2005||2005-09-01|May 2010|2010-05-01|April 2011|Anticipated|2011-04-01|June 2009|Anticipated|2009-06-01||Interventional|||Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder|Effect of Escitalopram vs. Reboxetine on Somatic and Visceral Sensitivity of Patients With Major Depressive Disorder: a Randomized, Double Blind Clinical Trial|Unknown status|Recruiting|Phase 4|42|Anticipated|Hospital Universitari Vall d'Hebron Research Institute||3|||f||||||||||||||2017-02-18 17:09:59.492435|2017-02-18 17:09:59.492435
NCT00209794|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-15|||September 2002||2002-09-01|November 2006|2006-11-01|December 2005||2005-12-01|||||Interventional|||IPTi in Mozambican Infants for Malaria Prevention|The Impact of Intermittent Malaria Treatment Administered Through the EPI Scheme on Malaria Morbidity in Mozambican Children|Unknown status|Active, not recruiting|Phase 1/Phase 2|1498||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 17:09:59.59888|2017-02-18 17:09:59.59888
NCT00209781|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-29|||August 2003||2003-08-01|February 2008|2008-02-01|December 2006||2006-12-01|||||Interventional|||IPTp Plus ITNs for Malaria Control in Pregnant Women|Effect of Intermittent Preventive Treatment (IPTp) With Sulfadoxine-Pyrimethamine Plus Insecticide Treated Nets, Delivered Through Antenatal Clinics for the Prevention of Malaria in Mozambican Pregnant Women|Unknown status|Active, not recruiting|N/A|1028||Hospital Clinic of Barcelona|||||f||||||||||||||2017-02-18 17:09:59.694235|2017-02-18 17:09:59.694235
NCT00209768|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-11-28|||February 2005||2005-02-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Use of In-Line Filtration in Critically Ill Children|Randomised, Prospective Study of the Use of In-Line Filtration on the Reduction of Complication Rate in Critically Ill Children|Completed||Phase 4|821|Actual|Hannover Medical School||2|||f||||||||||||||2017-02-18 17:09:59.78993|2017-02-18 17:09:59.78993
NCT00209755|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 2003||2003-10-01|September 2004|2004-09-01|July 2004||2004-07-01|||||Interventional|||Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C|Diagnostic Value of Plasma Ribavirin Assay During the Combination Therapy « Pegylated Interferon + Ribavirin » in Chronic Hepatitis C.|Terminated||N/A|40||Hopital A Michallon|||||f||||||||||||||2017-02-18 17:09:59.879133|2017-02-18 17:09:59.879133
NCT00209742|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-05-24|||April 2005||2005-04-01|May 2010|2010-05-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer|Randomized Phase III Clinical Study Comparing Postoperative UFT+LV, UFT+LV/UFT and UFT+LV+PSK/UFT+PSK Therapies for Stage III Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|340|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||3|||f||||t||||||||||2017-02-18 17:09:59.981159|2017-02-18 17:09:59.981159
NCT00209729|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-24|||April 2005||2005-04-01|May 2010|2010-05-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|||Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.|Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer|Suspended||Phase 1/Phase 2|50|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1||Registration is less|f||||t||||||||||2017-02-18 17:10:00.126935|2017-02-18 17:10:00.126935
NCT00209716|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-24|||December 2003||2003-12-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|October 2009|Actual|2009-10-01||Interventional|||Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.|Phase I/II Study of Docetaxel, Cisplatin and 5-fluorouracil(TPF) as Chemotherapy in Pre-treated Patients With Metastatic Esophageal Cancer.|Completed||Phase 1/Phase 2|30|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1|||f||||t||||||||||2017-02-18 17:10:00.238144|2017-02-18 17:10:00.238144
NCT00209703|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-04-19|||January 2005||2005-01-01|April 2006|2006-04-01|June 2007||2007-06-01|||||Interventional|||Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer|Feasibility Study of mFOLFOX6 (Oxaliplatin Combined With l-Leucovorin (l-LV) and 5-Fluorouracil) in Patients With Advanced Colorectal Cancer|Terminated||Phase 2|30||Hokkaido Gastrointestinal Cancer Study Group|||||f||||||||||||||2017-02-18 17:10:00.349499|2017-02-18 17:10:00.349499
NCT00209690|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-24|||October 2003||2003-10-01|May 2010|2010-05-01|April 2010|Actual|2010-04-01|December 2009|Actual|2009-12-01||Interventional|||Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.|Phase I/II Study of Docetaxel, Cisplatin and 5-fluorouracil(TPF) as 1st-line Chemotherapy in Patients With Metastatic Esophageal Cancer.|Completed||Phase 1/Phase 2|30|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1|||f||||t||||||||||2017-02-18 17:10:00.439879|2017-02-18 17:10:00.439879
NCT00209677|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-31|||December 2004||2004-12-01|October 2007|2007-10-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer|Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer|Suspended||Phase 1/Phase 2|40|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1||"Unfortunately, other Phase III clinical Study (GEM+S-1 vs GEM vs S-1) have been started in~   Japan.~    h"|f||||t||||||||||2017-02-18 17:10:03.410911|2017-02-18 17:10:03.410911
NCT00209664|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-01-31|||January 2004||2004-01-01|January 2004|2004-01-01|December 2008||2008-12-01|||||Interventional|||Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer|Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0303|Suspended||Phase 2|40||Hokkaido Gastrointestinal Cancer Study Group|||||f||||||||||||||2017-02-18 17:10:03.499812|2017-02-18 17:10:03.499812
NCT00209651|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-31|||January 2004||2004-01-01|October 2007|2007-10-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer|Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302|Unknown status|Active, not recruiting|Phase 2|40|Actual|Hokkaido Gastrointestinal Cancer Study Group||1|||f||||t||||||||||2017-02-18 17:10:03.58932|2017-02-18 17:10:03.58932
NCT00209638|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-04-19|||May 2000||2000-05-01|April 2006|2006-04-01|April 2003||2003-04-01|||||Interventional|||Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer|Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0101|Completed||Phase 1/Phase 2|24||Hokkaido Gastrointestinal Cancer Study Group|||||f||||||||||||||2017-02-18 17:10:03.704469|2017-02-18 17:10:03.704469
NCT00209625|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||April 2000||2000-04-01|April 2000|2000-04-01|November 2004||2004-11-01|||||Interventional|||Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer|Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer：Hokkaido Gastrointestinal Cancer Study Group:HGCSG0001|Completed||Phase 1/Phase 2|23||Hokkaido Gastrointestinal Cancer Study Group|||||f||||||||||||||2017-02-18 17:10:03.790815|2017-02-18 17:10:03.790815
NCT00209612|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-16|||April 2004||2004-04-01|February 2009|2009-02-01|March 2009|Anticipated|2009-03-01|November 2008|Anticipated|2008-11-01||Interventional|||Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.|Phase I/II Study of Biweekly Administration Regimen of Paclitaxel Combined With CPT-11 in Patients With Second Line Chemotherapy of Inoperable or Recurrent Gastric Cancer(GC).|Withdrawn||Phase 1/Phase 2|40|Anticipated|Hokkaido Gastrointestinal Cancer Study Group||1||due to strong side effect|f||||t||||||||||2017-02-18 17:10:03.884334|2017-02-18 17:10:03.884334
NCT00209599|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-11-06|||February 2005||2005-02-01|November 2008|2008-11-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy|A Phase II, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Colonoscopy Procedures|Terminated||Phase 2|100||Eisai Inc.|||||||||||||||||||2017-02-18 17:10:03.989542|2017-02-18 17:10:03.989542
NCT00209586|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-01-31|||September 2004||2004-09-01|January 2012|2012-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy|A Phase III, Randomized, Open-label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Flexible Bronchoscopy Procedures|Terminated||Phase 3|55|Actual|Eisai Inc.||||"Patient enrollment was stopped prior to completion of the study in order to re-evaluate the~   dosing regimen."|||||||||||||||2017-02-18 17:10:04.084655|2017-02-18 17:10:04.084655
NCT00209573|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-11-06|||September 2004||2004-09-01|November 2008|2008-11-01|December 2004|Actual|2004-12-01|||||Interventional|||A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy|A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN Injection Versus Midazolam HCl for Sedation in Patients Undergoing Colonoscopy Procedures|Completed||Phase 3|270||Eisai Inc.|||||||||||||||||||2017-02-18 17:10:04.167076|2017-02-18 17:10:04.167076
NCT00209560|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-22|2012-03-01||October 2004||2004-10-01|July 2014|2014-07-01|March 2005||2005-03-01|||||Interventional|||A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures|A Phase III, Randomized, Open-label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Minor Surgical Procedures|Terminated||Phase 3|168|Actual|Eisai Inc.|Analysis of results from a previous fospropofol study (3000-0410) completed during the enrollment of this study indicated that the dosing regimen needed to be re-evaluated. The study was prematurely terminated after 168 subjects were randomized.||||f||||||||||||||2017-02-18 17:10:04.257675|2017-02-18 17:10:04.257675
NCT00209547|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-11-06|||February 2004||2004-02-01|November 2008|2008-11-01|March 2005|Actual|2005-03-01|||||Interventional|||Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization|A Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Percutaneous Coronary (PC) Procedures|Completed||Phase 3|110||Eisai Inc.|||||||||||||||||||2017-02-18 17:10:05.262653|2017-02-18 17:10:05.262653
NCT00209534|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-12-03|||January 2003||2003-01-01|December 2009|2009-12-01|February 2004|Actual|2004-02-01|||||Interventional|||A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy|A Phase 2, Two Part Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy|Completed||Phase 2|200||Eisai Inc.|||||||||||||||||||2017-02-18 17:10:05.353452|2017-02-18 17:10:05.353452
NCT00209521|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-10|||June 2002||2002-06-01|June 2010|2010-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery|Phase 2, Randomized Study of AQUAVAN® Injection In Elective Coronary Artery Surgery With Comparison to DISOPRIVAN® Injectable Emulsion|Completed||Phase 2|16|Actual|Eisai Inc.||2|||f||||f||||||||||2017-02-18 17:10:05.435693|2017-02-18 17:10:05.435693
NCT00209508|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-11-06|||November 2002||2002-11-01|November 2008|2008-11-01|October 2005|Actual|2005-10-01|||||Interventional|||2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 2-Year Study To Evaluate The Effects Of GPI 1485 On [123I]b-CIT/SPECT Scanning And Clinical Efficacy In Symptomatic PD Patients Receiving Dopamine Agonist Therapy.|Completed||Phase 2|200||Eisai Inc.|||||f||||||||||||||2017-02-18 17:10:05.541055|2017-02-18 17:10:05.541055
NCT00209495|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-28|||June 2005||2005-06-01|February 2008|2008-02-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Paracetamol,Pregabalin and Dexamethasone on Pain and Opioid Requirements in Postoperative Patients|Effect of Paracetamol Versus Paracetamol Combined With Pregabalin Versus Paracetamol Combined With Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Abdominal Hysterectomy.|Completed||Phase 4|130|Actual|Glostrup University Hospital, Copenhagen||3|||f||||t||||||||||2017-02-18 17:10:05.630831|2017-02-18 17:10:05.630831
NCT00209482|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-04|||October 2003||2003-10-01|November 2005|2005-11-01|November 2007||2007-11-01|||||Interventional|||Glaser Obesity Study|A Multi-Center, Randomized, Placebo Controlled, Double Blind Trial of Metformin in Obese Adolescents.|Unknown status|Active, not recruiting|Phase 2/Phase 3|76||Glaser Pediatric Research Network|||||f||||||||||||||2017-02-18 17:10:05.741718|2017-02-18 17:10:05.741718
NCT00209469|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-13|||July 2002||2002-07-01|September 2005|2005-09-01|February 2007||2007-02-01|||||Interventional|||Network Osteoporosis Study|Double Blind Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid-Associated Osteopenia and Osteoporosis|Unknown status|Active, not recruiting|Phase 2/Phase 3|90||Glaser Pediatric Research Network|||||||||||||||||||2017-02-18 17:10:05.831489|2017-02-18 17:10:05.831489
NCT00209456|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-15|||November 2003||2003-11-01|May 2007|2007-05-01||||||||Interventional|||Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia|GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title|Completed||Phase 3|326||GE Healthcare|||||f||||||||||||||2017-02-18 17:10:05.922551|2017-02-18 17:10:05.922551
NCT00209443|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-30|||September 2004||2004-09-01|October 2007|2007-10-01||||||||Interventional|||A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-Iliac Arteries While Using Gadodiamide||Completed||Phase 3|295||GE Healthcare|||||||||||||||||||2017-02-18 17:10:06.023941|2017-02-18 17:10:06.023941
NCT00209430|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-30|||August 2005||2005-08-01|October 2007|2007-10-01||||||||Interventional|||Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography|GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title.|Completed||Phase 4|408||GE Healthcare|||||f||||||||||||||2017-02-18 17:10:06.108105|2017-02-18 17:10:06.108105
NCT00209417|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2014-10-09|2014-10-02||June 2005||2005-06-01|October 2014|2014-10-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography|GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title.|Terminated||Phase 4|656|Actual|GE Healthcare||2||"Supported by preliminary interim analysis. Not based on any safety signals in study or any~   quality issues that could affect efficacy of the product."|f||||||||||||||2017-02-18 17:10:06.201447|2017-02-18 17:10:06.201447
NCT00209404|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2007-10-30|||July 2005||2005-07-01|October 2007|2007-10-01||||||||Interventional|||Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)||Completed||Phase 4|50||GE Healthcare|||||f||||||||||||||2017-02-18 17:10:07.115812|2017-02-18 17:10:07.115812
NCT00209391|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-30|||September 2003||2003-09-01|October 2007|2007-10-01||||||||Interventional|||A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide|GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title|Completed||Phase 3|270||GE Healthcare|||||||||||||||||||2017-02-18 17:10:07.200598|2017-02-18 17:10:07.200598
NCT00209378|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-04-01|||May 2005||2005-05-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|CASH-CVVH||Citrate Versus Heparin Anticoagulation in Continuous Venovenous Hemofiltration|Citrate Versus Heparin Anticoagulation in Continuous Venovenous Hemofiltration in Critically Ill Patients With Acute Renal Failure: A Randomized Clinical Trial|Completed||N/A|139|Actual|Free University Medical Center||2|||f||||f||||||||||2017-02-18 17:10:07.297493|2017-02-18 17:10:07.297493
NCT00209352|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-17|||June 1985||1985-06-01|December 2007|2007-12-01|July 2004|Actual|2004-07-01|||||Interventional|||Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant|Randomized Trial of Long-Term Oral Acyclovir Usage to Prevent Varicella Zoster Virus Infection After Allogeneic Bone Marrow Transplant|Completed||Phase 3|120||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:10:07.503546|2017-02-18 17:10:07.503546
NCT00209339|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-20|2016-06-21||July 2003||2003-07-01|October 2016|2016-10-01|October 2011|Actual|2011-10-01|February 2006|Actual|2006-02-01||Interventional|EVEREST(I)||Feasibility Study of a Percutaneous Mitral Valve Repair System.|A Study of the Evalve Cardiovascular Valve Repair System Endovascular Valve Edge-to-Edge REpair STudy (EVEREST I).|Completed||Phase 1/Phase 2|55|Actual|Evalve||1|||f||||t||||||||||2017-02-18 17:10:07.626942|2017-02-18 17:10:07.626942
NCT00209326|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-12-15|||November 2003||2003-11-01|December 2011|2011-12-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor|A Randomised, Double-blind, Parallel Group, Dose-ranging, Placebo-controlled, Multi-centre, Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 (0.3, 1, 3, 10 mg) and Placebo on Stopping Preterm Labour and Uterine Contractions in Pregnant Women With Advanced Gestational Age|Completed||Phase 2|163|Actual|Ferring Pharmaceuticals|||||f||||||||||||||2017-02-18 17:10:09.232309|2017-02-18 17:10:09.232309
NCT00209313|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-12-14|||March 2005||2005-03-01|December 2011|2011-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon|A Randomized, Double-blind, Placebo-controlled Crossover Trial of Acyclovir for Suppression of HSV and HIV Shedding in HIV-1, HSV-2 Coinfected Persons in Cameroon|Completed||Phase 2/Phase 3|40|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-02-18 17:10:09.350633|2017-02-18 17:10:09.350633
NCT00209300|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-18|||May 2005||2005-05-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission|Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission. A European Multi-centre Investigator Blinded Randomized Controlled Study of Pentasa Sachet Comparing One Gram Twice With Two Grams Once Daily|Completed||Phase 3|362|Actual|Ferring Pharmaceuticals|||||f||||t||||||||||2017-02-18 17:10:09.475463|2017-02-18 17:10:09.475463
NCT00209287|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-20|||June 2005||2005-06-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|December 2006|Actual|2006-12-01||Interventional|||Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis|Study of Histological Modifications, of Pro-apoptotic Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis (Clinical and Endoscopic Remission) Taking 5-ASA|Terminated||Phase 4|6|Actual|Ferring Pharmaceuticals||1||Recruitment problematic|f||||f||||||||||2017-02-18 17:10:09.64166|2017-02-18 17:10:09.64166
NCT00209274|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-09-17||2013-07-31|May 2005||2005-05-01|September 2013|2013-09-01|December 2014|Anticipated|2014-12-01|November 2009|Actual|2009-11-01||Interventional|EVERESTIIRCT||Pivotal Study of a Percutaneous Mitral Valve Repair System|Pivotal Study: A Study of the Evalve Cardiovascular Valve Repair System - Endovascular Valve Edge-to-Edge REpair STudy (EVERESTIIRCT)|Unknown status|Active, not recruiting|N/A|1317|Anticipated|Evalve||2|||f||||t||||||||||2017-02-18 17:10:09.744108|2017-02-18 17:10:09.744108
NCT00209261|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-18|||December 2004||2004-12-01|May 2011|2011-05-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|PALAT||A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)|A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate (120 μg and 240 μg) and 2 Different Daily Doses of Minirin® Tablet (0.2 mg and 2 x 0.2 mg) in Children and Adolescents With Primary Nocturnal Enuresis (PNE)|Completed||Phase 4|221|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:10:09.88974|2017-02-18 17:10:09.88974
NCT00209235|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-23|||January 2003||2003-01-01|August 2016|2016-08-01|December 2025|Anticipated|2025-12-01|October 2019|Anticipated|2019-10-01||Interventional|||Albright Hereditary Osteodystrophy: Growth Hormone Trial and Cognitive/Behavioral Assessments|Study of Growth Hormone Use in Patients With Pseudohypoparathyroidism Type 1a and Assessment of Cognitive/Behavioral Status in Albright Hereditary Osteodystrophy|Recruiting||Phase 2/Phase 3|300|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1|||f||||t||||||||||2017-02-18 17:10:09.998259|2017-02-18 17:10:09.998259
NCT00209222|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-07|||July 2004||2004-07-01|July 2009|2009-07-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL|Efficacy of 6x R-CHOP Followed by Myeloablative Radiochemotherapy and Autologous Stem Cell Transplantation vs. 3 x (R-CHOP/R-DHAP) Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation|Unknown status|Recruiting|Phase 3|360|Anticipated|European Mantle Cell Lymphoma Network||2|||f||||t||||||||||2017-02-18 17:10:10.156822|2017-02-18 17:10:10.156822
NCT00209209|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-06|||January 2004||2004-01-01|September 2012|2012-09-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|MCLelderly||Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL|Efficacy of Maintenance Therapy With Rituximab After Induction Chemotherapy (R-CHOP vs. R-FC) for Elderly Patients With Mantle Cell Lymphoma Not Suitable for Autologous Stem Cell Transplantation|Unknown status|Recruiting|Phase 3|570|Anticipated|European Mantle Cell Lymphoma Network||2|||f||||t||||||||||2017-02-18 17:10:10.304318|2017-02-18 17:10:10.304318
NCT00209196|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-02-10|||May 2005||2005-05-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|July 2007|Actual|2007-07-01||Observational|||Quality of Life in Pediatric Transplant Recipients|Health Behaviors and Quality of Life in Pediatric Solid Organ Transplant Recipients|Completed||N/A|65|Actual|Emory University|||1||f||||f||||||||||2017-02-18 17:10:10.455982|2017-02-18 17:10:10.455982
NCT00209170|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-07-27|2015-06-23||May 2004||2004-05-01|July 2015|2015-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Depression-Diabetes Mechanisms: Urban African Americans|Depression-Diabetes Mechanisms: Urban African Americans|Completed||Phase 4|20|Actual|Emory University||2|||f||||t||||||||||2017-02-18 17:10:10.557876|2017-02-18 17:10:10.557876
NCT00207922|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||December 2003||2003-12-01|December 2003|2003-12-01||||||||Observational|||The Polarization and Expression of Chemokine Receptors of T Help Cell in the Pathogenesis of Acute and Chronic GVHD||Unknown status|Active, not recruiting|N/A|||China Medical University Hospital|||||f||||||||||||||2017-02-18 17:10:29.60813|2017-02-18 17:10:29.60813
NCT00209144|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-06-13|||October 2004||2004-10-01|June 2014|2014-06-01|December 2006|Actual|2006-12-01|December 2005|Actual|2005-12-01||Interventional|||Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.|Effects of Intense Glycemic Control on Markers of Inflammation and Thrombosis in Patients Treated With Percutaneous Coronary Intervention for Acute Myocardial Infarction.|Completed||Phase 1|58|Actual|Emory University||2|||f||||||||||||||2017-02-18 17:10:10.95899|2017-02-18 17:10:10.95899
NCT00209131|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-09-23|2012-06-05||April 2005||2005-04-01|September 2013|2013-09-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy|Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy|Terminated||N/A|24|Actual|Emory University|Study was terminated due to turnovers of personnel to assist with recruitment and execution of the study.Recruitment was strained and patients recruited could not be followed up in a timely fashion to adhere to protocol. Thus, no data was generated.|2||Due to frequent turnover of research coordinators and thus poor study accrual.|f||||f||||||||||2017-02-18 17:10:11.074389|2017-02-18 17:10:11.074389
NCT00209118|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-04-07||||||April 2016|2016-04-01|July 2005||2005-07-01|||||Interventional|||Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C|Paroxetine for the Prevention of IFN-Alpha Associated Depression in Patients With Chronic Hepatitis C|Completed||N/A|60||Emory University|||||f||||||||||||||2017-02-18 17:10:11.460286|2017-02-18 17:10:11.460286
NCT00209105|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-11|||January 2005||2005-01-01|November 2013|2013-11-01|March 2011|Actual|2011-03-01|December 2009|Actual|2009-12-01||Observational|||Characterizing Psychological Consequences of Childhood Trauma|Emory Conte Center for the Neuroscience of Mental Disorders: Psychobiology of Childhood Trauma|Completed||N/A|113|Actual|Emory University|||1||f||||t||||||||||2017-02-18 17:10:11.539041|2017-02-18 17:10:11.539041
NCT00209092|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-03-06|2012-03-15||August 2006||2006-08-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|July 2009|Actual|2009-07-01||Interventional|||Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer|Randomized Phase II Trial of Sequential Docetaxel Followed by Capecitabine Versus Concomitant, Dose-Dense Docetaxel/Capecitabine as in Induction Therapy for Early Stage Breast Cancer|Completed||Phase 2|51|Actual|Emory University||2|||f||||t||||||||||2017-02-18 17:10:11.640605|2017-02-18 17:10:11.640605
NCT00209079|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-12-27|||September 2004||2004-09-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma|Phase II Trial of Gleevec (Imatinib Mesylate) and Taxotere (Docetaxel) as a Combined Regimen for Advanced Gastric Adenocarcinoma|Terminated||Phase 2|5|Actual|Emory University||1||Terminated 4/17/07. Drug sponsor withdrew.|f||||t||||||||||2017-02-18 17:10:12.348949|2017-02-18 17:10:12.348949
NCT00209066|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-11-17|||November 1998||1998-11-01|November 2013|2013-11-01|April 2005||2005-04-01|||||Observational|||Treatment of Reduced Heart Rate Variability Associated With Major Depression With Electroconvulsive Therapy|A Means to Enhanced Cardiovascular Outcomes: Reduction of Exaggerated Platelet Activity Through Treatment of Depression.|Completed||N/A|50|Anticipated|Emory University|||1||f||||||||||||||2017-02-18 17:10:12.47115|2017-02-18 17:10:12.47115
NCT00209053|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-10-14|||January 2007||2007-01-01|October 2013|2013-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||SMART Trial Longitudinal Follow-Up:Off-Pump Versus On-Pump Coronary Artery Bypass Surgery|A Prospective, Randomized Comparison of Graft Patency and Clinical Outcomes After Coronary Bypass Surgery Performed With and Without the Use of Cardiopulmonary Bypass:Longitudinal Follow-Up|Completed||N/A|87|Actual|Emory University||2|||f||||||||||||||2017-02-18 17:10:12.565416|2017-02-18 17:10:12.565416
NCT00209040|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-11-22|||January 2001||2001-01-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|December 2017|Anticipated|2017-12-01||Observational|||Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder|Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder|Active, not recruiting||N/A|250|Anticipated|Emory University|||3||f||||f||||||||||2017-02-18 17:10:12.673274|2017-02-18 17:10:12.673274
NCT00209027|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-13|2012-04-13||April 2005||2005-04-01|November 2013|2013-11-01|April 2011|Actual|2011-04-01|December 2010|Actual|2010-12-01||Interventional|||The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia|Aripiprazole Effects on Reward Processing in Deficit Syndrome Schizophrenia|Terminated||N/A|20|Actual|Emory University|Although the study was planned as a repeated measures study with fMRI testing at baseline and after 3 months, difficulty with recruitment and technical difficulties with obtaining fMRI data relegated the study to a single baseline timepoint.|1||difficulty with technical aspect of fMRI, resources to complete the study ran out|f||||t||||||||||2017-02-18 17:10:12.781503|2017-02-18 17:10:12.781503
NCT00209014|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-05-06|||July 2003||2003-07-01|May 2009|2009-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease|Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease|Terminated||Phase 2|2|Actual|Emory University||1||Celgene unable to continue funds.|f||||||||||||||2017-02-18 17:10:13.196296|2017-02-18 17:10:13.196296
NCT00209001|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-10|||July 2003||2003-07-01|July 2015|2015-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer|Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer|Terminated||N/A|7|Actual|Emory University||3||Principal investigator Peter Johnstone, MD relocated to another institution|f||||t||||||||||2017-02-18 17:10:13.295969|2017-02-18 17:10:13.295969
NCT00208988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 2003||2003-05-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening|A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening|Completed||N/A|250||Emory University|||||f||||||||||||||2017-02-18 17:10:13.40328|2017-02-18 17:10:13.40328
NCT00208975|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-25|2012-03-16||July 2002||2002-07-01|May 2012|2012-05-01|September 2011|Actual|2011-09-01|December 2009|Actual|2009-12-01||Interventional|||Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab|Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab in Patients With Low Grade Non-Hodgkins Lymphoma: An Analysis of Efficacy and Tolerability|Terminated||Phase 2|15|Actual|Emory University|The protocol was closed early due to slow and poor accrual.|1||slow accrual|f||||t||||||||||2017-02-18 17:10:13.494472|2017-02-18 17:10:13.494472
NCT00208949|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-17|2012-03-22||September 2002||2002-09-01|August 2012|2012-08-01|May 2012|Actual|2012-05-01|May 2010|Actual|2010-05-01||Interventional|||A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF|A Randomized Comparison of Dendritic Cell Content and T-Cell Phenotype Between G-CSF(Granulocyte Colony-Stimulating Factor)or G-CSF+GM-CSF (Granulocyte Macrophage Colony-Stimulating Factor) for the Mobilization of Normal Allogeneic Peripheral Blood Stem Cell Donors|Terminated||Phase 2|50|Actual|Emory University||2||slow accrual|f||||t||||||||||2017-02-18 17:10:13.882279|2017-02-18 17:10:13.882279
NCT00208936|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-09-05|||January 1996||1996-01-01|September 2014|2014-09-01||||March 2006|Actual|2006-03-01||Interventional|||Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus|Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus|Terminated||Phase 2|20||Emory University|||||f||||||||||||||2017-02-18 17:10:14.294081|2017-02-18 17:10:14.294081
NCT00208923|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-05|||July 1998||1998-07-01|April 2012|2012-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies|Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies Using a Preparative Regimen of Busulfan, Cyclophosphamide, and Fludarabine|Completed||Phase 2|55|Anticipated|Emory University||1|||f||||t||||||||||2017-02-18 17:10:14.391386|2017-02-18 17:10:14.391386
NCT00208910|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-08|||November 2003||2003-11-01|November 2013|2013-11-01|May 2005||2005-05-01|||||Interventional|||Muscle Relaxation Therapy With Odorant Cue|A Study of Enhancement of Progressive Muscle Relaxation Therapy for Generalized Anxiety Disorder Through Use Of An Odorant Cue.|Completed||N/A|15||Emory University|||||f||||||||||||||2017-02-18 17:10:14.501866|2017-02-18 17:10:14.501866
NCT00208897|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-08|||December 1997||1997-12-01|November 2013|2013-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?|Does Fluoxetine Reverse the Effects of Early Life Stress on the CNS Corticotropin-Releasing Factor System and Improve Psychological and Neuroendocrine Function?: A Therapy Outcome Study in Women With Childhood Abuse Experiences|Completed||N/A|80|Anticipated|Emory University||1|||f||||f||||||||||2017-02-18 17:10:14.584421|2017-02-18 17:10:14.584421
NCT00208884|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-25|||October 2003||2003-10-01|November 2013|2013-11-01|November 2005||2005-11-01|||||Observational|||Terminal Graft Failure|Terminal Graft Failure: A Combined Pathologic and Clinical Study|Terminated||N/A|19||Emory University|||||f||||f||||||||||2017-02-18 17:10:14.686829|2017-02-18 17:10:14.686829
NCT00208871|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-19|||December 2004||2004-12-01|November 2013|2013-11-01|March 2011|Actual|2011-03-01|December 2007|Actual|2007-12-01||Interventional|||An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall|An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall|Completed||N/A|1467|Actual|Emory University||1|||f||||f||||||||||2017-02-18 17:10:14.764152|2017-02-18 17:10:14.764152
NCT00208858|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-13|||December 2004||2004-12-01|June 2014|2014-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving|Nicotine Craving: Neural Correlates of Treatment Effect - A Pilot Study|Completed||Phase 2|||Emory University|||||f||||||||||||||2017-02-18 17:10:14.870718|2017-02-18 17:10:14.870718
NCT00208845|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-19|||September 2005||2005-09-01|November 2013|2013-11-01||||||||Observational|||Hypernet- Hypertension Screening|Hypernet- Hypertension ED Surveillance|Terminated||N/A|100|Anticipated|Emory University|||1||f||||f||||||||||2017-02-18 17:10:14.962106|2017-02-18 17:10:14.962106
NCT00208832|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-18|||March 2004||2004-03-01|December 2013|2013-12-01|March 2006||2006-03-01|||||Interventional|||A Randomized Controlled Trial to Improve Medication Compliance Among Patients With Coronary Heart Disease|A Randomized Controlled Trial to Improve Medication Compliance Among Patients With Coronary Heart Disease|Completed||N/A|440||Emory University|||||f||||||||||||||2017-02-18 17:10:15.044198|2017-02-18 17:10:15.044198
NCT00208819|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-12|||September 2003||2003-09-01|November 2013|2013-11-01|July 2007|Actual|2007-07-01|||||Interventional|||A Comparison of Two Standard Therapies in the Management of Dementia With Agitation|Randomized Comparison of Monotherapy (Risperidone, Quetiapine, or Olanzapine) Versus Combination Therapy (Risperidone, Quetiapine, or Olanzapine + Divalproex)in the Management of Dementia With Agitation: A Pilot Comparison of Two Standard Therapies|Completed||Phase 4|50|Anticipated|Emory University|||||f||||||||||||||2017-02-18 17:10:15.129104|2017-02-18 17:10:15.129104
NCT00208806|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-09|||June 2004||2004-06-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Resynchronization Therapy in Young Patients With and Without CHD|Clinical Evaluation of Dilated Cardiomyopathy and Cardiac Resynchronization Therapy for Ventricular Dysfunction in Young Patients With and Without Congenital Heart Disease|Completed||N/A|50||Emory University|||1||f||||||||||||||2017-02-18 17:10:15.233777|2017-02-18 17:10:15.233777
NCT00208793|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-22|||May 2005||2005-05-01|November 2013|2013-11-01|February 2013|Actual|2013-02-01|September 2006|Actual|2006-09-01||Interventional|CaDvMAP||Calcium and Vitamin D vs Markers of Adenomatous Polyps|Calcium, Vitamin D, and Colon Cancer Risk Biomarkers|Completed||Phase 2|92|Actual|Emory University||4|||f||||f||||||||||2017-02-18 17:10:15.331966|2017-02-18 17:10:15.331966
NCT00208780|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-15|||December 2004||2004-12-01|November 2013|2013-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Effects of Tetrahydrobiopterin on Blood Pressure|Effects of Tetrahydrobiopterin on Blood Pressure|Completed||Early Phase 1|24|Actual|Emory University||2|||f||||f||||||||||2017-02-18 17:10:15.45036|2017-02-18 17:10:15.45036
NCT00208767|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-09|2014-09-12||February 2005||2005-02-01|November 2015|2015-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Effect of Valsartan on Carotid Artery Disease|Effect of Valsartan on Endothelial Function, Oxidative Stress, Carotid Atherosclerosis, and Endothelial Progenitor Cells (EFFERVESCENT)|Completed||Phase 2|120|Actual|Emory University||2|||f||||t||||||||||2017-02-18 17:10:15.555382|2017-02-18 17:10:15.555382
NCT00208754|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-08|||May 2004||2004-05-01|November 2013|2013-11-01|December 2005||2005-12-01|||||Observational|||Heart Failure in Adult Patients With a History of Congenital Heart Disease|Heart Failure in Adult Patients With a History of Congenital Heart Disease.|Terminated||N/A|350||Emory University|||||f||||||||||||||2017-02-18 17:10:15.94906|2017-02-18 17:10:15.94906
NCT00208741|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-08|||June 2002||2002-06-01|November 2013|2013-11-01|November 2003||2003-11-01|||||Interventional|||Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder|A 12-Week Open-Label Study Followed By A 24-Week Double-Blind Discontinuation Exploratory Study To Evaluate The Effects Of Gabitril™ (Tiagabine Hydrochloride) In Patients With Social Anxiety Disorder (SAD)|Completed||Phase 4|50||Emory University|||||f||||||||||||||2017-02-18 17:10:16.041989|2017-02-18 17:10:16.041989
NCT00208728|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-25|||May 2003||2003-05-01|November 2013|2013-11-01|June 2005||2005-06-01|||||Interventional|||Cardiopulmonary Circuits in the Pediatric Population|Prospective Evaluation of Modified Cardiopulmonary Bypass Circuits in the Pediatric Population|Completed||N/A|90||Emory University|||||f||||||||||||||2017-02-18 17:10:16.137598|2017-02-18 17:10:16.137598
NCT00208715|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-08|||February 2003||2003-02-01|November 2013|2013-11-01|October 2004||2004-10-01|||||Interventional|||Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.|A DOUBLE-BLIND PILOT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PROVIGIL® (MODAFINIL) AT FIXED/FLEXIBLE DOSES, IN CONJUNCTION WITH IDENTIFIED SSRIs FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH MILD TO MODERATE DEPRESSION WITH ATTENDANT SYMPTOMS OF SLEEPINESS AND FATIGUE|Completed||Phase 4|100||Emory University|||||f||||||||||||||2017-02-18 17:10:16.236493|2017-02-18 17:10:16.236493
NCT00208702|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-16|||September 1996||1996-09-01|November 2015|2015-11-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Thyroid Medication and Antidepressants for Treating Major Depression|Thyroid Axis in Major Depression|Completed||Phase 4|153|Actual|Emory University||2|||f||||f||||||||||2017-02-18 17:10:16.334285|2017-02-18 17:10:16.334285
NCT00208689|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-02-11|||January 2004||2004-01-01|February 2014|2014-02-01||||May 2006|Actual|2006-05-01||Observational|||Critical Congenital Heart Defect (CHD) Outcomes in Children|A Review of the Diagnosis, Treatment and Outcomes of Children With Critical Congenital Heart Defects|Terminated||N/A|150||Emory University|||||f||||||||||||||2017-02-18 17:10:16.455834|2017-02-18 17:10:16.455834
NCT00208676|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-25|||September 2005||2005-09-01|November 2013|2013-11-01|January 2006||2006-01-01|||||Observational|||Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease|Non-Invasive Quantitation of Myocardial Dysfunction by Tissue Doppler / Synchronization Imaging in Children With Congenital Heart Defects (CHD)|Terminated||N/A|200||Emory University|||||f||||||||||||||2017-02-18 17:10:16.545215|2017-02-18 17:10:16.545215
NCT00208663|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-10|||September 2005||2005-09-01|April 2015|2015-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Validation of an Instrument to Qualitatively and Quantitatively Profile Hospitalist Workflow|Validation of an Instrument to Qualitatively and Quantitatively Profile Hospitalist Workflow|Withdrawn||N/A|0|Actual|Emory University|||1|Resources|f||||f||||||||||2017-02-18 17:10:16.645617|2017-02-18 17:10:16.645617
NCT00208650|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-25|||September 2005||2005-09-01|November 2013|2013-11-01|September 2006|Actual|2006-09-01|||||Observational|||Tissue Doppler Echo Imaging of Heart Function After Transplant|Non-Invasive Quantitation of Myocardial Dysfunction by Tissue Doppler/Synchronization Imaging After Orthotopic Heart Transplantation in Children|Completed||N/A|75||Emory University|||||f||||||||||||||2017-02-18 17:10:16.731767|2017-02-18 17:10:16.731767
NCT00208637|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2002||2002-08-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||He Purongo Mo Nga Kai Hei Arai i Te Matehuka – Dietary Diabetes Prevention Study for Maori||Completed||N/A|90||Edgar National Centre for Diabetes Research|||||f||||||||||||||2017-02-18 17:10:17.054193|2017-02-18 17:10:17.054193
NCT00208624|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-01|||December 2004||2004-12-01|May 2014|2014-05-01|May 2005||2005-05-01|||||Observational|||Rhythm Disturbances After Ventricular Septal Defects|Rhythm Disturbances After Ventricular Septal Defects|Terminated||N/A|30||Emory University|||||f||||||||||||||2017-02-18 17:10:17.164869|2017-02-18 17:10:17.164869
NCT00208611|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-16|||September 2006||2006-09-01|December 2014|2014-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease|Assessment of Cobalamin Status and Responses to Supplementation in Patients With Parkinson's Disease : a Pilot Study|Terminated||Phase 2/Phase 3|57|Actual|Emory University||1||Funding ended and enrollment not completed within a certain time period|f||||f||||||||||2017-02-18 17:10:17.252245|2017-02-18 17:10:17.252245
NCT00208598|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2003||2003-01-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Observational|||Measures of Obesity and Co-Morbid Conditions in Maori||Completed||N/A|220||Edgar National Centre for Diabetes Research|||||f||||||||||||||2017-02-18 17:10:17.360891|2017-02-18 17:10:17.360891
NCT00208585|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-09|||February 2000||2000-02-01|October 2007|2007-10-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Sertraline vs. Placebo for Symptoms Following Traumatic Brain Injury|A Randomized Placebo-Controlled Trial of Sertraline for the Neurobehavioral Sequelae of Traumatic Brain Injury|Unknown status|Recruiting|N/A|100|Anticipated|Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 17:10:17.461886|2017-02-18 17:10:17.461886
NCT00208572|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-04|||November 2003||2003-11-01|October 2007|2007-10-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury|A Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury|Unknown status|Recruiting|N/A|104|Anticipated|Walter Reed Army Medical Center|||||f||||||||||||||2017-02-18 17:10:17.571879|2017-02-18 17:10:17.571879
NCT00208559|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-15|||February 2002||2002-02-01|June 2010|2010-06-01|August 2006|Actual|2006-08-01|June 2005|Actual|2005-06-01||Interventional|||Ziprasidone in Children With Autism: A Pilot Study|Ziprasidone in Children With Autism: A Pilot Study|Completed||Phase 2|15|Actual|Drexel University||1|||f||||t||||||||||2017-02-18 17:10:17.684681|2017-02-18 17:10:17.684681
NCT00208546|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-01|||June 2005||2005-06-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer|Cetuximab Added to Capecitabine, Oxaliplatin and Bevacizumab in Patients With Previously Untreated Advanced Colorectal Carcinoma, a Randomised Phase III Study|Completed||Phase 3|750|Actual|Dutch Colorectal Cancer Group||2|||f||||t||||||||||2017-02-18 17:10:17.801883|2017-02-18 17:10:17.801883
NCT00208533|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-13|||February 2004||2004-02-01|February 2017|2017-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Aripiprazole in Children With Autism: A Pilot Study|Aripiprazole in Children With Autism: A Pilot Study|Completed||Phase 2|11|Actual|Drexel University||1|||f||||t||||||||No|No sharing plan|2017-02-18 17:10:17.941676|2017-02-18 17:10:17.941676
NCT00208494|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-06|2011-07-11||August 2005||2005-08-01|August 2013|2013-08-01|June 2011|Actual|2011-06-01|December 2008|Actual|2008-12-01||Interventional|||Metal on Metal Versus Ceramic on Metal Hip Replacement|Comparative Study to Evaluate the Safety and Efficacy of the DePuy Ceramic-on-metal Total Hip Prosthesis Versus the DePuy Metal-on-metal Total Hip Prosthesis Through Clinical and Radiographical Data|Completed||N/A|392|Actual|DePuy Orthopaedics||2|||f||||f||||||||||2017-02-18 17:10:18.551516|2017-02-18 17:10:18.551516
NCT00208481|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-09-30|||August 2004||2004-08-01||||||||||N/A|||[Trial of device that is not approved or cleared by the U.S. FDA]|[Trial of device that is not approved or cleared by the U.S. FDA]|Withheld||N/A|||[Redacted]|||||||||||||||||||2017-02-18 17:10:18.947305|2017-02-18 17:10:18.947305
NCT00208468|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-06|||February 2000||2000-02-01|October 2016|2016-10-01|March 2015|Actual|2015-03-01|June 2005|Actual|2005-06-01||Interventional|||A Randomised Multi-centre Study to Compare the Long-term Performance of the Future Hip to 3 Other Implants in Primary Total Hip Replacement|A Multi-centre, Randomised, Parallel Group, Controlled Study to Compare the Performance of the Future Hip Against Three Currently Used Implants in Total Hip Replacement|Terminated||Phase 3|317|Actual|DePuy International||3||"Slow recruitment, investigators not wishing to continue with randomisation and a decision to~   rationalise this product from the Sponsors portfolio."|f||||f||||||||||2017-02-18 17:10:19.003324|2017-02-18 17:10:19.003324
NCT00208455|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-03|||February 2005||2005-02-01|July 2016|2016-07-01|February 2013|Actual|2013-02-01|September 2012|Actual|2012-09-01||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement|An Uncontrolled, Multi-Centre, Prospective, Post Marketing Surveillance Study to Monitor the Long Term Survivorship of the DePuy PROXIMA™ Hip in Subjects Requiring a Total Hip Replacement|Terminated||Phase 4|184|Actual|DePuy International||1||"DePuy discontinued this product in 2013, the clinical program was reviewed and this Study was~   closed."|f||||f||||||||||2017-02-18 17:10:19.124276|2017-02-18 17:10:19.124276
NCT00208442|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-07|||June 2001||2001-06-01|April 2009|2009-04-01||||September 2006|Actual|2006-09-01||Interventional|||A Randomised Single Centre Study to Compare the Long-Term Wear Characteristics of Marathon™ and Enduron™ Polyethylene Cup Liners in Primary Total Hip Replacement|A Prospective, Randomised, Controlled, Single Centre, Blinded Study of the Wear Characteristics of Two Polyethylene Bearing Surfaces, Enduron vs. Marathon|Unknown status|Active, not recruiting|Phase 4|119|Actual|DePuy International||2|||f||||f||||||||||2017-02-18 17:10:19.216418|2017-02-18 17:10:19.216418
NCT00208429|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-15||||||July 2016|2016-07-01||||||||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip Replacement|Uncontrolled Prospective Multi-Centre Post Marketing Surveillance Study to Monitor the Long Term Survivorship of Pinnacle Acetabular Cup System With a Metal on Enduron Polyethylene Bearing in Subjects With Aetiologies Requiring a Primary Total Hip Replacement|Withdrawn||Phase 4|0|Actual|DePuy International||1||"Site Principal Investigator became seriously ill, so study abandoned before the start of~   recruitment"|f||||f||||||||||2017-02-18 17:10:19.325452|2017-02-18 17:10:19.325452
NCT00208416|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-09|||October 2005||2005-10-01|March 2016|2016-03-01|November 2014|Actual|2014-11-01|December 2007|Actual|2007-12-01||Interventional|||A Randomised Multi-centre Study to Compare the Short-term Outcomes of Minimally Invasive and Conventional Surgery in Primary Total Hip Replacement|Randomised, Prospective, Post-Market Surveillance Study Comparing the Outcomes of Minimally Invasive and Conventional Surgical Procedures in Subjects Requiring Primary Total Hip Arthroplasty for Osteoarthritis.|Terminated||Phase 4|58|Actual|DePuy International||2||Combination of departure of Investigator from one site and slow recruitment rate|f||||f||||||||||2017-02-18 17:10:19.400305|2017-02-18 17:10:19.400305
NCT00208403|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-30|||October 2002||2002-10-01|January 2017|2017-01-01||||January 2006|Actual|2006-01-01||Interventional|||A Randomised Single Centre Study to Compare the Long-term Performance of SmartSet® HV and Palacos® R Bone Cements in Primary Total Hip Replacement|Randomised, Prospective, RSA, PMS Study Comparing SmartSet HV & Palacos R in Primary Total Hip Arthroplasty|Active, not recruiting||Phase 4|36|Actual|DePuy International||2|||f||||f||||||||||2017-02-18 17:10:19.498246|2017-02-18 17:10:19.498246
NCT00208390|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-03|||February 2003||2003-02-01|July 2016|2016-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement|Prospective, Uncontrolled, Multi-Centre, Post-Marketing Surveillance Study to Evaluate the Long-Term Performance of Summit Tapered Hip in Cementless Total Hip Arthroplasty|Terminated||Phase 4|275|Actual|DePuy International||1||"Study closed after the 5 year end-point was reached after a review of the status further to a~   request from the investigators to discontinue participation."|f||||f||||||||||2017-02-18 17:10:19.604985|2017-02-18 17:10:19.604985
NCT00208377|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-03|||July 2003||2003-07-01|July 2016|2016-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery|Prospective Multi-Centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-Term Performance of the DePuy ASR Hip System in Subjects With Suitable Indications for a Primary Resurfacing Hip Arthroplasty|Terminated||Phase 4|228|Actual|DePuy International||1||"DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all~   clinical studies for this product and decided to close this Study."|f||||f||||||||||2017-02-18 17:10:19.699054|2017-02-18 17:10:19.699054
NCT00208364|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-06|||April 2004||2004-04-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|October 2014|Actual|2014-10-01||Interventional|||A Two Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Metal-on-Metal Bearing in Primary Total Hip Replacement|Uncontrolled Prospective Multi-Centre Post Marketing Surveillance Study to Monitor the Long Term Survivorship of Pinnacle Acetabular Cup Prosthesis With a Metal on Metal Bearing in Subjects With Aetiologies Requiring a Primary Total Hip Replacement|Terminated||Phase 4|163|Actual|DePuy International||1||Study terminated early due to business reasons|f||||f||||||||||2017-02-18 17:10:19.79702|2017-02-18 17:10:19.79702
NCT00208351|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-09|||May 1997||1997-05-01|March 2016|2016-03-01|March 2015|Actual|2015-03-01|November 2004|Actual|2004-11-01||Interventional|||A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement|Clinical and Radiographic Evaluation to Compare a Polished and Non-polished Collared Stem and a Polished and Non Polished Collarless Stem in Primary Total Hip Replacement|Terminated||Phase 3|164|Actual|DePuy International||4||"The final assessments were conducted late and in a reduced format due to resource limitations~   at the site."|f||||f||||||||||2017-02-18 17:10:19.956662|2017-02-18 17:10:19.956662
NCT00208338|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-07-01|||July 2005||2005-07-01|June 2016|2016-06-01|April 2015|Actual|2015-04-01|February 2007|Actual|2007-02-01||Interventional|||Pilot Study to Evaluate the Restore Orthobiologic Implant in Rotator Cuff Tear Repair|A Prospective, Randomised Pilot Study to Determine the Variability of Early Clinical Outcome in Subjects Undergoing Full Thickness Rotator Cuff Tear Repair, When Augmented With or Without Porcine Small Intestine Submucosa (RESTORE)|Completed||Phase 4|33|Actual|DePuy International||2|||f||||f||||||||||2017-02-18 17:10:20.053419|2017-02-18 17:10:20.053419
NCT00208325|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-01|2015-06-05||May 2000||2000-05-01|August 2016|2016-08-01|September 2010|Actual|2010-09-01|January 2009|Actual|2009-01-01||Interventional||All participants who received treatment and were not mis-randomized.|PFC Sigma Fixed and Mobile Knee Study|Clinical Evaluation of the P.F.C. Sigma (Fixed Bearing) and P.F.C. Sigma RP (Mobile Bearing) Total Knee Systems|Terminated||Phase 4|754|Actual|DePuy International||4||"The study was terminated at the point the primary endpoint and early milestones were reached~   and because long term outcomes were available from other sources"|f||||f||||||||||2017-02-18 17:10:20.183009|2017-02-18 17:10:20.183009
NCT00208312|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-11-24|||April 2004||2004-04-01|November 2009|2009-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)|A Phase III, Randomized, Double-Blind Study of Intravenous CVT-3146 Versus Adenoscan® in Patients Undergoing Stress Myocardial Perfusion Imaging|Completed||Phase 3|787|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 17:10:25.937694|2017-02-18 17:10:25.937694
NCT00208299|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-11-24|||October 2003||2003-10-01|November 2009|2009-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)|A Phase III, Randomized, Double-Blind Study of Intravenous CVT-3146 Versus Adenoscan® in Patients Undergoing Stress Myocardial Perfusion Imaging|Completed||Phase 3|1231|Actual|Gilead Sciences||2|||f||||f||||||||||2017-02-18 17:10:26.063188|2017-02-18 17:10:26.063188
NCT00208286|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-06-17|||November 2001||2001-11-01|June 2016|2016-06-01|March 2015|Actual|2015-03-01|October 2006|Actual|2006-10-01||Interventional|||P.F.C. Sigma Fixed Versus P.F.C. RP Mobile Bearing Total Knee Systems|Clinical Evaluation of the P.F.C. Sigma (Fixed Bearing) and P.F.C. Sigma Rotating Platform (Mobile Bearing) Total Knee Systems.|Terminated||Phase 4|120|Actual|DePuy International||2||"Primary study outcome achieved; investigator decided to conduct the study without sponsor~   support after 2009."|f||||f||||||||||2017-02-18 17:10:26.167163|2017-02-18 17:10:26.167163
NCT00208273|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-13|||January 2005||2005-01-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer|A Phase II Randomized Study to Compare Skin Late Toxicities of Concomitant Letrozole-Radiotherapy and Radiotherapy Followed by Letrozole as Adjuvant Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors|Completed||Phase 2|150|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||2|||f||||||||||||||2017-02-18 17:10:26.260724|2017-02-18 17:10:26.260724
NCT00208260|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-15|||April 2004||2004-04-01|June 2010|2010-06-01|August 2007|Actual|2007-08-01|||||Interventional|||Intensified Chemotherapy in CRC After Resection of Liver Metastases|Randomized Phase II Trial Followed by Phase III Trial With Molecular Biology Study, Comparing a Standard Bi-therapy vs 3 Arms of Intensified Chemotherapy in Patients With Unresectable or Not Optimally Resectable Colorectal Cancer Liver Metastases.|Completed||Phase 2/Phase 3|124|Actual|Institut du Cancer de Montpellier - Val d'Aurelle||5|||f||||||||||||||2017-02-18 17:10:26.621222|2017-02-18 17:10:26.621222
NCT00208247|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-10|||December 2001||2001-12-01|August 2016|2016-08-01|March 2005|Actual|2005-03-01|January 2003|Actual|2003-01-01||Interventional|||KATHY:Cognitive-behavioural Therapy for Hypochondriasis|Cognitive-behavioural Therapy Versus Short-term Psychodynamic Psychotherapy: a Randomised Clinical Trial|Completed||Phase 2|80|Actual|Copenhagen Trial Unit, Center for Clinical Intervention Research||3|||f||||||||||||||2017-02-18 17:10:26.723744|2017-02-18 17:10:26.723744
NCT00208234|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-09-22|||January 2004||2004-01-01|September 2011|2011-09-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Effect of Xolair on Airway Hyperresponsiveness|The Effects of Xolair (Omalizumab) on Airway Hyperresponsiveness|Unknown status|Active, not recruiting|Phase 4|22|Anticipated|Creighton University||2|||f||||f||||||||||2017-02-18 17:10:26.816972|2017-02-18 17:10:26.816972
NCT00208221|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-07|||August 2006||2006-08-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes|Comparison of a Higher Dose of Ramipril to the Addition of Telmisartan 80 mg+Ramipril 10 mg in Patients With Hypertension and Diabetes|Terminated||Phase 3|50|Anticipated|Institut de Recherches Cliniques de Montreal||2||Not enough recruitment|f||||f||||||||||2017-02-18 17:10:26.931207|2017-02-18 17:10:26.931207
NCT00208208|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-09-14|||December 2002||2002-12-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Geodon (Ziprasidone) for Posttraumatic Stress Disorder|Geodon (Ziprasidone) for Posttraumatic Stress Disorder|Completed||Phase 4|80||Creighton University|||||f||||||||||||||2017-02-18 17:10:27.037289|2017-02-18 17:10:27.037289
NCT00208195|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-12-12|||March 2004||2004-03-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Depakote ER Therapy for Mania Comorbid With Substance Abuse|Depakote ER Therapy for Mania Comorbid With Substance Abuse|Completed||Phase 4|20|Actual|Creighton University||1|||f||||f||||||||||2017-02-18 17:10:27.124832|2017-02-18 17:10:27.124832
NCT00208182|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-03-08|||July 2001||2001-07-01|March 2006|2006-03-01|August 2004||2004-08-01|||||Interventional|||Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma|Risperidone Monotherapy in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma: a Double-Blind, Placebo Controlled, Randomized Clinical Trial|Completed||Phase 4|20||Creighton University|||||||||||||||||||2017-02-18 17:10:27.222375|2017-02-18 17:10:27.222375
NCT00208169|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-22|||March 2005||2005-03-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Abilify Therapy for Reducing Comorbid Substance Abuse|Aripiprazole (Abilify) Therapy for Reducing Comorbid Substance Abuse|Completed||Phase 4|30|Actual|Creighton University||1|||f||||f||||||||||2017-02-18 17:10:27.315782|2017-02-18 17:10:27.315782
NCT00208156|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-14|||May 2005||2005-05-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression|An Open-Label Extension Study of the Safety and Tolerability of CORLUX™ (Mifepristone) for Recurrent Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features|Completed||Phase 3|87|Actual|Corcept Therapeutics||1|||f||||f||||||||||2017-02-18 17:10:27.423775|2017-02-18 17:10:27.423775
NCT00208143|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-11|||November 2003||2003-11-01|October 2006|2006-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia|Seroquel (Quetiapine) Therapy for Schizophrenia and Schizoaffective Disorders and Comorbid Cocaine and/or Amphetamine Abuse/Dependence: A Comparative Study With Risperidone|Completed||Phase 4|20||Creighton University|||||f||||f||||||||||2017-02-18 17:10:27.552719|2017-02-18 17:10:27.552719
NCT00208130|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-28|||October 2001||2001-10-01|April 2009|2009-04-01|March 2004||2004-03-01|||||Interventional|||Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians|Completed||Phase 4|60||Creighton University|||||f||||f||||||||||2017-02-18 17:10:27.649231|2017-02-18 17:10:27.649231
NCT00208117|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-05-30|||April 2005||2005-04-01|May 2012|2012-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|CHIME||A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease|A Randomized Controlled Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease|Terminated||Phase 1|7|Actual|New York State Psychiatric Institute||2||Unable to enroll subjects|f||||f||||||||||2017-02-18 17:10:27.745483|2017-02-18 17:10:27.745483
NCT00208104|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-02-15|||July 2002||2002-07-01|February 2013|2013-02-01|September 2008|Actual|2008-09-01|May 2006|Actual|2006-05-01||Interventional|||Motivational Interviewing|Motivational Interviewing in Hypertensive African Americans|Terminated||N/A|167|Actual|Columbia University||2||PI left institution|f||||f||||||||||2017-02-18 17:10:27.853992|2017-02-18 17:10:27.853992
NCT00208091|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-11|2013-08-22||April 2003||2003-04-01|April 2014|2014-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia|An Open Label Evaluation of MIDI to Quantify Performance Change in Subjects With Musician's Dystonia After Treatment With Botulinum Toxin Type B (Myobloc ®).|Completed||Phase 4|16|Actual|Columbia University||1|||f||||f||||||||||2017-02-18 17:10:27.95799|2017-02-18 17:10:27.95799
NCT00208078|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-02-12|||May 2005||2005-05-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|May 2010|Actual|2010-05-01||Interventional|||Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.|Evaluation of the Effects of Long Term Non-Invasive Ventilation in Patient With Cystic Fibrosis and Chronic Hypercapnic Respiratory Failure.|Terminated||Phase 4|36|Actual|Cochin Hospital||2||Not enough patient recruited|f||||t||||||||||2017-02-18 17:10:28.257402|2017-02-18 17:10:28.257402
NCT00208065|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-05-05|||May 2004||2004-05-01|May 2009|2009-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers|"Evaluation of Histamine, CGRP and VIP as Biological Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers in Response to Sinus Symptoms"|Completed||Phase 4|50||Clinvest|||||f||||||||||||||2017-02-18 17:10:28.377199|2017-02-18 17:10:28.377199
NCT00208052|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2004||2004-01-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Observational|||Behavioral Indicators of Pain:Tool Development With Concurrent and Construct Validity||Completed||Phase 1|10||Cincinnati VA Medical Center|||||f||||||||||||||2017-02-18 17:10:28.465732|2017-02-18 17:10:28.465732
NCT00208039|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-19|||September 2004||2004-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates|Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates Less Than or Equal to 1250 gm Birthweight Ver 4.0|Completed||N/A|89|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 17:10:28.536234|2017-02-18 17:10:28.536234
NCT00208026|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-06|2011-03-09||September 2005||2005-09-01|December 2014|2014-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome|Exploratory Safety and Systemic Absorption of Elidel (Pimecrolimus) 1% Cream for the Treatment of Netherton Syndrome|Completed||Phase 1/Phase 2|3|Actual|Children's Hospital of Philadelphia|There were no early termination for any of the subjects.|1|||f||||t||||||||||2017-02-18 17:10:28.737378|2017-02-18 17:10:28.737378
NCT00208013|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-26|||July 2005||2005-07-01|July 2005|2005-07-01||||||||Observational|||The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients|The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients|Completed||N/A|100|Anticipated|China Medical University Hospital|||1||f||||t||||||||||2017-02-18 17:10:28.972917|2017-02-18 17:10:28.972917
NCT00208000|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2010-11-26|||July 2004||2004-07-01|September 2005|2005-09-01|April 2006|Anticipated|2006-04-01|||||Interventional|||A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.||Unknown status|Recruiting|Phase 2|||China Medical University Hospital|||||f||||||||||||||2017-02-18 17:10:29.056243|2017-02-18 17:10:29.056243
NCT00207987|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-20|||October 2003||2003-10-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Observational|||Changes in Cerebral Oxygenation During Deliberate Hypotensive Anesthesia||Unknown status|Recruiting|N/A|40|Anticipated|China Medical University Hospital|||||f||||||||||||||2017-02-18 17:10:29.147881|2017-02-18 17:10:29.147881
NCT00207974|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-11-16||||||September 2005|2005-09-01||||||||Interventional|||Pharmacokinetic Study of Marine Active in Health Men||Unknown status|Active, not recruiting|Phase 1|||China Medical University Hospital|||||f||||||||||||||2017-02-18 17:10:29.222621|2017-02-18 17:10:29.222621
NCT00207961|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-08|||October 2003||2003-10-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Observational|||The Threshold Value of Regional Cerebral Oxygenation in Detecting Cerebral Ischemia||Completed||N/A|||China Medical University Hospital|||||f||||||||||||||2017-02-18 17:10:29.306539|2017-02-18 17:10:29.306539
NCT00207948|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-08-03|||November 2004||2004-11-01|August 2015|2015-08-01|July 2009|Actual|2009-07-01|May 2009|Actual|2009-05-01||Observational|||Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents|Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents|Terminated||Phase 4|4|Actual|Children's Research Institute|||1|no measurable response was detected at the 50% increase threshold.|f||||t||||||||||2017-02-18 17:10:29.389779|2017-02-18 17:10:29.389779
NCT00207935|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-05-01|||August 2005||2005-08-01|September 2005|2005-09-01|March 2007||2007-03-01|||||Interventional|||Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population|Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population|Completed||Phase 4|20|Anticipated|Children's Research Institute|||||f||||||||||||||2017-02-18 17:10:29.502684|2017-02-18 17:10:29.502684
NCT00207909|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-06-13|||February 2005||2005-02-01|June 2016|2016-06-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Study of Patients With Acute Renal Failure on CVVH|The Role of Hemodynamics, Cytokine Response, and Modulators of Apoptosis on Urine Output in Patients With Acute Renal Failure on CVVH|Completed||N/A|39|Actual|Children's Healthcare of Atlanta|||1||f||||t||||||||||2017-02-18 17:10:29.852404|2017-02-18 17:10:29.852404
NCT00207896|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-11-25|||August 2004||2004-08-01|November 2014|2014-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Neuroendocrine Dysfunction in Critically Ill Pediatric Patients|Defining the Prevalence of Acute Neuroendocrine Dysfunction and Correlating the Dysfunction With Outcomes in Critically Ill Pediatric Patients: A Pilot Study|Completed||N/A|73|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 17:10:29.945391|2017-02-18 17:10:29.945391
NCT00207883|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-05|||January 2005||2005-01-01|May 2008|2008-05-01||||||||Observational|||Ultrasound Guided Vascular Access in Pediatric Intensive Care Patients|Ultrasound Guided Vascular Access: A Prospective Comparison Study|Unknown status|Active, not recruiting|N/A|250|Anticipated|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 17:10:30.038659|2017-02-18 17:10:30.038659
NCT00207870|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-07-21|||October 2006||2006-10-01|July 2011|2011-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Type II Supracondylar Fractures in Children|Comparison of Crossed Pin Versus Lateral-Entry Pin Fixation for Type II Supracondylar Fractures in Children: A Prospective, Randomized Trial|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||||2017-02-18 17:10:30.12182|2017-02-18 17:10:30.12182
NCT00207857|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-02-02|||March 2004||2004-03-01|February 2015|2015-02-01|August 2005|Anticipated|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy|Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy|Withdrawn||N/A|0|Actual|Children's Healthcare of Atlanta|||1||f||||||||||||||2017-02-18 17:10:30.215047|2017-02-18 17:10:30.215047
NCT00207844|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2002||2002-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Selenium, as Sodium Selenite, in the Treatment of Septic Shock|Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of a Therapeutic Administration of Selenium, as Selenite, in Septic Shock Patients.|Completed||Phase 2|60||Centre Hospitalier de Meaux|||||f||||||||||||||2017-02-18 17:10:30.306314|2017-02-18 17:10:30.306314
NCT00207831|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-07-20|||July 2004||2004-07-01|July 2010|2010-07-01|February 2008|Actual|2008-02-01|June 2007|Actual|2007-06-01||Interventional|UFT RT Phase 3||Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma|Trial UFT/RT Randomized Multicenter Phase III Randomized Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma|Terminated||Phase 3|219|Anticipated|ICO Paul Papin||2||Terminated after interim analysis|f||||t||||||||||2017-02-18 17:10:30.424254|2017-02-18 17:10:30.424254
NCT00207818|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-02-10|||September 1999||1999-09-01|February 2014|2014-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Treatment of Cutaneous Ulcers With a Novel Biological Dressing|Treatment of Cutaneous Ulcers With a Novel Biological Dressing|Completed||Phase 1/Phase 2|6|Actual|Centre Hospitalier Universitaire de Québec, CHU de Québec||1|||f||||f||||||||||2017-02-18 17:10:30.570688|2017-02-18 17:10:30.570688
NCT00207805|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-26|||May 2003||2003-05-01|January 2009|2009-01-01||||||||Interventional|||The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma||Completed||Phase 3|202||Centre National de Greffe de Moelle Osseuse|||||f||||||||||||||2017-02-18 17:10:30.678788|2017-02-18 17:10:30.678788
NCT00207792|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-05|||July 2005||2005-07-01|September 2007|2007-09-01||||||||Interventional|||Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation|Randomized Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation|Unknown status|Recruiting|Phase 3|160|Anticipated|Centre National de Greffe de Moelle Osseuse|||||f||||||||||||||2017-02-18 17:10:30.776443|2017-02-18 17:10:30.776443
NCT00207779|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-19|||May 2005||2005-05-01|September 2007|2007-09-01|August 2005||2005-08-01|||||Interventional|||Prevention of Catheter-Related Bloodstream Infection in Patients With Haemato-Oncological Disease||Completed||Phase 3|||Centre National de Greffe de Moelle Osseuse|||||f||||||||||||||2017-02-18 17:10:30.857344|2017-02-18 17:10:30.857344
NCT00207766|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-26|||June 2000||2000-06-01|January 2009|2009-01-01|August 2006|Actual|2006-08-01|||||Interventional|||A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease|ACCENT II - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long Term Treatment of Patients With Fistulizing CROHN'S Disease|Completed||Phase 3|306|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:10:30.961766|2017-02-18 17:10:30.961766
NCT00207753|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-11-16|||February 2005||2005-02-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections|Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren|Completed||N/A|550||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:31.064094|2017-02-18 17:10:31.064094
NCT00207740|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-14|2009-05-21||August 2004||2004-08-01|August 2012|2012-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma|A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 148 Administered Subcutaneously in Symptomatic Subjects With Severe Persistent Asthma|Completed||Phase 2|309|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <= 5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|2|||f||||t||||||||||2017-02-18 17:10:31.188943|2017-02-18 17:10:31.188943
NCT00207727|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-20|2009-10-25||July 2004||2004-07-01|April 2012|2012-04-01|August 2006|Actual|2006-08-01|March 2006|Actual|2006-03-01||Interventional|||A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis|A Phase II, Double-blind, Placebo-Controlled, Randomized, Dose-ranging Study of Multiple Subcutaneous Injections of Human Monoclonal Antibody to IL-12p40(CNTO1275) in Subjects With Relapsing-remitting Multiple Sclerosis|Completed||Phase 2|249|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <=5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.||||||||||||||||||2017-02-18 17:10:32.551739|2017-02-18 17:10:32.551739
NCT00207714|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-16|2009-05-21||November 2003||2003-11-01|October 2012|2012-10-01|February 2006|Actual|2006-02-01|February 2005|Actual|2005-02-01||Interventional|||An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis|A Randomized, Double-blind, Dose-ranging Trial of CNTO 148 Subcutaneous Injection Compared With Placebo in Subjects With Active Rheumatoid Arthritis Despite Treatment With Methotrexate|Completed||Phase 2|172|Actual|Centocor, Inc.|The count of patients with any nonserious adverse events (NAE) excludes patients who only had NAE that occurred in <= 5% of patients. This information may vary from existing approved labeling and publications due to the requirement of this website.|3|||||||f||||||||||2017-02-18 17:10:33.27279|2017-02-18 17:10:33.27279
NCT00207701|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-16|||September 2002||2002-09-01|August 2010|2010-08-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.|A Randomized, Double-blind Trial of the Efficacy of REMICADE (Infliximab) Compared With Placebo in Subjects With Ankylosing Spondylitis Receiving Standard Anti-inflammatory Drug Therapy|Completed||Phase 3|279|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:10:34.512257|2017-02-18 17:10:34.512257
NCT00207688|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-14|||August 2004||2004-08-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients|A Multicenter International Study of the Long-term Safety of Infliximab (REMICADE) in Ulcerative Colitis|Completed||Phase 4|505|Actual|Janssen Research & Development, LLC|||3||f||||f||||||||||2017-02-18 17:10:34.613441|2017-02-18 17:10:34.613441
NCT00207675|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-16|||February 2003||2003-02-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease|A Randomized, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Anti-TNF a Chimeric Monoclonal Antibody (Infliximab, REMICADE) in Pediatric Subjects With Moderate to Severe CROHN'S Disease.|Completed||Phase 3|112|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:10:34.836571|2017-02-18 17:10:34.836571
NCT00207662|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-26|||July 2000||2000-07-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|||||Interventional|||A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease|ACCENT I - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long-term Treatment of Patients With Moderately to Severely Active Crohn's Disease|Completed||Phase 3|580|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:10:34.937226|2017-02-18 17:10:34.937226
NCT00207649|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-03-23|||November 2005||2005-11-01|March 2011|2011-03-01|February 2011|Anticipated|2011-02-01|March 2010|Actual|2010-03-01||Interventional|||Shared Decision Making: Prostate Cancer Screening|Shared Decision Making: Prostate Cancer Screening|Unknown status|Active, not recruiting|N/A|641|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-02-18 17:10:35.026758|2017-02-18 17:10:35.026758
NCT00207636|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2005-09-15|||December 2004||2004-12-01|September 2005|2005-09-01|September 2007||2007-09-01|||||Interventional|||Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening|Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening - Harvard - SIP 21-04|Unknown status|Recruiting|Phase 3|1120||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:35.163645|2017-02-18 17:10:35.163645
NCT00207623|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||July 2002||2002-07-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Interventional|||Evaluation of the Arthritis Basics for Change (ABCs) Self Management Program|Evaluation of the Arthritis Basics for Change (ABCs) Self Management Program|Completed||N/A|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:35.251988|2017-02-18 17:10:35.251988
NCT00207610|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2009-01-30|||June 2003||2003-06-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Iron Supplementation Among Low-Income Postpartum Women|Phase 3 Study of the Prevention of Postpartum Anemia by Three Different Strategies|Completed||Phase 3|959|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-02-18 17:10:35.326648|2017-02-18 17:10:35.326648
NCT00206557|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-20|||October 2002||2002-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study|The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study|Completed||Phase 2|60||The Alfred|||||f||||||||||||||2017-02-18 17:10:35.414469|2017-02-18 17:10:35.414469
NCT00206544|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-23|||January 2004||2004-01-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?|Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?|Completed||Phase 2|51|Actual|The Alfred||3|||f||||||||||||||2017-02-18 17:10:35.510373|2017-02-18 17:10:35.510373
NCT00206531|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-03||||||June 2005|2005-06-01||||||||Observational|||The Role of Naive T-Cells in HIV Pathogenesis|Role of Naive T-Cells in the Pathogenesis of T-Cell Decline and Long Term Persistence of HIV|Unknown status|Recruiting|N/A|75||Bayside Health|||||f||||||||||||||2017-02-18 17:10:35.627933|2017-02-18 17:10:35.627933
NCT00206518|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-08-26|||September 2004||2004-09-01|August 2016|2016-08-01|September 2017|Anticipated|2017-09-01|October 2016|Anticipated|2016-10-01||Interventional|TACAC||Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients|A Randomized Multicenter Trial of Neoadjuvant Taxotere (T) and Adriamycin/Cytoxan (Ac): A Validation|Active, not recruiting||Phase 2|175|Actual|Baylor Breast Care Center||2|||f||||t||||||||No||2017-02-18 17:10:35.707941|2017-02-18 17:10:35.707941
NCT00206505|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-11-16|||January 1999||1999-01-01|November 2011|2011-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Neoadjuvant Taxotere|A PHASE II STUDY OF THE CLINICAL AND BIOLOGIC EFFECTS OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER|Completed||Phase 2|40||Baylor Breast Care Center|||||f||||f||||||||||2017-02-18 17:10:35.924481|2017-02-18 17:10:35.924481
NCT00206492|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-07-27|||July 2003||2003-07-01|July 2015|2015-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients|A Neoadjuvant Phase II Trial of ZD1839 (Iressa) and Tamoxifen in Inoperable Locally Advanced HER2-Overexpressing, ER-Positive Breast Cancer Patients: Biologic Correlative Study (AZ #1839US/0303)|Terminated||Phase 2|3|Actual|Baylor Breast Care Center||1||halted by the PI only 3 of 45 subjects were accrued.|f||||f||||||||||2017-02-18 17:10:36.043362|2017-02-18 17:10:36.043362
NCT00207415|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2003||2003-01-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||A Comparison of the ASHC and CDSMP|A Comparison of the ASHC and CDSMP|Completed||N/A|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:38.508459|2017-02-18 17:10:38.508459
NCT00206466|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-01-24|||April 2002||2002-04-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|April 2006|Actual|2006-04-01||Interventional|TAX/AC||Biologic Correlative Taxotere/AC|A Randomized Multicenter Trial of Neoadjuvant Taxotere and Adriamycin/Cytoxan(AC): A Biologic Correlative Study|Completed||Phase 2|70|Actual|Baylor Breast Care Center||1|||f||||||||||||||2017-02-18 17:10:36.161126|2017-02-18 17:10:36.161126
NCT00206453|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-02-04|||January 2002||2002-01-01|February 2013|2013-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer|An Extension Phase II Study of the Clinical and Biologic Effects of Docetaxel (Taxotere) in Patients With Locally Advanced Breast Cancer|Terminated||Phase 2|25|Actual|Baylor Breast Care Center||1||accrual too difficult to meet|f||||||||||||||2017-02-18 17:10:36.285523|2017-02-18 17:10:36.285523
NCT00206440|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-27|2012-02-01||August 2005||2005-08-01|April 2012|2012-04-01|February 2012|Actual|2012-02-01|February 2009|Actual|2009-02-01||Interventional|NEXIUM||Nexium Study To Suppress Nausea During Chemotherapy|Evaluation of the Efficacy of Esomeprazole in Suppressing Nausea and Vomiting in Patients Undergoing Chemotherapy for Breast Cancer|Terminated||Phase 3|43|Actual|Baylor Breast Care Center||2||Accrual was not optimized|f||||t||||||||||2017-02-18 17:10:36.39815|2017-02-18 17:10:36.39815
NCT00206427|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-07-26|2012-02-03||August 2004||2004-08-01|July 2013|2013-07-01|February 2012|Actual|2012-02-01|June 2011|Actual|2011-06-01||Interventional|GW||Neoadjuvant GW572016 to Treat Breast Cancer|A Neoadjuvant Phase II Trial of GW572016 in HER2 Overexpressing Breast Cancer Patients: Biologic Correlative Study|Completed||Phase 2|49|Actual|Baylor Breast Care Center||1|||f||||t||||||||||2017-02-18 17:10:36.835318|2017-02-18 17:10:36.835318
NCT00207597|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 1995||1995-09-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Joint Outcome Study|A Clinical Trial of Primary Prophylaxis Against Joint Disease in Children With Severe Hemophilia|Completed||N/A|64||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:37.264831|2017-02-18 17:10:37.264831
NCT00207584|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 1994||1994-01-01|September 2005|2005-09-01|April 1994||1994-04-01|||||Interventional|||Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting|A Double-Blind, Randomized Placebo-Controlled Trial of Doxycycline for Chemoprophylaxis in the Setting of an Outbreak of Mycoplasma Pneumoniae|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:37.334228|2017-02-18 17:10:37.334228
NCT00207571|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-26|||April 2001||2001-04-01|September 2012|2012-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Partner Notification Intervention for STD Clinics.|Computer-assisted STD Partner Notification|Completed||Phase 1/Phase 2|150||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:10:37.407511|2017-02-18 17:10:37.407511
NCT00207558|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-07-12||||||September 2005|2005-09-01||||||||Interventional|||Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification|Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification|Completed||N/A|1100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:37.506637|2017-02-18 17:10:37.506637
NCT00207532|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||March 2005||2005-03-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Dosage Effects of Folic Acid on Blood Folates of Honduran Women|Dosage Effects of Folic Acid on Blood Folates of Honduran Women|Completed||N/A|100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:37.63316|2017-02-18 17:10:37.63316
NCT00207519|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-10|||April 2003||2003-04-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|August 2004|Actual|2004-08-01||Interventional|||Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents|The Use of Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents: A 12 Week Safety and Efficacy Study|Completed||Phase 1|40||Boston Medical Center|||||f||||f||||||||||2017-02-18 17:10:37.719864|2017-02-18 17:10:37.719864
NCT00207506|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-10|||October 2004||2004-10-01|September 2012|2012-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Lay Health Advisors for Sexually Transmitted Disease Prevention|HoMBReS: A Lay Health Advisor Approach to Sexually Transmitted Disease Prevention|Completed||Phase 1/Phase 2|354|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:10:37.824719|2017-02-18 17:10:37.824719
NCT00207493|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-26|||October 2000||2000-10-01|September 2012|2012-09-01|September 2007|Actual|2007-09-01|September 2005|Actual|2005-09-01||Interventional|||The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.|The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.|Completed||Phase 1/Phase 2|494||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:10:37.932783|2017-02-18 17:10:37.932783
NCT00207480|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 2004||2004-10-01|September 2005|2005-09-01||||||||Interventional|||Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women|Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young Women|Suspended||Phase 1|270||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:38.031009|2017-02-18 17:10:38.031009
NCT00207467|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||December 2001||2001-12-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Study to Improve Partner Services for STD Prevention|Prospective Study for Cost-Effectiveness Strategies to Improve Partner Notification: Female Trichomonas and Male Urethritis Studies|Completed||Phase 2|1500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:38.11718|2017-02-18 17:10:38.11718
NCT00207454|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2001||2001-06-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Optimizing Strategies to Improve STD Partner Services|Optimizing Strategies to Improve STD Partner Services|Completed||Phase 1|800||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:10:38.21275|2017-02-18 17:10:38.21275
NCT00207441|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-23|||April 2003||2003-04-01|March 2011|2011-03-01|August 2006|Actual|2006-08-01|October 2004|Actual|2004-10-01||Interventional|||Comparing ASHC and CDSMP Outcomes In Arthritis|Comparing ASHC and CDSMP Outcomes In Arthritis|Completed||N/A|416|Actual|Centers for Disease Control and Prevention||2|||f||||||||||||||2017-02-18 17:10:38.302717|2017-02-18 17:10:38.302717
NCT00207428|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-05-15|||August 1999||1999-08-01|July 1999|1999-07-01|April 2000||2000-04-01|||||Interventional|||Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma|Randomized, Placebo Controlled, Double Blind Study of Carbamazepine in Treatment of Bronchial Asthma|Completed||Phase 4|65||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-02-18 17:10:38.414333|2017-02-18 17:10:38.414333
NCT00207402|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-13|||October 2005||2005-10-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|January 2010|Actual|2010-01-01||Interventional|||Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin|A Pilot Trial of Combination Therapy With Interferon Alfacon1, Ribavirin, & Rosiglitazone in a Group of Insulin Resistant, Chronic Hepatitis C, GT 1 Patients Who Are Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin|Completed||Phase 4|34|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-02-18 17:10:38.584561|2017-02-18 17:10:38.584561
NCT00207389|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-25|||March 2004||2004-03-01|January 2017|2017-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients|A Pilot Study to Examine the Relationship Between Changes in Plasma GIP Levels and Other Gastrointestinal Peptides Following Gastric Bypass Surgery in Obese Patients|Terminated||N/A|5|Actual|Boston Medical Center|||2|Insufficient funding|f||||f|f|f||||||||2017-02-18 17:10:38.699537|2017-02-18 17:10:38.699537
NCT00207376|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-23||||||February 2007|2007-02-01||||||||Interventional|||Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale|Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of an Intracardiac Septal Closure Device in Patients With Atrial Septum Defect (ASD) and Patent Foramen Ovale (PFO)|Completed||N/A|||Carag AG|||||f||||||||||||||2017-02-18 17:10:38.802608|2017-02-18 17:10:38.802608
NCT00207363|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-02-13|||February 2002||2002-02-01|February 2012|2012-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC|Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With Chronic Hepatitis C|Completed||Phase 4|610|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-02-18 17:10:38.873987|2017-02-18 17:10:38.873987
NCT00207350|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-08-14|||January 2002||2002-01-01|August 2013|2013-08-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|ILT||Neurosurgical Use of Interstitial Laser Therapy (ILT)|Neurosurgical Use of Interstitial Laser Therapy (ILT)|Unknown status|Recruiting|N/A|24|Anticipated|Brigham and Women's Hospital||1|||f||||t||||||||||2017-02-18 17:10:38.983696|2017-02-18 17:10:38.983696
NCT00207337|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-21|||July 2004||2004-07-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Exhale (R) Stent for Emphysema|A Prospective Feasibility Study to Evaluate the Safety and Performance of the Exhale(R) Drug-Eluting Stent System in Patients With Emphysema|Completed||Phase 2/Phase 3|60||Broncus Technologies|||||f||||||||||||||2017-02-18 17:10:39.282415|2017-02-18 17:10:39.282415
NCT00207324|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2007-06-26|||January 2004||2004-01-01|June 2007|2007-06-01|January 2007|Actual|2007-01-01|||||Interventional|||The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions|A Phase III Study of the Efficacy of Silver Leaf Nylon Dressing in the Prevention of Severe Skin Reactions in the Inframammary Skin Fold of Patients Receiving Adjuvant Whole Breast Radiotherapy|Completed||Phase 3|100||British Columbia Cancer Agency|||||f||||f||||||||||2017-02-18 17:10:39.385913|2017-02-18 17:10:39.385913
NCT00207311|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-13|||August 2005||2005-08-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|HCVNASH||Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus|A Multi-Centered, Prospective, Randomized, Placebo-Controlled Clinical Trial for the Treatment of Significant Steatosis or NASH With Xenical Followed by Treatment of Hepatitis C (HCV) With PEG-Interferon Alpha-2a/Copegus|Completed||Phase 4|30|Actual|Brooke Army Medical Center||2|||f||||f||||||||||2017-02-18 17:10:39.471699|2017-02-18 17:10:39.471699
NCT00207298|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-03|||June 2005||2005-06-01|November 2010|2010-11-01|November 2008||2008-11-01|||||Interventional|||18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology|Phase III Open Label Trial for Use of [18F]-Fluoro-Deoxy-Glucose (18F-FDG) in Positron Emission Tomography Imaging in Oncology|Unknown status|Recruiting|Phase 3|5000|Anticipated|British Columbia Cancer Agency|||||f||||||||||||||2017-02-18 17:10:39.582535|2017-02-18 17:10:39.582535
NCT00207285|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-15|||May 2005||2005-05-01|March 2016|2016-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Sleep Disorders Management, Health and Safety in Police|Sleep Disorders Management, Health and Safety in Police|Completed||N/A|731|Actual|Brigham and Women's Hospital||3|||f||||||||||||||2017-02-18 17:10:39.686044|2017-02-18 17:10:39.686044
NCT00207272|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-22|||July 2003||2003-07-01|March 2008|2008-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Use of MCT Oil for Enhancement of Weight Loss in Obese Patients|Use of MCT Oil for Enhancement of Weight Loss in Obese Patients-Preliminary Phase 2002-291G|Completed||N/A|24|Anticipated|Boston Medical Center|||||f||||||||||||||2017-02-18 17:10:39.796893|2017-02-18 17:10:39.796893
NCT00207259|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-02-14|||March 2005||2005-03-01|February 2013|2013-02-01|February 2013|Anticipated|2013-02-01|February 2013|Anticipated|2013-02-01||Interventional|||Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial|Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial|Unknown status|Active, not recruiting|Phase 3|60|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-02-18 17:10:39.908248|2017-02-18 17:10:39.908248
NCT00207233|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-01-24|||July 2004||2004-07-01|February 2009|2009-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients|Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients 2002-292G|Completed||Phase 1/Phase 2|42|Anticipated|Boston Medical Center||2|||f||||f||||||||||2017-02-18 17:10:40.023548|2017-02-18 17:10:40.023548
NCT00207220|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-07|||January 2004||2004-01-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Observational|||Ventricular-Vascular Coupling in Heart Failure|Ventricular-Vascular Coupling in Patients With Heart Failure and Preserved Ejection Fraction|Completed||N/A|53|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 17:10:40.154501|2017-02-18 17:10:40.154501
NCT00207207|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-10|||July 2003||2003-07-01|February 2009|2009-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control|Randomized Trial to Assess the Effect of Using Alternate Site Blood Glucose Testing Versus Finger-Tip Testing on Long-Term Glycemic Control.|Completed||Phase 1|174||Boston Medical Center|||||f||||f||||||||||2017-02-18 17:10:40.253352|2017-02-18 17:10:40.253352
NCT00207194|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-06-15|||October 2001||2001-10-01|June 2016|2016-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Interactive Multirisk-Factor Intervention for Hypertension (HTN) Blacks|Interactive Multirisk-Factor Intervention for HTN Blacks|Completed||N/A|337|Actual|Boston Medical Center||2|||f||||t||||||||||2017-02-18 17:10:40.549269|2017-02-18 17:10:40.549269
NCT00207181|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-30|||May 2005||2005-05-01|June 2011|2011-06-01|January 2007|Actual|2007-01-01|||||Observational|||The Development and Testing of an Electronic Tool to Measure Physical Activity in Domestic Settings|Context Sensitive Measurement of Physical Activity|Completed||Phase 1|40|Actual|Boston Medical Center|||1||f||||f||||||||||2017-02-18 17:10:40.653552|2017-02-18 17:10:40.653552
NCT00207168|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-08||2010-02-03|April 2004||2004-04-01|April 2011|2011-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine|A Randomized, Multi-center, Open Label Study in Well Controlled Treatment-experienced HIV- Infected Patients to Assess Compliance With a Once-daily Regimen|Completed||Phase 4|120||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 17:10:40.743787|2017-02-18 17:10:40.743787
NCT00207155|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-26|||December 2003||2003-12-01|October 2015|2015-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer|An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer|Completed||Phase 1|110||Eli Lilly and Company||1|||f||||||||||||||2017-02-18 17:10:40.821908|2017-02-18 17:10:40.821908
NCT00207142|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2010-01-07|2009-06-02||November 2005||2005-11-01|January 2010|2010-01-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Interventional|INDUMA||Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)|A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing the Efficacy of a Treatment Maintenance Phase With Unboosted vs. Boosted Reyataz After an Induction Phase With Reyataz and Ritonavir in Treatment Naive HIV Patients (the INDUMA Study)|Completed||Phase 4|252|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 17:10:40.957662|2017-02-18 17:10:40.957662
NCT00207129|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-27|||October 2004||2004-10-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies|Effect of Capecitabine on the Pharmacokinetics of BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies|Completed||Phase 1|25||R-Pharm||2|||f||||||||||||||2017-02-18 17:10:42.116057|2017-02-18 17:10:42.116057
NCT00207116|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-26|||September 2005||2005-09-01|October 2015|2015-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma|An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma|Completed||Phase 1|120||Eli Lilly and Company||1|||f||||||||||||||2017-02-18 17:10:42.212801|2017-02-18 17:10:42.212801
NCT00207103|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-11-03|||September 2004||2004-09-01|November 2008|2008-11-01|September 2008|Actual|2008-09-01|October 2007|Actual|2007-10-01||Interventional|||MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors|Phase I Dose Escalation Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors|Completed||Phase 1|68|Actual|Bristol-Myers Squibb||6|||f||||f||||||||||2017-02-18 17:10:42.313532|2017-02-18 17:10:42.313532
NCT00207090|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-09|2010-09-03||September 2005||2005-09-01|February 2016|2016-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer|Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer|Completed||Phase 1|19|Actual|R-Pharm||1|||f||||f||||||||||2017-02-18 17:10:42.437118|2017-02-18 17:10:42.437118
NCT00207077|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-26|||August 2005||2005-08-01|October 2015|2015-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors|A Phase I Study of Cetuximab in Combination With Erlotinib in Patients With Advanced Solid Malignancies|Completed||Phase 1|33|Anticipated|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 17:10:43.133511|2017-02-18 17:10:43.133511
NCT00207064|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-09-16|||April 2004||2004-04-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia|5-HT2A-receptor Binding: Implications for the Pathophysiology of Schizophrenia and Effects of Treatment With Antipsychotic Drugs|Completed||N/A|46|Actual|University of Copenhagen||1|||f||||f||||||||||2017-02-18 17:10:43.231451|2017-02-18 17:10:43.231451
NCT00207051|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-01-24|||January 2006||2006-01-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies|Phase I Dose Escalation Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-582664 in Combination With Full Dose Erbitux in Patients With Advanced Gastrointestinal Malignancies Who Have Failed Prior Therapy|Completed||Phase 1|62|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 17:10:43.342473|2017-02-18 17:10:43.342473
NCT00207038|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-02-10|||September 2005||2005-09-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|||||Observational|||Airway Inflammation in Swimmers|Airway Inflammation in Swimmers: Development and Risk Factors|Completed||N/A|90|Anticipated|Bispebjerg Hospital|||1||f||||||||||Samples Without DNA|"~     Blood samples EBC Sputum~   "|||2017-02-18 17:10:43.453939|2017-02-18 17:10:43.453939
NCT00207025|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-02-27||2010-02-27|October 2004||2004-10-01|July 2008|2008-07-01||||February 2007|Actual|2007-02-01||Interventional|||A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies|A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies|Terminated||Phase 1|60||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:10:43.715977|2017-02-18 17:10:43.715977
NCT00207012|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-02-27||2010-02-27|May 2004||2004-05-01|January 2009|2009-01-01||||February 2006|Actual|2006-02-01||Interventional|||MAD Refractory: Solid Tumor QD w/o Break|Continuous Dosing Phase I Study of BMS-599626 in Patients With HER2-Expressing Advanced Solid Malignancies|Completed||Phase 1|45||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 17:10:43.806003|2017-02-18 17:10:43.806003
NCT00206869|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-10|||January 2003||2003-01-01|December 2002|2002-12-01||||||||Interventional|||Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria||Unknown status|Recruiting|N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 17:10:45.877643|2017-02-18 17:10:45.877643
NCT00206999|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-09-19|||September 2004||2004-09-01|September 2011|2011-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||The Effect of Imipramine on Early Information Processing|Early Information Processing in Healthy Controls: Studies on the Relation Between Two Different Paradigms (PPI and P50ERP) and Effects of Pharmacological Interventions|Completed||N/A|20|Actual|University of Copenhagen||1|||f||||f||||||||||2017-02-18 17:10:43.895232|2017-02-18 17:10:43.895232
NCT00206986|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-19|||May 2005||2005-05-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?|Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?|Completed||N/A|40|Anticipated|University of Copenhagen||2|||f||||f||||||||||2017-02-18 17:10:44.002917|2017-02-18 17:10:44.002917
NCT00206414|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-04|||January 2003||2003-01-01|February 2013|2013-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer|Arimidex/Faslodex/Iressa Study: A Phase II Trial of Primary Systemic Therapy Using a Combination of Arimidex, Faslodex and Iressa (Gefitinib) in Postmenopausal Women With Hormone Receptor Positive Breast Cancer|Terminated||Phase 2|15|Actual|Baylor Breast Care Center||2||Difficulty accruing subjects the study accrual was closed|f||||t||||||||||2017-02-18 17:10:44.122518|2017-02-18 17:10:44.122518
NCT00206401|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-07-12|||November 2004||2004-11-01|July 2016|2016-07-01|October 2006||2006-10-01|||||Interventional|||Lantus in the Treatment of Type 1 Diabetes Children|Conventional Insulin Therapy Vs Intensive Insulin Management In Children With Type 1 Diabetes Mellitus|Completed||Phase 4|60||Baylor College of Medicine|||||f||||||||||||||2017-02-18 17:10:44.242501|2017-02-18 17:10:44.242501
NCT00206388|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-08-01|||April 2005||2005-04-01|August 2013|2013-08-01|May 2013|Actual|2013-05-01|April 2008|Actual|2008-04-01||Interventional|||Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement|A Phase I Study of Zoledronic Acid (Zometa) With Cyclophosphamide in Children With Recurrent or Refractory Neuroblastoma and Cortical Bone Involvement (NANT 2004-01)|Completed||Phase 1|21|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:10:44.348247|2017-02-18 17:10:44.348247
NCT00206375|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-18|||May 2003||2003-05-01|September 2015|2015-09-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism|Concomitant Use of Growth Hormone and GnRH Agonist in Adolescent Patients With Acquired Hypothyroidism|Completed||Phase 4|21|Actual|Baylor College of Medicine||3|||f||||t||||||||||2017-02-18 17:10:44.47393|2017-02-18 17:10:44.47393
NCT00206362|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-07-19|||July 2004||2004-07-01|July 2016|2016-07-01|April 2010|Actual|2010-04-01|February 2010|Actual|2010-02-01||Observational|||Ability to Cope With Type 1 Diabetes|Evaluation of Ongoing Management of Type 1 Diabetes|Completed||Phase 4|100|Actual|Baylor College of Medicine|||1||f||||f||||||||No||2017-02-18 17:10:44.598281|2017-02-18 17:10:44.598281
NCT00206349|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-07-12|||June 2004||2004-06-01|July 2016|2016-07-01|May 2005||2005-05-01|||||Observational|||Ability to Cope With Type 1 Diabetes|Evaluation of Coping Skills in Type 1 Diabetes|Completed||Phase 4|220||Baylor College of Medicine|||||f||||||||||||||2017-02-18 17:10:44.685087|2017-02-18 17:10:44.685087
NCT00206336|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-30|||October 2004||2004-10-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||An Open-Label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.|An Open-Label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome|Completed||Phase 3|||Baylor College of Medicine|||||f||||f||||||||||2017-02-18 17:10:44.769324|2017-02-18 17:10:44.769324
NCT00206973|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics.|Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics|Unknown status|Recruiting|N/A|40||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 17:10:45.069858|2017-02-18 17:10:45.069858
NCT00206960|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-09-16|||January 1998||1998-01-01|September 2011|2011-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia|Effects of Classical and Atypical Antipsychotics on Dopamine Receptor Binding of 123I-epidepride, Cognition, Startle Response and Extrapyramidal Side-effects in Drug-naive First-episode Schizophrenic Patients|Completed||N/A|56|Actual|University of Copenhagen||2|||f||||f||||||||||2017-02-18 17:10:45.155025|2017-02-18 17:10:45.155025
NCT00206947|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-09-19|||December 2002||2002-12-01|July 2008|2008-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia|PHARMACOLOGICAL TREATMENT OF COGNITIVE DEFICITS IN SCHIZOPHRENIC PATIENTS: The Effects of Central Cholinergic Augmentation on Cognitive Deficits and Psychopathology|Terminated||Phase 2|50|Anticipated|University of Copenhagen||2||No more funding|f||||f||||||||||2017-02-18 17:10:45.294871|2017-02-18 17:10:45.294871
NCT00206934|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-16|||March 2005||2005-03-01|July 2008|2008-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||The Effects of Increased Central Serotonergic Activity on Information Processing|The Effects of Increased Central Serotonergic Activity on Psychophysiological Parameters of Human Information Processing|Completed||N/A|40|Actual|University of Copenhagen||2|||f||||f||||||||||2017-02-18 17:10:45.427887|2017-02-18 17:10:45.427887
NCT00206921|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-23|||February 2005||2005-02-01|December 2004|2004-12-01|August 2005||2005-08-01|||||Interventional|||Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness|Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness|Unknown status|Recruiting|N/A|||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 17:10:45.54172|2017-02-18 17:10:45.54172
NCT00206908|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-20|||July 2002||2002-07-01|July 2015|2015-07-01||||||||Observational|||BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)|BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)|Completed||Phase 2/Phase 3|900||Biosite|||1||f||||||||||||||2017-02-18 17:10:45.630204|2017-02-18 17:10:45.630204
NCT00206895|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-10|||November 2004||2004-11-01|October 2004|2004-10-01||||||||Interventional|||Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study||Completed||N/A|24||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 17:10:45.724706|2017-02-18 17:10:45.724706
NCT00206882|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-10|||September 2005||2005-09-01|August 2005|2005-08-01||||||||Interventional|||The Sun Protection Effect and Efficacy in Treatment of Sunburn Using Topical Corticosteroids.||Unknown status|Recruiting|N/A|20||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 17:10:45.803227|2017-02-18 17:10:45.803227
NCT00206856|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-26|||July 2003||2003-07-01|July 2013|2013-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)|Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)|Terminated||Phase 4|720||Biosite||||Slow enrollment|f||||f||||||||||2017-02-18 17:10:45.951362|2017-02-18 17:10:45.951362
NCT00206843|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-07-23|||November 2004||2004-11-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)|Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)|Completed||N/A|630|Actual|Biosite||2|||f||||f||||||||||2017-02-18 17:10:46.076693|2017-02-18 17:10:46.076693
NCT00206830|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-23|||April 2005||2005-04-01|July 2015|2015-07-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||SHORTness of Breath In the Emergency Department (SHORTIE)|SHORTness of Breath In the Emergency Department (SHORTIE)|Completed||Phase 2/Phase 3|306||Biosite||2|||f||||||||||||||2017-02-18 17:10:46.188963|2017-02-18 17:10:46.188963
NCT00206817|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-20|||October 2003||2003-10-01|July 2015|2015-07-01||||||||Interventional|||Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)|Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)|Withdrawn||Phase 4|0|Actual|Biosite|||||f||||||||||||||2017-02-18 17:10:46.301392|2017-02-18 17:10:46.301392
NCT00206791|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-25|||May 2006||2006-05-01|October 2006|2006-10-01|May 2008||2008-05-01|||||Interventional|||Osteoconduction Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects|Study of Osteoconduction Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects From Various Origins|Unknown status|Recruiting|N/A|12||Biomatlante|||||f||||||||||||||2017-02-18 17:10:46.389395|2017-02-18 17:10:46.389395
NCT00206778|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2010-11-24|||July 2003||2003-07-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania|A Randomized Open-Label 6 Month Acute and Maintenance Trial of Lamotrigine vs. Standard of Care Sodium Valproate Monotherapy for Treatment of Mixed Mania.|Completed||Phase 2|36|Anticipated|Beth Israel Medical Center|||||f||||||||||||||2017-02-18 17:10:46.48564|2017-02-18 17:10:46.48564
NCT00206765|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-19|||January 2003||2003-01-01|October 2012|2012-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Risperidone vs. Paroxetine for Panic Attacks|A Single-blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks|Terminated||Phase 2|90|Anticipated|Beth Israel Medical Center|||||f||||||||||||||2017-02-18 17:10:46.594873|2017-02-18 17:10:46.594873
NCT00206752|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-27|||August 2004||2004-08-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|Unilateral||Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck|A Randomized Prospective Evaluation of Unilateral/Ipsilateral Neck Irradiation in Selected Patients With Squamous Cell Carcinoma of the Head and Neck Who Are Managed by Radiation Therapy|Completed||N/A|45|Actual|Beth Israel Medical Center||1|||f||||||||||||||2017-02-18 17:10:46.794045|2017-02-18 17:10:46.794045
NCT00206739|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-29|||January 2003||2003-01-01|September 2005|2005-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants|Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infant: a Randomized, Double-blind, and Placebo-controlled Clinical Trial|Completed||Phase 4|1070|Actual|Bernhard Nocht Institute for Tropical Medicine||2|||f||||t||||||||||2017-02-18 17:10:46.894142|2017-02-18 17:10:46.894142
NCT00206726|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-07-27|2009-11-19||May 2005||2005-05-01|July 2016|2016-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|ECO-1||Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)|Phase II Study Using Alemtuzumab Combined With Fludarabine for the Treatment of Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)|Completed||Phase 2|60|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:10:47.010961|2017-02-18 17:10:47.010961
NCT00206713|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-02|||July 2004||2004-07-01|December 2013|2013-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim|Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Retreatment Study of Sargramostim (Leukine®) in Patients With Active Crohn's Disease and Prior Treatment Response to Sargramostim|Terminated||Phase 3|264|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:10:48.045935|2017-02-18 17:10:48.045935
NCT00206700|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-02|||February 2003||2003-02-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Open-label Trial of Leukine in Active Crohn's Disease|Open-label Trial of Leukine® (Sargramostim), A Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF), in Active Crohn's Disease|Terminated||Phase 2|378|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:10:48.205906|2017-02-18 17:10:48.205906
NCT00206687|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-23||2015-09-23|January 2003||2003-01-01|November 2014|2014-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||STEPS Trial - Spheramine Safety and Efficacy Study|Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease|Terminated||Phase 2|71|Actual|Bayer||2||Study was completed, only life long extended follow-up phase was discontinued after 12 years.|f||||t||||||||||2017-02-18 17:10:48.539251|2017-02-18 17:10:48.539251
NCT00206674|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-02|||September 2004||2004-09-01|December 2013|2013-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease|Phase 3 Randomized, Double-Blind, Placebo Controlled Induction Study of Sargramostim (Leukine®) in Patients With Active Crohn's Disease|Completed||Phase 3|286|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:10:48.663515|2017-02-18 17:10:48.663515
NCT00206661|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-02|||December 2004||2004-12-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease|Phase 1/2 Safety, Pharmacokinetic, and Pharmacodynamic Study of Sargramostim (Leukine®) in Pediatric Patients With Active Crohn's Disease, With One-year Surveillance and Retreatment Extension|Terminated||Phase 1/Phase 2|22|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:10:48.841096|2017-02-18 17:10:48.841096
NCT00206232|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-15|||July 2004||2004-07-01|February 2013|2013-02-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Novel Treatment for Diastolic Heart Failure in Women|Novel Treatment for Diastolic Heart Failure in Women|Completed||Phase 4|48|Actual|Baylor College of Medicine||2|||f||||f||||||||||2017-02-18 17:10:54.783923|2017-02-18 17:10:54.783923
NCT00206648|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-30|||March 2003||2003-03-01|December 2014|2014-12-01|October 2005|Actual|2005-10-01|||||Interventional|ABOVE||An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS|A Randomized, Rater-blinded, Multicenter, Parallel-group Study Comparing the Efficacy and Safety of Betaseron 250 µg Subcutaneously Every Other Day With Avonex 30 µg Intramuscularly Once Per Week in Relapsing-remitting Multiple Sclerosis Patients Previously Treated With Avonex|Completed||Phase 4|271|Actual|Bayer||2|||f||||t||||||||||2017-02-18 17:10:48.960212|2017-02-18 17:10:48.960212
NCT00206635|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-11-21|||January 2005||2005-01-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|||||Observational|||Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis|A Long-term Follow up of Patients Enrolled in the Pivotal Study of Betaseron® (Interferon Beta 1b) in Relapsing-remitting Multiple Sclerosis|Completed||N/A|432|Actual|Bayer|||1||f||||f||||||Samples With DNA|"~     Whole blood, serum~   "|||2017-02-18 17:10:49.216456|2017-02-18 17:10:49.216456
NCT00206622|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-05-28|||December 2004||2004-12-01|May 2009|2009-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Comparing a 2.2mg 17 Beta-Estradiol/0.69mg Levonorgestrel Combination Transdermal Patch, and a 1mg 17 Beta-Estradiol Transdermal Patch With a Placebo Patch in Postmenopausal Women to Determine the Lowest Effective Dose of Estradiol for the Relief of Moderate to Severe Hot Flushes|Completed||Phase 4|425|Actual|Bayer||3|||f||||||||||||||2017-02-18 17:10:49.335772|2017-02-18 17:10:49.335772
NCT00206609|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2005-09-18|||November 2000||2000-11-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer|A Randomised, Double-Blind Cross-Over Trial of the Effect of Oxygen on Dyspnoea in Patients With Advanced Cancer|Completed||Phase 3|50||Bayside Health|||||f||||||||||||||2017-02-18 17:10:49.488727|2017-02-18 17:10:49.488727
NCT00206596|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-02|||July 2003||2003-07-01|December 2013|2013-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease|Randomized, Stratified, Double-Blind, Placebo-Controlled Phase 2 Study of Steroid-Sparing Properties of Sargramostim (Leukine) Therapy in Patients With Cortico-Dependent Crohn's Disease|Completed||Phase 2|127|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:10:49.573847|2017-02-18 17:10:49.573847
NCT00206583|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-09-30|||March 2005||2005-03-01|September 2014|2014-09-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety Study of an Oral Contraceptive in Healthy Females|A Multicenter, Open-label Uncontrolled Study to Investigate the Efficacy and Safety of a 4-phasic Oral Contraceptive SH T0065 in a 28-day Regimen for 13 Cycles in Healthy Female Subjects|Completed||Phase 3|499|Actual|Bayer||1|||f||||f||||||||||2017-02-18 17:10:49.683937|2017-02-18 17:10:49.683937
NCT00206570|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-02-02|||January 2001||2001-01-01|February 2015|2015-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Clinical Estradiol Trial in Women With Schizophrenia|Double Blind Study of Estradiol Plus Neuroleptic Versus Placebo Plus Neuroleptic in the Treatment of Psychotic Symptoms in Women With Schizophrenia|Completed||Phase 2|100|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:10:49.81874|2017-02-18 17:10:49.81874
NCT00206323|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-30|||September 2004||2004-09-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Randomized, Placebo-Controlled, Tourette Syndrome Study.|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Safety and Efficacy of Topiramate in the Treatment of Tourette Syndrome.|Completed||Phase 3|16|Anticipated|Baylor College of Medicine|||||f||||f||||||||||2017-02-18 17:10:49.926038|2017-02-18 17:10:49.926038
NCT00206310|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2010-11-17|||September 2003||2003-09-01|November 2010|2010-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Crestor Versus Placebo in Subjects With Heart Failure|Controlled Rosuvastatin Multinational Study in Heart Failure CORONA A Randomized, Double-Blind, Placebo Controlled Phase III Study With Rosuvastatin in Subjects With Chronic Symptomatic Systolic Heart Failure|Completed||Phase 3|5013||AstraZeneca|||||f||||||||||||||2017-02-18 17:10:50.022689|2017-02-18 17:10:50.022689
NCT00206297|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|||October 2003||2003-10-01|July 2016|2016-07-01|February 2006||2006-02-01|||||Interventional|||The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes|The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes|Completed||Phase 3|20||Baylor College of Medicine|||||||||||||||||||2017-02-18 17:10:53.61806|2017-02-18 17:10:53.61806
NCT00206284|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-01-03|||May 2004||2004-05-01|January 2013|2013-01-01|April 2005|Actual|2005-04-01|||||Interventional|||A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.|A 4-week, Randomised, Double-blind, Multicentre, Dose-finding Phase IIb Study With AZD0865 25, 50, 75 mg and Esomeprazole 20 mg, Given Orally Once Daily for the Treatment of GERD Without Erosive Esophagitis According to the LA Classification in Adult Subjects.|Completed||Phase 2|1400||AstraZeneca|||||||||||||||||||2017-02-18 17:10:53.73045|2017-02-18 17:10:53.73045
NCT00206271|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 2001||2001-05-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Comparison of the Effect of Neck Collar, Act-as-Usual, and Active Mobilisation Early After a Whiplash Injury|A Randomized Early Intervention Study Comparing the Effect of Stiff Neck Collar, “Act-as-Usual” and Active Mobilisation on the One Year Outcome Following Whiplash Injury.|Completed||Phase 3|450||The Back Research Center, Denmark|||||f||||||||||||||2017-02-18 17:10:54.285488|2017-02-18 17:10:54.285488
NCT00206258|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|||July 2002||2002-07-01|July 2016|2016-07-01|August 2005||2005-08-01|||||Interventional|||The Role of Amylin and Glucagon in T1DM|The Role of Amylin and Glucagon in the Management of Normalizing Glucose Excursions in Children With Type 1 Diabetes|Completed||Phase 3|30||Baylor College of Medicine|||||||||||||||||||2017-02-18 17:10:54.375124|2017-02-18 17:10:54.375124
NCT00206245|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-03|||May 2004||2004-05-01|January 2013|2013-01-01|March 2005|Actual|2005-03-01|||||Interventional|||A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.|A Randomised, Double-blind, Multicentre Dose-finding Phase IIb Study for up to 8 Weeks' Treatment With AZD0865 25, 50, 75 mg and Esomeprazole 40 mg, Given Orally Once Daily for the Healing of Erosive Esophagitis in Adult Subjects With GERD With Erosive Esophagitis According to the LA Classification in Adult Subjects.|Completed||Phase 2|1400||AstraZeneca|||||||||||||||||||2017-02-18 17:10:54.491974|2017-02-18 17:10:54.491974
NCT00005417|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1991||1991-09-01|May 2000|2000-05-01|September 1993|Actual|1993-09-01|||||Observational|||Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.224824|2017-02-18 18:15:01.224824
NCT00206219|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-01-25|||November 2003||2003-11-01|January 2011|2011-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)|A Phase III Randomised, Stratified, Parallel-Group, Multi-Centre, Comparative Study of ZD1839 (Iressa®) 250 Mg and 500 Mg Versus Methotrexate for Previously Treated Patients With Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|477||AstraZeneca|||||||||||||||||||2017-02-18 17:10:54.922147|2017-02-18 17:10:54.922147
NCT00206206|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-02-02|||July 2005||2005-07-01|September 2005|2005-09-01||||||||Interventional|||Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart|Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart.|Terminated||N/A|235||Atlantic Health System|||||f||||||||||||||2017-02-18 17:10:55.369305|2017-02-18 17:10:55.369305
NCT00206193|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-29||||||September 2005|2005-09-01||||||||Observational|||Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone||Unknown status|Recruiting|Phase 2|||Atrium Medical Center|||||||||||||||||||2017-02-18 17:10:55.449093|2017-02-18 17:10:55.449093
NCT00206180|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-03-25|||June 2004||2004-06-01|March 2009|2009-03-01|August 2005|Actual|2005-08-01|||||Interventional|||NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis|A Multicenter, Double-Blind, Randomized Trial of the Relationship of Intragastric Acid Control and Healing Status of Moderate and Severe Erosive Esophagitis After Treatment With Esomeprazole Magnesium (NEXIUM®) 10 mg and 40 mg Once Daily|Completed||Phase 4|120||AstraZeneca|||||||||||||||||||2017-02-18 17:10:55.530672|2017-02-18 17:10:55.530672
NCT00206167|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-26|||April 2005||2005-04-01|March 2009|2009-03-01|September 2007|Actual|2007-09-01|||||Interventional|||A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD|A 12-Month Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter Efficacy and Safety Study of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid Compared to Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD|Completed||Phase 3|1600||AstraZeneca|||||f||||||||||||||2017-02-18 17:10:55.665143|2017-02-18 17:10:55.665143
NCT00206154|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-26|||April 2005||2005-04-01|March 2009|2009-03-01|December 2006|Actual|2006-12-01|||||Interventional|||A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients|A 6-Month Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter Efficacy & Safety Study of SYMBICORT® pMDI 2 x 160/4.5 µg & 80/4.5 µg Bid Compared to Formoterol TBH, Budesonide pMDI (& the Combination) & Placebo in COPD Patients|Completed||Phase 3|1500|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 17:10:55.981596|2017-02-18 17:10:55.981596
NCT00206141|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-03|||August 2005||2005-08-01|January 2013|2013-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Seroquel in Bipolar Depression Versus Lithium|Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase 3 Study of the Efficacy & Safety of Quetiapine Fumarate & Lithium as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks & Quetiapine in Continuation (Abbreviated)|Completed||Phase 3|672||AstraZeneca|||||f||||||||||||||2017-02-18 17:10:56.519635|2017-02-18 17:10:56.519635
NCT00206128|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-03|||November 2004||2004-11-01|January 2013|2013-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia|6-week Multicenter, Double-blind, Randomized, Parallel-group, Phase 3 Study to Evaluate the Feasibility of Switching From Immediate-release Quetiapine Fumarate (SEROQUEL) to Sustained-release Quetiapine Fumarate in Outpatients With Schizophrenia (Abbreviated)|Completed||Phase 3|454|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 17:10:56.704294|2017-02-18 17:10:56.704294
NCT00206115|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-01-03|||November 2004||2004-11-01|January 2013|2013-01-01|December 2005|Actual|2005-12-01|||||Interventional|||SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia|A 6-week, Multicenter, Double-blind, Double-dummy, Randomized Comparison of the Efficacy & Safety of Sustained-Release Formulation Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia|Completed||Phase 3|535||AstraZeneca|||||f||||||||||||||2017-02-18 17:10:56.882144|2017-02-18 17:10:56.882144
NCT00206102|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-01-08|2009-10-22||September 2003||2003-09-01|January 2013|2013-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder|A Multicenter, Open Label, Flexible-dose, Parallel-group Evaluation of the Cataractogenic Potential of Quetiapine Fumarate (Seroquel) and Risperidone (Risperdal) in the Long Term Treatment of Participants With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|1098|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:10:57.016257|2017-02-18 17:10:57.016257
NCT00206089|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-11|||September 2005||2005-09-01|November 2010|2010-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|EXTEND||Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events|"The EXTEND Study: A Randomized, Double-blind, Parallel-group, Phase III b, Multi-centre Study Evaluating Extended Prophylactic Treatment With Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events in Patients Undergoing Elective Hip Replacement or Hip Fracture Surgery."|Terminated||Phase 3|3300||AstraZeneca||||"Melagatran/ximelagatran was withdrawn from the market and clinical development in February~   2006 in the interest of patient safety."|f||||||||||||||2017-02-18 17:10:57.967443|2017-02-18 17:10:57.967443
NCT00206076|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-31|2012-02-23||August 2006||2006-08-01|July 2013|2013-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation|CellCept (Mycophenolate Mofetil, MMF) Maintenance Immunosuppression in Liver Transplant Recipients With Long-term Follow-up Post-transplantation for Non-Autoimmune Liver Disease - A Prospective, Randomized, Multicenter Trial.|Completed||Phase 4|19|Actual|Albert Einstein Healthcare Network||2|||f||||f||||||||||2017-02-18 17:10:58.464083|2017-02-18 17:10:58.464083
NCT00206063|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10|||August 1999||1999-08-01|November 2010|2010-11-01|April 2006|Actual|2006-04-01|June 2004|Actual|2004-06-01||Interventional|||Long Term Open Follow-up With H376/95 vs. Warfarin|Long-Term Treatment With the Oral Direct Thrombin Inhibitor Ximelagatran, Compared to Warfarin, as Stroke Prophylaxis in Patients With Atrial Fibrillation. A Long Term Follow-Up Study|Terminated||Phase 2|220||AstraZeneca||||"Melagatran/ximelagatran was withdrawn from the market and clinical development in February~   2006 in the interest of patient safety."|f||||||||||||||2017-02-18 17:10:58.945785|2017-02-18 17:10:58.945785
NCT00206050|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-01-20|||September 2004||2004-09-01|January 2011|2011-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po|A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of the 24-Hour Intragastric pH Profile After 5 Days of Once Daily Oral Administration of Either Esomeprazole 40 mg or Pantoprazole 40 mg Following Once Daily Infusion of Intravenous Pantoprazole 40 mg for 5 Days in Healthy Volunteer Subjects|Completed||Phase 4|40||AstraZeneca|||||||||||||||||||2017-02-18 17:10:59.055438|2017-02-18 17:10:59.055438
NCT00206037|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-11-19|||May 2005||2005-05-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|||||Interventional|||Open Wedge High Tibia Osteotomy|Comparison of Open Wedge High Tibia Osteotomy Surgeries Using Colloss E and Tomofix and Tomofix Only, Regarding the Bone Healing|Terminated||Phase 4|49|Actual|AO Clinical Investigation and Documentation||2||Interim analysis showed significant results, thus study was stopped|f||||t||||||||||2017-02-18 17:10:59.130325|2017-02-18 17:10:59.130325
NCT00206024|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-11-18|||November 2004||2004-11-01|November 2010|2010-11-01|July 2005|Actual|2005-07-01|||||Interventional|||Acid-Associated Heartburn Symptoms and Dose of Esomeprazole|A 4-week Study to Investigate the Relationship Between Resolution of Acid-Associated Heartburn Symptoms and Dose of Esomeprazole Magnesium|Completed||Phase 4|330||AstraZeneca|||||||||||||||||||2017-02-18 17:10:59.224836|2017-02-18 17:10:59.224836
NCT00206011|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-01-29|||April 2003||2003-04-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2008|Actual|2008-10-01||Interventional|||Open Versus Endoscopic Surgery of Craniomaxillofacial (CMF) Condylar Neck Fractures|Open Versus Endoscopic Surgery of Condylar Neck Fractures|Completed||Phase 4|134|Actual|AO Clinical Investigation and Documentation||2|||f||||f||||||||||2017-02-18 17:10:59.345835|2017-02-18 17:10:59.345835
NCT00205998|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-26|||December 2001||2001-12-01|April 2007|2007-04-01|December 2005|Actual|2005-12-01|||||Interventional|||Surgical Plate Osteosynthesis of Distal Radius Fractures|Surgical Plate Osteosynthesis of Distal Radius Fractures. Prospective Study of the Locking Compression Plate (LCP)|Terminated||Phase 4|450|Actual|AO Clinical Investigation and Documentation||1||Study completed|f||||f||||||||||2017-02-18 17:10:59.44793|2017-02-18 17:10:59.44793
NCT00205985|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-11-16|||December 2003||2003-12-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Operative Versus Conservative Treatment of Scaphoid Fractures|Comparison of Time to Return to Previous Activity Between Operative Treatment and Cast Immobilization of Complete Fracture of the Middle Part of the Scaphoid Without Dislocation|Completed||Phase 4|100||AO Clinical Investigation and Documentation|||||f||||f||||||||||2017-02-18 17:10:59.540433|2017-02-18 17:10:59.540433
NCT00205972|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-19|||December 2000||2000-12-01|November 2007|2007-11-01|October 2004||2004-10-01|||||Interventional|||Non Randomized Humerusshaft Fracture|Comparison (Conservative Versus Operative) of Standardized Treatment for Defined Humerusshaft Fractures|Completed||Phase 4|300||AO Clinical Investigation and Documentation|||||f||||f||||||||||2017-02-18 17:10:59.631617|2017-02-18 17:10:59.631617
NCT00205959|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-06|||August 2002||2002-08-01|September 2005|2005-09-01|August 2006||2006-08-01|||||Interventional|||LPHP-Philos-PHN Conservative Treatment|Comparison of Standard Treatment Methods for Proximal Humerus Fractures|Completed||Phase 4|640||AO Clinical Investigation and Documentation|||||f||||||||||||||2017-02-18 17:10:59.722875|2017-02-18 17:10:59.722875
NCT00205946|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-04|||April 2005||2005-04-01|November 2007|2007-11-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity|The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity|Completed||Phase 1|32|Actual|Affective Neuroscience Laboratory||2|||f||||t||||||||||2017-02-18 17:10:59.811335|2017-02-18 17:10:59.811335
NCT00205933|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-04|||April 2004||2004-04-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Observational|||Behavioral Processes Underlying Reward Processing in Depression|Behavioral Processes Underlying Reward Processing in Depression|Completed||N/A|78|Actual|Affective Neuroscience Laboratory|||1||f||||t||||||||||2017-02-18 17:10:59.923806|2017-02-18 17:10:59.923806
NCT00205920|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-01-14|||May 2005||2005-05-01|January 2010|2010-01-01|May 2007|Actual|2007-05-01|September 2006|Actual|2006-09-01||Interventional|||Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation|Dose Escalation Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema|Terminated||Phase 2|5|Actual|Aeris Therapeutics||1||Change in formulation|f||||f||||||||||2017-02-18 17:11:00.009346|2017-02-18 17:11:00.009346
NCT00205907|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-27|||January 2005||2005-01-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|August 2006|Actual|2006-08-01||Interventional|||Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation|Phase 1/Phase 2 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema|Terminated||Phase 1/Phase 2|4|Actual|Aeris Therapeutics||1||Change in Formulation|f||||f||||||||||2017-02-18 17:11:00.11395|2017-02-18 17:11:00.11395
NCT00205894|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-04|||January 2004||2004-01-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|October 2006|Actual|2006-10-01||Interventional|||Occipital Nerve Stimulation to Treat Chronic Headaches|Multicenter Feasibility Study of the Bion for Occipital Nerve Stimulation for Treatment of Chronic Headaches|Completed||Phase 1/Phase 2|20|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 17:11:00.258124|2017-02-18 17:11:00.258124
NCT00205881|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-28|2011-09-29||October 2004||2004-10-01|February 2012|2012-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System|Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System|Completed||Phase 4|32|Actual|Advanced Bionics||1|||f||||f||||||||||2017-02-18 17:11:00.357442|2017-02-18 17:11:00.357442
NCT00205868|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-10|||December 2004||2004-12-01|October 2008|2008-10-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||Spinal Cord Stimulation for Low Back Pain|Effectiveness of the Precision Spinal Cord Stimulation System in Patients With Failed Back Surgery Syndrome and Axial Low Back Pain|Completed||Phase 4|304|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 17:11:00.592987|2017-02-18 17:11:00.592987
NCT00205855|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-26|2012-03-05||February 2003||2003-02-01|September 2012|2012-09-01|March 2005|Actual|2005-03-01|October 2003|Actual|2003-10-01||Interventional|||An Implantable Spinal Cord Stimulation Pain Management System|Stimulus Confirmatory Study - An Implantable Spinal Cord Stimulation Pain Management System|Completed||Phase 3|65|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 17:11:00.784222|2017-02-18 17:11:00.784222
NCT00205842|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-07|||June 2004||2004-06-01|January 2016|2016-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus|A Phase IIIb, Multicenter, Double-Blind, Placebo-Controlled, Parallel Study of Alvimopan for the Management of Opioid-Induced Postoperative Bowel Dysfunction/Postoperative Ileus|Completed||Phase 3|660||Cubist Pharmaceuticals LLC|||||f||||f||||||||||2017-02-18 17:11:01.038374|2017-02-18 17:11:01.038374
NCT00205829|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-31|||June 2004||2004-06-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|August 2007|Actual|2007-08-01||Interventional|||Bion for Occipital Nerve Stimulation|Bion for Occipital Nerve Stimulation|Completed||Phase 1/Phase 2|10|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 17:11:01.147083|2017-02-18 17:11:01.147083
NCT00205816|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-02-07|||January 2004||2004-01-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.|An Open-label, Noncomparative, Multi-center, Emergency Use Protocol Administering Tigecycline for the Treatment of Subjects With Infections Due to Resistant Pathogens.|Completed||Phase 3|26|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:11:01.244146|2017-02-18 17:11:01.244146
NCT00205803|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2012-07-06|2010-03-26||September 2004||2004-09-01|July 2012|2012-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Study Evaluating Pneumococcal Vaccine in Healthy Infants|A Phase I/II, 2-stage, Randomized, Double-Blind Trial of the Safety, Tolerability and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine (Serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) in Healthy Infants|Completed||Phase 1/Phase 2|249|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||||||||||||||||2017-02-18 17:11:01.369828|2017-02-18 17:11:01.369828
NCT00205790|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-08-06|||February 2003||2003-02-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|||||Interventional|||GORE-TEX PROPATEN Vascular Graft Study|Comparison of Primary Patency Between GORE-TEX PROPATEN Vascular Grafts and Thin Walled GORE-TEX Stretch Vascular Grafts|Completed||N/A|200||W.L.Gore & Associates|||||f||||||||||||||2017-02-18 17:11:07.115039|2017-02-18 17:11:07.115039
NCT00205777|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-02-28|2012-12-31||December 2001||2001-12-01|February 2013|2013-02-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women|Fracture Incidence Reduction And Safety Of TSE-424 (Bazedoxifene Acetate) Compared To Placebo And Raloxifene In Osteoporotic Postmenopausal Women|Completed||Phase 3|7609|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:11:07.311163|2017-02-18 17:11:07.311163
NCT00205764|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-21|||March 1999||1999-03-01|November 2013|2013-11-01|October 2009|Actual|2009-10-01|||||Interventional|||Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy|Randomised, Non-blind, Parallel Group Study to Compare Tandem High Dose Melphalan (200mg/m²) Versus Triple Intermediate Dose Melphalan (100mg/m²) and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy in Newly Diagnosed Patients With Multiple Myeloma|Completed||Phase 3|212|Anticipated|Austrian Forum Against Cancer|||||f||||||||||||||2017-02-18 17:11:15.209058|2017-02-18 17:11:15.209058
NCT00205751|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-21|||August 2001||2001-08-01|November 2013|2013-11-01|October 2009|Actual|2009-10-01|||||Interventional|||Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy|International, Multi-center, Prospective, Double Randomized, Open Phase III Study Evaluating Thalidomide/Dexamethasone Versus Melphalan/Prednisone as Induction Therapy and Thalidomide/Interferon-alpha Versus Interferon-alpha as Maintenance Therapy in Newly Diagnosed Patients With Multiple Myeloma|Completed||Phase 2/Phase 3|350|Anticipated|Austrian Forum Against Cancer|||||f||||||||||||||2017-02-18 17:11:15.303407|2017-02-18 17:11:15.303407
NCT00205738|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-12|||July 2000||2000-07-01|March 2014|2014-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Janssen - Glucose Regulation/Risp/Olanz|Glucose Regulation During Risperidone and Olanzapine Treatment|Completed||N/A|120|Actual|Washington University School of Medicine|||||f||||f||||||||||2017-02-18 17:11:15.398972|2017-02-18 17:11:15.398972
NCT00205725|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-12|||November 2000||2000-11-01|March 2014|2014-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Pfizer/IVGTT/Ziprasidone/Olanzapine|Glucose Regulation During Ziprasidone Treatment|Completed||N/A|120|Actual|Washington University School of Medicine|||||f||||f||||||||||2017-02-18 17:11:15.496061|2017-02-18 17:11:15.496061
NCT00205712|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-12|2009-10-27||February 2003||2003-02-01|January 2016|2016-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids|Prevention of NMDA Antagonist-induced Psychosis and Memory Impairment in Children|Completed||Phase 4|40|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 17:11:15.610588|2017-02-18 17:11:15.610588
NCT00205699|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-12|||October 2004||2004-10-01|March 2014|2014-03-01|July 2011|Actual|2011-07-01|June 2011|Actual|2011-06-01||Interventional|MEAC||Metabolic Effects of Antipsychotics in Children|Metabolic Effects of Antipsychotics in Children|Completed||Phase 4|240|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 17:11:16.044219|2017-02-18 17:11:16.044219
NCT00205686|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-01-04|||April 2001||2001-04-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Effects of DHEA and Exercise in the Elderly|DHEA+Exercise-Effect on Sarcopenia and Osteopenia of Aging|Completed||Phase 3|64||Washington University School of Medicine|||||f||||||||||||||2017-02-18 17:11:16.182871|2017-02-18 17:11:16.182871
NCT00205660|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-08|||February 2005||2005-02-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole|Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics|Completed||Phase 4|78|Actual|Washington University School of Medicine||4|||f||||f||||||||||2017-02-18 17:11:16.271635|2017-02-18 17:11:16.271635
NCT00205647|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-01-04|||January 1997||1997-01-01|March 2000|2000-03-01|March 2000||2000-03-01|||||Interventional|||Study of Expectorant Activity of Oral N-Acetylcystein (NAC) in Patients With Stable Chronic Bronchitis|A Phase II Multicenter Efficacy, Safety and Dose-Effect Study of the Expectorant Activity of Oral N-Acetylcystein (NAC) in Patients With Stable, Chronic Bronchitis|Completed||Phase 2|240||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 17:11:16.409427|2017-02-18 17:11:16.409427
NCT00205634|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-13|||December 2000||2000-12-01|December 2007|2007-12-01|October 2004||2004-10-01|||||Interventional|||Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis|Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis|Unknown status|Active, not recruiting|N/A|50||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 17:11:16.504075|2017-02-18 17:11:16.504075
NCT00205621|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-07|||October 2005||2005-10-01|August 2005|2005-08-01|December 2009||2009-12-01|||||Interventional|||Positron Emission Tomography of Amyloid in Alzheimer's Disease|Positron Emission Tomography of Cerebral Amyloid Load as a Potential Diagnostic Marker for Pre-Symptomatic Alzheimer’s Disease.|Suspended||Phase 1|50||VU University Medical Center|||||f||||||||||||||2017-02-18 17:11:16.598636|2017-02-18 17:11:16.598636
NCT00205608|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-25|||January 2004||2004-01-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|||Microglia Activation in Schizophrenia|Microglia Activation in Schizophrenia: a Pilot Study|Completed||Phase 1|20|Anticipated|VU University Medical Center||1|||f||||f||||||||||2017-02-18 17:11:16.688142|2017-02-18 17:11:16.688142
NCT00205595|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-07-03|||February 2001||2001-02-01|July 2008|2008-07-01|January 2007||2007-01-01|||||Interventional|||Normal Binding of R-[11C]PK11195 in Human Subjects|The Distribution and Quantification of Specific Binding of the Positron Emission Tomography Tracer R)-[11C]PK11195 in Normal Human Subjects|Unknown status|Active, not recruiting|Phase 1|40||VU University Medical Center|||||f||||||||||||||2017-02-18 17:11:16.783028|2017-02-18 17:11:16.783028
NCT00205582|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-03|||May 2001||2001-05-01|May 2001|2001-05-01|December 2004||2004-12-01|||||Interventional|||Excitatory Amino Acids and Activated Microglia After Traumatic Brain Injury: a (R)-[11C]PK11195 PET Study|The Role of Excitatory Amino Acids on Neuronal Damage and Outcome After Traumatic Brain Injury: Assessment in Patients Using Microdialysis and (R)-[11C]PK11195 Positron Emission Tomography|Unknown status|Active, not recruiting|Phase 1|20||VU University Medical Center|||||f||||||||||||||2017-02-18 17:11:16.877395|2017-02-18 17:11:16.877395
NCT00205569|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-02-21|||October 2002||2002-10-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|||||Observational|||Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation|Acute Cognitive and Neurobehavioral Intervention: Efficacy Evaluation (a Research Project Within the Traumatic Brain Injury Model System Grant)|Completed||N/A|103|Actual|Virginia Commonwealth University|||1||f||||f||||||||||2017-02-18 17:11:16.966391|2017-02-18 17:11:16.966391
NCT00205556|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-01-20|||June 2004||2004-06-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|CONTRAST||Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients|Effect of Increased Convective Clearance by On-line Hemodiafiltration on All Cause and Cardiovascular Mortality in Chronic Hemodialysis Patients: The Dutch Convective Transport Study (CONTRAST)|Completed||N/A|715|Actual|VU University Medical Center||2|||f||||t||||||||||2017-02-18 17:11:17.16668|2017-02-18 17:11:17.16668
NCT00205543|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-06-19|||July 2004||2004-07-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of Effects of Sutures on Results of Palate Surgery for Obstructive Sleep Apnea|Role of Suture Closure in Post-Operative Uvulopalatopharyngoplasty Outcomes|Completed||N/A|16|Actual|Virginia Commonwealth University||3|||f||||f||||||||||2017-02-18 17:11:17.311218|2017-02-18 17:11:17.311218
NCT00205530|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-29|||January 2003||2003-01-01|July 2013|2013-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Observational|||Evaluation of an Intervention Model for Family Crisis and Support|Evaluation of an Intervention Model for Family Crisis and Support (a Research Project Within the Traumatic Brain Injury Model System Grant)|Completed||N/A|160|Actual|Virginia Commonwealth University|||1||f||||f||||||||||2017-02-18 17:11:17.416283|2017-02-18 17:11:17.416283
NCT00205517|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-01-07|||September 2002||2002-09-01|January 2013|2013-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Sedation and Psychopharmacology in Critical Care|Pharmacokinetics and Dynamics in Patients Randomized to Once Daily Awakening and Sedated According to Standardized Algorithm|Terminated||N/A|75|Actual|Virginia Commonwealth University||||End point reached at interim analysis|f||||||||||||||2017-02-18 17:11:17.535214|2017-02-18 17:11:17.535214
NCT00205504|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-18|2012-01-25||June 2005||2005-06-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|June 2009|Actual|2009-06-01||Interventional|||Oral Contraceptives in the Metabolic Syndrome|Oral Contraceptives in the Metabolic Syndrome|Active, not recruiting||Phase 4|36|Actual|Virginia Commonwealth University||3|||f||||||||||||||2017-02-18 17:11:17.61846|2017-02-18 17:11:17.61846
NCT00205491|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-09-05|||October 2004||2004-10-01|September 2014|2014-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Pharmacological Intervention in Depression After Traumatic Brain Injury|Pharmacological Intervention in Depression After Traumatic Brain Injury (A Research Study Within the Traumatic Brain Injury Model System)|Completed||Phase 4|100|Anticipated|Virginia Commonwealth University|||||f||||||||||||||2017-02-18 17:11:18.451869|2017-02-18 17:11:18.451869
NCT00205478|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-05|||June 2005||2005-06-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702|A 12-Week, Double-Blind, Randomized, Parallel Group, Placebo Controlled Study of Two Doses of VX-702 in Subjects With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 2|300||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-02-18 17:11:18.555071|2017-02-18 17:11:18.555071
NCT00205465|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-03|||December 2004||2004-12-01|December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765|A Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of VX-765 in Subjects With Chronic Plaque Psoriasis Requiring Systemic Therapy|Completed||Phase 2|64||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-02-18 17:11:18.679336|2017-02-18 17:11:18.679336
NCT00205452|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-16|||June 2003||2003-06-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Quality of Life (QOL) Following Parathyroid Surgery|Does Quality of Life Improve Following Minimally Invasive Parathyroid Surgery?|Completed||N/A|200|Actual|University of Wisconsin, Madison|||1||f||||||||||||||2017-02-18 17:11:18.762581|2017-02-18 17:11:18.762581
NCT00205439|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-09|||December 2001||2001-12-01|July 2015|2015-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Surveillance For New Lung Primaries|"Fluorescence Bronchoscopic Surveillance For New Lung Primaries After Curative Therapy for Squamous Cell Carcinoma of the Aerodigestive Tract"|Terminated||N/A|200|Anticipated|University of Wisconsin, Madison|||1|low accrual|f||||||||||||||2017-02-18 17:11:18.836192|2017-02-18 17:11:18.836192
NCT00205426|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-13|||August 2005||2005-08-01|October 2015|2015-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Natrecor for Pulmonary Hypertension in Lung Transplants|Natrecor® (Nesiritide) as a Nitric Oxide Sparing Agent in Patients Undergoing Lung Transplantation|Completed||Phase 4|7|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 17:11:18.916288|2017-02-18 17:11:18.916288
NCT00205413|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-30|||September 2002||2002-09-01|September 2015|2015-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Surveillance For New Lung Primaries|Low Dose Helical Computed Tomographic (CT) Screening Followed by Anatomic Co-Registered Computed Tomography With Positron Emission Tomography (CT/PET) for Patients With Indeterminate (5-9 mm) Nodules|Terminated||N/A|250|Anticipated|University of Wisconsin, Madison||||low accrual|f||||||||||||||2017-02-18 17:11:19.042646|2017-02-18 17:11:19.042646
NCT00205400|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-25|||August 1999||1999-08-01|October 2016|2016-10-01||||March 2005|Actual|2005-03-01||Interventional|||Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care|Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care|Completed||N/A|192||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:19.138907|2017-02-18 17:11:19.138907
NCT00205387|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-08-28|||November 2005||2005-11-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Cardiac Elastography to Determine Strain and Strain Rates in the Heart|Cardiac Elastography|Completed||N/A|100|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 17:11:19.23795|2017-02-18 17:11:19.23795
NCT00205374|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-30|||November 1999||1999-11-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Use of Cidofovir for Recurrent Respiratory Papillomatosis|"Use of Cidofovir Injection in the Treatment of Recurrent Respiratory Papillomatosis."|Completed||Phase 4|19|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:11:19.332566|2017-02-18 17:11:19.332566
NCT00205361|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-16|||January 2002||2002-01-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Observational|||Airway IgA: Respiratory Tract IgA Levels in Anesthetized Patients Undergoing Elective Surgical Procedures|Respiratory Tract IgA Levels in Anesthetized Patients Undergoing Elective Surgical Procedures|Completed||N/A|9|Actual|University of Wisconsin, Madison|||2||f||||||||||||||2017-02-18 17:11:19.445429|2017-02-18 17:11:19.445429
NCT00205348|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-19|||April 2002||2002-04-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Swallowing Function Before and After Surgery for Thyroid Goiter|Swallowing Function Before and After Surgery for Thyroid Goiter|Completed||N/A|150|Anticipated|University of Wisconsin, Madison|||1||f||||||||||||||2017-02-18 17:11:19.529114|2017-02-18 17:11:19.529114
NCT00205335|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-29|||January 2004||2004-01-01|September 2015|2015-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Free Test Strips and Blood Glucose Control|The Impact of Increased Availability of Test Strips on Blood Glucose Control in Patients With Diabetes|Completed||N/A|22|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 17:11:19.597531|2017-02-18 17:11:19.597531
NCT00205322|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-12-02|||April 2004||2004-04-01|December 2011|2011-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer|A Phase II Study of Oxaliplatin, 5-fluorouracil, and Leucovorin in Combination With Oral Capecitabine in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|45|Actual|University of Wisconsin, Madison||1|||f||||t||||||||||2017-02-18 17:11:19.722567|2017-02-18 17:11:19.722567
NCT00205309|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-16|||January 2003||2003-01-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Airway IgA: Respiratory Tract IgA Levels in Critically Ill Intubated Patients|Respiratory Tract IgA Levels in Critically Ill Intubated Patients|Completed||N/A|13|Actual|University of Wisconsin, Madison|||1||f||||||||||||||2017-02-18 17:11:19.815869|2017-02-18 17:11:19.815869
NCT00205296|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-01|||March 2002||2002-03-01|October 2008|2008-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Fitness Training in Children|Effect of Fitness Training on Insulin Sensitivity and Body Composition in Children|Completed||N/A|300|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 17:11:19.898043|2017-02-18 17:11:19.898043
NCT00205283|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||August 2003||2003-08-01|September 2005|2005-09-01||||||||Interventional|||Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection|Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection|Unknown status|Recruiting|N/A|20|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:20.001545|2017-02-18 17:11:20.001545
NCT00205270|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||December 2004||2004-12-01|June 2013|2013-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Influenza Vaccine in Lung Transplant Patients|Influenza Vaccine in Lung Transplant Patients|Completed||N/A|152|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 17:11:20.112309|2017-02-18 17:11:20.112309
NCT00205257|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||September 2001||2001-09-01|December 2013|2013-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Prediction of Acute Rejection in Renal Transplant|Prediction of Acute Graft Rejection by Examining Urine Chemokines in Patients With Kidney Transplant|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:20.202359|2017-02-18 17:11:20.202359
NCT00205244|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01||||||August 2013|2013-08-01||||October 2007|Actual|2007-10-01||Interventional|||Preoperative Preparation for Children|Preoperative Preparation for Children: Use of Relaxation and Distraction|Unknown status|Recruiting|N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:20.266628|2017-02-18 17:11:20.266628
NCT00205231|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-25|||May 2002||2002-05-01|September 2005|2005-09-01||||July 2008|Actual|2008-07-01||Interventional|||A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease|A Pilot Study to Examine the Feasibility and Effect on Tumor Necrosis Factor (TNF) Inhibition on HIV Disease|Completed||N/A|25|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:20.346426|2017-02-18 17:11:20.346426
NCT00205218|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||November 1998||1998-11-01|April 2007|2007-04-01|August 2006|Actual|2006-08-01|||||Observational|||Validation of Methods to Estimate Body Fat|Validation of Methods to Estimate Body Fat|Completed||N/A|150||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:20.447202|2017-02-18 17:11:20.447202
NCT00205205|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01||||||June 2008|2008-06-01||||||||Interventional|||Peer Mentoring for Persons With Spinal Cord Injury (SCI)|Peer Mentoring for Persons With Spinal Cord Injury: Program Satisfaction and Outcome for Mentor/Mentee|Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:20.518684|2017-02-18 17:11:20.518684
NCT00205192|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-08-28|||June 2004||2004-06-01|August 2012|2012-08-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Observational|||Optimizing Cardiac Resynchronization|Optimizing Cardiac Resynchronization|Completed||N/A|100|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 17:11:20.608458|2017-02-18 17:11:20.608458
NCT00205179|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||January 2005||2005-01-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Alzheimer's Disease: Potential Benefit of Isoflavones|Alzheimer's Disease: Potential Benefit of Isoflavones|Completed||Phase 2|60|Anticipated|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:11:20.691776|2017-02-18 17:11:20.691776
NCT00205166|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-25|||June 1999||1999-06-01|October 2012|2012-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?|Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?|Completed||N/A|50|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 17:11:20.789975|2017-02-18 17:11:20.789975
NCT00205153|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-18|||December 2006||2006-12-01|December 2014|2014-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Team Model of Hypertension Care in African Americans|A Team Model of Hypertension Care in African Americans|Completed||N/A|576|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:11:20.898522|2017-02-18 17:11:20.898522
NCT00205140|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-06|||July 2005||2005-07-01|October 2015|2015-10-01|May 2007|Actual|2007-05-01|||||Observational|||Effect of Pharmacist Initiated Recommendations On Prescribing For Participants In the Senior MEDS Personalized Medication Review|Participant Characteristics, Medication Utilization, and the Effects of Pharmacist Initiated Recommendations On the Prescribing For Participants In the Senior MEDS Personalized Medication Review for Adults Age 55 and Older|Terminated||N/A|100|Anticipated|University of Wisconsin, Madison||||The program responsible for recruitment was dismantled in 2006.|f||||||||||||||2017-02-18 17:11:21.007697|2017-02-18 17:11:21.007697
NCT00205127|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-08-28|||January 2004||2004-01-01|August 2012|2012-08-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Cardiac Water and Fluoromethane Cardiac PET|Comparison of Cardiac Perfusion by O15-water and F17-fluoromethane PET|Completed||N/A|10||University of Wisconsin, Madison|||||f||||f||||||||||2017-02-18 17:11:21.187857|2017-02-18 17:11:21.187857
NCT00205114|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||December 2003||2003-12-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Dane County Safety Assessment for Elders (SAFE) Research Study|Dane County Safety Assessment for Elders (SAFE) Research Study|Completed||N/A|500|Actual|University of Wisconsin, Madison||1|||f||||f||||||||||2017-02-18 17:11:21.286419|2017-02-18 17:11:21.286419
NCT00205101|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-14|||September 2004||2004-09-01|December 2007|2007-12-01||||||||Observational|||Clinical Outcome Study of the Triad Allograft for Posterior Lumbar Fusion|Clinical Outcome Study of the Triad Allograft for Posterior Lumbar Fusion|Completed||N/A|70|Anticipated|University of Wisconsin, Madison|||4||f||||||||||||||2017-02-18 17:11:21.37182|2017-02-18 17:11:21.37182
NCT00205088|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||August 2002||2002-08-01|June 2008|2008-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||The Use of Shunt Tap in Assessing Ventriculoperitoneal (VP) Shunt Malfunction|The Use of Shunt Tap in Assessing Ventriculoperitoneal (VP) Shunt Malfunction|Completed||N/A|100|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:21.458162|2017-02-18 17:11:21.458162
NCT00205075|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-07|||August 2004||2004-08-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression|The Use of Validated Measures of Alcohol Intake to Measure the Impact of Moderate Alcohol Consumption on Hepatic Fibrogenesis in Individuals Infected With Hepatitis C|Completed||N/A|47|Actual|University of Wisconsin, Madison|||2||f||||||||||||||2017-02-18 17:11:21.529527|2017-02-18 17:11:21.529527
NCT00205062|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||October 2004||2004-10-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)|Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease|Terminated||Phase 4|||University of Wisconsin, Madison||||No Accrual|f||||||||||||||2017-02-18 17:11:21.610972|2017-02-18 17:11:21.610972
NCT00205049|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-10|2011-08-04||March 2005||2005-03-01|April 2014|2014-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Pentoxifylline for Acute Alcoholic Hepatitis (AAH)|A Pilot Study of Pentoxifylline-Therapy for Acute Alcoholic Hepatitis|Terminated||Phase 1|4|Actual|University of Wisconsin, Madison|Study was terminated before any data was gathered/analyzed.|1||lack of funding|f||||f||||||||||2017-02-18 17:11:21.701291|2017-02-18 17:11:21.701291
NCT00205036|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-25|||January 2005||2005-01-01|March 2016|2016-03-01|April 2008|Actual|2008-04-01|October 2005|Actual|2005-10-01||Observational|||Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density|Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density|Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:21.928478|2017-02-18 17:11:21.928478
NCT00205023|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-30|||January 2004||2004-01-01|June 2008|2008-06-01|August 2006|Actual|2006-08-01|February 2006|Actual|2006-02-01||Interventional|||Disseminated Endometrial Cancer Cells During Sonohysterography|The Incidence of Disseminated Endometrial Cancer Cells During Sonohysterography and Their Functional Viability: a Prospective Study|Completed||N/A|25|Actual|University of Wisconsin, Madison||1|||f||||||||||||||2017-02-18 17:11:22.018289|2017-02-18 17:11:22.018289
NCT00205010|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-30|||October 2003||2003-10-01|June 2008|2008-06-01|June 2006|Actual|2006-06-01|February 2006|Actual|2006-02-01||Observational|||Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer|Laparoscopic Sentinel Lymph Node Localization in Patients With Operable Cervical Cancer - A Pilot Study|Completed||Phase 1|20|Actual|University of Wisconsin, Madison|||||f||||t||||||||||2017-02-18 17:11:22.129756|2017-02-18 17:11:22.129756
NCT00204997|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-30|||September 2002||2002-09-01|June 2008|2008-06-01|February 2008|Actual|2008-02-01|September 2005|Actual|2005-09-01||Interventional|||Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix|Preservation of Ovarian Function Via Laparoscopic Transposition in Patients With Locally Advanced Squamous Cell Carcinoma of the Cervix|Terminated||N/A|10|Anticipated|University of Wisconsin, Madison||1||slow accrual|f||||t||||||||||2017-02-18 17:11:22.216586|2017-02-18 17:11:22.216586
NCT00204984|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||May 2005||2005-05-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial Relaxation|The Effect of Aortic Impedance on Myocardial Relaxation|Completed||N/A|60|Anticipated|University of Wisconsin, Madison||1|||f||||||||||||||2017-02-18 17:11:22.320964|2017-02-18 17:11:22.320964
NCT00204113|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-10|||June 2002||2002-06-01|June 2008|2008-06-01||||||||Interventional|||Control of Unsupported Paraplegic Standing|Integrated Voluntary Control of Unsupported Paraplegic Standing|Unknown status|Active, not recruiting|N/A|10|Anticipated|University of Glasgow|||||f||||||||||||||2017-02-18 17:11:35.487552|2017-02-18 17:11:35.487552
NCT00204971|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-29|||January 2003||2003-01-01|September 2015|2015-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Enteral Glutamine in Neurologically-injured Patients|Randomized, Placebo-controlled Clinical Trial of Enteral Glutamine Supplementation in Neurologically-injured Patients|Completed||Phase 4|102|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-02-18 17:11:22.417639|2017-02-18 17:11:22.417639
NCT00204958|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-29|||February 2004||2004-02-01|September 2015|2015-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients|Evaluation of Glutamine Popsicles in Adult/Pediatric Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients|Completed||Phase 4|50|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:22.509853|2017-02-18 17:11:22.509853
NCT00204945|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-15|||February 2005||2005-02-01|January 2009|2009-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Catheterization Laboratory Study: Acute Responses in Diastolic Heart Failure|Acute Responses in Diastolic Heart Failure|Completed||N/A|65|Anticipated|University of Wisconsin, Madison||1|||f||||||||||||||2017-02-18 17:11:22.596438|2017-02-18 17:11:22.596438
NCT00204932|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-01|2011-08-04||July 2004||2004-07-01|December 2014|2014-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects of CLA Supplements on Body Weight and Fat Oxidation|Effects of CLA Supplements on Body Weight and Fat Oxidation|Completed||Phase 2|53|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:11:22.693924|2017-02-18 17:11:22.693924
NCT00204919|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-30|||June 2001||2001-06-01|September 2015|2015-09-01|November 2004|Actual|2004-11-01|May 2004|Actual|2004-05-01||Interventional|||Vitamin D Administration in the Nursing Home|Intermittent Vitamin D Administration in the Nursing Home: Impact on Vitamin D Status, Falls, Bone Turnover and Bone Density|Completed||N/A|96|Actual|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 17:11:23.059993|2017-02-18 17:11:23.059993
NCT00204906|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||January 2005||2005-01-01|June 2015|2015-06-01||||January 2009|Actual|2009-01-01||Interventional|||Correction of Vitamin D Inadequacy in Nursing Home Residents|Effect of Vitamin D Supplementation on Skeletal and Overall Health of Nursing Home Residents|Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:23.173638|2017-02-18 17:11:23.173638
NCT00204893|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-28|||July 2003||2003-07-01|October 2013|2013-10-01||||March 2007|Actual|2007-03-01||Interventional|||Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects|Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects|Unknown status|Active, not recruiting|Phase 1|12||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:23.269424|2017-02-18 17:11:23.269424
NCT00204880|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-10-01|||February 2005||2005-02-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Aging and Cancer Effects (ACE) Study|Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment|Completed||N/A|34|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-02-18 17:11:23.362205|2017-02-18 17:11:23.362205
NCT00204867|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-06-17|||July 2004||2004-07-01|June 2016|2016-06-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Virtual Colonoscopy (VC) for Primary Colorectal Screening|CT Virtual Colonoscopy for Primary Colorectal Screening|Completed||N/A|272|Actual|University of Wisconsin, Madison|||1||f||||t||||||||||2017-02-18 17:11:26.112719|2017-02-18 17:11:26.112719
NCT00204854|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-01|||December 2001||2001-12-01|January 2011|2011-01-01|November 2004|Actual|2004-11-01|June 2004|Actual|2004-06-01||Interventional|TAMI||Telephone and Mail Intervention for Alcohol Use Disorders|Telephone and Mail Intervention for Alcohol Use Disorders|Completed||Phase 3|900||University of Wisconsin, Madison|||||f||||f||||||||||2017-02-18 17:11:26.254349|2017-02-18 17:11:26.254349
NCT00204841|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-24|||October 1998||1998-10-01|November 2015|2015-11-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|COAST||Childhood Origins of Asthma (COAST)|Rhinovirus Infection and Asthma in Childhood and Adolescents|Active, not recruiting||N/A|300|Anticipated|University of Wisconsin, Madison|||1||f||||f||||||Samples With DNA|"~     nasal mucus samples, cord blood, peripheral blood samples, nasal cell brushing samples, cell~     lines~   "|||2017-02-18 17:11:26.344822|2017-02-18 17:11:26.344822
NCT00204828|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-04|||October 2005||2005-10-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|June 2007|Actual|2007-06-01||Observational|||T Regulatory and Childhood Asthma|T Regulatory and Childhood Asthma|Active, not recruiting||N/A|58|Actual|University of Wisconsin, Madison|||2||f||||f||||||Samples Without DNA|"~     blood, PBMC culture supes and nasal lavage~   "|Yes||2017-02-18 17:11:26.43523|2017-02-18 17:11:26.43523
NCT00204815|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-01|||January 2005||2005-01-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|||||Observational|||Bone Mineral Density in Pediatric Epilepsy|Bone Mineral Density in Pediatric Epilepsy: AED-Specific and Duration of Treatment-Specific Effects|Completed||N/A|98|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 17:11:26.528898|2017-02-18 17:11:26.528898
NCT00204802|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-01|||January 2004||2004-01-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Patient-Centered Advance Care Planning|A Patient-Centered Approach to Advance Care Planning of Patients With End Stage Heart Failure and Renal Disease|Completed||Phase 3|313|Actual|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:11:26.618463|2017-02-18 17:11:26.618463
NCT00204789|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-09-30|||July 2003||2003-07-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients|Phase 2b Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients (OTR)|Completed||Phase 2|52|Anticipated|University of Wisconsin, Madison|||||||||||||||||||2017-02-18 17:11:26.704442|2017-02-18 17:11:26.704442
NCT00204776|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-09-30|||March 2005||2005-03-01|September 2005|2005-09-01|November 2006|Actual|2006-11-01|||||Interventional|||XELOX for Metastatic Breast Cancer|A Phase II Trial of Capecitabine and Oxaliplatin in Metastatic Breast Cancer|Completed||Phase 2|37|Anticipated|University of Wisconsin, Madison|||||f||||t||||||||||2017-02-18 17:11:26.786896|2017-02-18 17:11:26.786896
NCT00204763|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-01-11|||January 2004||2004-01-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Comparison of Esophageal and Anorectal Manometry Catheters|Comparison of Solid-State Esophageal Manometry and Water Perfused Anorectal Manometry Catheters With Air Filled Multi-Balloon Esophageal and Anorectal Manometry Catheters|Terminated||Phase 4|5|Actual|University of Utah||2||We determined that the results would not be worth reporting.|f||||f||||||||||2017-02-18 17:11:26.887355|2017-02-18 17:11:26.887355
NCT00204750|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-23|||August 2001||2001-08-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Trial of Electrosurgical Incision Versus Bougie Dilation of Symptomatic Lower Esophageal (Schatzki's) Rings|A Randomized, Prospective Trial of Electrosurgical Incision Followed by Rabeprazole Versus Bougie Dilation Followed by Rabeprazole of Symptomatic Lower Esophageal (Schatzki's) Rings|Completed||Phase 2/Phase 3|50|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 17:11:27.000354|2017-02-18 17:11:27.000354
NCT00204737|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-09-29|||December 2004||2004-12-01|September 2015|2015-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Short Course Glucocorticoid Treatment for PTSD|A Placebo-controlled, Randomized, Double-blind Comparison of Placebo vs Short Course Low Dose Corticosteroids on Posttraumatic Stress Disorder (PTSD)|Completed||N/A|12|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 17:11:27.10785|2017-02-18 17:11:27.10785
NCT00204711|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-26|||January 2005||2005-01-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|June 2008|Anticipated|2008-06-01||Observational|||Use of the SNAP II Electroencephalography (EEG) Monitor in Outpatients Undergoing Surgery/Procedures With Sedation|Use of the SNAP II EEG Monitor in Outpatients Undergoing Surgery/Procedures With Sedation|Completed||N/A|50|Anticipated|University of Wisconsin, Madison|||||f||||f||||||||||2017-02-18 17:11:27.208932|2017-02-18 17:11:27.208932
NCT00204698|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-01-11|||August 2003||2003-08-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment|Identification of Molecular Markers of Inflammatory Mediators in Posterior Laryngitis Due to Laryngopharyngeal Reflux and Evolution With PPI Treatment|Completed||Phase 2/Phase 3|24|Actual|University of Utah||1|||f||||f||||||||||2017-02-18 17:11:29.925326|2017-02-18 17:11:29.925326
NCT00204685|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-13|||August 2003||2003-08-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa|Beatmungsdauer Und Lungenfunktion Bei Beatmeten Patienten Unter Therapie Mit Dornase Alfa - Randomisierte, Doppel-Blinde, Placebo-Kontrollierte, Multizentrische, Prospektive Klinische Studie|Unknown status|Active, not recruiting|Phase 2/Phase 3|540||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:11:30.045494|2017-02-18 17:11:30.045494
NCT00204672|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2000||2000-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||The Role of GER in Exercise Triggered Asthma|The Role of GER in Exercise Triggered Asthma|Completed||Phase 2/Phase 3|36||University of Utah|||||f||||||||||||||2017-02-18 17:11:30.172726|2017-02-18 17:11:30.172726
NCT00204659|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-10-17|||March 2003||2003-03-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin`s Lymphoma|Phase II Study With Rituximab and CHOP in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin`s Lymphoma|Completed||Phase 2|30|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-02-18 17:11:30.270922|2017-02-18 17:11:30.270922
NCT00204646|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-19|||February 1999||1999-02-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)|Phase II Study of Neoadjuvant Dose-Intensive Chemotherapy With Adriamycin and Ifosfamide Followed by High-Dose ICE in Locally Advanced Soft Tissue Sarcomas|Completed||Phase 2|||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:11:30.383769|2017-02-18 17:11:30.383769
NCT00204633|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-13|||July 2003||2003-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||"Darbepoetin Alfa in Patients With Poor Prognosis Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)"|"Randomized Phase II-Trial to Determine the Impact of Darbepoetin Alfa on the Frequency of RBC Transfusions in Patients With Metastatic Poor Prognosis Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP Regimen)"|Completed||Phase 2|108|Actual|University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:11:30.468944|2017-02-18 17:11:30.468944
NCT00204620|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-19|||March 2002||2002-03-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)|Multicenter Phase II Study With Bendamustin for Patients With Refractory Soft Tissue Sarcoma|Completed||Phase 2|28||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:11:30.555257|2017-02-18 17:11:30.555257
NCT00204607|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-18|||July 2004||2004-07-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients|Induction of Specific Immune Responses Against Melanoma-Associated Antigens in Vivo by Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial|Completed||Phase 1/Phase 2|20||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:11:30.626259|2017-02-18 17:11:30.626259
NCT00204594|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-15|||October 2005||2005-10-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28|Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28|Completed||Phase 1/Phase 2|1|Actual|University Hospital Tuebingen||1|||f||||f||||||||||2017-02-18 17:11:30.956267|2017-02-18 17:11:30.956267
NCT00204581|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-18|||August 2003||2003-08-01|February 2009|2009-02-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional|||Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases|Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases. A Phase II, Prospective, Open, Multicenter Trial|Completed||Phase 2|51|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-02-18 17:11:31.068602|2017-02-18 17:11:31.068602
NCT00204568|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-07|||August 2004||2004-08-01|January 2013|2013-01-01|October 2013|Anticipated|2013-10-01|October 2013|Anticipated|2013-10-01||Interventional|||Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)|Randomized Phase II Trial of Trofosfamide vs. Adriamycin in Elderly Patients With Previously Untreated Metastatic Soft Tissue Sarcoma|Unknown status|Active, not recruiting|Phase 2|117|Anticipated|University of Schleswig-Holstein||2|||f||||||||||||||2017-02-18 17:11:31.177876|2017-02-18 17:11:31.177876
NCT00204555|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-31|||January 2002||2002-01-01|April 2007|2007-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma|A Randomized Open Label Study to Evaluate the Safety and Efficacy if Imiquimod 5% Cream Applied 3 Times Per Week for 8 or 12 Weeks in the Treatment of Low Risk Nodular Basal Cell Carcinoma|Completed||Phase 4|100|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-02-18 17:11:31.284968|2017-02-18 17:11:31.284968
NCT00204542|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-18|||June 2005||2005-06-01|March 2009|2009-03-01|December 2010|Actual|2010-12-01|March 2009|Actual|2009-03-01||Interventional|||Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head|Comparison of the Efficacy and Tolerability of Solaraze for 3 vs. 6 Months in Patients With Mild to Moderate Actinic Keratosis Located at the Face and Head|Completed||Phase 4|418|Actual|University Hospital Tuebingen||2|||f||||||||||||||2017-02-18 17:11:31.376443|2017-02-18 17:11:31.376443
NCT00204529|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-21|||October 2004||2004-10-01|April 2015|2015-04-01|December 2015|Anticipated|2015-12-01|May 2013|Actual|2013-05-01||Interventional|||Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB|Randomized, Multicenter, Open Label Study to Compare the Efficacy and Tolerability of Pegylated Interferon-alpha-2 (PEG-IFN) to 'Low-dose' Interferon-alpha-2a in Patients With Malignant Melanoma in Stages IIA (T3a) - IIIB (AJCC 2002)|Active, not recruiting||Phase 3|880|Anticipated|University Hospital Tuebingen||2|||f||||||||||||||2017-02-18 17:11:31.505448|2017-02-18 17:11:31.505448
NCT00204516|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-15|||April 2007||2007-04-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2011|Actual|2011-08-01||Interventional|||Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens|Pilot Study of Intradermal Vaccination of Melanoma Patients With a Fixed Combination of mRNAs Compared to an Individualized Selection After Analysis of Antigen Expression in Tumor Tissue|Completed||Phase 1/Phase 2|31|Actual|University Hospital Tuebingen||1|||f||||||||||||||2017-02-18 17:11:31.629327|2017-02-18 17:11:31.629327
NCT00204503|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-30|||June 2003||2003-06-01|March 2015|2015-03-01|May 2005||2005-05-01|||||Interventional|||Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence|An Open Label Pilot Study Evaluating Safety and Efficacy of Divalproex Sodium (Depakote ER) in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence.|Withdrawn||Phase 2|0|Actual|The University of Texas Medical Branch, Galveston|||||f||||||||||||||2017-02-18 17:11:31.739076|2017-02-18 17:11:31.739076
NCT00204490|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-10|||April 2004||2004-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Soy Isoflavones and Breast Cancer Risk Reduction|Mammographic Density and Soy Isoflavones|Active, not recruiting||Phase 2|187|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-02-18 17:11:31.841712|2017-02-18 17:11:31.841712
NCT00204477|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-05-10|||April 2002||2002-04-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Soy Protein and Breast Cancer Risk Reduction|Soybean Diet and Breast Density|Active, not recruiting||Phase 2|313|Actual|The University of Texas Medical Branch, Galveston||2|||f||||f||||||||||2017-02-18 17:11:31.950429|2017-02-18 17:11:31.950429
NCT00204464|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-11-03||||||December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Study of the Effects Strengthening Exercises in Individuals With ALS|Preliminary Study: The Effects of a Strengthening Program on Maximum Voluntary Isometric Contraction, Functional Abilities, Fatigue and Quality of Life in Individuals With Amyotrophic Lateral Sclerosis|Completed||Phase 2|40||University of Saskatchewan|||||f||||||||||||||2017-02-18 17:11:32.062153|2017-02-18 17:11:32.062153
NCT00204451|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-23|||July 2005||2005-07-01|November 2016|2016-11-01|June 2006||2006-06-01|||||Interventional|||Human Ovarian Follicular Dynamics and Emergency Contraception|Human Ovarian Follicular Dynamics and Emergency Contraception|Completed||Phase 4|40||University of Saskatchewan|||||f||||||||||||||2017-02-18 17:11:32.150435|2017-02-18 17:11:32.150435
NCT00204438|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-23|||February 2002||2002-02-01|November 2016|2016-11-01|December 2002||2002-12-01|||||Interventional|||Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle|Follicular Profiles After Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle|Completed||N/A|45||University of Saskatchewan|||||f||||||||||||||2017-02-18 17:11:32.252983|2017-02-18 17:11:32.252983
NCT00204425|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-09|||December 2004||2004-12-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|December 2007|Actual|2007-12-01||Interventional|||Effect of Exercise Training and Soy-based Nutritional Supplementation on Prevention of Osteoporosis|Effect of Combined Exercise Therapy and Isoflavone Supplementation on Prevention of Osteoporosis|Completed||Phase 3|351|Actual|University of Saskatchewan||4|||f||||t||||||||||2017-02-18 17:11:32.357017|2017-02-18 17:11:32.357017
NCT00204412|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-01|||March 2005||2005-03-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Exercise and Flax-Based Nutritional Supplementation for Lowering Cholesterol|Effectiveness of Flax Lignan and Exercise Training for Improving Lipid Profiles|Completed||Phase 3|100|Actual|University of Saskatchewan||2|||f||||f||||||||||2017-02-18 17:11:32.481673|2017-02-18 17:11:32.481673
NCT00204399|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||July 2001||2001-07-01|May 2000|2000-05-01|December 2004||2004-12-01|||||Interventional|||Examining Physician Counseling to Promote Adoption of Physical Activity: A Controlled Trial|Examining Physician Counseling to Promote Adoption of Physical Activity: A Controlled Trial|Completed||Phase 1|200||University of Saskatchewan|||||f||||||||||||||2017-02-18 17:11:32.58889|2017-02-18 17:11:32.58889
NCT00204386|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-29|||September 2002||2002-09-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Posttraumatic Stress Disorder|Completed||Phase 2/Phase 3|50|Actual|University of Oklahoma||2|||f||||t||||||||||2017-02-18 17:11:32.66049|2017-02-18 17:11:32.66049
NCT00204373|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-10-23|2012-05-16||March 2003||2003-03-01|October 2012|2012-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Treatment of Zollinger-Ellison Syndrome With Prevacid|Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors|Completed||Phase 4|72|Actual|University of Alabama at Birmingham||1|||f||||f||||||||||2017-02-18 17:11:32.760779|2017-02-18 17:11:32.760779
NCT00204360|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-18||||||August 2005|2005-08-01||||||||Observational|||Pediatric Epilepsy Database|Pediatric Epilepsy Database|Completed||N/A|||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 17:11:33.248937|2017-02-18 17:11:33.248937
NCT00204347|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-15|||July 2003||2003-07-01|March 2012|2012-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder|Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder: The UAB Borderline Rating Scale (BRS)|Completed||Phase 4|20||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 17:11:33.323836|2017-02-18 17:11:33.323836
NCT00204334|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-12|||June 2005||2005-06-01|May 2008|2008-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients|Effects of Anemia Correction on Vascular Function, Endothelial Cell Markers and Monocyte Apoptosis in Renal Transplant Recipients|Completed||Phase 4|60|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-02-18 17:11:33.42707|2017-02-18 17:11:33.42707
NCT00204321|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-12|||June 2005||2005-06-01|January 2010|2010-01-01|January 2010|Actual|2010-01-01|January 2008|Actual|2008-01-01||Interventional|||Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients|Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients - Positive Effects of Calcineurin-free Immunosuppression|Completed||Phase 4|80|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-02-18 17:11:33.52644|2017-02-18 17:11:33.52644
NCT00204308|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-05-30|||March 2005||2005-03-01|May 2012|2012-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|TD-2||Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP|Addition of Single-dose, Maternal Tenofovir and Emtricitabine to Reduce Non-nucleoside Reverse Transcriptase Inhibitor Resistance Mutations in the Setting of Zidovudine and Nevirapine for Prevention of Mother-to-child HIV Transmission|Completed||Phase 2|400|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 17:11:33.626324|2017-02-18 17:11:33.626324
NCT00204295|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-13|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Interventional|||Study on Amino Acid Uptake in Brain Tumors|Phase 2 Study on Brain Tumor Uptake of the Amino Acid O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET)|Unknown status|Active, not recruiting|Phase 2|60||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:11:33.963905|2017-02-18 17:11:33.963905
NCT00204282|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-20|||August 2003||2003-08-01|September 2013|2013-09-01|December 2005||2005-12-01|||||Interventional|||The Effectiveness of Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk|The Effectiveness of Nurse Practitioner Led Group Visits in Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk|Completed||N/A|150||University of Chicago|||||f||||||||||||||2017-02-18 17:11:34.057265|2017-02-18 17:11:34.057265
NCT00204269|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-05-12|||January 2003||2003-01-01|May 2006|2006-05-01|September 2006||2006-09-01|||||Interventional|||Three-Year Trial on a New Testosterone Gel|Three-Year Trial on a New Testosterone Gel: Clinical Efficacy, Tolerability and Compliance|Unknown status|Active, not recruiting|Phase 3|100||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:11:34.156571|2017-02-18 17:11:34.156571
NCT00204256|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||March 2004||2004-03-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Intravenous Iron in Patients With Anemia of Chronic Kidney Disease|Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease|Unknown status|Active, not recruiting|Phase 4|50||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:11:34.269606|2017-02-18 17:11:34.269606
NCT00204243|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-18|||May 2005||2005-05-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services|Naltrexone Implants Compared to Methadone Maintenance Treatment (MMT) Among Inmates About to be Released From Prison - a Randomized Controlled Trial|Completed||Phase 2|46|Actual|University of Oslo||2|||f||||t||||||||||2017-02-18 17:11:34.359903|2017-02-18 17:11:34.359903
NCT00204230|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 1999||1999-10-01|September 2005|2005-09-01|September 2002||2002-09-01|||||Interventional|||MMF and Calcineurin Inhibitor Withdrawal in CAN|Randomized Controlled Study: Effect of Mycophenolatmofetil in Patients With Histologically Proven Chronic Allograft Nephropathy|Terminated||N/A|86||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:11:34.473367|2017-02-18 17:11:34.473367
NCT00204217|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-24|||September 2004||2004-09-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Monitoring of Intubation and Ventilation During Resuscitation|Monitoring of Intubation and Ventilation During Resuscitation|Completed||Phase 2|15||University of Oslo|||||f||||f||||||||||2017-02-18 17:11:34.770268|2017-02-18 17:11:34.770268
NCT00204204|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-24|||January 2005||2005-01-01|August 2007|2007-08-01|January 2006|Actual|2006-01-01|||||Observational|||Importance of Forces and Safety Features in Car Crash Multitrauma|The Multitraumatized Patient. What is the Importance of Forces Involved and the Use of Safety Equipment for the Amount of Trauma to the Patient Inside the Vehicle.|Completed||N/A|200||University of Oslo|||||f||||f||||||||||2017-02-18 17:11:34.873591|2017-02-18 17:11:34.873591
NCT00204191|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-18|||May 2003||2003-05-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Interventional|||Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation|Open, Prospective, Randomized Study to Compare the Efficacy and Safety of Immunosuppression Regimens Based on Cyclosporine (Neoral®) and Tacrolimus (Prograf®) in Renal Transplant Patients|Unknown status|Recruiting|Phase 4|300|Anticipated|Uniwersytet Mikolaja Kopernika w Toruniu|||||f||||||||||||||2017-02-18 17:11:34.950322|2017-02-18 17:11:34.950322
NCT00204178|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-11-30|||April 2003||2003-04-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Observational|||The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney|The Role of Reactive Oxygen Species in Ischaemia-Reperfusion Injury of the Transplanted Kidney|Unknown status|Active, not recruiting|N/A|60||Uniwersytet Mikolaja Kopernika w Toruniu|||||f||||||||||||||2017-02-18 17:11:35.037618|2017-02-18 17:11:35.037618
NCT00204165|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-07|||November 2004||2004-11-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.|MRI of the Small Bowel. Comparison of Different Techniques and Contrast.|Unknown status|Active, not recruiting|Phase 3|40||University of Oslo|||||f||||||||||||||2017-02-18 17:11:35.12373|2017-02-18 17:11:35.12373
NCT00204152|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-09-04|||June 2004||2004-06-01|September 2013|2013-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Treatment for Chronic Depression|Treatment for Chronic Depression With Behavioral Interventions|Terminated||Phase 3|30||University of Chicago||||PI left U of C|f||||f||||||||||2017-02-18 17:11:35.206593|2017-02-18 17:11:35.206593
NCT00204139|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2002||2002-06-01|July 2004|2004-07-01|May 2004||2004-05-01|||||Interventional|||Routine Versus Selective Midtrimester Ultrasound in a Poorly Resourced Setting: a Cluster Randomised Controlled Trial||Completed||Phase 3|900||University of Johannesburg|||||f||||||||||||||2017-02-18 17:11:35.30398|2017-02-18 17:11:35.30398
NCT00204126|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-08|||February 2005||2005-02-01|September 2006|2006-09-01|February 2005||2005-02-01|||||Interventional|||Exercise Testing During Treadmill Gait in Incomplete Spinal Cord Injury|Determination of Novel Methods of Exercise Testing During Treadmill Gait in Incomplete Spinal Cord Injury|Unknown status|Active, not recruiting|N/A|4||University of Glasgow|||||f||||||||||||||2017-02-18 17:11:35.389133|2017-02-18 17:11:35.389133
NCT00204100|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-11|||January 2003||2003-01-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Paraplegic Cycling: Improving Health After Spinal Cord Injury|The Development of Systems for Paraplegic Cycling: Improving Health After Spinal Cord Injury|Unknown status|Active, not recruiting|N/A|5||University of Glasgow|||||f||||||||||||||2017-02-18 17:11:35.571074|2017-02-18 17:11:35.571074
NCT00204087|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-01-10|||January 2001||2001-01-01|June 1999|1999-06-01|June 2005||2005-06-01|||||Interventional|||Psychological Intervention for Persons in the Early Initial Prodromal State|Psychological Intervention for Persons at Risk of Psychosis in the Early Initial Prodromal State|Unknown status|Active, not recruiting|Phase 3|126||University of Cologne|||||f||||||||||||||2017-02-18 17:11:35.664705|2017-02-18 17:11:35.664705
NCT00204074|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-28|||October 2001||2001-10-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Treatment of Menstrual Migraine With Sequential, Transdermal, 17-Beta-Estradiol. A Double-Blind, Randomised, Cross-Over Trial.||Unknown status|Active, not recruiting|Phase 2/Phase 3|||University Hospital, Linkoeping|||||f||||||||||||||2017-02-18 17:11:35.761981|2017-02-18 17:11:35.761981
NCT00204061|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-12-23|||January 2001||2001-01-01|December 2014|2014-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis|Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis|Completed||Phase 4|124|Actual|University of Cologne||2|||f||||f||||||||||2017-02-18 17:11:35.855894|2017-02-18 17:11:35.855894
NCT00204048|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-24|||July 2001||2001-07-01|January 2017|2017-01-01|December 2025|Anticipated|2025-12-01|December 2020|Anticipated|2020-12-01||Observational|||A Multicenter Trial of Academic Hospitalists|A Multicenter Trial of Academic Hospitalists|Recruiting||N/A|100000|Anticipated|University of Chicago|||1||f||||f|f|f||||||No||2017-02-18 17:11:35.972237|2017-02-18 17:11:35.972237
NCT00204035|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-24|||June 2004||2004-06-01|January 2017|2017-01-01|September 2020|Anticipated|2020-09-01|September 2017|Anticipated|2017-09-01||Observational|||Evaluation of TEACH (Training Early Achievers for Careers in Health) Research|Evaluation of TEACH (Training Early Achievers for Careers in Health) Research|Recruiting||N/A|400|Anticipated|University of Chicago|||1||f||||f|f|f||||||No||2017-02-18 17:11:36.094171|2017-02-18 17:11:36.094171
NCT00204022|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-10-13|||February 2001||2001-02-01|October 2011|2011-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|MAINTAIN||Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.|A Randomized Multicenter Trial Comparing Mycophenolate Mofetil and Azathioprine as Remission-maintaining Treatment for Proliferative Lupus Glomerulonephritis. The MAINTAIN Nephritis Trial.|Completed||Phase 3|105|Actual|Université Catholique de Louvain||2|||f||||f||||||||||2017-02-18 17:11:36.204995|2017-02-18 17:11:36.204995
NCT00204009|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-09-04|||July 1992||1992-07-01|September 2013|2013-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Chicago Childhood Diabetes Registry|Population-based Epidemiologic Study of Childhood Diabetes in Chicago: a) Disease Surveillance; b) Family Studies; c) Questionnaire Followup.|Completed||N/A|2400|Actual|University of Chicago|||1||f||||||||||||||2017-02-18 17:11:36.384864|2017-02-18 17:11:36.384864
NCT00203996|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-16|2013-03-05||September 2003||2003-09-01|July 2013|2013-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Polycystic Ovary Syndrome (PCOS) and Sleep Apnea|Sleep, Metabolic, and Cardiovascular Dysfunction in Polycystic Ovary Syndrome|Terminated||Phase 4|37|Actual|University of Chicago|No participants were randomized to any of the 3 study arms in Aim 1. Also, the recruitment of control subjects for Aim 2 was hindered by the difficulty in finding subjects who met both inclusion and exclusion criteria.|10||Did not meet target patient accrual goals|f||||f||||||||||2017-02-18 17:11:36.490699|2017-02-18 17:11:36.490699
NCT00203970|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-17|||February 2001||2001-02-01|May 2016|2016-05-01|January 2017|Anticipated|2017-01-01|March 2001|Actual|2001-03-01||Observational|||Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services|Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services|Active, not recruiting||N/A|645|Actual|University of Chicago|||1||f||||f||||||||||2017-02-18 17:11:37.591869|2017-02-18 17:11:37.591869
NCT00203957|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-10|||March 2005||2005-03-01|June 2013|2013-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa|A Long-Term, Multicenter, Open-Label Safety Study With Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa Therapy|Completed||Phase 3|10|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 17:11:37.688863|2017-02-18 17:11:37.688863
NCT00203944|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-08|||July 2002||2002-07-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||International Adoption and Stress Response Study|International Adoption and Stress Response Study|Completed||N/A|39|Actual|University of Chicago|||2||f||||f||||||||||2017-02-18 17:11:37.797361|2017-02-18 17:11:37.797361
NCT00203931|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-02-12|2013-12-10||March 2005||2005-03-01|February 2014|2014-02-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Interventional||Includes evaluable patients (those that received at least 3 doses of cetuximab)|Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer|A Randomized Phase II Trial Comparing Cetuximab With Concurrent Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer Refractory to Primary Treatment|Terminated||Phase 2|55|Actual|University of Chicago||2||"Slow accrual and evidence from other studies showing benefit of early initiation of pemetrexed~   after first-line therapy"|f||||t||||||||||2017-02-18 17:11:37.90044|2017-02-18 17:11:37.90044
NCT00203918|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-17|||January 2004||2004-01-01|May 2016|2016-05-01|February 2013|Actual|2013-02-01|February 2011|Actual|2011-02-01||Observational|||Prostate Cancer Utilities and Cost-Effectiveness Analysis|Prostate Cancer Utilities and Cost-Effectiveness Analysis|Completed||N/A|481|Actual|University of Chicago|||1||f||||f||||||||||2017-02-18 17:11:38.372897|2017-02-18 17:11:38.372897
NCT00203905|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-01-16|||January 2004||2004-01-01|January 2014|2014-01-01|November 2008|Actual|2008-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck|A Randomized Phase II Study of Concomitant Chemoradiotherapy With 5-Fluorouracil/Hydroxyurea Compared to FHX Plus Bevacizumab for Intermediate Stage and Selected Stage IV Cancers of the Head and Neck|Completed||Phase 2|23|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 17:11:38.478494|2017-02-18 17:11:38.478494
NCT00005416|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-21|||July 1992||1992-07-01|April 2002|2002-04-01|June 1995||1995-06-01|||||Observational|||Diet, Exercise, and Cardiovascular Health Among Ethnic Children||Completed||N/A|||Augusta University|||||f||||||||||||||2017-02-18 18:15:01.297587|2017-02-18 18:15:01.297587
NCT00203892|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-03-21|2014-01-31||April 2003||2003-04-01|March 2014|2014-03-01|May 2012|Actual|2012-05-01|June 2009|Actual|2009-06-01||Interventional||The 19 patients who received at least 1 dose of the CEA vaccine are included in the baseline analysis population|Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma|A Randomized Pilot Phase II Study of Immunization With Modified CEA (CAP1-6D) Peptide In Patients With Locally Advanced Or Surgically Resected Adenocarcinoma of the Pancreas|Completed||Phase 1/Phase 2|23|Actual|University of Chicago||3|||f||||t||||||||||2017-02-18 17:11:38.59142|2017-02-18 17:11:38.59142
NCT00203879|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-04|||February 2002||2002-02-01|September 2013|2013-09-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma|Randomized Phase II Study of Immunization With MAGE-3/Melan-A/gp 100/NA17 Peptide-Pulsed Autologous PBMC and rhIL-12 With or Without Low Dose IL-2 Inpatients With Metastatic Melanoma|Completed||Phase 2|19|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 17:11:39.096483|2017-02-18 17:11:39.096483
NCT00203866|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-04|||October 2003||2003-10-01|September 2013|2013-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma|A Randomized Pilot Phase II Trial of Adjuvant Immunization With G250 Peptide andThree Different Dose Levels of IL-2 Following Surgical Resection of Locally Advanced or Metastatic Renal Cell Carcinoma|Terminated||Phase 2|40|Anticipated|University of Chicago||||Study completed|f||||t||||||||||2017-02-18 17:11:39.213681|2017-02-18 17:11:39.213681
NCT00203853|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-04|||January 2005||2005-01-01|September 2013|2013-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults|Evaluation of an Intervention (Consisting of an Electronic Reminder Device, Pillboxes, and Monthly Telephone Calls) on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults|Terminated||N/A|200||University of Chicago||1|||f||||||||||||||2017-02-18 17:11:39.321178|2017-02-18 17:11:39.321178
NCT00203840|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-12|||August 2004||2004-08-01|May 2016|2016-05-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Pediatric Sleep Questionnaire: Normalization and Validation Study|Pediatric Sleep Questionnaire: Normalization and Validation Study|Completed||N/A|325|Actual|University of Chicago|||1||f||||f||||||||||2017-02-18 17:11:39.42598|2017-02-18 17:11:39.42598
NCT00203827|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-04|||September 2004||2004-09-01|September 2013|2013-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Pediatric Sleep Questionnaire: Use for Collection of Clinical Data|Pediatric Sleep Questionnaire: Use for Collection of Clinical Data|Completed||N/A|300|Actual|University of Chicago|||1||f||||f||||||||||2017-02-18 17:11:39.515808|2017-02-18 17:11:39.515808
NCT00203814|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-15|||January 2004||2004-01-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria|Open-Label, Randomised, Parallel Group in Vivo Drug Study to Evaluate Combination Anti-Malarial Therapy (CAT), Artesunate and Sulfadoxine-Pyrimethamine Versus Sulfadoxine-Pyrimethamine Alone, in Terms of Therapeutic Efficacy, Prevalence of Gametocyte Carriage and Prevalence of Molecular Markers Associated With SP Resistance In Uncomplicated Plasmodium Falciparum Infections.|Completed||N/A|280||University of Cape Town|||||f||||||||||||||2017-02-18 17:11:39.606795|2017-02-18 17:11:39.606795
NCT00203801|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2006-09-07|||January 2002||2002-01-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Combination Antimalarials in Uncomplicated Malaria|An Open Label In Vivo Drug Study to Evaluate Combination Anti-Malarial Therapy (CAT),in Terms of Therapeutic Efficacy, Prevalence of Gametocyte Carriage and Prevalence of Molecular Markers Associated With SP Resistance in Uncomplicated Plasmodium Falciparum Infections.|Completed||N/A|700||University of Cape Town|||||f||||||||||||||2017-02-18 17:11:39.700736|2017-02-18 17:11:39.700736
NCT00203788|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-07-28|||May 1999||1999-05-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Improving Work Outcome in People With Recent-onset Schizophrenia|Developmental Processes in Schizophrenic Disorders: Improving and Predicting Work Outcome in Recent-Onset Schizophrenia|Completed||Phase 4|87|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 17:11:39.799266|2017-02-18 17:11:39.799266
NCT00203775|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-12|||July 2002||2002-07-01|May 2005|2005-05-01|April 2004||2004-04-01|||||Interventional|||Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates|Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates|Terminated||N/A|||UConn Health|||||f||||||||||||||2017-02-18 17:11:39.927071|2017-02-18 17:11:39.927071
NCT00203762|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-23|||May 2003||2003-05-01|March 2004|2004-03-01|December 2006||2006-12-01|||||Interventional|||Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care|Effect of the South African Public Sector Antiretroviral Treatment Programme on the Performance of Tuberculosis and Immunization Programmes - A Cluster Controlled (Non-Randomized) Trial|Unknown status|Recruiting|N/A|39|Anticipated|University of Cape Town|||||f||||||||||||||2017-02-18 17:11:39.99977|2017-02-18 17:11:39.99977
NCT00203749|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-11|||December 2004||2004-12-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand|NIMH Project Accept: A Phase III Randomized Controlled Trial of Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand|Completed||Phase 3|192814|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 17:11:40.098597|2017-02-18 17:11:40.098597
NCT00203736|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-15|||January 2003||2003-01-01|August 2005|2005-08-01|October 2003||2003-10-01|||||Interventional|||A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria|Open Label Drug Study (With Single and Parallel Group Components) to Evaluate Combination Antimalarial Therapy for Efficacy, Gametocyte Carriage and Molecular Markers Associated With SP Resistance in Uncomplicated Plasmodium Falciparum Infections|Completed||N/A|240||University of Cape Town|||||f||||||||||||||2017-02-18 17:11:40.214776|2017-02-18 17:11:40.214776
NCT00203723|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-05-17|||March 2005||2005-03-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Use of Risperidone in ECT for Treatment Resistant Depression|A Comparison Study of Combined ECT and Risperidone Versus ECT Alone for Treatment Resistant Depression.|Terminated||Phase 4|45||University of California, Los Angeles|||||f||||||||||||||2017-02-18 17:11:40.548061|2017-02-18 17:11:40.548061
NCT00005415|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1992||1992-09-01|June 2000|2000-06-01|September 1993|Actual|1993-09-01|||||Observational|||Physical Activity Effects on Health Care Utilization||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.362295|2017-02-18 18:15:01.362295
NCT00203710|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-10|||October 2003||2003-10-01|December 2015|2015-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Concentric Retriever Device (CRD) in Acute Ischemic Stroke|A Single-Center Controlled Registry to Evaluate the Concentric Retriever System for the Treatment of Stroke|Completed||N/A|50||University of California, Los Angeles|||||||||||||||||||2017-02-18 17:11:40.646787|2017-02-18 17:11:40.646787
NCT00203697|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-07||||||September 2006|2006-09-01||||||||Interventional|||Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study|Minocycline Treatment in Patients With Idiopathic Pulmonary Fibrosis Being Treated With Standard of Care Therapy- a Pilot Study|Unknown status|Active, not recruiting|Phase 3|||University of California, Los Angeles|||||||||||||||||||2017-02-18 17:11:40.749186|2017-02-18 17:11:40.749186
NCT00203684|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-15||||||February 2017|2017-02-01||||||||Interventional|||Mentored Patient-Oriented Research Career Development Award|The Effects of Different Sized Inhaled Corticosteroids on Peripheral Lung Inflammation in Asthma Assessed Through Lung Tissue Samples (SMART Protocol)|Recruiting||Phase 1/Phase 2|||University of California, Los Angeles|||||||||||||||||||2017-02-18 17:11:40.832223|2017-02-18 17:11:40.832223
NCT00203671|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-12|||April 2006||2006-04-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Observational|||Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation|Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation|Completed||N/A|651|Actual|University of California, Los Angeles|||1||f||||||||||||||2017-02-18 17:11:40.931356|2017-02-18 17:11:40.931356
NCT00203658|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-02-08|||April 1997||1997-04-01|September 2005|2005-09-01|October 2000||2000-10-01|||||Interventional|||Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin|LITE Study, Appendix A (HOME-LITE), Amendment 6|Completed||Phase 4|400||University of Calgary|||||||||||||||||||2017-02-18 17:11:41.014967|2017-02-18 17:11:41.014967
NCT00203645|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-13|||July 2003||2003-07-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|April 2006|Actual|2006-04-01||Interventional|||Minimal and Brief Treatments for Pathological Gamblers|Minimal and Brief Treatments for Pathological Gamblers: Developing Effective Treatment Systems|Completed||Phase 3|312|Actual|University of Calgary||4|||f||||f||||||||||2017-02-18 17:11:41.128025|2017-02-18 17:11:41.128025
NCT00203632|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-30|||September 2003||2003-09-01|October 2008|2008-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Glitazones and Endothelial Function (GATE)|A Trial of the Effect of Rosiglitazone as Add on to Metformin Therapy on Endothelial Function in Subjects With Type II DM|Terminated||Phase 3|40|Actual|University of Calgary||2||Terminated at 50% enrollment due to recent concerns about rosiglitazone|f||||t||||||||||2017-02-18 17:11:41.249392|2017-02-18 17:11:41.249392
NCT00203619|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-28|||May 2005||2005-05-01|August 2016|2016-08-01|September 2016|Anticipated|2016-09-01|September 2015|Actual|2015-09-01||Interventional|||Capsule Endoscopy in Obscure GI Bleeding|An Economic Evaluation of Capsule Endoscopy for Obscure Gastrointestinal Bleeding|Active, not recruiting||Phase 4|40|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 17:11:41.353565|2017-02-18 17:11:41.353565
NCT00203606|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-03|||January 2004||2004-01-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|January 2009|Actual|2009-01-01||Interventional|||Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C|Effectiveness of Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C|Completed||Phase 4|66|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 17:11:41.481385|2017-02-18 17:11:41.481385
NCT00203593|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-03-12|||March 2006||2006-03-01|March 2007|2007-03-01|June 2007||2007-06-01|||||Interventional|||Exercise and Prevention of Syncope: EXPOSE|EXercise for the Prevention of Syncope Evaluation|Suspended||Phase 1|20||University of Calgary||||No Resources - No Personnel|f||||||||||||||2017-02-18 17:11:41.584267|2017-02-18 17:11:41.584267
NCT00203580|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-02-08|||December 1994||1994-12-01|September 2005|2005-09-01|March 2002||2002-03-01|||||Interventional|||Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)|A Randomized Trial of the Effect of Low-Molecular-Weight Heparin Versus Warfarin Sodium on the Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (Main LITE Study)|Completed||Phase 4|910||University of Calgary|||||||||||||||||||2017-02-18 17:11:41.678029|2017-02-18 17:11:41.678029
NCT00203567|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-23|||August 2005||2005-08-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|February 2007|Actual|2007-02-01||Interventional|||Carbamazepine Extended-Release for the Treatment of Bipolar Depression|Carbamazepine Extended-Release for the Treatment of Bipolar Depression|Completed||Phase 4|25|Actual|Tuscaloosa Research & Education Advancement Corporation||1|||f||||f||||||||||2017-02-18 17:11:41.785868|2017-02-18 17:11:41.785868
NCT00203554|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2008-03-26|||March 2004||2004-03-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Percutaneous Vertebroplasty Versus Conservative Treatment of Pain|Percutaneous Vertebroplasty Versus Conservative Treatment of Pain: A Prospective, Randomized Controlled Study of Osteoporotic Fractures in the Spine|Completed||N/A|27|Actual|University of Aarhus||1|||f||||t||||||||||2017-02-18 17:11:41.903854|2017-02-18 17:11:41.903854
NCT00203541|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-16|||February 2004||2004-02-01|November 2007|2007-11-01|June 2006||2006-06-01|||||Interventional|||Effects of a New Antimicrobial Dressing on Wound Healing and Incidence of Sternal Wound Infections|Effects of a New Antimicrobial Dressing on Wound Healing and Incidence of Sternal Wound Infections in Subjects Who Have Undergone Cardiac Surgical Procedures Requiring Median Sternotomy|Terminated||N/A|1100||Tyco Healthcare Group||||Reallocation of funding.|f||||||||||||||2017-02-18 17:11:42.000572|2017-02-18 17:11:42.000572
NCT00203528|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-16|||January 2004||2004-01-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder|Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder|Completed||Phase 4|30||Tuscaloosa Research & Education Advancement Corporation|||||f||||f||||||||||2017-02-18 17:11:42.097011|2017-02-18 17:11:42.097011
NCT00203515|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-04|||January 2005||2005-01-01|January 2008|2008-01-01||||March 2007|Actual|2007-03-01||Interventional|||Study Comparing the DOVER Silver Foley Catheter to a Standard of Care Catheter and a Marketed Silver Coated Foley Catheter|A Prospective, Randomized, Controlled Study Comparing the DOVER Silver Foley Catheter to a Standard of Care Catheter and a Marketed Silver Coated Foley Catheter|Completed||N/A|1000||Tyco Healthcare Group|||||||||||||||||||2017-02-18 17:11:42.20907|2017-02-18 17:11:42.20907
NCT00203502|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-02|2015-10-21||September 2005||2005-09-01|May 2016|2016-05-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer|Primary Systemic Therapy Using Sequential Docetaxel/Cyclophosphamide/Bevacizumab Followed by Doxorubicin in Operable/Locally Advanced Breast Cancer|Completed||Phase 2|40|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 17:11:42.313492|2017-02-18 17:11:42.313492
NCT00203489|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-16|||June 2005||2005-06-01|November 2007|2007-11-01|August 2007||2007-08-01|||||Interventional|||A Clinical Study of An Antimicrobial Gauze Dressing|A Prospective Randomized Double-Blind Trial of a Polyhexamethylene Biguanide (PHMB) Impregnated Gauze Dressing for the Prevention of Chronic Wound Colonization With Resistant and Prevalent Microorganisms|Terminated||N/A|200|Anticipated|Tyco Healthcare Group||||Reallocation of funding.|f||||||||||||||2017-02-18 17:11:42.643438|2017-02-18 17:11:42.643438
NCT00203476|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-08-08|2013-12-05||May 2005||2005-05-01|August 2014|2014-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||100% male, age 50 years or greater|A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction|A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction|Completed||Phase 4|30|Actual|Tuscaloosa Research & Education Advancement Corporation|Open label.|3|||f||||f||||||||||2017-02-18 17:11:42.732852|2017-02-18 17:11:42.732852
NCT00203463|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-07-28|||July 2001||2001-07-01|July 2009|2009-07-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)|Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)|Completed||Phase 4|40||Tuscaloosa Research & Education Advancement Corporation|||||f||||||||||||||2017-02-18 17:11:43.428835|2017-02-18 17:11:43.428835
NCT00203450|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-08-30|||May 2003||2003-05-01|August 2012|2012-08-01|March 2006|Actual|2006-03-01|March 2005|Actual|2005-03-01||Interventional|Zonegran||Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial|Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial|Completed||Phase 4|20|Actual|Tuscaloosa Research & Education Advancement Corporation||2|||f||||f||||||||||2017-02-18 17:11:43.530732|2017-02-18 17:11:43.530732
NCT00203424|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-02-26|2011-04-12||January 2006||2006-01-01|February 2016|2016-02-01|June 2010|Actual|2010-06-01|February 2009|Actual|2009-02-01||Interventional|||Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib|A Phase II Trial of Adjuvant Bevacizumab and Erlotinib in Patients at High Risk for Early Relapse Following Radical Prostatectomy for Prostate Cancer|Completed||Phase 2|23|Actual|Translational Oncology Research International|This was a small study with only 22 participants who received study treatment. With such a small sample size the study doesnt have the statistcical power to make categorical assessments or statements.|1|||f||||t||||||||||2017-02-18 17:11:43.654408|2017-02-18 17:11:43.654408
NCT00203411|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-03|2016-02-10||March 2006||2006-03-01|March 2016|2016-03-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer|A Phase II Trial to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Capecitabine (Xeloda) in Frail Patients With Untreated Metastatic Colorectal Cancer|Completed||Phase 2|45|Actual|Translational Oncology Research International|This was a small study with only 45 participants who received study treatment. With such a small sample size the study does not have the statistical power to make categorical assessments or statements.|1|||f||||t||||||||||2017-02-18 17:11:44.020118|2017-02-18 17:11:44.020118
NCT00203385|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-16|||May 2003||2003-05-01|March 2007|2007-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder|Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder|Completed||Phase 4|30||Tuscaloosa Research & Education Advancement Corporation|||||f||||f||||||||||2017-02-18 17:11:44.399985|2017-02-18 17:11:44.399985
NCT00203372|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-09|||May 2005||2005-05-01|February 2011|2011-02-01||||June 2012|Actual|2012-06-01||Interventional|||Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)|A Multicenter, Placebo-Controlled, Double-Blind Randomized Phase II Trial of Neoadjuvant Treatment With Single-Agent Bevacizumab or Placebo, Followed by Six Cycles of Docetaxel, Doxorubicin, and Cyclophosphamide (TAC), With or Without Bevacizumab in Patients With Stage II or Stage III Breast Cancer|Completed||Phase 2|6|Actual|Translational Oncology Research International||4|||f||||t||||||||||2017-02-18 17:11:44.495721|2017-02-18 17:11:44.495721
NCT00203359|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-04-20|||September 2004||2004-09-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||TNF-Alpha Inhibition for Treatment of Alzheimer's Disease|Etanercept for Alzheimer's-Type Memory Loss Pilot Study|Completed||Phase 1|15||Tobinick, Edward Lewis, M.D.|||||f||||||||||||||2017-02-18 17:11:44.606816|2017-02-18 17:11:44.606816
NCT00203346|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-22|||June 2005||2005-06-01|January 2009|2009-01-01||||||||Observational|||Research Study Examining Nerve Block for Migraine|Greater Occipital Nerve (GON) Block for Migraine|Completed||N/A|30||Thomas Jefferson University|||||f||||||||||||||2017-02-18 17:11:44.699627|2017-02-18 17:11:44.699627
NCT00203333|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-17|||April 2002||2002-04-01|October 2016|2016-10-01|January 2010|Actual|2010-01-01|June 2007|Actual|2007-06-01||Observational|||Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death|Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death|Completed||Phase 2/Phase 3|19|Actual|Thomas Jefferson University|||1||f||||t||||||||||2017-02-18 17:11:44.771033|2017-02-18 17:11:44.771033
NCT00203320|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-04-20|||April 2005||2005-04-01|April 2006|2006-04-01|January 2006||2006-01-01|||||Interventional|||TNF-Alpha Inhibition for Treatment of Alzheimer's Disease|Etanercept for Alzheimer's-Type Memory Loss Pilot Study II|Completed||Phase 1|30||Tobinick, Edward Lewis, M.D.|||||f||||||||||||||2017-02-18 17:11:44.858521|2017-02-18 17:11:44.858521
NCT00203307|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-23|2011-05-24||May 2004||2004-05-01|August 2011|2011-08-01|June 2006|Actual|2006-06-01|March 2006|Actual|2006-03-01||Interventional|||A Research Study Examining the Use of Olanzapine for the Prevention of Migraine|A Single-Site, Double-Blind, Placebo-Controlled Cross-Over Trial Examining the Safety and Efficacy of Olanzapine Taken Daily for the Prevention of Episodic Migraine.|Terminated||N/A|3|Actual|Thomas Jefferson University||2||Study terminated by sponsor|f||||||||||||||2017-02-18 17:11:45.195281|2017-02-18 17:11:45.195281
NCT00203294|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-07|2011-05-19||June 2005||2005-06-01|April 2014|2014-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Research Study to Examine the Difference Between Local Anesthetics Alone and Local Anesthetics Plus Steroids in the Treatment of Chronic Headache|Comparison Of Greater Occipital Nerve Block With Lidocaine And Bupivicaine Alone Or With Steroids In a Chronic Headache Population|Completed||N/A|45|Actual|Thomas Jefferson University||2|||f||||f||||||||||2017-02-18 17:11:45.547312|2017-02-18 17:11:45.547312
NCT00203281|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-19|||February 2003||2003-02-01|October 2016|2016-10-01|September 2009|Anticipated|2009-09-01|September 2009|Anticipated|2009-09-01||Observational|||Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis|Pharmacokinetic Evaluation of Plasmapheresis in Cross Match Positive or ABO Incompatible Kidney Allograft Recipients|Withdrawn||Phase 4|0|Actual|Thomas Jefferson University|||1|funding withdrawn|f||||f||||||||||2017-02-18 17:11:45.926496|2017-02-18 17:11:45.926496
NCT00203268|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-08|2010-10-25||December 2003||2003-12-01|May 2014|2014-05-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity|An Open Label Pilot Trial to Collect and Evaluate Data on the Use of Dihydroergotamine Mesylate in the Treatment of Two Migraine Attacks Associated With Cutaneous Allodynia|Completed||N/A|13|Actual|Thomas Jefferson University||1|||f||||f||||||||||2017-02-18 17:11:46.045442|2017-02-18 17:11:46.045442
NCT00203255|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-22|||May 2003||2003-05-01|January 2009|2009-01-01|March 2005||2005-03-01|||||Interventional|||Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache|An Open-Label, Pilot Study Examining the Use of Soy Isoflavones in the Prevention of Menstrually-Associated Migraine|Completed||N/A|25||Thomas Jefferson University|||||f||||||||||||||2017-02-18 17:11:46.536716|2017-02-18 17:11:46.536716
NCT00203242|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-13|2011-06-07||July 2003||2003-07-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches.|An Open-label Pilot Study to Collect/Evaluate Data on the Use of Consecutive Daily Intravenous Doses of Depacon in Combination With Daily Dose of Depakote ER During a Cluster Headache Cycle.|Completed||N/A|15|Actual|Thomas Jefferson University||1|||f||||||||||||||2017-02-18 17:11:46.64163|2017-02-18 17:11:46.64163
NCT00203229|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-02|2014-02-07||June 2003||2003-06-01|May 2014|2014-05-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia|A Double-Blind Placebo Controlled Add-on Study to Determine the Efficacy and Safety of Lamictal (Lamotrigine) in Patients With Trigeminal Neuralgia (Tic Doloureux)|Completed||N/A|20|Actual|Thomas Jefferson University|Limited enrollment due to fear of placebo and high drop out rate.|2|||f||||f||||||||||2017-02-18 17:11:46.899482|2017-02-18 17:11:46.899482
NCT00203216|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-15|2011-05-23||September 2002||2002-09-01|July 2011|2011-07-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches|A Single-Center, Open-Label Trial Examining the Efficacy and Safety of Levetiracetam for the Prophylactic Treatment of Migraine, With or Without Aura|Completed||N/A|31|Actual|Thomas Jefferson University||1|||f||||||||||||||2017-02-18 17:11:47.277128|2017-02-18 17:11:47.277128
NCT00203203|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-10-17|2011-07-06||April 2004||2004-04-01|October 2016|2016-10-01|November 2009|Actual|2009-11-01|August 2008|Actual|2008-08-01||Interventional|||Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)|Randomized Controlled Single Blind Trial of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance for Therapeutic Angiogenesis|Completed||Phase 1|30|Actual|Texas Heart Institute|The study is a preliminary study based on a small sample size which limits the statistical rigor of the analysis.|2|||f||||t||||||||No|Data summarized and published. No need to share individual patient data.|2017-02-18 17:11:47.536897|2017-02-18 17:11:47.536897
NCT00203190|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-01-22|||September 2004||2004-09-01|January 2009|2009-01-01|June 2006||2006-06-01|||||Interventional|||A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache|A Single-Center, Randomized, Double-Blind, Placebo Controlled Trial Examining the Safety and Efficacy of Topiramate in the Treatment of Subjects With Episodic or Chronic Cluster Headache.|Terminated||Phase 4|60||Thomas Jefferson University|||||f||||||||||||||2017-02-18 17:11:48.330495|2017-02-18 17:11:48.330495
NCT00203177|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-08|||October 2001||2001-10-01|March 2010|2010-03-01||||December 2006|Actual|2006-12-01||Interventional|||Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.|A Bi-national, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Tolerability of Rasagiline Mesylate in Advanced Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Chronic Levodopa/Carbidopa Therapy.|Completed||Phase 3|254|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-02-18 17:11:48.416718|2017-02-18 17:11:48.416718
NCT00203164|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-08|||May 2002||2002-05-01|March 2010|2010-03-01|September 2006|Actual|2006-09-01|July 2005|Actual|2005-07-01||Interventional|||Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients|A Bi-national, Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Tolerability of Rasagiline Mesylate in Advanced Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Chronic Levodopa/Carbidopa Therapy|Completed||Phase 3|254|Actual|Teva Pharmaceutical Industries||1|||||||f||||||||||2017-02-18 17:11:48.582872|2017-02-18 17:11:48.582872
NCT00203151|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-08|||July 2005||2005-07-01|April 2011|2011-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|PRELUDE||A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus|A Multi-National, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Parallel Group Study to Assess the Efficacy, Tolerability and Safety of Edratide for Subcutaneous Injection in Systemic Lupus Erythematosus (SLE)|Terminated||Phase 2|340|Actual|Teva Pharmaceutical Industries||2||TV-4710/201 did not meet its primary endpoints in patients with SLE|t||||||||||||||2017-02-18 17:11:48.680004|2017-02-18 17:11:48.680004
NCT00203138|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-08|||June 2004||2004-06-01|April 2011|2011-04-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease|A Multicenter, Open-Label, Phase III Study for the Safety, Tolerability and Clinical Effect of Rasagiline Mesylate in Patients With Parkinson's Disease|Completed||Phase 3|306|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 17:11:48.762662|2017-02-18 17:11:48.762662
NCT00203125|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-08|||October 2000||2000-10-01|April 2011|2011-04-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.|Sub-study to Evaluate the Effect of An Oral Dose of Tyramine in Subjects Completing 26 Weeks of Participation in PRESTO (TVP-1012/133)|Completed||Phase 3|55|Actual|Teva Pharmaceutical Industries||1|||f||||t||||||||||2017-02-18 17:11:48.840887|2017-02-18 17:11:48.840887
NCT00203112|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-11|||June 2004||2004-06-01|April 2011|2011-04-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline|A Multi-Centered, Randomized, Double-Blind, Placebo-Controlled, Parallel Study Assessing the Add-on Effect of Minocycline in Relapsing-Remitting Multiple Sclerosis (RR-MS) Subjects Treated With Glatiramer Acetate (GA).|Completed||Phase 2|44|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-02-18 17:11:48.924722|2017-02-18 17:11:48.924722
NCT00203099|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-11|||December 2004||2004-12-01|May 2012|2012-05-01|June 2008|Actual|2008-06-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine|A Pilot, Multicenter, Open-label, One-group Study to Explore the Efficacy, Tolerability and Safety of the Combination of Glatiramer Acetate (GA) and N-Acetylcysteine (NAC) in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)|Completed||Phase 2|18|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 17:11:49.020679|2017-02-18 17:11:49.020679
NCT00203086|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-27|||October 2005||2005-10-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|October 2009|Actual|2009-10-01||Observational|||A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis|A Multi-Centered, Two Arm, Open Label Extension Study (to Protocol NC-100) to Evaluate the Long-Term Safety and Efficacy of Short-Term Induction Treatment With Mitoxantrone (Novantrone®) Preceding Treatment With Glatiramer Acetate (Copaxone®) vs. Chronic Treatment With Glatiramer Acetate Alone in Relapsing Forms of Multiple Sclerosis|Completed||Phase 4|30|Actual|Teva Pharmaceutical Industries|||1||f||||t||||||||||2017-02-18 17:11:49.109821|2017-02-18 17:11:49.109821
NCT00203073|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-13|||June 2003||2003-06-01|April 2011|2011-04-01|April 2005|Actual|2005-04-01|January 2005|Actual|2005-01-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.|A Multi-Center, Randomized, Open Label Study To Evaluate Safety, Tolerability And Efficacy Of Treatment With Mitoxantrone; Pre-Treatment With Glatiramer Acetate (GA) Versus Treatment With GA Alone In Relapsing Forms Of Multiple Sclerosis.|Completed||Phase 2|40|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:11:49.187322|2017-02-18 17:11:49.187322
NCT00203060|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-08|||July 1997||1997-07-01|April 2011|2011-04-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa|A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Phase III Clinical Trial For The Efficacy, Tolerability And Safety Of Two Doses Of Rasagiline Mesylate In Early Parkinson's Disease (PD) Patients Not Treated With Levodopa|Completed||Phase 3|404|Actual|Teva Pharmaceutical Industries||2|||f||||t||||||||||2017-02-18 17:11:49.277976|2017-02-18 17:11:49.277976
NCT00203047|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-15|2013-08-29||January 2005||2005-01-01|November 2013|2013-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|ASSERT|Represents database as of January 29, 2009|Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate|A Multi-Centered, Randomized, Double-Blind, Placebo Controlled Study Assessing the Add-on Effect of Oral Steroids in Relapsing Remitting Multiple Sclerosis Subjects Treated With Glatiramer Acetate (GA)|Terminated||Phase 4|414|Actual|Teva Pharmaceutical Industries||2||Slow enrollment decreased sample size; No unexpected safety issues.|f||||t||||||||||2017-02-18 17:11:49.381413|2017-02-18 17:11:49.381413
NCT00203034|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-08|||May 2000||2000-05-01|March 2010|2010-03-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations|A Multicenter, US and Canada, Double Blind, Randomized, Placebo-Controlled, Parallel Group Study, for the Efficacy, Tolerability and Safety of Rasagiline Mesylate in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations|Completed||Phase 3|472|Actual|Teva Pharmaceutical Industries||3|||f||||t||||||||||2017-02-18 17:11:53.791346|2017-02-18 17:11:53.791346
NCT00203021|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-01|||July 1994||1994-07-01|December 2016|2016-12-01|September 2019|Anticipated|2019-09-01|August 2019|Anticipated|2019-08-01||Interventional|||Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.|Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®|Active, not recruiting||Phase 4|102|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 17:11:53.895378|2017-02-18 17:11:53.895378
NCT00203008|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-10-14|||January 2003||2003-01-01|October 2010|2010-10-01|September 2003|Actual|2003-09-01|||||Observational|||A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma|A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients|Completed||N/A|2106|Actual|Teva Pharmaceutical Industries|||1||f||||f||||||||||2017-02-18 17:11:54.006327|2017-02-18 17:11:54.006327
NCT00202995|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-10-14|||July 2004||2004-07-01|October 2010|2010-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS|A Multi-Center, Randomized, Single-Blind, Parallel Group Study to Compare the Efficacy, Tolerability and Safety, of Copaxone® to That of High Dose Interferon (Betaseron® or Rebif®) in the Treatment of Relapsing Multiple Sclerosis Patients|Terminated||Phase 4|91|Actual|Teva Pharmaceutical Industries||2||Slow enrollment decreased sample size No unexpected safety issues.|f||||t||||||||||2017-02-18 17:11:54.080317|2017-02-18 17:11:54.080317
NCT00202982|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-12|||August 2003||2003-08-01|January 2010|2010-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose|A Multi-Center, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy, Tolerability and Safety of 40 mg of Copaxone in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients|Completed||Phase 2|90|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 17:11:54.182114|2017-02-18 17:11:54.182114
NCT00202969|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-07-06|||July 2005||2005-07-01|July 2011|2011-07-01|June 2007|Actual|2007-06-01|January 2007|Actual|2007-01-01||Interventional|||Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer|An Open-label, Multicenter, Randomized, 3 Arm Study of S-1 Compared With S-1/CDDP, or S-1/CDDP Compared With 5-FU/CDDP in Patients With Advanced Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease|Completed||Phase 3|180|Anticipated|Taiho Pharmaceutical Co., Ltd.||3|||f||||||||||||||2017-02-18 17:11:54.293917|2017-02-18 17:11:54.293917
NCT00202956|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2004||2004-06-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.|A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effects on Biomarkers and Safety of Bugusan (BGS) in Postmenopausal Patients With Osteoporosis.|Unknown status|Recruiting|Phase 2|||Taichung Veterans General Hospital|||||f||||||||||||||2017-02-18 17:11:54.404359|2017-02-18 17:11:54.404359
NCT00202943|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||March 2003||2003-03-01|September 2005|2005-09-01|March 2004||2004-03-01|||||Interventional|||Randomized Controlled Trial of TCRFVR and LAUP in Snorers|Comparison of Clinical Effect Between Temperature-Controlled Radio-Frequency Uvuloplasty and Laser Assisted Uvulo-Pharyngoplasty in Patients Who Snore|Completed||N/A|40||Taichung Veterans General Hospital|||||f||||||||||||||2017-02-18 17:11:54.485509|2017-02-18 17:11:54.485509
NCT00202930|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-19|||July 2005||2005-07-01|September 2006|2006-09-01|July 2008||2008-07-01|||||Interventional|||Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma|Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma|Unknown status|Recruiting|Phase 2|10||Tersak, Jean M., M.D.|||||||||||||||||||2017-02-18 17:11:54.569875|2017-02-18 17:11:54.569875
NCT00202917|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-28|||February 2004||2004-02-01|May 2014|2014-05-01|December 2010|Actual|2010-12-01|July 2009|Actual|2009-07-01||Interventional|||Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies|Multicenter Phase I/II Study of Haploidentical Hematopoietic Cell Transplantation With CD3/CD19 Depleted Grafts in Patients With Treatment Refractory Hematologic Malignancies|Completed||Phase 1/Phase 2|61|Actual|University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:11:54.918522|2017-02-18 17:11:54.918522
NCT00202904|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-28|||May 2005||2005-05-01|April 2015|2015-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)|A Multicenter, Randomized, Parallel Groups, Placebo-Controlled Study Comparing the Efficacy, Safety, and Tolerability of the Daily Co-Administration of Ezetimibe 10 mg or Ezetimibe Placebo to Ongoing Treatment With Atorvastatin 10 mg in Subjects With Primary Hypercholesterolemia and Coronary Heart Disease|Completed||Phase 4|81|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:11:55.025864|2017-02-18 17:11:55.025864
NCT00202891|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-06-02|||May 2007||2007-05-01|June 2015|2015-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)|Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas|Withdrawn||Phase 4|0|Actual|Merck Sharp & Dohme Corp.||||No further local interest in pursuing the study.|f||||||||||||||2017-02-18 17:11:55.138652|2017-02-18 17:11:55.138652
NCT00202878|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-02|2015-08-28||October 2005||2005-10-01|November 2015|2015-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)|A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting With Acute Coronary Syndrome (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial - IMPROVE IT)|Completed||Phase 3|18144|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:11:55.269531|2017-02-18 17:11:55.269531
NCT00202865|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-04-21|||May 2005||2005-05-01|April 2015|2015-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|CANDLE||Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)|CANaDian Evaluation of Low DosE Infliximab in Ankylosing Spondylitis|Completed||Phase 3|76|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:12:00.277989|2017-02-18 17:12:00.277989
NCT00202852|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-26|||June 2005||2005-06-01|May 2015|2015-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)|A Placebo-Controlled, Double-Blinded, Randomized Clinical Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methotrexate|Completed||Phase 3|143|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:12:00.402369|2017-02-18 17:12:00.402369
NCT00202839|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-07|2009-08-28||March 2005||2005-03-01|April 2015|2015-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)|Comparison of the Sustained Response of Peg-Intron/Ribavirin Combination Therapy in Genotype 1-Infected Hepatitis C Patients for Non-extended Versus 24-week Extended Treatment After 24 Weeks Pilot Treatment in Taiwan|Completed||Phase 4|160|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:12:00.498412|2017-02-18 17:12:00.498412
NCT00202826|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-16|||November 2003||2003-11-01|January 2009|2009-01-01|March 2004||2004-03-01|||||Interventional|||Study of Fluid Collection of the Chest in Children With Pneumonia|Parapneumonic Effusion in Children Study|Completed||Phase 3|30||Spectrum Health Hospitals|||||f||||||||||||||2017-02-18 17:12:00.89861|2017-02-18 17:12:00.89861
NCT00202813|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-12-29|||July 2003||2003-07-01|December 2009|2009-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study of the Use of Coated Venous Catheters in the Critically Ill Child|The Use of Antibiotic-coated Venous Catheters in the Critically Ill Child: Reducing the Rate of Bloodstream Related Infections|Completed||Phase 4|500||Spectrum Health Hospitals|||||f||||||||||||||2017-02-18 17:12:01.222931|2017-02-18 17:12:01.222931
NCT00202800|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-06-03|||March 2002||2002-03-01|June 2013|2013-06-01|January 2011|Actual|2011-01-01|September 2007|Actual|2007-09-01||Interventional|||Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer|Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|40|Anticipated|Spectrum Health Hospitals||1|||f||||||||||||||2017-02-18 17:12:01.32322|2017-02-18 17:12:01.32322
NCT00202787|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-19|||February 2005||2005-02-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer|Open-label, Phase II, Randomised, Pilot Study to Evaluate the Safety and Efficacy of Combination Therapy With Cetuximab and FOLFOX4 or FOLFOX4 Alone in Patients Colorectal Cancer and Initially Non-resectable|Completed||Phase 2|136|Actual|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)||2|||f||||f||||||||||2017-02-18 17:12:01.454535|2017-02-18 17:12:01.454535
NCT00005414|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1991||1991-09-01|July 2000|2000-07-01|September 1993|Actual|1993-09-01|||||Observational|||Validation of a Historical Physical Activity Survey||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.429674|2017-02-18 18:15:01.429674
NCT00202774|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-19|||April 2002||2002-04-01|February 2013|2013-02-01|December 2005|Actual|2005-12-01|August 2004|Actual|2004-08-01||Interventional|||Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer|Phase III, Multicenter, Ramdomised, Open-label, Study to Evaluate the Safety and Efficacy of Combination Therapy With XELOX vs. Oxaliplatin and 5-FU CI as First Line Treatment in Advanced or Metastatic Colorectal Cancer|Completed||Phase 3|348||Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|||||f||||f||||||||||2017-02-18 17:12:01.564076|2017-02-18 17:12:01.564076
NCT00202761|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-07|||March 2004||2004-03-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Project:Intensive Habilitation (PIH)|Project:Intensive Habilitation (PIH) -a New Norwegian Multidisciplinary Program for Intensive Training for Children With Disabilities|Active, not recruiting||Phase 2/Phase 3|20|Anticipated|Sorlandet Hospital HF||1|||f||||t||||||||||2017-02-18 17:12:01.674699|2017-02-18 17:12:01.674699
NCT00202748|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-22|||March 2004||2004-03-01|December 2003|2003-12-01|March 2007||2007-03-01|||||Interventional|||Change of Lifestyle by Persons in Risk of Type 2 Diabetes|Phase 3 Study of Changing of Lifestyle by Persons in Risk of Type 2 Diabetes|Unknown status|Active, not recruiting|Phase 3|220||Sorlandet Hospital HF|||||f||||||||||||||2017-02-18 17:12:01.784752|2017-02-18 17:12:01.784752
NCT00202735|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-05-07|||January 2005||2005-01-01|January 2005|2005-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Does Immobilization of the Shoulder in External Rotation Reduce the Recurrence Rate of Shoulder Dislocation?|Does Immobilization of the Shoulder in External Rotation Reduce the Recurrence Rate of Shoulder Dislocation?|Completed||Phase 2/Phase 3|188|Actual|Sorlandet Hospital HF||2|||f||||t||||||||||2017-02-18 17:12:01.883302|2017-02-18 17:12:01.883302
NCT00202722|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-22|2010-03-16||January 2004||2004-01-01|May 2014|2014-05-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour|Remifentanil as Analgesia for Labour Pain|Completed||Phase 4|41|Actual|Sorlandet Hospital HF||1|||f||||t||||||||||2017-02-18 17:12:01.999272|2017-02-18 17:12:01.999272
NCT00202709|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-07-27|||May 2002||2002-05-01|September 2005|2005-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?|Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder, a Prospective, Randomized Pilot Study With Wait List as Control Group.|Completed||N/A|52|Actual|Sorlandet Hospital HF||2|||f||||f||||||||||2017-02-18 17:12:02.238543|2017-02-18 17:12:02.238543
NCT00202696|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-15|||September 2005||2005-09-01|May 2008|2008-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Nalmefene Smoking Cessation Study|A Single Center Evaluation of Nalmefene HCl Versus Placebo on Smoking Cessation|Completed||Phase 2|76|Actual|Somaxon Pharmaceuticals||3|||f||||f||||||||||2017-02-18 17:12:02.36014|2017-02-18 17:12:02.36014
NCT00202683|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-05-16|||March 2005||2005-03-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Observational|||Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness|Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness Associated With Chemoreflex Failure|Completed||N/A|83|Actual|Société Française de Cardiologie|||||f||||f||||||||||2017-02-18 17:12:02.472639|2017-02-18 17:12:02.472639
NCT00202670|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-10-19|||January 2004||2004-01-01|January 2004|2004-01-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Observational|||Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients|Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients :Comparison Between Stress Echocardiography and Stress Scintigraphy in the Detection of Silent Myocardial Ischemia|Terminated||Phase 4|220|Anticipated|Société Française de Cardiologie|||2|Positive Predictive value not related to follow up duration.|f||||t||||||||||2017-02-18 17:12:02.573855|2017-02-18 17:12:02.573855
NCT00202657|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-12-05|||April 2005||2005-04-01|December 2011|2011-12-01|February 2007||2007-02-01|||||Observational|||Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide|Etude Observationnelle Des Valvulopathies Chez Les Patients Parkinsoniens Traites Par Pergolide Par Rapport a Une Population Temoin|Completed||Phase 4|149|Actual|Société Française de Cardiologie|||1||f||||||||||||||2017-02-18 17:12:02.673826|2017-02-18 17:12:02.673826
NCT00202644|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-18|||January 2006||2006-01-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients|A Phase IIIb, Randomized, Open Label Study to Compare the Safety, Efficacy and Tolerability of Anagrelide Hydrochloride Versus Hydroxyurea in High-Risk Essential Thrombocythaemia Patients.|Completed||Phase 4|150|Actual|Shire||2|||f||||||||||||||2017-02-18 17:12:02.771846|2017-02-18 17:12:02.771846
NCT00202631|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-24|||June 2002||2002-06-01|November 2006|2006-11-01|November 2006||2006-11-01|||||Interventional|||Abdominal Functional Electrical Stimulation in Tetraplegia|Abdominal Functional Electrical Stimulation to Augment Breathing in Tetraplegia|Unknown status|Active, not recruiting|N/A|4||South Glasgow University Hospitals NHS Trust|||||f||||||||||||||2017-02-18 17:12:02.904472|2017-02-18 17:12:02.904472
NCT00202618|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-04-27|||December 2003||2003-12-01|July 2005|2005-07-01|June 2006||2006-06-01|||||Interventional|||Rationale and Design for Shiga Microalbuminuria Reduction Trial|The Reduction of Microalbuminuria in Japanese Hypertensive Subjects With Type 2 Diabetes Mellitus Treated With Valsartan or Amlodipine: Study Design for the Shiga Microalbuminuria Reduction Trial (SMART)|Unknown status|Recruiting|Phase 4|160||Shiga University|||||f||||||||||||||2017-02-18 17:12:03.009501|2017-02-18 17:12:03.009501
NCT00202605|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-02|||September 2005||2005-09-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Safety and Efficacy of SPD465 in Adults With ADHD|A Phase II, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Crossover Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 2|72||Shire|||||||||||||||||||2017-02-18 17:12:03.118713|2017-02-18 17:12:03.118713
NCT00202592|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-15|||November 2003||2003-11-01|June 2011|2011-06-01|April 2010|Actual|2010-04-01|||||Interventional|||S90652 in Paediatric Hypertension|Safety and Effects on Blood Pressure of Daily Dose 0.025 to 0.135 Milligram Per Kilogram of S90625 a Paediatric Formulation of Perindopril, in Hypertensive Children - 24 Months|Completed||Phase 2|50|Anticipated|Servier|||||f||||||||||||||2017-02-18 17:12:03.208955|2017-02-18 17:12:03.208955
NCT00202384|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-07-26|||November 2004||2004-11-01|July 2010|2010-07-01||||||||Observational|||Gene Expression in MS Patients Before and During Treatment With Interferon-beta|Gene Expression in MS Patients Before and During Treatment With High-dose Interferon Beta: Prospective Study for the Identification of Predicting Factors of Therapeutic Response.|Completed||Phase 4|600|Actual|S. Andrea Hospital|||1||f||||t||||||||||2017-02-18 17:12:05.628785|2017-02-18 17:12:05.628785
NCT00202579|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-15|||September 2004||2004-09-01|June 2011|2011-06-01|February 2006|Actual|2006-02-01|||||Interventional|||Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure|Evaluation of the Effects on Peripheral and Central Haemodynamics Parameters, Safety, and Tolerance of Three-hour Intravenous Perfusion (0.1 mg/kg) of Ivabradine Given to Severe Congestive Heart Failure Patients|Completed||Phase 2|12|Anticipated|Servier|||||f||||||||||||||2017-02-18 17:12:03.310995|2017-02-18 17:12:03.310995
NCT00202566|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-15|||June 2005||2005-06-01|June 2011|2011-06-01|October 2007|Actual|2007-10-01|||||Interventional|ASSOCIATE||Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris|Evaluation of the Anti-anginal Efficacy and Safety of Oral Administration of Ivabradine Compared to Placebo on Top of Background Therapy With Atenolol in Patients With Stable Angina Pectoris. A Four-month Randomised Double-blind, Parallel Group International Multicentre Study.|Completed||Phase 3|750|Anticipated|Servier|||||f||||||||||||||2017-02-18 17:12:03.404332|2017-02-18 17:12:03.404332
NCT00202553|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-15|||July 2003||2003-07-01|June 2011|2011-06-01|December 2006|Actual|2006-12-01|||||Interventional|||S90652 in Paediatric Hypertension|Acceptability, Safety, Pharmacokinetics and Effects on Blood Pressure of a Daily Dose of 0.025 to 0.135 Milligram Per Kilogram of S90652, a Paediatric Formulation of Perindopril, in 2-16 Years Old Hypertensive Children - 3 Month Study|Completed||Phase 2|50|Anticipated|Servier|||||f||||||||||||||2017-02-18 17:12:03.492478|2017-02-18 17:12:03.492478
NCT00202540|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-11-15|||June 2005||2005-06-01|November 2010|2010-11-01|May 2006||2006-05-01|||||Interventional|||Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients|Efficacy of 15 mg and 50 mg of S18986 on Cognitive Symptoms in Mild Cognitive Impairment Patients Treated Over a 12-month Oral Administration Period|Suspended||Phase 2|450|Anticipated|Servier|||||f||||||||||||||2017-02-18 17:12:03.580257|2017-02-18 17:12:03.580257
NCT00202527|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-22|||January 2005||2005-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Spanish Cohort for the Study of the Effect of CPAP in Hypertension (CEPECTA)|Efficacy of the Treatment With Nasal Positive Continuous Airway Pressure to Reduce the Arterial Blood Pressure in Patients With Apneas-Hypopneas During the Sleep and Systemic Hypertension|Unknown status|Recruiting|N/A|340||Sociedad Española de Neumología y Cirugía Torácica|||||f||||||||||||||2017-02-18 17:12:03.666875|2017-02-18 17:12:03.666875
NCT00202514|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-10-07|||September 2004||2004-09-01|October 2009|2009-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms|Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms|Completed||Phase 2/Phase 3|40||Seattle Institute for Biomedical and Clinical Research|||||f||||t||||||||||2017-02-18 17:12:03.761356|2017-02-18 17:12:03.761356
NCT00202501|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-05-20|||September 2005||2005-09-01|May 2009|2009-05-01|March 2009|Actual|2009-03-01|December 2006|Actual|2006-12-01||Interventional|||Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome|Usefulness of Nasal CPAP Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome|Completed||N/A|80|Actual|Sociedad Española de Neumología y Cirugía Torácica||2|||f||||||||||||||2017-02-18 17:12:03.87378|2017-02-18 17:12:03.87378
NCT00202488|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-29|||November 2002||2002-11-01|July 2008|2008-07-01|September 2007||2007-09-01|||||Interventional|||The Effect of H. Pylori Infection on Iron Metabolism|The Effect of H. Pylori Infection on Iron Metabolism|Completed||Phase 2/Phase 3|39||Seattle Institute for Biomedical and Clinical Research|||||f||||||||||||||2017-02-18 17:12:03.961931|2017-02-18 17:12:03.961931
NCT00202475|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-10-19|||September 2003||2003-09-01|October 2009|2009-10-01|December 2007|Actual|2007-12-01|September 2006|Actual|2006-09-01||Interventional|||Collection of Autologous Blood Products by Double Erythrocytapheresis|Collection of Autologous Blood Products by Double Erythrocytapheresis - Cost Effectiveness Study|Completed||Phase 3|100|Actual|Sanquin Research & Blood Bank Divisions||2|||f||||f||||||||||2017-02-18 17:12:04.226214|2017-02-18 17:12:04.226214
NCT00202462|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-30|||November 2002||2002-11-01|September 2008|2008-09-01|November 2006|Actual|2006-11-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Testosterone on Mood and Quality of Life|The Effect of Testosterone Treatment on Depressive Symptoms and Quality of Life in Older Men With Age-Related Hypogonadism and Subsyndromal Depression.|Completed||N/A|33|Actual|Seattle Institute for Biomedical and Clinical Research||1|||f||||f||||||||||2017-02-18 17:12:04.344576|2017-02-18 17:12:04.344576
NCT00202449|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-06-11|2012-02-24||July 2004||2004-07-01|June 2012|2012-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance|A Placebo-Controlled Trial of Prazosin vs. Paroxetine in Combat Stress-Related PTSD Nightmares and Sleep Disturbance|Terminated||N/A|59|Actual|Seattle Institute for Biomedical and Clinical Research|High rate of early termination leading to small number of patients analyzed.|3||recruitment difficulties|f||||t||||||||||2017-02-18 17:12:04.450563|2017-02-18 17:12:04.450563
NCT00202436|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-10-19|||October 2004||2004-10-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|December 2008|Actual|2008-12-01||Interventional|||Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy|Therapeutic Erythrocytapheresis as Treatment for Hemochromatosis Patients.|Completed||Phase 3|40|Anticipated|Sanquin Research & Blood Bank Divisions||2|||f||||f||||||||||2017-02-18 17:12:05.011627|2017-02-18 17:12:05.011627
NCT00202423|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-28|||July 2005||2005-07-01|September 2005|2005-09-01||||||||Interventional|||Use of Cannabinoids in Patients With Multiple Sclerosis|fMRI and Neurophysiological Study Protocol on Cannabinoids in Multiple Sclerosis|Unknown status|Recruiting|Phase 2|20||S. Andrea Hospital|||||f||||||||||||||2017-02-18 17:12:05.11855|2017-02-18 17:12:05.11855
NCT00202410|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-18|||November 2001||2001-11-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|September 2007|Actual|2007-09-01||Interventional|||Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis|Phase 2-3 Use of Bacille Calmette-Guèrin (BCG) Vaccine in Patients With a First Clinical Demyelinating Episode: a Multicenter, Randomized, Single Blind Study.|Completed||Phase 2/Phase 3|80|Actual|S. Andrea Hospital||2|||f||||t||||||||||2017-02-18 17:12:05.21474|2017-02-18 17:12:05.21474
NCT00202397|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-02-10|||June 2005||2005-06-01|December 2013|2013-12-01|August 2008|Actual|2008-08-01|June 2008|Actual|2008-06-01||Interventional|||Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia|Phase 2 Study of Riluzole Effects on Patients With Chronic Cerebellar Ataxia|Completed||Phase 2|40|Actual|S. Andrea Hospital||2|||f||||t||||||||||2017-02-18 17:12:05.326539|2017-02-18 17:12:05.326539
NCT00005413|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1991||1991-09-01|March 2005|2005-03-01|September 1993|Actual|1993-09-01|||||Observational|||Stroke Risk in the NAS-NRC Twin Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.506822|2017-02-18 18:15:01.506822
NCT00202371|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-01|||July 2002||2002-07-01|June 2015|2015-06-01|July 2005|Anticipated|2005-07-01|||||Interventional|||Transfusion Effects in Myelodysplastic Patients: Limiting Exposure|Transfusion Effects in Myelodysplastic Patients: Limiting Exposure (Temple)|Withdrawn||Phase 4|0|Actual|Sanquin Research & Blood Bank Divisions||||Too few inclusions|f||||f||||||||||2017-02-18 17:12:05.718912|2017-02-18 17:12:05.718912
NCT00202358|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-13|||November 2002||2002-11-01|June 2008|2008-06-01|September 2008|Anticipated|2008-09-01|November 2007|Actual|2007-11-01||Interventional|||Perioperative Effect of Atenolol on Cytokine Profiles|The Effect of Perioperative Atenolol on Post-Operative Cytokines|Unknown status|Active, not recruiting|Phase 4|60|Anticipated|Saini Foundation||2|||f||||||||||||||2017-02-18 17:12:05.810475|2017-02-18 17:12:05.810475
NCT00202345|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-05-04|||August 2004||2004-08-01|May 2015|2015-05-01|February 2007|Actual|2007-02-01|||||Interventional|||Iron Sucrose in Stage 3/4 Kidney Disease|Assessment of the Use of Intravenous Iron Sucrose to Maintain Haemoglobin Levels and Delay the Onset of Use of Erythropoietic Agents and/or Dialysis in Stage 3/4 Chronic Kidney Disease|Completed||Phase 3|120||Melbourne Health|||||f||||||||||||||2017-02-18 17:12:05.921829|2017-02-18 17:12:05.921829
NCT00202332|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-07-15|||February 2001||2001-02-01|July 2015|2015-07-01|February 2004|Actual|2004-02-01|February 2003|Actual|2003-02-01||Interventional|||CABG Without the Use of CPB|A Prospective Randomised Study od Coronary Artery Bypass Surgery Without the Use of Cardiopulmonary Bypass|Completed||Phase 2|||Melbourne Health||2|||f||||||||||||||2017-02-18 17:12:06.030092|2017-02-18 17:12:06.030092
NCT00202319|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||November 2001||2001-11-01|September 2005|2005-09-01|September 2002||2002-09-01|||||Interventional|||Effectiveness of Sedation Management in an Australian Intensive Care Unit|Evaluating the Effectiveness of Protocol Directed Sedation Management With Non-Protocol Directed Sedation Management on Mechanically Ventilated Patients in an Australian Intensive Care Unit.|Completed||N/A|316||Melbourne Health|||||f||||||||||||||2017-02-18 17:12:06.11313|2017-02-18 17:12:06.11313
NCT00202306|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-05-28|||November 2001||2001-11-01|September 2005|2005-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Indicated Prevention of Psychotic Disorders With Low-dose Lithium|An Open-labeled, Parallel-group, Single-blinded (Rater) Pilot Study to Investigate the Neuroprotective Effects of of Low-dose Lithium in Young Subjects at Ultra High Risk (UHR) of Developing a First-episode Psychotic Disorder|Completed||Phase 4|30|Anticipated|Melbourne Health|||||f||||t||||||||||2017-02-18 17:12:06.212109|2017-02-18 17:12:06.212109
NCT00202293|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-11-18|||October 2001||2001-10-01|November 2015|2015-11-01||||||||Interventional|||Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features|Comparison of Combination Olanzapine and Lithium and Combination Chlorpromazine and Lithium in the Treatment of a First Manic Episode With Psychotic Features.|Recruiting||Phase 4|75|Anticipated|Melbourne Health|||||f||||||||||||||2017-02-18 17:12:06.323141|2017-02-18 17:12:06.323141
NCT00202280|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-11-18|||September 2004||2004-09-01|November 2015|2015-11-01|June 2009|Actual|2009-06-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication|VIP (Vitamins In Psychosis) Study. A Randomized Double Blind Placebo Controlled Trial of the Effects of Vitamin B12, B6 and Folic Acid Augmentation on Cognition and Symptoms in Early Psychosis.|Completed||Phase 2/Phase 3|120|Actual|Melbourne Health||2|||f||||t||||||||||2017-02-18 17:12:06.464192|2017-02-18 17:12:06.464192
NCT00202267|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-11-18|||January 2004||2004-01-01|November 2015|2015-11-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Community RCT of the Effectiveness of Two Compression Bandaging Technologies|Community Randomised Control Trial of the Effectiveness of Two Compression Bandaging Technologies|Completed||Phase 2|426|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 17:12:06.573838|2017-02-18 17:12:06.573838
NCT00202254|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-01|||December 2004||2004-12-01|June 2015|2015-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Multiple Sclerosis Rehabilitation Study|'Functioning and Disability' and 'Quality of Life' in an Australian Community Cohort With Multiple Sclerosis.|Completed||N/A|100||Melbourne Health|||||f||||||||||||||2017-02-18 17:12:06.704783|2017-02-18 17:12:06.704783
NCT00202241|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-12|||September 1999||1999-09-01|January 2016|2016-01-01|June 2001||2001-06-01|||||Interventional|||The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS|The Effects of Anabolic Steroids and Protease Inhibitors on Serum Blood Lipids,Muscle Mass, and Total Body Fat in People Living With HIV/AIDS|Completed||N/A|30||Queen's University|||||f||||||||||||||2017-02-18 17:12:06.787175|2017-02-18 17:12:06.787175
NCT00202228|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-12|||July 2002||2002-07-01|January 2016|2016-01-01|September 2011|Actual|2011-09-01|October 2008|Actual|2008-10-01||Interventional|||Lactate Metabolism Study in HIV Infected Persons|Lactic Acid Metabolism in HIV-Infected Persons. Predicting Abnormalities in Lactate Production and Clearance Related to Treatment and Liver Disease and Measuring the Impact of Vitamin Supplementation.|Completed||Phase 4|30|Actual|Queen's University||4|||f||||f||||||||||2017-02-18 17:12:06.897567|2017-02-18 17:12:06.897567
NCT00202215|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-10-15|||October 2001||2001-10-01|September 2005|2005-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Chrysalis Day Program Body Mass Index Study|A Study on the Effects of a Personality Disorder Day Hospital Program on Clients Body Mass Index|Completed||N/A|106|Actual|Queen's University||1|||f||||f||||||||||2017-02-18 17:12:07.019919|2017-02-18 17:12:07.019919
NCT00202202|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-03-10|||November 2002||2002-11-01|March 2015|2015-03-01|April 2004|Actual|2004-04-01|||||Interventional|||User Satisfaction Survey - Personality Disorder Service|Survey of the Consultation Service of the Providence Continuing Care Centre Personality Disorder Service Users Satisfaction With the Change in Service Delivery|Completed||N/A|100|Actual|Queen's University||1|||f||||f||||||||||2017-02-18 17:12:07.121135|2017-02-18 17:12:07.121135
NCT00202189|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-08-12|||September 2005||2005-09-01|August 2008|2008-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)|Acute Effects of Inhaled Corticosteroids on Dynamic Airway Function During Rest and Exercise in Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|4|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 17:12:07.235167|2017-02-18 17:12:07.235167
NCT00202176|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-18|||July 2005||2005-07-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)|The Effects of Bronchodilators on Exertional Dyspnea and Exercise Performance in Mild Chronic Obstructive Pulmonary Disease (COPD) Patients and Healthy Elderly Subjects.|Completed||Phase 4|32|Actual|Queen's University||2|||f||||t||||||||||2017-02-18 17:12:07.350879|2017-02-18 17:12:07.350879
NCT00202163|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-12|||December 2006||2006-12-01|January 2016|2016-01-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction|A Randomized Double-Blind Placebo-Controlled Study Comparing the Safety and Efficacy of Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction|Completed||Phase 2|120|Anticipated|Queen's University|||||f||||||||||||||2017-02-18 17:12:07.473074|2017-02-18 17:12:07.473074
NCT00202150|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-10|||September 2004||2004-09-01|March 2015|2015-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Primary Care Management/Action Plans for Advanced Chronic Diseases|Primary Care Management/Action Plans for Advanced Chronic Diseases (The RoadMAP Project)|Completed||Phase 2/Phase 3|139|Actual|Queen's University||1|||f||||||||||||||2017-02-18 17:12:07.570507|2017-02-18 17:12:07.570507
NCT00202137|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-13|||July 2002||2002-07-01|January 2016|2016-01-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Home Blood Pressure Monitoring and Blood Pressure Control|A Randomized Controlled Trial of the Effects of Home Blood Pressure Monitoring on Blood Pressure Control|Completed||N/A|597|Actual|Queen's University||2|||f||||f||||||||||2017-02-18 17:12:07.681271|2017-02-18 17:12:07.681271
NCT00202124|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||April 2001||2001-04-01|November 2002|2002-11-01|March 2002||2002-03-01|||||Interventional|||Double Blind Study of Trp01 in Patients With Alzheimer's Disease|Double Blind Medium Term Efficacy Study of Trp01 in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 4|12||Queen's University|||||f||||||||||||||2017-02-18 17:12:07.796044|2017-02-18 17:12:07.796044
NCT00202111|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-16|||January 1998||1998-01-01|February 2006|2006-02-01|March 2010||2010-03-01|||||Interventional|||Comparative Study of Laparoscopic Versus Open Operations for Colon Cancer|Australasian Multicentered Prospective Randomised Clinical Study Comparing Laparoscopic and Conventional Open Surgical Treatments of Colon Cancer in Adults|Unknown status|Active, not recruiting|N/A|600||The Queen Elizabeth Hospital|||||f||||||||||||||2017-02-18 17:12:07.907436|2017-02-18 17:12:07.907436
NCT00202098|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-18|||March 2005||2005-03-01|March 2015|2015-03-01|March 2015|Actual|2015-03-01|March 2013|Actual|2013-03-01||Interventional|||Effects of Variable Ventilation on Respiratory System of Acute Respiratory Distress Syndrome (ARDS) Patients|Effects of Variable Ventilation on Respiratory System of ARDS Patients|Completed||N/A|16|Anticipated|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 17:12:08.02549|2017-02-18 17:12:08.02549
NCT00202072|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2004||2004-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Mucin in Sputum of CF During Pulmonary Exacerbation||Unknown status|Recruiting|N/A|25||Philipps University Marburg Medical Center|||||f||||||||||||||2017-02-18 17:12:08.128275|2017-02-18 17:12:08.128275
NCT00202059|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-15|||June 2003||2003-06-01|April 2007|2007-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer|The Effects of Zoledronic Acid (Zometa) and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer|Completed||Phase 3|72||HealthPartners Institute|||||f||||||||||||||2017-02-18 17:12:08.210288|2017-02-18 17:12:08.210288
NCT00202046|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-02|||January 2003||2003-01-01|April 2007|2007-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Predictors of Lymphedema Following Breast Cancer Surgery|Predictors of Lymphedema Following Breast Cancer Surgery|Completed||N/A|188|Actual|HealthPartners Institute|||2||f||||t||||||||||2017-02-18 17:12:08.304043|2017-02-18 17:12:08.304043
NCT00202033|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-02|||September 2004||2004-09-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes|Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes|Completed||Phase 4|150|Actual|HealthPartners Institute||3|||f||||t||||||||||2017-02-18 17:12:08.39595|2017-02-18 17:12:08.39595
NCT00202020|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-15|||May 2004||2004-05-01|March 2006|2006-03-01|January 2006||2006-01-01|||||Interventional|||Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke|Cilostazol Stroke Prevention Study-a Randomized, Double Blind, Double Dummy, Parallel Comparative, Multicenter Clinical Trial|Completed||Phase 3|720||Otsuka Beijing Research Institute|||||f||||||||||||||2017-02-18 17:12:08.507539|2017-02-18 17:12:08.507539
NCT00202007|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||February 2005||2005-02-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia|A Multi-Center, Randomized, Double-Blind Study, Comparing With Risperidone, to Evaluate the Efficacy and Safety of Aripiprazole in the Treatment of Patients With Schizophrenia|Completed||Phase 2|240||Otsuka Beijing Research Institute|||||f||||||||||||||2017-02-18 17:12:08.604911|2017-02-18 17:12:08.604911
NCT00201994|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-02|||November 2003||2003-11-01|May 2012|2012-05-01|July 2005|Actual|2005-07-01|||||Interventional|||"SALT-2 Trial Study of Ascending Levels of Tolvaptan in Hyponatremia"|Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia, Study 2|Completed||Phase 3|243|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||f||||||||||2017-02-18 17:12:08.699943|2017-02-18 17:12:08.699943
NCT00201981|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-04|||May 2004||2004-05-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|||||Interventional|||Study of Rebamipide Eye Drops to Treat Dry Eye|Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, 52 Week Study|Completed||Phase 3|740|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||||||||||||2017-02-18 17:12:08.804622|2017-02-18 17:12:08.804622
NCT00201968|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-25|||April 2005||2005-04-01|February 2013|2013-02-01|April 2013|Anticipated|2013-04-01|April 2013|Anticipated|2013-04-01||Interventional|||Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury|Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury|Unknown status|Active, not recruiting|Phase 4|32|Anticipated|Ontario Neurotrauma Foundation||2|||f||||t||||||||||2017-02-18 17:12:09.085487|2017-02-18 17:12:09.085487
NCT00201955|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-31|||May 2004||2004-05-01|October 2006|2006-10-01|July 2006||2006-07-01|||||Interventional|||Study of Rebamipide Eye Drops to Treat Dry Eye|Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, 26 Week Study|Completed||Phase 3|740||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 17:12:09.194705|2017-02-18 17:12:09.194705
NCT00201942|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-17|||February 2005||2005-02-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)|A Prospective Study to Determine the Role of 2-[18F]Fluoro-2-Deoxy-D-Glucose (FDG)Positron Emission Tomography (PET)in the Assessment of Regional Nodal Spread of Disease in Breast Cancer Patients|Completed||Phase 3|336|Actual|Ontario Clinical Oncology Group (OCOG)|||||f||||t||||||||||2017-02-18 17:12:09.337534|2017-02-18 17:12:09.337534
NCT00201929|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-27|||April 2002||2002-04-01|June 2007|2007-06-01|November 2006|Actual|2006-11-01|||||Interventional|||A Decision Aid for Women With Early Stage Breast Cancer|Development and Evaluation of Different Versions of the Decision Board for Early Breast Cancer|Completed||Phase 3|300||Ontario Clinical Oncology Group (OCOG)|||||f||||||||||||||2017-02-18 17:12:09.624718|2017-02-18 17:12:09.624718
NCT00201916|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-16|||March 1995||1995-03-01|August 2010|2010-08-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Shorter Radiation Schedule for the Treatment of Prostate Cancer|A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer|Completed||Phase 3|936|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-02-18 17:12:09.737656|2017-02-18 17:12:09.737656
NCT00201903|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-18|||January 2004||2004-01-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Observational|||The Roles of Tissue Factor in Malignant Gliomas|The Roles of Tissue Factor in Malignant Gliomas|Completed||N/A|30|Actual|Ontario Clinical Oncology Group (OCOG)|||||f||||t||||||||||2017-02-18 17:12:09.882113|2017-02-18 17:12:09.882113
NCT00201890|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-09|||March 2003||2003-03-01|October 2012|2012-10-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|||"Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer DELTA STUDY"|DELTA - A Randomized Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer|Completed||Phase 3|103|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-02-18 17:12:09.981584|2017-02-18 17:12:09.981584
NCT00201877|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-15|2013-11-12||December 2004||2004-12-01|July 2016|2016-07-01|March 2012|Actual|2012-03-01|June 2009|Actual|2009-06-01||Interventional|||Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma|A Phase II Study of Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|25|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:10.11667|2017-02-18 17:12:10.11667
NCT00201864|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-14|2015-11-10||September 2005||2005-09-01|July 2016|2016-07-01|February 2014|Actual|2014-02-01|June 2012|Actual|2012-06-01||Interventional|||Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer|Phase II Trial of Exemestane (Aromasin) in Combination With Fulvestrant (Faslodex) in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer|Completed||Phase 2|40|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:10.487307|2017-02-18 17:12:10.487307
NCT00201851|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-13|2015-03-31||January 2004||2004-01-01|April 2015|2015-04-01|May 2013|Actual|2013-05-01|December 2011|Actual|2011-12-01||Interventional||Baseline measures were not available on all participants.|Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer|Phase III Randomized Study of Immediate Versus Luteal Phase Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-positive Breast Cancer|Completed||Phase 3|740|Actual|International Breast Cancer Research Foundation||3|||f||||t||||||||||2017-02-18 17:12:10.935135|2017-02-18 17:12:10.935135
NCT00201838|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-10-21|2014-11-04||July 2001||2001-07-01|October 2016|2016-10-01|May 2007|Actual|2007-05-01|October 2006|Actual|2006-10-01||Interventional|||Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma|A Phase I/II Study of Etanercept and Gemcitabine in Patients With Advanced Stage and Chemotherapy Naive Pancreatic Adenocarcinoma|Completed||Phase 1/Phase 2|38|Actual|Ohio State University Comprehensive Cancer Center|The interpretation of the results for this study is limited by the relatively small patient sample and correlative samples.|2|||f||||t||||||||||2017-02-18 17:12:11.630654|2017-02-18 17:12:11.630654
NCT00201825|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-10-01|2014-09-25||December 2004||2004-12-01|October 2014|2014-10-01|April 2013|Actual|2013-04-01|December 2012|Actual|2012-12-01||Interventional||Eligible patients had histologically confirmed advanced NSCLC and had not received prior chemotherapy.|A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients|A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients|Completed||Phase 2|29|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:12.149584|2017-02-18 17:12:12.149584
NCT00201812|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-18|||November 2000||2000-11-01|December 2012|2012-12-01|May 2005|Actual|2005-05-01|January 2004|Actual|2004-01-01||Interventional|||Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors|Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|27|Actual|Ohio State University Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 17:12:12.581363|2017-02-18 17:12:12.581363
NCT00201799|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-09|||February 2004||2004-02-01|June 2015|2015-06-01|March 2008|Actual|2008-03-01|August 2006|Actual|2006-08-01||Interventional|||Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation|Phase II Trial of Infliximab for the Prevention of Acute Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|19|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:12.684702|2017-02-18 17:12:12.684702
NCT00201786|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-04-25|||July 2003||2003-07-01|April 2016|2016-04-01|July 2013|Actual|2013-07-01|October 2007|Actual|2007-10-01||Interventional|||Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease|Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease|Completed||Phase 2|8|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:12.797441|2017-02-18 17:12:12.797441
NCT00201773|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-25|2015-02-17||July 2003||2003-07-01|June 2015|2015-06-01|June 2011|Actual|2011-06-01|November 2007|Actual|2007-11-01||Interventional|||Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer|A Phase II Trial of Exemestane (Aromasin) in Combination With Celecoxib (Celebrex) as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer|Completed||Phase 2|22|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:12.906795|2017-02-18 17:12:12.906795
NCT00201760|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-06|||February 2005||2005-02-01|November 2012|2012-11-01||||December 2012|Anticipated|2012-12-01||Interventional|||Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer|A Randomized Phase II Study of Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|13|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:12:13.308178|2017-02-18 17:12:13.308178
NCT00201747|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-18|||September 2001||2001-09-01|December 2012|2012-12-01|February 2010|Actual|2010-02-01|October 2006|Actual|2006-10-01||Interventional|||Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer|Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer|Completed||Phase 2|80|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:13.430828|2017-02-18 17:12:13.430828
NCT00201734|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-15|2016-04-25||June 2005||2005-06-01|August 2016|2016-08-01|June 2013|Actual|2013-06-01|November 2007|Actual|2007-11-01||Interventional|||Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary|A Phase I Dose Escalation Study of Capecitabine, Carboplatin and Weekly Paclitaxel and a Phase II Trial of the Same Combination in Patients With Adenocarcinoma of Unknown Primary|Terminated||Phase 1/Phase 2|57|Actual|Ohio State University Comprehensive Cancer Center||1||Due to lack of funding provided for Phase II portion of trial|f||||t||||||||||2017-02-18 17:12:13.540177|2017-02-18 17:12:13.540177
NCT00201721|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-02-06|||July 2002||2002-07-01|February 2017|2017-02-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia|Phase II Trial of Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|28|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:14.130359|2017-02-18 17:12:14.130359
NCT00201708|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-01|||October 2004||2004-10-01|September 2016|2016-09-01|February 2014|Actual|2014-02-01|December 2006|Actual|2006-12-01||Interventional|||Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer|Phase II Randomized Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide (AC) in Axillary Node-Positive Breast Cancer|Completed||Phase 2|56|Actual|Ohio State University Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:12:14.238591|2017-02-18 17:12:14.238591
NCT00201695|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-09|||July 2004||2004-07-01|June 2015|2015-06-01|August 2008|Actual|2008-08-01|September 2006|Actual|2006-09-01||Interventional|||Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma|Phase II Trial of Pegylated Liposomal Doxorubicin (Doxil), Vincristine, and Dexamethasone (DVd) in Combination With Arsenic Trioxide (Trisenox) in Untreated Patients With Symptomatic Multiple Myeloma|Completed||Phase 2|12|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:14.358443|2017-02-18 17:12:14.358443
NCT00201682|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-02-06|||October 2002||2002-10-01|February 2017|2017-02-01|August 2009|Actual|2009-08-01|August 2006|Actual|2006-08-01||Interventional|||Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Phase I/II Study of Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma|Completed||Phase 1/Phase 2|36|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:14.469132|2017-02-18 17:12:14.469132
NCT00201669|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-22|||October 2004||2004-10-01|April 2015|2015-04-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma|A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|6|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:12:14.584739|2017-02-18 17:12:14.584739
NCT00201656|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-17|||November 2004||2004-11-01|December 2014|2014-12-01|April 2014|Actual|2014-04-01|November 2013|Actual|2013-11-01||Interventional|PROMCerclage||Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)|Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial|Terminated||Phase 4|58|Actual|Mednax Center for Research, Education and Quality||2||"This trial was terminated following a futility analysis confirming futility of continuing the~   study"|f||||t||||||||||2017-02-18 17:12:14.698597|2017-02-18 17:12:14.698597
NCT00201643|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-12-17|2010-09-07||November 2003||2003-11-01|December 2014|2014-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|ACS||A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome|A Randomized Double-Blinded Study Comparing the Impact of One Versus Two Courses of Antenatal Steroids on Neonatal Outcome|Completed||Phase 4|437|Actual|Mednax Center for Research, Education and Quality||2|||f||||t||||||||||2017-02-18 17:12:17.680276|2017-02-18 17:12:17.680276
NCT00201630|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2005||2005-09-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Interventional|||Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy|Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy|Unknown status|Not yet recruiting|Phase 3|150||New York Prostate Institute|||||f||||||||||||||2017-02-18 17:12:18.283607|2017-02-18 17:12:18.283607
NCT00201617|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-13|||July 2004||2004-07-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|||||Observational|||Efficacy of the Bone-anchored Hearing Aid for Unilateral Deafness|Short-term and Long-term Efficacy of the BAHA for Single Sided Deafness|Completed||N/A|28|Actual|The New York Eye & Ear Infirmary|||2||f||||||||||||||2017-02-18 17:12:18.374382|2017-02-18 17:12:18.374382
NCT00201591|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-08-25|||August 2002||2002-08-01|August 2011|2011-08-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Training at Different Intensities in Coronary Artery Disease -Effects on Myocardial Function|Which Training Intensity is Most Effective in Improving Myocardial Function in Patients With Coronary Artery Disease?|Completed||N/A|17|Actual|Norwegian University of Science and Technology|||||f||||f||||||||||2017-02-18 17:12:18.471397|2017-02-18 17:12:18.471397
NCT00201578|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-04-27||||||January 2005|2005-01-01||||||||Observational|||Case Control Study of Non Viral Hepatitis Relating to Herbal Drug Use in the Emergency Department||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:12:18.633147|2017-02-18 17:12:18.633147
NCT00201565|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-19|||May 2005||2005-05-01|March 2005|2005-03-01||||||||Observational|||Association Between Peripheral Artery Stiffness and Cardiovascular Disease||Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:12:18.892097|2017-02-18 17:12:18.892097
NCT00201539|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-04-07|||April 2002||2002-04-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|November 2006|Actual|2006-11-01||Interventional|||Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients|Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients: A Randomized, Double-blind Cross-over Comparison of a Double Bedtime Dose Ver-sus Two Standard Doses at Bedtime and at Night|Completed||Phase 3|19|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:12:19.055654|2017-02-18 17:12:19.055654
NCT00201526|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-12-01|||January 2003||2003-01-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2019|Anticipated|2019-01-01||Observational|||Bipolar Research And Innovation Network - BRAIN|Bipolar Research And Innovation Network - BRAIN|Recruiting||N/A|3000|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 17:12:19.169933|2017-02-18 17:12:19.169933
NCT00201513|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-10-08|||January 2006||2006-01-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||Anticipatory Muscle Control and Effect of Stabilizing Exercises in Patients With Subacute and Chronic Low Back Pain|Randomized Controlled Trial of Stabilizing Exercises and Effect on Anticipatory Muscle Control in Patients With Subacute and Chronic Low Back Pain|Completed||N/A|99|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-02-18 17:12:19.277717|2017-02-18 17:12:19.277717
NCT00201500|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-08-03|||October 2004||2004-10-01|August 2016|2016-08-01|March 2006|Actual|2006-03-01|December 2005|Actual|2005-12-01||Observational|||Left Ventricular and Endothelial Function in Preeclampsia|Left Ventricular and Endothelial Function in Preeclampsia, a Case Control Study|Completed||Phase 1/Phase 2|39|Actual|Norwegian University of Science and Technology|||2||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 17:12:19.391853|2017-02-18 17:12:19.391853
NCT00201487|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-10-30|||November 2007||2007-11-01|October 2013|2013-10-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Choline Quantification in Breast Cancer by MRS|Choline Quantification in Breast Cancer by MRS|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology|||1|"We chose to use an exsisting NMR pulse sequence already established and available at the~   hospital."|f||||f||||||||||2017-02-18 17:12:19.484917|2017-02-18 17:12:19.484917
NCT00201474|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-08-03|||October 1998||1998-10-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|October 2004|Actual|2004-10-01||Observational|||Acute, Affective, Organic Disorders.|Signs of Organic Brain Dysfunction in Psychiatric Patients With Fluctuating Psychiatric Symptoms Including Brief Depressions Compared to Patients With a Major Depressive Episode.|Completed||N/A|32|Actual|Norwegian University of Science and Technology|||2||f||||f||||||Samples Without DNA|"~     Ordinary laboratory tests, medication, substances.~   "|||2017-02-18 17:12:19.562166|2017-02-18 17:12:19.562166
NCT00201461|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-12-29|||June 2003||2003-06-01|November 2008|2008-11-01|April 2010|Anticipated|2010-04-01|||||Interventional|||Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)|A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale|Unknown status|Active, not recruiting|Phase 2/Phase 3|900|Anticipated|NMT Medical||2|||f||||t||||||||||2017-02-18 17:12:19.656046|2017-02-18 17:12:19.656046
NCT00201448|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-27|2012-04-03||June 2007||2007-06-01|May 2016|2016-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women|Epidemiology of Cytomegalovirus -- Evaluation of the Immunogenicity and Efficacy of the Towne Strain of CMV in Seronegative Women: A Phase II-III Study|Terminated||Phase 2/Phase 3|82|Actual|Virginia Commonwealth University||2||Suspended due to lack of funding|f||||t||||||||||2017-02-18 17:12:19.75688|2017-02-18 17:12:19.75688
NCT00201435|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-19|||March 2005||2005-03-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|||Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC|Weekly Taxol® Plus Xeloda® Versus Taxotere® Every Three Weeks Plus Xeloda® in the Treatment of Metastatic Breast Cancer A Phase II/III Study|Completed||Phase 2/Phase 3|224|Anticipated|Norwegian Breast Cancer Group|||||f||||f||||||||||2017-02-18 17:12:20.193957|2017-02-18 17:12:20.193957
NCT00201422|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-25|||June 1996||1996-06-01|March 2016|2016-03-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma|Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type of The Stomach|Completed||N/A|70|Actual|National Health Research Institutes, Taiwan||1|||f||||t||||||||No||2017-02-18 17:12:20.28435|2017-02-18 17:12:20.28435
NCT00201409|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-30|2012-06-25||July 2004||2004-07-01|November 2015|2015-11-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||A Randomized Trial of GM-CSF in Patients With ALI/ARDS|A Randomized Trial of GM-CSF in Patients With ALI/ARDS|Completed||Phase 2|132|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 17:12:20.393078|2017-02-18 17:12:20.393078
NCT00201396|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-02-23|||August 2003||2003-08-01|May 2006|2006-05-01|December 2011|Actual|2011-12-01|August 2009|Actual|2009-08-01||Interventional|||A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma|A Multicenter Phase III Trial Comparing Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Stage IV Nasopharyngeal Carcinoma (NPC)|Completed||Phase 3|480|Actual|National Health Research Institutes, Taiwan||2|||f||||||||||||||2017-02-18 17:12:20.733334|2017-02-18 17:12:20.733334
NCT00201383|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 1999||1999-10-01|January 2005|2005-01-01|August 2009||2009-08-01|||||Interventional|||Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients|Phase III Study Of Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients|Completed||Phase 3|161||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 17:12:20.847019|2017-02-18 17:12:20.847019
NCT00201370|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-03-23|||August 1999||1999-08-01|September 2005|2005-09-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Observational|||A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL Cases|A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL Cases|Completed||N/A|1000|Actual|National Health Research Institutes, Taiwan|||1||f||||t||||||||No||2017-02-18 17:12:20.937651|2017-02-18 17:12:20.937651
NCT00201357|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-23|||October 2002||2002-10-01|March 2016|2016-03-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer|An Open, Non-Comparative Trial to Assess the Efficacy and Safety of Oral Thalidomide (THADO) in Patientswith Hormone-Refractory Prostate Cancer-A PHASE II CLINICAL TRIAL|Completed||Phase 2|30|Actual|National Health Research Institutes, Taiwan||1|||f||||t||||||||No||2017-02-18 17:12:21.099082|2017-02-18 17:12:21.099082
NCT00201344|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-25|||November 1994||1994-11-01|June 2009|2009-06-01|January 2000||2000-01-01|||||Interventional|||A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients|A Phase III Study of Radiotherapy With or Without Adjuvant Chemotherapy in Advanced Stage Nasopharyngeal Carcinoma Patients|Terminated||Phase 3|320||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 17:12:21.384262|2017-02-18 17:12:21.384262
NCT00201331|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-15|||April 2002||2002-04-01|December 2005|2005-12-01|October 2012||2012-10-01|||||Interventional|||Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer|Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer|Unknown status|Recruiting|Phase 2|162||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 17:12:21.493691|2017-02-18 17:12:21.493691
NCT00201318|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-13|||September 2001||2001-09-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen|A Randomized Study of Lamivudine Prophylaxis or Treatment Against Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen|Completed||Phase 2|50||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 17:12:21.591738|2017-02-18 17:12:21.591738
NCT00201305|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-30|||July 2002||2002-07-01|September 2005|2005-09-01|August 2012||2012-08-01|||||Interventional|||Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract|Prospective Phase II Randomized Trial-Weekly Gemcitabine Plus High-Dose 5-Fluorouracil/ Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract|Completed||Phase 2|50||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 17:12:21.688627|2017-02-18 17:12:21.688627
NCT00201292|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-14|||March 2005||2005-03-01|May 2007|2007-05-01|October 2008|Anticipated|2008-10-01|||||Observational|||Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)|Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)|Unknown status|Recruiting|N/A|1350|Anticipated|National Health Research Institutes, Taiwan|||||f||||t||||||||||2017-02-18 17:12:21.777153|2017-02-18 17:12:21.777153
NCT00201279|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||April 1999||1999-04-01|January 2005|2005-01-01|September 2012||2012-09-01|||||Interventional|||Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma|Phase III Placebo-Controlled Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma Patients|Completed||Phase 3|342||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 17:12:21.864743|2017-02-18 17:12:21.864743
NCT00201266|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-03-11|||July 2005||2005-07-01|March 2013|2013-03-01||||August 2011|Actual|2011-08-01||Observational|||Histoblood Group Antigens as a Risk Factor of Asthma|Histoblood Group Antigens, Viruses and Asthma|Completed||N/A|126|Actual|University of California, San Francisco|||2||f||||f||||||Samples With DNA|"~     DNA, plasma, saliva, induced sputum.~   "|||2017-02-18 17:12:21.964713|2017-02-18 17:12:21.964713
NCT00201253|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-01-22|||September 2000||2000-09-01|January 2015|2015-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Expression of Tuberculosis in the Lung|Expression of Tuberculosis in the Lung|Completed||N/A|40|Actual|Rutgers, The State University of New Jersey|||1||f||||||||||Samples With DNA|"~     Cell culture supernatants and cell lysates from bronchoalveolar cells, as well as peripheral~     blood mononuclear cells.~      Bronchoalveolar lavage fluid~   "|||2017-02-18 17:12:22.067027|2017-02-18 17:12:22.067027
NCT00201240|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-06-29|2012-05-14||June 2005||2005-06-01|April 2016|2016-04-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)|A Single Arm, Multicenter Phase II Trial of Transplants of HLA-Matched, CD34+ Enriched, T Cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With AML in First or Second Morphologic Complete Remission (BMT CTN #0303)|Completed||Phase 2|47|Actual|National Heart, Lung, and Blood Institute (NHLBI)||1|||f||||t||||||||Yes|Findings will be published in a manuscript|2017-02-18 17:12:22.17958|2017-02-18 17:12:22.17958
NCT00201227|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2015-10-27|||September 2002||2002-09-01|October 2015|2015-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|ULTRA||Trial to Enhance Adherence to Multiple Guidelines|Using Learning Teams for Reflective Adaptation|Completed||N/A|60|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-02-18 17:12:22.699864|2017-02-18 17:12:22.699864
NCT00201214|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-09-10|||December 2003||2003-12-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|January 2006|Actual|2006-01-01||Interventional|||Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery|Phase I/II Clinical Trial to Determine the Pharmacokinetics and Safety Profile of Citrulline in Children Undergoing Cardiopulmonary Bypass|Completed||Phase 1/Phase 2|26|Actual|Vanderbilt University||1|||f||||t||||||||||2017-02-18 17:12:22.809118|2017-02-18 17:12:22.809118
NCT00201201|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-12-17|2013-08-13||September 2007||2007-09-01|December 2013|2013-12-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|||Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension|Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension|Completed||N/A|160|Actual|University of Connecticut||2|||f||||t||||||||||2017-02-18 17:12:22.925938|2017-02-18 17:12:22.925938
NCT00201188|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-03-07|||December 2003||2003-12-01|March 2013|2013-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Enhancing Collaboration Between Doctors and Patients to Improve Asthma|Cueing Patient-Clinician Collaboration to Improve Asthma|Completed||N/A|139|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 17:12:23.480931|2017-02-18 17:12:23.480931
NCT00201162|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2014-03-19|||September 2001||2001-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Soy and Lipoproteins in Postmenopausal Women||Completed||N/A|||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:12:23.592612|2017-02-18 17:12:23.592612
NCT00201149|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-04-06|||February 2004||2004-02-01|April 2016|2016-04-01|December 2015|Actual|2015-12-01|April 2008|Actual|2008-04-01||Interventional|HCTA||Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence|Hypertension Control and Therapy Adherence|Completed||N/A|870|Actual|Boston Medical Center||3|||f||||t||||||||No||2017-02-18 17:12:23.666364|2017-02-18 17:12:23.666364
NCT00201136|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-11|||February 2004||2004-02-01|February 2012|2012-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|HIP||Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk|Hypertension Improvement Project (HIP)|Completed||Phase 2|574|Actual|Duke University||4|||f||||t||||||||||2017-02-18 17:12:23.77494|2017-02-18 17:12:23.77494
NCT00201123|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2016-12-14|2014-01-22||April 2005||2005-04-01|December 2016|2016-12-01|August 2007|Actual|2007-08-01|January 2007|Actual|2007-01-01||Interventional||"Demographic information provided for all subjects who were eligible for the study after all screening procedures were performed. 7 subjects who were found to be ineligible after randomization but prior to administration of treatment (listed as did not meet continuation criteria in participant flow section) are not included in baseline analysis."|Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs|Host Response to Tuberculosis and Acquired Immune Deficiency Syndrome|Completed||Phase 2|89|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-02-18 17:12:23.881941|2017-02-18 17:12:23.881941
NCT00201110|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-03-19|||July 2004||2004-07-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Problem Solving and Cardiovascular Disease Risk Management in Diabetic Blacks|Problem Solving & CVD Risk Management in Diabetic Blacks|Completed||N/A|139|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 17:12:24.399887|2017-02-18 17:12:24.399887
NCT00201084|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2014-07-17|||September 2004||2004-09-01|July 2014|2014-07-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Physician Uncertainty Reduction for Hypertension|Physician Uncertainty Reduction for Hypertension|Completed||N/A|670|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 17:12:24.518338|2017-02-18 17:12:24.518338
NCT00201071|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-27|||September 2004||2004-09-01|April 2007|2007-04-01|January 2011|Actual|2011-01-01|February 2010|Actual|2010-02-01||Observational|||Asthma Surveillance and Education in Preschool Settings|Asthma Surveillance and Education in Preschool Settings|Completed||N/A|208|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||||||2017-02-18 17:12:24.885543|2017-02-18 17:12:24.885543
NCT00201058|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2012-12-18|||July 2006||2006-07-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|Puff City||Tailored Asthma Management for Urban Teens|Tailored Asthma Management for Urban Teens|Completed||N/A|450|Actual|Henry Ford Health System||2|||f||||t||||||||||2017-02-18 17:12:24.99247|2017-02-18 17:12:24.99247
NCT00201045|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-03-26|||July 2003||2003-07-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Team Management of High Blood Pressure|Collaborative Management of Hypertension|Completed||N/A|179|Actual|University of Iowa||2|||f||||t||||||||||2017-02-18 17:12:25.122559|2017-02-18 17:12:25.122559
NCT00201019|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-30|||August 2003||2003-08-01|November 2015|2015-11-01|July 2009|Actual|2009-07-01|April 2008|Actual|2008-04-01||Interventional|||Improving Adherence to Blood Pressure Guidelines|Improving Adherence to Blood Pressure Guidelines|Completed||N/A|623|Actual|University of Iowa||3|||f||||t||||||||||2017-02-18 17:12:25.250506|2017-02-18 17:12:25.250506
NCT00201006|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-01-21|2013-11-02||June 2003||2003-06-01|January 2014|2014-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|TOURS||Treatment of Obesity in Underserved Rural Settings (TOURS)|Treatment of Obesity in Underserved Rural Settings (TOURS)|Completed||N/A|234|Actual|University of Florida||3|||f||||t||||||||||2017-02-18 17:12:25.370952|2017-02-18 17:12:25.370952
NCT00200993|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-04-13|||September 1998||1998-09-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:12:25.847049|2017-02-18 17:12:25.847049
NCT00200980|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-03-06|||August 2005||2005-08-01|March 2009|2009-03-01||||||||Observational|||Importance of Non-Acid Reflux in Asthma in Children|Importance of Non-Acid Reflux in Moderate and Severe Asthma|Completed||N/A|120|Anticipated|Nemours Children's Clinic|||||f||||||||||||||2017-02-18 17:12:25.947675|2017-02-18 17:12:25.947675
NCT00200967|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-24|2009-03-05||December 2004||2004-12-01|February 2013|2013-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)|Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)|Completed||Phase 3|87|Actual|Milton S. Hershey Medical Center|The study used a moderately high dose of ICS. Genotype-specific effects may be evident at lower doses of ICS often used in combination therapy. Also, short-acting β2-agonists have been shown to have genotype-specific effects on asthma outcomes.|2|||f||||t||||||||||2017-02-18 17:12:26.23641|2017-02-18 17:12:26.23641
NCT00200954|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-08-13|||January 2004||2004-01-01|May 2007|2007-05-01|August 2008|Actual|2008-08-01|December 2007|Actual|2007-12-01||Interventional|||Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics|Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics.|Completed||N/A|157|Actual|The Netherlands Asthma Foundation||2|||f||||||||||||||2017-02-18 17:12:26.92001|2017-02-18 17:12:26.92001
NCT00200941|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-15|||August 2001||2001-08-01|September 2005|2005-09-01|April 2005||2005-04-01|||||Interventional|||Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS)|Completed||Phase 4|44||Neurocare|||||f||||||||||||||2017-02-18 17:12:27.035536|2017-02-18 17:12:27.035536
NCT00200928|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-04-03|||January 1999||1999-01-01|April 2006|2006-04-01|July 2005||2005-07-01|||||Interventional|||Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.|Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood.|Completed||N/A|120||The Netherlands Asthma Foundation|||||f||||||||||||||2017-02-18 17:12:27.129043|2017-02-18 17:12:27.129043
NCT00200902|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-11-19|||August 2005||2005-08-01|November 2009|2009-11-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression|Factors of Treatment Response in Major Depressive Disorder|Suspended||Phase 4|140|Anticipated|University of California, Los Angeles||5|||f||||t||||||||||2017-02-18 17:12:27.226681|2017-02-18 17:12:27.226681
NCT00200889|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-09|||May 2005||2005-05-01|December 2013|2013-12-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Effect of Acupuncture on Human Brain Activity|Exploring Neurocircuitry of Acupuncture Action With fMRI|Completed||Early Phase 1|60|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 17:12:27.34421|2017-02-18 17:12:27.34421
NCT00005412|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1992||1992-07-01|June 2000|2000-06-01|June 1995|Actual|1995-06-01|||||Observational|||Dietary Antioxidants and Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.587822|2017-02-18 18:15:01.587822
NCT00200876|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-12|||September 2003||2003-09-01|June 2014|2014-06-01|June 2008|Actual|2008-06-01|February 2008|Actual|2008-02-01||Interventional|||Effects of Anticipation of Pain Relief on Brain Mechanisms|Neurochemical Mediation of Placebo Responses in Humans|Completed||N/A|60|Actual|University of Michigan|||||f||||t||||||||||2017-02-18 17:12:27.453587|2017-02-18 17:12:27.453587
NCT00200863|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-08-08|||April 2005||2005-04-01|August 2014|2014-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effects of Different Colors of Light on Human Physiology|Mechanism Underlying the Effects of Blue Light in Humans|Completed||N/A|47|Actual|Brigham and Women's Hospital||6|||f||||f||||||||||2017-02-18 17:12:27.546014|2017-02-18 17:12:27.546014
NCT00200850|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-12|||January 2006||2006-01-01|May 2016|2016-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy|Sublingual Immunotherapy in Dust Mite Allergy|Completed||N/A|31|Actual|University of Wisconsin, Madison||3|||f||||t||||||||||2017-02-18 17:12:27.653813|2017-02-18 17:12:27.653813
NCT00200837|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-03-27|||March 2002||2002-03-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Observational|||Ethnopharmacological Studies in Oral Medicine|Ethnopharmacological Studies in Oral Medicine|Completed||N/A|1000||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:12:27.762862|2017-02-18 17:12:27.762862
NCT00200824|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-10|||May 2000||2000-05-01|August 2006|2006-08-01|January 2005||2005-01-01|||||Interventional|||Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health|Effects of Soy Isoflavones on the Prostate, Breast and Bone|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:12:27.855041|2017-02-18 17:12:27.855041
NCT00200798|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-12-09|||May 2006||2006-05-01|December 2009|2009-12-01|August 2007||2007-08-01|||||Observational|||An Assessment of Milk Thistle Pharmacokinetics and Drug Interactions|Pharmacokinetics and Drug Interactions With Milk Thistle|Unknown status|Recruiting|Phase 2|32|Anticipated|Medical University of South Carolina|||1||f||||t||||||Samples Without DNA|"~     plasma & urine~   "|||2017-02-18 17:12:27.946727|2017-02-18 17:12:27.946727
NCT00200785|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-04|2009-04-23||March 2006||2006-03-01|December 2009|2009-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Identifying the Anti-Blood-Clotting Compounds in Garlic|Identification of the Antiplatelet Compounds of Garlic Ex Vivo|Completed||N/A|9|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 17:12:28.03555|2017-02-18 17:12:28.03555
NCT00200759|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-17|||October 2004||2004-10-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Drug Interactions and Bioavailability of Cranberry|Drug Interactions and Bioavailability of Cranberry|Completed||Phase 1|16|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-02-18 17:12:28.461858|2017-02-18 17:12:28.461858
NCT00200746|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-03-11|||April 2006||2006-04-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Treatment of Alcohol-Related Hepatitis With Arginine|Arginine Treatment for Alcoholic Hepatitis|Withdrawn||Phase 2|0|Actual|National Center for Complementary and Integrative Health (NCCIH)||3||lack of enrollment|f||||t||||||||||2017-02-18 17:12:28.544694|2017-02-18 17:12:28.544694
NCT00200733|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-08-17|||June 2003||2003-06-01|December 2005|2005-12-01|March 2004||2004-03-01|||||Observational|||The Use of Narrative in Public Health Research and Practice: Patient Experience of Wellness Acupuncture|The Use of Narrative in Public Health Research and Practice: Patient Experience of Wellness Acupuncture|Terminated||N/A|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:12:28.657501|2017-02-18 17:12:28.657501
NCT00200720|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-04|||April 2005||2005-04-01|February 2008|2008-02-01|June 2010|Actual|2010-06-01|March 2009|Actual|2009-03-01||Interventional|||Effectiveness of a Low Carbohydrate Diet Versus a High Carbohydrate Diet in Promoting Weight Loss and Improved Health|Metabolic Consequences of High and Low Carbohydrate Diets|Completed||Phase 2|260|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 17:12:28.726369|2017-02-18 17:12:28.726369
NCT00200707|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-29|||December 2004||2004-12-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||BONAMI (BOne Marrow in Acute Myocardial Infarction)|Intracoronary Injection of Autologous Bone Marrow Mononuclear Cells for Severe Myocardial Infarction|Completed||Phase 2|101|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-02-18 17:12:28.825491|2017-02-18 17:12:28.825491
NCT00200694|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-03|||March 2005||2005-03-01|February 2009|2009-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.||Terminated||Phase 4|18||Nantes University Hospital||||difficulty in patients's inclusion|f||||||||||||||2017-02-18 17:12:28.923461|2017-02-18 17:12:28.923461
NCT00200681|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-02-04|||June 2005||2005-06-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma|Etude Multicentrique Ouverte Randomisée de Phase III Comparant l'Association de VELCADE®-Dexaméthasone à la Chimiothérapie de Type VAD Pour le Traitement Des Patients Porteurs de Myélome Multiple de Novo Jusqu'à l'âge de 65 Ans|Completed||Phase 3|493|Actual|Nantes University Hospital|||||f||||t||||||||||2017-02-18 17:12:29.005159|2017-02-18 17:12:29.005159
NCT00200668|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-05|||March 2005||2005-03-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.||Terminated||N/A|0|Actual|Nantes University Hospital|||||f||||||||||||||2017-02-18 17:12:29.095921|2017-02-18 17:12:29.095921
NCT00200655|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-04-27|||December 2004||2004-12-01|June 2008|2008-06-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis|Safety and Efficacy of Pravastatin in Relapsing-remitting MS: a Double Blind Placebo Controlled Study|Completed||Phase 3|40|Actual|Nantes University Hospital|||||f||||f||||||||||2017-02-18 17:12:29.17586|2017-02-18 17:12:29.17586
NCT00200642|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-20|||December 2003||2003-12-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease|Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease|Completed||N/A|54|Actual|Nantes University Hospital|||||f||||||||||||||2017-02-18 17:12:29.254812|2017-02-18 17:12:29.254812
NCT00200005|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-01-09|||November 1998||1998-11-01|January 2014|2014-01-01|September 2012|Actual|2012-09-01|December 2006|Actual|2006-12-01||Interventional|MDT-301||Sacral Nerve Stimulation for Anal Incontinence and Bowel Control|Sacral Nerve Stimulation for Anal Incontinence and Bowel Control|Completed||Phase 4|140|Anticipated|MedtronicNeuro||1|||f||||f||||||||||2017-02-18 17:12:36.085566|2017-02-18 17:12:36.085566
NCT00200629|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-08-08|||June 2005||2005-06-01|August 2011|2011-08-01||||||||Interventional|||Both Exercise and Adenosine Stress Testing|A Pilot Study Examining the Value of Combined Exercise and Adenosine Stress Myocardial Perfusion Imaging as Compared With Adenosine Testing Alone for the Evaluation of Women at Intermediate or High Likelihood for Coronary Artery Disease|Terminated||Phase 4|200|Anticipated|Midwest Heart Foundation||||Poor enrollment|f||||||||||||||2017-02-18 17:12:29.575986|2017-02-18 17:12:29.575986
NCT00200616|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-30|||April 2001||2001-04-01|June 2008|2008-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Usefulness of Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux.|Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux. A Randomised Prospective Study of Continuous Low Dose of Trimethoprim-Sulfamethoxazole Versus Surveillance.|Completed||N/A|232||Nantes University Hospital|||||f||||f||||||||||2017-02-18 17:12:29.713254|2017-02-18 17:12:29.713254
NCT00200603|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-15|||May 1999||1999-05-01|May 2004|2004-05-01||||||||Interventional|||Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy|Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy|Unknown status|Active, not recruiting|N/A|50||Nantes University Hospital|||||f||||||||||||||2017-02-18 17:12:29.823684|2017-02-18 17:12:29.823684
NCT00200590|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-18|||December 2003||2003-12-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Analgesic Strategies in Newborns Receiving Prostaglandin Therapy|Analgesic Strategies in Newborns Receiving Prostaglandin Therapy|Terminated||N/A|30|Anticipated|Nantes University Hospital||||More important number of SAE in one arms|f||||||||||||||2017-02-18 17:12:29.915165|2017-02-18 17:12:29.915165
NCT00200577|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-10-03|||May 2005||2005-05-01|October 2016|2016-10-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|TIL||Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma|TIL (Tumor Infiltrating Lymphocytes) and IL2 (Interleukin 2) Versus Abstention as Adjuvant Treatment in Melanoma With Only One Invaded Lymphnode After Lymphnodes Excision|Completed||Phase 3|70|Actual|Nantes University Hospital||2|||f||||f||||||||||2017-02-18 17:12:30.005402|2017-02-18 17:12:30.005402
NCT00200564|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-22|||February 2004||2004-02-01|July 2005|2005-07-01||||||||Interventional|||Ketamine and Postoperative Analgesia in Children|Ketamine and Postoperative Analgesia in Children|Unknown status|Recruiting|Phase 4|74|Anticipated|Nantes University Hospital|||||f||||||||||||||2017-02-18 17:12:30.114757|2017-02-18 17:12:30.114757
NCT00200551|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-04|||January 2001||2001-01-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant|A Prospective, Randomized, Open, Multicentric Study Intended to Evaluate the Efficacy and Tolerability of Sequential Treatment Based on Rabbit Anti-T-lymphocyte Serum, of Mycophenolate Mofetil and of Cyclosporin, Without Concomitant Corticosteroids, After a First Cadaveric Renal Transplant|Completed||Phase 4|200||Nantes University Hospital|||||f||||||||||||||2017-02-18 17:12:30.210234|2017-02-18 17:12:30.210234
NCT00200538|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-02|||September 2005||2005-09-01|January 2005|2005-01-01||||||||Interventional|||Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients|Double-blind, Parallel Group, Placebo-controlled Trial of the Efficacy and Tolerability of Memantine (20 mg) in Frontotemporal Dementia (FTD) Patients|Completed||Phase 2|52|Actual|Nantes University Hospital|||||f||||||||||||||2017-02-18 17:12:30.299489|2017-02-18 17:12:30.299489
NCT00200525|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-15|||July 2001||2001-07-01|September 2005|2005-09-01|June 2002||2002-06-01|||||Interventional|||Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease|"A Randomized, Placebo-Controlled Study of the Continued Efficacy and Safety of SC Apomorphine in the Treatment of Off Episodes in Patients With On/Off or Wearing-Off Effects Associated With Late-Stage PD After Apomorphine Use"|Completed||Phase 3|60||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:12:30.392942|2017-02-18 17:12:30.392942
NCT00200512|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-15|||September 1999||1999-09-01|March 2000|2000-03-01|November 1999||1999-11-01|||||Interventional|||Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months|"A Prospective, Randomized, Placebo-Controlled, Crossover Study of the Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of Off Episodes in Patients With On/Off or Wearing Off Effects Associated With Late Stage Parkinson's Disease"|Completed||Phase 2/Phase 3|16||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:12:30.475238|2017-02-18 17:12:30.475238
NCT00200499|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-15|||March 2002||2002-03-01|September 2005|2005-09-01|September 2003||2003-09-01|||||Interventional|||A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients|A Multi-Center, Parallel Group Extension Study to Determine the Safety and Efficacy of Long-Term Nebivolol Exposure in Patients With Mild to Moderate Hypertension|Completed||Phase 3|845||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:12:30.565831|2017-02-18 17:12:30.565831
NCT00200486|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-15|||May 2002||2002-05-01|March 2016|2016-03-01||||May 2016|Anticipated|2016-05-01||Observational|||Molecular and Genomic Profiling of Head and Neck Tumors|Molecular and Genomic Profiling of Head and Neck Tumors to Explore Biomarkers Associated With Prognosis and Response to Therapy|Recruiting||N/A|400|Anticipated|Montefiore Medical Center|||1||f||||t||||||Samples With DNA|"~     1. Tumor specimens along with normal mucosa obtained at the time of surgery for biopsy or~          resection of primary or recurrent tumors of the head and neck~        2. blood, urine and sputum from patients participating in the tumor collection described~          above~   "|||2017-02-18 17:12:30.666244|2017-02-18 17:12:30.666244
NCT00200473|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2001||2001-09-01|September 2005|2005-09-01|March 2003||2003-03-01|||||Interventional|||A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients|A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Study of the Effects of Nebivolol on Safety and Efficacy in Patients With Mild to Moderate Hypertension|Completed||Phase 3|800||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:12:30.782205|2017-02-18 17:12:30.782205
NCT00200460|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2001||2001-09-01|September 2005|2005-09-01|March 2003||2003-03-01|||||Interventional|||A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients|A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Dosing Study Evaluating the Effects of Nebivolol on Blood Pressure in Patients With Mild to Moderate Hypertension|Completed||Phase 3|825||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:12:30.881789|2017-02-18 17:12:30.881789
NCT00199992|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Platelets in Acute Wounds: A Pilot Study (PAWS)|Platelets in Acute Wounds: A Pilot Study (PAWS)|Completed||N/A|8||Medtronic|||||f||||||||||||||2017-02-18 17:12:36.206915|2017-02-18 17:12:36.206915
NCT00200447|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-17|||March 2004||2004-03-01|January 2008|2008-01-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)|Assessment of Carbidopa/l-Dopa and Carbidopa/l Dopa/Entacapone on Synaptic Dopamine in Parkinson's Patients: An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)|Completed||Phase 2|3|Actual|Molecular NeuroImaging||1|||f||||||||||||||2017-02-18 17:12:30.97609|2017-02-18 17:12:30.97609
NCT00200434|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2002||2002-10-01|September 2005|2005-09-01|October 2003||2003-10-01|||||Interventional|||A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension|A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Mild to Moderate Hypertension|Completed||Phase 3|600||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:12:31.082137|2017-02-18 17:12:31.082137
NCT00200421|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-15|||May 2002||2002-05-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension|A Double-Blind, Randomized, Multi-Center, Active Comparator, Five Treatment Study of the Effects of Nebivolol Compared to Atenolol on Cardiovascular Hemodynamics and Exercise Capacity in Patients With Mild to Moderate Hypertension|Completed||Phase 2|110||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:12:31.183111|2017-02-18 17:12:31.183111
NCT00200408|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-07|||March 2004||2004-03-01|April 2015|2015-04-01||||January 2005|Actual|2005-01-01||Observational|||Assessment of Early Genetic Changes in Smokers|Assessment of Early Genetic Changes in Smokers|Terminated||N/A|10|Actual|Montefiore Medical Center|||2|unable to obtain funding|f||||||||||||||2017-02-18 17:12:31.276088|2017-02-18 17:12:31.276088
NCT00200395|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2003||2003-06-01|September 2005|2005-09-01||||||||Interventional|||Phs. II Study of OSI-774 (Erlotinib, Tarceva) in Elderly Patients W/Advanced Stage or Inoperable Non-Small Cell Lung Cancer (NSCLC)|Phase II Study of OSI-774 (Erlotinib, Tarceva) in Elderly Patients With Advanced Stage or Inoperable Non Small Cell Lung Cancer (NSCLC)|Suspended||Phase 2|27||Montefiore Medical Center|||||||||||||||||||2017-02-18 17:12:31.375289|2017-02-18 17:12:31.375289
NCT00200382|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-07|||May 2004||2004-05-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer|Phase II Study to Evaluate the Efficacy and Safety of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer|Terminated||Phase 2|27|Anticipated|Montefiore Medical Center||||The study did not achieve the statistical success to continue.|||||||||||||||2017-02-18 17:12:31.487144|2017-02-18 17:12:31.487144
NCT00200369|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-04|||May 2004||2004-05-01|November 2009|2009-11-01|March 2006|Actual|2006-03-01|||||Observational|||Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen|Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen|Completed||Phase 4|90|Anticipated|Montefiore Medical Center|||1||f||||||||||||||2017-02-18 17:12:31.582616|2017-02-18 17:12:31.582616
NCT00200356|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-09|2012-09-13||August 2004||2004-08-01|December 2012|2012-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke|Edaravone-Sodium Ozagrel (Thromboxane A2 Synthase Inhibitor) Comparative Post-Marketing Study on Acute Ischemic Stroke|Completed||Phase 4|401|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 17:12:31.674072|2017-02-18 17:12:31.674072
NCT00200343|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-07|2011-08-17||July 2002||2002-07-01|March 2012|2012-03-01|December 2004||2004-12-01|||||Interventional|||Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C|A 24-week Multicenter Double-blind Control Trial With Ursodeoxycholic Acid in Patients With Chronic Hepatitis C|Completed||Phase 3|596|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||||||||||||2017-02-18 17:12:32.308831|2017-02-18 17:12:32.308831
NCT00200330|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-17|||November 2004||2004-11-01|September 2005|2005-09-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Modifying Obesogenic Homes: Impact on Weight Maintenance||Unknown status|Active, not recruiting|N/A|400||The Miriam Hospital|||||f||||||||||||||2017-02-18 17:12:32.903799|2017-02-18 17:12:32.903799
NCT00200317|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-27|||February 2003||2003-02-01|September 2005|2005-09-01|May 2006|Actual|2006-05-01|||||Interventional|||Interactive Technologies to Increase Exercise Behavior|Interactive Technologies to Increase Exercise Behavior|Completed||Phase 1/Phase 2|240|Actual|The Miriam Hospital|||||f||||||||||||||2017-02-18 17:12:32.996775|2017-02-18 17:12:32.996775
NCT00200304|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-04-23|||January 2001||2001-01-01|September 2005|2005-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Evaluation of a SlimFast Internet Behavioral Weight Loss Program|Development and Evaluation of a SlimFast Internet Behavioral Weight Loss Program|Completed||N/A|225||The Miriam Hospital|||||f||||||||||||||2017-02-18 17:12:33.090466|2017-02-18 17:12:33.090466
NCT00200291|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-04-19|||July 2004||2004-07-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Changes in Food Reinforcement During Obesity Treatment|Changes in Food Reinforcement During Obesity Treatment|Completed||N/A|147|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-02-18 17:12:33.178706|2017-02-18 17:12:33.178706
NCT00200278|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2000||2000-08-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Exercise Instruction Via Phone or Print|Exercise Instruction Via Phone or Print|Completed||Phase 2|228||The Miriam Hospital|||||f||||||||||||||2017-02-18 17:12:33.26582|2017-02-18 17:12:33.26582
NCT00200265|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-04-19|||July 2005||2005-07-01|December 2007|2007-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Changing Eating Behaviors in Young Children: Should Healthy Foods be Increased or Unhealthy Foods Decreased?|Changing Eating Behaviors in Young Children: Should Healthy Foods be Increased or Unhealthy Foods Decreased?|Completed||N/A|101|Actual|The Miriam Hospital||3|||f||||||||||||||2017-02-18 17:12:33.370102|2017-02-18 17:12:33.370102
NCT00200252|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-08|||September 2005||2005-09-01|November 2012|2012-11-01|July 2007|Actual|2007-07-01|||||Interventional|||Oxytocin Administration in the Third Stage of Labour - A Study of Appropriate Route and Dose|Intramuscular Versus Intravascular Oxytocin for the Third Stage of Labour|Completed||Phase 4|300|Actual|Memorial University of Newfoundland||3|||f||||||||||||||2017-02-18 17:12:33.464815|2017-02-18 17:12:33.464815
NCT00200239|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-04-19|||September 2005||2005-09-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Provision of Breakfast Food in Behavioral Weight Loss|Provision of Breakfast Food in Behavioral Weight Loss|Completed||N/A|25|Anticipated|The Miriam Hospital||2|||f||||||||||||||2017-02-18 17:12:33.575465|2017-02-18 17:12:33.575465
NCT00200200|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-02-13|||November 19, 2004||2004-11-19|November 2016|2016-11-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer|Randomized Ph II Study of Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With IV Systemic Chemo With/Without Bevacizumab (mAB to Vascular Endothelial Growth Factor-A) in Patients With Resected Hepatic Metastases From Colorectal Cancer|Active, not recruiting||Phase 2|73|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:12:33.84114|2017-02-18 17:12:33.84114
NCT00200187|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-25|||February 2005||2005-02-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery|A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Radical Retropubic Prostatectomy|Completed||Phase 2|246||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:12:33.955469|2017-02-18 17:12:33.955469
NCT00200174|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-12-21|||July 1999||1999-07-01|December 2015|2015-12-01|August 2008|Actual|2008-08-01|July 2003|Actual|2003-07-01||Interventional|||Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease|Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease: A Pilot Chemoprevention Trial|Completed||N/A|11|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:12:34.058008|2017-02-18 17:12:34.058008
NCT00200161|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-26|||August 2005||2005-08-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma|A Randomized Phase II Trial of Concurrent Temozolomide and Radiotherapy Followed by Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid for Patients With Newly Diagnosed Glioblastoma and Other Malignant Gliomas|Active, not recruiting||Phase 2|140|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:12:34.415816|2017-02-18 17:12:34.415816
NCT00200148|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-04|||March 2004||2004-03-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy|A Prospective Randomized Trial of Acute Normovolemic Hemodilution Compared to Standard Intraoperative Management in Patients Undergoing Major Hepatic Resection and Pancreaticoduodenectomy|Completed||Phase 3|372|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:12:34.533746|2017-02-18 17:12:34.533746
NCT00200135|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-02|||June 2005||2005-06-01|July 2013|2013-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Financial and Clinical Impact of Repeal of the Pennsylvania Motorcycle Helmet Law|Financial and Clinical Impact of Repeal of the Pennsylvania Helmet Law: A Multi-Center Prospective Study Comparing Helmeted and Non-Helmeted Motorcycle Accident Victims|Completed||N/A|480|Anticipated|Memorial Medical Center|||4||f||||f||||||||||2017-02-18 17:12:34.643916|2017-02-18 17:12:34.643916
NCT00200122|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-01-20|||January 2005||2005-01-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Restore Claims Characterization Study|Restore Claims Characterization Study|Completed||Phase 4|100||MedtronicNeuro|||||||||||||||||||2017-02-18 17:12:34.739358|2017-02-18 17:12:34.739358
NCT00200109|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-10-07|||May 2004||2004-05-01|October 2011|2011-10-01|May 2011|Actual|2011-05-01|June 2008|Actual|2008-06-01||Interventional|ONSTIM||Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.|ONSTIM: Occipital Nerve Stimulation for the Treatment of Intractable Migraine.|Completed||Phase 1|110|Actual|MedtronicNeuro||4|||f||||f||||||||||2017-02-18 17:12:34.834943|2017-02-18 17:12:34.834943
NCT00200096|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-02-11|||July 2004||2004-07-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial|Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial|Completed||Phase 3|101|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:12:34.956095|2017-02-18 17:12:34.956095
NCT00200083|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-26|||May 2004||2004-05-01|March 2015|2015-03-01|January 2008|Actual|2008-01-01|September 2005|Actual|2005-09-01||Interventional|SHAPE||Study of Weight Loss Using Gastric Stimulation in Obese Patients|SHAPE: Screened Health Assessment & Pacer Evaluation|Completed||N/A|190|Actual|MedtronicNeuro||2|||f||||t||||||||||2017-02-18 17:12:35.066336|2017-02-18 17:12:35.066336
NCT00200070|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-26|||December 2002||2002-12-01|August 2010|2010-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|STARTSTIM||Neurostimulation to Treat Refractory Angina Pectoris Pain|STARTSTIM - Stimulation Therapy for Angina Refractory To Standard Treatments, Interventions and Medications|Terminated||Phase 3|228||MedtronicNeuro|||||f||||||||||||||2017-02-18 17:12:35.179682|2017-02-18 17:12:35.179682
NCT00200057|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-01-17|2011-04-13||January 2002||2002-01-01|January 2013|2013-01-01|September 2011|Actual|2011-09-01|August 2007|Actual|2007-08-01||Interventional|||Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence|Medtronic InterStim® Sacral Nerve Stimulation Therapy for Bowel Control: Fecal Incontinence Study|Completed||N/A|285|Actual|MedtronicNeuro||1|||f||||f||||||||||2017-02-18 17:12:35.295113|2017-02-18 17:12:35.295113
NCT00200044|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-07-10|||December 2002||2002-12-01|July 2009|2009-07-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|||An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD)|Gatekeeper® System Sham-Controlled Study for the Treatment of GERD|Terminated||N/A|143|Actual|MedtronicNeuro||2||Lack of efficacy|f||||t||||||||||2017-02-18 17:12:35.783368|2017-02-18 17:12:35.783368
NCT00200031|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-07-24|||July 2005||2005-07-01|July 2008|2008-07-01|April 2006|Actual|2006-04-01|||||Observational|||A Cost Analysis of Interstim Therapy|Interstim Therapy Retrospective Cost Analysis and Quality of Life|Completed||N/A|150||MedtronicNeuro|||||f||||||||||||||2017-02-18 17:12:35.906519|2017-02-18 17:12:35.906519
NCT00200018|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-02-03|||June 2005||2005-06-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|February 2007|Actual|2007-02-01||Interventional|ASSIST||Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes|ASSIST: Appetite Suppression Induced by Stimulation Trial|Completed||N/A|46|Actual|MedtronicNeuro||1|||f||||t||||||||||2017-02-18 17:12:35.992242|2017-02-18 17:12:35.992242
NCT00199979|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-15|||April 2005||2005-04-01|September 2005|2005-09-01|June 2008||2008-06-01|||||Interventional|||Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients|Multicenter, Randomized, Open-Label Trial, Assessing the Efficacy of Zidovudine, Lamivudine and Nevirapine Combination Administered Twice Daily, Versus the Association of Tenofovir, Lamivudine and Nevirapine, Once Daily, in Antiretroviral Naive HIV-1 Infected Patients|Unknown status|Recruiting|Phase 3|250||MEDEX|||||f||||||||||||||2017-02-18 17:12:36.294948|2017-02-18 17:12:36.294948
NCT00199966|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-03-06|||December 2003||2003-12-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|||||Interventional|||Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder|A Pilot Study Of Safety And Effectiveness For Depakote ER In Pediatric Bipolar Disorder|Completed||Phase 4|30||Medical College of Wisconsin|||||f||||f||||||||||2017-02-18 17:12:36.395493|2017-02-18 17:12:36.395493
NCT00199953|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-27|||June 2002||2002-06-01|November 2013|2013-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Post-nasal Drainage as an Extraesophageal Manifestation of Reflux|Post-nasal Drainage as an Extraesophageal Manifestation of Reflux|Completed||Phase 2|50||Medical College of Wisconsin|||||||||||||||||||2017-02-18 17:12:36.500297|2017-02-18 17:12:36.500297
NCT00199940|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-03-06|||December 2003||2003-12-01|March 2008|2008-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness|A Pilot Open Trial Of Ziprasidone, Early In The Course Of Pediatric Psychotic Illness|Completed||Phase 4|20||Medical College of Wisconsin|||||f||||f||||||||||2017-02-18 17:12:36.613934|2017-02-18 17:12:36.613934
NCT00199927|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-04-27|||March 2003||2003-03-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|ESPLANADE||Statins in Proteinuric Nephropathies|A Prospective, Randomized, Multicenter Trial Testing the Antiproteinuric Effect of Statins Added to Combined ACE-inhibitor and Angiotensin Receptor Antagonist Therapy in Proteinuric, Chronic Nephropathies|Completed||Phase 3|217|Actual|Mario Negri Institute for Pharmacological Research||2|||f||||f||||||||||2017-02-18 17:12:36.806707|2017-02-18 17:12:36.806707
NCT00199914|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-06|2013-05-19||January 2004||2004-01-01|September 2013|2013-09-01|June 2004|Actual|2004-06-01|May 2004|Actual|2004-05-01||Interventional|||Efficacy Study of Shortwave Diathermy for the Treatment of Patients With Knee Osteoarthritis|The Effectiveness of Shortwave Diathermy in Knee Osteoarthritis: A Randomized Controlled Trial|Completed||Phase 3|113|Actual|Mahidol University||2|||f||||f||||||||||2017-02-18 17:12:36.919703|2017-02-18 17:12:36.919703
NCT00199901|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2013-02-27|||September 2005||2005-09-01|February 2013|2013-02-01|December 2011|Actual|2011-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma|Randomized, Double-blind Phase II Trial of NY-ESO-1 ISCOMATRIX® Vaccine and ISCOMATRIX® Adjuvant Alone in Patients With Resected Stage IIc, III or IV Malignant Melanoma|Completed||Phase 2|111|Actual|Ludwig Institute for Cancer Research||2|||f||||||||||||||2017-02-18 17:12:37.237646|2017-02-18 17:12:37.237646
NCT00199888|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-08-29|||February 2005||2005-02-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Interventional|||Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.|Pilot Study of Iodine-124 Labeled Chimeric G250 (124 I-cG250) in Presurgical Patients With Renal Masses|Completed||Phase 1|54||Ludwig Institute for Cancer Research|||||||||||||||||||2017-02-18 17:12:37.36004|2017-02-18 17:12:37.36004
NCT00199875|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-09|||July 2005||2005-07-01|May 2011|2011-05-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250|Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (90Y-DOTA-cG250) in Patients With Advanced Renal Cancer|Unknown status|Recruiting|Phase 1|24|Anticipated|Ludwig Institute for Cancer Research|||||f||||||||||||||2017-02-18 17:12:37.459016|2017-02-18 17:12:37.459016
NCT00199862|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-04-28|||February 2004||2004-02-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer|A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer|Active, not recruiting||N/A|30|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:12:37.715956|2017-02-18 17:12:37.715956
NCT00199849|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-21|||May 2004||2004-05-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine|Safety and Immunological Evaluation of NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine Given by Particle-Mediated Epidermal Delivery (PMED) in Patients With Tumor Type Known to Express NY-ESO-1 or LAGE-1 Antigen.|Completed||Phase 1|15||Ludwig Institute for Cancer Research|||||||||||||||||||2017-02-18 17:12:37.843196|2017-02-18 17:12:37.843196
NCT00199836|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-08-21|||September 2003||2003-09-01|August 2006|2006-08-01|December 2005||2005-12-01|||||Interventional|||A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide ISA-51 in Patients With Cancer.|A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide ISA-51 in Patients With Cancer Expressing NY-ESO-1 or LAGE-1.|Completed||Phase 1|9||Ludwig Institute for Cancer Research|||||||||||||||||||2017-02-18 17:12:37.940773|2017-02-18 17:12:37.940773
NCT00199823|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-03|||September 2003||2003-09-01|September 2010|2010-09-01|May 2006||2006-05-01|||||Interventional|||Autologous Stem Cell Transplantation in Acute Myocardial Infarction|Autologous Stem Cell Transplantation in Acute Myocardial Infarction|Completed||Phase 2|100||Oslo University Hospital|||||f||||||||||||||2017-02-18 17:12:38.045611|2017-02-18 17:12:38.045611
NCT00199810|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-10-14|||July 2005||2005-07-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Hemodynamic Measurements in Women With Serious Preeclampsia|Hemodynamic Measurements in Women With Serious Preeclampsia|Completed||Phase 4|68|Actual|Oslo University Hospital|||1||f||||f||||||||||2017-02-18 17:12:38.135537|2017-02-18 17:12:38.135537
NCT00199797|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-03-02|||October 2004||2004-10-01|March 2009|2009-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer|Phase I Trial of huA33 Plus 5-Fluorouracil (5FU), Leucovorin and Oxaliplatin in Patients With Metastatic Colorectal Cancer|Completed||Phase 1|20|Actual|Ludwig Institute for Cancer Research||1|||f||||f||||||||||2017-02-18 17:12:38.217846|2017-02-18 17:12:38.217846
NCT00199784|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-03|||June 2005||2005-06-01|February 2009|2009-02-01|April 2007||2007-04-01|||||Interventional|||Hemodynamic Measurements During Cesarean Section With Spinal Anesthesia|Hemodynamic Measurements During Cesarean Section With Spinal Anesthesia|Completed||Phase 4|80|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-02-18 17:12:38.316294|2017-02-18 17:12:38.316294
NCT00199771|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-30|||June 2003||2003-06-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||Hypertonic Saline Dextran in Pediatric Cardiac Surgery|The Use of Hypertonic Saline Dextran in Cardiac Surgery Utilizing Cardio Pulmonary Bypass in Children Less Than 17 Weeks Old.|Completed||Phase 2|14||Oslo University Hospital|||||f||||||||||||||2017-02-18 17:12:38.414953|2017-02-18 17:12:38.414953
NCT00199758|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-11-09|||September 2003||2003-09-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer|A Randomized Phase II Trial of Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer.|Completed||Phase 2|227||University Hospital, Limoges|||||f||||||||||||||2017-02-18 17:12:38.518453|2017-02-18 17:12:38.518453
NCT00199745|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-05-09|||October 2005||2005-10-01|May 2012|2012-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity|Investigations on Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity|Completed||Phase 4|53|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-02-18 17:12:38.630145|2017-02-18 17:12:38.630145
NCT00199732|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-04-16|||December 2004||2004-12-01|September 2005|2005-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|DNA-EVAL||Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a|Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a|Completed||N/A|19|Actual|University Hospital, Limoges|||1||f||||f||||||||||2017-02-18 17:12:41.553655|2017-02-18 17:12:41.553655
NCT00199719|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-10-30|||June 2003||2003-06-01|June 2007|2007-06-01|September 2006|Actual|2006-09-01|||||Interventional|CINAM||Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM|Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C Non 2 -3 Genotype naïve Patients Treated With a 12 Weeks Bitherapy of Peginterferon Alpha 2a-Ribavirin, and Followed by a Tritherapy of Peginterferon Alpha 2a-Ribavirin-Amantadine for 36 Weeks|Completed||Phase 2|30|Actual|University Hospital, Limoges||1|||f||||||||||||||2017-02-18 17:12:41.650141|2017-02-18 17:12:41.650141
NCT00199706|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-30|||April 2002||2002-04-01|November 2005|2005-11-01|October 2004||2004-10-01|||||Interventional|||HyperHAES Versus Placebo - Effect on Intracranial Pressure in SAH Patients|7.2% NaCl in 6% Hydroxyethyl Starch Versus Placebo - Effect on Intracranial Pressure and Haemodynamics in Subarachnoidal Haemorrhage (SAH) Patients.|Completed||Phase 2|20||Oslo University Hospital|||||f||||||||||||||2017-02-18 17:12:41.741432|2017-02-18 17:12:41.741432
NCT00199693|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-03|||April 2007||2007-04-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Hemodynamic and Respiratory Function in Healthy Pregnant Women|Hemodynamic and Respiratory Function in Healthy Pregnant Women - A Longitudinal Study|Completed||Phase 4|100|Anticipated|Oslo University Hospital|||1||f||||||||||||||2017-02-18 17:12:41.823252|2017-02-18 17:12:41.823252
NCT00199680|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-01-31|||October 2003||2003-10-01|September 2005|2005-09-01||||||||Interventional|||Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer|Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer|Unknown status|Recruiting|Phase 2|42||University Hospital, Limoges|||||f||||||||||||||2017-02-18 17:12:41.902037|2017-02-18 17:12:41.902037
NCT00199667|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-12-14|||October 2002||2002-10-01|December 2008|2008-12-01||||||||Interventional|||Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients|APOMYGRE : Multicenter, Randomized, Open-Label Study of MMF Therapeutic Follow-up's Interest in the the 12 First Months in Kidney Transplantation|Unknown status|Active, not recruiting|Phase 4|137||University Hospital, Limoges|||||f||||||||||||||2017-02-18 17:12:42.002046|2017-02-18 17:12:42.002046
NCT00199654|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-04-08|||February 2004||2004-02-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|November 2012|Actual|2012-11-01||Interventional|||Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III|PET Interest in the Follow Up of Colorectal Cancer Stage II and III: Phase III Randomised Study|Completed||Phase 3|376|Actual|University Hospital, Limoges|||||f||||||||||||||2017-02-18 17:12:42.113853|2017-02-18 17:12:42.113853
NCT00199641|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-12-02|||July 2002||2002-07-01|December 2008|2008-12-01||||||||Interventional|||Evaluation of Two Enteral Nutrition Strategies in Mechanically Ventilated Patients|Evaluation of Two Enteral Nutrition Strategies in Mechanically Ventilated Patients|Completed||N/A|100|Actual|University Hospital, Limoges||2|||f||||||||||||||2017-02-18 17:12:42.208565|2017-02-18 17:12:42.208565
NCT00199628|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-03-10|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Observational|||Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization|Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization|Unknown status|Recruiting|N/A|100||University Hospital, Limoges|||||f||||||||||||||2017-02-18 17:12:42.285912|2017-02-18 17:12:42.285912
NCT00199615|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-10-30|||April 2001||2001-04-01|September 2005|2005-09-01|December 2006|Actual|2006-12-01|||||Interventional|||Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC|Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC : CT Scanning Versus 18 FDG Imaging.|Completed||N/A|73|Actual|University Hospital, Limoges||1|||f||||f||||||||||2017-02-18 17:12:42.357796|2017-02-18 17:12:42.357796
NCT00199602|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-12-30|||August 1999||1999-08-01|December 2008|2008-12-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients|Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients : Phase III Randomised Study|Unknown status|Recruiting|Phase 3|420|Anticipated|University Hospital, Limoges|||||f||||f||||||||||2017-02-18 17:12:42.686416|2017-02-18 17:12:42.686416
NCT00199589|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-12-29|||October 2002||2002-10-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Treatment of Spastic Equinovarus Foot After Stroke|Treatment of Spastic Equinovarus Foot After Stroke. Efficacy: Association Between Ankle Foot Orthosis and Botulinum Toxin A (BTA) Injection|Completed||N/A|46|Anticipated|University Hospital, Limoges||1|||f||||f||||||||||2017-02-18 17:12:42.773303|2017-02-18 17:12:42.773303
NCT00199576|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||December 2000||2000-12-01|September 2005|2005-09-01|January 2002||2002-01-01|||||Interventional|||Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids|Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids: a Prospective, Double-Blind, Placebo-Controlled Trial.|Completed||Phase 3|670||University Hospital, Limoges|||||f||||||||||||||2017-02-18 17:12:42.868427|2017-02-18 17:12:42.868427
NCT00199563|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-24|||August 2004||2004-08-01|September 2005|2005-09-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels|The Use and Efficacy of Sildenafil in Diabetic Men With Erectile Dysfunction: the Impact on Endothelial Function, a Pilot Feasibility Study|Completed||Phase 4|24|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 17:12:42.985888|2017-02-18 17:12:42.985888
NCT00199550|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-25|||May 2004||2004-05-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)|A Prospective Randomized Clinical Trial of Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)|Completed||Phase 4|43|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 17:12:43.107437|2017-02-18 17:12:43.107437
NCT00199537|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-25|||February 2005||2005-02-01|July 2008|2008-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer|Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer|Completed||N/A|25|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-02-18 17:12:43.23046|2017-02-18 17:12:43.23046
NCT00199524|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-10-13|||May 2005||2005-05-01|October 2009|2009-10-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free Rate|A Prospective Randomized Controlled Clinical Trial of the Use of a Ureteral Access Sheath During Ureteroscopy and Its Effect on Stone Free Rate|Terminated||Phase 4|44|Actual|Lawson Health Research Institute||2||Enrollment was slower than anticipated.|f||||f||||||||||2017-02-18 17:12:43.309757|2017-02-18 17:12:43.309757
NCT00199511|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-21|||January 2005||2005-01-01|June 2007|2007-06-01|April 2007|Actual|2007-04-01|||||Interventional|||Hypertonic Saline 75% vs Mannitol 20%|Comparison of Equiosmolar Doses of Mannitol 20% Versus Hypertonic Saline 7.5% Infusion in the Reduction of Brain Bulk During Elective Craniotomies for Supratentorial Brain Tumor Resection|Completed||N/A|162||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 17:12:43.417169|2017-02-18 17:12:43.417169
NCT00199498|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-04-11|||April 2005||2005-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|RASP||Right Apical Versus Septal Pacing Trial|Right Apical Versus Septal Pacing Trial|Active, not recruiting||N/A|160|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 17:12:43.510757|2017-02-18 17:12:43.510757
NCT00199485|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-25|||October 2002||2002-10-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer|Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer|Completed||Phase 4|44|Anticipated|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 17:12:43.612477|2017-02-18 17:12:43.612477
NCT00199472|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-06-19|||April 2001||2001-04-01|June 2006|2006-06-01||||||||Observational|||Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJO|Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of Ureteropelvic Junction Obstruction|Terminated||N/A|10||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 17:12:43.714678|2017-02-18 17:12:43.714678
NCT00199459|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-09-02|||January 2005||2005-01-01|September 2009|2009-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Proteomic Study of Urinary Stone Disease|Urinary Proteomic Profiling Using ProteinChip SELDI-TOF-MS: A Potential Means of Identifying Protein Biomarkers of Urinary Stone Formers|Completed||N/A|20|Actual|Lawson Health Research Institute|||1||f||||f||||||||||2017-02-18 17:12:43.800186|2017-02-18 17:12:43.800186
NCT00199446|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-07-12|||July 2005||2005-07-01|July 2016|2016-07-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome|A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) in Subjects With Restless Legs Syndrome|Completed||Phase 2|160||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-02-18 17:12:43.897614|2017-02-18 17:12:43.897614
NCT00199433|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|||May 2005||2005-05-01|July 2016|2016-07-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients|A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) as Monotherapy in Subjects With Parkinson's Disease|Completed||Phase 2|160||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-02-18 17:12:43.991225|2017-02-18 17:12:43.991225
NCT00199420|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|||July 2004||2004-07-01|July 2016|2016-07-01|December 2005|Actual|2005-12-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa|A 12-week, Double Blind, Placebo-controlled, Randomized, Parallel Group, Multicenter, Fixed Dose Study to Evaluate the Efficacy and Safety of 10, 20 and 40 mg/d Oral Dose of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy.|Completed||Phase 3|580||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-02-18 17:12:44.08851|2017-02-18 17:12:44.08851
NCT00199407|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|||June 2004||2004-06-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa|A 12-week, Double Blind, Placebo-controlled, Randomized, Parallel Group, Multicenter, Fixed Dose Study to Evaluate the Efficacy and Safety of a 20 mg/d Oral Dose of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy.|Completed||Phase 3|230||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-02-18 17:12:44.187569|2017-02-18 17:12:44.187569
NCT00199394|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|||November 2004||2004-11-01|July 2016|2016-07-01|November 2005|Actual|2005-11-01|October 2005|Actual|2005-10-01||Interventional|||A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease|A 16-week, Double-Blind, Placebo-Controlled, Randomised, Parallel-Group, Multicentre, International Study to Evaluate the Efficacy and Safety of 40 mg/Day KW-6002 (Istradefylline) and That of Entacapone Versus Placebo as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa Therapy.|Completed||Phase 3|405||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-02-18 17:12:44.283396|2017-02-18 17:12:44.283396
NCT00199381|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-29|2013-04-04||October 2005||2005-10-01|October 2013|2013-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional||503 subjects took at least 1 dose of study drug|An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001|An Open-Label Multicenter Study of the Continued Safety of Istradefylline (KW-6002) In Subjects With Parkinson's Disease Who Have Recently Completed One Year of Treatment With Istradefylline.|Terminated||Phase 3|504|Actual|Kyowa Kirin Pharmaceutical Development, Inc.|The Sponsor decided to terminate the study early (not for safety reasons); as a result 323 subjects discontinued early. Mean duration of therapy was 18.7 months (0.4 to 31.4 months); median duration was 21.0 months. Total exposure 767 subject years.|1||Additional long-term safety data no longer needed|f||||f||||||||||2017-02-18 17:12:44.374937|2017-02-18 17:12:44.374937
NCT00199368|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|||October 2004||2004-10-01|July 2016|2016-07-01|May 2007|Actual|2007-05-01|March 2007|Actual|2007-03-01||Interventional|||An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018|A Long-Term, Multicenter, Open-Label Safety Study With Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa Therapy.|Completed||Phase 3|1100||Kyowa Kirin Pharmaceutical Development, Inc.|||||f||||f||||||||||2017-02-18 17:12:45.115923|2017-02-18 17:12:45.115923
NCT00199355|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-21|||April 2005||2005-04-01|August 2012|2012-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa|Placebo-Controlled , Double-Blind , Exploratory Study of KW-6002(Istradefylline) in the Treatment of Parkinson's Disease. [Adjunctive Therapy to Levodopa]|Completed||Phase 2|75||Kyowa Hakko Kirin Co., Ltd|||||f||||f||||||||||2017-02-18 17:12:45.209513|2017-02-18 17:12:45.209513
NCT00199342|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-02-24|||November 2004||2004-11-01|February 2007|2007-02-01||||October 2005|Actual|2005-10-01||Interventional|||A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma|An Open-Label Study of KW-2871 Administered With a Premedication Regimen in Patients With Advanced Stage IV Melanoma|Terminated||Phase 1/Phase 2|5|Actual|Kyowa Kirin Pharmaceutical Development, Inc.||1||Occurrence of 2 dose-limiting toxicities at the initial dose level (60 mg/m2) in Part I.|f||||f||||||||||2017-02-18 17:12:45.321097|2017-02-18 17:12:45.321097
NCT00199329|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-10-31|||January 2005||2005-01-01|October 2007|2007-10-01||||||||Interventional|||Antiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA)||Completed||N/A|160|Actual|Khon Kaen University||1|||f||||||||||||||2017-02-18 17:12:45.418711|2017-02-18 17:12:45.418711
NCT00199316|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-10-31|||January 2005||2005-01-01|October 2007|2007-10-01|November 2005||2005-11-01|||||Interventional|||Postoperative Pain Control After Kidney Surgery : a Comparison of Intrathecal Morphine Plus PCA and PCA Only||Unknown status|Recruiting|N/A|80|Anticipated|Khon Kaen University||1|||f||||||||||||||2017-02-18 17:12:45.507127|2017-02-18 17:12:45.507127
NCT00199303|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||December 2002||2002-12-01|July 2002|2002-07-01|December 2003||2003-12-01|||||Interventional|||Efficacy of Pre- and Post-Operative Oral Dextromethorphan|Efficacy of Pre- and Post-Operative Oral Dextromethorphan for Reduction of Intra- and 24-Hr Post-Operative Morphine Consumption for Transabdominal Hysterectomy|Completed||N/A|100||Khon Kaen University|||||f||||||||||||||2017-02-18 17:12:45.59798|2017-02-18 17:12:45.59798
NCT00199290|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-02-01|||August 2005||2005-08-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|July 2007|Actual|2007-07-01||Interventional|||A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan|A Phase 2, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and the Safety of Trafermin in Patients With Marginal Periodontitis in Japan|Completed||Phase 2|267|Actual|Kaken Pharmaceutical||4|||f||||f||||||||||2017-02-18 17:12:45.694292|2017-02-18 17:12:45.694292
NCT00199277|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2005-09-16||||||September 2005|2005-09-01||||||||Interventional|||Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.|Randomized, Parallel Group, Clinical Trial Comparing Intravenous Iron Sucrose Versus Oral Ferrous Sulphate in the Treatment of Perioperative Iron Deficiency in Patients With Colo-Rectal Neoplasm and Iron Deficiency Anemia.|Unknown status|Not yet recruiting|Phase 4|150||J. Uriach and Company|||||f||||||||||||||2017-02-18 17:12:45.822419|2017-02-18 17:12:45.822419
NCT00199264|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-02|||June 2004||2004-06-01|October 2003|2003-10-01|October 2004||2004-10-01|||||Interventional|||Efficacy Vulvovaginitis Candida|A Single-Blind, Randomized, Dose-Finding Study Versus Fluconazole to Assess the Efficacy and Tolerability of Five Single Doses of Albaconazole in the Treatment of Acute Non-Recurrent Candida Spp Vulvovaginitis|Terminated||Phase 2|60||J. Uriach and Company|||||f||||||||||||||2017-02-18 17:12:45.933885|2017-02-18 17:12:45.933885
NCT00199251|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-22|||April 2004||2004-04-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria|A 6-Week Multicentre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Rupatadine 10 and 20 Mg in the Treatment of Chronic Idiopathic Urticaria (CIU): a Phase III Clinical Trial|Terminated||Phase 3|300||J. Uriach and Company|||||f||||||||||||||2017-02-18 17:12:46.015398|2017-02-18 17:12:46.015398
NCT00199238|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2002||2002-10-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Interventional|||Efficacy of Rupatadine 5, 10 and 20 Mg in Chronic Idiopathic Urticaria|A 4-Week Dose-Finding, Multicentre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Different Doses of Rupatadine Compared to Placebo in the Treatment of Chronic Idiopathic Urticaria|Terminated||Phase 2|248||J. Uriach and Company|||||f||||||||||||||2017-02-18 17:12:46.113259|2017-02-18 17:12:46.113259
NCT00199225|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-14|||February 2005||2005-02-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers|Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers: A Randomised, Parallel, Placebo and Positive Controlled Study|Completed||Phase 1|160||J. Uriach and Company|||||f||||||||||||||2017-02-18 17:12:46.208565|2017-02-18 17:12:46.208565
NCT00199212|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-23|||October 2003||2003-10-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2|A Phase I, Open Label, Dose-escalating Study of the Proteasome Inhibitor PS-341 in Combination With Two Schedules of Herceptin, in Patients With Advanced Breast Cancer That Overexpresses HER-2|Completed||Phase 1|19|Actual|Jules Bordet Institute||1|||f||||f||||||||||2017-02-18 17:12:46.310502|2017-02-18 17:12:46.310502
NCT00199186|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2007-10-18|||March 2002||2002-03-01|September 2005|2005-09-01||||||||Interventional|||Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)|A Randomized, Multicenter Open Label Phase II Study to Determine the Safety and Efficacy of Induction Therapy With Imatinib in Comparison With Standard Induction Chemotherapy in Elderly (> 55 Years) Patients With Ph Positive Acute Lymphoblastic Leukemia (ALL)|Unknown status|Recruiting|Phase 2|||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:46.417777|2017-02-18 17:12:46.417777
NCT00199173|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-23||||||February 2011|2011-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only|Comparison Hepatic Intra-arterial Injection of Yttrium-90 Versus 5FU in Colorectal Cancer Metastatic to the Liver Only|Completed||Phase 3|||Jules Bordet Institute|||||f||||||||||||||2017-02-18 17:12:46.506235|2017-02-18 17:12:46.506235
NCT00199160|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-19|||April 2005||2005-04-01|September 2005|2005-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer||Completed||Phase 2|60|Actual|Jules Bordet Institute||1|||f||||||||||||||2017-02-18 17:12:46.58758|2017-02-18 17:12:46.58758
NCT00199147|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-10-25|||January 2000||2000-01-01|September 2005|2005-09-01||||||||Interventional|||Efficacy of G-CSF-Priming in Elderly AML Patients|Treatment of Elderly Patients (>60 Years) With Acute Myeloblastic Leukemia or Advanced MDS (RAEB-T): An Open Randomized Study to Test the Efficacy of G-CSF-Priming and a Feasibility Trial of Dose-Reduced Allogeneic Transplantation and of Autologous Stem Cell Transplantation|Unknown status|Recruiting|Phase 4|250||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:46.680052|2017-02-18 17:12:46.680052
NCT00199134|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-01-05|||November 2004||2004-11-01|December 2014|2014-12-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole|FRAGRANCE Trial(Femara Reanalysed Through Genomics for Response Assessment, Calibration and Empowerment)|Completed||Phase 2|49|Anticipated|Jules Bordet Institute||1|||f||||t||||||||||2017-02-18 17:12:46.765976|2017-02-18 17:12:46.765976
NCT00199121|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-13||||||July 2005|2005-07-01||||||||Interventional|||A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients|An Open, Single-Arm, Multi-Center, Phase IV Pilot Study of Treatment of Antiretroviral Naive HIV-1 Infected Patients With Tenofovir Disoproxil Fumarate in Combination With Emtricitabine and Zidovudine|Unknown status|Recruiting|Phase 4|||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:46.867884|2017-02-18 17:12:46.867884
NCT00199108|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-29|||April 2004||2004-04-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt|A Phase-2 Clinical Study to Determine the Efficacy and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of CNS Relapse in Adult Patients With Acute Lymphoblastic Leukemia or Very Aggressive Lymphoma|Unknown status|Active, not recruiting|Phase 2/Phase 3|20|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:46.942988|2017-02-18 17:12:46.942988
NCT00199095|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-16|||February 1997||1997-02-01|May 2008|2008-05-01||||||||Interventional|||Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia|Pilot Study for Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia|Completed||Phase 4|40||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:47.276486|2017-02-18 17:12:47.276486
NCT00199082|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-04|||July 2002||2002-07-01|August 2016|2016-08-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults|Multicenter Study to Optimise Therapy of B-ALL, Burkitt's NHL and High-Grade Non-Hodgkin's Lymphoma in Adults (Amend 7)|Completed||Phase 4|650|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||f||||||||No||2017-02-18 17:12:47.376339|2017-02-18 17:12:47.376339
NCT00199069|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-16|||April 1993||1993-04-01|May 2008|2008-05-01||||||||Interventional|||German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)|Multicenter Trial for Treatment of Acute Lymphoblastic Leukemia in Adults (05/93)|Completed||Phase 4|720||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:47.505071|2017-02-18 17:12:47.505071
NCT00199056|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-16|||October 1999||1999-10-01|May 2008|2008-05-01||||||||Interventional|||German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)|Multicenter Trial for Treatment of Acute Lymphocytic Leukemia in Adults (Pilot Study 06/99)|Completed||Phase 4|225||Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:47.617967|2017-02-18 17:12:47.617967
NCT00199043|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-20|||May 2003||2003-05-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma|Randomised Phase III Trial of Effectivity and Safety of Rasburicase Compared With Allopurinol for Treatment of Hyperuricemia in Patients With Acute Lymphoblastic Leukemia or High-Grade NHL With High Risk of Tumorlysis Syndrome (> 15 Yrs)|Completed||Phase 3|80|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:47.728828|2017-02-18 17:12:47.728828
NCT00199030|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-29|||February 2004||2004-02-01|May 2008|2008-05-01|December 2007||2007-12-01|||||Interventional|||Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath|German Multicenter Phase II Trial to Study Effectivity and Feasibility of Alemtuzumab (MabCampath®) in T-ALL and T-Lymphoblastic Lymphomas With Minimal Residual Disease (MRD), in Refractory Relapse or in Primary Failure|Completed||Phase 2|25|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:47.818263|2017-02-18 17:12:47.818263
NCT00199017|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-20|||April 2004||2004-04-01|May 2008|2008-05-01||||March 2009|Actual|2009-03-01||Interventional|||German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults|Multicenter Trial for Treatment Optimization in T-lymphoblastic Lymphoma in Adults and Adolescents Older Than 15 Years (GMALL T-LBL 1/2004) (Amend 1)|Completed||Phase 4|75|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:47.912068|2017-02-18 17:12:47.912068
NCT00198120|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-04-08|||February 2004||2004-02-01|April 2016|2016-04-01|August 2010|Actual|2010-08-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Effectiveness of D-Cycloserine in Children With Autism|A Randomized Controlled Trial of D-Cycloserine in Autism|Completed||Phase 3|80|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 17:12:58.381735|2017-02-18 17:12:58.381735
NCT00199004|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-20|||April 2004||2004-04-01|May 2008|2008-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab|German Multicenter Trial for Treatment Optimisation in Acute Lymphoblastic Leukemia in Adults and Adolescents Above 15 Years With Rituximab for Improvement of Prognosis in CD20 Positive Standard Risk ALL (Amend 2)|Completed||Phase 4|60|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:48.0094|2017-02-18 17:12:48.0094
NCT00198991|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-29|||April 2003||2003-04-01|May 2008|2008-05-01||||December 2008|Anticipated|2008-12-01||Interventional|||German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)|German Multicenter Study for Treatment Optimisation in Acute Lymphoblastic Leukemia in Adults and Adolescents Above 15 Years (Amend 3) (GMALL 07/2003)|Unknown status|Recruiting|Phase 4|1250|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:48.115066|2017-02-18 17:12:48.115066
NCT00198978|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-04|||January 2003||2003-01-01|June 2008|2008-06-01||||June 2008|Anticipated|2008-06-01||Interventional|||German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|Multicenter Study To Optimize Treatment in Elderly Patients (> 55 Years, No Upper Age Limit) With Acute Lymphoblastic Leukemia (GMALL Elderly 1/2003)(Amend 2)|Unknown status|Recruiting|Phase 4|200|Anticipated|Johann Wolfgang Goethe University Hospital|||||f||||||||||||||2017-02-18 17:12:48.222272|2017-02-18 17:12:48.222272
NCT00198965|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||March 1999||1999-03-01|April 2004|2004-04-01|December 2003||2003-12-01|||||Interventional|||Olestra Containing Foods and Weight Loss and Weight Maintenance|Benefits of Sensory-Enhanced Products in Weight Loss and Maintenance|Completed||N/A|257||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:48.320484|2017-02-18 17:12:48.320484
NCT00198952|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||February 2000||2000-02-01|April 2002|2002-04-01|March 2001||2001-03-01|||||Interventional|||Effects of Herbal Products on Metabolism and Hunger|Effects of Herbal Products on Metabolism and Hunger|Completed||N/A|30||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:48.418337|2017-02-18 17:12:48.418337
NCT00198939|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-27|||January 2005||2005-01-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Neurological Influences on Drug Prevention Intervention|Neurological Influences on Drug Prevention Intervention|Completed||Phase 1/Phase 2|330|Actual|University of Florida||4|||f||||f||||||||||2017-02-18 17:12:48.511297|2017-02-18 17:12:48.511297
NCT00198926|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 2000||2000-05-01|September 2001|2001-09-01|August 2001||2001-08-01|||||Interventional|||Type 2 Diabetes Controlled Eating Experiment|Use of Modified Foods in the Dietary Treatment of Type II Diabetes Mellitus: Short Term Feeding Study|Completed||N/A|100||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:48.623677|2017-02-18 17:12:48.623677
NCT00198913|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2002||2002-06-01|April 2003|2003-04-01|February 2003||2003-02-01|||||Interventional|||Long Term Free Living Study With Modified Foods and Type 2 Diabetics|Use of Modified Foods in the Dietary Treatment of Type II Diabetes Mellitus: Long Term Free Living Study|Completed||N/A|100||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:48.709219|2017-02-18 17:12:48.709219
NCT00198900|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2000||2000-01-01|April 2000|2000-04-01|March 2000||2000-03-01|||||Observational|||Diabetes Knowledge Assessment|Use of Modified Foods in the Dietary Treatment of Type II Diabetes Mellitus: Knowledge Assessment|Completed||N/A|350||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:48.799351|2017-02-18 17:12:48.799351
NCT00198887|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-07-03|||January 2003||2003-01-01|July 2007|2007-07-01|October 2006|Actual|2006-10-01|||||Interventional|||Operations Research to Improve Newborn Health|Operations Research to Improve Newborn Health and Survival in the (INHP-II) Area of CARE/India|Completed||N/A|59651|Actual|Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:48.889912|2017-02-18 17:12:48.889912
NCT00198874|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-27|||January 2005||2005-01-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|June 2010|Actual|2010-06-01||Interventional|||Youth Drug Abuse Family and Cognitive-Behavioral Therapy|Youth Drug Abuse Family and Cognitive-Behavioral Therapy|Completed||Phase 2|296|Actual|University of Florida||4|||f||||||||||||||2017-02-18 17:12:48.975025|2017-02-18 17:12:48.975025
NCT00198861|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-01|||February 2002||2002-02-01|August 2016|2016-08-01|March 2016|Actual|2016-03-01|March 2015|Actual|2015-03-01||Observational|||Neurobehavioral Model of HIV in Injection Drug Users|Neurobehavioral Model of HIV in Injection Drug Users|Completed||Phase 1|836|Actual|The City College of New York|||1||f||||f||||||||||2017-02-18 17:12:49.088949|2017-02-18 17:12:49.088949
NCT00198848|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-06|||September 2005||2005-09-01|January 2006|2006-01-01|July 2007||2007-07-01|||||Interventional|||Iron Supplementation Among Adolescent Girls in India|Iron Supplementation Among Adolescent Girls in India|Unknown status|Recruiting|N/A|2800||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:49.184203|2017-02-18 17:12:49.184203
NCT00198835|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13||||||July 2005|2005-07-01||||||||Interventional|||Evaluation Research of the Nutrition Interventions in the INHP II Areas of CARE India|Evaluation Research of the Nutrition Interventions in the INHP II Areas of CARE India|Unknown status|Active, not recruiting|N/A|17000||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:49.270149|2017-02-18 17:12:49.270149
NCT00198822|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-05|2011-09-01||August 2001||2001-08-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|January 2007|Actual|2007-01-01||Interventional|||Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh|Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh|Completed||Phase 3|59666|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-02-18 17:12:49.356491|2017-02-18 17:12:49.356491
NCT00198809|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||November 2002||2002-11-01|April 2004|2004-04-01|February 2004||2004-02-01|||||Interventional|||Use of Herbal Supplements in Weight Loss and Weight Maintenance|Use of Herbal Supplements in Weight Loss and Weight Maintenance|Terminated||N/A|250||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:49.920901|2017-02-18 17:12:49.920901
NCT00198796|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 2005||2005-09-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Enterotoxigenic E. Coli (ETEC)|Dose-Finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic E. Coli (ETEC) Challenge Strains That Express Colonization Factors CS17 and CFA/I|Completed||Phase 1|5||Johns Hopkins Bloomberg School of Public Health|||||||||||||||||||2017-02-18 17:12:50.004201|2017-02-18 17:12:50.004201
NCT00005411|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1991||1991-09-01|March 2005|2005-03-01|September 1993|Actual|1993-09-01|||||Observational|||Study of Children's Activity and Nutrition (SCAN)--Extended Analyses||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.664096|2017-02-18 18:15:01.664096
NCT00198783|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-03|||August 2005||2005-08-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Observational|||Real-Time Assessment of Food Craving, Use, and Triggers During Outpatient Treatment of Obesity: A Development and Feasibility Study|Real-Time Assessment of Food Craving, Use, and Triggers During Outpatient Treatment of Obesity: A Development and Feasibility Study|Completed||N/A|75||Johns Hopkins Bloomberg School of Public Health|||||f||||f||||||||||2017-02-18 17:12:50.087151|2017-02-18 17:12:50.087151
NCT00198770|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-10-19|||March 2006||2006-03-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|Mush 1||Dietary Compensation With Substitution of Meat Products With White Button Mushrooms.|Does Substitution of Meat Products With White Button Mushrooms Have Potential for Weight Reduction? Studies of the Level of Short and Intermediate-term Caloric Compensation, Satiety, and Dietary Satisfaction Among Lean and Obese Men and Women.|Completed||N/A|55|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||||2017-02-18 17:12:50.164596|2017-02-18 17:12:50.164596
NCT00198757|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||July 2002||2002-07-01|May 2005|2005-05-01|January 2005||2005-01-01|||||Interventional|||Efficacy of 2 Diet Plans Designed for People With Type II Diabetes on Weight and Health Measures|Efficacy of 2 Diet Plans Designed for People With Type II Diabetes on Weight and Health Measures|Completed||N/A|120||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:50.2546|2017-02-18 17:12:50.2546
NCT00198744|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2004||2004-06-01|January 2005|2005-01-01|June 2006||2006-06-01|||||Interventional|||Efficacy of Parent-Child Dieting Plans Incorporating Medifast Meal Replacements for Weight Loss||Completed||N/A|80||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:50.333507|2017-02-18 17:12:50.333507
NCT00198731|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-07-13|||April 2005||2005-04-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Observational|||Evaluation of the Effects of Community-based Interventions|Evaluation of the Effects of Community-based Interventions on Maternal Morbidity in the Early Postpartum Period in Rural Bangladesh|Completed||N/A|1506|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||f||||||||||2017-02-18 17:12:50.415424|2017-02-18 17:12:50.415424
NCT00198718|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-09-16|||November 1997||1997-11-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|May 2001|Actual|2001-05-01||Interventional|ZVITAMBO||Single-dose Postpartum Vitamin A Supplementation of Mothers and Neonates|Vitamin A Supplementation of Breast Feeding Mothers and Their Neonates at Delivery: Impact on Mother to Child Transmission of HIV During Lactation, HIV Infection Among Women During the Postpartum Year, and Infant Mortality.|Active, not recruiting||Phase 2|28220|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||f||||||||||2017-02-18 17:12:50.498101|2017-02-18 17:12:50.498101
NCT00198705|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-09-12|||June 2003||2003-06-01|September 2014|2014-09-01|August 2012|Actual|2012-08-01|July 2007|Actual|2007-07-01||Interventional|||Community Based Interventions to Reduce Neonatal Mortality in Bangladesh|Community Based Interventions to Reduce Neonatal Mortality in Bangladesh|Completed||N/A|10670|Anticipated|Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:50.617982|2017-02-18 17:12:50.617982
NCT00198692|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-27|||August 2003||2003-08-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Interventional|||Self-Management Program for Persons With Limb Loss|Randomized Clinical Trial of Self-Management Educational Program for Persons With Limb Loss.|Completed||N/A|500||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:50.705122|2017-02-18 17:12:50.705122
NCT00198679|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-05-01|||March 2004||2004-03-01|May 2006|2006-05-01|March 2005||2005-03-01|||||Interventional|||Effect of Chlorhexidine Skin Cleansing on Skin Flora|Effect of Chlorhexidine Skin Cleansing on Skin Flora of Newborn Infants in Bangladesh|Unknown status|Active, not recruiting|Phase 4|210||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:51.043324|2017-02-18 17:12:51.043324
NCT00198666|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-01-09|||September 2003||2003-09-01|January 2015|2015-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Efficacy of Zinc in the Treatment of Pneumonia|Efficacy of Zinc in the Treatment of Pneumonia in Hospitalized Children Less Than 2 Years of Age|Completed||N/A|299|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-02-18 17:12:51.137311|2017-02-18 17:12:51.137311
NCT00198653|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-03|||March 2003||2003-03-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Newborn Thermal Care Practices: A Community Based Program to Prevent Hypothermia|Newborn Thermal Care Practices in Rural India: A Community Based Program to Prevent and Improve Recognition and Management of Hypothermia|Terminated||N/A|||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:51.235058|2017-02-18 17:12:51.235058
NCT00197158|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-09-20|||March 2005||2005-03-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response|Demonstrate the Non-inferiority of Immunogenicity Elicited by GSK Biologicals' Hepatitis B Vaccine, Multidose Engerix™-B to That of Monodose Engerix™-B When Administered According to 0,1,6 Mths Schedule in Healthy Adults Aged ≥ 18 Yrs|Completed||Phase 4|280|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:12:51.318726|2017-02-18 17:12:51.318726
NCT00197145|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-28|||July 2005||2005-07-01|March 2011|2011-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects|A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Compare the Efficacy and Safety of GW873140 400mg BID in Combination With a Ritonavir-containing Optimized Background Therapy (OBT) Regimen Versus Placebo Plus OBT Over 48 Weeks.|Terminated||Phase 3|23|Actual|GlaxoSmithKline||1||The study was terminated due to hepatoxicity of compound|||||||||||||||2017-02-18 17:12:51.420479|2017-02-18 17:12:51.420479
NCT00197132|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-12-02|||October 2002||2002-10-01|December 2016|2016-12-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Study In Patients With Insulin Resistance|A Single-centre, Randomised, Double-blind, Placebo Controlled, Two 12 Week Period, Cross-over Phase III Study to Investigate the Effect of Rosiglitazone 4mg bd on the Vasodilator Response to Hyperinsulinaemia in Obese Insulin Resistant Subjects.|Completed||Phase 3|18|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:12:51.53192|2017-02-18 17:12:51.53192
NCT00196482|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-11|||June 2004||2004-06-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Human Milk Fortifiers and Acid-Base Status|Impact of Human Milk Fortifiers on Acid-Base Status in Preterm Infants|Unknown status|Recruiting|N/A|30||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:13:23.223128|2017-02-18 17:13:23.223128
NCT00197119|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-09-08|2009-07-02||May 2004||2004-05-01|September 2016|2016-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years|Evaluate Persistence of Immune Response of GSK Biologicals' TWINRIX™ Vaccine Administered According to 0,6 Month Schedule Versus TWINRIX™ JUNIOR Administered According to 0,1,6 Month Schedule, in Subjects Aged 12-15 Years at Time of First Vaccine Dose|Completed||Phase 3|244|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:12:51.632406|2017-02-18 17:12:51.632406
NCT00197106|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-05-31|2009-09-11||June 2005||2005-06-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Treatment Of Symptomatic Asthma In Children|See Detailed Description|Completed||Phase 4|176|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 17:12:52.009786|2017-02-18 17:12:52.009786
NCT00197093|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-05-15|||September 2004||2004-09-01|May 2009|2009-05-01||||||||Interventional|||In-Patient Study In Schizophrenic Patients|A Placebo Controlled, Double-Blind, Randomised Study Investigating the Safety, Tolerability and Pharmacokinetics of Ascending Multiple Oral Doses of SB-773812 in Male and Female Schizophrenic Patients for up to 28 Days|Completed||Phase 1|60||GlaxoSmithKline||1|||||||||||||||||2017-02-18 17:12:52.721595|2017-02-18 17:12:52.721595
NCT00197080|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-22|||June 2005||2005-06-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome|A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole XR (Extended Release) in Patients With Restless Legs Syndrome|Completed||Phase 3|380||GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:12:52.807699|2017-02-18 17:12:52.807699
NCT00197067|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-26|||March 2004||2004-03-01|September 2011|2011-09-01||||||||Interventional|||A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.|A Bridging Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.|Completed||Phase 1|200||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:12:52.976678|2017-02-18 17:12:52.976678
NCT00198640|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-01||||||August 2005|2005-08-01||||||||Interventional|||AMR of Streptococcus Pneumoniae Carriage Strains|Antimicrobial Resistance of Streptococcus Pneumoniae Carriage Strains Among Bangladeshi Neonates: Epidemiology, Determinants and Risk Factors|Completed||N/A|||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:53.069682|2017-02-18 17:12:53.069682
NCT00198627|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-23|||December 2003||2003-12-01|April 2007|2007-04-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Etiology, Prevention and Treatment of Neonatal Infections in the Community|Etiology, Prevention, and Treatment of Neonatal Infections in the Community|Unknown status|Active, not recruiting|N/A|16359||Johns Hopkins Bloomberg School of Public Health|||||f||||t||||||||||2017-02-18 17:12:53.146662|2017-02-18 17:12:53.146662
NCT00198614|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-02-28|||January 2005||2005-01-01|February 2007|2007-02-01||||||||Interventional|||Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery|A Comparison of the Effectiveness of Carvedilol Versus Metoprolol for Atrial Fibrillation Appearing After Off-Pump Coronary Bypass Surgery in the Carvedilol or Metoprolol Post-Revascularization Atrial Fibrillation Controlled Trial (COMPACT)|Completed||N/A|650||Ministry of Health, Labour and Welfare, Japan|||||f||||||||||||||2017-02-18 17:12:53.237981|2017-02-18 17:12:53.237981
NCT00198601|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2003||2003-08-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Determination of Gentamicin Dosing in Neonatal Patients|Determination of Gentamicin Dosing in Neonatal Patients for Use in the Uniject Pre-Filled Syringe [A Three-Site Study at: 1) Dhaka Shishu Hospital, Dhaka Bangladesh; 2) Christain Medical Center, Vellore, India; and 3) Aga Khan University Medical Center, Karachi, Pakistan]|Unknown status|Active, not recruiting|Phase 4|||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:12:53.337013|2017-02-18 17:12:53.337013
NCT00198588|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-11-11|||June 2005||2005-06-01|November 2008|2008-11-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia|Open-Label Trial to Evaluate the Efficacy and Safety of the Use of Argatroban in Patients With Heparin-Induced Thrombocytopenia|Completed||Phase 3|8|Actual|Ministry of Health, Labour and Welfare, Japan||1|||f||||t||||||||||2017-02-18 17:12:53.438099|2017-02-18 17:12:53.438099
NCT00198575|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-02-15|||November 2004||2004-11-01|February 2006|2006-02-01|March 2006||2006-03-01|||||Observational|||A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients|A Multicenter, Prospective Cohort Study to Determine the Prevalence and Profile of Heparin-Induced Thrombocytopenia in Patients Undergoing Cardiovascular Surgery or Percutaneous Coronary Intervention|Unknown status|Active, not recruiting|N/A|1500||Ministry of Health, Labour and Welfare, Japan|||||f||||||||||||||2017-02-18 17:12:53.561674|2017-02-18 17:12:53.561674
NCT00198562|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-18|||April 2000||2000-04-01|April 2008|2008-04-01|March 2012|Anticipated|2012-03-01|March 2012|Anticipated|2012-03-01||Interventional|||Hypertension Control Based on Home Blood Pressure|Hypertension Control Based on Home Systolic Pressure Study (HOSP Study)|Unknown status|Active, not recruiting|Phase 4|2600|Anticipated|Ministry of Health, Labour and Welfare, Japan||2|||f||||t||||||||||2017-02-18 17:12:53.671536|2017-02-18 17:12:53.671536
NCT00198549|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-15|||September 2004||2004-09-01|March 2013|2013-03-01|March 2005|Actual|2005-03-01|January 2005|Actual|2005-01-01||Interventional|||Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics|Phase IV Post-Approval Evaluation of Vitrase as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Anesthetics for Ophthalmic Surgical Procedures|Completed||Phase 4|40|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 17:12:53.786852|2017-02-18 17:12:53.786852
NCT00198536|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-13|||April 2005||2005-04-01|March 2013|2013-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome|Efficacy and Safety of Ecabet Ophthalmic Solution (2.83% and 3.70%) for Treatment of Dry Eye Syndrome|Completed||Phase 2/Phase 3|159|Actual|Bausch & Lomb Incorporated||3|||f||||f||||||||||2017-02-18 17:12:53.885233|2017-02-18 17:12:53.885233
NCT00198523|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-13|||July 2005||2005-07-01|March 2013|2013-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte|A Multi-Center, Randomized, Double Masked, Bioequivalence Study of Tobramycin and Prednisolone Acetate (0.3/1.0%, ISTA) Ophthalmic Suspension Compared to PredForte (1.0% Prednisolone Acetate, Allergan) Ophthalmic Suspension|Completed||Phase 3|132||Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 17:12:53.998366|2017-02-18 17:12:53.998366
NCT00198510|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-14|||November 1998||1998-11-01|March 2013|2013-03-01|March 2003|Actual|2003-03-01|September 2001|Actual|2001-09-01||Interventional|||Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage|Phase III Safety and Efficacy Study of Vitrase (Ovine Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage|Completed||Phase 3|750||Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 17:12:54.120302|2017-02-18 17:12:54.120302
NCT00198497|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-13|||June 1999||1999-06-01|March 2013|2013-03-01|June 2003|Actual|2003-06-01|September 2001|Actual|2001-09-01||Interventional|||Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage|Phase III Safety and Efficacy Study of Vitrase (Ovine Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage|Completed||Phase 3|510||Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 17:12:54.287128|2017-02-18 17:12:54.287128
NCT00198484|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-13|||October 2004||2004-10-01|March 2013|2013-03-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||Evaluation of Vitrase as a Spreading Agent|Evaluation of Vitrase (Hyaluronidase for Injection) Ovine, 200 USP Units/mL, as an Adjuvant to Increase the Absorption and Dispersion of Other Injected Drugs Prior to Ocular Surgery|Completed||Phase 3|108|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 17:12:54.694324|2017-02-18 17:12:54.694324
NCT00198471|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-13|||July 2005||2005-07-01|March 2013|2013-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment|An Open-label Assessment of Intravitreous Injections of Vitrase (Hyaluronidase for Injection) for Inducing Posterior Vitreous Detachment in Subjects With Moderate to Severe Non-proliferative Diabetic Retinopathy|Completed||Phase 2|10||Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 17:12:54.822533|2017-02-18 17:12:54.822533
NCT00198458|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-14|||July 2004||2004-07-01|March 2013|2013-03-01|September 2004|Actual|2004-09-01|July 2004|Actual|2004-07-01||Interventional|||Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)|Clinical Evaluation of Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase, 150 USP Units/mL) Open Label, Normal Volunteer Study|Completed||Phase 1|65||Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 17:12:54.929377|2017-02-18 17:12:54.929377
NCT00198445|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-03-13|||May 2003||2003-05-01|March 2013|2013-03-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery|Efficacy and Safety of Topical Bromfenac Ophthalmic Solution, 0.1% vs. Placebo for Treatment of Ocular Inflammation Following Cataract Surgery|Completed||Phase 3|527|Actual|Bausch & Lomb Incorporated||2|||f||||f||||||||||2017-02-18 17:12:55.029892|2017-02-18 17:12:55.029892
NCT00198432|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-09|||March 2002||2002-03-01|March 2016|2016-03-01|December 2006||2006-12-01|||||Interventional|||Chemoradiotherapy of NSCLC Stage IIIB|Randomized Phase II Study Evaluating an Induction Chemotherapy Followed by a Concomitant Chemoradiotherapy and a Concomitant Chemoradiotherapy Followed by a Consolidation Chemotherapy Among Patients With NSCLC Stage III Not Resectable|Completed||Phase 2|130||Intergroupe Francophone de Cancerologie Thoracique|||||f||||||||||||||2017-02-18 17:12:55.192177|2017-02-18 17:12:55.192177
NCT00198419|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-13|||March 2004||2004-03-01|March 2013|2013-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)|Clinical Evaluation of Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) Open Label, Normal Volunteer Study|Completed||Phase 1|65|Actual|Bausch & Lomb Incorporated||1|||f||||f||||||||||2017-02-18 17:12:55.286911|2017-02-18 17:12:55.286911
NCT00198406|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 2002||2002-09-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Observational|||A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.|A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.|Completed||N/A|1653||Intergroupe Francophone de Cancerologie Thoracique|||||f||||||||||||||2017-02-18 17:12:55.390719|2017-02-18 17:12:55.390719
NCT00198393|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-28|||November 2004||2004-11-01|April 2010|2010-04-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV|Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV|Completed||Phase 2|126|Actual|Intergroupe Francophone de Cancerologie Thoracique||3|||f||||f||||||||||2017-02-18 17:12:55.467585|2017-02-18 17:12:55.467585
NCT00198380|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-28|||April 2005||2005-04-01|April 2010|2010-04-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature|Phase II of Gefitinib (IRESSA) Administered as First-line Treatment in Patients With Non-resectable Pneumonic-type Adenocarcinoma (P-ADC)|Completed||Phase 2|90|Actual|Intergroupe Francophone de Cancerologie Thoracique||1|||f||||f||||||||||2017-02-18 17:12:55.592153|2017-02-18 17:12:55.592153
NCT00198367|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-10|||January 2003||2003-01-01|May 2016|2016-05-01|July 2012|Actual|2012-07-01|January 2008|Actual|2008-01-01||Interventional|||Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)|Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) NSCLC. Randomized Phase II Study|Completed||Phase 2|120|Actual|Hospices Civils de Lyon||3|||f||||||||||||||2017-02-18 17:12:55.731797|2017-02-18 17:12:55.731797
NCT00198354|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-09|||May 2001||2001-05-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Stage I/II NSCLC Perioperative Chemotherapy|Phase III Trial Comparing 2 Chemotherapy Schedules (Preoperative vs Pre and Postoperative) in Stage I and II NSCLC|Completed||Phase 3|530|Actual|Intergroupe Francophone de Cancerologie Thoracique||4|||f||||t||||||||Undecided||2017-02-18 17:12:55.846869|2017-02-18 17:12:55.846869
NCT00198341|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-09|||January 2005||2005-01-01|March 2016|2016-03-01|December 2018|Anticipated|2018-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up|Multicentric Randomized Phase III Study of Post-Surgical NSCLC Follow-up|Active, not recruiting||Phase 3|1744|Anticipated|Intergroupe Francophone de Cancerologie Thoracique||2|||f||||||||||||||2017-02-18 17:12:55.965275|2017-02-18 17:12:55.965275
NCT00198328|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-09-27|||November 2004||2004-11-01|September 2012|2012-09-01|June 2007||2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma|A Randomized Trial Comparing Preservation of Function Status After Either Medpulser Electroporation With Intratumoral Bleomycin Therapy or Surgery in Patients With Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Base of the Tongue, Posterior Lateral Pharyngeal Wall, Hypopharynx, or Larynx That Have Failed Primary Curative Therapy|Suspended||Phase 3|200|Anticipated|Inovio Pharmaceuticals||2||Enrollment was stopped based on the Data Monitoring Committee's recommendation.|f||||t||||||||||2017-02-18 17:12:56.092022|2017-02-18 17:12:56.092022
NCT00198315|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-08||2013-10-08|June 2004||2004-06-01|October 2013|2013-10-01|June 2007||2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma|A Randomized Trial Comparing Preservation of Function Status After Either Medpulser Electroporation With Intratumoral Bleomycin Therapy or Surgery in Patients With Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Anterior Oral Cavity, Soft Palate, or Tonsil That Have Failed Primary Curative Therapy|Suspended||Phase 3|200|Anticipated|Inovio Pharmaceuticals||2||Enrollment was stopped based on the Data Monitoring Committee's recommendation.|f||||t||||||||||2017-02-18 17:12:56.214104|2017-02-18 17:12:56.214104
NCT00198302|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-03-28||||||March 2013|2013-03-01|February 2005||2005-02-01|||||Interventional|||Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)|A Phase II, Randomized, Double-blind, Multi-center Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)|Completed||Phase 2|60||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:12:56.337366|2017-02-18 17:12:56.337366
NCT00198289|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-03-28|||April 2005||2005-04-01|March 2013|2013-03-01|June 2006||2006-06-01|||||Interventional|||Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs|A Phase IIa Dose Escalation Study to Assess Safety and Pharmacokinetics of Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs|Completed||Phase 2|30||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:12:56.418298|2017-02-18 17:12:56.418298
NCT00198276|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-04-24||2013-04-24|February 2004||2004-02-01|September 2012|2012-09-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer|An Open-Label Study Using the MedPulser Electroporation System to Treat Cutaneous and Subcutaneous Foci of Cancer|Completed||Phase 4|88|Actual|Inovio Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:12:56.509539|2017-02-18 17:12:56.509539
NCT00198263|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-09||2012-11-09|January 2004||2004-01-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer|An Open-Label Study Using the Medpulser® Electroporation System to Treat Head and Neck Cancer|Completed||Phase 4|95|Actual|Inovio Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:12:56.614798|2017-02-18 17:12:56.614798
NCT00198250|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-11-13|||May 2000||2000-05-01|November 2008|2008-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Venlafaxine for Hot Flashes After Breast Cancer|Venlafaxine for Hot Flashes After Breast Cancer|Completed||Phase 2|75|Actual|Indiana University||1|||f||||f||||||||||2017-02-18 17:12:56.71662|2017-02-18 17:12:56.71662
NCT00198237|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-05-30|||March 2003||2003-03-01|May 2014|2014-05-01|December 2005||2005-12-01|||||Interventional|||Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer|Genomic and Proteomic Analysis of Docetaxel and Capecitabine as Primary Chemotherapy for Stage II-III Breast Cancer|Completed||Phase 2|40||Indiana University|||||f||||||||||||||2017-02-18 17:12:56.821501|2017-02-18 17:12:56.821501
NCT00198224|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2003||2003-01-01|November 2004|2004-11-01|May 2005||2005-05-01|||||Interventional|||Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients|Pilot Study of In Vitro Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients|Completed||N/A|50||Indiana University|||||f||||||||||||||2017-02-18 17:12:56.922373|2017-02-18 17:12:56.922373
NCT00198198|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-04-03|||August 2005||2005-08-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Aripiprazole Treatment of Bipolar Depression|Open Label Pilot Study of Aripiprazole Treatment of Difficult to Treat Bipolar Depression|Completed||Phase 4|10||Indiana University|||||f||||||||||||||2017-02-18 17:12:57.017121|2017-02-18 17:12:57.017121
NCT00198185|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-01-11|||January 2005||2005-01-01|September 2005|2005-09-01||||||||Interventional|||Cascade PRFM Study: The Evaluation of Cascade Platelet-Rich Fibrin Matrix (PRFM) on Rotator Cuff Healing|The Evaluation of Cascade PRFM on Rotator Cuff Healing|Unknown status|Recruiting|Phase 3|136||Hospital for Special Surgery, New York|||||f||||||||||||||2017-02-18 17:12:57.114195|2017-02-18 17:12:57.114195
NCT00198172|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-05-30|||October 2000||2000-10-01|May 2014|2014-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors|Phase II Study of Cisplatin Plus Epirubicin Salvage Chemotherapy in Refractory Germ Cell Tumors|Terminated||Phase 2|37||Indiana University||||Accrual Goal Met|f||||||||||||||2017-02-18 17:12:57.208308|2017-02-18 17:12:57.208308
NCT00198159|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-09-18|||September 2002||2002-09-01|September 2014|2014-09-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|IUCRO-0021||A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR|A Phase II Study of ZD1839 (Iressa)in Chemotherapy Refractory Germ Cell Tumors Expressing Epidermal Growth Factor Receptor (EGFR)|Terminated||Phase 2|21||Indiana University|||||||||||||||||||2017-02-18 17:12:57.298723|2017-02-18 17:12:57.298723
NCT00198146|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-10-25|||July 2000||2000-07-01|September 2005|2005-09-01||||||||Interventional|||Prevention of Diabetes Progression Trial (PDPT)|PD Initiated/Prevention of Diabetes Progression Trial (PDPT) ZEN119|Completed||Phase 2|40||Indiana University|||||||||||||||||||2017-02-18 17:12:57.462982|2017-02-18 17:12:57.462982
NCT00198133|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-16|2015-12-16||January 2005||2005-01-01|December 2015|2015-12-01|May 2012|Actual|2012-05-01|December 2006|Actual|2006-12-01||Interventional|||Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma|Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma|Completed||Phase 2|27|Actual|Indiana University||1|||f||||||||||||||2017-02-18 17:12:57.565671|2017-02-18 17:12:57.565671
NCT00196274|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 2000||2000-05-01|September 2005|2005-09-01||||||||Observational|||Autonomic Regulation Trial (ART)|Autonomic Regulation Trial (ART)|Completed||N/A|1000||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-02-18 17:13:26.038387|2017-02-18 17:13:26.038387
NCT00198107|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-30|||September 2005||2005-09-01|October 2015|2015-10-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism|Novel Pharmacological Strategies in Autism|Completed||Phase 3|88|Anticipated|Indiana University||4|||f||||t||||||||||2017-02-18 17:12:58.498757|2017-02-18 17:12:58.498757
NCT00198094|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-19|||December 2003||2003-12-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients|A Randomized Double-Blind Comparison of Sertraline With Early Alprazolam XR Co-Administration vs Sertraline/Placebo for Primary Care Panic Disorder Patients|Completed||Phase 4|150|Anticipated|Indiana University|||||f||||t||||||||||2017-02-18 17:13:01.422498|2017-02-18 17:13:01.422498
NCT00198081|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-26|2015-10-21||September 2005||2005-09-01|February 2016|2016-02-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)|A Phase II Trial of Celecoxib in Patients With IPMN|Terminated||Phase 2|8|Actual|Indiana University||2||Lack of funding and personnel to conduct study.|f||||t||||||||||2017-02-18 17:13:01.537279|2017-02-18 17:13:01.537279
NCT00198068|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-27|||September 2003||2003-09-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|PROMISSE||Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)|Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)|Recruiting||N/A|700|Anticipated|Hospital for Special Surgery, New York|||4||f||||t||||||Samples With DNA|"~     Serum, plasma, whole blood, RNA, urine~   "|No|Because the investigative team is still analyzing the data for biomarkers and genetics, the authors are not willing to make the data public at this time. Published study results can be found under Publications on the ClinicalTrials.gov site for this study.|2017-02-18 17:13:02.340433|2017-02-18 17:13:02.340433
NCT00198055|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-06-03|||January 2005||2005-01-01|June 2014|2014-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.|An Open-Label Study of Aripiprazole in Children and Adolescents With Autistic Disorder|Completed||Phase 2|25|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 17:13:02.480937|2017-02-18 17:13:02.480937
NCT00198042|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-20|||June 2004||2004-06-01|December 2006|2006-12-01|December 2008||2008-12-01|||||Interventional|||Bone Tunnel Widening Following ACL Reconstruction|Bone Tunnel Widening Following ACL Reconstruction|Unknown status|Recruiting|Phase 1|40|Anticipated|Hospital for Special Surgery, New York|||||f||||||||||||||2017-02-18 17:13:02.830417|2017-02-18 17:13:02.830417
NCT00198029|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-03|2013-01-31||October 2004||2004-10-01|May 2013|2013-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||The average baseline VAS for pain was 62(range 38-100), and DASH was 29.7 (range 1- 68). 53% had ≥ 1 previous corticosteroid injection. All patients had moderate or severe radiographic OA of the CMC joint: 59% were K+L Grade 4, 25% Grade 3, and 16% Grade 2. No patients had clinical evidence of carpal tunnel syndrome or DeQuervain’s tenosynovitis.|An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study|An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study|Completed||N/A|32|Actual|Hospital for Special Surgery, New York||1|||f||||t||||||||||2017-02-18 17:13:02.928436|2017-02-18 17:13:02.928436
NCT00198016|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-16|||January 2004||2004-01-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Coil Embolization of Coronary Artery Fistulas|Coil Embolization of Coronary Artery Fistulas: A Single Centre Experience|Completed||Phase 4|||HOSPITEN|||||f||||||||||||||2017-02-18 17:13:03.183508|2017-02-18 17:13:03.183508
NCT00198003|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-22|||November 2001||2001-11-01|November 2011|2011-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Addressing Patients' Expectations of Total Hip Arthroplasty in a Randomized Trial|Addressing Patients Expectations of Total Hip Arthroplasty: Developing and Testing an Educational Intervention in a Randomized Trial|Completed||N/A|178|Actual|Hospital for Special Surgery, New York|||||f||||f||||||||||2017-02-18 17:13:03.268474|2017-02-18 17:13:03.268474
NCT00197990|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-22|||July 2003||2003-07-01|November 2011|2011-11-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Observational|||Expectations, Satisfaction and Quality of Life in Total Hip Arthroplasty|Expectations, Satisfaction and Quality of Life in Total Hip Arthroplasty|Completed||N/A|405|Actual|Hospital for Special Surgery, New York|||1||f||||f||||||||||2017-02-18 17:13:03.372008|2017-02-18 17:13:03.372008
NCT00197977|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-22|||November 2001||2001-11-01|November 2011|2011-11-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Addressing Patients' Expectations of Total Knee Arthroplasty in a Randomized Trial|Addressing Patients' Expectations of Total Knee Arthroplasty: Developing and Testing an Educational Intervention in a Randomized Trial|Completed||N/A|146|Actual|Hospital for Special Surgery, New York|||||f||||f||||||||||2017-02-18 17:13:03.473926|2017-02-18 17:13:03.473926
NCT00197964|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-22|||August 2001||2001-08-01|November 2011|2011-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Randomized Trial to Improve Quality of Life Outcomes in Asthma Patients|A Randomized Trial to Improve Quality of Life Outcomes in Asthma Patients|Completed||N/A|180|Actual|Hospital for Special Surgery, New York|||||f||||f||||||||||2017-02-18 17:13:03.57695|2017-02-18 17:13:03.57695
NCT00197951|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-20|||October 2004||2004-10-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism|Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology, Not Being a Severe Mental Disorder, Associated to Alcohol Dependence Disorder.|Completed||Phase 3|60||Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|||||f||||t||||||||||2017-02-18 17:13:03.676546|2017-02-18 17:13:03.676546
NCT00197938|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-06-05|||November 2005||2005-11-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|||||Observational|||Lactic Acid in the Rectum and Life-Threatening Infection|Does the Concentration of L-Lactate in the Rectum Correlate With Mortality and Morbidity in Patients With Septic Shock?|Completed||N/A|130|Actual|Herlev Hospital|||1||f||||||||||||||2017-02-18 17:13:03.782238|2017-02-18 17:13:03.782238
NCT00197925|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-02|||September 2004||2004-09-01|January 2008|2008-01-01||||||||Interventional|||Dendritic Cell Based Therapy of Metastatic Breast Cancer|Vaccination With Autologous Dendritic Cells Pulsed With Onco-Peptides for Treatment of Patients With Metastatic Breast Cancer.A Phase I/II Study|Terminated||Phase 1/Phase 2|40|Anticipated|Herlev Hospital||||all patients recruited|f||||||||||||||2017-02-18 17:13:03.86539|2017-02-18 17:13:03.86539
NCT00197912|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-04-23|||September 2004||2004-09-01|July 2009|2009-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Dendritic Cell Based Therapy of Malignant Melanoma|Vaccination With Autologous Dendritic Cells Pulsed With Tumor Antigens for Treatment of Patients With Malignant Melanoma. Phase I/II Study|Completed||Phase 1/Phase 2|25|Actual|Herlev Hospital||1|||f||||||||||||||2017-02-18 17:13:03.959988|2017-02-18 17:13:03.959988
NCT00197054|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-02-01|||July 2005||2005-07-01|February 2013|2013-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study to Evaluate Safety, Immunogenicity and Proof-of-concept of RTS,S/AS02A, and RTS,S/AS01B, Two Candidate Malaria Vaccines in Malaria-experienced Adults Living in Western Kenya.|A Phase IIb Randomized, Double-blind, Controlled Study of the Safety, Immunogenicity and Proof-of-concept of RTS,S/AS02A, and RTS,S/AS01B, Two Candidate Malaria Vaccines in Malaria-experienced Adults Living in Western Kenya.|Completed||Phase 2|255|Actual|U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-02-18 17:13:04.075247|2017-02-18 17:13:04.075247
NCT00197041|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-20|||July 2003||2003-07-01|September 2016|2016-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.|A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, Administered Intramuscularly According to a 0, 1 and 2 Month Vaccination Schedule in Toddlers and Children Aged 1 to 4 Years in a Malaria-endemic Region of Mozambique.|Completed||Phase 2|2022|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:04.171586|2017-02-18 17:13:04.171586
NCT00197028|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-07-03|2012-12-13||August 2005||2005-08-01|July 2014|2014-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region|A Phase I/IIb Randomized, Double-blind, Controlled Study of the Safety, Immunogenicity and Proof-of-concept of RTS,S/AS02D, a Candidate Malaria Vaccine in Infants Living in a Malaria-endemic Region|Completed||Phase 2|214|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 17:13:04.281264|2017-02-18 17:13:04.281264
NCT00197015|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-11|2010-03-11||October 2003||2003-10-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children|Immunogenicity & Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine (Havrix™) Co-administered With Merck & Company, Inc. Measles-Mumps-Rubella Vaccine (M-M-RII) & Merck & Co Varicella Vaccine (VARIVAX™) to Children 15 Months of Age|Completed||Phase 3|1474|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:05.268322|2017-02-18 17:13:05.268322
NCT00197002|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-20|||September 2003||2003-09-01|September 2016|2016-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age|A Phase IIIb, Open, Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine Administered on a 0-6 Mth Schedule Concomitantly With Wyeth Lederle's Pneumococcal Conjugate Vaccine in Healthy Children 15 Months of Age|Completed||Phase 3|521|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:06.285875|2017-02-18 17:13:06.285875
NCT00196989|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-27|||September 2005||2005-09-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study In People With Type 2 Diabetes|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of Oral GW677954 as a Monotherapy for 12 Weeks Duration in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|448|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:06.406207|2017-02-18 17:13:06.406207
NCT00196976|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-22|||March 2005||2005-03-01|September 2016|2016-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old|Evaluate the Immunogenicity, Reactogenicity, Safety of 4 Different Formulations of GSK Biologicals' Conjugate Vaccine (MenACWY) vs 1 Dose of MenC-CRM197 or Mencevax™ ACWY in Children Aged 12-14 Months & 3-5 Years|Completed||Phase 2|461|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:06.909544|2017-02-18 17:13:06.909544
NCT00196963|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-20|||March 2005||2005-03-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs|Assess the Immunogenicity, Safety, Reactogenicity of 1 Dose of 4 Different Formulations of GSK Biologicals' Meningococcal Conjugate Vaccine (MenACWY) vs 1 Dose of Mencevax™ ACWY in Healthy Subjects Aged 15-19 Yrs|Completed||Phase 2|125|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:07.054316|2017-02-18 17:13:07.054316
NCT00196950|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-06|||September 2003||2003-09-01|September 2016|2016-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years|Assess the Safety, Reactogenicity, Immunogenicity & Long-term Persistence of One Intramuscular Dose of GSK Biologicals' MenACWY Conjugate Vaccine vs One Subcutaneous Dose of Mencevax™ ACWY in Healthy Adults Aged 18-25 Yrs|Completed||Phase 2|50|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:07.151646|2017-02-18 17:13:07.151646
NCT00196261|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|September 2005|2005-09-01||||||||Observational|||Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction|Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction|Completed||N/A|3500||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-02-18 17:13:26.114813|2017-02-18 17:13:26.114813
NCT00196937|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-23|2009-11-12||October 2004||2004-10-01|November 2016|2016-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18|Phase 3, Open, Age-stratified Study to Assess Immunogenicity and Safety of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly According to 3-dose Schedule (0,1,6 Months) in Healthy Female Subjects Aged 15 - 55 Years and Long Term Follow-up|Completed||Phase 3|667|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:07.262109|2017-02-18 17:13:07.262109
NCT00196924|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-20|||June 2004||2004-06-01|September 2016|2016-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.|Evaluate the Safety and Immunogenicity of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly According to a 0,1,6 Month Schedule in Healthy Female Subjects (10 - 14 Years)|Completed||Phase 3|2067|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:08.144945|2017-02-18 17:13:08.144945
NCT00196911|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2006-11-29|||January 2001||2001-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||STN-Stimulation Versus Best Medical Treatment in Advanced PD|Randomized, Multicenter, Prospective, Parallel-Group Study of the Effect of Deep Brain Stimulation (Subthalamic Nucleus) on Quality of Life and Motor Complications in Patients With Advanced Parkinson's Disease Compared With Best Medical Treatment|Completed||Phase 3|156||German Parkinson Study Group (GPS)|||||f||||||||||||||2017-02-18 17:13:08.297943|2017-02-18 17:13:08.297943
NCT00196898|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-16|||March 2005||2005-03-01|April 2011|2011-04-01|December 2013|Anticipated|2013-12-01|||||Observational|||Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson's Disease Treated With Dopamine Agonists|A National, Multicenter Study on Fibrotic Valvular Heart Disease in Patients With Parkinson´s Disease Treated With Dopamine Agonists|Unknown status|Recruiting|N/A|100|Anticipated|German Parkinson Study Group (GPS)|||1||f||||||||||||||2017-02-18 17:13:08.397158|2017-02-18 17:13:08.397158
NCT00196885|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-18|||December 2003||2003-12-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training|Effect of N-Acetylcysteine on Skeletal Muscle in Cachectic Cancer Patients Undergoing a Resistance Training Program (Phase 2 Study)|Completed||Phase 2|60||German Cancer Research Center|||||f||||||||||||||2017-02-18 17:13:08.483752|2017-02-18 17:13:08.483752
NCT00196872|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-16|||July 2004||2004-07-01|August 2012|2012-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)|A Phase III Trial to Compare ETC vs, EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN)|Completed||Phase 3|3000|Anticipated|German Breast Group||4|||f||||||||||||||2017-02-18 17:13:08.571341|2017-02-18 17:13:08.571341
NCT00196859|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-16|||June 2004||2004-06-01|August 2011|2011-08-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Study in Elderly Patients With Early Breast Cancer (ICE)|Ibandronate With or Without Capecitabine in Elderly Patients With Early Breast Cancer|Completed||Phase 3|1500|Anticipated|German Breast Group||2|||f||||t||||||||||2017-02-18 17:13:08.689477|2017-02-18 17:13:08.689477
NCT00196846|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-11|||March 2005||2005-03-01|June 2010|2010-06-01|March 2010|Actual|2010-03-01|December 2008|Actual|2008-12-01||Interventional|||Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)|Prospective Randomized Multicenter Study to Prevent Chemotherapy Induced Ovarian Failure With the GnRH-Agonist Goserelin in Young Hormone Insensitive Breast Cancer Patients Receiving Anthracycline Containing (Neo-)Adjuvant Chemotherapy|Completed||Phase 2|62|Anticipated|German Breast Group||1|||f||||t||||||||||2017-02-18 17:13:08.815983|2017-02-18 17:13:08.815983
NCT00196833|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-09|||April 2003||2003-04-01|February 2016|2016-02-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|BCP||Breast Cancer in Pregnancy Register Study|Prospective and Retrospective Register Study of the German Breast Group (GBG) for Diagnosis and Treatment of Breast Cancer in Pregnancy|Recruiting||N/A|500|Anticipated|German Breast Group|||1||f||||f||||||Samples With DNA|"~     Tumour and placenta specimens are collected~   "|||2017-02-18 17:13:08.928325|2017-02-18 17:13:08.928325
NCT00196820|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-10-05|||July 2005||2005-07-01|May 2008|2008-05-01|December 2008|Actual|2008-12-01|||||Interventional|||Mono Efficacy of Capecitabine (MoniCa)|A Multicenter Phase II Study to Determine the Efficacy of Capecitabine as First Line Monochemotherapy in Patients With HER2 Negative, Medium-risk, Metastatic Breast Cancer|Completed||Phase 2|200|Anticipated|German Breast Group||1|||f||||t||||||||||2017-02-18 17:13:09.04001|2017-02-18 17:13:09.04001
NCT00196807|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-19|||August 2004||2004-08-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Prostate Cancer Screening: Fostering Informed Decisions|Prostate Cancer Screening: Fostering Informed Decisions|Completed||Phase 3|543|Actual|Georgetown University||4|||f||||t||||||||||2017-02-18 17:13:09.151992|2017-02-18 17:13:09.151992
NCT00197899|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-12|||March 2004||2004-03-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Low-Dose Endotoxemia and the Acute Phase Response||Unknown status|Active, not recruiting|N/A|||Herlev Hospital|||||f||||||||||||||2017-02-18 17:13:09.266681|2017-02-18 17:13:09.266681
NCT00197886|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-09-19|||October 2004||2004-10-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Dose of Norepinephrine and the Concentration of L-Lactate in the Rectum and Stomach in Patients With Septic Shock.||Completed||N/A|10||Herlev Hospital|||||f||||||||||||||2017-02-18 17:13:09.336889|2017-02-18 17:13:09.336889
NCT00197873|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-04|||September 2005||2005-09-01|March 2016|2016-03-01|October 2016|Anticipated|2016-10-01|May 2016|Anticipated|2016-05-01||Interventional|||Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea|Randomized, Double Blind, Placebo Controlled, Cross-over Phase II Study on the Effects of Lactobacillus Rhamnosus GG Supplementation in Patients on 1st Line XELOXA Treatment for Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|84|Anticipated|Helsinki University||2|||f||||f||||||||||2017-02-18 17:13:09.676608|2017-02-18 17:13:09.676608
NCT00196248|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13||||||September 2005|2005-09-01||||||||Observational|||Out-of Hospital Resuscitation Study||Unknown status|Recruiting|Phase 4|||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-02-18 17:13:26.201685|2017-02-18 17:13:26.201685
NCT00197860|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-22|||September 2004||2004-09-01|November 2011|2011-11-01|October 2010|Actual|2010-10-01|December 2009|Actual|2009-12-01||Interventional|||Dendritic Cell Based Therapy of Renal Cell Carcinoma|Vaccination With Autologous Dendritic Cells Pulsed With Tumor Antigens for Treatment of Patients With Renal Cell Carcinoma.A Phase I/II Study.|Completed||Phase 1/Phase 2|40|Actual|Herlev Hospital||1|||f||||||||||||||2017-02-18 17:13:09.786135|2017-02-18 17:13:09.786135
NCT00197847|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||December 2002||2002-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Infection Surveillance in Intensive Care Patients||Unknown status|Active, not recruiting|N/A|549||Herlev Hospital|||||f||||||||||||||2017-02-18 17:13:09.878839|2017-02-18 17:13:09.878839
NCT00197834|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-08-10|||March 2004||2004-03-01|September 2005|2005-09-01||||||||Interventional|||Study of Depakote for Behavioral and Psychological Symptoms in Dementia|An Open-Label Prospective Study of Depakote for Behavioral and Psychological Symptoms in Dementia (BPSD): Use Alone and in Co-Prescription With Atypical Antipsychotic Medications|Unknown status|Recruiting|Phase 1|20||Hearthstone Alzheimer Care|||||f||||||||||||||2017-02-18 17:13:09.953576|2017-02-18 17:13:09.953576
NCT00197821|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-27|||January 2004||2004-01-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults||Completed||Phase 2|611|Actual|Public Health England||1|||f||||||||||||||2017-02-18 17:13:10.062535|2017-02-18 17:13:10.062535
NCT00197808|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-27|||April 2005||2005-04-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|sched1||Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines|Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines|Completed||Phase 4|392|Actual|Public Health England||6|||f||||||||||||||2017-02-18 17:13:10.14769|2017-02-18 17:13:10.14769
NCT00197795|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-27|||January 2005||2005-01-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults||Completed||Phase 2|30||Public Health England|||||f||||||||||||||2017-02-18 17:13:10.258633|2017-02-18 17:13:10.258633
NCT00197782|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-27|||April 2003||2003-04-01|March 2012|2012-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine||Completed||Phase 4|||Public Health England|||||f||||||||||||||2017-02-18 17:13:10.33171|2017-02-18 17:13:10.33171
NCT00197769|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-30|||September 2000||2000-09-01|February 2008|2008-02-01|January 2004||2004-01-01|||||Interventional|||Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants||Completed||Phase 2|||Public Health England|||||f||||||||||||||2017-02-18 17:13:10.406404|2017-02-18 17:13:10.406404
NCT00197756|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-08-20|||September 2004||2004-09-01|August 2009|2009-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Vitamins, Breastmilk HIV Shedding, and Child Health|Vitamins, Breastmilk HIV Shedding, and Child Health|Completed||Phase 3|771|Actual|Harvard School of Public Health|||4||f||||f||||||Samples Without DNA|"~     Breast milk samples collected from breast at delivery and at 3 month intervals thereafter.~   "|||2017-02-18 17:13:10.485274|2017-02-18 17:13:10.485274
NCT00197743|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-09|||April 1995||1995-04-01|November 2010|2010-11-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Trial of Vitamins in HIV Progression and Transmission|Trial of Vitamins in HIV Progression and Transmission|Completed||Phase 3|1085|Actual|Harvard School of Public Health||4|||f||||t||||||||||2017-02-18 17:13:10.600066|2017-02-18 17:13:10.600066
NCT00197730|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-08-20|||June 2004||2004-06-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Trial of Vitamins Among Children of HIV-infected Women|Trial of Vitamins Among Children of HIV-infected Women|Completed||Phase 3|2387|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-02-18 17:13:10.727142|2017-02-18 17:13:10.727142
NCT00197704|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-11-09|||March 2000||2000-03-01|November 2010|2010-11-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Nutrition, Immunology and Epidemiology of Tuberculosis|Nutrition, Immunology and Epidemiology of Tuberculosis|Completed||Phase 3|876|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-02-18 17:13:10.839722|2017-02-18 17:13:10.839722
NCT00197691|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-30|||March 2001||2001-03-01|March 2012|2012-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||Botswana Pediatric Respiratory Disease and Bloodstream Infection Study|Botswana Pediatric Respiratory Disease and Bloodstream Infection|Completed||N/A|||Harvard School of Public Health|||1||f||||f||||||||||2017-02-18 17:13:10.953378|2017-02-18 17:13:10.953378
NCT00197678|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-09|||November 2002||2002-11-01|November 2010|2010-11-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women|Comparison of Two Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women From Tanzania|Completed||Phase 3|1141|Actual|Harvard School of Public Health||2|||f||||f||||||||||2017-02-18 17:13:11.048726|2017-02-18 17:13:11.048726
NCT00197652|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-10-06|||March 2001||2001-03-01|October 2011|2011-10-01|March 2008|Actual|2008-03-01|October 2003|Actual|2003-10-01||Observational|||Botswana Diarrheal Diseases Study|Botswana Diarrheal Diseases Study|Completed||N/A|1350|Actual|Harvard School of Public Health|||2||f||||f||||||||||2017-02-18 17:13:11.178799|2017-02-18 17:13:11.178799
NCT00197639|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-10|||September 2006||2006-09-01|November 2010|2010-11-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Observational|||Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand|A Pharmacokinetic Study to Assess the Inter-patient Variability of Indinavir Drug Levels When Boosted With Ritonavir in Thai Patients on Highly Active Antiretroviral Therapy|Completed||N/A|19|Actual|Harvard School of Public Health|||1||f||||f||||||||||2017-02-18 17:13:11.267445|2017-02-18 17:13:11.267445
NCT00197613|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-09-14|||December 2002||2002-12-01|September 2012|2012-09-01|December 2007|Actual|2007-12-01|||||Interventional|||The Adult Antiretroviral Treatment and Resistance Study (Tshepo)|The Adult Antiretroviral Treatment and Resistance Study (Tshepo)|Completed||Phase 3|650||Harvard School of Public Health|||||f||||t||||||||||2017-02-18 17:13:11.369677|2017-02-18 17:13:11.369677
NCT00197587|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-17|||August 2002||2002-08-01|May 2013|2013-05-01||||May 2005|Actual|2005-05-01||Interventional|Mashi||Prevention of Milk-Borne Transmission of HIV-1C in Botswana|"Prevention of Milk-Borne Transmission of HIV-1C in Botswana (Mashi)"|Completed||N/A|1200|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-02-18 17:13:11.472139|2017-02-18 17:13:11.472139
NCT00197561|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-11-09|||September 2003||2003-09-01|November 2010|2010-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection|Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV Infection|Completed||Phase 3|915|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-02-18 17:13:11.584299|2017-02-18 17:13:11.584299
NCT00197548|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-11-09|||August 2001||2001-08-01|November 2010|2010-11-01|July 2006|Actual|2006-07-01|December 2004|Actual|2004-12-01||Interventional|||A Trial of Micronutrients and Adverse Pregnancy Outcomes|A Trial of Micronutrients and Adverse Pregnancy Outcomes|Completed||Phase 3|8468|Actual|Harvard School of Public Health||2|||f||||t||||||||||2017-02-18 17:13:11.70147|2017-02-18 17:13:11.70147
NCT00197522|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-31|||October 2004||2004-10-01|October 2012|2012-10-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2|A Phase I Study Investigating Multiple Injections of Autologous CD34+ Derived Dendritic Cells Transduced With an Adenovirus Vector Expressing Inactivated HER-2/Neu in Patients With Metastatic Breast Cancer|Completed||Phase 1|5|Actual|McMaster University||1|||f||||||||||||||2017-02-18 17:13:11.815692|2017-02-18 17:13:11.815692
NCT00197509|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2005||2005-01-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Sit-to-Stand Training for Survivors of Stroke in a Long-Term Care Setting|Task Specific Training for Stroke Patients|Unknown status|Active, not recruiting|Phase 2|120||Hamilton Health Sciences Corporation|||||f||||||||||||||2017-02-18 17:13:11.928495|2017-02-18 17:13:11.928495
NCT00197496|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-09-19|||January 2007||2007-01-01|September 2009|2009-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Body Weight Supported Treadmill Training Following Hip Fracture|Body Weight Supported Treadmill Training Following Hip Fracture|Completed||Phase 2|21|Actual|McMaster University||1|||f||||t||||||||||2017-02-18 17:13:12.025452|2017-02-18 17:13:12.025452
NCT00197483|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||March 2003||2003-03-01|September 2005|2005-09-01||||||||Observational|||Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia|Effective Adjunctive Use of Pergolide With Risperidone for Cognitive Impairment and Negative Symptoms in Schizophrenia|Suspended||Phase 2|20||Hamamatsu University|||||f||||||||||||||2017-02-18 17:13:12.124169|2017-02-18 17:13:12.124169
NCT00197470|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2000||2000-01-01|September 2005|2005-09-01||||||||Interventional|||Cytokine Gene Polymorphisms in Gastric Diseases|Effects of Pro-Inflammatory and Anti-Inflammatory Cytokine Gene Polymorphism on the Development of Gastric Cancer and Peptic Ulcer in Japanese|Unknown status|Recruiting|N/A|||Hamamatsu University|||||f||||||||||||||2017-02-18 17:13:12.223228|2017-02-18 17:13:12.223228
NCT00197457|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-01-31|||June 2001||2001-06-01|May 2001|2001-05-01||||||||Interventional|||Pepsinogens as the Early Marker of H. Pylori Eradication|Serum Pepsinogens as an Early Diagnostic Marker of H. Pylori Eradication|Completed||Phase 2|||Hamamatsu University|||||f||||||||||||||2017-02-18 17:13:12.337962|2017-02-18 17:13:12.337962
NCT00197444|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-19|||January 2003||2003-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer|A Phase II Study of Daily Low-Dose of Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum) and Continuous Infusion of 5-FU Combined With Radiation for the Treatment of Esophageal Cancer|Completed||Phase 2|33|Actual|Hamamatsu University||1|||f||||t||||||||||2017-02-18 17:13:12.419216|2017-02-18 17:13:12.419216
NCT00197431|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-21|||January 2004||2004-01-01|December 2003|2003-12-01||||||||Interventional|||Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer|Pharmacokinetic and Pharmacodynamic Study of S-1 and Its Effects in Patients With the Digestive Organ Cancer With Reference to Genetic Polymorphism and Activity of CYP2A6 and DPD|Unknown status|Recruiting|Phase 2|||Hamamatsu University|||||f||||||||||||||2017-02-18 17:13:12.541688|2017-02-18 17:13:12.541688
NCT00197418|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-20|||August 2003||2003-08-01|March 2003|2003-03-01||||||||Interventional|||Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection|Dual Therapy With High-Dose of Rabeprazole and Amoxicilline Versus Triple Therapy With Rabeprazole, Amoxicilline and Metronidazole as the Second Line Therapy for the Cure of H. Pylori Infection|Unknown status|Recruiting|Phase 2/Phase 3|||Hamamatsu University|||||f||||||||||||||2017-02-18 17:13:12.625114|2017-02-18 17:13:12.625114
NCT00197405|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-08-03|||August 1999||1999-08-01|August 2009|2009-08-01|December 2010|Anticipated|2010-12-01|||||Observational|||Comparison of Fecal Ribonucleic Acid (RNA) Test With Fecal Occult Blood Test (FOBT) for Detecting Colorectal Cancer and Adenoma|Comparative Study of Fecal RNA Test With Immunochemical Fecal Occult Blood Test for Detecting Colorectal Cancer and Adenoma|Unknown status|Recruiting|N/A|400|Anticipated|Hamamatsu University|||1||f||||t||||||Samples Without DNA|"~     freces, biopsy tissue samples~   "|||2017-02-18 17:13:12.721222|2017-02-18 17:13:12.721222
NCT00197392|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-11|2012-03-02||November 2004||2004-11-01|October 2013|2013-10-01|January 2010|Actual|2010-01-01|December 2009|Actual|2009-12-01||Interventional|||Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System|Establishment of Baseline and Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System|Completed||Phase 4|434|Actual|Codman & Shurtleff||2|||f||||f||||||||||2017-02-18 17:13:12.806007|2017-02-18 17:13:12.806007
NCT00197379|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-28|||May 2005||2005-05-01|April 2005|2005-04-01|January 2007|Anticipated|2007-01-01|||||Interventional|||The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia|The Study for New Effect of Roxithromycin on Androgenetic Alopecia.|Unknown status|Active, not recruiting|N/A|20|Anticipated|Hamamatsu University||1|||f||||||||||||||2017-02-18 17:13:13.626751|2017-02-18 17:13:13.626751
NCT00197366|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-06-11|||March 2005||2005-03-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Observational|||Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel|Development of Resistance Mutations in the Human Immunodeficiency Virus (HIV) in Pregnant HIV+ Women Receiving Perinatal Antiretroviral Therapy in Israel|Unknown status|Recruiting|N/A|50|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:13:13.736244|2017-02-18 17:13:13.736244
NCT00197353|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-05|||March 1999||1999-03-01|May 2005|2005-05-01|September 1999||1999-09-01|||||Interventional|||Study of Different Concentrations of Epidural Bupivacaine for the Effects on Vasodilatation and Sensory Block|Sympathectomy-Mediated Vasodilatation and Differential Sensory Block After Epidural Bupivacaine: a Randomized Concentration Ranging Study|Completed||Phase 3|60||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:13:13.815576|2017-02-18 17:13:13.815576
NCT00197340|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-14|||August 2003||2003-08-01|February 2006|2006-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction|Antepartum Chronic Epidural Therapy (ACET) Using Ropivacaine to Improve Uteroplacental Blood Flow in Pre-Eclampsia and Intrauterine Growth Restriction|Completed||Phase 3|20|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:13:13.906873|2017-02-18 17:13:13.906873
NCT00197327|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-03-02|||February 1998||1998-02-01|March 2003|2003-03-01|March 2000||2000-03-01|||||Interventional|||Dilute Versus Concentrated Epidural Bupivacaine in Labor|Analgesia Requirement and Maternal Satisfaction Following Epidural PCA in Nulliparous Labor: the Effect of a Four-Fold Change in Local Anesthetic Concentration.|Completed||Phase 3|60||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:13:14.263696|2017-02-18 17:13:14.263696
NCT00197314|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-06|||June 2004||2004-06-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Interventional|||Effectiveness of Circular Muscle Exercise (Paula Method) Versus Kegel Exercise for Urinary Stress Incontinence|A Randomized Controlled Trial of Circular Muscle Exercises (Paula Method) vs. Pelvic Floor Training (Kegel Exercises) for Urinary Stress Incontinence in Women|Completed||Phase 3|200||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:13:14.37454|2017-02-18 17:13:14.37454
NCT00197301|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-06|||October 2005||2005-10-01|September 2005|2005-09-01|April 2006||2006-04-01|||||Interventional|||Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy|Phase 1 Study to Examine the Safety and Efficacy of a Novel Liposomal Based Intranasal Influenza Vaccine|Completed||Phase 1/Phase 2|200||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:13:14.468955|2017-02-18 17:13:14.468955
NCT00197288|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2017-01-16|||October 2005||2005-10-01|January 2017|2017-01-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines|A Phase III, Observer-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix™ (GlaxoSmithKline Biologicals) Compared With Fluzone® (Aventis Pasteur) Administered Intramuscularly in Adults 18 Years and Older in the U.S.|Completed||Phase 3|1847|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:14.556427|2017-02-18 17:13:14.556427
NCT00197275|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-19|2016-10-06|||February 2006||2006-02-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants|Demonstrate Lot-to-lot Consistency of Final Production Method of GSK Biologicals' Hib-MenAC Vaccine Mixed Extemporaneously With Tritanrix™-HepB & Demonstrate Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Healthy Infants at 2, 4 and 6 Months|Completed||Phase 3|800||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:14.679087|2017-02-18 17:13:14.679087
NCT00197262|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2017-01-18|||August 2005||2005-08-01|January 2017|2017-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)|A Randomized, Single-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100 mcg for 2 Weeks in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|288||GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:14.793335|2017-02-18 17:13:14.793335
NCT00197249|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-09-08|||May 2002||2002-05-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|June 2003|Actual|2003-06-01||Interventional|||Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity|A Phase III, Open, Randomized, Multicentric Study to Compare the Reactogenicity and Immunogenicity of GSK Biologicals' Combined Vi Polysaccharide Typhoid Vaccine and Inactivated Hepatitis A Vaccine, to That Elicited by GSK Biologicals' Hepatitis A Vaccine, Administered Singly or Concomitantly With GSK Biologicals' Vi Polysaccharide Vaccine|Completed||Phase 3|1034|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:14.920015|2017-02-18 17:13:14.920015
NCT00197236|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-11-03|2008-12-02||November 2003||2003-11-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months|Immunogenicity and Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine (Havrix™) Co-administered With GSK Biologicals' DTaP Vaccine (Infanrix™) and Aventis Pasteur's Haemophilus b Conjugate Vaccine (ActHIB) in Healthy Children 15 Months of Age|Completed||Phase 3|468|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:15.047827|2017-02-18 17:13:15.047827
NCT00197223|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-09-23|||September 2005||2005-09-01|September 2016|2016-09-01|May 2006|Actual|2006-05-01|October 2005|Actual|2005-10-01||Interventional|||Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine|A Randomized, Double-blind, Placebo-controlled, Post-marketing Phase III Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine (Fluarix™) Administered Intramuscularly in Adults.|Completed||Phase 3|6213|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:16.017102|2017-02-18 17:13:16.017102
NCT00197210|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-11-03|||December 2003||2003-12-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants|A Phase III, Double-blind, Randomized, Placebo-controlled, Multi-country and Multi-center Study to Assess the Efficacy and Safety of Two Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants|Completed||Phase 3|10708|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:16.115251|2017-02-18 17:13:16.115251
NCT00197197|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-03-28|||July 2005||2005-07-01|March 2011|2011-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects|A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Compare the Efficacy and Safety of GW873140 400mg BID in Combination With a Ritonavir-containing Optimized Background Therapy (OBT) Regimen Versus Placebo Plus OBT Over 48 Weeks.|Terminated||Phase 3|18|Actual|GlaxoSmithKline||1||The study was terminated due to hepatoxicity of compound|||||||||||||||2017-02-18 17:13:16.227297|2017-02-18 17:13:16.227297
NCT00197184|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-10-21|2009-02-20||November 2003||2003-11-01|October 2016|2016-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared|Evaluate the Persistence of Immune Response of GSK Biologicals' Twinrix™ Vaccine, Administered According to a 0,6 Month Schedule and a 0,1,6 Month Schedule, in Healthy Children Aged Between 1-11 Years at the Time of First Vaccine Dose|Completed||Phase 3|276|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:16.329073|2017-02-18 17:13:16.329073
NCT00197171|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-09-06|||September 2003||2003-09-01|September 2016|2016-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine|Evaluate the Persistence of Immune Response of GSK Biologicals' TWINRIX™ ADULT, Administered According to 0,6 Month Schedule and 0,12 Month Schedule, in Volunteers Aged 12-15 Years Inclusive at the Time of First Vaccine Dose|Completed||Phase 3|143|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:13:16.839842|2017-02-18 17:13:16.839842
NCT00196794|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-17|||April 2005||2005-04-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea|A Randomized, Double-Blind Study of GT267-004 Versus Vancomycin, and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea|Completed||Phase 3|520|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:13:17.002549|2017-02-18 17:13:17.002549
NCT00196781|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-11|||September 2002||2002-09-01|January 2010|2010-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Treatment Decision Making in Early-Stage Prostate Cancer|Treatment Decision Making in Early-Stage Prostate Cancer: Evaluation of Computer Based Patient Education and an Interactive Decision Aid|Completed||Phase 3|168|Actual|Georgetown University||2|||f||||t||||||||||2017-02-18 17:13:19.953817|2017-02-18 17:13:19.953817
NCT00196768|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-22|||January 2005||2005-01-01|October 2007|2007-10-01|December 2010||2010-12-01|||||Interventional|||Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic|Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide (Phase IV Study)|Unknown status|Recruiting|Phase 4|30|Anticipated|German AML Cooperative Group|||||f||||||||||||||2017-02-18 17:13:20.112067|2017-02-18 17:13:20.112067
NCT00196755|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-03-17|||December 2004||2004-12-01|March 2015|2015-03-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis|An Open Label, Randomized, Parallel Design Study to Investigate the Efficacy and Safety of Sevelamer Hydrochloride (Renagel®) Compared With Calcium Acetate in Peritoneal Dialysis Patients|Completed||Phase 3|138|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:13:20.208229|2017-02-18 17:13:20.208229
NCT00196742|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-07-08|||July 2001||2001-07-01|July 2016|2016-07-01|July 2030|Anticipated|2030-07-01|July 2030|Anticipated|2030-07-01||Observational|||Fabry Disease Registry|Fabry Disease Registry|Recruiting||N/A|9000|Anticipated|Sanofi|||1||f||||f||||||||||2017-02-18 17:13:20.330065|2017-02-18 17:13:20.330065
NCT00196729|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-17|||December 2001||2001-12-01|March 2015|2015-03-01|September 2003||2003-09-01|||||Interventional|||Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration|A Randomized, Controlled, Open-Label, Multi-National Pilot Study of Thyroid Remnant Ablation Comparing the Safety and Ablation Rate Following 131I Administration Using Thyrogen® Versus the Safety and Ablation Rate Following 131I Administration in the Hypothyroid State|Completed||Phase 3|63||Sanofi|||||||||||||||||||2017-02-18 17:13:20.488011|2017-02-18 17:13:20.488011
NCT00196716|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-17|2008-12-05||June 2003||2003-06-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|April 2006|Actual|2006-04-01||Interventional|||A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease|A Multicenter, Open-label Study of Low Dose Maintenance Treatment of Fabrazyme (Recombinant Human Alpha-Galactosidase A (R-h Alpha-GAL)) Replacement Therapy in Patients With Fabry Disease|Completed||Phase 2|21|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:13:20.81946|2017-02-18 17:13:20.81946
NCT00196703|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||March 2005||2005-03-01|March 2005|2005-03-01|September 2005||2005-09-01|||||Interventional|||Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled Trial|A 24-Week Pilot, Double-Blind, Randomized, Parallel, Placebo-Controlled Study of Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:Correlation With Cognitive Evoked Potentials During Recovery.|Unknown status|Recruiting|Phase 4|30||Gabinete Berthier y Martínez|||||f||||||||||||||2017-02-18 17:13:21.305576|2017-02-18 17:13:21.305576
NCT00196690|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||February 2003||2003-02-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial|Treatment With Donepezil of Chronic Aphasia and Sensorimotor Deficits Associated to Cerebrovascular Accidents: a Double-Blind,Placebo-Controlled, Randomized Parallel Trial.|Completed||Phase 4|30||Gabinete Berthier y Martínez|||||f||||||||||||||2017-02-18 17:13:21.400949|2017-02-18 17:13:21.400949
NCT00196677|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-03-10|||September 2005||2005-09-01|March 2009|2009-03-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Study of Glaucoma Treatment With Food Additives|Treatment of Glaucomatous Neuropathy With Food Additives|Terminated||Phase 1/Phase 2|25|Anticipated|Future Products Management||||The trial was terminated due to investigator's decision|f||||||||||||||2017-02-18 17:13:21.500953|2017-02-18 17:13:21.500953
NCT00196235|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|September 2005|2005-09-01||||||||Observational|||Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus|Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus|Completed||N/A|650||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-02-18 17:13:26.268146|2017-02-18 17:13:26.268146
NCT00196664|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-05-12|||October 2005||2005-10-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|||||Interventional|||Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin|Assessment of the Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin. Multicentric, Double-Blinded, Randomized Study. ANRS HC18 Paropeg|Completed||Phase 3|144|Anticipated|French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:13:21.582153|2017-02-18 17:13:21.582153
NCT00196651|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2000||2000-08-01|September 2005|2005-09-01|February 2004||2004-02-01|||||Interventional|||HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection|Randomized Study on HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides (LIPO-6T) in Patients Treated Early With HAART During Primary Infection. ANRS 095 PRIMOVAC|Terminated||Phase 2|60||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:13:21.673831|2017-02-18 17:13:21.673831
NCT00196638|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-08-28|||May 2002||2002-05-01|August 2006|2006-08-01|March 2006||2006-03-01|||||Interventional|||Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection|Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection.ANRS 112 INTERPRIM|Terminated||Phase 2/Phase 3|90||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:13:21.756073|2017-02-18 17:13:21.756073
NCT00196625|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||November 2000||2000-11-01|September 2005|2005-09-01|February 2002||2002-02-01|||||Interventional|||Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.|Study on Safety and Efficacy of Salvage Therapy With Amprenavir, Lopinavir and Ritonavir 200 Mg/d or 400 Mg/d in HIV-Infected Patients in Virological Failure.ANRS 104 PUZZLE 1|Completed||Phase 2|100||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:13:21.840328|2017-02-18 17:13:21.840328
NCT00196612|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||April 2001||2001-04-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART|Phase II Randomized Trial Comparing Efficacy and Safety of the Maintenance of a HAART Association Protease Inhibitor Containing Versus a Once Daily Antiretroviral Triple Association, in HIV Adult Patients With Undetectable Viral Load.ANRS 099 ALIZE|Completed||Phase 3|350||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:13:21.938087|2017-02-18 17:13:21.938087
NCT00196599|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||February 1999||1999-02-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults|Pilot Study on Efficacy and Safety of a Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults. ANRS 091 MONTANA|Completed||Phase 2|39||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:13:22.026573|2017-02-18 17:13:22.026573
NCT00196586|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-15|||April 2003||2003-04-01|November 2007|2007-11-01|November 2006||2006-11-01|||||Interventional|||Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients|Pilot Study of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin for the Treatment of Chronic Hepatitis C in HIV-HCV Coinfected Patients Non Responders to Three Months of Therapy With Pegylated Interferon Alpha 2a and Ribavirin. ANRS HC09 SECOIIA|Completed||Phase 2|75||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:13:22.114726|2017-02-18 17:13:22.114726
NCT00196573|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-04-24|||November 2003||2003-11-01|April 2014|2014-04-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Subacromial Decompression Versus Subacromial Bursectomy for Patients With Rotator Cuff Tendinosis|A Randomized Clinical Trial Comparing the Effectiveness of Subacromial Decompression (Acromioplasty) Versus Subacromial Bursectomy (no Acromioplasty) in the Arthroscopic Treatment of Patients With Rotator Cuff Tendinosis|Unknown status|Active, not recruiting|Phase 3|114|Anticipated|University of Western Ontario, Canada||1|||f||||||||||||||2017-02-18 17:13:22.207664|2017-02-18 17:13:22.207664
NCT00196560|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-26|||September 2003||2003-09-01|November 2015|2015-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Immobilization in External Rotation of Acute Shoulder Dislocations|A Randomized Evaluation of Immobilization in External Rotation in the Management of Acute Anterior Dislocations of the Shoulder|Completed||Phase 3|50|Actual|Fowler Kennedy Sport Medicine Clinic||1|||f||||f||||||||||2017-02-18 17:13:22.586688|2017-02-18 17:13:22.586688
NCT00196547|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-15|||September 2005||2005-09-01|March 2012|2012-03-01|November 2005||2005-11-01|||||Interventional|||Montelukast in Modulating Exacerbations of Asthma in Children|Randomized Placebo-controlled Trial of Montelukast in Modulating Exacerbations of Asthma in Children, September 2005|Completed||Phase 4|200||Firestone Institute for Respiratory Health|||||f||||||||||||||2017-02-18 17:13:22.704594|2017-02-18 17:13:22.704594
NCT00196534|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-24|||November 2004||2004-11-01|August 2007|2007-08-01|July 2006||2006-07-01|||||Interventional|||A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery|A Comparative Evaluation of Human Thrombin Versus Bovine Thrombin in Achieving Hemostasis in Patients Undergoing Cardiovascular, Neurologic (Spine) and General Surgery Procedures.|Completed||Phase 3|304||Ethicon, Inc.|||||||||||||||||||2017-02-18 17:13:22.804034|2017-02-18 17:13:22.804034
NCT00196521|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-11|||January 2005||2005-01-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||A Clinical Evaluation of the Tension-Free Vaginal Tape Obturator System For Treatment of Stress Urinary Incontinence (Urinary Leakage)|A Clinical Evaluation of the Tension-Free Vaginal Tape Obturator System For Treatment of Stress Urinary Incontinence|Completed||N/A|300||Ethicon, Inc.|||||f||||f||||||||||2017-02-18 17:13:22.900511|2017-02-18 17:13:22.900511
NCT00196508|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-13|||April 2005||2005-04-01|June 2006|2006-06-01|January 2006||2006-01-01|||||Interventional|||A Study Comparing Topical Skin Adhesive or Sutures for Closure Due to Episiotomy or Perineal Tears Following Childbirth|A Randomized, Multi Center Study to Evaluate the Clinical Performance of Topical Skin Adhesive in Comparison to Sutures for Perineal Skin Closure Following Childbirth|Completed||Phase 3|118||Ethicon, Inc.|||||||||||||||||||2017-02-18 17:13:23.008808|2017-02-18 17:13:23.008808
NCT00196495|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-12-15|||June 2004||2004-06-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Clinical Assessment of the Total Vaginal Mesh Technique for Treatment of Genital Prolapse|Clinical Assessment of the Total Vaginal Mesh Technique for Treatment of Genital Prolapse|Completed||Phase 4|90||Ethicon, Inc.|||||f||||||||||||||2017-02-18 17:13:23.135544|2017-02-18 17:13:23.135544
NCT00196469|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-22|||December 2003||2003-12-01|September 2006|2006-09-01|March 2007||2007-03-01|||||Interventional|||Impact of Heparin on the Need for Mechanical Ventilation in Neonates|Randomized Double Blind Trial Comparing Heparin and Placebo as Additives to Continuous Infusion in Intensive Care Neonates for Prevention of Ventilation|Unknown status|Recruiting|Phase 4|270|Anticipated|University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:13:23.314885|2017-02-18 17:13:23.314885
NCT00196456|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||April 2004||2004-04-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Photodynamic Lasertherapy (PDT) in Periodontal Treatment (in Vivo)|Photodynamic Lasertherapy (PDT) in Periodontal Treatment (in Vivo)|Completed||Phase 2|60||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:13:23.404346|2017-02-18 17:13:23.404346
NCT00196443|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||The Influence of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Disease|Prospective, Randomized and Explorative Controlled Study About Influences of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Insufficiency|Completed||Phase 2/Phase 3|42||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:13:23.492681|2017-02-18 17:13:23.492681
NCT00196430|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2004||2004-01-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis|Prospective, Controlled Three-Armed Study About Effectiveness and Compatibility of Silver-Containing Textiles for Treatment of Acute Neurodermatitis|Completed||Phase 3|32||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:13:23.573156|2017-02-18 17:13:23.573156
NCT00196417|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2003||2003-01-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||The HIT-TRAP Trial|Randomized-Double Blind Trial to Assess the Incidence and Clinical Relevance of Heparin-Induced Thrombocytopenia (HIT) Antibodies in Trauma Patients Treated With Unfractionated or Low-Molecular Weight Heparin, the HIT-TRAP Trial|Unknown status|Active, not recruiting|Phase 4|600||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:13:23.656263|2017-02-18 17:13:23.656263
NCT00196404|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-17|||October 2004||2004-10-01|August 2012|2012-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder|A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder|Completed||Phase 2|800|Anticipated|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-02-18 17:13:23.758859|2017-02-18 17:13:23.758859
NCT00196391|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-07-29|||September 2005||2005-09-01|May 2014|2014-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea|A Multicenter Study to Evaluate Induction of Withdrawal Bleeding After Administration of DR-2021 in Women With Secondary Amenorrhea|Completed||Phase 2|180|Anticipated|Teva Pharmaceutical Industries||6|||f||||f||||||||||2017-02-18 17:13:23.918664|2017-02-18 17:13:23.918664
NCT00196378|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-30|||November 2004||2004-11-01|January 2010|2010-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy|A Randomized, Multicenter, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Synthetic Conjugated Estrogens, B (Enjuvia) 0.3 mg Tablets for the Treatment of Vulvovaginal Atrophy in Healthy Postmenopausal Women|Completed||Phase 3|300|Anticipated|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:13:24.069658|2017-02-18 17:13:24.069658
NCT00196365|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-09|||January 2005||2005-01-01|May 2014|2014-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain|A Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval Compared to Conventional Oral Contraceptive Therapy for Cyclic Pelvic Pain|Completed||Phase 3|97|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:13:24.207466|2017-02-18 17:13:24.207466
NCT00196352|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-04-07|||May 2003||2003-05-01|April 2014|2014-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.|A Prospective, Multiple Site Study to Evaluate the Safety of an Extended Cycle Combination Oral Contraceptive, Seasonique, Which Utilizes Ethinyl Estradiol During the Pill-free Interval.|Completed||Phase 3|320|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 17:13:24.582247|2017-02-18 17:13:24.582247
NCT00196339|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-20||2013-08-27|June 2005||2005-06-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients|A Dose-ranging Clinical Trial to Study the Efficacy and Safety of DR-2031 for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients|Completed||Phase 2|315|Actual|Teva Pharmaceutical Industries||4|||f||||t||||||||||2017-02-18 17:13:24.699865|2017-02-18 17:13:24.699865
NCT00196326|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-28|2008-11-21||June 2005||2005-06-01|September 2016|2016-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional||Safety population|Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive|A Multicenter, Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose, Combination Oral Contraceptive, Which Utilizes Ethinyl Estradiol During the Seven Day Interval Between Each 84-day Cycle|Completed||Phase 3|2235|Actual|Teva Pharmaceutical Industries||1|||f||||f||||||||||2017-02-18 17:13:24.95461|2017-02-18 17:13:24.95461
NCT00196313|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-16|2011-10-12||May 2005||2005-05-01|August 2016|2016-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain|A Multicenter Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval to Placebo for the Treatment of Cyclic Pelvic Pain in Adolescents|Completed||Phase 2|95|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:13:25.378397|2017-02-18 17:13:25.378397
NCT00196300|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|September 2005|2005-09-01||||||||Observational|||Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery|Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery|Completed||N/A|500||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-02-18 17:13:25.868481|2017-02-18 17:13:25.868481
NCT00196287|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 1995||1995-01-01|September 2005|2005-09-01||||||||Observational|||Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients|Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients|Completed||N/A|750||Deutsches Herzzentrum Muenchen|||||f||||||||||||||2017-02-18 17:13:25.949134|2017-02-18 17:13:25.949134
NCT00196222|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-03|||March 2003||2003-03-01|July 2013|2013-07-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||European Multicenter Study Radiofrequency (RF) Versus Cryo in Atrioventricular Nodal Reentry Tachycardia (AVNRT)|European Multicenter Study RF Versus Cryo in AVNRT: A Randomized Study Comparing Cryo-Energy vs. Radiofrequency-Energy Ablation Technique for AV Nodal Reentry Tachycardia (AVNRT)|Completed||Phase 4|509|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:13:26.35588|2017-02-18 17:13:26.35588
NCT00196209|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-18|||August 2005||2005-08-01|March 2008|2008-03-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation|Randomized Study Comparing Cardioversion vs. Catheter Ablation in Patients With Persistent Atrial Fibrillation|Unknown status|Recruiting|Phase 4|130|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:13:26.461242|2017-02-18 17:13:26.461242
NCT00196196|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-05-22|2008-11-04||September 2004||2004-09-01|February 2011|2011-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.|A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.|Completed||Phase 3|274|Actual|Codman & Shurtleff||1|||f||||f||||||||||2017-02-18 17:13:26.561581|2017-02-18 17:13:26.561581
NCT00196183|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-14|||August 2004||2004-08-01|March 2008|2008-03-01|June 2006|Actual|2006-06-01|||||Interventional|||Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation|Randomized Study Comparing Pulmonary Vein Isolation Alone vs. Pulmonary Vein Isolation Plus Electrogram-Guided Substrate Ablation|Completed||Phase 4|98|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:13:27.031937|2017-02-18 17:13:27.031937
NCT00196170|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-18|||May 2003||2003-05-01|March 2008|2008-03-01|July 2008|Anticipated|2008-07-01|April 2008|Anticipated|2008-04-01||Interventional|||Randomized Study of Radiofrequency- vs. Cryo-Ablation for Typical Isthmus-Dependent Atrial Flutter|Multicenter Prospective Randomized Clinical Study Comparing Radiofrequency- vs. Cryo-Ablation in Typical Isthmus-Dependent Atrial Flutter|Unknown status|Active, not recruiting|Phase 4|500|Anticipated|Deutsches Herzzentrum Muenchen||4|||f||||t||||||||||2017-02-18 17:13:27.132905|2017-02-18 17:13:27.132905
NCT00196157|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-05-28|||August 2004||2004-08-01|May 2009|2009-05-01|November 2008|Anticipated|2008-11-01|May 2008|Anticipated|2008-05-01||Interventional|||Line Versus Spot Ablation in Persistent Atrial Fibrillation|Linear Anatomically Versus Focal Electrophysiologically Guided Substrate Ablation in Patients With Persistent Atrial Fibrillation|Unknown status|Recruiting|Phase 4|116|Anticipated|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:13:27.242249|2017-02-18 17:13:27.242249
NCT00196144|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-23|||July 2002||2002-07-01|November 2007|2007-11-01|April 2004|Actual|2004-04-01|||||Interventional|||FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers|Far Field Sensing Test Study in Patients With Implanted Cardiac Dual Chamber Pacemakers|Completed||Phase 4|207|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:13:27.343369|2017-02-18 17:13:27.343369
NCT00196131|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-08|||January 2005||2005-01-01|September 2006|2006-09-01|April 2008|Anticipated|2008-04-01|||||Interventional|||Problems With Morphine Use in Patients With a Severe Brain Injury|Changes in Morphine Handling and Response in Patients With Brain Trauma|Unknown status|Active, not recruiting|Phase 1/Phase 2|20|Actual|Dalhousie University||1|||f||||f||||||||||2017-02-18 17:13:27.442823|2017-02-18 17:13:27.442823
NCT00196118|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-07|||April 2005||2005-04-01|December 2007|2007-12-01|July 2007||2007-07-01|||||Interventional|||Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter|A Non-Randomized Prospective Study of IVC Filter Retrieval|Completed||Phase 4|800||Cook|||||f||||||||||||||2017-02-18 17:13:27.563815|2017-02-18 17:13:27.563815
NCT00196105|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-28|2009-09-25||September 2003||2003-09-01|September 2011|2011-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)|Multicenter Prospective Randomized Controlled Trial of the Nitinol ZILVER Expandable Endoprosthesis in the Palliation of Extrahepatic Malignant Biliary Obstruction|Completed||N/A|241|Actual|Cook||3|||f||||||||||||||2017-02-18 17:13:27.66981|2017-02-18 17:13:27.66981
NCT00196092|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-11|||January 2000||2000-01-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Zenith® AAA Endovascular Graft Clinical Study|Zenith® AAA Endovascular Graft Clinical Study|Completed||N/A|819|Actual|Cook||8|||||||||||||||||2017-02-18 17:13:28.456457|2017-02-18 17:13:28.456457
NCT00196079|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-01-30|||February 2000||2000-02-01|January 2012|2012-01-01|August 2001||2001-08-01|||||Interventional|||The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial|The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial|Completed||N/A|177||Cook|||||f||||||||||||||2017-02-18 17:13:28.541459|2017-02-18 17:13:28.541459
NCT00196066|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-01-30|||October 2002||2002-10-01|January 2012|2012-01-01|April 2006||2006-04-01|||||Interventional|||Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)||Completed||Phase 2|150||Cook|||||||||||||||||||2017-02-18 17:13:28.628861|2017-02-18 17:13:28.628861
NCT00196053|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-30|||March 2005||2005-03-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||The Effectiveness of Pain Management Using the ARCHIMEDES® Constant-Flow Infusion Pump System for Intrathecal Delivery|Observational Registry: The Effectiveness of Pain Management Using the ARCHIMEDES® Implantable Constant-Flow Infusion Pump System for Intrathecal Delivery|Completed||Phase 4|55|Actual|Codman & Shurtleff|||||f||||f||||||||||2017-02-18 17:13:28.702833|2017-02-18 17:13:28.702833
NCT00196040|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-18|||October 2005||2005-10-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness|Feasibility Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness|Completed||N/A|60||Cierra|||||f||||||||||||||2017-02-18 17:13:28.805125|2017-02-18 17:13:28.805125
NCT00196027|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-27|||April 2005||2005-04-01|November 2006|2006-11-01||||||||Interventional|||Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism|Feasibility Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism|Unknown status|Active, not recruiting|N/A|40||Cierra|||||f||||||||||||||2017-02-18 17:13:28.891281|2017-02-18 17:13:28.891281
NCT00196014|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-07-31|||October 2001||2001-10-01|September 2005|2005-09-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|IWPS-R||Individual Workload Perception Scale - Revised (IWPS-R)|Evaluation of a Tool to Measure a Nurse's Individual Perception of Workload|Unknown status|Enrolling by invitation|N/A|12000|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||t||||||||||2017-02-18 17:13:28.976324|2017-02-18 17:13:28.976324
NCT00195988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-16|||September 2002||2002-09-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Interventional|||Comparison of Immunosuppression Protocols After LTx in Children|Comparison Of Efficacy Of Two Immunosuppressive Protocols Including Tacrolimus With Or Without Mycophenolate Mofetil In Pediatric Liver Transplantation Aimed In Early Termination Of Steroid Therapy|Completed||Phase 4|40||Children's Memorial Health Institute, Poland|||||f||||||||||||||2017-02-18 17:13:29.139288|2017-02-18 17:13:29.139288
NCT00195975|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-06-27|||June 2005||2005-06-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|August 2008|Actual|2008-08-01||Observational|||Heart Rate Variability in Children With a Functional Gastrointestinal Disorder|Heart Rate Variability in Children With Abdominal Pain Related to a Functional Gastrointestinal Disorder: Relationship to Anxiety/Stress, Electrogastrography, and Rapid Water Loading|Completed||N/A|44|Actual|Children's Mercy Hospital Kansas City|||2||f||||f||||||||||2017-02-18 17:13:29.228829|2017-02-18 17:13:29.228829
NCT00195962|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-17|||June 2004||2004-06-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Risk Factors of Breastfeeding Study|Identification of Risk Factors Among Breast-Fed Infants|Completed||N/A|1500|Anticipated|Children's Mercy Hospital Kansas City|||1||f||||||||||||||2017-02-18 17:13:29.340995|2017-02-18 17:13:29.340995
NCT00195949|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-05|||April 2003||2003-04-01|September 2005|2005-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Laparoscopic Versus Open Pyloromyotomy for Infants With Idiopathic Hypertrophic Pyloric Stenosis|Laparoscopic Versus Open Pyloromyotomy for Infants With Idiopathic Hypertrophic Pyloric Stenosis|Completed||Phase 3|200||Children's Mercy Hospital Kansas City|||||f||||f||||||||||2017-02-18 17:13:29.427647|2017-02-18 17:13:29.427647
NCT00195936|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-22|||June 2005||2005-06-01|August 2005|2005-08-01||||||||Interventional|||Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets|Effect of Calcimimetic (Cinacalcet) on Phosphate-Induced Hyperparathyroidism in Children With Hypophosphatemic Rickets|Unknown status|Recruiting|Phase 1|||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 17:13:29.52159|2017-02-18 17:13:29.52159
NCT00195923|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-05|||April 2005||2005-04-01|September 2005|2005-09-01|January 2007|Actual|2007-01-01|||||Observational|||Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis|Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis|Completed||Phase 4|100||Children's Mercy Hospital Kansas City|||||f||||f||||||||||2017-02-18 17:13:29.614499|2017-02-18 17:13:29.614499
NCT00195910|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2004||2004-10-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Safety and Efficacy Study of Hydromorphone and Morphine|Safety and Efficacy of Hydromorphone as an Analgesic Alternative to Morphine in Acute, Severe Pain: A Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 4|198||Chang, Andrew, M.D.|||||f||||||||||||||2017-02-18 17:13:29.702346|2017-02-18 17:13:29.702346
NCT00195897|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-19|||January 2006||2006-01-01|August 2016|2016-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)|Early Assessment of Anthracycline-induced Cardiotoxicity: Usefulness of Biochemical Markers and Ventricular Function Assessment.|Terminated||N/A|6|Actual|Centre Henri Becquerel|||1|No patients; only 6 enrolled after 2 years|f||||f||||||||No||2017-02-18 17:13:29.801963|2017-02-18 17:13:29.801963
NCT00195884|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-01-22|||September 1999||1999-09-01|January 2013|2013-01-01|April 2011|Actual|2011-04-01|March 2005|Actual|2005-03-01||Interventional|||Diabetes Aerobic and Resistance Exercise (DARE) Study|Resistance Exercise as an Intervention in Type 2 Diabetes Mellitus|Completed||N/A|251|Actual|Ottawa Hospital Research Institute||4|||f||||f||||||||||2017-02-18 17:13:29.889192|2017-02-18 17:13:29.889192
NCT00195871|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-06|||February 2004||2004-02-01|November 2013|2013-11-01|December 2015|Anticipated|2015-12-01|June 2014|Anticipated|2014-06-01||Interventional|||Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma|A Multicenter, Phase 2 Study, to Evaluate Safety and Efficacy of an Acute Lymphoblastic Leukemia (ALL) Intensive Chemotherapy for Adult Lymphoblastic Lymphoma (LL).|Unknown status|Active, not recruiting|Phase 2|155|Actual|Centre Henri Becquerel||1|||f||||f||||||||||2017-02-18 17:13:30.009236|2017-02-18 17:13:30.009236
NCT00195858|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-20|||April 2005||2005-04-01|April 2015|2015-04-01|June 2011|Actual|2011-06-01|November 2010|Actual|2010-11-01||Interventional|||Healthy Eating Aerobic and Resistance Training in Youth (HEARTY) Trial|Healthy Eating, Aerobic and Resistance Training in Youth (HEARTY) Trial|Completed||Phase 2/Phase 3|304|Actual|Ottawa Hospital Research Institute||4|||f||||f||||||||||2017-02-18 17:13:30.138793|2017-02-18 17:13:30.138793
NCT00195845|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-28|||April 2003||2003-04-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder|A Phase 4 Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder|Unknown status|Active, not recruiting|Phase 4|30||Cambridge Health Alliance|||||||||||||||||||2017-02-18 17:13:30.250022|2017-02-18 17:13:30.250022
NCT00195819|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2011-06-24|2009-12-17||December 2003||2003-12-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|October 2004|Actual|2004-10-01||Interventional|||Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis|A Phase 3, Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis|Completed||Phase 3|82|Actual|Abbott|The modified SASSS was pooled with a study (NCT00085644) similar in structure and sharing the same endpoints as this study.|2|||f||||f||||||||||2017-02-18 17:13:30.358489|2017-02-18 17:13:30.358489
NCT00195806|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-08-30|||February 2005||2005-02-01|August 2007|2007-08-01||||||||Interventional|||Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine|Divalproex Sodium Extended-Release Tablets for Migraine Prophylaxis in Adolescents: An Open-Label, Long-Term Safety Study|Completed||Phase 3|315||Abbott|||||||||||||||||||2017-02-18 17:13:31.941711|2017-02-18 17:13:31.941711
NCT00195793|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-10-02|||August 2004||2004-08-01|October 2007|2007-10-01||||||||Interventional|||A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin|A Multicenter, Randomized, Double-Blind, Prospective, Parallel Study to Compare the Safety and Efficacy of Fenofibrate or Ezetimibe as Add-On Therapy to Atorvastatin in Subjects With Combined Hyperlipidemia, Typical of the Metabolic Syndrome|Completed||Phase 3|174|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:13:32.028918|2017-02-18 17:13:32.028918
NCT00194571|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-19|||June 1999||1999-06-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|EC R01||Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child|Helping the Mother With Breast Cancer Support Her Child|Completed||Phase 3|181|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:09.636871|2017-02-18 17:14:09.636871
NCT00195780|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-06-29|||February 2005||2005-02-01|June 2007|2007-06-01||||||||Interventional|||A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents|An Open-Label Study to Evaluate the Safety of Depakote ER in the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents|Completed||Phase 3|227|Actual|Abbott||1|||||||||||||||||2017-02-18 17:13:32.108626|2017-02-18 17:13:32.108626
NCT00195767|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-03-17|||July 2004||2004-07-01|March 2007|2007-03-01||||||||Interventional|||Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents|An Open-Label Long-Term Study to Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents|Completed||Phase 3|150||Abbott|||||||||||||||||||2017-02-18 17:13:32.226674|2017-02-18 17:13:32.226674
NCT00195754|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-30|||July 2004||2004-07-01|July 2007|2007-07-01||||||||Interventional|||A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.|The Safety of Divalproex Sodium Extended Release Tablets in Migraine Prophylaxis: An Open-Label Extension Study in Adolescents|Completed||Phase 3|114|Actual|Abbott||1|||f||||||||||||||2017-02-18 17:13:32.318815|2017-02-18 17:13:32.318815
NCT00195741|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-02-07|||May 2003||2003-05-01|February 2007|2007-02-01||||||||Interventional|||The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents|Phase III, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Center Study Designed to Evaluate the Safety and Efficacy of Prophylactic Depakote ER in the Treatment of Adolescent Migraine|Completed||Phase 3|300||Abbott|||||||||||||||||||2017-02-18 17:13:32.414244|2017-02-18 17:13:32.414244
NCT00195728|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-17|||June 2005||2005-06-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain|An Open-Label Study Evaluating the Safety and Tolerability of Long Term Administration of Hydrocodone/Acetaminophen Extended ReleaseTablets (Vicodin® CR) in Subjects With Moderate to Severe Chronic, Non-Malignant Pain|Completed||Phase 3|431|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:13:32.528725|2017-02-18 17:13:32.528725
NCT00195715|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-08|2009-12-01||September 2004||2004-09-01|July 2011|2011-07-01|December 2008|Actual|2008-12-01|March 2006|Actual|2006-03-01||Interventional|||Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease|A Multi Center, Open Label Study of the Human Anti TNF Monoclonal Antibody Adalimumab to Evaluate the Long Term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects With Crohn's Disease|Completed||Phase 3|777|Actual|Abbott|This study was stopped by the sponsor in December 2008 when the pre-specified termination criteria were met. Subjects who continued in the study through the termination date were considered as having completed the study.|1|||f||||||||||||||2017-02-18 17:13:32.712246|2017-02-18 17:13:32.712246
NCT00195702|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-23|2009-12-08||February 2000||2000-02-01|August 2011|2011-08-01|August 2010|Actual|2010-08-01|September 2002|Actual|2002-09-01||Interventional|||Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Rheumatoid Arthritis Patients Currently Receiving Treatment With Methotrexate|Completed||Phase 3|619|Actual|Abbott||6|||f||||t||||||||||2017-02-18 17:13:34.064848|2017-02-18 17:13:34.064848
NCT00195689|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-28|||August 2003||2003-08-01|August 2007|2007-08-01||||||||Interventional|||Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis|A Multi-Center Continuation Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients With Moderate to Severely Active Psoriatic Arthritis|Completed||Phase 3|400||Abbott|||||f||||f||||||||||2017-02-18 17:13:40.022154|2017-02-18 17:13:40.022154
NCT00195676|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-11|2010-10-20||May 2004||2004-05-01|April 2011|2011-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis|A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Who Completed a Preceding Psoriasis Clinical Study With Adalimumab|Completed||Phase 3|1469|Actual|Abbott||1|||f||||||||||||||2017-02-18 17:13:40.11991|2017-02-18 17:13:40.11991
NCT00195663|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-07|2009-12-08||December 2000||2000-12-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|April 2004|Actual|2004-04-01||Interventional|PREMIER||Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis|A Prospective Multi-Centre Randomised, Double-Blind, Active Comparator-Controlled, Parallel-Groups Study Comparing the Fully Human Monoclonal Anti-TNFα Antibody Adalimumab Given Every Second Week With Methotrexate Given Weekly and the Combination of Adalimumab and Methotrexate Administered Over 2 Years in Patients With Early Rheumatoid Arthritis (PREMIER).|Completed||Phase 3|799|Actual|AbbVie||3|||f||||f||||||||||2017-02-18 17:13:41.080287|2017-02-18 17:13:41.080287
NCT00195650|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-24|2012-05-04||July 2000||2000-07-01|August 2012|2012-08-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Long Term Open Label Continuation Study|A Multi-Center Continuation Study of the Human Anti-TNF Antibody D2E7 Administered as a Subcutaneous Injection in Patients With Rheumatoid Arthritis|Completed||Phase 3|846|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:13:44.901967|2017-02-18 17:13:44.901967
NCT00195637|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-18|2017-01-24|||September 14, 2005||2005-09-14|May 4, 2016|2016-05-04|July 3, 2006|Actual|2006-07-03|July 3, 2006|Actual|2006-07-03||Interventional|||Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy|Pilot Study of the Use of Intravenous Immune Globulin in Hereditary Inclusion Body Myopathy|Completed||Phase 1|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:13:45.916617|2017-02-18 17:13:45.916617
NCT00195624|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-16|2017-01-24|||September 14, 2005||2005-09-14|November 15, 2016|2016-11-15|December 31, 2020|Anticipated|2020-12-31|December 31, 2018|Anticipated|2018-12-31||Interventional|||Alemtuzumab to Treat Severe Aplastic Anemia|A Pilot Study of Alemtuzumab (Campath) in Patients With Relapsed or Refractory Severe Aplastic Anemia|Active, not recruiting||Phase 2|47|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:13:46.016397|2017-02-18 17:13:46.016397
NCT00195611|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-27|||September 2005||2005-09-01|June 2010|2010-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media|Observational Study of the Rhinopharyngeal Carriage of Streptococcus Pneumoniae (Sp) in Infants With Acute Otitis Media (AOM)|Completed||Phase 4|3293|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 17:13:46.123673|2017-02-18 17:13:46.123673
NCT00195598|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-04-01|||January 2005||2005-01-01|March 2010|2010-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder|Pilot Study of Venlafaxine Extended Release (XR) in the Treatment of Panic Disorder (PD) in Comparison to Paroxetine.|Completed||Phase 3|70|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:46.424143|2017-02-18 17:13:46.424143
NCT00195585|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-08-12|||October 2002||2002-10-01|August 2009|2009-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Study Evaluating Isovorin in Colon Cancer|Post-Approved Phase III Study of 1-LV/5FU Therapy|Completed||Phase 3|650||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:46.514429|2017-02-18 17:13:46.514429
NCT00195572|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-08-12|||May 2002||2002-05-01|August 2009|2009-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer|Post-Approved Phase III Study of 1-LV/5FU Therapy|Completed||Phase 3|200|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:46.596449|2017-02-18 17:13:46.596449
NCT00195559|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-18|||September 2005||2005-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder|Completed||Phase 3|526|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:46.722845|2017-02-18 17:13:46.722845
NCT00195546|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-31|||April 2005||2005-04-01|May 2007|2007-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause|A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study of DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause|Completed||Phase 3|465|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:13:46.874586|2017-02-18 17:13:46.874586
NCT00195533|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-11-13|||July 2001||2001-07-01|November 2009|2009-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Observational|||Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients|Monotherapy With Piperacillin-tazobactam Versus Combination Therapy With Piperacillin-tazobactam Plus Glycopeptide as an Initial Empiric Therapy for Fever in Neutropenic Patients. An Observational Prospective Study.|Completed||Phase 4|801|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||Samples Without DNA|"~     Whole blood~   "|||2017-02-18 17:13:46.999102|2017-02-18 17:13:46.999102
NCT00195520|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-08-01|||December 2004||2004-12-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function|An Open Assessment of the Effect of Low-Dose Totelle® 1 mg on Menopausal Symptoms, Sexual Function and Quality of Life|Completed||Phase 4|100|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:47.10099|2017-02-18 17:13:47.10099
NCT00195507|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-02-20|2009-03-31||December 2004||2004-12-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis|A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects With Psoriasis|Completed||Phase 4|720|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:47.198315|2017-02-18 17:13:47.198315
NCT00195494|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-01|2009-03-31||November 2004||2004-11-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis|A 24-Month,Randomized,Double-Blind,Two-Period Study to Evaluate the Efficacy and Safety of the Combination of Etanercept and Methotrexate and Methotrexate Alone in Subjects With Early Rheumatoid Arthritis|Completed||Phase 4|542|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||f||||||||||2017-02-18 17:13:48.374917|2017-02-18 17:13:48.374917
NCT00195481|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-21|||April 2004||2004-04-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study Evaluating Sirolimus in Kidney Transplant Recipients in India|A Post Marketing Surveillance Looking at Safety of Rapamune (Sirolimus) in Indian Population Undergoing de Novo Renal Transplantation.|Completed||Phase 4|100||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:49.948173|2017-02-18 17:13:49.948173
NCT00195468|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-07|||March 2004||2004-03-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus|A Randomized, Open-label Study to Compare the Safety and Efficacy of Cyclosporine Dose Reduction With Cyclosporine Elimination in De Novo Renal Allograft Recipients Receiving Rapamune.|Completed||Phase 4|280|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:50.038138|2017-02-18 17:13:50.038138
NCT00195455|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-17|||February 2005||2005-02-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Interventional|||Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.|A Prospective Open Label Study to Evaluate Vasomotor Symptoms Control and Bleeding Patterns With a Continuous Regimen of a New Progestin Trimegestone 0.125 mg and 17 b Estradiol 1 mg (Totelle),as HT on Postmenopausal Women|Completed||Phase 4|133|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:50.14015|2017-02-18 17:13:50.14015
NCT00195442|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-07|2011-01-12||July 1999||1999-07-01|February 2011|2011-02-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Study Evaluating Refacto For Pharmacovigilance|Pharmacovigilance Evaluation Of Refacto In Usual Care Settings|Completed||N/A|288|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 17:13:50.243033|2017-02-18 17:13:50.243033
NCT00195429|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-04-22|2008-12-19||August 2005||2005-08-01|April 2010|2010-04-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients|A Randomized, Open-label and Multicenter Trial Comparing Withdrawal of Steroids or Tacrolimus From Sirolimus-based Immunosuppressive Regimen in de Novo Renal Allograft Recipients|Completed||Phase 4|47|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 17:13:51.080864|2017-02-18 17:13:51.080864
NCT00195416|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-09-15|||June 2005||2005-06-01|September 2009|2009-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Study Investigating Enbrel Treatment for Ankylosing Spondylitis|A Drug Use Investigation of Enbrel for Post-marketing Surveillance (PMS) for Ankylosing Spondylitis|Completed||Phase 4|526|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 17:13:51.396966|2017-02-18 17:13:51.396966
NCT00195403|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-06-11|2013-06-11||May 2004||2004-05-01|June 2013|2013-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational||Safety population included all participants who received at least (>=) 1 dose of study medication and had the safety assessment through appropriate follow-up.|A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA|A Drug Use Investigation of Enbrel for Post-Marketing Surveillance|Completed||N/A|1014|Actual|Pfizer|||1||f||||f||||||||||2017-02-18 17:13:51.503803|2017-02-18 17:13:51.503803
NCT00195390|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-24|||July 2004||2004-07-01|September 2008|2008-09-01|July 2008|Actual|2008-07-01|||||Observational|||Study Investigating Administration of Prevenar for Post-Marketing Surveillance|Investigation of Prevenar (Pneumococcal 7-Valent Conjugate Vaccine) Administration for Post-Marketing Surveillance|Completed||Phase 4|600|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 17:13:51.819666|2017-02-18 17:13:51.819666
NCT00195377|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-17|||April 2003||2003-04-01|June 2009|2009-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain|Evaluating Safety and QoL in Patients Treated With Etanercept: an Open Multicenter Study|Completed||Phase 4|1000||Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 17:13:51.905436|2017-02-18 17:13:51.905436
NCT00195364|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-03|||July 2003||2003-07-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain|Long-Term Safety Study of Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain|Completed||Phase 4|93||Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 17:13:54.848441|2017-02-18 17:13:54.848441
NCT00195351|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-20|2009-02-27||September 2005||2005-09-01|February 2013|2013-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection|A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection|Completed||Phase 4|467|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||||||||||||2017-02-18 17:13:54.933045|2017-02-18 17:13:54.933045
NCT00195338|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-12-16|2011-12-16||May 2004||2004-05-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg|A Post-Marketing Surveillance Looking At Safety And Adherence To Treatment Of Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg|Completed||N/A|25|Actual|Pfizer|||1||f||||t||||||||||2017-02-18 17:13:55.885398|2017-02-18 17:13:55.885398
NCT00195325|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-22|||August 2005||2005-08-01|March 2007|2007-03-01||||||||Interventional|||Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.|A Phase 1 Dose Escalation Study of TTI-237 Administered Intravenously (IV) Once Weekly in Subjects With Advanced Malignant Solid Tumors.|Terminated||Phase 1|45||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:13:56.201914|2017-02-18 17:13:56.201914
NCT00195312|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2007-12-03|||August 2005||2005-08-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Evaluating Vaccine in Adults With HIV|A Phase 1 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine Administered Alone or With Escalating Doses of IL-12 DNA or IL-15 DNA Molecular Adjuvants to HIV-1 Positive Adults Receiving Stable HAART.|Terminated||Phase 1|91|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:13:56.287853|2017-02-18 17:13:56.287853
NCT00195299|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-18|||April 2005||2005-04-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Observational|||Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck|An Exploratory Biomarker Trail of Temsirolimus in Subjects With Newly Diagnosed Advanced Stage Squamous Cell Carcinoma of the Head & Neck|Completed||N/A|20||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:13:56.393742|2017-02-18 17:13:56.393742
NCT00195286|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-09-24|||June 2004||2004-06-01|September 2009|2009-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.|Study of the Safety and Efficacy of Piperacillin/Tazobactam in the Treatment of Patients With Complicated Urinary Infections.|Completed||Phase 4|180|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 17:13:56.475419|2017-02-18 17:13:56.475419
NCT00195273|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-04-22|2009-07-31||November 2004||2004-11-01|April 2010|2010-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating Sirolimus in Kidney Transplant Recipients|A Randomized Open-Label Study Comparing the Efficacy and Safety of Sirolimus Combined With Daclizumab, Mycophenolate and Corticosteroids vs Cyclosporine, Mycophenolate and Corticosteroids in Renal Allograft Recipients Receiving Kidneys From Older Donors|Completed||Phase 3|61|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 17:13:56.591149|2017-02-18 17:13:56.591149
NCT00195260|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-01-03|2012-10-04||October 2004||2004-10-01|January 2013|2013-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors|Phase I Dose-Escalation Study Of Oral SKI-606 In Subjects With Advanced Malignant Solid Tumors|Completed||Phase 1|151|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 17:13:57.739758|2017-02-18 17:13:57.739758
NCT00195247|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-22|||May 2005||2005-05-01|March 2007|2007-03-01||||||||Interventional|||Study Evaluating TTI-237 in Advanced Malignant Solid Tumors|A Phase 1 Dose Escalation Study of TTI-237 Administered Intravenously Every 3 Weeks in Subjects With Advanced Malignant Solid Tumors|Terminated||Phase 1|45||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:14:02.598701|2017-02-18 17:14:02.598701
NCT00195234|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-03|||December 2004||2004-12-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Study Evaluating Vaccine in Adults With HIV|A Phase 1 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of an HIV CTL Multi-Epitope Peptide Vaccine Formulated With RC529-SE and GM-CSF Given to HIV-1 Positive Adults on Stable HAART.|Completed||Phase 1|60||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:14:02.710647|2017-02-18 17:14:02.710647
NCT00195221|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-03|||February 2005||2005-02-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Observational|||Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B|A Retrospective Study to Describe the Incidence of Moderate to Severe Allergic Reactions to Factor IX in Patients With Hemophilia B|Completed||Phase 4|166||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:14:02.82303|2017-02-18 17:14:02.82303
NCT00195208|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-07|||June 2005||2005-06-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis|A Randomized, 2-Period, Crossover, Pharmacodynamic Comparability Study Comparing A Pantoprazole Spheroid Formulation to the Currently Marketed Tablet Formulation in Subjects With GERD and a History of Erosive Esophagitis.|Completed||Phase 3|97|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:14:02.941949|2017-02-18 17:14:02.941949
NCT00195195|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-01-26|||January 2005||2005-01-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries|"A Rapamune Follow-up Registry in Transplant Recipients in the Nordic Countries, Wrap-up"|Completed||N/A|66|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||f||||||||||2017-02-18 17:14:03.059054|2017-02-18 17:14:03.059054
NCT00195182|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-05-15|||September 2003||2003-09-01|May 2008|2008-05-01|June 2008|Anticipated|2008-06-01|||||Observational|||Psychosocial Determinants of Medication Adherence in Hypertensive African Americans|Psychosocial Determinants of Medication Adherence in Hypertensive African Americans|Unknown status|Active, not recruiting|N/A|262|Anticipated|Weill Medical College of Cornell University|||2||f||||t||||||||||2017-02-18 17:14:03.162132|2017-02-18 17:14:03.162132
NCT00195169|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2010-08-10|||July 2001||2001-07-01|August 2010|2010-08-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Observational|||Quality of Life After Myocardial Infarction|Quality of Life After Myocardial Infarction: The Impact of Social Support|Completed||N/A|213|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||||2017-02-18 17:14:03.277974|2017-02-18 17:14:03.277974
NCT00195156|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-09-12|||July 2003||2003-07-01|September 2006|2006-09-01||||||||Interventional|||Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies|Phase I Trial of ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies|Terminated||Phase 1|||Weill Medical College of Cornell University|||||||||||||||||||2017-02-18 17:14:03.371054|2017-02-18 17:14:03.371054
NCT00195143|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-03-26|||August 2003||2003-08-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease|Phase I Study of Subthalamic GAD Gene Transfer in Medically Refractory Parkinson's Disease Patients|Completed||Phase 1|12||Neurologix, Inc.|||||||||||||||||||2017-02-18 17:14:03.461216|2017-02-18 17:14:03.461216
NCT00195130|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-03-27|||January 1998||1998-01-01|March 2008|2008-03-01|January 1999||1999-01-01|||||Observational|||Prognostic Measures in Ambulatory Care Settings|Prognostic Measures in Ambulatory Care Settings|Completed||N/A|2000||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:14:03.552861|2017-02-18 17:14:03.552861
NCT00195117|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-03-07|||October 2004||2004-10-01|March 2012|2012-03-01|July 2007|Actual|2007-07-01|July 2006|Actual|2006-07-01||Interventional|||A Randomized Trial of Changing Exercise and Physical Activity Behavior in Asthma Patients|A Randomized Trial of Changing Exercise and Physical Activity Behavior in Asthma Patients|Completed||N/A|258|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 17:14:03.654372|2017-02-18 17:14:03.654372
NCT00195104|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-10-02|||July 2003||2003-07-01|October 2007|2007-10-01||||||||Interventional|||Arsenic Trioxide in Combination With Cytarabine in Patients With High-Risk MDS and Poor-Prognosis AML|Phase I/II Study of Arsenic Trioxide in Combination With Cytosine Arabinoside in Patients With High-Risk Myelodysplastic Syndrome and Poor-Prognosis Acute Myelogenous Leukemia|Completed||Phase 1/Phase 2|120|Anticipated|Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:14:03.878378|2017-02-18 17:14:03.878378
NCT00195091|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2017-01-25|||December 2003||2003-12-01|January 2017|2017-01-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer|A Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer at Moderate to High Risk of Recurrence|Active, not recruiting||Phase 2|50|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||No||2017-02-18 17:14:03.973175|2017-02-18 17:14:03.973175
NCT00195078|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-07-19|||April 2004||2004-04-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer|Phase I-II Study of ZD1839 (IRESSA®), Cisplatin, and External-Beam Radiation Therapy in Patients With Locally Advanced, Non-Metastatic, Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 1/Phase 2|29|Anticipated|Weill Medical College of Cornell University|||||||||||||||||||2017-02-18 17:14:04.083219|2017-02-18 17:14:04.083219
NCT00195065|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-01|||April 2003||2003-04-01|April 2008|2008-04-01|September 2003||2003-09-01|||||Observational|||Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study|Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study|Completed||N/A|60||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 17:14:04.177719|2017-02-18 17:14:04.177719
NCT00195052|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2017-01-23|||May 2002||2002-05-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients|Intraoperative Optical Mapping of Human Epileptiform and Functional Cortex|Recruiting||N/A|40|Anticipated|Weill Medical College of Cornell University|||1||f||||f||||||||No||2017-02-18 17:14:04.281618|2017-02-18 17:14:04.281618
NCT00195039|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2017-02-03|||August 2004||2004-08-01|February 2017|2017-02-01|October 2013|Actual|2013-10-01|February 2012|Actual|2012-02-01||Interventional|||Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer|A Phase 2 Trial of 177Lu Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 2|59|Actual|Weill Medical College of Cornell University||1|||f||||||||||||No||2017-02-18 17:14:04.379742|2017-02-18 17:14:04.379742
NCT00195026|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-03-13|||March 2005||2005-03-01|March 2008|2008-03-01||||||||Observational|||Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection|Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection|Completed||N/A|200|Anticipated|Weill Medical College of Cornell University|||1||f||||||||||||||2017-02-18 17:14:04.495884|2017-02-18 17:14:04.495884
NCT00195013|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-12-14|||December 2003||2003-12-01|December 2015|2015-12-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy|A Randomized Placebo-controlled Trial of Glutamine to Reduce the Signs and Symptoms of Peripheral Neuropathy in Breast Cancer Patients With a Mild Peripheral Neuropathy Receiving Paclitaxel Chemotherapy|Active, not recruiting||Phase 3|45|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 17:14:04.585927|2017-02-18 17:14:04.585927
NCT00195000|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||May 2003||2003-05-01|June 2013|2013-06-01|February 2008|Actual|2008-02-01|May 2006|Actual|2006-05-01||Interventional|||Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS|Phase II Evaluation of Gemtuzumab Ozogamicin in Combination With Cytarabine in Untreated Patients Above the Age of 60 Years With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome|Completed||Phase 2|43|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 17:14:04.691266|2017-02-18 17:14:04.691266
NCT00194987|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-30|||April 2001||2001-04-01|January 2017|2017-01-01|June 30, 2017|Anticipated|2017-06-30|June 30, 2017|Anticipated|2017-06-30||Interventional|||A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia|A Randomized Multicenter Trial of Antenatal Treatment of Alloimmune Thrombocytopenia|Recruiting||Phase 2/Phase 3|120|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 17:14:04.799293|2017-02-18 17:14:04.799293
NCT00194974|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-27|||July 2004||2004-07-01|January 2017|2017-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Treatment Targets for Chronic Hypertension in Pregnancy|Treatment Targets for Chronic Hypertension in Pregnancy|Withdrawn||Phase 1/Phase 2|0|Actual|Weill Medical College of Cornell University||||Lack of funding|f||||f||||||||No|Study terminated|2017-02-18 17:14:05.104872|2017-02-18 17:14:05.104872
NCT00194961|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-24||||||March 2008|2008-03-01|December 2007||2007-12-01|||||Interventional|||Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease|A Multicenter Study of the Effect of Recombinant Human Growth Hormone on Leptin and Cytokines in Relation to Body Composition in Pediatric Patients With Growth Failure Due to Chronic Kidney Disease (CKD)|Terminated||Phase 4|15|Anticipated|Weill Medical College of Cornell University||||Funding was not approved|f||||||||||||||2017-02-18 17:14:05.212865|2017-02-18 17:14:05.212865
NCT00194948|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-01|||September 2003||2003-09-01|November 2013|2013-11-01|May 2007|Actual|2007-05-01|April 2007|Actual|2007-04-01||Interventional|||Treatment Choices for Improving Adherence and Outcome|Patient Preference in Primary Care Depression Treatment|Completed||N/A|60||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:14:05.312321|2017-02-18 17:14:05.312321
NCT00194935|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-12|||February 2003||2003-02-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Weekly Topotecan Therapy in Patients With Ovarian Cancer|A Phase II Trial of Weekly Topotecan As Consolidation Therapy in Ovarian Cancer Patients After Initial Chemotherapy|Terminated||Phase 2|32||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:14:05.402031|2017-02-18 17:14:05.402031
NCT00194922|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-03|||August 2004||2004-08-01|April 2008|2008-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Tolerance and Efficacy of the Probiotic E. Coli Strain M17 on Symptoms and Quality of Life in Individuals With Irritable Bowel Syndrome (IBS)|Completed||Phase 2|35|Actual|Weill Medical College of Cornell University||1|||f||||t||||||||||2017-02-18 17:14:05.499761|2017-02-18 17:14:05.499761
NCT00194909|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-24|||August 2004||2004-08-01|March 2008|2008-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)|An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)|Completed||Phase 4|8|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 17:14:05.613303|2017-02-18 17:14:05.613303
NCT00194896|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-08-16|2011-02-22||February 2000||2000-02-01|August 2011|2011-08-01|December 2008|Actual|2008-12-01|September 2008|Actual|2008-09-01||Interventional|||Preferred Treatment of Type 1.5 Diabetes|Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes|Completed||N/A|64|Actual|University of Washington|Small numbers based on high drop out of participants.|2|||f||||t||||||||||2017-02-18 17:14:05.711343|2017-02-18 17:14:05.711343
NCT00194883|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||April 1997||1997-04-01|September 2005|2005-09-01|May 2003||2003-05-01|||||Interventional|||Effect of Cytokines on Growth of Children With Chronic Kidney Failure|Cytokines and Growth in Children With CRI and ESRD|Suspended||Phase 4|50||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:14:06.335518|2017-02-18 17:14:06.335518
NCT00194870|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-11|||October 2003||2003-10-01|January 2017|2017-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy|Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy|Completed||N/A|5|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||No||2017-02-18 17:14:06.438063|2017-02-18 17:14:06.438063
NCT00194857|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-14|||February 2002||2002-02-01|December 2012|2012-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin|A Randomized Clinical Trial Comparing Two Management Strategies for Treatment of Neutropenia and Anemia Associated With Pegylated Interferon Plus Ribavirin Treatment of Compensated Chronic Hepatitis C in Adult Subjects Infected With HIV.|Terminated||Phase 4|||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:14:06.544237|2017-02-18 17:14:06.544237
NCT00194844|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-15|||September 2001||2001-09-01|February 2008|2008-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Couples Miscarriage Healing Project:Randomized Trial|Caring Interventions for Couples Who Have Miscarried|Completed||Phase 1/Phase 2|682|Actual|University of Washington||4|||f||||t||||||||||2017-02-18 17:14:06.651526|2017-02-18 17:14:06.651526
NCT00194831|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-11|||June 2005||2005-06-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Correlation of Volumetric Brain Analysis With Development at 18 Months|Volumetric Brain Analysis in the Premature Brain: Correlation With Future Development|Withdrawn||N/A|0|Actual|Weill Medical College of Cornell University|||1|No data. Study never completed.|f||||||||||||||2017-02-18 17:14:06.768118|2017-02-18 17:14:06.768118
NCT00194818|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-02-13|||June 2003||2003-06-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Asacol Dosing Study for Active Ulcerative Colitis|Open Label Safety and Efficacy Trial of Twice Daily Dosing of Asacol vs. Three Times Per Day Dosing for the Induction of Remission in Active Ulcerative Colitis|Completed||Phase 4|7|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:14:06.844233|2017-02-18 17:14:06.844233
NCT00194805|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2007-11-13|||September 2003||2003-09-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Telehealth for Diabetes Self-Management|Telehealth for Diabetes Self-Management|Completed||N/A|62|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 17:14:06.967827|2017-02-18 17:14:06.967827
NCT00194792|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-05-07|||August 2005||2005-08-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer|Neoadjuvant Complete Hormonal Blockade Followed by Neoadjuvant Chemotherapy for Resectable Hormone Receptor Positive, HER-2/Neu Negative Breast Cancer, A Phase II Study|Terminated||Phase 2|50|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:07.079532|2017-02-18 17:14:07.079532
NCT00194779|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-07|||October 2003||2003-10-01|May 2013|2013-05-01||||June 2010|Actual|2010-06-01||Interventional|||Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery|A Study of Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF Followed by Weekly Paclitaxel as Neoadjuvant Therapy for Resectable, Hormone Receptor Negative or Hormone Receptor Positive, HER-2/Neu Positive Breast Cancer Followed by a Novel Regimen of Capecitabine, Methotrexate and Vinorelbine for Patients Who Do Not Have Either a Macroscopic or Microscopic Pathologic Complete Response, a Phase II Study|Completed||Phase 2|50|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:07.210819|2017-02-18 17:14:07.210819
NCT00194766|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-11-13|||July 2000||2000-07-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer|Continuous Temozolomide (SCH 52365) in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer, Phase II|Completed||Phase 2|35|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:07.360849|2017-02-18 17:14:07.360849
NCT00194753|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-09-12|||December 2001||2001-12-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12|Adjuvant Therapy for High-Risk Localized Breast Cancer With Weekly Adriamycin +/- Oral Cytoxan With Continuous G-CSF Support for 12 Weeks Followed by Weekly Taxol for 12 Weeks, Phase II|Completed||Phase 2|80|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:07.464954|2017-02-18 17:14:07.464954
NCT00194740|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-12-03|||November 1997||1997-11-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer|Taxotere Plus Weekly Navelbine and G-CSF: A Phase II Study in Stage IV Breast Cancer|Completed||Phase 2|48|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:07.580914|2017-02-18 17:14:07.580914
NCT00194727|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-12|||May 2002||2002-05-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer|Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer: A Phase II Trial With Molecular Correlates|Completed||Phase 2|40|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:07.706798|2017-02-18 17:14:07.706798
NCT00194714|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-04|||May 2016||2016-05-01|January 2017|2017-01-01||||May 2018|Anticipated|2018-05-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab|Phase I/II Study of Combination Immunotherapy for the Generation of HER-2/Neu (HER2) Specific Cytotoxic T Cells (CTL) in Vivo|Enrolling by invitation||Phase 1/Phase 2|20|Anticipated|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:07.817462|2017-02-18 17:14:07.817462
NCT00194701|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-01-02|||April 1998||1998-04-01|January 2008|2008-01-01|March 2002||2002-03-01|||||Interventional|||Exercise to Improve Sleep in Heart Failure|Exercise to Improve Sleep in Heart Failure|Completed||Phase 3|152||University of Washington||2|||f||||||||||||||2017-02-18 17:14:07.932908|2017-02-18 17:14:07.932908
NCT00194688|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-01-02|||March 2003||2003-03-01|January 2008|2008-01-01|June 2005||2005-06-01|||||Interventional|||Breath Ammonia Method for H. Pylori Detection: Phase II|Breath Ammonia Method for H. Pylori Detection: Phase II|Completed||Phase 2|278||University of Washington|||||f||||||||||||||2017-02-18 17:14:08.039178|2017-02-18 17:14:08.039178
NCT00194675|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-16|2012-05-02||March 2005||2005-03-01|July 2012|2012-07-01|December 2010|Actual|2010-12-01|April 2010|Actual|2010-04-01||Interventional|TRADE||TRADE-Testosterone Replacement and Dutasteride Effectiveness|Testosterone Replacement and Dutasteride Effectiveness (TRADE)|Completed||Phase 4|53|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:14:08.142001|2017-02-18 17:14:08.142001
NCT00194649|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-18|||June 2005||2005-06-01|September 2008|2008-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|MIG-2||Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study (MIG 2)|Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study|Completed||Phase 4|8|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 17:14:08.783825|2017-02-18 17:14:08.783825
NCT00194636|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-17|||November 2003||2003-11-01|October 2007|2007-10-01|November 2006||2006-11-01|||||Interventional|||Effectiveness of Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)|Effectiveness 0f Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)|Suspended||Phase 4|20||University of Washington||||PI health issues|f||||||||||||||2017-02-18 17:14:08.924179|2017-02-18 17:14:08.924179
NCT00194623|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-17|||August 2003||2003-08-01|October 2007|2007-10-01|August 2007||2007-08-01|||||Interventional|||Botox as a Treatment for Chronic Male Pelvic Pain Syndrome|Botox (Botulinum Toxin A) as a Treatment for Chronic Male Pelvic Pain Syndrome: A Randomized Placebo Controlled Trial|Terminated||Phase 4|30||University of Washington||||Reorganization of personnel forced termination.|f||||||||||||||2017-02-18 17:14:09.010728|2017-02-18 17:14:09.010728
NCT00194610|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-12|2010-12-29||May 2004||2004-05-01|September 2012|2012-09-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|||Botox as a Treatment for Interstitial Cystitis in Women|Botox (Botulinum Toxin A) as a Treatment for Interstitial Cystitis in Women: A Randomized Placebo Controlled Trial|Completed||Phase 4|20|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:14:09.103348|2017-02-18 17:14:09.103348
NCT00194597|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-21|||July 2004||2004-07-01|October 2008|2008-10-01|July 2007||2007-07-01|||||Interventional|||Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III|Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III|Terminated||Phase 4|30||University of Washington||||Illness of PI forced termination.|||||||||||||||2017-02-18 17:14:09.431829|2017-02-18 17:14:09.431829
NCT00194584|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-25|||October 2004||2004-10-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|||||Interventional|||Childhood Chronic Illness: An Educational Program for Parents of Children With On-Going Health Care Needs|Building on Family Strengths: An Educational Program for Parents of Children With On-Going Health Care Needs|Completed||N/A|129|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:14:09.528118|2017-02-18 17:14:09.528118
NCT00194558|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-30|||February 2005||2005-02-01|September 2008|2008-09-01||||||||Interventional|||Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care|Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care|Completed||N/A|82|Actual|University of Washington|||||f||||||||||||||2017-02-18 17:14:09.734857|2017-02-18 17:14:09.734857
NCT00194545|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-07-05|||July 2004||2004-07-01|July 2012|2012-07-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children|Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children|Completed||Phase 2|100|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:14:09.823825|2017-02-18 17:14:09.823825
NCT00194532|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-03|2011-03-30||June 2005||2005-06-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Cefpodoxime vs Ciprofloxacin for Acute Cystitis|Cefpodoxime vs Ciprofloxacin for Acute Cystitis|Completed||N/A|300|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:14:10.120878|2017-02-18 17:14:10.120878
NCT00194519|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-16|||November 2004||2004-11-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|November 2009|Actual|2009-11-01||Interventional|||Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission|Phase III Randomized Placebo-Controlled Trial of HSV-2 Suppression to Prevent HIV Transmission Among HIV-Discordant Couples|Completed||Phase 3|3408|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:14:10.510821|2017-02-18 17:14:10.510821
NCT00194506|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-04-12|||August 2002||2002-08-01|April 2006|2006-04-01|May 2006||2006-05-01|||||Interventional|||Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home|Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home|Completed||N/A|82||University of Washington|||||f||||||||||||||2017-02-18 17:14:10.658339|2017-02-18 17:14:10.658339
NCT00194493|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-30|||April 2005||2005-04-01|April 2015|2015-04-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|ESRA-C||Computerized Assessment for Patients With Cancer|Computerized Assessment for Patients With Cancer|Completed||Phase 3|1058|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 17:14:10.757787|2017-02-18 17:14:10.757787
NCT00194480|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-11|||April 2003||2003-04-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users|Treatment of Acute Hepatitis C Virus Infection in Injection Drug Users With Pegylated Interferon for 24 Weeks|Completed||Phase 4|21|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-02-18 17:14:10.870487|2017-02-18 17:14:10.870487
NCT00194467|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-29|||December 2002||2002-12-01|December 2007|2007-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Suppression of Oral HHV8 Shedding With Valganciclovir|Suppression of Oral Shedding of Human Herpesvirus 8 (HHV-8) With Valganciclovir|Completed||Phase 2|32|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:14:10.987773|2017-02-18 17:14:10.987773
NCT00194454|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-21|||March 2002||2002-03-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Psychosocial/Behavioral Intervention in Post-Stroke Depression|Psychosocial/Behavioral Intervention in PSD|Completed||N/A|101|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:14:11.110155|2017-02-18 17:14:11.110155
NCT00194441|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-29|||April 1999||1999-04-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Cerebral Perfusion Pressure (CPP) Management Information Feedback and Nursing|CPP Management Information Feedback and Nursing|Completed||N/A|260|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:14:11.258891|2017-02-18 17:14:11.258891
NCT00194428|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-03-26|||February 2005||2005-02-01|January 2008|2008-01-01|October 2009|Actual|2009-10-01|October 2007|Actual|2007-10-01||Interventional|||Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons|Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons|Completed||Phase 1/Phase 2|123|Actual|Temple University||2|||f||||f||||||||||2017-02-18 17:14:11.377359|2017-02-18 17:14:11.377359
NCT00194415|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-29|||January 2004||2004-01-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study of HSV Testing Among Pregnant Women|A Randomized Clinical Trial of Antenatal vs Delayed (Post Partum) Testing for HSV Type-Specific Antibodies Among Pregnant Women.|Terminated||N/A|173|Actual|University of Washington||2||An interim data analysis found no significant difference between testing groups.|f||||f||||||||||2017-02-18 17:14:11.505006|2017-02-18 17:14:11.505006
NCT00194402|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-08-20|||August 2003||2003-08-01|August 2008|2008-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia|SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers|Completed||Phase 4|64|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:14:11.6199|2017-02-18 17:14:11.6199
NCT00194376|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-09-22|||June 2005||2005-06-01|September 2010|2010-09-01|June 2007|Actual|2007-06-01|September 2006|Actual|2006-09-01||Interventional|||Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea|Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea|Completed||N/A|10|Anticipated|University of Pennsylvania||1|||f||||||||||||||2017-02-18 17:14:11.744069|2017-02-18 17:14:11.744069
NCT00194363|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-15|||October 2005||2005-10-01|August 2016|2016-08-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Strength Training Intervention for Breast Cancer Survivors and the Effects on Lymphedema Status|The PAL Trial (Physical Activity and Lymphedema)|Active, not recruiting||N/A|295|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 17:14:11.834525|2017-02-18 17:14:11.834525
NCT00194350|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-08|||September 2001||2001-09-01|August 2011|2011-08-01|August 2005|Actual|2005-08-01|||||Observational|||Factor V Leiden Mutation and Implantation Failure|Evaluation of the Role of Factor V Leiden Mutation in Implantation Failure|Completed||N/A|399||University of Pennsylvania|||1||f||||f||||||||||2017-02-18 17:14:11.93985|2017-02-18 17:14:11.93985
NCT00194337|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-24|||October 1999||1999-10-01|January 2007|2007-01-01||||July 2012|Actual|2012-07-01||Interventional|||Digital Mammography, Ultrasound, MRI, and PET Scans in Women With Newly Diagnosed Breast Cancer|Evaluation of Multimodality Breast Imaging: Project 3-Lesion Staging|Unknown status|Active, not recruiting|Phase 2/Phase 3|400|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||||||||||||2017-02-18 17:14:12.066716|2017-02-18 17:14:12.066716
NCT00194324|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-08|||July 2004||2004-07-01|August 2011|2011-08-01|October 2004|Actual|2004-10-01|||||Interventional|||Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina|Vaginal Imaging Study to Evaluate the Effect of Exercise on the Distribution of Miconozole Nitrate OVULE|Completed||Phase 4|12||University of Pennsylvania|||||f||||f||||||||||2017-02-18 17:14:12.168483|2017-02-18 17:14:12.168483
NCT00194311|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-15|||April 2005||2005-04-01|August 2016|2016-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Human Papillomavirus (HPV) Infection in Pregnancy||Completed||N/A|620|Anticipated|University of Pennsylvania|||1||f||||||||||||||2017-02-18 17:14:12.259146|2017-02-18 17:14:12.259146
NCT00194298|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-29|||October 2002||2002-10-01|August 2016|2016-08-01||||January 2017|Anticipated|2017-01-01||Observational|||FDG-PET Imaging in Complicated Diabetic Foot|FDG-PET Imaging in Complicated Diabetic Foot (Protocol Version Dated 3/01/2004)|Active, not recruiting||Phase 2/Phase 3|240|Anticipated|University of Pennsylvania|||1||f||||||||||||||2017-02-18 17:14:12.370451|2017-02-18 17:14:12.370451
NCT00194285|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-29|||March 2001||2001-03-01|August 2016|2016-08-01||||January 2017|Anticipated|2017-01-01||Observational|||FDG-PET Imaging in Painful Joint Prosthesis|FDG-PET Imaging in Painful Joint Prosthesis (Protocol Amendment, Version 11, Dated 9/2005)|Active, not recruiting||Phase 2/Phase 3|530|Anticipated|University of Pennsylvania|||1||f||||||||||||||2017-02-18 17:14:12.473061|2017-02-18 17:14:12.473061
NCT00194272|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-08|||March 2001||2001-03-01|August 2011|2011-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Two-Dose Methotrexate for Ectopic Pregnancy|Two-Dose Methotrexate for Ectopic Pregnancy|Completed||Phase 3|100|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-02-18 17:14:12.564602|2017-02-18 17:14:12.564602
NCT00194259|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-05|||August 2001||2001-08-01|January 2008|2008-01-01|June 2014|Anticipated|2014-06-01|June 2014|Anticipated|2014-06-01||Observational|||Sleep Apnea in Look AHEAD (Action for Health in Diabetes)|Sleep Apnea in Look AHEAD (Action for Health in Diabetes)|Unknown status|Active, not recruiting|N/A|320|Anticipated|Temple University|||1||f||||t||||||Samples Without DNA|"~     Saliva Samples~   "|||2017-02-18 17:14:12.67271|2017-02-18 17:14:12.67271
NCT00194246|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-28|||August 2003||2003-08-01|August 2007|2007-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||Cognitive Function and Cue-Reactivity Study|Cognitive Performance and Food Reactivity During High and Low Carbohydrate Obesity Treatment|Completed||N/A|29|Actual|Temple University|||1||f||||f||||||Samples Without DNA|"~     salivary cortisol~   "|||2017-02-18 17:14:12.771525|2017-02-18 17:14:12.771525
NCT00194233|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-15|||November 2003||2003-11-01|August 2016|2016-08-01|June 2008|Actual|2008-06-01|January 2007|Actual|2007-01-01||Observational|||Serum and Peritoneal Fluid Bank for Endometriosis Markers|Serum and Peritoneal Fluid Bank for Assessment of Markers of Endometriosis|Completed||N/A|300|Anticipated|University of Pennsylvania|||1||f||||||||||Samples With DNA|"~     Serum, Plasma, Peritoneal fluid~   "|||2017-02-18 17:14:12.849641|2017-02-18 17:14:12.849641
NCT00194220|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-28|||September 2002||2002-09-01|September 2015|2015-09-01|February 2013|Actual|2013-02-01|July 2012|Actual|2012-07-01||Observational|||Infertility Markers in Serum, Urine, and Follicular Fluid|Markers in Women Undergoing Infertility Treatment|Completed||N/A|1235|Actual|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"~     Blood, Urine, Follicular Fluid~   "|||2017-02-18 17:14:12.92769|2017-02-18 17:14:12.92769
NCT00194207|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-15|||October 1999||1999-10-01|August 2016|2016-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Risk Factors of Ectopic Pregnancy|Risk Factors as Predictors of Ectopic PRegnancy|Completed||N/A|3000|Anticipated|University of Pennsylvania|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 17:14:13.139567|2017-02-18 17:14:13.139567
NCT00194194|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-03-13|||August 2004||2004-08-01|October 2008|2008-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Healthetech, Inc. SMART Study|The Effect of Measuring Resting Metabolic Rate (RMR) in the Context of Moderate or Intensive Behavior Modification Treatment on Weight Loss|Completed||Phase 2|56|Actual|Temple University||2|||f||||f||||||||||2017-02-18 17:14:13.224563|2017-02-18 17:14:13.224563
NCT00194181|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-14|||March 2003||2003-03-01|July 2006|2006-07-01|March 2005||2005-03-01|||||Interventional|||Rt-PA Infusion Versus Catheter Exchange for Dialysis Catheter Malfunction Due to Fibrin Sheath|Randomized Prospective Trial of Rt-PA Infusion Versus Catheter Exchange for Treatment of Dialysis Catheter Malfunction Due to Fibrin Sheath Formation|Terminated||N/A|40||University of Pennsylvania|||||f||||||||||||||2017-02-18 17:14:13.330697|2017-02-18 17:14:13.330697
NCT00194168|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-15|||June 2000||2000-06-01|August 2016|2016-08-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Ectopic Pregnancy Biomarkers|Serum Bank for Assessment of Markers of Ectopic Pregnancy|Completed||N/A|1306|Actual|University of Pennsylvania|||1||f||||f||||||Samples With DNA|"~     Blood (Plasma, Serum)~   "|||2017-02-18 17:14:13.411497|2017-02-18 17:14:13.411497
NCT00194155|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-15|||May 2003||2003-05-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Cytomegalovirus (CMV) Infection in Pregnancy|Cytomegalovirus Infection and Pregnancy Outcomes|Completed||N/A|283|Actual|University of Pennsylvania|||1||f||||||||||||||2017-02-18 17:14:13.488407|2017-02-18 17:14:13.488407
NCT00194142|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-15|||July 2007||2007-07-01|August 2016|2016-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Cytomegalovirus (CMV) Infection in Amniotic Fluid||Completed||N/A|37|Actual|University of Pennsylvania|||1||f||||||||||||||2017-02-18 17:14:13.56913|2017-02-18 17:14:13.56913
NCT00194129|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-04|2013-11-04||November 1997||1997-11-01|November 2013|2013-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder|A Randomized, Double Blind Comparison of Lithium Monotherapy Versus Lithium Plus Divalproex for the Outpatient Management of Hypomania/Mania in Patients With Rapid Cycling Bipolar Disorder Comorbid With Substance Abuse/Dependence|Completed||Phase 3|31|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-02-18 17:14:13.657253|2017-02-18 17:14:13.657253
NCT00194116|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-01|||September 2004||2004-09-01|December 2014|2014-12-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression|Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression|Completed||Phase 3|30|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-02-18 17:14:14.006923|2017-02-18 17:14:14.006923
NCT00194103|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-25|||May 2004||2004-05-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|August 2009|Actual|2009-08-01||Interventional|ETM||Effectiveness of Extended Telephone Monitoring||Completed||Phase 3|252|Actual|University of Pennsylvania||3|||f||||||||||||||2017-02-18 17:14:14.114436|2017-02-18 17:14:14.114436
NCT00194090|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2004||2004-06-01|July 2004|2004-07-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Celecoxib Vs Placebo to Prevent Pain in a Paced Walk|A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy of Celecoxib 200 Mg Qd in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee|Unknown status|Recruiting|Phase 4|40||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-02-18 17:14:14.207618|2017-02-18 17:14:14.207618
NCT00194077|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2014-12-17|2013-06-26||August 2004||2004-08-01|December 2014|2014-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||No differences.|Study of Aripiprazole (Abilify) in Children With Symptoms of Mania|Aripiprazole in Children With Symptoms of Mania|Completed||Phase 3|60|Actual|University Hospitals Cleveland Medical Center|No deaths occured during this study.|2|||f||||t||||||||||2017-02-18 17:14:14.298603|2017-02-18 17:14:14.298603
NCT00194064|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-03|||July 2002||2002-07-01|October 2016|2016-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine|Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania|Terminated||Phase 3|18|Actual|University Hospitals Cleveland Medical Center||1||Slow enrollment|f||||t||||||||||2017-02-18 17:14:14.63833|2017-02-18 17:14:14.63833
NCT00194051|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-05|||February 2003||2003-02-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Observational|||Symptomatic, Biomechanical and Radiographic Outcomes in Knee Osteoarthritis Following Gastric Bypass Surgery|Symptomatic, Biomechanical and Radiographic Outcomes in Knee Osteoarthritis Following Gastric Bypass Surgery|Unknown status|Active, not recruiting|N/A|35||University Hospitals Cleveland Medical Center|||||f||||||||||||||2017-02-18 17:14:14.732431|2017-02-18 17:14:14.732431
NCT00194038|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-16|||April 2004||2004-04-01|January 2010|2010-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Aripiprazole in Late Life Bipolar Disorder|Aripiprazole in Late Life Bipolar Disorder|Completed||Phase 4|20|Actual|University Hospitals Cleveland Medical Center||1|||f||||f||||||||||2017-02-18 17:14:14.816356|2017-02-18 17:14:14.816356
NCT00194025|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-16|2009-01-26||November 2004||2004-11-01|February 2011|2011-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Valproate in Late Life Schizophrenia|Add-on Valproate in Late Life Schizophrenia|Completed||Phase 4|20|Actual|University Hospitals Cleveland Medical Center|The findings of this study must be interpreted cautiously given the limitations of small sample size, open-label, add-on design and lack of a control or comparator group. The mean age of 61 years is not representative of the “old-old” populations.|1|||f||||f||||||||||2017-02-18 17:14:14.937455|2017-02-18 17:14:14.937455
NCT00194012|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2014-12-17|2013-06-26||August 2004||2004-08-01|December 2014|2014-12-01|June 2012|Actual|2012-06-01|May 2012|Actual|2012-05-01||Interventional|||Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder|Aripiprazole in At-Risk Children With Symptoms of Bipolar Disorder|Completed||Phase 3|59|Actual|University Hospitals Cleveland Medical Center||2|||f||||t||||||||||2017-02-18 17:14:18.15745|2017-02-18 17:14:18.15745
NCT00193999|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-10-26|||February 2003||2003-02-01|September 2008|2008-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Do Nasogastric Tubes After Cardiac Surgery Reduce Nausea and Vomiting|Do Nasogastric Tubes After Cardiac Surgery Reduce Nausea and Vomiting. A Prospective Randomized Clinical Trial.|Completed||Phase 4|300|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:14:18.553507|2017-02-18 17:14:18.553507
NCT00193986|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-11-13|||May 2005||2005-05-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Assessment of Prepulse Inhibition for Shock Pain Reduction|Assessment of Prepulse Inhibition for Shock Pain Reduction- Ventricular|Completed||N/A|10||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:14:18.636985|2017-02-18 17:14:18.636985
NCT00193973|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-15|||July 2001||2001-07-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|July 2008|Actual|2008-07-01||Interventional|||Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma|A Phase 2 Study of Idarubicin Based Combined Modality Therapy in Primary Central Nervous System Lymphoma|Completed||Phase 2|20|Actual|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||f||||||||||2017-02-18 17:14:18.722164|2017-02-18 17:14:18.722164
NCT00193960|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-29|||January 1997||1997-01-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Observational|||The Results of Ahmed Valve Operations|A Comparison Between Superior and Inferior Ahmed Glaucoma Valve Implantation: Surgical Success and Complications|Unknown status|Recruiting|N/A|80||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:14:18.848767|2017-02-18 17:14:18.848767
NCT00193947|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-08-02|||November 2003||2003-11-01|April 2007|2007-04-01|May 2008|Actual|2008-05-01|||||Observational|||An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy|An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy|Terminated||Phase 4|56|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 17:14:18.936957|2017-02-18 17:14:18.936957
NCT00193934|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-23|||January 2006||2006-01-01|January 2017|2017-01-01|May 15, 2014|Actual|2014-05-15|May 2014|Actual|2014-05-01||Observational|||Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer|Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer|Completed||N/A|109|Actual|Trans-Tasman Radiation Oncology Group (TROG)|||1||f||||f||||||||||2017-02-18 17:14:19.044808|2017-02-18 17:14:19.044808
NCT00193921|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-07-31|||February 2003||2003-02-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2009|Actual|2009-12-01||Interventional|||Chemoradiotherapy in Patients With Localised Lung Cancer|A Randomised Phase II Study of Two Regimens of Palliative Chemoradiation Therapy in the Management of Locally Advanced Non Small Cell Lung Cancer|Completed||Phase 2|82|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-02-18 17:14:19.40891|2017-02-18 17:14:19.40891
NCT00193908|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-05-13|||March 2004||2004-03-01|May 2009|2009-05-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||"Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine (Sorbolene) Cream"|"A Paired Double Blind Randomised Comparison of Cavilon(TM) Durable Barrier Cream(TM)[CDBC] to 10% Glycerine (Sorbolene) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care"|Completed||Phase 3|333|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-02-18 17:14:19.541181|2017-02-18 17:14:19.541181
NCT00188422|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-20|||August 2003||2003-08-01|April 2007|2007-04-01|January 2006||2006-01-01|||||Interventional|||Study of Low Dose CT in Sarcoma Patients|Surveillance Low Dose Computed Tomography of the Thorax in Patients With High Grade Extremity Soft Tissue Sarcoma|Completed||Phase 1|70||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:05.051234|2017-02-18 17:16:05.051234
NCT00193895|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-22|||April 2005||2005-04-01|January 2017|2017-01-01|March 31, 2016|Actual|2016-03-31|March 2016|Actual|2016-03-01||Interventional|||Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck|Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy in High-risk Cutaneous Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|321|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-02-18 17:14:19.6626|2017-02-18 17:14:19.6626
NCT00193882|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-23|||July 7, 2003||2003-07-07|January 2017|2017-01-01|June 18, 2013|Actual|2013-06-18|March 21, 2012|Actual|2012-03-21||Interventional|||Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.|A Randomised Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated With Radiotherapy vs ChemoRadiotherapy.|Completed||Phase 3|220|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||t||||||||||2017-02-18 17:14:19.813584|2017-02-18 17:14:19.813584
NCT00193869|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-05-08|||September 2001||2001-09-01|May 2007|2007-05-01|December 2003|Actual|2003-12-01|||||Interventional|||SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).|A Pilot Randomised Comparison of Dexamethasone 96 mg Versus 16 mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy|Completed||Phase 2|20|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-02-18 17:14:19.964615|2017-02-18 17:14:19.964615
NCT00193856|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-22|||October 2003||2003-10-01|January 2017|2017-01-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||RADAR Trial - Randomised Androgen Deprivation and Radiotherapy|A Randomised Trial Investigating the Effect on Biochemical (PSA) Control and Survival of Different Durations of Adjuvant Androgen Deprivation in Association With Definitive Radiation Treatment for Localised Carcinoma of the Prostate.|Active, not recruiting||Phase 3|1071|Actual|Trans-Tasman Radiation Oncology Group (TROG)||4|||f||||t||||||||||2017-02-18 17:14:20.077616|2017-02-18 17:14:20.077616
NCT00193843|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-23|||June 2005||2005-06-01|September 2005|2005-09-01|June 2017||2017-06-01|||||Interventional|||Oral Cancer Adjuvant Therapy (OCAT) Trial|Phase III Trial of Surgery Followed by Conventional RT(5fr/Week)Vs.Concurrent Chemo-Radiotherapy Vs.Accelerated RT(6fr/Week)in High Risk, Loco-Regionally Advanced, Stage III&IVA, Resectable, Squamous Cell Carcinomas of Oralcavity|Recruiting||Phase 3|900||Tata Memorial Hospital|||||f||||||||||||||2017-02-18 17:14:20.238808|2017-02-18 17:14:20.238808
NCT00193830|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-05|||May 1996||1996-05-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix|High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix|Completed||Phase 3|750||Tata Memorial Hospital|||||f||||||||||||||2017-02-18 17:14:20.349451|2017-02-18 17:14:20.349451
NCT00193817|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-02-06|||January 2005||2005-01-01|July 2005|2005-07-01|December 2015||2015-12-01|||||Interventional|||Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial||Unknown status|Recruiting|Phase 3|700||Tata Memorial Hospital|||||f||||||||||||||2017-02-18 17:14:20.435571|2017-02-18 17:14:20.435571
NCT00193804|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-24|||February 2005||2005-02-01|April 2015|2015-04-01|February 2016|Anticipated|2016-02-01|February 2016|Anticipated|2016-02-01||Observational|||A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix|A Phase II Randomized Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix|Active, not recruiting||Phase 2|200|Anticipated|Tata Memorial Hospital|||1||f||||t||||||||||2017-02-18 17:14:20.521388|2017-02-18 17:14:20.521388
NCT00193791|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-22|||July 2003||2003-07-01|April 2015|2015-04-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|CRACx||Concomitant Chemoradiation in Advanced Stage Carcinoma Cervix|Concomitant Chemo-radiation in Advanced Stage Carcinoma Cervix: A Phase III Randomized Trial|Active, not recruiting||Phase 3|850|Actual|Tata Memorial Hospital||2|||f||||t||||||||||2017-02-18 17:14:20.626293|2017-02-18 17:14:20.626293
NCT00193778|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-10-18|||February 2005||2005-02-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation|A Randomized Trial To Assess The Impact Of Loco-Regional Treatment On Survival Of Patients With Metastatic Breast Cancer At First Presentation|Active, not recruiting||Phase 3|350|Actual|Tata Memorial Hospital||2|||f||||t||||||||||2017-02-18 17:14:20.729284|2017-02-18 17:14:20.729284
NCT00193765|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-06|||January 2004||2004-01-01|April 2015|2015-04-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Interventional|||Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity|Elective Versus Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Cell Carcinoma of the Oral Cavity|Active, not recruiting||Phase 3|710|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||||2017-02-18 17:14:20.843995|2017-02-18 17:14:20.843995
NCT00193752|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-14|||September 2005||2005-09-01|July 2008|2008-07-01|September 2010|Anticipated|2010-09-01|||||Observational|||Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Advanced Cancer Cervix|Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Advanced Cancer Cervix|Unknown status|Recruiting|Phase 2|100|Anticipated|Tata Memorial Hospital|||1||f||||t||||||||||2017-02-18 17:14:21.025189|2017-02-18 17:14:21.025189
NCT00193739|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-11-06|||September 2003||2003-09-01|November 2015|2015-11-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|NACTcervix||Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix|A Prospective Randomized Trial of Neoadjuvant Chemotherapy and Surgery Versus Concurrent Chemoradiation Therapy in Patients With Stage IB2-IIB Squamous Carcinoma of the Uterine Cervix|Recruiting||Phase 3|730|Anticipated|Tata Memorial Hospital||2|||f||||t||||||||||2017-02-18 17:14:21.31581|2017-02-18 17:14:21.31581
NCT00193726|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2016-10-25|||July 2005||2005-07-01|October 2016|2016-10-01|June 2018|Anticipated|2018-06-01|December 2017|Anticipated|2017-12-01||Interventional|||Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer|Estrogen Priming to Increase the Efficacy of Standard Adjuvant Chemotherapy in Operable Breast Cancer.|Recruiting||Phase 3|730|Anticipated|Tata Memorial Hospital||2|||f||||f||||||||Undecided||2017-02-18 17:14:21.459031|2017-02-18 17:14:21.459031
NCT00188409|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-20|||February 2002||2002-02-01|September 2005|2005-09-01|February 2004||2004-02-01|||||Interventional|||Pneumothorax Post CT Lung Biopsy|Pneumothorax Following CT-Guided Lung Biopsy: Is There a Role for the Post Biopsy CT in Patient Management|Completed||N/A|200||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:05.136404|2017-02-18 17:16:05.136404
NCT00193713|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-01-15|||May 2005||2005-05-01|January 2007|2007-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Bifeprunox in the Treatment of Schizophrenia|A Randomized, Double-Blind, Olanzapine-Referenced, Parallel-Group Safety and Efficacy Study of Flexible Doses of Bifeprunox in the Long-term Treatment of Schizpohrenia (Extension of S1543003)|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:14:21.594475|2017-02-18 17:14:21.594475
NCT00193700|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2006-12-23|||August 2002||2002-08-01|November 2006|2006-11-01||||||||Interventional|||Pharmacokinetic Evaluation of Testosterone Gel (1%)|Pharmacokinetic Evaluation of Testosterone Gel (1%) in Prepubertal Boys of Adolescent Age|Completed||Phase 1|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:14:21.664557|2017-02-18 17:14:21.664557
NCT00192491|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-02-07|||December 2000||2000-12-01|February 2008|2008-02-01|December 2003|Actual|2003-12-01|September 2003|Anticipated|2003-09-01||Interventional|||Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children|A Randomized, Placebo-Controlled, Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, (MMRIIÒ) and Varicella (VARIVAXÒ) Vaccines Administered Concurrently to Healthy Children (AV018)|Completed||Phase 3|1200|Anticipated|MedImmune LLC||3|||f||||f||||||||||2017-02-18 17:14:21.7555|2017-02-18 17:14:21.7555
NCT00192478|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-24|||February 2004||2004-02-01|July 2008|2008-07-01|August 2006|Actual|2006-08-01|May 2006|Actual|2006-05-01||Interventional|||Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524|A Phase 1/2, Open-Label, Repeat-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children at Risk for Serious RSV Disease|Completed||Phase 1/Phase 2|217|Actual|MedImmune LLC||1|||f||||||||||||||2017-02-18 17:14:21.858151|2017-02-18 17:14:21.858151
NCT00192465|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-28|||November 2003||2003-11-01|January 2009|2009-01-01|November 2004|Actual|2004-11-01|April 2004|Actual|2004-04-01||Interventional|||Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults|A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 (NUMAX TM), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Healthy Adults|Completed||Phase 1|30|Actual|MedImmune LLC||5|||f||||||||||||||2017-02-18 17:14:21.960275|2017-02-18 17:14:21.960275
NCT00192452|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-23|||March 2001||2001-03-01|October 2006|2006-10-01|December 2001||2001-12-01|||||Interventional|||Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis|A Phase II Randomized, Double-Blind, Placebo-Controlled Study of MEDI-507, a Humanized Monoclonal Antibody That Binds to the CD2 Receptor, Administered by Intravenous Infusion to Adults With Plaque Psoriasis|Completed||Phase 2|120||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:22.071988|2017-02-18 17:14:22.071988
NCT00192439|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-04|||December 2003||2003-12-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Observational|||Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk|A Study to Describe the Incidence Rate and Clinical Features of Human Meta Pneumovirus (hMPV) Infection of the Lower Respiratory Tract in Hospitalized Children at High Risk for Severe Disease|Completed||N/A|1500|Actual|MedImmune LLC|||||f||||||||||||||2017-02-18 17:14:22.161353|2017-02-18 17:14:22.161353
NCT00192426|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-02|||September 2001||2001-09-01|October 2006|2006-10-01|December 2001||2001-12-01|||||Interventional|||Trial to Evaluate the Immune Response to OPV When Administered Concomitantly With CAIV-T to Healthy Children.|A Prospective, Randomized, Partially-Blinded, Placebo-Controlled, Phase III, Multicenter Trial to Assess Safety, Tolerability and Immunogenicity of Liquid CAIV-T Administered Concomitantly With OPV in Healthy Children|Completed||Phase 3|2400||MedImmune LLC|||||f||||||||||||||2017-02-18 17:14:22.270918|2017-02-18 17:14:22.270918
NCT00192413|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-13|||March 2002||2002-03-01|March 2012|2012-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|FluMist||Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza|A Prospective, Randomized, Open-Label, Controlled Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older|Completed||Phase 3|3009|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 17:14:22.347192|2017-02-18 17:14:22.347192
NCT00192400|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-02|||March 2002||2002-03-01|October 2006|2006-10-01|November 2002||2002-11-01|||||Interventional|||Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.|A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of One Dose and Two Doses of a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) Compared With Placebo in Healthy Children|Completed||Phase 3|2160||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:22.456898|2017-02-18 17:14:22.456898
NCT00192387|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-12-27|||September 2001||2001-09-01|December 2006|2006-12-01|December 2001||2001-12-01|||||Interventional|||Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)|A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate Viral Shedding in Healthy Children (6 Mos and Less Than or Equal to 18 Months of Age) Vaccinated With Two Doses of Liquid Formulation of Influenza Virus Vaccine, Live Cold Adapted (CAIV-T)|Completed||Phase 2|60||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:22.523418|2017-02-18 17:14:22.523418
NCT00192374|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-02|||February 2002||2002-02-01|October 2006|2006-10-01|November 2002||2002-11-01|||||Interventional|||Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase III, Multicenter Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B,Live, Cold-Adapted (CAIV-T) in Healthy Children|Completed||Phase 3|1920||MedImmune LLC|||||f||||||||||||||2017-02-18 17:14:22.608901|2017-02-18 17:14:22.608901
NCT00192946|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-07-09||||||February 2006|2006-02-01|September 2008|Anticipated|2008-09-01|||||Interventional|||The CRT-KIR Study (Cardiac Resynchronization Therapy [CRT] in the Early Phase After Heart Surgery)|Cardiac Resynchronization Therapy (CRT) in the Early Phase After Heart Surgery|Withdrawn||N/A|60|Anticipated|Rigshospitalet, Denmark||||The study population is smaller than expected. No subjects were included.|f||||||||||||||2017-02-18 17:14:33.147569|2017-02-18 17:14:33.147569
NCT00192361|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-23|||November 1999||1999-11-01|October 2006|2006-10-01||||||||Interventional|||Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)|A Randomized, Double-Blind Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)|Completed||Phase 3|200||MedImmune LLC|||||f||||||||||||||2017-02-18 17:14:22.700877|2017-02-18 17:14:22.700877
NCT00193687|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-03-20|||September 2005||2005-09-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Bifeprunox in the Treatment of Schizophrenia|An Open-Label, Flexible-Dose, Long-Term Safety and Efficacy Study of Bifeprunox in the Treatment of Schizpohrenia (Extension of S154.3.001)|Completed||Phase 3|986|Actual|Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:14:22.789557|2017-02-18 17:14:22.789557
NCT00193674|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-08-25|||September 2003||2003-09-01|August 2011|2011-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage|Oral Dydrogesterone Treatment During the First Trimester of Pregnancy in Women With Recurrent Miscarriage: A Double-Blind, Prospectively Randomized, Placebo-Controlled, Parallel Group Trial|Completed||Phase 3|71|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:14:22.857863|2017-02-18 17:14:22.857863
NCT00193661|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-01-15|||August 2002||2002-08-01|September 2006|2006-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism|A Multi-Center, Open-Label, Observational Study of Testosterone Gel (1%) in the Treatment of Adolescent Boys With Hypogonadism|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:14:22.966155|2017-02-18 17:14:22.966155
NCT00193648|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2007-10-19|||July 2005||2005-07-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)|Novel Therapies for Resistant FSGS|Completed||Phase 1|21|Actual|Northwell Health||2|||f||||t||||||||||2017-02-18 17:14:23.076814|2017-02-18 17:14:23.076814
NCT00193635|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-10-17|||March 2002||2002-03-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Pilot Study of Mycophenolate Mofetil in Congenital Uropathies|Pilot Study of Mycophenolate Mofetil in Congenital Uropathies|Completed||Phase 1|12|Actual|Northwell Health||1|||f||||t||||||||||2017-02-18 17:14:23.188334|2017-02-18 17:14:23.188334
NCT00193622|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-09-15|||April 2004||2004-04-01|September 2010|2010-09-01|January 2009|Actual|2009-01-01|September 2005|Actual|2005-09-01||Interventional|||Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site|A Phase II Trial of Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site|Completed||Phase 2|50||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:23.300591|2017-02-18 17:14:23.300591
NCT00193609|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-18|2013-08-15||September 2004||2004-09-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|April 2008|Actual|2008-04-01||Interventional|||Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site|A Phase II Trial of Oxaliplatin and Capecitabine in the Treatment of Patients With Relapsed/Refractory Carcinoma of Unknown Primary Site|Completed||Phase 2|48|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:23.387143|2017-02-18 17:14:23.387143
NCT00193596|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-03-22|2013-01-14||September 2003||2003-09-01|March 2013|2013-03-01|June 2009|Actual|2009-06-01|September 2008|Actual|2008-09-01||Interventional|||Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site|A Randomized, Phase III Comparison of Gemcitabine/Irinotecan Followed by IRESSA Versus Paclitaxel/Carboplatin/Etoposide Followed by IRESSA in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site|Completed||Phase 3|198|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 17:14:23.714166|2017-02-18 17:14:23.714166
NCT00193583|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-03|||May 2003||2003-05-01|May 2011|2011-05-01|May 2005|Actual|2005-05-01|May 2004|Actual|2004-05-01||Interventional|||Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors|A Phase I Study of Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Patients With Refractory and/or Advanced Solid Tumors|Completed||Phase 1|18||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:24.536609|2017-02-18 17:14:24.536609
NCT00193570|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-01-22|||February 2002||2002-02-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|August 2004|Actual|2004-08-01||Interventional|||Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors|A Phase I Study of Topotecan in Combination With Docetaxel in Patients With Refractory and/or Advanced Solid Tumors|Completed||Phase 1|20||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:24.632054|2017-02-18 17:14:24.632054
NCT00193557|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-28|||May 2004||2004-05-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|May 2006|Actual|2006-05-01||Interventional|||Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma|Phase I Trial of Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:24.713643|2017-02-18 17:14:24.713643
NCT00193544|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-01-21|||March 2002||2002-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2005|Actual|2005-10-01||Interventional|||Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma|Phase II Trial of Arsenic Trioxide and Thalidomide in the Treatment of Patients With Refractory Multiple Myeloma|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:24.814053|2017-02-18 17:14:24.814053
NCT00193531|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-28|||December 1998||1998-12-01|October 2008|2008-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma|Phase II Study of Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in the Treatment of High Grade Neuroendocrine Carcinoma|Completed||Phase 2|100||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:24.899489|2017-02-18 17:14:24.899489
NCT00193518|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||April 2004||2004-04-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|A Phase II Trial Of Arsenic Trioxide (TRISENOX) In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Completed||Phase 2|41||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:24.994217|2017-02-18 17:14:24.994217
NCT00193505|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||October 2003||2003-10-01|May 2011|2011-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma|Phase II Trial of Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in the Treatment of Patients With Relapsed/Refractory Intermediate Grade B-Cell Lymphoma|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||f||||||||||2017-02-18 17:14:25.10153|2017-02-18 17:14:25.10153
NCT00193492|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-12-11|2014-12-05||September 2005||2005-09-01|December 2014|2014-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma|Rituximab +/- Bevacizumab in the Treatment of Patients With Follicular Non-Hodgkin's Lymphoma: A Randomized, Phase II Trial|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||2|||f||||t||||||||||2017-02-18 17:14:25.197764|2017-02-18 17:14:25.197764
NCT00193479|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-01-08|2014-01-08||April 2003||2003-04-01|January 2014|2014-01-01|February 2010|Actual|2010-02-01|July 2008|Actual|2008-07-01||Interventional|||Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma|A Phase II Trial of Brief Duration Combination Chemotherapy and Rituximab With Prophylactic Pegfilgrastim, Followed by Maintenance Rituximab, in Elderly/Poor Performance Status Patients With Large B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|51|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:25.679159|2017-02-18 17:14:25.679159
NCT00193466|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-12-29|||January 2002||2002-01-01|December 2010|2010-12-01|April 2008|Actual|2008-04-01|January 2007|Actual|2007-01-01||Interventional|||Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase II Trial of Rituximab/Fludarabine Followed by CAMPATH-1H in the First-Line Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:25.977085|2017-02-18 17:14:25.977085
NCT00193453|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-11|2012-10-11||July 2005||2005-07-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|||Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer|A Phase II Trial of First-Line Therapy With Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Stage III or IV Non-Small Cell Lung Cancer|Completed||Phase 2|69|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:26.069963|2017-02-18 17:14:26.069963
NCT00193440|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-12-29|||April 2002||2002-04-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|April 2004|Actual|2004-04-01||Interventional|||Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma|Phase II Trial of Rituximab and Short Duration Chemotherapy Followed by Zevalin as First-Line Treatment for Patients With Low Grade Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:26.391384|2017-02-18 17:14:26.391384
NCT00193427|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-11|2012-10-11||April 2004||2004-04-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer|Phase II Trial of Preoperative (Neo-adjuvant) Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|76|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:26.473757|2017-02-18 17:14:26.473757
NCT00193414|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-11|2012-10-11||May 2005||2005-05-01|October 2012|2012-10-01|August 2009|Actual|2009-08-01|December 2008|Actual|2008-12-01||Interventional|||Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer|Phase II Study of First-Line Therapy With Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|74|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:27.020691|2017-02-18 17:14:27.020691
NCT00193401|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-27|||August 2002||2002-08-01|July 2010|2010-07-01|November 2004||2004-11-01|June 2004|Actual|2004-06-01||Interventional|||Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer|Phase II Trial of Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:27.355838|2017-02-18 17:14:27.355838
NCT00193388|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-27|||September 2002||2002-09-01|July 2010|2010-07-01|February 2007||2007-02-01|December 2004|Actual|2004-12-01||Interventional|||Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer|Phase II Trial of Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer|Completed||Phase 2|100||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:27.442731|2017-02-18 17:14:27.442731
NCT00193375|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-06-29|2012-10-05||August 2003||2003-08-01|June 2016|2016-06-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer|Phase II Trial of Concurrent Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab (Avastin) in the Treatment of Patients With Limited Stage Small Cell Lung Cancer|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:27.525315|2017-02-18 17:14:27.525315
NCT00193362|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-27|||June 2004||2004-06-01|July 2010|2010-07-01|September 2007|Actual|2007-09-01|June 2005|Actual|2005-06-01||Interventional|||Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer|Phase III Randomized Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine as First-Line Chemotherapy for Stage IIIB and IV Non-Small Cell Lung Cancer|Completed||Phase 3|200||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:27.823552|2017-02-18 17:14:27.823552
NCT00193349|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-24|||September 2002||2002-09-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer|Phase II Evaluation of Gleevec Combined With Camptosar Plus Paraplatin in Patients With Previously Untreated Extensive Stage SCLC|Completed||Phase 2|60||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:27.921335|2017-02-18 17:14:27.921335
NCT00193336|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||March 2003||2003-03-01|May 2011|2011-05-01|September 2005|Actual|2005-09-01|March 2004|Actual|2004-03-01||Interventional|||Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer|Phase II Trial of Single Agent ZD1839 (Iressa) in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|60||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:28.016955|2017-02-18 17:14:28.016955
NCT00193323|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-24|||August 2001||2001-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|May 2006|Actual|2006-05-01||Interventional|||Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients|A Randomized Phase III Comparison of Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Elderly or Poor Performance Status Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|346||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:28.12568|2017-02-18 17:14:28.12568
NCT00193310|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-17|||November 2000||2000-11-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|November 2003|Actual|2003-11-01||Interventional|||Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer|Preoperative (Neoadjuvant) or Postoperative (Adjuvant) Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer|Completed||Phase 2|250||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:28.228366|2017-02-18 17:14:28.228366
NCT00193297|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||February 2002||2002-02-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|June 2005|Actual|2005-06-01||Interventional|||Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma|A Phase II Study of a Three-Day Schedule of Topotecan Plus Paclitaxel and Carboplatin on Day Three in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma|Completed||Phase 2|50||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:28.311395|2017-02-18 17:14:28.311395
NCT00193284|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-18|||October 2003||2003-10-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|February 2006|Actual|2006-02-01||Interventional|||Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer|A Phase I/II Trial of Induction Chemotherapy Plus Gefitinib (Iressa) Followed by Concurrent Chemotherapy, Radiation Therapy, and Gefitinib (Iressa) For Patients With Locally Advanced Squamous Carcinoma of the Head and Neck|Completed||Phase 2|50||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:28.402407|2017-02-18 17:14:28.402407
NCT00193271|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||August 2004||2004-08-01|May 2011|2011-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer|Adjuvant Chemotherapy (Docetaxel and Estramustine Phosphate) for High Risk Localized Prostate Cancer|Completed||Phase 2|30||SCRI Development Innovations, LLC|||||f||||f||||||||||2017-02-18 17:14:28.505407|2017-02-18 17:14:28.505407
NCT00193258|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-01-24|2012-12-07||June 2004||2004-06-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma|A Phase I/II Trial of Bevacizumab (Avastin), Erlotinib (Tarceva), and Imatinib (Gleevec) in the Treatment of Patients With Advanced Renal Cell Carcinoma|Completed||Phase 1/Phase 2|94|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:28.605636|2017-02-18 17:14:28.605636
NCT00193245|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-24|||November 2000||2000-11-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|October 2005|Actual|2005-10-01||Interventional|||Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer|A Randomized Trial of Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer|Completed||Phase 2|80||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:28.932793|2017-02-18 17:14:28.932793
NCT00193232|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-27|||May 2004||2004-05-01|July 2010|2010-07-01|February 2007|Actual|2007-02-01|October 2005|Actual|2005-10-01||Interventional|||Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer|A Phase II Trial of Weekly Docetaxel and Bortezomib (Velcade; PS-341) in the Treatment of Patients With Advanced Hormone-Refractory Prostate Cancer|Completed||Phase 2|50||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:29.032919|2017-02-18 17:14:29.032919
NCT00193219|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-03-06|2012-12-07||July 2005||2005-07-01|March 2013|2013-03-01|July 2010|Actual|2010-07-01|June 2008|Actual|2008-06-01||Interventional|||Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer|A Randomized Phase II Study of Modified FOLFOX6 (Infusional 5-Fluorouracil/Leucovorin, Oxaliplatin) and Bevacizumab With or Without Cetuximab in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|36|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:29.135131|2017-02-18 17:14:29.135131
NCT00193206|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-31|2012-08-22||September 2005||2005-09-01|October 2012|2012-10-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|||Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer|Phase II Trial of Dose Dense Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer|Completed||Phase 2|123|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:29.467214|2017-02-18 17:14:29.467214
NCT00193193|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-03|||August 2000||2000-08-01|July 2010|2010-07-01|February 2007|Actual|2007-02-01|December 2003|Actual|2003-12-01||Interventional|||Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma|A Randomized, Phase II Trial of Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin Administered Either Weekly or Every Four Weeks in the Treatment of Hormone Refractory Prostate Carcinoma|Completed||Phase 2|100||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:29.729394|2017-02-18 17:14:29.729394
NCT00193180|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-04-27|2013-03-25||May 2005||2005-05-01|April 2016|2016-04-01|January 2009|Actual|2009-01-01|May 2008|Actual|2008-05-01||Interventional|||Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer|Phase II Trial of Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer|Completed||Phase 2|37|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:29.813469|2017-02-18 17:14:29.813469
NCT00193167|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||January 2004||2004-01-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer|Phase II Study of Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer|Completed||Phase 2|40||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:30.138664|2017-02-18 17:14:30.138664
NCT00193154|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-03-31|||February 2003||2003-02-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|January 2004|Actual|2004-01-01||Interventional|||OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma|A Phase II Trial of Tarceva (OSI-774) and Avastin (Bevacizumab) in the Treatment of Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|63|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:30.236047|2017-02-18 17:14:30.236047
NCT00192803|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-02-22||||||September 2005|2005-09-01||||||||Interventional|||Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs|ACE/ACE2 Ratio in Diabetic Patients Treated With Antihypertensive Drugs|Unknown status|Not yet recruiting|Phase 4|20||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:14:39.442653|2017-02-18 17:14:39.442653
NCT00193141|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||October 1999||1999-10-01|May 2011|2011-05-01|July 2007|Actual|2007-07-01|October 2004|Actual|2004-10-01||Interventional|||Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer|Paclitaxel, Carboplatin, Infusional 5-Fluorouracil, and Radiation Therapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer|Completed||Phase 2|200||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:30.365505|2017-02-18 17:14:30.365505
NCT00193128|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-03-26|2013-03-26||April 2004||2004-04-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|February 2008|Actual|2008-02-01||Interventional|||Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer|A Phase I/II Trial of Preoperative Oxaliplatin, Docetaxel, and Capecitabine With Concurrent Radiation Therapy in Localized Carcinoma of the Esophagus or Gastroesophageal Junction|Completed||Phase 1/Phase 2|59|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 17:14:30.708918|2017-02-18 17:14:30.708918
NCT00193115|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-03|||March 2004||2004-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|June 2005|Actual|2005-06-01||Interventional|||Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer|Phase II Pilot Trial of Dose-Dense Docetaxel Followed by Doxorubicin Plus Cyclophosphamide (T-AC) Given as Adjuvant or Neoadjuvant Treatment for Women With Node Positive or High-Risk Primary Breast Cancer|Completed||Phase 2|32||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:31.20106|2017-02-18 17:14:31.20106
NCT00193102|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||April 2001||2001-04-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|February 2005|Actual|2005-02-01||Interventional|||Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer|Phase II Study of Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer|Terminated||Phase 2|40|Anticipated|SCRI Development Innovations, LLC||1|||f||||||||||||||2017-02-18 17:14:31.302866|2017-02-18 17:14:31.302866
NCT00193089|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-09|||April 2001||2001-04-01|December 2015|2015-12-01|September 2009|Actual|2009-09-01|April 2005|Actual|2005-04-01||Interventional|||Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer|Phase II Trial of Weekly Docetaxel, Vinorelbine, and Herceptin in the First-Line Treatment of Patients With Metastatic Breast Cancer and Overexpression of Her-2|Completed||Phase 2|60|Actual|SCRI Development Innovations, LLC||1|||f||||t||||||||||2017-02-18 17:14:31.396152|2017-02-18 17:14:31.396152
NCT00193076|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||November 2003||2003-11-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|May 2006|Actual|2006-05-01||Interventional|||Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer|A Phase II Trial of Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer|Completed||Phase 2|96|Anticipated|SCRI Development Innovations, LLC||1|||f||||||||||||||2017-02-18 17:14:31.493756|2017-02-18 17:14:31.493756
NCT00193063|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-02-10|2013-08-16||July 2001||2001-07-01|February 2014|2014-02-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional|||Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer|Phase II Trial of Weekly Gemcitabine and Herceptin in the Treatment of Patients With HER-2 Overexpressing Metastatic Breast Cancer|Completed||Phase 2|41|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:31.608258|2017-02-18 17:14:31.608258
NCT00193050|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-08-22|2012-08-22||November 2001||2001-11-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer|Phase II Trial of Induction Chemotherapy With Weekly Gemcitabine, Epirubicin, Docetaxel as Primary Treatment of Locally Advanced or Inflammatory Breast Cancer Patients|Completed||Phase 2|110|Actual|SCRI Development Innovations, LLC||1|||f||||f||||||||||2017-02-18 17:14:31.888673|2017-02-18 17:14:31.888673
NCT00193037|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-24|2012-08-22||February 2001||2001-02-01|July 2013|2013-07-01|November 2009|Actual|2009-11-01|December 2008|Actual|2008-12-01||Interventional|||Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer|A Phase II Randomized Crossover Study Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer|Completed||Phase 2|102|Actual|SCRI Development Innovations, LLC||2|||f||||f||||||||||2017-02-18 17:14:32.155158|2017-02-18 17:14:32.155158
NCT00193024|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||September 2001||2001-09-01|May 2011|2011-05-01|October 2004|Actual|2004-10-01|October 2003|Actual|2003-10-01||Interventional|||Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer|A Phase II Trial of Epirubicin/Docetaxel in the First-Line Treatment of Patients With Metastatic Breast Cancer|Terminated||Phase 2|90||SCRI Development Innovations, LLC|||||f||||||||||||||2017-02-18 17:14:32.588187|2017-02-18 17:14:32.588187
NCT00193011|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-02|||March 2002||2002-03-01|May 2011|2011-05-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer|A Randomized Multicenter Trial Comparing Weekly Docetaxel and CMF in the Adjuvant Treatment of Women With High-Risk Breast Cancer Who Are > 65 Years Old or Are Not Candidates for Anthracycline-Based Adjuvant Therapy|Completed||Phase 3|150|Anticipated|SCRI Development Innovations, LLC||2|||f||||||||||||||2017-02-18 17:14:32.68136|2017-02-18 17:14:32.68136
NCT00192998|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-26|||October 2003||2003-10-01|September 2005|2005-09-01||||||||Observational|||The Serotonergic Transmitter System in Dementia and Affective Disorders||Unknown status|Recruiting|N/A|100|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:32.791885|2017-02-18 17:14:32.791885
NCT00192985|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-16|||May 2003||2003-05-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||Does a Nitrofurazone Coated Bladder Catheter Reduce the Number of Urinary Tract Infections in Trauma||Unknown status|Active, not recruiting|Phase 3|216||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:32.862976|2017-02-18 17:14:32.862976
NCT00192972|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-21|||November 2002||2002-11-01|November 2003|2003-11-01|June 2005||2005-06-01|||||Interventional|||A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation|A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation (LASso Vs CARto)|Completed||N/A|100||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:32.947026|2017-02-18 17:14:32.947026
NCT00192959|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-16|||March 2004||2004-03-01|June 2005|2005-06-01|December 2004||2004-12-01|||||Interventional|||Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects.|Xenon Inhalation as Cover Sedation During Orthopaedic Surgery in Elderly Subjects Comparing the Effects of Inhaled Xenon and Intravenous Propofol|Completed||Phase 3|44||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:33.059477|2017-02-18 17:14:33.059477
NCT00192348|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-02|||May 2002||2002-05-01|October 2006|2006-10-01|December 2002||2002-12-01|||||Interventional|||A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants|A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Infants|Completed||Phase 1|120||MedImmune LLC|||||f||||||||||||||2017-02-18 17:14:33.237131|2017-02-18 17:14:33.237131
NCT00192335|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-26|||July 2004||2004-07-01|November 2007|2007-11-01|February 2005|Actual|2005-02-01|||||Interventional|||Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants|A Prospective, Double-Blind, Randomized Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants Ages 5 Through 49 Years|Completed||Phase 3|890|Actual|MedImmune LLC||2|||f||||||||||||||2017-02-18 17:14:33.313871|2017-02-18 17:14:33.313871
NCT00192322|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-02-15|||September 2001||2001-09-01|February 2012|2012-02-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|CAIVT||Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children|A Randomized, Partially-Blinded, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent,Types A & B, Live Cold Adapted (CAIV-T) in Healthy Children Aged 6 to Less Than 36 Months|Completed||Phase 2|173|Actual|MedImmune LLC||4|||f||||f||||||||||2017-02-18 17:14:33.466293|2017-02-18 17:14:33.466293
NCT00192309|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-02-13|||September 2001||2001-09-01|February 2012|2012-02-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.|A Randomized, Open-Label, Placebo-Controlled Trial to Investigate the Kinetics of the Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent,Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Adults Aged 18 to <65 Years.|Completed||Phase 2|31|Actual|MedImmune LLC||3|||f||||f||||||||||2017-02-18 17:14:33.583136|2017-02-18 17:14:33.583136
NCT00192296|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-02-04|2013-10-17||August 2004||2004-08-01|February 2014|2014-02-01|March 2005|Actual|2005-03-01|February 2005|Actual|2005-02-01||Interventional|||Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528 in Healthy Adult Volunteers|A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528, a Humanized Monoclonal Anti-Interleukin-9 Antibody, in Healthy Adult Volunteers|Completed||Phase 1|24|Actual|MedImmune LLC||4|||f||||||||||||||2017-02-18 17:14:33.699839|2017-02-18 17:14:33.699839
NCT00192283|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-04-08|||September 2000||2000-09-01|April 2009|2009-04-01|May 2002|Actual|2002-05-01|April 2002|Actual|2002-04-01||Interventional|||Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in Healthy Children Attending Day Care Centers|Completed||Phase 3|2903|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 17:14:34.48279|2017-02-18 17:14:34.48279
NCT00192270|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-05|||October 2000||2000-10-01|March 2012|2012-03-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|FluMist||Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children|A Prospective, Open-label, Phase II, Multi-center Study of the Safety, Tolerability and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children, Aged 6 to 17 Years|Completed||Phase 2|498|Actual|MedImmune LLC||1|||f||||f||||||||||2017-02-18 17:14:34.576124|2017-02-18 17:14:34.576124
NCT00192257|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-02|||October 2002||2002-10-01|October 2006|2006-10-01|May 2003||2003-05-01|||||Interventional|||Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma|A Prospective, Randomized, Open-Label, Controlled Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, Trivalent, Type A&B, Live, Cold-Adapted (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children With Asthma Aged 6 Years to 17 Years|Completed||Phase 3|2229||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:37.466138|2017-02-18 17:14:37.466138
NCT00192244|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-02|||September 2000||2000-09-01|October 2006|2006-10-01|October 2002||2002-10-01|||||Interventional|||Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in Healthy Children|Completed||Phase 3|3000||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:37.583883|2017-02-18 17:14:37.583883
NCT00192231|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-23|||April 2001||2001-04-01|October 2006|2006-10-01|June 2001||2001-06-01|||||Interventional|||Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)|A Randomized, Double-Blind, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults Aged 18 and Older|Completed||Phase 3|120||MedImmune LLC|||||f||||||||||||||2017-02-18 17:14:37.664257|2017-02-18 17:14:37.664257
NCT00192218|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-19|||October 2004||2004-10-01|September 2008|2008-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program|A Phase IV Study to Evaluate the Effectiveness of Flumist (Influenza Vaccine, Live Intranasal) Vaccination in a School-Based Intervention Program|Completed||Phase 4|3022|Actual|MedImmune LLC||1|||f||||||||||||||2017-02-18 17:14:37.749258|2017-02-18 17:14:37.749258
NCT00192205|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-02|||October 2002||2002-10-01|October 2006|2006-10-01|June 2003||2003-06-01|||||Interventional|||Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children|A Prospective, Randomized, Open-Label, Controlled Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, Trivalent, Type A&B, Live, Cold-Adapted (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children With a History of Recurrent Respiratory Tract Infections Aged 6 Months to Less Than 72 Months|Completed||Phase 3|2200||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:37.83968|2017-02-18 17:14:37.83968
NCT00192790|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-10|||January 2004||2004-01-01|April 2007|2007-04-01|March 2005|Actual|2005-03-01|||||Observational|||Pain Perception is Attenuated in Patients With Painless Myocardial Infarction|Clinical and Experimental Pain Perception is Attenuated in Patients With Painless Myocardial Infarction|Completed||N/A|100||Rambam Health Care Campus|||||f||||t||||||||||2017-02-18 17:14:39.5276|2017-02-18 17:14:39.5276
NCT00192192|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-23|||November 2000||2000-11-01|October 2006|2006-10-01|December 2000||2000-12-01|||||Interventional|||Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults|A Randomized, Double-Blind, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults Aged 18 to 64 Years|Completed||Phase 3|20||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:37.922863|2017-02-18 17:14:37.922863
NCT00192179|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-02-29|||June 2003||2003-06-01|February 2012|2012-02-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|FluMist||A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.|A Phase II, Prospective, Randomized, Double-Blind, Placebo, Controlled Trial, to Assess the Safety and Tolerability of Influenza Virus Vaccine, Trivalent, Types A & B Live Cold-Adapted Liquid Formulation (CAIV-T) in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.|Completed||Phase 2|240|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 17:14:38.001578|2017-02-18 17:14:38.001578
NCT00192166|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-12-05|||October 2002||2002-10-01|December 2008|2008-12-01|May 2003|Actual|2003-05-01|March 2003|Actual|2003-03-01||Interventional|||Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months|Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months|Completed||Phase 2|1200||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:38.112915|2017-02-18 17:14:38.112915
NCT00192153|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-23|||July 2001||2001-07-01|October 2006|2006-10-01|October 2001||2001-10-01|||||Interventional|||Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older|A Randomized, Partially-Blinded, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Adults 18 to 59 Years and Healthy Adults,60 Years/Older|Completed||Phase 2|240||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:38.204187|2017-02-18 17:14:38.204187
NCT00192140|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-27|||June 2004||2004-06-01|December 2007|2007-12-01|January 2005|Actual|2005-01-01|October 2004|Actual|2004-10-01||Interventional|||Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age|An Open-Label, Single-Arm Trial to Assess the Shedding, Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age|Completed||Phase 4|345||MedImmune LLC||1|||f||||t||||||||||2017-02-18 17:14:38.277233|2017-02-18 17:14:38.277233
NCT00192933|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-18|||January 2000||2000-01-01|September 2005|2005-09-01|December 2010||2010-12-01|||||Observational|||Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital||Unknown status|Recruiting|N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:38.440015|2017-02-18 17:14:38.440015
NCT00192920|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-18|||January 2000||2000-01-01|September 2005|2005-09-01|December 2010||2010-12-01|||||Observational|||Evaluation of the Quality of the Transfusion Practice at Rigshospitalet, Copenhagen University Hospital||Unknown status|Recruiting|N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:38.697402|2017-02-18 17:14:38.697402
NCT00192907|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-16|||March 2003||2003-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Inflammation and Infection in Trauma, Role in Posttraumatic Complications||Unknown status|Active, not recruiting|N/A|380||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:38.786548|2017-02-18 17:14:38.786548
NCT00192894|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||May 2004||2004-05-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Observational|||New Methods to Detect a Decrease in Heart Function|Cardiac Output Changes During Onset of Spinal Anesthesia in Elderly Patients|Completed||Phase 4|32||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:38.8594|2017-02-18 17:14:38.8594
NCT00192881|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-17|||October 2002||2002-10-01|July 2010|2010-07-01||||||||Interventional|||Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease|Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease. A Randomised Comparison of Optimal Balloon Angioplasty and Primary Implantation of Stents With and Without Drug Elution in Complex Coronary Lesions|Unknown status|Not yet recruiting|N/A|||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:38.934219|2017-02-18 17:14:38.934219
NCT00192868|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-09-22|||May 2005||2005-05-01|September 2009|2009-09-01|November 2011|Anticipated|2011-11-01|November 2009|Anticipated|2009-11-01||Interventional|||Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction|Drug Elution and DIstal Protection During Percutaneous CoronAry Intervention in sT Elevation Myocardial InfarctiON. Acronym: Dedication|Unknown status|Active, not recruiting|N/A|600|Anticipated|Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:14:39.013854|2017-02-18 17:14:39.013854
NCT00192855|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-24|||June 2003||2003-06-01|September 2005|2005-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Entacapone Augmentation for Schizophrenia|Entacapone Augmentation for Schizophrenia- A Randomized Controlled Trial|Completed||N/A|52|Actual|Rambam Health Care Campus||1|||f||||||||||||||2017-02-18 17:14:39.102567|2017-02-18 17:14:39.102567
NCT00192842|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-09-21|||July 2004||2004-07-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|November 2007|Actual|2007-11-01||Interventional|||Gemcitabine With Curcumin for Pancreatic Cancer|Phase II Trial of Gemcitabine and Curcumin in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|17|Actual|Rambam Health Care Campus|||||f||||f||||||||||2017-02-18 17:14:39.198949|2017-02-18 17:14:39.198949
NCT00192829|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-10|||June 2005||2005-06-01|March 2007|2007-03-01||||||||Observational|||Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma|Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma|Unknown status|Recruiting|N/A|100||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:14:39.285564|2017-02-18 17:14:39.285564
NCT00192816|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2005||2005-06-01|September 2005|2005-09-01||||||||Observational|||Pain Perception in Alzheimer's Disease|Pain Perception in Alzheimer's Disease|Unknown status|Recruiting|N/A|60||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:14:39.372107|2017-02-18 17:14:39.372107
NCT00192777|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-05|||November 2004||2004-11-01|September 2005|2005-09-01||||||||Interventional|||Concurrent Xeloda and Radiotherapy for Bone Metastases|Concurrent Xeloda and Radiotherapy for Bone Metastases|Unknown status|Recruiting|Phase 2|20|Anticipated|Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:14:39.604552|2017-02-18 17:14:39.604552
NCT00192751|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-10-26|||February 2004||2004-02-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||From Compliance to Alliance: Engaging Psychiatric Patients in Illness Management|Impact of Psycho-Educational Intervention on Patients With Severe Mental Illness Recently Discharged From Psychiatric Inpatient Services|Unknown status|Recruiting|N/A|150||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:14:39.795973|2017-02-18 17:14:39.795973
NCT00192738|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-10|||April 2003||2003-04-01|April 2007|2007-04-01|January 2006|Actual|2006-01-01|||||Observational|||Does Telephone Follow-up Improve Patients Satisfaction|Does Telephone Follow-up After Discharge Improve Patients Satisfaction and Decrease Hospitalization|Completed||N/A|400||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:14:39.885593|2017-02-18 17:14:39.885593
NCT00192725|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2010-08-24|||March 2003||2003-03-01|September 2005|2005-09-01|June 2008|Actual|2008-06-01|October 2007|Actual|2007-10-01||Interventional|||Tryptophan Depletion in Acute Mania|Tryptophan Depletion in Acute Mania - A Randomized Controlled Trial|Completed||N/A|40|Anticipated|Rambam Health Care Campus||1|||f||||||||||||||2017-02-18 17:14:40.065596|2017-02-18 17:14:40.065596
NCT00192712|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2010-11-09|||November 2002||2002-11-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|||||Interventional|||Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer|Phase II Study of Irinotecan and Gemcitabine (IrinoGem) Combined With 3-D Conformal Radiation Therapy for Locally Advanced Pancreatic Cancer|Completed||Phase 2/Phase 3|20||Rambam Health Care Campus|||||f||||||||||||||2017-02-18 17:14:40.151524|2017-02-18 17:14:40.151524
NCT00192699|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2014-03-28|||January 2004||2004-01-01|March 2014|2014-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Bimetric-10: Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-Metric Stem|10 Year Follow-up Investigation of Patients Who Have Underwent Total Hip Arthroplasty With a Cemented Bi-metric Stem|Completed||N/A|80|Actual|Northern Orthopaedic Division, Denmark|||1||f||||t||||||||||2017-02-18 17:14:40.251409|2017-02-18 17:14:40.251409
NCT00192686|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2014-03-28|||January 2004||2004-01-01|March 2014|2014-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Cultures a.m.Kamme-Lindbergh in Suspicion of Infected TKA|Cultures From Total Knee Arthroplasties, Obtained a.m. Kamme-Lindberg in Revision Cases.|Completed||N/A|||Northern Orthopaedic Division, Denmark|||||f||||||||||||||2017-02-18 17:14:40.36175|2017-02-18 17:14:40.36175
NCT00192673|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2009-09-29|||June 2005||2005-06-01|September 2009|2009-09-01|December 2013|Anticipated|2013-12-01|||||Interventional|||Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses|PEG-asparaginase During Two Treatment Courses in the Treatment of Childhood Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 4|85|Anticipated|Nordic Society for Pediatric Hematology and Oncology|||||f||||||||||||||2017-02-18 17:14:40.446518|2017-02-18 17:14:40.446518
NCT00192660|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-04-11|||February 2003||2003-02-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|October 2006|Actual|2006-10-01||Interventional|||HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)|Analysis of Lipodystrophy in HIV-Infected Individuals A Prospective, Non-randomised, 48 Week Study of the Effect of PI Containing and Non-PI Containing Antiretroviral Regimens on the Expression of Adipocyte Specific Genes, Protein Levels and Cellular Structure in HIV-infected Individuals, Naive to Therapy, Who Are Starting Therapy for the First Time|Completed||Phase 4|80|Actual|Kirby Institute||1|||f||||f||||||||||2017-02-18 17:14:40.538563|2017-02-18 17:14:40.538563
NCT00192647|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-06-23|2016-05-06||August 2004||2004-08-01|June 2016|2016-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional||Intent-to-treat (ITT) analysis population included all randomized participants who received at least 1 dose of study drug.|A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection|A Phase IV, Randomised, Multicentre, Efficacy and Safety Study Examining the Effect of Induction Dosing With the Combination of Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Infected With Hepatitis C Genotype 1|Completed||Phase 4|896|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:14:40.662612|2017-02-18 17:14:40.662612
NCT00192634|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-24|||December 2005||2005-12-01|May 2011|2011-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study|A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study.|Completed||Phase 4|357|Actual|Kirby Institute||2|||f||||t||||||||||2017-02-18 17:14:41.685979|2017-02-18 17:14:41.685979
NCT00192621|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-04-11|||November 2004||2004-11-01|April 2012|2012-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects|A 3 Arm, Prospective Study to Compare the Effect of 6 Weeks Exposure to the Combination of Lopinavir (LPVr)/Combivir® (AZT/3TC) Versus Lopinavir Alone or Combivir® Alone in HIV-negative Healthy Subjects on the Development of Abnormalities of Lipid and Glucose Metabolism|Completed||Phase 4|50|Actual|Kirby Institute||1|||f||||f||||||||||2017-02-18 17:14:41.830176|2017-02-18 17:14:41.830176
NCT00192608|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-25|||November 2004||2004-11-01|June 2009|2009-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|ASK-500||A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study|A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation.|Completed||N/A|40|Actual|Kirby Institute||2|||f||||f||||||||||2017-02-18 17:14:41.934214|2017-02-18 17:14:41.934214
NCT00192595|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-03-30|||January 2004||2004-01-01|March 2015|2015-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|TICO||Tenofovir in HIV/HBV Coinfection|Virological and Clinical Anti-HBV Efficacy of Tenofovir in Antiretroviral naïve Patients With HIV/HBV Co-infection|Completed||Phase 4|36|Actual|Kirby Institute||3|||f||||t||||||||||2017-02-18 17:14:42.047239|2017-02-18 17:14:42.047239
NCT00192582|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-20|||July 2005||2005-07-01|May 2007|2007-05-01|August 2007|Anticipated|2007-08-01|||||Interventional|||AIMHI NT Relapse Prevention Trial|Relapse Prevention Trial in Top End Aboriginal People With Chronic Mental Illness|Unknown status|Active, not recruiting|N/A|90||Menzies School of Health Research|||||f||||||||||||||2017-02-18 17:14:42.158093|2017-02-18 17:14:42.158093
NCT00192569|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-04-13|||July 2004||2004-07-01|October 2009|2009-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Australian Trial in Acute Hepatitis C|Australian Trial in Acute Hepatitis C|Completed||Phase 4|167|Actual|Kirby Institute||2|||f||||t||||||||||2017-02-18 17:14:42.253437|2017-02-18 17:14:42.253437
NCT00192543|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-08-03|||May 2004||2004-05-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Fish and Fruit Study: Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal Disease|A Clinical Trial of Fish and Fruit to Improve Survival of Aboriginal People With End Stage Renal Disease|Completed||Phase 3|152|Actual|Menzies School of Health Research||2|||f||||f||||||||||2017-02-18 17:14:42.474684|2017-02-18 17:14:42.474684
NCT00192517|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-02|||December 2003||2003-12-01|April 2009|2009-04-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of MEDI-522, a Humanized Monoclonal Antibody to Integrin Alpha V Beta 3, Administered by Subcutaneous Injection to Adults With Plaque Psoriasis|Completed||Phase 2|44|Actual|MedImmune LLC||2|||f||||||||||||||2017-02-18 17:14:42.586038|2017-02-18 17:14:42.586038
NCT00192504|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-23|||March 2004||2004-03-01|October 2006|2006-10-01|January 2005||2005-01-01|||||Interventional|||A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection|A Phase 1, Randomized, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection|Completed||Phase 1|31||MedImmune LLC|||||||||||||||||||2017-02-18 17:14:42.944252|2017-02-18 17:14:42.944252
NCT00192127|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-12|||August 2004||2004-08-01|December 2007|2007-12-01|February 2005|Actual|2005-02-01|||||Interventional|||Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|Completed||Phase 3|300||MedImmune LLC||2|||f||||||||||||||2017-02-18 17:14:43.033787|2017-02-18 17:14:43.033787
NCT00192114|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-10-05||2009-02-17|August 2005||2005-08-01|October 2009|2009-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Enzastaurin for Patients With Metastatic Colorectal Cancer|A Phase 2 Study of Oral Enzastaurin HCl in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|30|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 17:14:43.146188|2017-02-18 17:14:43.146188
NCT00192101|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-16|||October 2004||2004-10-01|November 2007|2007-11-01|July 2005||2005-07-01|||||Interventional|||Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes|Randomized Phase II Study of the Combination of Gemcitabine (Gemzar) Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines an/or Taxanes|Completed||Phase 2|100||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:43.238279|2017-02-18 17:14:43.238279
NCT00192088|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||May 2004||2004-05-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma|Open-Label Single-Arm Phase II Study of ALIMTA in Combination With Oxaliplatin as First-Line Therapy in Advanced Gastric Carcinoma|Completed||Phase 2|43||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:43.322593|2017-02-18 17:14:43.322593
NCT00192075|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-04|2008-10-30||June 2003||2003-06-01|November 2009|2009-11-01|November 2007|Actual|2007-11-01|||||Interventional|||A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer|A Multicenter, Randomized Phase II Trial of Avastin Plus Gemcitabine Plus 5FU/Folinic Acid (A + FFG) vs. Avastin Plus Oxaliplatin Plus 5FU/Folinic Acid (A + FOLFOX 4) as Therapy for Patients With Metastatic Colorectal Cancer|Completed||Phase 2|84|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 17:14:43.426979|2017-02-18 17:14:43.426979
NCT00192062|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-29|||July 2004||2004-07-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer|A Phase II Trial of Gemcitabine (Gemzar) Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer|Completed||Phase 2|80||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:44.824232|2017-02-18 17:14:44.824232
NCT00192049|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-16|||December 2003||2003-12-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer|A Randomized Phase II Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer|Completed||Phase 2|90||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:44.923198|2017-02-18 17:14:44.923198
NCT00192036|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-11-22|2009-02-23||August 2004||2004-08-01|November 2010|2010-11-01|November 2009|Actual|2009-11-01|January 2008|Actual|2008-01-01||Interventional|||Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer|Multicenter Phase II Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer|Completed||Phase 2|49|Actual|Eli Lilly and Company|Enrollment was stopped early due to difficulties with patient recruitment. Given the number of missing/unknown tumor assessments, care should be taken when interpreting the primary outcome measure. An identified error was corrected in the results.|1|||f||||f||||||||||2017-02-18 17:14:45.022736|2017-02-18 17:14:45.022736
NCT00192023|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-09|2009-05-15||October 2004||2004-10-01|December 2009|2009-12-01|May 2008|Actual|2008-05-01|August 2006|Actual|2006-08-01||Interventional|||An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).|An Italian Randomised, Double-blind Placebo Controlled Study of the Efficacy of Atomoxetine Hydrochloride in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder|Completed||Phase 3|139|Actual|Eli Lilly and Company|Due to the open-ended timing of the open-label period (up to 1.5 years or until commercial availability) the efficacy data from the open-label extension phase is not included except for adverse event data.|2|||f||||f||||||||||2017-02-18 17:14:45.440686|2017-02-18 17:14:45.440686
NCT00187785|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-01-13|||September 2005||2005-09-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Doctor-Patient Communication in Spanish|Doctor-Patient Communication in Spanish|Terminated||N/A|100||University of California, San Francisco|||||f||||||||||||||2017-02-18 17:16:12.017884|2017-02-18 17:16:12.017884
NCT00191997|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-21|||October 2004||2004-10-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode|Optimal Treatment Duration With Olanzapine Following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies.|Completed||Phase 4|180||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:46.373903|2017-02-18 17:14:46.373903
NCT00191984|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-01-03|2009-04-27||June 2004||2004-06-01|January 2011|2011-01-01|May 2008|Actual|2008-05-01|February 2007|Actual|2007-02-01||Interventional|||A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer|Open Multicenter Phase II Study in Second-Line Metastatic Colorectal Cancer Patients: Combination of ALIMTA and Irinotecan Administered Every Two-Weeks|Completed||Phase 2|46|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 17:14:46.492557|2017-02-18 17:14:46.492557
NCT00191971|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||January 2004||2004-01-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen|A Phase II Study of Gemcitabine in Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|40||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:46.859886|2017-02-18 17:14:46.859886
NCT00191945|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-26|2009-02-06||May 2005||2005-05-01|January 2010|2010-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety of Atomoxetine up to 12 Weeks in Newly Diagnosed Children and Adolescents Outpatients With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|151|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:14:46.970881|2017-02-18 17:14:46.970881
NCT00191932|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-21|||August 2004||2004-08-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Switching to Duloxetine From Other Antidepressants|Switching to Duloxetine From Other Antidepressants: A Regional Multicentre Trial Comparing Two Switching Techniques|Completed||Phase 4|360||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:47.900704|2017-02-18 17:14:47.900704
NCT00191919|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||May 2005||2005-05-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain|A Ten-Week, Randomized, Double-Blind Study Evaluating the Efficacy of Duloxetine 60mg Once Daily Versus Placebo in Outpatients With Major Depressive Disorder and Pain|Completed||Phase 3|310||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:48.004907|2017-02-18 17:14:48.004907
NCT00191906|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-05-17|2008-12-11||April 2005||2005-04-01|May 2010|2010-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)|A Randomized, Double-Blind, Crossover Comparison of Atomoxetine and Placebo in Child Outpatients With Attention-Deficit/Hyperactivity Disorder, Reading Disorder, or Comorbid Attention-Deficit/Hyperactivity Disorder and Reading Disorder.|Completed||Phase 4|121|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 17:14:48.138929|2017-02-18 17:14:48.138929
NCT00191893|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|November 2006||2006-11-01|||||Interventional|||Bone Effects of Teriparatide Following Alendronate|Bone Effects of Subcutaneous Teriparatide Following Discontinuation of Alendronate Treatment in Postmenopausal Women With Osteoporosis|Completed||Phase 3|66||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:49.190802|2017-02-18 17:14:49.190802
NCT00191880|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-08-24|||May 2004||2004-05-01|August 2006|2006-08-01|June 2006||2006-06-01|||||Interventional|||Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder|A Phase IIIb Open-Label Trial of Atomoxetine Hydrochloride to Evaluate Academic Outcome in Children Ages 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|100||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:49.28034|2017-02-18 17:14:49.28034
NCT00191867|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||February 2005||2005-02-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Clinical Trial of Teriparatide in Japan|Assessment of Dose Response of LY333334 in Japanese Postmenopausal Women With Osteoporosis|Completed||Phase 2|160||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:49.628939|2017-02-18 17:14:49.628939
NCT00191854|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-02-24|2009-07-21||March 2005||2005-03-01|February 2010|2010-02-01|November 2009|Actual|2009-11-01|August 2008|Actual|2008-08-01||Interventional|||Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line|Randomized Phase II Study of Biweekly Gemcitabine-Paclitaxel, Biweekly Gemcitabine-Carboplatin and Biweekly Gemcitabine-Cisplatin as First-Line Treatment in Metastatic Breast Cancer After Anthracycline Failure|Completed||Phase 2|147|Actual|Eli Lilly and Company||3|||f||||t||||||||||2017-02-18 17:14:49.735727|2017-02-18 17:14:49.735727
NCT00191841|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-21|||December 2002||2002-12-01|July 2006|2006-07-01|February 2006||2006-02-01|||||Interventional|||Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy|Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy in Operable Non Small Cell Lung Cancer|Completed||Phase 2|50||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:51.109298|2017-02-18 17:14:51.109298
NCT00191828|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||March 2003||2003-03-01|January 2007|2007-01-01|August 2005||2005-08-01|||||Interventional|||A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme|A Prospective/Parallel Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme|Completed||Phase 4|60||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:51.205046|2017-02-18 17:14:51.205046
NCT00191815|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-09|2008-10-13||October 2002||2002-10-01|November 2009|2009-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Combination Chemotherapy for Metastatic Breast Cancer|Phase II Study of Gemcitabine Plus Cisplatin as First-line Treatment of Metastatic Breast Cancer|Completed||Phase 2|70|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 17:14:51.311864|2017-02-18 17:14:51.311864
NCT00191802|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients|Compliance With and Acceptance of Teriparatide Pen Injection in Severely Osteoporotic Patients [CATS]|Completed||Phase 3|120||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:51.914181|2017-02-18 17:14:51.914181
NCT00191594|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||March 2005||2005-03-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials|Open-Label Duloxetine Extension Phase in Patients Who Have Completed the HMDG Clinical Trial|Completed||Phase 3|105||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:58.558506|2017-02-18 17:14:58.558506
NCT00191789|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-21|2010-04-29||February 2003||2003-02-01|July 2010|2010-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer|Neoadjuvant Administration of Gemcitabine Plus Doxorubicin Followed by Gemcitabine Plus Cisplatin in Large or Locally Advanced Operable Breast Cancer: A Phase II Study|Completed||Phase 2|65|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 17:14:52.018995|2017-02-18 17:14:52.018995
NCT00191763|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||November 2002||2002-11-01|November 2007|2007-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer|Phase II Trial of Gemcitabine and Cisplatin as Neo-Adjuvant Chemotherapy for Operable Non-Small Cell Lung Cancer|Completed||Phase 2|52||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:52.599795|2017-02-18 17:14:52.599795
NCT00191750|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||July 2004||2004-07-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned|Phase II Trial of ALIMTA in Relapsed Small Cell Lung Cancer|Completed||Phase 2|80||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:52.686606|2017-02-18 17:14:52.686606
NCT00191737|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder|An Open-Label Study on Effectiveness and Tolerability of Atomoxetine, as Perceived by Patients, Parents, and Physicians in Adolescents With Attention-Deficit/Hyperactivity Disorder in Germany|Completed||Phase 3|147||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:52.764894|2017-02-18 17:14:52.764894
NCT00191724|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-06-16|2009-01-14||September 2004||2004-09-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study|Drotrecogin Alfa (Activated) (LY203638)] Exploratory, Safety Study, Multi-Center, Randomized, Placebo-Controlled, Dose Escalating Study Design, Comparing a Standard Therapy (Enoxaparin Sodium) for Submassive Pulmonary Embolism to a Combined Therapy of Drotrecogin Alfa (Activated) Plus Enoxaparin Sodium.|Completed||Phase 2|47|Actual|Eli Lilly and Company|This study was stopped early after 47 patients had been enrolled (planned enrollment was 48 patients). Study was stopped early due to slow enrollment.|5|||f||||t||||||||||2017-02-18 17:14:52.857377|2017-02-18 17:14:52.857377
NCT00191711|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||February 2004||2004-02-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.|Phase II Study of 6 Weeks Intravesical Gemcitabine Instillation Followed By Transurethral Resection in Patients Affected By Superficial Bladder Cancer at Low Risk|Completed||Phase 2|43||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:55.084631|2017-02-18 17:14:55.084631
NCT00191698|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-29|||December 2003||2003-12-01|October 2008|2008-10-01|November 2007|Actual|2007-11-01|June 2005|Actual|2005-06-01||Interventional|||Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD|A Randomized, Double-Blind Comparison of Atomoxetine Hydrochloride and Placebo in Child and Adolescent Outpatients With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder|Completed||Phase 3|226|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:14:55.181013|2017-02-18 17:14:55.181013
NCT00191685|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-21|||May 2004||2004-05-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||Duloxetine in the Treatment of Melancholic Depression|Duloxetine in the Treatment of Melancholic Depression: An 8-Week Open-Label Dose Study|Completed||Phase 3|200||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:55.319861|2017-02-18 17:14:55.319861
NCT00191672|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||December 2003||2003-12-01|January 2007|2007-01-01|November 2006||2006-11-01|||||Interventional|||A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer|A Phase II Randomized Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Patients With Metastatic Breast Cancer|Completed||Phase 2|120||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:55.435499|2017-02-18 17:14:55.435499
NCT00191659|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-02-28|||June 2004||2004-06-01|February 2007|2007-02-01|April 2006||2006-04-01|||||Interventional|||Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents|A Randomised, Controlled, Open-Label Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents|Completed||Phase 3|200||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:55.524716|2017-02-18 17:14:55.524716
NCT00191646|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-28|2010-08-12||October 2002||2002-10-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy|Phase III Randomized Trial of Induction Chemotherapy With Gemcitabine and Carboplatin Followed by Elective Paclitaxel Consolidation Versus Paclitaxel and Carboplatin Followed by Elective Paclitaxel Consolidation in Patients With Primary Epithelial Ovarian, Primary Peritoneal Cancer or Fallopian Tube Carcinoma|Completed||Phase 3|919|Actual|Eli Lilly and Company|Trial was designed with overall survival as primary endpoint. Enrollment was slower than expected. After 4 years, 919 patients were randomized and in August 2006, protocol was amended: primary endpoint was changed to progression free survival (PFS).|2|||f||||t||||||||||2017-02-18 17:14:55.658097|2017-02-18 17:14:55.658097
NCT00191633|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||April 2005||2005-04-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes|A 3 Month Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder; Symptomatic and Functional Outcomes.|Completed||Phase 4|200||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:58.273237|2017-02-18 17:14:58.273237
NCT00191620|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||March 2004||2004-03-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.|Randomized Phase II Study of Cisplatin + Gemcitabine Administered Either as Short Infusion or at a Fixed Dose Rate in Non-Small Cell Lung Cancer|Completed||Phase 2|64||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:58.383845|2017-02-18 17:14:58.383845
NCT00191607|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||July 2002||2002-07-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.|A Randomized Phase III Trial of Gemzar Versus Doxil With Crossover Treatment Option for Patients With Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer Undergoing Second or Third-Line Chemotherapy|Completed||Phase 3|162||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:58.472612|2017-02-18 17:14:58.472612
NCT00191581|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-28|||March 2005||2005-03-01|July 2006|2006-07-01|April 2006||2006-04-01|||||Interventional|||Local Registration Trial in China Humalog Mix 50|Comparison of 2-Hour Postprandial Blood Glucose Excursion in Response to a Standard Test Meal in Insulin-Requiring Diabetic Patients Treated Twice Daily With Either Insulin Lispro Mix 50/50 or Human Insulin Mix 50/50|Completed||Phase 3|120||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:14:58.640499|2017-02-18 17:14:58.640499
NCT00191568|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-18|||October 2002||2002-10-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer|A Phase II Trial of Adjuvant Treatment With Gemcitabine and Oxaliplatin Followed by Concomitant Gemcitabine and Radiation Therapy in Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 2|45||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:01.535091|2017-02-18 17:15:01.535091
NCT00191555|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-06-08|||August 2003||2003-08-01|July 2006|2006-07-01|May 2006||2006-05-01|||||Interventional|||Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment|Double-Blind Long-term Study Comparing the Efficacy and Safety of Olanzapine Versus Haloperidol in Patients With Schizophrenia Previously Stabilized With Conventional Antipsychotic Treatment|Completed||Phase 4|360||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:01.671922|2017-02-18 17:15:01.671922
NCT00191542|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-10|||March 2005||2005-03-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents|A Randomised, Double Blind Placebo Controlled Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Swedish Children and Adolescents|Completed||Phase 3|100||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:01.839515|2017-02-18 17:15:01.839515
NCT00191529|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-06-13|||December 2002||2002-12-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Growth Hormone Treatment in Short Children Born Small for Gestational Age|Optimization of Growth Hormone Treatment in Short Children Born Small for Gestational Age Based on a Growth Prediction Model-The OPTIMA Trial|Completed||Phase 3|200||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:01.949555|2017-02-18 17:15:01.949555
NCT00191516|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder|An Open-Label Study on Effectiveness and Tolerability of Atomoxetine as Perceived by Patients, Parents, and Physicians in Children With Attention-Deficit/Hyperactivity Disorder in Germany|Completed||Phase 3|257||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:02.045056|2017-02-18 17:15:02.045056
NCT00191503|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||January 2005||2005-01-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma|Phase II Study of Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma|Completed||Phase 2|30||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:02.138479|2017-02-18 17:15:02.138479
NCT00191490|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||July 2002||2002-07-01|January 2007|2007-01-01|May 2005||2005-05-01|||||Interventional|||A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer|A Multicenter Randomized Phase II Study Evaluating the Feasibility and Activity of Two Different Combinations of Docetaxel (RP56976, TAXOTERE *) and Gemcitabine and of Cisplatin/Gemcitabine Followed by Docetaxel as First Line Therapy for Locally Advanced Unresectable or Metastatic Non Small Cell Lung Cancer|Completed||Phase 2|162||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:02.501764|2017-02-18 17:15:02.501764
NCT00191477|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-09-24|2009-03-17||January 2004||2004-01-01|September 2009|2009-09-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Instillation of Gemcitabine in Patients With Superficial Bladder Cancer|A Randomized, Double-Blind, Placebo-Controlled Phase 3 Multicenter Study of Immediate Postoperative Instillation of Gemcitabine in Patients With Superficial Transitional Cell Carcinoma of the Bladder|Terminated||Phase 3|355|Actual|Eli Lilly and Company|The study was stopped early for futility reasons. In addition, due to limitations in this databank, some original outcome measures are not disclosed. Time to Recurrence and Recurrence-Free Survival in Subgroups had data that were un-estimated.|2||The study was stopped early for futility reasons.|f||||t||||||||||2017-02-18 17:15:02.609997|2017-02-18 17:15:02.609997
NCT00191464|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-10-12|||December 2003||2003-12-01|October 2010|2010-10-01|September 2005||2005-09-01|||||Interventional|||Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes|Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes: A Comparison of Premeal Insulin Lispro Mixtures to Once-Daily Insulin Glargine|Completed||Phase 4|320||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:03.796845|2017-02-18 17:15:03.796845
NCT00191451|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-17|2009-10-12||April 2004||2004-04-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer|Phase II Trial of Gemzar Plus Paraplatin (Plus Herceptin in HER2+ Patients) in Metastatic Breast Cancer|Completed||Phase 2|150|Actual|Eli Lilly and Company||3|||f||||||||||||||2017-02-18 17:15:03.908766|2017-02-18 17:15:03.908766
NCT00191438|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-25|||October 2002||2002-10-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents|Phase III Study of Docetaxel in Combination With Gemcitabine Versus Docetaxel in Combination With Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 3|300||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:05.213763|2017-02-18 17:15:05.213763
NCT00191425|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-07-12|||August 2002||2002-08-01|July 2007|2007-07-01|November 2005||2005-11-01|||||Interventional|||2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis|Comparison of a 2-Year Therapy of Teriparatide Alone and Its Sequential Use for 1 Year, With or Without Raloxifene HCl, in the Treatment of Severe Postmenopausal Osteoporosis|Completed||Phase 4|810||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:05.31479|2017-02-18 17:15:05.31479
NCT00191412|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-19|||January 2005||2005-01-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver|Phase II Study of Single-Agent Alimta in the Treatment of Patients With Advanced and Metastatic Hepatoma|Completed||Phase 2|41||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:05.398449|2017-02-18 17:15:05.398449
NCT00191386|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-12-14|2010-08-24||May 2005||2005-05-01|December 2010|2010-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)|Long-Term Extension, Open-Label Study of Atomoxetine Hydrochloride in Child Outpatients With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|228|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 17:15:05.589415|2017-02-18 17:15:05.589415
NCT00191373|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-11|||March 2002||2002-03-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease|Phase II Study of Gemcitabine and Trastuzumab Therapy in Patients With HER2 Overexpressing Metastatic Breast Cancer|Completed||Phase 2|66||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:06.15962|2017-02-18 17:15:06.15962
NCT00191360|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||January 2003||2003-01-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency|Extended Clinical Study of LY137998 [Somatropin (Recombinant DNA Origin)] in Adults With Growth Hormone Deficiency|Completed||Phase 3|68||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:06.257633|2017-02-18 17:15:06.257633
NCT00191347|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer|A Phase II Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer|Completed||Phase 2|30||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:06.348049|2017-02-18 17:15:06.348049
NCT00191334|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-02-24|2008-12-17||December 2004||2004-12-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Gemcitabine in Ovarian Cancer|Phase II Study of Gemcitabine Plus Cisplatin as First-Line Therapy in Patients With Epithelial Ovarian Cancer|Completed||Phase 2|50|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 17:15:06.699261|2017-02-18 17:15:06.699261
NCT00191321|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||July 2004||2004-07-01|January 2007|2007-01-01|December 2005||2005-12-01|||||Interventional|||Teriparatide Use in Hip Replaced Subjects|TUHRS Study - Teriparatide Use in Hip Replaced Subjects A Pilot Study on the Use of Teriparatide in Severe Osteoporotic Women With Hip Fracture and Submitted to Hip Replacement|Completed||Phase 3|60||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:07.224937|2017-02-18 17:15:07.224937
NCT00191308|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-10-13|2010-03-16||May 2005||2005-05-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|July 2008|Actual|2008-07-01||Interventional|||Molecular Profiling in Lung Cancer Patients|Molecular Profiling and Safety Study of Operable Lung Cancer Patients Treated With Alimta Combined With Cisplatin as Neoadjuvant Chemotherapy|Completed||Phase 2|30|Actual|Eli Lilly and Company|Trial enrollment was terminated early due to lack of eligible participants.|1|||f||||f||||||||||2017-02-18 17:15:07.323125|2017-02-18 17:15:07.323125
NCT00191295|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||February 2005||2005-02-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Comparison of Fixed-Dose Ranges of Atomoxetine Hydrochloride in Child Outpatients With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 2/Phase 3|240||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:07.667751|2017-02-18 17:15:07.667751
NCT00191282|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-01-18|2008-10-17||October 2002||2002-10-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|IONM||Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes|Hyperglycemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients With Type 2 Diabetes (HEART2D)|Completed||Phase 4|1116|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 17:15:07.802608|2017-02-18 17:15:07.802608
NCT00191269|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-03-10|2009-03-23||June 2005||2005-06-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2008|Actual|2008-03-01||Interventional|||Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen|A Multicenter Study of LY188011 in Anthracyclines and Taxanes Pre-treated Metastatic/Recurrent Breast Cancer|Completed||Phase 2|68|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 17:15:10.028673|2017-02-18 17:15:10.028673
NCT00191256|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||June 2001||2001-06-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer|Randomized Phase II Trial to Outline the Efficacy of Gemcitabine Containing Regimens (Gemcitabine/Carboplatin and Gemcitabine/Paclitaxel) When Used as Preoperative Chemotherapy In Patients With Stage I and II NSCLC|Completed||Phase 2|77||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:11.266059|2017-02-18 17:15:11.266059
NCT00191243|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-21|||March 2002||2002-03-01|November 2016|2016-11-01|April 2009|Actual|2009-04-01|August 2007|Actual|2007-08-01||Interventional|||Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer|A Randomized Phase II Study Comparing Single-Agent Docetaxel to Alternating Docetaxel-Gemcitabine as Primary Chemotherapy in Patients With Metastatic Breast Cancer|Completed||Phase 2|237|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 17:15:11.355421|2017-02-18 17:15:11.355421
NCT00191230|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2001||2001-09-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer|A Randomized Phase II Trial of Gemcitabine Containing Regimens (Gemcitabine/Carboplatin and Gemcitabine/ Cisplatin)When Used as Preoperative Chemotherapy for Patients With Stage I and II NSCLC|Completed||Phase 2|70||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:11.482686|2017-02-18 17:15:11.482686
NCT00191204|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2001||2001-09-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Open Label Phase III Duloxetine Study for Stress Urinary Incontinence|Long Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence|Completed||Phase 3|363||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:11.571252|2017-02-18 17:15:11.571252
NCT00190996|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||January 2003||2003-01-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence|The Safety and Effectiveness of Duloxetine Compared With Placebo and Its Long-Term Safety and Efficacy in the Treatment of Predominant Stress Urinary Incontinence|Completed||Phase 3|2765||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:19.754646|2017-02-18 17:15:19.754646
NCT00191191|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-04|2009-10-23||October 2004||2004-10-01|December 2009|2009-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)|LY231514 500 mg/m2 and LY231514 1000 mg/m2 in Patients With Advanced Non-Small Cell Lung Cancer Who Were Previously Treated With Prior Systemic Anti Cancer Therapy: A Randomized Phase II Trial|Completed||Phase 2|226|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:15:11.678204|2017-02-18 17:15:11.678204
NCT00191178|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-10-12|||August 2003||2003-08-01|October 2010|2010-10-01|July 2005||2005-07-01|||||Interventional|||Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes|Pilot Study Investigating the Effects of Insulin Lispro Low Mixture Therapy Compared With Insulin Glargine on Perceived Mood Symptoms in Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|60||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:12.474449|2017-02-18 17:15:12.474449
NCT00191165|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-06-08|2009-04-07||March 2004||2004-03-01|June 2009|2009-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency|Efficacy and Safety of a High Dosage Compared to the Label Dosage of Humatrope in Early Pubertal Stage Children With Growth Hormone Deficiency|Completed||Phase 3|27|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:15:12.572746|2017-02-18 17:15:12.572746
NCT00191152|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-21|2009-11-04||February 2002||2002-02-01|December 2009|2009-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||A Phase III Trial For Patients With Metastatic Breast Cancer|Randomized Trial of Gemcitabine Plus Docetaxel vs. Docetaxel Plus Capecitabine in Metastatic Breast Cancer in 1st and 2nd|Completed||Phase 3|475|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 17:15:13.647258|2017-02-18 17:15:13.647258
NCT00191139|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-02-04|2009-11-20||March 2003||2003-03-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|November 2008|Actual|2008-11-01||Interventional|||Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)|A Randomized Study of Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation Therapy in Stage III Unresectable NSCLC|Completed||Phase 2|64|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:15:15.020246|2017-02-18 17:15:15.020246
NCT00191126|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-21|||September 2000||2000-09-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC|Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages(T2N0, T1 - 2N1, T3N0 AND T3N1) Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|263|Actual|Eli Lilly and Company||2|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 17:15:15.883712|2017-02-18 17:15:15.883712
NCT00191113|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-13|2008-12-01||February 1989||1989-02-01|December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|GDCT||Somatropin Treatment to Final Height in Turner Syndrome|Humatrope Treatment to Final Height in Turner's Syndrome|Completed||Phase 3|154|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 17:15:16.0399|2017-02-18 17:15:16.0399
NCT00191100|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-08-08|2009-03-30||May 2002||2002-05-01|August 2009|2009-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix|Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA|Completed||Phase 3|515|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 17:15:17.721854|2017-02-18 17:15:17.721854
NCT00191087|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||April 2001||2001-04-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Duloxetine in the Treatment of Stress Urinary Incontinence.|Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence.|Completed||Phase 3|458||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:15:19.0896|2017-02-18 17:15:19.0896
NCT00191074|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-07|||February 2001||2001-02-01|March 2007|2007-03-01|January 2006||2006-01-01|||||Interventional|||Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature|Phase III Study of Humatrope in Non-Growth Hormone Deficient Children With Short Stature|Completed||Phase 3|11||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:19.176813|2017-02-18 17:15:19.176813
NCT00191061|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|January 2006||2006-01-01|||||Interventional|||A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder|A Comparison of Duloxetine Dosing Strategies in The Treatment of Patients With Major Depression|Completed||Phase 4|640||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:19.267477|2017-02-18 17:15:19.267477
NCT00191048|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||October 2003||2003-10-01|January 2007|2007-01-01|March 2006||2006-03-01|||||Interventional|||Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD|Open-Label Treatment With Atomoxetine Hydrochloride in Child and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia|Completed||Phase 4|105||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:19.387391|2017-02-18 17:15:19.387391
NCT00191035|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-12-12|||March 2004||2004-03-01|December 2006|2006-12-01|November 2006||2006-11-01|||||Interventional|||Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD|Maintenance of Benefit After 8-Week and 52-Week Treatment With Atomoxetine Hydrochloride in Adolescents With ADHD|Completed||Phase 4|520||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:19.47088|2017-02-18 17:15:19.47088
NCT00191022|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-02-12|||December 2004||2004-12-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Interventional|||Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder|A Randomized, Double-Blind Comparison of LY686017, Paroxetine, and Placebo in the Treatment of Social Anxiety Disorder|Completed||Phase 2|185||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:19.568373|2017-02-18 17:15:19.568373
NCT00191009|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||October 2003||2003-10-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease|Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer's Disease|Completed||Phase 2/Phase 3|124||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:19.664664|2017-02-18 17:15:19.664664
NCT00190983|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-13|2008-10-21||February 2005||2005-02-01|November 2009|2009-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Trial for Patients With Advanced/Recurrent Cervical Cancer|A Phase II Evaluation of Pemetrexed (Alimta) in the Treatment of Recurrent Carcinoma of the Cervix|Completed||Phase 2|29|Actual|Eli Lilly and Company||1|||||||||||||||||2017-02-18 17:15:19.838695|2017-02-18 17:15:19.838695
NCT00190970|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-25|||October 2004||2004-10-01|July 2016|2016-07-01|November 2005||2005-11-01|||||Interventional|||The Effect of Ruboxistaurin on Small Fiber Function|The Effect of Ruboxistaurin Mesylate (LY333531) on Small Fiber Function as Measured by Microvascular Skin Blood Flow, C-Fiber Quantitations in Skin and Quantitative Sensory Testing of Cold and Heat.|Completed||Phase 2|52||Chromaderm, Inc.|||||||||||||||||||2017-02-18 17:15:20.312496|2017-02-18 17:15:20.312496
NCT00190957|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||August 2004||2004-08-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse|Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse: A Randomized, Placebo-Controlled Trial|Completed||Phase 4|140||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:20.395359|2017-02-18 17:15:20.395359
NCT00190944|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-10|||December 2004||2004-12-01|October 2007|2007-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Effects of Teriparatide on Distal Radius Fracture Healing|Effects of Teriparatide on Distal Radius Fracture Healing|Completed||Phase 2|105||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:20.494807|2017-02-18 17:15:20.494807
NCT00190931|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-21|||November 2003||2003-11-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder|A Double-Blind Study of Functional Outcomes With Atomoxetine-Hydrochloride and Placebo in Adult Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder|Completed||Phase 4|400||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:20.582559|2017-02-18 17:15:20.582559
NCT00190918|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-07|||July 2006||2006-07-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||A Trial for Patients With Gestational Trophoblastic Disease|A Phase II Trial of Pemetrexed (Alimta) in the Treatment of Recurrent or Persistent Low Risk Gestational Trophoblastic Tumor|Completed||Phase 2|50|Anticipated|Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:20.660815|2017-02-18 17:15:20.660815
NCT00190905|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-21|||February 2004||2004-02-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.|Study of Duloxetine HCl in Women of Different Demographic Characteristics and Co-Morbidities With Stress Urinary Incontinence: Evaluation of Efficacy and Safety|Completed||Phase 4|4000||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:20.756827|2017-02-18 17:15:20.756827
NCT00190892|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2004||2004-09-01|January 2007|2007-01-01|June 2006||2006-06-01|||||Interventional|||Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania|Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder|Completed||Phase 4|120||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:23.647427|2017-02-18 17:15:23.647427
NCT00190879|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-06-06|||June 2005||2005-06-01|June 2007|2007-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder|Phase IV Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder|Completed||Phase 4|440||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:23.773312|2017-02-18 17:15:23.773312
NCT00190866|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||June 2005||2005-06-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome|Dose Response Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome|Completed||Phase 3|210||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:23.885514|2017-02-18 17:15:23.885514
NCT00190853|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||January 2005||2005-01-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence|Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women With Stress Urinary Incontinence|Completed||Phase 3|93||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:24.018216|2017-02-18 17:15:24.018216
NCT00190840|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer|Open-Label Single-Arm Phase 2 Study of ALIMTA in Patients With Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy|Completed||Phase 2|186||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:24.114361|2017-02-18 17:15:24.114361
NCT00190827|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)|The Effectiveness of Duloxetine Compared With Placebo in the Treatment of Predominant Stress Urinary Incontinence|Completed||Phase 3|500||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:24.471049|2017-02-18 17:15:24.471049
NCT00190814|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.|Efficacy and Safety of Duloxetine Compared With Placebo in Women With Symptoms of Mixed Urinary Incontinence.|Completed||Phase 3|600||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:24.577531|2017-02-18 17:15:24.577531
NCT00190801|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma|Open-Label Single-Arm Phase 2 Study of ALIMTA Plus Cisplatin in Korean Patients With Advanced Gastric Carcinoma|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:24.663491|2017-02-18 17:15:24.663491
NCT00190788|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-10|||June 2004||2004-06-01|October 2007|2007-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion|A Phase IIIb Study to Determine Efficacy and Safety of Extended Drotrecogin Alfa (Activated) Therapy in Patients With Persistent Requirement for Vasopressor Support After 96 Hour Infusion With Commercial Drotrecogin Alfa (Activated)|Completed||Phase 3|200|Anticipated|Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:24.755328|2017-02-18 17:15:24.755328
NCT00186134|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 2004||2004-10-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Walk to School and Physical Activity|Walk to School and Physical Activity|Completed||Phase 2|30||Stanford University|||||f||||||||||||||2017-02-18 17:16:28.748858|2017-02-18 17:16:28.748858
NCT00190775|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-08-18|2010-07-14||September 2004||2004-09-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|July 2009|Actual|2009-07-01||Interventional|||A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder: With a Secondary Examination of Impact of Treatment on Family Functioning|Completed||Phase 4|502|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:15:24.887366|2017-02-18 17:15:24.887366
NCT00190762|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||October 2001||2001-10-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma|A Randomized Phase 3 Trial Comparing ALIMTA Plus Best Supportive Care Versus Best Supportive Care Alone in Previously Treated Patients With Locally Advanced or Metastatic Malignant Pleural Mesothelioma|Completed||Phase 3|240||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:28.886848|2017-02-18 17:15:28.886848
NCT00190749|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-04-26|2009-06-03||October 2003||2003-10-01|April 2010|2010-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder|Insulin Sensitivity in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Risperidone|Completed||Phase 4|130|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:15:28.984553|2017-02-18 17:15:28.984553
NCT00190736|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-05|||September 2004||2004-09-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)|Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months); With a Brief Evaluation of Executive Cognition|Completed||Phase 4|440||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:30.653501|2017-02-18 17:15:30.653501
NCT00190723|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||October 2002||2002-10-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||A Study of LY317615 in Patients With Brain Tumors|A Phase II Trial of LY317615 in Patients With Recurrent High-Grade Gliomas|Completed||Phase 2|120||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:30.859804|2017-02-18 17:15:30.859804
NCT00190710|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-10|||March 2004||2004-03-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer|A Randomized Phase III Trial of Paraplatin (Carboplatin) + Gemzar Versus Gemzar Alone in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|242||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:30.945232|2017-02-18 17:15:30.945232
NCT00190697|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-23|||January 2001||2001-01-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment|Continuation of Treatment and Monitoring of Safety in Patients Treated With LY353381 for Advanced Cancer|Completed||Phase 4|70||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:31.030579|2017-02-18 17:15:31.030579
NCT00190684|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-12-15|2010-10-01||August 2000||2000-08-01|December 2010|2010-12-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Long-Term, Open Label Atomoxetine Study|Long-Term, Open Label Safety Study of Atomoxetine Hydrochloride in Patients, 6 Years and Older With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|1553|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 17:15:31.137502|2017-02-18 17:15:31.137502
NCT00190671|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-17|2009-03-17||June 2005||2005-06-01|November 2009|2009-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients|A Phase 1/2 Dose-Escalating Study of ALIMTA and Cyclophosphamide Administered Every 21 Days in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|103|Actual|Eli Lilly and Company|600 mg/m2 arm discontinued at end of Phase 1 because of lack of efficacy. Enrollment in 1800 mg/m2 arm continued to Phase 2. (Phase 1 outcomes were tumor response and pharmacokinetics). Secondary efficacy endpoints analyzed for 1800 mg/m2 arm only.|2|||f||||f||||||||||2017-02-18 17:15:32.477207|2017-02-18 17:15:32.477207
NCT00190658|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-12-17|||February 2000||2000-02-01|December 2010|2010-12-01|September 2010|Actual|2010-09-01|July 2004|Actual|2004-07-01||Interventional|||Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome|Safety and Efficacy of Humatrope in Pediatric Patients With Genetic Short Stature (SHOX Gene Defect)|Completed||Phase 3|75||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:33.563503|2017-02-18 17:15:33.563503
NCT00190645|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||February 2001||2001-02-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence|Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence|Completed||Phase 3|600||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:33.648465|2017-02-18 17:15:33.648465
NCT00190632|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||March 2001||2001-03-01|January 2007|2007-01-01|April 2006||2006-04-01|||||Interventional|||To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence|Long-Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence|Completed||Phase 3|600||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:33.73517|2017-02-18 17:15:33.73517
NCT00190619|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||May 2001||2001-05-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Efficacy and Safety of Duloxetine|Efficacy and Safety of Duloxetine Compared With Placebo in Subjects Electing Surgery for Severe Pure Genuine Stress Incontinence|Completed||Phase 3|100||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:33.819174|2017-02-18 17:15:33.819174
NCT00190606|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||January 2002||2002-01-01|January 2007|2007-01-01|April 2006||2006-04-01|||||Interventional|||Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence|Efficacy and Safety of Duloxetine Compared With Placebo,Pelvic Floor Muscle Training, and Combined Duloxetine/Pelvic Floor Muscle Training in Subjects With Moderate to Sever Stress Urinary Incontinence|Completed||Phase 2|200||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:33.909619|2017-02-18 17:15:33.909619
NCT00190593|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||June 1998||1998-06-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Raloxifene Use for The Heart|Raloxifene Hydrochloride or Placebo in Postmenopausal Women at Risk for Major Coronary Events|Completed||Phase 3|10000||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:34.078183|2017-02-18 17:15:34.078183
NCT00005410|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||June 1991||1991-06-01|May 2000|2000-05-01|May 1993|Actual|1993-05-01|||||Observational|||Epidemiology of Coronary Heart Disease in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.753624|2017-02-18 18:15:01.753624
NCT00190580|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-03-30|||February 2003||2003-02-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease|Effects of Valsartan on the Progression of Renal and Cardiovascular Disease - Kanagawa Valsartan Trial (KVT)|Completed||Phase 4|312|Actual|KVT-Study Group||2|||f||||t||||||||||2017-02-18 17:15:34.167819|2017-02-18 17:15:34.167819
NCT00190567|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-24|||October 2001||2001-10-01|January 2007|2007-01-01|April 2006||2006-04-01|||||Interventional|||Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence|Biomechanical Effects of Duloxetine on Bladder Function and Sphincter Resistance During the Emptying Phase and on Urethral Function During the Filling Phase of the Micturition Cycle in Women With Pure Genuine Stress Incontinence|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:15:34.279398|2017-02-18 17:15:34.279398
NCT00190554|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-20|||May 2000||2000-05-01|September 2016|2016-09-01|May 2009|Actual|2009-05-01|May 2004|Actual|2004-05-01||Interventional|||A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma|A Randomized Controlled Trial of Chemotherapy With 5FU and Cisplatin Before and After Surgery for Stage II,III Squamous Cell Carcinoma of the Thoracic Esophagus:JCOG9907|Terminated||Phase 3|330||Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:15:34.369722|2017-02-18 17:15:34.369722
NCT00190541|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-20|||June 2003||2003-06-01|September 2016|2016-09-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)|Mesorectal Excision With Lateral Lymph Node Dissection Versus Without Lateral Lymph Node Dissection for Clinical Stage II, III Lower Rectal Cancer (JCOG0212)|Completed||Phase 3|700|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:15:34.688616|2017-02-18 17:15:34.688616
NCT00190528|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-20|||February 2002||2002-02-01|September 2016|2016-09-01|February 2009|Actual|2009-02-01|December 2004|Actual|2004-12-01||Interventional|||A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer|Phase III Trial of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Bulky Stage I/II Cervical Cancer: Japan Clinical Oncology Group Trial (JCOG0102)|Terminated||Phase 3|200|Actual|Japan Clinical Oncology Group||2|||f||||||||||||||2017-02-18 17:15:34.884443|2017-02-18 17:15:34.884443
NCT00190515|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-20|||February 2003||2003-02-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)|Randomized Phase III Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)|Completed||Phase 3|1101|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:15:35.017206|2017-02-18 17:15:35.017206
NCT00190502|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-01-08|||November 2000||2000-11-01|February 2004|2004-02-01|December 2007||2007-12-01|||||Interventional|||Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes|The Use of Polyclonal Anti-T-Lymphocyte Globulin to Prevent Progression of Autoimmune Beta-Cell Destruction in Recent Type 1 Diabetes|Unknown status|Recruiting|N/A|28||Institute for Clinical and Experimental Medicine|||||f||||||||||||||2017-02-18 17:15:35.20374|2017-02-18 17:15:35.20374
NCT00190489|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-31|||January 1999||1999-01-01|August 2016|2016-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer|Phase III Trial of Doxorubicin /Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D (AC-D) as Front-line Chemotherapy for Metastatic Breast Cancer: Japan Clinical Oncology Group Trial (JCOG9802)|Completed||Phase 3|450||Japan Clinical Oncology Group||3|||f||||t||||||||||2017-02-18 17:15:35.311911|2017-02-18 17:15:35.311911
NCT00190476|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2016-09-08|||April 2003||2003-04-01|September 2016|2016-09-01|April 2007||2007-04-01|||||Interventional|||Elderly NSCLC/D vs DP (JCOG0207)|Randomized Controlled Trial Comparing Docetaxel-cisplatin Combination With Docetaxel Alone in Elderly Patients With Advanced Non-small-cell Lung Cancer(JCOG0207)|Terminated||Phase 3|230||Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:15:35.422117|2017-02-18 17:15:35.422117
NCT00190463|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2006-09-20|||April 2003||2003-04-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia|"The Strategy Antifungal Empirical Traditional is Again Justified in Prolonged Neutropenias . Study PREVERT"|Terminated||Phase 4|300||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:15:35.567837|2017-02-18 17:15:35.567837
NCT00190450|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-07-27|||January 2002||2002-01-01|March 2007|2007-03-01|May 2013|Anticipated|2013-05-01|May 2013|Anticipated|2013-05-01||Interventional|MIG-HD||MIG-HD: Multicentric Intracerebral Grafting in Huntington's Disease|Multicentric Intracerebral Grafting in Huntington's Disease|Unknown status|Recruiting|Phase 2|60|Anticipated|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:35.666769|2017-02-18 17:15:35.666769
NCT00190437|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-04-29|||August 2003||2003-08-01|March 2007|2007-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD|ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD|Completed||Phase 4|520|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:35.792724|2017-02-18 17:15:35.792724
NCT00190424|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-12-12|||September 2005||2005-09-01|September 2005|2005-09-01|October 2010|Actual|2010-10-01|October 2008|Actual|2008-10-01||Interventional|||Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma|Multicentric Randomized Phase 2. Immunotherapy With CpG-ODN in Malignant Glioblastoma|Completed||Phase 2|80|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||||||||||||2017-02-18 17:15:35.922081|2017-02-18 17:15:35.922081
NCT00190411|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-15|||October 2003||2003-10-01|March 2007|2007-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type|Prevention of Vascular Complications by BetaBlocker Treatment in Vascular Ehlers-Danlos Syndrome|Completed||Phase 4|54|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:36.035325|2017-02-18 17:15:36.035325
NCT00190398|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-04-29|||November 2000||2000-11-01|February 2007|2007-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||EVA3S: Endarterectomy Versus Angioplasty in Patients With Severe Symptomatic Carotid Stenosis|Endarterectomy Versus Angioplasty in Patients With Severe Symptomatic Carotid Stenosis|Completed||Phase 3|900|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:36.158971|2017-02-18 17:15:36.158971
NCT00190385|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-02-24|||July 2000||2000-07-01|March 2007|2007-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis|Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis. A Randomized Trial Comparing Two Periodicities of Ultrasonographic Surveillance: 3-month vs 6-month|Completed||Phase 3|1200|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:36.269517|2017-02-18 17:15:36.269517
NCT00190372|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-02-16|||October 2004||2004-10-01|March 2007|2007-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients|Contribution of a Psycho-Educational Program of Help to Help in the Pharmacological Assumption of Responsibility of the Disease of Alzheimer|Completed||N/A|240|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:36.378345|2017-02-18 17:15:36.378345
NCT00190359|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||September 2000||2000-09-01|April 2002|2002-04-01|February 2003||2003-02-01|||||Observational|||Growth Hormone and Heart Failure|Modifications of the Growth Hormone/IGF1 Axis in Heart Failure Patients|Terminated||N/A|180||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:15:36.492635|2017-02-18 17:15:36.492635
NCT00190346|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-10-25|||December 2001||2001-12-01|August 2005|2005-08-01|April 2003||2003-04-01|||||Interventional|||Comparison of Humidification Devices During Non Invasive Ventilation, in Acute Respiratory Failure|Randomized RCT Comparing HH and HME During NIV in Acute Respiratory Failure|Terminated||N/A|250||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:15:36.5728|2017-02-18 17:15:36.5728
NCT00190333|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-17|||June 2005||2005-06-01|March 2007|2007-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension|Evaluation of the Therapeutic Effects of Escitalopram in Pulmonary Hypertension, Either Primary or Associated|Completed||Phase 3|30|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:36.68677|2017-02-18 17:15:36.68677
NCT00190320|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-16|||February 2005||2005-02-01|March 2007|2007-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia|Induction of Labor or Waiting for Suspicion Fetal Macrosomia (DAME)|Completed||Phase 4|1000|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:36.795672|2017-02-18 17:15:36.795672
NCT00190307|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-20|||June 2005||2005-06-01|September 2005|2005-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|STRATAGEM||STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery|Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery|Completed||Phase 4|293|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:36.889245|2017-02-18 17:15:36.889245
NCT00190294|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-29|||April 2003||2003-04-01|March 2007|2007-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Expectant Versus Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW|Comparison Expectant With Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW|Completed||Phase 4|200|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:36.993|2017-02-18 17:15:36.993
NCT00190281|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-12|||August 2005||2005-08-01|March 2005|2005-03-01||||||||Observational|||Contrast-Enhanced US of Spleen, Liver and Kidney|Contrast-Enhanced US of Spleen, Liver and Kidney in Patients With Acute Infection (Malaria and Other Infectious Diseases: a Functional Study|Unknown status|Recruiting|Phase 3|53||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:15:37.090314|2017-02-18 17:15:37.090314
NCT00190268|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-18|||February 2005||2005-02-01|March 2007|2007-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis|Multicentric Study, Comparative, Randomized, in Double Knowledge of the Effectiveness (Versus Placebo) of a Salt Of 3,4 - Diaminopyridine in the Treatment of Tiredness During the Multiple Sclerosis|Completed||Phase 3|126|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:37.164256|2017-02-18 17:15:37.164256
NCT00190255|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-09|||April 2004||2004-04-01|March 2007|2007-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Pharmacogenetics of Gastrointestinal Bleeding|Pharmacogenetics of Gastrointestinal Bleeding Under Nonsteroidal Anti-inflammatory Drugs : the Role of Cytochrome P450 2C9|Completed||Phase 4|200|Actual|Assistance Publique - Hôpitaux de Paris|||1||f||||t||||||Samples With DNA|"~     Gastrointestinal bleeding is a severe adverse effect occurring in subjects secondary to the~     use of nonsteroidal anti-inflammatory drugs (NSAIDs). The enzyme CYP2C9 is responsible for~     the elimination of several NSAIDs. This protein is inactive in 12% of the subjects because~     of genetic mutations. We hypothesized that individuals carrying such mutations should be at~     higher risk of gastrointestinal bleeding since they display decreased NSAIDs elimination.~   "|||2017-02-18 17:15:37.268152|2017-02-18 17:15:37.268152
NCT00190242|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-12-15|||June 2003||2003-06-01|June 2005|2005-06-01|October 2009|Actual|2009-10-01|October 2006|Actual|2006-10-01||Interventional|HEPAVAC||Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients|Study of Immunogenicity of Anti-HAV Immunisation in HIV-1 Infected Patients, Co-infected or Not With HBV and/or HCV. HEP.A.VAC Study.|Completed||Phase 3|99|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 17:15:37.363144|2017-02-18 17:15:37.363144
NCT00190229|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-03|||September 2002||2002-09-01|March 2007|2007-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura|CESAR (Randomized Therapeutic Study of Steroid vs. Steroid Plus Cyclosphosphamide for Severe Viscera Henoch-Schoenlein Purpura)|Completed||N/A|200|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:15:37.472367|2017-02-18 17:15:37.472367
NCT00190216|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-06|||December 2001||2001-12-01|July 2005|2005-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS)|Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression|Terminated||Phase 3|60|Actual|Assistance Publique - Hôpitaux de Paris||1||terminated|f||||f||||||||||2017-02-18 17:15:37.573882|2017-02-18 17:15:37.573882
NCT00188487|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-20|||September 2005||2005-09-01|April 2007|2007-04-01|December 2005||2005-12-01|||||Interventional|||Magnetic Resonance (MR) in Asthmatic Patients|MR Perfusion Imaging in Asthmatic Patients|Suspended||Phase 1|80||University Health Network, Toronto||||no funding|f||||||||||||||2017-02-18 17:15:46.613328|2017-02-18 17:15:46.613328
NCT00190203|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-01-16|||December 2001||2001-12-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|DECIMAL||Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts|Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts : A Sequential Design, Multicenter, Randomized, Controlled Trial|Terminated||Phase 3|60|Actual|Assistance Publique - Hôpitaux de Paris||1||the study is publiched|f||||t||||||||||2017-02-18 17:15:37.747524|2017-02-18 17:15:37.747524
NCT00190190|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-16|||January 2005||2005-01-01|July 2007|2007-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Internal Limiting Membrane Peeling for Large Macular Holes|Comparison of the Success Rate of a Procedure With Peeling of Limiting the Intern of the Retina Versus a Traditional Procedure Without Peeling of Limiting, at Patients Presenting a Macular Hole.|Completed||N/A|80|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 17:15:37.858519|2017-02-18 17:15:37.858519
NCT00190177|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-17|||March 2003||2003-03-01|September 2005|2005-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||ECLAXIR:Search for an Association Between CX3CR1 V249I Polymorphism, Preeclampsia and Endothelial Injury||Completed||N/A|370|Anticipated|Assistance Publique - Hôpitaux de Paris|||||f||||f||||||||||2017-02-18 17:15:37.960074|2017-02-18 17:15:37.960074
NCT00190164|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-07-17|||August 2005||2005-08-01|July 2007|2007-07-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Alleviated Positioning for Small Macular Holes|Evaluation of the Success Rate of a Procedure Without Strict Positioning Post Surgical Versus With Positioning Face Towards the Strict Ground, at Patients Presenting a Macular Hole. Study of Non-Inferiority.|Completed||N/A|69|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:15:38.040118|2017-02-18 17:15:38.040118
NCT00190151|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-09-17|||September 2004||2004-09-01|September 2005|2005-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora|Pharmacokinetic/Pharmacodynamic Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora|Terminated||N/A|48|Actual|Assistance Publique - Hôpitaux de Paris||1||terminated|f||||f||||||||||2017-02-18 17:15:38.141723|2017-02-18 17:15:38.141723
NCT00190138|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-10-05||||||December 2004|2004-12-01||||||||Interventional|||Effect of Bi-ventricular Pacing on Autonomous Nervous System|Effect of Bi-ventricular Pacing on Autonomous Nervous System|Unknown status|Not yet recruiting|N/A|||Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 17:15:38.237527|2017-02-18 17:15:38.237527
NCT00190125|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2009-02-06||||||August 2005|2005-08-01|August 2007|Anticipated|2007-08-01|||||Observational|||The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients|The Influences of Malnutrition and Inflammation Complex Syndrome in Hemodialysis Patients|Unknown status|Not yet recruiting|N/A|300|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 17:15:38.309194|2017-02-18 17:15:38.309194
NCT00190112|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-10-05||||||December 2004|2004-12-01||||||||Interventional|||Change of Heart Rate Variability and Baroreflex Sensitivity After Ventral Cardiac Denervation||Unknown status|Not yet recruiting|N/A|30|Anticipated|Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 17:15:38.391743|2017-02-18 17:15:38.391743
NCT00190099|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-11-17|||January 2003||2003-01-01|December 2004|2004-12-01|December 2003||2003-12-01|||||Interventional|||Dexamethasone-Eluting Stent in Acute Coronary Syndrome to Prevent Restenosis||Completed||Phase 4|40||Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 17:15:38.462777|2017-02-18 17:15:38.462777
NCT00190086|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-11|||January 2001||2001-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||Syndrome X and Endothelial Dysfunction||Terminated||Phase 4|28||Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 17:15:38.537488|2017-02-18 17:15:38.537488
NCT00190073|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-11|||January 2005||2005-01-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Observational|||Cutaneous Denervation in Alcoholic Neuropathy|Cutaneous Denervation in Alcoholic Neuropathy|Unknown status|Recruiting|N/A|30||Far Eastern Memorial Hospital|||||f||||||||||||||2017-02-18 17:15:38.598909|2017-02-18 17:15:38.598909
NCT00190060|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-11-29|||October 2004||2004-10-01|November 2007|2007-11-01|March 2007|Actual|2007-03-01|||||Interventional|||Study of The Effects of Testosterone in Frail Elderly Men|Study of The Effects of Testosterone on Muscle Function, Physical Performance, Body Composition and Quality of Life in Frail Elderly Men|Completed||Phase 4|262|Actual|Central Manchester University Hospitals NHS Foundation Trust||2|||f||||t||||||||||2017-02-18 17:15:38.684872|2017-02-18 17:15:38.684872
NCT00190047|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-11-22|||February 2005||2005-02-01|November 2007|2007-11-01|October 2006||2006-10-01|||||Interventional|||Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Study To Evaluate The Effects Of DP-b99 On Neurologic Function And Disability In Subjects With Acute Ischemic Hemispheric Stroke|Completed||Phase 2|150||D-Pharm Ltd.|||||f||||||||||||||2017-02-18 17:15:38.810238|2017-02-18 17:15:38.810238
NCT00190034|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2009-02-06|||January 2005||2005-01-01|June 2006|2006-06-01|June 2007|Anticipated|2007-06-01|||||Interventional|||Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.|N-Acetylcysteine Protects Against Acute Renal Insult in Patients With Abnormal Renal Function Undergoing Cardiopulmonary Bypass.|Suspended||Phase 4|60|Anticipated|Far Eastern Memorial Hospital||||opposite result|f||||||||||||||2017-02-18 17:15:38.919972|2017-02-18 17:15:38.919972
NCT00190021|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2010-09-05||||||October 2005|2005-10-01||||||||Interventional|||Donepezil Treatment of Psychotic Symptoms in Dementia Patients|Donepezil as Add-On Treatment of Psychotic Symptoms in Patients With Dementia of the Alzheimer's Type|Unknown status|Not yet recruiting|Phase 3|80|Anticipated|Beersheva Mental Health Center|||||f||||||||||||||2017-02-18 17:15:39.012866|2017-02-18 17:15:39.012866
NCT00190008|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2009-11-23|||August 2003||2003-08-01|November 2009|2009-11-01||||||||Interventional|||Piracetam for Treatment Tardive Dyskinesia|Therapeutic Use of Piracetam for Treatment of Patients Suffering From Tardive Dyskinesia: a Double Blind, Placebo-Controlled Crossover Study|Completed||Phase 3|40||Beersheva Mental Health Center|||||f||||||||||||||2017-02-18 17:15:39.106958|2017-02-18 17:15:39.106958
NCT00189995|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2013-07-23||||||October 2005|2005-10-01||||||||Interventional|||Clozapine IM and Aggression in Schizophrenic Patients|Intramuscular Clozapine in the Management of Aggression in Schizophrenic Patients|Withdrawn||Phase 3|0|Actual|Beersheva Mental Health Center|||||f||||||||||||||2017-02-18 17:15:41.869974|2017-02-18 17:15:41.869974
NCT00189228|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2013-01-18|||September 2005||2005-09-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Immune Dysfunction in Allergic Asthma|Not a Drug Trial. We Are Using Anti-IgE to Examine the Role of Pulmonary Mast Cells in Asthma|Completed||N/A|18|Actual|University of New Mexico||1|||f||||t||||||||||2017-02-18 17:15:57.453931|2017-02-18 17:15:57.453931
NCT00189982|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||December 2004||2004-12-01|July 2013|2013-07-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101|Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (ADVATE rAHF-PFM): Safety Monitoring in Pediatric Patients Diagnosed With Severe to Moderately Severe Hemophilia A - A Continuation of Baxter Clinical Study 060101|Completed||Phase 2/Phase 3|4|Actual|Baxalta US Inc.|||||f||||||||||||||2017-02-18 17:15:41.958982|2017-02-18 17:15:41.958982
NCT00189969|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-04-20|||September 2003||2003-09-01|April 2006|2006-04-01|February 2006||2006-02-01|||||Interventional|||Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects|Phase I Study to Evaluate Take Rate, Immunogenicity and Safety of Bavarian Nordic’s Smallpox Vaccine Elstree-BN Administered to Healthy Vaccinia-Naive Subjects in the Age of 18-32 Years|Completed||Phase 1|50||Bavarian Nordic|||||f||||||||||||||2017-02-18 17:15:42.042479|2017-02-18 17:15:42.042479
NCT00189956|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-02-03|||April 2003||2003-04-01|February 2015|2015-02-01|November 2003|Actual|2003-11-01|||||Interventional|||Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.|Phase II, Double-blind, Randomised, Dose-finding Study to Evaluate the Immunogenicity of Three Different Doses of MVA-BN Smallpox Vaccine in 18-30 Year Old Smallpox naïve Healthy Subjects|Completed||Phase 2|165|Actual|Bavarian Nordic||3|||f||||||||||||||2017-02-18 17:15:42.125958|2017-02-18 17:15:42.125958
NCT00189943|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||April 2001||2001-04-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Interventional|||Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects|Phase I Study on Safety, Tolerability and Immunogenicity of the MVA-BN Vaccine Administered to Healthy Subjects|Completed||Phase 1|90||Bavarian Nordic|||||f||||||||||||||2017-02-18 17:15:42.235799|2017-02-18 17:15:42.235799
NCT00189930|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-09-28|||April 2005||2005-04-01|September 2012|2012-09-01|December 2006|Actual|2006-12-01|||||Interventional|||An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients|A Single-blind, Randomized, Controlled, Phase II Study to Evaluate Immunogenicity and Safety of Two Doses of the MVA-nef HIV Vaccine in HIV-1 Infected Patients With CD4 > 250/µl|Completed||Phase 2|77|Actual|Bavarian Nordic||3|||f||||f||||||||||2017-02-18 17:15:42.319163|2017-02-18 17:15:42.319163
NCT00189917|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-06-02|||April 2004||2004-04-01|June 2015|2015-06-01|April 2006||2006-04-01|||||Interventional|||Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders|An Open-label, Controlled Phase I Pilot Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in 18-40 Year Old Vaccinia-naïve Subjects With Atopic Disorders|Completed||Phase 1|60||Bavarian Nordic|||||||||||||||||||2017-02-18 17:15:42.431298|2017-02-18 17:15:42.431298
NCT00189904|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2012-09-27|||July 2005||2005-07-01|December 2007|2007-12-01||||||||Interventional|||Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients|A Multicenter, Open-label Phase I/II Study to Evaluate Safety and Immunogenicity of MVA-BN® Smallpox Vaccine in HIV Infected Subjects (CD4 Counts >350 / µl) and Healthy Subjects With and Without Previous Smallpox Vaccination|Completed||Phase 1/Phase 2|151|Actual|Bavarian Nordic|||||||||||||||||||2017-02-18 17:15:42.514356|2017-02-18 17:15:42.514356
NCT00189878|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2016-02-18|||August 2003||2003-08-01|February 2016|2016-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria|Multi-centre Prospective Randomised Double-blind Placebo-controlled Study of Methotrexate in the Treatment of Chronic Idiopathic Urticaria|Terminated||Phase 2|3|Actual|Barnsley Hospital||2||unable to recruit|f||||t||||||||||2017-02-18 17:15:42.606775|2017-02-18 17:15:42.606775
NCT00189852|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-02-18|||November 2005||2005-11-01|February 2016|2016-02-01|February 2009|Actual|2009-02-01|September 2007|Actual|2007-09-01||Interventional|||Supporting Care and Independence at Home|Supporting Care and Independence at Home|Completed||N/A|62|Actual|Barnsley Hospital||2|||f||||f||||||||||2017-02-18 17:15:42.710276|2017-02-18 17:15:42.710276
NCT00189839|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-07-07|||August 2004||2004-08-01|July 2014|2014-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation|A Multicentre, Randomised, Double Blind, Two Arm Parallel Group Study to Evaluate and Compare the Efficacy and Safety of Modified Release Tacrolimus FK506E (MR4) Versus Tacrolimus FK506 in Combination With MMF (Cellcept®) and Steroids in Patients Undergoing Kidney Transplantation|Completed||Phase 3|699|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 17:15:45.472002|2017-02-18 17:15:45.472002
NCT00189826|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-07-07|||August 2004||2004-08-01|July 2014|2014-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.|A Multicentre, Randomised, Double Blind, Two Arm Parallel Group Study to Evaluate and Compare the Efficacy and Safety of Modified Release Tacrolimus FK506E (MR4) Versus Tacrolimus FK506 in Combination With Steroids in Patients Undergoing Primary Liver Transplantation|Completed||Phase 3|475|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 17:15:45.671589|2017-02-18 17:15:45.671589
NCT00189813|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-08-27|||March 2005||2005-03-01|August 2014|2014-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Potential Efficacy, Safety and Tolerability of Different Oral Doses of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome|Completed||Phase 2|691|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:46.09222|2017-02-18 17:15:46.09222
NCT00189800|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-15||||||October 2006|2006-10-01||||||||Interventional|||A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:46.256794|2017-02-18 17:15:46.256794
NCT00189787|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-15||||||April 2008|2008-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma||Completed||Phase 2|370|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:46.373295|2017-02-18 17:15:46.373295
NCT00188500|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-28|||August 2005||2005-08-01|March 2004|2004-03-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy|Efficacy, Tolerability and Long-Term Adherence of a Modified Ketogenic Diet (Atkins) in the Management of Pharmacoresistant Epilepsy|Unknown status|Recruiting|N/A|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:15:46.519228|2017-02-18 17:15:46.519228
NCT00188474|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-29|||August 2004||2004-08-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||A Quality of Life Study re Management of Malignant Pleural Effusions|A Prospective Study of Patient Centered Outcomes in the Management of Malignant Pleural Effusions|Completed||N/A|149|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 17:15:46.704746|2017-02-18 17:15:46.704746
NCT00188253|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-03|||March 2005||2005-03-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.|Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma.|Active, not recruiting||Phase 2|30|Anticipated|University Health Network, Toronto|||1||f||||||||||||||2017-02-18 17:15:46.816681|2017-02-18 17:15:46.816681
NCT00188240|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-28|||August 2003||2003-08-01|September 2005|2005-09-01||||||||Interventional|||Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy|Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Anti-Viral Therapy|Unknown status|Recruiting|N/A|200||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:15:46.909146|2017-02-18 17:15:46.909146
NCT00188227|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2007-04-19|||September 2001||2001-09-01|September 2005|2005-09-01|November 2003||2003-11-01|||||Interventional|||Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture|Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture|Completed||Phase 4|748||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:15:47.008632|2017-02-18 17:15:47.008632
NCT00188214|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-07-29|||October 2003||2003-10-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy|Dynamic CT Perfusion for Assessment of Lung Cancer Before and After Neoadjuvant Chemo-/ Radiotherapy|Completed||Phase 2|38|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 17:15:47.130615|2017-02-18 17:15:47.130615
NCT00188201|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-28|||January 2002||2002-01-01|September 2005|2005-09-01||||||||Observational|||Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication|An Investigation of Cognitive Functioning and Brain Metabolites in Patients With Non-Cirrhotic Hepatitis-C Both Pre- and Post-Treatment With Antiviral Medication|Unknown status|Recruiting|N/A|150||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:15:47.241807|2017-02-18 17:15:47.241807
NCT00188188|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-28|||March 2002||2002-03-01|March 2005|2005-03-01||||||||Interventional|||Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease|Endothelial Dysfunction in Systemic Lupus Erythematosus: Its Contribution to Abnormalities in Coronary Perfusion.|Unknown status|Recruiting|Phase 4|50||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:15:47.328046|2017-02-18 17:15:47.328046
NCT00188175|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-06-02|||May 2003||2003-05-01|June 2014|2014-06-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||IMRT Lower Limb Soft Tissue Sarcoma|A Phase II Study of Preoperative Intensity-Modulated Radiation Therapy For Lower Limb Soft Tissue Sarcoma|Completed||Phase 2|59|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 17:15:47.408571|2017-02-18 17:15:47.408571
NCT00187759|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-05-06|||November 2004||2004-11-01|May 2015|2015-05-01|March 2005||2005-03-01|||||Interventional|||Placebo Controlled Study of Antibiotic Treatment of Soft Tissue Infection|A Placebo Controlled, Randomized, and Blinded Study of Antibiotic Treatment of Patients With Uncomplicated Soft Tissue Infection|Completed||N/A|500||University of California, San Francisco|||||f||||||||||||||2017-02-18 17:15:47.748546|2017-02-18 17:15:47.748546
NCT00187746|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-11-20|||August 2005||2005-08-01|November 2012|2012-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Age on the Renal Clearance of Adefovir|Effect of Age on the Renal Clearance of Adefovir|Withdrawn||Phase 4|0|Actual|University of California, San Francisco||2||Budget exceeded for project.|f||||t||||||||||2017-02-18 17:15:47.850874|2017-02-18 17:15:47.850874
NCT00187733|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-09-11|||January 2005||2005-01-01|September 2012|2012-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides|Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides|Completed||N/A|16|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     Blood Draw (10cc) to determine eligibility (CBC, blood chemistries). Blood draw (20cc) at~     t=0 in fasting state for baseline measurement of biochemical markers (including carnitine,~     acylcarnitines, creatinine, and total lipid panel) Urine collection at t=0 Blood draw (20cc)~     at t=2 hours for measurement of biochemical markers (including carnitine, acylcarnitines,~     creatinine, and total lipid panel) Urine collection at t=2 hours Transformation of blood to~     establish lymphoblastoid cell lines (from blood samples collected at t=0 and t=2 hours)~   "|||2017-02-18 17:15:47.972594|2017-02-18 17:15:47.972594
NCT00187720|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-12-06|2011-03-31||May 2002||2002-05-01|December 2012|2012-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Genetic Basis for Variation in the Renal Elimination of Metformin|Genetic Basis for Variation in the Renal Elimination of Metformin|Completed||Phase 4|23|Actual|University of California, San Francisco|Recruitment of subjects with interested genotypes was our limitation.|2|||f||||t||||||||||2017-02-18 17:15:48.088673|2017-02-18 17:15:48.088673
NCT00187707|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-08-07|||September 2005||2005-09-01|August 2012|2012-08-01|August 2008|Actual|2008-08-01|January 2007|Actual|2007-01-01||Interventional|||Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin|Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin|Completed||N/A|30|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 17:15:48.503606|2017-02-18 17:15:48.503606
NCT00187681|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-12-06|2011-05-20||July 2003||2003-07-01|December 2012|2012-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects|Effect of Genetic Variants in the Xenobiotic Transporter, OCT1, on Response to Metformin in Healthy Subjects|Completed||Phase 4|20|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 17:15:48.620719|2017-02-18 17:15:48.620719
NCT00187668|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-10-20|||February 2004||2004-02-01|October 2014|2014-10-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|SOPHIE||Study Of PHarmacogenetics in Ethnically Diverse Populations (SOPHIE Study)|Study Of PHarmacogenetics in Ethnically Diverse Populations (SOPHIE Study)|Unknown status|Recruiting|N/A|500|Anticipated|University of California, San Francisco|||4||f||||t||||||Samples With DNA|"~     40 mL of blood for DNA extraction~   "|||2017-02-18 17:15:49.039986|2017-02-18 17:15:49.039986
NCT00187655|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-10-21|2013-05-21||January 2004||2004-01-01|October 2014|2014-10-01|December 2013|Actual|2013-12-01|December 2011|Actual|2011-12-01||Interventional|||Effect of, OAT3, on the Renal Secretion of Cefotaxime|Effect of Genetic Variation in the Transporter, OAT3, on the Renal Secretion of Cefotaxime|Completed||Phase 1|24|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 17:15:49.157208|2017-02-18 17:15:49.157208
NCT00187629|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-08|||March 2004||2004-03-01|October 2013|2013-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Phosphate Intake's Effect on the Skeletal System - Pilot|Phosphate Intake's Effect on the Skeletal System Calcitropic Hormones and FGF23 - Pilot Study|Completed||N/A|27|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 17:15:49.401029|2017-02-18 17:15:49.401029
NCT00189774|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-03-11||||||March 2008|2008-03-01||||||||Interventional|||Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients||Completed||Phase 2/Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:49.51176|2017-02-18 17:15:49.51176
NCT00189761|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-19||||||September 2006|2006-09-01||||||||Interventional|||A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients|A Phase 2, Open-Label, Multi-Center Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in De Novo Bone Marrow Transplant Recipients|Completed||Phase 2|||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:49.605645|2017-02-18 17:15:49.605645
NCT00189748|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-19|||August 2004||2004-08-01|September 2006|2006-09-01||||||||Interventional|||A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-|An Extension Study of the Patients Enrolled in Acute Graft Versus Host Disease (GVHD) Prophylaxis Study (Protocol No. FJ-506E-BT01) to Assess Safety and Efficacy of GVHD Prophylaxis of a Tacrolimus New Oral Formulation (MR4).|Completed||Phase 2|||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:49.692562|2017-02-18 17:15:49.692562
NCT00189735|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-15|||September 2003||2003-09-01|April 2008|2008-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Evaluate FK778 in Kidney Transplant Patients|A Multicentre, Randomised, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Different Concentrations of FK778 With Tacrolimus (FK506) and Steroids Versus a Standard Regimen of Tacrolimus, MMF and Steroids in Renal Transplant Patients|Completed||Phase 2|364|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:49.776766|2017-02-18 17:15:49.776766
NCT00189722|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-15||||||April 2008|2008-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma||Completed||Phase 2|160|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:49.894251|2017-02-18 17:15:49.894251
NCT00189709|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-26|||August 2004||2004-08-01|December 2007|2007-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia|A Single Center, Open, Parallel, Comparative, Randomized Study of Micafungin (FK463) vs Fluconazole (Diflucan) in the Treatment of Invasive Candidiasis and Candidaemia (Protocol No: MCFGCAN-0301F-TW)|Completed||Phase 3|24|Actual|Astellas Pharma Inc||2|||f||||||||||||||2017-02-18 17:15:49.998048|2017-02-18 17:15:49.998048
NCT00189696|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-09||||||October 2015|2015-10-01||||||||Interventional|||Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)||Completed||Phase 3|||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:15:50.109524|2017-02-18 17:15:50.109524
NCT00189683|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Interventional|||Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy||Unknown status|Recruiting|Phase 3|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-02-18 17:15:50.201781|2017-02-18 17:15:50.201781
NCT00189670|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Interventional|||Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer|A Phase II Randomized Trial of 6 TEC Every 3 Weeks, Versus 4 EC Followed by 4 Taxotere Every 2 Weeks, Versus 4 Taxotere Followed by 4 EC Every 2 Weeks in Node Positive Breast Cancer|Completed||Phase 2|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-02-18 17:15:50.520985|2017-02-18 17:15:50.520985
NCT00189657|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Interventional|||5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer||Unknown status|Recruiting|Phase 3|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-02-18 17:15:50.608051|2017-02-18 17:15:50.608051
NCT00189644|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Interventional|||6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer||Unknown status|Active, not recruiting|Phase 3|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-02-18 17:15:50.700979|2017-02-18 17:15:50.700979
NCT00189631|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-07||||||September 2005|2005-09-01||||||||Interventional|||UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy||Unknown status|Recruiting|Phase 3|||Association Européenne de Recherche en Oncologie|||||f||||||||||||||2017-02-18 17:15:50.774932|2017-02-18 17:15:50.774932
NCT00189618|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-03|||May 2005||2005-05-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)|The Effects of Physical Training, Aspirin, and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease|Completed||Phase 4|250|Anticipated|Arteriogenesis Competence Network||2|||f||||t||||||||||2017-02-18 17:15:50.85865|2017-02-18 17:15:50.85865
NCT00189605|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-08-25|||September 2004||2004-09-01|August 2015|2015-08-01|April 2009|Actual|2009-04-01|December 2007|Actual|2007-12-01||Interventional|SPINE||Prospective, Randomized, Multi-center Clinical Study of Plasma Disc Decompression|Prospective, Randomized, Multi-center Clinical Study of Plasma Disc Decompression Efficacy|Completed||Phase 4|90|Actual|ArthroCare Corporation||2|||f||||f||||||||||2017-02-18 17:15:50.982847|2017-02-18 17:15:50.982847
NCT00189592|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-25|||August 2005||2005-08-01|August 2015|2015-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Plantar Fasciosis Treatment Using Coblation|Plantar Fasciosis Treatment Using Coblation® Prospective, Double-Blind, Randomized Controlled Study|Completed||Phase 4|45|Actual|ArthroCare Corporation||2|||f||||f||||||||||2017-02-18 17:15:51.107134|2017-02-18 17:15:51.107134
NCT00189215|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-03|||March 1998||1998-03-01|March 2005|2005-03-01|December 2005||2005-12-01|||||Interventional|||Long-Term Cognitive Decline After Coronary Artery Bypass Grafting: is Off-Pump Surgery Beneficial?|Long-Term Cognitive Decline After Coronary Artery Bypass Grafting: is Off-Pump Surgery Beneficial?|Completed||Phase 4|280||UMC Utrecht|||||f||||||||||||||2017-02-18 17:15:57.5605|2017-02-18 17:15:57.5605
NCT00189579|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-16||||||August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer|A Phase II Study Designed to Evaluate the Safety and Efficacy of the Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Early Relapse Patients (< 6 Months) With Ovarian Cancer, Overexpressing HER2, Previously Treated With Carboplatin-Paclitaxel|Terminated||Phase 2|45|Anticipated|ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-02-18 17:15:51.212058|2017-02-18 17:15:51.212058
NCT00189566|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-24|||April 2004||2004-04-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|||||Interventional|||Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse|National, Randomized, Phase II Study Comparing Efficacy of Weekly Administration of Paclitaxel in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse|Completed||Phase 2|165|Anticipated|ARCAGY/ GINECO GROUP|||||f||||||||||||||2017-02-18 17:15:51.303614|2017-02-18 17:15:51.303614
NCT00189553|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-01-09|||April 2005||2005-04-01|January 2014|2014-01-01|June 2012|Actual|2012-06-01|January 2009|Actual|2009-01-01||Interventional|CALYPSO||Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse|A Multi-National,Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin and Carboplatin Versus Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse (> 6 Months)|Completed||Phase 3|976|Actual|ARCAGY/ GINECO GROUP||2|||f||||t||||||||||2017-02-18 17:15:51.401316|2017-02-18 17:15:51.401316
NCT00189540|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-07-25|2011-06-21||August 2005||2005-08-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers|A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers|Completed||Phase 2|27|Actual|AnGes||2|||f||||f||||||||||2017-02-18 17:15:51.535025|2017-02-18 17:15:51.535025
NCT00189527|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-16|||January 2006||2006-01-01|February 2011|2011-02-01|October 2009|Actual|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Assist Control Versus Pressure Support Modes for Domiciliary Noninvasive Ventilation in Chronic Respiratory Failure|Assist Control Versus Pressure Support Modes for Domiciliary Noninvasive Ventilation|Completed||N/A|100|Actual|Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche||2|||f||||f||||||||||2017-02-18 17:15:52.143899|2017-02-18 17:15:52.143899
NCT00189514|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-10|||September 2005||2005-09-01|May 2015|2015-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects|Extension Study of Protocol 137OB-201 to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects|Completed||Phase 2|210|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 17:15:52.230367|2017-02-18 17:15:52.230367
NCT00189501|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-20|||December 2004||2004-12-01|December 2007|2007-12-01||||||||Observational|||A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)|A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)|Completed||N/A|1000||Amgen|||||f||||||||||||||2017-02-18 17:15:52.364132|2017-02-18 17:15:52.364132
NCT00189488|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-09-12|2009-11-25||December 2005||2005-12-01|September 2014|2014-09-01|August 2013|Actual|2013-08-01|November 2008|Actual|2008-11-01||Interventional|||Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation|A Randomized, Double-blind, Placebo-controlled Trial to Evaluate Palifermin (rHuKGF) in the Reduction of Acute Graft Versus Host Disease in Subjects With Hematologic Malignancies Undergoing Allogeneic Marrow/PBPC Transplantation|Completed||Phase 2|155|Actual|Swedish Orphan Biovitrum||2|||f||||||||||||||2017-02-18 17:15:52.458479|2017-02-18 17:15:52.458479
NCT00189475|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-10-13|2014-09-23||October 2003||2003-10-01|October 2014|2014-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds|A Pilot Study to Evaluate the Potential of Montelukast to Prevent the Development of Nasal Symptomatology During Natural Viral Upper Respiratory Infections|Completed||Phase 4|84|Actual|West Penn Allegheny Health System||2|||f||||f||||||||||2017-02-18 17:15:54.051983|2017-02-18 17:15:54.051983
NCT00189462|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-10-13|2014-09-23||March 2004||2004-03-01|October 2014|2014-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children|A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children|Completed||Phase 4|99|Actual|West Penn Allegheny Health System||2|||f||||f||||||||||2017-02-18 17:15:54.40118|2017-02-18 17:15:54.40118
NCT00189449|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-30||||||April 2008|2008-04-01|June 2007||2007-06-01|||||Observational|||Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis|Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis|Completed||Phase 4|||West Penn Allegheny Health System|||||f||||||||||||||2017-02-18 17:15:54.765368|2017-02-18 17:15:54.765368
NCT00189436|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-08|2014-07-08||March 2003||2003-03-01|July 2014|2014-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|BudER|61 subjects were enrolled and 31 were randomized to nebulized budesonide and 30 to standard of care. 74% of subjects enrolled in the nebulized budesonide and 83% enrolled in the standard care group completed the study.|Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children|A Pilot Study to Evaluate the Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Pediatric Patients Following Discharge From the Emergency Department/Outpatient Care Facility|Completed||Phase 4|61|Actual|West Penn Allegheny Health System||2|||f||||||||||||||2017-02-18 17:15:54.842854|2017-02-18 17:15:54.842854
NCT00189423|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|2012-03-01||October 2005||2005-10-01|July 2016|2016-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|ResQ||ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest|ResQ Trial: Comparison of Standard CPR Alone Versus Active Compression Decompression CPR Plus an ITD on Survival From Out-of-Hospital Cardiac Arrest|Terminated||N/A|1653|Actual|Advanced Circulatory Systems||2||Terminated due to lack of funding. Follow-up completed for all enrolled subjects.|f||||t||||||||||2017-02-18 17:15:55.126614|2017-02-18 17:15:55.126614
NCT00189410|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-19|||June 2003||2003-06-01|July 2010|2010-07-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours|Phase II Trial With Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin (PLD) and Carboplatin in Malignant Gynecologic Tumour's|Completed||Phase 2|140|Actual|AGO Study Group||1|||f||||||||||||||2017-02-18 17:15:55.700592|2017-02-18 17:15:55.700592
NCT00189397|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-06|||February 2003||2003-02-01|May 2008|2008-05-01|January 2006|Actual|2006-01-01|October 2005|Actual|2005-10-01||Interventional|||Azathioprine Versus Corticosteroids in Parthenium Dermatitis|Azathioprine Versus Corticosteroids for the Treatment of Parthenium Dermatitis|Completed||N/A|||All India Institute of Medical Sciences, New Delhi|||||f||||t||||||||||2017-02-18 17:15:55.820821|2017-02-18 17:15:55.820821
NCT00189384|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-07|||November 2003||2003-11-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants|Randomized Controlled Trial of Intramuscular Ceftriaxone Versus Procaine Penicillin Versus Cotrimoxazole and Gentamicin for Management of Serious Bacterial Infections in Young Infants in Community Settings|Unknown status|Active, not recruiting|Phase 3|426||Aga Khan University|||||f||||||||||||||2017-02-18 17:15:55.90777|2017-02-18 17:15:55.90777
NCT00189371|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-16|||February 2004||2004-02-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Interventional|||Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum|Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum|Terminated||Phase 3|300||AGO Study Group|||||f||||||||||||||2017-02-18 17:15:56.00012|2017-02-18 17:15:56.00012
NCT00189358|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-19||||||July 2010|2010-07-01||||||||Interventional|||A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy|A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy|Completed||Phase 2|||AGO Study Group|||||f||||||||||||||2017-02-18 17:15:56.085327|2017-02-18 17:15:56.085327
NCT00189345|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-07|||May 2004||2004-05-01|December 2003|2003-12-01|October 2005||2005-10-01|||||Interventional|||Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients|Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients|Completed||Phase 2|44||AGO Study Group|||||f||||||||||||||2017-02-18 17:15:56.172743|2017-02-18 17:15:56.172743
NCT00189332|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-24|||February 2005||2005-02-01|October 2008|2008-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Use of 852A in Metastatic Cutaneous Melanoma.|Pilot Phase II, Open Label, Multicenter, Efficacy and Safety Study of 852A Administered Intravenously to Subjects With Unresectable Metastatic Cutaneous Melanoma.|Completed||Phase 2|28||Pfizer|||||f||||||||||||||2017-02-18 17:15:56.261498|2017-02-18 17:15:56.261498
NCT00189319|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-02-20|||September 2003||2003-09-01|September 2006|2006-09-01||||||||Interventional|||To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation|Impact of Oral Controlled Release Flecainide Acetate Capsules on Health-Related QoL in Patients With Paroxysmal Atrial Fibrillation|Completed||Phase 4|200||MEDA Pharma GmbH & Co. KG|||||f||||||||||||||2017-02-18 17:15:56.352417|2017-02-18 17:15:56.352417
NCT00189306|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-05|2008-10-30||March 2001||2001-03-01|August 2010|2010-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream|An Open-label Study to Evaluate the Safety and Long-Term Clinical Efficacy of Imiquimod 5% Cream Applied Once Daily 7 Days Per Week for 6 Weeks in the Treatment of Superficial Basal Cell Carcinoma|Completed||Phase 3|169|Actual|Graceway Pharmaceuticals, LLC||1|||f||||f||||||||||2017-02-18 17:15:56.441163|2017-02-18 17:15:56.441163
NCT00189293|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-01-05|||June 2005||2005-06-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts|Multicenter, Randomised, Double-blind, Vehicle-controlled Study Comparing Recurrence Rate Following Imiquimod 5% Cream or Vehicle 3 Times Per Week for 4 Weeks Prior to Ablative Therapy in Subjects Suffering From External Ano-Genital Warts|Completed||Phase 4|128|Actual|MEDA Pharma GmbH & Co. KG||2|||f||||||||||||||2017-02-18 17:15:56.982034|2017-02-18 17:15:56.982034
NCT00189280|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-24|||May 2003||2003-05-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Aldara for the Treatment of Large and/or Multiple sBCC|Open Study to Evaluate the Efficacy and Tolerance of Imiquimod 5% Cream for the Treatment of a Large and/or Multiple Superficial Basal Cell Carcinoma.|Completed||Phase 3|111|Actual|MEDA Pharma GmbH & Co. KG||1|||f||||||||||||||2017-02-18 17:15:57.105281|2017-02-18 17:15:57.105281
NCT00189267|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-11-19|||November 2002||2002-11-01|August 2006|2006-08-01|September 2005|Actual|2005-09-01|||||Interventional|||A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients|Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream Applied Once Daily 3 Days Per Week for the Treatment of Actinic Keratoses in Immunosuppressed Organ Transplant Recipients.|Completed||Phase 2|45||MEDA Pharma GmbH & Co. KG|||||||||||||||||||2017-02-18 17:15:57.206336|2017-02-18 17:15:57.206336
NCT00189254|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-28|||April 2005||2005-04-01|April 2015|2015-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ|A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1487-IMIQ Study|Completed||Phase 3|72||MEDA Pharma GmbH & Co. KG|||1||||||||||||||||2017-02-18 17:15:57.287478|2017-02-18 17:15:57.287478
NCT00189241|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-25|||February 2001||2001-02-01|August 2010|2010-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma|An Open-Label Study to Evaluate the Safety and Long-Term Clinical Efficacy of Imiquimod 5% Cream Applied Once Daily 5 Days Per Week for 6 Weeks in the Treatment of Superficial Basal Cell Carcinoma|Completed||Phase 3|160||MEDA Pharma GmbH & Co. KG|||||||||||||||||||2017-02-18 17:15:57.374794|2017-02-18 17:15:57.374794
NCT00189202|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-09|||August 2004||2004-08-01|October 2008|2008-10-01||||||||Interventional|||Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans|Efficacy of Sirolimus-Based, Steroid Avoidance Maintenance Immunosuppression in Black de Novo Kidney Transplant Recipients|Unknown status|Active, not recruiting|Phase 4|35|Anticipated|University of Michigan|||||f||||||||||||||2017-02-18 17:15:57.655344|2017-02-18 17:15:57.655344
NCT00189189|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-01|||July 2003||2003-07-01|July 2005|2005-07-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Prevention of Oppositional Defiant and Conduct Disorders in Preschool Children|Parent Management Training to Prevent Oppositional Defiant and Conduct Disorders in Preschool Children|Unknown status|Recruiting|N/A|160|Anticipated|UMC Utrecht|||||f||||||||||||||2017-02-18 17:15:57.743182|2017-02-18 17:15:57.743182
NCT00189176|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2013-02-05|||March 2003||2003-03-01|February 2013|2013-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis|Phase I/II Trial of Tetrathiomolybdate (TM) in Patients With Usual Interstitial Pneumonia Refractory to Previous Therapy|Completed||Phase 1/Phase 2|23|Actual|University of Michigan||1|||f||||||||||||||2017-02-18 17:15:57.836581|2017-02-18 17:15:57.836581
NCT00189163|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-12-15|||January 2005||2005-01-01|December 2016|2016-12-01||||December 2007|Actual|2007-12-01||Interventional|||Pioglitazone in Hepatitis C|Pioglitazone in Hepatitis C: A Randomized, Double Blind, Placebo-controlled Study|Completed||Phase 4|40|Actual|University of Michigan||2|||f||||||||||||||2017-02-18 17:15:57.930224|2017-02-18 17:15:57.930224
NCT00189150|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-23|||April 2005||2005-04-01|May 2016|2016-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Pharmacokinetics of Mmf and Valganciclovir|Pharmacokinetics of Mycophenolate Mofetil Alone and in Combination With Valganciclovir in Renal and Heart Transplant Recipients|Completed||Phase 4|16|Actual|University of Michigan|||||f||||||||||||||2017-02-18 17:15:58.039424|2017-02-18 17:15:58.039424
NCT00189137|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-06|2014-11-17||August 2004||2004-08-01|November 2015|2015-11-01|October 2015|Actual|2015-10-01|November 2012|Actual|2012-11-01||Interventional|||Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma|Phase II Evaluation of Ifosfamide Plus Doxorubicin & Filgrastim Versus Gemcitabine Plus Docetaxel & Filgrastim in the Treatment of Localized Poor Prognosis Soft Tissue Sarcoma|Completed||Phase 2|84|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-02-18 17:15:58.130714|2017-02-18 17:15:58.130714
NCT00189124|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-17|||September 2003||2003-09-01|May 2016|2016-05-01|July 2006|Actual|2006-07-01|December 2005|Actual|2005-12-01||Interventional|||Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention|Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus?|Completed||Phase 2/Phase 3|13|Actual|University of Michigan||2|||||||||||||||||2017-02-18 17:15:58.554026|2017-02-18 17:15:58.554026
NCT00189111|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-11-13|||January 2005||2005-01-01|November 2008|2008-11-01|April 2012|Anticipated|2012-04-01|||||Interventional|||Non-Invasive Cardiac Screening in High Risk Patients -The GROUND Study|Non-Invasive Cardiac Screening in High Risk Patients -The GROUND Study|Unknown status|Recruiting|Phase 3|1200|Anticipated|UMC Utrecht|||||f||||||||||||||2017-02-18 17:15:58.673249|2017-02-18 17:15:58.673249
NCT00189098|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-06-08|2012-04-12||February 2003||2003-02-01|April 2012|2012-04-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Interventional|||Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media|Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media|Completed||N/A|101|Actual|UMC Utrecht||2|||f||||||||||||||2017-02-18 17:15:58.770502|2017-02-18 17:15:58.770502
NCT00189085|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-09|||December 2004||2004-12-01|August 2004|2004-08-01|July 2005||2005-07-01|||||Interventional|||Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function|The Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Dysfunction in Patients With the Metabolic Syndrome.|Completed||Phase 4|20||UMC Utrecht|||||f||||||||||||||2017-02-18 17:15:59.191844|2017-02-18 17:15:59.191844
NCT00189072|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||April 2003||2003-04-01|May 2005|2005-05-01||||||||Interventional|||Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition|Effects of Pain and the Treatment of Pain With Gabapentin (900-3600 Mg) on Driving Ability, Attentional Capacity and Psychomotor Performance in Chronic Neuropathic Pain Patients|Terminated||Phase 4|24||UMC Utrecht|||||f||||||||||||||2017-02-18 17:15:59.279056|2017-02-18 17:15:59.279056
NCT00189059|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2002||2002-10-01|April 2005|2005-04-01|May 2005||2005-05-01|||||Interventional|||Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.|Effects of Pain and the Treatment of Pain With Amitriptyline on Driving Performance, Attentional Capacity and Psychomotor Performance in Chronic Neuropathic Pain Patients|Terminated||Phase 4|24||UMC Utrecht|||||f||||||||||||||2017-02-18 17:15:59.371555|2017-02-18 17:15:59.371555
NCT00189046|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2004||2004-01-01|December 2004|2004-12-01|April 2005||2005-04-01|||||Observational|||Effects of Pain on Driving Performance and Cognition.|Effects of Pain on Driving Performance, Attentional Capacity and Psychomotor Performances: a Comparative Study Between Healthy Controls and Chronic Pain Patients.|Terminated||Phase 4|30||UMC Utrecht|||||f||||||||||||||2017-02-18 17:15:59.463973|2017-02-18 17:15:59.463973
NCT00189033|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-19|||April 2005||2005-04-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre?|Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre? A Randomized Controlled Trial in Primary Care.|Completed||N/A|285||UMC Utrecht|||||f||||||||||||||2017-02-18 17:15:59.543362|2017-02-18 17:15:59.543362
NCT00189020|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-19|||June 2005||2005-06-01|August 2011|2011-08-01||||February 2008|Actual|2008-02-01||Interventional|MNOES||Effect of Two Versus Three Pneumococcal Conjugate Vaccinations|Effect of 2 Versus 3 Pneumococcal Conjugate Vaccinations Prevnar on Nasopharyngeal Carriage, Transmission and Herd-immunity;a Randomized, Controlled Study|Completed||Phase 3|1005|Actual|UMC Utrecht||3|||f||||t||||||||||2017-02-18 17:15:59.64066|2017-02-18 17:15:59.64066
NCT00189007|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2012-03-28|||October 2009||2009-10-01|March 2012|2012-03-01|December 2016|Anticipated|2016-12-01|December 2011|Actual|2011-12-01||Interventional|||Antenatal Allopurinol During Fetal Hypoxia|Does Antenatal Allopurinol Administration Reduce Post-hypoxic-ischemic Reperfusion Damage During Fetal Hypoxia in the Newborn?|Unknown status|Active, not recruiting|Phase 3|222|Actual|UMC Utrecht||2|||f||||t||||||||||2017-02-18 17:15:59.752389|2017-02-18 17:15:59.752389
NCT00188994|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-28|||August 1999||1999-08-01|July 2005|2005-07-01||||||||Interventional|||Insulin Cardioplegia for Poor Left Ventricular Function|Insulin Cardioplegia Trial for Poor Left Ventricular Function|Unknown status|Recruiting|N/A|800||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:15:59.885151|2017-02-18 17:15:59.885151
NCT00188968|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-30|||November 2004||2004-11-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Randomized Trial of Nasal Continuous Positive Airway Pressure or Synchronized Nasal Ventilation in Premature Infants.|A Randomized, Controlled Trial of Synchronized Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Airway Pressure Using the Infant Flow Advance to Facilitate Successful Extubation in Premature Infants.|Completed||Phase 3|48|Actual|University of Manitoba||2|||f||||t||||||||||2017-02-18 17:16:00.094892|2017-02-18 17:16:00.094892
NCT00188955|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2010-02-19|||March 2004||2004-03-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|||||Interventional|||Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant|Phase 4 Randomized, Controlled Study Comparing Sirolimus and Mycophenolate Mofetil to Prevent or Reverse Progression in Pediatric Renal Transplants With Chronic Allograft Nephropathy|Completed||Phase 4|40||University of Manitoba|||||f||||||||||||||2017-02-18 17:16:00.195733|2017-02-18 17:16:00.195733
NCT00188942|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-06|||February 2005||2005-02-01|February 2013|2013-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder|Neural Correlates of Emotional Processing in Depressed and Remitted Bipolar and Unipolar Depressed Subjects: An fMRI Investigation|Completed||Phase 4|42|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:16:00.306085|2017-02-18 17:16:00.306085
NCT00188929|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-12|||August 2005||2005-08-01|August 2010|2010-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma|Spatio-temporal Response of Non-Hodgkin's Lymphoma to External Beam Radiation Therapy Measuring 18F-Fluorodeoxyglucose (FDG) Uptake Using a Combined PET/CT Scanner: A Pilot Study|Completed||Phase 2|10|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:00.454958|2017-02-18 17:16:00.454958
NCT00188357|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-02-13|||August 2003||2003-08-01|September 2005|2005-09-01||||||||Interventional|||HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus|HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|360||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:00.545119|2017-02-18 17:16:00.545119
NCT00188344|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||September 2005||2005-09-01|May 2014|2014-05-01|March 2015|Anticipated|2015-03-01|March 2011|Actual|2011-03-01||Interventional|||A Randomized Comparison of Laparoscopic Myotomy and Pneumatic Dilatation for Achalasia|A Randomized Comparison of Laparoscopic Myotomy and Pneumatic Dilatation for Achalasia|Unknown status|Active, not recruiting|N/A|56|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 17:16:00.638171|2017-02-18 17:16:00.638171
NCT00188331|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-21|||November 2003||2003-11-01|March 2016|2016-03-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Observational|||Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy|Cognitive Function and Fatigue in Cancer Patients After Chemotherapy: A Longitudinal Controlled Study in Patients With Colorectal Cancer|Completed||N/A|441|Actual|University Health Network, Toronto|||3||f||||f||||||Samples With DNA|"~     cytokines, genotyping apoE, EUC, LFTs, sex hormones, coagulation factors~   "|||2017-02-18 17:16:00.751501|2017-02-18 17:16:00.751501
NCT00188318|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-02-08|||June 1998||1998-06-01|February 2016|2016-02-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)|A Phase II Study of Hyperfractionated Accelerated Radiotherapy Delivered With Integrated Neck Surgery for Node-positive Cases in Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|169|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:16:00.855422|2017-02-18 17:16:00.855422
NCT00188305|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-08-14|||January 2005||2005-01-01|August 2015|2015-08-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients|A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients|Completed||Phase 3|252|Actual|University Health Network, Toronto||3|||f||||f||||||||||2017-02-18 17:16:00.951222|2017-02-18 17:16:00.951222
NCT00188292|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-04|||August 2002||2002-08-01|March 2016|2016-03-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|TRACE||Screening for HIV-Associated Anal Cancer|Screening for HIV-Associated Anal Cancer|Completed||N/A|401|Actual|University Health Network, Toronto|||2||f||||t||||||||||2017-02-18 17:16:01.080743|2017-02-18 17:16:01.080743
NCT00188279|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-07-29|||July 2005||2005-07-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|January 2017|Anticipated|2017-01-01||Interventional|||Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma|Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma|Active, not recruiting||Phase 2|250|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 17:16:01.173541|2017-02-18 17:16:01.173541
NCT00188266|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-10-31|||August 2002||2002-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|December 2013|Actual|2013-12-01||Interventional|||Study of Adjuvant Radiochemotherapy for Gastric Cancer|Prospective Phase I/II Study of Adjuvant Radiochemotherapy for Gastric Cancer|Active, not recruiting||Phase 1/Phase 2|65|Anticipated|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 17:16:01.274246|2017-02-18 17:16:01.274246
NCT00188916|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-11||||||September 2006|2006-09-01||||||||Observational|||A Clinical Comparison of Three Bronchial Blockers for One-Lung Ventilation in Thoracic Surgery||Unknown status|Recruiting|Phase 4|120|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:01.376141|2017-02-18 17:16:01.376141
NCT00188903|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-03|||March 2004||2004-03-01|April 2008|2008-04-01|March 2010|Actual|2010-03-01|November 2007|Actual|2007-11-01||Observational|||Diastolic Dysfunction and Atrial Fibrillation in CABG Surgery|Diastolic Dysfunction and Atrial Fibrillation in Patients Undergoing Coronary Revascularization Surgery|Completed||N/A|250|Anticipated|University Health Network, Toronto|||1||f||||||||||||||2017-02-18 17:16:01.701856|2017-02-18 17:16:01.701856
NCT00188890|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-17|||March 2005||2005-03-01|March 2016|2016-03-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers|Early Diagnosis of Mesothelioma and Lung Cancer Following Asbestos Exposure Using Low-dose Computed Tomography|Recruiting||N/A|2000|Anticipated|University Health Network, Toronto|||1||f||||f||||||||Undecided||2017-02-18 17:16:01.794487|2017-02-18 17:16:01.794487
NCT00183053|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-10-29|||May 2006||2006-05-01|October 2009|2009-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Proximity Alarms to Reduce Patient Falls|Trial of Proximity Alarms to Reduce Patient Falls|Completed||N/A|10000|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:17.648202|2017-02-18 17:17:17.648202
NCT00188877|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-08|||June 2003||2003-06-01|February 2016|2016-02-01|June 2018|Anticipated|2018-06-01|June 2008|Actual|2008-06-01||Interventional|||Intensity Modulated Radiation Therapy for Head and Neck Cancer|A Phase II Study of Intensity Modulated Radiation Therapy for Nasopharyngeal Cancer|Active, not recruiting||Phase 2|44|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:16:01.896801|2017-02-18 17:16:01.896801
NCT00188864|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-28|||November 2003||2003-11-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Dexamethasone for Palliation - Brain Metastases|Dexamethasone as Palliative Treatment in Addition to Radiation Therapy for Patients With Brain Metastases: A Prospective Study|Active, not recruiting||Phase 2|50|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:01.996183|2017-02-18 17:16:01.996183
NCT00188851|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2001||2001-01-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||Structured Treatment Interruption for HIV Patients With Virologic Failure|A Prospective Randomized Trial of Structured Treatment Interruption(STI) Followed by Initiation of a New Antiretroviral Regimen(ARV) Versus Immediate Switching to a New ARV in HIV-Infected Patients Experiencing Virologic Failure on HAART|Completed||N/A|196||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:02.094033|2017-02-18 17:16:02.094033
NCT00188838|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||July 2002||2002-07-01|July 2005|2005-07-01|August 2006||2006-08-01|||||Interventional|||Psychoeducation Versus Cognitive-Behavioral Therapy in Bipolar Disorder|Psychoeducation Versus Cognitive-Behavioral Therapy in Bipolar Disorder|Unknown status|Active, not recruiting|N/A|210||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:02.184622|2017-02-18 17:16:02.184622
NCT00188825|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-28|||May 2004||2004-05-01|July 2016|2016-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant|A Randomized, Double Blind, Placebo Controlled Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans Syndrome in Bilateral Lung and Single Lung Transplant Patients|Completed||Phase 3|22|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-02-18 17:16:02.296494|2017-02-18 17:16:02.296494
NCT00188812|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-01-09|||May 2004||2004-05-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease|Open-Label, Multicentre, One Year Extension of the Evaluation of the Safety of Donepezil Hcl in Patients With Dementia Associated With Cerebrovascular Disease|Completed||Phase 3|||University Health Network, Toronto|||||||||||||||||||2017-02-18 17:16:02.407417|2017-02-18 17:16:02.407417
NCT00188799|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-07-15|||November 2003||2003-11-01|July 2015|2015-07-01|November 2004||2004-11-01|||||Interventional|||Xray Volume Imaging (Cone Beam CT) - Prostate Cancer|A Clinical Study of X-ray Volume Imaging to Evaluate the Daily Set-up Accuracy of Conformal Prostate Radiotherapy|Completed||Phase 2|30||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:02.518813|2017-02-18 17:16:02.518813
NCT00188786|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-11|||April 2005||2005-04-01|February 2011|2011-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Cone Beam CT for Daily Image Guidance - Prostate Cancer|A Phase II Feasibility Study of Cone Beam Computed Tomography for Daily Image Guidance in Patients Receiving Dose Escalated Conformal Radiation Therapy for Prostate Cancer|Completed||Phase 2|30|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:02.622481|2017-02-18 17:16:02.622481
NCT00188773|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-04|||January 2004||2004-01-01|June 2007|2007-06-01|January 2008|Actual|2008-01-01|August 2007|Actual|2007-08-01||Interventional|||Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion||Completed||Phase 4|15|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 17:16:02.714367|2017-02-18 17:16:02.714367
NCT00188760|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-10-06|||May 2004||2004-05-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|||||Observational|||Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue Density|Optical Quantification of Breast Density Changes Due to Hormone Treatment, Pregnancy and Breast-feeding.|Completed||N/A|300|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 17:16:02.825742|2017-02-18 17:16:02.825742
NCT00188747|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-10|||June 2005||2005-06-01|April 2006|2006-04-01||||||||Interventional|||Comparison of Three Management Strategies for Post Cardiac Surgery Bleeding|Comparison of Three Management Strategies for Post Cardiac Surgery Coagulopathy.|Completed||Phase 4|150||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:02.936375|2017-02-18 17:16:02.936375
NCT00188734|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-09|||September 2003||2003-09-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|June 2016|Actual|2016-06-01||Observational|||Early Lung Cancer Detection Using Computed Tomography|Lung Cancer Screening in High-risk Smokers Using Low-dose Computed Tomography|Completed||N/A|5000|Actual|University Health Network, Toronto|||1||f||||||||||||||2017-02-18 17:16:03.034916|2017-02-18 17:16:03.034916
NCT00188721|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-11|||July 2006||2006-07-01|August 2011|2011-08-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Observational|||Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.|Transillumination for Breast Cancer Risk Assessment|Completed||N/A|500|Anticipated|University Health Network, Toronto|||2||f||||f||||||||||2017-02-18 17:16:03.128129|2017-02-18 17:16:03.128129
NCT00188708|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-06-21|||April 2001||2001-04-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2008|Actual|2008-04-01||Interventional|||Effect of Casodex on Tumour Hypoxia - Prostate Cancer|A Study of the Effect of Neoadjuvant Bicalutamide (Casodex) on Tumour Hypoxia in Patients With Clinically Localized Prostate Cancer|Active, not recruiting||Phase 2|30|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:16:03.233497|2017-02-18 17:16:03.233497
NCT00188695|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-05|||April 2004||2004-04-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide|A Pilot Study of MR Imaging With Ultra-Small Superparamagnetic Iron Oxide for Pelvic Lymph Node Target Definition|Completed||Phase 1/Phase 2|61|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 17:16:03.340813|2017-02-18 17:16:03.340813
NCT00188682|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-11-13|||March 2000||2000-03-01|November 2007|2007-11-01|September 2003|Actual|2003-09-01|||||Observational|||Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.|Optical Transillumination Spectroscopy of Breast Tissue in Pre- and Post-Menopausal Women.|Completed||N/A|300|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 17:16:03.443465|2017-02-18 17:16:03.443465
NCT00188669|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-10|||July 2002||2002-07-01|August 2010|2010-08-01||||||||Interventional|||The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain|A Phase II Study of the Use of Pentoxifylline and a-Tocopherol in the Treatment of Chronic Breast Pain Associated With Breast Radiotherapy|Terminated||Phase 2|48|Anticipated|University Health Network, Toronto||||date: August 2006. No annual renewal|f||||||||||||||2017-02-18 17:16:03.525598|2017-02-18 17:16:03.525598
NCT00188656|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-12-14|||August 2003||2003-08-01|December 2010|2010-12-01|September 2006||2006-09-01|||||Interventional|||Computed Tomography (CT) in Head and Neck Patients|Minimum Dose CT in the Detection of Lung Nodules in Patients With Head and Neck Cancer|Terminated||Phase 1|100||University Health Network, Toronto||||insufficient recruitment|f||||||||||||||2017-02-18 17:16:03.620845|2017-02-18 17:16:03.620845
NCT00188643|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-08|||January 2002||2002-01-01|February 2005|2005-02-01|January 2007||2007-01-01|||||Interventional|||Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression|Double-Blind, Acute Depression Study Comparing Venlafaxine XR and Lamotrigine When Added to Mood Stabilizer in the Treatment of Bipolar Depression|Completed||Phase 4|40||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:03.716099|2017-02-18 17:16:03.716099
NCT00188630|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-19|||July 2003||2003-07-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|February 2007|Actual|2007-02-01||Interventional|||N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery|The PRIME (Perioperative Renal Insufficiency Management) Study: A Randomized, Double-blinded, Placebo-controlled Trial of N-acetylcysteine for Preventing Renal Injury After Cardiac Surgery.|Completed||Phase 3|176|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-02-18 17:16:03.811482|2017-02-18 17:16:03.811482
NCT00188617|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-12-05|||January 2005||2005-01-01|December 2011|2011-12-01|November 2009|Actual|2009-11-01|June 2007|Actual|2007-06-01||Interventional|||Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC|Phase II Study Of Single Agent Gefitinib (Iressa) In Patients With Clinical Stage I Non-Small Cell Lung Cancer (NSCLC) Proceeding To Mediastinoscopy And Surgery|Completed||Phase 2|35|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 17:16:03.921439|2017-02-18 17:16:03.921439
NCT00188604|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-12|||January 2004||2004-01-01|August 2010|2010-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer|A Randomized Phase II Placebo-controlled Double Blind Study of Using Selenium in the Treatment of Secondary Lymphedema in Breast Cancer Patients|Completed||Phase 2|34|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:04.033437|2017-02-18 17:16:04.033437
NCT00188591|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-11-21|||April 2005||2005-04-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|||||Observational|||Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility Study|Pilot Study to Investigate the Feasibility of Optical Spectroscopy to Quantify Bulk Breast Tissue Properties in Girls Age 10 - 14 Years|Completed||N/A|20|Anticipated|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 17:16:04.128867|2017-02-18 17:16:04.128867
NCT00188578|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-08|||June 2003||2003-06-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)|A Pilot Study of Conformal Intensity Modulated Radiation Therapy (IMRT) for Gynaecological Cancer Patients Not Suitable for Intracavitary Brachytherapy Boost (GY03.2)|Completed||Phase 1/Phase 2|12|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:16:04.228748|2017-02-18 17:16:04.228748
NCT00188565|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-12|||March 2004||2004-03-01|August 2010|2010-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Celebrex With Preoperative Chemoradiation - Rectal Cancer|A Phase I/II Trial of Celecoxib With Preoperative Chemoradiation for Resectable Rectal Cancer With In Vivo Analysis of Celecoxib Effector Pathways|Completed||Phase 1/Phase 2|39|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:04.340045|2017-02-18 17:16:04.340045
NCT00188552|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-12|||July 2002||2002-07-01|August 2010|2010-08-01||||||||Interventional|||The Use of Pentoxifylline and Vitamin E in the Treatment of Late Radiation Related Injuries|A Phase II Study of the Use of Pentoxifylline and Vitamin E in the Treatment of Late Radiation Related Injuries|Terminated||Phase 2|50|Anticipated|University Health Network, Toronto||||May 2007: No annual renewal|f||||||||||||||2017-02-18 17:16:04.426749|2017-02-18 17:16:04.426749
NCT00188539|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-06-21|||December 1995||1995-12-01|June 2016|2016-06-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels|Predictive Assays in Cervix Cancer: Assessment of Hypoxia, Interstitial Fluid Pressure, and GSH Levels|Active, not recruiting||Phase 2|300|Anticipated|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 17:16:04.51677|2017-02-18 17:16:04.51677
NCT00188526|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-07|||September 2005||2005-09-01|March 2016|2016-03-01|September 2006||2006-09-01|||||Interventional|||Computed Tomography (CT) Guided Lung Biopsy: Core or Fine Needle Aspiration|CT Guided Lung Biopsy: Core or Fine Needle Aspiration|Recruiting||N/A|200|Anticipated|University Health Network, Toronto|||||f||||f||||||||||2017-02-18 17:16:04.613385|2017-02-18 17:16:04.613385
NCT00188513|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-06-21|||May 2001||2001-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|April 2006|Actual|2006-04-01||Interventional|||Intensity Modulated Radiation Therapy - Prostate Cancer|A Phase I-II Prospective Trial of Conformal Hypofractionated Intensity Modulated Radiotherapy (IMRT) for Localized Adenocarcinoma of the Prostate|Active, not recruiting||Phase 1/Phase 2|267|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:16:04.71659|2017-02-18 17:16:04.71659
NCT00188461|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-20|||January 2004||2004-01-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Dose Reduction in Thoracic CT|Dose Reduction in Thoracic CT: A Comparison of on Line Automatic Dose Reduction and a 50% Reduction in Dose|Completed||Phase 1|100||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:04.805893|2017-02-18 17:16:04.805893
NCT00188448|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-20|||April 2003||2003-04-01|September 2005|2005-09-01|April 2004||2004-04-01|||||Interventional|||MRI Superficial Temporal Artery|MRI of the Superficial Temporal Artery|Completed||Phase 1|5||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:04.886066|2017-02-18 17:16:04.886066
NCT00188435|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-23|||November 2003||2003-11-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Comparison of CXR and MnDCT|A Comparison of Chest Radiography and Minimum Dose Chest CT|Completed||Phase 1|100||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:04.971431|2017-02-18 17:16:04.971431
NCT00182598|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-08-11|||December 2004||2004-12-01|August 2008|2008-08-01||||||||Interventional|||Applying Web Technology to Buprenorphine Treatment|Applying Web Technology to Buprenorphine Treatment|Unknown status|Recruiting|N/A|90|Anticipated|National Development and Research Institutes, Inc.|||||f||||||||||||||2017-02-18 17:17:26.824899|2017-02-18 17:17:26.824899
NCT00188396|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-03-12|||April 2004||2004-04-01|January 2007|2007-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response|The Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response: A Comparison of Premenopausal, Perimenopausal and Postmenopausal Women|Completed||N/A|44|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 17:16:05.216281|2017-02-18 17:16:05.216281
NCT00188383|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-03-13|||January 2004||2004-01-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy|Effects of NMDA-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy in Young and Elderly Patients|Unknown status|Recruiting|Phase 1/Phase 2|132||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:05.333631|2017-02-18 17:16:05.333631
NCT00188370|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||April 1999||1999-04-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Ultrasound Biomicroscopy - Apoptosis|Ultrasound Biomicroscopy for Monitoring Apoptosis in Lymphoma, Melanoma and Basal Cell Carcinoma Patients During Chemotherapy or Radiation Therapy|Completed||Phase 2|50||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:05.42815|2017-02-18 17:16:05.42815
NCT00188162|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-20|||January 2004||2004-01-01|September 2005|2005-09-01|September 2005|Actual|2005-09-01|||||Interventional|||Minimum Dose CT Post Lung Biopsy|Can Minimum Dose CT Post Lung Biopsy Predict Patient Outcome?|Completed||Phase 1|100||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:16:05.58242|2017-02-18 17:16:05.58242
NCT00188149|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-12-28|||May 2000||2000-05-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Interventional|||Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET|Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy|Unknown status|Recruiting|Phase 4|300||University Hospital Carl Gustav Carus|||||f||||||||||||||2017-02-18 17:16:05.667141|2017-02-18 17:16:05.667141
NCT00188136|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-07|||August 2002||2002-08-01|December 2015|2015-12-01|December 2010|Actual|2010-12-01|July 2010|Actual|2010-07-01||Interventional|||Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)|Phase II Study of Early Allogeneic Blood Stem Cell Transplantation During Induction-chemotherapy Induced Aplasia in High-risk Acute Myeloid Leukemia|Completed||Phase 2|32|Actual|University Hospital Carl Gustav Carus||1|||f||||||||||||||2017-02-18 17:16:05.765063|2017-02-18 17:16:05.765063
NCT00188123|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-07-14|||April 2004||2004-04-01|September 2005|2005-09-01|April 2009|Actual|2009-04-01|September 2005|Actual|2005-09-01||Observational|||Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With Magnetic Resonance Imaging (MRI)|Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With MRI|Completed||Phase 4|20|Actual|University Hospital, Linkoeping|||1||f||||f||||||||||2017-02-18 17:16:05.869324|2017-02-18 17:16:05.869324
NCT00188110|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-08|||March 2003||2003-03-01|September 2005|2005-09-01||||||||Interventional|||Performance of the Water-Enema Computed Tomography (WE-CT)|Evaluation of the Water-Enema Computed Tomography for the Diagnosis of Colon Tumor|Unknown status|Recruiting|N/A|200||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:05.950926|2017-02-18 17:16:05.950926
NCT00188097|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-01-18|||November 1999||1999-11-01|August 2005|2005-08-01|June 2002||2002-06-01|||||Interventional|||Diagnosis of Variceal Bleeding and Its Control in Cirrhosis|Diagnosis of Variceal Bleeding and Its Control in Cirrhosis|Terminated||N/A|400||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:06.050488|2017-02-18 17:16:06.050488
NCT00188084|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-10-27|||November 2003||2003-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia|Analysis of Four Biological Parameters at Diagnosis of Adult Acute Lymphoblastic Leukaemia: DNA Index, Percentage of Cells in S-Phase, CD45 Fluorescence Index, and Protein P16: Prognostic Study in Patients Enrolled in a Multicentric Trial|Unknown status|Recruiting|N/A|400||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:06.123037|2017-02-18 17:16:06.123037
NCT00188071|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-28|||September 2002||2002-09-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen|Postoperative Pain After Medical Abortion Under Local Anesthesia : a Prospective and Randomized Trial Comparing Several Analgesic Regimen|Completed||N/A|240||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:06.192826|2017-02-18 17:16:06.192826
NCT00188058|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2002||2002-09-01|September 2005|2005-09-01||||||||Interventional|||Comparison of 2 Strategies of Adjustment of Mechanical Ventilation in Patients With Acute Respiratory Distress Syndrome|Comparison of Two Strategies for Setting Positive End-Expiratory Pressure in Acute Lung Injury/ Acute Respiratory Distress Syndrome (ExPress Study).|Unknown status|Recruiting|N/A|800||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:06.299878|2017-02-18 17:16:06.299878
NCT00188045|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-28|||April 1995||1995-04-01|December 2001|2001-12-01|December 2003||2003-12-01|||||Interventional|||Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients|Hemodynamic Effects of Chronic Administration of Spironolactone, Propranolol and Their Association in Alcoholic Cirrhotic Patients|Terminated||Phase 4|54||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:09.240256|2017-02-18 17:16:09.240256
NCT00188032|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-02-04|||June 2005||2005-06-01|February 2009|2009-02-01|September 2006|Actual|2006-09-01|||||Interventional|||Strategies for Suspected Pulmonary Embolism in Emergency Departments|Strategies for Suspected Pulmonary Embolism in Emergency Departments - SPEED Study|Completed||N/A|1331|Anticipated|University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:09.319787|2017-02-18 17:16:09.319787
NCT00188019|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-07-22|||November 2005||2005-11-01|July 2015|2015-07-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers|Evaluation Des méthodes de dépistage du Paragangliome héréditaire Chez Les Sujets prédisposés génétiquement|Completed||N/A|248|Actual|University Hospital, Angers||1|||f||||||||||||||2017-02-18 17:16:09.430695|2017-02-18 17:16:09.430695
NCT00188006|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09||||||September 2005|2005-09-01||||||||Interventional|||Complement Activation and Central Nervous System Injury After Coronary Artery Surgery|Biocompatible Cardiopulmonary Bypass and Neuropsychological Outcome After Coronary Artery Bypass Surgery|Completed||N/A|||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:09.508876|2017-02-18 17:16:09.508876
NCT00187993|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||May 2005||2005-05-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Growth Hormone Treatment of Young Growth Hormone-Deficient Adults|Growth Hormone Treatment of Young Adults Deficient in Growth Hormone Since Childhood : Study of Body Composition Modifications.|Unknown status|Recruiting|N/A|30||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:09.596803|2017-02-18 17:16:09.596803
NCT00187980|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||June 2005||2005-06-01|September 2005|2005-09-01||||||||Observational|||Sleep Disturbance in Lung Cancer Patients.||Unknown status|Recruiting|N/A|50||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:09.683224|2017-02-18 17:16:09.683224
NCT00187967|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-09-24|||January 2005||2005-01-01|September 2005|2005-09-01||||||||Interventional|||Cardiopulmonary Bypass (CPB) Pumps and Blood Activation|Blood Activation During Cardiopulmonary Bypass Using Roller or Centrifugal Pumps|Unknown status|Recruiting|N/A|||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:16:09.758638|2017-02-18 17:16:09.758638
NCT00187954|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-10-02|||June 2003||2003-06-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Observational|||WISE ARIC: Retinal Photography in Women With Chest Pain|Retinal Photography in Women With Chest Pain: A WISE/ARIC Collaboration|Completed||Phase 4|160|Actual|University of Florida|||1||f||||t||||||||||2017-02-18 17:16:09.845867|2017-02-18 17:16:09.845867
NCT00187941|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-19|||August 2005||2005-08-01|June 2012|2012-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression|Pilot Trial for Implementation of a Medroxyprogesterone(MPA)Pharmacokinetic(PK) Monitoring Strategy in Patients on Mycophenolate Mofetil(MMF)/FK Based Immunosuppression.|Completed||Early Phase 1|22|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 17:16:09.958834|2017-02-18 17:16:09.958834
NCT00187928|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-10-04|||January 2003||2003-01-01|October 2011|2011-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder|Completed||Phase 3|96||University of Florida|||||f||||t||||||||||2017-02-18 17:16:10.317112|2017-02-18 17:16:10.317112
NCT00187915|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-10-19|||July 2003||2003-07-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|MPA||Pilot Trial for Implementation of a MPA PK Monitoring Strategy|Pilot Trial for Implementation of a MPA PK Monitoring Strategy|Completed||N/A|24|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 17:16:10.417632|2017-02-18 17:16:10.417632
NCT00187902|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-04-13|||October 2005||2005-10-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|May 2007|Actual|2007-05-01||Observational|||Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM|Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM|Completed||N/A|907|Actual|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     self-collected glans swab; clinician-collected rectal and pharyngeal swabs~   "|||2017-02-18 17:16:10.542692|2017-02-18 17:16:10.542692
NCT00187889|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2013-08-07|2013-04-25||August 2004||2004-08-01|October 2011|2011-10-01|December 2011|Actual|2011-12-01|February 2009|Actual|2009-02-01||Interventional|||EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia|A Double-Blind, Multicenter, Placebo Controlled Study of Aldosterone Blockade (Eplerenone) in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease|Completed||Phase 4|70|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 17:16:10.642127|2017-02-18 17:16:10.642127
NCT00187876|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-01-30|2013-12-04||February 2004||2004-02-01|January 2014|2014-01-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Evaluation of Biocleanse Allografts For ACL Reconstruction|Evaluation of Biocleanse Patellar Tendon Allografts For The Reconstruction of Anterior Cruciate Ligaments: A Prospective, Randomized Investigation|Completed||Phase 4|67|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 17:16:11.066139|2017-02-18 17:16:11.066139
NCT00187863|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-20|||May 2005||2005-05-01|March 2015|2015-03-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Biopsychosocial Factors' Influence on Shoulder Pain|Biopsychosocial Factors' Influence on Shoulder Pain|Completed||N/A|340|Actual|University of Florida|||2||f||||||||||||||2017-02-18 17:16:11.418699|2017-02-18 17:16:11.418699
NCT00187850|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-14|||February 2005||2005-02-01|October 2016|2016-10-01|June 2013|Actual|2013-06-01|March 2007|Actual|2007-03-01||Interventional|||The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy|The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy on CAP-1 Patients: A Randomised, Patient - and Observer-Blinded Multicenter Trial|Completed||N/A|120|Anticipated|University of Copenhagen||2|||f||||t||||||||||2017-02-18 17:16:11.529951|2017-02-18 17:16:11.529951
NCT00187837|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-10-14|||February 2005||2005-02-01|October 2016|2016-10-01|June 2013|Actual|2013-06-01|March 2007|Actual|2007-03-01||Interventional|||The CAP-1 Trial: Stepwise Excavation Versus One Completed Excavation in Deep Caries|The CAP-1 Trial: Effect of Stepwise Versus One Completed Excavation in Deep Caries in Permanent Teeth: A Randomised, Patient - and Observer-blinded Multicenter Trial|Completed||N/A|314|Actual|University of Copenhagen||2|||f||||t||||||||Yes|1½ yr results published in European Journal of Oral Sciences 2010; 118: 290-297.|2017-02-18 17:16:11.642108|2017-02-18 17:16:11.642108
NCT00187824|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-11|||July 2004||2004-07-01|March 2004|2004-03-01|August 2007||2007-08-01|||||Observational|||Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis|Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis|Unknown status|Recruiting|N/A|30||University College London Hospitals|||||f||||||||||||||2017-02-18 17:16:11.753256|2017-02-18 17:16:11.753256
NCT00187811|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-28|||February 2001||2001-02-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||The Safety and Efficacy of Photodynamic Therapy for Femoral Artery Stenosis|Randomised Controlled Trial of Adjuvant Photodynamic Therapy to Reduce Restenosis After Percutaneous Transluminal Angioplasty to the Superficial Femoral Angioplasty|Unknown status|Active, not recruiting|Phase 2/Phase 3|120||University College London Hospitals|||||f||||||||||||||2017-02-18 17:16:11.833224|2017-02-18 17:16:11.833224
NCT00187798|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-24|||August 2001||2001-08-01|September 2012|2012-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Impact of Genetics on Metformin Pharmacokinetics|Impact of Genetics on Metformin Pharmacokinetics|Completed||N/A|24|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 17:16:11.915796|2017-02-18 17:16:11.915796
NCT00187772|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-09-17|||December 1996||1996-12-01|September 2013|2013-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Child-Parent Psychotherapy for Preschooler Witnesses of Domestic Violence Program|Preschooler Witnesses of Domestic Violence: A Preventive Intervention Program|Completed||Phase 3|60||University of California, San Francisco|||||f||||||||||||||2017-02-18 17:16:12.10352|2017-02-18 17:16:12.10352
NCT00187616|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||April 2002||2002-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial|Questioning Patients About Adverse Medical Events: A Randomized Controlled Trial|Completed||N/A|214||University of California, San Francisco|||||f||||||||||||||2017-02-18 17:16:12.202544|2017-02-18 17:16:12.202544
NCT00187603|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-05|||July 2003||2003-07-01|August 2005|2005-08-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|||Protecting the 'Hood Against Tobacco|Protecting the 'Hood Against Tobacco: Cessation Project|Completed||N/A|270|Anticipated|University of California, San Francisco|||||f||||||||||||||2017-02-18 17:16:12.292256|2017-02-18 17:16:12.292256
NCT00187590|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-01-21|||April 2004||2004-04-01|January 2014|2014-01-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Case Management Intervention to Prevent ER Visits in HIV-infected Persons||Terminated||N/A|612|Actual|University of California, San Francisco||2||Intervention was taken up as a standard of care.|f||||||||||||||2017-02-18 17:16:12.621286|2017-02-18 17:16:12.621286
NCT00187577|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-07|||June 2005||2005-06-01|June 2011|2011-06-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata|Efficacy and Safety of Latanoprost (Xalatan) and Bimatoprost (Lumigan) Ophthalmic Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata|Completed||N/A|14|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 17:16:12.72165|2017-02-18 17:16:12.72165
NCT00187564|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-02|||August 2004||2004-08-01|September 2005|2005-09-01|October 2005|Actual|2005-10-01|||||Interventional|||Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus|Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus|Completed||N/A|40||University of California, San Francisco|||||f||||||||||||||2017-02-18 17:16:12.849449|2017-02-18 17:16:12.849449
NCT00187551|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-08|||May 2000||2000-05-01|June 2006|2006-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance|Partial Treatment Interruptions in HIV-1 Patients With Multi-Drug Resistant Virus|Completed||Phase 4|25|Actual|University of California, San Francisco||1|||f||||f||||||||||2017-02-18 17:16:12.945345|2017-02-18 17:16:12.945345
NCT00187538|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-08-20|||February 2002||2002-02-01|August 2014|2014-08-01|July 2013|Actual|2013-07-01|December 2012|Actual|2012-12-01||Interventional|||Effect of Dietary Protein Source on Calcium Metabolism|Effect of Dietary Protein Source on Calcium Metabolism|Completed||N/A|183|Actual|University of California, San Francisco||4|||f||||f||||||||||2017-02-18 17:16:13.052745|2017-02-18 17:16:13.052745
NCT00187525|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-08|||May 2004||2004-05-01|November 2012|2012-11-01|October 2006|Actual|2006-10-01|October 2005|Actual|2005-10-01||Interventional|||A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration||Completed||Phase 4|||University of California, San Francisco||1|||f||||||||||||||2017-02-18 17:16:13.148505|2017-02-18 17:16:13.148505
NCT00187512|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-05|||March 2000||2000-03-01|May 2015|2015-05-01|December 2020|Anticipated|2020-12-01|March 2019|Anticipated|2019-03-01||Observational|SCOPE||SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era|SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era|Recruiting||N/A|2500|Anticipated|University of California, San Francisco|||1||f||||f||||||Samples With DNA|"~     Plasma, serum, PMBCs, saliva~   "|||2017-02-18 17:16:13.219581|2017-02-18 17:16:13.219581
NCT00187499|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-02|||October 2002||2002-10-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma|Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma|Completed||N/A|||University of California, San Francisco|||||f||||||||||||||2017-02-18 17:16:13.331111|2017-02-18 17:16:13.331111
NCT00187486|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-26|2011-04-25||August 2004||2004-08-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors|Phase II Study of Tarceva Plus Temodar During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme and Gliosarcoma|Completed||Phase 2|66|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 17:16:13.429593|2017-02-18 17:16:13.429593
NCT00187473|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-07-18|||June 2000||2000-06-01|July 2014|2014-07-01||||December 2014|Anticipated|2014-12-01||Observational|||Natural History of Hepatitis C in Patients With Normal Liver Tests|Determinants of Disease Severity in Patients With Chronic Hepatitis C and Normal Serum Aminotransferases (Normal Liver Tests)|Unknown status|Active, not recruiting|N/A|92|Actual|University of California, San Francisco|||1||f||||f||||||||||2017-02-18 17:16:13.690889|2017-02-18 17:16:13.690889
NCT00187460|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-11-30|||November 2001||2001-11-01|May 2005|2005-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|EFFECT||Study of the Effectiveness of Report Cards on the Quality of Care for Heart Attack and Heart Failure Patients|Enhanced Feedback for Effective Cardiac Treatment (EFFECT)|Completed||N/A|46000|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 17:16:13.780736|2017-02-18 17:16:13.780736
NCT00187447|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-06-02|||August 2003||2003-08-01|September 2005|2005-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus|Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus|Completed||Phase 2|100|Anticipated|University of California, San Francisco|||||f||||||||||||||2017-02-18 17:16:13.904015|2017-02-18 17:16:13.904015
NCT00187434|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-01-22|||September 2003||2003-09-01|September 2005|2005-09-01||||||||Interventional|||Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP)|A Randomized Control Trial Comparing Two Methods of Delivering Continuous Positive Airway Pressure (CPAP), Infant Flow System CPAP and Bubble CPAP, in Supporting Successful Extubation of Infants of Birth Weights Less Than or Equal to 1500 Grams at Birth (C2CPAP)|Unknown status|Recruiting|N/A|76||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 17:16:14.004236|2017-02-18 17:16:14.004236
NCT00187421|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-12-11|||July 2005||2005-07-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|GRIIP||Using Intraoperative Coronary Bypass Graft Imaging to Improve Graft Patency|Graft Imaging to Improve Patency (GRIIP)|Completed||Phase 3|156|Actual|Sunnybrook Health Sciences Centre||2|||f||||||||||||||2017-02-18 17:16:14.095042|2017-02-18 17:16:14.095042
NCT00187408|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-02-26|||August 2002||2002-08-01|February 2006|2006-02-01|January 2007||2007-01-01|||||Interventional|||The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial|Clinically-Important Venous Thromboembolism Following Lower Extremity Fractures: Epidemiology & Prevention|Completed||Phase 4|700||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 17:16:14.205873|2017-02-18 17:16:14.205873
NCT00187395|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-09|||April 2003||2003-04-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Interventional|||CHIPS (Control of Hypertension in Pregnancy Study): A Pilot Trial|Control of Hypertension in Pregnancy Study: A Pilot Trial|Completed||N/A|132||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 17:16:14.319534|2017-02-18 17:16:14.319534
NCT00187382|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-14|||April 2001||2001-04-01|June 2010|2010-06-01|December 2011||2011-12-01|June 2007|Actual|2007-06-01||Interventional|||Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS)|Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study (MACS)|Completed||Phase 4|1858|Actual|Sunnybrook Health Sciences Centre|||||f||||t||||||||||2017-02-18 17:16:14.410089|2017-02-18 17:16:14.410089
NCT00187369|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-08|||December 2003||2003-12-01|October 2013|2013-10-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||The Twin Birth Study: A Trial Comparing Planned Vaginal Birth to Elective Caesarean Section of Twins|The Twin Birth Study: A Multicentre Randomised Controlled Trial Comparing Planned Vaginal Birth to Elective Caesarean Section of Twins More Than or Equal to 32 Weeks Gestation|Completed||N/A|2804|Actual|Sunnybrook Health Sciences Centre||2|||f||||t||||||||||2017-02-18 17:16:14.500603|2017-02-18 17:16:14.500603
NCT00187356|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2013-06-04|||July 2002||2002-07-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|RAPS - 5 years||Multicentre Radial Artery Patency Study: Results of Patency Beyond 5 Years After Coronary Artery Bypass Surgery|Multicentre Radial Artery Patency Study: Results of Patency Beyond 5 Years After Coronary Artery Bypass Surgery|Completed||Phase 3|269|Actual|Sunnybrook Health Sciences Centre||1|||f||||||||||||||2017-02-18 17:16:14.605238|2017-02-18 17:16:14.605238
NCT00187343|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-05|||September 2003||2003-09-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT)|A Phase III Study of Adjuvant Radiation Therapy in Early Breast Cancer Comparing the Use of Breast Intensity Modulated Radiation Therapy (IMRT) to Conventional Wedge Technique|Completed||Phase 3|340||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 17:16:14.725428|2017-02-18 17:16:14.725428
NCT00187330|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||March 2004||2004-03-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass|A Randomized Placebo Controlled Trial of Intravenous N-Acetylcysteine (NAC) As A Renal Protective Agent for Prevention of Renal Dysfunction Following Cardiopulmonary Bypass (CPB)|Completed||Phase 2|104||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 17:16:14.823313|2017-02-18 17:16:14.823313
NCT00187317|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-04-01|||November 2005||2005-11-01|April 2010|2010-04-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Evaluation of a Balance-recovery Specific Falls Prevention Exercise Program|Development and Evaluation of a Perturbation-based Balance-training Program for Older Adults|Completed||Phase 1|37|Actual|Sunnybrook Health Sciences Centre||2|||f||||f||||||||||2017-02-18 17:16:14.905267|2017-02-18 17:16:14.905267
NCT00187304|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-06-04|||September 2005||2005-09-01|June 2013|2013-06-01||||||||Interventional|||ACTION - Anticoagulation Treatment Influence on Post-operative Patients|Anticoagulation Treatment Influence on Post-operative Patients -Action SJM EPIC Trial|Withdrawn||Phase 4|0|Actual|St. Jude Medical||||Study replaced by an observational study|f||||||||||||||2017-02-18 17:16:15.016312|2017-02-18 17:16:15.016312
NCT00187291|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-13|||April 2001||2001-04-01|April 2015|2015-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study)|Alternans Before Cardioverter Defibrillator (ABCD) Trial|Completed||Phase 3|618||St. Jude Medical|||||f||||t||||||||||2017-02-18 17:16:15.082757|2017-02-18 17:16:15.082757
NCT00187278|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-08-06|||May 2003||2003-05-01|August 2015|2015-08-01|October 2014|Actual|2014-10-01|May 2014|Actual|2014-05-01||Interventional|||Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization|Biventricular Pacing for Atrioventricular Block in Left Ventricular Dysfunction to Prevent Cardiac Desynchronization|Completed||N/A|1833|Actual|St. Jude Medical||2|||f||||t||||||||||2017-02-18 17:16:15.186983|2017-02-18 17:16:15.186983
NCT00187265|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-05|||April 2003||2003-04-01|April 2006|2006-04-01|October 2005||2005-10-01|||||Interventional|||Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients|Triple Resynchronization in Paced Heart Failure Patients|Completed||N/A|||St. Jude Medical|||||f||||||||||||||2017-02-18 17:16:15.293068|2017-02-18 17:16:15.293068
NCT00187252|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-11|||September 2003||2003-09-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|MASCOT||Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy|Management of Atrial Fibrillation Suppression in AF-HF COmorbidity Therapy|Completed||N/A|380|Anticipated|St. Jude Medical||2|||f||||f||||||||||2017-02-18 17:16:15.604958|2017-02-18 17:16:15.604958
NCT00187239|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2015-04-20|||July 2005||2005-07-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study|Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search (REDUCE Study)|Completed||Phase 4|157|Actual|St. Jude Medical||2|||f||||||||||||||2017-02-18 17:16:15.699247|2017-02-18 17:16:15.699247
NCT00187226|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-17|2012-05-04||June 1997||1997-06-01|August 2012|2012-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects|A Phase II Study of Image-Guided Radiation Therapy for Pediatric CNS Tumors and Quantification of Radiation-Related CNS Effects|Completed||Phase 2|202|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-02-18 17:16:15.792608|2017-02-18 17:16:15.792608
NCT00005409|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||May 1991||1991-05-01|June 2000|2000-06-01|April 1993|Actual|1993-04-01|||||Observational|||Longitudinal Studies of Blood Pressure in the Elderly||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.83485|2017-02-18 18:15:01.83485
NCT00187213|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-21|||December 2004||2004-12-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|July 2007|Actual|2007-07-01||Interventional|||B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure Patients|Biventricular Versus Left Univentricular Pacing With ICD Back-up in Heart Failure Patients|Completed||N/A|||St. Jude Medical|||||f||||t||||||||||2017-02-18 17:16:16.429135|2017-02-18 17:16:16.429135
NCT00187200|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2015-08-25|2014-08-27||January 2005||2005-01-01|August 2015|2015-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients|RESPONSE HF - Response of Cardiac Resynchronization Therapy Optimization With Interventricular (VV) Timing in Heart Failure Patients|Completed||Phase 4|816|Actual|St. Jude Medical|Due to the lower than expected non-responder rate at 3 months, the study did not reach the target randomized sample size.|2|||f||||f||||||||||2017-02-18 17:16:16.544184|2017-02-18 17:16:16.544184
NCT00187187|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2010-10-20|||June 2003||2003-06-01|October 2010|2010-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|DAVIDII||DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)|DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)|Completed||N/A|600|Actual|St. Jude Medical||2|||f||||t||||||||||2017-02-18 17:16:17.017548|2017-02-18 17:16:17.017548
NCT00187174|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-03|||October 2004||2004-10-01|December 2009|2009-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors|Phase I Trial of RAD001C (Everolimus) in Pediatric Patients With Recurrent Refractory Solid Tumors or Brain Tumors|Completed||Phase 1|41|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:17.119816|2017-02-18 17:16:17.119816
NCT00187161|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-06-03|||November 1994||1994-11-01|June 2008|2008-06-01|January 2007|Actual|2007-01-01|||||Interventional|||Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL|Small Noncleaved Cell (SNCC), Non-Hodgkin Lymphoma (NHL), Large Cell NHL (B-Cell) and B-Cell Acute Lymphoblastic Leukemia (B-ALL) Study II|Completed||Phase 2|68|Actual|St. Jude Children's Research Hospital||3|||f||||f||||||||||2017-02-18 17:16:17.23146|2017-02-18 17:16:17.23146
NCT00187148|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-01|||February 2005||2005-02-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults|Evaluation of the Tolerability and Safety of a Recombinant HIV-1 Multi-Envelope DNA Plasmid Vaccine (EnvDNA) in Healthy Adults|Completed||Phase 1|6|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:17.344446|2017-02-18 17:16:17.344446
NCT00187135|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-03|2009-10-13||March 2002||2002-03-01|March 2010|2010-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration|Fentanyl-Propofol-EMLA or L.M.X4™ Technique for Bone Marrow Aspiration in Pediatric Patients - A Phase III Study|Terminated||Phase 3|168|Actual|St. Jude Children's Research Hospital|All 162 participants were expected to receive three treatments. Not all participants received all three treatments. Therefore, analysis required the identification of subsets of treated participants. The trial terminated early due to slow accrual.|3||The study was terminated due to slow accrual.|f||||f||||||||||2017-02-18 17:16:17.461042|2017-02-18 17:16:17.461042
NCT00187122|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-21|||March 1993||1993-03-01|April 2008|2008-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma|Treatment for Newly Diagnosed Patients With Stage III/IV Non-Hodgkin Lymphoma-Study XIII (A Therapeutic Pilot Study)|Completed||N/A|42|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:18.132221|2017-02-18 17:16:18.132221
NCT00187109|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-08|||June 2000||2000-06-01|May 2007|2007-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy|A Phase I/II Trial of Recombinant Human Thrombopoietin in Children With Malignant Solid Tumors and Lymphoma Receiving Ifosfamide, Carboplatin and Etoposide|Completed||Phase 1/Phase 2|40||St. Jude Children's Research Hospital|||||f||||||||||||||2017-02-18 17:16:18.255071|2017-02-18 17:16:18.255071
NCT00187096|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-06-18|2012-10-10||September 2005||2005-09-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|February 2012|Actual|2012-02-01||Interventional|||Natural Killer (NK) Cell Transplantation for AML|Pilot Study Of Haplo-Identical Natural Killer Cell Transplantation For Acute Myeloid Leukemia|Completed||N/A|49|Actual|St. Jude Children's Research Hospital||2|||f||||t||||||||||2017-02-18 17:16:18.344333|2017-02-18 17:16:18.344333
NCT00187083|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-03|||February 1997||1997-02-01|June 2008|2008-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||A Study of Children With Refractory or Relapsed ALL|A Study of Children With Refractory or Relapsed Acute Lymphoblastic Leukemia (ALLR16)|Completed||Phase 3|40|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-02-18 17:16:18.964768|2017-02-18 17:16:18.964768
NCT00187070|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-06|||December 1997||1997-12-01|May 2008|2008-05-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Large Cell Lymphoma Pilot Study III|Large Cell Lymphoma, Pilot Study III|Completed||N/A|8|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:19.078206|2017-02-18 17:16:19.078206
NCT00187057|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-26|||September 2002||2002-09-01|August 2013|2013-08-01|June 2013|Actual|2013-06-01|August 2006|Actual|2006-08-01||Interventional|||Study for Treatment of Cancer in Children With Ataxia-telangiectasia|Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia|Completed||N/A|6|Actual|St. Jude Children's Research Hospital||5|||f||||f||||||||||2017-02-18 17:16:19.187837|2017-02-18 17:16:19.187837
NCT00187044|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-28|||October 1997||1997-10-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Evaluation of the Safety of a Polyvalent Virus in Healthy Adults|Evaluation of the Safety of a Polyvalent Vaccinia Virus-HIV-1 Envelope Recombinant Vaccine (PolyEnv1) in Healthy Adults|Completed||Phase 1|18|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:19.560903|2017-02-18 17:16:19.560903
NCT00187031|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-03|||November 2002||2002-11-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|||||Interventional|||A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor|A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor|Completed||Phase 2|37|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:16:19.67343|2017-02-18 17:16:19.67343
NCT00182585|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-08-11|||August 2004||2004-08-01|August 2008|2008-08-01||||||||Interventional|||Computer-Assisted HIV Prevention for Young Drug Users|Computer-Assisted HIV Prevention for Young Drug Users|Unknown status|Active, not recruiting|N/A|56|Anticipated|National Development and Research Institutes, Inc.|||||f||||||||||||||2017-02-18 17:17:26.921861|2017-02-18 17:17:26.921861
NCT00187018|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-03|||March 2004||2004-03-01|May 2007|2007-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study|Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study|Completed||N/A|9|Actual|St. Jude Children's Research Hospital|||||f||||f||||||||||2017-02-18 17:16:19.789267|2017-02-18 17:16:19.789267
NCT00187005|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-03-29|||July 1998||1998-07-01|June 2008|2008-06-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Terminated||Phase 3|53|Actual|St. Jude Children's Research Hospital||1||Toxicity|f||||t||||||||||2017-02-18 17:16:19.887497|2017-02-18 17:16:19.887497
NCT00186992|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-27|||January 2003||2003-01-01|July 2016|2016-07-01|January 2024|Anticipated|2024-01-01|January 2024|Anticipated|2024-01-01||Interventional|||Radiation Therapy to Treat Musculoskeletal Tumors|Image Guided Radiotherapy for the Treatment of Musculoskeletal Tumors: A Phase II Prospective Evaluation of Radiation-related Treatment Effects|Active, not recruiting||Phase 2|280|Anticipated|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:20.012643|2017-02-18 17:16:20.012643
NCT00186979|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-10-03|||May 2003||2003-05-01|October 2011|2011-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors|A Phase I Study of ZD1839 (Iressa) in Combination With Irinotecan (Camptosar or CPT-11) and Vincristine in Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|50|Anticipated|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:20.129088|2017-02-18 17:16:20.129088
NCT00186966|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-05|||March 2002||2002-03-01|April 2011|2011-04-01|September 2010|Actual|2010-09-01|April 2009|Actual|2009-04-01||Interventional|||Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia|A Randomized Phase III Study of the Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia|Completed||Phase 3|394|Actual|Dutch Childhood Oncology Group||2|||f||||t||||||||||2017-02-18 17:16:20.239348|2017-02-18 17:16:20.239348
NCT00186953|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-19|||June 2002||2002-06-01|September 2011|2011-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors|Determination of Optimal Dose and Safety Profile of Optison Ultrasound Contrast Agent in Pediatric Solid Tumor Patients|Completed||Phase 1|14|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:20.35419|2017-02-18 17:16:20.35419
NCT00186940|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-10-05|||March 2005||2005-03-01|October 2011|2011-10-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Observational|||Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients|A Study of Rasburicase Treatment for Chemotherapy of Malignancy-Induced Hyperuricemia in Patients With a History of Asthma Allergies|Completed||Phase 4|72|Anticipated|St. Jude Children's Research Hospital|||1||f||||f||||||||||2017-02-18 17:16:20.467744|2017-02-18 17:16:20.467744
NCT00186927|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-20|||March 2005||2005-03-01|December 2016|2016-12-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers|A Phase I Study of Unmodified Live Intranasal Sendai Virus Vaccine in Children and Toddlers: Assessment of Safety and Immunogenicity|Recruiting||Phase 1|54|Anticipated|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:16:20.589246|2017-02-18 17:16:20.589246
NCT00186914|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-03-03|||July 1999||1999-07-01|February 2008|2008-02-01|January 2008|Actual|2008-01-01|November 2001|Actual|2001-11-01||Interventional|||Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation|Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation: A Phase I Study|Completed||Phase 1|8|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:20.713886|2017-02-18 17:16:20.713886
NCT00186901|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-06|2011-12-20||July 2000||2000-07-01|December 2011|2011-12-01|September 2011|Actual|2011-09-01|June 2009|Actual|2009-06-01||Interventional|||A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors|Diminished Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL): A Severity-Adapted Clinical Trial|Completed||Phase 3|429|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-02-18 17:16:20.827446|2017-02-18 17:16:20.827446
NCT00186888|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-20|2011-06-29||February 2005||2005-02-01|June 2016|2016-06-01|September 2021|Anticipated|2021-09-01|November 2013|Actual|2013-11-01||Interventional|||Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma|Protocol for the Study and Treatment of Patients With Intraocular Retinoblastoma|Active, not recruiting||Phase 3|107|Actual|St. Jude Children's Research Hospital||3|||f||||t||||||||||2017-02-18 17:16:21.547375|2017-02-18 17:16:21.547375
NCT00186875|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-09-21|2013-10-25||November 2003||2003-11-01|September 2016|2016-09-01|August 2016|Actual|2016-08-01|August 2016|Actual|2016-08-01||Interventional||One patient who was >21 years at diagnosis was enrolled because early versions of the protocol had no upper age limit for participants previously treated on St Jude frontline protocols. The protocol was subsequently amended to change the age criteria to ≤21 years of age at diagnosis for all patients.|Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia|A Study of Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia|Completed||Phase 2|47|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:22.562944|2017-02-18 17:16:22.562944
NCT00186862|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-02|||August 1998||1998-08-01|June 2008|2008-06-01|October 2007|Actual|2007-10-01|April 2000|Actual|2000-04-01||Interventional|||Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma|Phase I Study of Chemokine and Cytokine Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma Using a Retroviral Vector|Completed||Phase 1|24|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:23.011711|2017-02-18 17:16:23.011711
NCT00186849|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-05-19|||October 1997||1997-10-01|May 2009|2009-05-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Therapy for Children With Advanced Stage High Risk Neuroblastoma|Therapy for Children With Advanced Stage High Risk Neuroblastoma|Completed||Phase 2|30|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:16:23.129644|2017-02-18 17:16:23.129644
NCT00186836|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-19|||November 2004||2004-11-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients|Efficacy of Combined Hepatitis A and Hepatitis B (Twinrix) Vaccine Compared With Hepatitis B Vaccine Alone in Providing Seroprotection Against Hepatitis B in Hemodialysis Patients|Completed||Phase 4|200||St. Joseph's Healthcare Hamilton|||||f||||||||||||||2017-02-18 17:16:23.242953|2017-02-18 17:16:23.242953
NCT00186823|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-28|||March 2002||2002-03-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|September 2005|Actual|2005-09-01||Interventional|||Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies|Haploidentical Stem Cell Transplantation Utilizing Purified CD34+ Hematopoietic Cells for Patients With Hematologic Malignancies|Completed||Phase 3|57|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:16:23.34221|2017-02-18 17:16:23.34221
NCT00186810|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-05-28|||December 1992||1992-12-01|May 2009|2009-05-01|October 2007|Actual|2007-10-01|February 2006|Actual|2006-02-01||Interventional|||Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease|Allogeneic Stem Cell Transplantation From HLA/MLC Genotype Identical Donors for Patients With High Risk Sickle Cell Disease|Completed||Phase 2|15|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:16:23.687576|2017-02-18 17:16:23.687576
NCT00186797|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-04-07|||December 2002||2002-12-01|April 2010|2010-04-01|May 2007|Actual|2007-05-01|September 2005|Actual|2005-09-01||Interventional|AACD34||Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia||Completed||N/A|28||St. Jude Children's Research Hospital|||||||||||||||||||2017-02-18 17:16:23.822994|2017-02-18 17:16:23.822994
NCT00186784|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-02|||December 2000||2000-12-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Transcranial Magnetic Treatment (TMS) in Unipolar Depression|Repetitive Transcranial Magnetic Stimulation (rTMS) in Unipolar Depression|Completed||Early Phase 1|21|Actual|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||||2017-02-18 17:16:23.920425|2017-02-18 17:16:23.920425
NCT00186771|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-27|||November 2004||2004-11-01|July 2011|2011-07-01|January 2015|Anticipated|2015-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia|Transcranial Magnetic Stimulation Used to Treat Auditory Hallucinations in Schizophrenia|Unknown status|Recruiting|Phase 4|10|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-02-18 17:16:24.018911|2017-02-18 17:16:24.018911
NCT00186758|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-02|||July 2002||2002-07-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|TMS||Transcranial Magnetic Stimulation in Bipolar Depression|A Randomized, Sham Controlled, Crossover Trial of rTMS for Bipolar Depression|Completed||Phase 4|40|Anticipated|St. Joseph's Healthcare Hamilton||2|||f||||f||||||||||2017-02-18 17:16:24.124173|2017-02-18 17:16:24.124173
NCT00186745|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-04-18|||March 2005||2005-03-01|April 2016|2016-04-01|February 2016|Actual|2016-02-01|November 2015|Actual|2015-11-01||Interventional|||Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure|Tinzaparin for Treatment of Venous Thromboembolism in Renal Insufficiency: A Pilot Study|Terminated||N/A|148|Actual|St. Joseph's Healthcare Hamilton||1||Funding ceased|f||||f||||||||Undecided||2017-02-18 17:16:24.227811|2017-02-18 17:16:24.227811
NCT00186732|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-08-10|||July 2005||2005-07-01|August 2011|2011-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Comparison of Subcuticular Suture Versus Surgical Staples for Closure of Pfannenstiel Skin Incisions|Pfannenstiel Incision Closure: Subcuticular Suture Versus Surgical Staples|Completed||N/A|288|Anticipated|St. Joseph's Healthcare Hamilton|||||f||||||||||||||2017-02-18 17:16:24.336738|2017-02-18 17:16:24.336738
NCT00186719|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-25|||May 2005||2005-05-01|July 2011|2011-07-01|April 2012|Anticipated|2012-04-01|||||Observational|||How Smoking Causes COPD: Examination of Immune System Changes|How Smoking Causes COPD: Examination of Immune System Changes|Unknown status|Recruiting|N/A|100|Anticipated|St. Joseph's Healthcare Hamilton|||1||f||||||||||||||2017-02-18 17:16:24.426545|2017-02-18 17:16:24.426545
NCT00186706|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-05-21|||September 2005||2005-09-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) Patients|The Effect of Selenium Supplementation on Anti-Oxidant Levels in COPD Patients: A 12-Week, Randomized, Placebo-Controlled Trial|Completed||Phase 4|60|Actual|St. Joseph's Healthcare Hamilton||1|||f||||||||||||||2017-02-18 17:16:24.522055|2017-02-18 17:16:24.522055
NCT00186693|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-07-25|||September 2006||2006-09-01|July 2006|2006-07-01|June 2009|Anticipated|2009-06-01|||||Observational|||How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma|How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma|Withdrawn||N/A|12|Anticipated|St. Joseph's Healthcare Hamilton|||1|never received funding|f||||||||||||||2017-02-18 17:16:24.618504|2017-02-18 17:16:24.618504
NCT00186680|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-02-26|||September 1996||1996-09-01|February 2010|2010-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant|Selection of CD34+THY-1 Positive Cells From Peripheral Blood Cells Procured for Autologous Hematopoietic Support Following High Dose Treatment With BCNU, Cyclophosphamide & Cisplatin for Stage IV Breast Cancer & Limited Prior Treatment|Completed||Phase 1/Phase 2|99|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:24.69884|2017-02-18 17:16:24.69884
NCT00186667|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-07-23|||January 1999||1999-01-01|July 2010|2010-07-01|September 2005|Actual|2005-09-01|January 2000|Actual|2000-01-01||Interventional|||Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease|An Open Label Study of Sirolimus as Primary Therapy for the Treatment of Chronic GVHD Following Allogeneic Bone Marrow Transplant|Completed||Phase 2|30|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:16:24.788368|2017-02-18 17:16:24.788368
NCT00186654|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-09-22||||||August 2008|2008-08-01||||||||Interventional|||Acupuncture and Massage for Depression During Pregnancy|Acupuncture and Massage for Depression During Pregnancy|Completed||Phase 2|180||Stanford University|||||f||||||||||||||2017-02-18 17:16:24.897036|2017-02-18 17:16:24.897036
NCT00186641|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-07-10||||||July 2007|2007-07-01|March 2005||2005-03-01|||||Interventional|||High Dose Chemotherapy and Autologous Transplant for Breast Cancer|High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||Stanford University|||||f||||||||||||||2017-02-18 17:16:24.989264|2017-02-18 17:16:24.989264
NCT00186628|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-03-11|||June 2005||2005-06-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|November 2010|Actual|2010-11-01||Interventional|||Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD|An Open Label, Phase II Trial of Prophylactic Rituximab Therapy for Prevention of Chronic Graft Versus Host Disease After TLI/ARG Nonmyeloablative Allogeneic Stem Cell Transplantation|Completed||Phase 2|36|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 17:16:25.077932|2017-02-18 17:16:25.077932
NCT00186602|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-10-04||||||September 2005|2005-09-01||||||||Interventional|||Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?|Does a Peer Navigator Improve Quality of Life at Diagnosis?|Unknown status|Active, not recruiting|Phase 2|||Stanford University|||||f||||||||||||||2017-02-18 17:16:25.188473|2017-02-18 17:16:25.188473
NCT00186589|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-06-05|||May 2004||2004-05-01|October 2010|2010-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL|90Y-Ibritumomab Tiuxetan and Autologous Hematopoietic Cell Infusion Followed by High Dose Chemotherapy and Autologous Transplantation for Relapsed or Resistant Non-Hodgkin's Lymphoma|Completed||Phase 1|30|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:25.265002|2017-02-18 17:16:25.265002
NCT00186576|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-10-13|||December 2001||2001-12-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|March 2004|Actual|2004-03-01||Interventional|||Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders|Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML)|Completed||N/A|40|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:25.356369|2017-02-18 17:16:25.356369
NCT00186563|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-06-18||||||June 2013|2013-06-01||||||||Interventional|||A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers|Proof-of-concept Study for Bio-marker Assay Validation in Humans|Completed||N/A|13||Stanford University|||||f||||||||||||||2017-02-18 17:16:25.457911|2017-02-18 17:16:25.457911
NCT00186550|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-03||||||December 2013|2013-12-01|November 2000|Actual|2000-11-01|||||Interventional|||Group Psychotherapy for People With HIV|An Evaluation of Group Psychotherapy for People With HIV|Completed||N/A|186|Actual|Stanford University|||||f||||f||||||||||2017-02-18 17:16:25.543011|2017-02-18 17:16:25.543011
NCT00186537|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-11-21|2016-04-01||September 2003||2003-09-01|November 2016|2016-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||Baseline analysis was done on those who completed the study|Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.|Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals.|Completed||N/A|47|Actual|Stanford University||3|||f||||f||||||||No||2017-02-18 17:16:25.638192|2017-02-18 17:16:25.638192
NCT00186524|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-03-11||||||March 2011|2011-03-01||||||||Interventional|||Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer?||Completed||Phase 2|||Stanford University|||||f||||||||||||||2017-02-18 17:16:26.05684|2017-02-18 17:16:26.05684
NCT00186511|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-12-04|||November 2004||2004-11-01|December 2006|2006-12-01|June 2006||2006-06-01|||||Interventional|||Expanding Rural Access: Distance Delivery of Support|Expanding Rural Access: Distance Delivery of Support|Completed||Phase 2|40||Stanford University|||||f||||||||||||||2017-02-18 17:16:26.148167|2017-02-18 17:16:26.148167
NCT00186498|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-11-06|||February 2004||2004-02-01|October 2008|2008-10-01||||||||Interventional|||Memantine as an Adjunctive Agent to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Severe Major Depressive Episode|Memantine as an Adjunctive Agent to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Severe Major Depressive Episode|Unknown status|Active, not recruiting|N/A|20||Stanford University|||||f||||||||||||||2017-02-18 17:16:26.241308|2017-02-18 17:16:26.241308
NCT00186485|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-12-14|||May 2003||2003-05-01|December 2007|2007-12-01||||||||Interventional|||Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression|Safety and Efficacy of Open Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression|Unknown status|Active, not recruiting|N/A|40||Stanford University|||||f||||||||||||||2017-02-18 17:16:26.328614|2017-02-18 17:16:26.328614
NCT00186472|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-31||||||December 2006|2006-12-01||||||||Interventional|||Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 17:16:26.413561|2017-02-18 17:16:26.413561
NCT00186459|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-12|||October 2000||2000-10-01|March 2013|2013-03-01||||||||Interventional|||Obesity, Weight Loss, and Cardiovascular Disease Risk|GCRC-CAP-Tracey McLaughlin, MD|Unknown status|Enrolling by invitation|N/A|550|Anticipated|Stanford University|||||f||||||||||||||2017-02-18 17:16:26.505549|2017-02-18 17:16:26.505549
NCT00186446|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-02-08|||June 2004||2004-06-01|February 2007|2007-02-01||||||||Interventional|||Treatment of Nicotine Dependence and Acute Depression|Treatment of Nicotine Dependence and Acute Depression|Unknown status|Active, not recruiting|Phase 4|30||Stanford University|||||f||||||||||||||2017-02-18 17:16:26.604197|2017-02-18 17:16:26.604197
NCT00186433|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-22|||November 2001||2001-11-01|May 2015|2015-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations|A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations|Completed||N/A|49|Actual|Stanford University|||1||f||||t||||||Samples With DNA|"~     blood~   "|||2017-02-18 17:16:26.697327|2017-02-18 17:16:26.697327
NCT00186420|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-12|||July 2003||2003-07-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|January 2006|Actual|2006-01-01||Interventional|||Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation|Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation|Completed||Phase 2|13|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 17:16:26.778648|2017-02-18 17:16:26.778648
NCT00186407|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-09-10|||April 1998||1998-04-01|September 2010|2010-09-01|February 2010|Actual|2010-02-01|February 2008|Actual|2008-02-01||Interventional|||Autologous Stem Cell Rescue for Primary Amyloidosis|High Dose Chemotherapy and Autologous Stem Cell Rescue for Primary Amyloidosis|Completed||Phase 2|50|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:26.87037|2017-02-18 17:16:26.87037
NCT00186394|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-07-23|||April 2000||2000-04-01|July 2010|2010-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma|High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma|Completed||Phase 2|35|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:26.956588|2017-02-18 17:16:26.956588
NCT00186381|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-07-23|||November 1995||1995-11-01|July 2010|2010-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission|Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission|Completed||Phase 2|200|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:27.045344|2017-02-18 17:16:27.045344
NCT00005408|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1992||1992-07-01|May 2000|2000-05-01|April 1994|Actual|1994-04-01|||||Observational|||Reanalysis of CVD Risk Factors Via Likelihood Methods||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.912612|2017-02-18 18:15:01.912612
NCT00186368|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-12|||April 1999||1999-04-01|January 2017|2017-01-01|December 2021|Anticipated|2021-12-01|December 2021|Anticipated|2021-12-01||Observational|||Microarray Analysis of Gene Expression in Prostate Tissues|Microarray Analysis of Gene Expression in Prostate Tissues (Translating Prostate Cancer Gene Expression Sub-types)|Active, not recruiting||N/A|2000|Anticipated|Stanford University|||1||f||||t||||||||||2017-02-18 17:16:27.132297|2017-02-18 17:16:27.132297
NCT00186355|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-10|||October 2003||2003-10-01|May 2012|2012-05-01|February 2010|Actual|2010-02-01|March 2007|Actual|2007-03-01||Interventional|||Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma|Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma|Completed||N/A|97|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:16:27.217105|2017-02-18 17:16:27.217105
NCT00186342|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-12-13|||September 1992||1992-09-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies|Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide|Completed||N/A|120|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:27.306803|2017-02-18 17:16:27.306803
NCT00186329|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-24|||March 2004||2004-03-01|April 2015|2015-04-01|October 2006||2006-10-01|||||Interventional|||BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)|B-type Natriuretic Peptide for Cardio-Renal Decompensation Syndrome|Completed||Phase 4|100||Stanford University|||||f||||||||||||||2017-02-18 17:16:27.416016|2017-02-18 17:16:27.416016
NCT00186316|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-08-21|||April 2003||2003-04-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|April 2006|Actual|2006-04-01||Interventional|||Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells|A Phase I/II Study of Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells|Completed||Phase 1/Phase 2|30|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:27.525837|2017-02-18 17:16:27.525837
NCT00186303|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-12-13|||November 1996||1996-11-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Transplantation for Patients With Chronic Lymphocytic Leukemia|Autologous and Allogeneic Peripheral Blood Progenitor (PBPC) Transplantation for Patients With Chronic Lymphocytic Leukemia|Completed||N/A|28|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:27.623835|2017-02-18 17:16:27.623835
NCT00186290|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-10-07|||December 1989||1989-12-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Allo BMT in Advanced Leukemia or High Grade Lymphoma|Fractionated Total Body Irradiation (FTBI), Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Allogeneic Bone Marrow Transplantation for Patients With Advanced Leukemia or High Grade Lymphoma|Completed||N/A|145|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:27.709775|2017-02-18 17:16:27.709775
NCT00186277|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-28|||December 2003||2003-12-01|March 2011|2011-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer|Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer|Completed||Phase 2|10|Actual|Stanford University|||||f||||t||||||||||2017-02-18 17:16:27.804313|2017-02-18 17:16:27.804313
NCT00186264|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-14|||August 2002||2002-08-01|December 2007|2007-12-01|April 2006||2006-04-01|||||Interventional|||Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?|Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?|Unknown status|Active, not recruiting|N/A|20||Stanford University|||||f||||||||||||||2017-02-18 17:16:27.899176|2017-02-18 17:16:27.899176
NCT00186251|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-09|||March 1998||1998-03-01|July 2012|2012-07-01|July 2005||2005-07-01|||||Interventional|||High Dose Chemotherapy Followed By PBSC Rescue for HD|Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease|Completed||N/A|200||Stanford University|||||f||||||||||||||2017-02-18 17:16:27.994038|2017-02-18 17:16:27.994038
NCT00186238|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-09-10|||September 1994||1994-09-01|September 2010|2010-09-01|April 2010|Actual|2010-04-01|September 2006|Actual|2006-09-01||Interventional|||High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma|High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma|Completed||Phase 2|300|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:28.080197|2017-02-18 17:16:28.080197
NCT00186225|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-07-23|||November 1989||1989-11-01|July 2010|2010-07-01|May 2010|Actual|2010-05-01|June 2007|Actual|2007-06-01||Interventional|||Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors|Stem Cell Transplantation From Matched Unrelated or Partially Matched Related Donors Using a Preparatory Regimen Consisting of Fractionated Total Body Irradiation (FTBI) and Cyclophosphamide (CY)|Completed||N/A|250|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:28.163805|2017-02-18 17:16:28.163805
NCT00186212|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-29|||September 2000||2000-09-01|June 2011|2011-06-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Alternative Support for Rural and Isolated Women in an HMO|Alternative Support for Rural and Isolated Women in an HMO|Completed||Phase 3|150|Actual|Stanford University|||||f||||f||||||||||2017-02-18 17:16:28.252881|2017-02-18 17:16:28.252881
NCT00186199|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-17|||June 2005||2005-06-01|June 2013|2013-06-01|December 2015|Anticipated|2015-12-01|July 2015|Anticipated|2015-07-01|12 Months|Observational [Patient Registry]|||Determination of Voiding Patterns of Children With Vesicoureteral Reflux|Determination of Voiding Patterns of Children With Vesicoureteral Reflux|Unknown status|Enrolling by invitation|N/A|250|Anticipated|Stanford University|||1||f||||f||||||||||2017-02-18 17:16:28.33363|2017-02-18 17:16:28.33363
NCT00186186|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-12-11|||January 2004||2004-01-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Depakote ER in Bipolar Depression|Depakote ER in Bipolar Depression|Completed||Phase 4|28|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 17:16:28.420623|2017-02-18 17:16:28.420623
NCT00186173|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-11|||November 2004||2004-11-01|July 2012|2012-07-01||||February 2006|Actual|2006-02-01||Interventional|||Sports to Prevent Obesity: Feasibility and Pilot RCT|Sports to Prevent Obesity: Feasibility and Pilot RCT|Completed||Phase 1/Phase 2|21|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 17:16:28.530817|2017-02-18 17:16:28.530817
NCT00186147|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-08|||March 1988||1988-03-01|November 2016|2016-11-01|December 2019|Anticipated|2019-12-01|December 2018|Anticipated|2018-12-01||Observational|||Bone Marrow Grafting for Leukemia and Lymphoma|Bone Marrow Grafting for Leukemia and Lymphoma|Recruiting||N/A|9999|Anticipated|Stanford University|||1||f||||||||||Samples With DNA|"~     Tissue samples will be obtained from subjects undergoing transplantation or donors providing~     the graft.~   "|||2017-02-18 17:16:28.636156|2017-02-18 17:16:28.636156
NCT00186121|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-24|||October 2000||2000-10-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|May 2013|Actual|2013-05-01||Interventional|||Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women|A Phase II Trial of Arimidex Plus Zoladex in the Treatment of Hormone Receptor Positive, Metastatic Carcinoma of the Breast in Premenopausal Women|Completed||N/A|30|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:16:28.843534|2017-02-18 17:16:28.843534
NCT00186108|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-24|||October 2002||2002-10-01|July 2007|2007-07-01|September 2005|Actual|2005-09-01|||||Interventional|||A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer|A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer|Completed||Phase 1|23|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 17:16:29.179828|2017-02-18 17:16:29.179828
NCT00186095|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-05|||December 2000||2000-12-01|October 2007|2007-10-01|September 2006||2006-09-01|||||Interventional|||Mixed Chimeric Transplantation for Primary Amyloidosis|Mixed Chimeric Transplantation for Primary Amyloidosis|Withdrawn||N/A|45|Anticipated|Stanford University||||Closed, never started.|f||||t||||||||||2017-02-18 17:16:29.265998|2017-02-18 17:16:29.265998
NCT00186082|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-13|||September 2003||2003-09-01|June 2011|2011-06-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|||Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs|A Randomized Controlled Trial of the Effect of Prophylactic Antibiotics on the Infection Rate in Postpartum Third and Fourth Degree Perineal Tear Repairs|Completed||N/A|147|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 17:16:29.345335|2017-02-18 17:16:29.345335
NCT00186069|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-25|||March 2004||2004-03-01|May 2016|2016-05-01|February 2017|Anticipated|2017-02-01|June 2014|Actual|2014-06-01||Interventional|||Magnesium Sulfate vs Placebo for Placental Abruption|Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption|Active, not recruiting||N/A|48|Anticipated|Stanford University||2|||f||||f||||||||||2017-02-18 17:16:29.458489|2017-02-18 17:16:29.458489
NCT00186056|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-23|||January 2003||2003-01-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Mifepristone in Refractory Depression|Mifepristone in Refractory Depression|Unknown status|Active, not recruiting|Phase 3|30||Stanford University|||||||||||||||||||2017-02-18 17:16:29.571713|2017-02-18 17:16:29.571713
NCT00186043|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-11|||August 2008||2008-08-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II|A Double-Blind, Placebo-Controlled Trial of Seroquel for the Treatment of Dysphoric Hypomania in Bipolar II Patients|Completed||Phase 4|55|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 17:16:29.66943|2017-02-18 17:16:29.66943
NCT00186030|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-05|||April 2003||2003-04-01|September 2005|2005-09-01|March 2004||2004-03-01|||||Interventional|||Reducing Risk and Trauma-Related Stress in Persons Living With HIV|Reducing Risk and Trauma-Related Stress in Persons Living With HIV|Terminated||Phase 1/Phase 2|102||Stanford University|||||f||||||||||||||2017-02-18 17:16:29.776833|2017-02-18 17:16:29.776833
NCT00186017|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-11|||July 2005||2005-07-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Short Term Rescue Study of Olanzapine|Double-Blind Placebo-Controlled Olanzapine Add-on Therapy in the Treatment of Acute Syndromal and Subsyndromal Exacerbations in Bipolar Disorders|Completed||Phase 4|50|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 17:16:29.866165|2017-02-18 17:16:29.866165
NCT00186004|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-13|||December 2002||2002-12-01|June 2011|2011-06-01|May 2008|Actual|2008-05-01|September 2006|Actual|2006-09-01||Observational|||Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes|Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes|Completed||N/A|21|Actual|Stanford University|||1||f||||f||||||||||2017-02-18 17:16:29.975169|2017-02-18 17:16:29.975169
NCT00185991|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-13|||June 2004||2004-06-01|June 2011|2011-06-01|February 2010|Actual|2010-02-01|October 2006|Actual|2006-10-01||Interventional|||Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis|Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis|Completed||N/A|126|Anticipated|Stanford University||2|||f||||||||||||||2017-02-18 17:16:30.082942|2017-02-18 17:16:30.082942
NCT00185978|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||April 1998||1998-04-01|September 2005|2005-09-01|March 2001||2001-03-01|||||Interventional|||Obesity Prevention for Pre-Adolescents|School- and Family-Based Obesity Prevention for Children|Completed||Phase 2|900||Stanford University|||||f||||||||||||||2017-02-18 17:16:30.194189|2017-02-18 17:16:30.194189
NCT00185965|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-07|2014-07-07||July 2004||2004-07-01|July 2014|2014-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas|Le23 CPG: A Phase 1-2 Study of Intratumoral Injection of CPG 7909, A TLR 9 Agonist, Combined With Local Radiation in Recurrent Low-Grade Lymphomas|Completed||Phase 1/Phase 2|30|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 17:16:30.309838|2017-02-18 17:16:30.309838
NCT00185952|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-10|||November 2001||2001-11-01|June 2011|2011-06-01|August 2008|Actual|2008-08-01|January 2007|Actual|2007-01-01||Interventional|||Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.|Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized Double Blind Trial|Completed||N/A|70|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 17:16:30.656741|2017-02-18 17:16:30.656741
NCT00185939|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-12-01|||August 2003||2003-08-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||The Use of Prophylactic Antibiotics In the Management of Dog Bites||Completed||Phase 2/Phase 3|125||Stanford University|||||f||||||||||||||2017-02-18 17:16:30.763462|2017-02-18 17:16:30.763462
NCT00185913|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-04-20|||September 2000||2000-09-01|April 2010|2010-04-01|May 2008|Actual|2008-05-01|October 2003|Actual|2003-10-01||Observational|||Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers|Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers|Completed||N/A|50|Anticipated|Stanford University|||1||f||||||||||Samples With DNA|"~     blood~   "|||2017-02-18 17:16:30.862069|2017-02-18 17:16:30.862069
NCT00185900|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-25|||April 1999||1999-04-01|May 2016|2016-05-01|July 2007|Actual|2007-07-01|July 2005|Actual|2005-07-01||Interventional|||Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial|Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial|Completed||N/A|192|Actual|Stanford University||2|||f||||||||||||No||2017-02-18 17:16:30.940303|2017-02-18 17:16:30.940303
NCT00185887|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-03-04|||October 2003||2003-10-01|March 2011|2011-03-01|October 2007|Actual|2007-10-01|July 2006|Actual|2006-07-01||Interventional|||Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation|Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation|Completed||N/A|110|Actual|Stanford University||2|||f||||||||||||||2017-02-18 17:16:31.0521|2017-02-18 17:16:31.0521
NCT00185874|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-11|||January 2004||2004-01-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases|A Phase I Trial of Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases|Terminated||Phase 1|22|Anticipated|Stanford University||1||Study closed due to lack of funding|f||||||||||||||2017-02-18 17:16:31.164407|2017-02-18 17:16:31.164407
NCT00185861|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-04-08|||December 2003||2003-12-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|January 2008|Actual|2008-01-01||Interventional|||Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma|Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma|Completed||Phase 1|12|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:16:31.253729|2017-02-18 17:16:31.253729
NCT00185848|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-16|||April 2005||2005-04-01|November 2015|2015-11-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis|Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.|Completed||Phase 2|10|Actual|Stanford University|||1||f||||t||||||None Retained|"~     Patients with intact or surgically removed gliomas.Patients with Rheumatoid Arthritis.~   "|||2017-02-18 17:16:31.346915|2017-02-18 17:16:31.346915
NCT00185835|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-03-25|||June 2002||2002-06-01|March 2010|2010-03-01||||July 2006|Actual|2006-07-01||Interventional|||Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck|Phase I Study of Cisplatin And ZD1839 (IRESSA®) in Combination With Concomitant Re-Irradiation in Patients With Loco-Regional Recurrent Squamous Cell Cancer of the Head and Neck|Completed||Phase 1|10|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:16:31.450098|2017-02-18 17:16:31.450098
NCT00185809|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-16|||November 2000||2000-11-01|July 2010|2010-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study|Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study|Completed||N/A|25|Anticipated|Stanford University|||1||f||||||||||Samples Without DNA|"~     Archival tissue blocks and blood~   "|||2017-02-18 17:16:31.548911|2017-02-18 17:16:31.548911
NCT00185796|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-16|||July 2004||2004-07-01|March 2015|2015-03-01|February 2015|Actual|2015-02-01|April 2014|Actual|2014-04-01||Interventional|||TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD|Total Lymphoid Irradiation and Anti-Thymocyte Globulin as Conditioning for Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for the Treatment of Myelodysplastic Syndromes and Myeloproliferative Disorders (Except CML)|Completed||Phase 2|77|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:16:31.640777|2017-02-18 17:16:31.640777
NCT00185783|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-07|||March 2005||2005-03-01|April 2011|2011-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis|Pilot Study of White Blood Cell Gene Expression in Critically Ill Patients With Severe Sepsis and Relative Adrenal Insufficiency After Hydrocortisone Administration|Completed||Phase 1|10|Actual|Stanford University|||1||f||||t||||||||||2017-02-18 17:16:31.753068|2017-02-18 17:16:31.753068
NCT00185770|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||April 1999||1999-04-01|September 2005|2005-09-01||||||||Interventional|||Reducing Television Viewing to Prevent Childhood Obesity|Reducing Television Viewing to Prevent Childhood Obesity|Completed||Phase 2/Phase 3|900||Stanford University|||||f||||||||||||||2017-02-18 17:16:31.86058|2017-02-18 17:16:31.86058
NCT00185757|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-13|||June 2004||2004-06-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation|Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:31.970889|2017-02-18 17:16:31.970889
NCT00185744|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-08|||September 2002||2002-09-01|December 2016|2016-12-01|March 2029|Anticipated|2029-03-01|March 2029|Anticipated|2029-03-01||Interventional|||Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer|Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer|Active, not recruiting||N/A|400|Anticipated|Stanford University||2|||f||||t||||||||No||2017-02-18 17:16:32.068971|2017-02-18 17:16:32.068971
NCT00185731|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-03-07|||April 2005||2005-04-01|March 2013|2013-03-01|December 2015|Anticipated|2015-12-01|December 2014|Anticipated|2014-12-01||Interventional|||Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma|A Phase II Study of Atorvastatin in Patients With Low Grade or Refractory Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|23|Anticipated|Stanford University||1|||f||||t||||||||||2017-02-18 17:16:32.174604|2017-02-18 17:16:32.174604
NCT00185718|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-12|||November 2003||2003-11-01|December 2012|2012-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Impact of Treatment Induced Premature Menopause on Quality of Life|Impact of Treatment Induced Premature Menopause on Quality of Life Following Blood and Marrow Transplantation|Completed||N/A|97|Actual|Stanford University|||1||f||||||||||||||2017-02-18 17:16:32.272653|2017-02-18 17:16:32.272653
NCT00185705|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-02-12|||October 2006||2006-10-01|February 2007|2007-02-01|June 2007||2007-06-01|||||Interventional|||Treatment of Insulin Resistance in Hypertensive, Obese Adolescents|Randomized, Placebo Controlled, Double Blind Trial of Telmisartan in Hypertensive, Obese Adolescents|Unknown status|Recruiting|N/A|30||Stanford University|||||f||||||||||||||2017-02-18 17:16:32.349865|2017-02-18 17:16:32.349865
NCT00185692|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-01|2016-12-01||August 2000||2000-08-01|January 2015|2015-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Allogeneic Transplantation From Related Haploidentical Donors|Allogeneic Hematopoietic Cell Transplantation of Positively Selected CD34+ Cells and Defined Inoculum of T Cells From Related Haploidentical Donors for Older Patients With Indolent Hematologic Malignancies|Completed||Phase 2|16|Actual|Stanford University||1|||f||||t||||||||No||2017-02-18 17:16:32.446614|2017-02-18 17:16:32.446614
NCT00185679|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-02-26|2015-02-26||November 2001||2001-11-01|February 2015|2015-02-01|February 2010|Actual|2010-02-01|October 2009|Actual|2009-10-01||Interventional|||Haploid Allogeneic Transplant Using the CliniMACS System|A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies|Terminated||Phase 2|13|Actual|Stanford University||1||This study was superseded by the subsequent study IRB-15919 (NCT01050764)|f||||t||||||||||2017-02-18 17:16:32.749156|2017-02-18 17:16:32.749156
NCT00185666|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-12|||May 2002||2002-05-01|July 2010|2010-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Cyberknife Precision Radiation Delivery System for Tumors of the Spine|Cyberknife Precision Radiation Delivery System for Tumors of the Spine|Completed||Phase 1/Phase 2|200|Actual|Stanford University||1|||f||||||||||||||2017-02-18 17:16:33.035419|2017-02-18 17:16:33.035419
NCT00185653|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-10|||October 2000||2000-10-01|February 2011|2011-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma|Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors for the Treatment of Multiple Myeloma|Completed||N/A|40|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:33.122647|2017-02-18 17:16:33.122647
NCT00185640|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-02-18|||March 2003||2003-03-01|February 2015|2015-02-01|January 2015|Actual|2015-01-01|April 2014|Actual|2014-04-01||Interventional|||Allogeneic Transplantation Using TL1 & ATG for Older Patients With Hematologic Malignancies|Allogeneic Hematopoietic Cell Transplantation Using a Non-Myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Older Patients With Hematologic Malignancies|Completed||Phase 2|299|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 17:16:33.214852|2017-02-18 17:16:33.214852
NCT00185614|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-18|||August 2000||2000-08-01|April 2011|2011-04-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional|||Mixed Chimera Allo Transplantation in Multiple Myeloma|Mixed Chimera Allogeneic Transplantation With or Without Allogeneic Idiotyped Pulsed Dendritic Cells for the Treatment of Multiple Myeloma|Completed||Phase 2|48|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 17:16:33.321073|2017-02-18 17:16:33.321073
NCT00185601|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-04-18|||February 2006||2006-02-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|June 2009|Actual|2009-06-01||Interventional|||Internet Diabetes Self-Management Workshop|Internet Diabetes Self-Management Evaluation|Completed||N/A|761|Actual|Stanford University||3|||f||||f||||||||||2017-02-18 17:16:33.4204|2017-02-18 17:16:33.4204
NCT00185588|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-09-10|2014-07-30||October 2004||2004-10-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|January 2009|Actual|2009-01-01||Interventional||33 adult patients with advanced pancreatic cancer|Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer|A Phase 1-2 Study of the VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 <Vatalanib> and Gemcitabine in Patients With Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|33|Actual|Stanford University||4|||f||||t||||||||||2017-02-18 17:16:33.524005|2017-02-18 17:16:33.524005
NCT00185575|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-04-07|||September 2004||2004-09-01|April 2009|2009-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Duloxetine for the Treatment of Dysthymia|Duloxetine for the Treatment of Dysthymia|Completed||N/A|24|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 17:16:37.440931|2017-02-18 17:16:37.440931
NCT00185562|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-03-23|||June 2005||2005-06-01|March 2006|2006-03-01|January 2006||2006-01-01|||||Interventional|||A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis|A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis|Completed||Phase 2|12||Stanford University|||||f||||||||||||||2017-02-18 17:16:37.543206|2017-02-18 17:16:37.543206
NCT00185549|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-04|||March 2004||2004-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||An Interactive Program to Improve Care for Children With CF|An Interactive Program to Improve Care for Children With Cystic Fibrosis|Completed||N/A|60||Stanford University|||||f||||||||||||||2017-02-18 17:16:37.625211|2017-02-18 17:16:37.625211
NCT00185536|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||April 2002||2002-04-01|September 2005|2005-09-01||||||||Observational|||Effects of Advertising on Young Children's Perception of Taste|Effects of Advertising on Young Children's Perception of Taste|Completed||Phase 1/Phase 2|100||Stanford University|||||f||||||||||||||2017-02-18 17:16:37.710756|2017-02-18 17:16:37.710756
NCT00185523|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-06-14|||May 2002||2002-05-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)|Allogeneic Peripheral Blood Stem Cell Transplantation for Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia in First or Second Remission or Chronic Myelogenous Leukemia in First and Second Chronic Phase or Accelerated Phase|Terminated||Phase 2|88|Actual|Stanford University|||2||f||||||||||||||2017-02-18 17:16:37.787717|2017-02-18 17:16:37.787717
NCT00185510|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-02-23|||March 2005||2005-03-01|February 2014|2014-02-01|June 2006|Actual|2006-06-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis|Double-Blind, Placebo Controlled, Randomized, Multicenter, Parallel-Group Study to Compare the Efficacy and Safety of Advantan Cream Twice Weekly With Advabase Cream During a Maintenance Phase of 16 Weeks After Successful Treatment of Atopic Dermatitis With Advantan Cream|Completed||Phase 4|250|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:16:37.893224|2017-02-18 17:16:37.893224
NCT00185484|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-12-30|||March 2004||2004-03-01|December 2014|2014-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Efficacy and Safety Oral Contraceptive Study|Multi-center, Open, Uncontrolled Study to Investigate the Efficacy and Safety of the Oral Contraceptive SH T 186 D Containing 0.02 mg Ethinylestradiol-b-cyclodextrin Clathrate and 3 mg Drospirenone in a 24-day Regimen for 13 Cycles in 1010 Healthy Female Volunteers|Completed||Phase 3|1113|Actual|Bayer||1|||f||||f||||||||||2017-02-18 17:16:37.994986|2017-02-18 17:16:37.994986
NCT00185458|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-05|2009-07-23||May 2000||2000-05-01|November 2013|2013-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).|A 60-month Non-comparative Study on Bleeding Profiles With Levonorgestrel Intrauterine System in Transition From Reproductive Age Contraception to Menopause Age Endometrial Protection During Estrogen Replacement Therapy.|Completed||Phase 3|394|Actual|Bayer||1|||f||||f||||||||||2017-02-18 17:16:38.354669|2017-02-18 17:16:38.354669
NCT00185081|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-04-06|||July 2005||2005-07-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging|Radioimmunodetection of CEA-Producing Tumors Using a Bispecific Antibody Pre-targeting Method and an In-Labeled Peptide|Completed||Phase 1|42|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 17:16:44.955933|2017-02-18 17:16:44.955933
NCT00185445|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-02|||June 2004||2004-06-01|December 2013|2013-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL|A Phase II Study to Evaluate the Efficacy and Safety of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL|Completed||Phase 2|62|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 17:16:39.185909|2017-02-18 17:16:39.185909
NCT00185419|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-01-13|||November 2003||2003-11-01|January 2009|2009-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception|An Open-Label, Randomised, Parallel-Group Comparison to Investigate the Efficacy of Yasmin® (30 µg Ethinylestradiol, 3mg Drospirenone) and Marvelon® (30 µg Ethinylestradiol, 150 µg Desogestrel) on Cycle Control in Healthy Chinese Women Over 13 Cycles|Completed||Phase 3|842|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:16:39.333767|2017-02-18 17:16:39.333767
NCT00185393|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-11-26|||August 2001||2001-08-01|November 2008|2008-11-01|February 2007|Actual|2007-02-01|||||Interventional|||Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy|Efficacy and Safety of Subsequent Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Further Treatment in Patients With Stage III or IV Follicular Non-Hodgkin's Lymphoma Having Achieved Partial or Complete Remission After First Line Chemotherapy. A Prospective, Multicenter, Randomized Phase III Clinical Trial|Completed||Phase 3|414|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:16:39.452251|2017-02-18 17:16:39.452251
NCT00185380|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-15|2009-12-10||April 2005||2005-04-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)|Multi-center, Open, Randomized, Dose Finding Phase II Study to Investigate Ultra Low Dose Levonorgestrel Contraceptive Intrauterine Systems (LCS) Releasing Different Amounts of Levonorgestrel Compared to MIRENA in Nulliparous and Parous Women in Need of Contraception.|Completed||Phase 2|742|Actual|Bayer||3|||f||||f||||||||||2017-02-18 17:16:39.92202|2017-02-18 17:16:39.92202
NCT00185367|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-14|||March 2005||2005-03-01|July 2011|2011-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Comparative Cycle Control Europe|A Multi-center, Double-blind, Double-dummy, Controlled, Randomized Study to Evaluate Cycle Control and Safety of a Four Phasic Oral Contraceptive (SH T00658ID) in Comparison to an Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D 593 B) in Healthy Female Volunteers Aged Between 18 and 50 Years.|Completed||Phase 3|798|Actual|Bayer||2|||f||||||||||||||2017-02-18 17:16:40.76438|2017-02-18 17:16:40.76438
NCT00185354|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-30|||November 2004||2004-11-01|December 2015|2015-12-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||FC Patch Comparator Study|Multi-center, Open, Randomized, Parallel Group Comparison of Cycle Control for Seven Cycles and Endometrial Safety in a Subgroup for Thirteen Cycles of Contraceptive Patch SH P00331F (0.9 mg Ethinylestradiol/1.9 mg Gestodene) vs. a Contraceptive Comparator Patch (0.6 mg Ethinylestradiol/6 mg Norelgestromin) in 400 Healthy Female Volunteers|Completed||Phase 3|422|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:16:40.916441|2017-02-18 17:16:40.916441
NCT00185341|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-04-29|||February 2005||2005-02-01|April 2016|2016-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Safety, Tolerability and Efficacy of the CCR1 Antagonist ZK 811752, Given Orally in a Dose of 600 mg Three Times Daily, for the Treatment of Endometriosis Over 12 Weeks|Completed||Phase 2|110|Actual|Bayer||2|||f||||||||||||||2017-02-18 17:16:41.043424|2017-02-18 17:16:41.043424
NCT00185328|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-12-11|||September 2005||2005-09-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy and Tolerability of Angeliq in Thai Women|A Multi-Center, Open-Label, Non-Comparative Study Investigating the Efficacy and Tolerability of Angeliq® in Postmenopausal Thai Women With Vasomotor Symptoms Over Three 28-Day Treatment Cycles|Completed||Phase 4|55|Actual|Bayer||1|||f||||f||||||||||2017-02-18 17:16:41.174872|2017-02-18 17:16:41.174872
NCT00185315|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-19|||February 2000||2000-02-01|April 2010|2010-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension|Open-label, Uncontrolled, Long-term Surveillance Study of Iloprost Aerosol Inhalation Therapy in the Treatment of Patients With Primary or Secondary Pulmonary Hypertension. Follow-up Program for Patients Who Completed 12 Weeks in Study ME97218/300180.|Completed||Phase 3|71|Actual|Bayer||1|||f||||||||||||||2017-02-18 17:16:41.275824|2017-02-18 17:16:41.275824
NCT00185302|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-10|||December 2004||2004-12-01|December 2015|2015-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma|Phase II Study of MS-275, a Histone Deacetylase Inhibitor, Comparing 2 Dosage Schedules in Patients With Metastatic Melanoma|Completed||Phase 2|28|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:16:41.38991|2017-02-18 17:16:41.38991
NCT00185289|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-07-14|||April 2004||2004-04-01|July 2011|2011-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Study to Investigate Efficacy and Safety of a New Oral Contraceptive|Multi-center , Open, Uncontrolled Study to Investigate the Efficacy and Safety of a 4 Phasic Oral Contraceptive SH T00658 in a 28-day Regimen for 20 Cycles in Healthy Female Volunteers|Completed||Phase 3|1392|Actual|Bayer||1|||f||||||||||||||2017-02-18 17:16:41.567187|2017-02-18 17:16:41.567187
NCT00185276|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2014-12-29|||March 2003||2003-03-01|December 2014|2014-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries|Randomized, Multi-center Open Label Study of the Safety (Open-label) and Efficacy (Open-label & Blinded Reader) of Magnevist® Injection-enhanced Magnetic Resonance Arteriography (MRA) at Two Dose Levels and 2-dimensional-time-of-flight (2D-TOF) MRA in Patients Undergoing MRA of the Infrarenal Aorta and Peripheral Arteries With Intra-arterial Digital Subtraction Arteriography (i.a. DSA) as Standard of Reference|Completed||Phase 3|365|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:16:41.917823|2017-02-18 17:16:41.917823
NCT00185263|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-11-04|||March 2002||2002-03-01|November 2008|2008-11-01|November 2008|Anticipated|2008-11-01|January 2005|Actual|2005-01-01||Interventional|AGENT-4||Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina|A Multinational Multicenter, Randomized , Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Patients With Stable Angina|Unknown status|Active, not recruiting|Phase 2/Phase 3|116|Actual|Cardium Therapeutics||3|||f||||t||||||||||2017-02-18 17:16:42.037994|2017-02-18 17:16:42.037994
NCT00185250|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-12-18|||December 2002||2002-12-01|December 2008|2008-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy|Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study to Evaluate Efficacy and Safety of 4 and 8 Million Units Betaferon®/Betaseron® (Interferon Beta-1b) Given Subcutaneously Every Other Day Over 24 Weeks in Patients With Chronic Viral Cardiomyopathy|Completed||Phase 2|138|Actual|Bayer||4|||f||||t||||||||||2017-02-18 17:16:42.147131|2017-02-18 17:16:42.147131
NCT00185237|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-12-22|||July 2005||2005-07-01|December 2014|2014-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch|A Multicenter, Double-blind, Randomized, Placebo Controlled Study on the Effect of Ultra-low Dose Transdermal Estradiol (Menostar®) on the Incidence and Severity of Hot Flushes, Other Menopausal Symptoms and on Well-being in Postmenopausal Asian Women Over 12 Weeks.|Completed||Phase 3|165|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:16:42.318551|2017-02-18 17:16:42.318551
NCT00185224|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-07-14|||March 2005||2005-03-01|July 2011|2011-07-01|March 2006|Actual|2006-03-01|||||Interventional|||Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive|A Single-center, Open-label, Controlled, Randomized Study to Investigate the Impact of a Sequential Oral Contraceptive (SH T00658ID) as Compared to a Sequential Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D00264A) on Plasma Lipids, Hemostatic Variables, and Carbohydrate Metabolism in Healthy Female Volunteers Aged 18-50 Years Over 7 Treatment Cycles, Including the Pharmacokinetics|Completed||Phase 2|58|Actual|Bayer||2|||f||||||||||||||2017-02-18 17:16:42.442171|2017-02-18 17:16:42.442171
NCT00185211|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-12-04|2009-07-23||August 2002||2002-08-01|December 2013|2013-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study|Open-label, Multi-center Phase III Extension of the Double-blind, Placebo-controlled BENEFIT Study (no. 92012/304747) to Obtain Long-term Follow-up Data of Patients With Clinically Definite Multiple Sclerosis (MS) and Patients With a First Demyelinating Event Suggestive of MS Treated With 8 MIU (250 µg) Interferon Beta-1b (Betaferon® / Betaseron®) Given Subcutaneously Every Other Day for at Least 36 Months.|Completed||Phase 3|468|Actual|Bayer|"Participant Flow: Subject with Other as reason for not completing a study period are presented according to the NIH pre-specified categories as far as possible."|2|||f||||t||||||||||2017-02-18 17:16:42.572158|2017-02-18 17:16:42.572158
NCT00185198|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-04-01|||September 2004||2004-09-01|April 2014|2014-04-01|October 2007|Actual|2007-10-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)|Multicenter, Double Blind, Randomized, Placebo Controlled Study of Testogel® (Testosterone 50-100mg) to Evaluate Its Efficacy and Safety in Men Presenting With Typical Symptoms of Partial Androgen Deficiency of Aging Males (PADAM) Over a Period of 6 Months With 12 Months Open Label Follow-up|Completed||Phase 3|363|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:16:43.641895|2017-02-18 17:16:43.641895
NCT00185185|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-12|||November 2001||2001-11-01|December 2007|2007-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Olmesartan Medoxomil in Atherosclerosis|Multi-Centre Olmesartan Atherosclerosis Regression Evaluation (MORE)|Completed||Phase 3|165|Actual|Daiichi Sankyo Inc.||2|||f||||||||||||||2017-02-18 17:16:43.771712|2017-02-18 17:16:43.771712
NCT00185172|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-28|||January 2002||2002-01-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Olmesartan in Essential Hypertension|Efficacy and Safety of Olmesartan: Reduction of Blood Pressure in the Treatment of Patients Suffering From Mild to Moderate Essential Hypertension|Completed||Phase 3|2333|Actual|Daiichi Sankyo Inc.||3|||f||||f||||||||||2017-02-18 17:16:43.877509|2017-02-18 17:16:43.877509
NCT00185159|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-19|||October 2004||2004-10-01|January 2010|2010-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Olmesartan Medoxomil in Diabetes Mellitus|Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study (ROADMAP)|Completed||Phase 3|4449|Actual|Daiichi Sankyo Inc.||2|||f||||||||||||||2017-02-18 17:16:44.225757|2017-02-18 17:16:44.225757
NCT00185146|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-27|||September 2002||2002-09-01|March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||Efficacy and Safety of Pactimibe in Patients With Atherosclerosis|Effect of Pactimibe on the Progression of Atherosclerosis as Measured by 2-D and 3-D Carotid Ultrasound|Completed||Phase 2|200||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:16:44.328302|2017-02-18 17:16:44.328302
NCT00185133|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-12|||May 2005||2005-05-01|December 2007|2007-12-01|January 2007||2007-01-01|||||Interventional|||Study of co-Administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension|A Randomized, Double-Blind, Placebo-Controlled Factorial Study Evaluating the Efficacy and Safety of co-Administration of Olmesartan Medoxomil Plus Amlodipine Compared to Monotherapy in Patients With Mild to Severe Hypertension|Completed||Phase 3|1900||Daiichi Sankyo Inc.|||||f||||f||||||||||2017-02-18 17:16:44.412563|2017-02-18 17:16:44.412563
NCT00185120|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-01-16|||September 2005||2005-09-01|January 2012|2012-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker|A Study on the Efficacy and Safety of Olmesartan Medoxomil and Its Combination With Hydrochlorothiazide Compared With an ACE Inhibitor and Its Combination With a Calcium Channel Blocker in Patients With Stage 2 Hypertension|Completed||Phase 4|152||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:16:44.639228|2017-02-18 17:16:44.639228
NCT00185107|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-09-10|||March 2005||2005-03-01|September 2007|2007-09-01|October 2005||2005-10-01|||||Interventional|||Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Combination With Zetia® Compared to Zetia® Alone in Patients With Primary Hypercholesterolemia|Completed||Phase 4|45||Daiichi Sankyo Inc.|||||f||||f||||||||||2017-02-18 17:16:44.76577|2017-02-18 17:16:44.76577
NCT00185094|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-22|||February 2004||2004-02-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin|The Effects of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on Insulin Sensitivity in Overweight and Obese Subjects With Hypertension|Completed||Phase 4|60||Daiichi Sankyo Inc.|||||||||||||||||||2017-02-18 17:16:44.861577|2017-02-18 17:16:44.861577
NCT00185068|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||March 2004||2004-03-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension|A Prospective, Open Label, Titration Study to Assess the Efficacy and Safety of Benicar® and Benicar ®HCT in Patients With Stage II Systolic Hypertension|Completed||Phase 4|110||Daiichi Sankyo Inc.|||||||||||||||||||2017-02-18 17:16:45.068848|2017-02-18 17:16:45.068848
NCT00184392|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-02-27|||January 2005||2005-01-01|February 2014|2014-02-01|September 2007|Actual|2007-09-01|December 2005|Actual|2005-12-01||Interventional|||Cleaning of the Nose After Sinus Surgery: Necessary or Only Bothersome?|Debridement After Functional Endoscopic Sinus Surgery|Completed||N/A|60|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 17:16:45.186258|2017-02-18 17:16:45.186258
NCT00184379|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-11|||April 2005||2005-04-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effects of Psychoeducation of Relatives to Patients With Serious Mental Illness|Effects of Psychoeducation of Relatives to Patients With Serious Mental Illness|Completed||N/A|100|Anticipated|Norwegian University of Science and Technology||4|||f||||f||||||||||2017-02-18 17:16:45.291266|2017-02-18 17:16:45.291266
NCT00184366|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-01-18|||May 2005||2005-05-01|January 2012|2012-01-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Observational|||Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis|Classification and Characterization of Patients Suffering From Moderate to Severe Plaque Psoriasis Responding to Subcutaneous Administered Efalizumab|Terminated||Phase 4|96|Actual|Norwegian University of Science and Technology|||1|efalizumab was withdrawn from market; full 2 years follow-up only 14 patients|f||||f||||||||||2017-02-18 17:16:45.395173|2017-02-18 17:16:45.395173
NCT00184353|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-10-20|||November 2003||2003-11-01|October 2011|2011-10-01|June 2005|Actual|2005-06-01|December 2004|Actual|2004-12-01||Observational|||Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.|In Vivo Proton MR Spectroscopy of Brain Metastases Obtained at 1,5T and 3T.|Completed||N/A|19|Actual|Norwegian University of Science and Technology|||2||f||||f||||||||||2017-02-18 17:16:45.506817|2017-02-18 17:16:45.506817
NCT00184340|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-08|||January 2004|Actual|2004-01-01|February 2017|2017-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Secured Internet-mediated Psychotherapy With Psychiatry Patients|Secured Internet-mediated Psychotherapy With Psychiatry Patients. Software Improvement, Clinical Trials and Development of Clinical Precautions|Completed||N/A|6|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 17:16:45.59634|2017-02-18 17:16:45.59634
NCT00184327|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-16|||January 2002||2002-01-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|December 2006|Actual|2006-12-01||Observational|||Changes Following Inpatient Child-oriented Family Treatment|Change Across Intensive Inpatient Family Treatment in Child and Adolescent Psychiatry. A Multi-site Study of Parents and Children in Inpatient Family Treatment|Completed||Phase 1|150|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 17:16:45.700319|2017-02-18 17:16:45.700319
NCT00185055|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-15|||November 2004||2004-11-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects|The Relative Effects of Single Doses of Olmesartan Medoxomil, Irbesartan and Valsartan at High Dosage Levels on the Renin-Angiotensin-Aldosterone System in Healthy Normal Subjects|Completed||Phase 4|20||Daiichi Sankyo Inc.|||||||||||||||||||2017-02-18 17:16:45.807884|2017-02-18 17:16:45.807884
NCT00185042|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-09-10|||November 2002||2002-11-01|September 2007|2007-09-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of the ACAT Inhibitor CS-505 for Reducing the Progression of Atherosclerosis in Subjects With Coronary Artery Disease Using Intravascular Ultrasound (IVUS)|Completed||Phase 2|534|Actual|Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:16:45.884992|2017-02-18 17:16:45.884992
NCT00185029|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-14|||April 2002||2002-04-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||MR-Lymphography and Lymph Node Staging in Prostate Cancer|MRI With a Lymph Node Specific Contrast Agent: an Alternative for CT-Scanning and Lymph Node Dissection in Patients With Prostate Cancer?|Unknown status|Active, not recruiting|Phase 4|396||Radboud University|||||f||||||||||||||2017-02-18 17:16:46.007303|2017-02-18 17:16:46.007303
NCT00185016|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2005-09-15|||March 2003||2003-03-01|September 2005|2005-09-01|November 2004||2004-11-01|||||Interventional|||Women Abuse and the Role of the Family Doctor.|Women Abuse and the Role of the Family Doctor. Testing an Intervention in a Randomised Controlled Trial.|Terminated||N/A|||Radboud University|||||f||||||||||||||2017-02-18 17:16:46.109923|2017-02-18 17:16:46.109923
NCT00185003|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-16|||January 2003||2003-01-01|April 2008|2008-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Blockade of Vascular Potassium Channels During Human Endotoxemia|Blockade of Vascular Potassium Channels During Human Endotoxemia|Completed||Phase 1|36|Actual|Radboud University||6|||f||||f||||||||||2017-02-18 17:16:46.19341|2017-02-18 17:16:46.19341
NCT00184990|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-14|||January 2005||2005-01-01|April 2008|2008-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Effect of Selective iNOS Inhibition During Human Endotoxemia|Effect of Selective iNOS Inhibition During Human Endotoxemia|Completed||Phase 1|7|Actual|Radboud University||1|||f||||f||||||||||2017-02-18 17:16:46.290181|2017-02-18 17:16:46.290181
NCT00184977|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-03-11|||December 1998||1998-12-01|August 2006|2006-08-01|January 2003||2003-01-01|||||Interventional|||COPD on Primary Care Treatment (COOPT)|A Double-blind Placebo-controlled Trial Comparing the Efficacy and Cost-effectiveness of Inhaled Fluticason Propionate Versus Oral N-acetylcysteine in the Treatment of Patients With COPD in General Practice|Completed||Phase 4|270||Radboud University|||||f||||||||||||||2017-02-18 17:16:46.375386|2017-02-18 17:16:46.375386
NCT00184964|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-03|||June 2004||2004-06-01|June 2008|2008-06-01||||||||Interventional|||Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis|The Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis With Histological Examination of the Resected Specimen|Unknown status|Recruiting|N/A|15|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 17:16:46.474716|2017-02-18 17:16:46.474716
NCT00005407|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||February 1991||1991-02-01|May 2000|2000-05-01|January 1993|Actual|1993-01-01|||||Observational|||Statistical Analysis of Pediatric Task Force Data Base||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:01.989795|2017-02-18 18:15:01.989795
NCT00184951|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-21|||April 2004||2004-04-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients|Pharmacodynamics and Pharmacokinetics of Combined Use of Rosuvastatin (Crestor) and Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients With Hyperlipidemia (ROSALKA)|Completed||Phase 2|30||Radboud University|||||f||||||||||||||2017-02-18 17:16:46.559097|2017-02-18 17:16:46.559097
NCT00184938|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-27|||January 2005||2005-01-01|March 2008|2008-03-01||||||||Interventional|||Opioid Receptors Influence Ischemia-Reperfusion Injury|Opioid Induced Acute Preconditioning|Suspended||N/A|40|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 17:16:46.658503|2017-02-18 17:16:46.658503
NCT00184925|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-11-05|||October 2003||2003-10-01|November 2014|2014-11-01|August 2005|Actual|2005-08-01|April 2005|Actual|2005-04-01||Interventional|||Ventilator Associated Pneumonia and Late Complications of Percutaneous Tracheostomy|The Development of Ventilator Associated Pneumonia and Late Complications of Two Different Percutaneous Tracheostomy Techniques|Terminated||N/A|120|Actual|Radboud University||1||Analysis was frustrated by inadequate PhD's....|f||||t||||||||||2017-02-18 17:16:46.751876|2017-02-18 17:16:46.751876
NCT00184912|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-28|||September 2003||2003-09-01|February 2006|2006-02-01|January 2006||2006-01-01|||||Interventional|||The Effect of Caffeine on Ischemic Preconditioning|Caffeine Reduces Acute Ischemic Preconditioning|Completed||N/A|24||Radboud University|||||f||||||||||||||2017-02-18 17:16:46.858784|2017-02-18 17:16:46.858784
NCT00184899|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-02-28|||August 2005||2005-08-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids|The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids|Completed||N/A|20||Radboud University|||||f||||||||||||||2017-02-18 17:16:46.963916|2017-02-18 17:16:46.963916
NCT00184886|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-02-13|||November 2003||2003-11-01|February 2006|2006-02-01|January 2005||2005-01-01|||||Interventional|||The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans|The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans|Completed||N/A|10||Radboud University|||||f||||||||||||||2017-02-18 17:16:47.060494|2017-02-18 17:16:47.060494
NCT00184873|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-02-08|||January 2005||2005-01-01|August 2007|2007-08-01|December 2008|Actual|2008-12-01|May 2008|Actual|2008-05-01||Interventional|||Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance in Leg Ulcer Patients|Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance With Compression Therapy and Prescribed Exercise in Leg Ulcer Patients|Completed||N/A|180|Actual|Radboud University||2|||f||||f||||||||||2017-02-18 17:16:47.137213|2017-02-18 17:16:47.137213
NCT00184860|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-26|||June 2003||2003-06-01|April 2007|2007-04-01||||||||Interventional|||The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patients|The Value of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes in Patients With a Squamous Cell Carcinoma of the Head-and-Neck Region, Who Are to be Treated With Definitive Radiotherapy|Completed||N/A|80||Radboud University|||||f||||||||||||||2017-02-18 17:16:47.500493|2017-02-18 17:16:47.500493
NCT00184847|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-27|||March 2005||2005-03-01|March 2008|2008-03-01||||||||Interventional|||Adenosine Receptors Influence Ischemia-Reperfusion Injury|Adenosine Receptor Involvement in Acute Ischemic Preconditioning of the Vascular Endothelium|Suspended||N/A|8|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 17:16:47.583539|2017-02-18 17:16:47.583539
NCT00184834|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 1999||1999-06-01|September 2005|2005-09-01|November 2002||2002-11-01|||||Observational|||Quality of Life and Liver Metastases|Quality of Life After Surgical Treatment of Colorectal Liver Metastases|Completed||N/A|100||Radboud University|||||f||||||||||||||2017-02-18 17:16:47.691127|2017-02-18 17:16:47.691127
NCT00184821|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-04|||June 2004||2004-06-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Observational|||Ischemic Injury and Ischemic Preconditioning in Diabetes|Acute Local Ischemic Preconditioning in Patients With Type 1 Diabetes in Vivo|Completed||N/A|20||Radboud University|||||f||||f||||||||||2017-02-18 17:16:47.792839|2017-02-18 17:16:47.792839
NCT00184808|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Observational|||Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily Life||Unknown status|Recruiting|N/A|15||Radboud University|||||f||||||||||||||2017-02-18 17:16:47.894449|2017-02-18 17:16:47.894449
NCT00184795|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-12-19|||May 2004||2004-05-01|December 2016|2016-12-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|CHOICE||Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations|A Six Month Double-blind, Randomised, Parallel-group, Placebo-controlled, Multi-centre Trial to Investigate the Efficacy and Safety of Two Ultra-low Dose Combinations With 0.5 mg Estradiol and 0.1 mg or 0.25 mg Norethisterone Acetate (Activelle Low Dose 0.1/Activelle Low Dose 0.25) for Treatment of Menopausal Symptoms|Completed||Phase 3|576|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-02-18 17:16:47.966796|2017-02-18 17:16:47.966796
NCT00184782|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-20|||September 2003||2003-09-01|September 2005|2005-09-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning|Exploratory Study on FDG-PET Scanning in Evaluating the Metabolic Activity of Liver Metastases Before and After Resection of the Primary Tumor in Patients With a Colorectal Malignancy|Unknown status|Recruiting|N/A|30|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 17:16:48.200966|2017-02-18 17:16:48.200966
NCT00184769|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-28|||January 1998||1998-01-01|June 2012|2012-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.|Open Randomized Trial Examining the Growth and Safety Effects of Treatment With Recombinant Growth Hormone on Infants Aged 1 to 2 Years With Growth Retardation Secondary to Chronic Renal Insufficiency|Completed||Phase 4|16|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:48.287684|2017-02-18 17:16:48.287684
NCT00184756|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-12|||November 2002||2002-11-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy on Height in SGA Children Treated With Growth Hormone|Effect of Two Years Treatment With Growth Hormone on Height in SGA Children.|Completed||Phase 3|151|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:48.385761|2017-02-18 17:16:48.385761
NCT00184743|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-28|||December 2003||2003-12-01|June 2012|2012-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)|Investigation of the Efficacy and Safety of NN-220 for 48 Weeks in Adults With Growth Hormone Deficiency|Completed||Phase 3|112|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:48.540504|2017-02-18 17:16:48.540504
NCT00184730|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-16|||November 2004||2004-11-01|November 2016|2016-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)|Investigation of the Efficacy and Safety of hGH in Long Term (More Than 48 Weeks) in GHDA.|Completed||Phase 3|86|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:48.652191|2017-02-18 17:16:48.652191
NCT00184717|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-23|2010-12-22||July 2003||2003-07-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|March 2006|Actual|2006-03-01||Interventional|||Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)|GHLIQUID-1516: A 104-week, Multi-centre, Randomised, Double-blind, Parallel-group, no Treatment Controlled (Open-label) Trial Investigating the Efficacy and Safety of Two Doses of NN-220 in Subjects With Short Stature Born Small for Gestational Age / GHLIQUID-1517: A Long-term, Multi-centre, Randomised, Controlled, Double-blind, Parallel-group Trial, Investigating the Efficacy and Safety of Two Doses of NN-220 in Subjects With Short Stature Born Small for Gestational Age|Completed||Phase 3|98|Actual|Novo Nordisk A/S||5|||f||||f||||||||||2017-02-18 17:16:48.763427|2017-02-18 17:16:48.763427
NCT00184691|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-17|||April 1999||1999-04-01|January 2017|2017-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years|Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone Which Will be Started Randomly at the Ages of 2 to 5, in Children Diagnosed of IUGR|Completed||Phase 3|78|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:50.160267|2017-02-18 17:16:50.160267
NCT00184678|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-12|||February 2002||2002-02-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency|Effect of Two Years of Treatment With Norditropin® SimpleXx® on Bone Mineral Density in Young Adults With Childhood-Onset Growth Hormone Deficiency|Completed||Phase 3|161|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:50.335511|2017-02-18 17:16:50.335511
NCT00184665|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-26|||June 2004||2004-06-01|January 2017|2017-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes|2 Year Efficiency and Safety Comparison of Insulin Detemir and NPH Insulin in Type 1 Diabetes.|Completed||Phase 3|501|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:50.455626|2017-02-18 17:16:50.455626
NCT00184652|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-23|||April 2003||2003-04-01|January 2017|2017-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease|The Effect of Norditropin® on Nutritional Status in Adult Patients in Chronic Haemodialysis|Completed||Phase 2|140|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:50.579996|2017-02-18 17:16:50.579996
NCT00184639|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-24|||August 2004||2004-08-01|July 2012|2012-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes|Comparison of Efficacy and Safety of Insulin Detemir and Insulin Semilente®MC in Children, Adolescents and Young Adults With Type 1 Diabetes on Basal-Bolus Regimen.|Completed||Phase 3|71|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:50.69203|2017-02-18 17:16:50.69203
NCT00184626|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-06-15|||September 2004||2004-09-01|June 2012|2012-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.|Safety and Efficacy of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.|Completed||Phase 4|97|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:50.783414|2017-02-18 17:16:50.783414
NCT00184613|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-10-14|||May 2005||2005-05-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes|An Open-label, Randomised, In-patient, Cross Over PK/PD Trial Investigating the Pharmackinectic and Pharmacodynamic Profiles Following Continuous Subcutaneous Infusion of Insulin Aspart or Injection of Insulin Glargine in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 1|22|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:53.710777|2017-02-18 17:16:53.710777
NCT00184600|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-02-29|2011-05-10||November 2004||2004-11-01|February 2016|2016-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|4T||Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes|A 36-month, Multi-centre, Open-label, Randomised, Parallel-group Trial Comparing the Safety, Efficacy and Durability of Adding a Basal Insulin Versus a Twice Daily Insulin Mixture Versus a Meal-time Rapid-Acting Insulin in Subjects With Type 2 Diabetes Inadequately Controlled on Therapy With Oral Agents, and Assessing the Requirement for More Complex Insulin Regimens to Achieve and Maintain Glycaemic Control, Their Efficacy and Durability|Completed||Phase 3|708|Actual|Novo Nordisk A/S||3|||f||||f||||||||||2017-02-18 17:16:53.82432|2017-02-18 17:16:53.82432
NCT00184587|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-04-22|||March 2005||2005-03-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Prophylactic Treatment of Episodic Cluster Headache|Prophylactic Treatment of Episodic Cluster Headache With an Angiotensin II Receptor Blocker (Candesartan Cilexetil); a Randomized, Placebo Controlled Parallel Study|Completed||Phase 2|40|Actual|Norwegian University of Science and Technology||2|||f||||||||||||||2017-02-18 17:16:56.60504|2017-02-18 17:16:56.60504
NCT00184574|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-04|||April 2005||2005-04-01|January 2017|2017-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes|Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30, Biphasic Insulin Aspart 50/50, and Biphasic Insulin Aspart 30/70 All in Combination With Metformin in Subjects With Type 2 Diabetes (the INTENSIMIX Trial).|Completed||Phase 3|603|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:56.959575|2017-02-18 17:16:56.959575
NCT00184561|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2017-01-05|||July 2005||2005-07-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes|Change in HbA1c With Biphasic Insulin Aspart 70/30 in Two Different Treatment Regiments in Subjects With Type 2 Diabetes Inadequately Controlled With Oral Anti-diabetic Drug Therapy.|Completed||Phase 4|321|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:16:57.165908|2017-02-18 17:16:57.165908
NCT00182572|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-08-11|||July 2005||2005-07-01|August 2008|2008-08-01||||||||Interventional|||Science-Based Treatment for Opioid-Dependent Adolescents|Science-Based Treatment for Opioid-Dependent Adolescents|Unknown status|Recruiting|Phase 2|80|Anticipated|National Development and Research Institutes, Inc.|||||||||||||||||||2017-02-18 17:17:27.01771|2017-02-18 17:17:27.01771
NCT00184548|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-06-13|2009-09-04||October 2005||2005-10-01|June 2014|2014-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|CONTROL||Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding|A Multi-centre, Randomised, Double-blind, Parallel Group, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Activated Recombinant Factor VII (rFVIIa/NovoSeven®/NiaStase®) in Severely Injured Trauma Patients With Bleeding Refractory to Standard Treatment|Terminated||Phase 3|554|Actual|Novo Nordisk A/S|Trial was terminated after planned interim analysis for futility showed a lower than expected conditional power for showing superiority (11.2% [actual] vs. 50% [required]). 554 of 1502 planned patients were included in the intent-to-treat population.|4||See termination reason in detailed description|f||||f||||||||||2017-02-18 17:16:57.288439|2017-02-18 17:16:57.288439
NCT00184535|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-10-17|||July 2005||2005-07-01|October 2012|2012-10-01|October 2005|Actual|2005-10-01|||||Observational|||"Recording Methods of Muscle Activity Onset."|"Muscle Activity Onset in the Transversus Abdominis - Simultaneous Recordings by Intramuscular Electromyography and High Frame Rate Ultrasound Imaging."|Completed||N/A|10|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 17:16:59.456595|2017-02-18 17:16:59.456595
NCT00184522|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-08-08|||August 2002||2002-08-01|September 2005|2005-09-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||On Demand Treatment of Reflux Disease|Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.|Completed||Phase 4|82|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:16:59.535306|2017-02-18 17:16:59.535306
NCT00184509|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2017-01-25|||February 1993||1993-02-01|January 2017|2017-01-01|May 1998||1998-05-01|||||Interventional|||Continued Early Intervention for Recent-onset Schizophrenia|Continued Early Intervention for Recent-onset Schizophrenia. A Randomized Controlled Study.|Terminated||Phase 3|50||Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 17:16:59.653848|2017-02-18 17:16:59.653848
NCT00184496|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-02-27|||August 2004||2004-08-01|February 2014|2014-02-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study|Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study|Completed||Phase 3|42|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:16:59.736953|2017-02-18 17:16:59.736953
NCT00184483|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-02-04|||October 2001||2001-10-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||A Multi-site Trial Comparing Lichtensteins Operation and Prolene Hernia System in Inguinal HErnia Repair|Randomized Multi Site Trial Comparing Lichtensteins Operation and Prolene Hernia System in Inguinal HErnia Repair.|Completed||N/A|405|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:16:59.847342|2017-02-18 17:16:59.847342
NCT00184470|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-04-18|||December 2004||2004-12-01|April 2008|2008-04-01|January 2007||2007-01-01|June 2006|Actual|2006-06-01||Observational|||Trauma Registration at St. Olavs Hospital 2000-2003|Mapping of Traumatized Patients Referred to St. Olavs Hospital in the Period 2000-2003-Norwegian University of Science and Technology|Terminated||Phase 3|1000||Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 17:16:59.940312|2017-02-18 17:16:59.940312
NCT00184457|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2017-01-16|||September 2005||2005-09-01|November 2011|2011-11-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|||Maximal Leg Press Strength Training Study for Coronary Artery Disease Patients|Maximal Leg Press Strength Training for Coronary Artery Disease Patients. Training Effect on Serum Testosterone and Work Economy|Completed||N/A|12|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 17:17:00.017181|2017-02-18 17:17:00.017181
NCT00184444|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-07-19|||September 2004||2004-09-01|July 2016|2016-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients|Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients|Completed||N/A|25|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:17:00.143969|2017-02-18 17:17:00.143969
NCT00184431|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2011-10-17|||April 2004||2004-04-01|October 2011|2011-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Does Intensive Task Specific Training Improve Balance After Acute Stroke?|A Randomized Controlled Trial Comparing Intensive Task Specific Training With Traditional Follow up Care After Discharge From a Stroke Unit.|Completed||N/A|62|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:17:00.269191|2017-02-18 17:17:00.269191
NCT00184418|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-04-07|||January 2005||2005-01-01|April 2015|2015-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||The Immune System and Psychiatric Disorders|The Immune System and Psychiatric Disorders|Completed||N/A|1400|Actual|Norwegian University of Science and Technology|||1||f||||f||||||Samples Without DNA|"~     Serum, frozen~   "|||2017-02-18 17:17:00.394681|2017-02-18 17:17:00.394681
NCT00184405|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-01-05|||March 2005||2005-03-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Child Results Following Preventive Children of Parents With Psychiatric and Addictive Problems (COPP) Groups|Preventive Peer Groups for Children of Parents With Psychiatric and Addictive Problems (COPP). Child Experiences and Observed Child Changes Following the Intervention|Terminated||Phase 1|6|Actual|Norwegian University of Science and Technology|||1|Terminated to financial cut|f||||t||||||||||2017-02-18 17:17:00.52133|2017-02-18 17:17:00.52133
NCT00184314|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-08|||March 2004|Actual|2004-03-01|February 2017|2017-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Observational|||Follow-up of Eating Disorder Patients From a 15-year Period.|Follow-up Eating Disorder Patients and Their Parents Leaving Treatment From 1988 to 2002 at Child and Adolescent Department at Levanger Hospital.|Completed||N/A|40|Actual|Norwegian University of Science and Technology|||1||f||||f||||||||||2017-02-18 17:17:00.608745|2017-02-18 17:17:00.608745
NCT00184301|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-09|||September 2005||2005-09-01|October 2013|2013-10-01|October 2013|Actual|2013-10-01|December 2011|Actual|2011-12-01||Interventional|||A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.|Treatment of Patients With Concurrent Eating Disorder and Personality Disorder: A Controlled Randomized Comparison Study, of Treatments Given to In-patients and Out-patients.|Completed||N/A|43|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:17:00.693173|2017-02-18 17:17:00.693173
NCT00182559|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2014-02-04|||April 2004||2004-04-01|February 2014|2014-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Vienna Prograf and Endothelial Progenitor Cell Study|The Vienna Prograf and Endothelial Progenitor Cell Study|Completed||Phase 4|148|Actual|Medical University of Vienna||2|||f||||f||||||||||2017-02-18 17:17:27.112442|2017-02-18 17:17:27.112442
NCT00184288|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-01|||November 2004||2004-11-01|October 2011|2011-10-01|December 2010|Actual|2010-12-01|June 2006|Actual|2006-06-01||Observational|||Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.|Single Volume 1H MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology|||1|no patients recruited|f||||f||||||||||2017-02-18 17:17:00.80021|2017-02-18 17:17:00.80021
NCT00184275|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-06|||May 2005||2005-05-01|March 2014|2014-03-01|December 2010|Actual|2010-12-01|May 2007|Actual|2007-05-01||Observational|||Characterization of Brain Metastases|Brain Metastases Tissue Characterized by High-resolution Magic Angle Spinning MR and Micro Array|Completed||N/A|26|Actual|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"~     frozen tumor tissue samples~   "|||2017-02-18 17:17:00.87979|2017-02-18 17:17:00.87979
NCT00184262|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-20|||January 2003||2003-01-01|March 2012|2012-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Exposure and Response Prevention With Behavioral- Versus Cognitive Therapy Rationale in Obsessive Compulsive Disorder|Exposure and Response Prevention (ERP) With Behavioral- Versus Cognitive Therapy Rationale in the Treatment of OCD|Completed||N/A|35|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:17:00.969248|2017-02-18 17:17:00.969248
NCT00184249|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-03-18|||June 2005||2005-06-01|March 2015|2015-03-01|June 2012|Actual|2012-06-01|June 2010|Actual|2010-06-01||Interventional|||A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation|A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation|Withdrawn||N/A|0|Actual|Norwegian University of Science and Technology||1||Collaborators did not enter patients into the study|f||||f||||||||||2017-02-18 17:17:01.083687|2017-02-18 17:17:01.083687
NCT00184236|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-10-31|||February 2005||2005-02-01|October 2011|2011-10-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Cardiovascular Risk Factors in Overweight Adolescents|Aerobic Interval Training Reduces Cardiovascular Risk Factors More Than a Multitreatment Approach in Overweight Adolescents|Completed||N/A|54|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:17:01.264464|2017-02-18 17:17:01.264464
NCT00184223|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-06-03|||October 2004||2004-10-01|May 2016|2016-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use|Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use|Completed||N/A|135|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||No||2017-02-18 17:17:01.383531|2017-02-18 17:17:01.383531
NCT00184210|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-16|||January 2000||2000-01-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue|HR MAS MR Spectroscopy of Breast Cancer Tissue|Recruiting||N/A|1000|Anticipated|Norwegian University of Science and Technology|||1||f||||f||||||Samples With DNA|"~     tissue~   "|||2017-02-18 17:17:01.696665|2017-02-18 17:17:01.696665
NCT00184197|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-09-01|||May 2005||2005-05-01|September 2010|2010-09-01|December 2009|Actual|2009-12-01|||||Interventional|||Botulinum Toxin Injection in Neck Muscles in Cervicogenic Headache|Botulinum Toxin Injection in Neck Muscles in Cervicogenic Headache: A Prospective, Randomized, Double-blind, Cross-over Study|Completed||Phase 2|30|Anticipated|Norwegian University of Science and Technology|||||f||||f||||||||||2017-02-18 17:17:01.798474|2017-02-18 17:17:01.798474
NCT00184184|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-24|||October 2004||2004-10-01|July 2006|2006-07-01|June 2010||2010-06-01|||||Observational|||Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients|Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients|Completed||Phase 1|500||Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 17:17:01.90434|2017-02-18 17:17:01.90434
NCT00184171|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2015-01-20|||November 2001||2001-11-01|January 2015|2015-01-01|October 2014|Actual|2014-10-01|September 2010|Actual|2010-09-01||Interventional|||Treatment of Microscopic Colitis|Treatment of Microscopic Colitis (Collagenous Colitis and Lymphocytic Colitis) With Budesonide, Bismuth or Fiber|Terminated||N/A|105|Actual|Norwegian University of Science and Technology||3||insufficient data quality|f||||f||||||||||2017-02-18 17:17:01.987059|2017-02-18 17:17:01.987059
NCT00184158|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-08-25|||January 2005||2005-01-01|August 2011|2011-08-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Treatment for Cubital Tunnel Syndrome|Cubital Tunnel Treatment, Evaluation of Conservative and Operative Alternatives|Completed||Phase 2|81|Actual|Norwegian University of Science and Technology||1|||f||||f||||||||||2017-02-18 17:17:02.109818|2017-02-18 17:17:02.109818
NCT00184145|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-01-22|||June 2004||2004-06-01|January 2008|2008-01-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||EMDR in the Treatment of Specific Phobia.|EMDR (Eye Movement Desensitization and Reprocessing) in the Treatment of Specific Phobia. A Randomised Controlled Trial.|Completed||N/A|24|Actual|Norwegian University of Science and Technology||1|||f||||t||||||||||2017-02-18 17:17:02.20692|2017-02-18 17:17:02.20692
NCT00184132|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-06-07|||November 2000||2000-11-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||The Effects of Different Interior Decorations in a Psychiatric Intensive Care Unit.|The Effects of Different Interior Decorations in a Psychiatric Intensive Care Unit.|Completed||N/A|50||Norwegian University of Science and Technology|||||f||||f||||||||||2017-02-18 17:17:02.315111|2017-02-18 17:17:02.315111
NCT00184119|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-06-07|||October 2001||2001-10-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effects of a Psychiatric Intensive Care Unit|Effects of a Psychiatric Intensive Care Unit in an Acute Psychiatric Department.|Completed||N/A|60||Norwegian University of Science and Technology|||||f||||||||||||||2017-02-18 17:17:02.426716|2017-02-18 17:17:02.426716
NCT00184106|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-02-13|||October 2004|Actual|2004-10-01|February 2017|2017-02-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo|A Randomised, Triple Blind, Placebo-controlled Trial Comparing the Effects of Cognitive Therapy, Paroxetine and Both Cognitive Therapy and Paroxetine in the Treatment of Patients With Primary Social Phobia|Completed||Phase 4|86|Actual|Norwegian University of Science and Technology||4|||f||||f||||||||||2017-02-18 17:17:02.517171|2017-02-18 17:17:02.517171
NCT00184093|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-20|||June 1999||1999-06-01|May 2014|2014-05-01|May 2009|Actual|2009-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma|Phase I/II Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma: Analysis of Prognostic Factors and Determinants of Response: A Pilot Study|Completed||Phase 1/Phase 2|35|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:02.633804|2017-02-18 17:17:02.633804
NCT00184080|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-20|||May 2004||2004-05-01|May 2014|2014-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Multicenter Open-Label Non-Randomized Phase II Study of Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|7|Actual|University of Southern California|||||f||||||||||||||2017-02-18 17:17:02.735323|2017-02-18 17:17:02.735323
NCT00184067|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-20|||May 2004||2004-05-01|January 2014|2014-01-01|September 2009|Actual|2009-09-01|April 2007|Actual|2007-04-01||Interventional|||Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma|A Randomized Phase II Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Resected Stages IIB/C, III, and IV Melanoma|Terminated||Phase 2|23|Actual|University of Southern California||2||Primary PI left institution|f||||||||||||||2017-02-18 17:17:02.82156|2017-02-18 17:17:02.82156
NCT00184054|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-16|2014-06-13||April 2002||2002-04-01|July 2014|2014-07-01|August 2011|Actual|2011-08-01|June 2009|Actual|2009-06-01||Interventional||All participants were included in the analysis.|Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia|Phase II Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-APL Acute Myelogenous Leukemia|Terminated||Phase 2|11|Actual|University of Southern California||1||Competing studies|f||||||||||||||2017-02-18 17:17:02.917574|2017-02-18 17:17:02.917574
NCT00184041|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-20|||July 2004||2004-07-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Intensified Post Remission Therapy Containing PEG-Asparaginase|Treatment Of Newly Diagnosed Adult Acute Lymphoblastic Leukemia With Intensified Post Remission Therapy Containing PEG-Asparaginase.|Completed||Phase 2|47|Actual|University of Southern California||1|||f||||t||||||||||2017-02-18 17:17:03.36056|2017-02-18 17:17:03.36056
NCT00184028|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-20|2013-03-21||September 2004||2004-09-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck|Phase II Trial of Taxotere and Oxaliplatin Combination Chemotherapy in Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 2|12|Actual|University of Southern California||1||Insufficient Accrual|f||||||||||||||2017-02-18 17:17:03.46203|2017-02-18 17:17:03.46203
NCT00184015|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-04-06|||August 2005||2005-08-01|April 2016|2016-04-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||"Bortezomib and Bevacizumab (BB-mib-mab) in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)"||Active, not recruiting||Phase 1/Phase 2|50|Actual|University of Southern California||2|||f||||||||||||||2017-02-18 17:17:03.829729|2017-02-18 17:17:03.829729
NCT00184002|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-24|||January 2003||2003-01-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas|A Phase II Study Of Pegylated Liposomal Doxorubicin (Doxil) In Combination With Rituxan, Cyclophosphamide, Vincristine and Prednisone (DR-COP) In Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas|Active, not recruiting||Phase 2|68|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:03.928834|2017-02-18 17:17:03.928834
NCT00183989|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-20|||August 2000||2000-08-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma|A Pilot Phase II Trial of Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma|Terminated||Phase 2|30|Anticipated|University of Southern California||||Insufficient accrual|f||||||||||||||2017-02-18 17:17:04.030301|2017-02-18 17:17:04.030301
NCT00183976|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-20|||April 2005||2005-04-01|May 2006|2006-05-01|January 2006|Actual|2006-01-01|September 2005|Actual|2005-09-01||Interventional|||Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas|A Pilot Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas|Terminated||Phase 2|15||University of Southern California||||Insufficient Accrual|f||||t||||||||||2017-02-18 17:17:04.122612|2017-02-18 17:17:04.122612
NCT00183963|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-20|2012-11-09||August 2006||2006-08-01|May 2014|2014-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)|A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)|Terminated||Phase 2|4|Actual|University of Southern California|Due to insufficient accrual, analysis was not conducted.|4||Insufficient accrual|f||||||||||||||2017-02-18 17:17:04.39925|2017-02-18 17:17:04.39925
NCT00183950|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||March 2000||2000-03-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy|Phase I/II Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy|Terminated||Phase 1/Phase 2|12|Actual|University of Southern California||1||No funding|||||t||||||||||2017-02-18 17:17:05.27073|2017-02-18 17:17:05.27073
NCT00183937|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||April 2005||2005-04-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|October 2010|Actual|2010-10-01||Interventional|||Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer|A Phase II Study of Bortezomib (Velcade®, PS-341) and Docetaxel for Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|15|Actual|University of Southern California||1|||f||||t||||||||||2017-02-18 17:17:05.353631|2017-02-18 17:17:05.353631
NCT00183924|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||March 2001||2001-03-01|May 2014|2014-05-01|December 2008|Actual|2008-12-01|July 2006|Actual|2006-07-01||Interventional|||Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.|A Phase II Pilot Study of Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.|Completed||Phase 2|20|Actual|University of Southern California||1|||f||||t||||||||||2017-02-18 17:17:05.459693|2017-02-18 17:17:05.459693
NCT00183716|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-07-20|||April 2004||2004-04-01|July 2012|2012-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|TREM||The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women|An Randomized Controlled Trial (RCT) of the Trauma Recovery and Empowerment Model|Completed||Phase 3|300|Anticipated|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 17:17:07.660436|2017-02-18 17:17:07.660436
NCT00183911|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||November 2003||2003-11-01|May 2014|2014-05-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma|Phase II Study of Adjuvant Intraperitoneal FUDR Treatment Added to Chemoradiation (5-Fluorouracil/Leucovorin Plus Total Dose 4500 cGy of External Beam Radiotherapy) in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma|Completed||Phase 2|25|Anticipated|University of Southern California|||||f||||t||||||||||2017-02-18 17:17:05.54448|2017-02-18 17:17:05.54448
NCT00183898|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-10-24|||December 2004||2004-12-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer|Phase II Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer|Active, not recruiting||Phase 2|75|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:05.633707|2017-02-18 17:17:05.633707
NCT00183885|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-12-17|||October 2004||2004-10-01|December 2014|2014-12-01|October 2015|Anticipated|2015-10-01|February 2013|Actual|2013-02-01||Interventional|||A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma|A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C|Unknown status|Active, not recruiting|Phase 2|76|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:05.74227|2017-02-18 17:17:05.74227
NCT00183872|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-10-24|||April 2005||2005-04-01|October 2015|2015-10-01|June 2017|Anticipated|2017-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma|Phase II Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma|Active, not recruiting||Phase 2|40|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:05.840596|2017-02-18 17:17:05.840596
NCT00183859|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||September 1999||1999-09-01|May 2014|2014-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan|Phase I Clinical and Pharmacokinetic Trial of Intra-Peritoneal Irinotecan|Completed||Phase 1|42|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:05.935895|2017-02-18 17:17:05.935895
NCT00183846|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||December 2000||2000-12-01|May 2014|2014-05-01|July 2009|Actual|2009-07-01|October 2007|Actual|2007-10-01||Interventional|||Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers|Phase I Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers|Completed||Phase 1|22|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:06.037016|2017-02-18 17:17:06.037016
NCT00183833|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||December 2002||2002-12-01|May 2014|2014-05-01|August 2010|Actual|2010-08-01|July 2009|Actual|2009-07-01||Interventional|||Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors|Phase I/II Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors|Completed||Phase 1|40|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:06.130064|2017-02-18 17:17:06.130064
NCT00183820|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-03-25|||November 2004||2004-11-01|March 2015|2015-03-01|June 2016|Anticipated|2016-06-01|December 2015|Anticipated|2015-12-01||Interventional|||Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma|A Phase II Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma|Active, not recruiting||Phase 2|30|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:06.234832|2017-02-18 17:17:06.234832
NCT00183807|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||October 2003||2003-10-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|February 2006|Actual|2006-02-01||Interventional|||A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer|A Phase II Study of Irinotecan (Camptosar), Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer|Terminated||Phase 2|6|Actual|University of Southern California||1||Insufficient Accrual|f||||t||||||||||2017-02-18 17:17:06.33295|2017-02-18 17:17:06.33295
NCT00183794|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|2012-10-06||November 2002||2002-11-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|May 2009|Actual|2009-05-01||Interventional|||Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma|Phase II Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma|Completed||Phase 2|20|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:17:06.421977|2017-02-18 17:17:06.421977
NCT00183781|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-08-20|||September 2000||2000-09-01|August 2013|2013-08-01|June 2004|Actual|2004-06-01|||||Interventional|||Effectiveness of a Telephone Intervention Program in Improving Depression, Coping, and Family Functioning in HIV-Infected Individuals and Caregivers|Adapting to HIV Disease - A Family Intervention|Completed||Phase 3|270||Butler Hospital|||||f||||||||||||||2017-02-18 17:17:06.870996|2017-02-18 17:17:06.870996
NCT00183768|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-08-20|||September 1999||1999-09-01|August 2013|2013-08-01|February 2003|Actual|2003-02-01|||||Interventional|||Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users|Antidepressant Treatment to Reduce HIV Risk Among IDUs|Completed||Phase 3|175||Butler Hospital|||||f||||||||||||||2017-02-18 17:17:06.970601|2017-02-18 17:17:06.970601
NCT00183755|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-04-16|||April 2005||2005-04-01|April 2014|2014-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Understanding Brain Reward Responses in Individuals With Major Depressive Disorder|Neuroimaging Studies of Reward Processing in Depression|Completed||N/A|87|Actual|Mclean Hospital|||2||f||||t||||||||||2017-02-18 17:17:07.080868|2017-02-18 17:17:07.080868
NCT00183742|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||December 2000||2000-12-01|May 2014|2014-05-01|May 2006|Actual|2006-05-01|October 2005|Actual|2005-10-01||Interventional|||Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)|Phase I Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)|Completed||Phase 1|35||University of Southern California|||||f||||||||||||||2017-02-18 17:17:07.183367|2017-02-18 17:17:07.183367
NCT00183729|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-10-20|2016-07-01||August 2005||2005-08-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults|Memantine for Enhancement of Rehabilitation Efficacy and Prevention of Major Depressive Disorder in Older Adults|Completed||Phase 4|35|Actual|University of Pittsburgh||2|||f||||f||||||||Yes|study has small sample size and is unlikely to be useful for data sharing efforts; however, interested researchers can contact the first author via email.|2017-02-18 17:17:07.273697|2017-02-18 17:17:07.273697
NCT00183703|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-07-01|||July 2004||2004-07-01|June 2013|2013-06-01|August 2007|Actual|2007-08-01|November 2006|Actual|2006-11-01||Observational|||Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar Disorder|Rapid Cycling Bipolar Disorder (RCBPD), Subjective Illness Experience and Gender|Completed||N/A|40|Actual|Case Western Reserve University|||1||f||||f||||||||||2017-02-18 17:17:07.790695|2017-02-18 17:17:07.790695
NCT00183690|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-11|||September 2004||2004-09-01|December 2008|2008-12-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Prolonged Exposure Therapy Versus Active Psychotherapy in Treating Post-Traumatic Stress Disorder in Adolescents|Treating Terror-Related PTSD in Adolescents|Completed||Phase 1|60|Actual|National Institute of Mental Health (NIMH)||2|||f||||t||||||||||2017-02-18 17:17:07.902341|2017-02-18 17:17:07.902341
NCT00183677|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-04|2011-09-22||July 2003||2003-07-01|November 2016|2016-11-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram|Biochemical Brain Changes Correlated With the Antidepressant Effect of Escitalopram: A Magnetic Resonance Spectroscopic Imaging Study|Completed||Phase 4|97|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:17:08.013824|2017-02-18 17:17:08.013824
NCT00183664|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-16|||December 1999||1999-12-01|March 2009|2009-03-01|June 2011|Anticipated|2011-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Cognitive Therapy for Treating Depression and Preventing Relapse|Prophylactic Cognitive Therapy for Depression|Terminated||Phase 4|523|Actual|National Institute of Mental Health (NIMH)||3||"Enrollment into acute phase therapy ended August 1st, 2008. Randomized continuation phase~   trial is slated to end in June 2009 and follow-up to end in June 2011."|f||||t||||||||||2017-02-18 17:17:08.432013|2017-02-18 17:17:08.432013
NCT00183651|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-01-31|||April 2004||2004-04-01|January 2012|2012-01-01|June 2010|Actual|2010-06-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Suicidal Women With Borderline Personality Disorder|Assessment and Treatment of Parasuicidal Patients|Completed||Phase 2|99|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 17:17:08.550062|2017-02-18 17:17:08.550062
NCT00183638|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-26|||June 2003||2003-06-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|Youthnet||A Tailored Interactive Website for Promoting Condom Use Among Young Adults|Randomized Controlled Trial to Establish Efficacy of a Website to Promote Condom Use for Adults Aged 18-25|Completed||Phase 2|1870|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 17:17:08.678763|2017-02-18 17:17:08.678763
NCT00183625|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-20|2010-05-21||June 2000||2000-06-01|November 2005|2005-11-01|September 2006|Actual|2006-09-01|June 2005|Actual|2005-06-01||Interventional|||Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients|The Effectiveness of Supplementing Supported Employment With Behavioral Skills Training|Completed||Phase 4|107|Actual|University of California, Los Angeles||4|||f||||t||||||||||2017-02-18 17:17:08.792343|2017-02-18 17:17:08.792343
NCT00183612|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-01-07|||May 2000||2000-05-01|January 2014|2014-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents|Developmental Pharmacokinetics of Psychotropic Drugs: Olanzapine|Terminated||N/A|68||Massachusetts General Hospital||1|||f||||||||||||||2017-02-18 17:17:09.135277|2017-02-18 17:17:09.135277
NCT00183599|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-17|||April 1999||1999-04-01|November 2011|2011-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Gambling and Brief Interventions|Effect of Type and Duration of Therapy on Treatment for Gambling|Completed||Phase 1|500||UConn Health||3|||f||||t||||||||||2017-02-18 17:17:09.241108|2017-02-18 17:17:09.241108
NCT00183586|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-06-16|||April 2004||2004-04-01|June 2016|2016-06-01||||March 2009|Actual|2009-03-01||Interventional|||Comparing the Effectiveness of Three Types of Therapy for the Treatment of Anorexia Nervosa in Adolescents|Treatment for Adolescent Anorexia Nervosa|Completed||Phase 2|121|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 17:17:09.366761|2017-02-18 17:17:09.366761
NCT00183573|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-06|||March 2004||2004-03-01|June 2013|2013-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||HIV Prevention Program for Patients Receiving Care at a Sexually Transmitted Diseases Clinic|HIV Prevention for STD Clinic Patients|Completed||Phase 2/Phase 3|1554|Actual|The Miriam Hospital||6|||f||||f||||||||||2017-02-18 17:17:09.49323|2017-02-18 17:17:09.49323
NCT00183560|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-06-30|||July 2004||2004-07-01|June 2015|2015-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Preventing Depression Relapse With Mindfulness-Based Cognitive Therapy|Prevention of Relapse in Recurrent Depression With MBCT|Completed||Phase 4|184|Actual|Centre for Addiction and Mental Health||3|||f||||f||||||||||2017-02-18 17:17:09.607372|2017-02-18 17:17:09.607372
NCT00183547|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-28|||January 2005||2005-01-01|December 2008|2008-12-01|September 2007||2007-09-01|March 2007|Actual|2007-03-01||Interventional|||Depression Prevention Program for American Indian Adolescents During and After Pregnancy|Depression Prevention in Pregnant American Indian Teens Using CBT|Completed||N/A|45||Johns Hopkins University||2|||f||||||||||||||2017-02-18 17:17:09.737236|2017-02-18 17:17:09.737236
NCT00183521|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-30|||March 2005||2005-03-01|November 2011|2011-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Breathing Regulation Training for Individuals With Panic Disorder|Respiratory Therapeutic Procedures in Panic Disorder|Completed||N/A|136|Actual|Stanford University||3|||f||||f||||||||||2017-02-18 17:17:09.846032|2017-02-18 17:17:09.846032
NCT00183508|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-11||||||December 2015|2015-12-01|May 2009|Actual|2009-05-01|December 2005|Actual|2005-12-01||Interventional|||Behavioral Treatments for Acute Stress Disorder In Firefighters|Developing Group Treatments for Acute Stress Disorder|Completed||N/A|169|Actual|Boston University||2|||f||||||||||||||2017-02-18 17:17:09.950519|2017-02-18 17:17:09.950519
NCT00183495|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-01|||March 2004||2004-03-01|June 2013|2013-06-01|August 2007|Actual|2007-08-01|March 2007|Actual|2007-03-01||Observational|||Understanding Treatment Adherence Among Individuals With Bipolar Disorder|Determinants and Manifestation of Illness Behavior in Promoting Treatment Adherence Among Individuals With Bipolar Depression|Completed||N/A|140|Actual|Case Western Reserve University|||1||f||||f||||||||||2017-02-18 17:17:10.057413|2017-02-18 17:17:10.057413
NCT00183482|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-17|||August 2014||2014-08-01|November 2015|2015-11-01|February 2018|Anticipated|2018-02-01|December 2017|Anticipated|2017-12-01||Interventional|||Family Cognitive Behavioral Therapy for Preventing Depression in Children|Family Cognitive Behavioral Prevention of Depression in Children of Parents With a History of Major Depressive Disorder|Recruiting||Phase 3|750|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-02-18 17:17:10.163862|2017-02-18 17:17:10.163862
NCT00183469|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-15|2013-04-10||December 2004||2004-12-01|April 2015|2015-04-01|April 2009|Actual|2009-04-01|February 2009|Actual|2009-02-01||Interventional|||Maintenance Treatment of Bipolar Depression|Eight-Month Maintenance Treatment of Bipolar Depression With Lamotrigine or Lamotrigine Plus Divalproex Combination|Completed||Phase 4|86|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||t||||||||||2017-02-18 17:17:10.287668|2017-02-18 17:17:10.287668
NCT00183456|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-24|2012-09-14||September 2005||2005-09-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|July 2007|Actual|2007-07-01||Interventional|||A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs|Network HIV Prevention Intervention for Drug Users|Completed||Phase 2|746|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||||||||||||2017-02-18 17:17:10.690153|2017-02-18 17:17:10.690153
NCT00183443|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-08|||February 2005||2005-02-01|October 2013|2013-10-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Treatment of Mania Symptoms With Drug Therapy|Divalproex Extended Release and Placebo, Lithium, or Quetiapine for Mania|Completed||Phase 3|75|Actual|Palo Alto Veterans Institute for Research||3|||f||||t||||||||||2017-02-18 17:17:11.53837|2017-02-18 17:17:11.53837
NCT00183430|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-26|2012-10-22||October 2003||2003-10-01|November 2012|2012-11-01|December 2010|Actual|2010-12-01|May 2009|Actual|2009-05-01||Interventional|||Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder|Prazosin for Noncombat Trauma PTSD|Terminated||N/A|20|Actual|Seattle Institute for Biomedical and Clinical Research||2||Insufficient Enrollment|f||||t||||||||||2017-02-18 17:17:11.654524|2017-02-18 17:17:11.654524
NCT00183417|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-23|||September 2004||2004-09-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Depression Prevention Program for Adolescents|Depression Prevention Program for High-Risk Adolescents|Completed||N/A|350|Actual|University of Texas at Austin||4|||f||||||||||||||2017-02-18 17:17:12.227671|2017-02-18 17:17:12.227671
NCT00183404|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-08-14|||September 2004||2004-09-01|August 2014|2014-08-01|October 2011|Actual|2011-10-01|July 2011|Actual|2011-07-01||Interventional|||Long-Term Olanzapine Treatment in Children With Autism|Long-Term Olanzapine Treatment in Children With Autism|Completed||Phase 2/Phase 3|32|Actual|Drexel University||1|||f||||t||||||||||2017-02-18 17:17:12.333454|2017-02-18 17:17:12.333454
NCT00183391|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-06|||July 2005||2005-07-01|April 2009|2009-04-01|November 2010|Anticipated|2010-11-01|November 2010|Anticipated|2010-11-01||Interventional|||Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children|Measuring and Predicting Response to Atomoxetine and Methylphenidate|Unknown status|Recruiting|Phase 3|160|Anticipated|National Institute of Mental Health (NIMH)||2|||f||||||||||||||2017-02-18 17:17:12.453496|2017-02-18 17:17:12.453496
NCT00183378|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-01-12|||September 2005||2005-09-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|September 2009|Actual|2009-09-01||Interventional|||Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease|Behavioral Treatment of Nocturnal Disturbances in Alzheimer's Disease|Completed||N/A|132|Actual|University of Washington||4|||f||||t||||||||||2017-02-18 17:17:12.578853|2017-02-18 17:17:12.578853
NCT00183365|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-02-06|||October 2005||2005-10-01|February 2014|2014-02-01|November 2009|Actual|2009-11-01|July 2008|Actual|2008-07-01||Interventional|||Effect of Family-Based Prevention on Children of Depressed Parents|Children of Depressed Parents: Family-Based Prevention|Completed||Phase 1|42|Actual|Children's Hospital of Philadelphia||2|||f||||||||||||||2017-02-18 17:17:12.690864|2017-02-18 17:17:12.690864
NCT00183352|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-14|||January 2004||2004-01-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Reproductive Function and Mood in Women With Bipolar Disorder|Reproductive Endocrine Function and Mood Over the Menstrual Cycle of Women Treated for Bipolar Disorder|Completed||N/A|90|Anticipated|Stanford University|||2||f||||f||||||||||2017-02-18 17:17:12.805023|2017-02-18 17:17:12.805023
NCT00183339|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-02-07|2013-09-10||July 2005||2005-07-01|February 2014|2014-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Early Intervention With Fluoxetine in Autism|A Randomized, Placebo-controlled Trial of Fluoxetine in Preschool Children|Completed||Phase 2|18|Actual|University of North Carolina, Chapel Hill|It took twice as long to recruit subjects for a study in children 30-58 months than it generally takes to recruit older children. It is possible to maintain subjects in double-blind trails for extended periods.|2|||f||||t||||||||||2017-02-18 17:17:12.902042|2017-02-18 17:17:12.902042
NCT00183326|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-07-20|||May 2004||2004-05-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|July 2015|Actual|2015-07-01||Interventional|||Treating Post Traumatic Stress Disorder in Children Exposed to Domestic Violence|Treating PTSD in Children Exposed to Domestic Violence|Completed||N/A|124|Actual|Allegheny Singer Research Institute||2|||f||||t||||||||||2017-02-18 17:17:13.7044|2017-02-18 17:17:13.7044
NCT00183313|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-18|||July 2004||2004-07-01|November 2013|2013-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Improving Primary Care in Patients With Mental Disorders|Improving Primary Care in Patients With Mental Disorders|Completed||Phase 3|407|Actual|Emory University||2|||f||||t||||||||||2017-02-18 17:17:13.823805|2017-02-18 17:17:13.823805
NCT00183300|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-02|||September 2001||2001-09-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Relationship Between the Biological and Psychological Correlates of PTSD|Effectiveness of Prolonged Exposure Therapy on Reducing Neuroendocrine-Related Symptoms of Post-Traumatic Stress Disorder in Women|Completed||Phase 2|120||University of Pennsylvania|||||f||||||||||||||2017-02-18 17:17:13.931703|2017-02-18 17:17:13.931703
NCT00183287|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-25||||||April 2012|2012-04-01|March 2003|Actual|2003-03-01|||||Observational|||Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials|Clinical, Virologic, and Immunologic Evaluation and Monitoring of Patients With Known or Suspected HIV Infection|Completed||N/A|150||National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood collection~   "|||2017-02-18 17:17:14.031346|2017-02-18 17:17:14.031346
NCT00183274|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-29|2012-12-14||January 2004||2004-01-01|November 2016|2016-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||334 participants were consented, but 64 withdrew consent and 2 deviated from protocol, resulting in 268 participants who entered the initial Phase 1.|Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR|Short-term Versus Long-term Treatment in Generalized Anxiety Disorder|Completed||Phase 4|268|Actual|University of Pennsylvania|Increased attrition occurring as a function of trial length|6|||f||||t||||||||No||2017-02-18 17:17:14.108445|2017-02-18 17:17:14.108445
NCT00183261|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-07|||March 2006||2006-03-01|June 2013|2013-06-01|October 2010|Actual|2010-10-01|August 2007|Actual|2007-08-01||Interventional|||Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection|A Randomized Phase II Study of Therapeutic Immunization and Treatment Interruption Among Subjects Who Began Potent Antiretroviral Therapy Within 30 Days of Diagnosis of Acute or Recent HIV Infection|Completed||Phase 2|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:17:14.534384|2017-02-18 17:17:14.534384
NCT00183248|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2012-09-17|2012-04-05||September 2004||2004-09-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients|Pilot Study Using Donor Stem Cells and Campath-1H to Induce Renal Transplant Tolerance (ITN022ST)|Completed||Phase 1/Phase 2|9|Actual|University of Miami|In July 2007 after the trial had been enrolling for approximately 42 months, enrollment was stopped at the current number of nine subjects due to time and resource constraints.|2|||f||||t||||||||||2017-02-18 17:17:14.680781|2017-02-18 17:17:14.680781
NCT00183235|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-04|||June 2005||2005-06-01|May 2010|2010-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Aripiprazole Effects on Alcohol Reactivity and Consumption|Effectiveness of Aripiprazole to Reduce Craving for Alcohol and Drinking Under Natural Observation, During Cue Induced Brain Imaging, and During a Motivated Free Choice Drinking Procedure Compared to Placebo|Completed||Phase 2|30||Medical University of South Carolina|||||f||||||||||||||2017-02-18 17:17:15.300843|2017-02-18 17:17:15.300843
NCT00183222|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-04|||May 2005||2005-05-01|May 2010|2010-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking|Alcohol Research Center Grant. Component #1. COMBINING MEDICATIONS: ALCOHOL REACTIVITY AND CONSUMPTION|Completed||Phase 2|160||Medical University of South Carolina|||||f||||||||||||||2017-02-18 17:17:15.39486|2017-02-18 17:17:15.39486
NCT00183209|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-29|||December 2001||2001-12-01|October 2006|2006-10-01|January 2008|Actual|2008-01-01|July 2006|Actual|2006-07-01||Interventional|||Interventions for HIV+ Mothers With Problem Drinking|Interventions for HIV+ Mothers With Problem Drinking|Completed||Phase 2|118|Actual|New York University||2|||f||||f||||||||||2017-02-18 17:17:15.487754|2017-02-18 17:17:15.487754
NCT00183196|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-17|2012-11-20||January 2003||2003-01-01|March 2016|2016-03-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone|Gabapentin as an Adjunct to Naltrexone for Alcoholism|Completed||Phase 3|150|Actual|Medical University of South Carolina||3|||f||||f||||||||||2017-02-18 17:17:15.595132|2017-02-18 17:17:15.595132
NCT00183183|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-05-21|||April 2004||2004-04-01|May 2010|2010-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Impact of a Brief Motivational Interview on Drinking Behaviors of At Risk Drinkers Screened in the Emergency Room|Alcohol Screening and Brief Intervention in the Emergency Department|Completed||Phase 3|1137|Actual|UConn Health||2|||f||||||||||||||2017-02-18 17:17:16.153676|2017-02-18 17:17:16.153676
NCT00183170|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-14|||February 2004||2004-02-01|June 2007|2007-06-01|January 2009|Anticipated|2009-01-01|||||Interventional|||Residual Effects of Intoxication on Student Performance|Residual Effects of Intoxication on Student Performance|Unknown status|Recruiting|Phase 2|200|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 17:17:16.254385|2017-02-18 17:17:16.254385
NCT00183157|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-02-12|||October 2004||2004-10-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Project RAP: Reaching Adolescents for Prevention|RAP: Reaching Adolescents for Prevention - A Randomized Trial of a Brief Negotiated Interview and Active Referral to Reduce Alcohol Related Morbidity Among Youth and Young Adults in the Pediatric Emergency Department|Unknown status|Recruiting|Phase 2|1400|Anticipated|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||3|||f||||||||||||||2017-02-18 17:17:16.354933|2017-02-18 17:17:16.354933
NCT00183144|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-18|||November 2001||2001-11-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||A Therapeutic Workplace for Alcohol Dependence|A Therapeutic Workplace for Alcohol Dependence|Completed||Phase 2|156||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:16.466307|2017-02-18 17:17:16.466307
NCT00183131|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-05-05|||October 2004||2004-10-01|December 2007|2007-12-01|November 2004|Actual|2004-11-01|||||Interventional|||The iHealth Study in College Students|Internet Screening and Brief Intervention for Hazardous Drinking in College Students: A Pilot Study|Completed||Phase 2|4300||Boston Medical Center|||||f||||||||||||||2017-02-18 17:17:16.56041|2017-02-18 17:17:16.56041
NCT00183118|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-06-01|||October 2004||2004-10-01|November 2007|2007-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)|HIV Prevention Partnership in Russian Alcohol Treatment|Completed||Phase 1/Phase 2|180||Boston Medical Center|||||f||||||||||||||2017-02-18 17:17:16.671036|2017-02-18 17:17:16.671036
NCT00183105|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-05-05|||February 2001||2001-02-01|December 2007|2007-12-01|April 2006|Actual|2006-04-01|||||Interventional|||ASAP Study - Hospital-Based Brief Intervention for Alcohol Problems|Hospital-based Brief Intervention for Alcohol Problems|Completed||Phase 3|350||Boston Medical Center|||||f||||||||||||||2017-02-18 17:17:16.770163|2017-02-18 17:17:16.770163
NCT00183092|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-05-28|2014-01-21||April 2005||2005-04-01|May 2014|2014-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||CJD (Creutzfeldt-Jakob Disease) Quinacrine Study|Novel Therapeutics For Prion Diseases: A Randomized, Double-blinded, Placebo-controlled Study of the Efficacy of Quinacrine in the Treatment of Sporadic Creutzfeldt-Jakob Disease|Completed||Phase 2|69|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 17:17:16.875848|2017-02-18 17:17:16.875848
NCT00183079|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-11-05|||March 2004||2004-03-01|October 2008|2008-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Reducing Alcohol Use in Depressed Patients|Brief Alcohol Intervention With Depressed Patients|Completed||Phase 2|200|Actual|Rhode Island Hospital||1|||f||||||||||||||2017-02-18 17:17:17.457226|2017-02-18 17:17:17.457226
NCT00183066|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-03|||July 2002||2002-07-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Collection of Bone Marrow Aspirate From Volunteer Donors|Collection of Bone Marrow Aspirate From Volunteer Donors for In Vitro Hematopoietic Research|Completed||N/A|63|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||||||||Samples With DNA|"~     Bone marrow aspirates Whole blood~   "|||2017-02-18 17:17:17.56837|2017-02-18 17:17:17.56837
NCT00183040|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-05-28|||September 2002||2002-09-01|May 2009|2009-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||HORMA: Hormonal Regulators of Muscle and Metabolism in Aging|Hormonal Regulators of Muscle and Metabolism in Aging|Completed||Phase 2|108|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:17.736775|2017-02-18 17:17:17.736775
NCT00183027|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-08|||November 2002||2002-11-01|November 2006|2006-11-01|December 2004||2004-12-01|||||Interventional|||Dietary Energy Restriction and Metabolic Aging in Humans|Dietary Energy Restriction and Metabolic Aging in Humans|Completed||N/A|44||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:17.833422|2017-02-18 17:17:17.833422
NCT00183014|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-16|||September 2005||2005-09-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Caminemos! Trial to Increase Walking Among Sedentary Older Latinos|Trial to Increase Walking Among Sedentary Older Latinos|Completed||N/A|600|Anticipated|National Institute on Aging (NIA)||2|||f||||||||||||||2017-02-18 17:17:17.919543|2017-02-18 17:17:17.919543
NCT00183001|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-02-13|||October 2001||2001-10-01|February 2009|2009-02-01|October 2006||2006-10-01|||||Interventional|||Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification|Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification|Completed||Phase 3|452||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:18.023721|2017-02-18 17:17:18.023721
NCT00182988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-11-24|||October 2004||2004-10-01|November 2009|2009-11-01|December 2007|Actual|2007-12-01|||||Observational|||Alzheimer's Caregiver Communication Study|Alzheimer's Caregiver Ratings of Communication & Coping Behavior|Completed||N/A|140|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:20.976447|2017-02-18 17:17:20.976447
NCT00182975|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-08-21|||September 2002||2002-09-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effects of Dehydroepiandrosterone (DHEA) in Humans|Is DHEA Replacement Beneficial?|Completed||Phase 3|142|Actual|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:21.054534|2017-02-18 17:17:21.054534
NCT00182962|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-16|||March 2002||2002-03-01|November 2006|2006-11-01|October 2006||2006-10-01|||||Interventional|||GRACE: Geriatric Resources for Assessment and Care of Elders|Geriatric Resources for Assessment and Care of Elders|Completed||N/A|1270||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:21.15124|2017-02-18 17:17:21.15124
NCT00182949|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-24|||November 19, 2003||2003-11-19|January 2, 2015|2015-01-02|January 2, 2015||2015-01-02|||||Observational|||Genetics and Epidemiology of Aging Associated Conditions in the Sardinian Population|Genetics and Epidemiology of Aging Associated Conditions in the Sardinian Population (SARDINIA)|Completed||N/A|15000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:17:21.249877|2017-02-18 17:17:21.249877
NCT00182936|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-16|||May 2000||2000-05-01|November 2006|2006-11-01|June 2004||2004-06-01|||||Interventional|||A Trial to Reduce Delirium in Aged Post Acute Patients|A Trial to Reduce Delirium in Aged Post Acute Patients|Completed||Phase 3|500||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:21.338475|2017-02-18 17:17:21.338475
NCT00182923|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-08-28|||May 2003||2003-05-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Forearm Vascular Relaxation|Determinants of Forearm Vascular Relaxation: Role of Genetic Polymorphisms|Completed||N/A|400||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:21.441386|2017-02-18 17:17:21.441386
NCT00182897|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-09|||October 2000||2000-10-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||PACT: Providers and Alzheimer's Caregivers Together|Providers and Alzheimer's Caregivers Together|Completed||N/A|120||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:21.52821|2017-02-18 17:17:21.52821
NCT00182884|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-02-28|||July 2004||2004-07-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Donepezil in Preventing Delirium in Hospitalized Elderly|Preventing Delirium in Hospitalized Elderly|Completed||Phase 4|30||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:21.621946|2017-02-18 17:17:21.621946
NCT00182871|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-10-29|||November 2001||2001-11-01|October 2009|2009-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Testosterone Effects on Bone and Frailty|Testosterone Effects on Bone and Frailty in Men With Osteoporosis|Completed||Phase 4|140||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:21.719098|2017-02-18 17:17:21.719098
NCT00182858|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-24|||February 10, 2003||2003-02-10|March 14, 2016|2016-03-14|December 31, 2018||2018-12-31|December 31, 2018|Anticipated|2018-12-31||Observational|||Gerontology Research Center Tissue Procurement for Biomedical Research|Tissue Procurement for Biomedical Research|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:17:21.824889|2017-02-18 17:17:21.824889
NCT00182845|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-02-28|||February 2005||2005-02-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Donepezil in the Prevention of Post-Operative Cognitive Decline|Preventing Post-Operative Cognitive Decline|Completed||Phase 4|30||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:17:21.979194|2017-02-18 17:17:21.979194
NCT00182832|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-04-11|||June 2006||2006-06-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||e-CHAMP: Enhancing Care for Hospitalized Older Adults With Memory Problems|Enhancing Care for Hospitalized Older Adults With Cognitive Impairment|Completed||N/A|424|Actual|Indiana University||2|||f||||f||||||||||2017-02-18 17:17:22.275492|2017-02-18 17:17:22.275492
NCT00182819|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-10-11|||July 2005||2005-07-01|October 2016|2016-10-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional|||Radiation Therapy or Temozolomide in Treating Patients With Gliomas|Primary Chemotherapy With Temozolomide Versus Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study|Completed||Phase 3|709|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 17:17:22.39929|2017-02-18 17:17:22.39929
NCT00182806|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-03-05|||September 2004||2004-09-01|March 2012|2012-03-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|||Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Irinotecan Followed by Gemcitabine in NSCLC Following Failure of Platinum Based Therapy|Completed||Phase 2|38|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:17:22.625026|2017-02-18 17:17:22.625026
NCT00182546|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-04-27|||August 1998||1998-08-01|August 2005|2005-08-01|January 2001||2001-01-01|||||Interventional|||Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)|Canadian Pulmonary Embolism Diagnosis Study|Terminated||Phase 3|1126||McMaster University|||||f||||||||||||||2017-02-18 17:17:27.243776|2017-02-18 17:17:27.243776
NCT00182793|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-10-09|||July 2005||2005-07-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Interventional|||Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer|Phase II Study of Tandem Cycle Dose-Intense Chemotherapy of Melphalan and Carboplatin, Thiotepa and Cyclophosphamide (STMP V) ± Trastuzumab Followed by Helical Tomotherapy or Local Regional Radiation Therapy for Stage IV Metastatic and Stage IIIB/C Breast Cancer|Completed||Phase 2|32|Actual|City of Hope Medical Center||2|||f||||t||||||||||2017-02-18 17:17:22.733716|2017-02-18 17:17:22.733716
NCT00182780|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-07-12|||October 2005||2005-10-01|July 2016|2016-07-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||American Ginseng in Treating Patients With Cancer-Related Fatigue|The Use of American Ginseng (Panax Quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind, Dose-Finding, Placebo-Controlled Study|Completed||N/A|290|Actual|Alliance for Clinical Trials in Oncology||4|||f||||f||||||||||2017-02-18 17:17:22.862105|2017-02-18 17:17:22.862105
NCT00182767|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-02-11|2015-06-17||January 2006||2006-01-01|February 2014|2014-02-01|May 2014|Actual|2014-05-01|April 2012|Actual|2012-04-01||Interventional|||Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer|A Phase I/II Study of BMS-247550 and Pegylated Liposomal Doxorubicin (Doxil®) in Patients With Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Who Have Been Previously Treated With a Platinum and a Taxane|Completed||Phase 1/Phase 2|45|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:17:22.975825|2017-02-18 17:17:22.975825
NCT00182754|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-08-12|||October 2005||2005-10-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|September 2009|Actual|2009-09-01||Interventional|||Octreotide in Treating Patients With Cancer-Related Malignant Ascites|An Exploratory, Randomized, Placebo-Controlled Trial of Depot Octreotide (Sandostatin LARDepot) for Symptomatic Ascites in Cancer Patients|Completed||Phase 3|33|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:17:24.001569|2017-02-18 17:17:24.001569
NCT00182741|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2012-05-24|||September 2004||2004-09-01|October 2009|2009-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer|Phase II Study of DN-101 (High Dose Pulse Calcitriol), Mitoxantrone, Prednisone in Androgen-Independent Prostate Cancer (AIPC)|Completed||Phase 2|19|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 17:17:24.251489|2017-02-18 17:17:24.251489
NCT00182728|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-01-20|||February 2003||2003-02-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|September 2011|Actual|2011-09-01||Interventional|NRR||Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer|Partial Breast Treatment Using Single Dose Intraoperative Radiotherapy for Patients With Early Stage Breast Cancer - A Feasibility Study With Molecular Analysis of Tumors and Normal Breast Epithelial Tissue|Active, not recruiting||Phase 2|89|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 17:17:24.365762|2017-02-18 17:17:24.365762
NCT00182715|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-09-16|||March 2005||2005-03-01|December 2007|2007-12-01||||May 2009|Anticipated|2009-05-01||Interventional|||Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer|A Three-Arm Randomised Controlled Trial Comparing Either Continuous Chemotherapy Plus Cetuximab or Intermittent Chemotherapy With Standard Continuous Palliative Combination Chemotherapy With Oxaliplatin and a Fluoropyrimidine in First Line Treatment of Metastatic Colorectal Cancer (COIN)|Unknown status|Active, not recruiting|Phase 3|2421|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:17:24.486429|2017-02-18 17:17:24.486429
NCT00182702|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-03-22|||July 2005||2005-07-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer|A Phase II Trial of BMS 247550 (Ixabepilone) in Advanced Renal Cell Carcinoma|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:17:24.696042|2017-02-18 17:17:24.696042
NCT00182689|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-05-06|2012-08-20||July 2005||2005-07-01|December 2012|2012-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer|A Phase II Trial of BAY 43-9006 (NSC-724772) in Patients With Platinum-Treated Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|89|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:17:24.81648|2017-02-18 17:17:24.81648
NCT00182663|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-10-24|||June 2003||2003-06-01|October 2016|2016-10-01||||April 2007|Actual|2007-04-01||Interventional|||Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant|Maintenance Therapy With Thalidomide, Dexamethasone and Clarithromycin (Biaxin) Following Autologous/Syngeneic Transplant for Multiple Myeloma|Active, not recruiting||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 17:17:25.870054|2017-02-18 17:17:25.870054
NCT00182650|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-12-23|||June 2004||2004-06-01|December 2009|2009-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma|Pilot/Feasibility Study To Evaluate The Safety Of Cellular Immunotherapy For CD19+ Follicular Lymphoma Using Autologous Cytolytic T Cells Genetically-Modified To Be CD19-Specific And Co-Express HyTK|Completed||Phase 1|5|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-02-18 17:17:25.987971|2017-02-18 17:17:25.987971
NCT00182637|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-01-19|2016-01-19||July 2004||2004-07-01|January 2016|2016-01-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma|A Phase II Study of Bortezomib (VELCADE®) in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL)|Completed||Phase 2|5|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:17:26.078472|2017-02-18 17:17:26.078472
NCT00182624|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2017-01-24|||February 2, 2004||2004-02-02|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Observational|||Magnetic Resonance Imaging to Evaluate Prostate Cancer|Comprehensive Prostate MRI for the Evaluation of Prostate Cancer at 3.0T: A Pilot Study|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:17:26.629061|2017-02-18 17:17:26.629061
NCT00182611|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-06-25|||April 2004||2004-04-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer|Phase III Clinical Study of Preoperative S-1/CDDP Combination Chemotherapy in Patients With Potentially Resectable Stage III Advanced Gastric Cancer|Completed||Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:17:26.716584|2017-02-18 17:17:26.716584
NCT00182533|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-12-12|||July 2002||2002-07-01|December 2016|2016-12-01|March 2017|Anticipated|2017-03-01|January 2017|Anticipated|2017-01-01||Interventional|||Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders|Sertraline in the Treatment of Generalized Social Phobia With Comorbidity|Enrolling by invitation||Phase 4|170|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 17:17:27.352213|2017-02-18 17:17:27.352213
NCT00182520|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-12-12|||January 2002||2002-01-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)|A Study of Topiramate Augmentation in Serotonin Reuptake Inhibitor (SRI) -Refractory Obsessive Compulsive Disorder|Recruiting||Phase 4|48|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 17:17:27.468745|2017-02-18 17:17:27.468745
NCT00182507|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-09-08|||June 2000||2000-06-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Olanzapine in the Treatment of Hair Pulling (Trichotillomania)|A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania|Completed||Phase 4|34||McMaster University|||||f||||||||||||||2017-02-18 17:17:27.602036|2017-02-18 17:17:27.602036
NCT00182494|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||February 2005||2005-02-01|July 2005|2005-07-01|January 2009||2009-01-01|||||Interventional|||Diabetes Prevention Program in Schizophrenia [DPPS]|A Five Year, Prospective, Randomized, Blinded, Controlled Trial Comparing the Efficacy of a Modified Diabetes Prevention Protocol and the Standard Comprehensive Outpatient Care in Lowering the Incidence of New Onset Diabetes Among People Treated for Schizophrenia and Are at Risk to Develop Type II Diabetes Mellitus.|Unknown status|Recruiting|Phase 4|200||McMaster University|||||f||||||||||||||2017-02-18 17:17:27.686965|2017-02-18 17:17:27.686965
NCT00182481|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-15|||September 1999||1999-09-01|October 2003|2003-10-01|September 2001||2001-09-01|||||Interventional|||LOMA: Long-Term Management of Asthma|Long Term Management of Asthma (LOMA) Study- How Useful is the Sputum Count Compared With the Usual Clincal Variables?|Completed||N/A|112||McMaster University|||||f||||||||||||||2017-02-18 17:17:27.778542|2017-02-18 17:17:27.778542
NCT00182468|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-09-08|||April 2005||2005-04-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Does Routine Screening for Intimate Partner Violence Against Women in Health Care Settings do More Good Than Harm?|If, When and How to Ask the Question(s): Assessing Screening Approaches to Identifying Woman Abuse in Health Care Settings|Completed||N/A|5681|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 17:17:27.894869|2017-02-18 17:17:27.894869
NCT00182455|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-12-12|||March 2004||2004-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)|Topiramate Augmentation to a Selective Serotonin Re-uptake Inhibitor (SSRI) in Treatment-Resistant Generalized Social Phobia: A Double-Blind Placebo -Controlled Trial.|Recruiting||Phase 4|48|Anticipated|McMaster University||2|||f||||f||||||||||2017-02-18 17:17:28.030874|2017-02-18 17:17:28.030874
NCT00182442|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2006-10-10|||October 2003||2003-10-01|March 2005|2005-03-01|March 2006||2006-03-01|||||Interventional|||Cognition, Functioning and Quality of Life|A One-Year Multi-Centre Randomized, Double Blind, Controlled Effectiveness Study of Quetiapine and Olanzapine, Comparing Their Relative Potential in Improving Neuro-Cognitive Deficits, Functional Outcomes and Quality of Life in Schizophrenia|Completed||Phase 4|80||McMaster University|||||f||||||||||||||2017-02-18 17:17:28.152094|2017-02-18 17:17:28.152094
NCT00182429|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-04-12|||February 2004||2004-02-01|April 2016|2016-04-01|April 2005||2005-04-01|||||Interventional|||Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment|Prospective, Randomized Study of Oral Metronidazole vs. Oral Metronidazole and Rifampin for Treatment of Clostridium Difficile-associated Diarrhea (CDAD)|Completed||Phase 3|100||McMaster University|||||f||||||||||||||2017-02-18 17:17:28.249048|2017-02-18 17:17:28.249048
NCT00182416|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-10-18|||May 2004||2004-05-01|October 2007|2007-10-01|January 2006|Actual|2006-01-01|||||Interventional|||Second Canadian Trial of Physiologic Pacing (CTOPP II): Pilot Trial|Second Canadian Trial of Physiologic Pacing (CTOPP II): Pilot Trial|Completed||Phase 3|300||McMaster University|||||f||||||||||||||2017-02-18 17:17:28.355405|2017-02-18 17:17:28.355405
NCT00182403|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-29|||September 1998||1998-09-01|September 2005|2005-09-01|May 2004||2004-05-01|||||Interventional|||Fixed Dose Heparin Study|Fixed Dose Unfractionated Heparin for Initial Treatment of Venous Thromboembolism|Completed||Phase 3|866||McMaster University|||||f||||||||||||||2017-02-18 17:17:28.43961|2017-02-18 17:17:28.43961
NCT00182390|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-22|||February 2001||2001-02-01|September 2015|2015-09-01|November 2005|Actual|2005-11-01|February 2003|Actual|2003-02-01||Interventional|||Premature Infants in Need of Transfusion (PINT)|A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns <1000g Birth Weight|Completed||Phase 3|424||McMaster University|||||f||||||||||||||2017-02-18 17:17:28.546462|2017-02-18 17:17:28.546462
NCT00182377|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-19||||||September 2004|2004-09-01||||||||Interventional|||Pentastarch Use in Cardiac Surgery|A Randomized, Prospective, Blinded Clinical Trial to Evaluate the Efficacy and Safety of Pentastarch Use in Patients Undergoing Coronary Artery Bypass Surgery or Valve Replacement Surgery Using Cardiopulmonary Bypass Circuits|Unknown status|Recruiting|N/A|||McMaster University|||||f||||||||||||||2017-02-18 17:17:28.658934|2017-02-18 17:17:28.658934
NCT00182364|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2006-11-16|||February 2003||2003-02-01|November 2006|2006-11-01|February 2004||2004-02-01|||||Interventional|||PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)|PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)|Completed||Phase 3|120||McMaster University|||||f||||||||||||||2017-02-18 17:17:28.756343|2017-02-18 17:17:28.756343
NCT00182351|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-07|||April 1996||1996-04-01|September 2006|2006-09-01|July 1999||1999-07-01|||||Interventional|||D-Dimer Vs Serial Compression Ultrasound Study|Evaluation of the Safety, Efficacy and Cost-Effectiveness of Two Strategies for the Diagnosis of Deep Vein Thrombosis|Completed||Phase 3|810||McMaster University|||||f||||||||||||||2017-02-18 17:17:28.871075|2017-02-18 17:17:28.871075
NCT00182338|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-19|||January 2005||2005-01-01|July 2011|2011-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Evaluation of Volume Status in Peritoneal Dialysis Patients|Evaluation of Volume Status in Peritoneal Dialysis Patients|Completed||N/A|22|Actual|McMaster University|||1||f||||f||||||||||2017-02-18 17:17:28.962445|2017-02-18 17:17:28.962445
NCT00182325|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-18|||February 2004||2004-02-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Effects of a Personalized Web-Based Antenatal Care Planner|Women's Web Access to Their Own Antenatal Health Record and Personalized Health Information: Effect on Pregnancy Health Outcomes and Patient Satisfaction|Completed||Phase 3|210||McMaster University|||||f||||f||||||||||2017-02-18 17:17:29.05957|2017-02-18 17:17:29.05957
NCT00182312|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-26|||October 1999||1999-10-01|September 2016|2016-09-01|July 2016|Actual|2016-07-01|March 2007|Actual|2007-03-01||Interventional|||Caffeine for Apnea of Prematurity (CAP)|Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants|Completed||Phase 3|2000|Anticipated|McMaster University||1|||f||||t||||||||||2017-02-18 17:17:29.15144|2017-02-18 17:17:29.15144
NCT00182299|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-19|||September 2003||2003-09-01|April 2007|2007-04-01|April 2008|Anticipated|2008-04-01|||||Interventional|||An RCT to Compare the Outcomes of Patients With Large Rotator Cuff Repair That Undergo Repair With or Without SIS|A Randomized Clinical Trial Comparing the Effectiveness of Rotator Cuff Repair With or Without Augmentation With Porcine Small Intestine Submucosa (SIS) for Large Rotator Cuff Tears: Pilot Study Phase|Unknown status|Active, not recruiting|Phase 4|60||McMaster University|||||f||||t||||||||||2017-02-18 17:17:29.314764|2017-02-18 17:17:29.314764
NCT00182286|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 1999||1999-09-01|August 2005|2005-08-01|July 2001||2001-07-01|||||Observational|||Evaluation of Continuity of Care at a Health Service Organization|The Evaluation of the Continuity of Care at the Group Health Centre, A Unique Multi-Specialty, Multi-Disciplinary Health Service Organization|Completed||N/A|342||McMaster University|||||f||||||||||||||2017-02-18 17:17:29.652383|2017-02-18 17:17:29.652383
NCT00182273|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2002||2002-01-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Canalith Repositioning Procedure for BPPV in Primary Care|Treatment of Benign Paroxysmal Positional Vertigo With the Canalith Repositioning Procedure in Family Practice: A Randomized Controlled Trial|Completed||Phase 3|56||McMaster University|||||f||||||||||||||2017-02-18 17:17:29.765197|2017-02-18 17:17:29.765197
NCT00182260|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-14|||January 2000||2000-01-01|November 2012|2012-11-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD|ELVIS (Esophagitis-Laparoscopy Versus Inhibitors of Secretion) A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication (LNF) Versus Omeprazole for Treatment of Patients With Chronic Gastro-Esophageal Reflux Disease (GERD)|Completed||N/A|216|Actual|McMaster University||2|||f||||||||||||||2017-02-18 17:17:29.860078|2017-02-18 17:17:29.860078
NCT00182247|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||December 1998||1998-12-01|September 2005|2005-09-01|January 2001||2001-01-01|||||Interventional|||D-Dimer and IPG for Recurrent Thrombosis (DIRECT)|D-Dimer and IPG for Recurrent Thrombosis (DIRECT) Study|Terminated||Phase 3|600||McMaster University|||||f||||||||||||||2017-02-18 17:17:29.975998|2017-02-18 17:17:29.975998
NCT00182234|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-17|||December 2005||2005-12-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||SONICS - Effectiveness of Specialist Oncology Nursing|A Study of the Effectiveness of Specialist Oncology Nursing Case Management in Improving Continuity of Supportive Cancer Care in the Community (SONICS)|Completed||Phase 3|183|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 17:17:30.075965|2017-02-18 17:17:30.075965
NCT00182221|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-18|||August 2003||2003-08-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Safety of a Diagnostic Strategy With D-Dimer Testing for PE|A Cohort Study Evaluating the Safety of a Diagnostic Strategy Involving D-Dimer Testing in Patients With Suspected Pulmonary Embolism|Completed||Phase 3|1000|Anticipated|McMaster University|||||f||||t||||||||||2017-02-18 17:17:30.169047|2017-02-18 17:17:30.169047
NCT00182208|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-07-21|||May 2004||2004-05-01|July 2008|2008-07-01|December 2005|Actual|2005-12-01|June 2005|Actual|2005-06-01||Interventional|||Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial|Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled Trial|Completed||Phase 3|32||McMaster University|||||f||||t||||||||||2017-02-18 17:17:30.270113|2017-02-18 17:17:30.270113
NCT00182195|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-19|||August 2000||2000-08-01|April 2007|2007-04-01|March 2006|Actual|2006-03-01|||||Interventional|LOVS||Lung Open Ventilation to Decrease Mortality in the Acute Respiratory Distress Syndrome|A Randomized Trial of a Lung-Open Ventilation Strategy in Acute Lung Injury|Completed||Phase 3|980||McMaster University|||||f||||t||||||||||2017-02-18 17:17:30.372051|2017-02-18 17:17:30.372051
NCT00182182|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-08|||July 2003||2003-07-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Interventional|||Evaluation of a Primary Care Based Heart Failure Management Program|Congestive Heart Failure Assessment and Management in Primary Care: CHAMP|Unknown status|Active, not recruiting|Phase 2/Phase 3|170||McMaster University|||||f||||||||||||||2017-02-18 17:17:30.477037|2017-02-18 17:17:30.477037
NCT00182169|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||July 1997||1997-07-01|March 2003|2003-03-01|June 2005||2005-06-01|||||Interventional|||Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure|Randomized, Placebo Control, Clinical Trial Evaluating the Effect of Human Recombinant Growth Hormone in Patients With Severe Congestive Heart Failure. The Growth Hormone In Heart Failure Trial (GIFT)|Completed||Phase 2|80||McMaster University|||||f||||||||||||||2017-02-18 17:17:30.588456|2017-02-18 17:17:30.588456
NCT00182156|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-06-16|||October 2004||2004-10-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Observational|||Cohort Study Comparing Short Daily Hemodialysis (HD) With Conventional HD|Cohort Study Examining the Effects of Short Daily Hemodialysis As Compared to Conventional Hemodialysis in Outpatients Treated at St Joseph's Healthcare, Hamilton|Unknown status|Active, not recruiting|N/A|40|Anticipated|McMaster University|||3||f||||f||||||||||2017-02-18 17:17:30.679449|2017-02-18 17:17:30.679449
NCT00182143|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-01-07|||May 2006||2006-05-01|October 2007|2007-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)|PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)|Completed||Phase 3|3659|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 17:17:30.776646|2017-02-18 17:17:30.776646
NCT00182130|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-09-10|||May 2002||2002-05-01|July 2005|2005-07-01|June 2007||2007-06-01|||||Interventional|||Quality Initiative in Rectal Cancer (QIRC) Trial|Quality Initiative in Rectal Cancer (QIRC) Trial|Unknown status|Active, not recruiting|N/A|691||McMaster University|||||f||||||||||||||2017-02-18 17:17:30.963377|2017-02-18 17:17:30.963377
NCT00182117|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-01-23|||October 2003||2003-10-01|September 2005|2005-09-01|April 2006||2006-04-01|||||Observational|||Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population|Pilot Bleeding Study|Unknown status|Recruiting|N/A|490||McMaster University|||||f||||||||||||||2017-02-18 17:17:31.04998|2017-02-18 17:17:31.04998
NCT00182104|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-19|||August 1998||1998-08-01|April 2007|2007-04-01|July 2005|Actual|2005-07-01|||||Interventional|||International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures|An International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures|Completed||Phase 4|111||McMaster University|||||f||||||||||||||2017-02-18 17:17:31.128909|2017-02-18 17:17:31.128909
NCT00182091|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-04-26|2012-02-07||August 2004||2004-08-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency|Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly|Completed||N/A|75|Actual|Massachusetts General Hospital||4|||f||||t||||||||||2017-02-18 17:17:31.236671|2017-02-18 17:17:31.236671
NCT00182078|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2014-07-08|2012-06-12||November 2002||2002-11-01|July 2014|2014-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional||Analysis was conducted with participants using available data. The different number participants who completed measures at the final time point is as follows: DICA-Parent (6 placebo, 15 sertraline); DICA-Child (6 placebo, 16 sertraline); and CDI (4 placebo, 16 sertraline).|A Study of Sertraline to Prevent PTSD|A Study of Sertraline to Prevent PTSD|Completed||Phase 4|26|Actual|Massachusetts General Hospital|One limitation of this study was the small sample size, due to the challenge of recruiting traumatized children and their parents for participation in a randomized controlled trial of a medication.|2|||f||||t||||||||||2017-02-18 17:17:31.715749|2017-02-18 17:17:31.715749
NCT00182065|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-07|||March 2004||2004-03-01|August 2005|2005-08-01|October 2006||2006-10-01|||||Observational|||Heart Failure, Functional and Cognitive Decline, and Psychiatric Symptoms in Nursing Home Patients|The Effect of Congestive Heart Failure on Functional and Cognitive Decline and Neuropsychiatric Symptoms in Residents of Long-Term Care Facilities|Unknown status|Active, not recruiting|N/A|586||McMaster University|||||f||||||||||||||2017-02-18 17:17:32.201176|2017-02-18 17:17:32.201176
NCT00182052|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-05-22|||September 2000||2000-09-01|May 2013|2013-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer|Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer: A Randomized Double-Blind, Placebo Controlled Phase III Study|Completed||Phase 3|100|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:17:32.289763|2017-02-18 17:17:32.289763
NCT00182039|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-04-10|||October 2002||2002-10-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|POISE||POISE Trial: Perioperative Ischemic Evaluation Study|Perioperative Ischemic Evaluation Study (POISE) Trial|Terminated||Phase 3|8351|Actual|McMaster University||2||Please see detailed description for reason why study was terminated.|f||||t||||||||||2017-02-18 17:17:32.409822|2017-02-18 17:17:32.409822
NCT00182026|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-10-07|||June 2005||2005-06-01|February 2009|2009-02-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Diabetes IN-CHARGE: Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation|A Randomized Trial of Diabetes Intervention in the Community to Help Achieve Reduced Glucose Elevation: Diabetes IN-CHARGE|Unknown status|Active, not recruiting|N/A|500|Anticipated|McMaster University||1|||f||||f||||||||||2017-02-18 17:17:32.532623|2017-02-18 17:17:32.532623
NCT00182013|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2013-06-12|||June 2001||2001-06-01|June 2013|2013-06-01||||February 2004|Actual|2004-02-01||Interventional|||Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder||Completed||Phase 4|106|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-02-18 17:17:32.625627|2017-02-18 17:17:32.625627
NCT00182000|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-10|2012-05-01||November 2003||2003-11-01|July 2012|2012-07-01||||January 2008|Actual|2008-01-01||Interventional|||Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy|A Randomized, Double-Blind, Placebo-Controlled Medication Trial With D-Cycloserine for Individuals With OCD Currently Receiving Behavior Therapy|Completed||Phase 3|33|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 17:17:32.701999|2017-02-18 17:17:32.701999
NCT00181987|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-21|||August 2002||2002-08-01|October 2013|2013-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder|Open-Label Study of Concerta in the Treatment of ADHD in Youth and Adults With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Completed||Phase 4|29|Actual|Massachusetts General Hospital||1|||f||||||||||||||2017-02-18 17:17:33.078769|2017-02-18 17:17:33.078769
NCT00181974|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-10-22|||March 2000||2000-03-01|October 2012|2012-10-01|November 2007|Actual|2007-11-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy of a Fibrin Sealant in Burn Surgery|Efficacy of a Fibrin Sealant in Burn Surgery|Completed||N/A|25|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:33.178214|2017-02-18 17:17:33.178214
NCT00181961|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-02-09|||April 2005||2005-04-01|February 2006|2006-02-01||||||||Interventional|||Safety and Effectiveness Study of Maca Root to Treat Antidepressant-Induced Sexual Dysfunction|A Dose-Finding Study of the Tolerability and Efficacy of Maca Root in Patients With Antidepressant-Induced Sexual Dysfunction|Unknown status|Active, not recruiting|Phase 3|20||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:33.276139|2017-02-18 17:17:33.276139
NCT00181948|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-18|||September 2004||2004-09-01|June 2010|2010-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy|A Pilot Study of Strattera Treatment in Children With Attention-Deficit/Hyperactivity Disorder Who Have Poor Response to Stimulant Therapy|Completed||Phase 4|30|Anticipated|Massachusetts General Hospital|||||f||||f||||||||||2017-02-18 17:17:33.364283|2017-02-18 17:17:33.364283
NCT00181935|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-03|||March 2001||2001-03-01|May 2013|2013-05-01|July 2004|Actual|2004-07-01|||||Interventional|||Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder|Open-Label Comparative Study of Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Spectrum Disorder|Completed||Phase 4|40||Massachusetts General Hospital|||||f||||f||||||||||2017-02-18 17:17:33.460929|2017-02-18 17:17:33.460929
NCT00181922|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-21|||March 2002||2002-03-01|October 2013|2013-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder|Open-Label Study of Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Spectrum Disorder|Completed||Phase 4|20||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:33.5669|2017-02-18 17:17:33.5669
NCT00181909|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-27|||September 2001||2001-09-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Efficacy of Proactive Telephone Counseling for Pregnant Smokers Enrolled in a Managed Care Organization||Completed||Phase 3|434||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:33.661824|2017-02-18 17:17:33.661824
NCT00181896|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-07-14|||January 2005||2005-01-01|July 2011|2011-07-01||||February 2007|Actual|2007-02-01||Interventional|||Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder|Open-Label Study of Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar and Bipolar Spectrum Disorder|Terminated||Phase 4|1|Actual|Massachusetts General Hospital||1||Study was terminated due to lack of recruitment|f||||t||||||||||2017-02-18 17:17:33.753603|2017-02-18 17:17:33.753603
NCT00181883|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-09|2011-07-19||February 2005||2005-02-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder|Open-Label Study of Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar and Bipolar Spectrum Disorder|Completed||Phase 4|30|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:17:33.853349|2017-02-18 17:17:33.853349
NCT00181870|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-06-18|||July 2005||2005-07-01|June 2010|2010-06-01||||August 2007|Actual|2007-08-01||Interventional|||Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder|Open-Label Study of Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Completed||Phase 4|33|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:17:34.371629|2017-02-18 17:17:34.371629
NCT00181857|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-30|||February 2005||2005-02-01|October 2013|2013-10-01|February 2008|Actual|2008-02-01|February 2006|Actual|2006-02-01||Observational|||Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)|Risk of Attention Deficit Hyperactivity Disorder in the Children of Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified: A Pilot Study|Completed||N/A|58|Actual|Massachusetts General Hospital|||1||f||||t||||||||||2017-02-18 17:17:34.476802|2017-02-18 17:17:34.476802
NCT00181844|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-09|2011-07-27||January 2005||2005-01-01|March 2012|2012-03-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder|A Pilot Open Study of the Safety and Effectiveness of Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorders|Completed||Phase 4|51|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:17:34.585438|2017-02-18 17:17:34.585438
NCT00181831|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-12|||December 2002||2002-12-01|June 2013|2013-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Spectroscopy in Children and Adolescents With Bipolar Disorder|Proton Magnetic Resonance Spectroscopy in Children and Adolescents With Bipolar Disorder|Completed||N/A|80||Massachusetts General Hospital|||1||f||||||||||||||2017-02-18 17:17:34.915744|2017-02-18 17:17:34.915744
NCT00181818|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 1999||1999-10-01|September 2005|2005-09-01|December 2003||2003-12-01|||||Interventional|||Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease|Safety and Efficacy of Sustained-Release (SR) Bupropion for Smokers Hospitalized Smokers With Acute Coronary Heart Disease|Completed||Phase 4|248||Massachusetts General Hospital|||||||||||||||||||2017-02-18 17:17:35.011789|2017-02-18 17:17:35.011789
NCT00181805|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-23|||September 2004||2004-09-01|October 2013|2013-10-01|December 2014|Anticipated|2014-12-01|June 2010|Actual|2010-06-01||Observational|||Natural History of Gastroesophageal Reflux (GER) in Children and Adolescents|The Natural History of Children With Persistent Gastroesophageal Reflux Disease (Ages 12 to 17 Years)|Unknown status|Active, not recruiting|N/A|25|Anticipated|Massachusetts General Hospital|||2||f||||f||||||||||2017-02-18 17:17:35.129237|2017-02-18 17:17:35.129237
NCT00181792|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-02|||May 2005||2005-05-01|May 2012|2012-05-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta|Family Risk Analysis of Substance Use in ADHD Youth Treated With Concerta|Completed||Phase 4|70|Actual|Massachusetts General Hospital|||1||f||||t||||||||||2017-02-18 17:17:35.214576|2017-02-18 17:17:35.214576
NCT00181779|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-21|||February 2003||2003-02-01|October 2013|2013-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder|Open-Label Pilot Study of Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Completed||Phase 4|20||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:35.302143|2017-02-18 17:17:35.302143
NCT00181766|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-02|2010-02-26||December 2003||2003-12-01|December 2013|2013-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)|A Pilot Study of Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified|Completed||Phase 4|45|Actual|Massachusetts General Hospital|"small, open label study~short exposure to medication"|1|||f||||t||||||||||2017-02-18 17:17:35.626101|2017-02-18 17:17:35.626101
NCT00181753|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-12|||November 2009||2009-11-01|January 2017|2017-01-01|October 2010|Anticipated|2010-10-01|October 2010|Anticipated|2010-10-01||Interventional|||Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition|Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition|Withdrawn||N/A|0|Actual|National Institute of General Medical Sciences (NIGMS)||4||"State of Mass. tightened regulations for making intravenous solutions for research subjects.~   Study was withdrawn and no participants were enrolled."|f||||t||||||||||2017-02-18 17:17:35.90576|2017-02-18 17:17:35.90576
NCT00181740|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-07-22|||December 2003||2003-12-01|July 2010|2010-07-01|July 2005|Actual|2005-07-01|||||Interventional|||Concerta Treatment in Adults With ADHD NOS|A Pilot Study of Concerta Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified|Completed||Phase 4|30||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:36.046358|2017-02-18 17:17:36.046358
NCT00181727|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-10-21|||January 2004||2004-01-01|October 2013|2013-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder|Open-Label Study of Divalproex Sodium Extended Release for the Treatment of Mania in Children Ages 6-12 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder|Completed||Phase 4|14||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:36.146104|2017-02-18 17:17:36.146104
NCT00181363|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-25|||December 2003||2003-12-01|April 2007|2007-04-01|January 2010|Anticipated|2010-01-01|||||Interventional|||Prone Breast Irradiation for Pendulous Breasts|Mamma Board Project: Prone Breast Irradiation for Pendulous Breasts|Unknown status|Active, not recruiting|N/A|10||Maastricht Radiation Oncology|||||f||||t||||||||||2017-02-18 17:17:38.56822|2017-02-18 17:17:38.56822
NCT00181714|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-02|2012-01-05||November 2003||2003-11-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta|Prevention of Cigarette Smoking in ADHD Youth With Concerta|Completed||Phase 4|203|Actual|Massachusetts General Hospital|The main limitation of this report stems from its uncontrolled, open-label design. Thus, we cannot assert a causal relationship between lower smoking rates and OROS MPH prescription.|1|||f||||t||||||||||2017-02-18 17:17:36.260092|2017-02-18 17:17:36.260092
NCT00181701|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-04|||October 2004||2004-10-01|December 2012|2012-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin|A Phase II Trial of Intraperitoneal Paclitaxel and Carboplatin Therapy in the Treatment of Women With Newly Diagnosed, Optimally Cytoreduced Carcinoma of Mullerian Origin|Completed||Phase 2|46|Anticipated|Massachusetts General Hospital|||||f||||t||||||||||2017-02-18 17:17:36.549765|2017-02-18 17:17:36.549765
NCT00181688|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-04|||October 2003||2003-10-01|December 2012|2012-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer|A Phase II Study of ZD1839 (Iressa) Plus Anastrozole (Arimidex) in Patients With Relapsed Ovarian Cancer|Completed||Phase 2|35||Massachusetts General Hospital|||||f||||t||||||||||2017-02-18 17:17:36.652084|2017-02-18 17:17:36.652084
NCT00181675|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-22|||December 2002||2002-12-01|July 2010|2010-07-01|September 2003||2003-09-01|||||Interventional|||A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder|A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 4|40||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:36.753564|2017-02-18 17:17:36.753564
NCT00181662|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-02|||August 2005||2005-08-01|April 2007|2007-04-01||||||||Interventional|||Pharmacokinetics of Curcumin in Healthy Volunteers|Evaluation of Naturally Occurring Inhibitors of UDP-Glucuronyltransferase on the Oral Bioavailability of Curcumin in Normal Healthy Volunteers|Completed||N/A|6||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:36.852244|2017-02-18 17:17:36.852244
NCT00181649|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-05-08|||September 2006||2006-09-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Recombinant Human Prolactin for Lactation Induction|Recombinant Human Prolactin for Lactation Induction in Adoptive Mothers|Withdrawn||Phase 2|0|Actual|Massachusetts General Hospital||1||Not able to recruit any subjects.|f||||||||||||||2017-02-18 17:17:36.937889|2017-02-18 17:17:36.937889
NCT00181636|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-23||||||April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder||Completed||N/A|25||Massachusetts General Hospital|||||f||||f||||||||||2017-02-18 17:17:37.041452|2017-02-18 17:17:37.041452
NCT00181623|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-05-07|2013-02-05||January 2005||2005-01-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Recombinant Human Prolactin for Lactation Induction|Recombinant Human Prolactin for Lactation Induction in Prolactin Deficient Mothers|Completed||Phase 2|6|Actual|Massachusetts General Hospital|Small numbers as this was an orphan disease trial.|1|||f||||||||||||||2017-02-18 17:17:37.126257|2017-02-18 17:17:37.126257
NCT00181610|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-05-08|2013-02-05||September 2004||2004-09-01|May 2013|2013-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||One subject did not complete the study and data was not analyzed for that subject.|Recombinant Human Prolactin for Lactation Induction|Recombinant Human Prolactin for Lactation Induction in Mothers of Premature Infants|Completed||Phase 2|11|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-02-18 17:17:37.34868|2017-02-18 17:17:37.34868
NCT00181597|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-12-02|||March 2004||2004-03-01|December 2013|2013-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Trilostane for Androgen-Independent Prostate Cancer|A Phase II Study of Trilostane for Androgen-Independent Prostate Cancer|Completed||Phase 2|24|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:17:37.790059|2017-02-18 17:17:37.790059
NCT00181584|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-07-09|||September 2003||2003-09-01|July 2013|2013-07-01||||February 2006|Actual|2006-02-01||Interventional|||Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer|Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer|Completed||Phase 2|60|Actual|Massachusetts General Hospital||2|||f||||||||||||||2017-02-18 17:17:37.964194|2017-02-18 17:17:37.964194
NCT00181571|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-26|||June 2003||2003-06-01|June 2013|2013-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder|A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 4|297|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:17:38.076177|2017-02-18 17:17:38.076177
NCT00181558|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-05-07|||December 2001||2001-12-01|May 2010|2010-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone|Atrasentan and Zometa for Men With Androgen Independent Prostate Cancer Metastatic to Bone: A Randomized Pilot Study|Completed||Phase 2|44||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:17:38.192387|2017-02-18 17:17:38.192387
NCT00181545|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-29|||December 2004||2004-12-01|June 2009|2009-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.|Individualised Radiation Dose Determination on Basis of Normal Tissue Dose Constraints in Patients With Non-Small-Cell Lung Cancer: A Phase I Study|Completed||Phase 1|30|Anticipated|Maastricht Radiation Oncology|||||f||||t||||||||||2017-02-18 17:17:38.291691|2017-02-18 17:17:38.291691
NCT00181532|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-29|||May 2003||2003-05-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|||||Interventional|||Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC|A Multicentre Randomised Double Blind Placebo-Controlled Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC. An Evaluation of Both Tumor Radiosensitization and Normal Tissue Protection|Completed||Phase 2|102||Maastricht Radiation Oncology|||||f||||t||||||||||2017-02-18 17:17:38.384061|2017-02-18 17:17:38.384061
NCT00181506|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-06-29|||December 2001||2001-12-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy|HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Accelerated Conformal Radiotherapy in Patients With Inoperable Non-Small Cell Lung Cancer.|Completed||Phase 1/Phase 2|180||Maastricht Radiation Oncology|||||f||||||||||||||2017-02-18 17:17:38.479944|2017-02-18 17:17:38.479944
NCT00181350|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-06-29|||November 2003||2003-11-01|June 2009|2009-06-01|July 2007|Actual|2007-07-01|||||Interventional|||Serial CT Scans in Fractionated Stereotactic Radiotherapy|Serial CT Scans for the Evaluation of Two Different Relocatable Fixation Systems in Fractionated Stereotactic Radiotherapy|Completed||Phase 3|20||Maastricht Radiation Oncology|||||f||||t||||||||||2017-02-18 17:17:38.645745|2017-02-18 17:17:38.645745
NCT00181311|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2006-10-25|||August 2005||2005-08-01|August 2005|2005-08-01|October 2006||2006-10-01|||||Observational|||Investigation of the Incidence of Complications After Vaginal and Abdominal Hysterectomy|Prospective Investigation of the Incidence of Complications After Vaginal and Abdominal Hysterectomy|Unknown status|Recruiting|N/A|200||Maasland Hospital|||||f||||||||||||||2017-02-18 17:17:38.730771|2017-02-18 17:17:38.730771
NCT00181298|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-03-05|||March 2006||2006-03-01|March 2008|2008-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Memantine in Systemic Lupus Erythematosus|Memantine in Systemic Lupus Erythematosus|Completed||N/A|61|Actual|Johns Hopkins University||2|||f||||f||||||||||2017-02-18 17:17:38.809963|2017-02-18 17:17:38.809963
NCT00181285|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-05-09|||October 2003||2003-10-01|May 2013|2013-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)|Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)|Completed||Phase 2|6|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 17:17:38.918689|2017-02-18 17:17:38.918689
NCT00181272|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2013-05-09|||September 2005||2005-09-01|May 2013|2013-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease|Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease|Terminated||Phase 2|18||Johns Hopkins University||||Principal Investigator moved institutions|f||||||||||||||2017-02-18 17:17:41.839176|2017-02-18 17:17:41.839176
NCT00181259|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-11|||January 1988||1988-01-01|November 2015|2015-11-01|August 2016|Anticipated|2016-08-01|January 2016|Anticipated|2016-01-01||Observational|||Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism|In Vivo Cardiac Metabolism in Normal, Ischemic, and Cardiomyopathic Patients During Rest and Stress|Recruiting||N/A|500|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 17:17:41.944558|2017-02-18 17:17:41.944558
NCT00181246|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||October 2003||2003-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain||Completed||N/A|53||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:42.037769|2017-02-18 17:17:42.037769
NCT00181233|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-11|||October 2003||2003-10-01|November 2015|2015-11-01|July 2017|Anticipated|2017-07-01|July 2016|Anticipated|2016-07-01||Observational|||Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk|Functional Energetics and Imaging for Phenotypic Characterization of Patients at Risk for Sudden Cardiac Death|Recruiting||N/A|400|Anticipated|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 17:17:42.127797|2017-02-18 17:17:42.127797
NCT00181220|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-08-21|||April 2004||2004-04-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma|Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma|Unknown status|Recruiting|Phase 1|20||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:42.218876|2017-02-18 17:17:42.218876
NCT00181207|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-29|||May 2004||2004-05-01|June 2011|2011-06-01|December 2012|Anticipated|2012-12-01|November 2012|Anticipated|2012-11-01||Interventional|||Airway Clearance for Prevention of COPD Exacerbation|A Randomized, Sham-controlled, Double-blinded Pilot Study to Assess the Effects of High Frequency Chest Wall Oscillation (HFCWO) Therapy in Patients With Chronic Bronchitis|Unknown status|Active, not recruiting|Phase 4|50|Anticipated|Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:42.304761|2017-02-18 17:17:42.304761
NCT00181194|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 2005||2005-05-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Reducing Asthma Disparities by Improving Provider-Patient Communication|Reducing Asthma Disparities by Improving Provider-Patient Communication About Asthma Severity and Adherence With Therapy|Unknown status|Recruiting|N/A|350||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:42.401213|2017-02-18 17:17:42.401213
NCT00181181|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-27|||May 2003||2003-05-01|September 2006|2006-09-01|April 2007|Actual|2007-04-01|June 2006|Actual|2006-06-01||Interventional|||The Effect of Statin Use on Vascular Function in Hypertensive Subjects|The Effect of Statin Use on Vascular Function in Hypertensive Subjects|Terminated||Phase 4|24|Actual|Johns Hopkins University||2||"Coronary flow by echo Doppler was obtainable in about 50% of subjects. The study was stopped~   early because of insufficient sample size to achieve adequate power"|f||||||||||||||2017-02-18 17:17:42.491306|2017-02-18 17:17:42.491306
NCT00181168|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-24|||March 2005||2005-03-01|September 2007|2007-09-01||||||||Interventional|||Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer|Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-Differentiated Epithelial Thyroid Cancer|Unknown status|Recruiting|Phase 2|70|Anticipated|Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:42.597892|2017-02-18 17:17:42.597892
NCT00181155|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-06|2015-11-11||November 2004||2004-11-01|January 2016|2016-01-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Intravenous Allopurinol in Heart Failure|Effects of Xanthine Oxidase Inhibition on Mechano-Energetic Coupling in Heart Failure|Completed||Phase 2|18|Actual|Johns Hopkins University|The limitations of the current study include the small placebo group sample size and the etiologic heterogeneity of the nonischemic cardiomyopathy group.|2|||f||||f||||||||||2017-02-18 17:17:42.695484|2017-02-18 17:17:42.695484
NCT00181142|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-09-10|||October 1999||1999-10-01|August 2004|2004-08-01|December 2004||2004-12-01|||||Interventional|||The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation|A Phase 3 Study Comparing the Use of Daclizumab Vs Thymoglobulin as Induction Therapy in Lung Transplantation|Completed||Phase 2/Phase 3|60||Johns Hopkins University|||||||||||||||||||2017-02-18 17:17:43.266622|2017-02-18 17:17:43.266622
NCT00181129|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-29|||September 2002||2002-09-01|September 2008|2008-09-01||||||||Interventional|||Fatigue and Cancer Treatment(FACT)- an Exercise Intervention|Mitigating Cancer Treatment-Related Fatigue by Exercise|Completed||N/A|140|Anticipated|Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:43.361203|2017-02-18 17:17:43.361203
NCT00181116|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2009-03-26|||March 2005||2005-03-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Levetiracetam for Benign Rolandic Epilepsy|Efficacy of Levetiracetam for Language Dysfunction Associated With Benign Epilepsy With Centrotemporal Spikes|Completed||Phase 4|6||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:17:43.448736|2017-02-18 17:17:43.448736
NCT00181077|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2012-09-21|||June 2003||2003-06-01|September 2012|2012-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Hypertonic Saline Use in Preeclampsia|Hypertonic Saline Use for Volume Expansion in Postpartum Preeclampsia|Completed||Phase 1|20||Johns Hopkins University|||||f||||f||||||||||2017-02-18 17:17:43.651501|2017-02-18 17:17:43.651501
NCT00181064|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-07-01|||September 2005||2005-09-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Atkins Diet for Difficult-to-Control Headaches in Teenagers|Use of the Atkins Diet for Adolescents With Chronic Daily Headache.|Completed||Phase 1|10|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 17:17:43.76663|2017-02-18 17:17:43.76663
NCT00181051|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||February 2003||2003-02-01|September 2005|2005-09-01||||||||Interventional|||Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia|Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia|Suspended||Phase 3|128||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:43.874362|2017-02-18 17:17:43.874362
NCT00181038|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-27|||June 2004||2004-06-01|September 2006|2006-09-01||||||||Interventional|||Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery|Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery: Comparing Continuous Infusion of Local Anesthetic With Systemic Multimodal Analgesia|Unknown status|Recruiting|Phase 3|40|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:43.961733|2017-02-18 17:17:43.961733
NCT00181025|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-11|||May 2004||2004-05-01|September 2006|2006-09-01||||||||Interventional|||Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs’ Girdle|Isolated Pelvic and Limb Perfusion With 1mg TNFa in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs’ Girdle|Unknown status|Recruiting|Phase 2|33|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.049072|2017-02-18 17:17:44.049072
NCT00181012|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-18|||May 2005||2005-05-01|September 2006|2006-09-01||||||||Interventional|||Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics|Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics: Efficacy Study in Adults and Children. Randomized Prospective Study With Direct Individual Benefit|Unknown status|Recruiting|Phase 3|100|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.136739|2017-02-18 17:17:44.136739
NCT00180999|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-07|||February 2002||2002-02-01|September 2006|2006-09-01||||||||Interventional|||Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course|Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course|Terminated||Phase 3|420||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.223726|2017-02-18 17:17:44.223726
NCT00180986|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-13|||October 1995||1995-10-01|September 2005|2005-09-01||||||||Interventional|||Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child|Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child|Unknown status|Active, not recruiting|Phase 3|120||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.299655|2017-02-18 17:17:44.299655
NCT00180973|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||February 1995||1995-02-01|September 2005|2005-09-01||||||||Interventional|||PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.|MULTICENTRIC INTERNATIONAL RANDOMIZED PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE.|Unknown status|Active, not recruiting|Phase 3|520||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.369214|2017-02-18 17:17:44.369214
NCT00180960|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-07|||June 2003||2003-06-01|September 2006|2006-09-01||||||||Interventional|||Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia|Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery With Intraperitoneal Chemohyperthermia Using Oxaliplatin Plus Irinotecan|Terminated||Phase 2|100||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.448963|2017-02-18 17:17:44.448963
NCT00180947|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-07|||June 2003||2003-06-01|September 2006|2006-09-01||||||||Interventional|||Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse|Phase II Study of Vinorelbine + Cyclofosfamide Association Among Patients Reached of Refractory Tumours or in Relapse|Unknown status|Recruiting|Phase 2|210||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.526376|2017-02-18 17:17:44.526376
NCT00180934|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-22|||July 1999||1999-07-01|September 2005|2005-09-01||||||||Interventional|||Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area|Interest of a Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area: a Multicentric Phase III Randomized Trial|Unknown status|Active, not recruiting|Phase 3|280||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.610825|2017-02-18 17:17:44.610825
NCT00180921|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-24|||July 2004||2004-07-01|September 2006|2006-09-01||||||||Interventional|||Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck|Phase II Study of Imatinib (Glivec) Administered as a Daily Oral Treatment in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck Overexpressing KIT|Unknown status|Recruiting|Phase 2|30|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.691941|2017-02-18 17:17:44.691941
NCT00180908|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 1994||1994-06-01|September 2005|2005-09-01||||||||Interventional|||Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children|SFOP-OS94: Multicentric Randomised Phase III Trial Comparing Efficacy of Preoperative High-Dose Methotrexate Plus Doxorubicin to Efficacy of High-Dose Methotrexate Plus Etoposide and Ifosfamide, in Children and Adolescents Osteosarcoma|Completed||Phase 3|226||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.780112|2017-02-18 17:17:44.780112
NCT00180895|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-07|||June 2004||2004-06-01|September 2006|2006-09-01||||||||Interventional|||Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL|A Phase II Study of Mabthera (Rituximab) in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL|Terminated||Phase 2|40||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.868216|2017-02-18 17:17:44.868216
NCT00180882|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-07|||October 2004||2004-10-01|September 2006|2006-09-01||||||||Interventional|||LMBA02 Protocol for Patients With a Burkitt Lymphoma||Unknown status|Recruiting|Phase 3|260||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:44.972058|2017-02-18 17:17:44.972058
NCT00180869|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 1997||1997-09-01|September 2005|2005-09-01||||||||Interventional|||Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients|A Randomized Study of Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion During Surgery in Cancer Patients|Completed||Phase 3|150||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:45.067034|2017-02-18 17:17:45.067034
NCT00180856|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-11|||January 2002||2002-01-01|September 2005|2005-09-01||||||||Interventional|||Radiofrequency Ablation of Lung Tumors|A Phase II Study of Radiofrequency Ablation of Lung Tumors|Completed||Phase 2|60||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:45.157211|2017-02-18 17:17:45.157211
NCT00180843|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-09-21|||September 2005||2005-09-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease|Assessment of Ventilation-perfusion Abnormalities in Patients With Smoking-related Airways Disease in Stable Condition and the Effect of Bronchodilator Therapy|Terminated||N/A|2|Actual|Imperial College London||2||lack of resources research fellow left|f||||f||||||||||2017-02-18 17:17:45.495475|2017-02-18 17:17:45.495475
NCT00180830|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-07|||December 2003||2003-12-01|September 2006|2006-09-01||||||||Interventional|||Glivec Phase II Pediatric Study|Open Label, Pilot Phase II Study of Glivec in Children and Adolescents With Life Threatening Diseases Known to Be Associated With One or More Glivec-Sensitive Tyrosine Kinases|Terminated||Phase 2|36||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:45.607704|2017-02-18 17:17:45.607704
NCT00180817|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 1998||1998-09-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.|Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies in Women Presenting as Recurrent Miscarriages.|Unknown status|Recruiting|N/A|250||Imperial College London|||||f||||||||||||||2017-02-18 17:17:45.695371|2017-02-18 17:17:45.695371
NCT00180804|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-13|||April 2005||2005-04-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages|Combination of Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages|Unknown status|Recruiting|N/A|400||Imperial College London|||||f||||||||||||||2017-02-18 17:17:45.786315|2017-02-18 17:17:45.786315
NCT00180791|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-09-17|||July 2002||2002-07-01|September 2006|2006-09-01||||||||Interventional|||High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood|Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy|Unknown status|Recruiting|Phase 2|71|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:17:45.876979|2017-02-18 17:17:45.876979
NCT00180778|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 2005||2005-10-01|September 2005|2005-09-01||||||||Interventional|||Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss|Randomised Controlled Trial of Low Dose Steroid +Aspirin +Heparin Versus Aspirin+Heparin Amongst Pregnant Women With APS|Unknown status|Not yet recruiting|Phase 1/Phase 2|90||Imperial College London|||||f||||||||||||||2017-02-18 17:17:45.974586|2017-02-18 17:17:45.974586
NCT00180765|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-08-24|||October 2001||2001-10-01|September 2005|2005-09-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Observational|||Regulation of the Release of Inflammatory Mediators From Blood Leukocytes|Regulation of the Release of Inflammatory Mediators From Blood Leukocytes: A Comparison of Healthy Subjects, Healthy Smokers and Patients With COPD.|Completed||N/A|30||Imperial College London|||||f||||||||||||||2017-02-18 17:17:46.061408|2017-02-18 17:17:46.061408
NCT00180752|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-02-17|||September 2005||2005-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||HDAC Activity in Peripheral Skeletal Muscle in COPD|The Investigation of HDAC and NF Kappa B Activity in Peripheral Skeletal Muscle in COPD|Completed||N/A|31|Actual|Imperial College London|||1||f||||f||||||Samples With DNA|"~     Plasma and serum samples, quadriceps muscle specimens~   "|No||2017-02-18 17:17:46.172951|2017-02-18 17:17:46.172951
NCT00180739|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-08-12|||April 2004||2004-04-01|August 2008|2008-08-01||||||||Interventional|||Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future|Magnetic Resonance Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids in Women Desiring Future Pregnancies|Completed||Phase 4|60|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:17:46.253672|2017-02-18 17:17:46.253672
NCT00180726|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-08-12|||December 2003||2003-12-01|August 2008|2008-08-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Molecular Mechanism of Asthma|Regulation of Inflammatory Mediators in Asthma|Withdrawn||N/A|30|Anticipated|Imperial College London|||||f||||t||||||||||2017-02-18 17:17:46.35376|2017-02-18 17:17:46.35376
NCT00180713|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-03|||October 2005||2005-10-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|||Simvastatin as a Treatment for Pulmonary Hypertension|Simvastatin as a Treatment for Pulmonary Hypertension|Completed||Phase 1/Phase 2|42|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 17:17:46.457508|2017-02-18 17:17:46.457508
NCT00180700|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-02-11|||June 2003||2003-06-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||The Influence of Psychological Interventions Upon Disease Progression in HIV-infected Patients Receiving no Medication|The Effects of Two Psychological Intervention Techniques, Self-hypnosis and Johrei Healing Method, on Quality of Life, Psychological Well-being, EEG Measures and Various Immunological Measures Including CD4+ Counts in Early HIV: a Randomly Controlled Pilot Study|Completed||N/A|100||Imperial College London|||||f||||||||||||||2017-02-18 17:17:46.58224|2017-02-18 17:17:46.58224
NCT00180687|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-12|2015-06-09||October 2004||2004-10-01|August 2015|2015-08-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Clinical Trial of the Use of Intraperitoneal Local Anaesthetic|Prospective Double Blind Randomized Controlled Trial of the Use of Intraperitoneal Nebulised Local Anaesthetic|Completed||Phase 3|80|Actual|Imperial College London||4|||f||||t||||||||||2017-02-18 17:17:46.670817|2017-02-18 17:17:46.670817
NCT00180674|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-10|||August 2005||2005-08-01|September 2005|2005-09-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||Anticoagulation in Liver Fibrosis|Anticoagulation for Liver Fibrosis in Patients With Hepatitis C Virus Infection: Pilot Study|Completed||Phase 2|12|Actual|Imperial College London||1|||f||||||||||||||2017-02-18 17:17:47.248314|2017-02-18 17:17:47.248314
NCT00180661|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-27|||August 2003||2003-08-01|October 2015|2015-10-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Observational|SARP||Inflammation and Corticosteroid Responsiveness in Severe Asthma|Inflammation and Corticosteroid Responsiveness in Severe Asthma|Completed||Phase 2/Phase 3|95|Actual|Imperial College London|||3||f||||t||||||Samples With DNA|"~     endobronchial biopsies and blood specimens.~   "|||2017-02-18 17:17:47.352521|2017-02-18 17:17:47.352521
NCT00180648|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-19|||February 2005||2005-02-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure|Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure|Completed||N/A|30|Actual|Imperial College London|||1||f||||t||||||Samples Without DNA|"~     Plasma~   "|||2017-02-18 17:17:47.461525|2017-02-18 17:17:47.461525
NCT00180635|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-06-03|||October 2003||2003-10-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD|A Double Blind, Crossover Placebo-controlled Study to Evaluate the Effect of L-arginine and Aminoguanidine on Bronchial and Alveolar Nitric Oxide and Nitric Oxide Metabolites in Exhaled Air, Breath Condensate, Nasal Lavage, Mouth Wash Fluid, and Induced Sputum in 7 Healthy Non-smokers, 10 Smokers and 12 COPD Patients|Completed||N/A|29|Anticipated|Imperial College London||2|||f||||||||||||||2017-02-18 17:17:47.5473|2017-02-18 17:17:47.5473
NCT00180622|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||July 2001||2001-07-01|September 2005|2005-09-01||||||||Observational|||Markers for COPD|Non-Invasive Markers for COPD|Completed||N/A|52||Imperial College London|||||f||||||||||||||2017-02-18 17:17:47.630268|2017-02-18 17:17:47.630268
NCT00180609|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2009-04-22|||December 2003||2003-12-01|April 2009|2009-04-01|July 2006||2006-07-01|||||Observational|||SCANCAP Scandinavian Automatic Capture Study|Scandinavian Automatic Capture Study|Completed||Phase 4|203||Guidant Corporation|||1||f||||||||||||||2017-02-18 17:17:47.703653|2017-02-18 17:17:47.703653
NCT00180596|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2016-01-05|||January 2000||2000-01-01|June 2005|2005-06-01|September 2005||2005-09-01|||||Interventional|||PACMAN - PAcing for CardioMyopathies, a EuropeAN Study|Pacing for Cardiomyopathies, a European Study- A Therapy Acceptance Study|Completed||Phase 4|262||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:17:47.780109|2017-02-18 17:17:47.780109
NCT00180583|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2008-07-31|||February 2002||2002-02-01|July 2008|2008-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Vision II: Evaluation of GALILEO Intravascular Radiotherapy System|Vision II: Non Randomized French Evaluation of GALILEO Intravascular Radiotherapy System in Patients With de Novo Coronary Arteries Lesions by Restenosis on Angioplasty or Restenosis on Endoprosthesis|Completed||Phase 4|268|Actual|Abbott Vascular||1|||f||||||||||||||2017-02-18 17:17:47.876564|2017-02-18 17:17:47.876564
NCT00180570|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-03-10|||January 1997||1997-01-01|September 2005|2005-09-01|January 2006||2006-01-01|||||Interventional|SALT||SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing Electrodes|Scandinavian Atrial Lead Trial|Suspended||Phase 4|385||Guidant Corporation|||||f||||||||||||||2017-02-18 17:17:47.983739|2017-02-18 17:17:47.983739
NCT00180557|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2015-03-10|||September 2003||2003-09-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Austria Study - Analysis of Difference Between Active and Passive Fixation Leads|Analyse Der Unterschiede Zwischen Aktiv-fixierenden Und Passiv-fixierenden Stimulations-Elektroden Hinsichtlich Implantationsdauer Und Elektrischer Parameter|Completed||Phase 4|120|Actual|Guidant Corporation||2|||f||||f||||||||||2017-02-18 17:17:48.070248|2017-02-18 17:17:48.070248
NCT00180544|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-07-24|||July 2000||2000-07-01|July 2008|2008-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|HERCULINK 14||Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease|A Prospective, Non-Randomized, Multicenter, Single-Arm, Clinical Trial to Assess the Safety and Efficacy of the RX HERCULINK 14 Peripheral Stent System for Treatment in de Novo or Restenotic Renal Artery Stenosis|Terminated||Phase 3|167|Actual|Abbott Vascular||1||"Device superceded by next generation device. Enrollment stopped, long term follow up was~   completed in August of 2004."|f||||t||||||||||2017-02-18 17:17:48.160676|2017-02-18 17:17:48.160676
NCT00180531|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-12-12|||February 2004||2004-02-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2|Monitoring of Arrhythmias and Heart Rate Variability in Patients With Congestive Heart Failure Treated With the Cardiac Resynchronisation Pacemaker Renewal TR2|Completed||Phase 4|500||Guidant Corporation|||||f||||||||||||||2017-02-18 17:17:48.255403|2017-02-18 17:17:48.255403
NCT00180518|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-10|||May 2000||2000-05-01|September 2008|2008-09-01|November 2003|Actual|2003-11-01|October 2003|Actual|2003-10-01||Interventional|||"ACCULINK for Revascularization of Carotids in High Risk Patients The ARCHeR Trial"|Prospective, Non-Randomized, Multi-Center, Single-Arm Trial to Assess Safety & Efficacy of the Acculink Carotid Stent System With the Accunet Embolic Protection System in High-Risk Patients With Carotid Artery Lesions.|Completed||Phase 2/Phase 3|581||Abbott Vascular||1|||f||||t||||||||||2017-02-18 17:17:48.356415|2017-02-18 17:17:48.356415
NCT00180505|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-23|||March 2005||2005-03-01|February 2010|2010-02-01|October 2009|Actual|2009-10-01|March 2006|Actual|2006-03-01||Interventional|||ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries|Non-Randomized, Prospective, Multi-center Evaluation of the ABSOLUTE™ .035 Peripheral Self-Expanding Stent System for Occluded or Stenotic Superficial Femoral or Proximal Popliteal Arteries|Completed||Phase 4|120|Anticipated|Abbott Vascular||1|||f||||f||||||||||2017-02-18 17:17:48.711068|2017-02-18 17:17:48.711068
NCT00180492|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-27|||October 2004||2004-10-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|December 2006|Actual|2006-12-01||Interventional|||Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE|Carotid RX ACCULINK(TM)/ACCUNET(TM) Post-Approval Trial to Uncover Unanticipated or Rare Events - CAPTURE|Completed||N/A|1500||Abbott Vascular|||||f||||||||||||||2017-02-18 17:17:48.841013|2017-02-18 17:17:48.841013
NCT00179881|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-22|||December 1999||1999-12-01|June 2011|2011-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma|Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma|Completed||Phase 2|47|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||||f||||||||||||||2017-02-18 17:17:56.694668|2017-02-18 17:17:56.694668
NCT00180479|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-16|2008-10-15||June 2005||2005-06-01|November 2011|2011-11-01|November 2011|Actual|2011-11-01|December 2006|Actual|2006-12-01||Interventional|||SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)|SPIRIT III: A Clinical Evaluation of the Investigational Device XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) in the Treatment of Subjects With de Novo Native Coronary Artery Lesions|Completed||Phase 3|1002|Actual|Abbott Vascular||2|||f||||t||||||||||2017-02-18 17:17:48.95529|2017-02-18 17:17:48.95529
NCT00180466|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-24|||October 2004||2004-10-01|May 2010|2010-05-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Observational|||PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions|Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) An Imaging Study in Patients With Unstable Atherosclerotic Lesions|Completed||N/A|697|Actual|Abbott Vascular|||1||f||||t||||||Samples With DNA|"~     Aproximately 1 ML blood~   "|||2017-02-18 17:17:50.650845|2017-02-18 17:17:50.650845
NCT00180453|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-01-05|||December 2003||2003-12-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|April 2005|Actual|2005-04-01||Interventional|||SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System|SPIRIT First: A Clinical Evaluation of an Investigational Device. The Abbott XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 3|60|Actual|Abbott Vascular||2|||f||||t||||||||||2017-02-18 17:17:50.779985|2017-02-18 17:17:50.779985
NCT00180440|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-03-25|||July 2002||2002-07-01|March 2009|2009-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||INSURE: INcidence Free SUrvival Before and After Implantable Cardioverter Defibrillator (ICD) Replacement|INcidence Free SUrvival Before and After ICD Replacement|Completed||Phase 4|528|Anticipated|Guidant Corporation|||1||f||||||||||||||2017-02-18 17:17:50.905989|2017-02-18 17:17:50.905989
NCT00180427|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-04-22|||June 2001||2001-06-01|April 2008|2008-04-01|November 2004|Actual|2004-11-01|||||Interventional|||"VERRARI - Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"|"VERRARI - Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"|Completed||Phase 4|75||Guidant Corporation|||||f||||||||||||||2017-02-18 17:17:50.993098|2017-02-18 17:17:50.993098
NCT00180414|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-09|||August 2003||2003-08-01|March 2015|2015-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||MODULA Modul 7 VRR: Correlation Between Ventricular Rate Regulation (VRR) and the Percentage of Biventricular Pacing in Cardiac Resynchronization Therapy (CRT) Patients With Atrial Fibrillation|MODULA-Study: Modul 7 VRR: Correlation Between Ventricular Rate Regulation (VRR) and the Percentage of Biventricular Pacing as Well as Subjective Quality of Life and Level of Physical Ability in CRT Patients With Atrial Fibrillation|Terminated||Phase 4|40|Anticipated|Guidant Corporation||||low enrolment rate|f||||||||||||||2017-02-18 17:17:51.084526|2017-02-18 17:17:51.084526
NCT00180401|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-09|||June 2002||2002-06-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|||||Observational|||MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms|MODULA-Study: Modul 10: Benefit of CRT-therapy in CRT-Patients With QRS-complex of 120 - 150 ms|Terminated||Phase 4|100|Anticipated|Guidant Corporation|||2|no longer interest from medical community|f||||||||||||||2017-02-18 17:17:51.423652|2017-02-18 17:17:51.423652
NCT00180388|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-31|||May 2004||2004-05-01|March 2007|2007-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||VENEK: Healing in Different Vein Harvesting Methods During Aortocoronary Coronary Artery Bypass Graft Surgery (CABG)|Comparison of Clinical and Economical Parameters of Healing in Different Vein Harvesting Methods During Aortocoronary CABG|Terminated||Phase 4|300|Anticipated|Boston Scientific Corporation||2||terminated for logistical reasons|f||||||||||||||2017-02-18 17:17:51.523699|2017-02-18 17:17:51.523699
NCT00180375|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-03|||May 2002||2002-05-01|June 2011|2011-06-01|August 2007|Actual|2007-08-01|||||Observational|||OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator|OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator|Completed||Phase 4|700||Guidant Corporation|||1||f||||f||||||||||2017-02-18 17:17:51.663609|2017-02-18 17:17:51.663609
NCT00180362|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-02-03|||May 2004||2004-05-01|February 2010|2010-02-01|September 2004||2004-09-01|||||Interventional|Quick ICD||Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ?|Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary in Patients After Survived Cardiac Arrest? A Prospective Randomised Multi-centre Trial.|Completed||Phase 4|200||Guidant Corporation|||||f||||||||||||||2017-02-18 17:17:51.797162|2017-02-18 17:17:51.797162
NCT00180349|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-03|||December 2004||2004-12-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|||||Observational|||Leader - Evaluation of Endotak Reliance|Short and Long Term Evaluation of Electrical Measurements and Defibrillation Energies, Results of ATP and Diagnostic Functions of Devices Connected to Endotak RELIANCE® Defibrillation Leads|Completed||Phase 4|900|Anticipated|Guidant Corporation|||1||f||||f||||||||||2017-02-18 17:17:51.884189|2017-02-18 17:17:51.884189
NCT00180336|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-06-22|||July 2004||2004-07-01|June 2007|2007-06-01||||||||Interventional|||Safety and Efficacy Study of RENEWAL 4 AVT|CONTAK RENEWAL 4 AVT Field Following|Completed||Phase 2/Phase 3|170||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:17:51.991262|2017-02-18 17:17:51.991262
NCT00180323|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-05|2012-03-09||November 2004||2004-11-01|October 2012|2012-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||ACC - Atrial Contribution to CRT|ACC - Atrial Contribution to CRT|Completed||Phase 4|43|Actual|Boston Scientific Corporation||1|||f||||f||||||||||2017-02-18 17:17:52.090052|2017-02-18 17:17:52.090052
NCT00180310|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-07-18|||July 2005||2005-07-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|July 2007|Actual|2007-07-01||Interventional|SPIRIT II||SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System|A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Native Coronary Artery Lesions|Completed||Phase 3|300|Actual|Abbott Vascular||2|||f||||t||||||||||2017-02-18 17:17:52.374671|2017-02-18 17:17:52.374671
NCT00180297|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-09-10|||April 2005||2005-04-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead|Evaluation of the Success Rate and the Clinical Evolution of a Ventricular Lead Implanted in the Septum Versus the Right Ventricular Apex.|Completed||Phase 4|208|Actual|Guidant Corporation||1|||f||||||||||||||2017-02-18 17:17:52.534477|2017-02-18 17:17:52.534477
NCT00180271|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-01-24|2011-02-23||December 2004||2004-12-01|January 2012|2012-01-01|September 2010|Actual|2010-09-01|June 2009|Actual|2009-06-01||Interventional|MADIT-CRT||MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy|Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy|Completed||Phase 2/Phase 3|1820|Actual|Boston Scientific Corporation|The FDA Circulatory Devices advisory panel recommended approval for the patient subpopulation with left bundle branch block (LBBB) only. Consequently, FDA has restricted indications for use to LBBB.|2|||f||||t||||||||||2017-02-18 17:17:52.744328|2017-02-18 17:17:52.744328
NCT00180258|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-01-23|||January 2000||2000-01-01|January 2007|2007-01-01|December 2002||2002-12-01|||||Interventional|||Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure|Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure|Completed||Phase 2/Phase 3|2200||Boston Scientific Corporation|||||||||||||||||||2017-02-18 17:17:53.472701|2017-02-18 17:17:53.472701
NCT00180245|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-15|||July 2005||2005-07-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Observational|||Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET||Completed||N/A|44|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-02-18 17:17:53.5593|2017-02-18 17:17:53.5593
NCT00180232|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-02-02|||April 2006||2006-04-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|||||Observational|||An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness|An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness (Changes of the Aortal Elasticity Due to a Newly Established Aminobiphosphinate Therapy for the Treatment of Osteoporosis)|Withdrawn||N/A|0|Actual|Technische Universität Dresden|||1|Clinical partner left University,|f||||f||||||||||2017-02-18 17:17:53.634134|2017-02-18 17:17:53.634134
NCT00180219|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2016-08-24|||January 2006||2006-01-01|August 2016|2016-08-01|June 2006|Actual|2006-06-01|||||Observational|||Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the Mother|An Open Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the Mother (Hormonal and Age Related Changes of the Aortal Elasticity)|Withdrawn||Phase 1|0|Actual|Technische Universität Dresden|||3|recruitment failure|f||||f||||||||||2017-02-18 17:17:53.711949|2017-02-18 17:17:53.711949
NCT00180206|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-01-13|||January 2005||2005-01-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Interventional|||Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing Endoprosthesis|Prospective, Non-Randomised, Non-Comparative Multicentric Investigation of the Functional and Radiological Result and Subjective Patient Outcome After Implantation of a Hip Resurfacing Endoprosthesis (Birmingham Hip Resurfacing)|Unknown status|Recruiting|Phase 4|300||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:17:53.796653|2017-02-18 17:17:53.796653
NCT00180193|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-08-25|||December 2003||2003-12-01|August 2009|2009-08-01||||||||Observational|||F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response|F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response|Terminated||Phase 2|40|Anticipated|Technische Universität Dresden|||1||f||||f||||||||||2017-02-18 17:17:53.891538|2017-02-18 17:17:53.891538
NCT00180180|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-03-15|||July 2006||2006-07-01|March 2016|2016-03-01|August 2018|Anticipated|2018-08-01|August 2018|Anticipated|2018-08-01||Observational|||Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO|Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO|Active, not recruiting||Phase 2|60|Actual|Technische Universität Dresden|||1||f||||f||||||||||2017-02-18 17:17:53.964041|2017-02-18 17:17:53.964041
NCT00180167|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-19|||January 2005||2005-01-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC|Therapy of AML in Patients Older Than 60 Years: Randomized Comparison of a Double Induction With Daunorubicin and AraC (as Continuous Infusion) With a Double Induction With Mitoxantrone and Intermittent, Medium High Dose AraC|Completed||Phase 4|492|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-02-18 17:17:54.03754|2017-02-18 17:17:54.03754
NCT00180154|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-23|||July 2005||2005-07-01|August 2011|2011-08-01||||||||Observational|||Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET|Tumor Metabolism of Lung Cancer Underwent Percutaneous Radiation Measured With F-18-FDG-PET|Completed||N/A|50|Anticipated|Technische Universität Dresden|||1||f||||||||||||||2017-02-18 17:17:54.156777|2017-02-18 17:17:54.156777
NCT00180141|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-06|||April 2005||2005-04-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Elidel-Study: Elidel in Patients With Atopic Dermatitis|Control of Therapy With Elidel vs Placebo in Patients With Atopic Dermatitis Using Bioengineering Methods|Completed||Phase 4|24|Anticipated|Technische Universität Dresden|||||f||||f||||||||||2017-02-18 17:17:54.23964|2017-02-18 17:17:54.23964
NCT00180128|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-07-08|||January 2000||2000-01-01|July 2011|2011-07-01|November 2012|Anticipated|2012-11-01|November 2012|Anticipated|2012-11-01||Interventional|||AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia|AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia(APL)|Unknown status|Recruiting|Phase 4|80|Anticipated|Technische Universität Dresden||1|||f||||||||||||||2017-02-18 17:17:54.323246|2017-02-18 17:17:54.323246
NCT00180115|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-07-16|||February 1996||1996-02-01|July 2007|2007-07-01|November 2008||2008-11-01|||||Interventional|||AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients|AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients. A Cooperative AML-Study of the German SHG-Study Group.|Completed||Phase 4|400||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:17:54.42397|2017-02-18 17:17:54.42397
NCT00180102|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-23|||December 2003||2003-12-01|December 2009|2009-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years|AML2003 - Randomized Comparison Between Standard-Therapy and Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years. A Prospective, Randomized, Multi-center Therapy-Optimizing-Study.|Completed||Phase 4|600|Anticipated|Technische Universität Dresden||4|||f||||||||||||||2017-02-18 17:17:54.524627|2017-02-18 17:17:54.524627
NCT00179491|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-02|||April 1998||1998-04-01|November 2007|2007-11-01|November 2001|Actual|2001-11-01|||||Interventional|||Study of the Therapeutic Effects of Intercessory Prayer (STEP)|Study of the Therapeutic Effects of Intercessory Prayer (STEP)|Completed||Phase 3|1802|Actual|Beth Israel Deaconess Medical Center||3|||f||||||||||||||2017-02-18 17:18:06.899755|2017-02-18 17:18:06.899755
NCT00180089|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-03-29|||January 2004||2004-01-01|March 2010|2010-03-01|January 2010||2010-01-01|March 2009|Actual|2009-03-01||Interventional|||Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation|Efficacy and Safety of Orale Budesonide in the Prevention of Acute Gastrointestinal Graft-versus-host Disease Following Allogenic Stem Cell Transplantation|Completed||Phase 3|242|Anticipated|Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:17:54.636749|2017-02-18 17:17:54.636749
NCT00180076|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-03-29|||July 2004||2004-07-01|March 2010|2010-03-01|March 2008||2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Budesonide for Maintenance Treatment of Collagenous Colitis|Efficacy and Safety of Budesonide in Maintenance Treatment of Collagenous Colitis|Completed||Phase 3|75|Anticipated|Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:17:54.733209|2017-02-18 17:17:54.733209
NCT00180063|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-01|||October 2003||2003-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Characterization of Local Vascular Effects of LNMMA||Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:17:54.83214|2017-02-18 17:17:54.83214
NCT00180050|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-03-29|||January 2002||2002-01-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|August 2006|Actual|2006-08-01||Interventional|||Budesonide Treatment for Lymphocytic Colitis|Efficacy and Safety of Budesonide for Treatment of Lymphocytic Colitis|Completed||Phase 3|40|Anticipated|Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:17:54.905486|2017-02-18 17:17:54.905486
NCT00180037|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-16|||September 2003||2003-09-01|January 2009|2009-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease|Multicenter, Placebo Controlled, Randomized, Double-Blinded Study: Coenzyme Q10 Nanodispersion Versus Placebo as Symptomatic Treatment in Parkinson's Disease|Completed||Phase 3|132||Technische Universität Dresden|||||f||||t||||||||||2017-02-18 17:17:55.001497|2017-02-18 17:17:55.001497
NCT00180024|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 2002||2002-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.||Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:17:55.126467|2017-02-18 17:17:55.126467
NCT00180011|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2012-02-27|||September 2005||2005-09-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma|Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma|Completed||Phase 2/Phase 3|18|Actual|DiMango, Emily, M.D.||1|||f||||f||||||||||2017-02-18 17:17:55.19931|2017-02-18 17:17:55.19931
NCT00179998|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2013-08-19|||January 2005||2005-01-01|August 2013|2013-08-01|July 2015|Anticipated|2015-07-01|October 2008|Actual|2008-10-01||Interventional|||Effectiveness of Pulmozyme in Infants With Cystic Fibrosis|Efficacy of Pulmozyme in Infants and Young Children With Cystic Fibrosis|Unknown status|Active, not recruiting|Phase 2|24|Actual|Nationwide Children's Hospital||2|||f||||f||||||||||2017-02-18 17:17:55.29591|2017-02-18 17:17:55.29591
NCT00179985|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2011-07-28|||December 2004||2004-12-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|May 2006|Actual|2006-05-01||Observational|||The Impact of Implementing NIDCAP on the Developmental Sensitivity of Nurses Caring for Preterm Infants|The Impact of Implementing The Newborn Individualized Developmental Care & Assessment Program on the Developmental Sensitivity of Nurses Caring for Preterm Infants|Completed||N/A|32|Actual|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||t||||||||||2017-02-18 17:17:55.394006|2017-02-18 17:17:55.394006
NCT00179972|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2015-07-29|||September 2005||2005-09-01|July 2015|2015-07-01|May 2010|Actual|2010-05-01|||||Observational|||Evaluation of Pulse Oximetry Sensors in Neonates|Evaluation of Pulse Oximetry Sensors in Neonates|Terminated||N/A|32|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1|"Lack of resources and loss of personnel precluded study progress. No adverse events or~   unanticipated problems involving risks to subjects."|f||||||||||||||2017-02-18 17:17:55.719951|2017-02-18 17:17:55.719951
NCT00179959|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-11-20|2011-04-04||September 2005||2005-09-01|November 2014|2014-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis|The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis|Completed||Phase 4|31|Actual|Northwestern University||2|||f||||f||||||||||2017-02-18 17:17:55.819989|2017-02-18 17:17:55.819989
NCT00179946|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-14|||June 2003||2003-06-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||HLA Matching - Unrelated Umbilical Cord Blood Transplantation|Impact of HLA Matching on Outcome in Pediatric Patients Undergoing Unrelated Umbilical Cord Blood Transplantation.|Completed||N/A|30|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||||f||||||||||||||2017-02-18 17:17:56.213347|2017-02-18 17:17:56.213347
NCT00179933|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-10-07|||September 2005||2005-09-01|October 2010|2010-10-01|February 2007|Actual|2007-02-01|||||Interventional|||The Impact of Implementing NIDCAP on Preterm Infants in the NICU|The Impact of Implementing the Newborn Individualized Developmental Care and Assessment Program on Neurobehavioral Organization of Preterm Infants in the NICU|Terminated||N/A|40||Ann & Robert H Lurie Children's Hospital of Chicago||||Unable to fulfill intention of study, lost investigators.|f||||f||||||||||2017-02-18 17:17:56.300083|2017-02-18 17:17:56.300083
NCT00179920|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-09-25|||April 1996||1996-04-01|June 2011|2011-06-01|September 2006||2006-09-01|||||Interventional|||Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma|Chemotherapy Plus Local Surgical Treatment in Children With Intraocular Germ-Line Retinoblastoma|Unknown status|Active, not recruiting|Phase 2|30||Ann & Robert H Lurie Children's Hospital of Chicago|||||f||||||||||||||2017-02-18 17:17:56.392578|2017-02-18 17:17:56.392578
NCT00179907|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-02-27|||May 2001||2001-05-01|February 2015|2015-02-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||A Phase I/II Study of the Photon Radiosurgery System|A Phase I/II Study of Reirradiation for Recurrent Pediatric Brain and Spinal Cord Tumors and Primary Glioblastoma Multiforme Using the Photon Radiosurgery System|Completed||Phase 1/Phase 2|35|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||||||||||||2017-02-18 17:17:56.490748|2017-02-18 17:17:56.490748
NCT00179894|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-14|||June 2003||2003-06-01|August 2015|2015-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings|Improving Medication Use for ADHD in Primary Care|Completed||N/A|270|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||f||||||||||2017-02-18 17:17:56.587637|2017-02-18 17:17:56.587637
NCT00179868|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-08-26|||January 2003||2003-01-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||C-Reactive Protein as a Predictor of Stem Cell Transplant Complications|C-Reactive Protein As a Predictor of Major Transplant Complications in Pediatric Stem Cell Transplant Patients|Completed||Phase 2/Phase 3|44|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||1||f||||f||||||||||2017-02-18 17:17:56.797697|2017-02-18 17:17:56.797697
NCT00179855|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2010-10-07|||July 2003||2003-07-01|October 2010|2010-10-01|July 2012|Anticipated|2012-07-01|July 2012|Anticipated|2012-07-01||Interventional|||Extracorporeal Photopheresis for Acute Graft Versus Host Disease|Extracorporeal Photopheresis for Steroid-refractory Acute GVHD in Children and Young Adults: a Safety and Feasibility Study.|Unknown status|Recruiting|Phase 2/Phase 3|50|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-02-18 17:17:56.885641|2017-02-18 17:17:56.885641
NCT00179842|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2015-09-21||||||January 2009|2009-01-01|December 2008||2008-12-01|||||Interventional|||Immune Ablation and Stem Cell Support for Crohn's Disease|Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease|Withdrawn||Phase 2|0|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-02-18 17:17:56.975751|2017-02-18 17:17:56.975751
NCT00179829|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-01-14|||February 1999||1999-02-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||WT1 for the Detection of Minimal Residual Disease|Detection of Minimal Residual Disease in Newly Diagnosed Patients With Leukemia and Those Who Undergo a Bone Marrow Transplant Using the Wilms Tumor Suppressor Gene (WT1) as a Marker By RT-PCR|Completed||Phase 2/Phase 3|50|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago|||||f||||||||||||||2017-02-18 17:17:57.068603|2017-02-18 17:17:57.068603
NCT00179816|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2010-10-07|||April 1999||1999-04-01|October 2010|2010-10-01|September 2012|Anticipated|2012-09-01|September 2012|Anticipated|2012-09-01||Interventional|||Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors|High-Dose Chemotherapy With Tandem Peripheral Blood Stem Cell (PBSC) Rescue for the Treatment of High-Risk Pediatric Solid Tumors.|Unknown status|Recruiting|Phase 1/Phase 2|12|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-02-18 17:17:57.176479|2017-02-18 17:17:57.176479
NCT00179803|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-03-10|||March 1998||1998-03-01|March 2011|2011-03-01||||January 2008|Actual|2008-01-01||Interventional|||Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors|Phase II Prospective Study of Sequential Myeloablative Chemotherapy With Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors|Unknown status|Active, not recruiting|Phase 2/Phase 3|50|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-02-18 17:17:57.283661|2017-02-18 17:17:57.283661
NCT00179790|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-03-10|||July 2005||2005-07-01|February 2009|2009-02-01|January 2010|Anticipated|2010-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Reduced Intensity Transplant Using Extracorporeal Photopheresis|Reduced Intensity Stem Cell Transplant in Children and Young Adults Utilizing Photopheresis, Fludarabine, and Busulfan|Unknown status|Recruiting|Phase 1/Phase 2|50|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||||||||||||2017-02-18 17:17:57.382173|2017-02-18 17:17:57.382173
NCT00179777|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2014-02-14|||March 2002||2002-03-01|February 2014|2014-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk|TRIGR - Trial to Reduce IDDM in the Genetically at Risk|Unknown status|Active, not recruiting|Phase 2|2032|Actual|Children's Hospital of Eastern Ontario||1|||f||||t||||||||||2017-02-18 17:17:57.483766|2017-02-18 17:17:57.483766
NCT00179764|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2016-07-25|||March 2000||2000-03-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])|Immunoablative Protocol for Allogeneic Related and Unrelated Hematopoietic Peripheral Blood Stem Cell Transplant (HPBSC)|Recruiting||Phase 2|100|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||f||||||||||2017-02-18 17:17:57.613639|2017-02-18 17:17:57.613639
NCT00179751|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-11-02|||April 2005||2005-04-01|November 2005|2005-11-01|August 2006||2006-08-01|||||Interventional|||A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas|A Phase I/II Study Of Lenalidomide (Revlimid ) In Combination With Gemcitabine In Patients With Untreated Advanced Carcinoma Of The Pancreas|Terminated||Phase 1/Phase 2|50||Celgene|||||||||||||||||||2017-02-18 17:17:57.731411|2017-02-18 17:17:57.731411
NCT00179738|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-11-22|||April 2005||2005-04-01|September 2005|2005-09-01|April 2007||2007-04-01|||||Interventional|||A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.|A Multicenter, Single-Arm, Open-Label, Study To Evaluate The Safety And Efficacy Of Single-Agent Lenalidomide (Revlimid®) In Subjects With Androgen Independent Prostate Cancer|Terminated||Phase 2|40||Celgene|||||||||||||||||||2017-02-18 17:17:57.8298|2017-02-18 17:17:57.8298
NCT00179725|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2006-04-10|||November 2005||2005-11-01|April 2006|2006-04-01|June 2007||2007-06-01|||||Interventional|||Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma|Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma|Terminated||Phase 1/Phase 2|60||Celgene|||||||||||||||||||2017-02-18 17:17:57.914832|2017-02-18 17:17:57.914832
NCT00179712|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2016-11-30|||April 2005||2005-04-01|November 2016|2016-11-01|November 2006||2006-11-01|||||Interventional|||Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma|Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid®) With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma|Completed||Phase 1/Phase 2|60||Celgene Corporation|||||||||||||||||||2017-02-18 17:17:58.008027|2017-02-18 17:17:58.008027
NCT00179699|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-11-02|||September 2005||2005-09-01|October 2005|2005-10-01|November 2006||2006-11-01|||||Interventional|||Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer|Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1|40||Celgene|||||||||||||||||||2017-02-18 17:17:58.101119|2017-02-18 17:17:58.101119
NCT00179686|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2006-12-19|||March 2005||2005-03-01|December 2006|2006-12-01|July 2006||2006-07-01|||||Interventional|||A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer|A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|40||Celgene|||||||||||||||||||2017-02-18 17:17:58.183113|2017-02-18 17:17:58.183113
NCT00179673|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2013-11-06|2013-08-09||August 2005||2005-08-01|November 2013|2013-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|A Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid®, CC-5013) in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|Completed||Phase 2|43|Actual|Celgene||1|||f||||f||||||||||2017-02-18 17:17:58.270506|2017-02-18 17:17:58.270506
NCT00179660|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-17|2013-06-25||August 2005||2005-08-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional||Intent to treat population includes all participants who received at least 1 dose of study drug.|Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)|A Phase II, Multicenter, Single-Arm, Open-Label Study To Evaluate The Safety And Efficacy Of Single-Agent Lenalidomide (Revlimid®, CC-5013) In Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|50|Actual|Celgene||1|||f||||||||||||||2017-02-18 17:17:58.805629|2017-02-18 17:17:58.805629
NCT00179647|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-10|2009-12-21||September 2005||2005-09-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|December 2008|Actual|2008-12-01||Interventional|||Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma|A Multicenter, Single-Arm, Open-Label, Expanded Access Program for Lenalidomide With or Without Dexamethasone in Previously Treated Subjects With Multiple Myeloma|Completed||Phase 3|1913|Actual|Celgene||1|||t||||f||||||||||2017-02-18 17:17:59.309378|2017-02-18 17:17:59.309378
NCT00179634|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-03|||March 2005||2005-03-01|February 2010|2010-02-01|January 2009|Anticipated|2009-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast Cancer|Using Visual Milieu Enrichment and Guided Visualization to Augment Patient Well-being and Post-surgical Recovery|Terminated||Phase 2/Phase 3|45|Anticipated|Beth Israel Deaconess Medical Center||3||Expired for lack of continuing review|f||||f||||||||||2017-02-18 17:18:03.305444|2017-02-18 17:18:03.305444
NCT00179621|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-04-12|2011-02-09||July 2005||2005-07-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|June 2008|Actual|2008-06-01||Interventional|||Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study of the Efficacy and Safety of 2 Doses of Lenalidomide Versus Placebo in Red Blood Cell (RBC) Transfusion-Dependent Subjects With Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated With a Deletion (Del) 5q[31] Cytogenetic Abnormality|Completed||Phase 3|205|Actual|Celgene||3|||f||||t||||||||||2017-02-18 17:18:03.43766|2017-02-18 17:18:03.43766
NCT00179608|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-30|||September 2005||2005-09-01|November 2016|2016-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy|Phase I Safety Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy|Completed||Phase 1|28||Celgene Corporation|||||||||||||||||||2017-02-18 17:18:05.903302|2017-02-18 17:18:05.903302
NCT00179595|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-14|||May 2002||2002-05-01|February 2017|2017-02-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Does the Relaxation Response Inhibit Acute Stress?|Does the Relaxation Response Inhibit Acute Stress?|Completed||Phase 2|140|Anticipated|Beth Israel Deaconess Medical Center|||||f||||f||||||||No||2017-02-18 17:18:05.989329|2017-02-18 17:18:05.989329
NCT00179582|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-26||||||May 2010|2010-05-01||||||||Interventional|||Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS|A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients|Unknown status|Active, not recruiting|N/A|180|Anticipated|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:18:06.083456|2017-02-18 17:18:06.083456
NCT00179569|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-02|||August 2005||2005-08-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||Molecular Processes of the Relaxation Response in Older Adults|Molecular Processes of the Relaxation Response in Older Adults|Completed||Phase 2|40|Anticipated|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-02-18 17:18:06.174648|2017-02-18 17:18:06.174648
NCT00179556|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-06|||June 2003||2003-06-01|November 2015|2015-11-01|September 2005|Actual|2005-09-01|July 2005|Actual|2005-07-01||Interventional|||Effects of Soy Isoflavones on Menopausal Hot Flashes|Daidzein-rich Isoflavone-aglycones for Menopausal Symptoms|Completed||Phase 2/Phase 3|210||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:18:06.25626|2017-02-18 17:18:06.25626
NCT00179543|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-09-18|||August 2001||2001-08-01|September 2006|2006-09-01||||||||Interventional|||Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients|Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients|Completed||Phase 2|122||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:18:06.344085|2017-02-18 17:18:06.344085
NCT00179530|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-02|||May 1999||1999-05-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults|The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults|Completed||Phase 2|16|Actual|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-02-18 17:18:06.419722|2017-02-18 17:18:06.419722
NCT00179517|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-05|||June 2001||2001-06-01|October 2007|2007-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Treatment of Sexual Dysfunction in Men With Epilepsy With Testosterone and Either Arimidex or Placebo|Comparison of Arimidex and Testosterone Versus Placebo and Testosterone Treatment of Reproductive and Sexual Dysfunction in Men With Epilepsy and Hypogonadism|Completed||Phase 2|40|Anticipated|Beth Israel Deaconess Medical Center|||||||||||||||||||2017-02-18 17:18:06.483752|2017-02-18 17:18:06.483752
NCT00179504|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-02|||July 2000||2000-07-01|November 2007|2007-11-01|September 2007|Actual|2007-09-01|||||Interventional|||The Effect of Relaxation Response Training on Declarative Memory and Learning in High School Students|The Effect of Relaxation Response Training on Declarative Memory and Learning in High School Students|Completed||Phase 2|90|Actual|Beth Israel Deaconess Medical Center||1|||f||||||||||||||2017-02-18 17:18:06.589857|2017-02-18 17:18:06.589857
NCT00179478|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-22|||February 2001||2001-02-01|June 2011|2011-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|CHAMPIONS10||Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis|Controlled High-risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurologic Surveillance (CHAMPIONS)|Completed||Phase 4|203|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 17:18:06.987095|2017-02-18 17:18:06.987095
NCT00179465|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-07-28|||November 2003||2003-11-01|July 2011|2011-07-01||||July 2012|Anticipated|2012-07-01||Interventional|||Treating Schizophrenia by Correcting Abnormal Brain Development|Addition of Tiagabine to Second-Generation Antipsychotics in the Treatment of Recent-Onset Schizophrenia by Modification of Developmental Reorganization of the Prefrontal Cortex|Unknown status|Recruiting|Phase 3|36|Anticipated|Beth Israel Deaconess Medical Center||2|||f||||||||||||||2017-02-18 17:18:07.124955|2017-02-18 17:18:07.124955
NCT00179452|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-27|||October 2003||2003-10-01|December 2007|2007-12-01|October 2004|Anticipated|2004-10-01|||||Interventional|||Yoga for Patients With Epilepsy|Is Yoga Safe for Patients With Epilepsy?|Unknown status|Recruiting|N/A|20|Anticipated|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:18:07.248145|2017-02-18 17:18:07.248145
NCT00179439|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-10|||January 2004||2004-01-01|March 2015|2015-03-01||||January 2006||2006-01-01||Observational|NPD||NPDT Evaluation in Children With CFTR and (PSC)|Nasal Potential Difference Testing: Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Children With Primary Sclerosing Cholangitis (PSC)|Terminated||N/A|50|Anticipated|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:18:07.350379|2017-02-18 17:18:07.350379
NCT00179426|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-07|||October 1999||1999-10-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Observational|||Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy|Antiseizure Medication-Induced Elevation of Serum Estradiol and Reproductive Dysfunction in Men With Epilepsy|Completed||N/A|175||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:18:07.448459|2017-02-18 17:18:07.448459
NCT00179413|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2006-06-23|||January 2001||2001-01-01|September 2005|2005-09-01|December 2009||2009-12-01|||||Interventional|||Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.|Phase IV Study of Long Term Peg-Intron for Patients Who Have Failed to Respond to Rebetron/Interferon With Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C- The Copilot Trial|Unknown status|Active, not recruiting|Phase 4|800||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:18:07.550342|2017-02-18 17:18:07.550342
NCT00179400|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-03-07||||||March 2012|2012-03-01||||||||Interventional|||Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone|The Role of Acute Combined Peroxisome Proliferator-Activated Receptors (PPAR) Alpha and Gamma Stimulation on Insulin Action in Humans|Unknown status|Active, not recruiting|N/A|||Albert Einstein College of Medicine, Inc.|||||f||||||||||||||2017-02-18 17:18:07.702971|2017-02-18 17:18:07.702971
NCT00179387|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-23|||December 1, 2004|Actual|2004-12-01|January 2017|2017-01-01|February 25, 2016|Actual|2016-02-25|February 25, 2016|Actual|2016-02-25||Interventional|||Mind-Body Program for Cancer Patients|Evaluation of Mind-Body Groups on the Quality of Life of Cancer Patients|Completed||N/A|166|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||t||||||||||2017-02-18 17:18:07.785866|2017-02-18 17:18:07.785866
NCT00179374|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-27|||July 2003||2003-07-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Improving Diabetes Outcomes With Activity, Nutrition and Medication|Improving Diabetes Medication Adherence and Outcomes|Completed||N/A|556|Anticipated|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-02-18 17:18:07.892697|2017-02-18 17:18:07.892697
NCT00179361|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-22|||November 2004||2004-11-01|November 2009|2009-11-01||||July 2014|Actual|2014-07-01||Observational|||Natural History of Oro-pharyngeal Cancer Precursors|Natural History of Oral Cancer Precursors|Completed||N/A|374|Actual|Albert Einstein College of Medicine, Inc.|||1||f||||f||||||Samples With DNA|"~     Oral brush samples.~   "|||2017-02-18 17:18:07.995565|2017-02-18 17:18:07.995565
NCT00179348|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-23|||February 8, 2001|Actual|2001-02-08|January 2017|2017-01-01|July 20, 2016|Actual|2016-07-20|July 20, 2016|Actual|2016-07-20||Interventional|||Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer|Evaluation of a Yoga-Based Cancer Rehabilitation Program|Completed||N/A|399|Actual|Albert Einstein College of Medicine, Inc.||2|||f||||f||||||||||2017-02-18 17:18:08.071721|2017-02-18 17:18:08.071721
NCT00179335|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2009-08-05|||August 2003||2003-08-01|August 2009|2009-08-01|September 2006|Actual|2006-09-01|January 2006|Actual|2006-01-01||Observational|||Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults|Cross Sectional Case-Sectional Control Pharmacokinetic Study of Efavirenz or Lopinavir/Ritonavir as Part of an Antiretroviral Regimen With Two Nucleosides in HIV-Infected Adults 55 Years of Age or Older Compared With Adults Aged 18-35 Years|Completed||N/A|45|Actual|Albert Einstein College of Medicine, Inc.|||4||f||||||||||Samples Without DNA|"~     Residual plasma left from measurement of drug levels.~   "|||2017-02-18 17:18:08.181363|2017-02-18 17:18:08.181363
NCT00179322|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2017-01-24|||September 10, 2005||2005-09-10|September 30, 2016|2016-09-30|September 30, 2016||2016-09-30|||||Observational|||Effects of Sleep Deprivation and Recovery on Cognitive Functions|Effects of Sleep Deprivation and Recovery Sleep on Speech, Language and Other Higher Cognitive Functions: A Combined EEG-fMRI Study|Completed||N/A|29|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:18:08.280123|2017-02-18 17:18:08.280123
NCT00179309|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-15|2014-06-30|2013-04-29||September 2005||2005-09-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|February 2013|Actual|2013-02-01||Interventional|||Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer|A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer|Completed||Phase 2|48|Actual|National Institutes of Health Clinical Center (CC)|The goal of this study was to get preliminary evidence of improved progression free survival with the combination compared with docetaxel alone and obtain data on which to plan a larger more definitive study in a more uniform patient population.|2|||f||||t||||||||||2017-02-18 17:18:08.381815|2017-02-18 17:18:08.381815
NCT00179283|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-06-01|||April 2002||2002-04-01|June 2015|2015-06-01|April 2003||2003-04-01|||||Interventional|||Sertraline vs. Venlafaxine XR|A Multi-center, Randomized, Double-blind, Parallel-group Study of Sertraline vs. Venlafaxine XR in the Acute Treatment of Outpatients With Major Depressive Disorder|Completed||Phase 3|20||Vanderbilt University|||||f||||||||||||||2017-02-18 17:18:09.370023|2017-02-18 17:18:09.370023
NCT00179257|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-06-01|||June 2004||2004-06-01|June 2015|2015-06-01|March 2005||2005-03-01|||||Interventional|||The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram|The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to|Completed||Phase 3|20||Vanderbilt University|||||f||||||||||||||2017-02-18 17:18:09.464857|2017-02-18 17:18:09.464857
NCT00179244|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-06-01|||July 2004||2004-07-01|June 2015|2015-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression|Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression|Completed||Phase 3|30||Vanderbilt University|||||f||||||||||||||2017-02-18 17:18:09.563159|2017-02-18 17:18:09.563159
NCT00179231|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 2000||2000-05-01|September 2005|2005-09-01|February 2004||2004-02-01|||||Interventional|||Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia||Completed||N/A|80||Vanderbilt University|||||f||||||||||||||2017-02-18 17:18:09.658239|2017-02-18 17:18:09.658239
NCT00179218|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-07-08|||April 2005||2005-04-01|July 2009|2009-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients|The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients|Completed||Phase 2|19|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:18:09.729002|2017-02-18 17:18:09.729002
NCT00179205|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-08-05|||May 2005||2005-05-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|November 2006|Actual|2006-11-01||Interventional|||Complementary Intradialytic Nutritional Supplementation in Dialysis Patients|Complementary Intradialytic Nutritional Supplementation in Dialysis Patients|Terminated||Phase 2|27|Actual|Vanderbilt University||2||funding exhausted|f||||f||||||||||2017-02-18 17:18:09.826535|2017-02-18 17:18:09.826535
NCT00179192|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-21|||May 1998||1998-05-01|May 2015|2015-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Prevention and Treatment of Hemodialysis Vascular Access Malfunction|Prevention and Treatment of Hemodialysis Vascular Access Malfunction|Withdrawn||Phase 2|0|Actual|Vanderbilt University||3||non-enrollment|f||||f||||||||||2017-02-18 17:18:09.926519|2017-02-18 17:18:09.926519
NCT00179179|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-07-08|||April 2005||2005-04-01|July 2009|2009-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis|The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis|Completed||Phase 2|11|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:18:10.035485|2017-02-18 17:18:10.035485
NCT00179166|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-09-23|||June 2004||2004-06-01|September 2010|2010-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure|Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure|Terminated||Phase 2|3|Actual|Vanderbilt University||2||lack of enrollment|f||||f||||||||||2017-02-18 17:18:10.310301|2017-02-18 17:18:10.310301
NCT00179153|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-27|||February 2005||2005-02-01|May 2014|2014-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee|Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee|Completed||Phase 2|352|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 17:18:10.405967|2017-02-18 17:18:10.405967
NCT00179140|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-21|||November 2002||2002-11-01|May 2015|2015-05-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients|The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients|Completed||Phase 2|26|Actual|Vanderbilt University||3|||f||||f||||||||||2017-02-18 17:18:10.511341|2017-02-18 17:18:10.511341
NCT00179127|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-20|||August 2004||2004-08-01|June 2012|2012-06-01|September 2012|Anticipated|2012-09-01|July 2009|Actual|2009-07-01||Interventional|||Use of Insulin Glargine to Treat Diabetic Ketoacidosis|Early Use of Insulin Glargine in Diabetic Ketoacidosis|Unknown status|Active, not recruiting|N/A|75|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:18:10.606928|2017-02-18 17:18:10.606928
NCT00179114|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-17|||August 2002||2002-08-01|August 2007|2007-08-01|February 2006||2006-02-01|||||Interventional|||Vanderbilt University Spasticity Management Program Evaluation Plan|Vanderbilt University Spasticity Management Program Evaluation Plan|Completed||Phase 4|20||Vanderbilt University|||||f||||f||||||||||2017-02-18 17:18:10.721292|2017-02-18 17:18:10.721292
NCT00179101|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-08-11|||April 2004||2004-04-01|August 2006|2006-08-01|November 2005||2005-11-01|||||Observational|||Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson’s Patients|Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson’s Patients|Completed||N/A|42||Vanderbilt University|||||f||||||||||||||2017-02-18 17:18:10.815985|2017-02-18 17:18:10.815985
NCT00179088|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-01|||May 2003||2003-05-01|November 2010|2010-11-01|December 2006||2006-12-01|||||Interventional|||Safety of Non-delayed Weight Bearing After Total Hip Replacement With Non-Cemented Fiber Metal Taper Stem|Fiber Metal Taper Prospective Randomized Weight Bearing Investigation|Completed||N/A|33||Vanderbilt University|||||f||||||||||||||2017-02-18 17:18:10.907982|2017-02-18 17:18:10.907982
NCT00179075|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-12|||April 2003||2003-04-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|||||Observational|||Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant|Repository for Study: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant (HSCT)|Completed||N/A|100|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-02-18 17:18:11.001872|2017-02-18 17:18:11.001872
NCT00179062|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-08-25|||February 2000||2000-02-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder|Effects of Risperidone and Olanzapine on Weight Gain, Physical Health, and Outcome in a Community Sample of Severity and Persistently Ill Patients|Completed||N/A|300|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:18:11.089261|2017-02-18 17:18:11.089261
NCT00179049|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-12|||April 2003||2003-04-01|December 2008|2008-12-01|April 2008|Actual|2008-04-01|||||Observational|||Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant|Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant (HSCT)|Completed||N/A|100|Anticipated|Vanderbilt University|||1||f||||f||||||||||2017-02-18 17:18:11.194662|2017-02-18 17:18:11.194662
NCT00179036|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-24|||January 2000||2000-01-01|June 2011|2011-06-01|June 2012|Anticipated|2012-06-01|||||Observational|SQUID||Biomagnetic Signals of Intestinal Ischemia II|Biomagnetic Signals of Intestinal Ischemia II|Unknown status|Recruiting|Phase 1|60|Anticipated|Vanderbilt University|||2||f||||f||||||||||2017-02-18 17:18:11.287375|2017-02-18 17:18:11.287375
NCT00179023|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-16|||April 2003||2003-04-01|January 2017|2017-01-01|January 2017|Actual|2017-01-01|January 2017|Actual|2017-01-01||Interventional|||The Autonomic Nervous System and Obesity|The Autonomic Nervous System and Obesity|Completed||Phase 1|128|Actual|Vanderbilt University Medical Center||5|||f||||f||||||||No||2017-02-18 17:18:11.382066|2017-02-18 17:18:11.382066
NCT00179010|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-02-02|||October 2003||2003-10-01|February 2015|2015-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||AMP as a Better Delivery System of Adenosine|Use of AMP to Improve Tissue Delivery of Adenosine|Suspended||N/A|64|Anticipated|Vanderbilt University||2||In process of renewing IND for AMP|f||||f||||||||||2017-02-18 17:18:11.509065|2017-02-18 17:18:11.509065
NCT00178997|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-24|||February 2004||2004-02-01|June 2011|2011-06-01|July 2011|Anticipated|2011-07-01|||||Observational|SQUID||Realistic Models of Gastrointestinal Bioelectromagnetism|Realistic Models of Gastrointestinal Bioelectromagnetism|Unknown status|Recruiting|Phase 1|60|Anticipated|Vanderbilt University|||2||f||||f||||||||||2017-02-18 17:18:11.614957|2017-02-18 17:18:11.614957
NCT00178984|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-24|||June 2000||2000-06-01|June 2011|2011-06-01|September 2013|Anticipated|2013-09-01|||||Observational|SQUID||Biomagnetic Characterization of Gastric Dysrhythmias:Study 2|Biomagnetic Characterization of Gastric Dysrhythmias:Study 2|Unknown status|Recruiting|Phase 1|60|Anticipated|Vanderbilt University|||2||f||||f||||||||||2017-02-18 17:18:11.709461|2017-02-18 17:18:11.709461
NCT00178971|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-06|||January 2003||2003-01-01|January 2010|2010-01-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Serotonin 1A Agonists and Cognition in Schizophrenia|Serotonin 1A Agonists and Cognition in Schizophrenia|Completed||Phase 3|60|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:18:11.803004|2017-02-18 17:18:11.803004
NCT00178958|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-03|||August 2003||2003-08-01|October 2007|2007-10-01|June 2006|Actual|2006-06-01|||||Interventional|||Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-Treated Patients With Schizophrenia||Completed||N/A|70||Vanderbilt University|||||f||||f||||||||||2017-02-18 17:18:11.913733|2017-02-18 17:18:11.913733
NCT00178945|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-27|||March 2004||2004-03-01|August 2007|2007-08-01|March 2006||2006-03-01|||||Interventional|||Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain|Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Botulinum Toxin Type A (Botox) for the Treatment of Pain Associated With Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome|Completed||Phase 1/Phase 2|20||Vanderbilt University|||||f||||||||||||||2017-02-18 17:18:11.983923|2017-02-18 17:18:11.983923
NCT00178932|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-11-01|||November 1998||1998-11-01|November 2010|2010-11-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Interventional|||Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors|Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors|Unknown status|Recruiting|N/A|1000|Anticipated|Vanderbilt University||1|||f||||f||||||||||2017-02-18 17:18:12.087553|2017-02-18 17:18:12.087553
NCT00178919|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-24|2009-04-10||August 2002||2002-08-01|May 2013|2013-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Nitric Oxide and the Autonomic Nervous System|Cardiovascular Regulation: Autonomic/Metabolic Mechanisms PO1 HL56693, Project 4: Cardiovascular Regulation: Autonomic/Metabolic Mechanisms|Completed||N/A|112|Actual|Vanderbilt University||2|||f||||f||||||||||2017-02-18 17:18:12.175489|2017-02-18 17:18:12.175489
NCT00178906|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-21|||December 1999||1999-12-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Acoustical Properties of Speech as Indicators of Suicidal Risk|Acoustical Properties of Speech as Indicators of Suicidal Risk|Completed||N/A|124|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 17:18:12.552691|2017-02-18 17:18:12.552691
NCT00178893|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-20|||April 2004||2004-04-01|August 2010|2010-08-01|December 2012|Anticipated|2012-12-01|||||Observational|||Hepatocellular Research Registry|CellzDirect: Hepatocellular Research Registry|Unknown status|Recruiting|N/A|200|Anticipated|Vanderbilt University|||1||f||||f||||||Samples Without DNA|"~     Hepatocytes~   "|||2017-02-18 17:18:12.631788|2017-02-18 17:18:12.631788
NCT00178880|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-30||||||December 2009|2009-12-01|November 2009|Actual|2009-11-01|||||Observational|||MRI Imaging of Chronobiologic Abnormalities in Depression|MRI Imaging of Chronobiologic Abnormalities in Depression|Completed||Phase 4|80|Anticipated|Vanderbilt University|||2||f||||||||||||||2017-02-18 17:18:12.704285|2017-02-18 17:18:12.704285
NCT00178867|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-09|||January 2002||2002-01-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|||||Observational|||A National Registry of Patients With Hepatocellular Carcinoma|A National Registry of Patients With Hepatocellular Carcinoma|Completed||N/A|150|Actual|Vanderbilt University|||1||f||||f||||||||||2017-02-18 17:18:12.792229|2017-02-18 17:18:12.792229
NCT00178854|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-02-05|||May 2004||2004-05-01|February 2010|2010-02-01|December 2006||2006-12-01|||||Interventional|||Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment|Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment|Withdrawn||Phase 4|6||Vanderbilt University||||failed recruitment efforts|f||||||||||||||2017-02-18 17:18:12.871603|2017-02-18 17:18:12.871603
NCT00178841|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-20|2014-05-27||June 2005||2005-06-01|January 2016|2016-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL|Open Label Pilot Study of Combination Therapy With Rosiglitazone and Bexarotene to Investigate a Possible Synergism in the Treatment of Cutaneous T-Cell Lymphoma|Completed||Phase 2|4|Actual|Vanderbilt University||1|||f||||f||||||||||2017-02-18 17:18:12.952924|2017-02-18 17:18:12.952924
NCT00178828|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-03-23|||October 2002||2002-10-01|March 2011|2011-03-01|June 2015|Anticipated|2015-06-01|April 2007|Actual|2007-04-01||Interventional|||Dynamic Measures of Neurochemistry in Mood Disorders|Dynamic Measures of Neurochemistry in Mood Disorders|Unknown status|Active, not recruiting|Phase 4|42|Actual|Vanderbilt University||1|||f||||||||||||||2017-02-18 17:18:13.20537|2017-02-18 17:18:13.20537
NCT00178802|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-22|||June 1996||1996-06-01|April 2010|2010-04-01|December 2010|Anticipated|2010-12-01|June 2010|Anticipated|2010-06-01||Interventional|||Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers|Phase II Study of Mild Whole Body Hyperthermia Combined With 5-Fluorouracil/Interferon-a/Liposomal Doxorubicin in Patients With Advanced Malignancy|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-02-18 17:18:13.309914|2017-02-18 17:18:13.309914
NCT00178412|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-06-13|||April 2003||2003-04-01|June 2012|2012-06-01|March 2009|Actual|2009-03-01|April 2006|Actual|2006-04-01||Interventional|||Improving Outcomes of Hospitalized Elders and Caregivers|Improving Outcomes of Hospitalized Elders and Caregivers|Completed||Phase 2|421|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 17:18:18.395726|2017-02-18 17:18:18.395726
NCT00178789|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-05-22|||September 2005||2005-09-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Observational|||Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis|Prospective Observational Trial of Point-of-Care, Limited Ultrasonography (PLUS) for Lower Extremity Deep Venous Thrombosis in the Emergency Department: The Sonography Outcomes Assessment Program (SOAP-4 Trial)|Completed||Phase 1/Phase 2|51|Anticipated|The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 17:18:13.419172|2017-02-18 17:18:13.419172
NCT00178776|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-10|||October 2003||2003-10-01|September 2014|2014-09-01|June 2007|Actual|2007-06-01|November 2006|Actual|2006-11-01||Interventional|||A Transtheoretical Model Group Therapy for Cocaine|A Transtheoretical Model Group Therapy for Cocaine|Completed||Phase 1|138|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 17:18:13.496433|2017-02-18 17:18:13.496433
NCT00178763|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-02|||September 2003||2003-09-01|March 2011|2011-03-01|June 2013|Anticipated|2013-06-01|June 2012|Anticipated|2012-06-01||Interventional|FR-WB-TT||Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer|Phase II Clinical Trial of Cisplatin + Gemcitabine in Combination With Mild, Fever-Range Whole-Body Hyperthermia to Treat Patients With Advanced, Inoperable Pancreatic Cancer|Unknown status|Recruiting|Phase 2|36|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-02-18 17:18:13.717318|2017-02-18 17:18:13.717318
NCT00178750|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-27||||||December 2007|2007-12-01||||||||Interventional|||"Loss of Resistance Versus CompuFlo® for Epidural Placement"|"A Randomized Clinical Comparison of the Loss of Resistance Technique Versus the CompuFlo® Computerized Syringe Pump for Proper Epidural Placement"|Withdrawn||Phase 1/Phase 2|100|Anticipated|The University of Texas Health Science Center, Houston||||Study did not start due to investigator time constraints|f||||||||||||||2017-02-18 17:18:13.837122|2017-02-18 17:18:13.837122
NCT00178737|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-18||||||February 2010|2010-02-01|December 2006||2006-12-01|||||Interventional|||Does the Message Matter? Enhancing Adherence in Healthcare Through Persuasive Messages|Does the Message Matter? Enhancing Adherence in Healthcare Through Persuasive Messages|Completed||N/A|1200|Anticipated|The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 17:18:13.934755|2017-02-18 17:18:13.934755
NCT00178724|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-24|||July 2005||2005-07-01|January 2017|2017-01-01|July 2023|Anticipated|2023-07-01|July 2020|Anticipated|2020-07-01||Observational|NACTN||North American Clinical Trials Network (NACTN) for Treatment of Spinal Cord Injury - Registry|North American Clinical Trials Network (NACTN) for Treatment of Spinal Cord Injury|Recruiting||N/A|1500|Anticipated|The Methodist Hospital System|||1||f||||f|f|f||||||No||2017-02-18 17:18:13.997417|2017-02-18 17:18:13.997417
NCT00178711|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-09-13|2014-07-31||November 2005||2005-11-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|NABIS:HIIR|hypothermia group-- 26 ± 9 years of age, 40 males/12 females normothermia group--31 ± 11 year of age, 41 males/4 females|Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury|National Acute Brain Injury Study: Hypothermia IIR|Terminated||Phase 3|232|Actual|The University of Texas Health Science Center, Houston|Early termination for futility.|2||Futility|f||||t||||||||||2017-02-18 17:18:14.163882|2017-02-18 17:18:14.163882
NCT00178698|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-02|||July 2002||2002-07-01|March 2011|2011-03-01|June 2014|Anticipated|2014-06-01|June 2013|Anticipated|2013-06-01||Interventional|FR-WB-TT/che||Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors|A Phase II Clinical Trial of Cisplatin + Gemcitabine HCl (GEM) + Low-Dose Metronomic Interferon-a (IFN-a) Combined With Fever-Range Whole-Body Thermal Therapy (FR-WB-TT) in Patients With Metastatic/or Locally Advanced Malignancies (Small-Cell Lung Cancer, Neuroendocrine Cancer, Gastric Cancer)|Unknown status|Recruiting|Phase 2|36|Anticipated|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-02-18 17:18:14.634593|2017-02-18 17:18:14.634593
NCT00178685|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-15|2013-01-15||August 2004||2004-08-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|SHP||Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence|Self-determination and Maintaining Tobacco Abstinence|Completed||Phase 4|837|Actual|University of Rochester|A limitation of this study is the low completion rate of smokers enrolling in the study. This increases the chance of accepting the null hypothesis when there may be differences between groups if all smokers had provided their outcomes.|1|||f||||||||||||||2017-02-18 17:18:14.950258|2017-02-18 17:18:14.950258
NCT00178672|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-11|||November 2002||2002-11-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease|A Single Center IDE Study on Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease|Completed||Phase 4|69|Actual|The University of Texas Health Science Center, Houston||1|||f||||t||||||||||2017-02-18 17:18:15.448546|2017-02-18 17:18:15.448546
NCT00178659|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-16|||July 2004||2004-07-01|January 2017|2017-01-01|December 2020|Anticipated|2020-12-01|April 2018|Anticipated|2018-04-01||Observational|Proteomics||Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)|Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)|Active, not recruiting||N/A|260|Anticipated|The University of Texas Health Science Center, Houston|||4||f||||f||||||Samples Without DNA|"~     Plasma and serum samples for use in identifying proteins related to head trauma~   "|No|There is no plan to make individual participant data available|2017-02-18 17:18:15.557703|2017-02-18 17:18:15.557703
NCT00178646|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-09||2013-12-09|January 2002||2002-01-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity|Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity|Completed||Phase 4|33|Actual|The University of Texas Health Science Center, Houston||3|||f||||f||||||||||2017-02-18 17:18:15.673941|2017-02-18 17:18:15.673941
NCT00178633|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-09-03|2013-08-01||May 2004||2004-05-01|September 2014|2014-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational||43 patients were originally enrolled, and 37 participated through 9 months; 15 female participants returned for an additional 2 year analysis.|Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery|Dramatic Reversal of Derangements in Muscle Metabolism and Left Ventricular Function After Bariatric Surgery|Completed||N/A|43|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples Without DNA|"~     Skeletal muscle biopsies, plasma~   "|||2017-02-18 17:18:15.822106|2017-02-18 17:18:15.822106
NCT00178399|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-06-02|||April 2001||2001-04-01|June 2014|2014-06-01|April 2020|Anticipated|2020-04-01|April 2020|Anticipated|2020-04-01||Interventional|||A Study For Using Radiosurgery On Limited Metastases|A Pilot Study For Using Radiosurgery On Limited Metastases|Suspended||N/A|300|Anticipated|University of Rochester||1||to analyze data of subjects already enrolled.|f||||t||||||||||2017-02-18 17:18:18.504592|2017-02-18 17:18:18.504592
NCT00178620|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-12-06|||November 2003||2003-11-01|December 2014|2014-12-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|PATCAR||Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization|PATCAR Pilot Trial: A Phase 4 Study, Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization|Completed||Phase 4|254|Actual|The University of Texas Health Science Center, Houston||2|||f||||t||||||||||2017-02-18 17:18:16.100693|2017-02-18 17:18:16.100693
NCT00178607|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-10|||August 2002||2002-08-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|October 2015|Actual|2015-10-01||Observational|||Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia|Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia|Completed||N/A|99|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||Samples With DNA|"~     Serum and Plasma~   "|Yes|The data will be analyzed and published|2017-02-18 17:18:16.231683|2017-02-18 17:18:16.231683
NCT00178594|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-10|||October 2002||2002-10-01|May 2016|2016-05-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Evaluation of Hemostasis in Bleeding and Thrombotic Disorders|Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay|Recruiting||N/A|100|Anticipated|The University of Texas Health Science Center, Houston|||1||f||||f||||||||Undecided|Undecided at this time|2017-02-18 17:18:16.322224|2017-02-18 17:18:16.322224
NCT00178581|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-04-22|||June 2005||2005-06-01|December 2007|2007-12-01|September 2006||2006-09-01|||||Interventional|||Enteral Glutamine Supplementation for the Patient With Major Torso Trauma|Early Enteral Glutamine Supplement to Enteral Nutrition Support of the Major Torso Trauma Patient: Proposal for a Prospective Randomized Clinical Trial|Terminated||Phase 1|20||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 17:18:16.434629|2017-02-18 17:18:16.434629
NCT00178568|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-26|||February 2003||2003-02-01|May 2015|2015-05-01|November 2009|Actual|2009-11-01|November 2008|Actual|2008-11-01||Observational|||Reducing Caregiver Stress and Sleep Disturbances in Patients With Progressive Dementia|AgeWise Project 2: Reducing Stress and Sleep Disturbances in Caregivers of Patients With Progressive Dementia|Completed||Phase 1|60|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     Saliva collected on cotton rolls and frozen by participant. Kept frozen until shipped for~     assay.~   "|||2017-02-18 17:18:16.541419|2017-02-18 17:18:16.541419
NCT00178555|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-22|||August 2003||2003-08-01|March 2016|2016-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Comparison of the Video and Macintosh Laryngoscope in Patients Who May be Difficult to Intubate|A Comparison of Laryngoscopy Techniques Using the Video Laryngoscope and the Traditional Macintosh Laryngoscope in Patients Who May be Difficult to Intubate|Completed||Phase 4|200||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 17:18:16.674505|2017-02-18 17:18:16.674505
NCT00178542|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-03|||September 2005||2005-09-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle|Changes in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle|Terminated||N/A|20|Actual|The University of Texas Health Science Center, Houston|||1|Insufficient enrollment|f||||f||||||||||2017-02-18 17:18:16.758862|2017-02-18 17:18:16.758862
NCT00178529|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-02|||July 2001||2001-07-01|March 2007|2007-03-01|September 2005||2005-09-01|||||Interventional|||Intervention for Stroke Survivors and Their Spousal Caregivers|Intervention for Stroke Survivors and Their Spousal Caregivers|Completed||N/A|160||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 17:18:16.85299|2017-02-18 17:18:16.85299
NCT00178516|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-07-29|||June 2004||2004-06-01|July 2009|2009-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Vitamin E and Male Infertility|Vitamin E and Male Infertility|Completed||N/A|58|Actual|University of Rochester|||2||f||||f||||||Samples With DNA|"~     whole blood, serum, semen~   "|||2017-02-18 17:18:16.945557|2017-02-18 17:18:16.945557
NCT00178503|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-06|2013-01-14||September 2005||2005-09-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children|ADHD Symptoms in Autism: Cognition, Behavior, Treatment|Completed||Phase 2/Phase 3|24|Actual|The University of Texas Health Science Center, Houston|We did not have teacher behavioral data for all of the children because some of them were seen during the summer, when teacher input was not available.|4|||f||||t||||||||||2017-02-18 17:18:17.039648|2017-02-18 17:18:17.039648
NCT00178490|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-02|||January 2005||2005-01-01|June 2014|2014-06-01|January 2010|Actual|2010-01-01|June 2009|Actual|2009-06-01||Interventional|||Effect of High Blood Pressure and Antihypertensive Treatment on Brain Functioning in Children|Neurocognitive Function in Children With Hypertension|Completed||Phase 1|100|Anticipated|University of Rochester||2|||f||||f||||||||||2017-02-18 17:18:17.44631|2017-02-18 17:18:17.44631
NCT00178477|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-04-18|2011-08-12||January 2002||2002-01-01|April 2013|2013-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Study of Breath-holding as a Means to Reduce Tumor Motion From Breathing|Feasibility Study for Gated External-Beam Radiotherapy for Patients With Internal, Extra-cranial Tumors|Terminated||N/A|10|Actual|University of Rochester||1||Drs Okunieff and ODell have left the University of Rochester|f||||f||||||||||2017-02-18 17:18:17.54902|2017-02-18 17:18:17.54902
NCT00178464|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-29|2011-08-09||March 2005||2005-03-01|September 2011|2011-09-01|November 2009|Actual|2009-11-01|April 2009|Actual|2009-04-01||Interventional|START||Aspirin Prophylaxis in Sickle Cell Disease|Aspirin Prophylaxis in Sickle Cell Disease|Completed||Phase 1/Phase 2|11|Actual|University of Rochester||1|||f||||t||||||||||2017-02-18 17:18:17.86833|2017-02-18 17:18:17.86833
NCT00178451|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-17||||||December 2015|2015-12-01||||||||Interventional|||Stroke Prevention With Abciximab in Carotid Endarterectomy|Stroke Prevention With Abciximab in Carotid Endarterectomy|Withdrawn||Phase 1/Phase 2|0|Actual|University of Rochester|||||||||||||||||||2017-02-18 17:18:18.133385|2017-02-18 17:18:18.133385
NCT00178438|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-09-16|||June 2005||2005-06-01|September 2015|2015-09-01|June 2006||2006-06-01|||||Interventional|||Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease|A Prospective Trial of Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease|Withdrawn||Phase 1/Phase 2|0|Actual|University of Rochester|||||f||||||||||||||2017-02-18 17:18:18.229878|2017-02-18 17:18:18.229878
NCT00178425|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-18|||January 2005||2005-01-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|||PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients|Pharmacokinetics of Intravenous / Oral MMF and Oral Tacrolimus in Live Donor and Deceased Donor Liver Transplant Patients|Completed||Phase 4|24||University of Rochester|||||f||||f||||||||||2017-02-18 17:18:18.312833|2017-02-18 17:18:18.312833
NCT00178386|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-11|||September 2004||2004-09-01|June 2015|2015-06-01|April 2008|Actual|2008-04-01|September 2005|Actual|2005-09-01||Observational|||Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer|Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer and Brain Tumor in Facilities With and Without Educational Liaison Services.|Completed||Phase 1|220|Actual|University of Rochester|||2||f||||f||||||||||2017-02-18 17:18:18.605035|2017-02-18 17:18:18.605035
NCT00178373|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-21|||May 2004||2004-05-01|December 2015|2015-12-01|March 2006|Actual|2006-03-01|December 2005|Actual|2005-12-01||Interventional|||Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer|Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer|Completed||Phase 2|96|Anticipated|University of Rochester||2|||f||||t||||||||||2017-02-18 17:18:18.705585|2017-02-18 17:18:18.705585
NCT00178360|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-08-19|||July 2004||2004-07-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|December 2008|Actual|2008-12-01||Interventional|||Effects of Music Therapy on Huntington's Disease|The Effects of Music Therapy on Depression, Chorea and Other Symptoms of Huntington's Disease|Completed||Phase 1|11|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 17:18:18.817319|2017-02-18 17:18:18.817319
NCT00178347|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-05-15|||December 2004||2004-12-01|May 2009|2009-05-01||||||||Observational|||Radiation Dosimetry in Teeth|Radiation Dosimetry in Teeth|Terminated||N/A|10|Anticipated|University of Rochester|||1||f||||f||||||||||2017-02-18 17:18:18.934188|2017-02-18 17:18:18.934188
NCT00178334|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-01-28|||March 2006||2006-03-01|January 2013|2013-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Screening for Urinary Incontinence by Primary Care Providers|Screening for Urinary Incontinence by Primary Care Providers|Completed||N/A|554|Actual|University of Rochester|||1||f||||f||||||||||2017-02-18 17:18:19.00859|2017-02-18 17:18:19.00859
NCT00178321|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-29|||September 2005||2005-09-01|April 2015|2015-04-01|August 2006||2006-08-01|||||Interventional|||Improving Sleep in the Pediatric Intensive Care Unit|Improving Sleep and Outcomes in Critically Ill Children|Withdrawn||N/A|0|Actual|University of Rochester|||||f||||||||||||||2017-02-18 17:18:19.098307|2017-02-18 17:18:19.098307
NCT00177320|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-21|||March 2005||2005-03-01|January 2016|2016-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||Rheumatic Diseases and Computer Use|Rheumatic Diseases and Computer Use: A Needs Assessment|Completed||N/A|359|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 17:18:19.196188|2017-02-18 17:18:19.196188
NCT00178308|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-06||||||September 2006|2006-09-01||||||||Observational|||Measuring Alterations of DNA in Human Blood||Completed||N/A|24||University of Rochester|||||f||||||||||||||2017-02-18 17:18:19.285315|2017-02-18 17:18:19.285315
NCT00178295|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-03|||November 1999||1999-11-01|August 2015|2015-08-01||||December 2013|Actual|2013-12-01||Observational|||Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury|Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury|Completed||N/A|44|Actual|University of Rochester|||1||f||||f||||||Samples Without DNA|"~     Blood plasma~   "|||2017-02-18 17:18:19.348219|2017-02-18 17:18:19.348219
NCT00178282|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-02|||June 2005||2005-06-01|November 2011|2011-11-01|October 2007|Actual|2007-10-01|January 2007|Actual|2007-01-01||Interventional|||Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence|Pilot Study: Low Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence|Terminated||N/A|23|Actual|University of Rochester||1||The study was terminated early due to poor subject enrollment.|f||||f||||||||||2017-02-18 17:18:19.436918|2017-02-18 17:18:19.436918
NCT00178269|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-05-15|||January 2005||2005-01-01|May 2009|2009-05-01||||June 2006|Actual|2006-06-01||Interventional|||Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix|A Phase Ii Clinical Study Using Weekly Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix|Completed||Phase 2|||University of Rochester|||||f||||||||||||||2017-02-18 17:18:19.53113|2017-02-18 17:18:19.53113
NCT00178256|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-03|2013-12-11||June 1998||1998-06-01|August 2015|2015-08-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer|A Phase I/II Clinical Trial Of Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable (Stage III) Lung Cancers|Completed||Phase 1/Phase 2|41|Actual|University of Rochester||4|||f||||||||||||||2017-02-18 17:18:19.619203|2017-02-18 17:18:19.619203
NCT00178243|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-06||||||September 2006|2006-09-01||||||||Interventional|||Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation|A Phase I/II Trial Of the Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation Delivered by 3D Conformal Radiation Therapy and Radiosurgery|Completed||Phase 1/Phase 2|||University of Rochester|||||f||||||||||||||2017-02-18 17:18:19.903647|2017-02-18 17:18:19.903647
NCT00178230|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-06||||||September 2006|2006-09-01||||||||Observational|||Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity|Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity in Thoracic Malignancies|Suspended||N/A|||University of Rochester|||||f||||||||||||||2017-02-18 17:18:22.805622|2017-02-18 17:18:22.805622
NCT00178217|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-22|||July 2002||2002-07-01|December 2015|2015-12-01|November 2015|Actual|2015-11-01|December 2014|Actual|2014-12-01||Interventional|||Music Therapy During Botulinum Injections|Music Therapy as Procedural Support During Botulinum Injections for Pediatric Patients|Completed||Phase 1/Phase 2|101|Actual|University of Rochester||2|||f||||f||||||||||2017-02-18 17:18:22.873438|2017-02-18 17:18:22.873438
NCT00178204|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-12-03|||November 2004||2004-11-01|December 2014|2014-12-01|December 2011|Actual|2011-12-01|May 2009|Actual|2009-05-01||Observational|||Sleep Architecture and Chemotherapy-Related Fatigue|Sleep Architecture and Chemotherapy-Related Fatigue|Completed||N/A|26|Actual|University of Rochester|||1||f||||f||||||||||2017-02-18 17:18:22.987998|2017-02-18 17:18:22.987998
NCT00178191|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-27|2009-06-12||June 2005||2005-06-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Randomized Trial for Botox Urinary Incontinence|A Randomized Trial of Botox for Severe Urge Incontinence|Completed||N/A|28|Actual|University of Rochester|Please see published manuscripts for additional details|3|||f||||t||||||||||2017-02-18 17:18:23.075842|2017-02-18 17:18:23.075842
NCT00177957|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-16|||April 2005||2005-04-01|December 2015|2015-12-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Gram Negative Bacteremia, Risk Factors for Failure of Therapy|Gram Negative Bacteremia, Risk Factors for Failure of Therapy|Recruiting||N/A|600|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 17:18:26.743108|2017-02-18 17:18:26.743108
NCT00178178|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-27|2015-04-09||March 2005||2005-03-01|August 2015|2015-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Arthroscopic Anterior Cruciate Ligament Reconstruction: A Comparison of Three Catheter Placement Positions|A Placebo Controlled, Prospective, Randomized Clinical Investigation of the Efficacy of Continuous Infusion Regional Anesthetic on Postoperative Pain Following Arthroscopic Anterior Cruciate Ligament Reconstruction: A Comparison of Three Catheter Placement Positions|Completed||N/A|96|Actual|University of Rochester||4|||f||||f||||||||||2017-02-18 17:18:23.536487|2017-02-18 17:18:23.536487
NCT00178165|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 1996||1996-09-01|September 2005|2005-09-01|November 2001||2001-11-01|||||Interventional|||Coordinating Center for Enhancing ADRD Caregiving|Coordinating Center for Enhancing Alzheimer Disease and Related Disorder Caregiving|Completed||N/A|1200||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:24.418775|2017-02-18 17:18:24.418775
NCT00178152|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-11|||May 2005||2005-05-01|May 2011|2011-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Erythema Toxicum Neonatorum in Newborns and the Development of Asthma|The Implication of Erythema Toxicum Neonatorum in Newborns on the Development of Future Asthma|Completed||N/A|334|Actual|University of Rochester|||1||f||||||||||||||2017-02-18 17:18:24.795829|2017-02-18 17:18:24.795829
NCT00178139|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-26|||April 2004||2004-04-01|August 2015|2015-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Music Therapy for Patients Being Weaned From Mechanical Ventilation|Music Therapy as an Adjunctive Treatment in the Management of Stress for Patients Being Weaned From Mechanical Ventilation|Completed||Phase 1|77|Actual|University of Rochester||1|||f||||f||||||||||2017-02-18 17:18:24.872458|2017-02-18 17:18:24.872458
NCT00178126|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-26|||March 2004||2004-03-01|June 2013|2013-06-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||An RCT on Preventing Pressure Ulcers With Wheelchair Seat Cushions|An RCT on Preventing Pressure Ulcers With Seat Cushions|Completed||Phase 2|232|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:18:24.977331|2017-02-18 17:18:24.977331
NCT00178113|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-26|||July 2003||2003-07-01|May 2015|2015-05-01|July 2004||2004-07-01|||||Interventional|||A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia|Phase I Clinical Trial: Randomized Lycopene Supplementation in Tobago Men With High-Grade Prostatic-Intraepithelial Neoplasia|Completed||Phase 1|80||University of Pittsburgh|||||||||||||||||||2017-02-18 17:18:25.295643|2017-02-18 17:18:25.295643
NCT00178100|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-31|||March 1999||1999-03-01|July 2013|2013-07-01|August 2005||2005-08-01|||||Interventional|||Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression|Maintenance Therapies in Late-Life Depression 2 (MTLD-2)|Completed||Phase 4|225||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:25.39424|2017-02-18 17:18:25.39424
NCT00178087|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-06|||August 2005||2005-08-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression|Pathways Linking Late-Life Depression to MCI & Dementia|Completed||N/A|331|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 17:18:25.497595|2017-02-18 17:18:25.497595
NCT00178074|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-31|||February 1999||1999-02-01|July 2013|2013-07-01|April 2003||2003-04-01|||||Interventional|||The Effects of Sleep Deprivation on Antidepressant Response|The Effects of Sleep Deprivation on Antidepressant Response in Geriatric Depression: Neurometabolic Substrates Studied With PET|Completed||Phase 4|80||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:25.608273|2017-02-18 17:18:25.608273
NCT00178061|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-21|||August 1997||1997-08-01|June 2013|2013-06-01|August 2002||2002-08-01|||||Interventional|||Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder|Treatment of Primary Mood Disorders in the Comorbidly Ill|Completed||Phase 4|13||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:25.705467|2017-02-18 17:18:25.705467
NCT00178048|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 1998||1998-09-01|September 2005|2005-09-01|December 2003||2003-12-01|||||Interventional|||Paroxetine in the Treatment of Chronic Primary Insomnia|Paroxetine in the Treatment of Chronic Primary Insomnia: A Double-Blind, Randomized, Placebo-Controlled Study of Efficacy Over Six Weeks|Completed||Phase 4|66||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:25.805531|2017-02-18 17:18:25.805531
NCT00178035|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-07-31|||December 1999||1999-12-01|July 2013|2013-07-01|August 2003||2003-08-01|||||Interventional|||Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals|Geriatric Depression: Neurobiology of Treatment|Completed||Phase 4|158||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:25.907225|2017-02-18 17:18:25.907225
NCT00178022|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-27|||February 2005||2005-02-01|May 2008|2008-05-01|September 2006|Actual|2006-09-01|||||Interventional|||A Trial of Two On-Line Interventions for Child Brain Injury|A Trial of Two On-Line Interventions for Child Brain Injury|Completed||N/A|120||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:26.017135|2017-02-18 17:18:26.017135
NCT00178009|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-18|||January 2006||2006-01-01|February 2011|2011-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Developing and Assessing Competencies for Caregivers and Patients With Ventricular Assist Devices|Developing and Assessing Competencies for Patients, Caregivers and Health Professionals for the Care of Patients Implanted With Ventricular Assist Devices|Completed||N/A|8|Actual|University of Pittsburgh|||1||f||||f||||||||||2017-02-18 17:18:26.114101|2017-02-18 17:18:26.114101
NCT00177996|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-14|||October 2001||2001-10-01|January 2016|2016-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Pharmacotherapy in Depression With Panic Spectrum|Pharmacotherapy in Depression With Panic Spectrum|Completed||Phase 4|30|Actual|University of Pittsburgh||2|||f||||f||||||||Undecided||2017-02-18 17:18:26.205085|2017-02-18 17:18:26.205085
NCT00177983|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-26|||January 2003||2003-01-01|June 2014|2014-06-01|January 2005||2005-01-01|||||Interventional|||Web-based Support for People With Schizophrenia and Their Families|Support to Patients and Families|Completed||N/A|80||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:26.311732|2017-02-18 17:18:26.311732
NCT00177970|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-09-14|2016-06-15||October 2003||2003-10-01|September 2016|2016-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||No results available record destroyed due to age of study. no publications|IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff|Intravenous Immunoglobulin G Versus Placebo for the Treatment of Patients With Severe Clostridium Difficile-Associated Diarrhea and Colitis|Terminated||Phase 4|14|Actual|University of Pittsburgh||2||We were unable to receive IVIG free from phamaceutical company.|f||||t||||||||No|records not available|2017-02-18 17:18:26.409189|2017-02-18 17:18:26.409189
NCT00177944|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-15|||August 2005||2005-08-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Invasive Fungal Infections Surveillance Initiative|Invasive Fungal Infections Surveillance Initiative|Completed||N/A|172|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 17:18:26.839371|2017-02-18 17:18:26.839371
NCT00177931|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-16|||March 2005||2005-03-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit|Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit|Completed||N/A|25|Actual|University of Pittsburgh|||1||f||||||||||Samples Without DNA|"~     All biologic samples will be under the control of the principal investigator of this~     research project. To protect confidentiality, all personal identifiers will be removed and~     replaced with a specific code number. The information linking these code numbers to the~     corresponding subjects' identities will be kept in a separate, secure location. The~     investigators on this study will keep the samples indefinitely. All samples will be provided~     to investigators not associated with the study without any identifiers and only contain a~     code number. If a subject withdraws samples collected and not already processed will be~     destroyed.~   "|||2017-02-18 17:18:26.928593|2017-02-18 17:18:26.928593
NCT00177918|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-03|||August 2006||2006-08-01|May 2016|2016-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Prospective Evaluations of Infectious Complication in Lung Transplant Recipients|Prospective Evaluations of Infectious Complications in Lung Transplant Recipients|Recruiting||N/A|600|Anticipated|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     All biologic samples will be under the control of the principal investigator of this~     research project. To protect confidentiality, all personal identifiers will be removed and~     replaced with a specific code number. The information linking these code numbers to the~     corresponding subjects' identities will be kept in a separate, secure location. The~     investigators on this study will keep the samples indefinitely. All samples that are~     provided to outside facilities will be sent with a code number. Samples may be sent to other~     investigators not associated with this study to perform diagnostic testing (e.g., viral,~     fungal, bacterial and immunological). All samples will be provided to investigators not~     associated with the study without any identifiers and only contain a code number. If a~     subject withdraws and provides the request in writing, samples collected and not already~     processed will be destroyed.~   "|||2017-02-18 17:18:27.021777|2017-02-18 17:18:27.021777
NCT00177892|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-02-28|||September 2003||2003-09-01|February 2008|2008-02-01|August 2008|Anticipated|2008-08-01|August 2008|Anticipated|2008-08-01||Interventional|||Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress|OSA and Metabolic Syndrome: Role of Oxidative Stress|Unknown status|Recruiting|N/A|76|Anticipated|National Institute on Aging (NIA)||5|||f||||t||||||||||2017-02-18 17:18:27.364351|2017-02-18 17:18:27.364351
NCT00177879|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-06|||August 2005||2005-08-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Usability of a Website for People With Schizophrenia|Schizophrenia Website Usability|Withdrawn||N/A|0|Actual|National Institute of Mental Health (NIMH)||||Funding was never granted for this study. No participants were ever enrolled.|f||||||||||||||2017-02-18 17:18:27.475489|2017-02-18 17:18:27.475489
NCT00177866|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-07-28|2016-06-15||December 2003||2003-12-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||No results or publication, data destroyed due to age of study.|Safety of Celecoxib in Patients With Crohn's Disease|The Safety of Celecoxib (Celebrex) in Patients With Crohn's Disease|Terminated||Phase 4|28|Actual|University of Pittsburgh||2||We were unable to get additional funding to complete study.|f||||t||||||||||2017-02-18 17:18:27.569536|2017-02-18 17:18:27.569536
NCT00177853|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-07-01|||December 2006||2006-12-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|December 2006|Actual|2006-12-01||Interventional|||Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer|A Phase I Study of Celecoxib, Irinotecan and Concurrent Radiotherapy in the Preoperative Treatment of Pancreatic Cancer|Terminated||Phase 1|23|Anticipated|University of Pittsburgh||1||terminated|f||||t||||||||||2017-02-18 17:18:27.814205|2017-02-18 17:18:27.814205
NCT00177840|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-03-27|||September 2005||2005-09-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients|Acupuncture for Cancer-Related Fatigue in Breast Cancer Patients|Completed||Phase 1|54|Anticipated|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:18:27.929512|2017-02-18 17:18:27.929512
NCT00177827|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-12-02|||March 2004||2004-03-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|||||Observational|||Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients|Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients: Pharmacokinetics and Correlation Between Plasma and Lung Concentrations With Toxicity/Efficacy|Completed||Phase 4|104||University of Pittsburgh|||1||f||||t||||||||||2017-02-18 17:18:28.029468|2017-02-18 17:18:28.029468
NCT00177814|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-16|||September 2005||2005-09-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit|Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit|Active, not recruiting||N/A|1000|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 17:18:28.112648|2017-02-18 17:18:28.112648
NCT00177801|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-14|||May 2006||2006-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Organ Transplant Infection Prevention and Detection Project|"Organ Transplant Infection Prevention and Detection Project 1.0; Cohort Study of Transplant Recipients at Ultra-High Risk for Invasive Fungal Infections"|Completed||Phase 4|200|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     No genetic testing will be performed on any of the samples being obtained. The biologic~     samples will be under the control of the principal investigator of this research project. To~     protect confidentiality, all personal identifiers (i.e., name, social security number, and~     birth date) will be removed (de-identified) and replaced with a specific code number. The~     information linking these code numbers to the corresponding subjects' identities will be~     kept in a separate, secure location. The investigators on this study will keep the samples~     indefinitely. The biologic samples may be given to the Centers for Disease Control and~     Prevention. If a subject withdraws and provides the request in writing, samples collected~     and not already processed will be destroyed. All samples will be kept in the investigator's~     laboratory located in Scaife Hall, Room 812, 3550 Terrace Street.~   "|||2017-02-18 17:18:28.20953|2017-02-18 17:18:28.20953
NCT00177788|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-14|||September 2005||2005-09-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Observational|||Voriconazole as Prophylaxis for Liver Transplant Recipients|Voriconazole as Prophylaxis for Liver Transplant Recipients|Completed||N/A|800|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 17:18:28.296349|2017-02-18 17:18:28.296349
NCT00177775|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-16|||April 2005||2005-04-01|December 2008|2008-12-01|August 2005||2005-08-01|||||Interventional|||Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea|Whey Protein Concentrate 40% (WPC-40) Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea: A Prospective, Randomized, Controlled Phase II Study - Version 5.1.B|Terminated||Phase 2/Phase 3|60||University of Pittsburgh||||Study is completed and analysis completed|f||||||||||||||2017-02-18 17:18:28.403609|2017-02-18 17:18:28.403609
NCT00177762|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 1999||1999-09-01|September 2005|2005-09-01|December 2002||2002-12-01|||||Interventional|||Dose-Response of Exercise on Long-Term Weight Loss|Dose-Response of Exercise on Long-Term Weight Loss|Completed||Phase 1/Phase 2|200||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:28.507378|2017-02-18 17:18:28.507378
NCT00177749|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-16|||August 2004||2004-08-01|December 2008|2008-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095|Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095|Terminated||Phase 4|10||University of Pittsburgh||||Study is complete Analysis is complete|||||||||||||||2017-02-18 17:18:28.592204|2017-02-18 17:18:28.592204
NCT00177736|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-11|||September 2005||2005-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Observational|||Pharmacodynamic Parameters of Two Different Doses of Cefepime|Pharmacodynamic Parameters of Two Different Doses of Cefepime|Completed||Phase 4|180|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:28.687721|2017-02-18 17:18:28.687721
NCT00177723|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-16|||August 2005||2005-08-01|December 2008|2008-12-01|February 2007|Actual|2007-02-01|||||Observational|||Towards Reducing Resistance and Hematological Toxicity of Linezolid|Towards Reducing Resistance and Hematological Toxicity of Linezolid|Completed||Phase 4|50||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:28.772043|2017-02-18 17:18:28.772043
NCT00177710|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-16|||January 2006||2006-01-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study|Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study|Completed||Phase 3|48|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:28.851253|2017-02-18 17:18:28.851253
NCT00177697|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 1999||1999-09-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Interventional|||A Mentor-Based Approach to Long-Term Weight Loss|A Mentor-Based Approach to Long-Term Weight Loss|Completed||Phase 1/Phase 2|174||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:28.951895|2017-02-18 17:18:28.951895
NCT00177684|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-16|||September 2004||2004-09-01|December 2008|2008-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)|Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)|Completed||Phase 3|48||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:29.034611|2017-02-18 17:18:29.034611
NCT00177671|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-31|2011-02-18||December 2003||2003-12-01|January 2013|2013-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Antidepressant Medication Plus Donepezil for Treating Late-life Depression|Maintenance Therapies in Late-Life Depression: MTLD III|Completed||Phase 4|220|Actual|University of Pittsburgh|Observations about dementia conversion rates were obtained from post hoc subgroup analyses of participants with mild cognitive impairment (N=57) and participants with normal cognition at time of randomization (N=63).|2|||f||||t||||||||||2017-02-18 17:18:29.125937|2017-02-18 17:18:29.125937
NCT00177658|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-12-16|||March 2006||2006-03-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Observational|||NCCLS Interpretive Criteria for Salmonella|NCCLS Interpretive Criteria for Salmonella|Enrolling by invitation||N/A|50|Anticipated|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 17:18:29.598427|2017-02-18 17:18:29.598427
NCT00177645|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-02-12|||March 2002||2002-03-01|January 2016|2016-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Inhaled Bicarbonate Therapy in Cystic Fibrosis|Inhaled Bicarbonate Therapy in Cystic Fibrosis|Completed||Phase 1|16|Actual|University of Pittsburgh||1|||f||||f||||||||No||2017-02-18 17:18:29.685133|2017-02-18 17:18:29.685133
NCT00177632|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||July 2003||2003-07-01|September 2005|2005-09-01|July 2004||2004-07-01|||||Interventional|||Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.|Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.|Completed||Phase 1/Phase 2|66||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:29.78546|2017-02-18 17:18:29.78546
NCT00177619|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-02-10|||May 2002||2002-05-01|February 2014|2014-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)|Prevention of Osteoporosis in Men With Prostate Cancer|Completed||Phase 3|120||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:29.86487|2017-02-18 17:18:29.86487
NCT00177606|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-03-31|||July 2003||2003-07-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|||||Observational|||Donors After Cardiac Death: Validating Identification Criteria|Donors After Cardiac Death: Validating Identification Criteria|Completed||N/A|600||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:29.956577|2017-02-18 17:18:29.956577
NCT00177593|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||June 2005||2005-06-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||The Effect of HealthWear on Short-Term Weight Loss|The Effect of HealthWear on Short-Term Weight Loss|Completed||Phase 1/Phase 2|75||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:30.041497|2017-02-18 17:18:30.041497
NCT00177580|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-01-08|||July 2003||2003-07-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|January 2007|Actual|2007-01-01||Interventional|||Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin|A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Adjunctive Treatment With Pravastatin in Partially Remitted Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|72|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:30.115726|2017-02-18 17:18:30.115726
NCT00177567|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||July 2001||2001-07-01|September 2005|2005-09-01|January 2004||2004-01-01|||||Interventional|||Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study|Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study|Completed||Phase 4|60||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:30.205563|2017-02-18 17:18:30.205563
NCT00177554|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-27|||November 2003||2003-11-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma|Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma|Completed||Phase 2|60|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 17:18:30.321209|2017-02-18 17:18:30.321209
NCT00177541|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-07|||February 2004||2004-02-01|January 2016|2016-01-01|September 2016|Anticipated|2016-09-01|September 2016|Anticipated|2016-09-01||Interventional|||Further Enhancing Non-pharmacologic Therapy for Incontinence|Further Enhancing Non-pharmacologic Therapy for Incontinence|Active, not recruiting||N/A|123|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 17:18:30.416922|2017-02-18 17:18:30.416922
NCT00177528|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-08|||October 2000||2000-10-01|October 2008|2008-10-01||||November 2004|Actual|2004-11-01||Interventional|||Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression|Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression|Completed||Phase 4|70||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:30.759339|2017-02-18 17:18:30.759339
NCT00177515|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-04|||March 2005||2005-03-01|May 2010|2010-05-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Computer-assisted Preventive Health Education for Women of Reproductive Age in Urgent Care Settings|Preventive Health Education for Women of Reproductive Age|Completed||Phase 3|446|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:18:30.865299|2017-02-18 17:18:30.865299
NCT00177502|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2003||2003-01-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Effect of Exercise on Prevention of Weight Gain|Effect of Exercise on Prevention of Weight Gain|Completed||Phase 1/Phase 2|294||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:30.978485|2017-02-18 17:18:30.978485
NCT00177489|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-04|||June 2002||2002-06-01|January 2016|2016-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|REACH||Coordinating Center for Caregiver Intervention Trial|Coordinating Center for Multisite Intervention Trial for Diverse Caregivers|Completed||N/A|613|Actual|University of Pittsburgh||2|||f||||t||||||||Yes|There is no plan to make individual participant data available.|2017-02-18 17:18:31.072902|2017-02-18 17:18:31.072902
NCT00177476|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2003||2003-09-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Interventional|||Enhancing Exercise Participation in Overweight Adults|Enhancing Exercise Participation in Overweight Adults|Completed||Phase 1/Phase 2|225||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:31.198505|2017-02-18 17:18:31.198505
NCT00177463|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-07|||September 2004||2004-09-01|January 2016|2016-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||L-Carnosine for Bipolar I Disorder|A Pilot Add-on Randomized, Placebo Controlled Intervention Trial of Cognitive Enhancement in Persons With Bipolar Disorder Using an Antioxidant and Advanced Glycation End (AGE) Product Inhibitor: L-Carnosine|Completed||N/A|47|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 17:18:31.274017|2017-02-18 17:18:31.274017
NCT00177437|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-12|||June 1999||1999-06-01|December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Home Screening for Chlamydia Surveillance|Home Screening for Chlamydia Surveillance|Completed||Phase 3|403||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:31.387134|2017-02-18 17:18:31.387134
NCT00177424|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-06-26|||July 2004||2004-07-01|February 2009|2009-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes|Intervention to Prevent Post-Stroke Major Depression.|Terminated||Phase 4|154|Anticipated|University of Pittsburgh||2||Recruitment goals could not be met.|f||||||||||||||2017-02-18 17:18:31.477752|2017-02-18 17:18:31.477752
NCT00177411|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-09-03|||July 2005||2005-07-01|September 2014|2014-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||"PTHrP(1-36) IV Dose Escalation Study"|"Determining the Maximum Tolerable Dose and Pharmacokinetic Parameters of Intravenous PTHrP(1-36)"|Withdrawn||Phase 1|0|Actual|University of Pittsburgh||1||Protocol design was changed so it no longer fit the description of this study.|f||||t||||||||||2017-02-18 17:18:31.589655|2017-02-18 17:18:31.589655
NCT00177398|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-13|||February 2005||2005-02-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings|The Effect of Insulin Glargine on Glycemic Control, Morbidity, and Length of Stay in Hospitalized Subjects With Diabetes Receiving Enteral Nutrition|Completed||Phase 4|50||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:31.707724|2017-02-18 17:18:31.707724
NCT00177385|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-05-27|||June 2003||2003-06-01|May 2015|2015-05-01|September 2011|Actual|2011-09-01|June 2009|Actual|2009-06-01||Interventional|AgeWise||Aging Well, Sleeping Efficiently: Protecting Health In Later Life|AGEWISE Project 4: PROTECTING HEALTH IN LATER LIFE|Completed||N/A|66||University of Pittsburgh|||||f||||t||||||||||2017-02-18 17:18:31.812482|2017-02-18 17:18:31.812482
NCT00177372|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-28|||January 2005||2005-01-01|January 2016|2016-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|MIMID||Mifepristone and Misoprostol for Fetal Demise|Mifepristone and Misoprostol for the Treatment of Early Pregnancy Failure: a Pilot Clinical Trial|Completed||Phase 4|30|Actual|University of Pittsburgh||1|||f||||f||||||||No||2017-02-18 17:18:31.901268|2017-02-18 17:18:31.901268
NCT00177359|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-12|||November 2005||2005-11-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Restoring Skill in Walking|Restoring Skill in Walking|Completed||Phase 2|48|Anticipated|University of Pittsburgh|||||f||||t||||||||||2017-02-18 17:18:32.242405|2017-02-18 17:18:32.242405
NCT00177346|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-05|||October 2003||2003-10-01|January 2016|2016-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection|A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection|Completed||N/A|52|Actual|University of Pittsburgh||2|||f||||||||||||||2017-02-18 17:18:32.330307|2017-02-18 17:18:32.330307
NCT00177333|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-28|||September 2005||2005-09-01|January 2016|2016-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens|Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens|Completed||Phase 4|40|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:18:32.433741|2017-02-18 17:18:32.433741
NCT00177125|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-03|||January 2004||2004-01-01|February 2012|2012-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP|Evaluating the Effect of the Vacuum Constriction Device on Erectile Function and Penile Length Post Radical Retropubic Prostatectomy|Completed||Phase 3|220||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-02-18 17:18:35.70966|2017-02-18 17:18:35.70966
NCT00177307|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-06-01|2016-01-12||January 2005||2005-01-01|June 2016|2016-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer|Phase II Study of the A-ICOX Regimen Consisting of Bevacizumab (Avastinâ), Intermittent Dose Capecitabine (Xelodaâ) and Oxaliplatin (Eloxatinâ) in Patients With Untreated Advanced Colorectal Cancer|Completed||Phase 2|40|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 17:18:32.546462|2017-02-18 17:18:32.546462
NCT00177294|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-01-10|2010-12-22||April 2004||2004-04-01|November 2010|2010-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression|Geriatric Depression: Getting Better, Getting Well|Completed||Phase 4|319|Actual|University of Pittsburgh|The study design does not allow an inference about which specific intervention led to further improvement. Was it simply a dose increase of escitalopram from 10mg to 20mg? Is this intensive contact necessary for improvement?|2|||f||||t||||||||||2017-02-18 17:18:32.885277|2017-02-18 17:18:32.885277
NCT00177281|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-18|||September 2003||2003-09-01|December 2013|2013-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of S-CKD602 in Patients With Advanced Malignancies|A Phase I Study to Evaluate the Safety and Pharmacokinetics of S-CKD602 in Patients With Advanced Malignancies|Completed||Phase 1|45|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:18:33.267651|2017-02-18 17:18:33.267651
NCT00177268|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-23|||October 2004||2004-10-01|September 2016|2016-09-01|January 2024|Anticipated|2024-01-01|January 2023|Anticipated|2023-01-01||Observational|||Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research|Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research|Recruiting||N/A|200|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"~     White blood cells and/or skin biopsy tissue are retained.~   "|Undecided||2017-02-18 17:18:33.356854|2017-02-18 17:18:33.356854
NCT00177255|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-10|2016-01-10||April 2005||2005-04-01|January 2016|2016-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers|A Phase II Study of Weekly Docetaxel (Taxotere®) in Combination With Capecitabine (Xeloda) in Advanced Gastric and Gastro-Esophageal Adenocarcinomas.|Terminated||Phase 2|40|Actual|University of Pittsburgh||1||Roche has withdrawn support|f||||t||||||||||2017-02-18 17:18:33.474672|2017-02-18 17:18:33.474672
NCT00177242|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-15|||September 2004||2004-09-01|January 2016|2016-01-01|December 2006|Actual|2006-12-01|||||Interventional|||Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma|Phase II Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma|Completed||Phase 2|45||University of Pittsburgh|||||f||||t||||||||||2017-02-18 17:18:33.775032|2017-02-18 17:18:33.775032
NCT00177229|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-02-15|||July 2001||2001-07-01|February 2008|2008-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||KidQuest Family-Based Weight Control|Family-Based Treatment of Severe Pediatric Obesity|Completed||N/A|192|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:18:33.868862|2017-02-18 17:18:33.868862
NCT00177216|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-29|2009-05-26||February 2002||2002-02-01|February 2016|2016-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Characteristics of Sleep Patterns in Young Adults With and Without Insomnia|Psychobiology and Treatment Response in Primary Insomnia|Completed||Phase 4|69|Actual|University of Pittsburgh||3|||f||||t||||||||Yes|To gain access to data, researchers must submit a description of their project to the Principal Investigator, including the investigator's personal identification and institutional affiliation, a current CV, qualifications, duration of the proposed research, source of funding, and a conflict of interest statement. The protocol must include study aims, background and significance, methods and types of analysis, and a description of the data requested. Once approved, the investigator must complete a University of Pittsburgh IRB exempt research application form and document completion of a responsible conduct of research program. Data will be prepared by an 'honest broker' from the data management staff of the project. This person will complete the honest broker certification form required by our IRB. Data will be provided as a SAS data set, and will not include information that could identify individual research participants or that the original consent form expressly forbade.|2017-02-18 17:18:33.9534|2017-02-18 17:18:33.9534
NCT00177203|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-05-27|||June 2003||2003-06-01|May 2015|2015-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|AW3||Agewise Project 3: Brief Behavioral Treatment of Insomnia in Primary Care|Agewise Project 3: Brief Behavioral Treatment of Insomnia in Primary Care|Completed||N/A|140|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 17:18:34.470842|2017-02-18 17:18:34.470842
NCT00177190|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-27|||June 2002||2002-06-01|June 2013|2013-06-01|January 2006|Actual|2006-01-01|January 2005|Actual|2005-01-01||Observational|||In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)|In Vitro Evaluation of Immune Responses in CTCL|Completed||N/A|8|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     White cells~   "|||2017-02-18 17:18:34.565146|2017-02-18 17:18:34.565146
NCT00177177|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-01-15|||March 2004||2004-03-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||L-carnosine for Schizophrenia|L-Carnosine, an Antioxidant and AGE Inhibitor (Advanced Glycation End Products) for Cognitive Enhancement Among Persons With Schizophrenia: A Randomized, Add-on Double-Blind, Placebo Controlled, Clinical Trial|Completed||N/A|84|Anticipated|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 17:18:34.647665|2017-02-18 17:18:34.647665
NCT00177164|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-17|2016-01-07||November 2003||2003-11-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Interventional||Two patients in the Risperidone LAI group were not included in the analysis as they did not receive any assessment after the baseline assessment|Risperdal Consta for Bipolar Disorder|A Random Assignment,Parallel Group, Open Label Comparison of Clinical Outcomes and Resource Utilization Among Bipolar Disorder Patients Receiving Either Long Acting Injectable Risperidone Microspheres (Risperdal Consta® ) or Other Second Generation Oral Antipsychotic Agents: A 15 Month Study|Completed||Phase 3|50|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 17:18:34.765308|2017-02-18 17:18:34.765308
NCT00177138|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-02-05|||July 2004||2004-07-01|February 2013|2013-02-01|November 2006|Actual|2006-11-01|||||Interventional|||Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation|Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation|Terminated||Phase 4|9|Actual|University of Minnesota - Clinical and Translational Science Institute||2||The clinical use of Campath for transplant patients was temporarily suspended.|f||||f||||||||||2017-02-18 17:18:35.599948|2017-02-18 17:18:35.599948
NCT00177112|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-01-31|||June 2005||2005-06-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy|Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy|Completed||Phase 3|275|Anticipated|University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 17:18:35.794911|2017-02-18 17:18:35.794911
NCT00177099|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-11-08|||July 2003||2003-07-01|November 2006|2006-11-01|September 2004||2004-09-01|||||Interventional|||Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice|Neurotrophic Effects of Immunophilin Ligands on Human Hair Follicles Grafted Onto Service Combined Immunodeficient (SCID) Mice|Completed||Phase 1|35||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 17:18:35.904926|2017-02-18 17:18:35.904926
NCT00177086|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-03-15|||September 2005||2005-09-01|March 2013|2013-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi|Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi|Completed||Phase 3|76|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 17:18:35.988523|2017-02-18 17:18:35.988523
NCT00177060|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-26|||October 2003||2003-10-01|February 2010|2010-02-01|May 2007|Actual|2007-05-01|||||Interventional|||Topical Hydromorphone for Wound Healing|Topical Hydromorphone for Wound Healing|Terminated||Phase 1/Phase 2|50|Anticipated|University of Minnesota - Clinical and Translational Science Institute||||No funding available.|f||||f||||||||||2017-02-18 17:18:36.090771|2017-02-18 17:18:36.090771
NCT00177047|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-08-15|||April 2004||2004-04-01|August 2016|2016-08-01|January 2018|Anticipated|2018-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Autologous Transplant for Multiple Myeloma|Autologous Transplantation for Multiple Myeloma|Recruiting||Phase 2/Phase 3|150|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 17:18:36.181057|2017-02-18 17:18:36.181057
NCT00177034|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-07-09|||November 2004||2004-11-01|July 2012|2012-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Examination Of Vitiligo Skin Samples Before and After UVB Treatment|Characterization of Keratinocyte Populations From Normal, Perilesional and Lesional Skin in Vitiligo Patients by Laser Capture Microdissection and Gene Array Analysis Before and After Narrow Band UVB Treatment|Terminated||N/A|12||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 17:18:36.319378|2017-02-18 17:18:36.319378
NCT00177021|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-11-08|||October 2000||2000-10-01|November 2006|2006-11-01|August 2002||2002-08-01|||||Interventional|||Aldara for the Treatment of Extensive Alopecia Areata|Aldara for the Treatment of Extensive Alopecia Areata|Completed||Phase 4|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 17:18:36.409321|2017-02-18 17:18:36.409321
NCT00177008|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-01-25|||March 2004||2004-03-01|January 2007|2007-01-01|January 2007||2007-01-01|||||Interventional|||Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety|Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety|Completed||Phase 4|18||Rutgers, The State University of New Jersey|||||||||||||||||||2017-02-18 17:18:36.502878|2017-02-18 17:18:36.502878
NCT00176995|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-08|||March 1999||1999-03-01|November 2006|2006-11-01|October 2000||2000-10-01|||||Interventional|||Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae|Phase II, Open-Label Study of the Effect of 15% Eflornithine Hydrochloride Cream on Facial Hair of Men of African-American Descent With Pseudofolliculitis Barbae: A Laser Scanning Confocal Microscopy and Video Imaging Study|Completed||Phase 2|15||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 17:18:36.62193|2017-02-18 17:18:36.62193
NCT00176982|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-08-12|||April 2002||2002-04-01|August 2009|2009-08-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Plaquenil for Alopecia Areata, Alopecia Totalis|Open Label Study of Hydroxychloroquine for Alopecia Areata, Alopecia Totalis|Completed||Phase 4|16||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 17:18:36.712068|2017-02-18 17:18:36.712068
NCT00176969|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-30|||August 1997||1997-08-01|May 2014|2014-05-01|June 2000||2000-06-01|||||Interventional|||Response of Topical Capsaicin in Alopecia Areata|Perifollicular Nerves in Alopecia Areata: Response to Topical Capsaicin|Completed||Phase 4|24||University of Minnesota - Clinical and Translational Science Institute|||||f||||t||||||||||2017-02-18 17:18:36.812875|2017-02-18 17:18:36.812875
NCT00176956|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-02-01|||November 2002||2002-11-01|February 2013|2013-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients|Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients|Terminated||Phase 3|30|Anticipated|University of Minnesota - Clinical and Translational Science Institute||||IRB approval has lapsed.|f||||f||||||||||2017-02-18 17:18:36.912358|2017-02-18 17:18:36.912358
NCT00176943|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-02-13|||October 2000||2000-10-01|February 2014|2014-02-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%|Phenotype and Cytokine Production Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Aldara 5% Cream Using Flow Cytometry|Completed||Phase 4|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-02-18 17:18:37.006185|2017-02-18 17:18:37.006185
NCT00176930|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-08-15|||October 2001||2001-10-01|August 2016|2016-08-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Stem Cell Transplant for Hematological Malignancy|Allogeneic Transplant for Hematological Malignancy|Recruiting||N/A|350|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 17:18:37.114761|2017-02-18 17:18:37.114761
NCT00176917|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-06|2009-07-28||May 1999||1999-05-01|November 2012|2012-11-01|May 2010|Actual|2010-05-01|May 2008|Actual|2008-05-01||Interventional|||Stem Cell Transplantation for Hurler|Hematopoietic Stem Cell Transplantation for Hurler Syndrome, Maroteaux Lamy Syndrome (MPS VI), and Alpha Mannosidase Deficiency (Mannosidosis)|Completed||Phase 2|41|Actual|Masonic Cancer Center, University of Minnesota|"Based on variability in age, diagnosis and condition of these patients, the data on enzyme levels and neuropsych testing is extremely difficult to report.~See Secondary Outcome Measures #3 and #4; no other adverse events were collected."|1|||f||||f||||||||||2017-02-18 17:18:37.25126|2017-02-18 17:18:37.25126
NCT00176514|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-10|||July 2000||2000-07-01|December 2009|2009-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Pilot Trial to Assess the Effects of Green Tea in the Prevention of Therapy-Induced Mucositis|A Pilot Trial to Assess the Effects of Green Tea in the Prevention of Therapy-Induced Mucositis|Terminated||N/A|37||Rutgers, The State University of New Jersey||||slow accrual|f||||f||||||||||2017-02-18 17:18:42.332911|2017-02-18 17:18:42.332911
NCT00176904|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-06|2011-05-17||January 1995||1995-01-01|November 2012|2012-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Stem Cell Transplant for Inborn Errors of Metabolism|Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation|Completed||Phase 2/Phase 3|135|Actual|Masonic Cancer Center, University of Minnesota|Change in Neuropsychometric function data is not available. Data would have been noted as descriptive and patient specific, as well as disease specific; not table format. No formal analysis was intended.|1|||f||||f||||||||||2017-02-18 17:18:37.540201|2017-02-18 17:18:37.540201
NCT00176891|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-08|||March 2004||2004-03-01|April 2014|2014-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Stem Cell Transplant w/Laronidase for Hurler|Phase II Study of Combined Laronidase (AldurazymeTM) Enzyme Replacement Therapy (ERT) With Hematopoietic Stem Cell Transplantation (HSCT) for Hurler Syndrome (MPS IH)|Completed||Phase 2|25|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-02-18 17:18:37.83494|2017-02-18 17:18:37.83494
NCT00176878|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-06|2009-06-18||June 2000||2000-06-01|November 2012|2012-11-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Stem Cell Transplant for Bone Marrow Failure Syndromes|Bone Marrow Transplantation for Non-Malignant Congenital Bone Marrow Failure Disorders|Completed||Phase 2/Phase 3|10|Actual|Masonic Cancer Center, University of Minnesota|Pharmacokinetic parameters in patients receiving 2 mg/kg/dose of busulfan twice daily was not performed. No data is available.|1|||f||||t||||||||||2017-02-18 17:18:37.950439|2017-02-18 17:18:37.950439
NCT00176865|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-26|||August 2002||2002-08-01|October 2012|2012-10-01|August 2017|Anticipated|2017-08-01|August 2012|Actual|2012-08-01||Interventional|||Stem Cell Transplant for Immunologic or Histiocytic Disorders|Allogeneic Hematopoietic Stem Cell Transplant for Patients With Immunologic or Histiocytic Disorders Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism|Active, not recruiting||Phase 2|30|Anticipated|Masonic Cancer Center, University of Minnesota||3|||f||||t||||||||||2017-02-18 17:18:38.258984|2017-02-18 17:18:38.258984
NCT00176852|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-23|||June 2002||2002-06-01|February 2016|2016-02-01|June 2016|Anticipated|2016-06-01|March 2014|Actual|2014-03-01||Interventional|||Stem Cell Transplant for Hemoglobinopathy|Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathy Using a Preparative Regimen to Achieve Stable Mixed Chimerism|Active, not recruiting||Phase 2/Phase 3|30|Anticipated|Masonic Cancer Center, University of Minnesota||3|||f||||t||||||||||2017-02-18 17:18:38.378221|2017-02-18 17:18:38.378221
NCT00176839|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-03-12|2013-01-11||June 2000||2000-06-01|March 2013|2013-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Stem Cell Transplantation for Hematological Malignancies|Busulfan, Cyclophosphamide, and Melphalan Followed by Allogeneic Hematopoietic Cell Transplantation in Patients With Hematological Malignancies|Terminated||Phase 2/Phase 3|11|Actual|Masonic Cancer Center, University of Minnesota||1||Replaced by a different study|f||||t||||||||||2017-02-18 17:18:38.512979|2017-02-18 17:18:38.512979
NCT00176826|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-22|2014-03-27||September 2000||2000-09-01|April 2015|2015-04-01|July 2015|Anticipated|2015-07-01|August 2012|Actual|2012-08-01||Interventional|||T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders|In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders|Active, not recruiting||Phase 2/Phase 3|22|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 17:18:38.860361|2017-02-18 17:18:38.860361
NCT00176813|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-04-29|||March 2003||2003-03-01|April 2008|2008-04-01|November 2006|Actual|2006-11-01|November 2003|Actual|2003-11-01||Interventional|||Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer|Phase II Study of Gemcitabine, Cisplatin, and Celecoxib in the Treatment of Metastatic Pancreatic Cancer|Completed||Phase 2|5|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-02-18 17:18:39.162613|2017-02-18 17:18:39.162613
NCT00176800|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-12|2016-04-14||November 2001||2001-11-01|July 2016|2016-07-01|May 2013|Actual|2013-05-01|February 2006|Actual|2006-02-01||Interventional|||Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma|Pre-Operative Chemoradiation Followed by Post-Operative Tetrathiomolybdate (TM) in Patients With Loco-Regional Esophageal Carcinoma (UMCC 2001-007)|Completed||Phase 2|69|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:18:39.254589|2017-02-18 17:18:39.254589
NCT00176787|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-12-28|||October 2000||2000-10-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|May 2005|Actual|2005-05-01||Interventional|||Radiation Therapy With Capecitabine in Rectal Cancer|Phase II Trial of Preoperative Radiation Therapy With Capecitabine in Rectal Cancer (UMCC 0046)|Terminated||Phase 2|30||University of Michigan Cancer Center||||recruitment goals met|f||||||||||||||2017-02-18 17:18:39.520293|2017-02-18 17:18:39.520293
NCT00176774|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-02-05|||February 2001||2001-02-01|February 2012|2012-02-01|April 2004|Actual|2004-04-01|February 2004|Actual|2004-02-01||Interventional|||Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma|A Pilot Trial of Irinotecan, 5-Fluorouracil, and Leucovorin Combined With the Anti-Angiogenesis Agent Tetrathiomolybdate in Metastatic Colorectal Carcinoma (UMCC 0075)|Completed||Phase 2|24|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-02-18 17:18:39.607168|2017-02-18 17:18:39.607168
NCT00176761|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-06|||March 2000||2000-03-01|September 2006|2006-09-01|May 2006||2006-05-01|||||Interventional|||Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine|A Phase II Trial Assessing Autologous, Tumor-Pulsed Dendritic Cells as a Tumor Vaccine Administered With IL-2 in Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|27||University of Michigan Cancer Center|||||||||||||||||||2017-02-18 17:18:39.699223|2017-02-18 17:18:39.699223
NCT00176748|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-01-14|||July 2005||2005-07-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|August 2006|Actual|2006-08-01||Interventional|||Treatment for Patients With Metastatic Thyroid Cancer|Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer Who Are Refractory to or Not Suitable Candidates for 131I Treatment|Completed||Phase 2|3|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-02-18 17:18:39.78941|2017-02-18 17:18:39.78941
NCT00176735|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-05-18|||December 2001||2001-12-01|May 2015|2015-05-01|August 2005||2005-08-01|||||Interventional|||Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer|Pilot Trial of Capecitabine and Radiation Therapy With Pre and Post Combination Chemotherapy in Advanced Pancreatic Cancer|Terminated||N/A|||University of Michigan Cancer Center|||||f||||||||||||||2017-02-18 17:18:39.884521|2017-02-18 17:18:39.884521
NCT00176501|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-18|2013-11-18||August 2004||2004-08-01|November 2013|2013-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer|Immunotherapy for Patients With Renal Cell Carcinoma|Terminated||Phase 2|3|Actual|Rutgers, The State University of New Jersey||1||Slow accrual|f||||f||||||||||2017-02-18 17:18:42.438978|2017-02-18 17:18:42.438978
NCT00176722|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-23|||June 2006||2006-06-01|April 2015|2015-04-01|January 2012|Actual|2012-01-01|October 2011|Actual|2011-10-01||Observational|||Intraocular Pressure During Prone Spinal Surgery|The Effect of Table Position on Intraocular Pressure (IOP) and Ocular Perfusion Pressure (OPP) During Prone Spine Surgery|Terminated||Phase 2|7|Actual|Rutgers, The State University of New Jersey|||1|Principal Investigator is leaving the UMDNJ|f||||f||||||||||2017-02-18 17:18:39.961109|2017-02-18 17:18:39.961109
NCT00176696|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-04|||August 2005||2005-08-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Biobehavioral Recovery From Surgery and Anesthesia|"Detection of Nociception (Pain) During General Anesthesia"|Terminated||Phase 2|20|Actual|Rutgers, The State University of New Jersey|||1|Principal Investigator has left the UMDNJ|f||||f||||||||No||2017-02-18 17:18:40.312723|2017-02-18 17:18:40.312723
NCT00176683|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-26|||July 2005||2005-07-01|January 2017|2017-01-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Observational|||The Use of Capnography as a Guide for Oral Intubation|Assessing the Use of Capnography as a Guide for Endotracheal Intubation|Terminated||N/A|20|Actual|Rutgers, The State University of New Jersey|||1|study was suspended because of difficluty maintaining equipment|f||||f||||||||||2017-02-18 17:18:40.4103|2017-02-18 17:18:40.4103
NCT00176670|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-10-04|||January 2004||2004-01-01|June 2008|2008-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A GameBoy as a Distraction Before Surgery in Children|Is Preoperative Distraction With a Hand Held Game Boy as Effective as Midazolam in Reducing Preoperative Anxiety Levels in Children?|Completed||Phase 2|158||Rutgers, The State University of New Jersey|||||f||||f||||||||No||2017-02-18 17:18:40.512069|2017-02-18 17:18:40.512069
NCT00176657|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-27|||September 2004||2004-09-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||The Use of HEMOBAG to Salvage Blood After Cardiac Surgery|Comparison of Whole Blood Return and Normal Practice Red Blood Cell Salvage Return Following Cardiopulmonary Bypass|Terminated||Phase 2|50||Rutgers, The State University of New Jersey||||Inability to attain sufficient numbers of subjects|f||||||||||||||2017-02-18 17:18:40.612989|2017-02-18 17:18:40.612989
NCT00176644|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-05|2013-11-05||May 2005||2005-05-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer|Phase II Trial of Transdermal Estradiol in Patients With Hormone Refractory Prostate Cancer|Terminated||Phase 2|23|Actual|Rutgers, The State University of New Jersey||1||Treatment ineffective|f||||f||||||||||2017-02-18 17:18:40.709084|2017-02-18 17:18:40.709084
NCT00176631|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-15|2013-11-15||September 2007||2007-09-01|November 2013|2013-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Trial of Licorice Root and Docetaxel in Patients With Hormone Refractory Prostate Cancer|Terminated||Phase 2|10|Actual|Rutgers, The State University of New Jersey||1||slow accrual|f||||f||||||||||2017-02-18 17:18:41.021165|2017-02-18 17:18:41.021165
NCT00176618|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-12-10|||April 2004||2004-04-01|December 2009|2009-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon|The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon|Terminated||N/A|60|Anticipated|Rutgers, The State University of New Jersey||1||principal Investigator left institution|f||||||||||||||2017-02-18 17:18:41.324274|2017-02-18 17:18:41.324274
NCT00176605|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-18|2013-09-17||May 2005||2005-05-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer|A Phase II Trial of Metronomic Dosing of Etoposide and Cyclophosphamide in Patients With Stage D0 Prostate Cancer.|Completed||Phase 2|15|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 17:18:41.438108|2017-02-18 17:18:41.438108
NCT00176592|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-11-07|||January 2003||2003-01-01|November 2014|2014-11-01|January 2016|Anticipated|2016-01-01|January 2007|Actual|2007-01-01||Interventional|BECOME||Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI|Phase IV, Rater-blinded, Randomized Study, Comparing 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting(RR) or CIS Forms of ms Using 3 Tesla(3T) Magnetic Resonance Imaging (MRI) With Triple-dose Gadolinium|Unknown status|Active, not recruiting|Phase 4|93|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-02-18 17:18:41.71543|2017-02-18 17:18:41.71543
NCT00176579|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-08-11|||June 2003||2003-06-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer|Assessing Bone Mineral Density as a Risk Factor for Early Clinically Significant Prostate Cancer|Completed||N/A|27|Actual|Rutgers, The State University of New Jersey|||1||f||||t||||||||||2017-02-18 17:18:41.831625|2017-02-18 17:18:41.831625
NCT00176566|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-10|||September 2003||2003-09-01|December 2009|2009-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia|A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia|Terminated||Phase 2|8|Actual|Rutgers, The State University of New Jersey||1||Transitioned into a national study through ECOG|f||||||||||||||2017-02-18 17:18:41.928916|2017-02-18 17:18:41.928916
NCT00176553|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-10|||March 2003||2003-03-01|December 2009|2009-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity|A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity|Terminated||N/A|20|Anticipated|Rutgers, The State University of New Jersey||1||slow accrual|f||||t||||||||||2017-02-18 17:18:42.02173|2017-02-18 17:18:42.02173
NCT00176540|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-16|||October 2003||2003-10-01|May 2011|2011-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Dextromethorphan in Treating Patients With Fatigue Caused by Cancer|A Pilot Trial to Evaluate the Effects of Dextromethorphan in Patients Suffering From Cancer-Related Fatigue|Terminated||N/A|30|Anticipated|Rutgers, The State University of New Jersey||||slow accrual|f||||t||||||||||2017-02-18 17:18:42.120782|2017-02-18 17:18:42.120782
NCT00176527|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-10|||November 2002||2002-11-01|December 2009|2009-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy|A Phase II Trial of 13-Cis Retinoic Acid, Alpha Interferon, Taxotere, and Estramustine (R.I.T.E.) for the Treatment of Hormone Refractory Prostate Cancer|Terminated||Phase 2|40|Anticipated|Rutgers, The State University of New Jersey||||accrual goal met|f||||t||||||||||2017-02-18 17:18:42.22907|2017-02-18 17:18:42.22907
NCT00176488|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-18|2013-09-18||June 2003||2003-06-01|September 2013|2013-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer|A Phase II Trial of Sequential Epirubicin/Vinorelbine in Patients With Advanced Breast Cancer|Terminated||Phase 2|31|Actual|Rutgers, The State University of New Jersey||1||Competing studies|f||||f||||||||||2017-02-18 17:18:42.698642|2017-02-18 17:18:42.698642
NCT00176475|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-13|||January 2005||2005-01-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease|A Pilot Study of Irradiated HLA-Partially Matched Allogeneic Related Donor Lymphocytes in Conjunction With Rituximab for Selected Patients With CD20 + Malignancies|Terminated||Phase 1|2|Actual|Rutgers, The State University of New Jersey||1||slow accrual|f||||t||||||||||2017-02-18 17:18:43.036019|2017-02-18 17:18:43.036019
NCT00176462|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-12|2013-11-15||February 2001||2001-02-01|May 2014|2014-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||CINJALL: Treatment for Children With Acute Lymphocytic Leukemia|CINJALL: Treatment for Children With Acute Lymphocytic Leukemia|Completed||Phase 2|60|Actual|Rutgers, The State University of New Jersey|Antifolate therapy was non-randomly assigned, therefore, we do not have a statistical basis to compare the toxicity observed among patients on the standard risk and high risk treatment arms.|2|||f||||f||||||||||2017-02-18 17:18:43.162117|2017-02-18 17:18:43.162117
NCT00176449|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-18|||April 2001||2001-04-01|January 2013|2013-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Comparison of Bupropion SR and Placebo for Smoking Cessation|A Comparison of Bupropion SR and Placebo for Smoking Cessation|Completed||Phase 4|52|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 17:18:43.750871|2017-02-18 17:18:43.750871
NCT00176436|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-07|2013-01-18||February 2004||2004-02-01|May 2013|2013-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients|Double-Blind Study of Atomoxetine for Weight Management in Patients Taking Olanzapine or Clozapine|Completed||Phase 4|40|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 17:18:43.942787|2017-02-18 17:18:43.942787
NCT00176423|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-06-26|||May 2002||2002-05-01|June 2007|2007-06-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia|Adjunctive Galantamine for Treatment of Cognitive Impairments in Patients With Schizophrenia|Completed||Phase 4|120||University of Maryland|||||f||||t||||||||||2017-02-18 17:18:44.333417|2017-02-18 17:18:44.333417
NCT00176410|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-01-13|||January 2003||2003-01-01|September 2006|2006-09-01|December 2009|Anticipated|2009-12-01|September 2009|Anticipated|2009-09-01||Interventional|||Statin Therapy in Asymptomatic Aortic Stenosis||Unknown status|Recruiting|Phase 2|100|Anticipated|University of Leipzig||1|||f||||||||||||||2017-02-18 17:18:44.437272|2017-02-18 17:18:44.437272
NCT00176397|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-06|||August 2003||2003-08-01|September 2005|2005-09-01||||||||Interventional|||Percutaneous Coronary Intervention (PCI) With Drug-Eluting Stents (DES) Versus Coronary Artery Bypass Graft (CABG) for Patients With Significant Left Main Stenosis|PCI With DES Versus CABG for Patients With Significant Left Main Stenosis|Unknown status|Recruiting|Phase 2|200|Anticipated|University of Leipzig|||||f||||||||||||||2017-02-18 17:18:44.548172|2017-02-18 17:18:44.548172
NCT00176384|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2007-07-31|||March 2003||2003-03-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Impact of Exercise Training on Exercise Capacity in Patients With Severe Chronic Heart Failure|Impact of Three Months of Aerobic Exercise Training on Exercise Capacity and Peripheral Maladaptations in Patients With Severe Chronic Heart Failure (NYHA III b)|Completed||Phase 2|36||University of Leipzig|||||f||||||||||||||2017-02-18 17:18:44.639202|2017-02-18 17:18:44.639202
NCT00176371|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-09-07|||July 2005||2005-07-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Improvement of Physical Activity and Correction of Body Mass Index in School Children||Unknown status|Recruiting|N/A|500|Anticipated|University of Leipzig|||||f||||||||||||||2017-02-18 17:18:44.729803|2017-02-18 17:18:44.729803
NCT00176358|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-09-07||||||September 2005|2005-09-01||||||||Interventional|||Percutaneous Coronary Angioplasty Compared With Exercise Training in Symptomatic Coronary Artery Disease||Unknown status|Recruiting|Phase 2/Phase 3|400|Anticipated|University of Leipzig|||||f||||||||||||||2017-02-18 17:18:44.821877|2017-02-18 17:18:44.821877
NCT00176345|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-11|||January 2001||2001-01-01|September 2005|2005-09-01||||||||Interventional|||Impact of Exercise Training on Endothelial Function in CAD|Impact of Exercise Training on Bradykinin-Mediated Endothelial Function in Patients With Coronary Artery Disease|Unknown status|Recruiting|Phase 2|20||University of Leipzig|||||f||||||||||||||2017-02-18 17:18:44.896741|2017-02-18 17:18:44.896741
NCT00176332|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2007-07-31|||March 2004||2004-03-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure|Impact of Three Months of Rosuvastatin Treatment on Peripheral Endothelial Function, Inflammatory Markers in the Blood and the Skeletal Muscle and on Postnatal Vasculogenesis in Patients With Severe Chronic Heart Failure|Completed||Phase 2|40||University of Leipzig|||||f||||||||||||||2017-02-18 17:18:44.979214|2017-02-18 17:18:44.979214
NCT00176319|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-07-14|||May 2005||2005-05-01|July 2009|2009-07-01||||December 2008|Actual|2008-12-01||Interventional|LEICA||Leipzig Exercise Intervention in Chronic Heart Failure and Aging|Age-related Functional and Molecular Effects of Short-term Aerobic Endurance Training in Patients With Stable Chronic Heart Failure and Age-matched Healthy Controls.|Completed||Phase 2|120|Actual|University of Leipzig||8|||f||||||||||||||2017-02-18 17:18:45.092552|2017-02-18 17:18:45.092552
NCT00176306|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-09-12|2011-08-02||January 2005||2005-01-01|September 2012|2012-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Levofloxacin Pharmacokinetics (PK) in the Severely Obese|Levofloxacin Pharmacokinetics in the Severely Obese|Completed||Phase 4|15|Actual|University of Kentucky|The number of ambulatory volunteers was low The acutely ill cohort was a heterogeneous population We remain unable to predict the precise effect of all of these different physiologic processes on drug pharmacokinetics|1|||f||||f||||||||||2017-02-18 17:18:48.02605|2017-02-18 17:18:48.02605
NCT00176293|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-20|||October 2005||2005-10-01|April 2015|2015-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer|A Randomized Phase II Trial of Doxil With or Without Dexamethasone in Treatment of Patients With Metastatic Hormone Refractory Prostate Cancer|Terminated||Phase 2|2|Actual|University of Kentucky||2||Slow accrual|f||||||||||||||2017-02-18 17:18:48.245309|2017-02-18 17:18:48.245309
NCT00176280|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-06-16|||September 2005||2005-09-01|June 2015|2015-06-01||||||||Interventional|||Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma|A Randomized Phase II Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemcitabine and 5-Fluorouracil (5-FU) in Patients With Metastatic Renal Cell Carcinoma (RCC)|Withdrawn||Phase 2|0|Actual|University of Kentucky||||Slow accrual|f||||||||||||||2017-02-18 17:18:48.351883|2017-02-18 17:18:48.351883
NCT00176267|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-21|||September 2002||2002-09-01|March 2016|2016-03-01||||January 2005|Actual|2005-01-01||Interventional|||Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer|Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer|Active, not recruiting||Phase 2|40|Actual|University of Kentucky||1|||f||||f||||||||||2017-02-18 17:18:48.443653|2017-02-18 17:18:48.443653
NCT00176254|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-01-24|2013-12-08||May 2000||2000-05-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer|Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer|Completed||Phase 2|40|Actual|University of Kentucky|Heterogeneity of post-induction treatment given. While definitive therapy did differ, it was stratified by response to induction therapy, an accepted practice. Conclusions remain exploratory, because of the small sample size and heterogeneity.|1|||f||||f||||||||||2017-02-18 17:18:48.556908|2017-02-18 17:18:48.556908
NCT00176241|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-06-03|||December 2005||2005-12-01|June 2015|2015-06-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer|A Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent Head & Neck Cancer|Terminated||Phase 1|7|Actual|University of Kentucky||1||Slow accrual|f||||f||||||||||2017-02-18 17:18:48.810247|2017-02-18 17:18:48.810247
NCT00176228|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-28|2013-06-20||February 2004||2004-02-01|June 2015|2015-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Lamotrigine Monotherapy in Pediatric Bipolar Disorder|Open Trial of Lamotrigine Monotherapy in Pediatric Bipolar Disorder|Completed||Phase 2|48|Actual|University of Illinois at Chicago||1|||f||||t||||||||||2017-02-18 17:18:48.918612|2017-02-18 17:18:48.918612
NCT00176215|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||May 2003||2003-05-01|July 2005|2005-07-01||||||||Interventional|||Clinical Comparison of RPDs Retained by Conical and Galvanoformed Double Crowns.||Unknown status|Active, not recruiting|Phase 4|||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:49.416796|2017-02-18 17:18:49.416796
NCT00176202|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-11-04|2015-06-02||April 2003||2003-04-01|November 2015|2015-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional||AGE 10 TO 20 YRS GENDER :BOTH|Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar|Controlled Trial of Risperidone and Divalproex Sodium With MRI Assessment of Affected Circuitry in Pre and Post Treatment in Pediatric Bipolar|Completed||Phase 3|65|Actual|University of Illinois at Chicago||2|||f||||t||||||||||2017-02-18 17:18:49.495548|2017-02-18 17:18:49.495548
NCT00176189|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-25|||February 2005||2005-02-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Clinical Performance of Extended All-Ceramic Fixed Partial Dentures Based on Zircon-Oxide Ceramics.|Clinical Performance of Extended All-Ceramic Fixed Partial Dentures Based on Zircon-Oxide Ceramics|Completed||N/A|30||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:49.919535|2017-02-18 17:18:49.919535
NCT00176176|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-11||||||November 2004|2004-11-01||||||||Interventional|||Investigation of Cognitive Function Before and After Induced Ventricular Fibrillation in Electrophysiological (EP) Study|Change of EEG Activity and Cerebral Circulation During Induced Ventricular Fibrillation and Investigation of Cognitive Function Before and After Induced Ventricular Fibrillation in EP Study|Unknown status|Recruiting|N/A|30||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:50.00712|2017-02-18 17:18:50.00712
NCT00176163|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-01|||August 2005||2005-08-01|September 2005|2005-09-01|May 2009||2009-05-01|||||Interventional|||Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain|Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain|Completed||Phase 2|240|Anticipated|Heidelberg University|||||f||||||||||||||2017-02-18 17:18:50.114834|2017-02-18 17:18:50.114834
NCT00176150|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13||||||April 2003|2003-04-01||||||||Observational|||Drug Transport in Patients With Anorexia Nervosa|Influence of Cholesterol Plasma Levels on Drug Transport in Patients With Anorexia Nervosa|Unknown status|Recruiting|N/A|||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:50.207666|2017-02-18 17:18:50.207666
NCT00176137|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-21|||October 1995||1995-10-01|April 2008|2008-04-01|September 2005||2005-09-01|||||Interventional|||Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)|Cisplatin/Etoposide Followed by Twice-Daily Chemoradiation (hfRT/CT) Versus Cisplatin/Etoposide Alone Before Surgery in Stage III Non-Small Cell Lung Cancer. A Phase III Trial of the German Lung Cancer Cooperative Group (GLCCG)|Completed||Phase 3|500||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:50.281678|2017-02-18 17:18:50.281678
NCT00176124|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-06-09|||April 2001||2001-04-01|June 2008|2008-06-01|September 2005|Actual|2005-09-01|April 2005|Actual|2005-04-01||Interventional|LDAWB-2001||Leukocyte Depletion of Autologous Whole Blood|Leukocyte Depletion of Autologous Whole Blood: Impact on Perioperative Infection Rate and Length of Hospital Stay for Hip Arthroplasty Patients|Completed||Phase 4|1089|Actual|Heidelberg University||2|||f||||t||||||||||2017-02-18 17:18:50.374032|2017-02-18 17:18:50.374032
NCT00176111|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-15|||January 2004||2004-01-01|January 2004|2004-01-01|January 2005||2005-01-01|||||Interventional|||Effects of Local Anesthetic or Saline Solution on Peripheral Nerve Stimulation – a Randomised Study|Effects of Local Anesthetic or Saline Solution on Peripheral Nerve Stimulation – a Randomised, Double-Blind, Multicenter Study About the Stimulability of Anesthetized Nerves|Terminated||Phase 4|40||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:50.498854|2017-02-18 17:18:50.498854
NCT00176098|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-02-06|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||Hypnosis for Eye Surgery|Correlation of Stress, Patient Comfort and Safety to Bispectral Index in Patients Under Hypnosis for Cataract Surgery|Unknown status|Recruiting|Phase 1/Phase 2|70||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:50.58594|2017-02-18 17:18:50.58594
NCT00173498|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||July 2005||2005-07-01|July 2005|2005-07-01|October 2005||2005-10-01|||||Observational|||Common Allergens in Skin Tests for Adult Atopic Dermatitis|Common Allergens in Skin Tests for Adult Atopic Dermatitis|Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.19567|2017-02-18 17:19:33.19567
NCT00176085|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-05-27|||October 2004||2004-10-01|May 2015|2015-05-01|March 2005|Actual|2005-03-01|||||Observational|||Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH|Pharmacokinetics of 11-Nor-9-carboxy-D9-tetrahydrocannabinol (THCCOOH) and Its Acyl-glucuronide (THCCOOH-GLu) After Intravenous Administration of THCCOOH in Healthy Human Subjects|Completed||Phase 1|10||Heidelberg University|||1||f||||||||||||||2017-02-18 17:18:50.671473|2017-02-18 17:18:50.671473
NCT00176072|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|July 2004|2004-07-01|November 2004||2004-11-01|||||Observational|||BlueCQ Bioavailability|B l u e C Q - P r o j e c t: Bioavailability of Methylene Blue (MB) - Comparison of an Intravenous and Two Oral Formulations - and Influence of Sustained Release MB on Chloroquine (CQ) Concentrations|Completed||Phase 1|18||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:50.746749|2017-02-18 17:18:50.746749
NCT00176059|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-05-08|||October 2001||2001-10-01|May 2007|2007-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients|Immunoglobulin Induction Therapy in Renal Transplant Recipients on Tacrolimus/Azathioprine or Tacrolimus/MMF: Effects on Th1, Th2, B Cell-/Monokine Responses and Immunoregulatory Autoantibody Levels|Completed||Early Phase 1|50|Actual|University of Giessen||2|||f||||f||||||||||2017-02-18 17:18:50.807845|2017-02-18 17:18:50.807845
NCT00176046|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-02-09|||May 1999||1999-05-01|June 2009|2009-06-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study|Prospective Controlled Randomized Feasibility Study on a Treatment With Viscum Album in Patients With Breast Cancer to Identify Appropriate Surrogate Parameters for a Randomized Study of the Efficacy of Treatment With Mistletoe Extracts|Unknown status|Active, not recruiting|Phase 4|114|Actual|Heidelberg University||2|||f||||f||||||||||2017-02-18 17:18:50.917308|2017-02-18 17:18:50.917308
NCT00176033|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-02-12|||January 2005||2005-01-01|February 2009|2009-02-01||||||||Observational|||Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra|Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra (Lopinavir/Ritonavir) and on the Concentration Relations Between Plasma, Blood Cells, Saliva and Urine|Completed||Phase 1|12|Anticipated|Heidelberg University|||||f||||||||||||||2017-02-18 17:18:51.029975|2017-02-18 17:18:51.029975
NCT00176020|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-14||||||August 2005|2005-08-01||||||||Interventional|||Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression|Double-Blind, Randomized, Placebo-Controlled, Single-Center, 2 Treatment, 3-Way Crossover Study to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of a Single Oral Repeated Dose of 500 Mg Nicotinic Acid as Tablets in Healthy Subjects|Unknown status|Not yet recruiting|Phase 1|18||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:51.115464|2017-02-18 17:18:51.115464
NCT00176007|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-09-10||||||June 2005|2005-06-01||||||||Interventional|||Hypoxia Impairs Endothelial Function in HAPEs|Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema.|Completed||Phase 1|||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:51.180781|2017-02-18 17:18:51.180781
NCT00175994|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-04-16|||July 2005||2005-07-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Observational|||Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism|Bioavailability and Metabolism of Voriconazole as a Function of the CYP2C19 Genotype|Completed||Phase 1|24||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:51.496912|2017-02-18 17:18:51.496912
NCT00175981|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||February 2003||2003-02-01|September 2005|2005-09-01|November 2004||2004-11-01|||||Interventional|||Interaction Between Fluvoxamine and Sildenafil|Pharmacokinetic and Pharmacodynamic Evaluation of the Interaction Between Fluvoxamine and Sildenafil in Healthy Males|Completed||Phase 1|12||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:51.589867|2017-02-18 17:18:51.589867
NCT00175968|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||March 2001||2001-03-01|September 2005|2005-09-01|April 2003||2003-04-01|||||Interventional|||Influence of Bedrest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity|Influence of Bed-Rest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity|Completed||Phase 1|10||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:51.672639|2017-02-18 17:18:51.672639
NCT00175955|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-12-05|||May 2005||2005-05-01|September 2009|2009-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia|An 8-week Exploratory, Double-blind, Placebo Controlled, Randomized Trial: Evaluation of the Efficacy and Safety of Levetiracetam up to 3000 mg/Day (250-500 mg Oral Tablets in b.i.d. Administration) on Neuroleptic-induced Tardive Dyskinesia in Subjects With Stable Axis I Psychiatric Disorder, Aged From at Least 18 Years to 80 Years.|Completed||Phase 2|70||UCB Pharma|||||f||||||||||||||2017-02-18 17:18:51.759071|2017-02-18 17:18:51.759071
NCT00175942|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-09-10|||February 2003||2003-02-01|May 2005|2005-05-01||||||||Observational|||Risk Indicators in Patients With Ventricular Fibrillation During Acute Myocardial Infarction|Indicators of Coagulation Activation and Inflammation Contributing to Ventricular Fibrillation Complicating Acute Myocardial Infarction|Unknown status|Recruiting|N/A|300||Heidelberg University|||||f||||||||||||||2017-02-18 17:18:51.867052|2017-02-18 17:18:51.867052
NCT00175929|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-04-10|||May 2005||2005-05-01|April 2015|2015-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of Brivaracetam in Subjects With Partial Onset Seizures|A Multicenter, Double-blind, Randomized, Placebo-controlled, 3 Parallel Groups, Dose-ranging Trial Evaluating the Efficacy and Safety of Ucb 34714 Used as Adjunctive Treatment at Doses of 50 and 150 mg/Day in b.i.d. Administration (Oral Capsules of 25 mg) for a Maximum of 12 Weeks in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures Whether or Not Secondarily Generalized|Completed||Phase 2|157|Actual|UCB Pharma||3|||f||||t||||||||||2017-02-18 17:18:51.950991|2017-02-18 17:18:51.950991
NCT00175916|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-02-16|||September 2005||2005-09-01|February 2017|2017-02-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy|An Open-label, Multicenter, Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment at a Flexible Dose up to a Maximum of 200 mg/Day in Subjects Aged 16 Years or Older Suffering From Epilepsy|Active, not recruiting||Phase 3|853|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:18:52.123523|2017-02-18 17:18:52.123523
NCT00175539|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-22|||November 2005||2005-11-01|June 2010|2010-06-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties|Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties|Completed||N/A|25|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:57.215981|2017-02-18 17:18:57.215981
NCT00175903|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-03-12|||February 2005||2005-02-01|March 2015|2015-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy|A Therapeutic Confirmatory, Open-label, Multi-center, Randomized 2 Parallel Groups, Community-based Trial Studying the Efficacy and Safety of Levetiracetam (1000 to 3000 mg/Day Oral Tablets 250-500 mg b.i.d.) Compared to Sodium Valproate (1000 to 2000 mg/Day Oral ER Tablets 300-500 mg b.i.d.) and Carbamazepine (600 to 1600 mg/Day Oral CR Tablets 200-400 mg b.i.d.) as Monotherapy in Subjects With Newly Diagnosed Epilepsy.|Completed||Phase 3|1701|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 17:18:52.396347|2017-02-18 17:18:52.396347
NCT00175890|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-07-06|||October 2004||2004-10-01|July 2015|2015-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.|A Double-Blind, Randomized, Multicenter, Placebo-controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/Day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age From 1 Month to Less Than 4 Years of Age. N01009|Completed||Phase 3|116|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 17:18:52.998657|2017-02-18 17:18:52.998657
NCT00175877|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-03-22|2013-02-04||June 2005||2005-06-01|March 2013|2013-03-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Baseline Characteristics refer to the Safety Set (SS). SS consists of all enrolled subjects who received at least 1 dose of study medication.|A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis|A Phase III Multi-centre, Open-label, follow-on Study to CDP870-027, to Assess the Efficacy and Safety of Lyophilized CDP870 an Engineered Human Anti-TNF PEG Conjugate, as Additional Medication to Methotrexate, in the Treatment of Signs and Symptoms and Preventing Structural Damage in Patients With Active Rheumatoid Arthritis|Completed||Phase 3|857|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:18:53.238765|2017-02-18 17:18:53.238765
NCT00175864|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-03-19|||February 2006||2006-02-01|March 2012|2012-03-01||||||||Interventional|||Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.|Open Label, Multicenter Study of the Safety and Efficacy of Oral Treatment With Immediate Release Seletracetam (Ucb 44212) at Individualized Doses up to a Maximum of 160mg/Day in Refractory Epileptic Patients.|Withdrawn||Phase 3|0|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:18:54.727693|2017-02-18 17:18:54.727693
NCT00175851|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-05-25|||May 2008||2008-05-01|May 2012|2012-05-01||||||||Interventional|||Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy|An Open-label, Multicenter, Follow-up Trial to Evaluate the Long-term Safety and Efficacy of Seletracetam Used as Adjunctive Treatment Using a Flexible Dosing Scheme of 4 to 80 mg b.i.d. in Subjects Aged 16 Years or Older Suffering From Epilepsy|Withdrawn||Phase 3|0|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:18:54.814984|2017-02-18 17:18:54.814984
NCT00175838|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-17|||July 1997||1997-07-01|January 2017|2017-01-01|November 2016|Actual|2016-11-01|November 2016|Actual|2016-11-01||Interventional|PT-1||Primary Thrombocythaemia 1 Trial|A Randomised Trial to Compare Aspirin vs Hydroxyurea/Aspirin in 'Intermediate Risk' Primary Thrombocythaemia and Aspirin Only With Observation in 'Low Risk'Primary Thrombocythaemia|Completed||N/A|1398|Actual|University of Cambridge||2|||f||||t||||||||||2017-02-18 17:18:54.915726|2017-02-18 17:18:54.915726
NCT00175825|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-08-28|||November 2005||2005-11-01|August 2012|2012-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.|A Double-blind, Randomized, Placebo-controlled, Dose-ranging Trial Evaluating the Efficacy and Safety of Brivaracetam as Adjunctive Treatment at Doses of 5, 20 and 50 mg/Day in Subjects From 16 to 65 Years With Refractory Epilepsy Suffering From Partial Onset Seizures.|Completed||Phase 2|210|Actual|UCB Pharma||4|||f||||f||||||||||2017-02-18 17:18:55.035353|2017-02-18 17:18:55.035353
NCT00175812|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-06-23|||November 2004||2004-11-01|June 2015|2015-06-01|November 2009|Actual|2009-11-01|May 2008|Actual|2008-05-01||Interventional|||Differentiation Induction in Acute Myelogenous Leukemia|Differentiation Induction Therapy for Acute Myelogenous Leukemia|Completed||Phase 1/Phase 2|24|Actual|University of Bergen||1|||f||||f||||||||||2017-02-18 17:18:55.190931|2017-02-18 17:18:55.190931
NCT00175799|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-05|||September 2007||2007-09-01|May 2015|2015-05-01|July 2013|Actual|2013-07-01|September 2011|Actual|2011-09-01||Observational|||Validation of Severity of Illness Scoring Systems in Paediatric Intensive Care Units in Canada|Validation of Severity of Illness Scoring Systems in Paediatric Intensive Care Units in Canada Outcome: Validation and Comparison of 2 Severity of Illness Scores in Canadian PICU Population|Completed||N/A|10000|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 17:18:55.316972|2017-02-18 17:18:55.316972
NCT00175786|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-24|||July 2005||2005-07-01|September 2008|2008-09-01||||||||Observational|||Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma|Neuroradiologic Screening of Patients With Normal Tension Glaucoma|Completed||N/A|50|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 17:18:55.407725|2017-02-18 17:18:55.407725
NCT00175773|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-10|||November 2004||2004-11-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Mechanisms of Orthostatic Intolerance in Spinal Cord Injured Individuals and Following Bed Rest|Mechanisms of Orthostatic Intolerance in Spinal Cord Injured Individuals and Following Bed Rest|Completed||N/A|51|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 17:18:55.49039|2017-02-18 17:18:55.49039
NCT00175760|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-11|||December 2004||2004-12-01|April 2011|2011-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Can a Very High Result From a Screening Test for Celiac Disease be Used to Diagnose Celiac Disease?|Prospective Assessment of High Titre TTG to Diagnose Celiac Disease in Select Paediatric Patients.|Completed||N/A|100|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 17:18:55.58388|2017-02-18 17:18:55.58388
NCT00175747|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2000||2000-01-01|September 2005|2005-09-01|December 2002||2002-12-01|||||Interventional|||A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)|A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People With Dysplasia of the Bronchial Epithelium|Completed||Phase 2/Phase 3|120||University of British Columbia|||||f||||||||||||||2017-02-18 17:18:55.676281|2017-02-18 17:18:55.676281
NCT00175734|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-01-30|||August 2005||2005-08-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2007|Actual|2007-12-01||Interventional|||Interactive Studies of Endstage Diabetic Dialysis Patients|Integrated Studies in Vascular Reactivity and Anemia Correction Therapy in Endstage Kidney Disease Patients|Unknown status|Active, not recruiting|N/A|80|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:55.78691|2017-02-18 17:18:55.78691
NCT00175721|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-03-14|||December 2005||2005-12-01|March 2014|2014-03-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Trial Comparing Care in Multiple Clinics Versus Care in a Cardiac, Diabetes and Kidney Care Clinic|Randomized Controlled Trial Comparing Current Care in Multiple Clinics Vs Care in a Novel Cardiac, Diabetes & Kidney Care Clinic|Completed||N/A|150|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:55.883062|2017-02-18 17:18:55.883062
NCT00175708|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-30|||September 2005||2005-09-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Observational|||Pedobarographic Assessments of Clubfoot Treated Patients|Pedobarographic Assessments of Clubfoot Treated Patients|Recruiting||N/A|100|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 17:18:55.986429|2017-02-18 17:18:55.986429
NCT00175695|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-02-03|||December 2004||2004-12-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Disease Modification in Toxaemia of Pregnancy|A Safety and Efficacy Trial of Recombinant Human Activated Protein C in Both Early-onset Pre-eclampsia and Severe Postpartum Pre-eclampsia.|Completed||Phase 2|30|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 17:18:56.084983|2017-02-18 17:18:56.084983
NCT00175682|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-15|||December 2004||2004-12-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study|Prophylactic Value of Prazosin in Reducing the Objective and Subjective Measures of Autonomic Dysreflexia Provoked by Ejaculation in Men With Spinal Cord Injury|Unknown status|Recruiting|N/A|8|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:56.181893|2017-02-18 17:18:56.181893
NCT00175669|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-11|||August 2007||2007-08-01|April 2011|2011-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Trial of a Botulinum A Toxin (Botox) Injection in the Gastrocnemius Muscle in Children With Idiopathic Toe Walking|Randomized Controlled Trial of a Botulinum A Toxin (Botox) Injection in the Gastrocnemius Muscle in Children With Idiopathic Toe Walking|Completed||Phase 2|32|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:56.279632|2017-02-18 17:18:56.279632
NCT00175656|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-04-12|||January 2007||2007-01-01|April 2011|2011-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Titanium Elastic Nails in the Treatment of Pediatric Femur Fractures|Titanium Elastic Nails in the Treatment of Paediatric Femoral Fractures: A Prospective Randomized Clinical Trial of Eliminating Nail Protrusion to Decrease Soft Tissue Complications|Completed||Phase 1|80|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:56.374176|2017-02-18 17:18:56.374176
NCT00175643|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2006-05-08|||February 2005||2005-02-01|May 2006|2006-05-01|November 2005||2005-11-01|||||Interventional|||Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses|Open-Label Study to Assess Safety and Efficacy of Imiquimod 5% Cream Applied 3 Days Per Week in 1 or 2 Cycles for Treatment of Actinic Keratoses on the Head|Completed||Phase 3|20||University of British Columbia|||||f||||||||||||||2017-02-18 17:18:56.463057|2017-02-18 17:18:56.463057
NCT00175630|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-05-30|||December 2010||2010-12-01|May 2016|2016-05-01|September 2016|Anticipated|2016-09-01|September 2011|Actual|2011-09-01||Interventional|||The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction|Effect of Femoral Nerve Block on Opioid Requirements Following Anterior Cruciate Ligament Reconstruction: A Double Blind, Prospective Randomized Controlled Trial|Active, not recruiting||Phase 1|30|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:56.56547|2017-02-18 17:18:56.56547
NCT00175617|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-15|||September 2005||2005-09-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss|Efficacy of Therapy With the Anti-androgen Spironolactone Compared to Topical Minoxidil in Female Pattern Hair Loss|Unknown status|Recruiting|Phase 2|40|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:56.65967|2017-02-18 17:18:56.65967
NCT00175604|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-05|||August 2004||2004-08-01|February 2011|2011-02-01|February 2008|Anticipated|2008-02-01|February 2008|Anticipated|2008-02-01||Interventional|||Comparative Trial of Botox in the Management of Children With Congenital Muscular Torticollis|Comparative Trial of Botox Versus Conventional Treatment Used in the Management of Children With Congenital Muscular Torticollis (CMT)|Withdrawn||Phase 1|0|Actual|University of British Columbia||1||Not able to recruit any subjects for the study and was closed in February 2008|f||||f||||||||||2017-02-18 17:18:56.75028|2017-02-18 17:18:56.75028
NCT00175591|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-08|||August 2007||2007-08-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||The Effect of Femoral Nerve Block on Opioid Requirements After Surgery for a Femur Fracture in Children|The Effect of Femoral Nerve Block on Opioid Requirements Following Femoral Fracture Fixation With Flexible Nails in the Paediatric Population: A Double Blind, Prospective Randomized Clinical Trial|Terminated||Phase 1|25|Actual|University of British Columbia||1||It has become a standard of care to give Femoral nerve blocks and have discontinued this study|f||||f||||||||||2017-02-18 17:18:56.854946|2017-02-18 17:18:56.854946
NCT00175578|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-15|||May 2005||2005-05-01|November 2011|2011-11-01|December 2011|Anticipated|2011-12-01|||||Observational|||Detection of Early Lung Cancer by Serum Protein Expression Profiling|Differences in SELDI Produced Serum Protein Profiles of Non-small Cell Lung Cancer Patients Compared to Healthy Heavy Smoking Adults|Unknown status|Recruiting|N/A|220|Anticipated|University of British Columbia|||1||f||||f||||||||||2017-02-18 17:18:56.94914|2017-02-18 17:18:56.94914
NCT00175565|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2010-07-26|||January 2002||2002-01-01|July 2010|2010-07-01|July 2003||2003-07-01|||||Interventional|||Inhaled Steroid Reduces Systemic Inflammation in COPD|Effects of Fluticasone On Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease|Completed||Phase 4|50||University of British Columbia|||||f||||||||||||||2017-02-18 17:18:57.031596|2017-02-18 17:18:57.031596
NCT00175552|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-16||||||July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Ministry of Child and Family Development (MCFD) Interpersonal Psychotherapy for Adolescents (IPT-A) Training Project|Evaluating the Effectiveness of Different Interpersonal Psychotherapy for Adolescents (IPT-A) Therapist Training Models|Completed||N/A|24|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 17:18:57.135847|2017-02-18 17:18:57.135847
NCT00175526|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-05-30|||September 2005||2005-09-01|May 2016|2016-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Predicting Complications in Women With Toxaemia|PIERS (Pre-eclampsia Integrated Estimate of RiSk) Model: Predicting Adverse Maternal Outcomes in Pre-eclampsia|Completed||N/A|650|Actual|University of British Columbia|||1||f||||f||||||||||2017-02-18 17:18:57.305325|2017-02-18 17:18:57.305325
NCT00175513|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-04-12|||September 2005||2005-09-01|April 2011|2011-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis|V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis|Completed||Phase 2|100|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:57.397301|2017-02-18 17:18:57.397301
NCT00175500|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-09-20|||September 2007||2007-09-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of Conventional and Large Diameter Femoral Heads for the Prevention of Hip Dislocation|A Randomized Multi-Centre Controlled Trial of Large Diameter (36/40 mm) Versus Conventional Diameter (32 mm) Femoral Heads for the Prevention of Post Revision Arthroplasty Dislocation|Unknown status|Active, not recruiting|N/A|400|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:57.487526|2017-02-18 17:18:57.487526
NCT00175487|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2014-03-17|||September 2007||2007-09-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Hip Resurfacing to Large Femoral Head Total Hip Arthroplasty|Femoral Head Resurfacing Versus a Large Femoral Head (Durom®) Total Hip System: A Prospective Randomized Trial|Unknown status|Active, not recruiting|N/A|56|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:57.570034|2017-02-18 17:18:57.570034
NCT00175474|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-10-12|||September 2005||2005-09-01|October 2011|2011-10-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of a Minimally Invasive Technique for Total Knee Replacement to a Standard Technique|Minimally Invasive Total Knee Arthroplasty Versus a Standard Surgical Technique: a Single-blinded Single-centre Randomized Controlled Trial|Completed||Phase 1|102|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:57.656029|2017-02-18 17:18:57.656029
NCT00175461|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-09-20|||September 2005||2005-09-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of Two Minimally Invasive Surgical Techniques for Hip Replacement|Comparison of the Clinical Effectiveness and Cost-effectiveness of the MIS Anterolateral Approach (MIS Watson Jones, G3) Versus Anterolateral Mini or Posterolateral Mini Approaches in Primary Total Hip Arthroplasty|Unknown status|Active, not recruiting|Phase 1|156|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:57.74536|2017-02-18 17:18:57.74536
NCT00175448|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-09-24|||September 2005||2005-09-01|September 2005|2005-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Comparison of Physiotherapy Versus Home Exercise Following Hip Replacement Surgery|A Randomized Controlled Trial of Outpatient Physiotherapy Versus a Self-Administered Home Exercise Program Following Discharge Home From Total Hip Arthroplasty|Completed||N/A|144|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 17:18:57.823417|2017-02-18 17:18:57.823417
NCT00175435|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2010-10-29|||August 2005||2005-08-01|October 2010|2010-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator|Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator|Completed||Phase 1/Phase 2|39|Actual|University of British Columbia||3|||f||||f||||||||||2017-02-18 17:18:58.136783|2017-02-18 17:18:58.136783
NCT00175422|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2010-12-15|||May 2005||2005-05-01|December 2010|2010-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Parents Helping Infants Study: Educational Intervention to Change the Knowledge, Attitudes and Behaviour of New Parents About Early Infant Crying|The Period of PURPLE Crying: An Educational Intervention to Change the Knowledge, Attitudes and Behaviour of New Parents About Early Infant Crying|Completed||Phase 1/Phase 2|1833|Actual|University of British Columbia||1|||f||||||||||||||2017-02-18 17:18:58.242582|2017-02-18 17:18:58.242582
NCT00175409|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-04-11|||January 2008||2008-01-01|April 2011|2011-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Breast Feeding Analgesia in Preterm Infants|Breast Feeding Analgesia in Preterm Infants|Completed||Phase 1|50|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 17:18:58.332826|2017-02-18 17:18:58.332826
NCT00175396|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2014-03-14|||May 2004||2004-05-01|March 2014|2014-03-01|June 2014|Anticipated|2014-06-01|December 2011|Actual|2011-12-01||Interventional|||Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy|A Randomized Phase III Study Comparing Androgen Suppression and Elective Pelvic Nodal Irradiation Followed by High Dose 3-D Conformal Boost Versus Androgen Suppression and Elective Pelvic Nodal Irradiation Followed by 125-Iodine Brachytherapy Implant Boost for Patients With Intermediate and High Risk Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 17:18:58.437274|2017-02-18 17:18:58.437274
NCT00175383|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2013-04-09|||June 2004||2004-06-01|April 2013|2013-04-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer|A Randomized Trial of Short Versus Long Acting LHRH Agonist Preparation Prior to Transperineal Implantation of the Prostate|Unknown status|Recruiting|Phase 3|100|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:58.54664|2017-02-18 17:18:58.54664
NCT00175370|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-06-18|||September 2000||2000-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus|Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus; Removal of Catheter Followed by 2 Days Compared With 7 Days Intravenous Vancomycin|Completed||N/A|60|Anticipated|University of British Columbia|||||f||||f||||||||||2017-02-18 17:18:58.654957|2017-02-18 17:18:58.654957
NCT00175357|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-09-25|||March 2005||2005-03-01|September 2014|2014-09-01|April 2009|Actual|2009-04-01|April 2007|Actual|2007-04-01||Interventional|||NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction|North American Opiate Medication Initiative (NAOMI): Multi-Centre, Randomized Controlled Trial of Heroin-Assisted Therapy for Treatment-Refractory Injection Opiate Users|Completed||Phase 3|192|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 17:18:58.756194|2017-02-18 17:18:58.756194
NCT00175344|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2014-02-18|||February 2004||2004-02-01|February 2014|2014-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Does Scar Massage Improve Postoperative Pain and Function in Women With Breast Cancer?|Does Scar Tissue Massage Improve Postoperative Pain and Function in Women With Breast Cancer? A Randomized Controlled Study.|Completed||Phase 3|96|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:18:58.868395|2017-02-18 17:18:58.868395
NCT00175318|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-02-09|||April 2005||2005-04-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Testing a Tooth Decay Prevention Program With Cree Mothers and Infants|A Clinical Trial of the Effectiveness of Motivational Interviewing as a Preventive Strategy for Dental Caries in Cree Infants|Completed||N/A|309|Anticipated|University of British Columbia||1|||f||||||||||||||2017-02-18 17:18:58.981851|2017-02-18 17:18:58.981851
NCT00175305|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-10-29|||August 2004||2004-08-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Prader-Willi Syndrome and Appetite|Effect of Somatostatin on Ghrelin Concentrations, Food Seeking Behaviour and Weight in Patients With Prader-Willi Syndrome|Terminated||Phase 3|10|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 17:18:59.073686|2017-02-18 17:18:59.073686
NCT00175292|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-12|||December 2003||2003-12-01|May 2008|2008-05-01||||||||Interventional|||A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.|A Randomized and Placebo-Controlled Double-Blind Multicentre Study to Determine the Efficacy and Safety of VSL#3 Probiotic Food Supplement Mixture in Prevention of Endoscopic Recurrence in Crohn's Disease Patients With Ileocolonic Surgical Resection and Small Intestine to Colon Anastomosis.|Completed||Phase 3|120|Anticipated|University of Alberta|||||f||||||||||||||2017-02-18 17:18:59.170115|2017-02-18 17:18:59.170115
NCT00175279|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-05-09|||January 2002||2002-01-01|May 2011|2011-05-01|April 2005||2005-04-01|||||Interventional|||A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease|A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease|Completed||N/A|160||University of Alberta|||||f||||||||||||||2017-02-18 17:18:59.274895|2017-02-18 17:18:59.274895
NCT00175266|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-10-01||||||October 2009|2009-10-01||||||||Interventional|||Islet Transplantation Using Campath-1H and Infliximab Induction|Islet Transplantation in Type 1 Diabetic Patients Using Campath-1H and Infliximab Induction|Completed||Phase 2|12||University of Alberta|||||f||||||||||||||2017-02-18 17:18:59.3733|2017-02-18 17:18:59.3733
NCT00175253|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-07-11|||November 2005||2005-11-01|July 2012|2012-07-01|April 2012|Actual|2012-04-01|||||Interventional|||Alemtuzumab Induction in Islet Transplantation|Alemtuzumab Induction With Tacrolimus and MMF Maintenance Immunosuppression in Islet Transplantation|Completed||Phase 2|12|Anticipated|University of Alberta|||||f||||||||||||||2017-02-18 17:18:59.459677|2017-02-18 17:18:59.459677
NCT00175240|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-07-25|||March 2005||2005-03-01|July 2015|2015-07-01|July 2015|Actual|2015-07-01|August 2011|Actual|2011-08-01||Interventional|||Enhancing the Secondary Prevention of Coronary Artery Disease|Enhancing the Use of Secondary Prevention Strategies in Patients With Coronary Artery Disease (The ESP-CAD Study)|Completed||Phase 4|480|Anticipated|University of Alberta|||||f||||||||||||||2017-02-18 17:18:59.569615|2017-02-18 17:18:59.569615
NCT00175227|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-05-09|||May 1996||1996-05-01|May 2011|2011-05-01||||October 2000|Actual|2000-10-01||Interventional|||Prevention of Contrast-Induced Nephropathy|Prevention of Contrast-Induced Nephropathy: a Randomized Controlled Trial of Saline + Furosemide + Mannitol in High Risk Patients Undergoing Cardiac Angiography|Completed||N/A|200|Anticipated|University of Alberta||2|||f||||f||||||||||2017-02-18 17:18:59.682407|2017-02-18 17:18:59.682407
NCT00175214|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-09-10|||January 2001||2001-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Controlled Trial to Increase Detection and Treatment of Osteoporosis in Older Patients With a Wrist Fracture|Controlled Trial to Increase Detection and Treatment of Osteoporosis in Older Patients With a Wrist Fracture|Completed||N/A|160||University of Alberta|||||f||||||||||||||2017-02-18 17:18:59.797135|2017-02-18 17:18:59.797135
NCT00175201|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2006-05-04|||May 2005||2005-05-01|May 2006|2006-05-01|March 2008||2008-03-01|||||Interventional|||Cost Efficacy of a Clinical Pathway to Patients Undergoing Hip and Knee Replacement Surgery|From Efficacy to Effectiveness of a Proactive Perioperative Care and Rehabilitation in Patients Undergoing Primary Total Hip or Knee Replacement|Unknown status|Recruiting|N/A|80||University of Aarhus|||||f||||||||||||||2017-02-18 17:18:59.90494|2017-02-18 17:18:59.90494
NCT00175188|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2010-10-12|||June 2004||2004-06-01|October 2010|2010-10-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||An RSA and DEXA Study on Migration of Proximal Interphalangeal (PIP) Joint Prostheses of the Hand|A Roentgen Stereophotogrammetric Analysis and DEXA Study on Migration of Proximal Interphalangeal Joint Prostheses of the Hand. A Randomised Prospective Study of Cemented Versus Non-cemented Implants|Completed||N/A|30|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 17:18:59.993079|2017-02-18 17:18:59.993079
NCT00175175|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-13|||March 2002||2002-03-01|September 2006|2006-09-01||||||||Interventional|||Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients|Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients|Completed||N/A|220||University of Alberta|||||f||||||||||||||2017-02-18 17:19:00.130327|2017-02-18 17:19:00.130327
NCT00175162|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2010-10-13|||June 2007||2007-06-01|October 2010|2010-10-01|December 2010||2010-12-01|||||Interventional|||A Comparison of Fixation Method in Total Knee Arthroplasty - Low Viscosity Versus High Viscosity Bone Cement|A Comparison of Fixation Method in Total Knee Arthroplasty - Low Viscosity Versus High Viscosity Bone Cement. A Prospective Randomized Migration- and Bone Density Study on Primary Cemented Knee Implants.|Withdrawn||N/A|50|Anticipated|University of Aarhus||2||No financing possible|f||||f||||||||||2017-02-18 17:19:00.239247|2017-02-18 17:19:00.239247
NCT00175149|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-12-06|||January 2002||2002-01-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Active Vitamin D Effect on Left Ventricular Hypertrophy|The Efficacy of 1,25 Dihydroxycholecalciferol on the Cardiovascular System in Patients With Renal Dysfunction|Terminated||Phase 4|24|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 17:19:00.358761|2017-02-18 17:19:00.358761
NCT00175136|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2010-10-12|||January 2005||2005-01-01|October 2010|2010-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Comparison of the Design of Tibia Stems in Cemented Total Knee Arthroplasty - Wedge Stem Versus I-beam Stem.|A Comparison of the Design of Tibia Stems - Wedge Stem Versus I-beam Stem. A Prospective Randomized Migration- and Bone Density Study on Primary Cemented Knee Implants.|Completed||N/A|54|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 17:19:00.465427|2017-02-18 17:19:00.465427
NCT00175123|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-02-19|||May 2005||2005-05-01|February 2009|2009-02-01|June 2008|Anticipated|2008-06-01|March 2008|Anticipated|2008-03-01||Interventional|||Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele|Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Children Born With Myelomeningocele|Unknown status|Active, not recruiting|Phase 4|30|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:19:00.572793|2017-02-18 17:19:00.572793
NCT00175110|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-02||||||December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure|The Effect of Hibiscus Sabdariffa L. Tisane on Blood Pressure in Prehypertensive and Mildly Hypertensive Men and Women|Completed||Phase 1/Phase 2|66|Actual|Tufts University||2|||f||||f||||||||||2017-02-18 17:19:00.671218|2017-02-18 17:19:00.671218
NCT00175097|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-11-26|||June 2001||2001-06-01|November 2014|2014-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Soybean Based Diets and CVD Risk Factors|Impact of Different Forms of Soybean Based Foods on Cardiovascular Disease Risk Factors in Hypercholesterolemic Subjects.|Completed||N/A|30|Actual|Tufts University||4|||f||||f||||||||||2017-02-18 17:19:00.758001|2017-02-18 17:19:00.758001
NCT00175084|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-05-21|||October 2004||2004-10-01|May 2014|2014-05-01|December 2012|Actual|2012-12-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers|Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers|Completed||N/A|30|Anticipated|Tufts University||1|||f||||f||||||||||2017-02-18 17:19:00.871891|2017-02-18 17:19:00.871891
NCT00175071|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-01|||March 2004||2004-03-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|April 2007|Actual|2007-04-01||Interventional|||Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers|Effect of Conventional and Reformulated Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers|Active, not recruiting||N/A|30|Anticipated|Tufts University||1|||f||||f||||||||||2017-02-18 17:19:00.960465|2017-02-18 17:19:00.960465
NCT00175058|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-06-15|||August 2005||2005-08-01|June 2012|2012-06-01|May 2008|Actual|2008-05-01|June 2007|Actual|2007-06-01||Interventional|AMIHOT II||Acute Myocardial Infarction With HyperOxemic Therapy II (AMIHOT II)|Acute Myocardial Infarction With HyperOxemic Therapy II|Completed||Phase 3|317|Actual|TherOx||2|||f||||t||||||||||2017-02-18 17:19:01.065134|2017-02-18 17:19:01.065134
NCT00175045|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-20|||June 2003||2003-06-01|July 2010|2010-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis|A Phase 2, Open-Label Multicenter Study to Evaluate the Pharmacodynamics of Intravenous Lansoprazole to That of Oral Lansoprazole in Subjects With Erosive Esophagitis|Completed||Phase 2|68|Actual|Takeda||2|||f||||f||||||||||2017-02-18 17:19:01.173123|2017-02-18 17:19:01.173123
NCT00175032|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-20|||July 2003||2003-07-01|July 2010|2010-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin|A Randomized, Double-Blind, Phase 3 Study to Compare the Efficacy and Safety of Lansoprazole 30 mg QD and Naproxen 500 mg BID Versus Celecoxib 200 mg QD in Risk Reduction of Non Steroidal Anti-Inflammatory-Associated Ulcers in Osteoarthritis Subjects Taking Low Dose Aspirin|Completed||Phase 3|1045|Actual|Takeda||2|||f||||f||||||||||2017-02-18 17:19:01.282364|2017-02-18 17:19:01.282364
NCT00175019|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-22|2009-03-12||July 2003||2003-07-01|July 2010|2010-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|EXCEL||Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010|A Phase 3, Open-Label, Randomized, Allopurinol-Controlled Study to Assess the Long-Term Safety of Oral Febuxostat in Subjects With Gout|Completed||Phase 3|1086|Actual|Takeda|Subjects may receive >1 treatment. Adverse events are summarized by treatment at time of observation and subjects who receive >1 treatment are summarized for each treatment they receive, so subjects at risk will not match number of participants.|3|||f||||f||||||||||2017-02-18 17:19:01.409348|2017-02-18 17:19:01.409348
NCT00175006|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-22|2009-03-12||November 2002||2002-11-01|July 2010|2010-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|||Validation Study of Physical Measurement of Tophi|A Study to Assess a Direct Physical Measurement Method for Evaluation of Tophus Nodules in Subjects With Gout.|Completed||Phase 2|13|Actual|Takeda|||1||f||||f||||||None Retained|"~     None taken or retained~   "|||2017-02-18 17:19:02.727689|2017-02-18 17:19:02.727689
NCT00174993|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-02-27|||May 2001||2001-05-01|February 2012|2012-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|PROactive||Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes|PROspective PioglitAzone Clinical Trial In MacroVascular Events: A Macrovascular Outcome Study in Type 2 Diabetic Patients Comparing Pioglitazone With Placebo in Addition to Existing Therapy|Completed||Phase 3|4373|Actual|Takeda||2|||f||||f||||||||||2017-02-18 17:19:02.970006|2017-02-18 17:19:02.970006
NCT00174980|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-06-09|||September 2005||2005-09-01|October 2008|2008-10-01|July 2008|Actual|2008-07-01|January 2008|Actual|2008-01-01||Interventional|||Study of Oxycyte in Severe Closed Head Injury|An Open Label, Proof of Concept Study, to Evaluate the Safety and Biological Effects of Oxycyte™ Perfluorocarbon in Patients With A Severe Head Injury Requiring Intracranial Pressure Monitoring-OX-CL-II-002|Completed||Phase 2|9|Actual|Tenax Therapeutics, Inc.||1|||f||||||||||||||2017-02-18 17:19:03.369184|2017-02-18 17:19:03.369184
NCT00174967|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-07-27|2009-03-12||January 2001||2001-01-01|July 2011|2011-07-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout|Phase II, Dose-Response, Safety and Efficacy Study of Oral TMX-67 in Subjects With Gout.|Completed||Phase 2|153|Actual|Takeda||4|||f||||f||||||||||2017-02-18 17:19:03.47982|2017-02-18 17:19:03.47982
NCT00174954|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-22|2009-03-12||March 2002||2002-03-01|July 2010|2010-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|||Magnetic Resonance Imaging in Subjects With Gouty Tophi|A Study to Validate Magnetic Resonance Imaging (MRI) in the Quantitative Assessment of Gouty Tophi.|Completed||Phase 2|32|Actual|Takeda|||1||f||||f||||||None Retained|"~     None taken or retained.~   "|||2017-02-18 17:19:04.918564|2017-02-18 17:19:04.918564
NCT00174941|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-01-25|2009-03-12||March 2001||2001-03-01|January 2011|2011-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|FOCUS||Long-Term Safety of Febuxostat in Subjects With Gout.|Phase II, Open-Label Study, to Assess the Long-Term Safety of Oral TMX-67 in Subjects With Gout|Completed||Phase 2|116|Actual|Takeda||3|||f||||f||||||||||2017-02-18 17:19:05.218865|2017-02-18 17:19:05.218865
NCT00174928|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-07-20|||May 2005||2005-05-01|July 2010|2010-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease|A Phase 1, Single- and Repeated-Dose, Randomized, Open-Label, Multi-center Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Lansoprazole in Neonates With Clinically-Evident Gastroesophageal Reflux Disease.|Completed||Phase 1|24|Actual|Takeda||2|||f||||f||||||||||2017-02-18 17:19:06.80148|2017-02-18 17:19:06.80148
NCT00174915|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-01-31|2009-03-12||February 2003||2003-02-01|January 2012|2012-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|APEX||Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.|A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.|Completed||Phase 3|1072|Actual|Takeda||5|||f||||f||||||||||2017-02-18 17:19:06.928117|2017-02-18 17:19:06.928117
NCT00174902|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-10-24|||October 2003||2003-10-01|October 2003|2003-10-01|August 2004||2004-08-01|||||Interventional|||The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress|The Effect of Beta-Blockers, Aspirin, and Natural Habituation on Procoagulant Activity, Expression of Cellular Adhesion Molecules, and Endothelial Activation in Response to Acute Mental Stress: a Randomized Controlled Trial.|Unknown status|Active, not recruiting|Phase 1/Phase 2|80||Swiss Federal Institute of Technology|||||f||||||||||||||2017-02-18 17:19:11.862981|2017-02-18 17:19:11.862981
NCT00174889|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-05-20|||January 2005||2005-01-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Pregnenolone in the Management of Schizophrenia Patients|Efficacy and Safety of Pregnenolone Augmentation in the Management of Schizophrenia Patients: a Randomised Double-Blind Placebo-Controlled Trial|Completed||Phase 1|60||Sha’ar Menashe Mental Health Center|||||f||||||||||||||2017-02-18 17:19:11.977188|2017-02-18 17:19:11.977188
NCT00174876|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-09-17|||July 2004||2004-07-01|September 2008|2008-09-01|May 2005||2005-05-01|||||Interventional|||Aripiprazole as Augmentation for TRD|An Open-Label Study of Aripiprazole (Abilify) as an Augmentation Agent in Patients With Treatment-Resistant Depression|Completed||Phase 2|20||State University of New York - Upstate Medical University|||||f||||||||||||||2017-02-18 17:19:12.085862|2017-02-18 17:19:12.085862
NCT00174863|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-12-22|||October 2003||2003-10-01|December 2008|2008-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|ODYSSEY||Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer|Evaluation of Two Doses of SR31747A (75 mg and 125 mg) in Non-Metastatic Androgen-Independent Prostate Cancer. Randomized, Double-Blind, Placebo Controlled Phase II Study|Completed||Phase 2|232|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:19:12.174622|2017-02-18 17:19:12.174622
NCT00174850|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2008-09-17|||July 2004||2004-07-01|September 2008|2008-09-01|May 2005||2005-05-01|||||Interventional|||Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction|A 14 Week Open-Label Study to Evaluate the Tolerability of Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction in Generalized Anxiety Disorder Patients|Completed||Phase 4|30||State University of New York - Upstate Medical University|||||f||||||||||||||2017-02-18 17:19:12.520966|2017-02-18 17:19:12.520966
NCT00174837|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-04-27||2016-04-27|April 2005||2005-04-01|April 2016|2016-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|TRACE||TRACE: Tirapazamine-Radiation And Cisplatin Evaluation|Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer|Completed||Phase 3|317|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 17:19:12.629201|2017-02-18 17:19:12.629201
NCT00174824|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-03-26|||June 2001||2001-06-01|March 2009|2009-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients|Evaluation of Diabetic Retinopathy Progression in Subjects With Type 2 Diabetes Mellitus Treated With Insulin|Completed||Phase 4|1024|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:19:12.775403|2017-02-18 17:19:12.775403
NCT00174811|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-02|||June 2005||2005-06-01|April 2009|2009-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections|Multinational, Randomized, Double-Blind, Double-Dummy, Comparative Study to Evaluate the Efficacy and Safety of Telithromycin 25 mg/kg Given Once Daily for 5 or 10 Days Depending on Age and Previous Treatment History Versus Cefuroxime Axetil 15 mg/kg, Given Twice Daily for 10 Days, in Children With Acute Otitis Media|Terminated||Phase 3|639|Actual|Sanofi||||Pediatric development program terminated by sponsor|f||||||||||||||2017-02-18 17:19:12.876356|2017-02-18 17:19:12.876356
NCT00174798|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-02-01|||May 2005||2005-05-01|February 2012|2012-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.|A Randomized, Double-blind, Placebo and Active-controlled Efficacy and Safety Study of SSR240600C in Patients With Overactive Bladder (OAB) or Urge Urinary Incontinence (UUI)|Completed||Phase 2|118|Actual|Sanofi||3|||f||||||||||||||2017-02-18 17:19:12.985203|2017-02-18 17:19:12.985203
NCT00174785|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-01-05|2009-07-24||June 2005||2005-06-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|ATHENA||A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation|A Placebo-controlled,Double-blind,Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (AF/AFL)|Completed||Phase 3|4628|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 17:19:13.146002|2017-02-18 17:19:13.146002
NCT00174772|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-02-15|||March 2004||2004-03-01|February 2010|2010-02-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)|A Two Arm Phase II Study Comparing Docetaxel/Cisplatin Induction Therapy Followed By Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Followed By Consolidation Docetaxel/Cisplatin in Patients With Locally Advanced Unresectable NSCLC (Stage IIIA-Multiple cN2 or IIIB)|Completed||Phase 2|72|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:19:15.239688|2017-02-18 17:19:15.239688
NCT00174759|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-01-10|||September 2004||2004-09-01|January 2011|2011-01-01||||||||Interventional|||CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease|A Double-blind, Randomized Study of Clopidogrel 75 mg/d vs Placebo, on a Background of ASA 75-100 mg/d,in Peripheral Arterial Disease (PAD) Patients Receiving a Unilateral Below Knee Bypass Graft.|Completed||Phase 3|1460|Anticipated|Sanofi|||||f||||||||||||||2017-02-18 17:19:15.364788|2017-02-18 17:19:15.364788
NCT00174746|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-07|||March 2005||2005-03-01|April 2009|2009-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma|A Placebo- and Active-Controlled (Ciclesonide Metered-Dose Inhaler), Randomized, Parallel-Group, Dose-Range Finding Study of Ciclesonide Administered by Dry Powder Inhaler (Ultrahaler) in Adult and Adolescent Patients With Persistent Asthma|Completed||Phase 2|1145|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:19:15.47432|2017-02-18 17:19:15.47432
NCT00174733|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-07|||July 2005||2005-07-01|April 2009|2009-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy of Ciclesonide Metered-Dose Inhaler at a Daily Dose of 160 μg Administered for Twelve Weeks Either in a Once-Daily Regimen in the Morning (160 μg qd AM) or in a Twice Daily Regimen (80 μg Bid) in Adults and Adolescents With Mild to Moderate Persistent Asthma Treated Previously With Inhaled Corticosteroids|Completed||Phase 3|456|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:19:15.56358|2017-02-18 17:19:15.56358
NCT00174720|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-04-07|||September 2005||2005-09-01|April 2009|2009-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.|A Multinational,Multicenter,Randomized,Double-Blind,Placebo-Controlled,Parallel-Group Study to Assess the Efficacy of Ciclesonide Metered-Dose Inhaler at a Daily Dose of 160 μg Administered Either in a Once-Daily in the Morning Regimen (160 μg qd AM) for 16 Weeks or in a 160 μg qd AM Regimen for 12 Weeks Preceded by a Twice-Daily Regimen (80 μg Bid) for 4 Weeks,or in an 80 μg Bid Regimen for 16 Weeks,in Adults and Adolescents With Mild to Moderate Persistent Asthma Not Treated With Steroids|Completed||Phase 3|708|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:19:15.649785|2017-02-18 17:19:15.649785
NCT00174707|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-12-04|||December 1997||1997-12-01|December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Docetaxel in Breast Cancer Patients|A Phase III Randomized Study of Sequential Epidoxorubicin Followed By CMF: Cyclophosphamide+Methotrexate+Fluorouracil (Arm A) Versus Sequential Epidoxorubicin Followed By Docetaxel Followed By CMF (Arm B) Versus Sequential Intensified Epidoxorubicin Followed By Docetaxel Followed By High-Dose Cyclophosphamide (Arm C) in Early Breast Cancer Patients With Positive Axillary Lymph Nodes|Completed||Phase 3|998|Actual|Sanofi||3|||f||||||||||||||2017-02-18 17:19:15.748123|2017-02-18 17:19:15.748123
NCT00174694|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-09-24|||November 2004||2004-11-01|September 2009|2009-09-01||||December 2005|Actual|2005-12-01||Interventional|||CHOOSE : Telithromycin, Acute Bacterial Sinusitis|A Prospective, Randomized, Open-label, Active-controlled Study in Adult Subjects With Acute Bacterial Sinusitis Comparing the Clinical Efficacy of Telithromycin (KETEK®) 800 mg Once a Day for 5 Days Versus Amoxicillin-clavulanic Acid (AUGMENTIN®) 875/125 mg Twice a Day for 10 Days|Completed||Phase 4|298|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:19:15.902597|2017-02-18 17:19:15.902597
NCT00174681|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-01-10|||April 2003||2003-04-01|January 2011|2011-01-01||||||||Interventional|||Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes|Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes|Completed||Phase 4|390||Sanofi|||||f||||||||||||||2017-02-18 17:19:16.186524|2017-02-18 17:19:16.186524
NCT00174668|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-09-14|||November 2004||2004-11-01|September 2009|2009-09-01||||November 2007|Actual|2007-11-01||Interventional|GINGER||Insulin Glulisine in Diabetes Mellitus, Type 2|52-week, Open, Randomized, Multinational, Multicenter Clinical Trial Comparing Insulin Glulisine in Combination With Insulin Glargine in an Intensified Insulin Regimen to a Two-injection Conventional Insulin Regimen in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control Pretreated With a Two-injection Conventional Insulin Therapy|Completed||Phase 3|311|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:19:16.282681|2017-02-18 17:19:16.282681
NCT00174655|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-11-09|||June 1998||1998-06-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||BIG 02/98 Docetaxel - Breast Cancer|An Intergroup Phase III Trial to Evaluate the Activity of Docetaxel, Given Either Sequentially or in Combination With Doxorubicin, Followed by CMF, in Comparison to Doxorubicin Alone or in Combination With Cyclophosphamide, Followed by CMF, in the Adjuvant Treatment of Node-positive Breast Cancer Patients.|Completed||Phase 3|2887|Actual|Sanofi||4|||f||||||||||||||2017-02-18 17:19:16.416169|2017-02-18 17:19:16.416169
NCT00174642|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-09-14|||December 2004||2004-12-01|September 2009|2009-09-01||||December 2008|Actual|2008-12-01||Interventional|OSIRIS||Opposing Step-by-step Insulin Reinforcement to Intensified Strategy|Comparison of Three Therapeutic Strategies for Treating Type 2 Diabetes Mellitus Patients Poorly Controlled With Basal Insulin Associated With Oral Antidiabetic Drugs|Completed||Phase 3|811|Actual|Sanofi||3|||f||||||||||||||2017-02-18 17:19:16.549636|2017-02-18 17:19:16.549636
NCT00174629|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-12-04|||June 2001||2001-06-01|December 2009|2009-12-01||||January 2007|Actual|2007-01-01||Interventional|||GILT Docetaxel - Non-Small Cell Lung Cancer|Open-Label, Cooperative, Randomized, Multicenter Phase III Study on the Use of Cisplatin Resistant Genotype (ERCC1 Over-Expression) in Tumor RNA to Customize Chemotherapy in Stage IV-IIIB (Malignant Pleural Effusion) Non-Small-Cell Lung Cancer Patients|Completed||Phase 3|449|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:19:16.687945|2017-02-18 17:19:16.687945
NCT00174616|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-12-04|||July 2003||2003-07-01|December 2009|2009-12-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision|Phase 2 Study of Weekly Oxaliplatin and Capecitabine (XELOX) in Combination With Preoperative Radiotherapy in Patients With MRI Defined Locally Advanced Rectal Cancer|Completed||Phase 2|87|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:19:16.802643|2017-02-18 17:19:16.802643
NCT00174603|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-28|||August 2005||2005-08-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Treatment of Depression With Quetiapine|Treatment of Major Depressive Disorder With Psychotic Features With Quetiapine Monotherapy; Quetiapine and Citalopram; or Haloperidol and Citalopram|Terminated||Phase 3|60||Rush University Medical Center||||Unable to recruit subjects|f||||f||||||||||2017-02-18 17:19:16.923933|2017-02-18 17:19:16.923933
NCT00174590|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-28|||September 2001||2001-09-01|December 2007|2007-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Treatment of Major Depressive Disorder With Psychotic Features.|Treatment of Major Depressive Disorder With Psychotic Features With Risperidone Monotherapy; Risperidone and Sertraline; or Haloperidol and Sertraline|Terminated||Phase 3|30||Rush University Medical Center|||||f||||||||||||||2017-02-18 17:19:17.035566|2017-02-18 17:19:17.035566
NCT00174577|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||February 2003||2003-02-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of Antidepressant|Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to an Adequate Trial of Antidepressant|Unknown status|Active, not recruiting|Phase 3|84||Rhode Island Hospital|||||f||||||||||||||2017-02-18 17:19:17.148121|2017-02-18 17:19:17.148121
NCT00174564|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-02-15|||April 2003||2003-04-01|February 2012|2012-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||EXIBIT: Oxaliplatin in Biliary Tract Cancer|A Multicentre Phase II Trial of Gemcitabine and Oxaliplatin (GEMOX) in Patients With Biliary Tract Cancer|Completed||Phase 2|67|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:19:17.25949|2017-02-18 17:19:17.25949
NCT00174551|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-07|||November 2003||2003-11-01|September 2005|2005-09-01|November 2005||2005-11-01|||||Interventional|||Feasibility Study: The Effect of Prazosin for Nighttime Symptoms of Civilian PTSD|The Effect of Prazosin for Nighttime Symptoms of Civilian PTSD|Unknown status|Active, not recruiting|N/A|20||Rainier Associates|||||f||||||||||||||2017-02-18 17:19:17.360289|2017-02-18 17:19:17.360289
NCT00174538|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-06-29|||March 2005||2005-03-01|July 2005|2005-07-01|December 2005||2005-12-01|||||Interventional|||Codeine in Sickle Cell Disease|The Effects of Cytochrome P450 2D6 Genotype on Pain Management With Codeine in Sickle Cell Disease|Completed||Phase 1/Phase 2|60|Anticipated|PriCara, Unit of Ortho-McNeil, Inc.|||||f||||||||||||||2017-02-18 17:19:17.459011|2017-02-18 17:19:17.459011
NCT00174525|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-05-08|||April 2005||2005-04-01|May 2012|2012-05-01|April 2008||2008-04-01|||||Interventional|||Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease|A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD|Unknown status|Active, not recruiting|Phase 2|||Pharmacology Research Institute|||||||||||||||||||2017-02-18 17:19:17.556324|2017-02-18 17:19:17.556324
NCT00174512|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-11-07|||March 2005||2005-03-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade|A Methodological Open-Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarisation and QT Interval At Fixed Heart Rate Under Autonomic Blockade|Completed||Phase 1|36||Pfizer|||||f||||||||||||||2017-02-18 17:19:17.643895|2017-02-18 17:19:17.643895
NCT00174499|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-07-06|||July 2005||2005-07-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||A Pilot Drug Trial That Evaluates the Whitening Potential of Nicotine Gum|An Open-label Study on Nicorette Freshmint Gum, 2 MG AND 4 MG in Smokers With Visible Teeth Staining Motivated to Quit|Completed||Phase 4|78|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||2|||f||||f||||||||||2017-02-18 17:19:17.734683|2017-02-18 17:19:17.734683
NCT00174486|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-07-23|||February 2005||2005-02-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction|A Double Blind, Placebo Controlled, Parallel Group, Multicenter Study To Assess The Duration Of Action, Safety And Toleration Of Differing Doses and Combinations Of Immediate and Modified Release Formulations Of UK-369,003 and Cialis Compared To Placebo In Adult Male Subjects With Erectile Dysfunction|Completed||Phase 2|300||Pfizer|||||f||||||||||||||2017-02-18 17:19:17.831834|2017-02-18 17:19:17.831834
NCT00174473|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-09|||June 2003||2003-06-01|May 2011|2011-05-01|August 2005|Actual|2005-08-01|||||Interventional|||A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children|An Open-label, Intravenous to Oral Switch, Multiple Dose Multi-Centre Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Hospitalized Children Aged 2 to 12 Years Who Require Treatment for the Prevention of Systemic Fungal Infections.|Completed||Phase 1/Phase 2|49|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:19:17.906172|2017-02-18 17:19:17.906172
NCT00174460|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-03-23|2009-03-16||August 2005||2005-08-01|March 2011|2011-03-01|March 2010|Actual|2010-03-01|March 2008|Actual|2008-03-01||Interventional|AGA||Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age|Somatropin Therapy For Short Children Born Of Premature Gestation, A Controlled, Prospective Randomized, Multicenter Study With An Untreated Control Group.|Completed||Phase 2|33|Actual|Pfizer|Result values for the primary outcome measures were revised at the final analysis due to programmatic corrections: age rounded up if >6 months past last birthday. Height and height SDS not rounded for final analysis; rounded only for the reports.|2|||f||||f||||||||||2017-02-18 17:19:18.013697|2017-02-18 17:19:18.013697
NCT00174447|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-20|2009-10-15||October 2001||2001-10-01|November 2009|2009-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031|Open Extension Study Evaluating The Long Term Efficacy , Safety And Tolerability Of Oral Ziprasidone In The Treatment Of Patients Who Have Successfully Completed The Previous Ziprasidone Study A1281031|Completed||Phase 3|43|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:19:19.092123|2017-02-18 17:19:19.092123
NCT00174434|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-01-26|||September 2005||2005-09-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer|A Phase 1 Study Of Paclitaxel In Combination With SU011248 For Patients With Breast Cancer As First-Line Treatment In The Advanced Disease Setting|Completed||Phase 1|22|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:19:19.709656|2017-02-18 17:19:19.709656
NCT00174421|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-01|||April 2001||2001-04-01|May 2007|2007-05-01|August 2005||2005-08-01|||||Interventional|||Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height|Genotropin in Short Children Born Small for Gestational Ag - A Long-Term Study in Belgium|Completed||Phase 3|36||Pfizer|||||f||||||||||||||2017-02-18 17:19:19.82516|2017-02-18 17:19:19.82516
NCT00174408|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-05-01|||March 1990||1990-03-01|May 2007|2007-05-01|February 2005||2005-02-01|||||Interventional|||Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age|Growth Hormone Treatment in Short Children Born Small for Date (Genotonorm)|Completed||Phase 3|110||Pfizer|||||f||||||||||||||2017-02-18 17:19:19.901963|2017-02-18 17:19:19.901963
NCT00174395|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-10-31|||March 2005||2005-03-01|October 2007|2007-10-01|October 2006|Actual|2006-10-01|||||Interventional|||A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine|A Multi-Center, Open-Label, Randomized, Parallel-Group Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine in Early Intervention.|Completed||Phase 4|220||Pfizer|||||f||||||||||||||2017-02-18 17:19:19.974314|2017-02-18 17:19:19.974314
NCT00174382|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-03-04|2009-04-24||June 2005||2005-06-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia|An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia|Terminated||Phase 3|149|Actual|Pfizer||1||See Detailed Description|f||||f||||||||||2017-02-18 17:19:20.11013|2017-02-18 17:19:20.11013
NCT00174369|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-03-16|||November 2005||2005-11-01|February 2009|2009-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer|Phase 2 Study Of The MEK Inhibitor PD-0325901 In Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 2|34|Actual|Pfizer||1||Terminated [See Detailed Description for Termination Reason.]|f||||f||||||||||2017-02-18 17:19:20.683292|2017-02-18 17:19:20.683292
NCT00174356|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-11-06|||December 2002||2002-12-01|January 2006|2006-01-01|October 2005||2005-10-01|||||Interventional|||PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients|A Phase 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel And Carboplatin As First-Line Chemotherapy In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|39||Pfizer|||||f||||||||||||||2017-02-18 17:19:20.792432|2017-02-18 17:19:20.792432
NCT00174343|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-21|||November 2001||2001-11-01|April 2011|2011-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients|Phase II Study Evaluating The Role Of Exemestane On Clinical And Pathologic Response Rates, And Its Aromatase Activity As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients.|Completed||Phase 2|46||Pfizer|||||f||||||||||||||2017-02-18 17:19:20.876463|2017-02-18 17:19:20.876463
NCT00174330|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-02-20|||May 2005||2005-05-01|February 2007|2007-02-01|February 2006||2006-02-01|||||Interventional|||Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia|A Multi-Center, Randomized, Open-Label Study To Evaluate Efficacy And Safety Of Dual Therapy With Atorvastatin Plus Amlodipine When Compared Amlodipine Therapy Alone In The Treatment Of Subjects With Concurrent Hyperlipidemia And Hypertension.|Completed||Phase 4|330||Pfizer|||||f||||||||||||||2017-02-18 17:19:20.975698|2017-02-18 17:19:20.975698
NCT00174317|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-11-30|||August 2003||2003-08-01|December 2005|2005-12-01|February 2005||2005-02-01|||||Interventional|||Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip|Clinical Protocol For A Multicentre, Double-Blind, Randomised, Parallel Group Study To Compare The Efficacy and Tolerability Of Celecoxib Vs. Diclofenac In The Treatment Of Subjects With Osteoarthritis Of The Hip Requiring Joint Replacement Therapy|Completed||Phase 4|250||Pfizer|||||f||||||||||||||2017-02-18 17:19:21.073813|2017-02-18 17:19:21.073813
NCT00174304|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-01-06|||October 2004||2004-10-01|April 2007|2007-04-01|September 2006||2006-09-01|||||Interventional|JEWEL II||Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.|An International, Multicentre, Open Label Study To Assess The Effectiveness Of Amlodipine/Atorvastatin Combination In Subjects With Hypertension And Dyslipidaemia. (The JEWEL II Study)|Completed||Phase 4|1120||Pfizer|||||f||||||||||||||2017-02-18 17:19:21.324048|2017-02-18 17:19:21.324048
NCT00174291|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-10-26|2012-10-26||March 2002||2002-03-01|October 2012|2012-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy|Prevention of Retarded Growth by Early Treatment With Recombinant Human Growth Factor Genotonorm (Registered) in Children With Systemic Forms of Chronic Juvenile Arthritis Receiving Long-term Corticosteroid Therapy. Extension of the Study Beyond Three Years|Terminated||Phase 3|21|Actual|Pfizer|Data for bone mineral density (BMD), bone mineral content (BMC) and IGFBP3 were not analyzed because of change in planned analysis after the study was prematurely terminated due to Good Clinical Practice (GCP) non-compliance issues.|1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 17:19:21.702562|2017-02-18 17:19:21.702562
NCT00174278|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-08-04|||February 1997||1997-02-01|August 2008|2008-08-01|October 2006|Actual|2006-10-01|||||Interventional|||Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary|Treatment With Recombinant Human Growth Hormone (Genotonorm®) In Children With Short Stature Secondary To A Long Term Corticoid Therapy. A Study of Efficacy and Safety.|Completed||Phase 3|14||Pfizer|||||f||||||||||||||2017-02-18 17:19:22.63346|2017-02-18 17:19:22.63346
NCT00174265|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-06-08|2010-05-27||July 2005||2005-07-01|June 2015|2015-06-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)|A Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the Safety and Efficacy of Asenapine With Olanzapine in Subjects Who Completed Protocol A7501013|Completed||Phase 3|196|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:19:22.72392|2017-02-18 17:19:22.72392
NCT00174252|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-06-10|2010-04-02||February 2005||2005-02-01|June 2009|2009-06-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age|Evolution of IGF-1 in Children Born Small for Gestational Age and With Growth Retardation, Treated by Genotonorm Especially Evolution After Dose Adaptation.|Completed||Phase 3|57|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:19:23.105796|2017-02-18 17:19:23.105796
NCT00174239|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-05-24|||July 2004||2004-07-01|May 2007|2007-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.|A Double-Blind, Randomized, Comparative Study of Cabaser and Sinemet CR For The Treatment Of Nocturnal Disability In Levodopa -Treated Parkinson's Disease Patients.|Terminated||Phase 4|220||Pfizer||||See Detailed Description for termination reason.|f||||f||||||||||2017-02-18 17:19:23.841382|2017-02-18 17:19:23.841382
NCT00174226|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-07-10|||November 2004||2004-11-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|||||Interventional|||Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar|Eight-Week, Double-Blind, 3-Arm Parallel, Placebo-Controlled, Randomized Efficacy And Safety Trial Of Atomoxetine, Atomoxetine Plus Buspirone, And Placebo In Adults With Attention Deficit Hyperactivity Disorder|Completed||Phase 2|241|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:19:23.953571|2017-02-18 17:19:23.953571
NCT00174213|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-08-29|||September 1994||1994-09-01|August 1994|1994-08-01||||||||Observational|||Validity and Reliability in Measuring Iliotibial Tract by Using Ultrasound|Validity and Reliability in Measuring Iliotibial Tract by Using Ultrasound|Unknown status|Recruiting|Phase 1|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:24.053796|2017-02-18 17:19:24.053796
NCT00174200|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-07-11|||December 2004||2004-12-01|July 2008|2008-07-01|May 2006|Actual|2006-05-01|||||Interventional|||Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone|A Randomized, Double-Blind, Crossover Add-On Study To Assess The Differential Sensitivity Of 2 Spatial Working Memory Tests (The Groton Maze Learning Test [GMLT] And The Motor Delayed Response Test [MDR]) In Non-Agitated, Antipsychotic Drug-Naive First-Episode Schizophrenic Or Schizophreniform Patients Treated With Risperidone 2 Mg Daily Or Placebo|Completed||N/A|20||Pfizer|||||f||||||||||||||2017-02-18 17:19:24.13217|2017-02-18 17:19:24.13217
NCT00174187|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-11-05|2012-09-11||September 2000||2000-09-01|November 2012|2012-11-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy|Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) in Children With Short Stature Secondary to a Long Term Corticoid Therapy. A Study of Efficacy and Safety.|Terminated||Phase 3|30|Actual|Pfizer|Results for secondary and other pre-specified endpoints (except IGF-1) are reported for only up to 3 years because data beyond Year 3 was not summarized as the study was terminated due to Good Clinical Practice (GCP) non-compliance issues.|1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 17:19:24.242124|2017-02-18 17:19:24.242124
NCT00174174|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2005-09-14|||September 2003||2003-09-01|October 2004|2004-10-01||||||||Interventional|||Provigil (Modafinil) Study by Taiwan Biotech Co.|A Placebo Control, Double Blind, Cross Over Study of Modafinil in Patients With Narcolepsy|Completed||N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:28.428199|2017-02-18 17:19:28.428199
NCT00174161|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|December 2005||2005-12-01|||||Observational|||The Symptom Experience of Women With Perimenstrual Syndrome;Women's Health Related Quality of Life.||Unknown status|Recruiting|N/A|1000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:28.506761|2017-02-18 17:19:28.506761
NCT00174148|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-20|||July 2005||2005-07-01|December 2004|2004-12-01|July 2006||2006-07-01|||||Observational|||Sensorimotor Dysfunction of Individuals With Neck Pain|Sensorimotor Dysfunction of Individuals With Neck Pain|Unknown status|Recruiting|Phase 1|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:28.587883|2017-02-18 17:19:28.587883
NCT00174135|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-08-29|||August 2005||2005-08-01|December 2004|2004-12-01||||||||Observational|||Sarcopenia Studies for the Elderly Population in Taiwan|Sarcopenia Studies for the Elderly Population in Taiwan|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:28.904599|2017-02-18 17:19:28.904599
NCT00174122|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-02-28|||July 2005||2005-07-01|September 2004|2004-09-01|June 2006||2006-06-01|||||Observational|||Procalcitonin in Diagnosing Bacteremia in the Emergency Department||Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:28.972339|2017-02-18 17:19:28.972339
NCT00174109|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Observational|||The Relation of Microtubule-Associated Protein 2 and Cell Migration||Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.045277|2017-02-18 17:19:29.045277
NCT00174096|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-03-30|||August 2005||2005-08-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Observational|||The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.133153|2017-02-18 17:19:29.133153
NCT00174083|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|December 2006||2006-12-01|||||Observational|||Diagnosis of Active Tuberculosis by ELISPOT|Diagnosis of Active Tuberculosis in Endemic Area by Using Enzyme-Linked Immunospot Assay for Gamma-Interferon|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.224425|2017-02-18 17:19:29.224425
NCT00174070|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-11-02|||August 2005||2005-08-01|July 2005|2005-07-01|February 2006||2006-02-01|||||Observational|||Etiologies and Outcomes of Acute Respiratory Failure in Community|Etiologies and Outcomes Analysis of Acute Respiratory Failure in Community|Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.309465|2017-02-18 17:19:29.309465
NCT00174057|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Observational|||The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy||Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.389328|2017-02-18 17:19:29.389328
NCT00174044|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-20|||August 2005||2005-08-01|August 2005|2005-08-01|July 2006||2006-07-01|||||Observational|||Control Strategies of the Locomotor System During Obstacle-Crossing in Stroke Patients|Control Strategies of the Locomotor System During Obstacle-Crossing in Stroke Patients|Unknown status|Recruiting|N/A|120||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.474576|2017-02-18 17:19:29.474576
NCT00174031|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-11-25|||December 1993||1993-12-01|September 1993|1993-09-01||||||||Observational|||Prevalence and Profiles of Sports Injury in Taiwanese Adolescent Baseball Players|Prevalence and Profiles of Sports Injury in Taiwanese Adolescent Baseball Players|Unknown status|Recruiting|Phase 1/Phase 2|800||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.560102|2017-02-18 17:19:29.560102
NCT00174018|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-06|||September 1993||1993-09-01|August 1993|1993-08-01||||||||Observational|||Validity and Reliability in Measuring the Subacromial Space by Using Ultrasound|Validity and Reliability in Measuring the Subacromial Space by Using Ultrasound|Completed||Phase 1|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.629892|2017-02-18 17:19:29.629892
NCT00173914|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-13|||March 2003||2003-03-01|September 2005|2005-09-01||||||||Observational|||The Association of Endothelial Dysfunction and Cardiac Allograft Vasculopathy||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.697667|2017-02-18 17:19:29.697667
NCT00173901|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-13|||March 2001||2001-03-01|January 2001|2001-01-01|April 2002||2002-04-01|||||Interventional|||Adverse Drug Reactions of Different Brands of Ceftazidime Injection|Adverse Drug Reactions of Different Brands of Ceftazidime Injection|Unknown status|Active, not recruiting|Phase 4|536||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:29.771004|2017-02-18 17:19:29.771004
NCT00173758|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-12-20|||September 2005||2005-09-01|June 2005|2005-06-01||||||||Interventional|||The Expression of IL-15 and Its Receptor in Decidua|The Expression of IL-15 and Its Receptor in Uterine NK Cells and Clinical Applications|Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.517401|2017-02-18 17:19:31.517401
NCT00173888|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-12-04|||July 2003||2003-07-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)|A Randomized Phase II Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer|Completed||Phase 2|15|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 17:19:29.862523|2017-02-18 17:19:29.862523
NCT00173875|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-27|||March 2005||2005-03-01|July 2005|2005-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer|A Phase II Study to Evaluate the Efficacy and Safety of Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|108|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:19:29.966842|2017-02-18 17:19:29.966842
NCT00173862|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-07-23|||May 2000||2000-05-01|June 2005|2005-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC|A Phase II Study of Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced Transitional Cell Carcinoma|Completed||Phase 2|18|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:19:30.065829|2017-02-18 17:19:30.065829
NCT00173849|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||January 2006||2006-01-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Observational|||The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma||Unknown status|Not yet recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.160225|2017-02-18 17:19:30.160225
NCT00173836|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-09-04|||August 2003||2003-08-01|August 2009|2009-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount|Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount|Completed||N/A|122|Anticipated|National Taiwan University Hospital|||2||f||||f||||||||||2017-02-18 17:19:30.240366|2017-02-18 17:19:30.240366
NCT00174005|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-05|||December 1994||1994-12-01|December 1994|1994-12-01||||||||Observational|||Validity and Reliability in Measuring Biceps and Triceps by Using Ultrasound|Validity and Reliability in Measuring Tendon and Muscular Morphologic Characteristics of Biceps and Triceps by Using Ultrasound|Unknown status|Recruiting|Phase 1|20|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.326447|2017-02-18 17:19:30.326447
NCT00173992|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2005-09-13|||September 2005||2005-09-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||Balance Recovery and Training on Fall Prevention in Stroke|Balance Recovery and Training on Fall Prevention in Stroke|Unknown status|Not yet recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.391217|2017-02-18 17:19:30.391217
NCT00173979|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-06-05|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||Tendon Mechanical Properties and Morphological Characteristics of Human Bicep and Tricep Muscles: An In Vivo Ultrasonographical Study|Tendon Mechanical Properties and Morphological Characteristics of Human Muscle|Unknown status|Recruiting|Phase 1|15|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.491737|2017-02-18 17:19:30.491737
NCT00173966|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-13|||January 2005||2005-01-01|December 2004|2004-12-01||||||||Observational|||A Case Control Study to Investigate the Possible Association Between Atrial Fibrillation and Endothelium Dysfunction by Using Flow-Mediated Vasodilation Method||Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.564964|2017-02-18 17:19:30.564964
NCT00173953|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-13|||January 2001||2001-01-01|December 2000|2000-12-01|October 2001||2001-10-01|||||Interventional|||Lymphocytic Subsets and Cytokine Production With H. Pylori Infection|Lymphocytic Subsets and Cytokine Production in the Gastric Samples of Patients With Helicobacter Pylori Infection|Completed||N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.636438|2017-02-18 17:19:30.636438
NCT00173940|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-27||||||July 2002|2002-07-01||||||||Observational|||Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination Services||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.727563|2017-02-18 17:19:30.727563
NCT00173927|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-29|||March 2004||2004-03-01|September 2005|2005-09-01||||||||Observational|||Images in Extracranial Artery Stenosis|The Differences in Images of Vertebral Artery Stenosis and Carotid Artery Stenosis Pre- and Post-Percutaneous Transluminal Angioplasty and the Gene Expression Patterns in Peripheral White Blood Cells|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.798352|2017-02-18 17:19:30.798352
NCT00173823|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-03-10|||June 2004||2004-06-01|August 2005|2005-08-01||||||||Observational|||Malnutrition and Inflammation in Dialysis Patients in Taiwan|Malnutrition and Inflammation in Taiwan: Prospective Outcome Evaluation Method (MIT-POEM) in Dialysis Patients|Unknown status|Recruiting|N/A|1500||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:30.871854|2017-02-18 17:19:30.871854
NCT00173810|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|April 2007||2007-04-01|||||Observational|||Development of a Refined Version of the Stroke Rehabilitation Assessment of Movement Scale for Stroke Patients|Development of a Refined Version of the Stroke Rehabilitation Assessment of Movement Scale for Stroke Patients|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.193975|2017-02-18 17:19:31.193975
NCT00173797|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|April 2008||2008-04-01|||||Observational|||Comparison of Psychometric Properties of Three Depression Measures in Patients With Stroke|Comparison of Psychometric Properties of Three Depression Measures in Patients With Stroke|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.278046|2017-02-18 17:19:31.278046
NCT00173784|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2005||2005-08-01|July 2005|2005-07-01|April 2008||2008-04-01|||||Observational|||Development of an Instrumental Activities of Daily Living Scale|Development of an Instrumental Activities of Daily Living Scale for Patients|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.360534|2017-02-18 17:19:31.360534
NCT00173771|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||August 2004||2004-08-01|August 2005|2005-08-01|May 2007||2007-05-01|||||Observational|||Development of a Comprehensive ADL Scale for Stroke Patients|Development of a Comprehensive ADL Scale for Stroke Patients|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.438938|2017-02-18 17:19:31.438938
NCT00173745|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||June 2003||2003-06-01|July 2002|2002-07-01|September 2005||2005-09-01|||||Interventional|||Treatment of Drooling With Type A Botulinum Toxin in Children With Cerebral Palsy|Treatment of Drooling With Type A Botulinum Toxin A in Children With Cerebral Palsy|Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.609962|2017-02-18 17:19:31.609962
NCT00173732|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||September 2005||2005-09-01|June 2005|2005-06-01||||||||Observational|||Establishment of Comprehensive Genetic Analysis From a Single Cell|Establishment of Comprehensive Genetic Analysis From a Single Cell|Unknown status|Not yet recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.703689|2017-02-18 17:19:31.703689
NCT00173719|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-08-26|||September 2003||2003-09-01|January 2013|2013-01-01|July 2004|Actual|2004-07-01|January 2004|Actual|2004-01-01||Interventional|||Influence of Assistive Device Use While Performing Dual Task in Patients With Stroke|Influence of Assistive Device Use on Dynamic Balance and the Associated Attentional Demands During Standing and Walking in Patients With Stroke|Completed||N/A|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.78173|2017-02-18 17:19:31.78173
NCT00173706|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-02-28|||October 2004||2004-10-01|August 2005|2005-08-01||||||||Interventional|||Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis|Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis|Unknown status|Recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.877737|2017-02-18 17:19:31.877737
NCT00173693|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-06|||January 2006||2006-01-01|November 2012|2012-11-01|December 2010|Anticipated|2010-12-01|||||Interventional|||What is the Best Policy to Prevent Osteoporotic Fracture?||Withdrawn||N/A|0|Actual|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:31.967127|2017-02-18 17:19:31.967127
NCT00173680|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||August 2005||2005-08-01|August 2005|2005-08-01||||||||Observational|||Methylation Status of CD44 Promoter Region in Primary Lung Cancer||Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.070833|2017-02-18 17:19:32.070833
NCT00173667|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20||||||July 2005|2005-07-01||||||||Interventional|||A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension|A Randomized Controlled Study of Nifecardia SRFC (Nifedipine) and Adalat OROS (Nifedipine) in the Treatment of Patients With Essential Hypertension|Unknown status|Not yet recruiting|Phase 4|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.145469|2017-02-18 17:19:32.145469
NCT00173654|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||August 2005||2005-08-01|August 2005|2005-08-01|August 2006||2006-08-01|||||Observational|||Mutation Analysis of 17βhydroxysteroid Dehydrogenase 3 Deficiency||Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.229922|2017-02-18 17:19:32.229922
NCT00173641|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||September 2005||2005-09-01|September 2005|2005-09-01|August 2006||2006-08-01|||||Observational|||The Role of Regulatory T Cell in Patients With Type 1 Diabetes Mellitus||Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.310628|2017-02-18 17:19:32.310628
NCT00173628|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||January 1990||1990-01-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Observational|||Autoantibodies in Patients With Type 1 Diabetes Mellitus||Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.392226|2017-02-18 17:19:32.392226
NCT00173615|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-01-16|||April 1996||1996-04-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|||||Observational|||Extracorporeal Membrane Oxygenation Effect in Prolonged Cardiopulmonary Resuscitation||Completed||N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.470029|2017-02-18 17:19:32.470029
NCT00173602|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-30|||September 2005||2005-09-01|August 2005|2005-08-01|August 2007|Anticipated|2007-08-01|||||Observational|||The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis Patients|The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis Patients|Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.557066|2017-02-18 17:19:32.557066
NCT00173589|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||August 2005|2005-08-01||||||||Observational|||Inflammatory and Fibrotic Markers and Atrial Fibrillation||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.630878|2017-02-18 17:19:32.630878
NCT00173576|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-10-26|||April 2003||2003-04-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Observational|||Clinical Study of SARS in Children|Clinical Study of SARS in Children|Completed||N/A|800||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.697062|2017-02-18 17:19:32.697062
NCT00173563|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-30|||January 2005||2005-01-01|August 2005|2005-08-01|September 2005|Anticipated|2005-09-01|||||Observational|||Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children|Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children|Unknown status|Recruiting|N/A|10|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.753175|2017-02-18 17:19:32.753175
NCT00173550|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-01-22|||August 2004||2004-08-01|July 2005|2005-07-01||||||||Observational|||Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women|Perception and Attitude Toward Estrogen Therapy Among Operated Women With Premature or Immature Menopause|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:32.830812|2017-02-18 17:19:32.830812
NCT00173537|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-26|||July 2005||2005-07-01|December 2012|2012-12-01|December 2013|Anticipated|2013-12-01|November 2009|Actual|2009-11-01||Interventional|||Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension|Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension|Unknown status|Recruiting|N/A|1|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-02-18 17:19:32.930147|2017-02-18 17:19:32.930147
NCT00173524|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-05-18|||September 2005||2005-09-01|April 2009|2009-04-01|September 2005|Anticipated|2005-09-01|||||Observational|||PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)|PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) : A Cost-Effectiveness Analysis and Cost-Utility Analysis|Unknown status|Active, not recruiting|Phase 4|200|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-02-18 17:19:33.027892|2017-02-18 17:19:33.027892
NCT00173511|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||July 2005||2005-07-01|July 2005|2005-07-01|February 2006||2006-02-01|||||Observational|||Cardiovascular Events in Patients With CAD During Emergent Endoscopy for Upper Gastrointestinal Bleeding||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.117269|2017-02-18 17:19:33.117269
NCT00173472|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||July 2002||2002-07-01|July 2002|2002-07-01|July 2005||2005-07-01|||||Observational|||Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer|Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.366377|2017-02-18 17:19:33.366377
NCT00173459|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||July 2004|2004-07-01||||||||Observational|||Dynamic Profiles of Cytokine/Chemokine in Severe Acute Respiratory Syndrome||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.443719|2017-02-18 17:19:33.443719
NCT00173446|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-06-07|||January 2002||2002-01-01|August 2005|2005-08-01||||||||Observational|||D2 Dopamine Receptor on Human Aldosterone-Producing Adenoma and Its Role in Aldosterone Secretion and Cell Proliferation|Expression of D2-Like Dopamine Receptor of Human Aldosterone-Producing Adenoma and Its Role in Regulation of Aldosterone Secretion and Cell Proliferation|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.499734|2017-02-18 17:19:33.499734
NCT00173433|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-12-08|||August 2005||2005-08-01|December 2014|2014-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Exogenous Reinfection of Tuberculosis in Taiwan|The Importance of Exogenous Reinfection in the Tuberculosis Endemic of Taiwan|Completed||N/A|150|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-02-18 17:19:33.57362|2017-02-18 17:19:33.57362
NCT00173420|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-22|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||Mechanisms of Neuropathic Pain: Investigation by Contact Heat Evoked Potential|Mechanisms of Neuropathic Pain: Investigation by Contact Heat Evoked Potential|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.671697|2017-02-18 17:19:33.671697
NCT00173407|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-26|||January 2006||2006-01-01|December 2012|2012-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion|Correlation of PTEN and IGFBP-3 in the Invasion of Ovarian Endometrioid Carcinoma|Withdrawn||N/A|0|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:19:33.755113|2017-02-18 17:19:33.755113
NCT00173394|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-12-18|||August 2005||2005-08-01|July 2005|2005-07-01|December 2008||2008-12-01|||||Observational|||The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients||Unknown status|Recruiting|N/A|250||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.845025|2017-02-18 17:19:33.845025
NCT00173381|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-29|||August 2004||2004-08-01|June 2005|2005-06-01||||||||Observational|||The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.922204|2017-02-18 17:19:33.922204
NCT00173368|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2003||2003-01-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Observational|||Study of Endoscopic Sphincterotomy With Needle Knife Papillotome in Patients of Ampullary Impacted Stone||Completed||N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:33.999149|2017-02-18 17:19:33.999149
NCT00173355|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||June 2005||2005-06-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans|Retrospective Clinical Outcome Study of Pediatric Dermatofibrosarcoma Protuberans: Single Institutional Experience of Twelve Cases From 1977-2002|Unknown status|Recruiting|N/A|12||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.065492|2017-02-18 17:19:34.065492
NCT00173342|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||Congenital or Idiopathic Complete Right Bundle Branch Block: Physiological Significance and Molecular Characterization|Congenital or Idiopathic Complete Right Bundle Branch Block: Physiological Significance and Molecular Characterization|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.150658|2017-02-18 17:19:34.150658
NCT00173329|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-10-20|||August 2005||2005-08-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Observational|||The Quality of Life of Patients With Severe Illnesses||Unknown status|Recruiting|Phase 2|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.467009|2017-02-18 17:19:34.467009
NCT00173316|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|August 2004|2004-08-01|June 2005||2005-06-01|||||Observational|||Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions|The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions|Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.544842|2017-02-18 17:19:34.544842
NCT00173303|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2006||2006-01-01|June 2005|2005-06-01|January 2008||2008-01-01|||||Observational|||The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective Study||Unknown status|Not yet recruiting|N/A|3000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.631447|2017-02-18 17:19:34.631447
NCT00173290|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-02|||July 2004||2004-07-01|June 2005|2005-06-01|December 2006|Anticipated|2006-12-01|||||Observational|||Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function||Unknown status|Recruiting|N/A|200|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.722673|2017-02-18 17:19:34.722673
NCT00173277|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2003||2003-06-01|June 2005|2005-06-01|July 2004||2004-07-01|||||Observational|||Screening for CRC Using a Mixed Strategy of Sigmoidoscopy and Colonoscopy in Average-Risk Population According to Age|Screening for CRC Using a Mixed Strategy of Sigmoidoscopy and Colonoscopy in Average-Risk Population According to Age|Unknown status|Recruiting|N/A|2500||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.804635|2017-02-18 17:19:34.804635
NCT00173264|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|May 2005|2005-05-01|June 2005||2005-06-01|||||Observational|||Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis||Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.88651|2017-02-18 17:19:34.88651
NCT00173251|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2006||2006-01-01|June 2005|2005-06-01|August 2006||2006-08-01|||||Interventional|||The Difference in Presentation Level of Variant Receptors in Female Breast Tissue in Macromastia and Micromastia||Unknown status|Not yet recruiting|Phase 1|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:34.962567|2017-02-18 17:19:34.962567
NCT00173238|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||June 2005||2005-06-01|June 2005|2005-06-01|June 2008||2008-06-01|||||Observational|||The Study of Human Atherosclerosis by Polarization-Sensitive Optical Coherence Tomography||Unknown status|Recruiting|N/A|5||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.042058|2017-02-18 17:19:35.042058
NCT00173225|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Sputum and Plasma Levels of Nociceptin and Substance P in Patients With Asthma, COPD and Chronic Cough|Association Between Sputum and Plasma Levels of Nociceptin and Substance P With Cough Severity and Airway Hyperreactivity in Patients With Asthma, COPD and Chronic Cough|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.117877|2017-02-18 17:19:35.117877
NCT00173212|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2005||2005-09-01|May 2005|2005-05-01|March 2006||2006-03-01|||||Observational|||Proliferation of Endometrial Stromal Cells in Adenomyosis||Unknown status|Active, not recruiting|N/A|45||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.199676|2017-02-18 17:19:35.199676
NCT00173199|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-29|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation|The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation|Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.281851|2017-02-18 17:19:35.281851
NCT00173186|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 1987||1987-01-01|June 2005|2005-06-01|February 2005||2005-02-01|||||Observational|||Aortic Regurgitation After Surgical Repair of Outlet-Type Ventricular Septal Defect|Aortic Regurgitation After Surgical Repair of Outlet-Type Ventricular Septal Defect|Unknown status|Recruiting|N/A|411||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.361226|2017-02-18 17:19:35.361226
NCT00173173|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2003||2003-08-01|August 2003|2003-08-01|July 2004||2004-07-01|||||Observational|||Epidemiological Studies of Eating Disorders in Gifted Dance Students(1st Year)|Epidemiological Studies of Eating Disorders in Gifted Dance Students and Ordinary High School Students:Prevalence Rate, Risk Factors and 1-Year Outcome (1st Year).|Completed||N/A|2200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.44159|2017-02-18 17:19:35.44159
NCT00173160|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|August 2004|2004-08-01|July 2005||2005-07-01|||||Observational|||Epidemiological Studies of Eating Disorders in Gifted Dance Students (2nd Year).|Epidemiological Studies of Eating Disorders in Gifted Dance Students: Prevalence Rate, Risk Factors and 1-Year Outcome (2nd Year).|Completed||N/A|700||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.519483|2017-02-18 17:19:35.519483
NCT00173147|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-24|||May 2005||2005-05-01|April 2005|2005-04-01||||||||Observational|||Morphology of the VMO in Patients With PFPS and Healthy Young Adults--A Sonographic Study|Morphology of the Vastus Medialis Obliquus in Patients With Patellofemoral Pain Syndrome and Healthy Young Adults --A Sonographic Study|Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.601576|2017-02-18 17:19:35.601576
NCT00173134|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||May 2005||2005-05-01|June 2005|2005-06-01|March 2006||2006-03-01|||||Observational|||The Prevalence of Erectile Dysfunction (ED) and ED Related Quality of Life of Diabetic Men|Investigating the Prevalence of Erectile Dysfunction and Erectile Dysfunction Related Quality of Life of Diabetic Men in Taiwan|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.672167|2017-02-18 17:19:35.672167
NCT00173121|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||May 2005||2005-05-01|April 2005|2005-04-01|June 2005||2005-06-01|||||Observational|||Environmental Enterovirus Monitoring|Environmental Enterovirus Monitoring|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.751455|2017-02-18 17:19:35.751455
NCT00173108|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-21|||January 2006||2006-01-01|March 2011|2011-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Early Intervention for Preterm Infants|Early Intervention for Preterm Infants|Completed||N/A|240|Actual|National Taiwan University Hospital||4|||f||||f||||||||||2017-02-18 17:19:35.838729|2017-02-18 17:19:35.838729
NCT00173095|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|January 2005|2005-01-01|January 2008||2008-01-01|||||Observational|||The Bilirubin Levels in Cerebrospinal Fluid of Spontaneous Subarachnoid Hemorrhage Patients|The Bilirubin Levels in Cerebrospinal Fluid of Spontaneous Subarachnoid Hemorrhage Patients|Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:35.946496|2017-02-18 17:19:35.946496
NCT00173082|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-28|||June 2005||2005-06-01|November 2007|2007-11-01|July 2008|Anticipated|2008-07-01|||||Observational|||Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism|Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism|Unknown status|Recruiting|N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.030356|2017-02-18 17:19:36.030356
NCT00173069|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||January 2006||2006-01-01|July 2005|2005-07-01|December 2010||2010-12-01|||||Observational|||A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)|A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)|Unknown status|Not yet recruiting|N/A|324||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.121588|2017-02-18 17:19:36.121588
NCT00173056|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-11-23||||||December 2004|2004-12-01||||||||Observational|||The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.198544|2017-02-18 17:19:36.198544
NCT00173043|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||October 2004||2004-10-01|October 2004|2004-10-01|August 2005||2005-08-01|||||Observational|||The Role of Insulin Resistance in PCOS|The Role of Insulin Resistance and Adiponectin in the Pathogenesis of Polycystic Ovary Syndrome|Unknown status|Recruiting|N/A|500||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.281407|2017-02-18 17:19:36.281407
NCT00173030|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||April 2004|2004-04-01||||||||Observational|||Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein Genes||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.362245|2017-02-18 17:19:36.362245
NCT00173017|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2003||2003-08-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||The Physiological Impact of N95 Masks on Medical Staff|The Physiological Impact of N95 Masks on Medical Staff|Completed||N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.433696|2017-02-18 17:19:36.433696
NCT00173004|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||February 2003|2003-02-01||||||||Observational|||Angiotensinogen Gene and Hypertension||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.520508|2017-02-18 17:19:36.520508
NCT00172991|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||January 2003|2003-01-01||||||||Observational|||Adiponectin Gene and Coronary Artery Disease||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:36.589801|2017-02-18 17:19:36.589801
NCT00172055|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-06-15|||December 2004||2004-12-01|June 2011|2011-06-01||||July 2009|Actual|2009-07-01||Interventional|||Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy|Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy|Completed||Phase 3|218|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:36.726756|2017-02-18 17:19:36.726756
NCT00172042|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-04-13|2011-06-16||March 2005||2005-03-01|April 2015|2015-04-01|June 2010|Actual|2010-06-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)|A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer|Completed||Phase 3|437|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:19:36.855469|2017-02-18 17:19:36.855469
NCT00172029|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-26|||April 2003||2003-04-01|March 2010|2010-03-01||||September 2005|Actual|2005-09-01||Interventional|||Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid|Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid|Completed||Phase 4|116|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:19:37.685451|2017-02-18 17:19:37.685451
NCT00172016|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-27|||January 2004||2004-01-01|April 2012|2012-04-01||||April 2005|Actual|2005-04-01||Interventional|||A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates|A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates|Completed||Phase 4|43|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:38.030484|2017-02-18 17:19:38.030484
NCT00172003|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-16|||September 2004||2004-09-01|November 2016|2016-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis|Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis|Completed||Phase 4|50|Actual|Novartis||1|||f||||t||||||||||2017-02-18 17:19:38.122125|2017-02-18 17:19:38.122125
NCT00171990|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-08-14|||January 2003||2003-01-01|August 2013|2013-08-01|February 2006|Actual|2006-02-01|||||Interventional|||Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes|Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes|Completed||Phase 3|1461|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:38.233112|2017-02-18 17:19:38.233112
NCT00171977|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-08-06|||July 2004||2004-07-01|August 2012|2012-08-01||||April 2009|Actual|2009-04-01||Interventional|||Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)|Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 4|64|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:38.322953|2017-02-18 17:19:38.322953
NCT00171964|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-12-08|||May 2002||2002-05-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions|Evaluation of the Efficacy and Tolerability of Zoledronic Acid in Combination With Radiotherapy in Patients With Advanced Osteolytic Bone Lesions|Completed||Phase 4|75|Actual|Novartis||1|||f||||t||||||||||2017-02-18 17:19:38.433284|2017-02-18 17:19:38.433284
NCT00171951|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-15|||August 2004||2004-08-01|November 2016|2016-11-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease|Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease|Completed||Phase 2|19|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:38.546586|2017-02-18 17:19:38.546586
NCT00171938|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-11-20|||April 2004||2004-04-01|November 2009|2009-11-01||||||||Interventional|||Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)|Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)|Suspended||Phase 2|40||Novartis|||||f||||||||||||||2017-02-18 17:19:38.656189|2017-02-18 17:19:38.656189
NCT00171925|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-05|2011-01-20||August 2000||2000-08-01|April 2012|2012-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I|Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I|Terminated||Phase 3|143|Actual|Novartis|Only exploratory analyses were performed as the trial was terminated early due to lack of obtaining the required sample size. Secondary Outcomes for Quality of Life and Bone Markers not posted due to sparse data.|2||Recruitment in study could not be reached after 8 yrs of recruiting|f||||||||||||||2017-02-18 17:19:38.74893|2017-02-18 17:19:38.74893
NCT00171912|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-29|||September 2004||2004-09-01|November 2012|2012-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes|Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes|Completed||Phase 2|38|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:39.428027|2017-02-18 17:19:39.428027
NCT00171899|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-11-14|||April 2005||2005-04-01|November 2012|2012-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)|Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Ph+ CML|Completed||Phase 4|80|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:39.542791|2017-02-18 17:19:39.542791
NCT00171886|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-23|||July 2002||2002-07-01|March 2011|2011-03-01||||May 2006|Actual|2006-05-01||Interventional|||Octreotide Efficacy and Safety in First-line Acromegalic Patients|Octreotide Efficacy and Safety in First-line Acromegalic Patients|Suspended||Phase 4|20|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:39.64122|2017-02-18 17:19:39.64122
NCT00005406|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||May 1991||1991-05-01|April 2000|2000-04-01|April 1992|Actual|1992-04-01|||||Observational|||Change in Coronary Heart Disease Risk Factors in Young Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:02.073093|2017-02-18 18:15:02.073093
NCT00172965|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|August 2004|2004-08-01|June 2005||2005-06-01|||||Observational|||Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography|Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography|Unknown status|Recruiting|Phase 4|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:39.75658|2017-02-18 17:19:39.75658
NCT00172952|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01|January 2006||2006-01-01|||||Observational|||The Role of SNP of ECM and MMP on the Development of Pathological High Myopia|National Taiwan University Hospital|Unknown status|Recruiting|N/A|600||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:39.843551|2017-02-18 17:19:39.843551
NCT00172939|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-14|||June 2005||2005-06-01|March 2005|2005-03-01|January 2008||2008-01-01|||||Interventional|||Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model|Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model|Unknown status|Recruiting|Phase 1|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:39.924608|2017-02-18 17:19:39.924608
NCT00172926|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||May 2005||2005-05-01|June 2005|2005-06-01|April 2007||2007-04-01|||||Observational|||Study on the Relationship Between Physical Constitution and Diseases|Cross Sectional Study on Relationship Between Physical Constitution and Diseases in the Integrative Chinese Medicine and Western Medicine|Unknown status|Recruiting|N/A|1000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.011469|2017-02-18 17:19:40.011469
NCT00172913|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01|July 2008||2008-07-01|||||Observational|||Aberration-Free Refraction Correction|National Taiwan University Hospital|Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.085773|2017-02-18 17:19:40.085773
NCT00172900|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Observational|||MRS and DTI of White Matter in Alzheimer's Disease|MR Spectroscopy and Diffusion Tensor Imaging of White Matter in Alzheimer's Disease|Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.157253|2017-02-18 17:19:40.157253
NCT00172887|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-22|||March 2005||2005-03-01|March 2005|2005-03-01|July 2005||2005-07-01|||||Observational|||Needs Assessment of Long-Term Care for Psychiatric Patients||Unknown status|Recruiting|N/A|1150|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.23339|2017-02-18 17:19:40.23339
NCT00172874|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-12-29|||January 1998||1998-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Observational|||Cross-Cultural Validity of EDI-1 Among Clinical and Non-Clinical Taiwanese Population|Cross-Cultural Validity of EDI-1 Among Clinical and Non-Clinical Taiwanese Population|Completed||N/A|1500|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 17:19:40.313775|2017-02-18 17:19:40.313775
NCT00172861|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|March 2005|2005-03-01||||||||Observational|||Cyclooxygenase-2-Associated Factors and Gastric Carcinogenesis Mechanisms-Clinical Association and Genomic Investigation||Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.400052|2017-02-18 17:19:40.400052
NCT00172848|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||October 2004||2004-10-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Observational|||Mastery, Social Support and Depression of Patients With Major Depression||Completed||Phase 1|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.474116|2017-02-18 17:19:40.474116
NCT00172835|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||March 2005||2005-03-01|March 2005|2005-03-01||||||||Observational|||Use of Procalcitonin in the Diagnosis of Pleural Effusion|Evaluation of Procalcitonin as a Diagnostic Tool for Patients With Pleural Effusion|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.543964|2017-02-18 17:19:40.543964
NCT00172822|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2003||2003-01-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Appendicitis With Medical Treatment||Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.623781|2017-02-18 17:19:40.623781
NCT00172809|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-05|||July 2005||2005-07-01|June 2007|2007-06-01|January 2007|Actual|2007-01-01|June 2006|Actual|2006-06-01||Interventional|||Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease|A Pilot Study in Comparing the Efficacy and Safety of Peginterferon Alfa-2a and Interferon Alfa-2a in Treating Patients With End Stage Renal Disease and Chronic Hepatitis C|Completed||Phase 4|50|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 17:19:40.713069|2017-02-18 17:19:40.713069
NCT00172796|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-29|||April 2005||2005-04-01|April 2005|2005-04-01||||||||Observational|||Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-Diabetes||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.846928|2017-02-18 17:19:40.846928
NCT00172783|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2005||2005-06-01|June 2005|2005-06-01|December 2005||2005-12-01|||||Observational|||PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period|PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period|Unknown status|Recruiting|N/A|460||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:40.924414|2017-02-18 17:19:40.924414
NCT00172770|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||August 2004||2004-08-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Observational|||The Establishment of the Early Intervention Program for Patients With Schizophrenia||Unknown status|Recruiting|Phase 1/Phase 2|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:41.004466|2017-02-18 17:19:41.004466
NCT00172757|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-25|||January 2002||2002-01-01|January 2003|2003-01-01|June 2005||2005-06-01|||||Observational|||Association of Colorectal Cancer With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations in Taiwan|Risk Factors of Colorectal Cancer in Taiwan-With Special Reference to the Association With Nutrition, Diet, Obesity, Diabetes Mellitus, and Genetic Alterations|Unknown status|Recruiting|Phase 2|1000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:41.086485|2017-02-18 17:19:41.086485
NCT00171873|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-08|2011-02-28||September 2001||2001-09-01|May 2012|2012-05-01|December 2013|Anticipated|2013-12-01|June 2008|Actual|2008-06-01||Interventional|||Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut|Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut|Unknown status|Active, not recruiting|Phase 3|85|Actual|Philipps University Marburg Medical Center||2|||f||||||||||||||2017-02-18 17:19:41.16792|2017-02-18 17:19:41.16792
NCT00171678|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-20|||October 2004||2004-10-01|April 2012|2012-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Completed||Phase 3|480||Novartis|||||f||||||||||||||2017-02-18 17:19:45.348346|2017-02-18 17:19:45.348346
NCT00171860|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-29|||September 2002||2002-09-01|April 2012|2012-04-01||||July 2007|Actual|2007-07-01||Interventional|||A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome|A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome|Terminated||Phase 2|24|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:41.481888|2017-02-18 17:19:41.481888
NCT00171847|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-03-30|||March 2003||2003-03-01|March 2010|2010-03-01||||October 2008|Actual|2008-10-01||Interventional|eLEcTRA||Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer|An Open Label, Randomized Comparison of Femara® 2.5mg Once Daily With or Without Weekly Herceptin® Until Disease Progression as First-line Treatment in Postmenopausal Women With Advanced Breast Cancer.|Terminated||Phase 4|93|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:19:41.583727|2017-02-18 17:19:41.583727
NCT00171834|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-01-06|2011-01-11||August 2003||2003-08-01|January 2014|2014-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer|An Open Label, Phase I/II Dose Escalating Study Evaluating the Safety and Efficacy of EPO906, qw3, in Patients With Non-small Cell Lung Cancer.|Completed||Phase 1/Phase 2|89|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:41.701078|2017-02-18 17:19:41.701078
NCT00171821|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-06-05|||April 2005||2005-04-01|June 2013|2013-06-01|July 2010|Actual|2010-07-01|May 2009|Actual|2009-05-01||Interventional|||A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload|A One Year, Open-label, Single-arm, Multi-center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20 mg/kg/Day) in Patients Diagnosed With Transfusion-dependent Iron Overload|Completed||Phase 3|1784|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:43.552093|2017-02-18 17:19:43.552093
NCT00171808|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-16|||April 2005||2005-04-01|November 2016|2016-11-01||||May 2010|Actual|2010-05-01||Interventional|deFEND||Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer|Phase II Study on Letrozole in Patients With Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer|Completed||Phase 2|26|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:19:43.771865|2017-02-18 17:19:43.771865
NCT00171795|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-22|||November 2002||2002-11-01|November 2011|2011-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment|Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment|Completed||Phase 3|67|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:43.889483|2017-02-18 17:19:43.889483
NCT00171782|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-07|||February 2004||2004-02-01|June 2006|2006-06-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Hypertension and Cardiovascular Risk Factors|Valsartan Plus Hydrochlorothiazide in Patients With Hypertension and Cardiovascular Risk Factors|Completed||Phase 4|76|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:43.966825|2017-02-18 17:19:43.966825
NCT00171769|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-31|||April 2005||2005-04-01|March 2008|2008-03-01||||August 2006|Actual|2006-08-01||Interventional|||Atrial Fibrillation Feasibility Certoparin Trial - AFFECT|An Open Label, Multi-center Trial to Evaluate the Feasibility and Safety of Short-term Treatment With Subcutaneously Injected Certoparin (8000 U Anti-Xa Twice Daily) in Patients With Persistent Nonvalvular Atrial Fibrillation|Completed||Phase 3|200||Novartis|||||f||||||||||||||2017-02-18 17:19:44.048063|2017-02-18 17:19:44.048063
NCT00171756|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-11-07|||June 2004||2004-06-01|November 2011|2011-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.|A Double-blind, Double-dummy, Multi-centre, Randomized, Active Controlled, Parallel Group Pilot Trial to Compare the Effects of Valsartan and Atenolol on the Pro-thrombotic State in Patients With Mild to Moderate Hypertension.|Completed||Phase 4|92|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:44.137419|2017-02-18 17:19:44.137419
NCT00171743|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-16|||April 2004||2004-04-01|November 2016|2016-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients|Switch From Tacrolimus to Cyclosporine Microemulsion: Immunosuppressive Agents and Diabetes Management in Liver Transplant Recipients in Maintenance (DIALIVER)|Completed||Phase 4|47|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:44.222645|2017-02-18 17:19:44.222645
NCT00171730|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-11-15|||August 2004||2004-08-01|November 2016|2016-11-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly|Extension to a Multi-center, Randomized, Crossover, Open Label, Dose Finding Study to Compare the Safety, Efficacy, and Pharmacokinetics/Pharmacodynamics (PK/PD) Relationship of Multiple Doses of Pasireotide (SOM230) (200, 400, and 600 μg Bid) and Doses of Open Label Sandostatin® (SMS) (100 μg Tid) in Acromegalic Patients|Completed||Phase 2|30|Actual|Novartis||1|||f||||f||||||||||2017-02-18 17:19:44.312887|2017-02-18 17:19:44.312887
NCT00171717|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-01-31|||February 2004||2004-02-01|January 2011|2011-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant|Pilot Study of the Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients Presenting With New Onset Diabetes After the 3rd Month Post-transplant.|Completed||Phase 4|39|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:44.426212|2017-02-18 17:19:44.426212
NCT00171704|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-05-01|2012-02-27||April 2005||2005-04-01|May 2012|2012-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer|A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer|Completed||Phase 3|263|Actual|Novartis|The study was designed to investigate the effects of letrozole compared with tamoxifen for 2 years on BMD spine (L2-L4). The study was too small to investigate the comparative efficacy of treatments on disease-free survival or on overall survival.|2|||f||||||||||||||2017-02-18 17:19:44.513409|2017-02-18 17:19:44.513409
NCT00171691|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-20|||October 2004||2004-10-01|April 2012|2012-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Completed||Phase 3|450||Novartis|||||f||||||||||||||2017-02-18 17:19:45.260018|2017-02-18 17:19:45.260018
NCT00172718|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-05|||March 2005||2005-03-01|February 2005|2005-02-01||||||||Observational|||Using 3.3mm Screw Tap and Cutting Resistance to Evaluate Bone Quality Around Dental Implant|Using 3.3mm Screw Tap to Modify the Standard Implantation Procedure and to Measure the Cutting Resistance for Establishing a More Objective Method to Evaluate the Peri-Implant Bone Quality|Unknown status|Recruiting|N/A|60|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:48.548368|2017-02-18 17:19:48.548368
NCT00172705|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2004||2004-09-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Observational|||Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique|Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:48.634962|2017-02-18 17:19:48.634962
NCT00172692|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-12-14|||July 2004||2004-07-01|June 2005|2005-06-01|August 2004||2004-08-01|||||Observational|||Observation and Evaluation of Chewing Velocity Changes on Soft Food Chewing Efficiency||Completed||Phase 2|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:48.705417|2017-02-18 17:19:48.705417
NCT00172679|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-26|||July 2005||2005-07-01|December 2004|2004-12-01|June 2006||2006-06-01|||||Observational|||Effects of Tai Chi Exercise on Innate and Adaptive Immune Function||Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:48.778613|2017-02-18 17:19:48.778613
NCT00172666|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-29|||August 2005||2005-08-01|December 2004|2004-12-01|July 2006||2006-07-01|||||Observational|||Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)|Investigating Genetic Polymorphism of Decoy Receptor 3 (DcR3) Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|450||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:48.858962|2017-02-18 17:19:48.858962
NCT00172653|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-15|||August 2005||2005-08-01|August 2005|2005-08-01|July 2006||2006-07-01|||||Observational|||Function-Related Tests for Subjects With Stiff Shoulders: Reliability and Validity|Assessment of Function-Related Tests for Subjects With Stiff Shoulders: Reliability, Validity, Clinical Usefulness, and Biomechanical Analysis|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:48.937535|2017-02-18 17:19:48.937535
NCT00172640|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|December 2004|2004-12-01||||||||Observational|||Genetic Studies in Liver Cancer Patients|Identification of Differentially Expressed Genes in Hepatocellular Carcinoma With DNA Microarrays|Unknown status|Recruiting|Phase 1|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:49.014641|2017-02-18 17:19:49.014641
NCT00172627|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|December 2004|2004-12-01||||||||Observational|||Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer|Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer|Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:49.100083|2017-02-18 17:19:49.100083
NCT00172614|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-28|||December 2004||2004-12-01|December 2004|2004-12-01||||||||Observational|||The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance||Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:49.2439|2017-02-18 17:19:49.2439
NCT00172601|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||August 2005||2005-08-01|December 2004|2004-12-01||||||||Interventional|||Mobilization Techniques in Patients With Frozen Shoulder: a Randomized Multiple-Treatment Trial||Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:49.512869|2017-02-18 17:19:49.512869
NCT00172588|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-25|||January 2005||2005-01-01|December 2004|2004-12-01|October 2005||2005-10-01|||||Observational|||Evaluation of Endometrial Stromal Cell Apoptosis in Adenomyosis||Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:49.605569|2017-02-18 17:19:49.605569
NCT00172575|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||December 2004||2004-12-01|December 2004|2004-12-01|December 2006||2006-12-01|||||Observational|||Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI||Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:49.686477|2017-02-18 17:19:49.686477
NCT00172562|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-02-28||||||August 2005|2005-08-01||||||||Observational|||Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image||Unknown status|Recruiting|Phase 3|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:49.767993|2017-02-18 17:19:49.767993
NCT00172549|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||March 2004||2004-03-01|July 2005|2005-07-01|October 2004||2004-10-01|||||Observational|||Quality of Life and Its Related Factors of Patients With Major Depressive Disorder||Completed||Phase 1|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:49.848346|2017-02-18 17:19:49.848346
NCT00172536|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-21|||October 2004||2004-10-01|March 2011|2011-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft|Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft|Completed||N/A|65|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 17:19:49.912745|2017-02-18 17:19:49.912745
NCT00172523|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2004||2004-10-01|October 2004|2004-10-01|August 2005||2005-08-01|||||Observational|||Metabolic Disorders in Polycystic Ovarian Syndrome||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.024393|2017-02-18 17:19:50.024393
NCT00172510|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2004||2004-08-01|August 2004|2004-08-01|August 2005||2005-08-01|||||Observational|||Mutation Analysis of 17α-Hydroxylase||Unknown status|Recruiting|N/A|25||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.101421|2017-02-18 17:19:50.101421
NCT00172497|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2001||2001-08-01|August 2001|2001-08-01|October 2005||2005-10-01|||||Observational|||Aggressive Acts Among Patients With Schizophrenia|A Study of the Aggressive Acts Among Patients With Schizophrenia|Suspended||N/A|450||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.197801|2017-02-18 17:19:50.197801
NCT00172484|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-15|||January 2005||2005-01-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||North Taiwan Stroke Center for Prevention and Treatment|North Taiwan Stroke Center for Prevention and Treatment|Completed||Phase 3|250|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-02-18 17:19:50.286414|2017-02-18 17:19:50.286414
NCT00172471|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20||||||December 2004|2004-12-01||||||||Observational|||The Relationship Between Sleep Disorders and Cytokine Levels Among Hemodialysis and Peritoneal Dialysis Patients||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.376499|2017-02-18 17:19:50.376499
NCT00172458|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-14||||||August 2005|2005-08-01||||||||Observational|||Clinical Results and Restenosis Analysis of Symptomatic Ostial Vertebral Artery Stenosis Treated With Tubular Coronary Stents|Clinical Results and Restenosis Analysis of Symptomatic Ostial Vertebral Artery Stenosis Treated With Tubular Coronary Stents|Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.452577|2017-02-18 17:19:50.452577
NCT00172445|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-06||||||June 2004|2004-06-01||||||||Interventional|||Clinical Studies of Kikuchi's Disease||Withdrawn||N/A|0|Actual|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.529565|2017-02-18 17:19:50.529565
NCT00172432|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||August 2005|2005-08-01||||||||Observational|||Aminoterminal Propeptide of Type III Procollagen and Severity of Coronary Artery Disease in Patients Without Myocardial Infarction||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.600034|2017-02-18 17:19:50.600034
NCT00172419|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-01-02|||March 2007||2007-03-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.|Statin-Induced Vulnerable Plaque Regression After Atorvastatin Treatment: Serial Evaluation by 18F-Fluorodeoxyglucose Positron Emission Tomography Study|Completed||N/A|43|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:19:50.66055|2017-02-18 17:19:50.66055
NCT00172406|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||August 2005|2005-08-01||||||||Observational|||The Relation Between Serum Level of Amioterminal Propeptide of Type I Procollagen and Diastolic Dysfunction in Hypertensive Patients Without Diabetes Mellitus||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.772642|2017-02-18 17:19:50.772642
NCT00172393|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-03|||January 2003||2003-01-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Observational|||Long Term Outcomes of EV71 CNS Infection|Long Term Outcomes of EV71 Central Nervous System Infection|Unknown status|Recruiting|N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:50.826481|2017-02-18 17:19:50.826481
NCT00172380|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-19|||February 2005||2005-02-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III|Phase II Study Evaluating Docetaxel and CDDP as Neoadjuvant Chemotherapy Prior to Surgery, Followed by Adjuvant Docetaxel Plus CDDP in Chemonaive Patients With NSCLC Stage III|Completed||Phase 2|41|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:19:50.917478|2017-02-18 17:19:50.917478
NCT00172367|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-25|||January 2006||2006-01-01|November 2004|2004-11-01||||||||Interventional|||Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma||Withdrawn||Phase 2|80|Anticipated|National Taiwan University Hospital||||"This study was for National Science Council project. The study was not funded, so the study~   was withdrawn."|f||||||||||||||2017-02-18 17:19:51.003349|2017-02-18 17:19:51.003349
NCT00172354|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-30|||October 2004||2004-10-01|November 2012|2012-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest|Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest|Completed||N/A|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.095332|2017-02-18 17:19:51.095332
NCT00172341|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-02||||||July 2004|2004-07-01||||||||Interventional|||Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children|Efficacy and Safety of Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children: A Double-Blind, Randomized, and Placebo-Controlled Study|Unknown status|Not yet recruiting|Phase 4|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.172096|2017-02-18 17:19:51.172096
NCT00172328|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||September 2004|2004-09-01||||||||Interventional|||Antibody Response and Immune Memory 15-18 Years After HBV Vaccination||Unknown status|Recruiting|N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.233603|2017-02-18 17:19:51.233603
NCT00172315|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-03-28|||December 2003||2003-12-01|August 2005|2005-08-01||||||||Observational|||Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects|Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects, With Serial Follow-Up|Unknown status|Recruiting|Phase 3|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.314717|2017-02-18 17:19:51.314717
NCT00172302|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||November 2005||2005-11-01|May 2005|2005-05-01||||||||Interventional|||Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?|Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?|Unknown status|Not yet recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.392848|2017-02-18 17:19:51.392848
NCT00172289|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-01-06|||August 2004||2004-08-01|December 2004|2004-12-01|December 2006||2006-12-01|||||Observational|||Measurement of Pulse Wave Velocity in Spinal Cord Injury and Stroke Patients|Measurement of Pulse Wave Velocity in Spinal Cord Injury and Stroke Patients|Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.474902|2017-02-18 17:19:51.474902
NCT00172276|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-14||||||June 2005|2005-06-01||||||||Observational|||Angiotensin Converting Enzyme Gene Polymorphism in Children With Idiopathic Nephrotic Syndrome||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.83109|2017-02-18 17:19:51.83109
NCT00172263|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-06||||||December 2012|2012-12-01||||||||Interventional|||The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes||Withdrawn||N/A|0|Actual|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.893662|2017-02-18 17:19:51.893662
NCT00172250|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||September 2003||2003-09-01|August 2005|2005-08-01||||||||Observational|||The Study of Relationship of Plasma Concentrations of Folic Acid, Vitamin B and Homocysteine With Carotid Atherosclerosis and Endothelium-Dependent Vasodilatation of Geriatric and Young Patients in the Ambulatory Care Department of NTUH||Completed||N/A|||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:51.976321|2017-02-18 17:19:51.976321
NCT00172237|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-28|||December 2009||2009-12-01|January 2010|2010-01-01|July 2010|Anticipated|2010-07-01|||||Observational|||Proprioception and Eye-head Coordination for the Cervical Spine|Proprioception and Eye-head Coordination for the Cervical Spine|Unknown status|Recruiting|N/A|80|Anticipated|National Taiwan University Hospital|||1||f||||f||||||||||2017-02-18 17:19:52.039267|2017-02-18 17:19:52.039267
NCT00171626|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-20|||August 2004||2004-08-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis|Completed||Phase 3|480||Novartis|||||f||||||||||||||2017-02-18 17:19:55.315875|2017-02-18 17:19:55.315875
NCT00172224|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-13|||August 2002||2002-08-01|November 2012|2012-11-01||||||||Observational|||Dynamic Magnetic Resonance (MR) Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related Research|Dynamic MR Study in Evaluating the Vertebral Bone Marrow Perfusion and Its Related Research|Completed||Phase 3|100|Actual|National Taiwan University Hospital|||1||f||||t||||||||||2017-02-18 17:19:52.118209|2017-02-18 17:19:52.118209
NCT00172211|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-04|||September 2005||2005-09-01|January 2007|2007-01-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients|Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients|Completed||N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:52.203996|2017-02-18 17:19:52.203996
NCT00172198|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||March 2005||2005-03-01|January 2005|2005-01-01|March 2007||2007-03-01|||||Interventional|||Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.|A Prospective, Controlled, Randomized, Study Evaluating the Clinical Efficacy, Including Nutritional Status, Immune Function and Safety of Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.|Unknown status|Recruiting|Phase 4|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:52.312059|2017-02-18 17:19:52.312059
NCT00172185|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-10|2013-03-12||January 2005||2005-01-01|September 2014|2014-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)|A Study of the Safety and Efficacy of Teduglutide in Subjects With Parenteral Nutrition-Dependent Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)|Completed||Phase 3|65|Actual|Shire||2|||f||||t||||||||||2017-02-18 17:19:52.414724|2017-02-18 17:19:52.414724
NCT00172172|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-11-11|||February 2004||2004-02-01|August 2008|2008-08-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|CAP||Calcium Supplementation in Postmenopausal Women|A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study)|Completed||Phase 3|374|Actual|Shire||3|||t||||f||||||||||2017-02-18 17:19:53.36403|2017-02-18 17:19:53.36403
NCT00172159|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-06-22|||January 2000||2000-01-01|January 2000|2000-01-01|June 2005|Anticipated|2005-06-01|||||Interventional|||Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers|Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers|Unknown status|Recruiting|Phase 2|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:53.513625|2017-02-18 17:19:53.513625
NCT00172146|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 2002||2002-08-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Observational|||Influences of Cane Use on Voluntary Forward Stepping Movement and Associated Attentional Demands in Hemiplegic Patients|Influences of Cane Use on Voluntary Forward Stepping Movement and Associated Attentional Demands in Hemiplegic Patients|Unknown status|Active, not recruiting|N/A|22||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:19:53.60833|2017-02-18 17:19:53.60833
NCT00172133|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-11|||October 2001||2001-10-01|August 2008|2008-08-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|OLES||Open Label Extension Study of PREOS|An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)|Completed||Phase 3|1683|Actual|Shire||1|||t||||t||||||||||2017-02-18 17:19:53.688052|2017-02-18 17:19:53.688052
NCT00172120|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-11|||January 2005||2005-01-01|September 2005|2005-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|TRES||Open Label Extension|An 18-month, Open-label Extension Study of Once-daily ALX1-11 for the Treatment of Postmenopausal Women With Osteoporosis (TRES)|Completed||Phase 3|91|Actual|Shire||1|||f||||f||||||||||2017-02-18 17:19:54.15991|2017-02-18 17:19:54.15991
NCT00172107|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-11-11|||May 1995||1995-05-01|September 2005|2005-09-01|March 1997|Actual|1997-03-01|March 1997|Actual|1997-03-01||Interventional|||A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis|A Double Blind, Placebo Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis|Completed||Phase 2|217|Actual|Shire||4|||f||||f||||||||||2017-02-18 17:19:54.262835|2017-02-18 17:19:54.262835
NCT00172094|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-11-11|||December 2003||2003-12-01|September 2005|2005-09-01|July 2004|Actual|2004-07-01|June 2004|Actual|2004-06-01||Interventional|||Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches|A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches|Completed||Phase 2|189|Actual|Shire||3|||f||||f||||||||||2017-02-18 17:19:54.413249|2017-02-18 17:19:54.413249
NCT00172081|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-11-10|||April 2000||2000-04-01|September 2005|2005-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis|An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis|Completed||Phase 3|2532|Actual|Shire||2|||f||||t||||||||||2017-02-18 17:19:54.56549|2017-02-18 17:19:54.56549
NCT00172068|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-12-21|||January 2002||2002-01-01|December 2009|2009-12-01||||November 2008|Actual|2008-11-01||Interventional|MRD-1||Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow|Efficacy and Tolerability of Intravenous Zometa® (Zoledronic Acid) 4 mg in Primary Breast Cancer Patients With Disseminated Tumor Cells in Bone Marrow. A Prospective, Randomized, Parallel Group, Open-label, Clinical Pilot Study.|Terminated||Phase 2|96|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:19:54.981949|2017-02-18 17:19:54.981949
NCT00171652|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-09|||May 2005||2005-05-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis|Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis|Completed||Phase 3|360||Novartis|||||||||||||||||||2017-02-18 17:19:55.09477|2017-02-18 17:19:55.09477
NCT00171639|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-24|||June 2004||2004-06-01|February 2011|2011-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis|The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis|Completed||Phase 3|28|Actual|Novartis|||||f||||f||||||||||2017-02-18 17:19:55.218593|2017-02-18 17:19:55.218593
NCT00171613|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-04-27|||February 2005||2005-02-01|April 2012|2012-04-01||||October 2005|Actual|2005-10-01||Interventional|||A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients|A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients|Completed||Phase 4|32||Novartis|||||f||||||||||||||2017-02-18 17:19:55.418517|2017-02-18 17:19:55.418517
NCT00171600|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||July 2005||2005-07-01|November 2011|2011-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Antialbuminuric Effects of Valsartan and Lisinopril|Comparative, Open Multicenter Trial Assessing the Effect on Albumin Excretion Rate of 320mg Valsartan (With or Without HCTZ) vs 40mg Lisinopril (With or Without HCTZ) on Hypertensive Patients With Diabetic and Non-diabetic Nephropathy and Albuminuria|Terminated||Phase 4|54|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:55.683036|2017-02-18 17:19:55.683036
NCT00171587|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-18|||May 2002||2002-05-01|November 2009|2009-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer|A Phase IB, Open-label, Dose-escalating Study of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer|Completed||Phase 1/Phase 2|22|Anticipated|Novartis|||||f||||||||||||||2017-02-18 17:19:55.781083|2017-02-18 17:19:55.781083
NCT00171574|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||November 2004||2004-11-01|November 2011|2011-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Antiproteinuric Effect of Valsartan and Lisinopril|Antiproteinuric Effect of Valsartan, Lisinopril and Valsartan Plus Lisinopril in Non-diabetic and Diabetic Renal Disease: a Randomized, Double Blind, Parallel Group, Controlled Trial With 5 Months Follow-up|Completed||Phase 4|124|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:55.880971|2017-02-18 17:19:55.880971
NCT00171561|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||March 2003||2003-03-01|November 2011|2011-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.|A 24-week Study to Evaluate the Effectiveness of Valsartan in Combination With Hydrochlorothiazide Versus Amlodipine on Arterial Compliance in Patients With Hypertension, Type 2 Diabetes and Albuminuria|Completed||Phase 4|144|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:55.981024|2017-02-18 17:19:55.981024
NCT00171548|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-19|||October 2004||2004-10-01|September 2008|2008-09-01||||July 2007|Actual|2007-07-01||Observational|||Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients|Project to Promote the Evaluation of Cardiovascular Risk in Clinical Practice, and Assess Its Evolution After the Implementation of Multifactorial Preventive Strategy Aimed at Reducing the Level of Global Risk (SCORE Algorithm) in Subjects With Metabolic Syndrome and a Risk Level of 5%|Completed||Phase 4|600|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:56.06837|2017-02-18 17:19:56.06837
NCT00171535|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||October 2004||2004-10-01|June 2006|2006-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension|A Study to Evaluate the Safety and Efficacy of Valsartan/Amlodipine Compared to Lisinopril/Hydrochlorothiazide Given Once Daily for 6 Weeks is Patients With Severe Hypertension|Completed||Phase 3|130|Actual|Novartis|||||||||||||||||||2017-02-18 17:19:56.146714|2017-02-18 17:19:56.146714
NCT00171522|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-02|||May 2005||2005-05-01|March 2016|2016-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Preference of Tegaserod vs. PEG 3350 in Patients With Constipation|A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation|Completed||Phase 4|52||Novartis|||||||||||||||||||2017-02-18 17:19:56.24078|2017-02-18 17:19:56.24078
NCT00171509|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-01-31|||May 2004||2004-05-01|January 2011|2011-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients|A Multicenter, Randomized Open-label Pilot Study to Explore the Benefit of a Conversion From a Twice a Day Administration of Cyclosporine Microemulsion to a Once a Day Administration and to Identify the C2 Ranges to Target After Conversion in Stable Liver Transplant Recipients|Completed||Phase 4|61|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:19:56.333775|2017-02-18 17:19:56.333775
NCT00171496|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-16|||October 2003||2003-10-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients|A Six-month Open Label, Multicenter, Randomized Study to Evaluate the Incidence of New Onset Diabetes Mellitus and Glucose Metabolism in Patients Receiving Cyclosporine Microemulsion With C-2 Monitoring Versus Tacrolimus After de Novo Kidney Transplantation|Completed||Phase 4|693|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:19:56.429836|2017-02-18 17:19:56.429836
NCT00171483|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-24|||January 2004||2004-01-01|January 2008|2008-01-01|April 2005|Actual|2005-04-01|||||Interventional|||Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).|Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).|Completed||Phase 3|30||Novartis|||||||||||||||||||2017-02-18 17:19:56.539855|2017-02-18 17:19:56.539855
NCT00171470|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-31|||April 2005||2005-04-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.|The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.|Completed||Phase 3|60||Novartis|||||||||||||||||||2017-02-18 17:19:56.648365|2017-02-18 17:19:56.648365
NCT00171457|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-10-09|||April 2005||2005-04-01|October 2007|2007-10-01|September 2006|Actual|2006-09-01|||||Interventional|||The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.|The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.|Completed||Phase 3|24||Novartis|||||||||||||||||||2017-02-18 17:19:56.736028|2017-02-18 17:19:56.736028
NCT00171444|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||June 2004||2004-06-01|September 2005|2005-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Comparison of Two Treatment Strategies in Hypertensive Patients|A 8-week Comparison, in a General Practice Setting, Between Two Treatment Strategies With Valsartan and Valsartan/HCTZ Aiming at Normalizing de Novo Hypertensive Patients Who Are Not Adequately Controlled With Their Monotherapy or Biotherapy Treatment or Experiencing Unacceptable Side-effects, According to Their Baseline Blood Pressure|Completed||Phase 4|4445|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:56.82539|2017-02-18 17:19:56.82539
NCT00171431|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-04-19|||November 2004||2004-11-01|April 2012|2012-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)|The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)|Terminated||Phase 3|20||Novartis||||This study was terminated early in May 2006 due to low patient enrollment|f||||||||||||||2017-02-18 17:19:56.914706|2017-02-18 17:19:56.914706
NCT00171418|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-24|||June 2003||2003-06-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).|Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).|Completed||Phase 3|54||Novartis|||||||||||||||||||2017-02-18 17:19:57.009518|2017-02-18 17:19:57.009518
NCT00171405|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2016-11-16|||June 2005||2005-06-01|November 2016|2016-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg|A 4 Month Extension to a 12 Month, Randomized, Open-label, Multicenter, Study to Assess the Long-term Safety of Aliskiren 150 mg Alone and 300 mg Alone or With the Optional Addition of Hydrochlorothiazide (12.5 mg or 25 mg) in Patients With Essential Hypertension|Completed||Phase 3|250||Novartis|||||||||||||||||||2017-02-18 17:19:57.103461|2017-02-18 17:19:57.103461
NCT00171392|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-01|||March 2004||2004-03-01|February 2011|2011-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus|Open-label Study to Evaluate the Tolerability, Safety and Efficacy of the Equimolar Conversion From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium in Patients With Stable Renal Transplant Receiving Tacrolimus|Completed||Phase 3|132|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:57.213844|2017-02-18 17:19:57.213844
NCT00171379|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-01|||March 2004||2004-03-01|February 2011|2011-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant|Open-label Study to Evaluate the Tolerability, Safety and Efficacy of the Equimolar Conversion From Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) in Patients With Renal Transplant|Completed||Phase 3|162|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:57.293006|2017-02-18 17:19:57.293006
NCT00171366|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-04-05|||July 2004||2004-07-01|April 2016|2016-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.|A Multicenter, Group Study to Evaluate the Safety and Efficacy of Amlodipine and Benazepril Administered in Combination Compared to Amlodipine Monotherapy in Hypertensive Patients Not Adequately Controlled With Amlodipine Alone|Completed||Phase 3|1422|Actual|Novartis|||||||||||||||||||2017-02-18 17:19:57.367968|2017-02-18 17:19:57.367968
NCT00171353|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||July 2004||2004-07-01|November 2011|2011-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure|A Study to Describe Vascular and Renal Effects and Safety of Valsartan 80 and 160 mg in Arterial Hypertension Patients|Completed||Phase 4|109|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:57.457245|2017-02-18 17:19:57.457245
NCT00171340|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-04-10|2011-03-22||May 2003||2003-05-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.|An Open-Label, Randomized, MultiCenter Study to Evaluate the Use of Zolendronic Acid in the Prevention of Cancer Treatment-Related Bone Loss in Postmenopausal Women With Estrogen Positive and/or Progesterone Positive Breast Cancer Receiving Letrozole as Adjuvant Therapy|Completed||Phase 3|1065|Actual|Novartis||2|||f||||t||||||||||2017-02-18 17:19:57.558421|2017-02-18 17:19:57.558421
NCT00171327|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||July 2004||2004-07-01|November 2011|2011-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction|Efficacy and Safety of Fluvastatin 80 mg or Valsartan 160 mg and Their Combination in Dyslipidemic Patients With Arterial Hypertension and Endothelial Dysfunction|Completed||Phase 4|213|Actual|Novartis|||||f||||||||||||||2017-02-18 17:19:59.026352|2017-02-18 17:19:59.026352
NCT00171314|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-19|2011-12-15||March 2004||2004-03-01|March 2012|2012-03-01||||November 2010|Actual|2010-11-01||Interventional|||The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer|The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer|Completed||Phase 3|527|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:19:59.134353|2017-02-18 17:19:59.134353
NCT00171301|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-08-28|2011-01-12||June 2005||2005-06-01|August 2011|2011-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|ESCALATOR||Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)|1-year Extension to CICL670A2402 an Open-label, Multi-center Trial of the Efficacy and Safety of Long-term Treatment With Deferasirox (10 to 20 mg/kg/Day) in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2- Year Duration)|Completed||Phase 4|233|Actual|Novartis|An internal review revealed major Good Clinical Practice violations at 2 sites in Saudi Arabia: 602 for core + extension, 601 for 2-yr extension. Therefore data was excluded (completely for 602 + partly for 601) from analyses.|1|||f||||t||||||||||2017-02-18 17:19:59.940378|2017-02-18 17:19:59.940378
NCT00171288|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||August 2003||2003-08-01|November 2011|2011-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone|Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone|Completed||Phase 3|83|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:00.52857|2017-02-18 17:20:00.52857
NCT00171275|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-07-15|||November 2003||2003-11-01|July 2010|2010-07-01||||February 2007|Actual|2007-02-01||Interventional|||Fluvastatin in the Therapy of Acute Coronary Syndrome|Fluvastatin in the Therapy of Acute Coronary Syndrome|Completed||Phase 4|1000||Novartis|||||f||||||||||||||2017-02-18 17:20:00.620277|2017-02-18 17:20:00.620277
NCT00171262|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||August 2004||2004-08-01|November 2011|2011-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers|Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers|Completed||Phase 4|120|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:00.708993|2017-02-18 17:20:00.708993
NCT00171249|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-03-21|||August 2004||2004-08-01|March 2014|2014-03-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia|An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia|Completed||Phase 2|57|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:20:00.806207|2017-02-18 17:20:00.806207
NCT00171236|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-07|||October 2001||2001-10-01|September 2005|2005-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia|Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|84|Actual|Novartis|||||||||||||||||||2017-02-18 17:20:00.921077|2017-02-18 17:20:00.921077
NCT00171223|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-06-24|||August 2004||2004-08-01|June 2014|2014-06-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia|An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia|Completed||Phase 2|356|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:20:01.022491|2017-02-18 17:20:01.022491
NCT00171210|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-24|2010-12-14||October 2004||2004-10-01|May 2011|2011-05-01||||April 2008|Actual|2008-04-01||Interventional|||An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload|An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670)in β-thalassemia Patients With Transfusional Iron Overload|Completed||Phase 3|506|Actual|Novartis||1|||f||||f||||||||||2017-02-18 17:20:01.169955|2017-02-18 17:20:01.169955
NCT00171184|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-14|||April 2005||2005-04-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|||||Interventional|||Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder|Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder|Completed||Phase 4|400|Actual|Novartis||2|||||||||||||||||2017-02-18 17:20:02.700895|2017-02-18 17:20:02.700895
NCT00171171|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-17|||May 2004||2004-05-01|November 2016|2016-11-01||||November 2006|Actual|2006-11-01||Interventional|||A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis|A Study of Efficacy and Safety of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis|Completed||Phase 3|252|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:20:02.812382|2017-02-18 17:20:02.812382
NCT00171158|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-03-25|||August 2004||2004-08-01|March 2014|2014-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis|An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis|Completed||Phase 2|20|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:20:02.932205|2017-02-18 17:20:02.932205
NCT00171145|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-01-18|||April 2004||2004-04-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|||||Interventional|||A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.|A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.|Completed||Phase 3|445|Actual|Novartis||2|||||||||||||||||2017-02-18 17:20:03.045304|2017-02-18 17:20:03.045304
NCT00171132|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||August 2004||2004-08-01|November 2011|2011-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women|A 26-week Double-blind, Randomized, Multicenter Parallel-group Trial to Compare the Effects of Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women With Impaired Exercise Tolerance|Completed||Phase 4|64|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:03.148854|2017-02-18 17:20:03.148854
NCT00171119|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-12-16|||January 2004||2004-01-01|December 2008|2008-12-01||||March 2005|Actual|2005-03-01||Interventional|||A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril|A 24-Week Study to Assess Blood Pressure Independent Effects of Valsartan Treatment, Benazepril Treatment and Combination of Both Valsartan and Benazepril Treatment on Urinary Albumin Excretion Rate With Type II Diabetes Mellitus and Microalbuminuria|Terminated||Phase 4|81|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:03.243285|2017-02-18 17:20:03.243285
NCT00171106|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2016-11-16|||December 2002||2002-12-01|November 2016|2016-11-01|February 2008|Actual|2008-02-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure|A Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Determine the Effects of Valsartan on Exercise Time in Subjects With Symptomatic Diastolic Heart Failure|Completed||Phase 4|150||Novartis|||||f||||||||||||||2017-02-18 17:20:03.338232|2017-02-18 17:20:03.338232
NCT00171093|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-09-19|||September 2004||2004-09-01|September 2008|2008-09-01||||January 2006|Actual|2006-01-01||Interventional|||A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia|A 10-12 Week Multicenter, Double-Blind Study to Evaluate the Efficacy and Safety of the Combination of Valsartan (320 mg) and Simvastatin (80 mg) Compared to Valsartan (320 mg) and Simvastatin (80 mg) Monotherapies in Essential Hypertension and Hypercholesterolemia|Completed||Phase 3|369||Novartis|||||||||||||||||||2017-02-18 17:20:03.446536|2017-02-18 17:20:03.446536
NCT00171080|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2016-11-16|||April 2004||2004-04-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis|A 2 x 5-week Multicenter, Cross-over Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan 80 mg Compared to Irbesartan 150 mg in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis|Completed||Phase 3|86|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:03.537169|2017-02-18 17:20:03.537169
NCT00005405|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-19|||September 1991||1991-09-01|January 2016|2016-01-01|September 1993|Actual|1993-09-01|September 1993|Actual|1993-09-01||Observational|||Parity and Serum Lipids in White and Hispanic Women||Completed||N/A|||University of Pennsylvania|||||f||||||||||||||2017-02-18 18:15:02.145753|2017-02-18 18:15:02.145753
NCT00171067|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||July 2004||2004-07-01|November 2011|2011-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria|A Study to Evaluate the Effectiveness of Valsartan 320 mg in Combination With Lisinopril 20 mg Versus Monotherapy With Lisinopril 40 mg or Valsartan 320 mg in Hypertensive Patients With Microalbuminuria on the Reduction of Urinary Albumin Creatinine Ratio|Completed||Phase 3|134|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:03.637892|2017-02-18 17:20:03.637892
NCT00171054|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-06-02|2010-12-21||September 2003||2003-09-01|June 2011|2011-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension|A Randomized, Double-blind, Parallel Group, Active-controlled, 38-week Study to Evaluate the Efficacy of Valsartan Versus Amlodipine on the Arterial Properties of Postmenopausal Women With Mild to Moderate Hypertension|Completed||Phase 4|125|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:20:03.73056|2017-02-18 17:20:03.73056
NCT00171041|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2016-11-16|||December 2002||2002-12-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age|A Double-Blind, Randomized, Multi-Center Study Followed By 12 Months Open-Label Treatment To Evaluate The Dose Response And Safety Of Valsartan In Pediatric Hypertensive Patients|Completed||Phase 3|265|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:04.238541|2017-02-18 17:20:04.238541
NCT00171028|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||December 2003||2003-12-01|June 2006|2006-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension|A Double-Blind, Randomized, Multi-Center Study Followed By 12 Months Open-Label Treatment To Evaluate The Dose Response And Safety Of Valsartan In Pediatric Hypertension Patients 1 - 5 Years Of Age|Completed||Phase 3|90|Actual|Novartis|||||||||||||||||||2017-02-18 17:20:04.329673|2017-02-18 17:20:04.329673
NCT00171015|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||December 2004||2004-12-01|November 2011|2011-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil|An Open,Multicenter Study to Evaluate the Efficacy and Safety of a 4 Week Therapy With Valsartan/Hydrochlorothiazide 160/25 (Fixed Dose Combination of Valsartan 160 mg Plus HCTZ 25 mg) in Patients Not Adequately Responding to a 4 Week Monotherapy With Olmesartan Medoxomil 40 mg or Combination Therapy With Olmesartan Medoxomil 20 mg Plus HCTZ 12.5 mg|Completed||Phase 3|212|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:04.420999|2017-02-18 17:20:04.420999
NCT00171002|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||November 2004||2004-11-01|June 2006|2006-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone|A Multicenter Trial to Evaluate the Safety and Efficacy of the Combination of Valsartan/Amlodipine 160/10 mg Versus Amlodipine 10 mg Alone for 8 Weeks in Hypertensive Patients Who Are Not Adequately Controlled on Amlodipine 10 mg Monotherapy|Completed||Phase 3|936|Actual|Novartis|||||||||||||||||||2017-02-18 17:20:04.632347|2017-02-18 17:20:04.632347
NCT00170989|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||September 2004||2004-09-01|June 2006|2006-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone|Comparison of the Combination of Valsartan 320 mg Plus Hydrochlorothiazide 12.5 mg and Valsartan 320 mg Plus Hydrochlorothiazide 25 mg to Valsartan 320 mg in Mild to Moderate Hypertensive Patients Not Adequately Controlled With Valsartan 320 mg|Completed||Phase 3|2714|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:04.723839|2017-02-18 17:20:04.723839
NCT00170976|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||April 2004||2004-04-01|November 2011|2011-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension|A 54 Week, Extension to the Double-blind, Multicenter, Multifactorial, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Valsartan (160 mg and 320 mg) and Amlodipine (10 mg) Combined and Alone in Hypertensive Patients|Completed||Phase 3|403|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:04.836096|2017-02-18 17:20:04.836096
NCT00170963|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||October 2004||2004-10-01|September 2005|2005-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone|Valsartan/Amlodipine 160/5 mg or 160/10 mg Versus Valsartan 160 mg Alone for 8 Weeks in Hypertensive Patients Who Are Not Adequately Controlled on Valsartan 160 mg Monotherapy|Completed||Phase 3|1018|Actual|Novartis|||||||||||||||||||2017-02-18 17:20:04.931654|2017-02-18 17:20:04.931654
NCT00170950|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-04-19|2011-01-13||October 2003||2003-10-01|April 2011|2011-04-01|May 2008|Actual|2008-05-01|January 2008|Actual|2008-01-01||Interventional|ACCOMPLISH||Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension|A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients With High Risk Hypertension|Terminated||Phase 3|11506|Actual|Novartis|Study was stopped early, as recommended by the Data Monitoring Committee, due to positive efficacy results.|2||"The study was terminated early because of significant efficacy results for the primary~   endpoint in favor of benazepril/amlodipine treatment."|f||||||||||||||2017-02-18 17:20:05.054842|2017-02-18 17:20:05.054842
NCT00170937|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2016-11-16|||November 2004||2004-11-01|November 2016|2016-11-01||||March 2006|Actual|2006-03-01||Interventional|||A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome|A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan and Hydrochlorothiazide Combined and Alone, in Patients With Metabolic Syndrome|Completed||Phase 4|507||Novartis|||||f||||||||||||||2017-02-18 17:20:08.074892|2017-02-18 17:20:08.074892
NCT00170924|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-11-07|||August 2004||2004-08-01|November 2011|2011-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.|A Multi-center, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Effect of the Angiotensin II Antagonist Valsartan on Diastolic Function in Patients With Hypertension and Diastolic Dysfunction|Completed||Phase 4|317|Actual|Novartis|||||f||||||||||||||2017-02-18 17:20:08.171486|2017-02-18 17:20:08.171486
NCT00170911|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-11-01|||March 2005||2005-03-01|November 2011|2011-11-01||||December 2005|Actual|2005-12-01||Interventional|||Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.|Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.|Completed||Phase 2|160||Novartis|||||f||||||||||||||2017-02-18 17:20:08.263284|2017-02-18 17:20:08.263284
NCT00170898|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-10-12|||November 2004||2004-11-01|June 2006|2006-06-01||||||||Interventional|||Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain|A 7-Day Multicenter Randomized Double-Blind, Double-Dummy Parallel Group Trial to Assess the Safety and Efficacy of 400 mg Lumiracoxib Once Daily Versus 500 mg Naproxen Twice Daily in Patients With Acute Musculoskeletal Pain Due to Uncomplicated Soft Tissue Injury|Completed||Phase 4|419||Novartis|||||f||||||||||||||2017-02-18 17:20:08.341469|2017-02-18 17:20:08.341469
NCT00170885|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-11-15|||May 2005||2005-05-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients|Multicenter, Randomized, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of Two Regimens of Everolimus Plus Cyclosporine Microemulsion, Given According to Different Blood Target Levels, in de Novo Renal Transplant Recipients|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 17:20:11.272384|2017-02-18 17:20:11.272384
NCT00170872|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-05-18|||November 2004||2004-11-01|May 2012|2012-05-01||||July 2005|Actual|2005-07-01||Interventional|||6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis|A 6 Week, Multicenter, Open-label Trial to Evaluate the Safety, Tolerability and Efficacy of Lumiracoxib 200mg o.d. in Patients With Primary Knee Osteoarthritis or Rheumatoid Arthritis|Completed||Phase 3|135||Novartis|||||f||||||||||||||2017-02-18 17:20:11.403677|2017-02-18 17:20:11.403677
NCT00170859|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-11-16|||August 2004||2004-08-01|November 2016|2016-11-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients|A One-year Multicenter, Randomized, Open-label Study of the Safety and Efficacy of Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 17:20:11.481741|2017-02-18 17:20:11.481741
NCT00170846|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-01-15|2010-12-17||February 2005||2005-02-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients|Assessment of Everolimus in Addition to Calcineurin Inhibitors Reduction in Maintenance Renal Transplant Recipients|Completed||Phase 4|394|Actual|Novartis||3|||f||||t||||||||||2017-02-18 17:20:11.585226|2017-02-18 17:20:11.585226
NCT00170833|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-11-01|||November 2003||2003-11-01|November 2011|2011-11-01||||November 2005|Actual|2005-11-01||Interventional|||Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients|A Prospective, Multicenter, Open Label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus (RAD001) With Basiliximab, Corticosteroids and Lower Levels Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Recipients|Completed||Phase 3|80||Novartis|||||||||||||||||||2017-02-18 17:20:13.22641|2017-02-18 17:20:13.22641
NCT00170820|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-11-01|||February 2005||2005-02-01|November 2011|2011-11-01||||March 2006|Actual|2006-03-01||Interventional|||Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen|A Single Arm, Prospective, Open-label, Pilot Study to Assess Effects of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen|Completed||Phase 4|20||Novartis|||||f||||||||||||||2017-02-18 17:20:13.298982|2017-02-18 17:20:13.298982
NCT00170794|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-11-16|||September 2004||2004-09-01|November 2016|2016-11-01||||July 2006|Actual|2006-07-01||Interventional|||Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.|A One Year, Multicenter, Open-Label, Single Arm, Pilot Study of the Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-02-18 17:20:13.385914|2017-02-18 17:20:13.385914
NCT00170781|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-11-29|||June 2005||2005-06-01|June 2006|2006-06-01||||||||Interventional|||Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout|A 1-Week, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel Trial Comparing Lumiracoxib (400 mg Once Daily) in Patients With Acute Flares of Gout, Using Indomethacin (50 mg Three Times a Day)|Completed||Phase 4|234||Novartis|||||f||||||||||||||2017-02-18 17:20:13.473053|2017-02-18 17:20:13.473053
NCT00170768|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-01-18|||February 2005||2005-02-01|January 2008|2008-01-01|May 2005|Actual|2005-05-01|||||Interventional|||Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over|Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over|Completed||Phase 2|150|Actual|Novartis||3|||||||||||||||||2017-02-18 17:20:13.565094|2017-02-18 17:20:13.565094
NCT00170755|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-01-15|||April 2002||2002-04-01|January 2008|2008-01-01|January 2005|Actual|2005-01-01|||||Interventional|||A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder|A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder|Completed||Phase 3|718|Actual|Novartis||1|||||||||||||||||2017-02-18 17:20:13.670675|2017-02-18 17:20:13.670675
NCT00170742|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-08-08|||December 2003||2003-12-01|August 2008|2008-08-01||||May 2006|Actual|2006-05-01||Interventional|||Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.|A Randomized, Open Label, Controlled Study on the Efficacy and Safety of Octreotide i.m. in Patients With Proliferative Diabetic Retinopathy (PDR) After Start of Laser Coagulation|Terminated||Phase 3|17||Novartis||||trial stopped on Sept 24, 2007|f||||||||||||||2017-02-18 17:20:13.773355|2017-02-18 17:20:13.773355
NCT00170729|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-06-07|||August 2004||2004-08-01|June 2006|2006-06-01||||||||Interventional|||A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery|Multi-Center, Randomized, Double Masked, Vehicle Controlled Phase IV Study to Compare the Efficacy, Ocular Safety and Tolerability of a Two Day Treatment With Eye Drops (0.5% Prednisolone Acetate, One Drop Four Times Per Day) in Patients With Intraocular Inflammation After Cataract Surgery, Followed by an Open Label Observational Period of 12 Days|Completed||Phase 4|60||Novartis|||||f||||||||||||||2017-02-18 17:20:13.855453|2017-02-18 17:20:13.855453
NCT00170716|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-18|||September 2004||2004-09-01|December 2007|2007-12-01|March 2008|Anticipated|2008-03-01|||||Interventional|EVEREST||Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis|Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Rehabilitation Activities to Enhance Motor Recovery in Patients Suffering From Upper Extremity Hemiparesis Following a Stroke|Unknown status|Active, not recruiting|Phase 3|174|Anticipated|Northstar Neuroscience||2|||f||||t||||||||||2017-02-18 17:20:13.939799|2017-02-18 17:20:13.939799
NCT00170703|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-19|||December 2004||2004-12-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.|Assessment of the Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Speech-Language Rehabilitation to Enhance Recovery in Patients Suffering From Broca's Aphasia, Following a Stroke.|Completed||Phase 1|8||Northstar Neuroscience|||||f||||f||||||||||2017-02-18 17:20:14.136286|2017-02-18 17:20:14.136286
NCT00170690|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-31|||August 2004||2004-08-01|May 2013|2013-05-01|April 2012|Actual|2012-04-01|December 2011|Actual|2011-12-01||Interventional|||Preference Study With Elderly Patients Recurrent Ovarian Cancer|Präferenz-Studie Bei älteren Patientinnen Mit Ovarialkarzinomrezidiv: Treosulfan Oral vs. intravenös|Completed||Phase 3|123|Actual|North Eastern Germany Society of Gynaecologic Oncology||2|||f||||f||||||||||2017-02-18 17:20:14.232999|2017-02-18 17:20:14.232999
NCT00170677|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-05-13|||September 2005||2005-09-01|July 2010|2010-07-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer|Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer|Completed||Phase 2|194|Actual|North Eastern Germany Society of Gynaecologic Oncology||2|||f||||f||||||||||2017-02-18 17:20:14.530715|2017-02-18 17:20:14.530715
NCT00170664|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-03-24|||January 1999||1999-01-01|March 2016|2016-03-01|September 2004|Actual|2004-09-01|March 2003|Actual|2003-03-01||Interventional|||Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer||Completed||Phase 2|129|Actual|North Eastern Germany Society of Gynaecologic Oncology||1|||f||||||||||||||2017-02-18 17:20:14.637697|2017-02-18 17:20:14.637697
NCT00170638|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-04-24|||April 2005||2005-04-01|January 2008|2008-01-01|April 2010||2010-04-01|||||Observational|||Tuberculosis Immunity in Children|Tuberculosis Immunity in Children|Completed||N/A|260||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:20:14.733754|2017-02-18 17:20:14.733754
NCT00170625|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-12-13|2016-10-04||June 2004||2004-06-01|December 2016|2016-12-01|September 2010|Actual|2010-09-01|May 2010|Actual|2010-05-01||Interventional|||Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer|Multicenter, Prospective Phase-I/II-study: Topotecan and Carboplatin in the Therapy of Patients With Relapsed Ovarian Cancer|Completed||Phase 1/Phase 2|28|Actual|North Eastern Germany Society of Gynaecologic Oncology||1|||f||||f||||||||No||2017-02-18 17:20:14.814191|2017-02-18 17:20:14.814191
NCT00170612|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-10-20|||November 2005||2005-11-01|October 2008|2008-10-01|August 2008|Actual|2008-08-01|January 2008|Actual|2008-01-01||Interventional|||Pneumococcal Vaccination of Fiji Infants|A Single-Blind Open-Label Randomized Phase II Study of the Safety, Immunogenicity and Impact on Pneumococcus (Pnc) Carriage of the Pnc Vaccination Regimens Combining 1, 2, or 3 Doses of 7-Valent Pneumococcal Conjugate Vaccine (PCV) in the First 4 Months of Life Followed by a Single Dose of 23-Valent Pneumococcal Polysaccharide Vaccine (PPS) at 12 Months of Age|Completed||Phase 2|552|Actual|University of Melbourne||8|||f||||t||||||||||2017-02-18 17:20:15.04753|2017-02-18 17:20:15.04753
NCT00170586|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-26|||September 2003||2003-09-01|March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||Novel Protective Underglove|Novel Protective Underglove|Completed||Phase 2|325||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:20:15.162295|2017-02-18 17:20:15.162295
NCT00170573|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-24|||October 2001||2001-10-01|March 2016|2016-03-01|August 2010|Actual|2010-08-01|April 2009|Actual|2009-04-01||Interventional|||Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer||Completed||Phase 2|82|Actual|North Eastern Germany Society of Gynaecologic Oncology||1|||f||||f||||||||||2017-02-18 17:20:15.241617|2017-02-18 17:20:15.241617
NCT00170560|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-08-26|||October 2001||2001-10-01|October 2007|2007-10-01|February 2007||2007-02-01|||||Observational|||Impact of Gender on Patients|Impact of Gender on Infected Hospitalized Patients|Unknown status|Recruiting|N/A|570||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:20:15.332887|2017-02-18 17:20:15.332887
NCT00170547|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-12-04|||September 2005||2005-09-01|July 2006|2006-07-01|February 2006||2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Comparison of Delivery Routes of Flu Vaccine in Adults|Immunogenicity and Safety of a Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route Compared to an Intramuscular Vaccination With Fluzone(R) in Healthy Adults|Completed||Phase 2|1597|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:20:15.409038|2017-02-18 17:20:15.409038
NCT00170534|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-26|||October 2004||2004-10-01|April 2009|2009-04-01|April 2007||2007-04-01|||||Interventional|||Intervention for Male STDs in India|An Intervention for Male STD Patients in India|Terminated||N/A|1892||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:20:15.548099|2017-02-18 17:20:15.548099
NCT00170521|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-26|||August 2006||2006-08-01|December 2006|2006-12-01|August 2008||2008-08-01|||||Observational|||Mol Epi GrAS in Nicaragua|The Molecular Epidemiology of Streptococcus Pyogenes Among Children in Leon, Nicaragua|Terminated||N/A|13000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:20:15.635387|2017-02-18 17:20:15.635387
NCT00170508|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-08-22|||June 2005||2005-06-01|July 2011|2011-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Young Adult Influenza Vaccine Immunogenicity Substudy|In Depth Immunologic Studies in Healthy Young Adults Who Receive The Standard Dose Fluzone® (15mcgHA/Virus Strain) Trivalent Inactivated Influenza Virus Vaccine|Completed||N/A|15|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:20:15.707772|2017-02-18 17:20:15.707772
NCT00170495|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-08-26|||September 2004||2004-09-01|September 2008|2008-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Acute Viral Respiratory Infections in Elderly|Etiology and Impact of Acute Viral Respiratory Infections in Ambulatory Elderly Populations|Terminated||N/A|3000|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples Without DNA|"~     blood, sputum, nasal and throat swabs~   "|||2017-02-18 17:20:15.786736|2017-02-18 17:20:15.786736
NCT00170482|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-11|||April 2005||2005-04-01|April 2011|2011-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||Elderly Influenza Vaccine Immunogenicity Substudy|In Depth Immunologic Studies in Elderly Subjects Receiving Either Standard-Dose Fluzone (15mcg HA/Virus Strain) or High-Dose (60 Mcg HA/Virus Strain) Trivalent Inactivated Influenza Virus Vaccine|Completed||N/A|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:20:15.869183|2017-02-18 17:20:15.869183
NCT00170469|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-09-12|||March 2005||2005-03-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed|A Phase II, Dose Ranging Multi-Centre, Single Blind, Parallel-Group, Controlled Study of the Safety, Tolerability and Immunogenicity of Recombinant (rPA Based) Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed in a Healthy Population|Completed||Phase 2|226|Actual|PharmAthene UK Limited||3|||f||||t||||||||||2017-02-18 17:20:15.953624|2017-02-18 17:20:15.953624
NCT00170456|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-09-12|||March 2005||2005-03-01|September 2008|2008-09-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Phase II Study of Range and Schedule of rPA Doses|A Double-Blind, Parallel-Group Study of the Safety, Tolerability and Immunogenicity of a Range of Doses and Dosing Schedules of Recombinant (rPA Based) Anthrax Vaccine in Healthy Subjects|Completed||Phase 2|415|Actual|PharmAthene UK Limited||4|||f||||t||||||||||2017-02-18 17:20:16.078573|2017-02-18 17:20:16.078573
NCT00170443|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-11||||||April 2006|2006-04-01|June 2004||2004-06-01|||||Interventional|||Trivalent rHA Dose Escalation Study in Elderly Subjects|A Phase II Evaluation of the Reactogenicity and Immunogenicity of Different Doses of Intramuscular Trivalent Baculovirus-expressed Influenza HA Vaccine in Healthy Elderly Adults|Completed||Phase 2|399|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:20:16.309504|2017-02-18 17:20:16.309504
NCT00170430|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-03-16|||May 2003||2003-05-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Reducing Vaginal Infections in Women|Reducing Vaginal Infections in Women at Risk for HIV-1|Completed||Phase 3|400||University of Washington|||||f||||||||||||||2017-02-18 17:20:16.397653|2017-02-18 17:20:16.397653
NCT00170417|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||December 2000||2000-12-01|December 2000|2000-12-01|May 2003||2003-05-01|||||Interventional|||Clinical Benefit of CBT for Insomnia in Primary Care|Clinical and Health Economic Benefit of Non-Pharmacological Treatment of Chronic Insomnia in Primary Care|Completed||N/A|||NHS Greater Clyde and Glasgow|||||f||||||||||||||2017-02-18 17:20:16.508575|2017-02-18 17:20:16.508575
NCT00170404|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-08-26|||June 2000||2000-06-01|February 2007|2007-02-01|October 2005||2005-10-01|||||Interventional|||TB Nutrition, Immunology and Epidemiology|Nutrition, Immunology, and Epidemiology of Tuberculosis|Completed||Phase 3|887||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:20:16.582805|2017-02-18 17:20:16.582805
NCT00170391|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-09-10|||October 2002||2002-10-01|October 2002|2002-10-01|December 2005||2005-12-01|||||Interventional|||Do People With Insomnia Sleep Better After Psychological Treatment?|Does CBT for Insomnia Improve the PSG Sleep of Patients Treated in Primary Care?|Unknown status|Active, not recruiting|N/A|||NHS Greater Clyde and Glasgow|||||f||||||||||||||2017-02-18 17:20:16.666587|2017-02-18 17:20:16.666587
NCT00170378|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-10-03|||December 2002||2002-12-01|October 2012|2012-10-01|August 2005||2005-08-01|||||Interventional|||The Use of Low Molecular Weight Heparin in Traumatic Brain Injury|The Use of Low Molecular Weight Heparin in Traumatic Brain Injury|Suspended||Phase 4|300||Minneapolis Medical Research Foundation|||||f||||||||||||||2017-02-18 17:20:16.742665|2017-02-18 17:20:16.742665
NCT00170365|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-09-12|||July 2004||2004-07-01|September 2016|2016-09-01|March 2005||2005-03-01|||||Interventional|||Restorative Yoga for Stress Management|Restorative Yoga for Stress Management|Completed||N/A|30||Minneapolis Medical Research Foundation|||||f||||||||||||||2017-02-18 17:20:16.842544|2017-02-18 17:20:16.842544
NCT00170352|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-08-27|||November 2002||2002-11-01|August 2015|2015-08-01|November 2008|Actual|2008-11-01|November 2007|Actual|2007-11-01||Interventional|||Comparison Between Different Types of Oxygen Treatment Following Traumatic Brain Injury|Hyperbaric and Normobaric Oxygen in Severe Brain Injury|Completed||Phase 2|80|Actual|Minneapolis Medical Research Foundation||4|||f||||t||||||||||2017-02-18 17:20:16.926932|2017-02-18 17:20:16.926932
NCT00170339|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-09-12|||April 2005||2005-04-01|September 2016|2016-09-01|April 2007|Actual|2007-04-01|||||Observational|||Bone Density and Serum Testosterone in Male Methadone Maintained Patients|Bone Density and Serum Testosterone in Male Methadone Maintained Patients|Completed||N/A|60||Minneapolis Medical Research Foundation|||||f||||||||||||||2017-02-18 17:20:17.019475|2017-02-18 17:20:17.019475
NCT00170326|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-08|||January 2002||2002-01-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|Prevent-HF||Progressive Ventricular Dysfunction Prevention in Pacemaker Patients|Progressive Ventricular Dysfunction Prevention in Pacemaker Patients|Completed||Phase 4|108|Actual|Medtronic Bakken Research Center||2|||f||||t||||||||||2017-02-18 17:20:17.101743|2017-02-18 17:20:17.101743
NCT00170313|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-02-14|||December 2003||2003-12-01|January 2017|2017-01-01|January 2007|Actual|2007-01-01|||||Interventional|||CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation|Conducted AF-Response Study (Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation Treated With InSync III Marquis)|Terminated||Phase 4|100|Anticipated|Medtronic Bakken Research Center||2||Ventricular rate during AF in CRT-patients much lower than expected|f||||f||||||||No||2017-02-18 17:20:17.209268|2017-02-18 17:20:17.209268
NCT00170300|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-12-29|||January 2001||2001-01-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Care-HF CArdiac Resynchronization in Heart Failure|Outcome Trial (Long Term)to Evaluate the Effects of Cardiac Resynchronization Therapy on the Mortality and Morbidity of Patients With Heart Failure|Completed||N/A|813||Medtronic Bakken Research Center|||||f||||||||||||||2017-02-18 17:20:17.505926|2017-02-18 17:20:17.505926
NCT00170287|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-01-14|||May 2002||2002-05-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|April 2010|Actual|2010-04-01||Interventional|SMS||SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)|Substrate Modification Study in Patients Getting an ICD|Completed||Phase 4|116|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-02-18 17:20:17.592606|2017-02-18 17:20:17.592606
NCT00170027|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-14|||July 2003||2003-07-01|February 2011|2011-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease|Safety and Efficacy of the CMI Magnetocardiograph Model 2409 for Diagnosing Coronary Heart Disease|Completed||Phase 3|250|Actual|Mayo Clinic|||||||||||||||||||2017-02-18 17:20:19.455422|2017-02-18 17:20:19.455422
NCT00170274|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-04-20|||August 2000||2000-08-01|April 2015|2015-04-01|October 2014|Actual|2014-10-01|June 2011|Actual|2011-06-01||Interventional|||APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias|Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias Who Need Cardiac Pacing|Completed||Phase 4|156|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-02-18 17:20:17.698192|2017-02-18 17:20:17.698192
NCT00170261|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-08|||April 2002||2002-04-01|October 2008|2008-10-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic Syncope|Early Loop-Recorder in Suspected Arrhythmogenic Syncope|Completed||Phase 4|100|Anticipated|Medtronic Bakken Research Center|||||f||||||||||||||2017-02-18 17:20:17.804116|2017-02-18 17:20:17.804116
NCT00170248|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-04-07|||October 2006||2006-10-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Computer-Based Decision Support in Managing Asthma in Primary Care|Evaluating the Impact of Computer-Based Decision Support for the Management of Asthma in Primary Care|Completed||N/A|4447|Actual|McGill University||2|||f||||||||||||||2017-02-18 17:20:17.892359|2017-02-18 17:20:17.892359
NCT00170235|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-09-03|||August 2004||2004-08-01|May 2008|2008-05-01|December 2009|Actual|2009-12-01|July 2009|Actual|2009-07-01||Interventional|||Reducing Arm Morbidity in Pre- and Post-breast Cancer Surgery|Reducing Arm Morbidity Through Physical Therapy Provided Pre- and Post-breast Cancer Surgery|Completed||N/A|50|Actual|McGill University||2|||f||||f||||||||||2017-02-18 17:20:18.002701|2017-02-18 17:20:18.002701
NCT00170222|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-09-26|||July 2002||2002-07-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)|The Value of Antibiotic Treatment of Exacerbations of Hospitalised COPD Patients|Completed||Phase 4|258|Anticipated|Medical Center Alkmaar|||||f||||||||||||||2017-02-18 17:20:18.110407|2017-02-18 17:20:18.110407
NCT00170209|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-04-07|||August 2011||2011-08-01|April 2016|2016-04-01|May 2015|Actual|2015-05-01|November 2014|Actual|2014-11-01||Interventional|||Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)|A Randomized Trial to Compare Effectiveness of 4 Months Rifampin (4 RIF) With 9 Months Isoniazid (9 INH) in the Prevention of Active TB in Children: The P4v9 Trial|Completed||Phase 3|844|Actual|McGill University||2|||f||||t||||||||||2017-02-18 17:20:18.204021|2017-02-18 17:20:18.204021
NCT00170196|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-09-26|||August 2005||2005-08-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy Studies of Corticosteroid Therapy in Community-Acquired Pneumonia|The CAPISCE-Trial: Community-Acquired Pneumonia; an Intervention Study With Corticosteroids|Completed||Phase 3|216|Actual|Medical Center Alkmaar||2|||f||||||||||||||2017-02-18 17:20:18.31997|2017-02-18 17:20:18.31997
NCT00170183|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-11-13|||March 2003||2003-03-01|November 2009|2009-11-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure|BNP as Adjuvant Therapy to Preserve Renal Function and Facilitate Diuresis in Hospitalized Patients With Heart Failure|Completed||Phase 3|104|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 17:20:18.414554|2017-02-18 17:20:18.414554
NCT00170170|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-01|||November 2004||2004-11-01|February 2010|2010-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation|Clinical Predictors of Late-onset CMV Disease in Solid Organ Transplant Recipients: A Strategy to Improve the Benefits and Reduce the Risks of Anti-CMV Prophylaxis|Completed||N/A|500|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 17:20:18.516921|2017-02-18 17:20:18.516921
NCT00170157|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-20|2013-05-03||June 2005||2005-06-01|December 2013|2013-12-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||MDX-010 for Advanced Prostate Cancer|A Phase II Immunotherapeutic Trial: Combination Androgen Ablative Therapy and CTLA-4 Blockade as a Treatment for Advanced Prostate Cancer|Completed||Phase 2|112|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 17:20:18.603071|2017-02-18 17:20:18.603071
NCT00170144|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-03-14|||September 2005||2005-09-01|March 2011|2011-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Branched Chain Amino Acids on Muscle|Branched Chain Amino Acids as Stimulant of Muscle Mitochondrial Function in Elderly People|Completed||N/A|40|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 17:20:18.959281|2017-02-18 17:20:18.959281
NCT00170131|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-20|||September 2002||2002-09-01|May 2011|2011-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||MMF Influence on HCV Viral Evolution After Liver Transplantation|The Influence MMF on 5UTR HCV Quasispecies Variation: A Potential Factor in the Natural History of Post-OLT x HCV Infection|Completed||Phase 4|17|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 17:20:19.038483|2017-02-18 17:20:19.038483
NCT00170118|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-01-27|||June 2005||2005-06-01|January 2010|2010-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||"Effects of Motivational Interviewing on Self-Efficacy and Standardized Low Back Pain Outcomes in Patients With Chronic Back Pain"|Effects of Motivational Interviewing on Self-Efficacy and Standardized Low Back Pain Outcomes in Patients With Chronic Back Pain|Completed||N/A|6|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 17:20:19.102189|2017-02-18 17:20:19.102189
NCT00170105|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-02-01|||August 2005||2005-08-01|February 2010|2010-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Posturing Effects on Perception of Time and Perceptions of the Provider-Patient Interaction in the Emergency Department|Posturing Effects on Perception of Time and Perceptions of the Provider-Patient Interaction in the Emergency Department|Completed||Phase 2|244|Actual|Mayo Clinic|||1||f||||t||||||||||2017-02-18 17:20:19.183167|2017-02-18 17:20:19.183167
NCT00170079|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-12-01|||April 2005||2005-04-01|December 2014|2014-12-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Prolonged Smoking Cessation Using Prescription Step Care|Prolonged Smoking Cessation Using Prescription Step Care|Completed||N/A|270|Actual|University of Tennessee||1|||f||||t||||||||||2017-02-18 17:20:19.263351|2017-02-18 17:20:19.263351
NCT00170053|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-07-27|||June 2005||2005-06-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids|Randomized Trial of Thymoglobulin Induction, Initial Tacrolimus, and Mycophenolate Mofetil Therapy With Steroid Avoidance in Primary Kidney Transplant Recipients Followed by Continued Tacrolimus/Mycophenolate Mofetil Therapy vs. Sirolimus/ Mycophenolate Mofetil Therapy|Completed||Phase 1|177|Actual|Mayo Clinic||1|||f||||||||||||||2017-02-18 17:20:19.35808|2017-02-18 17:20:19.35808
NCT00170014|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-14|||October 2004||2004-10-01|February 2011|2011-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Precision of the Magnetocardiographer for Data Aquision and Analysis.|Reproducibility of Magnetocardiography Measurements Using the Cardiomag Magnetocardiograph System Model 2409 and Its Software for Data Acquisition and Analysis|Completed||Phase 3|12|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 17:20:19.540584|2017-02-18 17:20:19.540584
NCT00170001|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-12-13|||April 2005||2005-04-01|December 2011|2011-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy|Which Supraesophageal Reflux Symptoms Reliably Respond to PPI Therapy: A Large Simple Trial|Completed||N/A|500|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 17:20:19.618564|2017-02-18 17:20:19.618564
NCT00169988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-12-16|||March 2004||2004-03-01|October 2007|2007-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms|Sertraline Alone vs. in Combination With Risperidone in the Treatment of Attenuated Positive and Negative Symptoms|Completed||N/A|8|Actual|Northwell Health||2|||f||||t||||||||||2017-02-18 17:20:19.725915|2017-02-18 17:20:19.725915
NCT00169975|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-07-15|||August 2004||2004-08-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.|Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina as Defined by ACC/AHA Guidelines|Completed||Phase 3|137|Actual|Mayo Clinic|||1||f||||f||||||||||2017-02-18 17:20:19.937429|2017-02-18 17:20:19.937429
NCT00169962|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-09|||January 2004||2004-01-01|October 2015|2015-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study of Pulmozyme to Treat Severe Asthma Episodes|Use of Aerosolized rhDNase (Pulmozyme®) in Emergency Department Adults With Refractory Acute Asthma: A Pilot Study|Completed||Phase 2|51|Anticipated|Northwell Health|||||f||||||||||||||2017-02-18 17:20:20.027937|2017-02-18 17:20:20.027937
NCT00169949|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-09-24|||January 2004||2004-01-01|April 2007|2007-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Aripiprazole Treatment of the Prodrome|Open-Label Study of Aripiprazole in Individuals at Risk for Chronic Mental Illness|Terminated||N/A|30||Northwell Health||||The study was terminated due to low enrollment.|f||||t||||||||||2017-02-18 17:20:20.110911|2017-02-18 17:20:20.110911
NCT00169936|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-26|||December 2004||2004-12-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients|Evaluation of Magnetocardiography as a Tool for Non-invasive Detection of Tissue Rejection in Cardiac Transplant Recipients|Completed||Phase 3|6|Actual|Mayo Clinic|||||||||||||||||||2017-02-18 17:20:20.207784|2017-02-18 17:20:20.207784
NCT00169923|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-30|||April 2007||2007-04-01|September 2008|2008-09-01|May 2009|Anticipated|2009-05-01|||||Interventional|Hercules||Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease|Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease|Withdrawn||Phase 2/Phase 3|200|Anticipated|Leiden University Medical Center||2||it was not possible to recruit any patient in the study|f||||t||||||||||2017-02-18 17:20:20.290911|2017-02-18 17:20:20.290911
NCT00169910|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-12-13|||December 2005||2005-12-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients|VIP: Vascular Imaging Project. Prospective Randomized Study on the Effect of AUC-monitored Treatment With Steroids Combined With Either a Calcineurin Inhibitor or Mycophenolate Mofetil on the Progression of Subclinical Cardiovascular Disease in Renal Transplant Recipients.|Completed||Phase 4|119|Actual|Leiden University Medical Center||2|||f||||||||||||||2017-02-18 17:20:20.378265|2017-02-18 17:20:20.378265
NCT00169897|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-11-11|||January 2004||2004-01-01|August 2005|2005-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Pulmonary Rehabilitation at Home Versus at the Gymnasium|Effects of a Home-based Versus a Hospital-based Outpatient Pulmonary Rehabilitation Program in Patients With COPD: a Multicenter, Randomized Trial|Completed||N/A|252|Actual|Laval University||2|||f||||f||||||||||2017-02-18 17:20:20.482826|2017-02-18 17:20:20.482826
NCT00169884|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-01-31|||March 2002||2002-03-01|January 2005|2005-01-01|March 2007||2007-03-01|||||Interventional|||The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients|The Efficacy of a Cognitive-Behavioural Intervention in Deliberate Self-Harm Patients: A Randomized Controlled Trial Among Adolescents and Young Adults|Unknown status|Recruiting|Phase 2|120||Leiden University Medical Center|||||f||||||||||||||2017-02-18 17:20:20.587249|2017-02-18 17:20:20.587249
NCT00169871|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-20|||March 2005||2005-03-01|May 2006|2006-05-01|December 2006|Actual|2006-12-01|||||Observational|||Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia|Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia|Completed||Phase 4|1000||Centre Hospitalier Universitaire de Québec, CHU de Québec|||||f||||||||||||||2017-02-18 17:20:20.676269|2017-02-18 17:20:20.676269
NCT00169858|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-24|||September 1995||1995-09-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Interventional|||Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections|Open Randomised Clinical Study of the Long Term Immunogenicity of Engerix-B in 10 Year Old Children and of the Effect of Booster Injections Given 5, 10 or 15 Years After Primary Vaccination|Completed||Phase 4|1129|Actual|Laval University||1|||f||||f||||||||||2017-02-18 17:20:20.753187|2017-02-18 17:20:20.753187
NCT00169845|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-10-17|||October 1994||1994-10-01|October 2016|2016-10-01|December 2020|Anticipated|2020-12-01|June 2003|Actual|2003-06-01||Interventional|||Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients|Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients|Active, not recruiting||Phase 3|540|Actual|Laval University||2|||f||||t||||||||Yes|A letter was sent to each participant.|2017-02-18 17:20:21.038621|2017-02-18 17:20:21.038621
NCT00169832|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-09|||June 2003||2003-06-01|October 2008|2008-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|VICTORY||Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial|A Multicenter Randomized Double-Blind Trial Comparing Rosiglitazone to Placebo for the Prevention of Atherosclerosis Progression After Coronary Bypass Surgery in Diabetic Patients|Completed||Phase 3|193|Actual|Laval University||2|||f||||t||||||||||2017-02-18 17:20:21.155401|2017-02-18 17:20:21.155401
NCT00169819|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-02-23|||October 2003||2003-10-01|February 2007|2007-02-01|April 2006||2006-04-01|||||Interventional|||EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study|A Randomized Trial Comparing Same Day Discharge and a Single Bolus of Abciximab to Overnight Hospitalization and Bolus + Perfusion Abciximab After Uncomplicated Trans-Radial Coronary Artery Stenting|Completed||Phase 4|1000||Laval University|||||f||||t||||||||||2017-02-18 17:20:21.282331|2017-02-18 17:20:21.282331
NCT00169806|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-02-14|||November 1998||1998-11-01|August 2016|2016-08-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Interventional|||Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis|Randall's Plaques: Pathogenesis and Relationship to Nephrolithiasis|Recruiting||N/A|400|Anticipated|Indiana Kidney Stone Institute||1|||f||||t||||||||||2017-02-18 17:20:21.390844|2017-02-18 17:20:21.390844
NCT00169793|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-03-04|||August 2005||2005-08-01|March 2014|2014-03-01|December 2012|Actual|2012-12-01|December 2009|Actual|2009-12-01||Interventional|||Nephrolithiasis and Bariatric Surgery|Nephrolithiasis and Bariatric Surgery|Completed||N/A|89|Actual|Indiana Kidney Stone Institute||1|||f||||f||||||||||2017-02-18 17:20:21.50534|2017-02-18 17:20:21.50534
NCT00169780|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-12-05|||July 2002||2002-07-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Kidney Stone Structural Analysis By Helical Computed Tomography (CT)|Kidney Stone Structural Analysis by Helical Computed Tomography (A Pilot Study)|Completed||N/A|7|Actual|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-02-18 17:20:21.614608|2017-02-18 17:20:21.614608
NCT00169767|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-04-23|||May 2005||2005-05-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate|Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate: A Randomized Comparison Study|Terminated||N/A|18|Actual|Indiana Kidney Stone Institute|||1|Poor enrollment|f||||f||||||||||2017-02-18 17:20:21.725617|2017-02-18 17:20:21.725617
NCT00169754|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-09-16|||April 2005||2005-04-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Attached Stone Project: Do Calcium Oxalate Renal Calculi Originate From Randall's Plaque?|Do Calcium Oxalate Renal Calculi Originate From Randall's Plaque?|Completed||N/A|32|Actual|Indiana Kidney Stone Institute||1|||f||||f||||||||||2017-02-18 17:20:21.833144|2017-02-18 17:20:21.833144
NCT00169741|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-02-22|||May 2005||2005-05-01|February 2016|2016-02-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC|Alterations in Renal Blood Flow as a Consequence of Percutaneous Nephrolithotomy (PERC)|Completed||N/A|4|Actual|Indiana Kidney Stone Institute||1|||f||||f||||||||||2017-02-18 17:20:21.94346|2017-02-18 17:20:21.94346
NCT00169728|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-06-06|||September 2003||2003-09-01|June 2012|2012-06-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Interventional|||Vaccination of Children Following Allogeneic Stem Cell Transplantation|Immunogenicity of the DTaP-IPV-HBV/Hib Combination Vaccine Infanrix Hexa and the Heptavalent Pneumococcal Conjugate Vaccine Prevenar in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplantation|Completed||Phase 3|53|Actual|Heinrich-Heine University, Duesseldorf||1|||f||||||||||||||2017-02-18 17:20:22.05576|2017-02-18 17:20:22.05576
NCT00169715|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-09-16|||February 2003||2003-02-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Database and Registry for Renal Diverticulum|Percutaneous Surgical Outcomes and Metabolic Findings in Patients With Stone-Bearing Calicial Diverticula|Completed||N/A|86|Actual|Indiana Kidney Stone Institute||1|||f||||f||||||||||2017-02-18 17:20:22.165083|2017-02-18 17:20:22.165083
NCT00169702|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-01-28|||June 2003||2003-06-01|April 2007|2007-04-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effect of a Weight Management Program During Treatment With Olanzapine|The Effect of a Weight Management Program to Prevent Weight Gain and Metabolic Abnormalities During Treatment With the Atypical Neuroleptic Olanzapine: A Randomised Study|Completed||N/A|100|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||f||||||||||2017-02-18 17:20:22.281845|2017-02-18 17:20:22.281845
NCT00169689|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-01-28|||June 2003||2003-06-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|||||Interventional|||Repetitive Transcranial Magnetic Stimulation|Therapeutic and Biological Effects of High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia|Completed||N/A|40|Actual|Heinrich-Heine University, Duesseldorf||1|||f||||f||||||||||2017-02-18 17:20:22.400128|2017-02-18 17:20:22.400128
NCT00169676|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-06-28|||June 2003||2003-06-01|September 2008|2008-09-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Observational|||Registry and Database Lap Prostatectomy|Laparoscopic Radical Prostatectomy: A Registry and Database|Completed||N/A|9|Actual|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-02-18 17:20:22.53009|2017-02-18 17:20:22.53009
NCT00169663|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-04-23|||July 2003||2003-07-01|April 2012|2012-04-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Observational|||Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings|Brushite Stones: A Registry and Database of Clinical and Laboratory Findings|Completed||N/A|90|Actual|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-02-18 17:20:22.639449|2017-02-18 17:20:22.639449
NCT00169650|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-02-14|||July 2003||2003-07-01|February 2017|2017-02-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Observational|||Laparoscopic Pyeloplasty Registry and Database|Laparoscopic Pyeloplasty: A Registry and Database|Completed||N/A|64|Actual|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-02-18 17:20:22.734428|2017-02-18 17:20:22.734428
NCT00169637|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-30|||June 2006||2006-06-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|||||Interventional|||Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome|Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome|Completed||Phase 3|14|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-02-18 17:20:22.837692|2017-02-18 17:20:22.837692
NCT00169624|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-10-04|||October 2005||2005-10-01|October 2007|2007-10-01||||||||Interventional|||Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin|The DIAMET Study: Peripheral and Coronary Endothelial Dysfunction in Type 2diabetic Patients- Evaluation of Reversibility Following 3 Months of Metformin Treatment|Terminated||Phase 3|30||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:20:22.929425|2017-02-18 17:20:22.929425
NCT00169065|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2015-04-06|||August 1998||1998-08-01|April 2015|2015-04-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|COES||Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia|Clozapine vs. Olanzapine: An Effectiveness Study|Completed||Phase 4|38|Actual|Harvard Medical School||2|||f||||t||||||||||2017-02-18 17:20:27.927205|2017-02-18 17:20:27.927205
NCT00169611|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-01-26|||January 2004||2004-01-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate|Comportemental and Neuropsychologic Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate. A Double-blind Randomised Study Methylphenidate Versus Placebo|Completed||Phase 4|80|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:20:23.017261|2017-02-18 17:20:23.017261
NCT00169598|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-26|||February 2002||2002-02-01|April 2007|2007-04-01||||||||Interventional|TEPELY||Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study|Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study|Unknown status|Active, not recruiting|N/A|80||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:20:23.115893|2017-02-18 17:20:23.115893
NCT00169585|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-28|||March 2005||2005-03-01|April 2011|2011-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)|A National, Multicentric, Randomised, Controlled Trial. Applications of a Critical Pathway Using Levofloxacin for the Management of Patients With Abnormal PSA.|Completed||Phase 3|240|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:20:23.201713|2017-02-18 17:20:23.201713
NCT00169572|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-05-06|||February 2005||2005-02-01|May 2010|2010-05-01||||||||Interventional|||Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy|See Detailed Description|Completed||Phase 2|492||GlaxoSmithKline||1|||f||||||||||||||2017-02-18 17:20:23.317525|2017-02-18 17:20:23.317525
NCT00169559|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-10-18|||November 2003||2003-11-01|October 2012|2012-10-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||"Dyslipidemia Study Investigating The Increase In Good Cholesterol"|A Multi-center, Three-staged, Randomized, Parallel Group, Sequential, Double-blind, fenofibrate-and Placebo-controlled Dose-response Evaluation of the Safety, Tolerability, and Effects on Plasma HDLc and TG of Eight Weeks Treatment With 1µg to 20µg Daily Doses of GW590735 in Otherwise Healthy Subjects With Low HDLc, Mildly to Moderately Elevated TG, and Normal LDLc|Completed||Phase 2|250|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 17:20:23.478813|2017-02-18 17:20:23.478813
NCT00169546|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-09-13|||January 2003||2003-01-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.|Randomised, Double-blind Parallel Group Study to Assess the Bronchodilative and Bronchoprotective Properties of SERETIDE DISKUS ® Inhlaer 50/100mcg Twice Daily vs. FLIXOTIDE® Inhaler 200mcg Twice Daily.|Completed||Phase 4|64|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:20:23.631108|2017-02-18 17:20:23.631108
NCT00169533|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-21|||August 2004||2004-08-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Rollover Study Of Lapatinib In Cancer Patients|An Open Label, Phase 1b Rollover Study to Assess the Long-Term Safety Profile of Lapatinib (GW572016) in Cancer Patients.|Completed||Phase 1|31|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 17:20:23.735359|2017-02-18 17:20:23.735359
NCT00169520|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-10-15|||June 2004||2004-06-01|October 2008|2008-10-01||||||||Interventional|||SB-715992 In Combination With Docetaxel In Patients With Solid Tumors|A Phase I, Open-Label Study of SB-715992 in Combination With Docetaxel in Patients With Advanced Solid Tumors.|Completed||Phase 1|30|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:20:23.842004|2017-02-18 17:20:23.842004
NCT00169507|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-12-08|||March 2005||2005-03-01|December 2015|2015-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23)|Phase III Multicentric Open Study to Evaluate Immunological Memory Induced by 3-dose Primary Vaccination Followed by Booster Dose of GSK Biologicals' 11-valent Conjugate Pneumococcal Vaccine Compared to Unprimed Subjects by Giving 1 Dose of Aventis Pasteur's Pneumo 23|Completed||Phase 3|100||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:20:23.940177|2017-02-18 17:20:23.940177
NCT00169494|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-09|||September 2004||2004-09-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18|Immunogenicity: 3 Consecutive Lots of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly at 0,1,6 Month Schedule in Healthy Females Aged 10-25 Years and Demonstrate Non-inferiority of Candidate HPV Vaccine Manufactured by Modified Production Process|Completed||Phase 3|770|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:20:24.146163|2017-02-18 17:20:24.146163
NCT00169481|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2017-01-09|||October 2004||2004-10-01|January 2017|2017-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine|A Randomized, Controlled, Phase II Study to Evaluate the Safety and Immunogenicity of Different Formulations of GlaxoSmithKline Biologicals' 11-valent Pneumococcal Conjugate Vaccine, When Administered Intramuscularly as a 3-dose Primary Immunization (2-3-4 Month Schedule) Before 6 Months of Age|Completed||Phase 2|689|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:20:24.249235|2017-02-18 17:20:24.249235
NCT00169468|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-05-26|||January 2005||2005-01-01|May 2009|2009-05-01|August 2011|Anticipated|2011-08-01|||||Interventional|||Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma|Phase II Study of the Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|48||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:20:24.408713|2017-02-18 17:20:24.408713
NCT00169052|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2013-09-06|||September 2001||2001-09-01|September 2001|2001-09-01|August 2006||2006-08-01|||||Interventional|||Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People|Rehabilitation and Health Care for Elderly With SMI|Completed||N/A|180||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 17:20:28.042476|2017-02-18 17:20:28.042476
NCT00169455|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-13|||March 2005||2005-03-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants|A Phase IIIb, Partially Blind, Randomized, Placebo-controlled Study to Asses the Effect on Immunogenicity of Administration of Vaccine Without Buffering Agent and to Assess Heat Stability in Terms of Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Following a 0, 2 Month Schedule, in Healthy Infants Previously Uninfected With Human Rotavirus|Completed||Phase 3|450|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:20:24.51183|2017-02-18 17:20:24.51183
NCT00169442|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-09-22|||February 2005||2005-02-01|September 2016|2016-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants|Immune Memory of GSK's DTPw-HBV/Hib Vaccine by Giving Plain PRP Polysaccharide at 10 Mths. Immuno & Reacto of a Booster Dose of DTPw-HBV/Hib or DTPw-HBV or DTPw-HBV+Hib at 15-18 Mths in Infants Previously Primed With DTPw-HBV/Hib|Completed||Phase 3|732|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:20:24.621599|2017-02-18 17:20:24.621599
NCT00169416|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-04-14|||March 2005||2005-03-01|April 2015|2015-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Evaluation Of Valaciclovir In Patients With Chickenpox|Clinical Evaluation of Valaciclovir Hydrochloride: 256U87 in Patients With Chickenpox - Open Uncontrolled Study.|Completed||Phase 3|43|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 17:20:24.912625|2017-02-18 17:20:24.912625
NCT00169403|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-28||||||September 2005|2005-09-01||||||||Interventional|||Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia||Unknown status|Recruiting|Phase 3|||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-02-18 17:20:25.009254|2017-02-18 17:20:25.009254
NCT00169390|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-03-17|||March 2004||2004-03-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Monoamine Oxidases in Smoking Pregnant Women and Newborns|Comparison of Monoamines Oxidases A and B Activities and the Metabolism of Nicotine in Smoking and Nonsmoking Pregnant Women and in Their Newborns. Evaluation of Their Effects on the Newborns' Behavior|Completed||N/A|59|Actual|Groupe Hospitalier Pitie-Salpetriere|||2||f||||f||||||Samples Without DNA|"~     plasma DHPG, HVA, 5HIAA, 5HT, cotinine~   "|||2017-02-18 17:20:25.121908|2017-02-18 17:20:25.121908
NCT00169377|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-07-22|||October 2005||2005-10-01|July 2008|2008-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD)|Study of the Effects of High Frequency Stimulation of the Subthalamic Stimulation in the Treatment of Severe Obsessive-Compulsive Disorders|Completed||Phase 1/Phase 2|16|Actual|Groupe Hospitalier Pitie-Salpetriere||2|||f||||t||||||||||2017-02-18 17:20:25.220052|2017-02-18 17:20:25.220052
NCT00169364|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-28|||May 2002||2002-05-01|September 2005|2005-09-01||||||||Interventional|||Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin Mutation|Comparison of Clinical, Molecular and Metabolic Characteristics of PD Patients With and Without Parkin Mutation|Unknown status|Recruiting|N/A|50|Anticipated|Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-02-18 17:20:25.331301|2017-02-18 17:20:25.331301
NCT00169351|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12||||||September 2005|2005-09-01||||||||Observational|||National Gilles De La Tourette Study Group||Unknown status|Recruiting|N/A|||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-02-18 17:20:25.417154|2017-02-18 17:20:25.417154
NCT00169338|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-09-14|||September 2005||2005-09-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia||Completed||Phase 2|13|Actual|Groupe Hospitalier Pitie-Salpetriere||2|||f||||||||||||||2017-02-18 17:20:25.495946|2017-02-18 17:20:25.495946
NCT00169325|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-09-11|||September 2005||2005-09-01|September 2015|2015-09-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions||Completed||N/A|11|Actual|Groupe Hospitalier Pitie-Salpetriere|||1||f||||||||||||||2017-02-18 17:20:25.60583|2017-02-18 17:20:25.60583
NCT00169312|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-09-19|||August 2005||2005-08-01|September 2009|2009-09-01|June 2007||2007-06-01|||||Interventional|||Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations|The HMO Cancer Research Network (CRN) - Making Effective Nutritional Choices for Cancer Prevention: The MENU Study|Unknown status|Active, not recruiting|N/A|2619|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:20:25.696095|2017-02-18 17:20:25.696095
NCT00169299|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||June 2001||2001-06-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||Herbal Alternatives for Menopause Symptoms (HALT Study)|Herbal Alternatives for Menopause Symptoms: A Randomized Trial|Unknown status|Active, not recruiting|Phase 4|351||Group Health Cooperative|||||f||||||||||||||2017-02-18 17:20:25.803826|2017-02-18 17:20:25.803826
NCT00169286|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-03-31|||July 2003||2003-07-01|March 2014|2014-03-01|June 2005||2005-06-01|||||Interventional|||Organized Self-management Support for Chronic Depression|Organized Self-management Support for Chronic Depression|Completed||N/A|104||Group Health Cooperative|||||f||||||||||||||2017-02-18 17:20:25.910578|2017-02-18 17:20:25.910578
NCT00169273|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-09-10|||April 2004||2004-04-01|September 2009|2009-09-01|April 2007|Actual|2007-04-01|February 2007|Actual|2007-02-01||Interventional|||Epidemiology and Care of Comorbid Obesity and Depression|Epidemiology and Care of Comorbid Obesity and Depression|Completed||N/A|192|Actual|Group Health Cooperative||2|||f||||t||||||||||2017-02-18 17:20:26.008548|2017-02-18 17:20:26.008548
NCT00169260|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-12-27|||February 2005||2005-02-01|December 2010|2010-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Proactive Health Intervention for Tobacco Users (Get PHIT)|Proactive Cessation Intervention With Biomarker Feedback|Completed||Phase 2/Phase 3|536|Actual|Group Health Cooperative||2|||f||||f||||||||||2017-02-18 17:20:26.112797|2017-02-18 17:20:26.112797
NCT00169039|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2015-04-06|||December 1994||1994-12-01|April 2015|2015-04-01|February 2002||2002-02-01|||||Interventional|||Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia|Clozapine Response and Biogenic Amines in Schizophrenia|Terminated||Phase 4|66||Harvard Medical School|||||f||||||||||||||2017-02-18 17:20:28.136433|2017-02-18 17:20:28.136433
NCT00169247|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-06-23|||October 2005||2005-10-01|June 2011|2011-06-01||||April 2011|Actual|2011-04-01||Interventional|||Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation|Larynx Preservation With Induction Chemotherapy (Cisplatin, 5FU, Docetaxel) Followed by Radiotherapy Combined With Either Cisplatin or Cetuximab in Laryngopharyngeal Squamous Cell Carcinoma - A Randomised Phase II Study|Completed||Phase 2|156|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou|||||f||||||||||||||2017-02-18 17:20:26.218755|2017-02-18 17:20:26.218755
NCT00169234|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-02-25|||May 2003||2003-05-01|February 2014|2014-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Pneumococcal Adult-dose Ranging Immunization Study|Immunogenicity and Safety of Varying Doses of a 7-valent Conjugate Pneumococcal Vaccine in Adults 70-79 Years of Age Who Were Previously Vaccinated With the 23-valent Pneumococcal Polysaccharide Vaccine|Completed||Phase 1/Phase 2|220|Actual|Group Health Cooperative||5|||f||||t||||||||||2017-02-18 17:20:26.332428|2017-02-18 17:20:26.332428
NCT00169221|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-11-14|||September 2005||2005-09-01|November 2011|2011-11-01|July 2011|Actual|2011-07-01|July 2009|Actual|2009-07-01||Interventional|||Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas|CARISSA Trial - Multicenter Randomized Phase II Trial Comparing Post-operative Radiotherapy and Cisplatin Alone or in Combination With the EGFR Inhibitor ZD 1839 (Iressa) in Upper Aerodigestive Tract Carcinomas|Terminated||Phase 2|54|Actual|Groupe Oncologie Radiotherapie Tete et Cou||2||"Toxicity in an independent study IMEX. The trial was subsequently terminated (54 pts instead~   of 140) despite safety analyses showing no excess of toxicity"|f||||||||||||||2017-02-18 17:20:26.474346|2017-02-18 17:20:26.474346
NCT00169208|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-09|||April 2001||2001-04-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma|An Open Label, Multicenter, Non Randomized Phase II Study to Evaluate Anti-Tumor Activity and Safety of a Combination of Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma.|Completed||Phase 2|50||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:20:26.584399|2017-02-18 17:20:26.584399
NCT00169195|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-09-01|||April 2003||2003-04-01|September 2015|2015-09-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma|Gemcitabine-oxaliplatin Plus Rituximab (R-GEMOX) in Refractory/Relapsed Patients With CD 20 Positive Diffuse Large B-cell Lymphoma, Non Eligible for High-dose Chemotherapy Followed by Autotransplantation|Completed||Phase 2|49|Actual|Lymphoma Study Association||1|||f||||||||||||||2017-02-18 17:20:26.723505|2017-02-18 17:20:26.723505
NCT00169182|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||December 2000||2000-12-01|September 2005|2005-09-01||||||||Interventional|||Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma|Randomized Study Comparing Induction Chemotherapy With Docetaxel, Cisplatin, 5FU Versus Cisplatin, 5 FU in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma|Completed||Phase 3|220||Groupe Oncologie Radiotherapie Tete et Cou|||||f||||||||||||||2017-02-18 17:20:26.843577|2017-02-18 17:20:26.843577
NCT00169169|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||October 1999||1999-10-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma|Randomised Phase 3 Study of Rituximab in High-Risk Patients With Diffuse Large B-Cell Lymphoma Who Received a First-Line Consolidative Chemotherapy With Autologous Stem Cell Transplant (ASCT).|Terminated||Phase 3|430||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:20:26.939788|2017-02-18 17:20:26.939788
NCT00169156|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-29|||September 2005||2005-09-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|||||Interventional|||A Phase II Study of Rituximab Combined With CHOP in T-Cell Angio-Immunoblastic Lymphoma|Study of the Efficacy and the Safety of First Line Treatment With CHOP Plus Rituximab (R-CHOP) in Patients Aged 60 to 80 Years With Previously Untreated T-Cell Angioimmunoblastic Lymphoma (AIL).|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|Lymphoma Study Association||1|||f||||||||||||||2017-02-18 17:20:27.044568|2017-02-18 17:20:27.044568
NCT00169143|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-09-06|||May 2004||2004-05-01|September 2006|2006-09-01|January 2007||2007-01-01|||||Interventional|||Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma|Study of R-ACVBP Regimen Supported by Pegfilgrastim in Previously Untreated Patients Aged From 18 to 60 Years With High-Risk Diffuse Large B-Cell Lymphoma (Age-Adjusted Ipi >or= 2)|Completed||Phase 2|60||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:20:27.154202|2017-02-18 17:20:27.154202
NCT00169130|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-07-12|||October 1999||1999-10-01|July 2007|2007-07-01||||||||Interventional|||ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma|Prospective Study of ACVBP Followed by Autologous Stem Cell Transplantation in Case of BCL-2 Overexpression in Non Previously Treated Patients Aged 60 Years or Less With Low-Intermediate Risk Diffuse Large B-Cell Lymphoma|Completed||Phase 2/Phase 3|300||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:20:27.26704|2017-02-18 17:20:27.26704
NCT00169117|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2017-01-11|||June 2002||2002-06-01|January 2017|2017-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||A Stitch in Time May Save Lives: Turning Poor Bednets Into Good Ones|A Stitch in Time May Save Lives: Turning Poor Bednets Into Good Ones|Completed||N/A|772|Actual|London School of Hygiene and Tropical Medicine||1|||f||||f||||||||||2017-02-18 17:20:27.365961|2017-02-18 17:20:27.365961
NCT00169104|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-10-19|||July 2002||2002-07-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function|A Phase II Trial of Trastuzumab, Neupogen, and Vinorelbine Investigating the Effects on Immune Function and Clinical Outcomes in Patients With Metastatic Breast Cancer Overexpressing Her-2/Neu|Terminated||Phase 2/Phase 3|23|Actual|Dartmouth-Hitchcock Medical Center||2||Closed due to achievement of primary study endpoint|f||||t||||||||||2017-02-18 17:20:27.477986|2017-02-18 17:20:27.477986
NCT00169091|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2015-04-06|||March 1996||1996-03-01|April 2015|2015-04-01|October 2003||2003-10-01|September 2003|Actual|2003-09-01||Interventional|||Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia|Clozapine or Haloperidol in First Episode Schizophrenia|Terminated||Phase 4|32|Actual|Harvard Medical School||2|||f||||||||||||||2017-02-18 17:20:27.597493|2017-02-18 17:20:27.597493
NCT00169078|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-11|||July 2002||2002-07-01|January 2017|2017-01-01|December 2002||2002-12-01|||||Interventional|||Impact of Insecticide-treated Curtains on Antimalarial Drug Resistance|A Study of the Impact of Insecticide-treated Curtains on the Prevalence of Antimalarial Drug Resistance in Children With Uncomplicated Malaria in Burkina Faso|Completed||N/A|1035||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:20:27.816756|2017-02-18 17:20:27.816756
NCT00169000|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-08-04|||January 2003||2003-01-01|August 2009|2009-08-01|March 2006|Actual|2006-03-01|September 2005|Actual|2005-09-01||Interventional|||Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers|Phase I Study of a Novel Schedule of Capecitabine and Docetaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|12|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 17:20:28.432847|2017-02-18 17:20:28.432847
NCT00168987|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-05-05|||January 2005||2005-01-01|May 2008|2008-05-01|June 2007|Actual|2007-06-01|November 2006|Actual|2006-11-01||Interventional|||Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors|Pilot Study: Randomized Controlled Trial on the Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors|Completed||Phase 4|30|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:20:28.538973|2017-02-18 17:20:28.538973
NCT00168974|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-11-15|||January 2004||2004-01-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Observational|||Neuropathic Pain and Fabry Disease|Somatosensoric and Autonomic Disturbances in Female Patients With Fabry Disease|Completed||N/A|25||Danish Pain Research Center|||||f||||||||||||||2017-02-18 17:20:28.623441|2017-02-18 17:20:28.623441
NCT00168961|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-06|||December 2003||2003-12-01|September 2005|2005-09-01|June 2007|Actual|2007-06-01|December 2006|Actual|2006-12-01||Interventional|||Enteral Nutrition in Liver Cirrhosis||Completed||Phase 4|||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:20:28.687522|2017-02-18 17:20:28.687522
NCT00168948|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-11-01|||March 2003||2003-03-01|February 2003|2003-02-01|August 2005||2005-08-01|||||Interventional|||Intermittent Antimalaria Treatment With SP in African Children|Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children: A Randomised, Double Blind, and Placebo-Controlled Clinical Trial|Unknown status|Active, not recruiting|Phase 4|1200||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:20:28.76646|2017-02-18 17:20:28.76646
NCT00168935|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-05-06|||March 2004||2004-03-01|September 2005|2005-09-01|December 2008|Actual|2008-12-01|August 2007|Actual|2007-08-01||Interventional|||Malnutrition in Gastroenterology Patients||Completed||Phase 4|||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:20:28.86478|2017-02-18 17:20:28.86478
NCT00168922|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-04-27|||February 2001||2001-02-01|January 2001|2001-01-01|December 2006||2006-12-01|||||Interventional|||Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)|Phase II Study to Determine the Efficacy of Bendamustin (Ribomustin) in Patients With Recurrent Small Cell Bronchial Carcinoma After Cytostatic Polychemotherapy|Unknown status|Recruiting|Phase 2|50||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:20:28.938442|2017-02-18 17:20:28.938442
NCT00168909|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-05-08|||June 2003||2003-06-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|July 2007|Actual|2007-07-01||Interventional|||Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)|Influence of Alfacalcidol on Falls in Elderly Postmenopausal, Alendronate-Treated, Osteopenic/Osteoporotic Women With High Risk of Falls|Completed||Phase 4|282|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 17:20:29.021845|2017-02-18 17:20:29.021845
NCT00168896|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-02-13|||October 2001||2001-10-01|September 2001|2001-09-01|December 2006||2006-12-01|||||Interventional|||A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage|A Randomised Phase II/III Study to Compare the Combination of Carboplatin Plus Irinotecan Vs. the Combination of Carboplatin Plus Etoposide for SCLC in Extensive Disease Stage|Unknown status|Recruiting|Phase 2/Phase 3|286||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:20:29.122163|2017-02-18 17:20:29.122163
NCT00168883|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-10-31|||October 2002||2002-10-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||Study for Patients With Non Small Cell Lung Cancer (NSCLC)|Randomized Phase II Study to Determine the Efficacy of a Three Weekly vs. Weekly Therapy With Paclitaxel Plus Carboplatin vs. Paclitaxel Plus Vinorelbine for Patients With Non Small Cell Lung Cancer According to UICC Stage IIIB and IV|Unknown status|Recruiting|Phase 2|80||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:20:29.210527|2017-02-18 17:20:29.210527
NCT00168870|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-08-30|||February 2003||2003-02-01|September 2006|2006-09-01||||||||Interventional|||Study of Metastatic Ocular Melanoma|Randomized Phase II Study to Compare a Combination Therapy With Gemcitabine and Treosulfan Versus a Monotherapy as First-Line Chemotherapy for Patients With Metastatic Ocular Melanoma|Unknown status|Recruiting|Phase 2|48|Anticipated|Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:20:29.303844|2017-02-18 17:20:29.303844
NCT00168857|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-04|||July 2003||2003-07-01|November 2013|2013-11-01||||June 2006|Actual|2006-06-01||Interventional|||A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)|A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare MICARDIS® (Telmisartan) 80 mg Versus COZAAR® (Losartan) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)|Completed||Phase 4|860|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:20:29.39836|2017-02-18 17:20:29.39836
NCT00168844|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-15|2009-01-30||January 2003||2003-01-01|September 2013|2013-09-01||||June 2005|Actual|2005-06-01||Interventional|||Tiotropium / Respimat One-Year Study|A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Comparison of One-Year Treatment of Two Doses (5mg and 10mg) of Tiotropium Inhalation Solution Delivered by the Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|983|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 17:20:32.494093|2017-02-18 17:20:32.494093
NCT00168831|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-15|2009-01-30||February 2003||2003-02-01|September 2013|2013-09-01||||June 2005|Actual|2005-06-01||Interventional|||Tiotropium / Respimat One-Year Study|A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Comparison of One-Year Treatment of Two Doses (5mg and 10mg) of Tiotropium Inhalation Solution Delivered by the Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|1007|Actual|Boehringer Ingelheim||3|||||||||||||||||2017-02-18 17:20:35.535291|2017-02-18 17:20:35.535291
NCT00168636|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-14|||November 2004||2004-11-01|November 2013|2013-11-01||||November 2013|Actual|2013-11-01||Interventional|||Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality|The Impact of Different Doses of Vitamin A Supplementation on Male and Female Childhood Morbidity and Mortality|Completed||Phase 4|11000||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:43.741966|2017-02-18 17:20:43.741966
NCT00168818|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-08|2010-11-18||November 2004||2004-11-01|February 2014|2014-02-01||||July 2006|Actual|2006-07-01||Interventional|||Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery|A Phase III Randomised, Parallel Group, Double-blind, Active Controlled Study to Investigate the Efficacy and Safety of Two Different Dose Regimens of Orally Administered Dabigatran Etexilate Capsules [150 or 220 mg Once Daily Starting With Half Dose (75 or 110 mg) on the Day of Surgery] Compared to Subcutaneous Enoxaparin 40 mg Once Daily for 28-35 Days, in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip Replacement Surgery. RE-NOVATE (Extended Thromboembolism Prevention After Hip Surgery)|Completed||Phase 3|3494|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 17:20:38.381629|2017-02-18 17:20:38.381629
NCT00168805|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-05-08|2010-11-18||November 2004||2004-11-01|February 2014|2014-02-01||||May 2006|Actual|2006-05-01||Interventional|||RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery|RE-MODEL (Thromboembolism Prevention After Knee Surgery). Two Different Dose Regimens of Orally Administered Dabigatran Etexilate Capsules [150 or 220 mg Once Daily Starting With a Half Dose (i.e.75 or 110 mg) on the Day of Surgery] Compared to Subcutaneous Enoxaparin 40 mg Once Daily for 6-10 Days|Completed||Phase 3|2101|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 17:20:40.364644|2017-02-18 17:20:40.364644
NCT00168792|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-10-28|||November 2003||2003-11-01|October 2013|2013-10-01||||July 2006||2006-07-01||Interventional|||A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)|A Phase IIIb - IV, Randomised, Open Label Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early PCI as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction. ASSENT 4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction.)|Terminated||Phase 4|1671||Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:20:41.783226|2017-02-18 17:20:41.783226
NCT00168779|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-31|||September 2005||2005-09-01|October 2013|2013-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension|A Randomized, Double-blind, Placebo-controlled, Forced-titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg Taken Orally for Eight Weeks in Patients With Stage 1 or Stage 2 Hypertension.|Completed||Phase 4|1185||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:20:42.062118|2017-02-18 17:20:42.062118
NCT00168766|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-09-12|||January 2003||2003-01-01|April 2011|2011-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS|A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Investigating Methylprednisolone in Combination With Interferon-beta-1a for the Treatment of Patients With Relapsing-remitting Multiple Sclerosis|Completed||Phase 4|345|Actual|Biogen||2|||f||||f||||||||||2017-02-18 17:20:42.43329|2017-02-18 17:20:42.43329
NCT00168753|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-09-05|||July 2004||2004-07-01|September 2014|2014-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Community Based Trial for AMEVIVE®|An Open-Label Community-Based Study to Determine the Safety and Efficacy of an Extended Course of Alefacept, Following a Standard 12-Week Course of Amevive®, With Commonly Used Clinical Assessment Tools|Completed||Phase 4|114|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 17:20:42.547819|2017-02-18 17:20:42.547819
NCT00168740|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||April 1995||1995-04-01|September 2005|2005-09-01||||||||Interventional|||Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)|Pivotal Phase III Multi-Center Study to Evaluate the Safety and Efficacy of Once Weekly Times Four Dosing of IDEC-C2B8 (IDEC-102) in Patients With Relapsed Low-Grade or Follicular B-Cell Lymphoma|Completed||Phase 3|150||Biogen|||||||||||||||||||2017-02-18 17:20:42.697208|2017-02-18 17:20:42.697208
NCT00168727|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-18|||June 2003||2003-06-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma|Zevalin® (Ibritumomab Tiuxetan) Followed by Rituxan® (Rituximab) Maintenance in Previously Treated Low Grade Non-Hodgkin’s Lymphoma|Completed||Phase 4|12||Biogen|||||f||||||||||||||2017-02-18 17:20:43.012281|2017-02-18 17:20:43.012281
NCT00168714|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-06-06|||February 2004||2004-02-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Observational|||Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)|Avonex Pregnancy Exposure Registry|Completed||N/A|329|Actual|Biogen|||1||f||||t||||||||||2017-02-18 17:20:43.12435|2017-02-18 17:20:43.12435
NCT00168701|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-11-14|||October 2004||2004-10-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy and Safety of BG00012 in MS|Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy and Safety of BG00012 in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|260||Biogen|||||f||||||||||||||2017-02-18 17:20:43.237536|2017-02-18 17:20:43.237536
NCT00168688|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-15|||January 2001||2001-01-01|November 2013|2013-11-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Prenatal Multi-micronutrient Supplementation and Pregnancy Outcome|The Effects of Prenatal Multi-micronutrient Supplements on Pregnancy Outcome, Peri- and Neonatal Mortality on Maternal and Infant Nutritional Status: A Randomised, Controlled Trial Among Women in Guinea-Bissau|Completed||Phase 1|2100|Actual|Bandim Health Project||3|||f||||||||||||||2017-02-18 17:20:43.376704|2017-02-18 17:20:43.376704
NCT00168662|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-02-25|||March 1995||1995-03-01|February 2008|2008-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Non-Specific Effects of Standard Titre Measles Vaccination|Trial of Two-Dose Standard Measles Vaccination Schedule: Long-Term Impact on Morbidity and Mortality of a Two-Dose Vaccination Schedule at 6 and 9 Months of Age Compared With a Standard Regimen of One Dose at 9 Months of Age|Completed||Phase 4|7800||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:43.504349|2017-02-18 17:20:43.504349
NCT00168649|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-14|||June 2005||2005-06-01|November 2013|2013-11-01|June 2014||2014-06-01|||||Interventional|||Vitamin A and Response to Endotoxin|The Effect of Vitamin A on the Response to Endotoxin|Unknown status|Active, not recruiting|N/A|40||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:43.634696|2017-02-18 17:20:43.634696
NCT00005404|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||February 1991||1991-02-01|May 2000|2000-05-01|January 1993|Actual|1993-01-01|||||Observational|||Compliance in the Physicians' Health Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:02.220004|2017-02-18 18:15:02.220004
NCT00168623|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-14|||November 2003||2003-11-01|November 2013|2013-11-01|December 2014|Anticipated|2014-12-01|||||Interventional|||Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity|Randomised Trial of Vitamin A Supplementation Given With Routine Childhood Vaccines at National Immunisation Days|Unknown status|Active, not recruiting|Phase 4|6200||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:43.840047|2017-02-18 17:20:43.840047
NCT00168610|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-14|||November 2004||2004-11-01|November 2013|2013-11-01||||||||Interventional|||Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine|Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries? Randomized Prospective Studies in Guinea-Bissau|Unknown status|Active, not recruiting|Phase 4|7600|Actual|Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:43.943978|2017-02-18 17:20:43.943978
NCT00168597|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-14|||August 2002||2002-08-01|November 2013|2013-11-01||||November 2013|Actual|2013-11-01||Interventional|||Vitamin A With BCG Vaccine|Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries?|Completed||Phase 4|4800||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:44.050039|2017-02-18 17:20:44.050039
NCT00168584|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||November 2002||2002-11-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||Different Doses of Vitamin A and Childhood Morbidity and Mortality|Randomised Study of the Impact of Different Doses of Vitamin A on Childhood Morbidity and Mortality|Completed||Phase 4|5400||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:44.152857|2017-02-18 17:20:44.152857
NCT00168571|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-09-21|||March 2002||2002-03-01|September 2006|2006-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Long-term Follow-up of Measles Antibodies|Long-term Follow-up of Protective Measles Antibodies in the Two-dose Study of Standard-titre Measles Vaccine in Guinea-Bissau|Completed||Phase 4|1960||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:44.250709|2017-02-18 17:20:44.250709
NCT00168558|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-03-04|||July 2003||2003-07-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Early Two-dose Measles Vaccination Trial|Measles Vaccination in Guinea-Bissau. Strategies to Reduce Disease Burden and Improve Child Survival|Completed||Phase 4|5879|Actual|Bandim Health Project||3|||f||||t||||||||||2017-02-18 17:20:44.349552|2017-02-18 17:20:44.349552
NCT00168545|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-09-21|||January 2006||2006-01-01|September 2006|2006-09-01|January 2007|Actual|2007-01-01|||||Interventional|||Immunology of Non-specific Effects of Vaccine|Non-specific Effects of Vaccines - In Search of the Immunological Background|Completed||Phase 4|400||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:44.470616|2017-02-18 17:20:44.470616
NCT00168532|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-02-25|||January 1998||1998-01-01|February 2008|2008-02-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Prophylactic Antibiotics in Measles|Prophylactic Antibiotics in Measles Infection. A Community-Based Randomised Double-Blind Placebo-Controlled Trial in Guinea-Bissau|Completed||Phase 3|218||Bandim Health Project|||||f||||||||||||||2017-02-18 17:20:44.573625|2017-02-18 17:20:44.573625
NCT00168519|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2009-12-14|||October 2002||2002-10-01|December 2009|2009-12-01|April 2009|Actual|2009-04-01|||||Interventional|||Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes|Contraction Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes|Completed||N/A|40|Anticipated|Baker Heart Research Institute||1|||f||||||||||||||2017-02-18 17:20:44.680624|2017-02-18 17:20:44.680624
NCT00168506|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2007-04-04|||June 2002||2002-06-01|April 2007|2007-04-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Panic Disorder and Cardiac Risk|Panic Disorder and Cardiac Risk: Evaluation of a Psychological Treatment Which Addresses Biology, Psychology and Behaviour|Unknown status|Recruiting|N/A|50||Baker Heart Research Institute|||||f||||||||||||||2017-02-18 17:20:44.786285|2017-02-18 17:20:44.786285
NCT00168493|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-05-19|||June 2000||2000-06-01|May 2008|2008-05-01|December 2009|Anticipated|2009-12-01|December 2008|Anticipated|2008-12-01||Interventional|||The Neurobiology of Depressive Illness|The Neurobiology of Depressive Illness: Causes and Consequences of Altered Brain Monoaminergic Function|Unknown status|Recruiting|N/A|40|Anticipated|Baker Heart Research Institute||1|||f||||f||||||||||2017-02-18 17:20:44.86524|2017-02-18 17:20:44.86524
NCT00168480|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-26|||November 2003||2003-11-01|September 2008|2008-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis||Completed||Phase 4|424|Actual|Allergan||1|||f||||||||||||||2017-02-18 17:20:44.958632|2017-02-18 17:20:44.958632
NCT00168467|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-28||||||January 2009|2009-01-01||||||||Interventional|||The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease|The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease|Completed||Phase 4|40||Baker Heart Research Institute|||||f||||||||||||||2017-02-18 17:20:45.101441|2017-02-18 17:20:45.101441
NCT00168454|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-11|2009-09-02||July 2005||2005-07-01|October 2013|2013-10-01|June 2008|Actual|2008-06-01|January 2008|Actual|2008-01-01||Interventional|||A Research Study for Patients With Overactive Bladder||Completed||Phase 2|313|Actual|Allergan||6|||f||||t||||||||||2017-02-18 17:20:45.205169|2017-02-18 17:20:45.205169
NCT00168441|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-27|||June 2004||2004-06-01|May 2011|2011-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia||Completed||Phase 2|117|Actual|Allergan|||||f||||||||||||||2017-02-18 17:20:46.670282|2017-02-18 17:20:46.670282
NCT00168428|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-10-24|2010-11-05||March 2006||2006-03-01|October 2013|2013-10-01|August 2008|Actual|2008-08-01|December 2007|Actual|2007-12-01||Interventional|||A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches||Completed||Phase 3|705|Actual|Allergan||2|||f||||||||||||||2017-02-18 17:20:46.747404|2017-02-18 17:20:46.747404
NCT00168415|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2008-09-26|||August 2005||2005-08-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis||Completed||Phase 4|144|Actual|Allergan||1|||f||||||||||||||2017-02-18 17:20:47.46334|2017-02-18 17:20:47.46334
NCT00168402|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2011-05-27|||February 2002||2002-02-01|May 2011|2011-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis||Completed||Phase 3|193|Actual|Allergan|||||f||||||||||||||2017-02-18 17:20:47.567055|2017-02-18 17:20:47.567055
NCT00168389|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-10|2014-07-10||February 2005||2005-02-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema||Completed||Phase 3|494|Actual|Allergan||3|||f||||f||||||||||2017-02-18 17:20:47.655849|2017-02-18 17:20:47.655849
NCT00168376|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-04-13|||July 2004||2004-07-01|April 2007|2007-04-01|April 2006|Actual|2006-04-01|||||Interventional|||A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder|A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder|Completed||N/A|60||The Alfred|||||f||||||||||||||2017-02-18 17:20:48.835893|2017-02-18 17:20:48.835893
NCT00168363|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-27|||January 2005||2005-01-01|May 2011|2011-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension||Completed||Phase 3|207|Actual|Allergan|||||f||||||||||||||2017-02-18 17:20:48.92229|2017-02-18 17:20:48.92229
NCT00166348|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-19|||March 2003||2003-03-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|February 2007|Actual|2007-02-01||Interventional|||Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?|Efficacy of Group Based Cognitive Rehabilitation Following Acquired Brain Injury|Completed||N/A|20|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 17:20:49.014834|2017-02-18 17:20:49.014834
NCT00166322|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-05-06|||January 2004||2004-01-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects||Completed||N/A|35|Actual|Ludwig-Maximilians - University of Munich||1|||f||||||||||||||2017-02-18 17:20:49.108059|2017-02-18 17:20:49.108059
NCT00166309|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-18|||July 2000||2000-07-01|April 2007|2007-04-01|June 2005|Actual|2005-06-01|||||Interventional|||The FEIBA NovoSeven Comparative Study|FENOC: The FEIBA NovoSeven Comparative Study|Completed||N/A|60||Skane University Hospital|||||f||||t||||||||||2017-02-18 17:20:49.195033|2017-02-18 17:20:49.195033
NCT00166296|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-03-04|2011-02-08||March 2005||2005-03-01|March 2011|2011-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients|Study of the Efficacy and Safety of Escitalopram for the Prevention of Depressive Episodes Induced by Peg-Interferon Alpha2a and Ribavirin in Chronic Hepatitis C Patients. Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 2|133|Actual|Germans Trias i Pujol Hospital|The low depression rate found may have underpowered the study. Selection of a much less depressive sample than in other studies. Limitation to the first 12 weeks of antiviral treatment.|2|||f||||f||||||||||2017-02-18 17:20:49.291008|2017-02-18 17:20:49.291008
NCT00166283|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-06-08|||February 2005||2005-02-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Improving New Learning and Memory in Multiple Sclerosis|Improving New Learning in Multiple Sclerosis: A Randomized Clinical Trial|Completed||N/A|88|Actual|Kessler Foundation||2|||f||||t||||||||||2017-02-18 17:20:49.858576|2017-02-18 17:20:49.858576
NCT00166270|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-13|||January 2005||2005-01-01|September 2012|2012-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids|Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids|Completed||Phase 4|70|Actual|InSightec||1|||f||||||||||||||2017-02-18 17:20:49.965406|2017-02-18 17:20:49.965406
NCT00166257|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-05-26|||February 2000||2000-02-01|May 2009|2009-05-01|May 2011|Anticipated|2011-05-01|February 2011|Anticipated|2011-02-01||Interventional|||PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism|Randomized Clinical Trial Comparing the Efficacy of Percutaneous Closure of Patent Foramen Ovale (PFO) With Medical Treatment in Patients With Cryptogenic Embolism|Unknown status|Active, not recruiting|Phase 4|414|Actual|Foundation for Cardiovascular Research, Zurich||2|||f||||t||||||||||2017-02-18 17:20:50.103016|2017-02-18 17:20:50.103016
NCT00166244|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-02-11|||May 2003||2003-05-01|February 2009|2009-02-01|April 2006|Actual|2006-04-01|March 2005|Actual|2005-03-01||Interventional|||Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation|An Open, Prospective, Randomised, Controlled, Multi-Center Study Comparing Fixed Dose vs Concentration Controlled Mycophenolate Mofetil Regimens for de Novo Patients Following Transplantation|Completed||Phase 4|901|Actual|Erasmus Medical Center||2|||f||||t||||||||||2017-02-18 17:20:50.220894|2017-02-18 17:20:50.220894
NCT00166231|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-02-24|||March 2004||2004-03-01|February 2015|2015-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Understanding Pediatric Chest Pain and Other Symptoms|Understanding Pediatric Symptoms and Other Symptoms|Completed||N/A|156|Actual|Emory University|||2||f||||f||||||||||2017-02-18 17:20:50.594625|2017-02-18 17:20:50.594625
NCT00166218|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-26|||February 2004||2004-02-01|November 2013|2013-11-01|February 2005||2005-02-01|||||Observational|||NIRS Monitoring in the Ambulatory Single Ventricle Patient|Evaluation of Near-infrared Spectroscopy for Non-invasive Monitoring of the Ambulatory Single Ventricle Patient|Terminated||N/A|30||Emory University|||||f||||||||||||||2017-02-18 17:20:50.698113|2017-02-18 17:20:50.698113
NCT00166205|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-08-03|2008-10-21||June 2003||2003-06-01|August 2015|2015-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity|A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity|Completed||Phase 3|276|Actual|Ethicon Endo-Surgery||1|||f||||f||||||||||2017-02-18 17:20:50.803796|2017-02-18 17:20:50.803796
NCT00166192|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-12|||January 2008||2008-01-01|November 2013|2013-11-01|November 2013|Actual|2013-11-01|January 2010|Actual|2010-01-01||Interventional|||Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid|Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid: A Comparison of Clinical Efficacy|Completed||Phase 4|19|Actual|Emory University||1|||f||||t||||||||||2017-02-18 17:20:51.326024|2017-02-18 17:20:51.326024
NCT00168350|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-11-03|||March 2000||2000-03-01|November 2010|2010-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Memantine in Patients With Chronic Glaucoma||Completed||Phase 3|1179|Actual|Allergan||3|||f||||f||||||||||2017-02-18 17:20:51.435211|2017-02-18 17:20:51.435211
NCT00168337|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-10|2014-07-10||May 2005||2005-05-01|July 2014|2014-07-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema||Completed||Phase 3|554|Actual|Allergan||3|||f||||f||||||||||2017-02-18 17:20:51.516874|2017-02-18 17:20:51.516874
NCT00168324|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-15|2009-07-15||October 2004||2004-10-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|March 2008|Actual|2008-03-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion||Completed||Phase 3|599|Actual|Allergan||3|||f||||f||||||||||2017-02-18 17:20:52.750891|2017-02-18 17:20:52.750891
NCT00168311|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2012-04-15|2010-06-15||August 2002||2002-08-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|rTMS||A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia|A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magentic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia and Related Disorders|Completed||N/A|22|Actual|The Alfred|Insufficient time period used to be able to establish a substantive therapeutic effect of rTMS; standard dosing method may be inadequate due to volumetric changes in brain regions in schizophrenia; concurrent antipsychotic medication.|2|||f||||f||||||||||2017-02-18 17:20:53.419634|2017-02-18 17:20:53.419634
NCT00168298|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-15|2009-07-15||November 2004||2004-11-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|||A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion||Completed||Phase 3|668|Actual|Allergan||3|||f||||f||||||||||2017-02-18 17:20:53.862644|2017-02-18 17:20:53.862644
NCT00168285|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-04-04|||March 2005||2005-03-01|April 2007|2007-04-01|May 2007|Anticipated|2007-05-01|||||Interventional|||Pulmonary Rehabilitation in Interstitial Lung Disease|Pulmonary Rehabilitation in Interstitial Lung Disease - a Multi-Centre, Single-Blinded Randomised Controlled Trial|Unknown status|Active, not recruiting|N/A|56||The Alfred|||||f||||f||||||||||2017-02-18 17:20:54.515199|2017-02-18 17:20:54.515199
NCT00168272|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2007-04-13|||June 2004||2004-06-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Priming rTMS In Major Depression|A Randomised Double-Blind Trial of Low and High Frequency Stimulation rTMS (Repetitive Transcranial Magnetic Stimulation) In Major Depression|Completed||N/A|100||The Alfred|||||f||||||||||||||2017-02-18 17:20:54.620726|2017-02-18 17:20:54.620726
NCT00168259|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-01-19|||December 2004||2004-12-01|January 2012|2012-01-01|December 2009|Actual|2009-12-01|||||Observational|||Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals|Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals|Completed||N/A|20|Actual|The Alfred|||1||f||||f||||||Samples With DNA|"~     Plasma, and DNA~   "|||2017-02-18 17:20:54.709916|2017-02-18 17:20:54.709916
NCT00168246|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-02-26|||June 2005||2005-06-01|February 2007|2007-02-01||||||||Observational|||Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific|A Cross-Sectional Study of HIV-Related Neurological Disorders in Ten Countries of the Asia Pacific Region|Unknown status|Active, not recruiting|N/A|600||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 17:20:54.790617|2017-02-18 17:20:54.790617
NCT00168233|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-01-19|||June 2005||2005-06-01|January 2012|2012-01-01|March 2011|Actual|2011-03-01|September 2010|Actual|2010-09-01||Observational|||Impact of HIV and Its Treatment on Reverse Cholesterol Transport|Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport|Completed||N/A|44|Actual|The Alfred|||3||f||||f||||||||||2017-02-18 17:20:55.059272|2017-02-18 17:20:55.059272
NCT00168220|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-01-19|||August 2005||2005-08-01|January 2012|2012-01-01||||||||Observational|||Predictors of Drug Hypersensitivity in HIV Infected Subjects|Predictors of Drug Hypersensitivity in HIV Infected Subjects|Withdrawn||N/A|0|Actual|The Alfred|||2|Insufficient recruitment|f||||f||||||Samples With DNA|"~     plasma, DNA~   "|||2017-02-18 17:20:55.154796|2017-02-18 17:20:55.154796
NCT00168207|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-01-19|||May 2005||2005-05-01|January 2012|2012-01-01|May 2009|Actual|2009-05-01|||||Observational|||IL-7 Receptor Polymorphisms and Immune Recovery With HAART|The Relationship of Single Nucleotide Polymorphisms in the Interleukin-7 Receptor-α Gene to CD4+ Immune Recovery in HIV Infected Patients Who Begin Antiretroviral Treatment With HAART|Completed||N/A|106|Actual|The Alfred|||1||f||||f||||||Samples With DNA|"~     Plasma, PBMC and DNA~   "|||2017-02-18 17:20:55.250312|2017-02-18 17:20:55.250312
NCT00168194|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-01-19|||December 2004||2004-12-01|January 2012|2012-01-01|December 2009|Actual|2009-12-01|||||Observational|||Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History|Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History|Completed||N/A|104|Actual|The Alfred|||1||f||||f||||||Samples Without DNA|"~     plasma~   "|||2017-02-18 17:20:55.340584|2017-02-18 17:20:55.340584
NCT00168181|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-15|||April 2002||2002-04-01|April 2011|2011-04-01|April 2008||2008-04-01|||||Interventional|||Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients|A Phase III Randomized Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients|Completed||Phase 3|220|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:20:55.433084|2017-02-18 17:20:55.433084
NCT00168168|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-14|2010-02-08|||July 2003||2003-07-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159|ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159|Completed||N/A|60||AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:20:55.528771|2017-02-18 17:20:55.528771
NCT00168155|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-01-18|||January 2002||2002-01-01|September 2011|2011-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma|Phase 2 Study of Neoadjuvant 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma|Completed||Phase 2|70||AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:20:55.611336|2017-02-18 17:20:55.611336
NCT00168142|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-02-23|||October 2003||2003-10-01|December 2011|2011-12-01|August 2009|Actual|2009-08-01|July 2008|Actual|2008-07-01||Observational|||MVCT Imaging Pilot Study Using Helical Tomotherapy|MVCT Imaging Pilot Study Using Helical Tomotherapy|Completed||N/A|16|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 17:20:55.706952|2017-02-18 17:20:55.706952
NCT00168129|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-12-08|||June 2001||2001-06-01|December 2011|2011-12-01|July 2005||2005-07-01|||||Interventional|||Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases|Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases|Completed||Phase 1|10||AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:20:55.784805|2017-02-18 17:20:55.784805
NCT00167934|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-03-10|||December 2004||2004-12-01|March 2009|2009-03-01|December 2008|Anticipated|2008-12-01|December 2008|Anticipated|2008-12-01||Interventional|||Determining Metabolic Effects of Valproate and Antipsychotic Therapy|Metabolic Effects of Valproate and Antipsychotic Therapy|Unknown status|Recruiting|N/A|88|Anticipated|National Institute of Mental Health (NIMH)||2|||f||||f||||||||||2017-02-18 17:20:58.907771|2017-02-18 17:20:58.907771
NCT00168116|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-02-23|||July 2000||2000-07-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|May 2009|Actual|2009-05-01||Interventional|||Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure|To Evaluate the Effects of Transfer of Submandibular Salivary Gland to the Submental Region (Outside the Radiation Field) on Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure|Completed||Phase 2|42|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 17:20:55.877107|2017-02-18 17:20:55.877107
NCT00168103|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-03-11|2010-04-21||June 2005||2005-06-01|February 2011|2011-02-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks|Human Pasteurized C1 Esterase Inhibitor Concentrate (CE1145) in Subjects With Congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks|Completed||Phase 2/Phase 3|126|Actual|CSL Behring|A test for futility of the C1-INH 10 U/kg bw group conducted during a planned interim analysis led to ceasing recruitment for the C1-INH 10 U/kg bw group.|3|||f||||t||||||||||2017-02-18 17:20:55.995792|2017-02-18 17:20:55.995792
NCT00168090|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-10|||October 2001||2001-10-01|February 2011|2011-02-01|May 2006||2006-05-01|||||Interventional|||Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)|Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrand's Disease.|Completed||Phase 4|30||CSL Behring|||||f||||||||||||||2017-02-18 17:20:56.953217|2017-02-18 17:20:56.953217
NCT00168077|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-10|||September 2005||2005-09-01|February 2011|2011-02-01|November 2006|Actual|2006-11-01|||||Interventional|||Prothrombin Complex Concentrate for Anticoagulant Reversal|Efficacy and Tolerance of BERIPLEX® P/N in Subjects With Acquired Deficiency of Coagulation Factors II, VII, IX and X Due to Oral Anticoagulation|Completed||Phase 3|40||CSL Behring|||||f||||||||||||||2017-02-18 17:20:57.04185|2017-02-18 17:20:57.04185
NCT00168064|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-10-02|2011-07-12||May 2006||2006-05-01|October 2012|2012-10-01|August 2011|Actual|2011-08-01|August 2010|Actual|2010-08-01||Interventional|||Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides|A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients With Stage I or IIA Mycosis Fungoides (MF)|Completed||Phase 2|260|Actual|Yaupon Therapeutics||2|||f||||f||||||||||2017-02-18 17:20:57.15294|2017-02-18 17:20:57.15294
NCT00168051|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2013-02-07|||April 2005||2005-04-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A|A Single Dose, Randomized, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of ReFacto (B-domain Deleted Recombinant Human Factor VIII (BDDrFVIII) and Advante (a Full-length Recombinant Factor VIII (FLrFVIII)|Completed||Phase 4|21|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:20:57.60036|2017-02-18 17:20:57.60036
NCT00168038|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-10-18|2011-08-22||December 2004||2004-12-01|October 2011|2011-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10|An Open-label, Multicenter Study on the Efficacy and Safety of IgPro10 in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)|Completed||Phase 3|58|Actual|CSL Behring||1|||f||||||||||||||2017-02-18 17:20:57.713455|2017-02-18 17:20:57.713455
NCT00168025|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-06-05|||September 2004||2004-09-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)|A Multicenter Study on the Efficacy, Safety and Pharmacokinetics of IgPro10 in Patients With Primary Immunodeficiency (PID)|Completed||Phase 3|89|Actual|CSL Behring||1|||f||||||||||||||2017-02-18 17:20:58.068606|2017-02-18 17:20:58.068606
NCT00168012|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-02-10|||September 2004||2004-09-01|February 2011|2011-02-01|September 2005|Actual|2005-09-01|||||Interventional|||Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)|An Open Study to Evaluate the Safety and Efficacy of IVIG-F10 in Patients With Primary Immunodeficiency Diseases (PID)|Completed||Phase 3|42||CSL Behring|||||||||||||||||||2017-02-18 17:20:58.170931|2017-02-18 17:20:58.170931
NCT00167999|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-03-14|||February 2005||2005-02-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units|Effects of Piperacillin-Tazobactam Use on the Prevalence Rate of Extended-Spectrum Beta-Lactamase (ESBL) Producing Escherichia Coli and Klebsiella Pneumoniae in Hematology and Oncology Units.|Completed||Phase 4|200||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:20:58.258624|2017-02-18 17:20:58.258624
NCT00167986|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-03-14|||January 2005||2005-01-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care|Antibiotic Intervention Trial in a Medical Intensive Care Unit to Reduce the Acquisition of Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae.|Completed||Phase 4|480||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:20:58.339888|2017-02-18 17:20:58.339888
NCT00167973|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2010-05-25|||January 2002||2002-01-01|May 2010|2010-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use|A Prospective Registry of European Hemophilia B Patients Receiving BeneFIX®(Nonacog Alfa, Recombinant Human Factor IX) for Usual Use|Completed||Phase 4|218|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||1||f||||||||||||||2017-02-18 17:20:58.430914|2017-02-18 17:20:58.430914
NCT00167960|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-03-14|||January 2005||2005-01-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit|Effects on the Emergence and Transmission of Vancomycin-Resistant Enterococci After Changes in Antibiotic Use in a Hematology Unit.|Completed||Phase 4|1500||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:20:58.711251|2017-02-18 17:20:58.711251
NCT00167947|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-13|||January 2005||2005-01-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study Evaluating Sirolimus in Kidney Transplant Recipients.|A Randomized, Open Label Study to Evaluate the Effects of a Regimen With Sirolimus,Low Doses Cyclosporine and Steroids vs a Regimen With Sirolimus and Steroids, After an Induction Period With Basiliximab, Sirolimus,Cyclosporine and Steroids in de Novo Renal Transplant Patients.|Completed||Phase 3|150|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 17:20:58.794398|2017-02-18 17:20:58.794398
NCT00167921|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-05-25|||October 2005||2005-10-01|May 2007|2007-05-01||||||||Interventional|||Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis|A Multiple-Dose, Comparative Bioavailability Study of Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Postmenopausal Women With Atrophic Vaginitis.|Completed||Phase 1|24||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:20:59.024072|2017-02-18 17:20:59.024072
NCT00167908|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-02-03|||October 2001||2001-10-01|February 2009|2009-02-01|May 2007|Actual|2007-05-01|||||Interventional|||Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer|Pilot Study to Test Whether Amifostine Can Further Protect Salivary Function in Head and Neck Cancer Patients Treated With IMRT|Completed||Phase 2|27||Washington University School of Medicine|||||f||||||||||||||2017-02-18 17:20:59.106123|2017-02-18 17:20:59.106123
NCT00167895|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2007-04-24|||October 2004||2004-10-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||The Use of Platelet Derived Growth Factors in Total Knee Arthroplasty, a Randomized Trial|The Use of Platelet Derived Growth Factors in Total Knee Arthroplasty, a Randomized Trial|Completed||Phase 3|100||Westfries Hospital|||||f||||t||||||||||2017-02-18 17:20:59.182833|2017-02-18 17:20:59.182833
NCT00167882|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-08|||July 2005||2005-07-01|August 2006|2006-08-01|August 2006||2006-08-01|||||Interventional|||The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels||Completed||Phase 4|24||VU University Medical Center|||||f||||||||||||||2017-02-18 17:20:59.279015|2017-02-18 17:20:59.279015
NCT00167869|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-23|||June 2004||2004-06-01|May 2008|2008-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.|LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.|Completed||Phase 2|135||Wageningen University|||||f||||||||||||||2017-02-18 17:20:59.381995|2017-02-18 17:20:59.381995
NCT00167856|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-03-26|||June 2005||2005-06-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|||Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury|Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury|Completed||N/A|16|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:20:59.468364|2017-02-18 17:20:59.468364
NCT00167843|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2013-01-23|||December 2002||2002-12-01|January 2013|2013-01-01|March 2007||2007-03-01|||||Interventional|||Reducing the Effects of Malaria in Children by Administering Repeated Preventive Doses|A Longitudinal Study Assessing the Infectious Status and Immunity of Mothers and Their Children in Lambaréné, Including Intermittent Treatment of Children With Sulfadoxine-pyrimethamine for Malaria Control and Its Impact on Long-term Health|Completed||Phase 4|1189||Albert Schweitzer Hospital|||||f||||||||||||||2017-02-18 17:20:59.584182|2017-02-18 17:20:59.584182
NCT00167830|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-01-16|||November 2003||2003-11-01|January 2014|2014-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Barriers to Treatment in Obese Adolescents|Understanding The Barriers in Treatment of Obesity in Adolescents 11-18 in Central Virginia|Completed||Phase 1/Phase 2|292|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-02-18 17:20:59.692115|2017-02-18 17:20:59.692115
NCT00167817|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2007-04-18|||July 2003||2003-07-01|April 2007|2007-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study|Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study|Completed||Phase 4|15||Veterans Medical Research Foundation|||||f||||f||||||||||2017-02-18 17:20:59.804187|2017-02-18 17:20:59.804187
NCT00167804|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-12-02|||September 2004||2004-09-01|December 2011|2011-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Comparing Virtual Reality Therapy to Usual Treatment for PTSD|Comparing Virtual Reality Therapy to Usual Treatment for PTSD|Completed||N/A|20|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 17:20:59.898586|2017-02-18 17:20:59.898586
NCT00167791|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-10-13|||July 2005||2005-07-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant|Multicenter Trial Using Multi-dose Rituximab as Induction and Desensitization Therapy for Patients on the Waiting List for Kidney Transplant With a Positive Donor Specific Crossmatch to a Living Donor|Withdrawn||N/A|0|Actual|University of Wisconsin, Madison||1||lack of enrollment|f||||t||||||||||2017-02-18 17:21:00.011274|2017-02-18 17:21:00.011274
NCT00167778|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2014-07-28|2013-10-25||January 2005||2005-01-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Prosthetic Components and Stability in Amputee Gait|Turning Corners: Prosthetic Components and Stability in Amputee Gait|Completed||N/A|12|Actual|VA Office of Research and Development|Our sample population consisted of community ambulators whose results may not generalize to all lower limb amputees.|2|||f||||f||||||||||2017-02-18 17:21:00.136728|2017-02-18 17:21:00.136728
NCT00167765|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-05-01|||March 2005||2005-03-01|May 2007|2007-05-01|May 2005|Actual|2005-05-01|||||Interventional|||Abciximab in Wake-up Stroke|Does Abciximab Save Hypoperfused Ischemic Brain Tissue in Wake-Up Stroke: A Placebo-Controlled, Randomized, MR Imaging Study|Terminated||Phase 3|50||University of Zurich||||Higher hemorrhage rates of Abciximab in ABESST II trial|f||||t||||||||||2017-02-18 17:21:03.646963|2017-02-18 17:21:03.646963
NCT00166179|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-09-25|||November 2003||2003-11-01|September 2014|2014-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Observational|||Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI|Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI|Completed||N/A|57|Actual|Emory University|||1||f||||f||||||||||2017-02-18 17:21:03.749892|2017-02-18 17:21:03.749892
NCT00166166|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-05-12|2015-05-08||July 2002||2002-07-01|May 2015|2015-05-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Baseline characteristics represent subjects that completed the study.|Endothelial Hyperpolarization in Humans|Physiology and Pathologic Role of Endothelium-Derived Hyperpolarizing Factor in Humans|Terminated||Phase 2|174|Actual|Emory University|Findings are limited to the forearm microcirculations, thus other vascular beds including conductance arteries warrant further investigation. Nevertheless, it is known that the contribution of EDHF is less in conductance vessels than in microvessels.|2||Limited clinical staff|f||||f||||||||||2017-02-18 17:21:03.839182|2017-02-18 17:21:03.839182
NCT00166153|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-19|||January 2003||2003-01-01|November 2013|2013-11-01|May 2005||2005-05-01|||||Interventional|||Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept|The Relationships Between Mycophenolic Acid Levels, T-Cell Subsets and Outcomes in Pediatric Heat Transplant Recipients Receiving Mycophenolate Mofetil (Cellcept)|Terminated||N/A|30||Emory University|||||f||||||||||||||2017-02-18 17:21:07.039446|2017-02-18 17:21:07.039446
NCT00166140|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-19|||December 2002||2002-12-01|November 2013|2013-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.|Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.|Completed||N/A|125||Emory University|||1||f||||||||||||||2017-02-18 17:21:07.143414|2017-02-18 17:21:07.143414
NCT00166127|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-13|||May 2005||2005-05-01|November 2013|2013-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Study of Blood Concentrations and Physiologic Effects of Levosimendan Given During Heart Surgery|Pharmacokinetics and Pharmacodynamics of Levosimendan During Cardiac Surgery|Terminated||Phase 3|1|Actual|Emory University||1||Unable to renegotiate an expired contract w/sponsor providing study med|f||||f||||||||||2017-02-18 17:21:07.239869|2017-02-18 17:21:07.239869
NCT00166114|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2015-07-15|2013-12-09||February 2002||2002-02-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Depression, Epinephrine, and Platelet Function|Do Antidepressants Reverse the Effects of Early Life Stress on the Brain and Thrombovascular System and Improve Psychological, Neuroendocrine, and Platelet Function: A Study of Men and Women With Childhood Abuse.|Completed||Phase 4|40|Actual|Emory University||2|||f||||t||||||||||2017-02-18 17:21:07.339499|2017-02-18 17:21:07.339499
NCT00166101|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-11-09|||August 2002||2002-08-01|November 2012|2012-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||NIRS in Neonatal Cardiac Surgery|Near Infrared Spectroscopy Monitoring of Cerebral Oxygen Saturation in Neonatal Cardiac Surgery - Comparison With Common Methods of Estimating Adequate Systemic Perfusion|Completed||N/A|25|Actual|Emory University|||1||f||||f||||||||||2017-02-18 17:21:07.754737|2017-02-18 17:21:07.754737
NCT00166088|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-15|||December 2004||2004-12-01|November 2013|2013-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)|Effects of Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and EPC's|Completed||Phase 2|30|Actual|Emory University||3|||f||||f||||||||||2017-02-18 17:21:07.851467|2017-02-18 17:21:07.851467
NCT00166075|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-12|||January 2004||2004-01-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Observational|||Mental Health Symptoms and Intimate Partner Violence|Mental Health Symptoms and Intimate Partner Violence|Completed||N/A|569|Actual|Emory University|||1||f||||f||||||||||2017-02-18 17:21:08.191657|2017-02-18 17:21:08.191657
NCT00166062|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-09-19|||January 2004||2004-01-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Effectiveness of Computer Screening for Intimate Partner Violence||Completed||N/A|||Emory University|||||f||||||||||||||2017-02-18 17:21:08.296406|2017-02-18 17:21:08.296406
NCT00167752|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2016-10-24|||December 2002||2002-12-01|October 2016|2016-10-01||||February 2006|Actual|2006-02-01||Observational|||Psychiatric Problems in Chronic Skin Diseases|Quality of Life, Emotional and Sleep Problems in Chronic Skin Diseases|Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:21:08.383211|2017-02-18 17:21:08.383211
NCT00167739|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-19|||April 2003||2003-04-01|September 2005|2005-09-01|February 2004||2004-02-01|||||Interventional|||Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine|Short Course of Quinine Plus a Single Dose of Sulphadoxine-Pyrimethamine for Plasmodium Falciparum Malaria|Completed||Phase 4|50||Albert Schweitzer Hospital|||||f||||||||||||||2017-02-18 17:21:08.449133|2017-02-18 17:21:08.449133
NCT00167726|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-12-05|||January 2005||2005-01-01|December 2014|2014-12-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Neuraxial and Neurolytic Analgesia for Intractable Pain|Neuraxial and Neurolytic Analgesia for Intractable Pain|Completed||N/A|19|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 17:21:08.636312|2017-02-18 17:21:08.636312
NCT00167713|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-19|||April 2003||2003-04-01|September 2005|2005-09-01|January 2004||2004-01-01|||||Interventional|||Treatment of Fever Due to Malaria With Ibuprofen|Randomised, Double-Blind, Placebo Controlled Study of the Antipyretic Effect of Ibuprofen in Children With Uncomplicated Malaria|Completed||Phase 4|50||Albert Schweitzer Hospital|||||f||||||||||||||2017-02-18 17:21:08.718123|2017-02-18 17:21:08.718123
NCT00167700|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2012-10-03|||February 1997||1997-02-01|September 2012|2012-09-01|December 2015|Anticipated|2015-12-01|||||Interventional|NAMI||Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight|Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI): Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight|Unknown status|Recruiting|N/A|800|Anticipated|University of Turku||6|||f||||f||||||||||2017-02-18 17:21:08.823849|2017-02-18 17:21:08.823849
NCT00167687|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-02-13|||September 2005||2005-09-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Prazosin Alcohol Dependence IVR Study|A Double-Blind Placebo-Controlled Trial of Prazosin for the Treatment of Alcohol Dependence|Completed||Phase 4|23|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 17:21:08.956957|2017-02-18 17:21:08.956957
NCT00167674|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-06-14|||May 2003||2003-05-01|June 2012|2012-06-01|April 2006|Actual|2006-04-01|March 2005|Actual|2005-03-01||Interventional|||ARVs to Prevent Breastmilk HIV:Viral and Immune Responses|ARVs to Prevent Breastmilk HIV:Viral and Immune Responses|Completed||Phase 2|58|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:21:09.070015|2017-02-18 17:21:09.070015
NCT00167661|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2015-10-09|||June 2004||2004-06-01|October 2015|2015-10-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation|Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation|Terminated||Phase 1/Phase 2|50|Anticipated|University of Wisconsin, Madison||1||Enrollment suspended pending protocol revision to change study to observational|f||||t||||||||||2017-02-18 17:21:09.187237|2017-02-18 17:21:09.187237
NCT00167648|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-15|||March 2005||2005-03-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|NE2||Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer|Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer|Completed||Phase 2|17|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:21:09.288837|2017-02-18 17:21:09.288837
NCT00167635|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-05-21|||January 2003||2003-01-01|May 2009|2009-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Nursing Management of Irritable Bowel Syndrome:Improving Outcomes|Nursing Management of Irritable Bowel Syndrome: Improving Outcomes|Completed||Phase 2/Phase 3|188|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 17:21:09.400167|2017-02-18 17:21:09.400167
NCT00167622|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2016-07-19|||April 2005||2005-04-01|July 2016|2016-07-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Early Mechanical Ventilation for Guillain Barré Syndrome|Efficacy and Safety of Preventive Mechanical Ventilation in Adults With Guillain Barré Syndrome|Completed||Phase 2|50|Actual|University of Versailles||2|||f||||f||||||||||2017-02-18 17:21:09.5169|2017-02-18 17:21:09.5169
NCT00167609|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2010-04-05|||November 2004||2004-11-01|April 2010|2010-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy and Safety of DHEA for Myotonic Dystrophy|Phase 3 Study of Oral Dehydroepiandrosterone (DHEA) in Adults With Myotonic Dystrophy|Completed||Phase 2/Phase 3|75|Actual|University of Versailles||3|||f||||t||||||||||2017-02-18 17:21:09.628806|2017-02-18 17:21:09.628806
NCT00167596|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-07-19|||July 2005||2005-07-01|July 2016|2016-07-01|December 2009|Actual|2009-12-01|May 2009|Actual|2009-05-01||Interventional|OTO-STS||Near Infrared Spectroscopy (NIRS) in Severe Sepsis|Phase III Study of Usefulness of Near Infrared Spectroscopy to Optimize Tissues Perfusion and Oxygenation in Severe Sepsis|Terminated||Phase 2/Phase 3|103|Actual|University of Versailles||2||recruitment was stopped as consequence of cessation of funding (economic crisis)|f||||t||||||||||2017-02-18 17:21:09.749893|2017-02-18 17:21:09.749893
NCT00167583|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-07-26|||November 2004||2004-11-01|March 2009|2009-03-01|December 2012|Anticipated|2012-12-01|September 2012|Anticipated|2012-09-01||Interventional|INCYTOB||Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)|Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet`s Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB)|Unknown status|Recruiting|Phase 3|100|Anticipated|University Hospital Tuebingen||2|||f||||t||||||||||2017-02-18 17:21:09.866829|2017-02-18 17:21:09.866829
NCT00167570|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-17|||April 2003||2003-04-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Long Term Clinical Evaluation of SLS Transtibial Sockets|Long Term Clinical Evaluation of SLS Transtibial Sockets|Completed||N/A|11|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||f||||||||||2017-02-18 17:21:09.994307|2017-02-18 17:21:09.994307
NCT00167557|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-18|||January 2005||2005-01-01|November 2013|2013-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment|Tacrolimus Monotherapy in OLT Recipients With HCV Under Preemptive Treatment With Interferon and Ribavirin|Withdrawn||Phase 4|0|Actual|The University of Texas Health Science Center, Houston||1||The PI left the institution.|f||||f||||||||||2017-02-18 17:21:10.092567|2017-02-18 17:21:10.092567
NCT00167544|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-07-29|2013-03-25||November 2005||2005-11-01|July 2013|2013-07-01|November 2012|Actual|2012-11-01|January 2009|Actual|2009-01-01||Interventional|||Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants|A Randomized Trial of Hydrocortisone in Very Preterm Infants at High Risk for Neurologic and Pulmonary Impairments|Completed||Phase 2|64|Actual|Nationwide Children's Hospital||2|||f||||t||||||||||2017-02-18 17:21:10.446308|2017-02-18 17:21:10.446308
NCT00167531|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-10-01|||August 2002||2002-08-01|September 2006|2006-09-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||The Efficacy of Treadmill Training in Establishing Walking After Stroke|The Efficacy of Treadmill Training in Establishing Walking After Stroke|Completed||Phase 2|126|Actual|University of Sydney||2|||f||||f||||||||||2017-02-18 17:21:10.913383|2017-02-18 17:21:10.913383
NCT00167518|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2005-09-11|||March 2002||2002-03-01|January 2005|2005-01-01|April 2005||2005-04-01|||||Interventional|||Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)|Phase II/III Intravitreal Triamcinolone for Treatment of Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment|Completed||Phase 2/Phase 3|70||University of Sydney|||||f||||||||||||||2017-02-18 17:21:11.030911|2017-02-18 17:21:11.030911
NCT00167505|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-10-25|||September 2006||2006-09-01|October 2010|2010-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School Students|SIP 4-04 Evaluation of Abstinence-Only and Abstinence-Plus Program to Prevent HIV, STD, and Pregnancy Among Middle School Students|Completed||N/A|1742|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 17:21:11.138983|2017-02-18 17:21:11.138983
NCT00167492|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-12-05|||September 2005||2005-09-01|December 2013|2013-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Enteric Coated Myfortic for Liver Transplant Recipients|Enteric Coated Mycophenolic Acid (Myfortic) in Liver Transplant Recipients- Effect on Compliance and Calcineurin Inhibitor and Corticosteroid Sparing|Withdrawn||Phase 4|0|Actual|The University of Texas Health Science Center, Houston||1|||f||||||||||||||2017-02-18 17:21:11.25031|2017-02-18 17:21:11.25031
NCT00167479|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2006-09-08|||September 2003||2003-09-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||A Study of Risperidone Monotherapy in Bipolar Anxiety|A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Current at Least Moderately Severe Anxiety and Lifetime Panic Disorder or Generalized Anxiety Disorder|Completed||Phase 4|60||University of South Florida|||||f||||||||||||||2017-02-18 17:21:11.356109|2017-02-18 17:21:11.356109
NCT00167466|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-10-26|||October 2005||2005-10-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Placebo Controlled Trial of a Titanium Dioxide Semiconductor Toothbrush on Mild-to-moderate Gum Disease|Randomized, Double-blind, Placebo-controlled Crossover Trial of the Soladey-3 Toothbrush on Periodontal Disease Indices in Patients With Mild-to-moderate Periodontal Disease|Completed||N/A|120|Anticipated|University of Saskatchewan||2|||f||||t||||||||||2017-02-18 17:21:11.478669|2017-02-18 17:21:11.478669
NCT00167453|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-10-04|||September 2005||2005-09-01|September 2006|2006-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Benefits of Exercise and Education for Individuals With Parkinson's Disease (BEEP)|Evaluation of the Benefits of a Group Exercise Program and a Group Exercise and Education Program for Individuals With Parkinson's Disease (BEEP)|Completed||Phase 1|45|Anticipated|University of Saskatchewan|||||f||||||||||||||2017-02-18 17:21:11.593093|2017-02-18 17:21:11.593093
NCT00167440|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-11-25|||August 2004||2004-08-01|November 2015|2015-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients|Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Patients|Withdrawn||Phase 3|0|Actual|University of Rochester|||1|Personelle changes mandated suspension.|f||||f||||||||||2017-02-18 17:21:11.733603|2017-02-18 17:21:11.733603
NCT00167427|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-09-22|||April 2006||2006-04-01|September 2016|2016-09-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Observational|||Genotoxicity Assessment for Patients Undergoing Radiation Treatment|Genotoxicity Assessment for Patients Receiving Large Field Irradiation|Recruiting||N/A|120|Anticipated|University of Rochester|||1||f||||f||||||||||2017-02-18 17:21:11.8432|2017-02-18 17:21:11.8432
NCT00167414|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-05-24|||December 2000||2000-12-01|May 2016|2016-05-01|October 2021|Anticipated|2021-10-01|October 2021|Anticipated|2021-10-01||Interventional|||Study for Using Radiosurgery on Limited Metastases of Breast Cancer|A Phase II Study for Using Radiosurgery on Limited Metastases of Breast Cancer|Active, not recruiting||Phase 2|49|Actual|University of Rochester||1|||f||||f||||||||No||2017-02-18 17:21:11.940581|2017-02-18 17:21:11.940581
NCT00167401|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-05-15|||February 2002||2002-02-01|May 2009|2009-05-01||||June 2007|Actual|2007-06-01||Interventional|||Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer|A Phase II Trial of One-Cycle Induction Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer|Completed||Phase 2|||University of Rochester|||||f||||t||||||||||2017-02-18 17:21:12.051908|2017-02-18 17:21:12.051908
NCT00167388|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-25|||September 2005||2005-09-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|||||Interventional|||The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants|The Effect of Packed Red Blood Cell Transfusion on Superior Mesenteric Artery Blood Flow Velocity in Premature Infants After Feeding|Completed||Phase 1|80|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:21:12.144079|2017-02-18 17:21:12.144079
NCT00167375|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-02-13|||January 2005||2005-01-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|||||Observational|||Testing the Nocturnal Sleep Latency Profile in Primary Insomnia|Testing the Nocturnal Sleep Latency Profile in Primary Insomnia|Completed||Phase 1|24|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:21:12.240784|2017-02-18 17:21:12.240784
NCT00167362|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-06|||August 2001||2001-08-01|January 2017|2017-01-01|December 2016|Actual|2016-12-01|August 2009|Actual|2009-08-01||Interventional|||Cognitive Enhancement Therapy for Early-Stage Schizophrenia|Rehabilitation, Brain Function and Early Schizophrenia|Completed||Phase 3|67|Actual|Beth Israel Deaconess Medical Center||2|||f||||f||||||||||2017-02-18 17:21:12.346085|2017-02-18 17:21:12.346085
NCT00167349|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-14|||December 2003||2003-12-01|April 2011|2011-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|CPB-I||Cardiopulmonary Bypass and Inflammatory Response|Cardiopulmonary Bypass and Inflammatory Response|Completed||N/A|37|Actual|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"~     plasma and serum~   "|||2017-02-18 17:21:12.462672|2017-02-18 17:21:12.462672
NCT00167336|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-12-15|||May 2004||2004-05-01|June 2006|2006-06-01|March 2005||2005-03-01|||||Observational|||Developing an Instrument to Measure Personal Keyboarding Style|Developing an Instrument to Measure Personal Keyboarding Style|Completed||N/A|40||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:21:12.552151|2017-02-18 17:21:12.552151
NCT00167323|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-05-16|||July 2003||2003-07-01|May 2008|2008-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Early Recovery Adherence Therapy for Bipolar Alcoholics|Early Recovery Adherence Therapy for Bipolar Alcoholics|Completed||N/A|48||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:21:12.640181|2017-02-18 17:21:12.640181
NCT00167310|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-07|||September 2005||2005-09-01|March 2016|2016-03-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|CAD||Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation|CAD Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation|Completed||Phase 2|57|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:21:12.734532|2017-02-18 17:21:12.734532
NCT00167297|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-10|||November 2004||2004-11-01|June 2010|2010-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Atomoxetine for the Treatment of Cannabis Dependence|A Pilot Trial of Atomoxetine to Enhance Motivational Interviewing Therapy for the Treatment of Cannabis Dependence|Completed||Phase 2|16|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 17:21:12.850649|2017-02-18 17:21:12.850649
NCT00167284|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||October 2001||2001-10-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Patient Provider Partnership: Improving Diabetes Care in the Community|Patient Provider Partnership: Improving Diabetes Care in the Community|Completed||N/A|270||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:21:12.967934|2017-02-18 17:21:12.967934
NCT00167271|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-02-18|||October 2002||2002-10-01|February 2011|2011-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Promoting Health in People With Fibromyalgia|Efficacy of Computer and SenseWear Technologies for Promoting Health in People With Fibromyalgia: A Randomized Clinical Trial|Completed||N/A|72|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:21:13.048041|2017-02-18 17:21:13.048041
NCT00167258|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-12-14||||||December 2009|2009-12-01|February 2007||2007-02-01|||||Interventional|||Effectiveness and Costs of Enhanced Cocaine Treatments||Completed||Phase 2|||University of Pennsylvania|||||f||||||||||||||2017-02-18 17:21:13.154782|2017-02-18 17:21:13.154782
NCT00167245|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-08-21|2013-04-24||September 2004||2004-09-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|March 2010|Actual|2010-03-01||Interventional|TOP2||Topiramate for Alcohol and Cocaine Dependence|A Phase II, Randomized, Double-blind, Placebo-Controlled, Pilot Trial of Topiramate for Alcohol and Comorbid Cocaine Dependence|Completed||Phase 2|170|Actual|University of Pennsylvania|The total number of subjects was relatively small and thus the results should be considered preliminary. The study drop-out rate was formidable, though it was comparable with most trials involving cocaine-dependent patients.|2|||f||||t||||||||||2017-02-18 17:21:13.232139|2017-02-18 17:21:13.232139
NCT00167232|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-10-05|||January 1998||1998-01-01|September 2013|2013-09-01|July 2003|Actual|2003-07-01|February 2003|Actual|2003-02-01||Interventional|||Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence|Naltrexone and Psychosocial Treatments for the Treatment of Cocaine Dependence Complicated by Alcohol Dependence|Completed||Phase 3|164|Actual|University of Pennsylvania||2|||f||||||||||||||2017-02-18 17:21:13.843128|2017-02-18 17:21:13.843128
NCT00167219|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-08-15|||December 1999||1999-12-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)|Hematopoietic Cell Transplantation in Children With Juvenile Myelomonocytic Leukemia|Recruiting||Phase 1/Phase 2|20|Anticipated|Masonic Cancer Center, University of Minnesota||1|||f||||t||||||||||2017-02-18 17:21:14.198304|2017-02-18 17:21:14.198304
NCT00005403|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||February 1991||1991-02-01|June 2000|2000-06-01|January 1993|Actual|1993-01-01|||||Observational|||Heart Disease and the Black Health Disadvantage||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:02.29417|2017-02-18 18:15:02.29417
NCT00167206|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-11-30|2009-07-07||March 2004||2004-03-01|November 2009|2009-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Stem Cell Transplantation for Fanconi Anemia|A Study of Thymic Shielding in Recipients of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Stem Cell Transplantation in Patients With Fanconi Anemia|Terminated||Phase 1/Phase 2|16|Actual|Masonic Cancer Center, University of Minnesota|Study ended early as thymic shielding was found to be safe. Therefore, a new study was designed using thymic shielding.|1||Treatment with thymic shielding found safe, another study started.|f||||t||||||||||2017-02-18 17:21:14.324963|2017-02-18 17:21:14.324963
NCT00167180|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-02-23|||January 2004||2004-01-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|February 2016|Actual|2016-02-01||Interventional|||Post Transplant Donor Lymphocyte Infusion|Use of Cyclophosphamide/Fludarabine to Promote in Vivo Expansion of Donor Lymphocyte Infusions (DLI) to Enhance Efficacy After Allogeneic Transplant|Active, not recruiting||Phase 2|100|Anticipated|Masonic Cancer Center, University of Minnesota||2|||f||||t||||||||||2017-02-18 17:21:14.64813|2017-02-18 17:21:14.64813
NCT00167167|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-07-07|||December 1995||1995-12-01|July 2009|2009-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia|Treatment of Relapsed Leukemia After Allogeneic Bone Marrow Transplantation Using Donor-Derived Lymphocytes|Completed||N/A|40|Actual|Masonic Cancer Center, University of Minnesota||1|||f||||f||||||||||2017-02-18 17:21:14.768804|2017-02-18 17:21:14.768804
NCT00167154|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2012-03-15|||June 2004||2004-06-01|March 2012|2012-03-01|August 2008|Actual|2008-08-01|April 2007|Actual|2007-04-01||Interventional|||Risperidone and Suicidality in Major Depressive Disorder|Efficacy of Risperidone in the Management of Suicidality in Major Depressive Disorder|Completed||Phase 3|30|Actual|University of Alabama at Birmingham||2|||f||||f||||||||||2017-02-18 17:21:14.873433|2017-02-18 17:21:14.873433
NCT00167141|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-02-01|||February 2005||2005-02-01|March 2007|2007-03-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Contraception in Normal and Subnormal Men|Hormonal Male Contraception in Men With Normal and Subnormal Semen Parameters|Terminated||Phase 2|41|Actual|University Hospital Muenster||1|||f||||||||||||||2017-02-18 17:21:14.983942|2017-02-18 17:21:14.983942
NCT00167128|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-14|||March 2005||2005-03-01|May 2006|2006-05-01||||||||Interventional|||The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility|The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility|Unknown status|Recruiting|N/A|30|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-02-18 17:21:15.090745|2017-02-18 17:21:15.090745
NCT00167115|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-07-09|||December 2004||2004-12-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Metabolic Effects of Alcohol|Metabolic Effects of Alcohol in the Form of Wine in Persons With Type 2 Diabetes Mellitus|Completed||N/A|20||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-02-18 17:21:15.195621|2017-02-18 17:21:15.195621
NCT00167102|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-02-27|2013-02-27||July 2005||2005-07-01|February 2013|2013-02-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Alefacept in Patients With Severe Scalp Alopecia Areata|A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate The Safety and Therapeutic Efficacy of Intramuscular Administration of Alefacept in Patients With Chronic, Severe Scalp Alopecia Areata|Completed||N/A|6|Actual|University of Minnesota - Clinical and Translational Science Institute|This study was limited by the number of patients randomized to receive treatment.|2|||f||||f||||||||||2017-02-18 17:21:15.299782|2017-02-18 17:21:15.299782
NCT00167089|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-10-05|||August 1998||1998-08-01|September 2009|2009-09-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Effects of Early Treadmill Training on Ambulatory Ability in Stroke Patients: Electromyographic and Kinematic Analyses|Effects of Early Treadmill Training on Ambulatory Ability in Stroke Patients: Electromyographic and Kinematic Analyses|Completed||N/A|40|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 17:21:15.815507|2017-02-18 17:21:15.815507
NCT00167076|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 1999||1999-08-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Observational|||Clinical Applications and Evaluations of A Portable In-Shoe Plantar Pressure Monitoring and Biofeedback Gait System for Ambulation Training in Stroke Rehabilitation|Clinical Applications and Evaluations of A Portable In-Shoe Plantar Pressure Monitoring and Biofeedback Gait System for Ambulation Training in Stroke Rehabilitation|Unknown status|Active, not recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:15.926962|2017-02-18 17:21:15.926962
NCT00167063|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 1999||1999-08-01|September 2005|2005-09-01|December 2000||2000-12-01|||||Observational|||Falls in Stroke Patients After Hospital Discharge: Prevalence and Risk Factors|Falls in Stroke Patients After Hospital Discharge: Prevalence and Risk Factors|Unknown status|Active, not recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:16.024058|2017-02-18 17:21:16.024058
NCT00167050|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-25|||July 2005||2005-07-01|June 2005|2005-06-01|June 2006||2006-06-01|||||Observational|||The Pathogenesis of Superior Limbic Keratoconjunctivitis||Unknown status|Recruiting|N/A|10||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:16.117002|2017-02-18 17:21:16.117002
NCT00167037|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||August 1999||1999-08-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Observational|||Fast Stepping in Stroke Patients for Fall Prediction and Prevention:Control Mechanisms and Clinical Implications|Fast Stepping in Stroke Patients for Fall Prediction and Prevention:Control Mechanisms and Clinical Implications|Unknown status|Active, not recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:16.191837|2017-02-18 17:21:16.191837
NCT00167024|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-25|||March 2005||2005-03-01|March 2005|2005-03-01||||||||Observational|||Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical Outcome||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:16.26508|2017-02-18 17:21:16.26508
NCT00166049|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-11-09|||April 2005||2005-04-01|September 2013|2013-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Education and Supportive Partners Improving Self-Care (ENSPIRE)|A Family Partnership Intervention in Heart Failure|Completed||N/A|170|Actual|Emory University||3|||f||||t||||||||||2017-02-18 17:21:16.345823|2017-02-18 17:21:16.345823
NCT00165841|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-13|2009-08-18||October 2004||2004-10-01|December 2009|2009-12-01|June 2008|Actual|2008-06-01|December 2005|Actual|2005-12-01||Interventional|||Maintenance Intermittent Therapy for Symptomatic GERD Patients|A Double-Blind, Placebo-Controlled Study of Rabeprazole 20 mg Maintenance Intermittent Therapy Following Acute Treatment in Patients Wth Symptomatic Gastroesophageal Reflux Disease|Completed||Phase 2|200|Actual|Eisai Inc.||2|||f||||f||||||||||2017-02-18 17:21:18.860237|2017-02-18 17:21:18.860237
NCT00166036|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-08-28|2012-06-08||September 2004||2004-09-01|August 2014|2014-08-01|April 2009|Actual|2009-04-01|March 2008|Actual|2008-03-01||Interventional|STOPCAP||Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells|Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells: Comparison of Atorvastatin With Pravastatin|Completed||Phase 2|36|Actual|Emory University|Detection of changes in Oxidative stress with significance requires a much larger cohort study.|2|||f||||f||||||||||2017-02-18 17:21:16.468986|2017-02-18 17:21:16.468986
NCT00166023|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-25|||August 2005||2005-08-01|November 2013|2013-11-01|December 2006||2006-12-01|||||Observational|||Outcomes Following Medical or Surgical Management of Endocarditis|A Review of Outcomes Following Medical or Surgical Management of Endocarditis|Completed||N/A|100||Emory University|||||f||||||||||||||2017-02-18 17:21:16.87355|2017-02-18 17:21:16.87355
NCT00166010|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-06-03|||October 2004||2004-10-01|June 2014|2014-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Effects of Nesiritide in Pediatric Patients With Heart Failure|A Single-center, Pharmacokinetic Evaluation of Nesiritide in the Pediatric Population With Heart Failure|Withdrawn||N/A|0|Actual|Emory University||1||"Observational study that DSMB placed on hold (withdrew 4 subjects). Protocol revised and~   received IND to become interventional PK study (no subjects enrolled)."|f||||t||||||||||2017-02-18 17:21:16.953582|2017-02-18 17:21:16.953582
NCT00165997|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-09|||February 2004||2004-02-01|December 2013|2013-12-01|October 2007|Actual|2007-10-01|||||Observational|||Quality of Life in Patients Post Radiofrequency Ablation|The Effects of Radiofrequency Ablation Procedures on Quality of Life in the Pediatric Cohort|Terminated||N/A|50|Anticipated|Emory University||||sufficient data collected for significant conclusive results|f||||||||||||||2017-02-18 17:21:17.060554|2017-02-18 17:21:17.060554
NCT00165984|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-04-04|2011-11-11||January 2004||2004-01-01|April 2012|2012-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy|Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy|Completed||N/A|224|Actual|Emory University|Relatively small number of patients given the low incidence of this mutation||1||f||||f||||||Samples With DNA|"~     Whole blood and serum.~   "|||2017-02-18 17:21:17.138276|2017-02-18 17:21:17.138276
NCT00165971|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-16|||December 2003||2003-12-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Recovery From General Anesthesia|Recovery From General Anesthesia|Completed||N/A|100||Emory University|||||f||||||||||||||2017-02-18 17:21:17.394891|2017-02-18 17:21:17.394891
NCT00165958|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-11|2013-07-17||January 2005||2005-01-01|July 2014|2014-07-01|July 2011|Actual|2011-07-01|July 2008|Actual|2008-07-01||Interventional|||Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts|Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts|Completed||Phase 4|40|Actual|Emory University|The limitations of this study include the small, predominately male patient population, lack of complete follow-up of secondary endpoint measurements at every time point.|2|||f||||f||||||||||2017-02-18 17:21:17.495665|2017-02-18 17:21:17.495665
NCT00165945|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-03-30|||June 2004||2004-06-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|March 2009|Actual|2009-03-01||Observational|||4-D Visualization Using Magnetic Resonance Imaging (MRI) in the Congenital Heart Disease Population|Using 4-D Visualization Software With Magnetic Resonance Images in the Congenital Heart Disease Population|Completed||N/A|500|Actual|Emory University|||1||f||||f||||||||||2017-02-18 17:21:17.860839|2017-02-18 17:21:17.860839
NCT00165932|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-05-30|||June 2004||2004-06-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|||Ventricular Synchrony in Pediatric Patients|A Single Center Prospective, Pilot Study Examining the Non-invasive Evaluation of Ventricular Synchrony in Pediatric Patients|Completed||N/A|145|Actual|Emory University|||1||f||||f||||||||||2017-02-18 17:21:17.958073|2017-02-18 17:21:17.958073
NCT00165919|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-12|||September 2005||2005-09-01|November 2013|2013-11-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Immune Response to Hepatitis C Virus|Immunologic Determinants of Hepatitis C Virus Infection Resolution or Persistence|Withdrawn||Phase 1|0|Actual|Emory University|||1|Not a clinical trial; human specimens from treatment site for basic research.|f||||f||||||||||2017-02-18 17:21:18.053278|2017-02-18 17:21:18.053278
NCT00165906|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-19|||January 2005||2005-01-01|November 2013|2013-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Thrombin Generation in Neonates|A Pilot Study Examining Thrombin Generation in the Neonatal Population|Completed||N/A|20|Actual|Emory University|||1||f||||f||||||Samples With DNA|"~     A blood sample is obtained to measure the thrombin level.~   "|||2017-02-18 17:21:18.167953|2017-02-18 17:21:18.167953
NCT00165893|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-12-23|||September 2004||2004-09-01|December 2013|2013-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease|Comparison of Internal Disc Decompression (IDD) vs. a Standardized Non-surgical Treatment Program for Chronic Low Back Pain Secondary to Mild to Moderate Degenerative Disc Disease (DDD)|Completed||Phase 4|50||Emory University|||||f||||||||||||||2017-02-18 17:21:18.260242|2017-02-18 17:21:18.260242
NCT00165880|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-30|||December 2004||2004-12-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|||||Interventional|||An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine|An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Metastatic Breast Cancer Patients Following Prior Anthracycline and Taxane Therapy|Terminated||Phase 2|62|Actual|Eisai Inc.||||This study was stopped prematurely due to lack of efficacy.|f||||||||||||||2017-02-18 17:21:18.343671|2017-02-18 17:21:18.343671
NCT00165867|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-06|||April 2005||2005-04-01|October 2006|2006-10-01||||||||Interventional|||An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin||Completed||Phase 2|40||Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:18.446204|2017-02-18 17:21:18.446204
NCT00165854|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-26|||March 2003||2003-03-01|October 2006|2006-10-01||||||||Interventional|||Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer||Completed||Phase 2|46||Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:18.770314|2017-02-18 17:21:18.770314
NCT00166829|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-07|||May 2004||2004-05-01|August 2003|2003-08-01||||||||Interventional|||The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus|The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus|Unknown status|Recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:20.948915|2017-02-18 17:21:20.948915
NCT00165828|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2014-06-26|||May 2005||2005-05-01|November 2013|2013-11-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization|Randomized Trial to Assess Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization|Terminated||Phase 4|157|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:21:19.33892|2017-02-18 17:21:19.33892
NCT00165815|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-05-08|||August 2002||2002-08-01|November 2005|2005-11-01|July 2005||2005-07-01|||||Interventional|||The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia||Completed||Phase 3|||Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:19.472377|2017-02-18 17:21:19.472377
NCT00165802|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-20|||May 2006||2006-05-01|August 2009|2009-08-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors|A Phase I Open Label Study of E7974 Administered on Day 1 of a 21-Day Cycle In Patients With Advanced Solid Tumors|Completed||Phase 1|40|Anticipated|Eisai Inc.||1|||f||||||||||||||2017-02-18 17:21:19.560574|2017-02-18 17:21:19.560574
NCT00167011|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-12-05|||July 1995||1995-07-01|November 2012|2012-11-01|January 2002|Actual|2002-01-01|||||Interventional|||Patterns of Coronary Artery Anatomy in Children With Congenital Heart Disease by Computed Tomography|Patterns of Coronary Artery Anatomy in Children With Congenital Heart Disease by Computed Tomography|Completed||N/A|200|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:19.666564|2017-02-18 17:21:19.666564
NCT00166998|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||March 2005||2005-03-01|February 2005|2005-02-01|July 2006||2006-07-01|||||Observational|||The Study of Infrared Imaging on Breast Cancer||Unknown status|Recruiting|N/A|600||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:19.76191|2017-02-18 17:21:19.76191
NCT00166985|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-12-26|||September 2004||2004-09-01|August 2004|2004-08-01|December 2008||2008-12-01|||||Observational|||The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients|The Role of Functional MRI and Doppler Sonography in Assessing Intratumoral Angiogenesis of Endometrial Cancer Patients|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:19.846893|2017-02-18 17:21:19.846893
NCT00166972|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Observational|||Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis|Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis|Completed||N/A|150||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:19.924044|2017-02-18 17:21:19.924044
NCT00166959|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||January 2005||2005-01-01|June 2005|2005-06-01|December 2005||2005-12-01|||||Observational|||Reliability and Validity of Modified Postural Assessment Scale for Stroke Patients and the Application of This Scale on Early Detection of Patients With Stroke at High Risk of Falls|Reliability and Validity of Modified Postural Assessment Scale for Stroke Patients and the Application of This Scale on Early Detection of Patients With Stroke at High Risk of Falls|Unknown status|Recruiting|N/A|90||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:19.999395|2017-02-18 17:21:19.999395
NCT00166946|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||June 2005||2005-06-01|November 2004|2004-11-01|January 2008||2008-01-01|||||Interventional|||Effects of Arsenic on Keratinocytes in a Skin Equivalent Model|Effects of Arsenic on Keratinocytes in a Skin Equivalent Model|Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:20.101329|2017-02-18 17:21:20.101329
NCT00166933|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-20|||June 2005||2005-06-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Minimal Erythema Dose of UV-B in Normal Population of Taiwan|Minimal Erythema Dose of UV-B in Normal Population of Taiwan|Completed||N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:20.183105|2017-02-18 17:21:20.183105
NCT00166920|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||July 2004||2004-07-01|February 2005|2005-02-01|July 2004||2004-07-01|||||Observational|||Measurement of Cerebral Oxygen Extraction Fraction Using MRI Technique||Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:20.260605|2017-02-18 17:21:20.260605
NCT00166907|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-13|||January 2002||2002-01-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||Balance Recovery and Training on Fall Prevention in Stroke|Balance Recovery and Training on Fall Prevention in Stroke|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:20.336727|2017-02-18 17:21:20.336727
NCT00166894|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||May 2005||2005-05-01|May 2005|2005-05-01||||||||Observational|||Use of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in the Diagnosis of Pleural Effusion|Evaluation of the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) as a Diagnostic Tool for Patients With Pleural Effusion|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:20.431028|2017-02-18 17:21:20.431028
NCT00166881|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-07-04|||June 2000||2000-06-01|November 2012|2012-11-01|June 2011|Actual|2011-06-01|December 2010|Actual|2010-12-01||Interventional|P-HDFL-DI||Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin|Phase II Trial of Consolidation or Salvage Chemotherapy by Using Weekly Docetaxel/Irinotecan After Cisplatin Plus Weekly 24-Hour Infusion of High-dose 5-Fluorouracil/Leucovorin for Non-resectable Gastric Cancers|Completed||Phase 2|29|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 17:21:20.516089|2017-02-18 17:21:20.516089
NCT00166868|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-08-19|||December 2003||2003-12-01|August 2013|2013-08-01|July 2012|Actual|2012-07-01|January 2012|Actual|2012-01-01||Interventional|||Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy|Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia|Completed||N/A|30|Actual|National Taiwan University Hospital||3|||f||||||||||||||2017-02-18 17:21:20.633295|2017-02-18 17:21:20.633295
NCT00166855|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-23|||July 2005||2005-07-01|May 2005|2005-05-01|July 2009||2009-07-01|||||Interventional|||Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma||Unknown status|Recruiting|N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:20.747496|2017-02-18 17:21:20.747496
NCT00166842|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2002||2002-09-01|July 2002|2002-07-01||||||||Interventional|||Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets|Effects of Conversion From Sirolimus Oral Solution to Tablets in Renal Transplant Recipients.|Unknown status|Active, not recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:20.851555|2017-02-18 17:21:20.851555
NCT00166816|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||March 2002||2002-03-01|July 2001|2001-07-01|June 2003||2003-06-01|||||Interventional|||The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients|The Pharmacokinetics and Dosage Regimen of Sirolimus in a Cyclosporine or Tacrolimus-Based Immunosuppression in Renal Transplant Patients|Unknown status|Active, not recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:21.036914|2017-02-18 17:21:21.036914
NCT00166803|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2009-01-02|||June 2005||2005-06-01|December 2008|2008-12-01||||November 2008|Anticipated|2008-11-01||Interventional|||The Impact of Rosiglitazone on Regression of Atherosclerosis|The Impact of Rosiglitazone on Regression of Atherosclerosis: A Serial 18F-Fluorodeoxyglucose Positron Emission Tomography Study|Suspended||N/A|60|Anticipated|National Taiwan University Hospital||1||no fund|f||||||||||||||2017-02-18 17:21:21.137516|2017-02-18 17:21:21.137516
NCT00166790|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2014-12-05|||September 2005||2005-09-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|December 2014|Anticipated|2014-12-01||Observational|||Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease|Detection of Minimal Amount of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease|Unknown status|Recruiting|N/A|30|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-02-18 17:21:21.238597|2017-02-18 17:21:21.238597
NCT00166777|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2006-09-07|||September 2005||2005-09-01|August 2005|2005-08-01|June 2006||2006-06-01|||||Interventional|||Effect of Hip Adduction Combination With Knee Extension Exercise on Morphology of Quadriceps Muscles, Pain and Functional Outcomes in Patients With PFPS||Unknown status|Recruiting|Phase 1|90||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:21.338788|2017-02-18 17:21:21.338788
NCT00166764|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-10-26|||September 2005||2005-09-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Observational|||A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders|A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:21.419925|2017-02-18 17:21:21.419925
NCT00166751|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-10-26|||September 2005||2005-09-01|December 2004|2004-12-01|November 2006||2006-11-01|||||Observational|||Sonographic Assessment of Laryngeal Elevation|Sonographic Assessment of Laryngeal Elevation in Cerebrovascular Accident Patients With Dysphagia|Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:21.500052|2017-02-18 17:21:21.500052
NCT00166738|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-08-23|||September 2005||2005-09-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Observational|||Analysis of Genomic DNA Alterations in Familial Schizophrenia|Analysis of Genomic DNA Alterations in Familial Schizophrenia|Unknown status|Recruiting|N/A|20|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:21:21.582851|2017-02-18 17:21:21.582851
NCT00166725|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-11-18|||February 2004||2004-02-01|November 2009|2009-11-01||||||||Interventional|||Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients|A Randomized, Open Label, Multicenter Study Evaluating the Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients|Completed||Phase 2|40|Anticipated|Novartis|||||f||||||||||||||2017-02-18 17:21:21.654186|2017-02-18 17:21:21.654186
NCT00166712|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-10-20|2012-11-29||April 2005||2005-04-01|October 2015|2015-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|Cell220||A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression|A Phase IV, Single Center Pilot Study Using Alemtuzumab (Campath-1H) Induction Combined With Prednisone-Free, Calcineurin-Inhibitor-Free Immunosuppression in Kidney Transplantation|Terminated||Phase 4|40|Actual|Northwestern University||2||Study stopped due to lack of efficacy & funding.|f||||t||||||||||2017-02-18 17:21:21.753482|2017-02-18 17:21:21.753482
NCT00166699|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-06-10|||September 2005||2005-09-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Trial of the Use of Ultrasound to Aid the Insertion of Combined Spinal Epidural Anaesthesia|The Clinical Evaluation of a Novel Ultrasound Probe to Guide the Insertion of Central Regional Anaesthesia Using a Regional Anaesthetic Needle Modified to Aid Insertion Under Ultrasound Guidance in Morbidly Obese Women Undergoing Elective Caesarean Section|Completed||Phase 3|42|Actual|NHS Greater Glasgow and Clyde||2|||f||||f||||||||||2017-02-18 17:21:22.323705|2017-02-18 17:21:22.323705
NCT00166686|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-01-10||||||January 2013|2013-01-01||||||||Interventional|||Clonidine for Neurocognitive Sequelae|Clonidine for the Treatment of Neurocognitive Sequelae Following Cancer Treatment in Children|Withdrawn||Phase 1/Phase 2|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Study was never initiated|f||||||||||||||2017-02-18 17:21:22.440081|2017-02-18 17:21:22.440081
NCT00166673|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-09-02|||August 2005||2005-08-01|September 2016|2016-09-01|August 2007|Actual|2007-08-01|||||Interventional|||Pilot Study of the Navigator Continuous Glucose Monitor|A Pilot Study to Evaluate the Navigator Continuous Glucose Sensor in the Management of Type 1 Diabetes in Children|Completed||Phase 2/Phase 3|60||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:21:22.537817|2017-02-18 17:21:22.537817
NCT00166660|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-04-01|||July 2004||2004-07-01|March 2009|2009-03-01|June 2009|Anticipated|2009-06-01|December 2008|Anticipated|2008-12-01||Interventional|||Preterm Fetal Growth Restriction and Developmental Care|Preterm Fetal Growth Restriction and Developmental Care|Unknown status|Recruiting|Phase 2|30|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-02-18 17:21:22.651004|2017-02-18 17:21:22.651004
NCT00166647|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-01-10|||February 2004||2004-02-01|January 2013|2013-01-01||||||||Observational|||Thiopurine Methyltransferase Polymorphisms Evaluation|Evaluation of Thiopurine Methyltransferase Polymorphisms in the Hispanic Population|Withdrawn||Phase 4|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Observational Study should not be in CT.gov|f||||||||||||||2017-02-18 17:21:22.761174|2017-02-18 17:21:22.761174
NCT00166634|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-01-10|||July 2003||2003-07-01|January 2011|2011-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Ambulatory Blood Pressure Monitoring in Hypertension|The Role of Ambulatory Blood Pressure Monitoring (ABPM) in Interventional Trials Conducted in Children With Hypertension|Completed||N/A|126|Anticipated|Arkansas Children's Hospital Research Institute|||||f||||f||||||||||2017-02-18 17:21:22.837186|2017-02-18 17:21:22.837186
NCT00166621|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-07-19|||March 2004||2004-03-01|July 2011|2011-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy|Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy|Completed||Phase 1/Phase 2|20||Chugani, Diane C.|||||f||||t||||||||||2017-02-18 17:21:22.934135|2017-02-18 17:21:22.934135
NCT00166608|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-04-10|||December 2002||2002-12-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|May 2007|Actual|2007-05-01||Observational|||Cytokines Polymorphisms and Acetaminophen Toxicity|Measurement of Nitrotyrosine Adducts and Cytokines in Acetaminophen Overdose Patients|Completed||N/A|111|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-02-18 17:21:23.028312|2017-02-18 17:21:23.028312
NCT00166595|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-01-27|||February 2003||2003-02-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|||||Interventional|||Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)|Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)|Completed||Phase 1/Phase 2|100||Children's Hospital Medical Center, Cincinnati|||||f||||f||||||||||2017-02-18 17:21:23.138416|2017-02-18 17:21:23.138416
NCT00166582|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-06-28|||April 2002||2002-04-01|November 2005|2005-11-01|September 2005||2005-09-01|||||Interventional|||Parent-Youth Teamwork in Pediatric Asthma Management|Parent-Youth Teamwork in Pediatric Asthma Management|Completed||Phase 2|60||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:21:23.23304|2017-02-18 17:21:23.23304
NCT00166569|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-10-05|||January 2003||2003-01-01|October 2015|2015-10-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Observational|||The Genetics of Polycystic Ovarian Syndrome|The Genetics of Polycystic Ovarian Syndrome|Recruiting||N/A|2700|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||1||f||||f||||||||||2017-02-18 17:21:23.324834|2017-02-18 17:21:23.324834
NCT00166556|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-20|||January 2005||2005-01-01|May 2011|2011-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation|Thistlethwaite Protocol # ITN025ST - Immunosuppression With Campath-1H and Tacrolimus in Liver Transplantation|Completed||Phase 2|10|Anticipated|Mayo Clinic|||||||||||||||||||2017-02-18 17:21:23.433084|2017-02-18 17:21:23.433084
NCT00166543|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-07-28||2015-06-26|May 2004||2004-05-01|June 2015|2015-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer|A Phase II, Randomized, Double-Blinded Efficacy and Safety Study of Three Doses of TAS-108 Administered Orally in Postmenopausal Patients With Locally Advanced or Locally Recurrent Inoperable or Progressive Metastatic Breast Cancer Following Standard First-Line Endocrine Therapy|Completed||Phase 2|146|Actual|SRI International||3|||f||||||||||||||2017-02-18 17:21:23.766264|2017-02-18 17:21:23.766264
NCT00166530|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-05-13|||November 2005||2005-11-01|May 2016|2016-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)|A Prospective Randomized Open Label Blinded Endpoint Multicenter Study in Patients With Coronary Artery Disease to Assess the LDL Lowering Effect of Switching to Ezetimibe (+) Simvastatin for Cholesterol Lowering, Compared the Dose of the Statin Used.|Completed||Phase 4|367|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:21:23.886365|2017-02-18 17:21:23.886365
NCT00166517|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-03-12|2009-07-06||August 2005||2005-08-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||V260 Registration Study (V260-013)(COMPLETED)|Immunogenicity and Safety of V260 in Healthy Infants in Korea|Completed||Phase 3|178|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:21:24.001286|2017-02-18 17:21:24.001286
NCT00166504|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-12-17|2008-10-13||October 2005||2005-10-01|December 2015|2015-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)|A Multicenter, Randomized, Open-label Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe (+) Simvastatin Versus Atorvastatin in Patients With Primary Hypercholesterolemia|Completed||Phase 4|203|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:21:24.501381|2017-02-18 17:21:24.501381
NCT00166491|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-04-15|||July 2005||2005-07-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care Unit|Comparison of Two Approved Insulin Infusion Protocols for Glycemic Control in Critically Ill Patients|Completed||N/A|238|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 17:21:24.90832|2017-02-18 17:21:24.90832
NCT00166478|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-26|||April 2002||2002-04-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Exisulind Prior to Radical Prostatectomy|A Prospective Controlled Phase II Study of Preoperative Exisulind Therapy Initiated Prior to Radical Prostatectomy: Effect on Apoptosis|Completed||Phase 2|130|Actual|Mayo Clinic|||||||||||||||||||2017-02-18 17:21:25.005654|2017-02-18 17:21:25.005654
NCT00166465|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-03-11|||August 2003||2003-08-01|March 2011|2011-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Stage IV Colorectal CA ALIMTA|A Phase I Dose-Finding Study and a Randomized Phase II Study of ALIMTA Plus Oxaliplatin Versus Oxaliplatin Plus 5-Fluorouracil and Leucovorin (FOLFOX 4 Regimen) in the First-Line Treatment of Patients With Locally Advanced Unresectable or Stage IV Colorectal Cancer|Completed||Phase 1/Phase 2|200||Mayo Clinic|||||f||||t||||||||||2017-02-18 17:21:25.093831|2017-02-18 17:21:25.093831
NCT00166452|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-03-22|||July 2005||2005-07-01|March 2011|2011-03-01|February 2009|Actual|2009-02-01|April 2007|Actual|2007-04-01||Interventional|||A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1|Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidamide in the Treatment of Complex Regional Pain Syndrome Type1|Completed||Phase 3|7|Actual|Mayo Clinic|||||||||||||||||||2017-02-18 17:21:25.193617|2017-02-18 17:21:25.193617
NCT00166439|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-10-29|||March 2005||2005-03-01|October 2015|2015-10-01||||September 2015|Actual|2015-09-01||Interventional|||Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma|A Phase II Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma|Completed||Phase 2|50|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 17:21:25.277673|2017-02-18 17:21:25.277673
NCT00166426|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-11-13|||February 2003||2003-02-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|May 2007|Actual|2007-05-01||Interventional|||Exisulind Versus Placebo After Surgical Removal of the Prostate|Prospective, Randomized, Double-Blind Trial of Adjuvant Exisulind Versus Placebo for Patients at Risk for Prostate Cancer Recurrence After Radical Prostatectomy|Completed||Phase 2|240|Anticipated|Mayo Clinic|||||||||||||||||||2017-02-18 17:21:25.377692|2017-02-18 17:21:25.377692
NCT00166413|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-05-05|||April 2005||2005-04-01|May 2011|2011-05-01||||December 2006|Actual|2006-12-01||Interventional|||Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis|A Phase II Trial of CC-5013 in Patients With Primary Systemic Amyloidosis|Completed||Phase 2|38|Anticipated|Mayo Clinic||1|||f||||t||||||||||2017-02-18 17:21:25.460758|2017-02-18 17:21:25.460758
NCT00166400|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-07-23|||July 2004||2004-07-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.|Beta Blockade in Mitral Regurgitation|Completed||Phase 4|60|Anticipated|Mayo Clinic||1|||f||||||||||||||2017-02-18 17:21:25.56262|2017-02-18 17:21:25.56262
NCT00166387|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-03-24|||April 2003||2003-04-01|March 2014|2014-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Hemophilia Inhibitor Genetics Study (HIGS)|Hemophilia Inhibitor Genetics Study (HIGS)|Completed||N/A|1137|Actual|Skane University Hospital|||1||f||||t||||||Samples With DNA|"~     Plasma, cells, DNA~   "|||2017-02-18 17:21:25.66082|2017-02-18 17:21:25.66082
NCT00166374|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-19||||||January 2010|2010-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||To Evaluate Success of Cement Treatment of Spinal Compression Fractures|Outcomes Following Balloon Kyphoplasty for Vertebral Compression Fracture|Completed||N/A|200|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 17:21:25.768453|2017-02-18 17:21:25.768453
NCT00166361|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-06-19|2014-06-19||February 2004||2004-02-01|June 2014|2014-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent|Long-Term Temporary Drainage of Malignant Extrinsic Ureteral Obstruction Secondary to Inoperable Pelvic or Abdominal Malignancies Using the Memokath 051 Ureteral Stent|Completed||N/A|29|Actual|Mayo Clinic|Low number of subjects in each cohort.|2|||f||||t||||||||||2017-02-18 17:21:25.862946|2017-02-18 17:21:25.862946
NCT00165789|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2015-05-28|2015-04-15||September 2005||2005-09-01|April 2015|2015-04-01|September 2006|Actual|2006-09-01|February 2006|Actual|2006-02-01||Interventional|||A Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations|A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Explore the Safety And Tolerability of Doses of E2007 Up to a Maximum of 8 mg In Patients With Parkinson's Disease Who Experience End-of-Dose Wearing Off Motor Fluctuations|Completed||Phase 2|75|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:26.358688|2017-02-18 17:21:26.358688
NCT00165776|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-02-06|2013-07-12||June 2004||2004-06-01|February 2014|2014-02-01|November 2006|Actual|2006-11-01|May 2006|Actual|2006-05-01||Interventional||After randomized to the treatment groups, 3 patients (2 of the placebo group and 1 of the 5000U group) had no treatment. The reason was that 2 of them requested withdrawal from the study and 1 ceased to return for visits.|Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis|Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis|Completed||Phase 2|133|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:27.500414|2017-02-18 17:21:27.500414
NCT00165763|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-05-02|||September 2005||2005-09-01|September 2009|2009-09-01||||September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia|An Open Label Study on the Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia|Completed||Phase 4|36|Actual|Eisai Inc.||1|||f||||t||||||||||2017-02-18 17:21:28.210903|2017-02-18 17:21:28.210903
NCT00165750|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-19|||March 2005||2005-03-01|November 2013|2013-11-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients|Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients|Terminated||Phase 4|40|Actual|Eisai Inc.||1||Lack of patients to enroll.|f||||||||||||||2017-02-18 17:21:28.329074|2017-02-18 17:21:28.329074
NCT00165737|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-03-31|||March 2003||2003-03-01|March 2011|2011-03-01|June 2006|Actual|2006-06-01|August 2005|Actual|2005-08-01||Interventional|||Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease|A 24-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy, Safety and Tolerability of Donepezil Hydrochloride (E2020) in Patients With Dementia Associated With Cerebrovascular Disease|Completed||Phase 3|974|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:28.423561|2017-02-18 17:21:28.423561
NCT00165724|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-05-02|||June 2004||2004-06-01|July 2010|2010-07-01|December 2006|Actual|2006-12-01|July 2006|Actual|2006-07-01||Interventional|||Alzheimer's Disease Long-term Follow-up Study (ALF Study)|Alzheimer's Disease Long-term Follow-up Study (ALF Study)|Completed||Phase 4|114|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:31.363956|2017-02-18 17:21:31.363956
NCT00165711|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-08|||March 2003||2003-03-01|December 2005|2005-12-01||||||||Interventional|||The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.||Completed||Phase 4|||Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:31.451887|2017-02-18 17:21:31.451887
NCT00165698|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-07-11|2010-12-02||May 2005||2005-05-01|July 2014|2014-07-01|July 2007|Actual|2007-07-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women|Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women|Completed||Phase 3|240|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:21:31.554022|2017-02-18 17:21:31.554022
NCT00165685|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-28|||July 2004||2004-07-01|January 2010|2010-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Comparative Study of KES524 in Patients With Obesity Disease|A Double-Blind, Placebo-Controlled, Comparative Study of KES524 in Patients With Obesity Disease|Completed||Phase 3|||Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:32.142049|2017-02-18 17:21:32.142049
NCT00165672|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-09-06|2011-07-19||May 2005||2005-05-01|August 2010|2010-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease|A Clinical Pharmacology Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease|Completed||Phase 3|26|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:21:32.515642|2017-02-18 17:21:32.515642
NCT00165659|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-28|||November 2002||2002-11-01|January 2010|2010-01-01||||May 2005|Actual|2005-05-01||Interventional|||A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020||Completed||Phase 2|||Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:32.892112|2017-02-18 17:21:32.892112
NCT00165646|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-07-14|2011-05-23||September 2004||2004-09-01|August 2010|2010-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease|A Double-Blind, Placebo-Controlled, Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease|Completed||Phase 3|288|Actual|Eisai Inc.||3|||f||||||||||||||2017-02-18 17:21:33.080925|2017-02-18 17:21:33.080925
NCT00165633|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-12-05|||March 2004||2004-03-01|December 2008|2008-12-01|March 2007|Actual|2007-03-01|||||Interventional|||A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma|A Randomized, Placebo-Controlled, Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma|Terminated||Phase 2/Phase 3|540|Anticipated|Eisai Inc.||3|||f||||||||||||||2017-02-18 17:21:33.706727|2017-02-18 17:21:33.706727
NCT00165620|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-28|||November 2004||2004-11-01|January 2010|2010-01-01||||April 2005|Actual|2005-04-01||Interventional|||A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease||Completed||Phase 2|||Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:34.100102|2017-02-18 17:21:34.100102
NCT00165607|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-28|||April 1996||1996-04-01|January 2010|2010-01-01||||June 2005|Actual|2005-06-01||Interventional|||Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)||Completed||Phase 4|||Eisai Inc.|||||f||||||||||||||2017-02-18 17:21:34.178528|2017-02-18 17:21:34.178528
NCT00165594|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-01-22|||February 2005||2005-02-01|January 2014|2014-01-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||A Study of E7070 in Patients With Gastric Cancer|Non-Randomized, Open, Uncontrolled, Dose Comparison Study of E7070 in Patients With Gastric Cancer|Terminated||Phase 1/Phase 2|50||Eisai Inc.||||Study was completed.|f||||||||||||||2017-02-18 17:21:34.259924|2017-02-18 17:21:34.259924
NCT00165581|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-12-20|||December 2002||2002-12-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma|A Pilot Clinical Trial to Evaluate High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Favorable Stage I and II Breast Cancer|Terminated||N/A|15||Dana-Farber Cancer Institute||||Due to continuing review|f||||||||||||||2017-02-18 17:21:34.358709|2017-02-18 17:21:34.358709
NCT00165568|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-10-30|||July 2005||2005-07-01|October 2009|2009-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer|Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer|Completed||Phase 2|20||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:34.453801|2017-02-18 17:21:34.453801
NCT00165555|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-03-26|||August 1999||1999-08-01|March 2014|2014-03-01|November 2009|Actual|2009-11-01|April 2002|Actual|2002-04-01||Interventional|||Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma|Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin and Intravenous Sodium Thiosulfate in the Multimodality Treatment of Malignant Pleural Mesothelioma|Completed||Phase 1|70|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:21:34.554827|2017-02-18 17:21:34.554827
NCT00165542|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-21|||June 1998||1998-06-01|November 2016|2016-11-01|August 2009|Actual|2009-08-01|February 2004|Actual|2004-02-01||Observational|||A-protein Levels in Adult and Pediatric Brain Tumor Patients|Determination of A-Protein Levels in Adult and Pediatric Brain Tumor Patients|Completed||N/A|54|Actual|Dana-Farber Cancer Institute|||1||f||||f||||||Samples With DNA|"~     whole blood cerebrospinal fluid~   "|No||2017-02-18 17:21:34.659173|2017-02-18 17:21:34.659173
NCT00165516|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2014-03-26|||January 2004||2004-01-01|March 2014|2014-03-01|December 2009|Actual|2009-12-01|July 2006|Actual|2006-07-01||Interventional|||Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate|A Phase II Feasibility Study of Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate|Completed||Phase 2|85|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:21:34.772676|2017-02-18 17:21:34.772676
NCT00165503|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-07-25|2014-04-23||April 2004||2004-04-01|July 2016|2016-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate|A Phase II Feasibility Study of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate Followed ny Adjuvant ALIMTA/Cisplatin|Terminated||Phase 2|16|Actual|Dana-Farber Cancer Institute|This trial was terminated due to low accrual and feasibility.|1||lack of acurral|f||||t||||||||No||2017-02-18 17:21:34.877431|2017-02-18 17:21:34.877431
NCT00165490|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-11-07|||August 2004||2004-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2007|Actual|2007-11-01||Interventional|||Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer|Phase II Trial of Cetuximab, Irinotecan, Cisplatin (CPC), Concurrent Radiation Therapy, and Surgery for Resectable Esophageal Cancer|Completed||Phase 2|19|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:21:35.121199|2017-02-18 17:21:35.121199
NCT00165477|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-03-08|||September 2005||2005-09-01|March 2010|2010-03-01|July 2009|Actual|2009-07-01|November 2007|Actual|2007-11-01||Interventional|||Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study of Lenalidomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme.|Completed||Phase 2|23|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:21:35.235816|2017-02-18 17:21:35.235816
NCT00165464|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-04-24|||August 2001||2001-08-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|March 2005|Actual|2005-03-01||Interventional|||Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer|A Phase II Trial of Taxotere, Cisplatin, and Irinotecan in Advanced Esophageal and Gastric Cancer|Completed||Phase 2|54|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:21:35.360466|2017-02-18 17:21:35.360466
NCT00165451|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-07-06|||June 2001||2001-06-01|July 2011|2011-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer|Anti-Angiogenic Chemotherapy: A Phase II Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer|Completed||Phase 2|20|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-02-18 17:21:35.471308|2017-02-18 17:21:35.471308
NCT00165438|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-12-19|||October 2001||2001-10-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|November 2005|Actual|2005-11-01||Observational|||Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy|A Prospective Study of Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy With or Without Mediastinal Irradiation|Completed||N/A|60|Actual|Dana-Farber Cancer Institute|||1||f||||t||||||||||2017-02-18 17:21:35.580363|2017-02-18 17:21:35.580363
NCT00165425|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-09|||February 2004||2004-02-01|March 2016|2016-03-01|April 2016|Anticipated|2016-04-01|October 2007|Actual|2007-10-01||Interventional|||Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation|Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation|Active, not recruiting||N/A|210|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||No||2017-02-18 17:21:35.679695|2017-02-18 17:21:35.679695
NCT00165412|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-08-13|||July 2005||2005-07-01|August 2012|2012-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease|Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease|Completed||N/A|168|Anticipated|Dana-Farber Cancer Institute|||1||f||||f||||||||||2017-02-18 17:21:35.782852|2017-02-18 17:21:35.782852
NCT00165399|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-07-02|||March 2004||2004-03-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|April 2005|Actual|2005-04-01||Interventional|||Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment|Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment|Completed||Phase 2|61|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:21:35.876969|2017-02-18 17:21:35.876969
NCT00165386|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-12-07|||July 2001||2001-07-01|December 2009|2009-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients|MRI-guided Bone Marrow Biopsies of Advanced CaP Patients|Completed||N/A|20||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:35.976359|2017-02-18 17:21:35.976359
NCT00165373|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-21|||January 2003||2003-01-01|December 2007|2007-12-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||rhEndostatin Protein Involving Pediatric Patients With Cancer|A Phase I, Safety, Pharmacokinetic and Pharmacodynamic Study of rhEndostatin Protein Administered by Continuous Intravenous Infusion to Pediatric Patients With Cancer|Terminated||Phase 1|21|Actual|Dana-Farber Cancer Institute||1||Lack of drug supply|f||||f||||||||||2017-02-18 17:21:36.061027|2017-02-18 17:21:36.061027
NCT00165360|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-10-30|||September 2001||2001-09-01|October 2009|2009-10-01|September 2009|Actual|2009-09-01|December 2006|Actual|2006-12-01||Interventional|||Prolonged Daily Temozolomide for Low-Grade Glioma|A Phase II Study of Prolonged Daily Temozolomide for Low-Grade Glioma|Completed||Phase 2|46|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:21:36.158896|2017-02-18 17:21:36.158896
NCT00165347|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-20|||December 2003||2003-12-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Protein Tyrosine Kinases (PTK) in Multiple Myeloma|Phase II Study of PTK787/ZK222584 in Multiple Myeloma|Completed||Phase 2|10||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:36.259203|2017-02-18 17:21:36.259203
NCT00165334|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-07-21|||June 2005||2005-06-01|July 2009|2009-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer|Phase II Trial of Cetuximab Plus Vinorelbine in Previously Untreated Patients > 70 With Advanced NSCLC|Completed||Phase 2|53||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:36.357434|2017-02-18 17:21:36.357434
NCT00165308|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-07-08|||April 2001||2001-04-01|July 2014|2014-07-01|June 2009|Actual|2009-06-01|March 2004|Actual|2004-03-01||Interventional|||Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors|A Feasibility Study of Tamoxifen Prevention of Breast Cancer in Hodgkin's Disease Survivors|Completed||N/A|29|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:21:36.467257|2017-02-18 17:21:36.467257
NCT00165295|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-06-23|||September 2005||2005-09-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Sildenafil Citrate in Waldenstrom's Macroglobulinemia|Phase II Study of Sildenafil Citrate in Waldenstrom's Macroglobulinemia|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:36.580341|2017-02-18 17:21:36.580341
NCT00165282|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-26|||April 2005||2005-04-01|November 2013|2013-11-01|June 2011|Actual|2011-06-01|January 2010|Actual|2010-01-01||Interventional|||Mindfulness Meditation in Bone Marrow Transplantation|Mindfulness Meditation in Bone Marrow Transplantation|Completed||Phase 2/Phase 3|241|Actual|Emory University||3|||f||||t||||||||||2017-02-18 17:21:36.689336|2017-02-18 17:21:36.689336
NCT00165269|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-10-30|||May 1992||1992-05-01|October 2009|2009-10-01|February 2008|Actual|2008-02-01|June 2000|Actual|2000-06-01||Interventional|||Mantle Irradiation for Hodgkin's Disease|Mantle Irradiation for Selected Hodgkin's Disease Patients With Stage IA-IIA Disease|Completed||Phase 2|100|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:21:36.801826|2017-02-18 17:21:36.801826
NCT00165256|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-07-05|||May 1995||1995-05-01|July 2016|2016-07-01|April 2017|Anticipated|2017-04-01|July 2002|Actual|2002-07-01||Observational|||Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast|Wide Excision Alone for DCIS-Grades 1 and 2|Terminated||Phase 2|158|Actual|Dana-Farber Cancer Institute|||1|The pre-specified stopping boundary was reached.|f||||f||||||||No||2017-02-18 17:21:36.974784|2017-02-18 17:21:36.974784
NCT00165243|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-01-26|||September 1998||1998-09-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|January 2004|Actual|2004-01-01||Interventional|||Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer|Tangential Radiation Therapy Without Axillary Dissection in Early-Stage Breast Cancer|Active, not recruiting||Phase 2|100|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-02-18 17:21:37.263425|2017-02-18 17:21:37.263425
NCT00165230|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-04-27|||May 2002||2002-05-01|April 2009|2009-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors|A Phase II Study of Thalidomide in Combination With Temodar in Patients With Metastatic Neuroendocrine Tumors|Completed||Phase 2|32||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:37.358007|2017-02-18 17:21:37.358007
NCT00165217|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-20|||November 2001||2001-11-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma|A Phase II Trial of Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma|Completed||Phase 2|37||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:37.46941|2017-02-18 17:21:37.46941
NCT00165204|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-20|||April 2004||2004-04-01|December 2007|2007-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy|A Randomized Study of the Effects of Tibolone on Bone Density, Menopause Symptoms and Breast Density in High Risk Women After Prophylactic Oophorectomy|Completed||Phase 2|50||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:37.565513|2017-02-18 17:21:37.565513
NCT00165191|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-04-27|||August 1998||1998-08-01|April 2009|2009-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus|A Phase II Study of Doxorubicin, Cisplatin, and 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus|Completed||Phase 2|32||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:37.674002|2017-02-18 17:21:37.674002
NCT00165178|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-04-23|||September 2000||2000-09-01|April 2013|2013-04-01|May 2011|Actual|2011-05-01|December 2004|Actual|2004-12-01||Interventional|||Treatment of Acute Lymphoblastic Leukemia in Children|Treatment of Acute Lymphoblastic Leukemia in Children|Completed||Phase 3|498|Actual|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-02-18 17:21:37.772045|2017-02-18 17:21:37.772045
NCT00165152|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-08-07|||July 1998||1998-07-01|August 2012|2012-08-01|June 2005|Actual|2005-06-01|September 2001|Actual|2001-09-01||Interventional|||Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing|A Randomized Study of Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing|Completed||N/A|150|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 17:21:37.914472|2017-02-18 17:21:37.914472
NCT00165139|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-10-30|||January 1996||1996-01-01|October 2009|2009-10-01|February 2009|Actual|2009-02-01|November 2000|Actual|2000-11-01||Interventional|||Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas|Double Dose Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Stage Neuroblastoma and Sarcomas|Completed||Phase 2|20|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:21:38.02562|2017-02-18 17:21:38.02562
NCT00165126|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-10-30|||January 2004||2004-01-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|January 2006|Actual|2006-01-01||Observational|||Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma|Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma|Completed||N/A|40|Actual|Dana-Farber Cancer Institute|||1||f||||t||||||||||2017-02-18 17:21:38.136751|2017-02-18 17:21:38.136751
NCT00165100|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-20|||January 2000||2000-01-01|December 2007|2007-12-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer|Dynamic Area Telethermometry (DAT) as an Auxiliary Imaging Modality in Assessment of Patients With Cancer|Completed||N/A|50||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:21:38.234952|2017-02-18 17:21:38.234952
NCT00165087|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-12-20|||January 1996||1996-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment of Childhood Acute Lymphoblastic Leukemia|Treatment of Childhood Acute Lymphoblastic Leukemia|Terminated||Phase 3|491||Dana-Farber Cancer Institute||||Terminated by IRB for continuing review|||||||||||||||2017-02-18 17:21:38.319932|2017-02-18 17:21:38.319932
NCT00165074|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-11-19|||June 2003||2003-06-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation|Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With|Completed||N/A|11|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 17:21:38.434473|2017-02-18 17:21:38.434473
NCT00165061|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2005-09-13|||July 2000||2000-07-01|September 2005|2005-09-01||||||||Interventional|||Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer – Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)|Phase 3 Multicenter Randomized Study Comparing Esophagectomy Against Definitive Chemoradiation for Treatment of Squamous Esophageal Cancer|Completed||Phase 3|80||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:38.528659|2017-02-18 17:21:38.528659
NCT00165048|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-08|||October 2004||2004-10-01|September 2005|2005-09-01||||||||Interventional|||Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial|Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial|Unknown status|Active, not recruiting|Phase 3|206||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:38.614818|2017-02-18 17:21:38.614818
NCT00165035|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-03|||May 2005||2005-05-01|August 2011|2011-08-01|July 2011|Actual|2011-07-01|January 2007|Actual|2007-01-01||Interventional|||Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)|Multi-Center, Single-Blind, Two-Arm, Randomized, Controlled, Non Inferiority Trial of the Conor CoStar Paclitaxel-Eluting Coronary Stent System vs the TAXUS DES in Patients With De Novo Lesions of the Native Coronary Arteries|Completed||Phase 3|1701|Actual|Cordis Corporation||2|||f||||t||||||||||2017-02-18 17:21:38.712661|2017-02-18 17:21:38.712661
NCT00165022|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-03-27|||September 2003||2003-09-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|||||Observational|||Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population|Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population|Completed||N/A|330|Actual|Chinese University of Hong Kong|||1||f||||||||||||||2017-02-18 17:21:38.827159|2017-02-18 17:21:38.827159
NCT00165009|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-05-10|||June 2005||2005-06-01|May 2013|2013-05-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|||Resolution Endoclips Vs Epinephrine Injection and Heater Probe|A Prospective Randomized Comparison of a Novel Hemostatic Clip (Resolution Clip™) to Combined Epinephrine Injection and Heater Probe Thermocoagulation in the Endoscopic Control of Ulcer Bleeding|Terminated||Phase 3|103|Actual|Chinese University of Hong Kong||2||Slow recruitment|f||||f||||||||||2017-02-18 17:21:38.915966|2017-02-18 17:21:38.915966
NCT00164996|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2012-02-16|||September 2004||2004-09-01|September 2005|2005-09-01||||September 2010|Actual|2010-09-01||Interventional|||Ultrathin Versus Conventional Esophagogastroduodenoscopy in Unsedated Patient With or Without Local Pharyngeal Anaesthesia|Comparison of Ultrathin Versus Conventional Esophagogastroduodenoscopy in Unsedated Patients With or Without Local Pharyngeal Anaesthesia: A Randomized Controlled Trial|Completed||Phase 3|400|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:39.029796|2017-02-18 17:21:39.029796
NCT00164970|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-02-02|||October 2004||2004-10-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?|Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?|Completed||Phase 4|166|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:39.134403|2017-02-18 17:21:39.134403
NCT00164957|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-02-02|||September 2002||2002-09-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effect of Continuous Versus Enteral Pump Feeding in Aspiration in Tube Fed Patients|The Effect of Continuous vs Enteral Pump Feeding in Aspiration in Tube Fed Patients|Completed||N/A|222|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:39.246319|2017-02-18 17:21:39.246319
NCT00164944|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-07|||April 2004||2004-04-01|March 2016|2016-03-01|June 2017|Anticipated|2017-06-01|December 2016|Anticipated|2016-12-01||Observational|||Screening for Colorectal Neoplasm in First Degree Relatives of the Affected|Colonoscopic Screening in First-degree Relatives of Hong Kong Chinese Patients With Sporadic Colorectal Cancer: a Cohort Study With Case Control Analysis|Recruiting||N/A|1000|Anticipated|Chinese University of Hong Kong|||2||f||||f||||||||||2017-02-18 17:21:39.342714|2017-02-18 17:21:39.342714
NCT00164931|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-06-09|||October 2003||2003-10-01|September 2005|2005-09-01||||||||Interventional|||A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer|Phase 3 Study of Prospective Randomized Trial Comparing Adjunctive High Dose Omeprazole Infusion Against Scheduled Second Endoscopy in the Prevention of Peptic Ulcer Rebleeding After Therapeutic Endoscopy|Completed||Phase 3|240|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:39.469479|2017-02-18 17:21:39.469479
NCT00164918|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||Role of Routine Nasogastric Decompression After Subtotal Gastrectomy|Role of Routine Nasogastric Decompression After Subtotal Gastrectomy|Unknown status|Recruiting|Phase 3|90||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:39.582769|2017-02-18 17:21:39.582769
NCT00164905|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-08-27|||September 2004||2004-09-01|August 2012|2012-08-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage|Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage: Can it Guide the Use of and Predict Failure of Endoscopic Treatment? A Prospective, Multicenter, Randomized, Controlled Study|Terminated||N/A|121|Actual|Chinese University of Hong Kong||2||Slow recruitment|f||||f||||||||||2017-02-18 17:21:39.664861|2017-02-18 17:21:39.664861
NCT00164892|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-16|||October 2004||2004-10-01|September 2005|2005-09-01||||||||Interventional|||Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial|Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial|Unknown status|Active, not recruiting|Phase 3|214||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:39.781206|2017-02-18 17:21:39.781206
NCT00164879|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-08-06|||January 2000||2000-01-01|September 2005|2005-09-01||||||||Interventional|||Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers|Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers: A Randomised Trial|Unknown status|Recruiting|Phase 3|70|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:39.875595|2017-02-18 17:21:39.875595
NCT00164866|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-06-05|||February 2004||2004-02-01|June 2007|2007-06-01|September 2005||2005-09-01|||||Interventional|||Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy|Administration of Intravenous Proton Pump Inhibitor Prior to Endoscopy [APPE] in Patients With Upper Gastrointestinal Bleeding; a Double-Blind Placebo-Controlled Randomised Study.|Completed||Phase 4|638||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:39.975595|2017-02-18 17:21:39.975595
NCT00164853|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2012-02-16|||September 2005||2005-09-01|September 2010|2010-09-01||||September 2011|Actual|2011-09-01||Interventional|||Compare Combined Sphincterotomy and Balloon Dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones|Combined Sphincterotomy and Balloon Dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones—a Randomized Controlled Trial|Completed||Phase 3|180|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 17:21:40.07913|2017-02-18 17:21:40.07913
NCT00164840|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-03-29|||May 2003||2003-05-01|March 2010|2010-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy|Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy|Completed||Phase 3|244|Anticipated|Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:40.182876|2017-02-18 17:21:40.182876
NCT00164827|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2005-09-11|||January 2003||2003-01-01|September 2005|2005-09-01||||||||Observational|||Surveillance of Bleeding Peptic Ulcer Using Wireless Capsule Endoscopy|Phase 3 Study on the Use of Capsule Endoscope for Surveillance and Detection of Peptic Ulcer Rebleeding After Therapeutic Endoscopy|Unknown status|Recruiting|Phase 3|50||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:21:40.263821|2017-02-18 17:21:40.263821
NCT00164814|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-25||||||March 2008|2008-03-01||||||||Observational|||The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients|Is Visceral Hyperalgesia the Culprit of Noncardiac Chest Pian in Chinese? Part I: The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients|Terminated||N/A|100|Actual|Chinese University of Hong Kong||||Funding ended|f||||||||||||||2017-02-18 17:21:40.343257|2017-02-18 17:21:40.343257
NCT00164801|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-25|||November 2004||2004-11-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|||||Interventional|||Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese?|Is Visceral Hyperalgesia the Culprit of Noncardiac Chest Pain in Chinese? Part 2: Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP Patients|Terminated||N/A|60|Actual|Chinese University of Hong Kong||||Funding ended|f||||||||||||||2017-02-18 17:21:40.411822|2017-02-18 17:21:40.411822
NCT00164788|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-08-27|||July 2004||2004-07-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole|A Randomized Comparison of High Dose Oral to Intravenous Esomeprazole in Patients After Endoscopic Control to Their Bleeding Peptic Ulcers: an Intra-gastric pH Study.|Terminated||Phase 2|7|Actual|Chinese University of Hong Kong||2||No suitable patients and many patients refused the study|f||||f||||||||||2017-02-18 17:21:40.50084|2017-02-18 17:21:40.50084
NCT00164775|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-09-14|||June 2005||2005-06-01|September 2016|2016-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia|The Efficacy of Imipramine in Treatment of Functional Dyspepsia: A Double Blind Randomized Placebo Controlled Trial|Completed||Phase 3|107|Actual|Chinese University of Hong Kong||2|||f||||f||||||||No||2017-02-18 17:21:40.613528|2017-02-18 17:21:40.613528
NCT00164762|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-27|||June 2005||2005-06-01|September 2007|2007-09-01|November 2006|Actual|2006-11-01|||||Observational|||Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers|Nevirapine Pharmacodynamics and Resistance Among HIV-Infected Mothers in Lilongwe, Malawi|Completed||N/A|126|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:40.720939|2017-02-18 17:21:40.720939
NCT00164749|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-04-25|||October 2004||2004-10-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease|A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease|Completed||Phase 1/Phase 2|36|Actual|Chinese University of Hong Kong||3|||f||||||||||||||2017-02-18 17:21:40.801984|2017-02-18 17:21:40.801984
NCT00164736|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2010-04-22|||March 2004||2004-03-01|April 2010|2010-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Breastfeeding, Antiretroviral, and Nutrition Study|HIV Infection and Breastfeeding: Interventions for Maternal and Infant Health|Completed||Phase 3|2369|Actual|Centers for Disease Control and Prevention||6|||f||||t||||||||||2017-02-18 17:21:40.91295|2017-02-18 17:21:40.91295
NCT00164723|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-08-10|||February 2005||2005-02-01|January 2011|2011-01-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Interventional|||Endoscopic Evaluation of Lower Gastrointestinal Bleeding (GIB) in Patients Presenting With Melena|Endoscopic Evaluation of the Incidence and Etiology of Lower Gastrointestinal Bleeding in Patients Presenting With Melena|Completed||N/A|165|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-02-18 17:21:41.030354|2017-02-18 17:21:41.030354
NCT00164710|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2012-09-26|||April 2005||2005-04-01|September 2012|2012-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi|An Open Randomised Trial of the Efficacy of Sulfadoxine-Pyrimethamine (SP), Amodiaquine + SP (AQ-SP), AQ + Artesunate (AQ-Art), Chlorproguanil-Dapsone + Art (CD-Art), and Lumefantrine-Artemether (LA) for Uncomplicated Malaria in Malawi|Completed||Phase 4|365||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:41.371351|2017-02-18 17:21:41.371351
NCT00164697|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-02-02|||October 1999||1999-10-01|September 2012|2012-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|Legacy||Legacy for Children, an Early Intervention Study to Promote Optimal Child Development in Low-income Families|Legacy for Children, The CDC Parenting Research Projects|Completed||N/A|547|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||No||2017-02-18 17:21:41.473|2017-02-18 17:21:41.473
NCT00164684|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-02-08|||September 2001||2001-09-01|February 2012|2012-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Men of Color Fatherhood Education and Violence Prevention Project|Men of Color Fatherhood Education and Violence Prevention Project|Completed||Phase 1|||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:41.586245|2017-02-18 17:21:41.586245
NCT00164671|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||November 2003||2003-11-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Testing the POWER Project: A Neighborhood Intervention Trial|Testing the POWER Project: A Neighborhood Intervention Trial|Completed||N/A|5000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:41.662979|2017-02-18 17:21:41.662979
NCT00164658|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-01-06|||September 2005||2005-09-01|January 2010|2010-01-01|October 2007|Actual|2007-10-01|||||Interventional|||Evaluating Tools for Health Promotion and Disease Prevention|Evaluating Tools for Health Promotion and Disease Prevention|Completed||Phase 1|8400|Anticipated|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 17:21:41.750284|2017-02-18 17:21:41.750284
NCT00164645|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-04-26||||||September 2005|2005-09-01||||||||Interventional|||Problem Solving for Caregivers of Persons With Brain Injury|Problem Solving for Caregivers of Patients With Traumatic Brain Injury|Unknown status|Recruiting|Phase 3|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:41.847028|2017-02-18 17:21:41.847028
NCT00164632|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2001||2001-10-01|September 2005|2005-09-01||||||||Interventional|||No More Falls Injury Prevention Study|California No More Falls! Senior Injury Prevention Program|Completed||N/A|552||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:41.930424|2017-02-18 17:21:41.930424
NCT00164619|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-06-04|||July 2001||2001-07-01|June 2008|2008-06-01|March 2008|Actual|2008-03-01|November 2006|Actual|2006-11-01||Interventional|||Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR|Testing the Effectiveness of the VOICES/VOCES Intervention Package as Implemented by STD and HIV Prevention Agencies That Target Hispanics and African Americans in the U.S. and Puerto Rico|Completed||Phase 2/Phase 3|3660|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 17:21:41.999534|2017-02-18 17:21:41.999534
NCT00164606|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-20|||May 2003||2003-05-01|September 2007|2007-09-01|September 2007|Actual|2007-09-01|||||Interventional|||A Dissemination Trial of the Positive Parenting Program to Reduce Child Maltreatment in South Carolina|A Dissemination Trial of the Positive Parenting Program to Reduce Child Maltreatment in South Carolina|Completed||Phase 2|14690|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:42.108374|2017-02-18 17:21:42.108374
NCT00164593|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-04-04|||April 2005||2005-04-01|April 2012|2012-04-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|||Youth Empowerment Solutions for Peaceful Communities|Youth Empowerment Solutions for Peaceful Communities|Completed||Phase 1|1142|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-02-18 17:21:42.193289|2017-02-18 17:21:42.193289
NCT00164580|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-26|||October 1996||1996-10-01|September 2012|2012-09-01|August 2004|Actual|2004-08-01|August 2002|Actual|2002-08-01||Interventional|||Community Intervention Trial for Youth (CITY) Study|Prevention of HIV Infection in Youth at Risk: Developing Community-Level Intervention Strategies That Work (Community Intervention Trial for Youth (CITY) Study)|Completed||Phase 2/Phase 3|12000||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:42.287741|2017-02-18 17:21:42.287741
NCT00164567|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2009-10-22||||||October 2009|2009-10-01||||||||Interventional|||Intimate Partner Violence (IPV)Screening in Health Care Clinics in Rural South Carolina|IPV Screening in Health Care Clinics in Rural South Carolina|Completed||Phase 2|1200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:42.403325|2017-02-18 17:21:42.403325
NCT00164541|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-09-20|||September 2004||2004-09-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||An Arts-Based Initiative for the Prevention of Violence Against Women and Girls|An Arts-Based Initiative for the Prevention of Violence Against Women and Girls|Completed||Phase 1|1440|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:42.58837|2017-02-18 17:21:42.58837
NCT00164528|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2001||2001-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Intervening With Children/Adolescents With FAS/ARND|Intervening With Children/Adolescents With FAS/ARND|Completed||Phase 1/Phase 2|52||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:42.692883|2017-02-18 17:21:42.692883
NCT00164515|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2011-07-27|||October 2004||2004-10-01|July 2011|2011-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|PEP||Increasing Physical Activity Among Overweight Women With Mobility Disabilities.|Personalized Exercise Programme (PEP) I: Physician Referral Approach to Increasing Awareness and Sustainability of Physical Activity for Overweight Adults With Mobility Limitations.|Completed||Phase 2|96|Actual|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-02-18 17:21:42.783036|2017-02-18 17:21:42.783036
NCT00164502|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2003||2003-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Limb Loss Self-Management Program|"Limb Loss Self-Management Program: Promoting Amputee Life Skills"|Completed||Phase 2|500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:42.895504|2017-02-18 17:21:42.895504
NCT00164489|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2003||2003-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Health Promotion of People With Disabilities|Intervention Research Grants to Promote the Health of People With Disabilities|Completed||Phase 2/Phase 3|400||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:42.985369|2017-02-18 17:21:42.985369
NCT00164476|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||October 2003||2003-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Promoting Clinical Preventive Services Among Adults With Disabilities|Promoting Prevention Among Adults With Disabilities|Completed||Phase 1|200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:43.077804|2017-02-18 17:21:43.077804
NCT00164463|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2011-06-07|||July 2004||2004-07-01|June 2011|2011-06-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment|TBTC Study 27/28 PK: Pharmacokinetic Issues in the Use of Moxifloxacin for Treatment of Tuberculosis|Completed||Phase 2|72|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 17:21:43.160615|2017-02-18 17:21:43.160615
NCT00164450|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-08-22|||September 2005||2005-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection|TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children Receiving Once Weekly Rifapentine and Isoniazid for the Treatment of Latent Tuberculosis Infection|Completed||N/A|230|Anticipated|Centers for Disease Control and Prevention|||||f||||t||||||||||2017-02-18 17:21:43.283721|2017-02-18 17:21:43.283721
NCT00164437|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||September 2002||2002-09-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||CD-ROM Intervention for Prostate Cancer Screening|CD-ROM Intervention for Prostate Cancer Screening|Completed||Phase 2/Phase 3|554||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:43.41428|2017-02-18 17:21:43.41428
NCT00164424|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-10|||March 2005||2005-03-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|March 2009|Actual|2009-03-01||Interventional|||Episodic Acyclovir Therapy for Genital Ulcers|Impact of Episodic Acyclovir Therapy on Ulcer Duration and HIV Shedding From Genital Ulcers Among Men in South Africa|Completed||Phase 2/Phase 3|613|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:43.510671|2017-02-18 17:21:43.510671
NCT00164411|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-03-13|||January 2004||2004-01-01|March 2012|2012-03-01|March 2005||2005-03-01|||||Interventional|||Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine|Pneumococcal Conjugate Vaccine (Prevnar; Wyeth) With Pneumococcal Polysaccharide Vaccine (23-valent) and Tetanus/Diphtheria Vaccine|Completed||Phase 1|30||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 17:21:43.613643|2017-02-18 17:21:43.613643
NCT00164398|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-10|||June 2004||2004-06-01|September 2012|2012-09-01|September 2008|Actual|2008-09-01|October 2006|Actual|2006-10-01||Interventional|||HIP: HIV Intervention for Providers|HIP: HIV Intervention for Providers|Completed||Phase 2|50|Anticipated|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:43.710936|2017-02-18 17:21:43.710936
NCT00164385|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-10-20||||||September 2005|2005-09-01||||||||Interventional|||Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS|Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:43.801554|2017-02-18 17:21:43.801554
NCT00164372|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-26|||May 2002||2002-05-01|September 2012|2012-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users|Collaborative Injection Drug Users Study III/Drug Users Intervention Trial (CIDUS III/DUIT)|Completed||Phase 2/Phase 3|1400||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:44.023312|2017-02-18 17:21:44.023312
NCT00164359|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-26|||April 2005||2005-04-01|September 2012|2012-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi|A Double-blind Randomised Trial to Assess the Tolerability of Amodiaquine Plus Artesunate (AQ-Art) Versus Chlorproguanil Plus Dapsone Plus Artesunate (CDA) in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi|Completed||Phase 4|212||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:44.133708|2017-02-18 17:21:44.133708
NCT00164346|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-03-23|||January 2002||2002-01-01|March 2011|2011-03-01|December 2009|Actual|2009-12-01|September 2008|Actual|2008-09-01||Interventional|||Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)|Neurocognitive Habilitation for Children With FAS/ARND|Completed||Phase 1/Phase 2|100|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:44.232851|2017-02-18 17:21:44.232851
NCT00164333|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-26|||September 2004||2004-09-01|September 2012|2012-09-01|April 2008|Actual|2008-04-01|May 2007|Actual|2007-05-01||Interventional|||The Treatment Advocacy Program|The Treatment Advocacy Program|Completed||Phase 2|300||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:44.330015|2017-02-18 17:21:44.330015
NCT00164307|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-07|||October 2001||2001-10-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships|Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships|Completed||Phase 1/Phase 2|100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:44.512443|2017-02-18 17:21:44.512443
NCT00164294|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09||||||September 2005|2005-09-01||||||||Interventional|||ED Intervention to Reduce Risky Behaviors in Drivers|ED Intervention to Reduce Risky Behaviors in Drivers|Completed||Phase 2|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:44.594232|2017-02-18 17:21:44.594232
NCT00164281|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-02-05|||November 2004||2004-11-01|February 2014|2014-02-01|May 2011|Actual|2011-05-01|July 2009|Actual|2009-07-01||Interventional|||Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana|A Randomized, Placebo-Controlled Study of Limited vs. Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana|Completed||Phase 4|2000|Actual|Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-02-18 17:21:44.670588|2017-02-18 17:21:44.670588
NCT00164268|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-09-06|||October 2002||2002-10-01|September 2007|2007-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Ke Ala Lokahi Demonstration Project for Sexual and Domestic Violence Prevention|Ke Ala Lokahi Demonstration Project for the Early Intervention and Prevention of Sexual and Domestic Violence Among Racial and Ethnic Populations|Completed||Phase 1|300||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:44.812663|2017-02-18 17:21:44.812663
NCT00164255|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-10|||January 2003||2003-01-01|September 2012|2012-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy|Efficacy of Intermittent Sulfadoxine-Pyrimethamine and Sulfadoxine-Pyrimethamine + Artesunate Treatment in the Prevention of Malaria in Pregnancy in an Area With Chloroquine-Resistant Plasmodium Falciparum|Completed||Phase 4|1614|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:21:44.911008|2017-02-18 17:21:44.911008
NCT00164242|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 2002||2002-01-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Treatment of Tardive Dyskinesia With Galantamine|Treatment of Tardive Dyskinesia With Galantamine|Completed||Phase 4|36||Caroff, Stanley N., M.D.|||||f||||||||||||||2017-02-18 17:21:45.03181|2017-02-18 17:21:45.03181
NCT00164229|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-04-25|||October 2001||2001-10-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Fetal Alcohol Syndrome: Socio-Cognitive Habilitation|Study to Investigate the Effectiveness of a Math Intervention for Children With Fetal Alcohol Syndrome or Related Condition|Completed||Phase 1/Phase 2|100||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:45.140428|2017-02-18 17:21:45.140428
NCT00164216|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-09-10|||March 2005||2005-03-01|September 2012|2012-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in Peru|Evaluation of the Efficacy and Effectiveness of Combined Therapy With Mefloquine and Artesunate for Uncomplicated Malaria Treatment in the Loreto Region (Amazon Basin), Peru|Completed||Phase 4|208|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:21:45.242631|2017-02-18 17:21:45.242631
NCT00164203|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-04|||April 2005||2005-04-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|December 2007|Actual|2007-12-01||Interventional|||The Feelings Club: Evaluating a School-based Intervention for Children at Risk for Depression and Anxiety Disorders|The Feelings Club: Evaluating a School-based Intervention for Children at Risk for Depression and Anxiety Disorders|Completed||N/A|150|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 17:21:45.332773|2017-02-18 17:21:45.332773
NCT00164190|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-10-14|||July 2004||2004-07-01|October 2010|2010-10-01|January 2009|Actual|2009-01-01|December 2007|Actual|2007-12-01||Interventional|||Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarction|Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction- The TRANSFER-AMI Trial|Completed||N/A|1200|Anticipated|Canadian Heart Research Centre||1|||f||||t||||||||||2017-02-18 17:21:45.44573|2017-02-18 17:21:45.44573
NCT00164177|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-02-06|||October 2004||2004-10-01|February 2013|2013-02-01||||December 2004|Actual|2004-12-01||Interventional|||Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.|A Preliminary Evaluation Of The Efficacy Of HalfLYTELY® For Bowel Cleansing Before Virtual Colonoscopy (VC) and Conventional Colonoscopy (CC).|Completed||Phase 4|20||Braintree Laboratories|||||||||||||||||||2017-02-18 17:21:45.551052|2017-02-18 17:21:45.551052
NCT00164164|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-02-06|||August 1999||1999-08-01|February 2013|2013-02-01||||June 2000|Actual|2000-06-01||Interventional|||HalfLytely Bowel Prep System for Colonoscopy|HalfLytely Bowel Prep System for Colonoscopy|Completed||Phase 3|200||Braintree Laboratories|||||||||||||||||||2017-02-18 17:21:45.623825|2017-02-18 17:21:45.623825
NCT00164151|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-02-06|||June 2001||2001-06-01|February 2013|2013-02-01||||May 2002|Actual|2002-05-01||Interventional|||A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.|A Comparison of the Efficacy and Safety of Two Bowel Preparations: HalfLytely® (2L NuLYTELY and 20 mg Bisacodyl), and Visicol™ Prior To Colonoscopy.|Completed||Phase 3|60||Braintree Laboratories|||||||||||||||||||2017-02-18 17:21:45.711417|2017-02-18 17:21:45.711417
NCT00164138|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-11-26|||December 2001||2001-12-01|September 2005|2005-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease|Development of an Intervention and and Education Program for Adult Women With Urinary Incontinence and Chronic Lung Disease Including Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|99|Actual|Bayside Health||1|||f||||f||||||||||2017-02-18 17:21:45.786119|2017-02-18 17:21:45.786119
NCT00164125|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-02-06|||July 2003||2003-07-01|February 2013|2013-02-01||||November 2004|Actual|2004-11-01||Interventional|||An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients|An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients|Completed||Phase 4|300||Braintree Laboratories|||||||||||||||||||2017-02-18 17:21:45.886554|2017-02-18 17:21:45.886554
NCT00164112|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-13|||November 2004||2004-11-01|March 2005|2005-03-01|June 2005||2005-06-01|||||Interventional|||Comparative Effects of Azithromycin, Telithromycin and Levofloxacin on Drug Metabolizing Enzymes|Comparison of the Effect of Azithromycin, Telithromycin and Levofloxacin on Drug Metabolizing Enzymes Using the Validated Cooperstown 5+1 Cocktail|Completed||Phase 4|16||Bassett Healthcare|||||f||||||||||||||2017-02-18 17:21:46.264172|2017-02-18 17:21:46.264172
NCT00164099|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-10-30|||November 2005||2005-11-01|September 2006|2006-09-01|June 2007|Actual|2007-06-01|||||Interventional|||The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study|The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study|Terminated||Phase 4|40|Actual|Beth Israel Medical Center||1||Patients would not take product|f||||f||||||||||2017-02-18 17:21:46.360229|2017-02-18 17:21:46.360229
NCT00164086|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2006-10-10||||||September 2005|2005-09-01||||||||Interventional|||Atorvastatin in Myeloma||Unknown status|Not yet recruiting|Phase 1|||Bayside Health|||||f||||||||||||||2017-02-18 17:21:46.456524|2017-02-18 17:21:46.456524
NCT00164073|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-31|||February 2004||2004-02-01|September 2005|2005-09-01|February 2007||2007-02-01|||||Observational|||Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection|Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection|Unknown status|Recruiting|N/A|60|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:21:46.544457|2017-02-18 17:21:46.544457
NCT00164060|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-03|||February 2004||2004-02-01|September 2005|2005-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection|Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection|Terminated||N/A|158|Actual|Bayside Health|||||f||||||||||||||2017-02-18 17:21:46.643188|2017-02-18 17:21:46.643188
NCT00164047|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2009-07-29|||April 2003||2003-04-01|July 2009|2009-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||ENIGMA - Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: a Randomised Controlled Trial|Evaluation of Nitrous Oxide In the Gas Mixture for Anaesthesia: a Randomised Controlled Trial|Completed||Phase 4|2070|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:21:46.734499|2017-02-18 17:21:46.734499
NCT00164034|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-02-10|||November 2005||2005-11-01|September 2005|2005-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Trauma Reception and Resuscitation Project|Trauma Reception and Resuscitation Project - 'Time for a New Approach'|Completed||N/A|1171|Actual|Bayside Health|||||f||||||||||||||2017-02-18 17:21:46.84273|2017-02-18 17:21:46.84273
NCT00164021|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2016-01-13|||February 2001||2001-02-01|January 2016|2016-01-01||||December 2016|Anticipated|2016-12-01||Observational|||The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation|The Prevalence and Significance of Gastro-oesophageal Reflux in Adults With Cystic Fibrosis Before and After Lung Transplantation, Together With the Effects of Physiotherapy Airway Clearance Techniques on Gastro-oesophageal Function|Recruiting||N/A|180|Anticipated|Bayside Health|||2||f||||f||||||||||2017-02-18 17:21:46.947453|2017-02-18 17:21:46.947453
NCT00164008|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2013-12-03|||October 2002||2002-10-01|September 2005|2005-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention|Comparison Between Pamidronate and Zoledronic Acid for the Treatment of Heart and Lung Transplant Related Osteopaenia and Osteoporosis|Completed||Phase 4|56|Actual|Bayside Health|||||f||||||||||||||2017-02-18 17:21:47.077084|2017-02-18 17:21:47.077084
NCT00163995|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-25||||||September 2005|2005-09-01||||||||Observational|||Urotensin II and Vascular Tone in Cirrhosis||Unknown status|Recruiting|N/A|40|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:21:47.155678|2017-02-18 17:21:47.155678
NCT00163514|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-01|||May 2004||2004-05-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial Designed to Assess the Efficacy and Safety of Ciclesonide Applied as a Nasal Spray at Three Dose Levels (200 Mcg, 100 Mcg, or 25 Mcg, Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 6-11 Years of Age|Completed||Phase 3|636||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:47.251003|2017-02-18 17:21:47.251003
NCT00163501|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-29|||December 2003||2003-12-01|October 2016|2016-10-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Trial to Assess the Long Term Safety of Ciclesonide, Applied as a Nasal Spray (200 Mcg, Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Patients 12 Years and Older|Completed||Phase 3|600||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:47.470224|2017-02-18 17:21:47.470224
NCT00163488|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-02|||January 2005||2005-01-01|October 2016|2016-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)|Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Fluticasone Propionate/Salmeterol (FP/SAL) in Patients (18-60 Years) With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|106||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:47.615143|2017-02-18 17:21:47.615143
NCT00163475|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-10-24|||May 2004||2004-05-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)|The MOVE-study: Morning Versus Evening Administration of 500 mcg Roflumilast Once Daily for 6 Weeks in Patients With Asthma|Completed||Phase 3|511||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:47.710999|2017-02-18 17:21:47.710999
NCT00163462|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-02|||October 2004||2004-10-01|October 2016|2016-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)|Comparison of Ciclesonide (80 mcg or 160 mcg Once Daily in the Evening) and Fluticasone Propionate (100 mcg Twice Daily in the Morning and Evening) in Pediatric Asthma Patients|Completed||Phase 3|750||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:47.816012|2017-02-18 17:21:47.816012
NCT00163449|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-07|||November 2005||2005-11-01|December 2016|2016-12-01|May 2007|Actual|2007-05-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)|BALLOON: Efficacy and Safety - Study by ALTANA on Ciclesonide in Pre-school Asthma Patients|Completed||Phase 3|1000|Anticipated|AstraZeneca||4|||f||||||||||||||2017-02-18 17:21:47.987053|2017-02-18 17:21:47.987053
NCT00163436|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-29|||September 2005||2005-09-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)|Comparison of the Efficacy and Safety of 160 mcg Ciclesonide Administered Once Daily in the Evening With or Without Different Spacer Types in Patients With Asthma|Completed||Phase 3|450||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:48.192056|2017-02-18 17:21:48.192056
NCT00163423|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-07|||November 2004||2004-11-01|December 2016|2016-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)|Comparison of Ciclesonide (80 mcg Once Daily in the Evening) and Fluticasone Propionate (100 mcg Twice Daily) in Patients With Mild to Moderate Asthma|Completed||Phase 3|480||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:48.41258|2017-02-18 17:21:48.41258
NCT00163410|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-01|||April 2003||2003-04-01|December 2016|2016-12-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)|A Comparative Study of Inhaled Ciclesonide 200 mcg/Day vs Fluticasone Propionate 200 mcg/Day in Children With Asthma|Completed||Phase 3|500||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:48.561561|2017-02-18 17:21:48.561561
NCT00163397|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-29|||January 2004||2004-01-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)|A Comparative Study of Inhaled Ciclesonide 160 mcg/Day vs Budesonide 400 mcg/Day in Patients With Asthma|Completed||Phase 3|120||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:48.672251|2017-02-18 17:21:48.672251
NCT00163384|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-29|||January 2004||2004-01-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)|A Comparative Study of Inhaled Ciclesonide 160 mcg/Day vs Budesonide 400 mcg/Day in Patients With Asthma|Completed||Phase 3|240||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:48.797448|2017-02-18 17:21:48.797448
NCT00163371|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-30|||September 2005||2005-09-01|October 2016|2016-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)|Effect of Ciclesonide (320 mcg/Day) vs Fluticasone Propionate (375 mcg/Day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children With Mild Asthma|Completed||Phase 3|28||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:51.795218|2017-02-18 17:21:51.795218
NCT00163358|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-11-29|||September 2003||2003-09-01|October 2016|2016-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)|Efficacy of Ciclesonide and of a Fixed Combination With Fluticasone Propionate and Salmeterol Versus Placebo on Long-term Asthma Control|Completed||Phase 3|630||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:51.896289|2017-02-18 17:21:51.896289
NCT00163345|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-07|||September 2003||2003-09-01|December 2016|2016-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)|Evaluation of Parameters of the Small Airways and Their Changes Under Treatment With Ciclesonide (320 mcg Once Daily) Versus Placebo in Patients With Asthma|Completed||Phase 3|20||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:52.352508|2017-02-18 17:21:52.352508
NCT00163332|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-02|||March 2003||2003-03-01|September 2016|2016-09-01||||||||Interventional|||Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)|Comparison of Inhaled Ciclesonide (160 mcg b.i.d. or 320 mcg b.i.d.) and Fluticasone Propionate (250 mcg b.i.d. or 500 mcg b.i.d.) in Pretreated Patients With Mild to Moderate Asthma|Completed||Phase 3|30||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:52.465167|2017-02-18 17:21:52.465167
NCT00163319|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-01|||November 2004||2004-11-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)|Comparison of Inhaled Ciclesonide (640 mcg/Day) and Fluticasone Propionate (1000 mcg/Day) in Patients With Moderate and Severe Persistent Asthma|Completed||Phase 3|500||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:52.579936|2017-02-18 17:21:52.579936
NCT00163306|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-05-04|||May 2005||2005-05-01|May 2007|2007-05-01||||||||Interventional|||Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)|Complete Remission: Evaluation of the Complete Remission Rates in Patients With Symptomatic Non-erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (GERD) Treated With Pantoprazole 40 Milligram o.d. Over 4 or 8 or 12 Weeks|Completed||Phase 3|1200||Takeda|||||f||||||||||||||2017-02-18 17:21:52.772209|2017-02-18 17:21:52.772209
NCT00163293|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-02|2010-12-01||January 2005||2005-01-01|September 2016|2016-09-01|April 2010|Actual|2010-04-01|June 2009|Actual|2009-06-01||Interventional|POPCICLE||Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 y) (BY9010/CA-101)|Effect of Low Dose Continuous Treatment With Ciclesonide Over One Year on the Time to First Exacerbation in Children With Mild Asthma Versus Intermittent Treatment for Exacerbations|Completed||Phase 3|240|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 17:21:53.176819|2017-02-18 17:21:53.176819
NCT00163982|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-25||||||September 2005|2005-09-01||||||||Interventional|||Vasoactive Peptides in Portal Pressure||Unknown status|Recruiting|N/A|||Bayside Health|||||f||||||||||||||2017-02-18 17:21:53.865786|2017-02-18 17:21:53.865786
NCT00163969|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-13|||April 2002||2002-04-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||The Use of Ketamine as Rescue Analgesia in the Recovery Room Following Opioid Administration. A Double-blind Randomised Trial in Postoperative Patients|The Use of Ketamine as Rescue Analgesia in the Recovery Room Following Opioid Administration. A Double-blind Randomised Trial in Postoperative Patients.|Completed||Phase 4|40||Bayside Health|||||f||||||||||||||2017-02-18 17:21:53.958549|2017-02-18 17:21:53.958549
NCT00163956|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-03|||August 2005||2005-08-01|September 2005|2005-09-01|December 2010||2010-12-01|||||Observational|||Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes|Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes|Unknown status|Recruiting|N/A|20||Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.074509|2017-02-18 17:21:54.074509
NCT00163943|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-07-31|||April 2005||2005-04-01|September 2005|2005-09-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions|Neural Mechanisms Predisposing to Cardiovascular Risk in Individuals With the Metabolic Syndrome: Benefits of Dietary Weight Loss, Weight Loss Maintenance and Aerobic Exercise|Unknown status|Recruiting|N/A|66|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.159201|2017-02-18 17:21:54.159201
NCT00163930|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-02|||January 2005||2005-01-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Observational|||Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata|Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic Leiomyomata|Unknown status|Recruiting|N/A|||Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.256122|2017-02-18 17:21:54.256122
NCT00163917|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-03-14|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||A Study of the Effectiveness of Virtual Reality Relaxation Combined With Patient-Controlled Analgesia (PCA) Morphine for Those Undergoing Burn Dressing Changes|Predicting the Effectiveness of Virtual Reality Relaxation on Pain and Anxiety When Added to PCA Morphine in a Population of Burn Patients Having Dressing Changes|Unknown status|Recruiting|N/A|90||Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.35273|2017-02-18 17:21:54.35273
NCT00163904|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-13|2007-07-31|||January 2005||2005-01-01|September 2005|2005-09-01||||||||Interventional|||Can a Modified Fat Diet With Low Glycaemic Load Improve Insulin Sensitivity and Inflammatory Mediators in Overweight People With Chronic Heart Failure?|Can a Modified Fat Diet With Low Glycaemic Load Improve Insulin Sensitivity and Inflammatory Mediators in Overweight People With Chronic Heart Failure?|Unknown status|Recruiting|Phase 1|50|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.462539|2017-02-18 17:21:54.462539
NCT00163891|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-03|||September 2003||2003-09-01|September 2005|2005-09-01||||||||Interventional|||Comparison of Two Chest Physiotherapy Protocols in Lung Transplant Recipients|A Prospective Randomised Two Month Trial Comparing Twho Chest Physiotherapy Protocols in Lung Transplant Recipients|Completed||N/A|40||Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.573319|2017-02-18 17:21:54.573319
NCT00163878|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2006-10-03|||November 2004||2004-11-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Is Sensory Stimulation Effective in Reducing Time Spent in a Coma or Vegetative State|A Randomised Control Trial to Determine the Effectiveness of Sensory Stimulation Program in Reducing the Length of Time Spent by Severely Brain Injured Patients in a Vegetative State in the Acute Hospital Environment|Unknown status|Recruiting|Phase 4|||Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.662877|2017-02-18 17:21:54.662877
NCT00163865|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-11-25|||May 2005||2005-05-01|September 2005|2005-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents|A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents|Completed||N/A|71|Actual|Bayside Health|||2||f||||f||||||||||2017-02-18 17:21:54.764221|2017-02-18 17:21:54.764221
NCT00163852|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-09-12|||February 2004||2004-02-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis|Salt Replacement for Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis|Unknown status|Recruiting|Phase 2/Phase 3|40||Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.860328|2017-02-18 17:21:54.860328
NCT00163839|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-02-14|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema|The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria or Angioedema: A Randomised Controlled Study|Unknown status|Not yet recruiting|N/A|50|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:21:54.956255|2017-02-18 17:21:54.956255
NCT00163826|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-06|||March 2004||2004-03-01|January 2016|2016-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Spinal Clearance Study: Expediting the Spinal Clearance Process in the Major Trauma Patient|Optimisation of Patient Management Through Expediting the Spinal Clearance Process in the Major Trauma Patient|Completed||Phase 4|299|Actual|Bayside Health|||1||f||||f||||||||||2017-02-18 17:21:55.047355|2017-02-18 17:21:55.047355
NCT00163813|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2007-02-23||||||August 2005|2005-08-01||||||||Interventional|ENTERIC||The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study|The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care Study|Unknown status|Not yet recruiting|N/A|180||Bayside Health|||||f||||||||||||||2017-02-18 17:21:55.128396|2017-02-18 17:21:55.128396
NCT00163800|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-12-07|||July 2003||2003-07-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Observational|||Outcome Predictors in Acute Brain Injury|Outcome Predictors in Acute Brain Injury, A Pilot Study|Completed||N/A|60||Bayside Health|||||f||||||||||||||2017-02-18 17:21:55.218403|2017-02-18 17:21:55.218403
NCT00163787|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-10-24|||June 2003||2003-06-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Observational|||Clinical Identification of Fall Risk Early After Unilateral Transtibial Amputation|Clinical Identification of Increased Fall Risk Early After Unilateral Transtibial Amputation|Completed||N/A|50||Bayside Health|||||f||||||||||||||2017-02-18 17:21:55.29311|2017-02-18 17:21:55.29311
NCT00163774|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-05-16|||November 2002||2002-11-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Interventional|||Intensive Monitoring of Brain Injured Patients|Intensive Monitoring of Brain Injured Patients; Icp Monitoring, Transcranial Doppler, Jugular Bulb Oximetry, Brain Oxygenation, Brain Temperature and Microdialysis.|Completed||N/A|20|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:21:55.622678|2017-02-18 17:21:55.622678
NCT00163761|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2016-01-06|||December 2002||2002-12-01|January 2016|2016-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy Study of Outpatient Therapy for Lymphoma|A Multicentre Phase II Study of Risk-adjusted Outpatient-based Salvage Therapy for Patients With Relapsed and Refractory Lymphoma|Completed||Phase 2|90|Actual|Bayside Health||2|||f||||f||||||||||2017-02-18 17:21:55.711973|2017-02-18 17:21:55.711973
NCT00163748|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-01-06|||February 2001||2001-02-01|January 2016|2016-01-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma|A Pilot Study of Outpatient Vinorelbine and Gemcitabine With Filgrastim Support for Patients With Relapsed or Refractory Lymphoma.|Completed||Phase 2|40||Bayside Health|||||f||||||||||||||2017-02-18 17:21:55.836351|2017-02-18 17:21:55.836351
NCT00155129|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 2005||2005-01-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||The Role of CGRPand Nociceptin in Migraine|The Role of Calcitonin Gene-Related Peptide(CGRP)and Nociceptin in the Pathogenesis of Migraine|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.373409|2017-02-18 17:24:24.373409
NCT00163735|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2013-12-03|||August 2002||2002-08-01|September 2005|2005-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Potential Allergens in Wine: Double-blind Placebo-controlled Trial|Potential Allergens in Wine: Double Blind Placebo-controlled Trial and Basophil Activation Analysis|Completed||N/A|48|Actual|Bayside Health|||||f||||||||||||||2017-02-18 17:21:55.936727|2017-02-18 17:21:55.936727
NCT00163722|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2013-02-17|||September 2005||2005-09-01|September 2005|2005-09-01|August 2011|Actual|2011-08-01|January 2011|Actual|2011-01-01||Interventional|||A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients|A Multicentre Randomised Controlled Trial Comparing the Current Standard Diagnostic Strategy for Invasive Aspergillosis to the New Diagnostic Strategy for Invasive Aspergillosis in High-Risk Haematology Patients in Order to Determine Which Strategy Results in the Lower Rates of Use of Empiric Antifungal Therapy|Completed||Phase 3|240|Actual|Bayside Health||2|||f||||t||||||||||2017-02-18 17:21:56.035681|2017-02-18 17:21:56.035681
NCT00163709|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2006-10-03|||August 2005||2005-08-01|May 2005|2005-05-01||||||||Interventional|||BNP Testing in Patients With SOB on Presentation to ED|A Randomised Trial of BNP Testing in Patients With Shortness of Breath in the Emergency Department to Improve Patient Outcome|Unknown status|Recruiting|Phase 1|600||Bayside Health|||||f||||||||||||||2017-02-18 17:21:56.142289|2017-02-18 17:21:56.142289
NCT00163696|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2007-07-25|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Observational|||Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease|Measurements of Inhomogeneity of the Small Airway With Patients With Cystic Fibrosis, Asthma and Bronchiolitis Obliterans Syndrome (Post Transplant) Using the Multi Breath Nitrogen Washout Technique|Unknown status|Recruiting|N/A|90|Anticipated|Bayside Health|||||f||||||||||||||2017-02-18 17:21:56.234769|2017-02-18 17:21:56.234769
NCT00163683|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2013-12-03|||January 2003||2003-01-01|September 2005|2005-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effects of a Mediterranean Style Diet on Vascular Health in Type 2 Diabetes|The Effect of a Mediterranean Style Diet Versus a Conventional High Carbohydrate, Low Fat Diet on Glycaemic and Lipid Control and on Vascular Inflammatory Markers in People With Newly Diagnosed Type 2 Diabetes|Completed||N/A|24|Actual|Bayside Health|||||f||||f||||||||||2017-02-18 17:21:56.318433|2017-02-18 17:21:56.318433
NCT00163670|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2013-12-04|||September 2005||2005-09-01|September 2005|2005-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||The Impact of Sleep Disorders on Motor Vehicle Accidents|The Impact of Sleep Disorders on Motor Vehicle Accidents|Completed||N/A|40|Actual|Bayside Health|||2||f||||f||||||||||2017-02-18 17:21:56.454659|2017-02-18 17:21:56.454659
NCT00163657|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-11-15|2012-02-23||July 2002||2002-07-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|April 2006|Actual|2006-04-01||Interventional|||Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection|An Open-Label, Randomized, Prospective Multicenter Study To Compare The Efficacy And Safety Among 3 Immunosuppressant Treatment Regimens In Patients Receiving A Liver Transplant For ESLD Caused By Chronic Hepatitis C|Completed||Phase 4|312|Actual|Baylor Research Institute||3|||f||||t||||||||No|No their is not a plan to make individual Participant data available|2017-02-18 17:21:56.534866|2017-02-18 17:21:56.534866
NCT00163644|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2016-01-06|||November 2003||2003-11-01|January 2016|2016-01-01||||December 2009|Actual|2009-12-01||Interventional|||RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT|Randomised Controlled Trial to Investigate the Effects of an Exercise Programme on Physical Performance and Quality of Life After a Bone Marrow Transplant|Active, not recruiting||N/A|66|Anticipated|Bayside Health||3|||f||||||||||||||2017-02-18 17:21:57.026604|2017-02-18 17:21:57.026604
NCT00163631|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2006-10-03||||||September 2005|2005-09-01||||||||Observational|||Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis|Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis|Completed||N/A|||Bayside Health|||||f||||||||||||||2017-02-18 17:21:57.137809|2017-02-18 17:21:57.137809
NCT00163618|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||June 2005||2005-06-01|May 2015|2015-05-01|July 2006|Actual|2006-07-01|||||Observational|||Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children|Multicenter Phase IV Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children|Completed||Phase 4|||Pfizer|||||f||||f||||||||||2017-02-18 17:21:57.208318|2017-02-18 17:21:57.208318
NCT00163605|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-11-14|||September 2004||2004-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures|A Prospective Clinical Study to Evaluate the Performance and Safety of the Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures|Completed||Phase 2/Phase 3|86||Baxter Healthcare Corporation|||||f||||||||||||||2017-02-18 17:21:57.303395|2017-02-18 17:21:57.303395
NCT00163592|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-20|||September 2003||2003-09-01|October 2006|2006-10-01|February 2004||2004-02-01|||||Observational|||Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis|Non- Interventional Study of Tissucol® for Hemostasis in Subjects With Femoral Vascular Anastomosis Undergoing Vascular Reconstruction With PTFE Prosthesis|Completed||Phase 4|60||Baxter Healthcare Corporation|||||f||||||||||||||2017-02-18 17:21:57.386779|2017-02-18 17:21:57.386779
NCT00163579|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-04-14|||July 2004||2004-07-01|September 2005|2005-09-01|March 2007|Anticipated|2007-03-01|||||Interventional|||The Impact of Bryophyllum on Preterm Delivery|The Impact of the Prophylactic or Therapeutic Application of Bryophyllum on Preterm Delivery - a Prospective Study|Unknown status|Recruiting|Phase 4|180|Anticipated|Basel Women’s University Hospital|||||f||||f||||||||||2017-02-18 17:21:57.486337|2017-02-18 17:21:57.486337
NCT00163566|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-07-10|||October 2004||2004-10-01|July 2012|2012-07-01|December 2012|Anticipated|2012-12-01|October 2006|Actual|2006-10-01||Interventional|||Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80|A Phase II, Placebo-Controlled, Double-Blind, Dose-Ranging (35mg/Day or 70 mg/Day), Randomized, Study of Cutaneous Dihydrotestosterone (DHT)-Gel (0.7% Hydroalcoholic Gel) in Older Hypogonadal Males Ages 55-80 Years: Effect on Body Composition, Libido, and Physical and Sexual Functioning|Unknown status|Active, not recruiting|Phase 2|128|Actual|ASCEND Therapeutics||3|||f||||||||||||||2017-02-18 17:21:57.581924|2017-02-18 17:21:57.581924
NCT00163553|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-29|||December 2004||2004-12-01|January 2009|2009-01-01||||||||Interventional|||Neuraxial Pethidine After Lumbar Surgery Trial|Neuraxial Pethidine After Lumbar Surgery Trial|Unknown status|Recruiting|Phase 3|60|Anticipated|Austin Health||2|||f||||||||||||||2017-02-18 17:21:57.710679|2017-02-18 17:21:57.710679
NCT00163540|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||May 2005||2005-05-01|May 2015|2015-05-01|June 2005||2005-06-01|||||Interventional|||Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)|Open-Label, Follow-up, Phase IV Clinical Study to Evaluate the Immunogenicity and Safety of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated Using a Rapid Immunization Schedule (Follow-up to Study 225)|Completed||Phase 4|||Pfizer|||||f||||||||||||||2017-02-18 17:21:57.823624|2017-02-18 17:21:57.823624
NCT00163527|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2016-12-01|||April 2003||2003-04-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)|A 24-Week, Double-Blind, Parallel Group, Placebo and Active Controlled Study to Investigate the Efficacy and Safety of Daily Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Chronic Asthma|Completed||Phase 3|2054||AstraZeneca|||||f||||||||||||||2017-02-18 17:21:57.903535|2017-02-18 17:21:57.903535
NCT00163280|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-02-11|||July 2004||2004-07-01|February 2008|2008-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis|Randomised Double-Blind Placebo-Controlled Study of Orally Administered ATL-104 to Assess Safety, Tolerance and Effect on Oral Mucositis in Patients Following Treatment With Chemotherapy and Peripheral Blood Stem Cell Transplant (PBSCT)|Completed||Phase 2|63|Actual|Alizyme||4|||f||||t||||||||||2017-02-18 17:21:58.0192|2017-02-18 17:21:58.0192
NCT00163267|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-08-05|||September 2005||2005-09-01|April 2007|2007-04-01|April 2011|Actual|2011-04-01|December 2009|Actual|2009-12-01||Interventional|||Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel|Follow-up Management of Peripheral Arterial Intervention With Clopidogrel MIRROR-Study|Completed||Phase 2/Phase 3|80|Actual|University Hospital Tuebingen||2|||f||||||||||||||2017-02-18 17:21:58.126599|2017-02-18 17:21:58.126599
NCT00163254|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-11|||September 2003||2003-09-01|September 2006|2006-09-01|November 2006||2006-11-01|||||Interventional|||Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee|Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee|Unknown status|Active, not recruiting|Phase 2|||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:21:58.237699|2017-02-18 17:21:58.237699
NCT00163241|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-07-17|||June 2004||2004-06-01|July 2007|2007-07-01|January 2006||2006-01-01|||||Interventional|||Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression|A Double-Blind, Placebo-Controlled, Randomized 24-Month Study, Assessing The Effect Of Celecoxib (Celebrex) Long Term Treatment On Hip Osteoarthritis (OA) Progression OSCARE|Terminated||Phase 3|666||Pfizer||||Please see detailed description for termination reason.|f||||||||||||||2017-02-18 17:21:58.327051|2017-02-18 17:21:58.327051
NCT00163228|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-10-15|||January 2001||2001-01-01|October 2008|2008-10-01|May 2007|Anticipated|2007-05-01|||||Observational|||Functional Evaluation of the Total Knee Prostheses:Rising From a Chair|Functional Evaluation of Total Knee Arthroplasties,Protocol for Rising From a Chair.|Withdrawn||N/A|100|Anticipated|Radboud University|||2||f||||||||||||||2017-02-18 17:21:58.79982|2017-02-18 17:21:58.79982
NCT00163215|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-11-19|2012-10-02||January 2005||2005-01-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Growth Retardation In Children With Special Pathological Conditions Or Disease|Evolution Of Growth Rate In Children Suffering From A Disease Associated With Growth Retardation and Treated By Genotonorm. A Pilot Study.|Completed||Phase 3|46|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 17:21:58.883766|2017-02-18 17:21:58.883766
NCT00163202|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-14|||June 2002||2002-06-01|April 2007|2007-04-01|August 2005|Actual|2005-08-01|||||Interventional|CAP||Comparative Atorvastatin Pleiotropic Effects|A Multicenter, Randomized Double-Blind Study Comparing The Pleiotropic Effects Of Atorvastatin 10 Mg And 80 Mg Over A 26-Week Period In Subjects With Coronary Atherosclerosis|Completed||Phase 4|330||Pfizer|||||f||||||||||||||2017-02-18 17:21:59.363531|2017-02-18 17:21:59.363531
NCT00163189|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-06-22|2015-06-01||January 2005||2005-01-01|June 2015|2015-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Safety analysis set included all participants (including a site with GCP issues) who had received at least 1 study dose of growth hormone (GH).|Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm|Evolution Of Growth Rate In Children With Growth Retardation Related To Long-term Corticotherapy And Treated By Genotonorm|Completed||Phase 3|98|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:21:59.54154|2017-02-18 17:21:59.54154
NCT00163176|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-12-15|||July 2005||2005-07-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Observational|||Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors|Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors|Completed||Phase 1|50|Actual|Radboud University|||1||f||||f||||||||||2017-02-18 17:22:00.346888|2017-02-18 17:22:00.346888
NCT00163163|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-17|||January 2003||2003-01-01|March 2008|2008-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women|Carotid Atorvastatin Study In Hyperlipidemic Post-Menopausal Women: A Randomized Evaluation of Atorvastatin, Versus Placebo (CASHMERE)|Completed||Phase 3|400||Pfizer|||||f||||||||||||||2017-02-18 17:22:00.435538|2017-02-18 17:22:00.435538
NCT00163150|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-13|||June 2003||2003-06-01|April 2007|2007-04-01|February 2006|Actual|2006-02-01|||||Interventional|LA BICHAT||Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke|Lacunar-Brain Infarction Cerebral Hyperactivity And Atorvastatin Trial. A Placebo-Controlled Trial Of High-Dose Atorvastatin In Patients With Cerebral Small Vessel Disease.|Completed||Phase 4|128||Pfizer|||||f||||||||||||||2017-02-18 17:22:00.876219|2017-02-18 17:22:00.876219
NCT00163137|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-10|||May 2003||2003-05-01|August 2011|2011-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|CORAL||Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss|Double-Blind Placebo-Controlled Trial Of The Safety, Toleration and Efficacy Of Lasofoxifene 0.25 Mg/D and Raloxifene 60Mg/D For The Prevention Of Bone Loss In Postmenopausal Women|Completed||Phase 3|540|Actual|Ligand Pharmaceuticals||3|||f||||||||||||||2017-02-18 17:22:00.977253|2017-02-18 17:22:00.977253
NCT00163124|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-12|||March 2005||2005-03-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||A Randomized Controlled Trial of Best Approach to Care Compared to Diversified Chiropractic Adjustive Technique|A Randomized Controlled Trial of Best Approach to Care Compared to Diversified Adjustive Technique|Completed||N/A|155||Parker College of Chiropractic|||||f||||||||||||||2017-02-18 17:22:01.169974|2017-02-18 17:22:01.169974
NCT00163111|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-25|||September 1998||1998-09-01|April 2011|2011-04-01|May 2003|Actual|2003-05-01|||||Interventional|||A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.|A Randomized, Open Label, Comparative Multicenter Study Of Voriconazole Versus Conventional Amphotericin B Followed By Fluconazole In The Treatment Of Candidaemia In Non Neutropenic Subjects.|Completed||Phase 3|412|Actual|Pfizer|||||||||||||||||||2017-02-18 17:22:01.265686|2017-02-18 17:22:01.265686
NCT00163098|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-12|||December 2004||2004-12-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD|A Multi-Centre, Multinational, Randomized, Double-Blind, Placebo Controlled, Proof Of Concept Trial To Assess The Effects Of A Subject-Optimized Dose Of UK-369,003 On Exercise Capacity In Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 1/Phase 2|136||Pfizer|||||f||||||||||||||2017-02-18 17:22:01.351498|2017-02-18 17:22:01.351498
NCT00163085|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-21|||May 2005||2005-05-01|September 2006|2006-09-01|January 2006||2006-01-01|||||Interventional|||The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Explore The Efficacy And Safety Of The NR2B NMDA Antagonist CP-101,606 In Patients With Idiopathic Parkinson's Disease|Completed||Phase 2|12||Pfizer|||||||||||||||||||2017-02-18 17:22:01.472858|2017-02-18 17:22:01.472858
NCT00163072|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-10-24|||October 2005||2005-10-01|April 2007|2007-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Pharmacokinetics and Safety of Transdermal Megestrol Acetate|Pharmacokinetics and Safety of Transdermal Megestrol Acetate|Withdrawn||Phase 4|0|Actual|Milton S. Hershey Medical Center||1|||f||||f||||||||||2017-02-18 17:22:01.571385|2017-02-18 17:22:01.571385
NCT00163059|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-21|||May 2004||2004-05-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD|A Randomized, Double-Blinded, Placebo-Controlled Trial To Assess The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With Treatment Refractory Major Depressive Disorder|Completed||Phase 2|30||Pfizer|||||||||||||||||||2017-02-18 17:22:01.678986|2017-02-18 17:22:01.678986
NCT00163046|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-04-23|||October 2005||2005-10-01|April 2008|2008-04-01|April 2006|Actual|2006-04-01|||||Interventional|||A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 28-Day, Polysomnographic Study of Gabapentin 250 mg in Transient Insomnia Induced by a Sleep Phase Advance|Completed||Phase 3|256|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:22:01.789213|2017-02-18 17:22:01.789213
NCT00163033|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2012-05-18|||June 2005||2005-06-01|May 2012|2012-05-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women|Phase I Study to Evaluate the Safety, Tolerability, PK and Pharmacodynamics of 3 Dosages of Estetrol, the Lowest Dose of 2 mg Estetrol Compared With 2 mg of E2, After Daily Oral Administration for 28 Days in Healthy Postmenopausal Women|Completed||Phase 1|49|Actual|Pantarhei Bioscience|||||f||||f||||||||||2017-02-18 17:22:01.917973|2017-02-18 17:22:01.917973
NCT00163020|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-03-11|2012-06-05||November 2004||2004-11-01|March 2016|2016-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|170HP||17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies|17-Alpha-Hydroxyprogesterone Caproate for Reduction of Neonatal Morbidity Due to Preterm Birth in Twin and Triplet Pregnancies - A Concurrent Randomized Double-blinded Clinical Trial|Completed||Phase 2/Phase 3|321|Actual|Mednax Center for Research, Education and Quality||2|||f||||t||||||||Undecided||2017-02-18 17:22:02.03791|2017-02-18 17:22:02.03791
NCT00163007|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-05-08|||May 2005||2005-05-01|May 2009|2009-05-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Nutritional Therapy for Stroke Patients|Nutritional Therapy for Patients With Acute Stroke and With Poor Nutritional Status or at Risk of Poor Nutritional Status|Completed||Phase 2/Phase 3|125|Anticipated|Ostfold Hospital Trust|||||f||||||||||||||2017-02-18 17:22:02.924844|2017-02-18 17:22:02.924844
NCT00162994|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-12-20|||February 2002||2002-02-01|February 2002|2002-02-01|August 2005||2005-08-01|||||Interventional|||Prevention Recurrent Otitis Media in the Young Children|Effect of Adenotomy and Tympanostomy on Preventing Recurrent Otitis Media in the Young Children|Unknown status|Active, not recruiting|N/A|300||Oulu University Hospital|||||f||||||||||||||2017-02-18 17:22:03.012718|2017-02-18 17:22:03.012718
NCT00162981|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-01-06|2011-11-07||October 2005||2005-10-01|January 2012|2012-01-01|October 2006|Actual|2006-10-01|August 2006|Actual|2006-08-01||Interventional|||Clobazam in Subjects With Lennox-Gastaut Syndrome|Safety and Efficacy of Clobazam in Subjects With Lennox-Gastaut Syndrome|Completed||Phase 2|68|Actual|Lundbeck LLC||2|||f||||t||||||||||2017-02-18 17:22:03.12279|2017-02-18 17:22:03.12279
NCT00162968|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-23|||December 2004||2004-12-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Escitalopram as a Treatment for Pain in Polyneuropathy|Escitalopram as a Treatment for Pain in Polyneuropathy. A Double-Blind, Randomized, Placebo Controlled Trial.|Completed||Phase 4|50||Odense University Hospital|||||f||||||||||||||2017-02-18 17:22:03.730357|2017-02-18 17:22:03.730357
NCT00162955|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-05-07|||May 2004||2004-05-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Prevention of CHOP-induced Chronic Cardiotoxicity|The Multi-centers Trial for Patients With Non-Hodgkin's Lymphoma to Assess the Protective Effect of Valsartan on Chronic Cardiotoxicity Induced by CHOP|Completed||Phase 4|150|Actual|Osaka City University||2|||f||||t||||||||||2017-02-18 17:22:03.829134|2017-02-18 17:22:03.829134
NCT00162942|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-03-05|2009-01-15||January 2005||2005-01-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study for the Treatment of Crohn's Disease With Adacolumn|A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Crohn's Disease|Completed||Phase 3|235|Actual|Otsuka America Pharmaceutical||2|||f||||||||||||||2017-02-18 17:22:03.960285|2017-02-18 17:22:03.960285
NCT00162929|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2012-05-31|||January 2005||2005-01-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|July 2009|Actual|2009-07-01||Interventional|AdHERe||Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)|A Phase I Study Investigating Multiple Injections of Autologous CD34+ Derived Dendritic Cells Transduced With an Adenovirus Expressing Rat Her-2/Neu in Patients With Metastatic or Locally Recurrent Breast Cancer|Completed||Phase 1|5|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-02-18 17:22:08.016864|2017-02-18 17:22:08.016864
NCT00162916|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2008-06-03|||May 2005||2005-05-01|June 2008|2008-06-01|October 2008|Anticipated|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||Antidepressant Maintenance in Traumatic Brain Injury|A Randomized Controlled Trial of Antidepressant Maintenance for Major Depression Following Mild Traumatic Brain Injury|Unknown status|Active, not recruiting|Phase 4|21|Actual|Ontario Neurotrauma Foundation||2|||f||||f||||||||||2017-02-18 17:22:08.106228|2017-02-18 17:22:08.106228
NCT00162903|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-22|||January 2002||2002-01-01|October 2001|2001-10-01|December 2002||2002-12-01|||||Observational|||Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants|The Role of Nitric Oxide, Endothelin-1, and Inflammatory Mediators in the Patency of Ductus Arteriosus in Preterm Infants|Completed||N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:22:08.479468|2017-02-18 17:22:08.479468
NCT00162890|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2010-03-15|||February 2002||2002-02-01|December 2009|2009-12-01|July 2003|Actual|2003-07-01|July 2002|Actual|2002-07-01||Observational|||Evaluation and Physical Therapy for Patients With Degenerated Cervical Spine|Evaluation and Physical Therapy for Patients With Degenerated Cervical Spine|Completed||N/A|100|Anticipated|National Taiwan University Hospital|||1||f||||||||||||||2017-02-18 17:22:08.559009|2017-02-18 17:22:08.559009
NCT00162877|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-22|||June 2004||2004-06-01|January 2004|2004-01-01|April 2005||2005-04-01|||||Interventional|||The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships|The Role of CYP2C19 Poor Metabolizers and Extensive Metabolizers of PPI in Short-Term Triple Therapy on the Eradication of H. Pylori Infection: Implication of PK/PD Relationships|Unknown status|Active, not recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:22:08.652262|2017-02-18 17:22:08.652262
NCT00162864|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-03-23|||December 1999||1999-12-01|September 2005|2005-09-01|April 2002||2002-04-01|||||Interventional|||A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary Disease|A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary Disease|Completed||Phase 3|200||Kaiser Permanente|||||f||||||||||||||2017-02-18 17:22:08.745725|2017-02-18 17:22:08.745725
NCT00162851|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-23|||April 2003||2003-04-01|August 2005|2005-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia|A Pilot Study to Evaluate the Safety of Subcutaneous Alemtuzumab (MabCampath, Campath) in Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|20|Anticipated|Karolinska University Hospital|||||f||||||||||||||2017-02-18 17:22:08.849703|2017-02-18 17:22:08.849703
NCT00162838|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2005-11-22|||October 2003||2003-10-01|May 2003|2003-05-01||||||||Observational|||Effects of Periodontal Pathogens, Porphyromonas Gingivalis and Tannerella Forsythensis, on Cytokine Production From Human Monocyte-Derived Dendritic Cells|Effects of Periodontal Pathogens, Porphyromonas Gingivalis and Tannerella Forsythensis, on Cytokine Production From Human Monocyte-Derived Dendritic Cells.|Unknown status|Recruiting|N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:22:08.927426|2017-02-18 17:22:08.927426
NCT00162825|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-12|2008-07-09|||January 2004||2004-01-01|June 2003|2003-06-01|December 2006|Actual|2006-12-01|||||Observational|||Role of CD7 in Skin Inflammation and Psoriasis||Completed||N/A|30|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:22:09.007001|2017-02-18 17:22:09.007001
NCT00162812|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-07-16|||January 2003||2003-01-01|July 2008|2008-07-01|April 2009|Anticipated|2009-04-01|December 2008|Anticipated|2008-12-01||Interventional|TOP||Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin|Prospective Evaluation of Topoisomerase II Alpha Gene Amplification and Protein Overexpression as Markers Predicting the Efficacy of Epirubicin in the Primary Treatment of Breast Cancer Patients|Terminated||Phase 2|338|Anticipated|Jules Bordet Institute||1||Low accrual rate|f||||f||||||||||2017-02-18 17:22:09.095157|2017-02-18 17:22:09.095157
NCT00162799|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-06-22|||July 2002||2002-07-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Efficacy Pilot Study of Triflusal in the Attenuation of Insulin Resistance in Human Obesity|Phase IIa Study of Triflusal in the Attenuation of Insulin Resistance in Men and Woman With Obesity|Completed||Phase 2|30||J. Uriach and Company|||||f||||||||||||||2017-02-18 17:22:09.203561|2017-02-18 17:22:09.203561
NCT00162786|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-10-19|||May 2005||2005-05-01|December 2005|2005-12-01|November 2005||2005-11-01|||||Interventional|||Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance|Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance|Terminated||Phase 4|20||J. Uriach and Company|||||f||||||||||||||2017-02-18 17:22:09.3005|2017-02-18 17:22:09.3005
NCT00162773|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-12|||April 2005||2005-04-01|September 2005|2005-09-01||||||||Interventional|||Effect of Anti-IgE in Non-Allergic Asthma|Effect of Anti-IgE in Non-Allergic Asthma|Unknown status|Recruiting|Phase 2|30||Johns Hopkins University|||||||||||||||||||2017-02-18 17:22:09.391739|2017-02-18 17:22:09.391739
NCT00162760|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-06-18|||October 2003||2003-10-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide|Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide|Completed||Phase 2|19||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:22:09.49131|2017-02-18 17:22:09.49131
NCT00162747|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-11|||December 2001||2001-12-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Topical Therapy for Prevention of Infections in Preterm Infants|Topical Emollient Therapy for Prevention of Infections in Preterm Infants|Completed||Phase 4|600||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:22:09.599841|2017-02-18 17:22:09.599841
NCT00162734|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-06-21|||February 2005||2005-02-01|June 2012|2012-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy|A Phase 3, Randomized, Open-Label Study of the Safety and Efficacy of Two Dose Levels of Interferon Alfacon-1 (Infergen, CIFN) Plus Ribavirin Administered Daily for 48 Weeks Versus No Treatment in Hepatitis C Infected Patients Who Are Nonresponders to Previous Pegylated Interferon Alfa Plus Ribavirin Therapy and During at Least 24 Weeks of No Treatment in IRHC-001|Completed||Phase 3|144|Actual|Valeant Pharmaceuticals International, Inc.||1|||f||||||||||||||2017-02-18 17:22:09.699358|2017-02-18 17:22:09.699358
NCT00162721|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-08-09|||September 2001||2001-09-01|August 2007|2007-08-01||||||||Interventional|||The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas|Phase III Study About the Effects of the Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas|Unknown status|Recruiting|Phase 3|270|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris||2|||f||||f||||||||||2017-02-18 17:22:09.79418|2017-02-18 17:22:09.79418
NCT00162708|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||July 1996||1996-07-01|September 2005|2005-09-01||||||||Interventional|||Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC|A Randomized Trial Evaluating a Very Intense Radiotherapy-Chemotherapy Regimen Versus a Very Accelerated Radiotherapy in Advanced Head and Neck Squamous Cell Carcinoma|Completed||Phase 2/Phase 3|120||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:22:09.892653|2017-02-18 17:22:09.892653
NCT00162695|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||July 1995||1995-07-01|September 2005|2005-09-01||||||||Interventional|||Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood||Terminated||Phase 3|400||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:22:09.986273|2017-02-18 17:22:09.986273
NCT00162682|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-01-04|||May 2005||2005-05-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|April 2010|Actual|2010-04-01||Interventional|||Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand|A Phase III, Randomized, Non-inferiority Trial Comparing the Standard Viral Load Based Antiretroviral Monitoring Strategy With a CD4 Based Monitoring Strategy Among Antiretroviral Naive Immunocompromised Adults in Thailand|Completed||Phase 3|716|Actual|Institut de Recherche pour le Developpement||2|||f||||t||||||||||2017-02-18 17:22:10.276424|2017-02-18 17:22:10.276424
NCT00162669|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-07|||May 2005||2005-05-01|September 2006|2006-09-01||||||||Interventional|||Bevacizumab in Advanced Hepatocellular Carcinoma|Phase II Study Evaluating the Efficacy of Bevacizumab (Avastin@) in Hepatocellular Carcinoma Not Amenable to Curative Treatment|Unknown status|Recruiting|Phase 2|50||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:22:10.408842|2017-02-18 17:22:10.408842
NCT00162656|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-03-27|||May 1996||1996-05-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|May 2004|Actual|2004-05-01||Interventional|||Treatment of Mature B-cell Lymphoma/Leukaemia|Treatment of Mature B-cell Lymphoma/Leukaemia A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study|Completed||Phase 3|848|Actual|Gustave Roussy, Cancer Campus, Grand Paris||6|||f||||t||||||||||2017-02-18 17:22:10.49218|2017-02-18 17:22:10.49218
NCT00162643|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-09-13|||December 2004||2004-12-01|September 2006|2006-09-01|December 2007||2007-12-01|||||Interventional|||PI Vs. NNRTI Based Therapy for HIV Advanced Disease|Boosted PI VS. NNRTI Based Therapy as Initial Treatment for HIV-1 Infected Patients With Advanced Disease|Unknown status|Recruiting|Phase 4|300||Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|||||f||||||||||||||2017-02-18 17:22:10.610154|2017-02-18 17:22:10.610154
NCT00162630|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-13|||May 2003||2003-05-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase|Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase|Completed||Phase 4|48||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:22:10.963294|2017-02-18 17:22:10.963294
NCT00162617|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-08-29|||January 2004||2004-01-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||The Effect of Liberal vs. Restrictive Transfusion Strategies on Rehabilitation After Hip Fracture Surgery|The Effect of Liberal vs. Restrictive Transfusion Strategies on Rehabilitation After Hip Fracture Surgery|Unknown status|Active, not recruiting|Phase 4|120||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:22:11.055665|2017-02-18 17:22:11.055665
NCT00162604|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-09-08|||May 2005||2005-05-01|February 2005|2005-02-01||||||||Interventional|||Prophylactic Antibiotic Treatment During Vaginal Repair|Antibiotikaprofylakse Ved Vaginalplastik|Unknown status|Recruiting|N/A|200||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:22:11.148265|2017-02-18 17:22:11.148265
NCT00162591|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2005-11-21|||October 2004||2004-10-01|October 2004|2004-10-01||||||||Interventional|||Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl|Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl|Unknown status|Recruiting|N/A|40||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:22:11.245596|2017-02-18 17:22:11.245596
NCT00162578|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-07-20|||December 2002||2002-12-01|July 2007|2007-07-01|November 2005|Actual|2005-11-01|||||Observational|||Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis|Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis Treated With Dexamethasone|Completed||N/A|14|Actual|Assistance Publique - Hôpitaux de Paris|||||f||||f||||||||||2017-02-18 17:22:11.358|2017-02-18 17:22:11.358
NCT00162565|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-05-22|||November 2004||2004-11-01|August 2005|2005-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|BConvinced||Beta-Blocker Continuation Versus Interruption in Heart Failure Worsening|Beta-Blocker Continuation Versus Interruption in Patients With Congestive Heart Failure Hospitalized for Heart Failure Worsening (B-CONVINCED)|Completed||Phase 4|180|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||t||||||||||2017-02-18 17:22:11.472236|2017-02-18 17:22:11.472236
NCT00162552|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-01-16|||August 2004||2004-08-01|August 2005|2005-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|PENTOCIR||Clinical Trial of Pentoxifylline in Patient With Cirrhosis|Clinical Trial of Pentoxifylline Administration Versus Placebo on Survival in Patients With Cirrhosis and Severe Liver Failure|Completed||Phase 3|342|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 17:22:11.630524|2017-02-18 17:22:11.630524
NCT00162539|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-10|2012-07-25|||October 2005||2005-10-01|May 2005|2005-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid Dimension|Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid Dimension|Completed||N/A|130|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 17:22:11.760845|2017-02-18 17:22:11.760845
NCT00162526|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-04-07|||December 2005||2005-12-01|September 2005|2005-09-01||||||||Interventional|||Tocopherol is a Novel Treatment for Cancer Related Mucositis|A Randomized Double Blind Placebo Controlled Clinical Trial Aim to Assess the Efficacy of Vitamin E Formulation (Tocopherol) in the Treatment of Chemotherapy Induced Stomatitis in Patients Undergoing Stem Cell Transplantation|Withdrawn||Phase 2|30|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-02-18 17:22:11.862105|2017-02-18 17:22:11.862105
NCT00162513|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2011-04-27|||December 2006||2006-12-01|September 2006|2006-09-01||||||||Interventional|||Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia|Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia|Withdrawn||Phase 1/Phase 2|||Hadassah Medical Organization||||PI is no longer work at Hadassah|f||||||||||||||2017-02-18 17:22:11.95523|2017-02-18 17:22:11.95523
NCT00162500|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2010-11-09||||||September 2005|2005-09-01||||||||Interventional|||A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies|A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies|Withdrawn||Phase 2|15|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.0356|2017-02-18 17:22:12.0356
NCT00162487|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-10-28|||August 2002||2002-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation|Evaluation of β2 Genetic Polymorphisms and the Effect of Albuterol Inhalation on Potassium and Glucose Plasma Concentration|Unknown status|Recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.120589|2017-02-18 17:22:12.120589
NCT00162474|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-10-28|||September 2003||2003-09-01|October 2008|2008-10-01||||||||Interventional|||Determinants of Warfarin Metabolism|Correlation Between Phenotypic Activity of CYP2C9 and Genetic Polymorphism in CYP2C9 and Warfarin Metabolism.|Unknown status|Recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.202463|2017-02-18 17:22:12.202463
NCT00162461|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-10-28|||August 1998||1998-08-01|October 2008|2008-10-01||||||||Interventional|||Evaluation of CYP2C9 Activity|The Use of Phenytoin Metabolic Ratio as a Putative Marker of CYP2C9 Activity in-Vivo|Unknown status|Recruiting|N/A|600|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.28736|2017-02-18 17:22:12.28736
NCT00162448|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-08-18|||January 2005||2005-01-01|August 2008|2008-08-01||||||||Interventional|||A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators|Double-Blind, Randomized, Single-Dose Study to Evaluate the Atrial Selectivity and Safety of BMS-394136 in Patients With Implanted Dual-Chamber Pacemakers or Defibrillators|Completed||Phase 1|36||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:22:12.374097|2017-02-18 17:22:12.374097
NCT00162435|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-10-28|||August 2002||2002-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of Warfarin Anticoagulation Effect|Warfarin Induction Regimen Based Upon CYP2C9, VKORC1 Factor VII Genotyping, PMR and INR Monitoring, as Compared to the Conventional Regimen: a Prospective Controlled Study|Unknown status|Recruiting|N/A|500|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.485103|2017-02-18 17:22:12.485103
NCT00162422|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-10-28|||August 2003||2003-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of the Bronchodilatation Effect of Albuterol ex-Vivo|The Effect of β2 Genetic Polymorphisms on the Brochodilatation Effect of Albuterol ex-Vivo|Unknown status|Recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.588991|2017-02-18 17:22:12.588991
NCT00162409|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-10-28|||August 2001||2001-08-01|October 2008|2008-10-01||||||||Interventional|||Relationship Between Folic Acid and Warfarin Metabolism and Effect|The Effect of Folic Acid Concentration and Folic Acid Supplementation on Warfarin Pharmacokinetic and Warfarin Dose Requirement at Steady State.|Unknown status|Recruiting|N/A|400|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.669316|2017-02-18 17:22:12.669316
NCT00162396|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-10-28|||August 1999||1999-08-01|October 2008|2008-10-01||||||||Interventional|||Genetic Determinants of the Response to Salbutamol Among Asthma Patients|Evaluation of Genetic Factors That May Account for Variability in the Response to Salbutamol Among Patients Suffering From Asthma|Unknown status|Recruiting|N/A|150|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.747811|2017-02-18 17:22:12.747811
NCT00162383|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-11|2008-10-28|||July 1995||1995-07-01|October 2008|2008-10-01||||||||Interventional|||Metabolic Capacity of Israeli Populations|Phenotypic and Genotypic Evaluation of Cytochrome P450 Isoforms in Populations of Different Ethnic Composition|Terminated||N/A|1200||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:22:12.835391|2017-02-18 17:22:12.835391
NCT00162370|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-10-14|2016-04-17||April 2004||2004-04-01|September 2014|2014-09-01|October 2012|Actual|2012-10-01|September 2012|Actual|2012-09-01||Interventional||Peri- or post-menopausal female subjects between 40 and 65 years of age with an intermediate likelihood of CAD who are scheduled to undergo stress echocardiography|A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease|SMART: Stress Echocardiography in Menopausal Women at Risk for Coronary Artery Disease Trial|Completed||Phase 4|400|Actual|Lantheus Medical Imaging||1|||f||||f||||||||No||2017-02-18 17:22:12.926461|2017-02-18 17:22:12.926461
NCT00162357|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-14|||April 2004||2004-04-01|April 2011|2011-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty|Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention|Completed||Phase 4|106|Actual|Lantheus Medical Imaging|||||f||||f||||||||||2017-02-18 17:22:13.257348|2017-02-18 17:22:13.257348
NCT00162344|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-14|||December 2003||2003-12-01|April 2011|2011-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.|AceP-D: Non-invasive Assessment of Atypical Chest Pain in Patients With Diabetes|Completed||Phase 4|205|Actual|Lantheus Medical Imaging||1|||f||||||||||||||2017-02-18 17:22:13.353799|2017-02-18 17:22:13.353799
NCT00162331|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-14|||January 2005||2005-01-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI|AIR-MI: Assessment of Ischemia and Remodeling Following Acute Myocardial Infarction|Completed||Phase 4|74|Actual|Lantheus Medical Imaging|||||f||||f||||||||||2017-02-18 17:22:13.452227|2017-02-18 17:22:13.452227
NCT00162318|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-10-26|||March 2005||2005-03-01|October 2015|2015-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1|30||Eli Lilly and Company||1|||f||||||||||||||2017-02-18 17:22:13.554088|2017-02-18 17:22:13.554088
NCT00162305|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-10-26|||April 2005||2005-04-01|October 2016|2016-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects|A Double-blind, Placebo-controlled, Randomized, Multiple-dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Bms-512148 in Diabetic Subjects|Completed||Phase 2|47|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 17:22:13.651042|2017-02-18 17:22:13.651042
NCT00162292|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-02-27||2010-02-27|November 2005||2005-11-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background|Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background|Completed||Phase 1|33|Anticipated|Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 17:22:14.01286|2017-02-18 17:22:14.01286
NCT00162279|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-12-02||2010-09-10|October 2000||2000-10-01|December 2010|2010-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||The Study of Abatacept in Combination With Etanercept|A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Clinical Efficacy of Intravenous Infusions of BMS-188667 (10 mg/kg) Given Monthly in Combination With Subcutaneous Injections of Etanercept (25mg)Given Twice Weekly to Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|141||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:22:14.116414|2017-02-18 17:22:14.116414
NCT00162266|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-05-30|2012-02-21||October 2000||2000-10-01|May 2012|2012-05-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Abatacept With Methotrexate- Phase IIB|A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Clinical Efficacy of Two Different Doses of BMS-188667 Administered Intravenously to Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate|Completed||Phase 2|524|Actual|Bristol-Myers Squibb||4|||f||||||||||||||2017-02-18 17:22:14.293658|2017-02-18 17:22:14.293658
NCT00162253|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-02-27||2010-02-27|April 2005||2005-04-01|September 2007|2007-09-01||||June 2006|Actual|2006-06-01||Interventional|||Study of BMS-587101 in Patients With Moderate to Severe Psoriasis|Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of BMS-587101 in Patients With Moderate to Severe Psoriasis|Terminated||Phase 2|120||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:22:19.858753|2017-02-18 17:22:19.858753
NCT00162240|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-04-26|||June 2003||2003-06-01|April 2012|2012-04-01|May 2004|Actual|2004-05-01|||||Interventional|||PPAR - Combination With Metformin|A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Metformin Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone|Completed||Phase 3|534||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:22:19.978582|2017-02-18 17:22:19.978582
NCT00162227|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-01-08|||September 2000||2000-09-01|January 2014|2014-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Expanded Access|||An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection|US Sustiva Oral Liquid Expanded Access Program: an Open-label, Multicenter Expanded Access Study of the Liquid Formulation of Sustiva (Efavirenz, DMP 266)|No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:22:20.371705|2017-02-18 17:22:20.371705
NCT00162214|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-13|||August 2005||2005-08-01|April 2011|2011-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Dasatinib in Patients With Advanced Solid Tumors|Phase I Study to Evaluate the Effect of Ketoconazole on the Pharmacokinetics of Dasatinib and the Effect of Dasatinib on Pharmacodynamic Markers in Patients With Advanced Solid Tumors|Terminated||Phase 1|60||Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 17:22:20.493547|2017-02-18 17:22:20.493547
NCT00162201|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-11|||October 2003||2003-10-01|April 2011|2011-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy|An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy|Completed||Phase 1|16|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 17:22:20.592617|2017-02-18 17:22:20.592617
NCT00162188|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-01-08|||May 2001||2001-05-01|January 2014|2014-01-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Expanded Access|||An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada|Canadian Sustiva Oral Liquid Expanded Access Program: An Open-Label, Multicenter Expanded Access Study of the Liquid Formulation of Sustiva (Efavirenz, DMP266)|No longer available||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 17:22:20.697951|2017-02-18 17:22:20.697951
NCT00162175|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-09-10||2010-09-10|July 2003||2003-07-01|September 2007|2007-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||PPAR-COMBO With Sulfonylurea|A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Glyburide Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone|Completed||Phase 3|534||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:22:20.807477|2017-02-18 17:22:20.807477
NCT00162149|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-07|||October 2005||2005-10-01|June 2008|2008-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||ATV/Ritonavir Nevirapine Interaction (USPAC)|Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Nevirapine on the Pharmacokinetics of Atazanavir in HIV-Infected Individuals|Completed||Phase 1|46||Bristol-Myers Squibb||4|||f||||||||||||||2017-02-18 17:22:21.228104|2017-02-18 17:22:21.228104
NCT00162136|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-02-09|2009-07-03||September 2005||2005-09-01|February 2016|2016-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.|Phase I Study of Ixabepilone Administered as a 24-Hour Infusion in Patients With Advanced Solid Malignancies|Completed||Phase 1|35|Actual|R-Pharm||1|||f||||f||||||||||2017-02-18 17:22:21.352704|2017-02-18 17:22:21.352704
NCT00162123|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-06-28|2013-12-31||May 2006||2006-05-01|June 2016|2016-06-01|April 2014|Actual|2014-04-01|September 2012|Actual|2012-09-01||Interventional||All patients who were enrolled and passed screening in the current study|A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies|A Multi-Center, Open-Label, Phase II Study of Ipilimumab (MDX-010 Extended-Treatment Monotherapy or Follow-up for Patients Previously Enrolled in Ipilimumab (MDX-010) Protocols.|Completed||Phase 2|248|Actual|Bristol-Myers Squibb|Significant heterogeneity existed between patients, who rolled over from 6 studies assessing ipilimumab in different doses and combinations. Since not all eligible patients from parent studies were enrolled, some selection bias existed.|7|||f||||t||||||||||2017-02-18 17:22:23.361552|2017-02-18 17:22:23.361552
NCT00162110|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-10-26|||November 2004||2004-11-01|October 2015|2015-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces|A Phase II Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces|Completed||Phase 2|40||Eli Lilly and Company||1|||f||||||||||||||2017-02-18 17:22:26.775749|2017-02-18 17:22:26.775749
NCT00161330|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||June 2000||2000-06-01|July 2004|2004-07-01|July 2005||2005-07-01|||||Interventional|||Oral Vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT|A Multicenter Randomized Controlled Trial of Antibiotic Treatment in Children With Urinary Tract Infections: Oral Amoxicillin/Clavulanic Acid Vs Initial Iv Ceftriaxone.|Terminated||Phase 3|440||University of Padova|||||f||||||||||||||2017-02-18 17:22:36.33386|2017-02-18 17:22:36.33386
NCT00162097|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-09-07|2010-07-28||November 2004||2004-11-01|September 2010|2010-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment|Pharmacokinetics of Efavirenz During Treatment of HIV-1 Infected Subjects With Hepatic Impairment.|Completed||Phase 1|21|Actual|Bristol-Myers Squibb|The study was terminated early leading to a small number of participants treated and analyzed. Due to the small sample size, no conclusion could be made for participants with Child-Pugh scores B and C (moderate and severe hepatic impairment).|4|||f||||f||||||||||2017-02-18 17:22:26.88183|2017-02-18 17:22:26.88183
NCT00162084|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-31|||April 2005||2005-04-01|January 2017|2017-01-01||||March 2006|Actual|2006-03-01||Interventional|||A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography|A Phase 3, Parallel, Double Blind, Multicenter Trial to Examine Inducible Myocardial Perfusion Abnormality Detection With BMS068645 and Adenosine Stress SPECT Compared to Coronary Angiography|Terminated||Phase 3|2000||Forest Laboratories||||Business decision to stop the program|f||||||||||||||2017-02-18 17:22:28.336983|2017-02-18 17:22:28.336983
NCT00162071|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-31|||July 2005||2005-07-01|January 2017|2017-01-01||||March 2006|Actual|2006-03-01||Interventional|||A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging|"A Phase II Open-Label, Non-Randomized, Single-Center Trial to Determine the Optimal Myocardial Perfusion Image Acquisition Time Following BMS068645 Administration"|Terminated||Phase 2|20||Forest Laboratories||||Sponsor decided not to continue with the development program|f||||||||||||||2017-02-18 17:22:28.506486|2017-02-18 17:22:28.506486
NCT00162058|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-17|||March 2004||2004-03-01|August 2011|2011-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Phase II Study of DMP 115 to Assess Focal Liver Lesions|An Open-Label, Non-Randomized, Phase II Trial To Assess Focal Liver Lesion Detection Using Definity-Enhanced Ultrasound Imaging|Completed||Phase 2|80||Lantheus Medical Imaging|||||f||||||||||||||2017-02-18 17:22:28.592453|2017-02-18 17:22:28.592453
NCT00162045|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-06-01|||January 2005||2005-01-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects|A Phase I-II, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of Technetium Tc99m Sestamibi in Pediatric Subjects|Completed||Phase 1/Phase 2|79|Actual|Lantheus Medical Imaging||1|||f||||f||||||||||2017-02-18 17:22:28.673441|2017-02-18 17:22:28.673441
NCT00162032|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-10-08|2013-04-30||August 2005||2005-08-01|April 2012|2012-04-01|December 2010|Actual|2010-12-01|May 2010|Actual|2010-05-01||Interventional|||A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease|A Phase III, Open-Label, Non-Randomized, International, Multicenter Trial to Evaluate the Efficacy and Safety of CARDIOLITE® Myocardial Perfusion Imaging in Pediatric Subjects With Kawasaki Disease|Completed||Phase 3|445|Actual|Lantheus Medical Imaging||2|||f||||f||||||||||2017-02-18 17:22:28.775558|2017-02-18 17:22:28.775558
NCT00162019|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||March 2003||2003-03-01|April 2008|2008-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients|Phase 3, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of IMMUNATE Solvent Detergent (IMMUNATE SD) in Previously Treated Patients With Severe or Moderately Severe Hemophilia A|Completed||Phase 3|56|Actual|Baxalta US Inc.|||||f||||t||||||||||2017-02-18 17:22:29.356816|2017-02-18 17:22:29.356816
NCT00162006|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||January 2003||2003-01-01|October 2006|2006-10-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura|Prospective Open-Label Study of the Efficacy and Safety of Immune Globulin Intravenous (Human), 10% TVR Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura|Completed||Phase 2|28|Actual|Baxalta US Inc.|||||f||||||||||||||2017-02-18 17:22:29.610842|2017-02-18 17:22:29.610842
NCT00161993|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||June 2002||2002-06-01|October 2006|2006-10-01|September 2003||2003-09-01|||||Interventional|||Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)|Prospective Open-Label Study of Pharmacokinetics, Efficacy and Safety of Immune Globulin Intravenous (Human), 10% TVR Solution in Patients With Hypo- or Agammaglobulinemia|Completed||Phase 2|||Baxalta US Inc.|||||f||||||||||||||2017-02-18 17:22:29.722212|2017-02-18 17:22:29.722212
NCT00161980|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-20|||June 2001||2001-06-01|October 2006|2006-10-01|December 2002||2002-12-01|||||Interventional|||Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites|A Randomized and Controlled Clinical Study to Evaluate the Efficacy and Safety of Fibrin Sealant VH S/D (FS VH S/D) in Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites|Completed||Phase 3|||Baxter Healthcare Corporation|||||f||||||||||||||2017-02-18 17:22:29.805459|2017-02-18 17:22:29.805459
NCT00161967|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||May 2005||2005-05-01|May 2015|2015-05-01|November 2008|Actual|2008-11-01|July 2008|Actual|2008-07-01||Interventional|||TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)|Open-label Follow-up Study to Investigate the Seropersistence of TBE Antibodies and the Booster Response to a Tick-borne Encephalitis Vaccine in Children and Adolescents Aged 3 - 18 Years|Completed||Phase 4|375|Anticipated|Pfizer||1|||f||||t||||||||||2017-02-18 17:22:29.897528|2017-02-18 17:22:29.897528
NCT00161954|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||March 2004||2004-03-01|May 2015|2015-05-01|May 2004||2004-05-01|||||Interventional|||Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years|Open Phase IV Clinical Study to Evaluate the Immunogenicity and Safety of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years|Completed||Phase 4|||Pfizer|||||f||||||||||||||2017-02-18 17:22:29.990682|2017-02-18 17:22:29.990682
NCT00161941|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||June 2003||2003-06-01|May 2015|2015-05-01|December 2003||2003-12-01|||||Observational|||Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216|Open-label Multicenter Phase 3B Follow-up Study to Investigate the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens One Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in the NeisVac-C Non-interference Study 216|Completed||N/A|321||Pfizer|||||f||||||||||||||2017-02-18 17:22:30.08343|2017-02-18 17:22:30.08343
NCT00161928|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||April 2002||2002-04-01|May 2015|2015-05-01|January 2003||2003-01-01|||||Interventional|||Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants|A Randomized, Open-Label Trial of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants|Completed||Phase 3|330||Pfizer|||||f||||||||||||||2017-02-18 17:22:30.170205|2017-02-18 17:22:30.170205
NCT00161915|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-20|||December 2000||2000-12-01|October 2006|2006-10-01|January 2004||2004-01-01|||||Interventional|||Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal Varices|Prospective Randomized Study on the Efficacy of Endoscopic Injection Therapy With Fibrin Sealant Versus Endoscopic Ligature for Acute Hemostasis and the Prophylaxis of Recurrent Bleeding From Esophageal Varices|Completed||Phase 3|||Baxter Healthcare Corporation|||||f||||||||||||||2017-02-18 17:22:30.269979|2017-02-18 17:22:30.269979
NCT00161902|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-20|||August 2001||2001-08-01|October 2006|2006-10-01|March 2003||2003-03-01|||||Interventional|||Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement|A Randomized, Controlled, Multicenter Study to Evaluate Efficacy and Safety of Fibrin Sealant VH S/D for Hemostasis in Subjects Undergoing Total Hip Replacement|Completed||Phase 3|||Baxter Healthcare Corporation|||||f||||||||||||||2017-02-18 17:22:30.546369|2017-02-18 17:22:30.546369
NCT00161889|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||February 2002||2002-02-01|May 2015|2015-05-01|August 2002||2002-08-01|||||Interventional|||FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years|Follow-up Study to Investigate the Safety and Immunogenicity of a Third Vaccination With Three Different Antigen Concentrations of FSME IMMUN NEW in Children Aged 6 to 16 Years|Completed||Phase 2|615||Pfizer|||||f||||||||||||||2017-02-18 17:22:30.651324|2017-02-18 17:22:30.651324
NCT00161876|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||May 2002||2002-05-01|May 2015|2015-05-01|August 2002||2002-08-01|||||Interventional|||FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years|Open-label, Multicenter, Follow-up Phase III Study to Investigate the Safety of the Third Vaccination of FSME-IMMUN NEW in Volunteers Aged 16 to 66 Years|Completed||Phase 3|3973||Pfizer|||||f||||||||||||||2017-02-18 17:22:30.757106|2017-02-18 17:22:30.757106
NCT00161863|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||September 2002||2002-09-01|May 2015|2015-05-01|January 2003||2003-01-01|||||Interventional|||Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years|Open-label Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 17:22:30.858688|2017-02-18 17:22:30.858688
NCT00161850|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||February 2002||2002-02-01|May 2015|2015-05-01|August 2002||2002-08-01|||||Interventional|||FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years|Follow-up Study to Investigate the Safety and Immunogenicity of a Third Vaccination With Three Different Antigen Concentrations of FSME IMMUN NEW in Children Aged 1 to 6 Years|Completed||Phase 2|615||Pfizer|||||f||||||||||||||2017-02-18 17:22:30.944873|2017-02-18 17:22:30.944873
NCT00161837|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-10-07|||December 2003||2003-12-01|October 2006|2006-10-01|July 2004||2004-07-01|||||Interventional|||Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004|Single-blind Randomized Controlled Phase II/III Study to Investigate the Immunogenicity and Safety of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived) in Comparison to a Licensed Egg-derived Influenza Vaccine for Season 2003/2004|Completed||Phase 2/Phase 3|||Nanotherapeutics, Inc.|||||f||||||||||||||2017-02-18 17:22:31.055577|2017-02-18 17:22:31.055577
NCT00161824|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||October 2001||2001-10-01|May 2015|2015-05-01|January 2002||2002-01-01|||||Interventional|||Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR|Single-blind, Randomized, Multicenter Comparison of FSME IMMUN NEW and ENCEPUR: Safety and Tolerability of Two Vaccinations in Healthy Volunteers Aged 16 to 65 Years.|Completed||Phase 3|3800||Pfizer|||||f||||||||||||||2017-02-18 17:22:31.138992|2017-02-18 17:22:31.138992
NCT00161811|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-10-07|||November 2004||2004-11-01|October 2006|2006-10-01|July 2005||2005-07-01|||||Interventional|||Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005|Single-blind Randomized Controlled Phase II/III Study to Investigate the Immunogenicity and Safety After a Single Vaccination With Three Different Lots of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell-derived) in Comparison to a Licensed Egg Derived Influenza Vaccine for Season 2004/2005.|Completed||Phase 2/Phase 3|1400||Nanotherapeutics, Inc.|||||f||||||||||||||2017-02-18 17:22:31.225938|2017-02-18 17:22:31.225938
NCT00161798|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||September 2001||2001-09-01|May 2015|2015-05-01|March 2002||2002-03-01|||||Interventional|||Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.|Double-blind, Randomized, Multicenter Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.|Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-02-18 17:22:31.308904|2017-02-18 17:22:31.308904
NCT00161785|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||June 2004||2004-06-01|May 2015|2015-05-01|July 2005||2005-07-01|||||Interventional|||Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years||Completed||Phase 4|340||Pfizer|||||f||||||||||||||2017-02-18 17:22:31.419839|2017-02-18 17:22:31.419839
NCT00161772|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||March 2002||2002-03-01|May 2015|2015-05-01|August 2002||2002-08-01|||||Interventional|||Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.|Double-blind, Randomized, Multicenter Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.|Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-02-18 17:22:31.506139|2017-02-18 17:22:31.506139
NCT00161759|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-19|||March 2002||2002-03-01|October 2006|2006-10-01|January 2004||2004-01-01|||||Interventional|||Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds|A Study to Assess the Safety and Efficacy of Fibrin Sealant (FS 4IU) for Wound Healing in Subjects With Burn Wounds Requiring Skin Grafting Procedures|Completed||Phase 1/Phase 2|40||Baxter Healthcare Corporation|||||||||||||||||||2017-02-18 17:22:31.621045|2017-02-18 17:22:31.621045
NCT00161317|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-01-05|||December 2003||2003-12-01|January 2016|2016-01-01|February 2006||2006-02-01|||||Interventional|||Evaluation of a Living With Hope Program|Development, Implementation and Evaluation of a Psychosocial Supportive Hope Focused Program for Patients With Advanced Cancer|Completed||N/A|60||University of Saskatchewan|||||f||||||||||||||2017-02-18 17:22:36.429429|2017-02-18 17:22:36.429429
NCT00161746|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-20|||April 1998||1998-04-01|May 2015|2015-05-01|June 1999||1999-06-01|||||Interventional|||Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years|Multicentre Randomized Double-Blind Phase II/III Study on the Safety and Immunogenicity of Three Vaccinations With TICOVAC in Two Dosages in Healthy Children Aged Between Six Months and Three Years|Completed||Phase 2/Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 17:22:31.730364|2017-02-18 17:22:31.730364
NCT00161733|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-20|||September 2002||2002-09-01|October 2006|2006-10-01|November 2004||2004-11-01|||||Interventional|||Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery|Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery|Completed||Phase 3|||Baxter Healthcare Corporation|||||||||||||||||||2017-02-18 17:22:31.823982|2017-02-18 17:22:31.823982
NCT00161720|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||June 2005||2005-06-01|October 2006|2006-10-01|December 2005||2005-12-01|||||Observational|||Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND|A Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND|Completed||Phase 4|||Baxalta US Inc.|||||||||||||||||||2017-02-18 17:22:31.955801|2017-02-18 17:22:31.955801
NCT00161707|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||January 2003||2003-01-01|October 2006|2006-10-01|October 2003||2003-10-01|||||Interventional|||Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency|Phase I Safety Investigation of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency|Completed||Phase 1/Phase 2|||Baxalta US Inc.|||||||||||||||||||2017-02-18 17:22:32.069881|2017-02-18 17:22:32.069881
NCT00161694|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-06-02|||July 2005||2005-07-01|June 2008|2008-06-01||||||||Interventional|||Use of Sucrose to Relieve Pain During Eye Exams in Infants|Effectiveness of an Oral Sucrose Solution in Reducing Pain and Anxiety Associated With Neonatal Ophthalmologic Examination|Terminated||N/A|300|Anticipated|Weill Medical College of Cornell University||||results did not show intervention was beneficial|f||||||||||||||2017-02-18 17:22:32.154776|2017-02-18 17:22:32.154776
NCT00161681|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-02-07|||July 2005||2005-07-01|May 2007|2007-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Levonorgestrel 90 Mcg and Ethinyl Estradiol 20 Mcg in a Continuous Daily Regimen on Menstrual Cycle-Related Symptoms|Completed||Phase 3|200||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:22:32.250712|2017-02-18 17:22:32.250712
NCT00161668|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-03-14|||October 2001||2001-10-01|March 2007|2007-03-01||||||||Observational|||Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care|Prospective Observational Study of Mylotarg (Gemtuzumab Ozogamicin) in Usual Care|Completed||Phase 4|500||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:22:32.417924|2017-02-18 17:22:32.417924
NCT00161655|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-09-25|||April 2005||2005-04-01|September 2009|2009-09-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis|A Multicenter, Open-label, Randomized, Pilot-study to Evaluate the Efficacy and Safety of the Combination of Etanercept (ETN) and Methotrexate and of Etanercept (ETN) Alone in Patients With Plaque Psoriasis Despite Methotrexate Therapy|Completed||Phase 4|60||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:22:32.664916|2017-02-18 17:22:32.664916
NCT00161642|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-09-09|||November 2004||2004-11-01|September 2009|2009-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study Evaluating CMD-193 in Advanced Malignant Solid Tumors|A Phase 1 Dose Escalation Study of CMD-193 in Subjects With Advanced Malignant Tumors.|Completed||Phase 1|54|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:22:32.75942|2017-02-18 17:22:32.75942
NCT00161629|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-12-03|||September 2005||2005-09-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures|A Phase 1 Dose-Escalating, Double-Blind, Placebo-Controlled, Multicenter, Safety and Feasibility Study of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)/Calcium Phosphate Matrix (CPM) as an Adjuvant Therapy for Closed Distal Radius Fractures|Completed||Phase 1|40|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:22:32.852136|2017-02-18 17:22:32.852136
NCT00161616|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-07-31|2009-07-31||September 2003||2003-09-01|July 2009|2009-07-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating InductOs in Diaphyseal Tibia Fractures|A Prospective, Randomized, Controlled, Stratified Study of InductOs in Subjects With Open Diaphyseal Tibia Fractures Treated With Reamed Locked Intramedullary Nail Fixation|Completed||Phase 4|277|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||f||||||||||2017-02-18 17:22:32.948749|2017-02-18 17:22:32.948749
NCT00161603|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-04-01|||April 2003||2003-04-01|April 2008|2008-04-01|September 2003||2003-09-01|||||Observational|||Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study|Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study|Completed||N/A|18||Weill Medical College of Cornell University|||||f||||f||||||||||2017-02-18 17:22:33.671775|2017-02-18 17:22:33.671775
NCT00161590|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-10-21|||July 2004||2004-07-01|October 2008|2008-10-01||||||||Interventional|||Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma|Phase I Study of CHOP Plus Campath (C-CHOP) for the Treatment of T-Cell, Null-Cell, and NK-Cell Lymphomas|Completed||Phase 1|||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:22:33.769757|2017-02-18 17:22:33.769757
NCT00161577|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-05-12|||January 2004||2004-01-01|May 2009|2009-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery|Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Ketorolac in the Management of Post-Operative Pain After Heart Surgery|Completed||Phase 4|25|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 17:22:33.864319|2017-02-18 17:22:33.864319
NCT00161304|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-11|||April 2003||2003-04-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Interventional|||Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency|Effects of Testosterone Administration on Tissues of Men With A.D.A.M. (Androgen Deficiency of Aging Men)|Completed||Phase 2/Phase 3|44||Urological Sciences Research Foundation|||||f||||||||||||||2017-02-18 17:22:36.500656|2017-02-18 17:22:36.500656
NCT00161564|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-15|||February 2004||2004-02-01|May 2008|2008-05-01||||||||Interventional|||A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone|A Randomized Trial Comparing Higher Doses of Rituximab (Rituxan) With Standard Doses of Rituxan in Combination With CVP (Cyclophosphamide, Vincristine,and Prednisone) in Subjects With Chronic ITP Who Have Failed/Relapsed After Rituxan Treatment|Withdrawn||Phase 2|||Weill Medical College of Cornell University|||||||||||||||||||2017-02-18 17:22:33.98027|2017-02-18 17:22:33.98027
NCT00161551|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-08-01|||November 2004||2004-11-01|October 2006|2006-10-01|December 2010||2010-12-01|||||Interventional|||Mode Evaluation in Sick Sinus Syndrome Trial (MODEST)|A Randomized, Prospective Multicenter Study to Determine the Incidence of Atrial Fibrillation and Heart Failure in Correlation to Stimulation Modes of Pacemakers|Unknown status|Recruiting|Phase 4|402|Anticipated|Medtronic BRC|||||f||||||||||||||2017-02-18 17:22:34.088017|2017-02-18 17:22:34.088017
NCT00161538|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-10-19|||July 2000||2000-07-01|October 2006|2006-10-01|June 2006||2006-06-01|||||Interventional|||Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation|A Randomized, Prospective Multicenter Study to Examine the Optimal Position of the Atrial Leads for Therapy of the Sinus Node Syndrome|Completed||Phase 4|456||Medtronic BRC|||||f||||||||||||||2017-02-18 17:22:34.20473|2017-02-18 17:22:34.20473
NCT00161525|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-01-03|||October 2003||2003-10-01|January 2011|2011-01-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon Gases|Perfluorocarbon Gases for the Repair of Retinal Detachments.|Unknown status|Recruiting|Phase 2|25|Anticipated|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 17:22:34.323889|2017-02-18 17:22:34.323889
NCT00161486|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-09-18|||July 2004||2004-07-01|September 2008|2008-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|ACYP-1||The Effects of Testosterone on Prostate Tissue (ACYP-1)|The Effects of Testosterone on Prostate Tissue in Normal Men (ACYP-1)|Completed||Phase 1|13|Actual|University of Washington||3|||f||||f||||||||||2017-02-18 17:22:34.428313|2017-02-18 17:22:34.428313
NCT00161473|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-06-26|2012-02-24||January 2001||2001-01-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Alzheimer's in Long-Term Care--Treatment for Agitation|Alzheimer's in Long-Term Care--Treatment for Agitation|Completed||N/A|24|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:22:34.566776|2017-02-18 17:22:34.566776
NCT00161460|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-05-11|||June 2005||2005-06-01|May 2016|2016-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Colorectal Cancer Screening Intervention in UWPN Clinics|Colorectal Cancer Screening Intervention in UWPN Clinics|Completed||N/A|80|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:22:35.004347|2017-02-18 17:22:35.004347
NCT00161447|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-09-18|||May 2004||2004-05-01|September 2008|2008-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|ACY-5||Male Hormonal Contraceptive Development-ACY-5|Male Hormonal Contraceptive Development: Suppression of Spermatogenesis With the Addition of a Potent Antagonist (Acyline) to Testosterone and DMPA (ACY-5)|Completed||Phase 1/Phase 2|43|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:22:35.108568|2017-02-18 17:22:35.108568
NCT00161434|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-12-29|||March 2003||2003-03-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons|A Randomized, Double-Blind, Placebo Controlled Crossover Trial Using Valacyclovir to Suppress HSV and HIV Shedding in HIV-1, HSV-2 Coinfected Persons|Completed||Phase 4|60|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:22:35.227077|2017-02-18 17:22:35.227077
NCT00161421|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-09-18|||March 2005||2005-03-01|September 2008|2008-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone|Oral Androgens in Man-3: Pharmacokinetics of Oral Testosterone With Concomitant Inhibition of 5α-Reductase by Dutasteride Short Title: ORAL T-3|Completed||Phase 2|18|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 17:22:35.335417|2017-02-18 17:22:35.335417
NCT00161408|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||December 2000||2000-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Psychological Intervention for Relapse Prevention in First Episode Schizophrenia|Psychological Intervention for Relapse Prevention in First Episode Schizophrenia|Unknown status|Active, not recruiting|N/A|106||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:22:35.451534|2017-02-18 17:22:35.451534
NCT00161395|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-14|||January 2003||2003-01-01|September 2005|2005-09-01|March 2007|Actual|2007-03-01|August 2006|Actual|2006-08-01||Interventional|||Study of Time to Pregnancy in Normal Fertility|Randomized Trial of Fertility Awareness and Time to Pregnancy in Couples of Normal Fertility|Completed||Phase 2|143|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 17:22:35.543551|2017-02-18 17:22:35.543551
NCT00161382|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-06-23|2014-05-21||September 2002||2002-09-01|June 2014|2014-06-01|July 2008|Actual|2008-07-01|March 2007|Actual|2007-03-01||Interventional|||Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students|HIV Prevention Programs for Middle School Students|Completed||N/A|3007|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 17:22:35.657552|2017-02-18 17:22:35.657552
NCT00161369|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-10-19|||April 2000||2000-04-01|October 2005|2005-10-01|March 2005||2005-03-01|||||Observational|||Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients|Contribution of Homocysteine and Asymmetric Dimethylarginine to Atherosclerosis and Cardiovascular Events in Maintenance Hemodialysis Patients|Completed||N/A|200||University of Shizuoka|||||f||||||||||||||2017-02-18 17:22:36.050054|2017-02-18 17:22:36.050054
NCT00161356|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-06-20|||September 2005||2005-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Ambisome in Liver Transplant Patients|Blood, Bile and Tissue Pharmacokinetics of Single Dose Liposomal Amphotericin B (AmBisome ®) in Liver Transplant Patients.|Terminated||Phase 4|10|Actual|The University of Texas Health Science Center, Houston||1||Budget issues|f||||f||||||||||2017-02-18 17:22:36.132385|2017-02-18 17:22:36.132385
NCT00161343|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-09-04|||December 2004||2004-12-01|April 2009|2009-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Maintaining HIV Prevention Gains in Female Adolescents|Randomized Controlled Trial of an Group Intervention to Maintain HIV Prevention Gains in Female Adolescents|Completed||Phase 2|640|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 17:22:36.220101|2017-02-18 17:22:36.220101
NCT00155116|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-22|||October 2004||2004-10-01|October 2004|2004-10-01|December 2006||2006-12-01|||||Observational|||SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.464587|2017-02-18 17:24:24.464587
NCT00161291|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-12-30|||June 2005||2005-06-01|December 2010|2010-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer|A Phase II Open Label Trial of Pre-Operative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer|Completed||Phase 2|28|Actual|University of Alabama at Birmingham|||||f||||t||||||||||2017-02-18 17:22:36.575256|2017-02-18 17:22:36.575256
NCT00161278|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-07-28|||December 2004||2004-12-01|July 2008|2008-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling|Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer Through Gene Expression Profiling.|Terminated||Phase 2|1|Actual|University of Michigan Cancer Center||||recruitment has ended|f||||t||||||||||2017-02-18 17:22:36.673507|2017-02-18 17:22:36.673507
NCT00161265|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-07-28|||May 2005||2005-05-01|July 2016|2016-07-01|June 2016|Actual|2016-06-01|August 2012|Actual|2012-08-01||Observational|||Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer|UMCC 2004.064: Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer|Completed||N/A|68|Actual|University of Michigan Cancer Center|||1||f||||t||||||Samples Without DNA|"~     tissue~   "|Undecided||2017-02-18 17:22:36.761599|2017-02-18 17:22:36.761599
NCT00161252|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-27|||March 2005||2005-03-01|May 2011|2011-05-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Observational|||Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly|Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly Men|Withdrawn||N/A|0|Actual|Rutgers, The State University of New Jersey|||1||f||||||||||||||2017-02-18 17:22:36.859262|2017-02-18 17:22:36.859262
NCT00161239|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-12-10|||February 2005||2005-02-01|December 2009|2009-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma|LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma|Terminated||N/A|64|Anticipated|Rutgers, The State University of New Jersey||||toxicity|f||||||||||||||2017-02-18 17:22:36.936511|2017-02-18 17:22:36.936511
NCT00161226|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-12-10|||February 2004||2004-02-01|December 2009|2009-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35|A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35|Terminated||Phase 2|44|Anticipated|Rutgers, The State University of New Jersey|||1|Principal investigator left institution|f||||||||||||||2017-02-18 17:22:37.022655|2017-02-18 17:22:37.022655
NCT00161213|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-11-21|2012-11-21||September 2005||2005-09-01|November 2012|2012-11-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer|Phase II Study of Imatinib Mesylate and Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer|Completed||Phase 2|44|Actual|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-02-18 17:22:37.120664|2017-02-18 17:22:37.120664
NCT00161200|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-12-10|||December 2002||2002-12-01|December 2009|2009-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor|Studies of Esophageal Metaplasia Using a Novel Antibody: Reversibility of Columnar Metaplasia by Proton Pump Inhibitor|Terminated||Phase 3|60||Rutgers, The State University of New Jersey||||slow accrual|||||||||||||||2017-02-18 17:22:37.424826|2017-02-18 17:22:37.424826
NCT00161187|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-11-05|||May 2001||2001-05-01|September 2013|2013-09-01|October 2011|Actual|2011-10-01|October 2010|Actual|2010-10-01||Interventional|||Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor|A Pilot Study of Irradiated HLA-Partially Matched Allogeneic Related Donor Lymphocytes for Patients With Selected Malignancies|Completed||Phase 1|37|Actual|Rutgers, The State University of New Jersey||1|||f||||f||||||||||2017-02-18 17:22:37.521147|2017-02-18 17:22:37.521147
NCT00161174|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-28|||July 2005||2005-07-01|April 2015|2015-04-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Observational|||Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity|Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity. (KWF RUG 2004-3157)|Completed||N/A|173|Actual|University Medical Center Groningen|||1||f||||||||||Samples With DNA|"~     For cured patients with complete data on cardiovascular risk factors and presence of~     subclinical cardiovascular damage only DNA will be collected.~   "|||2017-02-18 17:22:37.6553|2017-02-18 17:22:37.6553
NCT00161161|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-12-29|||October 1999||1999-10-01|September 2005|2005-09-01|December 2002||2002-12-01|||||Observational|||Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder|Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder|Completed||N/A|90||UMC Utrecht|||||f||||||||||||||2017-02-18 17:22:40.56211|2017-02-18 17:22:40.56211
NCT00161148|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-01-08|||January 2005||2005-01-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Probiotics in Patients With Primary Sclerosing Cholangitis|Probiotics in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease- a Randomized Placebo-Controlled Cross-Over Trial|Unknown status|Recruiting|Phase 3|12||UMC Utrecht|||||f||||||||||||||2017-02-18 17:22:40.687923|2017-02-18 17:22:40.687923
NCT00161135|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-04-19|||January 1999||1999-01-01|April 2007|2007-04-01||||||||Observational|||Magnetic Resonance Imaging in Children and Adolescents With Autism and Multiple Complex Developmental Disorders|Magnetic Resonance Imaging in Children and Adolescents With Autism and Multiple Complex Developmental Disorders|Completed||N/A|150||UMC Utrecht|||||f||||f||||||||||2017-02-18 17:22:40.78662|2017-02-18 17:22:40.78662
NCT00161122|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-02-13|||September 2003||2003-09-01|July 2005|2005-07-01|June 2006||2006-06-01|||||Interventional|||Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)|Effectiveness and Costs of Combined Influenza and Pneumococcal Vaccination in Pre-School Children With Recurrent Respiratory Tract Infections (RTI): a General Practice-Based Randomized Controlled Trial|Completed||Phase 4|660||UMC Utrecht|||||f||||||||||||||2017-02-18 17:22:40.869634|2017-02-18 17:22:40.869634
NCT00161109|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-12|||October 2002||2002-10-01|October 2004|2004-10-01|October 2012||2012-10-01|||||Observational|||Genetics and Psychopathology in the 22q11 Deletion Syndrome|Genetics and Psychopathology in the 22q11 Deletion Syndrome|Unknown status|Recruiting|N/A|175||UMC Utrecht|||||f||||||||||||||2017-02-18 17:22:40.963735|2017-02-18 17:22:40.963735
NCT00161096|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-02-01|||March 2004||2004-03-01|November 2004|2004-11-01|September 2005||2005-09-01|||||Interventional|||On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication|Comparison of the Percentage Chronic on-Demand Users Treated With 20 Mg Pantoprazole on-Demand and Placebo o.d Versus Placebo on-Demand and 20 Mg Pantoprazole o.d. After Symptom Relief With 20 Mg Pantoprazole o.d.|Unknown status|Active, not recruiting|Phase 3|276||UMC Utrecht|||||f||||||||||||||2017-02-18 17:22:41.099865|2017-02-18 17:22:41.099865
NCT00161083|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-07-26|||November 2001||2001-11-01|September 2005|2005-09-01|November 2004||2004-11-01|||||Interventional|||UDCA for Symptomatic Gallstone Disease|Studie Naar De Effectiviteit Van Ursodeoxycholzuur Ter Preventie Van Galsteen-Gerelateerde Klachten Bij patiënten in Afwachting Van Een Cholecystectomie|Completed||Phase 4|180||UMC Utrecht|||||f||||||||||||||2017-02-18 17:22:41.192826|2017-02-18 17:22:41.192826
NCT00161070|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-03-21|||July 1997||1997-07-01|March 2007|2007-03-01|December 2006|Actual|2006-12-01|||||Interventional|||ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial|ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial|Completed||Phase 4|4500||UMC Utrecht|||||f||||||||||||||2017-02-18 17:22:41.296913|2017-02-18 17:22:41.296913
NCT00161057|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-04-22|||December 2001||2001-12-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|||||Observational|||Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment|Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment|Completed||N/A|78|Actual|UMC Utrecht|||1||f||||||||||||||2017-02-18 17:22:41.404385|2017-02-18 17:22:41.404385
NCT00161044|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-03-04|||September 2004||2004-09-01|March 2015|2015-03-01|September 2005||2005-09-01|||||Interventional|||An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms|An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms|Completed||N/A|20||University of Maryland|||||f||||||||||||||2017-02-18 17:22:41.494289|2017-02-18 17:22:41.494289
NCT00161031|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-03-04|||April 2004||2004-04-01|March 2015|2015-03-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia|Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia|Completed||N/A|30|Anticipated|University of Maryland|||||f||||||||||||||2017-02-18 17:22:41.590418|2017-02-18 17:22:41.590418
NCT00161018|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-03-04|||November 2003||2003-11-01|March 2015|2015-03-01|November 2004|Actual|2004-11-01|||||Interventional|||New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia||Completed||Phase 3|150||University of Maryland|||||f||||||||||||||2017-02-18 17:22:41.935811|2017-02-18 17:22:41.935811
NCT00161005|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-04-16|||February 2005||2005-02-01|April 2009|2009-04-01|December 2009|Anticipated|2009-12-01|June 2009|Anticipated|2009-06-01||Interventional|||Norwegian Study on District Treatment of ST-Elevation Myocardial Infarction|Benefits and Costs in Two Different Strategies for Treating Acute Myocardial Infarction With ST-Elevation.|Unknown status|Active, not recruiting|N/A|266|Anticipated|Ullevaal University Hospital||1|||f||||t||||||||||2017-02-18 17:22:42.039577|2017-02-18 17:22:42.039577
NCT00160992|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||July 2004||2004-07-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients|Phase I Study of in Vivo Expansion of Melan-A/MART-1 Antigen-Specific CD8 T Lymphocytes Following Transient Immunosuppression in Patients With Advanced Melanoma|Suspended||Phase 1|6||University of Lausanne Hospitals|||||f||||||||||||||2017-02-18 17:22:42.132774|2017-02-18 17:22:42.132774
NCT00160979|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-02-05|||January 2001||2001-01-01|February 2016|2016-02-01|January 2017|Anticipated|2017-01-01|January 2017|Anticipated|2017-01-01||Interventional|||Transrectal Tumour Oxygen - US Army|A Study of Transrectal Tumour Oxygen Measurements in Patients With Clinically Localized Prostate Cancer|Active, not recruiting||Phase 2|195|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:22:42.223345|2017-02-18 17:22:42.223345
NCT00160966|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-07-02|||September 2004||2004-09-01|July 2010|2010-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy|Prospective Randomized Study to Characterize Risk Factors of Polyomavirus-related Transplant Nephropathy and the Impact of Three Immunosuppressive Regimens on Nephropathy Incidence|Completed||Phase 4|108|Actual|University of Giessen||3|||f||||t||||||||||2017-02-18 17:22:42.323465|2017-02-18 17:22:42.323465
NCT00160953|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-08-10|||February 2005||2005-02-01|August 2010|2010-08-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Endorectal Coil Magnetic Resonance Images (ERC-MRI)|Development of a Prostate Deformation Model to Enable Accurate Registration of Endorectal Coil Magnetic Resonance Images (ERC-MRI) to Reference Treatment Planning CT Images|Completed||Phase 2|20||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:22:42.464854|2017-02-18 17:22:42.464854
NCT00160940|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-29|||February 2002||2002-02-01|September 2005|2005-09-01||||||||Observational|||Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis|Differential Gene Expression in Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis With or Without a Complicating Hepatoma or Autoimmune Liver Disease|Unknown status|Recruiting|N/A|200||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:22:42.549354|2017-02-18 17:22:42.549354
NCT00160927|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-03-16|||January 2003||2003-01-01|March 2007|2007-03-01|January 2008|Anticipated|2008-01-01|||||Observational|||Microvascular Response in Diabetes Mellitus|Microcirculation cutanée et Vasodilatation Induite Par la Pression Non-Nociceptive Chez Les diabètiques|Unknown status|Recruiting|N/A|90||University Hospital, Angers|||||f||||f||||||||||2017-02-18 17:22:42.637072|2017-02-18 17:22:42.637072
NCT00160914|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-04-06|||December 2001||2001-12-01|April 2016|2016-04-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Childhood Obesity: Variations in Management|Childhood Obesity: Variations in Management|Completed||N/A|500|Actual|University of Chicago|||1||f||||f||||||||||2017-02-18 17:22:42.734478|2017-02-18 17:22:42.734478
NCT00160901|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-04-18|||August 2003||2003-08-01|March 2007|2007-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer|Prospective Randomized Trial With Complementary Therapies During Chemotherapy at the Women's Hospital of the University of Heidelberg|Completed||Phase 4|150||Heidelberg University|||||f||||f||||||||||2017-02-18 17:22:42.842304|2017-02-18 17:22:42.842304
NCT00160888|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-09|||November 1999||1999-11-01|September 2005|2005-09-01|December 2006||2006-12-01|||||Interventional|||Vasoreactivity in Carriers of Genetic Polymorphisms|Endothelium-Dependent Vasoreactivity in Nitric Oxide Synthase Gene (Glu298Asp) Polymorphism: Studies in Healthy Volunteers|Unknown status|Recruiting|Phase 1|100||Heidelberg University|||||f||||||||||||||2017-02-18 17:22:42.953907|2017-02-18 17:22:42.953907
NCT00160875|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-07-29|||April 2009||2009-04-01|July 2016|2016-07-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer|A Phase II Study to Assess the Efficacy of Combined Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy (External Beam, Brachytherapy), Plus Surgery for Potentially Resectable Thoracic Esophageal Cancer|Completed||Phase 2/Phase 3|54|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 17:22:43.042619|2017-02-18 17:22:43.042619
NCT00160862|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-09|||May 2003||2003-05-01|September 2005|2005-09-01|November 2003||2003-11-01|||||Interventional|||NK-1 Antagonism of SLV317 in Humans|A Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Effect of a Single Oral Dose of SLV 317 on Substance P-Induced Venodilation in the Hand Vein of Healthy Male Volunteers|Completed||Phase 1|18||Heidelberg University|||||f||||||||||||||2017-02-18 17:22:43.155608|2017-02-18 17:22:43.155608
NCT00160849|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-10-19|||August 2004||2004-08-01|July 2005|2005-07-01|March 2007||2007-03-01|||||Interventional|||Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression|Study on the Feasibility of Antiretroviral Therapy With a Single Agent - Lopinavir/r - in Patients Treated With HAART and With Viral Load Below 80 Copies/Ml|Completed||Phase 4|60||Universidade Federal do Rio de Janeiro|||||f||||||||||||||2017-02-18 17:22:43.238816|2017-02-18 17:22:43.238816
NCT00160836|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-04-18|||October 2004||2004-10-01|April 2007|2007-04-01||||||||Interventional|||Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter|Biliary Tissue Sampling Using a Cytology Brush or the G.I.U.M. Catheter: a Prospective Randomized Controlled Study.|Unknown status|Recruiting|Phase 1|68||University Hospital, Geneva|||||f||||||||||||||2017-02-18 17:22:43.337752|2017-02-18 17:22:43.337752
NCT00160823|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-11|||September 2005||2005-09-01|September 2006|2006-09-01||||||||Interventional|||Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients|Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital|Unknown status|Recruiting|Phase 3|102||University Hospital, Geneva|||||f||||||||||||||2017-02-18 17:22:43.46103|2017-02-18 17:22:43.46103
NCT00160810|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-05-17|||April 2001||2001-04-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|October 2010|Actual|2010-10-01||Observational|||Outcome Study of Complex Distal Radius Fractures|Outcome Study of Complex Distal Radius Fractures: Open Reduction Internal Fixation (ORIF) With A Volar Fixed Angled Plate Versus A Distal Radius Volar (DRV) Plate Versus External Fixation|Completed||Phase 4|74|Actual|University of Florida|||1||f||||f||||||||||2017-02-18 17:22:43.549593|2017-02-18 17:22:43.549593
NCT00160797|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-04-30|||August 2005||2005-08-01|April 2012|2012-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Total Knee Arthroplasty Outcome Study|MIS™ Minimally Invasive Solutions™ Total Knee Arthroplasty Outcome Study #02-800|Withdrawn||Phase 4|0|Actual|University of Florida||||10/2005 PI assigned duties as trauma physician in addition other duties|f||||||||||||||2017-02-18 17:22:43.639293|2017-02-18 17:22:43.639293
NCT00160784|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-12-04|||March 1997||1997-03-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Arthroscopy and Manipulation vs a Home Therapy Program in the Treatment of Adhesive Capsulitis|Arthroscopy and Manipulation vs a Home Therapy Program in the Treatment of Adhesive Capsulitis of the Shoulder - A Prospective Randomized Study|Completed||Phase 4|58|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 17:22:43.739528|2017-02-18 17:22:43.739528
NCT00160771|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-08-11|||January 2005||2005-01-01|August 2016|2016-08-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Biomechanics/Motion Analysis Laboratory Data Bank|University of Florida Biomechanics/Motion Analysis Laboratory Data Bank|Recruiting||N/A|10000|Anticipated|University of Florida|||1||f||||f||||||||||2017-02-18 17:22:43.86189|2017-02-18 17:22:43.86189
NCT00160758|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-10-26|||December 1999||1999-12-01|October 2012|2012-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Physical Characteristics of Retrieved Massive Allografts|Physical Characteristics of Retrieved Massive Allografts|Completed||Phase 4|18|Actual|University of Florida|||1||f||||f||||||||||2017-02-18 17:22:43.976639|2017-02-18 17:22:43.976639
NCT00160745|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-01-18||||||January 2013|2013-01-01|September 2006||2006-09-01|||||Interventional|||Rosuvastatin and Renal Endothelial Function|A Randomised, Double-blind, Placebo-controlled, Mono-centre, Explorative Phase II Trial to Study the Effects of Rosuvastatin on Basal Production and Release of Nitric Oxide From the Renal Vasculature in Patients With Hypercholesterolemia.|Completed||Phase 2|46||University of Erlangen-Nürnberg Medical School|||||f||||||||||||||2017-02-18 17:22:44.127215|2017-02-18 17:22:44.127215
NCT00160732|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-19|||October 2003||2003-10-01|January 2017|2017-01-01|October 2018|Anticipated|2018-10-01|October 2018|Anticipated|2018-10-01||Interventional|||Allogenic Islet Cell Transplantation|Allogenic Islet Cells (Human, U. of Chicago) Administered Via Intraportal Infusion; and Immunosuppressive Therapy|Active, not recruiting||Phase 1/Phase 2|50|Anticipated|University of Chicago||1|||f||||f||||||||||2017-02-18 17:22:44.416428|2017-02-18 17:22:44.416428
NCT00160719|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-10-26|||September 1999||1999-09-01|October 2012|2012-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Observational|||HLA Sensitization Following Major Cortical Allograft Bone Procedures|HLA Sensitization Following Major Cortical Allograft Bone Procedures|Completed||Phase 4|10|Actual|University of Florida|||1||f||||f||||||||||2017-02-18 17:22:44.527766|2017-02-18 17:22:44.527766
NCT00160706|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-05-16|2013-05-16||February 2004||2004-02-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|PRECiSE 4|Baseline Characteristics refer to the Safety Population, including all enrolled subjects who received at least one injection of study treatment in feeder study C87031 [NCT00152490] or C87032 [NCT00152425].|A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease|A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Re-exposure After a Variable Interval and Subsequent Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed at Weeks 0, 2 and 4 Then Every 4 Weeks), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Been Withdrawn From Studies CDP870-031 or CDP870-032 Due to an Exacerbation of Crohn's Disease.|Completed||Phase 3|310|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:22:44.633701|2017-02-18 17:22:44.633701
NCT00160693|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-06-04|2012-02-15||March 2003||2003-03-01|June 2012|2012-06-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis|A Phase III, Multicenter, Open-Label Long-Term Study to Assess the Safety and Tolerability of CDP870 400 mg Subcutaneously Every 4 Weeks, in Subjects With Rheumatoid Arthritis|Completed||Phase 3|402|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:22:45.525472|2017-02-18 17:22:45.525472
NCT00160680|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-12-13|||March 2005||2005-03-01|September 2009|2009-09-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)|A Pilot, Open, Monocenter Randomized Two Parallel Groups, Clinical Efficacy Trial: Comparison Continuous Versus on Demand Regimen of Treatment With Levocetirizine 5 mg Oral Tablets, Once a Day, in Adults Suffering From Persistent Allergic Rhinitis (PER) Over 6 Months|Completed||Phase 4|100||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:46.760022|2017-02-18 17:22:46.760022
NCT00160667|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-10-15|||October 2004||2004-10-01|October 2010|2010-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)|A Double Blind, Randomized, Placebo-controlled, Parallel Group Study, for the Assessment of Efficacy, Safety and Tolerability of Brivaracetam at the Doses of 200 mg/Day and 400 mg/Day, in Subjects (at Least 18 Years Old) Suffering From Post-herpetic Neuralgia (PHN)|Completed||Phase 2|152|Actual|UCB Pharma||3|||f||||f||||||||||2017-02-18 17:22:46.858878|2017-02-18 17:22:46.858878
NCT00160654|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-11-14|||November 2003||2003-11-01|July 2010|2010-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy|A Phase IV, Open-label, Multi-center, Community-based Trial Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.|Completed||Phase 4|345||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:47.015435|2017-02-18 17:22:47.015435
NCT00160641|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-04-10|2013-01-31||November 2005||2005-11-01|April 2013|2013-04-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||Baseline Characteristics refer to the Safety Set (SS). SS consists of all enrolled subjects who received at least 1 dose of study medication.|A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis|A Phase III Multi-center, Open-label, Follow-up Study, to Assess the Safety and Efficacy of Liquid Certolizumab Pegol as Additional Medication to Methotrexate, in the Treatment of Signs and Symptoms and in the Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis Who Participated in Study CDP870-050|Completed||Phase 3|567|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:22:47.150891|2017-02-18 17:22:47.150891
NCT00160628|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-11-25|||March 2004||2004-03-01|February 2010|2010-02-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy|A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Levetiracetam as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy for Bridging Purpose With a Similar Study on Caucasian Epileptic Subjects|Completed||Phase 3|100||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:48.35897|2017-02-18 17:22:48.35897
NCT00160615|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-03-03|||September 2001||2001-09-01|September 2009|2009-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method|Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method|Completed||Phase 3|97||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:48.458067|2017-02-18 17:22:48.458067
NCT00160602|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-09-06|||June 2005||2005-06-01|February 2010|2010-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis|A Phase III Multi-center, Double-blind, Placebo-controlled, Parallel Group 24-Week Study to Assess the Efficacy and Safety of Two Dose Regimens of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis Who Have an Incomplete Response to Methotrexate.|Completed||Phase 3|590||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:48.542866|2017-02-18 17:22:48.542866
NCT00160589|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-12-13|||April 2005||2005-04-01|September 2009|2009-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)|A Multicentre, Double-blind, Parallel, Randomized, Placebo-controlled Study : Evaluation of the Efficacy and Safety of Levocetirizine 5 mg and Desloratadine 5 mg Administered Orally as Capsules Once Daily, in the Morning, Over 2 Weeks in Patients Suffering From Allergic Rhinitis (AR)|Completed||Phase 4|729||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:48.725533|2017-02-18 17:22:48.725533
NCT00160576|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-12-05|||July 2003||2003-07-01|September 2009|2009-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias|A Therapeutic Exploratory, Single Arm, Multicenter Trial to Evaluate the Efficacy and Safety of Levetiracetam up to 4000 mg/Day (500mg Oral Tablets) on Levodopa Induced Dyskinesias in Adults With Idiopathic Parkinson's Disease|Completed||Phase 2|30||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:48.813546|2017-02-18 17:22:48.813546
NCT00160563|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-02-12|2009-06-17||June 2004||2004-06-01|May 2011|2011-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)|The Prolongation of the EPAAC™ Trial - NCT00152464 (The Early Prevention of Asthma in Atopic Children). A Multi-country, Double Blind, Placebo (PLC) Controlled, Follow-up Trial With 3 Parallel Groups (LCTZ-LCTZ, LCTZ-PLC and PLC-PLC) : Evaluation of the Long Term Efficacy and Safety of Levocetirizine (LCTZ) (5 mg/ml Oral Drops -0.125 mg/kg b.w. b.i.d.) Administered for an Additional 18 Months Period in Preventing the Onset of Asthma in Children Coming From the EPAAC Trial.|Terminated||Phase 3|207|Actual|UCB Pharma||3||"The predecessor study A00309 (NCT00152464) did not show statistical significance in time to~   onset of asthma between the levocetirizine and placebo groups."|f||||f||||||||||2017-02-18 17:22:48.913333|2017-02-18 17:22:48.913333
NCT00160550|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-11-25|||September 2001||2001-09-01|September 2009|2009-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures|A Double-blind, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adjunctive Treatment With 3000 mg/Day (Pediatric Target Dose of 60 mg/kg/Day) Oral Levetiracetam (LEV) (166, 250, and 500mg Tablets), in Adult and Pediatric Subjects (4-65 Years) Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic (PGTC) Seizures.|Completed||Phase 3|154||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:49.744502|2017-02-18 17:22:49.744502
NCT00160537|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-12-13|||May 2005||2005-05-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)|A Monocenter, Double-blind, Randomized Trial, With Two Parallel Groups Comparing the Clinical Efficacy of Levocetirizine 5 mg Capsules and Desloratadine 5 mg Capsules Taken Once a Day Over 3 Weeks of Treatment in Adult Subjects Suffering From Seasonal Allergic Rhinitis (SAR) Due to Grass Pollen|Completed||Phase 4|200||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:49.837211|2017-02-18 17:22:49.837211
NCT00160524|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-08-02|2013-08-02||July 2004||2004-07-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|PRECiSE 3|Baseline Characteristics refer to the Safety Population, including all enrolled subjects who received at least one injection of study treatment in feeder study C87031 [NCT00152490] or C87032 [NCT00152425].|A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]|A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed 4-weekly), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032|Completed||Phase 3|596|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:22:49.935082|2017-02-18 17:22:49.935082
NCT00160511|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-11-25|||April 2004||2004-04-01|September 2009|2009-09-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)|A Double-blind, Randomized, Placebo-controlled, Parallel-group, 16 Week, Multicenter Trial Evaluating the Efficacy and Safety of Levetiracetam 500 mg Tablets in Bid Administration (Daily Dose Ranging From 1000 mg to 3000 mg), in Adults (≥ 18 Years of Age) Suffering From Postherpetic Neuralgia|Completed||Phase 2|170||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:51.197759|2017-02-18 17:22:51.197759
NCT00160498|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-03-07|||May 2004||2004-05-01|March 2008|2008-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel, Dose-Titration Study to Assess the Efficacy of Lercanidipine 10 mg and 20 mg Once Daily p. o. in Hypertensive Subjects (I or II WHO) With Elevated Body Weight.|Completed||N/A|180||UCB Pharma|||||f||||||||||||||2017-02-18 17:22:51.283201|2017-02-18 17:22:51.283201
NCT00160485|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-02-10|||June 2004||2004-06-01|July 2011|2011-07-01|June 2010|Anticipated|2010-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes|Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes|Withdrawn||Phase 4|0|Actual|Tripler Army Medical Center||2||Active Duty principle investigator currently deployed|f||||t||||||||||2017-02-18 17:22:51.365159|2017-02-18 17:22:51.365159
NCT00160472|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-02-25|||March 2004||2004-03-01|March 2004|2004-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms|Evaluation of Vasopressin and Vasopressin Receptor Expression in the Arteries and Veins of Ovarian Neoplasms|Completed||N/A|110|Anticipated|Tripler Army Medical Center|||||f||||||||||||||2017-02-18 17:22:51.481458|2017-02-18 17:22:51.481458
NCT00160459|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-27|||May 2000||2000-05-01|May 2008|2008-05-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids|A Phase 2, Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Asoprisnil (J867) in Patients With Uterine Leiomyomata.|Completed||Phase 2|129|Actual|Abbott||4|||f||||f||||||||||2017-02-18 17:22:51.582229|2017-02-18 17:22:51.582229
NCT00160446|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-27|||May 2000||2000-05-01|May 2008|2008-05-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis|A Phase II Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of J867 Administered in Patients With Endometriosis|Completed||Phase 2|130|Actual|Abbott||4|||f||||f||||||||||2017-02-18 17:22:51.69026|2017-02-18 17:22:51.69026
NCT00160433|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-27|||August 2002||2002-08-01|May 2008|2008-05-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.|A Phase II, 3-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Doses of J867 (0.5, 1.5 and 5 mg QD) Versus Placebo in Subjects With Endometriosis|Completed||Phase 2|131|Actual|Abbott||4|||f||||f||||||||||2017-02-18 17:22:51.793615|2017-02-18 17:22:51.793615
NCT00160420|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-27|||December 2002||2002-12-01|May 2008|2008-05-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398|A Phase 2, 12-Month, Open Label Extension Study to Evaluate the Safety of J867(5 mg QD) in Subjects With Endometriosis|Completed||Phase 2|73|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:22:51.906979|2017-02-18 17:22:51.906979
NCT00160407|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-11-19|||October 2003||2003-10-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)|Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)|Completed||Phase 4|50||St. Louis University|||||f||||||||||||||2017-02-18 17:22:52.00141|2017-02-18 17:22:52.00141
NCT00160394|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-07-12|||December 2004||2004-12-01|July 2011|2011-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris|Multi-Centre, Single-Blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Duac® Gel And Differin® Gel in the Topical Treatment of Mild to Moderate Acne Vulgaris|Completed||Phase 4|130|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:22:52.102418|2017-02-18 17:22:52.102418
NCT00160381|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-27|||September 2002||2002-09-01|May 2008|2008-05-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids|A Phase III, 12-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Two Doses of J867 Versus Placebo in Subjects With Uterine Leiomyomata.|Completed||Phase 3|432|Actual|Abbott||3|||f||||t||||||||||2017-02-18 17:22:52.20302|2017-02-18 17:22:52.20302
NCT00160368|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-04-24|||January 2005||2005-01-01|April 2007|2007-04-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Effects of Potassium Salts on Blood Pressure and Target Organ Damage|Effect of Potassium Bicarbonate and Potassium Chloride on Blood Pressure and Markers of Target Organ Damage in Hypertensives|Unknown status|Recruiting|Phase 3|45||St George's, University of London|||||f||||||||||||||2017-02-18 17:22:52.302057|2017-02-18 17:22:52.302057
NCT00160355|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-02-12|||May 2005||2005-05-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional|||Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome|Haploidentical Hematopoietic Stem Cell Transplantation for Pediatric Patients With Wiskott-Aldrich Syndrome: A Pilot Study|Completed||Phase 1|12|Anticipated|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:22:52.415743|2017-02-18 17:22:52.415743
NCT00160342|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-08-14|||June 2005||2005-06-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes|A Multi-Center, Double-Blind, Placebo-Controlled Comparison of Multiple Doses of Esterified Estrogens and Methyltestosterone, in Combination and Alone, in Relieving Vasomotor Symptoms in Postmenopausal Women|Completed||Phase 2|1251|Anticipated|Solvay Pharmaceuticals||9|||f||||f||||||||||2017-02-18 17:22:52.539645|2017-02-18 17:22:52.539645
NCT00160329|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-07-19|||January 2004||2004-01-01|July 2011|2011-07-01|March 2009|Actual|2009-03-01|April 2007|Actual|2007-04-01||Interventional|||Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia|The De-Escalate Trial: Atazanavir or Atazanavir/Ritonavir Substitution for Ritonavir Boosted PI Therapy in HIV-Infected Individuals Experiencing Ongoing HIV Viremia and Hyperlipidemia: A Randomized Controlled Pilot Study|Completed||Phase 3|60|Actual|Stanford University||1|||f||||t||||||||||2017-02-18 17:22:52.804727|2017-02-18 17:22:52.804727
NCT00160316|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-11|||April 2005||2005-04-01|March 2008|2008-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination|Endometrial Safety of a Low Dose Continuous Combined 17 -Estradiol/Dydrogesterone Hormone Replacement Regimen (E2 0.5 mg/ D 2.5 mg) in Postmenopausal Women - A One-Year, Open Label, Multi-Center Study|Completed||Phase 3|454|Actual|Solvay Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:22:52.910616|2017-02-18 17:22:52.910616
NCT00160303|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-07-22|||January 2005||2005-01-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Efficacy Study of Prolotherapy vs Corticosteroid for Tennis Elbow|Prolotherapy vs. Corticosteroid Therapy for the Treatment of Lateral Epicondylitis of the Elbow, A Randomized Controlled Trial.|Completed||Phase 3|56|Anticipated|Spaulding Rehabilitation Hospital|||||f||||||||||||||2017-02-18 17:22:53.024101|2017-02-18 17:22:53.024101
NCT00160290|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-04-29|||March 2002||2002-03-01|April 2008|2008-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures|An Open, Randomized, Parallel Group, Single Center Study to Investigate the Effect of Lactulose Versus Plantago Ovate on the Quality of Life of Patients With Hard Stools and Hemorrhoids or Anal Fissure|Terminated||Phase 4|97|Actual|Solvay Pharmaceuticals||2||This trial discontinued on 30 JUN 2006 due to a lack of enrolment|f||||f||||||||||2017-02-18 17:22:53.116969|2017-02-18 17:22:53.116969
NCT00160277|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-29|||July 2005||2005-07-01|January 2009|2009-01-01||||||||Interventional|||Efficacy and Safety of Moxonidine in Indian Patients|Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension|Completed||Phase 3|100||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 17:22:53.222805|2017-02-18 17:22:53.222805
NCT00160264|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-29|||January 2003||2003-01-01|January 2009|2009-01-01||||||||Interventional|||Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women|A Randomized, Double-Blind, Multicenter, Parallel Pilot Clinical Trial to Study the Efficay of a Treatment of Lactulose + Vitamin D + Calcium 0.5 g Concurrently Controlled With a Standard Treatment (Vit D + Calcium) in Bone Mass Preservation Among Postmenopausal Women|Completed||Phase 4|40||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 17:22:53.316761|2017-02-18 17:22:53.316761
NCT00160251|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-10-13|2011-05-13||September 2005||2005-09-01|October 2015|2015-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)|PEG-Intron/REBETOL vs PEG-Intron/ SCH 503034 With and Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 (HCV-1) Peginterferon Alfa/Ribavirin Nonresponders: A SCH 503034 Dose-Finding Phase 2 Study|Completed||Phase 2|357|Actual|Merck Sharp & Dohme Corp.|The implementation of amendment 2 led to changes in boceprevir dose in all treatment arms and different overall lengths of therapy within the same treatment arm, making the SVR endpoint uninterpretable.|9|||f||||t||||||||||2017-02-18 17:22:53.429704|2017-02-18 17:22:53.429704
NCT00160238|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-12-21|||January 2003||2003-01-01|December 2006|2006-12-01||||||||Interventional|||Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy|A Double-Blind, Placebo-Controlled, Randomized, Clinical Study of the Effects of Betaserc® 24 mg (1 Tablet b.i.d Over 3 Months) on Vestibular Compensation Following Vestibular Neurotomy in Patients With Disabling Menière's Disease|Completed||Phase 4|20||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 17:22:55.998089|2017-02-18 17:22:55.998089
NCT00160225|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-11-09|||July 2005||2005-07-01|November 2007|2007-11-01||||||||Interventional|||Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension|A Randomized, Double-Blind, Placebo Controlled, Two-Treatment and Two-Period Cross-Over, Mono-Center Study to Evaluate the Efficacy and Safety of Daglutril 300 mg Once Daily Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:22:56.081097|2017-02-18 17:22:56.081097
NCT00160212|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-01-29|||December 2004||2004-12-01|January 2009|2009-01-01||||||||Interventional|||Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension|A Randomized, Placebo-Controlled, Double-Blind, Six-Arm, Dose Escalation, Multi-Center Study to Evaluate the Efficacy and Safety of SLV306: 150, 300, 600 mg Once Daily, 150-300 mg Twice Daily and Amlodipine 5-10 mg Once Daily in Subjects With Hypertension|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:22:56.188089|2017-02-18 17:22:56.188089
NCT00160199|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-06-30|2010-02-11||November 2004||2004-11-01|June 2010|2010-06-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion|Evaluation of Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding in Subjects With Secondary Amenorrhea|Completed||Phase 4|240|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:22:56.440044|2017-02-18 17:22:56.440044
NCT00160186|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-03-28|||December 2003||2003-12-01|March 2008|2008-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy|Double-Blind, Multicenter, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy|Completed||Phase 4|40||Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:22:56.905993|2017-02-18 17:22:56.905993
NCT00160173|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-07-11||||||July 2013|2013-07-01||||||||Interventional|||Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy|Efficacy Study Comparing 0.9 g and 1.25 g EstroGelÂ® 0.03% Doses With Placebo in the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated With Menopause|Completed||Phase 4|||ASCEND Therapeutics|||||f||||||||||||||2017-02-18 17:22:59.851665|2017-02-18 17:22:59.851665
NCT00160160|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-01-29|||October 2004||2004-10-01|January 2009|2009-01-01||||||||Interventional|||Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes|A Multi-Center, Double-Blind, Randomized Study Comparing the Efficacy of Combination Therapy of Eprosartan Respectively Ramipril With Low-Dose Hydrochlorothiazide and Moxonidine on Blood Pressure Levels in Patients With Hypertension and Associated Diabetes Mellitus Type 2|Completed||N/A|440||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 17:23:00.050685|2017-02-18 17:23:00.050685
NCT00160147|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-01-29||2015-01-29|December 2005||2005-12-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type|A Randomized, Double-Blind, Placebo-controlled, Efficacy, Safety, and Tolerability Study of Bifeprunox in the Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type|Terminated||Phase 3|60|Actual|Solvay Pharmaceuticals||2||The study was discontinued prematurely on 25 February 2008 due to slow enrollment|f||||||||||||||2017-02-18 17:23:00.462954|2017-02-18 17:23:00.462954
NCT00160134|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-01-29|||January 2005||2005-01-01|January 2009|2009-01-01||||||||Interventional|||Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure|A Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Parallel Group, Single Dose Study to Evaluate Cardiac Hemodynamics and Safety During Right Heart Catheterization of Three IV Doses of SLV320 in Subjects With Congestive Heart Failure Requiring Diuretic Treatment|Completed||Phase 2|||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 17:23:00.614019|2017-02-18 17:23:00.614019
NCT00160121|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-09-03|||January 2005||2005-01-01|December 2013|2013-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease|A Phase IV, Open-Label, Multi-Center Trial Evaluating the Efficacy of Fosrenol Compared to Existing Therapy in Adults With End Stage Renal Disease Treated for Hyperphosphatemia|Completed||Phase 4|2500||Shire|||||f||||||||||||||2017-02-18 17:23:00.699708|2017-02-18 17:23:00.699708
NCT00160108|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-11|||July 2005||2005-07-01|September 2006|2006-09-01|July 2007||2007-07-01|||||Interventional|||A Dietary Intervention- Randomized Controlled Trial (DIRECT) Study; BGU-Harvard–Robarts Collaboration||Unknown status|Active, not recruiting|Phase 1|300||The S. Daniel Abraham International Center for Health and Nutrition|||||f||||||||||||||2017-02-18 17:23:00.774222|2017-02-18 17:23:00.774222
NCT00160095|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-05-06|||July 2001||2001-07-01|May 2015|2015-05-01|March 2013|Actual|2013-03-01|March 2010|Actual|2010-03-01||Observational|||Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas|Patient Selection for Hypoxia Modifying Treatments Based on Functional Microregional Imaging of Tumor Vasculature, Oxygenation and Proliferation in Squamous Cell Carcinoma of the Larynx|Completed||Phase 3|79|Actual|Radboud University|||1||f||||||||||Samples With DNA|"~     Tumor biopsies~   "|||2017-02-18 17:23:00.856453|2017-02-18 17:23:00.856453
NCT00160082|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-04-02|||January 2001||2001-01-01|September 2005|2005-09-01|May 2003||2003-05-01|||||Interventional|||Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)|Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS): A Randomized, Two-Arm, Parallel, Double-Blind, Multi-Centre, Placebo Controlled Study|Completed||N/A|124||Pharmalink AB|||||f||||||||||||||2017-02-18 17:23:00.943072|2017-02-18 17:23:00.943072
NCT00160069|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-12-02|||August 2005||2005-08-01|December 2014|2014-12-01|April 2009|Actual|2009-04-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer|Phase II Study to Investigate the Efficacy and Safety of ZK 219477 as Second Line Therapy in Patients With Stage IIIB or Stage IV Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|128|Actual|Bayer||3|||f||||f||||||||||2017-02-18 17:23:01.05335|2017-02-18 17:23:01.05335
NCT00160056|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-05-08|||April 2005||2005-04-01|May 2015|2015-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity|The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity in Subjects With Homozygous Arg16 and gly16 Polymorphism of the β2-adrenergic Receptor|Completed||N/A|16|Actual|Radboud University||1|||f||||||||||||||2017-02-18 17:23:01.203758|2017-02-18 17:23:01.203758
NCT00160043|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-12-14|||March 2005||2005-03-01|December 2014|2014-12-01|November 2008|Actual|2008-11-01|August 2007|Actual|2007-08-01||Interventional|||Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.|Phase II Open-label Study to Investigate the Efficacy and Safety of PTK787/ZK 222584 Orally Administered Once Daily or Twice Daily at 1250 mg as Second-line Monotherapy in Patients With Stage IIIB or Stage IV Non-small-cell Lung Cancer (NSCLC)|Completed||Phase 2|112|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:23:01.295305|2017-02-18 17:23:01.295305
NCT00160030|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-12-04|||September 2004||2004-09-01|December 2009|2009-12-01||||October 2007|Actual|2007-10-01||Interventional|||Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer|Phase II Study Comparing Radiochemotherapy With the Folfox 4 Regimen Versus Radiochemotherapy With 5FU-Cisplatin (Herskovic Regimen) in First Line Treatment of Patients With Inoperable Esophageal Cancer|Completed||Phase 2|97|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 17:23:01.410539|2017-02-18 17:23:01.410539
NCT00160017|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-11-27|||January 2005||2005-01-01|November 2015|2015-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative|Effectiveness and Cost-effectiveness of the Diabetes Integrated Care Breakthrough Collaborative to Improve Diabetes Care, Its Health Outcomes and Economic Costs|Completed||N/A|1861|Actual|Radboud University|||2||f||||||||||||||2017-02-18 17:23:01.578372|2017-02-18 17:23:01.578372
NCT00160004|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-06-05|||March 2006||2006-03-01|June 2009|2009-06-01|December 2008|Actual|2008-12-01|||||Interventional|||The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis|The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis|Terminated||Phase 1/Phase 2|20|Anticipated|Radboud University||||problems with including patients and a large multicenter Trial is now starting as follow-up|f||||||||||||||2017-02-18 17:23:01.935888|2017-02-18 17:23:01.935888
NCT00159991|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-02-12|||February 2002||2002-02-01|January 2008|2008-01-01|February 2015|Anticipated|2015-02-01|February 2011|Anticipated|2011-02-01||Interventional|CARRPO||Copenhagen Arterial Revascularization Randomized Patency and Outcome Trial|Arterial Revascularization for Coronary Bypass Surgery: A Randomized Trial Comparing the Outcome After Using LIMA + Vein Grafts Versus Total Arterial Revascularization With LIMA + RIMA + Radial Artery Grafts|Unknown status|Active, not recruiting|Phase 3|331|Actual|Rigshospitalet, Denmark||2|||f||||f||||||||||2017-02-18 17:23:02.05902|2017-02-18 17:23:02.05902
NCT00159978|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-05-06|||July 2005||2005-07-01|May 2015|2015-05-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Observational|||Validation of 18F-MISO-PET and 18F-FLT-PET|Validation of 18F-MISO-PET and 18F-FLT-PET by Immunohistochemical Assessment of Head and Neck Cancer Resection Specimen|Terminated||Phase 1|21|Actual|Radboud University|||1|Problems with FMISO supply|f||||f||||||Samples With DNA|"~     Tumor resection specimen~   "|||2017-02-18 17:23:02.183374|2017-02-18 17:23:02.183374
NCT00159965|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-11-07|2010-08-11||December 2003||2003-12-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|June 2008|Actual|2008-06-01||Interventional|NES||Treatments for Psychogenic Nonepileptic Seizures (NES)|Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES|Completed||Phase 4|38|Actual|Rhode Island Hospital|pilot sample size; drop-outs because of some patient’s concern that they would receive the placebo, despite the equipoise that exists for NES treatment(s). Excluding patients who did not have vEEG may present a potential sampling bias.|2|||f||||t||||||||||2017-02-18 17:23:02.281083|2017-02-18 17:23:02.281083
NCT00159952|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-11-26|||November 2004||2004-11-01|February 2009|2009-02-01|November 2007|Actual|2007-11-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock|Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock|Completed||Phase 2/Phase 3|90|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 17:23:03.048379|2017-02-18 17:23:03.048379
NCT00159939|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-06-09|||February 2004||2004-02-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Prone-Supine Study II: The Effect of Prone Positioning for Patients Affected by Acute Respiratory Distress Syndrome|Prone-Supine Study II: The Effect of Prone Positioning for Patients Affected by Acute Respiratory Distress Syndrome|Completed||Phase 3|344|Actual|Policlinico Hospital||2|||f||||t||||||||||2017-02-18 17:23:03.159338|2017-02-18 17:23:03.159338
NCT00159926|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-01-04|||January 2003||2003-01-01|November 2007|2007-11-01|February 2004|Actual|2004-02-01|||||Interventional|||Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response|Does Cleansing of Suction Blood During Cardiac Surgery With Heart and Lung Machine Reduce the Postoperative Inflammatory Response ?|Terminated||Phase 3|30|Actual|Rigshospitalet, Denmark||2||For financial and logistical reasons|f||||f||||||||||2017-02-18 17:23:03.276283|2017-02-18 17:23:03.276283
NCT00159913|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-01-23|2009-06-02||August 2003||2003-08-01|January 2014|2014-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.|A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.|Completed||Phase 3|235|Actual|Pfizer||4|||f||||t||||||||||2017-02-18 17:23:03.395682|2017-02-18 17:23:03.395682
NCT00159900|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-04-04|||May 2005||2005-05-01|April 2008|2008-04-01|January 2006||2006-01-01|||||Interventional|||Quality of Erection Study|A Multicenter, Parallel Group Flexible Dose Study With A Double Blind, Randomized, Placebo Controlled Phase And An Open-Label Phase To Evaluate The Quality Of Erections In Men With Erectile Dysfunction Treated With Sildenafil Citrate|Completed||Phase 4|300||Pfizer|||||f||||||||||||||2017-02-18 17:23:05.477782|2017-02-18 17:23:05.477782
NCT00159887|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-06-07|||December 2002||2002-12-01|June 2011|2011-06-01|February 2007|Actual|2007-02-01|||||Interventional|||Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension|A Multi-Centre, Multinational, Long-Term Extension Study, to Assess the Safety and Toleration of Subject Optimised Treatment Regimens of Oral Sildenafil Citrate for Pulmonary Arterial Hypertension in Subjects Who Have Completed Study A1481140.|Completed||Phase 3|260|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:23:05.59135|2017-02-18 17:23:05.59135
NCT00159874|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-07-17|2013-12-19||January 2004||2004-01-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children|A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131|Completed||Phase 3|234|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 17:23:05.780227|2017-02-18 17:23:05.780227
NCT00159692|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-02-06|||March 2003||2003-03-01|February 2009|2009-02-01|August 2005|Actual|2005-08-01|||||Interventional|ADHERE||Amlodipine Diabetic Hypertension Efficacy Response Trial|A Multi-Center, Randomized, Double-Blind, Double-Dummy Study Evaluating The Safety and Efficacy Of The Addition Of Amlodipine To Quinapril Or Losartan In The Treatment Of Diabetic Hypertensive Subjects|Completed||Phase 4|739|Actual|Pfizer|||||||||||||||||||2017-02-18 17:23:16.220003|2017-02-18 17:23:16.220003
NCT00159861|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-12-20|2010-04-02||July 2003||2003-07-01|December 2013|2013-12-01|January 2006|Actual|2006-01-01|||||Interventional|||The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH|A Multinational, Multi-Center, Randomised, Double-Bind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Efficacy of a Subject Optimised Dose of Sildenafil Citrate (20, 40, or 80 mg. Sildenafil Citrate TID) Based on the Toleration, When Used in Combination With Intravenous Prostacyclin( Epoprostenol) in the Treatment of Pulmonary Arterial Hypertension.|Completed||Phase 3|267|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:23:08.915604|2017-02-18 17:23:08.915604
NCT00159848|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-05-02|||September 2003||2003-09-01|May 2013|2013-05-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra|Effectiveness Of An Educational Program To Improve Patients' Satisfaction Regarding Their Management Of Erectile Dysfunction With Sildenafil|Completed||Phase 4|8000||Pfizer|||||f||||||||||||||2017-02-18 17:23:13.156503|2017-02-18 17:23:13.156503
NCT00159835|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-21|||February 1999||1999-02-01|April 2015|2015-04-01|March 2005||2005-03-01|||||Interventional|IDEAL||Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD|Atorvastatin Compared With Simvastatin In The Prevention of CHD Morbidity And Mortality In Patients With CHD|Completed||Phase 4|8600||Pfizer|||||f||||||||||||||2017-02-18 17:23:13.236488|2017-02-18 17:23:13.236488
NCT00159822|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-01-13|2009-12-02||July 2005||2005-07-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Voriconazole For Chronic Bronchopulmonary Aspergillosis|Voriconazole For Primary Therapy Of Proven, Chronic Bronchopulmonary Aspergillosis, In Minimally Immunocompromised Or, Non-Immunocompromised Hosts|Completed||Phase 2/Phase 3|48|Actual|Pfizer|Study treatment duration is at least 6 months for subjects with best achievable response after 3 months of treatment, of 9 months for subjects with best achievable response after 6 months of treatment and of 12 months in other cases.|1|||f||||f||||||||||2017-02-18 17:23:13.760981|2017-02-18 17:23:13.760981
NCT00159809|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-01-18|||March 2004||2004-03-01|January 2008|2008-01-01|August 2004||2004-08-01|||||Interventional|||Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction|A Multi-Center, Flexible Dose Study With A Double-Blind, Randomized, Placebo-Controlled Phase Followed By An Open-Label Phase To Evaluate The Impact Of Treatment With Sildenafil Citrate On The Symptoms Of Depression And Quality Of Life (Qol) Of Male Patients With Erectile Dysfunction (ED)|Completed||Phase 4|140||Pfizer|||||f||||||||||||||2017-02-18 17:23:14.256516|2017-02-18 17:23:14.256516
NCT00159796|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-09-21|||December 2004||2004-12-01|September 2015|2015-09-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional|||3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)|A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501005 (Secondary Title: ARES)|Completed||Phase 3|489|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:23:14.329897|2017-02-18 17:23:14.329897
NCT00159783|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-02-06|2010-04-15||July 2005||2005-07-01|February 2015|2015-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)|A Double-Blind, 40-Week Continuation Study Evaluating the Safety of Asenapine and Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501007 (Secondary Title: ARES)|Completed||Phase 3|218|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:23:14.445621|2017-02-18 17:23:14.445621
NCT00159770|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-12-28|||November 2001||2001-11-01|December 2006|2006-12-01|September 2004||2004-09-01|||||Interventional|||Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients|Tolerability, Safety, And Efficacy Of Ziprasidone (80 - 160 Mg/D) Versus Olanzapine (10 - 20 Mg/D), Risperidone (4 - 8 Mg/D) Or Quetiapine (300 - 750 Mg/D) In Pretreated Patients With Schizophrenia, Schizoaffective Disorder Or Schizophreniform Disorders - A 12-Week Open-Label, Multicenter Clinical Trial.|Completed||Phase 3|290||Pfizer|||||f||||||||||||||2017-02-18 17:23:15.290222|2017-02-18 17:23:15.290222
NCT00159757|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-08-01|||November 2003||2003-11-01|August 2007|2007-08-01|February 2005||2005-02-01|||||Interventional|||12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients|12 Week Open Label, Multicenter, Non-Comparative Switch Study Evaluating Efficacy, Tolerability And Safety Of Oral Ziprasidone In Treatment Of Patients Suffering From Schizophrenia Who Have Already Been Treated With An Other Antipsychotic.|Terminated||Phase 4|150||Pfizer||||See Detailed Description for Termination Reason|f||||||||||||||2017-02-18 17:23:15.418763|2017-02-18 17:23:15.418763
NCT00159744|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-15|||November 2004||2004-11-01|May 2015|2015-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)|A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501004 (Secondary Title: ARES)|Completed||Phase 3|488|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:23:15.520473|2017-02-18 17:23:15.520473
NCT00159731|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-03-14|||January 2005||2005-01-01|July 2006|2006-07-01|May 2006||2006-05-01|||||Interventional|||Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy|An Open Label Extension Safety Trial of Pregabalin (CI-1008) in Subjects With Diabetic Peripheral Neuropathy|Completed||Phase 4|160||Pfizer|||||||||||||||||||2017-02-18 17:23:15.625409|2017-02-18 17:23:15.625409
NCT00159718|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-01-29|||July 2001||2001-07-01|January 2008|2008-01-01|January 2007||2007-01-01|||||Interventional|DUAAL||Double Blind Atorvastatin Amlodipine Study|Double Blind Atorvastatin Amlodipine Study (DUAAL) Effect Of Amlodipine, Atorvastatin And The Combination On Transient Myocardia Ischemia In Coronary Artery Disease.|Completed||Phase 4|360||Pfizer|||||f||||||||||||||2017-02-18 17:23:15.940146|2017-02-18 17:23:15.940146
NCT00159705|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-10-09|||April 2005||2005-04-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy|A Randomized Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy|Completed||Phase 3|276|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:23:16.069091|2017-02-18 17:23:16.069091
NCT00154050|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-11|||May 2004||2004-05-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty||Completed||N/A|22||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:24:41.900561|2017-02-18 17:24:41.900561
NCT00159679|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-04-28|||September 2004||2004-09-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy|A 13 Week, Double-Blind, Placebo-Controlled Phase 4 Trial of Pregabalin (CI-1008, 600 mg/Day) for Relief of Pain in Subjects With Painful Diabetic Peripheral Neuropathy|Completed||Phase 4|167|Actual|Pfizer|||||||||||||||||||2017-02-18 17:23:16.299346|2017-02-18 17:23:16.299346
NCT00159666|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-03-07|||October 2004||2004-10-01|November 2006|2006-11-01|June 2006||2006-06-01|||||Interventional|||Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia|A Double-Blind Randomized Placebo-Controlled Trial of the Time to Onset of Pain Relief in Subjects With Post Therapeutic Neuralgia (PHN) Treated With Pregabalin (150 - 600 Mg/Day Flexible Optimized Dose or 300 Mg/Day Fixed Dose) or Placebo|Completed||Phase 4|255||Pfizer|||||||||||||||||||2017-02-18 17:23:16.422747|2017-02-18 17:23:16.422747
NCT00159653|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-10-08|||July 2005||2005-07-01|October 2012|2012-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma|A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Xalacom Given In The Evening, Xalatan Given In The Evening, And Timolol Given In The Morning In Patients With Open Angle Glaucoma Or Ocular Hypertension.|Completed||Phase 3|500|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:23:16.555184|2017-02-18 17:23:16.555184
NCT00159640|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-03-27|||February 2004||2004-02-01|March 2007|2007-03-01||||||||Interventional|||Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia|A Multi-Center, Randomized, Double Blind, Dose-Response, Placebo And Gabapentin Controlled Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia|Terminated||Phase 2|315||Pfizer|||||f||||||||||||||2017-02-18 17:23:16.717995|2017-02-18 17:23:16.717995
NCT00159627|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-01-28|||August 2004||2004-08-01|January 2008|2008-01-01||||||||Interventional|||Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).|A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study of the Effects of KW-3902 on Diuresis in Patients With Congestive Heart Failure (CHF) Refractory to High Dose Diuretic Therapy|Completed||Phase 2|52||NovaCardia, Inc.|||||f||||||||||||||2017-02-18 17:23:16.835727|2017-02-18 17:23:16.835727
NCT00159614|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-01-28|||September 2005||2005-09-01|January 2008|2008-01-01||||||||Interventional|||Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment|Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With Congestive Heart Failure (CHF) and Renal Impairment|Completed||Phase 2|30||NovaCardia, Inc.|||||f||||||||||||||2017-02-18 17:23:16.925338|2017-02-18 17:23:16.925338
NCT00159601|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-16|||June 2003||2003-06-01|January 2017|2017-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Quality of Life and Mental Health in Children and Adolescents|Quality of Life and Mental Health in Children and Adolescents in a Child and Adolescent Psychiatric Outpatient Clinic and in the Normal Population|Completed||Phase 2/Phase 3|2342|Actual|Norwegian University of Science and Technology|||2||f||||f||||||||No||2017-02-18 17:23:17.027784|2017-02-18 17:23:17.027784
NCT00159588|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-07-18|||January 2004||2004-01-01|July 2016|2016-07-01|December 2007|Actual|2007-12-01|November 2006|Actual|2006-11-01||Interventional|||Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?|Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly? A Randomized Multi-centre Follow-up.|Completed||N/A|64|Actual|Norwegian University of Science and Technology||3|||f||||f||||||||||2017-02-18 17:23:17.134518|2017-02-18 17:23:17.134518
NCT00159575|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-01-02|||March 2005||2005-03-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|August 2009|Actual|2009-08-01||Interventional|||Metformin in Assisted Reproduction-MET-AR-study|Metformin Treatment Before IVF / ICSI in Non-obese Women With Polycystic Ovarian Syndrome|Terminated||Phase 4|150|Actual|Norwegian University of Science and Technology||1||Slow patient recruitment and expiry of study medication(aug2009)|f||||f||||||||||2017-02-18 17:23:17.245252|2017-02-18 17:23:17.245252
NCT00159562|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-06-04|||September 2005||2005-09-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|December 2011|Actual|2011-12-01||Interventional|||Effects of Psycho-education of Patients With Bipolar Disorder|Effects of Psycho-education of Patients With Bipolar Disorder|Completed||N/A|85|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:23:17.475922|2017-02-18 17:23:17.475922
NCT00159549|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-16|||January 2000||2000-01-01|January 2017|2017-01-01|December 2005||2005-12-01|||||Interventional|||Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease|Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|60|Actual|Norwegian University of Science and Technology||2|||f||||||||||||||2017-02-18 17:23:17.585723|2017-02-18 17:23:17.585723
NCT00159536|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-05-23|||February 2005||2005-02-01|May 2014|2014-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|PregMet||Metformin in Pregnant PCOS Women|Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome (PCOS)|Completed||Phase 3|257|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:23:17.674585|2017-02-18 17:23:17.674585
NCT00159523|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-02-04|||December 2003||2003-12-01|August 2015|2015-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic|The Impact of Perinatal Daily Supplement of a Probiotic (Lactobacillus Rhamnosus GG), Given to Mothers, on Immunological Development, Atopic Sensitisation and Allergic Disease in Their Off-spring|Completed||N/A|416|Actual|Norwegian University of Science and Technology||2|||f||||f||||||||||2017-02-18 17:23:17.799691|2017-02-18 17:23:17.799691
NCT00159510|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-10-05|||April 2004||2004-04-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MB-NO||Studies of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome|A Controlled Prospective Randomized Open-Label Study of Methylene Blue and Inhaled Nitric Oxide in Patients With Septic Shock and Acute Lung Injury|Terminated||Phase 1|28|Actual|Northern State Medical University||4||Inability to recruit the patients due to the short supply and changed local hospital protocol|f||||f||||||||||2017-02-18 17:23:17.910351|2017-02-18 17:23:17.910351
NCT00159497|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-03-28|||October 1998||1998-10-01|March 2014|2014-03-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Bone Remodeling Around HA-coated Acetabular Cups.|Bone Remodeling Around HA-coated Acetabular Cups.|Completed||Phase 4|100|Actual|Northern Orthopaedic Division, Denmark||2|||f||||f||||||||||2017-02-18 17:23:18.020986|2017-02-18 17:23:18.020986
NCT00159484|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-03-25|||October 2004||2004-10-01|March 2015|2015-03-01|January 2017|Anticipated|2017-01-01|December 2015|Anticipated|2015-12-01||Interventional|||Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer|Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer (CEPO906AUS10)|Active, not recruiting||Phase 1/Phase 2|80|Anticipated|University of Southern California||1|||f||||t||||||||||2017-02-18 17:23:18.131801|2017-02-18 17:23:18.131801
NCT00159471|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-20|||February 2005||2005-02-01|May 2014|2014-05-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.|A Pilot Trial of Germline Polymorphisms as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.|Terminated||N/A|1|Actual|University of Southern California||1||Insufficient Accrual|f||||t||||||||||2017-02-18 17:23:18.231471|2017-02-18 17:23:18.231471
NCT00159458|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-05-20|||July 2003||2003-07-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer|Phase II Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer|Terminated||Phase 2|7|Actual|University of Southern California||1||Insufficient Accrual|||||||||||||||2017-02-18 17:23:18.317447|2017-02-18 17:23:18.317447
NCT00159445|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-05-20|||March 2004||2004-03-01|May 2014|2014-05-01|November 2007|Actual|2007-11-01|March 2007|Actual|2007-03-01||Interventional|||Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer|Phase II Study of Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer|Completed||Phase 2|53|Anticipated|University of Southern California|||||f||||||||||||||2017-02-18 17:23:18.397448|2017-02-18 17:23:18.397448
NCT00159432|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-07-22|2013-11-27||February 2005||2005-02-01|July 2014|2014-07-01|March 2013|Actual|2013-03-01|June 2009|Actual|2009-06-01||Interventional||All the participants who were enrolled are included in the analysis as per protocol.|Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer|Phase II Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer|Completed||Phase 2|63|Actual|University of Southern California||1|||f||||||||||||||2017-02-18 17:23:18.670279|2017-02-18 17:23:18.670279
NCT00159419|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-02-29|2013-11-12||August 1999||1999-08-01|February 2016|2016-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Bisphosphonate Therapy for Osteogenesis Imperfecta|Bisphosphonate Therapy for Osteogenesis Imperfecta|Completed||Phase 4|18|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 17:23:19.112098|2017-02-18 17:23:19.112098
NCT00159406|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-08-29|||October 2003||2003-10-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Laser Prostatectomy Database and Registry|Laser Prostatectomy for Benign Prostatic Hyperplasia: A Registry and Database|Recruiting||N/A|3000|Anticipated|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-02-18 17:23:19.53826|2017-02-18 17:23:19.53826
NCT00159393|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-08-29|||October 2003||2003-10-01|August 2016|2016-08-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Percutaneous Nephrolithotomy: A Registry and Database|Percutaneous Nephrolithotomy: A Registry and Database|Recruiting||N/A|3000|Anticipated|Indiana Kidney Stone Institute|||1||f||||f||||||||||2017-02-18 17:23:19.672507|2017-02-18 17:23:19.672507
NCT00159380|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-06-03|||September 2003||2003-09-01|April 2008|2008-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects|A Double Blind, Crossover Placebo-controlled Study to Evaluate the Effect of L-arginine and Aminoguanidine on Bronchial, Alveolar and Nasal NO and NO Metabolites in Exhaled Air, Breath Condensate, Saliva, Nasal Lavage Fluid and Induced Sputum in 10 Normal and 15 Asthmatic Subjects|Completed||N/A|25|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:23:19.789255|2017-02-18 17:23:19.789255
NCT00159367|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-02-16|||January 2005||2005-01-01|August 2008|2008-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps Muscle|The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps Muscle in Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|20|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:23:19.873773|2017-02-18 17:23:19.873773
NCT00159354|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-28|||June 2005||2005-06-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Measurement of Smoking−Induced Neutrophil Activation|Evaluation of Smoking−Induced Neutrophil Activation as a Potential Biomarker of Response to Therapeutic Interventions in COPD: Proof of Concept Study|Completed||N/A|16|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:23:19.965364|2017-02-18 17:23:19.965364
NCT00159341|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-08-12|||September 2005||2005-09-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Cigarette Smoke Nasal and Whole Blood Challenge in Patients With COPD|Completed||Phase 1|16|Actual|Imperial College London||1|||f||||f||||||||||2017-02-18 17:23:20.05041|2017-02-18 17:23:20.05041
NCT00159328|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-08-12|||March 2003||2003-03-01|August 2008|2008-08-01|December 2006||2006-12-01|||||Interventional|||Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids|Phase 4 Study of Magnetic Resonance Guided Focused Ultrasound Surgery Following Gonadotrophin Releasing Hormone Agonist Treatment for Symptomatic Uterine Fibroids|Completed||Phase 4|50||Imperial College London|||||f||||||||||||||2017-02-18 17:23:20.152329|2017-02-18 17:23:20.152329
NCT00159315|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-03|||October 2002||2002-10-01|August 2008|2008-08-01||||||||Interventional|||ATP/AMP Challenge in Healthy Non-smokers, Smokers, Patients With Asthma, and Patients With Chronic Obstructive Pulmonary Disease (COPD)|Adenosine 5`-Triphosphate (ATP) Challenge in Healthy Non-smokers, Current Smokers and Patients With Mild Asthma and Chronic Obstructive Pulmonary Disease (COPD)|Withdrawn||N/A|0|Actual|Imperial College London||||no resources available|f||||||||||||||2017-02-18 17:23:20.241006|2017-02-18 17:23:20.241006
NCT00159302|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||September 2003||2003-09-01|September 2005|2005-09-01||||||||Observational|||Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control|A Pilot Study to Evaluate and Develop Biomarkers of iNOS Activity in Patients With COPD or Asthma and Healthy Volunteers|Completed||N/A|36||Imperial College London|||||f||||||||||||||2017-02-18 17:23:20.325572|2017-02-18 17:23:20.325572
NCT00005402|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-16|||May 1996||1996-05-01|April 2002|2002-04-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Observational|||Transfusion Associated HCV in a Pediatric Population||Completed||N/A|||Children's Research Institute|||||f||||||||||||||2017-02-18 18:15:02.364046|2017-02-18 18:15:02.364046
NCT00159289|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-03|||June 2003||2003-06-01|August 2008|2008-08-01||||||||Interventional|||Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)|Effect of Endotoxin on Inflammatory Markers in Exhaled Breath, Sputum, Saliva and Nasal Lavage in Healthy Non-Smokers and Current Smokers Including Patients With COPD|Withdrawn||N/A|0|Actual|Imperial College London||2||No resources available|f||||||||||||||2017-02-18 17:23:20.411897|2017-02-18 17:23:20.411897
NCT00159276|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-08-12|||December 2005||2005-12-01|August 2008|2008-08-01|December 2008||2008-12-01|||||Observational|||GR Defect in Sputum Cells in COPD|GR Defect in Sputum Cells in COPD|Completed||N/A|30|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:23:20.509265|2017-02-18 17:23:20.509265
NCT00159263|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||November 2004||2004-11-01|September 2005|2005-09-01||||||||Interventional|||Effect of Symbicort on GR Localisation in Asthma|Effect of Symbicort on GR (Glucocorticoid Receptor) Translocation in Induced Sputum in Comparison With Budesonide, Formoterol and Placebo. A Single Dose Exploratory Study in Patients With Mild Asthma|Completed||N/A|10||Imperial College London|||||f||||||||||||||2017-02-18 17:23:20.579464|2017-02-18 17:23:20.579464
NCT00159250|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-02-22|||October 2007||2007-10-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy|Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: A Phase I/II Clinical Trial Using AVI-4658|Completed||Phase 1/Phase 2|7|Actual|Imperial College London||1|||f||||t||||||||||2017-02-18 17:23:20.664873|2017-02-18 17:23:20.664873
NCT00159237|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-08-12|||February 2005||2005-02-01|August 2008|2008-08-01|December 2008||2008-12-01|||||Observational|||GR Defect in Peripheral Blood Mononuclear Cells in COPD|GR Defect in Peripheral Blood Mononuclear Cells in COPD|Completed||N/A|30|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:23:20.768987|2017-02-18 17:23:20.768987
NCT00159224|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-09-04|||April 2005||2005-04-01|September 2015|2015-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Induction-maintenance of Lopinavir/r in HIV-infected Subjects|"Study ACA-ARGE-04-001 A Pilot, Open-Label Study Assessing Safety, Tolerability, Efficacy of a Simplified Lopinavir/Ritonavir Induction/Maintenance Therapy in HIV-Infected Subjects on Their First Protease Inhibitor-Based Regimen."|Completed||Phase 4|100|Actual|The Huesped Foundation||2|||f||||f||||||||||2017-02-18 17:23:20.956961|2017-02-18 17:23:20.956961
NCT00159211|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-11-06|||May 2005||2005-05-01|April 2007|2007-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin|Evolution of Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin, in Association With Metformin or Sulfonylurea.|Terminated||N/A|28|Actual|Assistance Publique - Hôpitaux de Paris||2||inclusion was finished|f||||f||||||||||2017-02-18 17:23:21.067789|2017-02-18 17:23:21.067789
NCT00159198|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-09-05|||September 2002||2002-09-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|||||Observational|||Amyotrophic Lateral Sclerosis and Frontotemporal Dementia|Genetic Linkage in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia|Terminated||Phase 1|400|Actual|Assistance Publique - Hôpitaux de Paris|||2|Completed|f||||t||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 17:23:21.170068|2017-02-18 17:23:21.170068
NCT00159185|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-07-20|||January 2004||2004-01-01|September 2005|2005-09-01|May 2006||2006-05-01|||||Observational|||Epidemiology Study in Major Orthopaedic Surgery|Epidemiology Study in Major Orthopaedic Surgery|Completed||N/A|500||Hoersholm Hospital|||||f||||||||||||||2017-02-18 17:23:21.282532|2017-02-18 17:23:21.282532
NCT00159172|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-03-05|||September 2005||2005-09-01|September 2005|2005-09-01|May 2008||2008-05-01|||||Interventional|||Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease|Phase 1 Study of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease|Unknown status|Recruiting|Phase 1/Phase 2|10||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:23:21.359544|2017-02-18 17:23:21.359544
NCT00159159|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-04-26|||March 2004||2004-03-01|April 2007|2007-04-01||||||||Interventional|||LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant|LOW CYCLO: A Multicenter, Prospective, Randomized Study Evaluating the Benefit, on Renal Function, of Two Doses of Ciclosporine: Low Dose Versus Usual Dose, in Association With Mycophenolate and Corticoïds, in de Novo Cardiac Transplant|Unknown status|Active, not recruiting|Phase 4|106||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:23:21.461374|2017-02-18 17:23:21.461374
NCT00159146|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-12-20|||August 2002||2002-08-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression|A Short Term Double Blind Randomised Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression|Terminated||N/A|31|Actual|Hillerod Hospital, Denmark||2||lack of participants fulfilling inclusion criteria|f||||f||||||||||2017-02-18 17:23:21.548545|2017-02-18 17:23:21.548545
NCT00159133|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-01-28|||November 2001||2001-11-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia|Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepine in Patients With First-Episode Schizophrenia After One Year Maintenance Treatment Under Further Maintenance Treatment vs. Stepwise Discontinued Drugs|Completed||Phase 4|71|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-02-18 17:23:21.661291|2017-02-18 17:23:21.661291
NCT00159120|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-01-28|||November 2001||2001-11-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia|Maintenance Treatment vs. Stepwise Drug Discontinuation After One Year of Maintenance Treatment in First-Episode Schizophrenia|Completed||Phase 4|71|Anticipated|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-02-18 17:23:21.780519|2017-02-18 17:23:21.780519
NCT00159107|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-01-29|||May 2003||2003-05-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Integrative Therapy in Alcoholism|Acamprosate and Integrative Behavior Therapy in the Outpatient Treatment of Alcohol Dependents|Completed||Phase 4|371|Actual|Heinrich-Heine University, Duesseldorf||3|||f||||t||||||||||2017-02-18 17:23:21.914002|2017-02-18 17:23:21.914002
NCT00159094|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-30|||October 2003||2003-10-01|September 2005|2005-09-01||||||||Interventional|||A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer|A Phase II Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|30|Anticipated|Hematology Oncology Consultants|||||f||||||||||||||2017-02-18 17:23:22.05522|2017-02-18 17:23:22.05522
NCT00159081|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-02-06|||November 2000||2000-11-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||One Year Drug Treatment in First-Episode Schizophrenia|One Year Maintenance Treatment With Low Dose Haloperidol vs. Risperidone in First-Episode Schizophrenia|Completed||Phase 4|159|Actual|Heinrich-Heine University, Duesseldorf||2|||f||||t||||||||||2017-02-18 17:23:22.149283|2017-02-18 17:23:22.149283
NCT00159068|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-06-22|||February 2004||2004-02-01|June 2010|2010-06-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Analysis of Genetic Factors Which May Influence the Course of HIV Infection|Genetic Influences on the Course and Response to Treatment of HIV: Contribution of Polymorphisms in Drug Metabolism and Disposition Genes and Haptoglobin Polymorphisms|Completed||N/A|150|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"~     DNA isolated from peripheral blood.~   "|||2017-02-18 17:23:22.27176|2017-02-18 17:23:22.27176
NCT00159055|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-07|||February 2004||2004-02-01|September 2005|2005-09-01||||||||Interventional|||Adoptive Immunotherapy for CMV Disease|Prevention and Treatment of CMV Disease by Adoptive Immunotherapy With Immune Donor Lymphocytes in Conjunction With Non-myeloablative Stem Cell Transplantation (NST)|Withdrawn||Phase 1/Phase 2|20|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-02-18 17:23:22.354381|2017-02-18 17:23:22.354381
NCT00159042|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-06-22|||July 2004||2004-07-01|June 2011|2011-06-01|April 2012|Anticipated|2012-04-01|||||Observational|||Genetic Factors Affecting the Severity of Beta Thalassemia|Identification of Novel Genetic Modifiers in Beta-thalassemia|Unknown status|Recruiting|N/A|200|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"~     DNA isolated from peripheral blood~   "|||2017-02-18 17:23:22.427899|2017-02-18 17:23:22.427899
NCT00159029|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-06-22|||April 2004||2004-04-01|June 2011|2011-06-01|April 2012|Anticipated|2012-04-01|||||Observational|||Genetics of Alpha Thalassemia in Israeli Ethnic Groups|Haplotype Analysis of Alpha Globin Genes in Israeli Ethnic Groups|Unknown status|Recruiting|N/A|100|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"~     DNA isolated from peripheral blood.~   "|||2017-02-18 17:23:22.509851|2017-02-18 17:23:22.509851
NCT00159016|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-04-27|||August 2002||2002-08-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study.|The Possible Role of Glivec in Patients With Tumor Cells Positive for C-kit or Platelet Derived Growth Factor Receptor (PDGFR); a Multi Center Study.|Withdrawn||Phase 2|100||Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-02-18 17:23:22.594678|2017-02-18 17:23:22.594678
NCT00159003|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-06-22|||January 1998||1998-01-01|June 2011|2011-06-01|April 2012|Anticipated|2012-04-01|||||Observational|||Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel|Molecular Analysis of Genetic Elements Which May Influence Predisposition and Prognosis of Hematological Malignancies in Different Ethnic Groups in Israel|Unknown status|Recruiting|N/A|300|Anticipated|Hadassah Medical Organization|||1||f||||f||||||Samples With DNA|"~     DNA only~   "|||2017-02-18 17:23:22.681388|2017-02-18 17:23:22.681388
NCT00158990|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-01-02|||October 2002||2002-10-01|August 2005|2005-08-01|July 2007||2007-07-01|||||Interventional|||Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.|Triiodothyronine (T3) Supplementation in Bipolar and Unipolar Depression: A Random Assignment, Double Blind, Placebo-Controlled Study.|Completed||Phase 3|220||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:23:22.769887|2017-02-18 17:23:22.769887
NCT00158977|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-09-28|||November 2003||2003-11-01|September 2011|2011-09-01|February 2008|Actual|2008-02-01|October 2004|Actual|2004-10-01||Interventional|||CONTAK RENEWAL 3 AVT|CONTAK RENEWAL 3 AVT Study|Completed||Phase 3|73|Actual|Boston Scientific Corporation||1|||f||||||||||||||2017-02-18 17:23:22.869577|2017-02-18 17:23:22.869577
NCT00158964|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-06-22|||March 2005||2005-03-01|June 2007|2007-06-01|April 2007|Actual|2007-04-01|||||Interventional|||EASYTRAK 4 Steerable LV Lead|EASYTRAK® 4 STEERABLE LV Lead Clinical Investigation|Completed||Phase 2/Phase 3|110||Boston Scientific Corporation|||||||||||||||||||2017-02-18 17:23:25.740665|2017-02-18 17:23:25.740665
NCT00158951|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-06-22|||March 2003||2003-03-01|June 2007|2007-06-01|October 2004||2004-10-01|||||Interventional|||Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF|Device Evaluation of CONTAK(R) RENEWAL 2/4/4HE and EASYTRAK(R) 2: Assessment of Safety and Effectiveness in Heart Failure (DECREASE-HF)|Completed||Phase 2/Phase 3|360||Boston Scientific Corporation|||||||||||||||||||2017-02-18 17:23:25.872708|2017-02-18 17:23:25.872708
NCT00158938|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-06-22|||May 2003||2003-05-01|June 2007|2007-06-01|November 2004|Actual|2004-11-01|||||Interventional|||Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead|Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead|Completed||Phase 2/Phase 3|115||Boston Scientific Corporation|||||||||||||||||||2017-02-18 17:23:25.956587|2017-02-18 17:23:25.956587
NCT00158925|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-19|||September 2004||2004-09-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The EASYTRAK EPI Clinical Investigation|The EASYTRAK EPI Clinical Investigation|Completed||Phase 3|100|Actual|Boston Scientific Corporation||1|||f||||||||||||||2017-02-18 17:23:26.039789|2017-02-18 17:23:26.039789
NCT00158912|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-11-20|||August 2003||2003-08-01|November 2006|2006-11-01|May 2005||2005-05-01|||||Interventional|||VAST - Ventricular Arrhythmia Suppression Trial|Ventricular Arrhythmia Suppression Trial|Completed||Phase 4|550||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:23:26.150928|2017-02-18 17:23:26.150928
NCT00158899|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-19|||August 2004||2004-08-01|January 2017|2017-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol|A Multi-center, Three-staged With Interim Analyses, Parallel, Randomized, Double-blind, fenofibrate-and Placebo-controlled Proof of Concept and Dose-response Evaluation of the Safety, Tolerability, and Effects on Plasma High-density Lipoprotein Cholesterol (HDLc) and Triglycerides of Eight Weeks Treatment With GW501516 in Otherwise Healthy Patients With Low HDLc, Mildly to Moderately Elevated Triglycerides, and Normal Low-density Lipoprotein Cholesterol (LDLc)|Completed||Phase 2|424|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 17:23:26.237387|2017-02-18 17:23:26.237387
NCT00158886|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-05-21|||November 2001||2001-11-01|May 2009|2009-05-01||||||||Interventional|||Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer|A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Cancer|Terminated||Phase 1|36||GlaxoSmithKline||1|||||||||||||||||2017-02-18 17:23:26.384646|2017-02-18 17:23:26.384646
NCT00005401|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||August 1995||1995-08-01|July 2000|2000-07-01|July 1999||1999-07-01|||||Observational|||Validation and Exploration of Sleep and Mood Predictors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:02.426168|2017-02-18 18:15:02.426168
NCT00158873|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-10-15|||September 2004||2004-09-01|October 2008|2008-10-01||||||||Interventional|||Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects|A Centre-Randomized, Open-Label, Cross-Over Study to Compare the Pharmaco-Economic Consequences of an Ultiva (Remifentanil Hydrochloride) Based Regimen With Conventional Sedative Based Regimens in ICU Subjects Requiring Short-Term Mechanical Ventilation With Analgesia and Sedation|Completed||Phase 4|224||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:23:26.72445|2017-02-18 17:23:26.72445
NCT00158860|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-05-10|||June 2004||2004-06-01|May 2013|2013-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients|An International, Randomized, Double-Blind, Placebo-Controlled, Multicenter, 6- Month Study of the Efficacy and Safety of Valaciclovir 1g Once Daily vs. Placebo for the Suppression of HSV-2 Genital Herpes in Newly Diagnosed Immunocompetent Subjects|Completed||Phase 4|315|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:23:26.842106|2017-02-18 17:23:26.842106
NCT00158847|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-01-10|||April 2000||2000-04-01|January 2005|2005-01-01|May 2005||2005-05-01|||||Interventional|||Modification Of Disease Outcome In COPD|Modification of Disease Outcome in COPD. Shortterm Versus Longterm Treatment With Inhaled Corticosteroids, Either or Not Combined With a Long-Acting Beta2-Agonist.|Terminated||Phase 4|200||Leiden University Medical Center|||||f||||||||||||||2017-02-18 17:23:27.01797|2017-02-18 17:23:27.01797
NCT00158834|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-10-09|||November 1999||1999-11-01|October 2008|2008-10-01||||||||Interventional|||Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications|Comparison of Stepwise Treatment of Asthmatic Children With Salmeterol/Fluticasone Propionate Combination Product (Seretide®) and/or Fluticasone Propionate (Flixotide®) Based on PD20 Methacholine and Symptoms or Based on Symptoms Only (Children Asthma Therapy Optimal)|Completed||Phase 3|200||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:23:27.136232|2017-02-18 17:23:27.136232
NCT00158821|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-06-21|||March 2000||2000-03-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|December 2001|Actual|2001-12-01||Interventional|||Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.|A Phase 3, Randomized, Double-Blind, Multicenter Study of the Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.(Extension)|Completed||Phase 3|180|Anticipated|Gilead Sciences||1|||f||||||||||||||2017-02-18 17:23:27.255634|2017-02-18 17:23:27.255634
NCT00158808|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-02-10|||January 2005||2005-01-01|February 2011|2011-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths|Assess the Immunogenicity &d Reactogenicity of a Booster Dose of a Formulation of GSK Biologicals' DTPw-HBV/Hib Vaccine at 15-18 Mths of Age in Infants Previously Primed With the Same Vaccine|Completed||Phase 2|175|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:23:27.353647|2017-02-18 17:23:27.353647
NCT00158795|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-09-29|||January 2005||2005-01-01|September 2011|2011-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine|Assess the Safety & Reactogenicity of GSK Biologicals Hib Vaccine Co-administered With Chinese Local DTPw Vaccine When Compared to Chinese Local DTPw Vaccine Administered Alone, in Healthy Infants at 3,4 & 5 Mths of Age|Completed||Phase 4|454|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:23:27.448134|2017-02-18 17:23:27.448134
NCT00158782|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-03-17|||September 2004||2004-09-01|March 2011|2011-03-01||||||||Interventional|||Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients|An Open-Label, Safety, Pharmacokinetic and Pharmacodynamic Study of Multiple Doses of GW786034 and Lapatinib Concomitantly Administered in Cancer Patients.|Completed||Phase 1|65||GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:23:27.531835|2017-02-18 17:23:27.531835
NCT00158769|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-10-15|||March 2005||2005-03-01|October 2008|2008-10-01||||||||Interventional|||A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers|An Open-Label, Non-Randomised, Pharmacokinetic, Metabolic Disposition and Safety Study of a 3 Day Continuous Infusion of GR270773 in Healthy Subjects and Subjects With Hepatic Impairment.|Completed||Phase 1|16||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:23:27.630378|2017-02-18 17:23:27.630378
NCT00158756|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-10-06|||September 2005||2005-09-01|October 2016|2016-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants|A Phase III, Partially Blind, Randomized Study to Evaluate the Immunogenicity, Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Tritanrix™-HepB and GSK Biologicals Kft's DTPw-HBV Vaccines as Compared to Concomitant Administration of Commonwealth Serum Laboratory's (CSL's) DTPw (Triple Antigen™) and GSK Biologicals' HBV (Engerix™-B), When Co-administered With GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine, to Healthy Infants at 3, 4½ and 6 Months of Age, After a Birth Dose of Hepatitis B Vaccine.|Completed||Phase 3|307|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:23:27.721883|2017-02-18 17:23:27.721883
NCT00158743|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-07-17|2014-07-17||February 2004||2004-02-01|July 2014|2014-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy Study of Digibind for Treatment of Severe Preeclampsia|A Parallel, Double-blind, Placebo Controlled, Randomized Comparison of an Anti-digoxin Antibody (Digibind) Versus Placebo for the Treatment of Antepartum Patients With Severe Preeclampsia|Completed||Phase 2|51|Actual|BTG International Inc.||2|||f||||t||||||||||2017-02-18 17:23:27.831683|2017-02-18 17:23:27.831683
NCT00158730|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-11-17|||April 2003||2003-04-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment|Study of the Safety and Efficacy of AmBisome Loading Dose Regimen Vs. a Standard AmBisome Regimen for Initial Treatment of Invasive Aspergillosis and Other Filamentous Fungal Infections in Immunocompromised Patients|Completed||Phase 3|800||Gilead Sciences|||||||||||||||||||2017-02-18 17:23:28.515014|2017-02-18 17:23:28.515014
NCT00158327|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-01-21|||March 2004||2004-03-01|January 2014|2014-01-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||Telephone-Based Care Management Program for Individuals With Anxiety Disorders|The RELAX Trial: Reducing Limitations From Anxiety in Primary Care|Completed||Phase 3|360|Anticipated|University of Pittsburgh||2|||f||||||||||||||2017-02-18 17:23:33.52009|2017-02-18 17:23:33.52009
NCT00158717|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-01-06|||April 2003||2003-04-01|January 2014|2014-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.|A Phase 3b, Long-Term, Observational Study of the Durability of Seroconversion in Patients With Chronic Hepatitis B Virus Infection Who Have Seroconverted While Participating in a Previous Gilead-Sponsored Study of Adefovir Dipivoxil.|Completed||N/A|107|Actual|Gilead Sciences|||||||||||||||||||2017-02-18 17:23:28.596775|2017-02-18 17:23:28.596775
NCT00158704|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-03-07|||January 2002||2002-01-01|April 2006|2006-04-01|January 2005||2005-01-01|||||Interventional|||Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.|An Open-Label, Continued Access Study of Adefovir Dipivoxil for Patients With Chronic HBV Infection Who Have Completed a Gilead-Sponsored Study of Adefovir Dipivoxil.|Terminated||N/A|400||Gilead Sciences||||The study stopped due to marketing approval by the FDA.|||||||||||||||2017-02-18 17:23:28.695847|2017-02-18 17:23:28.695847
NCT00158691|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||March 2001||2001-03-01|September 2005|2005-09-01||||||||Interventional|||Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas|A Randomized Phase III Study Comparing Intravenous Versus Subcutaneous Administration of Amifostine in Prevention of Xerostomia for Patients Receiving Radiotherapy for Head and Neck Carcinomas|Completed||Phase 3|296||Groupe Oncologie Radiotherapie Tete et Cou|||||f||||||||||||||2017-02-18 17:23:28.782572|2017-02-18 17:23:28.782572
NCT00158678|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-03-23|||September 2005||2005-09-01|March 2015|2015-03-01|February 2018|Anticipated|2018-02-01|February 2018|Anticipated|2018-02-01||Interventional|||IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC|Phase III Trial of Intensity-modulated Radiotherapy Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma|Active, not recruiting||Phase 3|310|Anticipated|Groupe Oncologie Radiotherapie Tete et Cou||2|||f||||||||||||||2017-02-18 17:23:28.894519|2017-02-18 17:23:28.894519
NCT00158665|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-02-25|||August 2004||2004-08-01|February 2014|2014-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Comparison of One Versus Two Doses of Influenza Vaccine in Children 5-8 Years of Age|A Comparison of One Versus Two Doses of Influenza Vaccine in Children Aged 5-8 Years of Age Receiving Influenza Vaccine for the First Time|Completed||N/A|280|Actual|Group Health Cooperative||1|||f||||f||||||||||2017-02-18 17:23:29.102958|2017-02-18 17:23:29.102958
NCT00158652|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-11-07|||March 2000||2000-03-01|November 2011|2011-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC|Phase III Trial Comparing Conventional RT With Concomitant CT Versus Accelerated RT With Concomitant CT Versus Very Accelerated RT Alone in Patients With Head and Neck Squamous Cell Carcinoma|Completed||Phase 3|840|Actual|Groupe Oncologie Radiotherapie Tete et Cou||3|||f||||||||||||||2017-02-18 17:23:29.211101|2017-02-18 17:23:29.211101
NCT00158639|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-09-10|||June 2005||2005-06-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Electronic Communications and Home Blood Pressure Monitoring|Electronic Communications and Home Blood Pressure Monitoring|Completed||Phase 3|778|Actual|Group Health Cooperative|||||f||||t||||||||||2017-02-18 17:23:29.33771|2017-02-18 17:23:29.33771
NCT00158626|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-03-18|||September 2003||2003-09-01|March 2015|2015-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Does Doing Pelvic Floor Exercise Ease Symptoms for Women Living With Prolapse?|A Feasibility Study for an RCT of a Pelvic Floor Muscle Training Intervention for Pelvic Organ Prolapse|Completed||Phase 1/Phase 2|50||Glasgow Caledonian University|||||f||||||||||||||2017-02-18 17:23:29.427543|2017-02-18 17:23:29.427543
NCT00158613|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-11-03|||March 2000||2000-03-01|November 2016|2016-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study of the Treatment of Articular Repair (STAR)|A Prospective, Longitudinal Within-Patient Evaluation of the Effectiveness (Durability) of Carticel® (Autologous Cultured Chondrocytes) Compared to Non-Carticel Surgical Treatment for Articular Cartilage Defects of the Knee.|Completed||Phase 4|126|Actual|Vericel Corporation||1|||f||||f||||||||||2017-02-18 17:23:29.530122|2017-02-18 17:23:29.530122
NCT00158600|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-06|2010-06-24||September 2005||2005-09-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease|Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy and Pharmacokinetics of Myozyme in Patients With Late-Onset Pompe Disease.|Completed||Phase 3|90|Actual|Sanofi||2|||t||||t||||||||||2017-02-18 17:23:29.659495|2017-02-18 17:23:29.659495
NCT00158587|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-11|||April 2004||2004-04-01|January 2017|2017-01-01|March 2007|Actual|2007-03-01|||||Interventional|||Eight Week Primaquine Regimen for the Treatment of Vivax Malaria|A Placebo Controlled, Randomised Evaluation of an Eight Week Primaquine Regimen for the Treatment of Vivax Malaria.|Completed||Phase 3|150|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-02-18 17:23:31.241756|2017-02-18 17:23:31.241756
NCT00158574|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-11|||January 2005||2005-01-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Kilimanjaro IPTi Drug Options Trial|Drug Options for Intermittent Preventive Treatment for Malaria in Infants in an Area With High Resistance to Sulfadoxine/Pyrimethamine: an Evaluation of Short and Long-acting Antimalarial Drugs|Completed||Phase 2/Phase 3|2419|Actual|London School of Hygiene and Tropical Medicine||4|||f||||t||||||||||2017-02-18 17:23:31.334991|2017-02-18 17:23:31.334991
NCT00158561|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-11|||February 2004||2004-02-01|January 2017|2017-01-01|March 2006|Actual|2006-03-01|||||Interventional|||Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax Malaria|An Open-label Three Arm Trial of the Efficacy and Safety of Chlorproguanil / Dapsone (Lapdap) Compared With Chloroquine and Sulfadoxine / Pyrimethamine for the Treatment of Vivax Malaria in Pakistan and Afghanistan|Completed||Phase 3|750||London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-02-18 17:23:31.459581|2017-02-18 17:23:31.459581
NCT00158548|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-11|||June 2001||2001-06-01|January 2017|2017-01-01|December 2004|Actual|2004-12-01|||||Interventional|||ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan|Studies on Adding Artesunate to Existing Antimalarial Therapies With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan|Completed||Phase 3|650|Actual|London School of Hygiene and Tropical Medicine||9|||f||||t||||||||||2017-02-18 17:23:31.562258|2017-02-18 17:23:31.562258
NCT00158314|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-06-28|||March 1998||1998-03-01|June 2013|2013-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Cognitive Behavioral Therapy for Treatment of Pathological Gambling|Cognitive Behavioral Treatment for Pathological Gambling|Completed||Phase 1|231||UConn Health|||||f||||t||||||||||2017-02-18 17:23:33.629954|2017-02-18 17:23:33.629954
NCT00158535|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||June 2002||2002-06-01|September 2005|2005-09-01||||||||Interventional|||Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection|Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection ANRS HC08 Thevic|Terminated||Phase 2|15||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:23:31.669252|2017-02-18 17:23:31.669252
NCT00158522|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-02-06|||February 2003||2003-02-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)|Clinical Trial of the Efficacy of Pegylated Interferon (PEG-IFNα-2a) Alone in Egyptian Patients With Acute Hepatitis C|Completed||Phase 3|31|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-02-18 17:23:31.779955|2017-02-18 17:23:31.779955
NCT00158509|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-06-06|||August 2004||2004-08-01|June 2006|2006-06-01|July 2005||2005-07-01|||||Interventional|||Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding|Efficacy of an HSV2 Genital Herpes Suppressive Treatment on HIV and HSV2 Genital Shedding Among Co-Infected Patients Receiving or Not Antiretroviral Drugs|Completed||Phase 2|215||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:23:31.896193|2017-02-18 17:23:31.896193
NCT00158496|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-04-23|||August 2002||2002-08-01|April 2007|2007-04-01|January 2005|Actual|2005-01-01|||||Interventional|||Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)|Clinical Trial of the Efficacy of the Combination of Pegylated Interferon (PEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C|Completed||Phase 3|100||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-02-18 17:23:32.001482|2017-02-18 17:23:32.001482
NCT00158483|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-12-29|||May 2003||2003-05-01|December 2008|2008-12-01|October 2005|Actual|2005-10-01|||||Interventional|||Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)|Anti-Herpetic Treatment Associated With Syndromic Management of Genital Ulcer in Africa: Clinical and Biological Evaluation on HIV-1 and HSV-2 Shedding (ANRS 1212)|Completed||Phase 2|449|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||f||||||||||2017-02-18 17:23:32.175648|2017-02-18 17:23:32.175648
NCT00158470|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-07-02|||September 2003||2003-09-01|July 2007|2007-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)|Feasibility Study of a Once Daily Antiretroviral Regimen for HIV-Infected Patients With CD4 Below 200/mm3, in Hô Chi Minh City, Vietnam|Completed||Phase 3|100|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||f||||||||||2017-02-18 17:23:32.287781|2017-02-18 17:23:32.287781
NCT00158457|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-02|||June 2004||2004-06-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)|Pilot Trial to Evaluate the Efficacy and Tolerance of a Simple Once Daily Combined Regimen Including Tenofovir (TDF), Emtricitabine (FTC) and Efavirenz (EFV) in HIV-1 Infected Patients Naive to Prior Antiretroviral Treatment in Senegal|Completed||Phase 3|40|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||||||||||||2017-02-18 17:23:32.396429|2017-02-18 17:23:32.396429
NCT00158444|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-07-20|||August 2005||2005-08-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|January 2009|Actual|2009-01-01||Interventional|||"Study of the HemiCAP™ Unicondylar Femoral Resurfacing Prosthesis."|"A Prospective, Non-Randomized, Non-Comparative, Open Label Multi-Center, Feasibility Study to Examine the Safety and Effectiveness of the HemiCAP™ Unicondylar Femoral Resurfacing Prosthesis."|Completed||N/A|1|Actual|Arthrosurface, Inc.||1|||f||||t||||||||Undecided||2017-02-18 17:23:32.489422|2017-02-18 17:23:32.489422
NCT00158431|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-11-26|||January 1999||1999-01-01|November 2015|2015-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Surgery Versus no Surgery for OA of the Knee|Arthroscopic Surgery Versus Non-surgical Treatment of Osteoarthritis of the Knee|Completed||Phase 3|186|Actual|Fowler Kennedy Sport Medicine Clinic||2|||f||||t||||||||||2017-02-18 17:23:32.621683|2017-02-18 17:23:32.621683
NCT00158418|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-01-28|||August 2002||2002-08-01|September 2005|2005-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Cemented vs. Non-Cemented TSA for OA of the Shoulder|Cemented Versus Uncemented Fixation of Humeral Components in Total Shoulder Arthroplasty for Osteoarthritis of the Shoulder|Completed||Phase 3|160||Fowler Kennedy Sport Medicine Clinic|||||f||||||||||||||2017-02-18 17:23:32.751182|2017-02-18 17:23:32.751182
NCT00158405|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-12-29|||December 2002||2002-12-01|December 2008|2008-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)|Multicentric Randomised Controlled Trial Assessing the Efficacy of Two Strategies of Structured Treatment Interruption of Highly Active Antiretroviral Therapy (HAART) Compared With a Continuous HAART in HIV- Infected Adults in Abidjan|Completed||Phase 3|840|Actual|French National Agency for Research on AIDS and Viral Hepatitis||3|||f||||t||||||||||2017-02-18 17:23:32.858369|2017-02-18 17:23:32.858369
NCT00158379|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-12-12|2016-10-04||July 2003||2003-07-01|December 2016|2016-12-01|June 2008|Actual|2008-06-01|April 2008|Actual|2008-04-01||Interventional|||Taxol Carboplatin and Erythropoetin|Carboplatin With Following Taxol® Therapy Under Additional Application of Epoetin Alfa (ERYPO ®) With Female Patients With Advanced Ovarian Cancer FIGO IA/G3 - IV|Completed||Phase 2|105|Actual|North Eastern Germany Society of Gynaecologic Oncology||1|||f||||f||||||||No||2017-02-18 17:23:32.97188|2017-02-18 17:23:32.97188
NCT00158366|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-01-05|||May 2004||2004-05-01|January 2016|2016-01-01|December 2016|Anticipated|2016-12-01|May 2010|Actual|2010-05-01||Interventional|||Reducing the Weight of Overweight Schizophrenia Patients|A Clinical Trial Of Weight Reduction in Schizophrenia|Active, not recruiting||N/A|300|Anticipated|University of Pittsburgh||4|||f||||t||||||||||2017-02-18 17:23:33.183054|2017-02-18 17:23:33.183054
NCT00158353|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-06-18|||May 2005||2005-05-01|June 2013|2013-06-01|February 2014|Anticipated|2014-02-01|February 2014|Anticipated|2014-02-01||Interventional|||Evaluation of a Youth Mentoring Program|Development and Evaluation of a Youth Mentoring Program|Unknown status|Active, not recruiting|Phase 1/Phase 2|40|Anticipated|University of Illinois at Chicago||2|||f||||f||||||||||2017-02-18 17:23:33.294822|2017-02-18 17:23:33.294822
NCT00158340|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-11-04|||August 2004||2004-08-01|November 2011|2011-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|BEST||Guided Self-Help Treatment for Binge Eating Disorder|Binge Eating Self-Guided Treatment (BEST)|Completed||N/A|284|Actual|Kaiser Permanente||2|||f||||t||||||||||2017-02-18 17:23:33.411961|2017-02-18 17:23:33.411961
NCT00158301|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-11-07|||September 2004||2004-09-01|November 2013|2013-11-01|February 2008|Actual|2008-02-01|November 2007|Actual|2007-11-01||Interventional|||Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents|Continuation Phase CBT for Youth With MDD|Completed||N/A|72|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 17:23:33.738297|2017-02-18 17:23:33.738297
NCT00158288|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-11|||March 1997||1997-03-01|September 2005|2005-09-01|August 2001||2001-08-01|||||Interventional|||The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1|LAAM With Behavioral Treatment for Opioid/Cocaine Abuse|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:23:33.848662|2017-02-18 17:23:33.848662
NCT00158275|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-07-14|||October 2004||2004-10-01|July 2014|2014-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Combined Interventions for Treating Depression and Chronic Back Pain|Integrated Care for Depression and Chronic Back Pain|Completed||N/A|71|Actual|Group Health Cooperative||2|||f||||||||||||||2017-02-18 17:23:33.945986|2017-02-18 17:23:33.945986
NCT00158262|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-04-26|||August 2004||2004-08-01|April 2013|2013-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Propranolol on Preventing Post-Traumatic Stress Disorder|Prophylaxis of Post-Traumatic Stress Disorder With Post-Trauma Propranolol|Completed||Phase 4|45|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:23:34.057329|2017-02-18 17:23:34.057329
NCT00158249|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-10-15|2014-10-15||September 2009||2009-09-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|January 2013|Actual|2013-01-01||Interventional|||Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals|Cannabis Dependence: Imaging and Medication Development - 1|Completed||Phase 2|21|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 17:23:34.188313|2017-02-18 17:23:34.188313
NCT00158236|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-11|||January 1997||1997-01-01|January 2006|2006-01-01|March 1998||1998-03-01|||||Interventional|||Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users|Effects of Buprenorphine/Naloxone in Non-Dependent Opioid Abusers|Completed||N/A|7||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:23:34.704281|2017-02-18 17:23:34.704281
NCT00158223|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-04-07|2013-09-03||October 2004||2004-10-01|April 2015|2015-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia|Pimozide Augmentation of Clozapine in Schizophrenia|Completed||Phase 4|76|Actual|Icahn School of Medicine at Mount Sinai|Neither baseline nor follow-up clozapine plasma concentrations were reported. Possible that one or both groups did not have therapeutic baseline clozapine levels and/or had pharmacokinetic interactions with the study drug changing concentrations.|2|||f||||t||||||||||2017-02-18 17:23:34.862887|2017-02-18 17:23:34.862887
NCT00158210|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-11|||May 2006||2006-05-01|September 2009|2009-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Rivastigmine For Methamphetamine Dependent Individuals|Double-Blind Randomized Placebo Controlled Trial of Rivastigmine (Excelon) as a Potential Medication for Methamphetamine Abuse|Completed||Phase 1|18|Actual|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:23:35.440764|2017-02-18 17:23:35.440764
NCT00158197|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-08-11|2013-05-30||December 2004||2004-12-01|August 2015|2015-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long-term Behavior Change - 1|Behavior Change: Reinforcement Schedule Effects|Completed||N/A|119|Actual|Friends Research Institute, Inc.||4|||f||||t||||||||||2017-02-18 17:23:35.53811|2017-02-18 17:23:35.53811
NCT00158184|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-01-24|||June 2004||2004-06-01|December 2011|2011-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Prescription Opioid Effects in Abusers Versus Non-Abusers|Prescription Opioid Effects in Drug and Non-drug Abusers - 1|Completed||Phase 2|96|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 17:23:36.293993|2017-02-18 17:23:36.293993
NCT00158171|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-09|||April 2002||2002-04-01|October 2016|2016-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1|Interventions for Tobacco Dependent Adolescents|Completed||Phase 2|128|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 17:23:36.402754|2017-02-18 17:23:36.402754
NCT00158158|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-09|||September 2005||2005-09-01|October 2016|2016-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2|Interventions for Tobacco Dependent Adolescents|Completed||Phase 2/Phase 3|200|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 17:23:36.525841|2017-02-18 17:23:36.525841
NCT00158145|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-09|||September 2005||2005-09-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2|Longitudinal Study of Prostate, Lung, Colon, and Ovarian Cancer (PLCO) Screen Trial|Completed||Phase 2|72|Actual|National Institute on Drug Abuse (NIDA)|||1||f||||||||||Samples Without DNA|"~     Urine and blood samples.~   "|||2017-02-18 17:23:36.648747|2017-02-18 17:23:36.648747
NCT00158132|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-11|||September 1999||1999-09-01|October 2016|2016-10-01|February 2006|Actual|2006-02-01|March 2005|Actual|2005-03-01||Interventional|||Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2|A Double-Blind, Placebo Controlled Trial of Propranolol and Amantadine for the Treatment of Cocaine Dependent Subjects With Severe Cocaine Withdrawal Symptoms|Completed||Phase 2|199|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||f||||||||||2017-02-18 17:23:36.730084|2017-02-18 17:23:36.730084
NCT00158119|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-07-23|||July 2001||2001-07-01|July 2010|2010-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Comparison of Weighted Vest Exercise and Strength Training|Ameliorating Disability Through Power Training|Completed||Phase 3|160||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:23:36.855188|2017-02-18 17:23:36.855188
NCT00158106|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||February 2005||2005-02-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Assessing the Effectiveness of Communication Therapy in the North West (The ACT NoW Pilot Study)|Assessing the Effectiveness of Communication Therapy in the North West (The ACT NoW Pilot Study)|Completed||N/A|60||NHS Health Technology Assessment Programme|||||f||||||||||||||2017-02-18 17:23:36.952555|2017-02-18 17:23:36.952555
NCT00157742|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-15|||September 2000||2000-09-01|September 2005|2005-09-01|January 2007||2007-01-01|||||Interventional|||Comparison of SCS and PMR in Patients With Refractory Angina Pectoris|An Open Single-Centre Parallel Randomised Trial of Spinal Cord Stimulation (SCS) and Percutaneous Myocardial Revascularisation (PMR) in Patients With Refractory Angina Pectoris|Terminated||Phase 4|66||Medtronic|||||f||||||||||||||2017-02-18 17:23:42.097671|2017-02-18 17:23:42.097671
NCT00158093|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||June 2003||2003-06-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Interventional|||A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo|A Randomized, Parallel Group Safety Evaluation of Electrocardiographic Intervals and Blood Pressure in Normal Healthy Volunteers After Nebivolol, Atenolol, Moxifloxacin, or Placebo Administration After Single and Repeated Doses|Completed||Phase 1|260||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:23:37.041684|2017-02-18 17:23:37.041684
NCT00158080|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07||||||September 2005|2005-09-01||||||||Interventional|||Hemofiltration for Contrast-Induced Nephropathy|Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration|Unknown status|Recruiting|N/A|100||Nara Medical University|||||f||||||||||||||2017-02-18 17:23:37.131088|2017-02-18 17:23:37.131088
NCT00158067|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-08-24|||March 2002||2002-03-01|August 2010|2010-08-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|||Study of an External Responsive Neurostimulator System on Epileptiform Activity|Automated Response to Spontaneous Epileptiform Activity Using the External Responsive Neurostimulator (eRNS) System Clinical Investigation|Completed||Phase 2|150|Anticipated|NeuroPace|||||||||||||||||||2017-02-18 17:23:37.222429|2017-02-18 17:23:37.222429
NCT00158054|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-02-04|2015-03-04||January 2005||2005-01-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|February 2008|Actual|2008-02-01||Interventional|||COPES Phase I Randomized Controlled Trial of Treatment For Distress in Heart Disease Patients|Consortium for Translation of Psychosocial Depression Theories to Interventions and Dissemination - Project 2: Phase I Randomized Controlled Trial of Patient Preference, Stepped-Care Treatment For Distress in Heart Disease Patients|Completed||N/A|157|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 17:23:37.325484|2017-02-18 17:23:37.325484
NCT00158041|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||January 2002||2002-01-01|September 2005|2005-09-01|January 2005||2005-01-01|||||Interventional|||Subcutaneous Amifostine Safety Study|Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities|Completed||Phase 4|452||Mt. Sinai Medical Center, Miami|||||f||||||||||||||2017-02-18 17:23:38.105569|2017-02-18 17:23:38.105569
NCT00158028|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-08-02|||November 1995||1995-11-01|August 2016|2016-08-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder|Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder|Completed||N/A|25|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||f||||||||||2017-02-18 17:23:38.19627|2017-02-18 17:23:38.19627
NCT00158015|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-10-03|||October 2004||2004-10-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy|Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy|Completed||N/A|70|Actual|Minneapolis Medical Research Foundation|||1||f||||f||||||||||2017-02-18 17:23:38.306382|2017-02-18 17:23:38.306382
NCT00158002|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-04-04|||February 2004||2004-02-01|April 2007|2007-04-01|August 2006||2006-08-01|||||Interventional|||A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine|An Open-Label Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine|Completed||Phase 2|40||Monarch Medical Research|||||f||||||||||||||2017-02-18 17:23:38.399166|2017-02-18 17:23:38.399166
NCT00157989|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-08|||October 2004||2004-10-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Pilot Study to Assess Safety and Feasibility of Resuscitation of Preterm Infants With Controlled Volume of Air/Oxygen|Safety and Feasibility of Controlled Tidal Volume Resuscitation of Preterm Infants ≤ 28 Weeks’ Gestation: A Randomized Controlled Pilot Study|Terminated||Phase 3|40||Mount Sinai Hospital, Canada|||||f||||||||||||||2017-02-18 17:23:38.500006|2017-02-18 17:23:38.500006
NCT00157976|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-29|||September 2005||2005-09-01|November 2005|2005-11-01||||||||Interventional|||Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration|A Phase III Randomized, Multicenter, Multinational, Double-Masked, Placebo-Controlled Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Classic and Occult Subfoveal Choroidal Neovascularization Associated With AMD|Unknown status|Recruiting|Phase 3|660||Miravant Pharmaceuticals|||||||||||||||||||2017-02-18 17:23:38.586183|2017-02-18 17:23:38.586183
NCT00157963|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-04-01|||February 2005||2005-02-01|April 2015|2015-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)|A 12 Week, Open, Randomized, Parallel, Multicenter Study of Efficacy, Tolerability & Safety of Hydrochlorothiazide (+) Losartan Potassium Versus Amlodipine in Essential Hypertensive Patients.|Completed||Phase 4|174|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:23:38.670855|2017-02-18 17:23:38.670855
NCT00157950|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-01-07|2010-08-17||October 2005||2005-10-01|January 2016|2016-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)|An Immunogenicity and Safety Study of Gardasil (V501 (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine)) in Females 9 to 23 Years of Age in Korea|Completed||Phase 3|176|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:23:38.7551|2017-02-18 17:23:38.7551
NCT00157937|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-10-07|||February 2003||2003-02-01|October 2015|2015-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)|A Randomized, Open Label, Cross-Over Study Comparing Effectiveness for the Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics|Completed||Phase 4|31|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:23:39.169515|2017-02-18 17:23:39.169515
NCT00157924|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-05-13|||November 2005||2005-11-01|May 2016|2016-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)|A Multicenter, Randomized, Open-label Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe (+) Simvastatin Versus Atorvastatin in Hypercholesterolemic Patients With Diabetes Mellitus or Metabolic Syndrome|Completed||Phase 4|190|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:23:39.249186|2017-02-18 17:23:39.249186
NCT00157729|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-30|||August 2004||2004-08-01|October 2006|2006-10-01|July 2005||2005-07-01|||||Interventional|||MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)|Evaluation of the Effects of MC-1 Alone and in Combination With an ACE Inhibitor on Ambulatory Blood Pressure and Metabolic Function in Hypertensive Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|160||Medicure|||||f||||||||||||||2017-02-18 17:23:42.188955|2017-02-18 17:23:42.188955
NCT00157911|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-11-02|||December 2002||2002-12-01|November 2015|2015-11-01|December 2003|Actual|2003-12-01|October 2003|Actual|2003-10-01||Interventional|||A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)|A Double-Blind, Randomized, Multicenter, Active-Comparative, 12-Week Study to Assess the Efficacy and Safety of the Drug in Conjunction With Another Drug in Korean Patients With Primary Hypercholesterolemia|Completed||Phase 3|136|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:23:39.350995|2017-02-18 17:23:39.350995
NCT00157898|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-01-28|||January 2004||2004-01-01|January 2015|2015-01-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)|A Prospective, Multicenter, Open, Randomized, Comparative Study to Evaluate the Safety and Efficacy of Ertapenem Versus it's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults|Completed||Phase 4|134|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:23:39.435354|2017-02-18 17:23:39.435354
NCT00157885|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-06-23|||July 2005||2005-07-01|June 2006|2006-06-01|December 2005||2005-12-01|||||Interventional|||A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.|A Randomized Trial to Compare the Efficacy of Artekin and Amodiaquine Plus Artesunate for the Treatment of Acute Falciparum and Vivax Malaria in Timika, Papua|Completed||N/A|400||Menzies School of Health Research|||||f||||||||||||||2017-02-18 17:23:39.52076|2017-02-18 17:23:39.52076
NCT00157872|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-06-17|||January 2004||2004-01-01|June 2015|2015-06-01|September 2004|Actual|2004-09-01|July 2004|Actual|2004-07-01||Interventional|||A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)|A Multicenter, Randomized, Parallel-Group, 8-Week, Double-Blind, and Active Comparator-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Rofecoxib Tablet 25 mg Once Daily Versus Naproxen Table 500 mg Twice Daily in the Treatment of Chinese Patient With Rheumatoid Arthritis|Completed||Phase 4|150||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:23:39.610821|2017-02-18 17:23:39.610821
NCT00157859|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||April 2004||2004-04-01|September 2005|2005-09-01|September 2004||2004-09-01|||||Interventional|||To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, Indonesia|To Evaluate the Efficacy of Chloroquine and SP for Acute Uncomplicated P. Falciparum and the Efficacy of Chloroquine for Acute Uncomplicated P. Vivax in the Timika Region of Papua, Indonesia.|Completed||N/A|150||Menzies School of Health Research|||||f||||||||||||||2017-02-18 17:23:39.69036|2017-02-18 17:23:39.69036
NCT00157846|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-02-14|||October 2003||2003-10-01|February 2017|2017-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||X-Change HF - Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure|Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure to Investigate the Effect of Preventive Stimulation|Terminated||Phase 4|36|Actual|Medtronic Bakken Research Center||2||Due to existing evidence eligible patients receive CRT treatment in first place|f||||f||||||||No||2017-02-18 17:23:40.018871|2017-02-18 17:23:40.018871
NCT00157833|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-06-23|||July 2004||2004-07-01|June 2006|2006-06-01|August 2005||2005-08-01|||||Interventional|||A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.|A Randomized Trial to Determine the Efficacy and Safety of Coartemether and Artekin for the Treatment of Acute Falciparum and Vivax Malaria in Timika, Papua|Completed||N/A|750||Menzies School of Health Research|||||f||||||||||||||2017-02-18 17:23:40.128015|2017-02-18 17:23:40.128015
NCT00157820|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-07-17|2011-03-10||November 2000||2000-11-01|July 2012|2012-07-01|October 2005|Actual|2005-10-01|May 2005|Actual|2005-05-01||Interventional|DATAS||DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study|DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study|Completed||Phase 4|354|Actual|Medtronic Bakken Research Center|"The follow-up might have been too short to reveal differences in heart failure-related hospitalizations and related mortality.~Premature crossovers are a limitation of RCT. However, our scoring system severely penalized this cross-overs."|3|||f||||t||||||||||2017-02-18 17:23:40.2392|2017-02-18 17:23:40.2392
NCT00157807|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-02-14|||September 2005||2005-09-01|February 2017|2017-02-01|August 2013|Actual|2013-08-01|June 2008|Actual|2008-06-01||Interventional|||Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac Surgery|Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac Surgery. A Prospective Randomized Multi Center Trial|Terminated||N/A|24|Actual|Medtronic Bakken Research Center||2||no eligible patients can be found|f||||||||||||||2017-02-18 17:23:40.984435|2017-02-18 17:23:40.984435
NCT00157794|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-02-14|||February 2004||2004-02-01|February 2017|2017-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||EnTRINSIC - EnPulse Trial on Search AV+ Influence|EnPulse Trial on Search AV+ Influence|Terminated||Phase 4|135|Actual|Medtronic Bakken Research Center||2||"Protocol pre-specified interim analysis showed that difference between groups was too small to~   reach significance."|f||||f||||||||||2017-02-18 17:23:41.100858|2017-02-18 17:23:41.100858
NCT00157781|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-13|||August 2000||2000-08-01|September 2005|2005-09-01|November 2003||2003-11-01|||||Interventional|||LEAF - Low Energy In Atrial Fibrillation|Low Energy in Atrial Fibrillation AF Phase IV Study in AT/AF Population Atrial Arrhythmias Prevention and Reduction With Low Energy Atrial Antitachycardia Pacemaker|Terminated||Phase 4|237||Medtronic Bakken Research Center|||||f||||||||||||||2017-02-18 17:23:41.220072|2017-02-18 17:23:41.220072
NCT00157768|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-08-04|||June 1999||1999-06-01|August 2008|2008-08-01|April 2008|Anticipated|2008-04-01|||||Interventional|||IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction|IRIS - Immediate Risk-Stratification Improves Survival - Joint Study of the German University Hospitals and German Society of Leading Cardiological Hospital Physicians (ALKK)|Unknown status|Active, not recruiting|Phase 4|900|Anticipated|Medtronic Bakken Research Center|||||f||||||||||||||2017-02-18 17:23:41.316597|2017-02-18 17:23:41.316597
NCT00157755|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-02-23|2009-12-18||June 2002||2002-06-01|December 2009|2009-12-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis)|Gastric Stimulation for Vomiting, Nausea and Related Symptoms Associated With Gastroparesis Using Enterra® Gastric Stimulation System|Terminated||N/A|87|Actual|MedtronicNeuro|Early termination of the study impacted the ability to analyze the primary endpoint and secondary endpoint 1 for the idiopathic arm of the study. The minimum sample size for analysis of these endpoints was 32 subjects.|1|||f||||||||||||||2017-02-18 17:23:41.408487|2017-02-18 17:23:41.408487
NCT00157716|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-30|||April 2004||2004-04-01|October 2006|2006-10-01|October 2005||2005-10-01|||||Interventional|||MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multi-Center Study to Evaluate the Cardiovascular and Cerebrovascular Effects of MC-1 in Patients Undergoing High-Risk Coronary Artery Bypass Graft (CABG) Surgery|Completed||Phase 2|900||Medicure|||||f||||||||||||||2017-02-18 17:23:42.288998|2017-02-18 17:23:42.288998
NCT00157703|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-12-12|||May 2005||2005-05-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||G207 Followed by Radiation Therapy in Malignant Glioma|A Staged Phase 1 Study of the Treatment of Malignant Glioma With G207, a Genetically Engineered HSV-1, Followed by Radiation Therapy|Completed||Phase 1|9|Actual|MediGene||1|||f||||t||||||||||2017-02-18 17:23:42.614881|2017-02-18 17:23:42.614881
NCT00157690|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-10-22|||December 2003||2003-12-01|October 2008|2008-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients|A Multicentre, Double-Blind, Randomized Placebo-Controlled Study of 70mg Alendronate Once Weekly for the Prevention and Treatment of Osteoporosis in Canadian Adult Cystic Fibrosis Patients|Completed||Phase 4|56|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 17:23:42.710525|2017-02-18 17:23:42.710525
NCT00157677|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-10-25|||October 2004||2004-10-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|SELECT||Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)|Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis: A Randomized Trial|Completed||Phase 3|1727|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 17:23:42.834624|2017-02-18 17:23:42.834624
NCT00157664|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-06-16|||July 2004||2004-07-01|June 2008|2008-06-01|December 2008|Anticipated|2008-12-01|May 2008|Anticipated|2008-05-01||Observational|||Long Study - Longitudinal Thrombosis in End Stage Renal Disease|Canadian Longitudinal Thrombosis in End Stage Renal Disease Pilot Study|Unknown status|Active, not recruiting|N/A|400|Anticipated|McMaster University|||1||f||||t||||||Samples Without DNA|"~     serum and plasma~   "|||2017-02-18 17:23:42.94162|2017-02-18 17:23:42.94162
NCT00157651|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-06-16|||February 1999||1999-02-01|June 2008|2008-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters|A Double-Blind, Placebo Controlled, Randomized Trial of Low-Intensity Adjusted-Dose Warfarin for the Prevention of Mechanical Malfunction of Double-Lumen Haemodialysis Catheters|Completed||Phase 3|170|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 17:23:43.023974|2017-02-18 17:23:43.023974
NCT00157638|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-08|||February 2004||2004-02-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics|Optimizing Drug Therapy in Primary Care: Integrating Pharmacists With Ontario Family Physician Group Practices.|Completed||Phase 4|1400||McMaster University|||||f||||||||||||||2017-02-18 17:23:43.140122|2017-02-18 17:23:43.140122
NCT00157625|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-09-11|||April 2003||2003-04-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Automatic Stop Orders for Urinary Catheters|A Randomized Controlled Trial of Automatic Stop Orders for Urinary Catheterization in Hospitalized Patients|Completed||N/A|630||McMaster University|||||f||||||||||||||2017-02-18 17:23:43.243381|2017-02-18 17:23:43.243381
NCT00157612|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-07-19|||January 2001||2001-01-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||A Clinical Pathway for Nursing Home Acquired Pneumonia|A Randomized Control Trial of a Clinical Pathway for Nursing Home Pneumonia.|Completed||N/A|680||McMaster University|||||f||||||||||||||2017-02-18 17:23:43.331415|2017-02-18 17:23:43.331415
NCT00157599|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-07-25|||January 2002||2002-01-01|October 2007|2007-10-01|March 2007||2007-03-01|||||Interventional|||MDA D-Dimer / Recurrent DVT Study|A Cohort Study Evaluating the Safety of a Diagnostic Strategy Involving D-Dimer and Compression Ultrasonography in Patients With Suspected Recurrent Deep Vein Thrombosis|Completed||N/A|500||McMaster University|||||f||||||||||||||2017-02-18 17:23:43.424084|2017-02-18 17:23:43.424084
NCT00157586|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-08|||February 2002||2002-02-01|March 2006|2006-03-01|June 2008||2008-06-01|||||Interventional|||Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)|A Multicenter, Randomized, Prospective, Double-blind Study to Evaluate the Nephroprotective Effect of Delapril Alone or Combined With Manidipine in Patients With Type 2 Diabetes|Completed||Phase 3|342||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-02-18 17:23:43.586583|2017-02-18 17:23:43.586583
NCT00157573|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-04-27|||December 2004||2004-12-01|April 2012|2012-04-01|April 2010|Actual|2010-04-01|October 2008|Actual|2008-10-01||Interventional|||GM-CSF in Women With Recurrent Ovary Cancer|Phase II Trial of GM-CSF in Women With Asymptomatic Ovarian, Primary Peritoneal, or Tubal Carcinoma|Completed||Phase 2|70|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 17:23:43.677389|2017-02-18 17:23:43.677389
NCT00157560|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-12-28|||December 2000||2000-12-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|November 2006|Actual|2006-11-01||Interventional|||Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma|A Phase II Trial of ModifiedTriple Doublet Therapy in the Treatment of Women With Newly Diagnosed Carcinoma of Müllerian Origin|Completed||Phase 2|83||Massachusetts General Hospital|||||f||||f||||||||||2017-02-18 17:23:43.768135|2017-02-18 17:23:43.768135
NCT00157547|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-23|||April 2003||2003-04-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression|The Use of Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Major Depressive Disorder|Completed||Phase 4|95|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:23:43.871303|2017-02-18 17:23:43.871303
NCT00157534|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||October 2004||2004-10-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection|A Phase II, Randomised, Dose-Ranging, Open-Label, Multi-Centre Study to Evaluate the Safety and Efficacy of Celgosivir for 12 Weeks in Patients With Chronic Hepatitis C Infection|Completed||Phase 2|43||BioWest Therapeutics Inc|||||f||||||||||||||2017-02-18 17:23:43.964261|2017-02-18 17:23:43.964261
NCT00157521|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-12-21|||September 2002||2002-09-01|December 2006|2006-12-01|May 2006||2006-05-01|||||Interventional|||L-Arginine in Pre-Eclampsia|A Double-Blind, Randomized, Pilot Study to Explore Whether Enhancing L-Arginine Bioavailability by Oral Supplementation Increases NO Production and Prevents Peroxynitrite Generation in the Pre-Eclamptic Placenta|Completed||Phase 3|30||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-02-18 17:23:44.036299|2017-02-18 17:23:44.036299
NCT00157508|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-08|||March 2003||2003-03-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy|A Pilot, Randomised, Double-blind, Cross-over Study to Assess the Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy|Terminated||Phase 2|13||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-02-18 17:23:44.115855|2017-02-18 17:23:44.115855
NCT00157482|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-02-12|||January 2005||2005-01-01|December 2006|2006-12-01|December 2006||2006-12-01|||||Interventional|||Ezetimibe and Simvastatin in Dyslipidemia of Diabetes|A Randomized, Prospective, Double-Blind Study to Evaluate the Effects on Lipid Profile of Combined Ezetimibe and Simvastatin Therapy as Compared to Simvastatin Alone in People With Type 2 Diabetes|Completed||Phase 2|108||Mario Negri Institute for Pharmacological Research|||||f||||||||||||||2017-02-18 17:23:44.202557|2017-02-18 17:23:44.202557
NCT00157378|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||November 2000||2000-11-01|January 2000|2000-01-01|December 2004||2004-12-01|||||Interventional|||Optimization of Acute Treatment in First Episode Schizophrenia|Optimization of Acute Treatment in First Episode Schizophrenic Patients by New Pharmacological Treatments|Unknown status|Active, not recruiting|Phase 4|300||Ludwig-Maximilians - University of Munich|||||f||||||||||||||2017-02-18 17:23:44.291891|2017-02-18 17:23:44.291891
NCT00157339|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-11-21|||August 2005||2005-08-01|November 2016|2016-11-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD|A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma|Completed||Phase 3|299|Actual|Eli Lilly and Company||2|||f||||f||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 17:23:44.396404|2017-02-18 17:23:44.396404
NCT00157326|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-10-23|||September 2005||2005-09-01|October 2007|2007-10-01|June 2006|Actual|2006-06-01|||||Interventional|||Tadalafil in Subjects With Mild to Moderate Hypertension|A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Tadalafil (5mg and 20mg) Administered Once Daily to Subjects With Mild to Moderate Hypertension|Completed||Phase 2|180|Actual|Eli Lilly and Company|||||||||||||||||||2017-02-18 17:23:47.475989|2017-02-18 17:23:47.475989
NCT00157313|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-01-27|||January 1998||1998-01-01|September 2005|2005-09-01|December 2022|Anticipated|2022-12-01|||||Interventional|||Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis|Randomised Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis|Active, not recruiting||N/A|600||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 17:23:47.571052|2017-02-18 17:23:47.571052
NCT00157300|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-07-30|||July 2005||2005-07-01|July 2010|2010-07-01|July 2010|Actual|2010-07-01|March 2010|Actual|2010-03-01||Interventional|||PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation|PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation|Completed||Phase 4|92|Actual|Leiden University Medical Center||1|||f||||t||||||||||2017-02-18 17:23:47.668975|2017-02-18 17:23:47.668975
NCT00157287|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-04-24|||June 2003||2003-06-01|April 2006|2006-04-01|July 2005||2005-07-01|||||Interventional|||A Cluster Randomized Trial to Improve Weaning and Extubation From Mechanical Ventilation in Community Hospitals||Completed||Phase 3|||Lawson Health Research Institute|||||f||||||||||||||2017-02-18 17:23:48.026312|2017-02-18 17:23:48.026312
NCT00157274|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-04-02|||July 2005||2005-07-01|September 2005|2005-09-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome|Phase II Study of Alemtuzumab in Patients With Advanced Mycosis Fungoides/Sezary Syndrome|Unknown status|Recruiting|Phase 2|20||Latin American Cooperative Onco-Haematology Group - Peru|||||f||||||||||||||2017-02-18 17:23:48.116765|2017-02-18 17:23:48.116765
NCT00157261|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-10-28|||January 2004||2004-01-01|October 2013|2013-10-01|June 2006||2006-06-01|June 2006||2006-06-01||Interventional|||Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial|A Prospective, Randomised, Double-blind, Placebo-controlled, International, Multicentre, Parallel-group Comparison Trial Evaluating the Efficacy and Safety of Tenecteplase During Cardiopulmonary Resuscitation as Compared With Standard Treatment in Patients Suffering From Out-of-hospital Cardiac Arrest of Presumed Cardiac Origin Thrombolysis in Cardiac Arrest (TROICA) Trial|Terminated||Phase 3|1050||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:23:48.222512|2017-02-18 17:23:48.222512
NCT00157248|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-05-08|2010-11-18||December 2003||2003-12-01|February 2014|2014-02-01||||January 2009|Actual|2009-01-01||Interventional||All patients in follow-up study.|Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048|Long-term, Open-label Follow-up Treatment of Patients With Atrial Fibrillation Who Have Been Previously Treated With BIBR 1048 in the PETRO Trial (Trial 1160.20 - NCT01227629). (PETRO Extension Trial: PETRO-Ex)|Terminated||Phase 2|361|Actual|Boehringer Ingelheim||4|||f||||||||||||||2017-02-18 17:23:48.432115|2017-02-18 17:23:48.432115
NCT00157235|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-10-31|||September 2002||2002-09-01|October 2013|2013-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients|A Randomized, Double Blind , Placebo Controlled Trial to Compare the Effect of Tiotropium Inhalation Capsules on Exercise Tolerance in Patients With COPD Participating in 8 Weeks of Pulmonary Rehabilitation|Completed||Phase 3|234||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:23:52.096509|2017-02-18 17:23:52.096509
NCT00157222|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-12-07|||May 2005||2005-05-01|September 2005|2005-09-01|April 2008||2008-04-01|||||Observational|||Characterizing and Diagnosis’s of the Charcot Foot (Charcot Osteoarthropathy) in Diabetic Patients|Characterizing and Diagnosis’s of the Charcot Foot (Charcot Osteoarthropathy) in Diabetic Patients|Unknown status|Recruiting|N/A|50||Bispebjerg Hospital|||||f||||||||||||||2017-02-18 17:23:52.209671|2017-02-18 17:23:52.209671
NCT00157209|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-10-19|2015-07-23||August 2000||2000-08-01|October 2015|2015-10-01|July 2012|Actual|2012-07-01|March 2006|Actual|2006-03-01||Interventional||Baseline analysis population included all randomized participants.|Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)|A Multicenter Phase IIb Randomised, Controlled Study of BLP25 Liposome Vaccine for Active Specific Immunotherapy of Non-Small Cell Lung Cancer|Completed||Phase 2|171|Actual|Merck KGaA||2|||f||||||||||||||2017-02-18 17:23:52.299117|2017-02-18 17:23:52.299117
NCT00157196|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-07-23|2015-07-23||April 2005||2005-04-01|July 2015|2015-07-01|April 2012|Actual|2012-04-01|September 2007|Actual|2007-09-01||Interventional||The intention-to-treat (ITT) analysis set included all the enrolled participants who received at least 1 dose of trial treatment.|Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease|A Multi-center, Non-randomized, Open Label Safety Study of BLP25 Liposome Vaccine (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Patients With Unresectable Stage III Disease|Completed||Phase 2|22|Actual|Merck KGaA||1|||f||||||||||||||2017-02-18 17:23:52.898004|2017-02-18 17:23:52.898004
NCT00157183|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-12-04|||March 2003||2003-03-01|September 2005|2005-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation|Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation|Completed||Phase 1/Phase 2|59|Actual|Bayside Health|||||f||||||||||||||2017-02-18 17:23:53.396741|2017-02-18 17:23:53.396741
NCT00157170|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-10-19|||September 2002||2002-09-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||The Effects of a Supervised Exercise Program on Self Efficacy of People Living With HIV/AIDS.|The Effects of a Supervised Exercise Program on Self Efficacy, Quality of Life Status, Cardiovascular Fitness and Hospital Readmission Rates of People Living With HIV/AIDS.|Completed||N/A|40||Bayside Health|||||f||||||||||||||2017-02-18 17:23:53.496206|2017-02-18 17:23:53.496206
NCT00157157|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-06-26|2011-02-15||April 2004||2004-04-01|June 2014|2014-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients|Recombinant Antihemophilic Factor Manufactured and Formulated Without Added Human or Animal Proteins (rAHF-PFM): Evaluation of Immunogenicity, Efficacy, and Safety in Previously Untreated Patients With Hemophilia A|Completed||Phase 3|66|Actual|Baxalta US Inc.||1|||f||||t||||||||||2017-02-18 17:23:53.594177|2017-02-18 17:23:53.594177
NCT00157144|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-03-06|||October 2004||2004-10-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005||Completed||N/A|||Bayside Health|||||f||||||||||||||2017-02-18 17:23:54.123964|2017-02-18 17:23:54.123964
NCT00157131|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-02-06|||June 2004||2004-06-01|February 2008|2008-02-01|September 2007|Actual|2007-09-01|February 2007|Actual|2007-02-01||Interventional|||Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients|A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing|Completed||Phase 3|||Baxter Healthcare Corporation|||||||||||||||||||2017-02-18 17:23:54.203054|2017-02-18 17:23:54.203054
NCT00157118|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||August 2003||2003-08-01|July 2013|2013-07-01|March 2005|Actual|2005-03-01|||||Interventional|||Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency|A Phase II/III Clinical Study for the Determination of the Efficacy and Safety of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency|Completed||Phase 2/Phase 3|18|Actual|Baxalta US Inc.|||||||||||||||||||2017-02-18 17:23:54.457071|2017-02-18 17:23:54.457071
NCT00157105|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||February 2001||2001-02-01|October 2006|2006-10-01|August 2004||2004-08-01|||||Interventional|||Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery|Recombinant Antihemophilic Factor (rAHF PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Safety and Efficacy in Hemophilia A Patients Undergoing Surgical or Invasive Procedures|Completed||N/A|||Baxalta US Inc.|||||||||||||||||||2017-02-18 17:23:54.567115|2017-02-18 17:23:54.567115
NCT00157092|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||March 2004||2004-03-01|October 2006|2006-10-01|October 2004||2004-10-01|||||Interventional|||Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency|A Phase 1B/2A Study to Evaluate the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency|Completed||Phase 1/Phase 2|15||Baxalta US Inc.|||||||||||||||||||2017-02-18 17:23:54.657877|2017-02-18 17:23:54.657877
NCT00157079|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||June 2002||2002-06-01|October 2006|2006-10-01|December 2003||2003-12-01|||||Interventional|||Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders|A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders|Completed||Phase 3|||Baxalta US Inc.|||||||||||||||||||2017-02-18 17:23:54.74839|2017-02-18 17:23:54.74839
NCT00157066|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-01-05|||December 2002||2002-12-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||Effects of Vitamin D Supplementation on Antimycobacterial Immunity|Effects of Vitamin D Supplementation on Antimycobacterial Immunity: A Randomised Trial|Completed||N/A|230||Barts & The London NHS Trust|||||f||||||||||||||2017-02-18 17:23:54.844053|2017-02-18 17:23:54.844053
NCT00157053|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||November 2001||2001-11-01|February 2011|2011-02-01|August 2004|Actual|2004-08-01|||||Interventional|||Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901|Evaluation of Pharmacokinetics, Safety, Efficacy and Immunogenicity of rAHF-PFM in Previously Treated Hemophilia A Patients - A Continuation Study|Completed||Phase 2/Phase 3|||Baxalta US Inc.|||||||||||||||||||2017-02-18 17:23:54.935903|2017-02-18 17:23:54.935903
NCT00157040|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-26|||June 2002||2002-06-01|September 2011|2011-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A|Recombinant Antihemophilic Factor (rAHF-PFM) Manufactured and Formulated Without Added Human or Animal Proteins: Evaluation of Pharmacokinetics, Immunogenicity, Efficacy and Safety in Previously Treated Pediatric Patients With Hemophilia A|Completed||Phase 2/Phase 3|50||Baxalta US Inc.|||||f||||||||||||||2017-02-18 17:23:55.038678|2017-02-18 17:23:55.038678
NCT00157027|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-01-15|||December 2003||2003-12-01|January 2014|2014-01-01|April 2010|Anticipated|2010-04-01|||||Interventional|HIV-HAART||RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)|The Use of Extracorporeal Photochemotherapy With UVADEX in Patients With HIV Who Are Refractory or Intolerant to HAART|Withdrawn||Phase 1|0|Actual|Atlantic Health System||1|||f||||t||||||||||2017-02-18 17:23:55.334305|2017-02-18 17:23:55.334305
NCT00005400|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-19|||August 1995||1995-08-01|January 2016|2016-01-01|July 2003||2003-07-01|||||Observational|||Angiotensinogen Variants and Adverse Pregnancy Outcomes||Completed||N/A|||University of Utah|||||f||||||||||||||2017-02-18 18:15:02.503333|2017-02-18 18:15:02.503333
NCT00157014|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-01-24|2010-10-28||July 2004||2004-07-01|January 2011|2011-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens|Clinical and Laboratory Evaluation of Acute Rejection, Myocyte Growth, Repair, and Oxidative Stress Following de Novo Cardiac Transplant: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens With MPA TDM|Completed||Phase 3|111|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|4|||f||||t||||||||||2017-02-18 17:23:55.455281|2017-02-18 17:23:55.455281
NCT00157001|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-01-15|||August 2000||2000-08-01|January 2014|2014-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Feasibility Study of Photopheresis Post Angioplasty|Feasibility Study of Photopheresis Post Angioplasty|Terminated||Phase 2|120||Atlantic Health System|||||f||||t||||||||||2017-02-18 17:23:57.877532|2017-02-18 17:23:57.877532
NCT00156988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-08-07|||March 2004||2004-03-01|August 2009|2009-08-01|December 2005||2005-12-01|||||Interventional|||The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns|The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns|Completed||Phase 4|||Association of Dutch Burn Centres|||||f||||||||||||||2017-02-18 17:23:57.963959|2017-02-18 17:23:57.963959
NCT00156975|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-12-24|||November 2004||2004-11-01|April 2007|2007-04-01||||||||Interventional|||Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases|Adjuvant Chemotherapy With Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases- Randomized Phase III Study|Unknown status|Active, not recruiting|Phase 3|384||Arbeitsgruppe Lebermetastasen und Tumoren|||||f||||||||||||||2017-02-18 17:23:58.064|2017-02-18 17:23:58.064
NCT00156962|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-07-17|||April 2005||2005-04-01|July 2008|2008-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)|A Randomized, Open-Label Study to Assess the Safety of Epoetin Alfa Manufactured by Deep Tank Technology and Epoetin Alfa Manufactured by Roller Bottle Technology in Subjects With Chronic Kidney Disease Not on Dialysis|Terminated||Phase 3|850|Anticipated|Amgen||2||Regulatory decision not to proceed|f||||||||||||||2017-02-18 17:23:58.159127|2017-02-18 17:23:58.159127
NCT00156949|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-02-18|||April 2005||2005-04-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||EPO Deep Tank in Dialysis Subjects|An Open-Label, Single-Arm Study to Assess the Safety of Epoetin Alfa Manufactured by a Deep Tank Technology in Subjects With Chronic Kidney Disease Receiving Dialysis|Completed||Phase 3|580|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:23:58.264683|2017-02-18 17:23:58.264683
NCT00156936|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-11-05|2010-10-08||August 2004||2004-08-01|November 2010|2010-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])|An Open-Label, Multi-Center Study to Evaluate the Long-Term Safety of Medisorb® Naltrexone|Terminated||Phase 3|108|Actual|Alkermes, Inc.||2||Business decision|f||||f||||||||||2017-02-18 17:23:58.369946|2017-02-18 17:23:58.369946
NCT00156923|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-12-07|2010-10-08||October 2003||2003-10-01|December 2010|2010-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults|A Multi-Center Extension of Alkermes' Study ALK21-003-EXT (NCT01218971) to Evaluate the Long-Term Safety of Medisorb® Naltrexone|Completed||Phase 3|108|Actual|Alkermes, Inc.||2|||f||||f||||||||||2017-02-18 17:23:59.052195|2017-02-18 17:23:59.052195
NCT00156910|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-10-24|2010-11-05||February 2006||2006-02-01|October 2013|2013-10-01|July 2008|Actual|2008-07-01|November 2007|Actual|2007-11-01||Interventional|||A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches||Completed||Phase 3|679|Actual|Allergan||2|||f||||||||||||||2017-02-18 17:23:59.527452|2017-02-18 17:23:59.527452
NCT00156897|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-08-25|||December 2004||2004-12-01|August 2006|2006-08-01|October 2005||2005-10-01|||||Interventional|||Efficacy and Safety of ATL-962 in Obese Diabetics|Multicentre Double Blind Placebo Controlled Parallel Group Dose Ranging Study of ATL-962 to Assess Weight Loss, Safety and Tolerability in Obese Patients With Type II Diabetes Being Treated With Metformin, in Comparison With Orlistat|Completed||Phase 2|600||Alizyme|||||f||||||||||||||2017-02-18 17:24:00.083931|2017-02-18 17:24:00.083931
NCT00156884|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-01-18|||August 2003||2003-08-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer|A Randomized Phase II Trial of Strontium-89 With or Without Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer|Completed||Phase 2|58|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:24:00.229032|2017-02-18 17:24:00.229032
NCT00156871|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-01-18|||April 2003||2003-04-01|August 2011|2011-08-01|December 2005|Actual|2005-12-01|||||Interventional|||Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant (HSCT)|Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant|Completed||N/A|24|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:24:00.339039|2017-02-18 17:24:00.339039
NCT00156858|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-01-18|||January 1998||1998-01-01|September 2011|2011-09-01|December 2010||2010-12-01|||||Interventional|||Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study|Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell|Unknown status|Recruiting|N/A|200|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:24:00.431129|2017-02-18 17:24:00.431129
NCT00156845|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-07-13|||December 2003||2003-12-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography|A Phase 3, International, Multicenter, Open-Label, Dual-Injection, Echocardiographic Imaging and Safety Study in Patients With Suspected Ischemic Heart Disease Undergoing Diagnostic Coronary Angiography (Real-Time Assessment of Myocardial Perfusion With Echocardiography: RAMP 2)|Completed||Phase 3|450||Acusphere|||||||||||||||||||2017-02-18 17:24:00.529657|2017-02-18 17:24:00.529657
NCT00156819|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-11-04|2015-11-04||June 2003||2003-06-01|November 2015|2015-11-01|August 2006|Actual|2006-08-01|August 2005|Actual|2005-08-01||Interventional|||The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial|The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial|Completed||Phase 4|500|Actual|JHSPH Center for Clinical Trials||3|||f||||||||||||||2017-02-18 17:24:00.632917|2017-02-18 17:24:00.632917
NCT00156806|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2017-01-23|||March 2002||2002-03-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|May 2005|Actual|2005-05-01||Interventional|||Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.|Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.|Completed||Phase 3|231||AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:24:01.058918|2017-02-18 17:24:01.058918
NCT00156793|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-07-13|||December 2003||2003-12-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging|A Phase 3, International, Multicenter, Open Label, Dual-Injection, Echocardiographic Imaging and Safety Study of AI-700 in Patients With Suspected Ischemic Heart Disease Undergoing Single-Photon Emission Computed Tomography (Real-Time Assessment of Myocardial Perfusion With Echocardiography: RAMP 1)|Completed||Phase 3|400||Acusphere|||||||||||||||||||2017-02-18 17:24:01.150532|2017-02-18 17:24:01.150532
NCT00156780|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-19|||August 2004||2004-08-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF|A Phase 1, Double Blind, Crossover, Placebo-Controlled, Dual-Injection, Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and Chronic Obstructive Pulmonary Disease (COPD) and/or Congestive Heart Failure (CHF)|Completed||Phase 1|||Acusphere|||||||||||||||||||2017-02-18 17:24:01.244446|2017-02-18 17:24:01.244446
NCT00156767|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-02-14|||October 20, 2004||2004-10-20|January 26, 2017|2017-01-26||||||||Observational|||Adrenal Function in Critical Illness|Adrenal Function in Critical Illness|Completed||N/A|225|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:24:01.330137|2017-02-18 17:24:01.330137
NCT00156741|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-08-01|||April 2004||2004-04-01|September 2005|2005-09-01|April 2006||2006-04-01|||||Interventional|||Efficacy of a Pacemaker Algorithm in Promotion of the Intrinsic Heart Activity.|IntAct, Study on Promotion of Intrinsic Activity.|Unknown status|Active, not recruiting|Phase 4|150||Medtronic BRC|||||f||||||||||||||2017-02-18 17:24:01.428837|2017-02-18 17:24:01.428837
NCT00156728|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-11-03|||October 2003||2003-10-01|November 2008|2008-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT|Congestive Heart Failure Atrial Arrhythmia Monitoring and Pacing (CHAMP)|Completed||Phase 4|172||Medtronic BRC||1|||f||||||||||||||2017-02-18 17:24:01.686464|2017-02-18 17:24:01.686464
NCT00156715|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-02-16|2010-11-19||March 2004||2004-03-01|February 2012|2012-02-01|October 2008|Actual|2008-10-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder|Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia|Completed||Phase 4|23|Actual|Dartmouth-Hitchcock Medical Center|Lack of a control group; Small study group size, and the consequent lack of power to detect a significant change; Differences between the populations at the two sites.|1|||f||||t||||||||||2017-02-18 17:24:01.826561|2017-02-18 17:24:01.826561
NCT00156702|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-01-07|||January 2001||2001-01-01|January 2013|2013-01-01|October 2006|Actual|2006-10-01|||||Interventional|||Researching the Youth Smoking Experience|Researching the Youth Smoking Experience|Completed||Phase 1|40|Actual|Virginia Commonwealth University||2|||f||||f||||||||||2017-02-18 17:24:02.112664|2017-02-18 17:24:02.112664
NCT00156689|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-01-02|||August 2005||2005-08-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy.|A Pilot Study in a Double Blind, Randomized, Placebo-Controlled, Parallel-Group, 16 Week, Trial Design Evaluating the Efficacy and Safety of Levetiracetam 500 mg Tablets in Bid Administration (Daily Dose Ranging From 1000 mg to 3000 mg), in Adults (>18 Years of Ages) Suffering From Chronic Idiopathic Axonal Polyneuropathy|Completed||Phase 2|30|Actual|Vanderbilt University|||||f||||f||||||||||2017-02-18 17:24:02.229775|2017-02-18 17:24:02.229775
NCT00156676|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-09-18|||September 2004||2004-09-01|September 2013|2013-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Restoration of Walking in Multiple Sclerosis Using Treadmill Training.|Pilot Study on Gait & Motor Function in MS Using BWS Treadmill Training|Completed||N/A|30|Anticipated|VA Office of Research and Development||2|||f||||||||||||||2017-02-18 17:24:02.335282|2017-02-18 17:24:02.335282
NCT00156663|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-04-06|||May 2004||2004-05-01|February 2007|2007-02-01|September 2005|Actual|2005-09-01|||||Interventional|||Toward Gender Aware VA Healthcare: Development and Evaluation of an Intervention|Toward Gender Aware VA Health Care: Development and Evaluation of an Intervention|Completed||N/A|250|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:24:02.448112|2017-02-18 17:24:02.448112
NCT00156650|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-09-18|||December 2004||2004-12-01|September 2008|2008-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|IHOP-5||Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum|Male Hormonal Contraception Development: Suppression of Spermatogenesis With the Addition of a Potent GnRH Antagonist (Acyline) to Testosterone and DMPA (ACY-5) -Sub-Study (HOP 5)|Completed||Phase 1/Phase 2|23|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:24:02.741728|2017-02-18 17:24:02.741728
NCT00156637|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-04-06|||June 2005||2005-06-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Strategies to Improve Schizophrenia Treatment|A Study of Strategies to Improve Schizophrenia Treatment|Completed||N/A|106|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:24:02.867406|2017-02-18 17:24:02.867406
NCT00156624|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-04-24|||July 2004||2004-07-01|September 2005|2005-09-01|October 2007||2007-10-01|||||Interventional|||Thunder Trial - Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries|Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries (Thunder – Trial)|Unknown status|Active, not recruiting|Phase 2/Phase 3|135||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:24:02.99218|2017-02-18 17:24:02.99218
NCT00156611|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-09-11|||January 2002||2002-01-01|September 2006|2006-09-01|December 2009||2009-12-01|||||Interventional|||Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease|ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease – A Randomized Prospective Trial (RIO-Trial)|Unknown status|Active, not recruiting|Phase 2/Phase 3|420||University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:24:03.086896|2017-02-18 17:24:03.086896
NCT00156598|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-06-28|||August 2004||2004-08-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Metal Ion Serum Concentrations in Patients With Total Hip Replacements|Cobalt, Chromium and Titanium Serum Concentrations in Patients With Metal-on-Metal vs. Metal on Polyethylene Total Hip Replacements|Terminated||N/A|5|Actual|The University of Texas Health Science Center at San Antonio|||1|Resident graduated; faculty mentor retired|f||||||||||||||2017-02-18 17:24:03.191135|2017-02-18 17:24:03.191135
NCT00156585|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-01-13|||August 2005||2005-08-01|January 2015|2015-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Predictive Value of Dynamic Contrast Enhancement MRI on a Cerebral Tumor Response to Gamma Knife Treatment|Prospective Study of Predictive Value of Dynamic Contrast Enhancement Magnetic Resonance Imaging With Gadolinium on the Response of a Cerebral Tumor to a Treatment With Gamma Knife|Completed||N/A|31|Actual|Université de Sherbrooke|||1||f||||f||||||||||2017-02-18 17:24:03.274621|2017-02-18 17:24:03.274621
NCT00156572|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-12-26|||April 2005||2005-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Management of Hyponatremia in Preterm Infants on Diuretics|Management of Hyponatremia in Preterm Infants on Diuretics|Terminated||Phase 3|58|Anticipated|The University of Texas Health Science Center, Houston||||decreasing rate of enrollment|f||||||||||||||2017-02-18 17:24:03.360827|2017-02-18 17:24:03.360827
NCT00156559|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-09-15|||January 2004||2004-01-01|September 2015|2015-09-01|May 2005|Actual|2005-05-01|||||Observational|||MMR and Varicella Vaccine in Premature Infants|MMR and Varicella Vaccine Responses in Extremely Premature Infants|Completed||Phase 4|32||University of Rochester|||||f||||||||||||||2017-02-18 17:24:03.454687|2017-02-18 17:24:03.454687
NCT00156546|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-11-30|||May 2000||2000-05-01|September 2005|2005-09-01|July 2006||2006-07-01|||||Interventional|||Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a Previous Urinary Tract Infection|Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a History of Upper Urinary Tract Infections:a Multicentre Randomised Study|Unknown status|Active, not recruiting|Phase 4|660||University of Padova|||||f||||||||||||||2017-02-18 17:24:03.554605|2017-02-18 17:24:03.554605
NCT00156533|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-10-21|2011-10-10||March 2005||2005-03-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing|Long Term Treatment With Zolpidem: The Relative Efficacy of Nightly (Quaque Hora Somni [QHS]) & Intermittent Dosing and the Potential for Long Term Clinical Gains After Treatment Discontinuation.|Completed||Phase 4|20|Actual|University of Rochester|About 25% of the target sample was obtained. As a result our capacity to detect trends and to calculate effect sizes was greatly diminished. Accordingly, our observations must be very limited in scope.|4|||f||||t||||||||||2017-02-18 17:24:03.679766|2017-02-18 17:24:03.679766
NCT00156520|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-04-09|||March 2005||2005-03-01|April 2010|2010-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis|Jeanne Grace; Head Research Subjects Review Board|Completed||Phase 4|40|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 17:24:04.202725|2017-02-18 17:24:04.202725
NCT00156507|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-05-11|||January 2003||2003-01-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Improving Asthma Care for Very Low Birth Weight Infants|Improving Asthma Care for Very Low Birth Weight Infants|Completed||N/A|192|Actual|University of Rochester||1|||f||||f||||||||||2017-02-18 17:24:04.29398|2017-02-18 17:24:04.29398
NCT00156494|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-05-11|||June 2004||2004-06-01|May 2011|2011-05-01||||||||Observational|||Attitudes About Smoking: A Telephone Survey|"Attitudes About Smoking A Telephone Survey of Parents of Young Urban Children"|Completed||N/A|371|Actual|University of Rochester|||1||f||||f||||||||||2017-02-18 17:24:04.385777|2017-02-18 17:24:04.385777
NCT00156481|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-05-11|||December 2004||2004-12-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||A Qualitative Study About Smoking Practices|Smoking Practices Among Parents of Urban Children With Asthma: A Qualitative Study|Completed||N/A|35|Actual|University of Rochester|||1||f||||||||||||||2017-02-18 17:24:04.464306|2017-02-18 17:24:04.464306
NCT00156468|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-05-11|||October 2003||2003-10-01|May 2011|2011-05-01|September 2005||2005-09-01|||||Interventional|||Office-Based Asthma Screening Intervention|Office-Based Asthma Screening Intervention|Completed||N/A|365||University of Rochester|||||f||||||||||||||2017-02-18 17:24:04.545312|2017-02-18 17:24:04.545312
NCT00156455|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-29|||September 2004||2004-09-01|April 2015|2015-04-01||||March 2008|Actual|2008-03-01||Observational|||Sleep Disordered Breathing in Children With Single Ventricle Physiology|Sleep Disordered Breathing in Children With Single Ventricle Physiology|Withdrawn||N/A|0|Actual|University of Rochester|||1|lack of study personel|f||||f||||||||||2017-02-18 17:24:04.637314|2017-02-18 17:24:04.637314
NCT00156442|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-01-11|||September 2005||2005-09-01|September 2006|2006-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||A Study to Examine the Relationship Between Sleep Apnea and Cleft Lip/Palate|OSAS in Children With Cleft Lip/Palate|Completed||N/A|100|Anticipated|University of Rochester|||1||f||||f||||||||||2017-02-18 17:24:04.722542|2017-02-18 17:24:04.722542
NCT00156429|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-10-24|||July 2005||2005-07-01|October 2016|2016-10-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Genetic Predictors of Outcome in HCM Patients|Genetic Predictors of Outcome in HCM Patients|Active, not recruiting||N/A|540|Anticipated|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"~     Blood sample for DNA analysis~   "|||2017-02-18 17:24:04.803642|2017-02-18 17:24:04.803642
NCT00156416|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-12-02|||February 2005||2005-02-01|December 2014|2014-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Menopause and Meditation for Breast Cancer Survivors|Menopause and Meditation for Breast Cancer Survivors|Completed||Phase 1/Phase 2|51|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 17:24:04.896413|2017-02-18 17:24:04.896413
NCT00156403|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-12-13|||August 2005||2005-08-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|||||Interventional|||A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis|Hereditary Pancreatitis Amlodipine Trial(H-PAT): A Pilot Study|Completed||Phase 1/Phase 2|8||University of Pittsburgh|||||||||||||||||||2017-02-18 17:24:05.008401|2017-02-18 17:24:05.008401
NCT00156390|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-11-21|2014-05-21||June 2005||2005-06-01|November 2014|2014-11-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Predictors of Response to Biventricular Pacing in Heart Failure|Predictors of Response to Biventricular Pacing in Heart Failure|Completed||N/A|187|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:24:05.100993|2017-02-18 17:24:05.100993
NCT00156377|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-05-24|||November 2002||2002-11-01|September 2005|2005-09-01||||||||Interventional|||Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections|Investigation of the Influence of Intranasal Mupirocin on the Prevalence of S. Aureus Nosocomial Infections by Eradication of Intranasal S. Aureus|Completed||Phase 4|1200||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:24:05.415179|2017-02-18 17:24:05.415179
NCT00156364|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-12-10|||January 1981||1981-01-01|December 2014|2014-12-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Observational|||Studies of Organ Transplantation in Animals and Man|"Ii-Pancreas Transplantation in Man, Long Term Effects of Cyclosporine (CSA) and Tacrolimus (FK506) on Renal Structure and Function, Studies of the Renal Interstitium Type I Diabetic Patients,"|Completed||N/A|655|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||t||||||Samples With DNA|"~     Skin Fibroblasts, Plasma and Serum samples, Urine samples, kidney biopsy culture samples.~   "|||2017-02-18 17:24:05.515998|2017-02-18 17:24:05.515998
NCT00156351|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-03-26|||January 2003||2003-01-01|March 2008|2008-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Walking For Wellness Program Evaluation|Evaluation of the National Black Women's Health Project Walking for Wellness Program|Completed||N/A|186||University of Pennsylvania|||||f||||||||||||||2017-02-18 17:24:05.622744|2017-02-18 17:24:05.622744
NCT00156338|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-01-16|||July 2005||2005-07-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Intraoperative Fluid Management on Morbidity|Effect of Intraoperative Fluid Management on Morbidity in Patients Undergoing Colorectal Surgery|Completed||N/A|108|Actual|University Hospital Muenster||3|||f||||f||||||||||2017-02-18 17:24:05.710433|2017-02-18 17:24:05.710433
NCT00156325|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-12-30|||February 2004||2004-02-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Escitalopram as a Mood Stabilizer for Bipolar II Disorder|A Double-Blind, Placebo-Controlled Trial of Escitalopram as a Mood Stabilizer for Bipolar II Disorder|Completed||Phase 2|10||The University of New South Wales|||||f||||||||||||||2017-02-18 17:24:05.809116|2017-02-18 17:24:05.809116
NCT00156312|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-02-05|||July 2003||2003-07-01|February 2012|2012-02-01|February 2007|Actual|2007-02-01|May 2005|Actual|2005-05-01||Interventional|||Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine|Evaluation of Thymidine Phosphorylase and Other Predictive/Prognostic Factors in Primary Breast Cancer Treated With Docetaxel and Capecitabine (DC)|Completed||N/A|25|Anticipated|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:24:06.012663|2017-02-18 17:24:06.012663
NCT00156299|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-11-18|||March 2003||2003-03-01|November 2013|2013-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate|A Pilot Study of Nuclear Factor-kappa B (NFkB) Inhibition During Induction Chemotherapy for Patients With Acute Myelogenous Leukemia (AML)|Terminated||Phase 1|15|Actual|Rutgers, The State University of New Jersey||2||Replaced by another study|f||||f||||||||||2017-02-18 17:24:06.103424|2017-02-18 17:24:06.103424
NCT00156286|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-11-12|||March 2002||2002-03-01|November 2010|2010-11-01|April 2006|Actual|2006-04-01|January 2006|Actual|2006-01-01||Interventional|||Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC|Phase II Trial of Gleevec (Imatinib Mesylate, STI571) Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive, Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|20||University of Michigan Cancer Center|||||f||||t||||||||||2017-02-18 17:24:06.220041|2017-02-18 17:24:06.220041
NCT00156273|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-06-02|||April 2005||2005-04-01|June 2016|2016-06-01||||October 2008|Actual|2008-10-01||Observational|||Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer|A Pilot Study to Determine the Feasibility of Quantifying Apoptosis and Bcl-2 Expression in Circulating Tumor Cells (CTCs) in Women Undergoing Treatment for Metastatic Breast Cancer|Active, not recruiting||N/A|36|Anticipated|University of Michigan Cancer Center|||1||f||||t||||||||||2017-02-18 17:24:06.297479|2017-02-18 17:24:06.297479
NCT00156260|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-10-04|||January 2003||2003-01-01|October 2008|2008-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage|UMCC 2-48 Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage|Terminated||N/A|88|Anticipated|University of Michigan Cancer Center|||||f||||||||||||||2017-02-18 17:24:06.374023|2017-02-18 17:24:06.374023
NCT00156247|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-02-13|2011-07-11||September 2005||2005-09-01|February 2015|2015-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Acitretin and Etanercept in Psoriasis|Pilot, Single-Arm Study of the Effect of Adding Acitretin to Etanercept Therapy in Patients With Moderate to Severe Psoriasis Who Fail to Respond to Etanercept Monotherapy|Completed||Phase 2|10|Actual|Rutgers, The State University of New Jersey|small sample size; lack of control group|1|||f||||f||||||||||2017-02-18 17:24:06.454165|2017-02-18 17:24:06.454165
NCT00156234|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||March 2005||2005-03-01|September 2005|2005-09-01||||||||Interventional|||Skeletal Muscle Dysfunction in Heart Failure|Training and Congestive Heart Failure|Unknown status|Recruiting|N/A|45||Ullevaal University Hospital|||||f||||||||||||||2017-02-18 17:24:06.694801|2017-02-18 17:24:06.694801
NCT00156221|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||September 2000||2000-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||MR Scanning of Very Young Children With Severe Developmental Disorders|MR Scanning of Very Young Children With Severe Developmental Disorders (Autistic Spectrum Disorders and/or Mental Retardation and/or Language Disorders)|Completed||N/A|||UMC Utrecht|||||f||||||||||||||2017-02-18 17:24:06.779721|2017-02-18 17:24:06.779721
NCT00156208|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-27|||April 2004||2004-04-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety of Treatment of Uterine Fibroids With Asoprisnil|A Phase III, 18-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata|Completed||Phase 3|166|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:24:07.066377|2017-02-18 17:24:07.066377
NCT00156195|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-27|||September 2003||2003-09-01|May 2008|2008-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids|A Phase 3, 12-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata|Completed||Phase 3|523|Actual|Abbott||2|||f||||t||||||||||2017-02-18 17:24:07.178604|2017-02-18 17:24:07.178604
NCT00156182|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-03-03|||April 2001||2001-04-01|May 2008|2008-05-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.|A Phase 2, Long-Term, Open-Label, Safety Extension Study of Asoprisnil (J867) in Patients With Uterine Leiomyomata|Completed||Phase 2|38|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:24:07.30008|2017-02-18 17:24:07.30008
NCT00156169|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-08-10|||May 2001||2001-05-01|August 2009|2009-08-01|December 2006|Actual|2006-12-01|||||Interventional|||The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.|The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid|Completed||Phase 3|50|Anticipated|Sheba Medical Center|||||f||||f||||||||||2017-02-18 17:24:07.399093|2017-02-18 17:24:07.399093
NCT00156156|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-27|||November 2004||2004-11-01|May 2008|2008-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of Asoprisnil in the Treatment of Uterine Fibroids.|A Phase 3, Continuation Study to Evaluate the Long-Term Safety of Asoprisnil in Subjects With Uterine Leiomyomata|Completed||Phase 3|149|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:24:07.47824|2017-02-18 17:24:07.47824
NCT00156143|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-07-27|||April 2002||2002-04-01|July 2007|2007-07-01|April 2005||2005-04-01|||||Interventional|TAUBER||Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents|GH Therapy in Partial GHD Adolescents : Evaluation of Efficacy Based on Body Composition and Comparison of 2 Different Doses of Genotonorm®. Open-Label, Randomised, Comparative, Controlled, Parallel-Group, Multi-Center Phase IIIB Clinical Trial.|Completed||Phase 3|90||Pfizer|||||f||||||||||||||2017-02-18 17:24:07.589948|2017-02-18 17:24:07.589948
NCT00156130|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-05-06|||October 2003||2003-10-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Accelerated Radiotherapy Outcomes in Women|Accelerated Radiotherapy Outcomes in Women (Long Term Outcomes of a Randomized Trial of Breast Irradiation Schedules After Lumpectomy in Women With Node-Negative Breast Cancer)(AROW)|Completed||Phase 4|1234|Actual|Ontario Clinical Oncology Group (OCOG)|||2||f||||f||||||||||2017-02-18 17:24:07.658321|2017-02-18 17:24:07.658321
NCT00156117|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-12|||May 2005||2005-05-01|June 2015|2015-06-01|May 2006|Actual|2006-05-01|April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)|A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-Week Trial of the Efficacy and Safety of Asenapine Compared With Placebo Using Olanzapine Positive Control in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 3|417|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:24:07.762511|2017-02-18 17:24:07.762511
NCT00156104|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-02-01|||July 2005||2005-07-01|February 2016|2016-02-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Fixed-Dose, 6-Week Trial of the Efficacy and Safety of Asenapine Compared With Placebo Using Haloperidol Positive Control in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 3|460|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 17:24:07.86257|2017-02-18 17:24:07.86257
NCT00156091|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-08-10|||April 2005||2005-04-01|August 2015|2015-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)|A Multicenter, Randomized, Double-Blind, Flexible-Dose, Long-Term Extension Trial of the Safety and Maintenance of Effect of Asenapine Using Olanzapine Positive Control in Subjects Who Complete Protocols 041021 or 041022.|Completed||Phase 3|260|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:24:07.960184|2017-02-18 17:24:07.960184
NCT00156078|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-03-28|||January 2005||2005-01-01|March 2008|2008-03-01|May 2007||2007-05-01|||||Interventional|||A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)|A 14-Week, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study To Evaluate The Safety And Efficacy Of Pregabalin (150mg-600mg/Day) Using A Flexible Optimal Dose Schedule In Patients With Painful Diabetic Peripheral Neuropathy (DPN).|Completed||Phase 4|450||Pfizer|||||f||||||||||||||2017-02-18 17:24:08.050946|2017-02-18 17:24:08.050946
NCT00156065|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-10-12|2010-02-24||September 2005||2005-09-01|October 2015|2015-10-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)|A Multicenter, Randomized, Double-Blind, Flexible-Dose, Long-Term Extension Trial of the Safety and Maintenance of Effect of Asenapine Using Haloperidol Positive Control in Subjects Who Complete Protocol 041023 [NCT00156104]|Completed||Phase 3|187|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:24:11.073573|2017-02-18 17:24:11.073573
NCT00156052|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-03|||April 1993||1993-04-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer|A Randomized Trial of Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer|Completed||N/A|1234|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-02-18 17:24:11.565336|2017-02-18 17:24:11.565336
NCT00156039|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-07-24|||January 1997||1997-01-01|July 2009|2009-07-01|June 2003|Actual|2003-06-01|||||Interventional|||Randomized Trial of Follow-up Strategies in Breast Cancer|A Randomized Trial of Follow-up Strategies in Breast Cancer|Completed||Phase 4|968|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-02-18 17:24:11.717262|2017-02-18 17:24:11.717262
NCT00156026|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-01-28|||November 2000||2000-11-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1|Randomized Trial of Immediate Treatment vs. Colposcopic Follow-up for Biopsy-Proven CIN 1|Completed||Phase 3|415|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||f||||||||||2017-02-18 17:24:11.828381|2017-02-18 17:24:11.828381
NCT00156013|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-20|2011-10-06||September 2005||2005-09-01|April 2015|2015-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)|A Phase I/II Open-label Study of Clofarabine in Patients With Relapsed or Refractory Diffuse Large Cell B-Cell NHL|Completed||Phase 1/Phase 2|33|Actual|Oncology Specialists, S.C.||1|||f||||f||||||||||2017-02-18 17:24:12.19318|2017-02-18 17:24:12.19318
NCT00156000|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-12-17|||August 2005||2005-08-01|December 2014|2014-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo|Fetal Fibronectin (fFN) and Salivary Estriol (E3) in the Prediction of Preterm Birth in Women With Twin Pregnancies Receiving 17-Alpha-Hydroxyprogesterone Caproate or Placebo|Withdrawn||Phase 1|0|Actual|Mednax Center for Research, Education and Quality|||1|This study was stopped because of insufficient enrollment.|f||||f||||||||||2017-02-18 17:24:12.557117|2017-02-18 17:24:12.557117
NCT00155376|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-25|||September 2005||2005-09-01|April 2005|2005-04-01|September 2005||2005-09-01|||||Interventional|||Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography||Unknown status|Recruiting|Phase 4|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:22.78826|2017-02-18 17:24:22.78826
NCT00155987|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-07-22|||August 2003||2003-08-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Interventional|||The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury|Multi-centre Prospective Randomised Trial of Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury|Unknown status|Active, not recruiting|Phase 3|165|Anticipated|National Trauma Research Institute||1|||f||||t||||||||||2017-02-18 17:24:12.688985|2017-02-18 17:24:12.688985
NCT00155974|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-21|||February 2004||2004-02-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Rapid Vaccination of Hard-To-Reach Populations|Rapid Vaccination of Hard-to-Reach Populations|Unknown status|Recruiting|N/A|4000||The New York Academy of Medicine|||||f||||||||||||||2017-02-18 17:24:12.789754|2017-02-18 17:24:12.789754
NCT00155961|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-02-02|||March 2002||2002-03-01|September 2005|2005-09-01||||||||Observational|||Odense Androgen Study in the Elderly|Odense Androgen Study in the Elderly|Completed||Phase 1|600||Odense University Hospital|||||f||||||||||||||2017-02-18 17:24:12.892738|2017-02-18 17:24:12.892738
NCT00155948|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||September 2003||2003-09-01|April 2004|2004-04-01|May 2004||2004-05-01|||||Observational|||Estimation of Muscle Area and Thickness of Deep Cervical Muscle Contraction During Cervical and Limb Movements|Estimation of Muscle Area and Thickness of Deep Cervical Muscle Contraction During Cervical and Limb Movements|Completed||N/A|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:12.982674|2017-02-18 17:24:12.982674
NCT00155935|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-08-10|||January 2004||2004-01-01|January 2004|2004-01-01|December 2008||2008-12-01|||||Interventional|||The Development of Human Immunologic Assays Specific to Folate Receptor Antigen|The Development of Human Immunologic Assays Specific to Folate Receptor Antigen|Unknown status|Recruiting|N/A|50|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.052865|2017-02-18 17:24:13.052865
NCT00155922|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-12-13|||November 2003||2003-11-01|September 2005|2005-09-01||||||||Observational|||The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients|The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients, Special Relevance to Atherosclerosis|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.146636|2017-02-18 17:24:13.146636
NCT00155909|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-22|||July 2003||2003-07-01|June 2005|2005-06-01|June 2006||2006-06-01|||||Observational|||Risk Factors of Radiation Pneumonitis|To Investigate Risk Factors of Radiation Pneumonitis, Fibrosis, and Impairment of Quality of Life by Radiotherapeutic Dosimetric and Biological Parameters for Lung Cancer Patients Receiving Thoracic Radiotherapy|Unknown status|Recruiting|N/A|53||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.226965|2017-02-18 17:24:13.226965
NCT00155896|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 2003||2003-01-01|September 2002|2002-09-01|December 2008||2008-12-01|||||Observational|||Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer||Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.306277|2017-02-18 17:24:13.306277
NCT00155883|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-08-14|||June 2004||2004-06-01|July 2005|2005-07-01|July 2005|Anticipated|2005-07-01|||||Interventional|||Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer|Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer|Terminated||Phase 2|54|Anticipated|National Taiwan University Hospital||||slow a accrul due to many competitive trials.|f||||||||||||||2017-02-18 17:24:13.391745|2017-02-18 17:24:13.391745
NCT00155870|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||June 2005||2005-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Health-Related QoL Among Women Receiving Hysterectomy in NTUH|Health-Related Quality of Life Among Women Receiving Hysterectomy in National Taiwan University Hospital|Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.494307|2017-02-18 17:24:13.494307
NCT00155857|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-22|||July 2003||2003-07-01|June 2005|2005-06-01|July 2007||2007-07-01|||||Observational|||The Genetic Study of Primary Angle-Closure Glaucoma|National Taiwan University Hospital|Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.579626|2017-02-18 17:24:13.579626
NCT00155844|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||February 2003||2003-02-01|January 2003|2003-01-01|July 2004||2004-07-01|||||Observational|||"Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing ThroughMarrow-Blood Barrier"||Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.659185|2017-02-18 17:24:13.659185
NCT00155831|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-03-29|||August 2003||2003-08-01|March 2010|2010-03-01|March 2007|Actual|2007-03-01|March 2005|Actual|2005-03-01||Observational|||Neural Development and Its Influencing Factors in Premature Infants With Chronic Lung Disease||Completed||N/A|120|Anticipated|National Taiwan University Hospital|||2||f||||t||||||||||2017-02-18 17:24:13.734405|2017-02-18 17:24:13.734405
NCT00155818|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||August 2003||2003-08-01|August 2003|2003-08-01|July 2004||2004-07-01|||||Observational|||Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia|Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia|Completed||N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.827445|2017-02-18 17:24:13.827445
NCT00155805|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||February 2004||2004-02-01|February 2004|2004-02-01|December 2006||2006-12-01|||||Observational|||Immunologic Factors in Reflux Esophagitis and Barrett’s Esophagus|Immunologic Factors Correlating With Cyclooxygenase and Nitric Oxide Synthase in Reflux Esophagitis and Barrett’s Esophagus|Unknown status|Recruiting|N/A|90||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.900341|2017-02-18 17:24:13.900341
NCT00155792|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||January 2002||2002-01-01|December 2001|2001-12-01|December 2006||2006-12-01|||||Observational|||The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being||Unknown status|Recruiting|N/A|300||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:13.985661|2017-02-18 17:24:13.985661
NCT00155779|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||December 2003||2003-12-01|December 2003|2003-12-01|December 2004||2004-12-01|||||Observational|||ACE Gene Polymorphism and ARDS Outcome|Polymorphism of the Angiotensin-Converting Enzyme Gene and the Outcome of Acute Respiratory Distress Syndrome|Completed||N/A|250||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:14.318971|2017-02-18 17:24:14.318971
NCT00155766|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||January 2003||2003-01-01|June 2002|2002-06-01|March 2006||2006-03-01|||||Interventional|||Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)|A Pilot Study for the Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs) Pulsed With Human Papillomavirus Type 16 E7 Antigen|Unknown status|Recruiting|Phase 1|12||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:14.4046|2017-02-18 17:24:14.4046
NCT00155753|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-06-08|||August 2002||2002-08-01|April 2010|2010-04-01|August 2010|Anticipated|2010-08-01|August 2010|Anticipated|2010-08-01||Observational|||Genomewide Screening of Pathological Myopia|Genomewide Screening of Pathological Myopia|Unknown status|Recruiting|N/A|600|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     DNA extracted from blood~   "|||2017-02-18 17:24:14.498732|2017-02-18 17:24:14.498732
NCT00155740|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||January 2002||2002-01-01|October 2001|2001-10-01|December 2006||2006-12-01|||||Observational|||Mesothelin as a New Tumor Marker for Ovarian Cancer||Unknown status|Recruiting|N/A|250||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:14.604363|2017-02-18 17:24:14.604363
NCT00155727|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||January 2000||2000-01-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Comparison of Laparoscopic Colectomy Versus Open Colectomy for Colorectal Cancer: … A Prospective Randomized Trial|Comparison of Treatment Outcome for Laparoscopic Colectomy Versus Traditional Open Colectomy for the Treatment of Colorectal Cancer: … A Prospective Randomized Clinical Trial|Unknown status|Recruiting|Phase 3|600||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:14.693392|2017-02-18 17:24:14.693392
NCT00155714|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-03-15|||November 2002||2002-11-01|January 2010|2010-01-01|May 2005|Anticipated|2005-05-01|||||Interventional|||Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension|Clinical Efficacy of Type-5 Phosphodiesterase Inhibitors (Sildenafil and Vadenafil) in Primary and Secondary Pulmonary Hypertension|Withdrawn||N/A|20|Anticipated|National Taiwan University Hospital||||"We can't obtained the test drug (Vadenafil) from Bayer. They decided not to carry out this~   trail in Taiwan. Therefore this trail has never been started."|f||||||||||||||2017-02-18 17:24:14.780306|2017-02-18 17:24:14.780306
NCT00155701|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||August 2002||2002-08-01|August 2002|2002-08-01|July 2003||2003-07-01|||||Observational|||Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia|Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia|Completed||N/A|500||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:14.880871|2017-02-18 17:24:14.880871
NCT00155688|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||December 1998||1998-12-01|December 1998|1998-12-01|December 2002||2002-12-01|||||Observational|||A Genetic Linkage Study of Schizophrenia|A Genetic Linkage Study of Schizophrenia|Completed||N/A|2400||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:14.965505|2017-02-18 17:24:14.965505
NCT00155675|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-01-11|||January 2000||2000-01-01|December 2009|2009-12-01|January 2001|Actual|2001-01-01|||||Interventional|||Pseudodrynaria Coronana (Wall) Ching|"Clinical Effect of Traditional Chinese Medicine - Gusuibu"|Completed||Phase 1|120|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:15.046302|2017-02-18 17:24:15.046302
NCT00155662|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-12-05|||August 2002||2002-08-01|December 2012|2012-12-01|September 2007|Actual|2007-09-01|December 2004|Actual|2004-12-01||Interventional|||The Effect of a Work-hardening Program for Return-to-work for Workers With Low Back Pain||Completed||N/A|60|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:15.133303|2017-02-18 17:24:15.133303
NCT00155649|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||April 2002||2002-04-01|October 2001|2001-10-01|April 2005||2005-04-01|||||Observational|||A Positional Cloning Study on Schizophrenia||Completed||N/A|320||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:15.241727|2017-02-18 17:24:15.241727
NCT00155636|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||January 2002||2002-01-01|January 2002|2002-01-01|December 2005||2005-12-01|||||Observational|||A Study on Etiological Factors of Schizophrenia|A Study on Etiological Factors of Schizophrenia|Terminated||N/A|1056||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:15.322852|2017-02-18 17:24:15.322852
NCT00155623|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-10-19|||February 2001||2001-02-01|January 2001|2001-01-01|July 2003||2003-07-01|||||Observational|||Establish Epidemiologic Data of H. Pylori Infection in Children and Adolescents-Using C13-UBT|Establish the Precise Epidemiologic Data of Helicobacter Pylori Infection in Children and Adolescents – Using the 13C-Urea Breath Test|Completed||N/A|3000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:15.404024|2017-02-18 17:24:15.404024
NCT00155610|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-01-28||||||September 2005|2005-09-01|December 2006||2006-12-01|||||Observational|||The Relationship Between Voiding Dysfunction and Intravesical Sensory Threshold in Diabetes Women|A Cross-Sectional Study of the Relationship Between Voiding Dysfunction and Intravesical Sensory Threshold in Diabetes Women|Terminated||Phase 1/Phase 2|120|Anticipated|National Taiwan University Hospital||||No clinical significant|f||||||||||||||2017-02-18 17:24:15.488025|2017-02-18 17:24:15.488025
NCT00155597|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2010-01-11|||August 1999||1999-08-01|December 2009|2009-12-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||The Outcome and Cost Analysis of Home-care Physical Therapy for Postoperative Hip Fracture Patients||Completed||N/A|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:15.565876|2017-02-18 17:24:15.565876
NCT00155584|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||December 1994||1994-12-01|December 1994|1994-12-01|December 1996||1996-12-01|||||Observational|||Topical 5-ALA Photodynamic Therapy for the Treatment of Verruca Vulgaris|Topical 5-Aminolevulinic Acid Photodynamic Therapy for the Treatment of Verruca Vulgaris: Comparison of Red and Green Light-Emitting Diode Array|Unknown status|Recruiting|Phase 3|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:15.658615|2017-02-18 17:24:15.658615
NCT00155571|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||August 2001||2001-08-01|January 2001|2001-01-01||||||||Observational|||The Occurrence of Periopathogens in Betel-Nut Chewers and the Effects of Areca-Nut on Periopathogens|The Occurrence of Periopathogens in Betel-Nut Chewers and the Effects of Areca-Nut on Periopathogens|Completed||N/A|186||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:15.745069|2017-02-18 17:24:15.745069
NCT00155558|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-07-23|||March 2001||2001-03-01|November 2000|2000-11-01|December 2005|Actual|2005-12-01|||||Interventional|||A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers|A Phase I Trial of HDFL48(Weekly 48-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin) in Recurrent or Metastatic Colorectal Cancers|Completed||Phase 1|16|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:24:15.832979|2017-02-18 17:24:15.832979
NCT00155545|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-12-06|||September 2005||2005-09-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Influence of Leg Length Discrepancy on the Spinal Shape and Biomechanics in Functional and Idiopathic Scoliosis Patients|Influence of Leg Length Discrepancy on the Spinal Shape and Biomechanics During Static and Dynamic Activities in Functional and Idiopathic Scoliosis Patients|Completed||Phase 1|30|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-02-18 17:24:15.945005|2017-02-18 17:24:15.945005
NCT00155532|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||April 2002||2002-04-01|June 2005|2005-06-01|March 2004||2004-03-01|||||Interventional|||Skin Denervation in Systemic Lupus Erythematosus||Completed||Phase 1|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.058956|2017-02-18 17:24:16.058956
NCT00155519|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||July 2002||2002-07-01|August 2000|2000-08-01|July 2002||2002-07-01|||||Observational|||A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions|A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions|Completed||N/A|130||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.153965|2017-02-18 17:24:16.153965
NCT00155506|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||November 2002||2002-11-01|November 2002|2002-11-01|December 2004||2004-12-01|||||Observational|||Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios|Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios|Completed||N/A|600||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.228919|2017-02-18 17:24:16.228919
NCT00155493|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 2006||2006-01-01|June 2005|2005-06-01|August 2006||2006-08-01|||||Interventional|||Age-Related Changes in Proliferation and Differentiation Capacity of Human Preadipocytes From Periorbital Fat.||Unknown status|Not yet recruiting|Phase 1|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.303626|2017-02-18 17:24:16.303626
NCT00155480|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-12-05|||January 2000||2000-01-01|November 2012|2012-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Establish Finite Element Mesh of the Numerical Models of the Thoracic Aorta|Establish Finite Element Mesh of the Numerical Models of the Thoracic Aorta|Completed||N/A|80|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.382944|2017-02-18 17:24:16.382944
NCT00155467|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-10-19|||January 1995||1995-01-01|January 1995|1995-01-01|December 2010||2010-12-01|||||Interventional|||Establish a CT Images Database of Patients With Congenital Heart Disease|Establish a CT Images Database of Patients With Congenital Heart Disease|Unknown status|Recruiting|N/A|5000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.485631|2017-02-18 17:24:16.485631
NCT00155454|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-12-26|||September 2004||2004-09-01|December 2012|2012-12-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy|Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy|Completed||N/A|61|Actual|National Taiwan University Hospital||2|||f||||t||||||||||2017-02-18 17:24:16.580753|2017-02-18 17:24:16.580753
NCT00155441|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-01-08|||June 2005||2005-06-01|May 2005|2005-05-01||||||||Interventional|||Effects of Cognitive-Behavioral Therapy on Sleep Disturbance in Peritoneal Dialysis Patients|Effects of Cognitive-Behavioral Therapy on Sleep Disturbance in Peritoneal Dialysis Patients|Unknown status|Recruiting|Phase 3|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.689514|2017-02-18 17:24:16.689514
NCT00155025|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||May 2004||2004-05-01|April 2004|2004-04-01||||||||Observational|||Family History in Prostate Cancer Patients in Taiwan||Unknown status|Recruiting|N/A|1500||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.783604|2017-02-18 17:24:16.783604
NCT00155012|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||August 2004||2004-08-01|April 2004|2004-04-01|August 2006||2006-08-01|||||Observational|||Clinical Application of MDCT in Coronary Artery Disease|Clinical Application of 16-Detector Row Computed Tomography in Coronary Artery Disease|Unknown status|Recruiting|Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.869307|2017-02-18 17:24:16.869307
NCT00154999|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-28|||April 2005||2005-04-01|March 2004|2004-03-01|June 2005||2005-06-01|||||Observational|||The Predictors of the Neonatal Hyperbilirubinemia|The Predictors of the Neonatal Hyperbilirubinemia|Completed||N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:16.953515|2017-02-18 17:24:16.953515
NCT00154986|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||August 2004||2004-08-01|April 2004|2004-04-01|July 2005||2005-07-01|||||Interventional|||IGFBP-3 in Ovarian Cancer Invasion|Study of IGFBP-3 in the Ovarian Carcinoma Cell Invasion|Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:17.025294|2017-02-18 17:24:17.025294
NCT00153972|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-12-17|||February 2005||2005-02-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease|Dopamine Turnover Rate Measured With F-Dopa-PET as Surrogate Parameter for Diagnosis and Progression Analysis of Early Parkinson's Disease|Completed||Phase 4|39|Actual|Technische Universität Dresden||2|||f||||t||||||||||2017-02-18 17:24:17.120671|2017-02-18 17:24:17.120671
NCT00153959|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07||||||September 2005|2005-09-01||||||||Interventional|||Psychiatric Day Hospital Treatment||Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:24:17.246839|2017-02-18 17:24:17.246839
NCT00153946|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-12|||August 2004||2004-08-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|EAST||Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke|Multicenter Randomized Open-Label Comparison Study on the Efficacy and Safety of Argatroban Monotherapy With Argatroban-Edaravone Combination Therapy|Completed||Phase 4|814|Actual|Combination Therapy for Acute Ischemic Stroke Study Group||2|||f||||t||||||||||2017-02-18 17:24:17.336392|2017-02-18 17:24:17.336392
NCT00153933|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-01-21|||August 2004||2004-08-01|January 2016|2016-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma|An Open-Label Phase I Study of the Safety and Efficacy of Bortezomib in Combination With CC-5013 in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma|Completed||Phase 1|58|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:24:17.447663|2017-02-18 17:24:17.447663
NCT00153920|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-01-21|2016-01-21||December 2003||2003-12-01|January 2016|2016-01-01|September 2008|Actual|2008-09-01|July 2007|Actual|2007-07-01||Interventional||The analysis population is comprised of eligible and treated participants.|Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma|Phase II Trial of Velcade (Bortezomib) in Patients With Previously Untreated Multiple Myeloma|Completed||Phase 2|66|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 17:24:17.834492|2017-02-18 17:24:17.834492
NCT00153907|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-02-05|||March 2002||2002-03-01|February 2013|2013-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer|A Phase I Study of Oral Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer|Completed||Phase 1|40|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:24:18.320856|2017-02-18 17:24:18.320856
NCT00153894|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-06-24|||December 2003||2003-12-01|June 2016|2016-06-01|February 2008|Actual|2008-02-01|June 2006|Actual|2006-06-01||Interventional|||Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors|Pilot Study of the Effects of an Exercise Intervention on Insulin Levels in Breast Cancer Survivors|Completed||N/A|100|Actual|Dana-Farber Cancer Institute||2|||f||||f||||||||No||2017-02-18 17:24:18.429297|2017-02-18 17:24:18.429297
NCT00153881|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-11-11|||February 2000||2000-02-01|November 2014|2014-11-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|||Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer|Docetaxel and Carboplatin Followed by a Dose-Ranging Study of Oral Capecitabine, Weekly Docetaxel, and Concomitant External Beam Radiotherapy for the Treatment of Patients With Stage II-III Carcinoma of the Esophagus and Gastro-Esophageal Junction|Completed||Phase 1|44|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 17:24:18.553216|2017-02-18 17:24:18.553216
NCT00153868|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-06-27|||October 2003||2003-10-01|June 2016|2016-06-01|December 2025|Anticipated|2025-12-01|December 2025|Anticipated|2025-12-01||Interventional|||A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer|Pilot Web-based Study of Functional Status, Symptom Palliation and Quality of Life Benefits Associated With Darbepoetin Alfa (Aranesp®) Administration in Anemic Patients With Cancer.|Active, not recruiting||N/A|43|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 17:24:18.679289|2017-02-18 17:24:18.679289
NCT00153855|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-06|||January 2005||2005-01-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Observational|||Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates|Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates|Terminated||Phase 3|50||Children's Hospital of Philadelphia|||||f||||||||||||||2017-02-18 17:24:18.79906|2017-02-18 17:24:18.79906
NCT00153842|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-10-19|||August 2001||2001-08-01|October 2011|2011-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer|Phase I and II Clinical Studies of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules for the Treatment of Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|33|Actual|Dartmouth-Hitchcock Medical Center||1||"study closed to enrollment 04/07/2005 due to two large phase III trials showing no survival~   benefit of combining bexarotene with platinum-based chemotherapy"|f||||t||||||||||2017-02-18 17:24:18.904271|2017-02-18 17:24:18.904271
NCT00153829|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-02-20|||December 2004||2004-12-01|February 2015|2015-02-01|February 2006||2006-02-01|||||Interventional|||Chronic Illness Care Management (CICM) Study In Primary Care||Completed||Phase 1|200||Bruyere Research Institute|||||f||||||||||||||2017-02-18 17:24:19.0369|2017-02-18 17:24:19.0369
NCT00153816|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-09-21|2015-09-21||July 2004||2004-07-01|September 2015|2015-09-01|July 2016|Anticipated|2016-07-01|October 2013|Actual|2013-10-01||Interventional|||Vitamin D/Calcium Polyp Prevention Study|Vitamin D/Calcium Polyp Prevention Study|Active, not recruiting||Phase 2/Phase 3|2813|Actual|Dartmouth-Hitchcock Medical Center||6|||f||||t||||||||||2017-02-18 17:24:19.142876|2017-02-18 17:24:19.142876
NCT00153803|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-11-11|||May 2005||2005-05-01|November 2014|2014-11-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)|A National Web-Based Randomized Phase III Study of Erlotinib or Placebo Following Concurrent Docetaxel, Carboplatin, and Thoracic Radiotherapy in Patients With Inoperable Stage III Non-Small Cell Lung Cancer (D0410).|Completed||Phase 3|30|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 17:24:21.626945|2017-02-18 17:24:21.626945
NCT00153790|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-03-12|||April 2005||2005-04-01|March 2014|2014-03-01|May 2006||2006-05-01|||||Interventional|||LEAN Project: Weight Loss and Appetite Suppression|The Effect of Soy Lecithin-derived N-oleoyl-phosphatidyl-ethanolamine (NOPE) and Green Tea-derived Epigallocatechin Gallate (EGCG) on Indices of Weight Loss and Appetite Suppression|Completed||Phase 1|60||The Cooper Institute|||||f||||||||||||||2017-02-18 17:24:21.82103|2017-02-18 17:24:21.82103
NCT00153777|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-08-27|||July 2005||2005-07-01|August 2015|2015-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Cellulose Sulfate and HIV Transmission Among Women|Randomized Controlled Trial of 6% Cellulose Sulfate Gel and the Effect on Vaginal HIV Transmission|Terminated||Phase 3|1428|Actual|CONRAD||2||IDMC recommendation|f||||t||||||||||2017-02-18 17:24:21.93484|2017-02-18 17:24:21.93484
NCT00153764|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-08-01|||September 2004||2004-09-01|August 2012|2012-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|Omega-3||Effectiveness of a Vitamin Mineral Supplement|Effectiveness of a One-a-Day Cooper Complete Vitamin / Mineral Supplement With or Without Omega-3 Fatty Acid Ingestion|Completed||Phase 1|75|Actual|The Cooper Institute||1|||f||||f||||||||||2017-02-18 17:24:22.048863|2017-02-18 17:24:22.048863
NCT00153751|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-09|||September 2005||2005-09-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS)|Clinical Study to Test the Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With IBS|Completed||Phase 2|84|Actual|Chinese University of Hong Kong||3|||f||||f||||||||||2017-02-18 17:24:22.151022|2017-02-18 17:24:22.151022
NCT00153738|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-03-12|||March 2004||2004-03-01|March 2014|2014-03-01|August 2005||2005-08-01|||||Interventional|||Phytosterol Supplementation and Cardiovascular Risk|Effectiveness of Phytosterol Supplementation on Select Indices of Cardiovascular Risk|Completed||N/A|72||The Cooper Institute|||||f||||||||||||||2017-02-18 17:24:22.263684|2017-02-18 17:24:22.263684
NCT00155428|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-12-19|||May 2005||2005-05-01|May 2005|2005-05-01|December 2008||2008-12-01|||||Interventional|||Biomodel in Tetralogy of Fallot|Application of Biocardiac Model in Total Correction of Tetralogy of Fallot|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:22.361553|2017-02-18 17:24:22.361553
NCT00155415|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-12-01|||April 2005||2005-04-01|September 2005|2005-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Prospective Single-Blinded Randomized Trial Comparing Colonoscopic Preparation at Different Time||Completed||N/A|120||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:22.457655|2017-02-18 17:24:22.457655
NCT00155402|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-28|||April 2005||2005-04-01|March 2005|2005-03-01|March 2008||2008-03-01|||||Interventional|||The Application of Fibrin Glue in Ocular Surface Diseases|Phase 1 Study of Applying Fibrin Glue in Patients With Corneal Ulcer or Patients Requiring Wound Closure by Suture|Withdrawn||Phase 1|30|Anticipated|National Taiwan University Hospital||1||Short of supply of fibrin glue|f||||f||||||||||2017-02-18 17:24:22.550201|2017-02-18 17:24:22.550201
NCT00155389|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-11-12|||January 2004||2004-01-01|July 2012|2012-07-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Community-based Helicobacter Pylori Eradication|Community-based Helicobacter Pylori Eradication With Two Sequential Antibiotic Regimens for the Residents and Migrants From a High-risk Area for Gastric Cancer|Unknown status|Recruiting|Phase 4|5000|Anticipated|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 17:24:22.666793|2017-02-18 17:24:22.666793
NCT00155363|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-12-19|||September 2004||2004-09-01|June 2005|2005-06-01||||||||Interventional|||Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis|The Impact of Conventional Hemodialysis, High Flux Hemodialysis and Hemodiafiltration on Adiponectin, Vascular Function and Clinical Prognosis|Unknown status|Recruiting|Phase 4|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:22.884796|2017-02-18 17:24:22.884796
NCT00155350|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-02-24|||November 2004||2004-11-01|August 2005|2005-08-01|December 2007||2007-12-01|||||Interventional|||Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients|Treatment of Coronary Atherosclerosis and Calcification by Insulin Sensitizers in Insulin-Resistant Patients: Evaluated by EBCT, 16-Slice MDCT Coronary Angiography/Scanning, and Intravascular Ultrasound|Unknown status|Recruiting|Phase 4|120||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:22.969479|2017-02-18 17:24:22.969479
NCT00155337|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-12-20|||August 2004||2004-08-01|December 2012|2012-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia|Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia|Completed||Phase 4|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:23.074412|2017-02-18 17:24:23.074412
NCT00155324|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-11-30|||October 2004||2004-10-01|November 2012|2012-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Change and Clinical Significance of Plantar Fascia Thickness After ESWT|Change and Clinical Significance of Plantar Fascia Thickness After Extracorporeal Shock Wave Therapy|Completed||N/A|60|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:23.159245|2017-02-18 17:24:23.159245
NCT00155311|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-03-14|||January 2005||2005-01-01|March 2013|2013-03-01||||December 2008|Actual|2008-12-01||Interventional|||The Regulation of Osteoprotegerin by Mechanical Stimulation||Completed||Phase 1|10|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-02-18 17:24:23.248096|2017-02-18 17:24:23.248096
NCT00155285|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-10-19|||January 2000||2000-01-01|April 2003|2003-04-01|December 2006||2006-12-01|||||Interventional|||Evaluating the Infant Complex Congenital Heart Disease by Multidetector Computed Tomography|Integrated Evaluating the Infant Complex Congenital Heart Disease by Multidetector(16)Spiral Computed Tomography|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:23.34299|2017-02-18 17:24:23.34299
NCT00155272|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||March 2005||2005-03-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma|A Pilot Clinical and Mechanistic Study of Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 1/Phase 2|19||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:23.432427|2017-02-18 17:24:23.432427
NCT00155259|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-23|||October 2004||2004-10-01|July 2005|2005-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer|Docetaxel by 1 Hour Infusion Followed by 24 Hour Infusion of Cisplatin Plus Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer|Completed||Phase 2|47|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:24:23.523925|2017-02-18 17:24:23.523925
NCT00155246|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-01-27|||July 2004||2004-07-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy of Pentoxifylline on Chronic Kidney Disease|Phase 4 Study of the Efficacy of Pentoxifylline in Patients With Chronic Kidney Disease Receiving Angiotensin Receptor Blockade|Completed||Phase 4|60|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 17:24:23.625526|2017-02-18 17:24:23.625526
NCT00155233|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-22|||January 2005||2005-01-01|June 2005|2005-06-01||||||||Interventional|||Interaction Between Nalbuphine and Morphine in PCA|Interaction Between Nalbuphine and Morphine in Postoperative PCA for Gynecologic Patients|Unknown status|Recruiting|Phase 4|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:23.72067|2017-02-18 17:24:23.72067
NCT00155220|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-01-25|||August 2004||2004-08-01|August 2004|2004-08-01|March 2006||2006-03-01|||||Interventional|||Treatment of Lymphedema: Application of the Kinesio Taping|Treatment of Lymphedema- Application of the Kinesio Taping|Unknown status|Recruiting|Phase 2|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:23.808895|2017-02-18 17:24:23.808895
NCT00155207|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||May 2005||2005-05-01|May 2005|2005-05-01|April 2008||2008-04-01|||||Observational|||A Study on Risk Mutations of Vulnerability Genes of Schizophrenia|A Study on Risk Mutations of Vulnerability Genes of Schizophrenia|Unknown status|Recruiting|N/A|1065||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:23.890481|2017-02-18 17:24:23.890481
NCT00155194|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||April 2004||2004-04-01|June 2005|2005-06-01||||||||Observational|||Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice|Impaired T-Lymphocyte Proliferative Function in Biliary Atresia Children With Prolonged Jaundice|Unknown status|Recruiting|N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:23.974835|2017-02-18 17:24:23.974835
NCT00155181|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 2005||2005-01-01|January 2005|2005-01-01|August 2005||2005-08-01|||||Observational|||Molecular Mechanism of Nasopharyngeal Carcinoma|the Garduate Institute of Microbiology in National Taiwan University|Unknown status|Recruiting|N/A|25||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.05618|2017-02-18 17:24:24.05618
NCT00155168|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||April 2004||2004-04-01|April 2004|2004-04-01||||||||Observational|||Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System|Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System: Establishing a Novel Highly Efficient and Reliable SMA Carrier Screening Test|Unknown status|Recruiting|N/A|500||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.134162|2017-02-18 17:24:24.134162
NCT00155155|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2008-12-01|||May 2005||2005-05-01|November 2008|2008-11-01||||April 2008|Actual|2008-04-01||Observational|||Studies of Immune Responses in Patients With Chronic Hepatitis B|Analysis of HBV-Specific T Cell Responses and Regulatory T Cells in Patients With Chronic Hepatitis B Virus Infection|Completed||Phase 1|100|Anticipated|National Taiwan University Hospital|||||f||||f||||||||||2017-02-18 17:24:24.209389|2017-02-18 17:24:24.209389
NCT00155142|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||September 2004||2004-09-01|September 2004|2004-09-01||||||||Observational|||Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.|Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.|Unknown status|Recruiting|N/A|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.290654|2017-02-18 17:24:24.290654
NCT00155103|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2007-03-20|||August 2004||2004-08-01|July 2005|2005-07-01||||||||Observational|||Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma|Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma|Unknown status|Recruiting|N/A|1600||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.641386|2017-02-18 17:24:24.641386
NCT00155090|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 2005||2005-01-01|January 2005|2005-01-01|December 2005||2005-12-01|||||Observational|||Proton Magnetic Resonance Spectroscopy of Normal Breast Tissues in Women Volunteers||Unknown status|Recruiting|N/A|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.722087|2017-02-18 17:24:24.722087
NCT00155077|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-10-19|||June 2004||2004-06-01|June 2004|2004-06-01|June 2009||2009-06-01|||||Observational|||The Correlation Between Tumor Angiogenesis and the Effect of Radiation Therapy in Cervical Cancer Patients|The Correlation Between Tumor Angiogenesis and the Effect of Radiation Therapy in Cervical Cancer Patients|Unknown status|Recruiting|N/A|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.812544|2017-02-18 17:24:24.812544
NCT00155064|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-12-15|||July 2002||2002-07-01|December 2014|2014-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism||Completed||Phase 4|100|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.894883|2017-02-18 17:24:24.894883
NCT00155051|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||July 2004||2004-07-01|June 2004|2004-06-01|April 2005||2005-04-01|||||Observational|||Progestin Treatment for Endometrial Stromal Cells in Adenomyosis||Unknown status|Recruiting|N/A|45||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:24.99897|2017-02-18 17:24:24.99897
NCT00155038|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 1998||1998-01-01|May 2004|2004-05-01|December 2005||2005-12-01|||||Observational|||Imaging Characteristics of Breast Cancer in Women Under 40 Years of Age||Unknown status|Recruiting|N/A|75||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:25.070647|2017-02-18 17:24:25.070647
NCT00154973|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||August 2004||2004-08-01|August 2004|2004-08-01|June 2005||2005-06-01|||||Observational|||Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers||Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:25.147752|2017-02-18 17:24:25.147752
NCT00154960|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-25|||June 2004||2004-06-01|June 2004|2004-06-01||||||||Observational|||Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.|Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.|Unknown status|Recruiting|N/A|1000||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:25.24145|2017-02-18 17:24:25.24145
NCT00154947|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-07-18|||May 2004||2004-05-01|July 2006|2006-07-01|May 2006||2006-05-01|||||Observational|||Develop Biomarkers for Assessing RA Joint Erosion|Develop Biomarkers for Assessing RA Joint Erosion|Unknown status|Active, not recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:25.328018|2017-02-18 17:24:25.328018
NCT00154934|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2009-02-02|||January 2004||2004-01-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|||||Observational|||the Implications of Pathogenesis of Pre-Eclampsia|The Impact of Interleukin-10 in the Invasion Capacity and Immunoregulation During Pregnancy: the Implications of Pathogenesis of Pre-Eclampsia.|Terminated||N/A|0|Actual|National Taiwan University Hospital|||1|difficult to enroll subjects|f||||t||||||Samples Without DNA|"~     placenta biopsy~   "|||2017-02-18 17:24:25.401183|2017-02-18 17:24:25.401183
NCT00154921|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-22|||January 2004||2004-01-01|January 2004|2004-01-01|December 2007||2007-12-01|||||Observational|||Clinical Usefulness of Optical Skin Biopsy|Clinical Usefulness of Optical Skin Biopsy|Unknown status|Recruiting|Phase 1|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:25.479591|2017-02-18 17:24:25.479591
NCT00154895|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-10-19|||June 2001||2001-06-01|June 2001|2001-06-01|March 2005||2005-03-01|||||Interventional|||Additional Minocycline Pleurodesis After Thoracoscopic Procedures for Primary Spontaneous Pneumothorax|Phase III Study of Additional Minocycline Pleurodesis After Video-Assisted Thoracoscopic Surgery for Primary Spontaneous Pneumothorax|Unknown status|Recruiting|Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:25.55615|2017-02-18 17:24:25.55615
NCT00154882|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-01-20|||September 2003||2003-09-01|July 2005|2005-07-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer|Weekly Low-dose Paclitaxel (Phyxol) Plus 24-Hour Infusion of Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|43|Anticipated|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:24:25.650336|2017-02-18 17:24:25.650336
NCT00154869|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-08-10|||June 2004||2004-06-01|August 2005|2005-08-01|August 2007||2007-08-01|||||Interventional|||Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C|An Open Label, Comparative, Multi-Center Study, to Evaluate the Efficacy and Safety of Peginterferon Alfa-2a Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C|Unknown status|Recruiting|Phase 3|320|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:25.961637|2017-02-18 17:24:25.961637
NCT00154856|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||August 2004||2004-08-01|February 2003|2003-02-01|July 2005||2005-07-01|||||Interventional|||Influence of Mechanical Stimulus on Distraction Osteogenesis|Influence of Mechanical Stimulus on Distraction Osteogenesis|Completed||Phase 4|10||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:26.071442|2017-02-18 17:24:26.071442
NCT00154843|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-01-08|||March 2004||2004-03-01|August 2006|2006-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation|A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation|Completed||Phase 2|74|Actual|National Taiwan University Hospital||2|||f||||f||||||||||2017-02-18 17:24:26.161433|2017-02-18 17:24:26.161433
NCT00154830|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-22|||August 2004||2004-08-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Alterations of Functional Activities and Leg Stiffness After Hamstring Lengthening in Cerebral Palsy Children|Alterations of Functional Activities and Leg Stiffness After Hamstring Lengthening in Cerebral Palsy Children|Completed||Phase 4|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:26.360939|2017-02-18 17:24:26.360939
NCT00154817|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-21|||January 2002||2002-01-01|January 2002|2002-01-01|May 2005||2005-05-01|||||Interventional|||A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)|A Phase II Clinical and Mechanistic Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma|Completed||Phase 2|12||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:26.462012|2017-02-18 17:24:26.462012
NCT00154804|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-08-22|||August 2001||2001-08-01|April 2004|2004-04-01|April 2004|Actual|2004-04-01|||||Interventional|||CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer|A Phase II Study of Concurrent Chemoradiotherapy With Twice Weekly Paclitaxel and Cisplatin (Twice Weekly TP) Followed by Surgery for Locally Advanced Esophageal Cancer|Completed||Phase 2|40|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:24:26.546972|2017-02-18 17:24:26.546972
NCT00154791|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||March 2003||2003-03-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Phase I/II Trial GOFL in Advanced Pancreatic Adenocarcinoma|Phase I/II Trial of Biweekly Gemcitabine, Oxaliplatin, and 48-Hour Infusion of High-Dose 5-FU/Leucovorin (GOFL) in Advanced Pancreatic Adenocarcinoma|Completed||Phase 1/Phase 2|45||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:26.667447|2017-02-18 17:24:26.667447
NCT00154778|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-30|||March 2003||2003-03-01|July 2005|2005-07-01|June 2005|Actual|2005-06-01|||||Interventional|||Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer|An Open,Multi-Center,Phase II Clinical Trial tO Evaluate Efficacy and Safety oF TAXOL(PACLITAXEL),UFT,and LEUCOVORIN in Patients With Advanced Gastric Cancer|Completed||Phase 2|55|Actual|National Taiwan University Hospital||1|||f||||t||||||||||2017-02-18 17:24:26.77367|2017-02-18 17:24:26.77367
NCT00154765|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-21|||March 2003||2003-03-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Interventional|||Effect of Sling Suspension Exercises in Proprioception of Patients With Knee Osteoarthritis|Graduate School of Physical Therapy, College of Medicine, NTU, Taiwan|Completed||N/A|30||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:26.890036|2017-02-18 17:24:26.890036
NCT00154752|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-21|||January 1999||1999-01-01|January 1999|1999-01-01|June 2005||2005-06-01|||||Interventional|||Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer|A Randomized Trial Comparing Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer|Unknown status|Recruiting|Phase 3|200||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:26.992434|2017-02-18 17:24:26.992434
NCT00154739|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-08-01|||October 1998||1998-10-01|July 2005|2005-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)|A Phase II Randomized Trial of Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin in Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|86|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:27.084822|2017-02-18 17:24:27.084822
NCT00154726|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-21|||April 1997||1997-04-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers|A Phase II Study of Weekly Paclitaxel(Taxol)and 24-Hour Infusion High-Dose 5-Fluorouracil and Leucovorin(HDFL)in the Treatment Locally Advanced and Recurrent/Metastatic Gastric Cancers|Completed||Phase 2|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:27.191413|2017-02-18 17:24:27.191413
NCT00154713|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||July 2005||2005-07-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment|A Phase I/II Clinical Study of Immunotherapy for Advanced Colorectal Cancers Using CEA-Pulsed Dendritic Cells Mixed With Tetanus Toxoid and Subsequent IL-2 Treatment|Unknown status|Recruiting|Phase 1/Phase 2|37||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:27.274843|2017-02-18 17:24:27.274843
NCT00154700|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-12-19|||January 2001||2001-01-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer|A Phase II Study of Twice Weekly Paclitaxel, Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid in the Treatment of Recurrent or Metastatic Esophageal Cancer|Completed||Phase 2|40||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:27.365204|2017-02-18 17:24:27.365204
NCT00154687|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-30|||October 2000||2000-10-01|July 2005|2005-07-01|December 2004|Actual|2004-12-01|||||Interventional|||Weekly TP-HDFL in the Treatment of Advanced TCC|A Phase II Study of Weekly Paclitaxel, Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin(Weekly TP-HDFL) in the Treatment of Advanced Transitional Cell Carcinoma(TCC)|Completed||Phase 2|40|Actual|National Taiwan University Hospital||1|||f||||f||||||||||2017-02-18 17:24:27.463583|2017-02-18 17:24:27.463583
NCT00154674|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-21|||April 2005||2005-04-01|January 2004|2004-01-01|October 2005||2005-10-01|||||Interventional|||Safety and Feasibility of Endovascular Cooling Device in Patients With Hypothermic Cardiopulmonary Resuscitation||Unknown status|Recruiting|N/A|15||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:27.572398|2017-02-18 17:24:27.572398
NCT00154661|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||January 2000||2000-01-01|June 2001|2001-06-01|June 2001||2001-06-01|||||Interventional|||Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis|Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis|Completed||N/A|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:27.658639|2017-02-18 17:24:27.658639
NCT00154648|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-06-04|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Interventional|||CE-MRA Using Gadovist in Comparison to IA DSA Using Ultravist|An Open, Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA) Study of Arteries Using Gadovist 1.0 in Comparison to Intra-Arterial Digital Subtraction Angiography (IA DSA) Using Ultravist|Unknown status|Recruiting|Phase 4|40|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:27.7677|2017-02-18 17:24:27.7677
NCT00154635|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||September 2005||2005-09-01|September 2005|2005-09-01||||||||Interventional|||Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease|A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of DCB-AD1 in Patients With Mild to Moderate Alzheimer’s Disease|Unknown status|Not yet recruiting|Phase 2|80||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:27.862541|2017-02-18 17:24:27.862541
NCT00154622|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2012-12-05|||January 2004||2004-01-01|December 2012|2012-12-01|December 2008|Actual|2008-12-01|December 2006|Actual|2006-12-01||Interventional|||Management and Outcome of Work-Related Musculoskeletal Disorders|National Taiwan University Hospital|Completed||N/A|160|Actual|National Taiwan University Hospital||1|||f||||||||||||||2017-02-18 17:24:27.959273|2017-02-18 17:24:27.959273
NCT00154609|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-01-20|||January 2002||2002-01-01|January 2002|2002-01-01||||||||Interventional|||Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis|The Use Tradition Chinese Native Medicine Treats the Osteoporosis Research|Unknown status|Recruiting|Phase 1|100||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:28.067053|2017-02-18 17:24:28.067053
NCT00154596|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2015-03-15|||February 2004||2004-02-01|March 2015|2015-03-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Etiology Study of Kawasaki Disease|Etiology Study of Kawasaki Disease--A Prospective Household and Case Control Study|Recruiting||N/A|700|Anticipated|National Taiwan University Hospital|||1||f||||f||||||Samples With DNA|"~     Blood, throat swab, nasopharyngeal aspiration, and rectal swab will be obtained during acute~     illness and at convalescence (about 2 weeks after discharge). These specimens will be~     processed for viral isolation, bacterial culture and toxin detection, PCR, subtractive~     cloning, VIDISCA, gene chips, peptide library, cytokine/chemokine measurement, antibody~     detection for specific pathogens, etc. Questionnaire for contact history and clinical~     symptoms will be performed.~   "|||2017-02-18 17:24:28.16104|2017-02-18 17:24:28.16104
NCT00154583|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-12-20|||January 2003||2003-01-01|January 2003|2003-01-01|December 2008||2008-12-01|||||Observational|||Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions||Unknown status|Recruiting|N/A|500||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:28.267375|2017-02-18 17:24:28.267375
NCT00154570|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-11-21|||February 2004||2004-02-01|February 2004|2004-02-01|August 2005||2005-08-01|||||Observational|||24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis|Integrating Simultaneous Recording of 24 Hour Esophageal pH and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis|Unknown status|Recruiting|N/A|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:28.349135|2017-02-18 17:24:28.349135
NCT00154557|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||August 2004||2004-08-01|August 2004|2004-08-01|July 2006||2006-07-01|||||Observational|||Influence of the Psychophysiological Status of Elite Judo Athletes on Their Performance and Injury||Unknown status|Recruiting|N/A|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:28.430134|2017-02-18 17:24:28.430134
NCT00154544|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||August 2004||2004-08-01|December 2003|2003-12-01||||||||Observational|||Searching for the Liver Cancer-Related Biomarkers|Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by PROTEOMEX|Unknown status|Recruiting|Phase 1|50||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:28.511473|2017-02-18 17:24:28.511473
NCT00154531|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-12-19|||August 2004||2004-08-01|December 2003|2003-12-01|May 2005||2005-05-01|||||Observational|||Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI|Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by Surface-Enhanced Laser Desorption/Ionization (SELDI)|Unknown status|Recruiting|N/A|230||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:28.584399|2017-02-18 17:24:28.584399
NCT00154518|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-02-20|||January 2004||2004-01-01|February 2013|2013-02-01|December 2005||2005-12-01|||||Interventional|||The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement|The Role of Matrix Metalloproteinases in Orthodontic Treatment|Completed||Phase 1|12|Anticipated|National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:28.662357|2017-02-18 17:24:28.662357
NCT00154505|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||September 2002||2002-09-01|August 2002|2002-08-01|November 2004||2004-11-01|||||Interventional|||Effects of Lateral Trunk Support on Spinal Alignment in Spinal Cord Injured Persons|Effects of Lateral Trunk Support on Spinal Alignment in Spinal Cord Injured Persons|Completed||Phase 1|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:28.758079|2017-02-18 17:24:28.758079
NCT00154492|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-12|||April 2004||2004-04-01|January 2017|2017-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Use of NovoSeven® in Active Variceal Bleeding|Effectiveness and Safety of Use of NovoSeven® in the Treatment of Active Variceal Bleeding in Patients With Advanced Cirrhosis|Completed||Phase 2|265|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:24:28.941928|2017-02-18 17:24:28.941928
NCT00154479|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2006-12-13|||October 2003||2003-10-01|October 2003|2003-10-01|December 2008||2008-12-01|||||Observational|||The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human Papillomavirus||Unknown status|Recruiting|N/A|700||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:29.094809|2017-02-18 17:24:29.094809
NCT00154466|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-25|2012-12-06||July 2004||2004-07-01|May 2014|2014-05-01|December 2011|Actual|2011-12-01|July 2010|Actual|2010-07-01||Interventional|||Study on the Efficacy and Mechanism of Cardiac Rehabilitation for Stem Cell Mobilization and Heart Failure Improvement|An Association Study Between Cardiac Rehabilitation and Stem Cell Mobilization in Patients With Myocardial Infarction|Completed||N/A|58|Actual|National Taiwan University Hospital|First, our trial is small size. Second, these results are applicable only for male patients less than 65 years old with ST-segment elevation MI after successful PCI. Third, the source of angiogenic cytokines cannot be elucidated.|3|||f||||t||||||||||2017-02-18 17:24:29.170626|2017-02-18 17:24:29.170626
NCT00154453|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2005-09-09|||January 2004||2004-01-01|October 2003|2003-10-01|August 2004||2004-08-01|||||Interventional|||Age-Related Changes in Myosin Heavy Chain Composition in Human Orbicularis Oculi Muscle||Completed||Phase 1|60||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:24:29.638132|2017-02-18 17:24:29.638132
NCT00154440|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-03-23|||November 2001||2001-11-01|March 2007|2007-03-01|October 2013|Anticipated|2013-10-01|||||Interventional|||Helicobacter – Lymphoma – Radiation Part I: Eradication, Part II: Radiation|Treatment of Low-Grade Gastric Non-Hodgkin‘s Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type Stages IE & II1E (HELYX-Study)|Unknown status|Recruiting|Phase 3|200||Technische Universität Dresden|||||f||||t||||||||||2017-02-18 17:24:29.722866|2017-02-18 17:24:29.722866
NCT00154427|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2017-01-11|||August 2004||2004-08-01|January 2017|2017-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Use of Activated Recombinant Human Factor VII in Cardiac Surgery|A Multi-centre, Randomised, Double-blind, Placebocontrolled, Dose Escalation Trial on Safety and Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in the Treatment of Post-operative Bleeding in Patients Following Cardiac Surgery Requiring Cardiopulmonary Bypass|Terminated||Phase 2|172|Actual|Novo Nordisk A/S||||"Trial terminated after recruiting 172 patients but without proceeding to the highest dosing~   cohort as this no longer reflects common clinical practice"|f||||f||||||||||2017-02-18 17:24:29.83031|2017-02-18 17:24:29.83031
NCT00154414|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-24|||January 2005||2005-01-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes|Effect of Liraglutide on Glycaemic Control in Japanese Subjects With Type 2 Diabetes.|Completed||Phase 2|226|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:24:29.994042|2017-02-18 17:24:29.994042
NCT00154401|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-24|||January 2005||2005-01-01|January 2017|2017-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes|Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.|Completed||Phase 2|177|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:24:30.103266|2017-02-18 17:24:30.103266
NCT00154388|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2016-11-16|||February 2001||2001-02-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases|Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases|Completed||Phase 2|185|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:24:30.240337|2017-02-18 17:24:30.240337
NCT00154375|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-04-19|2011-01-13||October 2004||2004-10-01|April 2011|2011-04-01||||August 2008|Actual|2008-08-01||Interventional|||Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma|Phase III Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma|Completed||Phase 3|240|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:24:33.17473|2017-02-18 17:24:33.17473
NCT00154362|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-11-22|||April 2003||2003-04-01|November 2011|2011-11-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.|A Multi-center, Randomized, Double-blind, Cross-over, Placebo-controlled Clinical Trial to Evaluate Efficacy and Safety of Oxcarbazepine p.o. (300-1200 mg/Day) as Adjuvant Therapy for Impulsivity and Aggressive Behavior in Conduct Disorders in Adolescents|Completed||Phase 4|50|Actual|Novartis|||||f||||||||||||||2017-02-18 17:24:33.970556|2017-02-18 17:24:33.970556
NCT00154349|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2011-03-09|||October 2003||2003-10-01|March 2011|2011-03-01||||February 2007|Actual|2007-02-01||Interventional|||Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia|Phase II Study of Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia|Completed||Phase 2|8|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:24:34.299128|2017-02-18 17:24:34.299128
NCT00154336|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-11-19|||July 2004||2004-07-01|November 2009|2009-11-01||||||||Interventional|||A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.|3-Month, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety & Tolerability of Imatinib 400 mg Daily in Combination With Methotrexate (MTX)Compared to MTX Alone in the Treatment of Rheumatoid Arthritis (RA).|Completed||Phase 2|52||Novartis|||||f||||||||||||||2017-02-18 17:24:34.400219|2017-02-18 17:24:34.400219
NCT00154323|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-11-22|||January 2003||2003-01-01|November 2011|2011-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.|A Multi-center, Randomized, Double-blind, Parallel Group, Placebo-controlled 52 Weeks Clinical Trial to Evaluate Efficacy and Safety of Oxcarbazepine p.o.(300-1200 mg/Day) as Adjuvant Therapy in the Bipolar Disorder I or II Treatment|Completed||Phase 4|55|Actual|Novartis|||||f||||||||||||||2017-02-18 17:24:34.50338|2017-02-18 17:24:34.50338
NCT00154310|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-10-21|2011-01-11||June 2005||2005-06-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients|Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a CNI-free Regimen With Enteric-Coated Mycophenolate Sodium (EC-MPS) and Everolimus in Comparison to Standard Therapy With Enteric-Coated Mycophenolate Sodium (EC-MPS) and Cyclosporine Microemulsion in de Novo Renal Transplant Patients|Completed||Phase 4|300|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:24:34.604565|2017-02-18 17:24:34.604565
NCT00154297|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-03-30|2011-01-04||June 2005||2005-06-01|March 2011|2011-03-01||||June 2008|Actual|2008-06-01||Interventional|||Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients|A National Multicentre Randomized Study Comparing the Early Versus Delayed Administration of Everolimus in de Novo Kidney Transplant Recipients at Risk of Delayed Graft Function|Completed||Phase 4|139|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:24:35.612092|2017-02-18 17:24:35.612092
NCT00154284|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-03-28|2011-01-04||July 2005||2005-07-01|March 2011|2011-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|CERTES02||Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients|A 12 Month, Multicenter, Randomized, Parallel, Open-label Study, to Evaluate Renal Function and Efficacy of Everolimus With Basiliximab and Cyclosporine Microemulsion Discontinuation at 3 Month Post-transplant Versus Minimization, in de Novo Kidney Transplant Recipients|Completed||Phase 3|114|Actual|Novartis|This is a combined analysis using 81 patients randomized and treated in CRAD001A2419 with 33 randomized and treated in CRAD001A2423. This approach is reflected in the protocol amendments for each study, and the one clinical study report for both.|2|||f||||||||||||||2017-02-18 17:24:36.708363|2017-02-18 17:24:36.708363
NCT00154271|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-11-07|||January 2004||2004-01-01|August 2006|2006-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)|Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)|Completed||Phase 4|1677|Actual|Novartis|||||||||||||||||||2017-02-18 17:24:37.177326|2017-02-18 17:24:37.177326
NCT00154258|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-05-03|||April 2001||2001-04-01|May 2012|2012-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia|An Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia|Completed||Phase 2|19|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:24:37.262823|2017-02-18 17:24:37.262823
NCT00154245|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-02-01|||January 2004||2004-01-01|February 2011|2011-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients.||Completed||Phase 4|20||Novartis|||||f||||||||||||||2017-02-18 17:24:37.374884|2017-02-18 17:24:37.374884
NCT00154232|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-11-01|||June 2004||2004-06-01|November 2011|2011-11-01||||March 2005|Actual|2005-03-01||Interventional|||Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)|A 3 Month, Multicenter, Open-label Study to Evaluate the Impact of the Immunosuppressive Combination of Enteric-Coated Mycophenolate Sodium (EC- MPS), Basiliximab and Cyclosporine for Microemulsion With C2 Monitoring, on Efficacy and Safety Outcomes in de Novo Kidney Transplant Recipients at Potential High Risk of DGF.|Completed||Phase 4|46||Novartis|||||f||||||||||||||2017-02-18 17:24:37.45619|2017-02-18 17:24:37.45619
NCT00154219|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-05-18|||November 2004||2004-11-01|May 2012|2012-05-01||||October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis|A 13-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Group Trial of Lumiracoxib (COX189) 100 mg o.d. in Patients With Primary Hip Osteoarthritis Using Celecoxib (200 mg o.d.) as a Positive Control|Completed||Phase 3|1200||Novartis|||||||||||||||||||2017-02-18 17:24:37.550635|2017-02-18 17:24:37.550635
NCT00154206|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-03-06|||September 2004||2004-09-01|March 2014|2014-03-01||||January 2007|Actual|2007-01-01||Interventional|||Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients|A Multicenter, Open, Single Arm, Pilot Study to Evaluate Efficacy, Tolerability and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients|Completed||Phase 4|15||Novartis|||||f||||||||||||||2017-02-18 17:24:37.661347|2017-02-18 17:24:37.661347
NCT00154193|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-04-20|||June 2004||2004-06-01|April 2016|2016-04-01||||November 2007|Actual|2007-11-01||Interventional|||Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels|A 12-month Study to Investigate the Correlations Between Cyclosporine Microemulsion C2 Levels (High, Medium and Low) and AUC0-4 With Regard to Outcome in de Novo Heart and Lung Transplantation - Identification of Target Cyclosporine Microemulsion C2 Levels.|Completed||Phase 4|190|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:24:37.7544|2017-02-18 17:24:37.7544
NCT00154180|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-09-10|||September 2005||2005-09-01|September 2009|2009-09-01|July 2012|Anticipated|2012-07-01|May 2012|Anticipated|2012-05-01||Interventional|||Kronos Early Estrogen Prevention Study (KEEPS)|Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women|Unknown status|Active, not recruiting|Phase 4|728|Anticipated|Kronos Longevity Research Institute||2|||f||||t||||||||||2017-02-18 17:24:37.858679|2017-02-18 17:24:37.858679
NCT00154167|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-12|||February 2003||2003-02-01|September 2005|2005-09-01|June 2003||2003-06-01|||||Interventional|||Safety and Efficacy Study of NV-101 in Dental Patients|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of NV-101 in Dental Patients|Completed||Phase 2|122||Novalar Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:24:38.005743|2017-02-18 17:24:38.005743
NCT00154154|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-12-11|||October 2002||2002-10-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|June 2007|Actual|2007-06-01||Interventional|||Hope for the Chronically Suicidal Patient|Hope for the Chronically Suicidal Patient: Evaluating the Clinical and Health Services Impact of Dialectical Behaviour Therapy in Individuals With Borderline Personality Disorder|Completed||N/A|180|Actual|Centre for Addiction and Mental Health||2|||f||||f||||||||||2017-02-18 17:24:38.085972|2017-02-18 17:24:38.085972
NCT00154141|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-07-11|||June 2005||2005-06-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures|A Prospective, Randomized Controlled Study to Compare the Effects of a Fibrin Sealant (FS2) Versus Manual Compression on Haemostatic Efficacy During Vascular Surgical Procedures Utilising Polytetrafluorethylene Graft Material on an End-to-Side Femoral or Upper Extremity Vascular Access Arterial Anastomosis|Completed||Phase 3|150||Ethicon, Inc.|||||||||||||||||||2017-02-18 17:24:38.215471|2017-02-18 17:24:38.215471
NCT00154128|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-17|||April 2005||2005-04-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||The Influence of a Stabilization Splint on the Body Posture|The Influence of of a Stabilization Splint on the Body Posture in TMD Cases and Controls|Completed||Phase 1|40||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:24:38.558586|2017-02-18 17:24:38.558586
NCT00154115|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-01-20|||March 2005||2005-03-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Levosimendan in High Risk Heart Valve Surgery|Efficacy of Levosimendan in Cardiac Failure After Heart Valve Surgery|Completed||Phase 4|200|Anticipated|Kuopio University Hospital||2|||f||||t||||||||||2017-02-18 17:24:38.643564|2017-02-18 17:24:38.643564
NCT00154102|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-01-12|2010-11-30||May 2004||2004-05-01|January 2017|2017-01-01|March 2011|Actual|2011-03-01|December 2006|Actual|2006-12-01||Interventional|CRYSTAL||Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)|Open, Randomized, Controlled, Multicenter Phase III Study Comparing 5FU/ FA Plus Irinotecan Plus Cetuximab Versus 5FU/FA Plus Irinotecan as First-line Treatment for Epidermal Growth Factor Receptor-expressing Metastatic Colorectal Cancer|Completed||Phase 3|1221|Actual|Merck KGaA|A non-specific outcome measure 'Safety' was deleted from the entry in error. A replacement outcome was created. The outcome refers to adverse events.|2|||f||||t||||||||||2017-02-18 17:24:38.771026|2017-02-18 17:24:38.771026
NCT00154089|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-02-20|||November 2004||2004-11-01|August 2006|2006-08-01|December 2006|Actual|2006-12-01|April 2006|Actual|2006-04-01||Interventional|||A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia|A Pilot Translational Study of Tetra-O-Methyl Nordihydroguaiaretic Acid (EM-1421) for the Treatment of Cervical Intraepithelial Neoplasia Induced by Human Papilloma Virus|Completed||Phase 1/Phase 2|8|Actual|Erimos Pharmaceuticals||1|||f||||f||||||||No||2017-02-18 17:24:40.694546|2017-02-18 17:24:40.694546
NCT00154076|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-09-01|||September 2005||2005-09-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies||Completed||Phase 4|140|Anticipated|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:24:40.795769|2017-02-18 17:24:40.795769
NCT00154063|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-05-21|2015-05-21||January 2005||2005-01-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy and Safety Study of E2007 in Migraine Prophylaxis|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 in Migraine Prophylaxis|Completed||Phase 2|206|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:24:40.910157|2017-02-18 17:24:40.910157
NCT00154037|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-12|||October 2005||2005-10-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.|Characterization of Vascular Effects of Candesartan and Pioglitazone.|Completed||N/A|40||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:24:42.109855|2017-02-18 17:24:42.109855
NCT00154024|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-27|||March 2003||2003-03-01|July 2006|2006-07-01|October 2006||2006-10-01|||||Interventional|||Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.|Characterization of Local Vascular Effects of Angiotensin II and Histamine After Treatment With Irbesartan and Atorvastatin.|Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:24:42.200602|2017-02-18 17:24:42.200602
NCT00154011|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-09-11|||September 2005||2005-09-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.|Characterization of Vascular Effects of Rosiglitazone.|Completed||N/A|24||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:24:42.292755|2017-02-18 17:24:42.292755
NCT00153998|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-02-26|||November 2004||2004-11-01|April 2007|2007-04-01||||March 2008|Actual|2008-03-01||Interventional|||Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)|Open, Randomized, Multicenter, Randomized Phase II Trial Comparing the Combination of Cetuximab With Oxaliplatin/5-FU/FA Versus the Combination of Cetuximab With Irinotecan/5-FU/FA as Neoadjuvant Treatment in Patients With Non-Resectable Colorectal Liver Metastases|Completed||Phase 2|135|Actual|Technische Universität Dresden||2|||f||||f||||||||||2017-02-18 17:24:42.381183|2017-02-18 17:24:42.381183
NCT00153985|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-07-24|2012-12-05||March 2004||2004-03-01|July 2013|2013-07-01|July 2009|Actual|2009-07-01|March 2008|Actual|2008-03-01||Interventional|||Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies|Multi-Center Study Using Allogeneic Stem Cell Transplantation Following Reduced Intensity Chemotherapy in Patients With Hemoglobinopathies|Completed||Phase 2|2|Actual|Dana-Farber Cancer Institute|Early termination leading to small numbers of subjects analyzed.|1|||f||||t||||||||||2017-02-18 17:24:42.535025|2017-02-18 17:24:42.535025
NCT00153725|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-10-26|||February 2003||2003-02-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||Intravenous Pantoloc In Aspirin-Induced Ulcer Bleeding||Completed||N/A|156||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:24:42.790882|2017-02-18 17:24:42.790882
NCT00153712|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-02-28|||August 2002||2002-08-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers|A Prospective Cohort Study to Study the Natural History and Ulcer Recurrence Without Acid Suppression of Non-NSAID, Non-HP Bleeding Peptic Ulcer Patients|Completed||N/A|391|Actual|Chinese University of Hong Kong|||2||f||||f||||||||||2017-02-18 17:24:43.067637|2017-02-18 17:24:43.067637
NCT00153699|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-10-30|||September 2004||2004-09-01|October 2007|2007-10-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Relationship Between Topiramate Use and Ocular Angle Status|Relationship Between Topiramate Use and Ocular Angle Status: A Prospective Pilot Study|Unknown status|Active, not recruiting|Phase 4|15|Anticipated|Chinese University of Hong Kong||1|||f||||||||||||||2017-02-18 17:24:43.171459|2017-02-18 17:24:43.171459
NCT00153686|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-09|||June 2005||2005-06-01|May 2008|2008-05-01|March 2008|Actual|2008-03-01|November 2007|Actual|2007-11-01||Interventional|||Capsule Endoscopy or Mesenteric Angiogram in Patients With Overt Gastrointestinal Bleeding (GIB) of Obscure Origin|Capsule Endoscopy or Mesenteric Angiogram in Patients With Overt Gastrointestinal Bleeding of Obscure Origin: A Randomized Study|Completed||N/A|58|Actual|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 17:24:43.274366|2017-02-18 17:24:43.274366
NCT00153673|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-02-18|||February 2001||2001-02-01|February 2014|2014-02-01||||December 2016|Anticipated|2016-12-01||Interventional|||Effect of Selective COX-2 Inhibition on Ulcer Healing|Phase III Study of a Double-Blind Randomized Comparison of Famotidine Plus Celecoxib Versus Dologesics for Gastric Ulcer Healing in Arthritis Patients (NSAID#5A Study)|Suspended||Phase 3|200|Anticipated|Chinese University of Hong Kong||2||slow recruitment|f||||||||||||||2017-02-18 17:24:43.379643|2017-02-18 17:24:43.379643
NCT00153660|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-12-30|||June 2005||2005-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2014|Actual|2014-11-01||Interventional|||Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients|A Double-blind Randomized Comparison of Celecoxib Plus Esomeprazole Versus Naproxen Plus Esomeprazole for Prevention of Recurrent Ulcer Bleeding in Patients With Arthritis and Cardiothrombotic Diseases (NSAID#8 Study)|Completed||Phase 3|514|Actual|Chinese University of Hong Kong||2|||f||||t||||||||No||2017-02-18 17:24:43.48406|2017-02-18 17:24:43.48406
NCT00153647|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-03-14|||May 2005||2005-05-01|August 2007|2007-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|CAC||A Study to Assess Cap-Assisted Colonoscopy Versus Regular Colonoscopy for the First or Repeated Colonoscopy|A Study to Assess the Success Rate of Cap-Assisted Colonoscopy Versus Regular Colonoscopy for the First or Repeated Colonoscopy (CAC Study)|Completed||N/A|1000|Actual|Chinese University of Hong Kong||2|||f||||||||||||||2017-02-18 17:24:43.586453|2017-02-18 17:24:43.586453
NCT00153634|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-03-12|||March 2004||2004-03-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)|Standard vs. Biofilm Susceptibility Testing in CF|Completed||N/A|75|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-02-18 17:24:43.681924|2017-02-18 17:24:43.681924
NCT00153621|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-02|||September 2004||2004-09-01|September 2005|2005-09-01|September 2007|Actual|2007-09-01|||||Observational|||Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients|Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric Patients in the Special Immunology, Burgess, and Nephrology Clinics|Completed||N/A|320|Anticipated|Children's Research Institute|||||f||||||||||||||2017-02-18 17:24:43.811987|2017-02-18 17:24:43.811987
NCT00153608|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-02-13|||April 2004||2004-04-01|September 2005|2005-09-01||||||||Interventional|||WT1 Peptid Vaccination in Carcinomas|Phase II Study of WT1 126-134 Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in Carcinomas|Unknown status|Recruiting|Phase 2|25||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:24:43.888066|2017-02-18 17:24:43.888066
NCT00153595|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-23|||November 2004||2004-11-01|September 2005|2005-09-01||||||||Interventional|||EWO1 in Persistent Allergic Rhinitis Patients|A Double-Blind, Randomized Parallel Group, Placebo-Control Study of EW01 in Persistent Allergic Rhinitis (PAR) Patients|Unknown status|Recruiting|Phase 2/Phase 3|60|Anticipated|China Medical University Hospital|||||f||||||||||||||2017-02-18 17:24:43.971648|2017-02-18 17:24:43.971648
NCT00153582|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-02-21|||April 2002||2002-04-01|September 2005|2005-09-01||||||||Interventional|||WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)|Phase II Study of WT1 126-134 Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in AML|Unknown status|Recruiting|Phase 2|25||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:24:44.060811|2017-02-18 17:24:44.060811
NCT00153569|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-05-25|||March 2003||2003-03-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Multiepitope Peptide Vaccination in Melanoma|Phase II Study of Multiepitope Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in Metastatic Melanoma|Unknown status|Active, not recruiting|Phase 2|25||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:24:44.157661|2017-02-18 17:24:44.157661
NCT00153556|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||September 2001||2001-09-01|September 2005|2005-09-01|November 2003||2003-11-01|||||Interventional|||Study to Eliminate Hib Carriage in Rural Alaska Native Villages|A Demonstration Project for the Elimination of Haemophilus Influenzae Type B in Three Rural Alaska Native Villages|Completed||Phase 4|3200||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 17:24:44.250342|2017-02-18 17:24:44.250342
NCT00153543|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-03-19|||May 2002||2002-05-01|September 2005|2005-09-01|June 2003||2003-06-01|||||Interventional|||Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders|Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders|Completed||Phase 1|90||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 17:24:44.34456|2017-02-18 17:24:44.34456
NCT00153530|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-12-23|||May 2000||2000-05-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|||||Interventional|||Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)|Phase IV Study on the Role of Whole Brain Irradiation in Primary CNS Lymphoma (PCNSL) After High-dose Methotrexate|Completed||Phase 4|604|Anticipated|Charite University, Berlin, Germany||2|||f||||||||||||||2017-02-18 17:24:44.434978|2017-02-18 17:24:44.434978
NCT00153517|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||October 1999||1999-10-01|September 2005|2005-09-01|March 2005||2005-03-01|||||Interventional|||Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy|Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy (Randomized Trial of BV Treatment in Pregnancy)|Completed||Phase 2|126||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:44.54965|2017-02-18 17:24:44.54965
NCT00153504|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-04-04|||July 2004||2004-07-01|April 2012|2012-04-01|January 2007|Actual|2007-01-01|||||Interventional|H&H||Housing and Health Study|Housing and Health Study|Completed||N/A|630|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 17:24:44.637376|2017-02-18 17:24:44.637376
NCT00153491|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||August 2002||2002-08-01|September 2005|2005-09-01|August 2006||2006-08-01|||||Observational|||Adherence to Lumefantrine-Artemether|Assessment of Adherence to a 6-Dose Regimen of Coartem for Treatment of Uncomplicated Malaria in Children Under 5 Years in Tanzania|Completed||Phase 4|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:44.736753|2017-02-18 17:24:44.736753
NCT00153478|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||July 2002||2002-07-01|September 2005|2005-09-01|August 2004||2004-08-01|||||Interventional|||Project CHOICES Efficacy Study|Project CHOICES Efficacy Study for Preventing Alcohol-Exposed Pregnancies|Completed||Phase 2|1200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:44.82923|2017-02-18 17:24:44.82923
NCT00153465|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-09-06|||January 2004||2004-01-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||University of Oklahoma Parenting Program Attrition|University of Oklahoma Health Sciences Center Parenting Program Attrition and Compliance Efficacy Trial|Completed||Phase 1|450||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:24:44.938119|2017-02-18 17:24:44.938119
NCT00153452|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||November 2004||2004-11-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Observational|||Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners|Workplace Productivity of Persons Who Use Controlling Behavior With Intimate Partners|Completed||N/A|630||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:45.044968|2017-02-18 17:24:45.044968
NCT00153439|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-09-06|||July 2003||2003-07-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Purdue University Parenting Program Attrition|Purdue University Parenting Program Attrition and Compliance Efficacy Trial|Completed||Phase 1|560||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:24:45.128386|2017-02-18 17:24:45.128386
NCT00153426|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-06-27|||July 2003||2003-07-01|June 2012|2012-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||West Virginia WISEWOMAN Project|West Virginia WISEWOMAN Project|Completed||N/A|733|Actual|West Virginia University||1|||f||||f||||||||||2017-02-18 17:24:45.23458|2017-02-18 17:24:45.23458
NCT00153413|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08||||||September 2005|2005-09-01||||||||Interventional|||West Virginia WISEWOMAN Focus Groups|West Virginia WISEWOMAN Focus Groups|Unknown status|Active, not recruiting|N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:45.330084|2017-02-18 17:24:45.330084
NCT00153400|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-02-10||||||September 2005|2005-09-01||||||||Interventional|||California WISEWOMAN Project|California WISEWOMAN Project|Unknown status|Not yet recruiting|N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:45.396168|2017-02-18 17:24:45.396168
NCT00153387|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08||||||September 2005|2005-09-01||||||||Interventional|||Illinois WISEWOMAN Project|Illinois WISEWOMAN Project|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:45.470422|2017-02-18 17:24:45.470422
NCT00152620|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-09-04|||June 2004||2004-06-01|September 2013|2013-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease|Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease|Terminated||N/A|40||University of Chicago||||study completed|f||||||||||||||2017-02-18 17:24:45.550361|2017-02-18 17:24:45.550361
NCT00152607|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-09-26|||April 2000||2000-04-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Orthotopic Liver Transplantation Using a Living Donor|Orthotopic Liver Transplantation Using a Living Donor Into An Adult Recipient|Terminated||Phase 4|20|Actual|University of Chicago||1||Poor accrual|f||||||||||||||2017-02-18 17:24:45.665829|2017-02-18 17:24:45.665829
NCT00152594|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-11-13|||October 2004||2004-10-01|November 2006|2006-11-01|January 2006||2006-01-01|||||Interventional|||Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia|Phase III Study of Safety, Tolerance, Efficacy, Pharmacokinetics, and Costs of Therapy With Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia|Terminated||Phase 3|150||University of Cologne|||||f||||||||||||||2017-02-18 17:24:45.890871|2017-02-18 17:24:45.890871
NCT00152581|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-11-29|||April 2002||2002-04-01|September 2005|2005-09-01||||||||Interventional|||Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication|Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication|Completed||Phase 4|40||University College London Hospitals|||||f||||||||||||||2017-02-18 17:24:45.981936|2017-02-18 17:24:45.981936
NCT00152568|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-09-04|||June 2001||2001-06-01|September 2013|2013-09-01|December 2003|Actual|2003-12-01|September 2003|Actual|2003-09-01||Interventional|||The Effectiveness of Car Seat Checks at Routine Pediatric Visits|The Effectiveness of Car Seat Checks at Routine Pediatric Visits|Completed||N/A|364|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 17:24:46.079973|2017-02-18 17:24:46.079973
NCT00152555|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-06-11|||March 2003||2003-03-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Physical Therapy for Systemic Lupus Erythematosus (SLE)|Physical Therapy for Improvement of Quality of Life in Patients With Systemic Lupus Erythematosus (SLE)|Terminated||N/A|100||University of Chicago||||study completed|f||||||||||||||2017-02-18 17:24:46.182422|2017-02-18 17:24:46.182422
NCT00152542|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-06-11|||May 2005||2005-05-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants|Follow up at School-age of Children Participating in the Nitric Oxide Ventilatory Approach (NOVA) Study|Completed||Phase 3|160|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 17:24:46.279475|2017-02-18 17:24:46.279475
NCT00152529|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-09-04|||October 2003||2003-10-01|September 2013|2013-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Observational|||C.A.T.C.H.-I.T.Competent Adulthood Transition With Cognitive, Humanistic and Interpersonal Teaching|"C.A.T.C.H.-I.T. Competent Adulthood Transition With Cognitive, Humanistic and Interpersonal Teaching"|Terminated||N/A|8||University of Chicago||||Study completed|f||||||||||||||2017-02-18 17:24:46.3962|2017-02-18 17:24:46.3962
NCT00152516|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-02-08|2009-08-27||October 2004||2004-10-01|April 2010|2010-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures|A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures.|Completed||Phase 3|255|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:24:46.492522|2017-02-18 17:24:46.492522
NCT00152503|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-09-30|||August 2005||2005-08-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam|An Open Label, Exploratory, Dose-Escalation, Multicenter Study Examining the Safety, Tolerability and Efficacy of Ucb 44212 (Seletracetam) Used at Doses of 10, 20, 40, and 80 mg b.i.d. (Total Daily Doses of 20 - 160 mg) Administration (Oral Capsules) in Adult Subjects (18 - 65 Years) With Refractory Epilepsy Suffering From Partial Onset Seizures Who Are Currently Receiving Levetiracetam (LEV) But Still Experiencing Seizures|Completed||Phase 2|60||UCB Pharma|||||f||||||||||||||2017-02-18 17:24:47.418415|2017-02-18 17:24:47.418415
NCT00152490|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-09-06|||December 2003||2003-12-01|February 2010|2010-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)|A Phase III Multi-national, Multi-centre, Double-blind Placebo-controlled Parallel Group, 26 Week Study to Assess the Safety and Efficacy of the Humanised Anti-TNF PEG Conjugate, CDP870 400 mg sc, (Dosed at Weeks 0, 2, 4 Then 4-weekly to Week 24), in the Treatment of Patients With Active Crohn's Disease|Completed||Phase 3|604||UCB Pharma|||||f||||||||||||||2017-02-18 17:24:47.52179|2017-02-18 17:24:47.52179
NCT00153374|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-03-13||||||March 2012|2012-03-01||||||||Interventional|||Iowa WISEWOMAN Project|Iowa WISEWOMAN Project|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:47.613523|2017-02-18 17:24:47.613523
NCT00153361|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-01-06|||October 2002||2002-10-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Project MIX: Behavioral Intervention to Reduce Risk Among Substance-Using MSM|Project Mix: Behavioral Intervention to Reduce Sexual Risk Behavior of Substance-Using (Non-Injection) Men Who Have Sex With Men|Completed||N/A|1750|Anticipated|Centers for Disease Control and Prevention||3|||f||||||||||||||2017-02-18 17:24:47.681356|2017-02-18 17:24:47.681356
NCT00153348|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-03-13|||January 2001||2001-01-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||South Central Foundation - WISEWOMAN Project|South Central Foundation - WISEWOMAN Project|Completed||N/A|||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:47.792758|2017-02-18 17:24:47.792758
NCT00153335|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-02-24|||June 2005||2005-06-01|February 2010|2010-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Computerized Risk Assessment in an Employee Population|Computerized Risk Assessment in an Employee Population|Completed||N/A|300|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:47.863424|2017-02-18 17:24:47.863424
NCT00153322|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||November 2002||2002-11-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Shape Up Somerville: Eat Smart Play Hard|Shape Up Somerville: Eat Smart Play Hard|Completed||N/A|3000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:47.962937|2017-02-18 17:24:47.962937
NCT00153309|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-11-16|||June 2003||2003-06-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Program Evaluation of People With Arthritis Can Exercise|Evaluation of the Health Benefits of the People With Arthritis Can Exercise Program|Completed||Phase 2/Phase 3|320||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:24:48.07005|2017-02-18 17:24:48.07005
NCT00153296|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-02-18|||August 2004||2004-08-01|February 2009|2009-02-01|April 2005||2005-04-01|||||Interventional|||Study of Efficacy of Carbamazepine in Therapy of Patients With Moderate Persistent and Severe Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Carbamazepine Efficacy in Moderate Persistent and Severe Asthma Therapy|Completed||Phase 4|68||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-02-18 17:24:48.170096|2017-02-18 17:24:48.170096
NCT00153283|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-02-18|||September 2003||2003-09-01|February 2009|2009-02-01|April 2004||2004-04-01|||||Interventional|||Study of Efficacy of Gabapentin in Therapy of Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Gabapentin Efficacy in Asthma Therapy|Completed||Phase 4|68||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-02-18 17:24:48.265927|2017-02-18 17:24:48.265927
NCT00153270|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-02-18|||September 2000||2000-09-01|February 2009|2009-02-01|April 2001||2001-04-01|||||Interventional|||Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Sodium Valproate Efficacy in Asthma Therapy|Completed||Phase 4|46||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-02-18 17:24:48.356036|2017-02-18 17:24:48.356036
NCT00153257|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||June 2005||2005-06-01|September 2005|2005-09-01|June 2011||2011-06-01|||||Interventional|||Comparative Study of Mesh Versus No Mesh in Prolapse Surgery|Comparison of the Prosthesis Ugytex by the Trans-Obturator Approach and Anterior Colporrhaphy for the Surgical Treatment of Anterior Vaginal Wall Prolapse.|Unknown status|Recruiting|Phase 4|194||Centre Hospitalier Universitaire de Nīmes|||||f||||||||||||||2017-02-18 17:24:48.448086|2017-02-18 17:24:48.448086
NCT00153244|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-02-18|||August 2002||2002-08-01|February 2009|2009-02-01|May 2003||2003-05-01|||||Interventional|||Study of Efficacy of Lamotrigine in Therapy of Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Lamotrigine Efficacy in Asthma Therapy|Completed||Phase 4|76||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-02-18 17:24:48.530362|2017-02-18 17:24:48.530362
NCT00153231|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-03-26|||March 2003||2003-03-01|March 2015|2015-03-01|May 2007|Actual|2007-05-01|December 2005|Actual|2005-12-01||Interventional|||Posterior IVS Versus Sacrospinous Suspension in Vaginal Vault Prolapse Repair|Clinical Evaluation of Morbidity and Efficacy of Posterior IVS (Infracoccygeal Sacropexy), in Comparison to the Standard Sacrospinous Suspension in the Surgical Treatment of Vaginal Vault Prolapse by the Vaginal Route.|Completed||Phase 4|49|Actual|Centre Hospitalier Universitaire de Nīmes||2|||f||||f||||||||||2017-02-18 17:24:48.620455|2017-02-18 17:24:48.620455
NCT00153218|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-02-13|||June 2004||2004-06-01|February 2012|2012-02-01||||||||Observational|||An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu|An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu|Completed||N/A|94|Actual|Cancer Research Network|||1||f||||||||||||||2017-02-18 17:24:48.712154|2017-02-18 17:24:48.712154
NCT00153205|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2017-02-14|||February 2000||2000-02-01|February 2017|2017-02-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||Serious Medication Errors in Pediatrics: Evaluation of Prevention Strategies|Serious Medication Errors in Pediatrics: Evaluation of Prevention Strategies|Withdrawn||N/A|0|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-02-18 17:24:48.798685|2017-02-18 17:24:48.798685
NCT00153192|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-04-25|||April 2001||2001-04-01|April 2013|2013-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain|A Randomized Controlled Clinical Trial of Dronabinol (Marinol) vs Placebo as Add-on Therapy For Patients on Opioids for Chronic Pain|Completed||Phase 2/Phase 3|30||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:24:48.89452|2017-02-18 17:24:48.89452
NCT00153179|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-05-30|2013-03-19||September 2005||2005-09-01|May 2013|2013-05-01|March 2013|Actual|2013-03-01|December 2011|Actual|2011-12-01||Interventional|||Free Fatty Acids and Vascular Function in Subjects With Diabetes|The Impact of Free Fatty Acid Reduction on Vascular Function and Skeletal Muscle Glucose Utilization in Type 2 Diabetes Mellitus|Completed||Phase 1/Phase 2|110|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 17:24:49.009434|2017-02-18 17:24:49.009434
NCT00153166|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-09-22|2013-04-24||January 2004||2004-01-01|September 2014|2014-09-01|December 2011|Actual|2011-12-01|November 2010|Actual|2010-11-01||Interventional||Baseline Characteristics were collected according to the clinical diagnosis of the patients and not according to randomization. Participants are grouped at Baseline regardless of randomization because we are measuring baseline characteristics that do not depend on which intervention they received.|ARREST PAD (Peripheral Arterial Disease)|The Contribution of Inflammation and Insulin Resistance to Intermittent Claudication|Completed||Phase 2/Phase 3|76|Actual|Brigham and Women's Hospital||3|||f||||t||||||||||2017-02-18 17:24:49.40299|2017-02-18 17:24:49.40299
NCT00153153|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-02-06|||August 2003||2003-08-01|February 2013|2013-02-01||||December 2004|Actual|2004-12-01||Interventional|||Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients|Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients|Completed||Phase 4|300||Braintree Laboratories|||||||||||||||||||2017-02-18 17:24:49.893397|2017-02-18 17:24:49.893397
NCT00153140|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-02-06|||July 2004||2004-07-01|February 2013|2013-02-01||||October 2004|Actual|2004-10-01||Interventional|||Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation|Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation|Completed||Phase 4|239||Braintree Laboratories|||||||||||||||||||2017-02-18 17:24:50.141902|2017-02-18 17:24:50.141902
NCT00153127|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-02-06|||November 2001||2001-11-01|February 2013|2013-02-01||||September 2004|Actual|2004-09-01||Interventional|||Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications|Comparison of Braintree PolyethyleneGlycol(PEG) Laxative and Placebo for Relief of Constipation From Constipating Medications|Completed||Phase 4|100||Braintree Laboratories|||||||||||||||||||2017-02-18 17:24:50.253013|2017-02-18 17:24:50.253013
NCT00153114|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-02-06|||January 2003||2003-01-01|February 2013|2013-02-01||||September 2004|Actual|2004-09-01||Interventional|||PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children|PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children|Completed||Phase 4|100||Braintree Laboratories|||||||||||||||||||2017-02-18 17:24:50.333669|2017-02-18 17:24:50.333669
NCT00153101|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-05-13|2009-06-15||November 2001||2001-11-01|May 2014|2014-05-01||||June 2008|Actual|2008-06-01||Interventional||The Full Analysis Set (FAS) followed the intent-to-treat principle; it included all patients who were randomised and had any follow-up information available (i.e. 'date last seen' was available for these patients).|Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.|ONTARGET ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial A Large, Simple Randomized Trial of an Angiotensin II Receptor Antagonist (Telmisartan) and an ACE-Inhibitor (Ramipril) in Patients at High Risk for Cardiovascular Events and TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects With Cardiovascular Disease. A Parallel Study Comparing the Effects of Telmisartan With Placebo and Outcomes in Patients at High Risk for Cardiovascular Events and Intolerant to ACE-I.|Completed||Phase 4|31546|Actual|Boehringer Ingelheim|Only non-serious Adverse Events (AE) which lead to discontinuation of study medication were assessed and collected; the frequency was under 5%. Non-serious AEs per se were not assessed or collected.||||f||||||||||||||2017-02-18 17:24:50.737538|2017-02-18 17:24:50.737538
NCT00153088|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-10-31|||January 2003||2003-01-01|October 2013|2013-10-01|November 2005||2005-11-01|November 2005|Actual|2005-11-01||Interventional|||INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy|A Randomised, Double-blind, Placebo-controlled, Multicenter Trial to Investigate the Preventive Effect of BIBR277 (Telmisartan) in Diabetic Nephropathy on Transition From Incipient to Overt Nephropathy - Incipient to Overt : Angiotensin 2 Receptor Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION Study -|Completed||Phase 4|527|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:25:18.843816|2017-02-18 17:25:18.843816
NCT00153075|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-10-28|||September 2005||2005-09-01|October 2013|2013-10-01|December 2005||2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised Open Label, Six Way, Cross-over Scintigraphic Evaluation of the Effect of Inspiratory Flow Rate on Lung and Oropharyngeal Deposition With the Respimat Inhaler vs. a Metered Dose Inhaler (HFA-MDI) Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 4|19||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:25:19.377961|2017-02-18 17:25:19.377961
NCT00153062|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-04-22|2009-02-06||August 2003||2003-08-01|April 2014|2014-04-01||||April 2008|Actual|2008-04-01||Interventional|||PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes|PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis|Completed||Phase 4|20332|Actual|Boehringer Ingelheim|All SAEs and AEs that led to temporary or permanent trial drug discontinuation were reported, except in Japan, where all AEs were collected. Protocol-defined outcome events were not reported as AEs, but were recorded on the appropriate form|4|||f||||||||||||||2017-02-18 17:25:19.667201|2017-02-18 17:25:19.667201
NCT00153049|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-07|||June 2004||2004-06-01|November 2013|2013-11-01|June 2005||2005-06-01|June 2005|Actual|2005-06-01||Interventional|||3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension|A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension|Completed||Phase 2|583|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:25:27.982411|2017-02-18 17:25:27.982411
NCT00153036|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2014-04-30||2014-04-30|April 2003||2003-04-01|April 2014|2014-04-01||||February 2008|Actual|2008-02-01||Interventional|||Rt-PA in the Treatment of Acute Ischemic Stroke|ECASS III - European Cooperative Acute Stroke Study III: A Placebo Controlled Trial of Alteplase (Rt-PA) in Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4 Hours 30 Minutes After Stroke Onset|Completed||Phase 3|821|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:25:28.10644|2017-02-18 17:25:28.10644
NCT00153023|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-11-12|||April 2003||2003-04-01|November 2013|2013-11-01|December 2005||2005-12-01|December 2005|Actual|2005-12-01||Interventional|||1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy|A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Investigate the Efficacy of Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy VIVALDI-Study|Completed||Phase 4|885||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:25:28.449125|2017-02-18 17:25:28.449125
NCT00153010|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-10-28|||February 2003||2003-02-01|October 2013|2013-10-01||||March 2005|Actual|2005-03-01||Interventional|||An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type|A Phase II Double-Blind, Randomized, Dose-Ranging, Placebo-Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type|Completed||Phase 2|430|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:25:28.657852|2017-02-18 17:25:28.657852
NCT00152997|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-09|2013-10-30|||August 2004||2004-08-01|October 2013|2013-10-01||||December 2005|Actual|2005-12-01||Interventional|||Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome|A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pramipexole With the Dose Range From 0.125 mg to 0.75 mg Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome.|Completed||Phase 2|41|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:25:31.98695|2017-02-18 17:25:31.98695
NCT00152984|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-10-31|||December 2004||2004-12-01|October 2013|2013-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma|A 12-week Randomised, Double Blind, Placebo Controlled, Parallel Group Trial Evaluating the Efficacy and Safety of Inhaled Tiotropium 18μg q.d. in Patients With COPD and a Concomitant Diagnosis of Asthma|Completed||Phase 4|472||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:25:32.100395|2017-02-18 17:25:32.100395
NCT00152971|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-04-22|2010-11-18||November 2004||2004-11-01|April 2014|2014-04-01||||June 2006|Actual|2006-06-01||Interventional|||Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement|A Phase III, Randomized, Parallel-group, Double-blind, Active Controlled Study to Investigate the Efficacy and Safety of Two Different Dose Regimens (75mg Day 1 Followed by 150 mg Day 2-completion, and 110 mg Day 1 Followed by 220 mg Day 2-completion) of Dabigatran Etexilate Administered Orally (Capsules), Compared to Enoxaparin 30 mg Twice a Day Subcutaneous for 12 - 15 Days in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Knee Replacement Surgery|Completed||Phase 3|2615|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 17:25:34.962314|2017-02-18 17:25:34.962314
NCT00152958|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-11-18|||January 2004||2004-01-01|November 2013|2013-11-01||||February 2005|Actual|2005-02-01||Interventional|||A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)|A Double-blind, Placebo-controlled, Randomised Withdrawal Study of 3 Month Duration in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)|Completed||Phase 3|224||Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:25:36.417891|2017-02-18 17:25:36.417891
NCT00152945|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-09-28|||April 2005||2005-04-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|July 2008|Actual|2008-07-01||Interventional|||Determining the Responsiveness of Intestinal Lipoprotein Production to an Elevation of Plasma Free Fatty Acids||Completed||N/A|10|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 17:25:36.515649|2017-02-18 17:25:36.515649
NCT00152932|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-23|||May 2005||2005-05-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide|Ocular Blood Flow Measured by HRF and CLBF in Newly Diagnosed and Early Glaucoma Patients Before and After Instillation of Dorzolamide 2%|Unknown status|Recruiting|N/A|17|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:25:36.612134|2017-02-18 17:25:36.612134
NCT00152919|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-08-12|||February 2004||2004-02-01|August 2010|2010-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy|A Comparison of 2 Schedules of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy - A Randomized Phase III Trial|Completed||Phase 3|100|Anticipated|University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:25:36.72496|2017-02-18 17:25:36.72496
NCT00152906|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-10-31|||July 2003||2003-07-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Stereotactic Radiotherapy (SRT) Liver (COLD 1)|Phase I/II Trial of Highly Conformal Radiotherapy for Unresectable Liver Metastases and Hepatobiliary Carcinoma|Active, not recruiting||Phase 1/Phase 2|140|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:25:36.809758|2017-02-18 17:25:36.809758
NCT00152893|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-07-17|||August 2002||2002-08-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities|The Effects of Chromium Supplementation on Glucose and Lipid Metabolism in Patients With HIV Infection|Completed||Phase 2|52|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-02-18 17:25:37.155001|2017-02-18 17:25:37.155001
NCT00152880|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-11-29|||July 2005||2005-07-01|September 2005|2005-09-01||||||||Observational|||Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative|Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative, Have Normal ALT, and HBV DNA ≥10,000 Copies/mL|Unknown status|Recruiting|N/A|30||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:25:37.285864|2017-02-18 17:25:37.285864
NCT00152867|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-06-26|||January 2005||2005-01-01|June 2012|2012-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy|A Randomised Double-Blind Placebo Controlled Cross Over Trial of the Impact on Quality of Life of Continuing Dexamethasone Beyond 24 Hours Following Moderately Emetogenic Chemotherapy|Completed||Phase 3|86|Actual|University Health Network, Toronto||2|||f||||f||||||||||2017-02-18 17:25:37.377482|2017-02-18 17:25:37.377482
NCT00152854|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-03-04|||July 2005||2005-07-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Acetaminophen for Cancer Pain|A Randomised, Placebo-controlled, Crossover Trial of Acetaminophen in Cancer Patients on Strong Opioids|Completed||Phase 3|12|Actual|University Health Network, Toronto||2|||f||||||||||||||2017-02-18 17:25:37.478652|2017-02-18 17:25:37.478652
NCT00152841|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-03-16|||June 2002||2002-06-01|March 2009|2009-03-01||||February 2009|Actual|2009-02-01||Interventional|||Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis|Effect of Iron and Antioxidant Vitamins on Disease Activity and Oxidative Stress in Inflammatory Bowel Disease (IBD)|Terminated||Phase 2|30|Anticipated|University Health Network, Toronto||||Lack of patients|f||||f||||||||||2017-02-18 17:25:37.58889|2017-02-18 17:25:37.58889
NCT00152828|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-02-08|||February 2001||2001-02-01|February 2016|2016-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix|A Phase I/II Trial of the Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix|Completed||Phase 1/Phase 2|31|Actual|University Health Network, Toronto||1|||f||||t||||||||||2017-02-18 17:25:37.68723|2017-02-18 17:25:37.68723
NCT00152815|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-07-17|||October 2003||2003-10-01|July 2013|2013-07-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions|Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions|Terminated||Phase 2|30|Actual|University Health Network, Toronto||1||Not enough eligible patients available|f||||f||||||||||2017-02-18 17:25:37.791304|2017-02-18 17:25:37.791304
NCT00152802|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-02-16|||January 2005||2005-01-01|September 2005|2005-09-01|January 2009||2009-01-01|||||Interventional|||Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine|Immunogenicity of Pneumococcal Vaccine in Liver Transplant Recipients Using a Conjugate-Polysaccharide Priming-Booster Strategy|Unknown status|Active, not recruiting|Phase 4|130||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:25:37.902658|2017-02-18 17:25:37.902658
NCT00152789|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-08-07|||April 2001||2001-04-01|January 2008|2008-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy|Oxygenation of the Prostate Gland: a Polarographic Electrode Study in Men Undergoing Prostate Biopsy.|Completed||Phase 2|40|Anticipated|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:25:37.991188|2017-02-18 17:25:37.991188
NCT00152776|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-04-18|||February 2005||2005-02-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Treating Climacteric Symptoms With a Complex Homeopathic Remedy|Treatment of Climacteric Symptoms With Ovaria Comp - A Prospective Randomized Placebo Controlled Doubleblind Study|Completed||Phase 4|102||Heidelberg University|||||f||||f||||||||||2017-02-18 17:25:38.077882|2017-02-18 17:25:38.077882
NCT00152763|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-01-05|2010-10-27||October 2003||2003-10-01|January 2011|2011-01-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Psychological Support for Patients With an Implantable Cardioverter Defibrillator|Psychological Support for Patients With an Implantable Cardioverter Defibrillator|Completed||Phase 3|193|Actual|University Health Network, Toronto||4|||f||||||||||||||2017-02-18 17:25:38.178485|2017-02-18 17:25:38.178485
NCT00152750|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-02-27|||September 2006||2006-09-01|October 2006|2006-10-01|October 2008||2008-10-01|||||Interventional|||Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD|Aggressive Behaviour in Children With Tourette's Syndrome (TS) and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)|Unknown status|Recruiting|Phase 4|32||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:25:39.460935|2017-02-18 17:25:39.460935
NCT00152737|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-07-16|||March 2004||2004-03-01|July 2015|2015-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Objective Evaluation of Proximal Ischemia|Effet Des Gestes de Revascularisation à l'étage Proximal|Completed||N/A|165|Actual|University Hospital, Angers|||1||f||||t||||||||||2017-02-18 17:25:39.565032|2017-02-18 17:25:39.565032
NCT00152724|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-03-16|||January 1996||1996-01-01|March 2007|2007-03-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Mechanisms of Human Cutaneous Microcirculation in Healthy Volunteers|Etude de la Reserve Vasomotrice Microcirculatoire cutanée|Unknown status|Recruiting|Phase 4|85||University Hospital, Angers|||||f||||f||||||||||2017-02-18 17:25:39.655241|2017-02-18 17:25:39.655241
NCT00152711|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-02-12|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis|Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis: A Prospective Cross Over Trial|Unknown status|Recruiting|N/A|40||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:25:39.753233|2017-02-18 17:25:39.753233
NCT00152698|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-01-18|||November 2009||2009-11-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia|A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Study the Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia|Completed||Phase 3|80||University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-02-18 17:25:39.821479|2017-02-18 17:25:39.821479
NCT00152685|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-11-29||||||September 2005|2005-09-01||||||||Interventional|||High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury||Unknown status|Recruiting|Phase 2/Phase 3|40||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:25:39.993665|2017-02-18 17:25:39.993665
NCT00152672|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-10-27|||June 2005||2005-06-01|February 2005|2005-02-01||||||||Interventional|||Treatment of Sleep Apnea Syndrome With nCPAP Versus Oral Appliance|Treatment of Sleep Apnea Syndrome With nCPAP Versus Oral Appliance: a Multicentre Prospective Randomized Crossover Trial|Unknown status|Recruiting|N/A|60||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:25:40.073234|2017-02-18 17:25:40.073234
NCT00152659|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-05-16|||September 1998||1998-09-01|May 2016|2016-05-01||||December 2030|Anticipated|2030-12-01||Observational|||Developing Criteria for Cortical Resections|Developing Functional and Structural Criteria for Cortical Resections|Recruiting||N/A|1000|Anticipated|University of Chicago|||1||f||||f||||||||||2017-02-18 17:25:40.324065|2017-02-18 17:25:40.324065
NCT00152646|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-02-03|||March 2005||2005-03-01|September 2005|2005-09-01|January 2008|Anticipated|2008-01-01|||||Interventional|||Platelets Induced Vasodilation, in Vitro and in Vivo Study|Platelets Induced Vasodilation, in Vitro and in Vivo Study in Patients With Arteriopathy and Healthy Subjects.|Unknown status|Recruiting|Phase 4|36|Anticipated|University Hospital, Angers|||||f||||t||||||||||2017-02-18 17:25:40.45213|2017-02-18 17:25:40.45213
NCT00152633|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-07-04|||September 2005||2005-09-01|July 2012|2012-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension|Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension|Withdrawn||Phase 2/Phase 3|0|Actual|University of Erlangen-Nürnberg Medical School||2||No patient could be recruited.|f||||f||||||||||2017-02-18 17:25:40.538939|2017-02-18 17:25:40.538939
NCT00152477|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-09-02|||August 2005||2005-08-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer|A Two-Part, Open Label Phase II Trial: Part One, Dose Escalation Safety; Part Two, Randomized/Comparing CDP791 Plus Carboplatin/Paclitaxel With Carboplatin/Paclitaxel Alone in Subjects With Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer|Completed||Phase 2|165|Actual|UCB Pharma||3|||f||||||||||||||2017-02-18 17:25:40.652382|2017-02-18 17:25:40.652382
NCT00152464|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-04-09|||March 2002||2002-03-01|September 2009|2009-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)|The Early Prevention of Asthma in Atopic Children (EPAAC™) Study. A Multi-country, Double Blind, Placebo (PLC) Controlled, Randomized, Parallel Group Trial: Evaluation of the Efficacy and Safety of Levocetirizine (LCTZ) (5 mg/ml Oral Drops -0.125 mg/kg b.w. b.i.d.) Administered for 18 Months in Preventing the Onset of Asthma in 12 to 24 Months Old Children Who Suffer From Atopic Dermatitis and Are Sensitized to Grass Pollen and / or House Dust Mite Allergens.|Completed||Phase 3|2500||UCB Pharma|||||f||||||||||||||2017-02-18 17:25:40.794016|2017-02-18 17:25:40.794016
NCT00152451|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2017-02-09|||May 2005||2005-05-01|February 2017|2017-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures|An Open-label, Exploratory, Multicenter, Dose-escalation Study Examining the Efficacy, Safety and Tolerability of Ucb 44212 Used at Doses of 10 mg, 20 mg, 40 mg and 80 mg b.i.d. (Total Daily Dose of 20 to 160 mg) in Adult Subjects (18-65 Years) With Refractory Epilepsy Suffering From Partial Onset Seizures (Whether or Not Secondarily Generalized) and Treated With 1, 2 or 3 Approved Antiepileptic Drugs|Completed||Phase 2|30||UCB Pharma|||||f||||||||||||||2017-02-18 17:25:40.876267|2017-02-18 17:25:40.876267
NCT00152438|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-09-20|||September 2005||2005-09-01|September 2011|2011-09-01|December 2012|Anticipated|2012-12-01|October 2009|Actual|2009-10-01||Interventional|||Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized Progesterone|Vasomotor Symptoms and Endothelial Function—A Randomized Placebo-controlled Trial of Oral Micronized Progesterone (Prometrium®)|Unknown status|Active, not recruiting|Phase 2|125|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 17:25:40.968966|2017-02-18 17:25:40.968966
NCT00152425|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-09-06|||February 2004||2004-02-01|July 2010|2010-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).|A Phase III Multi-national, Multi-centre, Double-blind Placebo-controlled Parallel Group, 26 Week Study to Assess the Maintenance of Clinical Response to Humanised Anti-TNF PEG Conjugate, CDP870 400 mg sc, (Dosed 4-weekly From Weeks 8 to 24), in the Treatment of Patients With Active Crohn's Disease Who Have Responded to Open Induction Therapy (Dosed at Weeks 0, 2 and 4) With CDP870|Completed||Phase 3|392||UCB Pharma|||||f||||||||||||||2017-02-18 17:25:41.080723|2017-02-18 17:25:41.080723
NCT00152412|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-08-25|||June 2004||2004-06-01|September 2009|2009-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis|A 4 Week Open, Multi-center Study Evaluating the Safety of Levocetirizine 1.25 mg b.i.d. Given as 0.5 mg/mL Oral Solution in 2 to 6 Year-old Children Suffering From Allergic Rhinitis.|Completed||Phase 2|30||UCB Pharma|||||f||||||||||||||2017-02-18 17:25:41.166483|2017-02-18 17:25:41.166483
NCT00152399|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-09-17|||September 2000||2000-09-01|September 2012|2012-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding|A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial To Study The Efficacy And The Safety Of The Early Administration Of Somatostatin (Ucb) 12 Mg/24 H IV Infusion And Two IV Boluses Of 250 Mcg During 72 Hours In The Treatment Of Subjects With Acute Severe Upper Gastrointestinal Bleeding (UGIB) With Suspicion Of Peptic Ulcer Bleeding [The PUB Study]|Completed||Phase 2|370||UCB Pharma|||||f||||||||||||||2017-02-18 17:25:41.249088|2017-02-18 17:25:41.249088
NCT00152386|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-08-26|||February 2005||2005-02-01|July 2010|2010-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis|A Phase III Multicentre, Double Blind, Placebo-controlled, Parallel Group 52-week Study to Assess the Efficacy and Safety of 2 Dose Regimens of Lyophilised CDP870 as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms and Preventing Structural Damage in Patients With Active Rheumatoid Arthritis Who Have an Incomplete Response to Methotrexate|Completed||Phase 3|950||UCB Pharma|||||f||||||||||||||2017-02-18 17:25:41.365251|2017-02-18 17:25:41.365251
NCT00152373|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-12-02|||July 2004||2004-07-01|September 2009|2009-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS|A Double-blind, Placebo-controlled, Randomized Study: 16-week Evaluation of the Efficacy and Safety of Levetiracetam (LEV) as add-on Therapy in Adults and Adolescents Older Than 16 Years Suffering From Partial Seizures.|Completed||Phase 3|192||UCB Pharma|||||f||||||||||||||2017-02-18 17:25:41.543843|2017-02-18 17:25:41.543843
NCT00152360|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-03-28|||June 2005||2005-06-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||The Effect of Xenical on Weight and Risk Factors|The Effect of Xenical on Weight, Risk Factors and Burden of Medication|Completed||Phase 4|25|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:25:41.623584|2017-02-18 17:25:41.623584
NCT00152347|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-07-30|||September 2005||2005-09-01|July 2015|2015-07-01|June 2016|Anticipated|2016-06-01|December 2012|Actual|2012-12-01||Interventional|||A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot|A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot|Active, not recruiting||N/A|36|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:25:41.721443|2017-02-18 17:25:41.721443
NCT00152334|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-05-30|||September 2005||2005-09-01|May 2016|2016-05-01|June 2016|Anticipated|2016-06-01|June 2016|Anticipated|2016-06-01||Interventional|||Efficacy of Botox in Patients With Idiopathic Clubfoot|Treatment of Idiopathic Clubfoot Utilizing Botulinum Toxin A: A New Treatment for Correction|Active, not recruiting||N/A|50|Anticipated|University of British Columbia||1|||f||||||||||||||2017-02-18 17:25:41.81009|2017-02-18 17:25:41.81009
NCT00152321|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-07-25|||September 2003||2003-09-01|July 2015|2015-07-01|March 2010|Actual|2010-03-01|March 2006|Actual|2006-03-01||Interventional|||Strategies Targeting Osteoporosis to Prevent Recurrent Fractures|Strategies Targeting Osteoporosis to Prevent Recurrent Fractures (STOP# Study)|Completed||N/A|242|Actual|University of Alberta||2|||f||||f||||||||||2017-02-18 17:25:41.903754|2017-02-18 17:25:41.903754
NCT00152308|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||December 2004||2004-12-01|September 2005|2005-09-01|February 2007||2007-02-01|||||Interventional|||Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis|A Prospective, Placebo-Controlled, Double-Blind, Randomized Study Evaluating the Efficacy of Non-Polymer-Based Coating With Two Different Rapamycin-Dosages for the Prevention of Restenosis After Percutaneous Coronary Interventions|Unknown status|Recruiting|Phase 4|333||Translumina GmbH|||||f||||||||||||||2017-02-18 17:25:42.022149|2017-02-18 17:25:42.022149
NCT00152295|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-27|||April 2001||2001-04-01|May 2008|2008-05-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women|A Phase II Long-Term Extension Safety Study of J867 Administered With Estrogen to Postmenopausal Women|Completed||Phase 2|18|Actual|Abbott||1|||f||||f||||||||||2017-02-18 17:25:42.121654|2017-02-18 17:25:42.121654
NCT00152282|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-27|||September 2000||2000-09-01|May 2008|2008-05-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women|A Phase II Pilot Study to Evaluate the Safety and Efficacy of J867 Administered With Estrogen to Postmenopausal Women|Completed||Phase 2|105|Actual|Abbott||4|||f||||f||||||||||2017-02-18 17:25:42.216716|2017-02-18 17:25:42.216716
NCT00152269|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-27|||July 2002||2002-07-01|May 2008|2008-05-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Treatment of Uterine Fibroids With Asoprisnil(J867)|A Phase III, 12-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety (Including Bone Density Assessment) of Two Doses of J867 Versus Placebo in Subjects With Uterine Leiomyomata|Completed||Phase 3|475|Actual|Abbott||3|||f||||t||||||||||2017-02-18 17:25:42.418187|2017-02-18 17:25:42.418187
NCT00152256|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-27|||September 2003||2003-09-01|May 2008|2008-05-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids|A Phase 3,6-Month, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Two Doses of Asoprisnil Versus Placebo in Subjects With Uterine Leiomyomata|Completed||Phase 3|239|Actual|Abbott||3|||f||||t||||||||||2017-02-18 17:25:42.514526|2017-02-18 17:25:42.514526
NCT00152243|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-07-06|||June 1997||1997-06-01|July 2011|2011-07-01|August 2007|Actual|2007-08-01|March 2006|Actual|2006-03-01||Interventional|||A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)|A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of UFT Compared With Surgery Alone for Serosa-negative Advanced Gastric Cancer (NSAS-GC)|Completed||Phase 3|500|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 17:25:42.617177|2017-02-18 17:25:42.617177
NCT00152230|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-07-06|||October 1996||1996-10-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|March 2006|Actual|2006-03-01||Interventional|||A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)|A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of UFT Compared With Surgery Alone in Patients With Dukes C Colorectal Cancer (NSAS-CC)|Completed||Phase 3|900|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 17:25:42.719329|2017-02-18 17:25:42.719329
NCT00152217|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-07-06|||September 2001||2001-09-01|July 2011|2011-07-01|December 2010|Actual|2010-12-01|May 2007|Actual|2007-05-01||Interventional|||Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)|Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)|Completed||Phase 3|1000|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 17:25:42.838271|2017-02-18 17:25:42.838271
NCT00152204|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-05-21|||March 2005||2005-03-01|May 2008|2008-05-01|December 2008|Anticipated|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||The Community Effectiveness of IPTi in Southern Tanzania|Community Effectiveness of Intermittent Preventive Treatment Delivered Through the Expanded Programme of Immunisation for Malaria and Anaemia Control in Tanzanian Infants|Unknown status|Active, not recruiting|Phase 3|13000|Anticipated|Swiss Tropical & Public Health Institute||2|||f||||t||||||||||2017-02-18 17:25:43.139064|2017-02-18 17:25:43.139064
NCT00152191|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-07-06|||October 1996||1996-10-01|July 2011|2011-07-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)|A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared With CMF in High-risk Women With Axillary Node-negative Breast Cancer (NSAS-BC)|Completed||Phase 3|1300|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 17:25:43.266425|2017-02-18 17:25:43.266425
NCT00152178|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-07-06|||July 1996||1996-07-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|April 2008|Actual|2008-04-01||Interventional|||The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)|The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)|Completed||Phase 3|680|Anticipated|Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 17:25:43.379103|2017-02-18 17:25:43.379103
NCT00152165|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-12-01|||November 2003||2003-11-01|December 2008|2008-12-01||||||||Observational|||Use of Radiostereometric Analysis (RSA) Following Spinal Fusion Versus the DYNESYS Stabilization System|A Biomechanical Assessment of the DYNESYS Stabilization System Using Radiostereometric Analysis|Completed||N/A|12||State University of New York - Upstate Medical University|||||f||||||||||||||2017-02-18 17:25:43.493206|2017-02-18 17:25:43.493206
NCT00152152|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-05-22|||October 2002||2002-10-01|May 2008|2008-05-01||||September 2007|Actual|2007-09-01||Observational|||Use of Radiostereometric Analysis Beads (RSA) to Measure Motion in the Spine, Following Lumbar Spinal Surgery|Use of Radiostereometric Analysis (RSA) for Measuring Spinal Motion Following Lumbar Spinal Surgery|Completed||N/A|75|Anticipated|State University of New York - Upstate Medical University|||||f||||||||||||||2017-02-18 17:25:43.586194|2017-02-18 17:25:43.586194
NCT00152139|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2009-01-28|||May 2002||2002-05-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|June 2005|Actual|2005-06-01||Interventional|||Stem Cell Transplantation for Patients With Hematologic Malignancies|Hematopoietic Stem Cell Transplantation Using Matched Unrelated Donor Peripheral Blood or Bone Marrow for Patients With Hematologic Malignancies|Completed||Phase 3|33|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:25:43.678463|2017-02-18 17:25:43.678463
NCT00152126|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-02-12|||August 2003||2003-08-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|August 2005|Actual|2005-08-01||Interventional|||Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas|Busulfan and Melphalan With Autologous Hematopoietic Stem Cell Support With Positively-Selected CD133+ Hematopoietic Cells for Children With High Risk Solid Tumors and Lymphomas|Completed||N/A|26|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:25:43.798112|2017-02-18 17:25:43.798112
NCT00152113|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-02-03|||April 2005||2005-04-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound|Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Doppler Ultrasound Using Reduced-Intensity Conditioning and T-Cell Depleted HSC From Partially Matched Family Donors|Completed||Phase 1|5|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:25:43.917622|2017-02-18 17:25:43.917622
NCT00152100|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-05-19|||February 2004||2004-02-01|May 2009|2009-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome|Transplantation of Highly Purified Haploidentical CD133 Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome|Completed||Phase 1|4|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:25:44.031331|2017-02-18 17:25:44.031331
NCT00152087|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||October 2002||2002-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.|Treatment of Unresectable Hepatocellular Carcinoma With Therasphere. A Human Device Evaluation Protocol.|Unknown status|Recruiting|Phase 2|25||St. Joseph's Hospital, Florida|||||||||||||||||||2017-02-18 17:25:44.133178|2017-02-18 17:25:44.133178
NCT00152074|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-06-08|||April 2004||2004-04-01|September 2006|2006-09-01|December 2007|Actual|2007-12-01|||||Interventional|||Salt Reduction on Blood Pressure and Cardiovascular Organ Damage|Effects of Modest Salt Reduction on Blood Pressure and Markers of Target Organ Damage in Patients With Untreated Essential Hypertension or Prehypertension|Completed||Phase 3|210|Anticipated|St George's, University of London|||||f||||||||||||||2017-02-18 17:25:44.239188|2017-02-18 17:25:44.239188
NCT00152061|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2013-06-18|||January 2005||2005-01-01|June 2013|2013-06-01|August 2005|Actual|2005-08-01|||||Interventional|||The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens|The Role of 3TC/FTC in Partially Suppressive Antiretroviral Regimens: The Switch Study|Completed||N/A|40||Stanford University|||||f||||f||||||||||2017-02-18 17:25:44.350585|2017-02-18 17:25:44.350585
NCT00152048|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2014-06-06|||November 2004||2004-11-01|September 2007|2007-09-01|October 2005|Actual|2005-10-01|||||Interventional|||Evaluation of Eflornithine on Facial and Forearm Skin|A 24 Week Randomised Double Blind Placebo Controlled Study to Evaluate the Atrophogenic Potential of Eflornithine in the Treatment of Women With Excessive Facial Hair|Completed||Phase 4|78||Shire|||||f||||||||||||||2017-02-18 17:25:44.445746|2017-02-18 17:25:44.445746
NCT00152035|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2017-01-12|||March 2005||2005-03-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety of SPD465 in Treating Adults With ADHD.|A Phase III, Multi-center, 12-month, Open-label Safety Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).|Completed||Phase 3|1040||Shire|||||f||||||||||||||2017-02-18 17:25:44.530121|2017-02-18 17:25:44.530121
NCT00152022|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2017-01-12|||April 2005||2005-04-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.|A Phase III, Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).|Completed||Phase 3|412||Shire|||||||||||||||||||2017-02-18 17:25:44.602487|2017-02-18 17:25:44.602487
NCT00152009|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-11-25|2009-09-10||January 2003||2003-01-01|November 2009|2009-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17|A Phase III, Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Safety and Efficacy Study of SPD503 in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|345|Actual|Shire||4|||||||||||||||||2017-02-18 17:25:44.677761|2017-02-18 17:25:44.677761
NCT00151996|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-11-25|2009-09-10||August 2004||2004-08-01|November 2009|2009-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|A Phase II, Open-Label Co-Administration Study of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|75|Actual|Shire||2|||||||||||||||||2017-02-18 17:25:45.523407|2017-02-18 17:25:45.523407
NCT00151983|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-07-08|||June 2005||2005-06-01|July 2015|2015-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy|A Prospective, Open-Label, Multi-Center Study Evaluating the Safety and Tolerability of Methylphenidate Transdermal System (MTS) in Children Aged 6-12 Previously Treated With Extended-Release Methylphenidate Product.|Completed||Phase 3|175|Actual|Noven Therapeutics||2|||f||||f||||||||||2017-02-18 17:25:46.091112|2017-02-18 17:25:46.091112
NCT00151970|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-07-08|||June 2005||2005-06-01|July 2015|2015-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD|A Phase IIB, Randomized, Double-blind, Multi-Center, Placebo-Controlled, Dose-Optimization, 3-way Cross-Over, Analog Classroom Study to Assess the Efficacy, Duration of Effect, Tolerability and Safety of 4- and 6- Hour Wear Times of Methylphenidate Transdermal System (MTS) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|128|Actual|Noven Therapeutics||3|||f||||f||||||||||2017-02-18 17:25:46.205799|2017-02-18 17:25:46.205799
NCT00151957|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-07-08|||October 2004||2004-10-01|July 2015|2015-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials|A Phase III, Multi-center, Open-label Study of Methylphenidate Transdermal System (MTS) in Pediatric Patients Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 3|450|Actual|Noven Therapeutics||1|||f||||f||||||||||2017-02-18 17:25:46.417535|2017-02-18 17:25:46.417535
NCT00151944|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-06-06|||November 2003||2003-11-01|December 2008|2008-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.|A Phase III, Randomized, Multi-center, Open-label, 12 to 14 Month Extension Study to Evaluate the Safety and Tolerability of SPD476 (Mesalazine) Given Once Daily vs. Twice Daily for the Maintenance of Ulcerative Colitis in Remission.|Completed||Phase 3|400||Shire|||||f||||||||||||||2017-02-18 17:25:46.534751|2017-02-18 17:25:46.534751
NCT00151931|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-08-31|||May 2004||2004-05-01|August 2011|2011-08-01|January 2006|Actual|2006-01-01|||||Interventional|||Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis|A Multi-Centre, Open-Label Study Assessing the Efficacy and Tolerability of Lanthanum Carbonate in the Reduction of Serum Phosphate Levels in End Stage Renal Disease Patients Receiving Dialysis|Completed||Phase 3|456||Shire|||||f||||||||||||||2017-02-18 17:25:46.619504|2017-02-18 17:25:46.619504
NCT00151918|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-06-06|||January 2005||2005-01-01|September 2007|2007-09-01|August 2006|Actual|2006-08-01|||||Interventional|||Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease|A Multi-Centre, Open Label, Randomized, Parallel Group Pilot Study to Assess the Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease|Completed||Phase 3|48||Shire|||||||||||||||||||2017-02-18 17:25:46.709637|2017-02-18 17:25:46.709637
NCT00151905|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-05-04|||November 2003||2003-11-01|September 2005|2005-09-01|September 2006||2006-09-01|||||Interventional|||The Use of an Inhaled Salt Solution to Treat Viral Lung Infections in Infants.|Nebulized Hypertonic Saline in the Treatment of Bronchiolitis in Infants|Completed||Phase 2/Phase 3|||Sheikh Khalifa Medical City|||||f||||||||||||||2017-02-18 17:25:46.781508|2017-02-18 17:25:46.781508
NCT00151892|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-06-06|2010-08-26||April 2005||2005-04-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis|A Phase III, Randomized Multi-centre, Double-blind, Parallel Group, Active Comparator Study to Compare the Efficacy and Safety of SPD476 (Mesalazine)2.4g/Day Once Daily With Asacol 1.6g/Day Twice Daily in the Maintenance of Remission in Patients With Ulcerative Colitis|Completed||Phase 3|829|Actual|Shire||2|||f||||||||||||||2017-02-18 17:25:47.072743|2017-02-18 17:25:47.072743
NCT00151879|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-09-19|||February 2005||2005-02-01|July 2010|2010-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures|A Multicenter, Open-label Trial to Investigate the Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures With or Without Secondary Generalization.|Completed||Phase 2/Phase 3|160|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:25:48.288135|2017-02-18 17:25:48.288135
NCT00151866|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-02-26|||October 2003||2003-10-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma|A Multicentre Randomised Study of the Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma|Completed||Phase 3|180||Sanquin Research & Blood Bank Divisions|||||f||||||||||||||2017-02-18 17:25:48.385971|2017-02-18 17:25:48.385971
NCT00151853|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-01-30|||March 2002||2002-03-01|January 2006|2006-01-01|September 2004||2004-09-01|||||Interventional|||Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery|Phase IV Study on the Efficacy of PPSB-SD and VP-VI in Patients Using Oral Anticoagulant Therapy and Undergoing Acute Cardiac Surgery With a Cardiopulmonary Bypass|Completed||Phase 4|40||Sanquin|||||f||||||||||||||2017-02-18 17:25:48.472355|2017-02-18 17:25:48.472355
NCT00151840|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-01-30|||October 2001||2001-10-01|January 2006|2006-01-01|March 2002||2002-03-01|||||Interventional|||Efficacy and Safety of IVIG-L in ITP Patients|Efficacy and Safety of IVIG-L (Human Normal Immunoglobulin for Intravenous Use)in Idiopathic Thrombocytopenic Purpura (ITP)Patients|Completed||Phase 3|20||Sanquin|||||f||||||||||||||2017-02-18 17:25:48.559607|2017-02-18 17:25:48.559607
NCT00151827|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-10-13|||August 2003||2003-08-01|October 2010|2010-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Olmesartan Medoxomil in Hypertension and Renal Impairment|Efficacy and Safety of Olmesartan Medoxomil Compared With Losartan in Patients With Hypertension and Mild to Moderate Renal Impairment|Completed||Phase 3|393|Actual|Daiichi Sankyo Inc.||2|||f||||f||||||||||2017-02-18 17:25:48.656606|2017-02-18 17:25:48.656606
NCT00151814|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2010-04-12|2010-03-19||September 2005||2005-09-01|April 2010|2010-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Olmesartan Pediatric Pharmacokinetic (PK) Study|An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension|Completed||Phase 1|24|Actual|Daiichi Sankyo Inc.||1|||f||||||||||||||2017-02-18 17:25:48.760794|2017-02-18 17:25:48.760794
NCT00151801|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-08|||May 2002||2002-05-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Interventional|||Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients|Safety and Tolerability of Oral Two-Doses Estroprogestins Associated With Interferon-Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis|Unknown status|Recruiting|Phase 2|200||S. Andrea Hospital|||||f||||||||||||||2017-02-18 17:25:49.300678|2017-02-18 17:25:49.300678
NCT00151788|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-01-16|||February 2004||2004-02-01|January 2012|2012-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.|A Randomized, Double-blind, Stratified, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of the ACAT Inhibitor CS-505 for Reducing the Progression of Atherosclerosis in Subjects With Heterozygous Familial Hypercholesterolemia and Carotid Atherosclerosis Using Carotid Ultrasound (CUS)|Terminated||Phase 2/Phase 3|796||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:25:49.406247|2017-02-18 17:25:49.406247
NCT00151775|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-05-26|2010-03-08||May 2005||2005-05-01|May 2016|2016-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure|Dose-ranging Study to Evaluate the Safety and Efficacy of Olmesartan Medoxomil in Children and Adolescents With Hypertension|Completed||Phase 2/Phase 3|362|Actual|Daiichi Sankyo Inc.||3|||f||||||||||||||2017-02-18 17:25:49.642176|2017-02-18 17:25:49.642176
NCT00151762|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-12-26|||December 2004||2004-12-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes|A Multi-Center, 52-Week, Open-Label Extension Study (From Studies WEL-301, WEL-302, and WEL-303) to Evaluate the Long-Term Safety and Tolerability of WelChol® in Type 2 Diabetic Patients|Completed||Phase 3|780||Daiichi Sankyo Inc.|||||f||||f||||||||||2017-02-18 17:25:51.94965|2017-02-18 17:25:51.94965
NCT00151749|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-01-16|||June 2004||2004-06-01|January 2012|2012-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||WelChol® and Insulin in Treating Patients With Type 2 Diabetes|A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetes With Inadequate Glycemic Control on Insulin Therapy Alone or Insulin Therapy Combination With Other Oral Anti-diabetic Agents|Completed||Phase 3|260||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:25:52.093799|2017-02-18 17:25:52.093799
NCT00151736|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-06-08|||September 2004||2004-09-01|June 2012|2012-06-01|February 2008|Actual|2008-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)|A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 2|88|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 17:25:52.323152|2017-02-18 17:25:52.323152
NCT00151723|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-07-17|||April 2004||2004-04-01|September 2005|2005-09-01||||||||Interventional|||Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?|Subclinical Hyperthyroidism ”To Treat or Not to Treat?” A Dutch Multicenter Trial|Unknown status|Recruiting|N/A|200|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 17:25:52.456414|2017-02-18 17:25:52.456414
NCT00151710|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-02-28||||||February 2007|2007-02-01||||||||Interventional|||Effects of Pioglitazone in Congenital Adrenal Hyperplasia|Effects of Pioglitazone in Glucocorticoid-Induced Insulin Resistance. Studies in Congenital Adrenal Hyperplasia.|Completed||N/A|||Radboud University|||||f||||||||||||||2017-02-18 17:25:52.545222|2017-02-18 17:25:52.545222
NCT00151697|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2011-08-08|||May 2005||2005-05-01|August 2011|2011-08-01||||||||Interventional|||LANN-study: Lantus, Amaryl, Novorapid, Novomix Study|New Approach to Treat Type II Diabetes Failing on Maximal Oral Treatment|Completed||Phase 3|150|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-02-18 17:25:52.626492|2017-02-18 17:25:52.626492
NCT00151684|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2008-02-27|||November 2004||2004-11-01|February 2008|2008-02-01||||||||Interventional|||Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men|Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men: a Dose Response Study, Part II|Completed||Phase 2|25|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-02-18 17:25:52.727954|2017-02-18 17:25:52.727954
NCT00151671|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-02-24|||April 2003||2003-04-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|April 2008|Actual|2008-04-01||Interventional|IMPACT||Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer|Prospective, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Effect of Oral Immune-Enhancing Nutritional Supplement on Hepatic Function After Liver Resection for Primary or Secondary Cancer on Cirrhosis or Liver Fibrosis|Terminated||Phase 2/Phase 3|35|Actual|Rennes University Hospital||2||insufficient enrollment rate|f||||f||||||||||2017-02-18 17:25:52.829992|2017-02-18 17:25:52.829992
NCT00151658|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-09-12|||October 2002||2002-10-01|September 2005|2005-09-01|June 2006||2006-06-01|||||Interventional|||Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)|Randomized Multicenter Comparison of Sirolimus Versus Bare Metal Stent Implantation in Complex Coronary Lesions. Acronym: Scand Stent|Completed||N/A|322||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:25:53.148891|2017-02-18 17:25:53.148891
NCT00151645|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-12-30|||December 2003||2003-12-01|December 2005|2005-12-01|July 2005||2005-07-01|||||Interventional|||Efficacy of Activated Lymphocytes in Renal Cell Carcinoma.|Renal Cell Carcinoma Treatment With Activated Tumor- Infiltrated Lymphocytes. A Non-Randomized Phase II Trial.|Terminated||Phase 2|36||Rennes University Hospital|||||f||||||||||||||2017-02-18 17:25:53.240701|2017-02-18 17:25:53.240701
NCT00151632|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-07-03|||May 2003||2003-05-01|July 2012|2012-07-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|MMF-FK||Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation|Evaluation of the Benefit/Risk Ratio of a Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil on the Prevention of Complications in Adult Liver Transplantation|Terminated||Phase 3|195|Actual|Rennes University Hospital||2||insufficient enrollment|f||||t||||||||||2017-02-18 17:25:53.348674|2017-02-18 17:25:53.348674
NCT00151619|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2005-12-30|||February 1999||1999-02-01|December 2005|2005-12-01||||||||Interventional|||Effects of Amlodipine in the Management of Chronic Heart Failure|Regional and Systemic Hemodynamic Effects of a Long-Term Administration of Amlodipine in Patients With Chronic Heart Failure Treated With a Combination of Enalapril, Furosemide and Digoxin|Suspended||Phase 2|24||Rennes University Hospital|||||f||||||||||||||2017-02-18 17:25:53.469623|2017-02-18 17:25:53.469623
NCT00151606|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2006-01-09|||December 2002||2002-12-01|January 2006|2006-01-01|February 2004||2004-02-01|||||Interventional|||Comparison of Two Protocols to Prevent the Acquisition of Methicillin-Resistant Staphylococcus Aureus.|Evaluation of Two Protocols to Prevent the Acquisition of Methicillin-Resistant Staphylococcus Aureus in Intensive Care Units.|Completed||N/A|500||Rennes University Hospital|||||f||||||||||||||2017-02-18 17:25:53.583352|2017-02-18 17:25:53.583352
NCT00151593|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2007-11-22|||February 2002||2002-02-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Evaluation of Celsior® in Liver Transplant Preservation.|Celsior®: Evaluation of an Organ Preservation Solution in Liver Transplantation.|Completed||Phase 2|140|Actual|Rennes University Hospital||1|||f||||f||||||||||2017-02-18 17:25:53.684222|2017-02-18 17:25:53.684222
NCT00151580|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-05-18|||February 2002||2002-02-01|November 2007|2007-11-01|July 2006|Actual|2006-07-01|||||Interventional|TRANSPEG||Treatment of Recurrent Hepatitis C After Liver Transplantation|Comparison of Maintenance Treatment by Ribavirin to a Placebo, After an Initial One-year Treatment With Pegylated Interferon-α2a - Ribavirin Association in Hepatitis C Viral Recurrence After Liver Transplantation|Completed||Phase 3|200|Actual|Rennes University Hospital||2|||f||||||||||||||2017-02-18 17:25:53.796228|2017-02-18 17:25:53.796228
NCT00151567|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2012-12-03|||February 2002||2002-02-01|September 2008|2008-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|TAMSULOSINE||Evaluation of Tamsulosin in the Treatment of Ureteral Stones|Interest of a Treatment With the alpha1-blocker Tamsulosin in the Elimination of Pelvis Ureteral Stones|Completed||Phase 3|129|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-02-18 17:25:53.93222|2017-02-18 17:25:53.93222
NCT00151554|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-07-28|||February 2005||2005-02-01|July 2010|2010-07-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Reducing Intensive Care Unit (ICU) Related Anxiety Through a Structured Information Program|Reducing ICU Related Anxiety Through a Structured Information Program. A Randomized Controlled Clinical Trial|Completed||N/A|140|Actual|Philipps University Marburg Medical Center||2|||f||||||||||||||2017-02-18 17:25:54.059295|2017-02-18 17:25:54.059295
NCT00151541|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-05-27|||February 2005||2005-02-01|May 2011|2011-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%|A Phase 3, Randomized, Double-blind, Multi-dose Study to Evaluate the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG 5%) When Co-administered With Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% in the Treatment of Acne Vulgaris.|Completed||Phase 3|301|Actual|Allergan|||||||||||||||||||2017-02-18 17:25:54.17788|2017-02-18 17:25:54.17788
NCT00151528|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-03-07|||January 2005||2005-01-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||An Open-Label Trial of Pregabalin in Patients With Fibromyalgia|A Long-Term, Open-Label, Safety Trial of Pregabalin in Patients With Fibromyalgia|Completed||Phase 3|428||Pfizer|||||||||||||||||||2017-02-18 17:25:54.276435|2017-02-18 17:25:54.276435
NCT00151515|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-09-28|||October 2003||2003-10-01|September 2016|2016-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss|A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of 5 Percent Minoxidil Foam in the Treatment of Androgenetic Alopecia in Males|Completed||Phase 3|352|Actual|Johnson & Johnson Consumer and Personal Products Worldwide||1|||f||||f||||||||||2017-02-18 17:25:54.662283|2017-02-18 17:25:54.662283
NCT00151502|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-07-09|||November 2002||2002-11-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|||||Interventional|||To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.|An 80-Week, Randomized, Multi-Center, Parallel-Group, Double-Blind Study of the Efficacy and Safety of Atorvastatin 80 MG Plus an Acetylcholinesterase Inhibitor Versus an Acetylcholinesterase Inhibitor Alone in the Treatment of Mild to Moderate Alzheimer's Disease.|Completed||Phase 3|600||Pfizer|||||||||||||||||||2017-02-18 17:25:54.791796|2017-02-18 17:25:54.791796
NCT00151489|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-03-14|||April 2005||2005-04-01|September 2006|2006-09-01|June 2006|Actual|2006-06-01|||||Interventional|||Safety and Efficacy Study of Pregabalin in Fibromyalgia|A Six-Month, Double-Blind, Placebo Controlled, Durability of Effect Study of Pregabalin for Pain Associated With Fibromyalgia|Completed||Phase 3|1020||Pfizer|||||||||||||||||||2017-02-18 17:25:55.194553|2017-02-18 17:25:55.194553
NCT00151294|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-09-12|||November 2004||2004-11-01|September 2006|2006-09-01|October 2006||2006-10-01|||||Interventional|||The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis|A Double-Blind, Placebo-Controlled Investigation Into the Safety and Efficacy of Escitalopram for Depression in Multiple Sclerosis|Terminated||Phase 4|20||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 17:25:58.875387|2017-02-18 17:25:58.875387
NCT00151476|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-03-04|2009-11-19||November 2004||2004-11-01|March 2010|2010-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients|A Registry-Based Observational Study Assessing Clinical Outcomes In Familial Adenomatous Polyposis In Patients Receiving Celecoxib (Celebrex(Registered), Onsenal(Registered)) Compared With Control Patients|Terminated||Phase 4|68|Actual|Pfizer|Study prematurely discontinued May 2008 prior to reaching enrollment target; due to limited number of matched pairs, results do not provide sufficient data to evaluate effectiveness of celecoxib. Last subject last visit was November 2008.||2|See Detailed Description|f||||f||||||||||2017-02-18 17:25:55.412076|2017-02-18 17:25:55.412076
NCT00151463|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-08-15|||January 2005||2005-01-01|August 2007|2007-08-01||||||||Interventional|||QEQ Treatment Responsiveness Evaluation Study|An Open-Label, Non-Comparative Study To Evaluate Treatment Responsiveness To The Quality Of Erection Questionnaire (QEQ) In Men With Erectile Dysfunction Treated With Viagra (Sildenafil Citrate)|Completed||Phase 4|100||Pfizer|||||f||||||||||||||2017-02-18 17:25:56.502614|2017-02-18 17:25:56.502614
NCT00151450|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-03-19|||March 2005||2005-03-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|||||Interventional|||Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder|An 8-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study Of Pregabalin (300-600 Mg/Day) And Venlafaxine XR (75-225 Mg/Day) For The Acute Treatment Of DSM-IV Generalized Anxiety Disorder In Outpatients|Completed||Phase 3|390||Pfizer|||||f||||||||||||||2017-02-18 17:25:56.716121|2017-02-18 17:25:56.716121
NCT00151437|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-04-22|||November 2004||2004-11-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Canadian Pegvisomant Compassionate Study In Acromegalic Patients|A Multi-Center, Open-Label Study For The Compassionate Use Of Pegvisomant In Acromegalic Patients Refractory To Conventional Therapy and For Patients Who Received The Product During The Clinical Development Program.|Completed||Phase 4|30||Pfizer|||||f||||||||||||||2017-02-18 17:25:56.843191|2017-02-18 17:25:56.843191
NCT00151424|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2015-05-05|||February 2005||2005-02-01|May 2015|2015-05-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)|A Multicenter, Randomized, Double-Blind, Flexible-Dose, 6-Week Trial of the Efficacy and Safety of Asenapine Compared With Placebo Using Olanzapine Positive Control in Subjects With an Acute Exacerbation of Schizophrenia|Completed||Phase 3|277|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:25:56.939114|2017-02-18 17:25:56.939114
NCT00151411|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-08|2016-09-26|2011-06-07||October 2004||2004-10-01|September 2016|2016-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)|The Effect of Combination Therapy With Lifestyle Intervention and Metformin in Females With Polycystic Ovary Syndrome|Completed||Phase 2|114|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-02-18 17:25:57.050414|2017-02-18 17:25:57.050414
NCT00151398|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-02-07||2013-02-07|September 2005||2005-09-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)|A 3-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability, and Efficacy Study Of 3 Doses Of Lecozotan (SRA-333) SR In Outpatients With Mild To Moderate Alzheimer's Disease With Donepezil As Active Control.|Completed||Phase 2|229|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||4|||f||||t||||||||||2017-02-18 17:25:57.481822|2017-02-18 17:25:57.481822
NCT00151385|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-06-26|||November 2005||2005-11-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|||||Interventional|||Study Evaluating Inhibitor Specificity in Hemophilia A|A Multicenter Study to Describe the Immunogenic Epitope(s) of Factor VIII in Previously Treated Patients With Congenital Hemophilia A Who Develop De Novo Factor VIII Inhibitors While Receiving Factor VIII Infusion Therapy.|Withdrawn||Phase 4|0|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:25:57.839146|2017-02-18 17:25:57.839146
NCT00151372|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-12-07|2009-07-07||March 2002||2002-03-01|December 2009|2009-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients|Treatment Effectiveness in Depressed Patients With Chronic Obstructive Pulmonary Disease|Completed||N/A|141|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 17:25:57.958976|2017-02-18 17:25:57.958976
NCT00151359|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||February 2002||2002-02-01|September 2005|2005-09-01||||||||Observational|||Clinical Trials Stage of 'SoleSensor': A Balance-Enhancing Shoe Insert.|Clinical Trials Stage of 'SoleSensor': A Balance-Enhancing Shoe Insert.|Completed||N/A|||Wilfrid Laurier University|||||f||||||||||||||2017-02-18 17:25:58.379526|2017-02-18 17:25:58.379526
NCT00151346|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-03-17|||October 2003||2003-10-01|March 2008|2008-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Combined Spinal-Epidural Versus Traditional Labor Epidural|Combined Spinal-Epidural Versus Traditional Labor Epidural: A Randomized, Controlled Trial Comparing Maternal and Fetal Effects|Completed||Phase 4|127|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 17:25:58.473397|2017-02-18 17:25:58.473397
NCT00151333|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-09-03|||February 2005||2005-02-01|September 2009|2009-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)|A Randomized, Double-blind, Placebo-controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics Trial of Multiple Ascending Fixed Doses of SRA-333 in Subjects With Mild to Moderate Alzheimer's Disease.|Completed||Phase 2|16||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:25:58.593348|2017-02-18 17:25:58.593348
NCT00151320|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-07-27|||January 2004||2004-01-01|July 2010|2010-07-01||||June 2010|Anticipated|2010-06-01||Interventional|||Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL|Phase I/II Trial of VELCADE+ CHOP-Rituximab in Patients With Previously Untreated Diffuse Large B Cell or Mantle Cell Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|78|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 17:25:58.677083|2017-02-18 17:25:58.677083
NCT00151307|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-06-05|||February 2001||2001-02-01|June 2008|2008-06-01|April 2007||2007-04-01|||||Interventional|||Effects of Cerebral Oxygen Saturation on Neuropsychological Outcomes|The Effects of Monitoring and Maintaining Cerebral Oxygen Saturation on Neuropsychological Outcomes in Patients Undergoing Cardiac Surgery|Terminated||Phase 2/Phase 3|200|Anticipated|Weill Medical College of Cornell University||||Could not recruit any more people.|f||||||||||||||2017-02-18 17:25:58.774765|2017-02-18 17:25:58.774765
NCT00151281|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-06-16|||November 2004||2004-11-01|June 2010|2010-06-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|||Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma|Phase II Trial of Anti-Angiogenic Therapy With RT-PEPC in Patients With Relapsed Mantle Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|46|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 17:25:58.971069|2017-02-18 17:25:58.971069
NCT00151268|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-07-28|||March 2004||2004-03-01|July 2016|2016-07-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Genotype - Phenotype Correlations of LINCL|Genotype - Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis|Completed||N/A|18|Actual|Weill Medical College of Cornell University|||1||f||||t||||||Samples With DNA|"~     whole blood, serum~   "|No||2017-02-18 17:25:59.064515|2017-02-18 17:25:59.064515
NCT00151255|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-10-12|||June 2004||2004-06-01|October 2011|2011-10-01|January 2011|Actual|2011-01-01|June 2009|Actual|2009-06-01||Interventional|||All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia|Phase III - Study on All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 3|500|Anticipated|University of Ulm||1|||f||||||||||||||2017-02-18 17:25:59.145779|2017-02-18 17:25:59.145779
NCT00151242|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-07-22|||July 2004||2004-07-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2011|Actual|2011-08-01||Interventional|||Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia|Randomized Phase II/III-Study on All-Trans Retinoic Acid in Combination With Induction and Consolidation Therapy as Well as Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 2/Phase 3|920|Actual|University of Ulm||2|||f||||||||||||||2017-02-18 17:25:59.279052|2017-02-18 17:25:59.279052
NCT00151229|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-06-03|||October 2003||2003-10-01|June 2015|2015-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|VALISH||Valsartan in Elderly Isolated Systolic Hypertension Study|Valsartan in Elderly Isolated Systolic Hypertension|Completed||Phase 4|3079|Actual|VALISH study||2|||f||||t||||||||||2017-02-18 17:25:59.425239|2017-02-18 17:25:59.425239
NCT00151216|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-05-03|||June 2004||2004-06-01|May 2016|2016-05-01|June 2019|Anticipated|2019-06-01|June 2019|Anticipated|2019-06-01||Interventional|||Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis|Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Expressing the Human CLN2 cDNA to the Brain of Children With Late Infantile Neuronal Ceroid Lipofuscinosis|Active, not recruiting||Phase 1|11|Anticipated|Weill Medical College of Cornell University||1|||f||||t||||||||Undecided||2017-02-18 17:25:59.591534|2017-02-18 17:25:59.591534
NCT00151203|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2017-02-13|||December 2004|Actual|2004-12-01|February 2017|2017-02-01|August 2022|Anticipated|2022-08-01|April 2007|Actual|2007-04-01||Interventional|||Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma|A Phase II Study of Clarithromycin (Biaxin), Lenalidomide (Revlimid), and Dexamethasone (Decadron) for Newly Diagnosed Subjects With Multiple Myeloma|Active, not recruiting||Phase 2|50|Anticipated|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 17:25:59.702566|2017-02-18 17:25:59.702566
NCT00151190|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-01-07|||April 2005||2005-04-01|January 2010|2010-01-01|August 2006||2006-08-01|||||Interventional|||"Community Diabetes Education Program Evaluation Code Evaluation"|Community Diabetes Education Program Evaluation|Completed||Phase 3|180||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 17:25:59.790483|2017-02-18 17:25:59.790483
NCT00151177|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-11-23|||April 2005||2005-04-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Continuous Positive Airway Pressure Ventilation After Acute Ischemic Stroke|Feasibility and Efficacy Study of Early Continuous Positive Airway Pressure Ventilation in Patients With Acute Ischemic Stroke|Completed||Phase 1/Phase 2|100|Anticipated|University Hospital Muenster||2|||f||||f||||||||||2017-02-18 17:25:59.995507|2017-02-18 17:25:59.995507
NCT00151164|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-07-11|||April 2004||2004-04-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Thymic Tolerance in Pediatric Heart Transplantation|Thymic Tolerance in Pediatric Heart Transplantation|Terminated||Phase 2|48|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||||"Due to failure to control sufficient patients in the active arm, this study has now been~   closed."|f||||||||||||||2017-02-18 17:26:00.104715|2017-02-18 17:26:00.104715
NCT00151151|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-09-12|||February 2003||2003-02-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The S.A.F.E. Study : Computer-Aided Counseling to Prevent Teen Pregnancy/Sexually Transmitted Diseases (STDs)|The S.A.F.E. Study: Computer-Aided Counseling to Prevent Teen Pregnancy/STDs - Validity and Reliability Testing of Computer Measures, Pilot-testing of Timeline Followback Calendar Protocol, and Randomized Efficacy Study|Completed||N/A|660|Anticipated|University of Pittsburgh|||||f||||f||||||||||2017-02-18 17:26:00.199292|2017-02-18 17:26:00.199292
NCT00151138|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-12-13|||September 2002||2002-09-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Cognitive/Cerebrovascular Consequences of HTN Treatment|Cognitive and Cerebrovascular Sequelae of Hypertension|Completed||N/A|50||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:26:00.296349|2017-02-18 17:26:00.296349
NCT00151125|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-05-16|||July 2004||2004-07-01|May 2016|2016-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Phase II Study of IL-11 (Neumega) in Von Willebrand Disease|Phase II Comparison Study of Hemostatic Efficacy of Escalating Doses of Interleukin-11 (rhIL-11, Neumega) in Subjects With Type 1 Von Willebrand Disease|Completed||Phase 2|12|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 17:26:00.393848|2017-02-18 17:26:00.393848
NCT00151112|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-09-10|||September 2005||2005-09-01|September 2008|2008-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Comparison of Two Different Procedures for Plexus Anesthesia|Comparison of Two Different Procedures for Plexus Anesthesia: Standard Position Versus Combination of Lateral Position and 20° Trendelenburg Position|Completed||N/A|100|Actual|University Hospital Muenster||2|||f||||f||||||||||2017-02-18 17:26:00.511198|2017-02-18 17:26:00.511198
NCT00151099|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-12-17|||September 2005||2005-09-01|August 2007|2007-08-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Safety of Preoperative Oral Administration of a High Caloric Drink With Protein|Safety of Preoperative Oral Administration of a High Caloric Drink With Protein in Patients With Dysgnathia|Withdrawn||Phase 4|0|Actual|University Hospital Muenster||||There is no possibility to reach the target patient number within the set time frame|f||||||||||||||2017-02-18 17:26:00.612461|2017-02-18 17:26:00.612461
NCT00151086|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-01-20|||December 2001||2001-12-01|January 2015|2015-01-01|August 2006|Actual|2006-08-01|March 2004|Actual|2004-03-01||Interventional|||Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer|Phase I/II Evaluation of Oral Estramustine and Oral Vinorelbine on an Intermittent Schedule in Patients With Hormone-Refractory Adenocarcinoma of the Prostate|Completed||Phase 1/Phase 2|33|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:26:00.693989|2017-02-18 17:26:00.693989
NCT00151073|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-01-21|||April 2002||2002-04-01|January 2015|2015-01-01|September 2007|Actual|2007-09-01|September 2005|Actual|2005-09-01||Interventional|||Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate|An Evaluation of Estramustine, Docetaxel and Zoledronate in Patients With Hormone-Refractory Adenocarcinoma of the Prostate|Completed||Phase 2|28|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-02-18 17:26:00.797726|2017-02-18 17:26:00.797726
NCT00151060|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-01-19|||December 1998||1998-12-01|January 2015|2015-01-01|June 2006|Actual|2006-06-01|November 2004|Actual|2004-11-01||Interventional|||Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate|Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Patients With Hormonally Responsive Adenocarcinoma of the Prostate|Completed||Phase 2|28|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:26:00.914572|2017-02-18 17:26:00.914572
NCT00151047|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-01-19|||March 2003||2003-03-01|January 2015|2015-01-01|October 2007|Actual|2007-10-01|January 2005|Actual|2005-01-01||Interventional|||Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer|Evaluation of Primary Chemotherapy With Docetaxel Plus Capecitabine in Selected Patients With Newly Diagnosed Localized or Locally Advanced Prostate Cancer|Completed||Phase 2|15|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:26:01.010389|2017-02-18 17:26:01.010389
NCT00151034|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-01-20|||September 2000||2000-09-01|January 2015|2015-01-01|October 2007|Actual|2007-10-01|August 2004|Actual|2004-08-01||Interventional|||Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer|Phase II Evaluation of Trastuzumab (Herceptin), Paclitaxel, Carboplatin, and Gemcitabine in the Treatment of Advanced Urothelial Cancer|Completed||Phase 2|33|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:26:01.296579|2017-02-18 17:26:01.296579
NCT00151021|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-12-08|||June 2005||2005-06-01|December 2009|2009-12-01|January 2006||2006-01-01|||||Interventional|||Stepping Up to Health: Feedback to Promote Physical Activity in Diabetes|Automated Step-count Feedback to Promote Physical Activity in Diabetes|Completed||N/A|40|Anticipated|University of Michigan|||||f||||||||||||||2017-02-18 17:26:01.41989|2017-02-18 17:26:01.41989
NCT00151008|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-08-06|||November 2003||2003-11-01|August 2008|2008-08-01|August 2005||2005-08-01|||||Interventional|||Bexarotene With Narrow-Band UVB for Psoriasis|Investigator-Initiated, Double Blind, Vehicle-Controlled, Bilateral Comparison Trial of Bexarotene (Targretin) Gel 1% vs. Vehicle Gel in Combination With Narrow Band UVB Phototherapy for Moderate to Severe Psoriasis Vulgaris|Completed||Phase 2|35||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-02-18 17:26:01.512592|2017-02-18 17:26:01.512592
NCT00150995|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-01-20|||May 2001||2001-05-01|January 2015|2015-01-01|April 2006|Actual|2006-04-01|October 2003|Actual|2003-10-01||Interventional|||Tetrathiomolybdate in Hormone Refractory Prostate Cancer|A Phase II Trail of Tetrathiomolybdate in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|19|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:26:01.607479|2017-02-18 17:26:01.607479
NCT00150982|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-08-06|||September 2003||2003-09-01|August 2008|2008-08-01|February 2005||2005-02-01|||||Interventional|||Alefacept Mechanism of Action in Psoriasis|In Vivo Induction of T Cell Apoptosis by Alefacept (LFA-3/IgG1 Fusion Protein, Amevive) in Patients With Psoriasis: An Investigator-Initiated, Open-Label, Mechanism of Action Study|Completed||Phase 2|9||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-02-18 17:26:01.717786|2017-02-18 17:26:01.717786
NCT00150969|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-11-19|2012-01-10||January 2002||2002-01-01|November 2012|2012-11-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||Vitamin K Supplementation in Post-Menopausal Osteopenia|Evaluation of the Clinical Use of Vitamin K Supplementation in Post-Menopausal Women With Osteopenia (ECKO Trial)|Completed||Phase 3|440|Actual|University Health Network, Toronto|Originally designed as a 2-year study with BMD as primary outcome. Thus, the number of women followed to 3 and 4 years was small, and the study was not powered to examine fracture outcomes.|2|||f||||t||||||||||2017-02-18 17:26:01.835993|2017-02-18 17:26:01.835993
NCT00150956|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||April 1999||1999-04-01|October 2000|2000-10-01|January 2002||2002-01-01|||||Interventional|||Effects of Daily Home Hemodialysis on Circulation, Mental Functions, and Quality of Life|Study Into the Effects of Daily Home Hemodialysis on Hemodynamics, Neurocognitive Functions, and Quality of Life|Completed||Phase 3|12||UMC Utrecht|||||f||||||||||||||2017-02-18 17:26:02.427212|2017-02-18 17:26:02.427212
NCT00150943|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-04-26|||June 2000||2000-06-01|April 2006|2006-04-01||||||||Interventional|||Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis|The Benefit of STent Placement and Blood Pressure and Lipid-Lowering for the Prevention of Progression of Renal Dysfunction Caused by Atherosclerotic Ostial Stenosis of the Renal Artery (STAR)|Completed||Phase 3|140||UMC Utrecht|||||f||||||||||||||2017-02-18 17:26:02.520224|2017-02-18 17:26:02.520224
NCT00150930|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-11-27|||October 2002||2002-10-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness|Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness|Unknown status|Active, not recruiting|Phase 4|200||UMC Utrecht|||||f||||||||||||||2017-02-18 17:26:02.615886|2017-02-18 17:26:02.615886
NCT00150917|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-06-12|||July 2001||2001-07-01|December 2006|2006-12-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||RCT of a Group Intervention for Women With a Family History of Breast Cancer|A Randomized Controlled Trial of a Group Intervention for Women With a Family History of Breast Cancer|Completed||Phase 3|150|Actual|University Health Network, Toronto||1|||f||||f||||||||||2017-02-18 17:26:02.705922|2017-02-18 17:26:02.705922
NCT00150904|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-02-13|||August 2005||2005-08-01|February 2009|2009-02-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Observational|||Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)|Request for Blood Samples to Examine the Effect of Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Patients With Hepatitis C and in Patients Coinfected With Hepatitis C and HIV|Completed||N/A|28|Actual|UMC Utrecht|||||f||||||||||||||2017-02-18 17:26:02.801003|2017-02-18 17:26:02.801003
NCT00150891|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-05-08|||January 1998||1998-01-01|May 2007|2007-05-01|January 2006|Actual|2006-01-01|||||Observational|||Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection|Role of Th1, Th2 and Monokine Responses as Risk Factors of Acute and Chronic Renal Transplant Rejection – Impact of Different Immunosuppressive Protocols|Completed||N/A|84|Actual|University of Giessen|||||f||||f||||||||||2017-02-18 17:26:02.894239|2017-02-18 17:26:02.894239
NCT00150878|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-06-19|||December 2003||2003-12-01|June 2013|2013-06-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission|Randomized Phase III Comparison of 12 Gy TBI and Cyclophosphamide 120 mg/kg With Fludarabine 120 mg/Sqm and 8 Gy TBI Before Allogeneic Transplantation in Patients With Acute Myeloid Leukemia in First Remission|Terminated||Phase 3|198|Actual|University Hospital Carl Gustav Carus||2||Insurance coverage reached|f||||t||||||||||2017-02-18 17:26:03.000459|2017-02-18 17:26:03.000459
NCT00150865|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||September 2001||2001-09-01|September 2005|2005-09-01|March 2002||2002-03-01|||||Interventional|||Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery|Study of Posterior Lumbar Plexus Block for Pain Relief After Hip Surgery|Completed||N/A|60||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:26:03.114774|2017-02-18 17:26:03.114774
NCT00150852|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-12-28|||September 2004||2004-09-01|September 2005|2005-09-01||||||||Interventional|||Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus.|Vancomycin for Prophylaxis of PEG-Related Wound Infection in MRSA-Positive Patients: a Double-Blind, Randomized, Placebo-Controlled Study|Unknown status|Recruiting|Phase 2|96||University Hospital, Geneva|||||f||||||||||||||2017-02-18 17:26:03.197036|2017-02-18 17:26:03.197036
NCT00150839|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-11-20|||March 2006||2006-03-01|July 2008|2008-07-01|December 2009|Anticipated|2009-12-01|December 2009|Anticipated|2009-12-01||Interventional|COATS||Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy|Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy - a Monocentric, Double-Blind, Placebo-Controlled Trial|Unknown status|Recruiting|Phase 4|80|Anticipated|University of Erlangen-Nürnberg Medical School||2|||f||||t||||||||||2017-02-18 17:26:03.287461|2017-02-18 17:26:03.287461
NCT00150826|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-04-12|||May 2000||2000-05-01|April 2012|2012-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia|A Double-Blind, Multicenter, Placebo Controlled Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease.|Completed||Phase 4|78|Actual|University of Florida||2|||f||||t||||||||||2017-02-18 17:26:03.400306|2017-02-18 17:26:03.400306
NCT00150813|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-12-05|||August 2005||2005-08-01|September 2009|2009-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.|A Multicenter, Open-label, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam Individualized Dose From 1000 to 3000 mg/Day (Oral Tablets of 500 mg b.i.d.), Used as Monotherapy in Subjects (≥ 16 Years) Suffering From Epilepsy and Coming From the N01061 or the N01093 Trials.|Completed||Phase 3|70||UCB Pharma|||||f||||||||||||||2017-02-18 17:26:03.512209|2017-02-18 17:26:03.512209
NCT00150800|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2017-01-12|||January 2006||2006-01-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment|An Open-label, Multi-center, Follow-up Trial to Evaluate Long Term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment at a Flexible Dose up to a Maximum of 200 mg/Day in Subjects Aged 16 Years or Older Suffering From Epilepsy|Active, not recruiting||Phase 3|668|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:26:03.628005|2017-02-18 17:26:03.628005
NCT00150787|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-11-25|||July 2003||2003-07-01|September 2009|2009-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.|A Multicenter, Double-blind, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam (1000 to 3000 mg/Day Oral b.i.d.) and Carbamazepine (400 to 1200 mg/Day Oral b.i.d.), Used as Monotherapy in Subjects (≥ 16 Years) Coming From the N01061 Trial.|Completed||Phase 3|250||UCB Pharma|||||f||||||||||||||2017-02-18 17:26:03.95584|2017-02-18 17:26:03.95584
NCT00150774|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-09-16|||November 2001||2001-11-01|February 2010|2010-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults|A Double-blind, Multicenter, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Levetiracetam (LEV) (Oral Tablets of 500 mg b.i.d.) at a Dose of 3000 mg/Day as Adjunctive Treatment in Adolescents (≥ 12 Years) and Adults (≤ 65 Years) Suffering From Idiopathic Generalized Epilepsy With Myoclonic Seizures.|Completed||Phase 3|116||UCB Pharma|||||f||||||||||||||2017-02-18 17:26:04.043908|2017-02-18 17:26:04.043908
NCT00150761|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-08-25|||July 2004||2004-07-01|September 2009|2009-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Facial Thermography Study of Levocetirizine Versus Cetirizine|A Randomized, Double-blind, Double Dummy, Placebo Controlled, Cross-over Exploratory Trial in Healthy Male Adult Subjects: Comparison by Means of Infrared Thermography of the Anti-H1 Potency of Levocetirizine 5 mg and Cetirizine 10 mg Tablet Single Oral Dose After Nasal Histamine Provocation.|Completed||Phase 4|60||UCB Pharma|||||f||||||||||||||2017-02-18 17:26:04.136707|2017-02-18 17:26:04.136707
NCT00150748|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-03-24|||November 2001||2001-11-01|March 2015|2015-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy|An Open-label, Multicenter, Follow-up Study to Evaluate the Safety and Efficacy of Levetiracetam (LEV) (Oral Tablets of 166, 250 or 500 mg b.i.d.), at Individualized Doses up to a Maximum of 4000 mg/Day (or 80 mg/kg/Day for Children and Adolescents Less Than 50 kg), in Children (≥ 4 Years Old), Adolescents and Adults Suffering From Primary Generalized Seizures|Completed||Phase 3|217|Actual|UCB Pharma||1|||f||||f||||||||||2017-02-18 17:26:04.229|2017-02-18 17:26:04.229
NCT00150540|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-09-13|||October 2002||2002-10-01|September 2007|2007-09-01|January 2006|Actual|2006-01-01|||||Interventional|||A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.|A Long Term, Open Label Extension Study of Protocols LAM-IV-301, LAM-IV 303, LAM-IV 307 AND LAM-IV 308.|Completed||Phase 3|93||Shire|||||||||||||||||||2017-02-18 17:26:07.226478|2017-02-18 17:26:07.226478
NCT00150735|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-11-25|||June 2002||2002-06-01|July 2010|2010-07-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy|A Multicenter, Double-blind, Randomized, Parallel Group, Positive-controlled Trial Comparing the Efficacy and Safety of Levetiracetam (1000 to 3000 mg/Day Oral b.i.d.) to Carbamazepine (400 to 1200 mg/Day Oral b.i.d.), Used as Monotherapy for up to a Maximum of 121 Weeks in Subjects (≥ 16 Years) Newly or Recently Diagnosed as Suffering From Epilepsy, and Experiencing Partial or Generalized Tonic-clonic Seizures|Completed||Phase 3|580||UCB Pharma|||||f||||||||||||||2017-02-18 17:26:04.334897|2017-02-18 17:26:04.334897
NCT00150722|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-11-07|||September 2005||2005-09-01|November 2008|2008-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||High-Density Lipoprotein (HDL) Modulation and Endothelial Function|HDL Modulation and Endothelial Function|Completed||Phase 3|75|Actual|University of Calgary||1|||f||||||||||||||2017-02-18 17:26:04.419231|2017-02-18 17:26:04.419231
NCT00150709|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2017-02-14|||February 1998||1998-02-01|February 2017|2017-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy|A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of The Safety And Efficacy Of Levetiracetam (Ucb L059) In Children With Epilepsy|Completed||Phase 3|238||UCB Pharma|||||f||||||||||||||2017-02-18 17:26:04.516165|2017-02-18 17:26:04.516165
NCT00150696|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-11-20|||February 2000||2000-02-01|November 2007|2007-11-01|November 2005||2005-11-01|||||Interventional|||Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.|Risedronate for Prevention of Osteoporosis After Spinal Cord Injury|Completed||Phase 3|38||Toronto Rehabilitation Institute|||||f||||||||||||||2017-02-18 17:26:04.62851|2017-02-18 17:26:04.62851
NCT00150683|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||March 1999||1999-03-01|September 2005|2005-09-01|July 2001||2001-07-01|||||Interventional|||Effectiveness of Vibration and Standing Versus Standing Alone for the Treatment of Osteoporosis for People With Spinal Cord Injury.|Evaluation of Conventional and Innovative Standing Frame for the Treatment of Osteoporosis After Spinal Cord Injury|Completed||N/A|60||Toronto Rehabilitation Institute|||||f||||||||||||||2017-02-18 17:26:04.714142|2017-02-18 17:26:04.714142
NCT00150670|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-07-06|||March 2002||2002-03-01|July 2011|2011-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer|Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer|Completed||Phase 3|300||Taiho Pharmaceutical Co., Ltd.||2|||f||||||||||||||2017-02-18 17:26:04.999397|2017-02-18 17:26:04.999397
NCT00150657|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-11-28|||November 2004||2004-11-01|September 2005|2005-09-01||||||||Interventional|||Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer|Phase II Trial of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 2|45||St. John Providence Health System|||||||||||||||||||2017-02-18 17:26:05.11368|2017-02-18 17:26:05.11368
NCT00150644|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-05-27|||July 2003||2003-07-01|May 2008|2008-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy|A Phase 2, 12-Week, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of J867 on Uterine Artery Blood Flow and the Morphology of the Endometrium, Myometrium, and Uterine Leiomyomata in Subjects With Uterine Leiomyomata Scheduled for Hysterectomy.|Completed||Phase 2|33|Actual|Abbott||3|||f||||f||||||||||2017-02-18 17:26:05.209644|2017-02-18 17:26:05.209644
NCT00150631|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-11-25|||November 2000||2000-11-01|November 2014|2014-11-01|December 2014|Anticipated|2014-12-01|January 2004|Actual|2004-01-01||Interventional|||Danish Hypertension Prevention Project - DHYPP|Danish Hypertension Prevention Project|Unknown status|Active, not recruiting|Phase 3|100|Actual|Aarhus University Hospital Skejby||2|||f||||t||||||||||2017-02-18 17:26:05.334355|2017-02-18 17:26:05.334355
NCT00150618|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-11-25|2009-09-10||April 2004||2004-04-01|November 2009|2009-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17|A Phase III, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled Safety and Efficacy Study of SPD503 in Children and Adolescents Aged 6-17 With Attention Deficit Hyperactivity Disorder (ADHD)|Completed||Phase 3|324|Actual|Shire||5|||||||||||||||||2017-02-18 17:26:05.471503|2017-02-18 17:26:05.471503
NCT00150605|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-11-01|||February 2005||2005-02-01|June 2006|2006-06-01|October 2005||2005-10-01|||||Interventional|||Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder|A Phase IIIb, Open Label Observational Study of SPD417 Used in Combination With Other Psychotropic Medications for the Treatment of Bipolar I Disorder|Completed||Phase 3|50||Validus Pharmaceuticals|||||||||||||||||||2017-02-18 17:26:06.40301|2017-02-18 17:26:06.40301
NCT00150592|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-05-06|2009-09-10||May 2005||2005-05-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|||||Interventional|||Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17|A Phase II Study to Assess the Safety, Tolerability and Efficacy of SPD503 Administered to Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)|Completed||Phase 2|182|Actual|Shire||2|||||||||||||||||2017-02-18 17:26:06.482431|2017-02-18 17:26:06.482431
NCT00150579|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-11-02|||January 2005||2005-01-01|November 2007|2007-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Efficacy and Safety of SPD465 in Adults With ADHD|A Phase III, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).|Completed||Phase 3|240||Shire|||||||||||||||||||2017-02-18 17:26:07.016628|2017-02-18 17:26:07.016628
NCT00150566|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-04-29|||February 2004||2004-02-01|April 2010|2010-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood|A Phase IIIb, Multi-center, Two-Cohort, Randomized Study, With an Open-Label Run-In and a Long-Term Extensions Phase, Assessing an Extended Dose Range of Lanthanum Carbonate in End Stage Renal Disease Subjects Receiving Hemodialysis|Completed||Phase 3|460||Shire|||||f||||||||||||||2017-02-18 17:26:07.089509|2017-02-18 17:26:07.089509
NCT00150553|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-11-01|||January 2005||2005-01-01|May 2006|2006-05-01|October 2005||2005-10-01|||||Interventional|||Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder|A Phase IIIb, Randomized, Double-Blind, Parallel Group Study in Bipolar I Patients to Assess the Efficacy and Safety of SPD417 Administered Once Daily vs Twice Daily in the Treatment of Manic Symptoms|Completed||Phase 3|102||Validus Pharmaceuticals|||||||||||||||||||2017-02-18 17:26:07.160348|2017-02-18 17:26:07.160348
NCT00150527|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-02-04|||September 2005||2005-09-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Observational|||Specific Effects of Escitalopram on Neuroendocrine Response|Specific Effects of Escitalopram on Neuroendocrine Response|Completed||N/A|8|Actual|Queen's University|||1||f||||f||||||||||2017-02-18 17:26:07.293708|2017-02-18 17:26:07.293708
NCT00150514|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||January 2002||2002-01-01|November 2003|2003-11-01|December 2006||2006-12-01|||||Interventional|||Effects of Sublingual Immunotherapy on Grasspollen Allergy|A Placebo Controlled, Double-Blind, Randomised Study to Assess Efficacy of Sublingual Immunotherapy in Patients With Grass Pollen Allergy Through Assessment of Its Immunological Effects on the Mucosal Tissue of the Nose.|Completed||Phase 4|38||Radboud University|||||f||||||||||||||2017-02-18 17:26:07.390805|2017-02-18 17:26:07.390805
NCT00150488|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-09-17|||September 2005||2005-09-01|September 2008|2008-09-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||URACYST® For the Treatment of GAG Deficient Interstitial Cystitis|URACYST® For the Treatment of GAG Deficient Interstitial Cystitis|Completed||Phase 2/Phase 3|53|Actual|Queen's University||1|||f||||f||||||||||2017-02-18 17:26:07.4738|2017-02-18 17:26:07.4738
NCT00150475|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||January 2005||2005-01-01|September 2005|2005-09-01|May 2005||2005-05-01|||||Interventional|||Contamination During Removal of Two Different Personal Protective Systems|Contamination During Removal of Two Different Personal Protective Systems When Working Under Conditions Requiring Enhanced Respiratory and Contact Precautions|Completed||N/A|50||Queen's University|||||f||||||||||||||2017-02-18 17:26:07.581556|2017-02-18 17:26:07.581556
NCT00150462|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-10-29|2015-10-29||September 2005||2005-09-01|October 2015|2015-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies|A Phase I Study of the Safety and Pharmacokinetics of Escalating Intravenous Doses of the Proteasome Inhibitor PR-171 in Patients With Hematological Malignancies|Completed||Phase 1|48|Actual|Onyx Pharmaceuticals||11|||f||||f||||||||||2017-02-18 17:26:07.691516|2017-02-18 17:26:07.691516
NCT00150449|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-07-13|||January 2001||2001-01-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.|A 1-Year Open-Label Safety Extension Study of Pregabalin in Patients With Anxiety Disorders|Completed||Phase 3|511||Pfizer|||||f||||||||||||||2017-02-18 17:26:12.368652|2017-02-18 17:26:12.368652
NCT00150436|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-12-20|||February 2002||2002-02-01|December 2006|2006-12-01|July 2005||2005-07-01|||||Interventional|||To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.|An Open-Label Extension Safety and Efficacy Study of Pregabalin in Patients With Postherpetic Neuralgia|Completed||Phase 3|276||Pfizer|||||f||||||||||||||2017-02-18 17:26:12.697547|2017-02-18 17:26:12.697547
NCT00150423|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-12-28|||January 2001||2001-01-01|December 2006|2006-12-01|July 2005||2005-07-01|||||Interventional|||To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.|An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.|Completed||Phase 3|384||Pfizer|||||f||||||||||||||2017-02-18 17:26:12.778895|2017-02-18 17:26:12.778895
NCT00150410|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-10-28|||January 2003||2003-01-01|October 2008|2008-10-01|June 2007|Actual|2007-06-01|||||Interventional|||Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose|A One-Year, Open, Randomized, Parallel, Three-Arm Study Comparing Exubera® (Insulin Dry Powder Pulmonary Inhaler) vs. Avandia® (Rosiglitazone Maleate) as Add-On Therapy vs. Exubera® Substitution of Sulfonylurea in Patients With Type 2 Diabetes, Poorly Controlled on Combination Sulfonylurea and Metformin Treatment|Completed||Phase 3|626|Actual|Pfizer|||||||||||||||||||2017-02-18 17:26:12.863077|2017-02-18 17:26:12.863077
NCT00150397|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-06-07|||March 2005||2005-03-01|June 2012|2012-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Six-Week Study Of The Efficacy And Safety Of Tofimilast Dry Powder For Inhalation In Adults With Persistent Asthma|Completed||Phase 2|112||Pfizer|||||f||||||||||||||2017-02-18 17:26:13.253924|2017-02-18 17:26:13.253924
NCT00150384|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-04-21|||July 2004||2004-07-01|April 2015|2015-04-01|August 2005|Actual|2005-08-01|||||Interventional|CAPABLE||Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population|Clinical Utility Of Caduet In Simultaneously Achieving Blood Pressure And Lipid Endpoints In A Specific Patient Population (CAPABLE)|Completed||Phase 4|500||Pfizer|||||||||||||||||||2017-02-18 17:26:13.368375|2017-02-18 17:26:13.368375
NCT00150371|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-07-01|||June 2004||2004-06-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Interventional|CANACTFAST||Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration|A Multicenter, 12 Week Treatment Single Step Titration Open-Label Study Assessing The % Of Patients Achieving Ldl-C Target With Atorvastatin Starting Doses Of 10mg, 20mg, 40mg and 80mg.|Completed||Phase 3|1100||Pfizer|||||f||||||||||||||2017-02-18 17:26:14.005709|2017-02-18 17:26:14.005709
NCT00150358|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-12-07|||March 2005||2005-03-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .|Open Label, Multicenter, Non Comparative Study, To Confirm The Efficacy And Tolerability Of Viagra In Subjects With Erectile Dysfunction And Arterial Hypertension Who Are Taking Antihypertensive Treatment.|Completed||Phase 4|253||Pfizer|||||f||||||||||||||2017-02-18 17:26:14.170154|2017-02-18 17:26:14.170154
NCT00150345|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-01-17|2010-04-05||January 2005||2005-01-01|January 2012|2012-01-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|IDEA||Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients|Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In High-Risk Neutropenic Patients With Fever And A Positive Panfungal Polymerase Chain Reaction Assay (IDEA Study)|Completed||Phase 3|147|Actual|Pfizer|One participant in the Immediate Voriconazole treatment group was incorrectly included in the original Primary efficacy analysis and has now been excluded; IFI was identified on the day study treatment started (not prior to study treatment).|2|||f||||f||||||||||2017-02-18 17:26:14.47883|2017-02-18 17:26:14.47883
NCT00150332|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-05-09|||January 2003||2003-01-01|May 2011|2011-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan|Linezolid (PNU-10766/PNU10766SS) in the Treatment of MRSA Infections in Patients Whose Conventional Therapy Has Failed, or Who Are Intolerant to Conventional Therapy; an Open-label, Multi-center Trial|Completed||Phase 3|24|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:26:15.61964|2017-02-18 17:26:15.61964
NCT00150319|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-09-25|||June 2005||2005-06-01|September 2008|2008-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend|An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Iv Containing Sbecd As An Excipient Following Multiple Dosing With Vfend®; I.V. In Subjects With Moderately Impaired Renal Function|Terminated||Phase 1/Phase 2|1|Actual|Pfizer||||See Detailed Description|f||||||||||||||2017-02-18 17:26:15.723925|2017-02-18 17:26:15.723925
NCT00150306|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-08-16|||November 2002||2002-11-01|August 2007|2007-08-01|July 2007|Actual|2007-07-01|||||Interventional|||A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD|A Multicenter, 10-Week, Randomized, Double-Blind Study Of Sertraline And Placebo In Children And Adolescents With Posttraumatic Stress Disorder (PTSD)|Terminated||Phase 3|160||Pfizer||||Please see Detailed Description below for termination reason.|||||f||||||||||2017-02-18 17:26:15.824005|2017-02-18 17:26:15.824005
NCT00150293|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-03-04|||March 2002||2002-03-01|March 2015|2015-03-01|November 2005||2005-11-01|||||Interventional|||Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.|Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.|Completed||Phase 3|337||Pfizer|||||f||||||||||||||2017-02-18 17:26:16.061998|2017-02-18 17:26:16.061998
NCT00150280|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-07-23|||October 2004||2004-10-01|November 2005|2005-11-01|July 2005||2005-07-01|||||Interventional|||Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery|A Prospective, Randomized, Double-Blind, Double-Dummy, Multi-Center Study Comparing Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery|Completed||Phase 3|132||Pfizer|||||f||||||||||||||2017-02-18 17:26:16.22475|2017-02-18 17:26:16.22475
NCT00150267|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-11-04|||February 2002||2002-02-01|November 2008|2008-11-01||||||||Interventional|||A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension|A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension|Completed||Phase 3|976|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:26:16.309637|2017-02-18 17:26:16.309637
NCT00150254|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-06-01|||September 2001||2001-09-01|June 2007|2007-06-01|October 2002|Actual|2002-10-01|||||Interventional|||12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.|A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Four Dosing Strategies for CP-526,555 ( 0.5 mg BID Titrated, 0.5 mg BID, 1 mg BID, and Titrated 1 mg BID ) in Smoking Cessation|Completed||Phase 2|625||Pfizer|||||||||||||||||||2017-02-18 17:26:16.672355|2017-02-18 17:26:16.672355
NCT00150241|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-10-16|||February 2000||2000-02-01|October 2015|2015-10-01|January 2002|Actual|2002-01-01|||||Interventional|||A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation|A Seven-Week Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Three Doses of CP-526,555 ( 0.3 mg QD, 1 mg QD, and 1 mg BID ) in Comparison With Zyban in Smoking Cessation|Completed||Phase 2|625||Pfizer|||||||||||||||||||2017-02-18 17:26:16.784369|2017-02-18 17:26:16.784369
NCT00150228|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-05-31|||December 2001||2001-12-01|May 2007|2007-05-01|September 2002|Actual|2002-09-01|||||Interventional|||12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation|A Twelve-Week Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety and Efficacy of a Flexible-Dosing Strategy for CP-526,555 ( 0.5 mg to 2.0 mg Total Daily Dose ) in Smoking Cessation|Completed||Phase 2|300||Pfizer|||||||||||||||||||2017-02-18 17:26:16.877898|2017-02-18 17:26:16.877898
NCT00150215|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-07-24|||July 2005||2005-07-01|April 2006|2006-04-01|October 2005||2005-10-01|||||Interventional|||A First In Human Study Of PF-00184562 In Healthy Volunteers|An Oral, Rising Single-Dose Tolerance, Pharmacokinetic, and Pharmacodynamic Study of Pf-00184562 Capsules In Healthy Volunteers|Completed||Phase 1|18||Pfizer|||||||||||||||||||2017-02-18 17:26:16.966039|2017-02-18 17:26:16.966039
NCT00150202|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-05-04|||July 2004||2004-07-01|November 2006|2006-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)|Clinical Study Of EYE001 In Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|Completed||Phase 3|90||Pfizer|||||f||||||||||||||2017-02-18 17:26:17.05276|2017-02-18 17:26:17.05276
NCT00150189|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-12-22|||November 2003||2003-11-01|December 2006|2006-12-01||||||||Interventional|||Utilization of Oral Sucrose to Decrease Pain in Infants During Immunizations|Efficacy of Oral Sucrose Analgesia During Routine Immunizations at 6 Weeks and 4 Months of Age|Completed||N/A|140||Penn State University|||||f||||||||||||||2017-02-18 17:26:17.146092|2017-02-18 17:26:17.146092
NCT00150176|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-10-29|2010-04-28||April 2005||2005-04-01|October 2015|2015-10-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)|A Randomized, Placebo-Controlled, Double-Blind Trial of Asenapine in the Prevention of Relapse After Long-Term Treatment of Schizophrenia|Completed||Phase 3|831|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:26:17.241977|2017-02-18 17:26:17.241977
NCT00150163|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-03-28|||March 2002||2002-03-01|September 2005|2005-09-01|December 2008||2008-12-01|||||Observational|||Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men|Odense Androgen Study – A Population-Based Study of Androgens, Body Composition, and Muscle Function in 20-29 Year-Old Danish Men|Unknown status|Active, not recruiting|N/A|800||Odense University Hospital|||||f||||||||||||||2017-02-18 17:26:17.847233|2017-02-18 17:26:17.847233
NCT00150150|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-03-26|||January 2001||2001-01-01|March 2007|2007-03-01|March 2006||2006-03-01|||||Interventional|||Laser Therapy of Benign Thyroid Nodules|Ultrasound Guided Interstitial Laser Photocoagulation on Benign Thyroid Nodules|Unknown status|Active, not recruiting|Phase 3|70||Odense University Hospital|||||f||||||||||||||2017-02-18 17:26:17.931311|2017-02-18 17:26:17.931311
NCT00150137|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-02-02|||January 2003||2003-01-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Antithyroid Drugs During Radioiodine Therapy|The Influence of Continuous Treatment With Antithyroid Drugs on the Effect of Radioiodine in Patients With Hyperthyroidism|Completed||Phase 4|80||Odense University Hospital|||||f||||||||||||||2017-02-18 17:26:18.009374|2017-02-18 17:26:18.009374
NCT00149721|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2010-03-01|||September 2005||2005-09-01|March 2010|2010-03-01|December 2007||2007-12-01|||||Interventional|||Anterior Pituitary Function in Patients With Hydrocephalus|Anterior Pituitary Function in Patients With Hydrocephalus|Terminated||N/A|30||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:26:24.348583|2017-02-18 17:26:24.348583
NCT00150124|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-12-03|||January 2003||2003-01-01|December 2013|2013-12-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Block-replacement Therapy During Radioiodine Therapy|The Influence of Continuous Block-replacement Therapy on the Effect of Radioiodine in Patients With Hyperthyroidism|Completed||Phase 4|100|Actual|Odense University Hospital||2|||f||||f||||||||||2017-02-18 17:26:18.100127|2017-02-18 17:26:18.100127
NCT00150111|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-10-05|||June 2003||2003-06-01|October 2006|2006-10-01|October 2006||2006-10-01|||||Interventional|||Rituximab in the Treatment of Graves' Disease|B Cell Depletion With the Anti-CD20 Monoclonal Antibody Rituximab in the Treatment of Graves' Disease|Completed||Phase 1/Phase 2|20||Odense University Hospital|||||f||||||||||||||2017-02-18 17:26:18.195878|2017-02-18 17:26:18.195878
NCT00150098|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-04-07|||February 2005||2005-02-01|April 2014|2014-04-01|October 2010|Actual|2010-10-01|November 2009|Actual|2009-11-01||Interventional|||Project UNITY - HIV Risk Reduction and Vaccine Education Interventions|Project UNITY - A Randomized Trial of Enhanced HIV Risk Reduction and Vaccine Education Interventions in Reducing Sexual Risk and Increasing Vaccine Trial Knowledge Among HIV-negative, High-risk Women Who Use Non-injection Drugs|Completed||N/A|400|Actual|New York Blood Center||1|||f||||f||||||||||2017-02-18 17:26:18.296479|2017-02-18 17:26:18.296479
NCT00150085|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-02-17|||February 2004||2004-02-01|February 2011|2011-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion|A Prospective, Randomized, Open-label, Twenty-six Week Study of the Efficacy and Safety of Converting Kidney and Liver Transplant Recipients With Tacrolimus-associated Abnormal Glucose Metabolism to Cyclosporine Micro-emulsion With C2 Monitoring|Terminated||Phase 4|50|Actual|Novartis|||||f||||||||||||||2017-02-18 17:26:18.401775|2017-02-18 17:26:18.401775
NCT00150072|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-08-06|||October 2004||2004-10-01|August 2012|2012-08-01||||April 2008|Actual|2008-04-01||Interventional|||Efficacy and Safety of Imatinib in Chordoma|Phase II Study of Imatinib Mesylate in Chordoma|Completed||Phase 2|55|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:26:18.604044|2017-02-18 17:26:18.604044
NCT00150059|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-02-14|||December 2004||2004-12-01|February 2008|2008-02-01|December 2005|Actual|2005-12-01|||||Interventional|||Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis||Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 17:26:18.734083|2017-02-18 17:26:18.734083
NCT00150046|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-11-01|||December 2004||2004-12-01|November 2011|2011-11-01||||May 2007|Actual|2007-05-01||Interventional|||Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients|A 12-month, Multicenter, Randomized, Open-label Non-inferiority Study of Renal Function and Efficacy Comparing Concentration-controlled Certican (1.5 mg/Day Starting Dose) With Reduced Neoral Dose Versus MMF With Standard Neoral Dose in de Novo Heart Transplant Recipients|Completed||Phase 3|176|Anticipated|Novartis|||||f||||||||||||||2017-02-18 17:26:18.846163|2017-02-18 17:26:18.846163
NCT00150033|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-05-21|||May 2005||2005-05-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|||||Observational|||Health-Related Quality of Life for Thyroid Patients|Development and Validation of a Thyroid-Specific Quality of Life Measure|Completed||Phase 2|1200|Anticipated|Odense University Hospital|||||f||||||||||||||2017-02-18 17:26:18.942558|2017-02-18 17:26:18.942558
NCT00150020|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-01-21|||October 2004||2004-10-01|January 2008|2008-01-01||||February 2006|Actual|2006-02-01||Interventional|||Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance|Safety and Tolerability of Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients With GI Intolerance|Completed||Phase 4|728|Anticipated|Novartis|||||||||||||||||||2017-02-18 17:26:19.026858|2017-02-18 17:26:19.026858
NCT00150007|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-11-01|||June 2004||2004-06-01|November 2011|2011-11-01||||June 2005|Actual|2005-06-01||Interventional|||Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)|Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)|Completed||Phase 4|335||Novartis|||||f||||||||||||||2017-02-18 17:26:19.119666|2017-02-18 17:26:19.119666
NCT00149994|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-04-07|2011-01-25||December 2002||2002-12-01|April 2011|2011-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients|DELTA Study Dutch Evaluation in Liver Transplantation To Assess the Efficacy of Cyclosporine A Microemulsion With C-2h Monitoring Versus Tacrolimus With Trough Monitoring in de Novo Liver Transplant Recipients|Completed||Phase 4|171|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:26:19.211235|2017-02-18 17:26:19.211235
NCT00149981|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-12-10|||August 2003||2003-08-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional|Umbrella||A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation|A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation|Completed||Phase 4|1025|Actual|Novartis||1|||f||||f||||||||||2017-02-18 17:26:20.031428|2017-02-18 17:26:20.031428
NCT00149968|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-10-14|||April 2005||2005-04-01|October 2009|2009-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife)|Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife)|Completed||Phase 4|196|Actual|Novartis||1|||f||||f||||||||||2017-02-18 17:26:20.286611|2017-02-18 17:26:20.286611
NCT00149942|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-11-16|||October 2004||2004-10-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy|Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-Coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From GI Adverse Events While on Mycophenolate Mofetil Therapy|Completed||Phase 4|23|Actual|Novartis|||||f||||||||||||||2017-02-18 17:26:20.39373|2017-02-18 17:26:20.39373
NCT00149929|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-02-01|||December 1999||1999-12-01|February 2011|2011-02-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301|Multicenter, Open-label Follow-up Study on the Safety of Enteric-coated Mycophenolate Sodium in de Novo Renal Transplant Patients|Completed||Phase 3|246|Actual|Novartis|||||||||||||||||||2017-02-18 17:26:20.479783|2017-02-18 17:26:20.479783
NCT00149916|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-11-01|||April 2000||2000-04-01|November 2011|2011-11-01||||April 2004|Actual|2004-04-01||Interventional|||Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107|Multicenter, Open-label Follow-up Study on the Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Patients.|Completed||Phase 3|139|Actual|Novartis||1|||||||||||||||||2017-02-18 17:26:20.559766|2017-02-18 17:26:20.559766
NCT00149903|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01||||June 2006|Actual|2006-06-01||Interventional|||Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients|Multicenter, Double-blind, Randomized, Parallel Group Study on Efficacy and Safety of Enteric-coated Mycophenolate Sodium vs. Mycophenolate Mofetil in de Novo Chinese Renal Transplant Recipients|Completed||Phase 3|300||Novartis|||||f||||||||||||||2017-02-18 17:26:20.64767|2017-02-18 17:26:20.64767
NCT00149890|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-08-17|2011-01-20||March 2004||2004-03-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids|A Multicenter, Open-label, Randomized, Two Arm Study to Investigate the Efficacy and Safety of a Therapy Avoiding Intraoperative Steroids in Combination With Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients|Completed||Phase 3|77|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:26:20.741118|2017-02-18 17:26:20.741118
NCT00149877|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-01-31|||April 2004||2004-04-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation|Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation|Completed||Phase 4|250||Novartis|||||f||||||||||||||2017-02-18 17:26:21.688407|2017-02-18 17:26:21.688407
NCT00149864|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-02-01|||February 2000||2000-02-01|February 2011|2011-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302|Multicenter, Open-label Follow-up Study on the Safety of Enteric-coated Mycophenolate Sodium in Maintenance Renal Transplant Patients|Completed||Phase 3|264|Actual|Novartis|||||||||||||||||||2017-02-18 17:26:21.782446|2017-02-18 17:26:21.782446
NCT00149851|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-08-31|||January 2004||2004-01-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)|A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)|Completed||Phase 2|832||Novartis|||||||||||||||||||2017-02-18 17:26:21.859316|2017-02-18 17:26:21.859316
NCT00149838|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-04-26|||February 2005||2005-02-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||Magnetic Brain Stimulation for the Treatment of Adult Depression|Optimization of TMS for Depression|Completed||Phase 2/Phase 3|199|Actual|National Institute of Mental Health (NIMH)||4|||f||||t||||||||||2017-02-18 17:26:21.951578|2017-02-18 17:26:21.951578
NCT00149825|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-05-12|2009-07-30||June 2004||2004-06-01|May 2014|2014-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome||Completed||Phase 2|30|Actual|Stanford University|Limitations of the current pilot study include a small sample size, relative racial homogeneity, and exclusion of patients with comorbidity.|2|||f||||||||||||||2017-02-18 17:26:22.072946|2017-02-18 17:26:22.072946
NCT00149812|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-08-03|||January 2005||2005-01-01|August 2016|2016-08-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||A Clinic-based Prevention Program for Families of Depressed Mothers|A Clinic-based Program for Families of Depressed Mothers|Completed||Phase 1|26|Actual|Johns Hopkins Bloomberg School of Public Health||1|||f||||f||||||||No||2017-02-18 17:26:22.704955|2017-02-18 17:26:22.704955
NCT00149799|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-11-14|2014-10-17||May 2005||2005-05-01|November 2014|2014-11-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||As the primary endpoint is based on participants randomized to Phase II (i.e. those who completed Phase I, met criteria for response, and were willing to continue on in the study), baseline characteristics are provided for the 58 Phase II participants.|Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder|Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder|Completed||Phase 3|100|Actual|Massachusetts General Hospital|Our findings may not be fully generalizable - for example, we excluded those with a co-occurring substance use disorder, higher levels of suicidality, and more severely ill patients who required concomitant therapy or a higher level of care.|2|||f||||t||||||||||2017-02-18 17:26:22.82794|2017-02-18 17:26:22.82794
NCT00149786|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-04-09|||October 2004||2004-10-01|April 2012|2012-04-01|March 2009|Actual|2009-03-01|March 2008|Actual|2008-03-01||Interventional|||Effectiveness of Family-Based Versus Individual Psychotherapy in Treating Adolescents With Anorexia Nervosa|Treatment of Adolescents With Anorexia Nervosa|Completed||Phase 1|120|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 17:26:23.512462|2017-02-18 17:26:23.512462
NCT00149773|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-04-06|||May 2005||2005-05-01|June 2006|2006-06-01|February 2011|Actual|2011-02-01|December 2008|Actual|2008-12-01||Interventional|||Cognitive Therapy for Suicidal Older Men in Primary Care Settings|Cognitive Therapy for Suicidal Older Men in Primary Care Settings|Completed||Phase 1|34|Actual|University of Pennsylvania||2|||f||||||||||||||2017-02-18 17:26:23.630349|2017-02-18 17:26:23.630349
NCT00149760|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-02-19|||August 2003||2003-08-01|February 2014|2014-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder|Cognitive Affective Behavior Therapy for Somatization|Completed||Phase 2|88|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 17:26:23.735603|2017-02-18 17:26:23.735603
NCT00149747|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-04-25|2013-06-18||August 1999||1999-08-01|April 2016|2016-04-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|RTC||The Effectiveness of Regular Exercise on Improving Sleep in Older Adults|Promoting Exercise, Sleep and Well-Being in Older Adults|Completed||Phase 2/Phase 3|66|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 17:26:23.858958|2017-02-18 17:26:23.858958
NCT00149734|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-08-05|||January 2005||2005-01-01|August 2015|2015-08-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia|Atypical Antipsychotics and P50 Sensory Gating|Completed||N/A|85|Actual|University of Colorado, Denver||2|||f||||f||||||||||2017-02-18 17:26:24.237135|2017-02-18 17:26:24.237135
NCT00149708|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-06-13|||September 2005||2005-09-01|June 2010|2010-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Consequence of Lifetime Isolated Growth Hormone Deficiency|Consequence of Lifetime Isolated Growth Hormone Deficiency|Completed||N/A|400|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||||||||||||2017-02-18 17:26:24.444124|2017-02-18 17:26:24.444124
NCT00149695|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2010-08-20|||July 2004||2004-07-01|August 2010|2010-08-01|December 2005|Actual|2005-12-01|||||Interventional|||Soft Drink, Milk and Obesity in Chilean Children|Soft Drink, Milk and Obesity in Chilean Children|Completed||N/A|96||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:26:24.554462|2017-02-18 17:26:24.554462
NCT00149682|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-01-12|||July 2005||2005-07-01|January 2010|2010-01-01|December 2007||2007-12-01|||||Interventional|||Obesity Assessment and Education Through the Internet|Obesity Assessment and Education Through the Internet|Completed||Phase 2|100||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:26:24.666274|2017-02-18 17:26:24.666274
NCT00149669|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-11-03||||||November 2005|2005-11-01||||||||Interventional|||Employment-Based Reinforcement to Motivate Naltrexone Ingestion and Drug Abstinence in the Treatment of Drug Addiction. - 1|Employment-Based Addiction Pharmacotherapy|Unknown status|Not yet recruiting|N/A|275||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:26:24.755891|2017-02-18 17:26:24.755891
NCT00149656|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-04-26|||June 2003||2003-06-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|July 2010|Actual|2010-07-01||Interventional|||The Effects of Nutritional Supplementation and Drug Abuse on HIV|HIV Disease, Drug Abuse, and Nutrient Therapy in Botswana|Completed||N/A|878|Actual|Florida International University||4|||f||||t||||||||||2017-02-18 17:26:24.844393|2017-02-18 17:26:24.844393
NCT00149643|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-06-17|2012-02-08||September 2004||2004-09-01|June 2013|2013-06-01|December 2012|Actual|2012-12-01|August 2009|Actual|2009-08-01||Interventional|CADY||Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence|Fluoxetine for Major Depressive Disorder/Cannabis Disorder in Young People|Completed||Phase 2|70|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 17:26:24.962211|2017-02-18 17:26:24.962211
NCT00149630|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-11-27|2012-10-22||January 2005||2005-01-01|November 2012|2012-11-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|Disulfiram||Pharmacogenetics of Disulfiram for Cocaine|Effectiveness of Disulfiram for Treating Cocaine Dependence in Individuals With Different Dopamine Beta Hydroxylase (DBH) Genes|Completed||Phase 2|93|Actual|Baylor College of Medicine|The sample size is small for this genetic association study, and larger replications of this preliminary study are needed. Most cocaine abusers are not also opioid dependent, which limits generalization of findings.|2|||f||||t||||||||||2017-02-18 17:26:25.391753|2017-02-18 17:26:25.391753
NCT00149617|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-10-08|||April 2004||2004-04-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1|Career Training in Marijuana Dependence|Completed||Phase 2|81|Actual|Medical University of South Carolina|||||f||||||||||||||2017-02-18 17:26:25.817433|2017-02-18 17:26:25.817433
NCT00149604|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-12-01|||March 2000||2000-03-01|December 2009|2009-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||AFTER: Altering Fat Through Estrogen and Raloxifene|Modulation of Visceral Fat by Estrogens After Menopause|Completed||Phase 2|108||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:26:25.916211|2017-02-18 17:26:25.916211
NCT00149591|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-09-04|||April 2001||2001-04-01|September 2006|2006-09-01|January 2007||2007-01-01|||||Interventional|||The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)|Early and Long-Term Outcome of Elective Stenting of the Infarct-Related Artery in Patients With Viability in the Infarct-Area Early After Acute Myocardial Infarction. The VIAMI-Trial.|Unknown status|Active, not recruiting|N/A|300||Netherlands Heart Foundation|||||f||||||||||||||2017-02-18 17:26:26.022269|2017-02-18 17:26:26.022269
NCT00149578|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-05-16|||October 2004||2004-10-01|May 2007|2007-05-01|October 2008|Anticipated|2008-10-01|||||Interventional|||A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer|A Phase II Study of Induction Chemotherapy Followed by Concurrent Chemotherapy With Radiotherapy in Locally Advanced Pancreatic Cancer|Unknown status|Recruiting|Phase 2|45|Anticipated|National Health Research Institutes, Taiwan|||||f||||t||||||||||2017-02-18 17:26:26.277273|2017-02-18 17:26:26.277273
NCT00149565|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-12-15|||October 1997||1997-10-01|December 2004|2004-12-01|July 2005||2005-07-01|||||Interventional|||Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma|Hepatocellular Carcinoma Postoperative Adjuvant Therapy Disease Committee of Taiwan Cooperative Oncology Group|Completed||Phase 3|268||National Health Research Institutes, Taiwan|||||f||||||||||||||2017-02-18 17:26:26.377107|2017-02-18 17:26:26.377107
NCT00149552|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-03-01|||June 2001||2001-06-01|March 2012|2012-03-01|January 2007|Actual|2007-01-01|||||Interventional|||Zinc Therapy in HIV Infected Individuals Who Abuse Drugs|Zinc Therapy in Zinc Deficient HIV Positive Drug Users|Completed||N/A|231|Actual|Florida International University||2|||f||||t||||||||||2017-02-18 17:26:26.468897|2017-02-18 17:26:26.468897
NCT00149539|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2017-01-11|||June 2004||2004-06-01|July 2007|2007-07-01|January 2006|Actual|2006-01-01|||||Interventional|||Abuse Potential of Buprenorphine/Naloxone|Abuse Potential of Buprenorphine/Naloxone as a Function of Maintenance Dose of Buprenorphine/Naloxone|Terminated||Phase 2|12|Actual|National Institute on Drug Abuse (NIDA)||1||Funding ended for the study|f||||f||||||||||2017-02-18 17:26:26.581257|2017-02-18 17:26:26.581257
NCT00149526|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-02-17|||June 2001||2001-06-01|January 2008|2008-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Does Shared Decision-Making Improve Asthma Outcomes?||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:26:26.671818|2017-02-18 17:26:26.671818
NCT00149513|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-12-18|||September 2003||2003-09-01|December 2012|2012-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Post-Hospital Case Management to Improve Clinical Outcomes in Individuals Requiring Mechanical Ventilation|King County Lung Injury Project: Survivor Outcome Study (KCLIP:SOS)|Completed||N/A|600|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:26:26.73836|2017-02-18 17:26:26.73836
NCT00149500|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-07-01|||September 2003||2003-09-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Social Support and Education in Asthma Follow-up (SSEA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:26:26.833413|2017-02-18 17:26:26.833413
NCT00148408|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-04-28|||December 2003||2003-12-01|September 2006|2006-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Trial of Asthma Patient Education (TAPE)|Trial of Asthma Patient Education (TAPE)|Completed||Phase 4|600||American Lung Association Asthma Clinical Research Centers|||||f||||||||||||||2017-02-18 17:26:44.29723|2017-02-18 17:26:44.29723
NCT00149487|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-11-06|||January 2001||2001-01-01|November 2006|2006-11-01||||||||Interventional|||Enhancing Treatment Adherence in Pediatric Asthma With a Problem Solving Intervention|Randomized Controlled Trial of Problem Solving Intervention to Enhance Treatment Adherence in Pediatric Asthma|Unknown status|Active, not recruiting|N/A|120||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:26:26.91547|2017-02-18 17:26:26.91547
NCT00149474|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-02-17|||August 1994||1994-08-01|September 2005|2005-09-01|July 1999|Actual|1999-07-01|||||Interventional|||Peak Flow Monitoring in Older Adults With Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:26:27.014783|2017-02-18 17:26:27.014783
NCT00149461|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-01-16|||September 2006||2006-09-01|January 2014|2014-01-01|July 2009|Actual|2009-07-01|April 2008|Actual|2008-04-01||Interventional|||Written Asthma Actions Plans Versus No Written Instructions In Specialty Care|The Efficacy of Written Treatment Plans in Asthma|Completed||N/A|407|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 17:26:27.08118|2017-02-18 17:26:27.08118
NCT00149448|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-04-13|||May 2004||2004-05-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Effectiveness of the TB Contact Priority Model||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:26:27.383694|2017-02-18 17:26:27.383694
NCT00149435|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-12-18|||September 2005||2005-09-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Cardiovascular Health Study (CHS) Events Follow-up Study||Completed||N/A|5888|Actual|University of Washington|||1||f||||||||||||||2017-02-18 17:26:27.459795|2017-02-18 17:26:27.459795
NCT00149422|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-02-08|||June 2004||2004-06-01|August 2008|2008-08-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|||Effect of NT-proBNP Guided Treatment of Chronic Heart Failure|Can Pro-brain-natriuretic Peptide Guided Therapy of Chronic Heart Failure Improve Heart Failure Morbidity and Mortality?|Completed||N/A|||Netherlands Heart Foundation||2|||f||||t||||||||||2017-02-18 17:26:27.5584|2017-02-18 17:26:27.5584
NCT00149409|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-07-12|||September 2005||2005-09-01|September 2005|2005-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure|Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure:Effects On Endothelial Function, Left Ventricular Remodelling, Natriuretic Peptide Levels, And Exercise Capacity|Completed||Phase 2/Phase 3|||Medical University of Vienna||3|||f||||||||||||||2017-02-18 17:26:27.67213|2017-02-18 17:26:27.67213
NCT00149396|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-12-12|||July 2004||2004-07-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver|A Phase I/II, Open-Label Study (With a Sequential Dose Escalation Stage Followed by an Expansion of a Selected Dose Cohort), to Evaluate the Safety and Anti-Tumor Effects of NV1020 Administered Repeatedly Via Hepatic Artery Infusion Prior to Second-Line Chemotherapy, in Patients With Colorectal Adenocarcinoma Metastatic to the Liver|Completed||Phase 1/Phase 2|27|Anticipated|MediGene||1|||f||||t||||||||||2017-02-18 17:26:27.780729|2017-02-18 17:26:27.780729
NCT00149383|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-04-10|||December 2004||2004-12-01|April 2015|2015-04-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria|A Randomized, Double-blind, Placebo-controlled Trial of Rosiglitazone as Adjunctive Therapy for P.Falciparum Infection|Completed||Phase 1/Phase 2|140|Actual|Mahidol University||2|||f||||||||||||||2017-02-18 17:26:27.892989|2017-02-18 17:26:27.892989
NCT00149370|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||January 2001||2001-01-01|August 2005|2005-08-01|August 2003||2003-08-01|||||Observational|||Quality of Life Among Breast Reduction Patients|A Prospective Study of Patients Undergoing Breast Reduction Surgery: Health-Related Quality of Life and Clinical Outcomes|Completed||N/A|52||McMaster University|||||f||||||||||||||2017-02-18 17:26:28.01398|2017-02-18 17:26:28.01398
NCT00149357|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-04-18|||July 2005||2005-07-01|April 2008|2008-04-01|April 2008|Anticipated|2008-04-01|February 2008|Actual|2008-02-01||Observational|||Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)|Determining the Risk of Fetal Loss in Women With Unprovoked Venous Thromboembolism (VTE) Who Do NOT Have Identifiable Inherited Thrombophilia Compared With Women Who Have the Diagnosis of VTE Excluded|Terminated||N/A|1880|Anticipated|McMaster University|||1|Funding withdrawn due to low enrollment|f||||t||||||||||2017-02-18 17:26:28.112091|2017-02-18 17:26:28.112091
NCT00149344|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-07-27|||September 2005||2005-09-01|July 2011|2011-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Vertical Scar Versus Inferior Pedicle Reduction Mammoplasty|Vertical Scar Versus Inferior Pedicle Reduction Mammoplasty: A Randomized Controlled Trial and Cost-Utility Analysis|Completed||N/A|254|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 17:26:28.211434|2017-02-18 17:26:28.211434
NCT00149331|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-09-07|||July 2005||2005-07-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||The Effects of Two Education Strategies About Insulin on Patient Preferences and Perceptions About Insulin Therapy|A Randomized Controlled Trial Comparing the Effects of Two Education Strategies About Insulin on Preferences and Perceptions About Insulin Therapy|Completed||Phase 4|86||McMaster University|||||f||||||||||||||2017-02-18 17:26:28.311233|2017-02-18 17:26:28.311233
NCT00149318|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-11-07|||December 2002||2002-12-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|October 2008|Actual|2008-10-01||Observational|||Enzyme Replacement Therapy in Fabry Disease|Evaluation of the Long Term Efficacy of Enzyme Replacement Therapy in Fabry Disease|Terminated||N/A|2|Actual|Mario Negri Institute for Pharmacological Research|||1|Difficulties in the patient's enrolment|f||||f||||||Samples With DNA|"~     Whole blood on EDTA. Serum. Urine samples.~   "|||2017-02-18 17:26:28.403943|2017-02-18 17:26:28.403943
NCT00149305|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-04-08|||May 2005||2005-05-01|October 2009|2009-10-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Observational|||Genetic Study of Nephrolithiasis in Gouty Diathesis|Genetic Study of Nephrolithiasis in Gouty Diathesis|Terminated||N/A|37|Actual|Mario Negri Institute for Pharmacological Research|||2|Non significative preliminary data|f||||f||||||Samples With DNA|"~     Whole blood on EDTA~   "|||2017-02-18 17:26:28.496055|2017-02-18 17:26:28.496055
NCT00149292|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-07-31|||August 2005||2005-08-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Study of LY2140023 in Schizophrenia|A Randomized, Double-Blind Comparison of LY2140023, Olanzapine, and Placebo in the Treatment of Patients With Schizophrenia|Completed||Phase 2|250||Eli Lilly and Company|||||f||||||||||||||2017-02-18 17:26:28.599061|2017-02-18 17:26:28.599061
NCT00149279|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-09-20|||July 1995||1995-07-01|September 2016|2016-09-01|April 2006||2006-04-01|||||Interventional|||A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer|Randomized Controlled Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer (JCOG9501)|Completed||Phase 3|520||Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:26:28.682202|2017-02-18 17:26:28.682202
NCT00149266|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-02-02|||July 1995||1995-07-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)|Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)|Terminated||Phase 3|167|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:26:28.775738|2017-02-18 17:26:28.775738
NCT00149253|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||December 2004||2004-12-01|October 2004|2004-10-01|May 2005||2005-05-01|||||Interventional|||Pre-Emptive Analgesia Efficacy of Etoricoxib for Postoperative Pain|A Randomized, Double-Blind, Controlled Trial of Etoricoxib as a Pre-Emptive Analgesic for Abdominal Hysterectomy|Completed||Phase 3|50||Khon Kaen University|||||f||||||||||||||2017-02-18 17:26:28.864709|2017-02-18 17:26:28.864709
NCT00149240|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-09-29|||January 2005||2005-01-01|July 2007|2007-07-01|September 2005||2005-09-01|||||Interventional|||Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome|A Phase II, Multicentre, Randomised, Double-blind, Parallel and Controlled With Placebo Pilot Study to Evaluate the Efficacy and Safety of a Single Dose of Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment, in Patients With Primary Myofascial Syndrome of Cervical and Dorsal Localisation|Completed||Phase 2|24||Ipsen|||||f||||||||||||||2017-02-18 17:26:28.94602|2017-02-18 17:26:28.94602
NCT00149227|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-12-09|2011-07-05||January 2004||2004-01-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)|Add-on Effects of Valsartan on Morbi- Mortality in High Risk Hypertension|Completed||Phase 4|3031|Actual|Kyoto Prefectural University of Medicine|The study was performed using PROBE design, which does not exclude possible bias for softer endpoints such as angina and TIA. However, all softer endpoints were diagnosed by CAG and CT/MRI. We believe that under reporting would be unlikely.|2|||f||||t||||||||||2017-02-18 17:26:29.051883|2017-02-18 17:26:29.051883
NCT00149214|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-03-15|2009-02-11||September 2005||2005-09-01|March 2012|2012-03-01|March 2011|Actual|2011-03-01|February 2008|Actual|2008-02-01||Interventional|||Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens|A Randomized Phase 2 Trial of Doxorubicin Plus Pemetrexed Followed by Docetaxel, Versus Doxorubicin Plus Cyclophosphamide Followed by Docetaxel, as Neoadjuvant Treatment for Early Breast Cancer|Completed||Phase 2|257|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:26:29.541917|2017-02-18 17:26:29.541917
NCT00149201|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-02-02|||November 2002||2002-11-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis|Randomized Phase III Study of 5-FU Continuous Infusion (5FUci) Versus MTX+5-FU Sequential Therapy (MF) in Gastric Cancer With Peritoneal Metastasis (JCOG0106-MF, MF/5FU)|Completed||Phase 3|160||Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:26:30.581767|2017-02-18 17:26:30.581767
NCT00149188|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2012-06-18|||February 2004||2004-02-01|June 2012|2012-06-01||||||||Interventional|||Somatuline Autogel: Acromegaly Self/Partner Injection Study|A Phase IV, Multicentre, Open Label, Controlled Study to Assess the Ability of Patients With Acromegaly, or Their Partners, to Administer Somatuline Autogel.|Completed||Phase 4|30||Ipsen|||||f||||||||||||||2017-02-18 17:26:30.727988|2017-02-18 17:26:30.727988
NCT00149175|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-03-12|||December 2002||2002-12-01|March 2010|2010-03-01|October 2007|Anticipated|2007-10-01|||||Observational|||Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment|Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment|Unknown status|Recruiting|Phase 1|4000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||3||f||||||||||||||2017-02-18 17:26:30.840431|2017-02-18 17:26:30.840431
NCT00149162|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-02-11|||March 2005||2005-03-01|February 2009|2009-02-01|March 2012|Anticipated|2012-03-01|December 2010|Anticipated|2010-12-01||Interventional|Elam02||Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2|Multicenter Protocol in Treating Patients With Childhood Acute Myeloid Leukemia. Randomized Study of Maintenance Treatment With Interleukin-2|Unknown status|Recruiting|Phase 3|580|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:26:30.9533|2017-02-18 17:26:30.9533
NCT00149149|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-07-16|||May 2005||2005-05-01|September 2005|2005-09-01||||||||Interventional|||Effect of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers|Use of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers Taking Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)|Unknown status|Recruiting|Phase 1|12|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:26:31.073765|2017-02-18 17:26:31.073765
NCT00149136|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-04-26|||August 2002||2002-08-01|April 2007|2007-04-01||||||||Interventional|||Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.|Evaluation of Imatinib (GLIVEC) After Induction Therapy in Patients Aged More Than 55 Years With Philadelphia Positive Acute Lymphoblastic Leukaemia (Ph+ ALL) : a Non Randomised, Controlled, Open, Multicentric, International Phase II Clinical Study (CSTI 571 AFR09 Trial)|Unknown status|Active, not recruiting|Phase 2|30||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:26:31.159819|2017-02-18 17:26:31.159819
NCT00149123|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-02-11|||April 2005||2005-04-01|October 2007|2007-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Low-dose Hydrocortisone in Acutely Burned Patients|Low-dose Hydrocortisone in the Treatment of the Shock of Burned Patients|Completed||Phase 4|40|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:26:31.24864|2017-02-18 17:26:31.24864
NCT00149110|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-08-04|||September 2005||2005-09-01|August 2009|2009-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Chronos: the Use of Chronobiological Treatment in Depression|"The CHRONOS Study: Can the Sleep-deprivation Induced Antidepressive Effect in Patients With Major Depression be Sustained by Correction of Diurnal Rhythms, Long Term Light Treatment and Duloxetine Treatment?"|Completed||N/A|75|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-02-18 17:26:31.33125|2017-02-18 17:26:31.33125
NCT00149097|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-05-06|||March 2005||2005-03-01|May 2008|2008-05-01|January 2007|Actual|2007-01-01|||||Observational|||Role of the Autonomic Nervous System in HIV-Lipodystrophy|Autonomic Nervous System Activity in the Pathogenesis of the Lipodystrophy Syndrome in HIV-Infected Patients.|Completed||N/A|54|Actual|Hannover Medical School|||2||f||||f||||||Samples Without DNA|"~     Serum and Plasma~   "|||2017-02-18 17:26:31.454121|2017-02-18 17:26:31.454121
NCT00149084|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-09-08|||April 2003||2003-04-01|September 2005|2005-09-01||||||||Interventional|||Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori|Pharmacogenomics-Based Tailor-Made Strategy for Eradication of Helicobacter Pylori|Unknown status|Recruiting|Phase 3|296||Hamamatsu University|||||f||||||||||||||2017-02-18 17:26:34.409679|2017-02-18 17:26:34.409679
NCT00149071|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-11-02|||March 2004||2004-03-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||Transcranial Magnetic Stimulation (rTMS) Accelerates the Response to Escitalopram in Major Depression|Treatment of Therapy-Resistant Major Depression With Transcranial Stimulation rTMS in Combination With Escitalopram|Completed||N/A|61|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-02-18 17:26:34.532228|2017-02-18 17:26:34.532228
NCT00149058|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||October 2005||2005-10-01|September 2005|2005-09-01|January 2008||2008-01-01|||||Interventional|||Erythropoietin in Acute Myocardial Infarction|A Phase II Randomised Trial to Investigate the Safety and Efficacy of Recombinant Human Erythropoietin on Infarct Size in Patients Undergoing Primary Percutaneous Coronary Angioplasty for ST-Segment Elevation Myocardial Infarction|Unknown status|Not yet recruiting|Phase 2|124||Hammersmith Hospitals NHS Trust|||||f||||||||||||||2017-02-18 17:26:34.642673|2017-02-18 17:26:34.642673
NCT00148343|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2011-12-22|||July 2005||2005-07-01|December 2011|2011-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Functional Electrical Stimulation for Footdrop in Hemiparesis|Functional Electrical Stimulation for Footdrop in Hemiparesis|Completed||Phase 2|110|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 17:26:34.754897|2017-02-18 17:26:34.754897
NCT00148330|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-06-29|||May 2005||2005-05-01|May 2005|2005-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study|An Open Label Extension of the Phase II/III Clinical Trial of Intravitreal Triamcinolone on the Effects and Safety of Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment|Completed||Phase 2/Phase 3|64|Actual|University of Sydney||1|||f||||t||||||||||2017-02-18 17:26:34.877053|2017-02-18 17:26:34.877053
NCT00148317|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-11-20|||June 2005||2005-06-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|February 2011|Actual|2011-02-01||Interventional|||Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma|A Sequential Phase II Trial of the Combination of Bortezomib (VELCADE), Dexamethasone (DECADRON) and Pegylated Liposomal Doxorubicin (DOXIL) Followed by High Dose Cyclophosphamide in Multiple Myeloma Patients|Completed||Phase 2|38|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 17:26:34.987539|2017-02-18 17:26:34.987539
NCT00148304|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2016-06-03|||September 2005||2005-09-01|June 2016|2016-06-01|June 2008|Actual|2008-06-01|August 2007|Actual|2007-08-01||Observational|||Insulin Treatment Variation in Southwestern Diabetics|Insulin Treatment Variation in Southwestern Diabetics - Therapeutic Decision-making|Completed||N/A|1248|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:26:35.089885|2017-02-18 17:26:35.089885
NCT00148291|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-01-05|||June 1999||1999-06-01|September 2005|2005-09-01||||||||Interventional|||Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer|Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|180||West Japan Thoracic Oncology Group|||||f||||||||||||||2017-02-18 17:26:35.180478|2017-02-18 17:26:35.180478
NCT00148278|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2010-07-21|||October 1999||1999-10-01|July 2010|2010-07-01|December 2005|Actual|2005-12-01|December 2004|Actual|2004-12-01||Interventional|CATS||Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock|Prospective, Multicenter, Randomized, Double-Blind Study Comparing Safety and Efficacy of Norepinephrine Plus Dobutamine Versus Epinephrine Alone in Septic Shock.|Completed||Phase 2/Phase 3|330|Actual|University of Versailles||2|||f||||t||||||||||2017-02-18 17:26:35.250855|2017-02-18 17:26:35.250855
NCT00148265|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-06-21|||April 2005||2005-04-01|November 2005|2005-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema|Phase II/III Multicentre Randomised Clinical Trial of Laser Treatment Plus 4 mg Intravitreal Triamcinolone Injection to Reduce Diabetic Macular Oedema|Completed||Phase 2/Phase 3|54|Actual|University of Sydney||1|||f||||t||||||||||2017-02-18 17:26:35.631559|2017-02-18 17:26:35.631559
NCT00149045|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-11-06|||November 2001||2001-11-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Follow up and Observation of Charcot Marie Tooth Disease in Families|Clinical and Genetic Features of Familial Neuropathy|Completed||N/A|||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:26:35.763138|2017-02-18 17:26:35.763138
NCT00149032|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-04-07|||August 2001||2001-08-01|September 2005|2005-09-01||||||||Interventional|||Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host|Treatment of Patients With Resistant Cancer/ Post Allogeneic Stem Cell Transplantation With Donor Lymphocytes Sensitized by Antigens Expressed by the Host|Withdrawn||Phase 2|50|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:26:35.837082|2017-02-18 17:26:35.837082
NCT00149019|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-04-07|||May 2002||2002-05-01|September 2005|2005-09-01|September 2005|Anticipated|2005-09-01|||||Interventional|||Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.|Innovative Approaches for Targeted Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.|Withdrawn||Phase 2|12|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-02-18 17:26:35.921823|2017-02-18 17:26:35.921823
NCT00149006|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-03-13|||December 1996||1996-12-01|September 2005|2005-09-01||||||||Interventional|||Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors|Tumor-Selective and Systemic Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With rIL-2 and Non-Myeloablative Stem Cell Transplantation|Unknown status|Recruiting|Phase 2|100|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:26:35.996369|2017-02-18 17:26:35.996369
NCT00148993|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-04-07|||July 1998||1998-07-01|July 2005|2005-07-01|July 2005|Anticipated|2005-07-01|||||Interventional|||Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors|Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors|Withdrawn||Phase 1/Phase 2|100|Anticipated|Hadassah Medical Organization||||PI (Prof. Slavin) not longer work at Hadassah|f||||||||||||||2017-02-18 17:26:36.079994|2017-02-18 17:26:36.079994
NCT00005399|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-11|||August 1996||1996-08-01|April 2016|2016-04-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Observational|||Cohort Study of Heart Rate Variability|Cohort Study of Heart Rate Variability|Completed||N/A|111654|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 18:15:02.574474|2017-02-18 18:15:02.574474
NCT00148980|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-04-27|||April 2003||2003-04-01|February 2006|2006-02-01||||||||Interventional|||Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation|Creation of Bone Marrow Microenvironment for Treatment of MDS in Conjunction With Allogeneic Stem Cell Transplantation|Withdrawn||Phase 2|24|Anticipated|Hadassah Medical Organization||||the PI is no longer work at Hadassah|f||||||||||||||2017-02-18 17:26:36.162621|2017-02-18 17:26:36.162621
NCT00148967|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2006-11-20|||July 2003||2003-07-01|November 2006|2006-11-01|October 2005||2005-10-01|||||Interventional|||INTRINSIC RV - Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs|Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs|Completed||Phase 4|1535||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:26:36.244605|2017-02-18 17:26:36.244605
NCT00148954|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-01-10|2011-10-07||July 2005||2005-07-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|March 2009|Actual|2009-03-01||Interventional|||RIGHT: Rhythm ID Going Head-to-Head Trial|Rhythm ID Going Head-to-head Trial|Completed||Phase 4|1962|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 17:26:36.323247|2017-02-18 17:26:36.323247
NCT00148941|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-10-06|||January 2005||2005-01-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Immune Response & Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccine.|Safety, Immunogenicity&Consistency of 3 Manufacturing Lots of DTaP-IPV Vaccine vs Separate Injections of GSK Biologicals' DTaP + Aventis Pasteur's IPV Admd as Booster Doses to Healthy Children 4-6 Yrs, Each Co-admd With Merck's MMR Vaccine|Completed||Phase 3|4087|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:26:36.737862|2017-02-18 17:26:36.737862
NCT00148928|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-03-24|||March 2005||2005-03-01|March 2011|2011-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA|A Multicenter, Open-label Phase I/II Trial to Evaluate the Safety and Activity of CPC-P501 Protein Formulated With the Adjuvant AS15 as First-line Treatment in Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA|Completed||Phase 1|25|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:26:36.858477|2017-02-18 17:26:36.858477
NCT00148915|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-11-04|||August 2005||2005-08-01|November 2016|2016-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo|A One Year, Parallel, Placebo-controlled, Double-blind, Randomized Study to Assess the Effect of Monthly 150 mg Oral Ibandronate Dosing Versus Placebo on Bone Quality and Strength at the Proximal Femur in Women With Osteoporosis|Completed||Phase 4|98|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-02-18 17:26:36.966955|2017-02-18 17:26:36.966955
NCT00148902|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-10-06|||April 2003||2003-04-01|October 2008|2008-10-01||||||||Interventional|||Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)|A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Docetaxel (TAXOTERE)|Completed||Phase 1|50||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:26:37.095384|2017-02-18 17:26:37.095384
NCT00148889|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-02-10|||July 2005||2005-07-01|February 2009|2009-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Double-Blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical Dystonia|Prospective,Randomised, Double-Blind, Multicenter Study to Assess the Efficacy and Safety of Bilateral Globus Pallidus Internus - in Patients With Medically Refractory Primary Cervical Dystonia|Completed||Phase 3|63|Actual|German Parkinson Study Group (GPS)||2|||f||||f||||||||||2017-02-18 17:26:37.176772|2017-02-18 17:26:37.176772
NCT00148876|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2011-02-22|||September 2003||2003-09-01|February 2011|2011-02-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||TBP Study With Capecitabine Plus Minus Trastuzumab|A Multicenter Randomized Phase III Study to Compare Capecitabine Alone or in Combination With Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer and Progression After Previous Treatment With Trastuzumab|Completed||Phase 3|482|Anticipated|German Breast Group||2|||f||||t||||||||||2017-02-18 17:26:37.55575|2017-02-18 17:26:37.55575
NCT00148863|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-08-29|||June 2004||2004-06-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C|Pilot Study on Interferon Gamma in Association With Peg-Interferon Alpha 2a and Ribavirin Among Patients With a Chronic Hepatitis C and Non Responders to the Association of Peg-Interferon Alpha 2b or 2a and Ribavirin ANRS HC16 Gammatri|Completed||Phase 2|65||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:26:37.672784|2017-02-18 17:26:37.672784
NCT00148850|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-10-19|||February 2003||2003-02-01|September 2005|2005-09-01|October 2004||2004-10-01|||||Interventional|||Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients|A Randomized, Phase 3, Double Blind, Multicentre Trial, Evaluating the Effect of Pioglitazone Versus Placebo on Change in Lipoatrophy in HIV- 1 Infected Patients Treated With Stable Antiretroviral Therapy for at Least 6 Months.ANRS 113 LIPIOT Study|Terminated||Phase 3|130||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:26:37.779992|2017-02-18 17:26:37.779992
NCT00148837|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-02-06|||September 2004||2004-09-01|February 2008|2008-02-01||||||||Interventional|||Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis|Randomized Double Blind Trial Comparing the Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin for Initial Treatment of Patients With Hepatitis C With Genotype 1 or 4 and Severe Fibrosis|Unknown status|Active, not recruiting|Phase 2|112|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||f||||||||||2017-02-18 17:26:37.890803|2017-02-18 17:26:37.890803
NCT00148824|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-03-20|||February 2003||2003-02-01|March 2008|2008-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.|Immunological Efficacy of a Prime-Boost Strategy Combining a 7-Valent Pneumococcal Conjugate Vaccine (PCV) Followed by a 23-Valent Pneumococcal Polysaccharide Vaccine (PPV) Versus PPV Alone in HIV-Infected Adults. ANRS 114 PNEUMOVAC.|Completed||Phase 2|212||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:26:38.004482|2017-02-18 17:26:38.004482
NCT00148798|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2014-06-13|2011-08-24||October 2004||2004-10-01|June 2014|2014-06-01|May 2012|Actual|2012-05-01|July 2007|Actual|2007-07-01||Interventional|FLEX||Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)|Open, Randomized, Controlled, Multicenter Phase III Study Comparing Cisplatin/Vinorelbine Plus Cetuximab Versus Cisplatin/Vinorelbine as First-line Treatment for Patients With Epidermal Growth Factor Receptor Expressing (EGFR-expressing) Advanced NSCLC.|Completed||Phase 3|1861|Actual|Merck KGaA||2|||f||||t||||||||||2017-02-18 17:26:38.123634|2017-02-18 17:26:38.123634
NCT00148785|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-11-08|||July 2005||2005-07-01|November 2013|2013-11-01|January 2007|Actual|2007-01-01|||||Interventional|||A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir|Pharmacokinetics of an Indinavir, Ritonavir and Amprenavir Regimen in HIV-Infected Individuals: A Pilot Study|Completed||Phase 4|15|Anticipated|Emory University|||||f||||||||||||||2017-02-18 17:26:40.194486|2017-02-18 17:26:40.194486
NCT00148772|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-06-24|||August 2005||2005-08-01|August 2005|2005-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy|Phase II Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising PSA on Hormone Therapy|Completed||Phase 2|29|Anticipated|NorthShore University HealthSystem Research Institute|||||f||||||||||||||2017-02-18 17:26:40.289779|2017-02-18 17:26:40.289779
NCT00148759|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-11-08|2009-11-24||June 2005||2005-06-01|November 2013|2013-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|LPVGenderPK||Kaletra Sex/Gender Pharmacokinetics (PK) Study|A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir: A 24-hour Pharmacokinetic Profile to Evaluate Sex Differences|Completed||Phase 4|23|Actual|Emory University||2|||f||||f||||||||||2017-02-18 17:26:40.395565|2017-02-18 17:26:40.395565
NCT00148746|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-06-08|||May 2004||2004-05-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|September 2006|Actual|2006-09-01||Interventional|||Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis|Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis|Completed||N/A|||Technische Universität Dresden|||||f||||||||||||||2017-02-18 17:26:40.823566|2017-02-18 17:26:40.823566
NCT00148733|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-08-23|2015-02-02||January 2004||2004-01-01|August 2016|2016-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia|Community- and Health Facility-based Intervention With Zinc as Adjuvant Therapy for Pneumonia to Enhance Child Health and Nutrition|Completed||Phase 2/Phase 3|2628|Actual|Centre For International Health||2|||f||||t||||||||No||2017-02-18 17:26:40.915367|2017-02-18 17:26:40.915367
NCT00148720|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2015-11-09|||September 2004||2004-09-01|November 2015|2015-11-01||||September 2007|Actual|2007-09-01||Interventional|||Capecitabine in Women With Operable Breast Cancer|A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer|Terminated||Phase 2|80|Anticipated|Dana-Farber Cancer Institute||1||Slow accrual|f||||||||||||||2017-02-18 17:26:41.226163|2017-02-18 17:26:41.226163
NCT00148707|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-12-19|||October 2004||2004-10-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer|Phase II Study of CT-2103 in Patients With Metastatic Breast Cancer|Completed||Phase 2|45||Dana-Farber Cancer Institute|||||||||||||||||||2017-02-18 17:26:41.327097|2017-02-18 17:26:41.327097
NCT00148694|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2016-08-29|||July 2004||2004-07-01|August 2016|2016-08-01|May 2010|Actual|2010-05-01|May 2006|Actual|2006-05-01||Interventional|||Preoperative Cisplatin in Early Stage Breast Cancer|A Phase II Trial of Cisplatin in Early Stage ER-, PR-, HER-2 Negative Breast Cancer|Completed||Phase 2|27|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 17:26:41.431282|2017-02-18 17:26:41.431282
NCT00148681|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2009-10-30|||May 2001||2001-05-01|October 2009|2009-10-01|April 2010|Anticipated|2010-04-01|May 2003|Actual|2003-05-01||Interventional|||Preoperative Herceptin and Navelbine for Breast Cancer|Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer|Unknown status|Active, not recruiting|Phase 2|49|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 17:26:41.546595|2017-02-18 17:26:41.546595
NCT00148668|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-03-29|2012-12-19||December 2003||2003-12-01|March 2013|2013-03-01|August 2011|Actual|2011-08-01|January 2009|Actual|2009-01-01||Interventional|||Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer|A Randomized Phase II Study of Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in Early Stage, HER-2 Positive Breast Cancer|Completed||Phase 2|81|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 17:26:41.671309|2017-02-18 17:26:41.671309
NCT00148655|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-12-22|||May 2003||2003-05-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Educational Interventions for Patients With DCIS|A Randomized Trial for Educational Interventions for Patients With DCIS Actually Making Treatment Decisions|Completed||N/A|120|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:26:42.014472|2017-02-18 17:26:42.014472
NCT00148642|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2017-01-14|||November 2002||2002-11-01|January 2017|2017-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|NASCENT||Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)|Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)|Completed||Phase 3|2003|Actual|C. R. Bard||2|||f||||t||||||||||2017-02-18 17:26:42.11196|2017-02-18 17:26:42.11196
NCT00148629|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-11-16|||April 2004||2004-04-01|September 2005|2005-09-01||||||||Interventional|||Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women|Preventing Unnecessary Blood Transfusions in Pregnant Women in Africa Through Effective Primary Health Care|Unknown status|Active, not recruiting|Phase 3|2500||Cornell University|||||f||||||||||||||2017-02-18 17:26:42.230254|2017-02-18 17:26:42.230254
NCT00148616|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-10-17|||April 2004||2004-04-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Memantine for the Treatment of Negative Symptomatology|Memantine for the Treatment of Negative Symptomatology and Cognitive Impairment in Schizophrenia|Terminated||Phase 3|40|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 17:26:42.322702|2017-02-18 17:26:42.322702
NCT00148603|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-12-26|||September 2005||2005-09-01|December 2011|2011-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Montelukast in the Treatment of Duodenal Eosinophilia|Montelukast in the Treatment of Duodenal Eosinophilia in Children With Dyspepsia: Effect on Eosinophil Density and Activation in Relation to Pharmacokinetics|Completed||N/A|24|Anticipated|Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 17:26:42.425976|2017-02-18 17:26:42.425976
NCT00148590|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-10-17|||November 2005||2005-11-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||Memantine for the Prevention of Negative Symptomatology|Memantine for the Prevention of Negative Symptomatology and Cognitive Impairment in Schizophrenia|Terminated||Phase 3|40|Anticipated|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 17:26:42.51812|2017-02-18 17:26:42.51812
NCT00148577|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-07|||August 2002||2002-08-01|September 2005|2005-09-01|December 2003||2003-12-01|||||Observational|||Pain Relief by Applying TENS on Acupuncture Points During the First Stage of Labour|Pain Relief by Applying Transcutaneous Electrical Nerve Stimulation (TENS) on Acupuncture Points During the First Stage of Labour: a Randomised Controlled Trial|Unknown status|Active, not recruiting|Phase 3|100||Chang Gung Memorial Hospital|||||f||||||||||||||2017-02-18 17:26:42.619592|2017-02-18 17:26:42.619592
NCT00148564|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-09-26|||March 2004||2004-03-01|September 2008|2008-09-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Energy Homeostasis Under Treatment With Atypical Antipsychotics|Energy Homeostasis and Metabolism in Patients With Schizophrenic Disorders Under Treatment With Atypical Antipsychotics|Completed||Phase 4|40|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 17:26:42.701443|2017-02-18 17:26:42.701443
NCT00148551|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-07-26|||January 2004||2004-01-01|July 2007|2007-07-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.|Triamcinolone Acetonide as an Adjunctive Treatment to Verteporfin Therapy in Neovascular Age-Related Macular Degeneration: Randomized Placebo-Controlled Clinical Trial.|Unknown status|Active, not recruiting|Phase 2/Phase 3|120|Anticipated|Canadian Retinal Trials Group|||||f||||||||||||||2017-02-18 17:26:42.900124|2017-02-18 17:26:42.900124
NCT00148538|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2013-02-25|||July 2005||2005-07-01|February 2013|2013-02-01|April 2012|Actual|2012-04-01|December 2010|Actual|2010-12-01||Interventional|||Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)|Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)|Completed||Phase 2/Phase 3|66|Actual|Ottawa Hospital Research Institute||1|||f||||||||||||||2017-02-18 17:26:43.179402|2017-02-18 17:26:43.179402
NCT00148525|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-07-01|||July 2006||2006-07-01|June 2011|2011-06-01|July 2011|Actual|2011-07-01|August 2010|Actual|2010-08-01||Interventional|||The Study of Automated Telephone Programs for the Maintenance of Dietary Change|Trial of 2 TeleComputer Diet Change Maintenance Programs|Completed||Phase 1|1049|Actual|Boston Medical Center||3|||f||||t||||||||||2017-02-18 17:26:43.291768|2017-02-18 17:26:43.291768
NCT00148512|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-10-28|||March 2003||2003-03-01|October 2013|2013-10-01|February 2005||2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations|A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Exploratory Study of NS 2330 (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations (Study for Proof of Concept in ADVAnced Parkinson Disease of NS 2330 / ADVANS)|Completed||Phase 2|254|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:26:43.40132|2017-02-18 17:26:43.40132
NCT00148499|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-10-30|||October 2005||2005-10-01|October 2013|2013-10-01|June 2006||2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis|Efficacy and Tolerability of Ambroxol Lozenge 20 mg in Relieving Pain of Sore Throat in Patients With Acute Viral Pharyngitis-A Randomised, Double-blind,Placebo- and Active-controlled Parallel Group Study|Completed||Phase 3|751||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:26:43.550802|2017-02-18 17:26:43.550802
NCT00148486|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-10-28|||June 2003||2003-06-01|October 2013|2013-10-01||||March 2005|Actual|2005-03-01||Interventional|||A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)|A Fourteen-week Placebo-controlled Dose-response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)|Completed||Phase 2|261||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:26:43.661241|2017-02-18 17:26:43.661241
NCT00148473|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||March 2000||2000-03-01|September 2005|2005-09-01|October 2001||2001-10-01|||||Interventional|||Oral Versus Vaginal Misoprostol for Induction of Labor|A Single Dose of Oral Versus Vaginal Misoprostol for Induction of Labor: A Randomized Controlled Trial|Completed||Phase 2/Phase 3|180||Bangkok Metropolitan Administration Medical College and Vajira Hospital|||||f||||||||||||||2017-02-18 17:26:43.796393|2017-02-18 17:26:43.796393
NCT00148460|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2013-10-28|||March 2001||2001-03-01|October 2013|2013-10-01|February 2006||2006-02-01|||||Interventional|||Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction|A Randomised, Open-label, Multi-center, Angiographic Trial to Compare the Efficacy and Safety of Single Bolus of Tenecteplase (Metalyse®) With Accelerated Infusion of Alteplase in Asian Patients With Acute Myocardial Infarction|Completed||Phase 3|270||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:26:43.893115|2017-02-18 17:26:43.893115
NCT00148447|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-05-02|||November 2004||2004-11-01|February 2007|2007-02-01|September 2005||2005-09-01|||||Interventional|||The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia|Placebo-Controlled Trial of Cipralex in the Treatment of Negative Symptoms in Schizophrenia|Completed||Phase 3|40||BeerYaakov Mental Health Center|||||f||||f||||||||||2017-02-18 17:26:44.002251|2017-02-18 17:26:44.002251
NCT00148434|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2005-09-26|||January 2002||2002-01-01|September 2005|2005-09-01|March 2003||2003-03-01|||||Interventional|||Study on Impact of Patient-Held Guidelines on Blood Pressure|A Pilot Randomised Controlled Trial to Assess the Impact on Blood Pressure Control of Empowering Patients to Become Involved in Their Own Blood Pressure Management.|Completed||Phase 2|300||Ashgrove Research Practice|||||f||||||||||||||2017-02-18 17:26:44.10816|2017-02-18 17:26:44.10816
NCT00148421|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-05-13||||||May 2013|2013-05-01||||||||Interventional|||Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.|A Study of Darbepoetin Alfa Administered Once Every 2 Weeks (Q2W) Compared With Epoetin Alfa Administered Once Every Week (QW) for the Treatment of Anemia in Subjects With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-02-18 17:26:44.202735|2017-02-18 17:26:44.202735
NCT00148395|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2008-04-21|||June 2002||2002-06-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|||||Interventional|||Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.|Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.|Completed||Phase 3|280||Aktion Bronchialkarzinom e.V.|||||f||||||||||||||2017-02-18 17:26:44.425526|2017-02-18 17:26:44.425526
NCT00148382|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-07|2007-04-10|||April 2005||2005-04-01|April 2007|2007-04-01|July 2005||2005-07-01|||||Interventional|||Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects|Randomized, Double Blind, Parallel Group, Repeat Dose Pharmacokinetic and Pharmacodynamic Study of Four Doses of ATL-962 (40mg, 80mg, 120mg 240mg) in Otherwise-Healthy Obese Volunteers|Completed||Phase 1|80||Alizyme|||||f||||||||||||||2017-02-18 17:26:44.510713|2017-02-18 17:26:44.510713
NCT00148369|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-02-18|||June 2005||2005-06-01|February 2010|2010-02-01|September 2007|Actual|2007-09-01|November 2006|Actual|2006-11-01||Observational|||A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin|A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin|Completed||N/A|31|Actual|Amgen|||1||f||||||||||None Retained|"~     none collected.~   "|||2017-02-18 17:26:44.607047|2017-02-18 17:26:44.607047
NCT00148356|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-03-31|||September 2004||2004-09-01|March 2011|2011-03-01|October 2010|Actual|2010-10-01|May 2006|Actual|2006-05-01||Interventional|ZoMaxx™ I||Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries|A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System Compared to the TAXUS™ Express2 Paclitaxel-Eluting Coronary Stent System in de Novo Coronary Artery Lesions|Completed||Phase 2/Phase 3|401|Actual|Abbott Vascular||2|||f||||t||||||||||2017-02-18 17:26:44.695388|2017-02-18 17:26:44.695388
NCT00148252|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-06-06|||February 2003||2003-02-01|June 2012|2012-06-01|February 2007|Actual|2007-02-01|November 2005|Actual|2005-11-01||Interventional|||Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant|Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant - Randomised Withdrawal of Mycophenolate Mofetil (CellCept®) or Cyclosporine A (Sandimmun Neoral®)|Terminated||Phase 4|298||University of Oslo School of Pharmacy||||To high rejection rate in CsA withdrawal arm|f||||||||||||||2017-02-18 17:26:44.969941|2017-02-18 17:26:44.969941
NCT00148239|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-11-30|||September 2002||2002-09-01|November 2015|2015-11-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|SCI||Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury|Caregiver Intervention for Caregivers of SCI Patients|Completed||Phase 2/Phase 3|380|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 17:26:45.073119|2017-02-18 17:26:45.073119
NCT00148226|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2006-01-03|||November 2003||2003-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial|Randomized Controlled Trial of Patient Decision Aids for Faecal Occult Blood Test Screening|Completed||Phase 2|||University of Sydney|||||f||||||||||||||2017-02-18 17:26:45.203582|2017-02-18 17:26:45.203582
NCT00148213|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||September 2003||2003-09-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Observational|||Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma|Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma|Completed||N/A|100||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:26:45.286384|2017-02-18 17:26:45.286384
NCT00148200|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-02-17|||February 2005||2005-02-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|November 2006|Actual|2006-11-01||Observational|||Female Sexual Dysfunction: Prevalence Among Italian Healthy Women|Prevalence of Female Sexual Dysfunctions Among Healthy Women Coming to the University of Bologna Gynecology Clinic as Outpatients.|Completed||N/A|500|Actual|Unita Complessa di Ostetricia e Ginecologia|||1||f||||||||||||||2017-02-18 17:26:45.371297|2017-02-18 17:26:45.371297
NCT00148187|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-05-28|||January 2003||2003-01-01|May 2015|2015-05-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Prediction of Medication Compliance Following Renal Transplantation|Prediction of Medication Compliance Following Renal Transplantation|Completed||N/A|30|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-02-18 17:26:45.468739|2017-02-18 17:26:45.468739
NCT00148174|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-05-28|||August 1998||1998-08-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|November 2014|Actual|2014-11-01||Interventional|||Predictors and Intervention for Noncompliance|Predictors and Intervention for Noncompliance|Completed||N/A|273|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||t||||||||||2017-02-18 17:26:45.553433|2017-02-18 17:26:45.553433
NCT00148161|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-04-26|||November 2004||2004-11-01|September 2006|2006-09-01||||||||Observational|||Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering|Evoked and Induced Auditory Cortical Activity During Speech Perception and Speech Production in Stuttering|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-02-18 17:26:45.651714|2017-02-18 17:26:45.651714
NCT00148148|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-01-09|||May 2004||2004-05-01|January 2007|2007-01-01|December 2007||2007-12-01|||||Interventional|||A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation|Phase II Randomised Study of the Safety, Efficacy and Pharmacokinetics of Caspofungin (CAS), Liposomal Amphotericin B (LAMB) or the Combination of Caspofungin With Liposomal Amphotericin B for Patients After Stem-Cell Transplantation|Completed||Phase 2|75|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-02-18 17:26:45.726982|2017-02-18 17:26:45.726982
NCT00148135|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-12-28|||May 2001||2001-05-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|April 2006|Actual|2006-04-01||Interventional|||Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site|A Phase II Trial Evaluating the Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site|Terminated||Phase 2|||University of Michigan Cancer Center||||recruitment goals met|f||||||||||||||2017-02-18 17:26:45.821123|2017-02-18 17:26:45.821123
NCT00147914|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2016-05-20|||February 2005||2005-02-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|February 2007|Actual|2007-02-01||Interventional|||Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life|A Comparison Study Between Cefdinir and Amoxicilline/Clavulanate in Patients With Acute Sinusitis and Assessment of Quality of Life (QOL)|Active, not recruiting||Phase 4|100|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 17:26:48.832398|2017-02-18 17:26:48.832398
NCT00148122|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-03-28|2014-02-13||November 2002||2002-11-01|March 2014|2014-03-01|July 2010|Actual|2010-07-01|August 2008|Actual|2008-08-01||Interventional||Although 40 patients were enrolled, 2 patients withdrew consent after treatment started, therefore only 38 were included in baseline analysis.|A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer|A Phase II Trial Evaluating Weekly Docetaxel and Capecitabine in Patients With Metastatic or Advanced, Locally, Recurrent Head and Neck Cancer|Completed||Phase 2|40|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:26:46.114436|2017-02-18 17:26:46.114436
NCT00148109|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-01-15|2011-04-12||June 2005||2005-06-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|July 2008|Actual|2008-07-01||Interventional|||Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas|Phase II Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas|Completed||Phase 2|36|Actual|University of Michigan Cancer Center|accrual to EGFR + cohort suspended after first step for lack of efficacy of cetuximab.|2|||f||||t||||||||||2017-02-18 17:26:46.65519|2017-02-18 17:26:46.65519
NCT00148096|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-12-23|||February 2003||2003-02-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Mechanical Heat Recovery Ventilation on House Dust Mite Sensitive Asthma|Randomised Controlled Trial of Mechanical Heat Recovery Ventilation on Asthma Control of Patients Allergic to the House Dust Mite|Completed||Phase 2|119|Actual|University of Glasgow||2|||f||||f||||||||||2017-02-18 17:26:47.151149|2017-02-18 17:26:47.151149
NCT00148083|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-02-27|||September 2005||2005-09-01|August 2005|2005-08-01|August 2007||2007-08-01|||||Interventional|||Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia|Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia|Unknown status|Recruiting|Phase 3|60||University of Illinois at Chicago|||||f||||||||||||||2017-02-18 17:26:47.26186|2017-02-18 17:26:47.26186
NCT00148070|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-10-03|||March 1999||1999-03-01|October 2012|2012-10-01|February 2006|Actual|2006-02-01|September 2004|Actual|2004-09-01||Interventional|||Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer|Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer|Completed||Phase 2|45|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:26:47.356722|2017-02-18 17:26:47.356722
NCT00148057|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02|||January 1988||1988-01-01|August 2005|2005-08-01|December 2005||2005-12-01|||||Interventional|||Diet and Breast Cancer Prevention Trial|An Explanatory Clinical Trial of Breast Cancer Prevention|Completed||Phase 3|4695||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:26:47.449149|2017-02-18 17:26:47.449149
NCT00148044|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-12-19|||October 2003||2003-10-01|December 2007|2007-12-01|February 2004|Actual|2004-02-01|||||Observational|||Uremic Toxins of Patients With Acute Kidney Failure|Uremic Toxins of Patients With Acute Kidney Failure|Completed||N/A|30||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:26:47.534708|2017-02-18 17:26:47.534708
NCT00148031|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-04-23|||September 2003||2003-09-01|April 2013|2013-04-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Improving Hepatitis C Treatment in Injection Drug Users|Improving Hepatitis C Treatment in Injection Drug Users|Completed||Phase 4|111|Actual|State University of New York - Upstate Medical University||2|||f||||t||||||||||2017-02-18 17:26:47.619965|2017-02-18 17:26:47.619965
NCT00148018|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-07-09|||March 2005||2005-03-01|September 2006|2006-09-01||||||||Interventional|||Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma|A Phase II Study of Bortezomib in Combination With Dexamethasone in Patients With Relapsed Hodgkin's Lymphoma|Terminated||Phase 2|37||University of Cologne|||||f||||||||||||||2017-02-18 17:26:47.752562|2017-02-18 17:26:47.752562
NCT00148005|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-12-19|||September 2004||2004-09-01|December 2007|2007-12-01||||||||Interventional|||Prevalence, Etiology and Therapy of Micturition Disorders of Children With a Mental and/or Motoric Disability|Prevalence, Etiology and Therapy of Micturition Disorders of Children With a Mental and/or Motoric Disability|Completed||N/A|250||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:26:47.862052|2017-02-18 17:26:47.862052
NCT00147992|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-06-02|||June 2005||2005-06-01|June 2015|2015-06-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Immediate Loading of Implants in Totally Edentate Upper and Lower Jaw. Trial to Evaluate Survival of the Implants and Bridges, Quality of Prosthetic Work and Patient Satisfaction|Immediate Loading of Implants in Totally Edentate Upper and Lower Jaw. A Retrospective Trial to Evaluate Survival of the Implants and Bridges, Quality of Prosthetic Work and Patient Satisfaction|Recruiting||N/A|50|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 17:26:47.955646|2017-02-18 17:26:47.955646
NCT00147979|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-12-04|||April 2004||2004-04-01|December 2014|2014-12-01|August 2013|Actual|2013-08-01|January 2009|Actual|2009-01-01||Interventional|||Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE|Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE|Completed||N/A|596|Actual|University Hospital, Ghent||2|||f||||f||||||||||2017-02-18 17:26:48.060598|2017-02-18 17:26:48.060598
NCT00147966|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2010-03-22|2010-03-19||June 2008||2008-06-01|June 2008|2008-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)|Assessment of the Immunomodulatory Effects of Rituximab in Seropositive Rheumatoid Arthritis Using Arthroscopic Synovial Biopsies|Completed||Phase 2|24|Actual|University of California, San Diego||1|||f||||f||||||||||2017-02-18 17:26:48.16967|2017-02-18 17:26:48.16967
NCT00147953|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2010-01-26|||June 2004||2004-06-01|January 2010|2010-01-01||||||||Interventional|||Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma|A Phase II Study of Rituximab Plus Low-Dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 2|30|Anticipated|University of Cologne|||||f||||||||||||||2017-02-18 17:26:48.419454|2017-02-18 17:26:48.419454
NCT00147940|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-06-11|||April 2004||2004-04-01|June 2013|2013-06-01|August 2005||2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Correlation of Nasal Volume, Cross-Sectional Area With Nasalance Scores Measured by Acoustic Rhinometry and Nasometry|Correlation of Nasal Volume and Cross-Sectional Area With Nasalance Scores as Measured by Acoustic Rhinometry and Nasometry|Terminated||Phase 4|20||University of Chicago|||||f||||||||||||||2017-02-18 17:26:48.643289|2017-02-18 17:26:48.643289
NCT00147927|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-07-31|||December 2003||2003-12-01|July 2007|2007-07-01|December 2005||2005-12-01|||||Interventional|||Using Tailored Emails to Motivate Healthy Behavior Among Employees|Using Tailored Emails to Motivate Healthy Behavior, Improve Health Status, & Reduce Health Care Costs in Employee Populations: A Randomized Trial|Completed||N/A|2000||Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 17:26:48.746872|2017-02-18 17:26:48.746872
NCT00147901|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2016-09-30|||January 2005||2005-01-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2008|Actual|2008-11-01||Interventional|||Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)|Multicenter Phase II Trial of Fludarabine and Cyclophosphamide in Combination With Alemtuzumab (FC-Cam) for Patients With Relapsed Chronic Lymphocytic Leukemia - CLL-2L Protocol of the German CLL-Study Group (GCLLSG)|Completed||Phase 2|61|Actual|German CLL Study Group||1|||f||||f||||||||No||2017-02-18 17:26:48.935535|2017-02-18 17:26:48.935535
NCT00147888|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-09-04|||March 2004||2004-03-01|September 2013|2013-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Changes in Nasal Patency With Changes in Posture, Temperature, Humidity and Nasal Patency Seen by Acoustic Rhinometry|Physiological Changes in Nasal Patency in Response to Changes in Posture, Temperature, Humidity and Nasal Patency Measured by Acoustic Rhinometry|Completed||Phase 4|15|Actual|University of Chicago||1|||f||||t||||||||||2017-02-18 17:26:49.045448|2017-02-18 17:26:49.045448
NCT00147875|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-09-04|||March 2004||2004-03-01|September 2009|2009-09-01||||July 2007|Actual|2007-07-01||Interventional|||Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma|PVAG - Phase I/II Dose Finding Trial in Elderly Patients (> 60 Years) With Advanced Stages Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|60|Actual|University of Cologne|||||f||||||||||||||2017-02-18 17:26:49.142621|2017-02-18 17:26:49.142621
NCT00147862|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-02-06|||May 2005||2005-05-01|February 2007|2007-02-01|January 2007||2007-01-01|||||Interventional|||Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?|Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?|Completed||Phase 3|240||Tata Memorial Hospital|||||f||||||||||||||2017-02-18 17:26:49.234827|2017-02-18 17:26:49.234827
NCT00147849|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-11-28|||September 2000||2000-09-01|September 2005|2005-09-01|March 2006||2006-03-01|||||Interventional|||A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice Guidelines for Children With Croup|A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice|Terminated||N/A|||University of Calgary|||||f||||||||||||||2017-02-18 17:26:49.324711|2017-02-18 17:26:49.324711
NCT00147836|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2008-03-31|||September 2004||2004-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients|Evaluation of the Effects of Oral Anti-Hyperglycemic Agents, Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion on Glycemic Control, B-Cell Function and the Remission Rate in Newly-Diagnosed Type 2 Diabetic Patients|Completed||N/A|436|Actual|Sun Yat-sen University||3|||f||||t||||||||||2017-02-18 17:26:49.416157|2017-02-18 17:26:49.416157
NCT00147823|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-06-04|2013-12-17||December 2004||2004-12-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Subjects were randomized|Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions|A Prospective Randomized Study Comparing Vitoss Alone Versus Vitoss With Bone Marrow Aspirate in Benign Bone Lesions|Completed||N/A|63|Actual|State University of New York - Upstate Medical University|Limitation due to incomplete follow up by subjects or unavailability of radiographs. Also difficulties in assessing the outcomes of resorption if lesions were small or there was artifact from hardware in the area.|2|||f||||t||||||||||2017-02-18 17:26:49.543527|2017-02-18 17:26:49.543527
NCT00147810|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-03-23|||November 2001||2001-11-01|September 2005|2005-09-01|July 2004||2004-07-01|||||Interventional|||Adult Asthma Surveillance and Intervention in a Managed Care Setting|Adult Asthma Surveillance and Intervention in a Managed Care Setting|Completed||N/A|6948||Kaiser Permanente|||||f||||||||||||||2017-02-18 17:26:50.351199|2017-02-18 17:26:50.351199
NCT00147797|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2016-10-24|||May 2003||2003-05-01|April 2007|2007-04-01|June 2005||2005-06-01|||||Observational|||Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy|Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy|Completed||N/A|84||Saint Antoine University Hospital|||2||f||||||||||||||2017-02-18 17:26:50.461583|2017-02-18 17:26:50.461583
NCT00147784|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-03-26|||March 2006||2006-03-01|March 2008|2008-03-01|January 2008|Actual|2008-01-01|June 2007|Actual|2007-06-01||Interventional|||HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.|HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a Methadone Maintenance Treated (MMT) Opioid Addicted Group.|Completed||Phase 3|10|Anticipated|Sorlandet Hospital HF||1|||f||||||||||||||2017-02-18 17:26:50.550554|2017-02-18 17:26:50.550554
NCT00147771|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-08-01|||September 2005||2005-09-01|August 2013|2013-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Imiquimod in Children With Plaque Morphea|Evaluation of the Efficacy and Safety of the Imiquimod 5% Topical Cream in Plaque Morphea: A Prospective, Multiple Baseline, Open Label Pilot Study|Completed||Phase 3|10|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||||2017-02-18 17:26:50.662113|2017-02-18 17:26:50.662113
NCT00147758|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-01-16|||June 2004||2004-06-01|January 2012|2012-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetics With Inadequate Glycemic Control on Sulfonylurea Monotherapy or Sulfonylurea Therapy in Combination With Other Oral Anti-Diabetic Agents|Completed||Phase 3|400||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:26:50.774711|2017-02-18 17:26:50.774711
NCT00147745|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-03-05|2009-07-15||June 2005||2005-06-01|March 2014|2014-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes|Effects of Colesevelam on Insulin Sensitivity in Type 2 Diabetes Mellitus|Completed||Phase 2|36|Actual|Daiichi Sankyo Inc.||3|||f||||f||||||||||2017-02-18 17:26:50.913535|2017-02-18 17:26:50.913535
NCT00147732|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-05-06|||April 2001||2001-04-01|May 2015|2015-05-01|April 2013|Actual|2013-04-01|February 2008|Actual|2008-02-01||Interventional|||Randomized Trial of ARCON in Larynx Cancer|A Multicentre, Randomised, Phase III Clinical Trial Comparing Accelerated Radiotherapy With Accelerated Radiotherapy Plus Carbogen and Nicotinamide (ARCON) in Clinical Stage T2-4 Laryngeal Carcinoma.|Completed||Phase 3|345|Actual|Radboud University||2|||f||||||||||||||2017-02-18 17:26:51.702663|2017-02-18 17:26:51.702663
NCT00146926|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2007-04-26|||September 2005||2005-09-01|April 2007|2007-04-01||||||||Interventional|||Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion|Comparison of Three Different Strategies to Prevent Propofol Induced Pain During Infusion|Unknown status|Active, not recruiting|Phase 3|200||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:27:18.184088|2017-02-18 17:27:18.184088
NCT00147719|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-01-16|||June 2004||2004-06-01|January 2012|2012-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||WelChol® With Metformin in Treating Patients With Type 2 Diabetes|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Monotherapy or Metformin Therapy in Combination With Other Oral Anti-Diabetic Agents|Completed||Phase 3|300||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:26:51.81366|2017-02-18 17:26:51.81366
NCT00147706|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2011-07-25|||September 2004||2004-09-01|July 2011|2011-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Does Access to an EHR Patient Portal Influence Chronic Disease Outcomes?|Does Access to an EHR Patient Portal Influence Chronic Disease Outcomes? A Randomised Trial Assessing Clinical and Behavioural Change Outcomes in Patients With CHF, Diabetes, or Secondary CVD|Completed||N/A|6000|Anticipated|Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 17:26:51.943296|2017-02-18 17:26:51.943296
NCT00147693|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-09-30|||June 2005||2005-06-01|September 2008|2008-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?|Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?|Completed||N/A|304|Actual|Radboud University||1|||f||||||||||||||2017-02-18 17:26:52.033138|2017-02-18 17:26:52.033138
NCT00147680|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-02-01|||September 2004||2004-09-01|February 2012|2012-02-01|October 2009|Actual|2009-10-01|June 2008|Actual|2008-06-01||Interventional|||Uterine Papillary Serous Cancer (UPSC) Trial|Prospective, Non-randomised Phase 2 Clinical Trial of Carboplatin Plus Paclitaxel With Sequential Radical Pelvic Radiotherapy for Uterine Serous Papillary Cancer|Completed||Phase 2|30|Anticipated|Queensland Centre for Gynaecological Cancer||1|||f||||f||||||||||2017-02-18 17:26:52.141437|2017-02-18 17:26:52.141437
NCT00147667|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02|||April 2004||2004-04-01|March 2004|2004-03-01|March 2006||2006-03-01|||||Interventional|||Effects of Long Term Macrolide Antibiotic Therapy in Patients With COPD|Randomised Double Blind Placebo Controlled Trial of Effects of Long Term Low Dose Oral Erythromycin Therapy in Patients With Chronic Obstructive Pulmonary Disease|Unknown status|Active, not recruiting|Phase 2/Phase 3|120||Royal Free and University College Medical School|||||f||||||||||||||2017-02-18 17:26:52.365173|2017-02-18 17:26:52.365173
NCT00147654|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2011-06-07|||November 2004||2004-11-01|June 2011|2011-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction|A Randomized, Double Blind, Placebo Controlled, Four Arm (Placebo, Tolterodine ER, Tamsulosin, and Tolterodine ER Plus Tamsulosin) Study To Evaluate The Clinical Efficacy And Safety Of Tolterodine ER 4 mg In Men Who Have Frequency and Urgency, With Or Without Urinary Urge Incontinence, With Or Without Bladder Outlet Obstruction|Completed||Phase 4|830||Pfizer|||||f||||||||||||||2017-02-18 17:26:52.456987|2017-02-18 17:26:52.456987
NCT00147628|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2011-06-07|||November 2005||2005-11-01|June 2011|2011-06-01|September 2006|Actual|2006-09-01|||||Interventional|||Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire|A Multi-Center, Double-Blind Placebo Controlled, Flexible-Dose Study With An Open-Label Phase To Assess The Efficacy Of Sildenafil Citrate On Erectile Function And Intercourse Satisfaction As Well As To Validate The Sexual Experience Questionnaire And Its Treatment Responsiveness In Men With Erectile Dysfunction|Completed||Phase 4|209|Actual|Pfizer|||||||||||||||||||2017-02-18 17:26:52.641815|2017-02-18 17:26:52.641815
NCT00147615|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-06-04|||October 2004||2004-10-01|June 2007|2007-06-01|June 2006||2006-06-01|||||Interventional|||The Long-Term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years|Peds II (Pediatric Eplerenone Development Study II)--An Open Label, Long-Term Study To Evaluate The Safety Of Eplerenone In The Treatment Of Hypertension In Children|Completed||Phase 3|140||Pfizer|||||||||||||||||||2017-02-18 17:26:52.927848|2017-02-18 17:26:52.927848
NCT00147602|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-04-21|||November 1998||1998-11-01|April 2015|2015-04-01|November 2005||2005-11-01|||||Interventional|SPARCL||Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke|A Double-Blind, Randomized, Placebo- Controlled Study Of Atorvastatin As Prevention Of Cerebrovascular Events In Patients With A Previous Transient Ischemic Attack (TIA) Or Stroke|Completed||Phase 4|4732||Pfizer|||||||||||||||||||2017-02-18 17:26:53.044982|2017-02-18 17:26:53.044982
NCT00147589|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-01-23|||September 2004||2004-09-01|March 2007|2007-03-01|January 2007|Actual|2007-01-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.|Peds I (Pediatric Eplerenone Development Study I): A Randomized, Double-Blind, Placebo Withdrawal, Parallel Group, Dose-Response Study To Evaluate The Efficacy And Safety Of Eplerenone In The Treatment Of Hypertension In Children|Completed||Phase 3|320||Pfizer|||||||||||||||||||2017-02-18 17:26:53.276248|2017-02-18 17:26:53.276248
NCT00147576|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-10-01|||December 2003||2003-12-01|October 2012|2012-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.|Randomized, Placebo-Controlled Parallel Group Study Comparing Effect Of Three Doses Of CP-866,087 And Naltrexone On Acute Alcohol Consumption And Craving After Seven Days Of Treatment In Alcohol Dependent (DSM IV) Subjects Who Are Not Currently Seeking Treatment|Completed||Phase 2|88|Actual|Pfizer|||||||||||||||||||2017-02-18 17:26:53.40293|2017-02-18 17:26:53.40293
NCT00147563|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-04-14|||October 2003||2003-10-01|May 2007|2007-05-01||||May 2006|Actual|2006-05-01||Interventional|||Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT|A Double-Blind, Parallel Design Study to Compare the Effectiveness of Eplerenone Versus Atenolol in Reversing the Remodeling of Resistance Arteries in Subjects With Mild to Moderate Primary Hypertension|Completed||Phase 4|34||Pfizer|||||||||||||||||||2017-02-18 17:26:53.495836|2017-02-18 17:26:53.495836
NCT00147550|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-09-11|||February 2004||2004-02-01|September 2013|2013-09-01|July 2013|Actual|2013-07-01|May 2007|Actual|2007-05-01||Interventional|||MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.|A Multicenter, Open-Label, Noncomparative Phase 1-2 Clinical And Pharmacokinetic Study Of Oral PD 0325901 In Patients With Advanced Cancer|Terminated||Phase 1/Phase 2|79|Actual|Pfizer||1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 17:26:53.586141|2017-02-18 17:26:53.586141
NCT00147199|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-07-11|2012-12-03||June 2005||2005-06-01|July 2013|2013-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|TRIUMPH||Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)|TRIUMPH I: Double Blind Placebo Controlled Clinical Investigation Into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension|Completed||Phase 3|235|Actual|United Therapeutics||2|||f||||f||||||||||2017-02-18 17:27:14.637314|2017-02-18 17:27:14.637314
NCT00147537|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-10-01|2013-01-18||February 2005||2005-02-01|October 2013|2013-10-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer|A Phase 1b Dose Escalation/Phase 2 Randomized, Non-Comparative, Multiple Center, Open Label Study Of CP 751,871 In Combination With Paclitaxel And Carboplatin And Of Paclitaxel And Carboplatin Alone As First Line Treatment For Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|282|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:26:53.937604|2017-02-18 17:26:53.937604
NCT00147524|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-04-26|||October 2003||2003-10-01|April 2007|2007-04-01|May 2005|Actual|2005-05-01|||||Interventional|||Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women|Multicenter, Open-Label (Non-Comparative) Study To Evaluate Changes In Flow Mediated Dilatation During And After A 6 Months Treatment Period With Step By Step Increased Doses With Quinapril Therapy In Post-Menopausal Women With Mild Or Moderate Hypertension|Completed||Phase 4|70||Pfizer|||||f||||||||||||||2017-02-18 17:27:02.031904|2017-02-18 17:27:02.031904
NCT00146471|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-12-29|||January 2006||2006-01-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|July 2007|Actual|2007-07-01||Interventional|||Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome|Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome [Sicherheit Und Wirksamkeit Von Levetiracetam (Keppra) für Die Behandlung Des stationären Alkoholentzugsyndroms]|Completed||Phase 3|120|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 17:27:02.130014|2017-02-18 17:27:02.130014
NCT00146458|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2006-09-19|||January 2002||2002-01-01|September 2006|2006-09-01|December 2007||2007-12-01|||||Interventional|||Usefulness of FDG-PET for Advanced Cervical Cancer|A Phase III Randomized Trial of FDG-PET in the Management of Advanced Cervical Cancer With Enlarged Pelvic Lymph Node on MRI Image|Unknown status|Active, not recruiting|Phase 3|200||Chang Gung Memorial Hospital|||||f||||||||||||||2017-02-18 17:27:02.254557|2017-02-18 17:27:02.254557
NCT00146445|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-09-26|||August 2001||2001-08-01|September 2012|2012-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Behavioral Intervention Trial for HIV-infected Injection Drug Users|Intervention for Seropositive Injection Drug Users - Research and Evaluation (INSPIRE)|Completed||Phase 2/Phase 3|1000||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:27:02.362161|2017-02-18 17:27:02.362161
NCT00146432|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-08-21||||||August 2009|2009-08-01||||||||Interventional|||Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)|Prospective, Controlled Pilot Trial: Treatment of Patients in Severe Sepsis and Septic Shock With Immunoadsorption of LPS, IL-6, C5a|Completed||Phase 2/Phase 3|||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:27:02.469049|2017-02-18 17:27:02.469049
NCT00146419|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-07-28|||March 2004||2004-03-01|September 2012|2012-09-01|June 2013|Actual|2013-06-01|August 2006|Actual|2006-08-01||Observational|||Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)|Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)|Completed||N/A|699|Actual|Centers for Disease Control and Prevention|||1||f||||f||||||||||2017-02-18 17:27:02.739513|2017-02-18 17:27:02.739513
NCT00146406|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-09-10|||January 2005||2005-01-01|September 2012|2012-09-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Multi-level Interventions for STD Prevention Among Adolescents|Integrated Multi-level Interventions to Improve Adolescent Health Through the Prevention of STD, Including HIV, and Teen Pregnancy|Terminated||N/A|36502|Actual|Centers for Disease Control and Prevention||||IRB terminated due to no continuation request.|f||||||||||||||2017-02-18 17:27:02.847382|2017-02-18 17:27:02.847382
NCT00146393|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-12-08|||July 2003||2003-07-01|September 2005|2005-09-01|June 2004||2004-06-01|||||Interventional|||Health Benefits of an Exercise Program for Adults With Arthritis|Evaluation of People With Arthritis Can Exercise|Completed||Phase 2/Phase 3|347||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:27:02.948157|2017-02-18 17:27:02.948157
NCT00146380|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-09-26|||July 2003||2003-07-01|September 2012|2012-09-01|January 2013|Anticipated|2013-01-01|January 2009|Actual|2009-01-01||Interventional|KiBS||A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding|A Phase II Open Label Clinical Trial of Maternal Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Maximal Reduction of Mother-to-child HIV Transmission in Resource-limited Settings Among Breastfeeding Populations|Unknown status|Active, not recruiting|Phase 2|520|Anticipated|Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-02-18 17:27:03.037896|2017-02-18 17:27:03.037896
NCT00146367|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-12|||January 2004||2004-01-01|September 2005|2005-09-01|October 2005||2005-10-01|||||Interventional|||Evaluation of the Active Living Every Day Exercise Program for People With Arthritis|Evaluation of the Health Benefits of the Active Living Every Day Physical Activity Program Among Persons With Arthritis|Completed||Phase 2/Phase 3|355||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:27:03.141182|2017-02-18 17:27:03.141182
NCT00146354|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-03-01||||||August 2005|2005-08-01||||||||Interventional|||The Effects of a Results Management System on Physician Awareness of Post-Discharge Test Results|The Effects of a Results Management System on Physician Awareness of Post-Discharge Laboratory and Radiology Results|Completed||Phase 3|||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:27:03.228168|2017-02-18 17:27:03.228168
NCT00146341|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2013-11-18|||April 2005||2005-04-01|November 2013|2013-11-01|September 2006||2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg|An Eight Week Randomized, Double-Blind, Double-Dummy Study Comparing a Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlorothiazide 12.5mg to Telmisartan 80mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 80mg.|Completed||Phase 3|345|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:27:03.316275|2017-02-18 17:27:03.316275
NCT00146328|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2014-01-31|2009-05-26||April 2001||2001-04-01|January 2014|2014-01-01||||May 2008|Actual|2008-05-01||Interventional|||Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects|A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects|Completed||Phase 2/Phase 3|997|Actual|Boehringer Ingelheim||3|||f||||||||||||||2017-02-18 17:27:03.443144|2017-02-18 17:27:03.443144
NCT00146315|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-05-31|||January 2005||2005-01-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||ESCAP: Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting|Effectiveness of the Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting (ESCAP): a Randomized Clinical Trial|Completed||Phase 3|97|Actual|Basque Health Service||2|||f||||f||||||||||2017-02-18 17:27:06.999524|2017-02-18 17:27:06.999524
NCT00146302|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2012-03-16|||November 2002||2002-11-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?|BCG Vaccination and Childhood Morbidity and Mortality: Interventions With Possible Implications for the Immunisation Policy in Developing Countries. Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth?|Completed||Phase 4|2320|Actual|Bandim Health Project||1|||f||||||||||||||2017-02-18 17:27:07.121048|2017-02-18 17:27:07.121048
NCT00146289|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-10-31|||February 2005||2005-02-01|October 2013|2013-10-01||||October 2005|Actual|2005-10-01||Interventional|||The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects|A Randomised, DB, Placebo-controlled, Parallel Group, 16-wk MICARDIS (160mg) Tab, Proof-of-concept, Evaluating Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive, Using the OGTT, With a Clamp Sub-group|Completed||Phase 2|138||Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:27:07.218526|2017-02-18 17:27:07.218526
NCT00146276|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-09-26|||July 2000||2000-07-01|September 2005|2005-09-01||||||||Interventional|||Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer|Adjuvant vs. Progression-Triggered Treatment With Gemcitabine After Radical Cystectomy for Locally Advanced Transitional Cell Carcinoma of the Bladder in Patients Not Suitable for Cisplatin-Based Chemotherapy - A Phase 3 Study|Unknown status|Recruiting|Phase 3|178||Association of Urogenital Oncology (AUO)|||||f||||||||||||||2017-02-18 17:27:07.322863|2017-02-18 17:27:07.322863
NCT00146263|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2010-09-05|||September 2005||2005-09-01|September 2005|2005-09-01|June 2007||2007-06-01|||||Interventional|||Cognitive Training in the Elderly|The Effect of Computerized Cognitive Training on Neuropsychological Measures of Cognitive Function in the Elderly|Unknown status|Recruiting|N/A|300|Anticipated|Beersheva Mental Health Center|||||f||||||||||||||2017-02-18 17:27:07.422816|2017-02-18 17:27:07.422816
NCT00146250|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||January 2005||2005-01-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||The Effect of N2O Administration on Arterial Oxygenation|Relationship of Oxygenation During Anaesthesia in the Presence of N2O or N2 to Mode of Ventilation|Completed||Phase 4|20||Austin Health|||||f||||||||||||||2017-02-18 17:27:07.501425|2017-02-18 17:27:07.501425
NCT00147511|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2011-05-09|||June 2003||2003-06-01|May 2011|2011-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Time To Efficacy and Onset Of Action Of Linezolid|Time To Efficacy and Onset Of Action Of Linezolid In Skin and Soft Tissue Infections|Completed||Phase 4|118|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:27:07.581362|2017-02-18 17:27:07.581362
NCT00147498|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-12-20|2012-11-19||January 2005||2005-01-01|December 2012|2012-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks|A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Compare 3 Dose Levels Of CP-690,550 Versus Placebo, Administered Orally Twice Daily (BID) For 6 Weeks, In The Treatment Of The Signs And Symptoms Of Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|264|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 17:27:07.681534|2017-02-18 17:27:07.681534
NCT00147485|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-08-14|||December 2004||2004-12-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer|A Phase 1 Safety, Pharmacokinetic And Pharmacodynamic Study Of AG-024322, An Inhibitor Of Cyclin-Dependent Kinase 1, 2 And 4, Administered Intravenously Daily For 5 Days Every 3 Weeks To Patients With Advanced Cancer|Terminated||Phase 1|37|Actual|Pfizer||1||See Detailed Description|f||||||||||||||2017-02-18 17:27:09.736911|2017-02-18 17:27:09.736911
NCT00147472|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-06-20|||May 2004||2004-05-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|August 2009|Actual|2009-08-01||Interventional|||Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)|A Prospective Cohort Study to Determine the Sensitivity of Positron Emission Tomography (PET) in Detecting Metastatic Cancer in Neck Lymph Nodes in Patients With Squamous Cell Head & Neck Cancer Managed With Primary Radiation Therapy|Completed||Phase 3|400|Actual|Ontario Clinical Oncology Group (OCOG)||1|||f||||t||||||||||2017-02-18 17:27:09.85325|2017-02-18 17:27:09.85325
NCT00147459|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2012-12-04|||September 2005||2005-09-01|December 2012|2012-12-01|December 2012|Anticipated|2012-12-01|December 2006|Actual|2006-12-01||Interventional|||Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation|Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation|Unknown status|Recruiting|N/A|31|Anticipated|National Taiwan University Hospital||1|||f||||||||||||||2017-02-18 17:27:09.971764|2017-02-18 17:27:09.971764
NCT00147446|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-09-06|2012-10-26||May 2005||2005-05-01|September 2013|2013-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Stress Management for Patients With Multiple Sclerosis|Phase II Study of the Effects of Stress Management on Neuroimaging, Clinical, Immune and Psychosocial Outcomes|Completed||Phase 2|121|Actual|Northwestern University|we caution that it is premature to make specific clinical recommendations regarding the use of SMT-MS to manage MS disease-related activity. Future work should identify, refine, and optimize the active ingredients in this behavioral intervention.|2|||f||||t||||||||||2017-02-18 17:27:10.091697|2017-02-18 17:27:10.091697
NCT00147433|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-03-30|||February 2004||2004-02-01|September 2005|2005-09-01|November 2008||2008-11-01|||||Observational|||The Effect of Thyroid Hormone Levels in Pregnant Women on the Intelligence Quotient (IQ) of Their Children|Are IQs Low in Offspring of Euthyroid Women With Low T4?|Unknown status|Recruiting|N/A|5000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:27:10.518197|2017-02-18 17:27:10.518197
NCT00147420|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-12-16|||September 2005||2005-09-01|December 2013|2013-12-01|March 2007|Actual|2007-03-01|||||Interventional|||RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet|RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet|Completed||N/A|848||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 17:27:10.615846|2017-02-18 17:27:10.615846
NCT00147394|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-10-25|||December 2001||2001-12-01|October 2012|2012-10-01|June 2004|Actual|2004-06-01|||||Interventional|||Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)|Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder|Completed||Phase 1|100||Children's Hospital Medical Center, Cincinnati|||||f||||f||||||||||2017-02-18 17:27:10.728274|2017-02-18 17:27:10.728274
NCT00147186|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-01-12|||January 2000||2000-01-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Interventional|||The Effectiveness of Hylan GF-20 on Joint Reaction Forces and Kinematic Patterns During Gait in Patients With Knee Osteoarthritis||Unknown status|Active, not recruiting|N/A|||Kessler Foundation|||||f||||||||||||||2017-02-18 17:27:15.438587|2017-02-18 17:27:15.438587
NCT00147381|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-06-18|||January 2004||2004-01-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|August 2008|Actual|2008-08-01||Interventional|||Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection|Effectiveness and Safety of Campath-1H as an Induction Agent in Combination With Tacrolimus Monotherapy for Prevention of Graft Rejection Compared to Tacrolimus in Combination With MMF and Steroids in Cadaveric Kidney Transplantation|Completed||Phase 3|197|Actual|Medical University Innsbruck||3|||f||||f||||||||||2017-02-18 17:27:10.839878|2017-02-18 17:27:10.839878
NCT00147368|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-05-30|||February 2005||2005-02-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|April 2006|Actual|2006-04-01||Interventional|||Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria|Pharmacokinetic-Pharmacodynamic Study of Adjunctive Arginine in Falciparum Malaria|Completed||Phase 1/Phase 2|50|Anticipated|Menzies School of Health Research|||||f||||t||||||||||2017-02-18 17:27:10.959281|2017-02-18 17:27:10.959281
NCT00147355|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2012-04-11|||November 2005||2005-11-01|April 2012|2012-04-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy|An Open-label, Randomised Study Comparing the Uptake of rIL-2 in HIV-1 Infected Individuals Receiving Different Combinations of Antiemetics and Analgesic Agents During rIL-2 Dosing in ESPRIT: Toxicity Substudy of ESPRIT: TOXIL-2 Substudy|Terminated||Phase 3|28|Actual|Kirby Institute||4||28 of 168 patients only were enrolled, numbers too low to be conclusive|f||||t||||||||||2017-02-18 17:27:11.064448|2017-02-18 17:27:11.064448
NCT00147342|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2016-09-02|||May 2005||2005-05-01|September 2016|2016-09-01|December 2005||2005-12-01|||||Observational|||The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes|The Effect of Basal Insulin During Exercise on the Development of Hypoglycemia in Children With Type 1 Diabetes|Completed||N/A|55||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:27:11.206893|2017-02-18 17:27:11.206893
NCT00147329|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-02-21|||September 2005||2005-09-01|February 2007|2007-02-01|July 2006||2006-07-01|||||Interventional|||Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis|A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study To Evaluate the Tolerability, Pharmacokinetics, Pharmacodynamics, and Biologic Activity of MM-093 in Patients With Moderate to Severe Chronic Plaque Psoriasis|Completed||Phase 2|30||Merrimack Pharmaceuticals|||||f||||||||||||||2017-02-18 17:27:11.298285|2017-02-18 17:27:11.298285
NCT00147316|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2012-02-29|2012-01-19||April 2002||2002-04-01|February 2012|2012-02-01|September 2003||2003-09-01|||||Interventional|||Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke|Japan Alteplase Clinical Trial (J-ACT): Phase 3 Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Acute Ischemic Stroke Within 3 Hours of Onset|Completed||Phase 3|103|Actual|Mitsubishi Tanabe Pharma Corporation||1|||f||||||||||||||2017-02-18 17:27:11.380118|2017-02-18 17:27:11.380118
NCT00147303|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2015-04-08|||April 2004||2004-04-01|April 2015|2015-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-responsive Clinical Pharmacology Study|Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Clinical-pharmacological Dose-response Study.|Completed||Phase 3|46|Actual|Mitsubishi Tanabe Pharma Corporation||3|||f||||f||||||||||2017-02-18 17:27:11.86651|2017-02-18 17:27:11.86651
NCT00147290|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-08-12|2008-11-20||February 2004||2004-02-01|August 2015|2015-08-01|January 2008|Actual|2008-01-01|April 2007|Actual|2007-04-01||Interventional|ADVANCE-CRTD||ADVANCE CRT - D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy|ADVANCE CRT - D: ATP Delivery for Painless ICD Therapy|Completed||Phase 4|526|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-02-18 17:27:11.962669|2017-02-18 17:27:11.962669
NCT00147277|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-08-12|2008-11-20||March 2004||2004-03-01|August 2015|2015-08-01|January 2008|Actual|2008-01-01|January 2006|Actual|2006-01-01||Interventional|ADVANCE_D||ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy|ADVANCE-D: ATP Delivery for Painless ICD Therapy|Completed||Phase 4|925|Actual|Medtronic Bakken Research Center||2|||f||||f||||||||||2017-02-18 17:27:12.43568|2017-02-18 17:27:12.43568
NCT00147264|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2016-12-13|||April 2004||2004-04-01|December 2016|2016-12-01|November 2006|Actual|2006-11-01|January 2006|Actual|2006-01-01||Interventional|||Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial|A Randomized, Double Blind, 2X2 Factorial Design Study to Evaluate the Effects of Telmisartan vs Placebo, and of a Low-Glycemic Diet vs Control Diet, in Reducing Intra-Myocellular Lipids In Individuals With Abdominal Obesity|Completed||Phase 3|120||McMaster University|||||f||||||||||||||2017-02-18 17:27:12.946847|2017-02-18 17:27:12.946847
NCT00147251|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-10-31|||May 2003||2003-05-01|September 2005|2005-09-01|May 2007||2007-05-01|||||Interventional|||Stop Atherosclerosis in Native Diabetics Study|Stop Atherosclerosis in Native Diabetics Study|Completed||Phase 4|548||Medstar Health Research Institute|||||f||||||||||||||2017-02-18 17:27:13.049103|2017-02-18 17:27:13.049103
NCT00147238|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-07-31|2009-04-24||July 2005||2005-07-01|July 2012|2012-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast|A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast|Terminated||N/A|10|Actual|M.D. Anderson Cancer Center||2||Terminated at request of sponsor.|f||||f||||||||||2017-02-18 17:27:13.352304|2017-02-18 17:27:13.352304
NCT00147225|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-04-07|2014-04-07||August 2005||2005-08-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||Cycle 1, Chemotherapy alone (Control Cycle); Beginning Cycle 2, Chemotherapy followed by AMG 531 subcutaneously of 21-28 day treatment cycle. There were 51 participants who received at least one dose of the study drug.|AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin|Phase I/II Study of AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin|Completed||Phase 1/Phase 2|55|Actual|M.D. Anderson Cancer Center||6|||f||||f||||||||||2017-02-18 17:27:13.593786|2017-02-18 17:27:13.593786
NCT00147212|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-12-11|2012-03-16||June 2002||2002-06-01|December 2012|2012-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||ET 743 (Yondelis) in Men With Advanced Prostate Cancer|A Phase II Study of Three Hour, Weekly Infusion of ET 743 (Yondelis) in Men With Advanced Prostate Cancer|Completed||Phase 2|50|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 17:27:14.388575|2017-02-18 17:27:14.388575
NCT00005398|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-10-20|||May 1996||1996-05-01|October 2016|2016-10-01||||May 2026|Anticipated|2026-05-01||Observational|||University of North Carolina Alumni Heart Study|University of North Carolina Alumni Heart Study|Active, not recruiting||N/A|6340|Actual|Duke University|||1||f||||f||||||||||2017-02-18 18:15:02.663167|2017-02-18 18:15:02.663167
NCT00147160|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-04-10|||October 2003||2003-10-01|September 2006|2006-09-01|December 2007|Actual|2007-12-01|July 2006|Actual|2006-07-01||Interventional|||Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents|Phase II Study of the Combination of Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents at Diagnosis or in Relapse|Completed||Phase 2|87|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:27:15.542289|2017-02-18 17:27:15.542289
NCT00147147|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2016-09-20|||January 1993||1993-01-01|September 2016|2016-09-01|March 2004||2004-03-01|||||Interventional|||Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)|Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by Oral Fluorouracil (UFT) in Serosa-positive Gastric Cancer (JCOG9206-2)|Completed||Phase 3|280||Japan Clinical Oncology Group|||||f||||||||||||||2017-02-18 17:27:15.636751|2017-02-18 17:27:15.636751
NCT00147134|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2016-09-20|||November 2004||2004-11-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer|Randomized Controlled Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer（JCOG 0404,CRC Surg-LAP/OPEN)|Completed||Phase 3|1050|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:27:15.888126|2017-02-18 17:27:15.888126
NCT00147121|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2016-09-20|||September 2002||2002-09-01|September 2016|2016-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)|Rituximab + Standard CHOP (R･S-CHOP) vs Rituximab+ Bi-weekly CHOP (R･Bi-CHOP) RCT(Phase II/III) for Stage III/IV Low-grade B-cell Lymphoma (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)|Completed||Phase 2/Phase 3|300|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:27:16.030033|2017-02-18 17:27:16.030033
NCT00147108|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-09-13|||January 2003||2003-01-01|September 2012|2012-09-01|October 2005|Actual|2005-10-01|August 2005|Actual|2005-08-01||Interventional|||MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas|Phase 3 Study of MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas|Terminated||Phase 3|102|Actual|InSightec||1|||f||||||||||||||2017-02-18 17:27:16.201722|2017-02-18 17:27:16.201722
NCT00147095|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-05-27|||February 2003||2003-02-01|September 2005|2005-09-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease|Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease|Completed||N/A|80|Actual|Imperial College London|||1||f||||||||||Samples Without DNA|"~     RNA was isolated and sent to GeneLogic~   "|||2017-02-18 17:27:16.300269|2017-02-18 17:27:16.300269
NCT00147082|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-08-24|||February 2001||2001-02-01|September 2006|2006-09-01|April 2007|Actual|2007-04-01|December 2004|Actual|2004-12-01||Observational|||Leukocyte Function in Chronic Obstructive Pulmonary Disease (COPD)|Leukocyte Migration and Differentiation in COPD Patients Compared to Healthy Smokers and Healthy Non-smoking Subjects.|Completed||N/A|90|Anticipated|Imperial College London|||3||f||||||||||||||2017-02-18 17:27:16.387205|2017-02-18 17:27:16.387205
NCT00147069|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-05-27|||April 2004||2004-04-01|September 2005|2005-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Leukocyte Function in Asthma and COPD|Investigation Into Inflammatory Mechanisms in Airway Cells in Smokers and Non-smokers With Inflammatory Lung Disease.|Completed||N/A|90|Actual|Imperial College London|||1||f||||f||||||||||2017-02-18 17:27:16.66025|2017-02-18 17:27:16.66025
NCT00147056|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2016-08-16|||August 2012||2012-08-01|August 2016|2016-08-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors|A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors|Recruiting||Phase 1|10|Anticipated|InSightec||1|||f||||t||||||||||2017-02-18 17:27:16.749927|2017-02-18 17:27:16.749927
NCT00147043|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2016-02-11|||January 2005||2005-01-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||Adult Stem Cell Therapy in Liver Insufficiency|Adult Stem Therapy for Patients With Liver Insufficiency|Completed||Phase 1|5||Imperial College London|||||f||||||||||||||2017-02-18 17:27:16.892151|2017-02-18 17:27:16.892151
NCT00147030|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2016-04-06|2016-03-08||December 2002||2002-12-01|November 2013|2013-11-01|August 2008|Actual|2008-08-01|November 2006|Actual|2006-11-01||Interventional||Infants who were less than 6 hours of age who had a gestational age of at least 36 weeks and perinatal asphyxial encephalopathy confirmed by 30 minutes’ amplitude-integrated electro-encephalography that showed abnormal background activity or seizures.|TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia|Whole Body Hypothermia for the Treatment of Perinatal Asphyxial Encephalopathy|Completed||N/A|325|Actual|Imperial College London||2|||f||||t||||||||No||2017-02-18 17:27:16.995541|2017-02-18 17:27:16.995541
NCT00147017|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2015-03-23|||June 2001||2001-06-01|September 2005|2005-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Observational|||Regulation of the Release of Inflammatory Mediators From Lung Macrophages.|Regulation of the Release of Inflammatory Mediators From Lung Macrophages.|Completed||N/A|60|Actual|Imperial College London|||1||f||||||||||Samples Without DNA|"~     protein samples have been retained~   "|||2017-02-18 17:27:17.74659|2017-02-18 17:27:17.74659
NCT00147004|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-04-23|||March 2002||2002-03-01|April 2008|2008-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|Corticus||Corticosteroid Therapy of Septic Shock - Corticus|Corticosteroid Therapy of Septic Shock - Corticus. A Multi-National, Prospective, Double-Blind, Randomized, Placebo-Controlled Study|Completed||Phase 3|500|Actual|Hadassah Medical Organization||2|||f||||t||||||||||2017-02-18 17:27:17.837842|2017-02-18 17:27:17.837842
NCT00146978|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2006-11-06|||December 2000||2000-12-01|March 2006|2006-03-01|August 2005||2005-08-01|||||Interventional|||Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD)|A Phase 1/2 Study to Evaluate Intra-Arterial Catheter Directed Therapy for Severe Gastro-Intestinal and/or Hepatic Graft vs. Host Disease (GVHD)|Completed||Phase 1/Phase 2|50||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:27:18.014008|2017-02-18 17:27:18.014008
NCT00146952|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2016-11-10|||January 2005||2005-01-01|September 2005|2005-09-01|December 2007||2007-12-01|||||Interventional|||Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation|Evaluation of a Vibrotactile Sensory Aid Developed by the US Navy to Combat Pilot Disorientation as a Prosthesis in Patients With Postural Imbalance and Spatial Disorientation|Unknown status|Recruiting|Phase 1|30|Anticipated|Imperial College London|||||f||||||||||||||2017-02-18 17:27:18.102675|2017-02-18 17:27:18.102675
NCT00146913|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2007-04-26|||March 2004||2004-03-01|April 2007|2007-04-01||||||||Interventional|||AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year|A Phase II Study Evaluating the Efficacy and Tolerance of Combination Therapy of Imatinib Mesylate (IM) +-2A Interféron for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year|Unknown status|Active, not recruiting|Phase 2|30||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:27:18.274587|2017-02-18 17:27:18.274587
NCT00146900|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2016-02-17|||August 2004||2004-08-01|February 2016|2016-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Prevention of Post Traumatic Stress Disorder by Early Treatment|Prevention of Post Traumatic Stress Disorder by Early Treatment|Completed||N/A|298|Actual|Hadassah Medical Organization||5|||f||||f||||||||||2017-02-18 17:27:18.370396|2017-02-18 17:27:18.370396
NCT00146887|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2006-11-06|||January 2005||2005-01-01|August 2005|2005-08-01|August 2005|Anticipated|2005-08-01|||||Interventional|||Comparison of Coronary CT Angiography to Invasive Coronary Angiography|A Trial Comparing the Sensitivity and Specificity of Coronary Angiography With Coronary CT Angiography|Unknown status|Recruiting|N/A|40|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:27:18.491517|2017-02-18 17:27:18.491517
NCT00146874|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2010-08-17|||May 2004||2004-05-01|November 2006|2006-11-01||||March 2007|Actual|2007-03-01||Observational|||CRT RENEWAL Registry|Cardiac Resynchronization Therapy Registry Evaluating Patient Response With RENEWAL Family Devices|Completed||Phase 4|1000||Boston Scientific Corporation|||1||f||||||||||||||2017-02-18 17:27:18.578708|2017-02-18 17:27:18.578708
NCT00146861|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-11-20|||June 2003||2003-06-01|November 2006|2006-11-01||||||||Interventional|||LIFE Study - Limiting Chronotropic Incompetence for Pacemaker Recipients|Limiting Chronotropic Incompetence for Pacemaker Recipients|Completed||Phase 4|1500||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:27:18.649937|2017-02-18 17:27:18.649937
NCT00146848|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2011-12-20|2010-02-28||December 2004||2004-12-01|December 2011|2011-12-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|PEGASUS CRT||PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy|Pacing Evaluation - Atrial Support Study in Cardiac Resynchronization Therapy|Completed||Phase 4|1742|Actual|Boston Scientific Corporation|Lack of longer-term follow-up. Single blind design where investigator could be aware of treatment assignment. Two conservative atrial support pacing modes; results should not be extended to substantially more atrial pacing and higher heart rates.|3|||f||||t||||||||||2017-02-18 17:27:18.733785|2017-02-18 17:27:18.733785
NCT00146835|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-01-09|||April 2003||2003-04-01|January 2014|2014-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine|Phase IV, Prospective Study of the Safety of GSK Bios' Pediarix Administered to a Cohort of Infants in a US Health Maintenance Organization (HMO). (Post-Marketing PEDIARIX Safety Study)|Completed||N/A|120794|Actual|GlaxoSmithKline|||3||f||||||||||||||2017-02-18 17:27:19.302993|2017-02-18 17:27:19.302993
NCT00146822|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2017-02-02|||February 2004||2004-02-01|February 2017|2017-02-01|March 2006||2006-03-01|||||Interventional|||REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance|ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance Study|Completed||Phase 4|1500||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:27:19.410401|2017-02-18 17:27:19.410401
NCT00146809|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-03-03|||December 2003||2003-12-01|March 2007|2007-03-01|December 2005||2005-12-01|||||Interventional|||Study About Efficacy and Safety to Treat Multi-System-Atrophy|Double-Blind, Randomised, Two-Armed Study for the Evaluation of Efficacy and Safety of Minocycline for Treatment|Completed||Phase 3|60||German Parkinson Study Group (GPS)|||||f||||||||||||||2017-02-18 17:27:19.478148|2017-02-18 17:27:19.478148
NCT00146796|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2017-01-11|||January 2005||2005-01-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|||||Interventional|||A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Malaria in Tanzania|A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Non-Severe Malaria at Different Transmission Intensities of Plasmodium Falciparum in Tanzania|Completed||Phase 4|2400|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-02-18 17:27:19.591868|2017-02-18 17:27:19.591868
NCT00146783|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2017-01-11|||June 2004||2004-06-01|January 2017|2017-01-01|February 2007|Actual|2007-02-01|||||Interventional|||Navrongo Drug Options for IPT in Pregnancy Trial|Efficacy of Sulphadoxine-pyrimethamine and Amodiaquine Alone or in Combination as Intermittent Preventive Treatment in Pregnancy in the Kassena-Nankana District of Ghana: a Randomized Controlled Trial|Completed||Phase 2/Phase 3|3642|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-02-18 17:27:19.699087|2017-02-18 17:27:19.699087
NCT00146770|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-03-17|2009-01-07||May 2001||2001-05-01|March 2015|2015-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients|A Multicenter, Multinational, Open-Label Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I|Completed||Phase 3|45|Actual|Sanofi|Rare disease with limited sample size, lack of control group.FVC calculations less reliable for patients whose height is below the 3rdpercent of general population.Height term used to calculate FVC may be influenced by joint contractures and posture.|2|||f||||||||||||||2017-02-18 17:27:19.817449|2017-02-18 17:27:19.817449
NCT00146757|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-03-17|2008-11-20||October 2002||2002-10-01|March 2015|2015-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old|A Phase II Open-Label Clinical Trial of Recombinant Human Alpha-L-iduronidase (Aldurazyme®) to Evaluate the Safety and Pharmacokinetics in Mucopolysaccharidosis I (MPS I) Patients Less Than 5 Years Old|Completed||Phase 2|20|Actual|Sanofi|Due to the rarity of the disease, this study is limited by its small sample size and lack of a control group.|2|||f||||||||||||||2017-02-18 17:27:21.505099|2017-02-18 17:27:21.505099
NCT00146744|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2011-02-10|||July 2005||2005-07-01|February 2011|2011-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults|Double-blind (Observer-blind), Randomised, Controlled, Phase I/II Study, to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Candidate Tuberculosis Vaccine, Mtb72F/AS02A Administered Intramuscularly at 0, 1, 2 Months to Healthy PPD-positive Volunteers Aged 18 to 50 Years|Completed||Phase 2|38||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:27:22.174689|2017-02-18 17:27:22.174689
NCT00146731|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2017-01-11|||January 2004||2004-01-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Trial of Antimalarial Drugs Used in Pregnancy in Tanzania|Treating Malaria During Pregnancy: A Randomized Trial of Potential Options for Treatment in an Area of High Drug Resistance in Tanzania|Completed||Phase 3|310|Actual|London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-02-18 17:27:22.258773|2017-02-18 17:27:22.258773
NCT00146718|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2017-01-11|||August 2003||2003-08-01|January 2017|2017-01-01|May 2005||2005-05-01|||||Interventional|||Anti-Malarial Drug Resistance in Cameroon|Anti-malarial Drug Resistance in Cameroon: Therapeutic Efficacy and Biological Markers of Resistance|Completed||Phase 2/Phase 3|755||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:27:22.368944|2017-02-18 17:27:22.368944
NCT00146705|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2007-07-31|||May 2005||2005-05-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Observational|||Long Term Follow-up of Pegylated-Interferon Alpha-2b|Long Term Follow-up of Pegylated-Interferon Alpha-2b and Lamivudine Combination Therapy in Patients With Chronic HBV Infection|Completed||N/A|266|Actual|Foundation for Liver Research|||||f||||f||||||||||2017-02-18 17:27:22.459344|2017-02-18 17:27:22.459344
NCT00146692|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-05|2017-01-11|||April 2004||2004-04-01|January 2017|2017-01-01|February 2005|Actual|2005-02-01|||||Interventional|||A Trial of Improved Financial Access to Healthcare in Ghana|Impact of Improved Financial Access to Health Care on Morbidity Due to Severe Malaria and Healthcare Utilization Among Children 6 Months to Five Years of Age in a Hyper Endemic Area in Ghana: a Randomized Controlled Trial|Completed||Phase 4|2000||London School of Hygiene and Tropical Medicine|||||f||||f||||||||||2017-02-18 17:27:22.5471|2017-02-18 17:27:22.5471
NCT00146679|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-09-06|||March 2001||2001-03-01|September 2013|2013-09-01|February 2006|Actual|2006-02-01|June 2005|Actual|2005-06-01||Interventional|||Psychoeducational Intervention for ICD Patients (PEACE)|Psychoeducational Intervention for ICD Patients (PEACE)|Completed||N/A|246|Actual|Emory University||3|||f||||t||||||||||2017-02-18 17:27:22.640342|2017-02-18 17:27:22.640342
NCT00146666|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-03|2009-12-16|||September 2005||2005-09-01|August 2009|2009-08-01|September 2006|Anticipated|2006-09-01|||||Interventional|||Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)|Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)|Unknown status|Recruiting|Phase 2|90|Anticipated|FlowMedic|||||f||||||||||||||2017-02-18 17:27:22.765308|2017-02-18 17:27:22.765308
NCT00146653|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-11-19|||December 2005||2005-12-01|November 2013|2013-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Heparin Management During Cardiopulmonary Bypass in Children|A Comparison of Heparin Management Strategies in Children Undergoing Cardiopulmonary Bypass.|Completed||N/A|20|Actual|Emory University|||1||f||||f||||||Samples With DNA|"~     Blood is being collected to obtain Xa results.~   "|||2017-02-18 17:27:22.857824|2017-02-18 17:27:22.857824
NCT00146640|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2014-02-17|||August 2004||2004-08-01|February 2014|2014-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Prednisone Timed-Release Tablet (TRT) Study: TRT Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis|A New Timed-release Tablet Formulation of Prednisone Compared to Standard Prednisone in Patients With Rheumatoid Arthritis- A Randomized, Multi-centre, Double-blind, Active Controlled Study With Open Extension on the New Drug Only|Completed||Phase 3|288|Actual|Merck KGaA|||||f||||||||||||||2017-02-18 17:27:23.155023|2017-02-18 17:27:23.155023
NCT00146627|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2016-09-28||||||September 2009|2009-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis|Clinical Study Comparing the Nifurtimox-Eflornithine Combination With the Standard Eflornithine Regimen for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis in the Meningoencephalitic Phase|Completed||Phase 3|280|Anticipated|Drugs for Neglected Diseases|||||f||||||||||||||2017-02-18 17:27:23.277588|2017-02-18 17:27:23.277588
NCT00146614|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2012-03-06|||July 2002||2002-07-01|March 2012|2012-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation|Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Allogeneic Non-Myeloablative Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|105||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:27:23.387876|2017-02-18 17:27:23.387876
NCT00146601|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2007-12-20|||June 2004||2004-06-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer|A Phase II Study of Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer|Completed||Phase 2|35|Anticipated|Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:27:23.495801|2017-02-18 17:27:23.495801
NCT00146588|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2015-03-23|||April 2002||2002-04-01|October 2014|2014-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer|A Pilot Study of Cytoxan, Epirubicin, and Capecitabine in Women With Stage I/II/IIIA Breast Cancer|Completed||N/A|55|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:27:23.604937|2017-02-18 17:27:23.604937
NCT00146575|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2008-01-10|||June 2003||2003-06-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)|Randomized Trial of Paclitaxel-Eluting Stent and Sirolimus-Eluting Stent for Restenosis Reduction in Small Coronary Vessels (ISAR-SMART-3)|Completed||Phase 4|360|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:27:23.722593|2017-02-18 17:27:23.722593
NCT00146562|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-02-15|||July 2003||2003-07-01|February 2013|2013-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer|A Phase II Study of Pegfilgrastim (Neulasta) and Darbepoetin Alfa (Aranesp) in Support of Dose-Dense Adjuvant Chemotherapy for Breast Cancer|Completed||Phase 2|109|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:27:23.851146|2017-02-18 17:27:23.851146
NCT00146549|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-10-30|||August 2001||2001-08-01|October 2009|2009-10-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer|A Randomized Phase III Study of Trastuzumab (Herceptin) in Combination With Either Vinorelbine (Navelbine), or Taxane-based Chemotherapy in Patients With HER2 Overexpressing Metastatic Breast Cancer|Completed||Phase 3|250||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:27:23.980857|2017-02-18 17:27:23.980857
NCT00146536|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-11-29|||November 2004||2004-11-01|November 2012|2012-11-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Observational|||Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy|The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS, or Atypical Ductal Hyperplasia (ADH) in Patients Diagnosed With Lobular Neoplasia of the Breast by Core Needle Biopsy|Completed||N/A|78|Anticipated|Dana-Farber Cancer Institute|||1||f||||f||||||Samples With DNA|"~     Option of keeping tissue sample for further research~   "|||2017-02-18 17:27:24.08964|2017-02-18 17:27:24.08964
NCT00146523|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-02-14|||May 2005||2005-05-01|February 2012|2012-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression|An International, Double-Blind, Placebo-Controlled, Study of the Efficacy and Safety of CORLUX™ (Mifepristone) vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Psychotic Major Depression (PMD)|Completed||Phase 3|247|Actual|Corcept Therapeutics||2|||f||||f||||||||||2017-02-18 17:27:24.185414|2017-02-18 17:27:24.185414
NCT00146510|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-03-12|||March 2004||2004-03-01|March 2014|2014-03-01|February 2006||2006-02-01|||||Interventional|||HealtheTech Lifestyle Program|HealtheLifestyle Behavioral Intervention Clinical Trial|Completed||Phase 1|130||The Cooper Institute|||||f||||||||||||||2017-02-18 17:27:24.318458|2017-02-18 17:27:24.318458
NCT00146497|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2006-06-26|||August 2004||2004-08-01|June 2006|2006-06-01||||||||Interventional|||Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature Infants||Terminated||Phase 4|30||China Medical University Hospital|||||f||||||||||||||2017-02-18 17:27:24.409789|2017-02-18 17:27:24.409789
NCT00146484|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2005-09-06|||April 1996||1996-04-01|September 2005|2005-09-01|January 2001||2001-01-01|||||Interventional|||A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes|A Randomized Controlled Trial of Two Versus Three Daily Insulin Injections in Children and Adolescents With New Onset Type 1 Diabetes Mellitus|Completed||Phase 2|100||Children's Hospital of Eastern Ontario|||||f||||||||||||||2017-02-18 17:27:24.506687|2017-02-18 17:27:24.506687
NCT00146237|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2009-11-23|||November 2003||2003-11-01|November 2009|2009-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Phenytoin as an Augmentation for SSRI Failures|Phenytoin as an Augmentation for SSRI Failures: A Controlled Study|Completed||Phase 4|40|Anticipated|Beersheva Mental Health Center|||||f||||||||||||||2017-02-18 17:27:24.611513|2017-02-18 17:27:24.611513
NCT00146224|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-06|2010-02-25|||September 2005||2005-09-01|February 2010|2010-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis|A Randomized, Double-Blind, Equivalence Study of the Efficacy of Epoetin Alfa Manufactured by Deep Tank Bioreactor Technology and Epoetin Alfa Manufactured by Roller-Bottle Technology for the Treatment of Anemia in Patients With Chronic Kidney Disease (CKD) Receiving Hemodialysis|Completed||Phase 3|420|Anticipated|Amgen||2|||f||||||||||||||2017-02-18 17:27:24.723515|2017-02-18 17:27:24.723515
NCT00146211|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-12-24|||September 2005||2005-09-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|August 2007|Actual|2007-08-01||Interventional|||TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease|A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-Controlled Trial of Ethyl-EPA (Miraxion™) in Subjects With Mild to Moderate Huntington's Disease|Completed||Phase 3|300|Actual|Amarin Neuroscience Ltd|||||f||||||||||||||2017-02-18 17:27:24.836248|2017-02-18 17:27:24.836248
NCT00146198|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2006-12-18|||September 2005||2005-09-01|December 2006|2006-12-01|February 2006||2006-02-01|||||Interventional|||Efficacy and Safety of ALGRX 4975 in Treatment of Postoperative Pain After Hernia Repair|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Inguinal Hernia Repair|Completed||Phase 2|40||AlgoRx Pharmaceuticals|||||f||||||||||||||2017-02-18 17:27:24.970451|2017-02-18 17:27:24.970451
NCT00146185|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-04|2005-11-15|||February 2005||2005-02-01|April 2005|2005-04-01|July 2005||2005-07-01|||||Interventional|||Efficacy and Safety of ALGRX 3268 in Children Undergoing Minor Needle-Stick Procedures.|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Effectiveness and Safety of ALGRX 3268 in Pediatric Subjects.|Completed||Phase 3|504||AlgoRx Pharmaceuticals|||||||||||||||||||2017-02-18 17:27:25.060497|2017-02-18 17:27:25.060497
NCT00146172|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-05-10|||November 2003||2003-11-01|May 2012|2012-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Evaluating HKI-272 in Tumors|An Ascending Single and Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HKI-272 Administered Orally to Subjects With HER-2/NEU or HER-1/EGFR-Positive Tumors|Completed||Phase 1|72|Actual|Puma Biotechnology, Inc.|||||f||||||||||||||2017-02-18 17:27:25.142392|2017-02-18 17:27:25.142392
NCT00146159|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-12-21|||March 2005||2005-03-01|December 2007|2007-12-01||||September 2007|Actual|2007-09-01||Interventional|||Study Evaluating Mitoxantrone in Multiple Sclerosis|A Double-Blind, Three-Armed, Randomized Phase-III-Study, to Compare the Efficacy, Tolerability and Safety of Three Doses of Mitoxantrone in the Treatment of Patients With Secondary Progressive Multiple Sclerosis|Terminated||Phase 3|336|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer||3|||f||||||||||||||2017-02-18 17:27:25.232761|2017-02-18 17:27:25.232761
NCT00146146|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-02-17|||May 2005||2005-05-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|May 2006|Actual|2006-05-01||Interventional|||Testosterone and Its Metabolites in GID|Role of Testosterone and Its Metabolites Regarding Different Physiological Functions in Subjects Affected by Gender Identity Disorder (FtM Transsexuals)|Completed||Phase 3|15|Actual|Unita Complessa di Ostetricia e Ginecologia||1|||f||||f||||||||||2017-02-18 17:27:25.340647|2017-02-18 17:27:25.340647
NCT00146133|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-05-02|||January 2003||2003-01-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Weight Loss and Exercise in Physically Limited Obese Elderly Subjects|Effect of Weight Loss and Physical Training on Musculoskeletal Status, Physical Function, and Quality-of-Life in Physically Limited, Obese, Elderly Subjects|Completed||Phase 3|28||Washington University School of Medicine|||||f||||||||||||||2017-02-18 17:27:25.57058|2017-02-18 17:27:25.57058
NCT00146120|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-02-05|||May 1998||1998-05-01|December 2008|2008-12-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result|Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result|Completed||Phase 3|400||University of Ulm|||||f||||||||||||||2017-02-18 17:27:25.699473|2017-02-18 17:27:25.699473
NCT00146107|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-04-22|||January 2005||2005-01-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Weight Loss and Exercise in Obese, Physically Limited, Older Women and Men|Weight Loss and Exercise in Frail Obese Elderly Subjects|Completed||Phase 3|107|Actual|Washington University School of Medicine||4|||f||||t||||||||||2017-02-18 17:27:25.811669|2017-02-18 17:27:25.811669
NCT00146094|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2011-08-29|||March 2003||2003-03-01|August 2011|2011-08-01||||||||Interventional|||Bone Mineral Density (BMD) in HIV Infection|Osteopenia and Osteoporosis in HIV Infection. Prospective BMD Measurement in Antiretroviral (ARV) Treated and Untreated HIV-1 Infected Patients|Completed||N/A|||University Hospital, Strasbourg, France|||||f||||||||||||||2017-02-18 17:27:25.924431|2017-02-18 17:27:25.924431
NCT00146081|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-03-26|||August 2002||2002-08-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|SHARE||Weight Management Skills in African American Outpatients|Weight Management Skills in African American Outpatients|Completed||N/A|344||University of Pennsylvania||4|||f||||||||||||||2017-02-18 17:27:26.030925|2017-02-18 17:27:26.030925
NCT00146068|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-02-28|||September 2004||2004-09-01|February 2008|2008-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis|Phase IV Double-Blind Randomized Study to Evaluate Safety and Efficacy of Interferon Beta-1a (Avonex) Plus Simvastatin (Zocor) Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis Over a One Year Period|Completed||Phase 4|30||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 17:27:26.142359|2017-02-18 17:27:26.142359
NCT00146055|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-08-07|||March 2000||2000-03-01|August 2012|2012-08-01|October 2007|Actual|2007-10-01|November 2004|Actual|2004-11-01||Interventional|||Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood|Low-Intensity Preparative Regimen and Allogeneic Peripheral Blood Stem Cell Transplantation From Unrelated Donor in Patients With Hematologic Malignancy|Completed||Phase 2|60||University of Michigan Cancer Center|||||f||||||||||||||2017-02-18 17:27:26.237671|2017-02-18 17:27:26.237671
NCT00146042|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-10-03|||March 1999||1999-03-01|October 2012|2012-10-01|March 2005|Actual|2005-03-01|March 2004|Actual|2004-03-01||Interventional|||UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer|Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer|Completed||Phase 2|22|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:27:26.322579|2017-02-18 17:27:26.322579
NCT00146029|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-03-24||||||March 2008|2008-03-01||||||||Observational|||Companion Pharmacogenetic Study to UMCC 9900/9901||Terminated||N/A|||University of Michigan Cancer Center|||||f||||||||||||||2017-02-18 17:27:26.417359|2017-02-18 17:27:26.417359
NCT00146016|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-09-01|||February 2000||2000-02-01|September 2005|2005-09-01|January 2007||2007-01-01|||||Interventional|||Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients|Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients|Completed||Phase 3|390||UMC Utrecht|||||f||||||||||||||2017-02-18 17:27:26.498052|2017-02-18 17:27:26.498052
NCT00146003|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-08-06|||March 2005||2005-03-01|August 2008|2008-08-01|December 2007||2007-12-01|||||Interventional|||Efalizumab for Eczema|Investigator-Initiated Trial of Efalizumab for Atopic Dermatitis: A Proof of Concept Study in Adults|Completed||Phase 2|10||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-02-18 17:27:26.593628|2017-02-18 17:27:26.593628
NCT00145990|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-03-01|||September 2005||2005-09-01|March 2012|2012-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine||Completed||N/A|12||University of Florida|||||f||||||||||||||2017-02-18 17:27:26.697977|2017-02-18 17:27:26.697977
NCT00145977|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-04-14|||July 2001||2001-07-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Texture Analysis for Postmenopausal Osteoporosis|Changes in Bone Density, Radiographic Texture Analysis and Bone Turnover During Two Years of Antiresorptive Therapy for Postmenopausal Osteoporosis|Completed||N/A|36|Actual|University of Chicago||2|||f||||f||||||||No||2017-02-18 17:27:26.791829|2017-02-18 17:27:26.791829
NCT00145964|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-11-28|||August 2004||2004-08-01|August 2005|2005-08-01||||||||Observational|||Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)|Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)|Unknown status|Recruiting|N/A|500||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:27:26.922251|2017-02-18 17:27:26.922251
NCT00145951|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-03-27|||May 2006||2006-05-01|March 2014|2014-03-01|December 2011|Actual|2011-12-01|September 2007|Actual|2007-09-01||Observational|||Reducing the Risk of Developing Major Depression in Adolescents/Young Adults With Minor Depression/Depression Symptoms|Randomized Trial of a Motivational Interview Versus Brief Advice in Primary Care to Engage Mid-Late Adolescents With a Web-based Depression Prevention Intervention|Terminated||N/A|93|Actual|University of Chicago|||3|Lost funding|f||||||||||||||2017-02-18 17:27:27.002428|2017-02-18 17:27:27.002428
NCT00145938|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-10-07|||September 2003||2003-09-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Sildenafil and Pulmonary Artery Pressure|A Pilot Study of the Effect of Chronic Administration of Sildenafil on Pulmonary Artery Pressure in Patients With Portopulmonary Hypertension|Terminated||Phase 2|10||University of Chicago||||Unable to complete study|f||||||||||||||2017-02-18 17:27:27.092842|2017-02-18 17:27:27.092842
NCT00145925|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-09-16|||June 2001||2001-06-01|September 2008|2008-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes|ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation|Completed||Phase 3|11140|Actual|The George Institute||2|||f||||t||||||||||2017-02-18 17:27:27.188086|2017-02-18 17:27:27.188086
NCT00145912|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-09-04|||February 2007||2007-02-01|September 2013|2013-09-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|CATCH-IT||Primary Care Based Depression Prevention for Adolescents/Young Adults/Young Adults and Young Adults|Primary Care Based Depression Prevention for Adolescents/Young Adults/Young Adults and Young Adults|Completed||N/A|49|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 17:27:27.310394|2017-02-18 17:27:27.310394
NCT00145678|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-01-05|||June 2004||2004-06-01|January 2015|2015-01-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder|Psychodynamic Therapy for Patients With Borderline Personality Disorder and Alcohol Abuse|Completed||Phase 2|30|Actual|State University of New York - Upstate Medical University||2|||f||||f||||||||||2017-02-18 17:27:35.613922|2017-02-18 17:27:35.613922
NCT00145886|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-01-08|||February 2003||2003-02-01|January 2016|2016-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||rhPTH Therapy for Low Turnover Bone Fragility|Effect of 12 Months Treatment With rhPTH on Calcium Balance, Bone Turnover, Bone Mineral Density, and Bone Micro-architecture in Patients With Fractures Associated With Low Bone Turnover and Sclerosing Bone Disorders|Terminated||Phase 1|2|Actual|University of Chicago||1||Slow enrollment|f||||f||||||||||2017-02-18 17:27:27.411668|2017-02-18 17:27:27.411668
NCT00145873|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-10-07|||August 2003||2003-08-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Nesiritide in Chronic Heart Failure|Continuous Infusion Nesiritide in Chronic Heart Failure-University of Chicago (CINCH-UC)|Terminated||Phase 2|20||University of Chicago||||Unable to complete study|f||||||||||||||2017-02-18 17:27:27.510101|2017-02-18 17:27:27.510101
NCT00145860|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-09-04|||April 2002||2002-04-01|September 2013|2013-09-01|August 2005||2005-08-01|||||Observational|||Do Patients With Colorectal Cancer Understand That Their Family is at Risk?|Do Patients With Colorectal Cancer Understand That Their Family is at Increased Risk?|Terminated||N/A|650||University of Chicago|||||f||||||||||||||2017-02-18 17:27:30.349711|2017-02-18 17:27:30.349711
NCT00145847|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-01-07|||April 2003||2003-04-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Naltrexone Treatment of Alcohol Abuse in Schizophrenia|Naltrexone Treatment of Alcohol Abuse in Schizophrenia|Completed||Phase 4|90|Actual|State University of New York - Upstate Medical University||2|||f||||t||||||||||2017-02-18 17:27:30.438782|2017-02-18 17:27:30.438782
NCT00145834|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-09-01|||February 2004||2004-02-01|September 2005|2005-09-01|April 2005||2005-04-01|||||Interventional|||Early Breastfeeding Cessation - is It Possible to Prevent?|A Randomised Community Based Experimental Trial in the Health Visitor's Practice Field|Completed||Phase 1|1456||University of Aarhus|||||f||||||||||||||2017-02-18 17:27:30.563832|2017-02-18 17:27:30.563832
NCT00145808|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-09-04|||June 2005||2005-06-01|September 2013|2013-09-01|November 2008|Actual|2008-11-01|June 2007|Actual|2007-06-01||Interventional|||Wireless Capsule Endoscopy in Ulcerative Colitis|Prospective Controlled Assessment of Wireless Capsule Endoscopy (WCE) in Ulcerative Colitis (UC)|Completed||Phase 3|116|Anticipated|University of Chicago||1|||f||||||||||||||2017-02-18 17:27:30.662164|2017-02-18 17:27:30.662164
NCT00145795|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-08-23|2012-10-24||April 2004||2004-04-01|August 2013|2013-08-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment|Randomized Trial of a Switch to a Kaletra + Current Dual Nucleoside Reverse Transcriptase Inhibitor (NRTI) Backbone Versus Continuation of the Current Regimen in Patients With Poor Immune Responses to Highly Active Antiretroviral Therapy (HAART) in Patients With Complete Viral Suppression: A Pilot Study|Completed||Phase 4|20|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 17:27:30.758825|2017-02-18 17:27:30.758825
NCT00145782|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-09-01|||September 1991||1991-09-01|September 2005|2005-09-01|December 1999||1999-12-01|||||Interventional|||The Ebeltoft Health Promotion Project|The Ebeltoft Health Promotion Project - A Randomized Controlled Trial With Multiphasic Preventive Health Screenings and Discussions in General Practice.|Completed||Phase 3|||University of Aarhus|||||f||||||||||||||2017-02-18 17:27:31.448094|2017-02-18 17:27:31.448094
NCT00145769|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-08-07|||July 2001||2001-07-01|August 2013|2013-08-01|May 2011|Actual|2011-05-01|June 2009|Actual|2009-06-01||Interventional|||A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum|A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum|Completed||Phase 3|326|Actual|Trans-Tasman Radiation Oncology Group (TROG)||3|||f||||t||||||||||2017-02-18 17:27:34.251084|2017-02-18 17:27:34.251084
NCT00145756|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02|||May 2004||2004-05-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||China Salt Substitute Study|China Salt Substitute Study-A Randomised Trial to Determine the Long-Term Effects of a Low Sodium, High Potassium Salt Substitute on Blood Pressure Among High-Risk Individuals in Northern China|Completed||N/A|600||The George Institute|||||f||||||||||||||2017-02-18 17:27:34.401739|2017-02-18 17:27:34.401739
NCT00145743|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-11-26|||November 2004||2004-11-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer|Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer: Protocol of a Randomized Clinical Trial at the Tumor Center Regensburg|Completed||Phase 1/Phase 2|200|Actual|Tumorzentrum Regensburg e.V.||2|||f||||t||||||||||2017-02-18 17:27:34.496681|2017-02-18 17:27:34.496681
NCT00145730|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-11-28|||February 2002||2002-02-01|September 2005|2005-09-01|May 2004||2004-05-01|||||Interventional|||Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative Ibuprofen|A Multicentre Randomised Placebo-Controlled Trail of Ibuprofen for the Prevention of Ectopic Bone-Related Pain and Disability After Elective Hip Replacement Surgery (HIPAID)|Completed||Phase 4|1000||The George Institute|||||f||||||||||||||2017-02-18 17:27:34.604245|2017-02-18 17:27:34.604245
NCT00145717|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02|||April 2005||2005-04-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||China Plant Sterol Trial|China Plant Sterol Trial – A Randomised Trial to Determine the Effects on Blood Cholesterol Levels of a Milk Tea Product Enriched With Plant Sterol Among 300 Chinese Living in Beijing|Completed||Phase 3|300||The George Institute|||||f||||||||||||||2017-02-18 17:27:34.696444|2017-02-18 17:27:34.696444
NCT00145704|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-03-01|2010-10-26||June 2002||2002-06-01|March 2013|2013-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density|Treatment of Childhood Cancer Therapy-induced Osteopenia in Growth Hormone Deficient Adult Survivors: Does Bisphosphonate Treatment Improve Bone Mineral Density?|Terminated||N/A|6|Actual|State University of New York - Upstate Medical University|Early termination due to low enrollment, and lost to follow up of three subjects. Data was limited and therefore not reviewed/analyzed|2||due to low enrollment, participants are no longer being examined or treated|f||||f||||||||||2017-02-18 17:27:34.785226|2017-02-18 17:27:34.785226
NCT00145691|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-03-20|||September 2005||2005-09-01|March 2007|2007-03-01|October 2006|Actual|2006-10-01|||||Interventional|||The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)|The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD) - An Eight Week Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi Center Trial. A Phase III Study|Completed||Phase 3|100||Sykehuset Innlandet HF|||||f||||t||||||||||2017-02-18 17:27:35.523572|2017-02-18 17:27:35.523572
NCT00145665|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-09-02|||January 2005||2005-01-01|February 2007|2007-02-01|December 2012|Anticipated|2012-12-01|December 2011|Anticipated|2011-12-01||Interventional|||The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases|The Role of 3-Deoxy-3[18]Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases|Terminated||Phase 1/Phase 2|80|Anticipated|Radboud University||1||no accrual achieved|f||||||||||||||2017-02-18 17:27:35.746053|2017-02-18 17:27:35.746053
NCT00145652|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-07-27|||December 2003||2003-12-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.|Phase 3 Study of Recombinant Erythropoetin and Adjuvant I.V. Iron Therapy of Anemic Patients With Lymphoproliferative Disorders|Completed||Phase 3|66||Sundsvall Hospital|||||f||||||||||||||2017-02-18 17:27:35.854634|2017-02-18 17:27:35.854634
NCT00145639|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-06-08|||May 1999||1999-05-01|June 2011|2011-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma|Osteosarcoma 1999-A Study Of Intensive Chemotherapy Utilizing Ifosfamide, Carboplatin, and Doxorubicin for Adjuvant Chemotherapy for Treatment of Osteosarcoma|Completed||Phase 2|80|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:27:35.960473|2017-02-18 17:27:35.960473
NCT00145626|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-11-09|2015-06-08||May 2004||2004-05-01|November 2016|2016-11-01|July 2016|Actual|2016-07-01|March 2015|Actual|2015-03-01||Interventional||All evaluable participants are included.|HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies|HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies|Completed||Phase 2|40|Actual|St. Jude Children's Research Hospital|The study was limited due to the unavailability of the study drug OKT3 beginning in June 2011. The study was temporarily closed to accrual. Because OKT3 is still unavailable, the study was formally closed to accrual in March 2015.|1|||f||||f||||||||||2017-02-18 17:27:36.089629|2017-02-18 17:27:36.089629
NCT00145613|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-02-12|||June 2003||2003-06-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|July 2006|Actual|2006-07-01||Interventional|||Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies|Haploidentical Stem Cell Transplantation Utilizing T-Cell Depletion as Therapy for Patients With Refractory Hematological Malignancies|Completed||Phase 2|25|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:27:36.876266|2017-02-18 17:27:36.876266
NCT00145600|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2016-07-25|2013-02-12||March 2000||2000-03-01|July 2016|2016-07-01|October 2021|Anticipated|2021-10-01|May 2012|Actual|2012-05-01||Interventional|||Therapy for Pediatric Hodgkin Lymphoma|Risk-Adapted Therapy for Pediatric Hodgkin's Disease|Active, not recruiting||Phase 2|296|Actual|St. Jude Children's Research Hospital||4|||f||||t||||||||||2017-02-18 17:27:37.008501|2017-02-18 17:27:37.008501
NCT00145587|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-07-26|2011-06-22||July 2004||2004-07-01|January 2011|2011-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Stem Cell Transplantation for Children Affected With Osteopetrosis|Allogeneic Hematopoietic Stem Cell Transplantation for Children Affected With Malignant Osteopetrosis: A Pilot Study|Terminated||N/A|15|Actual|St. Jude Children's Research Hospital|This study closed prior to completion of enrollment due to the principal investigator having left the institution.|1||Due to the principal investigator having left the institution.|f||||f||||||||||2017-02-18 17:27:38.935746|2017-02-18 17:27:38.935746
NCT00145574|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2010-04-08|2009-11-06||November 2005||2005-11-01|April 2010|2010-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol|Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients With Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naive to Lipid-lowering Therapy|Completed||Phase 4|194|Actual|Daiichi Sankyo Inc.||3|||f||||||||||||||2017-02-18 17:27:39.415109|2017-02-18 17:27:39.415109
NCT00145561|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-10-21|||August 2005||2005-08-01|October 2008|2008-10-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-Infected Pregnant Women.|The Pharmacokinetics of SAquinavir (Invirase New Tablet Formulation) 1,000mg + Ritonavir (Norvir) 100mg q12h in HIV-Infected Pregnant Women (SARA)|Completed||Phase 1/Phase 2|40|Actual|Radboud University||1|||f||||f||||||||||2017-02-18 17:27:41.200011|2017-02-18 17:27:41.200011
NCT00145548|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-06-14|||December 2003||2003-12-01|May 2007|2007-05-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Pilot Study of the Spiration IBV™ System|Pilot Study of the Spiration IBV™ System|Completed||Phase 2|91|Actual|Spiration, Inc.||1|||f||||t||||||||||2017-02-18 17:27:41.306187|2017-02-18 17:27:41.306187
NCT00145535|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2010-01-28|||May 2004||2004-05-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||SOLX Titanium Sapphire Laser for Trabeculoplasty|SOLX Titanium Sapphire Laser for Trabeculoplasty|Completed||Phase 3|120|Anticipated|SOLX, Inc.||2|||f||||f||||||||||2017-02-18 17:27:41.416413|2017-02-18 17:27:41.416413
NCT00145522|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-03-31|||November 2005||2005-11-01|March 2009|2009-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women|A Twelve 28-Day Cycles, Multicenter, Prospective, Randomized, Open, Blinded Endpoint, Parallel Group Study Comparing the Effect on Breast and Cardiovascular Metabolic Markers of Continuously Combined 17β-Estradiol/Dydrogesterone and Tibolone in Postmenopausal Women.|Completed||Phase 4|135|Actual|Solvay Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:27:41.537139|2017-02-18 17:27:41.537139
NCT00145509|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-01-07|2010-03-26||August 2005||2005-08-01|January 2015|2015-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)|A Phase 3, Placebo-Controlled, Double-Blinded Continuation Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Completing a 12-week Lead-in Trial and Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode|Completed||Phase 3|77|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:27:41.645558|2017-02-18 17:27:41.645558
NCT00145132|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2010-06-01|||June 2005||2005-06-01|May 2010|2010-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Beta-CIT-SPECT and Neurophysiology in Depression|Serotonin and Dopamine Transporter (SERT, DAT) Availabilities as Assessed by b-CIT and SPECT, and Neurophysiological Measures of Central Serotonergic Activity in Patients With Depression Under Treatment With Escitalopram|Completed||Phase 4|30|Actual|Ludwig-Maximilians - University of Munich||1|||f||||||||||||||2017-02-18 17:27:49.370811|2017-02-18 17:27:49.370811
NCT00145496|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-09-24|2010-03-05||December 2004||2004-12-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)|A Multicenter, Double-Blind, Flexible -Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine With Olanzapine in Stable Subjects With Predominant, Persistent Negative Symptoms of Schizophrenia.|Completed||Phase 3|468|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:27:42.034298|2017-02-18 17:27:42.034298
NCT00145483|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-01-30|||June 2002||2002-06-01|January 2008|2008-01-01||||||||Interventional|||Sildenafil For Meniere's Disease|A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study Of The Efficacy and Safety Of Sildenafil Given For The Acute Treatment Of Meniere's Disease|Completed||Phase 2|180||Pfizer|||||f||||||||||||||2017-02-18 17:27:42.501848|2017-02-18 17:27:42.501848
NCT00145470|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-04-21|||June 2005||2005-06-01|April 2015|2015-04-01|March 2007|Actual|2007-03-01|February 2007|Actual|2007-02-01||Interventional|||12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008)(COMPLETED)(P05844)|A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode|Completed||Phase 3|324|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:27:42.591864|2017-02-18 17:27:42.591864
NCT00145457|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-06-05|||April 2001||2001-04-01|May 2007|2007-05-01|January 2005||2005-01-01|||||Interventional|CAREL||IGF1 Generation Test|A Multicentre Study on the Capacity of the IGF-1 Stimulation Test to Predict the Growth Promoting Effect of Standard and High Doses of Genotonorm® in Prepubertal Children With Growth Hormone Deficiency.|Completed||Phase 4|82||Pfizer|||||f||||||||||||||2017-02-18 17:27:42.69793|2017-02-18 17:27:42.69793
NCT00145444|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-12-28|||March 2003||2003-03-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study|A Multicenter, Double-Blind, Randomized Trial Of Ziprasidone (80 - 160 Mg) Versus Olanzapine (10 - 20 Mg) In Patients With Recent-Onset Schizophrenia, Schizoaffective And Schizophreniform Disorder.|Completed||Phase 3|100||Pfizer|||||f||||||||||||||2017-02-18 17:27:42.777269|2017-02-18 17:27:42.777269
NCT00145431|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2012-02-15||2012-02-15|March 2005||2005-03-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.|Phase 3, Multi-Center, Double-Blind, Randomized, Crossover Study Of The Efficacy, Safety, And Tolerability Of Fixed Combination Torcetrapib (Cp-529,414)/Atorvastatin, Compared With Atorvastatin Therapy Alone, And Fenofibrate Alone, In Subjects With Fredrickson Type III Hyperlipoproteinemia (Familial Dysbetalipoproteinemia).|Terminated||Phase 3|41|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:27:42.869761|2017-02-18 17:27:42.869761
NCT00145418|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-06-19|2011-07-20||February 2005||2005-02-01|June 2014|2014-06-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer|Phase 2 Study Evaluating the Safety and Efficacy of Eloxatin (Oxaliplatin) and Docetaxel as First-line Therapy of Stage IV or IIIB Unresectable Non-Small Cell Lung Cancer|Terminated||Phase 2|15|Actual|Oncology Specialists, S.C.|Due to lack of recruitment, the study was closed early and conclusions should not necessarily be drawn from the data presented for duration of response|1||low enrollment|f||||f||||||||||2017-02-18 17:27:43.082995|2017-02-18 17:27:43.082995
NCT00145405|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-09-06|||September 2002||2002-09-01|September 2005|2005-09-01|December 2004||2004-12-01|||||Interventional|||Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction|Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction - A Twelve Month Randomized Cross-Over Study in Patients With Acromegaly|Completed||Phase 4|12||Odense University Hospital|||||f||||||||||||||2017-02-18 17:27:43.380937|2017-02-18 17:27:43.380937
NCT00145392|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-06-23|||September 2002||2002-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|January 2007|Actual|2007-01-01||Observational|||Body Composition, Glucose Metabolism, Insulin Resistance and Gene Expression in Muscle Cells in Healthy Overweight Women|Body Composition, Glucose Metabolism, Insulin Resistance and Gene Expression in Muscle Cells in Healthy Overweight Women|Completed||Phase 4|10||Odense University Hospital|||||f||||f||||||||||2017-02-18 17:27:43.46941|2017-02-18 17:27:43.46941
NCT00145379|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-05-17|||March 2003||2003-03-01|May 2013|2013-05-01|June 2006|Actual|2006-06-01|||||Interventional|||The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus|The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus|Completed||Phase 4|42|Actual|Odense University Hospital||2|||f||||||||||||||2017-02-18 17:27:43.752206|2017-02-18 17:27:43.752206
NCT00145366|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2010-12-27|||April 2002||2002-04-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|||||Interventional|||rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter|Pretreatment With Recombinant Human Thyrotropin (rhTSH) for the Effect on Thyroid Size and Function, and for the Effect of Radioiodine Treatment in Patients With Nodular Goiter. Prospective, Randomized Double-blinded Trials.|Completed||Phase 2|110||Odense University Hospital|||||f||||||||||||||2017-02-18 17:27:43.851608|2017-02-18 17:27:43.851608
NCT00145353|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2006-10-10|||November 2004||2004-11-01|October 2006|2006-10-01|June 2006||2006-06-01|||||Interventional|||Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose|Is Insulin NovoRapid Better Than Actrapid for Treating Type 1 Diabetic Patients When Simultaneously, Daily Adjusting the Insulin Dose?|Unknown status|Active, not recruiting|Phase 4|16||Odense University Hospital|||||f||||||||||||||2017-02-18 17:27:43.944577|2017-02-18 17:27:43.944577
NCT00145340|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-09-25|||September 2002||2002-09-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Pioglitazone Treatment in Polycystic Ovary Syndrome|The Effect of PPARgamma Stimulation on Glucose Metabolism, Insulin Resistance, Growth Hormone and Cortisol on Women Suffering From Polycystic Ovary Syndrome|Completed||Phase 4|30||Odense University Hospital|||||f||||t||||||||||2017-02-18 17:27:44.030964|2017-02-18 17:27:44.030964
NCT00145327|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-06-24|2011-01-21||May 2005||2005-05-01|June 2011|2011-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)|A 3-year, Double-blind Extension to CZOL446H2301 to Evaluate the Long-term Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D|Completed||Phase 3|2456|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:27:44.14864|2017-02-18 17:27:44.14864
NCT00145314|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2011-01-13|||May 2005||2005-05-01|January 2011|2011-01-01|August 2010|Actual|2010-08-01|May 2009|Actual|2009-05-01||Interventional|||FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer|5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin) (FLOX Regimen), Given Continuously or Intermittently, in Combination With Cetuximab (Erbitux), in First-line Treatment of Metastatic Colorectal Cancer. A Phase III Multicenter Trial.|Completed||Phase 3|571|Actual|The Nordic Colorectal Cancer Biomodulation Group||3|||f||||||||||||||2017-02-18 17:27:46.540988|2017-02-18 17:27:46.540988
NCT00145301|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-05-18|||September 2004||2004-09-01|May 2012|2012-05-01||||November 2005|Actual|2005-11-01||Interventional|||52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine|A 52-week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability and Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid and Celecoxib 200 mg od in Patients With Primary Osteoarthritis of Hip, Knee, Hand or Spine|Completed||Phase 3|3036||Novartis|||||||||||||||||||2017-02-18 17:27:46.737891|2017-02-18 17:27:46.737891
NCT00145288|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-03-23|||October 2003||2003-10-01|March 2007|2007-03-01|March 2005||2005-03-01|||||Observational|||Prospective Study of Patients With Hirsutism|Prospective Study of Patients Med Hirsutism as Primary Work Diagnose|Unknown status|Active, not recruiting|Phase 2/Phase 3|340||Odense University Hospital|||||f||||f||||||||||2017-02-18 17:27:46.822105|2017-02-18 17:27:46.822105
NCT00145275|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-04-26|||December 2004||2004-12-01|April 2012|2012-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women|To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women|Completed||Phase 3|455||Novartis|||||||||||||||||||2017-02-18 17:27:46.914476|2017-02-18 17:27:46.914476
NCT00145262|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-12-29|||August 2003||2003-08-01|August 2003|2003-08-01||||||||Observational|||TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation|Therapeutic Angiogenesis Using Cell Transplantation (TACT) Study at Nagoya|Unknown status|Recruiting|Phase 2|||Nagoya University|||||f||||||||||||||2017-02-18 17:27:47.013663|2017-02-18 17:27:47.013663
NCT00145249|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-05-10|2010-03-18||May 2005||2005-05-01|October 2009|2009-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis|A Phase II Randomized Trial of Amphotericin B Alone or Combined With Fluconazole in the Treatment of AIDS-Associated Cryptococcal Meningitis|Completed||Phase 2|143|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 17:27:47.294688|2017-02-18 17:27:47.294688
NCT00145236|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-09-12|||November 2001||2001-11-01|September 2005|2005-09-01|August 2003||2003-08-01|||||Interventional|||Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension|A Double-Blind, Multicenter, Randomized, Placebo-Controlled, Parallel Group Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension.|Completed||Phase 3|300||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:27:48.591592|2017-02-18 17:27:48.591592
NCT00145223|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2010-08-26|||August 2003||2003-08-01|March 2007|2007-03-01|July 2005||2005-07-01|||||Observational|||Research for Elim of Filariasis|Research for Elimination of Human Filariasis|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:27:48.695715|2017-02-18 17:27:48.695715
NCT00145210|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-03-06|||April 2005||2005-04-01|September 2005|2005-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans|A Double-Blind, Randomized, Placebo- and Active-Controlled, Forced Titration Study Evaluating the Effects of Nebivolol on Blood Pressure and Heart Rate in African American Patients With Hypertension|Completed||Phase 3|630|Anticipated|Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:27:48.778388|2017-02-18 17:27:48.778388
NCT00145197|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-12-02|||January 2004||2004-01-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities|Improving the Delivery of Effective Care to Minorities|Completed||N/A|1164|Actual|Icahn School of Medicine at Mount Sinai||1|||f||||f||||||||||2017-02-18 17:27:48.864297|2017-02-18 17:27:48.864297
NCT00145184|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-03-28|||May 2005||2005-05-01|March 2015|2015-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis|Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis|Terminated||Phase 3|40|Actual|Harvard School of Public Health||2||Slow recruitment|f||||t||||||||||2017-02-18 17:27:48.962504|2017-02-18 17:27:48.962504
NCT00145171|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02|||February 2001||2001-02-01|November 2002|2002-11-01|August 2002||2002-08-01|||||Interventional|||A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.|Study of Orthostatic Changes Upon Apomorphine Dose Initiation in Late Stage Parkinson’s Disease Patients. A Dose Escalation Study With a Double-Blind Placebo-Controlled Efficacy Determination at 4 Mg.|Completed||Phase 3|56||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:27:49.065396|2017-02-18 17:27:49.065396
NCT00145158|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-06-19|||January 2005||2005-01-01|June 2009|2009-06-01|December 2009|Anticipated|2009-12-01|March 2009|Anticipated|2009-03-01||Interventional|||Immunization With 8 Peptides Mixed With Adjuvant Montanide ISA 51 in HLA-A2 Patients With Metastatic Cutaneous Melanoma|Phase I/II Study of Immunization With Multiple Peptides Mixed With the Immunological Montanide ISA 51 in HLA-A2 Patients With Metastatic Cutaneous Melanoma|Suspended||Phase 1/Phase 2|28|Anticipated|Ludwig Institute for Cancer Research||||Availability of Investigational agent|f||||||||||||||2017-02-18 17:27:49.154106|2017-02-18 17:27:49.154106
NCT00145145|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-08-21|||January 2005||2005-01-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma|Phase I/II Study of Immunization With the MAGE-3.A1 Peptide Mixed With the Immunological Adjuvant CpG 7909 in Patients With Metastatic Melanoma|Terminated||Phase 1/Phase 2|14|Anticipated|Ludwig Institute for Cancer Research||||Poor Accrual|f||||||||||||||2017-02-18 17:27:49.258051|2017-02-18 17:27:49.258051
NCT00145119|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-11-04|2013-12-02||August 2001||2001-08-01|January 2014|2014-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational||Survivors of an acute Myocardial Infarction (AMI) with impaired left ventricular ejection fraction|CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction|Incidence and Prediction of Life-threatening Cardiac Arrhythmias in Patients With Depressed Left Ventricular Function After Acute Myocardial Infarction|Completed||N/A|312|Actual|Medtronic Bakken Research Center|||||f||||||||||||||2017-02-18 17:27:49.474192|2017-02-18 17:27:49.474192
NCT00145106|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-12-14|||March 2002||2002-03-01|September 2005|2005-09-01|August 2002||2002-08-01|||||Interventional|||Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris|Regimen of Tazorac .1% Gel & Minocycline Cap in Tx of Individuals w/Acne Vulgaris: Effects of Maintenance Therapy on Duration of Improvement of Tazorac .1% Gel Used in Conjunction w/Placebo Cap Compared w/Minocycline Cap Used in Conjunction w/Either Tazorac .1% Gel or Vehicle Gel|Completed||Phase 4|189||KGL, Inc.|||||f||||||||||||||2017-02-18 17:27:49.694192|2017-02-18 17:27:49.694192
NCT00145093|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-11-21|||August 2004||2004-08-01|September 2005|2005-09-01|February 2005||2005-02-01|||||Interventional|||Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus|The Effects of Organic Chromium Supplementation on Clinical Parameters of the Metabolic Syndrome, in Patients With Type 2 Diabetes Mellitus. A Randomised, Double-Blind, Placebo-Controlled Trial|Completed||Phase 3|60||Medical Research Foundation, The Netherlands|||||f||||||||||||||2017-02-18 17:27:49.868388|2017-02-18 17:27:49.868388
NCT00145080|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-10-30|||July 2004||2004-07-01|October 2015|2015-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Comparison of Osteoporosis Disease Management Strategies (0000-039)|Evaluation of Strategies for Increasing Osteoporosis Screening and Treatment in a Managed Care Organization|Completed||N/A|4685|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:27:49.982523|2017-02-18 17:27:49.982523
NCT00145067|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-11-02|||November 2003||2003-11-01|November 2015|2015-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Osteoporosis Disease Management Demonstration Project (0000-040)|Three Methods of Delivering Health Care for Secondary Prevention of Osteoporosis|Completed||N/A|230|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:27:50.057058|2017-02-18 17:27:50.057058
NCT00145054|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-03-23||||||September 2005|2005-09-01||||||||Interventional|||Study of a Self-Help Depression Skills Program for College-Aged Youth|Randomized, Controlled Pilot Study of a Self-Help Depression Skills Program for College-Aged Youth|Completed||Phase 2/Phase 3|150||Kaiser Permanente|||||f||||||||||||||2017-02-18 17:27:50.124898|2017-02-18 17:27:50.124898
NCT00145041|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-03-27|2011-11-29||February 2005||2005-02-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|September 2007|Actual|2007-09-01||Interventional|||Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction|An Evaluation of the Pharmacokinetic Profile of VSLI (Vincristine Sulfate Liposome Injection, 0.16 mg/mL) in Patients With Malignant Melanoma and Hepatic Dysfunction Secondary to Metastases|Completed||Phase 1|7|Actual|Spectrum Pharmaceuticals, Inc|The dose administered to subjects with impaired liver function was ~1 mg/m2 which is lower than is administered to subjects with normal liver function (2 mg/m2). The impact of liver impairment on that higher dose remains unknown.|1|||f||||f||||||||||2017-02-18 17:27:50.209417|2017-02-18 17:27:50.209417
NCT00145028|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-03-17|||May 2005||2005-05-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|December 2007|Actual|2007-12-01||Interventional|||Determination of Carboplatin's Optimal Plasmatic Exposure|Determination of Carboplatin's Optimal Plasmatic Exposure|Completed||N/A|400|Anticipated|Institut Claudius Regaud|||||f||||f||||||||||2017-02-18 17:27:50.524216|2017-02-18 17:27:50.524216
NCT00145015|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-07-29|||December 2004||2004-12-01|July 2008|2008-07-01|April 2008|Actual|2008-04-01|||||Interventional|||FishGastro Study: Fish Consumption and Gastro-Intestinal Health|Fish Consumption and Gastro-Intestinal Health With Special Emphasis on Reduction of Risk of Colon Cancer and Inflammatory Bowel Disease|Completed||N/A|270|Anticipated|Institute of Food Research|||||f||||||||||||||2017-02-18 17:27:50.626352|2017-02-18 17:27:50.626352
NCT00145002|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-09-20|||August 1998||1998-08-01|September 2016|2016-09-01|December 2004||2004-12-01|||||Interventional|||A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)|Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-cell Leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.|Completed||Phase 3|130||Japan Clinical Oncology Group|||||f||||||||||||||2017-02-18 17:27:50.722041|2017-02-18 17:27:50.722041
NCT00144989|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-09-20|||September 2002||2002-09-01|September 2016|2016-09-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC|A Phase III Study Comparing Etoposide and Cisplatin (EP) With Irinotecan and Cisplatin (IP) Following EP Plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for Limited-Stage Small-Cell Lung Cancer : JCOG0202-MF|Completed||Phase 3|281|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:27:50.827858|2017-02-18 17:27:50.827858
NCT00144976|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-03-26|||October 2003||2003-10-01|May 2008|2008-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma|Pilot Study, Without Direct Individual Benefice, of Biological Effect of Tarceva (OSI-774) at Posology of 150 mg by Day for Patients Stricken by ENT Epidermoid Carcinoma Waiting for First Surgical Picking up.|Completed||N/A|43|Actual|Institut Claudius Regaud||1|||f||||t||||||||||2017-02-18 17:27:50.978028|2017-02-18 17:27:50.978028
NCT00144963|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-03-27|2012-05-11||July 2002||2002-07-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|Phase I-II Study of Liposomal Vincristine (VSLI) and Dexamethasone in Relapsed or Refractory Acute Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|36|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-02-18 17:27:53.924142|2017-02-18 17:27:53.924142
NCT00144950|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02||||||September 2005|2005-09-01||||||||Interventional|||Urokinase Versus Primary Video-Assisted Thorascopic Surgery for Empyema||Completed||Phase 1|60||Institute of Child Health|||||f||||||||||||||2017-02-18 17:27:54.277517|2017-02-18 17:27:54.277517
NCT00144937|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-09-01|||March 2003||2003-03-01|September 2005|2005-09-01|August 2005||2005-08-01|||||Interventional|||Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease|A Randomized Controlled Trial Comparing Usual Care With a Multifactorial Intensified Intervention on Cardiovascular Risk Factors in Subjects With Arterial Peripheral Disease With and Without Diabetes. The Taulí Intervention Program (TIP).|Unknown status|Active, not recruiting|Phase 4|120||Hospital de Sabadell|||||f||||||||||||||2017-02-18 17:27:54.353233|2017-02-18 17:27:54.353233
NCT00144911|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-10-26|||October 2004||2004-10-01|October 2016|2016-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.|A Randomized, Double-Blind, Parallel Group, 52-Week Study to Compare the Effect of Fluticasone Propionate/Salmeterol DISKUS® Inhaler Combination Product 250/50mcg Twice Daily With Salmeterol DISKUS® Inhaler 50mcg Twice Daily on the Annual Rate of Moderate/Severe Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 4|740|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:27:54.533427|2017-02-18 17:27:54.533427
NCT00144898|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-07-26|||July 2003||2003-07-01|July 2013|2013-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer|A Randomized, Phase III Clinical Trial GF-GS 01 to Compare Conventional Axillary Dissection Versus Sentinel Node Resection (GS) in Clinically Node-negative Operable Breast Cancer Unifocal N0 Patients|Completed||Phase 3|1627|Actual|Hospices Civils de Lyon||2|||f||||f||||||||||2017-02-18 17:27:55.026003|2017-02-18 17:27:55.026003
NCT00144885|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-02-11|||June 2005||2005-06-01|September 2005|2005-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|IMAGE||IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis|Resonance Magnetic Imaging at the Acute Phase of Endocarditis: Diagnostic and Therapeutic Impact|Completed||N/A|150|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 17:27:55.121743|2017-02-18 17:27:55.121743
NCT00144872|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2017-01-16|||November 2004||2004-11-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|||||Interventional|||LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures|An Open-label Evaluation of LAMICTAL (Lamotrigine) Monotherapy for the Treatment of Newly-diagnosed Typical Absence Seizures in Children and Adolescents|Completed||Phase 1|50||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:27:55.224308|2017-02-18 17:27:55.224308
NCT00144859|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-05-31|||July 2005||2005-07-01|March 2011|2011-03-01||||||||Interventional|||Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)|A 28-day, Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Anti-inflammatory Effect and Steady-state Pharmacokinetics of SB-681323 7.5 mg Per Day in Patients With Chronic Obstructive Pulmonary Disease.|Completed||Phase 2|82||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:27:55.340457|2017-02-18 17:27:55.340457
NCT00144846|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-09-22|||September 2004||2004-09-01|September 2016|2016-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children|A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease|Completed||Phase 3|80|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:27:55.446379|2017-02-18 17:27:55.446379
NCT00144833|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-11-09|||March 2005||2005-03-01|November 2007|2007-11-01||||||||Interventional|||Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects|A Phase III, Randomized, Controlled, Open-Label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-Boosted HIV-1 Protease Inhibitor Regimen of Fosamprenavir/Lopinavir/Ritonavir 1400mg/533mg/133mg Twice Daily and an Increased Dosage Regimen of FPV/RTV 1400mg/100mg BID Versus the Standard Dosage Regimen of FPV/RTV 700mg/100mg BID for 24 Weeks in Multiple-PI Experienced, HIV-Infected Adults Experiencing Virological Failure|Terminated||Phase 3|150|Anticipated|GlaxoSmithKline||1||Incomplete data|f||||t||||||||||2017-02-18 17:27:55.578146|2017-02-18 17:27:55.578146
NCT00144820|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02|||May 1999||1999-05-01|August 2005|2005-08-01|November 2001||2001-11-01|||||Interventional|||Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee Osteoarthritis|Intra-Articular Injections of Hyaluronan Versus 20 Ml NaCl Versus Placebo in Treatment of Knee Osteoarthritis: a Randomised, Double-Blind, Placebo Controlled Single Centre Trial.|Unknown status|Active, not recruiting|Phase 4|251||Glostrup University Hospital, Copenhagen|||||f||||||||||||||2017-02-18 17:27:55.699944|2017-02-18 17:27:55.699944
NCT00144807|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-09-01|||December 2003||2003-12-01|September 2015|2015-09-01|April 2012|Actual|2012-04-01|September 2008|Actual|2008-09-01||Interventional|||ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma|Study of ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 59 Years With High Risk Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 2-3)|Completed||Phase 2|128|Actual|Lymphoma Study Association||1|||f||||t||||||||||2017-02-18 17:27:56.035476|2017-02-18 17:27:56.035476
NCT00144794|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2017-02-13|||November 2003||2003-11-01|February 2017|2017-02-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Observational|||Mucopolysaccharidosis I (MPS I) Registry|Mucopolysaccharidosis I (MPS I) Registry|Recruiting||N/A|1500|Anticipated|Sanofi|||1||f||||f||||||||||2017-02-18 17:27:56.174439|2017-02-18 17:27:56.174439
NCT00144781|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-03-17|2009-03-27||December 2004||2004-12-01|March 2015|2015-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease|A Multicenter, Multinational, Randomized, Dose-Optimization Study of the Safety and Pharmacodynamic Response of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I|Completed||Phase 4|34|Actual|Sanofi|This study is limited by its small sample size and ability to detect small differences in urinary GAG levels between groups.|4|||f||||||||||||||2017-02-18 17:27:56.347517|2017-02-18 17:27:56.347517
NCT00144768|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-05-02|||July 2004||2004-07-01|April 2013|2013-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients|A Multicenter, Multinational, Open-Label Study of Anti-Laronidase Antibody Formation and Urinary GAG Levels in Patients With Mucopolysaccharidosis I (MPS I) Being Treated With Aldurazyme® (Laronidase).|Completed||Phase 4|25|Anticipated|Sanofi||1|||f||||f||||||||||2017-02-18 17:27:57.414843|2017-02-18 17:27:57.414843
NCT00144755|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2015-09-01|||December 2003||2003-12-01|September 2015|2015-09-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma|Intensified CHOP Plus Rituximab (R-CHOP 14) Versus CHOP Plus Rituximab (R-CHOP 21) and Frontline/Prophylactic Darbepoetin Alfa Treatment Versus Usual Symptomatic Treatment of Anemia in Patients Aged 60 to 80 Years With Diffuse Large B-cell Lymphoma.|Completed||Phase 3|600|Actual|Lymphoma Study Association||4|||f||||t||||||||||2017-02-18 17:27:57.511182|2017-02-18 17:27:57.511182
NCT00144729|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-04-28|||May 1993||1993-05-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|||||Interventional|||Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor|Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor|Completed||Phase 1/Phase 2|85||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:27:57.634783|2017-02-18 17:27:57.634783
NCT00144716|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2017-01-11|||June 2003||2003-06-01|January 2017|2017-01-01|October 2003||2003-10-01|||||Interventional|||Evaluation of Combined Use of ITN's and Insect Repellents Against Malaria|Clinical Evaluation of Combined Use of ITN's and Plant-based Insect Repellent Against Malaria in the Amazon|Completed||Phase 3|4250||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:27:57.714389|2017-02-18 17:27:57.714389
NCT00144703|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-01-24|||July 2002||2002-07-01|January 2009|2009-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation|Open Label Phase II Trial of Sirolimus in Combination With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|55||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:27:57.797568|2017-02-18 17:27:57.797568
NCT00144690|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-11-02|||March 2005||2005-03-01|November 2015|2015-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures|A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures|Completed||Phase 2|||Eisai Inc.|||||f||||||||||||||2017-02-18 17:27:57.906506|2017-02-18 17:27:57.906506
NCT00144677|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-01-24|||November 2003||2003-11-01|March 2009|2009-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation|Open Label Phase II Trial of Sirolimus in Combination With Tacrolimus for Graft-vs-Host Disease Prophylaxis After HLA-Matched, Unrelated, Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:27:58.002|2017-02-18 17:27:58.002
NCT00144664|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-07-29|||November 2004||2004-11-01|July 2008|2008-07-01|October 2005|Actual|2005-10-01|April 2005|Actual|2005-04-01||Interventional|||Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)|An Open-Label, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With pJIA|Completed||Phase 3|19|Actual|Chugai Pharmaceutical||1|||f||||f||||||||||2017-02-18 17:27:58.11399|2017-02-18 17:27:58.11399
NCT00144651|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-08-06|||August 2001||2001-08-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Study of MRA in Patients With Rheumatoid Arthritis (RA)|An Open-label, Extension, Phase II Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Were Participated in Study MRA009JP|Completed||Phase 2|135|Actual|Chugai Pharmaceutical||1|||f||||f||||||||||2017-02-18 17:27:58.198356|2017-02-18 17:27:58.198356
NCT00144638|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-09-01|||January 2002||2002-01-01|February 2005|2005-02-01|January 2003||2003-01-01|||||Observational|||Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality|Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality|Completed||N/A|450||Danish Procalcitonin Study Group|||||f||||||||||||||2017-02-18 17:27:58.528204|2017-02-18 17:27:58.528204
NCT00144625|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-12-21|||February 2005||2005-02-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|July 2005|Actual|2005-07-01||Interventional|||Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety, Efficacy and PK of MRA in Patients With pJIA Who Participated in Study MRA318JP|Completed||Phase 3|19|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-02-18 17:27:58.603073|2017-02-18 17:27:58.603073
NCT00144612|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-12-21|||July 2004||2004-07-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|June 2005|Actual|2005-06-01||Interventional|||Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With sJIA Who Participated in Studies MRA011JP or MRA316JP|Completed||Phase 3|60|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-02-18 17:27:58.687293|2017-02-18 17:27:58.687293
NCT00144599|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-07-29|||May 2004||2004-05-01|July 2008|2008-07-01|October 2005|Actual|2005-10-01|||||Interventional|||Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)|A Double-Blind, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With sJIA|Completed||Phase 3|56|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 17:27:58.77127|2017-02-18 17:27:58.77127
NCT00144586|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-08-06|||March 2005||2005-03-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Participated in Study MRA220JP or MRA221JP|Completed||Phase 3|42|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-02-18 17:27:58.856599|2017-02-18 17:27:58.856599
NCT00144573|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-12-11|||January 2005||2005-01-01|December 2008|2008-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment|An Open-Label, Clinical Pharmacology Study to Evaluate the Safety and PK of MRA in Patients With RA With Renal Impairment|Completed||N/A|14|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-02-18 17:27:58.941752|2017-02-18 17:27:58.941752
NCT00144560|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2008-12-11|||February 2005||2005-02-01|December 2008|2008-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)|An Open-Label, Clinical Pharmacology Study to Investigate Drug-Drug Interaction in Patients With RA|Completed||N/A|31|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-02-18 17:27:59.017816|2017-02-18 17:27:59.017816
NCT00144547|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-08-06|||April 2004||2004-04-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Participated in Study MRA012JP|Completed||Phase 3|241|Actual|Chugai Pharmaceutical||1|||f||||f||||||||||2017-02-18 17:27:59.095594|2017-02-18 17:27:59.095594
NCT00144534|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-12-21|||June 2004||2004-06-01|December 2009|2009-12-01|June 2009|Actual|2009-06-01|August 2005|Actual|2005-08-01||Interventional|||Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP|An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Participated in Study MRA213JP|Completed||Phase 3|115|Actual|Chugai Pharmaceutical||1|||f||||||||||||||2017-02-18 17:27:59.177214|2017-02-18 17:27:59.177214
NCT00144521|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-01-30|||February 2004||2004-02-01|January 2009|2009-01-01|April 2006|Actual|2006-04-01|August 2004|Actual|2004-08-01||Interventional|||Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)|A Double-Blind, Phase III Study to Evaluate the Efficacy and Safety of MRA in Patients With RA|Completed||Phase 3|127|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 17:27:59.269199|2017-02-18 17:27:59.269199
NCT00144508|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-01-30|||March 2003||2003-03-01|January 2009|2009-01-01|February 2006|Actual|2006-02-01|May 2004|Actual|2004-05-01||Interventional|||Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)|An Open-Label, Phase III Study to Evaluate the Efficacy and Safety of MRA in Patients With RA|Completed||Phase 3|306|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 17:27:59.364179|2017-02-18 17:27:59.364179
NCT00144495|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-01-29|||February 2004||2004-02-01|January 2009|2009-01-01|May 2005|Actual|2005-05-01|November 2004|Actual|2004-11-01||Interventional|||A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy|A Multicenter, Open-Label Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy|Completed||Phase 3|104|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 17:27:59.46329|2017-02-18 17:27:59.46329
NCT00144482|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-01-29|||December 2003||2003-12-01|January 2009|2009-01-01|August 2005|Actual|2005-08-01|March 2005|Actual|2005-03-01||Interventional|||A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy|A Randomized, Double-Blind Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy|Completed||Phase 3|122|Actual|Chugai Pharmaceutical||2|||f||||f||||||||||2017-02-18 17:27:59.550389|2017-02-18 17:27:59.550389
NCT00144469|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2009-01-29|||May 2002||2002-05-01|January 2009|2009-01-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C|A Phase III Study of Ro25-8310 (Peginterferon Alfa-2a) in Combination With Ro20-9963 (Ribavirin) in Patients With Chronic Hepatitis C|Completed||Phase 3|300|Actual|Chugai Pharmaceutical|||||f||||f||||||||||2017-02-18 17:27:59.642701|2017-02-18 17:27:59.642701
NCT00144456|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-08-06|||September 2004||2004-09-01|August 2013|2013-08-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||A New Active Vitamin D, ED-71 for Osteoporosis|A Prospective, Randomized, Double-blind Study to Compare the Effect of ED-71 With That of Alfacalcidol on Fracture Incidence in Osteoporotic Patients|Completed||Phase 3|1056|Actual|Chugai Pharmaceutical||2|||f||||||||||||||2017-02-18 17:27:59.734639|2017-02-18 17:27:59.734639
NCT00144443|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-12-08|||March 2003||2003-03-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Kansas City Community Environmental Remediation And Training (KC CERT)|Kansas City Community Environmental Remediation And Training (KC CERT)|Unknown status|Active, not recruiting|N/A|200||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 17:27:59.820294|2017-02-18 17:27:59.820294
NCT00144430|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-02-02|||January 2004||2004-01-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children|A Phase II Study of Pentostatin For the Treatment of High Risk or Refractory Chronic GVHD in Children|Completed||Phase 2|60|Anticipated|Ann & Robert H Lurie Children's Hospital of Chicago||1|||f||||t||||||||||2017-02-18 17:27:59.919529|2017-02-18 17:27:59.919529
NCT00144417|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-08-02|||February 2006||2006-02-01|June 2011|2011-06-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment|TBTC Study 28: Evaluation of a Moxifloxacin-based, Isoniazid-sparing Regimen for Tuberculosis Treatment|Completed||Phase 2|433|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 17:28:00.085866|2017-02-18 17:28:00.085866
NCT00144404|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-02-23|||August 2002||2002-08-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism|Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism|Unknown status|Recruiting|Phase 4|50|Anticipated|Charles Drew University of Medicine and Science||1|||f||||t||||||||||2017-02-18 17:28:00.243867|2017-02-18 17:28:00.243867
NCT00144391|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-02-23|||July 2003||2003-07-01|February 2009|2009-02-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Testosterone Gel Applied to Women With Pituitary Gland Problems|Physiologic Testosterone Replacement in Women With Hypopituitarism|Unknown status|Recruiting|Phase 4|160|Anticipated|Charles Drew University of Medicine and Science||1|||f||||t||||||||||2017-02-18 17:28:00.360449|2017-02-18 17:28:00.360449
NCT00144378|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-04-17|||October 2002||2002-10-01|April 2007|2007-04-01||||||||Interventional|||Irinotecan Versus Only Best Supportive Care for Gastric Cancer|Randomized Phase III Study With Irinotecan+Best Supportive Care Versus Only Best Supportive Care as Second Line Therapy for Metastatic Gastric Cancer|Completed||Phase 3|44||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:28:00.467945|2017-02-18 17:28:00.467945
NCT00144365|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2012-09-10|||February 2005||2005-02-01|September 2012|2012-09-01|December 2010|Actual|2010-12-01|December 2008|Actual|2008-12-01||Interventional|||Comparison of Facility and Home-based ART Delivery Systems in Uganda|Comparison of Facility and Home-based ART Delivery Systems in Uganda|Completed||Phase 3|1453|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:28:00.568356|2017-02-18 17:28:00.568356
NCT00144352|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02|||September 2002||2002-09-01|September 2005|2005-09-01|July 2004||2004-07-01|||||Interventional|||In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults|The in-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Individuals-a 28 Day Efficacy Trial Involving HIV+ and HIV- Adults.|Completed||Phase 4|540||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:28:00.660243|2017-02-18 17:28:00.660243
NCT00144339|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-05-15|2009-02-21||December 2002||2002-12-01|April 2014|2014-04-01||||February 2008|Actual|2008-02-01||Interventional|||Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients|A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function With Tiotropium 18 mcg Inhalation Capsule Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|5993|Actual|Boehringer Ingelheim|Tio patients had significantly longer drug exposure,thus had increased chance of AE.Simple frequencies are biased for AE comparisons;exposure-adjusted incidence rates (IR) should be used. IR for serious AE(>1% patients) are in Outcome Measures.||||f||||||||||||||2017-02-18 17:28:00.927564|2017-02-18 17:28:00.927564
NCT00144326|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-10-31|||July 2003||2003-07-01|October 2013|2013-10-01|October 2005||2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)|A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect, of Tiotropium Inhalation Capsules on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD).|Completed||Phase 3|250|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:10.515574|2017-02-18 17:28:10.515574
NCT00144313|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2007-09-20|||August 2005||2005-08-01|September 2007|2007-09-01|January 2006|Actual|2006-01-01|||||Interventional|||VaxTeen Hepatitis B Vaccine Booster Study|Persistence of Antibody and Response to Booster of a Recombinant Hepatitis B Vaccine in Children Who Responded to a Primary Course of 2.5µg Recombinant Hepatitis B Vaccine as Infants|Completed||Phase 4|60|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:28:10.637395|2017-02-18 17:28:10.637395
NCT00144300|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-02-17|2011-09-16||January 2005||2005-01-01|February 2014|2014-02-01||||September 2010|Actual|2010-09-01||Interventional|||Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients|A Two Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson's Disease Patients|Completed||Phase 4|246|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 17:28:10.742921|2017-02-18 17:28:10.742921
NCT00144287|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-11-04|||May 2004||2004-05-01|November 2013|2013-11-01|April 2006||2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options|An Open Label Safety Study of Tipranavir Co-Administered With Low-Dose Ritonavir (TVP/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options|Completed||Phase 3|255|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:12.277328|2017-02-18 17:28:12.277328
NCT00144274|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-10-28|||April 2005||2005-04-01|October 2013|2013-10-01|November 2005||2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis|Efficacy and Tolerability of Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis - A Randomised, Double-blind, Placebo-controlled Parallel Group Study. AMBROSIA: Ambroxol Lozenges In Sore Throat In Adolescents|Completed||Phase 3|220||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:12.605566|2017-02-18 17:28:12.605566
NCT00144261|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-11-04|||November 2003||2003-11-01|November 2013|2013-11-01||||December 2006|Actual|2006-12-01||Interventional|||An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects|An Open-label, Non-randomized, Single-arm Study, to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma High Density Lipoproteins Concentration in HIV+ Subjects Treated With VIRAMUNE® Tablets|Completed||Phase 4|15|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:12.708664|2017-02-18 17:28:12.708664
NCT00144248|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-11-04|||May 2004||2004-05-01|November 2013|2013-11-01||||June 2006|Actual|2006-06-01||Interventional|||A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions|A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function|Completed||Phase 4|51|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:28:12.813217|2017-02-18 17:28:12.813217
NCT00144235|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-10-30|||March 2005||2005-03-01|October 2013|2013-10-01|July 2005||2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue|A 28 Day, Randomised, Double-blind, Placebo-controlled, Single-centre Trial to Evaluate the Efficacy and Safety of Pharmaton® PHL 00749 Film Coated Tablets (G115 40 mg, Multivitamin, Multimineral + Guarana 75 mg) 1/Day p.o. in Improving Mental Performance and to Decrease Fatigue in Healthy Male and Female Subjects in Regular Employment.|Completed||Phase 3|412||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:12.910774|2017-02-18 17:28:12.910774
NCT00144222|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-11-04|||January 2005||2005-01-01|November 2013|2013-11-01|August 2005||2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy|A Randomized, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 40 mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 40 mg|Completed||Phase 3|218|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:12.996435|2017-02-18 17:28:12.996435
NCT00144209|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-10-31|||February 2003||2003-02-01|October 2013|2013-10-01|February 2005||2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome|Swiss Restless Legs Syndrome Trial (SRLS) A Double-blind, Randomised, Crossover Trial Investigating the Efficacy and Safety of the Dopamine Agonist Pramipexole (Sifrol®, 0.25-0.75 mg Per Day) Versus Levodopa / Benserazide (Madopar® DR, 125-375 mg Per Day) in Patients With Restless Legs Syndrome|Completed||Phase 3|58|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:13.084955|2017-02-18 17:28:13.084955
NCT00144196|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-07-22|||March 2004||2004-03-01|July 2014|2014-07-01|July 2005||2005-07-01|July 2005|Actual|2005-07-01||Interventional|||12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)|A 12-week Double-blind, Randomised, Parallel-group, Multi-centre Study Evaluating the Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD, According to Swedish Guidelines (SPIRIMILD)|Completed||Phase 4|224||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:13.178508|2017-02-18 17:28:13.178508
NCT00144183|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-11-01|||January 2003||2003-01-01|November 2013|2013-11-01|January 2007||2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)|An Open-label Study Evaluating the Resistance Profile of Single Dose Nevirapine(NVP) When Combined With a 4 or 7 Day Course of Combivir® (ZDV/3TC) Compared to Single Dose Nevirapine for the Prevention of Mother to Child Transmission (pMTCT) of HIV - Treatment Options Preservation Study (T.O.P.S.)|Completed||Phase 3|407||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:13.29919|2017-02-18 17:28:13.29919
NCT00144170|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2014-06-23|2009-09-11||February 2003||2003-02-01|April 2014|2014-04-01||||October 2008|Actual|2008-10-01||Interventional|||Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)|Randomized, Open-label, Comparative Safety and Efficacy Study of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) Versus Genotypically-defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-experienced Patients (RESIST 2: Randomized Evaluation of Strategic Intervention in Multi-Drug Resistant Patients With Tipranavir)|Completed||Phase 3|882|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 17:28:13.430003|2017-02-18 17:28:13.430003
NCT00144157|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-11-13|||June 2003||2003-06-01|November 2013|2013-11-01|July 2006||2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV|An Open-Label Study of Nevirapine Plus Combivir® (ZDV+3TC) Treatment in Women Who Have Previously Received a Nevirapine Regimen for the Prevention of Mother to Child Transmission (pMTCT) of HIV-1.|Completed||Phase 4|53|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:28:16.713377|2017-02-18 17:28:16.713377
NCT00144144|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-07-13|||September 2004||2004-09-01|July 2006|2006-07-01|September 2008||2008-09-01|||||Interventional|||A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes|A Randomized, Controlled Study on Calcium Channel Blocker Versus Angiotensin II Antagonists in the Hypertensive Patients With Type 2 Diabetes Mellitus Under the Inadequately Controlled Blood Pressure With Angiotension II Antagonists|Unknown status|Active, not recruiting|Phase 4|300||Advanced-J|||||f||||||||||||||2017-02-18 17:28:16.816023|2017-02-18 17:28:16.816023
NCT00144131|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-05-22|||August 2005||2005-08-01|May 2013|2013-05-01||||||||Interventional|||Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy|Flexibility: A Study to Assess the Impact of Once Per Cycle Correction and Maintenance Dosing of Darbepoetin Alfa in Subjects With Non-Myeloid Malignancies With Anemia Due to Chemotherapy|Completed||Phase 2|750||Amgen||1|||||||||||||||||2017-02-18 17:28:16.904275|2017-02-18 17:28:16.904275
NCT00144118|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2005-09-02|||January 2002||2002-01-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||The Effect of Isoflurane or Sevoflurane on Kidney Function|Post-Operative Creatinine Changes In Patients With Pre-Existing Renal Impairment After Low-Flow Isoflurane Or Sevoflurane: A Randomised Clinical Trial|Terminated||Phase 4|270||Austin Health|||||f||||||||||||||2017-02-18 17:28:16.99515|2017-02-18 17:28:16.99515
NCT00144105|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-02|2013-10-31|||February 2004||2004-02-01|October 2013|2013-10-01||||November 2006|Actual|2006-11-01||Interventional|||A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.|A Randomised, Open Label, Active Controlled Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir Plus 100 mg or 200 mg Ritonavir p.o. BID in Combination With Standard Background Regimen in Comparison to 400 mg Lopinavir Plus 100 mg Ritonavir p.o. BID in Combination With Standard Background Regimen in Antiretroviral Therapy Naive Patients for 48 With Extension up to 156 Weeks|Terminated||Phase 2|562|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:28:17.090945|2017-02-18 17:28:17.090945
NCT00144092|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-11-18|||May 2001||2001-05-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|||||Interventional|||HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma|High Dose Chemotherapy and Autologous or Allogeneic Blood Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma|Completed||Phase 2|60|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:28:17.44205|2017-02-18 17:28:17.44205
NCT00144079|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-05-08|||January 2000||2000-01-01|September 2005|2005-09-01|January 2010||2010-01-01|||||Interventional|||Multicenter Study Differentiated Thyroid Carcinoma|Phase 3 Trial of Adjuvant External Beam Radiotherapy for Locally Invasive Differentiated Thyroid Carcinoma|Completed||Phase 3|500||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:28:17.524273|2017-02-18 17:28:17.524273
NCT00144066|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-09-01|||January 2003||2003-01-01|September 2005|2005-09-01||||||||Interventional|||A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer|A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 3|600||West Japan Thoracic Oncology Group|||||f||||||||||||||2017-02-18 17:28:17.632952|2017-02-18 17:28:17.632952
NCT00144053|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2006-01-05|||April 2001||2001-04-01|August 2005|2005-08-01||||||||Interventional|||A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer|A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer|Completed||Phase 3|450||West Japan Thoracic Oncology Group|||||f||||||||||||||2017-02-18 17:28:17.712698|2017-02-18 17:28:17.712698
NCT00144040|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-04-06|||February 2004||2004-02-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|||||Interventional|IMPAACT||Improving Antibiotic Use in Acute Care Treatment|Improving Antibiotic Use in Acute Care Setting|Completed||N/A|1000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:28:17.798591|2017-02-18 17:28:17.798591
NCT00144027|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-04-06|2014-10-28||December 2004||2004-12-01|July 2014|2014-07-01|July 2009|Actual|2009-07-01|June 2009|Actual|2009-06-01||Interventional|AMAIS||Patient-Centered Medication Adherence Intervention for Schizophrenia|Patient-Centered Medication Adherence Intervention for Schizophrenia|Completed||N/A|75|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:28:17.934053|2017-02-18 17:28:17.934053
NCT00144014|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-05-04||2016-05-04|August 2005||2005-08-01|May 2016|2016-05-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|VASST||Safety and Efficacy Study in Acute Ischaemic Stroke|A Phase II, Multi-centre, Two-part Study to Evaluate the Safety and Efficacy of Study Drug in Acute Ischaemic Stroke.|Completed||Phase 2|49|Actual|Vernalis (R&D) Ltd||5|||f||||t||||||||Undecided||2017-02-18 17:28:18.387113|2017-02-18 17:28:18.387113
NCT00144001|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-04-06|||October 2000||2000-10-01|September 2008|2008-09-01|September 2008|Actual|2008-09-01|September 2004|Actual|2004-09-01||Observational|TIGER||Factors Associated With in Suboptimal Prescribing for Older Patients With Epilepsy|Appropriateness of Antiepileptic Drug Use for Older Veterans|Completed||N/A|9682|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:28:18.527995|2017-02-18 17:28:18.527995
NCT00143988|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-08-06|||May 2004||2004-05-01|August 2009|2009-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|SEXERRCISE||Heart Rate and Blood Pressure Response During Exercise and Sexual Activity in Normotensive and Hypertensive Volunteers|Heart Rate and Blood Pressure Response During Exercise and Sexual Activity in Normotensive and Hypertensive Volunteers|Completed||N/A|36|Actual|Rutgers, The State University of New Jersey|||4||f||||f||||||||||2017-02-18 17:28:18.639833|2017-02-18 17:28:18.639833
NCT00143975|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2010-08-11|||June 2004||2004-06-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|July 2007|Actual|2007-07-01||Interventional|||Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)|Phase II Study on Gemtuzumab Ozogamicin in Combination With All-trans-Retinoic Acid, High-dose Cytarabine and Mitoxantrone in Patients With Primary Refractory Acute Myeloid Leukemia|Completed||Phase 2|95|Actual|University of Ulm||1|||f||||||||||||||2017-02-18 17:28:18.764584|2017-02-18 17:28:18.764584
NCT00143962|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-08-15|||July 2004||2004-07-01|August 2016|2016-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Comparison of Two Approaches to Weight Loss Follow-Up Study|Comparison of Two Approaches to Weight Loss Follow-Up Study|Completed||Phase 4|6|Actual|University of Pennsylvania||1|||f||||||||||||||2017-02-18 17:28:19.108228|2017-02-18 17:28:19.108228
NCT00143949|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-11-05|||March 1997||1997-03-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|March 2007|Actual|2007-03-01||Interventional|||Renin Angiotensin System Study (RASS/B-RASS)|Renin Angiotensin System Blockage-DN (RASS)|Completed||Phase 2|285|Actual|University of Minnesota - Clinical and Translational Science Institute||3|||f||||t||||||||||2017-02-18 17:28:19.20564|2017-02-18 17:28:19.20564
NCT00143936|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2010-01-14|||April 2003||2003-04-01|January 2008|2008-01-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||The Safety and Efficacy of Low and High Carbohydrate Diets|The Safety and Efficacy of Low and High Carbohydrate Diets|Completed||Phase 4|360|Actual|Temple University||2|||f||||t||||||||||2017-02-18 17:28:19.315626|2017-02-18 17:28:19.315626
NCT00143923|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-12-15|||March 2003||2003-03-01|December 2015|2015-12-01|December 2024|Anticipated|2024-12-01|December 2024|Anticipated|2024-12-01||Interventional|||Novel Strategies for Reducing Heart Disease Risk Disparities|Heart Strategies Concentrating On Risk Evaluation (Heart SCORE) Study|Active, not recruiting||N/A|2000|Actual|University of Pittsburgh||3|||f||||f||||||||||2017-02-18 17:28:19.430707|2017-02-18 17:28:19.430707
NCT00143910|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-12-05|||April 1993||1993-04-01|December 2013|2013-12-01|October 1999|Actual|1999-10-01|October 1999|Actual|1999-10-01||Observational|||Natural History Study of Azathioprine Adherence|Measurement of Compliance in Renal Transplant Recipients|Completed||N/A|180||University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||||2017-02-18 17:28:19.536071|2017-02-18 17:28:19.536071
NCT00143884|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-04-20|||March 2000||2000-03-01|January 2007|2007-01-01||||||||Interventional|||Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood|Adjuvant Cellular Immunotherapy for High-Risk Hematologic Malignancy After Allogeneic Stem Cell Transplantation Using Low Intensity Conditioning|Terminated||Phase 2|30||University of Michigan Cancer Center|||||f||||||||||||||2017-02-18 17:28:19.634074|2017-02-18 17:28:19.634074
NCT00143871|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2012-01-30|||April 2001||2001-04-01|January 2012|2012-01-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma|Rituximab Plus High-dose Chemotherapy With Autologous Stem Cell Support for Non-Hodgkin's Lymphoma|Completed||Phase 2|35||University of Michigan Cancer Center|||||f||||t||||||||||2017-02-18 17:28:19.725124|2017-02-18 17:28:19.725124
NCT00143858|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-08-06|||September 2004||2004-09-01|August 2009|2009-08-01|October 2007|Actual|2007-10-01|||||Observational|||Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume|Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume|Completed||N/A|16|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-02-18 17:28:19.808765|2017-02-18 17:28:19.808765
NCT00143845|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2014-08-13|2014-05-19||April 2003||2003-04-01|August 2014|2014-08-01|February 2013|Actual|2013-02-01|November 2010|Actual|2010-11-01||Interventional||54 patients were enrolled however 9 patients did not receive planned donor lymphocyte infusion. 45 patients were analyzed.|Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant|Phase II Trial of Adjuvant Cellular Immunotherapy for High-Risk Hematologic Malignancy After Reduced Intensity Allogeneic Stem Cell Transplantation|Completed||Phase 2|54|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:28:19.899953|2017-02-18 17:28:19.899953
NCT00143832|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-03-18|||September 2004||2004-09-01|March 2007|2007-03-01||||||||Observational|||Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning|Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning|Unknown status|Recruiting|N/A|90||UMC Utrecht|||||f||||||||||||||2017-02-18 17:28:20.364705|2017-02-18 17:28:20.364705
NCT00143819|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-02-02|||September 2005||2005-09-01|February 2015|2015-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis|Double-Blind, Bilateral, Vehicle-Controlled, Randomized Trial of Neuroskin Forte to Relieve Symptoms of Dry Skin|Completed||Phase 2|13|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 17:28:20.459108|2017-02-18 17:28:20.459108
NCT00143806|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-12-31|||October 2003||2003-10-01|December 2008|2008-12-01|May 2007||2007-05-01|||||Interventional|||Transitioning From Cyclosporine to Alefacept in Psoriasis|Investigator-Initiated, Use Study of Alefacept (Amevive) in Combination With Tapering Doses of Cyclosporine in Patients With Moderate to Severe Psoriasis|Completed||Phase 2|13||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-02-18 17:28:20.566898|2017-02-18 17:28:20.566898
NCT00143793|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2016-11-22|||June 2005||2005-06-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|||||Observational|MANPRO||NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema|Mannheim NT-proBNP Study (MANPRO) Evaluating NT-proBNP and New Biomarkers in Patients Suffering From Dyspnea and/or Peripheral Edema for the Differential Diagnosis of Congestive Heart Failure|Active, not recruiting||Phase 4|400|Anticipated|Universitätsmedizin Mannheim|||1||f||||f||||||Samples Without DNA|"~     Peripheral blood samples~   "|||2017-02-18 17:28:20.66148|2017-02-18 17:28:20.66148
NCT00143780|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-04-15|||May 2002||2002-05-01|August 2005|2005-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination|Immunogenicity of Pneumococcal Conjugate Vaccine in Adult Allogeneic Bone Marrow Transplant Recipients - Randomized Controlled Trial of Pre-Transplant Donor Immunization|Completed||Phase 4|70||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:28:20.753182|2017-02-18 17:28:20.753182
NCT00143767|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-03-18|||August 2005||2005-08-01|March 2007|2007-03-01||||||||Observational|||Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder|Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder|Unknown status|Recruiting|N/A|400||UMC Utrecht|||||f||||||||||||||2017-02-18 17:28:20.848024|2017-02-18 17:28:20.848024
NCT00143078|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-11-13|||June 2005||2005-06-01|November 2015|2015-11-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Observational|||Obesity and Weight Loss on Reproductive Function|The Effects of Morbid Obesity and Weight Loss on Reproductive Function: The Bariatric Surgery Model|Terminated||Phase 2|35|Actual|Milton S. Hershey Medical Center|||1|Close-out of the grant - study ceased on 1/1/2010|f||||f||||||Samples With DNA|"~     whole blood & urine~   "|||2017-02-18 17:28:20.934943|2017-02-18 17:28:20.934943
NCT00143065|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2017-02-06|||August 2005||2005-08-01|February 2017|2017-02-01|July 2009|Actual|2009-07-01|February 2007|Actual|2007-02-01||Interventional|||Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Feasibility/Phase II Trial of Fludarabine, Rituximab, and Alemtuzumab for Previously Treated B-Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)|Completed||Phase 2|8|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:28:21.029884|2017-02-18 17:28:21.029884
NCT00143052|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-06-23|||January 2002||2002-01-01|June 2008|2008-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Bone Status and Insulin Resistance in Hirsutism|Body Composition, Insulin Concentration, Androgens and Bone Status in Women Referred With Hirsutism|Completed||N/A|50|Actual|Odense University Hospital|||2||f||||||||||||||2017-02-18 17:28:21.141662|2017-02-18 17:28:21.141662
NCT00143039|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2014-12-17|||March 2006||2006-03-01|December 2014|2014-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|TandemMS||Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR|Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by Nonimmune Hydrops and Severe Symmetrical Intrauterine Growth Restriction-A Multicenter Prospective Pilot Cohort Study|Terminated||Phase 1|48|Actual|Mednax Center for Research, Education and Quality|||2|No metabolic disordered ID'd by TMS in either control/test group at >50%enrolled|f||||t||||||||||2017-02-18 17:28:21.219302|2017-02-18 17:28:21.219302
NCT00143026|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-11-22|||July 2005||2005-07-01|November 2011|2011-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States|Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease.|Completed||Phase 4|184|Actual|Novartis|||||f||||||||||||||2017-02-18 17:28:21.340893|2017-02-18 17:28:21.340893
NCT00143013|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-06-11|||October 2004||2004-10-01|June 2008|2008-06-01|April 2007||2007-04-01|||||Observational|||Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes|Gene Expression Profiling by DNA Chips and Subsequent Bioinformatic Analysis for Identification of Genes and Biochemical Pathways Associated With Type 2 Diabetes|Unknown status|Recruiting|N/A|100|Anticipated|Odense University Hospital|||||f||||||||||||||2017-02-18 17:28:21.454804|2017-02-18 17:28:21.454804
NCT00143000|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-04-04|||April 2004||2004-04-01|April 2008|2008-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3|A Multicenter Study Evaluating the Efficacy and Safety of 12 Weeks Versus 24 Weeks Peginterferon Alfa-2a 40KD Combination Therapy With Ribavirin in Interferon Naïve Patients With Chronic Hepatitis C Genotype 2 or 3 Infection|Completed||Phase 4|392|Actual|NORDynamIC Study Group||2|||f||||t||||||||||2017-02-18 17:28:21.530308|2017-02-18 17:28:21.530308
NCT00142987|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-01-24|||April 2004||2004-04-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|||||Interventional|||Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS|Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS|Completed||Phase 4|664||Novartis|||||||||||||||||||2017-02-18 17:28:21.634313|2017-02-18 17:28:21.634313
NCT00142974|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2012-04-19|||May 2004||2004-05-01|April 2012|2012-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy|Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy|Terminated||Phase 2|120||Novartis||||This study was terminated early in April 2005 due to low patient enrollment|||||||||||||||2017-02-18 17:28:21.714536|2017-02-18 17:28:21.714536
NCT00142961|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-04-06|||October 2005||2005-10-01|March 2016|2016-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder|Marijuana-Abusing Attention Deficit Hyperactivity Disorder (ADHD) Teens: Atomoxetine Treatment|Completed||Phase 2|2|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 17:28:21.802781|2017-02-18 17:28:21.802781
NCT00142948|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-10-22|||February 2006||2006-02-01|October 2012|2012-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts|Heroin Addiction Treatment: Naltrexone and Adrenergic Agents|Completed||Phase 2|301|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 17:28:21.913883|2017-02-18 17:28:21.913883
NCT00142935|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-05-08|2013-12-05||September 2006||2006-09-01|May 2009|2009-05-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1|Opiate Replacement Therapy at Release From Incarceration|Completed||N/A|87|Actual|The Miriam Hospital||3|||f||||t||||||||||2017-02-18 17:28:22.03068|2017-02-18 17:28:22.03068
NCT00142922|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2010-03-01|||October 2002||2002-10-01|March 2010|2010-03-01|October 2007||2007-10-01|||||Interventional|||Breaking Down Barriers to Diabetes Self-Care|Breaking Down Barriers to Diabetes Self-Care|Completed||N/A|222||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 17:28:22.642344|2017-02-18 17:28:22.642344
NCT00142909|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-07-28|2012-11-01||February 2005||2005-02-01|July 2015|2015-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1|Lofexidine: Enhancing Naltrexone Treatment for Opiate Addiction|Completed||Phase 2|86|Actual|Yale University||2|||f||||t||||||||||2017-02-18 17:28:22.755035|2017-02-18 17:28:22.755035
NCT00142896|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2017-01-11|||February 2005||2005-02-01|August 2008|2008-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Tramadol to Reduce Opioid Withdrawal Symptoms|Withdrawal Suppression Efficacy of Tramadol|Completed||Phase 2|16|Actual|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:28:23.370406|2017-02-18 17:28:23.370406
NCT00143754|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-08-31||||||August 2005|2005-08-01||||||||Interventional|||Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope|Benefit of Controlled Rehydration in Unexplained Syncope|Terminated||Phase 3|||University Hospital, Angers|||||f||||||||||||||2017-02-18 17:28:23.47518|2017-02-18 17:28:23.47518
NCT00143741|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-01-09|||May 2005||2005-05-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers|Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers|Completed||Phase 1|20|Actual|University of Chicago||1|||f||||||||||||||2017-02-18 17:28:23.53964|2017-02-18 17:28:23.53964
NCT00143728|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-09-24|||January 2004||2004-01-01|September 2008|2008-09-01|May 2010|Anticipated|2010-05-01|May 2010|Anticipated|2010-05-01||Interventional|||3TC or No 3TC for HIV With 3TC Resistance|A Randomized Study to Evaluate Virologic Response Following Discontinuation vs. no Discontinuation of 3TC in Patients Who Are Infected With HIV With Previously Documented Reduced Susceptibility to 3TC and Who Have Adequate Virologic Suppression on Combination Antiretroviral Therapy|Suspended||Phase 4|152|Anticipated|University of British Columbia||||Enrollment.|f||||||||||||||2017-02-18 17:28:23.64933|2017-02-18 17:28:23.64933
NCT00143715|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-07-19|||September 2004||2004-09-01|July 2011|2011-07-01|January 2007|Actual|2007-01-01|October 2006|Actual|2006-10-01||Interventional|||Oral Vitamin K for Warfarin Associated Coagulopathy|A Multicentre, Multinational Study of Oral Vitamin K for the Treatment of Warfarin Associated Coagulopathy|Completed||Phase 3|690|Actual|St. Joseph's Healthcare Hamilton||2|||f||||t||||||||||2017-02-18 17:28:23.749014|2017-02-18 17:28:23.749014
NCT00143702|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-09-24|||August 2001||2001-08-01|September 2005|2005-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)|Randomized, Open-Label Study of Continued Stavudine Versus Abacavir Substitution With or Without Riboflavin and Thiamine Supplementation in HIV-Infected Patients Who Have Elevated Venous Lactic Acid While on Stavudine-Based Therapy (DAVE)|Completed||Phase 2/Phase 3|80|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 17:28:23.892595|2017-02-18 17:28:23.892595
NCT00143689|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2014-09-25|||April 2002||2002-04-01|September 2014|2014-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||NRTI-Sparing Pilot Study|A Pilot Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor Sparing Regimen in Antiretroviral-Naïve, HIV-infected Patients|Completed||Phase 4|13|Actual|University of British Columbia||1|||f||||||||||||||2017-02-18 17:28:23.985505|2017-02-18 17:28:23.985505
NCT00143676|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2012-05-23|||August 2005||2005-08-01|May 2012|2012-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia|A Double-blind, Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of TAK-475 50 mg, 100 mg, or Placebo When Co-administered With Atorvastatin (10 mg to 40 mg) in Subjects With Primary Hypercholesterolemia|Completed||Phase 3|448|Actual|Takeda||3|||f||||f||||||||||2017-02-18 17:28:24.290382|2017-02-18 17:28:24.290382
NCT00143663|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2012-05-23|||September 2005||2005-09-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol|A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 100 mg Versus Placebo in Subjects With Primary Hypercholesterolemia|Completed||Phase 3|361|Actual|Takeda||2|||f||||f||||||||||2017-02-18 17:28:24.514128|2017-02-18 17:28:24.514128
NCT00143650|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-01-16|||January 2001||2001-01-01|January 2005|2005-01-01|September 2002||2002-09-01|||||Interventional|||SENOC-I Det Sunda Huset II - Sensitization of Occupants of Water Damaged Buildings.|Does House Dust From Water Damaged Buildings Cause Stronger Responses Among Occupants Than Dust From Buildings Without Water Damage? Can Occupants’ Sensitivity be Predicted by Biomarkers?|Completed||Phase 1/Phase 2|27||University of Aarhus|||||f||||||||||||||2017-02-18 17:28:24.68374|2017-02-18 17:28:24.68374
NCT00143637|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-03-26|||May 2005||2005-05-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Dose Response Relations for Health Effects Caused by Office Dust|Dose Response Relations for Health Effects Caused by Office Dust.|Completed||Phase 1/Phase 2|24|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 17:28:24.769162|2017-02-18 17:28:24.769162
NCT00143624|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-12-08|||June 2003||2003-06-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels|Effect of Rosiglitazone Maleate (Avandia®) on Carotid Intima Media Thickness, Brachial Artery Reactivity, Glucose Metabolism, Blood Lipid Concentrations, Body Fat Distribution, and Biochemical Markers of Cardiovascular Risk in Patients With the HIV Metabolic Syndrome|Completed||N/A|50|Anticipated|University of British Columbia||2|||f||||f||||||||||2017-02-18 17:28:24.881754|2017-02-18 17:28:24.881754
NCT00143611|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2012-01-31|||September 2005||2005-09-01|January 2012|2012-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy & Safety of Resatorvid in Adults With Severe Sepsis|A Pivotal, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety of TAK-242 in Adults With Severe Sepsis|Completed||Phase 3|277|Actual|Takeda||3|||f||||t||||||||||2017-02-18 17:28:24.998346|2017-02-18 17:28:24.998346
NCT00143429|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-03-04||||||March 2015|2015-03-01||||||||Interventional|||Corneal Versus Conjunctival Delivery Using a Delivery Device|Effect Of Corneal Versus Conjunctival Delivery On The Corneal Safety, Tolerability, and Antihypertensive Efficacy Of The Xalatan Ophthalmic Delivery Device|Withdrawn||Phase 2|0|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:28:34.967102|2017-02-18 17:28:34.967102
NCT00143416|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-07-24|||April 2004||2004-04-01|July 2008|2008-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Long Term Study With B2036-PEG|Long-Term Study of B2036-PEG in Acromegaly - Long Term Study With B2036-PEG -|Completed||Phase 3|16||Pfizer|||||f||||||||||||||2017-02-18 17:28:35.041591|2017-02-18 17:28:35.041591
NCT00143598|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-08-15|2014-06-03||June 2004||2004-06-01|August 2014|2014-08-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional||806 patients were randomly assigned to an intervention. Three patients were identified as ineligible soon after randomization and were excluded from further analysis (ie, modified intention-to-treat). In the active ECS group, one patient had no DVT and in the placebo ECS group one patient had a previous DVT and another patient was moribund.|The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome|The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome After Symptomatic Proximal Deep Venous Thrombosis|Completed||Phase 3|806|Actual|Sir Mortimer B. Davis - Jewish General Hospital|While 14% withdrew or were lost to follow-up (F/U), the total rate of withdrawal, loss to F/U and death was less than what was projected. Adherence to study stockings tended to diminish over F/U; this occurred to a similar degree in both groups.|2|||f||||t||||||||||2017-02-18 17:28:25.261183|2017-02-18 17:28:25.261183
NCT00143585|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-07-24|||June 2002||2002-06-01|July 2008|2008-07-01|June 2007|Anticipated|2007-06-01|||||Interventional|||NOGA Angiogenesis Revascularization Therapy: Evaluation by RadioNuclide Imaging - The Northern Trial|Multicentre, Randomized,Double Blind,Placebo Controlled Trial of Myocardial Angiogenesis Using VEGF165, Intramyocardial Gene Delivery in Patients With Severe Angina|Unknown status|Active, not recruiting|Phase 2/Phase 3|120||St. Michael's Hospital, Toronto|||||f||||||||||||||2017-02-18 17:28:26.217868|2017-02-18 17:28:26.217868
NCT00143572|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2010-02-23|||November 2004||2004-11-01|February 2010|2010-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease|Phase I Study of Combination Treatment With Hydroxyurea and Magnesium Pidolate in Patients With Sickle Cell Disease|Completed||Phase 1|16|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:28:26.442201|2017-02-18 17:28:26.442201
NCT00143559|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-01-28|||August 2005||2005-08-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|July 2006|Actual|2006-07-01||Interventional|||Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies|Haploidentical Hematopoietic Stem Cell Transplantation Utilizing Partial T-Cell Depletion as Immunotherapy for Hematologic Malignancies|Completed||Phase 2|17|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:28:26.555641|2017-02-18 17:28:26.555641
NCT00143546|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-11-23|||November 2003||2003-11-01|June 2011|2011-06-01||||||||Expanded Access|||Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver|Compassionate Use of Defibrotide for Patients With Veno-Occlusive Disease|No longer available||Phase 2|||St. Jude Children's Research Hospital|||||||||||||||||||2017-02-18 17:28:26.674168|2017-02-18 17:28:26.674168
NCT00143533|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-09-29|||September 2003||2003-09-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|September 2010|Actual|2010-09-01||Interventional|||Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors|Phase I Study of Intravenous Irinotecan Using Selective Gastrointestinal Decontamination for Prevention of Diarrhea in Relapsed or Refractory Pediatric Solid Tumors|Completed||Phase 1|20|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:28:26.778275|2017-02-18 17:28:26.778275
NCT00143520|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-04-08|||December 2004||2004-12-01|April 2011|2011-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes|A Randomized, Double-blind, Double-dummy, Placebo-controlled 26-week Dose-response Study of Rivoglitazone HCl (CS-011) With Active Comparator (Pioglitazone HCl) in Subjects With Type 2 Diabetes|Completed||Phase 2/Phase 3|441|Actual|Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:28:26.891855|2017-02-18 17:28:26.891855
NCT00143507|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-06-22|2015-05-13||December 2004||2004-12-01|June 2015|2015-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction|Effects of Ivabradine on Cardiovascular Events in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction. A Three-year Randomised Double-blind Placebo-controlled International Multicentre Study.|Completed||Phase 3|10917|Actual|Servier|The section Other Adverse Events (Not including serious) has been completed by the sponsor to include only the Non Serious Adverse Events emergent on treatment during the study.|2|||f||||||||||||||2017-02-18 17:28:27.266271|2017-02-18 17:28:27.266271
NCT00143494|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-09-24|||July 2005||2005-07-01|September 2008|2008-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure|The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure|Completed||N/A|13|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 17:28:29.688963|2017-02-18 17:28:29.688963
NCT00143481|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-04-09|||March 2005||2005-03-01|April 2013|2013-04-01||||June 2006|Actual|2006-06-01||Interventional|||Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women|A Multi-Center, Double-Phase, Randomized, Double-Blind, Placebo Controlled (12-Week Double-Blind Followed by 12-Week Open-Label) Study Evaluating the Effect of Tolterodine ER on Urgency Urinary Incontinence (UUI), Urgency, Frequency, Sexual Quality of Life and Sexual Function in Women With Overactive Bladder|Completed||Phase 4|400||Pfizer|||||||||||||||||||2017-02-18 17:28:29.803834|2017-02-18 17:28:29.803834
NCT00143468|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-11-30|||March 2005||2005-03-01|November 2011|2011-11-01|May 2008|Actual|2008-05-01|March 2007|Actual|2007-03-01||Interventional|||The Specific Elastance in Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) Patients|The Specific Elastance in Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) Patients: Barotrauma and Volutrauma|Completed||N/A|100|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 17:28:32.861096|2017-02-18 17:28:32.861096
NCT00143455|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2010-02-10|2009-12-11||June 2002||2002-06-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer|Open Label, Randomised Multicentre Phase III Study Of Irinotecan Hydrochloride (Campto (Registered)) And Cisplatin Versus Etoposide And Cisplatin In Chemotherapy Naive Patients With Extensive Disease - Small Cell Lung Cancer|Completed||Phase 3|485|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 17:28:32.978947|2017-02-18 17:28:32.978947
NCT00143442|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-08-04|||December 2003||2003-12-01|August 2006|2006-08-01|October 2004||2004-10-01|||||Interventional|||Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures|A 5-Week, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN), Who Are Gabapentin Treatment Failures.|Completed||Phase 2|184||Pfizer|||||||||||||||||||2017-02-18 17:28:34.89159|2017-02-18 17:28:34.89159
NCT00143403|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2010-09-24|2009-02-26||December 2001||2001-12-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|February 2008|Actual|2008-02-01||Interventional|||Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer|Multi-Centre Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone, As Adjuvant Treatment After Resection Of Liver Metastases For Colorectal Cancer.|Completed||Phase 3|321|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:28:35.134458|2017-02-18 17:28:35.134458
NCT00143390|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-12-19|2011-10-12||April 2005||2005-04-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer|A Randomized, Double-Blind, Controlled Study Of Exemestane (Aromasin) Vs Anastrozole (Arimidex) As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer|Completed||Phase 3|298|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 17:28:35.970429|2017-02-18 17:28:35.970429
NCT00143377|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-11-17|||September 2004||2004-09-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB|A Global Phase IV, Double-Blind, Placebo-Controlled, Randomized Trial To Evaluate The Effectiveness Of Detrusitol Sr 4mg On Patient's Perception Of Bladder Condition (PPBC).|Completed||Phase 4|600||Pfizer|||||f||||||||||||||2017-02-18 17:28:36.629583|2017-02-18 17:28:36.629583
NCT00143364|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-06-01|||June 2003||2003-06-01|June 2007|2007-06-01|March 2005|Actual|2005-03-01|||||Interventional|||A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation|A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation|Completed||Phase 3|1005||Pfizer|||||||||||||||||||2017-02-18 17:28:36.701519|2017-02-18 17:28:36.701519
NCT00143351|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2006-12-28|||June 2003||2003-06-01|December 2006|2006-12-01|September 2005||2005-09-01|||||Interventional|||Mozart Relapse Study|Open Extension Study Evaluating the Long-Term Efficacy, Safety, and Tolerability of Oral Ziprasidone in the Treatment of Resistant/Intolerant Schizophrenic Patients Who Have Acutely Responded to Ziprasidone in the Mozart Study|Completed||Phase 3|75||Pfizer|||||f||||||||||||||2017-02-18 17:28:36.927331|2017-02-18 17:28:36.927331
NCT00143338|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-02-11|||November 2004||2004-11-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|||||Interventional|||To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.|A Phase 2, Exploratory Study to Examine the Effects of Inhaled Insulin, Compared With Subcutaneously Administered Insulin, on Airway Lining Fluid Composition in Subjects With Type 2 Diabetes Mellitus.|Completed||Phase 2|20||Pfizer|||||||||||||||||||2017-02-18 17:28:37.028182|2017-02-18 17:28:37.028182
NCT00143325|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-06-01|||January 2005||2005-01-01|June 2007|2007-06-01|June 2006|Actual|2006-06-01|||||Interventional|||An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation|An Open-Label, Multicenter Study With Follow-Up Evaluating the Safety and Efficacy of Varenicline Tartrate in Comparison to Transdermal Nicotine Patch for Smoking Cessation|Completed||Phase 3|730||Pfizer|||||||||||||||||||2017-02-18 17:28:37.114295|2017-02-18 17:28:37.114295
NCT00143312|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-09-23|2009-04-02||February 2005||2005-02-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|VOSIFI||Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants|Prospective, Open-Label, Non-Comparative, Multicenter Study for the Secondary Prophylaxis of Invasive Fungal Infections (IFI) With Voriconazole in Patients With Allogeneic Stem Cell Transplants (SCT).|Completed||Phase 4|45|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 17:28:37.22728|2017-02-18 17:28:37.22728
NCT00143299|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-06-01|||October 2003||2003-10-01|June 2007|2007-06-01|March 2005||2005-03-01|||||Interventional|||A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline|A 52-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety of Varenicline Tartrate ( CP-526,555) for Smoking Cessation|Completed||Phase 3|375||Pfizer|||||||||||||||||||2017-02-18 17:28:37.812559|2017-02-18 17:28:37.812559
NCT00143286|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-06-01|||April 2003||2003-04-01|June 2007|2007-06-01|March 2005|Actual|2005-03-01|||||Interventional|||A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation|A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline ( CP-526,555) for the Maintenance of Smoking Cessation|Completed||Phase 3|2000||Pfizer|||||||||||||||||||2017-02-18 17:28:37.89941|2017-02-18 17:28:37.89941
NCT00143273|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-08-08|||June 2004||2004-06-01|August 2011|2011-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|JADE||Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation|Dose Response Study Of Lasofoxifene In Postmenopausal Women With Osteoporosis (Placebo-Controlled, Multicenter, Double-Blind, Comparative Study) - Japanese Asian Dose Evaluation: JADE|Completed||Phase 2|497|Actual|Ligand Pharmaceuticals||4|||f||||||||||||||2017-02-18 17:28:38.003464|2017-02-18 17:28:38.003464
NCT00143260|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2012-06-07|||August 2005||2005-08-01|June 2012|2012-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose|Multicenter Randomized Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose - II|Completed||Phase 4|250||Pfizer|||||||||||||||||||2017-02-18 17:28:38.118705|2017-02-18 17:28:38.118705
NCT00143247|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2010-04-10|2009-01-16||March 2003||2003-03-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus|An Open-Label, Phase 2, Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus Participating in Extension Protocols 217-102, 103, or 104|Terminated||Phase 2|173|Actual|Pfizer|Study terminated early due to business and operational issues. All subjects who were treated with inhaled insulin in parent protocols(217-102,-103,or-104) or in extension protocols (217-102E,-103E,-104E,or A2171036)are included in safety evaluation.|1||See termination reason in detailed description.|f||||f||||||||||2017-02-18 17:28:38.257521|2017-02-18 17:28:38.257521
NCT00143234|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-04-21|||May 2004||2004-05-01|April 2015|2015-04-01|July 2005||2005-07-01|||||Interventional|GEMINI-AALA||Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels|Clinical Utility of Amlodipine/Atorvastatin to Improve Concomitant Cardiovascular Risk Factors of Hypertension and Dyslipidemia|Completed||Phase 3|1825||Pfizer|||||f||||||||||||||2017-02-18 17:28:39.789329|2017-02-18 17:28:39.789329
NCT00143221|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2006-12-07|||March 2004||2004-03-01|December 2006|2006-12-01|May 2005||2005-05-01|||||Interventional|||Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)|A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo-Controlled Flexible Dose Study With and Open-Label Extension to Assess the Efficacy and Safety of Viagra (Sildenafil Citrate) in the Treatment of Men With Erectile Dysfunction (ED) and Concomitant Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) in the United States|Completed||Phase 4|350||Pfizer|||||||||||||||||||2017-02-18 17:28:39.989836|2017-02-18 17:28:39.989836
NCT00143208|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-01-18|||May 2003||2003-05-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.|Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom (Fixed Combination Of Latanoprost And Timolol) In Patients With Poag Or Oh. A 6-Month, Open, Multi-Center Trial In Italy|Completed||Phase 4|250||Pfizer|||||f||||||||||||||2017-02-18 17:28:40.084629|2017-02-18 17:28:40.084629
NCT00143195|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-04-17|||April 2001||2001-04-01|April 2007|2007-04-01|January 2005||2005-01-01|||||Interventional|ANISSA||Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina|Open Label Study Comparing Amlodipine vs Long-Acting Nitrates in Patients With Chronic Stable Angina.|Completed||Phase 4|200||Pfizer|||||f||||||||||||||2017-02-18 17:28:40.188077|2017-02-18 17:28:40.188077
NCT00143182|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-05-15|||January 2005||2005-01-01|May 2015|2015-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)|A Double-Blind, 9-Week Extension Study Evaluating the Safety and Maintenance of Effect of Asenapine vs. Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501006 (Secondary Title: ARES)|Completed||Phase 3|504|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:28:40.290072|2017-02-18 17:28:40.290072
NCT00143169|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-04-14|||September 2004||2004-09-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain|A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Of Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain Following Orthopedic Or Gynecological Surgery|Completed||Phase 3|220||Pfizer|||||f||||||||||||||2017-02-18 17:28:40.394456|2017-02-18 17:28:40.394456
NCT00143156|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-04-09|||March 2005||2005-03-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Pregabalin Versus Placebo in the Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy|Completed||Phase 3|450||Pfizer|||||||||||||||||||2017-02-18 17:28:40.482497|2017-02-18 17:28:40.482497
NCT00143143|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-07-21|||September 2001||2001-09-01|March 2006|2006-03-01|February 2006||2006-02-01|||||Interventional|||Pregabalin Open-Label Extension Trial in Patients With Partial Seizures|Pregabalin BID Open-Label Add-On Trial: A Follow-Up Study To Determine Long-Term Safety and Efficacy in Patients With Partial Seizures|Completed||Phase 3|300||Pfizer|||||f||||||||||||||2017-02-18 17:28:40.755923|2017-02-18 17:28:40.755923
NCT00143130|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-03-04|||April 2005||2005-04-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|||||Interventional|PREPS EXT||Pregabalin In Partial Seizures Extension Study|Pregabalin in Partial Seizures (PREPS) Extension Study: An 18-month Follow-on Open-label, International, Multicenter Add-on Therapy Trial|Completed||Phase 3|227|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:28:40.885692|2017-02-18 17:28:40.885692
NCT00143117|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2012-11-05|||August 2004||2004-08-01|November 2012|2012-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation|A Phase 2b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Dose Response Study to Assess the Efficacy and Safety of Oral UK-390,957 in Men With Premature Ejaculation|Completed||Phase 2/Phase 3|460||Pfizer|||||||||||||||||||2017-02-18 17:28:41.036005|2017-02-18 17:28:41.036005
NCT00143104|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-03-09|||December 2004||2004-12-01|February 2007|2007-02-01|October 2006|Actual|2006-10-01|||||Interventional|||To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.|A Phase 2, Exploratory Study to Examine the Effects of Inhaled Insulin, Compared With Subcutaneously Administered Insulin, on Airway Lining Fluid Composition in Subjects With Type 1 Diabetes Mellitus.|Completed||Phase 2|20||Pfizer|||||||||||||||||||2017-02-18 17:28:41.390784|2017-02-18 17:28:41.390784
NCT00143091|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-03-19|||April 2005||2005-04-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|||||Interventional|||Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder|A Six-Week, Fixed Dose, Double-Blind, Double-Dummy, Placebo and Sertraline Controlled, Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Outpatients With Major Depressive Disorder|Terminated||Phase 2|200||Pfizer||||See Detailed Description for termination reason.|||||t||||||||||2017-02-18 17:28:41.482211|2017-02-18 17:28:41.482211
NCT00142883|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-07-07|||September 2004||2004-09-01|July 2015|2015-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3|The Effects of GABA Medications on Cocaine Responses in Humans|Terminated||N/A|72|Actual|Yale University||2||Study has been completed|f||||t||||||||||2017-02-18 17:28:41.584209|2017-02-18 17:28:41.584209
NCT00142870|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2017-01-11|||March 2005||2005-03-01|October 2016|2016-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Effectiveness of Bupropion in Treating Marijuana Dependent Individuals|Effects of Bupropion on Marijuana Withdrawal Symptoms|Completed||Phase 2|30|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 17:28:41.713977|2017-02-18 17:28:41.713977
NCT00142844|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2017-01-11|||September 1999||1999-09-01|October 2016|2016-10-01|January 2008|Actual|2008-01-01|March 2005|Actual|2005-03-01||Interventional|||Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1|Two Medications, Disulfiram and Naltrexone, in the Treatment of Patients With Both Cocaine and Alcohol Dependence|Completed||Phase 2|208|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||f||||||||||2017-02-18 17:28:41.828347|2017-02-18 17:28:41.828347
NCT00142831|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2017-01-11|||April 1999||1999-04-01|August 2008|2008-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Bupropion as an Adjunct to the Nicotine Patch Plus CBT|Effectiveness of Bupropion Used in Combination With the Nicotine Replacement Patch and Cognitive Behavioral Therapy for Treating Nicotine Dependent Individuals - 1|Completed||Phase 4|293|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 17:28:41.945073|2017-02-18 17:28:41.945073
NCT00142818|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-08-27|2014-08-12||February 2006||2006-02-01|August 2014|2014-08-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|Mod-Nal||Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence|A Phase II, Double-blind, Placebo-Controlled, Pilot Trial of the Combination of Modafinil and Naltrexone for the Treatment of Cocaine and Alcohol Dependence|Completed||Phase 2|164|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 17:28:42.058288|2017-02-18 17:28:42.058288
NCT00142805|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-12-30|||October 2004||2004-10-01|September 2006|2006-09-01|March 2006||2006-03-01|||||Interventional|||Ketasyn in Mild to Moderate Alzheimer's Disease|Safety, Tolerability and Efficacy Study of Ketasyn™ (AC-1202) Administered for Ninety Days in Subjects With Probable Alzheimer's Disease of Mild to Moderate Severity|Completed||Phase 2|100||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:28:42.589535|2017-02-18 17:28:42.589535
NCT00142792|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-12-22|||December 2005||2005-12-01|December 2011|2011-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke|Electrical Stimulation for Upper Limb Recovery in Stroke|Completed||Phase 2|122|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||f||||||||||2017-02-18 17:28:42.71327|2017-02-18 17:28:42.71327
NCT00142779|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2017-01-11|||April 2001||2001-04-01|May 2009|2009-05-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts|Serotonin Treatment of Cocaine Dependence|Completed||N/A|220||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:28:42.827559|2017-02-18 17:28:42.827559
NCT00142766|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-10-05|||February 2004||2004-02-01|October 2015|2015-10-01|March 2007|Actual|2007-03-01|July 2006|Actual|2006-07-01||Interventional|||Sedation Management in Pediatric Patients Supported on Mechanical Ventilation|Sedation Management in Pediatric Patients Supported on Mechanical Ventilation|Completed||Phase 2|245|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 17:28:42.934778|2017-02-18 17:28:42.934778
NCT00142753|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2016-02-29|||August 2005||2005-08-01|February 2016|2016-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Immunologic Memory (Supp. of ATN 024)|Correlates of HBV-Specific B Cell Memory Following Vaccination in HIV-Infected Adolescents and HIV-Uninfected Adolescents: A Substudy of ATN 024 and ATN 025|Completed||Phase 4|95|Actual|Westat||5|||f||||||||||||||2017-02-18 17:28:43.032155|2017-02-18 17:28:43.032155
NCT00142740|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2016-02-29|||October 2005||2005-10-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025|Population Genetics and Immune Response to Hepatitis B Vaccination in Adolescents: A Substudy of ATN 024 and ATN 025|Completed||Phase 4|337|Actual|Westat|||2||f||||t||||||Samples With DNA|"~     Approximately 5 ml whole blood or 5 x 106 peripheral blood mononuclear cells.~   "|||2017-02-18 17:28:43.157805|2017-02-18 17:28:43.157805
NCT00142727|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2017-01-11|||January 2004||2004-01-01|July 2007|2007-07-01|February 2006||2006-02-01|||||Interventional|||Opioid Agonist and Antagonist Effects on Opioid Dependence|The Variability of Agonist and Antagonist Effects as a Function of Level of Physical Dependence|Terminated||Phase 2|16|Anticipated|National Institute on Drug Abuse (NIDA)||1||Study terminated due to halt in funding; may resume recruiting in future|f||||f||||||||||2017-02-18 17:28:43.439406|2017-02-18 17:28:43.439406
NCT00142714|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-10-13|||August 2003||2003-08-01|October 2006|2006-10-01|June 2005||2005-06-01|||||Interventional|||Effects of Spinal Cord Injury on Female Sexual Response|Effects of SCI on Female Sexual Response|Unknown status|Recruiting|N/A|70||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:28:43.530007|2017-02-18 17:28:43.530007
NCT00142701|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-02-04|||April 1999||1999-04-01|February 2016|2016-02-01|March 2005|Actual|2005-03-01|September 2004|Actual|2004-09-01||Interventional|||Enhancing Support for Women at Risk for Heart Disease||Completed||N/A|||Oregon Research Institute|||||f||||f||||||||Undecided||2017-02-18 17:28:43.611654|2017-02-18 17:28:43.611654
NCT00142688|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-10-28|||August 2004||2004-08-01|October 2015|2015-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Examining Psychosocial Mediators of Exercise Behavior|Examining Psychosocial Mediators of Exercise Behavior|Completed||Phase 1|448|Actual|HealthPartners Institute||2|||f||||||||||||||2017-02-18 17:28:43.693248|2017-02-18 17:28:43.693248
NCT00142675|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-03-04|||February 2003||2003-02-01|March 2014|2014-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Using Peers to Promote Exercise in Older Adults||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 17:28:43.794131|2017-02-18 17:28:43.794131
NCT00142662|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-03-26|||September 2002||2002-09-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Cafeteria-Based Study of Weight Gain Prevention||Completed||N/A|||Drexel University|||||f||||||||||||||2017-02-18 17:28:43.864084|2017-02-18 17:28:43.864084
NCT00142649|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-01-18|||September 2002||2002-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Adherence to Weight Loss for Hypertension in African American Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:28:43.936137|2017-02-18 17:28:43.936137
NCT00142636|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-11-21|||February 2004||2004-02-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Observational|||CRICKET Study, Coronary Calcium Scores in Patients With Chronic Kidney Disease|Coronary Artery Calcification in Chronic Kidney Disease Using Multidetector Row Spiral Computed Tomography|Unknown status|Active, not recruiting|N/A|200||United States Naval Medical Center, San Diego|||||f||||||||||||||2017-02-18 17:28:44.003456|2017-02-18 17:28:44.003456
NCT00142623|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-07-29|||February 2006||2006-02-01|July 2008|2008-07-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Interventional|ETS||Tailored Videos to Reduce Tobacco Smoke Exposure Among Pregnant Women and Newborns|Reducing ETS Exposure of Pregnant Women and Newborns|Unknown status|Recruiting|N/A|650|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 17:28:44.083924|2017-02-18 17:28:44.083924
NCT00142610|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-03-01|||August 2005||2005-08-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|VITAS||The Role of Vitamins E and C in Maintaining Lung Health in People With Asthma|Effect of Alpha Tocopherol and Ascorbate Supplementation on Airway Antioxidant Levels in Allergic Asthmatics|Completed||Phase 1|16|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 17:28:44.179534|2017-02-18 17:28:44.179534
NCT00142597|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2015-04-09|2014-12-04||May 2005||2005-05-01|December 2014|2014-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia|Mechanisms of Acupuncture Analgesia|Completed||Phase 1/Phase 2|46|Actual|University of Michigan||2|||f||||||||||||||2017-02-18 17:28:44.29561|2017-02-18 17:28:44.29561
NCT00142584|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-03-06|||August 2005||2005-08-01|August 2005|2005-08-01|March 2008|Actual|2008-03-01|March 2008|Anticipated|2008-03-01||Interventional|||Evaluation of the Long-Term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension|An Open-Label, Randomized Study Evaluating the Long-Term Effects of Metoprolol Versus Nebivolol as Monotherapy or in Combination With Amlodipine or Hydrochlorothiazide for the Treatment of Patients With Hypertension|Completed||Phase 3|1000|Anticipated|Mylan Bertek Pharmaceuticals||2|||f||||||||||||||2017-02-18 17:28:44.79244|2017-02-18 17:28:44.79244
NCT00142571|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-10-01|||January 2003||2003-01-01|October 2007|2007-10-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma|Ph III Random Trial of 120-Min Infusion Gemcitabine v. 90-Min Infusion Gemcitabine + Docetaxel in Unresectable Soft Tissue Sarcoma: A Multi-Disciplinary Trial of the North Amer. Sarcoma Study Group of the Connective Tissue Oncology Society|Completed||Phase 3|120||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:28:44.904262|2017-02-18 17:28:44.904262
NCT00142558|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-06-15|||January 2005||2005-01-01|June 2015|2015-06-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)|A Randomized, Double-Blind, Active-Comparator-Controlled 5-Day Trial of the Effect of Etoricoxib 120 mg Versus Indomethacin 150 mg in the Treatment of Acute Gout|Completed||Phase 4|180|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:28:45.013861|2017-02-18 17:28:45.013861
NCT00142545|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-08-31|||July 1999||1999-07-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||"Long Term Safety and Efficacy of SC Apomorphine in Treatment of Off Episodes in Late-Stage Parkinson's Disease"|Long-Term Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of “Off” Episodes in Patients With “On-Off” or “Wearing-Off” Effects Associated With Late-Stage Parkinson’s Disease|Completed||Phase 3|800||Mylan Bertek Pharmaceuticals|||||||||||||||||||2017-02-18 17:28:45.143644|2017-02-18 17:28:45.143644
NCT00142532|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-01-13|||June 2005||2005-06-01|January 2009|2009-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Acupuncture for Post-Thoracotomy Pain|Acupuncture for Post-Thoracotomy Pain: A Randomized Controlled Trial|Completed||Phase 3|162|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:28:45.252936|2017-02-18 17:28:45.252936
NCT00142519|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2016-04-28|||March 2005||2005-03-01|April 2016|2016-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain|Translational Studies in Analgesic Pharmacology: Analgesic Synergy in Clinical Pain. A Phase 2 Study Comparing a Single Dose of a 1:1 Combination of Methadone and Morphine With Morphine Alone in Patients With Post-operative Pain.|Active, not recruiting||Phase 2|70|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:28:45.365568|2017-02-18 17:28:45.365568
NCT00142506|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2014-04-23|||February 2005||2005-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer|This Protocol is a Randomized Prospective Study Comparing Prophylactic and on Demand Sildenafil Citrate Usage Administered During and After Radiotherapy With or Without Hormone Therapy Versus Radiotherapy With or Without Hormone Therapy Alone for the Preservation of Erectile Function After Therapy for Potent Patients With Clinically Localized Prostate Cancer|Completed||Phase 3|290|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:28:45.476494|2017-02-18 17:28:45.476494
NCT00142493|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-12-23|||September 2004||2004-09-01|December 2015|2015-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Effect of Affective Content on Drug Induced Amnesia of Episodic Memory|Effect of Affective Content on Drug Induced Amnesia of Episodic Memory|Completed||Phase 1|79|Actual|Memorial Sloan Kettering Cancer Center||5|||f||||||||||||||2017-02-18 17:28:45.602254|2017-02-18 17:28:45.602254
NCT00142480|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-12-28|||December 2004||2004-12-01|December 2007|2007-12-01||||July 2007|Actual|2007-07-01||Interventional|||Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer|Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Biliary Tract and Gallbladder Cancer|Unknown status|Active, not recruiting|Phase 2|26|Anticipated|Massachusetts General Hospital||1|||f||||||||||||||2017-02-18 17:28:45.720492|2017-02-18 17:28:45.720492
NCT00142467|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2014-03-15|||April 2004||2004-04-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|August 2006|Actual|2006-08-01||Interventional|||Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma|Phase II Study of Gemcitabine, Oxaliplatin in Combination With Bevacizumab (Avastin) in Patients With Hepatocellular Carcinoma|Completed||Phase 2|33|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:28:45.826629|2017-02-18 17:28:45.826629
NCT00142454|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-09-20|||August 2005||2005-08-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)|NY-ESO-1 Protein Vaccination in Malignant Melanoma Administered With Imiquimod as Adjuvant|Completed||Phase 1|9||Ludwig Institute for Cancer Research|||||||||||||||||||2017-02-18 17:28:45.944659|2017-02-18 17:28:45.944659
NCT00142441|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-06-01|||June 2003||2003-06-01|June 2016|2016-06-01|December 2004||2004-12-01|||||Interventional|||Effect of Pulse Width on Scar Treatment Using a 595-nm Pulsed Dye Laser|Effect of Pulse Width of a 595-nm Flashlamp-pumped Pulsed-dye Laser on the Treatment Response of Keloidal and Hypertrophic Sternotomy Scars|Completed||N/A|19||Mahidol University|||||f||||||||||||||2017-02-18 17:28:46.046014|2017-02-18 17:28:46.046014
NCT00142428|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2014-03-16|||January 2005||2005-01-01|March 2014|2014-03-01|October 2008|Actual|2008-10-01|October 2005|Actual|2005-10-01||Interventional|||Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma|A Phase II Study of Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|30|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:28:46.149539|2017-02-18 17:28:46.149539
NCT00142415|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2013-12-30|||February 2005||2005-02-01|December 2013|2013-12-01|July 2013|Actual|2013-07-01|March 2010|Actual|2010-03-01||Interventional|||Study of Lutetium-177 Labeled cG250 in Patients With Advanced Renal Cancer|Phase I/II Study of Increasing Doses of Lutetium-177 Labeled Chimeric Monoclonal Antibody cG250 in Patients With Advanced Renal Cancer|Completed||Phase 1/Phase 2|27|Actual|Ludwig Institute for Cancer Research||6|||f||||f||||||||||2017-02-18 17:28:46.26799|2017-02-18 17:28:46.26799
NCT00142389|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-06-21|||August 2004||2004-08-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Mother's Gift Project|Comparison of Maternal and Infant Immunization Strategies to Prevent Pneumococcal Disease|Completed||Phase 1/Phase 2|680||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:28:46.483896|2017-02-18 17:28:46.483896
NCT00142376|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-09-01|||September 2004||2004-09-01|September 2004|2004-09-01|August 2005||2005-08-01|||||Observational|||Short Term Outcomes of Children With Acute Respiratory Distress Syndrome||Completed||N/A|||Nationwide Children's Hospital|||||f||||||||||||||2017-02-18 17:28:46.580025|2017-02-18 17:28:46.580025
NCT00142363|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-02-28|||May 2004||2004-05-01|February 2006|2006-02-01|December 2006||2006-12-01|||||Observational|||Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies|The DNA and Cell Bank of IFR of Neurosciences: Clinical and Genetic Study of Parkinson's Disease and Epilepsies|Terminated||Phase 1|1700||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||||||||||||2017-02-18 17:28:46.657439|2017-02-18 17:28:46.657439
NCT00142350|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-09-08|||November 2000||2000-11-01|September 2016|2016-09-01|January 2007||2007-01-01|||||Interventional|||A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer|Randomized Phase III Study of 5-FU Continuous Infusion (5-FUci) Versus CPT-11 Plus CDDP (CP) Versus S-1 Alone (S-1) in Advanced Gastric Cancer (JCOG9912)|Completed||Phase 3|690||Japan Clinical Oncology Group||3|||f||||t||||||||||2017-02-18 17:28:46.751952|2017-02-18 17:28:46.751952
NCT00142337|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-01-04|||December 2004||2004-12-01|January 2012|2012-01-01|February 2009|Actual|2009-02-01|May 2006|Actual|2006-05-01||Interventional|||One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine|A Phase 2, One Arm, Open Label, Feasibility Study Assessing One Month Zidovudine/Didanosine Postpartum Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine to Prevent Mother to Child Transmission of HIV|Completed||Phase 2|244|Actual|Institut de Recherche pour le Developpement||1|||f||||||||||||||2017-02-18 17:28:46.883618|2017-02-18 17:28:46.883618
NCT00142324|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-12-13|||November 2003||2003-11-01|September 2005|2005-09-01|December 2005||2005-12-01|||||Interventional|||CALM-AD|A Randomised Placebo Controlled Trial of a Cholinesterase Inhibitor in the Management of Agitation in Dementia That is Unresponsive to a Psychological Intervention|Unknown status|Active, not recruiting|Phase 4|190||Institute of Psychiatry, London|||||f||||||||||||||2017-02-18 17:28:47.010702|2017-02-18 17:28:47.010702
NCT00142311|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-04-18|||November 2003||2003-11-01|April 2007|2007-04-01|September 2006||2006-09-01|||||Observational|||Functional Characterization of Parkin + Patients|Clinical, Molecular and Metabolic Comparison Between Early Onset Parkinsonian, With or Without Parkin Mutation: Physiopathological Perspectives|Terminated||Phase 1|97||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||||||||||||2017-02-18 17:28:47.239218|2017-02-18 17:28:47.239218
NCT00142298|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-03-24|2011-01-12||March 2005||2005-03-01|March 2015|2015-03-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies|An Open Label Trial of Telbivudine (LdT) in Adults With Chronic Hepatitis B Previously Treated in Idenix-Sponsored Telbivudine Studies|Completed||Phase 3|1869|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:28:47.360892|2017-02-18 17:28:47.360892
NCT00142285|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-01-06|||November 2004||2004-11-01|July 2006|2006-07-01|May 2008|Actual|2008-05-01|May 2006|Actual|2006-05-01||Interventional|||Zinc Pneumonia Outpatient Trial in Children < 2 Years|Efficacy of Zinc in the Treatment of Outpatient Pneumonia in an Urban Slum Among Children Less Than 2 Years Old|Completed||Phase 3|2260|Anticipated|International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 17:28:50.348951|2017-02-18 17:28:50.348951
NCT00142272|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2005-11-18|||May 2001||2001-05-01|September 2005|2005-09-01|July 2002||2002-07-01|||||Interventional|||Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial|Randomised, Open, Parallel Group Clinical Trial to Compare the Efficacy and Safety of a Single Dose of Ciprofloxacin Oral Suspension 20 Mg/Kg With a 3-Day Course of Erythromycin Oral Suspension Administered in a Dose of 12.5 Mg/Kg Every 6 Hours (12 Doses) in the Treatment of Children,With Clinically Severe Cholera Due to V. Cholerae O1 or O139.|Completed||Phase 3|180||International Centre for Diarrhoeal Disease Research, Bangladesh|||||f||||||||||||||2017-02-18 17:28:50.450967|2017-02-18 17:28:50.450967
NCT00142259|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2006-12-05|||October 2002||2002-10-01|September 2005|2005-09-01|August 2009||2009-08-01|||||Interventional|||Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia|Randomisierte, Doppelblinde Langzeitstudie Zur Klinischen Wirksamkeit Der Bilateralen Globus Pallidus Internus-Stimulation Bei Idiopathischer Generalisierter Oder Segmentaler Dystonie|Unknown status|Active, not recruiting|Phase 4|40||German Parkinson Study Group (GPS)|||||f||||||||||||||2017-02-18 17:28:50.54786|2017-02-18 17:28:50.54786
NCT00142246|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2017-01-25|||January 2005||2005-01-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.|Intermittent Preventive Treatment in Schools: a Randomised Controlled Trial of the Impact of IPT on Malaria, Anaemia and Education Amongst Schoolchildren in Western Kenya|Completed||Phase 3|6758|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 17:28:50.759174|2017-02-18 17:28:50.759174
NCT00142233|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-09-11|||June 2004||2004-06-01|August 2005|2005-08-01|December 2008|Anticipated|2008-12-01|||||Interventional|||EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis|Double Blind Randomised Controlled Trial to Investigate the Efficacy of ANTOX (Vers) 1.2 and MGCT (Magnesiocard) for the Treatment of Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis|Unknown status|Recruiting|Phase 2/Phase 3|240|Anticipated|University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:28:50.870679|2017-02-18 17:28:50.870679
NCT00142220|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2006-09-08|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Interventional|||The Benefit of Adding Fish Oil to the Nutrition of Critically Ill Patients|Comparison Between Two Different Proportions of Omega-3- and Omega-6-Fatty Acids in the Parenteral Nutrition of Critically Ill Patients|Completed||Phase 4|160||University Medicine Greifswald|||||f||||||||||||||2017-02-18 17:28:50.969066|2017-02-18 17:28:50.969066
NCT00142207|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2017-01-11|||January 2004||2004-01-01|January 2017|2017-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Preventing Malaria During Pregnancy in Epidemic-prone Areas.|The Efficacy and Cost-effectiveness of Malaria Prevention in Pregnancy in an Area of Low and Unstable Transmission in Kabale, Uganda: Use of Intermittent Preventive Treatment and Insecticide-treated Nets.|Completed||Phase 3|4775|Actual|London School of Hygiene and Tropical Medicine||3|||f||||t||||||||||2017-02-18 17:28:51.046916|2017-02-18 17:28:51.046916
NCT00142194|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2013-09-26|||June 2005||2005-06-01|September 2013|2013-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation|Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation|Completed||Phase 1|47|Actual|Emory University|||1||f||||f||||||||||2017-02-18 17:28:51.164969|2017-02-18 17:28:51.164969
NCT00142181|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-12-19|||March 2003||2003-03-01|December 2012|2012-12-01|June 2008|Actual|2008-06-01|October 2005|Actual|2005-10-01||Interventional|||Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia|Phase II Study of Campath-1H in Patients With Lymphoplasmacytic Lymphoma (Waldenstrom's Macroglobulinemia)|Completed||Phase 2|27|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:28:51.25801|2017-02-18 17:28:51.25801
NCT00142168|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2016-03-23|2012-12-19||September 2004||2004-09-01|March 2016|2016-03-01|April 2008|Actual|2008-04-01|May 2006|Actual|2006-05-01||Interventional|||CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia|Phase II Study of CC-5103 and Rituximab in Waldenstrom's Macroglobulinemia|Terminated||Phase 2|16|Actual|Dana-Farber Cancer Institute|Due to toxicity, study was terminated.|1||Toxicity|f||||t||||||||||2017-02-18 17:28:51.369817|2017-02-18 17:28:51.369817
NCT00142155|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-06-23|||January 2002||2002-01-01|June 2011|2011-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia|Correlation of Fc Gamma RIIIA Receptor Expression and Response to Rituximab and Other Monoclonal Antibodies in Patients With Waldenstrom's Macroglobulinemia|Completed||N/A|300|Anticipated|Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:28:51.847835|2017-02-18 17:28:51.847835
NCT00142129|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-06-23|||December 2003||2003-12-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia|Phase II Study of Velcade in Waldenstrom's Macroglobulinemia|Completed||Phase 2|27||Dana-Farber Cancer Institute|||||||||||||||||||2017-02-18 17:28:51.935774|2017-02-18 17:28:51.935774
NCT00142116|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2014-05-08|2013-06-13||May 2003||2003-05-01|May 2014|2014-05-01|February 2008|Actual|2008-02-01|February 2004|Actual|2004-02-01||Interventional|||Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia|Phase II Study of Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia|Completed||Phase 2|25|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:28:52.022246|2017-02-18 17:28:52.022246
NCT00142103|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-05-13|||September 2005||2005-09-01|May 2011|2011-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects|CPG10101 Combination Therapy For The Treatment Of Hepatitis C: A Phase 1b Open Label Randomized Trial Of CPG10101 Alone, With Interferon, Ribavirin, Or Interferon And Ribavirin In The Treatment Of Relapsed Hepatitis C Virus (HCV) Subjects|Completed||Phase 1|91|Actual|Pfizer||6|||f||||t||||||||||2017-02-18 17:28:52.275696|2017-02-18 17:28:52.275696
NCT00142090|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-02-02|||November 2004||2004-11-01|January 2009|2009-01-01|July 2007|Actual|2007-07-01|December 2005|Actual|2005-12-01||Interventional|||Use of Salt-Water Solution to Improve Symptoms in Concussion|Use of 3% Hypertonic Saline to Improve Clinical Symptoms in Concussed Patients|Completed||N/A|8|Actual|Rady Children's Hospital, San Diego||2|||f||||f||||||||||2017-02-18 17:28:52.396161|2017-02-18 17:28:52.396161
NCT00142077|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-04-04|||October 2005||2005-10-01|January 2006|2006-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Electronic Health Records for Health Promotion|Health Promotion in the Workplace Using Personally Controlled Health Records|Completed||N/A|700||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:28:52.499737|2017-02-18 17:28:52.499737
NCT00142064|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-04-16|||August 2005||2005-08-01|September 2006|2006-09-01|April 2007|Actual|2007-04-01|||||Interventional|||A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures|A Randomized Control Trial Comparing Single to Multiple Application Lidocaine Analgesia Prior to Urethral Catheterization Procedures|Completed||Phase 2|200||Children's Mercy Hospital Kansas City|||||f||||t||||||||||2017-02-18 17:28:52.593555|2017-02-18 17:28:52.593555
NCT00142051|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2014-07-21|||April 2005||2005-04-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis|Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis|Terminated||Phase 2|18|Actual|Boston Children’s Hospital||2||18 or 20 enrolled, stopped due to paucity of available participants|f||||t||||||||||2017-02-18 17:28:52.697272|2017-02-18 17:28:52.697272
NCT00142038|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2007-04-17|||March 2004||2004-03-01|April 2007|2007-04-01|December 2007||2007-12-01|||||Interventional|||Docetaxel and Capecitabine in Advanced Gastric Cancer|Phase II Study of Docetaxel and Capecitabine as 1st Line Therapy for Patients With Locally Advanced or Metastatic Gastric Cancer|Completed||Phase 2|80||Charite University, Berlin, Germany|||||f||||||||||||||2017-02-18 17:28:52.812025|2017-02-18 17:28:52.812025
NCT00142025|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2009-02-18|||September 2001||2001-09-01|February 2009|2009-02-01|March 2002||2002-03-01|||||Interventional|||Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma|Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Oxcarbazepine Efficacy in Asthma Therapy|Completed||Phase 4|55||Centre of Chinese Medicine, Georgia|||||f||||||||||||||2017-02-18 17:28:52.920208|2017-02-18 17:28:52.920208
NCT00142012|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-11-16|||October 2002||2002-10-01|September 2005|2005-09-01|June 2005||2005-06-01|||||Interventional|||School-Based Obesity Prevention Program|School-Based Obesity Prevention Program|Completed||N/A|1500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:28:53.242561|2017-02-18 17:28:53.242561
NCT00141999|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2012-09-26|||May 2001||2001-05-01|September 2012|2012-09-01|March 2008|Actual|2008-03-01|March 2005|Actual|2005-03-01||Observational|||Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents|An Evaluation of Long-Term Protection Against Hepatitis B Virus Infection: Response of Alaska Native Children and Adolescents Who Received the Primary Recombinant Hepatitis B Vaccine Series Beginning at Birth to an Additional Dose of Vaccine|Completed||Phase 4|400||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:28:53.348705|2017-02-18 17:28:53.348705
NCT00141986|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-04-25|||November 2003||2003-11-01|September 2005|2005-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 Diabetes|Pilot Trial of Vitamin D for the Prevention of Type 1 Diabetes|Completed||Phase 1|9|Actual|Canadian Diabetes Association||2|||f||||f||||||||||2017-02-18 17:28:53.447371|2017-02-18 17:28:53.447371
NCT00141973|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2008-05-13|||November 2004||2004-11-01|May 2008|2008-05-01|December 2005||2005-12-01|||||Observational|||Time Course of Procalcitonin and C Reactive Protein in Septic Patients Under Treatment With Corticosteroids||Completed||N/A|||Ospedale Regionale Bellinzona e Valli|||||f||||||||||||||2017-02-18 17:28:53.562232|2017-02-18 17:28:53.562232
NCT00141960|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2011-11-18|||September 2005||2005-09-01|June 2010|2010-06-01||||||||Interventional|||Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease|YM1170 Phase 2/3 Study: A Double Blind, Placebo Controlled, Group-comparison Study in Patients With Non-erosive Gastroesophageal Reflux Disease|Completed||Phase 2/Phase 3|480||Astellas Pharma Inc|||||f||||||||||||||2017-02-18 17:28:53.63689|2017-02-18 17:28:53.63689
NCT00141947|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-07-23|||September 2005||2005-09-01|October 2005|2005-10-01|September 2006||2006-09-01|||||Interventional|||Bexarotene Treatment in Schizophrenia|Safety and Efficacy of Add-On Oral Bexarotene to Antipsychotic Treatment in Schizophrenia Patients: An Open Label Trial|Unknown status|Recruiting|Phase 3|15|Anticipated|Beersheva Mental Health Center|||||f||||t||||||||||2017-02-18 17:28:53.733988|2017-02-18 17:28:53.733988
NCT00141934|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-04-04|||August 2005||2005-08-01|April 2007|2007-04-01||||||||Interventional|||A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.|Phase II Randomised, Double-Blind, Multicentre, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Compare the Efficacy, Safety and Tolerability of 3 Strengths of AD 452 in Adults With Active RA Who Are Currently Taking Methotrexate.|Completed||Phase 2|232||Sosei|||||||||||||||||||2017-02-18 17:28:53.820611|2017-02-18 17:28:53.820611
NCT00141921|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2016-12-15|2016-11-29||August 2005||2005-08-01|December 2016|2016-12-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis|An Open-Label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects With Plaque Psoriasis|Completed||Phase 3|182|Actual|Amgen||1|||f||||t||||||||||2017-02-18 17:28:53.917834|2017-02-18 17:28:53.917834
NCT00141908|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-07-18|||October 2006||2006-10-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate|Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate|Completed||Phase 2|290|Anticipated|American University of Beirut Medical Center||2|||f||||f||||||||||2017-02-18 17:28:54.811873|2017-02-18 17:28:54.811873
NCT00141895|ClinicalTrials.gov processed this data on February 17, 2017|2005-09-01|2013-07-18|||September 2004||2004-09-01|July 2013|2013-07-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Termination for Intrauterine Fetal Death|A Randomized Trial of Two Regimens of Misoprostol for Second Trimester Intrauterine Fetal Death|Terminated||Phase 3|73|Actual|American University of Beirut Medical Center||2||Difficulty recruiting|f||||f||||||||||2017-02-18 17:28:54.929689|2017-02-18 17:28:54.929689
NCT00141882|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2010-11-03|||March 1999||1999-03-01|November 2010|2010-11-01|August 2006|Actual|2006-08-01|January 2006|Actual|2006-01-01||Interventional|||Memantine in Patients With Chronic Glaucoma||Completed||Phase 3|1119|Actual|Allergan||3|||f||||f||||||||||2017-02-18 17:28:55.042883|2017-02-18 17:28:55.042883
NCT00141869|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2017-01-24|||August 30, 2005||2005-08-30|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Observational|||Brain Activity Associated With Tics in Patients With Tourette Syndrome|MEG Study of Altered Sensory Processing in Tourette Syndrome: An Exploration of Sensory Tics|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:28:55.113541|2017-02-18 17:28:55.113541
NCT00141856|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-06-19|||June 2005||2005-06-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study)|Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study)|Completed||Phase 4|420|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 17:28:55.223957|2017-02-18 17:28:55.223957
NCT00141843|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-04-21|||July 2005||2005-07-01|April 2008|2008-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A|A Randomized Two-Way Blinded Crossover-Design Study to Establish the Bioequivalence of B-Domain Deleted Recombinant Factor VIII (BDDrFVIII,Refacto AF) With a Full Length Recombinant Factor VIII Preparation (FLrFVIII,Advate), Followed by an Open-Label Trial of the Safety and Efficacy of ReFacto AF in Previously Treated Patients With Hemophilia A.|Completed||Phase 3|100||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:28:55.336725|2017-02-18 17:28:55.336725
NCT00141830|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-09-15|||August 2005||2005-08-01|September 2009|2009-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis|A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 3 Oral Doses of ERB-041 in Subjects With Rheumatoid Arthritis on a Background of Methotrexate Therapy|Completed||Phase 2|159|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:28:55.458515|2017-02-18 17:28:55.458515
NCT00141817|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-11-23|2011-11-23||August 2005||2005-08-01|November 2011|2011-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study Evaluating Pantoprazole in Children With GERD|A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of Pantoprazole Sodium in Children Aged 1 Through 11 Years With Endoscopically Proven GERD|Completed||Phase 3|41|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:28:55.710259|2017-02-18 17:28:55.710259
NCT00141804|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-11-30|||January 2002||2002-01-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Efficacy and Safety of Sirolimus in Combination With Tacrolimus|A Randomized Multicenter Study to Compare Tacrolimus and MMF With Tacrolimus and Rapamycin in Patients After Renal Transplantation|Unknown status|Active, not recruiting|Phase 3|190||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:28:56.403026|2017-02-18 17:28:56.403026
NCT00141791|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-08-06|||May 2005||2005-05-01|August 2009|2009-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study Evaluating Etanercept in Moderate to Severe Asthma|A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Safety and Efficacy of Etanercept 25mg Twice Weekly in Subjects With Moderate to Severe Persistent Asthma|Completed||Phase 2|120||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:28:56.495043|2017-02-18 17:28:56.495043
NCT00141778|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2013-02-19|2012-08-03||April 2005||2005-04-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|July 2010|Actual|2010-07-01||Interventional|||Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)|RAAS, Inflammation, and Post-operative AF|Completed||Phase 2/Phase 3|455|Actual|Vanderbilt University|We excluded patients with an ejection fraction less than 30% or a creatinine above 1.6 and therefore the results are not applicable to patients with left ventricular dysfunction or more severe chronic kidney disease.|3|||f||||t||||||||||2017-02-18 17:28:56.783722|2017-02-18 17:28:56.783722
NCT00141765|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2014-05-19|2014-05-19||January 1997||1997-01-01|May 2014|2014-05-01|February 2010|Actual|2010-02-01|December 2008|Actual|2008-12-01||Interventional|||Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers|Myeloablative Chemotherapy With Stem Cell Rescue for Rare Poor-Prognosis Cancers|Completed||Phase 2|25|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:28:57.613224|2017-02-18 17:28:57.613224
NCT00141752|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-10-31|||October 2002||2002-10-01|January 2012|2012-01-01||||December 2006|Actual|2006-12-01||Observational|||Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke Patients|Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke Patients|Completed||N/A|311|Actual|University Health Network, Toronto|||1||f||||||||||||||2017-02-18 17:28:57.832821|2017-02-18 17:28:57.832821
NCT00141739|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-12-01|2014-01-21||August 2004||2004-08-01|December 2016|2016-12-01|September 2012|Actual|2012-09-01|August 2011|Actual|2011-08-01||Interventional|||Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)|The Addition of Etanercept to Standard GVHD Prophylaxis in Patients Undergoing a Full Intensity Allogeneic Hematopoietic Stem Cell Transplant for the Prevention of Transplant Related Complications|Completed||Phase 2|100|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:28:57.92552|2017-02-18 17:28:57.92552
NCT00141726|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-11-04|2014-03-12||October 2003||2003-10-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|July 2008|Actual|2008-07-01||Interventional||All patients enrolled that received at least one scheduled dose.|Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant|Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Sub-Acute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation. A Phase II Study|Completed||Phase 2|34|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:28:58.336239|2017-02-18 17:28:58.336239
NCT00141713|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2013-03-12|||October 2003||2003-10-01|March 2013|2013-03-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease|The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease|Completed||Phase 2|40|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-02-18 17:28:58.726574|2017-02-18 17:28:58.726574
NCT00141700|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-12-28|||March 2003||2003-03-01|December 2007|2007-12-01|December 2005|Actual|2005-12-01|March 2005|Actual|2005-03-01||Interventional|||Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma|Rituximab Plus High-Dose Chemotherapy With Autologous Stem Cell Support for Poor-Prognosis Non-Hodgkin's Lymphoma|Terminated||Phase 2|30||University of Michigan Cancer Center||||enrollment completed|f||||||||||||||2017-02-18 17:28:58.827425|2017-02-18 17:28:58.827425
NCT00141687|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-09-14|||December 2004||2004-12-01|September 2016|2016-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Early External Cephalic Version (ECV) 2 Trial|Early External Cephalic Version 2 Trial|Completed||N/A|1543|Actual|McMaster University||2|||f||||f||||||||||2017-02-18 17:28:58.916704|2017-02-18 17:28:58.916704
NCT00141674|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-09-02|||March 2005||2005-03-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Age of Blood in Brain Injury|A Prospective Randomized Controlled Trial Comparing the Effects of Fresh vs. Old Blood on Cerebral Oxygen Extraction in Patients With Traumatic Brain Injuries|Completed||N/A|60|Anticipated|University of British Columbia|||||f||||||||||||||2017-02-18 17:28:59.029497|2017-02-18 17:28:59.029497
NCT00141661|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-08-19|||October 2005||2005-10-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients|A Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multiple Dose, Multicenter Study in Subjects With Mild to Moderate Dementia of the Alzheimer's Type to Evaluate the Safety and Tolerability of Two 10-Week Dose Regimens of Orally-Administered PF-04494700|Completed||Phase 2|67|Actual|Pfizer||3|||f||||f||||||||||2017-02-18 17:28:59.120929|2017-02-18 17:28:59.120929
NCT00141648|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-09-29|||September 2000||2000-09-01|September 2009|2009-09-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Chemotherapy and Radiotherapy for Osteolymphoma|A Prospective Non-randomised Trial of Chemotherapy and Radiotherapy for Osteolymphoma|Completed||N/A|70|Actual|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||f||||||||||2017-02-18 17:28:59.368297|2017-02-18 17:28:59.368297
NCT00141635|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-08-31|||December 2002||2002-12-01|August 2005|2005-08-01|June 2004||2004-06-01|||||Observational|||Implementation of Quality of Life Diagnostics and Therapy|Enhancing the Status of Quality of Life Diagnostics in Caring for Breast Cancer Patients: Results From a Multilevel Implementation Study in a Regional Tumor Centre|Completed||Phase 1|190||Tumorzentrum Regensburg e.V.|||||f||||||||||||||2017-02-18 17:28:59.503415|2017-02-18 17:28:59.503415
NCT00141622|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-05-14|||April 2005||2005-04-01|August 2005|2005-08-01|October 2006||2006-10-01|||||Interventional|||Sodium-Endothelial Function-CKD Study|Does Sodium Affect Endothelial Function in Individuals With Chronic Kidney Disease?|Completed||N/A|50|Anticipated|St George's, University of London|||||f||||||||||||||2017-02-18 17:28:59.598564|2017-02-18 17:28:59.598564
NCT00141609|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-05-10|||April 2004||2004-04-01|May 2007|2007-05-01|October 2006||2006-10-01|||||Interventional|||Haemodialysis Salt Reduction Study|A Study Looking at the Effects of a Modest Reduction in Dietary Salt Intake on Blood Pressure Control in Haemodialysis Patients|Completed||N/A|20|Anticipated|St George's, University of London|||||f||||||||||||||2017-02-18 17:28:59.692313|2017-02-18 17:28:59.692313
NCT00141596|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-06-05|||July 2003||2003-07-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Interventional|||Extracellular Fluid in Resistant Hypertension|A Study to Investigate the Contribution of Extracellular Fluid Volume Expansion to Drug Resistant Hypertension|Terminated||N/A|32|Anticipated|St George's, University of London||||Insufficient accrual rate|f||||||||||||||2017-02-18 17:28:59.780796|2017-02-18 17:28:59.780796
NCT00141583|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-06-05|||April 2004||2004-04-01|May 2007|2007-05-01|October 2006|Actual|2006-10-01|||||Interventional|||The Renin-Angiotensin System in Essential Hypertension|The Renin-Angiotensin System in Essential Hypertension|Terminated||N/A|11|Anticipated|St George's, University of London||||Insufficient accrual rate|f||||||||||||||2017-02-18 17:28:59.876907|2017-02-18 17:28:59.876907
NCT00141570|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-01-15|||June 2004||2004-06-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women|A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women|Completed||Phase 2|350||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:28:59.966144|2017-02-18 17:28:59.966144
NCT00141557|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-04-10|||July 2004||2004-07-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|||The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women|A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women|Terminated||Phase 2|133|Actual|Solvay Pharmaceuticals||2||Lack of enrollment|f||||f||||||||||2017-02-18 17:29:00.33078|2017-02-18 17:29:00.33078
NCT00141544|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-04-10|||July 2004||2004-07-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|April 2007|Actual|2007-04-01||Interventional|||The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women|A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women|Terminated||Phase 2|28|Actual|Solvay Pharmaceuticals||2||Lack of enrollment|f||||f||||||||||2017-02-18 17:29:00.533346|2017-02-18 17:29:00.533346
NCT00141531|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2012-06-13|||July 2005||2005-07-01|June 2012|2012-06-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Phase II Trial of EOquin in High-risk Superficial Bladder Cancer|Phase II Study of Intravesical Instillation of EOQUIN™ in High Risk Superficial Bladder Cancer|Completed||Phase 2|53|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||f||||||||||2017-02-18 17:29:00.717375|2017-02-18 17:29:00.717375
NCT00141518|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-06-06|2016-04-11||March 2006||2006-03-01|June 2016|2016-06-01|April 2011|Actual|2011-04-01|March 2011|Actual|2011-03-01||Interventional|DAPHNE||Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact|A Long-term Health Economics Study of Intraduodenal Levodopa (Duodopa®) in Routine Care for Patients With Advanced Idiopathic Parkinson's Disease With Severe Motor Fluctuations and Hyper-/Dyskinesia|Completed||Phase 4|77|Actual|AbbVie||3|||f||||||||||||||2017-02-18 17:29:00.891157|2017-02-18 17:29:00.891157
NCT00141505|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-01-15|||February 2005||2005-02-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||PK Effects of Bifeprunox & Valproate in Bipolar I|Placebo-controlled Study on the Pharmacokinetics,Pharmacodynamics, Safety and Tolerability of Concurrent Valproate and Bifeprunox Administration in Subjects With Bipolar I Disorder|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:29:09.065071|2017-02-18 17:29:09.065071
NCT00141492|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-01-19|||October 2004||2004-10-01|January 2009|2009-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes|A Double Blind, Randomized, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of Androgel, as an Adjunct to Hypoglycemic Therapy, in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:29:09.151631|2017-02-18 17:29:09.151631
NCT00141479|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-01-15|||May 2005||2005-05-01|May 2006|2006-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox|A Single-center Safety and Tolerability Study to Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:29:09.410986|2017-02-18 17:29:09.410986
NCT00141466|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-04-22|||September 2005||2005-09-01|February 2007|2007-02-01|July 2007|Anticipated|2007-07-01|||||Interventional|||Implementation of a New Strategy to Identify HNPCC Patients|Cost Effectiveness of Two Different Implementation Procedures to Change Clinicians Practice Roles in the Detection of Hereditary Colorectal Cancer|Unknown status|Recruiting|N/A|360|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 17:29:09.490972|2017-02-18 17:29:09.490972
NCT00141453|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-05-09|2009-08-31||April 2003||2003-04-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|August 2008|Actual|2008-08-01||Interventional|||ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial|CS-866DM Phase 3 Clinical Study: A Double-Blind Controlled Trial in Patients With Diabetic Nephropathy and Overt Proteinuria Secondary to Type 2 Diabetes Mellitus|Completed||Phase 3|577|Actual|Daiichi Sankyo Inc.||2|||f||||||||||||||2017-02-18 17:29:09.817386|2017-02-18 17:29:09.817386
NCT00141440|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-12-29|||July 2005||2005-07-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The Effect of Cycling Off Criteria During Pressure Support Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients|The Effect of Cycling Off Criteria During Pressure Support Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients|Completed||N/A|13|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 17:29:11.101694|2017-02-18 17:29:11.101694
NCT00141427|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-03-21|||November 2004||2004-11-01|June 2006|2006-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.|Pregabalin In Partial Seizures (Preps) : An Open-Label, International, Multicenter Add-On Therapy Trial|Completed||Phase 4|540||Pfizer|||||f||||||||||||||2017-02-18 17:29:11.294187|2017-02-18 17:29:11.294187
NCT00141414|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-12-28|||November 1997||1997-11-01|December 2006|2006-12-01|October 2005||2005-10-01|||||Interventional|||To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.|Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.|Completed||Phase 2|82||Pfizer|||||||||||||||||||2017-02-18 17:29:11.621574|2017-02-18 17:29:11.621574
NCT00141401|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-08-15|||September 1999||1999-09-01|August 2007|2007-08-01|July 2005|Actual|2005-07-01|||||Interventional|||Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.|An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.|Completed||Phase 3|240||Pfizer|||||f||||||||||||||2017-02-18 17:29:11.734116|2017-02-18 17:29:11.734116
NCT00141388|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-11-05|||July 1998||1998-07-01|November 2009|2009-11-01|October 2005|Actual|2005-10-01|||||Interventional|||To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures|Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.|Completed||Phase 3|455|Actual|Pfizer|||||||||||||||||||2017-02-18 17:29:11.815212|2017-02-18 17:29:11.815212
NCT00141375|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-01-09|||August 2002||2002-08-01|January 2008|2008-01-01|January 2006|Actual|2006-01-01|||||Interventional|||To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.|An Open-Label Extension to Evaluate the Safety and Efficacy of Pregabalin for Treatment of Chronic Central Neuropathic Pain After Spinal Cord Injury.|Completed||Phase 3|132||Pfizer|||||f||||||||||||||2017-02-18 17:29:11.983807|2017-02-18 17:29:11.983807
NCT00141362|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-12-29|||October 2001||2001-10-01|December 2006|2006-12-01|August 2005||2005-08-01|||||Interventional|||Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.|An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Chronic Neuropathic Pain.|Completed||Phase 3|325||Pfizer|||||f||||||||||||||2017-02-18 17:29:12.072006|2017-02-18 17:29:12.072006
NCT00141349|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-07-23|||February 2005||2005-02-01|January 2006|2006-01-01|August 2005||2005-08-01|||||Interventional|||Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction|A Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study to Assess the Time to Onset, Safety, and Toleration of Differing Doses and Combinations of Immediate Release and Modified Release Formulations of UK369,003 in Adult Male Subject With Erectile Dysfunction|Completed||Phase 2|300||Pfizer|||||||||||||||||||2017-02-18 17:29:12.146791|2017-02-18 17:29:12.146791
NCT00141336|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-12-28|||November 1999||1999-11-01|December 2006|2006-12-01|July 2005||2005-07-01|||||Interventional|||To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.|Pregabalin BID Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.|Completed||Phase 3|750||Pfizer|||||||||||||||||||2017-02-18 17:29:12.274028|2017-02-18 17:29:12.274028
NCT00141323|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-08-08||2009-03-26|November 2001||2001-11-01|August 2011|2011-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|PEARL||Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)|PEARL: Postmenopausal Evaluation And Risk-Reduction With Lasofoxifene|Completed||Phase 3|8556|Anticipated|Ligand Pharmaceuticals||3|||f||||t||||||||||2017-02-18 17:29:12.463838|2017-02-18 17:29:12.463838
NCT00141310|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-07-23|||September 2004||2004-09-01|July 2007|2007-07-01|April 2006|Actual|2006-04-01|||||Interventional|||Sildenafil Citrate for the Treatment of Established Pre-Eclampsia|A Randomised, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study to Evaluate the Efficacy, Safety and Toleration of Oral Sildenafil Citrate Administered in the Dose Range of 20 - 80 Mg TID for the Treatment of Pre-Eclampsia. (PET)|Terminated||Phase 2|76||Pfizer||||"Study prematurely discont’d 20-Apr-2006 after interim analysis suggested sample size could be~   reduced without losing power. No safety concerns led to decision."|f||||||||||||||2017-02-18 17:29:13.1009|2017-02-18 17:29:13.1009
NCT00141297|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-12-03|2015-03-04||September 2004||2004-09-01|December 2015|2015-12-01|December 2014|Actual|2014-12-01|July 2008|Actual|2008-07-01||Interventional||Full Analysis Set (FAS) included all enrolled participants who received at least one dose of study medication.|A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer|A Phase I Clinical, Pharmacokinetic, And Pharmacodynamic Evaluation Of 2 Schedules Of Oral PD 0332991, A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer|Completed||Phase 1|74|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:29:13.250087|2017-02-18 17:29:13.250087
NCT00141284|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-05-09||2011-01-03|October 2005||2005-10-01|May 2011|2011-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C|A Phase Iv Single-Arm Open-Label Non-Randomized Study To Evaluate The Safety And Pharmacokinetics Of Nelfinavir (Viracept, A430) 1250mg Twice Daily (250mg Or 625mg Forms) With Lamivudine/Zidovudine (Combivir) Background Therapy In Hiv/Hepatitis C Virus (Hcv) Co-Infected Subjects With Hepatic Dysfunction.|Completed||Phase 4|12|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:29:18.070403|2017-02-18 17:29:18.070403
NCT00141271|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-04-03|2009-02-24||July 2005||2005-07-01|April 2009|2009-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression|A Six-Week, Randomized, Double-Blind, Multicenter, Fixed-Flexible Dose, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral Ziprasidone in Outpatients With Bipolar I Depression|Completed||Phase 3|536|Actual|Pfizer||3|||f||||t||||||||||2017-02-18 17:29:18.217966|2017-02-18 17:29:18.217966
NCT00141258|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-04-28|||October 2005||2005-10-01|April 2009|2009-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Pregabalin Epilepsy Add-On Trial|Pregabalin Add-On Titration Trial: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Pregabalin (150 mg - 600 mg/Day) Using a Flexible, Optimized Dose Schedule in Subjects With Partial Seizures|Completed||Phase 3|178|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:29:21.074957|2017-02-18 17:29:21.074957
NCT00141245|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-12-28|||October 1998||1998-10-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.|Pregabalin Open-Label, Multicenter Add-On Trial Following a 4-Day Double-Blind Transition Period to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.|Completed||Phase 3|325||Pfizer|||||f||||||||||||||2017-02-18 17:29:21.169868|2017-02-18 17:29:21.169868
NCT00141232|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-11-21|||November 2004||2004-11-01|November 2008|2008-11-01|July 2006|Actual|2006-07-01|||||Interventional|AFORRD||Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes|A Multicentre, Randomised, Double Blind Placebo Controlled Trial Evaluating Atorvastatin in Factorial With Omega-3 Fatty Acids Cardiovascular Risk Reduction in Patients With Type 2 Diabetes|Completed||Phase 4|810|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:29:21.300709|2017-02-18 17:29:21.300709
NCT00141219|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-09-23|2008-12-19||December 2005||2005-12-01|September 2009|2009-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pregabalin Peripheral Neuropathic Pain Study|A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pregabalin (150 mg - 600 mg/Day) Using a Flexible, Optimized Dose Schedule in Subjects With Peripheral Neuropathic Pain|Completed||Phase 3|241|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:29:21.648282|2017-02-18 17:29:21.648282
NCT00141206|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-06-01|||May 2003||2003-05-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation|A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation|Completed||Phase 3|1005||Pfizer|||||||||||||||||||2017-02-18 17:29:22.555211|2017-02-18 17:29:22.555211
NCT00141193|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-08-05|||February 2001||2001-02-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|PRESAP||Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)|Clinical Protocol For a Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Celecoxib (SC-58635) In The Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)|Completed||Phase 3|1561|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 17:29:22.670033|2017-02-18 17:29:22.670033
NCT00141180|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-07-23|||September 2003||2003-09-01|November 2005|2005-11-01|October 2005||2005-10-01|||||Interventional|||CP-481,715 Nickel Allergy Study.|Placebo-Controlled, Randomized, Parallel Group, Multiple-Dose Study to Evaluate the Effects of CP-481,715 on Clinical Response and Cellular Infiltration Following Contact Allergen Challenge to the Skin of Nickel Allergic Subjects.|Completed||Phase 1|48||Pfizer|||||||||||||||||||2017-02-18 17:29:22.876641|2017-02-18 17:29:22.876641
NCT00141167|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2010-09-03|||February 2005||2005-02-01|September 2010|2010-09-01|January 2006|Actual|2006-01-01|||||Interventional|||A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation|A Twelve-Week, Double-Blind, Placebo-Controlled, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate 1 MG BID for Smoking Cessation|Completed||Phase 3|250|Actual|Pfizer|||||||||||||||||||2017-02-18 17:29:22.967778|2017-02-18 17:29:22.967778
NCT00141154|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-05-27|||October 2004||2004-10-01|May 2011|2011-05-01||||||||Interventional|||Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan|A Randomized, Multicenter, Active And Placebo Controlled Parallel Group Study To Evaluate The Efficacy And Safety Of Celecoxib (Ym177) 200 Bid Compared To Loxoprofen 60 Mg Tid In Patients With Low Back Pain|Completed||Phase 3|1234|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:29:23.059061|2017-02-18 17:29:23.059061
NCT00141141|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-10-28|||January 2004||2004-01-01|October 2008|2008-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia|A Phase IV, Multicenter, Randomized, Open Label Study To Evaluate The Efficacy And Safety Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia|Completed||Phase 4|383|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:29:23.373678|2017-02-18 17:29:23.373678
NCT00141128|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2011-05-31|||December 2005||2005-12-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.|Measurement Of Urethral Function In Women With Stress Urinary Incontinence - Evaluation Of The Sensitivity Of Urethral Reflectometry Compared To Urethral Pressure Profilometry, Using [S,S]-Reboxetine To Detect Pharmacological Augmentation Of Urethral Pressure.|Completed||Phase 2|18|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:29:23.491146|2017-02-18 17:29:23.491146
NCT00141115|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-12-14|||March 2004||2004-03-01|December 2011|2011-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Levetiracetam for the Treatment of Alcohol Dependence and Anxiety|Pilot Trial of Levetiracetam in the Treatment of Alcohol Dependence With Comorbid Anxiety|Completed||Phase 2|3|Actual|New York State Psychiatric Institute||1|||f||||||||||||||2017-02-18 17:29:23.572271|2017-02-18 17:29:23.572271
NCT00141102|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2011-04-18|2010-05-11||October 2005||2005-10-01|April 2011|2011-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|CONDOR||Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis|Double-Blind, Triple Dummy, Parallel-Group, Randomized, Six-Month Study To Compare Celecoxib (200 Mg BID) With Diclofenac Sr (75 Mg BID) Plus Omeprazole (20 Mg QD) For Gastrointestinal Events In Subjects With Osteoarthritis And Rheumatoid Arthritis At High-Risk Of Gastrointestinal Adverse Events|Completed||Phase 4|4484|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 17:29:23.708126|2017-02-18 17:29:23.708126
NCT00141089|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-01-31|||March 2004||2004-03-01|January 2008|2008-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.|Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.|Completed||Phase 3|1026||Novartis|||||f||||||||||||||2017-02-18 17:29:25.212119|2017-02-18 17:29:25.212119
NCT00141076|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2010-08-27|||October 2003||2003-10-01|August 2010|2010-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Glycemic Index and CVD: a Crossover Feeding Study|Glycemic Index, Obesity, Insulin Resistance and CVD Risk, Part 2|Completed||N/A|24||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:29:25.29021|2017-02-18 17:29:25.29021
NCT00141063|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-12-17|||June 2005||2005-06-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Interventional|||Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD|Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD|Completed||Phase 3|90||Novartis|||||||||||||||||||2017-02-18 17:29:25.377417|2017-02-18 17:29:25.377417
NCT00141050|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-12-17|||May 2005||2005-05-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|||||Interventional|||Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD|Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD|Completed||Phase 3|90||Novartis|||||||||||||||||||2017-02-18 17:29:25.465239|2017-02-18 17:29:25.465239
NCT00141037|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2016-10-19|2013-05-21||March 2004||2004-03-01|October 2016|2016-10-01|November 2010|Actual|2010-11-01|September 2006|Actual|2006-09-01||Interventional|||Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation|Randomized, Multi-Center Comparative Trial of Tacrolimus w/Steroids and Standard Daclizumab Induction vs a Novel Steroid-Free Tacrolimus Based Immunosuppression Protocol w/ Extended Daclizumab Induction in Pediatric Renal Transplantation|Completed||Phase 1/Phase 2|130|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|"The results cannot be generalized and daclizumab has since been withdrawn from the United States market (business-related, not due to any safety issues).~The study was not powered to definitively evaluate small differences in rejection rate."|2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 17:29:25.557508|2017-02-18 17:29:25.557508
NCT00141024|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-06-28|||January 2006||2006-01-01|June 2016|2016-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the Recombinant Protein Vaccine EP-1043 and the DNA Vaccine EP HIV-1090 Given Alone or in Combination in Healthy, HIV-1-Uninfected Adult Participants|Completed||Phase 1|84|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-02-18 17:29:26.422484|2017-02-18 17:29:26.422484
NCT00141011|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-12-21|||September 2005||2005-09-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke|ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke|Terminated||Phase 3|277|Actual|Neurobiological Technologies||2||Futility|f||||t||||||||||2017-02-18 17:29:26.539168|2017-02-18 17:29:26.539168
NCT00140998|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2010-08-12|||January 2001||2001-01-01|August 2010|2010-08-01|June 2004||2004-06-01|||||Interventional|||Estrogen Treatment (Oral vs. Patches) in Turner Syndrome|Estrogen Replacement in Hypogonadal Girls Treated With GH: Differential Effects of Mode of Estrogen Delivery|Completed||Phase 3|16||Nemours Children's Clinic|||||f||||||||||||||2017-02-18 17:29:26.940393|2017-02-18 17:29:26.940393
NCT00140985|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-01-09|||February 2000||2000-02-01|January 2015|2015-01-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)|A Randomized, Parallel, Double Blind Study of Losartan Versus Amlodipine in Patients With Mild to Moderate Hypertension and Chronic Nondiabetic Proteinuric Nephropathy: Evaluation of the Effect on Proteinuria and on the Plasmatic Levels of Growth Factors (TGFß and VEGF)|Completed||Phase 4|97|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:27.044559|2017-02-18 17:29:27.044559
NCT00140972|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-04-06|||December 2004||2004-12-01|April 2015|2015-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)|A Multicenter, Randomized, Parallel-group, 4-Week, Double-Blind and Active Comparator-Controlled Study to Assess Efficacy, Safety, and Tolerability of Etoricoxib 60 mg Once Daily Versus Diclofenac Sodium 75 mg Twice Daily in the Treatment of Chinese Patients With Osteoarthritis of the Knee or Hip|Completed||Phase 4|160|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:27.145529|2017-02-18 17:29:27.145529
NCT00140959|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-03-27|||February 2003||2003-02-01|March 2015|2015-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)|Antihypertensive Effects of a Fixed-dose Combination of Losartan and Hydrochlorothiazide Plus Amlodipine Versus a Hydrochlorothiazide and Atenolol Combination Plus Amlodipine in Subjects With Ambulatory Systolic Hypertension.|Completed||Phase 4|120||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:27.256975|2017-02-18 17:29:27.256975
NCT00140946|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-01-21|||March 1998||1998-03-01|January 2016|2016-01-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|||A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)|A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Two-Period, Parallel-group Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients.|Completed||Phase 4|546|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:27.350709|2017-02-18 17:29:27.350709
NCT00140933|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-12-01|||April 2003||2003-04-01|December 2006|2006-12-01||||||||Interventional|||A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome|A Randomized, Double-Blind, 7-Day Study of the Efficacy and Safety of Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome|Terminated||Phase 3|274||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:27.433122|2017-02-18 17:29:27.433122
NCT00140920|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-06-01|||May 2004||2004-05-01|June 2015|2015-06-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)|A Study to Compare Pre-Operative Administration of Rofecoxib Vs Post-Operative Administration of Diclofenac or Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement in Patients With Osteoarthritis of the Knee.|Terminated||Phase 4|11|Actual|Merck Sharp & Dohme Corp.||||Recruitment/study discontinued after withdrawal of marketing authorisation. No data entered.|f||||||||||||||2017-02-18 17:29:27.513334|2017-02-18 17:29:27.513334
NCT00140907|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-03-17|||March 2000||2000-03-01|March 2015|2015-03-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)|A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Renal Transplant|Completed||N/A|367|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:29:27.594427|2017-02-18 17:29:27.594427
NCT00140894|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-11-30|||March 2003||2003-03-01|November 2006|2006-11-01||||||||Interventional|||A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Rofecoxib in Familial Adenomatous Polyposis (FAP)|Terminated||Phase 4|62||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:27.689339|2017-02-18 17:29:27.689339
NCT00140881|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-11-27|||June 2000||2000-06-01|November 2015|2015-11-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children|Completed||Phase 4|220|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:27.79236|2017-02-18 17:29:27.79236
NCT00140868|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-12-06|||December 2002||2002-12-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery|Outcome of Palliative Management of Malignant Large Bowel Obstruction With Colorectal Stents or Surgery|Completed||Phase 3|180||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:29:27.882616|2017-02-18 17:29:27.882616
NCT00140855|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-04-04|||July 2005||2005-07-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma|A Phase II Study of Anti-CTLA4 Antibody in Advanced Synovial Sarcoma Patients|Terminated||Phase 2|17||Ludwig Institute for Cancer Research||||Study discontinued due to poor accrual.|f||||t||||||||||2017-02-18 17:29:27.981792|2017-02-18 17:29:27.981792
NCT00140842|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-10-03|2011-03-03||May 2005||2005-05-01|September 2011|2011-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents|Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents|Completed||N/A|47|Actual|Massachusetts General Hospital|Limited number of participants-pilot study||2||f||||f||||||Samples Without DNA|"~     Serum and urine collected~   "|||2017-02-18 17:29:28.091993|2017-02-18 17:29:28.091993
NCT00140829|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2012-03-26|||July 2003||2003-07-01|March 2012|2012-03-01|December 2012|Anticipated|2012-12-01|||||Observational|Spatax||SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias|Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias|Unknown status|Recruiting|Phase 1|6000|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||f||||||||||2017-02-18 17:29:28.496072|2017-02-18 17:29:28.496072
NCT00140816|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-07-03|||September 2005||2005-09-01|February 2009|2009-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Dairy Products and Metabolic Effects (Norwegian Part)|Dairy Products and Metabolic Effects - A Multicentre Nordic Study|Completed||N/A|40|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-02-18 17:29:28.638695|2017-02-18 17:29:28.638695
NCT00140803|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-07-11|||October 2003||2003-10-01|July 2007|2007-07-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration|A Randomized, Single-Masked, Multi-Center, Phase 2 Evaluation Of The Effect Of PDT Using Visudyne In Combination With Intravitreal Injection Of Either 0 mg, 1mg or 4mg of Kenalog In Subfoveal Occult & Minimally Classic CNV Secondary To ARMD|Completed||Phase 2|106|Actual|Manhattan Eye, Ear & Throat Hospital||3|||t||||t||||||||||2017-02-18 17:29:28.731491|2017-02-18 17:29:28.731491
NCT00140790|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2016-02-25|||August 2006||2006-08-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|March 2015|Actual|2015-03-01||Interventional|||Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study|Effects of Valsartan on Cardiovascular Events in Patients With Renal Dysfunction|Terminated||Phase 4|1000|Actual|Kumamoto University||2||"The number of actual events was extremely low. We extended the study period, but it was still~   not enough. Also, many patients were loss of follow up."|f||||t||||||||||2017-02-18 17:29:28.832855|2017-02-18 17:29:28.832855
NCT00140764|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-08-09|||January 2003||2003-01-01|August 2011|2011-08-01|March 2005||2005-03-01|||||Interventional|||Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi||Completed||Phase 3|||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:29:28.950532|2017-02-18 17:29:28.950532
NCT00140751|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2013-09-18|||October 2005||2005-10-01|September 2013|2013-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|KALESOLO||Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients|A 48-Weeks National Multicenter Randomized Open Clinical Trial Evaluating Tolerance and Efficacy of a Treatment Simplification by Lopinavir/Ritonavir Versus Continuation of Current Treatment in HIV-Infected Patients With a Viral Load Inferior to 50 Copies/mL Since 6 Months At Least|Completed||Phase 3|186|Actual|Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba||2|||f||||||||||||||2017-02-18 17:29:29.054465|2017-02-18 17:29:29.054465
NCT00140738|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-06-16|||March 2005||2005-03-01|June 2011|2011-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer|A Multicenter, Open-label Phase I/II Trial of the Safety and Efficacy of the dHER2 Recombinant Protein Combined With Immunological Adjuvant AS15 in Patients With Metastatic Breast Cancer Overexpressing HER2/Neu|Completed||Phase 1|3|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 17:29:29.204835|2017-02-18 17:29:29.204835
NCT00140725|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-10-15|||April 2000||2000-04-01|October 2008|2008-10-01||||||||Interventional|||Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)|A Randomised Trial of Lamivudine Plus Interferon Versus Lamivudine for the Treatment of HBeAg Positive Chronic Hepatitis B Virus (HBV)|Completed||Phase 3|160||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:29:29.482884|2017-02-18 17:29:29.482884
NCT00140712|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-09-24|||June 2005||2005-06-01|May 2011|2011-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Ropinirole Tablets In Young Patients With Restless Legs Syndrome|An Open Label, Single Dose, Dose Rising, Multi-centre Study to Assess the Tolerability and Pharmacokinetics of Ropinirole Immediate Release in Adolescent Patients With RLS.|Completed||Phase 1|20|Actual|GlaxoSmithKline||1|||||||f||||||||||2017-02-18 17:29:29.587904|2017-02-18 17:29:29.587904
NCT00140699|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-04-26||||||April 2007|2007-04-01||||||||Observational|||Balance Control and Maturation in Normal and Deaf Children Aged From 6 to 14 Years Old|Balance Control and Maturation in Normal and Deaf Children Aged From 6 to 14 Years Old|Unknown status|Active, not recruiting|N/A|240||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:29:29.691527|2017-02-18 17:29:29.691527
NCT00140686|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2017-01-16|||September 2004||2004-09-01|January 2017|2017-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines|A Multi-country & Multi-center Study to Assess the Efficacy, Safety & Immunogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines|Completed||Phase 3|3994|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:29:29.775269|2017-02-18 17:29:29.775269
NCT00140673|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2016-09-20|||August 2003||2003-08-01|September 2016|2016-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.|A Placebo-controlled, Multi-country & Multi-center Study to Assess the Efficacy, Safety & Immunogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants|Completed||Phase 3|63227|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:29:30.191005|2017-02-18 17:29:30.191005
NCT00140660|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-03-03|||December 2003||2003-12-01|March 2011|2011-03-01|December 2008|Anticipated|2008-12-01|||||Interventional|||ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma|Randomized Study of ACVBP Versus ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 65 Years With Low-risk Localized Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 0)|Terminated||Phase 3|400|Anticipated|Lymphoma Study Association||||Low acrual|f||||||||||||||2017-02-18 17:29:30.328831|2017-02-18 17:29:30.328831
NCT00140647|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-08-21|||July 2001||2001-07-01|August 2008|2008-08-01|July 2006|Actual|2006-07-01|||||Interventional|||The Study of Atherosclerosis With Ramipril and Rosiglitazone|The Study of Atherosclerosis With Ramipril and Rosiglitazone|Completed||Phase 3|1200||Gerstein, Hertzel, MD|||||||||||||||||||2017-02-18 17:29:30.458013|2017-02-18 17:29:30.458013
NCT00140634|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2016-11-03|||March 1995||1995-03-01|November 2016|2016-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||The Objectives of the Cartilage Repair Registry is to Report Long Term Efficacy and Safety of Cartilage Repair Procedures in Registry Patients|Cartilage Repair Registry|Completed||Phase 4|2233|Actual|Vericel Corporation|||1||f||||f||||||||||2017-02-18 17:29:30.555786|2017-02-18 17:29:30.555786
NCT00140621|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-04-16|2015-04-01||July 2005||2005-07-01|April 2015|2015-04-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Efficacy evaluable population (EEP) included all registered participants except those who had serious deviations from protocol compliance requirements, did not receive study drug, had no data available at baseline or after study drug administration, and who were found to have no condition in cardiac Fabry disease.|A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease|A Multicenter Open-label Study of the Safety and Efficacy of α-galactosidase A (R-h α-GAL) Replacement Therapy in Patients With Cardiac Fabry Disease|Completed||Phase 4|6|Actual|Sanofi||1|||f||||f||||||||||2017-02-18 17:29:30.658548|2017-02-18 17:29:30.658548
NCT00140608|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2015-03-17|||June 2003||2003-06-01|March 2015|2015-03-01|May 2005||2005-05-01|||||Interventional|||Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery||Terminated||N/A|||Sanofi|||||f||||||||||||||2017-02-18 17:29:31.091657|2017-02-18 17:29:31.091657
NCT00140595|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2011-03-03|||December 2003||2003-12-01|March 2011|2011-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1|Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients Aged From 18 to 59 Years With Diffuse Large B-cell Lymphoma and a Age-adjusted IPI of 1.|Completed||Phase 3|380|Anticipated|Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:29:31.181148|2017-02-18 17:29:31.181148
NCT00140582|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2015-09-01|||December 2004||2004-12-01|September 2015|2015-09-01|December 2016|Anticipated|2016-12-01|May 2007|Actual|2007-05-01||Interventional|||Primary Rituximab and Maintenance|Advanced Follicular Lymphoma Evaluating the Benefit of Maintenance Therapy With Rituximab (MabThera®) After Induction of Response With Chemotherapy Plus Rituximab in Comparison With no Maintenance Therapy|Active, not recruiting||Phase 3|1217|Actual|Lymphoma Study Association||2|||f||||t||||||||||2017-02-18 17:29:31.297299|2017-02-18 17:29:31.297299
NCT00140569|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-08-31|||January 1994||1994-01-01|August 2005|2005-08-01|January 2004||2004-01-01|||||Interventional|||Randomized Study for Patients With Follicular Lymphoma Needing Treatment|Randomized Study for Patients With Follicular Lymphoma Needing Treatment|Completed||Phase 3|400||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:29:31.433964|2017-02-18 17:29:31.433964
NCT00140556|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-01-14|2010-08-19||August 2005||2005-08-01|January 2013|2013-01-01|April 2010|Actual|2010-04-01|May 2009|Actual|2009-05-01||Interventional|||Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer|Concurrent Angiogenic and EGFR Blockade in Conjunction With Curative Intent Chemoradiation for Locally Advanced Head and Neck Cancer|Completed||Early Phase 1|28|Actual|Duke University||1|||f||||f||||||||||2017-02-18 17:29:31.545999|2017-02-18 17:29:31.545999
NCT00140543|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-11-17|||February 2002||2002-02-01|August 2005|2005-08-01|April 2008||2008-04-01|||||Interventional|||European Trial of Immunosuppression in SPK Tx|A European Multicenter Open-Label Randomised Trial to Evaluate the Efficacy and Safety of Sirolimus and Tacrolimus Compared to MMF and Tacrolimus With Short-Course Induction Therapy, Short-Term Steroids Application in De Novo SPK Transplanted Diabetic Patients|Unknown status|Active, not recruiting|Phase 3|228||EUROSPK Study Group|||||f||||||||||||||2017-02-18 17:29:31.82882|2017-02-18 17:29:31.82882
NCT00140530|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2008-01-10|||March 2004||2004-03-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|||||Interventional|||Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)|A Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Prevention of Restenosis (ISAR-TEST-1)|Completed||Phase 4|450|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:29:32.073275|2017-02-18 17:29:32.073275
NCT00140517|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2017-01-11|||October 2002||2002-10-01|January 2017|2017-01-01|March 2008|Actual|2008-03-01|June 2007|Actual|2007-06-01||Interventional|||Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance|Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance|Completed||N/A|700||London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-02-18 17:29:32.185618|2017-02-18 17:29:32.185618
NCT00140504|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2013-02-24|||April 2003||2003-04-01|February 2013|2013-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Preventing Adverse Drug Events With PatientSite|Preventing Adverse Drug Events With PatientSite|Completed||N/A|800|Anticipated|Dana-Farber Cancer Institute||2|||f||||f||||||||||2017-02-18 17:29:32.296208|2017-02-18 17:29:32.296208
NCT00140491|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2013-10-22|||August 2005||2005-08-01|October 2013|2013-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy|Visual Field Defects in Non-Arteritic Anterior Ischemic Optic Neuropathy: Effect of Vision Restoration Therapy (VRT)|Completed||N/A|20||Emory University|||||f||||||||||||||2017-02-18 17:29:32.424625|2017-02-18 17:29:32.424625
NCT00140478|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2009-12-07|||February 2005||2005-02-01|December 2009|2009-12-01|January 2008|Actual|2008-01-01|June 2006|Actual|2006-06-01||Interventional|||Mifepristone (RU-486) in Androgen Independent Prostate Cancer|A Phase II Study of Mifepristone (RU-486) in Androgen Independent Prostate Cancer With Correlative Assessment of Androgen Receptor Co-Repressor Proteins|Completed||Phase 2|48|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:29:32.520164|2017-02-18 17:29:32.520164
NCT00140465|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-11-13|||October 2004||2004-10-01|November 2007|2007-11-01|July 2005|Actual|2005-07-01|||||Interventional|||75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)|A Double-Blind, Randomized Comparison Between Two Different Clopidogrel Maintenance Doses After Percutaneous Coronary Intervention (ISAR-CHOICE-2)|Completed||Phase 4|60|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:29:32.632043|2017-02-18 17:29:32.632043
NCT00140452|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2007-11-20|||February 2005||2005-02-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Phase II Study Using Thalidomide for the Treatment of ALS|Phase II Study Using Thalidomide for the Treatment of Amyotrophic Lateral Sclerosis|Completed||Phase 2|24|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-02-18 17:29:32.743629|2017-02-18 17:29:32.743629
NCT00140439|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-08-21|||April 2002||2002-04-01|August 2015|2015-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Improving Asthma Outcomes in an Urban Pediatric Population|Improving Asthma Outcomes in a High Morbidity Urban Pediatric Population: an Emergency Department-based Randomized Clinical Trial|Completed||N/A|488|Actual|Children's Research Institute||1|||f||||f||||||||||2017-02-18 17:29:32.832249|2017-02-18 17:29:32.832249
NCT00140426|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-12-29|2015-06-08||August 2004||2004-08-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional||Females age 12 - 21|A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa|A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa|Completed||Phase 4|41|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 17:29:32.93978|2017-02-18 17:29:32.93978
NCT00140413|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2015-03-27|2015-02-17||December 2004||2004-12-01|March 2015|2015-03-01|February 2014|Actual|2014-02-01|February 2014|Actual|2014-02-01||Interventional||Please note, 3 children were unenrolled from the study and were therefore excluded from our analysis of results. Therefore, while the participant flow section lists 20 participants, the baseline analysis and results are based on 17 participants.|Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia|Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia|Completed||Phase 4|20|Actual|Children's Hospital Los Angeles||2|||f||||f||||||||||2017-02-18 17:29:33.587795|2017-02-18 17:29:33.587795
NCT00140400|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2005-08-30|||May 1999||1999-05-01|August 2005|2005-08-01|January 2001||2001-01-01|||||Interventional|||Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer|Phase I/II Study of a Prime-Boost Schedule of Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Hormone-Refractory Prostate Cancer|Completed||Phase 1/Phase 2|50||Cell Genesys|||||||||||||||||||2017-02-18 17:29:34.138488|2017-02-18 17:29:34.138488
NCT00140387|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2005-08-30|||May 1999||1999-05-01|August 2005|2005-08-01|March 2001||2001-03-01|||||Interventional|||Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)|Phase I/II Study of a Prime-Boost Schedule of Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) in Hormone-naïve Prostate Cancer Patients|Completed||Phase 1/Phase 2|20||Cell Genesys|||||||||||||||||||2017-02-18 17:29:34.205027|2017-02-18 17:29:34.205027
NCT00140374|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2005-08-30|||December 1998||1998-12-01|August 2005|2005-08-01|February 2001||2001-02-01|||||Interventional|||Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)|Phase I/II Study of Vaccination Priming and Vaccine Boosting With Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines in Patients With Prostate Cancer|Completed||Phase 1/Phase 2|36||Cell Genesys|||||||||||||||||||2017-02-18 17:29:34.277151|2017-02-18 17:29:34.277151
NCT00140361|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2012-09-10|||January 2000||2000-01-01|September 2012|2012-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria|Assessing and Monitoring the Efficacy of Sulfadoxine/ Pyrimethamine (SP) and the Combination of SP Plus Artesunate for Uncomplicated Malaria Infections Among Children|Completed||Phase 4|390|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:29:37.230359|2017-02-18 17:29:37.230359
NCT00140348|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-12-18|||December 2001||2001-12-01|December 2007|2007-12-01|April 2005|Actual|2005-04-01|||||Interventional|||Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine|A Phase I/II Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine in Patients With Metastatic Hormone-Refractory Prostate Cancer|Completed||Phase 1/Phase 2|80||Cell Genesys|||||||||||||||||||2017-02-18 17:29:37.371411|2017-02-18 17:29:37.371411
NCT00140335|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2010-03-08|||December 2004||2004-12-01|March 2010|2010-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Evaluation of a Handwashing Promotion Program in Chinese Elementary Schools|Evaluation of a Handwashing Promotion Program in Chinese Elementary Schools|Completed||Phase 4|5000||Centers for Disease Control and Prevention|||||f||||t||||||||||2017-02-18 17:29:37.460664|2017-02-18 17:29:37.460664
NCT00140322|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-02-02|||October 2002||2002-10-01|February 2016|2016-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Dane County Safety Assessment (SAFE) Research Study|Dane County Safety Assessment for Elders (SAFE) Research Study|Completed||N/A|455||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:29:37.566474|2017-02-18 17:29:37.566474
NCT00140309|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-03-16|||July 2003||2003-07-01|March 2007|2007-03-01|December 2005|Actual|2005-12-01|||||Interventional|||TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment|TBTC Study 27: An Evaluation of the Activity and Tolerability of Moxifloxacin During the First Two Months of Treatment for Pulmonary Tuberculosis--A Double-Blind, Randomized, Multicenter Study by the Tuberculosis Trials Consortium|Completed||Phase 2|350||Centers for Disease Control and Prevention|||||f||||t||||||||||2017-02-18 17:29:37.656292|2017-02-18 17:29:37.656292
NCT00140296|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2005-08-30|||March 2003||2003-03-01|August 2005|2005-08-01|September 2005||2005-09-01|||||Interventional|||Using the Healthcare Visit to Improve Contraceptive Use|Using the Healthcare Visit to Improve Contraceptive Use|Completed||N/A|747||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:29:37.785735|2017-02-18 17:29:37.785735
NCT00140283|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-08-31|||July 2004||2004-07-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||Effectiveness of a Educational Intervention to Improve the Resolution Capacity of Primary Health Care Teams.|Phase IV Cluster Randomised Controlled Trial With 2 Parallel Groups, to Evaluate the Effectiveness of a Educational Intervention to Improve the Resolution Capacity.|Unknown status|Active, not recruiting|Phase 4|48||Catalan Institute of Health|||||f||||||||||||||2017-02-18 17:29:37.871464|2017-02-18 17:29:37.871464
NCT00140270|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2005-08-30|||August 2002||2002-08-01|August 2005|2005-08-01|December 2002||2002-12-01|||||Interventional|||RCT of PEP Program to Reduce ACL Injuries in Female Collegiate Soccer Players|Evaluating the Effectiveness of a Neuromuscular and Proprioceptive Training Program to Reduce Ligamentous Knee Injuries Among Female Collegiate Soccer Players.|Completed||Phase 2|4000||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:29:37.954618|2017-02-18 17:29:37.954618
NCT00140257|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-12-30|||November 2004||2004-11-01|December 2008|2008-12-01||||December 2008|Anticipated|2008-12-01||Interventional|||DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome|A Double-Blind, Placebo-Controlled Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome|Unknown status|Active, not recruiting|Phase 4|240|Actual|Bispebjerg Hospital||2|||f||||f||||||||||2017-02-18 17:29:38.031101|2017-02-18 17:29:38.031101
NCT00139451|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2011-10-11|||May 2004||2004-05-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|December 2007|Actual|2007-12-01||Interventional|||Nutrients and Hormones: Effects in Boys With Disordered Growth|Nutrients and Hormones: Effects in Boys With Disordered Growth|Completed||Phase 2|20|Actual|Nemours Children's Clinic||2|||f||||f||||||||||2017-02-18 17:29:52.252603|2017-02-18 17:29:52.252603
NCT00140244|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-01-27|||December 2001||2001-12-01|January 2011|2011-01-01|July 2003||2003-07-01|||||Interventional|||Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome|Role of Leptin in Highly Active Antiretroviral Therapy (HAART)-Induced Lipodystrophy and Metabolic Syndrome in HAART-Treated HIV Patients|Unknown status|Active, not recruiting|Phase 2|15||Beth Israel Deaconess Medical Center|||||||||||||||||||2017-02-18 17:29:38.376881|2017-02-18 17:29:38.376881
NCT00140231|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2012-01-19|||October 2002||2002-10-01|January 2012|2012-01-01||||October 2012|Anticipated|2012-10-01||Interventional|||Role of Leptin in the Neuroendocrine and Immune Response to Fasting|Role of Leptin in the Neuroendocrine and Immune Response to Fasting in Humans|Unknown status|Active, not recruiting|Phase 1/Phase 2|24|Anticipated|Beth Israel Deaconess Medical Center|||||f||||f||||||||||2017-02-18 17:29:38.48231|2017-02-18 17:29:38.48231
NCT00140218|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-01-05|||August 2005||2005-08-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|January 2007|Actual|2007-01-01||Interventional|||R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis|Futility Study of R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis|Completed||Phase 1/Phase 2|30|Actual|Bennett, James P., Jr., M.D., Ph.D.||1|||t||||t||||||||||2017-02-18 17:29:38.590636|2017-02-18 17:29:38.590636
NCT00140205|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-01-15|||February 2001||2001-02-01|January 2016|2016-01-01|December 2018|Anticipated|2018-12-01|June 2004|Actual|2004-06-01||Interventional|||Pharmacokinetics of Leptin Administration During Fasting|Pharmacokinetics of Leptin Administration During Fasting|Active, not recruiting||Phase 1|28|Actual|Beth Israel Deaconess Medical Center|||||||||f||||||||||2017-02-18 17:29:38.69708|2017-02-18 17:29:38.69708
NCT00140192|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-07-28|||September 2004||2004-09-01|October 2005|2005-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Creatine Treatment in Psychiatric Disorders|Creatine as a New Treatment for Schizophrenia:A Double-Blind Trial|Completed||Phase 3|12|Actual|Beersheva Mental Health Center|||||f||||||||||||||2017-02-18 17:29:38.798551|2017-02-18 17:29:38.798551
NCT00140179|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-11-23|||September 2004||2004-09-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|||||Interventional|||Valnoctamide in Mania|Valnoctamide as a Valproate Substitute With Low Teratogenic Potential: Double-Blind Controlled Clinical Trial|Completed||Phase 3|80|Anticipated|Beersheva Mental Health Center|||||f||||t||||||||||2017-02-18 17:29:38.898383|2017-02-18 17:29:38.898383
NCT00140166|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-11-23|||July 2005||2005-07-01|November 2009|2009-11-01|May 2008|Actual|2008-05-01|||||Interventional|||Treatment of Acute Schizophrenia With Vitamin Therapy|The Treatment of Acute Schizophrenia With High Dose Niacinmide Plus Ascorbate Plus Pyridoxine Plus Centrum Forte vs. Centrum Forte Only as an Add-On to Risperidone and Dietary Counseling|Completed||Phase 4|55|Anticipated|Beersheva Mental Health Center|||||f||||t||||||||||2017-02-18 17:29:39.023065|2017-02-18 17:29:39.023065
NCT00140153|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2009-11-23|||April 2005||2005-04-01|November 2009|2009-11-01|April 2006||2006-04-01|||||Interventional|||Testosterone in Female Hypoactive Sexual Desire Disorder|Transdermal Testosterone Gel Prn Application for Hypoactive Sexual Desire Disorder in Women: A Controlled Study|Completed||Phase 3|20||Beersheva Mental Health Center|||||f||||||||||||||2017-02-18 17:29:39.13517|2017-02-18 17:29:39.13517
NCT00140140|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2013-08-20|2013-08-20||August 2005||2005-08-01|August 2013|2013-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer|An Open-Label Phase I/II Study of Weekly ABI-007 and Vinorelbine With or Without G-CSF in Patients With Stage IV (Metastatic) Breast Cancer|Terminated||Phase 1/Phase 2|16|Actual|Celgene||3||Unable to determine the optimum tolerated dose|f||||f||||||||||2017-02-18 17:29:39.244823|2017-02-18 17:29:39.244823
NCT00140114|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2012-07-12|||January 2004||2004-01-01|August 2008|2008-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Sublingual Versus Vaginal Misoprostol for Labor Induction at Term||Completed||Phase 3|170|Actual|American University of Beirut Medical Center||2|||f||||t||||||||||2017-02-18 17:29:40.841897|2017-02-18 17:29:40.841897
NCT00140101|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2012-01-06|||May 2005||2005-05-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|September 2007|Actual|2007-09-01||Interventional|ZoMaxx™ II||Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries|A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System as Compared to the TAXUS™ Express2™ Paclitaxel-Eluting Stent in de Novo Coronary Artery Lesions|Completed||Phase 2|1099|Actual|Abbott Vascular||2|||f||||t||||||||||2017-02-18 17:29:40.954504|2017-02-18 17:29:40.954504
NCT00140088|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-31|2005-08-31|||December 2004||2004-12-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Effectiveness and Safety of ALGRX 3268 in Pediatric Subjects.|Completed||Phase 3|504||AlgoRx Pharmaceuticals|||||||||||||||||||2017-02-18 17:29:41.148036|2017-02-18 17:29:41.148036
NCT00140075|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2011-05-24|||November 2000||2000-11-01|May 2011|2011-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer|Phase III, Randomized Study Of Epirubicin/Cyclophosphamide Followed By Taxane (Sequential Chemotherapy) Versus Epirubicin/Taxane (Concurrent Chemotherapy) As Adjuvant Treatment For Operable, Node-Positive Breast Cancer|Completed||Phase 3|606|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 17:29:41.239547|2017-02-18 17:29:41.239547
NCT00140062|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-04-04|||February 2002||2002-02-01|April 2008|2008-04-01|April 2006||2006-04-01|||||Interventional|||Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.|"A Randomized Post-Marketing Efficacy And Safety Study Of Xalatan Compared With Usual Care Over 36 Months In Patients With Primary Open-Angle Glaucoma, Exfoliative Glaucoma Or Ocular Hypertension"|Completed||Phase 4|329||Pfizer|||||f||||||||||||||2017-02-18 17:29:41.406834|2017-02-18 17:29:41.406834
NCT00140049|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-11-29|||July 2005||2005-07-01|November 2007|2007-11-01|July 2006|Actual|2006-07-01|||||Interventional|||A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma|A 12-Week Randomized, Evaluator-Masked, Parallel-Group, Multinational, Multi-Center Study Comparing The Efficacy And Safety Of The Fixed Combination Of Latanoprost And Timolol (Xalacom) With The Fixed Combination Of Dorzolamide And Timolol (Cosopt) In Patients With Open-Angle Glaucoma Or Ocular Hypertension.|Completed||Phase 4|238||Pfizer|||||f||||||||||||||2017-02-18 17:29:41.526251|2017-02-18 17:29:41.526251
NCT00140036|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-02-28|||September 2002||2002-09-01|February 2008|2008-02-01|August 2005||2005-08-01|||||Interventional|||Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).|Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).|Completed||Phase 4|137||Pfizer|||||f||||||||||||||2017-02-18 17:29:41.635892|2017-02-18 17:29:41.635892
NCT00140023|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2011-05-09|||September 2005||2005-09-01|May 2011|2011-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia|A Multi-center, Open Label Study to Evaluate the Efficacy and Safety of Azithromycin Microspheres in Subjects Identified as Having Low Risk Community Acquired Pneumonia (CAP)|Completed||Phase 3|47|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:29:41.848237|2017-02-18 17:29:41.848237
NCT00140010|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2009-05-19|||April 2005||2005-04-01|May 2009|2009-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Erythropoietin Therapy for Subarachnoid Hemorrhage|Effects of Systemic Erythropoietin Therapy on Cerebral Autoregulation and Incidence of Delayed Ischemic Deficits in Patients With Aneurysmal Subarachnoid Hemorrhage|Completed||Phase 2|80|Actual|University of Cambridge||1|||f||||t||||||||||2017-02-18 17:29:41.948312|2017-02-18 17:29:41.948312
NCT00139997|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-01-29|2012-09-07||January 2002||2002-01-01|January 2013|2013-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Environmental Treatment for Seasonal Affective Disorder (SAD)|A Multicenter, Randomized Controlled Trial of Negative Ion Generation Versus Light-Emitting Diode Phototherapy For Seasonal Affective Disorder|Completed||N/A|26|Actual|Yale University||2|||f||||f||||||||||2017-02-18 17:29:42.082605|2017-02-18 17:29:42.082605
NCT00139984|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2017-02-01|||October 2003||2003-10-01|February 2017|2017-02-01|May 2007|Actual|2007-05-01|||||Interventional|||Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance|Impact of Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance in Medical Outpatients: The Hyper-ABC Study|Completed||Phase 4|170|Anticipated|University Hospital, Basel, Switzerland|||||f||||f||||||||||2017-02-18 17:29:42.747588|2017-02-18 17:29:42.747588
NCT00139971|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2006-01-05|||December 2001||2001-12-01|August 2005|2005-08-01||||||||Interventional|||Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer||Unknown status|Recruiting|Phase 3|600||West Japan Thoracic Oncology Group|||||f||||||||||||||2017-02-18 17:29:42.856746|2017-02-18 17:29:42.856746
NCT00139958|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2010-07-26|||November 2003||2003-11-01|May 2010|2010-05-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Prognosis of Acute Coronary Syndrome in HIV-infected Patients|Prognosis After Acute Coronary Syndrome in HIV-infected Patients|Completed||Phase 4|300|Actual|Saint Antoine University Hospital|||2||f||||t||||||Samples Without DNA|"~     Lipids, CRP, glycemia, insulinemia~   "|||2017-02-18 17:29:42.94783|2017-02-18 17:29:42.94783
NCT00139945|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2010-01-19|||October 2005||2005-10-01|January 2010|2010-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients|Effects of Acute Ghrelin Infusion to Growth Hormone Deficient Adults: Growth Hormone and Cortisol Interaction|Completed||N/A|8|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:29:43.054289|2017-02-18 17:29:43.054289
NCT00139932|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-05-13|||September 2005||2005-09-01|May 2016|2016-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)|A Double-Blind Randomized, Parallel-Group, Multicenter Clinical Study to Compare the Efficacy and Tolerability of Tiotropium Bromide Alone vs. the Co-Administration of Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD|Completed||Phase 4|255|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:43.14048|2017-02-18 17:29:43.14048
NCT00139919|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-01-15|||January 2006||2006-01-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder|A Randomized, Double-Blind, Placebo-Controlled, Sequential Panel Study of the Safety and Tolerability of Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Either Schizophrenia or Bipolar Disorder With an Optional Open-Label 26-Week Extension Study|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:29:43.251831|2017-02-18 17:29:43.251831
NCT00139906|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-01-15|||August 2005||2005-08-01|March 2006|2006-03-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled, Twice Daily Titration Study of the Safety and Tolerability of Bifeprunox in Subjects With Schizophrenia|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:29:43.340141|2017-02-18 17:29:43.340141
NCT00139893|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-03-25|||June 2005||2005-06-01|May 2008|2008-05-01||||October 2005|Actual|2005-10-01||Interventional|||A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis|A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis|Completed||N/A|||UCB Pharma|||||f||||||||||||||2017-02-18 17:29:43.421301|2017-02-18 17:29:43.421301
NCT00139880|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-09-03|||June 2005||2005-06-01|September 2009|2009-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease|A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-02-18 17:29:43.508415|2017-02-18 17:29:43.508415
NCT00139867|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2014-10-17|||January 2004||2004-01-01|September 2009|2009-09-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease|A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-02-18 17:29:43.594782|2017-02-18 17:29:43.594782
NCT00139854|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-08-29|||August 2004||2004-08-01|September 2009|2009-09-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety|A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety|Completed||Phase 3|||UCB Pharma|||||f||||||||||||||2017-02-18 17:29:43.686838|2017-02-18 17:29:43.686838
NCT00139841|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2014-05-08|||October 2005||2005-10-01|May 2014|2014-05-01|October 2009|Actual|2009-10-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab|A Multi-Center Phase III Study to Investigate the Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab|Completed||Phase 3|103|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 17:29:43.781054|2017-02-18 17:29:43.781054
NCT00139828|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-08-29|||May 2003||2003-05-01|August 2007|2007-08-01|February 2007|Actual|2007-02-01|||||Interventional|||Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)|Post Marketing Study in Haemophilia B Patients Using Nonafact® 100 IU/ml Powder and Solvent for Solution for Injection(Human Coagulation Factor IX)(Human Plasma Derived Factor IX Product, Freeze Dried)|Completed||Phase 4|12|Actual|Sanquin||1|||f||||f||||||||||2017-02-18 17:29:43.919983|2017-02-18 17:29:43.919983
NCT00139815|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-09-13|||April 2003||2003-04-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Michelangelo - Oasis 5|An International, Randomized, Double-blind Study Evaluating the Efficacy and Safety of Fondaparinux Versus Enoxaparin in the Acute Treatment of Unstable Angina/Non ST-segment Elevation MI Acute Coronary Syndromes|Completed||Phase 3|20078|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:29:44.032218|2017-02-18 17:29:44.032218
NCT00139802|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2005-08-30|||April 1997||1997-04-01|January 1997|1997-01-01|June 2001||2001-06-01|||||Interventional|||DANish Multicenter STENT Trial|Low Restenosis Rate of the NIR Coronary Stent: Results of the Danish Multicenter Stent Study (DANSTENT) – a Randomized Study Comparing a First-Generation With a Second-Generation Stent.|Completed||Phase 4|400||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:29:44.144369|2017-02-18 17:29:44.144369
NCT00139789|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-08-29|||January 2005||2005-01-01|September 2009|2009-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis|A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis|Completed||Phase 3|60|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:29:44.220968|2017-02-18 17:29:44.220968
NCT00139776|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2009-06-24|2009-02-20||July 2005||2005-07-01|June 2009|2009-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||"Study Of Continuous Use Of Celecoxib Vs. Usual or Intermittent Use"|"Double-Blind Parallel-Group Randomized Study Of Efficacy And Safety Of Continuous Use Of Celecoxib Vs. The Usual Use Of Celecoxib In The Treatment Of Subjects With Chronic Osteoarthritis Of The Hip Or Knee Who Require an Anti-Inflammatory Medication for Control Of Their Pain"|Completed||Phase 4|875|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 17:29:44.32892|2017-02-18 17:29:44.32892
NCT00139763|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-03-15|||July 2005||2005-07-01|March 2007|2007-03-01|March 2006||2006-03-01|||||Interventional|||US Inhaled Insulin Therapeutic Choice Questionnaire Study|A US Randomized Questionnaire-Based Trial Assessing The Impact Of The Availability Of Inhaled Insulin On Therapeutic Choice In Patients With Suboptimally Controlled Type 2 Diabetes|Completed||Phase 3|740||Pfizer|||||f||||||||||||||2017-02-18 17:29:46.108374|2017-02-18 17:29:46.108374
NCT00139750|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-06-01|||December 2004||2004-12-01|June 2007|2007-06-01|February 2006|Actual|2006-02-01|||||Interventional|||12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation|A Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating The Efficacy And Safety Of CP-526,555 In Smokers Motivated To Stop Smoking|Completed||Phase 2|600||Pfizer|||||f||||||||||||||2017-02-18 17:29:46.2369|2017-02-18 17:29:46.2369
NCT00139737|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2010-08-02|2010-06-15||March 2002||2002-03-01|August 2010|2010-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia|Open Extension Study Evaluating the Safety and Tolerability of Oral Ziprasidone in the Treatment of Subjects Who Have Successfully Completed a Previous Ziprasidone Study|Completed||Phase 3|344|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:29:46.343555|2017-02-18 17:29:46.343555
NCT00139724|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2009-12-18|||May 2005||2005-05-01|December 2009|2009-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet|A Phase III Randomized, Double-Blind, Double Dummy, Multi-Center Study To Compare The Efficacy, Safety And Tolerability Of Tolterodine Extended Release Capsule With Tolterodine Immediate Release Tablet In Subjects With Symptoms Of Overactive Bladder|Completed||Phase 3|260|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:29:47.065729|2017-02-18 17:29:47.065729
NCT00139711|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-03-27|||March 2003||2003-03-01|October 2006|2006-10-01|June 2006||2006-06-01|||||Interventional|||Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer|A Multicenter Randomized Phase II Study Evaluating The Activity And Tolerability Of Three Different Combinations Of Docetaxel (Taxotere) And Irinotecan (Campto) As Second Line Therapy For Recurrent Or Metastatic Non Small Cell Lung Cancer (NSCLS)|Completed||Phase 2|138||Pfizer|||||f||||||||||||||2017-02-18 17:29:47.164675|2017-02-18 17:29:47.164675
NCT00139698|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-07-30|||September 2005||2005-09-01|April 2007|2007-04-01|July 2006||2006-07-01|||||Interventional|OSCAR||Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension|A Phase III, Multicenter, Open-Label, Dose-Titrating, 16-Week Study Evaluating The Efficacy, Tolerability and Safety of Olmesartan Medoxomil 20 Mg and 40 Mg Alone or in Combination With 12.5 Mg to 25 Mg of Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension|Completed||Phase 3|410||Pfizer|||||f||||||||||||||2017-02-18 17:29:47.275357|2017-02-18 17:29:47.275357
NCT00139685|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-09-23|||April 1998||1998-04-01|September 2008|2008-09-01|July 2007|Actual|2007-07-01|August 2006|Actual|2006-08-01||Interventional|||Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception|Depo-Provera: Evaluation of Bone Mineral Density and Total Body Calcium in Adolescent DP 150 CI Users and Matched Controls|Completed||Phase 4|350||Pfizer|||||f||||||||||||||2017-02-18 17:29:47.402869|2017-02-18 17:29:47.402869
NCT00139438|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-04-21|||September 2004||2004-09-01|April 2016|2016-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)|Improving Management of Patients at High Risk for Osteoporotic Fractures|Completed||N/A|4266||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:52.368988|2017-02-18 17:29:52.368988
NCT00139672|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-06-12|||January 2004||2004-01-01|June 2008|2008-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study To Investigate The Effect Of Pd-217,014 In Patients With Irritable Bowel Syndrome (IBS)|Completed||Phase 2|330||Pfizer|||||f||||||||||||||2017-02-18 17:29:47.50686|2017-02-18 17:29:47.50686
NCT00139659|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2010-05-26|2009-10-21||January 2003||2003-01-01|October 2009|2009-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma|Efficacy and Safety of Inhaled Human Insulin (Exubera) Compared With Subcutaneous Human Insulin in the Therapy of Adult Subjects With Type 1 or Type 2 Diabetes Mellitus and Chronic Asthma: A One-Year, Multicenter, Randomized, Outpatient, Open-Label, Parallel-Group Comparative Trial|Completed||Phase 3|288|Actual|Pfizer|Data for some secondary endpoints were not tabulated or analyzed for this study and some concomitant medication data were not accurately recorded and tabulated due to lack of resources resulting from scaling down of Exubera® development.|2|||f||||f||||||||||2017-02-18 17:29:47.595657|2017-02-18 17:29:47.595657
NCT00139646|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-05-02|||April 2002||2002-04-01|May 2008|2008-05-01|April 2004||2004-04-01|||||Interventional|||Parecoxib in Renal Colic|A Multicenter Single-Blind, Single Dose Efficacy and Safety Pilot Study Comparing Intramuscular Parecoxib and Diclofenac in Renal Colic|Terminated||Phase 3|50||Pfizer||||See Detailed Description|f||||||||||||||2017-02-18 17:29:50.342262|2017-02-18 17:29:50.342262
NCT00139633|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-08-29|||July 2000||2000-07-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Selective Dose Escalation for Esophageal Cancer|Phase II Selective Dose Escalation of Chemoradiotherapy for Esophageal Cancer|Unknown status|Active, not recruiting|Phase 2|25||The Oregon Clinic|||||f||||||||||||||2017-02-18 17:29:50.439276|2017-02-18 17:29:50.439276
NCT00139620|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-06-12|||May 2005||2005-05-01|June 2015|2015-06-01|September 2007|Actual|2007-09-01|||||Interventional|||A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function|An Open-Label Study to Characterize the Pharmacokinetic Parameters of Erlotinib (Tarceva®, OSI-774) in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function|Completed||Phase 1|39|Actual|Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:29:50.53548|2017-02-18 17:29:50.53548
NCT00139607|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2009-08-13|||September 2002||2002-09-01|August 2009|2009-08-01|January 2005||2005-01-01|||||Interventional|||Parecoxib In Post Surgery (Hemicolectomy) Pain|A Multicenter, Open Label, Pilot Study To Evaluate Analgesic Activity And Safety Of Parecoxib 40 Mg IV In Patients Undergoing Hemicolectomy, In The Optimal Management Of Acute Post-Operative Pain Of Surgical Patients|Terminated||Phase 3|60||Pfizer||||Please see detailed description for termination reason.|f||||||||||||||2017-02-18 17:29:50.61765|2017-02-18 17:29:50.61765
NCT00139594|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2011-11-16|||December 2004||2004-12-01|November 2011|2011-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder|A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder|Completed||Phase 4|181|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:29:50.702437|2017-02-18 17:29:50.702437
NCT00139581|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-04-22|||September 2004||2004-09-01|April 2008|2008-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects|Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects|Completed||Phase 4|||Novartis||2|||f||||||||||||||2017-02-18 17:29:51.030376|2017-02-18 17:29:51.030376
NCT00139568|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2008-01-31|||February 2005||2005-02-01|January 2008|2008-01-01|October 2005|Actual|2005-10-01|||||Interventional|||An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation|An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation|Completed||Phase 3|600||Novartis|||||f||||||||||||||2017-02-18 17:29:51.133841|2017-02-18 17:29:51.133841
NCT00139555|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2011-11-07|||July 2004||2004-07-01|November 2011|2011-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension|Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension|Completed||Phase 4|125|Actual|Novartis|||||||||||||||||||2017-02-18 17:29:51.232382|2017-02-18 17:29:51.232382
NCT00139542|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2009-05-08|||September 2005||2005-09-01|May 2009|2009-05-01|June 2008|Actual|2008-06-01|March 2007|Actual|2007-03-01||Interventional|DEFI2005||"AED Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named One Shock Per Minute"|"Automated External Defibrillator (AED) Use in Out-of-Hospital Cardiac Arrest: A New Algorithm Named One Shock Per Minute"|Completed||Phase 3|5107|Actual|Fire Brigade Of Paris Emergency Medicine Dept||2|||f||||t||||||||||2017-02-18 17:29:51.319863|2017-02-18 17:29:51.319863
NCT00139529|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2015-12-21|||March 2006||2006-03-01|December 2015|2015-12-01|August 2011|Actual|2011-08-01|May 2011|Actual|2011-05-01||Interventional|||Education and Counseling for Abstinence From Tobacco After Pregnancy|Postpartum Maintenance of Abstinence From Tobacco|Completed||N/A|757|Actual|Brown University||2|||f||||f||||||||||2017-02-18 17:29:51.455905|2017-02-18 17:29:51.455905
NCT00139516|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2014-03-11|||September 2001||2001-09-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Chinese Community Smoking Cessation Project||Completed||N/A|||University of California, San Francisco|||||f||||||||||||||2017-02-18 17:29:51.552448|2017-02-18 17:29:51.552448
NCT00139490|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2012-12-19|||February 2006||2006-02-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|May 2009|Actual|2009-05-01||Interventional|||Home-Based Program to Treat High Blood Pressure in African Americans|Home-Based Blood Pressure Interventions for African Americans|Completed||N/A|846|Actual|Visiting Nurse Service of New York||3|||f||||t||||||||||2017-02-18 17:29:51.629295|2017-02-18 17:29:51.629295
NCT00139477|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2012-10-21|2012-06-25||November 2003||2003-11-01|October 2012|2012-10-01|September 2011|Actual|2011-09-01|May 2009|Actual|2009-05-01||Interventional|||Study of Serum Markers for Cardiovascular Risk in Obese Youth and Impact of Lifestyle and Medication Intervention|Understanding the Effects of Therapeutic Intervention on Cardiovascular Risk Markers, Insulin Resistance, and Intra-Hepatic Fat Contents in Obese Children at High Risk for the Metabolic Syndrome.|Completed||N/A|66|Actual|Nemours Children's Clinic|Protocol #2 attrition was high, such that, we could not derive conclusions beyond the 6 month time period. Therefore, conclusions were based on participants after completing the first intervention without crossover to the second intervention.|2|||f||||t||||||||||2017-02-18 17:29:51.73849|2017-02-18 17:29:51.73849
NCT00139425|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-04-21|||May 2003||2003-05-01|April 2016|2016-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Osteoporosis Disease Management Demonstration Project (0000-037)|Osteoporosis Prevention and Treatment Program: A Disease Management Demonstration Project|Completed||N/A|10000||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:29:52.448943|2017-02-18 17:29:52.448943
NCT00139399|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2011-10-19|||May 1998||1998-05-01|October 2011|2011-10-01|November 2006|Actual|2006-11-01|July 2006|Actual|2006-07-01||Interventional|RSVP||Radial Artery Versus Saphenous Vein Patency (RSVP) Study|A Randomised Controlled Trial to Compare Angiographic Patency of Radial Artery Versus Saphenous Vein Used as Free Aorto-coronary Grafts in Coronary Revascularisation|Completed||Phase 3|142|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 17:29:52.523149|2017-02-18 17:29:52.523149
NCT00139386|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-04-17|||October 2005||2005-10-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2009|Actual|2009-04-01||Interventional|||Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial|Effects of Candesartan Cilexetil on Cardiovascular Events in Japanese Patients With Hypertension After Sirolimus- or Paclitaxel-Eluting Stents Implantation|Completed||Phase 4|1119|Actual|Kumamoto University||2|||f||||t||||||||||2017-02-18 17:29:52.633856|2017-02-18 17:29:52.633856
NCT00139373|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2007-09-12||||||July 2005|2005-07-01||||||||Interventional|||Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy|Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy|Unknown status|Recruiting|Phase 2|16|Anticipated|Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-02-18 17:29:52.763177|2017-02-18 17:29:52.763177
NCT00139360|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2015-08-26|||May 2005||2005-05-01|August 2015|2015-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma|Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma and Predictive Value of Angiogenic Markers|Completed||Phase 2|35|Actual|Haukeland University Hospital||1|||f||||||||||||||2017-02-18 17:29:52.845642|2017-02-18 17:29:52.845642
NCT00139347|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-10-27|||December 2003||2003-12-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants|A Multi-country & Multi-center Study to Assess the Efficacy, Immunogenicity & Safety of Two Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants|Completed||Phase 3|6360||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:29:52.948405|2017-02-18 17:29:52.948405
NCT00139334|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2016-09-20|||June 2005||2005-06-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|||||Interventional|||A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh|Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine (RIX4414 at 106.5 CCID50) When Given Concomitantly With OPV Versus Given Alone (HRV Vaccine Dose Given 15 Days After the OPV Dose) in Healthy Infants in Bangladesh|Completed||Phase 2|300||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:29:53.06034|2017-02-18 17:29:53.06034
NCT00139321|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2013-01-07|||June 2004||2004-06-01|January 2013|2013-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes|Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian Syndromes|Terminated||N/A|110|Anticipated|Groupe Hospitalier Pitie-Salpetriere||1|||f||||||||||||||2017-02-18 17:29:53.159451|2017-02-18 17:29:53.159451
NCT00139308|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2005-08-30||||||August 2005|2005-08-01||||||||Interventional|||High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome|Pilot Study of Internal Globus Pallidus or Median Centre of the Thalamus High Frequency Stimulation for the Treatment of Patients With Severe Tourette's Syndrome|Completed||Phase 1|||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-02-18 17:29:53.245891|2017-02-18 17:29:53.245891
NCT00139295|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2014-02-04|||October 2004||2004-10-01|February 2014|2014-02-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee|Comparison of the Efficacy and Safety of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee|Completed||Phase 3|||Sanofi|||||||||||||||||||2017-02-18 17:29:53.477683|2017-02-18 17:29:53.477683
NCT00139282|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-11-27|||June 2005||2005-06-01|November 2007|2007-11-01||||||||Interventional|||"A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for Wet Age-Related Macular Degeneration"|A Phase 3, Multicenter, Randomized, Double-Masked, Controlled Study of Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration|Terminated||Phase 3|||Genaera Corporation|||||||||||||||||||2017-02-18 17:29:53.600613|2017-02-18 17:29:53.600613
NCT00139269|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-06-02|||February 1998||1998-02-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Phase I/II Pilot Study of Induction Chemotherapy With Docetaxel in Combination With Cisplatin and 5-Fluorouracil (5-FU) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 1/Phase 2|38||Dana-Farber Cancer Institute|||||||||||||||||||2017-02-18 17:29:53.713781|2017-02-18 17:29:53.713781
NCT00139256|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-11-25|||August 2005||2005-08-01|November 2013|2013-11-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|||Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section|Randomized Controlled Trial of Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section|Terminated||Phase 2/Phase 3|67|Actual|Emory University||2||Slow enrollment and lack of funds.|f||||f||||||||||2017-02-18 17:29:53.806319|2017-02-18 17:29:53.806319
NCT00139243|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-06-02|||October 1997||1997-10-01|June 2008|2008-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck|A Phase I/II Study of Taxotere, Cisplatin, 5-Fluorouracil and Leucovorin for Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|30||Dana-Farber Cancer Institute|||||||||||||||||||2017-02-18 17:29:53.916797|2017-02-18 17:29:53.916797
NCT00139230|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-06-02|||January 1997||1997-01-01|June 2008|2008-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|TPLF-4, Compressed TPLF for Locally Advanced Squamous Cell Carcinoma|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:29:54.028774|2017-02-18 17:29:54.028774
NCT00139217|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2014-05-27|||August 2005||2005-08-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn|NO Need to Ventilate: A Trial of Non-invasive iNO in Persistent Pulmonary Hypertension of the Newborn|Completed||N/A|400|Anticipated|Emory University||1|||f||||t||||||||||2017-02-18 17:29:54.140735|2017-02-18 17:29:54.140735
NCT00139204|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2009-10-30|||April 2005||2005-04-01|October 2009|2009-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients|An Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine (C11 MET) in Prostate Cancer, as Assessed by Positron Emission Tomography (PET)|Completed||N/A|20||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:29:54.236027|2017-02-18 17:29:54.236027
NCT00139191|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2009-10-30|||July 2005||2005-07-01|October 2009|2009-10-01|May 2006|Actual|2006-05-01|||||Interventional|||Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer|A Pilot Study Evaluating the Correlation Between Carbon 11 Acetate (C-11 Acetate) Uptake and Retention as Measured by Positron Emission Tomography (PET) and Fatty Acid Synthase (FAS) Expression in Prostate Cancer|Completed||N/A|20||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:29:54.522485|2017-02-18 17:29:54.522485
NCT00139178|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-30|2005-09-02|||March 2004||2004-03-01|August 2005|2005-08-01|April 2007||2007-04-01|||||Interventional|||Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.|Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. Influence on Metabolic Abnormalities|Completed||Phase 4|100||Danish HIV Research Group|||||f||||||||||||||2017-02-18 17:29:54.61986|2017-02-18 17:29:54.61986
NCT00139165|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-03-03|||September 2004||2004-09-01|August 2005|2005-08-01|March 2006||2006-03-01|||||Interventional|||Long-Term Treatment of Collagenous Colitis With Budesonide|Long-Term Treatment of Collagenous Colitis With Budesonide. Prospective, Doubleblind Placebo-Controlled Trial.|Unknown status|Active, not recruiting|Phase 3|36||Bonderup, Ole K., M.D.|||||f||||t||||||||||2017-02-18 17:29:54.732764|2017-02-18 17:29:54.732764
NCT00139152|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2014-01-06|||September 2005||2005-09-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair|Exhaled Breath Condensate and Nitric Oxide: Non-invasive Evaluation of Lung Disease After Treatment With Xolair|Completed||Phase 4|65|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 17:29:54.825663|2017-02-18 17:29:54.825663
NCT00139139|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-08-29|||September 2003||2003-09-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A|A Blinded Randomized Comparative Study of Hepatitis A Vaccine and Immune Globulin for Postexposure Prophylaxis for Hepatitis A Disease|Completed||N/A|1500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:29:54.942718|2017-02-18 17:29:54.942718
NCT00139126|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2012-03-13|||August 2005||2005-08-01|March 2012|2012-03-01||||May 2008|Actual|2008-05-01||Interventional|||Research to Improve Smoke Alarm Functioning and Maintenance|Research to Improve Smoke Alarm Functioning and Maintenance|Completed||N/A|4500|Actual|Centers for Disease Control and Prevention||1|||f||||||||||||||2017-02-18 17:29:55.043404|2017-02-18 17:29:55.043404
NCT00139113|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2012-08-29|||September 1996||1996-09-01|August 2012|2012-08-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children|Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children|Completed||Phase 4|248|Actual|Centers for Disease Control and Prevention||6|||f||||t||||||||||2017-02-18 17:29:55.129055|2017-02-18 17:29:55.129055
NCT00139100|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-10-23|||February 2001||2001-02-01|August 2005|2005-08-01|March 2002||2002-03-01|||||Interventional|||Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area|Evaluation of Antibacterial Soap for Treatment of Lymphedema and Elephantiasis in an Area Endemic for Lymphatic Filariasis|Completed||N/A|200||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:29:55.261593|2017-02-18 17:29:55.261593
NCT00139087|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-08-29|||January 2002||2002-01-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.|Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.|Completed||N/A|300||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:29:55.349481|2017-02-18 17:29:55.349481
NCT00139074|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-01-25|||July 2005||2005-07-01|January 2013|2013-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients|Phase IV Study to Investigate if Valproate Add-on Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients|Terminated||Phase 4|17|Actual|AstraZeneca||2||terminated due to very low recruitment rate (27 June 2006)|f||||f||||||||||2017-02-18 17:29:55.425376|2017-02-18 17:29:55.425376
NCT00139061|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-10-30|||March 2005||2005-03-01|December 2006|2006-12-01|May 2006||2006-05-01|||||Interventional|||Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate|Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Forced Titration Study Of The Efficacy, Safety, And Tolerability Of Torcetrapib/Atorvastatin Compared To Fenofibrate In Subjects With Fredrickson Type IIB Dyslipidemia (Mixed Hyperlipidemia|Completed||Phase 3|128||Pfizer|||||||||||||||||||2017-02-18 17:29:55.538095|2017-02-18 17:29:55.538095
NCT00139048|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-28|2007-04-25|||September 2005||2005-09-01|August 2005|2005-08-01|February 2007|Actual|2007-02-01|||||Interventional|||Australian Screening Mammography Decision Aid Trial: A Decision Aid for Women Aged 40 Thinking About Starting Mammography Screening|A Randomised Controlled Trial of an on-Line Decision Aid for Women Aged 40 Considering Whether to Have Screening Mammograms to Evaluate the Change in Knowledge Regarding Mammography Screening.|Completed||N/A|200||University of Sydney|||||f||||||||||||||2017-02-18 17:29:55.649314|2017-02-18 17:29:55.649314
NCT00139035|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2012-10-31|||April 2005||2005-04-01|October 2012|2012-10-01||||January 2006|Actual|2006-01-01||Interventional|||Effects of Cyclosporine A on Pancreatic Insulin Secretion|Effects of Cyclosporine A on Pancreatic Insulin Secretion|Completed||Phase 4|16||University of Oslo School of Pharmacy|||||f||||||||||||||2017-02-18 17:29:55.723478|2017-02-18 17:29:55.723478
NCT00139022|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-10-04|||November 2004||2004-11-01|February 2007|2007-02-01|June 2007|Actual|2007-06-01|||||Interventional|||Home Diagnosis and Treatment of Obstructive Sleep Apnea|Can Obstructive Sleep Apnea be Diagnosed at Home? A Randomised Trial of Home vs.in-Lab Diagnosis and Treatment of OSA.|Completed||N/A|50|Anticipated|University of Saskatchewan|||||f||||||||||||||2017-02-18 17:29:55.818815|2017-02-18 17:29:55.818815
NCT00139009|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-06-14|||June 2005||2005-06-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation||Completed||Phase 4|30||University of Oslo School of Pharmacy|||||f||||||||||||||2017-02-18 17:29:55.909666|2017-02-18 17:29:55.909666
NCT00138996|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-08-24|||March 2002||2002-03-01|August 2007|2007-08-01|June 2006|Actual|2006-06-01|||||Interventional|||Quality of Cardiopulmonary Resuscitation Without and With Defibrillator Feedback|Can the Quality of Cardiopulmonary Resuscitation Improve With Direct Online Feedback From the Defibrillator to the Rescuers on Their Resuscitation Efforts|Completed||Phase 2|300||University of Oslo|||||f||||f||||||||||2017-02-18 17:29:55.997274|2017-02-18 17:29:55.997274
NCT00138983|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2006-11-28|||May 2000||2000-05-01|March 2000|2000-03-01|November 2003||2003-11-01|||||Interventional|||Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.|Prevention of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatic Diseases. The STOP-Study: a Randomized Placebo Controlled Trial With Alendronate Versus Alfacalcidol.|Completed||Phase 3|200||UMC Utrecht|||||f||||||||||||||2017-02-18 17:29:56.103884|2017-02-18 17:29:56.103884
NCT00138970|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-11-30|||January 2002||2002-01-01|August 2005|2005-08-01|February 2005||2005-02-01|||||Interventional|||Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk|Randomised, Double-Arm, Controlled, Open-Label Study Comparing Calcineurin Inhibitor-Free Immunosuppression (Zenapax®, CellCept® and Prednisolone) and Cyclosporine A Based Immunosuppression (Sandimmun Neoral®, CellCept® and Prednisolone) on the Outcome of Renal Function and Acute Rejection in 0 DR Mis-Matched Renal Allograft Recipients|Completed||Phase 4|70||University of Oslo School of Pharmacy|||||f||||||||||||||2017-02-18 17:29:56.200931|2017-02-18 17:29:56.200931
NCT00138957|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-07-09|||September 2005||2005-09-01|July 2008|2008-07-01|December 2007|Anticipated|2007-12-01|||||Interventional|||Study of a New Laparoscopic Technique for Parastomal Hernia Repair With Mesh|Laparoscopic Parastomal Hernia Repair Using an Innovative Composite Polypropylene Mesh - A Prospective Study|Withdrawn||N/A|20|Anticipated|University Hospital, Gentofte, Copenhagen||||too few patients included|f||||||||||||||2017-02-18 17:29:56.286822|2017-02-18 17:29:56.286822
NCT00138944|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-04-16|||January 2007||2007-01-01|April 2013|2013-04-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension|Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension|Completed||Phase 3|85|Actual|University of Erlangen-Nürnberg Medical School||2|||f||||f||||||||||2017-02-18 17:29:56.378764|2017-02-18 17:29:56.378764
NCT00138931|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-08-23|||September 1996||1996-09-01|August 2016|2016-08-01||||January 2025|Anticipated|2025-01-01||Observational|||Genetics of Cardiovascular and Neuromuscular Disease|Genetic Studies of Patients and Their Families With Inherited Cardiovascular and Neuromuscular Diseases.|Recruiting||N/A|2000|Anticipated|University of Chicago|||1||f||||f||||||||||2017-02-18 17:29:56.492157|2017-02-18 17:29:56.492157
NCT00138918|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2012-04-24|||June 2005||2005-06-01|April 2012|2012-04-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer|A Phase II Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer|Unknown status|Recruiting|Phase 2|45|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:29:56.606368|2017-02-18 17:29:56.606368
NCT00138905|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-09-06|||February 2005||2005-02-01|September 2007|2007-09-01|April 2006|Actual|2006-04-01|||||Interventional|||Experimental Study of Mobile Base Station Related Radio-Frequency Electromagnetic Radiation|Experimental Study of Mobile Base Station Related Radio-Frequency Electromagnetic Radiation in Healthy Adults and Adolescents|Completed||Phase 4|80||University of Aarhus|||||f||||||||||||||2017-02-18 17:29:56.699456|2017-02-18 17:29:56.699456
NCT00138892|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-10-12|||August 2002||2002-08-01|October 2011|2011-10-01|October 2012|Anticipated|2012-10-01|October 2012|Anticipated|2012-10-01||Interventional|||A Randomized Controlled Trial of Long Versus Short Wait For Primary Total Hip and Knee Arthroplasty|A Randomized Controlled Trial of Long Versus Short Wait For Primary Total Hip and Knee Arthroplasty|Unknown status|Active, not recruiting|Phase 4|236|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:29:56.783764|2017-02-18 17:29:56.783764
NCT00138879|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-12-14|||May 2003||2003-05-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Observational|||Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients|Plasma Citrulline Level: A Simple, Sensitive Method to Assess and Monitor Small Bowel Absorptive Function in Patients With Crohn's Disease?|Completed||N/A|54||St Mark's Hospital Foundation|||||f||||||||||||||2017-02-18 17:29:56.87338|2017-02-18 17:29:56.87338
NCT00138866|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2010-10-12|||November 2004||2004-11-01|July 2008|2008-07-01|March 2009|Actual|2009-03-01|January 2009|Actual|2009-01-01||Interventional|||Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury|Risedronate for Treatment of Sublesional Osteoporosis After Spinal Cord Injury|Completed||Phase 3|46|Anticipated|Toronto Rehabilitation Institute||2|||f||||t||||||||||2017-02-18 17:29:57.095997|2017-02-18 17:29:57.095997
NCT00138853|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2010-10-12|||November 2003||2003-11-01|October 2010|2010-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|Ti-Tan||A Roentgen Stereophotogrammetric Analysis on Migration of Knee Prostheses.|A Roentgen Stereophotogrammetric Analysis on Migration of Knee Prostheses. A Randomised Prospective Study of Tantalum Versus Titanium Implants.|Completed||N/A|50|Actual|University of Aarhus||2|||f||||t||||||||||2017-02-18 17:29:57.197753|2017-02-18 17:29:57.197753
NCT00138840|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2008-12-03|||August 2005||2005-08-01|December 2008|2008-12-01||||||||Interventional|||Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease|A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, for the Induction of Clinical Response in Patients With Crohn's Disease|Completed||Phase 2|282||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-02-18 17:29:57.310377|2017-02-18 17:29:57.310377
NCT00138827|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-12-14|||November 1999||1999-11-01|May 1998|1998-05-01|March 2003||2003-03-01|||||Interventional|||Mouth Care Regimes During Radiotherapy|A Pilot Randomised Comparison of Bicarbonate Based Mouth Care Versus Biotene Based Mouth Care During Radiotherapy|Completed||Phase 4|50||St George Hospital, Australia|||||f||||||||||||||2017-02-18 17:29:57.425962|2017-02-18 17:29:57.425962
NCT00138814|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-12-14|||January 1997||1997-01-01|September 2005|2005-09-01|December 2015||2015-12-01|||||Interventional|||Boost Use in Breast Conservation Radiotherapy|A Randomised Comparison of Breast Conservation With or Without Lumpectomy Radiotherapy Boost|Unknown status|Recruiting|Phase 3|680||St George Hospital, Australia|||||f||||||||||||||2017-02-18 17:29:57.51183|2017-02-18 17:29:57.51183
NCT00138801|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2010-02-04|||March 2004||2004-03-01|March 2005|2005-03-01|December 2008|Actual|2008-12-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis|Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis. A Randomized Double-blind Comparison|Completed||Phase 3|||Sorlandet Hospital HF||2|||f||||f||||||||||2017-02-18 17:29:57.60894|2017-02-18 17:29:57.60894
NCT00138788|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-11-19|||February 1996||1996-02-01|November 2008|2008-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases|To Determine Which of Two Radiotherapy Brain Fractionation Schemes is Superior in the Treatment of Brain Metastases|Completed||Phase 3|112|Anticipated|St George Hospital, Australia|||||f||||||||||||||2017-02-18 17:29:57.696328|2017-02-18 17:29:57.696328
NCT00138775|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-28|2006-12-24|||October 2004||2004-10-01|October 2006|2006-10-01|October 2007||2007-10-01|||||Interventional|||Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia|D-Serine Adjuvant Pharmacotherapy for the Treatment of Schizophrenia|Unknown status|Recruiting|Phase 2|200||Sheba Medical Center|||||f||||||||||||||2017-02-18 17:29:57.791772|2017-02-18 17:29:57.791772
NCT00138762|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2012-02-15||2012-02-15|July 2004||2004-07-01|February 2012|2012-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol|A Phase 3, Double Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety and Tolerability of Fixed Combination Torcetrapib/Atorvastatin Administered Orally Once Daily for 6 Months, Compared to Atorvastatin Alone or Placebo in Subjects With Mixed Dyslipidemia (Fredrickson Types IIa and IIb).|Completed||Phase 3|3800||Pfizer|||||f||||||||||||||2017-02-18 17:29:58.091921|2017-02-18 17:29:58.091921
NCT00138749|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-04-06|||November 2004||2004-11-01|April 2011|2011-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.|An 8-Week, Multi-Centre,Randomised Double-Blind, Placebo Controlled, Parallel Group Study To Evaluate The Efficacy,Toleration And Safety Of (+)- [S,S]- Reboxetine In The Treatment Of Stress Urinary Incontinence (SUI) In Women.|Completed||Phase 2|402||Pfizer|||||f||||||||||||||2017-02-18 17:29:58.362594|2017-02-18 17:29:58.362594
NCT00138736|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-08-29|||April 2004||2004-04-01|August 2007|2007-08-01|October 2006|Actual|2006-10-01|||||Interventional|||Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia|Phase II Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia|Completed||Phase 2|12|Actual|Sanquin||1|||f||||f||||||||||2017-02-18 17:29:58.547107|2017-02-18 17:29:58.547107
NCT00138723|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2008-04-09|||October 2003||2003-10-01|March 2008|2008-03-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome|A Phase 3, Parallel Group, Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome|Completed||Phase 3|||Pfizer|||||||||||||||||||2017-02-18 17:29:58.651493|2017-02-18 17:29:58.651493
NCT00138710|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2010-10-21|||August 2005||2005-08-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Short-term Effects of Aromatase Inhibition in Obese Men|Short-term Effects of Aromatase Inhibition in Obese Men|Completed||Phase 3|50|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-02-18 17:29:58.711639|2017-02-18 17:29:58.711639
NCT00138697|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-04-18|||May 2001||2001-05-01|April 2007|2007-04-01|December 2004|Actual|2004-12-01|||||Interventional|||Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients|Kinetics, Efficacy and Safety of IVIG-L (Human Normal Intravenous Immunoglobulin for Intravenous Use) in Hypogammaglobulinemia Patients|Completed||Phase 2/Phase 3|15||Sanquin|||||f||||||||||||||2017-02-18 17:29:58.802726|2017-02-18 17:29:58.802726
NCT00138684|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2012-05-18|||September 2003||2003-09-01|May 2012|2012-05-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Cytochrome P450 2E1 and Iron Overload|Cytochrome P450 2E1 and Iron Overload|Completed||Phase 2|50|Actual|Rennes University Hospital||2|||f||||t||||||||||2017-02-18 17:29:58.896981|2017-02-18 17:29:58.896981
NCT00138671|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-01-25|2009-09-02||January 2003||2003-01-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD|Efficacy and Safety of Inhaled Human Insulin (Exubera) Compared With Subcutaneous Human Insulin in the Therapy of Adult Subjects With Type 1 or Type 2 Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: A One-Year, Multicenter, Randomized, Outpatient, Open-Label, Parallel-Group Comparative Trial|Terminated||Phase 3|105|Actual|Pfizer|This study was terminated due to Pfizer's decision to stop marketing Exubera®. Due to inconsistency in concomitant medication data entry, interpretation of the event rates for non-severe exacerbations may be of limited clinical value.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 17:29:59.011983|2017-02-18 17:29:59.011983
NCT00138658|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2012-02-02|2011-10-06||November 2004||2004-11-01|February 2012|2012-02-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|A Phase 1-2 Study of Weekly OGX-011 Plus a Gemcitabine/Platinum-Based Regimen in Patients With Stage IIIB or IV Non Small Cell Lung Cancer|Completed||Phase 1/Phase 2|85|Actual|OncoGenex Technologies||1|||f||||f||||||||||2017-02-18 17:30:00.831857|2017-02-18 17:30:00.831857
NCT00138645|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-01-15|2009-04-21||April 2005||2005-04-01|January 2016|2016-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|FORMULA||The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet|The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet|Completed||Phase 4|60|Actual|Pennington Biomedical Research Center||2|||f||||f||||||||||2017-02-18 17:30:01.449638|2017-02-18 17:30:01.449638
NCT00138047|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2005-12-02|||March 2003||2003-03-01|August 2005|2005-08-01|September 2004||2004-09-01|||||Interventional|||Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa|Randomized, Double-Blind, Placebo-Controlled Trial of Zinc Supplementation in HIV-1-Infected Children|Completed||Phase 2|100||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:30:11.615234|2017-02-18 17:30:11.615234
NCT00138632|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2008-11-12|||September 2005||2005-09-01|November 2008|2008-11-01||||November 2007|Actual|2007-11-01||Interventional|ADVANCE||Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)|A Randomized, Double-Masked, Multicenter, Phase I/II Study of the Safety of PTK787 Administered to Patients With Predominantly Classic , Minimally Classic or Occult With no Classic Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration|Completed||Phase 1/Phase 2|50|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:30:01.839546|2017-02-18 17:30:01.839546
NCT00138619|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2012-05-04|||November 2004||2004-11-01|May 2012|2012-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|478|Actual|Novartis|||||f||||||||||||||2017-02-18 17:30:01.952476|2017-02-18 17:30:01.952476
NCT00138606|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes|Completed||Phase 3|179|Actual|Novartis|||||f||||||||||||||2017-02-18 17:30:02.069633|2017-02-18 17:30:02.069633
NCT00138593|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2012-05-04|||July 2004||2004-07-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%|Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%|Completed||Phase 3|180||Novartis|||||f||||||||||||||2017-02-18 17:30:02.174191|2017-02-18 17:30:02.174191
NCT00138580|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2012-05-04|||November 2004||2004-11-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes|Completed||Phase 3|345||Novartis|||||f||||||||||||||2017-02-18 17:30:02.265696|2017-02-18 17:30:02.265696
NCT00138567|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|530||Novartis|||||f||||||||||||||2017-02-18 17:30:02.365844|2017-02-18 17:30:02.365844
NCT00138554|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2012-05-03|||November 2004||2004-11-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes|Completed||Phase 3|318|Actual|Novartis||2|||||||||||||||||2017-02-18 17:30:02.482087|2017-02-18 17:30:02.482087
NCT00138541|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2012-05-01|||October 2004||2004-10-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes|Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes|Completed||Phase 3|440|Actual|Novartis|||||f||||||||||||||2017-02-18 17:30:02.5819|2017-02-18 17:30:02.5819
NCT00138528|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-11-07|||October 2004||2004-10-01|November 2011|2011-11-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome|Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome|Completed||Phase 4|55|Actual|Novartis|||||f||||||||||||||2017-02-18 17:30:02.671564|2017-02-18 17:30:02.671564
NCT00138515|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2012-05-01|||November 2004||2004-11-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes|Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|418|Actual|Novartis|||||f||||||||||||||2017-02-18 17:30:02.762633|2017-02-18 17:30:02.762633
NCT00138502|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26|||September 2001||2001-09-01|October 2007|2007-10-01|April 2005||2005-04-01|||||Observational|||Funguria in Hospitalized Patients|The Significance of Funguria In Hospitalized Patients|Unknown status|Active, not recruiting|N/A|926||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:02.858135|2017-02-18 17:30:02.858135
NCT00138489|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26|||January 2004||2004-01-01|October 2007|2007-10-01||||||||Observational|||Papua New Guinean Duffy Negativity And Vivax Malar|Protocol 3B Susceptibility to Plasmodium Vivax Infection and Malaria During Early Childhood|Suspended||N/A|266||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:02.928563|2017-02-18 17:30:02.928563
NCT00138476|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2014-05-08|||August 2004||2004-08-01|April 2012|2012-04-01|September 2012|Actual|2012-09-01|April 2012|Actual|2012-04-01||Interventional|||New Challenge Pool of Norwalk Virus Inoculum|Evaluation of a New Challenge Pool of Norwalk Virus Inoculum (Lot 42399) in Human Subjects|Completed||Phase 1|57|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-02-18 17:30:03.002884|2017-02-18 17:30:03.002884
NCT00138463|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-11-03|||September 2003||2003-09-01|February 2010|2010-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||West Nile Virus Natural History|Investigation of the Natural History of West Nile Virus Infection in Patients With Recently Acquired West Nile Fever or Neuroinvasive Disease|Completed||N/A|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     Cerebrospinal fluid, urine, serum.~   "|||2017-02-18 17:30:03.112728|2017-02-18 17:30:03.112728
NCT00138450|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26||||||March 2007|2007-03-01|November 2004||2004-11-01|||||Observational|||Urinary Schistosomiasis Infection|Village Surveys of Morbidity Due to S. Haematobium for 1U01AI4547 Urinary Schistosomiasis-Determinants of Infection and Disease|Completed||N/A|4400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:06.115241|2017-02-18 17:30:06.115241
NCT00005397|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2008-12-03|||September 1995||1995-09-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Epidemiology of Carotid Artery Atherosclerosis in Youth||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:02.768206|2017-02-18 18:15:02.768206
NCT00138437|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2014-11-05|||April 2006||2006-04-01|November 2014|2014-11-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Molecular and Immunological Tools for Detection of Strain Diversity, Drug Resistance and Immunological Responses|Molecular Epidemiology of Leprosy in Colombia|Completed||N/A|1554|Actual|Colorado State University|||3||f||||f||||||Samples With DNA|"~     Blood, Nasal Swabs, Skin Biopsies and scrapings~   "|||2017-02-18 17:30:06.186246|2017-02-18 17:30:06.186246
NCT00138424|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2013-02-28|2012-06-14||May 2006||2006-05-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|June 2010|Actual|2010-06-01||Interventional|||Cidofovir in Renal Transplant Recipients With BKVN|A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy|Terminated||Phase 1/Phase 2|22|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The study closed early due to failure to enroll in a timely manner.|2|||f||||||||||||||2017-02-18 17:30:06.301527|2017-02-18 17:30:06.301527
NCT00138411|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26|||October 2005||2005-10-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Monoclonal Antibody for Treatment of Inhalation Anthrax|Randomized, Placebo-Controlled, Double Blind, Dose-Escalation Phase I Study of the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of ETI-204 [Anthim(TM)] and Its Potential Interaction With Ciprofloxacin|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:30:07.907841|2017-02-18 17:30:07.907841
NCT00138398|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26|||October 2005||2005-10-01|October 2007|2007-10-01|October 2007||2007-10-01|||||Interventional|||T-cell Response-Flu Risk in Older Adults|T-cell Responses Predict Influenza Risk in Older Adults|Unknown status|Recruiting|N/A|850||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:07.995246|2017-02-18 17:30:07.995246
NCT00138385|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26|||August 2005||2005-08-01|November 2007|2007-11-01|June 2007||2007-06-01|||||Interventional|||Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment|A Randomized Comparison of the Immune Response to Either Inactivated or Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age|Completed||Phase 4|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:08.071722|2017-02-18 17:30:08.071722
NCT00138372|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2008-09-30||||||September 2008|2008-09-01||||||||Observational|||Human Immunity to MSP-1 in Western Kenya|Human Immunity to MSP-1 in Western Kenya|Unknown status|Not yet recruiting|N/A|445||Case Western Reserve University|||||f||||f||||||||||2017-02-18 17:30:08.158234|2017-02-18 17:30:08.158234
NCT00138359|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26|||December 2004||2004-12-01|December 2006|2006-12-01|January 2005||2005-01-01|||||Interventional|||Mass Treatment T Solium Community Study|The Effect of a Single Control Intervention in the T Solium Life Cycle|Terminated||N/A|4200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:08.246021|2017-02-18 17:30:08.246021
NCT00138346|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26|||August 2004||2004-08-01|December 2006|2006-12-01|April 2007||2007-04-01|||||Observational|||Epi Cystic Hydatid Disease Peru|Epidemiology of Human Cystic Hydatid Disease|Completed||N/A|840||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:08.330027|2017-02-18 17:30:08.330027
NCT00138333|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-11-10|||December 2005||2005-12-01|October 2007|2007-10-01|November 2006||2006-11-01|||||Observational|||Mercury Levels in Premature and LBW Infants Receiving Thimerosal-containing Vaccines|Assessment of Mercury Levels and Metabolism in Premature and Low Birth Weight (LBW) Infants Receiving Vaccines Containing Thimerosal|Completed||N/A|71|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:08.405826|2017-02-18 17:30:08.405826
NCT00138320|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2013-09-12|||August 2005||2005-08-01|August 2013|2013-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Herpevac Neonatal Substudy|Transfer of Herpes Simplex Virus Type 2 gD Subunit Vaccine-Induced Antibodies From Mothers to Neonates|Terminated||N/A|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||Samples Without DNA|"~     Sera obtained from collected blood samples will be used. Ten mL of blood will be collected~     at the maternal blood draw and from the umbilical vein. Three to 5 mL of blood will be~     collected at each infant blood draw~   "|||2017-02-18 17:30:08.482469|2017-02-18 17:30:08.482469
NCT00138307|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26||||||March 2007|2007-03-01|March 2006||2006-03-01|||||Observational|||Correlates of Protection in Ghana|Immunological Correlates of Protection Against Clinical Malaria in a Cohort of Young Children in the Kassena Nankana District of Ghana|Completed||N/A|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:08.57773|2017-02-18 17:30:08.57773
NCT00138294|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-03-04|||October 2003||2003-10-01|March 2010|2010-03-01|December 2011|Anticipated|2011-12-01|May 2011|Anticipated|2011-05-01||Interventional|CEI||Control of Epidemic Influenza Through a School-based Influenza Vaccination Program|Phase 4, School-based, Open-labeled Research Trial for Control of Epidemic Influenza Through a School-based Influenza Vaccination Program in Central Texas.|Unknown status|Active, not recruiting|Phase 4|12000|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:30:08.661168|2017-02-18 17:30:08.661168
NCT00138281|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26||||||March 2010|2010-03-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|||Influenza Immunity Against Pandemic Respiratory Virus|Influenza Immunity: Protective Mechanisms Against a Pandemic Respiratory Virus|Completed||Phase 4|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:08.802636|2017-02-18 17:30:08.802636
NCT00138268|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26||||||October 2007|2007-10-01|February 2005||2005-02-01|||||Observational|||Pilot Study Freeze and Transport Immune Cells|Pilot Study to Optimize and Standardize Umbilical Cord Blood Collection and the Isolation, Freezing and Transportation of Cells for Studies of Cellular Immune Responses to Immunization|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:30:08.885056|2017-02-18 17:30:08.885056
NCT00138255|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-08-26|||June 2004||2004-06-01|May 2005|2005-05-01|June 2005||2005-06-01|||||Observational|||Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines|MMR and Varicella Vaccine Responses in Extremely Premature Infants|Terminated||Phase 4|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:30:08.966221|2017-02-18 17:30:08.966221
NCT00138242|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-06-25|||December 2004||2004-12-01|October 2006|2006-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer|Phase II Trial of Weekly Docetaxel (Taxotere®) and Carboplatin as Initial Chemotherapy for Women With Ovarian Cancer and Similar Malignancies|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:30:09.03956|2017-02-18 17:30:09.03956
NCT00138229|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2012-03-28|||July 2005||2005-07-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma|Phase II Trial Using Aldesleukin (IL-2) Following a Lymphodepleting Chemotherapy and Reinfusion of Autologous Lymphocytes Depleted of T Regulatory Lymphocytes in Metastatic Melanoma|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:30:09.138381|2017-02-18 17:30:09.138381
NCT00138216|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2014-02-18|||October 2005||2005-10-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|June 2009|Actual|2009-06-01||Interventional|||Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors|A Phase I Study of Temozolomide, Oral Irinotecan, and Vincristine for Children With Refractory Solid Tumors|Completed||Phase 1|42|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:30:09.490068|2017-02-18 17:30:09.490068
NCT00138203|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2014-04-25|2013-02-13||June 2005||2005-06-01|December 2012|2012-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed Non-small Cell Lung Cancer|Completed||Phase 2|16|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:30:09.636969|2017-02-18 17:30:09.636969
NCT00138177|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-09-27|||July 2005||2005-07-01|September 2013|2013-09-01||||August 2011|Actual|2011-08-01||Interventional|||Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors|A Phase I Study of Suberoylanilide Hydroxamic Acid (Vorinostat) in Combination With 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX) in Patients With Colorectal Cancer and Other Solid Tumors|Completed||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:30:09.927189|2017-02-18 17:30:09.927189
NCT00138164|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-05-29|||December 2004||2004-12-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|February 2006|Actual|2006-02-01||Interventional|||Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Multicenter Study of Ontak® (Denileukin Diftitox) in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:30:10.056568|2017-02-18 17:30:10.056568
NCT00138151|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-09-17|2013-09-17||March 2001||2001-03-01|September 2013|2013-09-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer|A Phase II Trial of Chemosensitization With Paclitaxel, 13-cis Retinoic Acid and Interferon Alpha-2b in Advanced Uterine Cervical Carcinoma|Terminated||Phase 2|33|Actual|Rutgers, The State University of New Jersey||1||Slow accrual and lack of study drug|f||||f||||||||||2017-02-18 17:30:10.157676|2017-02-18 17:30:10.157676
NCT00138138|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-12-06|||October 2002||2002-10-01|December 2007|2007-12-01|August 2006|Actual|2006-08-01|||||Interventional|||Psychostimulants for Fatigue in Prostate Cancer|Psychostimulants for Fatigue in Advanced Prostate Cancer|Completed||Phase 2|120||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:30:10.508064|2017-02-18 17:30:10.508064
NCT00138125|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-01-28|2013-01-08||April 2005||2005-04-01|January 2013|2013-01-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer|Phase II Randomized Trial of Faslodex and Herceptin, Alone and Combined, in the First - Line Treatment of Hormone Receptor-Positive, HER-2/Neu-Overexpressing Metastatic Breast Cancer|Terminated||Phase 2|2|Actual|Translational Oncology Research International|Trial terminated due to slow patient accrual.Study closed with two subjects enrolled to treatment phase.Slow accrual was due to specific requirements of study population limiting enrollment and possibly due to availability of study drugs in clinic.|1||Due to low accrual|f||||t||||||||||2017-02-18 17:30:10.603558|2017-02-18 17:30:10.603558
NCT00138112|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2006-09-07|||November 2003||2003-11-01|September 2006|2006-09-01|November 2005||2005-11-01|||||Interventional|||Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation|Randomized Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Early Viridans Streptococcal Sepsis After Hematopoietic Cell Transplantation|Completed||Phase 3|126||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:30:10.84771|2017-02-18 17:30:10.84771
NCT00138099|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-05-30|||July 2004||2004-07-01|November 2006|2006-11-01|June 2006|Actual|2006-06-01|||||Observational|||Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)|Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)|Completed||Phase 2/Phase 3|140|Actual|McMaster University|||||f||||t||||||||||2017-02-18 17:30:10.949871|2017-02-18 17:30:10.949871
NCT00138086|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2006-09-06|||March 2005||2005-03-01|September 2006|2006-09-01|March 2009||2009-03-01|||||Interventional|||Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma|Targeted Intensification by a New Preparative Regimen for Patients With Low-Grade B-Cell Lymphoma Utilizing Standard-Dose Yttrium-90 Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy (RIT) Combined With High-Dose Beam Followed by Autologous Stem Cell Transplantation (ASCT)|Completed||Phase 2|75||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:30:11.180484|2017-02-18 17:30:11.180484
NCT00138073|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2014-05-29|2014-03-24||December 2005||2005-12-01|May 2014|2014-05-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Effectiveness of a Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation|Effectiveness of a Web-Based Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation Among Nurses and Physicians|Terminated||N/A|55|Actual|Massachusetts General Hospital|Study not completed.|1||The study was terminated because of lack of resources to complete it.|f||||t||||||||||2017-02-18 17:30:11.293301|2017-02-18 17:30:11.293301
NCT00138060|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-07-19|||June 2005||2005-06-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants|Protocole Evaluant Chez Des Patients Porteurs de Cancers Colorectaux Metastatiques l'Interet Des Determinants Genotypiques Pour l'Optimisation de l'Efficacite et de la Tolerance de la Chimiotherapie Par Irinotecan et 5-fluorouracile|Completed||Phase 4|71|Actual|Institut de Recherche Clinique sur les Cancers et le Sang||1|||f||||f||||||||||2017-02-18 17:30:11.505472|2017-02-18 17:30:11.505472
NCT00138034|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2012-04-25|2012-02-20||January 2005||2005-01-01|April 2012|2012-04-01|February 2010|Actual|2010-02-01|January 2010|Actual|2010-01-01||Interventional|||APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3|A Multicenter Randomized Trial in the Prevention of Reocclusion Following Successful Thrombolysis for Suspected Acute Myocardial Infarction: An Invasive Versus a Conservative Strategy|Completed||Phase 4|49|Actual|Heartcenter, University Medical Center St. Radboud||2|||f||||f||||||||||2017-02-18 17:30:11.717956|2017-02-18 17:30:11.717956
NCT00138021|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-10-31|||July 2005||2005-07-01|October 2007|2007-10-01|May 2008|Anticipated|2008-05-01|||||Interventional|CT+SE||Cognitive Remediation in Supported Employment at Human Service Center (HSC)|Cognitive Remediation in Supported Employment at HSC|Unknown status|Active, not recruiting|N/A|50|Anticipated|Human Service Center, Illinois||1|||f||||f||||||||||2017-02-18 17:30:12.351724|2017-02-18 17:30:12.351724
NCT00138008|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-09-20|||May 2004||2004-05-01|September 2016|2016-09-01|May 2016|Actual|2016-05-01|May 2016|Actual|2016-05-01||Interventional|||Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy|Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy (JCOG0401)|Completed||Phase 3|200|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:30:12.459169|2017-02-18 17:30:12.459169
NCT00137995|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-09-01|||June 2003||2003-06-01|September 2015|2015-09-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma|Randomized Study of ICE Plus RITUXIMAB Versus DHAP Plus Rituximab in Previously Treated Patients With Diffuse Large B-cell Lymphoma, Followed by Randomized Maintenance With Rituximab|Completed||Phase 3|481|Actual|Lymphoma Study Association||2|||f||||t||||||||||2017-02-18 17:30:12.615219|2017-02-18 17:30:12.615219
NCT00137982|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2006-09-07|||August 2004||2004-08-01|August 2005|2005-08-01|July 2008||2008-07-01|||||Interventional|||Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility|Prospective Study, Randomized Controlled Trial Between Medical Treatment by Methotrexate Versus Conservative Surgical Treatment (Group 1) and Conservative Versus Radical Surgical Treatment (Group 2) to Evaluate Subsequent Fertility|Unknown status|Recruiting|Phase 4|600||Hopital Antoine Beclere|||||f||||||||||||||2017-02-18 17:30:12.757658|2017-02-18 17:30:12.757658
NCT00137969|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2015-04-30|2009-06-05||May 2005||2005-05-01|April 2015|2015-04-01||||August 2008|Actual|2008-08-01||Interventional|EXPLORER|Intent-to-treat population: All randomized participants who received any amount of study drug.|A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus|Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With Moderate to Severe Systemic Lupus Erythematosus|Completed||Phase 2/Phase 3|262|Actual|Genentech, Inc.||2|||f||||f||||||||||2017-02-18 17:30:12.884257|2017-02-18 17:30:12.884257
NCT00137956|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-08-14|||December 2004||2004-12-01|August 2009|2009-08-01||||||||Interventional|||Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-Study|Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-Study|Terminated||Phase 3|270||Emphasys Medical|||||||||||||||||||2017-02-18 17:30:13.805013|2017-02-18 17:30:13.805013
NCT00137943|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2012-09-26|||September 1999||1999-09-01|September 2012|2012-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Parents Matter!: Interventions to Promote Effective Parent-Child Communication|Parents Matter!: Interventions to Promote Effective Parent-Child Communication About Sex and Sexual Risk Among African American Families|Completed||Phase 1|2210||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:30:13.907581|2017-02-18 17:30:13.907581
NCT00137930|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-09-20|||August 2005||2005-08-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis|Compare the Immunogenicity, Reactogenicity & Safety of 2 Different Formulations of GSK Biologicals' Live Attenuated Human Rotavirus (HRV) Vaccine Given as a Two-dose Primary Vaccination in Healthy Infants Previously Uninfected With HRV|Completed||Phase 2|250||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:30:14.201001|2017-02-18 17:30:14.201001
NCT00137917|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2016-09-15|||July 2002||2002-07-01|September 2016|2016-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs|A Primary Vaccination Study to Evaluate Immunogenicity, Safety and Reactogenicity of 3 Doses of GSK Biologicals/Finlay's Meningococcal B Candidate Vaccine Given Intramuscularly Using Either 0-2-4 Month or 0-1-6 Month Schedule to Healthy Subjects Aged 12-18 Years|Completed||Phase 2|478|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:30:14.312426|2017-02-18 17:30:14.312426
NCT00137904|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2006-02-08||||||August 2005|2005-08-01||||||||Observational|||Sleep Disorders in Patients With Multiple Sclerosis|Study of Sleep Disorders and Fatigue in Patients With Multiple Sclerosis|Unknown status|Recruiting|N/A|51||Groupe Hospitalier Pitie-Salpetriere|||||f||||||||||||||2017-02-18 17:30:14.405023|2017-02-18 17:30:14.405023
NCT00137891|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2015-03-17|||June 2005||2005-06-01|March 2015|2015-03-01|August 2005||2005-08-01|||||Interventional|||Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone|Phase I Study Comparing Pharmacokinetics and Safety Profile of Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating Hormone|Completed||Phase 1|46||Sanofi|||||||||||||||||||2017-02-18 17:30:14.479937|2017-02-18 17:30:14.479937
NCT00137878|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2012-02-22||||||May 2011|2011-05-01||||||||Interventional|||TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer|A Phase II Randomized Trial Comparing TNFerade™ Biologic With Capecitabine and Radiation Therapy Followed by Surgical Resection Versus Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer|Completed||Phase 2|||GenVec|||||||||||||||||||2017-02-18 17:30:14.555835|2017-02-18 17:30:14.555835
NCT00137670|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2012-09-26|||April 2002||2002-04-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2006|Actual|2006-03-01||Interventional|||Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients|Effectiveness of a Video-based Educational Intervention to Prevent Human Immunodeficiency Virus (HIV) and Sexually Transmitted Diseases (STDs) Among Patients Attending STD Clinics|Completed||N/A|45000||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:30:16.483193|2017-02-18 17:30:16.483193
NCT00137865|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2013-02-27|||August 2005||2005-08-01|February 2013|2013-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer|A Phase 1, Open Label, Dose Escalation Study of the Safety, Tolerability and Preliminary Efficacy of Intraperitoneal EGEN-001 in Patients With Recurrent Epithelial Ovarian Cancer|Terminated||Phase 1|18|Actual|EGEN, Inc.||1||"Sponsor decided to terminate the study early so they could begin a second dose-escalation~   study of EGEN-001 in combination with standard chemotherapy."|f||||||||||||||2017-02-18 17:30:14.631822|2017-02-18 17:30:14.631822
NCT00137852|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-07-08|||January 2002||2002-01-01|July 2016|2016-07-01|October 2016|Anticipated|2016-10-01|November 2003|Actual|2003-11-01||Interventional|||Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer|Phase II Trial of Cisplatin, CPT-11, Celecoxib (PCC), Concurrent Radiation Therapy, and Surgery for Resectable Esophageal Cancer|Active, not recruiting||Phase 2|35|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:30:14.742512|2017-02-18 17:30:14.742512
NCT00137839|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-08-02|||October 2004||2004-10-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung|A Phase II Study of Erlotinib (OSI-774); Tarceva in Women With Previously Untreated Advance Adenocarcinoma of the Lung|Active, not recruiting||Phase 2|75|Anticipated|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:30:15.056241|2017-02-18 17:30:15.056241
NCT00137826|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2011-12-23|||February 2004||2004-02-01|December 2011|2011-12-01|July 2009|Actual|2009-07-01|March 2007|Actual|2007-03-01||Interventional|||Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma|Phase II Study of Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Malignant Mesothelioma|Completed||Phase 2|37|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:30:15.199855|2017-02-18 17:30:15.199855
NCT00137813|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-05-09|||August 2004||2004-08-01|May 2016|2016-05-01|July 2016|Anticipated|2016-07-01|September 2006|Actual|2006-09-01||Interventional|||Avastin and Taxotere for Esophagogastric Cancer|Phase II Study of Bevacizumab and Docetaxel (AvaTax) in Metastatic Esophagogastric Cancer|Active, not recruiting||Phase 2|42|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:30:15.331602|2017-02-18 17:30:15.331602
NCT00137800|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2016-08-02|||February 2003||2003-02-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|May 2005|Actual|2005-05-01||Interventional|||Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients|A Phase II Study of OSI-774 (Tarceva) in Elderly Subjects With Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)|Active, not recruiting||Phase 2|80|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:30:15.442252|2017-02-18 17:30:15.442252
NCT00137787|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-28|2008-11-11|||April 2005||2005-04-01|November 2008|2008-11-01|March 2010|Anticipated|2010-03-01|December 2009|Anticipated|2009-12-01||Interventional|||Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases|Randomized Controlled Trial Comparing Ciprofloxacin With Cefepime in Febrile Neutropenic Patients With Hematologic Diseases|Unknown status|Recruiting|Phase 3|200|Anticipated|Center for Supporting Hematology-Oncology Trials||2|||f||||t||||||||||2017-02-18 17:30:15.555676|2017-02-18 17:30:15.555676
NCT00137774|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2013-04-07|||November 2004||2004-11-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|July 2005|Actual|2005-07-01||Interventional|||Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors|A Phase II Study of Bevacizumab in Combination With Temozolomide in Patients With Advanced Neuroendocrine Tumors|Completed||Phase 2|34|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:30:15.670952|2017-02-18 17:30:15.670952
NCT00137761|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-10-30|||October 2004||2004-10-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|June 2007|Actual|2007-06-01||Interventional|||Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer|A Phase II Study of Docetaxel in Combination With ZD 1839 (IRESSA) in Previously Treated Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|32|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:30:15.787138|2017-02-18 17:30:15.787138
NCT00137748|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2010-06-08|||January 2001||2001-01-01|June 2010|2010-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients|Does Replacement With CMVIG in Hypogammaglobulinemic Patients Decrease the Rate of Opportunistic Infections and Chronic Rejection?|Completed||Phase 2/Phase 3|50|Anticipated|The Cleveland Clinic||1|||f||||||||||||||2017-02-18 17:30:15.887896|2017-02-18 17:30:15.887896
NCT00137735|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-10-30|||October 2003||2003-10-01|October 2007|2007-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Gabapentin for Carpal Tunnel Syndrome|Gabapentin for Carpal Tunnel Syndrome: A Randomised Controlled Trial|Completed||Phase 3|150|Actual|Chinese University of Hong Kong||2|||f||||||||||||||2017-02-18 17:30:15.977915|2017-02-18 17:30:15.977915
NCT00137722|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2015-02-02|||January 2000||2000-01-01|December 2008|2008-12-01|August 2005||2005-08-01|||||Observational|||Outcomes From an Asthma Disease Management Program|Identification of Outcomes From an Asthma Disease Management Program|Completed||N/A|||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 17:30:16.084366|2017-02-18 17:30:16.084366
NCT00137709|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2007-10-30|||November 2004||2004-11-01|October 2007|2007-10-01|July 2008|Anticipated|2008-07-01|||||Interventional|||Hormone Profiles in Adults With Newly Diagnosed Epilepsy|Hormone Profiles in Adults Treated With Valproate vs. Lamotrigine Monotherapy for Newly Diagnosed Epilepsy: A Prospective Randomised Study|Unknown status|Recruiting|Phase 4|80|Anticipated|Chinese University of Hong Kong||2|||f||||||||||||||2017-02-18 17:30:16.17726|2017-02-18 17:30:16.17726
NCT00137696|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2005-12-12|||September 2002||2002-09-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine|Immunogenicity of Inactivated Polio Vaccine in Puerto Rico; A Comparative Cohort Study of Two Vaccination Schedules|Completed||N/A|500||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:30:16.277067|2017-02-18 17:30:16.277067
NCT00137683|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-27|2012-03-13|||September 2001||2001-09-01|March 2012|2012-03-01|March 2005||2005-03-01|||||Interventional|||Colorectal Cancer Control in Appalachian Churches|Colorectal Cancer Control in Appalachian Churches|Withdrawn||Phase 2/Phase 3|0|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:30:16.386978|2017-02-18 17:30:16.386978
NCT00137267|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-04-29|2014-08-25||June 2005||2005-06-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|TLC||A Brief Community Linkage Intervention for Dually Diagnosed Individuals|A Brief Community Linkage Intervention for Dually Diagnosed Individuals|Completed||N/A|102|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:30:24.484291|2017-02-18 17:30:24.484291
NCT00137657|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-12-12|||February 2002||2002-02-01|August 2005|2005-08-01|November 2003||2003-11-01|||||Interventional|||Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance|An Evaluation of the Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on the Development of Antifolate Resistance Among Plasmodium Falciparum, Streptococcus Pneumoniae, and Escherichia Coli|Completed||Phase 4|1478||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:30:16.610088|2017-02-18 17:30:16.610088
NCT00137644|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-01-06|||March 2005||2005-03-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|||||Interventional|||Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents|Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Innovative HIV Prevention Intervention for Minority Adolescents by the Philadelphia Health Management Corporation in Philadelphia, PA|Completed||Phase 1/Phase 2|264|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 17:30:16.721991|2017-02-18 17:30:16.721991
NCT00137631|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-06-23|2010-03-10||August 2005||2005-08-01|April 2010|2010-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|3MV||Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM|Evaluation of Many Men, Many Voices, A Group Intervention for STD/HIV Prevention for Black Men Who Have Sex With Men (MSM) in the New York Metropolitan Area by People of Color in Crisis, Brooklyn, NY|Completed||Phase 1/Phase 2|341|Actual|Centers for Disease Control and Prevention||2|||f||||f||||||||||2017-02-18 17:30:16.833637|2017-02-18 17:30:16.833637
NCT00137618|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-03-16|||November 2004||2004-11-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening|Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening - Univ of Texas - SIP 21-04|Completed||N/A|264|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:30:17.286527|2017-02-18 17:30:17.286527
NCT00137605|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2014-02-11|||September 2004||2004-09-01|February 2014|2014-02-01|October 2007|Actual|2007-10-01|||||Interventional|||Early Versus Delayed Pneumococcal Vaccination in HIV|A Pilot Study Assessing the Efficacy of Pneumococcal Vaccine in HIV Patients: Delayed Versus Immediate Immunization|Completed||Phase 1/Phase 2|79|Actual|CIHR Canadian HIV Trials Network||4|||f||||||||||||||2017-02-18 17:30:17.387514|2017-02-18 17:30:17.387514
NCT00137592|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2012-09-06|||October 2005||2005-10-01|September 2012|2012-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Promoting Colorectal Cancer Screening in Rural Colorado|Promoting Colorectal Cancer Screening in Rural Colorado|Completed||N/A|480|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-02-18 17:30:17.518706|2017-02-18 17:30:17.518706
NCT00137579|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2005-12-12|||September 2003||2003-09-01|January 2003|2003-01-01|May 2004||2004-05-01|||||Interventional|||Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy|Phase IV, Simple Blind, 2-Parallel Groups Randomized Trial to Evaluate the Safety and Effectiveness of the Intramuscular Vs Subcutaneous Route for the Administration of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation|Completed||Phase 4|216||Catalan Institute of Health|||||f||||||||||||||2017-02-18 17:30:17.648906|2017-02-18 17:30:17.648906
NCT00137566|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-28|2010-07-06|||May 2004||2004-05-01|July 2010|2010-07-01|January 2010|Anticipated|2010-01-01|November 2006|Actual|2006-11-01||Interventional|||The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau|The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau|Unknown status|Active, not recruiting|Phase 4|||Bandim Health Project||2|||f||||||||||||||2017-02-18 17:30:17.759565|2017-02-18 17:30:17.759565
NCT00137553|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-28|2010-03-15|||May 2001||2001-05-01|March 2010|2010-03-01|March 2004||2004-03-01|||||Interventional|||The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children|The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children With Recrudescent Malaria in Guinea-Bissau|Completed||Phase 4|60||Bandim Health Project|||||f||||f||||||||||2017-02-18 17:30:17.88653|2017-02-18 17:30:17.88653
NCT00137540|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2014-11-03|||September 2005||2005-09-01|November 2014|2014-11-01|July 2008|Actual|2008-07-01|April 2007|Actual|2007-04-01||Interventional|||FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)|First Line Radiofrequency Ablation vs. Antiarrhythmic Drugs for Atrial Fibrillation Treatment|Completed||Phase 3|40|Actual|Biosense Webster, Inc.|||||f||||||||||||||2017-02-18 17:30:18.112794|2017-02-18 17:30:18.112794
NCT00137527|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2014-01-16|||February 2004||2004-02-01|January 2014|2014-01-01|February 2009|Actual|2009-02-01|||||Interventional|||Brain Oxygenation Monitoring in Patients Undergoing Coronary Artery Bypass Surgery|Prospective, Randomized Trial of Cerebral Oximetry Monitoring in Patients Undergoing Coronary Artery Bypass Surgery|Terminated||N/A|250||Atlantic Health System|||||f||||||||||||||2017-02-18 17:30:18.234793|2017-02-18 17:30:18.234793
NCT00137514|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-28|2008-04-06|||March 2001||2001-03-01|April 2008|2008-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Chloroquine and Amodiaquine for Treatment of Malaria in Children|Chloroquine and Amodiaquine for Treatment of Symptomatic Children With Plasmodium Malaria in Guinea-Bissau|Completed||Phase 4|720||Bandim Health Project|||||f||||||||||||||2017-02-18 17:30:18.35873|2017-02-18 17:30:18.35873
NCT00137501|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-29|2013-07-18|||May 2003||2003-05-01|July 2013|2013-07-01|June 2009|Actual|2009-06-01|January 2009|Actual|2009-01-01||Interventional|||Two Dose Regimens of Nifedipine for the Management of Preterm Labor|Study of Different Doses of Nifedipine to Treat Preterm Labor|Terminated||Phase 3|102|Actual|American University of Beirut Medical Center||2||The trial was terminated because of difficulties in recruitement.|f||||f||||||||||2017-02-18 17:30:18.470872|2017-02-18 17:30:18.470872
NCT00137488|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2016-02-24|||November 2005||2005-11-01|April 2012|2012-04-01||||December 2007|Actual|2007-12-01||Observational|||Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)|Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)|Completed||N/A|10|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 17:30:18.606387|2017-02-18 17:30:18.606387
NCT00137475|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2016-02-24|||February 2002||2002-02-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function|A Phase I/II Feasibility/Efficacy Study Using Intensity-Modulated Radiation Therapy in Head and Neck (H&N) Cancer Patients to Permit Sparing of Parotid Gland Function|Completed||Phase 1/Phase 2|130|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 17:30:18.733253|2017-02-18 17:30:18.733253
NCT00137462|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-11-15|||November 2004||2004-11-01|December 2006|2006-12-01|September 2006||2006-09-01|||||Interventional|||Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.|A Phase 3, Double-Blind, Randomized, Multisite Trial Of The Efficacy, Safety, And Tolerability Of The Fixed Combination Torcetrapib/Atorvastatin Administered Orally, Once Daily For 12 Months, Compared To Atorvastatin Alone, Titrated Based On NCEP ATP-III LDL-C Goals In Subjects With Fredrickson Types IIa And IIb Dyslipidemias|Completed||Phase 3|900||Pfizer|||||||||||||||||||2017-02-18 17:30:18.834349|2017-02-18 17:30:18.834349
NCT00137449|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-09-09|2009-04-10||September 2005||2005-09-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor|A Phase 2 Efficacy And Safety Study Of SU011248 Administered In A Continuous Daily Regimen In Patients With Advanced Gastrointestinal Stromal Tumor|Completed||Phase 2|60|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:30:19.184019|2017-02-18 17:30:19.184019
NCT00137436|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-08-25|2009-05-28||October 2005||2005-10-01|August 2011|2011-08-01|March 2010|Actual|2010-03-01|May 2008|Actual|2008-05-01||Interventional|||Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer|A Phase 1/2 Safety And Pharmacokinetic Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Metastatic Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 1/Phase 2|93|Actual|Pfizer|Per FDAAA, only the Phase 2 study results are posted.|1|||f||||f||||||||||2017-02-18 17:30:20.353077|2017-02-18 17:30:20.353077
NCT00137423|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-09-24|2009-05-14||May 2005||2005-05-01|September 2009|2009-09-01|May 2008|Actual|2008-05-01|September 2007|Actual|2007-09-01||Interventional|||Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer|A Phase 2 Efficacy And Safety Study Of SU011248 Administered In A Continuous Daily Regimen In Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma|Completed||Phase 2|107|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:30:21.134768|2017-02-18 17:30:21.134768
NCT00137410|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2008-06-09|||November 2002||2002-11-01|July 2006|2006-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee|Protocol For A Multicentre, Double Blind, Parallel Group Pilot Study To Compare Celecoxib Long Term Vs Celecoxib Short Term Therapy In Treatment And Prevention Of New Flare In Patients With Osteoarthritis Of The Knee|Completed||Phase 3|200||Pfizer|||||f||||||||||||||2017-02-18 17:30:22.06635|2017-02-18 17:30:22.06635
NCT00137397|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2006-10-05|||November 2004||2004-11-01|October 2006|2006-10-01|August 2006||2006-08-01|||||Interventional|||A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder|A Multi-Centre, Randomised, Placebo Controlled, Double Blind, Parallel Group Study in Female Patients to Evaluate Whether Tolterodine ER Can Reverse the Increased Bladder Wall Thickness in Patients With Overactive Bladder.|Completed||Phase 4|80||Pfizer|||||f||||||||||||||2017-02-18 17:30:22.175775|2017-02-18 17:30:22.175775
NCT00137384|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2017-01-24|||August 25, 2005||2005-08-25|February 18, 2016|2016-02-18||||||||Observational|||Movement-Related Brain Networks Involved in Hand Dystonia|The Role of Cortical Coherence in Focal Hand Dystonia|Completed||N/A|60|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:30:22.280575|2017-02-18 17:30:22.280575
NCT00137371|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-12-07|||August 2005||2005-08-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis|Efficacy and Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women With Atrophic Vaginitis|Completed||Phase 3|480||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:30:22.386834|2017-02-18 17:30:22.386834
NCT00137358|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2013-01-23||||||January 2013|2013-01-01||||||||Interventional|||Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer|Phase I Trial of Dose Escalated IMRT to the Para-aortic Nodes With Concurrent Cisplatin and Amifostine in Locally Advanced Cervical Cancer|Withdrawn||Phase 1|0|Actual|University of Alabama at Birmingham||1||unable to obtain funding to conduct study|f||||||||||||||2017-02-18 17:30:22.523943|2017-02-18 17:30:22.523943
NCT00137345|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2013-02-07|||June 2005||2005-06-01|September 2006|2006-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients|A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine When Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients|Terminated||Phase 3|500||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:30:22.633924|2017-02-18 17:30:22.633924
NCT00137332|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-12-06|||November 2005||2005-11-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery Disease|A Study of the Effects GAP-486 on Ventricular Tachyarrhythmia Induction|Terminated||Phase 2|90||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:30:22.804284|2017-02-18 17:30:22.804284
NCT00137319|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-07-20|||October 2004||2004-10-01|July 2015|2015-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Impedance Threshold Device Tilt Study|An Evaluation of an Impedance Threshold Device (ITD) to Improve Hemodynamic Function During Orthostatic Challenge in Burn Patients|Terminated||N/A|2|Actual|United States Army Institute of Surgical Research||2||Aims of the study re-evaluated, did not justify allocation of resources.|f||||f||||||||||2017-02-18 17:30:23.066692|2017-02-18 17:30:23.066692
NCT00137306|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-04-06|||January 2004||2004-01-01|February 2007|2007-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Facilitating the Adoption of Evidence-Based Depression Management in Substance Use Treatment Programs|Translating Depression Guidelines Into Substance Abuse Treatment|Completed||Phase 4|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:30:23.162765|2017-02-18 17:30:23.162765
NCT00137293|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-12-06|||November 2005||2005-11-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Study Evaluating GAP-486 in Heart Rhythm|A Study to Characterize the Acute Electrophysiologic Properties, Safety and Tolerability of GAP-486|Terminated||Phase 2|30||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:30:23.27451|2017-02-18 17:30:23.27451
NCT00137280|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-04-06|2014-10-03||June 2007||2007-06-01|July 2014|2014-07-01|May 2011|Actual|2011-05-01|March 2010|Actual|2010-03-01||Interventional|EQUIP-2|People with schizophrenia|Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)|Implementing Effective, Collaborative Care for Schizophrenia|Completed||N/A|1067|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:30:23.366953|2017-02-18 17:30:23.366953
NCT00137254|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2012-04-10|||December 2005||2005-12-01|April 2012|2012-04-01|August 2008|Actual|2008-08-01|February 2007|Actual|2007-02-01||Interventional|||Insulin on Post Burn Hypermetabolism|Effects of Insulin on Post Burn Hypermetabolism|Completed||N/A|14|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-02-18 17:30:25.101112|2017-02-18 17:30:25.101112
NCT00137241|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-04-06|||July 2004||2004-07-01|October 2006|2006-10-01|November 2005|Actual|2005-11-01|||||Observational|||Veterans as Leaders in Understanding and Education (VALUE)|Determining the Prevalence of Health Literacy Among Veterans|Completed||N/A|1850|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:30:25.224668|2017-02-18 17:30:25.224668
NCT00137228|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-12-24|||January 2005||2005-01-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Measuring Hand Edema in Burn Patients|The Reliability and Concurrent Validity of the Figure-of-Eight Method of Measuring Hand Edema in Patients With Burn Injuries|Completed||N/A|20|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-02-18 17:30:25.315292|2017-02-18 17:30:25.315292
NCT00137215|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2008-07-24|||January 2006||2006-01-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Evaluation of Silverlon Dressing for Autogenous Skin Donor Sites|Evaluation of Silverlon Dressing for Autogenous Skin Donor Sites|Completed||N/A|17|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-02-18 17:30:25.406622|2017-02-18 17:30:25.406622
NCT00137202|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2008-07-24|||June 2005||2005-06-01|July 2008|2008-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Post Burn Pruritus Study in Patients Undergoing Wound Healing|A Pilot Study to Determine the Pruritic Benefits of Ondansetron Versus Diphenhydramine in Burn Patients Undergoing Wound Healing|Completed||N/A|36|Actual|United States Army Institute of Surgical Research||1|||f||||f||||||||||2017-02-18 17:30:25.506731|2017-02-18 17:30:25.506731
NCT00137189|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-02-25|||April 2005||2005-04-01|June 2007|2007-06-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation|Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation: A Randomised Controlled Trial|Completed||Phase 3|144|Actual|Uni Research||2|||f||||||||||||||2017-02-18 17:30:25.615564|2017-02-18 17:30:25.615564
NCT00137176|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-06-22|||October 2004||2004-10-01|June 2009|2009-06-01|October 2008|Actual|2008-10-01|October 2007|Actual|2007-10-01||Interventional|||EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis|EARLY IFNb-1a (Rebif) and Atorvastatin (Lipitor) Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis|Completed||N/A|30|Anticipated|University of North Carolina, Chapel Hill||1|||f||||f||||||||||2017-02-18 17:30:25.745169|2017-02-18 17:30:25.745169
NCT00137163|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2008-07-24|||March 2005||2005-03-01|July 2008|2008-07-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Evaluation of Dermafill Dressing for Donor Sites|Evaluation of Dermafill Dressing for Autogenous Skin Donor Sites|Completed||N/A|17||United States Army Institute of Surgical Research|||||f||||f||||||||||2017-02-18 17:30:25.8473|2017-02-18 17:30:25.8473
NCT00137150|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-12-19|||January 2005||2005-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Comparison of Outcome and Complications Encountered in Flapless Surgery and Immediate Loading Versus the Classical Surgical Approach and Loading After 6-8 Weeks in the Posterior Maxilla|Comparison of Outcome and Complications Encountered in Flapless Surgery and Immediate Loading Versus the Classical Surgical Approach and Loading After 6-8 Weeks in the Posterior Maxilla|Completed||N/A|15||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:30:25.948202|2017-02-18 17:30:25.948202
NCT00137137|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-12-19|||June 2005||2005-06-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||The Mini-Screw as Orthodontic Anchoring: Survival, Clinical Efficiency and Experience of the Patient|The Mini-Screw as Orthodontic Anchoring: A Clinical Trial to Study Survival, Clinical Efficiency and Experience of the Patient|Completed||N/A|20||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:30:26.047074|2017-02-18 17:30:26.047074
NCT00137124|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2012-07-06|||May 2006||2006-05-01|July 2012|2012-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||L-Arginine Metabolism in Essential Hypertension|Transport and Metabolism of L-arginine: Role for Endothelial Dysfunction in Essential Hypertension|Completed||Phase 2/Phase 3|120|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||f||||||||||2017-02-18 17:30:26.12793|2017-02-18 17:30:26.12793
NCT00137111|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-06-01|2011-02-28||June 2000||2000-06-01|April 2016|2016-04-01|November 2020|Anticipated|2020-11-01|November 2010|Actual|2010-11-01||Interventional|||Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 3|501|Actual|St. Jude Children's Research Hospital||2|||f||||t||||||||||2017-02-18 17:30:26.226213|2017-02-18 17:30:26.226213
NCT00137098|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-10-02|||September 2003||2003-09-01|October 2009|2009-10-01|January 2006|Actual|2006-01-01|||||Observational|||Coronary Care Caffeine: Influence of Coffee on Heart Rate Post Myocardial Infarction|Influence of Coffee on Heart Rate Variability Post Myocardial Infarction|Completed||Phase 3|100|Actual|The Royal Bournemouth Hospital|||2||f||||t||||||||||2017-02-18 17:30:26.809843|2017-02-18 17:30:26.809843
NCT00137085|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-06-13|||September 2004||2004-09-01|April 2006|2006-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation|Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation|Completed||N/A|124||Queen's University|||||f||||||||||||||2017-02-18 17:30:26.893642|2017-02-18 17:30:26.893642
NCT00137072|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-09-03|||April 2005||2005-04-01|September 2011|2011-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Mild To Moderate Erectile Dysfunction Study|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study of Men With Mild to Moderate Erectile Dysfunction to Evaluate the Efficacy of Viagra 8 Hours Post-Dose|Completed||Phase 4|355|Actual|Pfizer|||||||||||||||||||2017-02-18 17:30:26.991302|2017-02-18 17:30:26.991302
NCT00137059|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2005-12-12|||November 2002||2002-11-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||Acetaminophen-Induced Hepatotoxicity in Chronic Alcohol Abusers||Completed||N/A|40||Queen's University|||||f||||||||||||||2017-02-18 17:30:27.107052|2017-02-18 17:30:27.107052
NCT00136877|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2006-12-27|||October 2001||2001-10-01|December 2006|2006-12-01|December 2005||2005-12-01|||||Interventional|||Tonsillectomy in Recurrent Tonsillitis|Effect of Tonsillectomy on Preventing Recurrent Streptococcal Throat Infections: A Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|70||Oulu University Hospital|||||f||||||||||||||2017-02-18 17:30:37.79627|2017-02-18 17:30:37.79627
NCT00137046|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-02-03|2009-12-07||May 2002||2002-05-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes|Efficacy and Safety of Exubera (Inhaled Insulin) Compared With Subcutaneous Human Insulin Therapy in Adult Subjects With Type 1 Diabetes Mellitus: A Long-Term, Outpatient, Open-Label, Parallel-Group Comparative Trial|Terminated||Phase 3|582|Actual|Pfizer|Due to early termination of study, none of the subjects completed the study as planned. Subjects active at the time of study termination completed an end-of-study assessment and a 3-month follow-up visit.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 17:30:27.334555|2017-02-18 17:30:27.334555
NCT00137033|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2008-07-14|||September 2004||2004-09-01|September 2007|2007-09-01|July 2005|Actual|2005-07-01|||||Interventional|||Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population|A Multicenter, Randomized, Active-Controlled Comparison Study of the Incidence of Gastroduodenal Ulcers Associated With Celecoxib and Low Dose ASA Versus Naproxen and Low Dose ASA in Healthy Subjects (50-75 Years of Age)|Completed||Phase 4|605||Pfizer|||||||||||||||||||2017-02-18 17:30:29.960645|2017-02-18 17:30:29.960645
NCT00137020|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2006-08-11|||November 2004||2004-11-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder|A Multi-Center Study to Examine The Clinical Effects of Cross Titration of Antipsychotics With Ziprasidone in Subjects With Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|294||Pfizer|||||f||||||||||||||2017-02-18 17:30:30.072705|2017-02-18 17:30:30.072705
NCT00137007|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-04-20|||November 2003||2003-11-01|April 2011|2011-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Zithromax EV in Community-Acquired Pneumonia (CAP)|A Multicenter, Open Label Trial Evaluating Intravenous Azithromycin Plus Intravenous Ampicillin/Sulbactam Followed by Oral Azithromycin Plus Intravenous Ampicillin/Sulbactam for the Treatment of Hospitalized Subjects With Community-Acquired Pneumonia (CAP)|Completed||Phase 4|151|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:30:30.409846|2017-02-18 17:30:30.409846
NCT00136994|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-07-28|||March 2003||2003-03-01|July 2011|2011-07-01|November 2005|Actual|2005-11-01|||||Interventional|||IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)|An Open Trial to Evaluate the Efficacy and Tolerability of Ziprasidone IM and Oral in Patients With Psychosis and Acute Agitation.|Completed||Phase 3|160||Pfizer|||||f||||||||||||||2017-02-18 17:30:30.501906|2017-02-18 17:30:30.501906
NCT00136981|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-04-21|||December 2003||2003-12-01|April 2015|2015-04-01|November 2006|Actual|2006-11-01|||||Interventional|RADIANCE 1||Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.|Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-Mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Maximally Tolerated Atorvastatin Therapy Alone, in Subjects With Heterozygous Familial Hypercholesterolemia.|Completed||Phase 3|800||Pfizer|||||||||||||||||||2017-02-18 17:30:30.634977|2017-02-18 17:30:30.634977
NCT00136968|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2009-03-10|||April 2005||2005-04-01|March 2009|2009-03-01|May 2005|Actual|2005-05-01|||||Interventional|||Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy|Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy|Completed||Phase 1|12|Actual|Pfizer|||||||||||||||||||2017-02-18 17:30:30.783105|2017-02-18 17:30:30.783105
NCT00136955|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-05-22|2009-05-07||June 2004||2004-06-01|May 2015|2015-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Irinotecan Study For Cervical Cancer|An Open Labeled, Single-Arm, Multicentre Phase II Study To Evaluate The Efficacy And Safety Of Weekly Irinotecan Plus Cisplatin As First-Line Chemotherapy For Advanced Or Recurrent Squamous Cell Carcinoma Of The Uterine Cervix|Completed||Phase 2|41|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:30:30.868897|2017-02-18 17:30:30.868897
NCT00136942|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2008-02-28|||April 2005||2005-04-01|April 2007|2007-04-01||||||||Interventional|ACTFAST SWISS||A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol|A Multicenter, 6-Week-Treatment, Open-Label Study Assessing The Percentage Of Hyperlipidemic Patients Achieving Low Density Lipoprotein Cholesterol Target With Atorvastatin|Completed||Phase 3|370||Pfizer|||||f||||||||||||||2017-02-18 17:30:31.236114|2017-02-18 17:30:31.236114
NCT00136929|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2005-12-12||||||August 2005|2005-08-01||||||||Interventional|||Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly|"A Prospective Randomized Trial of Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly Senior PAMI"|Unknown status|Active, not recruiting|N/A|530||PAMI Coordinating Center|||||f||||||||||||||2017-02-18 17:30:31.351403|2017-02-18 17:30:31.351403
NCT00136916|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2010-02-12|2009-12-10||June 2002||2002-06-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes|Efficacy and Safety of Exubera® (Inhaled Insulin) Compared With Subcutaneous Human Insulin Therapy in Adult Subjects With Type 2 Diabetes Mellitus: A Long-Term, Outpatient, Open-Label, Parallel-Group Comparative Trial|Terminated||Phase 3|635|Actual|Pfizer|Due to early termination of study, none of the subjects completed the study as planned. Subjects active at the time of study termination completed an end-of-study assessment and a 3-month follow-up visit.|2||See termination reason in detailed description.|f||||f||||||||||2017-02-18 17:30:31.480189|2017-02-18 17:30:31.480189
NCT00136903|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2009-09-03|||February 2005||2005-02-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.|A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of aGVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 2|33|Actual|Osiris Therapeutics||2|||f||||f||||||||||2017-02-18 17:30:37.271334|2017-02-18 17:30:37.271334
NCT00136890|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2013-01-14|||July 2004||2004-07-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|November 2008|Actual|2008-11-01||Interventional|ELPET||PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers|The Impact of Positron Emission Tomography (PET) Imaging in Staging Potentially Surgically Resectable Non-small Cell Lung Cancers: A Prospective Multicentre Randomized Clinical Trial|Completed||Phase 3|337|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-02-18 17:30:37.692862|2017-02-18 17:30:37.692862
NCT00135681|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2016-01-14|||December 1996||1996-12-01|January 2016|2016-01-01|November 2001||2001-11-01|||||Interventional|||Immune Dysregulation in Children and Adults With Asthma||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-02-18 17:30:53.262174|2017-02-18 17:30:53.262174
NCT00136864|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-11-17|||August 2004||2004-08-01|November 2011|2011-11-01|September 2011|Actual|2011-09-01|November 2009|Actual|2009-11-01||Interventional|||Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)|The Impact of Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer: A Prospective Randomized Clinical Trial (PET START Trial)|Completed||Phase 3|310|Actual|Ontario Clinical Oncology Group (OCOG)||2|||f||||t||||||||||2017-02-18 17:30:37.885285|2017-02-18 17:30:37.885285
NCT00136851|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2011-11-07|||December 2004||2004-12-01|June 2006|2006-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension|A 6-Week Multi-center, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension|Completed||Phase 4|259|Actual|Novartis|||||||||||||||||||2017-02-18 17:30:37.991685|2017-02-18 17:30:37.991685
NCT00136838|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-04-06|2015-04-14||October 2001||2001-10-01|December 2015|2015-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2|Effect of Smoking Exposure on Tobacco Self-Administration Following Brief Abstinence|Completed||N/A|12|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 17:30:38.089606|2017-02-18 17:30:38.089606
NCT00136825|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2017-01-11|||March 2003||2003-03-01|August 2007|2007-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1|N-acetylcysteine as Treatment in Cocaine Addiction|Completed||Phase 1|17|Actual|National Institute on Drug Abuse (NIDA)||2|||||||t||||||||||2017-02-18 17:30:38.383456|2017-02-18 17:30:38.383456
NCT00136812|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-04-23|2016-02-22||July 2006||2006-07-01|April 2016|2016-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Treating Tobacco Dependence in Inpatient Psychiatry - 1|Treating Tobacco Dependence in Inpatient Psychiatry|Completed||Phase 2|224|Actual|Stanford University||2|||f||||t||||||||No|no plan to make individual participant data available|2017-02-18 17:30:38.494737|2017-02-18 17:30:38.494737
NCT00136799|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-09-22|||June 2005||2005-06-01|September 2016|2016-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia|Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia|Completed||Phase 3|325|Actual|Novartis|||||f||||||||||||||2017-02-18 17:30:38.819838|2017-02-18 17:30:38.819838
NCT00136786|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-12-07|||December 2006||2006-12-01|December 2015|2015-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3|Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals|Completed||Phase 1|25|Actual|New York State Psychiatric Institute||3|||f||||||||||||||2017-02-18 17:30:38.931524|2017-02-18 17:30:38.931524
NCT00136773|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-03-08|||April 2003||2003-04-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|October 2005|Actual|2005-10-01||Interventional|||Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus|Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|332|Actual|Novartis|||||||||||||||||||2017-02-18 17:30:39.048127|2017-02-18 17:30:39.048127
NCT00136760|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-10-05|2012-11-16||September 2003||2003-09-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia|Incentives Plus Bupropion for Smoking in Schizophrenics|Completed||Phase 2|57|Actual|Brown University||4|||f||||t||||||||||2017-02-18 17:30:39.140357|2017-02-18 17:30:39.140357
NCT00136747|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-12-03|||January 2004||2004-01-01|December 2015|2015-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1|Developing Medication For Tobacco Addiction: NMDA Agents|Completed||Phase 1|45|Actual|New York State Psychiatric Institute||3|||f||||||||||||||2017-02-18 17:30:39.730762|2017-02-18 17:30:39.730762
NCT00136734|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-04-06|||April 1998||1998-04-01|April 2016|2016-04-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Methylphenidate Treatment for Cocaine Abuse and ADHD - 1|Methylphenidate Treatment for Cocaine Abuse and ADHD|Completed||Phase 1|124|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 17:30:39.852313|2017-02-18 17:30:39.852313
NCT00136721|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-12-03|||June 2002||2002-06-01|December 2007|2007-12-01|May 2006||2006-05-01|||||Observational|||Parkin Mutations and Their Functional Consequences|Parkin Mutations and Their Functional Consequences|Unknown status|Active, not recruiting|Phase 1|2500||Institut National de la Santé Et de la Recherche Médicale, France|||||f||||||||||||||2017-02-18 17:30:39.969272|2017-02-18 17:30:39.969272
NCT00136708|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2014-07-29|||March 2005||2005-03-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||First Breath: Neonatal Resuscitation in Developing Countries|FIRST BREATH: Neonatal Resuscitation in Developing Countries|Completed||N/A|120009|Actual|NICHD Global Network for Women's and Children's Health||2|||f||||t||||||||||2017-02-18 17:30:40.166901|2017-02-18 17:30:40.166901
NCT00136695|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-11-30|2016-11-30||October 2004||2004-10-01|November 2016|2016-11-01|October 2009|Actual|2009-10-01|October 2008|Actual|2008-10-01||Interventional|||Anastrozole Administration in Elderly Hypogonadal Men|Anastrozole Administration in Elderly Hypogonadal Men|Completed||Phase 2|100|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 17:30:40.285494|2017-02-18 17:30:40.285494
NCT00136682|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2008-11-06|||August 2004||2004-08-01|November 2008|2008-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery|Postoperative Recovery in Patients Receiving Patient-Controlled Epidural Analgesia (PCEA) Compared to Patient-Controlled Intravenous Analgesia (PCA) After Major Open Gynecologic Surgery: A Randomized Controlled Trial|Completed||Phase 3|240|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:30:40.602174|2017-02-18 17:30:40.602174
NCT00136669|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2006-09-07|||September 2003||2003-09-01|September 2006|2006-09-01|September 2005||2005-09-01|||||Interventional|||Acupuncture For Pancreatic Cancer Pain|Acupuncture For Pancreatic Cancer Pain: A Randomized Phase III Study|Completed||Phase 3|60||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:30:40.718882|2017-02-18 17:30:40.718882
NCT00134914|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-11|||August 1996||1996-08-01|July 2008|2008-07-01|May 1998|Actual|1998-05-01|April 1998|Actual|1998-04-01||Interventional|||Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence|Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals|Completed||N/A|10|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 17:31:04.28652|2017-02-18 17:31:04.28652
NCT00136656|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-02-11|||July 2005||2005-07-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|June 2008|Actual|2008-06-01||Interventional|||Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old|Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old. Cefixime PO 10d vs Ceftriaxone IV 4d Followed by Cefixime PO 6d. Multicenter, Randomised Trial of Equivalence.|Completed||Phase 4|700|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:30:41.001943|2017-02-18 17:30:41.001943
NCT00136643|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-10-09|||June 2005||2005-06-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women|A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance and Acceptability of a Vaginal Gel Containing Sodium Lauryl Sulfate (Invisible Condom®) in Healthy Female Subjects|Completed||Phase 1/Phase 2|452||Laval University|||||||||||||||||||2017-02-18 17:30:41.129427|2017-02-18 17:30:41.129427
NCT00136630|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2012-01-27|||May 2005||2005-05-01|January 2012|2012-01-01|December 2012|Anticipated|2012-12-01|||||Observational|||Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations|Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations|Unknown status|Active, not recruiting|Phase 1|225|Anticipated|Institut National de la Santé Et de la Recherche Médicale, France|||1||f||||||||||||||2017-02-18 17:30:41.222819|2017-02-18 17:30:41.222819
NCT00136617|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-02-27|||August 2003||2003-08-01|February 2009|2009-02-01|September 2008|Actual|2008-09-01|July 2006|Actual|2006-07-01||Interventional|||Outpatient Treatment of Alcohol Withdrawal Syndrome|Comparison of a Fixed-Schedule Therapy Versus a Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome in Medical Out-Patients|Completed||Phase 3|165|Actual|Hvidovre University Hospital||2|||f||||t||||||||||2017-02-18 17:30:41.322852|2017-02-18 17:30:41.322852
NCT00136604|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2016-09-22|||January 2006||2006-01-01|September 2016|2016-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m|Assess Immunogenicity, Safety & Reactogenicity of a 4th Dose of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC at 15-24 m & of a Dose of Mencevax™ ACWY at 24-30 m in Subjects Primed With 3 Doses of Tritanrix™-HepB/Hib-MenAC|Completed||Phase 3|617|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:30:41.421299|2017-02-18 17:30:41.421299
NCT00136591|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2010-10-22|||September 2005||2005-09-01|October 2010|2010-10-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma|A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma|Terminated||Phase 2|87|Actual|Lymphoma Study Association||2||An arm closed due to lack of efficacy|f||||t||||||||||2017-02-18 17:30:41.526636|2017-02-18 17:30:41.526636
NCT00136578|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2008-10-15|||October 2004||2004-10-01|October 2008|2008-10-01||||||||Interventional|||Ispinesib In Combination With Carboplatin In Patients With Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study of the Safety and Tolerability of Ispinesib in Combination With Carboplatin on an Every 21-Day Schedule in Subjects With Advanced Solid Tumors.|Completed||Phase 1|30||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:30:41.648223|2017-02-18 17:30:41.648223
NCT00136565|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2007-11-06|||November 2005||2005-11-01|November 2007|2007-11-01|November 2008|Anticipated|2008-11-01|||||Interventional|||Study of Bortezomib Combined With ACVBP in Peripheral T-Cell Lymphoma|A Phase II Study Evaluating the Efficacy and Safety of Bortezomib (Velcade™) Combined With ACVBP Regimen in Patients With Previously Untreated Peripheral T-Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|Lymphoma Study Association||1|||f||||||||||||||2017-02-18 17:30:41.743851|2017-02-18 17:30:41.743851
NCT00136552|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-07-02|||May 2000||2000-05-01|July 2007|2007-07-01|December 2004||2004-12-01|||||Interventional|||Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden|FL-2000 Study for Newly Diagnosed Follicular Lymphoma Patients With a High Tumor Burden|Completed||Phase 3|360||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:30:41.855123|2017-02-18 17:30:41.855123
NCT00136539|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2013-02-15|||March 1999||1999-03-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|November 2006|Actual|2006-11-01||Interventional|||Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer|Neoadjuvant Therapy With Herceptin and Taxol for Stage II/III Breast Cancer|Completed||Phase 2|41|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:30:41.957234|2017-02-18 17:30:41.957234
NCT00136526|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2013-05-07|||December 2002||2002-12-01|May 2013|2013-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer|Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer: A Phase II Study|Completed||Phase 2|30|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 17:30:42.054904|2017-02-18 17:30:42.054904
NCT00136513|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2008-10-15|||April 2004||2004-04-01|October 2008|2008-10-01||||||||Interventional|||SB-743921 In Patients With Solid Tumors|A Phase I Study to Determine the Safety and Pharmacokinetics of Intravenous Administration of SB743921 on a Once Every 3 Week Schedule in Patients With Solid Tumors|Completed||Phase 1|30|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:30:42.15402|2017-02-18 17:30:42.15402
NCT00136500|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-07-18|||February 2005||2005-02-01|July 2016|2016-07-01||||December 2019|Anticipated|2019-12-01||Observational|CRiALS||Clinical Research in ALS Study|Clinical Research in ALS|Recruiting||N/A|10000|Anticipated|University of Miami|||1||f||||f||||||Samples With DNA|"~     DNA, blood, urine, CSF, skin biopsies~   "|||2017-02-18 17:30:42.256756|2017-02-18 17:30:42.256756
NCT00136487|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2009-12-07|||October 2002||2002-10-01|December 2009|2009-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer|A Randomized, Double Blind, Placebo-Controlled Trial of Celecoxib Versus Placebo in Men With Prostate Cancer With Rising PSA Following Prostatectomy or Radiation Therapy|Completed||Phase 2/Phase 3|85||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:30:42.369174|2017-02-18 17:30:42.369174
NCT00136474|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2009-10-30|||May 2003||2003-05-01|October 2009|2009-10-01|March 2009|Actual|2009-03-01|May 2005|Actual|2005-05-01||Interventional|||Amifostine for Head and Neck Irradiation in Lymphoma|A Randomized Phase II Trial of Amifostine for Head and Neck Irradiation in Lymphoma|Completed||Phase 2|75|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 17:30:42.489878|2017-02-18 17:30:42.489878
NCT00136461|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-03-09|||May 1997||1997-05-01|March 2011|2011-03-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)|A Randomized Phase II Trial of All-Trans Retinoic Acid and One of Two Schedules of Bryostatin 1 in Patients With Refractory Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)|Completed||Phase 2|40||Dana-Farber Cancer Institute|||||||||||||||||||2017-02-18 17:30:42.600502|2017-02-18 17:30:42.600502
NCT00136448|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-03-09|||February 1993||1993-02-01|March 2011|2011-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML)|High-Dose Ara-C Followed by Continuous Infusion Interleukin-2 for Acute Myelogenous Leukemia in First Remission|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:30:42.700382|2017-02-18 17:30:42.700382
NCT00136435|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-02-11|||June 2002||2002-06-01|February 2016|2016-02-01|December 2016|Anticipated|2016-12-01|December 2016|Anticipated|2016-12-01||Interventional|||A Study in Adults With Untreated Acute Lymphoblastic Leukemia|A Multicenter Phase II Study in Adults With Untreated Acute Lymphoblastic Leukemia: Testing Pharmacokinetically Individualized Doses of L-Asparaginase Following the DFCI Pediatric Consortium Protocol|Active, not recruiting||Phase 2|100|Anticipated|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:30:42.791431|2017-02-18 17:30:42.791431
NCT00136422|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-03-09|||January 2000||2000-01-01|March 2011|2011-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia|A Phase I Study of Vaccination With Lethally Irradiated, Autologous Acute Myeloblastic Leukemia Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Colony Stimulating Factor in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia|Completed||Phase 1|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:30:42.92114|2017-02-18 17:30:42.92114
NCT00136409|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-12-22|||May 2002||2002-05-01|December 2016|2016-12-01|December 2008|Actual|2008-12-01|August 2005|Actual|2005-08-01||Interventional|||A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)|A Phase II Study of Gleevec (Imatinib Mesylate) In Patients With BCR-Negative Myeloproliferative Disorders Including Patients With Idiopathic Myelofibrosis With Myeloid Dysplasia or Chronic Myelomonocytic Leukemia|Completed||Phase 2|34|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:30:43.013684|2017-02-18 17:30:43.013684
NCT00136396|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2013-06-10|||January 2004||2004-01-01|June 2013|2013-06-01|November 2010|Actual|2010-11-01|November 2006|Actual|2006-11-01||Interventional|||Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease|An Open Label, Phase I/II Trial of Rituximab Therapy for Steroid-Refractory Chronic Graft vs. Host Disease|Completed||Phase 1/Phase 2|30|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:30:43.122105|2017-02-18 17:30:43.122105
NCT00136383|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2014-07-18|||March 2005||2005-03-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|||Comparing Paroxetine and Duloxetine on Cardiovascular Measures|A Study of the Effects of Paroxetine vs. Duloxetine on Heart Rate Variability and Autonomic Cardiovascular Control|Completed||Phase 2/Phase 3|40|Anticipated|Duke University|||||||||||||||||||2017-02-18 17:30:43.217155|2017-02-18 17:30:43.217155
NCT00136370|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-09-21|||April 2004||2004-04-01|September 2007|2007-09-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn|Preventing Serious Neonatal and Maternal Peripartum Infections in Developing Country Settings With a High Prevalence of HIV Infection: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa|Unknown status|Recruiting|Phase 3|8000|Anticipated|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 17:30:43.315226|2017-02-18 17:30:43.315226
NCT00136357|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2015-02-02|2014-01-27||August 2004||2004-08-01|February 2015|2015-02-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Treatment of Posttraumatic Stress Disorder in Kosovar High School Students Using Mind-Body Skills Groups|Treatment of Posttraumatic Stress Disorder in Kosovar High School Students Using Mind-Body Skills Groups: A Randomized Controlled Trial|Completed||N/A|82|Actual|The Center for Mind-Body Medicine||2|||f||||f||||||||||2017-02-18 17:30:43.532284|2017-02-18 17:30:43.532284
NCT00136344|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2016-02-11|||September 2003||2003-09-01|June 2007|2007-06-01|May 2006||2006-05-01|||||Interventional|||Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery|Antibiotic Prophylaxis for Cataract Surgery Version 7e January 22 2003|Completed||N/A|35000||City, University of London|||||f||||||||||||||2017-02-18 17:30:43.919136|2017-02-18 17:30:43.919136
NCT00136331|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2016-07-17|||October 2005||2005-10-01|November 2008|2008-11-01|November 2006||2006-11-01|||||Interventional|||Study of a Pandemic Influenza Vaccine|Phase Ia Study of a Pandemic Influenza Vaccine|Completed||Phase 1|400||Seqirus|||||f||||||||||||||2017-02-18 17:30:44.040825|2017-02-18 17:30:44.040825
NCT00136318|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2013-03-20|2012-10-25||January 2004||2004-01-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|CIPPAD||Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients|Efficacy and Tolerability of Escitalopram for the Prevention of Pegylated Interferon Alfa Associated Depression in Patients With Chronic Hepatitis C Infection: a Randomized Controlled Trial.|Completed||Phase 3|208|Actual|Charite University, Berlin, Germany|Random assignment of patients before the preobservation period followed by patient withdrawal from the trial independent of antidepressant treatment weakens the strength of the randomization.|2|||f||||t||||||||||2017-02-18 17:30:44.315372|2017-02-18 17:30:44.315372
NCT00136305|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-26|2015-02-03|||August 2005||2005-08-01|February 2015|2015-02-01||||May 2006|Actual|2006-05-01||Interventional|||Comparing Asthma Action Plans for Pediatric Asthma|Relative Effectiveness of Pictorial and Written Asthma Action Plans for Pediatric Asthma|Terminated||Phase 2|4|Actual|Children's Mercy Hospital Kansas City||2||PI moved to a different institution|f||||f||||||||||2017-02-18 17:30:45.015425|2017-02-18 17:30:45.015425
NCT00136292|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-01-16||||||January 2007|2007-01-01||||||||Interventional|||Study of Single Dose Daptomycin in Pediatric Patients With Gram-Positive Infection for Which They Are Receiving Standard Antibiotics|An Evaluation of the Pharmacokinetics of a Single Dose of Daptomycin (4 mg/kg) in Pediatric Patients Aged Two to Seventeen Years Who Are Concurrently Receiving Standard Antibiotic Therapy for Proven or Suspected Gram-Positive Infection|Completed||Phase 1|24||Cubist Pharmaceuticals LLC|||||||||||||||||||2017-02-18 17:30:45.14642|2017-02-18 17:30:45.14642
NCT00136279|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2009-01-30|||January 2004||2004-01-01|January 2009|2009-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Linking Lives: Building Quality Parent Components for School-Based Health Programs in Middle Schools|RCT of Tobacco Use Prevention and Sexual Risk Reduction Interventions for Parents of African American and Latino Youth in Middle School|Completed||N/A|9510|Anticipated|Centers for Disease Control and Prevention||3|||f||||f||||||||||2017-02-18 17:30:45.254712|2017-02-18 17:30:45.254712
NCT00136266|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-02-02|||March 2005||2005-03-01|September 2007|2007-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Adherence With Iron Sprinkles Among High-Risk Infants|Adherence With Iron Sprinkles Among High-Risk Infants|Completed||Phase 3|128|Actual|Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:30:45.365328|2017-02-18 17:30:45.365328
NCT00136253|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2005-12-12|||February 2002||2002-02-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Overcoming Nutritional Barriers in Hemodialysis Patients||Completed||N/A|||Case Western Reserve University|||||f||||||||||||||2017-02-18 17:30:45.472138|2017-02-18 17:30:45.472138
NCT00136240|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2013-07-24|||April 2003||2003-04-01|August 2008|2008-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Automated Telephone System to Improve Treatment Adherence in People With Depression|Telecom System to Improve Adherence to Antidepressants|Completed||N/A|144||Boston Medical Center|||||f||||||||||||||2017-02-18 17:30:45.543749|2017-02-18 17:30:45.543749
NCT00136227|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2012-09-06|||October 2005||2005-10-01|September 2012|2012-09-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and Women|Trial of Interventions to Increase Utilization of Colorectal Cancer Screening and Promote Informed Decision Making About Colorectal Cancer Screening Among Hispanic Men and Women|Completed||N/A|521|Actual|Centers for Disease Control and Prevention||1|||f||||f||||||||||2017-02-18 17:30:45.639709|2017-02-18 17:30:45.639709
NCT00136214|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-12-19|||March 2004||2004-03-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Observational|||Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects|A Study of the Cerebral Effect of Pegylated Interferon in Hepatitis C Positive Subjects|Unknown status|Recruiting|N/A|26|Anticipated|Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:30:45.747188|2017-02-18 17:30:45.747188
NCT00136201|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2009-07-06|||November 2005||2005-11-01|July 2009|2009-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections|A Multicenter, Randomized, Open-Label Comparison of the Safety and Efficacy of Tigecycline> vs Imipenem/Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Chinese Subjects|Completed||Phase 3|200||Wyeth is now a wholly owned subsidiary of Pfizer||1|||f||||||||||||||2017-02-18 17:30:45.831899|2017-02-18 17:30:45.831899
NCT00136188|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2012-06-18|||August 2009||2009-08-01|June 2012|2012-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Nitric Oxide (NO) Activity and Diabetic Nephropathy|Role of NO Activity for the Development of Diabetic Nephropathy|Completed||Phase 2/Phase 3|100|Actual|University of Erlangen-Nürnberg Medical School||1|||f||||||||||||||2017-02-18 17:30:45.94087|2017-02-18 17:30:45.94087
NCT00136175|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-01-20|||November 1999||1999-11-01|January 2015|2015-01-01|October 2007|Actual|2007-10-01|December 2005|Actual|2005-12-01||Interventional|||Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder|Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Transitional Cell Carcinoma of the Bladder|Completed||Phase 2|68|Actual|University of Michigan Cancer Center||2|||f||||t||||||||||2017-02-18 17:30:46.03904|2017-02-18 17:30:46.03904
NCT00136149|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2014-12-04|||January 2005||2005-01-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Study on Immediate Placement to Evaluate Astra Tech Osseospeed Implants in an Immediate Loading Protocol in Extraction Sockets and Healed Ridges|An Open, Prospective, Controlled Study on Immediate Placement to Evaluate Clinical Outcome of Astra Tech Implants, Fixture Microthread Osseospeed in an Immediate Loading Protocol in Extraction Sockets and Healed Ridges|Unknown status|Active, not recruiting|N/A|51|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 17:30:46.149396|2017-02-18 17:30:46.149396
NCT00136136|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2014-12-04|||August 2003||2003-08-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Observational|||Validation of Bispectral Index (BIS)-Monitor in 3 Groups of Newborn Children|Validation of BIS-monitor in 3 Groups of Newborn Children|Unknown status|Recruiting|N/A|60|Anticipated|University Hospital, Ghent|||3||f||||f||||||||||2017-02-18 17:30:46.251702|2017-02-18 17:30:46.251702
NCT00136123|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2014-12-04|||December 2005||2005-12-01|December 2014|2014-12-01|December 2015|Anticipated|2015-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Immediate Load of Dental Implants, Placed in Atrophic Upper and/or Lower Jaw of Partial or Complete Edentate Patients, According to Flapless Technique|Immediate Load of Dental Implants, Placed in Atrophic Upper and/or Lower Jaw of Partial or Complete Edentate Patients, According to Flapless Technique|Unknown status|Recruiting|N/A|20|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 17:30:46.360235|2017-02-18 17:30:46.360235
NCT00136110|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2007-04-30|||April 2005||2005-04-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis|A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS|Completed||Phase 3|165|Actual|UMC Utrecht|||||f||||||||||||||2017-02-18 17:30:46.470871|2017-02-18 17:30:46.470871
NCT00136097|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-12-19|||August 2005||2005-08-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Study on the Infection Risk of Long Dwell Period Catheters in High Risk Intensive Care Unit (ICU) Patients|Study on the Infection Risk of Long Dwell Period Catheters in High Risk ICU Patients|Terminated||N/A|142||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:30:46.568221|2017-02-18 17:30:46.568221
NCT00136084|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2012-11-02|2010-03-05||August 2002||2002-08-01|November 2012|2012-11-01|June 2012|Actual|2012-06-01|July 2008|Actual|2008-07-01||Interventional|||Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia|A Collaborative Trial for the Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia|Completed||Phase 3|238|Actual|St. Jude Children's Research Hospital||2|||f||||t||||||||||2017-02-18 17:30:46.662514|2017-02-18 17:30:46.662514
NCT00134316|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2011-02-28|||August 2005||2005-08-01|February 2011|2011-02-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Cervical or Endometrial Cancer and Sexual Health Study|Cervical or Endometrial Cancer and Sexual Health Study|Completed||N/A|31|Actual|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:31:13.97646|2017-02-18 17:31:13.97646
NCT00136071|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2005-12-19|||May 2005||2005-05-01|May 2005|2005-05-01|May 2010||2010-05-01|||||Interventional|||Transvaginal Tension Free Vaginal Tape-Obturator (TVT-O) Versus Transobturator Tape-Mentor (TOT) in the Management of Urodynamic Stress Urinary Incontinence|Randomised Prospective Blinded Trial Comparing Transvaginal Tension Free Vaginal Tape-Obturator (Outside-In) With Transobturator Tape-Mentor (Inside-Out) in Surgical Management of Urodynamic Stress Urinary Incontinence|Unknown status|Recruiting|N/A|230||South Glasgow University Hospitals NHS Trust|||||f||||||||||||||2017-02-18 17:30:47.359188|2017-02-18 17:30:47.359188
NCT00136058|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-12-15|||January 2002||2002-01-01|December 2011|2011-12-01|April 2006||2006-04-01|||||Interventional|||Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients|Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients|Completed||Phase 3|250||University of Alberta|||||f||||||||||||||2017-02-18 17:30:47.453029|2017-02-18 17:30:47.453029
NCT00136045|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2014-09-24|||May 2005||2005-05-01|February 2010|2010-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome|A Multi-center, Randomized, Double-blind, Placebo-controlled, Four-arm Parallel-group Trial to Investigate the Efficacy and Safety of Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome|Completed||Phase 3|549|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:30:47.546868|2017-02-18 17:30:47.546868
NCT00136032|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2008-02-12|||January 2002||2002-01-01|February 2008|2008-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women|Gender-Specific Effects of Physiologic GH Administration on Cardiovascular Risk Factors in Women With Growth Hormone Deficiency|Completed||N/A|63|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:30:47.642382|2017-02-18 17:30:47.642382
NCT00136019|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2014-09-19|||March 2004||2004-03-01|July 2010|2010-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization|A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization|Completed||Phase 3|400|Anticipated|UCB Pharma|||||f||||||||||||||2017-02-18 17:30:47.778483|2017-02-18 17:30:47.778483
NCT00136006|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2013-01-30|||August 2005||2005-08-01|January 2013|2013-01-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Observational|||The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung Disease|The Burden of Chronic Obstructive Lung Disease (BOLD) Study|Unknown status|Active, not recruiting|N/A|1000|Anticipated|University of British Columbia|||1||f||||||||||||||2017-02-18 17:30:48.049081|2017-02-18 17:30:48.049081
NCT00135993|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2014-09-24|||May 2005||2005-05-01|September 2009|2009-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Five-Arm Parallel-Group Trial to Investigate the Efficacy and Safety of Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome|Completed||Phase 3|811|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:30:48.147646|2017-02-18 17:30:48.147646
NCT00135980|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-02-28|||August 2004||2004-08-01|February 2007|2007-02-01|July 2007||2007-07-01|||||Interventional|||Integrated Care for Cancer Patients; Developing, Implementing and Testing a Programme to Improve Integrated Care|Integrated Care for Cancer Patients|Unknown status|Recruiting|N/A|300||Radboud University|||||f||||||||||||||2017-02-18 17:30:48.255847|2017-02-18 17:30:48.255847
NCT00135967|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2005-12-05|||May 2002||2002-05-01|August 2005|2005-08-01||||||||Interventional|||Mycophenolate Mofetil in Membranous Nephropathy|Treatment of Patients With Membranous Nephropathy and Renal Insufficiency With Mycophenolate Mofetil and Prednisone: a Pilot Study|Completed||Phase 2/Phase 3|30||Radboud University|||||f||||||||||||||2017-02-18 17:30:48.359888|2017-02-18 17:30:48.359888
NCT00135954|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2014-01-27|||July 1997||1997-07-01|February 2007|2007-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Treatment of Patients With Idiopathic Membranous Nephropathy|Treatment of Patients With Idiopathic Membranous Nephropathy at Risk for Renal Insufficiency: Comparison of Early Versus Late Start of Immunosuppressive Therapy|Completed||Phase 3|29|Actual|Radboud University||2|||f||||||||||||||2017-02-18 17:30:48.470034|2017-02-18 17:30:48.470034
NCT00135941|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2009-06-02|||August 2005||2005-08-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)|Insulin Glargine Plus Insulin Glulisine MDI Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) Evaluating Differences in Patient Reported Outcomes|Completed||Phase 3|582|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:30:48.58913|2017-02-18 17:30:48.58913
NCT00135928|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-08-04|||May 2003||2003-05-01|February 2005|2005-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Stem Cells in Myocardial Infarction|Bone Marrow Stimulation With G-CSF in Acute Myocardial Infarction,|Completed||Phase 2|78||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:30:48.698565|2017-02-18 17:30:48.698565
NCT00135915|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2009-10-30|||August 2005||2005-08-01|October 2009|2009-10-01|February 2007|Actual|2007-02-01|||||Observational|||Influence of Binge Drinking on Glucose Metabolism in Patients With Type 1 Diabetes - A Pilot Study|Influence of Binge Drinking on Glucose Metabolism in Patients With Type 1 Diabetes - A Pilot Study|Completed||Phase 2/Phase 3|10|Actual|The Royal Bournemouth Hospital|||2||f||||t||||||||||2017-02-18 17:30:48.802381|2017-02-18 17:30:48.802381
NCT00135902|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-09-29|||February 2005||2005-02-01|September 2016|2016-09-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies|A Randomized Trial of Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in Pregnancies at High Risk|Completed||Phase 3|800|Actual|The George Washington University Biostatistics Center||1|||f||||t||||||||Yes|The data will be shared after completion and publication of the main analyses in accordance with NIH policy. The contact to obtain datasets is mfmudatasets@bsc.gwu.edu.|2017-02-18 17:30:48.882015|2017-02-18 17:30:48.882015
NCT00135889|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2009-10-07|||January 2005||2005-01-01|October 2009|2009-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Continuous Femoral Nerve Block Following Total Knee Replacement|Improving Postoperative Rehabilitation Following Total Knee Arthroplasty With Perineural Local Anesthetic Infusion|Completed||N/A|50||National Institute of General Medical Sciences (NIGMS)|||||f||||t||||||||||2017-02-18 17:30:49.024762|2017-02-18 17:30:49.024762
NCT00135876|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2007-04-25|||October 2002||2002-10-01|April 2007|2007-04-01|November 2006|Actual|2006-11-01|||||Interventional|||Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients|A Trial of Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients (PRODIGE)|Completed||Phase 3|512||Ontario Clinical Oncology Group (OCOG)|||||f||||f||||||||||2017-02-18 17:30:49.135072|2017-02-18 17:30:49.135072
NCT00135863|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2015-05-20|||May 2004||2004-05-01|January 2004|2004-01-01|May 2005||2005-05-01|||||Interventional|||MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis|Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis|Terminated||N/A|36||Ribe County Hospital|||||f||||||||||||||2017-02-18 17:30:49.24496|2017-02-18 17:30:49.24496
NCT00135850|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-08-04|||March 2003||2003-03-01|October 2002|2002-10-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris|The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris|Completed||Phase 1/Phase 2|48||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:30:49.335346|2017-02-18 17:30:49.335346
NCT00135837|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2006-06-20|||June 2003||2003-06-01|June 2006|2006-06-01||||||||Interventional|||Photodynamic Therapy in Occult-Only Lesions (POOL)|An Open-Label, Multicenter, Phase 4 Study of the Effect of Verteporfin for Injection Therapy in Subjects With Occult With No Classic Choroidal NeoVascularization Secondary to Age-Related Macular Degeneration|Completed||Phase 4|202||Novartis|||||f||||||||||||||2017-02-18 17:30:49.429666|2017-02-18 17:30:49.429666
NCT00135824|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-11-16|||March 2004||2004-03-01|November 2011|2011-11-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers|Local Tolerability and Safety of Povidone K25 (Artificial Tears Containing Povidone) vs. Placebo in Healthy Volunteers|Completed||Phase 4|30|Actual|Novartis|||||f||||||||||||||2017-02-18 17:30:49.515821|2017-02-18 17:30:49.515821
NCT00135811|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2012-05-21|||November 2004||2004-11-01|May 2012|2012-05-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)|Focal Segmental Glomerulosclerosis Clinical Trial|Completed||Phase 3|207|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 17:30:49.606048|2017-02-18 17:30:49.606048
NCT00135798|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2013-04-11|2012-06-13||September 2005||2005-09-01|April 2013|2013-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|LADR||Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation|The Adult-to-adult Living Donor Liver Transplantation Cohort Study (A2ALL) Low Accelerated Dosing Regimen (LADR) Protocol: Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C Virus (HCV) After Liver Transplantation|Completed||Phase 2|79|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Failure to reach target of 84 transplanted patients (47 achieved); Inability to complete planned 12 weeks of treatment for some; Incomplete HCV RNA follow up; Inconsistent limits of detection of HCV RNA; Noncompliance with assigned treatment.|3|||f||||t||||||||||2017-02-18 17:30:49.732481|2017-02-18 17:30:49.732481
NCT00135785|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-11|||October 2005||2005-10-01|September 2009|2009-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2|A Randomized, Double-Blind, Placebo-Controlled Evaluation of Bupropion vs Placebo for the Treatment of Methamphetamine Dependence|Completed||Phase 2|73|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 17:30:50.389686|2017-02-18 17:30:50.389686
NCT00135772|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-11|||October 2003||2003-10-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Observational|||Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2|Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder|Completed||N/A|100||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:30:50.497805|2017-02-18 17:30:50.497805
NCT00135759|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-11|||April 2005||2005-04-01|August 2008|2008-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Addition of Naltrexone to Methadone Taper|Place of Low-Dose Naltrexone in Opiate Detoxification|Completed||Phase 2|174|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 17:30:50.591308|2017-02-18 17:30:50.591308
NCT00135746|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-11|||May 2004||2004-05-01|October 2015|2015-10-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2|Effects of Transdermal Nicotine on Tobacco Withdrawal and the Effects of Smoking in Men and Women|Completed||N/A|128|Anticipated|National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:30:50.707349|2017-02-18 17:30:50.707349
NCT00135733|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2009-02-10|||April 2004||2004-04-01|February 2009|2009-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus|A Randomized, Double-Blind, Placebo-Controlled Pilot Study of the Efficacy and Safety of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus|Terminated||Phase 2|13|Actual|Massachusetts General Hospital||2||Pharmaceutical sponsor withdrew financial support.|f||||f||||||||||2017-02-18 17:30:50.809029|2017-02-18 17:30:50.809029
NCT00135720|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2015-06-02|||June 2004||2004-06-01|May 2008|2008-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris|A Double-Blinded, Placebo-Controlled Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris|Completed||Phase 2|12|Anticipated|Massachusetts General Hospital|||||f||||t||||||||||2017-02-18 17:30:50.924975|2017-02-18 17:30:50.924975
NCT00135707|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2010-05-12|||June 2003||2003-06-01|May 2010|2010-05-01|January 2009|Actual|2009-01-01|February 2008|Actual|2008-02-01||Interventional|CAPPS||Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)|A Randomized Clinical Trial of Antioxidants to Prevent Preeclampsia and An Observational Cohort Study to Predict Preeclampsia|Completed||Phase 3|10154|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 17:30:51.034498|2017-02-18 17:30:51.034498
NCT00135694|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-12-08|2016-10-13||October 2005||2005-10-01|December 2016|2016-12-01|September 2015|Actual|2015-09-01|September 2015|Actual|2015-09-01||Interventional|A-WISH|Enrolled sample (subjects transplanted in the study)|Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant|A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients|Completed||Phase 2|275|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:30:51.295719|2017-02-18 17:30:51.295719
NCT00135668|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2009-05-26|||August 2005||2005-08-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|March 2008|Actual|2008-03-01||Interventional|||Dose-Response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room|A Phase 2 Multicenter, Randomized, Double-Blind, Parallel Group, Dose-Ranging, Effect-Controlled Study to Determine the Pharmacokinetics and Pharmacodynamics of Sodium Nitroprusside in Pediatric Subjects|Completed||Phase 2|203|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||4|||f||||t||||||||||2017-02-18 17:30:53.335999|2017-02-18 17:30:53.335999
NCT00135655|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2013-05-20|||August 2005||2005-08-01|May 2013|2013-05-01||||||||Interventional|||A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema|A Randomized, Double-Masked, Parallel, Group, Multi-Center, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema|Withdrawn||Phase 2|0|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:30:53.444295|2017-02-18 17:30:53.444295
NCT00135642|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-02-11|||February 1996||1996-02-01|August 2005|2005-08-01|October 1998||1998-10-01|||||Interventional|||Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma|Randomized Double Blind Placebo Controlled Trial of Grass Pollen Immunotherapy Using a Cluster Regime|Completed||Phase 3|44||Imperial College London|||||f||||||||||||||2017-02-18 17:30:53.518869|2017-02-18 17:30:53.518869
NCT00135629|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2010-11-22|||October 2002||2002-10-01|November 2010|2010-11-01|February 2004||2004-02-01|||||Interventional|||Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever|Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: A Pilot Study. (Up-dosing Study)|Unknown status|Active, not recruiting|Phase 3|18||Imperial College London|||||f||||||||||||||2017-02-18 17:30:53.606675|2017-02-18 17:30:53.606675
NCT00135616|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-04-27|||March 2005||2005-03-01|April 2007|2007-04-01|March 2008|Anticipated|2008-03-01|||||Interventional|||Treatment of Female Stress Urinary Incontinence: Study Comparing Two Suburethral Slings, Retropubic Approach (TVT) and Trans-Obturator (TVT-O) Approach|Randomized Controlled Study Comparing Two Types of Suburethral Slings for the Surgical Treatment of Female Stress Incontinence : TVT and TVT-O.|Unknown status|Active, not recruiting|Phase 4|180|Anticipated|Hopital Antoine Beclere|||||f||||||||||||||2017-02-18 17:30:53.695613|2017-02-18 17:30:53.695613
NCT00135603|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2009-02-11|||February 2004||2004-02-01|January 2009|2009-01-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Antibiotic Therapy Versus Appendectomy for Acute Appendicitis|A Prospective Randomized Multicentric Trial Comparing Amoxicillin/Clavulanate Potassium Therapy to Appendectomy for Acute Non Complicated Appendicitis|Completed||N/A|243|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:30:53.799624|2017-02-18 17:30:53.799624
NCT00135590|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2007-11-20|||November 2004||2004-11-01|November 2004|2004-11-01|October 2007|Actual|2007-10-01|||||Interventional|PRO-PULSé||Evaluation of the Effectiveness of a Protein Pulse-Feeding Pattern in Elderly Patients|Evaluation of the Effectiveness of a Protein Pulse-Feeding Pattern in Elderly Patients|Completed||N/A|68|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:30:53.913664|2017-02-18 17:30:53.913664
NCT00135577|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2015-09-01|||September 2004||2004-09-01|September 2009|2009-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects|A Double-Blind, Placebo-Controlled, Multicenter Phase IIb Extension Study to Evaluate the Safety and Efficacy of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects|Completed||Phase 2|67|Actual|Cubist Pharmaceuticals LLC||4|||f||||||||||||||2017-02-18 17:30:54.022258|2017-02-18 17:30:54.022258
NCT00135564|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-09-15|||January 2003||2003-01-01|September 2016|2016-09-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers|Evaluate the Persistence and Immune Memory Induced by a Primary Vaccination Course With GSK Biologicals' MenC-TT (1 Formulation) & GSK Biologicals' Hib-MenC-TT (2 Formulations) or Meningitec™ in Healthy Toddlers Aged 12-15 Months Primed in Study 711202/001|Completed||Phase 2|500|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:30:54.154922|2017-02-18 17:30:54.154922
NCT00135551|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2012-02-19|||May 2003||2003-05-01|February 2012|2012-02-01|November 2010|Actual|2010-11-01|May 2010|Actual|2010-05-01||Interventional|COPE||Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients|The Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial|Completed||Phase 4|3501|Actual|COPE Trial Group||3|||f||||t||||||||||2017-02-18 17:30:54.351107|2017-02-18 17:30:54.351107
NCT00135538|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2007-04-04|||November 2004||2004-11-01|April 2007|2007-04-01|April 2009|Anticipated|2009-04-01|||||Interventional|||The Additional Value of Noninvasive Ventilation Next to Rehabilitation in Hypercapnic COPD Patients|Does Chronic Ventilatory Support Improve the Outcomes of Rehabilitation in Hypercapnic COPD Patients?|Unknown status|Active, not recruiting|Phase 3|100||Groningen Research Institute for Asthma and COPD|||||f||||f||||||||||2017-02-18 17:30:54.474642|2017-02-18 17:30:54.474642
NCT00135525|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2011-01-27|||May 2003||2003-05-01|January 2011|2011-01-01|May 2006|Actual|2006-05-01|October 2005|Actual|2005-10-01||Interventional|||Study Of Generalized Anxiety Disorder|Clinical Evaluation of BRL29060 A in Generalized Anxiety Disorder|Completed||Phase 2|||GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 17:30:54.570551|2017-02-18 17:30:54.570551
NCT00135512|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2017-01-16|||December 2004||2004-12-01|January 2017|2017-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Study Of 323U66 SR In Major Depressive Disorder|Clinical Evaluation of 323U66 SR in Patients With Depression - Open-Label Study -|Completed||Phase 2|100|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 17:30:54.665877|2017-02-18 17:30:54.665877
NCT00135499|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2006-09-07|||January 2002||2002-01-01|September 2006|2006-09-01|January 2011||2011-01-01|||||Interventional|||R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-Cell Lymphoma|Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Non Previously Treated Patients Aged From 60 to 65 Years With Diffuse Large B-Cell Lymphoma|Terminated||Phase 3|560||Lymphoma Study Association|||||f||||||||||||||2017-02-18 17:30:54.754898|2017-02-18 17:30:54.754898
NCT00135317|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2013-05-21|||November 2004||2004-11-01|May 2013|2013-05-01||||||||Interventional|||AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies|A Randomized Open-Label Study of Darbepoetin Alfa Administered Every Three Weeks With or Without Parenteral Iron in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-02-18 17:31:00.74564|2017-02-18 17:31:00.74564
NCT00135486|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-09-15|||March 2002||2002-03-01|September 2016|2016-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants|Evaluate Immunogenicity, Reactogenicity, Safety of GSK Biologicals' MenC-TT Vaccine (2 Formulations) Given With Infanrix Hexa® + GSK Biologicals' Hib MenC-TT Vaccine (2 Formulations) Given With Infanrix Penta® to Infants in Mths 3,4,5 of Life|Completed||Phase 2|500|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:30:55.054863|2017-02-18 17:30:55.054863
NCT00135473|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2016-02-10|||April 2003||2003-04-01|February 2016|2016-02-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)|Prospective Randomized Multicenter Study on the Influence of Colloid vs Crystalloid Volume Resuscitation and of Intensive vs Conventional Insulin Therapy on Outcome in Patients With Severe Sepsis and Septic Shock|Completed||Phase 3|600||German Competence Network Sepsis|||||f||||||||||||||2017-02-18 17:30:55.175127|2017-02-18 17:30:55.175127
NCT00135460|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2006-03-13|||June 2003||2003-06-01|September 2005|2005-09-01|November 2007||2007-11-01|||||Interventional|||Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients|Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in Patients With HIV. Influence on Morphological and Metabolic Disorders. A Randomized, Open-Label Multicenter Trial.|Unknown status|Active, not recruiting|Phase 4|100||Danish HIV Research Group|||||f||||||||||||||2017-02-18 17:30:55.304359|2017-02-18 17:30:55.304359
NCT00135447|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-04-13|||September 2004||2004-09-01|April 2011|2011-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen|A Phase IV, Multicenter, Cross-sectional Study to Evaluate the I50L Substitution Among Subjects Experiencing Virologic Failure on a HAART Regimen Containing Atazanavir (ATV)|Completed||N/A|5000|Anticipated|Bristol-Myers Squibb|||1||f||||f||||||Samples Without DNA|"~     Serum~   "|||2017-02-18 17:30:55.413512|2017-02-18 17:30:55.413512
NCT00135434|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-04-07|||September 2004||2004-09-01|November 2009|2009-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism|Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism|Completed||Phase 1|25||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 17:30:55.585891|2017-02-18 17:30:55.585891
NCT00135421|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2010-02-27||2010-02-27|November 2005||2005-11-01|September 2008|2008-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder|Completed||Phase 1/Phase 2|271|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 17:30:55.681132|2017-02-18 17:30:55.681132
NCT00135408|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2016-09-26|||December 2005||2005-12-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide|Randomized, Double-Blind, Placebo-Controlled Phase II Study Comparing the Safety of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide (Entocort EC) in Patients With Previously Treated Unresectable Stage III or IV Malignant Melanoma|Completed||Phase 2|115|Actual|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:30:55.835593|2017-02-18 17:30:55.835593
NCT00135395|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2010-02-03||2010-02-03|May 2004||2004-05-01|July 2008|2008-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen|A Phase IIIb, Open -Label, Randomized Multi-center Study Comparing the Antiviral Efficacy, Safety, and Effect on Serum Lipids of Atazanavir/Ritonavir Versus Lopinavir/Ritonavir, in Combination With Two Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIs) in HIV-1 Infected Subjects Experiencing Their First Virologic Failure While Receiving a NNRTI-containing HAART Regimen.|Completed||Phase 3|200|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:30:55.952736|2017-02-18 17:30:55.952736
NCT00135382|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2010-01-27||2010-01-27|June 2002||2002-06-01|January 2010|2010-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen|A Phase 3 Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen|Completed||Phase 3|254||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:30:56.288437|2017-02-18 17:30:56.288437
NCT00135369|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-04-08||2010-01-28|September 2002||2002-09-01|April 2011|2011-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen|A Phase 3 Study Switching HIV-1 Infected Subjects With an Undetectable Viral Load From a HAART Regimen Dosed Twice Daily or More Frequently to a Once-Daily HAART Regimen|Completed||Phase 3|300||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:30:56.432663|2017-02-18 17:30:56.432663
NCT00135356|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2010-04-20|2009-12-15||July 2005||2005-07-01|April 2010|2010-04-01|June 2008|Actual|2008-06-01|July 2007|Actual|2007-07-01||Interventional|||Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome|A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing a Reyataz-Based Substitution Approach in the Management of Lipodystrophy Syndrome. Research Into Atazanavir in Lipodystrophy (The REAL Study)|Completed||Phase 4|219|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 17:30:56.77555|2017-02-18 17:30:56.77555
NCT00135343|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-25|2011-04-07||2010-01-27|April 2004||2004-04-01|July 2008|2008-07-01|October 2005||2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen|A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen|Completed||Phase 3|60||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:30:58.857428|2017-02-18 17:30:58.857428
NCT00135330|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2015-03-19|2009-07-21||October 2005||2005-10-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus|An Evaluation of the Metabolic Effects of Exenatide, Rosiglitazone, and Exenatide Plus Rosiglitazone in Subjects With Type 2 Diabetes Mellitus Treated With Metformin|Completed||Phase 3|137|Actual|AstraZeneca||3|||f||||f||||||||||2017-02-18 17:30:58.996665|2017-02-18 17:30:58.996665
NCT00135304|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2014-02-07|||August 2005||2005-08-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism|ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism: A Comparison of Sensipar® and Low Dose Vitamin D vs. Escalating Doses of Vitamin D Alone|Completed||Phase 4|170|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:31:00.84441|2017-02-18 17:31:00.84441
NCT00135291|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2008-01-02|||February 2003||2003-02-01|January 2008|2008-01-01|September 2004|Actual|2004-09-01|||||Interventional|||Effect of Leukoreduced Blood Transfusions on Infection Following Trauma|Effect of Leukoreduction in Infection Risk in Trauma|Completed||Phase 2/Phase 3|300||University of Washington|||||f||||||||||||||2017-02-18 17:31:00.959481|2017-02-18 17:31:00.959481
NCT00135278|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-04-08|||March 2008||2008-03-01|April 2011|2011-04-01|July 2011|Anticipated|2011-07-01|July 2011|Anticipated|2011-07-01||Interventional|||Cerebrospinal Fluid (CSF) Drainage and Cytokine Profiling in the Treatment of Acute Spinal Cord Injury (SCI)|Cerebrospinal Fluid (CSF) Drainage and Cytokine Profiling in the Treatment of Acute Spinal Cord Injury (SCI) - A Pilot Study|Unknown status|Recruiting|N/A|30|Anticipated|University of British Columbia||1|||f||||f||||||||||2017-02-18 17:31:01.067534|2017-02-18 17:31:01.067534
NCT00135265|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2010-06-24|||October 2006||2006-10-01|June 2010|2010-06-01|January 2010|Actual|2010-01-01|October 2009|Actual|2009-10-01||Interventional|||PROS Smokebusters: Adolescent Smoking Cessation in Pediatric Primary Care|Adolescent Smoking Cessation in Pediatric Primary Care|Completed||Phase 1|4100|Anticipated|University of Rochester||1|||f||||||||||||||2017-02-18 17:31:01.160015|2017-02-18 17:31:01.160015
NCT00135252|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-12-23|||August 2005||2005-08-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2|Method of Oxygen Delivery (Comparison Nasal Cannula vs Oxygen Hood) and the Effect on Transcutaneous PaCO2|Terminated||Phase 2/Phase 3|44|Anticipated|The University of Texas Health Science Center, Houston||||Investigator left institution|f||||||||||||||2017-02-18 17:31:01.24664|2017-02-18 17:31:01.24664
NCT00135239|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2008-06-16|||January 2006||2006-01-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Care Versus Usual Care for Acute Mechanical Lower Back Pain|Study Care Versus Usual Care for Acute Mechanical Lower Back Pain|Completed||N/A|88|Anticipated|University of British Columbia||1|||f||||||||||||||2017-02-18 17:31:01.343902|2017-02-18 17:31:01.343902
NCT00135226|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2015-12-02|||March 2005||2005-03-01|December 2015|2015-12-01||||September 2017|Anticipated|2017-09-01||Interventional|||ASCEND: A Study of Cardiovascular Events iN Diabetes|A Study of Cardiovascular Events iN Diabetes - A Randomized 2x2 Factorial Study of Aspirin Versus Placebo, and of Omega-3 Fatty Acid Supplementation Versus Placebo, for Primary Prevention of Cardiovascular Events in People With Diabetes|Active, not recruiting||Phase 4|15480|Actual|University of Oxford||4|||f||||||||||||||2017-02-18 17:31:01.437783|2017-02-18 17:31:01.437783
NCT00135213|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-12-20|||October 2005||2005-10-01|September 2006|2006-09-01|July 2007|Actual|2007-07-01|||||Interventional|||PROS Brief Smoking Cessation Counseling in Pediatric Practice to Reduce Secondhand Smoke Exposure of Young Children|PROS Brief Smoking Cessation Counseling in Pediatric Practice to Reduce Secondhand Smoke Exposure of Young Children|Completed||Phase 1|1200|Anticipated|University of Rochester||1|||f||||||||||||||2017-02-18 17:31:01.565081|2017-02-18 17:31:01.565081
NCT00135200|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2015-12-06|2014-11-13||August 2005||2005-08-01|December 2015|2015-12-01|January 2017|Anticipated|2017-01-01|August 2013|Actual|2013-08-01||Interventional|||Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma|A Phase II Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma|Active, not recruiting||Phase 2|16|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:31:01.652923|2017-02-18 17:31:01.652923
NCT00135187|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2012-02-05|||July 2004||2004-07-01|February 2012|2012-02-01|December 2007|Actual|2007-12-01|August 2006|Actual|2006-08-01||Interventional|||Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma|A Pilot Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma|Completed||N/A|30|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:31:01.901759|2017-02-18 17:31:01.901759
NCT00135174|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2008-06-12|||September 2003||2003-09-01|June 2008|2008-06-01|January 2012|Anticipated|2012-01-01|January 2012|Anticipated|2012-01-01||Observational|||Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study|Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The FOLLOWPACE Study|Unknown status|Active, not recruiting|N/A|1526|Actual|UMC Utrecht|||1||f||||t||||||||||2017-02-18 17:31:02.135791|2017-02-18 17:31:02.135791
NCT00135161|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2014-12-04|||September 2003||2003-09-01|December 2014|2014-12-01|August 2015|Anticipated|2015-08-01|August 2015|Anticipated|2015-08-01||Interventional|||Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer|Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 17:31:02.233847|2017-02-18 17:31:02.233847
NCT00135148|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2007-12-19|||April 2004||2004-04-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Observational|||Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group|Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group|Completed||N/A|150||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:31:02.344041|2017-02-18 17:31:02.344041
NCT00135135|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2008-06-02|||August 2005||2005-08-01|June 2008|2008-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Therapy for Children With Neuroblastoma|Neuroblastoma Protocol 2005: Therapy for Children With Advanced Stage High-Risk Neuroblastoma|Completed||Phase 2|23|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:31:02.434647|2017-02-18 17:31:02.434647
NCT00135122|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2008-09-11|||September 2003||2003-09-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache|Medication Overuse Headache: A Randomised Double Blind Study of Prednisolone or Placebo in Withdrawal Therapy (Phase 3), and a Randomised 1 Year Follow up by Neurologist or General Physician After Successful Withdrawal Therapy|Completed||Phase 3|100|Actual|Sorlandet Hospital HF||1|||f||||f||||||||||2017-02-18 17:31:02.550464|2017-02-18 17:31:02.550464
NCT00134927|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-09|||September 2005||2005-09-01|October 2008|2008-10-01|November 2006|Actual|2006-11-01|May 2006|Actual|2006-05-01||Observational|||A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches|Usage Patterns of OTC Nicotine Patches: Consumer Survey|Completed||N/A|600|Actual|National Institute on Drug Abuse (NIDA)|||1||f||||t||||||||||2017-02-18 17:31:04.201665|2017-02-18 17:31:04.201665
NCT00135109|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2014-09-19|||October 2004||2004-10-01|February 2010|2010-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy|Completed||Phase 3|654|Actual|UCB Pharma|||||f||||||||||||||2017-02-18 17:31:02.659363|2017-02-18 17:31:02.659363
NCT00135096|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-01-10|||August 2004||2004-08-01|January 2011|2011-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin|APIDRA® (Insulin Glulisine) Administered Premeal vs Postmeal in Adult Subjects With Type 2 Diabetes Mellitus Receiving LANTUS® (Insulin Glargine) as Basal Insulin: a Multicenter, Randomized, Parallel, Open Label Clinical Study|Completed||Phase 3|345|Actual|Sanofi||2|||||||||||||||||2017-02-18 17:31:02.747434|2017-02-18 17:31:02.747434
NCT00135083|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-01-10|||August 2004||2004-08-01|January 2011|2011-01-01|November 2007|Actual|2007-11-01|||||Interventional|||Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus|One Versus Two Versus Three Daily Rapid-acting Insulin Injections of APIDRA (Insulin Glulisine) as add-on to Lantus® and Oral Sensitizer Basal Therapy in Type 2 Diabetes: a Multicenter, Randomized, Parallel, Open-label Clinical Study|Completed||Phase 3|347|Actual|Sanofi||3|||||||f||||||||||2017-02-18 17:31:02.84094|2017-02-18 17:31:02.84094
NCT00135070|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-04-27|||July 2005||2005-07-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Hospital In-Patient Insulin Study|A Randomised Study Comparing Continuous Intravenous Insulin Infusion With Subcutaneous Insulin Analogues in Hospitalised Patients With Type II Diabetes and Hyperglycaemia|Terminated||Phase 4|41|Actual|The Royal Bournemouth Hospital||2||No documentation with MHRA to support clinical trial of a medicinal product.|f||||t||||||||||2017-02-18 17:31:02.931874|2017-02-18 17:31:02.931874
NCT00135057|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-01-10|||April 2004||2004-04-01|January 2011|2011-01-01|August 2005||2005-08-01|||||Interventional|||Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin|Insulin Glulisine Administered in a Fixed Bolus Regimen Versus Variable Bolus Regimen Based on Carbohydrate Counting in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin|Completed||Phase 3|281||Sanofi|||||||||||||||||||2017-02-18 17:31:03.016142|2017-02-18 17:31:03.016142
NCT00135044|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2007-09-21|||June 2005||2005-06-01|September 2007|2007-09-01||||||||Interventional|||A Trial of Taurine Supplementation in Parenteral Nutrition 1|A Randomised Double Blind Controlled Crossover Trial of Intravenous Taurine Supplementation in Parenteral Nutrition as an Effective Treatment for Reducing Hepatobiliary Complications in Chronic Intestinal Failure|Unknown status|Recruiting|N/A|24|Anticipated|London North West Healthcare NHS Trust|||||f||||||||||||||2017-02-18 17:31:03.096763|2017-02-18 17:31:03.096763
NCT00135031|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-06-14|||January 2004||2004-01-01|June 2011|2011-06-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Safety and Efficacy Evaluation of Bifidobacterium Infantis 35624 in Female Subjects With Irritable Bowel Syndrome|Completed||Phase 3|362||Procter and Gamble|||||f||||f||||||||||2017-02-18 17:31:03.378397|2017-02-18 17:31:03.378397
NCT00135018|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2012-05-22|||February 2006||2006-02-01|May 2012|2012-05-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|||Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer|Phase II Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer|Completed||Phase 2|||Organisation for Oncology and Translational Research||1|||f||||t||||||||||2017-02-18 17:31:03.487638|2017-02-18 17:31:03.487638
NCT00135005|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2013-05-09|||August 2005||2005-08-01|May 2013|2013-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)|A Phase I Multicenter, Dose Escalation Study of AMN107 in Combination With Imatinib on a Continuous Daily Dosing Schedule in Adult Patients With Imatinib-resistant Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 1|59|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:31:03.569994|2017-02-18 17:31:03.569994
NCT00134992|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2006-06-07|||August 2004||2004-08-01|June 2006|2006-06-01||||||||Interventional|||A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers|Single-Center, Randomized, Double Masked, Two-Period Cross-Over, Three Days Per Period, Phase IV Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers|Completed||Phase 4|30||Novartis|||||f||||||||||||||2017-02-18 17:31:03.681677|2017-02-18 17:31:03.681677
NCT00134979|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2011-10-24|||October 2004||2004-10-01|October 2011|2011-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease|Efficacy and Safety of Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease|Completed||Phase 4|847|Actual|Novartis|||||f||||||||||||||2017-02-18 17:31:03.76445|2017-02-18 17:31:03.76445
NCT00134966|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2008-03-28|||August 2005||2005-08-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|||||Interventional|||A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa|A 39 Week Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Effect of Fixed Dose Carbidopa/Levodopa/Entacapone 100 mg t.i.d. vs. Immediate Release Carbidopa/Levodopa 25/100 mg (t.i.d.) in Parkinson's Disease Patients Requiring Levodopa|Completed||Phase 3|493|Actual|Novartis||2|||||||||||||||||2017-02-18 17:31:03.853308|2017-02-18 17:31:03.853308
NCT00134953|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-12-14|||January 2003||2003-01-01|December 2007|2007-12-01|May 2004|Actual|2004-05-01|||||Interventional|||Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment|Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment|Terminated||Phase 3|24||Novartis||||"The Principal Investigator left the clinic and there was no one who could take over this~   study."|f||||||||||||||2017-02-18 17:31:04.02949|2017-02-18 17:31:04.02949
NCT00134940|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-06-15|||January 2005||2005-01-01|June 2011|2011-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus|A Non-interventional Protocol to Collect Prospective and Retrospective Data in Patients Receiving Everolimus to Prevent Acute Rejection Following Cardiac Transplantation|Completed||Phase 4|100|Actual|Novartis|||1||f||||||||||||||2017-02-18 17:31:04.115046|2017-02-18 17:31:04.115046
NCT00134901|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2016-04-06|2014-08-25||March 2003||2003-03-01|April 2016|2016-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2|A Double-Blind, Placebo-Controlled Trial of the Effectiveness of Memantine in Treating Cocaine Dependence|Completed||Phase 2|81|Actual|New York State Psychiatric Institute|participants who had achieved abstinence during the lead-in remained abstinent throughout the trial and there was little relapse-like behavior for a medication to address.|2|||f||||t||||||||||2017-02-18 17:31:04.391289|2017-02-18 17:31:04.391289
NCT00134888|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-11|||December 2000||2000-12-01|July 2007|2007-07-01|November 2002|Actual|2002-11-01|||||Interventional|||Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence|The Acute and Protracted Blockade Efficacy of Buprenorphine/Naloxone|Completed||N/A|8|Actual|National Institute on Drug Abuse (NIDA)||4|||||||f||||||||||2017-02-18 17:31:04.805156|2017-02-18 17:31:04.805156
NCT00134875|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-11|||December 2000||2000-12-01|October 2008|2008-10-01|December 2017|Anticipated|2017-12-01|December 2002|Actual|2002-12-01||Interventional|||Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers|Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers|Terminated||N/A|9|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-02-18 17:31:04.909078|2017-02-18 17:31:04.909078
NCT00134849|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2007-09-21|||September 2005||2005-09-01|September 2007|2007-09-01|March 2006|Actual|2006-03-01|||||Observational|||Hypertension in Management of Military Medicine|Hypertension in Management of Military Medicine|Terminated||N/A|1000|Anticipated|United States Naval Medical Center, San Diego||||Inadequate number of records screened; primary investigator left institution.|f||||f||||||||||2017-02-18 17:31:05.006809|2017-02-18 17:31:05.006809
NCT00134836|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2008-12-11|||April 2004||2004-04-01|December 2008|2008-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|PPCO||Preventive Primary Care Outreach for High Risk Older Persons|Preventive Primary Care Outreach for High Risk Older Persons|Completed||Phase 1|719|Actual|McMaster University||1|||f||||f||||||||||2017-02-18 17:31:05.094479|2017-02-18 17:31:05.094479
NCT00134823|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-07-20|||March 2005||2005-03-01|July 2011|2011-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Improving Pediatric Safety and Quality With Health Care Information Technology|Improving Pediatric Safety and Quality With Health Care IT|Completed||N/A|5420|Actual|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 17:31:05.183407|2017-02-18 17:31:05.183407
NCT00134810|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-01-09|||March 2005||2005-03-01|January 2007|2007-01-01|May 2006||2006-05-01|||||Interventional|||Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome|A Phase II Multicentre Multinational Prospective Randomised Double-Blind Placebo-Controlled Study Assessing the Efficacy and Safety of a Single Application of Three Doses of Dysport® in Patients With Upper Back Myofascial Pain Syndrome|Completed||Phase 2|340||Ipsen|||||f||||||||||||||2017-02-18 17:31:05.454305|2017-02-18 17:31:05.454305
NCT00134797|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2005-11-04|||February 2005||2005-02-01|August 2005|2005-08-01|February 2006||2006-02-01|||||Observational|||Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists|The Effect of MDRD GFR Reporting on Nephrology Referral Patterns by Internists|Unknown status|Recruiting|N/A|1500||United States Naval Medical Center, San Diego|||||f||||||||||||||2017-02-18 17:31:05.566736|2017-02-18 17:31:05.566736
NCT00134784|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2014-07-15|2010-10-07||April 2000||2000-04-01|July 2014|2014-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|ELLDOPA||Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression|[123I]ß-CIT and SPECT in Vivo Three Year Imaging Assessment of Dopamine Transporter Density in Subjects With Early Parkinson's Disease Participating in Earlier vs. Later Levodopa in Parkinson's Disease|Completed||Phase 2|142|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 17:31:05.642072|2017-02-18 17:31:05.642072
NCT00134771|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2005-11-04|||February 2001||2001-02-01|August 2005|2005-08-01|June 2003||2003-06-01|||||Interventional|||Trial of Nutritional Supplementation in Infants Born Small for Gestational Age||Completed||N/A|||Institute of Child Health|||||f||||||||||||||2017-02-18 17:31:06.015729|2017-02-18 17:31:06.015729
NCT00134758|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2009-07-28|||October 2004||2004-10-01|July 2009|2009-07-01|October 2009|Anticipated|2009-10-01|June 2009|Actual|2009-06-01||Interventional|||Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients|Efficiency of Ursodesoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis Patients. URSOPAF|Unknown status|Active, not recruiting|Phase 2/Phase 3|90|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:31:06.109044|2017-02-18 17:31:06.109044
NCT00134745|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2013-06-13|||June 2005||2005-06-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome|The Growth of Genitalia Interna and the Bone Mineralization Under Hormonal Replacement Therapy and the Presence of Aortic Root Dilatation in Girls With Turner Syndrome|Completed||Phase 4|43|Actual|Hillerod Hospital, Denmark||2|||f||||t||||||||||2017-02-18 17:31:06.229305|2017-02-18 17:31:06.229305
NCT00134732|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2016-09-22|||July 2005||2005-07-01|September 2016|2016-09-01|May 2006|Actual|2006-05-01|||||Interventional|||Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis|Assess the Immunogenicity, Safety & Reactogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants (6-12 Weeks of Age at First Dose) Previously Uninfected With Human Rotavirus|Completed||Phase 3|150||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:31:06.350816|2017-02-18 17:31:06.350816
NCT00134719|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2016-09-23|2012-06-15||April 2005||2005-04-01|September 2016|2016-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines|A Multicentre Primary & Booster Vaccination Study of GSK Biologicals' Hib-MenCY-TT Conjugate Vaccine vs ActHIB® & MenC Conjugate Licensed Vaccine When Given According to the 2-4-6 Month Schedule to Healthy Infants With Booster Dose at 12 to 15 Months|Completed||Phase 2|1104|Actual|GlaxoSmithKline||3|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:31:06.672511|2017-02-18 17:31:06.672511
NCT00134134|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2006-09-07|||February 2005||2005-02-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa|An Open-Label Assessment of the Efficacy & Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa|Completed||Phase 1|5||New York University School of Medicine|||||||||||||||||||2017-02-18 17:31:16.403716|2017-02-18 17:31:16.403716
NCT00134706|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2009-12-07|||January 2004||2004-01-01|December 2009|2009-12-01|September 2009|Actual|2009-09-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer|A Phase II Study of Docetaxel Plus Carboplatin in Hormone Refractory Prostate Cancer Patients Refractory to Prior Docetaxel-based Chemotherapy|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:31:08.731354|2017-02-18 17:31:08.731354
NCT00134693|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2015-04-15|||June 2005||2005-06-01|April 2015|2015-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis|A Randomised, Placebo-controlled, Parallel Group Single Dose Study of SB681323 in Patients With Active RA to Investigate the CRP Dose Response Relationship|Completed||Phase 2|77|Actual|GlaxoSmithKline|||||f||||t||||||||||2017-02-18 17:31:08.966237|2017-02-18 17:31:08.966237
NCT00134680|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2014-09-12|||January 2000||2000-01-01|October 2012|2012-10-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC|Phase II Trial of the Combination of Letrozole 2.5 mg Daily and Trastuzumab 2 mg/kg Weekly in ErbB2 Positive and Estrogen Receptor and/or Progesterone Receptor Positive Metastatic Breast Cancer|Completed||Phase 2|33|Actual|Duke University||1|||f||||f||||||||||2017-02-18 17:31:09.0786|2017-02-18 17:31:09.0786
NCT00134667|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2007-01-12|||March 2005||2005-03-01|January 2007|2007-01-01|October 2008||2008-10-01|||||Interventional|||Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)|A Phase IIIb/IV Randomized, Double-Masked, Active Controlled, Dose-Ranging, Multi-Center Comparative Trial, in Parallel Groups, to Compare the Safety and Efficacy of Intravitreal Injections of Pegaptanib Sodium (Macugen) Given Every 6 Weeks for 102 Weeks, to Pegaptanib Sodium Plus Photodynamic Therapy (PDT) With Visudyne, in Patients With Exudative Age-Related Macular Degeneration (AMD)|Terminated||Phase 4|360||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 17:31:09.196518|2017-02-18 17:31:09.196518
NCT00134654|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2011-06-14|||March 2003||2003-03-01|June 2011|2011-06-01|June 2011|Actual|2011-06-01|July 2005|Actual|2005-07-01||Interventional|||Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer|A Phase II Trial of Two Doses of Conjugated Estrogens (Premarin) in Patients With Androgen-Independent Prostate Cancer|Completed||Phase 2|48|Actual|Dana-Farber Cancer Institute||2|||f||||||||||||||2017-02-18 17:31:09.280262|2017-02-18 17:31:09.280262
NCT00134641|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2007-12-20|||February 2003||2003-02-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas|A Phase II Study Evaluating Efficacy of the Combination of Gemcitabine and Vinorelbine in Advanced Soft Tissue Sarcoma|Completed||Phase 2|40||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:31:09.390271|2017-02-18 17:31:09.390271
NCT00134628|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2016-01-11|||January 2001||2001-01-01|February 2012|2012-02-01|December 2015|Actual|2015-12-01|August 2011|Actual|2011-08-01||Interventional|||Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries|Hyperbaric Oxygen Radiation Tissue Injury Study - Project HORTIS|Terminated||Phase 3|248|Actual|Baromedical Research Foundation||2||"Discontinued cystitis study due to poor recruitment. To continue the trial under these~   circumstances is considered non-viable."|f||||t||||||||||2017-02-18 17:31:09.494405|2017-02-18 17:31:09.494405
NCT00134615|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2016-06-02|||August 2004||2004-08-01|June 2016|2016-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|RQP||Testing the Right Question Project (RQP) Health Education Strategy in a Mental Health Setting|Testing the Right Question Project Health Education Strategy in a Mental Health Setting|Completed||N/A|231|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 17:31:09.62099|2017-02-18 17:31:09.62099
NCT00134602|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-24|2012-09-26|||April 2003||2003-04-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|January 2007|Actual|2007-01-01||Interventional|||Pediatric Impact: Promoting Adherence to Medications Among HIV-infected Children|An Intervention to Promote Adherence to Antiretroviral Medications Among HIV-infected Children 5-12 Years of Age|Completed||N/A|180||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:31:09.731664|2017-02-18 17:31:09.731664
NCT00134589|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2009-08-03|||April 2005||2005-04-01|July 2007|2007-07-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||CHOICE: Communicating Health Options Through Information and Cancer Education|Increasing CRC Screening in Health Plan Members|Completed||Phase 4|450|Actual|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:31:10.023541|2017-02-18 17:31:10.023541
NCT00134576|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2010-06-01|||May 2007||2007-05-01|May 2010|2010-05-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Automated Assessment of Mental Health in the Workplace|Automated Assessment of Mental Health in the Workplace|Completed||N/A|150|Anticipated|Boston Medical Center||1|||f||||f||||||||||2017-02-18 17:31:10.125859|2017-02-18 17:31:10.125859
NCT00134563|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2013-01-02|2012-10-03||September 2004||2004-09-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|TEMSO||Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Design Study to Evaluate the Efficacy and Safety of Teriflunomide in Reducing the Frequency of Relapses and Delaying the Accumulation of Physical Disability in Subjects With Multiple Sclerosis With Relapses|Completed||Phase 3|1088|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 17:31:10.225353|2017-02-18 17:31:10.225353
NCT00134550|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2009-09-22|||February 2005||2005-02-01|September 2009|2009-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Improving Diabetic Foot Ulcers With Atorvastatin|Improving Diabetic Foot Ulcers With Atorvastatin|Completed||Phase 2|13|Actual|Asker & Baerum Hospital||1|||f||||f||||||||||2017-02-18 17:31:11.691711|2017-02-18 17:31:11.691711
NCT00134537|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-10-03|||November 2004||2004-11-01|October 2011|2011-10-01|April 2012|Anticipated|2012-04-01|April 2011|Actual|2011-04-01||Interventional|||Wallis Mechanical Normalization System for Low Back Pain||Unknown status|Active, not recruiting|Phase 3|300|Anticipated|Zimmer Spine||2|||f||||t||||||||||2017-02-18 17:31:11.802112|2017-02-18 17:31:11.802112
NCT00134524|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2007-07-08|||July 2005||2005-07-01|July 2007|2007-07-01|January 2008|Anticipated|2008-01-01|||||Interventional|||The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy|A Randomized, Sham-Controlled Clinical Study to Evaluate The Effect of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|Advanced Magnetic Research Institute International|||||f||||f||||||||||2017-02-18 17:31:11.91397|2017-02-18 17:31:11.91397
NCT00134511|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2007-11-05|||March 2005||2005-03-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder|Phase 3 Multi-Center, Open Label, Forced Titration Study To Evaluate The Efficacy, Safety, And Tolerability Of Torcetrapib/Atorvastatin Combination Administered Orally, Once Daily (Qd) In Patients With Homozygous Familial Hypercholesterolaemia|Completed||Phase 3|30||Pfizer|||||||||||||||||||2017-02-18 17:31:12.008603|2017-02-18 17:31:12.008603
NCT00134498|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2007-11-15|||February 2005||2005-02-01|March 2007|2007-03-01|November 2006||2006-11-01|||||Interventional|||A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides|Phase 3, Multi-Site, Double-Blind, Randomized, Forced Titration, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Fixed Combination Torcetrapib (CP 529,414)/Atorvastatin Administered Orally, Once Daily (Qd) For Eighteen Weeks, Compared With Atorvastatin Alone, In Subjects With Fredrickson Type IV Hypertriglyceridemia|Completed||Phase 3|160||Pfizer|||||||||||||||||||2017-02-18 17:31:12.097766|2017-02-18 17:31:12.097766
NCT00134485|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2007-10-28|||March 2005||2005-03-01|December 2006|2006-12-01|March 2006||2006-03-01|||||Interventional|||Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia|Phase 3, Multi-Center, Double-Blind, Randomized, Parallel Group, Study of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib (CP-529,414) / Atorvastatin Administered Orally, Once Daily (QD) for Six Months, Compared With Maximally Tolerated Atorvastatin Therapy Alone, in Subjects With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|400||Pfizer|||||||||||||||||||2017-02-18 17:31:12.250892|2017-02-18 17:31:12.250892
NCT00134472|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2012-05-10|||December 2002||2002-12-01|May 2012|2012-05-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan|Therapeutic Strategy for Severe Head Trauma Patients With Mild Hypothermia and Estimation of Medical Expenses in Japan|Completed||Phase 3|150|Actual|Yamaguchi University Hospital||1|||f||||||||||||||2017-02-18 17:31:12.514243|2017-02-18 17:31:12.514243
NCT00134459|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2013-02-12|||June 2005||2005-06-01|July 2009|2009-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study Evaluating Bifeprunox in Bipolar Depression|A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder|Completed||Phase 3|434|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:31:12.658216|2017-02-18 17:31:12.658216
NCT00134446|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2005-10-28|||March 2004||2004-03-01|March 2005|2005-03-01||||||||Interventional|||Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder|A Prospective Double Blind Randomized Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder|Unknown status|Recruiting|Phase 4|40||White River Junction VAMC|||||f||||||||||||||2017-02-18 17:31:12.775334|2017-02-18 17:31:12.775334
NCT00134433|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2012-06-20|||November 2004||2004-11-01|June 2012|2012-06-01|October 2007|Actual|2007-10-01|March 2007|Actual|2007-03-01||Interventional|||Endothelial Modulation for Angiogenic Therapy|Endothelial Modulation With L-Arginine in Patients Undergoing Angiogenic Therapy (EMAT): A 2x2 Factorial Trial|Completed||Phase 1/Phase 2|20|Actual|Ottawa Heart Institute Research Corporation|||||f||||t||||||||||2017-02-18 17:31:13.054265|2017-02-18 17:31:13.054265
NCT00134420|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2016-08-04|||February 2001||2001-02-01|August 2016|2016-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Growth Hormone and Chromosome 18q- and Abnormal Growth|Growth Hormone Trial for Children With 18q- and Abnormal Growth|Completed||Phase 3|20|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||||2017-02-18 17:31:13.155479|2017-02-18 17:31:13.155479
NCT00134407|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2011-09-02|||February 2001||2001-02-01|September 2011|2011-09-01|June 2006||2006-06-01|||||Interventional|||Postoperative Oral Intake Trial|Postoperative Enteral Feeding or Early Oral Intake at Will. Effects on Clinical Outcome|Completed||Phase 1|450||University Hospital of North Norway|||||f||||||||||||||2017-02-18 17:31:13.265766|2017-02-18 17:31:13.265766
NCT00134394|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2008-08-06|||February 2005||2005-02-01|August 2008|2008-08-01|December 2007||2007-12-01|||||Interventional|||Etanercept With Tacrolimus for Psoriasis|Double-Blind, Placebo-Controlled, Bilateral Comparison of Topical Tacrolimus 0.1% vs. Placebo Ointment as Adjunctive Therapy for Patients With Moderate to Severe Psoriasis Who Are Candidates for or Poor Responders to Etanercept Therapy|Completed||Phase 2|20||Rutgers, The State University of New Jersey|||||f||||f||||||||||2017-02-18 17:31:13.36641|2017-02-18 17:31:13.36641
NCT00134381|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2015-02-02|||May 2003||2003-05-01|February 2015|2015-02-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Green Tea and Ultraviolet Light-induced Skin Damage|The Effects of Topically Applied Constituents of Green Tea on UV Induced Increase in p53 and Apoptotic Markers in the Skin of Human Volunteers|Terminated||Phase 2|80|Actual|Rutgers, The State University of New Jersey||1||Principal Investigator left institution before study could complete.|f||||f||||||||||2017-02-18 17:31:13.462084|2017-02-18 17:31:13.462084
NCT00134368|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2008-08-06|||November 2003||2003-11-01|August 2008|2008-08-01|December 2007||2007-12-01|||||Interventional|||Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo|Pilot, Investigator-Initiated, Proof-of-Concept, Study of the Efficacy and Safety of Etanercept (Enbrel) in Adults With Vitiligo|Completed||Phase 2|40||Rutgers, The State University of New Jersey|||||||||||||||||||2017-02-18 17:31:13.571879|2017-02-18 17:31:13.571879
NCT00134355|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2015-01-15|||July 2005||2005-07-01|January 2015|2015-01-01|March 2007|Actual|2007-03-01|November 2006|Actual|2006-11-01||Interventional|||Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer|Phase II Evaluation of PTK787, an Oral Vascular Endothelial Growth Factor Inhibitor, in Patients With Non-Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|5|Actual|University of Michigan Cancer Center||1|||f||||t||||||||||2017-02-18 17:31:13.67274|2017-02-18 17:31:13.67274
NCT00134342|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2010-12-22|||January 2005||2005-01-01|July 2005|2005-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Observational|||Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations|A Comparison of Traditional Tuberculosis Screening Methods With the T-SPOT TB Test for the Diagnosis of Latent Tuberculosis Infection in Immunocompromised Populations|Completed||Phase 3|203|Actual|University Health Network, Toronto|||1||f||||f||||||||||2017-02-18 17:31:13.784706|2017-02-18 17:31:13.784706
NCT00134329|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-12-19|||May 2005||2005-05-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|||||Observational|||Erectile Dysfunction and Diabetes Mellitus|Erectile Dysfunction and Diabetes Mellitus|Completed||N/A|300||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:31:13.881617|2017-02-18 17:31:13.881617
NCT00134303|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2014-12-04|||June 2005||2005-06-01|December 2014|2014-12-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity|Double Blinded Randomised Trial Comparing Metformin Versus Placebo in NASH Patients Receiving Bariatric Surgery for Obesity|Unknown status|Recruiting|Phase 4|200|Anticipated|University Hospital, Ghent||1|||f||||f||||||||||2017-02-18 17:31:14.09177|2017-02-18 17:31:14.09177
NCT00134290|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-12-19|||January 2002||2002-01-01|December 2007|2007-12-01|May 2004|Actual|2004-05-01|||||Interventional|||The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance|The Effects of Calorie Restriction - Whether or Not Calculated Based on BMR (Basic Metabolic Rate) - With or Without Metformin on Weight and Insulin Resistance of Obese Insulin Resistant Patients|Completed||Phase 4|48||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:31:14.206406|2017-02-18 17:31:14.206406
NCT00134277|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-09-08|||September 2004||2004-09-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|January 2009|Actual|2009-01-01||Interventional|||Trial Comparing Different Medical Devices for Infragenual Dilatation|Prospective Randomised Comparing Trial Between an Infragenual Dilatation (ID), an ID With Stenting, an ID With Cutting Balloon and Laser Therapy|Completed||N/A|35|Actual|University Hospital, Ghent||4|||f||||f||||||||||2017-02-18 17:31:14.313777|2017-02-18 17:31:14.313777
NCT00134264|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2012-01-30||2012-01-30|July 2004||2004-07-01|January 2012|2012-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|ILLUMINATE||A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease|Phase 3 Multi Center, Double Blind, Randomized, Parallel Group Evaluation Of The Fixed Combination Torcetrapib/Atorvastatin, Administered Orally, Once Daily (Qd), Compared With Atorvastatin Alone, On The Occurrence Of Major Cardiovascular Events In Subjects With Coronary Heart Disease Or Risk Equivalents|Terminated||Phase 3|15067|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:31:14.436748|2017-02-18 17:31:14.436748
NCT00134251|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2009-01-29|||October 2005||2005-10-01|January 2009|2009-01-01||||||||Interventional|||Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Parallel Group Study Exploring Effects of SLV308 up to 42 mg/Day Administered as an Adjunctive Therapy to L-Dopa in Patients With Advanced Stage Parkinson's Disease|Completed||Phase 3|||Solvay Pharmaceuticals|||||f||||||||||||||2017-02-18 17:31:14.911043|2017-02-18 17:31:14.911043
NCT00134238|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2012-02-15||2012-02-15|November 2003||2003-11-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|RADIANCE 2||Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.|Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Atorvastatin Alone, in Subjects With Mixed Hyperlipidemia|Terminated||Phase 3|755|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:31:15.005427|2017-02-18 17:31:15.005427
NCT00134225|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2005-10-25|||April 2005||2005-04-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain|Multi-Center, Multi-National Study to Demonstrate That Muscle Pattern Recognition is a Reliable and Valid Evaluation Tool for Patients Who Present With Acute, Sub-Acute, or Chronic Symptoms of Neck or Back Pain of a Musculoskeletal Origin|Unknown status|Recruiting|N/A|480||iTech Medical, Inc.|||||f||||||||||||||2017-02-18 17:31:15.157381|2017-02-18 17:31:15.157381
NCT00134212|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2005-12-30|||March 2002||2002-03-01|December 2005|2005-12-01|June 2004||2004-06-01|||||Interventional|||Dopexamine and Norepinephrine Compared With Epinephrine Alone in Septic Shock|Prospective, Randomized Study on Two Parallel Groups Comparing Dopexamine and Norepinephrine in Combination to Epinephrine Alone on Systemic and Pulmonary Hemodynamics, Gastric Mucosal Perfusion, and Oxidative Stress in Septic Shock|Completed||Phase 2|20||Rennes University Hospital|||||f||||||||||||||2017-02-18 17:31:15.453645|2017-02-18 17:31:15.453645
NCT00134199|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2009-08-11|||March 2005||2005-03-01|April 2006|2006-04-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects|A 6-Month, Randomized, Double-Blind, Placebo And Positive-Controlled Phase 2b Study To Evaluate The Effect Of Various Doses Of CP-945,598 On Weight Loss In Obese Subjects|Completed||Phase 2/Phase 3|282|Actual|Pfizer|||||||||||||||||||2017-02-18 17:31:15.565868|2017-02-18 17:31:15.565868
NCT00134186|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2007-03-02||||||March 2007|2007-03-01||||||||Interventional|||Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer|Phase II Trial of Motexafin Gadolinium for Treatment of Metastatic Renal Cell Carcinoma|Completed||Phase 2|43||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:31:15.673408|2017-02-18 17:31:15.673408
NCT00134173|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2007-12-06|||October 2003||2003-10-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|ILLUSTRATE||A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease|Phase 3, Multi-Center, Double-Blind, Randomized, Parallel Group, Coronary Artery Intravascular Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Atorvastatin Alone, in Subjects With Angiographically Documented Coronary Heart Disease.|Completed||Phase 3|1100||Pfizer|||||||||||||||||||2017-02-18 17:31:15.772993|2017-02-18 17:31:15.772993
NCT00134160|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2010-10-03|||August 2005||2005-08-01|October 2010|2010-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study|The Study Comparing the Incidence of Cardiovascular Events Between High-dose ARB Monotherapy and Combination Therapy With ARB and Calcium Channel Blocker in Japanese Elderly Hypertensive Patients at High Cardiovascular Risk|Completed||Phase 4|1000|Anticipated|OSCAR Study||2|||f||||t||||||||||2017-02-18 17:31:16.054198|2017-02-18 17:31:16.054198
NCT00134147|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2008-04-16|||April 2005||2005-04-01|April 2008|2008-04-01|May 2007|Actual|2007-05-01|||||Interventional|||A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control|A One Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera) on Glycemic Control in Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled on a Minimum of Two Oral Anti Diabetic Agents|Completed||Phase 3|1100||Pfizer|||||f||||||||||||||2017-02-18 17:31:16.188211|2017-02-18 17:31:16.188211
NCT00005396|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1994||1994-09-01|April 2002|2002-04-01|August 1999|Actual|1999-08-01|||||Observational|||Motivating Smokers--Reduce Child Environmental Tobacco Smoke Exposure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:02.847459|2017-02-18 18:15:02.847459
NCT00134108|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2005-10-25|||January 2003||2003-01-01|January 2003|2003-01-01|December 2005||2005-12-01|||||Interventional|||Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer Patients|Randomised Controlled Clinical Effectiveness Trial of Cognitive Behaviour Therapy (CBT) Versus Treatment as Usual (TAU) for Insomnia in Cancer Patients|Unknown status|Active, not recruiting|N/A|||NHS Greater Clyde and Glasgow|||||f||||||||||||||2017-02-18 17:31:16.499637|2017-02-18 17:31:16.499637
NCT00134095|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2013-09-16|||September 2004||2004-09-01|January 2010|2010-01-01||||August 2008|Actual|2008-08-01||Interventional|||S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer|Phase II Clinical Study of Preoperative S-1/CPT-11 Combination Chemotherapy in Patients With Locally Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|70|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:31:16.575576|2017-02-18 17:31:16.575576
NCT00134082|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2015-10-30|||July 2005||2005-07-01|October 2015|2015-10-01|December 2017|Anticipated|2017-12-01|October 2017|Anticipated|2017-10-01||Interventional|||Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma|Pilot Study of Rituximab, High Dose Cyclophosphamide, and GM-CSF Based Immunotherapy for Relapsed Hodgkin's Lymphoma|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:31:16.805541|2017-02-18 17:31:16.805541
NCT00134069|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-04-15|||June 2005||2005-06-01|April 2014|2014-04-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Interventional|||Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer|Phase I/II Clinical, Pharmacological, and Biological Study of BAY 43-9006 in Combination With Cetuximab and Irinotecan in Patients With Advanced Colorectal Cancer|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:31:16.906507|2017-02-18 17:31:16.906507
NCT00134056|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2016-10-13|||August 2006||2006-08-01|October 2016|2016-10-01|February 2016|Actual|2016-02-01|February 2016|Actual|2016-02-01||Interventional|||S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy|Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer|Completed||Phase 3|1038|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 17:31:17.053604|2017-02-18 17:31:17.053604
NCT00134043|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-07-23|2014-04-18||December 2005||2005-12-01|July 2014|2014-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer|Phase II Study of Histone Deacetylase Inhibitor SAHA (Vorinostat) in Patients With Metastatic Thyroid Carcinoma|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:31:17.975971|2017-02-18 17:31:17.975971
NCT00134030|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2016-11-23|||November 2005||2005-11-01|November 2016|2016-11-01||||January 2017|Anticipated|2017-01-01||Interventional|||Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma|A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy (IND# 12697)|Active, not recruiting||Phase 3|1164|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 17:31:18.987556|2017-02-18 17:31:18.987556
NCT00134017|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2016-10-17|||May 2004||2004-05-01|October 2016|2016-10-01||||April 2017|Anticipated|2017-04-01||Interventional|||Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer|HLA Matched Related and Unrelated Bone Marrow Transplantation With Busulfan/Cyclophosphamide and Post Transplantation Cyclophosphamide for Hematological Malignancies|Active, not recruiting||Phase 2|92|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:31:19.534581|2017-02-18 17:31:19.534581
NCT00134004|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2015-09-02|2015-06-26||October 2004||2004-10-01|September 2015|2015-09-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer|A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Bone Marrow for Patients With Hematologic Malignancies|Completed||Phase 2|210|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:31:19.677067|2017-02-18 17:31:19.677067
NCT00133991|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-04-16|||March 2005||2005-03-01|April 2014|2014-04-01|July 2012|Actual|2012-07-01|July 2010|Actual|2010-07-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia|Phase II Study of Intensified CVP, Rituximab, and High Dose Cyclophosphamide for Adult Burkitt or Burkitt-Like Lymphoma|Completed||Phase 2|21|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:31:20.004819|2017-02-18 17:31:20.004819
NCT00133978|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-08-26|2013-04-29||April 2005||2005-04-01|August 2014|2014-08-01|May 2012|Actual|2012-05-01|December 2011|Actual|2011-12-01||Interventional|REDOXS|Five randomized patients were not evaluable because we could not ascertain their 28-day vital status leaving 1218 patients in the final intention-to-treat analysis.|Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients|REducing Deaths Due to OXidative Stress The REDOXS© Study|Completed||Phase 3|1223|Actual|Clinical Evaluation Research Unit at Kingston General Hospital||4|||f||||t||||||||||2017-02-18 17:31:20.145539|2017-02-18 17:31:20.145539
NCT00133965|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2011-04-19|||May 2005||2005-05-01|April 2011|2011-04-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Observational|||Psychosocial Support for Cancer Patients|Psychosocial Support for Cancer Patients|Completed||N/A|281|Actual|Memorial Sloan Kettering Cancer Center|||3||f||||||||||||||2017-02-18 17:31:20.98473|2017-02-18 17:31:20.98473
NCT00133952|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2016-08-25|2015-12-22||August 2005||2005-08-01|August 2016|2016-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Effect of Ruboxistaurin on Clinically Significant Macular Edema|The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema|Completed||Phase 3|309|Actual|Chromaderm, Inc.||2|||f||||||||||||||2017-02-18 17:31:21.106047|2017-02-18 17:31:21.106047
NCT00133939|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-04-26||||||April 2007|2007-04-01||||||||Interventional|||Proportional Ventilation and Ventilatory Synchronism|Proportional Ventilation and Ventilatory Synchronism|Unknown status|Recruiting|N/A|10||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:31:22.298978|2017-02-18 17:31:22.298978
NCT00131157|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2007-02-28|||January 2003||2003-01-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||Evaluation of Spirometry Expert Support in General Practice|A Randomized-Controlled Evaluation of Spirometry Expert Support in General Practice|Unknown status|Active, not recruiting|N/A|39||Radboud University|||||f||||||||||||||2017-02-18 17:32:04.573457|2017-02-18 17:32:04.573457
NCT00133926|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2007-04-04|||March 2005||2005-03-01|April 2007|2007-04-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Prevention of Pre-Term Birth by Treatment of Periodontal Disease|Prevention of Pre-Term Birth by Treatment of Periodontal Disease During Pregnancy - The Smile Study|Unknown status|Recruiting|Phase 2|1094||King Edward Memorial Hospital|||||f||||t||||||||||2017-02-18 17:31:22.381298|2017-02-18 17:31:22.381298
NCT00133913|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2008-03-17|||March 2004||2004-03-01|March 2008|2008-03-01|January 2009|Anticipated|2009-01-01|January 2007|Actual|2007-01-01||Observational|IMMC-06||Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer|Longitudinal Enumeration of Circulating Tumor Cells in Patients With Metastatic Colorectal Carcinomas|Unknown status|Active, not recruiting|N/A|486|Actual|Immunicon|||1||f||||f||||||||||2017-02-18 17:31:22.471783|2017-02-18 17:31:22.471783
NCT00133900|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2009-07-27|||December 2004||2004-12-01|March 2008|2008-03-01|February 2009|Anticipated|2009-02-01|February 2009|Anticipated|2009-02-01||Observational|IMMC-38||Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy|Circulating Tumor Cells and the Prediction of Overall Survival in Patients With Androgen Independent Prostate Cancer Entering Onto Chemotherapy|Unknown status|Active, not recruiting|N/A|276|Actual|Immunicon|||1||f||||f||||||Samples With DNA|"~     Serum Samples and RNA samples have been retained.~   "|||2017-02-18 17:31:22.568387|2017-02-18 17:31:22.568387
NCT00133887|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2014-07-01|||April 2004||2004-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|March 2011|Actual|2011-03-01||Interventional|||TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients|Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients - Multicentric Randomized, Open-label Study of Rapamycin vs Calcineurin Inhibitors|Completed||Phase 3|77|Actual|Hospices Civils de Lyon||2|||f||||||||||||||2017-02-18 17:31:22.663215|2017-02-18 17:31:22.663215
NCT00133874|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2017-01-20|||April 2005||2005-04-01|January 2017|2017-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo|An Observer-blind, Multicenter, Non-inferiority, Comparative Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, Versus Topical 2% Fusidic Acid Cream Applied Three Times Daily for 7 Days in the Treatment Adult and Paediatric Subjects With Impetigo|Completed||Phase 3|520|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:31:22.777609|2017-02-18 17:31:22.777609
NCT00133861|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2008-06-30|||April 2005||2005-04-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles|Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles. Assessment of Efficiency of Botulinum Toxin on Spasticity in Agonist and Antagonist Muscles Using Clinical Assessment and Gait Analysis in Cerebral Palsy Children: Rectus Femoris and Semitendinosus|Completed||Phase 2/Phase 3|23|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:31:25.866211|2017-02-18 17:31:25.866211
NCT00133848|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2016-09-22|||April 2005||2005-04-01|September 2016|2016-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment|A Randomised, Double-blind, Multicentre, Superiority Placebo-controlled, Phase III Study to Assess the Efficacy and Safety of Topical 1% SB-275833 Ointment Versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adults and Paediatric Subjects With Impetigo.|Completed||Phase 3|210||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:31:25.957558|2017-02-18 17:31:25.957558
NCT00133835|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2005-10-24|||March 1998||1998-03-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Comparison of Extracorporeal Shock Wave Lithotripsy (ESWL) Alone and ESWL Plus Endoscopy for Painful Chronic Pancreatitis|Comparison of ESWL Alone and ESWL Combined With Endoscopic Drainage of the Main Pancreatic Duct for Painful Chronic Pancreatitis|Completed||Phase 1/Phase 2|50||Erasme University Hospital|||||f||||||||||||||2017-02-18 17:31:26.06851|2017-02-18 17:31:26.06851
NCT00133822|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2015-08-18|||April 2004||2004-04-01|August 2015|2015-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial|Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD|Completed||Phase 1/Phase 2|65||Emory University|||||f||||||||||||||2017-02-18 17:31:26.166271|2017-02-18 17:31:26.166271
NCT00133809|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2016-06-16|2016-04-25||July 2002||2002-07-01|June 2016|2016-06-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Eligible participants who received islet transplantation|Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression|Islet Transplantation in Type 1 Diabetes Using the Edmonton Protocol of Steroid Free Immunosuppression|Completed||Phase 2|8|Actual|Emory University||1|||f||||t||||||||||2017-02-18 17:31:26.264389|2017-02-18 17:31:26.264389
NCT00133796|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2017-02-03|||October 2001||2001-10-01|February 2017|2017-02-01|April 2007|Actual|2007-04-01|September 2005|Actual|2005-09-01||Interventional|||Neoadjuvant Herceptin in Patients With Breast Cancer|A Phase II Study of the Effects of Herceptin in Patients With Locally Advanced HER-2/NEU Overexpressing Breast Cancer|Terminated||Phase 2|40|Actual|Baylor Breast Care Center||1||Closed to accrual 4/19/2006 / Study doesn't qualify for reporting.|f||||t||||||||No||2017-02-18 17:31:26.862533|2017-02-18 17:31:26.862533
NCT00133783|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2005-10-25|||May 2005||2005-05-01|May 2005|2005-05-01|May 2007||2007-05-01|||||Observational|||Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure|Intermedin is an Estrogen- Modulated Factor for Reducing Blood Pressure|Unknown status|Recruiting|N/A|500||Chang Gung Memorial Hospital|||||f||||||||||||||2017-02-18 17:31:26.974784|2017-02-18 17:31:26.974784
NCT00133770|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2013-07-29|||July 2004||2004-07-01|July 2013|2013-07-01|March 2007|Actual|2007-03-01|July 2006|Actual|2006-07-01||Interventional|||Intravenous (IV) Pantoprazole in Erosive Esophagitis|A Pilot Study of Efficacy and Safety of Continuous Intravenous Infusion of Pantoprazole in the Treatment of Severe Erosive Esophagitis|Completed||Phase 4|20|Actual|Emory University||1|||f||||f||||||||||2017-02-18 17:31:27.067314|2017-02-18 17:31:27.067314
NCT00133757|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2013-02-13|||June 2005||2005-06-01|February 2013|2013-02-01|May 2006||2006-05-01|||||Interventional|||Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers|Pharmacotherapy-assisted Extinction (Pharmacoextinction): A Novel Approach to the Treatment of Nicotine Dependence in Humans|Completed||Phase 1|50||Centre for Addiction and Mental Health|||||f||||||||||||||2017-02-18 17:31:27.175919|2017-02-18 17:31:27.175919
NCT00133744|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2011-03-18|||May 2006||2006-05-01|March 2011|2011-03-01|December 2010|Actual|2010-12-01|December 2009|Actual|2009-12-01||Interventional|||Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality|Impact of Iron/Folic Acid Versus Multimicronutrient Versus Folic Acid Supplements During Pregnancy on Mortality, Morbidity, and Complications During Pregnancy, Labor, and Delivery: A Randomized Controlled Trial in China|Completed||Phase 3|18962|Actual|Centers for Disease Control and Prevention||3|||f||||t||||||||||2017-02-18 17:31:27.286154|2017-02-18 17:31:27.286154
NCT00133731|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2008-07-01|||September 2004||2004-09-01|June 2008|2008-06-01|October 2005|Actual|2005-10-01|||||Interventional|SEPIA-PCI||The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention|A Multinational, Randomized, Double-Blind, Double-Dummy, Exploratory, Parallel Group, Dose-Ranging Phase II Study to Evaluate Pharmacodynamics, Safety and Tolerability, and Pharmacokinetics of Several Intravenous Regimens of Factor Xa Inhibitor Otamixaban (XRP0673), in Comparison to Intravenous Unfractionated Heparin, in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention|Completed||Phase 2|947|Actual|Sanofi|||||||||||||||||||2017-02-18 17:31:27.408425|2017-02-18 17:31:27.408425
NCT00133718|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-23|2017-01-23|||January 2002||2002-01-01|January 2017|2017-01-01|May 29, 2012|Actual|2012-05-29|April 2006|Actual|2006-04-01||Interventional|||A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control|Asker and Baerum Cardiovascular Diabetes Study|Completed||Phase 4|120|Actual|Asker & Baerum Hospital||2|||f||||t|t|f|||f|||No||2017-02-18 17:31:27.592114|2017-02-18 17:31:27.592114
NCT00133705|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-02-13|2012-11-01||July 2003||2003-07-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Trial of Mifepristone for Fibroids|Randomized Control Trial Of Mifepristone for Fibroids|Completed||Phase 3|70|Actual|University of Rochester|There were no adverse events in this clinical trial.|2|||f||||t||||||||||2017-02-18 17:31:27.722009|2017-02-18 17:31:27.722009
NCT00133692|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2011-09-16|||September 1997||1997-09-01|August 2010|2010-08-01|February 2003||2003-02-01|||||Interventional|||INVEST: INternational VErapamil SR Trandolapril STudy|INternational VErapamil SR Trandolapril STudy|Completed||Phase 4|22000||University of Florida|||||f||||||||||||||2017-02-18 17:31:28.076664|2017-02-18 17:31:28.076664
NCT00133679|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-08-11|||February 2006||2006-02-01|August 2014|2014-08-01|October 2013|Actual|2013-10-01|July 2013|Actual|2013-07-01||Interventional|||Chronic Sildenafil for Severe Diaphragmatic Hernia|Chronic Sildenafil for Severe Diaphragmatic Hernia|Terminated||Phase 4|9|Actual|University of California, San Francisco||2||"Change in clinical practice allowing chronic therapy at 6 weeks of age, incompatible with~   possibility of placebo beyond 6 weeks of age on study protocol"|f||||t||||||||||2017-02-18 17:31:28.199128|2017-02-18 17:31:28.199128
NCT00133666|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2008-07-16|||September 2004||2004-09-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Improving Asthma Communication in Minority Families|Improving Asthma Communication in Minority Families|Completed||Phase 2|231|Actual|National Institute of Nursing Research (NINR)||2|||f||||||||||||||2017-02-18 17:31:28.574684|2017-02-18 17:31:28.574684
NCT00133653|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2005-10-28|||August 2001||2001-08-01|August 2004|2004-08-01|July 2004||2004-07-01|||||Observational|||The Double Exposure Study: The Impact of Job Strain and Marital Cohesion on Blood Pressure|The Impact of Job Strain and Marital Cohesion on Ambulatory Blood Pressure Over One Year: The Double Exposure Study|Completed||N/A|250||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 17:31:28.685941|2017-02-18 17:31:28.685941
NCT00133640|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2006-09-07|||January 2005||2005-01-01|August 2006|2006-08-01|December 2008||2008-12-01|||||Interventional|||Early Rehabilitation After Hip Fracture|Early Rehabilitation After Hip Fracture: A Randomized Controlled Trial Comparing Different Vitamin D and Rehabilitation Programs|Unknown status|Recruiting|Phase 3|204||Swiss National Science Foundation|||||f||||||||||||||2017-02-18 17:31:28.773492|2017-02-18 17:31:28.773492
NCT00133627|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2011-11-16|||April 2005||2005-04-01|November 2011|2011-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis|Safety and Efficacy Comparison Ketotifen Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis|Completed||Phase 4|229|Actual|Novartis|||||f||||||||||||||2017-02-18 17:31:28.88361|2017-02-18 17:31:28.88361
NCT00133614|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2005-10-28|||August 2001||2001-08-01|August 2005|2005-08-01|April 2004||2004-04-01|||||Interventional|||Prone Positioning in Pediatric Acute Lung Injury|Prone Positioning in Pediatric Acute Lung Injury|Completed||Phase 3|102||National Institute of Nursing Research (NINR)|||||f||||||||||||||2017-02-18 17:31:28.975634|2017-02-18 17:31:28.975634
NCT00133601|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2009-01-15|||October 2004||2004-10-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|July 2007|Actual|2007-07-01||Interventional|||Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients|Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients|Completed||Phase 1|28|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-02-18 17:31:29.065984|2017-02-18 17:31:29.065984
NCT00133588|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26|||November 2006||2006-11-01|May 2007|2007-05-01|January 2007||2007-01-01|||||Interventional|||Proteomic Profiling for Influenza|Proteomic Profiling for Influenza Vaccination|Completed||Phase 4|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:31:29.165238|2017-02-18 17:31:29.165238
NCT00133575|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2014-12-11|2009-03-26||October 2005||2005-10-01|September 2009|2009-09-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||ACAM 3000 MVA at Harvard Medical School|ACAM 3000 MVA (Acambis Modified Vaccinia Ankara) Immunization Followed by Dryvax® Vaccination of Healthy Vaccinia-Naïve Adults: A Phase I/II, Placebo-Controlled Study of the Effects of Dose and Route of Administration of MVA on Safety, Reactogenicity and Immunogenicity, Followed by Dryvax® Immunization to Assess Effects of MVA Vaccination on Dryvax® Takes|Completed||Phase 1/Phase 2|72|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The Dryvax challenge was optional and administered to only a subset of participants before being discontinued prior to being offered to the subjects in the last cohort.|6|||f||||||||||||||2017-02-18 17:31:29.263355|2017-02-18 17:31:29.263355
NCT00133562|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2008-10-27|||August 2004||2004-08-01|October 2008|2008-10-01|May 2006||2006-05-01|||||Interventional|||HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition|Prospective Double Blind Randomized Clinical Trial of Alanyl-Glutamine or Glycine in Hospitalized Children With Persistent Diarrhea or Malnutrition.|Withdrawn||Phase 3|108||University of Virginia|||||f||||f||||||||||2017-02-18 17:31:31.505554|2017-02-18 17:31:31.505554
NCT00125073|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2010-06-25|||July 2005||2005-07-01|June 2010|2010-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Postoperative Dietary Counseling After Bariatric Surgery|Postoperative Dietary Counseling After Bariatric Surgery|Completed||N/A|100|Anticipated|University of Pennsylvania|||||f||||||||||||||2017-02-18 17:34:07.724357|2017-02-18 17:34:07.724357
NCT00133549|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2014-10-16|||November 2000||2000-11-01|May 2011|2011-05-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||9-valent CRM 197 Pneumococcal|Evaluation of a 9-valent CRM 197- Conjugated Pneumococcal Polysaccharide Vaccine in Elderly Adults|Completed||Phase 2|180|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 17:31:31.598663|2017-02-18 17:31:31.598663
NCT00133536|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26|||January 2006||2006-01-01|June 2008|2008-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||A/H5N1 Vaccine in Healthy Children Aged 2-9 Years|A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II, Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Children Aged 2 Years Through 9 Years|Completed||Phase 1/Phase 2|157|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:31:31.951654|2017-02-18 17:31:31.951654
NCT00133523|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2014-12-04|||October 2004||2004-10-01|October 2009|2009-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||FLU-VACS Comparative Study in Adults|Comparative Study of Influenza Vaccines in Adults - FLU-VACS|Completed||Phase 4|2349|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:31:32.066396|2017-02-18 17:31:32.066396
NCT00133510|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26|||November 2004||2004-11-01|March 2008|2008-03-01|September 2006||2006-09-01|||||Interventional|||Influenza Vaccine in Pediatric Transplant Subjects|Prospective Comparative Study of the Humoral and Cell-Mediated Immune Responses to the Trivalent Subviron Influenza Vaccine in Pediatric Liver Transplant Recipients as an Indicator for Response of Immunocompromised Subjects to Vaccination Against Agents of Bioterrorism|Completed||Phase 4|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:31:32.186501|2017-02-18 17:31:32.186501
NCT00133497|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2013-09-19|||June 2006||2006-06-01|September 2013|2013-09-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females|A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Safety and Efficacy of the Cytomegalovirus gB/MF59 Vaccine in Preventing Systemic Cytomegalovirus Infection in Healthy Adolescent Females|Completed||Phase 2|409|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:31:32.291368|2017-02-18 17:31:32.291368
NCT00133484|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26||||||December 2005|2005-12-01|May 2007||2007-05-01|||||Interventional|||UMD rPA Regimen Trial in Adults|A Phase II Study to Assess the Safety, Tolerability, Immunogenicity, and Optimal Primary Schedule of 3 Recombinant Protective Antigen (rPA) Anthrax Vaccines Administered in Two Intramuscular Doses to Healthy Adults|Terminated||Phase 2|270||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:31:32.401166|2017-02-18 17:31:32.401166
NCT00133471|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26|||March 2005||2005-03-01|January 2009|2009-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults|Evaluation of the Reactogenicity and Immunogenicity of Four Dosage Levels of Intramuscular Monovalent Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults|Completed||Phase 1/Phase 2|96|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||||||||||||2017-02-18 17:31:32.489659|2017-02-18 17:31:32.489659
NCT00133458|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26||||||October 2005|2005-10-01|June 2007||2007-06-01|||||Interventional|||RCT ALB for SA Cysticercosis|Randomized, Double Blind Comparison of Two Lenghts of Albendazole Therapy for Subarachnoid Cysticercosis|Withdrawn||Phase 3|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:31:32.609524|2017-02-18 17:31:32.609524
NCT00133445|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2011-11-03|||December 2005||2005-12-01|October 2009|2009-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Pentavalent DTaP-Hep B-IPV|Randomized, Single Blinded Study of the Safety and Immunogenicity of Pentavalent DTaP-Hep B-IPV Combination Vaccine (Pediarix™; GlaxoSmithKline (GSK) Biologicals) Administered to Healthy Neonates and Infants at Birth, 2, and 6 Months of Age Compared to a Routine Infant Schedule at 2, 4, and 6 Months of Age|Completed||Phase 2|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:31:32.699634|2017-02-18 17:31:32.699634
NCT00133432|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26|||September 2005||2005-09-01|March 2010|2010-03-01|July 2007|Anticipated|2007-07-01|July 2007|Anticipated|2007-07-01||Interventional|||Zinc and Pneumonia Protocol|The Effect of Zinc Supplementation on Duration of Hospitalization in Tanzanian Children Presenting With Acute Pneumonia|Terminated||Phase 3|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:31:32.80843|2017-02-18 17:31:32.80843
NCT00133419|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26||||||March 2007|2007-03-01|January 2006||2006-01-01|||||Interventional|||Micronutrients and Enteric Infections in African Children|The Effect of Prophylactic Micronutrient Supplementation of Morbidity and Growth in HIV-infected and HIV-uninfected Children in South Africa|Completed||Phase 2|516||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:31:32.895776|2017-02-18 17:31:32.895776
NCT00133406|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2011-03-04|||June 2006||2006-06-01|March 2011|2011-03-01|December 2011|Anticipated|2011-12-01|December 2011|Anticipated|2011-12-01||Interventional|||Long-term Impact and Intervention for Diarrhea in Brazil|Long-term Impact and Intervention for Diarrhea in Brazil|Unknown status|Recruiting|Phase 3|321|Anticipated|University of Virginia||6|||f||||f||||||||||2017-02-18 17:31:32.984934|2017-02-18 17:31:32.984934
NCT00133393|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2010-08-26|||January 2002||2002-01-01|October 2005|2005-10-01|July 2005||2005-07-01|||||Interventional|||Pentoxifylline in Children With Malaria|Dose Finding Study of Pentoxifylline in Children With Cerebral Malaria|Terminated||Phase 2|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:31:33.097412|2017-02-18 17:31:33.097412
NCT00133380|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2007-04-04|||July 2005||2005-07-01|April 2007|2007-04-01|September 2006||2006-09-01|||||Interventional|||A Study in People With High Cholesterol|PPAR Alpha (LY518674): A Phase 2 Study of the Combinatorial Effect of LY518674 and Atorvastatin in Subjects With Hypercholesterolemia|Completed||Phase 2|300||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:31:33.186439|2017-02-18 17:31:33.186439
NCT00133367|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2016-07-22|||August 2005||2005-08-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus|Phase II Study of Sequential Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis|Completed||Phase 2|32|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:31:33.309812|2017-02-18 17:31:33.309812
NCT00133354|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2011-10-11|||November 2001||2001-11-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2006|Actual|2006-08-01||Interventional|||Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys|Double-blind Trial Investigating the Safety and Efficacy of the Inhibitor Anastrozole (ARIMIDEX) in Delaying Epiphyseal Fusion and Increasing Height Potential of Adolescent Males With Growth Hormone (GH) Deficiency|Completed||Phase 2/Phase 3|53|Actual|Nemours Children's Clinic||2|||f||||t||||||||||2017-02-18 17:31:33.408765|2017-02-18 17:31:33.408765
NCT00133341|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2006-02-24|||April 2005||2005-04-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate|Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate for ”TRUE Test® Panel 3” – a Phase II, Dose-Response Study.|Completed||Phase 2|60||Mekos Laboratories AS|||||f||||||||||||||2017-02-18 17:31:33.529111|2017-02-18 17:31:33.529111
NCT00133328|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2005-10-27|||January 2002||2002-01-01|January 2002|2002-01-01|November 2005||2005-11-01|||||Interventional|||A Morbidity-Mortality and Remodeling Study With Valsartan|A Morbi-Mortality and Remodeling Study With Valsartan in Patients With Hypertension and Cardiovascular Disease|Unknown status|Active, not recruiting|Phase 4|3000||Jikei University School of Medicine|||||f||||||||||||||2017-02-18 17:31:33.633114|2017-02-18 17:31:33.633114
NCT00133315|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2007-04-09|||September 2004||2004-09-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||TNFalfa Blocking Treatment of Spondylarthropathies|TNFalfa Blocking Treatment of Spondylarthropathies - A Danish Multicenter Study of New Methods for Better Monitoring and Prognostifying Patients With Spondylarthropathies|Completed||Phase 4|50||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:31:33.74352|2017-02-18 17:31:33.74352
NCT00133302|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2007-01-17|||February 1999||1999-02-01|August 2006|2006-08-01|February 2005||2005-02-01|||||Interventional|||Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)|Randomized Phase III Study of Standard CHOP (S-CHOP) Versus Biweekly CHOP (Bi-CHOP) in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)|Terminated||Phase 3|450||Japan Clinical Oncology Group|||||f||||||||||||||2017-02-18 17:31:33.826238|2017-02-18 17:31:33.826238
NCT00133289|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2007-07-09|||July 2005||2005-07-01|July 2007|2007-07-01|June 2007|Actual|2007-06-01|||||Interventional|||ULTRA Study for Pacemaker Patients|Ventricular Automatic Capture Assessment Study|Completed||Phase 4|950||Boston Scientific Corporation|||||f||||||||||||||2017-02-18 17:31:33.917039|2017-02-18 17:31:33.917039
NCT00133276|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2010-02-18|||August 2005||2005-08-01|February 2010|2010-02-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment|Prophylactic Treatment of Peginterferon-associated Psychopathology. A Double-blind Placebo-controlled Trial on the Effects of Escitalopram (Lexapro®) in Patients Treated With Peginterferon and Ribavirin (POPS Study)|Completed||Phase 2/Phase 3|80|Anticipated|Foundation for Liver Research||2|||f||||f||||||||||2017-02-18 17:31:33.995578|2017-02-18 17:31:33.995578
NCT00133263|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-07-09|||January 2001||2001-01-01|March 2008|2008-03-01|December 2006|Actual|2006-12-01|April 2005|Actual|2005-04-01||Interventional|||Effectiveness of a Standardized Bereavement Intervention in Primary Care|"Effectiveness of Primary Bereavement Care (PBC) in Widows: A Cluster Randomized Controlled Trial"|Completed||Phase 3|87|Actual|Carlos III Health Institute||2|||f||||f||||||||||2017-02-18 17:31:34.10906|2017-02-18 17:31:34.10906
NCT00133250|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-20|2010-03-15|||June 2003||2003-06-01|March 2010|2010-03-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)|Value of Abciximab in Patients With AMI Undergoing PCI After High Dose Clopidogrel Pretreatment (BRAVE 3)|Completed||Phase 4|800|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:31:34.222022|2017-02-18 17:31:34.222022
NCT00133237|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2010-03-12|||July 2005||2005-07-01|October 2008|2008-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)|Prospective, Randomized Trial of the Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent for the Treatment of Unprotected Left Main Coronary Artery Disease(ISAR-LEFT-MAIN)|Completed||Phase 4|607|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:31:34.33715|2017-02-18 17:31:34.33715
NCT00133224|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2008-09-19|||July 2005||2005-07-01|September 2008|2008-09-01|June 2009|Anticipated|2009-06-01|August 2008|Actual|2008-08-01||Interventional|||Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients|A Phase III Randomized, Open-Label Study of Docetaxel in Combination With CG1940 and CG8711 Versus Docetaxel and Prednisone in Taxane-Naïve Patients With Metastatic Hormone-Refractory Prostate Cancer With Pain|Terminated||Phase 3|408|Actual|Cell Genesys||2||Accrual and treatment with CG1940/CG8711 stopped due to IDMC recommendation.|f||||||||||||||2017-02-18 17:31:34.456353|2017-02-18 17:31:34.456353
NCT00133211|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2015-03-05|||September 2005||2005-09-01|March 2015|2015-03-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|MANTRA-PAF||Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation|Medical Antiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: A Randomized Prospective Multicentre Study (MANTRA-PAF)|Completed||Phase 3|294|Actual|Danish Heart Foundation||2|||f||||t||||||||||2017-02-18 17:31:34.960606|2017-02-18 17:31:34.960606
NCT00133198|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2013-11-07|||April 2004||2004-04-01|November 2013|2013-11-01|February 2005||2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)|A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Trial Comparing Fixed Doses of 0.25 mg, 0.50 mg and 0.75 mg Pramipexole (Mirapex®) Administered Orally to Investigate the Safety and Efficacy in Patients With Idiopathic Restless Legs Syndrome for 12 Weeks|Completed||Phase 3|345|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:31:35.090809|2017-02-18 17:31:35.090809
NCT00133185|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2013-11-18|||March 2004||2004-03-01|November 2013|2013-11-01|March 2005||2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension|A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5 mg in Comparison With Losartan 50 mg Plus Hydrochlorothiazide 12.5 mg in Taiwanese Patients With Mild to Moderate Hypertension|Completed||Phase 3|31||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:31:35.243934|2017-02-18 17:31:35.243934
NCT00133172|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2014-09-05|||July 2005||2005-07-01|September 2014|2014-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection|Evaluation of the Long-term Safety and Efficacy of a Tacrolimus-based 5-day Steroid Rapid Withdrawal Immunoprophylactic Regimen in de Novo Renal Transplantation|Terminated||Phase 4|85|Actual|Astellas Pharma Inc||2||Varience of supply chain from that required by protocol|f||||t||||||||||2017-02-18 17:31:35.335281|2017-02-18 17:31:35.335281
NCT00133159|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2010-06-16|||September 2005||2005-09-01|June 2010|2010-06-01||||||||Interventional|||Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen|A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Grass/Rye Pollen Allergoid With MPL in Patients Sensitized to Grass and Rye Pollen|Completed||Phase 2|68||Allergy Therapeutics|||||||||||||||||||2017-02-18 17:31:35.463698|2017-02-18 17:31:35.463698
NCT00133146|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-22|2010-06-16|||September 2005||2005-09-01|September 2009|2009-09-01||||||||Interventional|||Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine|A Double-Blind Phase IIa Study to Demonstrate the Contribution of MPL to Tyrosine Adsorbed Grass/Rye Pollen Allergoid (Grass MATA) With a Single-Blind Portion to Evaluate the Residual Allergenicity in Skin Test in Volunteers Allergic to Grass and Rye Pollen|Completed||Phase 2|40||Allergy Therapeutics|||||||||||||||||||2017-02-18 17:31:35.559598|2017-02-18 17:31:35.559598
NCT00133133|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2006-12-18|||July 2005||2005-07-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Efficacy and Safety of ALGRX 4975 in the Treatment of Postoperative Pain After Gall Bladder Removal|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Open Cholecystectomy|Completed||Phase 2|40||AlgoRx Pharmaceuticals|||||f||||||||||||||2017-02-18 17:31:35.655863|2017-02-18 17:31:35.655863
NCT00133107|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2011-08-18|||January 2005||2005-01-01|August 2011|2011-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus|A Single Center, Open-label, Pilot Study Evaluating the Safety and Effectiveness of Subcutaneous Efalizumab in the Treatment of Oral Lichen Planus|Completed||N/A|4|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 17:31:35.757485|2017-02-18 17:31:35.757485
NCT00133094|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2015-04-06|||June 2006||2006-06-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Systematic Management of High Cholesterol Utilizing Computer Monitoring|Management of Hypercholesterolemia Utilizing a Case Management System, Incorporating Computer-Based Decision Support Technology|Completed||N/A|220|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:31:35.852285|2017-02-18 17:31:35.852285
NCT00133081|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2005-10-20|||October 2002||2002-10-01|March 2004|2004-03-01|August 2006||2006-08-01|||||Interventional|||Study to Improve the Treatment of Epilepsy (SITE)|Study to Improve the Treatment of Epilepsy (SITE). A Randomized Study Comparing Adjustment of Treatment to Reduce Side Effects of Antiepileptic Drugs With Continuing Treatment Unchanged|Unknown status|Active, not recruiting|Phase 4|255||UMC Utrecht|||||f||||||||||||||2017-02-18 17:31:35.952363|2017-02-18 17:31:35.952363
NCT00133068|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2016-05-10|||March 2005||2005-03-01|May 2016|2016-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Collaboration to Reduce Disparities in Hypertension|Collaboration to Reduce Disparities in Hypertension|Completed||Phase 4|802|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 17:31:36.056575|2017-02-18 17:31:36.056575
NCT00133055|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2011-08-15|||July 2005||2005-07-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Parenting Matters: Helping Parents With Young Children|Parenting Matters: Helping Parents With Young Children|Completed||Phase 2|548|Actual|University of Western Ontario, Canada||2|||f||||||||||||||2017-02-18 17:31:36.16942|2017-02-18 17:31:36.16942
NCT00133042|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2011-09-16|||December 2004||2004-12-01|February 2009|2009-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma||Completed||Phase 4|16||University of Florida|||||||||||||||||||2017-02-18 17:31:36.2787|2017-02-18 17:31:36.2787
NCT00133029|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2016-08-12|||July 2004||2004-07-01|August 2016|2016-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity||Terminated||Phase 4|||University of Pennsylvania|||||f||||||||||||||2017-02-18 17:31:36.378428|2017-02-18 17:31:36.378428
NCT00133016|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2015-12-01|||August 2006||2006-08-01|December 2015|2015-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Efficacy of Early Amniotomy for Induction of Labor|The Efficacy of Early Amniotomy for Induction of Labor|Withdrawn||N/A|0|Actual|University of Pennsylvania||||no funding|f||||||||||||||2017-02-18 17:31:36.451792|2017-02-18 17:31:36.451792
NCT00133003|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2008-04-12|||March 2003||2003-03-01|April 2008|2008-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)|Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of the Glycoprotein IIb/IIIa Inhibition With Abciximab in Patients With ACS Undergoing Coronary Stenting After Pretreatment With a High Loading Dose of Clopidogrel (ISAR-REACT-2)|Completed||Phase 4|2022|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:31:36.541051|2017-02-18 17:31:36.541051
NCT00132990|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2007-01-11|||February 2003||2003-02-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||A Multicenter Pilot Study of Pallidal Deep Brain Stimulation for Cervical Dystonia|A Multicenter Pilot Study of Pallidal Deep Brain Stimulation of Cervical Dystonia|Unknown status|Active, not recruiting|N/A|10||University of Calgary|||||f||||||||||||||2017-02-18 17:31:36.661545|2017-02-18 17:31:36.661545
NCT00132977|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2015-04-13|||July 2005||2005-07-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|RethinQ||RethinQ Study - Evaluating Pacing in Heart Failure Patients|Resynchronization Therapy in Normal QRS (RethinQ) Clinical Investigation|Completed||Phase 3|250|Actual|St. Jude Medical||2|||f||||t||||||||||2017-02-18 17:31:36.764723|2017-02-18 17:31:36.764723
NCT00132964|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2012-06-05|||July 2003||2003-07-01|January 2007|2007-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Brace Versus Casting in Pediatric Low Risk Ankle Fractures|Randomized Control Trial of Casting Versus Ankle Bracing in Children With Low-risk Ankle Fractures|Completed||Phase 4|112|Actual|The Hospital for Sick Children||2|||f||||f||||||||||2017-02-18 17:31:36.931998|2017-02-18 17:31:36.931998
NCT00132951|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2009-08-26|||October 2004||2004-10-01|August 2009|2009-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|KEYS||KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections|A Randomized, Investigator Blinded, Multi-Center Clinical Study To Compare Patient Outcomes and Clinical Effectiveness of Telithromycin Versus Azithromycin in Outpatients With Lower Respiratory Tract Infections|Terminated||Phase 4|2051|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:31:37.042973|2017-02-18 17:31:37.042973
NCT00132938|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2011-06-07|||January 2004||2004-01-01|June 2011|2011-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis|An Open-label, Randomized, Multicenter, Clinical Study to Compare the Effects of Telithromycin, Azithromycin and Cefuroxime Axetil on the Penicillin or Macrolide Resistance of Streptococcus Pneumoniae in Patients With Acute Exacerbation of Chronic Bronchitis|Completed||Phase 4|5660||Sanofi|||||f||||||||||||||2017-02-18 17:31:37.13435|2017-02-18 17:31:37.13435
NCT00132925|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2011-01-10|||November 2003||2003-11-01|January 2011|2011-01-01|February 2006||2006-02-01|||||Interventional|||An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis|An Efficacy and Safety Evaluation of Nasacort AQ 110 µg QD Children Ages 2-5 Years With Perennial Allergic Rhinitis|Completed||Phase 3|460||Sanofi|||||f||||||||||||||2017-02-18 17:31:37.227615|2017-02-18 17:31:37.227615
NCT00132912|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2016-11-16|||August 2005||2005-08-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention|Completed||Phase 2|1030|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:31:37.424223|2017-02-18 17:31:37.424223
NCT00132899|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2013-12-10|||December 2005||2005-12-01|December 2005|2005-12-01|July 2008|Actual|2008-07-01|February 2008|Actual|2008-02-01||Interventional|||COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)|A Phase III Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Multi-Centre Study to Evaluate the Safety and Efficacy of Infliximab in Combination With Methotrexate for the Long-term Treatment of Crohn's Disease (CD)|Completed||Phase 3|128|Actual|University of Western Ontario, Canada||2|||f||||t||||||||||2017-02-18 17:31:37.511297|2017-02-18 17:31:37.511297
NCT00132886|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2012-05-02|||December 2004||2004-12-01|May 2012|2012-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure|Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Single Oral Tolvaptan Tablets on Hemodynamic Parameters in Subjects With Heart Failure|Completed||Phase 2|140|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 17:31:37.629284|2017-02-18 17:31:37.629284
NCT00132873|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2013-09-18|2013-09-18||October 2004||2004-10-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy|Long-Term, Open-Label, Multi-Center Extension Trial of Xyrem® (Sodium Oxybate) Oral Solution for the Treatment of Narcolepsy|Completed||Phase 3|59|Actual|Jazz Pharmaceuticals||1|||f||||||||||||||2017-02-18 17:31:37.75469|2017-02-18 17:31:37.75469
NCT00132860|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2005-10-18|||May 2001||2001-05-01|August 2005|2005-08-01|December 2007||2007-12-01|||||Interventional|||Prophylactic ﻿Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)|﻿Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease: A Prospective, Randomized, Double-Blind Placebo-Controlled Study of Intermittent, Prophylactic Antibiotic Treatment With Azithromycin|Unknown status|Active, not recruiting|Phase 4|800||Odense University Hospital|||||f||||||||||||||2017-02-18 17:31:38.183103|2017-02-18 17:31:38.183103
NCT00132847|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2013-01-18|||April 2004||2004-04-01|January 2013|2013-01-01|October 2004||2004-10-01|||||Observational|||Comparing Allergenic Effects of 3 German Cockroach Extracts in Adults|German Cockroach Allergen Standardization Evaluation (CASE)|Terminated||N/A|4|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||||||2017-02-18 17:31:38.280226|2017-02-18 17:31:38.280226
NCT00132834|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2013-01-24|||November 2003||2003-11-01|January 2013|2013-01-01|March 2004|Actual|2004-03-01|||||Observational|||Methods of Determining Asthma Severity in Children|"Exhaled Breath Condensates (EBC) Study: Research Plan NIH/NIAID: Inner City Asthma Consortium (ICAC)"|Completed||N/A|80|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||||||||||||2017-02-18 17:31:38.375038|2017-02-18 17:31:38.375038
NCT00132821|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2017-01-11|||August 2005||2005-08-01|June 2009|2009-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Impact of Smoking Cessation on Sleep - 5|Impact of Smoking Cessation on Sleep|Completed||Phase 4|59|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||t||||||||||2017-02-18 17:31:38.465674|2017-02-18 17:31:38.465674
NCT00132808|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2016-08-01|2010-12-10||July 2004||2004-07-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older|A 2-year Randomized, Multicenter, Double-blind, Placebo-controlled Study to Determine the Efficacy and Safety of Intravenous Zoledronic Acid 5 mg Administered Either Annually at Randomization and 12 Months, or Administered at Randomization Only in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia|Completed||Phase 3|581|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:31:38.607592|2017-02-18 17:31:38.607592
NCT00132795|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2012-06-20|||May 2005||2005-05-01|June 2012|2012-06-01|July 2010|Actual|2010-07-01|December 2009|Actual|2009-12-01||Interventional|ATIVR||Using Telephone Technology to Prevent Relapse After Alcoholism Treatment|Therapeutic IVR to Augment CBT in Alcohol Dependence|Completed||Phase 2|158|Actual|University of Vermont||2|||f||||f||||||||||2017-02-18 17:31:39.562591|2017-02-18 17:31:39.562591
NCT00132782|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2014-03-03|||March 2003||2003-03-01|February 2009|2009-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Observational|||Relationship Between Functional Health Status and Ventricular Performance After Fontan--Pediatric Heart Network|Relationship Between Functional Health Status and Ventricular Performance After Fontan (A Trial Conducted by the Pediatric Heart Network)|Completed||N/A|546|Actual|New England Research Institutes|||1||f||||t||||||||||2017-02-18 17:31:39.673656|2017-02-18 17:31:39.673656
NCT00132587|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2008-06-30|||March 2004||2004-03-01|June 2008|2008-06-01|March 2007|Actual|2007-03-01|December 2006|Actual|2006-12-01||Interventional|||Total Knee Arthroplasty (TKA) Cemented Versus Cementless|Prospective Randomized Study of 130 Total Knee Arthroplasty With Cemented Femoral Implant Versus Cementless|Completed||N/A|130||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:31:44.61155|2017-02-18 17:31:44.61155
NCT00132769|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-07-29|2013-10-07||January 2005||2005-01-01|July 2015|2015-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)|A Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, Safety, and Tolerability of MK-0873 in Rheumatoid Arthritis|Completed||Phase 2|106|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:31:39.755431|2017-02-18 17:31:39.755431
NCT00132756|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2006-11-06|||December 2003||2003-12-01|November 2006|2006-11-01||||||||Interventional|||Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer|Liposomal Doxorubicin and Estramustine Phosphate: A Phase II Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer|Terminated||Phase 1/Phase 2|30||Morton Plant Mease Health Care|||||f||||||||||||||2017-02-18 17:31:40.198955|2017-02-18 17:31:40.198955
NCT00132743|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2013-04-24|||February 2007||2007-02-01|April 2013|2013-04-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|CLEVER||Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)|Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)|Unknown status|Active, not recruiting|Phase 3|119|Actual|Rhode Island Hospital||3|||f||||t||||||||||2017-02-18 17:31:40.285884|2017-02-18 17:31:40.285884
NCT00132730|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2016-01-07|2014-03-17||June 2004||2004-06-01|January 2016|2016-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of MK-0873 in Patients With COPD|Terminated||Phase 2|604|Actual|Merck Sharp & Dohme Corp.|The extension studies were terminated based on data from the completed base study suggesting that MK-0873, at doses up to 2.5 mg per day, demonstrated no benefits versus placebo in lung function or symptoms in participants with COPD.|6|||f||||f||||||||||2017-02-18 17:31:40.42794|2017-02-18 17:31:40.42794
NCT00132717|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-11-30|||January 2005||2005-01-01|November 2015|2015-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)|An Open-Label, Multicenter Study to Assess the Efficacy of Switching to a Combination Tablet Ezetimibe/Simvastatin 10mg/40mg, Compared to Doubling the Dose of Statin in Patients Hospitalized With a Coronary Event|Completed||Phase 3|450|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:31:41.762142|2017-02-18 17:31:41.762142
NCT00132704|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2014-07-23|||August 2004||2004-08-01|July 2014|2014-07-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation|An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation|Completed||Phase 3|149|Actual|Memorial Sloan Kettering Cancer Center|||2||f||||||||||Samples With DNA|"~     tissue~   "|||2017-02-18 17:31:41.858594|2017-02-18 17:31:41.858594
NCT00132691|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2016-10-13|2012-05-14||September 2005||2005-09-01|October 2016|2016-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|MUST||Multicenter Uveitis Steroid Treatment (MUST) Trial|Multicenter Uveitis Steroid Treatment (MUST) Trial|Completed||Phase 4|255|Actual|JHSPH Center for Clinical Trials||2|||f||||t||||||||||2017-02-18 17:31:41.987439|2017-02-18 17:31:41.987439
NCT00132678|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-07-23|2008-10-24||February 2005||2005-02-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|October 2007|Actual|2007-10-01||Interventional|||A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes|A Randomized, Double-blind, Placebo-controlled Study to Explore the Efficacy and Safety of Risperidone Long-acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar 1 Disorder, With Open-label Extension|Completed||Phase 3|559|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-02-18 17:31:43.239311|2017-02-18 17:31:43.239311
NCT00132665|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2012-12-06|||July 2003||2003-07-01|December 2012|2012-12-01|February 2012|Actual|2012-02-01|November 2011|Actual|2011-11-01||Interventional|||Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)|Randomized Controlled Trial to Evaluate Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatine in Elderly Patients With Locally Advanced Non-small Cell Lung Cancer (JCOG0301, NCSLC-Elderly-CBDCA-RT Phase III)|Completed||Phase 3|200|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:31:43.831995|2017-02-18 17:31:43.831995
NCT00132652|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2015-05-08|||February 2005||2005-02-01|May 2015|2015-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B|A Randomized Trial of Switching Antiviral Therapy From Lamivudine to Telbivudine (LdT) vs. Continued Lamivudine Treatment in Adults With Chronic Hepatitis B|Completed||Phase 3|240||Novartis|||||||||||||||||||2017-02-18 17:31:44.091973|2017-02-18 17:31:44.091973
NCT00132639|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2016-09-20|||October 2002||2002-10-01|September 2016|2016-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)|Randomized Phase II Study of the Induction Chemotherapy With Docetaxel Alone vs CDDP + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)|Completed||Phase 2|80|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:31:44.179559|2017-02-18 17:31:44.179559
NCT00132626|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2007-02-20|||September 1992||1992-09-01|February 2007|2007-02-01|August 2005||2005-08-01|||||Interventional|||Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome|Dynamic SPECT Imaging With [123I]ß-CIT in Patients With Parkinsonism|Completed||Phase 2|500||Institute for Neurodegenerative Disorders|||||f||||||||||||||2017-02-18 17:31:44.288976|2017-02-18 17:31:44.288976
NCT00132613|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2016-09-20|||August 1999||1999-08-01|September 2016|2016-09-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion|A Randomized Controlled Trial to Evaluate the Efficacy of Intra-pericardial Instillation of a Sclerosing Agent After Pericardial Drainage in Patients With Malignant Pericardial Effusion Associated With Lung Cancer (JCOG9811)|Completed||Phase 3|80|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:31:44.373931|2017-02-18 17:31:44.373931
NCT00132600|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2005-10-18|||April 2005||2005-04-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Clinical Evaluation of Bacitracin|Clinical Evaluation of Bacitracin. A Phase II Dose-Response Study|Completed||Phase 2|20||Mekos Laboratories AS|||||||||||||||||||2017-02-18 17:31:44.52276|2017-02-18 17:31:44.52276
NCT00132561|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2017-01-11|||June 2002||2002-06-01|January 2017|2017-01-01|December 2003||2003-12-01|||||Interventional|||A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children|A Double-blind, Randomised, Placebo-controlled Trial to Measure the Potential of Intermittent Treatment With Artesunate Plus Sulphadoxine/Pyrimethamine (SP) to Reduce the Malaria Burden in Sub-Saharan Africa|Completed||Phase 2/Phase 3|1200||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:31:44.977485|2017-02-18 17:31:44.977485
NCT00132548|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2017-01-11|||June 2004||2004-06-01|January 2017|2017-01-01|December 2004||2004-12-01|||||Interventional|||A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children|A Randomised Trial of the Efficacy and Safety of Four Drug Regimens When Used for Intermittent Preventive Treatment of Malaria in Senegalese Children|Completed||Phase 3|2200||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:31:45.087292|2017-02-18 17:31:45.087292
NCT00132535|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2017-01-11|||August 2003||2003-08-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|||||Interventional|||Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda|Influence of HIV Infection on the Effectiveness of Malaria Prevention During Pregnancy, With Emphasis on the Effect of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda|Completed||N/A|2548||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:31:45.199494|2017-02-18 17:31:45.199494
NCT00132522|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2013-10-23|||May 2005||2005-05-01|October 2013|2013-10-01|April 2009|Actual|2009-04-01|June 2008|Actual|2008-06-01||Interventional|||EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide|A Study to Find the Highest Dose of Biological Study Drug (EMD 273066) That Can Be Given Safely to Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-Small Cell Lung Cancers When First Given a Low Dose of Cyclophosphamide|Completed||Phase 1|45|Actual|EMD Serono||1|||f||||f||||||||||2017-02-18 17:31:45.309349|2017-02-18 17:31:45.309349
NCT00132509|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2011-07-21|||September 2001||2001-09-01|February 2009|2009-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke|Comparison of the Classical Rt-PA Procedure (0.9mg/kg Over 60 Minutes) With a Longer Procedure With Lower Dose (0.8mg/kg Over 90 Minutes) in Acute Ischemic Stroke|Terminated||Phase 2|500|Anticipated|Hospices Civils de Lyon||2||End of promotion by the sponsor|f||||||||||||||2017-02-18 17:31:45.418559|2017-02-18 17:31:45.418559
NCT00132496|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2009-11-02|2009-08-25||August 2005||2005-08-01|November 2009|2009-11-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole|Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients|Completed||Phase 2|111|Actual|Eisai Inc.|||||f||||f||||||||||2017-02-18 17:31:45.520768|2017-02-18 17:31:45.520768
NCT00132483|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2007-10-19|||September 2003||2003-09-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||ExStroke Pilot Trial: Physical Exercise After Acute Ischaemic Stroke||Completed||Phase 3|314|Actual|Bispebjerg Hospital||2|||f||||t||||||||||2017-02-18 17:31:46.012569|2017-02-18 17:31:46.012569
NCT00132470|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2007-07-23|||December 2004||2004-12-01|July 2007|2007-07-01|March 2007||2007-03-01|||||Interventional|||Treatment With AX200 for Acute Ischemic Stroke|AXIS IIa - Treatment With AX200 for Acute Ischemic Stroke|Completed||Phase 2|42||Axaron Bioscience AG|||||f||||||||||||||2017-02-18 17:31:46.121313|2017-02-18 17:31:46.121313
NCT00132457|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2010-01-06|||October 2003||2003-10-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection|Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection|Completed||N/A|1830|Anticipated|Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:31:46.208051|2017-02-18 17:31:46.208051
NCT00132444|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2010-01-06|||October 2005||2005-10-01|January 2010|2010-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of UC-781 Vaginal Microbicide|Phase I Study of the Safety and Acceptability of UC-781 Topical Vaginal Microbicide in Heterosexual Women and Their Male Partners|Completed||Phase 1|90|Anticipated|Centers for Disease Control and Prevention||3|||f||||||||||||||2017-02-18 17:31:46.294864|2017-02-18 17:31:46.294864
NCT00132431|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2009-02-12|||July 2004||2004-07-01|February 2009|2009-02-01|July 2005||2005-07-01|||||Interventional|||START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism|Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism|Completed||Phase 4|300||Amgen|||||f||||||||||||||2017-02-18 17:31:46.406603|2017-02-18 17:31:46.406603
NCT00132418|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2011-01-20|||April 2000||2000-04-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders|Double-blind, Randomized, Placebo-controlled Study of Enbrel (Etanercept) in the Treatment of Rheumatoid Arthritis Subjects With Comorbid Disorders|Completed||Phase 4|564|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:31:46.498244|2017-02-18 17:31:46.498244
NCT00132405|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2005-10-07|||May 2004||2004-05-01|August 2005|2005-08-01|September 2004||2004-09-01|||||Interventional|||Study of ALGRX 3268 for Needlestick Pain in Children|Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effectiveness and Safety of ALGRX 3268 0.5 Mg/20 Bar at the Back of the Hand in Pediatric Subjects|Completed||Phase 2|260||AlgoRx Pharmaceuticals|||||||||||||||||||2017-02-18 17:31:46.605581|2017-02-18 17:31:46.605581
NCT00132392|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2006-12-18|||July 2005||2005-07-01|August 2005|2005-08-01|December 2005||2005-12-01|||||Interventional|||ALGRX 4975 After Total Knee Replacement|A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Total Knee Arthroplasty|Completed||Phase 2|40||AlgoRx Pharmaceuticals|||||||||||||||||||2017-02-18 17:31:46.689186|2017-02-18 17:31:46.689186
NCT00132379|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-19|2014-08-26|||November 2005||2005-11-01|August 2014|2014-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer|An Open-label, Phase I, Dose-escalation Study of ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1|13|Actual|Active Biotech AB||1|||f||||f||||||||||2017-02-18 17:31:46.785743|2017-02-18 17:31:46.785743
NCT00132366|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2017-01-24|||August 16, 2005||2005-08-16|June 25, 2009|2009-06-25|June 30, 2008|Actual|2008-06-30|June 30, 2008|Actual|2008-06-30||Observational|||Brain Excitability in Patients With Succinic Semialdehyde Dehydrogenase Deficiency|Cortical Excitability in Succinic Semialdehyde Dehydrogenase Deficiency|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:31:46.89509|2017-02-18 17:31:46.89509
NCT00132340|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2006-07-04|||August 2005||2005-08-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Deep Brain Stimulation to Treat Cervical Dystonia|Deep Brain Stimulation of the Globus Pallidus Interna or the Subthalamic Nucleus for Treatment of Primary Cervical Dystonia|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:31:47.068797|2017-02-18 17:31:47.068797
NCT00132327|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2017-01-24|||August 16, 2005||2005-08-16|December 13, 2016|2016-12-13||||||||Observational|||Analysis of Lyme Disease Lesions|Analysis of Erythema Migrans Lesions|Recruiting||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:31:47.162805|2017-02-18 17:31:47.162805
NCT00132314|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2013-10-30|2013-05-29||September 2006||2006-09-01|October 2013|2013-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional||We used the intention to treat (ITT) population as defined in Milestone 2.|Long-Acting Injectable Risperidone in the Treatment of Schizophrenia|CSP #555 - Long-Acting Injectable Risperidone in the Treatment of Schizophrenia|Completed||Phase 3|382|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:31:47.281755|2017-02-18 17:31:47.281755
NCT00132301|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2016-06-22|||June 2006||2006-06-01|June 2016|2016-06-01|September 2016|Anticipated|2016-09-01|October 2015|Actual|2015-10-01||Interventional|CAP||Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma|CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment (CAP)|Active, not recruiting||Phase 3|298|Actual|VA Office of Research and Development||2|||f||||t||||||||Undecided||2017-02-18 17:31:47.96869|2017-02-18 17:31:47.96869
NCT00132288|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2007-12-13|||May 2005||2005-05-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||MY PALS: A Community-Based Physical Activity Support Program for Older Adults|A Randomized Controlled Trial Linking Clinical Quality Improvement Programs for Older Diabetics to a Community Based Activity Support Center|Completed||N/A|305|Actual|University of Washington||1|||f||||t||||||||||2017-02-18 17:31:48.112068|2017-02-18 17:31:48.112068
NCT00132275|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2008-05-19|||November 2003||2003-11-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Guidelines for Acute Sinusitis|Evaluation of National Guidelines for Acute Sinusitis|Completed||N/A|240|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 17:31:48.211728|2017-02-18 17:31:48.211728
NCT00132262|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2013-01-29|||May 2003||2003-05-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|August 2006|Actual|2006-08-01||Interventional|||Brief Intervention to Reduce Injury in Minorities|Brief Intervention to Reduce Injury in Minorities|Completed||N/A|1493|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 17:31:48.314166|2017-02-18 17:31:48.314166
NCT00132249|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2015-06-08|||April 2004||2004-04-01|June 2015|2015-06-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Observational|||Vietnam Head Injury Study - Phase III|A 40+ Year Post-Injury Follow-Up Study of Vietnam Veterans Who Sustained Traumatic Brain Injury While in Combat.|Completed||Phase 3|254|Actual|U.S. Army Medical Research and Materiel Command|||2||f||||f||||||||||2017-02-18 17:31:48.419197|2017-02-18 17:31:48.419197
NCT00132236|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2005-10-20|||February 2002||2002-02-01|July 2005|2005-07-01|June 2004||2004-06-01|||||Interventional|||Nurse Smoking Cessation of Patients With Chronic Obstructive Pulmonary Disease (COPD) With Nicotine Replacement Therapy (NRT) and Behavioral Support|Smoking Cessation of Patients With COPD: A Multi-Center, Randomized, Placebo Controlled Nurse Conducted Smoking Cessation Trial|Terminated||Phase 3|300||University Hospital, Gentofte, Copenhagen|||||f||||||||||||||2017-02-18 17:31:48.508506|2017-02-18 17:31:48.508506
NCT00132223|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2006-04-11|||April 2005||2005-04-01|April 2006|2006-04-01|December 2005||2005-12-01|||||Interventional|||Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients|Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients With Headache and Dizziness or Epilepsy and Clinical Indication for an Angiography by Magnetic Imaging|Unknown status|Recruiting|Phase 4|10||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:31:48.788328|2017-02-18 17:31:48.788328
NCT00132210|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2010-10-20|||September 2002||2002-09-01|November 2009|2009-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients|Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients|Completed||Phase 4|200|Anticipated|University Hospital, Bonn||1|||f||||f||||||||||2017-02-18 17:31:48.89007|2017-02-18 17:31:48.89007
NCT00132197|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2011-11-11|||April 2005||2005-04-01|November 2011|2011-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Treatment of Patients With Longstanding Unexplained Health Complaints|Treatment of Patients With Chronic Functional Disorders. A Randomized Controlled Trial of Specialized Treatment Compared to Usual Care.|Completed||Phase 2/Phase 3|120|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:31:49.020241|2017-02-18 17:31:49.020241
NCT00132184|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2007-04-12|||September 2005||2005-09-01|April 2007|2007-04-01|February 2008|Anticipated|2008-02-01|||||Interventional|||Vitamin D Treatment for Crohn´s Disease|Remission Keeping and Remission Inducing Effect by Vitamin-D in Crohns Disease, and in Vitro Vitamin-D Mediated T-Cell Immunomodulation|Unknown status|Active, not recruiting|Phase 2/Phase 3|110||University of Aarhus|||||f||||||||||||||2017-02-18 17:31:49.122239|2017-02-18 17:31:49.122239
NCT00132171|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2005-10-19|||January 2001||2001-01-01|March 2002|2002-03-01|December 2001||2001-12-01|||||Interventional|||Helicobacter Pylori Eradication With a New Sequential Treatment|High Eradication Rates of Helicobacter Pylori With a New Sequential Treatment|Completed||Phase 3|1000||St. Orsola Hospital|||||f||||||||||||||2017-02-18 17:31:49.22135|2017-02-18 17:31:49.22135
NCT00132158|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2012-04-16|||September 2005||2005-09-01|April 2012|2012-04-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors|A Dose Finding Study (Phase I) of the Combination of ZD1839 (Iressa®) and an Oral Formulation of Irinotecan (Camptosar™) in Children With Refractory Solid Tumors|Completed||Phase 1|19|Actual|St. Jude Children's Research Hospital||1|||f||||f||||||||||2017-02-18 17:31:49.3426|2017-02-18 17:31:49.3426
NCT00132145|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2016-10-18|||April 2003||2003-04-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III)|A Randomized Trial of Electronic Integration of Care for Better Vascular Outcomes: The Compete III Study Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III)|Completed||N/A|1000|Actual|St. Joseph's Healthcare Hamilton||1|||f||||f||||||||No||2017-02-18 17:31:49.450879|2017-02-18 17:31:49.450879
NCT00132132|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2015-05-04|2012-06-22||August 2005||2005-08-01|May 2015|2015-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Impact of Behavioral Intervention- Exercise, Nutrition, Education- on Body Mass Index (BMI)|Type 2 Diabetes and Obesity Pediatric Prevention Project|Completed||N/A|30|Actual|Steward St. Elizabeth's Medical Center of Boston, Inc.|A limitation of the study is the lost to follow up. However, our rate of lost to follow up is comparable to rates seen in similar studies in this field|2|||f||||t||||||||||2017-02-18 17:31:49.57252|2017-02-18 17:31:49.57252
NCT00132119|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2008-05-15|||August 2005||2005-08-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Nalmefene HCl in the Treatment of Pathological Gambling|Completed||Phase 2/Phase 3|233|Actual|Somaxon Pharmaceuticals||3|||f||||f||||||||||2017-02-18 17:31:49.975641|2017-02-18 17:31:49.975641
NCT00132106|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2007-08-30|||August 2005||2005-08-01|August 2007|2007-08-01||||||||Interventional|||The Effect of Alfa-Adrenergic Receptor Blockade on Insulin-Stimulated Forearm Glucose Uptake and Metabolism in Chronic Heart Failure|The Effect of a-Adrenergic Receptor Blockade on Insulin-Stimulated Forearm Glucose Uptake and Metabolism in Chronic Heart Failure|Unknown status|Recruiting|N/A|||Radboud University|||||f||||||||||||||2017-02-18 17:31:50.077823|2017-02-18 17:31:50.077823
NCT00132093|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2006-04-07|||April 2005||2005-04-01|November 2004|2004-11-01||||||||Interventional|||Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack|The Effects of Eplerenone on Left Ventricular Remodelling Post-Acute Myocardial Infarction: a Double-Blind Placebo-Controlled Cardiac MR-Based Study|Completed||Phase 4|100||NHS Greater Glasgow and Clyde|||||f||||||||||||||2017-02-18 17:31:50.164542|2017-02-18 17:31:50.164542
NCT00132080|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2014-03-03|||December 2002||2002-12-01|April 2012|2012-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network|Trial of Pulse Steroid Therapy in Kawasaki Disease (A Trial Conducted by the Pediatric Heart Network)|Completed||Phase 3|199|Actual|New England Research Institutes||1|||f||||t||||||||||2017-02-18 17:31:50.26179|2017-02-18 17:31:50.26179
NCT00132067|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2014-06-11|||October 2005||2005-10-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|August 2006|Actual|2006-08-01||Interventional|||Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer|A Phase II Evaluation of Vorinostat, (SAHA, NCI-Supplied Agent [NSC #701852]) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:31:50.357132|2017-02-18 17:31:50.357132
NCT00132054|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2013-05-29|||May 2004||2004-05-01|December 2006|2006-12-01|November 2008|Actual|2008-11-01|December 2006|Actual|2006-12-01||Interventional|||Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer|Phase I Study of Weekly Irinotecan Combined With Amrubicin in Previously Treated Small-Cell Lung Cancer|Completed||Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:31:50.461524|2017-02-18 17:31:50.461524
NCT00132041|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2009-02-06|||December 2005||2005-12-01|November 2007|2007-11-01||||||||Interventional|||Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis|Multicenter Feasibility Study of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in Cirrhotic Patients|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:31:50.556679|2017-02-18 17:31:50.556679
NCT00132028|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2014-05-07|2012-02-28||September 2005||2005-09-01|January 2013|2013-01-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma|A Phase II Trial of Suberoylanilide Hydroxamic Acid (NSC-701852) for Recurrent or Primary Refractory Hodgkin's Lymphoma|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:31:50.674484|2017-02-18 17:31:50.674484
NCT00132015|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2012-03-14|||May 2006||2006-05-01|March 2012|2012-03-01|June 2008|Actual|2008-06-01|December 2007|Actual|2007-12-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis|A Phase II Clinical Trial of 17-(Allylamino)-17- Demethoxygeldanamycin (17-AAG, NSC 330507 and EPL Diluent, NSC 704057) in Adults With Systemic Mastocytosis|Completed||Phase 2|37|Anticipated|National Institutes of Health Clinical Center (CC)||1|||||||||||||||||2017-02-18 17:31:51.079083|2017-02-18 17:31:51.079083
NCT00132002|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2015-03-06|2015-03-06||June 2005||2005-06-01|February 2013|2013-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer|Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) (NSC 701852) as Salvage Therapy in Metastatic Breast Cancer|Terminated||Phase 2|14|Actual|National Cancer Institute (NCI)|Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results|1||Early termination for discouraging results|f||||||||||||||2017-02-18 17:31:51.193098|2017-02-18 17:31:51.193098
NCT00131989|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2013-01-08|||June 2005||2005-06-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia|Phase I Dose Escalation Trial of the Raf Kinase Inhibitor BAY 43-9006 (NSC #724772) as Single Agent for Adults With Relapsed and Refractory Acute Leukemias and Chronic Myeloid Leukemia in Blast Crisis|Completed||Phase 1|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:31:51.478111|2017-02-18 17:31:51.478111
NCT00131963|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2016-07-22|||October 2003||2003-10-01|November 2015|2015-11-01|October 2014|Actual|2014-10-01|October 2014|Actual|2014-10-01||Observational|||A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel|A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel|Completed||N/A|94|Actual|Duke University|||2||f||||f||||||Samples With DNA|"~     DNA will be extracted from blood samples taken at the first cycle of Doxorubicin and/or~     Paclitaxel to analyze certain genes that may predict the severity of side-effects that may~     be experienced with chemotherapy.~   "|||2017-02-18 17:31:51.596087|2017-02-18 17:31:51.596087
NCT00131950|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2013-07-09|||August 2003||2003-08-01|October 2005|2005-10-01|November 2005|Actual|2005-11-01|||||Interventional|||Effect of Lifestyle Factors and Hormone Function on Breast Density in Healthy Hispanic Women Who Are Undergoing Mammography for Breast Cancer Screening|Chicago Breast Health Project, Phase II|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:31:51.706851|2017-02-18 17:31:51.706851
NCT00131937|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2015-08-05|2015-06-10||October 2005||2005-10-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|September 2011|Actual|2011-09-01||Interventional|||Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma|A Phase II Study of Sorafenib (BAY 43-9006) in Recurrent Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|14|Actual|National Cancer Institute (NCI)|The study did not meet pre-specified criteria for continuing to second stage accrual (at least one response among the first 12 eligible patients), and was therefore closed per protocol without full accrual.|1|||f||||f||||||||||2017-02-18 17:31:51.913826|2017-02-18 17:31:51.913826
NCT00131924|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2012-06-07||2011-02-18|March 2004||2004-03-01|June 2012|2012-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy|Phase II Study of High-Dose Estrogen in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapies|Terminated||Phase 2|1|Actual|Northwestern University||||Data Monitoring Committee recommended closure due to poor accrual.|f||||||||||||||2017-02-18 17:31:52.181677|2017-02-18 17:31:52.181677
NCT00131911|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2014-11-14|2014-06-19||June 2005||2005-06-01|June 2014|2014-06-01|April 2013|Actual|2013-04-01|October 2010|Actual|2010-10-01||Interventional|||Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors|A Phase II Trial of Bay 43-9006 in Progressive Metastatic Neuroendocrine Tumors|Completed||Phase 2|93|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:31:52.286528|2017-02-18 17:31:52.286528
NCT00131898|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2008-12-22|||May 2003||2003-05-01|December 2008|2008-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma|Phase III Prospective Randomized Trial of Pre-Operative Intensity Modulated Radiation Therapy (IMRT) Plus Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma|Completed||Phase 3|150||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:31:53.097017|2017-02-18 17:31:53.097017
NCT00131885|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2015-07-15|2010-03-21||August 2005||2005-08-01|July 2015|2015-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel|Effects of St. John's Wort on Levonorgestrel|Completed||Phase 4|36|Actual|University of Utah||4|||f||||t||||||||||2017-02-18 17:31:53.204611|2017-02-18 17:31:53.204611
NCT00131872|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2008-01-24|||March 2004||2004-03-01|November 2006|2006-11-01|November 2006|Actual|2006-11-01|||||Interventional|||Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts|Clinical Study Comparing Expedial and ePTFE Vascular Access Grafts|Terminated||Phase 2|172||LeMaitre Vascular|||||||||||||||||||2017-02-18 17:31:54.010038|2017-02-18 17:31:54.010038
NCT00131859|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2009-08-12|||October 2004||2004-10-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Diffusion-Tensor Magnetic Resonance Imaging (MRI) and the Evaluation of Perinatal Brain Injury|Diffusion-Tensor Magnetic Resonance Imaging and the Evaluation of Perinatal Brain Injury|Completed||N/A|5|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 17:31:54.10458|2017-02-18 17:31:54.10458
NCT00131846|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2012-08-22|||January 2004||2004-01-01|August 2012|2012-08-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|||Diuretics In the Management of Essential Hypertension (DIME) Study|Effect of Low Dose Thiazide Diuretics on New Onset Type 2 Diabetes in Patients With Essential Hypertension|Unknown status|Active, not recruiting|Phase 4|1130|Actual|Kyoto University||2|||f||||t||||||||||2017-02-18 17:31:54.211159|2017-02-18 17:31:54.211159
NCT00131833|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2008-03-10|||October 2001||2001-10-01|March 2008|2008-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China|Typhoid Vi Vaccine Effectiveness in a Population Older Than 5 Years of Age Living in an Endemic Area in Hechi, Guangxi, P.R. China: A Group-Randomized Controlled Demonstration Project|Completed||Phase 4|96468||International Vaccine Institute|||||f||||||||||||||2017-02-18 17:31:54.325453|2017-02-18 17:31:54.325453
NCT00131820|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2008-03-10|||December 2001||2001-12-01|March 2008|2008-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam|Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam. An Evaluation of Feasibility, Public Acceptability, Effectiveness and Cost-Effectiveness in Students|Completed||Phase 4|100742||International Vaccine Institute|||||f||||||||||||||2017-02-18 17:31:54.433926|2017-02-18 17:31:54.433926
NCT00131807|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2015-05-27|||September 2005||2005-09-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Observational|||A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy|A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy|Completed||N/A|3000||Imperial College London|||||f||||||||||||||2017-02-18 17:31:54.545129|2017-02-18 17:31:54.545129
NCT00131794|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2016-09-01|||January 2003||2003-01-01|August 2005|2005-08-01|December 2003||2003-12-01|||||Interventional|||Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria|The Effect of BCG Vaccine on Morbidity From Malaria|Completed||Phase 3|1200||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:31:54.634681|2017-02-18 17:31:54.634681
NCT00131781|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2007-04-26|||March 2001||2001-03-01|April 2007|2007-04-01||||||||Interventional|||Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder|Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder|Unknown status|Active, not recruiting|N/A|70||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:31:54.735372|2017-02-18 17:31:54.735372
NCT00131768|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2015-03-17|||November 2003||2003-11-01|March 2015|2015-03-01|February 2006||2006-02-01|||||Interventional|||A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis||Completed||Phase 3|||Sanofi|||||f||||||||||||||2017-02-18 17:31:54.831184|2017-02-18 17:31:54.831184
NCT00131755|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2011-07-15|||February 2005||2005-02-01|July 2011|2011-07-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Efficacy of Diazoxide in Type 1 Diabetes|Efficacy of 6 Months Treatment With Diazoxide at Bedtime in Preventing Beta-cell Demise in Newly Diagnosed Type 1 Diabetes|Completed||Phase 4|40|Actual|Grill, Valdemar, M.D.||1|||f||||f||||||||||2017-02-18 17:31:54.934789|2017-02-18 17:31:54.934789
NCT00131742|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2015-05-08|||July 2004||2004-07-01|May 2015|2015-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B|A Phase III Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B|Completed||Phase 3|||Novartis|||||||||||||||||||2017-02-18 17:31:55.034964|2017-02-18 17:31:55.034964
NCT00131729|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2006-03-17|||July 2001||2001-07-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Interventional|||Electronic Recording of Compliance With Occlusion Therapy for Amblyopia|Electronic Recording of Compliance With Occlusion Therapy for Amblyopia: 1 Effects of Patient Education on Compliance 2 Predictors for Non-Compliance|Completed||Phase 3|200||Erasmus Medical Center|||||f||||||||||||||2017-02-18 17:31:55.115556|2017-02-18 17:31:55.115556
NCT00131716|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2017-01-11|||May 2003||2003-05-01|January 2017|2017-01-01|May 2005||2005-05-01|||||Interventional|||Prevention of Severe Anaemia in Gambian Children|Chemoprophylaxis With Sulfadoxine-pyrimethamine to Prevent Recurrence of Severe Anaemia in Gambian Children Aged 3 Months to 9 Years|Completed||Phase 3|1200|Actual|London School of Hygiene and Tropical Medicine||2|||f||||t||||||||||2017-02-18 17:31:55.217739|2017-02-18 17:31:55.217739
NCT00131703|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2017-01-11|||March 2003||2003-03-01|January 2017|2017-01-01|March 2005||2005-03-01|||||Interventional|||Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women|A Randomised Double Blind Clinical Trial of Amodiaquine (AQ) and Sulphadoxine-pyrimethamine (SP) Used Singly and in Combination (AQ+SP) Compared With Chloroquine (CQ) in the Treatment of Falciparum Malaria Infection in Pregnancy|Completed||Phase 3|900||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:31:55.328976|2017-02-18 17:31:55.328976
NCT00131690|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2005-10-07|||April 1996||1996-04-01|August 2005|2005-08-01|August 2002||2002-08-01|||||Interventional|||Effect of Caffeine on Fetal Growth|The Importance of Caffeine in Fetal Growth|Completed||Phase 4|1200||The Danish Epdiemiology Science Centre|||||f||||||||||||||2017-02-18 17:31:55.439926|2017-02-18 17:31:55.439926
NCT00131677|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2014-01-22|2013-08-08||February 2005||2005-02-01|August 2013|2013-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional||400 participants enrolled (200 in San Francisco, 121 in Atlanta, and 79 in Boston). 201 were randomized to TDF and 199 to placebo. Participants were distributed similarly in terms of age, ethnicity, education, no. male partners in previous 3 mo., and no. of unprotected anal sexual contacts within the previous 3 mo.|Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men|Phase II Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men|Completed||Phase 2|400|Actual|Centers for Disease Control and Prevention||4|||f||||t||||||||||2017-02-18 17:31:55.556002|2017-02-18 17:31:55.556002
NCT00131664|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2013-04-15|2012-01-28||September 2005||2005-09-01|April 2013|2013-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|AVALANCHE||Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)|Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin: A 48-week Randomized, Open-label, Multicentre Phase IIIB Study to Compare the Effectiveness of Combination Therapy to Monotherapy in Type 2 Diabetes Mellitus Patients|Completed||Phase 3|391|Actual|Canadian Heart Research Centre|The LOCF used in the ITT population for withdrawn subjects or missing values was analyzed as per protocol. The 3 treatment groups used throughout the results section were the numbers where the patients were originally randomized to.|3|||f||||t||||||||||2017-02-18 17:31:56.230782|2017-02-18 17:31:56.230782
NCT00131651|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2007-12-04|||August 2005||2005-08-01|December 2007|2007-12-01||||||||Interventional|||ATN-161 in Advanced Renal Cell Cancer|A Dose-Ranging, Phase II, Open Label Study of ATN 161 in Advanced Renal Cell Cancer|Terminated||Phase 2|36||Attenuon|||||||||||||||||||2017-02-18 17:31:57.085365|2017-02-18 17:31:57.085365
NCT00131638|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2016-12-14|||January 2005||2005-01-01|December 2016|2016-12-01|July 2016|Actual|2016-07-01|November 2007|Actual|2007-11-01||Interventional|||A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer|Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (rHuKGF) for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Receiving Adjuvant Radiotherapy and Chemotherapy(RT/CT)|Completed||Phase 3|241|Actual|Amgen||2|||f||||f||||||||||2017-02-18 17:31:57.364099|2017-02-18 17:31:57.364099
NCT00131625|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-18|2005-10-07|||March 2000||2000-03-01|August 2005|2005-08-01|February 2002||2002-02-01|||||Interventional|||Impact of Exclusive Breast-Feeding in Guinea Bissau|Aspects of Exclusive Breast-Feeding in Guinea Bissau. Intervention Study to Clarify Recommendations for Breast-Feeding Policy in Developing Countries|Completed||Phase 4|1500||Bandim Health Project|||||f||||||||||||||2017-02-18 17:31:57.493093|2017-02-18 17:31:57.493093
NCT00131612|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2016-02-24|||January 2002||2002-01-01|June 2012|2012-06-01|January 2013|Actual|2013-01-01|December 2005|Actual|2005-12-01||Observational|||An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment|An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 Using Epirubicin Clearance and the Ratios of Epirubicin and Epirubicinol Glucuronide to Epirubicin|Terminated||N/A|120|Actual|AHS Cancer Control Alberta|||1|did not apply for ethics renewal|f||||t||||||||||2017-02-18 17:31:57.587324|2017-02-18 17:31:57.587324
NCT00131599|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2017-01-13|||August 2002||2002-08-01|January 2017|2017-01-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer|Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer|Active, not recruiting||N/A|104|Anticipated|AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 17:31:57.688101|2017-02-18 17:31:57.688101
NCT00131586|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2016-02-24|||April 2003||2003-04-01|April 2012|2012-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Observational|||Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins|Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins|Terminated||N/A|100|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 17:31:57.788435|2017-02-18 17:31:57.788435
NCT00131573|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2013-10-25|2013-04-11||May 2004||2004-05-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|March 2008|Actual|2008-03-01||Interventional|||An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome|Battery Powered Bion Clinical Investigation: Bion - An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urgency-Frequency Syndrome|Completed||Phase 3|118|Actual|Boston Scientific Corporation|This study was limited by poor adherence to the clinical protocol and by incomplete data recovery. Analysis of efficacy-related endpoints was not possible.|2|||f||||f||||||||||2017-02-18 17:31:57.884341|2017-02-18 17:31:57.884341
NCT00131560|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2011-06-07|||July 2005||2005-07-01|June 2011|2011-06-01|June 2023|Anticipated|2023-06-01|November 2008|Actual|2008-11-01||Interventional|||Safety and Efficacy of T Cell Genetic Immunotherapy for HIV|A Phase II, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Biological Activity of Single and Repeated Doses of Autologous T Cells Transduced With VRX496 in HIV-Positive Subjects|Active, not recruiting||Phase 2|60|Anticipated|VIRxSYS Corporation||1|||f||||t||||||||||2017-02-18 17:31:58.283007|2017-02-18 17:31:58.283007
NCT00131547|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2008-10-15|||September 2004||2004-09-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Randomized Study of a Simple Weight Loss Program for Obese Patients With Obstructive Sleep Apnea|A Randomized Controlled Pilot Study of a Simple Weight Loss Program for Obese Patients With Mild to Moderate Obstructive Sleep Apnea|Completed||N/A|56|Actual|Lawson Health Research Institute||2|||f||||f||||||||||2017-02-18 17:31:58.40183|2017-02-18 17:31:58.40183
NCT00131534|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2008-06-17|||August 1991||1991-08-01|June 2008|2008-06-01|August 2010|Anticipated|2010-08-01|||||Observational|||The Trauma Recovery and Resiliency Research Project|The Trauma Recovery and Resiliency Research Project|Unknown status|Recruiting|Phase 2|1000|Anticipated|Cambridge Health Alliance|||1||f||||||||||||||2017-02-18 17:31:58.501979|2017-02-18 17:31:58.501979
NCT00131521|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2009-06-20|||January 2005||2005-01-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Comparison of Different Mucoactive Agents for the Care of the Intubated Patient in a Surgical Trauma Intensive Care Unit|Comparison of Different Mucoactive Agents for the Care of the Intubated Patient in a Surgical Trauma Intensive Care Unit: A Randomized, Double Blind, Controlled Trial|Completed||N/A|260|Anticipated|The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 17:31:58.592864|2017-02-18 17:31:58.592864
NCT00131508|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2010-05-18|2010-02-19||May 2004||2004-05-01|March 2010|2010-03-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Trial of Oral Glutamine in Patients With Sickle Cell Anemia|A Randomized Controlled Trial of Oral Glutamine Supplementation Versus a Placebo Supplement in Children With Sickle Cell Anemia|Terminated||Phase 2|27|Actual|St. Jude Children's Research Hospital|The study was designed to enroll 46 participants (23 per arm). Due to slow accrual the study was terminated after enrolling 27 participants. Of the 27 participants enrolled, 2 dropped out of the study prior to randomization.|2||Due to slow participant accrual|f||||t||||||||||2017-02-18 17:31:58.689101|2017-02-18 17:31:58.689101
NCT00131495|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2013-04-15|||July 2004||2004-07-01|April 2013|2013-04-01|February 2007|Actual|2007-02-01|February 2006|Actual|2006-02-01||Interventional|||Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido|A Randomized, Double-Blind, Placebo-controlled, Parallel-group, 52-week Study to Evaluate the Efficacy/Safety of Transdermal Patches Delivering Testosterone in Menopausal Women With Low Libido Not Receiving Estrogen Therapy|Completed||Phase 3|814|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 17:31:59.241332|2017-02-18 17:31:59.241332
NCT00131482|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2010-08-23|||November 2004||2004-11-01|August 2010|2010-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist|A Double-blind, Randomized, Placebo-controlled Phase 2b Study to Establish the Effective Dose Range and to Evaluate the Safety of Chrysalin in Adult Subjects With a Fractured Distal Radius|Terminated||Phase 2|274|Actual|Capstone Therapeutics||5||Treatment with Chrysalin did not demonstrate benefit compared to placebo.|f||||f||||||||||2017-02-18 17:31:59.352404|2017-02-18 17:31:59.352404
NCT00131469|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2013-10-30|||June 2005||2005-06-01|October 2013|2013-10-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|OI||Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta|A Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)|Completed||Phase 4|79|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 17:31:59.463923|2017-02-18 17:31:59.463923
NCT00131456|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2016-04-06|2013-04-18||March 2004||2004-03-01|March 2016|2016-03-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|VEN||Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1|Marijuana Addiction and Depression: Venlafaxine Treatment|Completed||Phase 2|123|Actual|New York State Psychiatric Institute|This was an outpatient study and excluded patients with very severe depression. Thus we cannot generalize the findings to individuals with more severe depressive symptoms. The study length was relatively brief.|2|||f||||t||||||||||2017-02-18 17:31:59.577305|2017-02-18 17:31:59.577305
NCT00131443|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2012-11-09|||February 2004||2004-02-01|November 2006|2006-11-01|August 2006||2006-08-01|||||Interventional|||Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine|A Double-Blind Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine|Completed||Phase 2/Phase 3|40||Monarch Medical Research|||||f||||||||||||||2017-02-18 17:31:59.974309|2017-02-18 17:31:59.974309
NCT00131430|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2016-06-06|||August 2005||2005-08-01|March 2016|2016-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)|An 18-Month Study to Assess the Safety, Tolerability, and Efficacy of MK0364 in Obese Patients|Completed||Phase 2/Phase 3|500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:32:00.092302|2017-02-18 17:32:00.092302
NCT00131417|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2005-10-04|||October 2004||2004-10-01|August 2005|2005-08-01|February 2005||2005-02-01|||||Interventional|||Ready to Use Therapeutic Food in the Rehabilitation of Severely Malnourished Children|Comparison of the Efficacy of a Ready-to-Use Therapeutic Food With a Milk-Based Diet in the Rehabilitation of Severely Malnourished Ugandan Children|Unknown status|Active, not recruiting|Phase 3|128||Makerere University|||||f||||||||||||||2017-02-18 17:32:00.202692|2017-02-18 17:32:00.202692
NCT00131404|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2015-02-04|||September 2005||2005-09-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|February 2007|Actual|2007-02-01||Interventional|||A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)|A 2-Year Study to Assess the Efficacy, Safety, and Tolerability of Taranabant in Obese Patients Followed by a 1-Year Extension|Terminated||Phase 3|2400|Actual|Merck Sharp & Dohme Corp.||5||The overall profile does not support development for obesity|f||||||||||||||2017-02-18 17:32:00.300475|2017-02-18 17:32:00.300475
NCT00131391|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2015-04-02|||July 2005||2005-07-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||A Study of MK0364 in Obese Patients (0364-014)|A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of Taranabant (MK0364) in Obese Patients Followed by a 1-Year Extension|Terminated||Phase 3|2400|Actual|Merck Sharp & Dohme Corp.||6||The overall profile does not support development for obesity|f||||||||||||||2017-02-18 17:32:00.552952|2017-02-18 17:32:00.552952
NCT00131378|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2016-03-09|2013-08-19||November 2004||2004-11-01|March 2016|2016-03-01|June 2013|Actual|2013-06-01|November 2012|Actual|2012-11-01||Interventional|||Growth Hormone, Cardiovascular Risk, and Visceral Adiposity|Growth Hormone, Cardiovascular Risk, and Visceral Adiposity|Completed||N/A|142|Actual|Massachusetts General Hospital||4|||f||||t||||||||||2017-02-18 17:32:00.657195|2017-02-18 17:32:00.657195
NCT00131365|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2012-09-13|||January 2006||2006-01-01|September 2012|2012-09-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids|Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids|Completed||Phase 3|20|Actual|InSightec||1|||f||||||||||||||2017-02-18 17:32:01.318266|2017-02-18 17:32:01.318266
NCT00131352|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2015-03-17|2009-08-03||May 2005||2005-05-01|March 2015|2015-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee|A Multi-Centre, Parallel, Double-Blind, Blinded Evaluator, Randomised, Placebo-Controlled Evaluation of the Efficacy and Safety of a Single Dose of 6 mL of Synvisc in Patients With Symptomatic Osteoarthritis of the Knee|Completed||Phase 3|253|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 17:32:01.433712|2017-02-18 17:32:01.433712
NCT00131339|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2009-08-25|||November 2004||2004-11-01|August 2009|2009-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder|Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Panic Disorder|Completed||N/A|40||Hartford Hospital|||||f||||||||||||||2017-02-18 17:32:02.671854|2017-02-18 17:32:02.671854
NCT00131326|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2015-03-17|||November 2003||2003-11-01|March 2015|2015-03-01|April 2006||2006-04-01|||||Interventional|||A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip||Completed||Phase 3|||Sanofi|||||||||||||||||||2017-02-18 17:32:02.765695|2017-02-18 17:32:02.765695
NCT00131313|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2005-08-17|||January 2003||2003-01-01|August 2005|2005-08-01|April 2009||2009-04-01|||||Interventional|||Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.|A Multicenter, Open-Label Study of Nipent, Cytoxan and Rituxan in Patients With Previously Untreated or Treated Chronic Lymphocytic Leukemia.|Unknown status|Recruiting|Phase 4|180||East Valley Hematology and Oncology Medical Group|||||f||||||||||||||2017-02-18 17:32:02.891697|2017-02-18 17:32:02.891697
NCT00131300|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2015-03-17|||April 2004||2004-04-01|March 2015|2015-03-01|February 2006||2006-02-01|||||Interventional|||A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis||Completed||Phase 3|||Sanofi|||||f||||||||||||||2017-02-18 17:32:03.042649|2017-02-18 17:32:03.042649
NCT00131287|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2010-01-04|||July 2005||2005-07-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)||Completed||Phase 3|108||ECbiotech Taiwan|||||f||||||||||||||2017-02-18 17:32:03.266269|2017-02-18 17:32:03.266269
NCT00131274|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2005-10-04|||April 2003||2003-04-01|August 2005|2005-08-01|August 2007||2007-08-01|||||Interventional|||Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study|A Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy (Gleevec Imatinib Mesylate) in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 2/Phase 3|120||Daniels, Craig E., M.D.|||||||||||||||||||2017-02-18 17:32:03.362677|2017-02-18 17:32:03.362677
NCT00131261|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-17|2015-07-07|||January 2005||2005-01-01|July 2015|2015-07-01|June 2007|Actual|2007-06-01|January 2007|Actual|2007-01-01||Interventional|||Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma|A Phase II Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma|Completed||Phase 2|25|Actual|Onxeo||1|||||||||||||||||2017-02-18 17:32:03.466571|2017-02-18 17:32:03.466571
NCT00131248|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2013-12-12|2009-11-23||April 2004||2004-04-01|December 2013|2013-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||18 participants initially enrolled; 1 withdrew, leaving 17 participants analyzed.|Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants|Cross-over Trial of Medical Treatment for GERD in Preterm Infants|Completed||Phase 3|18|Actual|The University of Texas Health Science Center, Houston||2|||f||||||||||||||2017-02-18 17:32:03.572608|2017-02-18 17:32:03.572608
NCT00131235|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2014-01-21|||December 2003||2003-12-01|January 2014|2014-01-01|March 2012|Actual|2012-03-01|May 2007|Actual|2007-05-01||Interventional|||Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth|Lungwena Antenatal Intervention Study. A Single-centre Intervention Trial in Rural Malawi, Testing Maternal and Infant Health Effects of Presumptive Intermittent Treatment of Pregnant Women With Sulfadoxine-pyrimethamine and Azithromycin|Completed||Phase 3|1320|Actual|University of Tampere||3|||f||||t||||||||||2017-02-18 17:32:03.875372|2017-02-18 17:32:03.875372
NCT00131222|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2014-05-19|||February 2005||2005-02-01|April 2007|2007-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Trial to Alleviate Malnutrition With Fortified Spread Given as a Food Supplement to Underweight Infants|Lungwena Child Nutrition Intervention Study-4, LCNI-4. A Single-centre Intervention Trial in Rural Malawi, Testing the Potency of RUTF Supplementation to Alleviate Moderate Malnutrition Among 6-17 Month Old Infants|Completed||Phase 3|176||University of Tampere|||||f||||t||||||||||2017-02-18 17:32:04.006976|2017-02-18 17:32:04.006976
NCT00131209|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2008-07-03|||October 2004||2004-10-01|July 2008|2008-07-01|January 2008|Actual|2008-01-01|January 2006|Actual|2006-01-01||Interventional|||Trial to Test the Growth-Promoting Effect of Fortified Spreads When Used as Complementary Food for Infants|Lungwena Child Nutrition Intervention Study 3, LCNI-3. A Single-Centre Intervention Trial in Rural Malawi, Testing the Anthropometric and Health Benefits of Provision of Ready to - Use - Therapeutic Food RUTF as a Complementary Food|Completed||Phase 3|180||University of Tampere|||||f||||t||||||||||2017-02-18 17:32:04.103071|2017-02-18 17:32:04.103071
NCT00131196|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2016-05-13|||September 2005||2005-09-01|May 2016|2016-05-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Observational|GAinS||Functional Genomic Influences on Disease Progression and Outcome in Sepsis|Functional Genomic Influences on Disease Progression and Outcome in Sepsis Due to Pneumonia or Peritonitis|Recruiting||N/A|4000|Anticipated|University of Oxford|||1||f||||t||||||Samples With DNA|"~     whole blood, plasma and extracted DNA~   "|||2017-02-18 17:32:04.211498|2017-02-18 17:32:04.211498
NCT00131183|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2006-09-11|||September 2005||2005-09-01|September 2006|2006-09-01||||||||Interventional|||Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina|The Effect of Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina|Unknown status|Recruiting|Phase 4|80||Sheffield Teaching Hospitals NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:32:04.399741|2017-02-18 17:32:04.399741
NCT00131170|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2007-07-04|||September 2005||2005-09-01|July 2007|2007-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Paravertebral Block for Breast Surgery||Completed||Phase 4|90|Actual|University of Aarhus||2|||f||||f||||||||||2017-02-18 17:32:04.497279|2017-02-18 17:32:04.497279
NCT00005395|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|February 2005|2005-02-01|July 2000|Actual|2000-07-01|||||Observational|||Honolulu Heart Program-Study of Stroke and Dementia||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:02.920322|2017-02-18 18:15:02.920322
NCT00131144|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2011-11-16|||November 1999||1999-11-01|November 2011|2011-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy|A Randomized, Controlled Study on the Efficacy and Safety of Octreotide Acetate in Microspheres in the Therapy of Patients With Moderately Severe or Severe Non-proliferate Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR)|Completed||Phase 3|583|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:32:04.668575|2017-02-18 17:32:04.668575
NCT00131131|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2010-03-17|||May 2003||2003-05-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|||||Interventional|||Epidemiology of Gallbladder Sludge and Stones in Pregnancy|Epidemiology of Gallbladder Sludge & Stones in Pregnancy|Completed||Phase 3|670||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:32:04.767151|2017-02-18 17:32:04.767151
NCT00131118|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2016-11-16|||July 2004||2004-07-01|November 2016|2016-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta|Efficacy and Safety of Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta|Completed||Phase 2|127||Novartis|||||||||||||||||||2017-02-18 17:32:04.852171|2017-02-18 17:32:04.852171
NCT00131105|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2008-12-22|||July 2003||2003-07-01|December 2008|2008-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The TLC2 (Teaching Healthy Lifestyles to Caregivers 2)/CALM (Counseling Advice for Lifestyle Management) Study|Combining Exercise and Diet in Older Adults|Completed||Phase 2|200|Actual|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:32:07.833898|2017-02-18 17:32:07.833898
NCT00131092|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2009-12-09|||June 1999||1999-06-01|December 2008|2008-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||The CHAT (Community Health Advice by Telephone) Study|Exercise Advice by Human or Computer: Testing 2 Theories|Completed||Phase 2|225||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:32:07.943151|2017-02-18 17:32:07.943151
NCT00131079|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2007-10-16|||October 2003||2003-10-01|October 2007|2007-10-01|March 2006|Actual|2006-03-01|||||Interventional|||PEPAF: Evaluation of Family Physician's Effectiveness for Physical Activity Promotion|Multi-Center Evaluation of the Experimental Program for Physical Activity Promotion (PEPAF), Carried Out by Family Physicians|Completed||Phase 3|4317|Actual|Basque Health Service||2|||f||||f||||||||||2017-02-18 17:32:08.034782|2017-02-18 17:32:08.034782
NCT00131066|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2008-09-18|||August 2002||2002-08-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|October 2003|Actual|2003-10-01||Observational|||Long-Term Follow-Up Study of Psoriasis Patients|Long-Term Safety Follow-Up Study of Psoriasis Patients Who Have Received MEDI-507|Completed||N/A|200|Actual|MedImmune LLC|||1||f||||||||||||||2017-02-18 17:32:08.126163|2017-02-18 17:32:08.126163
NCT00131053|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2008-11-13|||September 2002||2002-09-01|November 2008|2008-11-01|September 2011|Anticipated|2011-09-01|May 2011|Anticipated|2011-05-01||Interventional|||Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)|Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients With BCR-ABL-Negative Acute Lymphoblastic Leukemia|Unknown status|Recruiting|Phase 2|120|Anticipated|Japan Adult Leukemia Study Group||1|||f||||t||||||||||2017-02-18 17:32:08.23341|2017-02-18 17:32:08.23341
NCT00131040|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2015-05-27|||January 2003||2003-01-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass|Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass|Completed||N/A|24||Imperial College London|||||f||||||||||||||2017-02-18 17:32:08.351525|2017-02-18 17:32:08.351525
NCT00131027|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2008-11-13|||September 2002||2002-09-01|November 2008|2008-11-01|September 2011|Anticipated|2011-09-01|March 2011|Anticipated|2011-03-01||Interventional|||High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)|Randomized Controlled Trial to Test Efficacy of High-Dose Methotrexate Consolidation Therapy for BCR-ABL-Negative Acute Lymphoblastic Leukemia in Adults|Unknown status|Recruiting|Phase 3|240|Anticipated|Japan Adult Leukemia Study Group||2|||f||||t||||||||||2017-02-18 17:32:08.44813|2017-02-18 17:32:08.44813
NCT00131014|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2016-11-16|||August 2004||2004-08-01|November 2016|2016-11-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies|Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies|Recruiting||N/A|1500|Anticipated|Dana-Farber Cancer Institute|||3||f||||||||||Samples With DNA|"~     Whole blood Cheek cells Paraffin blocks of tumor tissue~   "|||2017-02-18 17:32:08.568734|2017-02-18 17:32:08.568734
NCT00131001|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2008-10-17|||April 2001||2001-04-01|April 2007|2007-04-01||||||||Interventional|||CARMEDAS: Cost-Effectiveness Analysis of Imaging Strategies in Symptomatic Carotid Stenosis|Cost-Effectiveness Analysis of Imaging Strategies in Symptomatic Carotid Stenosis|Unknown status|Active, not recruiting|N/A|300||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:32:08.931897|2017-02-18 17:32:08.931897
NCT00130988|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2008-07-11|||January 2001||2001-01-01|July 2008|2008-07-01|March 2003|Actual|2003-03-01|February 2002|Actual|2002-02-01||Interventional|||DEPENAS: A Psychosocial Intervention for Patients With Medically Unexplained Symptoms|Efficacy of a Biopsychosocial Treatment for Somatizing Patients Carried Out by the General Practitioner|Completed||Phase 3|156||Basque Health Service|||||f||||f||||||||||2017-02-18 17:32:09.026037|2017-02-18 17:32:09.026037
NCT00130975|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-16|2007-01-03|||April 2001||2001-04-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Candesartan in the Prevention of Relapsing Atrial Fibrillation||Completed||Phase 3|200||Asker & Baerum Hospital|||||f||||||||||||||2017-02-18 17:32:09.121358|2017-02-18 17:32:09.121358
NCT00130962|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2005-09-30|||September 2004||2004-09-01|August 2005|2005-08-01|February 2006||2006-02-01|||||Interventional|||ALGRX 4975 in the Treatment of Patients With Morton's Neuroma|A Randomized, Double-Blind, Placebo-Controlled Trial of ALGRX 4975 in Subjects With Painful Intermetatarsal Neuroma|Completed||Phase 2|60||AlgoRx Pharmaceuticals|||||||||||||||||||2017-02-18 17:32:09.226154|2017-02-18 17:32:09.226154
NCT00130949|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2006-12-18|||November 2004||2004-11-01|August 2005|2005-08-01|November 2005||2005-11-01|||||Interventional|||ALGRX 4975 in the Treatment of Tennis Elbow|A Randomized, Double-Blind, Placebo-Controlled, Phase II, Exploratory Evaluation of ALGRX 4975 in Subjects With Acute Lateral Epicondylitis|Completed||Phase 2|45||AlgoRx Pharmaceuticals|||||f||||||||||||||2017-02-18 17:32:09.326944|2017-02-18 17:32:09.326944
NCT00130572|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2008-05-21|||June 2004||2004-06-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Elidel Cream on Erosive Oral Lichen Planus|Randomized Placebo-Controlled Clinical Pilot Trial Regarding the Efficacy of Elidel Cream on Erosive Oral Lichen Planus|Completed||Phase 3|20|Actual|University Hospital Tuebingen|||||f||||||||||||||2017-02-18 17:32:16.510071|2017-02-18 17:32:16.510071
NCT00130936|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2016-02-12|||October 2005||2005-10-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|||||Interventional|||Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates|Combined Phase I/II Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates|Terminated||Phase 1/Phase 2|50|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:32:09.424082|2017-02-18 17:32:09.424082
NCT00130923|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2015-08-03|2012-07-23||September 2005||2005-09-01|August 2015|2015-08-01|July 2010|Actual|2010-07-01|June 2009|Actual|2009-06-01||Interventional|||Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder|Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST)|Completed||Phase 4|95|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 17:32:09.538533|2017-02-18 17:32:09.538533
NCT00130910|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2007-11-13|||March 2006||2006-03-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation|Randomized, Double Blind, Placebo Controlled Trial of Albendazole in Soil-Transmitted Helminth and HIV-1 co-Infected Kenyan Individuals to Determine the Effect of Such Treatment on HIV-1 Disease Progression and Genital Shedding.|Completed||N/A|234|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:32:10.006441|2017-02-18 17:32:10.006441
NCT00130897|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-14|2012-03-08|||July 2005||2005-07-01|March 2012|2012-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Expanded Access|||Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma|A SU011248 Expanded Access Protocol For Systemic Therapy Of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible For Participation In Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248|Approved for marketing||N/A|||Pfizer|||||||||f||||||||||2017-02-18 17:32:10.138759|2017-02-18 17:32:10.138759
NCT00130884|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2007-02-19|||March 2005||2005-03-01|February 2007|2007-02-01|March 2006||2006-03-01|||||Interventional|||Peroral Levosimendan in Chronic Heart Failure|Effects of Peroral Levosimendan in the Prevention of Further Hospitalisations in Patients With Chronic Heart Failure. A Randomised, Phase II, Double-Blind, Placebo-Controlled, Multi-Centre, Parallel-Group Study|Completed||Phase 2|300||Orion Corporation, Orion Pharma|||||f||||||||||||||2017-02-18 17:32:10.776911|2017-02-18 17:32:10.776911
NCT00130871|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2007-02-19|||January 2004||2004-01-01|February 2007|2007-02-01|January 2006||2006-01-01|||||Interventional|||Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass|Impact of Levosimendan Pretreatment on Weaning From Cardiopulmonary Bypass (CPB) in Patients With Diminished Left Ventricular Function Before Coronary Artery Bypass Grafting (CABG)|Completed||Phase 2|60||Orion Corporation, Orion Pharma|||||f||||||||||||||2017-02-18 17:32:10.877909|2017-02-18 17:32:10.877909
NCT00130858|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2009-04-01|||January 2005||2005-01-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|December 2007|Actual|2007-12-01||Interventional|||a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4|a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4|Completed||Phase 2|90|Anticipated|Cooperative Weichteilsarkom Study Group|||||f||||||||||||||2017-02-18 17:32:11.052319|2017-02-18 17:32:11.052319
NCT00130845|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2011-11-16|||February 2000||2000-02-01|November 2011|2011-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy|A Randomized, Controlled Study on the Efficacy and Safety of Octreotide Acetate in Microspheres in the Therapy of Patients With Moderately Severe or Severe Non-proliferate Diabetic Retinopathy (NPDR) or Low Risk Proliferative Diabetic Retinopathy (PDR)|Completed||Phase 3|312|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:32:11.180709|2017-02-18 17:32:11.180709
NCT00130832|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2015-03-12|2009-08-07||October 2005||2005-10-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)|Safety and Immunogenicity of Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants|Completed||Phase 3|735|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:32:11.283156|2017-02-18 17:32:11.283156
NCT00130819|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2015-04-14|||November 2005||2005-11-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants|Buprenorphine Effectiveness Evaluation in HIV Enhancement (BEEHIVE): A Randomized Trial of HIV Clinic-based Buprenorphine/Naloxone vs. Case Management and Referral in Opioid-dependent Individuals|Completed||Phase 2|120|Anticipated|Johns Hopkins University||2|||f||||||||||||||2017-02-18 17:32:11.884049|2017-02-18 17:32:11.884049
NCT00130806|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2016-09-06|||September 2005||2005-09-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)|A Study to Assess the Efficacy and Tolerability of MK0478 (Muraglitazar, Also, BMS 298585) Coadministered With Insulin in Patients With Type 2 Diabetes|Terminated||Phase 3|600||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:32:12.009325|2017-02-18 17:32:12.009325
NCT00130793|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-01-14|2009-05-11||August 2005||2005-08-01|January 2015|2015-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)|A Double-Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety, Tolerability and Immunogenicity of a Refrigerator-Stable Formulation of Zoster Vaccine Live (Oka/Merck)|Completed||Phase 3|368|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:32:12.110125|2017-02-18 17:32:12.110125
NCT00130780|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2015-12-18|2015-12-18||August 2005||2005-08-01|December 2015|2015-12-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC|Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) (BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC)|Completed||Phase 2|71|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:32:12.858257|2017-02-18 17:32:12.858257
NCT00130767|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2007-04-26|||December 2004||2004-12-01|April 2007|2007-04-01||||||||Interventional|||Kinetics of the Finasteride Prostate Induced Apoptosis|Kinetics of the Finasteride Prostate Induced Apoptosis|Unknown status|Active, not recruiting|Phase 4|90||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:32:13.284662|2017-02-18 17:32:13.284662
NCT00130754|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2011-02-22|||February 2005||2005-02-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation|A Prospective Randomized, Controlled Pilot Study in Order to Evaluate the Place of Thymoglobuline in Non-myeloablative Allogeneic Hemapoietic Stem-cell Transplantation (NST)|Completed||Phase 3|30|Actual|Hadassah Medical Organization||2|||f||||||||||||||2017-02-18 17:32:13.387918|2017-02-18 17:32:13.387918
NCT00130741|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2007-04-10|||July 2005||2005-07-01|April 2007|2007-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)|A Phase I, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of a Combination Herbal Therapy (CHT), Versus Placebo in Improving the Overall Quality of Life and Symptoms in Patients With Irritable Bowel Syndrome (IBS)|Completed||Phase 1|100||Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:32:13.490495|2017-02-18 17:32:13.490495
NCT00130728|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2011-09-26|2009-11-16||June 2005||2005-06-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer|A Phase III, Multicenter, Placebo-Controlled, Double-Blind, Randomized Clinical Trial to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva (Erlotinib) Compared With Tarceva Alone for Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) After Failure of Standard First-Line Chemotherapy|Completed||Phase 3|636|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 17:32:13.58918|2017-02-18 17:32:13.58918
NCT00130715|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2015-03-11|||June 1998||1998-06-01|March 2015|2015-03-01|August 2003||2003-08-01|||||Interventional|||Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery|A Prospective, Randomized, Multicenter, Controlled Evaluation of the Efficacy and Safety of Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery|Completed||N/A|||Sanofi|||||||||||||||||||2017-02-18 17:32:14.495091|2017-02-18 17:32:14.495091
NCT00130702|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2014-04-29|||August 2005||2005-08-01|April 2014|2014-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia|A Phase II Study of Iressa (Gefitinib), in Patients With Relapsed or Refractory Acute Myelogenous Leukemia and in Older Patients With Newly Diagnosed Acute Myelogenous Leukemia|Completed||Phase 2|18|Actual|Dana-Farber Cancer Institute||1|||f||||f||||||||||2017-02-18 17:32:14.599136|2017-02-18 17:32:14.599136
NCT00130689|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2015-05-12|2014-05-28||July 2005||2005-07-01|May 2015|2015-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional||The analysis dataset is comprised of eligible and treated patients.|Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer|A Phase II Trial of Cetuximab in Unresectable or Metastatic Esophageal and Gastric Carcinoma|Completed||Phase 2|43|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:32:14.716981|2017-02-18 17:32:14.716981
NCT00130676|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2012-02-14|||September 2004||2004-09-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression|A Randomized, Double-Blind, Placebo-Controlled Study of Safety and Efficacy of CORLUX™ (Mifepristone) in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features|Completed||Phase 3|257|Actual|Corcept Therapeutics||2|||f||||f||||||||||2017-02-18 17:32:15.005898|2017-02-18 17:32:15.005898
NCT00130663|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2007-10-19|||January 2006||2006-01-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Recognition of Abnormal Pediatric Blood Pressures in Primary Care|Recognition of Abnormal Pediatric Blood Pressures in Primary Care|Completed||N/A|||Nationwide Children's Hospital|||||f||||||||||||||2017-02-18 17:32:15.136154|2017-02-18 17:32:15.136154
NCT00130650|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-15|2008-01-24|||May 2006||2006-05-01|January 2008|2008-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Pain Ease Spray in Reducing Needle Pain Associated With Intravenous Insertion in Children|Efficacy of Pain Ease Spray in Reducing Needle Pain Associated With Intravenous Insertion in Children|Completed||Phase 4|80|Actual|Children's Hospital of Eastern Ontario||1|||f||||t||||||||||2017-02-18 17:32:15.214457|2017-02-18 17:32:15.214457
NCT00130637|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2017-01-27|2010-08-12||August 2005||2005-08-01|January 2017|2017-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis|Treatment of Active Anterior Uveitis Associated With JIA, Using Humanized Anti-Tac (HAT, Daclizumab)|Completed||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|The results of this trial need to be interpreted cautiously because of the small number of patients, the heterogeneity of the patient population (such as one participant with systemic JIA), and the nonrandomized and unmasked nature of the trial.|1|||f||||t||||||||No||2017-02-18 17:32:15.308239|2017-02-18 17:32:15.308239
NCT00130624|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2005-10-04|||June 2001||2001-06-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||The Winchester Falls Project|The Winchester Falls Project: A Cluster Randomised Community Intervention Trial of Secondary Prevention of Falls in Community-Dwelling Older People|Completed||Phase 3|516||Winchester and Eastleigh Healthcare NHS Trust|||||f||||||||||||||2017-02-18 17:32:15.601294|2017-02-18 17:32:15.601294
NCT00130611|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2013-05-28|||January 2004||2004-01-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice|B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice|Completed||Phase 4|250|Actual|University Hospital, Basel, Switzerland||2|||f||||||||||||||2017-02-18 17:32:15.950616|2017-02-18 17:32:15.950616
NCT00130598|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2010-03-04|||June 2005||2005-06-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION|PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION|Completed||Phase 2/Phase 3|258|Actual|University Hospital, Basel, Switzerland||3|||f||||f||||||||||2017-02-18 17:32:16.093119|2017-02-18 17:32:16.093119
NCT00130585|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2005-10-03|||May 2005||2005-05-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Bioavailability of Folate From a Mixed Diet Using a Stable Isotope Method|The Relative Bioavailability of Folate From a Mixed Diet Compared to Synthetic Folic Acid Using a Stable Isotope Method|Completed||N/A|75||Wageningen University|||||f||||||||||||||2017-02-18 17:32:16.419485|2017-02-18 17:32:16.419485
NCT00128076|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2016-05-26|||August 2006||2006-08-01|May 2016|2016-05-01|December 2015|Actual|2015-12-01|August 2014|Actual|2014-08-01||Interventional|||All-Arthroscopic Versus Mini-Open Repair of Small or Moderate Rotator Cuff Tears|All-Arthroscopic Versus Mini-Open Repair of Small or Moderate Rotator Cuff Tears|Completed||Phase 3|275|Actual|McMaster University||2|||f||||t||||||||||2017-02-18 17:33:15.078673|2017-02-18 17:33:15.078673
NCT00130559|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2011-10-18|||December 2003||2003-12-01|October 2011|2011-10-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||B-type Natriuretic Peptide (BNP)-Guided Diagnostic Strategy in Intensive Care Unit (ICU) Patients With Respiratory Failure|Does a Diagnostic Strategy Reduce Duration and Cost of Hospitalization in Patients With Acute Dyspnea? BASEL II Intensive Care Unit|Completed||Phase 4|286|Actual|University Hospital, Basel, Switzerland||1|||f||||||||||||||2017-02-18 17:32:16.597844|2017-02-18 17:32:16.597844
NCT00130546|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2009-05-14|||November 2004||2004-11-01|May 2009|2009-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)|A Prospective, Randomized Intra-Individual Study With the Sirolimus Coated Cypher Select(TM) and the Paclitaxel(TM) Coated Express Balloon Expandable Stents for the Treatment of Patients With Two de Novo Native Coronary Artery Lesions.|Completed||Phase 3|112|Actual|University Hospital Freiburg||2|||f||||t||||||||||2017-02-18 17:32:16.713636|2017-02-18 17:32:16.713636
NCT00130533|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2015-07-31|||January 2006||2006-01-01|July 2015|2015-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients|Multicenter, Open-label, Randomized Phase III Trial, to Evaluate Efficacy of Maintenance Treatment With Capecitabine (X) Following Standard Adjuvant Chemotherapy, in Operable Breast Cancer Patients With Negative Hormone Receptor, Negative HER2 Tumours|Active, not recruiting||Phase 3|876|Actual|Spanish Breast Cancer Research Group||2|||f||||||||||||||2017-02-18 17:32:16.833986|2017-02-18 17:32:16.833986
NCT00130520|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2012-05-22|2010-12-13||June 2005||2005-06-01|December 2010|2010-12-01|May 2010|Actual|2010-05-01|January 2010|Actual|2010-01-01||Interventional|||Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer|Phase II Open-Label Trial of Erlotinib (Tarceva) and Bevacizumab in Women With Advanced Ovarian Cancer|Completed||Phase 2|40|Actual|University of Arizona||1|||f||||t||||||||||2017-02-18 17:32:16.938039|2017-02-18 17:32:16.938039
NCT00130507|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2011-10-25|||November 2005||2005-11-01|October 2011|2011-10-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab|Randomized Clinical Trial to Assess the Benefit of Adding Trastuzumab to Capecitabine and Vinorelbine as Second Line Treatment for HER2 Positive Breast Cancer Patients With Locally Advanced or Metastatic Disease, Progressing to a Previous Therapy Line With Trastuzumab and Taxanes|Terminated||Phase 2|14|Actual|Spanish Breast Cancer Research Group||2||"A new alternative treatment caused the decrease in the rhythm of recruitment and finally~   termination of the trial."|f||||||||||||||2017-02-18 17:32:17.31234|2017-02-18 17:32:17.31234
NCT00130494|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2007-02-06|||August 2002||2002-08-01|February 2007|2007-02-01|December 2006||2006-12-01|||||Interventional|||Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-Symptomatic Bone Lesions|Multicenter, Open-Label, Randomized Phase III Trial for Administration of Zoledronate to Breast Cancer Metastatic Patients With Non-Symptomatic Bone Lesions|Terminated||Phase 3|224||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:32:17.430055|2017-02-18 17:32:17.430055
NCT00130481|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2012-03-06|||April 2005||2005-04-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)|Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)|Completed||N/A|100||University of Florida|||||f||||||||||||||2017-02-18 17:32:17.522465|2017-02-18 17:32:17.522465
NCT00130468|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2008-04-01|||November 2004||2004-11-01|April 2008|2008-04-01|May 2006||2006-05-01|||||Interventional|||TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis|A Double Blind, Randomized Trial of Intra-Articular Injections of 20 mg of Hyalgan® for the Treatment of Knee Pain Due to Osteoarthritis (Three Injection-Regimen for Efficacy And Duration-20 mg/2mL Dose: Tread-20)|Completed||Phase 4|150||Sanofi|||||f||||||||||||||2017-02-18 17:32:17.618818|2017-02-18 17:32:17.618818
NCT00130455|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2007-02-05|||April 2006||2006-04-01|February 2007|2007-02-01|January 2008||2008-01-01|||||Interventional|||Treatment of Depression in the Elderly|A 12 Week Multi-Centre, Randomized, Double-Blind, Placebo Controlled Evaluation of the Most Efficacious and Tolerable Dose of Escitalopram in the Treatment of Elderly Patients|Terminated||Phase 4|189||Psychiatric Hospital, Hillerod|||||f||||||||||||||2017-02-18 17:32:17.709347|2017-02-18 17:32:17.709347
NCT00130442|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2016-03-30|||June 2005||2005-06-01|March 2016|2016-03-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma|A Phase II Study of PI-88 With Dacarbazine in Patients With Metastatic Melanoma|Completed||Phase 2|131|Actual|Medigen Biotechnology Corporation||2|||f||||t||||||||||2017-02-18 17:32:17.808318|2017-02-18 17:32:17.808318
NCT00130429|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2009-08-20|||January 2004||2004-01-01|August 2009|2009-08-01|September 2005|Actual|2005-09-01|||||Interventional|||Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease|Phase II Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Investigate the Safety, Effect on Cognition and Pharmacokinetic Profile of PYM50028 in Subjects With Mild Dementia of the Alzheimer's Type|Completed||Phase 2|250||Phytopharm|||||f||||||||||||||2017-02-18 17:32:17.920021|2017-02-18 17:32:17.920021
NCT00130416|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2008-07-03|||September 2004||2004-09-01|July 2008|2008-07-01|December 2007|Actual|2007-12-01|||||Interventional|||Improving Chronic Disease Care With PatientSite|Improving Chronic Disease Care With PatientSite|Completed||N/A|750||Robert Wood Johnson Foundation|||||f||||f||||||||||2017-02-18 17:32:18.006468|2017-02-18 17:32:18.006468
NCT00130403|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2011-01-10|||March 2004||2004-03-01|January 2011|2011-01-01|March 2007|Actual|2007-03-01|||||Interventional|||OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women|Open-Label Study to Determine How Prior Therapy With Alendronate or Risedronate in Postmenopausal Women With Osteoporosis Influences the Clinical Effectiveness of Teriparatide|Completed||Phase 4|290|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:32:18.101457|2017-02-18 17:32:18.101457
NCT00130390|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2012-05-30|||August 2005||2005-08-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease|Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in Adults|Terminated||Phase 2|98|Actual|Romark Laboratories L.C.||2||terminated due to slow recruitment|f||||f||||||||||2017-02-18 17:32:18.19698|2017-02-18 17:32:18.19698
NCT00127647|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2015-06-09|||November 2004||2004-11-01|June 2015|2015-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)|MK0476 Phase III Double-Blind Comparative Study - Allergic Rhinitis|Completed||Phase 3|1375|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 17:33:24.702588|2017-02-18 17:33:24.702588
NCT00130377|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2016-09-26|||August 2002||2002-08-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com|Biological Cell Therapy for the Treatment of Patients With Thoracic & Cardiovascular Disease|Recruiting||Phase 2/Phase 3|1000|Anticipated|Amit, Patel N, M.D.||2|||f||||t||||||||||2017-02-18 17:32:18.316693|2017-02-18 17:32:18.316693
NCT00130364|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2008-01-10|||August 2005||2005-08-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis|Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis|Completed||Phase 4|200||Novartis||2|||f||||||||||||||2017-02-18 17:32:18.43226|2017-02-18 17:32:18.43226
NCT00130351|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2011-10-24|||July 2005||2005-07-01|October 2011|2011-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma|A 3-week Multicenter Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma|Completed||Phase 3|155|Actual|Novartis|||||||||||||||||||2017-02-18 17:32:18.53753|2017-02-18 17:32:18.53753
NCT00130338|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2011-11-16|||February 2002||2002-02-01|November 2011|2011-11-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Rivastigmine Capsules in Patients With Probable Vascular Dementia|An Open-label Extension to Evaluate the Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia|Completed||Phase 3|521|Actual|Novartis|||||f||||||||||||||2017-02-18 17:32:18.744214|2017-02-18 17:32:18.744214
NCT00130325|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2010-01-12|||October 2004||2004-10-01|January 2010|2010-01-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Interventional|IRS||A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts|A Double Blind Placebo-controlled Randomized Trial of Isoniazid for the Reversion of a Positive IFNg ELISPOT in TB Case Contacts|Completed||N/A|214|Actual|Medical Research Council Unit, The Gambia||2|||f||||f||||||||||2017-02-18 17:32:18.831029|2017-02-18 17:32:18.831029
NCT00130312|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-04-13||2015-04-13|August 2005||2005-08-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of Sulodexide in Overt Diabetic Nephropathy|The Collaborative Study Group Trial: The Effect of Sulodexide in Overt Type 2 Diabetic Nephropathy|Terminated||Phase 4|1248|Actual|Keryx Biopharmaceuticals||2||No difference in protein excretion at 6&12 months. No safety issues.|f||||t||||||||||2017-02-18 17:32:18.948419|2017-02-18 17:32:18.948419
NCT00130299|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2010-08-27|||July 2004||2004-07-01|August 2010|2010-08-01|December 2006|Actual|2006-12-01|||||Interventional|||An 18-month Trial of a Low Glycemic Load Diet|An 18-month Randomized Controlled Trial of a Low Glycemic Load Diet|Completed||N/A|||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:32:19.06217|2017-02-18 17:32:19.06217
NCT00130286|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2014-02-10|2013-12-16||March 2005||2005-03-01|February 2014|2014-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance|Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Recombinant Human Growth Hormone and/or Rosiglitazone in the Treatment of Human Immunodeficiency Virus-Associated Visceral Adiposity and Insulin Resistance|Completed||Phase 1/Phase 2|77|Actual|Weill Medical College of Cornell University||4|||f||||t||||||||||2017-02-18 17:32:19.151707|2017-02-18 17:32:19.151707
NCT00130273|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2012-07-12|||July 2005||2005-07-01|July 2012|2012-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|MAPS||Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV|Managed Problem Solving: An HIV Adherence Trial|Completed||N/A|180|Actual|University of Pennsylvania||2|||f||||||||||||||2017-02-18 17:32:20.214707|2017-02-18 17:32:20.214707
NCT00130260|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2007-12-26|||August 2005||2005-08-01|December 2007|2007-12-01|April 2006|Actual|2006-04-01|December 2005|Actual|2005-12-01||Interventional|SHIELD-2||Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease|Phase 3b Multicenter, Randomized, Placebo-Controlled, Double-Blind Study Evaluating Immunogenicity and Safety of a 3rd and 4th Dose of StaphVAX®, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adults With End-Stage Renal Disease|Terminated||Phase 3|99|Actual|Nabi Biopharmaceuticals||4||unsatisfactory efficacy data from preceding trial|f||||f||||||||||2017-02-18 17:32:20.322096|2017-02-18 17:32:20.322096
NCT00130247|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2013-01-31|2009-08-20||April 2002||2002-04-01|April 2010|2010-04-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||Tuberculosis Treatment Shortening Trial|A Prospective Study of Shortening the Duration of Standard Short Course Chemotherapy From 6 Months to 4 Months in HIV-non-infected Patients With Fully Drug-Susceptible, Non-cavitary Pulmonary Tuberculosis With Negative Sputum Cultures After 2 Months of Anti-TB Treatment|Completed||Phase 3|394|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|Enrollment was stopped early and the number of patients enrolled was 1/2 of the original sample size. The study was completed.|2|||f||||||||||||||2017-02-18 17:32:20.437766|2017-02-18 17:32:20.437766
NCT00130234|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2008-05-06|||November 2004||2004-11-01|May 2008|2008-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Effect of Anti-IgE in Chronic Urticaria|Effect of Anti-IgE in Chronic Urticaria|Completed||Phase 2|20||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:32:21.137168|2017-02-18 17:32:21.137168
NCT00130221|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2007-04-03|||June 2005||2005-06-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Interventional|||Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections|Skin Cleansing With Chlorhexidine to Improve Nosocomial Infection Risks. (SCCIN Project)|Completed||Phase 1|208||John H. Stroger Hospital|||||f||||f||||||||||2017-02-18 17:32:21.228738|2017-02-18 17:32:21.228738
NCT00130208|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-04-13||2015-04-13|August 2005||2005-08-01|April 2015|2015-04-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Effect of Sulodexide in Early Diabetic Nephropathy|The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria|Completed||Phase 3|1000|Actual|Keryx Biopharmaceuticals||2|||f||||||||||||||2017-02-18 17:32:21.330418|2017-02-18 17:32:21.330418
NCT00130195|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2008-11-13|||September 2002||2002-09-01|November 2008|2008-11-01|May 2008|Actual|2008-05-01|February 2008|Actual|2008-02-01||Interventional|||Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)|Phase 2 Study of Imatinib-Combined Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia|Completed||Phase 2|100|Actual|Japan Adult Leukemia Study Group||1|||f||||t||||||||||2017-02-18 17:32:21.439392|2017-02-18 17:32:21.439392
NCT00130182|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2013-05-21|||August 2005||2005-08-01|May 2013|2013-05-01||||September 2006|Actual|2006-09-01||Interventional|||A Study in Pediatric Patients With Cystic Fibrosis Lung Disease|A Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Pediatric Patients With Cystic Fibrosis Lung Disease|Completed||Phase 2|13|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:32:21.558399|2017-02-18 17:32:21.558399
NCT00130169|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2015-06-29|||January 2006||2006-01-01|June 2015|2015-06-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies|A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies|Completed||Phase 1|30|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 17:32:21.646037|2017-02-18 17:32:21.646037
NCT00130156|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2013-05-13|||October 2005||2005-10-01|February 2011|2011-02-01|March 2009|Actual|2009-03-01|September 2008|Actual|2008-09-01||Interventional|||Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension|Effects of Combination Therapy With an α1-blocker (Sustained-release Preparation of Bunazosin or Doxazosin) in Inadequate Responders to an Angiotensin II Antagonist (Valsartan) in the Treatment of Patients With Mild to Moderate Essential Hypertension|Completed||Phase 4|93|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:32:21.748554|2017-02-18 17:32:21.748554
NCT00130143|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2005-09-26|||June 2003||2003-06-01|August 2005|2005-08-01|September 2004||2004-09-01|||||Interventional|||Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities|Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities|Completed||N/A|20||The Dale & Frances Hughes Cancer Center|||||f||||||||||||||2017-02-18 17:32:21.864586|2017-02-18 17:32:21.864586
NCT00130130|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2012-01-30|||August 2005||2005-08-01|January 2012|2012-01-01|December 2011|Actual|2011-12-01|September 2010|Actual|2010-09-01||Observational|||Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes|Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes|Completed||Phase 1/Phase 2|20|Actual|Dartmouth-Hitchcock Medical Center|||1||f||||||||||||||2017-02-18 17:32:21.973098|2017-02-18 17:32:21.973098
NCT00130117|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-01-12|||April 2010||2010-04-01|January 2015|2015-01-01|December 2015|Anticipated|2015-12-01|August 2011|Actual|2011-08-01||Interventional|||Study of Leptin for the Treatment of Hypothalamic Amenorrhea|Randomized, Double-blind, Placebo-controlled Trial of Human Recombinant Leptin (r-metHuLeptin) for the Treatment of Hypothalamic (Exercise-Induced) Amenorrhea|Unknown status|Active, not recruiting|Phase 2|57|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 17:32:22.062737|2017-02-18 17:32:22.062737
NCT00130104|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2007-10-03|||July 2005||2005-07-01|August 2005|2005-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Transthecal Metacarpal Block Versus Traditional Digital Block for Painful Finger Procedures in Children|Transthecal Metacarpal Block vs Traditional Digital Block for Painful Finger Procedures in Children|Completed||Phase 4|92|Actual|Children's Hospital of Philadelphia||1|||f||||f||||||||||2017-02-18 17:32:22.197988|2017-02-18 17:32:22.197988
NCT00130091|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-02-18|||September 2009||2009-09-01|February 2015|2015-02-01|December 2014|Actual|2014-12-01|February 2014|Actual|2014-02-01||Interventional|||The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children|The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children|Completed||Phase 2|120|Actual|Children's Hospital of Eastern Ontario||2|||f||||t||||||||||2017-02-18 17:32:22.318427|2017-02-18 17:32:22.318427
NCT00130078|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2005-09-22|||September 2004||2004-09-01|August 2005|2005-08-01||||||||Interventional|||Trial of SAVVY Vaginal Gel and HIV in Nigeria|Randomized Controlled Trial of SAVVY and HIV in Nigeria|Unknown status|Recruiting|Phase 3|2142||Biosyn|||||||||||||||||||2017-02-18 17:32:22.431643|2017-02-18 17:32:22.431643
NCT00130065|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2012-09-26|||November 2003||2003-11-01|September 2012|2012-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||The Effect of Folic Acid on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenya|The Effect of Folic Acid Supplementation on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenya|Completed||Phase 4|600||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:32:22.532692|2017-02-18 17:32:22.532692
NCT00130039|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2010-01-04|2009-10-23||August 2005||2005-08-01|November 2009|2009-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|TOSS-2||Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II|Trial for Efficacy and Safety of Cilostazol on the Progression of Symptomatic Intracranial Stenosis Comparing Clopidogrel|Completed||Phase 4|457|Actual|Asan Medical Center||2|||f||||t||||||||||2017-02-18 17:32:22.648995|2017-02-18 17:32:22.648995
NCT00130026|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2017-02-03|||March 2005||2005-03-01|February 2017|2017-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Caffeine in the Prevention of Post-operative Nausea and Vomiting|A Prospective, Randomized, Double-blind, Placebo-controlled Study of Caffeine in the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Ambulatory Surgery Under General Anesthesia|Completed||N/A|135|Actual|Beth Israel Deaconess Medical Center||1|||f||||f||||||||||2017-02-18 17:32:23.377593|2017-02-18 17:32:23.377593
NCT00130013|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-12|2005-09-22|||September 2003||2003-09-01|July 2004|2004-07-01|June 2004||2004-06-01|||||Interventional|||Efficacy of Single Versus Double Dose of Oral Amoxicillin for Non-Severe Pneumonia in Children|Comparison of Standard Versus Double Dose of Amoxicillin in the Treatment of Non-Severe Pneumonia in Children Aged 2-59 Months: A Multi-Centre Randomized Double Blind Controlled Trial in Pakistan|Completed||Phase 1/Phase 2|900||ARI Research Cell|||||f||||||||||||||2017-02-18 17:32:23.49572|2017-02-18 17:32:23.49572
NCT00130000|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2017-01-24|||August 9, 2005||2005-08-09|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Interventional|||Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria|SHEPHERD: Safety in Hemolytic PNH Patients Treated With Eculizumab: A Multi-Center Open-Label Research Design|Completed||Phase 3|87||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:32:23.586372|2017-02-18 17:32:23.586372
NCT00129987|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-06-03|||November 2003||2003-11-01|May 2008|2008-05-01|August 2006||2006-08-01|||||Interventional|||Trial of Lay-led Individualised Self-management Education for Adults With Asthma|A Multi-centre Randomised Trial of Lay-led Individualised Self-management Education for Adults With Asthma|Completed||N/A|640||Imperial College London|||||f||||||||||||||2017-02-18 17:32:23.68066|2017-02-18 17:32:23.68066
NCT00005394|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1995||1995-08-01|August 2004|2004-08-01|July 2000|Actual|2000-07-01|||||Observational|||Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:02.997835|2017-02-18 18:15:02.997835
NCT00129974|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2009-07-24|||August 2005||2005-08-01|October 2007|2007-10-01||||||||Interventional|||Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer|A Phase II Trial of Pemetrexed in Combination With Gemcitabine as First Line Treatment in Extensive-Stage Small Cell Lung Carcinoma|Terminated||Phase 2|46|Anticipated|Tufts Medical Center||||failure to accrue|f||||||||||||||2017-02-18 17:32:23.791557|2017-02-18 17:32:23.791557
NCT00129961|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2012-04-09|2010-01-29||August 2005||2005-08-01|April 2012|2012-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients|A Randomized, Open-Label Study to Compare the Rate of New Non-Melanoma Skin Cancer in Maintenance Renal Allograft Recipients Converted to a Sirolimus-based Regimen Versus Continuation of a Calcineurin Inhibitor-based Regimen|Completed||Phase 4|86|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|A blinded review of data in May 2007 determined there was minimal added power in follow-up through 2 years vs. 1 year. The study was then amended to require at least 1 year of follow-up instead of 2 years.|2|||f||||f||||||||||2017-02-18 17:32:24.105953|2017-02-18 17:32:24.105953
NCT00129948|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2006-11-01|||July 2005||2005-07-01|November 2006|2006-11-01|October 2007||2007-10-01|||||Interventional|||Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)|An Open-Label, Single-Arm, Multi-Center, Phase II Study of Troxatyl™ (Troxacitabine) Administered by Continuous Infusion in Patients With Acute Myeloid Leukemia (AML) in Second Salvage|Terminated||Phase 2|211||SGX Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:32:25.257522|2017-02-18 17:32:25.257522
NCT00129935|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2007-02-06|||February 2004||2004-02-01|February 2007|2007-02-01|February 2012||2012-02-01|||||Interventional|||EC (Epirubicin, Cyclophosphamide) Followed by T (Docetaxel) Versus ET (Epirubicin, Docetaxel) Followed by X (Capecitabine) as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Patients|Multicenter, Randomized Phase III Trial to Compare Epirubicin and Cyclophosphamide (EC) Followed by Docetaxel (T) to Epirubicin and Docetaxel (ET) Followed by Capecitabine (X) as Adjuvant Treatment for Operable, Node Positive Breast Cancer Patients|Completed||Phase 3|1382||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:32:25.371797|2017-02-18 17:32:25.371797
NCT00129922|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2005-09-26|||November 1999||1999-11-01|August 2005|2005-08-01|July 2007||2007-07-01|||||Interventional|||Fluorouracil, Epirubicin, and Cyclophosphamide (FEC) Versus FEC Plus Paclitaxel as Adjuvant Treatment for Node Positive Breast Cancer Patients|Multicenter Randomized Phase III Clinical Trial to Compare 6 Courses of FEC (Fluorouracil, Epirubicin and Cyclophosphamide) Vs. 4 Courses of FEC Followed by 8 Weekly Paclitaxel Administrations, as Adjuvant Treatment for Node Positive Operable Breast Cancer Patients|Completed||Phase 3|1250||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:32:25.466611|2017-02-18 17:32:25.466611
NCT00129909|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2012-06-13|||May 2005||2005-05-01|June 2012|2012-06-01|January 2007|Actual|2007-01-01|September 2006|Actual|2006-09-01||Interventional|||STITCH (Simplified Therapeutic Intervention To Control Hypertension)|Evaluation of a Primary Treatment Algorithm Using Fixed Dose Combination Therapy for the Management of Hypertension - Control and Intervention Arms|Completed||Phase 4|2081|Actual|University of Western Ontario, Canada||1|||f||||f||||||||||2017-02-18 17:32:25.572729|2017-02-18 17:32:25.572729
NCT00129896|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2009-04-27|||January 2004||2004-01-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|||||Interventional|||Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients|Open-Label Phase I-II Clinical Trial to Evaluate Treatment With Myocet/Taxotere/Herceptin as Primary Chemotherapy Treatment for HER2neu Positive Breast Cancer Patients|Completed||Phase 1/Phase 2|59|Anticipated|Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:32:25.683015|2017-02-18 17:32:25.683015
NCT00129883|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2005-09-26|||September 2002||2002-09-01|August 2002|2002-08-01|April 2005||2005-04-01|||||Interventional|||Adherence to Guidelines for Antibiotic Use in Respiratory Infections at Hospitals|Prevention of Antimicrobial Resistance in Hospitals: Promoting Appropriate Use of Antibiotics in Hospital Departments of Internal and Pulmonary Medicine|Completed||N/A|2000||Radboud University|||||f||||||||||||||2017-02-18 17:32:25.7951|2017-02-18 17:32:25.7951
NCT00129870|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2009-02-12|||February 2005||2005-02-01|February 2009|2009-02-01|December 2007|Actual|2007-12-01|||||Interventional|||CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer|CONCEPT - Phase IV, Randomized, Prospective, Multicenter Comparison of Intermittent Schedule of Oxaliplatin Combined With FOLFOX/Bevacizumab vs Conventional Mode of Administration of FOLFOX/Bevacizumab + Neuroprophylaxis With Calcium/Magnesium for Optimization of First-Line Therapy of Metastatic Colorectal Cancer|Terminated||Phase 4|180|Actual|Sanofi||||"Unplanned interim analysis by DSMB indicated possible reduced response rate with the addition~   of Ca/Mg in pooled population. Further analysis pending."|f||||t||||||||||2017-02-18 17:32:25.905762|2017-02-18 17:32:25.905762
NCT00129857|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2006-05-04|||January 2001||2001-01-01|November 2004|2004-11-01|September 2004||2004-09-01|||||Interventional|||Dexanabinol in Severe Traumatic Brain Injury|Efficacy and Safety Evaluation of a Single Intravenous Dose of Dexanabinol in Patients Suffering From Severe Traumatic Brain Injury|Completed||Phase 3|860||Pharmos|||||||||||||||||||2017-02-18 17:32:25.999649|2017-02-18 17:32:25.999649
NCT00129844|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2008-08-19|||September 2005||2005-09-01|August 2008|2008-08-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer|Randomized Phase II Trial of Single Agent Motexafin Gadolinium for Second Line Treatment of Non-Small-Cell Lung Cancer|Completed||Phase 2|108|Anticipated|Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:32:26.090816|2017-02-18 17:32:26.090816
NCT00129831|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2011-10-24|||September 2004||2004-09-01|October 2011|2011-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)|Dose Escalation Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|6|Actual|Novartis|||||||||||||||||||2017-02-18 17:32:26.211095|2017-02-18 17:32:26.211095
NCT00129818|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2012-04-26|||July 2004||2004-07-01|April 2012|2012-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding|A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding|Completed||Phase 4|||Novartis|||||||||||||||||||2017-02-18 17:32:26.301073|2017-02-18 17:32:26.301073
NCT00125892|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2007-05-16|||July 2005||2005-07-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study of Duloxetine in the Treatment of Fibromyalgia|A 1-Year Safety Study of Duloxetine in Patients With Fibromyalgia Syndrome|Completed||Phase 3|320||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:33:56.191664|2017-02-18 17:33:56.191664
NCT00129805|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2008-08-18|||January 2001||2001-01-01|August 2008|2008-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)|Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial|Completed||Phase 3|1510|Actual|Mitsubishi Tanabe Pharma Corporation||2|||f||||f||||||||||2017-02-18 17:32:26.401492|2017-02-18 17:32:26.401492
NCT00129792|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2014-10-27|||January 2005||2005-01-01|October 2014|2014-10-01|April 2014|Actual|2014-04-01|June 2007|Actual|2007-06-01||Interventional|||Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome|Expectancy, Self-Efficacy and Outcomes in Metabolic Syndrome|Completed||N/A|79|Actual|Oregon Health and Science University||3|||f||||t||||||||||2017-02-18 17:32:26.49689|2017-02-18 17:32:26.49689
NCT00129779|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-06-04|||December 2003||2003-12-01|May 2008|2008-05-01|August 2006||2006-08-01|||||Interventional|||Assessment of the Effects of an Intermediate Care Package in Preventing Hospitalisation of Patients With COPD|A Randomised Control Trial Assessing the Effects of an Intermediate Care Package in Preventing Hospitalisation of Elderly Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||N/A|122||Imperial College London|||||f||||||||||||||2017-02-18 17:32:26.718681|2017-02-18 17:32:26.718681
NCT00129766|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2013-06-21|2013-06-21||November 2004||2004-11-01|June 2013|2013-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children|A Pivotal Phase 3 Study of MEDI-524 (Numax; Motavizumab), an Enhanced Potency Humanized RSV Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children|Completed||Phase 3|6635|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 17:32:26.86335|2017-02-18 17:32:26.86335
NCT00129753|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2016-04-06|||June 2005||2005-06-01|October 2010|2010-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease|Phase II Study of Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Terminated due to slow accrual.|f||||f||||||||||2017-02-18 17:32:29.28419|2017-02-18 17:32:29.28419
NCT00129740|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2016-08-01|||June 2005||2005-06-01|August 2016|2016-08-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Oral Nilotinib|Active, not recruiting||Phase 2|150|Anticipated|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 17:32:29.51275|2017-02-18 17:32:29.51275
NCT00129727|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2016-04-24|2011-07-20||June 2005||2005-06-01|April 2016|2016-04-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)|Phase II Evaluation of Carboplatin, Paclitaxel and Bevacizumab as First Line Chemotherapy and Consolidation for Advanced Ovarian Cancer|Completed||Phase 2|62|Actual|Massachusetts General Hospital|Phase II uncontrolled trial|1|||f||||t||||||||Yes|Manuscript was published in JCO|2017-02-18 17:32:29.628191|2017-02-18 17:32:29.628191
NCT00129714|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2012-04-23|||August 2003||2003-08-01|April 2012|2012-04-01|July 2007|Actual|2007-07-01|April 2007|Actual|2007-04-01||Interventional|WEB||Westeinde Brachialgia Study|A Randomized Controlled Trial of Conservative Therapy in Cervical Radiculopathy|Completed||N/A|240||Medical Center Haaglanden||3|||f||||||||||||||2017-02-18 17:32:29.92023|2017-02-18 17:32:29.92023
NCT00129701|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-05-27|||November 2003||2003-11-01|August 2005|2005-08-01|January 2006||2006-01-01|||||Interventional|||Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation|Proposal to Study Whether we Can Reduce Hospital Attendance by Those With Respiratory Conditions Without Compromising Care by the Use of Telephone Consultation|Completed||N/A|500||Imperial College London|||||f||||||||||||||2017-02-18 17:32:30.030632|2017-02-18 17:32:30.030632
NCT00129688|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2005-09-22|||April 2002||2002-04-01|February 2005|2005-02-01|June 2004||2004-06-01|||||Interventional|||Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children|Comparison of Efficacy, Safety and Economic Outcomes Between Once-Daily Versus Twice-Daily Amikacin in Combination With Cloxacillin in Febrile Neutropenic Children|Completed||N/A|166||Khon Kaen University|||||f||||||||||||||2017-02-18 17:32:30.122965|2017-02-18 17:32:30.122965
NCT00129675|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2014-07-14||2014-07-14|February 2003||2003-02-01|July 2014|2014-07-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty|Development of a Imaging Marker for Parkinson's Disease Through Use of Dynamic SPECT Imaging With [123I] Beta-CIT in Individuals With Parkinson's Symptoms|Completed||Phase 2|169|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 17:32:30.395118|2017-02-18 17:32:30.395118
NCT00129662|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2010-05-25|||January 2005||2005-01-01|May 2010|2010-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Comprehension and Evaluation of a Pictorial Action Plan for Those With Asthma or COPD|Comprehension and Evaluation of a Pictorial Action Plan for Those With Asthma or Chronic Obstructive Pulmonary Disease|Completed||N/A|80|Anticipated|Imperial College London||1|||f||||||||||||||2017-02-18 17:32:30.499705|2017-02-18 17:32:30.499705
NCT00129649|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-10-21|||May 2005||2005-05-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||Service Development: Assessing Non-attendance Rates in Outpatient Clinics|Service Development: Assessing Non-attendance Rates in Outpatient Clinics|Completed||N/A|500||Imperial College London|||||f||||||||||||||2017-02-18 17:32:30.592015|2017-02-18 17:32:30.592015
NCT00129636|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-10-21|||March 2004||2004-03-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||The Usefulness of Patients Receiving Their Own Letter After an Outpatient Attendance|A Study to Determine the Usefulness of Patients Receiving Their Own Letter After an Outpatient Attendance Compared to Receiving a Copy of the Letter Being Sent to Their General Practitioner|Completed||N/A|150||Imperial College London|||||f||||||||||||||2017-02-18 17:32:30.683208|2017-02-18 17:32:30.683208
NCT00129623|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2015-12-05|2015-12-05||December 2005||2005-12-01|December 2015|2015-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional||Baseline characteristics are presented for the safety population which included participants who had at least one dose of the trial medication documented in the case report form (CRF) whether withdrawn prematurely or not.|A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia|Double-blind, Placebo-controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of Oral Ibandronate Once Monthly in Postmenopausal Women With Osteopenia|Completed||Phase 4|160|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:32:30.78707|2017-02-18 17:32:30.78707
NCT00129610|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2007-04-26|||January 2004||2004-01-01|April 2007|2007-04-01||||||||Interventional|||Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia|A Comparative Controlled Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia|Unknown status|Active, not recruiting|N/A|90||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:32:31.390292|2017-02-18 17:32:31.390292
NCT00129597|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2007-03-09|||December 2004||2004-12-01|March 2007|2007-03-01||||||||Interventional|||Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy|Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy|Unknown status|Active, not recruiting|Phase 4|40||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:32:31.506242|2017-02-18 17:32:31.506242
NCT00129584|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2009-08-14|||January 2004||2004-01-01|August 2009|2009-08-01||||||||Interventional|||Endobronchial Valve for Emphysema Palliation Trial (VENT)|Endobronchial Valve for Emphysema Palliation Trial (VENT)|Completed||Phase 3|270||Emphasys Medical|||||||||||||||||||2017-02-18 17:32:31.603278|2017-02-18 17:32:31.603278
NCT00129571|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2008-06-02|||August 2005||2005-08-01|June 2008|2008-06-01||||||||Interventional|||Study of XL820 in Adults With Solid Tumors|A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of XL820 Administered Orally to Subjects With Solid Tumors|Completed||Phase 1|||Exelixis|||||||||||||||||||2017-02-18 17:32:31.698157|2017-02-18 17:32:31.698157
NCT00129558|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2013-12-02|||July 2005||2005-07-01|December 2013|2013-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Evaluate PT-523 in Patients With Refractory Leukemia|A Phase I/II Study of PT-523 in Patients With Refractory Leukemia|Withdrawn||Phase 1/Phase 2|0|Actual|Spectrum Pharmaceuticals, Inc|||||f||||||||||||||2017-02-18 17:32:31.780207|2017-02-18 17:32:31.780207
NCT00129545|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2015-04-29|2014-10-03||February 2005||2005-02-01|April 2015|2015-04-01|May 2014|Actual|2014-05-01|August 2013|Actual|2013-08-01||Interventional||2:1 randomazation, outcome analysis excludes the 93 subjects in the Roll-in arm|WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation|WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation (PROTECT AF)|Completed||Phase 2/Phase 3|800|Actual|Boston Scientific Corporation||3|||f||||t||||||||||2017-02-18 17:32:31.872286|2017-02-18 17:32:31.872286
NCT00129532|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2005-09-07|||January 2004||2004-01-01|August 2005|2005-08-01||||||||Interventional|||Trial of SAVVY and HIV in Ghana|Randomized Controlled Trial of SAVVY and HIV in Ghana|Unknown status|Active, not recruiting|Phase 3|2142||Biosyn|||||||||||||||||||2017-02-18 17:32:32.690894|2017-02-18 17:32:32.690894
NCT00129519|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-11|2010-07-14|||January 2004||2004-01-01|July 2010|2010-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence|Open-label Study to Evaluate the Use of Imiquimod 5% Cream for Reducing Postsurgical Recurrence or Persistence of Basal Cell Carcinoma Following Excision by Curettage|Completed||Phase 3|63|Actual|Graceway Pharmaceuticals, LLC||1|||f||||f||||||||||2017-02-18 17:32:32.776653|2017-02-18 17:32:32.776653
NCT00129506|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2007-04-18|||May 2005||2005-05-01|April 2007|2007-04-01|October 2005||2005-10-01|||||Interventional|||Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion|Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion|Completed||Phase 4|300||Wiebe, Ellen, M.D.|||||f||||||||||||||2017-02-18 17:32:32.88611|2017-02-18 17:32:32.88611
NCT00129493|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2015-04-06|||February 2004||2004-02-01|May 2009|2009-05-01|August 2007|Actual|2007-08-01|March 2006|Actual|2006-03-01||Interventional|||Group Visits to Improve Hypertension Management|Group Visits to Improve Hypertension Management|Completed||N/A|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:32:32.97751|2017-02-18 17:32:32.97751
NCT00129480|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2015-04-06|2014-06-10||January 2006||2006-01-01|May 2014|2014-05-01|July 2010|Actual|2010-07-01|January 2009|Actual|2009-01-01||Interventional|SEACAP|Veterans receiving healthcare in VA primary care|Improving Chronic Pain Treatment in Primary Care|Improving the Treatment of Chronic Pain in Primary Care|Completed||N/A|401|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:32:33.18571|2017-02-18 17:32:33.18571
NCT00129467|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2015-04-06|2013-10-16||February 2005||2005-02-01|August 2013|2013-08-01|December 2010|Actual|2010-12-01|September 2009|Actual|2009-09-01||Interventional||The number of baseline participants is the number of subjects who received the intervention|Methylphenidate for Depressed Cancer Patients Receiving Palliative Care|Methylphenidate for Depressed Cancer Patients in Hospice|Completed||N/A|47|Actual|VA Office of Research and Development|Frequency threshold for reporting nonserious adverse events was not determined at the start of the study, but a % was required to be entered in order to complete the adverse event module|2|||f||||t||||||||||2017-02-18 17:32:33.574729|2017-02-18 17:32:33.574729
NCT00129454|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2016-11-14|||September 2005||2005-09-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|February 2008|Actual|2008-02-01||Interventional|||Telemedicine Treatment for Veterans With Gulf War Illness|Telemedicine Treatment for Veterans With Gulf War Illness|Completed||N/A|128|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 17:32:34.447305|2017-02-18 17:32:34.447305
NCT00129441|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2011-10-14|2011-05-25||August 2005||2005-08-01|October 2011|2011-10-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study|Treatment of Cognitive Disability in Schizophrenia With a GABA-A Alpha2/3 Receptor Agonist|Completed||Phase 2|16|Actual|University of Pittsburgh|Small sample size; RBANS may lack appropriate sensitivity for short-term study; between-group differences in baseline clinical symptoms & neuropsychological function; excluding those with more modest cognitive impairments (RBANS standard score >90).|2|||f||||f||||||||||2017-02-18 17:32:34.553533|2017-02-18 17:32:34.553533
NCT00129428|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2015-04-30|||August 2002||2002-08-01|April 2015|2015-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix|The Effectiveness of UVB Irradiation in the Treatment of Skin Conditions With Altered Dermal Matrix: An Open Pilot Study|Completed||Phase 1/Phase 2|33|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 17:32:35.237987|2017-02-18 17:32:35.237987
NCT00129415|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2015-05-21|||August 2000||2000-08-01|May 2015|2015-05-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions|The Effectiveness of UVA1 and UVB Irradiation in the Treatment of Inflammatory Dermatoses: An Open Pilot Study|Terminated||Phase 1/Phase 2|28|Actual|University of Michigan||2||Slow enrollment|f||||f||||||||||2017-02-18 17:32:35.348294|2017-02-18 17:32:35.348294
NCT00005369|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1992||1992-09-01|April 2002|2002-04-01|August 1996|Actual|1996-08-01|||||Observational|||Coronary Artery Disease Mechanisms in High Risk Families--Racial Difference||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.190782|2017-02-18 18:15:05.190782
NCT00129402|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2015-09-02|2010-01-14||August 2005||2005-08-01|September 2015|2015-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)|Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia|Completed||Phase 3|248|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:32:35.464445|2017-02-18 17:32:35.464445
NCT00129389|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2012-11-21|||September 2003||2003-09-01|November 2012|2012-11-01|December 2013|Anticipated|2013-12-01|December 2013|Anticipated|2013-12-01||Interventional|||FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients|Multicenter Randomized Phase III Clinical Trial to Compare 6 FAC Cycles(Fluorouracil, Doxorubicin, Cyclophosphamide) vs. 4 FAC Cycles Followed by 8 Weekly Paclitaxel Administrations, as Adjuvant Treatment for Node Negative Operable Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 3|1929|Actual|Spanish Breast Cancer Research Group||2|||f||||f||||||||||2017-02-18 17:32:38.960094|2017-02-18 17:32:38.960094
NCT00129376|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2005-09-07|||December 2002||2002-12-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Interventional|||Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients|Multicenter Phase II Trial of Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel (T) as Neoadjuvant Treatment for Operable Stage II and IIIA Breast Cancer Patients|Completed||Phase 2|63||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:32:39.065716|2017-02-18 17:32:39.065716
NCT00129363|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2008-12-24|||January 2002||2002-01-01|December 2008|2008-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study to Evaluate the Safety of Twice Daily Oral Carvedilol|A Multicenter, Open Label Extension Study to Evaluate the Safety of Twice Daily Oral Carvedilol in Pediatric Patients With Chronic Heart Failure|Completed||Phase 3|75|Actual|Shaddy, Robert, M.D.||1|||f||||||||||||||2017-02-18 17:32:39.154223|2017-02-18 17:32:39.154223
NCT00129350|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2005-09-06|||September 2004||2004-09-01|August 2005|2005-08-01|February 2008||2008-02-01|||||Interventional|||Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation|An Assessment of Patient Outcomes Following a Rehabilitation Programme for Patients Who Have Received Lung or Heart-Lung Transplant - a Randomised Controlled Trial|Unknown status|Recruiting|Phase 1|60||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:32:39.268714|2017-02-18 17:32:39.268714
NCT00129337|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2011-02-28|||June 2005||2005-06-01|February 2011|2011-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies|A Multicenter, Open-Label Safety and Pharmacokinetics Study of Chimeric Anti-Phosphatidylserine Monoclonal Antibody (Bavituximab) in Patients With Refractory Advanced Solid Tumor Malignancies|Completed||Phase 1|28|Anticipated|Peregrine Pharmaceuticals||4|||t||||f||||||||||2017-02-18 17:32:39.356432|2017-02-18 17:32:39.356432
NCT00129324|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2016-10-18|||March 2003||2003-03-01|October 2016|2016-10-01|August 2021|Anticipated|2021-08-01|August 2021|Anticipated|2021-08-01||Interventional|||HOME Study (Health Outcomes and Measures of the Environment Study)|Neurobehavioral Effects of Prevalent Neurotoxicants in Children: A Cohort Study of the Cincinnati Center for Children's Environmental Health|Enrolling by invitation||N/A|468|Actual|National Institute of Environmental Health Sciences (NIEHS)||2|||f||||f||||||||||2017-02-18 17:32:39.724328|2017-02-18 17:32:39.724328
NCT00129311|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2015-03-11|2014-06-16||July 2004||2004-07-01|July 2014|2014-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Usefulness of Selegiline as an Aid to Quit Smoking - 1|Usefulness of Selegiline for Smoking Cessation|Completed||Phase 2|101|Actual|Yale University||2|||f||||t||||||||||2017-02-18 17:32:39.864366|2017-02-18 17:32:39.864366
NCT00129298|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2017-01-11|||December 2004||2004-12-01|December 2007|2007-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1|Tiagabine for the Treatment of Cocaine Dependence in Methadone-Maintained Individuals|Completed||Phase 2|80|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 17:32:40.277979|2017-02-18 17:32:40.277979
NCT00129285|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2015-10-07|||July 2004||2004-07-01|June 2012|2012-06-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Modafinil Treatment for Cocaine-Dependent Individuals|A Double-Blind, Placebo-Controlled Study of Modafinil for Cocaine Dependence|Completed||Phase 2|210|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-02-18 17:32:40.382161|2017-02-18 17:32:40.382161
NCT00129272|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2009-09-02|||May 2004||2004-05-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|July 2010|Anticipated|2010-07-01||Interventional|||Effectiveness of Bupropion for Treating Nicotine Dependence in Young People|Stress Response and Smoking Cessation in Depressed Youth|Unknown status|Recruiting|Phase 2|150|Anticipated|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 17:32:40.49943|2017-02-18 17:32:40.49943
NCT00129259|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2014-06-04|2013-06-21||September 2005||2005-09-01|June 2014|2014-06-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|AbATE|Intent-to-treat|Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes|Phase II Multiple-Dose Treatment of New Onset Type 1 Diabetes Mellitus With Anti-CD3 mAb|Completed||Phase 2|83|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:32:40.61479|2017-02-18 17:32:40.61479
NCT00129246|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2013-01-02|2013-01-02||December 2004||2004-12-01|January 2013|2013-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain|Naltrexone & Bupropion to Stop Smoking With Less Weight Gain|Completed||Phase 1/Phase 2|40|Actual|Yale University||2|||f||||||||||||||2017-02-18 17:32:41.283559|2017-02-18 17:32:41.283559
NCT00129233|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2013-04-29|||October 2004||2004-10-01|April 2013|2013-04-01|April 2013|Actual|2013-04-01|July 2010|Actual|2010-07-01||Interventional|||Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance|The Novel Antihypertensive Goal Of hYpertension With diAbetes ― Hypertensive Events and ARb Treatment (NAGOYA-HEART) Study|Completed||Phase 4|1150|Actual|Nagoya University||2|||f||||t||||||||||2017-02-18 17:32:41.641074|2017-02-18 17:32:41.641074
NCT00129220|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2010-12-10|2010-01-21||July 2005||2005-07-01|December 2010|2010-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder|Placebo- and Haloperidol-Controlled Double-Blind Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder|Completed||Phase 3|224|Actual|Eli Lilly and Company|Identified errors were corrected.|3|||f||||||||||||||2017-02-18 17:32:41.755114|2017-02-18 17:32:41.755114
NCT00005368|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||July 1993||1993-07-01|January 2005|2005-01-01|August 2003||2003-08-01|||||Observational|||Genetic Epidemiology of Hypertriglyceridemia||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:05.258868|2017-02-18 18:15:05.258868
NCT00129207|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2008-02-07||||||February 2008|2008-02-01||||September 2006|Actual|2006-09-01||Interventional|||Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade|Effect of Ketoconazole Administration on the Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Advanced Solid Tumors|Completed||Phase 1|||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 17:32:43.377885|2017-02-18 17:32:43.377885
NCT00129194|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2007-12-30|||August 2005||2005-08-01|December 2007|2007-12-01||||June 2007|Actual|2007-06-01||Interventional|||Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens|A Double-Blind, Placebo-Controlled, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of KP-1461 in HIV+ Adults Who Have Failed Two or More Highly Active Antiretroviral Regimens (HAART)|Completed||Phase 1|40|Anticipated|Koronis Pharmaceuticals.|||||f||||||||||||||2017-02-18 17:32:43.448365|2017-02-18 17:32:43.448365
NCT00129181|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2009-08-27|||January 2005||2005-01-01|August 2009|2009-08-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease|A Single-blinded Assessment of the Short-term Effects of Cabergoline vs. Carbidopa/Levodopa on SPECT Dopamine Transporter Density in Out-patient Subjects With Parkinson's Disease|Completed||N/A|30|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 17:32:43.540272|2017-02-18 17:32:43.540272
NCT00129168|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2008-03-28|||August 2005||2005-08-01|March 2008|2008-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)|An Open-Label, Phase I/II, Multicenter Dose Escalation Study of Zosuquidar, Daunorubicin, and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|100|Anticipated|Kanisa Pharmaceuticals|||||||||||||||||||2017-02-18 17:32:43.650718|2017-02-18 17:32:43.650718
NCT00129155|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2007-10-03|||February 2005||2005-02-01|October 2007|2007-10-01||||||||Interventional|||MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies|Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies|Unknown status|Recruiting|Phase 2|30|Anticipated|Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:32:43.739926|2017-02-18 17:32:43.739926
NCT00129142|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2013-11-13|||October 2003||2003-10-01|November 2013|2013-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy|A Randomized, Double Blind, Placebo Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy|Completed||Phase 3|1200||GTx|||||f||||||||||||||2017-02-18 17:32:43.832397|2017-02-18 17:32:43.832397
NCT00129129|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2016-09-22|2012-06-15||August 2004||2004-08-01|September 2016|2016-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine|Evaluate Immuno and Safety of GSKBiologicals' HibMenCYTT vs Licensed Hib Conjugate Vaccine, Each Coadministered With Pediarix® and Prevnar®, in Healthy Infants. An Exploratory Control Group Will Receive Licensed Menomune® at 3 to 5 Years|Completed||Phase 2|756|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:32:44.378843|2017-02-18 17:32:44.378843
NCT00129116|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2016-10-21|2012-06-15||March 2003||2003-03-01|October 2016|2016-10-01|October 2004|Actual|2004-10-01|December 2003|Actual|2003-12-01||Interventional|||3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age|A Phase II, Open (Partially Double-blind), Randomised, Controlled, Multicentre, Primary Vaccination Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Three Different Formulations of GSK Biologicals' Combined Haemophilus Influenzae Type B-meningococcal Serogroups C and Y- Conjugate Vaccine and One Formulation of GSK Biologicals' Haemophilus Influenzae Type B-meningococcal Serogroup C Conjugate Vaccine Each Given Concomitantly With InfanrixTM Penta, Versus MeningitecTM, Given Concomitantly With InfanrixTM Hexa in Infants According to a 2-3-4 Month Schedule|Completed||Phase 2|388|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:32:47.833012|2017-02-18 17:32:47.833012
NCT00129090|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2015-09-08|||March 2003||2003-03-01|September 2015|2015-09-01|October 2017|Anticipated|2017-10-01|October 2014|Actual|2014-10-01||Interventional|||Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma|A Randomized Phase III Study to Compare Conventional Chemotherapy (CHOEP-14) + Rituximab vs High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation (Mega-CHOEP-21) + Rituximab in Younger Patients With Aggressive NHL|Active, not recruiting||Phase 3|450|Actual|German High-Grade Non-Hodgkin's Lymphoma Study Group||1|||f||||t||||||||||2017-02-18 17:32:50.999899|2017-02-18 17:32:50.999899
NCT00129077|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2007-07-09|||March 2004||2004-03-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?|Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?|Completed||N/A|207|Actual|Ann & Robert H Lurie Children's Hospital of Chicago||2|||f||||t||||||||||2017-02-18 17:32:51.102754|2017-02-18 17:32:51.102754
NCT00129064|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2007-04-23|||November 2005||2005-11-01|April 2007|2007-04-01|March 2007||2007-03-01|||||Interventional|||Improving the Outpatient Referral Process With Electronic Communications|Improving the Outpatient Referral Process With Electronic Communications|Completed||N/A|200||Brigham and Women's Hospital|||||f||||t||||||||||2017-02-18 17:32:51.206451|2017-02-18 17:32:51.206451
NCT00129051|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2010-02-08|||August 2001||2001-08-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases|Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases|Completed||Phase 1|20||AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:32:51.295256|2017-02-18 17:32:51.295256
NCT00127686|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2007-11-30|||September 2005||2005-09-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep|Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents|Completed||Phase 1|105|Actual|Penn State University||3|||f||||||||||||||2017-02-18 17:33:24.161554|2017-02-18 17:33:24.161554
NCT00129038|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-10|2013-10-28|||April 2004||2004-04-01|October 2013|2013-10-01||||January 2007|Actual|2007-01-01||Interventional|||Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients|A Randomised, Crossover Study Comparing the Biochemical and Platelet Effects of Modified-release Dipyridamole/Aspirin (200mg/25 mg bd; Asasantin Retard®) With Aspirin (75 mg qd) in Coronary Artery Disease Patients With Aspirin Resistance Manifesting as Persistent Thromboxane Formation.|Completed||Phase 4|11|Actual|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:32:51.385792|2017-02-18 17:32:51.385792
NCT00129025|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2011-10-06|||October 2004||2004-10-01|October 2011|2011-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer|A Phase I/II Study of Escalated-Dose Short-Course Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer|Completed||Phase 1/Phase 2|35|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 17:32:51.474676|2017-02-18 17:32:51.474676
NCT00129012|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2016-02-24|||April 2005||2005-04-01|March 2012|2012-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer|Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer: A Feasibility Study|Completed||Phase 1|30|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 17:32:51.563328|2017-02-18 17:32:51.563328
NCT00128999|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2010-02-08|||September 2003||2003-09-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer|A Phase I/II Dose Escalation Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|5||AHS Cancer Control Alberta|||||f||||t||||||||||2017-02-18 17:32:51.655845|2017-02-18 17:32:51.655845
NCT00128986|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2016-04-05|||May 2005||2005-05-01|March 2016|2016-03-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||Study of Tomotherapy in Patients With Benign Brain Tumour|A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour|Completed||Phase 1|49|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 17:32:51.746216|2017-02-18 17:32:51.746216
NCT00128973|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2017-01-25|||August 3, 2005||2005-08-03|January 24, 2017|2017-01-24||||||||Observational|||Evaluation of Patients With Immune Function Abnormalities|Screening and Baseline Assessment of Patients With Abnormalities of Immune Function|Recruiting||N/A|2400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:32:51.837826|2017-02-18 17:32:51.837826
NCT00128960|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2017-01-24|||August 5, 2005||2005-08-05|December 7, 2016|2016-12-07||||||||Observational|||Quality of Life in Patients Who Have Undergone Stem Cell Transplant|Prospective Assessment of Functional Status, Psychosocial Adjustment, Health Related Quality of Life and the Symptom Experience in Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation|Completed||N/A|173|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:32:51.942975|2017-02-18 17:32:51.942975
NCT00128947|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2008-03-03|||July 2005||2005-07-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers|Pharmacokinetics of Mycophenolic Acid and Mycophenolate 7-O-Phenolic Glucuronide in Healthy Subjects With or Without Two Common Genetic Polymorphisms in the Promoter Region of Uridine Diphosphate Glucuronosyltransferase 1A9|Completed||Phase 1|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:32:52.036485|2017-02-18 17:32:52.036485
NCT00128934|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2007-12-18|||August 2005||2005-08-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder|Completed||Phase 3|744|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:32:52.120874|2017-02-18 17:32:52.120874
NCT00128921|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-04-25|2011-04-15||April 2006||2006-04-01|April 2012|2012-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma|A Phase II Dose-Response Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma|Terminated||Phase 2|18|Actual|University of Arkansas|Early termination due to difficulty in accruing participants.|3||study terminated due to low accrual|f||||t||||||||||2017-02-18 17:32:52.285693|2017-02-18 17:32:52.285693
NCT00128908|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2009-09-14|||September 2005||2005-09-01|September 2009|2009-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients|Sequential HAART in Treatment Resistant HIV-1 Infected Patients|Terminated||Phase 4|3|Actual|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||2||Did not recruit|f||||f||||||||||2017-02-18 17:32:52.781978|2017-02-18 17:32:52.781978
NCT00128895|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2014-12-31|||June 2003||2003-06-01|December 2014|2014-12-01|December 2014|Anticipated|2014-12-01|June 2014|Actual|2014-06-01||Interventional|||Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis|Prevention of Relapses in PR3-ANCA-associated Vasculitis, a Tailored Approach|Unknown status|Active, not recruiting|Phase 4|180|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-02-18 17:32:52.884629|2017-02-18 17:32:52.884629
NCT00128882|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2009-02-02|||November 2004||2004-11-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|January 2008|Actual|2008-01-01||Interventional|||Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D|Treatment of Idiopathic Thrombocytopenic Purpura in Children With Subcutaneously Administered Anti-D|Completed||Phase 2|45|Actual|University of Aarhus||1|||f||||t||||||||||2017-02-18 17:32:52.995923|2017-02-18 17:32:52.995923
NCT00128869|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2008-05-08|||May 2005||2005-05-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of the Effectiveness of Mobilization and Manipulation of the Thoracic Spine in Patients With Mechanical Neck Pain|Comparison of the Effectiveness of Mobilization and Manipulation of the Thoracic Spine in Patients With Mechanical Neck Pain: A Randomized Clinical Trial|Completed||Phase 1|96|Anticipated|Newton-Wellesley Hospital|||||f||||||||||||||2017-02-18 17:32:53.117241|2017-02-18 17:32:53.117241
NCT00125476|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2006-10-10|||July 2004||2004-07-01|October 2006|2006-10-01||||||||Interventional|||Effects of Exercise Training on Diastolic Heart Function in Postmenopausal Women|Training and Diastolic Function in Postmenopausal Women|Completed||N/A|215||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:34:01.617567|2017-02-18 17:34:01.617567
NCT00128856|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2005-08-29|||December 2002||2002-12-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients|Phase II Pharmacogenomic and Clinical Trial for the Administration of Gemcitabine-Doxorubicin-Paclitaxel (GAT) as Neoadjuvant Treatment of Patients With Stage III Breast Cancer|Completed||Phase 2|43||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:32:53.384821|2017-02-18 17:32:53.384821
NCT00128843|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2008-09-23|||August 2001||2001-08-01|September 2008|2008-09-01|July 2005||2005-07-01|||||Interventional|||Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients|Phase II Randomized, Multicenter, Crossover Clinical Trial for Administration of Exemestane vs. Anastrozole as First Line Treatment for Postmenopausal Patients With Hormone Receptor Positive Advanced Breast Cancer|Completed||Phase 2|100||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:32:53.479885|2017-02-18 17:32:53.479885
NCT00128830|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2013-06-10|2013-02-27||June 2005||2005-06-01|June 2013|2013-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study|An Open-Label Trial With TMC125 in HIV-1 Infected Subjects, Who Were Randomized to a TMC125 Treatment Arm in a Sponsor-Selected TMC125 Trial and Were Treated for at Least 48 Weeks|Completed||Phase 2|211|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||f||||||||||2017-02-18 17:32:53.582863|2017-02-18 17:32:53.582863
NCT00128817|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2013-01-21|||May 2005||2005-05-01|January 2013|2013-01-01|May 2015|Anticipated|2015-05-01|May 2015|Anticipated|2015-05-01||Interventional|||Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers|Phase III Randomized Clinical Trial to Compare Results of Concurrent Chemo-radiation With Surgery and Postoperative Radiotherapy/Chemoradiotherapy in Advanced Laryngeal and Hypopharyngeal Cancers|Terminated||Phase 3|900|Anticipated|Tata Memorial Hospital||2||Slow Accrual|f||||t||||||||||2017-02-18 17:32:54.262429|2017-02-18 17:32:54.262429
NCT00128804|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2005-08-26|||July 2004||2004-07-01|August 2005|2005-08-01|October 2004||2004-10-01|||||Interventional|||The STOVITA Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Ileostomy Patients|Bioefficacy and Bioavailability of Beta-Carotene in Oil and in a Mixed Diet in Ileostomy Patients Measuring Using Specifically 13C-Labelled Beta-Carotene and Retinol|Completed||N/A|18||Radboud University|||||f||||||||||||||2017-02-18 17:32:54.377881|2017-02-18 17:32:54.377881
NCT00128791|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2007-05-24|||January 2003||2003-01-01|May 2007|2007-05-01|April 2005||2005-04-01|||||Interventional|||Nitroprusside for Prevention of no-Reflow in Primary Angioplasty|Intracoronary Nitroprusside for the Prevention of the No-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. A Randomized, Double Blind, Placebo-Controlled Clinical Trial|Terminated||Phase 4|100||Soroka University Medical Center|||||f||||||||||||||2017-02-18 17:32:54.464852|2017-02-18 17:32:54.464852
NCT00128778|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2007-09-04|||October 2002||2002-10-01|September 2007|2007-09-01|December 2006||2006-12-01|||||Interventional|||Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients|Phase IV.III Clinical Trial to Evaluate Maintenance Treatment With Caelyx vs. Observation After Administration of Induction Chemotherapy in Metastatic Breast Cancer Patients|Completed||Phase 4|154|Anticipated|Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:32:54.564952|2017-02-18 17:32:54.564952
NCT00128765|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2011-11-21|||January 2005||2005-01-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice|Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease (COPD) in General Practice. A Randomized Controlled Trial Comparing Regular Practice Nurse Review, Self-management Education and Usual Care|Completed||N/A|165|Actual|Radboud University||3|||f||||t||||||||||2017-02-18 17:32:54.660914|2017-02-18 17:32:54.660914
NCT00128752|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2005-08-26|||March 2003||2003-03-01|August 2005|2005-08-01|October 2003||2003-10-01|||||Interventional|||The CARO Study - Bioefficacy of Beta-Carotene in Oil and in a Mixed Diet in Healthy Subjects|Bioefficacy and Bioavailability of Beta-Carotene in Oil and in a Mixed Diet in Healthy Subjects Measured Using Specifically 13C-Labelled Beta-Carotene and Retinol|Completed||N/A|24||Radboud University|||||f||||||||||||||2017-02-18 17:32:54.789637|2017-02-18 17:32:54.789637
NCT00128739|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2005-08-26|||January 2001||2001-01-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation|A Phase 3 Study to Evaluate the Place of Budesonide in the Treatment of GVHD|Completed||Phase 3|24||Rafa Laboratories|||||f||||||||||||||2017-02-18 17:32:54.88428|2017-02-18 17:32:54.88428
NCT00128726|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-12-20|||June 2001||2001-06-01|December 2012|2012-12-01|August 2006|Actual|2006-08-01|||||Observational|||The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function|The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function|Completed||Phase 1|62|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||Samples With DNA|"~     whole blood, urines, tissue~   "|||2017-02-18 17:32:54.9737|2017-02-18 17:32:54.9737
NCT00128713|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2015-10-05|2009-01-30||July 2004||2004-07-01|August 2013|2013-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|PLADO||Optimal Platelet Dose Strategy for Management of Thrombocytopenia|Determination of the Optimal Prophylactic Platelet Dose Strategy to Prevent Bleeding in Thrombocytopenic Patients (A TMH CTN Study)|Completed||Phase 3|1351|Actual|New England Research Institutes||3|||f||||t||||||||||2017-02-18 17:32:55.070082|2017-02-18 17:32:55.070082
NCT00128700|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-09-20|||June 2005||2005-06-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I/II Study on Concomitant and Adjuvant Temozolomide and Radiotherapy With or Without PTK787/ZK222584 in Newly Diagnosed GBM|Completed||Phase 1/Phase 2|20|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:32:56.46588|2017-02-18 17:32:56.46588
NCT00128687|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2014-02-07|||April 2003||2003-04-01|February 2014|2014-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Improving Coronary Prevention in a County Health System|Improving Coronary Prevention in a County Health System|Completed||N/A|419|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 17:32:56.703804|2017-02-18 17:32:56.703804
NCT00128661|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-05-24|2011-12-15||June 2004||2004-06-01|May 2012|2012-05-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants|A Double-Blind, Controlled, Randomized, Phase III Study of the Efficacy of an HPV16/18 VLP Vaccine in the Prevention of Advanced Cervical Intraepithelial Neoplasia (CIN2, CIN3, Adenocarcinoma In Situ [AIS] and Invasive Cervical Cancer) Associated With HPV 16 or HPV 18 Cervical Infection in Healthy Young Adult Women in Costa Rica.|Completed||Phase 3|7466|Actual|GlaxoSmithKline|"The following analysis occurence of histopathologically confirmed CIN2+ cases associated with HPV16 or HPV18 infection was not performed, in accordance with the Statistical Analysis Plan submitted to the FDA."|2|||f||||||||||||||2017-02-18 17:32:56.824174|2017-02-18 17:32:56.824174
NCT00128635|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2016-02-17|||October 2005||2005-10-01|May 2007|2007-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme|An Open-Label, Dose Confirmation and Dosimetry Study of Interstitial 131 I-chTNT-1/B MAb (COTARA(TM)) For the Treatment of Glioblastoma Multiforme (GBM) at 1st or 2nd Relapse|Completed||Phase 1|22|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||||||||||||2017-02-18 17:33:01.23313|2017-02-18 17:33:01.23313
NCT00128622|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-11-08|||September 2005||2005-09-01|November 2012|2012-11-01|May 2009|Actual|2009-05-01|March 2007|Actual|2007-03-01||Interventional|||Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer|A Phase I Study of Regulatory T Cell Depletion With Denileukin Diftitox Followed by Active Immunotherapy With Autologous Dendritic Cells Infected With CEA-6D Expressing Fowlpox-Tricom in Patients With Advanced or Metastatic Malignancies Expressing CEA|Completed||Phase 1|24|Actual|Duke University||1|||f||||||||||||||2017-02-18 17:33:01.546535|2017-02-18 17:33:01.546535
NCT00128596|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2009-08-18|||June 2004||2004-06-01|January 2006|2006-01-01||||December 2005|Actual|2005-12-01||Interventional|||Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery|A Phase II Study of Trisenox (Arsenic Trioxide) in the Treatment of Unresectable Liver Cancer|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:33:01.675749|2017-02-18 17:33:01.675749
NCT00128583|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2013-12-18|||July 2005||2005-07-01|September 2005|2005-09-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Malignant Melanoma|Response of In-Transit Melanoma to Systemic Treatment With the Specific Active Immunotherapeutic Agent, Canvaxin™|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:33:01.774362|2017-02-18 17:33:01.774362
NCT00128570|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2013-09-16|||April 2006||2006-04-01|June 2009|2009-06-01|March 2011|Actual|2011-03-01|February 2010|Actual|2010-02-01||Interventional|||An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physical Activity and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index|Cancer Prevention Mastery Model Internet Intervention|Completed||N/A|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:33:01.886104|2017-02-18 17:33:01.886104
NCT00128557|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2007-04-09|||January 2004||2004-01-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh|A Randomized Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh|Terminated||Phase 3|25000||Johns Hopkins Bloomberg School of Public Health||||Study terminated based on DSMB recommendation in December 2006|f||||t||||||||||2017-02-18 17:33:01.982184|2017-02-18 17:33:01.982184
NCT00128544|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2015-05-08|||May 2005||2005-05-01|May 2015|2015-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B|A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) Versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients With Chronic Hepatitis B|Completed||Phase 2|130||Novartis|||||||||||||||||||2017-02-18 17:33:02.091832|2017-02-18 17:33:02.091832
NCT00128531|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2007-11-12|||September 2005||2005-09-01|November 2007|2007-11-01|November 2007|Actual|2007-11-01|||||Interventional|||Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer|Efficacy and Safety of a New Leuprolide Acetate 3.75 mg Depot Formulation, GP-Pharm S.A., When Given as Palliative Treatment to Prostate Cancer Patients|Completed||Phase 3|120||GP-Pharm|||||f||||||||||||||2017-02-18 17:33:02.446855|2017-02-18 17:33:02.446855
NCT00128518|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2011-12-29|||October 2004||2004-10-01|December 2011|2011-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs|IDEAL Study : Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs|Completed||Phase 4|139|Actual|Hospices Civils de Lyon||4|||f||||||||||||||2017-02-18 17:33:02.575112|2017-02-18 17:33:02.575112
NCT00128505|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-02-14|||August 2005||2005-08-01|February 2012|2012-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression|An International, Open-Label Extension Study of the Safety and Tolerability of CORLUX™ (Mifepristone) for Recurrent Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features|Completed||Phase 3|104|Actual|Corcept Therapeutics||1|||f||||f||||||||||2017-02-18 17:33:02.680589|2017-02-18 17:33:02.680589
NCT00128492|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2011-05-17|2010-06-03||August 2005||2005-08-01|May 2011|2011-05-01|January 2009|Actual|2009-01-01|November 2008|Actual|2008-11-01||Interventional|AIR-CF3||Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)|A Phase 3, Open-label, Follow-On Study of Multiple Courses of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients (AIR-CF3)|Completed||Phase 3|274|Actual|Gilead Sciences|Descriptive statistics for all participants receiving 1 or more doses of AZLI were summarized for the safety, microbiology, and efficacy endpoints. No formal hypothesis tests were planned. Rates of AEs and SAEs are not adjusted for time on study.||||f||||t||||||||||2017-02-18 17:33:02.8274|2017-02-18 17:33:02.8274
NCT00128479|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-02-14|||September 2004||2004-09-01|February 2012|2012-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Three Dose Levels of CORLUX™ (Mifepristone) Plus an Antidepressant vs. Placebo Plus an Antidepressant in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features (PMD)|Completed||Phase 3|443|Actual|Corcept Therapeutics||4|||f||||f||||||||||2017-02-18 17:33:04.847661|2017-02-18 17:33:04.847661
NCT00128466|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2009-02-24|||August 2004||2004-08-01|February 2009|2009-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Treatment and Diagnosis of Plague|Safety and Efficacy of Gentamicin Versus Streptomycin for the Treatment of Naturally Occurring Human Plague and Evaluation of Rapid Diagnostic Test Kits for Yersinia Pestis|Completed||Phase 2/Phase 3|114|Actual|Centers for Disease Control and Prevention|||||||||t||||||||||2017-02-18 17:33:05.010156|2017-02-18 17:33:05.010156
NCT00128453|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-06-06|||August 2005||2005-08-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences|Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The ICAP Trial: Investigation on Colchicine for Acute Pericarditis|Completed||Phase 3|240|Actual|Azienda Sanitaria Locale 3, Torino||2|||f||||||||||||||2017-02-18 17:33:05.103616|2017-02-18 17:33:05.103616
NCT00128440|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-09|2013-10-28|||August 2005||2005-08-01|October 2013|2013-10-01||||September 2006|Actual|2006-09-01||Interventional|||High Dose Trial in COPD|A Randomized, Multiple-dose, Double-Blind, Crossover Study to Compare the Efficacy and Safety of 200 μg and 400 μg of BEA 2180 BR to Tiotropium 5 μg and Placebo When Each is Delivered by the Respimat® Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|78|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:33:05.224167|2017-02-18 17:33:05.224167
NCT00128427|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2010-06-13|||June 2005||2005-06-01|June 2010|2010-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Study of Colchicine to Prevent the Postpericardiotomy Syndrome|Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The COPPS Trial: COlchicine for the Prevention of Postpericardiotomy Syndrome|Completed||Phase 3|360|Anticipated|Azienda Sanitaria Locale 3, Torino||2|||f||||t||||||||||2017-02-18 17:33:05.327921|2017-02-18 17:33:05.327921
NCT00128414|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2011-02-14|||August 2005||2005-08-01|February 2011|2011-02-01|October 2010|Actual|2010-10-01|April 2009|Actual|2009-04-01||Interventional|CORP||Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)|Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP Trial: COlchicine for Recurrent Pericarditis|Completed||Phase 3|120|Anticipated|Azienda Sanitaria Locale 3, Torino||2|||f||||t||||||||||2017-02-18 17:33:05.436451|2017-02-18 17:33:05.436451
NCT00128401|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2014-04-17|2013-07-01||August 2005||2005-08-01|April 2014|2014-04-01|August 2012|Actual|2012-08-01|June 2012|Actual|2012-06-01||Interventional||The baseline mean and SD for CGI outcome measure was captured for 42 subjects only. The baseline mean and SD for LSAS outcome measure was captured for 40 subjects. Only 39 subjects were randomized.|Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia|Effect of D-Cycloserine on Treatment of Social Phobia|Completed||Phase 2|48|Actual|National Institutes of Health Clinical Center (CC)|The baseline mean and SD for CGI outcome measure was captured for 42 subjects only. The baseline mean and SD for LSAS outcome measure was captured for 40 subjects.|2|||f||||||||||||||2017-02-18 17:33:05.557101|2017-02-18 17:33:05.557101
NCT00128388|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2013-06-26|||February 2000||2000-02-01|June 2013|2013-06-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||Psychodynamic Therapy for Treating Panic Disorder|Randomized Controlled Trial of Psychodynamic Psychotherapy vs. Applied Relaxation for Panic Disorder|Completed||Phase 2/Phase 3|49|Actual|Weill Medical College of Cornell University||2|||f||||f||||||||||2017-02-18 17:33:06.284633|2017-02-18 17:33:06.284633
NCT00128375|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2007-12-12|||March 2005||2005-03-01|December 2007|2007-12-01|April 2008||2008-04-01|||||Interventional|||Financial Incentives for Smoking Cessation|Financial Incentives for Smoking Cessation|Completed||N/A|878||University of Pennsylvania|||||f||||||||||||||2017-02-18 17:33:06.588852|2017-02-18 17:33:06.588852
NCT00128362|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2014-06-23|||September 2005||2005-09-01|June 2014|2014-06-01||||December 2011|Actual|2011-12-01||Interventional|||Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer|Clinical Trial of Sentinel Node Biopsy Versus Axillary Sampling in Women With Clinically Node Negative Operable Breast Cancer|Terminated||Phase 2|478|Actual|Tata Memorial Hospital||1||"After initiation of study many studies reported an equivalence of SNB and ALND which led to~   widespread adoption of the former as standard procedure."|f||||||||||||||2017-02-18 17:33:06.675536|2017-02-18 17:33:06.675536
NCT00128336|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2016-05-12|||May 2004||2004-05-01|May 2016|2016-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management|The Heat Study: A 2-year Lifestyle Intervention in Overweight Women to Determine Optimal Approaches for Successful Maintenance of Weight Loss|Completed||Phase 3|200|Actual|University of Otago||4|||f||||f||||||||||2017-02-18 17:33:06.784762|2017-02-18 17:33:06.784762
NCT00128323|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-07|2008-02-07|||November 2002||2002-11-01|February 2008|2008-02-01|April 2005|Actual|2005-04-01|||||Interventional|||A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis|A Comparison of Gentian Violet Mouth Washes, Nystatin Drops and Ketoconazole Tabs in the Treatment of Oropharyngeal Candidiasis|Completed||Phase 3|558||University of Malawi College of Medicine|||||f||||||||||||||2017-02-18 17:33:06.909459|2017-02-18 17:33:06.909459
NCT00128310|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2007-02-06|||January 2001||2001-01-01|February 2007|2007-02-01|October 2005||2005-10-01|||||Interventional|||Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients|Randomized Phase III Trial Comparing Vinorelbine vs. Gemcitabine Plus Vinorelbine in Patients With Advanced Breast Cancer, Previously Treated With Anthracyclines and Taxanes|Completed||Phase 3|252||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:33:07.015449|2017-02-18 17:33:07.015449
NCT00128297|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2009-09-25|||January 2001||2001-01-01|September 2009|2009-09-01|December 2002||2002-12-01|||||Interventional|||Pamidronate Administration in Breast Cancer Patients With Bone Metastases|Randomized, Multicentric Phase IV Clinical Trial for the Administration of Pamidronate in Breast Cancer Patients With Bone Metastases|Completed||Phase 4|120||Spanish Breast Cancer Research Group|||||f||||f||||||||||2017-02-18 17:33:07.118951|2017-02-18 17:33:07.118951
NCT00128284|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2008-05-21|||February 2005||2005-02-01|May 2008|2008-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time|A Comparison Trial of SmartPill Corporation GI Monitoring System With Scintigraphic Gastric Emptying Procedure for Determining Gastric Residence Time|Completed||N/A|148|Actual|The SmartPill Corporation|||2||f||||f||||||||||2017-02-18 17:33:07.210788|2017-02-18 17:33:07.210788
NCT00127673|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2014-01-31|||September 2004||2004-09-01|January 2014|2014-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Comparison of Two Treatments for Post-Traumatic Stress Disorder|Effectiveness of PTSD Treatment: CBT Versus Sertraline|Completed||Phase 3|200|Actual|Case Western Reserve University||4|||f||||t||||||||||2017-02-18 17:33:24.471727|2017-02-18 17:33:24.471727
NCT00128271|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2008-04-28|||August 2005||2005-08-01|August 2006|2006-08-01||||August 2006|Actual|2006-08-01||Interventional|||Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection|A Phase 1 Study of Chimeric Anti-Phosphatidylserine Monoclonal Antibody (Bavituximab) in Patients Chronically Infected With Hepatitis C Virus (HCV) Who Are Non-Responders or Relapsers After Treatment With Pegylated Interferon Plus Ribavirin|Completed||Phase 1|32||Peregrine Pharmaceuticals|||||f||||||||||||||2017-02-18 17:33:07.321868|2017-02-18 17:33:07.321868
NCT00128258|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2016-09-26|||May 2005||2005-05-01|September 2016|2016-09-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01||Interventional|||Autologous/Allogeneic Progenitor Stem Cell Therapy for Congestive Heart Failure|Phase 1 Study: Autologous/Allogeneic Bone Marrow Progenitor Cell Treatment for Heart Failure|Terminated||Phase 1|10|Actual|Amit, Patel N, M.D.||1||study no longer at pittsburgh|f||||t||||||||||2017-02-18 17:33:07.422596|2017-02-18 17:33:07.422596
NCT00128245|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2007-12-19|||September 2004||2004-09-01|December 2007|2007-12-01||||||||Interventional|||Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca|A 24-Week Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Evaluation of the Safety and Efficacy of 0.3% and 1% Pimecrolimus Ophthalmic Suspensions Used Twice Daily in Patients With Moderate to Severe Keratoconjunctivitis Sicca|Completed||N/A|440||Novartis|||||||||||||||||||2017-02-18 17:33:07.508965|2017-02-18 17:33:07.508965
NCT00128232|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-04-27|||December 2002||2002-12-01|April 2012|2012-04-01||||August 2004|Actual|2004-08-01||Interventional|||Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients|Safety and Efficacy of Octreotide LAR in Treatment Naïve Acromegalic Patients|Completed||Phase 3|100||Novartis|||||f||||||||||||||2017-02-18 17:33:07.592932|2017-02-18 17:33:07.592932
NCT00128219|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2015-01-15|2009-08-03||July 2003||2003-07-01|August 2009|2009-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Prevention of GBS Colonization Via Immunity|A Phase II Randomized, Double-Blinded, Comparative Clinical Trial for a Group B Streptococcus Serotype III-Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Acquisition of GBS Type III|Completed||Phase 2|667|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:33:07.689016|2017-02-18 17:33:07.689016
NCT00128206|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2013-05-09|2010-09-21||November 2004||2004-11-01|May 2013|2013-05-01|September 2009|Actual|2009-09-01|October 2008|Actual|2008-10-01||Interventional|||Treatment of Latent TB Infection for Jailed Persons|Clinical Trial of Short Course Rifampin Versus INH for LTBI in Jail|Completed||Phase 3|364|Actual|University of California, San Francisco|Initial enrollment estimates were not met, from lower TB rates, increased deportation rates and fewer Jail personnel for LTBI testing. The complexity of treatment in the jail led to technical problems in the analytic plan.|2|||f||||t||||||||||2017-02-18 17:33:09.253144|2017-02-18 17:33:09.253144
NCT00128193|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2014-12-04|2010-09-30||April 2002||2002-04-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Leprosy Skin Test Antigens Trial|Two New Leprosy Skin Test Antigens: MLSA-LAM and MLCwA Phase II Study in a Leprosy-Endemic Region|Completed||Phase 2|260|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-02-18 17:33:09.878136|2017-02-18 17:33:09.878136
NCT00128180|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2014-12-05|2011-12-05||January 2003||2003-01-01|December 2014|2014-12-01|October 2011|Actual|2011-10-01|December 2010|Actual|2010-12-01||Interventional|||Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome|A Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Methylprednisolone as a Treatment for Presumed Hantavirus Cardiopulmonary Syndrome|Completed||Phase 2|66|Actual|University of New Mexico|While the study reached the target accrual of 60 confirmed cases, it was not powered to detect a difference in mortality. Higher disease severity in the placebo group at entry complicated both the efficacy and safety analyses.|2|||f||||t||||||||||2017-02-18 17:33:13.399048|2017-02-18 17:33:13.399048
NCT00128167|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2006-07-05|||October 2004||2004-10-01|July 2006|2006-07-01|December 2005||2005-12-01|||||Interventional|||Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6–59 Months of Age|A Randomized, Double-Blind Trial to Assess the Safety and Relative Efficacy of CAIV-T Against Inactivated Influenza Vaccine in Children 6–59 Months of Age|Completed||Phase 3|8500||MedImmune LLC|||||||||||||||||||2017-02-18 17:33:14.169853|2017-02-18 17:33:14.169853
NCT00128154|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2006-08-17|||January 2004||2004-01-01|August 2006|2006-08-01|December 2005||2005-12-01|||||Interventional|||Chromium Picolinate for the Treatment of Metabolic Syndrome|A Double-Blind Randomized Controlled Clinical Trial of Chromium Picolinate on Clinical and Biochemical Features of the Metabolic Syndrome|Completed||N/A|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:33:14.428278|2017-02-18 17:33:14.428278
NCT00128141|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2008-02-04|||August 2003||2003-08-01|February 2008|2008-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Effect of Tactile and Kinesthetic Stimulation on Very Low Birth Weight Preterm Infants|Effect of Maternal Tactile and Kinesthetic Stimulation on Length of Hospital Stay of Very Low Birth Weight Infants|Completed||N/A|104|Actual|National Bioethics Commission of Brazil||2|||f||||f||||||||||2017-02-18 17:33:14.555699|2017-02-18 17:33:14.555699
NCT00128128|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2015-05-14||2015-04-27|August 2005||2005-08-01|May 2015|2015-05-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Cranberry Juice for the Prevention of Recurrent Urinary Tract Infections|Cranberry and Prevention of UTI A Comprehensive Approach|Completed||Phase 2|176|Actual|National Center for Complementary and Integrative Health (NCCIH)||4|||f||||f||||||||||2017-02-18 17:33:14.658264|2017-02-18 17:33:14.658264
NCT00128115|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2016-01-19|||September 2005||2005-09-01|January 2016|2016-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)|Proprietary Information - Exploratory (Non-Confirmatory) Trial|Terminated||Phase 2|83|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:33:14.77386|2017-02-18 17:33:14.77386
NCT00128102|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2015-04-17|||June 2005||2005-06-01|April 2015|2015-04-01|November 2011|Actual|2011-11-01|July 2011|Actual|2011-07-01||Interventional|||Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy|Completed||Phase 3|662|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:33:14.865021|2017-02-18 17:33:14.865021
NCT00128089|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2005-12-20|||August 2005||2005-08-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Trial of New Dietary Treatment of Diabetes|Phase 1 Trial of A New Dietary Treatment of Obesity Related Type 2 Diabetes|Terminated||Phase 1|10||Manassas Internal Medicine|||||f||||||||||||||2017-02-18 17:33:14.976376|2017-02-18 17:33:14.976376
NCT00128063|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2007-04-23|||August 2005||2005-08-01|April 2007|2007-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection|A Phase 1 & 2, Randomized Open-Label Study to Evaluate the Pharmacokinetics, Safety and Antiretroviral Activity of Succinylated Human Serum Albumin (Suc-HSA) in Treatment Naïve HIV-1 Infected Subjects|Completed||Phase 1/Phase 2|6||International Antiviral Therapy Evaluation Center|||||f||||t||||||||||2017-02-18 17:33:15.202926|2017-02-18 17:33:15.202926
NCT00128050|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2009-02-03|||January 2005||2005-01-01|February 2009|2009-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|PRE-SICH||Efficacy and Safety of Factor VIIa on Rebleeding After Surgery for Spontaneous Intracerebral Hemorrhage (ICH)|Efficacy and Safety of Factor VIIa (Eptacog Alfa) on Rebleeding After Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage. A Randomized, Controlled, Open-Label, Investigator-Blinded Pilot Study|Completed||Phase 2|30|Actual|IRCCS Policlinico S. Matteo||2|||f||||t||||||||||2017-02-18 17:33:15.294825|2017-02-18 17:33:15.294825
NCT00128037|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2016-09-20|||May 1999||1999-05-01|September 2016|2016-09-01|February 2006||2006-02-01|||||Interventional|||Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)|A Phase II Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors: Initial Report of Japan Clinical Oncology Group Trial (JCOG 9806)|Completed||Phase 2|75||Japan Clinical Oncology Group|||||f||||||||||||||2017-02-18 17:33:15.410056|2017-02-18 17:33:15.410056
NCT00128024|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2013-04-17|||February 2002||2002-02-01|April 2013|2013-04-01|February 2006|Actual|2006-02-01|February 2004|Actual|2004-02-01||Interventional|||Effects of Early Statin Treatment After Acute Myocardial Infarction (AMI) in Japanese Patients|Effects of Early Statin Treatment on Symptomatic Heart Failure and Ischemic Events After Acute Myocardial Infarction. The MUSASHI-AMI: A Multicenter Randomized Controlled Trial|Completed||Phase 4|460|Actual|Kumamoto University||2|||f||||||||||||||2017-02-18 17:33:15.517035|2017-02-18 17:33:15.517035
NCT00128011|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2006-11-08|||May 2005||2005-05-01|November 2006|2006-11-01|June 2005||2005-06-01|||||Interventional|||Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine|A Safety and Immunogenicity Study of a New Formulation of the Locally-Produced Bivalent Killed, Whole-Cell Oral Cholera Vaccine in Vietnamese Subjects|Completed||Phase 2|150||International Vaccine Institute|||||f||||||||||||||2017-02-18 17:33:15.783801|2017-02-18 17:33:15.783801
NCT00127998|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2006-08-15|||July 2005||2005-07-01|August 2006|2006-08-01||||||||Interventional|||Antimalarial Drug Resistance in Mali|Characterization of Novel Molecular Tools for the Epidemiological Surveillance of Antimalarial Drug Resistance in Mali|Completed||N/A|1011||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:33:15.893243|2017-02-18 17:33:15.893243
NCT00127985|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2008-05-12|||August 2005||2005-08-01|May 2008|2008-05-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|NAIF||6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome|The Effect of 6-Methyl-Prednisolone on Organ Dysfunction and Mortality of Patients With Unresolving Multiple Organ Dysfunction Syndrome|Unknown status|Recruiting|Phase 4|240|Anticipated|Hospital Universitario Principe de Asturias||2|||f||||t||||||||||2017-02-18 17:33:16.002197|2017-02-18 17:33:16.002197
NCT00127972|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2007-04-27|||February 2004||2004-02-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||2NN & CHARM Long-Term Follow-up Study|A Retrospective Study to Compare the 3-Year Antiviral Efficacy of Nevirapine and Efavirenz in Combination With D4t and 3tc in 2NN Patients and of Trizivir Versus Trizivir Plus Nevirapine in CHARM Patients|Completed||Phase 4|763|Actual|International Antiviral Therapy Evaluation Center|||||f||||f||||||||||2017-02-18 17:33:16.124781|2017-02-18 17:33:16.124781
NCT00127959|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2007-04-23|||March 2004||2004-03-01|April 2007|2007-04-01|August 2006|Actual|2006-08-01|||||Interventional|||Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection|Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Antiretroviral Naïve Patients With HIV/HBV co-Infection|Completed||Phase 4|24||International Antiviral Therapy Evaluation Center|||||f||||f||||||||||2017-02-18 17:33:16.224005|2017-02-18 17:33:16.224005
NCT00127946|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2011-08-08|||November 2005||2005-11-01|August 2005|2005-08-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|AMNIOECHANGE||Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses|Randomized Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses|Unknown status|Active, not recruiting|Phase 3|140|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 17:33:16.320996|2017-02-18 17:33:16.320996
NCT00127933|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2011-07-13|2011-03-30||August 2005||2005-08-01|July 2011|2011-07-01|July 2009|Actual|2009-07-01|April 2009|Actual|2009-04-01||Interventional|||XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer|An Open-label Study of Xeloda Plus Taxotere on Treatment Response in Patients With HER2-neu-negative, and the Addition of Herceptin for HER2-neu-positive Breast Cancer|Completed||Phase 4|157|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:33:16.434174|2017-02-18 17:33:16.434174
NCT00127920|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2015-03-09|||August 2004||2004-08-01|March 2015|2015-03-01|October 2012|Actual|2012-10-01|August 2006|Actual|2006-08-01||Interventional|||Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients|A Phase II, Open-Label, Non-Randomized, Multi-Center Pilot Study of Intravenous Taxol, Carboplatin, Bevacizumab Given Every 21 Days in Patients With Newly Diagnosed Stage III/IV Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer|Completed||Phase 2|20|Actual|Gynecologic Oncology Associates||1|||f||||f||||||||||2017-02-18 17:33:17.242714|2017-02-18 17:33:17.242714
NCT00127907|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2007-10-16|||May 2004||2004-05-01|October 2007|2007-10-01||||||||Interventional|||Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest|Comparison of Epinephrine Associated With Vasopressin vs Epinephrine Alone in the Treatment of Out-of-Hospital Cardiac Arrests|Completed||Phase 4|2416||Hospices Civils de Lyon|||||f||||||||||||||2017-02-18 17:33:17.36826|2017-02-18 17:33:17.36826
NCT00127881|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2012-07-24|||July 2005||2005-07-01|July 2012|2012-07-01||||February 2014|Anticipated|2014-02-01||Interventional|||Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome|Open Label, Dose Escalation, Followed by Open Label,Single Arm Clinical Trial of HuMax-CD4 in Patients With Mycosis Fungoides Type CTCL (Stage IB-IVB) or Sezary Syndrome Who Are Refractory or Intolerant to Targretin® (Bexarotene) and One Other Standard Therapy|Terminated||Phase 3|76|Actual|Emergent Product Development Seattle LLC||1||New sponsor, other treatments available|f||||t||||||||||2017-02-18 17:33:17.454291|2017-02-18 17:33:17.454291
NCT00127660|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2010-01-12|||September 2005||2005-09-01|January 2010|2010-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Effect of Nutrition Labeling on Fast Food Choices|Effect of Nutrition Labeling on Fast Food Choices|Completed||N/A|605|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||4|||f||||||||||||||2017-02-18 17:33:24.606595|2017-02-18 17:33:24.606595
NCT00127868|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2008-07-07|||March 2005||2005-03-01|May 2006|2006-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Selenium Sulfide, Ketoconazole and Ciclopirox Shampoo as Additional Treatments for Tinea Capitis (Scalp Ringworm)|A Randomized, Double-Blinded, Placebo-Controlled Study Observing the Efficacy of Selenium Sulfide 1% Shampoo, Ketoconazole 2% Shampoo, and Ciclopirox 1% Shampoo as Adjunctive Treatments for Tinea Capitis in Children|Completed||N/A|47|Actual|Chen, Catherine, M.D.||4|||f||||||||||||||2017-02-18 17:33:17.589437|2017-02-18 17:33:17.589437
NCT00127855|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-08|2016-10-21|2012-06-15||March 2003||2003-03-01|October 2016|2016-10-01|August 2004|Actual|2004-08-01|February 2004|Actual|2004-02-01||Interventional|||Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine|A Phase II, Open (Partially Double-blind), Randomised, Controlled, Multicentre, Primary Vaccination Study to Evaluate the Immunogenicity (Including Immune Memory), Reactogenicity and Safety of Three Different Formulations of the GSK Biologicals' Combined Haemophilus Influenzae Type B-meningococcal Serogroups CY Conjugate Vaccine Given Concomitantly With Infanrix® Penta and Prevenar®, Versus ActHIB® and Meningitec® Given Concomitantly With Infanrix® Penta and Versus ActHIB® Given Concomitantly With Infanrix® Penta and Prevenar® in Infants According to a 2-4-6 Month Schedule.|Completed||Phase 2|409|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:33:17.72716|2017-02-18 17:33:17.72716
NCT00127842|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2014-03-24|2010-11-04||August 2005||2005-08-01|March 2014|2014-03-01|September 2009|Actual|2009-09-01|August 2005|Actual|2005-08-01||Interventional|||REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)|Rating Evaluations in Psoriatic Arthritis (PsA) With Enbrel®|Completed||Phase 4|110|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:33:20.800581|2017-02-18 17:33:20.800581
NCT00127829|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2009-04-22|||July 2005||2005-07-01|April 2009|2009-04-01|January 2008|Actual|2008-01-01|||||Interventional|AGUS||Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic|A Phase I, Open-Label, Dose Escalation Study Evaluating High-Dose Gefitinib (IRESSA®) on Weekly and Twice Weekly Schedules in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic|Completed||Phase 1|66|Anticipated|AstraZeneca||1|||f||||||||||||||2017-02-18 17:33:21.234565|2017-02-18 17:33:21.234565
NCT00127816|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2016-03-14|||April 2005||2005-04-01|March 2016|2016-03-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Interventional|||Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy|Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy|Completed||N/A|40|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 17:33:21.327985|2017-02-18 17:33:21.327985
NCT00127803|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2012-09-07|2012-03-13||July 2005||2005-07-01|September 2012|2012-09-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers|A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study of the Safety, Tolerability and Immunogenicity of a Clostridium Difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Adult Volunteers (18-55 Years)|Completed||Phase 1|50|Actual|Sanofi||4|||f||||f||||||||||2017-02-18 17:33:21.435228|2017-02-18 17:33:21.435228
NCT00127790|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2012-09-14|2012-06-12||June 2005||2005-06-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|October 2008|Actual|2008-10-01||Interventional|||Treatment of Insomnia Secondary to Chronic Pain|CBT for Co-Morbid Insomnia and Chronic Pain: Sleep, Pain and Immune Function Outcomes|Completed||N/A|28|Actual|University of Rochester|The foremost limitation of this pilot study is its small sample size, particularly for a four-arm design. Accordingly, a cautious approach to the interpretation of the findings is warranted.|4|||f||||f||||||||||2017-02-18 17:33:22.367686|2017-02-18 17:33:22.367686
NCT00127777|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2005-08-24|||July 2002||2002-07-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)|Randomized, Multi-Center, Partially Placebo-Controlled Phase IV-Study to Compare Efficacy and Tolerability of 48-Week Combined Therapy With Peginterferon Alfa-2a, Ribavirin and Amantadine Sulphate Versus Placebo in Untreated Patients With Chronic Hepatitis C Virus-Genotype-1-Infection|Unknown status|Active, not recruiting|Phase 4|700||University Hospital, Saarland|||||f||||||||||||||2017-02-18 17:33:23.113682|2017-02-18 17:33:23.113682
NCT00127764|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2007-08-29|||January 2001||2001-01-01|August 2004|2004-08-01|April 2005||2005-04-01|||||Interventional|||European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus|European Randomised Placebo-Controlled Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus (Pempuls Trial)|Completed||Phase 2/Phase 3|60||University Medical Center Groningen|||||f||||||||||||||2017-02-18 17:33:23.225074|2017-02-18 17:33:23.225074
NCT00127751|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2005-08-24|||May 2000||2000-05-01|August 2005|2005-08-01|May 2003||2003-05-01|||||Interventional|||Heart Disease on the Mend|A Cardiovascular Disease Multifactor Risk Reduction Program for Medically Underserved High-Risk Patients|Completed||Phase 2|150||Stanford University|||||f||||||||||||||2017-02-18 17:33:23.323822|2017-02-18 17:33:23.323822
NCT00127738|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2007-01-08|||January 2005||2005-01-01|February 2006|2006-02-01|December 2006||2006-12-01|||||Interventional|||Renal Atherosclerotic Revascularization Evaluation: RAVE Study||Completed||N/A|240||Sunnybrook Health Sciences Centre|||||f||||||||||||||2017-02-18 17:33:23.414722|2017-02-18 17:33:23.414722
NCT00127725|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2005-11-14|||August 2005||2005-08-01|August 2005|2005-08-01|August 2009||2009-08-01|||||Interventional|||Pulsed Electromagnetic Field (PEMF) Stimulation for Tibia Fractures|A Double Blind Randomised Controlled Trial of Pulsed Electromagnetic Field (PEMF) Stimulation in Acute Tibial Shaft Fractures|Unknown status|Recruiting|Phase 2|340||Sydney South West Area Health Service|||||f||||||||||||||2017-02-18 17:33:23.507541|2017-02-18 17:33:23.507541
NCT00127712|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2013-09-06|2010-03-02||September 2004||2004-09-01|September 2013|2013-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery|Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery|Completed||Phase 4|130|Actual|Indiana University||2|||f||||t||||||||||2017-02-18 17:33:23.606926|2017-02-18 17:33:23.606926
NCT00127699|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2007-11-30|||August 2005||2005-08-01|November 2007|2007-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care|Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care|Completed||Phase 1|400||Penn State University|||||f||||||||||||||2017-02-18 17:33:24.061304|2017-02-18 17:33:24.061304
NCT00005367|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||February 1993||1993-02-01|March 2005|2005-03-01|January 1995||1995-01-01|||||Observational|||Epidemiology of Long QTand Asian Sudden Death in Sleep||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.342091|2017-02-18 18:15:05.342091
NCT00127634|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2008-08-06|||July 2005||2005-07-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes|A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus|Completed||Phase 3|385|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 17:33:24.839088|2017-02-18 17:33:24.839088
NCT00127621|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2005-08-24|||April 2002||2002-04-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||Early Tracheotomy Versus Prolonged Endotracheal Intubation in Intensive Care Unit (ICU) Patients|Early Tracheotomy Versus Prolonged Endotracheal Intubation in Intensive Care Unit Patients|Terminated||Phase 3|468||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:33:25.017562|2017-02-18 17:33:25.017562
NCT00127608|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2011-09-29|||June 2005||2005-06-01|September 2011|2011-09-01||||July 2006|Actual|2006-07-01||Interventional|||Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients|An Open, Prospective, Non-prophylactic, Non Therapeutic Study for the Detection and Characterisation of Varicella Zoster Virus Collected From Dermal Lesions of Patients Who Are Diagnosed of Having Varicella|Completed||Phase 3|||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:33:25.120281|2017-02-18 17:33:25.120281
NCT00127595|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2005-08-23|||January 2002||2002-01-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract|A Phase II Monocentric Study of Oxaliplatin in Combination With Gemcitabine in Patients With Advanced/Metastatic Transitional Cell Carcinoma of the Urothelial Tract|Terminated||Phase 2|28||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:33:25.212682|2017-02-18 17:33:25.212682
NCT00127582|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2005-08-24|||January 2003||2003-01-01|May 2005|2005-05-01||||||||Interventional|||RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy|Evaluation of Arrhythmic Risk in Myotonic Dystrophy Type I (DM 1)|Unknown status|Recruiting|Phase 3|537||Catholic University of the Sacred Heart|||||f||||||||||||||2017-02-18 17:33:25.302423|2017-02-18 17:33:25.302423
NCT00127569|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2007-01-11|||May 2003||2003-05-01|January 2007|2007-01-01|January 2006||2006-01-01|||||Interventional|||Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy|Multicenter, Phase II Trial Assessing the Efficacy of Rituximab in HIV Infected Patients With Multicentric Castleman Disease Dependent on Chemotherapy (ANRS 117 Study, CastlemaB)|Terminated||Phase 2|25||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:33:25.403404|2017-02-18 17:33:25.403404
NCT00127556|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2008-05-06|||April 2005||2005-04-01|May 2008|2008-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Transfusion Medicine - Prevention of Bedside Errors|Cluster-Randomised Controlled Trial of a Simple Intervention to Prevent Bedside Checking Errors in Blood Transfusion|Completed||N/A|300||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 17:33:25.494908|2017-02-18 17:33:25.494908
NCT00127543|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2006-02-06|||August 2005||2005-08-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Kid Cards: Teaching Kids About Medicines|Kid Cards: Teaching Kids About Medicines|Unknown status|Active, not recruiting|N/A|50||Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 17:33:25.602396|2017-02-18 17:33:25.602396
NCT00127530|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2016-01-04|2011-04-12||May 2005||2005-05-01|January 2016|2016-01-01|September 2006|Actual|2006-09-01|June 2006|Actual|2006-06-01||Interventional||Safety Population = Placebo (72), Fampridine-SR (228) Intent to Treat (ITT) Population = Placebo (72), Fampridine-SR (224). Four (4) randomized patients discontinued from the study prior to completing any of the scheduled double-blind assessments and therefore were excluded from the ITT population, which consisted of 296 patients.|Study of Oral Fampridine-SR in Multiple Sclerosis|Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis|Completed||Phase 3|301|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-02-18 17:33:25.700092|2017-02-18 17:33:25.700092
NCT00127517|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-05|2011-06-06|||March 2005||2005-03-01|June 2011|2011-06-01|August 2006|Actual|2006-08-01|||||Interventional|||Palliative Care Study in Patients With Advanced Cancer|A Phase II Double Blind, Placebo Controlled, Randomized, > Multicenter Study With AVR118 Solution in Patients With Advanced > Malignancies Who Are Not Candidates for Curative Chemotherapy.|Terminated||Phase 2|||Advanced Viral Research Corp||||Company shifted focus|||||||||||||||2017-02-18 17:33:26.407619|2017-02-18 17:33:26.407619
NCT00127504|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2005-08-23|||July 2003||2003-07-01|August 2005|2005-08-01|May 2004||2004-05-01|||||Interventional|||Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness|Trial of Rifampin and Azithromycin for Treatment of Endosymbiotic Bacteria (Wolbachia) in Onchocerca Volvulus in Guatemala|Completed||Phase 2|80||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:33:26.494383|2017-02-18 17:33:26.494383
NCT00127491|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2013-12-09|||May 2004||2004-05-01|December 2013|2013-12-01|May 2010|Actual|2010-05-01|August 2007|Actual|2007-08-01||Interventional|||Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury|A RCT of Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury|Completed||Phase 2/Phase 3|63|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 17:33:26.587651|2017-02-18 17:33:26.587651
NCT00127478|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2007-11-28|||July 2001||2001-07-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||A Long Term Safety Study With Atrasentan|A Phase II/III Extension Study to Evaluate the Safety and Tolerability of Atrasentan|Completed||Phase 2/Phase 3|166|Actual|Abbott||1|||f||||||||||||||2017-02-18 17:33:26.6998|2017-02-18 17:33:26.6998
NCT00127465|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2008-12-10|||November 2001||2001-11-01|August 2005|2005-08-01|July 2003||2003-07-01|||||Interventional|||Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants|Investigating the Impact of Tailored Reports on Anxiety|Completed||Phase 1/Phase 2|400||University of Plymouth|||||f||||||||||||||2017-02-18 17:33:26.808573|2017-02-18 17:33:26.808573
NCT00127452|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2010-07-06|||April 2002||2002-04-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|November 2009|Actual|2009-11-01||Interventional|||Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality|Alpha Omega Trial: A Randomised, Placebo Controlled, Double Blind Intervention Study of the Effect of Low Doses of Omega-3 Fatty Acids on Cardiovascular Diseases in Patients With a History of Myocardial Infarction|Completed||N/A|4837|Actual|Wageningen University||4|||f||||t||||||||||2017-02-18 17:33:27.11081|2017-02-18 17:33:27.11081
NCT00127439|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2013-09-17|||June 2005||2005-06-01|September 2013|2013-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|DE||Effects of Robotic Versus Manually-Assisted Locomotor Training for Individuals With Incomplete Spinal Cord Injury|Differential Effects of Robotic vs. Manually-Assisted Locomotor Training|Completed||N/A|20|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:33:27.279122|2017-02-18 17:33:27.279122
NCT00127413|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2015-03-23|2014-11-17||September 2004||2004-09-01|March 2015|2015-03-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Integrated Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)|Integrated Treatment for Chronic Pain and PTSD|Completed||N/A|42|Actual|VA Office of Research and Development|Failure to engage in treatment, failure to complete treatment in a timely manner due to missed treatment sessions, and difficulty with compliance with treatment session recommendations led to lower completion rates|4|||f||||f||||||||||2017-02-18 17:33:27.388322|2017-02-18 17:33:27.388322
NCT00127400|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2013-09-04|||February 2002||2002-02-01|September 2013|2013-09-01|July 2006||2006-07-01|||||Interventional|||A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED|A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With Intermittent Explosive Disorder|Completed||Phase 2|72||University of Chicago|||||f||||||||||||||2017-02-18 17:33:28.076687|2017-02-18 17:33:28.076687
NCT00127387|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2012-06-22|||May 2001||2001-05-01|June 2012|2012-06-01|November 2005|Actual|2005-11-01|September 2005|Actual|2005-09-01||Interventional|||Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia|A Prospective, Randomized Pilot Study of Enbrel VS Placebo in Patients Receiving Radiation Therapy to Combat Fatigue and Cachexia|Terminated||Phase 2/Phase 3|54|Anticipated|The University of Texas Health Science Center at San Antonio||||PI moved to Oregon|f||||||||||||||2017-02-18 17:33:28.176256|2017-02-18 17:33:28.176256
NCT00127374|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2016-11-07|||January 2005||2005-01-01|November 2016|2016-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||Mood and Behavior Changes Among Overweight Adolescent Females|Mood and Behavior Changes Among Overweight Adolescent Females|Withdrawn||N/A|0|Actual|University of Kentucky||||withdrawn due to non-response. PI left university|f||||||||||||||2017-02-18 17:33:28.272318|2017-02-18 17:33:28.272318
NCT00127361|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2005-08-22|||January 1998||1998-01-01|April 2005|2005-04-01|February 2003||2003-02-01|||||Interventional|||Study of Having a Female Friend as Labor Support|Evaluation of Continuous Support in Labor|Completed||N/A|600||Saint Peters University Hospital|||||f||||||||||||||2017-02-18 17:33:28.367921|2017-02-18 17:33:28.367921
NCT00127348|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2007-04-02|||May 2004||2004-05-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness|Effect of CPAP on Arterial Hypertension and Cardiovascular Morbi-Mortality in Patients With Sleep Apnea and Without Daytime Sleepiness|Completed||Phase 4|700||Sociedad Española de Neumología y Cirugía Torácica|||||f||||||||||||||2017-02-18 17:33:28.452994|2017-02-18 17:33:28.452994
NCT00127335|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2011-07-26|||August 2005||2005-08-01|July 2011|2011-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Is Myopathy Part of Statin Therapy (IMPOSTER-16)|Double Blind, Prospective Randomized, Crossover Study of Patients With Muscle Complaints on Statin Therapy|Terminated||Phase 4|60|Anticipated|Scripps Health||2||Lack of funding|f||||f||||||||||2017-02-18 17:33:28.53154|2017-02-18 17:33:28.53154
NCT00127322|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2006-02-09|||January 2004||2004-01-01|February 2006|2006-02-01|January 2006||2006-01-01|||||Observational|||The Early High Risk Period for Patients With Heart Failure|The Early High Risk Period for Patients With Incident Heart Failure: A Population Based Study|Unknown status|Active, not recruiting|N/A|450||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:33:28.647515|2017-02-18 17:33:28.647515
NCT00127309|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2005-08-23|||June 2005||2005-06-01|July 2005|2005-07-01|August 2005||2005-08-01|||||Interventional|||Effect of Glutathione on Blood Alcohol and Hangover Symptoms||Completed||N/A|100||Piyavate Hospital|||||f||||||||||||||2017-02-18 17:33:28.724678|2017-02-18 17:33:28.724678
NCT00127296|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2017-01-05|||July 2005||2005-07-01|January 2017|2017-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe|Comparison of the Accuracy and Precision of NovoLog® Mix 70/30 FlexPen® to Vial and Syringe in Patients With Type 2 Diabetes Mellitus|Completed||Phase 1|60|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:33:28.816062|2017-02-18 17:33:28.816062
NCT00127283|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2017-01-11|||May 2005||2005-05-01|January 2017|2017-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|FAST||Recombinant Factor VIIa in Acute Intracerebral Haemorrhage|Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral Haemorrhage|Completed||Phase 3|829|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:33:28.920323|2017-02-18 17:33:28.920323
NCT00127270|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-01-23|||May 2005||2005-05-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|||||Interventional|||Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder|Using Behavioral Therapy in Combination With Drug-Darifenacin for Symptoms of Overactive Bladder|Completed||Phase 4|395|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:33:29.311388|2017-02-18 17:33:29.311388
NCT00127257|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2010-01-12|||September 1999||1999-09-01|January 2010|2010-01-01|June 2006||2006-06-01|||||Interventional|||Biofeedback for Dyssynergic Constipation|Biofeedback for Fecal Incontinence and Constipation|Completed||N/A|117||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:33:29.683196|2017-02-18 17:33:29.683196
NCT00127244|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2010-11-30|||June 2000||2000-06-01|November 2010|2010-11-01|October 2004||2004-10-01|||||Interventional|||Study Comparing Two Different Methods of Treating Periodontal Disease|Outcomes of Traditional and Medical Models of Periodontal Therapy|Completed||Phase 2|400||The Forsyth Institute|||||f||||||||||||||2017-02-18 17:33:29.787844|2017-02-18 17:33:29.787844
NCT00127231|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2016-02-23|||September 2007||2007-09-01|February 2016|2016-02-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women|Brief Alcohol Intervention in HIV+ Women|Completed||Phase 3|387|Actual|Johns Hopkins University||2|||f||||t||||||||Undecided||2017-02-18 17:33:29.878948|2017-02-18 17:33:29.878948
NCT00127218|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2015-10-12|2015-09-01||September 2003||2003-09-01|October 2015|2015-10-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|NIA-Plaque||High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly|HDL Increased Plaque Stabilization in the Elderly|Completed||Phase 3|145|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 17:33:29.999789|2017-02-18 17:33:29.999789
NCT00127205|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2017-01-04|||July 2005||2005-07-01|January 2017|2017-01-01|May 2020|Anticipated|2020-05-01|March 2017|Anticipated|2017-03-01||Interventional|||S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.|Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer|Active, not recruiting||Phase 3|5400|Anticipated|Southwest Oncology Group||3|||f||||t||||||||||2017-02-18 17:33:30.34289|2017-02-18 17:33:30.34289
NCT00127192|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2015-05-20|2009-08-18||July 2005||2005-07-01|May 2015|2015-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)|Sitagliptin (MK0431) Late Phase II Double-Blind Dose-Response Study - Type 2 Diabetes Mellitus|Completed||Phase 2|363|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 17:33:30.461857|2017-02-18 17:33:30.461857
NCT00127179|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2015-10-14|||January 2004||2004-01-01|October 2015|2015-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)|MK0906 Phase III Double-Blind Comparative Study - Benign Prostate Hyperplasia|Completed||Phase 3|600|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:33:31.225122|2017-02-18 17:33:31.225122
NCT00127166|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-08-24|2009-06-16||December 2005||2005-12-01|August 2015|2015-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)|A Multicenter, Double-Blind, Randomized, Crossover Design Study to Evaluate the Effect of Montelukast Vs. Salmeterol on the Inhibition of Exercise-Induced Bronchoconstriction in Asthmatic Patients Aged 6-14 Years|Completed||Phase 3|154|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:33:31.311165|2017-02-18 17:33:31.311165
NCT00127153|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-01-28|||March 2005||2005-03-01|January 2015|2015-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)|A Comparative Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of V110 Formulated With Either All New Process Polysaccharides or All Current Process Polysaccharides|Completed||Phase 3|130||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:33:31.895408|2017-02-18 17:33:31.895408
NCT00127140|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2015-09-25|||June 2005||2005-06-01|September 2015|2015-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030)|A Phase I Clinical Study of MK0683 in Patients With Malignant Lymphoma|Completed||Phase 1|10|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 17:33:31.975168|2017-02-18 17:33:31.975168
NCT00127127|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2015-02-02|||June 2005||2005-06-01|February 2015|2015-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Solid Tumors (0683-029)(COMPLETED)|A Phase I Clinical Study of MK0683 in Patients With Solid Tumors.|Completed||Phase 1|21|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 17:33:32.080369|2017-02-18 17:33:32.080369
NCT00127114|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2009-03-16|||September 2005||2005-09-01|March 2009|2009-03-01||||||||Interventional|||Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)|Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)|Terminated||Phase 4|52|Anticipated|Johns Hopkins University||||Recruitment difficulties|f||||||||||||||2017-02-18 17:33:32.179665|2017-02-18 17:33:32.179665
NCT00127101|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-04-02|2009-07-06||September 2005||2005-09-01|April 2015|2015-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)|A Phase I Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (Vorinostat; Zolinza) in Combination With Bexarotene in Patients With Advanced Cutaneous T-Cell Lymphoma|Terminated||Phase 1|23|Actual|Merck Sharp & Dohme Corp.|Study was discontinued due to low enrollment|6||The study was stopped due to low enrollment.|f||||||||||||||2017-02-18 17:33:32.298437|2017-02-18 17:33:32.298437
NCT00127088|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2006-09-07|||October 2004||2004-10-01|September 2006|2006-09-01||||||||Interventional|||Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients|A Prospective Phase II of Peri-Operative Docetaxel + Laparoscopic Radical Prostatectomy in Patients With Localized Gleason 7 pT2a-pT2b Adenocarcinoma and a Risk of Relapse After Radical Prostatectomy|Suspended||Phase 2|37||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:33:33.810403|2017-02-18 17:33:33.810403
NCT00127075|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2011-12-28|||June 2005||2005-06-01|December 2011|2011-12-01|April 2012|Anticipated|2012-04-01|April 2012|Anticipated|2012-04-01||Interventional|||POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis|POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|Hospices Civils de Lyon||2|||f||||t||||||||||2017-02-18 17:33:33.892069|2017-02-18 17:33:33.892069
NCT00127062|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2015-03-25|||May 2003||2003-05-01|August 2005|2005-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Health Effects of Diesel Exhaust in Asthmatic Patients: A Real-world Study in a London Street|Health Effects of Diesel Exhaust in Asthmatic Patients: A Real-world Study in a London Street|Completed||Phase 3|60||Imperial College London|||2||f||||t||||||Samples Without DNA|"~     Exhaled breath condensate~   "|||2017-02-18 17:33:34.19633|2017-02-18 17:33:34.19633
NCT00127049|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2006-09-07|||December 2004||2004-12-01|September 2006|2006-09-01||||||||Interventional|||Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors|A Prospective Multicenter Phase II Trial of Gemcitabine, Cisplatin, and Ifosfamide (GIP) in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors (NSGCT) and a Predicted Favorable Prognosis|Unknown status|Recruiting|Phase 2|37||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:33:34.292096|2017-02-18 17:33:34.292096
NCT00127036|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2013-11-21|2012-01-05||October 2003||2003-10-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)|A Multicenter Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)|Terminated||Phase 2|65|Actual|H. Lee Moffitt Cancer Center and Research Institute|Study was Terminated early, not Completed. Study Drug now on the market. Due to slow accrual, too few patients who had both clinical and microarray data to perform the proposed analysis. 65 of 92 patients consented were assigned to treatment arms.|2||drug now on market|f||||t||||||||||2017-02-18 17:33:34.383882|2017-02-18 17:33:34.383882
NCT00127023|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2016-09-20|||May 2005||2005-05-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases|Blinded, Randomised, Controlled Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Combined Measles-mumps-rubella-varicella Candidate Vaccine Given to Healthy Children in Their Second Year of Life|Completed||Phase 3|944||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:33:34.886528|2017-02-18 17:33:34.886528
NCT00127010|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2016-09-23|||November 2005||2005-11-01|September 2016|2016-09-01|June 2006|Actual|2006-06-01|||||Interventional|||Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases|Blinded, Randomized Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Measles-mumps-rubella-varicella Candidate Vaccine Given to Healthy Children During the Second Year of Life|Completed||Phase 3|||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:33:35.097418|2017-02-18 17:33:35.097418
NCT00126997|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2016-09-20|||May 2005||2005-05-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases|Blinded, Randomised Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-mumps-rubella-varicella Candidate Vaccine When Given to Healthy Children in Their Second Year of Life|Completed||Phase 4|1439|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:33:35.249825|2017-02-18 17:33:35.249825
NCT00126984|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2016-10-06||2009-09-03|July 2005||2005-07-01|October 2016|2016-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine|A Phase II, Open (Partially Double-blind), Randomized, Controlled Dose-range Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Investigational Vaccination Regimens Versus MENINGITEC™ or MENCEVAX™ ACWY When Given as One Dose to Children Aged 12 to 14 Months and 3 to 5 Years Old|Completed||Phase 2|508|Actual|GlaxoSmithKline||5|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:33:35.589211|2017-02-18 17:33:35.589211
NCT00126971|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2006-08-14|||July 2005||2005-07-01|August 2006|2006-08-01||||||||Interventional|||Chlorproguanil-Dapsone in Pregnant Women|Pharmacokinetics of Chlorproguanil-Dapsone in Pregnant Women With Plasmodium Falciparum Infection, and Reinfection With P. Falciparum During Pregnancy Following Treatment|Suspended||Phase 1|132||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:33:35.766908|2017-02-18 17:33:35.766908
NCT00126958|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2009-02-18|||July 2002||2002-07-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Observational|||Cost-Effectiveness in Bladder Cancer|Cost-Effectiveness of Follow-up of Patients With Superficial Bladder Cancer|Unknown status|Active, not recruiting|Phase 4|500||Erasmus Medical Center|||||f||||||||||||||2017-02-18 17:33:35.87755|2017-02-18 17:33:35.87755
NCT00126945|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-04|2016-09-20|||August 2005||2005-08-01|September 2016|2016-09-01|October 2005|Actual|2005-10-01|||||Interventional|||Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs|A Primary Vaccination Study to Assess the Immunogenicity, Safety & Reactogenicity of 1 Dose of 4 Different Formulations of GSK Biologicals' Meningococcal Conjugate Vaccine (MenACWY) vs 1 Dose of MENCEVAX™ ACWY in Healthy Subjects Aged 15-19 Years|Completed||Phase 2|125|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:33:35.952943|2017-02-18 17:33:35.952943
NCT00126932|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2007-12-20|||October 2004||2004-10-01|December 2007|2007-12-01|December 2004||2004-12-01|||||Interventional|||Reduction of Topical Anesthetic Onset Time Using Ultrasound|Reduction of Topical Anesthetic Onset Time Using Ultrasound: A Randomized Controlled Trial Prior to Venipuncture in Young Children|Completed||Phase 4|70||Connecticut Children's Medical Center|||||f||||||||||||||2017-02-18 17:33:36.061569|2017-02-18 17:33:36.061569
NCT00126919|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2012-02-08|||October 2004||2004-10-01|February 2012|2012-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Reduction of Topical Anesthetic Time for Subcutaneous Port Access Using Ultrasound|Randomized Crossover Trial of Sonication Followed by 5 Minute LMX4 Application Compared With 30 Minute LMX4 Application for Topical Anesthesia Prior to Subcutaneous Port Access in Children|Completed||Phase 4|40|Anticipated|Connecticut Children's Medical Center|||||f||||||||||||||2017-02-18 17:33:36.330133|2017-02-18 17:33:36.330133
NCT00126906|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2005-08-22|||October 2002||2002-10-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi|Intermittent Preventive Treatment With Sulfadoxine/Pyrimethamine During Pregnancy Among HIV-Positive and HIV-Negative Women: 2-Dose Versus Monthly – Malawi|Completed||N/A|700||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:33:36.424688|2017-02-18 17:33:36.424688
NCT00126893|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2007-05-14|||October 2005||2005-10-01|December 2006|2006-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia|Phase 1 Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia|Terminated||Phase 1|36||Celgene|||||||||||||||||||2017-02-18 17:33:36.536717|2017-02-18 17:33:36.536717
NCT00126880|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2011-06-22|||July 2005||2005-07-01|June 2011|2011-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV|A Phase II, Randomised, Double-blind, Dose-ranging Study of AVX754 Versus Lamivudine in Treatment-experienced HIV-1 Infected Patients With the M184V Mutation in Reverse Transcriptase|Completed||Phase 2|52|Actual|Avexa||3|||f||||t||||||||||2017-02-18 17:33:36.622813|2017-02-18 17:33:36.622813
NCT00126867|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2017-01-12|||May 2005||2005-05-01|January 2017|2017-01-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Observational|||Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment|Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Based Adjuvant Chemotherapy in Colon Cancer Treatment|Recruiting||N/A|104|Anticipated|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 17:33:36.740731|2017-02-18 17:33:36.740731
NCT00126854|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2016-02-24|||October 2005||2005-10-01|March 2012|2012-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation|High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation|Completed||N/A|10|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 17:33:36.844163|2017-02-18 17:33:36.844163
NCT00126841|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2011-12-08|||November 2004||2004-11-01|December 2011|2011-12-01|November 2005||2005-11-01|||||Observational|||Computed Tomotherapy (CT) and Magnetic Resonance Imaging (MRI) Fusion on Radiation Treatment Planning for Patients With Cancer of the Cervix|To Assess the Feasibility and Impact of Computed Tomotherapy (CT) and Magnetic Resonance Imaging (MRI) Fusion on Radiation Treatment Planning for Ten Patients With Cancer of the Cervix|Completed||N/A|10||AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 17:33:36.936002|2017-02-18 17:33:36.936002
NCT00126828|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2016-02-23|||January 2003||2003-01-01|October 2011|2011-10-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer|A Phase I/II Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer|Completed||Phase 1/Phase 2|18||AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:33:37.027236|2017-02-18 17:33:37.027236
NCT00126815|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2016-02-23|||February 2004||2004-02-01|December 2011|2011-12-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Observational|||Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy|Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy|Completed||N/A|1000|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 17:33:37.122527|2017-02-18 17:33:37.122527
NCT00126802|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2016-07-04|||April 2005||2005-04-01|July 2016|2016-07-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer|The Role of Tomotherapy (Dynamic IMRT and Megavoltage CT Scanning) in Hypofractionated/Dose Escalated Conformal Radiation Treatment Using Magnetic Resonance Spectroscopy (MRS) Scans to Predict and Document the Pattern of Local Failure for High Risk Prostate Cancer|Active, not recruiting||Phase 1/Phase 2|60|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 17:33:37.203695|2017-02-18 17:33:37.203695
NCT00126789|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2012-06-04|||August 2005||2005-08-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain|An Open-Label, Long-Term Safety Study to Evaluate the Safety of the ZR-02-01 Matrix Transdermal Fentanyl Patch for the Treatment of Moderate to Severe Cancer Pain|Terminated||Phase 3|24|Actual|ZARS Pharma Inc.||1||Based on PK data, product did not meet requirement for further development.|f||||f||||||||||2017-02-18 17:33:37.289709|2017-02-18 17:33:37.289709
NCT00126776|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2009-07-14|2009-07-14||July 2004||2004-07-01|July 2009|2009-07-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Veterans Integrated Service Network (VISN) 23 Lung Disease Self Management/Case Management Program|VISN 23 Lung Disease Self Management/Case Management Program|Completed||N/A|743|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:33:37.404138|2017-02-18 17:33:37.404138
NCT00126763|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2012-06-04|||July 2005||2005-07-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain|An Open-Label, Long-Term Safety Study to Evaluate the Safety of the ZR-02-01 Matrix Transdermal Fentanyl Patch for the Treatment of Moderate to Severe Non-Malignant Chronic Pain|Terminated||Phase 3|105|Actual|ZARS Pharma Inc.||1||PK results suggested product did not meet requirement for further development.|f||||f||||||||||2017-02-18 17:33:37.786091|2017-02-18 17:33:37.786091
NCT00126750|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-06-24|2015-01-27||September 2003||2003-09-01|June 2015|2015-06-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|VA MI Plus||Web-Enhanced Guideline Implementation for Post MI CBOC Patients|MI-Plus: Web-enhanced Guideline Implementation for Post MI CBOC Patients|Completed||N/A|847|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:33:37.905168|2017-02-18 17:33:37.905168
NCT00126737|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2014-12-30|2014-12-02||October 2002||2002-10-01|December 2014|2014-12-01|December 2008|Actual|2008-12-01|February 2008|Actual|2008-02-01||Interventional|||Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee|Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee|Completed||N/A|110|Actual|VA Office of Research and Development|Due to the small number of females, the results may not be generalizable to females. Limitations include requirement of having good upper body strength, shoulder range, hand eye coordination, and an investment of purchasing poles of $30 per pair.|4|||f||||f||||||||||2017-02-18 17:33:38.280429|2017-02-18 17:33:38.280429
NCT00126724|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2009-07-27|||August 2005||2005-08-01|July 2009|2009-07-01|May 2009|Actual|2009-05-01|October 2008|Actual|2008-10-01||Interventional|||Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects|A Phase I/II Study of Repeat Intra-articular Administration of tgAAC94, a Recombinant Adeno-Associated Vector Containing the TNFR:Fc Fusion Gene, in Inflammatory Arthritis Subjects With and Without Concurrent TNF-alpha Antagonists|Completed||Phase 1/Phase 2|120|Anticipated|Targeted Genetics Corporation||4|||f||||t||||||||||2017-02-18 17:33:39.363849|2017-02-18 17:33:39.363849
NCT00126698|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2007-04-18|||January 2005||2005-01-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Interventional|||Prophylactic Antibiotics on Urethral Catheter Withdrawal|Use of Antibiotic Prophylaxis on Urethral Catheter Withdrawal: A Randomized Double-Blind Placebo-Controlled Trial|Completed||Phase 4|100||St. Antonius Hospital|||||f||||||||||||||2017-02-18 17:33:39.508181|2017-02-18 17:33:39.508181
NCT00126685|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2013-09-16|||April 2005||2005-04-01|June 2007|2007-06-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With Unselected Autologous Amplified Tumor-RNA|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:33:39.608182|2017-02-18 17:33:39.608182
NCT00126672|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2010-02-01|||June 2005||2005-06-01|October 2008|2008-10-01||||April 2010|Anticipated|2010-04-01||Interventional|||Sirolimus in Treating Patients With Angiomyolipoma of the Kidney|A Phase II Multi-Center Study of Rapamycin for Treating Kidney Angiomyolipomas in TSC or LAM Patients|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:33:39.716816|2017-02-18 17:33:39.716816
NCT00126659|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2014-04-21|2012-09-28||January 2006||2006-01-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer|A Phase II Neoadjuvant Clinical Trial to Evaluate the Efficacy of BAY 43-9006 (Sorafenib) in Metastatic Renal Cell Carcinoma|Terminated||Phase 2|10|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 17:33:39.853803|2017-02-18 17:33:39.853803
NCT00126646|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2010-06-17|||June 2005||2005-06-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|||BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma|Phase I Study of BL22, A Recombinant Immunotoxin for Chronic Lymphocytic Leukemia and CD22+ Lymphomas|Completed||Phase 1|24|Anticipated|MedImmune LLC||4|||f||||f||||||||||2017-02-18 17:33:40.684602|2017-02-18 17:33:40.684602
NCT00126633|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2012-09-13|||April 2004||2004-04-01|September 2012|2012-09-01|October 2008|Actual|2008-10-01|September 2006|Actual|2006-09-01||Interventional|||Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer|A Study of Fixed-Dose Rate Gemcitabine, Cisplatin, and Bevacizumab in Previously Untreated Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|53|Actual|University of California, San Francisco||1|||f||||t||||||||||2017-02-18 17:33:40.797019|2017-02-18 17:33:40.797019
NCT00126620|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-07-22|||September 2005||2005-09-01|July 2015|2015-07-01||||May 2011|Actual|2011-05-01||Interventional|||Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib; Tarceva) in Advanced Solid Tumors|Completed||Phase 1|17|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:33:40.907539|2017-02-18 17:33:40.907539
NCT00126607|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2013-02-27|||July 2005||2005-07-01|February 2013|2013-02-01||||May 2007|Actual|2007-05-01||Interventional|||Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer|Phase II Study of Trastuzumab (NSC-688097) in Advanced High Grade Salivary Gland Carcinoma|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Poor accrual.|f||||||||||||||2017-02-18 17:33:41.020351|2017-02-18 17:33:41.020351
NCT00126594|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2016-07-28|2016-02-09||June 2005||2005-06-01|July 2016|2016-07-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|||Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer|A Phase II Clinical Trial to Evaluate the Efficacy of BAY 43-9006 With or Without Low Dose Interferon in Metastatic Renal Cell Carcinoma|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:33:41.147361|2017-02-18 17:33:41.147361
NCT00126581|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2016-11-29|2013-10-07||August 2005||2005-08-01|October 2016|2016-10-01||||June 2010|Actual|2010-06-01||Interventional|||Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer|A Phase II Randomized Study of OSI-774 (ERLOTINIB) (NSC #718781) With or Without Carboplatin/Paclitaxel in Patients With Previously Untreated Adenocarcinoma of the Lung Who Never Smoked or Were Former Light Smokers|Active, not recruiting||Phase 2|188|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:33:42.173489|2017-02-18 17:33:42.173489
NCT00126568|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2014-05-07|2012-05-23||June 2005||2005-06-01|December 2012|2012-12-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer|Phase II Trial of BAY 43-9006 in Patients With Advanced Anaplastic Carcinoma of the Thyroid|Terminated||Phase 2|20|Actual|National Cancer Institute (NCI)|The study met the pre-specified criteria for enrollment of all planned 32 patients. However due to poor accrual the study was halted.|1|||f||||||||||||||2017-02-18 17:33:43.526214|2017-02-18 17:33:43.526214
NCT00126555|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2014-12-16|2014-12-16||March 2005||2005-03-01|September 2014|2014-09-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional||Of the 23 participants enrolled, one participant who was not evaulable for response withdrew before beginning treatment.|Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer|A Phase II Study of ZD1839 and Radiation in Patients With Squamous Cell Carcinoma of the Skin|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 17:33:44.155056|2017-02-18 17:33:44.155056
NCT00126542|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2014-05-13|||April 2005||2005-04-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|January 2007|Actual|2007-01-01||Interventional|||Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer|A Phase II Trial of Bevacizumab (NSC# 704865) and OSI-774 (NSC# 718781) In Recurrent Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:33:44.75466|2017-02-18 17:33:44.75466
NCT00126516|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2013-10-28|||May 2004||2004-05-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline|Effects of Angiotensin II Receptor Blockers (ARB) and Angiotensin Converting Enzyme Inhibitors (ACEI) on Progression of Silent Brain Infarction and Cognitive Decline in Japanese Patients With Essential Hypertension in the Elderly|Completed||Phase 4|395|Actual|Nara Medical University||2|||f||||t||||||||||2017-02-18 17:33:44.867345|2017-02-18 17:33:44.867345
NCT00126503|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-01-06|2012-11-16||May 2005||2005-05-01|September 2014|2014-09-01|February 2012|Actual|2012-02-01|October 2011|Actual|2011-10-01||Interventional|||Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer|A Phase I/II Trial of BAY 43-9006 in Combination With Bevacizumab in Patients With Advanced Renal Cancer|Completed||Phase 1/Phase 2|73|Actual|National Cancer Institute (NCI)|To depict results of this Phases I/II study accurately, each phase was entered as an ARM to enable separation of the data by phase. Events reported in the Adverse Event and Serious Adverse Event sections include AEs and SAEs from Phase I and Phase II|1|||f||||||||||||||2017-02-18 17:33:44.981884|2017-02-18 17:33:44.981884
NCT00126490|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-06-03|2013-05-29||March 2005||2005-03-01|December 2013|2013-12-01|August 2013|Actual|2013-08-01|June 2012|Actual|2012-06-01||Interventional||18 of the 19 who started treatment were evaluable. One participant had to withdraw after only one infusion because they fell and broke both wrists.|Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|Phase 2 Trial of Sequential Bevacizumab Then Subcutaneous Interleukin-2 in Metastatic Renal Cancer|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)|"Investigators planned to have 38 participants treated on this study. 0 had to be entered for Other (not including Serious) Adverse Events, because they were not tabulated for treatment 3/30/05 through 1/24/07."|1|||f||||||||||||||2017-02-18 17:33:45.782885|2017-02-18 17:33:45.782885
NCT00126477|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2013-04-29|||March 1996||1996-03-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|April 2007|Actual|2007-04-01||Observational|||Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer|The Quality of Life of Adult Survivors Who Received a Marrow Transplant as a Child|Completed||Phase 2|750|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:33:46.094156|2017-02-18 17:33:46.094156
NCT00126464|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2013-11-05|||November 2004||2004-11-01|July 2006|2006-07-01||||||||Interventional|||Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast|A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant (Faslodex) in Breast Ductal Carcinoma (DCIS)|Unknown status|Active, not recruiting|N/A|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:33:46.186096|2017-02-18 17:33:46.186096
NCT00126451|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2013-05-21|||December 2004||2004-12-01|May 2013|2013-05-01||||October 2005|Actual|2005-10-01||Interventional|||A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)|A Phase II Clinical Study of Oral Suberoylanilide Hydroxamic Acid in Patients With Relapsed or Refractory Breast, Colorectal, and Non-small Cell Lung Cancer.|Terminated||Phase 2|42||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:33:46.281805|2017-02-18 17:33:46.281805
NCT00126438|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-03|2009-12-02|||July 2005||2005-07-01|December 2009|2009-12-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease|An Open-Label, Multicenter, Phase 3 Study Evaluating the Prognostic Usefulness of I-123 mIBG Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event|Completed||Phase 3|515|Actual|GE Healthcare||1|||f||||t||||||||||2017-02-18 17:33:46.3644|2017-02-18 17:33:46.3644
NCT00126425|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2016-10-19|2015-06-30||July 2005||2005-07-01|October 2016|2016-10-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional||All participants who received IMP manufactured by the sponsor.|Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease|An Open-Label, Multicenter, Phase 3 Study Evaluating the Prognostic Usefulness of I-123 mIBG Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event|Completed||Phase 3|587|Actual|GE Healthcare||1|||f||||t||||||||||2017-02-18 17:33:46.468735|2017-02-18 17:33:46.468735
NCT00126412|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2007-05-15|||July 2005||2005-07-01|May 2007|2007-05-01||||||||Interventional|||Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma||Completed||Phase 3|185||GE Healthcare|||||||||||||||||||2017-02-18 17:33:46.777891|2017-02-18 17:33:46.777891
NCT00126399|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2005-08-18|||June 2004||2004-06-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea||Completed||Phase 3|528||CollaGenex Pharmaceuticals|||||||||||||||||||2017-02-18 17:33:46.85875|2017-02-18 17:33:46.85875
NCT00126386|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2011-11-18|||January 2004||2004-01-01|August 2011|2011-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community|Zoledronic Acid (Zometa) for the Management of Tumor-induced Hypercalcemia (TIH) and Malignant Bone Pain (MBP) in the Community: A Feasibility Study|Completed||N/A|11|Actual|AHS Cancer Control Alberta||1|||f||||t||||||||||2017-02-18 17:33:46.944182|2017-02-18 17:33:46.944182
NCT00126373|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2012-01-19|||May 2005||2005-05-01|January 2012|2012-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Trial of Wellbutrin for Crohn's Disease|A Randomized Controlled Trial of Wellbutrin for Crohn's Disease|Completed||Phase 2/Phase 3|1|Actual|Altschuler, Eric, M.D.||2|||f||||||||||||||2017-02-18 17:33:47.036818|2017-02-18 17:33:47.036818
NCT00126360|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2005-11-07|||August 2005||2005-08-01|August 2005|2005-08-01|May 2016||2016-05-01|||||Interventional|||STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)|Pilot for a Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Ant-Oestrogen Therapy Delayed Until After Radiotherapy|Unknown status|Recruiting|Phase 4|100||St George Hospital, Australia|||||f||||||||||||||2017-02-18 17:33:47.280461|2017-02-18 17:33:47.280461
NCT00126347|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2005-08-17|||August 2002||2002-08-01|August 2005|2005-08-01|July 2003||2003-07-01|||||Interventional|||Effect of Betaine, Serine and Folic Acid on Vascular Function in Healthy Volunteers|Effect of Lowering of Plasma Homocysteine Concentrations After an Oral Methionine Load on Vascular Function in Healthy Volunteers|Completed||N/A|40||Wageningen Centre for Food Sciences|||||f||||||||||||||2017-02-18 17:33:47.378891|2017-02-18 17:33:47.378891
NCT00126334|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2011-07-20|||April 2003||2003-04-01|July 2011|2011-07-01|January 2011|Actual|2011-01-01|December 2010|Actual|2010-12-01||Interventional|CRIT||Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot||Completed||Phase 4|45|Actual|Medstar Health Research Institute||2|||f||||t||||||||||2017-02-18 17:33:47.474153|2017-02-18 17:33:47.474153
NCT00126321|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2010-02-01|||November 2004||2004-11-01|February 2010|2010-02-01|March 2011|Anticipated|2011-03-01|November 2010|Anticipated|2010-11-01||Interventional|||Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)|Phase II Study of Cladribine, High-dose Cytarabine and Idarubicin in Patients With Relapsed Acute Myeloid Leukemia|Unknown status|Recruiting|Phase 2|50|Anticipated|University Hospital, Bonn||1|||f||||f||||||||||2017-02-18 17:33:47.586475|2017-02-18 17:33:47.586475
NCT00126308|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2009-03-31|||November 2005||2005-11-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy|A Multi-Centre, Open-Label, Randomised Study to Assess the Efficacy, Durability and Safety of Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy (FLASH)|Terminated||Phase 4|100|Actual|Kirby Institute||2||no change in primary endpoint at week 48|f||||f||||||||||2017-02-18 17:33:47.684176|2017-02-18 17:33:47.684176
NCT00126295|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2005-08-18|||June 2003||2003-06-01|August 2005|2005-08-01|May 2005||2005-05-01|||||Interventional|||Evaluation of an Individualised Written Education Package for Stroke Patients|Evaluation of a Computer-Generated Individualised Written Education Package for Patients Following Stroke and Their Carers|Completed||Phase 2|130||Medical Benefits Fund of Australia|||||f||||||||||||||2017-02-18 17:33:47.821514|2017-02-18 17:33:47.821514
NCT00126282|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2009-07-27|||December 2003||2003-12-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|||||Interventional|||A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder|A Randomized, Double-blind, Placebo-controlled Medication Trial With D-Cycloserine for Individuals With Obsessive-compulsive Disorder Currently Receiving Behavior Therapy|Completed||N/A|50|Anticipated|Massachusetts General Hospital|||||f||||t||||||||||2017-02-18 17:33:47.90109|2017-02-18 17:33:47.90109
NCT00005366|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|April 2001|2001-04-01|August 1998|Actual|1998-08-01|||||Observational|||Biobehavioral Mechanisms of Blood Pressure Regulation||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.422053|2017-02-18 18:15:05.422053
NCT00126269|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2006-09-07|||May 2003||2003-05-01|September 2006|2006-09-01||||||||Interventional|||Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary|A Randomized Phase III Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary and a Predicted Favorable Prognosis|Unknown status|Recruiting|Phase 3|192||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:33:48.009802|2017-02-18 17:33:48.009802
NCT00126256|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2015-08-11|||February 2002||2002-02-01|August 2015|2015-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer|Randomized Trial of Treatment Strategy for Chemotherapy in Colorectal Cancer, FFCD 2000-05|Completed||Phase 3|570|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:33:48.310827|2017-02-18 17:33:48.310827
NCT00126243|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2005-08-16|||January 1999||1999-01-01|August 2005|2005-08-01|October 2003||2003-10-01|||||Interventional|||Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin’s Lymphoma|Multicenter, Open Label, Phase II Trial to Evaluate the Efficacy and Safety of Treatment With Rituximab + CHOP Regimen in Patients With HIV Related Non-Hodgkin’s Lymphomas. ANRS 085 Rituximab|Terminated||Phase 2|60||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:33:48.435286|2017-02-18 17:33:48.435286
NCT00126230|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2006-09-07|||January 2004||2004-01-01|September 2006|2006-09-01||||||||Interventional|||Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer|A Prospective Phase II Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer Who Achieve a Response or a Stabilization to Docetaxel-Estramustine|Terminated||Phase 2|55||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 17:33:48.541502|2017-02-18 17:33:48.541502
NCT00126217|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2008-10-20|||July 2002||2002-07-01|October 2008|2008-10-01|September 2006|Actual|2006-09-01|May 2006|Actual|2006-05-01||Interventional|||Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine|BCG Vaccination and Childhood Morbidity and Mortality: Interventions With Possible Implications for the Immunisation Policy in Developing Countries. Revaccination of Young Children With BCG Vaccine.|Terminated||Phase 4|2871|Actual|Bandim Health Project||2||A cluster of deaths in the BCG-arm compared with controls|f||||||||||||||2017-02-18 17:33:48.637169|2017-02-18 17:33:48.637169
NCT00126204|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2010-03-03|||March 2004||2004-03-01|September 2006|2006-09-01|July 2006||2006-07-01|||||Interventional|||Adjunctive Treatment With Doxycycline to Enhance the Durability of Endovascular Aortic Aneurysm Repair|Adjunctive Treatment With Doxycycline in Endovascular Aneurysm Repair|Completed||N/A|75||Barnes-Jewish Hospital|||||f||||||||||||||2017-02-18 17:33:48.754844|2017-02-18 17:33:48.754844
NCT00126191|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2013-04-17|2012-11-30||July 2005||2005-07-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|December 2009|Actual|2009-12-01||Interventional|||Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma|Phase II Study of Intensive Chemotherapy and Rituximab in Burkitt Lymphoma|Terminated||Phase 2|10|Actual|Dana-Farber Cancer Institute|Early termination leading to small numbers of subjects analyzed.|2||closed due to slow accrual|f||||t||||||||||2017-02-18 17:33:48.863876|2017-02-18 17:33:48.863876
NCT00126178|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2012-09-06|||May 2005||2005-05-01|September 2012|2012-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer|A Multi-Center, Randomized, Phase 3 Study of Adjuvant Oncophage® Versus Observation in Patients With High Risk After Surgical Treatment for Renal Cell Carcinoma|Terminated||Phase 3|600||Agenus Inc.|||||||||||||||||||2017-02-18 17:33:49.339637|2017-02-18 17:33:49.339637
NCT00126165|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-02|2012-01-18|||September 2004||2004-09-01|January 2012|2012-01-01|August 2011|Actual|2011-08-01|||||Interventional|||Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer|A Phase I/II Study of Escalated-dose Short-course Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer|Completed||Phase 1/Phase 2|72|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:33:49.452022|2017-02-18 17:33:49.452022
NCT00126152|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2005-07-29|||September 2003||2003-09-01|July 2005|2005-07-01|May 2005||2005-05-01|||||Interventional|||Senior Falls Prevention Study|Targeted Injury Prevention Program: Preventing Falls Among Older Adults|Completed||N/A|453||Washington State, Department of Health|||||f||||||||||||||2017-02-18 17:33:49.544019|2017-02-18 17:33:49.544019
NCT00126139|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2007-05-01|||April 2004||2004-04-01|May 2007|2007-05-01|May 2005|Actual|2005-05-01|||||Interventional|||Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis|Abciximab Versus Aspirin for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic >50% Carotid Stenosis: A Pilot Study (ASTERICS)|Terminated||Phase 3|100||University of Zurich||||Higher hemorrhage rates of Abciximab in ABESST II trial|f||||t||||||||||2017-02-18 17:33:49.636568|2017-02-18 17:33:49.636568
NCT00126126|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2015-09-21|2014-11-24||January 2005||2005-01-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|EBAR||Evidence Based Amputee Rehabilitation (EBAR) Program|Evidence Based Amputee Rehabilitation (EBAR) Program|Completed||N/A|20|Actual|VA Office of Research and Development|Recruitment was challenging. We screened over 350 veterans and non-veterans with lower limb loss and we were only able to enroll 20.|2|||f||||t||||||||||2017-02-18 17:33:49.750457|2017-02-18 17:33:49.750457
NCT00126113|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2014-10-06|2014-09-26||August 2005||2005-08-01|October 2014|2014-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|PPT||The Performance-Perceptual Test as a Counseling Tool|The Performance-Perceptual Test as a Counseling Tool|Completed||N/A|74|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:33:50.183727|2017-02-18 17:33:50.183727
NCT00126100|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2007-11-23|||February 2004||2004-02-01|November 2007|2007-11-01|July 2005|Actual|2005-07-01|||||Interventional|||Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)|A Randomized Clinical Trial of Stem Cell Mobilization by Granulocyte-Colony-Stimulating Factor in Patients With Acute Myocardial Infarction. Regenerate Vital Myocardium by Vigorous Activation of Bone Marrow Stem Cells (REVIVAL-2) Trial|Completed||Phase 4|114|Actual|Deutsches Herzzentrum Muenchen||2|||f||||t||||||||||2017-02-18 17:33:50.692687|2017-02-18 17:33:50.692687
NCT00126087|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-31|2013-01-18|||July 2005||2005-07-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|December 2007|Actual|2007-12-01||Interventional|||Potentiation of Procedural Motor Learning in Health and Disease|Potentiation of Procedural Motor Learning by Pharmacological Neuromodulation and Transcranial Direct Current Stimulation in Health and Disease|Terminated||Phase 4|18|Actual|University Hospital Muenster||||no further funding available for recruiting and testing participants|f||||||||||||||2017-02-18 17:33:50.823424|2017-02-18 17:33:50.823424
NCT00126074|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2015-01-15|||October 2004||2004-10-01|March 2006|2006-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus Rhythm in Female Subjects With Recent Onset Atrial Fibrillation or Flutter|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:33:50.931504|2017-02-18 17:33:50.931504
NCT00126061|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2015-01-15|||October 2004||2004-10-01|March 2006|2006-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus Rhythm in Male Subjects With Recent Onset Atrial Fibrillation or Flutter|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:33:51.043927|2017-02-18 17:33:51.043927
NCT00126048|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-03-17|||July 2005||2005-07-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma|Randomised Controlled Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma|Completed||Phase 2/Phase 3|54|Actual|University of Glasgow||2|||f||||t||||||||||2017-02-18 17:33:51.148742|2017-02-18 17:33:51.148742
NCT00126035|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2005-08-16|||February 2004||2004-02-01|July 2005|2005-07-01|December 2004||2004-12-01|||||Interventional|||Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura|Open, Randomised, Multi-Centre, Cross-Over Study to Investigate the Efficacy of the Migraid Device Compared With No Device Treatment in the Acute, Early Treatment of Migraine With Typical Aura|Completed||N/A|134||Profess Medical Consultancy|||||f||||||||||||||2017-02-18 17:33:51.280847|2017-02-18 17:33:51.280847
NCT00126022|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2015-01-15|||December 2004||2004-12-01|March 2006|2006-03-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus Rhythm in Female Subjects With Recent Onset Atrial Fibrillation|Completed||Phase 3|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:33:51.512394|2017-02-18 17:33:51.512394
NCT00126009|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2008-04-08|||May 2004||2004-05-01|April 2008|2008-04-01||||||||Interventional|||SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients|A 3-Month, Open, Randomised Trial Comparing the Efficacy and Safety of the Association Valproate-Amisulpride to the Association Valproate-Haloperidol in Bipolar I Patients Suffering From a Manic Episode|Completed||Phase 2|120||Sanofi|||||f||||||||||||||2017-02-18 17:33:51.679209|2017-02-18 17:33:51.679209
NCT00125996|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2005-08-16|||July 2004||2004-07-01|January 2005|2005-01-01|February 2006||2006-02-01|||||Interventional|||Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure|A Randomised Controlled Study to Assess the Acute and Chronic Effects of Intravenous Iron Supplementation in Anaemic and Non-Anaemic Iron Deficient Patients With Chronic Heart Failure|Unknown status|Recruiting|Phase 1/Phase 2|42||National Heart and Lung Institute|||||f||||||||||||||2017-02-18 17:33:51.772864|2017-02-18 17:33:51.772864
NCT00125983|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2012-05-17||||||May 2012|2012-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women|A Phase II Pharmacokinetic Study of the Transdermal Contraceptive System and Oral Contraceptive in HIV-1 Infected Women on Lopinavir/Ritonavir|Completed||Phase 2|32|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:33:51.883781|2017-02-18 17:33:51.883781
NCT00125970|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-11-07||2010-01-30|September 2005||2005-09-01|November 2012|2012-11-01|January 2010|Actual|2010-01-01|February 2008|Actual|2008-02-01||Interventional|||Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults|A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed By a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRC-HIVADV014-00-VP, in HIV-1 Uninfected Adult Participants|Completed||Phase 2|480|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:33:52.010925|2017-02-18 17:33:52.010925
NCT00125957|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2014-08-05|2014-06-11||August 2005||2005-08-01|August 2014|2014-08-01|December 2011|Actual|2011-12-01|January 2010|Actual|2010-01-01||Interventional|||The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression|The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression|Completed||Phase 3|32|Actual|Mclean Hospital||2|||f||||f||||||||||2017-02-18 17:33:52.159591|2017-02-18 17:33:52.159591
NCT00125944|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2007-05-08|||July 2005||2005-07-01|May 2007|2007-05-01|January 2006||2006-01-01|||||Interventional|||Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults|Completed||Phase 3|300||MedImmune LLC|||||||||||||||||||2017-02-18 17:33:52.601894|2017-02-18 17:33:52.601894
NCT00125931|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2014-08-25|2012-10-22||September 2005||2005-09-01|August 2014|2014-08-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional||Inpatients with manic symptoms.|Effects of Pentazocine on Manic Symptoms|Inpatient Clinical Trial Examining the Effects of Pentazocine on Manic Symptoms|Completed||Phase 2|10|Actual|Mclean Hospital|Small number of participants in open-label trial.|1|||f||||f||||||||||2017-02-18 17:33:52.689787|2017-02-18 17:33:52.689787
NCT00125918|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2008-02-13|||August 2005||2005-08-01|February 2008|2008-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension|PHIRST-1: Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment in Patients With Pulmonary Arterial Hypertension|Completed||Phase 3|406|Actual|Eli Lilly and Company||5|||f||||f||||||||||2017-02-18 17:33:52.963172|2017-02-18 17:33:52.963172
NCT00125905|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2009-09-29|||October 2003||2003-10-01|November 2003|2003-11-01|July 2006||2006-07-01|||||Interventional|||ISTAPS: A Stepped Primary Care Smoking Cessation Intervention|Effectiveness of a Stepped Primary Care Smoking Cessation Intervention Based on an Evidence Based Clinical Practice Guideline (ISTAPS Project)|Unknown status|Active, not recruiting|N/A|3012||Jordi Gol i Gurina Foundation|||||f||||||||||||||2017-02-18 17:33:53.100286|2017-02-18 17:33:53.100286
NCT00125879|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2014-02-04|||June 2005||2005-06-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|June 2006|Actual|2006-06-01||Interventional|||Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602|A Long-Term Continuation Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602|Completed||Phase 2/Phase 3|16|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:33:56.302029|2017-02-18 17:33:56.302029
NCT00125866|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2015-05-27|||September 2005||2005-09-01|April 2007|2007-04-01|January 2006|Actual|2006-01-01|||||Interventional|||The Effect of Cocoa Flavonoids on Blood Pressure|The Effect of Cocoa Polyphenols on Various Cardiovascular Measurements Including Blood Pressure|Completed||N/A|50||Imperial College London|||||f||||||||||||||2017-02-18 17:33:56.425207|2017-02-18 17:33:56.425207
NCT00125853|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2014-04-07|||July 2006||2006-07-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||The Effect of Nebivolol on Insulin Sensitivity|A Trial to Compare the Effects of Nebivolol Versus Atenolol on Various Cardiovascular Measurements Including Insulin Sensitivity|Completed||N/A|54|Actual|Imperial College London||2|||f||||f||||||||||2017-02-18 17:33:56.51526|2017-02-18 17:33:56.51526
NCT00125840|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2014-02-04|||August 2002||2002-08-01|February 2014|2014-02-01|August 2007|Actual|2007-08-01|||||Interventional|||Clofarabine in Adult Patients With Advanced Solid Tumors|A Phase I and Pharmacokinetic Study of Clofarabine in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|||Sanofi|||||||||||||||||||2017-02-18 17:33:56.624957|2017-02-18 17:33:56.624957
NCT00125827|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2014-03-17|||October 2003||2003-10-01|March 2014|2014-03-01|February 2006|Actual|2006-02-01|October 2004|Actual|2004-10-01||Interventional|||Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors|A Phase I Dose Escalation and Pharmacokinetic Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors|Completed||Phase 1|24|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:33:56.715986|2017-02-18 17:33:56.715986
NCT00125814|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2005-08-15|||December 2001||2001-12-01|August 2005|2005-08-01|January 2005||2005-01-01|||||Interventional|||Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression|Multi-Center Trial to Evaluate the Efficacy and Safety of Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression (ANRS 105 INTERVAC)|Terminated||Phase 3|200||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:33:56.818431|2017-02-18 17:33:56.818431
NCT00125801|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2008-10-13|||August 2005||2005-08-01|October 2008|2008-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Pain Pen for Breakthrough Cancer Pain|Breakthrough Cancer Pain: A Randomized Trial Comparing Oral Morphine Immediate Release and Self-Administration of Subcutaneous Hydromorphone Using an Injection Pen|Terminated||Phase 3|50|Anticipated|Erasmus Medical Center||1||Lack of patients|f||||t||||||||||2017-02-18 17:33:57.163095|2017-02-18 17:33:57.163095
NCT00125788|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2013-03-15||2011-11-17|March 2004||2004-03-01|November 2011|2011-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia|A Phase II, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of L Glutamine Therapy for Sickle Cell Anemia and Sickle ß0-Thalassemia|Completed||Phase 2|81|Actual|Emmaus Medical, Inc.||2|||f||||f||||||||||2017-02-18 17:33:57.270128|2017-02-18 17:33:57.270128
NCT00125775|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2010-01-06|||May 2005||2005-05-01|July 2009|2009-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?|Phase 4 Study of Recombinant Hepatitis B Vaccine in Peritoneal Dialysis Subjects|Completed||Phase 4|130|Anticipated|Chinese University of Hong Kong||2|||f||||f||||||||||2017-02-18 17:33:57.390294|2017-02-18 17:33:57.390294
NCT00125762|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2005-08-12|||March 2005||2005-03-01|July 2005|2005-07-01||||||||Interventional|||FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy|Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy|Unknown status|Recruiting|Phase 3|300||Beth Israel Deaconess Medical Center|||||||||||||||||||2017-02-18 17:33:57.489273|2017-02-18 17:33:57.489273
NCT00125749|ClinicalTrials.gov processed this data on February 17, 2017|2005-08-01|2013-09-20|||July 2005||2005-07-01|September 2013|2013-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Vaccination of Patients With Stage IV Melanoma With Dendritic Cells|Vaccination of Patients With Stage IV Melanoma With Dendritic Cells Generated Ex Vivo From Monocytes and Loaded With Heat Treated Killed Allogeneic Melanoma Cells|Completed||Phase 1/Phase 2|30|Actual|Baylor Research Institute||1|||f||||f||||||||||2017-02-18 17:33:57.580101|2017-02-18 17:33:57.580101
NCT00125736|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2010-01-28|||August 2005||2005-08-01|January 2010|2010-01-01||||September 2008|Actual|2008-09-01||Interventional|||A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium|A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium|Completed||Phase 4|520||Eisai Inc.|||||f||||||||||||||2017-02-18 17:33:57.683766|2017-02-18 17:33:57.683766
NCT00125723|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2010-12-22|||May 2004||2004-05-01|December 2010|2010-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy|A Multicenter, Open-label, Phase 4 Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy|Completed||Phase 4|2252|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:33:57.805504|2017-02-18 17:33:57.805504
NCT00125710|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2016-07-14|||June 1998||1998-06-01|June 2014|2014-06-01||||August 2012|Actual|2012-08-01||Observational|||Comparative 2-D Tumor Analysis in Familial Gliomas|Comparative 2-D Tumor Analysis in Familial Gliomas|Completed||N/A|5|Anticipated|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 17:33:57.899627|2017-02-18 17:33:57.899627
NCT00125697|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2016-07-14|||May 2005||2005-05-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Observational|||Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy|Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy|Completed||N/A|49|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 17:33:57.9866|2017-02-18 17:33:57.9866
NCT00125684|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2012-01-18|||July 2003||2003-07-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Bioavailability and Effectiveness of Transdermally Administered Morphine|Bioavailability and Effectiveness of Transdermally Administered Morphine|Completed||Phase 1|6|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:33:58.086076|2017-02-18 17:33:58.086076
NCT00125671|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2009-09-27|||January 2000||2000-01-01|September 2009|2009-09-01|April 2006||2006-04-01|||||Interventional|||Warfarin and Antiplatelet Vascular Evaluation|A Phase III Randomized Trial of Warfarin Plus Antiplatelet Therapy Versus Antiplatelet Therapy Alone in Patients With Peripheral Vascular Disease|Unknown status|Active, not recruiting|Phase 3|2400||Warfarin and Antiplatelet Vascular Evaluation|||||f||||||||||||||2017-02-18 17:33:58.182314|2017-02-18 17:33:58.182314
NCT00125658|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2014-10-27|||February 2008||2008-02-01|October 2014|2014-10-01|September 2011|Actual|2011-09-01|June 2009|Actual|2009-06-01||Interventional|||Mechanisms of Upper-Extremity Motor Recovery in Post-stroke Hemiparesis|Mechanisms of Upper-Extremity Motor Recovery in Post-stroke Hemiparesis|Completed||Phase 3|40|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 17:33:58.275768|2017-02-18 17:33:58.275768
NCT00125645|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2011-08-15|||March 2005||2005-03-01|April 2007|2007-04-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)|Global Left Ventricular Function After Acute Myocardial Infarction. Treatment With the Angiotensin 2-Receptor Blocker Irbesartan|Suspended||Phase 4|200|Anticipated|University of Southern Denmark||1||Study terminated due to lack of patients|f||||||||||||||2017-02-18 17:33:58.375826|2017-02-18 17:33:58.375826
NCT00125632|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2009-02-03|||August 2005||2005-08-01|December 2006|2006-12-01|May 2008|Actual|2008-05-01|||||Interventional|||Measuring Reading Rehabilitation Outcomes|Measuring Reading Rehabilitation Outcomes|Completed||N/A|90|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:33:58.467393|2017-02-18 17:33:58.467393
NCT00125619|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2016-12-23|2015-04-17||September 2005||2005-09-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Internally Versus Externally Guided Body Weight-Supported Treadmill Training (BWSTT) for Locomotor Recovery Post-stroke|Internally v. Externally Guided BWSTT for Locomotor Recovery Post-stroke|Completed||N/A|16|Actual|VA Office of Research and Development|Small sample size, but consistent with intent of pilot study Inclusion criterion was >6 months post-event, allowing for large heterogeneity in chronicity Intervention was limited (12 sessions distributed over 4 weeks)|2|||f||||f||||||||||2017-02-18 17:33:58.559884|2017-02-18 17:33:58.559884
NCT00125606|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2012-12-17|||October 2004||2004-10-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide|Randomized Phase 3 Trial for Patients With AML in CR2 Comparing Total Body Irradiation (TBI) With 8Gy/Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide|Terminated||Phase 3|30|Actual|University Hospital Muenster||2||insufficient patient recruitement|f||||t||||||||||2017-02-18 17:33:59.533837|2017-02-18 17:33:59.533837
NCT00125593|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2012-01-31|2011-08-19||June 2003||2003-06-01|January 2012|2012-01-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|SHARP||Study of Heart and Renal Protection|Study of Heart and Renal Protection (SHARP): The Effects of Lowering LDL-cholesterol With Simvastatin 20mg Plus Ezetimibe 10mg in Patients With Chronic Kidney Disease: a Randomized Placebo-controlled Trial|Completed||Phase 4|9438|Actual|University of Oxford||3|||f||||t||||||||||2017-02-18 17:33:59.645631|2017-02-18 17:33:59.645631
NCT00125580|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2007-11-30|||August 2005||2005-08-01|November 2007|2007-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Healthy Sleeping and Feeding During Infancy|Healthy Sleeping and Feeding During Infancy: Pilot Study for the Primary Prevention of Obesity in Primary Care|Completed||Phase 1|40|Actual|Penn State University||1|||f||||||||||||||2017-02-18 17:34:00.166389|2017-02-18 17:34:00.166389
NCT00125567|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2009-06-19|||August 2005||2005-08-01|June 2009|2009-06-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|SEWOP||Stalevo in Early Wearing-Off Patients|Multicentre, Randomised, Double-Blind Study to Compare Stalevo to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off|Completed||Phase 4|223|Actual|Orion Corporation, Orion Pharma||2|||f||||f||||||||||2017-02-18 17:34:00.263571|2017-02-18 17:34:00.263571
NCT00125554|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2005-08-11|||May 1998||1998-05-01|July 2005|2005-07-01|July 2001||2001-07-01|||||Interventional|||Metyrapone as Additive Treatment in Major Depression|Double-Blind, Placebo Controlled Trial of Metyrapone as Augmenting Agent in the Treatment of Major Depression|Completed||Phase 2|63||Universitätsklinikum Hamburg-Eppendorf|||||f||||||||||||||2017-02-18 17:34:00.386693|2017-02-18 17:34:00.386693
NCT00125541|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2009-05-01|||November 2006||2006-11-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|April 2008|Actual|2008-04-01||Interventional|||C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema|Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema|Completed||Phase 2/Phase 3|6|Anticipated|Sanquin||1|||f||||||||||||||2017-02-18 17:34:00.480624|2017-02-18 17:34:00.480624
NCT00125528|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2016-12-16|2015-02-03||July 2012||2012-07-01|December 2016|2016-12-01|November 2014|Actual|2014-11-01|April 2014|Actual|2014-04-01||Interventional|||D-cycloserine in the Management of Chronic Low Back Pain|D-Cycloserine in the Management of Chronic Low Back Pain: A Double-Blind, Randomized, Placebo-Controlled Pilot Study|Completed||Phase 2|41|Actual|Northwestern University|It is not clear whether observed effects are due to escalating dose or duration of D-cycloserine use. A larger population and longer duration of treatment would be needed to determine this.|2|||f||||f||||||||||2017-02-18 17:34:00.576418|2017-02-18 17:34:00.576418
NCT00125515|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2013-01-28|2012-12-18||June 2005||2005-06-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|NAMHS-1||Memantine and Naltrexone Treatment for Opioid Dependence|Evaluation of NMDA Antagonist for Opiate Dependence|Completed||Phase 2|81|Actual|New York State Psychiatric Institute|It is possible that concomitant naltrexone might have exacerbated protracted withdrawal, thus masking the potential ameliorative effects of memantine that have been previously observed in other trials.|3|||f||||t||||||||||2017-02-18 17:34:00.926238|2017-02-18 17:34:00.926238
NCT00125502|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2011-09-16|||August 1999||1999-08-01|September 2011|2011-09-01|January 2010|Actual|2010-01-01|June 2007|Actual|2007-06-01||Interventional|||Recombinant CMV gB Vaccine in Postpartum Women|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Recombinant CMV gB Vaccine in Postpartum Women|Completed||Phase 2|464|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 17:34:01.413656|2017-02-18 17:34:01.413656
NCT00125489|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2010-08-26|||May 2005||2005-05-01|March 2007|2007-03-01|December 2005||2005-12-01|||||Interventional|||CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi|Chloroquine and Sulfadoxine-Pyrimethamine Efficacy for the Treatment of Uncomplicated Falciparum Malaria in Blantyre, Malawi|Completed||Phase 4|210||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:34:01.526653|2017-02-18 17:34:01.526653
NCT00125463|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2005-08-08|||September 2001||2001-09-01|April 2005|2005-04-01|December 2005||2005-12-01|||||Interventional|||Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients|Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients|Unknown status|Active, not recruiting|Phase 3|3200||The Japanese Society of Hypertension|||||f||||||||||||||2017-02-18 17:34:01.715589|2017-02-18 17:34:01.715589
NCT00125450|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2008-05-26|||September 2004||2004-09-01|October 2006|2006-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|BRONKINOU||Evaluation of Chest Physiotherapy for Acute Bronchiolitis in Toddlers (BRONKINOU)|Efficacy and Safety of Chest Physiotherapy With Forced Expiratory Technique for Acute Bronchiolitis in Toddlers|Completed||N/A|500|Actual|Assistance Publique - Hôpitaux de Paris||2|||f||||t||||||||||2017-02-18 17:34:01.820852|2017-02-18 17:34:01.820852
NCT00125437|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2009-07-13|||September 2005||2005-09-01|December 2008|2008-12-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy|Safety and Efficacy of Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy|Terminated||N/A|200|Anticipated|Hebei Medical University||||Poor compliance with the therapy and lot of patients were lost to follow up.|f||||||||||||||2017-02-18 17:34:02.211218|2017-02-18 17:34:02.211218
NCT00125424|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2008-11-06|||July 2005||2005-07-01|November 2008|2008-11-01|September 2005|Actual|2005-09-01|||||Interventional|||Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy|A Randomized, Double-Blind, Dose-Response Study to Assess the Efficacy and Safety of AQUAVAN® Injection for Procedural Sedation in Patients Undergoing Colonoscopy|Completed||Phase 2/Phase 3|125||Eisai Inc.|||||||||||||||||||2017-02-18 17:34:02.309496|2017-02-18 17:34:02.309496
NCT00125411|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2012-03-22|||March 2007||2007-03-01|March 2012|2012-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Study of Satraplatin (JM-216) in Combination With Docetaxel|Phase I Study of the Oral Platinum Agent Satraplatin (JM-216) in Combination With Docetaxel in Treatment of Advanced Malignancies|Terminated||Phase 1|28|Actual|Agennix||1||Sponsor decided to discontinue study drug development.|f||||||||||||||2017-02-18 17:34:02.4343|2017-02-18 17:34:02.4343
NCT00125398|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2008-11-06|||July 2005||2005-07-01|November 2008|2008-11-01|May 2007|Actual|2007-05-01|||||Interventional|||GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting|A Phase II, Randomized, Open-Label Study to Examine the Safety and Efficacy of GPI 15715 for Sedation of Patients Requiring Intubation and Mechanical Ventilation in the Intensive Care Unit Setting|Completed||Phase 2|60||Eisai Inc.|||||f||||||||||||||2017-02-18 17:34:02.530013|2017-02-18 17:34:02.530013
NCT00125385|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2015-04-09|||July 2005||2005-07-01|April 2015|2015-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)|Phase I, Open-Label, Multi-Center, Single-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic of GC1008 in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 1|25|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 17:34:02.641833|2017-02-18 17:34:02.641833
NCT00125372|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2014-07-14|||December 2005||2005-12-01|July 2014|2014-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Study of Tarceva and Targretin in Stage I-II Lung Cancer|A Clinical and Pharmacologic Study of the Combination of Erlotinib and Bexarotene in Resectable Clinical Stage I-II Non-Small Cell Lung Cancer|Completed||N/A|15|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 17:34:02.763747|2017-02-18 17:34:02.763747
NCT00125359|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2014-11-11|||August 2005||2005-08-01|July 2013|2013-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer|A Phase II Clinical Study of Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Patients With Advanced Non-small Cell Lung Cancer|Completed||Phase 2|42|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 17:34:02.870507|2017-02-18 17:34:02.870507
NCT00125346|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2011-10-10|||September 2005||2005-09-01|October 2011|2011-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|EVOLVE||Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Trial to Assess the Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis (CF) Subjects|Terminated||Phase 3|98|Actual|Novartis||||per Data Monitoring Committee recommendation|||||||||||||||2017-02-18 17:34:02.974135|2017-02-18 17:34:02.974135
NCT00125333|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2008-11-18|||March 2005||2005-03-01|November 2008|2008-11-01|November 2005||2005-11-01|||||Interventional|||Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis|A Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Safety of Repeated Topical Application of Three Concentrations of NF-kappaB Decoy in Adults With Mild-to-Moderate Atopic Dermatitis|Completed||Phase 1/Phase 2|75||Anesiva, Inc.|||||||||||||||||||2017-02-18 17:34:03.108772|2017-02-18 17:34:03.108772
NCT00125320|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2007-12-19|||June 2004||2004-06-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery|A Phase III Study of the Conversion Efficacy and Safety of Repeated Intravenous Doses of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter Following Valvular and/or Coronary Artery Bypass Graft Surgery|Completed||Phase 3|190|Actual|Astellas Pharma Inc|||||f||||t||||||||||2017-02-18 17:34:03.214675|2017-02-18 17:34:03.214675
NCT00125307|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2015-07-31|||January 2004||2004-01-01|May 2008|2008-05-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis|Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis|Completed||Phase 4|20||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:34:03.325938|2017-02-18 17:34:03.325938
NCT00125294|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2012-01-18|||September 2003||2003-09-01|August 2011|2011-08-01|January 2007|Actual|2007-01-01|June 2006|Actual|2006-06-01||Interventional|||Sublingual Methadone for the Management of Cancer Breakthrough Pain|Evaluation of a Dose Titration Protocol for Sublingual Methadone Hydrochloride for the Management of Cancer-related Breakthrough Pain|Completed||Phase 1|10|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:34:03.415653|2017-02-18 17:34:03.415653
NCT00125281|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-29|2017-01-24|||July 25, 2005||2005-07-25|July 2, 2008|2008-07-02|July 2, 2008|Actual|2008-07-02|July 31, 2007|Actual|2007-07-31||Interventional|||SAMe to Treat Biliary Cirrhosis Symptoms|S-Adenosyl Methionine for Symptomatic Treatment of Primary Biliary Cirrhosis|Terminated||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:34:03.500144|2017-02-18 17:34:03.500144
NCT00125268|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-08-02|2012-08-02||July 2005||2005-07-01|August 2012|2012-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Near Infrared Light for the Treatment of Painful Peripheral Neuropathy|A Phase III, Double Blind, Randomized, Placebo-controlled Study to Assess the Efficacy of Adjunct Monochromatic Near-infrared Photoenergy (MIRE) in Patients With Painful Axonal Peripheral Neuropathy|Terminated||Phase 3|30|Actual|Mayo Clinic|This study was terminated early because the study was unable to enroll enough patients.|2||Unable to enroll enough patients|f||||t||||||||||2017-02-18 17:34:03.610299|2017-02-18 17:34:03.610299
NCT00125255|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children|A Randomized, Double-blind, Placebo Controlled, Parallel Study Evaluating the Efficacy of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) for Induction of Local Dermal Anesthesia Before Vascular Access Procedures in Children|Completed||Phase 3|81|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-02-18 17:34:03.94575|2017-02-18 17:34:03.94575
NCT00125242|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2014-12-22|2014-11-21||July 2005||2005-07-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|February 2009|Actual|2009-02-01||Interventional||SFA Treatment Participants = Stroke survivors with chronic aphasia. Non Treatment Stimuli Development Participants = non-brain-damaged persons who were enrolled for purposes of stimuli development.|Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis|Word-Retrieval for Aphasia: Facilitation of Generalization|Completed||N/A|110|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:34:04.055052|2017-02-18 17:34:04.055052
NCT00125229|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-06-22|||August 2005||2005-08-01|June 2012|2012-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients|Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients|Terminated||Phase 4|10|Anticipated|The University of Texas Health Science Center at San Antonio|||1|Dr. Hladky died Sept 2006 prior to study completion|f||||||||||||||2017-02-18 17:34:04.34269|2017-02-18 17:34:04.34269
NCT00125216|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2014-04-04|||December 2004||2004-12-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of the Effects of Response Elaboration Training for Aphasia|Evaluation of the Effects of Response Elaboration Training for Aphasia|Completed||N/A|47|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:34:04.448444|2017-02-18 17:34:04.448444
NCT00125203|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-03-13|||July 2003||2003-07-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Randomized, Double-Blind, Placebo-Controlled Study of Safety and Efficacy of Botulinum Toxin Type B (Myobloc) in Sialorrhea in Amyotrophic Lateral Sclerosis|Completed||Phase 2/Phase 3|20||The University of Texas Health Science Center at San Antonio|||||f||||t||||||||||2017-02-18 17:34:04.56733|2017-02-18 17:34:04.56733
NCT00125190|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-06-14|2010-03-23||July 2005||2005-07-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency|Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With Primary IGF-1 Deficiency: A Multi-Center, Open Label, Concentration-Controlled Study|Completed||Phase 2/Phase 3|45|Actual|Ipsen||1|||f||||t||||||||||2017-02-18 17:34:04.757986|2017-02-18 17:34:04.757986
NCT00125177|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2010-11-09|||January 2003||2003-01-01|July 2005|2005-07-01|April 2008|Actual|2008-04-01|||||Interventional|||IRIS: Incontinence Research Intervention Study|Office for Research on Women's Health (ORWH): Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women's Health. Project 3: Selection Criteria For Muscle Therapy in SUI|Completed||Phase 1/Phase 2|320|Anticipated|University of Michigan|||||f||||||||||||||2017-02-18 17:34:05.345188|2017-02-18 17:34:05.345188
NCT00125164|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-06-14|2009-07-08||March 2004||2004-03-01|June 2012|2012-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency|Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Prepubertal Children With Growth Failure Associated With Primary IGF-1 Deficiency: A Phase 3, Randomized, Open Label, Observation-Controlled, Multicenter, Parallel-Dose Comparison Trial|Completed||Phase 3|137|Actual|Ipsen||4|||f||||t||||||||||2017-02-18 17:34:05.448746|2017-02-18 17:34:05.448746
NCT00125151|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2009-05-01|||February 2006||2006-02-01|May 2009|2009-05-01|April 2007|Actual|2007-04-01|||||Interventional|||C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema|Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema|Completed||Phase 3|15|Anticipated|Sanquin|||||f||||||||||||||2017-02-18 17:34:06.728956|2017-02-18 17:34:06.728956
NCT00125138|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2011-05-17|2011-04-11||July 2005||2005-07-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease|Safety and Efficacy of Melperone in the Treatment of Patients With Psychosis Associated With Parkinson's Disease|Completed||Phase 2|90|Actual|Lundbeck LLC||4|||f||||t||||||||||2017-02-18 17:34:06.825474|2017-02-18 17:34:06.825474
NCT00125125|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2011-11-07|||May 2005||2005-05-01|November 2011|2011-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Fluvastatin in Adults With Dislipidemia With History of Muscle Problems|Efficacy and Tolerability of Fluvastatin in Adults With Dislipidemia With History of Muscle Problems Due to Other Previous Statin Intake|Completed||Phase 4|218|Actual|Novartis|||||||||||||||||||2017-02-18 17:34:07.342201|2017-02-18 17:34:07.342201
NCT00125112|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2010-01-15|||February 2005||2005-02-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Internet Weight Control for Bingeing Adolescents|Internet Weight Control for Bingeing Adolescents|Completed||Phase 1|120|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:34:07.438833|2017-02-18 17:34:07.438833
NCT00125099|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-05-16||||||May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection|Safety and Immunogenicity of the HIV-1 DNA Vaccine VRC-HIVDNA009-00-VP (GAG-POL-NEF-MULTICLADE ENV) in HIV-1 Infected Subjects Treated During Acute HIV Infection|Completed||Phase 1/Phase 2|21|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:34:07.527165|2017-02-18 17:34:07.527165
NCT00125086|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2005-09-12|||July 2005||2005-07-01|September 2005|2005-09-01|February 2006||2006-02-01|||||Interventional|||Platelets for Acute Wound Healing|Platelets in Acute Wounds: A Punch Biopsy Study (PAWS II)|Completed||N/A|4||Medtronic|||||f||||||||||||||2017-02-18 17:34:07.632028|2017-02-18 17:34:07.632028
NCT00125060|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2005-08-09|||August 2000||2000-08-01|February 2004|2004-02-01|April 2004||2004-04-01|||||Interventional|||Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures|Transesophageal MRI in Conjunction With Lipid Lowering Measures|Completed||N/A|72||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:34:07.802|2017-02-18 17:34:07.802
NCT00125047|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2008-08-25|||October 2001||2001-10-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood|Effectiveness of a Combined Vi Vaccination and Health Education Program on Reducing the Burden of Typhoid During Childhood: A Demonstration Project in Karachi|Completed||Phase 4|27231|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-02-18 17:34:07.897061|2017-02-18 17:34:07.897061
NCT00125034|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2014-08-05|2011-08-23||July 2005||2005-07-01|August 2011|2011-08-01|November 2010|Actual|2010-11-01|March 2007|Actual|2007-03-01||Interventional|OPUS||Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)|Open, Randomized, Controlled, Multicenter Phase II Study Comparing 5-FU/FA Plus Oxaliplatin (FOLFOX-4) Plus Cetuximab Versus 5-FU/FA Plus Oxaliplatin (FOLFOX-4) as First-line Treatment for Epidermal Growth Factor Receptor-expressing Metastatic Colorectal Cancer|Completed||Phase 2|344|Actual|Merck KGaA|A non-specific outcome measure 'Safety' was deleted from this entry in error. A replacement outcome has been created. The 'Safety' outcome refers to adverse events and these are shown in the 'Adverse Events' section.|2|||f||||f||||||||||2017-02-18 17:34:08.021263|2017-02-18 17:34:08.021263
NCT00125021|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2009-10-30|||October 2003||2003-10-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|June 2004|Actual|2004-06-01||Interventional|||Tarceva and Capecitabine for Pancreatic Cancer|A Phase II Study of OSI-774 (Tarceva) in Combination With Capecitabine in Previously Treated Patients With Metastatic Pancreatic Cancer|Completed||Phase 2|32|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:34:09.532257|2017-02-18 17:34:09.532257
NCT00125008|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-28|2008-08-25|||May 2003||2003-05-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever|Randomized Controlled Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever in Eastern Kolkata, West Bengal, India|Completed||Phase 4|37673|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-02-18 17:34:09.645087|2017-02-18 17:34:09.645087
NCT00124995|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2013-02-12|||October 2003||2003-10-01|February 2013|2013-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Trial of Terbutaline for the Treatment of Status Asthmaticus in Children|Double-blinded Randomized Trial of Terbutaline to Shorten ICU Length of Stay in the Treatment of Status Asthmaticus in Children|Completed||Phase 4|40||Connecticut Children's Medical Center|||||f||||||||||||||2017-02-18 17:34:09.76993|2017-02-18 17:34:09.76993
NCT00124982|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-02-23|2011-02-18||April 2005||2005-04-01|February 2012|2012-02-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy|A Phase III, Multi-Center, Open Label Study to Evaluate the Efficacy, Tolerability and Safety of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-Biologic DMARDs Who Have an Inadequate Response to Anti-TNF Therapy and Have Limited Therapeutic Options|Completed||Phase 3|1286|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 17:34:09.917337|2017-02-18 17:34:09.917337
NCT00124969|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-05-07|||January 2002||2002-01-01|October 2006|2006-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure|Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure (ADAM [Amlodipine and Dialysis Patients, Action on Mortality])|Completed||Phase 4|356|Actual|Charite University, Berlin, Germany||2|||f||||t||||||||||2017-02-18 17:34:13.288875|2017-02-18 17:34:13.288875
NCT00124956|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2006-01-17|||June 2003||2003-06-01|January 2006|2006-01-01||||||||Interventional|||Doxorubicin Pharmacokinetic (PK) Study|Impact of Body Composition on Pharmacokinetics of Doxorubicin in Pediatric Patients|Terminated||Phase 1/Phase 2|9||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:34:13.406665|2017-02-18 17:34:13.406665
NCT00124943|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-03-28|2012-02-21||July 2005||2005-07-01|March 2012|2012-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|SNAPIST-III||Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis|A Phase I/II Safety Trial of Intracoronary Administration of Systemic Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis|Completed||Phase 1/Phase 2|112|Actual|Celgene||4|||f||||f||||||||||2017-02-18 17:34:13.497113|2017-02-18 17:34:13.497113
NCT00124930|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-01-18|||May 2005||2005-05-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer|A Randomized Double-blind, Parallel Group Study Comparing Olanzapine (Zyprexa) With Haloperidol (Novo-peridol) for the Relief of Nausea and Vomiting in Patients With Advanced Cancer|Terminated||Phase 3|80|Anticipated|AHS Cancer Control Alberta||||Study suspended due to low enrollment|f||||||||||||||2017-02-18 17:34:14.805815|2017-02-18 17:34:14.805815
NCT00124917|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2017-01-24|||July 21, 2005||2005-07-21|September 26, 2016|2016-09-26|March 6, 2011|Actual|2011-03-06|March 6, 2011|Actual|2011-03-06||Interventional|||Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer|A Phase I Study of Image Guided Dose Escalation With Intensity Modulated Radiation Therapy (IMRT) to Histologically Confirmed Regions of Prostate Cancer|Completed||Phase 1|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:34:14.918648|2017-02-18 17:34:14.918648
NCT00124904|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2010-01-12|||September 1999||1999-09-01|January 2010|2010-01-01|December 2006||2006-12-01|||||Interventional|||Biofeedback for Fecal Incontinence|Biofeedback for Fecal Incontinence and Constipation|Completed||N/A|165||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:34:15.033584|2017-02-18 17:34:15.033584
NCT00124891|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2007-12-06|||June 2005||2005-06-01|December 2007|2007-12-01|November 2006|Actual|2006-11-01|||||Interventional|||Study Evaluating GAP-486 in Non-Sustained Ventricular Tachycardia|Study Evaluating Subjects With Non-Sustained Ventricular Tachycardia|Terminated||Phase 2|500||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:34:15.140035|2017-02-18 17:34:15.140035
NCT00124878|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2007-08-09|||August 2003||2003-08-01|July 2005|2005-07-01|September 2009|Anticipated|2009-09-01|||||Interventional|||Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community|Trial of Male Circumcision: HIV, STD and Behavioral Effects in Men, Women and the Community|Unknown status|Active, not recruiting|Phase 3|5200|Actual|Wawer, Maria J., M.D.||2|||f||||t||||||||||2017-02-18 17:34:15.292066|2017-02-18 17:34:15.292066
NCT00124865|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2015-06-02|||July 2005||2005-07-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study|Safety and Immunogenicity Evaluation of an Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) in Volunteers|Completed||Phase 1|32||U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-02-18 17:34:15.394867|2017-02-18 17:34:15.394867
NCT00124852|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2011-01-11|||October 2005||2005-10-01|January 2011|2011-01-01|July 2007|Actual|2007-07-01|December 2006|Actual|2006-12-01||Interventional|||The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People|The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People: a Double-blind Placebo-controlled Trial|Completed||N/A|302|Actual|Wageningen University||3|||f||||f||||||||||2017-02-18 17:34:15.48185|2017-02-18 17:34:15.48185
NCT00124839|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2008-04-14|||October 2005||2005-10-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Naltrexone in Borderline Personality Disorder|Evaluation of the Efficacy of the Opioid Antagonist Naltrexone on the Incidence and Intensity of Flashbacks and Dissociative States in Patients With Borderline Personality Disorder|Terminated||Phase 3|48|Anticipated|Central Institute of Mental Health, Mannheim||4||Difficulties in recruiting enough subjects|f||||f||||||||||2017-02-18 17:34:15.580565|2017-02-18 17:34:15.580565
NCT00124826|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2006-01-31|||May 2004||2004-05-01|July 2005|2005-07-01||||||||Interventional|||SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points|Spectroscopic Evaluation of Lesion Evolution in Stroke: Trial of Insulin for Acute Lactic Acidosis (SELESTIAL)|Completed||Phase 2|45||University of Glasgow|||||f||||||||||||||2017-02-18 17:34:15.838992|2017-02-18 17:34:15.838992
NCT00124813|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2010-02-01|||August 2002||2002-08-01|February 2010|2010-02-01|November 2010|Anticipated|2010-11-01|May 2010|Anticipated|2010-05-01||Interventional|||Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma|Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) as Induction Therapy and a Randomized Trial of Thalidomide vs Thalidomide Plus Oral Idarubicin as Maintenance Therapy in Patients With Multiple Myeloma|Unknown status|Recruiting|Phase 2|80|Anticipated|University Hospital, Bonn||1|||f||||||||||||||2017-02-18 17:34:15.941135|2017-02-18 17:34:15.941135
NCT00124800|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2009-09-23|||November 2005||2005-11-01|September 2009|2009-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus|The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus|Completed||Phase 1|41|Actual|Tinnitus Research Consortium||1|||f||||||||||||||2017-02-18 17:34:16.050558|2017-02-18 17:34:16.050558
NCT00124787|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2012-02-29|||April 2005||2005-04-01|February 2012|2012-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|GAG||A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Gastroenteritis|A Randomized Double-blind Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Moderate Vomiting Due to Acute Gastroenteritis|Completed||Phase 4|150|Actual|St. Justine's Hospital||2|||f||||f||||||||||2017-02-18 17:34:16.153253|2017-02-18 17:34:16.153253
NCT00124774|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2008-03-28|||November 2004||2004-11-01|March 2008|2008-03-01|April 2006|Actual|2006-04-01|||||Interventional|||Nucleoplasty for Contained Herniated Lumbar Discs|Nucleoplasty for Contained Herniated Lumbar Discs: A Randomised, Double Blind, Prospective Comparison With Sham Treatment|Completed||Phase 3|50|Anticipated|Rijnstate Hospital|||||f||||||||||||||2017-02-18 17:34:16.263327|2017-02-18 17:34:16.263327
NCT00124761|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2010-09-02|||December 2002||2002-12-01|September 2010|2010-09-01|May 2009|Actual|2009-05-01|April 2009|Actual|2009-04-01||Interventional|||A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases|A Randomised Trial of Surgery Plus Whole Brain Radiotherapy (WBRT) Versus Radiosurgery Plus WBRT for Solitary Brain Metastases|Completed||Phase 3|22|Actual|Royal Adelaide Hospital||2|||f||||f||||||||||2017-02-18 17:34:16.36034|2017-02-18 17:34:16.36034
NCT00124748|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2012-01-05|2011-11-02||June 2005||2005-06-01|January 2012|2012-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|TOPS||Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)|A Randomized Open-label Study of 400 mg Versus 800 mg of Imatinib Mesylate in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Using Molecular Endpoints.|Terminated||Phase 3|476|Actual|Novartis||2||"This study was prematurely discontinued because no improvement was observed in the 800mg dose~   compared to 400mg dose"|f||||||||||||||2017-02-18 17:34:16.498938|2017-02-18 17:34:16.498938
NCT00124735|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2016-07-14|2008-12-05||October 2004||2004-10-01|June 2016|2016-06-01|September 2007|Actual|2007-09-01|August 2007|Actual|2007-08-01||Interventional|||A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)|An Open-label, Randomized, Phase IIIB, Multicenter Trial to Evaluate the Pharmacodynamic Parameters of Intubation Bolus, and Bolus and Infusion Maintenance Doses of Zemuron® in Pediatric and Adolescent Subjects|Completed||Phase 3|149|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:34:18.158079|2017-02-18 17:34:18.158079
NCT00124722|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2015-05-29|||December 2004||2004-12-01|May 2015|2015-05-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Study to Compare Different Intubating Doses of Zemuron in Pediatric and Adolescent Subjects Under General Anesthesia|A Randomized, Assessor-blind, Dose-ranging, Phase IIIB, Multicenter Trial Comparing the Intubating Conditions and Time Course of Block of Three Different Intubating Doses (0.45 mg/kg, 0.6 mg/kg, and 1.0 mg/kg) of Zemuron® in Pediatric and Adolescent Subjects Under General Anesthesia|Completed||Phase 3|207|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 17:34:19.29043|2017-02-18 17:34:19.29043
NCT00124709|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2011-02-25|2010-12-08||October 2003||2003-10-01|February 2011|2011-02-01|November 2008|Actual|2008-11-01|January 2008|Actual|2008-01-01||Interventional|||Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification|An Investigation of the Safety and Efficacy of Elidel® 1% Cream in Atopic Disease Modification, Assessed in a 3-year Randomized Double-blind Vehicle Controlled Phase to Evaluate Effects on Atopic Dermatitis in Infants, and a 2-3 Year Open-label Phase to Evaluate the Effect of Early Intervention Versus Delayed Intervention With Elidel® on the Incidence of Asthma in Children|Terminated||Phase 4|1091|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:34:19.397286|2017-02-18 17:34:19.397286
NCT00005365|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||February 1993||1993-02-01|August 2004|2004-08-01|January 1998||1998-01-01|||||Observational|||Central Obesity and Disease Risk in Japanese Americans||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:05.506864|2017-02-18 18:15:05.506864
NCT00124696|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2017-01-11|||December 2002||2002-12-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||Cocaethylene as a Treatment for Cocaine Dependence - 1|Cocaethylene Substitution Therapy and Tolerance Induction in Treating Cocaine Dependence|Completed||Phase 1|8||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:34:20.155158|2017-02-18 17:34:20.155158
NCT00124683|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2017-01-11|||September 2001||2001-09-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1|Optimizing Treatment for Schizophrenic Smokers|Completed||Phase 2|59|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||t||||||||||2017-02-18 17:34:20.246641|2017-02-18 17:34:20.246641
NCT00124657|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2015-10-29|2013-09-10||March 2005||2005-03-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|July 2012|Actual|2012-07-01||Interventional|||Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma|A Phase I/II Trial of a New Tyrosine Kinase Inhibitor (Tarceva; Erlotinib Hydrochloride; OSI-774) During and After Radiotherapy in the Treatment of Patients With Newly Diagnosed High Grade Glioma and Unfavorable Low-Grade Glioma|Completed||Phase 1/Phase 2|62|Actual|St. Jude Children's Research Hospital||1|||f||||t||||||||||2017-02-18 17:34:20.356385|2017-02-18 17:34:20.356385
NCT00124644|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2013-05-01|||March 2006||2006-03-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase I Study of R115777 (Zarnestra) in Combination With Induction Chemotherapy in Patients With Newly Diagnosed, High Risk Acute Myeloid Leukemia|Terminated||Phase 1|30||National Cancer Institute (NCI)||||"Withdrawn due to toxicity problems"|f||||||||||||||2017-02-18 17:34:24.711193|2017-02-18 17:34:24.711193
NCT00124618|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2016-07-01|2015-03-09||January 2006||2006-01-01|July 2016|2016-07-01|March 2015|Actual|2015-03-01|February 2008|Actual|2008-02-01||Interventional|||Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|Cetuximab (C225) and Radiation in Elderly and /or Poor Performance Status Patients With Locally Advanced Non-Small Cell Lung Cancer: A Phase II Study to Evaluate Survival and Toxicity|Completed||Phase 2|58|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:34:25.067461|2017-02-18 17:34:25.067461
NCT00124605|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2013-01-04|||April 2005||2005-04-01|January 2013|2013-01-01||||June 2009|Actual|2009-06-01||Interventional|||Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma|Phase I Trial of Arsenic Trioxide in Combination With Pamidronate Disodium|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:34:25.702376|2017-02-18 17:34:25.702376
NCT00124579|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2015-03-05|2013-01-02||August 2005||2005-08-01|March 2015|2015-03-01|June 2010|Actual|2010-06-01|June 2008|Actual|2008-06-01||Interventional|||S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|S0417 A Phase II Study of Bortezomib (Velcade™, PS-341), Thalidomide, and Dexamethasone in Patients With Refractory Multiple Myeloma|Terminated||Phase 2|7|Actual|Southwest Oncology Group||1||poor accrual|f||||t||||||||||2017-02-18 17:34:25.826186|2017-02-18 17:34:25.826186
NCT00124566|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2016-01-15|||June 2004||2004-06-01|January 2016|2016-01-01|December 2009|Actual|2009-12-01|January 2006|Actual|2006-01-01||Interventional|||Study of Irofulven in Patients With Hormone-refractory Prostate Cancer|Three-Arm Randomized Phase II Clinical Study of Irofulven/Prednisone, Irofulven/Capecitabine/Prednisone or Mitoxantrone/Prednisone in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer Patients|Completed||Phase 2|135|Actual|Eisai Inc.||3|||f||||||||||||||2017-02-18 17:34:26.466269|2017-02-18 17:34:26.466269
NCT00124553|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-27|2007-03-27|||August 2006||2006-08-01|March 2007|2007-03-01|June 2008|Anticipated|2008-06-01|||||Interventional|||LOADD (Lifestyle Over and Above Drugs in Diabetes) Study|The Potential for Diet Modification to Improve Glycaemic Control and Cardiovascular Risk Factors Over and Above Drug Therapy in Type 2 Diabetes at High Risk of Cardiovascular Disease|Unknown status|Recruiting|N/A|220||Edgar National Centre for Diabetes Research|||||f||||||||||||||2017-02-18 17:34:26.618026|2017-02-18 17:34:26.618026
NCT00124540|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2008-05-26|||August 2005||2005-08-01|May 2008|2008-05-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Misoprostol for Preventing Postpartum Hemorrhage|Misoprostol for Preventing Postpartum Hemorrhage|Completed||N/A|1200|Actual|Gynuity Health Projects||2|||f||||||||||||||2017-02-18 17:34:26.721786|2017-02-18 17:34:26.721786
NCT00124527|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2008-11-06|||March 2005||2005-03-01|November 2008|2008-11-01||||||||Interventional|||Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer|Phase 2 Clinical Trial of Bi-Weekly Dosing of Irofulven Plus Capecitabine in Patients With Anaplastic or Locally Advanced/Metastatic Differentiated Thyroid Cancer|Completed||Phase 2|35||Eisai Inc.|||||||||||||||||||2017-02-18 17:34:26.831891|2017-02-18 17:34:26.831891
NCT00124514|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2014-07-25|||June 2003||2003-06-01|July 2014|2014-07-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Triptorelin for Ovary Protection in Childhood Onset Lupus||Completed||Phase 2|30|Actual|Children's Hospital Medical Center, Cincinnati||1|||f||||t||||||||||2017-02-18 17:34:27.059214|2017-02-18 17:34:27.059214
NCT00124501|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2008-05-29|||October 2004||2004-10-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effectiveness of Biofeedback-Assisted Relaxation Training in Children With Eosinophilic Duodenitis|The Impact of Biofeedback-Assisted Relaxation Training on Pain and Functional Disability in Children Diagnosed With Eosinophilic Duodenitis: Pilot Study|Completed||N/A|20|Actual|Children's Mercy Hospital Kansas City||2|||f||||f||||||||||2017-02-18 17:34:27.195588|2017-02-18 17:34:27.195588
NCT00124488|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2011-12-08|||June 2005||2005-06-01|December 2011|2011-12-01|November 2005||2005-11-01|||||Observational|||Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix|Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix|Completed||N/A|10||AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 17:34:27.311619|2017-02-18 17:34:27.311619
NCT00124475|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2010-07-16|||December 2004||2004-12-01|July 2010|2010-07-01|September 2007|Actual|2007-09-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis|Efficacy and Safety of BAL4079 in the Treatment of Severe Refractory Chronic Hand Dermatitis|Completed||Phase 3|1035||Basilea Pharmaceutica|||||f||||||||||||||2017-02-18 17:34:27.417674|2017-02-18 17:34:27.417674
NCT00114907|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2007-04-05|||June 2005||2005-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Effects of Black Tea on Cardiovascular Disease in the Mauritian Population|Effects of Black Tea on Cardiovascular Disease in the Mauritian Population|Completed||N/A|270||University of Mauritius|||||f||||||||||||||2017-02-18 17:38:05.894039|2017-02-18 17:38:05.894039
NCT00124462|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2009-01-28|||March 2008||2008-03-01|January 2009|2009-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Trial of Realignment Therapy for Treatment of Medial Knee Osteoarthritis|A Randomized Trial of Realignment Therapy for Treatment of Medial Knee Osteoarthritis|Completed||N/A|80|Actual|Boston University||2|||f||||||||||||||2017-02-18 17:34:27.516416|2017-02-18 17:34:27.516416
NCT00124449|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-03-18|2009-05-21||February 2005||2005-02-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|May 2007|Actual|2007-05-01||Interventional|||Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients|A Phase II Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients With Undifferentiated Arthritis Who Are at High Risk for the Development of RA|Completed||Phase 2|56|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 17:34:27.625711|2017-02-18 17:34:27.625711
NCT00124436|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2010-07-16|||March 2005||2005-03-01|July 2010|2010-07-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis|Follow up Efficacy and Safety Study of BAL4979 in the Treatment of Chronic Hand Dermatitis Refractory to Topical Treatment|Completed||Phase 3|300||Basilea Pharmaceutica|||||f||||||||||||||2017-02-18 17:34:28.788329|2017-02-18 17:34:28.788329
NCT00124423|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2016-02-24|||June 2004||2004-06-01|April 2012|2012-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer|Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer|Completed||N/A|5|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 17:34:28.881238|2017-02-18 17:34:28.881238
NCT00124410|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2016-02-24|||January 2000||2000-01-01|December 2011|2011-12-01||||December 2008|Actual|2008-12-01||Observational|||Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation|A Pilot Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation|Completed||N/A|100|Actual|AHS Cancer Control Alberta|||1||f||||||||||||||2017-02-18 17:34:28.970243|2017-02-18 17:34:28.970243
NCT00124397|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2005-08-04|||July 2001||2001-07-01|July 2005|2005-07-01|December 2004||2004-12-01|||||Interventional|||Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)|Effect of High Dose Statin Therapy on Endothelial Function in Patients With Type 2 Diabetes Mellitus Without CAD|Completed||Phase 4|186||University of Southern Denmark|||||f||||||||||||||2017-02-18 17:34:29.052703|2017-02-18 17:34:29.052703
NCT00124384|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2008-04-22|||January 2005||2005-01-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||The Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia|Phase 4 Study of the Effects of Modafinil on Waking Function and on Sleep in Individuals With Primary Insomnia|Completed||Phase 4|40|Anticipated|University of Rochester|||||f||||t||||||||||2017-02-18 17:34:29.141359|2017-02-18 17:34:29.141359
NCT00124371|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2005-08-04|||January 2003||2003-01-01|July 2005|2005-07-01|October 2005||2005-10-01|||||Interventional|||Programme to Optimise Risk Factors in Patients Waiting for Coronary Artery Bypass Surgery|Fit For Surgery Study: A Randomised Controlled Trial of a Nurse-Led Programme to Optimise Mental and Physical Fitness for Surgery and Coronary Risk Factor Control in Patients Waiting for Coronary Artery Bypass Surgery|Completed||Phase 2/Phase 3|200||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:34:29.240663|2017-02-18 17:34:29.240663
NCT00124358|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2007-03-23|||August 2005||2005-08-01|March 2007|2007-03-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Buprenorphine and Integrated HIV Care Evaluation|An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings|Unknown status|Recruiting|Phase 4|1350||The New York Academy of Medicine|||||f||||||||||||||2017-02-18 17:34:29.344016|2017-02-18 17:34:29.344016
NCT00124345|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2008-09-24|||June 2005||2005-06-01|September 2008|2008-09-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Medical Gas Humidification During Noninvasive Mechanical Ventilation|The Humidification During Noninvasive Mechanical Ventilation Delivered by Helmet|Completed||N/A|19|Actual|Policlinico Hospital||1|||f||||f||||||||||2017-02-18 17:34:29.453741|2017-02-18 17:34:29.453741
NCT00124332|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2009-04-17|||January 2005||2005-01-01|April 2009|2009-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)|Randomized, Multicenter, Double-Blind, Placebo-Controlled, Two-Arm Parallel Group Trial of Rimonabant 20-mg od, for Inhibition of Atherosclerosis Progression Assessed by IVUS (IntraVascular UltraSounds), in Overweight Patients With Clustering Risk Factors|Completed||Phase 3|839|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:34:29.551692|2017-02-18 17:34:29.551692
NCT00124319|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2011-10-03|||June 2005||2005-06-01|May 2009|2009-05-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Observational|||Risk Factors for Anterior Cruciate Ligament (ACL) Injury|Epidemiology of Jump-Landing Movements and ACL Injury|Completed||N/A|4800|Anticipated|University of North Carolina, Chapel Hill|||1||f||||||||||||||2017-02-18 17:34:29.668695|2017-02-18 17:34:29.668695
NCT00124306|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2013-10-28|||February 2005||2005-02-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|April 2008|Actual|2008-04-01||Interventional|IC01||Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)|A Randomized Multicenter Clinical Trial to Evaluate the Efficacy of Amitriptyline for the Treatment of Painful Bladder Syndrome (PBS) in Newly Diagnosed Patients|Completed||Phase 3|271|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||||||||||||2017-02-18 17:34:29.766342|2017-02-18 17:34:29.766342
NCT00124293|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-10-23|||October 2004||2004-10-01|October 2013|2013-10-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury|A Multi Centre Observational Study to Evaluate the Incidence and Magnitude of Haemorrhagic Progression of Cerebral Contusions and the Identification of Important Safety Issues Following Traumatic Brain Injury|Completed||N/A|63|Actual|Novo Nordisk A/S|||1||f||||f||||||||||2017-02-18 17:34:29.889746|2017-02-18 17:34:29.889746
NCT00124280|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2016-11-16|||July 2005||2005-07-01|November 2016|2016-11-01||||October 2007|Actual|2007-10-01||Interventional|||Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Open Label, Non-randomized, Phase 2 Study Investigating the Effect of RAD001 Monotherapy in Patients With Advanced NSCLC Previously Treated With Either Chemotherapy Only or With Chemotherapy and EGFR Inhibitor(s)|Completed||Phase 2|85|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:34:29.988073|2017-02-18 17:34:29.988073
NCT00124267|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2005-08-03|||September 2003||2003-09-01|July 2005|2005-07-01|January 2004||2004-01-01|||||Interventional|||Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria|Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria: a Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 3|108||Makerere University|||||f||||||||||||||2017-02-18 17:34:30.106429|2017-02-18 17:34:30.106429
NCT00124254|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2016-10-24|||September 2003||2003-09-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Study of People With Rheumatoid Arthritis Who Require Joint Surgery in the Hand|An Outcome Study of Rheumatoid Hand Arthroplasty|Active, not recruiting||Phase 4|200|Anticipated|University of Michigan||2|||f||||t||||||||||2017-02-18 17:34:30.212066|2017-02-18 17:34:30.212066
NCT00124241|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2015-05-08||||||May 2015|2015-05-01|November 2005|Actual|2005-11-01|February 2003|Actual|2003-02-01||Interventional|||An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B|A Phase IIb Extension Study of LdT (Telbivudine), Lamivudine or LdT Plus Lamivudine in Patients With Chronic Hepatitis B Who Have Completed Study NV-02B-003|Completed||Phase 2|||Novartis|||||||||||||||||||2017-02-18 17:34:30.457988|2017-02-18 17:34:30.457988
NCT00124228|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2010-05-26|||November 2004||2004-11-01|August 2009|2009-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|Infecir||Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis|Effects of Intravenous Albumin Administration on Renal Function and Survival in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. A Prospective, Stratified, Randomized and Controlled Study.|Completed||Phase 3|110|Actual|Hospital Clinic of Barcelona||2|||f||||f||||||||||2017-02-18 17:34:30.549267|2017-02-18 17:34:30.549267
NCT00124215|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2010-05-03|||June 2005||2005-06-01|May 2010|2010-05-01|February 2010|Actual|2010-02-01|June 2007|Actual|2007-06-01||Interventional|||Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection|A Phase 1 Double-Blind, Placebo Controlled, Dose-Escalation, Multi-center Therapeutic Trial of the Safety, Immunogenicity, and Efficacy of GI-5005; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing a Hepatitis C Virus NS3-Core Fusion Protein, in Patients With Chronic Hepatitis C Infection|Completed||Phase 1|48|Anticipated|GlobeImmune||1|||f||||||||||||||2017-02-18 17:34:30.662551|2017-02-18 17:34:30.662551
NCT00124202|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2013-07-29|||May 2003||2003-05-01|July 2013|2013-07-01|May 2007|Actual|2007-05-01|December 2004|Actual|2004-12-01||Interventional|||Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP)|Effect of a Fatty Meal on Cannulation at Endoscopic Retrograde Cholangiopancreatography|Completed||Phase 1/Phase 2|80|Actual|Emory University||1|||f||||f||||||||||2017-02-18 17:34:30.750711|2017-02-18 17:34:30.750711
NCT00124189|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2015-12-22|||July 2005||2005-07-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)|A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of GRN163L in Patients With Chronic Lymphoproliferative Disease|Completed||Phase 1|48|Anticipated|Geron Corporation||1|||f||||f||||||||||2017-02-18 17:34:30.849867|2017-02-18 17:34:30.849867
NCT00124176|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2013-02-12|2010-07-14||April 2004||2004-04-01|December 2012|2012-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Continuous Levalbuterol for Treatment of Status Asthmaticus in Children|Continuous Levalbuterol for Treatment of Status Asthmaticus in Children|Completed||Phase 4|81|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-02-18 17:34:30.971626|2017-02-18 17:34:30.971626
NCT00124163|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2006-01-31|||July 2005||2005-07-01|January 2006|2006-01-01||||||||Observational|||Evaluation of Stool Tagging for Improved Patient Compliance|CT Colonography Ph. I CDI Trial: Evaluation of Stool Tagging for Improved Patient Compliance|Unknown status|Recruiting|Phase 1|60||Center for Diagnostic Imaging|||||f||||||||||||||2017-02-18 17:34:31.593212|2017-02-18 17:34:31.593212
NCT00124150|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-26|2009-12-21|||June 2002||2002-06-01|July 2009|2009-07-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)|Phase 3 Study (Multi-center, Randomized Controlled Clinical Trial) of Intravenous Magnesium Sulfate to Improve Outcome After Aneurysmal Subarachnoid Haemorrhage|Completed||Phase 3|327|Actual|Chinese University of Hong Kong||2|||f||||t||||||||||2017-02-18 17:34:31.685159|2017-02-18 17:34:31.685159
NCT00124137|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2007-03-14|||April 2004||2004-04-01|December 2005|2005-12-01|October 2005||2005-10-01|||||Interventional|||Ultrafiltration Versus Intravenous (IV) Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: (UNLOAD)|Ultrafiltration Versus IV Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Clinical Trial|Completed||N/A|200||CHF Solutions|||||f||||||||||||||2017-02-18 17:34:31.807696|2017-02-18 17:34:31.807696
NCT00124124|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2015-02-11|||July 2005||2005-07-01|February 2015|2015-02-01|April 2009|Actual|2009-04-01|July 2008|Actual|2008-07-01||Interventional|||Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine|A Randomized, Controlled Trial of Melanoma Treatment: Comparison of Dendritic Cells Versus Montanide as Adjuvants to Stimulate Anti-tumor Immunity|Completed||Phase 1|50|Actual|Bhardwaj, Nina, M.D.||2|||f||||t||||||||||2017-02-18 17:34:31.929363|2017-02-18 17:34:31.929363
NCT00124111|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2010-02-25||||||February 2010|2010-02-01||||||||Interventional|||A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer|A Single-arm Study Evaluating the Relative Dose Intensity of IV CMF Given on Day 1 and Day 8 With Pegfilgrastim Support in Subjects With Stage I-III Breast Cancer|Completed||Phase 2|||Amgen||1|||f||||||||||||||2017-02-18 17:34:32.037388|2017-02-18 17:34:32.037388
NCT00124098|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-06-13||||||June 2008|2008-06-01||||||||Interventional|||An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)|An Open-Label Study of Aranesp® (Darbepoetin Alfa) Administration Once Every Four Weeks in Anaemic Chronic Kidney Disease (CKD) Subjects|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-02-18 17:34:32.150343|2017-02-18 17:34:32.150343
NCT00124085|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2012-08-07|||October 2003||2003-10-01|August 2012|2012-08-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Asthma in a Decentralized Patient Population: Is Traditional Disease Management Enough?|Asthma in a Decentralized Patient Population: Is Traditional Disease Management Enough? A Randomized, Controlled Trial Comparing Traditional Care to Two Systems of Disease Management for a Decentralized Population of Patients in South Texas|Completed||N/A|1053||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 17:34:32.247001|2017-02-18 17:34:32.247001
NCT00124072|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2012-01-31|2010-03-29||July 1998||1998-07-01|January 2012|2012-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|SEARCH||Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine|SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine|Completed||Phase 3|12064|Actual|University of Oxford||4|||f||||t||||||||||2017-02-18 17:34:32.346272|2017-02-18 17:34:32.346272
NCT00124059|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2015-10-02|||March 2003||2003-03-01|September 2013|2013-09-01|October 2005|Actual|2005-10-01|September 2005|Actual|2005-09-01||Interventional|||Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.|A Double-Blind Study of Quetiapine Fumarate (Seroquel) for the Treatment of Type A vs.Type B Alcoholics.|Completed||Phase 3|61|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-02-18 17:34:32.901527|2017-02-18 17:34:32.901527
NCT00124046|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2016-05-30|||September 2005||2005-09-01|May 2016|2016-05-01|October 2015|Actual|2015-10-01|December 2014|Actual|2014-12-01||Interventional|||Treatment of Persistent Urinary Incontinence in Children|Treatment of Persistent Urinary Incontinence in Children|Completed||N/A|14|Actual|University of British Columbia||2|||f||||f||||||||||2017-02-18 17:34:33.012349|2017-02-18 17:34:33.012349
NCT00124033|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2006-09-07|||March 2004||2004-03-01|June 2005|2005-06-01|December 2015||2015-12-01|||||Interventional|||Management of Common Bile Duct (CBD) Stones at Laparoscopic Cholecystectomy|Management of CBD Stones at Laparoscopic Cholecystectomy: A NSW Collaborative Prospective Randomised Trial to Assess the Value of Transcystically Inserted CBD Stents to Facilitate Post-Operative ERCP|Terminated||N/A|340||South West Sydney Local Health District|||||f||||||||||||||2017-02-18 17:34:33.125442|2017-02-18 17:34:33.125442
NCT00124020|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2010-05-14|2009-11-03||January 2005||2005-01-01|May 2010|2010-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|ATTAIN2||Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus|A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia With a Focus on Patients With Infections Due to Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 3|771|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-02-18 17:34:33.242828|2017-02-18 17:34:33.242828
NCT00124007|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2014-07-07|||November 2005||2005-11-01|July 2014|2014-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults|A Phase I, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine Followed by Recombinant, Multiclade HIV-1 Adenoviral Vector Vaccine or the Multiclade HIV-1 Adenoviral Vector Vaccine Alone in Healthy Adult Volunteers Not Infected With HIV|Completed||Phase 1|114|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:34:34.633537|2017-02-18 17:34:34.633537
NCT00123994|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2005-11-02|||February 2004||2004-02-01|July 2005|2005-07-01|October 2005||2005-10-01|||||Interventional|||Tai Chi or Hydrotherapy for People With Osteoarthritis of the Hip(s) or Knee(s)|Tai Chi or Hydrotherapy for People With Osteoarthritis of the Hip(s) or Knee(s)|Unknown status|Active, not recruiting|N/A|150||St George Hospital, Australia|||||f||||||||||||||2017-02-18 17:34:34.73184|2017-02-18 17:34:34.73184
NCT00123981|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2013-11-05|||January 2005||2005-01-01|November 2013|2013-11-01|January 2011|Actual|2011-01-01|November 2008|Actual|2008-11-01||Interventional|||The Danish On-pump, Off-pump Randomization Study (DOORS)|The Impact of Avoiding Cardiopulmonary By-pass During Coronary Artery Bypass Surgery for Ischemic Heart Disease in Elderly Patients: The Danish On-pump, Off-pump Randomization Study (DOORS)|Completed||N/A|900|Actual|Odense University Hospital||2|||f||||t||||||||||2017-02-18 17:34:34.821585|2017-02-18 17:34:34.821585
NCT00123968|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2014-07-21||2013-07-18|May 2006||2006-05-01|July 2014|2014-07-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults|A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Boosted by a Multiclade HIV-1 Recombinant Adenovirus-5 Vector Vaccine, VRC-HIVADV014-00-VP, in HIV Uninfected Adult Volunteers in East Africa|Completed||Phase 1/Phase 2|326|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-02-18 17:34:34.926915|2017-02-18 17:34:34.926915
NCT00123955|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2015-02-23|2015-02-06||April 2005||2005-04-01|February 2015|2015-02-01|December 2012|Actual|2012-12-01|June 2009|Actual|2009-06-01||Interventional|||PIE II: Pharmacological Intervention in the Elderly II|Exercise Intolerance in Elderly Diastolic Heart Failure|Completed||Phase 3|80|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 17:34:35.05106|2017-02-18 17:34:35.05106
NCT00123942|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2007-06-12|||April 2004||2004-04-01|June 2007|2007-06-01||||||||Interventional|||Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease|Phase I Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease|Terminated||Phase 1|31|Anticipated|MedImmune LLC||||"After review of safety events and have decided that further dose escalation of MEDI-507 as a~   single agent is not feasible."|||||||||||||||2017-02-18 17:34:35.505388|2017-02-18 17:34:35.505388
NCT00123929|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2009-08-03|||January 2005||2005-01-01|August 2009|2009-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer|Patterns of Genetic Expression Associated to Sensibility to Doxorubicin Versus Docetaxel as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer|Completed||Phase 2|250|Anticipated|Hospital San Carlos, Madrid||2|||f||||f||||||||||2017-02-18 17:34:35.583053|2017-02-18 17:34:35.583053
NCT00123916|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2011-08-01|||November 2004||2004-11-01|June 2005|2005-06-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|BENEFIT||BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease|Benznidazole Evaluation for Interrupting Trypanosomiasis - The BENEFIT Trial|Unknown status|Recruiting|Phase 3|1000|Anticipated|Population Health Research Institute||2|||f||||t||||||||||2017-02-18 17:34:35.700303|2017-02-18 17:34:35.700303
NCT00123903|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2017-01-16|||July 2005||2005-07-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria|A Randomized, Double-blind, Positive-Controlled, Multicenter Study Comparing the Efficacy of Carvedilol Phosphate Modified Release Formulation (COREG MR) and Metoprolol Succinate Extended Release (TOPROL-XL) on the Reduction of Microalbuminuria in Patients With Hypertension and Microalbuminuria|Terminated||Phase 3|1220||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:34:36.052102|2017-02-18 17:34:36.052102
NCT00123890|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2011-03-28|||June 2005||2005-06-01|March 2011|2011-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140|A Screening Protocol to Determine Eligibility for One of Three Phase III Treatment Studies Evaluating the Efficacy and Safety of GW873140 in R5-tropic and R5/X4-tropic HIV-1 Infected, Treatment-experienced Subjects With Drug-resistant Virus or an Observational Study.|Terminated||Phase 3|0|Actual|GlaxoSmithKline||1||The study was terminated due to hepatoxicity of compound|||||||||||||||2017-02-18 17:34:36.266114|2017-02-18 17:34:36.266114
NCT00123877|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-23|2007-01-05|||March 2005||2005-03-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Study of GPX-100 in the Treatment of Metastatic Breast Cancer|Phase II, Open Label, Non-Randomized, Efficacy and Safety Study of an Intravenous Formulation of the Anthracycline Analog, GPX-100, in the Treatment of Metastatic Breast Cancer|Terminated||Phase 2|40||Gem Pharmaceuticals|||||f||||||||||||||2017-02-18 17:34:36.393775|2017-02-18 17:34:36.393775
NCT00123864|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2010-02-08|||January 2000||2000-01-01|July 2005|2005-07-01||||||||Interventional|||Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function|A Phase I/II Feasibility Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function|Completed||Phase 1/Phase 2|25||AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:34:36.488827|2017-02-18 17:34:36.488827
NCT00123851|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2009-04-27|||March 2003||2003-03-01|April 2009|2009-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer|A Phase II Study of OSI-774 (Tarceva) in Combination With Oxaliplatin and Capecitabine in Previously Treated Patients With Stage IV Colorectal Cancer|Completed||Phase 2|32||Dana-Farber Cancer Institute|||||||||||||||||||2017-02-18 17:34:36.593508|2017-02-18 17:34:36.593508
NCT00123838|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2016-04-26|||July 2005||2005-07-01|April 2016|2016-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Positioning and Tracking the Prostate During External Beam Radiation|Beacon® Transponder Implantation and Localization in the Prostate|Completed||N/A|43|Actual|Varian Medical||1|||f||||f||||||||No||2017-02-18 17:34:36.705504|2017-02-18 17:34:36.705504
NCT00123825|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-25|2007-12-20|||July 2002||2002-07-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer|A Phase II Trial of Gemcitabine and Cisplatin In Unresectable Or Metastatic Biliary Tract and Gallbladder Cancer|Completed||Phase 2|30||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:34:36.816811|2017-02-18 17:34:36.816811
NCT00123812|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2016-02-23|||March 2004||2004-03-01|December 2011|2011-12-01|July 2006||2006-07-01|||||Observational|||Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy|Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy|Withdrawn||N/A|0|Actual|AHS Cancer Control Alberta|||1||f||||f||||||||||2017-02-18 17:34:36.914739|2017-02-18 17:34:36.914739
NCT00123799|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2014-06-10|||June 2004||2004-06-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|||||Interventional|||Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection|A Phase II Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection|Terminated||Phase 2|199|Actual|AHS Cancer Control Alberta||1||sufficient enrollment reached|f||||f||||||||||2017-02-18 17:34:36.992131|2017-02-18 17:34:36.992131
NCT00123786|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2016-02-24|||August 2005||2005-08-01|March 2012|2012-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma|A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma|Terminated||Phase 2|4|Actual|AHS Cancer Control Alberta||1||Lack of Enrollment|f||||f||||||||||2017-02-18 17:34:37.087779|2017-02-18 17:34:37.087779
NCT00123773|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2016-02-24|||April 2004||2004-04-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence|A Phase II Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence|Completed||Phase 2|1075|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 17:34:37.181974|2017-02-18 17:34:37.181974
NCT00123760|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2016-02-24|||February 2004||2004-02-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer|A Phase I/II, Phase III and Extended Phase III Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer|Completed||Phase 2/Phase 3|10838|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 17:34:37.279625|2017-02-18 17:34:37.279625
NCT00123747|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2016-02-24|||August 2005||2005-08-01|March 2012|2012-03-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer|A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|23|Actual|AHS Cancer Control Alberta||1|||f||||f||||||||||2017-02-18 17:34:37.393324|2017-02-18 17:34:37.393324
NCT00123734|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-24|2009-07-09|2009-07-09||March 2005||2005-03-01|July 2009|2009-07-01|May 2006||2006-05-01|||||Interventional|||Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis|Phase II Clinical Trial to Evaluate the Accuracy of Anti-Fibrin Humanized Monoclonal Antibody (DI-DD3B6/22-80B3) Fab' Protein Fragment (ThromboView) Conjugated With Technetium-99m in the Detection of Deep Vein Thrombosis|Completed||Phase 2|94|Actual|Agen Biomedical|||||||||||||||||||2017-02-18 17:34:37.492393|2017-02-18 17:34:37.492393
NCT00123708|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-23|2017-01-24|||July 19, 2005||2005-07-19|November 13, 2009|2009-11-13||||November 13, 2009|Actual|2009-11-13||Observational|||Hypertonia in Patients With Cerebral Palsy|Hypertonia in Patients With Cerebral Palsy|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:34:38.106938|2017-02-18 17:34:38.106938
NCT00122889|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2009-12-30|||July 2005||2005-07-01|December 2009|2009-12-01|March 2009|Actual|2009-03-01|||||Observational|||Effects of Garlic Supplements on Drug Metabolism|Garlic Metabolism and Cytochrome P450 Modulation|Completed||Phase 4|80|Actual|Fred Hutchinson Cancer Research Center|||1||f||||f||||||Samples With DNA|"~     Whole blood, urine~   "|||2017-02-18 17:34:59.512813|2017-02-18 17:34:59.512813
NCT00123695|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2008-03-26|||May 2005||2005-05-01|March 2008|2008-03-01|June 2008|Anticipated|2008-06-01|June 2008|Anticipated|2008-06-01||Observational|SEAS||Serial Echocardiography After Subarachnoid Hemorrhage|Serial Echocardiography After Subarachnoid Hemorrhage (S.E.A.S.)|Unknown status|Active, not recruiting|N/A|350|Anticipated|VU University Medical Center|||1||f||||t||||||||||2017-02-18 17:34:38.18584|2017-02-18 17:34:38.18584
NCT00123682|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2015-02-26|2015-01-08||May 2005||2005-05-01|February 2015|2015-02-01|September 2009|Actual|2009-09-01|March 2009|Actual|2009-03-01||Interventional|||TeleQuit Smoking Cessation Program|Telephone Care Coordination to Improve Smoking Cessation Counseling|Completed||N/A|3120|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 17:34:38.280053|2017-02-18 17:34:38.280053
NCT00123669|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2016-10-18|||October 1997||1997-10-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2009|Actual|2009-12-01||Interventional|||Primary Progesterone Therapy for Operable Breast Cancer|The Primary Progesterone Therapy for Operable Breast Cancer : A Randomized Controlled Trial|Active, not recruiting||Phase 2/Phase 3|1000|Actual|Tata Memorial Hospital||2|||f||||f||||||||||2017-02-18 17:34:39.014997|2017-02-18 17:34:39.014997
NCT00123656|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2008-01-10|||August 2004||2004-08-01|January 2008|2008-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis|Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis|Completed||Phase 2|30|Actual|University of Utah||2|||f||||f||||||||||2017-02-18 17:34:39.122029|2017-02-18 17:34:39.122029
NCT00123643|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2013-06-26|2012-07-02||May 2003||2003-05-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients|Comparison of Rosiglitazone Versus Glyburide on Vascular Structure and Function in Type 2 Diabetic Patients|Completed||Phase 4|36|Actual|St. Paul Heart Clinic|Small sample size; unbalanced sex distribution between groups|2|||f||||f||||||||||2017-02-18 17:34:39.229644|2017-02-18 17:34:39.229644
NCT00123630|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2016-05-18|2012-09-05||November 2005||2005-11-01|March 2016|2016-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab|A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab|Completed||Phase 2|30|Actual|University of Utah|small numbers enrolled|2|||f||||f||||||||||2017-02-18 17:34:39.594349|2017-02-18 17:34:39.594349
NCT00123617|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2015-04-21|||January 2003||2003-01-01|April 2015|2015-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||The Impact of Cardiac Rehabilitation Participation on Cardiac Syndrome X|The Impact of Cardiac Rehabilitation on Angina Frequency, Psychological Morbidity and Quality of Life in Women With Syndrome X|Completed||Phase 2|64|Actual|National Heart and Lung Institute||2|||f||||f||||||||||2017-02-18 17:34:40.02753|2017-02-18 17:34:40.02753
NCT00123604|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2014-11-17|2012-06-29||June 2004||2004-06-01|November 2014|2014-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes|Effects of Carvedilol and Metoprolol on Endothelial Function in Hypertensive Patients With Type 2 Diabetes Mellitus|Completed||Phase 4|36|Actual|St. Paul Heart Clinic|The sample size was relatively small|2|||f||||f||||||||||2017-02-18 17:34:40.158716|2017-02-18 17:34:40.158716
NCT00123591|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2017-01-11|||January 2005||2005-01-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury|A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Recombinant Factor VIIa (NovoSeven®/NiaStase®) in Subjects With Brain Contusions|Completed||Phase 2|96|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:34:40.622393|2017-02-18 17:34:40.622393
NCT00123578|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2016-05-10|||August 2004||2004-08-01|May 2016|2016-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1|GHB: Effects, Withdrawal and Treatment|Withdrawn||Phase 1/Phase 2|0|Actual|University of California, Los Angeles||2||Unable to recruit adaquate number of GHB dependent subjects|f||||t||||||||||2017-02-18 17:34:40.736661|2017-02-18 17:34:40.736661
NCT00123565|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2008-08-20|||December 2004||2004-12-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|SHINE||Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction|A Randomized Dose Ranging Study of Hexadecasaccharide Including Active Control, in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous Coronary Intervention (SHINE)|Completed||Phase 2|1257|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:34:40.84924|2017-02-18 17:34:40.84924
NCT00123552|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-22|2011-11-28|||November 2004||2004-11-01|November 2011|2011-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Longitudinal Antimalarial Combinations in Uganda|Longitudinal Comparison of Combination Antimalarial Therapies in Ugandan Children: Evaluation of Safety, Tolerability, and Efficacy|Completed||Phase 3|690|Actual|University of California, San Francisco||3|||f||||||||||||||2017-02-18 17:34:40.966548|2017-02-18 17:34:40.966548
NCT00123539|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2016-07-28|||June 2001||2001-06-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Interventional|||Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery|Estradiol for Neurocognitive Dysfunction After CABG|Terminated||N/A|334||National Heart, Lung, and Blood Institute (NHLBI)||||"DSMB stopped the study based on conclusion of likely futility of treatment on the primary~   outcome."|f||||||||||||||2017-02-18 17:34:41.083745|2017-02-18 17:34:41.083745
NCT00123526|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2013-09-23|||September 2004||2004-09-01|September 2013|2013-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Workplace-Sponsored Diet and Exercise Program to Reduce Obesity|Active Living and Healthy Diet at the Workplace|Completed||Phase 3|899|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 17:34:41.185494|2017-02-18 17:34:41.185494
NCT00123513|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2012-06-12|||September 2004||2004-09-01|June 2012|2012-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Workplace-Sponsored Program to Reduce Obesity|Images of a Healthy Worksite-Preventing Weight Gain in the Workplace|Completed||N/A|3938|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 17:34:41.489925|2017-02-18 17:34:41.489925
NCT00123500|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2013-11-25|||September 2004||2004-09-01|November 2013|2013-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Wellness Program for Elementary School Personnel|ACTION! Wellness Program for Elementary School Personnel|Completed||N/A|1202|Actual|Tulane University School of Public Health and Tropical Medicine||2|||f||||t||||||||||2017-02-18 17:34:41.621028|2017-02-18 17:34:41.621028
NCT00123487|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2014-10-30|2014-10-16||June 2005||2005-06-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|November 2006|Actual|2006-11-01||Interventional||Randomized Population analyzed. Baseline data are based on what participants were randomized to receive and not what they actually received.|Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML|A Randomized Two-Arm, Multicenter, Open-Label Phase III Study of BMS-354825 Administered Orally at a Dose of 70 mg Twice Daily or 140 mg Once Daily in Subjects With Chronic Myeloid Leukemia in Accelerated Phase or in Myeloid or Lymphoid Blast Phase or With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Who Are Resistant or Intolerant to Imatinib Mesylate (Gleevec)|Completed||Phase 3|638|Actual|Bristol-Myers Squibb|Amendment 3 (7 March 2007) allowed participants to switch from BID to QD dosing. Therefore, results for BID summarized by treatment group after Year 2 may not be a complete reflection of the BID experience and should be interpreted with this in mind.|2|||f||||f||||||||||2017-02-18 17:34:41.776907|2017-02-18 17:34:41.776907
NCT00123474|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2016-07-25|2015-06-29||July 2005||2005-07-01|July 2016|2016-07-01|July 2014|Actual|2014-07-01|September 2006|Actual|2006-09-01||Interventional||All participants randomized to a treatment arm are summarized.|Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML|A Randomized Two-by-Two, Multicenter, Open-Label Phase III Study of BMS-354825 Administered Orally at a Dose of 50 mg or 70 mg Twice Daily or 100 mg or 140 mg Once Daily in Subjects With Chronic Phase Philadelphia Chromosome or BCR-ABL Positive Chronic Myelogenous Leukemia Who Are Resistant or Intolerant to Imatinib Mesylate (Gleevec)|Completed||Phase 3|724|Actual|Bristol-Myers Squibb||4|||f||||f||||||||||2017-02-18 17:34:44.218305|2017-02-18 17:34:44.218305
NCT00123461|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2015-05-04|||July 2005||2005-07-01|May 2015|2015-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism|A Phase 4, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Assess the Efficacy and Safety of Doxercalciferol Capsules in Vitamin D-replete Subjects With Chronic Kidney Disease (CKD) Stages 3 or 4 With Secondary Hyperparathyroidism (SHPT).|Completed||Phase 4|70|Anticipated|Sanofi||2|||||||||||||||||2017-02-18 17:34:50.315717|2017-02-18 17:34:50.315717
NCT00123448|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2017-01-24|||July 20, 2005||2005-07-20|July 2, 2008|2008-07-02|July 2, 2008||2008-07-02|||||Observational|||Mirroring a Movement|Mirroring a Movement|Completed||N/A|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:34:50.692939|2017-02-18 17:34:50.692939
NCT00123435|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2015-08-19|||July 2005||2005-07-01|August 2015|2015-08-01|June 2009|Actual|2009-06-01|November 2007|Actual|2007-11-01||Interventional|VWH||Veterans Walk for Health Study|Does Step Count Feedback Enhance Counseling for Weight Loss?|Completed||N/A|254|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 17:34:50.770678|2017-02-18 17:34:50.770678
NCT00123422|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2014-10-06|2014-10-02||October 2005||2005-10-01|October 2014|2014-10-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Innovation in Pulmonary Rehabilitation|Innovation Methods to Augment Pulmonary Rehabilitation|Completed||N/A|103|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 17:34:50.88969|2017-02-18 17:34:50.88969
NCT00123409|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2015-04-06|2014-09-26||January 2004||2004-01-01|June 2014|2014-06-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Telephone Disease Management At-Risk Drinking (TDM II)|Telephone Disease Management At-Risk Drinking (TDM 11)|Completed||N/A|146|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:34:51.416308|2017-02-18 17:34:51.416308
NCT00123396|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2015-04-06|||August 2004||2004-08-01|April 2015|2015-04-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||VHA Clinicians and Bioterror Events: Interactive Web-based Learning|VHA Clinicians and Bioterror Events: Interactive Web-based Learning|Completed||N/A|15|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:34:51.9248|2017-02-18 17:34:51.9248
NCT00123383|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2007-04-29|||July 2005||2005-07-01|July 2006|2006-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence|Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|The University of New South Wales||2|||f||||f||||||||||2017-02-18 17:34:52.045415|2017-02-18 17:34:52.045415
NCT00123370|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2007-04-29|||July 2006||2006-07-01|July 2006|2006-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Trial of Modafinil for Methamphetamine Dependence|Randomised Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence|Unknown status|Active, not recruiting|Phase 2|87|Anticipated|The University of New South Wales||2|||f||||f||||||||||2017-02-18 17:34:52.154214|2017-02-18 17:34:52.154214
NCT00123357|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2015-04-06||||||January 2005|2005-01-01|March 2003|Actual|2003-03-01|||||Observational|||Measuring Health Related Quality of Life in Veterans With Stroke|Measuring Health Related Quality of Life in Veterans With Stroke|Completed||N/A|800|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:34:52.260244|2017-02-18 17:34:52.260244
NCT00123344|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2008-12-10|||December 1999||1999-12-01|December 2008|2008-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Atrial Pacing for Termination and Prevention of Atrial Fibrillation|Atrial Pacing for Termination and Prevention of Atrial Fibrillation|Completed||N/A|120|Actual|University of Calgary|||||f||||||||||||||2017-02-18 17:34:52.355884|2017-02-18 17:34:52.355884
NCT00123331|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2005-08-01|||October 2003||2003-10-01|June 2005|2005-06-01|April 2005||2005-04-01|||||Interventional|||Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation|Rapamycin Use in CNI-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation|Completed||Phase 4|40||Heidelberg University|||||f||||||||||||||2017-02-18 17:34:52.460482|2017-02-18 17:34:52.460482
NCT00123318|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2013-06-17|||February 2003||2003-02-01|June 2013|2013-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer|A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer|Completed||Phase 3|52|Actual|Trans-Tasman Radiation Oncology Group (TROG)||1|||f||||f||||||||||2017-02-18 17:34:52.569501|2017-02-18 17:34:52.569501
NCT00123305|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2014-11-06|||October 2005||2005-10-01|November 2014|2014-11-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke|A Multicentre, Double-Blind, Placebo-Controlled, Ascending-dose, Clinical Trial of Intravenous Microplasmin Administration in Patients With Acute Ischemic Stroke|Completed||Phase 2|40|Actual|ThromboGenics||4|||f||||t||||||||||2017-02-18 17:34:52.708991|2017-02-18 17:34:52.708991
NCT00123292|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2014-04-04|||March 2005||2005-03-01|April 2014|2014-04-01|November 2009|Actual|2009-11-01|June 2007|Actual|2007-06-01||Interventional|||Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion|An Open-label, Ascending-dose, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion|Terminated||Phase 2|19|Actual|ThromboGenics||5||Sponsor's decision not to pursue development of uPLi for vascular conditions|f||||t||||||||||2017-02-18 17:34:52.846459|2017-02-18 17:34:52.846459
NCT00123279|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2014-04-04|||December 2004||2004-12-01|April 2014|2014-04-01|November 2008|Actual|2008-11-01|February 2007|Actual|2007-02-01||Interventional|||Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy|A Dose-escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy|Completed||Phase 2|60|Actual|ThromboGenics||6|||f||||t||||||||||2017-02-18 17:34:52.972777|2017-02-18 17:34:52.972777
NCT00123266|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2014-04-04|||December 2006||2006-12-01|April 2014|2014-04-01|August 2008|Actual|2008-08-01|July 2007|Actual|2007-07-01||Interventional|MITI-IA||Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion|An Open-label, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion|Terminated||Phase 2|2|Actual|ThromboGenics||1||Sponsor's decision not to pursue development of uPLi for vascular conditions.|f||||t||||||||||2017-02-18 17:34:53.086233|2017-02-18 17:34:53.086233
NCT00123253|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2013-11-26|||June 2005||2005-06-01|November 2013|2013-11-01|April 2007|Actual|2007-04-01|November 2006|Actual|2006-11-01||Interventional|||TH9507 in Patients With HIV-Associated Lipodystrophy|A Phase 3 Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety of a 2 mg Dose of TH9507, a Growth Hormone Releasing Factor Analog, in HIV Patients With Excess of Abdominal Fat Accumulation|Completed||Phase 3|412|Actual|Theratechnologies|||||||||||||||||||2017-02-18 17:34:53.20664|2017-02-18 17:34:53.20664
NCT00123240|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2012-01-10|||July 2004||2004-07-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||High Carbohydrate vs. High Fat Diets in the Treatment of Obesity (JBR 0512)|High Carbohydrate vs. High Fat Diets in the Treatment of Obesity (JBR 0512)|Completed||N/A|40|Anticipated|Rockefeller University||2|||f||||t||||||||||2017-02-18 17:34:53.447272|2017-02-18 17:34:53.447272
NCT00123227|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2005-07-29|||October 2002||2002-10-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Rosiglitazone Plaque Study|A Randomised, Double-Blind, Placebo-Controlled, Cardiovascular Magnetic Resonance (CMR) Study to Evaluate the Effect of Rosiglitazone on Carotid Atherosclerotic Plaques in Type 2 Diabetics With Vascular Disease or Hypertension|Unknown status|Active, not recruiting|Phase 3|60||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:34:53.557785|2017-02-18 17:34:53.557785
NCT00123214|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2006-06-26|||September 2004||2004-09-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Interventional|||A Change in Diet May Decrease the Negative Consequences of Chronic Sleep Deprivation|Pilot Study: A Dietary Intervention May Decrease the Negative Metabolic and Cognitive Consequences of Chronic Sleep Deprivation|Completed||N/A|18||St. Vincent's Medical Center|||||f||||||||||||||2017-02-18 17:34:53.667285|2017-02-18 17:34:53.667285
NCT00123201|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2015-01-15|||September 2005||2005-09-01|September 2006|2006-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache|A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Efficacy, Safety and Tolerability Study of Dronabinol MDI in the Acute Treatment of Migraine Headache|Completed||Phase 2|||Solvay Pharmaceuticals|||||||||||||||||||2017-02-18 17:34:53.961989|2017-02-18 17:34:53.961989
NCT00123188|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2015-01-16|||April 2005||2005-04-01|January 2015|2015-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Ultrasound and Endometrial Hyperplasia|Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort|Terminated||N/A|36|Actual|Milton S. Hershey Medical Center||1||enrollment of participants has halted prematurely; difficulty with recruitment|f||||f||||||||||2017-02-18 17:34:54.085241|2017-02-18 17:34:54.085241
NCT00123175|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2013-01-07|||September 2009||2009-09-01|January 2013|2013-01-01|September 2011|Anticipated|2011-09-01|September 2011|Anticipated|2011-09-01||Interventional|||Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)|Levonorgestrel Containing Intrauterine Device in the Treatment of Endometrial Hyperplasia Without Atypia|Withdrawn||Phase 1/Phase 2|0|Actual|Milton S. Hershey Medical Center||1||Study has never received funding and has never been initiated|f||||f||||||||||2017-02-18 17:34:54.200334|2017-02-18 17:34:54.200334
NCT00123162|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2015-11-18|2015-01-16||May 2007||2007-05-01|November 2015|2015-11-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Viagra in the Treatment of Primary Dysmenorrhea|Sildenafil Citrate in the Treatment of Primary Dysmenorrhea|Completed||Phase 1/Phase 2|25|Actual|Milton S. Hershey Medical Center||2|||f||||f||||||||||2017-02-18 17:34:54.296562|2017-02-18 17:34:54.296562
NCT00123149|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2016-09-19||||||July 2011|2011-07-01|October 2007|Anticipated|2007-10-01|||||Interventional|||Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis|An Open-Label (OL) Extension Study to Assess Safety of PROCRIT (Epoetin Alfa) in Patients With Anemia of Chronic Disease (ACD) Due to Rheumatoid Arthritis (RA)|Withdrawn||Phase 2|0|Actual|Ortho Biotech Products, L.P.|||||||||||||||||||2017-02-18 17:34:54.867966|2017-02-18 17:34:54.867966
NCT00123136|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2006-06-28|||August 2005||2005-08-01|June 2006|2006-06-01|December 2006||2006-12-01|||||Interventional|||Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy|Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy. Multi-Center, Randomized Placebo Controlled Trial|Unknown status|Recruiting|Phase 4|250||Weintraub, Michael I., MD, FACP, FAAN|||||f||||||||||||||2017-02-18 17:34:54.956971|2017-02-18 17:34:54.956971
NCT00123123|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2010-08-12|2010-08-12||March 2004||2004-03-01|August 2010|2010-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients|Oral Health and Ventilator-associated Pneumonia|Completed||Phase 2|175|Actual|State University of New York at Buffalo||3|||f||||||||||||||2017-02-18 17:34:55.047965|2017-02-18 17:34:55.047965
NCT00123110|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2010-03-09|||July 2005||2005-07-01|March 2010|2010-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Insulin Resistance and Testosterone in Women|Insulin Resistance and Testosterone in Non-Diabetic Postmenopausal Women|Completed||Phase 2|36|Actual|University of Pennsylvania||3|||f||||f||||||||||2017-02-18 17:34:55.54927|2017-02-18 17:34:55.54927
NCT00123097|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2011-06-10|||February 2005||2005-02-01|June 2011|2011-06-01|August 2012|Anticipated|2012-08-01|July 2012|Anticipated|2012-07-01||Interventional|||Clinical Trial of New Elastomer for Maxillofacial Prosthetics|Multicenter Trial of CPE for Maxillofacial Prosthetics|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|University of Louisville||1|||f||||||||||||||2017-02-18 17:34:55.678413|2017-02-18 17:34:55.678413
NCT00123084|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2011-05-06|||March 2002||2002-03-01|May 2011|2011-05-01|December 2012|Anticipated|2012-12-01|May 2011|Anticipated|2011-05-01||Interventional|||Efficacy of Voice Treatment for Parkinson's Disease|Efficacy of Voice Treatment for Parkinson's Disease|Unknown status|Recruiting|Phase 2|620|Anticipated|University of Colorado, Boulder||4|||f||||||||||||||2017-02-18 17:34:55.775586|2017-02-18 17:34:55.775586
NCT00123071|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2013-01-24|||May 2005||2005-05-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Observational|VVV||Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network|Variability of Ventricular Mass, Volume, and Ejection Fraction in Pediatric Cardiomyopathy Patients (A Study Conducted by the Pediatric Heart Network)|Completed||N/A|131|Actual|New England Research Institutes|||1||f||||t||||||||||2017-02-18 17:34:55.891055|2017-02-18 17:34:55.891055
NCT00123058|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2014-09-05|||June 2003||2003-06-01|September 2014|2014-09-01|June 2007|Actual|2007-06-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Two Programs to Improve Blood Pressure Treatment Adherence|Take Control of Your Blood Pressure (TCYB)|Completed||N/A|777|Actual|Duke University||4|||f||||t||||||||||2017-02-18 17:34:56.185786|2017-02-18 17:34:56.185786
NCT00123045|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2016-07-28|||September 2001||2001-09-01|July 2011|2011-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Patient-Physician Partnership to Improve High Blood Pressure Adherence|Patient-Physician Partnership to Improve High Blood Pressure Adherence|Completed||Phase 4|279|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||||f||||t||||||||||2017-02-18 17:34:56.30956|2017-02-18 17:34:56.30956
NCT00123032|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2011-04-18|||January 2005||2005-01-01|April 2011|2011-04-01|December 2011|Anticipated|2011-12-01|August 2008|Actual|2008-08-01||Interventional|||School- and Home-Based Program to Prevent Obesity in American Indian Children|Bright Start: Obesity Prevention in American Indian Children|Unknown status|Active, not recruiting|N/A|500|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 17:34:56.389364|2017-02-18 17:34:56.389364
NCT00123019|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2016-07-11|||September 2004||2004-09-01|February 2009|2009-02-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Work, Weight, and Wellness Program: The 3W Program|Overweight and Obesity Control in Worksites|Completed||N/A|6100|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||||||||||||2017-02-18 17:34:56.514239|2017-02-18 17:34:56.514239
NCT00123006|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2016-01-12|||January 2006||2006-01-01|January 2016|2016-01-01|October 2014|Actual|2014-10-01|June 2009|Actual|2009-06-01||Interventional|||Effectiveness of the DASH Diet at Reducing High Blood Pressure|Cardiovascular and Renal Hemodynamics and the DASH Diet|Completed||N/A|44|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 17:34:56.626838|2017-02-18 17:34:56.626838
NCT00122993|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2015-01-23|||September 2004||2004-09-01|January 2015|2015-01-01|April 2008|Actual|2008-04-01|December 2007|Actual|2007-12-01||Interventional|||Worksite Program to Prevent Weight Gain Among Bus Drivers|Worksite Environmental Interventions for Weight Control|Completed||N/A|1200|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 17:34:56.73712|2017-02-18 17:34:56.73712
NCT00122980|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2013-01-14|2011-12-28||October 2006||2006-10-01|August 2012|2012-08-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Stroke With Transfusions Changing to Hydroxyurea|Stroke With Transfusions Changing to Hydroxyurea|Terminated||Phase 3|134|Actual|St. Jude Children's Research Hospital|The trial was stopped early due to a projected futility of the liver iron component of the primary endpoint in conjunction with the significantly higher number of strokes in the Hydroxyurea/Phlebotomy arm as compared to the Transfusion/Chelation arm.|2||The study has been stopped due to safety and futility concerns.|f||||t||||||||||2017-02-18 17:34:57.006696|2017-02-18 17:34:57.006696
NCT00122954|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2015-02-27|2013-11-25||July 2005||2005-07-01|February 2015|2015-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional||The study was powered to enroll twenty six subjects (13/group), the number needed to see a difference in Hamilton Depression Rating Scale (HDRS) over 3 months. The Montgomery Asberg Rating Scale has good validation with the HDRS and is more sensitive to emotional change than the HDRS.|Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis|Fish Oil as an Adjunct Therapy for Depression in Multiple Sclerosis|Completed||Phase 1/Phase 2|39|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 17:34:58.741136|2017-02-18 17:34:58.741136
NCT00122941|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2008-06-13|||June 2005||2005-06-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|MMS||Effect of Multiple Micronutrient Supplementation on Growth, Morbidity, and Mortality of HIV Infected Children in Uganda|Effect of Multiple Micronutrient Supplementation on Growth, Morbidity, and Mortality of HIV Infected Children in Uganda: a Randomised Double Blind Placebo-Controlled Trial|Completed||Phase 3|860|Actual|Makerere University||2|||f||||t||||||||||2017-02-18 17:34:59.09419|2017-02-18 17:34:59.09419
NCT00122928|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2013-11-12|||October 2004||2004-10-01|November 2013|2013-11-01|September 2009|Actual|2009-09-01|March 2008|Actual|2008-03-01||Interventional|||Comparison of Workplace Obesity Management Programs|Environmental Approaches for Obesity Management at Dow|Completed||N/A|5124|Actual|Emory University||3|||f||||t||||||||||2017-02-18 17:34:59.208251|2017-02-18 17:34:59.208251
NCT00122915|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2015-04-13|||June 2005||2005-06-01|April 2015|2015-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain|A Prospective, Randomized, Double Blind, Crossover, Multi-center Study to Evaluate the Safety and the Efficacy of Motor Cortex Stimulation With the Cortical Stimulation Lead Model 2976 in Patients With Neuropathic Pain|Terminated||Phase 3|104|Anticipated|Medtronic||||"Based on a consistently low enrolment rate and procedural challenges that were unknown at~   study start. It was not based on safety or efficacy concerns."|f||||||||||||||2017-02-18 17:34:59.325623|2017-02-18 17:34:59.325623
NCT00122902|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2006-08-17|||February 2002||2002-02-01|August 2006|2006-08-01|February 2004||2004-02-01|||||Observational|||Spirituality and Will to Live in Patients With HIV/AIDS|Spirituality and Will to Live in Patients With HIV/AIDS|Completed||N/A|350||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:34:59.42456|2017-02-18 17:34:59.42456
NCT00005364|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1994||1994-04-01|June 2000|2000-06-01|March 1999|Actual|1999-03-01|||||Observational|||Genetic Epidemiology of CHD Risk Factors in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.586395|2017-02-18 18:15:05.586395
NCT00122876|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2007-12-05|||April 2005||2005-04-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)|A Phase 1/2 Open-Label Study to Evaluate Safety and Preliminary Evidence of Effectiveness of Tumor Ablation With Talaporfin Sodium (LS11) and Interstitial Light Emitting Diodes (LEDs) in the Treatment of Subjects With Inoperable Hepatocellular Carcinoma (HCC)|Completed||Phase 1/Phase 2|25||Light Sciences LLC|||||||||||||||||||2017-02-18 17:34:59.611945|2017-02-18 17:34:59.611945
NCT00122863|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2007-08-29|||January 2005||2005-01-01|August 2007|2007-08-01|March 2007|Actual|2007-03-01|||||Interventional|||Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder|Duloxetine 60 to 120 mg Once Daily Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder|Completed||Phase 3|380||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:34:59.720907|2017-02-18 17:34:59.720907
NCT00122850|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2007-11-05|||October 2004||2004-10-01|November 2007|2007-11-01|November 2005|Actual|2005-11-01|||||Interventional|||A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder|A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder.|Completed||Phase 3|480||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:34:59.867849|2017-02-18 17:34:59.867849
NCT00122837|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2007-10-17|||April 2005||2005-04-01|October 2007|2007-10-01|January 2007|Actual|2007-01-01|||||Interventional|||A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder|A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|560||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:34:59.980798|2017-02-18 17:34:59.980798
NCT00122824|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2007-11-05|||June 2004||2004-06-01|November 2007|2007-11-01|September 2005|Actual|2005-09-01|||||Interventional|||Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder|Duloxetine Hydrochloride 60 mg or 120 mg Once Daily Compared With Placebo in Patients With Generalized Anxiety Disorder.|Completed||Phase 3|480||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:35:00.097017|2017-02-18 17:35:00.097017
NCT00122811|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2007-08-20|||November 2000||2000-11-01|August 2007|2007-08-01|October 2008|Anticipated|2008-10-01|||||Interventional|||The Hypertension in the Very Elderly Trial (HYVET)|The Hypertension in the Very Elderly Trial (HYVET)|Unknown status|Active, not recruiting|Phase 4|4000|Anticipated|Imperial College London||2|||f||||t||||||||||2017-02-18 17:35:00.209274|2017-02-18 17:35:00.209274
NCT00122798|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2006-06-23|||January 2002||2002-01-01|December 2004|2004-12-01|January 2005||2005-01-01|||||Observational|||Improved Stroke Outcome at 6 Months|Improved Stroke Outcome at 6 Months Attained by a Chain of Structured Acute Treatment With Integrated Rehabilitation and Supported Discharge|Completed||Phase 4|200||Kantonsspital Baden|||||f||||||||||||||2017-02-18 17:35:00.319719|2017-02-18 17:35:00.319719
NCT00122785|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2005-07-28|||April 2002||2002-04-01|February 2005|2005-02-01|September 2004||2004-09-01|||||Interventional|||Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children|Efficacy of Single Injection of Dexamethasone for Acute Bronchiolitis in Children Younger Than 2 Years Old: A Randomized, Double-Blind, Placebo Controlled Trial|Completed||N/A|170||Khon Kaen University|||||f||||||||||||||2017-02-18 17:35:00.411468|2017-02-18 17:35:00.411468
NCT00122772|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2011-10-13|||November 2005||2005-11-01|October 2011|2011-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy|CRP on Radiobiological and Clinical Studies on Viral-induced Cancer's Response to Radiotherapy With Comprehensive Morbidity Assessment|Completed||Phase 3|601|Actual|International Atomic Energy Agency||4|||f||||t||||||||||2017-02-18 17:35:00.512414|2017-02-18 17:35:00.512414
NCT00122759|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2007-07-20|||December 2005||2005-12-01|July 2007|2007-07-01|September 2007|Anticipated|2007-09-01|||||Interventional|||Ketamine Sedation in Mechanically Ventilated Patients|Prospective Study on the Cost-Effectiveness of Adding Ketamine to Midazolam-Sufentanil Sedation Regimen in Mechanically Ventilated Patients|Unknown status|Recruiting|N/A|100|Anticipated|Assistance Publique - Hôpitaux de Paris||2|||f||||f||||||||||2017-02-18 17:35:00.769254|2017-02-18 17:35:00.769254
NCT00122746|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2011-10-12|||December 2004||2004-12-01|October 2011|2011-10-01||||June 2012|Anticipated|2012-06-01||Interventional|||Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients|Doctoral CRP on Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients|Unknown status|Recruiting|Phase 3|322|Anticipated|International Atomic Energy Agency||2|||f||||t||||||||||2017-02-18 17:35:00.876483|2017-02-18 17:35:00.876483
NCT00122733|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2007-07-20|||December 2005||2005-12-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Loxapine and Weaning From Ventilator|Facilitation of Weaning From Ventilator by Loxapine|Completed||N/A|9|Actual|Assistance Publique - Hôpitaux de Paris||1|||f||||f||||||||||2017-02-18 17:35:00.994581|2017-02-18 17:35:00.994581
NCT00122720|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2006-07-03|||June 2003||2003-06-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery|The Effect of Darbepoetin Alfa Treatment Upon the Rehabilitation Following Planned Surgery for Colorectal Cancer|Completed||Phase 4|200||Herning Hospital|||||f||||||||||||||2017-02-18 17:35:01.084846|2017-02-18 17:35:01.084846
NCT00122707|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2006-03-21|||April 2004||2004-04-01|June 2005|2005-06-01|October 2005||2005-10-01|||||Interventional|||Comparison of Central and Peripheral Venous Catheters|Randomized Controlled Trial of Mechanical and Infectious Complications of Central Versus Peripheral Venous Catheters in ICU Patients|Completed||N/A|300||Assistance Publique - Hôpitaux de Paris|||||f||||||||||||||2017-02-18 17:35:01.183236|2017-02-18 17:35:01.183236
NCT00122694|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2006-09-11|||January 2005||2005-01-01|July 2006|2006-07-01|March 2006||2006-03-01|||||Interventional|||Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)|Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable COPD|Completed||Phase 2|20||Groningen Research Institute for Asthma and COPD|||||f||||||||||||||2017-02-18 17:35:01.278991|2017-02-18 17:35:01.278991
NCT00122681|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2016-02-29|2009-11-30||May 2004||2004-05-01|April 2015|2015-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18|A Phase III, Double-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy of GlaxoSmithKline Biologicals. HPV-16/18 VLP AS04 Vaccine Compared to Hepatitis A Vaccine as Control in Prevention of Persistent HPV-16 or HPV-18 Cervical Infection and Cervical Neoplasia, Administered Intramuscularly According to a 0, 1, 6 Month Schedule in Healthy Females 15-25 Years of Age.|Completed||Phase 3|18729|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 17:35:01.436075|2017-02-18 17:35:01.436075
NCT00122668|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2005-11-14|||November 2003||2003-11-01|November 2005|2005-11-01|July 2005||2005-07-01|||||Interventional|||Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients|Randomized Comparative Study Evaluating the Rate of Occurrence of a Lipoatrophy Syndrome in ARVnaive HIV-1 Infected Patients Receiving NRTI-Sparing Antiretroviral Regimen (Hippocampe - ANRS 121)|Terminated||Phase 4|112||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:05.01975|2017-02-18 17:35:05.01975
NCT00122655|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2005-11-14|||January 2001||2001-01-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy|A Randomized Prospective Study Evaluating the Impact on Fat Distribution of NRTI-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy ANRS 108 NONUKE Study|Terminated||Phase 4|100||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:05.127315|2017-02-18 17:35:05.127315
NCT00122642|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2009-09-24|||August 2005||2005-08-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|||Alcohol Locks for the Prevention of Tunneled Catheter-related Infections|Short Daily Alcohol Locks for the Prevention of Tunneled Catheter Infection in Patients With Haematological Disease. Randomised Placebo Controlled Trial|Completed||Phase 2/Phase 3|440|Anticipated|Erasmus Medical Center||2|||f||||||||||||||2017-02-18 17:35:05.225972|2017-02-18 17:35:05.225972
NCT00122629|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2005-07-28|||October 2000||2000-10-01|July 2005|2005-07-01|May 2003||2003-05-01|||||Interventional|||Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders|Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous HCV Non Responders ANRSHC03 BITRI|Terminated||Phase 3|405||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:05.349883|2017-02-18 17:35:05.349883
NCT00122616|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2012-02-21|||November 2003||2003-11-01|February 2012|2012-02-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C|Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and C Hepatitis Who Failed to Active Treatment for HCV. ANRSHC12 Fibrostop|Completed||Phase 3|52|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||t||||||||||2017-02-18 17:35:05.44316|2017-02-18 17:35:05.44316
NCT00122603|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2011-12-21|||December 2005||2005-12-01|December 2011|2011-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)|Efficacy and Safety of Regimens Restricted to a Combination of Two Boosted Protease Inhibitors as Potent Antiretroviral Therapy in HIV-1 Infected Patients. ANRS 127 2IP|Completed||Phase 2|61|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2|||f||||t||||||||||2017-02-18 17:35:05.551083|2017-02-18 17:35:05.551083
NCT00122590|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2005-07-29|||July 2002||2002-07-01|July 2005|2005-07-01|March 2005||2005-03-01|||||Interventional|||Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)|Prospective Trial to Evaluate How Therapeutic Drug Monitoring of Protease Inhibitors Increases Virologic Success and Tolerance of HAART (ANRS 111 COPHAR2)|Terminated||N/A|115||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:05.655492|2017-02-18 17:35:05.655492
NCT00122577|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2005-07-27|||March 2002||2002-03-01|July 2005|2005-07-01|July 2004||2004-07-01|||||Interventional|||Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients|Randomized Open Label Study Assessing the Antiviral Activity, Toxicity and Pharmacologic Interaction of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir as Part of a Salvage Regimen in HIV Infected Patients With Multiple Treatment Failures (ANRS 107 Trial PUZZLE 2)|Terminated||Phase 2|50||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:05.753627|2017-02-18 17:35:05.753627
NCT00122564|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2005-11-10|||June 2003||2003-06-01|November 2005|2005-11-01|April 2005||2005-04-01|||||Interventional|||Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers|Phase I Study Evaluating the Systemic and Mucosal Safety and Immunogenicity of a Recombinant HIV-1 Gp 160 (MN/LAI) Administered by Transmucosal (Nasal or Vaginal) Routes, Alone or Formulated With DC-Chol, in HIV Negative Volunteers (ANRS VAC14)|Terminated||Phase 1|36||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:05.852343|2017-02-18 17:35:05.852343
NCT00122551|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2005-07-28|||December 2001||2001-12-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Interventional|||Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)|A Prospective, Randomized, Multicenter Trial of Intermittent Therapy in HIV-Infected Patients With Successful Viral Suppression Under HAART (ANRS 106 Window Trial)|Terminated||Phase 3|400||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:05.940061|2017-02-18 17:35:05.940061
NCT00122538|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2011-12-02|||February 2006||2006-02-01|December 2011|2011-12-01|May 2009|Actual|2009-05-01|November 2008|Actual|2008-11-01||Interventional|||Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)|HAART Regimen Comprising 3TC + ddI + EFV in Once-daily Administration in HIV-1 Infected Children in Burkina Faso|Completed||Phase 2|52|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-02-18 17:35:06.031672|2017-02-18 17:35:06.031672
NCT00122525|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2009-04-29|||July 2002||2002-07-01|April 2009|2009-04-01|July 2005|Actual|2005-07-01|||||Interventional|||Effect of Male Circumcision on HIV Incidence (ANRS 1265)|Effect of Safe Male Circumcision on Incidence of Infection by HIV, HSV-2 and of Genital Ulceration|Terminated||Phase 3|3274|Actual|French National Agency for Research on AIDS and Viral Hepatitis||2||following DSMB recommandation.|f||||t||||||||||2017-02-18 17:35:06.135445|2017-02-18 17:35:06.135445
NCT00122512|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2006-02-09||||||February 2006|2006-02-01||||||||Interventional|||Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV|Phase 2a Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV – An Extended Safety Evaluation|Terminated||Phase 2|500||FHI 360|||||f||||||||||||||2017-02-18 17:35:06.341893|2017-02-18 17:35:06.341893
NCT00122499|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2005-07-26|||February 2003||2003-02-01|July 2005|2005-07-01|February 2005||2005-02-01|||||Interventional|||A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer|A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer|Completed||Phase 3|||Erasmus Medical Center|||||f||||||||||||||2017-02-18 17:35:06.439661|2017-02-18 17:35:06.439661
NCT00122473|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2011-07-28|||January 2004||2004-01-01|July 2011|2011-07-01|January 2007||2007-01-01|||||Interventional|||Imatinib in Dermatofibrosarcoma Protuberans (DFSP)|Open-label Trial of Glivec® (Imatinib Mesylate) in Patients With Primary or Recurrent Dermatofibrosarcoma Protuberans|Completed||Phase 1/Phase 2|30||Dermatologic Cooperative Oncology Group|||||f||||||||||||||2017-02-18 17:35:06.630809|2017-02-18 17:35:06.630809
NCT00122460|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2014-07-11|2011-08-25||December 2004||2004-12-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|March 2007|Actual|2007-03-01||Interventional|||Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)|Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|442|Actual|Merck KGaA|Non-specific outcome measures 'Safety' & 'QOL assessments' were deleted from this entry in error.Replacement outcomes have been created. The 'Safety' outcome refers to adverse events.|2|||f||||t||||||||||2017-02-18 17:35:06.747691|2017-02-18 17:35:06.747691
NCT00122447|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2013-11-12|2012-05-18||May 2005||2005-05-01|November 2013|2013-11-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance|CVD Risk and Prevention in Early Glucose Intolerance|Completed||N/A|84|Actual|Emory University|Not fully powered due to under-enrollment and high drop-out rate. Higher than anticipated precision error of FMD measures. Possible Hawthorne effect with lifestyle changes. Short treatment period relative to long-term CVD risk in prediabetes.|4|||f||||f||||||||||2017-02-18 17:35:11.067166|2017-02-18 17:35:11.067166
NCT00122434|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2013-10-28|||July 2005||2005-07-01|October 2013|2013-10-01||||May 2006|Actual|2006-05-01||Interventional|||Dose Finding Study in COPD|A Randomized, Multiple-dose, Double-blind, Placebo- and Active-controlled, Parallel Group Efficacy and Safety Study to Determine the Optimum Dose of BEA 2180 BR Delivered by the Respimat® Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 2|389|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:35:11.642593|2017-02-18 17:35:11.642593
NCT00122421|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2012-02-17|||June 2003||2003-06-01|February 2012|2012-02-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients|The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients|Completed||N/A|300|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-02-18 17:35:12.049726|2017-02-18 17:35:12.049726
NCT00122408|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2010-09-23|||January 2006||2006-01-01|September 2010|2010-09-01|December 2009|Anticipated|2009-12-01|August 2009|Anticipated|2009-08-01||Interventional|||Probiotic Enteral Administration in Mechanically Ventilated Patients|Effect of Enterally Administered Probiotics in Mechanically Ventilated Patients: Double-Blind, Prospective Randomized Study Versus Placebo|Terminated||Phase 1|740|Anticipated|Central Hospital, Nancy, France||2|||f||||||||||||||2017-02-18 17:35:12.156149|2017-02-18 17:35:12.156149
NCT00122395|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2006-05-03|||January 2005||2005-01-01|July 2005|2005-07-01|March 2005||2005-03-01|||||Interventional|||Trial Regarding the Acceptability of Audiotape Intimate Partner Violence (IPV) Screening|A Randomized Clinical Trial Regarding the Acceptability of an Audiotape Questionnaire for Intimate Partner Violence Screening in a Pediatric ED|Completed||N/A|500||Children's Hospital of Philadelphia|||||f||||||||||||||2017-02-18 17:35:12.267283|2017-02-18 17:35:12.267283
NCT00122382|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2010-11-03|2010-05-03||July 2005||2005-07-01|November 2010|2010-11-01|February 2009|Actual|2009-02-01|February 2008|Actual|2008-02-01||Interventional|||Remission and Joint Damage Progression in Early Rheumatoid Arthritis|A Phase IIIB Multi-center, Randomized, Double-Blind Study to Evaluate Remission and Joint Damage Progression in Methotrexate Naive Early Erosive RA Subjects Treated With Abatacept Plus Methotrexate Compared With Methotrexate|Completed||Phase 3|1052|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 17:35:12.379533|2017-02-18 17:35:12.379533
NCT00122369|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2013-02-23|2012-02-03||March 2002||2002-03-01|February 2013|2013-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy|Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy|Completed||Phase 2|240|Actual|Beth Israel Deaconess Medical Center|For the assessment of the Secondary Outcome parameter we were able to recruit only 19 women whom we could contact early enough on the day of their breast cancer surgery to fill out the IES. This limits the power of the statistical analysis.|3|||f||||t||||||||||2017-02-18 17:35:14.246156|2017-02-18 17:35:14.246156
NCT00122356|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2013-03-11|||September 2005||2005-09-01|March 2013|2013-03-01|March 2013|Actual|2013-03-01|February 2013|Actual|2013-02-01||Interventional|BATMAN||Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment|Maintaining Skeletal Health in Postmenopausal Women With Surgically Resected Stage I-IIIa Hormone-receptor Positive Breast Cancer Who Are Receiving Anastrozole, Through the Use of Alendronate as Determined by the Osteoporosis Australia Bone Maintenance Algorithm|Completed||Phase 3|303|Actual|Barwon Health||1|||f||||||||||||||2017-02-18 17:35:15.440892|2017-02-18 17:35:15.440892
NCT00122343|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-21|2015-02-18|||August 2005||2005-08-01|February 2015|2015-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)|A Phase II Study of AP23573, an mTOR Inhibitor, in Female Adult Patients With Recurrent or Persistent Endometrial Cancer|Completed||Phase 2|45|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 17:35:15.550272|2017-02-18 17:35:15.550272
NCT00122330|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2006-11-30|||October 2004||2004-10-01|November 2006|2006-11-01|January 2006||2006-01-01|||||Interventional|||Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients|Randomized, Double-Blind, and Placebo-Controlled Study Using Eculizumab in Transfusion Dependent PNH Patients|Completed||Phase 3|75||Alexion Pharmaceuticals|||||||||||||||||||2017-02-18 17:35:15.655161|2017-02-18 17:35:15.655161
NCT00122317|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2009-01-14|||May 2005||2005-05-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)|Open Label Extension Study of Eculizumab in Patients With Transfusion Dependent PNH|Completed||Phase 3|187|Actual|Alexion Pharmaceuticals||1|||t||||||||||||||2017-02-18 17:35:15.771128|2017-02-18 17:35:15.771128
NCT00122304|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2007-02-20|||December 2004||2004-12-01|February 2007|2007-02-01|November 2006||2006-11-01|||||Interventional|||Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab|Safety in Hemolytic PNH Patients Treated With Eculizumab: a Multi-Center Open-Label Research Design Study|Completed||Phase 3|85||Alexion Pharmaceuticals|||||f||||||||||||||2017-02-18 17:35:16.153367|2017-02-18 17:35:16.153367
NCT00122291|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2012-01-18|||January 2002||2002-01-01|August 2011|2011-08-01||||||||Interventional|||A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer|A Phase 2 Study of Preoperative Radiation Therapy and Capecitabine (an Oral Fluoropyrimidine Carbamate) in Locally Advanced Rectal Cancer|Unknown status|Active, not recruiting|Phase 2|66|Anticipated|AHS Cancer Control Alberta|||||f||||||||||||||2017-02-18 17:35:16.281956|2017-02-18 17:35:16.281956
NCT00122278|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2008-02-15|||July 2005||2005-07-01|February 2008|2008-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines|Parenteral Corticosteroids as Adjuvant Therapy for Migraine Headaches|Completed||Phase 3|205|Actual|Montefiore Medical Center||2|||f||||||||||||||2017-02-18 17:35:16.378914|2017-02-18 17:35:16.378914
NCT00122265|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2016-02-24|||April 2003||2003-04-01|April 2012|2012-04-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Observational|||Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer|Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal RT for Prostate Cancer|Terminated||N/A|83|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 17:35:16.486271|2017-02-18 17:35:16.486271
NCT00122252|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2011-12-08|||May 2004||2004-05-01|December 2011|2011-12-01|February 2007|Actual|2007-02-01|||||Observational|||Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation|Biological Imaging for Optimising CTV and GTV Contouring in Prostate Cancer to Improve the Possibilities for IMRT Dose Escalation|Terminated||N/A|20||AHS Cancer Control Alberta|||1|Study abandoned.|f||||||||||||||2017-02-18 17:35:16.577696|2017-02-18 17:35:16.577696
NCT00122239|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2016-03-14|||January 2005||2005-01-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Observational|||A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers|A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers|Active, not recruiting||N/A|13|Actual|AHS Cancer Control Alberta|||1||f||||t||||||||||2017-02-18 17:35:16.666762|2017-02-18 17:35:16.666762
NCT00122226|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2006-04-24|||January 2003||2003-01-01|July 2005|2005-07-01|July 2008||2008-07-01|||||Interventional|||MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)|MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)|Unknown status|Active, not recruiting|Phase 4|50||VU University Medical Center|||||f||||||||||||||2017-02-18 17:35:16.770582|2017-02-18 17:35:16.770582
NCT00122213|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2010-04-20|||September 2003||2003-09-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Physical Activity and Diet Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women|An Individual-based Diet and Physical Activity Intervention Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women|Completed||Phase 2|400||Wageningen University|||||f||||||||||||||2017-02-18 17:35:16.880553|2017-02-18 17:35:16.880553
NCT00122187|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2015-04-06|2013-12-05||August 2005||2005-08-01|September 2013|2013-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||The population is the number of VAMCs that enrolled in the study.|Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention|Translation of Colorectal Cancer Screening Guidelines: A System Intervention|Completed||N/A|8|Actual|VA Office of Research and Development|Half of the sites randomized did not complete the study. GI referral rates should have been nearly 100%, yet were not. Because of programming limitations, we were unable to evaluate the type of diagnostic interventions the patients received.|2|||f||||f||||||||||2017-02-18 17:35:16.960039|2017-02-18 17:35:16.960039
NCT00122174|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2015-04-06|||July 2004||2004-07-01|January 2007|2007-01-01|June 2006|Actual|2006-06-01|||||Interventional|||Stress-Busting Program for Caregivers of Patients With Neruological Diseases|Stress-Busting Program for Caregivers of Patients With Neurological Diseases|Completed||N/A|50|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:35:17.33216|2017-02-18 17:35:17.33216
NCT00122161|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2015-04-06||||||October 2007|2007-10-01|September 2005|Actual|2005-09-01|||||Interventional|||Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation|Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation|Completed||Phase 3|190|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:35:17.441657|2017-02-18 17:35:17.441657
NCT00122148|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2010-02-04|||September 2005||2005-09-01|August 2006|2006-08-01|June 2006|Actual|2006-06-01|||||Interventional|||Can Vignettes Be Used to Improve Practice & Outcome|Can Vignettes be Used to Improve Practice and Outcomes?|Terminated||N/A|||VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:35:17.57045|2017-02-18 17:35:17.57045
NCT00122135|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2015-11-16|2015-07-10||December 2004||2004-12-01|November 2015|2015-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|Aim3||A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making|A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making|Completed||N/A|120|Actual|VA Office of Research and Development|Difficulties in recruiting enough surrogates led to abandoning having a surrogate arm.|2|||f||||f||||||||||2017-02-18 17:35:17.679676|2017-02-18 17:35:17.679676
NCT00122122|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2015-04-06||||||February 2007|2007-02-01|March 2004|Actual|2004-03-01|||||Interventional|||Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients|Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients|Completed||Phase 3|600|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:35:18.071212|2017-02-18 17:35:18.071212
NCT00122109|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2015-04-06|2014-08-22||August 2005||2005-08-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|October 2008|Actual|2008-10-01||Interventional|||Telemedicine and Anger Management Groups With PTSD Veterans in the Hawaiian Islands|Telemedicine and Anger Management Groups for PTSD Veterans in the Hawaiian Islands|Completed||N/A|125|Actual|VA Office of Research and Development|We conservatively excluced participants with acute safety concerns (homicidal or suicidal) and current substance dependence. However other literature suugests that both issues can be safely addressed via telemedicine.|2|||f||||f||||||||||2017-02-18 17:35:18.173808|2017-02-18 17:35:18.173808
NCT00122096|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2008-09-25|||November 2002||2002-11-01|September 2008|2008-09-01|January 2006||2006-01-01|||||Interventional|||Perioperative Inflammation and Cyclooxygenase 2 (COX-2)|Preoperative Valdecoxib: CNS Penetration and Effects on Biochemical Markers of Pain and Sensitization|Completed||Phase 4|30||University of Washington|||||f||||||||||||||2017-02-18 17:35:18.675223|2017-02-18 17:35:18.675223
NCT00122083|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2005-07-25|||April 2004||2004-04-01|March 2004|2004-03-01|June 2004||2004-06-01|||||Interventional|||An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression|A Cluster Randomised Controlled Trial to Assess the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression|Completed||N/A|1680||University of Oxford|||||f||||||||||||||2017-02-18 17:35:18.770796|2017-02-18 17:35:18.770796
NCT00122070|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2008-06-09|||May 2005||2005-05-01|June 2008|2008-06-01|May 2008|Actual|2008-05-01|September 2007|Actual|2007-09-01||Interventional|||Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder|Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder|Completed||Phase 3|15|Actual|Rutgers, The State University of New Jersey||1|||f||||t||||||||||2017-02-18 17:35:18.878199|2017-02-18 17:35:18.878199
NCT00122057|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2011-05-31|||June 2005||2005-06-01|September 2006|2006-09-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Impact of Antibiotic Treatment on Outcome in Patients With Ventilator-Associated Tracheobronchitis||Completed||N/A|58|Actual|University Hospital, Lille|||||f||||||||||||||2017-02-18 17:35:19.00697|2017-02-18 17:35:19.00697
NCT00122044|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2014-05-21|||January 2003||2003-01-01|May 2014|2014-05-01|December 2004||2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects|Childhood Hypertonia of Central Origin: An Open Label Trial of Anticholinergic Treatment Effects|Completed||Phase 2|35||University of Southern California|||||f||||||||||||||2017-02-18 17:35:19.116795|2017-02-18 17:35:19.116795
NCT00122031|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2012-06-13|||July 2005||2005-07-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|April 2009|Actual|2009-04-01||Interventional|||Deep Brain Stimulation for Treatment-Refractory Major Depression|Deep Brain Stimulation for Treatment-Refractory Major Depression|Completed||Phase 1|13|Actual|University Hospital, Bonn||1|||f||||f||||||||||2017-02-18 17:35:19.234786|2017-02-18 17:35:19.234786
NCT00122018|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2014-11-06|||May 2002||2002-05-01|November 2014|2014-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery|N-acetylcysteine and Fenoldopam Protect the Renal Function of Patients With Chronic Renal Insufficiency Undergoing Cardiac Surgery.|Completed||Phase 2|80||Pulmonary Critical Care Associates of Baltimore||4|||f||||f||||||||||2017-02-18 17:35:19.346756|2017-02-18 17:35:19.346756
NCT00122005|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2009-02-23|||July 2005||2005-07-01|February 2009|2009-02-01|July 2005|Anticipated|2005-07-01|||||Interventional|||GVAX in Advanced Prostate Cancer Patients Made Lymphopenic|Phase I/II Study of Human GM-CSF Gene-Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (GVAX®) in Advanced Prostate Cancer Patients Made Lymphopenic and Infused With Autologous Peripheral Blood Mononuclear Cells|Unknown status|Active, not recruiting|Phase 1/Phase 2|18|Anticipated|Providence Health & Services|||||||||||||||||||2017-02-18 17:35:19.458454|2017-02-18 17:35:19.458454
NCT00121992|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2005-08-08|||June 1999||1999-06-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Docetaxel in Combination With Doxorubicin and Cyclophosphamide (TAC) Versus 5-Fluorouracil in Combination With Doxorubicin and Cyclophosphamide (5 FAC) as Adjuvant Treatment of Breast Cancer Patients|A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination With Doxorubicin and Cyclophosphamide (TAC) Versus 5-Fluorouracil in Combination With Doxorubicin and Cyclophosphamide (FAC) as Adjuvant Treatment of High Risk Operable Breast Cancer Patients With Negative Axillary Lymph Nodes|Completed||Phase 3|1054||Spanish Breast Cancer Research Group|||||f||||||||||||||2017-02-18 17:35:19.557677|2017-02-18 17:35:19.557677
NCT00121979|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2007-07-02|||September 2004||2004-09-01|July 2005|2005-07-01|March 2006||2006-03-01|||||Interventional|||Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects|Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Exploring the Safety, Tolerability, and Antiviral Effect of Substituting 600 mg Racivir for 3TC in HIV-Infected Subjects Who Have the M184V Mutation and Are Currently Failing on a HAART Regimen Containing Lamivudine|Completed||Phase 2|60||Pharmasset|||||||||||||||||||2017-02-18 17:35:19.656235|2017-02-18 17:35:19.656235
NCT00121966|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2008-06-18|||January 2003||2003-01-01|June 2008|2008-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|SDDS||South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus|South Danish Diabetes Study: A Prospective Randomised Multi-Centre Study for the Evaluation of the Optimal Pharmacological Antidiabetic Treatment of Type 2 Diabetes Mellitus|Completed||Phase 4|400||Odense University Hospital|||||f||||||||||||||2017-02-18 17:35:19.837918|2017-02-18 17:35:19.837918
NCT00121953|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2012-10-16|||July 2005||2005-07-01|October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis|Endometriosis: Immunomodulation|Withdrawn||Phase 2/Phase 3|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Due to the recent meta-analysis about CV adverse effects.|f||||||||||||||2017-02-18 17:35:20.128032|2017-02-18 17:35:20.128032
NCT00121940|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2012-04-18|||February 2006||2006-02-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Guided Care: Integrating High Tech and High Touch|Guided Care: Integrating High Tech and High Touch|Completed||N/A|904|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||||2017-02-18 17:35:20.246922|2017-02-18 17:35:20.246922
NCT00121927|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2010-01-26|||June 2004||2004-06-01|February 2007|2007-02-01|June 2007||2007-06-01|||||Interventional|||Use of the Atkins Diet for Adults With Intractable Epilepsy|Use of the Atkins Diet for Adults With Intractable Epilepsy|Completed||N/A|30||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:35:20.36863|2017-02-18 17:35:20.36863
NCT00121914|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2005-10-17|||October 2000||2000-10-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone|Treatment of Hepatocellular Carcinoma: A Randomized Controlled Study With Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone|Unknown status|Active, not recruiting|Phase 3|120||Medical University of Vienna|||||f||||||||||||||2017-02-18 17:35:20.479592|2017-02-18 17:35:20.479592
NCT00121901|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-10-16|||October 2004||2004-10-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Does Glyceryl Nitrate Prevent Post-Endoscopic Retrograde Cholangiopancreaticography (ERCP) Pancreatitis?||Completed||Phase 3|1600|Anticipated|Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:35:20.583698|2017-02-18 17:35:20.583698
NCT00121485|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2016-04-08|2012-11-13||February 2005||2005-02-01|April 2016|2016-04-01|January 2012|Actual|2012-01-01|June 2009|Actual|2009-06-01||Interventional|||Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy|The HeartMate II LVAS Pivotal Study Protocol, Destination Therapy|Completed||N/A|200|Actual|St. Jude Medical||2|||f||||t||||||||||2017-02-18 17:35:40.641527|2017-02-18 17:35:40.641527
NCT00121888|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2014-06-05|||December 2002||2002-12-01|June 2014|2014-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy|Randomized Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy|Completed||Phase 1/Phase 2|60||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:35:20.700167|2017-02-18 17:35:20.700167
NCT00121875|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2009-09-28|||June 2005||2005-06-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|||||Observational|||Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature|Growth Hormone and Insulin Resistance in Girls With Turner Syndrome or Idiopathic Short Stature|Terminated||Phase 4|1|Actual|Massachusetts General Hospital|||2|Enrollment was too low.|f||||t||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 17:35:20.811021|2017-02-18 17:35:20.811021
NCT00121862|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2006-05-04|||August 2005||2005-08-01|May 2006|2006-05-01|March 2006||2006-03-01|||||Interventional|||Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite|A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Leish-111f + MPL-SE Vaccine Compared to the Leish-111f Protein Alone in Montenegro Skin Test-Negative Healthy Adults|Completed||Phase 2|60||IDRI|||||||||||||||||||2017-02-18 17:35:20.924772|2017-02-18 17:35:20.924772
NCT00121849|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2006-05-04|||August 2005||2005-08-01|May 2006|2006-05-01|February 2006||2006-02-01|||||Interventional|||Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite|A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Leish-111f + MPL-SE Vaccine in Montenegro Skin Test-Positive Healthy Adults|Completed||Phase 1|12||IDRI|||||||||||||||||||2017-02-18 17:35:21.031589|2017-02-18 17:35:21.031589
NCT00121836|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2011-04-25|2009-12-16||June 2005||2005-06-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer|An Open-label Study of Xeloda Plus Avastin at Time of Disease Progression in Treatment-naïve Women With HER2-negative Metastatic Breast Cancer|Completed||Phase 4|109|Actual|Hoffmann-La Roche|The primary endpoint TTP was changed to overall survival (OS) due to issues regarding tumor assessment data based on RECIST and poor response from investigators to related queries that developed after the planned interim analysis.|1|||f||||||||||||||2017-02-18 17:35:21.133003|2017-02-18 17:35:21.133003
NCT00121823|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2017-01-11|||June 2004||2004-06-01|January 2017|2017-01-01|December 2004||2004-12-01|||||Interventional|||Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines|Malaria Infection Diagnosed by PCR as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines|Completed||Phase 1/Phase 2|120||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:35:21.59481|2017-02-18 17:35:21.59481
NCT00121810|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2011-04-13|2009-11-18||August 2003||2003-08-01|April 2011|2011-04-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients|An Open Label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Early Calcineurin Inhibitor Withdrawal in Recipients of Primary Renal Allografts Maintained Long-term on Mycophenolate Mofetil (MMF) (CellCept®) and Sirolimus (Rapamune®)|Completed||Phase 4|305|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:35:21.71127|2017-02-18 17:35:21.71127
NCT00121797|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-17|2006-11-06|||January 2004||2004-01-01|July 2005|2005-07-01|June 2005|Anticipated|2005-06-01|||||Interventional|||Peripartum Bacteruria and Urinary Tract Infections (UTI)|Risk Factors for Postpartum Bacteruria, Does Labor Cause UTI?|Unknown status|Recruiting|N/A|1000|Anticipated|Hadassah Medical Organization|||||f||||||||||||||2017-02-18 17:35:22.694667|2017-02-18 17:35:22.694667
NCT00121784|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2016-11-01|||October 2005||2005-10-01|November 2016|2016-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients|A Randomized, Open-label Study of the Effect of Replacing CNI With Sirolimus in a Standard Care Regimen of CNI, CellCept, and Steroids on Renal Function in Heart Transplant Patients|Terminated||Phase 4|12|Actual|Hoffmann-La Roche||1||Poor recruitment|f||||||||||||||2017-02-18 17:35:23.00205|2017-02-18 17:35:23.00205
NCT00121771|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2017-01-11|||January 2004||2004-01-01|January 2017|2017-01-01|July 2004||2004-07-01|||||Interventional|||Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men|A Phase 1 Trial of the Malaria Candidate Vaccines FP9 CS and MVA CS in Adult Gambian Men Aged 18 - 45 Years|Completed||Phase 1|32||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:35:23.136208|2017-02-18 17:35:23.136208
NCT00121758|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2008-06-05|||September 2004||2004-09-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|November 2007|Actual|2007-11-01||Interventional|||AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers|Randomised Double Blinded Phase II AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptide (LIPO-5) Versus Placebo in Non Infected HIV Volunteers (ANRS VAC 18)|Completed||Phase 2|156|Anticipated|French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-02-18 17:35:23.249444|2017-02-18 17:35:23.249444
NCT00121745|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2007-12-15|||July 2005||2005-07-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer|Phase I Evaluation of Safety of Intravenous Infusion of a Pathotropic Vector Bearing a Cytocidal Cyclin G1 Construct (Rexin-G) as Intervention for Locally Advanced and Metastatic Pancreatic Cancer Refractory to Standard Chemotherapy|Terminated||Phase 1|12|Actual|Epeius Biotechnologies||4||poor enrollment|f||||t||||||||||2017-02-18 17:35:23.362334|2017-02-18 17:35:23.362334
NCT00121732|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2015-06-29|||July 2005||2005-07-01|June 2015|2015-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies|A Phase 1, Two-Arm, Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies|Completed||Phase 1|39|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:35:23.480749|2017-02-18 17:35:23.480749
NCT00121472|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2016-04-08|2009-05-29||March 2005||2005-03-01|April 2016|2016-04-01|May 2010|Actual|2010-05-01|November 2006|Actual|2006-11-01||Interventional|||Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation|The HeartMate II LVAS Pivotal Study Protocol, Bridge to Cardiac Transplantation|Completed||N/A|194|Actual|St. Jude Medical||1|||f||||t||||||||||2017-02-18 17:35:41.745766|2017-02-18 17:35:41.745766
NCT00121719|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2016-04-19|2016-04-19||July 2005||2005-07-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|June 2009|Actual|2009-06-01||Interventional||Intent-to-treat population included all participants who received at least one dose of lenvatinib.|An Open Label Phase I Dose Escalation Study Of E7080|An Open Label Phase I Dose Escalation Study Of E7080|Active, not recruiting||Phase 1|87|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 17:35:23.629964|2017-02-18 17:35:23.629964
NCT00121706|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2006-02-03|||July 2005||2005-07-01|January 2006|2006-01-01|September 2005||2005-09-01|||||Interventional|||Fast Food Feeding in Youth|Fast Food Feeding in Youth|Completed||N/A|18||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:35:29.451235|2017-02-18 17:35:29.451235
NCT00121693|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2016-01-26|||December 2003||2003-12-01|January 2016|2016-01-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||The Use of Music Therapy in the Prevention of Falls|Posturographic Changes Associated With Music Therapy and Fall Prevention|Completed||Early Phase 1|266|Actual|Carrick Institute for Graduate Studies||4|||f||||f||||||||No||2017-02-18 17:35:29.550041|2017-02-18 17:35:29.550041
NCT00121680|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2015-12-09|||July 2005||2005-07-01|November 2015|2015-11-01|May 2015|Actual|2015-05-01|September 2011|Actual|2011-09-01||Interventional|||A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma|A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma|Completed||Phase 1|115|Actual|Eisai Inc.||1|||f||||f||||||||||2017-02-18 17:35:29.652512|2017-02-18 17:35:29.652512
NCT00121667|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2015-04-08|2011-03-15||August 2005||2005-08-01|March 2015|2015-03-01|February 2010|Actual|2010-02-01|October 2006|Actual|2006-10-01||Interventional|||Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone|"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial to Evaluate the Efficacy and Safety of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone"|Completed||Phase 3|1462|Actual|AstraZeneca||4|||f||||||||||||||2017-02-18 17:35:29.794975|2017-02-18 17:35:29.794975
NCT00121654|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2009-03-09|||July 2005||2005-07-01|March 2009|2009-03-01|December 2009|Anticipated|2009-12-01|December 2008|Actual|2008-12-01||Interventional|||Spinal Cord Stimulation (SCS) in Refractory Angina|Randomized Study on SCS for the Treatment of Refractory Angina Pectoris|Unknown status|Recruiting|Phase 4|60|Anticipated|Catholic University of the Sacred Heart||3|||f||||f||||||||||2017-02-18 17:35:34.386094|2017-02-18 17:35:34.386094
NCT00121641|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2015-03-16|2011-04-12||July 2005||2005-07-01|March 2015|2015-03-01|February 2010|Actual|2010-02-01|August 2006|Actual|2006-08-01||Interventional|||Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise|Completed||Phase 3|1035|Actual|AstraZeneca||5|||f||||||||||||||2017-02-18 17:35:34.653618|2017-02-18 17:35:34.653618
NCT00121628|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2013-10-07|||July 2005||2005-07-01|October 2013|2013-10-01|October 2010|Actual|2010-10-01|November 2006|Actual|2006-11-01||Interventional|||A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer|A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer|Completed||Phase 2|184|Actual|Amgen||1|||||||||||||||||2017-02-18 17:35:39.462839|2017-02-18 17:35:39.462839
NCT00121615|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-03-05|||October 2004||2004-10-01|March 2009|2009-03-01||||||||Interventional|||Study of Etanercept in the Treatment of Psoriasis in Adult Subjects|An Open-Label, Long-Term Extension Study to Assess the Safety and Efficacy of Etanercept in the Treatment of Psoriasis in Adult Subjects|Completed||Phase 3|391||Amgen|||||f||||||||||||||2017-02-18 17:35:39.559451|2017-02-18 17:35:39.559451
NCT00121602|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-18|2008-02-21|||March 2005||2005-03-01|February 2008|2008-02-01|October 2006|Actual|2006-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease|Randomized, Double-Blind, Equivalence Study of the Efficacy of Darbepoetin Alfa Manufactured by Serum Free Bioreactor Technology and Darbepoetin Alfa Manufactured by Roller-Bottle Technology for the Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis|Completed||Phase 3|446|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:35:39.647568|2017-02-18 17:35:39.647568
NCT00121589|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2017-01-24|||July 14, 2005||2005-07-14|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60|Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:35:39.877794|2017-02-18 17:35:39.877794
NCT00121563|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-20|2008-03-03|||July 2005||2005-07-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Evaluation of a TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect|Evaluation of TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect|Completed||Phase 2|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:35:39.963613|2017-02-18 17:35:39.963613
NCT00121550|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2016-08-10|||October 1999||1999-10-01|August 2016|2016-08-01|September 2002|Actual|2002-09-01|April 2000|Actual|2000-04-01||Interventional|||The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease|The Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease - a Randomized, Placebo Controlled, Double Blinded, Multicentre, Clinical Trial|Completed||Phase 3|4372|Actual|Copenhagen Trial Unit, Center for Clinical Intervention Research||2|||f||||||||||||||2017-02-18 17:35:40.071564|2017-02-18 17:35:40.071564
NCT00121537|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2015-10-07|||July 2005||2005-07-01|October 2015|2015-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes|A Prospective Study to Determine the Utility of Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes With Regards to Lower Extremity Fasciotomy Wound Healing, Complications, Cost and Patient and Nursing Satisfaction|Terminated||N/A|30||The University of Texas Health Science Center at San Antonio||||terminated, due to lack enrollment,|f||||||||||||||2017-02-18 17:35:40.209842|2017-02-18 17:35:40.209842
NCT00121524|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2015-05-28|||January 2003||2003-01-01|May 2015|2015-05-01|June 2008|Actual|2008-06-01|May 2008|Actual|2008-05-01||Interventional|||Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome|Effects of Epinephrine and I.V. Needle on CPR Outcome|Completed||Phase 2|904|Actual|University of Oslo||2|||f||||t||||||||||2017-02-18 17:35:40.305008|2017-02-18 17:35:40.305008
NCT00121459|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2015-03-03|||September 2003||2003-09-01|March 2015|2015-03-01||||||||Interventional|||Effectiveness of the Diaphragm for HIV Prevention|The Latex Diaphragm to Prevent HIV Acquisition Among Women: A Female-Controlled, Physical Barrier of the Cervix|Withdrawn||Phase 3|0|Actual|University of California, San Francisco||||PI left and no data or information is available.|f||||||||||||||2017-02-18 17:35:42.156259|2017-02-18 17:35:42.156259
NCT00121446|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2006-01-19|||July 2003||2003-07-01|July 2005|2005-07-01||||||||Interventional|||Which Therapy for Acute Heart Attacks? (The WEST Study)|Which Early ST Elevation Myocardial Infarction Therapy? The WEST Study|Completed||Phase 2/Phase 3|300||University of Alberta|||||f||||||||||||||2017-02-18 17:35:42.258102|2017-02-18 17:35:42.258102
NCT00121433|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2006-06-23|||September 2004||2004-09-01|July 2005|2005-07-01|December 2004||2004-12-01|||||Interventional|||Leptin and Endothelial Function|The Role of Leptin in Modulating Vascular Tone and Endothelial Function in Obese and Normal Weight Adults: A Vascular-Protective Effect of Leptin?|Completed||Phase 4|15||University of Michigan|||||||||||||||||||2017-02-18 17:35:42.372702|2017-02-18 17:35:42.372702
NCT00121420|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2014-05-07||||||May 2014|2014-05-01||||||||Interventional|||Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases|Phase II Trial of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases|Terminated||Phase 2|45||Pharmacyclics LLC.|||||f||||||||||||||2017-02-18 17:35:42.441583|2017-02-18 17:35:42.441583
NCT00121407|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2005-07-19|||March 2002||2002-03-01|July 2005|2005-07-01|August 2005||2005-08-01|||||Interventional|||Visudyne® in Occult (VIO)|A Randomized, Placebo-Controlled, Double-Masked, Multicenter, Phase III Study of the Effect of Visudyne Therapy in Occult With No Classic Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD): Visudyne in Occult (VIO)|Completed||Phase 3|364||QLT Inc.|||||||||||||||||||2017-02-18 17:35:42.559717|2017-02-18 17:35:42.559717
NCT00121394|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2014-07-29|||June 2005||2005-06-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Chlorhexidine Vaginal and Infant Wash in Pakistan|Randomized Trial of Chlorhexidine Vaginal and Infant Wash to Reduce Neonatal Mortality|Completed||Phase 3|5008|Actual|NICHD Global Network for Women's and Children's Health||1|||f||||t||||||||||2017-02-18 17:35:42.860926|2017-02-18 17:35:42.860926
NCT00121381|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2008-01-10|||May 2005||2005-05-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|||||Interventional|||Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis|Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis|Completed||Phase 4|400||Novartis||2|||||||||||||||||2017-02-18 17:35:42.972211|2017-02-18 17:35:42.972211
NCT00121368|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2013-11-22|||February 2004||2004-02-01|November 2013|2013-11-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||GN Tobacco Use Survey|Survey on Tobacco Use in the GN Sites|Completed||N/A|6000|Actual|NICHD Global Network for Women's and Children's Health|||1||f||||t||||||||||2017-02-18 17:35:43.093207|2017-02-18 17:35:43.093207
NCT00121355|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2016-10-17|||July 2005||2005-07-01|October 2016|2016-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Novofine Autocover Safety Needle Versus BD Safety Glide|An Open-Label, Multi-Center, Prospective Cross-Over Study of Preference and Safety of NovoFine® Autocover(TM) Needles Compared to BD Safety Glide (TM) Syringes in the Hospital Setting|Completed||Phase 4|83|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:35:43.19525|2017-02-18 17:35:43.19525
NCT00121329|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2005-07-19||||||July 2005|2005-07-01|December 2004||2004-12-01|||||Interventional|||4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions|4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions|Completed||N/A|80||Oregon Health and Science University|||||f||||||||||||||2017-02-18 17:35:43.273962|2017-02-18 17:35:43.273962
NCT00121316|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2008-01-10|||October 2004||2004-10-01|January 2008|2008-01-01|July 2005|Actual|2005-07-01|||||Interventional|||Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients|Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) of Patients Intolerant to, or Dependant on, Topical Corticosteroids|Completed||Phase 4|200||Novartis||2|||f||||||||||||||2017-02-18 17:35:43.356828|2017-02-18 17:35:43.356828
NCT00121303|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2016-09-19|||January 2005||2005-01-01|September 2016|2016-09-01|June 2016|Actual|2016-06-01|January 2009|Actual|2009-01-01||Interventional|||Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes|Randomised Induction and Post Induction Therapy in Older Patients (≥61 Years of Age) With Acute Myeloid Leukemia (AML) and Refractory Anemia With Excess Blasts (RAEB, RAEB-t)|Completed||Phase 3|600|Anticipated|Stichting Hemato-Oncologie voor Volwassenen Nederland||4|||f||||||||||||||2017-02-18 17:35:43.461054|2017-02-18 17:35:43.461054
NCT00121290|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2014-02-21|||February 2005||2005-02-01|April 2013|2013-04-01||||April 2008|Actual|2008-04-01||Interventional|||SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery|A Phase I Dose Escalation Study of Daily x 3 Intravenous SJG-136 in Patients With Advanced Solid Tumors|Completed||Phase 1|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:35:43.595316|2017-02-18 17:35:43.595316
NCT00121277|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2015-07-22|||September 2005||2005-09-01|July 2015|2015-07-01||||August 2009|Actual|2009-08-01||Interventional|||Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Capecitabine in Patients With Solid Tumors|Completed||Phase 1|28|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:35:43.700736|2017-02-18 17:35:43.700736
NCT00121264|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2014-06-16|||March 2005||2005-03-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors|A Phase I Dose-Escalation Study of Intravenous 17-Allylaminogeldanamycin (17-AAG) [NSC 330507and Oral BAY 43-9006 [NSC 724772] Administered in Patients With Pretreated Advanced Solid Tumors|Completed||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:35:44.011232|2017-02-18 17:35:44.011232
NCT00121251|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2017-01-31|||April 2005||2005-04-01|November 2016|2016-11-01||||August 2017|Anticipated|2017-08-01||Interventional|||Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer|A Phase I/II Trial of BAY 43-9006 Plus Gemcitabine and Capecitabine in the Treatment of Patients With Advanced Renal Cell Carcinoma|Active, not recruiting||Phase 1/Phase 2|35|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:35:44.130655|2017-02-18 17:35:44.130655
NCT00121238|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2016-03-28|2015-07-29||January 2005||2005-01-01|February 2013|2013-02-01|November 2015|Actual|2015-11-01|November 2010|Actual|2010-11-01||Interventional||16 patients were enrolled but only 13 were analyzed. 1 patient progressed clinically before any treatment.Two patients who received study drug were deemed ineligible as they did not meet entry PSA criteria of three consecutive rises in PSA.|Cilengitide in Treating Patients With Prostate Cancer|Phase II Evaluation of EMD 121974 (NSC 707544, Cilengitide) in Patients With Non-Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|16|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:35:44.259922|2017-02-18 17:35:44.259922
NCT00121225|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2014-10-01|2014-10-01||September 2005||2005-09-01|May 2013|2013-05-01|June 2013|Actual|2013-06-01|March 2009|Actual|2009-03-01||Interventional|||Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma|A Phase II Study of Vorinostat in Patients With Advanced Melanoma|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:35:44.65546|2017-02-18 17:35:44.65546
NCT00121212|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2015-10-28|||July 2003||2003-07-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|July 2010|Actual|2010-07-01||Interventional|||Positron Emission Tomography in Prostate Cancer|Positron Emission Tomography in Prostate Cancer|Completed||N/A|179|Actual|Washington University School of Medicine||3|||f||||f||||||||||2017-02-18 17:35:44.952782|2017-02-18 17:35:44.952782
NCT00121199|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2014-05-06|2012-10-30||June 2005||2005-06-01|December 2012|2012-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma|Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell NHL|Completed||Phase 2|73|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:35:45.079446|2017-02-18 17:35:45.079446
NCT00121186|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2012-03-05|2012-03-05||July 2005||2005-07-01|March 2012|2012-03-01|December 2011|Actual|2011-12-01|January 2008|Actual|2008-01-01||Interventional|||S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma|Nonmyeloablative Allogeneic Stem Cell Transplantation For Relapsed Hodgkin's or Non-Hodgkin's Lymphoma After Autologous Transplantation ( A BMT Study)|Terminated||Phase 2|1|Actual|Southwest Oncology Group||1||poor accrual|f||||f||||||||||2017-02-18 17:35:45.627241|2017-02-18 17:35:45.627241
NCT00121173|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-19|2013-06-10|||November 2003||2003-11-01|June 2013|2013-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia|A Phase I/II Clinical Trial of pNGVL4a-Sig/E7 (Detox)/HSP70 for the Treatment of Patients With HPV 16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)|Completed||Phase 1/Phase 2|70|Actual|Sidney Kimmel Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 17:35:45.970845|2017-02-18 17:35:45.970845
NCT00121160|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2012-03-26|||September 2005||2005-09-01|March 2012|2012-03-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response|Can Stress Management Improve Vaccine Immune Response|Completed||Phase 1|126|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:35:46.103559|2017-02-18 17:35:46.103559
NCT00121147|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2006-02-22|||September 2003||2003-09-01|July 2005|2005-07-01|October 2005||2005-10-01|||||Interventional|||Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan|A Comparison of the Additivity of Brinzolamide Ophthalmic Suspension, 1% (Azopt) and Brimonidine Tartrate Ophthalmic Solution, 0.15% (Alphagan P) to Travoprost Ophthalmic Solution, 0.004% (Travatan) in Patients With Elevated IOP on Travoprost. A Three Month Double-Masked, Multi-Center Trial in the United States|Completed||N/A|200||Hermann Eye Center|||||f||||||||||||||2017-02-18 17:35:46.216397|2017-02-18 17:35:46.216397
NCT00121134|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2013-11-26|2013-08-08||June 2005||2005-06-01|November 2013|2013-11-01|May 2011|Actual|2011-05-01|May 2009|Actual|2009-05-01||Interventional|||Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer|Anti-Angiogenesis Treatment After Preoperative Chemotherapy: A Pilot Study in Women With Operable Breast Cancer|Completed||N/A|164|Actual|Dana-Farber Cancer Institute||4|||f||||t||||||||||2017-02-18 17:35:46.344998|2017-02-18 17:35:46.344998
NCT00121121|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2007-03-14|||July 2004||2004-07-01|November 2005|2005-11-01|December 2005||2005-12-01|||||Interventional|||Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers|A Phase Ib Vaccine Trial Evaluating the Safety and Immunogenicity of HIV Lipopeptides by Two Administration Routes (Intramuscular And Intradermal) in Healthy Adult Volunteers. ANRS VAC16 Trial|Completed||Phase 1|70||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:47.274451|2017-02-18 17:35:47.274451
NCT00121108|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2012-06-27||2012-03-08|November 2004||2004-11-01|June 2012|2012-06-01|March 2011|Actual|2011-03-01|December 2010|Actual|2010-12-01||Interventional|||MEDI-524 (Motavizumab) for the Prevention of Respiratory Syncytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States|A Phase 3 Study of MEDI-524 (Motavizumab) for the Prevention of RSV Disease Among Native American Infants in the Southwestern United States|Completed||Phase 3|2127|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 17:35:47.363816|2017-02-18 17:35:47.363816
NCT00121095|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2007-12-17|||July 2005||2005-07-01|December 2007|2007-12-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer|Phase I/II Trial of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Androgen-Independent Prostate Cancer|Unknown status|Recruiting|Phase 1/Phase 2|69|Anticipated|Cytogen Corporation||1|||f||||f||||||||||2017-02-18 17:35:47.455826|2017-02-18 17:35:47.455826
NCT00121069|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2005-07-19|||September 2002||2002-09-01|July 2005|2005-07-01|September 2004||2004-09-01|||||Interventional|||Study of Escitalopram in the Treatment of Specific Phobia|Placebo-Controlled Pilot Study of Escitalopram in the Treatment of Specific Phobia|Completed||Phase 2/Phase 3|12||Connor, Kathryn M., M.D.|||||||||||||||||||2017-02-18 17:35:47.567439|2017-02-18 17:35:47.567439
NCT00121056|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-12-04|||September 2002||2002-09-01|December 2008|2008-12-01||||||||Observational|||REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations|Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations (REKinDLE)|Completed||N/A|||Amgen|||||f||||||||||||||2017-02-18 17:35:47.664986|2017-02-18 17:35:47.664986
NCT00121043|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-11-25||||||December 2007|2007-12-01||||||||Interventional|||Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire|An Open Label, Randomized, Crossover Study to Assess Acceptability and Functionality of SimpleJectTM Vs Pre-Filled Syringe(s) Using Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using A Self-Reported Questionnaire|Completed||Phase 4|||Swedish Orphan Biovitrum|||||f||||||||||||||2017-02-18 17:35:47.741882|2017-02-18 17:35:47.741882
NCT00121030|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-20|||October 2002||2002-10-01|December 2007|2007-12-01|December 2003||2003-12-01|||||Interventional|||Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy|An Open-Label, Randomized Phase 2 Study to Validate a Patient Satisfaction Questionnaire for Anemia Treatment in Patients With Gynecological Malignancies Treated With Darbepoetin Alfa or Recombinant Human Erythropoietin for Anemia Due to Chemotherapy|Completed||Phase 2|||Amgen|||||f||||||||||||||2017-02-18 17:35:47.830241|2017-02-18 17:35:47.830241
NCT00121017|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2006-07-26||||||July 2006|2006-07-01||||||||Interventional|||A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects|A Randomized, Open-Label Study Assessing Safety, Tolerability and Efficacy of an Induction-Maintenance Treatment Strategy Including Lopinavir/Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine Versus Efavirenz Plus Tenofovir Disoproxil Fumarate and Emtricitabine in Antiviral-naïve HIV-1/HCV Co-Infected Subjects|Withdrawn||Phase 2|200||Abbott|||||||||||||||||||2017-02-18 17:35:48.119741|2017-02-18 17:35:48.119741
NCT00121004|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2013-09-04|||July 2005||2005-07-01|September 2013|2013-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||A Study to Tailor Advance Directives|A Study to Tailor Advance Directives|Completed||N/A|100||University of Chicago|||1||f||||f||||||||||2017-02-18 17:35:48.212616|2017-02-18 17:35:48.212616
NCT00120991|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2008-02-29|||April 2002||2002-04-01|February 2008|2008-02-01|July 2008|Anticipated|2008-07-01|March 2006|Actual|2006-03-01||Interventional|||Best Bypass Surgery (BBS) Trial|Off-Pump Coronary Artery Bypass Grafting Versus Conventional Coronary Artery Bypass Grafting on Postoperative Mortality and Morbidity, A Randomized Clinical Trial|Unknown status|Active, not recruiting|Phase 3|341|Actual|Rigshospitalet, Denmark||1|||f||||||||||||||2017-02-18 17:35:48.326834|2017-02-18 17:35:48.326834
NCT00120978|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2006-05-08|||December 2004||2004-12-01|April 2005|2005-04-01|August 2006||2006-08-01|||||Interventional|||Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial|Advair - CRP Study|Unknown status|Recruiting|Phase 4|250||University of British Columbia|||||f||||||||||||||2017-02-18 17:35:48.644642|2017-02-18 17:35:48.644642
NCT00120965|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-01-26|||June 2004||2004-06-01|January 2011|2011-01-01|March 2005|Actual|2005-03-01|||||Interventional|||AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)|AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)|Terminated||Phase 3|1837|Actual|University of Washington||2||"DSMB recommended termination due to lower survival to discharge in primary population and~   worse discharge CPC scores in the treatment arm than control arm."|f||||t||||||||||2017-02-18 17:35:48.767816|2017-02-18 17:35:48.767816
NCT00120952|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2006-08-04|||January 2003||2003-01-01|August 2006|2006-08-01|October 2009||2009-10-01|||||Interventional|||A Comparison Between Titanium Femoral Stem and Cobalt-Chromium Femoral Stem in Cemented Hip Arthroplasty|A Comparison Between Titanium Femoral Stem and Cobalt-Chromium Femoral Stem in Cemented Hip Arthroplasty. A Randomized Prospective Roentgen Stereogrammetric Analysis.|Unknown status|Active, not recruiting|N/A|40||University of Aarhus|||||f||||||||||||||2017-02-18 17:35:48.875517|2017-02-18 17:35:48.875517
NCT00120939|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2009-04-02||||||May 2007|2007-05-01||||||||Interventional|||Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer|Phase I Trial of Motexafin Gadolinium (MGd) and Docetaxel Chemotherapy in the Treatment of Advanced Solid Tumors|Completed||Phase 1|25||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:35:48.969977|2017-02-18 17:35:48.969977
NCT00120926|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2006-09-27|||August 2005||2005-08-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Dose Comparison of Amino Acids on Growth in Premature Neonates|Randomized Control Trial Evaluating the Effect of Two Different Doses of Amino Acids on Growth and Serum Amino Acids in Premature Neonates Admitted to the NICU|Completed||Phase 3|150||Mednax Center for Research, Education and Quality|||||f||||||||||||||2017-02-18 17:35:49.071868|2017-02-18 17:35:49.071868
NCT00120913|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2005-07-18||||||July 2005|2005-07-01|August 2004||2004-08-01|||||Interventional|||Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?||Completed||N/A|160||Oregon Health and Science University|||||f||||||||||||||2017-02-18 17:35:49.170102|2017-02-18 17:35:49.170102
NCT00120900|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2017-01-18|||May 2005||2005-05-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee|A Phase III, 12-week, Multicentre, Double-Blind, Double-Dummy, Randomised, Placebo - and Active Comparator - Contolled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381 XXmg and YYmg Administered Orally Once Daily, in Adults With Osteoarthritis of the Knee|Completed||Phase 3|1340|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:35:49.262812|2017-02-18 17:35:49.262812
NCT00120887|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2007-04-04|||April 2002||2002-04-01|September 2006|2006-09-01|December 2005||2005-12-01|||||Interventional|||Lupus Atherosclerosis Prevention Study|Lupus Atherosclerosis Prevention Study|Completed||Phase 4|200||Johns Hopkins University|||||f||||||||||||||2017-02-18 17:35:49.387999|2017-02-18 17:35:49.387999
NCT00120874|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2016-09-15|2016-04-28||August 2006||2006-08-01|September 2016|2016-09-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training|Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial|Completed||Phase 4|20|Actual|New York University School of Medicine|The original statistician who worked on this study left the institution prior to completing data analysis. A new statistician has been engaged. In the unlikely event that outcome measures data changes, it will be updated accordingly in this record.|2|||f||||t||||||||||2017-02-18 17:35:49.501582|2017-02-18 17:35:49.501582
NCT00120861|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2010-06-09|||January 2005||2005-01-01|June 2010|2010-06-01||||||||Interventional|||Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy|A Randomized, Phase IIb Clinical Trial to Evaluate the Safety and Antiviral Activity of NM283 and the Combination of Pegylated Interferon Plus NM283, in Patients With Chronic Hepatitis C Who Have Previously Failed to Respond to Standard Therapy|Completed||Phase 2|||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:35:50.332287|2017-02-18 17:35:50.332287
NCT00120653|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||July 14, 2005||2005-07-14|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Interventional|||Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)|Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)|Withdrawn||Phase 2|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:35:52.000541|2017-02-18 17:35:52.000541
NCT00120848|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2016-11-02|||November 2003||2003-11-01|November 2016|2016-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults|Study of the Efficacy of Candidate HPV 16/18 VLP Vaccine in the Prevention of HPV-16 and/or HPV-18 Cervical Infection in Adolescent & Young Adult Women in North America and Brazil Vaccinated in Primary Study 580299/001|Completed||Phase 2|776|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:35:50.435319|2017-02-18 17:35:50.435319
NCT00120835|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2010-06-09|||July 2004||2004-07-01|June 2010|2010-06-01||||||||Interventional|||Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C|An Open-Label, Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and the Antiviral Activity of NM283 When Administered Alone and in Combination With Pegylated Interferon Alfa 2b to Treatment-Naive Adults With Genotype-1 Chronic Hepatitis C|Completed||Phase 1/Phase 2|||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:35:50.55979|2017-02-18 17:35:50.55979
NCT00120822|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2017-01-11|||July 2002||2002-07-01|January 2017|2017-01-01|January 2004||2004-01-01|||||Interventional|||Folic Acid Supplementation in Gambian Primigravidae|A Study of the Effect of Folic Acid Supplementation on the Anti-malarial Action of Sulfadoxine-pyrimethamine When Used for Intermittent Preventive Treatment in Gambian Primigravidae.|Completed||Phase 3|1000||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:35:50.649156|2017-02-18 17:35:50.649156
NCT00120809|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2017-01-11|||July 2002||2002-07-01|January 2017|2017-01-01|September 2004||2004-09-01|||||Interventional|||Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae|A Randomised, Placebo Controlled Trial of Intermittent Preventative Treatment With Sulfadoxine-pyrimethamine in Gambian Multigravidae.|Completed||Phase 3|3000||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:35:50.750906|2017-02-18 17:35:50.750906
NCT00120796|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2016-07-20|||August 2005||2005-08-01|March 2008|2008-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)|Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection|Terminated||Phase 3|8|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2||poor patient recrutment|f||||t||||||||||2017-02-18 17:35:50.85696|2017-02-18 17:35:50.85696
NCT00120783|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2007-01-17|||February 2002||2002-02-01|January 2007|2007-01-01|August 2003||2003-08-01|||||Interventional|||Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance|Efficacy and Tolerability of an Antiretroviral bi-Therapy in HIV-1 Infected Patients With Multidrug Resistant HIV ANRS 109 Vista Trial.|Terminated||Phase 2|40||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:35:51.095937|2017-02-18 17:35:51.095937
NCT00120770|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2007-02-27|||November 2004||2004-11-01|February 2007|2007-02-01|March 2007||2007-03-01|||||Interventional|||Cellulose Sulfate (CS) Gel and HIV in Nigeria|Randomized Controlled Trial of Cellulose Sulfate Gel and HIV in Nigeria|Terminated||Phase 3|2160||FHI 360||||The study was halted in January 2007 due to safety concerns.|||||||||||||||2017-02-18 17:35:51.190171|2017-02-18 17:35:51.190171
NCT00120757|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2011-12-21|||October 2004||2004-10-01|December 2011|2011-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)|Efficacy of Alendronate Versus Placebo in the Treatment of HIV-1 Associated Osteoporosis, a Multicenter, Randomized, Controlled Trial. ANRS 120 Fosivir|Completed||Phase 3|140||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-02-18 17:35:51.291994|2017-02-18 17:35:51.291994
NCT00120744|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2013-12-10|||January 2004||2004-01-01|December 2013|2013-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department|Randomized Trial of the Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Acute Gastroenteritis in a Pediatric Emergency Department|Completed||N/A|||The Hospital for Sick Children|||||f||||||||||||||2017-02-18 17:35:51.392579|2017-02-18 17:35:51.392579
NCT00120731|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2007-06-14|||July 2005||2005-07-01|July 2005|2005-07-01|May 2007|Actual|2007-05-01|||||Interventional|||Effects of Potassium Citrate in Urine of Children With Elevated Calcium in Urine and Kidney Stones|Urinary Chemistry and Acid-Base Effects of Potassium Citrate in Children With Idiopathic Hypercalciuria and Urolithiasis|Completed||N/A|23|Actual|Children's Mercy Hospital Kansas City|||||f||||f||||||||||2017-02-18 17:35:51.486454|2017-02-18 17:35:51.486454
NCT00120718|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2008-09-26|||June 2002||2002-06-01|September 2008|2008-09-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||The Effect of Fasudil on Vascular Function in Humans|The Effect of Fasudil on Vascular Function in Humans|Completed||Phase 2|60|Anticipated|Brigham and Women's Hospital|||||f||||t||||||||||2017-02-18 17:35:51.58671|2017-02-18 17:35:51.58671
NCT00120705|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-03-24|||November 2002||2002-11-01|March 2009|2009-03-01|September 2003||2003-09-01|||||Interventional|||Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy|A Randomized, Open-Label, Pilot Study to Evaluate Every Three Week Maintenance Dosing of Darbepoetin Alfa Therapy in Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy|Completed||Phase 2|204||Amgen|||||f||||||||||||||2017-02-18 17:35:51.671802|2017-02-18 17:35:51.671802
NCT00120692|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-20|||October 2002||2002-10-01|December 2007|2007-12-01|December 2003||2003-12-01|||||Interventional|||Treatment for Patients Suffering From Anemia Due to Chemotherapy|An Open-Label, Randomized Phase 2 Study to Validate a Patient Satisfaction Questionnaire for Anemia Treatment in Female Breast Cancer Patients Treated With Darbepoetin Alfa or Recombinant Human Erythropoietin for Anemia Due to Chemotherapy|Completed||Phase 2|||Amgen|||||f||||||||||||||2017-02-18 17:35:51.752895|2017-02-18 17:35:51.752895
NCT00120679|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-20|||October 2002||2002-10-01|December 2007|2007-12-01|December 2003||2003-12-01|||||Interventional|||Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy|An Open-Label, Randomized Phase 2 Study to Validate a Patient Satisfaction Questionnaire for Anemia Treatment in Patient With Non-Small Cell Lung Cancer Treated With Darbepoetin Alfa or Recombinant Human Erythropoietin for Anemia Due to Chemotherapy|Completed||Phase 2|||Amgen|||||f||||||||||||||2017-02-18 17:35:51.842736|2017-02-18 17:35:51.842736
NCT00120666|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-16|2017-01-24|||July 8, 2005||2005-07-08|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Observational|||Interhemispheric Plasticity in Humans|Interhemispheric Plasticity in Humans|Completed||N/A|108||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:35:51.927867|2017-02-18 17:35:51.927867
NCT00120627|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2015-04-06|2014-09-23||November 2005||2005-11-01|August 2014|2014-08-01|September 2010|Actual|2010-09-01|February 2009|Actual|2009-02-01||Interventional|||Mantram Repetition to Manage PTSD in Veterans|Efficacy of Mantram Repetition on PTSD Symptoms in Veterans|Completed||N/A|146|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:35:52.193799|2017-02-18 17:35:52.193799
NCT00120614|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2009-04-07|||September 2001||2001-09-01|April 2009|2009-04-01|June 2007||2007-06-01|||||Interventional|||Educational/Behavioral Intervention Program for Parents of Premature Infants|Improving Outcomes of LBW Premature Infants and Parents|Completed||N/A|260||University of Rochester|||||f||||||||||||||2017-02-18 17:35:52.92516|2017-02-18 17:35:52.92516
NCT00120601|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2005-07-15|||March 2003||2003-03-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Trial for the Treatment of Alcohol Dependence|The Role of Pharmacotherapy in Prevention of Relapse in Alcohol Dependence|Unknown status|Active, not recruiting|Phase 4|200||University of Sydney|||||f||||||||||||||2017-02-18 17:35:53.018468|2017-02-18 17:35:53.018468
NCT00120588|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2013-06-17|||July 1997||1997-07-01|June 2013|2013-06-01|July 2005|Actual|2005-07-01|||||Interventional|||Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth|Effect of Magnesium Sulfate on the Incidence of Periventricular Leukomalacia in the Very Preterm Neonate|Completed||Phase 4|700||University Hospital, Rouen|||||f||||f||||||||||2017-02-18 17:35:55.849518|2017-02-18 17:35:55.849518
NCT00120575|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2006-12-01|||January 2005||2005-01-01|December 2006|2006-12-01|September 2008||2008-09-01|||||Interventional|||Hemofiltration for Respiratory Failure After Bone Marrow Transplantation|Hemofiltration for Respiratory Failure Following Hematopoietic Stem Cell Transplantation|Unknown status|Recruiting|Phase 2/Phase 3|112||Stanford University|||||f||||||||||||||2017-02-18 17:35:55.959478|2017-02-18 17:35:55.959478
NCT00120562|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2009-08-27|||July 2007||2007-07-01|August 2009|2009-08-01||||||||Observational|||Studies of Biological Changes Related to Weight Loss After Gastric Bypass Surgery|A Gene Expression and Metabolic Profile of Weight Loss: Studies of Patients Following Gastric Bypass Surgery|Terminated||Phase 2|13|Anticipated|Rockefeller University|||1||f||||||||||||||2017-02-18 17:35:56.053925|2017-02-18 17:35:56.053925
NCT00120549|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2005-07-15|||August 2001||2001-08-01|July 2005|2005-07-01|March 2005||2005-03-01|||||Interventional|||Study of Assisted Hatching of Cleavage Stage Embryos|Prospective Randomized Trial of Assisted Hatching of Cleavage Stage Embryos|Completed||N/A|200||Shady Grove Fertility Reproductive Science Center|||||f||||||||||||||2017-02-18 17:35:56.143554|2017-02-18 17:35:56.143554
NCT00120536|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2012-05-04|||June 2005||2005-06-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|288|Actual|Novartis|||||f||||||||||||||2017-02-18 17:35:56.231689|2017-02-18 17:35:56.231689
NCT00120523|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2016-04-26|2012-11-09||April 2004||2004-04-01|April 2016|2016-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis|Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age With Mild to Moderate Atopic Dermatitis|Completed||Phase 3|2418|Actual|MEDA Pharma GmbH & Co. KG||2|||f||||f||||||||No||2017-02-18 17:35:56.350389|2017-02-18 17:35:56.350389
NCT00120510|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2014-10-13|||July 2007||2007-07-01|October 2014|2014-10-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti|A Randomized Clinical Trial to Determine the Efficacy of Early Versus Standard Antiretroviral Therapy in HIV Infected Adults With CD4+ T Cell Counts Between 200 and 350 Cells/mm3|Completed||N/A|816|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:36:01.401511|2017-02-18 17:36:01.401511
NCT00120497|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2011-07-19|||July 2005||2005-07-01|July 2011|2011-07-01|December 2011|Anticipated|2011-12-01|July 2011|Anticipated|2011-07-01||Observational|||Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight|Growth Hormone and Insulin Resistance in Children With Intrauterine Growth Restriction|Unknown status|Recruiting|Phase 4|12|Anticipated|Massachusetts General Hospital|||1||f||||t||||||Samples Without DNA|"~     Blood~   "|||2017-02-18 17:36:01.552582|2017-02-18 17:36:01.552582
NCT00120484|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-13|2010-01-12|||April 2005||2005-04-01|January 2010|2010-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|||Effects of Vitamin B12 on the Body's Internal Clock|Effect of Vitamin B12 on the Human Circadian Pacemaker|Completed||N/A|10|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-02-18 17:36:01.662102|2017-02-18 17:36:01.662102
NCT00120471|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2013-09-12|||November 2006||2006-11-01|September 2013|2013-09-01|December 2011|Actual|2011-12-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies|A Phase I Open Label Trial of the Safety and Pharmacokinetics of Tenofovir Disoproxil Fumarate in HIV-1 Infected Pregnant Women and Their Infants|Completed||Phase 1|122|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:36:01.773164|2017-02-18 17:36:01.773164
NCT00120458|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-14|2010-03-01|||July 2005||2005-07-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety|Black Cohosh Therapy for Menopause-Related Anxiety|Completed||Phase 4|50|Anticipated|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 17:36:01.916232|2017-02-18 17:36:01.916232
NCT00120445|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2012-03-07|||July 2004||2004-07-01|March 2012|2012-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Comparison of Air and Expansile Gas in Pneumatic Retinopexy|Comparison of Air and Expansile Gas in Pneumatic Retinopexy|Completed||Phase 3|126|Actual|Khon Kaen University||1|||f||||t||||||||||2017-02-18 17:36:02.029859|2017-02-18 17:36:02.029859
NCT00120432|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2012-03-07|||December 2004||2004-12-01|March 2012|2012-03-01|June 2005|Actual|2005-06-01|||||Interventional|||Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation|Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation|Completed||Phase 3|80|Actual|Khon Kaen University||1|||f||||t||||||||||2017-02-18 17:36:02.158892|2017-02-18 17:36:02.158892
NCT00120419|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2009-07-21|||April 2005||2005-04-01|January 2006|2006-01-01||||||||Interventional|||Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)||Unknown status|Recruiting|Phase 4|90|Anticipated|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|||||f||||t||||||||||2017-02-18 17:36:02.273355|2017-02-18 17:36:02.273355
NCT00005363|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1992||1992-08-01|April 2000|2000-04-01|July 1994|Actual|1994-07-01|||||Observational|||Ambulatory Blood Pressure and Prognosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.663541|2017-02-18 18:15:05.663541
NCT00120406|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2014-07-21|2014-02-05||March 2005||2005-03-01|July 2014|2014-07-01|February 2014|Actual|2014-02-01|October 2009|Actual|2009-10-01||Interventional|Zilver PTX||Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery|Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery|Completed||N/A|474|Actual|Cook||2|||f||||t||||||||||2017-02-18 17:36:02.387614|2017-02-18 17:36:02.387614
NCT00120393|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2010-02-03||2010-02-03|January 2004||2004-01-01|July 2009|2009-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir|A Phase IIIB, Open-label, Randomized, Multi-center Study Evaluating the Effect on Serum Lipids Following a Switch to ATV/r in HIV-1 Infected Subjects Who Have Achieved Virologic Suppression on a LPV/r Based Regimen.|Completed||Phase 3|192|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:36:03.493854|2017-02-18 17:36:03.493854
NCT00120380|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2012-08-20|||September 2004||2004-09-01|January 2006|2006-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)|Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension|Terminated||Phase 4|40|Actual|Hannover Medical School||2||Futility analysis|f||||||||||||||2017-02-18 17:36:03.617196|2017-02-18 17:36:03.617196
NCT00120367|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2011-12-21|||April 2005||2005-04-01|December 2011|2011-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)|Early Intensification of Combination Antiretroviral Therapy Including FUZEON® in the Treatment of Progressive Multifocal Leucoencephalopathy During HIV-1 Infection ANRS 125 Trial|Completed||Phase 2|30||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:36:03.725104|2017-02-18 17:36:03.725104
NCT00120354|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-15|2017-01-24|||July 11, 2005||2005-07-11|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Interventional|||Long-Term Lamivudine Therapy for Chronic Hepatitis B|Long-Term Lamivudine Therapy for Chronic Hepatitis B|Completed||Phase 4|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:36:03.829379|2017-02-18 17:36:03.829379
NCT00120341|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-05-30|||April 2005||2005-04-01|May 2007|2007-05-01|June 2006||2006-06-01|||||Interventional|||Anodyne Therapy in Diabetic Sensory Neuropathy|A Randomized, Double Blind, Placebo Controlled Prospective Study to Evaluate the Effectiveness of Monochromatic Infrared Photo Energy to Improve Diabetic Sensory Neuropathy|Completed||Phase 4|60||Scott and White Hospital & Clinic|||||f||||||||||||||2017-02-18 17:36:03.919286|2017-02-18 17:36:03.919286
NCT00120328|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-10-04|||July 2005||2005-07-01|October 2007|2007-10-01|February 2007|Actual|2007-02-01|||||Interventional|||To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy|ASCEND - A Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Assess the Effect of the Endothelin Receptor Antagonist Avosentan on Time to Doubling of Serum Creatinine, End Stage Renal Disease or Death in Patients With Type 2 Diabetes Mellitus and Diabetic Nephropathy|Terminated||Phase 3|2364||Speedel Pharma Ltd.|||||||||t||||||||||2017-02-18 17:36:04.014443|2017-02-18 17:36:04.014443
NCT00120315|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2009-10-05|||December 2003||2003-12-01|October 2009|2009-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Proton Pump Inhibitor Treatment Stop|Proton Pump Inhibitor Treatment Stop: Discontinuation of Acid-suppressive Medication Among Long-term Users in a Primary Health Care Setting|Completed||Phase 4|171|Actual|Odense University Hospital||2|||f||||f||||||||||2017-02-18 17:36:04.121775|2017-02-18 17:36:04.121775
NCT00120302|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2008-01-15|||March 2005||2005-03-01|January 2008|2008-01-01|January 2006|Actual|2006-01-01|||||Interventional|||Quality of Life Study in Adults With Facial Eczema|Quality of Life Study in Adults With Facial Eczema|Completed||Phase 4|76|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:36:04.242574|2017-02-18 17:36:04.242574
NCT00120289|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2016-03-08|2015-06-01||September 2005||2005-09-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|September 2012|Actual|2012-09-01||Interventional||Intention-to-treat|Niacin Plus Statin to Prevent Vascular Events|AIM HIGH: Niacin Plus Statin to Prevent Vascular Events|Terminated||Phase 3|3414|Actual|Axio Research. LLC||2||"AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin~   in preventing primary outcome events."|f||||t||||||||||2017-02-18 17:36:04.393021|2017-02-18 17:36:04.393021
NCT00120276|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2009-05-05|||June 2004||2004-06-01|May 2008|2008-05-01||||||||Interventional|||RESTOR-MV: Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve|Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve (RESTOR-MV)|Completed||Phase 2|250|Anticipated|Myocor|||||f||||t||||||||||2017-02-18 17:36:07.552409|2017-02-18 17:36:07.552409
NCT00120263|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2006-05-08|||September 1998||1998-09-01|July 2005|2005-07-01|April 2004||2004-04-01|||||Interventional|||Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma|A Randomized Controlled Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma|Completed||N/A|92||London Health Sciences Centre|||||f||||||||||||||2017-02-18 17:36:07.663769|2017-02-18 17:36:07.663769
NCT00120250|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2016-03-24|2013-07-19||June 2005||2005-06-01|March 2016|2016-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional||Baseline data are unavailable for the 3 participants that did not complete the study, and therefore, the baseline data will only reflect the information of the 24 completed participants, instead of the 27 that began baseline.|Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder|Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder|Completed||Phase 4|27|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:36:07.756632|2017-02-18 17:36:07.756632
NCT00120237|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2009-03-17|||July 2005||2005-07-01|March 2009|2009-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan|A Placebo-Controlled Randomized Trial of Misoprostol in the Management of the Third Stage of Labor in the Home Delivery Setting in Rural Pakistan|Completed||N/A|1600|Actual|Gynuity Health Projects||1|||f||||t||||||||||2017-02-18 17:36:08.280927|2017-02-18 17:36:08.280927
NCT00120224|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-04-25|||May 2005||2005-05-01|April 2007|2007-04-01|April 2007|Actual|2007-04-01|||||Observational|||De-Medicalizing Mifepristone Medical Abortion|De-Medicalizing Mifepristone Medical Abortion|Completed||N/A|4410||Gynuity Health Projects|||||f||||||||||||||2017-02-18 17:36:08.378527|2017-02-18 17:36:08.378527
NCT00120211|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2011-10-12|||September 1998||1998-09-01|October 2011|2011-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer|Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer|Completed||Phase 3|855|Actual|International Atomic Energy Agency||2|||f||||||||||||||2017-02-18 17:36:08.467938|2017-02-18 17:36:08.467938
NCT00120198|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2007-11-15|||March 2005||2005-03-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients|A Pilot Study of Cyclophosphamide/Pegylated Liposomal Doxorubicin/Vincristine/Prednisone (CDOP) Plus Rituximab for Treatment of Elderly Patients With Previously Untreated Non-Hodgkin's Lymphoma|Terminated||Phase 2|50|Anticipated|Geriatric Oncology Consortium||||slow accrual|f||||||||||||||2017-02-18 17:36:08.5602|2017-02-18 17:36:08.5602
NCT00120185|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2011-12-21|||December 2003||2003-12-01|December 2011|2011-12-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)|Study of the Immunological Efficacy of Using Subcutaneous Interleukin-2 (IL-2) in Antiretroviral Naïve HIV-1-Infected Subjects With a CD4 Cell Count Above 300/mm3. ANRS 119 Trial INTERSTART|Completed||Phase 2|130||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-02-18 17:36:08.665697|2017-02-18 17:36:08.665697
NCT00120172|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2007-11-15|||May 2005||2005-05-01|November 2007|2007-11-01|June 2006|Actual|2006-06-01|||||Interventional|||Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer|A Phase II Study of Oxaliplatin, Capecitabine, and Bevacizumab in the Treatment of Elderly Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|40|Anticipated|Geriatric Oncology Consortium||||positive results from a larger study with same regimen was released.|f||||||||||||||2017-02-18 17:36:08.783224|2017-02-18 17:36:08.783224
NCT00120159|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-01-14|||December 2003||2003-12-01|January 2006|2006-01-01||||||||Observational|||Necrotizing Enterocolitis (NEC) Surgical Database|GPRN Neonatal Surgical Database: Necrotizing Enterocolitis (NEC) Protocol|Unknown status|Active, not recruiting|N/A|300|Anticipated|Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:36:08.888673|2017-02-18 17:36:08.888673
NCT00120146|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2006-01-17|||October 2002||2002-10-01|January 2006|2006-01-01||||||||Interventional|||Metformin Obesity Study|A Multi-Center, Randomized, Placebo Controlled, Double- Blind Trial of Metformin in Obese Adolescents|Unknown status|Active, not recruiting|Phase 3|22||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:36:08.96253|2017-02-18 17:36:08.96253
NCT00120133|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2008-05-19|||December 2004||2004-12-01|July 2005|2005-07-01|December 2007|Actual|2007-12-01|||||Interventional|||Atorvastatin (Lipitor) to Prevent Bone Pain|Use of Atorvastatin (Lipitor) to Prevent Bone Pain Following Infusion of Pamidronate or Zoledronic Acid|Completed||N/A|12|Actual|Children's Mercy Hospital Kansas City|||||f||||||||||||||2017-02-18 17:36:09.051532|2017-02-18 17:36:09.051532
NCT00120120|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2009-09-22|||January 2005||2005-01-01|September 2009|2009-09-01|November 2007|Actual|2007-11-01|October 2007|Actual|2007-10-01||Interventional|||Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy|A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy|Completed||Phase 2/Phase 3|181|Actual|Celgene||2|||f||||t||||||||||2017-02-18 17:36:09.145923|2017-02-18 17:36:09.145923
NCT00120107|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2005-11-07|||July 2003||2003-07-01|July 2005|2005-07-01|April 2005||2005-04-01|||||Interventional|||Tea's Effect on Atherosclerosis Pilot Study (TEA Study)|Tea's Effect on Atherosclerosis Pilot Study (TEA Study)|Completed||N/A|30||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:36:09.280012|2017-02-18 17:36:09.280012
NCT00120094|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2006-04-10|||June 2002||2002-06-01|July 2005|2005-07-01|June 2005||2005-06-01|||||Observational|||International Study on Syncope of Uncertain Etiology|ISSUE 2. The Management of Patients With Suspected or Certain Neurally-Mediated Syncope After the Initial Evaluation|Terminated||Phase 4|400||Arcispedale Santa Maria Nuova-IRCCS|||||f||||||||||||||2017-02-18 17:36:09.368063|2017-02-18 17:36:09.368063
NCT00120081|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2012-07-20|||April 2005||2005-04-01|July 2012|2012-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection|Phase 1, Single-Center, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study to Compare the Safety, Tolerability, and Immunogenicity of Three Intramuscular Administrations of Na-ASP-2 Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection|Completed||Phase 1|36|Actual|Albert B. Sabin Vaccine Institute||4|||f||||t||||||||||2017-02-18 17:36:09.460629|2017-02-18 17:36:09.460629
NCT00120068|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2015-04-06|||November 2004||2004-11-01|February 2007|2007-02-01|July 2005|Actual|2005-07-01|March 2005|Actual|2005-03-01||Interventional|||Improving Care for Nursing Home Pneumonia in NHCUs and Veterans' Homes|Improving Care for Nursing Home Pneumonia in NHCUs and Veterans' Homes|Completed||Phase 2|100|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:36:09.574881|2017-02-18 17:36:09.574881
NCT00120055|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2014-12-02|||February 2005||2005-02-01|December 2014|2014-12-01|April 2005||2005-04-01|||||Interventional|||Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity||Completed||Phase 4|||University of Oslo School of Pharmacy|||||f||||||||||||||2017-02-18 17:36:09.861968|2017-02-18 17:36:09.861968
NCT00120042|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2009-06-29|2009-04-01||February 2005||2005-02-01|June 2009|2009-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption|Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption|Completed||N/A|251|Actual|The University of Western Australia|Planned interim analysis not performed as mifepristone became available in Australia. Study ceased at 251 women and enough power available to calculate the groups as a single stage analysis.|3|||f||||f||||||||||2017-02-18 17:36:09.958124|2017-02-18 17:36:09.958124
NCT00120029|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2008-09-04|||January 2004||2004-01-01|June 2008|2008-06-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Peer Counseling for Weight Loss|Peer Counseling for Weight Loss in African American Breast Cancer Survivors|Unknown status|Recruiting|N/A|100|Anticipated|Wayne State University|||||f||||||||||||||2017-02-18 17:36:10.419128|2017-02-18 17:36:10.419128
NCT00120016|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2012-12-19|||January 2004||2004-01-01|November 2008|2008-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Design and Feasibility of a Mediterranean Diet|Design and Feasibility of a Mediterranean Diet|Completed||N/A|80|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 17:36:10.515952|2017-02-18 17:36:10.515952
NCT00120003|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2011-06-30|||June 2005||2005-06-01|September 2006|2006-09-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Scandinavian Candesartan Acute Stroke Trial (SCAST)|Scandinavian Candesartan Acute Stroke Trial|Completed||Phase 3|2500|Anticipated|Oslo University Hospital||2|||f||||t||||||||||2017-02-18 17:36:10.620304|2017-02-18 17:36:10.620304
NCT00119990|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2008-12-05|||January 2006||2006-01-01|December 2008|2008-12-01|January 2010|Anticipated|2010-01-01|January 2009|Anticipated|2009-01-01||Interventional|||Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis|Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis; the Effect of Different Dialysates|Terminated||N/A|15|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:36:10.73642|2017-02-18 17:36:10.73642
NCT00119977|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2008-01-31|||October 2003||2003-10-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Periacetabular Osteotomy.A Prospective Study With Reference to Cartilage, Migration and Bone Density|Periacetabular Osteotomy. A Prospective Study With Reference to Cartilage, Migration and Bone Density|Completed||N/A|35|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:36:10.827945|2017-02-18 17:36:10.827945
NCT00119964|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2011-07-25|||September 2004||2004-09-01|July 2011|2011-07-01|August 2007|Actual|2007-08-01|||||Interventional|||The Healthy Lifestyle Study|Weight Management for a Defined Employee Population Using an Interactive eHealth Portal|Completed||Phase 1|500|Anticipated|Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 17:36:10.934885|2017-02-18 17:36:10.934885
NCT00119951|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2007-08-02|||September 2003||2003-09-01|August 2007|2007-08-01|August 2006||2006-08-01|||||Observational|||Health eCommunities - The Impact of Listservs on Cancer Patients|Health eCommunities - The Impact of Listservs on Cancer Patients|Completed||N/A|3360||Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 17:36:11.013682|2017-02-18 17:36:11.013682
NCT00119938|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2008-08-19|||September 2004||2004-09-01|July 2007|2007-07-01|December 2006|Actual|2006-12-01|||||Interventional|||An Online System to Improve Diabetes Self-Care|D-STAR (Diabetes-System To Access Records): An Online Patient Portal to Improve and Sustain Diabetes Self-Care|Completed||N/A|331|Actual|Robert Wood Johnson Foundation||2|||f||||f||||||||||2017-02-18 17:36:11.282586|2017-02-18 17:36:11.282586
NCT00119925|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2008-10-28|||October 2005||2005-10-01|October 2008|2008-10-01|May 2009|Anticipated|2009-05-01|February 2009|Anticipated|2009-02-01||Interventional|||"'SPRING'-Study: Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"|Cost Effectiveness of Two Different Strategies to Implement the NVOG Guideline Programme on Subfertility|Unknown status|Recruiting|N/A|5200|Anticipated|Radboud University||2|||f||||||||||||||2017-02-18 17:36:11.379797|2017-02-18 17:36:11.379797
NCT00119912|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2015-04-28|||January 1999||1999-01-01|April 2015|2015-04-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||NORCCAP: Norwegian Colorectal Cancer Prevention Trial|Norwegian Colorectal Cancer Prevention Trial|Active, not recruiting||Phase 2/Phase 3|100000|Actual|Norwegian Department of Health and Social Affairs||3|||f||||t||||||||||2017-02-18 17:36:11.514583|2017-02-18 17:36:11.514583
NCT00119899|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2005-08-30|||March 2002||2002-03-01|August 2005|2005-08-01|June 2005||2005-06-01|||||Interventional|||Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases|Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases|Completed||Phase 3|150||Radboud University|||||f||||||||||||||2017-02-18 17:36:11.639296|2017-02-18 17:36:11.639296
NCT00119886|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2007-04-18|||April 2005||2005-04-01|April 2007|2007-04-01|June 2008|Anticipated|2008-06-01|||||Interventional|||Botox on Vulvar Vestibulitis||Unknown status|Recruiting|Phase 4|64||Rigshospitalet, Denmark|||||f||||||||||||||2017-02-18 17:36:11.737879|2017-02-18 17:36:11.737879
NCT00119873|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2015-03-03||||||March 2015|2015-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults|A Phase I Dose-Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade, Multivalent Recombinant Adenoviral Vector HIV Vaccine, VRC-HIVADV014-00-VP, in Healthy, HIV-1 Uninfected Adult Participants Who Have Low Titers of Pre-Existing Ad5 Neutralizing Antibodies|Completed||Phase 1|48|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:36:11.837111|2017-02-18 17:36:11.837111
NCT00119847|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2006-02-22|||September 2002||2002-09-01|February 2006|2006-02-01||||||||Interventional|||Balloon Catheters and Stents to Prevent Heart Rhythm Irregularities in Individuals Post-Heart Attack|Electrophysiologic Effects of Late PCI (OAT-EP)|Unknown status|Active, not recruiting|N/A|300||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:36:12.002613|2017-02-18 17:36:12.002613
NCT00119834|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2016-04-05|||June 2005||2005-06-01|April 2016|2016-04-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)|Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)|Recruiting||Phase 2|15000|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||Samples With DNA|"~     DNA sample collection was an optional portion of the project during the first contract~     period (2005-2010). Tissue and Blood specimens were collected at the time of implant,~     explant or exchange of the mechanical circulatory assist device. Intermacs no longer~     collects blood or tissue specimens.~   "|Yes|Individual participant data (IPD) is not available. De-identified datasets may be available upon approval.|2017-02-18 17:36:12.113984|2017-02-18 17:36:12.113984
NCT00119821|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2015-11-30|||September 2004||2004-09-01|July 2011|2011-07-01|June 2011|Actual|2011-06-01|May 2011|Actual|2011-05-01||Interventional|||Strategies to Reduce Weight Gain in Hypertensive Smokers|Weight Gain Prevention in Hypertensive Smokers|Completed||N/A|459|Actual|University of Tennessee||3|||f||||t||||||||||2017-02-18 17:36:12.22592|2017-02-18 17:36:12.22592
NCT00119795|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2011-11-02|||August 2005||2005-08-01|November 2011|2011-11-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|CLIP||Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese|Cooperative Lifestyle Intervention Program (CLIP)|Completed||N/A|288|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||||2017-02-18 17:36:12.336748|2017-02-18 17:36:12.336748
NCT00119782|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2012-08-21|||September 2004||2004-09-01|August 2012|2012-08-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|PACE||Promoting Activity and Changes in Eating (PACE) to Reduce Obesity|Reducing Obesity at the Workplace: a Randomized Trial|Completed||N/A|3000|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 17:36:12.454593|2017-02-18 17:36:12.454593
NCT00119769|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2008-08-26|||February 2005||2005-02-01|August 2008|2008-08-01|July 2008|Actual|2008-07-01|May 2007|Actual|2007-05-01||Interventional|||The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients|The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients on Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 4|46|Actual|Hvidovre University Hospital||2|||f||||f||||||||||2017-02-18 17:36:12.562077|2017-02-18 17:36:12.562077
NCT00119756|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2011-06-06|||June 2005||2005-06-01|April 2010|2010-04-01|November 2006|Actual|2006-11-01|||||Interventional|||A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia|A Randomized, Crossover Study to Evaluate the Overall Safety and Tolerability of Paliperidone Palmitate Injected in the Deltoid or Gluteus Muscle in Patients With Schizophrenia|Completed||Phase 3|253|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:36:12.691631|2017-02-18 17:36:12.691631
NCT00119743|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2016-09-14|||October 2000||2000-10-01|September 2016|2016-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine|Assess, in Young Children, the Efficacy in Preventing Acute Otitis Media (AOM) of GSK Biologicals Undecavalent Pneumococcal-protein D Conjugate Vaccine, When Administered as a Three Dose Primary Vaccination Course During the First Year of Life With a Booster Dose in the Second Year of Life.|Terminated||Phase 3|5000||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:36:12.780693|2017-02-18 17:36:12.780693
NCT00119730|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2014-04-22|||February 2005||2005-02-01|April 2014|2014-04-01|December 2013|Actual|2013-12-01|December 2006|Actual|2006-12-01||Interventional|||Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma|Abbreviated Fludarabine / Mitoxantrone / Rituximab Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute||1|||f||||||||||||||2017-02-18 17:36:12.923875|2017-02-18 17:36:12.923875
NCT00119717|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2011-05-16|||June 2005||2005-06-01|May 2011|2011-05-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|SENTIS||Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)|Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)|Completed||Phase 3|515|Actual|CoAxia||2|||f||||t||||||||||2017-02-18 17:36:13.05162|2017-02-18 17:36:13.05162
NCT00119704|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2006-05-08|||September 2002||2002-09-01|June 2005|2005-06-01|March 2005||2005-03-01|||||Interventional|||Treatment of Tennis Elbow With Botulinum Toxin|Treatment of Lateral Epicondylitis With Botulinum Toxin: A Randomized Controlled Trial|Completed||Phase 3|60||Chinese University of Hong Kong|||||f||||||||||||||2017-02-18 17:36:13.361816|2017-02-18 17:36:13.361816
NCT00119691|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2013-09-11|||April 2003||2003-04-01|September 2013|2013-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction|Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction|Completed||Phase 2|34|Actual|Brigham and Women's Hospital||2|||f||||f||||||||||2017-02-18 17:36:13.458135|2017-02-18 17:36:13.458135
NCT00119678|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-09-11|2011-01-10||September 2005||2005-09-01|September 2014|2014-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone|A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept vs Placebo on a Background of Oral Glucocorticosteroids in the Treatment of Subjects With Systemic Lupus Erythematosus and the Prevention of Subsequent Lupus Flares|Completed||Phase 2|183|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 17:36:13.579424|2017-02-18 17:36:13.579424
NCT00119665|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2007-05-16|||February 2006||2006-02-01|March 2007|2007-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes|A Phase II, Double-Blind, Placebo-Controlled, Randomized Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes and Menopausal Symptoms|Completed||Phase 2|180||Bionovo|||||f||||||||||||||2017-02-18 17:36:15.023859|2017-02-18 17:36:15.023859
NCT00119652|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2013-01-03|||May 2005||2005-05-01|January 2013|2013-01-01|May 2007|Actual|2007-05-01|||||Interventional|EMBOLDEN II||Seroquel in Bipolar Depression Versus SSRI|Multicentre, Double-blind, Randomised, Parallel Group, Placebo Controlled, Phase 3 Study of the Efficacy & Safety of Quetiapine Fumarate & Paroxetine as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks & Quetiapine in Continuation (Abbreviated)|Completed||Phase 3|676|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 17:36:15.110358|2017-02-18 17:36:15.110358
NCT00119639|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2009-01-15|||June 2005||2005-06-01|January 2009|2009-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006|A Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of Sorafenib (BAY 43-9006, Nexavar).|Completed||Phase 1|32|Actual|Bayer||1|||f||||||||||||||2017-02-18 17:36:15.274194|2017-02-18 17:36:15.274194
NCT00119626|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2010-11-10|||June 2003||2003-06-01|November 2010|2010-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke|SAINT I (Stroke - Acute Ischemic - NXY Treatment) A Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter, Phase IIb/III Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke.|Completed||Phase 3|1700||AstraZeneca|||||||||||||||||||2017-02-18 17:36:15.373101|2017-02-18 17:36:15.373101
NCT00119613|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2008-08-07|||December 2002||2002-12-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa|A Randomized, Double Blind, Placebo-Controlled Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa|Completed||Phase 3|600|Anticipated|Amgen||2|||f||||||||||||||2017-02-18 17:36:15.465942|2017-02-18 17:36:15.465942
NCT00119600|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2009-05-07||||||May 2009|2009-05-01||||||||Interventional|||A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|A Randomised, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Finding Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|Terminated||Phase 1/Phase 2|||Amgen||1|||f||||||||||||||2017-02-18 17:36:15.577673|2017-02-18 17:36:15.577673
NCT00119587|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-20|||August 2002||2002-08-01|December 2007|2007-12-01|September 2003||2003-09-01|||||Interventional|||Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects|A Double-Blind, Randomized, Comparative Study of Darbepoetin Alfa Given Once Weekly or Once Every Other Week for Treatment of Anemia in Hemodialysis Subjects|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-02-18 17:36:15.663708|2017-02-18 17:36:15.663708
NCT00119574|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2015-04-06|||January 2002||2002-01-01|July 2005|2005-07-01|December 2004|Actual|2004-12-01|||||Interventional|||Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)|Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)|Completed||N/A|443|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:36:15.747515|2017-02-18 17:36:15.747515
NCT00119561|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2015-04-06|||February 2005||2005-02-01|July 2014|2014-07-01|January 2014|Actual|2014-01-01|June 2007|Actual|2007-06-01||Interventional|CONNECT||Testing the Effectiveness of Telephone Support for Dementia Caregivers|Testing the Effectiveness of Telephone Support for Dementia Caregivers|Completed||N/A|154|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:36:15.857842|2017-02-18 17:36:15.857842
NCT00119548|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2015-04-06|||March 2005||2005-03-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling|Improving HIV Screening by Nurse Rapid Testing, Streamlined Counseling|Completed||N/A|251|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 17:36:15.957907|2017-02-18 17:36:15.957907
NCT00119535|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2015-04-06|||August 2004||2004-08-01|April 2006|2006-04-01|December 2005|Actual|2005-12-01|||||Interventional|||Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes|An Evaluation of a Coordinated Proactive Diabetes Eye Care Program|Completed||N/A|2000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:36:16.071713|2017-02-18 17:36:16.071713
NCT00119522|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2015-04-06|||April 2004||2004-04-01|July 2008|2008-07-01|March 2008|Actual|2008-03-01|March 2006|Actual|2006-03-01||Observational|||Epidemiology and Cost of Falls in Veterans With a Spinal Cord Injury|Epidemiology and Cost of Falls in Veterans With Spinal Cord Injury|Completed||N/A|702|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:36:16.179649|2017-02-18 17:36:16.179649
NCT00119509|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2007-04-24|||January 2004||2004-01-01|April 2007|2007-04-01|April 2008|Anticipated|2008-04-01|||||Interventional|||The IMAP Study Improving Management of Mildly Abnormal Pap Smears|HPV DNA Testing Versus Conventional Management for Women With Minor Atypia on Pap Smear: Psychosocial and Quality of Life Outcomes and Development of a Decision Analytic Model|Unknown status|Active, not recruiting|Phase 3|300||University of Sydney|||||f||||||||||||||2017-02-18 17:36:16.273467|2017-02-18 17:36:16.273467
NCT00119496|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2010-01-26|||July 2005||2005-07-01|November 2007|2007-11-01|June 2007|Actual|2007-06-01|||||Interventional|||Rosiglitazone Versus Theophylline in Asthmatic Smokers|A Clinical Study to Investigate the Effect of Rosiglitazone, Theophylline and Inhaled Corticosteroid, Inflammation and Pulmonary Function in Asthmatic Smokers|Completed||Phase 2/Phase 3|79|Actual|University of Glasgow||4|||f||||f||||||||||2017-02-18 17:36:16.378489|2017-02-18 17:36:16.378489
NCT00119483|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2011-09-02|||September 2005||2005-09-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|||||Interventional|||Older Men and Testosterone||Completed||N/A|200||University Hospital of North Norway|||||f||||||||||||||2017-02-18 17:36:16.49332|2017-02-18 17:36:16.49332
NCT00119470|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2007-12-19|||February 2005||2005-02-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer|EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer: A Randomized Trial|Completed||Phase 2|40||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:36:16.603574|2017-02-18 17:36:16.603574
NCT00119457|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2009-06-02|||January 2005||2005-01-01|June 2009|2009-06-01|April 2006||2006-04-01|||||Interventional|||Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)|A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Weeks Extended VTE Prophylaxis With Daily Oral Doses of TTP889 After One Week of Standard Prophylactic Treatment Following Hip Fracture Surgery|Completed||Phase 2|300||vTv Therapeutics|||||f||||||||||||||2017-02-18 17:36:16.81303|2017-02-18 17:36:16.81303
NCT00119444|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2015-11-19|||January 2004||2004-01-01|September 2009|2009-09-01|August 2009|Actual|2009-08-01|January 2008|Actual|2008-01-01||Interventional|||Evaluation of Acetabular Perfusion After Ganz Osteotomy by Positron Emission Tomography|Evaluation of Acetabular Perfusion After Ganz Osteotomy by Positron Emission Tomography|Completed||N/A|12|Actual|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:36:16.924097|2017-02-18 17:36:16.924097
NCT00119431|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-04|2009-05-01|||September 2005||2005-09-01|May 2009|2009-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Kinetics, Efficacy and Safety of C1-Esteraseremmer-N|Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema|Completed||Phase 2|12|Anticipated|Sanquin|||||f||||||||||||||2017-02-18 17:36:17.03529|2017-02-18 17:36:17.03529
NCT00119418|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-04|2010-10-25|||November 2004||2004-11-01|July 2005|2005-07-01|February 2006||2006-02-01|||||Interventional|||TU 025 Keishi Bukuryo Gan for Post-menopausal Hot Flash Management|TU 025 Keishi Bukuryo Gan for Post-Menopausal Hot Flash Management|Completed||Phase 2|180|Anticipated|Plotnikoff, Gregory A., M.D.|||||||||||||||||||2017-02-18 17:36:17.12503|2017-02-18 17:36:17.12503
NCT00119405|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2010-02-22|||April 2005||2005-04-01|December 2007|2007-12-01|December 2010|Anticipated|2010-12-01|November 2010|Anticipated|2010-11-01||Observational|||Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)|Role of Mitochondria in the Development of HIV Atrophy|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||f||||||Samples With DNA|"~     Fat and Blood for mitochindrial DNA and different nuclear genes that regulate fat and lipid~     metabolism~   "|||2017-02-18 17:36:17.214055|2017-02-18 17:36:17.214055
NCT00119392|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2016-03-21|||June 2004||2004-06-01|March 2016|2016-03-01||||July 2009|Actual|2009-07-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial Evaluating the Safety and Efficacy of Non-myeloablative 90Y-Ibritumomab Tiuxetan (Anti-CD20) Antibody With Fludarabine, Low-Dose Total Body Irradiation (TBI) and HLA Matched Allogeneic Transplantation for Relapsed B-cell Lymphoma|Active, not recruiting||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:36:17.306729|2017-02-18 17:36:17.306729
NCT00119379|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-11|2016-09-22|||April 2005||2005-04-01|August 2007|2007-08-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults|Reversibility of Mitochondrial Toxicity in HIV Lipoatrophy|Completed||Phase 2|63|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:36:17.436042|2017-02-18 17:36:17.436042
NCT00119366|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2016-11-14|||May 2003||2003-05-01|November 2016|2016-11-01||||August 2014|Actual|2014-08-01||Interventional|||Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome|A Phase II Trial Combining Radiolabeled BC8 (Anti-CD45) Antibody With Fludarabine and Low Dose TBI Followed by Related or Unrelated PBSC Infusion and Post-Transplant Immunosuppression for Patients With Advanced AML or High Risk Myelodysplastic Syndrome|Active, not recruiting||Phase 2|15|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 17:36:17.556471|2017-02-18 17:36:17.556471
NCT00119340|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2010-09-20|||April 2005||2005-04-01|September 2010|2010-09-01|November 2007|Actual|2007-11-01|||||Interventional|||Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia|Fludarabine and Low-Dose TBI Dose Escalation to Determine the Optimal Regimen for Achieving High Rates Engraftment of Unrelated Donor Peripheral Blood Stem Cell in Patients With Chronic Myeloid Leukemia - A Multi-Center Trial|Completed||Phase 1/Phase 2|75|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 17:36:17.881873|2017-02-18 17:36:17.881873
NCT00119314|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2015-05-22|||July 2004||2004-07-01|April 2011|2011-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin|Carcinoma Unknown Primary: Treatment With Gemcitabine, Docetaxel and Capecitabine (GTX) an Evaluation and Treatment Study of The Cancer Institute of New Jersey Oncology Group|Withdrawn||Phase 2|0|Actual|Rutgers, The State University of New Jersey||||slow accrual|f||||t||||||||||2017-02-18 17:36:17.994853|2017-02-18 17:36:17.994853
NCT00119301|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2013-01-15|||April 2005||2005-04-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma|Phase I Study of High Dose Methotrexate With Simultaneous Trimetrexate and Leucovorin in Patients With Recurrent Osteosarcoma|Completed||Phase 1|18|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:36:18.102487|2017-02-18 17:36:18.102487
NCT00119262|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2014-04-29|2011-04-04||October 2005||2005-10-01|December 2012|2012-12-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer|Phase II Feasibility Trial Incorporating Bevacizumab Into Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Patients With Lymph Node Positive Breast Cancer|Completed||Phase 2|226|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:36:18.220631|2017-02-18 17:36:18.220631
NCT00119249|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2013-01-14|||June 2005||2005-06-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery|A Phase II Study of BAY 43-9006 (NSC 724772) in Unresectable Stage III and IV Melanoma (IND 69,869)|Completed||Phase 2|74|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:36:18.943403|2017-02-18 17:36:18.943403
NCT00119236|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-12|2013-06-03|||May 2005||2005-05-01|June 2013|2013-06-01||||October 2008|Actual|2008-10-01||Interventional|||17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors|An Open-Labeled Non-Randomized Phase I Study of 17-N-allylamino-17-demethoxy Geldanamycin (17AAG) Administered With Irinotecan (CPT-11) in Patients With Advanced Solid Tumors|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:36:19.049453|2017-02-18 17:36:19.049453
NCT00119210|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2011-04-28|||March 2005||2005-03-01|April 2011|2011-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women|Bupropion for Smoking Cessation in Postpartum Women|Terminated||Phase 4|40|Anticipated|Massachusetts General Hospital||2||"We were unable to recruit sufficient numbers of patients and decided that the study protocol~   was not feasible to implement"|f||||||||||||||2017-02-18 17:36:19.146812|2017-02-18 17:36:19.146812
NCT00119197|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-04|2008-06-26|||August 2005||2005-08-01|June 2008|2008-06-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata|Safety and Immunogenicity of a Killed, Oral Cholera Vaccine in Indian Subjects in Eastern Kolkata, West Bengal|Completed||Phase 2|200|Actual|International Vaccine Institute||2|||f||||t||||||||||2017-02-18 17:36:19.25303|2017-02-18 17:36:19.25303
NCT00119184|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-03|2008-06-05|||October 2002||2002-10-01|May 2008|2008-05-01|May 2008|Actual|2008-05-01|March 2006|Actual|2006-03-01||Interventional|||Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version|A Prospective Randomized Study to Examine the Success Rate of External Cephalic Version for Breech Presentation at Term Presentation: Spinal Analgesia Versus No Analgesia|Terminated||Phase 1|140|Anticipated|Hadassah Medical Organization||2||"Multiparas study terminated due to poor recruitment. Randomization revealed only after~   decision recorded on clinicaltrials.gov"|f||||f||||||||||2017-02-18 17:36:19.369205|2017-02-18 17:36:19.369205
NCT00119171|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2008-10-15|||November 2004||2004-11-01|October 2008|2008-10-01||||||||Interventional|||Ispinesib In Combination With Capecitabine In Patients With Solid Tumors|A Phase I, Open-Label, Dose-Escalation Study of the Safety and Tolerability of Ispinesib in Combination With Capecitabine on an Every 21-Day Schedule in Subjects With Advanced Solid Tumors|Completed||Phase 1|30||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:36:19.474481|2017-02-18 17:36:19.474481
NCT00119158|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-05|2010-07-23|2010-02-19||October 2004||2004-10-01|July 2010|2010-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Combination Therapy for Atopic Dermatitis|An Exploratory Double-blind, Randomized, Vehicle-controlled, Paired Study to Evaluate the Efficacy and Safety of Concomitant Use of Elidel Cream 1% and Cutivate Cream 0.05% in Patients With Severe Lesions of Atopic Dermatitis (AD)|Completed||Phase 4|90|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 17:36:19.565389|2017-02-18 17:36:19.565389
NCT00119145|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-04|2017-01-11|||June 2005||2005-06-01|January 2017|2017-01-01|May 2006|Actual|2006-05-01|||||Interventional|||Kintampo Trial of Combination Therapy for Malaria|A Non-Inferiority, Open-Labelled, Randomised Trial Of The Efficacy And Safety Of Artesunate-Amodiaquine, Artemether-Lumefantrine, And Artesunate-Lapdap For Treatment Of Uncomplicated P. Falciparum Malaria Among Children In Ghana|Completed||Phase 4|510|Anticipated|London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-02-18 17:36:19.961157|2017-02-18 17:36:19.961157
NCT00118027|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2017-01-11|||May 2003||2003-05-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|||||Interventional|||A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda|A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in Uganda|Completed||N/A|2150||London School of Hygiene and Tropical Medicine|||||f||||f||||||||||2017-02-18 17:36:51.012324|2017-02-18 17:36:51.012324
NCT00119132|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-04|2017-01-11|||June 2005||2005-06-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Effectiveness of Intermittent Preventive Treatment for Malaria in Children|A Study Of Impact Of Intermittent Preventive Treatment In Children With Amodiaquine Plus Artesunate Versus Sulphadoxine-Pyrimethamine On Hemoglobin Levels And Malaria Morbidity In Hohoe District Of Ghana|Completed||Phase 2/Phase 3|2602|Actual|London School of Hygiene and Tropical Medicine||4|||f||||t||||||||||2017-02-18 17:36:20.056467|2017-02-18 17:36:20.056467
NCT00119119|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-04|2007-01-11|||February 2002||2002-02-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C|Efficacy and Safety of the Association With Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C|Terminated||Phase 3|100||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:36:20.281205|2017-02-18 17:36:20.281205
NCT00119106|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2015-02-04|||June 2005||2005-06-01|February 2015|2015-02-01|October 2014|Actual|2014-10-01|July 2013|Actual|2013-07-01||Interventional|||Bangkok Tenofovir Study|Study of the Safety and Efficacy of Daily Tenofovir to Prevent HIV Infection Among Injection Drug Users in Bangkok, Thailand|Completed||Phase 2/Phase 3|2413|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 17:36:20.379375|2017-02-18 17:36:20.379375
NCT00119093|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2012-09-10|||May 2003||2003-05-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Home-based AIDS Care Project|Home-based AIDS Care Project, Tororo, Uganda|Terminated||N/A|1000|Actual|Centers for Disease Control and Prevention||1||Terminated by IRB for non-compliance with human subject regulations.|f||||f||||||||||2017-02-18 17:36:20.491754|2017-02-18 17:36:20.491754
NCT00119080|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2007-03-16|||August 2006||2006-08-01|March 2007|2007-03-01|May 2007||2007-05-01|||||Interventional|||Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage|Evaluation of the Effect of Tetravalent (A, C, Y, W-135) Meningococcal Conjugate Vaccine on Serogroup-Specific Carriage of Neisseria Meningitidis|Completed||Phase 4|4000||Centers for Disease Control and Prevention|||||f||||f||||||||||2017-02-18 17:36:20.584266|2017-02-18 17:36:20.584266
NCT00119067|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2014-02-25|||May 2002||2002-05-01|September 2012|2012-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||CDC Anthrax Vaccine Clinical Trial|Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction|Completed||Phase 4|1560|Actual|Centers for Disease Control and Prevention||6|||f||||||||||||||2017-02-18 17:36:20.669|2017-02-18 17:36:20.669
NCT00119054|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2015-04-06|||September 2005||2005-09-01|January 2008|2008-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Effectiveness of Home-Based Health Messaging for Patients With Hypertension and Diabetes|Effectiveness of Care Coordination in Managing Medically Complex Patients|Completed||N/A|302|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:36:20.787114|2017-02-18 17:36:20.787114
NCT00119041|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2015-05-18|2014-07-02||September 2005||2005-09-01|May 2015|2015-05-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional||"Cohort I will consist of high-risk patients referred to a specialist during the 9-month active intervention and enrollment phase.Cohort II will consist of all other patients with diabetes (i.e., all non-Cohort I patients). We didn't collect gender or the complete age data.~Qualitative interviews with providers"|Diabetes Telemedicine Consultation: A Systems Improvement Intervention|Diabetes Telemedicine Consultation: A Systems Improvement Intervention|Completed||N/A|304|Actual|VA Office of Research and Development|A potential factor jeopardizing both internal and external validity relates to fact that the consultation process may be very dependent on the particular individuals involved.|3|||f||||f||||||||||2017-02-18 17:36:20.898498|2017-02-18 17:36:20.898498
NCT00119028|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2012-04-23|||April 2005||2005-04-01|April 2012|2012-04-01|October 2009|Actual|2009-10-01|December 2008|Actual|2008-12-01||Interventional|ReTIDES||Expanding and Testing VA Collaborative Care Models for Depression|Expanding and Testing VA Collaborative Care Models for Depression|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||This study was withdrawn prior to enrollment.|f||||f||||||||||2017-02-18 17:36:21.245155|2017-02-18 17:36:21.245155
NCT00119015|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2014-01-27|2012-12-20||July 2005||2005-07-01|January 2014|2014-01-01|January 2009|Actual|2009-01-01|June 2008|Actual|2008-06-01||Interventional|||The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis|The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis|Terminated||Phase 4|102|Actual|University of Chicago|Early termination of study due to difficulty recruiting|2||Difficulty in recruitment|f||||f||||||||||2017-02-18 17:36:21.358912|2017-02-18 17:36:21.358912
NCT00119002|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2008-03-13|||January 2004||2004-01-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis|The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis: A Multicenter Randomized Controlled Trial|Completed||Phase 4|598|Actual|University of Utah||2|||f||||t||||||||||2017-02-18 17:36:21.867906|2017-02-18 17:36:21.867906
NCT00118989|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-02|2014-12-12|||July 2005||2005-07-01|November 2011|2011-11-01|July 2012|Actual|2012-07-01|September 2010|Actual|2010-09-01||Interventional|||Curcumin for the Chemoprevention of Colorectal Cancer|Phase II Double Blind Placebo-Controlled Trial of Curcuminoids' Effect on Cellular Proliferation, Apoptosis and COX-2 Expression in the Colorectal Mucosa of Subjects With Recently Resected Sporadic Adenomatous Polyps|Completed||Phase 2|56|Actual|University of Pennsylvania||1|||f||||f||||||||||2017-02-18 17:36:21.990572|2017-02-18 17:36:21.990572
NCT00118976|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2006-11-22|||March 2005||2005-03-01|November 2006|2006-11-01|September 2006||2006-09-01|||||Interventional|||Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease|Optimal Dose of ACE Inhibitor for Treatment of Diabetic Nephropathy in Type 1 Diabetic Patients With Hypertension and Diabetic Nephropathy|Completed||N/A|60||Steno Diabetes Center|||||f||||||||||||||2017-02-18 17:36:22.091497|2017-02-18 17:36:22.091497
NCT00118963|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2008-12-05|||January 2003||2003-01-01|December 2008|2008-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes|Effect of Repaglinide Versus Metformin Treatment in Combination With Insulin Biasp30 (Novologmix 70/30) Predinner on Glycemic and Non-Glycemic Cardiovascular Risk-Factors in Non-Obese Patients With Type-2-Diabetes With Unsatisfactory Glycaemic Control With Oral Hypoglycaemic Agents|Completed||Phase 4|102|Actual|Steno Diabetes Center||3|||f||||||||||||||2017-02-18 17:36:22.182737|2017-02-18 17:36:22.182737
NCT00117078|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-09-29||||||September 2008|2008-09-01||||||||Interventional|||Aranesp® Monthly Preference Study - 2|Aranesp® Monthly Preference Study - 2|Completed||Phase 4|||Amgen|||||f||||||||||||||2017-02-18 17:37:18.93856|2017-02-18 17:37:18.93856
NCT00118950|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2008-12-05|||March 2001||2001-03-01|December 2008|2008-12-01|March 2003||2003-03-01|||||Interventional|||Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet|Effect of Metformin Versus Repaglinide Treatment on Glycemic Control and Non-Glycaemic Cardiovascular Risk Factors in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet|Completed||Phase 4|100||Steno Diabetes Center||4|||f||||||||||||||2017-02-18 17:36:22.292591|2017-02-18 17:36:22.292591
NCT00118937|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2008-12-05|||December 2003||2003-12-01|December 2008|2008-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet|Effect of Metformin On Glycaemic Control and Non-Glycaemic Cardiovascular Risk-Factors in Patients With Type-1 Diabetes, With Long-Standing Inadequate Glycaemic Control by Insulin and Diet|Completed||Phase 4|100|Actual|Steno Diabetes Center||3|||f||||||||||||||2017-02-18 17:36:25.314227|2017-02-18 17:36:25.314227
NCT00118924|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2008-01-18|||July 2005||2005-07-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of Tick-Borne Langat/Dengue 4 Chimera (LGT(TP21)/DEN4), a Live Attenuated Vaccine for Tick-Borne Encephalitis|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 17:36:25.418544|2017-02-18 17:36:25.418544
NCT00118911|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2013-03-07|2010-12-10||September 2004||2004-09-01|March 2013|2013-03-01|July 2010|Actual|2010-07-01|July 2009|Actual|2009-07-01||Interventional|||Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder|Efficacy of CBT for Residual ADHD in Adults|Completed||N/A|86|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:36:25.538082|2017-02-18 17:36:25.538082
NCT00118898|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2016-01-04|2010-01-08||September 2005||2005-09-01|January 2016|2016-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults|A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects|Completed||Phase 3|1864|Actual|AIDS Clinical Trials Group|HIV-1 drug resistance testing and HLA-B*5701 testing were not standard of care during enrollment. EFV and RTV-boosted ATV were open-label, and blinded FTC/TDF vs. ABC/3TC were unblinded in the >=100,000 cp/mL screening viral load stratum Feb 2008.|4|||f||||t||||||||||2017-02-18 17:36:25.95693|2017-02-18 17:36:25.95693
NCT00118885|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2009-12-09|||July 2001||2001-07-01|November 2006|2006-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Shingles: Immune Effects of Tai Chi|Behavioral Intervention for Herpes Zoster Risk in Aging|Completed||Phase 2|140||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:36:28.716736|2017-02-18 17:36:28.716736
NCT00118872|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2014-12-22|||March 2006||2006-03-01|December 2007|2007-12-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Beneficial Bacteria to Prevent Malnutrition and Diarrhea in Pakistani Infants|Feasibility Study of Probiotics for Growth Faltering in Pakistan|Completed||N/A|120|Actual|Tufts University||2|||f||||t||||||||||2017-02-18 17:36:28.813109|2017-02-18 17:36:28.813109
NCT00118859|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2009-12-10|||July 2004||2004-07-01|December 2009|2009-12-01|April 2006||2006-04-01|||||Interventional|||Pilot Study to Test the Effectiveness of Combining Conventional and Complementary Medicine to Treat Low Back Pain|Model of Integrative Care in an Academic Health Center|Completed||N/A|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:36:29.192358|2017-02-18 17:36:29.192358
NCT00118846|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2008-08-14|||March 2004||2004-03-01|August 2008|2008-08-01|June 2009|Anticipated|2009-06-01|January 2009|Anticipated|2009-01-01||Interventional|||Women's Isoflavone Soy Health (WISH) Trial|Phytoestrogens and Progression of Atherosclerosis|Unknown status|Active, not recruiting|Phase 2/Phase 3|350|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 17:36:29.278507|2017-02-18 17:36:29.278507
NCT00118833|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2007-09-25|||August 2002||2002-08-01|September 2007|2007-09-01|June 2006|Actual|2006-06-01|||||Interventional|||St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)|Placebo-Controlled Trial of Hypericum Perforatum in the Treatment of Generalized Social Anxiety Disorder (GSAD)|Completed||Phase 2/Phase 3|56|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:36:29.383714|2017-02-18 17:36:29.383714
NCT00118820|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2010-07-14|||March 2004||2004-03-01|July 2010|2010-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Antibiotic Efficacy in Third Molar Surgery|Antibiotic Efficacy in Third Molar Surgery|Completed||Phase 3|132|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:36:29.476433|2017-02-18 17:36:29.476433
NCT00118807|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2006-01-06|||August 2003||2003-08-01|June 2003|2003-06-01|February 2004||2004-02-01|||||Interventional|||Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children|Randomized Trial of the Effectiveness of Amodiaquine-Artesunate, Amodiaquine-Sulfadoxine-Pyrimethamine, and Chloroquine-Sulfadoxine-Pyrimethamine, for Treatment of Uncomplicated Malaria in Gambian Children|Completed||Phase 3|1800||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:36:29.571133|2017-02-18 17:36:29.571133
NCT00118794|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2006-01-31|||September 2004||2004-09-01|January 2005|2005-01-01|June 2005||2005-06-01|||||Interventional|||Lapdap and Coartemether for Uncomplicated Malaria|Randomized Trial of the Safety and Effectiveness of Lapdap and Coartemether for Uncomplicated Malaria in Operational Settings|Completed||Phase 3|1200||London School of Hygiene and Tropical Medicine|||||f||||||||||||||2017-02-18 17:36:29.67581|2017-02-18 17:36:29.67581
NCT00118781|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2005-07-11|||September 2003||2003-09-01|July 2005|2005-07-01|June 2004||2004-06-01|||||Interventional|||Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia|Randomized, Double-Blind, Placebo-Controlled, Multinational Phase 3 Trial Of Iseganan In Prevention Of Ventilator-Associated Pneumonia|Terminated||Phase 2/Phase 3|900||IntraBiotics Pharmaceuticals|||||||||||||||||||2017-02-18 17:36:29.779644|2017-02-18 17:36:29.779644
NCT00118768|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-02-27|||August 2005||2005-08-01|February 2009|2009-02-01||||||||Interventional|||A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C|A Randomized, Phase IIb Clinical Trial to Evaluate the Safety and Antiviral Activity of the Combination of Pegylated Interferon Alfa Plus NM283 (Valopicitabine) in Treatment-Naive Patients With Chronic Hepatitis C|Completed||Phase 2|175||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:36:29.891|2017-02-18 17:36:29.891
NCT00118755|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2011-02-09|2010-04-25||July 2005||2005-07-01|February 2011|2011-02-01||||April 2009|Actual|2009-04-01||Interventional|||A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer|A Randomized, Open-label Study of the Effect of 2 Different Treatment Schedules of Xeloda With Eloxatin and Avastin on Progression-free Survival in Treatment-naïve Patients With Locally Advanced or Metastatic Colorectal Cancer|Completed||Phase 2|435|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:36:30.0082|2017-02-18 17:36:30.0082
NCT00118742|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-07-30|2009-05-13||August 2005||2005-08-01|July 2010|2010-07-01|December 2008|Actual|2008-12-01|July 2008|Actual|2008-07-01||Interventional|||Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant|A Randomized, Open-label Study of the Effect of a Long-term Calcineurin Inhibitor-free Maintenance Regimen With CellCept and Sirolimus on Preservation of Renal Function and Prevention of Acute Rejection in Recipients of an Orthotropic Liver Transplant|Completed||Phase 4|293|Actual|Hoffmann-La Roche|There were no overall limitations and caveats.|2|||f||||||||||||||2017-02-18 17:36:30.725453|2017-02-18 17:36:30.725453
NCT00118729|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2016-09-13|||April 2005||2005-04-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action|A Randomized, Double Blind, Placebo-Controlled, Single-Dose, Parallel-Group Study to Evaluate the Onset of Action of a Single Dose of Intranasal GW685698X Aqueous Nasal Spray 100mcg in Adolescent and Adult Subjects (12 Years of Age and Older) With Seasonal Allergic Rhinitis Exposed to Ragweed Pollen in an Allergen Challenge Chamber|Completed||Phase 3|380|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:36:32.046695|2017-02-18 17:36:32.046695
NCT00118716|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2016-09-22|||December 2003||2003-12-01|September 2016|2016-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise|A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and Adolescent Subjects With Activity-Induced Bronchospasm|Completed||Phase 4|255|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:36:32.159415|2017-02-18 17:36:32.159415
NCT00118703|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2016-09-22|||July 2005||2005-07-01|September 2016|2016-09-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 4 Weeks in Adult and Adolescent Subjects (12 Years of Age and Older) With Vasomotor Rhinitis|Completed||Phase 3|350|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:36:32.310576|2017-02-18 17:36:32.310576
NCT00118690|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2016-09-22|||December 2003||2003-12-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise|A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and Adolescent Subjects With Activity-Induced Bronchospasm|Completed||Phase 4|227|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:36:32.468786|2017-02-18 17:36:32.468786
NCT00118677|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2007-08-29|||February 2003||2003-02-01|August 2007|2007-08-01|May 2007|Actual|2007-05-01|||||Interventional|||Long-Term Supervised Treatment Interruption in HIV-Infected Patients|Long-Term Supervised Treatment Interruption in HIV-Infected Patients Who Started Antiretroviral Treatment With CD4 Over 350/mm3 and Plasma HIV RNA Below 50 000/mL ANRS 116 Trial SALTO|Completed||Phase 3|130||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:36:32.615106|2017-02-18 17:36:32.615106
NCT00118664|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2016-06-13|||May 2005||2005-05-01|June 2016|2016-06-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Observational|TAMOF||Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children|Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children|Completed||N/A|86|Actual|Children's Healthcare of Atlanta|||1||f||||f||||||||No||2017-02-18 17:36:32.706793|2017-02-18 17:36:32.706793
NCT00118651|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2013-09-25|||October 2004||2004-10-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Observational|||Clinical Indicators of Radiographic Findings in Patients With Suspected Community-Acquired Pneumonia|Clinical Indicators of Radiographic Findings in Patients With Suspected Community-Acquired Pneumonia: Who Needs a Chest X-Ray?|Withdrawn||N/A|0|Actual|David Grant U.S. Air Force Medical Center||||PI location unknown|f||||||||||||||2017-02-18 17:36:32.81665|2017-02-18 17:36:32.81665
NCT00118638|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-04-25|||March 2004||2004-03-01|April 2013|2013-04-01|January 2005|Actual|2005-01-01|December 2004|Actual|2004-12-01||Interventional|||A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy|A Randomized, Double Blind, Active-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy|Completed||Phase 3|705|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:36:32.89447|2017-02-18 17:36:32.89447
NCT00118625|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2010-06-16|||July 2005||2005-07-01|June 2010|2010-06-01|September 2005||2005-09-01|||||Interventional|||Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine|A Double-Blind Phase IIa Study to Demonstrate the Contribution of MPL® to Tyrosine Adsorbed Birch + Hazel + Alder Pollen Allergoid (Tree MATA) With a Single-Blind Portion to Evaluate the Residual Allergenicity in Skin Test in Volunteers Allergic to Birch and Hazel and Alder Pollen|Completed||Phase 2|40||Allergy Therapeutics|||||||||||||||||||2017-02-18 17:36:33.147367|2017-02-18 17:36:33.147367
NCT00117065|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-04-24||||||April 2013|2013-04-01||||||||Interventional|||Study of Transplant Related Anemia Treated With Aranesp® (STRATA)|Study of Transplant Related Anemia Treated With Aranesp® (STRATA)|Completed||Phase 4|||Amgen|||||f||||||||||||||2017-02-18 17:37:19.093838|2017-02-18 17:37:19.093838
NCT00118612|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2010-06-16|||July 2005||2005-07-01|June 2010|2010-06-01||||||||Interventional|||Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen|A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Birch + Hazel + Alder Pollen Allergoid With MPL® in Patients Sensitized to Birch, Hazel, Alder Pollen|Completed||Phase 2|68||Allergy Therapeutics|||||||||||||||||||2017-02-18 17:36:33.253694|2017-02-18 17:36:33.253694
NCT00118586|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2017-01-24|||July 6, 2005||2005-07-06|November 30, 2016|2016-11-30||||||||Observational|||Neuropathology of Spasmodic Dysphonia|Neuropathological Basis of Spasmodic Dysphonia and Related Voice Disorders|Active, not recruiting||N/A|97|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:36:33.342397|2017-02-18 17:36:33.342397
NCT00118573|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-12-09|||September 2004||2004-09-01|December 2015|2015-12-01|September 2017|Anticipated|2017-09-01|May 2010|Actual|2010-05-01||Interventional|CAESAR||Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair|Randomized Clinical Trial Comparing Surveillance and Selective Surgical Treatment for Abdominal Aortic Aneurysms Less Than 5.5 cm in Diameter Versus Early Endovascular Treatment|Terminated||Phase 4|360|Actual|University Of Perugia||2||lower than anticipated events;slow recruitment;larger than predicted sample size|f||||t||||||||||2017-02-18 17:36:33.439137|2017-02-18 17:36:33.439137
NCT00118560|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-03-16|||June 2005||2005-06-01|March 2011|2011-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Exercise Training for Patients With Poor Leg Circulation|Perfusion and Metabolism During Exercise in Peripheral Arterial Disease|Completed||N/A|50|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 17:36:33.590857|2017-02-18 17:36:33.590857
NCT00118547|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2011-08-11|||September 2005||2005-09-01|August 2011|2011-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Health Behavior Change in Chronic Disease Management|Health Behavior Change in Chronic Disease Management|Completed||N/A|20|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:36:33.702962|2017-02-18 17:36:33.702962
NCT00118534|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2014-04-18|2013-08-22||July 2004||2004-07-01|April 2014|2014-04-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder|CSP #519 - Integrating Practice Guidelines for Smoking Cessation Into Mental Health Care for PTSD (SCP)|Completed||N/A|943|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:36:33.843261|2017-02-18 17:36:33.843261
NCT00118521|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2013-12-18|||May 2004||2004-05-01|September 2006|2006-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Clinical Study in the Use of Orthotics in Treating Pain in the Front of the Knee|Foot Orthotics in the Treatment of Patellofemoral Pain Syndrome: A Randomised Clinical Trial in Primary Care|Completed||Phase 3|176||The University of Queensland|||||f||||||||||||||2017-02-18 17:36:36.213426|2017-02-18 17:36:36.213426
NCT00118508|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-08-10|||May 2003||2003-05-01|August 2015|2015-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)|The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)|Completed||N/A|87|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 17:36:36.311056|2017-02-18 17:36:36.311056
NCT00118495|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-07-04|||March 2006||2006-03-01|July 2007|2007-07-01|March 2007||2007-03-01|||||Interventional|||Zestra in Women With Mixed Sexual Dysfunction|A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial of the Efficacy and Safety of Zestra(TM) in Women With Mixed Desire/Interest/Arousal/Orgasm Disorders|Completed||Phase 3|200||QualiLife Pharmaceuticals|||||f||||t||||||||||2017-02-18 17:36:36.425581|2017-02-18 17:36:36.425581
NCT00118482|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-12-05|||May 2005||2005-05-01|December 2013|2013-12-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Clinical Trial for the Prevention of Vasovagal Syncope|A Randomized Clinical Trial of Fludrocortisone for Vasovagal Syncope: The Second Prevention of Syncope Trial (POST II)|Completed||Phase 4|214|Actual|University of Calgary||2|||f||||t||||||||||2017-02-18 17:36:36.536983|2017-02-18 17:36:36.536983
NCT00118469|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2008-04-01|||July 2004||2004-07-01|February 2008|2008-02-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Parent Psychoeducation and Cognitive Behavior Therapy for Latino Adolescents With Depression|Parent Psychoeducation Intervention in CBT for Depressed Latino Youth|Unknown status|Recruiting|Phase 2|144|Anticipated|National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 17:36:36.652318|2017-02-18 17:36:36.652318
NCT00118456|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2012-01-05|||July 2003||2003-07-01|January 2012|2012-01-01||||January 2008|Actual|2008-01-01||Interventional|||Study of Oral AEE788 in Adults With Advanced Cancer|A Phase I/II, Multicenter, Randomized Dose-Escalation Study of Oral AEE788 on Intermittent Dosing Schedules in Adult Patients With Advanced Cancer (Effective Amendment 5) Previously Entitled A Phase IA, Multicenter, Dose-Escalating Study of Oral AEE788 on a Continuous Daily Dosing Schedule in Adult Patients With Advanced Cancer|Completed||Phase 1|189|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:36:36.740322|2017-02-18 17:36:36.740322
NCT00118443|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2013-06-27|||March 2004||2004-03-01|June 2013|2013-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Evaluation of a School-Based Training Program for Suicide Prevention|RCT of Gatekeeper Training for Suicide Prevention|Completed||Phase 2/Phase 3|50000|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 17:36:36.842992|2017-02-18 17:36:36.842992
NCT00118430|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2014-06-09|||September 2004||2004-09-01|June 2014|2014-06-01|August 2008|Actual|2008-08-01|July 2008|Actual|2008-07-01||Interventional|||Stepped Care for Depression and Musculoskeletal Pain|Stepped Care for Affective Disorders and Musculoskeletal Pain|Completed||Phase 4|500|Actual|Indiana University||3|||f||||t||||||||||2017-02-18 17:36:37.144198|2017-02-18 17:36:37.144198
NCT00118417|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2014-06-05|2009-06-05||March 1999||1999-03-01|June 2014|2014-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Therapies for Treatment-Resistant Panic Disorder Symptoms|Treatment Refractory Panic Disorder|Completed||Phase 2/Phase 3|46|Actual|Massachusetts General Hospital|Power in Phase 2 limited detection to a large effect size. High drop-out for increased SSRI dose may indicate poor tolerability. Effectiveness of adding an SSRI to initial CBT was unexamined, limiting generalization to community treatment decisions.|2|||f||||||||||||||2017-02-18 17:36:37.257394|2017-02-18 17:36:37.257394
NCT00114478|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2008-01-23|||November 2003||2003-11-01|January 2008|2008-01-01|May 2006||2006-05-01|||||Interventional|||Trial of Epinephrine and Albuterol in Bronchiolitis|Randomized Controlled Trial of Epinephrine and Albuterol in Bronchiolitis|Unknown status|Active, not recruiting|N/A|600||Kern Medical Center|||||f||||||||||||||2017-02-18 17:38:13.274866|2017-02-18 17:38:13.274866
NCT00118404|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2014-05-13|2013-12-12||March 2000||2000-03-01|May 2014|2014-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||523 adults with recurrent major depressive disorder began acute phase cognitive therapy; only the 241 eligible higher-risk responders were randomized to the 3 arms above.|Cognitive Therapy for Recurrent Depression|Prophylactic Cognitive Therapy for Depression.|Completed||Phase 3|523|Actual|University of Texas Southwestern Medical Center|"To our knowledge in 2014 this is of the largest, cognitive therapy responders who presented with recurrent MDD and were followed longitudinally~Proficient therapists;competency measured.~Generalizability is limited by design characteristics."|3|||f||||t||||||||||2017-02-18 17:36:37.605258|2017-02-18 17:36:37.605258
NCT00118391|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2013-06-28|||November 2002||2002-11-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|CBT/CM||Cognitive-Behavioral Treatment of Gambling|Enhanced Cognitive Behavior Therapy for the Treatment of Pathological Gambling|Completed||Phase 1|120||UConn Health|||||f||||t||||||||||2017-02-18 17:36:38.163477|2017-02-18 17:36:38.163477
NCT00118378|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2014-06-06|2012-01-03||December 2004||2004-12-01|March 2013|2013-03-01|November 2010|Actual|2010-11-01|June 2010|Actual|2010-06-01||Interventional|||Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDS|Modafinil Treatment for Fatigue in HIV+ Patients|Completed||Phase 4|115|Actual|New York State Psychiatric Institute|This study was conducted at a single site in an urban setting where most patients have good access to medical care. Women were under-represented despite outreach efforts.|2|||f||||t||||||||||2017-02-18 17:36:38.264234|2017-02-18 17:36:38.264234
NCT00118365|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2015-01-12|2014-04-18||July 1998||1998-07-01|February 2014|2014-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional||Randomized participants|Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps|A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Combination of DFMO and Sulindac to Decrease the Rate of Recurrence of Adenomatous Polyps in the Colon|Completed||Phase 3|375|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:36:38.768425|2017-02-18 17:36:38.768425
NCT00118352|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2016-06-13|||March 2005||2005-03-01|June 2016|2016-06-01||||July 2010|Actual|2010-07-01||Interventional|||Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer|Campath (Alemtuzumab) Dose Escalation, Low-Dose TBI and Fludarabine Followed by HLA Class II Mismatched Donor Stem Cell Transplantation for Patients With Hematologic Malignancies: A Multicenter Trial|Active, not recruiting||Phase 2|11|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:36:42.053956|2017-02-18 17:36:42.053956
NCT00118339|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2011-08-30|||July 2003||2003-07-01|August 2011|2011-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma|A Prospective Randomized Pilot Study Using Ice Chips Versus Room Temperature Normal Saline Rinses Orally During Administration of Melphalan to Decrease the Severity and Duration of Oral Mucositis in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplant|Completed||N/A|41|Actual|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:36:42.209529|2017-02-18 17:36:42.209529
NCT00118326|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2010-05-12|||August 2003||2003-08-01|May 2010|2010-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease|Feasibility of Granulocyte-Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow From Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:36:42.301002|2017-02-18 17:36:42.301002
NCT00118313|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2014-12-18|||November 2004||2004-11-01|December 2014|2014-12-01||||November 2007|Actual|2007-11-01||Interventional|||Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma|Evaluation of Different Adjuvants for the Transdermal Administration of a Peptide-Based Vaccine in Participants With High-Risk Melanoma|Completed||Phase 1|||University of Virginia|||||f||||t||||||||||2017-02-18 17:36:42.393401|2017-02-18 17:36:42.393401
NCT00118300|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2011-07-07|||April 2005||2005-04-01|July 2011|2011-07-01||||||||Interventional|||Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer|Phase I Study of Capecitabine (Xeloda) and Radiation Therapy in Patients With Locally Advanced Cervical and Pelvic Malignancies|Withdrawn||Phase 1|0|Actual|Case Comprehensive Cancer Center||1||Competing studies|f||||t||||||||||2017-02-18 17:36:42.493647|2017-02-18 17:36:42.493647
NCT00118287|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2012-02-17|||April 2005||2005-04-01|February 2012|2012-02-01||||October 2008|Actual|2008-10-01||Interventional|||Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes|Therapy of Myelodysplastic Syndrome (MDS) With Azacitidine Given in Combination With Etanercept: A Phase I/II Study.|Completed||Phase 1/Phase 2|32|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:36:42.603352|2017-02-18 17:36:42.603352
NCT00118274|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2009-02-06|||March 2005||2005-03-01|November 2008|2008-11-01||||February 2010|Anticipated|2010-02-01||Interventional|||Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma|A Multicenter Trial to Evaluate the Effects of Administration of Cyclophosphamide and Melanoma-Derived Helper Peptides on the Immunogenicity of a Class I MHC-Restricted Peptide-Based Vaccine in Participants With Resected Melanoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|173|Anticipated|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 17:36:42.721689|2017-02-18 17:36:42.721689
NCT00118261|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2012-08-31|||March 2005||2005-03-01|August 2012|2012-08-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer|A Phase IB Study in Patients With Metastatic Colorectal Cancer to Evaluate Pharmacodynamic Effects of Erlotinib and Safety and Efficacy of Erlotinib in Combination With Modified FOLFOX6 (mFOLFOX6) and Bevacizumab|Completed||Phase 1|17|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:36:42.835052|2017-02-18 17:36:42.835052
NCT00118248|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2016-12-28|2013-09-20||December 2004||2004-12-01|December 2016|2016-12-01|April 2012|Actual|2012-04-01|August 2009|Actual|2009-08-01||Interventional|||Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer|A Phase II Trial of 17-Allylaminogeldanamycin (17AAG) in Advanced Medullary and Differentiated Thyroid Carcinoma|Completed||Phase 2|41|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:36:43.064816|2017-02-18 17:36:43.064816
NCT00118235|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2014-06-16|||December 2004||2004-12-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|April 2007|Actual|2007-04-01||Interventional|||Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer|Cisplatin, Irinotecan and Bevacizumab (NSC# 704865) for Untreated Extensive Stage Small Cell Lung Cancer: A Phase II Study|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:36:43.541087|2017-02-18 17:36:43.541087
NCT00118222|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2010-06-09|||March 2005||2005-03-01|June 2010|2010-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||High Light and Low Light Dose PDT in Glioma|A Randomized Prospective Two Arm Clinical Trial of High Light Dose And Low Light Dose PDT in the Treatment of Recurrent Malignant Supratentorial Gliomas Using Porfimer Sodium [Photofrin]|Completed||Phase 3|1|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:36:43.666564|2017-02-18 17:36:43.666564
NCT00118209|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2016-07-01|||May 2005||2005-05-01|July 2016|2016-07-01||||May 2018|Anticipated|2018-05-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma|Phase III Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R With Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas|Active, not recruiting||Phase 3|13|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:36:43.799041|2017-02-18 17:36:43.799041
NCT00118196|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2012-04-26|||April 2005||2005-04-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia|A Phase II Study of Arsenic Trioxide in Combination With 5-Azacitidine in Myelodysplastic Syndromes|Completed||Phase 2|41|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-02-18 17:36:43.960457|2017-02-18 17:36:43.960457
NCT00118183|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2013-06-03|||July 2005||2005-07-01|June 2013|2013-06-01||||April 2007|Actual|2007-04-01||Interventional|||Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II Trial of Docetaxel Plus Cetuximab and Docetaxel Plus Bortezomib (NSC #681239, IND #58443) in Advanced Non-Small Cell Lung Cancer Patients With Performance Status (PS) 2|Completed||Phase 2|62|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:36:44.052312|2017-02-18 17:36:44.052312
NCT00118170|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2013-01-04|||October 2004||2004-10-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function|Pharmacokinetic and Phase I Study of Sorafenib (BAY 43-9006, NSC 724772, IND 69896) for Solid Tumors and Hematologic Malignancies in Patients With Hepatic or Renal Dysfunction|Completed||Phase 1|150|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:36:44.170223|2017-02-18 17:36:44.170223
NCT00118157|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2015-07-28|2014-11-21||May 2005||2005-05-01|April 2014|2014-04-01|September 2014|Actual|2014-09-01|July 2011|Actual|2011-07-01||Interventional|||Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen|A Phase II Study of GW572016 and Tamoxifen in Patients With Metastatic Breast Cancer Resistant to Single-Agent Tamoxifen|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)|The main limitation in this study was poor enrollment. The small number of cases makes the interpretation of results difficult.|1|||f||||||||||||||2017-02-18 17:36:44.292766|2017-02-18 17:36:44.292766
NCT00118144|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2014-08-04|2014-08-04||June 2005||2005-06-01|April 2013|2013-04-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer|Phase II Study of Bortezomib (PS-341) for Patients With Advanced Bronchiolo-Alveolar Carcinoma (BAC) or Adenocarcinoma With BAC Features|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:36:47.514494|2017-02-18 17:36:47.514494
NCT00118131|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2013-09-19|2013-09-19||December 2003||2003-12-01|September 2013|2013-09-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Weekly Docetaxel Together With Weekly Cisplatin in Chemotherapy-Naive Patients With Stage IV or Select Stage IIIB (Malignant Effusion) Non-Small Cell Lung Cancer|Terminated||Phase 2|49|Actual|Rutgers, The State University of New Jersey||1||Slow accrual|f||||f||||||||||2017-02-18 17:36:47.887447|2017-02-18 17:36:47.887447
NCT00118105|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2013-01-02|||November 2006||2006-11-01|January 2013|2013-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer|A Phase II Trial of Neoadjuvant Capecitabine, Oxaliplatin, and Bevacizumab for Resectable Colorectal Metastases in the Liver|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||1||Budget Constraints|f||||t||||||||||2017-02-18 17:36:48.521875|2017-02-18 17:36:48.521875
NCT00118092|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2013-10-07|||January 2005||2005-01-01|October 2013|2013-10-01||||May 2006|Actual|2006-05-01||Interventional|||17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy|A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Patients With Hormone-Refractory Metastatic Prostate Cancer|Completed||Phase 2|28|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:36:48.706441|2017-02-18 17:36:48.706441
NCT00118066|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2015-05-22|||May 2004||2004-05-01|May 2015|2015-05-01|August 2011|Actual|2011-08-01|June 2011|Actual|2011-06-01||Interventional|||Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia|A Randomized Phase II Trial Of Calcitriol In Patients With Prostatic Intraepithelial Neoplasia|Terminated||Phase 2|12|Actual|Rutgers, The State University of New Jersey||2||Slow accruaL, lack of scientific progress|f||||f||||||||||2017-02-18 17:36:48.81734|2017-02-18 17:36:48.81734
NCT00118053|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2013-09-17|2013-09-17||April 2005||2005-04-01|September 2013|2013-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer|A Phase II Trial of Taxotere, Carboplatin and Herceptin in Locally Advanced or Inflammatory Breast Cancer|Terminated||Phase 2|5|Actual|Rutgers, The State University of New Jersey||1||slow accrual|f||||f||||||||||2017-02-18 17:36:48.93895|2017-02-18 17:36:48.93895
NCT00118040|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2016-02-23|2015-12-10||June 2005||2005-06-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer|Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 17:36:49.270536|2017-02-18 17:36:49.270536
NCT00118014|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2008-05-19|||January 2000||2000-01-01|May 2008|2008-05-01|August 2004|Actual|2004-08-01|April 2004|Actual|2004-04-01||Interventional|||Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania|Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania|Completed||Phase 4|75|Actual|Massachusetts General Hospital||4|||f||||f||||||||||2017-02-18 17:36:51.122835|2017-02-18 17:36:51.122835
NCT00118001|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-03-31|||October 2001||2001-10-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Interventional|||Psychotherapy of Generalized Anxiety Disorder|Worry Exposure Versus Applied Relaxation in the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|70||German Research Foundation|||||f||||||||||||||2017-02-18 17:36:51.227289|2017-02-18 17:36:51.227289
NCT00117988|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2014-05-21|2011-05-05||February 2005||2005-02-01|February 2013|2013-02-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma|A Phase II Study of 17-AAG in Patients With Relapsed/Refractory CD30+ Anaplastic Large Cell Lymphoma (ALCL), Relapsed/Refractory Mantle Cell Lymphoma (MCL), and Relapsed/Refractory Classical Hodgkin's Lymphoma (HL)|Completed||Phase 2|22|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:36:51.324101|2017-02-18 17:36:51.324101
NCT00117975|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2016-07-01|||June 2005||2005-06-01|July 2016|2016-07-01|August 2013|Actual|2013-08-01|June 2007|Actual|2007-06-01||Interventional|||Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|A Phase II Trial of Extended Induction Galiximab (Anti-CD80 Monoclonal Antibody) (IND #12373) Plus Rituximab in Previously Untreated Follicular Non-Hodgkin Lymphoma (NHL)|Completed||Phase 2|62|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:36:51.566359|2017-02-18 17:36:51.566359
NCT00117962|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-08|2016-08-29|2012-11-05||September 2005||2005-09-01|August 2016|2016-08-01|September 2012|Actual|2012-09-01|March 2009|Actual|2009-03-01||Interventional|||Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Randomized Phase II Study of Radiation Therapy, Pemetrexed and Carboplatin With or Without Cetuximab in Stage III Non-Small Cell Lung Cancer|Completed||Phase 2|109|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 17:36:51.759383|2017-02-18 17:36:51.759383
NCT00117949|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-05-18|2009-01-22||April 2002||2002-04-01|May 2011|2011-05-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486|An Open-Label, Multi-Center, Ascending, Single Dose Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486|Completed||Phase 2|82|Actual|Ferring Pharmaceuticals||4|||f||||t||||||||||2017-02-18 17:36:53.289514|2017-02-18 17:36:53.289514
NCT00117936|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-11-07|||September 2008||2008-09-01|August 2013|2013-08-01|December 2015|Anticipated|2015-12-01|June 2015|Anticipated|2015-06-01||Interventional|ACORD||Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease|Human Recombinant Fibroblast Growth Factor-1 (FGF-1) for Intramyocardial Injection for the Treatment of Coronary Heart Disease|Unknown status|Active, not recruiting|Phase 2|120|Anticipated|CardioVascular BioTherapeutics, Inc.||4|||f||||t||||||||||2017-02-18 17:36:54.804985|2017-02-18 17:36:54.804985
NCT00117923|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-02-16|||August 2004||2004-08-01|November 2006|2006-11-01||||||||Interventional|||Study With a Topical Gel to Treat Common Warts in Adults|A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 5 Times Per Week for 4 Weeks for the Treatment of Common Warts in Adults|Completed||Phase 2|88||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-02-18 17:36:54.936748|2017-02-18 17:36:54.936748
NCT00117910|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-05-15|||October 2002||2002-10-01|May 2008|2008-05-01|May 2004||2004-05-01|||||Interventional|||Treatment for Elderly Patients With High Risk Breast Cancer|An Open Label, Randomised, Multicentre Study of Pegfilgrastim in Primary Versus Secondary Prophylaxis of Neutropenia as an Adjunct to Chemotherapy in Elderly Subjects With High Risk Breast Cancer.|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-02-18 17:36:55.021157|2017-02-18 17:36:55.021157
NCT00117897|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-07-16|||July 2002||2002-07-01|July 2009|2009-07-01|February 2004||2004-02-01|||||Interventional|||Treatment for Subjects With Non-Hodgkin's Lymphoma|An Open-Label, Randomized, Parallel, Phase II Study of CHOP Chemotherapy and Rituximab Administered Every 14 Days, With Pegfilgrastim or Filgrastim Support, for the Treatment of Subjects With Non-Hodgkin's Lymphoma|Completed||Phase 2|||Amgen||1|||f||||||||||||||2017-02-18 17:36:55.371396|2017-02-18 17:36:55.371396
NCT00117884|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2016-08-16||2016-08-16|April 2006||2006-04-01|August 2016|2016-08-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.|A Randomized, Double-blind, Placebo-Controlled, Dose Response Study to Evaluate 851B Gel Delivered Intravaginally Twice a Week for Two, Three-Week Cycles in Women Who Are Positive For High-Risk Genotypes of Human Papillomavirus and Have Mild Cytological Abnormalities|Terminated||Phase 2|240|Actual|Takeda||11||Lack of efficacy|f||||f||||||||||2017-02-18 17:36:55.468836|2017-02-18 17:36:55.468836
NCT00117871|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-02-16|||October 2004||2004-10-01|November 2006|2006-11-01||||||||Interventional|||Study With a Topical Gel to Treat Common Warts in Adults|A Two-Stage, Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 5 Times Per Week for up to 12 Weeks for the Treatment of Common Warts in Adults|Completed||Phase 2|48||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-02-18 17:36:55.61224|2017-02-18 17:36:55.61224
NCT00117858|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2017-01-24|||June 28, 2005||2005-06-28|May 10, 2007|2007-05-10|May 10, 2007||2007-05-10|||||Interventional|||Double Blind Trial of DC Polarization in FTD|Double Blind Trial of DC Polarization in FTD|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:36:55.692338|2017-02-18 17:36:55.692338
NCT00117845|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-07|2013-10-31|2012-09-25||July 2005||2005-07-01|October 2013|2013-10-01|June 2013|Actual|2013-06-01|December 2011|Actual|2011-12-01||Interventional|||Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia|Phase II Study of the Efficacy and Toxicity of Ontak (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia|Completed||Phase 2|17|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 17:36:55.784266|2017-02-18 17:36:55.784266
NCT00117832|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-09-04|||March 2005||2005-03-01|September 2013|2013-09-01|October 2006|Actual|2006-10-01|May 2006|Actual|2006-05-01||Interventional|||Nasal Ocular Reflexes Contribute to Eye Symptoms|Nasal Ocular Reflexes Contribute to Eye Symptoms in Patients With Allergic Rhinitis|Completed||N/A|20||University of Chicago|||||f||||f||||||||||2017-02-18 17:36:56.21882|2017-02-18 17:36:56.21882
NCT00117819|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-04-09||2014-04-09|March 2001||2001-03-01|April 2014|2014-04-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease|Dynamic SPECT Imaging With [123I] B-CIT in Individuals With Parkinsonian Syndrome (PS) and in Individuals at Risk for Parkinsonian Syndrome|Completed||Phase 2|232|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 17:36:56.349525|2017-02-18 17:36:56.349525
NCT00117806|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2016-02-03|2014-10-24||April 2006||2006-04-01|February 2016|2016-02-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|SCI-VIP|"AIS DATA-Missing 1 participant for Supported Employment and Treatment As Usual groups.~AIS & Neurologival Level- Missing 1 participant for Supported employment."|Spinal Cord Injury Vocational Integration Program (SCI-VIP)|A Spinal Cord Injury Vocational Integration Program: Implementation and Outcomes|Completed||N/A|249|Actual|VA Office of Research and Development|Majority of sample is male; Potential selection bias (participants who decided to remain in study for second year may be different from those who did not though no statistical significance was detected between groups)|2|||f||||t||||||||||2017-02-18 17:36:56.465963|2017-02-18 17:36:56.465963
NCT00117793|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-01|2014-07-28|2013-10-24||August 2005||2005-08-01|July 2014|2014-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional||The sample population descriptors are based on the participants who completed the study protocol.|Vacuum Suspension: Effects on Tissue Oxygenation, Activity and Fit|Vacuum Suspension: Effects on Tissue Oxygenation, Activity and Fit|Completed||N/A|20|Actual|VA Office of Research and Development|The small number of participants who completed the protocol precluded a statistical analysis on the secondary outcome measures.|2|||f||||f||||||||||2017-02-18 17:36:57.571455|2017-02-18 17:36:57.571455
NCT00117780|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2017-01-30|||June 2005||2005-06-01|January 2017|2017-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|ADAPT||Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes|Comparison of Efficacy and Safety of Insulin Detemir Once or Twice Daily in a Basal-Bolus Regimen With Insulin Aspart in Patients With Type 1 Diabetes|Completed||Phase 4|520|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:36:57.949199|2017-02-18 17:36:57.949199
NCT00117767|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-11-01|||June 2004||2004-06-01|November 2011|2011-11-01||||March 2006|Actual|2006-03-01||Interventional|||Terbinafine Compared to Griseofulvin in Children With Tinea Capitis|Efficacy and Safety of Terbinafine Compared to Griseofulvin in Children With Tinea Capitis|Completed||Phase 3|720||Novartis||2|||||||||||||||||2017-02-18 17:36:58.174251|2017-02-18 17:36:58.174251
NCT00117754|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-02-20|||July 2004||2004-07-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Terbinafine Compared to Griseofulvin in Children With Tinea Capitis|Efficacy and Safety of Terbinafine Compared to Griseofulvin in Children With Tinea Capitis|Completed||Phase 3|720||Novartis|||||||||||||||||||2017-02-18 17:36:58.277251|2017-02-18 17:36:58.277251
NCT00117741|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-01-31|||June 2004||2004-06-01|January 2012|2012-01-01|April 2010|Actual|2010-04-01|October 2008|Actual|2008-10-01||Interventional|||Evaluation of DBT Compared to Drug Counseling for Opiate Addicts|Evaluation of Dialectical Behavior Therapy (DBT)|Completed||N/A|86|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:36:58.353517|2017-02-18 17:36:58.353517
NCT00117728|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2007-06-28|||April 2005||2005-04-01|January 2006|2006-01-01|September 2010|Anticipated|2010-09-01|||||Interventional|||Pediatric Nevirapine Resistance Study|Clinical Relevance of Nevirapine Resistance|Unknown status|Recruiting|Phase 3|250|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:36:58.465598|2017-02-18 17:36:58.465598
NCT00117715|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-06|2013-04-29|||October 2000||2000-10-01|April 2013|2013-04-01||||January 2010|Actual|2010-01-01||Observational|||Developmental Regulation of Proteins Responsible for Transforming Drugs in the Body|Developmental Regulation of CYPs 1A2, 2D6, 3A4|Completed||N/A|121|Actual|Children's Mercy Hospital Kansas City|||1||f||||f||||||Samples With DNA|"~     Urine DNA (source: blood or saliva)~   "|||2017-02-18 17:36:58.568153|2017-02-18 17:36:58.568153
NCT00117702|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-06-17|||October 2005||2005-10-01|June 2009|2009-06-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus|Prophylaxis of the Graft-Versus-Host-Disease in Patients After Allogeneic Stem Cell Transplantation With a Combination of Tacrolimus and Everolimus|Terminated||Phase 2/Phase 3|24|Actual|Technische Universität Dresden||1||safety reasons|f||||t||||||||||2017-02-18 17:36:58.663913|2017-02-18 17:36:58.663913
NCT00117689|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-03-17|||April 2005||2005-04-01|March 2015|2015-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection|A Randomized, Controlled, Multi-Center Study of Thymoglobulin Induction Therapy With a Calcineurin Inhibitor Sparing Regimen in Liver Transplant Patients|Completed||Phase 2|75|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:36:58.778379|2017-02-18 17:36:58.778379
NCT00117676|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-02-04|2010-02-11||February 2005||2005-02-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|April 2007|Actual|2007-04-01||Interventional||Randomized and Treated Analysis Set: all participants who were randomized and received at least one dose of study medication|A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B|A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF Versus Adefovir Dipivoxil for the Treatment of Presumed Pre-Core Mutant Chronic Hepatitis B|Completed||Phase 3|375|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 17:36:58.92487|2017-02-18 17:36:58.92487
NCT00117663|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-09-10|||November 2004||2004-11-01|September 2009|2009-09-01|November 2006|Anticipated|2006-11-01|||||Interventional|||Radiologic Evaluation and Breast Density (READ)|A Population-Based Randomized Trial to Assess the Effects of Short-Term Cessation of Hormone Replacement Therapy (HRT) on Mammography Assessments and Breast Density|Unknown status|Recruiting|N/A|1500|Anticipated|Group Health Cooperative|||||f||||||||||||||2017-02-18 17:37:01.683062|2017-02-18 17:37:01.683062
NCT00117650|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-03-17||2010-10-02|February 2005||2005-02-01|March 2015|2015-03-01|March 2010|Actual|2010-03-01|September 2008|Actual|2008-09-01||Interventional|WALK||Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication|A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-Selection Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 in Patients With Intermittent Claudication|Completed||Phase 2|289|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 17:37:01.784142|2017-02-18 17:37:01.784142
NCT00005362|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1992||1992-09-01|May 2000|2000-05-01|August 1995|Actual|1995-08-01|||||Observational|||Dose Estimation for Studies of Acute Respiratory Effects||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.748879|2017-02-18 18:15:05.748879
NCT00117637|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-10-24|2010-08-27||June 2005||2005-06-01|October 2014|2014-10-01|March 2009|Actual|2009-03-01|September 2006|Actual|2006-09-01||Interventional|||BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma|A Randomised, Open-label, Multi-centre Phase II Study of BAY43-9006 (Sorafenib) Versus Standard Treatment With Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma.|Completed||Phase 2|189|Actual|Bayer||2|||f||||t||||||||||2017-02-18 17:37:01.974022|2017-02-18 17:37:01.974022
NCT00117624|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-20|||December 2002||2002-12-01|December 2007|2007-12-01|December 2003||2003-12-01|||||Interventional|||A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy|A Randomized, Double-Blind, Study of Front-Loading Darbepoetin Alfa Compared With Standard Weekly Administration for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy and Receiving Multicycle Chemotherapy|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-02-18 17:37:04.077518|2017-02-18 17:37:04.077518
NCT00117611|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-09-27|||July 2005||2005-07-01|September 2013|2013-09-01|January 2009|Actual|2009-01-01|May 2007|Actual|2007-05-01||Interventional|||Xolair in Patients With Chronic Sinusitis|Effects of Anti-IgE Antibody Omalizumab (Xolair) on Patients With Chronic Sinusitis and a Positive Allergen Test|Completed||Phase 4|14|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 17:37:04.175295|2017-02-18 17:37:04.175295
NCT00117598|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-03-10|2012-02-02||May 2005||2005-05-01|March 2015|2015-03-01|January 2011|Actual|2011-01-01|August 2007|Actual|2007-08-01||Interventional|OPTIMAL||Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)|An Open-Label, Randomized, Phase 3 Trial Of Intravenous Temsirolimus (CCI-779) At Two Dose Levels Compared To Investigator's Choice Therapy In Relapsed, Refractory Subjects With Mantle Cell Lymphoma (MCL)|Completed||Phase 3|169|Actual|Pfizer|After the primary analysis was completed, efficacy data was no longer collected nor analyzed; Participants were followed for safety up to 6 months after the last dose of temsirolimus.|3|||f||||t||||||||||2017-02-18 17:37:04.329886|2017-02-18 17:37:04.329886
NCT00117585|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-03-18|2013-11-05||November 2005||2005-11-01|March 2016|2016-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Orthostatic Hypotension in Rehabilitation Patients|Orthostatic Hypotension in Rehabilitation Patients|Completed||N/A|341|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:37:06.171845|2017-02-18 17:37:06.171845
NCT00117572|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-10-09|||November 2004||2004-11-01|October 2012|2012-10-01|August 2013|Anticipated|2013-08-01|May 2009|Actual|2009-05-01||Interventional|||Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)|A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients With N2/N3 Locally Advanced Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|University of Chicago||2|||f||||t||||||||||2017-02-18 17:37:06.415694|2017-02-18 17:37:06.415694
NCT00117559|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-12-09|2014-11-17||July 2005||2005-07-01|December 2014|2014-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Improving Quality of Life for Veterans Undergoing Interferon Treatment|Improving Quality of Life for Veterans Undergoing Interferon Treatment|Completed||N/A|19|Actual|VA Office of Research and Development|Small sample size, all male, no in-person comparison group, reporting bias in self-report measures.|2|||f||||f||||||||||2017-02-18 17:37:06.569132|2017-02-18 17:37:06.569132
NCT00117546|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-06-07|||September 2005||2005-09-01|July 2007|2007-07-01|December 2008|Anticipated|2008-12-01|||||Interventional|||Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia|Cardiovascular Performance and Autonomic Reactivity in Formerly Preeclamptic Women With a Contracted Plasma Volume (CAPACITY Trial)|Unknown status|Recruiting|Phase 4|35|Anticipated|Radboud University|||||f||||t||||||||||2017-02-18 17:37:06.919953|2017-02-18 17:37:06.919953
NCT00117533|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2006-05-24|||September 2005||2005-09-01|September 2005|2005-09-01|June 2007||2007-06-01|||||Interventional|||Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta|A Pilot Study to Evaluate the Efficacy and Safety of Pegylated Interferon Alfa-2b Plus Ribavirin in the Treatment of Patients With Dual Chronic Hepatitis B and Delta|Unknown status|Recruiting|Phase 4|20||National Taiwan University Hospital|||||f||||||||||||||2017-02-18 17:37:07.025535|2017-02-18 17:37:07.025535
NCT00117520|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2006-07-03|||July 2002||2002-07-01|July 2002|2002-07-01|March 2006||2006-03-01|||||Interventional|||The Effect of Caffeine in Elderly Citizens|The Effect of Caffeine as Endurance Enhancing Drug in the Elderly|Completed||Phase 4|30||Herning Hospital|||||f||||||||||||||2017-02-18 17:37:07.128981|2017-02-18 17:37:07.128981
NCT00117507|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-11-16|||April 2005||2005-04-01|November 2016|2016-11-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients|An Open Label, Safety and Tolerability Study of Deferasirox for Treatment of Transfusional Iron Overload in Low-Risk and INT-1 Myelodysplastic Patients|Completed||Phase 2|24|Actual|Novartis||1|||f||||f||||||||||2017-02-18 17:37:07.234593|2017-02-18 17:37:07.234593
NCT00117494|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-12-21|||October 2005||2005-10-01|December 2011|2011-12-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)|Randomised Comparative Study of the Efficacy and Safety of Rosuvastatin and Pravastatin in Dyslipidemic Patients Treated With Antiretroviral Agents. Anrs 126|Completed||Phase 4|86||French National Agency for Research on AIDS and Viral Hepatitis|||||f||||||||||||||2017-02-18 17:37:07.363282|2017-02-18 17:37:07.363282
NCT00117481|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-05-08|||June 2005||2005-06-01|May 2014|2014-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain|A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate DR-2001 for the Management of Moderate to Severe Endometriosis-Related Nonmenstrual Pelvic Pain|Completed||Phase 2|90|Anticipated|Teva Pharmaceutical Industries||3|||f||||||||||||||2017-02-18 17:37:07.467188|2017-02-18 17:37:07.467188
NCT00117468|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-05-09|||June 2005||2005-06-01|May 2014|2014-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement|A Phase 2, Single-Center, Open-Label, Randomized, Controlled, Pharmacodynamic Study to Compare DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement|Completed||Phase 2|20|Anticipated|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 17:37:07.612554|2017-02-18 17:37:07.612554
NCT00117052|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-05-21|||September 2004||2004-09-01|May 2013|2013-05-01|February 2006|Actual|2006-02-01|November 2005|Actual|2005-11-01||Interventional|||SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism|SENSOR: Study to InvestigatE Cinacalcet TreatmeNt in Haemodialysis Patients With SecOndary HyperparathyRoidism|Completed||Phase 3|673|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:37:19.370027|2017-02-18 17:37:19.370027
NCT00117455|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-05-15||||||May 2008|2008-05-01||||||||Interventional|||A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma|A Randomised, Multi-Centre, Double-Blind Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim for Autologous Transplantation in Subjects With Non-Hodgkin's Lymphoma|Completed||Phase 2|||Amgen|||||f||||||||||||||2017-02-18 17:37:07.724871|2017-02-18 17:37:07.724871
NCT00117442|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-05-09|||August 2002||2002-08-01|May 2013|2013-05-01|December 2004|Actual|2004-12-01|August 2004|Actual|2004-08-01||Interventional|||A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood|An Open-Label, Randomised Study of Multi-Cycle, Dose Intensive Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood|Completed||Phase 2|61|Actual|Amgen||4|||f||||||||||||||2017-02-18 17:37:07.816761|2017-02-18 17:37:07.816761
NCT00117429|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-02-12|||June 2005||2005-06-01|February 2010|2010-02-01|January 2010|Actual|2010-01-01|September 2007|Actual|2007-09-01||Interventional|||Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)|A Phase I, Randomized, Double-Blind Clinical Trial of the HIV gp120/NefTat/AS02A Vaccine Candidate in Subjects With Well-Controlled Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1|20|Anticipated|Marcus Altfeld, M.D., Ph.D.|||||f||||||||||||||2017-02-18 17:37:07.927481|2017-02-18 17:37:07.927481
NCT00117416|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-19|||February 2003||2003-02-01|December 2007|2007-12-01||||||||Interventional|||Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function|MAP and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function|Suspended||N/A|60||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:37:08.032854|2017-02-18 17:37:08.032854
NCT00117403|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-04-01|||January 2006||2006-01-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Anti-Oxidant Treatment of Alzheimer's Disease|Evaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease|Completed||Phase 1|75|Anticipated|National Institute on Aging (NIA)||3|||f||||t||||||||||2017-02-18 17:37:08.126353|2017-02-18 17:37:08.126353
NCT00117390|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-19|||June 2004||2004-06-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill Patients|Evaluation of the Optimal Technique for Determination of the Renal Function of Critically Ill Patients|Completed||N/A|50||University Hospital, Ghent|||||f||||f||||||||||2017-02-18 17:37:08.262378|2017-02-18 17:37:08.262378
NCT00117377|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-13|||April 2004||2004-04-01|December 2007|2007-12-01|June 2005|Actual|2005-06-01|||||Interventional|||Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis|Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis|Completed||Phase 4|70||Novartis||2|||||||||||||||||2017-02-18 17:37:08.348048|2017-02-18 17:37:08.348048
NCT00117364|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2005-07-05|||January 2005||2005-01-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Effect of SACCHACHITIN on Healing of a Chronic Wound|Effect of SACCHACHITIN on Healing of Chronic Wound ---A Clinical Trial|Unknown status|Recruiting|Phase 2|30||Min-Sheng General Hospital|||||f||||||||||||||2017-02-18 17:37:08.457206|2017-02-18 17:37:08.457206
NCT00117351|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-02-16|||April 2005||2005-04-01|February 2011|2011-02-01|July 2007|Actual|2007-07-01|June 2007|Actual|2007-06-01||Interventional|||VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features|A Multicenter, Open-Label, Phase 2 Study of VELCADE (Bortezomib) for Injection in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma and Adenocarcinoma With Bronchioloalveolar Features|Terminated||Phase 2|||Millennium Pharmaceuticals, Inc.||||insufficient efficacy|||||||||||||||2017-02-18 17:37:08.538565|2017-02-18 17:37:08.538565
NCT00117338|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-03-27|2009-03-16||July 2005||2005-07-01|March 2015|2015-03-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)|A Multicenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast With Placebo in Pediatric Patients (Ages 6 to 14 Years) With Acute Asthma|Completed||Phase 3|276|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:37:08.631512|2017-02-18 17:37:08.631512
NCT00117325|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-09-22|||July 2005||2005-07-01|September 2016|2016-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Study Of Adults And Adolescents With Vasomotor Rhinitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 4 Weeks in Adult and Adolescent Subjects (12 Years of Age and Older) With Vasomotor Rhinitis|Completed||Phase 3|350||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:37:09.263953|2017-02-18 17:37:09.263953
NCT00117312|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-05-18|2009-01-22||October 2002||2002-10-01|May 2011|2011-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients|An Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients|Terminated||Phase 2|37|Actual|Ferring Pharmaceuticals||4||After 190 weeks [7 patients left] it was terminated for administrative reasons|f||||t||||||||||2017-02-18 17:37:09.537985|2017-02-18 17:37:09.537985
NCT00117299|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-05-25|||September 2004||2004-09-01|May 2010|2010-05-01|January 2009|Actual|2009-01-01|September 2007|Actual|2007-09-01||Interventional|||PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib|A Phase II, Open-Label Study of PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors (GISTs) Resistant to Imatinib Mesylate|Completed||Phase 2|45|Actual|Helsinki University||1|||f||||f||||||||||2017-02-18 17:37:10.791262|2017-02-18 17:37:10.791262
NCT00117286|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-09-29|2010-09-29||March 2005||2005-03-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer|An Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Patients With Prostate Cancer|Completed||Phase 2/Phase 3|57|Actual|Ferring Pharmaceuticals||2|||f||||f||||||||||2017-02-18 17:37:10.905847|2017-02-18 17:37:10.905847
NCT00117273|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-05-08|||June 2005||2005-06-01|May 2014|2014-05-01|June 2006||2006-06-01|||||Interventional|||A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens|A Prospective, Single-Center, Open-Label, Randomized Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Regimens of Oral Contraceptive Pills|Completed||Phase 3|36|Anticipated|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-02-18 17:37:14.578131|2017-02-18 17:37:14.578131
NCT00117260|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-08-08|||July 2005||2005-07-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a 91-Day Extended-Cycle Combination Oral Contraceptive (Seasonale) for the Treatment of Low Bone Mineral Density in Adolescent Females With Secondary Amenorrhea and Osteopenia|Withdrawn||Phase 3|0|Actual|Teva Pharmaceutical Industries||||Sponsor decision|||||||||||||||2017-02-18 17:37:14.680614|2017-02-18 17:37:14.680614
NCT00117247|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-10-15|||June 2002||2002-06-01|October 2009|2009-10-01|July 2004||2004-07-01|||||Interventional|||A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects|A Study to Assess the Pharmacokinetics and Pharmacodynamics of Repeat-Sose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects|Completed||Phase 1/Phase 2|||Amgen|||||f||||||||||||||2017-02-18 17:37:14.764625|2017-02-18 17:37:14.764625
NCT00117234|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-12-02|||September 2002||2002-09-01|December 2010|2010-12-01|July 2004||2004-07-01|||||Interventional|||Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia|A Study to Assess the Impact of Subcutaneous (SC) Darbepoetin Alfa Treatment on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia|Completed||N/A|||Amgen||1|||f||||||||||||||2017-02-18 17:37:14.850998|2017-02-18 17:37:14.850998
NCT00117221|ClinicalTrials.gov processed this data on February 17, 2017|2005-07-02|2017-01-24|||June 28, 2005||2005-06-28|February 11, 2014|2014-02-11|February 11, 2014||2014-02-11|||||Observational|||MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle|MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle|Completed||N/A|56|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:37:14.935569|2017-02-18 17:37:14.935569
NCT00117208|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-01-31|||November 2005||2005-11-01|January 2010|2010-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis|A Cross-Over Comparative Study of Inhaled Mannitol, Alone and in Combination With Daily rhDNase, in Children With Cystic Fibrosis|Completed||Phase 2|20|Actual|Pharmaxis||3|||f||||||||||||||2017-02-18 17:37:15.014437|2017-02-18 17:37:15.014437
NCT00117195|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-02-08|||May 2003||2003-05-01|February 2012|2012-02-01|January 2012|Actual|2012-01-01|January 2011|Actual|2011-01-01||Observational|||A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease|Open-Label Validation Study of Neurophysiologic Changes in Individuals With Parkinson's Disease, at Risk for Parkinson's Disease and Healthy Controls|Completed||N/A|620|Actual|Institute for Neurodegenerative Disorders|||1||f||||t||||||Samples Without DNA|"~     In addition, the study will evaluate serum samples for changes in proteins or metabolites~     that may be indicators of early changes associated with Parkinson's disease or parkinsonian~     syndrome.~   "|||2017-02-18 17:37:15.133656|2017-02-18 17:37:15.133656
NCT00117182|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-04-18|||July 2005||2005-07-01|April 2016|2016-04-01|August 2006||2006-08-01|||||Interventional|||Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD|A Phase II Study to Investigate Mannitol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD|Completed||Phase 2|140||Pharmaxis|||||f||||||||||||||2017-02-18 17:37:15.240199|2017-02-18 17:37:15.240199
NCT00117169|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-10-12|||January 2005||2005-01-01|October 2012|2012-10-01|October 2006||2006-10-01|||||Interventional|||Multi-Detector Spiral Computed Tomography Alone Versus Combined Strategy With Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary Embolism|Multi-Detector Spiral Computed Tomography Alone Versus Combined Strategy With Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary Embolism: A Randomised Non-Inferiority Trial [CTEP4]|Completed||N/A|1500||University Hospital, Geneva|||||f||||||||||||||2017-02-18 17:37:15.346396|2017-02-18 17:37:15.346396
NCT00117156|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-07-28|2014-09-26||December 2003||2003-12-01|July 2016|2016-07-01|January 2012|Actual|2012-01-01|October 2008|Actual|2008-10-01||Interventional|||Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma|A Phase II Study of Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma|Completed||Phase 2|26|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:37:18.156966|2017-02-18 17:37:18.156966
NCT00117143|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-05-21||||||May 2009|2009-05-01||||||||Interventional|||Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)|An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Efficacy of Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)|Completed||Phase 1/Phase 2|||Amgen||1|||f||||||||||||||2017-02-18 17:37:18.514186|2017-02-18 17:37:18.514186
NCT00117130|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-01-20||||||January 2011|2011-01-01||||||||Interventional|||Study to Evaluate Effectiveness of Aranesp®|Aranesp® Monthly Preference Study|Completed||Phase 4|||Amgen||1|||f||||||||||||||2017-02-18 17:37:18.597391|2017-02-18 17:37:18.597391
NCT00117117|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-03-24|||September 2002||2002-09-01|March 2009|2009-03-01|December 2003||2003-12-01|||||Interventional|||A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®|A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®|Completed||Phase 4|2423||Amgen|||||f||||||||||||||2017-02-18 17:37:18.681725|2017-02-18 17:37:18.681725
NCT00117104|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-10-15||||||October 2009|2009-10-01||||||||Interventional|||Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis|A Multicenter Study Evaluating Once Weekly Intravenous Administration of Aranesp® in Subjects With End Stage Renal Disease on Chronic Hemodialysis|Completed||Phase 4|||Amgen|||||f||||||||||||||2017-02-18 17:37:18.774322|2017-02-18 17:37:18.774322
NCT00117091|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-12-20||||||December 2007|2007-12-01||||||||Interventional|||Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)|An Open-Label Multicentre Study of Anakinra (Kineret®) in Combination With DMARDS in Subjects With Active Rheumatoid Arthritis (RA)|Completed||Phase 3|||Amgen|||||f||||||||||||||2017-02-18 17:37:18.858806|2017-02-18 17:37:18.858806
NCT00117039|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-10-14|||January 2004||2004-01-01|August 2008|2008-08-01|April 2005||2005-04-01|||||Interventional|||A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia|SYNCHRONICITY: A Study to Evaluate the Effectiveness of Aranesp® at 300 Mcg Q3W on Clinical Outcomes in Cancer Patients With Anemia Due to Chemotherapy|Completed||Phase 4|1500||Amgen|||||f||||||||||||||2017-02-18 17:37:19.479771|2017-02-18 17:37:19.479771
NCT00117026|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-05-08|||August 2005||2005-08-01|May 2013|2013-05-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||Effects of Vitamin B1 in Type 1 Diabetic Patients|Can Oral Benfotiamine Supplementation Influence Progression of Microvascular Complications in Patients With Type 1 Diabetes?|Completed||Phase 1/Phase 2|67|Actual|Oslo University Hospital||2|||f||||||||||||||2017-02-18 17:37:19.57871|2017-02-18 17:37:19.57871
NCT00117013|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2017-01-24|||June 28, 2005||2005-06-28|August 25, 2011|2011-08-25|October 25, 2010|Actual|2010-10-25|October 25, 2010|Actual|2010-10-25||Interventional|||A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a|A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1 Alpha|Completed||Phase 1|16|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:37:19.701518|2017-02-18 17:37:19.701518
NCT00117000|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2006-09-07|||July 2003||2003-07-01|September 2006|2006-09-01|February 2007||2007-02-01|||||Interventional|||The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly|The Effects of Testosterone and Nutritional Supplementation, Alone and Combined, on the Adverse Effects of Under-Nutrition in the Elderly|Unknown status|Active, not recruiting|Phase 3|200||University of Adelaide|||||f||||||||||||||2017-02-18 17:37:19.797187|2017-02-18 17:37:19.797187
NCT00116987|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2015-06-11|||August 2003||2003-08-01|June 2015|2015-06-01|November 2009|Actual|2009-11-01|September 2008|Actual|2008-09-01||Interventional|||Dual Chamber Versus Single Chamber Cardiac Pacing in People 80 Years of Age and Older|Pacing the Octogenarian Plus Population (POPP) A Comparison of Physiologic Versus Ventricular Pacing in Those Who Are 80 Years of Age and Older|Terminated||N/A|800|Anticipated|University of Calgary||2||Unable to recruit adequate number of participants in required time frame.|f||||f||||||||||2017-02-18 17:37:19.914871|2017-02-18 17:37:19.914871
NCT00116974|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-08-12|||October 2004||2004-10-01|August 2016|2016-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Periodontal Infection and Prematurity Study|Periodontal Infection and Prematurity Study|Terminated||Phase 3|2100|Anticipated|University of Pennsylvania||2||Protocol Expired. Terminated by IRB|f||||||||||||||2017-02-18 17:37:20.019703|2017-02-18 17:37:20.019703
NCT00116961|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-02-05|||June 2005||2005-06-01|February 2012|2012-02-01|December 2007|Actual|2007-12-01|January 2007|Actual|2007-01-01||Interventional|||Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma|A Phase II Study of Combination of Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma|Completed||Phase 2|40|Actual|University of Michigan Cancer Center||1|||f||||||||||||||2017-02-18 17:37:20.114775|2017-02-18 17:37:20.114775
NCT00116948|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2014-12-03|||January 2005||2005-01-01|December 2014|2014-12-01|January 2012|Actual|2012-01-01|September 2011|Actual|2011-09-01||Interventional|||A Comparison of Two Total Hip Replacements: Hip Resurfacing System Versus Mallory-Head/Exeter|A Comparison of Two Total Hip Replacements: Hip Resurfacing System Versus Mallory-Head/Exeter|Completed||Phase 4|50|Anticipated|University of Aarhus||1|||f||||f||||||||||2017-02-18 17:37:20.202104|2017-02-18 17:37:20.202104
NCT00116935|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-12-28|||February 2004||2004-02-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)|Short (12 Months) Versus Long (36 Months) Duration of Adjuvant Treatment With the Tyrosine Kinase Inhibitor Imatinib Mesylate of Operable GIST With a High Risk of Recurrence|Completed||Phase 3|400|Actual|Scandinavian Sarcoma Group||2|||f||||f||||||||||2017-02-18 17:37:20.304149|2017-02-18 17:37:20.304149
NCT00116922|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-05-22|||June 2004||2004-06-01|May 2012|2012-05-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||A Lifestyle and Combination Medication Therapy Diabetes Prevention Study|CAnadian Normoglycemia Outcomes Evaluation Study|Completed||Phase 3|207|Actual|Samuel Lunenfeld Research Institute, Mount Sinai Hospital||1|||f||||t||||||||||2017-02-18 17:37:20.418311|2017-02-18 17:37:20.418311
NCT00116909|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-03-13|||August 2004||2004-08-01|March 2007|2007-03-01|August 2005||2005-08-01|||||Interventional|||A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy|A Phase II Study of Single-Agent OSI-7904L in Patients With Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Have Failed First-Line Therapy|Completed||Phase 2|85||OSI Pharmaceuticals|||||||||||||||||||2017-02-18 17:37:20.529365|2017-02-18 17:37:20.529365
NCT00116896|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-01-16|||June 2003||2003-06-01|November 2003|2003-11-01|December 2004||2004-12-01|||||Interventional|||Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors|Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|25||OSI Pharmaceuticals|||||||||||||||||||2017-02-18 17:37:20.597935|2017-02-18 17:37:20.597935
NCT00116883|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-09-13|||February 2005||2005-02-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics|A Randomized, Double-blind, Parallel Group, Placebo Controlled, 6-week Study of the Effect of GW685698X Aqueous Nasal Spray 100mcg QD on the Hypothalamic Pituitary Adrenocortical (HPA) Axis in Children 2 to 11 Years of Age With Perennial Allergic Rhinitis (PAR).|Completed||Phase 3|90|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:37:20.669404|2017-02-18 17:37:20.669404
NCT00116870|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2009-12-09|||June 1985||1985-06-01|June 2005|2005-06-01|February 1992|Actual|1992-02-01|February 1992|Actual|1992-02-01||Interventional|||MARS - Monitored Atherosclerosis Regression Study|A Double-Blind, Placebo-Controlled Angiographic Study to Evaluate the Effect of Lovastatin on the Progression Rate of Atherosclerosis in the Coronary Arteries of Patients With Coronary Heart Disease|Completed||Phase 2/Phase 3|270||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:37:20.774557|2017-02-18 17:37:20.774557
NCT00116857|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2012-09-11|2012-07-03||February 2005||2005-02-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors|Omega-3 for Depression and Other Cardiac Risk Factors|Completed||Phase 3|122|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 17:37:20.866266|2017-02-18 17:37:20.866266
NCT00116844|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-12-21|||March 2005||2005-03-01|December 2016|2016-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Two-Way Crossover Study to Investigate the Effect of VALTREX 1g Once Daily for 60 Days on Viral Shedding in HSV-2 Seropositive Subjects With No Previous History of Symptomatic Genital Herpes Infection.|Completed||Phase 4|73|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:37:21.479941|2017-02-18 17:37:21.479941
NCT00116831|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-11-04|2009-08-07||January 2005||2005-01-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes|A Phase III, 18 Month, Multicenter, Randomized, Double-Blind, Active-Controlled Clinical Trial to Compare Rosiglitazone Versus Glipizide on the Progression of Atherosclerosis in Subjects With Type 2 Diabetes Mellitus and Cardiovascular Disease (APPROACH)|Completed||Phase 3|672|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:37:21.633326|2017-02-18 17:37:21.633326
NCT00116818|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-09-13|||January 2005||2005-01-01|September 2016|2016-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults|A Randomized, Double-blind, Parallel Group, Placebo and Active (Prednisone) Controlled, 6-week Study of the Effect of Fluticasone Furoate Aqueous Nasal Spray 100mcg QD on the Hypothalamic Pituitary Adrenocortical (HPA) Axis in Adolescents and Adults 12 to 65 Years of Age With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|90|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:37:23.805329|2017-02-18 17:37:23.805329
NCT00116805|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-02-22|2010-02-11||June 2005||2005-06-01|February 2016|2016-02-01|January 2016|Actual|2016-01-01|May 2007|Actual|2007-05-01||Interventional||Randomized and Treated Analysis Set: all participants who were randomized and received at least one dose of study medication.|A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B|A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF Versus Adefovir Dipivoxil for the Treatment of HBeAg Positive Chronic Hepatitis B|Completed||Phase 3|266|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 17:37:23.94778|2017-02-18 17:37:23.94778
NCT00116792|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-05-15|||March 2004||2004-03-01|May 2007|2007-05-01||||||||Interventional|||PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions|PROVIDENCE: Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With de Novo Coronary Lesions|Unknown status|Active, not recruiting|Phase 2/Phase 3|120|Anticipated|Gold, Herman K., MD|||||||||||||||||||2017-02-18 17:37:26.341606|2017-02-18 17:37:26.341606
NCT00116779|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-12-15|2009-01-22||February 2004||2004-02-01|December 2011|2011-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer|An Open-label, Randomized, Multi-center, Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer Dosed for Thirteen 28-day Cycles|Completed||Phase 2|127|Actual|Ferring Pharmaceuticals||2|||f||||t||||||||||2017-02-18 17:37:26.448926|2017-02-18 17:37:26.448926
NCT00116766|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2016-09-01|||July 2005||2005-07-01|February 2007|2007-02-01|September 2006|Actual|2006-09-01|||||Interventional|||Field Evaluation of Plant-based Mosquito Control|Field Evaluation of Malaria Vector Control Using Traditional Plant-based Anti-mosquito Measures in Yunnan Province, P.R. China|Completed||Phase 2|240|Actual|London School of Hygiene and Tropical Medicine||2|||f||||f||||||||||2017-02-18 17:37:27.657927|2017-02-18 17:37:27.657927
NCT00116753|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-11-12|2010-10-06||January 2005||2005-01-01|November 2010|2010-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer|An Open-label Multi-center, Randomized Parallel Group Comparison of Efficacy and Safety of Degarelix Three-Month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer|Completed||Phase 2|460|Actual|Ferring Pharmaceuticals||3|||f||||t||||||||||2017-02-18 17:37:27.753389|2017-02-18 17:37:27.753389
NCT00116740|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-03-24|||June 2005||2005-06-01|December 2006|2006-12-01|November 2005||2005-11-01|||||Interventional|||Safety and Efficacy of APD356 in the Treatment of Obesity|A 12-Week, Dose-Ranging, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of APD356 in Obese Patients|Completed||Phase 2|400||Arena Pharmaceuticals|||||||||||||||||||2017-02-18 17:37:29.617827|2017-02-18 17:37:29.617827
NCT00116727|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-05-05|||October 2002||2002-10-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|June 2008|Actual|2008-06-01||Observational|||Rheumatoid Arthritis DMARD Intervention and UtilizationStudy|Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study (RADIUS 2)|Completed||N/A|5103|Actual|Amgen|||1||f||||||||||||||2017-02-18 17:37:29.725195|2017-02-18 17:37:29.725195
NCT00116714|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2011-05-05|||October 2001||2001-10-01|May 2011|2011-05-01|October 2008|Actual|2008-10-01|December 2007|Actual|2007-12-01||Observational|||Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy|Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study (RADIUS 1)|Completed||N/A|4968|Actual|Amgen|||1||f||||||||||||||2017-02-18 17:37:29.813075|2017-02-18 17:37:29.813075
NCT00116701|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2008-05-01|||May 2005||2005-05-01|May 2008|2008-05-01||||||||Interventional|||Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis|A Study to Evaluate the Efficacy of Converting From Intravenous or Subcutaneous rHuEPO to Intravenous Darbepoetin Alfa (Aranesp®) in Subjects With Chronic Kidney Disease Receiving Haemodialysis|Completed||Phase 3|200||Amgen|||||f||||||||||||||2017-02-18 17:37:29.904278|2017-02-18 17:37:29.904278
NCT00116688|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2013-11-25|2011-03-04||August 2004||2004-08-01|November 2013|2013-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|An Open Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|Completed||Phase 3|313|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:37:30.003386|2017-02-18 17:37:30.003386
NCT00116675|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-02-16|||March 2005||2005-03-01|June 2006|2006-06-01|April 2006||2006-04-01|||||Interventional|||Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects|A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Pediatric Subjects|Completed||Phase 2|84||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-02-18 17:37:31.129469|2017-02-18 17:37:31.129469
NCT00116662|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2007-02-16|||March 2005||2005-03-01|November 2006|2006-11-01||||||||Interventional|||An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects|A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for up to 12 Weeks for the Treatment of Common Warts in Pediatric Subjects|Completed||Phase 2|84||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-02-18 17:37:31.213815|2017-02-18 17:37:31.213815
NCT00116649|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-30|2010-07-14|2008-10-21||June 2005||2005-06-01|July 2010|2010-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis|Open-Label Safety and Pharmacokinetic Study of AldaraTM (Imiquimod) Cream, 5% for One, Two, or Three Treatment Cycles to Surface Areas Greater Than 25 cm2 With Actinic Keratosis|Completed||Phase 4|551|Actual|Graceway Pharmaceuticals, LLC||1|||f||||f||||||||||2017-02-18 17:37:31.312381|2017-02-18 17:37:31.312381
NCT00116636|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2005-07-18|||June 2005||2005-06-01|June 2005|2005-06-01||||||||Interventional|||Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients|A Phase II, Open Label, Single Arm Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) as a Single Agent in a Cohort of HIV Positive Adult Patients|Unknown status|Recruiting|Phase 2|40||Therapeutic Concepts|||||f||||||||||||||2017-02-18 17:37:31.981872|2017-02-18 17:37:31.981872
NCT00116623|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2016-08-12|||February 2003||2003-02-01|August 2016|2016-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Magnesium Sulfate Versus Indomethacin for Preterm Labor||Terminated||Phase 4|||University of Pennsylvania||||Funding completed|f||||||||||||||2017-02-18 17:37:32.090413|2017-02-18 17:37:32.090413
NCT00116610|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2009-01-19|||June 2005||2005-06-01|February 2007|2007-02-01|March 2008|Actual|2008-03-01|March 2007|Actual|2007-03-01||Interventional|||Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer|A Phase II Study of Picoplatin as Second-Line Therapy for Subjects With Resistant or Refractory Small Cell Lung Cancer|Completed||Phase 2|75||Poniard Pharmaceuticals|||||f||||||||||||||2017-02-18 17:37:32.172799|2017-02-18 17:37:32.172799
NCT00116597|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2009-12-01|||November 2002||2002-11-01|December 2009|2009-12-01|December 2008|Actual|2008-12-01|July 2007|Actual|2007-07-01||Interventional|||Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma|Active Specific Intranodal Immunotherapy With a Recombinant Vaccinia Virus Expressing Three Melanoma Associated Epitopes and Two Costimulatory Molecules, Followed by Immunization With Synthetic Melanoma Associated Epitopes. A Phase I/II Trial in Patients With Stages IIb to IV Melanoma|Completed||Phase 1/Phase 2|15|Actual|University Hospital, Basel, Switzerland||1|||f||||t||||||||||2017-02-18 17:37:32.363432|2017-02-18 17:37:32.363432
NCT00116584|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2013-06-17|||December 2004||2004-12-01|June 2013|2013-06-01|October 2011|Actual|2011-10-01|March 2008|Actual|2008-03-01||Interventional|||Heliox-Driven Racemic Epinephrine Nebulization in Treatment of Moderate to Severe Bronchiolitis in Pediatric ED Patients|The Use of Heliox Driven Racemic Epinephrine Nebulization in the Treatment of Moderate to Severe Bronchiolitis in Pediatric Emergency Department Patients|Completed||Phase 3|72|Actual|University of Louisville||1|||f||||f||||||||||2017-02-18 17:37:32.481206|2017-02-18 17:37:32.481206
NCT00116571|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2006-10-02|||May 2005||2005-05-01|May 2006|2006-05-01|December 2006||2006-12-01|||||Interventional|||Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)|A Phase II Randomized, Sham-Controlled, Double-Blind, Dose-Finding Study to Assess the Efficacy and Safety of Transurethral Photodynamic Therapy With Lemuteporfin in Subjects With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia|Terminated||Phase 2|180||QLT Inc.|||||||||||||||||||2017-02-18 17:37:32.583885|2017-02-18 17:37:32.583885
NCT00116558|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2008-01-08|||August 2004||2004-08-01|January 2008|2008-01-01|October 2008|Anticipated|2008-10-01|July 2008|Anticipated|2008-07-01||Interventional|||Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation (NIPPV)|Early Treatment of Amyotrophic Lateral Sclerosis With Nutrition and Non-Invasive Positive Pressure Ventilation|Unknown status|Active, not recruiting|N/A|220|Anticipated|National Institute of Neurological Disorders and Stroke (NINDS)||2|||f||||t||||||||||2017-02-18 17:37:32.689188|2017-02-18 17:37:32.689188
NCT00116545|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2009-12-09|||January 1997||1997-01-01|June 2005|2005-06-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||TART - Troglitazone Atherosclerosis Regression Trial|TART - Troglitazone Atherosclerosis Regression Trial|Completed||Phase 2/Phase 3|288||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:37:32.804752|2017-02-18 17:37:32.804752
NCT00116532|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2007-04-23|||October 2002||2002-10-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)|Escitalopram for the Treatment of Obsessive Compulsive Disorder|Completed||Phase 4|30||Massachusetts General Hospital|||||f||||f||||||||||2017-02-18 17:37:32.900555|2017-02-18 17:37:32.900555
NCT00116519|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2007-01-24|||July 2005||2005-07-01|January 2007|2007-01-01|October 2006||2006-10-01|||||Interventional|||A Study in People With Abnormal Fat Levels in the Blood|PPAR Alpha: A Phase 2 Dose-Finding and Safety Study for Atherogenic Dyslipidemia by Eli Lilly|Completed||Phase 2|300||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:37:33.007039|2017-02-18 17:37:33.007039
NCT00116506|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2007-12-19|||January 2005||2005-01-01|December 2007|2007-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer|A Phase II Study of Bevacizumab (Avastin™) and Erlotinib (Tarceva™) in Combination With FOLFOX for Patients With Untreated Metastatic Colorectal Cancer|Completed||Phase 2|35||Dana-Farber Cancer Institute|||||f||||||||||||||2017-02-18 17:37:33.153729|2017-02-18 17:37:33.153729
NCT00116493|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2012-04-06|||April 2004||2004-04-01|April 2012|2012-04-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Severe Anemia Treatment Trials, Pakistan|Evaluation of Anthelminthics and Multivitamins for Treatment of Severe Anemia in Pregnant Women and Children 6-24 Months of Age in Pakistan|Completed||Phase 3|1009|Actual|Johns Hopkins Bloomberg School of Public Health||4|||f||||t||||||||||2017-02-18 17:37:33.259935|2017-02-18 17:37:33.259935
NCT00005361|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1993||1993-04-01|June 2000|2000-06-01|March 1998|Actual|1998-03-01|||||Observational|||Determinants of Respiratory Health in Young Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.837424|2017-02-18 18:15:05.837424
NCT00116480|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2009-03-17|||December 2005||2005-12-01|March 2009|2009-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Misoprostol in the Treatment of Postpartum Hemorrhage|Misoprostol in the Treatment of Post Partum Hemorrhage: A Placebo Randomised Controlled Trial in 4 Karachi Hospitals|Completed||N/A|61|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-02-18 17:37:33.385251|2017-02-18 17:37:33.385251
NCT00116467|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2007-12-18|||March 2001||2001-03-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia|Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line|Completed||Phase 2|55||Cell Genesys|||||||||||||||||||2017-02-18 17:37:33.493989|2017-02-18 17:37:33.493989
NCT00116454|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2013-09-20|||July 2005||2005-07-01|September 2013|2013-09-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Interventional|Lipiocis||Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis|A Randomized and Multicenter Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis|Completed||Phase 3|73|Actual|French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)||2|||f||||t||||||||||2017-02-18 17:37:33.580985|2017-02-18 17:37:33.580985
NCT00116441|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2007-12-18|||October 2000||2000-10-01|December 2007|2007-12-01|October 2004||2004-10-01|||||Interventional|||Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma|Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line|Completed||Phase 1/Phase 2|22||Cell Genesys|||||||||||||||||||2017-02-18 17:37:33.704939|2017-02-18 17:37:33.704939
NCT00116428|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2013-12-03|2013-02-11||October 2004||2004-10-01|December 2013|2013-12-01|March 2011|Actual|2011-03-01|October 2007|Actual|2007-10-01||Interventional|Afib IDE||NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation|NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation|Completed||Phase 3|167|Actual|Biosense Webster, Inc.||2|||f||||t||||||||||2017-02-18 17:37:33.80259|2017-02-18 17:37:33.80259
NCT00116415|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-29|2011-04-08||2010-01-27|March 2002||2002-03-01|April 2011|2011-04-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy|Daily Antiretroviral Therapy (DART 1): An Open-Label, Single-Arm, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Didanosine Enteric Coated (Ddl-EC) in Combination With Lamivudine (3TC) and Efavirenz (EFV) Once Daily in Anti-Retroviral Therapy (ART) Naive HIV-Infected Patients|Completed||N/A|65||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 17:37:34.486526|2017-02-18 17:37:34.486526
NCT00116402|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2014-08-04|||January 2005||2005-01-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations|A Pilot Study of the Mechanism of Synergism Between Fluticasone (FP) and Salmeterol in Preventing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations|Completed||Phase 1|15|Actual|University of Chicago||2|||f||||t||||||||||2017-02-18 17:37:34.593611|2017-02-18 17:37:34.593611
NCT00116389|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|||Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas|An Open-Label Phase 2 Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas|Terminated||Phase 2|60||Point Therapeutics||||FDA Hold May 2007|||||||||||||||2017-02-18 17:37:34.711941|2017-02-18 17:37:34.711941
NCT00116376|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2015-11-07|||January 2004||2004-01-01|November 2015|2015-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)|A Phase I/II, Two-arm, Multicenter, Dose Escalation Study of Oral AEE788 Administered on a Continuous Once Daily Dosing Schedule in Adult Patients With Recurrent or Relapsing Glioblastoma Multiforme|Completed||Phase 1/Phase 2|64|Actual|Novartis||2|||f||||f||||||||||2017-02-18 17:37:34.816479|2017-02-18 17:37:34.816479
NCT00116363|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2008-03-28|||March 2005||2005-03-01|March 2008|2008-03-01|December 2006|Anticipated|2006-12-01|||||Interventional|||Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma|Phase II Study Examining the Biological Efficacy of Intratumoral INGN 241 (Ad-mda7) Administration in Patients With In Transit Melanoma|Unknown status|Recruiting|Phase 2|25|Anticipated|Introgen Therapeutics|||||t||||t||||||||||2017-02-18 17:37:34.917155|2017-02-18 17:37:34.917155
NCT00116350|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2009-03-17|||July 2005||2005-07-01|March 2009|2009-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Misoprostol for the Treatment of Postpartum Hemorrhage|Misoprostol for the Treatment of Primary Postpartum Hemorrhage|Completed||N/A|1786|Actual|Gynuity Health Projects||2|||f||||t||||||||||2017-02-18 17:37:35.007967|2017-02-18 17:37:35.007967
NCT00116337|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2015-04-20|||September 2004||2004-09-01|April 2015|2015-04-01|June 2017|Anticipated|2017-06-01|January 2017|Anticipated|2017-01-01||Interventional|||Spinal Cord Stimulation to Restore Cough|Spinal Cord Stimulation to Restore Cough|Active, not recruiting||N/A|18|Anticipated|Case Western Reserve University||1|||f||||t||||||||||2017-02-18 17:37:35.199342|2017-02-18 17:37:35.199342
NCT00116324|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2007-04-02|||April 2003||2003-04-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|||||Interventional|||Predicting the Response to Montelukast by Genetic Variation in Asthmatics|Predicting the Bronchoprotective Response to a Leukotriene Modifier by Genetic Polymorphism|Completed||Phase 3|150||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:37:35.328922|2017-02-18 17:37:35.328922
NCT00116311|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2007-03-20|||July 2005||2005-07-01|March 2007|2007-03-01|February 2007||2007-02-01|||||Observational|||Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood|Effects of Allergen Inhalation on Adenosine Receptor Expression and Mast Cell Activation in Peripheral Blood and Sputum of Asthmatics and Healthy Subjects|Unknown status|Active, not recruiting|N/A|20||Groningen Research Institute for Asthma and COPD|||||f||||f||||||||||2017-02-18 17:37:35.425073|2017-02-18 17:37:35.425073
NCT00116298|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2011-04-08||2010-01-28|January 2001||2001-01-01|April 2011|2011-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)|A Study to Compare Long-Term Safety and Tolerability of Stavudine (d4T) Extended Release (ER) Versus Conventional (Immediate Release, IR) Formulations, Each In Combination With Lamivudine (3TC) and Efavirenz (EFV) in Subjects Who Have Completed BMS Studies AI455-096 and AI455-099|Completed||Phase 3|900||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:37:35.505096|2017-02-18 17:37:35.505096
NCT00116285|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2010-06-16|||June 2005||2005-06-01|September 2009|2009-09-01|June 2005||2005-06-01|||||Interventional|||Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing|A Single-Blind Phase I Study to Assess the Residual Allergenicity of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL Using Skin Prick Testing|Completed||Phase 1|12||Allergy Therapeutics|||||f||||||||||||||2017-02-18 17:37:35.645496|2017-02-18 17:37:35.645496
NCT00116272|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-28|2015-08-19|2015-05-29||April 2005||2005-04-01|August 2015|2015-08-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Observational|||Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project|OTIS Autoimmune Diseases in Pregnancy Project|Completed||N/A|830|Actual|Amgen|||3||f||||f||||||None Retained|"~     This is a prospective & observational, exposure cohort study~   "|||2017-02-18 17:37:35.759939|2017-02-18 17:37:35.759939
NCT00116259|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2008-08-06|||March 2005||2005-03-01|August 2008|2008-08-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)|Aripiprazole in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Double Blind Placebo Controlled Trial|Completed||N/A|50|Anticipated|Federal University of Rio Grande do Sul|||||f||||||||||||||2017-02-18 17:37:44.029698|2017-02-18 17:37:44.029698
NCT00116246|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2006-09-07|||August 2005||2005-08-01|August 2005|2005-08-01|December 2006||2006-12-01|||||Interventional|||McRoberts Manoeuvre Or Pushing Study (McMOPS)||Unknown status|Recruiting|Phase 1|222||University of Melbourne|||||f||||||||||||||2017-02-18 17:37:44.130029|2017-02-18 17:37:44.130029
NCT00116233|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2005-06-27||||||June 2005|2005-06-01||||||||Interventional|||Pediatric Multicenter Study of REPEL-CV|Peds. Multicenter Study|Unknown status|Recruiting|Phase 2|||SyntheMed|||||||||||||||||||2017-02-18 17:37:44.21958|2017-02-18 17:37:44.21958
NCT00116220|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2016-08-01|||September 1995||1995-09-01|August 2016|2016-08-01|April 2017|Anticipated|2017-04-01|April 2001|Actual|2001-04-01||Interventional|||Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer|A Phase III Trial of External Beam of Radiotherapy +/- Total Androgen Suppression for High Risk Clinically Organ-Confined Prostate Cancer|Active, not recruiting||Phase 3|226|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 17:37:44.561016|2017-02-18 17:37:44.561016
NCT00116207|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2016-06-30|2014-01-06||January 2000||2000-01-01|June 2016|2016-06-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|||An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes|Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial|Completed||Phase 3|44|Actual|University of Michigan||2|||f||||t||||||||No||2017-02-18 17:37:44.689245|2017-02-18 17:37:44.689245
NCT00116194|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2010-03-24|||April 2004||2004-04-01|December 2008|2008-12-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot|Physical Exercise to Prevent Disability Pilot Study|Completed||Phase 1/Phase 2|424||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:37:45.156735|2017-02-18 17:37:45.156735
NCT00116181|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2011-03-16|||October 2004||2004-10-01|March 2011|2011-03-01||||January 2007|Actual|2007-01-01||Interventional|||Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis|A Multicenter, Open-Label, Prospective Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects With Psoriasis-EASE in Psoriasis|Completed||Phase 3|30|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 17:37:45.263306|2017-02-18 17:37:45.263306
NCT00116168|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2013-10-17|2013-10-17||June 2005||2005-06-01|October 2013|2013-10-01|July 2006|Actual|2006-07-01|April 2006|Actual|2006-04-01||Interventional|||Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528|A Phase I, Open Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528, a Humanized Monoclonal Anti-Interleukin-9 Antibody, in Healthy Adult Volunteers|Completed||Phase 1|29|Actual|MedImmune LLC||4|||f||||||||||||||2017-02-18 17:37:45.376474|2017-02-18 17:37:45.376474
NCT00115466|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2005-06-23|||October 2004||2004-10-01|June 2005|2005-06-01|July 2006||2006-07-01|||||Interventional|||Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula|Phase II Clinical Trial, Multicentre, Randomised and Comparative, to Evaluate the Efficacy and Safety of a New Therapy With Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula|Unknown status|Active, not recruiting|Phase 2|50||Cellerix|||||f||||||||||||||2017-02-18 17:37:46.30243|2017-02-18 17:37:46.30243
NCT00115453|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2008-08-14|||May 1999||1999-05-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma|Boron Neutron Capture Therapy in the Treatment of Glioblastoma Multiforme|Terminated||Phase 1/Phase 2|50|Actual|Boneca Corporation||1||Slow accrual|f||||f||||||||||2017-02-18 17:37:46.395342|2017-02-18 17:37:46.395342
NCT00115440|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2009-01-27|||March 2001||2001-03-01|September 2007|2007-09-01|January 2009|Actual|2009-01-01|December 2008|Actual|2008-12-01||Interventional|||BNCT to Treat Glioma That Has Progressed Following Radiotherapy|BPA-Mediated Boron Neutron Capture Therapy (BNCT) in the Treatment of Glioblastoma or Anaplastic Astrocytoma Progressing After Conventional External Beam Radiotherapy|Completed||Phase 1/Phase 2|22|Actual|Boneca Corporation||1|||f||||f||||||||||2017-02-18 17:37:46.517717|2017-02-18 17:37:46.517717
NCT00115427|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2008-01-10|||March 2003||2003-03-01|January 2008|2008-01-01||||||||Interventional|||Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease|Completed||Phase 1|||Amgen|||||||||||||||||||2017-02-18 17:37:46.638662|2017-02-18 17:37:46.638662
NCT00115414|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2008-07-31||||||July 2008|2008-07-01||||||||Interventional|||Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)|A Randomized, Double-Blind, Phase 2 Study Evaluating the Safety of Same Day Versus Next Day Administration of Pegfilgrastim With Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) in Women With Breast Cancer|Completed||Phase 2|||Amgen|||||||||||||||||||2017-02-18 17:37:46.806531|2017-02-18 17:37:46.806531
NCT00115401|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2017-01-24|||June 16, 2005||2005-06-16|October 17, 2007|2007-10-17|October 17, 2007||2007-10-17|||||Observational|||Gait Adaptations to Passive Dynamic Ankle-Foot Orthosis Use|Gait Adaptations to Passive Dynamic Ankle-Foot Orthosis Use|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:37:46.891963|2017-02-18 17:37:46.891963
NCT00115388|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2014-11-21|||September 2004||2004-09-01|November 2014|2014-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|POPI||Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease|Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease|Completed||N/A|2531|Actual|St George's, University of London||1|||f||||f||||||||||2017-02-18 17:37:47.166468|2017-02-18 17:37:47.166468
NCT00115375|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2009-03-24|||January 2004||2004-01-01|March 2009|2009-03-01|April 2006|Actual|2006-04-01|||||Interventional|||Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)|Dose-Ranging Pharmacodynamic Assessment of Platelet Aggregation Inhibition With Clopidogrel in Children of Blalock-Taussig Shunt Age Categories (Neonates and Infants/Toddlers)|Completed||Phase 2|92|Actual|Sanofi|||||||||||||||||||2017-02-18 17:37:47.280459|2017-02-18 17:37:47.280459
NCT00115362|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2007-09-21|||July 2005||2005-07-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Serotonin Effect in Functional Dyspepsia|Serotonin Effect in Non-Ulcer Dyspepsia|Completed||N/A|300|Anticipated|Radboud University|||||f||||||||||||||2017-02-18 17:37:47.406473|2017-02-18 17:37:47.406473
NCT00115349|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2015-10-05|2013-05-16||June 2005||2005-06-01|January 2014|2014-01-01|April 2009|Actual|2009-04-01|July 2008|Actual|2008-07-01||Interventional|||Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases|Thalassemia Clinical Research Network - Cardiac L1/DFO Trial|Terminated||Phase 2|20|Actual|New England Research Institutes|The study was stopped early by NHLBI when analysis of the interim data confirmed a required sample size of 86 that was not achievable within the required time frame within the participating or planned centres.|2||due to low enrollment|f||||t||||||||||2017-02-18 17:37:47.510521|2017-02-18 17:37:47.510521
NCT00115336|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2013-01-18|||January 2005||2005-01-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease|Ketorolac Versus Ibuprofen for the Painful Crisis of Sickle Cell Disease - Southwestern Comprehensive Sickle Cell Center|Terminated||Phase 4|12|Actual|University of Texas Southwestern Medical Center||2||Poor accrual|f||||t||||||||||2017-02-18 17:37:48.060554|2017-02-18 17:37:48.060554
NCT00115323|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2013-12-20|||May 2005||2005-05-01|December 2013|2013-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Comparison of Two Medication Adherence Strategies to Improve Asthma Treatment Adherence|Individualized Interventions to Improve Asthma Adherence|Completed||N/A|397|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 17:37:48.184823|2017-02-18 17:37:48.184823
NCT00115310|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2008-03-04|||June 2005||2005-06-01|March 2008|2008-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|A Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|Completed||Phase 3|400||NeurogesX|||||||||||||||||||2017-02-18 17:37:48.295505|2017-02-18 17:37:48.295505
NCT00115297|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2016-12-12|2016-12-12||September 2004||2004-09-01|December 2016|2016-12-01|October 2016|Actual|2016-10-01|October 2016|Actual|2016-10-01||Interventional|||Montelukast for Early Life Wheezing|Effects of Montelukast on Early Life Wheezing|Completed||Phase 2/Phase 3|62|Actual|University of Massachusetts, Worcester||2|||f||||t||||||||||2017-02-18 17:37:48.387425|2017-02-18 17:37:48.387425
NCT00115284|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2009-02-12|||January 2005||2005-01-01|February 2009|2009-02-01|December 2006|Actual|2006-12-01|July 2006|Actual|2006-07-01||Interventional|||Changes in Physician Performance Through Continuous Professional Development|An Evaluation of Changes in Physician Performance Through Continuous Professional Development|Completed||N/A|40||Henry Ford Health System|||||f||||||||||||||2017-02-18 17:37:48.912872|2017-02-18 17:37:48.912872
NCT00115271|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2014-08-22|||January 1999||1999-01-01|August 2014|2014-08-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Antenatal Micronutrient Supplementation and Birth Weight|Maternal Micronutrient Supplementation to Reduce Low Birth Weight and Infant and Maternal Morbidity in Rural Nepal|Completed||Phase 3|5000||Johns Hopkins Bloomberg School of Public Health|||||f||||||||||||||2017-02-18 17:37:49.003099|2017-02-18 17:37:49.003099
NCT00115258|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2013-02-12|||January 2004||2004-01-01|February 2013|2013-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Nutrition Support in Pediatric Stem Cell Transplantation|Nutrition Support in Pediatric Stem Cell Transplantation - A Randomized, Controlled Trial|Completed||Phase 3|26|Actual|Boston Children’s Hospital||2|||f||||f||||||||||2017-02-18 17:37:49.103023|2017-02-18 17:37:49.103023
NCT00115245|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2015-05-08|||November 2004||2004-11-01|May 2015|2015-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B|A Randomized, Open-Label Trial of Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B|Completed||Phase 3|||Novartis|||||f||||||||||||||2017-02-18 17:37:49.193455|2017-02-18 17:37:49.193455
NCT00115232|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2008-01-14|||July 2004||2004-07-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Observational|||Inflammatory Profiles of Children at High Risk for Atherosclerosis|Inflammatory Profiles of Children at High Risk for Atherosclerosis|Completed||N/A|300|Actual|Boston Children’s Hospital|||4||f||||f||||||Samples Without DNA|"~     Fasting serum samples, frozen.~   "|||2017-02-18 17:37:49.295051|2017-02-18 17:37:49.295051
NCT00116155|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2005-06-27||||||June 2005|2005-06-01||||||||Interventional|||Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer|A Phase I/II Dose Finding Trial of the Intravenous Injection of CV787, a Prostate-Specific Antigen Cytolytic Adenovirus, in Patients With Hormone Refractory Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|||Cell Genesys|||||||||||||||||||2017-02-18 17:37:49.383753|2017-02-18 17:37:49.383753
NCT00116142|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2016-09-21|||June 2005||2005-06-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|January 2019|Anticipated|2019-01-01||Interventional|||Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer|Docetaxel Plus 6-month Androgen Suppression and Radiation Therapy Versus 6-month Androgen Suppression and Radiation Therapy for Patients With High Risk Localized or Locally Advanced Prostate Cancer: A Randomized Controlled Trial|Active, not recruiting||Phase 3|350|Anticipated|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 17:37:49.456138|2017-02-18 17:37:49.456138
NCT00116129|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2012-08-02|||July 2005||2005-07-01|August 2012|2012-08-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in the Treatment of Primary Fibromyalgia|Completed||Phase 2|64|Actual|Bennett, Robert, M.D.||1|||f||||f||||||||||2017-02-18 17:37:49.563768|2017-02-18 17:37:49.563768
NCT00116116|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2011-04-14||2010-01-27|March 2002||2002-03-01|April 2011|2011-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy|Daily Antiretroviral Therapy (DART-II): An Open-Label, Single-Arm, Prospective, Multicenter Clinical Trial To Evaluate the Efficacy and Safety fo Stavudine Extended Release (d4T XR) in Combination With Lamivudine (3TC) and Efavirenz (EFV) Once Daily in Anti-Retroviral Therapy (ART) Naive HIV-Infected Subjects|Completed||Phase 4|70||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:37:49.675334|2017-02-18 17:37:49.675334
NCT00116103|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-27|2012-06-06|||June 2005||2005-06-01|June 2012|2012-06-01|April 2006|Actual|2006-04-01|||||Interventional|||A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma|A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma|Completed||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:37:49.850196|2017-02-18 17:37:49.850196
NCT00116090|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2017-01-24|||June 16, 2005||2005-06-16|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study|Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study|Completed||N/A|6300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:37:50.145582|2017-02-18 17:37:50.145582
NCT00116077|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2017-01-24|||June 21, 2005||2005-06-21|November 12, 2010|2010-11-12|November 12, 2010||2010-11-12|||||Observational|||Dopamine Receptor Imaging in Mood Disorders|Dopamine Receptor Imaging in Mood Disorders|Completed||N/A|145|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:37:50.230701|2017-02-18 17:37:50.230701
NCT00116064|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2006-07-20|||July 2004||2004-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions|A Randomised Trial to Compare the Efficacy and Safety of Intranasal Lorazepam and Intramuscular Paraldehyde in the Treatment of Convulsions in Children|Completed||Phase 3|156||University of Malawi College of Medicine|||||f||||||||||||||2017-02-18 17:37:50.321883|2017-02-18 17:37:50.321883
NCT00116051|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2009-07-06|||September 2004||2004-09-01|July 2009|2009-07-01|April 2006||2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Comparison of Two Surface Materials (Tantalum Versus Titanium Fiber Mesh) of Acetabular Components in Hip Arthroplasty|A Comparison of Two Surface Materials (Tantalum Versus Titanium Fiber Mesh) of Acetabular Components in Hip Arthroplasty|Completed||N/A|50||University of Aarhus|||||f||||t||||||||||2017-02-18 17:37:50.424546|2017-02-18 17:37:50.424546
NCT00116038|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2009-07-06|||January 2004||2004-01-01|July 2009|2009-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Comparison of Two Metal Surface Finishes on Femoral Components in Hip Arthroplasty|A Comparison of Two Metal Surface Finishes (Proximal-Coated Titanium Surface Versus Mid-Coated Titanium Surface) on Femoral Components in Hip Arthroplasty|Completed||N/A|50||University of Aarhus|||||f||||||||||||||2017-02-18 17:37:50.51874|2017-02-18 17:37:50.51874
NCT00116025|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2007-02-27|||March 2005||2005-03-01|February 2007|2007-02-01|January 2006||2006-01-01|||||Interventional|||Pharmacokinetics of Ghrelin|Pharmacokinetics of Ghrelin in Normal Subjects|Completed||N/A|17||University of Aarhus|||||f||||f||||||||||2017-02-18 17:37:50.611634|2017-02-18 17:37:50.611634
NCT00116012|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2006-11-27|||June 2005||2005-06-01|November 2006|2006-11-01||||||||Interventional|||Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32|A Randomized, Double-Blind Placebo-Controlled Study to Assess the Safety of Factor VIIa/Tissue Factor Inhibitor, Recombinant Nematode Anticoagulant Protein c2 (rNAPc2), in Subjects With Non-ST-Elevation Acute Coronary Syndromes - ANTHEM (Anticoagulation With rNAPc2 to Help Eliminate MACE)/TIMI 32. Amendment #3 - A Single Arm, Open-Label Study of rNAPc2 With Reduced Doses of Unfractionated Heparin|Completed||Phase 2|300||ARCA Biopharma, Inc.|||||||||||||||||||2017-02-18 17:37:50.691407|2017-02-18 17:37:50.691407
NCT00115999|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2008-01-08|||April 2005||2005-04-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries|Phase 3, Multicenter, Multi-National, Randomized, Partial Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects With Acute Peripheral Arterial Occlusion|Completed||Phase 3|300||ARCA Biopharma, Inc.|||||f||||t||||||||||2017-02-18 17:37:50.789943|2017-02-18 17:37:50.789943
NCT00115986|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2013-08-22|||March 2005||2005-03-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||A/H5N1in Adult - Aventis|A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Adults|Completed||Phase 1/Phase 2|452|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:37:50.971687|2017-02-18 17:37:50.971687
NCT00115973|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2016-10-17|||June 2005||2005-06-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump|An Open-Label, Stepwise Basal Insulin Dose Titration Study Using Continuous Subcutaneous Insulin Infusion (CSII) in Oral Antidiabetic Drug-Treated Type 2 Diabetes Mellitus Subjects Followed by a 10-Week Out-Patient Maintenance Phase|Completed||Phase 1|71|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:37:51.060001|2017-02-18 17:37:51.060001
NCT00115960|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2012-03-26||||||March 2012|2012-03-01|July 2008|Actual|2008-07-01|||||Interventional|||Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Gag DNA Vaccine Alone or With IL-15 DNA, Boosted With HIV-1 Gag DNA + IL-15 DNA or HIV-1 Gag DNA + IL-12 DNA, in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|120|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-02-18 17:37:51.160239|2017-02-18 17:37:51.160239
NCT00115947|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2006-03-08|||December 2004||2004-12-01|June 2005|2005-06-01|January 2006||2006-01-01|||||Interventional|||Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites||Completed||Phase 2/Phase 3|||Hvidovre University Hospital|||||f||||||||||||||2017-02-18 17:37:51.292826|2017-02-18 17:37:51.292826
NCT00115557|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2010-08-11|||October 2004||2004-10-01|September 2007|2007-09-01|July 2006|Actual|2006-07-01|May 2006|Actual|2006-05-01||Interventional|||Delivery of Preventive Services in Primary Care|Delivery of Preventive Services in Primary Care|Completed||N/A|24|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-02-18 17:37:58.742251|2017-02-18 17:37:58.742251
NCT00115934|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2016-03-22|2010-09-14||May 2005||2005-05-01|August 2013|2013-08-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Comparison of Two Types of Shunts in Infants With Single Ventricle Defect Undergoing Staged Reconstruction--Pediatric Heart Network|Trial of Right Ventricular Versus Modified Blalock-Taussig Shunt in Infants With Single Ventricle Defect Undergoing Staged Reconstruction (A Trial Conducted by the Pediatric Heart Network)|Completed||Phase 3|555|Actual|New England Research Institutes|As in all surgical trials comparing two operations, it was not possible to blind the personnel caring for the subjects to the intervention. However, the components of the primary endpoint, death and transplantation, are discrete objective events.|2|||f||||t||||||||||2017-02-18 17:37:51.381103|2017-02-18 17:37:51.381103
NCT00115921|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2017-01-11|||July 2005||2005-07-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Evaluation of Home-Based Management of Fever in Urban Ugandan Children|Evaluation of Home-Based Management of Fever in Urban Ugandan Children|Completed||N/A|540||London School of Hygiene and Tropical Medicine|||||f||||t||||||||||2017-02-18 17:37:52.161467|2017-02-18 17:37:52.161467
NCT00115908|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2013-11-05|||May 2005||2005-05-01|November 2013|2013-11-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1|A Phase 2b, Randomized, Multi-Center, Active-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Albuferon (Recombinant Human Albumin-Interferon Alfa Fusion Protein) in Combination With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 1|Completed||Phase 2|458|Actual|Human Genome Sciences Inc.|||||f||||t||||||||||2017-02-18 17:37:52.261569|2017-02-18 17:37:52.261569
NCT00115895|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2016-03-18|||January 2000||2000-01-01|March 2016|2016-03-01|September 2020|Anticipated|2020-09-01|October 2004|Actual|2004-10-01||Interventional|||The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy|Effect of the Radioiodine Dose in Thyroid Ablation- A Randomized Comparison of 1110 MBq to 3700 MBq|Active, not recruiting||Phase 3|160|Actual|Helsinki University||2|||f||||f||||||||||2017-02-18 17:37:52.539492|2017-02-18 17:37:52.539492
NCT00115882|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2016-05-20|||September 2000||2000-09-01|May 2016|2016-05-01|November 2015|Actual|2015-11-01|May 2014|Actual|2014-05-01||Interventional|||Hutchinson Study of High School Smoking|Proactive Smoking Cessation for Adolescents|Completed||Phase 3|2151|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-02-18 17:37:52.664166|2017-02-18 17:37:52.664166
NCT00115869|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2012-10-31|2012-04-30||September 1984||1984-09-01|October 2012|2012-10-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|HSPP||Hutchinson Smoking Prevention Project|Hutchinson Smoking Prevention Project|Completed||Phase 3|8388|Actual|Fred Hutchinson Cancer Research Center||2|||f||||f||||||||||2017-02-18 17:37:52.777273|2017-02-18 17:37:52.777273
NCT00115856|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2015-07-31|||January 2001||2001-01-01|July 2015|2015-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Imaging of Plaque With Magnetic Resonance Imaging (MRI)|Imaging of Plaque in Atherosclerosis With Intravascular MRI|Completed||N/A|20|Actual|Brigham and Women's Hospital||1|||f||||f||||||||||2017-02-18 17:37:53.427308|2017-02-18 17:37:53.427308
NCT00115843|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2006-09-06|||April 2005||2005-04-01|September 2006|2006-09-01|August 2006||2006-08-01|||||Interventional|||Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring|Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring|Unknown status|Active, not recruiting|N/A|45||Beth Israel Deaconess Medical Center|||||f||||||||||||||2017-02-18 17:37:53.546843|2017-02-18 17:37:53.546843
NCT00115830|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2007-04-23|||December 2004||2004-12-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Rho Kinase in Patients With Atherosclerosis|Rho Kinase in Patients With Atherosclerosis: Effects of Statins - A Double Blind, Randomized Clinical Trial Comparing Rosuvastatin and Atorvastatin|Completed||Phase 3|40||Brigham and Women's Hospital|||||f||||t||||||||||2017-02-18 17:37:53.638095|2017-02-18 17:37:53.638095
NCT00115817|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2007-04-23|||June 2005||2005-06-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||The Effects of Atorvastatin in Patients With Atherosclerosis|The Effects of Atorvastatin on the Rho/Rho Kinase Pathway in Patients With Atherosclerosis|Completed||Phase 3|36||Brigham and Women's Hospital|||||f||||t||||||||||2017-02-18 17:37:53.739061|2017-02-18 17:37:53.739061
NCT00115804|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2017-02-06|2012-11-07||June 2005||2005-06-01|February 2017|2017-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia|An Open-Label Clinical Trial of Fluoxetine Treatment of Juvenile Primary Fibromyalgia Syndrome|Completed||Phase 3|6|Actual|University of Cincinnati||1|||f||||f||||||||No||2017-02-18 17:37:53.828741|2017-02-18 17:37:53.828741
NCT00115791|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2008-03-29|||June 2004||2004-06-01|March 2008|2008-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter|A Phase 3, Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Tolerance and Efficacy Study of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter|Completed||Phase 3|276|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 17:37:54.184947|2017-02-18 17:37:54.184947
NCT00115778|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2009-06-18|||June 2005||2005-06-01|June 2009|2009-06-01|December 2009|Anticipated|2009-12-01|November 2009|Anticipated|2009-11-01||Interventional|||Intravenous Immunoglobulin (IVIG) in Lung Transplantation|IVIG for Acquired Immunodeficiency in Lung Transplant Patients|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|Arcasoy, Selim, M.D.||1|||f||||||||||||||2017-02-18 17:37:54.338518|2017-02-18 17:37:54.338518
NCT00115765|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-26|2013-06-13|2010-08-19||June 2005||2005-06-01|June 2013|2013-06-01|December 2009|Actual|2009-12-01|March 2007|Actual|2007-03-01||Interventional|||PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study|PACCE: A Randomized, Open-Label, Controlled, Clinical Trial of Chemotherapy and Bevacizumab With and Without Panitumumab in the First-Line Treatment of Subjects With Metastatic Colorectal Cancer|Completed||Phase 3|1053|Actual|Amgen||4|||f||||||||||||||2017-02-18 17:37:54.46209|2017-02-18 17:37:54.46209
NCT00115752|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2017-01-24|||June 20, 2005||2005-06-20|October 4, 2006|2006-10-04|October 4, 2006||2006-10-04|||||Interventional|||Genetic Basis For Variation In NSAID Analgesia In A Clinical Model Of Acute Pain|Genetic Basis For Variation In NSAID Analgesia In A Clinical Model Of Acute Pain|Completed||Phase 2|96||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:37:56.658157|2017-02-18 17:37:56.658157
NCT00115544|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2016-02-09|||September 2005||2005-09-01|February 2016|2016-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Safety and Pharmacology of Stanate|An Open-Label Study of the Safety and Clinical Pharmacology of Stanate® in Infants At-Risk for Exchange Transfusion|Completed||Phase 2|55|Actual|InfaCare Pharmaceuticals Corporation||3|||f||||t||||||||||2017-02-18 17:37:58.852827|2017-02-18 17:37:58.852827
NCT00115739|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2014-03-19|2012-07-24||February 2004||2004-02-01|March 2014|2014-03-01|August 2010|Actual|2010-08-01|May 2008|Actual|2008-05-01||Interventional||11 patients with Anaplastic thyroid cancer were enrolled and were started on imatinib.|Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma|Phase II Trial Evaluating Gleevec (Imatinib Mesylate Formerly Known as STI571) in Patients With Anaplastic Thyroid Cancer|Terminated||Phase 2|11|Actual|University of Michigan Cancer Center|Study was closed early due to slow accrual. Planned accrual was 28|1||Study was closed early due to slow accrual|f||||t||||||||||2017-02-18 17:37:56.95145|2017-02-18 17:37:56.95145
NCT00115726|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2008-02-20|||September 2000||2000-09-01|February 2008|2008-02-01|April 2007|Actual|2007-04-01|February 2006|Actual|2006-02-01||Interventional|||Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure|Randomized Controlled Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure|Completed||Phase 4|198|Actual|University of Calgary||2|||f||||f||||||||||2017-02-18 17:37:57.299109|2017-02-18 17:37:57.299109
NCT00115713|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2007-03-22|||April 2003||2003-04-01|March 2007|2007-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Effects of Aerobic Exercise Versus Weight Training in Breast Cancer Survivors During Chemotherapy|Comparison of Aerobic Versus Resistance Exercise Training in Enhancing Quality of Life in Early Stage Breast Cancer Survivors Receiving Chemotherapy: A Multi-Centre Randomized Trial|Completed||Phase 3|240||University of Alberta, Physical Education|||||f||||t||||||||||2017-02-18 17:37:57.426779|2017-02-18 17:37:57.426779
NCT00115700|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2017-02-15|||February 2000||2000-02-01|February 2017|2017-02-01|December 2022|Anticipated|2022-12-01|December 2021|Anticipated|2021-12-01||Interventional|||Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma|A Randomised Multicentre Trial of Involved Field Radiotherapy Versus Involved Field Radiotherapy Plus Chemotherapy in Combination With Rituximab (Mabthera®) for Stage I - II Low Grade Follicular Lymphoma|Active, not recruiting||Phase 3|150|Actual|Trans-Tasman Radiation Oncology Group (TROG)||2|||f||||f||||||||||2017-02-18 17:37:57.531819|2017-02-18 17:37:57.531819
NCT00115687|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2017-01-11|||June 2002||2002-06-01|May 2010|2010-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Nicotine Replacement Treatment for Pregnant Smokers - 1|Nicotine Replacement Treatment for Pregnant Smokers|Terminated||Phase 2|250|Actual|National Institute on Drug Abuse (NIDA)||2||Efficacy rates did not show large enough differences between treatments|f||||t||||||||||2017-02-18 17:37:57.680769|2017-02-18 17:37:57.680769
NCT00115674|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2015-10-06|||September 2002||2002-09-01|August 2015|2015-08-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||To Examine Smoking Behavior of Prisoners - 1|Smoking Research With Incarcerated Females|Completed||N/A|360|Actual|University of Alabama at Birmingham|||1||f||||t||||||||||2017-02-18 17:37:57.807936|2017-02-18 17:37:57.807936
NCT00115661|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2012-10-16|||July 2005||2005-07-01|October 2012|2012-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Use of Rosiglitazone in the Treatment of Endometriosis|Treatment of Endometriosis Pain With Rosiglitazone: A Prospective Phase 2 Clinical Trial|Terminated||Phase 2|25|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1||Due to the meta-analysis about CV adverse effects of rosiglitazone.|f||||||||||||||2017-02-18 17:37:57.886821|2017-02-18 17:37:57.886821
NCT00115648|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2014-03-06|||April 2004||2004-04-01|March 2014|2014-03-01|October 2009|Actual|2009-10-01|August 2007|Actual|2007-08-01||Interventional|||Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission|Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission|Completed||Phase 3|3300|Anticipated|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-02-18 17:37:57.999432|2017-02-18 17:37:57.999432
NCT00115635|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2007-10-01|||March 2005||2005-03-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|||Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer|A Phase I/II Study With Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|60|Actual|Herlev Hospital||1|||f||||t||||||||||2017-02-18 17:37:58.121576|2017-02-18 17:37:58.121576
NCT00115622|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2016-08-30|||December 2004||2004-12-01|August 2016|2016-08-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study In Adults And Adolescents With Seasonal Allergic Rhinitis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 14 Days in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis|Completed||Phase 3|304|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:37:58.217193|2017-02-18 17:37:58.217193
NCT00115609|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2011-12-21|||January 2006||2006-01-01|December 2011|2011-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)|Pilot Trial Evaluating Once Daily Triple Combination Antiretroviral Therapy With Tenofovir-Emtricitabine and Efavirenz in HIV-1 Infected Patients With Mycobacterium Tuberculosis Infection ANRS129 BKVIR|Completed||Phase 3|70|Actual|French National Agency for Research on AIDS and Viral Hepatitis||1|||f||||t||||||||||2017-02-18 17:37:58.331288|2017-02-18 17:37:58.331288
NCT00115596|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2005-06-26|||June 2005||2005-06-01|June 2005|2005-06-01|June 2006||2006-06-01|||||Interventional|||Reforming Pediatric Procedural Training|Reforming Pediatric Procedural Training: Developing an Evidence-Based Curriculum|Unknown status|Active, not recruiting|N/A|38||Boston Children’s Hospital|||||f||||||||||||||2017-02-18 17:37:58.440034|2017-02-18 17:37:58.440034
NCT00115583|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2016-12-08|||November 1998||1998-11-01|December 2016|2016-12-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries|The Contribution of Endothelin to Vasoreactivity in Atherosclerotic Coronary Arteries|Completed||N/A|200||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:37:58.525233|2017-02-18 17:37:58.525233
NCT00115570|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-23|2016-05-19|||April 2005||2005-04-01|May 2016|2016-05-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents|Efficacy and Safety of Insulin Glulisine Compared With Insulin Lispro in Children and Adolescents With Type 1 Diabetes Mellitus: A 26 Week, Multicenter, Open, Parallel Clinical Trial|Completed||Phase 3|572|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 17:37:58.620413|2017-02-18 17:37:58.620413
NCT00005360|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||August 1992||1992-08-01|December 2001|2001-12-01|July 1997|Actual|1997-07-01|||||Observational|||HIV Diversity and Pathogenesis in Donor-Recipient Clusters||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.901649|2017-02-18 18:15:05.901649
NCT00115531|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2014-12-18|||April 2005||2005-04-01|February 2007|2007-02-01|November 2005||2005-11-01|||||Interventional|||Eldery High Dose TIV 2005|Comparisons of the Reactogenicity and Immunogenicity in Ambulatory Elderly Subjects of a Standard-Dose Fluzone® (15 µg HA/Virus Strain) and a High-Dose (60 µg HA/Virus Strain) of a Trivalent Inactivated Influenza Virus Vaccine|Completed||Phase 2|414|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:37:58.964939|2017-02-18 17:37:58.964939
NCT00115518|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2011-08-03|||May 2005||2005-05-01|February 2011|2011-02-01|August 2010|Actual|2010-08-01|June 2009|Actual|2009-06-01||Interventional|||Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Locoregional Radiotherapy in Combination With Cetuximab in Inoperable Non-Small Cell Lung Cancer Stage III|Completed||Phase 2|30|Actual|Heidelberg University||1|||f||||f||||||||||2017-02-18 17:37:59.063408|2017-02-18 17:37:59.063408
NCT00115505|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2016-07-01|||October 2005||2005-10-01|July 2016|2016-07-01||||January 2100|Anticipated|2100-01-01||Observational|||Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer|Quality of Life, Employment and Informal Care Cost Analysis in Women Receiving Adjuvant Chemotherapy for Breast Cancer With 0-3 Positive Axillary Lymph Nodes|Active, not recruiting||N/A|684|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 17:37:59.170933|2017-02-18 17:37:59.170933
NCT00115492|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2017-01-19|||December 2004||2004-12-01|January 2017|2017-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations|A Randomized, Double-Blind, Parallel Group, 52-Week Study to Compare the Effect of Fluticasone Propionate/Salmeterol Diskus Combination Product 250/50mcg BID With Salmeterol Diskus 50mcg BID on the Annual Rate of Moderate/Severe Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|797|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:37:59.869282|2017-02-18 17:37:59.869282
NCT00115479|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-22|2006-05-03|||March 2002||2002-03-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients|KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients|Completed||Phase 2|1200||Katholieke Universiteit Leuven|||||f||||||||||||||2017-02-18 17:38:00.086791|2017-02-18 17:38:00.086791
NCT00115219|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2013-05-28|||May 2005||2005-05-01|May 2013|2013-05-01||||||||Interventional|||Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)|A Multi-center, Randomized, Double-Blind, Active-Controlled Study Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis Subjects Who Are Sub-optimal Responders to Etanercept 50 mg Once Weekly (QW)|Completed||Phase 4|200||Amgen||1|||||||||||||||||2017-02-18 17:38:00.21074|2017-02-18 17:38:00.21074
NCT00115206|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2009-04-02|||July 2002||2002-07-01|April 2009|2009-04-01|July 2004||2004-07-01|||||Interventional|||Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy|A Pilot Study of the Effects of Neutropenia on Patient Reported Outcomes During Chemotherapy With or Without Neulasta® (Pegfilgrastim) in Subjects With Advanced NSCLC|Completed||Phase 4|||Amgen|||||||||||||||||||2017-02-18 17:38:00.311634|2017-02-18 17:38:00.311634
NCT00115193|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2013-08-27|||February 2003||2003-02-01|August 2013|2013-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma|A Multicenter, Double-Blind, Randomized Study of Pegfilgrastim Administered on the Same Day or the Next Day of R-Chop Chemotherapy in Subjects With Non-Hodgkin's Lymphoma|Completed||Phase 2|77|Actual|Amgen||2|||f||||t||||||||||2017-02-18 17:38:00.395717|2017-02-18 17:38:00.395717
NCT00115180|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2016-01-05|||September 2003||2003-09-01|November 2005|2005-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Racial and Ethnic Disparities in Acute Pain Control|Racial and Ethnic Disparities in Acute Pain Control|Completed||N/A|285|Actual|Agency for Healthcare Research and Quality (AHRQ)|||3||f||||f||||||||No||2017-02-18 17:38:00.506564|2017-02-18 17:38:00.506564
NCT00115167|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2009-05-07|||August 2004||2004-08-01|May 2009|2009-05-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study|A Multicenter, Randomised, Double-Blind, Placebo-Controlled Roll Over Study to Protocol 20010103 of Darbepoetin Alfa for the Treatment of Anemia of Cancer|Completed||Phase 3|371|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:38:00.625033|2017-02-18 17:38:00.625033
NCT00115154|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2007-02-16|||May 2005||2005-05-01|February 2007|2007-02-01|September 2006||2006-09-01|||||Interventional|||Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands|Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Upper Extremities|Completed||Phase 4|270||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-02-18 17:38:00.731847|2017-02-18 17:38:00.731847
NCT00115141|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2007-02-16|||April 2004||2004-04-01|November 2006|2006-11-01||||||||Interventional|||Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults|A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Adults|Completed||Phase 2|88||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-02-18 17:38:00.836652|2017-02-18 17:38:00.836652
NCT00115128|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-21|2013-05-10|||November 2003||2003-11-01|May 2013|2013-05-01|September 2007|Actual|2007-09-01|May 2007|Actual|2007-05-01||Observational|||Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors|Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors|Completed||N/A|309|Actual|Amgen|||1||f||||||||||None Retained|"~     none collected~   "|||2017-02-18 17:38:00.910206|2017-02-18 17:38:00.910206
NCT00115115|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2009-04-22|||March 2004||2004-03-01|April 2009|2009-04-01|March 2009|Actual|2009-03-01|December 2007|Actual|2007-12-01||Interventional|||Donor Dopamine and Initial Graft Function|Prospective Randomized Trial to Evaluate the Efficacy of Donor Preconditioning With Dopamine on Initial Graft Function After Kidney Transplantation|Completed||Phase 4|487|Actual|Universitätsmedizin Mannheim||1|||f||||f||||||||||2017-02-18 17:38:01.009265|2017-02-18 17:38:01.009265
NCT00115102|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2006-06-15|||March 2004||2004-03-01|June 2006|2006-06-01|October 2005||2005-10-01|||||Interventional|||Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls||Completed||Phase 4|20||University of Aarhus|||||f||||||||||||||2017-02-18 17:38:01.108408|2017-02-18 17:38:01.108408
NCT00115089|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2005-11-09|||July 2005||2005-07-01|November 2005|2005-11-01|September 2005||2005-09-01|||||Interventional|||7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis|A Phase II Multi-Center, Randomized, Double-Blind, Active and Placebo-Controlled 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis|Completed||Phase 2|375||Rigel Pharmaceuticals|||||||||||||||||||2017-02-18 17:38:01.207922|2017-02-18 17:38:01.207922
NCT00115076|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2012-05-31|||October 2003||2003-10-01|May 2012|2012-05-01||||May 2007|Actual|2007-05-01||Interventional|||Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis|A Phase IIIB Study to Evaluate the Mechanism of Action of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy|Completed||Phase 3|31|Actual|Rockefeller University||1|||f||||f||||||||||2017-02-18 17:38:01.304037|2017-02-18 17:38:01.304037
NCT00115063|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2016-01-22|2010-03-01||July 2005||2005-07-01|January 2016|2016-01-01|January 2008|Actual|2008-01-01|December 2007|Actual|2007-12-01||Interventional|LOSS||LOSS- Louisiana Obese Subjects Study|Loss - Louisiana Obese Subjects Study|Terminated||Phase 4|390|Actual|Pennington Biomedical Research Center|The study was stopped prematurely for efforts to be focused on assisting the Office of Group Benefits (OGB) in translating a policy that would allow for physician certification in order to offer participants the intensive treatment.|2||ethical issues of continuing control group without treatment|f||||t||||||||||2017-02-18 17:38:01.43721|2017-02-18 17:38:01.43721
NCT00115050|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2011-06-02||2011-06-02|June 2005||2005-06-01|June 2011|2011-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options|Open-label Safety Study of TMC114 in Combination With Low Dose RTV and Other ARVs in Highly Experienced HIV-1 Infected Patients With Limited or no Treatment Options.|Completed||Phase 3|260|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-02-18 17:38:02.057251|2017-02-18 17:38:02.057251
NCT00115037|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2011-08-04|||September 2003||2003-09-01|August 2011|2011-08-01|July 2008|Actual|2008-07-01|April 2008|Actual|2008-04-01||Interventional|EXTEND||Managing Alcoholism in People Who Do Not Respond to Naltrexone|Non-Response to Naltrexone (NTX): Next Steps in Managing Alcoholism|Completed||Phase 4|302|Actual|University of Pennsylvania||5|||f||||t||||||||||2017-02-18 17:38:02.262171|2017-02-18 17:38:02.262171
NCT00115024|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2009-12-09|||April 1994||1994-04-01|June 2005|2005-06-01|November 1998|Actual|1998-11-01|November 1998|Actual|1998-11-01||Interventional|||EPAT: Estrogen in the Prevention of Atherosclerosis Trial|Estrogen in the Prevention of Atherosclerosis Trial|Completed||Phase 2/Phase 3|222||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:38:02.390952|2017-02-18 17:38:02.390952
NCT00115011|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2008-05-19|||September 2002||2002-09-01|May 2008|2008-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Escitalopram for the Treatment of Self-Injurious Skin Picking|Escitalopram for the Treatment of Self-Injurious Skin Picking|Completed||Phase 4|30|Actual|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 17:38:02.500029|2017-02-18 17:38:02.500029
NCT00114998|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2012-07-31|||June 2005||2005-06-01|July 2012|2012-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||CV Disease in Adolescents With Type 2 Diabetes|CV Disease in Adolescents With Type 2 Diabetes|Completed||N/A|750|Actual|Children's Hospital Medical Center, Cincinnati|||1||f||||f||||||||||2017-02-18 17:38:02.610838|2017-02-18 17:38:02.610838
NCT00114985|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2012-08-22|||April 2001||2001-04-01|August 2012|2012-08-01|October 2008|Actual|2008-10-01|January 2005|Actual|2005-01-01||Interventional|||Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding|A Phase II Study of Late Rectal Toxicity Following 3-D Conformal External Beam Radiation Therapy Performed Using a Prostate Immobilization Device|Completed||Phase 2|100|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:38:02.689997|2017-02-18 17:38:02.689997
NCT00114972|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2010-05-27|2009-03-27||March 2005||2005-03-01|May 2010|2010-05-01|May 2012|Anticipated|2012-05-01|April 2008|Actual|2008-04-01||Interventional|SYNTAX||SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries|SYNTAX Study: SYNergy Between PCI With TAXUS and Cardiac Surgery|Unknown status|Active, not recruiting|Phase 3|1800|Actual|Boston Scientific Corporation||2|||f||||t||||||||||2017-02-18 17:38:02.784802|2017-02-18 17:38:02.784802
NCT00114959|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2015-01-08|2015-01-08||October 2005||2005-10-01|January 2015|2015-01-01|March 2009|Actual|2009-03-01|June 2008|Actual|2008-06-01||Interventional|||Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)|A Phase II Open-Label Study of the Intravenous Administration of Homoharringtonine (CGX-635) Combined With the Oral Administration of Gleevec in the Treatment of Patients With Chronic Myeloid Leukemia (CML) in Chronic, Accelerated, and Blast Phase|Terminated||Phase 2|15|Actual|Teva Pharmaceutical Industries|This study was intended to follow a Simon two stage design to test 18 patients in each stratum (chronic, accelerated and blast phase) for efficacy. Only 15 were enrolled, an insufficient number for a formal statistical analysis of efficacy.|1||Poor enrollment|f||||f||||||||||2017-02-18 17:38:05.023079|2017-02-18 17:38:05.023079
NCT00114946|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2006-05-26|||May 2005||2005-05-01|May 2006|2006-05-01|December 2007||2007-12-01|||||Interventional|||A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer|A Randomized, Open-Label Trial Comparing Two Avastin (Bevacizumab)-Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer|Terminated||Phase 4|800||Genentech, Inc.|||||f||||||||||||||2017-02-18 17:38:05.47401|2017-02-18 17:38:05.47401
NCT00114933|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2008-03-20|||January 2005||2005-01-01|September 2005|2005-09-01|May 2007||2007-05-01|||||Interventional|||"OK 2004 Study (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects"|Phase III-IV, Comparative, Randomized, Open-Label, Study to Evaluate Safety and Efficacy of Suspending Nucleosides From a Triple-Drug Therapy Based on Lopinavir/Ritonavir Versus Continuing Triple-Drug Therapy in HIV-Infected Subjects With Undetectable Plasma HIV Viremia for Six Months|Completed||Phase 4|200||Arribas, Jose R., M.D.|||||f||||||||||||||2017-02-18 17:38:05.6867|2017-02-18 17:38:05.6867
NCT00114920|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-20|2007-02-16|||March 2004||2004-03-01|November 2006|2006-11-01||||||||Interventional|||Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults|A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel for the Treatment of Common Warts in Adults|Completed||Phase 2|88||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-02-18 17:38:05.812562|2017-02-18 17:38:05.812562
NCT00005359|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-11|||July 1994||1994-07-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Genetics of Asthma and Bronchial Hyperresponsiveness||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.974145|2017-02-18 18:15:05.974145
NCT00114894|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2009-08-12|||April 2004||2004-04-01|August 2009|2009-08-01|February 2006|Actual|2006-02-01|January 2006|Actual|2006-01-01||Interventional|||Prevention of Jellyfish Stings|Field Study of the Prevention of Jellyfish Stings With a Topical Sting Inhibitor|Completed||Phase 3|12|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 17:38:05.985128|2017-02-18 17:38:05.985128
NCT00114881|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2017-01-09|||January 2005||2005-01-01|January 2017|2017-01-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|URECA||Urban Environmental Factors and Childhood Asthma|Urban Environment and Childhood Asthma (URECA)|Active, not recruiting||N/A|609|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||t||||||Samples With DNA|"~     -  Sample of umbilical cord blood (mother)~        -  Maternal blood sample~        -  Blood and nasal mucus collection (infant through age 14 or 16 years)~        -  DNA sample of mother and child~        -  Urine sample~        -  Saliva sample~        -  Induced sputum sample~        -  Nasal epithelial cells sample~   "|||2017-02-18 17:38:06.095837|2017-02-18 17:38:06.095837
NCT00114868|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2013-04-24|||June 1998||1998-06-01|January 2010|2010-01-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Vitamin A Supplementation in Newborns Study|Vitamin A Supplementation in Newborns Study|Completed||Phase 3|14035|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-02-18 17:38:06.202659|2017-02-18 17:38:06.202659
NCT00114855|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2011-07-03|||March 2005||2005-03-01|February 2009|2009-02-01|June 2006|Actual|2006-06-01|December 2005|Actual|2005-12-01||Interventional|||The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose|A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose|Completed||N/A|40||Oslo University Hospital|||||f||||||||||||||2017-02-18 17:38:06.320285|2017-02-18 17:38:06.320285
NCT00114842|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2007-09-19|||March 2006||2006-03-01|September 2007|2007-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Magnetic Resonance (MR) Colonography With Fecal Tagging|MR Colonography With Fecal Tagging: A Prospective, Randomized Study|Completed||Phase 4|60|Anticipated|Herlev Hospital|||||f||||||||||||||2017-02-18 17:38:06.42662|2017-02-18 17:38:06.42662
NCT00114829|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2006-03-08|||July 2005||2005-07-01|May 2005|2005-05-01||||||||Interventional|||Preoperative Assessment of Colon Tumor|Preoperative Assessment of Colon Tumor: A Prospective, Blinded Study.|Unknown status|Recruiting|Phase 4|60||Herlev Hospital|||||f||||||||||||||2017-02-18 17:38:06.514622|2017-02-18 17:38:06.514622
NCT00114816|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2007-05-18|||January 2004||2004-01-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer|A Randomized Phase III Study Comparing Docetaxel Followed by Cyclophosphamide, Epirubicin and 5-FU to Docetaxel With Capecitabine Followed by Cyclophosphamide, Epirubicin and Capecitabine as Adjuvant Treatment for Early Breast Cancer|Completed||Phase 3|1500|Anticipated|Finnish Breast Cancer Group|||||f||||||||||||||2017-02-18 17:38:06.601885|2017-02-18 17:38:06.601885
NCT00114803|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2007-12-04|||January 2004||2004-01-01|April 2007|2007-04-01|October 2006|Actual|2006-10-01|||||Interventional|||Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease|Use of Intranasally Administered Calcitonin in the Treatment of Osteopenia and Osteoporosis in Children, Adolescents and Young Adults With IBD: A Pilot Study|Completed||N/A|66||Boston Children’s Hospital|||||||||||||||||||2017-02-18 17:38:06.698757|2017-02-18 17:38:06.698757
NCT00114790|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2013-05-03|||December 2003||2003-12-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|October 2008|Actual|2008-10-01||Interventional|||Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors|Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Inoperable and Irradiated Head and Neck Tumors: A Feasibility Study|Completed||Phase 1/Phase 2|30|Actual|Boneca Corporation||1|||f||||f||||||||||2017-02-18 17:38:06.805317|2017-02-18 17:38:06.805317
NCT00114777|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2015-10-02||2010-04-29|February 2005||2005-02-01|October 2015|2015-10-01|September 2014|Actual|2014-09-01|May 2008|Actual|2008-05-01||Interventional|BENEFIT-EXT||Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant|Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial - Extended Criteria Donors (BENEFIT-EXT)|Completed||Phase 3|580|Actual|Bristol-Myers Squibb||3|||f||||f||||||||||2017-02-18 17:38:06.925881|2017-02-18 17:38:06.925881
NCT00114764|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2008-10-30|||March 2003||2003-03-01|October 2008|2008-10-01|August 2004|Actual|2004-08-01|April 2004|Actual|2004-04-01||Interventional|||Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)|A Multicentre, Double-Blind, Randomised Phase 2 Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)|Completed||Phase 2|84|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:38:09.992639|2017-02-18 17:38:09.992639
NCT00114738|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-17|2017-02-03|||June 15, 2005||2005-06-15|January 6, 2017|2017-01-06|May 10, 2020|Anticipated|2020-05-10|May 10, 2018|Anticipated|2018-05-10||Interventional|||EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma|Randomized Phase II Study of Dose-Adjusted EPOCH-Rituximab-Bortezomib (EPOCH-R-B) Induction Followed by Bortezomib Maintenance Versus Observation in Untreated Mantle Cell Lymphoma With Microarray Profiling and Proteomics|Active, not recruiting||Phase 2|53|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 17:38:10.089114|2017-02-18 17:38:10.089114
NCT00114725|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-16|2005-06-23|||March 2004||2004-03-01|June 2005|2005-06-01|October 2004||2004-10-01|||||Interventional|||Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection|Laser-Assisted Versus Conventional Intracytoplasmic Sperm Injection|Completed||N/A|60||Shady Grove Fertility Reproductive Science Center|||||f||||||||||||||2017-02-18 17:38:10.206116|2017-02-18 17:38:10.206116
NCT00114712|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-16|2017-01-23|||January 2004||2004-01-01|January 2017|2017-01-01|December 2025|Anticipated|2025-12-01|December 2024|Anticipated|2024-12-01|12 Months|Observational [Patient Registry]|RPR||The Ribavirin Pregnancy Registry|The Ribavirin Pregnancy Registry|Recruiting||N/A|600|Anticipated|INC Research|||1||f||||t|f|f||||||Yes|A condensed version of the annual interim report is available to healthcare providers upon request.|2017-02-18 17:38:10.299366|2017-02-18 17:38:10.299366
NCT00114504|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2015-05-13|2015-03-31||September 2004||2004-09-01|May 2015|2015-05-01|April 2009|Actual|2009-04-01|April 2007|Actual|2007-04-01||Interventional|||Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation|Detection of Atherosclerotic Plaque Inflammation and Visualization of Anti-inflammatory Effects of Statins on Plaque Inflammation by FDG-PET|Completed||N/A|43|Actual|Kurume University||2|||f||||f||||||||||2017-02-18 17:38:12.538054|2017-02-18 17:38:12.538054
NCT00114699|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-16|2013-08-01|||April 2005||2005-04-01|August 2013|2013-08-01|April 2006|Actual|2006-04-01|||||Interventional|||Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy|A Phase 1, Randomized, Placebo-Controlled, Single-Injection, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ccr5mab004 (Human Monoclonal Igg4 Antibody To Ccr5) in Hiv-1 Seropositive Individuals Who Are Not Receiving Concurrent Antiretroviral Therapy|Completed||Phase 1|40||Human Genome Sciences Inc.|||||||||||||||||||2017-02-18 17:38:10.409416|2017-02-18 17:38:10.409416
NCT00114686|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-16|2013-01-03|||January 2006||2006-01-01|January 2013|2013-01-01|April 2007|Actual|2007-04-01|||||Interventional|||Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder|A Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, Phase III Study to Compare the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) Versus Placebo as Adjunct Therapy With Mood Stabilizers (Lithium or Divalproex) for the Treatment of Alcohol Dependence in Patients With Bipolar I Disorder|Completed||Phase 3|350||AstraZeneca|||||f||||||||||||||2017-02-18 17:38:10.507517|2017-02-18 17:38:10.507517
NCT00114673|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-16|2007-02-16|||June 2005||2005-06-01|January 2006|2006-01-01||||||||Observational|||A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling|A Multicenter Study to Validate Cosmetic Outcome Scales Used to Assess Irregular Skin Pigmentation and Wrinkling|Completed||N/A|48||Graceway Pharmaceuticals, LLC|||||f||||||||||||||2017-02-18 17:38:10.630624|2017-02-18 17:38:10.630624
NCT00114660|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-16|2009-03-05|||November 2004||2004-11-01|March 2007|2007-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Cocoa Butter for Prevention of Stretch Marks|Topical Application of Cocoa Butter for Prevention of Striae Gravidarum|Completed||N/A|200||American University of Beirut Medical Center|||||f||||||||||||||2017-02-18 17:38:10.960049|2017-02-18 17:38:10.960049
NCT00114647|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2017-01-24|||October 19, 1981||1981-10-19|December 1, 2016|2016-12-01||||||||Observational|||Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies|Procedures to Obtain Plasma, Lymphocytes, or Other Specimens for Research Studies|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:38:11.062025|2017-02-18 17:38:11.062025
NCT00114634|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2015-12-24|2010-03-19||June 2005||2005-06-01|December 2015|2015-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome|Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome|Completed||Phase 2|13|Actual|National Institutes of Health Clinical Center (CC)|Poor power due to low enrollment|2|||f||||f||||||||||2017-02-18 17:38:11.176134|2017-02-18 17:38:11.176134
NCT00114621|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2017-01-24|||September 8, 2004||2004-09-08|March 16, 2012|2012-03-16|May 25, 2011|Actual|2011-05-25|||||Interventional|||Anthrax Vaccine Clinical Trials|Anthrax Vaccine Clinical Trials|Completed||Phase 1|93|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:38:11.511313|2017-02-18 17:38:11.511313
NCT00114608|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2008-03-10|||June 2005||2005-06-01|March 2008|2008-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot|Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot|Completed||Phase 1|40|Actual|University at Buffalo||1|||f||||t||||||||||2017-02-18 17:38:11.622793|2017-02-18 17:38:11.622793
NCT00114595|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2005-06-23|||April 2003||2003-04-01|June 2005|2005-06-01|March 2005||2005-03-01|||||Interventional|||Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia|A Double-Blind, Randomised, Parallel-Group Comparison of Ethyl-Eicosapentaenoic Acid (Ethyl-EPA) Versus Placebo as Add-on Medication in Patients With Established Tardive Dyskinesia|Completed||Phase 4|84||University of Stellenbosch|||||f||||||||||||||2017-02-18 17:38:11.735286|2017-02-18 17:38:11.735286
NCT00114582|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2009-02-12|||April 2002||2002-04-01|February 2009|2009-02-01|December 2003||2003-12-01|||||Interventional|||Optimizing the Ambiance During Mealtimes in Dutch Nursing Homes|Optimizing the Ambiance During Mealtimes in Dutch Nursing Homes|Completed||Phase 2|120||Wageningen University|||||f||||||||||||||2017-02-18 17:38:11.82549|2017-02-18 17:38:11.82549
NCT00114569|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2016-05-20|||March 2005||2005-03-01|May 2009|2009-05-01|February 2009|Actual|2009-02-01|April 2007|Actual|2007-04-01||Interventional|||Lorazepam for the Treatment of Status Epilepticus in Children|Use of Lorazepam for the Treatment of Status Epilepticus|Completed||Phase 1|69|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||t||||||||||2017-02-18 17:38:11.917888|2017-02-18 17:38:11.917888
NCT00114556|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2006-05-08|||February 2000||2000-02-01|December 2004|2004-12-01|August 2004||2004-08-01|||||Interventional|||The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients|The Effect Of The Bisphosphonate, Zoledronic Acid, On Bone Density In Liver Transplant Patients – A Prospective, Randomised, Controlled Clinical Trial|Completed||Phase 4|100||Royal Prince Alfred Hospital, Sydney, Australia|||||f||||||||||||||2017-02-18 17:38:12.008193|2017-02-18 17:38:12.008193
NCT00114543|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2015-06-03|||September 2002||2002-09-01|June 2015|2015-06-01|November 2007|Actual|2007-11-01|April 2005|Actual|2005-04-01||Interventional|Phototherapy||Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight|A Randomized Trial of Aggressive or Conservative Phototherapy for Extremely Low Birth Weight Infants|Completed||Phase 3|1974|Actual|NICHD Neonatal Research Network||4|||f||||t||||||||||2017-02-18 17:38:12.100526|2017-02-18 17:38:12.100526
NCT00114530|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2017-02-01|||June 2005||2005-06-01|February 2017|2017-02-01|April 2016|Actual|2016-04-01|April 2016|Actual|2016-04-01||Interventional|||Scleroderma: Cyclophosphamide or Transplantation (SCOT)|A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)|Completed||Phase 2/Phase 3|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|The plan is to share data in ImmPort [https://immport.niaid.nih.gov/ ], a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts, after completion of the study and data analysis.|2017-02-18 17:38:12.253356|2017-02-18 17:38:12.253356
NCT00114517|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-15|2010-06-17|||July 2004||2004-07-01|June 2010|2010-06-01|July 2013|Anticipated|2013-07-01|December 2012|Anticipated|2012-12-01||Interventional|||ELITE: Early Versus Late Intervention Trial With Estradiol|Biologic Response of Menopausal Women to 17B-Estradiol|Unknown status|Active, not recruiting|Phase 2/Phase 3|643|Actual|University of Southern California||2|||f||||t||||||||||2017-02-18 17:38:12.409291|2017-02-18 17:38:12.409291
NCT00114465|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2009-09-17|||June 2005||2005-06-01|September 2009|2009-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease|Randomized, Double-Blind, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohn's Disease|Completed||Phase 4|38|Actual|Orphan Australia||2|||f||||t||||||||||2017-02-18 17:38:13.380072|2017-02-18 17:38:13.380072
NCT00114452|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2014-12-02|||February 2005||2005-02-01|December 2014|2014-12-01|February 2009|Actual|2009-02-01|October 2006|Actual|2006-10-01||Interventional|||Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction|A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction|Completed||Phase 1|53|Actual|Mesoblast, Ltd.||1|||f||||||||||||||2017-02-18 17:38:13.513064|2017-02-18 17:38:13.513064
NCT00114439|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2007-09-26|||September 2005||2005-09-01|September 2007|2007-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Lithium Cannabis Withdrawal Study|An Open Label Trial of Lithium for the Management of Cannabis Withdrawal|Completed||Phase 2|25|Anticipated|Sydney South West Area Health Service|||||f||||||||||||||2017-02-18 17:38:13.640992|2017-02-18 17:38:13.640992
NCT00114426|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2005-08-16|||January 2002||2002-01-01|February 2005|2005-02-01|December 2004||2004-12-01|||||Interventional|||Effects of NIMV on the Health Status of Chronic Obstructive Pulmonary Disease (COPD )Patients|Effects of Nocturnal Noninvasive Mechanical Ventilation on the Health Status of Patients With COPD|Terminated||Phase 3|40||University of British Columbia|||||f||||||||||||||2017-02-18 17:38:13.739253|2017-02-18 17:38:13.739253
NCT00114413|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2017-02-08|||August 2004||2004-08-01|February 2017|2017-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents|Asthma Control Evaluation (ACE): A Biomarker-Based Approach to Improving Asthma Control and Mechanistic Studies (DAIT ICAC-02)|Completed||N/A|547|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 17:38:13.828788|2017-02-18 17:38:13.828788
NCT00114400|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2009-12-09|||November 2000||2000-11-01|February 2007|2007-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||BVAIT: B-Vitamin Atherosclerosis Intervention Trial|B-Vitamin Atherosclerosis Intervention Trial (BVAIT)|Completed||Phase 2/Phase 3|506||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:38:13.95812|2017-02-18 17:38:13.95812
NCT00114387|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2009-12-09|||July 1996||1996-07-01|June 2005|2005-06-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||VEAPS: Vitamin E Atherosclerosis Prevention Study|VEAPS: Vitamin E Atherosclerosis Prevention Study|Completed||Phase 2/Phase 3|353||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:38:14.062193|2017-02-18 17:38:14.062193
NCT00114374|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2014-06-05|||June 2005||2005-06-01|June 2014|2014-06-01|June 2007|Actual|2007-06-01|||||Interventional|||SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims|SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and Posttraumatic Stress Disorder in Physical Trauma Victims in the Medical Setting|Terminated||Phase 3|60|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:38:14.161415|2017-02-18 17:38:14.161415
NCT00114361|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2010-06-18|||March 2005||2005-03-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|May 2008|Actual|2008-05-01||Interventional|||48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection|Peginterferon Alfa-2a and Ribavirin Combination Therapy in Patients With HBeAg-negative Chronic HBV Infection (PARC Study)|Completed||Phase 3|138|Actual|Foundation for Liver Research||2|||f||||t||||||||||2017-02-18 17:38:14.268108|2017-02-18 17:38:14.268108
NCT00114348|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2013-02-01|||August 2003||2003-08-01|February 2013|2013-02-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia|ALL-REZ BFM 2002: Protocol for the Treatment of Children With Relapsed Acute Lymphoblastic Leukemia|Completed||Phase 4|338|Actual|Charite University, Berlin, Germany||2|||f||||||||||||||2017-02-18 17:38:14.380399|2017-02-18 17:38:14.380399
NCT00114335|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2008-10-09|||May 2005||2005-05-01|October 2008|2008-10-01|July 2005|Actual|2005-07-01|||||Observational|||Epidemiologic Data of Patients in a Teaching Hospital|Prevalence of Impaired Renal Function in Medical Inpatients|Completed||N/A|352|Actual|Luzerner Kantonsspital|||1||f||||||||||||||2017-02-18 17:38:14.504978|2017-02-18 17:38:14.504978
NCT00114322|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-14|2007-01-12|||May 2005||2005-05-01|June 2005|2005-06-01||||||||Interventional|||Light-Emitting Diode (LED) Light for Seasonal Affective Disorder (SAD) Treatment|Comparing Wavelengths Using LED Light for SAD Treatment|Unknown status|Recruiting|N/A|24||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:38:14.593481|2017-02-18 17:38:14.593481
NCT00114309|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2009-04-01|||November 2004||2004-11-01|April 2009|2009-04-01|August 2009|Anticipated|2009-08-01|March 2009|Actual|2009-03-01||Interventional|||131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma|A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131-I-TM-601 in Adult Patients With Recurrent High-Grade Glioma|Unknown status|Active, not recruiting|Phase 2|66|Anticipated|TransMolecular||2|||f||||||||||||||2017-02-18 17:38:14.693589|2017-02-18 17:38:14.693589
NCT00114296|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2013-09-16|||April 2005||2005-04-01|July 2006|2006-07-01||||||||Interventional|||Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer|A Pilot Study to Evaluate the Effects of Omega-3 Fatty Acids on Intermediate Markers of Breast Cancer|Unknown status|Active, not recruiting|N/A|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:14.835319|2017-02-18 17:38:14.835319
NCT00114283|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2015-04-14|||March 2005||2005-03-01|November 2012|2012-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|A Phase 2 Trial of GW572016 in Patients With Metastatic and Recurrent Squamous Cell Carcinomas of the Head and Neck|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:38:14.931335|2017-02-18 17:38:14.931335
NCT00114270|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2013-03-25|||May 2004||2004-05-01|April 2006|2006-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density|Evaluating the Effect of Letrozole With or Without Concomitant Zoledronic Acid on Estrogen Responsive Targets in Postmenopausal Women|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:15.054487|2017-02-18 17:38:15.054487
NCT00114257|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2013-02-08|||May 2005||2005-05-01|September 2006|2006-09-01||||September 2006|Actual|2006-09-01||Interventional|||Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders|A Phase I Study of 5-AZA-2'-Deoxycytidine and Depsipeptide in Patients With Relapsed/Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disease|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:38:15.147007|2017-02-18 17:38:15.147007
NCT00114244|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2015-01-06|2015-01-06||December 2004||2004-12-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer|A Randomized Phase II Study of BAY 43-9006 in Combination With Gemcitabine in Metastatic Pancreatic Carcinoma|Completed||Phase 2|52|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:38:15.27173|2017-02-18 17:38:15.27173
NCT00114231|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2016-07-01|||May 2006||2006-05-01|July 2016|2016-07-01||||October 2020|Anticipated|2020-10-01||Interventional|||Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer|A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer|Active, not recruiting||Phase 2|90|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 17:38:16.187208|2017-02-18 17:38:16.187208
NCT00114218|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2014-12-23|||March 2005||2005-03-01|December 2014|2014-12-01||||July 2010|Actual|2010-07-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer|A Phase II Evaluation of Gemcitabine (NSC #613327) and Docetaxel (NSC # 628503) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus|Completed||Phase 2|28|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:38:16.428743|2017-02-18 17:38:16.428743
NCT00114205|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2010-03-17|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion|Phase I Trial of Intrapleural Docetaxel Administered Via an Implantable Catheter in Subjects With a Malignant Pleural Effusion|Completed||Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:16.538046|2017-02-18 17:38:16.538046
NCT00114192|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2010-01-29|||June 2004||2004-06-01|January 2010|2010-01-01||||June 2007|Actual|2007-06-01||Interventional|||Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Docetaxel and Thalidomide as a Second-Line Treatment for Non-Small Cell Lung Cancer|Completed||Phase 2|37|Anticipated|University of Virginia||1|||f||||t||||||||||2017-02-18 17:38:16.630128|2017-02-18 17:38:16.630128
NCT00114179|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2015-04-14|||January 2005||2005-01-01|December 2013|2013-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery|A Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab For Locally Advanced Pancreatic Cancer|Completed||Phase 2|82|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:38:16.731606|2017-02-18 17:38:16.731606
NCT00114166|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2014-05-27|2014-05-27||January 2005||2005-01-01|May 2014|2014-05-01||||January 2011|Actual|2011-01-01||Interventional||Total number eligible and evaluable participants from Regimen I and Regimen II|Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|A Randomized Phase II Evaluation of Topotecan (NSC #609699) Administered Daily x 5 Every 3 Weeks vs Weekly Topotecan in the Treatment of Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|Completed||Phase 2|81|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 17:38:16.864176|2017-02-18 17:38:16.864176
NCT00114153|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2009-11-25|||June 2003||2003-06-01|April 2007|2007-04-01||||||||Interventional|||Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Phase I Trial of Induction Paraplatin® and Xeloda® Followed by Concurrent Paraplatin and Xeloda With Intensity Modulated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:17.77301|2017-02-18 17:38:17.77301
NCT00114140|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2016-10-19|||January 2005||2005-01-01|October 2016|2016-10-01||||February 2013|Actual|2013-02-01||Interventional|||Temozolomide and Radiation Therapy in Treating Patients With Gliomas|A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas|Active, not recruiting||Phase 2|136|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 17:38:17.875377|2017-02-18 17:38:17.875377
NCT00114127|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2014-06-05|2012-01-27||June 2004||2004-06-01|June 2014|2014-06-01|July 2010|Actual|2010-07-01|November 2008|Actual|2008-11-01||Interventional|||Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome|Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome|Completed||Phase 3|28|Actual|Massachusetts General Hospital|Open-label in phase Phase 1; Limited power due to small sample size.|3|||f||||||||||||||2017-02-18 17:38:18.031371|2017-02-18 17:38:18.031371
NCT00114114|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2016-09-16|||September 2004||2004-09-01|September 2016|2016-09-01|July 2018|Anticipated|2018-07-01|July 2018|Anticipated|2018-07-01||Interventional|||Dose-Response of Gonadal Steroids and Bone Turnover in Men|Dose-Response of Gonadal Steroids and Bone Turnover in Men|Recruiting||N/A|900|Anticipated|Massachusetts General Hospital||3|||f||||t||||||||||2017-02-18 17:38:18.960266|2017-02-18 17:38:18.960266
NCT00114101|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2016-11-29|2013-03-28||December 2004||2004-12-01|November 2016|2016-11-01||||December 2012|Actual|2012-12-01||Interventional|||Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant|A Phase III Randomized, Double-Blind Study of Maintenance Therapy With CC-5013 (NSC # 703813) or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma|Active, not recruiting||Phase 3|460|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 17:38:19.107685|2017-02-18 17:38:19.107685
NCT00114088|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2005-06-23|||November 1997||1997-11-01|June 2005|2005-06-01|January 2004||2004-01-01|||||Interventional|||Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)|Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)|Completed||Phase 3|242||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:38:20.219972|2017-02-18 17:38:20.219972
NCT00114075|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2012-07-17|||January 2005||2005-01-01|August 2011|2011-08-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Effects of Walking Analysis on Surgical Outcomes|Impact of Gait Analysis on Surgical Outcomes|Completed||Phase 2|186|Actual|Agency for Healthcare Research and Quality (AHRQ)||2|||f||||f||||||||||2017-02-18 17:38:20.301267|2017-02-18 17:38:20.301267
NCT00114062|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2016-11-28|||September 2005||2005-09-01|November 2016|2016-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study to Treat Uveitis Associated Macular Edema|A Randomized, Double-Masked, Parallel Group, Multi-Center, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Uveitis Associated Macular Edema|Terminated||Phase 2|15|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:38:20.703291|2017-02-18 17:38:20.703291
NCT00114049|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2017-01-18|||December 2004||2004-12-01|January 2017|2017-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Dental Pain (Following Third Molar Tooth Extraction) Study|A Pivotal Phase III, Single Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Investigate the Efficacy and Safety of Single Oral Doses of 10mg, 25mg, 50mg and 70mg GW406381 and 550mg Naproxen Sodium in Subjects With Pain Following Third Molar Tooth Extraction|Completed||Phase 3|300||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:38:20.802387|2017-02-18 17:38:20.802387
NCT00114036|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2005-06-23|||August 2002||2002-08-01|June 2005|2005-06-01|December 2005||2005-12-01|||||Interventional|||Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE)|Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE)|Unknown status|Active, not recruiting|N/A|||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:38:20.907283|2017-02-18 17:38:20.907283
NCT00113061|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2016-07-28|||July 2004||2004-07-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|||Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults|INFLAME: Inflammation and Exercise|Completed||N/A|162||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:38:21.010089|2017-02-18 17:38:21.010089
NCT00113048|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2014-02-04|||December 2003||2003-12-01|February 2014|2014-02-01|September 2005||2005-09-01|||||Interventional|||Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies|A Phase I Study of Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies|Terminated||Phase 1|24||Sanofi|||||||||||||||||||2017-02-18 17:38:21.103644|2017-02-18 17:38:21.103644
NCT00113035|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2015-05-04|||May 2005||2005-05-01|May 2015|2015-05-01|October 2005|Actual|2005-10-01|||||Observational|||Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease|Screening Protocol to Evaluate Acid Alpha Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease for Potential Inclusion in Future Clinical Studies With Myozyme (Alglucosidase Alfa)|Completed||N/A|60||Sanofi|||1||||||||||||||||2017-02-18 17:38:21.197305|2017-02-18 17:38:21.197305
NCT00113022|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2012-07-09|2011-04-13||May 2005||2005-05-01|July 2012|2012-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Org 24448 to Treat Major Depression|An Investigation of the Antidepressant Efficacy and Safety of an AMPAkine (Org 24448) in Major Depressive Disorder, A Double-Blind, Placebo-Controlled, Randomized Study|Terminated||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||2||Terminated due to concerns about adverse events in separate study.|f||||t||||||||||2017-02-18 17:38:21.278838|2017-02-18 17:38:21.278838
NCT00113009|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2007-11-21|||March 2005||2005-03-01|March 2006|2006-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease|A Phase II, Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease|Completed||Phase 2|148||Valentis|||||||||||||||||||2017-02-18 17:38:21.709606|2017-02-18 17:38:21.709606
NCT00112996|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2014-04-07|||January 2007||2007-01-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer|Prevention of Cisplatin- or Oxaliplatin-Induced Peripheral Neuropathy With Alpha-Lipoic Acid: A Placebo-Controlled Phase III Trial|Completed||Phase 3|244|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 17:38:21.831395|2017-02-18 17:38:21.831395
NCT00114023|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-13|2007-02-16|||January 2005||2005-01-01|October 2006|2006-10-01||||||||Observational|||1-Year Follow up to the 1473-IMIQ Study|A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1473-IMIQ Study|Completed||Phase 3|84||Graceway Pharmaceuticals, LLC|||||||||||||||||||2017-02-18 17:38:21.965663|2017-02-18 17:38:21.965663
NCT00114010|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-11|2017-01-24|||April 1, 2005||2005-04-01|August 19, 2010|2010-08-19|December 22, 2006|Actual|2006-12-22|December 22, 2006|Actual|2006-12-22||Interventional|||Experimental Vaccine for Malaria|Phase 1 Study of the Safety of Immunization of Naive Individuals With AMA1-C1/Alhydrogel [R], an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria, and the Effect of Immunization on Antigen-specific Memory and Plasma B Cells and T Cells|Completed||Phase 1|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:38:22.049803|2017-02-18 17:38:22.049803
NCT00113997|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-11|2008-03-03|||June 2005||2005-06-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Safety and Dosing Evaluation of REG1 Anticoagulation System|The Healthy Volunteer Evaluation of an Aptamer-RNA Target to Factor IXa|Completed||Phase 1|106||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:38:22.131602|2017-02-18 17:38:22.131602
NCT00113984|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-11|2017-01-24|||June 8, 2005||2005-06-08|November 7, 2012|2012-11-07|December 1, 2011|Actual|2011-12-01|February 1, 2008|Actual|2008-02-01||Interventional|||Vaccine and Antibody Treatment of Prostate Cancer|Phase I Trial of a PSA Based Vaccine and an Anti-CTLA-4 Antibody in Adults With Metastatic Androgen Independent Prostrate Cancer|Completed||Phase 1|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:38:22.213975|2017-02-18 17:38:22.213975
NCT00113971|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2012-03-30|||April 2005||2005-04-01|March 2012|2012-03-01|June 2007|Actual|2007-06-01|March 2007|Actual|2007-03-01||Interventional|||Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)|A Randomized Phase II Pharmacokinetics/Pharmacodynamics Study of Epratuzumab in Patients With Systemic Lupus Erythematosus|Terminated||Phase 2|20||UCB Pharma|||||f||||||||||||||2017-02-18 17:38:22.31843|2017-02-18 17:38:22.31843
NCT00113958|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2013-05-10||||||May 2013|2013-05-01||||||||Interventional|||Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels|Cinacalcet Open Label Study to Reach K/DOQI Levels|Completed||Phase 2|||Amgen|||||||||||||||||||2017-02-18 17:38:22.419908|2017-02-18 17:38:22.419908
NCT00113945|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2013-05-10|||July 2003||2003-07-01|May 2013|2013-05-01||||||||Interventional|||Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)|TARGET: Treatment Strategies to Achieve Recommended K/DOQI Goals in ESRD Patients on CinacalceT|Completed||Phase 2|360||Amgen|||||||||||||||||||2017-02-18 17:38:22.516677|2017-02-18 17:38:22.516677
NCT00113932|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2011-09-01|||December 2003||2003-12-01|September 2011|2011-09-01|July 2010|Actual|2010-07-01|February 2009|Actual|2009-02-01||Interventional|||UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma|UARK 2003-41: A Phase II Study of High-Dose Density Therapy With Tandem Autologous Transplants for Patients With Multiple Myeloma|Completed||Phase 2|140|Actual|University of Arkansas||1|||f||||t||||||||||2017-02-18 17:38:22.617387|2017-02-18 17:38:22.617387
NCT00113919|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2015-04-10|2011-04-14||June 2004||2004-06-01|April 2015|2015-04-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients|UARK 2003-25: A Phase I/II Open Label Study of IV Busulfan (Busulfex®) in Multiple Myeloma Patients Older Than 65 Years of Age or With Renal Insufficiency|Terminated||Phase 1/Phase 2|14|Actual|University of Arkansas|"Early termination, only 5 of the 14 completed, reasons as follows:~Death Unrelated to Protocol Adverse Event Relapse Patient Choice"|1||Due to poor accrual|f||||t||||||||||2017-02-18 17:38:22.71718|2017-02-18 17:38:22.71718
NCT00113906|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2014-02-10|||March 2005||2005-03-01|June 2005|2005-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Melatonin Treatment After Laparoscopic Cholecystectomy|The Effect of Melatonin Treatment on Postoperative Fatigue and Sleep Disturbances: A Placebo Controlled Randomized Clinical Trial|Completed||Phase 2/Phase 3|200||University Hospital, Gentofte, Copenhagen|||||f||||t||||||||||2017-02-18 17:38:22.991719|2017-02-18 17:38:22.991719
NCT00113893|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2013-10-15||2013-09-13|May 2005||2005-05-01|October 2013|2013-10-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.|A Randomized, MultiCenter, Open-Label, Modified Dose-Ascension, Parallel Study of the Safety, Tolerability, and Efficacy of Oral SCIO-469 in Patients With Myelodysplastic Syndromes|Completed||Phase 2|62|Actual|Scios, Inc.||4|||f||||||||||||||2017-02-18 17:38:23.16821|2017-02-18 17:38:23.16821
NCT00113880|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2012-12-03|2012-04-02||October 2003||2003-10-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|September 2008|Actual|2008-09-01||Observational|||A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults|Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults 5-49 Years of Age|Completed||N/A|63061|Actual|MedImmune LLC|||3||f||||f||||||||||2017-02-18 17:38:23.297262|2017-02-18 17:38:23.297262
NCT00113867|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2009-12-09|||September 2003||2003-09-01|November 2006|2006-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women|Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women|Completed||N/A|80||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:38:25.181022|2017-02-18 17:38:25.181022
NCT00113854|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2005-06-23|||October 2004||2004-10-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Interventional|||Mannitol as Adjunct Therapy for Childhood Cerebral Malaria|Effect of Mannitol as Adjunct Therapy on the Clinical Outcome of Childhood Cerebral Malaria in Mulago Hospital: A Randomised Clinical Trial|Unknown status|Active, not recruiting|Phase 3|156||Makerere University|||||f||||||||||||||2017-02-18 17:38:25.264519|2017-02-18 17:38:25.264519
NCT00113841|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2011-11-15|2011-09-13||November 2004||2004-11-01|November 2011|2011-11-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma|Pilot Study of Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma|Completed||N/A|42|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 17:38:25.356356|2017-02-18 17:38:25.356356
NCT00113828|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2007-12-28|||December 2004||2004-12-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Non-Myeloablative HLA-Matched Ex-Vivo T-Cell Depleted Stem Cell Transplantation for Hematologic Malignancies|Non-Myeloablative HLA-Matched Ex-Vivo T-Cell Depleted Stem Cell Transplantation for Hematologic Malignancies|Terminated||Phase 2|5|Actual|Massachusetts General Hospital||1||Insufficient accrual|f||||t||||||||||2017-02-18 17:38:25.700099|2017-02-18 17:38:25.700099
NCT00113815|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2014-03-25|||May 2005||2005-05-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures|A Randomized, Double-Blind, Placebo-Controlled, Fixed Dose-Ranging Study to Assess the Safety, Tolerability, and Efficacy of Topiramate Oral Liquid and Sprinkle Formulations as an Adjunct to Concurrent Anticonvulsant Therapy for Infants (1-24 Months of Age) With Refractory Partial-Onset Seizures|Completed||Phase 3|118|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||4|||f||||||||||||||2017-02-18 17:38:25.816792|2017-02-18 17:38:25.816792
NCT00113802|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2008-02-04|||August 2004||2004-08-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Epratuzumab (hLL2) in Patients With Waldenstrom's Macroglobulinemia|A Phase II, Single-Arm Trial of Epratuzumab, an Anti-CD22 Humanized Antibody, in Patients With Waldenstrom's Macroglobulinemia|Terminated||Phase 2|31||Immunomedics, Inc.||||low accrual|||||||||||||||2017-02-18 17:38:26.112132|2017-02-18 17:38:26.112132
NCT00113789|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2009-02-12|||October 2003||2003-10-01|February 2009|2009-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer|Randomized, Phase 2 Study of Pegfilgrastim Given on the Last Day of a Multi-Day Topotecan Regimen or the Day After in Subjects With Relapsed or Refractory Ovarian Cancer|Completed||Phase 2|21|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:38:26.197878|2017-02-18 17:38:26.197878
NCT00113776|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2011-01-20||||||January 2011|2011-01-01||||||||Interventional|||Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer|A Multicenter, Open-label, Single Arm Clinical Trial to Determine the Safety of ABX-EGF Extended Therapy in Subjects With Metastatic Colorectal Cancer|Completed||Phase 2|||Amgen||1|||||||||||||||||2017-02-18 17:38:26.294027|2017-02-18 17:38:26.294027
NCT00113763|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2014-07-15|2010-08-06||January 2004||2004-01-01|July 2014|2014-07-01|June 2009|Actual|2009-06-01|October 2008|Actual|2008-10-01||Interventional|||Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer|An Open-label, Randomized, Phase 3 Clinical Trial of ABX-EGF Plus Best Supportive Care Versus Best Supportive Care in Subjects With Metastatic Colorectal Cancer|Completed||Phase 3|463|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:38:26.397371|2017-02-18 17:38:26.397371
NCT00113542|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-08|2015-05-20|||June 2004||2004-06-01|August 2008|2008-08-01|June 2005||2005-06-01|||||Interventional|||A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris|An Open Label Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris|Completed||Phase 2|10||University of Michigan|||||||||||||||||||2017-02-18 17:38:34.513659|2017-02-18 17:38:34.513659
NCT00113750|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-10|2010-06-16|||July 2005||2005-07-01|June 2010|2010-06-01|December 2005||2005-12-01|||||Interventional|||Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen|A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Tree MATA in Subjects Allergic to Tree Pollen|Completed||Phase 2|70||Allergy Therapeutics|||||||||||||||||||2017-02-18 17:38:30.410777|2017-02-18 17:38:30.410777
NCT00113737|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2016-02-17|||February 1998||1998-02-01|June 2005|2005-06-01|January 2002|Actual|2002-01-01|||||Interventional|||Fluoxetine as a Quit Smoking AID for Depression Prone||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:38:30.50742|2017-02-18 17:38:30.50742
NCT00113724|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2009-06-03|||May 2005||2005-05-01|June 2009|2009-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Study of TPI 287 in Patients With Advanced Malignancies|A Phase I, Open-Label, Dose Escalation, Multi-Center Study of TPI 287 in Patients With Advanced Malignancies|Completed||Phase 1|48|Anticipated|Cortice Biosciences, Inc.|||||t||||f||||||||||2017-02-18 17:38:30.590785|2017-02-18 17:38:30.590785
NCT00113711|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2016-05-12|||January 1995||1995-01-01|June 2005|2005-06-01|August 1999|Actual|1999-08-01|||||Interventional|||Promoting Smoking Cessation and Reducing Weight Gain||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:38:30.681318|2017-02-18 17:38:30.681318
NCT00113698|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2014-03-11|||December 2004||2004-12-01|March 2014|2014-03-01|January 2006|Actual|2006-01-01|November 2005|Actual|2005-11-01||Interventional|AceiMR||Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation|Trial of ACE Inhibition in Children With Mitral Regurgitation After Repair of AVSD|Terminated||Phase 3|5|Actual|University of Utah||2||lower than expected enrollment|f||||t||||||||||2017-02-18 17:38:30.839414|2017-02-18 17:38:30.839414
NCT00113685|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2016-02-08|||April 2003||2003-04-01|April 2007|2007-04-01|March 2007||2007-03-01|||||Interventional|||Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury|Effect of Hypertonic Resuscitation for Blunt Trauma|Completed||N/A|209||University of Washington|||||f||||||||||||||2017-02-18 17:38:31.150685|2017-02-18 17:38:31.150685
NCT00113672|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2013-04-02|||August 2004||2004-08-01|April 2013|2013-04-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|MBC||Make Better Choices Study|Multiple Behavior Change in Diet and Activity|Completed||N/A|204|Actual|Northwestern University||4|||f||||t||||||||||2017-02-18 17:38:31.253399|2017-02-18 17:38:31.253399
NCT00113659|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2015-02-27|||June 2005||2005-06-01|February 2015|2015-02-01|June 2015|Anticipated|2015-06-01|May 2014|Actual|2014-05-01||Interventional|||Use of a Probiotic Supplement to Prevent Asthma in Infants|Trial of Infant Probiotic Supplementation to Prevent Asthma|Unknown status|Active, not recruiting|N/A|203|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 17:38:31.35846|2017-02-18 17:38:31.35846
NCT00113646|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2016-03-04|||November 2002||2002-11-01|March 2016|2016-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies|Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies|Terminated||Phase 2|14|Actual|Massachusetts General Hospital||1||Expiration of MEDI-507. MEDI-507 did not become available again to re-open the trial|f||||||||||||||2017-02-18 17:38:31.482312|2017-02-18 17:38:31.482312
NCT00113633|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2014-03-03|||September 2003||2003-09-01|March 2014|2014-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma|A Three-part Intervention to Improve Regular Care for Asthma After a Pediatric Emergency Department Visit: A Randomized Clinical Trial|Completed||N/A|439|Actual|Children's Hospital of Philadelphia||2|||f||||f||||||||||2017-02-18 17:38:31.580897|2017-02-18 17:38:31.580897
NCT00113620|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2016-07-13|||July 2005||2005-07-01|July 2016|2016-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy|A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine at Two Dose Levels in the Treatment of the Pain of Diabetic Neuropathy|Completed||Phase 3|450|Anticipated|Avanir Pharmaceuticals|||||||||||||||||||2017-02-18 17:38:31.695152|2017-02-18 17:38:31.695152
NCT00113607|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2014-06-18|2013-06-18||April 2005||2005-04-01|June 2014|2014-06-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer|An Open-Label Multicenter Randomized Phase 3 Study Comparing the Combination of DOXIL/CAELYX and YONDELIS With DOXIL/CAELYX Alone in Subjects With Advanced Relapsed Ovarian Cancer|Completed||Phase 3|672|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-02-18 17:38:31.840446|2017-02-18 17:38:31.840446
NCT00113594|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2007-11-05|||June 2005||2005-06-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder|Population Pharmacokinetic Study in Adolescent Patients With Schizophrenia or Bipolar I Disorder Treated With Olanzapine|Completed||Phase 3|100||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:38:33.555061|2017-02-18 17:38:33.555061
NCT00113581|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-09|2014-02-17|||October 2002||2002-10-01|February 2014|2014-02-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer|A Phase I Study to Determine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Three Doses of Humanised EGFR Antibody EMD 72000 in Combination With ECX in Patients With Advanced Oesophagogastric Adenocarcinoma|Completed||Phase 1|26||Merck KGaA|||||f||||||||||||||2017-02-18 17:38:33.6588|2017-02-18 17:38:33.6588
NCT00113568|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-08|2010-06-09|2009-12-11||June 2005||2005-06-01|June 2010|2010-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Safety Study of XP12B in Women With Menorrhagia|Multicenter Study to Evaluate the Safety of XP12B in Women With Heavy Menstrual Bleeding Associated With Menorrhagia|Completed||Phase 3|784|Actual|Ferring Pharmaceuticals||1|||f||||t||||||||||2017-02-18 17:38:33.750818|2017-02-18 17:38:33.750818
NCT00113555|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-08|2011-06-10|||December 2001||2001-12-01|May 2011|2011-05-01|November 2010|Actual|2010-11-01|July 2008|Actual|2008-07-01||Interventional|ACT||Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence|Clinical Investigation of an Adjustable Continence Therapy (ACT) Periurethral Prosthetic System for Treatment of Female Stress Urinary Incontinence With or Without Hypermobility|Completed||Phase 2/Phase 3|221|Actual|Uromedica||1|||f||||f||||||||||2017-02-18 17:38:34.414688|2017-02-18 17:38:34.414688
NCT00005358|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||April 1994||1994-04-01|January 2016|2016-01-01|March 1999||1999-03-01|||||Observational|||Thrombogenic Factors and Recurrent Coronary Events||Completed||N/A|||University of Rochester|||||f||||||||||||||2017-02-18 18:15:06.063273|2017-02-18 18:15:06.063273
NCT00113529|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-08|2011-08-25|2010-03-01||October 2004||2004-10-01|August 2011|2011-08-01|October 2008|Actual|2008-10-01|September 2007|Actual|2007-09-01||Interventional|||Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma|A Phase 1/2 Safety And Pharmacokinetic Study Of SU011248 In Combination With Gefitinib (Iressa) In Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|42|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:38:34.629884|2017-02-18 17:38:34.629884
NCT00113516|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-08|2010-05-14|2010-03-08||September 2005||2005-09-01|May 2010|2010-05-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer|Phase 2 Study Of SU011248 As Consolidation Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|84|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:38:35.941292|2017-02-18 17:38:35.941292
NCT00113503|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-08|2010-01-12|||February 2005||2005-02-01|January 2010|2010-01-01|November 2007|Anticipated|2007-11-01|||||Interventional|||Imuran Dosing in Crohn's Disease Study|A Multi-site Trial of Azathioprine Dosing in Crohn's Disease|Terminated||Phase 2|226|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:38:37.740142|2017-02-18 17:38:37.740142
NCT00113490|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-08|2013-04-03|2013-04-03||May 2005||2005-05-01|April 2013|2013-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children|A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), After Dosing for a Second Season in Children Who Previously Received MEDI-524 in Protocol MI-CP104|Completed||Phase 1/Phase 2|136|Actual|MedImmune LLC||2|||f||||f||||||||||2017-02-18 17:38:37.855455|2017-02-18 17:38:37.855455
NCT00113477|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-08|2011-06-30|||May 2005||2005-05-01|September 2008|2008-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy|A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy|Completed||Phase 4|40|Anticipated|Oslo University Hospital|||||f||||||||||||||2017-02-18 17:38:38.373738|2017-02-18 17:38:38.373738
NCT00113464|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2017-01-24|||June 2, 2005||2005-06-02|April 13, 2007|2007-04-13|April 13, 2007||2007-04-13|||||Observational|||Developing Newborn Screening for Infants With Primary Immunodeficiency|Developing Newborn Screening for Infants With Primary Immunodeficiency|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:38:38.466406|2017-02-18 17:38:38.466406
NCT00113451|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2005-06-23|||January 2004||2004-01-01|June 2005|2005-06-01|May 2005||2005-05-01|||||Observational|||Radial Artery Bypass Graft Study of Tromsø|Radial Artery Bypass Graft Study of Tromsø|Completed||N/A|119||University Hospital of North Norway|||||f||||||||||||||2017-02-18 17:38:38.552873|2017-02-18 17:38:38.552873
NCT00113438|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2011-10-28||2011-10-28|March 2005||2005-03-01|October 2011|2011-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors|A Randomized Open-Labeled Phase II Study of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin to Evaluate the Safety and Efficacy in Subjects With Advanced Imageable Malignancies|Completed||Phase 2|13|Actual|Mateon Therapeutics||2|||f||||f||||||||||2017-02-18 17:38:38.645139|2017-02-18 17:38:38.645139
NCT00113425|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2016-08-22|2016-04-07||August 2005||2005-08-01|August 2016|2016-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Non-cutting Laser Therapy in the Treatment of Acne|Photodynamic Therapy in the Treatment of Acne Vulgaris|Completed||Phase 2|44|Actual|University of Michigan||2|||f||||f||||||||No||2017-02-18 17:38:38.766471|2017-02-18 17:38:38.766471
NCT00113412|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2006-03-21|||May 2005||2005-05-01|March 2006|2006-03-01||||||||Interventional|||A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study Of Orally Administered SP01A As Monotherapy Treatment Of HIV-Infected Patients|Unknown status|Active, not recruiting|Phase 2|32||Samaritan Pharmaceuticals, Inc|||||||||||||||||||2017-02-18 17:38:39.242993|2017-02-18 17:38:39.242993
NCT00113399|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2013-06-26|2012-11-27||April 2005||2005-04-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery|A Phase III Trial for Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-Irradiation and Chemotherapy Versus Chemotherapy Alone|Terminated||Phase 3|15|Actual|Radiation Therapy Oncology Group|This study terminated early with 15 subjects out of 240 subjects accrued, therefore no analysis was performed.|2||Terminated early due to low accrual.|f||||t||||||||||2017-02-18 17:38:39.348777|2017-02-18 17:38:39.348777
NCT00113386|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2013-06-21|2012-11-27||April 2005||2005-04-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer|Phase III Randomized Trial of Preoperative Chemotherapy Versus Preoperative Concurrent Chemotherapy and Thoracic Radiotherapy Followed by Surgical Resection and Consolidation Chemotherapy in Favorable Prognosis Patients With Stage IIIA (N2) Non-Small Cell Lung Cancer|Terminated||Phase 3|19|Actual|Radiation Therapy Oncology Group|This study terminated early with 19 out of 574 subjects accrued. Therefore no analysis was performed.|2||This study terminated early due to low accrual.|f||||t||||||||||2017-02-18 17:38:40.22143|2017-02-18 17:38:40.22143
NCT00113373|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2015-05-28|2015-05-28||May 2005||2005-05-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional||Eligible and treated patients.|Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer|A Phase II Evaluation of Lapatinib (GW572016) (NCI-Supplied Agent, NSC #727989) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|28|Actual|National Cancer Institute (NCI)|The clinical trial was a two-stage design, accruing approximately 25 patients in each stage. Early termination of the study would result if warranted from an interim futility analysis. This study stopped early for lack of treatment efficacy.|1|||f||||||||||||||2017-02-18 17:38:40.803976|2017-02-18 17:38:40.803976
NCT00113360|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2012-08-01|2009-08-12||January 2005||2005-01-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma|Phase II Study of RAD001 Plus Octreotide Depot in Patients With Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma (Carcinoid, Islet Cell)|Completed||Phase 2|67|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:38:41.187676|2017-02-18 17:38:41.187676
NCT00113347|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2012-02-23|||April 2005||2005-04-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)|Phase I Evaluation of Erlotinib and Docetaxel With Concomitant Boost Radiation for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:38:41.457654|2017-02-18 17:38:41.457654
NCT00113334|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2014-07-14|2009-04-24||April 2005||2005-04-01|July 2014|2014-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer|A Phase 1b/2 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer|Completed||Phase 1/Phase 2|6|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:38:41.583401|2017-02-18 17:38:41.583401
NCT00113321|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2012-08-01|2009-09-25||March 2005||2005-03-01|August 2012|2012-08-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure|Phase II Study of Low-Dose Decitabine (5-AZA-2'-Deoxycytidine) in Myelodysplastic Syndrome (MDS) Post Azacytidine (AZA) Failure|Terminated||Phase 2|16|Actual|M.D. Anderson Cancer Center||1||Low Accrual|f||||f||||||||||2017-02-18 17:38:41.810569|2017-02-18 17:38:41.810569
NCT00113308|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2017-01-16|||June 2005||2005-06-01|January 2017|2017-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis|A Phase III, 12-Week, Multicentre, Double-Blind, Randomised, Placebo- and Active Comparator-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381, 5mg, 10mg, 25mg, and 50mg Administered Orally Once Daily, in Adults With Rheumatoid Arthritis|Completed||Phase 3|2208|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:38:42.070723|2017-02-18 17:38:42.070723
NCT00113295|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2014-03-20|2013-05-16||February 2004||2004-02-01|March 2014|2014-03-01|November 2007|Actual|2007-11-01|February 2007|Actual|2007-02-01||Interventional||Eligible participants were men or women aged 18 and older with a primary diagnosis of DSM-IV GAD.|Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder|Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder|Completed||Phase 4|50|Actual|Massachusetts General Hospital|"Relatively small sample size of the randomized controlled phase (phase 2); conclusions from the study are limited to low power; improvement in Phase I open label paroxetine CR may include placebo response to ancillary aspects of a treatment study."|2|||f||||t||||||||||2017-02-18 17:38:42.851982|2017-02-18 17:38:42.851982
NCT00113282|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2011-12-21|||June 2004||2004-06-01|June 2009|2009-06-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)|Study of the Immunological Efficacy of Adding Subcutaneous Interleukin-2 (IL-2) to an Optimized Antiretroviral Regimen in HIV-1-infected Subjects Experiencing Therapeutic Failure on an Ongoing Antiretroviral Combination With a CD4 Cell Count ≤ 200/mm3 ANRS 123 Trial|Completed||Phase 2|57|Actual|French National Agency for Research on AIDS and Viral Hepatitis|||||f||||t||||||||||2017-02-18 17:38:43.574507|2017-02-18 17:38:43.574507
NCT00113269|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-07|2011-08-09|2011-06-07||May 2005||2005-05-01|August 2011|2011-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|INTAC||Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients|Phase 4, Randomized, Open-label, Comparative, Multicenter Study to Assess the Safety and Efficacy of Induction Agents, Alemtuzumab, Basiliximab or Rabbit Anti-thymocyte Globulin in Combination With Tacrolimus, MMF, and a Rapid Steroid Withdrawal in Renal Transplant Recipients|Completed||Phase 4|501|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|4|||f||||t||||||||||2017-02-18 17:38:43.717922|2017-02-18 17:38:43.717922
NCT00113256|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-06|2013-01-22|||February 2005||2005-02-01|October 2009|2009-10-01||||February 2006|Actual|2006-02-01||Interventional|||Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer|Randomized Trial of Orathecin and Gemcitabine Versus Placebo and Gemcitabine in Patients With Non-Resectable Pancreatic Cancer Who Have Not Already Received Chemotherapy|Terminated||Phase 2/Phase 3|39|Actual|Astex Pharmaceuticals||1|||f||||||||||||||2017-02-18 17:38:46.267202|2017-02-18 17:38:46.267202
NCT00113243|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-06|2005-06-23|||December 2004||2004-12-01|June 2005|2005-06-01|December 2007||2007-12-01|||||Interventional|||Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease|Phase I Study of Stem Cell Mediated Angiogenesis for Limb Threatening Ischemia|Unknown status|Recruiting|Phase 1|20||Murphy, Michael P., MD|||||||||||||||||||2017-02-18 17:38:46.36604|2017-02-18 17:38:46.36604
NCT00113230|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-06|2012-07-31|2009-04-17||February 2005||2005-02-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer|Phase II Trial Of Neoadjuvant Concurrent Capecitabine, RHUMAB VEGF (Avastin) And Radiotherapy In Patients Presenting With Locally Advanced Rectal Cancer|Completed||Phase 2|25|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:38:46.457603|2017-02-18 17:38:46.457603
NCT00113217|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-06|2013-12-02|2013-09-04||February 2005||2005-02-01|December 2013|2013-12-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma|A Phase II Neoadjuvant Clinical Trial to Evaluate the Efficacy of Recombinant Humanized Monoclonal Anti-VEGF Antibody rhuMab VEGF (Bevacizumab) for Renal Cell Carcinoma|Completed||Phase 2|52|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:38:49.573143|2017-02-18 17:38:49.573143
NCT00113204|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-06|2008-05-15|||June 2005||2005-06-01|May 2008|2008-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|IPi-504-01||Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma|A Phase 1, Safety Assessment and Pharmacokinetic Study of IPI-504 in Patients With Relapsed, and Relapsed Refractory Multiple Myeloma|Completed||Phase 1|18|Actual|Infinity Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 17:38:49.897678|2017-02-18 17:38:49.897678
NCT00113191|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-06|2012-07-26||2012-07-26|May 2004||2004-05-01|July 2012|2012-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants|A Phase III, Randomized, Double-blind, Multi-center Clinical Trial Comparing the Safety and Efficacy of Veronate® Versus Placebo for the Prevention of Nosocomial Staphylococcal Sepsis in Premature Infants (Birth Weight 500 - 1250 g)|Completed||N/A|2000||Bristol-Myers Squibb|||||f||||t||||||||||2017-02-18 17:38:50.003086|2017-02-18 17:38:50.003086
NCT00113178|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-06|2011-02-23|||January 2004||2004-01-01|February 2011|2011-02-01|June 2005|Actual|2005-06-01|||||Interventional|||Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter|Clinical Study to Evaluate the Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Cavo-Tricuspid Valve Isthmus-Dependent Atrial Flutter|Completed||Phase 3|160||Boston Scientific Corporation|||||||||||||||||||2017-02-18 17:38:50.450624|2017-02-18 17:38:50.450624
NCT00113165|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-06|2016-12-02|||October 2004||2004-10-01|December 2016|2016-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures|A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures|Completed||Phase 3|244|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:38:50.549058|2017-02-18 17:38:50.549058
NCT00113152|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2017-01-24|||June 2, 2005||2005-06-02|October 2, 2007|2007-10-02|October 2, 2007||2007-10-02|||||Observational|||Heart Disease in Sickle Cell Anemia|Are Left Ventricular Abnormalities Associated With Pulmonary Hypertension in Sickle Cell Anemia?|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:38:50.812712|2017-02-18 17:38:50.812712
NCT00113139|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2014-07-11|||September 2000||2000-09-01|March 2014|2014-03-01|August 2008|Actual|2008-08-01|August 2007|Actual|2007-08-01||Interventional|INSPIRE||Investigational Study of Psychological Intervention in Recipients of Lung Transplant (INSPIRE)|An Investigation to Examine a Telephone Based Stress Management and Coping Skills Intervention for Patients Waiting for Lung Transplant|Completed||N/A|389|Actual|Duke University||2|||f||||t||||||||||2017-02-18 17:38:50.895082|2017-02-18 17:38:50.895082
NCT00113126|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2006-11-28|||January 2002||2002-01-01|June 2005|2005-06-01|October 2005||2005-10-01|||||Interventional|||Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection|A Randomized Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection|Completed||N/A|526||University Hospital, Geneva|||||f||||||||||||||2017-02-18 17:38:51.001153|2017-02-18 17:38:51.001153
NCT00113113|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2013-01-22|||August 2001||2001-08-01|June 2005|2005-06-01||||||||Interventional|||Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction|Phase I Study of Rubitecan (RFS 2000) in the Treatment of Cancer Patients With Organ Dysfunction|Completed||Phase 1|54|Anticipated|Astex Pharmaceuticals|||||f||||||||||||||2017-02-18 17:38:51.105547|2017-02-18 17:38:51.105547
NCT00113100|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2015-05-20|||August 2004||2004-08-01|August 2008|2008-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Mechanisms of Skin Repair by Topical Estrogen|Mechanisms of Skin Repair by Topical Estrogen in Vivo|Completed||N/A|152|Actual|University of Michigan|||||f||||||||||||||2017-02-18 17:38:51.192734|2017-02-18 17:38:51.192734
NCT00113087|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2010-09-16|2009-09-04||August 2003||2003-08-01|September 2009|2009-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|ISV||Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network|Trial of ACE Inhibition in Infants With Single Ventricle (A Trial Conducted by the Pediatric Heart Network)|Completed||Phase 3|230|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 17:38:51.314827|2017-02-18 17:38:51.314827
NCT00113074|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-03|2013-01-07|||September 2004||2004-09-01|January 2013|2013-01-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers|Blood Pressure Control in Hypertensive Smokers|Completed||N/A|376|Actual|University of Iowa||2|||f||||t||||||||||2017-02-18 17:38:52.76757|2017-02-18 17:38:52.76757
NCT00112983|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-05-29|||November 2004||2004-11-01|June 2005|2005-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria|TRIUMPH: A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:52.882267|2017-02-18 17:38:52.882267
NCT00112957|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-04-09|||July 2004||2004-07-01|April 2013|2013-04-01|May 2010|Actual|2010-05-01|January 2008|Actual|2008-01-01||Interventional|||Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|Phase II Study of Recombinant Vaccinia-NY-ESO-1 (rF-NY-ESO-1) and Recombinant Fowlpox-NY-ESO-1 (rF-NY-ESO-1) in Patients With Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma Whose Tumors Express NY-ESO-1 or LAGE-1 Antigen|Completed||Phase 2|22|Actual|Ludwig Institute for Cancer Research||1|||f||||t||||||||||2017-02-18 17:38:52.974648|2017-02-18 17:38:52.974648
NCT00112931|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2016-11-14|||September 2004||2004-09-01|November 2016|2016-11-01|May 2022|Anticipated|2022-05-01|March 2014|Actual|2014-03-01||Interventional|||Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma|An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy in Patients With Advanced Stage, Asymptomatic, Non-Bulky Follicular Lymphoma|Active, not recruiting||Phase 3|600|Anticipated|University College, London||2|||f||||t||||||||Undecided||2017-02-18 17:38:53.083609|2017-02-18 17:38:53.083609
NCT00112918|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-06-19|2012-06-01||December 2004||2004-12-01|June 2013|2013-06-01|June 2012|Actual|2012-06-01|June 2010|Actual|2010-06-01||Interventional||Baseline Measures are based on the Intent-to-Treat - Stage III Disease Patient Population.|Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer|A Randomized, Three Arm Multinational Phase III Study to Investigate Bevacizumab (q3w or q2w) in Combination With Either Intermittent Capecitabine Plus Oxaliplatin (XELOX) (q3w) or Fluorouracil/Leucovorin With Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 Regimen Alone as Adjuvant Chemotherapy in Colon Carcinoma: The AVANT Study|Completed||Phase 3|3451|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:38:53.244104|2017-02-18 17:38:53.244104
NCT00112905|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2014-05-20|2010-12-30||October 2005||2005-10-01|December 2012|2012-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium|Phase II Trial of Sorafenib (BAY 43-9006) (IND 69896; NSC 724772) in Patients With Advanced Urothelial Cancer|Terminated||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:38:55.422526|2017-02-18 17:38:55.422526
NCT00111878|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2007-07-02|||April 2005||2005-04-01|July 2007|2007-07-01|December 2005||2005-12-01|||||Observational|||Study to Evaluate MEDI-534 in Healthy Adults|Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults|Completed||Phase 1|120||MedImmune LLC|||||||||||||||||||2017-02-18 17:39:23.517174|2017-02-18 17:39:23.517174
NCT00112892|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2014-01-10|||August 2004||2004-08-01|January 2014|2014-01-01|December 2007|Actual|2007-12-01|September 2007|Actual|2007-09-01||Interventional|||Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacokinetic Study of Selenomethionine With Fixed Dose Irinotecan in Advanced Solid Tumors|Completed||Phase 1|36|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 17:38:55.684117|2017-02-18 17:38:55.684117
NCT00112879|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma|Phase II Study of Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Patients With Previously Untreated High-Risk or Relapsed or Refractory Multiple Myeloma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:55.779147|2017-02-18 17:38:55.779147
NCT00112866|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-10-25|||January 2005||2005-01-01|October 2013|2013-10-01||||December 2008|Actual|2008-12-01||Interventional|||Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme|Phase II Trial of EMD 121974 for Recurrent Glioblastoma: A Clinical Trial With Tissue Correlates of Response|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:38:55.865503|2017-02-18 17:38:55.865503
NCT00112853|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-01-08|||March 2005||2005-03-01|January 2013|2013-01-01||||May 2009|Actual|2009-05-01||Interventional|||Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase I Trial of Oral Etoposide in Combination With the Farnesyltransferase Inhibitor R115777 (ZARNESTRA, Tipifarnib, NSC #702818, IND #58,359) in Elderly Adults With Newly Diagnosed Acute Myelogenous Leukemia (AML)|Completed||Phase 1|100|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:38:55.966897|2017-02-18 17:38:55.966897
NCT00112840|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2015-10-22|2014-01-06||May 2005||2005-05-01|July 2015|2015-07-01|September 2015|Actual|2015-09-01|August 2010|Actual|2010-08-01||Interventional|||CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Phase I/II Trial of CCI-779 and Bevacizumab in Stage IV Renal Cell Carcinoma|Completed||Phase 1/Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:38:56.085027|2017-02-18 17:38:56.085027
NCT00112827|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2016-11-17|||November 2004||2004-11-01|November 2016|2016-11-01||||November 2017|Anticipated|2017-11-01||Interventional|||Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma|Tandem High-Dose Therapy With Melphalan and Total Marrow Irradiation (TMI) With Peripheral Blood Progenitor Cell Support and Lenalidomide Maintenance in Multiple Myeloma: A Phase I/II Trial|Active, not recruiting||Phase 1/Phase 2|86|Anticipated|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 17:38:57.254804|2017-02-18 17:38:57.254804
NCT00112775|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2011-06-04|||March 2005||2005-03-01|April 2006|2006-04-01||||||||Interventional|||BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate|A Randomized Multi-Center Open Label Study of BMS-354825 vs Imatinib Mesylate (Gleevec®) 800 mg/d in Subjects With Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Disease That is Resistant to Iamtinib at a Dose of 400-600 mg/d|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:57.383311|2017-02-18 17:38:57.383311
NCT00112749|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2016-02-12|||February 2005||2005-02-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|January 2007|Actual|2007-01-01||Interventional|||Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer|Does Blocking Proinflammatory Cytokines Diminish Cancer-Related Fatigue?|Terminated||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center||1||"Recruitment stopped due to slow accrual and lack of evidence of need for further continuation~   of protocol in inpatient setting."|f||||t||||||||||2017-02-18 17:38:57.484853|2017-02-18 17:38:57.484853
NCT00112736|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2015-05-29|2015-04-28||April 2005||2005-04-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2010|Actual|2010-04-01||Interventional||"pts had to meet eligibility criteria and recieve at least one dose of treatment.~22 eligible pts enrolled in phase 1, but 1 pt declined before starting any treatment and was excluded from analysis - 12 pts were treated at MTD and thus included in the Phase 2 analysis, hence only 9 patients remained for analysis for phase 1"|Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma|Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|69|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 17:38:57.602862|2017-02-18 17:38:57.602862
NCT00112723|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2016-06-27|2015-03-23||December 2005||2005-12-01|June 2016|2016-06-01|November 2015|Actual|2015-11-01|February 2011|Actual|2011-02-01||Interventional|||Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma|A Phase I/II Study of Flavopiridol Administered as a 30-Minute Bolus Followed by a 4-Hour Infusion in Lymphomas and Multiple Myeloma|Terminated||Phase 1/Phase 2|46|Actual|National Cancer Institute (NCI)||1||Administratively Complete|f||||||||||||||2017-02-18 17:38:58.189513|2017-02-18 17:38:58.189513
NCT00112710|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-08-23|||March 2005||2005-03-01|May 2007|2007-05-01||||||||Interventional|||Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A British Thoracic Oncology Group Phase III Trial of Gemcitabine Plus Cisplatin at 80mg/m Versus Gemcitabine Plus Carboplatin At 50 mg/m Versus Gemcitabine Plus Carboplatin AUC 6 in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Recruiting|Phase 3|1350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:58.68166|2017-02-18 17:38:58.68166
NCT00112697|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2011-11-01|||December 2002||2002-12-01|December 2006|2006-12-01||||||||Interventional|||Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery|Randomized Phase II Trial Evaluating [Radiotherapy-Docetaxel-5 Fluorouracil] Association Versus [Radiotherapy-Docetaxel-Cisplatin] Association in Non Resecables First Line of Chemotherapy in Metastatics Pancreas Cancers Patients|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:58.795455|2017-02-18 17:38:58.795455
NCT00112684|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2014-02-21|||February 2006||2006-02-01|November 2011|2011-11-01||||July 2012|Actual|2012-07-01||Interventional|||Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Pilot Study of Flavopiridol in Patients With Advanced Solid Tumors|Terminated||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:38:58.906213|2017-02-18 17:38:58.906213
NCT00112671|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2015-08-04|2015-08-04||April 2005||2005-04-01|May 2013|2013-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional||All participants|Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract|A Phase II Study of BAY 43-9006 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter and Renal Pelvis)|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:38:59.135864|2017-02-18 17:38:59.135864
NCT00112658|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2011-05-19|||November 2004||2004-11-01|December 2006|2006-12-01||||||||Interventional|||Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer|Randomized Phase II/III Trial Comparing Folririnox Association [Oxaliplatin / Irinotecan / LV5FU2] Versus Gemcitabine in First Line of Chemotherapy in Metastatics Pancreas Cancers Patients|Unknown status|Active, not recruiting|Phase 2/Phase 3|348|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:59.401869|2017-02-18 17:38:59.401869
NCT00112645|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-07-17|||April 2005||2005-04-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|April 2010|Actual|2010-04-01||Interventional|||Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors|A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Pediatric Solid Tumors With Relapsed or Therapy Refractory Disease|Completed||Phase 1|10|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:38:59.550029|2017-02-18 17:38:59.550029
NCT00112632|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2012-03-07|||February 2005||2005-02-01|March 2012|2012-03-01||||||||Interventional|||Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor|Open-Label Trial of Neoadjuvant Imatinib Mesylate (Glivec) in Patients With Locally Advanced Malignant Gastrointestinal Stromal Tumors (GIST) Expressing c-Kit or Platelet-Derived Growth Factor Receptor-alpha|Completed||Phase 2|40|Anticipated|Technische Universität München|||||f||||||||||||||2017-02-18 17:38:59.64448|2017-02-18 17:38:59.64448
NCT00112619|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2011-06-29|||August 2005||2005-08-01|June 2011|2011-06-01||||August 2010|Actual|2010-08-01||Interventional|||Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors|A Phase I Pharmacokinetic Optimal Dosing Study of Intraventricular Topotecan for Children With Neoplastic Meningitis|Terminated||Phase 1|19|Actual|Pediatric Brain Tumor Consortium||1||Slow accrual and company withdrawing support to supply the drug|f||||t||||||||||2017-02-18 17:38:59.99613|2017-02-18 17:38:59.99613
NCT00112593|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2015-08-28|||November 1999||1999-11-01|August 2015|2015-08-01||||November 2014|Actual|2014-11-01||Interventional|||Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer|Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Completed||N/A|5|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:39:00.123965|2017-02-18 17:39:00.123965
NCT00112580|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2015-09-23||2015-09-23|July 2005||2005-07-01|September 2015|2015-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery|Phase II Trial of Single Agent Ipilimumab (MDX-010 Anti CTLA-4) for Subjects With Locally Advanced or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|82|Anticipated|Bristol-Myers Squibb||1|||||||||||||||||2017-02-18 17:39:00.3146|2017-02-18 17:39:00.3146
NCT00112567|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2010-09-17|||April 2003||2003-04-01|September 2010|2010-09-01|July 2007||2007-07-01|||||Interventional|||Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer|A Phase I/II Study of Total Body Irradiation, Thiotepa, and Fludarabine as Conditioning for Haploidentical CD34+ Purified Peripheral Blood Stem Cell Transplants|Completed||Phase 1/Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:39:00.432615|2017-02-18 17:39:00.432615
NCT00112554|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-11-05|||March 2005||2005-03-01|February 2009|2009-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia|A Phase III Randomized of Cloretazine™ (VNP40101M) and Cytosine Arabinoside (AraC) in Patients With Acute Myeloid Leukemia in First Relapse|Completed||Phase 3|420|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:39:00.537235|2017-02-18 17:39:00.537235
NCT00112528|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2016-12-09|||June 2005||2005-06-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|August 2006|Actual|2006-08-01||Interventional|||Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer|Phase II Trial of Bevacizumab, Gemcitabine, Oxaliplatin in Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|53|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:39:00.723752|2017-02-18 17:39:00.723752
NCT00112515|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2009-08-19|||February 2004||2004-02-01|May 2006|2006-05-01||||||||Interventional|||Modafinil in Treating Fatigue in Patients With Cancer|Pilot Study Evaluating the Safety and Efficacy of Modafinil in Improving Fatigue, Mood, Cognitive Ability, Functional Status, and Quality of Life of Cancer Patients|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:39:01.237443|2017-02-18 17:39:01.237443
NCT00112502|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2014-09-23|||September 2005||2005-09-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme|A Randomized, Factorial-Design, Phase II Trial of Temozolomide Alone and in Combination With Possible Permutations of Thalidomide, Isotretinoin and/or Celecoxib as Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme|Completed||Phase 2|178|Actual|M.D. Anderson Cancer Center||8|||f||||f||||||||||2017-02-18 17:39:01.339755|2017-02-18 17:39:01.339755
NCT00112489|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2014-04-11|2014-04-11||May 2005||2005-05-01|April 2014|2014-04-01||||July 2010|Actual|2010-07-01||Interventional||Total eligible and treated participants|Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer|A Phase II Evaluation of Paclitaxel (Taxol, NSC # 673089) and Carboplatin (Paraplatin, NSC #241240) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma|Completed||Phase 2|55|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 17:39:01.698847|2017-02-18 17:39:01.698847
NCT00112476|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-05-01|||March 2005||2005-03-01|May 2013|2013-05-01||||July 2010|Actual|2010-07-01||Interventional|||Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors|A Phase I Study of Intravenous CCI-779 in Combination With Bryostatin-1 in Solid Tumors (10038414)|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:39:02.131344|2017-02-18 17:39:02.131344
NCT00112463|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2016-11-03|||January 2004||2004-01-01|November 2016|2016-11-01||||July 2013|Actual|2013-07-01||Interventional|||Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma|A Phase II Study of Single Agent Depsipeptide (FK228) in Metastatic or Unresectable Soft Tissue Sarcomas|Active, not recruiting||Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:39:02.264545|2017-02-18 17:39:02.264545
NCT00112437|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2016-03-03|2010-04-13||June 2005||2005-06-01|March 2016|2016-03-01|January 2016|Actual|2016-01-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of MK0822 in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 2|399|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 17:39:02.472277|2017-02-18 17:39:02.472277
NCT00112424|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2008-01-29|||January 2004||2004-01-01|January 2008|2008-01-01|January 2008|Actual|2008-01-01|June 2006|Actual|2006-06-01||Interventional|||Trial of Cardiac Magnetic Resonance Imaging (MRI) Versus Cardiac Catheterization Prior to Glenn Operation|Clinical Trial of Cardiac Magnetic Resonance Imaging in Routine Evaluation Prior to Superior Cavo-Pulmonary Anastomosis|Completed||N/A|80|Actual|Boston Children’s Hospital||1|||f||||t||||||||||2017-02-18 17:39:09.850719|2017-02-18 17:39:09.850719
NCT00112411|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2012-07-03|||June 2005||2005-06-01|December 2005|2005-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics|Dose-ranging Double-blind, Placebo-controlled Efficacy Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics|Completed||Phase 2|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:39:09.952572|2017-02-18 17:39:09.952572
NCT00112398|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2013-03-10|||May 2005||2005-05-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Head Injury Retrieval Trial|Randomised, Controlled Trial of Physician Prehospital Management of Severe Blunt Head Injury|Terminated||N/A|338|Actual|CareFlight||2||"Inadequate recruitment rate combined with a high rate of patients dropping in to the treatment~   group from standard care"|f||||t||||||||||2017-02-18 17:39:10.040154|2017-02-18 17:39:10.040154
NCT00112385|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2011-05-23|2011-04-25||March 2006||2006-03-01|May 2011|2011-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||A Pilot Study of Etanercept in Dermatomyositis|A Pilot Study of Etanercept in Dermatomyositis|Completed||Phase 1|16|Actual|Brigham and Women's Hospital||2|||f||||t||||||||||2017-02-18 17:39:10.16442|2017-02-18 17:39:10.16442
NCT00112372|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-02|2015-02-11|||May 2005||2005-05-01|February 2015|2015-02-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional|||Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)|A Phase I/IIa, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability and Maximum Tolerated Dose of AP23573 When Administered Orally in Patients With Refractory or Advanced Malignancies|Completed||Phase 1|147|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 17:39:11.774822|2017-02-18 17:39:11.774822
NCT00112359|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-01|2011-03-21|2010-09-10||May 2005||2005-05-01|March 2011|2011-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|AIR-CF1||International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa|A Phase 3, Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysinate for Inhalation in Cystic Fibrosis Patients With Pulmonary Pseudomonas Aeruginosa (AIR-CF1)|Completed||Phase 3|166|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 17:39:12.01123|2017-02-18 17:39:12.01123
NCT00112346|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-01|2015-10-26|||January 2005||2005-01-01|October 2015|2015-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|A Randomized Multicenter Phase II Study of Gemcitabine/Platinum/Cetuximab Versus Gemcitabine/Platinum as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|120||Eli Lilly and Company||2|||f||||||||||||||2017-02-18 17:39:13.069245|2017-02-18 17:39:13.069245
NCT00112333|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-01|2011-07-19|||October 2003||2003-10-01|July 2011|2011-07-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Defining Central Circuits of Pain|Defining Central Circuits of Visceral Pain|Completed||N/A|60|Anticipated|Massachusetts General Hospital||1|||f||||f||||||||||2017-02-18 17:39:13.22934|2017-02-18 17:39:13.22934
NCT00112320|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-01|2012-12-03|||April 2004||2004-04-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Comparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of Fallot|Randomized Trial of Pulmonary Valve Replacement in Tetralogy of Fallot|Completed||N/A|68|Actual|Boston Children’s Hospital||2|||f||||t||||||||||2017-02-18 17:39:13.323359|2017-02-18 17:39:13.323359
NCT00112307|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-01|2009-09-15|||March 2003||2003-03-01|September 2009|2009-09-01|October 2005||2005-10-01|||||Interventional|||Magnetic Resonance Imaging Guided Gynecologic Brachytherapy|Pilot Study of Magnetic Resonance Imaging Guided Brachytherapy|Completed||N/A|15||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:39:13.435216|2017-02-18 17:39:13.435216
NCT00112294|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-01|2015-11-24|2010-06-30||December 2004||2004-12-01|November 2015|2015-11-01|August 2008|Actual|2008-08-01|April 2007|Actual|2007-04-01||Interventional|||Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|A Randomized Multicenter Phase III Study of Taxane/Carboplatin/Cetuximab Versus Taxane/Carboplatin as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|755|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:39:13.542553|2017-02-18 17:39:13.542553
NCT00112281|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-01|2006-08-02|||May 2005||2005-05-01|May 2005|2005-05-01|January 2007||2007-01-01|||||Interventional|||A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack|A Phase III International, Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition With Tilarginine Acetate Injection in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction, or the TRIUMPH Trial|Terminated||Phase 3|658||Arginox Pharmaceuticals|||||||||||||||||||2017-02-18 17:39:15.410207|2017-02-18 17:39:15.410207
NCT00112268|ClinicalTrials.gov processed this data on February 17, 2017|2005-06-01|2006-10-26|||June 2005||2005-06-01|October 2006|2006-10-01|July 2006||2006-07-01|||||Interventional|||Quitlink : A Leveraging Solution to Tobacco Counseling|Quitlink : A Leveraging Solution to Tobacco Counseling|Completed||Phase 3|3200||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:39:15.590735|2017-02-18 17:39:15.590735
NCT00112255|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-31|2006-05-09|||March 2001||2001-03-01|May 2005|2005-05-01|December 2002||2002-12-01|||||Interventional|||Partner Notification for Chlamydia in Primary Care|Partner Notification for Chlamydia in Primary Care: Randomised Controlled Trial and Economic Evaluation|Completed||Phase 3|214||University of Bristol|||||f||||||||||||||2017-02-18 17:39:15.689179|2017-02-18 17:39:15.689179
NCT00112242|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-31|2013-04-19|||February 2004||2004-02-01|April 2013|2013-04-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Immunotherapy of Stage III/IV Melanoma Patients|Vaccination of Patients With Stage III or IV Malignant Melanoma With Melanoma Antigen Peptides [Melan-A/Mart-1 Analog (ELA), NY-ESO-1b(A) Analog and MAGE-A10] and Montanide Adjuvant|Completed||Phase 1|38|Actual|Centre Hospitalier Universitaire Vaudois||5|||f||||f||||||||||2017-02-18 17:39:15.981726|2017-02-18 17:39:15.981726
NCT00112229|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-31|2013-04-19|||April 2003||2003-04-01|April 2013|2013-04-01|June 2012|Actual|2012-06-01|August 2011|Actual|2011-08-01||Interventional|||Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients|Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients With CpG7909, Tumor Antigenic Peptides and Montanide|Completed||Phase 1|29|Actual|Centre Hospitalier Universitaire Vaudois||4|||f||||||||||||||2017-02-18 17:39:16.099943|2017-02-18 17:39:16.099943
NCT00112216|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-31|2013-04-23|||May 1999||1999-05-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Immunotherapy of Melanoma Patients|Specific Immunotherapy of Skin Melanoma Patients With Antigenic Peptides and Immunological Analysis of the Vaccine Site Sentinel Lymph Node|Completed||Phase 1|9|Actual|Centre Hospitalier Universitaire Vaudois||1|||f||||f||||||||||2017-02-18 17:39:16.214403|2017-02-18 17:39:16.214403
NCT00112203|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-31|2017-02-06|||November 2004||2004-11-01|February 2017|2017-02-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia|A Multicentre, Open-Label Extension Phase to Study the Long-Term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia|Completed||Phase 3|466|Actual|Forest Laboratories|||||f||||f||||||||||2017-02-18 17:39:16.322071|2017-02-18 17:39:16.322071
NCT00112190|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-31|2017-02-06|||July 2004||2004-07-01|February 2017|2017-02-01|March 2006|Actual|2006-03-01|March 2005|Actual|2005-03-01||Interventional|||Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal|A Multicentre, Randomized, Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Itopride HCl in Patients Suffering From Functional Dyspepsia|Completed||Phase 3|645|Actual|Forest Laboratories||2|||f||||t||||||||||2017-02-18 17:39:16.413891|2017-02-18 17:39:16.413891
NCT00112177|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-31|2017-02-06|||July 2004||2004-07-01|February 2017|2017-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal|A Multicentre, Randomized, Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Itopride HCl in Patients Suffering From Functional Dyspepsia|Completed||Phase 3|500||Forest Laboratories|||||f||||f||||||||||2017-02-18 17:39:16.515945|2017-02-18 17:39:16.515945
NCT00112164|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2014-03-11|||January 2005||2005-01-01|March 2014|2014-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Activated Protein C to Treat Acute Lung Injuries|Prospective, Randomized Phase II Clinical Trial of Activated Protein C (Xigris) Versus Placebo for the Treatment of Acute Lung Injury|Terminated||Phase 2|90|Anticipated|University of California, San Francisco||||Per recommendation of the NHLBI DSMB|f||||||||||||||2017-02-18 17:39:16.620557|2017-02-18 17:39:16.620557
NCT00112151|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2015-12-14|2015-11-04||January 2005||2005-01-01|November 2015|2015-11-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||TEAM: Testosterone Supplementation and Exercise in Elderly Men|Testosterone Supplementation and Exercise in Elderly Men|Completed||Phase 2|167|Actual|University of Colorado, Denver||6|||f||||t||||||||||2017-02-18 17:39:16.729708|2017-02-18 17:39:16.729708
NCT00112138|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2011-05-20|||March 2004||2004-03-01|May 2011|2011-05-01|February 2006||2006-02-01|||||Interventional|||Gabapentin for the Treatment of Hot Flashes in Menopausal Women|Effectiveness and Safety of Gabapentin for the Treatment of Hot Flashes in Menopausal Women: A Randomized Controlled Trial|Completed||Phase 3|200||North Toronto Primary Care Research Network|||||f||||||||||||||2017-02-18 17:39:17.671325|2017-02-18 17:39:17.671325
NCT00112125|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2016-08-29|||February 2005||2005-02-01|August 2016|2016-08-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Evaluation of the Safety and Effectiveness of the OPTIMIZER System in Subjects With Heart Failure: FIX-HF-5|Evaluation of the Safety and Efficacy of the OPTIMIZER System With Active Fixation Leads in Subjects With Heart Failure Resulting From Systolic Dysfunction: FIX-HF-5|Active, not recruiting||Phase 2/Phase 3|428|Actual|Impulse Dynamics||2|||f||||t||||||||||2017-02-18 17:39:17.777921|2017-02-18 17:39:17.777921
NCT00112112|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2012-07-31|2012-02-27||August 2005||2005-08-01|July 2012|2012-07-01|May 2008|Actual|2008-05-01|March 2008|Actual|2008-03-01||Interventional|||Safety Study to Evaluate FluMist in Immunocompromised Children|A Phase I Randomized, Double-Blind Trial of the Safety and Immunogenicity of FluMist® A Live, Intranasal Influenza Virus Vaccine vs. Placebo in Immunocompromised Children Ages 5 Through 17 Years of Age|Completed||Phase 1|20|Actual|MedImmune LLC||2|||f||||t||||||||||2017-02-18 17:39:17.903921|2017-02-18 17:39:17.903921
NCT00112099|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2016-09-20|||June 2002||2002-06-01|September 2016|2016-09-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110|Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110|Completed||Phase 3|500|Actual|Japan Clinical Oncology Group||2|||f||||t||||||||||2017-02-18 17:39:19.173034|2017-02-18 17:39:19.173034
NCT00112086|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2016-08-30|||January 2003||2003-01-01|August 2016|2016-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206|Feasibility Study of Neoadjuvant Chemotherapy Followed by Interval Cytoreductive Surgery for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: JCOG0206|Completed||Phase 2|56|Actual|Japan Clinical Oncology Group||1|||f||||t||||||||||2017-02-18 17:39:19.318491|2017-02-18 17:39:19.318491
NCT00112073|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2012-03-12||2012-03-12|April 2005||2005-04-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||AAB-001 in Patients With Mild to Moderate Alzheimer's Disease|A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients With Mild to Moderate AD|Completed||Phase 2|234|Actual|JANSSEN Alzheimer Immunotherapy Research & Development, LLC||8|||f||||||||||||||2017-02-18 17:39:19.423737|2017-02-18 17:39:19.423737
NCT00112060|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2014-03-27|||April 2008||2008-04-01|March 2014|2014-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase I/II, Open-Label, Multicenter Study of Single Agent PT-523 in the Treatment of Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)|Withdrawn||Phase 1/Phase 2|0|Actual|Spectrum Pharmaceuticals, Inc||1|||f||||||||||||||2017-02-18 17:39:19.561032|2017-02-18 17:39:19.561032
NCT00112047|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2010-10-11|2010-06-22||July 2003||2003-07-01|October 2010|2010-10-01|June 2009|Actual|2009-06-01|February 2005|Actual|2005-02-01||Interventional|||Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects|A Phase 3, Randomized, Multicenter Study of the Treatment of Antiretroviral-Naive HIV-1 Infected Subjects Comparing Tenofovir Disoproxil Fumarate and Emtricitabine in Combination With Efavirenz vs Combivir (Lamivudine/Zidovudine) and Efavirenz|Completed||Phase 3|517|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 17:39:19.872017|2017-02-18 17:39:19.872017
NCT00112034|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2008-05-05|||June 2003||2003-06-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|June 2006|Actual|2006-06-01||Interventional|||"AVONEX® Combination Trial - ACT"|A Multi-Center, Randomized, Blinded, Parallel-Group Study of AVONEX Compared With AVONEX in Combination With Oral Methotrexate, Intravenous Methylprednisolone, or Both in Subjects With Relapsing Remitting MS Who Have Breakthrough Disease on AVONEX Monotherapy.|Completed||Phase 4|350||Biogen|||||f||||||||||||||2017-02-18 17:39:21.984834|2017-02-18 17:39:21.984834
NCT00112021|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2015-04-09|||May 2005||2005-05-01|April 2015|2015-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects|A Phase 2B, Randomized, Double-Blinded, Placebo-Controlled, Dose Ranging, Multicenter Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects|Completed||Phase 2|400|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:39:22.195173|2017-02-18 17:39:22.195173
NCT00112008|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2009-07-09|||May 2004||2004-05-01|July 2009|2009-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis|A Multi-Center, Single-Arm Study Evaluating De Novo Once Every Two Week Darbepoetin Alfa Dosing in Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis|Completed||Phase 3|100|Anticipated|Amgen||1|||f||||||||||||||2017-02-18 17:39:22.31216|2017-02-18 17:39:22.31216
NCT00111995|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2008-08-07|||May 2002||2002-05-01|August 2008|2008-08-01||||||||Interventional|||Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis|A Randomized, Double-Blind Study Comparing Aranesp® (Darbepoetin Alfa) and Recombinant Human Erythropoietin (rHuEPO) in the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis|Completed||Phase 4|400||Amgen|||||||||||||||||||2017-02-18 17:39:22.410006|2017-02-18 17:39:22.410006
NCT00111982|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-27|2010-02-25|||December 2003||2003-12-01|February 2010|2010-02-01|February 2006|Actual|2006-02-01|November 2005|Actual|2005-11-01||Interventional|||Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin|Multi-Center, Open-Label Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin (Protocol 20020168)|Completed||Phase 1/Phase 2|34|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:39:22.490208|2017-02-18 17:39:22.490208
NCT00111969|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2006-06-28|||June 2003||2003-06-01|June 2006|2006-06-01|November 2005||2005-11-01|||||Interventional|||ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy|A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Effects of the Celacade™ System on Mortality and Morbidity in Patients With Chronic Heart Failure|Completed||Phase 3|2016||Vasogen|||||||||||||||||||2017-02-18 17:39:22.582216|2017-02-18 17:39:22.582216
NCT00111956|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2010-01-12|||April 2004||2004-04-01|January 2010|2010-01-01|May 2005|Actual|2005-05-01|||||Interventional|||Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome||Completed||N/A|56||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 17:39:22.66235|2017-02-18 17:39:22.66235
NCT00111943|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2012-03-26||||||March 2012|2012-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Safety and Acceptability of a Vaginal Microbicide|Phase II Expanded Safety and Acceptability Study of the Vaginal Microbicide 1% Tenofovir Gel|Completed||Phase 2|200|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:39:22.748975|2017-02-18 17:39:22.748975
NCT00111930|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2009-12-09|||August 2000||2000-08-01|February 2009|2009-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Biological Effects of Dehydroepiandrosterone (DHEA) in the Elderly|Biological Effects of DHEA in the Elderly|Completed||N/A|144||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:39:22.863254|2017-02-18 17:39:22.863254
NCT00111917|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2016-05-03|2013-10-29||February 2005||2005-02-01|March 2016|2016-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|BISCIT||Beryllium Infliximab Study: Clinical Interventional Trial|Clinical Efficacy of Remicade in Chronic Beryllium Disease: A Randomized, Double-Blind, Placebo-Controlled, Investigator Initiated Trial|Terminated||Phase 1/Phase 2|13|Actual|Maier, Lisa, M.D.|Although our goal was 20 CBD subjects, only 11 subjects were enrolled, 8:3 in the infliximab:placebo treatment arms as the study was stopped by the sponsor due to slow recruitment.|2||Not enough patients meeting criteria to enroll in the time period|f||||t||||||||||2017-02-18 17:39:22.971872|2017-02-18 17:39:22.971872
NCT00111904|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2011-12-13|||May 2005||2005-05-01|June 2009|2009-06-01||||August 2007|Actual|2007-08-01||Interventional|||Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer|Phase II Clinical Trial of Genexol -PM in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|43|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:39:23.316032|2017-02-18 17:39:23.316032
NCT00111891|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2017-02-16|||June 2005||2005-06-01|February 2017|2017-02-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)|A Dose Ranging Study to Evaluate the Tolerability of MK0524 (Niacin (+) Laropiprant) and Its Effects on Niacin-Induced Acute Flushing in Lipid Clinic Patients and/or Normal Healthy Subjects|Completed||Phase 2|575|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:39:23.421053|2017-02-18 17:39:23.421053
NCT00111865|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2008-08-22|||April 2005||2005-04-01|August 2008|2008-08-01|April 2009|Anticipated|2009-04-01|August 2008|Actual|2008-08-01||Interventional|HELP||Healthy Exercise for Lymphoma Patients (HELP)|Randomized Controlled Trial of Exercise in Lymphoma Patients|Unknown status|Active, not recruiting|Phase 3|122|Actual|Lance Armstrong Foundation||2|||f||||f||||||||||2017-02-18 17:39:23.59663|2017-02-18 17:39:23.59663
NCT00111852|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2012-03-19|||April 2005||2005-04-01|March 2012|2012-03-01||||March 2007|Actual|2007-03-01||Interventional|||Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)|A Prospective, Randomized, Double-blind, Placebo-controlled, Single Bolus, Multinational, Multi-center, Parallel Group, Dose-ranging Study of Desmoteplase (INN) in the Indication of Acute Stroke|Completed||Phase 3|193|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 17:39:23.69915|2017-02-18 17:39:23.69915
NCT00111839|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-26|2017-01-19|||May 2005||2005-05-01|January 2017|2017-01-01|March 2009|Actual|2009-03-01|July 2007|Actual|2007-07-01||Interventional|||Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer|Randomized, Phase II,Open-Label Controlled Study of Two Different Doses and Schedules of EMD 72000 (Matuzumab) in Combination With Pemetrexed, or Pemetrexed Alone, as Second-Line Treatment for Stage IIIB/IV Non-Small Cell Lung Cancer and Progressive Disease on or After First-Line Treatment With a Platinum in Combination With Taxanes, Gemcitabine and Vinorelbine|Completed||Phase 2|153|Actual|EMD Serono||3|||f||||f||||||||||2017-02-18 17:39:26.705002|2017-02-18 17:39:26.705002
NCT00111826|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-25|2010-03-30|||January 2003||2003-01-01|November 2007|2007-11-01|December 2005||2005-12-01|||||Interventional|||SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes|Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of the Celacade™ System in Improving Walking Distance in Patients With Intermittent Claudication Secondary to Peripheral Arterial Disease|Terminated||Phase 3|500||Vasogen|||||||||||||||||||2017-02-18 17:39:26.873832|2017-02-18 17:39:26.873832
NCT00111813|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-25|2015-05-05|2011-03-10||September 2005||2005-09-01|May 2015|2015-05-01|May 2011|Actual|2011-05-01|December 2009|Actual|2009-12-01||Interventional|||Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))|Phase I Clinical Trial of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Advanced Multiple Myeloma|Completed||Phase 1|34|Actual|Merck Sharp & Dohme Corp.||6|||f||||||||||||||2017-02-18 17:39:26.986795|2017-02-18 17:39:26.986795
NCT00111800|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-25|2017-01-16|||April 2005||2005-04-01|January 2017|2017-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A New Oral Treatment For Type II Diabetes Mellitus|A 12-Week, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Efficacy, Safety and Tolerability of Denagliptin, Administered Orally, Once Daily, as Monotherapy in Subjects With Type 2 Diabetes Mellitus Followed by a 12-week Active Treatment Extension|Completed||Phase 2|366|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:39:31.355693|2017-02-18 17:39:31.355693
NCT00111787|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-25|2010-10-01|||April 2005||2005-04-01|October 2010|2010-10-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer|A Phase II Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of Lapatinib in Combination With Paclitaxel as Neoadjuvant Therapy in Patients With Newly Diagnosed Inflammatory Breast Cancer|Completed||Phase 2|60||GlaxoSmithKline||1|||||||||||||||||2017-02-18 17:39:31.575143|2017-02-18 17:39:31.575143
NCT00111774|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-25|2013-05-10|||March 2002||2002-03-01|May 2013|2013-05-01||||||||Interventional|||Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma|An Open Label Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of ABX-EGF in Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|150||Amgen|||||||||||||||||||2017-02-18 17:39:31.702503|2017-02-18 17:39:31.702503
NCT00111761|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-25|2013-11-15|2010-08-06||July 2002||2002-07-01|November 2013|2013-11-01|October 2008|Actual|2008-10-01|February 2008|Actual|2008-02-01||Interventional|||Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer|A Clinical Trial of the Safety and Efficacy of ABX-EGF in Combination With Irinotecan, Leucovorin, and 5-Fluorouracil in Subjects With Metastatic Colorectal Cancer|Completed||Phase 2|43|Actual|Amgen||2|||f||||t||||||||||2017-02-18 17:39:31.825126|2017-02-18 17:39:31.825126
NCT00111748|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2015-10-02|||February 2005||2005-02-01|October 2015|2015-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients|UARK 2005-01, A Phase III Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients|Completed||Phase 3|180|Anticipated|University of Arkansas||2|||f||||||||||||||2017-02-18 17:39:33.039823|2017-02-18 17:39:33.039823
NCT00111735|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2005-06-23|||April 2003||2003-04-01|May 2005|2005-05-01|March 2005||2005-03-01|||||Interventional|||Thyroxine Titration Study|What is the Optimal Serum TSH Concentration During Thyroxine Treatment for Primary Hypothyroidism? Effects of Fine Titration of Thyroxine Dosage on Wellbeing, Quality of Life and Cognitive Function|Unknown status|Active, not recruiting|Phase 4|55||Sir Charles Gairdner Hospital|||||f||||||||||||||2017-02-18 17:39:33.147259|2017-02-18 17:39:33.147259
NCT00111722|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2015-10-30|||May 2005||2005-05-01|October 2015|2015-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine|Completed||Phase 3|393|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:39:33.236604|2017-02-18 17:39:33.236604
NCT00111709|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2015-10-09|||May 2005||2005-05-01|October 2015|2015-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)|A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine|Completed||Phase 3|393|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:39:33.330134|2017-02-18 17:39:33.330134
NCT00111696|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2012-03-13|||May 2005||2005-05-01|March 2012|2012-03-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma|Phase I Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin), a Humanized Monoclonal Antibody Directed Against the Human Alpha V Beta 3 Integrin, in Patients With Advanced Malignant Melanoma|Completed||Phase 1|18|Actual|MedImmune LLC||1|||f||||f||||||||||2017-02-18 17:39:33.416149|2017-02-18 17:39:33.416149
NCT00111683|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2015-08-21|||June 2005||2005-06-01|August 2015|2015-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||MK0457 in Patients With Leukemia (0457-003)|A Phase I/II Dose Escalation Study of MK0457 in Patients With Leukemia|Completed||Phase 1|28|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 17:39:33.50759|2017-02-18 17:39:33.50759
NCT00111670|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2016-11-01|||June 2005||2005-06-01|November 2016|2016-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes|A Randomized, Double-blind Study of the Effect of the DPP-IV Inhibitor on HbA1c and Safety in Patients With Type 2 Diabetes|Completed||Phase 2|291|Actual|Hoffmann-La Roche||5|||f||||||||||||||2017-02-18 17:39:33.614847|2017-02-18 17:39:33.614847
NCT00111657|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2014-09-24|2012-12-12||December 2004||2004-12-01|September 2014|2014-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout|A Phase II Multidose Study of Intravenous PEG-uricase in Patients With Refractory Gout|Completed||Phase 2|30|Actual|Duke University||1|||f||||f||||||||||2017-02-18 17:39:33.772867|2017-02-18 17:39:33.772867
NCT00111644|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2016-11-01|||March 2005||2005-03-01|November 2016|2016-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia|A Randomized, Double-blind Study of the Effect of Beta-lactam on Treatment Response in Patients Hospitalized With Bacterial Pneumonia|Completed||Phase 2|302|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:39:34.130178|2017-02-18 17:39:34.130178
NCT00111631|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2016-11-01|||May 2005||2005-05-01|November 2016|2016-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes|A Randomized, Double-blind Study of the Effect of the DPP-IV Inhibitor on HbA1c and Safety in Patients With Type 2 Diabetes Treated With a Stable Dose of Metformin|Completed||Phase 2|218|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 17:39:34.380233|2017-02-18 17:39:34.380233
NCT00111618|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-24|2009-01-29|||May 2005||2005-05-01|January 2009|2009-01-01|August 2008|Actual|2008-08-01|June 2007|Actual|2007-06-01||Interventional|||Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer|An Open Label, Randomized, Phase II Study of AS1404 in Combination With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer|Completed||Phase 2|70|Anticipated|Antisoma Research|||||||||||||||||||2017-02-18 17:39:34.724181|2017-02-18 17:39:34.724181
NCT00111605|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-23|2012-09-07||||||September 2012|2012-09-01|May 2008|Actual|2008-05-01|||||Interventional|||Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine With or Without IL-12 DNA Adjuvant, Boosted With Homologous Plasmids in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|144|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-02-18 17:39:34.85143|2017-02-18 17:39:34.85143
NCT00111592|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-23|2016-11-08|||August 2000||2000-08-01|November 2007|2007-11-01|December 2004|Actual|2004-12-01|||||Interventional|||Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice|Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice|Completed||N/A|208|Actual|Maastricht University Medical Center||2|||f||||f||||||||||2017-02-18 17:39:34.979841|2017-02-18 17:39:34.979841
NCT00111579|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-23|2008-07-22|||May 2005||2005-05-01|July 2008|2008-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)|A Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With Trivalent Inactivated Vaccine (TIV) in Children 6 to <36 Months of Age|Completed||Phase 2|52||MedImmune LLC||2|||f||||f||||||||||2017-02-18 17:39:35.078105|2017-02-18 17:39:35.078105
NCT00111566|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-23|2013-11-27|||December 2004||2004-12-01|November 2013|2013-11-01|August 2007|Actual|2007-08-01|July 2007|Actual|2007-07-01||Interventional|||BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention|Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention|Completed||Phase 4|624|Actual|Cardiology Research UBC||2|||f||||f||||||||||2017-02-18 17:39:35.179918|2017-02-18 17:39:35.179918
NCT00111553|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-23|2007-02-13|||October 2004||2004-10-01|February 2007|2007-02-01|August 2006||2006-08-01|||||Interventional|||Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis|Randomized, Double-Blind, Adjuvant- and Placebo-Controlled, Dose-Escalating Study to Evaluate Safety, Tolerability, and Immunogenicity of Leish-111f + MPL-SE Vaccine With Meglumine Antimoniate (Glucantime) in Cutaneous Leishmaniasis|Completed||Phase 1|45||IDRI|||||||||||||||||||2017-02-18 17:39:35.296049|2017-02-18 17:39:35.296049
NCT00111540|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-23|2015-02-19|||November 2002||2002-11-01|January 2015|2015-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes|An Open Label Study to Examine the Long Term Effect on Glucose Control (HbA1c) and Safety and Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|456|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 17:39:35.393418|2017-02-18 17:39:35.393418
NCT00111527|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2010-03-22|||May 2005||2005-05-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation|An Assessment of the Echo-guided Optimal Cardiac Resynchronization Therapy in Patients Undergoing 'Ablate And Pace' Therapy for Permanent Atrial Fibrillation|Completed||Phase 3|458|Anticipated|Arcispedale Santa Maria Nuova-IRCCS||2|||f||||f||||||||||2017-02-18 17:39:35.55956|2017-02-18 17:39:35.55956
NCT00111514|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2007-02-13|||July 2004||2004-07-01|February 2007|2007-02-01|May 2006||2006-05-01|||||Interventional|||Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis|A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate Safety, Tolerability, and Immunogenicity of Leish-111f + MPL-SE Vaccine in Combination With Pentavalent Antimony in Treatment of Mucosal Leishmaniasis|Completed||Phase 1|48||IDRI|||||||||||||||||||2017-02-18 17:39:35.66716|2017-02-18 17:39:35.66716
NCT00111501|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2015-03-05|||September 2002||2002-09-01|March 2015|2015-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||LGBT Internet Based Smoking Treatment - 1|LGBT Internet Based Smoking Treatment|Completed||Phase 3|792|Actual|University of California, San Francisco||2|||f||||f||||||||||2017-02-18 17:39:35.764546|2017-02-18 17:39:35.764546
NCT00111488|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2016-01-05|||June 2005||2005-06-01|May 2014|2014-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation|Randomized Study of Surgical Ablation With Microwave Energy for the Treatment of Atrial Fibrillation|Terminated||Phase 3|200||Boston Scientific Corporation||||Slow enrollment|||||||||||||||2017-02-18 17:39:35.862257|2017-02-18 17:39:35.862257
NCT00111475|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2008-11-20||||||November 2008|2008-11-01||||||||Interventional|||Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)|A Dose-Finding Study Evaluating the Safety and Efficacy of AMG 531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)|Completed||Phase 2|||Amgen|||||||||||||||||||2017-02-18 17:39:35.97261|2017-02-18 17:39:35.97261
NCT00111462|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2013-05-06||||||May 2013|2013-05-01||||||||Interventional|||Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy|A Randomized, Open-Label Study of Darbepoetin Alfa (Novel Erythropoiesis Stimulating Protein, NESP) Using Fixed and Weight-Based Dosing for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 2|||Amgen|||||||||||||||||||2017-02-18 17:39:36.056105|2017-02-18 17:39:36.056105
NCT00111449|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2013-05-13|||June 2003||2003-06-01|May 2013|2013-05-01||||||||Interventional|||Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis|A Phase 3 Multicenter Study to Assess the Efficacy and Safety of Etanercept 50 mg Twice Weekly in Psoriasis|Completed||Phase 3|600||Amgen|||||||||||||||||||2017-02-18 17:39:36.153487|2017-02-18 17:39:36.153487
NCT00111436|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2013-04-24|||April 2003||2003-04-01|April 2013|2013-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects|An Open-Label, Long-Term Extension Study to Assess the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects|Completed||Phase 3|912|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:39:36.264966|2017-02-18 17:39:36.264966
NCT00111423|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2009-03-04|||August 2002||2002-08-01|December 2007|2007-12-01||||||||Interventional|||Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)|Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI) in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 2|216||Amgen|||||||||||||||||||2017-02-18 17:39:36.375088|2017-02-18 17:39:36.375088
NCT00111410|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-20|2016-08-10||||||August 2016|2016-08-01|November 2003|Actual|2003-11-01|||||Interventional|||Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)|A Multicenter, Double-Blind, Randomized, Placebo Controlled Study to Estimate the Effect of Anakinra (r-metHuIL-1ra) on Vaccine Antibody Response in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 4|||Swedish Orphan Biovitrum|||||f||||||||||||||2017-02-18 17:39:36.4588|2017-02-18 17:39:36.4588
NCT00111397|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-19|2017-01-24|||May 13, 2005||2005-05-13|August 4, 2010|2010-08-04|August 4, 2010|Actual|2010-08-04|August 4, 2010|Actual|2010-08-04||Interventional|||Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection|A Study of Adjuvant Cytokine Therapy in Pulmonary Mycobacterium Avium Complex and Other Pulmonary Nontuberculous Mycobacterial Infections|Completed||Phase 1|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:39:36.550731|2017-02-18 17:39:36.550731
NCT00111384|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-19|2017-01-24|||May 9, 2005||2005-05-09|October 11, 2016|2016-10-11||||||||Observational|||Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)|Variation in Gene Expression in Neurofibromatosis Type 1|Active, not recruiting||N/A|313|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:39:36.64245|2017-02-18 17:39:36.64245
NCT00111371|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-19|2014-12-04|||January 2005||2005-01-01|September 2006|2006-09-01|October 2015|Anticipated|2015-10-01|||||Interventional|||Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia|Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Dyslexia)|Unknown status|Recruiting|Phase 4|100|Anticipated|University Hospital Muenster|||||f||||||||||||||2017-02-18 17:39:36.735707|2017-02-18 17:39:36.735707
NCT00111358|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-19|2011-04-15|||June 2003||2003-06-01|April 2011|2011-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of Lifestyle Modification in HIV Lipodystrophy|The Effects of a Lifestyle Modification Program (REACH) in Patients With HIV and Metabolic Syndrome|Completed||N/A|80|Anticipated|Massachusetts General Hospital||2|||f||||f||||||||||2017-02-18 17:39:36.838689|2017-02-18 17:39:36.838689
NCT00111345|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-19|2012-05-21|||March 2004||2004-03-01|March 2012|2012-03-01|March 2017|Anticipated|2017-03-01|March 2012|Actual|2012-03-01||Interventional|||Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents|Multicenter Therapy-Optimization Trial AML-BFM 2004 for the Treatment of Acute Myeloid Leukemias in Children and Adolescents|Active, not recruiting||Phase 2/Phase 3|550|Actual|University Hospital Muenster||4|||f||||t||||||||||2017-02-18 17:39:36.959457|2017-02-18 17:39:36.959457
NCT00111332|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-19|2010-04-12|||November 2002||2002-11-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||Study of Home-Based Resistance and Strength Training in HIV-Infected Women|Exercise Effects in HIV-Infected Women|Completed||N/A|40||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:39:37.077994|2017-02-18 17:39:37.077994
NCT00111319|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-19|2009-03-25|||December 2004||2004-12-01|March 2009|2009-03-01||||July 2007|Actual|2007-07-01||Interventional|||VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma|An Open-Label, Randomized Study of VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Subjects With Previously Untreated Multiple Myeloma|Completed||Phase 3|||Millennium Pharmaceuticals, Inc.|||||t||||||||||||||2017-02-18 17:39:37.172003|2017-02-18 17:39:37.172003
NCT00111306|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-19|2011-11-07|||June 2005||2005-06-01|November 2011|2011-11-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Epratuzumab in Systemic Lupus Erythematosus|A Phase III, Randomized, Double-Blind. Placebo-Controlled, Multi-Center Study of Systemic Lupus Erythematosus With Acute Severe SLE Flares Excluding Renal or Neurological Systems|Terminated||Phase 3|510||UCB Pharma|||||f||||||||||||||2017-02-18 17:39:37.266835|2017-02-18 17:39:37.266835
NCT00111293|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-18|2017-01-24|||May 16, 2005||2005-05-16|May 14, 2010|2010-05-14|May 14, 2010||2010-05-14|||||Observational|||Attention and Visual Perception|Top-Down Attentional Control of Visual Processing|Completed||N/A|8|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:39:37.463296|2017-02-18 17:39:37.463296
NCT00108927|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-20|2010-03-01|||December 2003||2003-12-01|March 2010|2010-03-01|December 2005||2005-12-01|||||Observational|||Improving Diabetes in Primary Care (IMPACT)|Improving Diabetes Through Primary Care Translation (IMPACT)|Completed||N/A|6000||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:40:37.686257|2017-02-18 17:40:37.686257
NCT00111280|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-18|2011-05-18|||September 2004||2004-09-01|April 2010|2010-04-01|March 2007|Actual|2007-03-01|||||Interventional|||TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial|HIV-1 Infected Subjects Who Were Randomized in Any Sponsor-selected TMC125 Trial to an Active Control Arm and Either Virologically Failed or Completed the Entire Treatment Period, or to Placebo Arm and Were Treated for at Least 48 Weeks.|Completed||Phase 2|48|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-02-18 17:39:37.545013|2017-02-18 17:39:37.545013
NCT00111267|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-18|2005-06-23|||May 2003||2003-05-01|May 2005|2005-05-01|January 2005||2005-01-01|||||Interventional|||Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People|The Effect of Oral Vitamin B12 Supplementation on Cognitive Performance in Elderly People: the Brain12 Study|Completed||N/A|165||Wageningen University|||||f||||||||||||||2017-02-18 17:39:37.824434|2017-02-18 17:39:37.824434
NCT00111254|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-18|2015-05-20|||June 2002||2002-06-01|June 2011|2011-06-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||The Effects of Microdermabrasion on Skin Remodeling|The Effects of Microdermabrasion on Collagen and Elastin Biosynthesis|Completed||N/A|257|Actual|University of Michigan||2|||f||||f||||||||||2017-02-18 17:39:37.919734|2017-02-18 17:39:37.919734
NCT00111241|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-18|2009-09-17|||May 2005||2005-05-01|September 2009|2009-09-01|December 2010|Anticipated|2010-12-01|May 2010|Anticipated|2010-05-01||Observational|||Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors|Assessment of Knee Joint Articular Cartilage Volume Change, Bone Loss and Change in Body Composition in Women Treated With Anastrozole or Letrozole and Comparison With Untreated Controls|Unknown status|Active, not recruiting|Phase 4|170|Anticipated|Monash University|||1||f||||||||||||||2017-02-18 17:39:38.014663|2017-02-18 17:39:38.014663
NCT00111228|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-18|2006-10-24|||October 2004||2004-10-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-Time Values of Guardian RT|Randomised, Controlled, Multi-Centric, Clinical Study to Assess Whether Type 1 Diabetic Patients in Poor Glycemic Control Can Improve Using the Real-Time Values of Guardian T Versus Conventional Self-Monitoring Blood Glucose|Completed||Phase 4|162||Medtronic|||||f||||||||||||||2017-02-18 17:39:38.107069|2017-02-18 17:39:38.107069
NCT00111215|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-18|2007-03-12|||January 2001||2001-01-01|June 2006|2006-06-01|September 2006||2006-09-01|||||Interventional|||Treatment and Management of Women With Bleeding Disorders|Treatment and Management of Women With Bleeding Disorders|Completed||N/A|100||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 17:39:38.203908|2017-02-18 17:39:38.203908
NCT00111202|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2005-09-28|||May 2005||2005-05-01|May 2005|2005-05-01|June 2006||2006-06-01|||||Observational|||Schizophrenia and Genetic Counseling|Schizophrenia and Genetic Counseling: A Survey of People With Schizophrenia and Their Relatives|Unknown status|Active, not recruiting|Phase 1|100||Sarah Lawrence College|||||f||||||||||||||2017-02-18 17:39:38.301429|2017-02-18 17:39:38.301429
NCT00111189|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2014-06-19|||February 2005||2005-02-01|June 2014|2014-06-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.|A Randomized Double-blind Placebo-controlled Parallel Group Study Evaluating Paliperidone Palmitate in the Prevention of Recurrence in Patients With Schizophrenia. Placebo Consists of 20% Intralipid (200 mg/mL) Injectable Emulsion.|Completed||Phase 3|414|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-02-18 17:39:38.383201|2017-02-18 17:39:38.383201
NCT00111176|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2014-08-15|||March 2004||2004-03-01|August 2014|2014-08-01|May 2013|Actual|2013-05-01|July 2007|Actual|2007-07-01||Interventional|STARZ-TX2||STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft|Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft|Completed||N/A|260|Actual|Cook||2|||f||||t||||||||||2017-02-18 17:39:38.55632|2017-02-18 17:39:38.55632
NCT00111163|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2012-09-26|||March 2004||2004-03-01|September 2012|2012-09-01|March 2008|Actual|2008-03-01|March 2006|Actual|2006-03-01||Interventional|||Intermittent Preventive Treatment With Antimalarials in Kenyan Infants|Efficacy and Safety of Pediatric Immunization-linked Preventive Intermittent Treatment With Antimalarials in Decreasing Anemia and Malaria Morbidity in Rural Western Kenya|Completed||N/A|1516||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 17:39:38.714168|2017-02-18 17:39:38.714168
NCT00111150|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2007-03-16|||September 2005||2005-09-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|||||Interventional|||Botswana Tenofovir Oral HIV Prophylaxis Trial|Study of the Safety and Efficacy of Daily Tenofovir Disoproxil Fumarate for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana|Terminated||Phase 2/Phase 3|1200||Centers for Disease Control and Prevention||||Consenting participants entered tenofovir/emtricitabine oral prophylaxis trial|f||||t||||||||||2017-02-18 17:39:38.824512|2017-02-18 17:39:38.824512
NCT00111137|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2008-02-20|||February 2003||2003-02-01|February 2008|2008-02-01|April 2004|Actual|2004-04-01|November 2003|Actual|2003-11-01||Interventional|||Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy|A Randomized, Open Label Study to Assess Time to Hemoglobin Response of a Front Load Dosing Regimen for Darbepoetin Alfa Compared to a Weekly Dose Regimen for Recombinant Human Erythropoietin in Patients With Non-Myeloid Malignancies Receiving Chemotherapy|Completed||Phase 3|718|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:39:38.922148|2017-02-18 17:39:38.922148
NCT00111124|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2013-05-13||||||May 2013|2013-05-01||||||||Interventional|||Enbrel® in Psoriatic Arthritis|Enbrel® in Psoriatic Arthritis|Completed||Phase 4|||Amgen|||||||||||||||||||2017-02-18 17:39:39.028508|2017-02-18 17:39:39.028508
NCT00111111|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2009-05-28||||||May 2009|2009-05-01||||||||Interventional|||An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis|A Multicenter, Open-Label, Prospective Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects With Psoriasis|Completed||Phase 3|||Amgen||1|||||||||||||||||2017-02-18 17:39:39.121837|2017-02-18 17:39:39.121837
NCT00111098|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2008-08-07|||March 2004||2004-03-01|August 2008|2008-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis|A Multicenter, Single Arm Study Evaluating Once Monthly Darbepoetin Alfa Dosing In Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis|Completed||Phase 3|150|Anticipated|Amgen||1|||f||||||||||||||2017-02-18 17:39:39.215381|2017-02-18 17:39:39.215381
NCT00110318|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-05|2013-12-09|||March 2002||2002-03-01|December 2013|2013-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Trial of Physiotherapy and Corticosteroid Injections in Lateral Epicondylalgia|A Pragmatic, Randomised Controlled Trial of Physiotherapy and Corticosteroid Injections in Lateral Epicondylalgia|Completed||Phase 3|198||The University of Queensland|||||f||||||||||||||2017-02-18 17:40:00.164564|2017-02-18 17:40:00.164564
NCT00111085|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-17|2010-02-11||2010-02-11|January 2005||2005-01-01|February 2010|2010-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|CONSCIOUS-1||Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH)|A Phase IIb, Multi-center, International, Double-blind, Randomized, Placebo-controlled, Parallel-group, Dose-finding Study for the Prevention of Cerebral Vasospasm After aSAH by Intravenous Administration of Clazosentan, a Selective ETA Receptor Antagonist|Completed||Phase 2|413|Actual|Actelion|||||||||||||||||||2017-02-18 17:39:39.315999|2017-02-18 17:39:39.315999
NCT00111072|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2008-03-03|||May 2005||2005-05-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Dexamethasone to Treat Oral Lichen Planus|Dexamethasone 0.01% Solution for the Treatment of Oral Lichen Planus|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:39:39.416153|2017-02-18 17:39:39.416153
NCT00111059|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2005-06-23|||January 2005||2005-01-01|May 2005|2005-05-01|April 2006||2006-04-01|||||Observational|||Primary Prevention Study: Study on Obesity, Cardiovascular and Psycho-Social Characteristics in the City of Merzig|Cross-Sectional Case-Control Study on Obesity, Cardiovascular and Psycho-Social Characteristics in the City of Merzig|Unknown status|Recruiting|N/A|600||University Hospital, Saarland|||||f||||||||||||||2017-02-18 17:39:39.507483|2017-02-18 17:39:39.507483
NCT00111046|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2005-11-09|||February 2001||2001-02-01|May 2005|2005-05-01|February 2004||2004-02-01|||||Interventional|||Pain Relief - Tramadol Versus Ibuprofen|Post-Operative Pain Relief Following Insertion of Radioactive Plaque for Choroidal Melanoma: Randomised Control Trial of Tramadol Vs Ibuprofen: A Pilot Study|Unknown status|Active, not recruiting|Phase 1/Phase 2|40||Royal Liverpool University Hospital|||||f||||||||||||||2017-02-18 17:39:39.58522|2017-02-18 17:39:39.58522
NCT00111020|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2014-08-05|||June 2005||2005-06-01|August 2014|2014-08-01|October 2008|Actual|2008-10-01|June 2007|Actual|2007-06-01||Interventional|||Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma|Open Label, Non-Comparative Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 3|2567|Actual|Bayer||1|||t||||f||||||||||2017-02-18 17:39:39.684259|2017-02-18 17:39:39.684259
NCT00111007|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2014-10-23|2011-01-27||May 2005||2005-05-01|October 2014|2014-10-01|January 2009|Actual|2009-01-01|September 2006|Actual|2006-09-01||Interventional|||A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma|Phase III Randomized, Placebo Controlled Study of Sorafenib in Repeated Cycles of 21 Days in Combination With Paclitaxel/Carboplatin Chemotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma.|Completed||Phase 3|270|Actual|Bayer|Metastatic melanoma is notorious for its resistance to chemotherapy. Thus, it is unlikely that inhibition of a single factor or pathway would produce a sustained clinical effect in patients with previously treated, highly refractory disease.|2|||f||||t||||||||||2017-02-18 17:39:40.414709|2017-02-18 17:39:40.414709
NCT00110994|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2015-05-13|2011-01-26||April 2005||2005-04-01|May 2015|2015-05-01|March 2008|Actual|2008-03-01|October 2006|Actual|2006-10-01||Interventional|||Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma|Phase II Randomized, Placebo Controlled Study of Sorafenib in Repeated Cycles of 21 Days in Combination With Dacarbazine (DTIC) Chemotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma|Completed||Phase 2|101|Actual|Bayer||2|||f||||t||||||||||2017-02-18 17:39:41.393846|2017-02-18 17:39:41.393846
NCT00110981|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2013-05-22|||March 2005||2005-03-01|May 2013|2013-05-01|March 2006|Actual|2006-03-01|February 2006|Actual|2006-02-01||Interventional|||Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis|A Multicenter, Open-Label, Pilot Trial to Evaluate the Effectiveness and Safety of ENBREL(r) in Combination With Narrowband UVB Phototherapy for the Treatment of Psoriasis|Completed||Phase 4|86|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:39:42.42668|2017-02-18 17:39:42.42668
NCT00110968|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2017-02-06|||September 2004||2004-09-01|February 2017|2017-02-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia|A Multicentre, Open-label Extension Phase to Study the Long-term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia|Completed||Phase 3|300||Forest Laboratories|||||f||||||||||||||2017-02-18 17:39:42.536723|2017-02-18 17:39:42.536723
NCT00110955|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2010-01-14|||February 2004||2004-02-01|January 2010|2010-01-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|||Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy|A Randomized, Double-Blind, Placebo-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy|Completed||Phase 3|391|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:39:42.619076|2017-02-18 17:39:42.619076
NCT00110942|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2008-06-20|||February 2005||2005-02-01|June 2008|2008-06-01|November 2005|Actual|2005-11-01|June 2005|Actual|2005-06-01||Interventional|||Treatment for Patients With Osteoarthritis (OA)|A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Systemic AMG 108 in Subjects With Osteoarthritis (OA)|Completed||Phase 2|160|Actual|Amgen||4|||f||||||||||||||2017-02-18 17:39:42.725941|2017-02-18 17:39:42.725941
NCT00110929|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2010-04-22|||November 2002||2002-11-01|April 2010|2010-04-01||||||||Interventional|||Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)|A Study to Compare the Efficacy and Safety of an Oral Calcimimetic Agent (AMG 073) When Two Different Vitamin D Regimens Are Used in Subjects With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)|Completed||Phase 2|850||Amgen||1|||||||||||||||||2017-02-18 17:39:42.827912|2017-02-18 17:39:42.827912
NCT00110916|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2008-02-20|||June 2004||2004-06-01|February 2008|2008-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Treatment for Patients With Osteoarthritis (OA) of the Knee|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Intra-Articular metHuIL-1ra (Anakinra) in Subjects With Osteoarthritis (OA) of the Knee|Completed||Phase 2|165|Anticipated|Amgen||2|||f||||||||||||||2017-02-18 17:39:42.922154|2017-02-18 17:39:42.922154
NCT00110903|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2013-04-24||||||April 2013|2013-04-01||||||||Interventional|||Treatment for Subjects With Active Rheumatoid Arthritis (RA)|Open-Label Study to Assess the Safety of Etanercept Liquid Administered Once Weekly in Subjects With Active Rheumatoid Arthritis (RA)|Completed||Phase 3|||Amgen|||||||||||||||||||2017-02-18 17:39:43.014417|2017-02-18 17:39:43.014417
NCT00110890|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-16|2011-02-11|2010-10-15||May 2004||2004-05-01|February 2011|2011-02-01|September 2007|Actual|2007-09-01|April 2005|Actual|2005-04-01||Interventional|||A Research Study for Patients With End-Stage Renal Disease (ESRD)|An Open-Label, Randomised Study Using Cinacalcet to Improve Achievement of Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With ESRD|Completed||Phase 4|552|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:39:43.117862|2017-02-18 17:39:43.117862
NCT00110877|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-13|2015-07-01|||April 2005||2005-04-01|July 2015|2015-07-01|October 2011|Actual|2011-10-01|January 2007|Actual|2007-01-01||Interventional|||TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients|A Randomized, Controlled, Open-label Trial to Compare the Efficacy, Safety and Tolerability of TMC114/RTV Versus LPV/RTV in Treatment-Experienced HIV-1 Infected Patients|Completed||Phase 3|604|Actual|Tibotec Pharmaceuticals, Ireland||2|||f||||t||||||||||2017-02-18 17:39:46.85527|2017-02-18 17:39:46.85527
NCT00110864|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-13|2007-08-21|||May 2005||2005-05-01|August 2007|2007-08-01|April 2007|Actual|2007-04-01|||||Interventional|||Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes|Completed||Phase 2|90|Anticipated|Wellstat Therapeutics|||||||||||||||||||2017-02-18 17:39:47.362102|2017-02-18 17:39:47.362102
NCT00110851|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-13|2007-08-21|||April 2005||2005-04-01|August 2007|2007-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) Therapy|Completed||Phase 2|90|Anticipated|Wellstat Therapeutics|||||||||||||||||||2017-02-18 17:39:47.473559|2017-02-18 17:39:47.473559
NCT00110838|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-13|2006-07-20|||October 2001||2001-10-01|May 2005|2005-05-01|January 2005||2005-01-01|||||Interventional|||SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia|Study on Omega-3 Fatty Acids and Ventricular Arrhythmia, a Parallel, Placebo-Controlled, Double Blind Intervention Study|Completed||Phase 3|546||Wageningen Centre for Food Sciences|||||f||||||||||||||2017-02-18 17:39:47.585898|2017-02-18 17:39:47.585898
NCT00110825|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-13|2017-01-11|||February 2004||2004-02-01|June 2009|2009-06-01|June 2009|Actual|2009-06-01|March 2006|Actual|2006-03-01||Interventional|||Behavioral Smoking Cessation Treatment - 1|Behavioral Maintenance Treatment for Smoking Cessation|Completed||N/A|304|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-02-18 17:39:47.707156|2017-02-18 17:39:47.707156
NCT00110812|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-13|2014-04-07|2012-12-12||September 2005||2005-09-01|April 2014|2014-04-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|STALWART||Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People|STALWART: A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 With and Without Concomitant Antiretroviral Therapy in Patients With HIV-1 Infection and CD4+ Cell Counts of 300 Cells/mm3 or More|Completed||Phase 2|267|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|All randomized patients were followed through 28 Feb 2009. A subset of 222 consenting patients were followed 2 additional years, through 28 Feb 2011.|3|||f||||t||||||||||2017-02-18 17:39:47.826854|2017-02-18 17:39:47.826854
NCT00110799|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-13|2012-05-31|||April 2005||2005-04-01|March 2011|2011-03-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C|A Double-Blind, Randomized, Placebo-Controlled, Multi-Centre, Dose-Ranging, Parallel Group, Phase II Study to Assess Efficacy, Safety/Tolerability, and Pharmacokinetics of a Thrombopoietin Receptor Agonist, SB-497115-GR, When Administered as 30, 50, and 75 mg Once Daily for 12 Weeks in Subjects With|Completed||Phase 2|75|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 17:39:49.379167|2017-02-18 17:39:49.379167
NCT00110786|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-13|2010-06-16|||May 2005||2005-05-01|September 2009|2009-09-01|December 2005||2005-12-01|||||Interventional|||Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy|A Double Blind Study to Investigate the Clinical Efficacy and Safety of Ragweed MATAMPL (Allergy Therapeutics®), Pollinex®-R (Allergy Therapeutics®) and Placebo in Patients With Seasonal Allergic Rhinitis With Ragweed Allergy, in an Environmental Exposure Chamber (EEC) Model, With Follow-Up During a Natural Ragweed Pollen Season|Completed||Phase 2|240||Allergy Therapeutics|||||f||||||||||||||2017-02-18 17:39:49.524036|2017-02-18 17:39:49.524036
NCT00110773|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults|A Randomized, Double-Blind, Placebo Controlled, Parallel Study Evaluating the Efficacy of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) to Provide Local Dermal Anesthesia for Pulsed Dye Laser Therapy in Adults|Completed||Phase 3|80|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-02-18 17:39:49.613468|2017-02-18 17:39:49.613468
NCT00110760|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face|Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream)for Induction of Local Dermal Anesthesia for Dermal Filler Injection on the Face of Adults|Completed||Phase 3|70|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-02-18 17:39:49.721806|2017-02-18 17:39:49.721806
NCT00110747|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults|A Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating the Efficacy of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Providing Local Dermal Anesthesia for Non-Ablative Facial Laser Resurfacing in Adults|Completed||Phase 3|54|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-02-18 17:39:49.827169|2017-02-18 17:39:49.827169
NCT00110734|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2005-09-21||||||September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults|A Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) for Induction of Local Dermal Anesthesia for Laser-Assisted Tattoo Removal in Adults|Completed||Phase 3|60||ZARS Pharma Inc.|||||||||||||||||||2017-02-18 17:39:49.934786|2017-02-18 17:39:49.934786
NCT00110721|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2012-03-05|||May 2005||2005-05-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|June 2007|Actual|2007-06-01||Interventional|||GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer|A Phase II, Multi-Center, Open-Label Trial to Evaluate the Efficacy and Safety of Intravenous GM-CT-01 in Combination With 5-Fluorouracil When Administered in Monthly Cycles as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer|Terminated||Phase 2|20|Actual|Galectin Therapeutics Inc.||1||Study protocol amended to a new treatment regimen: study DAVFU-006.|f||||f||||||||||2017-02-18 17:39:50.013199|2017-02-18 17:39:50.013199
NCT00110708|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2006-02-20|||April 2005||2005-04-01|February 2006|2006-02-01|June 2006||2006-06-01|||||Interventional|||Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism|A Randomized, Placebo-Controlled Phase II Trial Evaluating Safety and Efficacy of Oral Human Immunoglobulin in the Treatment of Gastrointestinal Dysfunction Associated With Autistic Disorder in Pediatric Patients From 2 to 18 Years of Age|Unknown status|Active, not recruiting|Phase 2|120||PediaMed Pharmaceuticals|||||||||||||||||||2017-02-18 17:39:50.126253|2017-02-18 17:39:50.126253
NCT00110695|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2010-03-24|||April 2005||2005-04-01|March 2010|2010-03-01|July 2008|Actual|2008-07-01|December 2006|Actual|2006-12-01||Interventional|||Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer|A Phase 2 Study of Neoadjuvant Chemotherapy With Sequential Weekly Nanoparticle Albumin Bound Paclitaxel (Abraxane) Followed by 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) in Locally Advanced Breast Cancer|Completed||Phase 2|66|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-02-18 17:39:50.242694|2017-02-18 17:39:50.242694
NCT00110682|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2008-04-21|||April 2005||2005-04-01|April 2008|2008-04-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses|A Randomized, Parallel-Group, Vehicle-Controlled, Double-Blind Study of Topical Imiquimod 5% Cream Used as an Adjunct to Cryotherapy in the Management of Actinic Keratoses, With a Long-Term (1 Year) Follow-Up|Completed||Phase 4|60||Derm Research @ 888 Inc.|||||f||||t||||||||||2017-02-18 17:39:50.353271|2017-02-18 17:39:50.353271
NCT00110669|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2011-10-26|||January 2004||2004-01-01|October 2011|2011-10-01|February 2008|Actual|2008-02-01|December 2007|Actual|2007-12-01||Interventional|||High-dose Prednisone in Duchenne Muscular Dystrophy|A Randomized Study of Daily vs. High-dose Weekly Prednisone Therapy in Duchenne Muscular Dystrophy|Completed||Phase 3|64|Actual|Cooperative International Neuromuscular Research Group||2|||f||||t||||||||||2017-02-18 17:39:50.453072|2017-02-18 17:39:50.453072
NCT00110656|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-12|2011-01-20|||March 2004||2004-03-01|January 2011|2011-01-01|October 2004|Actual|2004-10-01|September 2004|Actual|2004-09-01||Observational|||Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation|A Retrospective Follow Up Study to Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation|Completed||N/A|38|Actual|Amgen|||1||f||||||||||None Retained|"~     Retrospective data collected.~   "|||2017-02-18 17:39:50.559139|2017-02-18 17:39:50.559139
NCT00110643|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-11|2015-04-30|||February 2003||2003-02-01|April 2015|2015-04-01|December 2005||2005-12-01|||||Interventional|||Infrared Non-Cutting Laser Therapy for Acne|CoolTouch Non-ablative Laser Therapy for Acne Vulgaris|Completed||Phase 2/Phase 3|50||University of Michigan|||||f||||f||||||||||2017-02-18 17:39:50.65406|2017-02-18 17:39:50.65406
NCT00110630|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-11|2017-01-11|||June 2005||2005-06-01|September 2008|2008-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|STOP||Smoking Treatment of Prisoners|"Smoking Treatment of Prisoners: Project STOP"|Completed||Phase 3|250|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-02-18 17:39:50.743812|2017-02-18 17:39:50.743812
NCT00110617|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2011-05-23|2011-01-11||May 2005||2005-05-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients|A Randomized, Open-label, Multi-center, Phase II Study to Evaluate the Safety and Efficacy of Deferasirox (ICL670) 20 mg/kg/Day Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients With Iron Overload From Repeated Blood Transfusions|Completed||Phase 2|212|Actual|Novartis|Due to severe good clinical practice violations, data from 9 participants recruited for Center 512 was excluded from the main analysis of the study.|2|||f||||||||||||||2017-02-18 17:39:50.849845|2017-02-18 17:39:50.849845
NCT00110604|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2008-12-29|||September 2000||2000-09-01|May 2005|2005-05-01|December 2004||2004-12-01|||||Interventional|||The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing|The Folic Acid and Carotid Intima-Media Thickness (FACIT) Study: A Randomized Controlled Trial|Completed||N/A|835||Wageningen University|||||f||||||||||||||2017-02-18 17:39:52.578754|2017-02-18 17:39:52.578754
NCT00110591|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2015-12-14|||April 2004||2004-04-01|December 2015|2015-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers|A Phase I, Randomized, Double Blind, Placebo Controlled, Single-Dose, Rising Dose Cohort Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRO 140 in Healthy Volunteers|Completed||Phase 1|20|Actual|CytoDyn, Inc.||5|||f||||f||||||||||2017-02-18 17:39:52.714902|2017-02-18 17:39:52.714902
NCT00110578|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2008-08-07|||September 1998||1998-09-01|July 2007|2007-07-01|April 2005||2005-04-01|||||Interventional|||Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults|Safety and Antiviral Efficacy of Cellular Adoptive Immunotherapy With Autologous CD8+ HIV-Specific Cytotoxic T Cells Combined With Interleukin-2 For HIV Seropositive Individuals|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:39:52.823893|2017-02-18 17:39:52.823893
NCT00110565|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2008-08-04|||January 2005||2005-01-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Effects of Pulsed Magnetic Pads on Rheumatoid Arthritis Symptoms in Postmenopausal Women|Pulsed Electromagnetic Field (PEMF) Efficacy in Reducing Rheumatoid Arthritis Symptoms|Completed||Phase 2|87||National Center for Complementary and Integrative Health (NCCIH)|||||f||||f||||||||||2017-02-18 17:39:52.926169|2017-02-18 17:39:52.926169
NCT00110552|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2014-10-27|||July 2005||2005-07-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|December 2012|Actual|2012-12-01||Interventional|||Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients|Effects of a Cognitive Enhancer on Memory and Cognitive Performance|Completed||Phase 1|111|Actual|Oregon Health and Science University||2|||f||||t||||||||||2017-02-18 17:39:53.024459|2017-02-18 17:39:53.024459
NCT00110539|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2012-05-23|||February 2004||2004-02-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Effectiveness of an Internet-Based Curriculum in Increasing Health Care Providers' Knowledge of Herbs and Dietary Supplements|Internet-Based Curriculum About Herbs and Dietary Supplements|Completed||N/A|1500||National Library of Medicine (NLM)|||||f||||||||||||||2017-02-18 17:39:53.129534|2017-02-18 17:39:53.129534
NCT00110526|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2013-10-23|||April 2005||2005-04-01|October 2013|2013-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Gene Therapy for Prostate Cancer That Returns After Radiation Therapy|Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients With Radiorecurrent Prostate Cancer|Withdrawn||Phase 1|0|Actual|Icahn School of Medicine at Mount Sinai||1||No participants met eligibility requirements|f||||t||||||||||2017-02-18 17:39:53.205376|2017-02-18 17:39:53.205376
NCT00110513|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-10|2012-08-10|2012-03-19||April 2005||2005-04-01|August 2012|2012-08-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery|A Multicenter, Multinational Study to Assess the Safety and Efficacy of Antithrombin Alfa in Hereditary Antithrombin (AT) Deficient Patients in High-Risk Situations for Thrombosis|Completed||Phase 3|18|Actual|rEVO Biologics||1|||f||||f||||||||||2017-02-18 17:39:53.310398|2017-02-18 17:39:53.310398
NCT00110500|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-09|2011-06-06|||April 2005||2005-04-01|June 2011|2011-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy|A Phase I Dose-Escalation Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy|Completed||Phase 1|12|Anticipated|Sangamo Therapeutics|||||||||||||||||||2017-02-18 17:39:53.915026|2017-02-18 17:39:53.915026
NCT00110487|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-09|2015-04-30|||January 2005||2005-01-01|December 2007|2007-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women|A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study of the Effect of ERB-041 in the Reduction of Symptoms Associated With Endometriosis in Reproductive-Age Women|Completed||Phase 2|200||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:39:54.014056|2017-02-18 17:39:54.014056
NCT00110474|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-09|2006-09-18|||May 2000||2000-05-01|September 2006|2006-09-01|December 2002||2002-12-01|||||Interventional|||Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoarthritis|Efficacy and Safety of Glucosamine Sulfate Versus a Pure Analgesic (Acetaminophen/Paracetamol) and Placebo in Patients Suffering From Osteoarthritis of the Knee|Completed||Phase 3|300||Rottapharm|||||f||||||||||||||2017-02-18 17:39:54.154391|2017-02-18 17:39:54.154391
NCT00110461|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-09|2012-04-19|2011-08-11||March 2005||2005-03-01|April 2012|2012-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Aripiprazole in Children and Adolescents With Bipolar I Disorder|A Phase III Trial to Test the Safety and Efficacy of Two Doses of Aripiprazole in Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features|Completed||Phase 3|296|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.|Primary efficacy endpoint is change from baseline in Y-MRS total score. Only randomized subjects with both baseline and 1+ post-baseline were included in primary efficacy analysis so # randomized is different from # included in the efficacy analysis.|3|||f||||||||||||||2017-02-18 17:39:54.28134|2017-02-18 17:39:54.28134
NCT00110448|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-09|2016-10-31|||December 2002||2002-12-01|August 2008|2008-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial|Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial|Completed||Phase 4|2539|Actual|Kumamoto University||2|||f||||t||||||||||2017-02-18 17:39:56.288754|2017-02-18 17:39:56.288754
NCT00110435|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-09|2015-10-30|||May 2005||2005-05-01|October 2015|2015-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)|A Multicenter, Randomized, Double-blind, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypercholesterolemia|Completed||Phase 3|1229|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:39:56.392859|2017-02-18 17:39:56.392859
NCT00110422|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-09|2011-04-07||2010-02-15|November 2005||2005-11-01|June 2010|2010-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome|Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome|Completed||Phase 4|400||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:39:56.483421|2017-02-18 17:39:56.483421
NCT00110409|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-06|2013-06-07|||January 2005||2005-01-01|June 2013|2013-06-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Asthma Patient Education in the Emergency Room|Trial of Asthma Patient Education in the Emergency Room|Completed||N/A|296|Anticipated|Hospital for Special Surgery, New York||2|||f||||t||||||||||2017-02-18 17:39:56.807676|2017-02-18 17:39:56.807676
NCT00110396|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-06|2015-06-18|2010-04-30||January 2005||2005-01-01|June 2015|2015-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|RNF||Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis|A Multicentre, Single Arm, Open-Label, Phase IIIB Study to Evaluate the Safety and Antigenicity of Rebif® (Interferon-beta-1a) in Subjects With Relapsing Forms of Multiple Sclerosis|Completed||Phase 3|260|Actual|EMD Serono||1|||f||||||||||||||2017-02-18 17:39:56.911093|2017-02-18 17:39:56.911093
NCT00110383|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-06|2014-03-02|||May 2004||2004-05-01|December 2007|2007-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Comparison of School-Based Supervised Versus Parental Supervised Asthma Therapy|Effectiveness of School Based Supervised Asthma Therapy|Completed||N/A|295|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 17:39:57.294918|2017-02-18 17:39:57.294918
NCT00110370|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-06|2007-11-26|||April 2004||2004-04-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes|A Comparison of Prandial Insulin Lispro Mixtures Therapy to Glargine Basal-Bolus Therapy With Insulin Lispro on the Overall Glycemic Control of Patients With Type 2 Diabetes Previously Treated With Oral Agents Combined With Insulin Glargine|Completed||Phase 4|300||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:39:57.394854|2017-02-18 17:39:57.394854
NCT00110357|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-06|2015-11-24|2009-04-21||August 2005||2005-08-01|November 2015|2015-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors|Phase I Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|48|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:39:57.567005|2017-02-18 17:39:57.567005
NCT00110344|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-06|2013-10-10|||November 2005||2005-11-01|October 2013|2013-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Research Study for Patients With Metastatic Renal Cell Carcinoma|A Phase II Study of BAY 43-9006 Prior to and Following Nephrectomy in Patients With Metastatic Renal Cell Carcinoma.|Terminated||Phase 2|1|Actual|Bayer||2|||f||||f||||||||||2017-02-18 17:39:59.956401|2017-02-18 17:39:59.956401
NCT00110331|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-05|2017-01-24|||May 3, 2005||2005-05-03|September 9, 2014|2014-09-09|September 9, 2014||2014-09-09|||||Observational|||Central Nervous System Disease in HIV-infected Children on HAART||Completed||N/A|21|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:40:00.06957|2017-02-18 17:40:00.06957
NCT00110305|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-05|2014-06-11|2013-04-26||June 2005||2005-06-01|June 2014|2014-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines|A Phase IIb Randomized, Partially Blinded, Dose-Finding Trial of TMC278 in Antiretroviral-Naive HIV-1 Infected Subjects|Completed||Phase 2|368|Actual|Tibotec Pharmaceuticals, Ireland||4|||f||||t||||||||||2017-02-18 17:40:00.295964|2017-02-18 17:40:00.295964
NCT00110292|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-05|2005-06-23|||March 2002||2002-03-01|May 2005|2005-05-01|February 2006||2006-02-01|||||Interventional|||Preventing Learning Problems in Young Children: A Public Health and Physician-Based Outreach|An RCT of a Low-Intensity Intervention to Reduce Delay|Unknown status|Active, not recruiting|Phase 1|600||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:40:01.942379|2017-02-18 17:40:01.942379
NCT00110279|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-05|2008-01-18|||June 2005||2005-06-01|January 2008|2008-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)|Phase I Inpatient Study of the Safety and Immunogenicity of H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H9N2 Infection in the Event of a Pandemic (Study A)|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:40:02.039665|2017-02-18 17:40:02.039665
NCT00110266|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-04|2016-11-16|||May 2005||2005-05-01|November 2016|2016-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients|An Open Label, Safety and Tolerability Study of Deferasirox for Treatment of Transfusional Iron Overload in Low-risk and INT-1, Myelodysplastic Patients Using Serum Ferritin Monitoring|Completed||Phase 2|176|Actual|Novartis||1|||f||||f||||||||||2017-02-18 17:40:02.185421|2017-02-18 17:40:02.185421
NCT00110253|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-04|2012-06-04|||June 2005||2005-06-01|June 2012|2012-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Duration of Skin Numbing Effect Created by the S-Caine™ Peel|A Randomized, Double-Blind, Paired, Placebo Controlled Study Evaluating the Duration of Anesthetic Effect Produced by the S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) When Applied for 30 and 60 Minutes|Completed||Phase 3|40|Actual|ZARS Pharma Inc.||1|||f||||f||||||||||2017-02-18 17:40:02.367732|2017-02-18 17:40:02.367732
NCT00110240|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-04|2012-05-04|||April 2005||2005-04-01|May 2012|2012-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|594|Actual|Novartis|||||f||||||||||||||2017-02-18 17:40:02.486047|2017-02-18 17:40:02.486047
NCT00110227|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-04|2013-03-05|||September 2005||2005-09-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|NEXT-Heart||Tai Chi Mind-Body Therapy for Chronic Heart Failure|Tai Chi Mind-Body Therapy for Chronic Heart Failure|Completed||Phase 3|100|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 17:40:02.586202|2017-02-18 17:40:02.586202
NCT00110214|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-04|2014-04-21|2013-03-07||April 2005||2005-04-01|December 2012|2012-12-01|August 2011|Actual|2011-08-01|March 2010|Actual|2010-03-01||Interventional|||Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy|A Randomized Double-Blinded Placebo Controlled Phase III Trial Comparing Doctaxel and Prednisone With and Without Bevacizumab (IND #7921, NSC #704865) in Men With Hormone Refractory Prostate Cancer|Completed||Phase 3|1050|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:40:02.731244|2017-02-18 17:40:02.731244
NCT00110201|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-04|2005-06-23|||March 2005||2005-03-01|May 2005|2005-05-01|December 2007||2007-12-01|||||Interventional|||The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure|Prophylactic Use of Nesiritide (Brain Natriuretic Peptide, BNP) for the Prevention of Acute Renal Failure in Thoracic Aortic Aneurysm Surgery Patients|Unknown status|Recruiting|Phase 3|124||Ejaz, Abulate A, MD|||||||||||||||||||2017-02-18 17:40:03.929743|2017-02-18 17:40:03.929743
NCT00110188|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-04|2015-11-18|||May 2005||2005-05-01|November 2015|2015-11-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)|A Phase II Study of the Efficacy and Safety of AP23573 in Patients With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)|Completed||Phase 2|39|Actual|Merck Sharp & Dohme Corp.||1|||f||||f||||||||||2017-02-18 17:40:04.028467|2017-02-18 17:40:04.028467
NCT00110175|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2017-01-24|||April 28, 2005||2005-04-28|March 27, 2008|2008-03-27|March 27, 2008||2008-03-27|||||Observational|||Motor Performance in Chronic Stroke Patients|Improvement of Motor Performance in Chronic Stroke Patients by Combined Transcranial DC Stimulation and Somatosensory Stimulation|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:40:04.148881|2017-02-18 17:40:04.148881
NCT00110162|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2013-08-06|||October 2004||2004-10-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|||Androgen Deprivation Therapy in Treating Patients With Prostate Cancer|A Collaborative Randomized Phase III Trial: The Timing of Intervention With Androgen Deprivation in Prostate Cancer Patients With Rising PSA|Unknown status|Recruiting|Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:40:04.240589|2017-02-18 17:40:04.240589
NCT00110149|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2009-07-07|||May 2004||2004-05-01|July 2009|2009-07-01||||May 2012|Anticipated|2012-05-01||Interventional|||Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Study of Yttrium-90-Labeled Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as First Line Treatment in Indolent Non-Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 2|28|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:40:04.361124|2017-02-18 17:40:04.361124
NCT00110136|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2014-12-17|2014-09-04||March 2006||2006-03-01|December 2014|2014-12-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional||All registered participants are used in the analysis.|St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer|A Phase II Study of St. John's Wort for the Treatment of Hot Flashes in Women With a History of Breast Cancer|Terminated||Phase 2|9|Actual|Wake Forest University Health Sciences|This study was stopped early due to concerns about the interaction between St. John's wort and tamoxifen.|1||Stopped due to concerns about interaction between St. John's wort and Tamoxifen.|f||||t||||||||||2017-02-18 17:40:04.473817|2017-02-18 17:40:04.473817
NCT00110123|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2012-09-20|||January 2005||2005-01-01|September 2012|2012-09-01||||June 2011|Actual|2011-06-01||Interventional|||Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma|Intravenous Versus Intra-Arterial Fotemustine Chemotherapy in Patients With Liver Metastases From Uveal Melanoma: A Randomized Phase III Study of the EORTC Melanoma Group|Terminated||Phase 3|171|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 17:40:04.819605|2017-02-18 17:40:04.819605
NCT00110110|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2016-04-14|||June 2004||2004-06-01|April 2016|2016-04-01|December 2019|Anticipated|2019-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma|Multicenter Phase II Study for International Intraocular Retinoblastoma Classification Groups B, C & D Tumors Treated With Carboplatin-Etoposide-Vincristine-Cyclosporine-Focal Therapy Multimodality Protocol (OCRN Multicenter RB 2003)|Active, not recruiting||Phase 2|71|Anticipated|The Hospital for Sick Children||1|||f||||t||||||||||2017-02-18 17:40:04.93193|2017-02-18 17:40:04.93193
NCT00110084|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2011-05-31|2011-03-29||August 2005||2005-08-01|May 2011|2011-05-01|August 2010|Actual|2010-08-01|May 2010|Actual|2010-05-01||Interventional|||ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer|Phase II Trial of Weekly Nab (Nanoparticle Albumin Bound)-Paclitaxel (Nab-paclitaxel) (Abraxane®) in Combination With Gemcitabine in Patients With Metastatic Breast Cancer|Completed||Phase 2|50|Actual|Mayo Clinic||1|||f||||t||||||||||2017-02-18 17:40:07.997002|2017-02-18 17:40:07.997002
NCT00110071|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2014-08-04|||January 2005||2005-01-01|August 2014|2014-08-01||||June 2011|Actual|2011-06-01||Interventional|||Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma|A Clinical Trial Evaluating I131-Tositumomab (Anti-CD20) With Escalating Doses of Fludarabine Followed by Autologous or Syngeneic Stem Cell Transplantation for Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma in Patients 60 Years of Age and Older|Completed||Phase 1|38|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 17:40:08.923713|2017-02-18 17:40:08.923713
NCT00110058|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2011-11-15|||February 2005||2005-02-01|November 2011|2011-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia|A Multi-Center Phase II Study of Nonmyeloablative Conditioning With TBI and Fludarabine for HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Chronic Myeloid Leukemia in Chronic and Accelerated Phase|Completed||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:40:09.048196|2017-02-18 17:40:09.048196
NCT00110045|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2012-09-20|||February 2005||2005-02-01|September 2012|2012-09-01||||March 2008|Actual|2008-03-01||Interventional|||Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant|A Multicenter, Open, Phase II Study to Estimate the Activity and Safety of Caspofungin (CASP) in the First-Line Treatment of Probable and Proven Invasive Aspergillosis (IA) in Patients With Hematological Malignancies (HM) or Recipients of Autologous Haematopoietic Stem Cell Transplantation and Those With Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)|Completed||Phase 2|171|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:40:09.146861|2017-02-18 17:40:09.146861
NCT00110032|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2013-01-15|||June 2005||2005-06-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors|Microenvironment: Imaging/Implications in Brain Tumors; A Preliminary Investigation of the Biodistribution of [F-18]-EF5 in Patients With Brain Tumors|Terminated||Phase 1|46|Actual|National Cancer Institute (NCI)||3||Administratively complete.|f||||||||||||||2017-02-18 17:40:09.300129|2017-02-18 17:40:09.300129
NCT00110019|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2015-09-28|2012-08-28||June 2005||2005-06-01|July 2015|2015-07-01|August 2012|Actual|2012-08-01|January 2011|Actual|2011-01-01||Interventional|||Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery|A Double-Blind, Randomized, Placebo-Controlled Phase III Trial of Carboplatin, Paclitaxel and Sorafenib Versus Carboplatin, Paclitaxel and Placebo in Patients With Unresectable Locally Advanced or Stage IV Melanoma|Completed||Phase 3|823|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 17:40:09.436971|2017-02-18 17:40:09.436971
NCT00110006|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2010-06-10|||December 2004||2004-12-01|June 2010|2010-06-01||||||||Interventional|||Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma|Prognostic Significance of Early Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F] FDG) in Intermediate and High Grade Non-Hodgkin's Lymphoma|Withdrawn||N/A|0|Actual|Case Comprehensive Cancer Center||1||No accrual|f||||t||||||||||2017-02-18 17:40:10.737743|2017-02-18 17:40:10.737743
NCT00109993|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2010-06-10|||January 2005||2005-01-01|June 2010|2010-06-01|May 2007|Actual|2007-05-01|June 2006|Actual|2006-06-01||Interventional|||Campath-1H + FK506 and Methylprednisolone for GVHD|Phase II Clinical Trial Incorporating Alemtuzumab (Campath-1H) in Combination With FK506 and Methylprednisolone for Treatment of Severe Acute Graft vs Host Disease|Completed||Phase 2|34|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:40:10.844136|2017-02-18 17:40:10.844136
NCT00109980|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2013-10-30|||March 2005||2005-03-01|October 2013|2013-10-01||||July 2011|Actual|2011-07-01||Observational|||Medicinal Plant Use for Treating Inflammation Among Dominicans in New York City and the Dominican Republic|Dominican Herbal Medicine: Plants Used for Inflammation|Completed||N/A|320|Actual|New York Botanical Garden|||1||f||||f||||||||||2017-02-18 17:40:10.973719|2017-02-18 17:40:10.973719
NCT00109967|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2014-03-21|2013-12-03||May 2005||2005-05-01|December 2013|2013-12-01|March 2012|Actual|2012-03-01|September 2009|Actual|2009-09-01||Interventional|||CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Study of CCI-779 in Combination With Rituximab in Patients With Relapsed or Refractory Mantle Cell Lymphoma|Completed||Phase 2|71|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:40:11.082678|2017-02-18 17:40:11.082678
NCT00109746|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-02|2016-03-22|||November 2005||2005-11-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|May 2009|Actual|2009-05-01||Interventional|NT||Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults|A Novel Therapy for Glucose Intolerance in HIV Disease|Completed||Phase 1/Phase 2|39|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 17:40:16.987543|2017-02-18 17:40:16.987543
NCT00109954|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2016-01-15|||February 2005||2005-02-01|March 2015|2015-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery|A Prospectively Randomized Controlled Clinical Trial Comparing TheraSphere With Cisplatin-Based TACE (Trans Arterial Chemo Embolization) in the Management of Advanced Stage, Unresectable Hepatocellular Carcinoma (HCC)|Completed||Phase 3|120|Anticipated|University of Pittsburgh|||||f||||t||||||||||2017-02-18 17:40:12.238028|2017-02-18 17:40:12.238028
NCT00109941|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2013-05-16|||October 2003||2003-10-01|March 2013|2013-03-01|April 2009|Actual|2009-04-01|September 2007|Actual|2007-09-01||Interventional|OGF||Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery|Treatment of Advanced Pancreatic Cancer With Opioid Growth Factor (OGF): Phase II|Completed||Phase 2|25|Actual|Penn State University||1|||f||||t||||||||||2017-02-18 17:40:12.341172|2017-02-18 17:40:12.341172
NCT00109928|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2014-09-18|2014-06-11||September 2005||2005-09-01|September 2014|2014-09-01|April 2014|Actual|2014-04-01|June 2012|Actual|2012-06-01||Interventional||Peripheral T-cell lymphomas (PTCLs) with stage II bulky, III or IV with extra-nodal, nodal and transformed cutaneous presentations were eligible.|S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma|Phase II Trial of Cisplatin Plus Etoposide Plus Gemcitabine Plus Solumedrol (PEGS) in Peripheral T-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|34|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 17:40:12.472952|2017-02-18 17:40:12.472952
NCT00109889|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2012-04-02|||April 2005||2005-04-01|April 2012|2012-04-01|February 2017|Anticipated|2017-02-01|April 2007|Actual|2007-04-01||Interventional|||S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma|A Prospective Observational Study of Patients With Solitary Plasmacytoma Using a Modified Staging System Supplemented by an MRI and Whole Body FDG-PET Scan|Terminated||Phase 2|2|Actual|Southwest Oncology Group||1||poor accrual|f||||f||||||||||2017-02-18 17:40:13.004856|2017-02-18 17:40:13.004856
NCT00109876|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2016-11-29|2016-11-29||September 2006||2006-09-01|November 2016|2016-11-01|February 2013|Actual|2013-02-01|August 2012|Actual|2012-08-01||Interventional||All enrolled participants who met the eligibility criteria.|Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer|A Pilot Study of Radiofrequency Ablation in High-Risk Patients With Stage IA Non-Small Cell Lung Cancer|Completed||N/A|54|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 17:40:13.142858|2017-02-18 17:40:13.142858
NCT00109863|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2015-02-13|||May 2005||2005-05-01|February 2015|2015-02-01|February 2014|Actual|2014-02-01|July 2007|Actual|2007-07-01||Interventional|||Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma|Phase II Trial of Hu14.18-IL2 (EMD 273063) in Subjects With Advanced Melanoma|Completed||Phase 2|14|Actual|University of Wisconsin, Madison||1|||f||||||||||||||2017-02-18 17:40:13.777495|2017-02-18 17:40:13.777495
NCT00109850|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2015-11-16|2012-06-14||May 2005||2005-05-01|November 2015|2015-11-01|May 2012|Actual|2012-05-01|September 2009|Actual|2009-09-01||Interventional|||S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer|Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates|Terminated||Phase 2|22|Actual|Southwest Oncology Group||1||Closed due to poor accrual|f||||t||||||||||2017-02-18 17:40:13.89629|2017-02-18 17:40:13.89629
NCT00109837|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2015-03-05|2012-04-04||April 2005||2005-04-01|March 2015|2015-03-01|November 2014|Actual|2014-11-01|November 2010|Actual|2010-11-01||Interventional|||S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|A Phase II Study of Double Induction Chemotherapy for Newly Diagnosed Non-L3 Adult Acute Lymphoblastic Leukemia With Investigation of Minimal Residual Disease and Risk of Relapse Following Maintenance Chemotherapy|Completed||Phase 2|79|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:40:14.459071|2017-02-18 17:40:14.459071
NCT00109824|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2013-06-03|||March 2006||2006-03-01|June 2013|2013-06-01||||March 2009|Actual|2009-03-01||Interventional|||Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:40:15.342017|2017-02-18 17:40:15.342017
NCT00109811|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2013-01-22|||March 2005||2005-03-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer|A Phase 2 Study of Prostate Specific Antigen Peptide 3A (PSA: 154-163(155L) ) (NSC # 722932, IND#9787) With Montanide ISA-51(NSC #675756, IND #9787) or Montanide® ISA 51 VG (NSC 737063) Vaccination in Prostate Cancer Recurrent|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:40:15.645947|2017-02-18 17:40:15.645947
NCT00109798|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2016-03-15|||March 2005||2005-03-01|March 2016|2016-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma|Phase II Trial of Salvage Chemotherapy With Temozolomide in Combination With Topotecan for Primary CNS Lymphoma|Withdrawn||N/A|0|Actual|The Methodist Hospital System||1||Sub-Investigator reloacted to another institution|f||||f||||||||No||2017-02-18 17:40:15.750084|2017-02-18 17:40:15.750084
NCT00109785|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2015-12-23|||March 1997||1997-03-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||PET Scans in Patients With Locally Advanced Breast Cancer|Positron Emitter I-124-Iododeoxyuridine to Follow DNA Metabolism on Scans and in Tumor Samples in Advanced Breast Cancer: Comparison to 18-F-2-Fluoro-2-Deoxy-(D)-Glucose, as a Tracer for Glycolysis|Completed||Phase 1|8|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:40:15.856229|2017-02-18 17:40:15.856229
NCT00109772|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2013-08-26|2013-05-07||February 2005||2005-02-01|August 2013|2013-08-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|CRPS-002|Safety population|Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1|A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1|Terminated||Phase 2|184|Actual|Celgene||2||Interim analysis showed the primary outcome was not reached|f||||t||||||||||2017-02-18 17:40:15.968238|2017-02-18 17:40:15.968238
NCT00109759|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-03|2010-06-16|||May 2005||2005-05-01|June 2010|2010-06-01|June 2005||2005-06-01|||||Interventional|||Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)|A Double-Blind Phase I Study to Evaluate the Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL® in Healthy Volunteers.|Withdrawn||Phase 1|15||Allergy Therapeutics|||||f||||||||||||||2017-02-18 17:40:16.87769|2017-02-18 17:40:16.87769
NCT00109733|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-02|2013-08-04|2010-05-19||January 2005||2005-01-01|August 2013|2013-08-01|July 2006|Actual|2006-07-01|June 2006|Actual|2006-06-01||Interventional|||Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency|A Phase IIIb, Prospective, Multicenter, Randomized, Open-label Study to Determine the Safety and Efficacy of Two Different Dosing Regimens of Saizen® (Recombinant Human Growth Hormone (r-hGH), Using Cool.Click™ in Subjects With Childhood-onset Growth Hormone Deficiency During the Adolescent Transition Phase (CATS)|Completed||Phase 3|31|Actual|EMD Serono||2|||f||||||||||||||2017-02-18 17:40:17.110934|2017-02-18 17:40:17.110934
NCT00109720|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-02|2010-01-14|||August 2002||2002-08-01|January 2010|2010-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Evaluation of Diabetes Self-Management Consultant Care|Evaluation of Diabetes Self-Management Consultant Care|Completed||N/A|310|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 17:40:17.728214|2017-02-18 17:40:17.728214
NCT00109707|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-02|2016-04-27|||May 2004||2004-05-01|April 2016|2016-04-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers|A Phase IA/II Multicenter, Dose-escalation Study of Oral AMN107 on a Continuous Daily Dosing Schedule in Adult Patients With Imatinib-resistant/Intolerant CML in Chronic or Accelerated Phase or Blast Crisis, Relapsed/Refractory Ph+ ALL, and Other Hematologic Malignancies.|Completed||Phase 1/Phase 2|942|Actual|Novartis||6|||f||||||||||||||2017-02-18 17:40:17.844452|2017-02-18 17:40:17.844452
NCT00109681|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-02|2010-02-11||2010-02-11|April 2005||2005-04-01|February 2010|2010-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis|A Randomized, Double-blind, Placebo-Controlled Phase II Study to Evaluate the Safety and Pilot Efficacy of Iloprost Inhalation Solution in Adults With Abnormal Pulmonary Arterial Pressure and Exercise Limitation Associated With Idiopathic Pulmonary Fibrosis (IPF)|Completed||Phase 2|50||Actelion|||||||||t||||||||||2017-02-18 17:40:18.1752|2017-02-18 17:40:18.1752
NCT00109668|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-02|2014-05-09|||July 2004||2004-07-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids||Completed||Phase 3|415||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:40:18.287566|2017-02-18 17:40:18.287566
NCT00109655|ClinicalTrials.gov processed this data on February 17, 2017|2005-05-02|2008-10-01|||April 2005||2005-04-01|October 2008|2008-10-01|September 2010|Anticipated|2010-09-01|October 2008|Anticipated|2008-10-01||Interventional|||Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure|A Phase 1 Dose-Escalation Trial of Intravesical CG0070 for Superficial Transitional Cell Carcinoma of the Bladder After Bacillus Calmette-Guerin Failure|Unknown status|Active, not recruiting|Phase 1|75|Anticipated|Cell Genesys||1|||f||||||||||||||2017-02-18 17:40:18.397079|2017-02-18 17:40:18.397079
NCT00109642|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-29|2017-01-24|||April 26, 2005||2005-04-26|June 8, 2009|2009-06-08|March 15, 2009|Actual|2009-03-15|March 15, 2009|Actual|2009-03-15||Observational|||The Role of Norepinephrine in Emotional Processing|Investigating the Role of Norepinephrine in Emotional Processing Through Alpha-2 Adrenergic Receptor Modulation|Completed||N/A|216||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:40:18.700827|2017-02-18 17:40:18.700827
NCT00109629|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-29|2017-01-24|||April 26, 2005||2005-04-26|January 22, 2008|2008-01-22|January 22, 2008||2008-01-22|||||Interventional|||"Prime-Boost Vaccine Schedule for Prevention of HIV Infection"|VRC 008: A Phase I Clinical Trial of a Prime-Boost HIV-1 Vaccination Schedule: Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, Followed by Multiclade Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:40:18.788441|2017-02-18 17:40:18.788441
NCT00109616|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-29|2013-04-30|||October 2002||2002-10-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Community Trial of Newborn Skin and Umbilical Cord Cleansing on Neonatal Mortality in Nepal|Newborn Antiseptic Washing and Neonatal Mortality-Nepal|Completed||Phase 3|17000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:40:18.871113|2017-02-18 17:40:18.871113
NCT00109603|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-29|2012-10-26|||May 2005||2005-05-01|October 2012|2012-10-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy|A Pilot Study to Determine the Impact on Dyslipidemia of the Addition of Tenofovir to Stable Background Antiretroviral Therapy in HIV-Infected Subjects|Completed||N/A|17|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:40:18.980998|2017-02-18 17:40:18.980998
NCT00109590|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-29|2014-12-30|2012-06-26||June 2006||2006-06-01|December 2014|2014-12-01|November 2009|Actual|2009-11-01|October 2008|Actual|2008-10-01||Interventional|||Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth|Phase II Study of the Pharmacokinetics of Nevirapine and the Incidence of Nevirapine Resistance Mutations in HIV-Infected Women Receiving a Single Intrapartum Dose of Nevirapine With the Concomitant Administration of Zidovudine/Didanosine or Zidovudine/Didanosine/Lopinavir/Ritonavir|Completed||Phase 2|175|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 17:40:19.118255|2017-02-18 17:40:19.118255
NCT00109577|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2012-09-11|2012-06-25||April 2005||2005-04-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder|Randomized Placebo-controlled Phase II Trial of MCN36 in Adults With Bipolar Disorder|Terminated||Phase 2|40|Actual|University of Calgary||2||Unable to recruit large enough sample; large expectancy effects but no adverse events|f||||t||||||||||2017-02-18 17:40:20.693177|2017-02-18 17:40:20.693177
NCT00109564|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2008-07-17|||January 2005||2005-01-01|July 2008|2008-07-01|October 2005||2005-10-01|||||Interventional|||A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)|A Safety and Efficacy Study of TC-1734-112 in Subjects With Age Associated Memory Impairment (AAMI)|Completed||Phase 2|174||Targacept Inc.|||||||||||||||||||2017-02-18 17:40:21.073739|2017-02-18 17:40:21.073739
NCT00109551|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2013-04-30|||October 2001||2001-10-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal|Zinc Supplementation Impact on Child Mortality--Nepal|Completed||Phase 3|58000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:40:21.165456|2017-02-18 17:40:21.165456
NCT00109538|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2015-04-09||2009-04-14|May 2005||2005-05-01|April 2015|2015-04-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)|A Pivotal Randomized Study of Lonafarnib Versus Placebo in the Treatment of Subjects With Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) Who Are Platelet Transfusion Dependent With or Without Anemia|Terminated||Phase 3|47|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:40:21.268613|2017-02-18 17:40:21.268613
NCT00109525|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2015-06-16|||March 2004||2004-03-01|June 2015|2015-06-01|December 2009|Actual|2009-12-01|July 2007|Actual|2007-07-01||Observational|Candida||Early Diagnosis of Candidiasis in Premature Infants|Early Diagnosis of Nosocomial Candidiasis Study|Completed||N/A|1500|Actual|NICHD Neonatal Research Network|||1||f||||f||||||||||2017-02-18 17:40:21.366491|2017-02-18 17:40:21.366491
NCT00109512|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2012-02-21|||April 2005||2005-04-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Endometriosis Trial: Study of NBI-56418 in Endometriosis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of NBI-56418 in Endometriosis|Completed||Phase 2|76|Actual|Abbott||3|||f||||||||||||||2017-02-18 17:40:21.623241|2017-02-18 17:40:21.623241
NCT00109499|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2011-05-11||||||May 2011|2011-05-01||||||||Interventional|||Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)|An Open-label, Phase I, Single Administration, Dose- Escalation Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)|Completed||Phase 1|||GenVec|||||||||||||||||||2017-02-18 17:40:21.736903|2017-02-18 17:40:21.736903
NCT00109486|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2016-09-13|||April 2005||2005-04-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray|A Randomised, Double-Blind, Placebo-Controlled, Two-Week Crossover, Knemometric Assessment of the Effect of Fluticasone Furoate Nasal Spray 100mcg Once Daily on Short-Term Growth in Children Aged 6 to 11 Years With Seasonal and/or Perennial Allergic Rhinitis|Completed||Phase 3|56|Actual|GlaxoSmithKline||1|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:40:21.829266|2017-02-18 17:40:21.829266
NCT00109473|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-28|2017-01-11|2011-06-24||April 2005||2005-04-01|January 2017|2017-01-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Trial of Growth Hormone Therapy in Pediatric Crohn's Disease|A Phase II Randomized Trial of Growth Hormone Therapy in Pediatric Crohn's Disease|Completed||Phase 2|22|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-02-18 17:40:21.933427|2017-02-18 17:40:21.933427
NCT00109460|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2015-05-11|||March 2003||2003-03-01|May 2015|2015-05-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Tobacco Cessation Field Study for Adults in Recovery - 1|Tobacco Cessation Clinical Field Study for Adults in Alcohol Abuse Recovery|Completed||Phase 2|203|Actual|Inflexxion, Inc.|||||f||||t||||||||||2017-02-18 17:40:22.876051|2017-02-18 17:40:22.876051
NCT00109434|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2016-09-02|||June 2004||2004-06-01|September 2016|2016-09-01|November 2004||2004-11-01|||||Observational|||Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes|The Effect of Exercise on the Development of Hypoglycemia in Children With Type 1 Diabetes; A Study Being Conducted by the Diabetes Research in Children Network|Completed||N/A|50||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:40:22.970471|2017-02-18 17:40:22.970471
NCT00109421|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2016-02-29|||November 2004||2004-11-01|February 2016|2016-02-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Friendship Based HIV/STI (Sexually Transmitted Infections) Intervention for African American Females|PROJECT ÒRÉ: An Innovative Friendship Based HIV/STI Intervention for High Risk African American Females|Completed||N/A|420|Actual|Westat||2|||f||||f||||||||||2017-02-18 17:40:23.063396|2017-02-18 17:40:23.063396
NCT00109408|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2016-11-01|||July 2005||2005-07-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis|A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Monotherapy Versus Methotrexate Monotherapy in Patients With Moderate to Severe Active Rheumatoid Arthritis|Completed||Phase 3|673|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:40:23.178277|2017-02-18 17:40:23.178277
NCT00109395|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2016-05-20|||September 2004||2004-09-01|November 2011|2011-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Lorazepam Sedation for Critically Ill Children|A Randomized Controlled Trial Comparing Lorazepam With Midazolam for Sedation of Mechanically Ventilated Pediatric Patients|Completed||Phase 2/Phase 3|179|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||t||||||||||2017-02-18 17:40:23.425594|2017-02-18 17:40:23.425594
NCT00109382|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2008-04-07|||May 2003||2003-05-01|June 2007|2007-06-01|February 2007|Actual|2007-02-01|||||Interventional|||Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)|Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)|Completed||Phase 2/Phase 3|500|Anticipated|University of Calgary||4|||f||||||||||||||2017-02-18 17:40:23.539755|2017-02-18 17:40:23.539755
NCT00109369|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2011-01-31|||June 2003||2003-06-01|January 2011|2011-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Vermont Diabetes Information System|Vermont Diabetes Information System|Completed||N/A|7500|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 17:40:23.859187|2017-02-18 17:40:23.859187
NCT00109356|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2007-05-04|||March 2005||2005-03-01|May 2007|2007-05-01|March 2007||2007-03-01|||||Interventional|||Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia|A Phase 1/2, Open Label, Dose Escalation Study of AQ4N for Safety, Tolerability, Pharmacokinetics and Activity in Patients With Lymphoid Neoplasms|Unknown status|Active, not recruiting|Phase 1/Phase 2|55||Novacea|||||||||||||||||||2017-02-18 17:40:23.970044|2017-02-18 17:40:23.970044
NCT00109187|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-26|2013-06-19|||June 2002||2002-06-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|||||Interventional|||An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g|Open-Label Extension Study II of Xolair (Omalizumab) in Moderate to Severe, Persistent Asthma Subjects Who Completed Study Q2143g (ALTO)|Completed||Phase 3|0||Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:26.208713|2017-02-18 17:40:26.208713
NCT00109343|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2015-02-11|2009-09-23||March 2006||2006-03-01|February 2015|2015-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)|An Open, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of V221 Given Concomitantly With Pneumococcal Conjugate Vaccine in Healthy Children 12 to 15 Months of Age|Completed||Phase 3|1027|Actual|Merck Sharp & Dohme Corp.|One subject (Group 3-ProQuad™ followed by PREVNAR™) was diagnosed (Day 8) with Stage IV neuroblastoma (considered not related to study vaccine by investigator) and discontinued from the study. Subject died (Day 218) due to neuroblastoma.|3|||f||||||||||||||2017-02-18 17:40:24.070708|2017-02-18 17:40:24.070708
NCT00109330|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2016-09-08|||November 2002||2002-11-01|September 2016|2016-09-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine|A Phase III, Observer-blinded Randomised, Multi-centre Clinical Study of the Safety, Immunogenicity and Consistency of Three Manufacturing Lots of GSK Biologicals' Candidate Tdap Vaccine as Compared to a US-licensed Td Vaccine When Given as a Booster Dose to Healthy Adolescents (10-18 Years of Age)|Completed||Phase 3|4116|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:40:25.164229|2017-02-18 17:40:25.164229
NCT00109317|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2013-06-19|||September 2002||2002-09-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|||||Interventional|||A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy|A Phase IIIb, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy|Completed||Phase 3|686|Actual|Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:25.30032|2017-02-18 17:40:25.30032
NCT00109304|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2015-09-17|||July 2005||2005-07-01|September 2015|2015-09-01|December 2006||2006-12-01|||||Interventional|||Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine|Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine VEE IA/B V3526 in VEE-Naive Healthy Volunteers After Single Dose Subcutaneous Administration|Withdrawn||Phase 1|0|Actual|DynPort Vaccine Company LLC, A CSC Company||1||Funding withdrawn|f||||t||||||||||2017-02-18 17:40:25.370043|2017-02-18 17:40:25.370043
NCT00109291|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-27|2012-12-19|||March 2005||2005-03-01|December 2012|2012-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease|A Phase 2a, Randomized, Double-blind, Placebo-controlled, Sequential Dose Escalation Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Patients With Chronic Kidney Disease Who Are Not on Dialysis and Who Have Not Had Prior Erythropoiesis Stimulating Agent (ESA) Treatment|Terminated||Phase 2|17|Actual|Affymax||4||Due to slow enrollment|f||||f||||||||||2017-02-18 17:40:25.467919|2017-02-18 17:40:25.467919
NCT00109278|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-26|2015-10-22|||October 2004||2004-10-01|October 2015|2015-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)|A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured From the 2003 Measles Stock Seed With Recombinant Human Albumin (rHA) Versus Currently Licensed V205C Manufactured From the 1967 Measles Stock Seed With Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age|Completed||Phase 2|1100|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:40:25.588066|2017-02-18 17:40:25.588066
NCT00109265|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-26|2015-07-01|||May 2001||2001-05-01|June 2013|2013-06-01|October 2002|Actual|2002-10-01|||||Interventional|||A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy|A Phase II, Multicenter, Open-Label Clinical Trial to Evaluate the Efficacy and Safety of OSI-774 in Patients With Advanced or Metastatic Breast Cancer and Disease Progression During or Following Chemotherapy|Completed||Phase 2|||Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:25.683271|2017-02-18 17:40:25.683271
NCT00109252|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-26|2013-06-19|||January 2002||2002-01-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|||||Interventional|||A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g|An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab Followed by Efalizumab Taper in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g|Completed||Phase 3|0||Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:25.760482|2017-02-18 17:40:25.760482
NCT00109239|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-26|2014-06-16|||November 2000||2000-11-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|||||Interventional|||A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer|A Multicenter, Open-Label, Phase III, Randomized, Active-Controlled Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of rhuMAb VEGF (Bevacizumab), in Combination With Capecitabine Chemotherapy, in Subjects With Previously Treated Metastatic Breast Cancer|Completed||Phase 3|||Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:25.845172|2017-02-18 17:40:25.845172
NCT00109226|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-26|2014-04-07|||August 2000||2000-08-01|April 2014|2014-04-01|September 2003|Actual|2003-09-01|||||Interventional|||A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer|A Phase II, Multicenter, Double-Blind, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab), a Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor, in Combination With 5-Fluorouracil and Leucovorin Chemotherapy in Subjects With Metastatic Colorectal Cancer Who Are Not Optimal Candidates for First Line CPT-11|Completed||Phase 2|||Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:25.920986|2017-02-18 17:40:25.920986
NCT00109213|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-26|2015-12-02|||May 2002||2002-05-01|December 2015|2015-12-01|October 2014|Actual|2014-10-01|September 2009|Actual|2009-09-01||Interventional|SLIP||Greenwich Lumbar Stenosis SLIP Study|Greenwich Lumbar Stenosis SLIP Study: A Multi-center, Randomized, Prospective Clinical Trial Comparing Spinal Laminectomy to Laminectomy With Instrumented Pedicle Screw Fusion for Lumbar Stenosis With Grade I Spondylolisthesis|Completed||Phase 3|66|Actual|Greenwich Hospital||2|||f||||t||||||||||2017-02-18 17:40:25.996993|2017-02-18 17:40:25.996993
NCT00109200|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-26|2013-06-19|||May 2003||2003-05-01|June 2013|2013-06-01|September 2003|Actual|2003-09-01|||||Interventional|||A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma|A Continued Access Protocol to Provide Xolair® (Omalizumab) to Subjects With Severe Allergic Asthma Who Have Received Xolair Treatment in a Previous Investigational Study|Completed||Phase 3|||Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:26.126149|2017-02-18 17:40:26.126149
NCT00109174|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2017-01-26|||April 20, 2005||2005-04-20|June 30, 2016|2016-06-30|January 23, 2018|Anticipated|2018-01-23|January 23, 2018|Anticipated|2018-01-23||Interventional|||MRS Measurement of Glutamate and GABA Metabolism in Brain|MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:40:26.29095|2017-02-18 17:40:26.29095
NCT00109161|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2008-08-02|||April 2005||2005-04-01|August 2008|2008-08-01|October 2006||2006-10-01|||||Interventional|||Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis|A Phase II Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis|Completed||Phase 2|270||Facet Biotech|||||||||||||||||||2017-02-18 17:40:26.403659|2017-02-18 17:40:26.403659
NCT00107939|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2011-11-22|||November 2004||2004-11-01|November 2011|2011-11-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Licarbazepine 750 ¿ 2000 mg/d as Adjunctive Therapy to an Atypical Antipsychotic in the Treatment of Manic Episodes of Bipolar I Disorder Over 6 Weeks|Completed||Phase 3|453|Actual|Novartis|||||f||||||||||||||2017-02-18 17:40:26.560388|2017-02-18 17:40:26.560388
NCT00107926|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2011-11-16|||October 2004||2004-10-01|November 2011|2011-11-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder|Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder|Completed||Phase 3|343|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:40:26.675347|2017-02-18 17:40:26.675347
NCT00107913|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2005-06-23|||September 2001||2001-09-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura|Phase II Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura|Unknown status|Recruiting|Phase 2|10||Hematology and Oncology Specialists|||||f||||||||||||||2017-02-18 17:40:26.805399|2017-02-18 17:40:26.805399
NCT00107900|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2015-02-26|2015-02-05||January 2005||2005-01-01|February 2015|2015-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement|A Phase IIa, Multi-center, Multi-national, Open Label, Dose Ranging Study of the Efficacy, Safety, and Tolerability of Oral DU-176b Administered Once or Twice Daily in the Treatment of Adult Patients Undergoing Total Hip Arthroplasty|Completed||Phase 2|606|Actual|Daiichi Sankyo Inc.||6|||f||||||||||||||2017-02-18 17:40:26.908755|2017-02-18 17:40:26.908755
NCT00107887|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2011-06-14|||June 2005||2005-06-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)|Impact of TB Preventive Therapy for HIV/TB Co-infected Patients With Access to Highly Active Antiretroviral Therapy in Rio de Janeiro, Brazil: A Phased Implementation Trial|Completed||Phase 4|17415|Actual|Communicable Disease Program, Brazil||2|||f||||t||||||||||2017-02-18 17:40:28.648937|2017-02-18 17:40:28.648937
NCT00107874|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2005-06-23|||January 1999||1999-01-01|April 2005|2005-04-01|February 2002||2002-02-01|||||Interventional|||Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-Scheduled Cesarean Section|Oral Misoprostol as a Second-Line Alternative to Intravenous Oxytocin in Preventing Postoperative Blood Loss After Non-Scheduled Cesarean Section: a Randomized, Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|56||Basel Women’s University Hospital|||||f||||||||||||||2017-02-18 17:40:28.757646|2017-02-18 17:40:28.757646
NCT00107861|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2009-07-10|||May 2005||2005-05-01|July 2009|2009-07-01|September 2006|Actual|2006-09-01|||||Interventional|||Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases|A Phase I/II Study of Interferon-Beta Gene Transfer (Ad.hIFN-β) in the Treatment of Refractory Colorectal Carcinoma With Liver Metastases|Completed||Phase 1/Phase 2|44||Biogen|||||||||||||||||||2017-02-18 17:40:28.845751|2017-02-18 17:40:28.845751
NCT00107848|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-08|2014-05-08|||October 2004||2004-10-01|May 2014|2014-05-01|September 2005||2005-09-01|||||Interventional|||PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|A 1 Year Open Label, Flexible Dosage Extension Study to Assess the Safety and Continued Effectiveness of PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|280||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:40:28.949891|2017-02-18 17:40:28.949891
NCT00107835|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-08|2012-06-04|||May 2005||2005-05-01|June 2012|2012-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults|An Open-Label Safety Study to Evaluate the Use of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Adult Patients Undergoing a Minor or Major Dermal Procedure|Completed||Phase 3|408|Actual|ZARS Pharma Inc.||1|||f||||f||||||||||2017-02-18 17:40:29.304849|2017-02-18 17:40:29.304849
NCT00107822|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-08|2005-10-05|||April 2005||2005-04-01|October 2005|2005-10-01|May 2005||2005-05-01|||||Interventional|||Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children|An Open-Label Safety Study to Evaluate the Use of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Pediatric Patients Undergoing a Minor or Major Dermal Procedure|Completed||Phase 3|80||ZARS Pharma Inc.|||||||||||||||||||2017-02-18 17:40:29.429251|2017-02-18 17:40:29.429251
NCT00107809|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-08|2014-05-08|||October 2004||2004-10-01|May 2014|2014-05-01|September 2005||2005-09-01|||||Interventional|||Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of PROVIGIL ® (Modafinil) Treatment (100, 200, and 400 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|140||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:40:29.525226|2017-02-18 17:40:29.525226
NCT00109148|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2015-09-08|||July 2004||2004-07-01|September 2015|2015-09-01|February 2005|Actual|2005-02-01|January 2005|Actual|2005-01-01||Interventional|||An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)|A Study to Assess the Safety and Efficacy of MK0364 in Obese Patients|Completed||Phase 2|500|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:40:29.697752|2017-02-18 17:40:29.697752
NCT00109135|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2015-09-24|||January 2005||2005-01-01|September 2015|2015-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)|A Double-Blind, Multicenter, Randomized, Titrated-Dose, Placebo-Controlled, Study of MK0364 (4 mg to 8 mg) in Chronic Cigarette Smokers as an Aid for Smoking Cessation|Completed||Phase 2|300|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:40:29.775423|2017-02-18 17:40:29.775423
NCT00109122|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2015-03-10|||November 2001||2001-11-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|February 2003|Actual|2003-02-01||Interventional|||Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)|A Double-Blind, Placebo-Controled, Randomized Study to Evaluate Safety, Tolerability, and Immunogenicity After 1 and 2 Doses of Zoster Vaccine|Completed||Phase 2|180|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:40:29.856707|2017-02-18 17:40:29.856707
NCT00109109|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2015-02-26|||December 2003||2003-12-01|February 2015|2015-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)|Phase II Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma|Terminated||Phase 1|60||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:40:29.953632|2017-02-18 17:40:29.953632
NCT00109096|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2007-05-16|||June 2005||2005-06-01|May 2007|2007-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy|A Randomized, Double-Blind Phase 2 Study of Two Doses of Pemetrexed in the Treatment of Platinum-Resistant, Epithelial Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|100|Anticipated|Eli Lilly and Company|||||||||||||||||||2017-02-18 17:40:30.0377|2017-02-18 17:40:30.0377
NCT00109083|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2012-08-01|||March 2002||2002-03-01|August 2012|2012-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging, Multicenter Study of the Efficacy of RWJ-333369 in the Prophylaxis of Migraine|Completed||Phase 2|300||SK Life Science|||||f||||||||||||||2017-02-18 17:40:30.166883|2017-02-18 17:40:30.166883
NCT00109070|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2013-06-19|||September 2000||2000-09-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|||||Interventional|||A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer|A Phase III, Multicenter, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab) in Combination With Standard Chemotherapy in Subjects With Metastatic Colorectal Cancer|Completed||Phase 3|||Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:30.276374|2017-02-18 17:40:30.276374
NCT00109057|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2013-06-19|||February 1998||1998-02-01|June 2013|2013-06-01|February 2004|Actual|2004-02-01|||||Interventional|||An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study|An Open-Label, Multicenter Extension Study of Recombinant Humanized Monoclonal Anti-VEGF Antibody (rhuMAb VEGF, Bevacizumab) in Subjects Treated With rhuMAb VEGF in a Previous Genentech-Sponsored Phase I or Phase II Cancer Study|Completed||Phase 2|56|Actual|Genentech, Inc.|||||||||||||||||||2017-02-18 17:40:30.349838|2017-02-18 17:40:30.349838
NCT00109044|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2012-03-01|||March 2005||2005-03-01|March 2012|2012-03-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder|Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder|Completed||Phase 3|540||Forest Laboratories|||||f||||||||||||||2017-02-18 17:40:30.422376|2017-02-18 17:40:30.422376
NCT00109031|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-22|2014-09-12|2014-01-24||January 2005||2005-01-01|September 2014|2014-09-01|December 2010|Actual|2010-12-01|February 2006|Actual|2006-02-01||Interventional||Primary Analysis Set (all randomized participants who signed informed consent before invasive, protocol-specified procedures).|Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)|A Randomized, Blinded, Active-control Trial of Palifermin (rHuKGF) to Evaluate Oral Mucositis in Subjects With Hematologic Malignancies Undergoing Fractionated Total Body Irradiation (fTBI) and High Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell (PBPC) Transplantation|Completed||Phase 3|47|Actual|Swedish Orphan Biovitrum||4|||f||||t||||||||||2017-02-18 17:40:30.540372|2017-02-18 17:40:30.540372
NCT00109018|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-21|2017-01-24|||April 19, 2005||2005-04-19|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Observational|||Biomarkers for Cardiovascular Disease|Nitrite as a Marker of Cardiovascular Risk; Development of Novel Biomarkers in Patients With Coronary Artery Disease|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:40:32.420157|2017-02-18 17:40:32.420157
NCT00109005|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-21|2016-11-14|2012-08-29||April 2005||2005-04-01|November 2016|2016-11-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma|A Randomized Phase II Study of Oral Lenalidomide (Revlimid [TM]), an Antiangiogenic and Immunomodulatory Agent, in Subjects With Stage IV Ocular Melanoma|Completed||Phase 2|17|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||No||2017-02-18 17:40:32.517059|2017-02-18 17:40:32.517059
NCT00108992|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-21|2007-01-04|||February 2004||2004-02-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis||Completed||Phase 3|750||Nuvo Research Inc.|||||f||||||||||||||2017-02-18 17:40:33.213742|2017-02-18 17:40:33.213742
NCT00108979|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-21|2012-03-01|||March 2005||2005-03-01|March 2012|2012-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study of Escitalopram in Adult Patients With Major Depressive Disorder|Double-Blind Study of Escitalopram in Adult Patients With Major Depressive Disorder|Completed||Phase 3|240||Forest Laboratories|||||||||||||||||||2017-02-18 17:40:33.325712|2017-02-18 17:40:33.325712
NCT00108953|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-21|2014-10-24|2009-04-23||April 2005||2005-04-01|October 2014|2014-10-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma|A Randomized Controlled Study of BAY43-9006 in Combination With Doxorubicin Versus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma.|Completed||Phase 2|96|Actual|Bayer|The study had been prematurely terminated by the sponsor because positive results were obtained in another Nexavar trial (Phase 3 study 100554 NCT00105443). NCI-CTC was translated to MedDRA for SOCs only.|2|||f||||f||||||||||2017-02-18 17:40:33.418711|2017-02-18 17:40:33.418711
NCT00108940|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-20|2011-09-23|||December 2000||2000-12-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|June 2009|Actual|2009-06-01||Observational|SWISS||Siblings With Ischemic Stroke Study|Siblings With Ischemic Stroke Study|Completed||N/A|900|Anticipated|Mayo Clinic|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 17:40:37.314534|2017-02-18 17:40:37.314534
NCT00108914|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-20|2017-01-18|||February 2005||2005-02-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Perennial Allergic Rhinitis Study In Pediatric Subjects|A Two Week Randomized, Double Blind Placebo Controlled, Parallel Group Study of GW685698X Aqueous Nasal Spray 100mcg and 50mcg QD in Pediatric Subjects With Perennial Allergic Rhinitis|Completed||Phase 3|558|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:40:37.775954|2017-02-18 17:40:37.775954
NCT00108901|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-20|2014-12-22|||June 2003||2003-06-01|December 2014|2014-12-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||The Medical College of Georgia PLAY Project: Exercise Dose and Insulin Sensitivity in Obese Children|Exercise Dose and Insulin Sensitivity in Obese Children|Completed||Phase 2|222|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||f||||||||||2017-02-18 17:40:37.946578|2017-02-18 17:40:37.946578
NCT00108875|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-19|2006-07-27|||April 2003||2003-04-01|June 2005|2005-06-01||||||||Interventional|||Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer|Vaccination of Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer With HLA-A1, -A2 and -B35 Restricted Survivin Peptides|Unknown status|Recruiting|Phase 1/Phase 2|70||Julius-Maximilians University|||||f||||||||||||||2017-02-18 17:40:38.074428|2017-02-18 17:40:38.074428
NCT00108862|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-19|2016-01-04|2011-09-27||August 2006||2006-08-01|January 2016|2016-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|STRIDE||Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis|A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3|Completed||Phase 4|809|Actual|AIDS Clinical Trials Group||2|||f||||t||||||||||2017-02-18 17:40:38.200596|2017-02-18 17:40:38.200596
NCT00108849|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-19|2017-02-06|||March 2005||2005-03-01|February 2017|2017-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms|A 12 Month Double-blind, Randomized, Parallel-group, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of Vagifem Low Dose (10 mcg 17beta-estradiol Vaginal Tablet) for the Treatment of Postmenopausal Atrophic Vaginitis Symptoms|Completed||Phase 3|309|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:40:39.708751|2017-02-18 17:40:39.708751
NCT00108836|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-19|2010-05-19|||March 2005||2005-03-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder|Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder|Completed||Phase 2|400||Novartis|||||||||||||||||||2017-02-18 17:40:39.868074|2017-02-18 17:40:39.868074
NCT00108823|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-19|2016-10-24|||October 2004||2004-10-01|September 2016|2016-09-01||||||||Interventional|||The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)|A 24-week, Double Blind, Randomized Study to Investigate the Effect of 500 µg Roflumilast Tablets Once Daily Versus Placebo on Parameters Indicative of Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|550||AstraZeneca|||||f||||||||||||||2017-02-18 17:40:39.978673|2017-02-18 17:40:39.978673
NCT00108810|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-18|2012-05-30||2012-03-14|April 2005||2005-04-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee|Randomized, Double-Blind, Parallel, Placebo Controlled 4 Week Proof-of-Concept Study to Evaluate the Safety and Efficacy of Transdermal Ketoprofen When Administered With Controlled Heat in Patients With Mild to Moderate OA Pain of the Knee|Completed||Phase 2|118|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-02-18 17:40:40.08663|2017-02-18 17:40:40.08663
NCT00108797|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-18|2017-01-11|||September 2001||2001-09-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Trial of NovoSeven® in Haemophilia - Joint Bleeds|NovoSeven® (rFVIIa) by Single Dose for Home Treatment of Joint Bleeds in Haemophilia Patients With Inhibitors: A Pilot, Double-Blind Study Versus Standard Multiple Doses of NovoSeven® and Open-Label FEIBA®|Completed||Phase 4|42|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:40:40.203153|2017-02-18 17:40:40.203153
NCT00108784|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-18|2010-01-12|||March 2003||2003-03-01|January 2010|2010-01-01|July 2004||2004-07-01|||||Interventional|||Factors Affecting Caloric Regulation in Human Feeding|The Effect of Decreases in Energy Density on Weight Loss and Weight Maintenance|Completed||N/A|100||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:40:40.315903|2017-02-18 17:40:40.315903
NCT00108771|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-18|2012-06-04|||April 2004||2004-04-01|June 2012|2012-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain|Double-Blind, Parallel, Randomized, Placebo-Controlled 12-Week Efficacy and Safety Assessment of ZR-02-01 in the Treatment of Chronic, Moderate to Severe Osteoarthritis (OA) Pain|Completed||Phase 2|202|Actual|ZARS Pharma Inc.||2|||f||||f||||||||||2017-02-18 17:40:40.416481|2017-02-18 17:40:40.416481
NCT00108758|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-18|2017-01-11|||March 2004||2004-03-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia|Exploratory, Multi-centre, Randomised, Double-blind, Uncontrolled Trial Evaluating the Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in Secondary Bleeding Prophylaxis in Congenital Haemophilia A or B Patients With Inhibitors|Completed||Phase 2|23|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:40:40.558228|2017-02-18 17:40:40.558228
NCT00108745|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-18|2016-03-17|||March 2005||2005-03-01|March 2016|2016-03-01||||January 2022|Anticipated|2022-01-01||Interventional|||Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer|A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or CT-2103 Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy|Active, not recruiting||Phase 3|1100|Anticipated|Gynecologic Oncology Group||3|||f||||t||||||||||2017-02-18 17:40:40.719474|2017-02-18 17:40:40.719474
NCT00107575|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-09-20|2009-11-30||August 2003||2003-08-01|September 2016|2016-09-01|April 2008|Actual|2008-04-01|June 2007|Actual|2007-06-01||Interventional|||Improving Smoking Cessation Outcomes in Heavy Drinkers - 1|Improving Smoking Cessation Outcomes in Heavy Drinkers|Completed||Phase 2|236|Actual|Brown University||2|||f||||f||||||||||2017-02-18 17:40:51.249798|2017-02-18 17:40:51.249798
NCT00108732|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-18|2015-06-03|2012-10-19||February 2006||2006-02-01|December 2013|2013-12-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer|A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:40:41.438148|2017-02-18 17:40:41.438148
NCT00108706|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-18|2006-09-11|||December 2004||2004-12-01|September 2006|2006-09-01|September 2007||2007-09-01|||||Interventional|||Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)|Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)|Unknown status|Active, not recruiting|Phase 4|50||City Hospitals Sunderland NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:40:41.761697|2017-02-18 17:40:41.761697
NCT00108680|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-16|2017-01-24|||April 13, 2005||2005-04-13|January 14, 2011|2011-01-14|January 14, 2011||2011-01-14|||||Observational|||Effects of Two Different Kinds of Exercise on Stroke Rehabilitation|Effects of Unilateral and Bilateral Training on Motor Function in Chronic Stroke|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:40:41.859749|2017-02-18 17:40:41.859749
NCT00108667|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2008-03-03|||April 2005||2005-04-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Talampanel to Treat Parkinson's Disease|AMPA Receptor Antagonist Treatment of Parkinson's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:40:41.958668|2017-02-18 17:40:41.958668
NCT00108654|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2017-01-24|||April 13, 2005||2005-04-13|January 15, 2008|2008-01-15|January 15, 2008||2008-01-15|||||Interventional|||Vaccine Treatment for HIV-Infection|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Booster Dose of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Subjects Who Where Previously Immunized With VRC-HIVDNA016-00-VP in VRC 00|Completed||Phase 1|14||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:40:42.049355|2017-02-18 17:40:42.049355
NCT00108628|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2015-02-17|2014-12-03||April 2004||2004-04-01|February 2015|2015-02-01|July 2013|Actual|2013-07-01|September 2008|Actual|2008-09-01||Interventional|||Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance|7857 Cognitive - Behavioral Treatments for PTSD Sleep Disturbance|Completed||N/A|134|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:40:42.151296|2017-02-18 17:40:42.151296
NCT00108615|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2008-04-23|||January 2004||2004-01-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance|Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance|Completed||Phase 4|48|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:40:42.699111|2017-02-18 17:40:42.699111
NCT00108602|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2015-06-25|||May 2007||2007-05-01|June 2015|2015-06-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Sleep Apnea: Mechanism and Cerebrovascular Consequences|Sleep Apnea: Mechanism and Cerebrovascular Consequences|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||This study of the overall grant was not pursued as the aims were changed|f||||||||||||||2017-02-18 17:40:42.816952|2017-02-18 17:40:42.816952
NCT00108589|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2009-01-20|||January 2004||2004-01-01|May 2007|2007-05-01|December 2006||2006-12-01|||||Interventional|||S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis|S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis|Completed||Phase 3|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:42.919716|2017-02-18 17:40:42.919716
NCT00108576|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2015-10-20|||October 2003||2003-10-01|October 2015|2015-10-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)|Divalproex Sodium in the Treatment of PTSD: A Placebo-Controlled Study|Completed||Phase 3|101|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:40:42.994261|2017-02-18 17:40:42.994261
NCT00108563|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2009-01-20|||October 2003||2003-10-01|May 2007|2007-05-01|September 2006||2006-09-01|||||Interventional|||VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients|VISN 20 Prophylactic Treatment of IFN-Induced Depression in Hepatitis C|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:43.096042|2017-02-18 17:40:43.096042
NCT00108550|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2013-12-20|2013-07-15||October 2004||2004-10-01|December 2013|2013-12-01|September 2009|Actual|2009-09-01|July 2009|Actual|2009-07-01||Interventional|||Chronic Low Back Pain Research Project|Efficacy of Antidepressants in Chronic Back Pain|Completed||Phase 2|108|Actual|VA Office of Research and Development|Limitations include small sample size, high rate of early termination, and moderate baseline levels of pain intensity and disability in everyday function which may have limited ability to detect an effect.|2|||f||||t||||||||||2017-02-18 17:40:43.189529|2017-02-18 17:40:43.189529
NCT00108537|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2008-04-02|||October 2003||2003-10-01|October 2006|2006-10-01|September 2005||2005-09-01|||||Interventional|||Non-Nicotine Agents for Smoking Cessation|Non-Nicotine Agents for Smoking Cessation|Completed||Phase 3|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:43.860763|2017-02-18 17:40:43.860763
NCT00108524|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2014-03-26|2013-09-26||July 2004||2004-07-01|March 2014|2014-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional||160 participants were randomized (81 allocated to LCKD, 79 to Orlistat plus LFD). 14 did not receive the intervention. 33 discontinued the intervention. Out of the 146 participants analyzed, 113 completed the intervention.|A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss|A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss|Completed||N/A|146|Actual|VA Office of Research and Development|We provided orlistat at no cost. This could have increased dietary adherence, attendance, and/or retention compared with the LCKD and may lead to different results than what might be seen in patients who must pay for orlistat.|2|||f||||f||||||||||2017-02-18 17:40:43.943875|2017-02-18 17:40:43.943875
NCT00108511|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2009-01-20|||October 2004||2004-10-01|May 2007|2007-05-01|September 2007||2007-09-01|||||Interventional|||Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides|Effect of Gemfibrozil on Serum GPI Phospholipase D and Triglycerides|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:44.373736|2017-02-18 17:40:44.373736
NCT00108498|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2009-01-20|||October 2003||2003-10-01|May 2007|2007-05-01|March 2007||2007-03-01|||||Interventional|||New Pharmacological Treatment for Obstructive Sleep Apnea|New Pharmacological Treatment for Obstructive Sleep Apnea|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:44.475307|2017-02-18 17:40:44.475307
NCT00108485|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2016-05-17|2015-09-04||April 2005||2005-04-01|May 2016|2016-05-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy|Randomized, Double-blind, Placebo-controlled Trial of Niaspan® in Patients With Overt Diabetic Nephropathy and Moderate Renal Impairment|Terminated||Phase 3|9|Actual|University of Miami|Early termination of study lead to small number of subjects analyzed.|2||Unable to recruit sufficient study subjects|f||||f||||||||||2017-02-18 17:40:44.564744|2017-02-18 17:40:44.564744
NCT00108459|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2009-01-20|||September 2004||2004-09-01|July 2007|2007-07-01|December 2007||2007-12-01|||||Interventional|||Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes|Safety and Efficacy of Low Carbohydrate Diet in Obesity and Type 2 DM: RCT|Completed||Phase 3|156|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:44.944126|2017-02-18 17:40:44.944126
NCT00108446|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2009-01-20|||October 2003||2003-10-01|May 2007|2007-05-01|March 2006||2006-03-01|||||Interventional|||Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome|Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:45.057942|2017-02-18 17:40:45.057942
NCT00108433|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-15|2012-06-28|2012-06-28||September 2005||2005-09-01|June 2012|2012-06-01|September 2006|Actual|2006-09-01|||||Interventional|||Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections|Linezolid vs Vancomycin/Cefazolin in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections|Terminated||Phase 3|61|Actual|Pfizer|Efficacy results were not reported because the study was prematurely terminated.|||See Detailed Description|f||||||||||||||2017-02-18 17:40:45.15128|2017-02-18 17:40:45.15128
NCT00108420|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-01-20|||October 2003||2003-10-01|May 2007|2007-05-01|March 2007||2007-03-01|||||Interventional|||Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance|Prazosin Treatment for Combat Trauma PTSD Nightmares and Sleep Disturbance|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:45.594136|2017-02-18 17:40:45.594136
NCT00108407|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-03-04|||October 2004||2004-10-01|March 2009|2009-03-01||||||||Interventional|||Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse|Integrated CBT for Substance Use and Depressive Disorders|Completed||N/A|||VA Office of Research and Development||2|||f||||||||||||||2017-02-18 17:40:45.695392|2017-02-18 17:40:45.695392
NCT00108394|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-01-20|||October 2002||2002-10-01|March 2008|2008-03-01|September 2007||2007-09-01|||||Interventional|||Osteopenia and Renal Osteodystrophy: Evaluation and Management|Osteopenia and Renal Osteodystrophy: Evaluation and Management|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:45.805333|2017-02-18 17:40:45.805333
NCT00108381|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2014-07-01|||January 2004||2004-01-01|June 2014|2014-06-01|September 2013|Actual|2013-09-01|February 2010|Actual|2010-02-01||Interventional|||Efficacy of Tailored Cognitive-Behavioral Therapy for Chronic Back Pain|Efficacy of Tailored Cognitive-Behavioral Therapy for Chronic Back Pain|Completed||N/A|162|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:40:45.889256|2017-02-18 17:40:45.889256
NCT00108368|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-01-20|||October 2003||2003-10-01|September 2007|2007-09-01|March 2006||2006-03-01|||||Interventional|||The Effects of Risperidone and Olanzapine on Thinking|The Cognitive Effects of Risperidone and Olanzapine|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:45.994334|2017-02-18 17:40:45.994334
NCT00108355|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2014-02-03|2013-12-11||December 2003||2003-12-01|February 2014|2014-02-01|August 2012|Actual|2012-08-01|August 2010|Actual|2010-08-01||Interventional|||Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis|Vasoconstrictors as Alternatives to Albumin After Large Volume Paracentesis in Cirrhosis|Completed||Phase 4|29|Actual|VA Office of Research and Development|Difficulty to enroll patient population lead to small sample size. Midodrine not titrated for a goal increase in mean arterial pressure. Blood tests for day 6 assessment of post paracentesis circulatory dysfunction not available for all patients.|2|||f||||t||||||||||2017-02-18 17:40:46.076354|2017-02-18 17:40:46.076354
NCT00108342|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2014-06-02|2013-12-19||October 2007||2007-10-01|June 2014|2014-06-01|December 2009|Actual|2009-12-01|September 2009|Actual|2009-09-01||Interventional|NDS||Nicotine Delivery Systems: Research & Treatment|Nicotine Delivery Systems: Research and Treatment|Terminated||N/A|25|Actual|VA Office of Research and Development|Limitations of the study: early termination of the study occurred due to widespread comorbidities precluding recruitment and enrollment of Veterans in this NRT trial. Specifically, the sample size was too small for any data analyses.|2||Common comorbidities of Veterans precluded sufficient recruitment and enrollment.|f||||f||||||||||2017-02-18 17:40:46.496593|2017-02-18 17:40:46.496593
NCT00107796|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-08|2012-08-22|||October 2004||2004-10-01|May 2006|2006-05-01|September 2005||2005-09-01|||||Interventional|||Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy|A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of PROVIGIL ® (Modafinil) Treatment (100, 200, and 400 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy|Completed||Phase 3|140||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:40:46.853972|2017-02-18 17:40:46.853972
NCT00107783|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-07|2010-12-20|2010-12-20||January 2005||2005-01-01|December 2010|2010-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Long-Term Study of Nitisinone to Treat Alkaptonuria|Long-Term Clinical Trial of Nitisinone in Alkaptonuria|Completed||Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)|Small number of patients involved in study and several patients dropped out; primary outcome parameter selection possibly inappropriate because hip joint damage that is already present may be irreversible.|2|||f||||t||||||||||2017-02-18 17:40:47.003061|2017-02-18 17:40:47.003061
NCT00107770|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-07|2010-01-08|||April 2005||2005-04-01|October 2008|2008-10-01|September 2007|Actual|2007-09-01|November 2006|Actual|2006-11-01||Interventional|||Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)|Safety and Dose Escalating Study of Oral Sodium Phenylbutyrate in Subjects With Amyotrophic Lateral Sclerosis|Completed||Phase 1/Phase 2|40|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:40:47.566986|2017-02-18 17:40:47.566986
NCT00108329|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-01-20|||April 2003||2003-04-01|April 2007|2007-04-01|March 2006||2006-03-01|||||Interventional|||Weight Loss in Diabetic, Older Obese Adults|5449 Genetics, Weight Loss and Glucose Metabolism in Older Obese Men|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:51.844223|2017-02-18 17:40:51.844223
NCT00107757|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-07|2016-09-13|||March 2005||2005-03-01|September 2016|2016-09-01|November 2005|Actual|2005-11-01|||||Interventional|||Seasonal Allergic Rhinitis In Pediatric Subjects|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50mcg and 100mcg for 2 Weeks in Pediatric Subjects Ages 2 to <12 Years With Seasonal Allergic Rhinitis (SAR)|Completed||Phase 3|576||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:40:47.745098|2017-02-18 17:40:47.745098
NCT00107744|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-07|2005-06-23|||January 2000||2000-01-01|April 2005|2005-04-01|January 2004||2004-01-01|||||Interventional|||Clinical Trial of Protein and Blood Pressure|Clinical Trial of Protein and Blood Pressure|Completed||Phase 3|300||Tulane University Health Sciences Center|||||f||||||||||||||2017-02-18 17:40:48.116802|2017-02-18 17:40:48.116802
NCT00107731|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-07|2009-03-24|||April 2004||2004-04-01|March 2009|2009-03-01|October 2006|Actual|2006-10-01|||||Interventional|||Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder|A Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Valproate) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)|Completed||Phase 3|710||AstraZeneca|||||f||||||||||||||2017-02-18 17:40:48.195228|2017-02-18 17:40:48.195228
NCT00107718|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-07|2010-10-01|||November 2004||2004-11-01|October 2010|2010-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma|A Phase II, Multi-center, Open-label, Randomized Study Evaluating the Anti-tumor Activity of SB-485232, rhIL-18, Administered as Five Daily Intravenous Infusions Every 28 Days in Subjects With Previously Untreated Metastatic Melanoma|Completed||Phase 2|64||GlaxoSmithKline||1|||||||||||||||||2017-02-18 17:40:48.446811|2017-02-18 17:40:48.446811
NCT00107705|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-07|2010-06-16|||April 2005||2005-04-01|June 2010|2010-06-01|May 2005||2005-05-01|||||Interventional|||Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing|A Single-blind Phase I Study to Assess the Residual Allergenicity of Tree (Birch, Hazel and Alder) Pollen Allergoid Using Skin Prick Testing|Completed||Phase 1|12||Allergy Therapeutics|||||f||||||||||||||2017-02-18 17:40:48.552886|2017-02-18 17:40:48.552886
NCT00107692|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-06|2006-09-11|||March 2005||2005-03-01|September 2006|2006-09-01|October 2007||2007-10-01|||||Interventional|||Can a Physical Activity Skill Development and Parent-Centered Dietary Intervention Help Combat Child Obesity?|Effect of a Weight Management Program for Overweight and Obese Children: a Randomized Controlled Trial|Unknown status|Active, not recruiting|N/A|216||University of Wollongong|||||f||||||||||||||2017-02-18 17:40:48.646962|2017-02-18 17:40:48.646962
NCT00107679|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-06|2014-04-15|||February 2005||2005-02-01|April 2014|2014-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||A Study of Anal Cancer Development in HIV Infected People|Anal Dysplasia: A Substudy of a Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)|Completed||N/A|560||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:40:48.741526|2017-02-18 17:40:48.741526
NCT00107666|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-06|2006-03-15|||April 2005||2005-04-01|March 2006|2006-03-01|April 2006||2006-04-01|||||Interventional|||CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Proof of Concept Clinical Study of CTI-01 in Patients Undergoing Major Cardiac Surgery With Cardiopulmonary Bypass|Terminated||Phase 2|150||Critical Therapeutics|||||||||||||||||||2017-02-18 17:40:48.853601|2017-02-18 17:40:48.853601
NCT00107653|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-06|2016-05-13|2016-03-16||October 2004||2004-10-01|May 2016|2016-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.|A Prospective, Multicenter, Open-label, Comparative, Efficacy Study of Pegasys® Plus Copegus® in Treatment-naïve Latino Patients With Chronic Hepatitis C-genotype 1, as Compared to Treatment-naïve Non- Latino Caucasian Patients With Chronic Hepatitis C-genotype 1|Completed||Phase 4|569|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:40:49.165386|2017-02-18 17:40:49.165386
NCT00107640|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-06|2012-08-11|||May 2005||2005-05-01|September 2010|2010-09-01|September 2009|Actual|2009-09-01|September 2008|Actual|2008-09-01||Interventional|||Project SHARE (Senior Health and Alcohol Risk Education)|Costs of Preventing Alcohol Problems in Older Adults|Completed||Phase 2|1186|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 17:40:50.586472|2017-02-18 17:40:50.586472
NCT00107627|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-06|2009-06-24|||March 2005||2005-03-01|June 2009|2009-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery|Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery|Completed||Phase 3|90|Actual|Queensland Centre for Gynaecological Cancer||3|||f||||f||||||||||2017-02-18 17:40:50.704714|2017-02-18 17:40:50.704714
NCT00107614|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2011-08-24|2011-04-15||November 2002||2002-11-01|August 2011|2011-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients|UARK 2002-10, A Phase II Study of DT PACE Induction, Followed by Tandem Autologous Transplant and Maintenance Therapy for Patients With Advanced and/or Symptomatic Waldenstrom's Macroglobulinemia|Terminated||Phase 2|12|Actual|University of Arkansas|Early termination due to small numbers of subjects enrolled. Only one participant completed the study. Other participants came off study due to death, toxicity, physician choice, or patient choice.|1||Terminated due to poor accrual.|f||||t||||||||||2017-02-18 17:40:50.811804|2017-02-18 17:40:50.811804
NCT00107601|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2008-06-26|||October 2004||2004-10-01|February 2006|2006-02-01|May 2006||2006-05-01|||||Interventional|||Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients|A Multi-Center Study Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients|Completed||N/A|3500||University Hospital of Liege|||||f||||||||||||||2017-02-18 17:40:51.043139|2017-02-18 17:40:51.043139
NCT00107588|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2014-01-07|||February 2007||2007-02-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|April 2011|Actual|2011-04-01||Interventional|MTP-3||Marijuana Treatment Project - 3|Contingency Management for Marijuana Dependence|Completed||N/A|234|Anticipated|UConn Health||3|||f||||t||||||||||2017-02-18 17:40:51.149117|2017-02-18 17:40:51.149117
NCT00108316|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2013-09-25|||January 2004||2004-01-01|September 2013|2013-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Determinants in Antidepressant Outcomes|SERT Affinity Determinants in Antidepressant Outcomes|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1||Study PI resigned|f||||||||||||||2017-02-18 17:40:51.925914|2017-02-18 17:40:51.925914
NCT00108303|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2015-12-02|2014-11-03||January 2004||2004-01-01|December 2015|2015-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes|Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes in Individuals Extensively Diagnosed and Genotyped|Completed||N/A|538|Actual|VA Office of Research and Development|Genetic linkage and association do not replicate well across studies. This study should be viewed in this context.||1||f||||f||||||Samples With DNA|"~     dna~   "|||2017-02-18 17:40:52.027205|2017-02-18 17:40:52.027205
NCT00108290|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2008-04-02|||April 2004||2004-04-01|April 2007|2007-04-01|March 2007||2007-03-01|||||Interventional|||Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer|Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:52.808602|2017-02-18 17:40:52.808602
NCT00108277|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2015-01-07|2014-12-16||April 2005||2005-04-01|January 2015|2015-01-01|September 2010|Actual|2010-09-01|December 2008|Actual|2008-12-01||Interventional|||Respiratory Dysregulation and Breathing Training in Anxious Outpatients|Respiratory Dysregulation and Breathing Training in Anxious Outpatients|Completed||N/A|92|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 17:40:52.883678|2017-02-18 17:40:52.883678
NCT00108264|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-01-20||||||May 2007|2007-05-01|September 2005||2005-09-01|||||Interventional|||Tumor RNA Transfected Dendritic Cell Vaccines|Tumor RNA Transfected Dendritic Cell Vaccines|Completed||Phase 1|||VA Office of Research and Development|||||||||||||||||||2017-02-18 17:40:53.294491|2017-02-18 17:40:53.294491
NCT00108251|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2011-09-07|||August 2004||2004-08-01|September 2011|2011-09-01|October 2007|Actual|2007-10-01|September 2007|Actual|2007-09-01||Interventional|||Aldosterone Antagonism in Diastolic Heart Failure|Aldosterone Antagonism in Diastolic Heart Failure|Completed||Phase 4|48|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:40:53.581406|2017-02-18 17:40:53.581406
NCT00108238|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-01-20|||April 2003||2003-04-01|April 2007|2007-04-01|December 2006||2006-12-01|||||Interventional|||Estrogen Alternatives Study|Estrogen Alternatives and Vascular Function in Post-Menopausal Women|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:53.700886|2017-02-18 17:40:53.700886
NCT00108225|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2014-06-30|||July 2004||2004-07-01|June 2014|2014-06-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)|2895 Effect of a High Protein Diet on the 24-hr Profile of Ghrelin, GH and IGF-1|Completed||N/A|8|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:40:53.780194|2017-02-18 17:40:53.780194
NCT00108212|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-01-20|||January 2005||2005-01-01|April 2007|2007-04-01|December 2007||2007-12-01|||||Interventional|||Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests|Clinical Implications of Genetic Alterations in TG Rich Lipoproteins|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:53.894005|2017-02-18 17:40:53.894005
NCT00108199|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-01-20|||October 2001||2001-10-01|May 2007|2007-05-01|September 2004||2004-09-01|||||Interventional|||Generalization of Training in Schizophrenia|Generalization of Training in Schizophrenia|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:40:53.963917|2017-02-18 17:40:53.963917
NCT00108186|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2014-10-28|||October 2004||2004-10-01|October 2014|2014-10-01|June 2011|Actual|2011-06-01|June 2010|Actual|2010-06-01||Interventional|||Celecoxib Treatment for Lung Cancer|Celecoxib-Mediated Inhibition of T Regulatory Cells in Human Lung Cancer|Withdrawn||Phase 1|0|Actual|VA Office of Research and Development||1||Couldn't accrue patients|f||||t||||||||||2017-02-18 17:40:54.045587|2017-02-18 17:40:54.045587
NCT00108173|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2013-04-05|||October 2002||2002-10-01|April 2013|2013-04-01|June 2011|Actual|2011-06-01|April 2007|Actual|2007-04-01||Interventional|||Brain Reaction to Treatment of Nicotine Dependence|Neural Substrates of Treatment for Nicotine Dependence|Completed||Phase 1|104|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:40:54.150135|2017-02-18 17:40:54.150135
NCT00108160|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2014-03-20|2013-12-16||April 2005||2005-04-01|March 2014|2014-03-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Preventing Staphylococcal (Staph) Infection|Intermittent Mupirocin to Prevent Staphylococcal Infection|Completed||Phase 4|146|Actual|VA Office of Research and Development|The study is underpowered to detect differences between the two treatment arms. We achieved only 75% of target enrollment, and 41.1% dropped out before reaching a primary endpoint. Our re-infection rate was also lower than anticipated (14.4%).|2|||f||||f||||||||||2017-02-18 17:40:54.259453|2017-02-18 17:40:54.259453
NCT00108147|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2009-03-04|||October 2003||2003-10-01|March 2009|2009-03-01||||||||Interventional|||Functional Circuit Training in Older Adults With Congestive Heart Failure|Functional Circuit Training in Older Adults With Congestive Heart Failure|Completed||N/A|||VA Office of Research and Development||3|||f||||||||||||||2017-02-18 17:40:54.684294|2017-02-18 17:40:54.684294
NCT00108134|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2008-12-22|||March 2005||2005-03-01|December 2008|2008-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Superficial Basal Cell Carcinoma|Completed||Phase 2|60||Peplin|||||f||||||||||||||2017-02-18 17:40:54.796136|2017-02-18 17:40:54.796136
NCT00108121|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2015-01-16|||March 2005||2005-03-01|January 2015|2015-01-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma|A Multi-center, Randomized, Double-blind, Parallel-group, Vehicle-controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Nodular Basal Cell Carcinoma|Completed||Phase 2|60||Peplin|||||f||||||||||||||2017-02-18 17:40:54.909156|2017-02-18 17:40:54.909156
NCT00107185|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2012-08-02|||January 2005||2005-01-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|October 2009|Actual|2009-10-01||Interventional|||Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma|Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients|Completed||Phase 1|7|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:41:10.619238|2017-02-18 17:41:10.619238
NCT00108108|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-14|2012-09-28|||April 2005||2005-04-01|September 2012|2012-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy|An Open-label,Multi-center, Phase l/ll Study of Anti-CD40 Monoclonal Antibody (HCD122) Administered Intravenously to Subjects With Advanced Chronic Lymphocytic Leukemia That is Refractory or Relapsed After at Least One Previous Fludarabine-containing Chemotherapy Regimen|Terminated||Phase 1|26|Actual|Novartis||1||Slow enrollment and minimal preliminary biological and clinical efficacy.|f||||f||||||||||2017-02-18 17:40:55.019175|2017-02-18 17:40:55.019175
NCT00108095|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-13|2017-01-19|||October 2004||2004-10-01|January 2017|2017-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting|A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Oral Neurokinin-1 Receptor Antagonist, GW679769, When Administered With Intravenous Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting (PONV) and Post-discharge Nausea and Vomiting (PDNV) in Female Subjects With Known Risk Factors for PONV Who Are Undergoing Surgical Procedures Associated With an Increased Emetogenic Risk|Completed||Phase 2|701|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:40:55.131121|2017-02-18 17:40:55.131121
NCT00108082|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-13|2016-11-04|2009-08-13||January 2005||2005-01-01|November 2016|2016-11-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||The CLEVER Study - Coreg And Left Ventricular Mass Regression|A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Modified Release Formulation (COREG MR) and Atenolol in Combination With and Compared to an Angiotensin Converting Enzyme Inhibitor (Lisinopril) on Left Ventricular Mass Regression in Hypertensive Patients With Left Ventricular Hypertrophy (LVH).|Completed||Phase 3|287|Actual|GlaxoSmithKline||3|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:40:55.301861|2017-02-18 17:40:55.301861
NCT00108069|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-12|2015-10-13|2014-03-06||April 2005||2005-04-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional||One participant in the AG cohort was not evaluable/did not receive study drug.|Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors|A Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas|Completed||Phase 2|43|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 17:40:56.524934|2017-02-18 17:40:56.524934
NCT00108056|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-12|2017-01-24|||April 7, 2005||2005-04-07|April 1, 2014|2014-04-01|April 1, 2014|Actual|2014-04-01|April 1, 2014|Actual|2014-04-01||Interventional|||Enzastaurin to Treat Recurrent Brain Tumor|A Phase I Trial of Enzastaurin (LY317615) in Patients With Recurrent Gliomas|Terminated||Phase 1|26|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:40:57.629938|2017-02-18 17:40:57.629938
NCT00108043|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-12|2015-12-02|||March 2004||2004-03-01|December 2015|2015-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Orthostatic Tolerance During FES (Functional Electrical Stimulation)-Walking in Paraplegia|Orthostatic Tolerance During FES-evoked Stepping in Paraplegia: A Safety and Viability Study|Completed||Phase 1|10|Anticipated|University of Sydney|||||f||||||||||||||2017-02-18 17:40:57.72801|2017-02-18 17:40:57.72801
NCT00108030|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-12|2015-12-02|||March 2004||2004-03-01|December 2015|2015-12-01|December 2006|Actual|2006-12-01|||||Interventional|||PBWST (Partial Body-Weight Supported Treadmill Training) and Muscle Power Training After Sub-acute Stroke|A RCT of Power Training and Treadmill Training to Improve Walking Ability in Sub-acute Stroke Patients|Completed||Phase 2/Phase 3|102|Anticipated|University of Sydney|||||f||||||||||||||2017-02-18 17:40:57.832354|2017-02-18 17:40:57.832354
NCT00108017|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-12|2015-05-12|||April 2005||2005-04-01|May 2015|2015-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)|Randomized, Multicenter, Dbl-Masked, Parallel Study Evaluating the 24 Hr. Diurnal Ocular Hypotensive Effect of 2% Dorzolamide Hydrochloride/0.5% Timolol Maleate Combo. Ophthalmic Sol. in Patients w/ Open Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|330|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:40:57.931473|2017-02-18 17:40:57.931473
NCT00108004|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-12|2015-05-20|||April 2003||2003-04-01|May 2015|2015-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus|A Phase 3B, Multicenter, Open-Label Study Investigating the Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Insulin Therapy|Completed||Phase 3|400|Anticipated|AstraZeneca||1|||f||||||||||||||2017-02-18 17:40:58.032287|2017-02-18 17:40:58.032287
NCT00107991|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2011-01-04|2011-01-04||April 2005||2005-04-01|January 2011|2011-01-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Etanercept for Treatment of Hidradenitis|A Phase II Open Label Clinical Trial of Etanercept for the Treatment of Hidradenitis Suppurativa|Completed||Phase 2|15|Actual|University of Pennsylvania|This study did not have a control group, and therefore, it is possible that observed benefits could be as a result of natural remission or a placebo effect.|1|||f||||f||||||||||2017-02-18 17:40:58.194482|2017-02-18 17:40:58.194482
NCT00107978|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2010-12-10|2009-11-03||February 2005||2005-02-01|December 2010|2010-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|ATLAS2||Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus|A Phase 3, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections With a Focus on Patients With Infections Due to Methicillin-resistant Staphylococcus Aureus|Completed||Phase 3|1035|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||t||||||||||2017-02-18 17:40:58.65564|2017-02-18 17:40:58.65564
NCT00107965|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2015-03-24|||March 2005||2005-03-01|March 2015|2015-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses|A Multi-center, Randomized, Double-blind, Parallel-group, Vehicle-controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Actinic Keratoses|Completed||Phase 2|60||Peplin||8|||f||||||||||||||2017-02-18 17:40:59.956924|2017-02-18 17:40:59.956924
NCT00106327|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-22|2012-07-24|||September 2003||2003-09-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|July 2008|Actual|2008-07-01||Interventional|||Improving Functioning in Peripheral Arterial Disease|Improving Functioning in Peripheral Arterial Disease|Completed||N/A|156|Actual|Northwestern University||3|||f||||||||||||||2017-02-18 17:41:39.883462|2017-02-18 17:41:39.883462
NCT00107952|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-11|2014-08-13|2009-11-03||February 2005||2005-02-01|August 2014|2014-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|ATTAIN1||Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus|A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia With a Focus on Patients With Infections Due to Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 3|761|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||t||||||||||2017-02-18 17:41:00.122248|2017-02-18 17:41:00.122248
NCT00107562|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-02-29|||February 2005||2005-02-01|February 2016|2016-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Adolescent Safer Sex Social Network Intervention|Adolescent Safer Sex Social Network Intervention|Completed||N/A|200|Actual|Westat||1|||f||||f||||||||||2017-02-18 17:41:02.105629|2017-02-18 17:41:02.105629
NCT00107549|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2012-05-17||||||May 2012|2012-05-01|February 2009|Actual|2009-02-01|||||Interventional|||Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy|A Phase I, Open-Label Study to Evaluate the Safety and Tolerability of Recombinant HIV-1 Vaccines in HIV-1 Infected Young Adults With Control of HIV-1 Replication and on Stable Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:41:02.219774|2017-02-18 17:41:02.219774
NCT00107536|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2015-04-08|2014-10-24||October 2005||2005-10-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer|A Phase II Study of Efficacy and Tolerability of GW572016 in Patients With Advanced Hepatocellular and Biliary Carcinomas|Completed||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:41:02.35531|2017-02-18 17:41:02.35531
NCT00107523|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2010-09-20|||January 2005||2005-01-01|September 2010|2010-09-01|October 2005|Actual|2005-10-01|||||Interventional|||Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia|A Phase I Trial Evaluating the Effect of the Addition of HMGCoA-Reductase Inhibition With Pravastatin to Salvage Chemotherapy Idarubicin-HDAC in Patients With Relapsed or Refractory Acute Myelogenous Leukemia|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:41:02.823728|2017-02-18 17:41:02.823728
NCT00107510|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-07-01|||August 2005||2005-08-01|July 2016|2016-07-01||||September 2007|Actual|2007-09-01||Interventional|||Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer|Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer|Completed||Phase 2|58|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:41:02.918526|2017-02-18 17:41:02.918526
NCT00107497|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2009-02-06|||January 2005||2005-01-01|May 2007|2007-05-01||||||||Interventional|||Radiation Therapy in Treating Women With Localized Breast Cancer|Prospective Randomised Clinical Trial Testing 5.7 Gy and 6.0 Gy Fractions of Whole Breast Radiotherapy in Terms of Late Normal Tissue Responses and Tumour Control - FAST|Completed||N/A|900|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:41:06.031424|2017-02-18 17:41:06.031424
NCT00107484|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2010-04-30|||September 2005||2005-09-01|April 2010|2010-04-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer|Phase II Study of Combidex in Axillary Node Staging in Breast Cancer|Completed||Phase 2|3|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 17:41:06.13217|2017-02-18 17:41:06.13217
NCT00107471|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2013-12-09|||October 2005||2005-10-01|December 2013|2013-12-01||||October 2007|Actual|2007-10-01||Interventional|||Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma|A Phase I/II Study of Topotecan With G-CSF and Radiation Therapy in Children With Malignant Intrinsic Pontine Brainstem Gliomas of Childhood|Terminated||Phase 1/Phase 2|7|Actual|Children's Oncology Group||2||"The unpromising experience of the French group with topotecan given at a dosage of 0.4~   mg/m2/day over 30 mins w/in 1 hr of radiation (Cancer 2005; 104: 2792)."|f||||t||||||||||2017-02-18 17:41:06.235993|2017-02-18 17:41:06.235993
NCT00107458|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2014-08-06|||May 2005||2005-05-01|August 2014|2014-08-01|March 2012|Actual|2012-03-01|October 2007|Actual|2007-10-01||Interventional|||Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors|A Phase I Study of Valproic Acid in Children With Recurrent/Progressive Solid Tumors Including CNS Tumors|Completed||Phase 1|26|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 17:41:06.70618|2017-02-18 17:41:06.70618
NCT00107445|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2013-01-15|||February 2005||2005-02-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer|Evaluation of Hypoxia by EF5 Binding in Gynecologic Cancer|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:41:06.840185|2017-02-18 17:41:06.840185
NCT00107432|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2013-06-04|||October 2004||2004-10-01|June 2013|2013-06-01||||June 2007|Actual|2007-06-01||Interventional|||Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.|A Phase II Study of BAY 43-9006 (NSC #724772) in Patients With Malignant Mesothelioma|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:41:06.940661|2017-02-18 17:41:06.940661
NCT00107419|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2012-01-13|||September 2005||2005-09-01|January 2012|2012-01-01|August 2009|Actual|2009-08-01|May 2007|Actual|2007-05-01||Interventional|||S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma|Phase II Trial of Pemetrexed for Advanced Chondrosarcomas|Completed||Phase 2|75|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 17:41:07.052362|2017-02-18 17:41:07.052362
NCT00107393|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2013-07-09|||June 2003||2003-06-01|October 2006|2006-10-01|November 2008|Actual|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer|Phase II Study of Trastuzumab (Herceptin) and Capecitabine (Xeloda) in Women With Taxanes and Anthracyclines Refractory Metastatic Breast Cancer and HER2 Over-Expression|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:41:07.226863|2017-02-18 17:41:07.226863
NCT00107172|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-10-31|2015-09-02||July 2005||2005-07-01|October 2016|2016-10-01||||April 2011|Actual|2011-04-01||Interventional||All intent-to-treat (ITT) participants.|Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer|A Randomized Phase III Study of Sublobar Resection Versus Sublobar Resection Plus Brachytherapy in High Risk Patients With Non-Small Cell Lung Cancer (NSCLC), 3cm or Smaller|Active, not recruiting||Phase 3|224|Actual|Alliance for Clinical Trials in Oncology||2|||f||||||||||||||2017-02-18 17:41:10.742|2017-02-18 17:41:10.742
NCT00107380|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-02-04|2013-12-23||November 2005||2005-11-01|February 2016|2016-02-01|December 2015|Actual|2015-12-01|November 2013|Actual|2013-11-01||Interventional||All eligible patients who started treatment were included in the analysis|S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|Iodine-131-Labeled Monoclonal Anti-B1 Antibody (I-131 Tositumomab) in Combination With Cyclophosphamide, Doxorubicin, Vincristine, Prednisone and Rituximab Therapy for Patients ≥ Age 60 With Advanced Stage Diffuse Large B-Cell NHL: A Phase II Study|Completed||Phase 2|86|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 17:41:07.349306|2017-02-18 17:41:07.349306
NCT00107367|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2014-01-09|||April 2004||2004-04-01|July 2009|2009-07-01||||April 2010|Anticipated|2010-04-01||Interventional|||Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor|A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis|Unknown status|Recruiting|Phase 1/Phase 2|62|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:41:08.144492|2017-02-18 17:41:08.144492
NCT00107354|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2010-09-16|||December 1998||1998-12-01|September 2010|2010-09-01||||August 2009|Actual|2009-08-01||Interventional|||Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant|Phase I Study of Adoptive Immunotherapy With CD8 Minor Histocompatibility (H) Antigen-Specific CTL Clones for Patients With Relapsed of AML or ALL After Allogeneic Hematopoietic Stem Cell Transplant|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||||||||||||||||2017-02-18 17:41:08.241745|2017-02-18 17:41:08.241745
NCT00107341|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-12-09|||August 2005||2005-08-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|February 2007|Actual|2007-02-01||Interventional|||Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Trial of PS-341 in Combination With Paclitaxel and Carboplatin for Metastatic Adenocarcinoma of the Lower Esophagus, Gastroesophageal Junction, and Gastric Cardia|Completed||Phase 2|37|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:41:08.352619|2017-02-18 17:41:08.352619
NCT00107315|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2014-06-03|2014-01-08||July 2004||2004-07-01|June 2014|2014-06-01||||June 2008|Actual|2008-06-01||Interventional||All treated and eligible patients|Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer|A Phase II Study of Capecitabine and Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer|Terminated||Phase 2|16|Actual|Roswell Park Cancer Institute|Due to the study's early termination, as a result of low accrual, target accrual was not reached and no statistical inference of the primary and secondary aims were carried forth.|1||Terminated due to low accrual|f||||||||||||||2017-02-18 17:41:08.468813|2017-02-18 17:41:08.468813
NCT00107289|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-10-04|||May 2006||2006-05-01|October 2016|2016-10-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|||Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma|Open Access Protocol of Targeted Radiotherapy With I-metaiodobenzylguanidine (I-MIBG) in Patients With Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors|Recruiting||Phase 2|80|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:41:08.809139|2017-02-18 17:41:08.809139
NCT00107276|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2013-07-03|2012-11-15||August 2005||2005-08-01|July 2013|2013-07-01|August 2009|Actual|2009-08-01|March 2008|Actual|2008-03-01||Interventional|||S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer|Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer|Completed||Phase 2|112|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:41:08.939872|2017-02-18 17:41:08.939872
NCT00107263|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-12-02|||January 2005||2005-01-01|December 2016|2016-12-01|August 2012|Actual|2012-08-01|March 2007|Actual|2007-03-01||Interventional|||Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer|A Randomized, Controlled, Open-Label Trial of Empiric Prophylactic vs. Delayed Use of Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women With Breast Cancer Initiating Therapy With Letrozole After Tamoxifen|Completed||Phase 3|558|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 17:41:09.645289|2017-02-18 17:41:09.645289
NCT00107250|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-11-25|||January 2005||2005-01-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)|A Phase I, Open-Label, Dose-Seeking Study of AZD2171 Given Daily Orally in Combination With Standard Chemotherapy Regimens (CT) in Patients With Advanced Incurable Non-Small Cell Lung Cancer (NSCLC) or Colorectal Cancer or Other Tumor Types Suitable for Treatment With Capecitabine|Completed||Phase 1|50|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 17:41:09.756479|2017-02-18 17:41:09.756479
NCT00107237|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2013-06-11|||October 2003||2003-10-01|June 2013|2013-06-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme|A Phase IB/II Multicenter, Two-Arm, Dose-Escalation Study of Oral AEE788 Administered in Combination With Oral RAD001 on a Continuous Once Daily Dosing Schedule in Adult Patients With First or Second Recurrent or Relapsing Glioblastoma Multiforme|Completed||Phase 1/Phase 2|16|Actual|Novartis||2|||||||||||||||||2017-02-18 17:41:09.870145|2017-02-18 17:41:09.870145
NCT00107211|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2014-09-16|||January 2005||2005-01-01|September 2014|2014-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast|A HER-2/Neu Pulsed DC1 Vaccine for Patients With DCIS|Completed||Phase 1|30|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||t||||||||||2017-02-18 17:41:09.990383|2017-02-18 17:41:09.990383
NCT00107198|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2016-12-20|2016-06-30||January 2006||2006-01-01|March 2016|2016-03-01||||November 2012|Actual|2012-11-01||Interventional|||Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease|Treatment of Children With Newly-Diagnosed Low Stage Lymphocyte Predominant Hodgkin Disease (LPHD)|Active, not recruiting||N/A|188|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:41:10.081969|2017-02-18 17:41:10.081969
NCT00105664|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||October 2004||2004-10-01|October 2007|2007-10-01|July 2007|Actual|2007-07-01|||||Interventional|C3P||Collaborative Cardiac Care Project|Collaborative Cardiac Care Project (C3P)|Completed||N/A|287|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 17:41:56.438795|2017-02-18 17:41:56.438795
NCT00107159|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2013-11-05|||January 2005||2005-01-01|April 2007|2007-04-01|September 2010|Actual|2010-09-01|||||Interventional|||Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma|A Phase II Study Of Matured Dendritic Cells Pulsed Ex Vivo With 3 Melanoma Cell Line Lysates (IDD-3) in Patients With In-Transit or Metastatic Melanoma|Completed||Phase 2|37|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:41:12.110166|2017-02-18 17:41:12.110166
NCT00107120|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2012-04-04|2009-04-21||March 2005||2005-03-01|April 2012|2012-04-01||||May 2007|Actual|2007-05-01||Interventional|||The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder|A Double-blind Flexible Dose Study of Escitalopram in Pediatric Patients With Major Depressive Disorder|Completed||Phase 3|312|Actual|Forest Laboratories||2|||f||||||||||||||2017-02-18 17:41:12.218707|2017-02-18 17:41:12.218707
NCT00107107|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2015-09-22|||November 2002||2002-11-01|August 2015|2015-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus|A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150|Completed||Phase 3|190|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 17:41:12.736835|2017-02-18 17:41:12.736835
NCT00107094|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-05|2007-07-18|||March 2005||2005-03-01|July 2007|2007-07-01||||||||Interventional|||Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer|An Open Label, Pilot Study of Dose-Dense Adriamycin Plus Cyclophosphamide (AC) Followed by ABI-007 as Adjuvant Therapy for Patients With Breast Cancer|Completed||Phase 1|30||Celgene Corporation|||||||||||||||||||2017-02-18 17:41:12.864077|2017-02-18 17:41:12.864077
NCT00107081|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-04|2014-12-23|||January 2004||2004-01-01|December 2014|2014-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting|A Prospective Multi-Center Study on Pediatric Patients With Fever in Severe Chemotherapy Induced Neutropenia, Including a Randomized Comparison of Outpatient Management and Oral Antimicrobial Therapy Versus Inpatient Management and Intravenous Antimicrobial Therapy in a Subgroup With Low Risk of Adverse Events (Low-Risk Subgroup Study)|Terminated||Phase 3|70|Actual|Swiss Pediatric Oncology Group||2||Accrual goal for interventional part not achievable|f||||f||||||||||2017-02-18 17:41:12.964988|2017-02-18 17:41:12.964988
NCT00107068|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-04|2015-12-02|||January 2001||2001-01-01|December 2015|2015-12-01|May 2004|Actual|2004-05-01|March 2003|Actual|2003-03-01||Interventional|||Exercise Training and Walking Ability After Chronic Stroke|Does Aerobic or Resistance Exercise Training Improve Walking Ability in Chronic Stroke Patients?|Completed||N/A|48||University of Sydney|||||f||||||||||||||2017-02-18 17:41:13.106293|2017-02-18 17:41:13.106293
NCT00107055|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-04|2005-06-23|||December 2003||2003-12-01|June 2005|2005-06-01|April 2005||2005-04-01|||||Interventional|||Study of REN-1654 in Patients With Sciatica Pain|REN-1654 in Sciatica: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study in Subjects With Pain Due to Lumbosacral Radiculopathy|Unknown status|Active, not recruiting|Phase 2|72||Renovis|||||||||||||||||||2017-02-18 17:41:13.20379|2017-02-18 17:41:13.20379
NCT00107042|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-04|2016-03-03|2011-09-05||February 2004||2004-02-01|March 2016|2016-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths|Hepatitis B Vaccination in Youth at Adolescent Trial Network Sites: Effectiveness of Two Strategies and Evaluation of Tools To be Used in Future HIV Prevention Trials.|Completed||Phase 2|123|Actual|Westat||2|||f||||t||||||||||2017-02-18 17:41:13.345474|2017-02-18 17:41:13.345474
NCT00107029|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-04|2016-02-29|||December 2002||2002-12-01|February 2016|2016-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth|Evaluation of HIV-Specific CD8+ T-Cell Responses and Escape Mutations as Explanations for the Observed Differences in Disease Progression Conferred by HLA Class I Alleles|Completed||N/A|113|Actual|Westat|||1||f||||f||||||Samples Without DNA|"~     Biomedical HIV-1 related data and samples are available for the time the subjects were~     enrolled in REACH. HIV-1 genotyping will certainly be possible from these retrospective~     samples and the stored PBMCs will be evaluated for usefulness in the HIV-1 specific assays.~     Prospectively, samples will be collected every six months over a two-year period to evaluate~     both HIV-1 specific CD8+ T cell responses and the dominant HIV-1 genotype longitudinally.~   "|||2017-02-18 17:41:14.921908|2017-02-18 17:41:14.921908
NCT00107016|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-04|2013-02-28|||March 2005||2005-03-01|February 2013|2013-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women|A Phase 2, Double-blind, Randomized, Placebo-controlled, Multi-center Study Assessing the Value of Adding Everolimus to Letrozole as Preoperative Therapy of Primary Breast Cancer in Postmenopausal Women|Completed||Phase 2|267|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:41:15.035016|2017-02-18 17:41:15.035016
NCT00107003|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-02|2017-01-24|||March 30, 2005||2005-03-30|November 30, 2012|2012-11-30|November 30, 2012|Actual|2012-11-30|December 5, 2007|Actual|2007-12-05||Interventional|||GW572016 to Treat Recurrent Malignant Brain Tumors|A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:41:15.19402|2017-02-18 17:41:15.19402
NCT00106977|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-01|2017-01-24|||March 30, 2005||2005-03-30|September 26, 2016|2016-09-26||||||||Observational|||Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)|Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:15.296938|2017-02-18 17:41:15.296938
NCT00106964|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-01|2016-02-29|2012-10-26||January 2004||2004-01-01|February 2016|2016-02-01|June 2009|Actual|2009-06-01|January 2008|Actual|2008-01-01||Interventional|||Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth|A Randomized, Open-Label Trial of Three Hepatitis B Vaccination Schemas in HIV-Positive Youth|Completed||Phase 4|371|Actual|Westat||3|||f||||t||||||||||2017-02-18 17:41:15.407498|2017-02-18 17:41:15.407498
NCT00106951|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-01|2012-01-29|||April 2005||2005-04-01|January 2012|2012-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Effects of Neighborhood SES on Coronary Heart Disease Burden in Communities - Ancillary to ARIC|Effects of Neighborhood SES on Coronary Heart Disease Burden in Communities - Ancillary to ARIC|Completed||N/A|12000|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 17:41:16.214118|2017-02-18 17:41:16.214118
NCT00106938|ClinicalTrials.gov processed this data on February 17, 2017|2005-04-01|2014-10-13|2014-04-02||April 2005||2005-04-01|October 2014|2014-10-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|ACT I||Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)|Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)|Terminated||Phase 3|1663|Actual|Abbott Vascular||2||Business decision and not a result of any patient or product safety issues.|f||||||||||||||2017-02-18 17:41:16.307587|2017-02-18 17:41:16.307587
NCT00106925|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2017-01-24|||March 28, 2005||2005-03-28|November 1, 2016|2016-11-01||||||||Observational|||Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants|Long-Term Evaluation and Follow Up Care of Patients Treated With Allogeneic Stem Cell Transplants|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:17.419867|2017-02-18 17:41:17.419867
NCT00106912|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2017-01-24|||March 28, 2005||2005-03-28|March 27, 2008|2008-03-27|March 27, 2008||2008-03-27|||||Observational|||Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity|A Study to Collect Normative Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:17.519557|2017-02-18 17:41:17.519557
NCT00106899|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2014-09-15|||July 2005||2005-07-01|September 2014|2014-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||ADNI: Alzheimer's Disease Neuroimaging Initiative|Alzheimer's Disease Neuroimaging Initiative|Completed||N/A|818|Actual|Alzheimer's Disease Cooperative Study (ADCS)|||3||f||||t||||||Samples With DNA|"~     blood, urine, cerebrospinal fluid~   "|||2017-02-18 17:41:17.599021|2017-02-18 17:41:17.599021
NCT00106886|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2005-09-16|||December 1999||1999-12-01|March 2005|2005-03-01|October 2005||2005-10-01|||||Interventional|||HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)|HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)|Unknown status|Active, not recruiting|Phase 4|5000||McMaster University|||||f||||||||||||||2017-02-18 17:41:17.772073|2017-02-18 17:41:17.772073
NCT00106860|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2008-01-07|||March 2005||2005-03-01|January 2008|2008-01-01|March 2006||2006-03-01|||||Interventional|||A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder|A Long-Term, Open Label, Safety and Efficacy Study of an Experimental Medication in Adults With Generalized Anxiety Disorder (GAD)|Completed||Phase 3|158||Jazz Pharmaceuticals|||||||||||||||||||2017-02-18 17:41:18.131927|2017-02-18 17:41:18.131927
NCT00106847|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2011-05-16|||January 2003||2003-01-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Infliximab Induction Therapy Followed by Multiple Regimens of Maintenance InfliximabTherapy in Patients With Plaque-Type Psoriasis|Completed||Phase 3|683|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:41:18.236048|2017-02-18 17:41:18.236048
NCT00106834|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2011-05-18||||||March 2010|2010-03-01|October 2004|Actual|2004-10-01|||||Interventional|||A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Infliximab Induction and Maintenance Therapy in Patients With Moderate to Severe Plaque Psoriasis|Completed||Phase 3|378|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:41:18.332198|2017-02-18 17:41:18.332198
NCT00106821|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2013-10-31|||June 2004||2004-06-01|October 2013|2013-10-01||||August 2005|Actual|2005-08-01||Interventional|||Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease|An 8 Week Randomized, Placebo Controlled, Double-blind Study to Assess the Efficacy of Tiotropium Inhalation Capsules in Patients of African Descent With Chronic Obstructive Pulmonary Disease|Completed||Phase 4|166|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:41:18.427355|2017-02-18 17:41:18.427355
NCT00106808|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-31|2010-09-10||2010-09-10|August 2005||2005-08-01|September 2007|2007-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes|A Phase 3, Randomized, Double-blind, Active Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar (BMS-298585) Compared to Pioglitazone in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control|Completed||Phase 3|1440||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:41:18.546053|2017-02-18 17:41:18.546053
NCT00106795|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-30|2017-01-24|||March 22, 2005||2005-03-22|April 10, 2014|2014-04-10|April 10, 2014||2014-04-10|||||Observational|||Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS|Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients With HIV/AIDS|Completed||N/A|82|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:18.869923|2017-02-18 17:41:18.869923
NCT00106782|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-29|2017-01-24|||March 18, 2005||2005-03-18|May 14, 2010|2010-05-14|May 14, 2010|Actual|2010-05-14|May 14, 2010|Actual|2010-05-14||Interventional|||Transcranial Electrical Polarization to Treat Focal Hand Dystonia|Placebo Controlled Study of the Therapeutic Effect of the Transcranial Electrical Polarization in Patients With Focal Hand Dystonia|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 17:41:18.962618|2017-02-18 17:41:18.962618
NCT00106769|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-29|2017-01-24|||March 22, 2005||2005-03-22|January 15, 2008|2008-01-15|January 15, 2008||2008-01-15|||||Interventional|||Vaccine to Prevent West Nile Virus Disease|A Phase I Study of the Safety and Immunogenicity of a West Nile Virus Recombinant DNA Plasmid Vaccine, VRC-WNVDNA017-00 VP, in Healthy Adult Volunteers|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:19.074778|2017-02-18 17:41:19.074778
NCT00106756|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-29|2017-01-24|||March 18, 2005||2005-03-18|June 26, 2009|2009-06-26|November 1, 2006|Actual|2006-11-01|November 1, 2006|Actual|2006-11-01||Observational|||Clinical and Genetic Studies of Familial Exudative Vitreoretinopathy|Familial Exudative Vitreoretinopathy Clinical and Molecular Studies|Completed||N/A|105||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:19.157853|2017-02-18 17:41:19.157853
NCT00106743|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-29|2017-01-24|||March 18, 2005||2005-03-18|May 3, 2016|2016-05-03||||||||Observational|||Natural History and Genetic Studies of Usher Syndrome|Natural History and Genetic Studies of Usher Syndrome|Active, not recruiting||N/A|237|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:19.243267|2017-02-18 17:41:19.243267
NCT00106717|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-29|2008-03-19|||January 2004||2004-01-01|March 2005|2005-03-01|August 2006|Actual|2006-08-01|||||Interventional|||Effectiveness of Narrative Medicine on Pain Intensity and Quality of Life|Effectiveness of Narrative Medicine on Pain Intensity and Quality of Life|Completed||N/A|210||Javeriana University|||||f||||||||||||||2017-02-18 17:41:19.347944|2017-02-18 17:41:19.347944
NCT00106704|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-29|2015-06-04|2010-11-19||March 2005||2005-03-01|June 2015|2015-06-01|January 2007|Actual|2007-01-01|June 2006|Actual|2006-06-01||Interventional|||Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)|A Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of MK0431 to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Glimepiride Alone or in Combination With Metformin|Completed||Phase 3|441|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:41:19.447483|2017-02-18 17:41:19.447483
NCT00106691|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-29|2013-01-31|||January 2005||2005-01-01|January 2013|2013-01-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia (PIN)|Completed||Phase 3|1590|Actual|GTx||2|||f||||t||||||||||2017-02-18 17:41:20.015814|2017-02-18 17:41:20.015814
NCT00106678|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-28|2016-02-29|||June 2004||2004-06-01|February 2016|2016-02-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Observational|||Typology of Adherence in Adolescents: Phase II|Typology of Adherence in Adolescents: Phase II|Completed||Phase 2|1200|Actual|Westat|||2||f||||f||||||||||2017-02-18 17:41:20.157247|2017-02-18 17:41:20.157247
NCT00106665|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-28|2016-01-15|||June 2005||2005-06-01|January 2016|2016-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||New Onset Weakness in Critically Ill Patients and the Risk of Death and Recurrent ICU Admission|Intensive Care Unit(ICU)-Acquired Paresis and the Risk for Mortality and Recurrent ICU Admission (Weakness and ICU Readmission Evaluation-WIRE)|Completed||N/A|170|Actual|Ohio State University|||1||f||||f||||||||||2017-02-18 17:41:20.257017|2017-02-18 17:41:20.257017
NCT00106652|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-28|2015-04-13|||September 2001||2001-09-01|April 2015|2015-04-01|May 2018|Anticipated|2018-05-01|May 2018|Anticipated|2018-05-01||Observational|||Childhood Autism Risks From Genetics and the Environment (The CHARGE Study)|Environmental Factors in the Etiology of Autism|Active, not recruiting||N/A|2000|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 17:41:20.347742|2017-02-18 17:41:20.347742
NCT00106639|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-28|2013-02-06|2012-12-06||May 2005||2005-05-01|February 2013|2013-02-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients|A 6-Month, Phase 2, Multicenter, Randomized, Open-Label, Comparative Study Of 2 Dose Levels Of CP-690,550 Administered Concomitantly With IL-2 Receptor Antagonist Induction Therapy, Mycophenolate Mofetil And Corticosteroids Versus A Tacrolimus-Based Immunosuppressive Regimen For The Prevention Of Allograft Rejection In De Novo Renal Allograft Recipients|Completed||Phase 2|61|Actual|Pfizer|Results for first BPAR, BPCAN, treatment and efficacy failure, rejection, clinically significant infections, NODM and discontinuation reported as number and not percentage as planned. Stage 2 of study was not conducted due to administrative reasons.|3|||f||||t||||||||||2017-02-18 17:41:20.527926|2017-02-18 17:41:20.527926
NCT00106626|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-28|2009-03-16|2008-11-25||August 2005||2005-08-01|March 2009|2009-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors|Phase I Clinical Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Pemetrexed and Cisplatin in Patients With Advanced Cancer|Completed||Phase 1|52|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 17:41:26.149461|2017-02-18 17:41:26.149461
NCT00106613|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-28|2012-08-30|||May 2003||2003-05-01|August 2012|2012-08-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||A Research Study for Patients With Metastatic Renal Cell Carcinoma|An Exploratory Phase II, Multicenter, Open-label Trial Evaluating the Activity and Tolerability of FK228 in Patients With Metastatic Renal Cell Carcinoma That is Progressive Following or During Immunotherapy|Completed||Phase 2|30|Actual|Celgene||1|||f||||f||||||||||2017-02-18 17:41:26.737191|2017-02-18 17:41:26.737191
NCT00106600|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-28|2007-08-21|||March 2005||2005-03-01|August 2007|2007-08-01|March 2007||2007-03-01|||||Interventional|||Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)|A Phase I/II Study of Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)|Completed||Phase 1/Phase 2|119||CTI BioPharma|||||||||||||||||||2017-02-18 17:41:27.127279|2017-02-18 17:41:27.127279
NCT00106587|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-25|2005-11-09|||December 2003||2003-12-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH – ISR I)|Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons|Completed||Phase 1/Phase 2|52||University Hospital, Saarland|||||f||||||||||||||2017-02-18 17:41:27.238584|2017-02-18 17:41:27.238584
NCT00106574|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-25|2016-11-01|||April 2005||2005-04-01|November 2016|2016-11-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis|A Randomized, Double-blind Study of the Effect of Tocilizumab on Reduction in Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to DMARD Therapy|Completed||Phase 3|1220|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:41:27.355257|2017-02-18 17:41:27.355257
NCT00106561|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-25|2005-06-23|||January 2002||2002-01-01|March 2005|2005-03-01|September 2004||2004-09-01|||||Interventional|||Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney|A Double-Blind, Placebo-Controlled Study on the Effect of Spironolactone, in Patients With Persistent Proteinuria on Long-Term Angiotensin Converting Enzyme Inhibitor Therapy, With or With Out an Angiotensin II Receptor Blocker|Completed||Phase 2/Phase 3|60||Melbourne Health|||||f||||||||||||||2017-02-18 17:41:27.745309|2017-02-18 17:41:27.745309
NCT00106548|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-25|2010-06-10||||||June 2010|2010-06-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis|A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|623|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:41:27.845486|2017-02-18 17:41:27.845486
NCT00106340|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-22|2012-12-28||2012-10-22|March 2005||2005-03-01|December 2012|2012-12-01||||May 2008|Actual|2008-05-01||Interventional|||Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes|Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|3118|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:41:39.774988|2017-02-18 17:41:39.774988
NCT00106535|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-25|2013-12-18|2010-02-09||January 2005||2005-01-01|December 2013|2013-12-01|July 2012|Actual|2012-07-01|May 2007|Actual|2007-05-01||Interventional||Baseline measures are based on the Intent-to-treat population that included all randomized participants who received study drug.|A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)|A Randomized, Double-blind Study of Safety and Prevention of Structural Joint Damage During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Rheumatoid Arthritis|Completed||Phase 3|1196|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:41:28.25795|2017-02-18 17:41:28.25795
NCT00106522|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-25|2016-11-01|||May 2005||2005-05-01|November 2016|2016-11-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy|A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Active Rheumatoid Arthritis and Inadequate Response to Anti-TNF Therapy|Completed||Phase 3|499|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:41:32.894878|2017-02-18 17:41:32.894878
NCT00106509|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-25|2015-03-04|||March 2005||2005-03-01|March 2015|2015-03-01|February 2007|Actual|2007-02-01|||||Interventional|||A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea|A Randomized, Double-Blind Study of GT267-004 Versus Vancomycin, and GT267-004 Versus Metronidazole, in Patients With C.Difficile - Associated Diarrhea|Completed||Phase 3|520||Sanofi|||||||||||||||||||2017-02-18 17:41:33.357428|2017-02-18 17:41:33.357428
NCT00106496|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-25|2014-09-17|||October 2004||2004-10-01|September 2014|2014-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis|A Multi-Center Study to Assess the Impact of Topical Corticosteroids on the Safety and Efficacy of Protopic Ointment in the Short-Term Treatment of Atopic Dermatitis and to Assess Protopic in the Long-term Management of Atopic Dermatitis|Completed||Phase 4|410|Actual|Astellas Pharma Inc||6|||f||||f||||||||||2017-02-18 17:41:33.780323|2017-02-18 17:41:33.780323
NCT00106483|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-24|2015-03-18|||February 2005||2005-02-01|March 2015|2015-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Autoimmunity and Coronary Artery Disease - Ancillary to CARDIA||Completed||N/A|3020|Actual|Northwestern University|||1||f||||||||||||||2017-02-18 17:41:33.94416|2017-02-18 17:41:33.94416
NCT00106470|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-24|2012-12-12|||February 2005||2005-02-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics|Genetic Epidemiology of COPD in Costa Rica|Completed||N/A|679|Actual|University of Pittsburgh|||1||f||||f||||||Samples With DNA|"~     Serum~   "|||2017-02-18 17:41:34.033807|2017-02-18 17:41:34.033807
NCT00106457|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-24|2016-07-11|||February 2005||2005-02-01|November 2008|2008-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:41:34.13459|2017-02-18 17:41:34.13459
NCT00106431|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-24|2011-03-14|2010-03-02||January 2005||2005-01-01|March 2011|2011-03-01|December 2008|Actual|2008-12-01|June 2008|Actual|2008-06-01||Interventional|||A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)|A Single Agent Phase II Study of Depsipeptide (FK228) in the Treatment of Cutaneous T-cell Lymphoma|Completed||Phase 2|102|Actual|Celgene||1|||f||||t||||||||||2017-02-18 17:41:34.207605|2017-02-18 17:41:34.207605
NCT00106418|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-24|2016-10-28|||May 2003||2003-05-01|October 2016|2016-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Research Study for Patients With Prostate Cancer|An Exploratory Phase II, Multicenter, Open-label Trial Evaluating the Activity and Tolerability of FK228 in Androgen Independent Metastatic Prostate Cancer Patients With Rising PSA|Completed||Phase 2|35|Actual|Celgene Corporation||1|||f||||||||||||||2017-02-18 17:41:34.842002|2017-02-18 17:41:34.842002
NCT00106405|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-24|2012-03-01|||February 2005||2005-02-01|March 2012|2012-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder|A Pilot Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder|Completed||Phase 2|35|Actual|Forest Laboratories|||||||||||||||||||2017-02-18 17:41:34.951138|2017-02-18 17:41:34.951138
NCT00106392|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-23|2010-11-15|2010-09-30||February 2005||2005-02-01|November 2010|2010-11-01|November 2008|Actual|2008-11-01|April 2008|Actual|2008-04-01||Interventional|||A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy|A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Prograf (Tacrolimus, FK 506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-sparing Radical Prostatectomy|Completed||Phase 4|131|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|2|||f||||t||||||||||2017-02-18 17:41:35.045516|2017-02-18 17:41:35.045516
NCT00106379|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-23|2010-02-01|||October 2004||2004-10-01|April 2008|2008-04-01|January 2007|Actual|2007-01-01|||||Interventional|||Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients|A Phase 4, Single-Arm Study to Evaluate the Safety, Antiviral Activity and Pharmacokinetics of Tenofovir Disoproxil Fumarate in Combination With Emtricitabine in HIV-1 Infected Patients Experiencing Various Degrees of Renal Impairment|Completed||Phase 4|52||Gilead Sciences|||||||||||||||||||2017-02-18 17:41:35.524648|2017-02-18 17:41:35.524648
NCT00106366|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-22|2017-01-30|||March 2005||2005-03-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes|Efficacy and Safety Comparison of Insulin Detemir and Insulin Glargine Plus Insulin Aspart in Patients With Type 2 Diabetes|Completed||Phase 3|389|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:41:35.623269|2017-02-18 17:41:35.623269
NCT00106353|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-22|2013-01-04|2010-11-05||March 2005||2005-03-01|January 2013|2013-01-01|January 2012|Actual|2012-01-01|October 2009|Actual|2009-10-01||Interventional|||Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors|A Phase I/II Safety and Exploratory Pharmacogenomic/Pharmacodynamic Study of Intravenous Temsirolimus (CCI-779) in Pediatric Subjects With Relapsed/Refractory Solid Tumors|Completed||Phase 1/Phase 2|71|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:41:35.940116|2017-02-18 17:41:35.940116
NCT00106314|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-22|2007-10-17|||January 2005||2005-01-01|October 2007|2007-10-01|October 2006|Actual|2006-10-01|||||Interventional|||An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease|A Randomized, Double-Blind, Multi-Center, Dose Response, Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Moderately Active Crohn's Disease|Completed||Phase 2|75||Inflabloc Pharmaceuticals|||||||||||||||||||2017-02-18 17:41:40.181429|2017-02-18 17:41:40.181429
NCT00106301|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-22|2016-03-30|||April 2004||2004-04-01|March 2016|2016-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228|A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Have Completed a Prior Clinical Study With FK228|Completed||Phase 2|2|Actual|Celgene Corporation||1|||f||||f||||||||||2017-02-18 17:41:40.322095|2017-02-18 17:41:40.322095
NCT00106288|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-22|2014-09-17|||January 2003||2003-01-01|September 2014|2014-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia|A Multicenter, Double Blind, Comparative, Randomized Study to Evaluate the Efficacy and Safety of Micafungin (FK463) Versus Liposomal Amphotericin B (AmBisome) in the Treatment of Invasive Candidiasis and Candidemia|Completed||Phase 3|637|Actual|Astellas Pharma Inc||2|||f||||t||||||||||2017-02-18 17:41:40.436354|2017-02-18 17:41:40.436354
NCT00106275|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2006-01-30|||November 2003||2003-11-01|November 2005|2005-11-01|November 2006||2006-11-01|||||Interventional|||Mindfulness-Based Stress Reduction Program as an Intervention in Patients With Fibromyalgia|Mindfulness-Based Stress Reduction Program as an Intervention in Patients With Fibromyalgia: A Three-Armed Randomized Clinical Study|Unknown status|Active, not recruiting|N/A|180||University Hospital Freiburg|||||f||||||||||||||2017-02-18 17:41:40.593797|2017-02-18 17:41:40.593797
NCT00106262|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2007-04-17|||March 2005||2005-03-01|April 2007|2007-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer|A Phase II Study of VELCADE TM(PS-341) and Irinotecan in the Treatment of Progressive, Recurrent or Metastatic Cervical, Vulvar, or Vaginal Cancer|Terminated||Phase 2|38||Women and Infants Hospital of Rhode Island||||Lack of accrual|f||||||||||||||2017-02-18 17:41:40.688195|2017-02-18 17:41:40.688195
NCT00106249|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2016-12-01|2016-09-06||November 2004||2004-11-01|December 2016|2016-12-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional||A total of 22 patients with at least 1 follow up were included in the final analyses. Four subjects only had baseline measure. The reason for them to withdraw from the study was their inability to attend daily treatment sessions due to schedule conflict with their job and long commute to the TMS laboratory.|Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)|Treatment of Obsessive Compulsive Disorder (OCD) With Transcranial Magnetic Stimulation (TMS)|Completed||Phase 2|27|Actual|New York State Psychiatric Institute||2|||f||||t||||||||No||2017-02-18 17:41:40.787332|2017-02-18 17:41:40.787332
NCT00106236|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2009-07-13|||April 2003||2003-04-01|March 2005|2005-03-01|April 2004||2004-04-01|||||Interventional|||Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction|Sapporo Fitness Club Trial (SFCT): A Randomized Controlled Trial to Test the Efficacy of Exercise at a Fitness Club for the Reduction of Cardiovascular Risk Factors|Completed||Phase 1/Phase 2|561||Sapporo Health Promotion Foundation|||||f||||||||||||||2017-02-18 17:41:41.153177|2017-02-18 17:41:41.153177
NCT00106223|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2012-01-03|||April 2004||2004-04-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder|A Randomized Waitlist Controlled Treatment Trial Investigating CBT for Body Dysmorphic Disorder|Completed||N/A|36|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:41:41.242845|2017-02-18 17:41:41.242845
NCT00106210|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2013-07-03|||May 2003||2003-05-01|July 2013|2013-07-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||School- and Home-Based Early Intervention for Toddlers With Autism|Early Detection, Intervention, and Neurobiology in Autism: Early Intervention Portion|Completed||N/A|50|Actual|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||2|||f||||f||||||||||2017-02-18 17:41:41.355852|2017-02-18 17:41:41.355852
NCT00106197|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2013-08-29|||June 2004||2004-06-01|August 2013|2013-08-01|March 2014|Anticipated|2014-03-01|March 2014|Anticipated|2014-03-01||Interventional|||Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression|Treatment Prediction in Adolescent and Adult Depression|Unknown status|Active, not recruiting|Phase 4|130|Anticipated|Meharry Medical College||1|||f||||t||||||||||2017-02-18 17:41:41.461457|2017-02-18 17:41:41.461457
NCT00106184|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2015-03-03|2013-10-10||March 2006||2006-03-01|March 2015|2015-03-01|August 2010|Actual|2010-08-01|February 2010|Actual|2010-02-01||Interventional||3 subjects in Group A and 2 subjects in Group B were excluded from analysis due to withdrawing from the study. These subjects either did not receive a full dose of study drug at week 0 or no study drug at all.|Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)|Rituximab Therapy in Refractory Adult and Juvenile Idiopathic Inflammatory Myopathy (IIM)|Completed||Phase 2|200|Actual|University of Pittsburgh|There was an overestimate of the rapidity of the rituximab response and an underestimate of DOI in those receiving placebo.|6|||f||||t||||||||||2017-02-18 17:41:41.569817|2017-02-18 17:41:41.569817
NCT00106171|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2011-02-17|||February 2005||2005-02-01|February 2011|2011-02-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Anti-HIV Medications for People Recently Infected With HIV|A Randomized Trial of HAART in Acute/Early HIV Infection|Completed||Phase 4|180|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:41:42.361467|2017-02-18 17:41:42.361467
NCT00106158|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2010-11-04|||June 2004||2004-06-01|August 2007|2007-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1|Immunization of Patients With Tumors Expressing NY-ESO-1 or LAGE Antigen With Complex of NY-ESO-1 Protein and Cholesterol-bearing Hydrophobized Pullulan (CHP)|Completed||Phase 1|9|Anticipated|Ludwig Institute for Cancer Research|||||f||||||||||||||2017-02-18 17:41:42.492875|2017-02-18 17:41:42.492875
NCT00106145|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-21|2015-01-29|||April 2005||2005-04-01|January 2015|2015-01-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)|A Phase I Study of MK0752, a Notch Inhibitor, in Patients With Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors|Completed||Phase 1|103|Actual|Merck Sharp & Dohme Corp.||5|||f||||||||||||||2017-02-18 17:41:42.582419|2017-02-18 17:41:42.582419
NCT00106132|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-19|2008-03-03|||March 2005||2005-03-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage|The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study|Completed||Phase 3|1260||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:42.683796|2017-02-18 17:41:42.683796
NCT00106119|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-19|2015-02-20|2014-11-12||March 2005||2005-03-01|February 2015|2015-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional||Subjects who completed the study|Thyroid and Glucose and Energy Metabolism|Peripheral Thyroid Hormone Conversion and Glucose and Energy Metabolism|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 17:41:42.977057|2017-02-18 17:41:42.977057
NCT00106106|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-19|2012-01-10|2011-11-30||March 2005||2005-03-01|January 2012|2012-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Acamprosate to Reduce Symptoms of Alcohol Withdrawal|Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal|Completed||Phase 2|56|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 17:41:43.407091|2017-02-18 17:41:43.407091
NCT00106093|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-19|2017-01-24|||March 16, 2005||2005-03-16|September 8, 2015|2015-09-08|September 8, 2015||2015-09-08|||||Observational|||Alcoholism Assessment and Treatment|Assessment and Treatment of People With Alcohol Drinking Problems|Completed||N/A|1192|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:41:43.881743|2017-02-18 17:41:43.881743
NCT00106080|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2015-04-06|2014-08-06||November 2004||2004-11-01|May 2014|2014-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||42 clinicians were randomized to the intervention group. 50 clinicians were randomized to the control group. 376 patients were enrolled and assigned to their clinician's treatment group.|Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD)|Improving the Quality of End-of-Life Communication for Patients With COPD|Completed||N/A|376|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:41:43.995264|2017-02-18 17:41:43.995264
NCT00106067|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2015-04-06|||June 2004||2004-06-01|April 2009|2009-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|A&SC||Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients|Aging and Family Outcomes in Supportive Care of Advanced Cancer Patients|Completed||N/A|559|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:41:44.499956|2017-02-18 17:41:44.499956
NCT00106054|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2010-08-26|||January 2006||2006-01-01|August 2010|2010-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases|An Open-Label, Multi-Center Phase II Trial of Neoadjuvant Irinotecan in Combination With Infusional 5-FU, Leucovorin (Folfiri) Plus Bevacizumab in Patients With Unresectable Hepatic-Only Metastases of Colorectal Carcinoma|Terminated||Phase 2|2|Actual|Pfizer||||"After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could~   be performed."|f||||||||||||||2017-02-18 17:41:44.61398|2017-02-18 17:41:44.61398
NCT00106041|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2015-04-06|||August 2004||2004-08-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|November 2007|Actual|2007-11-01||Interventional|||Study to Improve Care for Veterans During Serious Illness|Randomized Trial of Care Management to Improve End of Life Care|Completed||N/A|400|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:44.716976|2017-02-18 17:41:44.716976
NCT00106028|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2013-04-15|2009-04-15||November 2004||2004-11-01|April 2013|2013-04-01|March 2010|Actual|2010-03-01|April 2008|Actual|2008-04-01||Interventional|||Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children|Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children|Completed||Phase 3|143|Actual|Warner Chilcott|The clinical meaningfulness of new fractures in the thoracic spine scored as Genant Grade I is unclear, thus the morphometric vertebral fracture data are evaluated further.|2|||f||||f||||||||||2017-02-18 17:41:44.847023|2017-02-18 17:41:44.847023
NCT00106015|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2016-12-20|||September 2004||2004-09-01|December 2016|2016-12-01||||April 2019|Anticipated|2019-04-01||Observational|DBAR||Diamond Blackfan Anemia Registry (DBAR)|Diamond Blackfan Anemia Registry (DBAR)|Recruiting||N/A|850|Anticipated|Northwell Health|||1||f||||||||||||||2017-02-18 17:41:47.203444|2017-02-18 17:41:47.203444
NCT00106002|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2009-05-29|2008-12-23||April 2005||2005-04-01|April 2009|2009-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer|A Phase II Study of Alimta as First Line Chemotherapy for Advanced or Metastatic Breast Cancer|Completed||Phase 2|37|Actual|Eli Lilly and Company||1|||f||||t||||||||||2017-02-18 17:41:47.368477|2017-02-18 17:41:47.368477
NCT00105989|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2009-07-21|2009-01-23||March 2005||2005-03-01|July 2009|2009-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder|Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder|Completed||Phase 3|514|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 17:41:47.83162|2017-02-18 17:41:47.83162
NCT00105976|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2008-07-10|||February 2005||2005-02-01|July 2008|2008-07-01||||||||Interventional|||Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)|A Phase 2, Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Efficacy and Safety of 3 Different Dose Levels (2.5, 7.5 and 20 mg) of MM-093 in Patients With Active Rheumatoid Arthritis on Stable Doses of Methotrexate|Completed||Phase 2|260||Merrimack Pharmaceuticals|||||||||||||||||||2017-02-18 17:41:50.853372|2017-02-18 17:41:50.853372
NCT00105963|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2005-06-23|||January 2005||2005-01-01|March 2005|2005-03-01|August 2006||2006-08-01|||||Interventional|||Prevention of Shaken Baby Syndrome|Parents Helping Infants Study: Preventing Shaken Baby Syndrome and Child Abuse|Unknown status|Recruiting|N/A|3000||Harborview Injury Prevention and Research Center|||||f||||||||||||||2017-02-18 17:41:51.076985|2017-02-18 17:41:51.076985
NCT00105950|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2015-09-24|||March 2005||2005-03-01|May 2015|2015-05-01|May 2010|Actual|2010-05-01|September 2007|Actual|2007-09-01||Interventional|||Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer|A Phase II Study to Evaluate the Efficacy, Safety and Pharmacodynamics of Lapatinib in Patients With Relapsed or Refractory Inflammatory Breast Cancer|Completed||Phase 2|126|Actual|GlaxoSmithKline||1|||f||||f||||||||||2017-02-18 17:41:51.180198|2017-02-18 17:41:51.180198
NCT00105937|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-18|2012-06-27|||April 2004||2004-04-01|May 2007|2007-05-01|November 2006||2006-11-01|||||Interventional|||OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients|Multi-center, Open Label, Long-term Study of OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients|Completed||Phase 3|300||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:41:51.329435|2017-02-18 17:41:51.329435
NCT00105911|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-17|2015-04-06|||July 2002||2002-07-01|February 2007|2007-02-01|June 2005|Actual|2005-06-01|||||Interventional|||A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD|A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD|Completed||N/A|222|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:51.486432|2017-02-18 17:41:51.486432
NCT00105898|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-17|2015-04-06|||February 2005||2005-02-01|August 2010|2010-08-01|June 2010|Actual|2010-06-01|April 2007|Actual|2007-04-01||Interventional|||Internet-based Diabetes Education and Case Management|Internet-based Diabetes Education and Case Management|Completed||N/A|152|Actual|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 17:41:51.599525|2017-02-18 17:41:51.599525
NCT00105885|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-17|2014-02-06|||November 2003||2003-11-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|Telepsych||Telephone Care as a Substitute for Routine Psychiatric Medication|Telephone Care as a Substitute for Routine Psychiatric Medication Management|Completed||N/A|324|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:41:51.710009|2017-02-18 17:41:51.710009
NCT00105872|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-17|2015-04-06|||March 2002||2002-03-01|March 2007|2007-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Behavioral Insomnia Therapy in Primary Care|Behavioral Insomnia Therapy in Primary Care|Completed||N/A|100|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:51.845843|2017-02-18 17:41:51.845843
NCT00105859|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-17|2010-05-06||||||June 2005|2005-06-01||||||||Interventional|||Preventing Pressure Ulcers in Veterans With Spinal Cord Injury (SCI)|Preventing Pressure Ulcers in Veterans With Spinal Cord Injury (SCI)|Terminated||N/A|278|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:51.95992|2017-02-18 17:41:51.95992
NCT00105846|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-17|2015-04-06||||||February 2007|2007-02-01|June 2004|Actual|2004-06-01|||||Interventional|||An Evaluation of Home-Based Telemedicine Services|An Evaluation of Home-Based Telemedicine Services|Completed||Phase 2|200|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:52.067204|2017-02-18 17:41:52.067204
NCT00105833|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||July 2002||2002-07-01|March 2009|2009-03-01|December 2008|Actual|2008-12-01|November 2004|Actual|2004-11-01||Interventional|DEP-PC||Improving Outcomes of Depression in Primary Care|Improving Outcomes of Depression in Primary Care|Completed||N/A|400|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:41:52.178556|2017-02-18 17:41:52.178556
NCT00105820|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||June 2003||2003-06-01|February 2007|2007-02-01|March 2006|Actual|2006-03-01|||||Interventional|||Evaluation Study of TIDES Depression Care Quality Improvement Intervention|Well-being Among Veterans Enhancement Study (WAVES)|Completed||N/A|750|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:52.291501|2017-02-18 17:41:52.291501
NCT00105807|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||July 2002||2002-07-01|February 2007|2007-02-01|April 2006|Actual|2006-04-01|||||Interventional|||The Effect of Exercise on Muscle, Function and Cost in VA Nursing Home Residents|The Effect of Exercise on Muscle, Function and Cost in VA Nursing Home Residents|Completed||Phase 2|120|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:52.414055|2017-02-18 17:41:52.414055
NCT00105794|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||March 2004||2004-03-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Psychiatric Advance Directives for Improved Mental Health Care|Psychiatric Advance Directives for Improved Healthcare|Completed||N/A|360|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:52.51481|2017-02-18 17:41:52.51481
NCT00105781|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||November 2002||2002-11-01|May 2007|2007-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Nurse Physical Activity Counseling in Primary Care|Nurse Physical Activity Counseling in Primary Care|Completed||N/A|240|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:52.626439|2017-02-18 17:41:52.626439
NCT00105768|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||July 2002||2002-07-01|March 2007|2007-03-01|October 2005|Actual|2005-10-01|||||Interventional|||Effectiveness of Advisor-Teller Money Manager|Effectiveness of Advisor - Teller Money Manager (ATM)|Completed||Phase 1/Phase 2|120|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:52.745224|2017-02-18 17:41:52.745224
NCT00105755|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||January 2003||2003-01-01|April 2015|2015-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Dermal Thermometry and Self-Care of High Risk Diabetic Patients|Dermal Thermometry and Self-Care of High Risk Diabetic Patients|Completed||N/A|400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:52.84981|2017-02-18 17:41:52.84981
NCT00105742|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06||||||July 2006|2006-07-01|June 2005|Actual|2005-06-01|||||Interventional|||Audiology Visits After Screening for Hearing Loss: An RCT|Audiology Visits After Screening for Hearing Loss: An RCT|Completed||Phase 2|1400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:55.777719|2017-02-18 17:41:55.777719
NCT00105729|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||January 2003||2003-01-01|September 2006|2006-09-01|April 2005|Actual|2005-04-01|||||Interventional|||Substance Abuse Self-Help Group Referral: Outcomes and Services Use|Substance Abuse Self-Help Group Referral: Outcome and Services Use|Completed||N/A|345|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:55.885457|2017-02-18 17:41:55.885457
NCT00105716|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||March 2002||2002-03-01|April 2006|2006-04-01|April 2005|Actual|2005-04-01|||||Interventional|||Study to Lower Veterans BP: Patient/Physician Intervention|Study to Lower Veterans Blood Pressure: Patient/Physician Intervention|Completed||N/A|544|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:55.992017|2017-02-18 17:41:55.992017
NCT00105703|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||February 2002||2002-02-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|CHF ENCORE||Evaluation of a Nurse Case Management Model for Chronic Heart Failure|Evaluation of a Nurse Case Management Model for Chronic Heart Failure|Completed||N/A|969|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:56.110694|2017-02-18 17:41:56.110694
NCT00105690|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||April 2003||2003-04-01|September 2006|2006-09-01|October 2004|Actual|2004-10-01|||||Interventional|||TEAM Study to Improve Depression Care in Rural CBOCs|Telemedicine Intervention to Improve Depression Care in Rural CBOCs|Completed||N/A|400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:56.22846|2017-02-18 17:41:56.22846
NCT00105677|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||August 2004||2004-08-01|October 2006|2006-10-01|September 2006|Actual|2006-09-01|||||Observational|||Understanding the Differences in the Management of Patients With Arthritis of the Knee or Hip|Reasons for Disparities in Joint Replacement Utilization|Completed||N/A|980|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:41:56.343286|2017-02-18 17:41:56.343286
NCT00105651|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06||||||February 2007|2007-02-01|March 2004|Actual|2004-03-01|||||Interventional|||A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer|A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer|Completed||N/A|128|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:56.566631|2017-02-18 17:41:56.566631
NCT00105638|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||September 2005||2005-09-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||Telehealth Education Program for Caregivers of Veterans With Dementia|A Telehealth Education Program for Caregivers of Veterans With Dementia|Completed||N/A|160|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:56.67003|2017-02-18 17:41:56.67003
NCT00105625|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-16|2015-04-06|||March 2003||2003-03-01|June 2008|2008-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||VA Nutrition Study on Immune Function|Immunocompetency and Nutritive Status in Inpatient Gero-Rehabilitation|Completed||N/A|100|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 17:41:59.530952|2017-02-18 17:41:59.530952
NCT00105612|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2009-12-23|||September 2004||2004-09-01|December 2009|2009-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Memory Aid for Informed Consent in Alzheimer's Research|Improving Informed Consent in Alzheimer's Disease Research|Completed||N/A|110||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:41:59.658825|2017-02-18 17:41:59.658825
NCT00105599|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2015-04-06||||||February 2007|2007-02-01|September 2004|Actual|2004-09-01|||||Interventional|||Effectiveness of the FairCare System for Patients With Advanced Illness|Effectiveness of the FairCare System for Patients With Advanced Illness|Completed||Phase 2|140|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 17:41:59.748612|2017-02-18 17:41:59.748612
NCT00105586|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2008-09-08|||December 2004||2004-12-01|September 2008|2008-09-01|April 2008|Actual|2008-04-01|January 2008|Actual|2008-01-01||Interventional|||Drug Therapy for Generalized Anxiety Disorder Among the Elderly|Pharmacotherapy of Late-Life Generalized Anxiety Disorder|Completed||Phase 4|177|Actual|National Institute of Mental Health (NIMH)||2|||f||||||||||||||2017-02-18 17:41:59.843596|2017-02-18 17:41:59.843596
NCT00105573|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2013-04-29|||January 2004||2004-01-01|April 2013|2013-04-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Interventions for Depressed Low Income Mothers and Their Infants|Prevention for Infants of Low-Income Depressed Mothers|Completed||N/A|218|Actual|University of Rochester||3|||f||||t||||||||||2017-02-18 17:41:59.950806|2017-02-18 17:41:59.950806
NCT00105560|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2016-03-14|||May 2002||2002-05-01|March 2016|2016-03-01||||December 2016|Anticipated|2016-12-01||Interventional|||Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma|Phase II Study of Craniospinal and Posterior Fossa Irradiation Using Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma: Assessment of Acute and Long Term Sequelae|Active, not recruiting||Phase 2|60|Actual|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:42:00.055485|2017-02-18 17:42:00.055485
NCT00105547|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2009-05-03|||February 2005||2005-02-01|May 2009|2009-05-01|May 2008|Actual|2008-05-01|||||Interventional|||Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's|Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment With MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subjects With Mild Dementia of the Alzheimer's Type|Completed||Phase 3|1600|Actual|Myrexis Inc.||2|||f||||t||||||||||2017-02-18 17:42:00.167059|2017-02-18 17:42:00.167059
NCT00105534|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2013-10-29|2011-08-01||July 2004||2004-07-01|October 2013|2013-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)|A Study to Evaluate the Clinical and Microbial Efficacy and Safety of 1.0 % AzaSite Compared to Vehicle in the Treatment of Bacterial Conjunctivitis|Completed||Phase 3|685|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:42:00.693283|2017-02-18 17:42:00.693283
NCT00105521|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2017-01-19|||September 2004||2004-09-01|January 2017|2017-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Sarizotan HCl in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia|A Double-blind, Placebo-controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan HCl 1 mg b.i.d. in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia|Completed||Phase 3|594|Actual|EMD Serono|||||||||||||||||||2017-02-18 17:42:01.050072|2017-02-18 17:42:01.050072
NCT00105508|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2017-01-19|||September 2004||2004-09-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia|A Double-blind, Placebo-controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan HCl 1 mg b.i.d. in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia|Completed||Phase 3|611|Actual|EMD Serono|||||||||||||||||||2017-02-18 17:42:01.158839|2017-02-18 17:42:01.158839
NCT00105495|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-15|2016-01-04|||December 2002||2002-12-01|October 2006|2006-10-01|October 2004||2004-10-01|||||Interventional|||Efficacy Study in Removing Excess Iron From the Heart|Randomized Trial Comparing the Relative Efficacy of Deferiprone to That of Deferoxamine in Removing Excess Cardiac Iron in Thalassemia Major Patients|Completed||Phase 4|60||ApoPharma|||||f||||||||||||||2017-02-18 17:42:01.272949|2017-02-18 17:42:01.272949
NCT00105482|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-14|2013-01-28|2013-01-28||January 2005||2005-01-01|January 2013|2013-01-01|October 2009|Actual|2009-10-01|April 2009|Actual|2009-04-01||Interventional|||Targeted Interventions for Weight-Concerned Smokers|Testing the Effectiveness of Low Dose Naltrexone for Smoking Cessation and Minimization of Post-cessation Weight Gain|Completed||Phase 2|172|Actual|Yale University||2|||f||||t||||||||||2017-02-18 17:42:01.377472|2017-02-18 17:42:01.377472
NCT00105469|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-14|2013-11-21|2011-08-01||July 2004||2004-07-01|November 2013|2013-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)|A Study to Evaluate the Clinical and Microbial Efficacy and Safety of 1.0% AzaSite Compared to 0.3% Tobramycin Ophthalmic Solution in the Treatment of Bacterial Conjunctivitis|Completed||Phase 3|743|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:42:02.125186|2017-02-18 17:42:02.125186
NCT00105456|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-14|2010-05-04|||March 2003||2003-03-01|May 2010|2010-05-01|May 2009|Actual|2009-05-01|||||Observational|||A Study of Patients With HER2-Positive Metastatic Breast Cancer|registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer|Completed||Phase 4|1000||Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:42:02.497159|2017-02-18 17:42:02.497159
NCT00105443|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-14|2014-10-24|2009-12-11||March 2005||2005-03-01|October 2014|2014-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|SHARP||A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma|A Phase III Randomized, Placebo-controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 3|602|Actual|Bayer||2|||f||||t||||||||||2017-02-18 17:42:02.598112|2017-02-18 17:42:02.598112
NCT00105430|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2006-07-04|||March 2005||2005-03-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Deep Brain Stimulation for Cervical Dystonia|Deep Brain Stimulation of the Globus Pallidus Interna or the Subthalamic Nucleus for Treatment of Generalized Primary Dystonia|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:04.845986|2017-02-18 17:42:04.845986
NCT00105417|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2008-03-03|||March 2005||2005-03-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment|A Phase I, Randomized, Placebo-Controlled, Double-Blind Study Evaluating the Safety of Subcutaneous Single Dose Interleukin-7 in HIV-1-Infected Subjects Who Are Receiving Antiretroviral Treatment (A5214)|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:04.95306|2017-02-18 17:42:04.95306
NCT00105404|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2017-01-24|||March 9, 2005||2005-03-09|October 30, 2006|2006-10-30|October 30, 2006||2006-10-30|||||Interventional|||Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation|A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema|Completed||Phase 3|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:05.049751|2017-02-18 17:42:05.049751
NCT00105378|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2007-08-09|||April 2003||2003-04-01|August 2007|2007-08-01|July 2005|Actual|2005-07-01|||||Interventional|||Dutch EASYcare Study|Effectiveness of EASYcare-Based Geriatric Intermediate Care|Completed||N/A|155|Actual|Radboud University||2|||f||||||||||||||2017-02-18 17:42:05.163012|2017-02-18 17:42:05.163012
NCT00105365|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2015-10-20|||March 2004||2004-03-01|October 2015|2015-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Shoe Modification and Knee Osteoarthritis|Shoe Modification and Knee Osteoarthritis|Completed||N/A|40|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 17:42:05.274824|2017-02-18 17:42:05.274824
NCT00105352|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2016-06-01|||November 2004||2004-11-01|June 2016|2016-06-01|November 2005|Actual|2005-11-01|||||Interventional|||Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials|Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials|Completed||N/A|120||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:42:05.388496|2017-02-18 17:42:05.388496
NCT00105339|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2016-02-29|||December 2003||2003-12-01|February 2016|2016-02-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Observational|||Simplified Consent for HIV Vaccine Trials|Simplified Consent for HIV Vaccine Trials|Completed||N/A|255|Actual|Westat|||3||f||||f||||||||||2017-02-18 17:42:05.5213|2017-02-18 17:42:05.5213
NCT00105326|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2010-05-20|||February 2005||2005-02-01|May 2010|2010-05-01|August 2005|Actual|2005-08-01|||||Interventional|||Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients|A Double-blind, Placebo-controlled, Randomized Study Evaluating the Effect of Paliperidone ER Compared With Placebo on Sleep Architecture in Subjects With Schizophrenia|Completed||Phase 2|5|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:42:05.626141|2017-02-18 17:42:05.626141
NCT00105313|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2007-06-12|||February 2005||2005-02-01|June 2007|2007-06-01||||||||Interventional|||Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia|A Phase I Open-Label Dose Escalation Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia|Terminated||Phase 1|80|Anticipated|MedImmune LLC||||"After review of safety events and have decided that further dose escalation of MEDI-507 as a~   single agent is not feasible."|||||||||||||||2017-02-18 17:42:05.730645|2017-02-18 17:42:05.730645
NCT00105300|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2006-08-13|||October 2004||2004-10-01|August 2006|2006-08-01||||||||Interventional|||Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Moderate to Severe Crohn's Disease Who Have Lost Response or Are Intolerant to Infliximab|Completed||Phase 3|300||Abbott|||||||||||||||||||2017-02-18 17:42:05.824963|2017-02-18 17:42:05.824963
NCT00105287|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-11|2014-05-08|||January 2005||2005-01-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients|Multi-center Study Evaluating OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients|Completed||Phase 3|100||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:42:06.228057|2017-02-18 17:42:06.228057
NCT00105274|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-10|2017-01-24|||March 7, 2005||2005-03-07|February 2, 2010|2010-02-02|February 2, 2010||2010-02-02|||||Observational|||Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study|Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:06.333302|2017-02-18 17:42:06.333302
NCT00105248|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-10|2016-05-10|||January 2004||2004-01-01|May 2016|2016-05-01|June 2004||2004-06-01|||||Interventional|||Patient Centered Communication Training to Reduce Antibiotic Use in Acute Respiratory Tract Infections|Multidimensional Intervention Program to Reduce Antibiotic Prescriptions for Acute Respiratory Tract Infections in Adults: a Randomized Controlled Trial in Primary Care|Completed||N/A|900||University Hospital, Basel, Switzerland|||||f||||f||||||||||2017-02-18 17:42:06.4203|2017-02-18 17:42:06.4203
NCT00105235|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-10|2012-11-23|2012-03-02||June 2005||2005-06-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|March 2007|Actual|2007-03-01||Interventional|TILT||Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients|A Phase II Multicenter Trial to Assess the Safety and Efficacy of Campath-1H and Tacrolimus Followed By Immunosuppression Withdrawal in Liver Transplantation (ITN024ST)|Completed||Phase 2|27|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|This study was converted to a pilot study on May 23, 2006. Only 27 of the planned 211 participants were enrolled, thus reducing the number of subjects available for analysis.|1|||f||||t||||||||||2017-02-18 17:42:06.553669|2017-02-18 17:42:06.553669
NCT00105222|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-09|2017-01-24|||March 8, 2005||2005-03-08|August 16, 2013|2013-08-16|August 16, 2013|Actual|2013-08-16|August 16, 2013|Actual|2013-08-16||Interventional|||Effect of Nitrite on Exercise Physiology and Metabolism|Evaluation of Systemic Nitrite Infusion and Its Effect on Exercise Physiology and Metabolism|Terminated||Phase 1|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:42:07.298258|2017-02-18 17:42:07.298258
NCT00105209|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-09|2005-06-23|||April 2002||2002-04-01|March 2005|2005-03-01|December 2003||2003-12-01|||||Interventional|||A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension|A Double-Blind, Placebo-Controlled, Three Treatment Cross-Over Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension|Completed||Phase 2|20||Kawut, Steven, MD|||||f||||||||||||||2017-02-18 17:42:07.622653|2017-02-18 17:42:07.622653
NCT00105196|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-09|2013-11-07|2009-03-27||March 2005||2005-03-01|April 2011|2011-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||A Study of Aripiprazole in Patients With Major Depressive Disorder|A Study of Aripiprazole in Patients With Major Depressive Disorder|Completed||Phase 3|349|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||f||||||||||2017-02-18 17:42:07.733349|2017-02-18 17:42:07.733349
NCT00105183|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-08|2012-06-07|2012-03-07||January 2005||2005-01-01|June 2012|2012-06-01|January 2011|Actual|2011-01-01|January 2010|Actual|2010-01-01||Interventional|||EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection|A Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of an Anti-human-T-lymphocyte Immune Globulin (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of Primary Pulmonary Allograft(s)|Completed||Phase 3|223|Actual|Neovii Biotech|Interim analysis: Dropped 5mg/kg arm. Study was insufficiently powered & focus shifted to safety endpoints. Eliminated some secondary endpoints eg. steroid resistant&antibody treated rejection,CNI&antiproliferative agent, bronchiolitis obliterans.|3|||f||||t||||||||||2017-02-18 17:42:08.658229|2017-02-18 17:42:08.658229
NCT00105170|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-08|2013-04-25|||January 2005||2005-01-01|April 2013|2013-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid Tumors|A Phase I, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of hCBE-11, a Humanized Monoclonal Antibody, in Subjects With Advanced Solid Tumors|Terminated||Phase 1|13|Actual|Biogen||1|||||||||||||||||2017-02-18 17:42:10.618025|2017-02-18 17:42:10.618025
NCT00105157|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-08|2015-12-03|2009-09-14||March 2005||2005-03-01|December 2015|2015-12-01|July 2009|Actual|2009-07-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)|Multicenter Study to Evaluate the Safety and Efficacy of MK0518 in Combination With An Optimized Background Therapy (OBT), Versus OBT Alone, in HIV-Infected Patients With Documented Resistance|Completed||Phase 2|179|Actual|Merck Sharp & Dohme Corp.|Due to a 3:1 randomization of MK-0518 to placebo and more discontinuations for placebo in the doubleblind phase, exposure for MK-0518 and placebo differs significantly with follow-up times of 336.3 and 39.7 patient-years, respectively.|4|||f||||||||||||||2017-02-18 17:42:10.724751|2017-02-18 17:42:10.724751
NCT00105144|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-07|2014-09-17|||September 2004||2004-09-01|September 2014|2014-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Micafungin in Patients With Invasive Candidiasis or Candidemia|A Phase 3, Randomized, Double-Blind, Comparative Study of Micafungin (FK463) Versus Caspofungin as Antifungal Treatment in Patients With Invasive Candidiasis or Candidemia|Completed||Phase 3|611|Actual|Astellas Pharma Inc||3|||f||||f||||||||||2017-02-18 17:42:13.67273|2017-02-18 17:42:13.67273
NCT00105131|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-05|2008-03-03|||March 2005||2005-03-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Genetic Characterization of Parkinson's Disease|Genetic Characterization of Parkinson's Disease|Completed||N/A|2500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:14.058183|2017-02-18 17:42:14.058183
NCT00105118|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-04|2008-03-03|||March 2005||2005-03-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Observational|||Effect of Transcranial Magnetic Stimulation on Memory|10 Hz rTMS to Subject Specific Regions of Cerebral Cortex Improves Memory in Healthy Subjects|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:14.139617|2017-02-18 17:42:14.139617
NCT00105105|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-04|2009-12-10|||April 2003||2003-04-01|September 2005|2005-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Mifepristone as Adjunctive Therapy in Alzheimer's Disease|A Double-blind, Placebo-controlled Trial of the Safety and Efficacy of C-1073 (Mifepristone) as Adjunctive Therapy in Alzheimer's Disease|Terminated||Phase 2|160||National Institute on Aging (NIA)|||||||||||||||||||2017-02-18 17:42:14.227735|2017-02-18 17:42:14.227735
NCT00105092|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-04|2007-04-27|||March 2005||2005-03-01|April 2007|2007-04-01|February 2007|Actual|2007-02-01|||||Interventional|||Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.|A Phase II Evaluation of Oral Enzastaurin HCl in Second-and Third- Line Treatment of Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:42:14.35553|2017-02-18 17:42:14.35553
NCT00105079|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-04|2011-09-23|2011-03-29||April 2005||2005-04-01|September 2011|2011-09-01|July 2008|Actual|2008-07-01|August 2007|Actual|2007-08-01||Interventional|||GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection|A 48-week, Randomized, Open-label, 2-arm Study to Compare the Efficacy of Saquinavir/Ritonavir Twice Daily (BID) Plus Emtricitabine/Tenofovir Once Daily (QD) Versus Lopinavir/Ritonavir BID Plus Emtricitabine/Tenofovir QD in Treatment-naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients (GEMINI Study)|Completed||Phase 3|337|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:42:14.455439|2017-02-18 17:42:14.455439
NCT00105066|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2017-01-12|2013-04-25||January 2004||2004-01-01|January 2017|2017-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||The Effects of Metformin on Blood Vessel Structure and Function|The Effects of Metformin on Vascular Structure and Function in Subjects With the Metabolic Syndrome (MET Trial)|Completed||Phase 2|77|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 17:42:15.236359|2017-02-18 17:42:15.236359
NCT00105053|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2009-06-30|||March 2005||2005-03-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Vaccine Treatment for Hormone Refractory Prostate Cancer|A Phase I/II Study of an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 1/Phase 2|8|Actual|NewLink Genetics Corporation||1|||f||||f||||||||||2017-02-18 17:42:15.623405|2017-02-18 17:42:15.623405
NCT00105040|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2015-02-27|||September 2004||2004-09-01|February 2015|2015-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures|A 19-week, Randomized, Double-blind, Multicenter, Placebo-controlled Safety Study to Evaluate the Cognitive and Neuropsychological Effects of Levetiracetam 20 - 60 mg/kg/Day, Divided in Twice Daily Dosing, as Adjunctive Treatment in Children 4 - 16 Years Old, Inclusive, With Refractory Partial Onset Seizures|Completed||Phase 2|87|Actual|UCB Pharma||2|||f||||f||||||||||2017-02-18 17:42:15.731121|2017-02-18 17:42:15.731121
NCT00105027|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2012-07-09|2010-11-09||October 2004||2004-10-01|July 2012|2012-07-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|SCORE||The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study|The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study: Two Randomized Trials to Compare the Efficacy and Safety of Intravitreal Injection(s) of Triamcinolone Acetonide With Standard Care to Treat Macular Edema|Completed||Phase 3|682|Actual|The EMMES Corporation||6|||f||||t||||||||||2017-02-18 17:42:15.92288|2017-02-18 17:42:15.92288
NCT00105001|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2016-11-23|2015-08-13||November 2004||2004-11-01|November 2016|2016-11-01||||May 2011|Actual|2011-05-01||Interventional|||Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer|A Randomized Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor G-CSF Mobilized Peripheral Blood Mononuclear Cell (G-PBMC) Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies A Multi-Center Trial|Active, not recruiting||Phase 2|210|Actual|Fred Hutchinson Cancer Research Center||3|||f||||t||||||||||2017-02-18 17:42:18.082332|2017-02-18 17:42:18.082332
NCT00104988|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2012-08-20|||June 2005||2005-06-01|August 2012|2012-08-01|August 2009|Actual|2009-08-01|July 2007|Actual|2007-07-01||Interventional|||S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery|A Phase II Trial of Combination Thalidomide Plus Temozolomide in Patients With Metastatic Malignant Melanoma|Completed||Phase 2|64|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:42:19.013374|2017-02-18 17:42:19.013374
NCT00104975|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2016-12-13|||February 2005||2005-02-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer|Reduced Intensity Conditioning Regimen for Haplo-identical Family Donor Stem Cell Transplants for Hematologic Malignancies With Delayed Add-back of Non-alloreactive T Cells|Completed||Phase 1|20|Anticipated|Yale University|||||f||||||||||||||2017-02-18 17:42:19.460908|2017-02-18 17:42:19.460908
NCT00104962|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2014-06-10|||March 2005||2005-03-01|December 2012|2012-12-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes|Phase I Study of CC-5013 (Lenalidomide NSC# 703813) in Pediatric Patients With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:42:19.567603|2017-02-18 17:42:19.567603
NCT00104949|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2013-06-21|||July 2005||2005-07-01|December 2006|2006-12-01|August 2007|Actual|2007-08-01|||||Interventional|||Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma|Phase II Study of Trastuzumab (NSC-688097) in Treatment of Locally Advanced or Metastatic Synovial Sarcoma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:42:19.687039|2017-02-18 17:42:19.687039
NCT00104936|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2012-09-20|||December 2004||2004-12-01|September 2012|2012-09-01||||November 2006|Actual|2006-11-01||Interventional|||Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery|Observation Versus Conventional-Fractionated Radiotherapy or Radiosurgery After Non-radical Surgery for Benign Intracranial Meningiomas: A Phase III Study|Terminated||Phase 3|9|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 17:42:19.793504|2017-02-18 17:42:19.793504
NCT00104923|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2016-07-25|||February 2005||2005-02-01|February 2015|2015-02-01||||June 2017|Anticipated|2017-06-01||Interventional|||Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer|Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients With Hematologic Malignancies|Active, not recruiting||Phase 1|40|Anticipated|California Cancer Consortium||1|||f||||t||||||||||2017-02-18 17:42:19.897442|2017-02-18 17:42:19.897442
NCT00104910|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2014-12-29|||January 2005||2005-01-01|December 2014|2014-12-01||||January 2013|Actual|2013-01-01||Interventional|||Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer|A Phase I Trial of Tailored Radiation Therapy With Concomitant Cetuximab (C225, NSC #714692) and Cisplatin (NSC #119875) in the Treatment of Patients With Cervical Cancer|Completed||Phase 1|64|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:42:20.010208|2017-02-18 17:42:20.010208
NCT00104897|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2013-06-25|||March 2005||2005-03-01|March 2008|2008-03-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma|A Phase II Trial to Assess the Activity of 17-allylamino, 17-demethoxygeldanamycin (17-AAG) in Patients With Metastatic (M1, M1b & M1c) Malignant Melanoma|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:42:20.138655|2017-02-18 17:42:20.138655
NCT00104884|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2016-02-01|2015-12-15||January 2005||2005-01-01|February 2016|2016-02-01|March 2009|Actual|2009-03-01|May 2006|Actual|2006-05-01||Interventional||All enrolled patients|FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma|Phase II Trial of Depsipeptide (NSC 630176) in Advanced Malignant Melanoma|Terminated||Phase 2|4|Actual|Eastern Cooperative Oncology Group||1||The study was terminated on May 17, 2006 due to slow accrual.|f||||f||||||||No||2017-02-18 17:42:20.237808|2017-02-18 17:42:20.237808
NCT00104871|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2014-10-24|2013-11-20||December 2004||2004-12-01|June 2014|2014-06-01|April 2014|Actual|2014-04-01|May 2010|Actual|2010-05-01||Interventional|||Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy|A Phase II Study of Bortezomib in Metastatic Papillary Thyroid Carcinoma or Follicular Thyroid Carcinoma|Completed||Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 17:42:20.466482|2017-02-18 17:42:20.466482
NCT00104858|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2016-03-28|||December 2004||2004-12-01|March 2016|2016-03-01||||December 2018|Anticipated|2018-12-01||Interventional|||Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Nonmyeloablative Conditioning With Pre- and Post-Transplant Rituximab Followed by Related or Unrelated Donor Hematopoietic Cell Transplantation for Patients With Advanced Chronic Lymphocytic Leukemia: A Multi-Center Trial|Active, not recruiting||Phase 2|94|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:42:20.866642|2017-02-18 17:42:20.866642
NCT00005357|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-09|||April 1994||1994-04-01|February 2016|2016-02-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Observational|||Pulmonary Hypertension--Mechanisms and Family Registry|Pulmonary Hypertension--Mechanisms and Family Registry|Completed||N/A|||Vanderbilt University|||||f||||||||||||||2017-02-18 18:15:06.133278|2017-02-18 18:15:06.133278
NCT00104845|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2013-03-11|||September 2004||2004-09-01|March 2013|2013-03-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma|Injection of AJCC Stage IIB, IIC, III, and IV Melanoma Patients With Human and Mouse gp100 DNA: A Phase I Trial to Assess Safety and Immune Response|Completed||Phase 1|19|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:42:21.015344|2017-02-18 17:42:21.015344
NCT00104819|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2013-08-01|||September 2004||2004-09-01|August 2008|2008-08-01||||June 2011|Anticipated|2011-06-01||Interventional|||Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma|Phase II Trial of FavId™ (Patient-Specific Idiotype/KLH) and GM-CSF in Subjects Who Demonstrated Progressive Disease and Did Not Receive FavId on Study FavId-06|Terminated||Phase 2|238|Anticipated|National Cancer Institute (NCI)||1||Withdrawn as company has shut down and filed for bankruptcy|f||||||||||||||2017-02-18 17:42:21.121669|2017-02-18 17:42:21.121669
NCT00104806|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2017-01-18|||November 2004||2004-11-01|July 2012|2012-07-01|May 2010|Actual|2010-05-01|January 2006|Actual|2006-01-01||Interventional|||Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes|Phase II Trial of Arsenic Trioxide and Dose-Escalated Cholecalciferol in Myelodysplastic Syndrome|Terminated||Phase 2|5|Actual|Wake Forest University Health Sciences||1||sponsor discontinues support|f||||f||||||||||2017-02-18 17:42:21.272872|2017-02-18 17:42:21.272872
NCT00104793|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2013-05-29|||June 2003||2003-06-01|October 2007|2007-10-01|November 2008|Actual|2008-11-01|February 2007|Actual|2007-02-01||Interventional|||Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer|Phase II Study of Weekly Irinotecan and Carboplatin in Extensive-Stage Small-Cell Lung Cancer|Completed||Phase 2|55|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:42:21.370073|2017-02-18 17:42:21.370073
NCT00104780|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2013-11-05|||December 2004||2004-12-01|March 2006|2006-03-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Phase II, Open Label, Multi-center Study of EP2101 Therapeutic Vaccine in Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:42:21.474487|2017-02-18 17:42:21.474487
NCT00104767|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2015-10-01|||January 2009||2009-01-01|October 2015|2015-10-01|October 2015|Actual|2015-10-01|October 2014|Actual|2014-10-01||Interventional|||Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase I Trial to Evaluate Cyclooxygenase 2 Inhibitor-Mediated Modulation of T Regulatory Cells in Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|7|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 17:42:21.591855|2017-02-18 17:42:21.591855
NCT00104754|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2016-07-19||||||July 2016|2016-07-01||||||||Interventional|||Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer|Phase II Trial of Liposome Encapsulated SN38 (LE-SN38) in the Treatment of Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Alliance for Clinical Trials in Oncology||1|||f||||||||||||||2017-02-18 17:42:21.697947|2017-02-18 17:42:21.697947
NCT00104741|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2011-02-18|||July 2004||2004-07-01|April 2008|2008-04-01||||||||Interventional|||Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer|Multicentre Randomized Trial Assessing the Efficacy of a Short Neoadjuvant and Concomitant Hormone Therapy to an Exclusive Curative Cornformational Radiotherapy of Locolized Prostate Cancer With Intermediate Prognosis|Unknown status|Recruiting|Phase 3|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:42:21.932885|2017-02-18 17:42:21.932885
NCT00104728|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2012-10-01|2012-10-01||October 2004||2004-10-01|September 2012|2012-09-01|March 2009|Actual|2009-03-01|May 2008|Actual|2008-05-01||Interventional|||Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates|Pilot Neoadjuvant Study of ZD1839 (IRESSA®) as Single Agent Preoperative Therapy for Clinical Stage 1A and 1B (T1-2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC) With Molecular Correlates|Terminated||N/A|42|Actual|H. Lee Moffitt Cancer Center and Research Institute|Pilot study. At the time of interim analysis, the second early stopping rule was invoked for lack of activity (not enough responses to continue). Study closed to accrual 5/9/08.|1||Early Stopping Rule: Would not meet interim analysis goal to proceed with enrollment|f||||f||||||||||2017-02-18 17:42:22.059867|2017-02-18 17:42:22.059867
NCT00104715|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2010-11-06|||October 2004||2004-10-01|April 2008|2008-04-01||||||||Interventional|||Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer|Randomized Phase III Trial Comparing an Association of Hormonal Treatment and Docetaxel Versus the Hormonal Treatment Alone in Metastatic Prostate Cancers|Unknown status|Active, not recruiting|Phase 3|378|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:42:22.30383|2017-02-18 17:42:22.30383
NCT00104702|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2013-09-02|||July 2004||2004-07-01|September 2013|2013-09-01|March 2011|Actual|2011-03-01|April 2008|Actual|2008-04-01||Interventional|GERICO03||Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer|Radio-Surgical Treatment of Breast Cancer of Women Aged Over 70: Phase II Trial of Feasibility and Reproducibility of a Concentrated and Focalized Radiotherapy|Completed||Phase 2|46|Actual|UNICANCER||1|||f||||||||||||||2017-02-18 17:42:22.43797|2017-02-18 17:42:22.43797
NCT00104689|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2008-07-23|||July 2003||2003-07-01|December 2006|2006-12-01||||||||Interventional|||Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer|Phase II Trial Assessing the Impact on the Activity of Daily Living of an Oral Chemotherapy by Capecitabine Associated With an Intravenous Chemotherapy by Oxaliplatin as First Line Treatment of Metastatic Colorectal Adenocarcinoma of Patients Aged Over 70|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:42:22.555715|2017-02-18 17:42:22.555715
NCT00104676|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2009-12-13|||November 2003||2003-11-01|November 2008|2008-11-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors|A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors|Unknown status|Recruiting|Phase 3|260|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:42:22.662476|2017-02-18 17:42:22.662476
NCT00104663|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2015-04-06|||June 2004||2004-06-01|April 2015|2015-04-01|March 2007||2007-03-01|||||Interventional|||PRION-1: Quinacrine for Human Prion Disease|PRION-1: Quinacrine for Human Prion Disease. A Partially Randomized Patient Preference Trial to Evaluate the Activity and Safety of Quinacrine in Human Prion Disease|Completed||N/A|160||Medical Research Council|||||f||||||||||||||2017-02-18 17:42:22.793748|2017-02-18 17:42:22.793748
NCT00104650|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2011-01-20|2010-12-09||January 2005||2005-01-01|January 2011|2011-01-01|March 2010|Actual|2010-03-01|January 2008|Actual|2008-01-01||Interventional|||Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates|A Randomized, Open Label, Active Controlled Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous Bisphosphonates|Completed||Phase 2|111|Actual|Amgen||3|||f||||||||||||||2017-02-18 17:42:22.898622|2017-02-18 17:42:22.898622
NCT00104637|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2012-05-18|2012-04-04||February 2005||2005-02-01|May 2012|2012-05-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Sildenafil for Chronic Obstructive Pulmonary Disease|A Double-blind, Placebo-controlled, Crossover Study of Sildenafil in Patients With Chronic Obstructive Pulmonary Disease|Completed||Phase 2|10|Actual|Kawut, Steven, MD|The study had slow enrollment.|2|||f||||t||||||||||2017-02-18 17:42:27.235619|2017-02-18 17:42:27.235619
NCT00104624|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-03|2013-09-02|||May 2005||2005-05-01|September 2013|2013-09-01|July 2008|Actual|2008-07-01|July 2007|Actual|2007-07-01||Interventional|||Docetaxel in Treating Older Women With Metastatic Breast Cancer|Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy With Biweekly Docetaxel in the Treatment of Metastatic Breast Cancer in Patients Over 70|Terminated||Phase 2|53|Anticipated|UNICANCER||||Toxicity issues|f||||f||||||||||2017-02-18 17:42:30.452767|2017-02-18 17:42:30.452767
NCT00104611|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-02|2013-09-19|||January 2004||2004-01-01|September 2013|2013-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder|A Randomized, Parallel-Group, Sham-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of the Neuronetics Model 2100 CRS Repetitive Transcranial Magnetic Stimulation (rTMS) System in Patients With Major Depression|Completed||Phase 3|286|Actual|Neuronetics||2|||f||||t||||||||||2017-02-18 17:42:30.565226|2017-02-18 17:42:30.565226
NCT00104598|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2013-08-07|||September 2000||2000-09-01|August 2013|2013-08-01|December 2006|Actual|2006-12-01|September 2004|Actual|2004-09-01||Interventional|||Framing Messages for Smoking Cessation With Bupropion - 6|Framing Messages for Smoking Cessation With Buproprion|Completed||N/A|252|Actual|Yale University||2|||f||||f||||||||||2017-02-18 17:42:30.676643|2017-02-18 17:42:30.676643
NCT00104585|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2012-01-18|||July 2004||2004-07-01|January 2012|2012-01-01||||September 2012|Anticipated|2012-09-01||Observational|||Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)|Genetic Epidemiology of Parkinson's Disease|Unknown status|Recruiting|N/A|800|Anticipated|Columbia University|||1||f||||f||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 17:42:30.775174|2017-02-18 17:42:30.775174
NCT00104572|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2016-03-11|2015-05-04||March 2004||2004-03-01|March 2016|2016-03-01|January 2015|Actual|2015-01-01|December 2013|Actual|2013-12-01||Interventional|||Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.|The Effects of Aromatase Inhibition and Testosterone Replacement in Sex Steroids, Pituitary Hormones, Markers of Bone Turnover, Muscle Strength, and Cognition in Older Men|Completed||Phase 2|44|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-02-18 17:42:30.876789|2017-02-18 17:42:30.876789
NCT00104559|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2008-09-25|||January 2005||2005-01-01|September 2008|2008-09-01|March 2009|Anticipated|2009-03-01|July 2007|Anticipated|2007-07-01||Interventional|||Computer-Generated Vs. Standard Informed Consent for HIV Research Studies|Interactive Multimedia Informed Consent (iMIC) for HIV Research|Unknown status|Active, not recruiting|N/A|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:42:31.990564|2017-02-18 17:42:31.990564
NCT00104546|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2008-01-23|||September 2004||2004-09-01|January 2008|2008-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Vitamin K Injections for the Treatment of Painful Menstruation|Vitamin K Injection Treatment for Primary Dysmenorrhea: A Controlled Pilot Study|Completed||Phase 1|36||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:42:32.109161|2017-02-18 17:42:32.109161
NCT00104533|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2008-03-19|||September 2004||2004-09-01|March 2005|2005-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Effectiveness of Magnetic Therapy on Pain Intensity|Effectiveness of Magnetic Therapy on Pain Intensity|Completed||Phase 3|164||Javeriana University|||||f||||||||||||||2017-02-18 17:42:32.205871|2017-02-18 17:42:32.205871
NCT00104520|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2011-02-16|2010-09-10||February 2005||2005-02-01|September 2010|2010-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|AIR-CF2||Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa|A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial With Aztreonam Lysinate for Inhalation in Cystic Fibrosis Patients With Pulmonary P. Aeruginosa Requiring Frequent Antibiotics (AIR-CF2)|Completed||Phase 3|211|Actual|Gilead Sciences|The study was designed such that participants were discontinued from study participation upon meeting the primary endpoint (time to need for inhaled or IV antipseudomonal antibiotics).|2|||f||||t||||||||||2017-02-18 17:42:32.308516|2017-02-18 17:42:32.308516
NCT00104507|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2010-02-01|||December 2004||2004-12-01|December 2006|2006-12-01|May 2005||2005-05-01|||||Interventional|||Safety and Efficacy of APD356 in the Treatment of Obesity|A 4-Week, Dose-ranging, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of APD356 in Obese Patients|Completed||Phase 2|400||Arena Pharmaceuticals|||||||||||||||||||2017-02-18 17:42:33.232377|2017-02-18 17:42:33.232377
NCT00104494|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2015-07-29|||May 2004||2004-05-01|March 2005|2005-03-01|September 2007|Actual|2007-09-01|||||Interventional|||Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)|Zinc Homeostasis and Kinetics in Children With CF|Completed||N/A|30|Actual|Cystic Fibrosis Foundation Therapeutics||3|||f||||t||||||||||2017-02-18 17:42:33.329131|2017-02-18 17:42:33.329131
NCT00104481|ClinicalTrials.gov processed this data on February 17, 2017|2005-03-01|2011-12-07|||January 2005||2005-01-01|March 2007|2007-03-01|August 2007||2007-08-01|||||Interventional|||Group Counseling for Smoking Cessation|Cognitive Behavior Therapy for Smoking Cessation|Completed||Phase 1/Phase 2|240||American University|||||f||||||||||||||2017-02-18 17:42:33.434155|2017-02-18 17:42:33.434155
NCT00104468|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-28|2008-01-14|||April 2003||2003-04-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)|An Open-Label, Single-Arm, Multi-Center, Phase I Study of Troxatyl™ (Troxacitabine) Administered by Continuous Infusion in Subjects With Refractory Acute Myelogenous Leukemia|Terminated||Phase 1/Phase 2|50||SGX Pharmaceuticals, Inc.||||Trial stopped June 2007|||||||||||||||2017-02-18 17:42:33.52787|2017-02-18 17:42:33.52787
NCT00005349|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-06-18|||April 1991||1991-04-01|June 2013|2013-06-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|ECAC||Epidemiology of Coronary Artery Calcification||Completed||N/A|1736|Actual|University of Michigan|||1||f||||||||||||||2017-02-18 18:15:06.210237|2017-02-18 18:15:06.210237
NCT00104455|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-28|2017-01-11|||June 2004||2004-06-01|January 2017|2017-01-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Dose Response to Recombinant Factor VIIa When Administered for Bleed|Recombinant Activated Factor VII (rFVIIa/NovoSeven) Dose Response Trial in Healthy Volunteers: A Double-Blind, Placebo-Controlled, Cross-over, Dose-Escalation Trial to Investigate the Dose Response to REcombinant Factor VIIa When Administered for Bleeding Following Punch Biopsies in Healthy Volunteers|Completed||Phase 1|64|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:42:33.617303|2017-02-18 17:42:33.617303
NCT00104442|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-28|2007-12-17|||October 2003||2003-10-01|December 2007|2007-12-01|April 2006|Actual|2006-04-01|||||Interventional|||Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease|Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease|Completed||Phase 4|80||Novartis|||||||||||||||||||2017-02-18 17:42:33.707778|2017-02-18 17:42:33.707778
NCT00104429|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-28|2017-02-06|||January 2005||2005-01-01|February 2017|2017-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||GW873140 In Combination With Combivir In HIV Infected Subjects|A PhaseIIb, 96 Week, Randomised, Partially Double-blinded, Multicentre, Parallel Group, Repeat Dose Study to Evaluate the Safety, Tolerability, PK and Antiviral Effect of GW873140 in Combination With COMBIVIR (Lamivudine and Zidovudine) Upon Selected Immunological and Virological Markers of HIV-1 Infection in Antiretroviral Therapy Naive Adults|Terminated||Phase 2|125||ViiV Healthcare|||||f||||||||||||||2017-02-18 17:42:33.793608|2017-02-18 17:42:33.793608
NCT00104416|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-28|2016-11-15|2010-04-16||December 2004||2004-12-01|November 2016|2016-11-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures|A Multicenter, Double-blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Patients With Primary Generalized Tonic-Clonic Seizures|Completed||Phase 3|153|Actual|GlaxoSmithKline||2|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:42:33.965927|2017-02-18 17:42:33.965927
NCT00104403|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-28|2015-04-15|||December 2004||2004-12-01|April 2015|2015-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy|A Phase II Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Study of the Safety and Efficacy of the Oral NeuroKinin-1 Receptor Antagonist, GW679769 in Combination With Ondansetron Hydrochloride and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea|Completed||Phase 2|722|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:42:35.460982|2017-02-18 17:42:35.460982
NCT00104390|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-28|2010-06-09|||March 2005||2005-03-01|June 2010|2010-06-01|April 2005||2005-04-01|||||Interventional|||Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing|A Single-blind Phase 1 Study to Assess the Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing|Completed||Phase 1|14||Allergy Therapeutics|||||||||||||||||||2017-02-18 17:42:35.697249|2017-02-18 17:42:35.697249
NCT00104377|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-28|2010-06-16|||March 2005||2005-03-01|September 2009|2009-09-01|November 2005||2005-11-01|||||Interventional|||Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen|A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen|Completed||Phase 2|70||Allergy Therapeutics|||||||||||||||||||2017-02-18 17:42:35.785407|2017-02-18 17:42:35.785407
NCT00104364|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-25|2015-01-29|||May 2005||2005-05-01|January 2015|2015-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)|An Open-label, Dose Escalation Phase I/II Trial of a KSP Inhibitor Given as a Constant 24-Hour Infusion in Patients With Advanced Solid Tumors|Completed||Phase 1|30|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:42:35.877853|2017-02-18 17:42:35.877853
NCT00104338|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2012-06-06|||January 2005||2005-01-01|June 2012|2012-06-01|August 2006|Actual|2006-08-01|||||Interventional|||Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy|A Phase 2, Proof of Concept, Randomized, Open-label, Two-arm, Parallel Group, Multi-center Study to Assess the Efficacy and Safety of FK778 Compared With Standard Care in Renal Transplant Recipients With Untreated BK Nephropathy|Terminated||Phase 2|45||Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:42:35.955493|2017-02-18 17:42:35.955493
NCT00104325|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2017-01-24|||January 31, 2003||2003-01-31|June 23, 2016|2016-06-23||||||||Observational|||Cytapheresis of Volunteer Donors|Cytapheresis of Volunteer Donors|Recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:36.068939|2017-02-18 17:42:36.068939
NCT00104312|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2009-05-28|||April 2001||2001-04-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Osteoarthritis: Weakness From Inflammation|Weakness From Inflammation: A Basis of Disability From Knee Osteoarthritis|Completed||N/A|88|Anticipated|National Institute on Aging (NIA)|||2||f||||||||||Samples Without DNA|"~     Synovial fluid and tissue blood serum muscle biopsy~   "|||2017-02-18 17:42:36.163349|2017-02-18 17:42:36.163349
NCT00104299|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2016-04-14|2011-02-02||January 2005||2005-01-01|April 2016|2016-04-01|January 2010|Actual|2010-01-01|December 2008|Actual|2008-12-01||Interventional|RAVE||Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis|Rituximab Therapy for the Induction of Remission and Tolerance in ANCA-Associated Vasculitis (ITN021AI)|Completed||Phase 2/Phase 3|197|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:42:36.271137|2017-02-18 17:42:36.271137
NCT00104286|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2006-11-01|||January 2003||2003-01-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors|An Open-Label, Single-Arm, Phase I Study of Troxatyl™ (Troxacitabine) Administered by Continuous Infusion in Subjects With an Advanced Solid Malignancy|Terminated||Phase 1/Phase 2|50||SGX Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:42:37.620297|2017-02-18 17:42:37.620297
NCT00104273|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2009-07-14|||August 2004||2004-08-01|April 2008|2008-04-01||||March 2007|Actual|2007-03-01||Interventional|||Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)|A 1-Year, Double-Blind, Randomized, Placebo-Controlled, Study of Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Dementia of the Alzheimer's Type|Completed||Phase 2|376|Actual|Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:42:37.714337|2017-02-18 17:42:37.714337
NCT00104260|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2007-04-05|||December 2004||2004-12-01|April 2007|2007-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria|A Phase 2, Multicenter, Open-Label Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels|Completed||Phase 2|700||BioMarin Pharmaceutical|||||||||||||||||||2017-02-18 17:42:37.863227|2017-02-18 17:42:37.863227
NCT00104247|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2014-07-15|2009-01-29||March 2005||2005-03-01|July 2014|2014-07-01|February 2006|Actual|2006-02-01|||||Interventional|||Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels|Completed||Phase 3|89|Actual|BioMarin Pharmaceutical|||||||||||||||||||2017-02-18 17:42:37.964071|2017-02-18 17:42:37.964071
NCT00104234|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-24|2010-01-26|2009-02-04||February 2004||2004-02-01|January 2010|2010-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of rhASB in Patients With Mucopolysaccharidosis VI|A Multicenter, Multinational Open-Label Extension Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With Mucopolysaccharidosis VI|Completed||Phase 3|39|Actual|BioMarin Pharmaceutical||2|||||||||||||||||2017-02-18 17:42:38.383324|2017-02-18 17:42:38.383324
NCT00104195|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-23|2014-04-15|||February 2004||2004-02-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Observational|||A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions|Decision-Making Processes and Brain Function in Anxiety-Disordered and Non-Anxious Youth|Completed||Phase 1|127|Actual|New York University School of Medicine|||1||f||||f||||||||||2017-02-18 17:42:39.076719|2017-02-18 17:42:39.076719
NCT00104182|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-23|2017-01-27|||February 2005||2005-02-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes|Efficacy and Safety Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening as Add-on to Oral Antidiabetic Drug(s) in Patients With Type 2 Diabetes|Completed||Phase 3|503|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:42:39.163217|2017-02-18 17:42:39.163217
NCT00104169|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-23|2008-08-28|||August 2004||2004-08-01|August 2008|2008-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Idiopathic Anemia of Aging (IAA)|Pilot Study of Epoetin Alfa in Idiopathic Anemia of Aging (IAA)|Terminated||Phase 2|0|Actual|National Institute on Aging (NIA)||||No subject accrual|f||||||||||||||2017-02-18 17:42:39.344511|2017-02-18 17:42:39.344511
NCT00104156|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-23|2008-01-23|||January 2005||2005-01-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Qigong Therapy for Individuals With Knee Osteoarthritis|Qigong Therapy for Osteoarthritis at Knees|Completed||Phase 2|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:42:39.441676|2017-02-18 17:42:39.441676
NCT00104143|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-23|2016-08-23|||October 2007||2007-10-01|August 2016|2016-08-01||||||||Interventional|||A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis.|A Randomized, Double-blind, Placebo Controlled Dose-ranging Study to Determine the Effect on MRI Lesions and Safety of A4I Antagonist in Relapsing Multiple Sclerosis.|Withdrawn||Phase 2|0|Actual|Hoffmann-La Roche|||||f||||||||||||||2017-02-18 17:42:39.536406|2017-02-18 17:42:39.536406
NCT00104130|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-23|2008-09-16|||December 2004||2004-12-01|September 2008|2008-09-01|February 2005||2005-02-01|||||Interventional|||Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer|A Phase 2 Study of KOS-862 Administered Intravenously Weekly for 3 Weeks Every 4 Weeks, in Patients With Hormone Resistant Prostate Cancer Who Have Progressed Following Initial Therapy for Metastatic Disease|Terminated||Phase 2|53||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:42:39.923718|2017-02-18 17:42:39.923718
NCT00104117|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-23|2010-02-18|||November 2004||2004-11-01|February 2010|2010-02-01|October 2008|Actual|2008-10-01|September 2008|Actual|2008-09-01||Interventional|||Study of XL999 in Adults With Solid Tumors|A Phase 1 Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL999 Administered Intravenously to Subjects With Solid Tumors|Completed||Phase 1|52|Actual|Symphony Evolution, Inc.||1|||f||||t||||||||||2017-02-18 17:42:40.017475|2017-02-18 17:42:40.017475
NCT00104104|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-22|2011-06-27|2011-01-06||October 2004||2004-10-01|June 2011|2011-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||A Multiple Myeloma Trial in Patients With Bone Metastases|A Multicenter,Open Label, Randomized Trial Evaluating the Duration of Infusion of Zoledronic Acid 4 mg IV in Multiple Myeloma Patients With Bone Metastases|Completed||Phase 4|179|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:42:40.119066|2017-02-18 17:42:40.119066
NCT00104091|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-22|2011-05-20|||December 2004||2004-12-01|May 2011|2011-05-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors|A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection|Completed||Phase 2|56|Anticipated|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 17:42:41.226237|2017-02-18 17:42:41.226237
NCT00104078|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-22|2007-12-19|||February 2005||2005-02-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study Evaluating MYO-029 in Adult Muscular Dystrophy||Completed||Phase 1/Phase 2|108||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:42:41.317313|2017-02-18 17:42:41.317313
NCT00104065|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-22|2016-03-14|||January 2005||2005-01-01|February 2016|2016-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of CG53135-05 Administered Intravenously as a Single Dose for the Prevention of Oral Mucositis in Patients Receiving Autologous Hematopoietic Stem Cell Transplant|Completed||Phase 2|||Celldex Therapeutics|||||f||||||||||||||2017-02-18 17:42:41.426628|2017-02-18 17:42:41.426628
NCT00104052|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-22|2015-03-26|2008-11-14||February 2005||2005-02-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)|Assessment of the Safety, Efficacy, Tolerability and Pharmacokinetics of PEG-Intron® Plus REBETOL® in Pediatric Patients With Chronic Hepatitis C|Completed||Phase 3|107|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 17:42:41.520092|2017-02-18 17:42:41.520092
NCT00104039|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-19|2017-01-24|||February 17, 2005||2005-02-17|July 21, 2016|2016-07-21|July 21, 2016||2016-07-21|||||Observational|||Brain Changes in Children and Adolescents With Behavioral Problems|Investigating the Neuro-Cognitive Underpinnings of the Emotional Dysfunction Linked to Childhood Behavioral Disturbance|Completed||N/A|318|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:41.776948|2017-02-18 17:42:41.776948
NCT00104026|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-18|2017-01-24|||February 15, 2005||2005-02-15|April 19, 2011|2011-04-19|April 19, 2011||2011-04-19|||||Observational|||Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth|Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth|Completed||N/A|45|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:41.868814|2017-02-18 17:42:41.868814
NCT00104013|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-18|2008-08-20|||November 2003||2003-11-01|August 2008|2008-08-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type|Completed||Phase 3|1455|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:42:41.954814|2017-02-18 17:42:41.954814
NCT00104000|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-17|2008-03-03|||February 2005||2005-02-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Effect of Surface Electrical Stimulation on Movement of the Larynx|The Effect of Surface Electrical Stimulation on Hyo-Laryngeal Movement in Healthy Individuals at Rest and During Swallow|Completed||N/A|47||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:42.091354|2017-02-18 17:42:42.091354
NCT00103987|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-17|2017-01-24|||February 14, 2005||2005-02-14|November 12, 2010|2010-11-12|November 12, 2010||2010-11-12|||||Observational|||Neurobiological Mechanisms in Panic Disorder|Neurobiological Mechanisms in Panic Disorder: Behavioral, Genetic, & Neural Correlates of Noradrenergic Function|Completed||N/A|54|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:42:42.370358|2017-02-18 17:42:42.370358
NCT00103974|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-17|2008-04-04|||July 2004||2004-07-01|February 2008|2008-02-01|March 2007||2007-03-01|||||Interventional|||Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis|A Phase I Trial of Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis|Completed||Phase 1|30||Bayhill Therapeutics|||||||||||||||||||2017-02-18 17:42:42.454124|2017-02-18 17:42:42.454124
NCT00103961|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-17|2008-09-25|||January 2004||2004-01-01|September 2008|2008-09-01|December 2014|Anticipated|2014-12-01|October 2007|Actual|2007-10-01||Observational|||An Observational Study of People Who Have Recently Been Infected With HIV|Primary HIV & Early Disease Research: American Cohort (PHAEDRA) AIEDRP|Unknown status|Active, not recruiting|N/A|500|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood collection~   "|||2017-02-18 17:42:42.549746|2017-02-18 17:42:42.549746
NCT00103948|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-17|2015-11-02|||February 2005||2005-02-01|November 2015|2015-11-01|February 2007|Actual|2007-02-01|October 2006|Actual|2006-10-01||Interventional|||The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment|An 18-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment|Completed||Phase 2|165|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:42:42.673396|2017-02-18 17:42:42.673396
NCT00103935|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-17|2015-02-23|||February 2005||2005-02-01|January 2015|2015-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes|A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine Safety and Pharmacokinetics of Exenatide Long-Acting Release Administered Weekly in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|45|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 17:42:42.760041|2017-02-18 17:42:42.760041
NCT00103922|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-17|2016-10-26|||November 2004||2004-11-01|October 2016|2016-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)|A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|600|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:42:43.079412|2017-02-18 17:42:43.079412
NCT00103896|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-15|2016-07-06|||September 2003||2003-09-01|July 2016|2016-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Connect to Protect Partnerships for Youth Prevention Interventions: Phase II|Connect to Protect (C2P) Partnerships for Youth Prevention Interventions: Phase II|Completed||N/A|16706|Actual|Westat|||3||f||||f||||||||||2017-02-18 17:42:43.554177|2017-02-18 17:42:43.554177
NCT00103883|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-15|2016-02-29|||February 2003||2003-02-01|February 2016|2016-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||A Novel Method to Determine HIV Incidence Among Youth|A Novel Method to Determine HIV Incidence Among Youth|Completed||Phase 1/Phase 2|440|Actual|Westat|||3||f||||f||||||Samples Without DNA|"~     Phenotypic and genotypic testing for antiretroviral drug (ART) resistance will be done on~     stored samples from all subjects who are identified as recently infected by the serum based~     DV S/LS reference method. An assay for viral replication fitness will also be done on these~     same samples. This testing will provide a recent assessment of prevalence of transmitted ART~     resistant HIV-1 in this population.~   "|||2017-02-18 17:42:43.688771|2017-02-18 17:42:43.688771
NCT00103870|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-15|2009-12-08|||February 2005||2005-02-01|December 2009|2009-12-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Mind Engagement With Music for Nondrug Pain Relief|Music Engagement for Non-Pharmacological Analgesia R21 AT001586-01|Completed||Phase 1|120|Anticipated|University of Utah|||||f||||||||||||||2017-02-18 17:42:43.80181|2017-02-18 17:42:43.80181
NCT00103857|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-15|2016-02-03|2009-02-19||March 2005||2005-03-01|February 2016|2016-02-01|February 2008|Actual|2008-02-01|July 2006|Actual|2006-07-01||Interventional|||MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)|A Multicenter, Randomized, Double-Blind Factorial Study of the Co-Administration of MK0431 and Metformin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 3|1208|Actual|Merck Sharp & Dohme Corp.|Non-serious adverse experience results represent those events included in the primary safety analysis for this study (i.e., events that occurred prior to the initiation of glycemic rescue therapy).|7|||f||||f||||||||||2017-02-18 17:42:43.92564|2017-02-18 17:42:43.92564
NCT00103844|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-15|2010-08-03|2009-12-02||February 2005||2005-02-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|August 2006|Actual|2006-08-01||Interventional|||Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia|A Randomized Multi-Center Open Label Study of BMS-354825 vs. Imatinib Mesylate (Gleevec) 800 mg/d in Subjects With Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Disease That is Resistant to Imatinib at a Dose at 400 - 600 mg/d|Completed||Phase 2|150|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 17:42:46.194356|2017-02-18 17:42:46.194356
NCT00103831|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-15|2010-02-27||2010-02-27||||August 2008|2008-08-01||||May 2005|Actual|2005-05-01||Interventional|||Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer|Phase I Alimta Combination With BMS-275183 (Oral Taxane)|Completed||Phase 1/Phase 2|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 17:42:50.326164|2017-02-18 17:42:50.326164
NCT00103818|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-15|2015-01-13|||February 2005||2005-02-01|January 2015|2015-01-01|October 2006|Actual|2006-10-01|||||Interventional|||An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Efficacy Study of MK0928 15 mg and 10 mg in the Treatment of Adult Outpatients With Primary Insomnia|Completed||Phase 3|900|Actual|H. Lundbeck A/S|||||f||||||||||||||2017-02-18 17:42:50.416621|2017-02-18 17:42:50.416621
NCT00103805|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2014-05-20|||March 2003||2003-03-01|May 2014|2014-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Improved Language Acquisition With Levodopa|Improved Language Acquisition With Levodopa|Completed||Phase 4|20||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:42:50.49921|2017-02-18 17:42:50.49921
NCT00103792|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2009-02-12|||December 2004||2004-12-01|February 2009|2009-02-01|January 2012|Anticipated|2012-01-01|January 2010|Anticipated|2010-01-01||Interventional|||Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)|Comparative Study of the Efficacy of Induction Therapy With Cyclophosphamide or Mycophenolate Mofetil for Non-Life-Threatening Relapses of PR3- or MPO-ANCA Associated Vasculitis|Unknown status|Recruiting|Phase 3|90|Anticipated|University Medical Center Groningen||2|||f||||f||||||||||2017-02-18 17:42:50.6012|2017-02-18 17:42:50.6012
NCT00103779|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2014-12-17|||December 2004||2004-12-01|December 2014|2014-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma|A Phase I, Multi-Dose Study of SGN-40 (Anti-huCD40 mAb) in Patients With Non-Hodgkin's Lymphoma|Completed||Phase 1|50|Actual|Seattle Genetics, Inc.||1|||t||||f||||||||||2017-02-18 17:42:50.977086|2017-02-18 17:42:50.977086
NCT00103766|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2006-07-31|||October 2004||2004-10-01|July 2006|2006-07-01||||||||Interventional|||Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion|Randomized Comparison of Two Dose and Frequency Regimens of Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion|Unknown status|Recruiting|N/A|75||O'Brien, Jeana D., MD, FACP, FCCP|||||||||||||||||||2017-02-18 17:42:51.102194|2017-02-18 17:42:51.102194
NCT00103753|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2005-06-23|||May 2004||2004-05-01|February 2005|2005-02-01|June 2005||2005-06-01|||||Interventional|||Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major|A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance|Unknown status|Active, not recruiting|Phase 4|65||Royal Brompton & Harefield NHS Foundation Trust|||||f||||||||||||||2017-02-18 17:42:51.199492|2017-02-18 17:42:51.199492
NCT00103740|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2012-05-29|2012-04-05||April 2002||2002-04-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|December 2003|Actual|2003-12-01||Interventional|||Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period|Randomized, Double-Blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget's Disease of Bone Using Risedronate as a Comparator, Including an Extended Observation Period|Completed||Phase 3|185|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:42:51.301615|2017-02-18 17:42:51.301615
NCT00103727|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2015-04-27|||December 2004||2004-12-01|April 2015|2015-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia|A Multicenter, Double-Blind, Double-Dummy, Placebo-Controlled, Randomized, Parallel Group Evaluation of the Efficacy and Safety of a Fixed-Dose of Talnetant Versus Placebo Versus Risperidone in Subjects With Schizophrenia|Completed||Phase 2|282|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 17:42:51.877358|2017-02-18 17:42:51.877358
NCT00103714|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2015-10-19|||January 2005||2005-01-01|October 2015|2015-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Patients With Cystic Fibrosis Lung Disease|Completed||Phase 2|72|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:42:51.997085|2017-02-18 17:42:51.997085
NCT00103701|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-14|2011-04-13|||November 2003||2003-11-01|April 2011|2011-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia|Phase I Study of BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia|Completed||Phase 1|||Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 17:42:52.080155|2017-02-18 17:42:52.080155
NCT00103675|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-11|2007-02-26|||September 2004||2004-09-01|February 2007|2007-02-01|February 2007||2007-02-01|||||Interventional|||Sensor Measurement of Acupuncture Needle Manipulation|Acupuncture Needling Torque Sensor|Completed||Phase 1|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:42:52.183621|2017-02-18 17:42:52.183621
NCT00103662|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-11|2014-02-10|2009-02-02||January 2005||2005-01-01|February 2014|2014-02-01|January 2008|Actual|2008-01-01|October 2006|Actual|2006-10-01||Interventional|||Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 Plus G-CSF Versus G-CSF Plus Placebo to Mobilize and Collect ≥ 6*10^6 CD34+ Cells/kg in Multiple Myeloma Patients for Autologous Transplantation|Completed||Phase 3|302|Actual|Sanofi||2|||f||||f||||||||||2017-02-18 17:42:52.284082|2017-02-18 17:42:52.284082
NCT00103649|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-11|2008-08-20|||November 2003||2003-11-01|August 2008|2008-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type|Completed||Phase 3|1306|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:42:53.587277|2017-02-18 17:42:53.587277
NCT00103636|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-11|2005-06-23|||March 2004||2004-03-01|February 2005|2005-02-01|December 2004||2004-12-01|||||Interventional|||Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change|Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change|Unknown status|Active, not recruiting|Phase 2/Phase 3|200||Royal Brisbane and Women's Hospital|||||f||||||||||||||2017-02-18 17:42:53.797772|2017-02-18 17:42:53.797772
NCT00103623|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-11|2006-09-18|||June 2004||2004-06-01|September 2006|2006-09-01|December 2008||2008-12-01|||||Interventional|||The Plenaxis® Experience Study|Incidence of Immediate Onset Systemic Allergic Reactions in Patients Treated With Plenaxis®|Suspended||Phase 4|2000||PRAECIS Pharmaceuticals Inc.|||||||||||||||||||2017-02-18 17:42:53.894516|2017-02-18 17:42:53.894516
NCT00103610|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-11|2014-02-10|2009-02-06||January 2005||2005-01-01|February 2014|2014-02-01|December 2007|Actual|2007-12-01|July 2006|Actual|2006-07-01||Interventional|||Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 Plus G-CSF Versus G-CSF Plus Placebo to Mobilize and Collect ≥ 5 * 10^6 CD34+ Cells/kg in Non-Hodgkin's Lymphoma Patients for Autologous Transplantation|Completed||Phase 3|298|Actual|Sanofi||2|||||||||||||||||2017-02-18 17:42:54.320079|2017-02-18 17:42:54.320079
NCT00103597|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-11|2005-10-19|||January 2005||2005-01-01|July 2005|2005-07-01|September 2005||2005-09-01|||||Interventional|||Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy|Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy|Completed||Phase 1|50||Royal Brisbane and Women's Hospital|||||f||||||||||||||2017-02-18 17:42:55.352675|2017-02-18 17:42:55.352675
NCT00103584|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-10|2007-01-11|||October 2004||2004-10-01|January 2007|2007-01-01|July 2006||2006-07-01|||||Interventional|||Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers|A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LC16m8, A Modified Vaccinia Vaccine, in Healthy Volunteers|Unknown status|Active, not recruiting|Phase 1/Phase 2|150||VaxGen|||||||||||||||||||2017-02-18 17:42:55.454247|2017-02-18 17:42:55.454247
NCT00103571|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-10|2007-11-05|||July 2004||2004-07-01|November 2007|2007-11-01|August 2006|Actual|2006-08-01|||||Interventional|||Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia|Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia|Completed||Phase 4|600||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:42:55.534099|2017-02-18 17:42:55.534099
NCT00103558|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-10|2015-09-17||2015-09-17|March 2004||2004-03-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)|A Phase I/II Study of Lumiliximab in Combination With Fludarabine, Cyclophosphamide, and Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|31|Actual|Biogen|||||f||||t||||||||||2017-02-18 17:42:55.637808|2017-02-18 17:42:55.637808
NCT00103545|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-10|2006-09-29|||July 2003||2003-07-01|February 2006|2006-02-01|August 2004||2004-08-01|||||Interventional|||Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response|A Phase I/II Trial of ACA 125 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer|Completed||Phase 1/Phase 2|36||AGO Study Group|||||f||||||||||||||2017-02-18 17:42:55.737234|2017-02-18 17:42:55.737234
NCT00103532|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-09|2016-02-29|||March 2005||2005-03-01|February 2016|2016-02-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth|Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth|Completed||N/A|225|Actual|Westat||2|||f||||t||||||||No||2017-02-18 17:42:55.845642|2017-02-18 17:42:55.845642
NCT00103519|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-09|2013-03-27|||December 2004||2004-12-01|November 2006|2006-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of DITPA in Patients With Congestive Heart Failure|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DITPA in Patients With NYHA Class III and IV Congestive Heart Failure Who Have Low Serum T3 Levels|Terminated||Phase 2|86|Actual|Titan Pharmaceuticals||3||Study terminated for reasons unrelated to safety or efficacy.|f||||||||||||||2017-02-18 17:42:55.957899|2017-02-18 17:42:55.957899
NCT00103506|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-09|2015-09-28|2015-05-08||December 2004||2004-12-01|September 2015|2015-09-01|June 2014|Actual|2014-06-01|May 2014|Actual|2014-05-01||Interventional|||Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma|A Randomized Controlled Study of DOXIL/CAELYX (Doxorubicin HCL Liposome Injection) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma|Completed||Phase 3|646|Actual|Janssen Research & Development, LLC|Study stopped in terms of primary endpoint based on its results at planned interim analysis (28 Apr 2006). However, Long-term follow-up for survival continued until 16 May 2014.|2|||f||||t||||||||||2017-02-18 17:42:56.090853|2017-02-18 17:42:56.090853
NCT00103493|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-09|2010-11-19|||October 2004||2004-10-01|July 2009|2009-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Oral Health Education Program|Efficacy of a Tailored Oral Health Education Program|Completed||Phase 3|1021|Actual|Temple University|||||f||||||||||||||2017-02-18 17:42:57.696492|2017-02-18 17:42:57.696492
NCT00103467|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-08|2005-06-23|||June 2003||2003-06-01|February 2005|2005-02-01||||||||Interventional|||Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine|A Phase 1 Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine|Completed||Phase 1|100||VaxGen|||||||||||||||||||2017-02-18 17:42:57.786365|2017-02-18 17:42:57.786365
NCT00103454|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-08|2016-09-15|||January 2005||2005-01-01|September 2016|2016-09-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 4 Weeks in Adult and Adolescent Subjects (12 Years of Age and Older) With Perennial Allergic Rhinitis (PAR)|Completed||Phase 3|288|Actual|GlaxoSmithKline||1|||f||||||||||||Yes||2017-02-18 17:42:57.87479|2017-02-18 17:42:57.87479
NCT00103428|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-08|2006-01-31|||August 2004||2004-08-01|January 2006|2006-01-01||||||||Interventional|||Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer|A Phase 1/2a Dose-Escalation Trial of Intravenous CG7870 in Combination With Docetaxel in Chemotherapy-Naïve Patients With Metastatic Hormone-Refractory Prostate Cancer|Terminated||Phase 1/Phase 2|69||Cell Genesys|||||||||||||||||||2017-02-18 17:42:58.043783|2017-02-18 17:42:58.043783
NCT00005348|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1991||1991-04-01|April 2000|2000-04-01|March 1993|Actual|1993-03-01|||||Observational|||Adipose Distribution and Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.309316|2017-02-18 18:15:06.309316
NCT00103415|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-08|2006-07-12|||February 2005||2005-02-01|February 2005|2005-02-01|February 2007||2007-02-01|||||Interventional|||Trial Investigating the Effect of Different Exercise Forms on Depression|Randomized Clinical Trial Investigating the Effect of Different Exercise Forms on Depression|Unknown status|Active, not recruiting|N/A|300||Demostudiet|||||f||||||||||||||2017-02-18 17:42:58.132962|2017-02-18 17:42:58.132962
NCT00103402|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2011-04-25|||February 2005||2005-02-01|April 2011|2011-04-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome|A Randomized Multicenter Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of 10mg Alfuzosin in the Treatment of Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) in Recently-Diagnosed and/or Newly-Symptomatic Alpha-blocker Naïve Patients|Completed||Phase 3|270|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 17:42:58.228724|2017-02-18 17:42:58.228724
NCT00103389|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2016-08-30|||February 2004||2004-02-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of Docetaxel With PI-88 in Patients With Advanced Non-Small-Cell Lung Cancer|Completed||Phase 2|98|Actual|Medigen Biotechnology Corporation||2|||f||||f||||||||No||2017-02-18 17:42:58.353268|2017-02-18 17:42:58.353268
NCT00103376|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2012-04-26|||October 2004||2004-10-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer|VELCADE® (Bortezomib) for Injection Therapy for Early Relapsed Prostate Cancer|Completed||Phase 2|42|Anticipated|Medical University of South Carolina||1|||f||||t||||||||||2017-02-18 17:42:58.482027|2017-02-18 17:42:58.482027
NCT00103363|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2014-05-05|||February 1993||1993-02-01|May 2014|2014-05-01|February 1994|Actual|1994-02-01|February 1994|Actual|1994-02-01||Interventional|||Sputum Cytology in Screening Heavy Smokers For Lung Cancer|Lung Cancer Screening and Tissue Procurement|Completed||Phase 2|3270|Actual|University of Colorado, Denver|||||f||||f||||||||||2017-02-18 17:42:58.58796|2017-02-18 17:42:58.58796
NCT00103350|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2008-05-16|||January 2005||2005-01-01|May 2008|2008-05-01|January 2008|Actual|2008-01-01|December 2006|Actual|2006-12-01||Interventional|||Safety of TG100-115 for Heart Attack Treated With Angioplasty|A Phase 1-2, Multicenter, Randomized, Double-Blind, Placebo Controlled, Prospective Study to Evaluate the Safety and Potential Efficacy of Single, Increasing Doses of TG100-115 in Subjects Undergoing Percutaneous Coronary Intervention for Acute Anterior ST Elevation Myocardial Infarction|Completed||Phase 1/Phase 2|100||TargeGen|||||f||||||||||||||2017-02-18 17:42:58.685203|2017-02-18 17:42:58.685203
NCT00103337|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-02-27|||January 2005||2005-01-01|February 2013|2013-02-01||||October 2007|Actual|2007-10-01||Interventional|||Cilengitide in Treating Patients With Metastatic Prostate Cancer|Phase II Evaluation of EMD121974 (NSC 707544, Cilengitide) in Asymptomatic Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|106|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:42:58.7633|2017-02-18 17:42:58.7633
NCT00103324|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-01-16|||December 2004||2004-12-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer|Phase II Study of GW572016 (NSC-727989) as First Line Therapy in Patients With Advanced or Metastatic Gastric Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:42:58.869124|2017-02-18 17:42:58.869124
NCT00103311|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2015-02-13|2015-02-13||January 2005||2005-01-01|October 2013|2013-10-01|September 2010|Actual|2010-09-01|January 2010|Actual|2010-01-01||Interventional|||SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer|A Randomized Phase II Non-Comparative Study of SB-715992 Given Weekly or Every Three Weeks in Advanced or Metastatic Colorectal Cancer|Completed||Phase 2|64|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:42:58.981695|2017-02-18 17:42:58.981695
NCT00103298|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-06-18|||December 2004||2004-12-01|February 2006|2006-02-01|July 2006|Actual|2006-07-01|||||Interventional|||Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer|A Phase II Trial of Isolated Hepatic Perfusion (IHP) and Systemic FOLFOX4 for Subjects With Metastatic Unresectable Colorectal Cancers of the Liver With ≥ 40% Hepatic Tumor Burden|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:42:59.520026|2017-02-18 17:42:59.520026
NCT00103285|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2016-05-26|||April 2005||2005-04-01|May 2016|2016-05-01||||December 2013|Actual|2013-12-01||Interventional|||Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL)|Active, not recruiting||Phase 3|5377|Actual|Children's Oncology Group||8|||f||||t||||||||||2017-02-18 17:42:59.884108|2017-02-18 17:42:59.884108
NCT00103272|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-06-03|||April 2005||2005-04-01|June 2013|2013-06-01||||April 2008|Actual|2008-04-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer|A Phase I Study of PS-341 (Velcade, Bortezomib) in Combination With 17-allylamino-17-demethoxygeldanamycin (17-AAG) in Patients With Relapsed or Refractory Hematologic Malignancies|Terminated||Phase 1|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:00.320749|2017-02-18 17:43:00.320749
NCT00103259|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2014-05-07|2012-11-24||July 2005||2005-07-01|December 2012|2012-12-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Phase II Two Arm Trial of the Proteasome Inhibitor, PS-341 (Velcade TM) in Combination With Irinotecan or PS-341 Alone Followed by the Addition of Irinotecan at Time of Progression in Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|71|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:43:00.456966|2017-02-18 17:43:00.456966
NCT00103246|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2011-01-19|||September 2004||2004-09-01|January 2011|2011-01-01|August 2010|Actual|2010-08-01|December 2008|Actual|2008-12-01||Interventional|||Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides|Phase I Clinical Trial Using Topical Silicon Phthalocyanine (Pc 4) Photodynamic Therapy (PDT) for the Treatment of Pre-Malignant and Malignant Skin Conditions|Completed||Phase 1|43|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:43:01.153848|2017-02-18 17:43:01.153848
NCT00005347|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||February 1992||1992-02-01|May 2000|2000-05-01|January 1997|Actual|1997-01-01|||||Observational|||Framingham Cycle V Offspring-Spouse Nutrition Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.378191|2017-02-18 18:15:06.378191
NCT00103233|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-06-21|||December 2004||2004-12-01|August 2005|2005-08-01|April 2006|Actual|2006-04-01|||||Interventional|||Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer|A Randomized Study of Weekly Vinorelbine (Navelbine®) Alone or in Combination With Trastuzumab (Herceptin®) (NSC-688097) for Patients With HER-2-Positive Metastatic Breast Cancer Whose Tumors Have Progressed After Taxane + Trastuzumab Combination Therapy - Phase III|Completed||Phase 3|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:43:01.263219|2017-02-18 17:43:01.263219
NCT00103220|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-12-10|||November 2004||2004-11-01|December 2013|2013-12-01||||February 2007|Actual|2007-02-01||Interventional|||SJG-136 in Treating Patients With Advanced Solid Tumors|A Phase I Study With SJG-136 (NSC #694501) in Patients With an Advanced Solid Tumor|Completed||Phase 1|36|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:01.3552|2017-02-18 17:43:01.3552
NCT00103207|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2012-12-03|2012-12-03||August 2005||2005-08-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|April 2010|Actual|2010-04-01||Interventional|||Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer|Phase II Study of C225 (Cetuximab) for the Treatment of Patients With Advanced Bronchioalveolar Carcinoma (BAC) or Adenocarcinoma With BAC Features|Completed||Phase 2|72|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 17:43:01.480098|2017-02-18 17:43:01.480098
NCT00103194|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2014-09-19|2011-11-03||September 2005||2005-09-01|June 2014|2014-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer|Phase II Trial of GW572016 in Patients With Recurrent Prostate Cancer as Evident by a Rising PSA|Completed||Phase 2|49|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:43:02.074148|2017-02-18 17:43:02.074148
NCT00103181|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2015-10-08|||March 2005||2005-03-01|October 2015|2015-10-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer|A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women With Stage 0, I, or II Breast Cancer|Active, not recruiting||Phase 3|4216|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 17:43:05.290119|2017-02-18 17:43:05.290119
NCT00103168|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-10-28|||December 2004||2004-12-01|October 2013|2013-10-01||||October 2008|Actual|2008-10-01||Interventional|||Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor|Intermediate and High Risk Localized, Completely Resected, Gastrointestinal Stromal Tumors (GIST) Expressing KIT Receptor: A Controlled Randomized Trial on Adjuvant Imatinib Mesylate (Glivec) Versus No Further Therapy After Complete Surgery|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:43:06.05033|2017-02-18 17:43:06.05033
NCT00103155|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-09-19|||September 2004||2004-09-01|August 2005|2005-08-01||||||||Interventional|||Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer|Radiofrequency Ablation for Low Risk Papillary Thyroid Cancer: A Pilot Study|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:43:06.48952|2017-02-18 17:43:06.48952
NCT00103142|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2015-10-11|2014-01-16||February 2005||2005-02-01|October 2015|2015-10-01|March 2013|Actual|2013-03-01|June 2009|Actual|2009-06-01||Interventional||37 PANVAC-V + PANVAC-F + DC arm patients and 37 PANVAC-V + PANVAC-F + GM-CSF arm. One participant in PANVAC-V + PANVAC-F + DC Arm was consented and contributed baseline data, but was not considered to have started or enrolled in the study patients signed consent.|Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer|A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma|Completed||Phase 2|74|Actual|Duke University||2|||f||||t||||||||||2017-02-18 17:43:06.589266|2017-02-18 17:43:06.589266
NCT00103116|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2013-02-21|||October 2004||2004-10-01|February 2013|2013-02-01||||April 2008|Actual|2008-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer|Autologous Dendritic Cell Vaccines in Non-small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|University of Kentucky||1|||f||||||||||||||2017-02-18 17:43:07.157754|2017-02-18 17:43:07.157754
NCT00103103|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2010-10-11|||March 2005||2005-03-01|October 2010|2010-10-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer|A Phase II Combination Trial of PS-341 and 5-FU/LV in Gastric and/or GE Junction Adenocarcinoma|Terminated||Phase 2|||California Cancer Consortium|||||f||||||||||||||2017-02-18 17:43:07.267713|2017-02-18 17:43:07.267713
NCT00103090|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2012-11-12|||January 2005||2005-01-01|November 2012|2012-11-01|November 2006|Actual|2006-11-01|January 2006|Actual|2006-01-01||Interventional|||Fenretinide and Lonafarnib in Treating Patients With Advanced or Recurrent Head and Neck Cancer|A Phase IB Randomized Translational Study of Fenretinide (4-HPR) in Combination With SCH66336, a Farnesyl Transferase Inhibitor, in Patients With Advanced or Recurrent Head and Neck Cancer|Terminated||Phase 1|1|Actual|M.D. Anderson Cancer Center||1||Slow Accrual.|f||||f||||||||||2017-02-18 17:43:07.374676|2017-02-18 17:43:07.374676
NCT00103051|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2012-07-13|||December 2004||2004-12-01|July 2012|2012-07-01||||November 2005|Actual|2005-11-01||Interventional|||Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer|Phase II Study With Gefitinib (Sequentially) Following Gemcitabine/Cisplatin as Induction Regimen for Patients With Stage IIIA N2 NSCLC|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:43:07.503107|2017-02-18 17:43:07.503107
NCT00103038|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-07|2017-02-07|||February 2004||2004-02-01|February 2017|2017-02-01|April 2020|Anticipated|2020-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases|NCI-Sponsored Multi-Disciplinary Study for MR Imaging of Intravenous Superparamagnetic Crystalline Particle Ferumoxytol in Primary High-Grade Brain Tumors and/or Cerebral Metastases|Active, not recruiting||N/A|155|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 17:43:07.598594|2017-02-18 17:43:07.598594
NCT00103025|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-05|2017-01-24|||February 4, 2005||2005-02-04|May 10, 2011|2011-05-10|May 10, 2011|Actual|2011-05-10|May 10, 2011|Actual|2011-05-10||Interventional|||Nitrite Infusion in Healthy Volunteers|Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Long-Term Intravenous Nitrite Infusion in Healthy Volunteers|Completed||Phase 1|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:43:07.732017|2017-02-18 17:43:07.732017
NCT00103012|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-05|2012-03-13|2011-12-12||January 2005||2005-01-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|January 2011|Actual|2011-01-01||Interventional|||Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers|The Influence of Concurrent Administration of Echinacea Purpurea, Ginkgo Biloba, or Panax Ginseng on the Steady State Pharmacokinetic Profile of Lopinavir/Ritonavir in Healthy Volunteers|Completed||Phase 4|47|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-02-18 17:43:07.823815|2017-02-18 17:43:07.823815
NCT00102999|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-04|2017-01-24|||January 31, 2005||2005-01-31|January 22, 2009|2009-01-22|January 22, 2009||2009-01-22|||||Observational|||Brain Function in Focal Dystonia|Impaired Motor Learning and LTP/LTD-like Plasticity in Dystonia, Are Associated With Abnormal Modulation of Cortical Excitability by Somatosensory Volleys|Completed||N/A|118||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:08.332229|2017-02-18 17:43:08.332229
NCT00102986|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-04|2015-12-02|||October 2005||2005-10-01|December 2015|2015-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women|Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women|Completed||N/A|116|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:43:08.412552|2017-02-18 17:43:08.412552
NCT00102973|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-04|2012-05-30|||December 2004||2004-12-01|June 2006|2006-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer|Phase III Randomized Study of TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Liposomal Doxorubicin (Doxil) as Second-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-3]|Completed||Phase 3|244|Actual|Telik||2|||f||||||||||||||2017-02-18 17:43:08.62507|2017-02-18 17:43:08.62507
NCT00102960|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-04|2014-07-21|||July 2005||2005-07-01|July 2014|2014-07-01|January 2013|Actual|2013-01-01|September 2012|Actual|2012-09-01||Interventional|||Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth|A Phase III, Randomized, Open-Label Trial to Evaluate Strategies for Providing Antiretroviral Therapy to Infants Shortly After Primary Infection in a Resource Poor Setting|Completed||Phase 3|451|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:43:09.121961|2017-02-18 17:43:09.121961
NCT00102947|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-04|2016-07-22|||January 2005||2005-01-01|July 2016|2016-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections|An Open Label Phase 4 Trial to Further Evaluate the Pharmacokinetic Profile of Intravenous Daptomycin, and a Comparison of the Safety and Efficacy of Daptomycin Versus Comparator in the Treatment of Adult Patients With Renal Impairment and Complicated Skin and Skin Structure Infections Due, at Least in Part, to Gram-positive Bacteria|Terminated||Phase 4|72||Cubist Pharmaceuticals LLC|||||||||||||||||||2017-02-18 17:43:09.267203|2017-02-18 17:43:09.267203
NCT00102934|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-04|2008-09-16|||March 2003||2003-03-01|September 2008|2008-09-01|March 2009|Anticipated|2009-03-01|December 2005|Actual|2005-12-01||Interventional|||Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus|Treatment Intensification in HIV-1 Patients With Multi-Drug Resistant Virus|Unknown status|Active, not recruiting|N/A|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:43:09.367245|2017-02-18 17:43:09.367245
NCT00102921|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-04|2006-03-12|||August 2004||2004-08-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Interventional|||Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn’s Disease|Pilot, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety Clinical Activity of CCX282-B in Patients With Moderate to Severe Crohn’s Disease|Completed||Phase 2|70||ChemoCentryx|||||||||||||||||||2017-02-18 17:43:09.489262|2017-02-18 17:43:09.489262
NCT00102908|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-04|2008-09-25|||May 2005||2005-05-01|September 2008|2008-09-01|December 2009|Anticipated|2009-12-01|October 2007|Anticipated|2007-10-01||Interventional|||Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density|Bisphosphonate Therapy for HIV-Associated Osteopenia|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:43:09.607666|2017-02-18 17:43:09.607666
NCT00102895|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-03|2010-08-26|||April 2005||2005-04-01|August 2010|2010-08-01|September 2005|Actual|2005-09-01|||||Interventional|||A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer|An Open-Label, Multi-Center, Phase 2 Study Of Cp 724,714 In Patients With Her2 Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy For Metastatic Disease And Is Previously Untreated With A Her2 Inhibitor|Terminated||Phase 2|25||Pfizer||||See Detailed Description|f||||||||||||||2017-02-18 17:43:09.722257|2017-02-18 17:43:09.722257
NCT00102882|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-03|2017-02-02|||October 2004||2004-10-01|February 2017|2017-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate|Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone|Completed||Phase 4|547|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:43:09.818976|2017-02-18 17:43:09.818976
NCT00102869|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-03|2013-10-04|||January 2005||2005-01-01|June 2008|2008-06-01|December 2008|Actual|2008-12-01|February 2007|Actual|2007-02-01||Interventional|||Dopaminergic Enhancement of Learning and Memory in Aphasia|Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Aphasia)|Completed||Phase 4|12|Actual|University Hospital Muenster||1|||f||||t||||||||||2017-02-18 17:43:10.104014|2017-02-18 17:43:10.104014
NCT00102856|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-03|2010-06-23|||January 2005||2005-01-01|September 2006|2006-09-01|June 2006||2006-06-01|||||Interventional|||Neuromodulation and Language Acquisition (Stage Ib)|Neuromodulation and Language Acquisition (KS-Neuromod_01, Stage Ib)|Suspended||Phase 4|60||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:43:10.208441|2017-02-18 17:43:10.208441
NCT00102843|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-03|2005-08-02|||October 2002||2002-10-01|August 2005|2005-08-01|June 2003||2003-06-01|||||Interventional|||Effect of Betaine and Folic Acid on Vascular Function in Healthy Humans|Effect of Lowering of Fasting Plasma Homocysteine Concentrations Through Supplementation With Betaine or Folic Acid on Vascular Function in Healthy Volunteers|Completed||N/A|40||Wageningen Centre for Food Sciences|||||f||||||||||||||2017-02-18 17:43:10.497236|2017-02-18 17:43:10.497236
NCT00102830|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-03|2010-08-19||||||August 2010|2010-08-01||||||||Interventional|||Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors|A Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of AMG 386 in Adult Patients With Advanced Solid Tumors|Completed||Phase 1|||Amgen||1|||||||||||||||||2017-02-18 17:43:10.603471|2017-02-18 17:43:10.603471
NCT00102817|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2017-01-17|||May 2003||2003-05-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children|Somatropin (Norditropin) in Children With Growth Failure Associated With ICF Deficiency.|Completed||Phase 3|149|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:43:10.711496|2017-02-18 17:43:10.711496
NCT00102804|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2014-12-17|2014-12-17||March 2005||2005-03-01|December 2014|2014-12-01|December 2013|Actual|2013-12-01|August 2007|Actual|2007-08-01||Interventional||Participants who signed the ICF and completed the randomized process are reported according to the treatment arm to which they were randomized.|Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)|A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment for Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|663|Actual|Eli Lilly and Company|Four participants (pts) assigned to placebo received pemetrexed; pts analyzed for efficacy as randomized. Three treated pts did not sign ICF, 1 treated pt signed ICF but did not complete entire randomization process; pts excluded from all analyses.|2|||f||||t||||||||||2017-02-18 17:43:10.861859|2017-02-18 17:43:10.861859
NCT00102791|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2008-03-26|||February 2005||2005-02-01|September 2007|2007-09-01|June 2007|Actual|2007-06-01|||||Interventional|ASSERT||A Stratified Sickle Event Randomized Trial (ASSERT)|A Phase III Multicenter, 52-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Clinical Efficacy and Safety of ICA-17043 With or Without HU Therapy in Patients With Sickle Cell Disease Who Have Had =>2 Acute Sickle-Related Painful Crises Within the Preceding 12 Months|Terminated||Phase 3|297|Actual|Icagen||2||Because of the low probability of achieving the primary endpoint.|f||||t||||||||||2017-02-18 17:43:12.821072|2017-02-18 17:43:12.821072
NCT00102778|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2017-01-13|||December 2004||2004-12-01|January 2017|2017-01-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||GW873140 In Combination With Kaletra In HIV Infected Subjects|A Phase IIb, 96 Week, Randomized, Open-label Multicenter, Parallel Group, Repeat Dose Study to Evaluate the Safety, Tolerability, PK and Antiviral Effect of Different Doses and Regimens of GW873140 in Combination With Kaletra (Lopinavir and Ritonavir) in HIV-1 Infected Antiretroviral Therapy naïve Subjects|Terminated||Phase 2|175||ViiV Healthcare|||||||||||||||||||2017-02-18 17:43:13.14751|2017-02-18 17:43:13.14751
NCT00102765|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2017-01-16|||November 2004||2004-11-01|January 2017|2017-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study Of Asthma In Patients Of African Descent|A Multicenter, Randomized, Double-Blind, Parallel Group, 52-Week Comparison of Asthma Control and Measures of Airway Inflammation in Subjects of African Descent Receiving Fluticasone Propionate/Salmeterol 100/50mcg DISKUS® BID or Fluticasone Propionate 100mcg DISKUS® BID Alone|Completed||Phase 4|479|Actual|GlaxoSmithKline|||||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:43:13.352076|2017-02-18 17:43:13.352076
NCT00102752|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2009-04-28|||December 2004||2004-12-01|April 2009|2009-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer|A Phase 1/2 Dose-Escalation Study of the Safety, Efficacy and Pharmacokinetics of Glufosfamide in Combination With Gemcitabine in Advanced Solid Tumors and Pancreatic Adenocarcinoma|Completed||Phase 1/Phase 2|47||Threshold Pharmaceuticals|||||||||||||||||||2017-02-18 17:43:13.528768|2017-02-18 17:43:13.528768
NCT00102739|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2013-04-11|||February 2005||2005-02-01|November 2012|2012-11-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)|See Detailed Description|Completed||Phase 2|99|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:43:13.64261|2017-02-18 17:43:13.64261
NCT00102726|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2015-04-16|||February 2005||2005-02-01|March 2012|2012-03-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel Group, Dose Ranging Study to Assess the Efficacy, Safety, and Pharmacokinetics of an Oral Thrombopoietin Receptor Agonist(SB497115-GR) Administered at 50, 75, and 100 mg to Cancer Patients Receiving Multiple Cycles of Chemotherapy|Completed||Phase 2|183|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 17:43:13.79944|2017-02-18 17:43:13.79944
NCT00102713|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2007-05-17|||February 2005||2005-02-01|May 2007|2007-05-01||||||||Interventional|||A Study for Treatment of Partial Seizures in Children|An Open Label Study for Treatment of Partial Seizures in Children|Completed||Phase 3|50||Abbott|||||||||||||||||||2017-02-18 17:43:14.033499|2017-02-18 17:43:14.033499
NCT00102700|ClinicalTrials.gov processed this data on February 17, 2017|2005-02-01|2009-04-28|||January 2005||2005-01-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer|A Phase II Study of ARQ 501 in Combination With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|66||ArQule|||||||||||||||||||2017-02-18 17:43:14.14048|2017-02-18 17:43:14.14048
NCT00102687|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-31|2010-06-22|2010-05-03||January 2005||2005-01-01|June 2010|2010-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes|A Multicenter, Randomized, Open-Label Study Comparing Three Alternative Dosing Regimens of Subcutaneous Azacitidine Plus Best Supportive Care for the Treatment of Myelodysplastic Syndromes|Completed||Phase 2|151|Actual|Celgene||5|||f||||f||||||||||2017-02-18 17:43:14.418592|2017-02-18 17:43:14.418592
NCT00102674|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-31|2011-08-15|||March 2005||2005-03-01|March 2005|2005-03-01|May 2005||2005-05-01|||||Interventional|||Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor|The Pharmacokinetics and Pharmacodynamics of a Cangrelor Bolus Plus Infusion in Healthy Volunteers|Completed||Phase 1|40||The Medicines Company|||||||||||||||||||2017-02-18 17:43:17.139449|2017-02-18 17:43:17.139449
NCT00102661|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-31|2012-07-27|||October 2002||2002-10-01|July 2012|2012-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia|Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|10|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:43:17.226512|2017-02-18 17:43:17.226512
NCT00102648|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-31|2016-06-07|||December 2004||2004-12-01|June 2016|2016-06-01||||December 2017|Anticipated|2017-12-01||Interventional|||Sarasar and Temodar for Glioblastoma Multiforme Patients|Phase I/Ib Study of Sarasar and Temodar in Patients With Recurrent or Temodar-Refractory Glioblastoma Multiforme|Active, not recruiting||Phase 1|35|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:43:17.333117|2017-02-18 17:43:17.333117
NCT00102635|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-31|2012-07-27|||January 2005||2005-01-01|July 2012|2012-07-01|November 2006|Actual|2006-11-01|January 2006|Actual|2006-01-01||Interventional|||4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)|A Phase IB Randomized Translational Study of Fenretinide (4-HPR) in Combination With SCH66336, a Farnesyl Transferase Inhibitor, in Patients With Advanced or Recurrent Head and Neck Cancer|Terminated||Phase 1|1|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-02-18 17:43:17.443592|2017-02-18 17:43:17.443592
NCT00102622|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-31|2014-06-04|||December 2004||2004-12-01|August 2012|2012-08-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer|Phase I of Phase I/II Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer|Terminated||Phase 1|18|Actual|M.D. Anderson Cancer Center||2||Phase I/II study that did not progress to Phase II due to low accrual.|f||||t||||||||||2017-02-18 17:43:17.555011|2017-02-18 17:43:17.555011
NCT00102609|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-31|2013-01-09|||April 2005||2005-04-01|January 2013|2013-01-01|October 2007|Actual|2007-10-01|||||Interventional|||A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma|A Phase I Study to Determine the Dose of the Combination of Yondelis and Doxorubicin for Which Neutropenia is Manageable With the Support of Granulocyte-Colony Stimulation Factor in Subjects With Recurrent or Persistent Soft Tissue Sarcoma|Completed||Phase 1|41|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 17:43:17.668819|2017-02-18 17:43:17.668819
NCT00102596|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-30|2012-01-31|2010-11-10||January 2005||2005-01-01|January 2012|2012-01-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor|Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor|Completed||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)|Enrollment to study was ended early, as evidence became available, that a metabolite of the study substance promised significantly higher feasibility for treatment in ET.|1|||f||||f||||||||||2017-02-18 17:43:17.778643|2017-02-18 17:43:17.778643
NCT00102583|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2017-01-24|||October 14, 2004||2004-10-14|March 15, 2011|2011-03-15|March 15, 2011|Actual|2011-03-15|March 15, 2011|Actual|2011-03-15||Interventional|||Cyclosporine Implant for Ocular Graft-Versus-Host Disease|A Phase I Clinical Trial to Study the Safety of a Sustained-Release Subconjunctival Cyclosporine Implant for Ocular Graft-vs-Host Disease (GVHD1)|Completed||Phase 1|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:43:18.291773|2017-02-18 17:43:18.291773
NCT00102570|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2017-01-24|||January 26, 2005||2005-01-26|August 10, 2010|2010-08-10|August 10, 2010||2010-08-10|||||Observational|||Clinical and Immunological Evaluation of Children With Allergies|Clinical and Immunological Evaluation of Children With Allergic Disease|Completed||N/A|270|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:18.400223|2017-02-18 17:43:18.400223
NCT00102557|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2008-03-03|||January 2005||2005-01-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus|Hydroxychloroquine Versus Clobetasol 0.05% Rinse for the Treatment of Oral Lichen Planus|Completed||Phase 2|74||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:18.482262|2017-02-18 17:43:18.482262
NCT00102544|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2017-01-24|||January 26, 2005||2005-01-26|December 27, 2016|2016-12-27||||||||Observational|||Use of Tracking Devices to Locate Abnormalities During Invasive Procedures|Electromagnetic Tracking of Devices During Interventional Procedures|Recruiting||N/A|3215|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:18.570009|2017-02-18 17:43:18.570009
NCT00102531|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2010-07-07|||January 2005||2005-01-01|July 2010|2010-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung|Phase Ib/IIa Study of SLIT Cisplatin by Inhalation in the Treatment of Patients Wtih Relapsed/Progressive Osteosarcoma Metastatic to the Lung|Completed||Phase 1/Phase 2|21|Anticipated|Insmed Incorporated|||||f||||||||||||||2017-02-18 17:43:18.676217|2017-02-18 17:43:18.676217
NCT00102518|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2012-07-31|2012-05-16||September 2004||2004-09-01|July 2012|2012-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|APEX 241||Aripiprazole Open-Label, Safety and Tolerability Study|A Multi-Center, Open-Label, Safety and Tolerability Study of Flexible-Dose Oral Aripiprazole (2 Mg-30 mg) in the Treatment of Adolescent Patients With Schizophrenia and Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features|Completed||Phase 3|325|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-02-18 17:43:18.773335|2017-02-18 17:43:18.773335
NCT00102505|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2009-04-02|||November 2004||2004-11-01|April 2009|2009-04-01||||||||Interventional|||A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)|Phase I Trial of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|36||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:43:19.329618|2017-02-18 17:43:19.329618
NCT00102492|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2015-04-14|||October 2004||2004-10-01|April 2015|2015-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Study Of GW679769 In Major Depressive Disorder|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Evaluating the Efficacy and Safety of GW679769 in Subjects With Major Depressive Disorder.|Completed||Phase 2|356|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:43:19.414067|2017-02-18 17:43:19.414067
NCT00101816|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-13|2010-08-03|2009-12-15||December 2004||2004-12-01|June 2010|2010-06-01|March 2008|Actual|2008-03-01|August 2006|Actual|2006-08-01||Interventional|||Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate|A Phase II Study of BMS-354825 in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate|Completed||Phase 2|124|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 17:43:19.562837|2017-02-18 17:43:19.562837
NCT00005346|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||January 1993||1993-01-01|November 2001|2001-11-01|December 1995|Actual|1995-12-01|||||Observational|||Mechanisms Underlying Abnormal Ambulatory BP Patterns||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.445675|2017-02-18 18:15:06.445675
NCT00101803|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-13|2012-05-04|||January 2005||2005-01-01|May 2012|2012-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|527|Actual|Novartis|||||f||||||||||||||2017-02-18 17:43:21.702797|2017-02-18 17:43:21.702797
NCT00101790|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-13|2010-01-06|||September 2003||2003-09-01|January 2010|2010-01-01|June 2010|Anticipated|2010-06-01|June 2010|Anticipated|2010-06-01||Interventional|||A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain|A Pilot Trial of IV Pamidronate for Low Back Pain|Unknown status|Active, not recruiting|Phase 1|44|Anticipated|Icahn School of Medicine at Mount Sinai||1|||f||||t||||||||||2017-02-18 17:43:21.790783|2017-02-18 17:43:21.790783
NCT00101777|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2008-03-03|||December 2001||2001-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Ventilatory Physiology in Children at Risk for Anxiety|Ventilatory Physiology in Children at Risk for Anxiety|Completed||N/A|479||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:21.894502|2017-02-18 17:43:21.894502
NCT00101764|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2017-01-24|||January 5, 2005||2005-01-05|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Interventional|||Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders|Phase I Study of Intravitreal Injections Versus Anterior Sub-Tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:21.978192|2017-02-18 17:43:21.978192
NCT00101751|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2014-10-16|||October 2004||2004-10-01|October 2014|2014-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|INITIATE plus||INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study|Efficacy and Safety of a Standard Titration Algorithm Coupled With a Conventional Dietary Intervention or Intensive Dietary Intervention Versus a Standard Titration Algorithm, Alone, in Patients With Type 2 Diabetes Initiating NovoLog® Mix 70/30 Therapy|Completed||Phase 4|4877|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:43:22.068797|2017-02-18 17:43:22.068797
NCT00101738|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2011-01-28|||March 2003||2003-03-01|January 2011|2011-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Freedom Study: Myfortic in Kidney Transplant Patients|Study to Investigate the Clinical Outcomes of Different Regimens of Myfortic® in De Novo Kidney Tx Pts Using Simulect® and Neoral® With or Without Steroids|Completed||Phase 3|342|Actual|Novartis|||||||||||||||||||2017-02-18 17:43:22.171193|2017-02-18 17:43:22.171193
NCT00101725|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2010-11-19|||December 2004||2004-12-01|November 2010|2010-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome|A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRN 002 (Crofelemer) for the Symptomatic Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)|Completed||Phase 2|245|Actual|Valeant Pharmaceuticals International, Inc.||4|||f||||f||||||||||2017-02-18 17:43:22.309722|2017-02-18 17:43:22.309722
NCT00101712|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2012-05-04|||October 2004||2004-10-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia|Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia|Completed||Phase 3|274|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:43:22.432392|2017-02-18 17:43:22.432392
NCT00101699|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2006-08-17|||November 2001||2001-11-01|January 2005|2005-01-01|August 2003||2003-08-01|||||Observational|||Effects of Soy Consumption on Symptoms of Menopause|Influence of Soy Consumption on Menopause|Completed||N/A|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:43:22.531647|2017-02-18 17:43:22.531647
NCT00101686|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2010-01-04|2009-10-20||February 2003||2003-02-01|January 2010|2010-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.|A Randomized, Multi-Center Phase III Trial Of Irinotecan In Combination With Three Different Methods Of Administration Of Fluoropyrimidine: Infusional 5-FU (FOLFIRI), Modified-Bolus 5-FU (Day 1 & 8), And Oral Capecitabine (Day 1-14); With Celecoxib Versus Placebo As First-Line Treatment For Patients With Metastatic Colorectal Cancer Study Amended April 23, 2004 To Include Bevacizumab|Completed||Phase 3|547|Actual|Pfizer||5|||f||||t||||||||||2017-02-18 17:43:22.747223|2017-02-18 17:43:22.747223
NCT00101673|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2012-05-04|||March 2004||2004-03-01|May 2012|2012-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%|Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%|Completed||Phase 3|251|Actual|Novartis|||||f||||||||||||||2017-02-18 17:43:25.239773|2017-02-18 17:43:25.239773
NCT00101660|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2012-02-29|2009-12-22||February 2005||2005-02-01|February 2012|2012-02-01|April 2008|Actual|2008-04-01|September 2006|Actual|2006-09-01||Interventional|||Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib|A Phase II Study to Determine the Activity of BMS-354825 in Subjects With Chronic Phase Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Disease That is Resistant to High Dose Imatinib Mesylate (Gleevec) or Who Are Intolerant of Imatinib|Completed||Phase 2|387|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 17:43:25.459391|2017-02-18 17:43:25.459391
NCT00101647|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2011-04-13|2009-12-22||December 2004||2004-12-01|April 2011|2011-04-01|March 2008|Actual|2008-03-01|August 2006|Actual|2006-08-01||Interventional|||Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia|A Phase II Study of BMS-354825 in Subjects With Accelerated Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate|Completed||Phase 2|197|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 17:43:27.133207|2017-02-18 17:43:27.133207
NCT00101634|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2011-06-06|||December 2004||2004-12-01|January 2011|2011-01-01|March 2006|Actual|2006-03-01|||||Interventional|||Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia|A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mg eq, 50 mg eq, and 100 mg eq) of Paliperidone Palmitate in Patients With Schizophrenia|Completed||Phase 3|518|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:43:29.13655|2017-02-18 17:43:29.13655
NCT00102375|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2006-08-03|||December 1999||1999-12-01|February 2006|2006-02-01|October 2004||2004-10-01|||||Interventional|||Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer|Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan|Completed||Phase 3|900||AGO Study Group|||||f||||||||||||||2017-02-18 17:43:33.692509|2017-02-18 17:43:33.692509
NCT00101621|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2006-02-08|||August 2004||2004-08-01|February 2006|2006-02-01|August 2005||2005-08-01|||||Interventional|||Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain|A Randomized, Double-Blind, Placebo Controlled, Multi-Center, Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent in a Cancer Pain Model|Terminated||Phase 2|24||MetaPhore Pharmaceuticals|||||||||||||||||||2017-02-18 17:43:29.231494|2017-02-18 17:43:29.231494
NCT00101608|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2010-02-27||2010-02-27|January 2005||2005-01-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium|A Phase II Study of Intravenous (IV) Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium|Completed||Phase 2|150|Anticipated|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 17:43:29.315608|2017-02-18 17:43:29.315608
NCT00101595|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2011-04-07||2010-02-04|January 2005||2005-01-01|April 2011|2011-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|A Phase II Study of BMS-354825 in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate|Completed||Phase 2|96|Actual|Bristol-Myers Squibb||1|||f||||f||||||||||2017-02-18 17:43:29.705135|2017-02-18 17:43:29.705135
NCT00101582|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2016-08-19|2014-01-03||August 2005||2005-08-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|September 2007|Actual|2007-09-01||Interventional|||Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer|Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (rHuKGF) for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Receiving Radiotherapy With Concurrent Chemotherapy (RT/CT)|Completed||Phase 3|188|Actual|Swedish Orphan Biovitrum||2|||f||||t||||||||||2017-02-18 17:43:29.90486|2017-02-18 17:43:29.90486
NCT00101569|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-12|2013-11-07|||March 2004||2004-03-01|July 2008|2008-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Aripiprazole Oral Acceptability Trial|Aripiprazole Oral Acceptability Trial|Completed||Phase 3|59||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 17:43:30.97326|2017-02-18 17:43:30.97326
NCT00101543|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2009-02-03|||August 2003||2003-08-01|January 2005|2005-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Gait Training For Acute Stroke: Functional Neuromuscular Stimulation (FNS) and Weight Supported Treadmill Training|Gait Training For Acute Stroke: FNS and Weight Supported Treadmill Training|Completed||Phase 4|70|Anticipated|VA Office of Research and Development|||||||||||||||||||2017-02-18 17:43:31.073956|2017-02-18 17:43:31.073956
NCT00101530|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2015-09-29|||September 2004||2004-09-01|September 2015|2015-09-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|LUCHAR||Improving Prevention of Heart Disease in Latinos|Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk|Completed||N/A|179|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-02-18 17:43:31.157097|2017-02-18 17:43:31.157097
NCT00102479|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2006-04-13|||July 2004||2004-07-01|April 2006|2006-04-01|July 2005||2005-07-01|||||Interventional|||Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents|A Phase II Study to Test PK Tolerability in Children and Adolescents|Completed||Phase 2|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 17:43:31.234986|2017-02-18 17:43:31.234986
NCT00102466|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2013-01-03||2013-01-02|January 2005||2005-01-01|January 2013|2013-01-01||||January 2009|Actual|2009-01-01||Interventional|||Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes|Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|1007|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:43:31.315755|2017-02-18 17:43:31.315755
NCT00102453|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2011-10-26|||March 2002||2002-03-01|October 2011|2011-10-01|May 2007|Actual|2007-05-01|July 2006|Actual|2006-07-01||Interventional|||Pentoxifylline in Duchenne Muscular Dystrophy|An Open-Label Pilot Study of Pentoxifylline in Steroid-naive Duchenne Muscular Dystrophy|Completed||Phase 1/Phase 2|17|Actual|Cooperative International Neuromuscular Research Group||1|||f||||t||||||||||2017-02-18 17:43:31.419531|2017-02-18 17:43:31.419531
NCT00102440|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2012-01-31|2009-03-12||July 2002||2002-07-01|January 2012|2012-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|FACT||Febuxostat Versus Allopurinol Control Trial in Subjects With Gout|A Phase 3, Randomized, Multicenter Study Comparing the Safety and Efficacy of Oral Febuxostat Versus Allopurinol in Subjects With Gout|Completed||Phase 3|760|Actual|Takeda||3|||f||||f||||||||||2017-02-18 17:43:31.548126|2017-02-18 17:43:31.548126
NCT00102427|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2014-01-21|||July 2000||2000-07-01|January 2014|2014-01-01|May 2003||2003-05-01|||||Interventional|||Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders|Improving Quality of Primary Care for Anxiety Disorders|Completed||Phase 2/Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:43:33.279644|2017-02-18 17:43:33.279644
NCT00102414|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2006-11-13|||September 1999||1999-09-01|January 2005|2005-01-01|November 2004||2004-11-01|||||Interventional|||Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer|A Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy|Completed||Phase 3|356||AGO Study Group|||||f||||||||||||||2017-02-18 17:43:33.379384|2017-02-18 17:43:33.379384
NCT00102401|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2007-08-13|||September 2003||2003-09-01|August 2007|2007-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Internet-Based and Established Dyspnea Self-Management Programs in Chronic Obstructive Pulmonary Disease (COPD) Patients|Comparing the Effects of an Internet-Based to an Established Dyspnea Self-Management Program on Dyspnea, Exercise Behavior, and Pulmonary Exacerbations in Patients With COPD|Completed||N/A|50|Actual|Robert Wood Johnson Foundation|||||f||||||||||||||2017-02-18 17:43:33.484648|2017-02-18 17:43:33.484648
NCT00102388|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-29|2016-11-16|||January 2005||2005-01-01|November 2016|2016-11-01||||March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|1092|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:43:33.582475|2017-02-18 17:43:33.582475
NCT00102362|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-27|2017-01-11|||December 2004||2004-12-01|October 2016|2016-10-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Job-Seekers Training for Patients With Drug Dependence - 1|Job Seekers Training for Patients With Drug Dependence|Completed||Phase 3|627||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:43:33.80444|2017-02-18 17:43:33.80444
NCT00102349|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-27|2017-01-11|||November 2004||2004-11-01|October 2016|2016-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||HIV and HCV Intervention In Drug Treatment Settings - 1|HIV and HCV Intervention in Drug Treatment Settings|Completed||Phase 3|706||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:43:33.899922|2017-02-18 17:43:33.899922
NCT00102336|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-27|2009-05-07|||April 2005||2005-04-01|May 2009|2009-05-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy|A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy|Completed||Phase 3|62|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:43:33.983778|2017-02-18 17:43:33.983778
NCT00102323|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-27|2009-01-09|||March 2005||2005-03-01|January 2009|2009-01-01|March 2007|Actual|2007-03-01|September 2006|Actual|2006-09-01||Interventional|||AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy|A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy|Completed||Phase 3|63|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:43:36.911439|2017-02-18 17:43:36.911439
NCT00102310|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-26|2015-06-15|||March 2004||2004-03-01|June 2015|2015-06-01|March 2006|Actual|2006-03-01|||||Interventional|||YM443 in Subjects With Functional Dyspepsia|A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia|Completed||Phase 2|416|Actual|Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:43:37.047174|2017-02-18 17:43:37.047174
NCT00102297|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-26|2007-12-10|||January 2005||2005-01-01|December 2007|2007-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus|A Phase 1 Study of the Safety, Pharmacokinetics, and Biologic Activity of Escalating Doses of FG-3019 in Subjects With Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus|Completed||Phase 1|20|Anticipated|FibroGen|||||f||||||||||||||2017-02-18 17:43:37.192959|2017-02-18 17:43:37.192959
NCT00102284|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-26|2010-01-26|||March 2004||2004-03-01|September 2006|2006-09-01|April 2005||2005-04-01|||||Interventional|||Neuromodulation and Language Acquisition (Project Stage Ia)|Improved Language Acquisition Through Neuromodulation, Project Stage Ia|Terminated||Phase 4|100||University Hospital Muenster|||||f||||||||||||||2017-02-18 17:43:37.27932|2017-02-18 17:43:37.27932
NCT00102271|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-25|2017-01-24|||January 19, 2005||2005-01-19|April 12, 2011|2011-04-12|April 12, 2011|Actual|2011-04-12|||||Interventional|||Nitrite Infusion Studies|Evaluation of the Mechanism of NO Formation and Pharmacokinetics of Systemic Nitrite Infusion|Completed||Phase 1|36|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:43:37.378521|2017-02-18 17:43:37.378521
NCT00102258|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-25|2017-01-24|||January 19, 2005||2005-01-19|October 2, 2007|2007-10-02|October 2, 2007||2007-10-02|||||Interventional|||Role of Nutrition and Hormones in Boys With Disordered Growth|Nutrients and Hormones: Effects in Boys With Disordered Growth - Pilot Study|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:37.470067|2017-02-18 17:43:37.470067
NCT00102245|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-25|2017-01-24|||January 18, 2005||2005-01-18|November 21, 2016|2016-11-21||||||||Observational|||Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes|Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:37.559287|2017-02-18 17:43:37.559287
NCT00102232|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-25|2005-06-23|||May 2003||2003-05-01|January 2005|2005-01-01|July 2003||2003-07-01|||||Interventional|||Effect of Phosphatidylcholine on Plasma Homocysteine in Healthy Volunteers|Effect of Choline Supplemented as Phosphatidylcholine on Post-Methionine Loading and Fasting Concentrations of Plasma Homocysteine in Healthy Volunteers|Completed||N/A|26||Wageningen Centre for Food Sciences|||||f||||||||||||||2017-02-18 17:43:40.4361|2017-02-18 17:43:40.4361
NCT00102219|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-25|2007-11-28|||October 2004||2004-10-01|November 2007|2007-11-01|October 2007|Actual|2007-10-01|||||Interventional|||A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer|A Phase 2 Study of ALIMTA Plus Doxorubicin Administered Every 21 Days in Patients With Advanced Breast Cancer|Completed||Phase 2|77|Actual|Eli Lilly and Company|||||||||||||||||||2017-02-18 17:43:40.532406|2017-02-18 17:43:40.532406
NCT00102206|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-25|2012-05-17||||||May 2012|2012-05-01|May 2007|Actual|2007-05-01|||||Interventional|||A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy|A Phase II, Randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Two Antiretroviral Therapeutic Strategies: A Dual PI-Based HAART Regimen Versus a Multi-NRTI ART Regimen, in ART-Experienced Children and Youth Who Have Experienced Virologic Failure|Completed||Phase 2|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:43:40.629868|2017-02-18 17:43:40.629868
NCT00102193|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-24|2008-09-05|||July 2004||2004-07-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study for the Treatment of Ulcerative Colitis With Adacolumn|A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Ulcerative Colitis|Completed||Phase 3|168||Otsuka America Pharmaceutical|||||||||||||||||||2017-02-18 17:43:40.743704|2017-02-18 17:43:40.743704
NCT00102180|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-21|2015-11-30|||January 2005||2005-01-01|November 2015|2015-11-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Drug-Induced Sudden Death & Ventricular Arrhythmia||Completed||N/A|31000000|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-02-18 17:43:40.867908|2017-02-18 17:43:40.867908
NCT00102167|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-21|2015-01-13|||February 2005||2005-02-01|January 2015|2015-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study of MK0928 in Healthy Adult Volunteers Participating in a 4-Hour Phase Advance Model of Transient Insomnia|Completed||Phase 3|663|Actual|H. Lundbeck A/S|||||f||||||||||||||2017-02-18 17:43:40.94231|2017-02-18 17:43:40.94231
NCT00102154|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-21|2015-01-13|||January 2005||2005-01-01|August 2014|2014-08-01||||||||Interventional|||An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study of MK0928 in Healthy Adult Volunteers Participating in a 4-Hour Phase Advance Model of Transient Insomnia|Withdrawn||Phase 3|0|Actual|H. Lundbeck A/S|||||f||||||||||||||2017-02-18 17:43:41.032691|2017-02-18 17:43:41.032691
NCT00102141|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-21|2014-12-11|||April 2004||2004-04-01|December 2014|2014-12-01|July 2005|Actual|2005-07-01|||||Interventional|||Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women|A Multicenter, Double-blind, Randomized, Placebo-controlled Study Comparing 3 Continuous Oral Angeliq (Drospirenone 3 mg/17ß-estradiol 1 mg, Drospirenone 2 mg /17ß-estradiol 1 mg, Drospirenone 1 mg /17ß-estradiol 1 mg) Combinations and 17ß-estradiol (1 mg) With Placebo for a Treatment Period of 8 Weeks on Ambulatory and Office Cuff Blood Pressure in Postmenopausal Women With Stage 1 or Stage 2 Essential Hypertension|Completed||Phase 3|750|Actual|Bayer||5|||f||||f||||||||||2017-02-18 17:43:41.368365|2017-02-18 17:43:41.368365
NCT00102128|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-21|2015-05-21|||November 2002||2002-11-01|May 2015|2015-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.|Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure|Terminated||Phase 2|||Sanofi||||DMC recommended stop|f||||||||||||||2017-02-18 17:43:41.491089|2017-02-18 17:43:41.491089
NCT00102115|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-21|2010-03-11|||December 2004||2004-12-01|December 2005|2005-12-01|January 2006||2006-01-01|||||Interventional|||Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease|Phase 1 Dose Ranging Study to Evaluate Safety and Tolerability of Talaporfin Sodium (LS11) Photodynamic Therapy in Subjects With Advanced Age-Related Macular Disease|Terminated||Phase 1|27||Light Sciences LLC|||||||||||||||||||2017-02-18 17:43:41.607502|2017-02-18 17:43:41.607502
NCT00102102|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-20|2008-03-03|||January 2005||2005-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Role of Substance P in Post-Traumatic Stress Disorder|PET Evaluation of NK1 Receptor Using [18F]SPA-RQ in Post-Traumatic Stress Disorder|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:41.701744|2017-02-18 17:43:41.701744
NCT00102089|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-20|2017-01-24|||January 18, 2005||2005-01-18|October 10, 2007|2007-10-10|October 10, 2007||2007-10-10|||||Interventional|||HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Booster Dose of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Subjects Who Were Previously Immunized With VRC-HIVDNA009-00-VP in VRC 004|Completed||Phase 1|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:41.800268|2017-02-18 17:43:41.800268
NCT00102076|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-19|2017-01-24|||November 16, 2001||2001-11-16|September 18, 2006|2006-09-18|September 18, 2006||2006-09-18|||||Observational|||Implementing the Assent Requirement for Research With Children|Implementing the Assent Requirement for Research With Children|Completed||N/A|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:41.898406|2017-02-18 17:43:41.898406
NCT00102063|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-19|2012-08-06|2012-05-11||July 2004||2004-07-01|August 2012|2012-08-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|APEX 239||Aripiprazole in Adolescents With Schizophrenia|Aripiprazole in Adolescents With Schizophrenia|Completed||Phase 3|302|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||||||||||||2017-02-18 17:43:41.975245|2017-02-18 17:43:41.975245
NCT00102050|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-19|2006-05-17|||April 2003||2003-04-01|May 2006|2006-05-01|April 2006||2006-04-01|||||Interventional|||Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication|A Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of NM-702 in Subjects With Intermittent Claudication|Completed||Phase 2|390||Nissan Chemical Industries|||||||||||||||||||2017-02-18 17:43:42.783785|2017-02-18 17:43:42.783785
NCT00102037|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-19|2017-01-12|||July 2004||2004-07-01|January 2017|2017-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Use of Activated Recombinant FVII in Spinal Surgery|Evaluation of Safety of Activated Recombinant FVII as an Add-On Therapy in Spinal Surgery|Completed||Phase 2|50|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:43:43.151056|2017-02-18 17:43:43.151056
NCT00102024|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-19|2010-08-25|||January 2005||2005-01-01|August 2010|2010-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma|A Phase I/II, Open-Label, Dose-Escalation Study to Evaluate the Safety and Activity of Single Dose 90Y-Labeled IDEC-159, Humanized, Domain Deleted, Anti TAG-72 Monoclonal Antibody, in Subjects With Metastatic Colorectal Adenocarcinoma|Terminated||Phase 1/Phase 2|30||Biogen|||||||||||||||||||2017-02-18 17:43:43.260549|2017-02-18 17:43:43.260549
NCT00102011|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2016-06-01|||May 2000||2000-05-01|June 2016|2016-06-01|May 2017|Anticipated|2017-05-01|May 2017|Anticipated|2017-05-01||Interventional|00-046||Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer|Colonoscopy Screening Trial|Active, not recruiting||Phase 3|4952|Anticipated|Memorial Sloan Kettering Cancer Center||4|||f||||||||||||||2017-02-18 17:43:43.363732|2017-02-18 17:43:43.363732
NCT00101998|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2015-09-01|||October 2003||2003-10-01|September 2009|2009-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects|Completed||Phase 2|233|Actual|Cubist Pharmaceuticals LLC||4|||||||||||||||||2017-02-18 17:43:43.49325|2017-02-18 17:43:43.49325
NCT00101985|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2015-04-10|||October 2004||2004-10-01|April 2015|2015-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)|An Eight-week, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate Efficacy and Safety of Talnetant in Subjects With Irritable Bowel Syndrome|Completed||Phase 2|741|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:43:43.774585|2017-02-18 17:43:43.774585
NCT00101972|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2012-04-18|||December 2004||2004-12-01|April 2012|2012-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma|A Phase I, Multi-Dose Study of RAV12 (ANTI-RAAG12 MAB) in Patients With Metastatic or Recurrent Adenocarcinoma|Completed||Phase 1|53|Actual|MacroGenics||1|||f||||f||||||||||2017-02-18 17:43:44.28618|2017-02-18 17:43:44.28618
NCT00101959|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2013-08-04|||November 2004||2004-11-01|August 2013|2013-08-01||||||||Interventional|||Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects|An Implementation Study of Treatment Optimization Recommendations Comparing Subjects Continuing Treatment With IFN-ß-1a 30 Mcg qw IM (Avonex®) or Glatiramer Acetate 20 mg qd SC (Copaxone®) to Those Randomized to IFN-ß-1a 44 Mcg Tiw SC (Rebif®), in a Multicenter Study of Subjects With Relapsing Remitting Multiple Sclerosis Currently on Disease-Modifying Therapy|Withdrawn||Phase 4|0|Actual|EMD Serono|||||||||||||||||||2017-02-18 17:43:44.419601|2017-02-18 17:43:44.419601
NCT00101946|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2015-04-10|||October 2004||2004-10-01|April 2015|2015-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Nine-weeks Administration of Three Doses of SB-683699 in Subjects With Moderately to Severely Active Crohn's Disease|Completed||Phase 2|17|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:43:44.501201|2017-02-18 17:43:44.501201
NCT00101933|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2016-03-30|2012-10-01||December 2003||2003-12-01|March 2016|2016-03-01|October 2018|Anticipated|2018-10-01|June 2008|Actual|2008-06-01||Interventional|||SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy|SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy|Active, not recruiting||Phase 3|157|Actual|MedtronicNeuro|No limitations leading to unreliable data were identified.|2|||f||||t||||||||||2017-02-18 17:43:44.610254|2017-02-18 17:43:44.610254
NCT00101920|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2010-10-14|||June 2003||2003-06-01|October 2010|2010-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)|A Clinical Trial of the Safety and Efficacy of ABX-EGF as Second Line Treatment for Advanced Non-Small Lung Cancer|Completed||Phase 2|50|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:43:45.216873|2017-02-18 17:43:45.216873
NCT00101907|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2014-02-03|2010-08-13||December 2004||2004-12-01|February 2014|2014-02-01|April 2008|Actual|2008-04-01|June 2007|Actual|2007-06-01||Interventional|||Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer|An Open-Label, Dose-Finding Study to Evaluate the Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Subjects With Advanced Cancer|Terminated||Phase 1|41|Actual|Amgen||6||Study terminated per recommendation of Data Review Team|f||||||||||||||2017-02-18 17:43:45.334293|2017-02-18 17:43:45.334293
NCT00101894|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2012-09-13|||December 2004||2004-12-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|April 2010|Actual|2010-04-01||Interventional|||Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer|An Open-Label, Dose-Finding Study to Evaluate the Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer|Completed||Phase 1|119|Actual|Amgen||14|||f||||f||||||||||2017-02-18 17:43:47.758839|2017-02-18 17:43:47.758839
NCT00101881|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-18|2008-09-30|||November 2002||2002-11-01|September 2008|2008-09-01|January 2005|Actual|2005-01-01|||||Interventional|||Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)|Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)|Completed||Phase 4|168|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:43:47.884818|2017-02-18 17:43:47.884818
NCT00101868|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-14|2012-04-16|2012-03-18||December 2004||2004-12-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Value of Technology to Transfer Discharge Information|Value of Technology to Transfer Discharge Information|Completed||N/A|631|Actual|Agency for Healthcare Research and Quality (AHRQ)|Required medication reconciliation in both groups might have reduced the adverse event rates in both groups.|2|||f||||f||||||||||2017-02-18 17:43:47.991168|2017-02-18 17:43:47.991168
NCT00101855|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-14|2005-06-23|||October 2003||2003-10-01|January 2005|2005-01-01|June 2006||2006-06-01|||||Interventional|||Can Parental Activation Over the Internet Improve Pediatric Preventive Care?|Parent Initiated Prevention Program|Unknown status|Active, not recruiting|N/A|2000||Agency for Healthcare Research and Quality (AHRQ)|||||f||||||||||||||2017-02-18 17:43:48.558227|2017-02-18 17:43:48.558227
NCT00101842|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-14|2006-08-24|||December 2004||2004-12-01|August 2006|2006-08-01|July 2006||2006-07-01|||||Interventional|||Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer|Phase I/II Study of Gemzar and Platinol Followed by Alimta and Gemzar in Patients With Advanced or Metastatic Bladder Cancer|Completed||Phase 1/Phase 2|61||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:43:48.62886|2017-02-18 17:43:48.62886
NCT00101829|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-13|2015-11-12|||April 2004||2004-04-01|November 2015|2015-11-01|August 2009|Actual|2009-08-01|August 2006|Actual|2006-08-01||Interventional|||Anti-CD20 Antibody Therapy for Sjogren's Syndrome|An Open-Label, One Arm, Phase I Safety Study of Anti-CD20 Antibody (Rituximab, Rituxan) Therapy in the Treatment of Primary Sjogren's Syndrome|Completed||Phase 1|12|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 17:43:48.715315|2017-02-18 17:43:48.715315
NCT00101517|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2014-09-12|||September 2004||2004-09-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Observational|META-HEALTH||Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease|Partnership Programs to Reduce Cardiovascular Disparities - Morehouse-Emory Partnership|Completed||N/A|4024|Actual|Emory University|||1||f||||t||||||||||2017-02-18 17:43:48.828107|2017-02-18 17:43:48.828107
NCT00101504|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2016-07-11|||September 2004||2004-09-01|April 2006|2006-04-01|August 2009|Actual|2009-08-01|||||Observational|||Hypertension Education and Treatment Partnership for Reducing Ethnic Differences in the Risk of Cardiovascular Disease|Partnership Programs to Reduce Cardiovascular Disparities - Hypertension Education and Treatment (HEAT)|Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:43:48.913484|2017-02-18 17:43:48.913484
NCT00101491|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2016-07-11|||September 2004||2004-09-01|February 2009|2009-02-01|August 2010|Actual|2010-08-01|September 2009|Actual|2009-09-01||Interventional|||STORIES-Stories to Communicate Risk About Tobacco|Partnership Programs to Reduce Cardiovascular Disparities - Deep South Partnerships for Prevention of CVD Disparities|Completed||N/A|300|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 17:43:48.979677|2017-02-18 17:43:48.979677
NCT00101478|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2009-04-10|||September 2004||2004-09-01|April 2009|2009-04-01|August 2009||2009-08-01|||||Observational|||Improving Cardiovascular Treatment Approaches Among Minorities|Partnership Programs to Reduce Cardiovascular Disparities - Baltimore Partnership|Unknown status|Active, not recruiting|N/A|800|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||||||2017-02-18 17:43:49.083537|2017-02-18 17:43:49.083537
NCT00101465|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2013-07-02|||September 2004||2004-09-01|July 2009|2009-07-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians|Partnership Programs to Reduce Cardiovascular Disparities - Heart Failure Disparities in Native Hawaiians|Completed||N/A|276|Anticipated|University of Hawaii|||1||f||||||||||||||2017-02-18 17:43:49.164382|2017-02-18 17:43:49.164382
NCT00099697|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2009-12-09|||June 2001||2001-06-01|December 2004|2004-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans|Biologic Effects of DHEA in Humans|Completed||N/A|56||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:44:08.404285|2017-02-18 17:44:08.404285
NCT00101452|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2016-11-13|2012-06-13||April 2005||2005-04-01|November 2016|2016-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression|A Double-Blind, Placebo-Controlled Study of the Alternative Therapy S-Adenosyl-L-Methionine (SAMe) vs Escitalopram in Major Depressive Disorder (MDD)|Completed||N/A|199|Actual|Massachusetts General Hospital||3|||f||||t||||||||Undecided||2017-02-18 17:43:49.250941|2017-02-18 17:43:49.250941
NCT00101439|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2016-05-03|2016-03-15||November 2005||2005-11-01|April 2016|2016-04-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|||A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, 2-Period, Crossover Study to Evaluate the Effects of Ezetimibe on the Postprandial Lipoprotein Response in Patients With Primary Hypercholesterolemia|Completed||Phase 3|58|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:43:49.839575|2017-02-18 17:43:49.839575
NCT00101426|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2008-01-10|||October 2004||2004-10-01|January 2008|2008-01-01|September 2006||2006-09-01|||||Interventional|||Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy||Completed||Phase 3|500||Sumitomo Dainippon Pharma Co., Ltd.|||||||||||||||||||2017-02-18 17:43:50.344088|2017-02-18 17:43:50.344088
NCT00101413|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2013-09-29|2009-04-17||April 2004||2004-04-01|September 2013|2013-09-01|April 2008|Actual|2008-04-01|June 2005|Actual|2005-06-01||Interventional|||BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)|A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Patients With Relapsed or Refractory Advanced Non-small Cell Lung Carcinoma|Completed||Phase 2|52|Actual|Bayer|Due to rapid enrollment, no IA (interim analysis) was performed.|1|||f||||f||||||||||2017-02-18 17:43:50.429644|2017-02-18 17:43:50.429644
NCT00101400|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2013-11-19|2009-01-30||February 2004||2004-02-01|November 2013|2013-11-01|January 2008|Actual|2008-01-01|January 2006|Actual|2006-01-01||Interventional|||BAY43-9006 - Phase II in Advanced Breast Cancer|A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Subjects With Metastatic Breast Cancer.|Completed||Phase 2|54|Actual|Bayer|Subjects had advanced disease and were heavily pretreated. Not all adverse events mentioned were assessed as drug-related. NCI-CTCAE was translated to Medical Dictionary for Regulatory Activities (MedDRA) for System Organ Classes (SOCs) only.|1|||f||||f||||||||||2017-02-18 17:43:50.84531|2017-02-18 17:43:50.84531
NCT00101387|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-10|2011-02-17|||September 2003||2003-09-01|February 2011|2011-02-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Effects of Lumbar PENS and Exercise in Older Adults With Chronic Low Back Pain|Functional Impact of PENS for 65+ Chronic Low Back Pain|Completed||Phase 3|200|Actual|University of Pittsburgh||4|||f||||t||||||||||2017-02-18 17:43:51.490256|2017-02-18 17:43:51.490256
NCT00101374|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2017-01-24|||January 5, 2005||2005-01-05|February 2, 2010|2010-02-02|May 21, 2008|Actual|2008-05-21|May 21, 2008|Actual|2008-05-21||Interventional|||Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients|A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of Leflunomide on HIV-1 Associated Immune Proliferation In Vivo|Completed||Phase 1|41|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:43:51.596713|2017-02-18 17:43:51.596713
NCT00101361|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-11-26|2013-06-27||August 2005||2005-08-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional||overall baseline participants were determined by number of participants that were eligible after screening based on a pressure ulcer that is defined as hard-to-heal or worsening at randomization.|Oxandrolone to Heal Pressure Ulcers|CSP #535 - Anabolic Steroid Therapy on Pressure Ulcer Healing in Persons With Spinal Cord Injury|Terminated||Phase 3|212|Actual|VA Office of Research and Development|Selection of severe wounds may have reduced treatment response. The study was terminated after a futility analysis showed a low probability of detecting a significant difference between groups.|2||futility analysis showed low probability of detecting a significant difference|f||||t||||||||||2017-02-18 17:43:51.697337|2017-02-18 17:43:51.697337
NCT00101348|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2014-06-10|||January 2005||2005-01-01|December 2012|2012-12-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer|A Phase I, and Biologic Correlative Study of Erlotinib, in Combination With Cetuximab and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|66|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:52.16847|2017-02-18 17:43:52.16847
NCT00101335|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-07-09|||November 2003||2003-11-01|July 2013|2013-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia|A Phase IIb Cancer Prevention Trial of Celecoxib, a Selective COX-2 Inhibitor, in Oral Leukoplakia|Completed||Phase 2|||Fox Chase Cancer Center|||||f||||f||||||||||2017-02-18 17:43:52.311267|2017-02-18 17:43:52.311267
NCT00101309|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-12-17|||November 2004||2004-11-01|November 2007|2007-11-01||||November 2007|Anticipated|2007-11-01||Interventional|||Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma|A Phase I Pilot Study of Tumor Cell - B Lymphoblastoid Cell Line Vaccination in Pediatric Subjects With Relapsed Ewing's Sarcoma and Neuroblastoma|Unknown status|Active, not recruiting|Phase 1|10|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:43:52.423288|2017-02-18 17:43:52.423288
NCT00101296|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-02-01|||October 2004||2004-10-01|January 2013|2013-01-01||||May 2011|Actual|2011-05-01||Interventional|||Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|Phase I Trial of R115777 (NSC 702818) in Relapsed, Refractory or High Risk Myeloid Leukemia|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:52.720109|2017-02-18 17:43:52.720109
NCT00101283|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2012-11-30|2010-02-12||November 2005||2005-11-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|September 2009|Actual|2009-09-01||Interventional|||Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma|Pemetrexed Plus Gemcitabine Or Carboplatin In Patients With Advanced Malignant Mesothelioma: A Randomized Phase II Trial|Completed||Phase 2|32|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 17:43:52.857907|2017-02-18 17:43:52.857907
NCT00101270|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-06-04|||March 2005||2005-03-01|June 2013|2013-06-01||||September 2007|Actual|2007-09-01||Interventional|||Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas|A Phase I Study of Oxaliplatin (NSC# 266046, IND #57004) and Irinotecan in Pediatric Patients With Refractory Solid Tumors and Lymphomas|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:53.478553|2017-02-18 17:43:53.478553
NCT00101257|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2010-05-05|||October 2004||2004-10-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|||||Interventional|||Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer|Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD4+ Antigen-Specific T Cell Clones for Patients With Advanced Ovarian Cancer|Completed||Phase 1|18|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:43:53.596566|2017-02-18 17:43:53.596566
NCT00101244|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-01-11|||November 2004||2004-11-01|January 2013|2013-01-01||||February 2010|Actual|2010-02-01||Interventional|||SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma|A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Days 1-3 of a 21-Day Cycle in Patients With Solid Tumors|Terminated||Phase 1|31|Actual|National Cancer Institute (NCI)||1||Administratively Complete.|f||||||||||||||2017-02-18 17:43:53.68198|2017-02-18 17:43:53.68198
NCT00101231|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-06-03|||October 2004||2004-10-01|June 2013|2013-06-01||||November 2012|Actual|2012-11-01||Interventional|||Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia|A Dose Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With Relapsed and Refractory Acute Leukemias|Terminated||Phase 1|88|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:53.789579|2017-02-18 17:43:53.789579
NCT00101205|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2014-02-21|||November 2004||2004-11-01|April 2013|2013-04-01||||January 2012|Actual|2012-01-01||Interventional|||Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma|A Phase I Trial of the Combination of Oxaliplatin (NSC 266046, IND 57004), Ifosfamide, and Etoposide in Recurrent or Refractory Pediatric Solid Tumors and Lymphomas|Terminated||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:53.894487|2017-02-18 17:43:53.894487
NCT00101192|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2014-02-03|2014-02-03||September 2004||2004-09-01|February 2014|2014-02-01||||July 2011|Actual|2011-07-01||Interventional||Eligible and evaluable participants|Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer|A Limited Access Phase II Trial of Cetuximab (C225, NSC #714692) in Combination With Cisplatin (NSC #119875) in the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix|Completed||Phase 2|76|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 17:43:54.018977|2017-02-18 17:43:54.018977
NCT00101179|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2017-01-31|||November 2004||2004-11-01|November 2016|2016-11-01||||April 2011|Actual|2011-04-01||Interventional|||MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia|A Dose-Finding Trial of the Histone Deacetylase Inhibitor MS-275 (NSC 706995) in Combination With 5-Azacitidine (5AC, NSC 102816) in Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMMoL) and Acute Myeloid Leukemia (AML)|Active, not recruiting||Phase 1|63|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:54.632676|2017-02-18 17:43:54.632676
NCT00101166|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2012-11-16|2012-10-18||October 2004||2004-10-01|September 2012|2012-09-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma|A Phase II Trial Using a Universal GM-CSF-Producing and CD40L-Expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-Based Vaccines for Patients With Malignant Melanoma|Completed||Phase 2|43|Actual|H. Lee Moffitt Cancer Center and Research Institute|Due to the heterogeneity of the patient population, results were mainly descriptive in nature.|1|||f||||f||||||||||2017-02-18 17:43:54.749373|2017-02-18 17:43:54.749373
NCT00101153|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2015-07-22|||April 2007||2007-04-01|July 2015|2015-07-01||||March 2010|Actual|2010-03-01||Interventional|||Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia|A Phase I Study Of Therapy With The Farnesyl Transferase Inhibitor R115777 (Zarnestra) Combined With Conventional Induction And Consolidation Chemotherapy For Previously Untreated Patients Over Age 55 With Acute Myeloid Leukemia (AML)|Completed||Phase 1|24|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:43:55.193651|2017-02-18 17:43:55.193651
NCT00101140|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2006-07-06||||||July 2006|2006-07-01||||||||Interventional|||Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission|Phase II Study of Haploidentical Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With High-Risk Acute Myeloid Leukemia in First Remission|Withdrawn||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:43:55.330637|2017-02-18 17:43:55.330637
NCT00101127|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2014-02-12|||December 2003||2003-12-01|February 2014|2014-02-01||||July 2006|Actual|2006-07-01||Interventional|||Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma|A Phase II Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||t||||||||||2017-02-18 17:43:55.421708|2017-02-18 17:43:55.421708
NCT00101114|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-02-27|||September 2004||2004-09-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer|A Phase II Study of the RAF-Kinase Inhibitor BAY 43-9006 (NSC-724772, IND-69,896) in Combination With Interferon-Alpha 2B in Patients With Advanced Renal Cancer|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:55.585437|2017-02-18 17:43:55.585437
NCT00101101|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2016-10-05|2013-06-20||July 2004||2004-07-01|October 2016|2016-10-01|October 2017|Anticipated|2017-10-01|October 2012|Actual|2012-10-01||Interventional||All participants who started the study.|Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma|A Phase II Trial Using a Universal GM-CSF-Producing and CD40L-Expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-Based Vaccines for Patients With Mantle Cell Lymphoma|Active, not recruiting||Phase 2|43|Actual|H. Lee Moffitt Cancer Center and Research Institute|With a median follow-up of 67 months, the median overall survival (OS) has not yet been reached.|1|||f||||f||||||||||2017-02-18 17:43:55.700236|2017-02-18 17:43:55.700236
NCT00101088|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-01-11|||April 2005||2005-04-01|January 2013|2013-01-01||||June 2010|Actual|2010-06-01||Interventional|||Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A Phase I Study of CCI-779 in Combination With Imatinib Mesylate in Chronic Myelogenous Leukemia|Terminated||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:43:55.99923|2017-02-18 17:43:55.99923
NCT00101075|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2008-07-23|||October 2004||2004-10-01|November 2006|2006-11-01||||||||Interventional|||Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery|Phase II Study of Capecitabine and Oxaliplatin (XELOX) in Patients With Locally Advanced, Incurable, Salivary Gland Cancers|Unknown status|Active, not recruiting|Phase 2|33|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:43:56.109704|2017-02-18 17:43:56.109704
NCT00101062|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2011-06-03|||January 2004||2004-01-01|June 2011|2011-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer|Phase II Study of Letrozole (Femara) and Celecoxib (Celebrex) in Postmenopausal Women With Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer|Terminated||Phase 2|||Rutgers, The State University of New Jersey||||study drug unavailable|f||||t||||||||||2017-02-18 17:43:56.207405|2017-02-18 17:43:56.207405
NCT00101036|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2014-12-18|2014-07-21||November 2004||2004-11-01|October 2013|2013-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery|A Phase II Study of GW572016 (Lapatanib) in Locally Advanced or Metastatic Hepato-Biliary Cancers|Completed||Phase 2|57|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:56.313338|2017-02-18 17:43:56.313338
NCT00101010|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2014-09-10|||September 2005||2005-09-01|September 2014|2014-09-01||||September 2014|Actual|2014-09-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma|A Phase II Study Of Rituximab-CHOP With Pegylated Liposomal Doxorubicin In Patients Older Than 60 Years Of Age With Untreated Aggressive B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|80|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:43:56.890225|2017-02-18 17:43:56.890225
NCT00100997|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-07-09|||October 2004||2004-10-01|May 2005|2005-05-01|October 2006|Actual|2006-10-01|||||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate|A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered CNF1010 )17-(Allylamino)-17-Demethoxygeldanamycin [17-AAG]) in Patients With Gleevec-Resistent Chronic Myelogenous Leukemia|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:43:57.016469|2017-02-18 17:43:57.016469
NCT00100984|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2005-12-15||||||December 2005|2005-12-01||||||||Interventional|||A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1||Terminated||Phase 4|||Hoffmann-La Roche|||||||||||||||||||2017-02-18 17:43:57.093263|2017-02-18 17:43:57.093263
NCT00100971|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2013-01-03|||April 2004||2004-04-01|January 2013|2013-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia|Dendritic/Leukemic Fusion Cell Vaccine Therapy For AML Patients In First Remission; A Phase I Clinical Trial|Terminated||Phase 1|9||Boston Medical Center||||Protocol is withdrawn due to inadequate accrual|f||||||||||||||2017-02-18 17:43:57.181473|2017-02-18 17:43:57.181473
NCT00100958|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2008-07-23|||November 2004||2004-11-01|May 2006|2006-05-01||||||||Interventional|||Indole-3-Carbinol in Preventing Cancer in Healthy Participants|Phase I Ascending Single Dose Pharmacokinetics (PK) and Safety Study of 3,3' Di-Indolymethane (DIM) Nutritional Product|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:43:57.269744|2017-02-18 17:43:57.269744
NCT00100945|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2016-12-09|||July 2005||2005-07-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|August 2007|Actual|2007-08-01||Interventional|||Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer|A Phase II Study Of Maintenance ZD1839 (IRESSA) In Patients With Locally Advanced Esophageal Cancer After Treatment Given With Curative Intent|Completed||Phase 2|70|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:43:57.354588|2017-02-18 17:43:57.354588
NCT00100932|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-07|2012-03-22|2011-12-26||December 2004||2004-12-01|March 2012|2012-03-01||||June 2008|Actual|2008-06-01||Interventional|||Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy|Phase II Study of E7389, a Halichondrin B Analog, in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC), Who Progressed During or After Platinum-Based Doublet Chemotherapy Stratified for Prior Taxane Therapy|Completed||Phase 2|106|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 17:43:57.699556|2017-02-18 17:43:57.699556
NCT00100919|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2017-01-24|||January 4, 2005||2005-01-04|July 6, 2010|2010-07-06|July 6, 2010||2010-07-06|||||Observational|||Sensing of Leg Position and Movement|Coupled Joint Proprioception and Multi-Joint Movement in the Lower Extremity: A Pilot Study|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:43:58.707857|2017-02-18 17:43:58.707857
NCT00100906|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2013-08-15|||August 2004||2004-08-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|June 2006|Actual|2006-06-01||Interventional|||Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer|Randomized Phase II Trial Of Sequential ATRA Then IL-2 For Modulation Of Dendritic Cells And Treatment Of Metastatic Renal Cancer|Completed||Phase 2|18|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f||||||||||2017-02-18 17:43:58.787977|2017-02-18 17:43:58.787977
NCT00100893|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2015-06-03|||January 2005||2005-01-01|June 2015|2015-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer|A Phase I Prevention Trial of ACTIVIN Grape Seed Extract as an Aromatase Inhibitor In Healthy Postmenopausal Women at Risk for Breast Cancer|Completed||Phase 1|37|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 17:43:58.910798|2017-02-18 17:43:58.910798
NCT00100880|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2013-09-27|||November 2004||2004-11-01|September 2013|2013-09-01||||November 2010|Actual|2010-11-01||Interventional|||Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors|A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients With Recurrent or Refractory Primary CNS Tumors|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:43:59.01953|2017-02-18 17:43:59.01953
NCT00100867|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2016-03-31|||June 2006||2006-06-01|March 2016|2016-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women|Assessment of Safety and Toxicity Among Infants Born to HIV-1-Infected Women Enrolled in Antiretroviral Treatment Protocols in Diverse Areas of the World|Completed||N/A|236|Actual|AIDS Clinical Trials Group|||1||f||||||||||Samples With DNA|"~     Blood and urine collection~   "|||2017-02-18 17:43:59.137641|2017-02-18 17:43:59.137641
NCT00100854|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2016-02-01|||October 2004||2004-10-01|February 2016|2016-02-01|April 2017|Anticipated|2017-04-01|April 2015|Actual|2015-04-01||Interventional|||Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Randomized, Open-Label Phase II Clinical Trial of Combination Erlotinib (Tarceva®) and Fulvestrant (Faslodex®) Versus Erlotinib (Tarceva®) Alone in Advanced Non-Small Cell Lung Cancer Patients|Active, not recruiting||Phase 2|50|Anticipated|Translational Oncology Research International||2|||f||||t||||||||||2017-02-18 17:43:59.258484|2017-02-18 17:43:59.258484
NCT00100841|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2015-06-26|2015-06-26||November 2004||2004-11-01|July 2013|2013-07-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer|Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer|Completed||Phase 2|66|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:43:59.372625|2017-02-18 17:43:59.372625
NCT00100828|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2016-10-12|||November 2004||2004-11-01|October 2016|2016-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer|Phase II Trial of Irinotecan for Treatment of Metastatic Medullary Thyroid Cancer|Completed||Phase 2|6|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:43:59.680208|2017-02-18 17:43:59.680208
NCT00100815|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2015-11-19|2015-09-28||August 2004||2004-08-01|November 2015|2015-11-01||||August 2008|Actual|2008-08-01||Interventional||All treated and eligible patients|Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer|Multicenter, Open Label, Phase II Clinical Study of Gemcitabine, Capecitabine and Avastin in Pancreatic Cancer|Completed||Phase 2|50|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:43:59.799981|2017-02-18 17:43:59.799981
NCT00100802|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2016-11-18|2016-11-18||July 2005||2005-07-01|November 2016|2016-11-01||||September 2012|Actual|2012-09-01||Interventional|||Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas|A Phase II Study of Concurrent Radiation and Temozolomide Followed By Temozolomide and CCNU in the Treatment of Children With High-Grade Glioma|Active, not recruiting||Phase 2|118|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:44:00.364546|2017-02-18 17:44:00.364546
NCT00100789|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2012-08-29|2012-07-12||January 2005||2005-01-01|August 2012|2012-08-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer|A Phase II Study of Biweekly Gemcitabine and Paclitaxel (GEMTAX) Combination in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|67|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 17:44:00.870387|2017-02-18 17:44:00.870387
NCT00100776|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2007-01-24|||September 2003||2003-09-01|January 2007|2007-01-01|November 2005||2005-11-01|||||Interventional|||Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder|Efficacy of High Dose Olanzapine in a Controlled Fixed Dose-Response Trial for the Treatment of Schizophrenia and Schizoaffective Disorder|Completed||Phase 4|600||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:44:04.354017|2017-02-18 17:44:04.354017
NCT00100750|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2015-01-12|||September 2005||2005-09-01|October 2014|2014-10-01|January 2010|Actual|2010-01-01|October 2007|Actual|2007-10-01||Interventional|||Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer|Gemcitabine and R115777 Combination Therapy for Metastatic Breast Cancer|Completed||Phase 1/Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:44:04.743554|2017-02-18 17:44:04.743554
NCT00100737|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-06|2006-02-02||||||February 2006|2006-02-01||||||||Interventional|||Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin’s Lymphoma (NHL)|A Phase 2 Randomized, Open-Label, Controlled Trial of the Addition of 8 Weeks SC Administration of Aldesleukin (Rh-Interleukin-2 [IL-2]) to 4 Weeks of IV Administration of Rituximab in the Treatment of Rituximab Naïve Subjects With Follicular Non-Hodgkin’s Lymphoma, Refractory or Relapsed After Previous Chemotherapy|Terminated||Phase 2|300||Chiron Corporation|||||||||||||||||||2017-02-18 17:44:04.862172|2017-02-18 17:44:04.862172
NCT00100724|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-05|2006-01-10|||April 2004||2004-04-01|January 2006|2006-01-01|July 2005||2005-07-01|||||Interventional|||Trial of rPA-102 Vaccine in Healthy Adult Volunteers|A Phase 2 Multi-Center, Randomized Dose-Finding Trial of rPA-102 Vaccine in Healthy Adult Volunteers|Completed||Phase 2|480||VaxGen|||||||||||||||||||2017-02-18 17:44:04.947618|2017-02-18 17:44:04.947618
NCT00100711|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-04|2014-05-07||2014-04-14|October 2004||2004-10-01|May 2014|2014-05-01||||February 2010|Actual|2010-02-01||Interventional|||Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma With Refractory or Relapsed Disease|Terminated||Phase 2|27||Pharmacyclics LLC.|||||f||||||||||||||2017-02-18 17:44:05.055513|2017-02-18 17:44:05.055513
NCT00100698|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-04|2010-07-22|2010-04-09||January 2004||2004-01-01|July 2010|2010-07-01|April 2009|Actual|2009-04-01|October 2007|Actual|2007-10-01||Interventional|||Physiologic Growth Hormone Effects in HIV Lipodystrophy|Physiologic Growth Hormone Effects in HIV Lipodystrophy|Completed||N/A|56|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:44:05.170797|2017-02-18 17:44:05.170797
NCT00100685|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-04|2012-04-25|||January 2005||2005-01-01|April 2012|2012-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)|Phase 2 Open-Label Study of Volociximab (M200) in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|48|Actual|Abbott||2|||f||||t||||||||||2017-02-18 17:44:05.878141|2017-02-18 17:44:05.878141
NCT00100672|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-04|2011-06-30|||December 2004||2004-12-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|October 2009|Actual|2009-10-01||Interventional|||Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer|Phase I Study of an Easy-to-Use Intravenous Formulation of Liposome Entrapped C-raf Antisense Oligonucleotide (LErafAON-ETU) Administered on a Weekly Schedule in Patients With Advanced Cancer|Completed||Phase 1|40||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 17:44:05.982059|2017-02-18 17:44:05.982059
NCT00100659|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-04|2013-07-10|2013-05-10||December 2004||2004-12-01|July 2013|2013-07-01|February 2010|Actual|2010-02-01|August 2008|Actual|2008-08-01||Interventional|||PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C|Pegylated Interferon +/- Ribavirin for Children With Hepatitis C|Completed||Phase 3|114|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||||||||||||2017-02-18 17:44:06.070212|2017-02-18 17:44:06.070212
NCT00100646|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-04|2014-08-26|||March 2007||2007-03-01|November 2013|2013-11-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa|A Randomized Clinical Trial Assessing Continuous HAART Versus Interrupted HAART in a Resource Poor Clinic|Completed||N/A|30|Actual|The Wistar Institute||2|||f||||t||||||||||2017-02-18 17:44:06.717139|2017-02-18 17:44:06.717139
NCT00100633|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-04|2008-09-29|||December 2004||2004-12-01|December 2007|2007-12-01|October 2007|Actual|2007-10-01|February 2007|Actual|2007-02-01||Interventional|||Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People|Immunologic Effects of CpG ODN Administration to HIV Uninfected and HIV Infected Patients|Completed||Phase 1/Phase 2|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:44:06.858066|2017-02-18 17:44:06.858066
NCT00100620|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-03|2012-04-26|||June 2004||2004-06-01|April 2012|2012-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis|Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis|Completed||Phase 3|802||Novartis|||||||||||||||||||2017-02-18 17:44:06.972429|2017-02-18 17:44:06.972429
NCT00100607|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-03|2012-05-07|||February 2004||2004-02-01|May 2012|2012-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis|Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis|Completed||Phase 2|676|Actual|Novartis|||||f||||||||||||||2017-02-18 17:44:07.077252|2017-02-18 17:44:07.077252
NCT00100594|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-03|2011-02-22|||May 2005||2005-05-01|February 2011|2011-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China|A Feasibility Study of Lamivudine/Zidovudine (3TC/ZDV) Plus Efavirenz (EFV) as Initial Therapy of HIV-1 Infected Patients in a Rural Area of China|Completed||N/A|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:44:07.161009|2017-02-18 17:44:07.161009
NCT00100581|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-03|2012-05-17||||||May 2012|2012-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults|An Open-Label, Randomized Study to Determine the Impact of Antiretroviral Treatment in HCV/HIV-Coinfected Subjects With High CD4+ Cell Count on the Efficacy of Hepatitis C Treatment With Pegylated Interferon Alfa-2A and Ribavirin|Completed||N/A|2|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:44:07.25072|2017-02-18 17:44:07.25072
NCT00100568|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-03|2013-09-04|||July 2006||2006-07-01|September 2013|2013-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal|A Pilot Study of Safety, Effectiveness, and Adherence of Lamivudine/Zidovudine and Efavirenz (3TC/ZDV + EFV) to Treat HIV-1 Infection in Senegal|Completed||N/A|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:44:07.377514|2017-02-18 17:44:07.377514
NCT00100555|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-03|2012-04-26|||June 2004||2004-06-01|April 2012|2012-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate|A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate|Completed||Phase 3|120||Novartis|||||||||||||||||||2017-02-18 17:44:07.511997|2017-02-18 17:44:07.511997
NCT00100542|ClinicalTrials.gov processed this data on February 17, 2017|2005-01-03|2011-01-20|||April 2005||2005-04-01|January 2011|2011-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||Psychiatric Problems in Children and Adolescents Infected With HIV at Birth|Psychiatric Co-Morbidity in Perinatally HIV-Infected Children and Adolescents|Completed||N/A|800|Anticipated|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|||1||f||||||||||||||2017-02-18 17:44:07.622777|2017-02-18 17:44:07.622777
NCT00100529|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-31|2017-01-24|||December 21, 2004||2004-12-21|June 29, 2012|2012-06-29|June 29, 2012||2012-06-29|||||Observational|||Stereo Photogrammetry Imaging in Normal Volunteers and Patients With Head and Facial Malformations|Stereo Photogrammetry Soft Tissue in Normal Individuals and Patients With Craniofacial Dysmorphologies|Completed||N/A|1577|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:07.769978|2017-02-18 17:44:07.769978
NCT00100516|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-31|2017-01-24|||December 23, 2004||2004-12-23|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Observational|||Donor Recipient Kidney Function Following Open Surgical vs. Laparoscopic Kidney Donation|Infrared Image Guided Minimally Invasive Live Donor Kidney Donation for Kidney Transplantation|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:07.867945|2017-02-18 17:44:07.867945
NCT00100503|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-31|2017-01-24|||December 27, 2004||2004-12-27|August 30, 2006|2006-08-30|August 30, 2006||2006-08-30|||||Observational|||Brain Reorganization Following Constraint-Induced Therapy in Children With Cerebral Palsy|Cortical Reorganization Following Pediatric Constraint-Induced Therapy|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:07.955658|2017-02-18 17:44:07.955658
NCT00100490|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Observational|||Immune and Endocrine Function in Post-Traumatic Stress Disorder|Immune and Endocrine Function in Post-Traumatic Stress Disorder|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:44:08.040571|2017-02-18 17:44:08.040571
NCT00100477|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2013-09-24|||August 1998||1998-08-01|September 2013|2013-09-01|June 2001|Actual|2001-06-01|January 2001|Actual|2001-01-01||Interventional|||Use of Topotecan in Patients With Refractory Acute Leukemia|Study of Topoisomerase Inhibition in the Treatment of Acute Leukemia|Completed||Phase 2|10|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 17:44:08.115553|2017-02-18 17:44:08.115553
NCT00100464|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2013-09-16|||November 2000||2000-11-01|September 2013|2013-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Serotonin and the Upper Airway in Obstructive Sleep Apnea|Serotonin and the Upper Airway in Obstructive Sleep Apnea|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:44:08.220208|2017-02-18 17:44:08.220208
NCT00100451|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2009-01-20|||June 1994||1994-06-01|December 2004|2004-12-01|June 2001||2001-06-01|||||Interventional|||Aging, Exercise, and Hormonal Influences of Fat Metabolism|Aging, Exercise, and Hormonal Influences of Fat Metabolism|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:44:08.302118|2017-02-18 17:44:08.302118
NCT00005345|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||January 1993||1993-01-01|August 2004|2004-08-01|July 2000|Actual|2000-07-01|||||Observational|||Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.5068|2017-02-18 18:15:06.5068
NCT00099684|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2012-10-26|||November 2005||2005-11-01|October 2012|2012-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults|A Pilot Study of the Safety, Efficacy, and Tolerability of Ezetimibe (Zetia) in Combination With Statin Therapy for the Treatment of Elevated LDL Cholesterol in HIV-Infected Subjects|Completed||N/A|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:44:08.524508|2017-02-18 17:44:08.524508
NCT00099671|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2013-07-30|||April 2005||2005-04-01|July 2013|2013-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs|A Phase I, Randomized, Placebo-Controlled, Double-Blind Study Evaluating the Safety of Subcutaneous Single Dose Interleukin-7 in HIV-1-Infected Subjects Who Are Receiving Antiretroviral Treatment|Completed||Phase 1|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:44:08.678138|2017-02-18 17:44:08.678138
NCT00099658|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2011-02-14|||April 2005||2005-04-01|February 2011|2011-02-01|June 2014|Anticipated|2014-06-01|December 2013|Anticipated|2013-12-01||Interventional|||Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children|Evaluation of Quantitative and Qualitative Antibody Responses to Streptococcus Pneumoniae and Haemophilus Influenzae Type b Conjugate Vaccines Amongst HIV-1-Exposed-Infected Children That Are Receiving Vs. Those Not Receiving Antiretroviral Therapy, as Well as Among HIV-1-Exposed-Uninfected Children and HIV-1-Unexposed-Uninfected Children|Unknown status|Active, not recruiting|N/A|579|Actual|CIPRA SA||5|||f||||t||||||||||2017-02-18 17:44:08.780187|2017-02-18 17:44:08.780187
NCT00099645|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2012-05-17||||||May 2012|2012-05-01|August 2005|Actual|2005-08-01|||||Interventional|||Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People|A Randomized, Placebo-Controlled, Phase I/II Trial of the Anti-HIV Activity and Safety of VGX-410 (Mifepristone) at Three Dose Levels in HIV-1 Infected Subjects|Completed||Phase 1/Phase 2|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:44:08.890006|2017-02-18 17:44:08.890006
NCT00099632|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2015-12-29|2011-12-06||March 2006||2006-03-01|December 2015|2015-12-01|November 2011|Actual|2011-11-01|April 2010|Actual|2010-04-01||Interventional|||Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy|Maintaining Options for Mothers Study (MOMS): A Phase II Randomized Comparison of Three Antiretroviral Strategies Administered for 7 or 21 Days to Reduce the Emergence of Nevirapine Resistant HIV-1 Following a Single Intrapartum Dose of Nevirapine|Completed||Phase 2|484|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||t||||||||||2017-02-18 17:44:09.008129|2017-02-18 17:44:09.008129
NCT00099619|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2015-02-20|||September 2004||2004-09-01|January 2015|2015-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy|Efficacy of Exenatide Compared With Insulin Glargine in Patients With Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate Therapy|Completed||Phase 3|138|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:44:11.262507|2017-02-18 17:44:11.262507
NCT00099606|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2011-04-18|||July 2004||2004-07-01|April 2011|2011-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Phase I (PH I) Mad Refractory Solid Tumor Study|A Phase I Dose-Escalation Study of BMS-354825 in Patients With Refractory Solid Tumors|Completed||Phase 1|60||Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 17:44:11.401135|2017-02-18 17:44:11.401135
NCT00099593|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2015-03-24|||September 2004||2004-09-01|December 2006|2006-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Immunization Against Tumor Cells in Sezary Syndrome|Phase II Evaluation of Immunization Against Tumor Cells in Subjects With Sezary Syndrome Using Autologous Mature Dendritic Cells|Completed||Phase 2|17|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 17:44:11.507326|2017-02-18 17:44:11.507326
NCT00099580|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2015-01-16|||March 2005||2005-03-01|December 2014|2014-12-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure|PROCLAIM: A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Examine the Effects of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure|Completed||Phase 2|61|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:44:11.604394|2017-02-18 17:44:11.604394
NCT00099567|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-16|2005-10-31|||January 1997||1997-01-01|December 2004|2004-12-01|December 2002||2002-12-01|||||Observational|||Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline|Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline|Completed||N/A|2632||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:44:11.732424|2017-02-18 17:44:11.732424
NCT00099554|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-16|2009-11-12|||May 2004||2004-05-01|November 2009|2009-11-01||||||||Interventional|||Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)|A Phase 4, Open-Label, Single Arm, Observational Study Evaluating the Effectiveness and Safety of Enbrel® (Etanercept) 50 mg Once Weekly in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)|Completed||Phase 4|200||Amgen|||||||||||||||||||2017-02-18 17:44:11.820566|2017-02-18 17:44:11.820566
NCT00099541|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-15|2009-11-20|||November 2004||2004-11-01|November 2009|2009-11-01|November 2007||2007-11-01|||||Interventional|||Non-small Cell Lung Cancer Registry|A Dual-Cohort, Prospective, Observational Study of Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer Patients With and Without Bone Metastasis|Completed||Phase 4|300||Novartis|||||f||||||||||||||2017-02-18 17:44:11.922749|2017-02-18 17:44:11.922749
NCT00099528|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-15|2010-07-28|||August 2003||2003-08-01|March 2005|2005-03-01|December 2004||2004-12-01|||||Interventional|||Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia|REN-1654 in Post-Herpetic Neuralgia: a Multi-Center, Placebo Controlled, 3-week Dose-Finding Study, With a 3-Week Active-Treatment Extension|Unknown status|Active, not recruiting|Phase 2|90||Renovis|||||||||||||||||||2017-02-18 17:44:12.11048|2017-02-18 17:44:12.11048
NCT00099515|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-15|2007-12-18|||November 2004||2004-11-01|December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|IDAP||Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)|Standard Training Versus Intensive Training for HIIP Delivery System Usage in Insulin-Naïve Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|97|Actual|Eli Lilly and Company||2|||||||f||||||||||2017-02-18 17:44:12.468821|2017-02-18 17:44:12.468821
NCT00005344|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||May 1992||1992-05-01|August 2004|2004-08-01|April 1998|Actual|1998-04-01|||||Observational|||Mediators of Social Support in Coronary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.580007|2017-02-18 18:15:06.580007
NCT00099502|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-15|2008-12-18|||November 2003||2003-11-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|||||Interventional|||BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients|International, Randomized, Multicenter, Phase IIIb Study in Patients With Relapsing-Remitting Multiple Sclerosis Comparing Over a Treatment Period of at Least 104 Weeks: 1. Double-Blinded Safety, Tolerability, and Efficacy of Betaseron/ Betaferon 250 µg (8 MIU) and Betaseron/-Betaferon 500 µg (16 MIU), Both Given Subcutaneously Every Other Day, and 2. Rater-Blinded Safety, Tolerability, and Efficacy of Betaseron/-Betaferon s.c. Every Other Day With Copaxone 20 mg s.c. Once Daily.|Completed||Phase 3|2244|Actual|Bayer||3|||f||||t||||||||||2017-02-18 17:44:12.573552|2017-02-18 17:44:12.573552
NCT00099489|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-15|2010-03-04|||February 2004||2004-02-01|March 2010|2010-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Safety and Efficacy of AVONEX When Used in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)|Completed||Phase 2|67||Biogen|||||||||||||||||||2017-02-18 17:44:13.073632|2017-02-18 17:44:13.073632
NCT00099476|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-14|2017-01-24|||December 10, 2004||2004-12-10|April 16, 2009|2009-04-16|April 16, 2009||2009-04-16|||||Interventional|||Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood Pressure|Effects of Cocoa Consumption on Insulin Sensitivity and Capillary Recruitment in Subjects With Essential Hypertension|Completed||Phase 1|65||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:44:13.20678|2017-02-18 17:44:13.20678
NCT00099463|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-14|2017-01-24|||December 9, 2004||2004-12-09|August 22, 2007|2007-08-22|August 22, 2007||2007-08-22|||||Interventional|||Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)|A Phase I Study of the Safety and Immunogenicity of a SARS Recombinant DNA Plasmid Vaccine, VRC-SRSDNA015-00-VP, in Healthy Adult Volunteers|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:13.299541|2017-02-18 17:44:13.299541
NCT00100438|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Observational|||Incidence of Parkinson's Disease Among Veterans|Incidence of Parkinson's Disease Among Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:44:13.396924|2017-02-18 17:44:13.396924
NCT00100425|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2009-01-20|||September 2000||2000-09-01|December 2004|2004-12-01||||||||Interventional|||Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome|Central Nervous System Modulation of Visceral Pain in Persian Gulf War Syndrome|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:44:13.468034|2017-02-18 17:44:13.468034
NCT00100412|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Interventional|||Hyporeactivity and Gulf War Illness|Cardiovascular Hyporeactivity and Fatiguing Illness in Gulf War Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:44:13.550896|2017-02-18 17:44:13.550896
NCT00100399|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2010-08-26|||December 2004||2004-12-01|March 2007|2007-03-01|December 2004||2004-12-01|||||Interventional|||Fluarix Immunogenicity and Safety Trial|A Randomized, Double-blinded, Placebo Controlled Phase III Study to Evaluate the Immunogenicity and Safety of GSK Bio Influenza Vaccine (Fluarix) Administered Intramuscularly in Healthy Adults|Completed||Phase 3|1050||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:44:13.632414|2017-02-18 17:44:13.632414
NCT00100386|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2011-06-09|||March 2005||2005-03-01|October 2007|2007-10-01|August 2006||2006-08-01|||||Interventional|||Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial|Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial|Completed||N/A|30000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:44:13.914973|2017-02-18 17:44:13.914973
NCT00100373|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-30|2010-08-26|||September 2004||2004-09-01|February 2007|2007-02-01|May 2005||2005-05-01|||||Interventional|||RSV Challenge in Healthy Adults|Characterization of the Immune Response and Viral Shedding to Experimental Infection With Respiratory Syncytial Virus, Strain A-2, in Healthy Adults Ages 21 to 40 Years Old|Completed||N/A|13||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:44:14.036371|2017-02-18 17:44:14.036371
NCT00100360|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-29|2017-01-24|||December 22, 2004||2004-12-22|December 15, 2016|2016-12-15|December 15, 2016||2016-12-15|||||Observational|||Hormonal Causes of Menstrual-Related Mood Disorders|5HT1A and SERT Imaging During Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement|Completed||N/A|22|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:14.118865|2017-02-18 17:44:14.118865
NCT00100347|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-29|2007-07-23|||December 2004||2004-12-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin’s Lymphoma and Solid Tumors|A Phase 1 Dose Escalation Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin’s Lymphoma and Solid Tumors|Terminated||Phase 1|45|Actual|PRAECIS Pharmaceuticals Inc.||1||terminated due to corporate transaction.|f||||f||||||||||2017-02-18 17:44:14.214498|2017-02-18 17:44:14.214498
NCT00100334|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-29|2006-09-18|||December 2004||2004-12-01|September 2006|2006-09-01|August 2005||2005-08-01|||||Interventional|||Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer’s Disease|Multiple Dose Safety and Preliminary Pharmacodynamic Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer’s Disease|Completed||Phase 1/Phase 2|24||PRAECIS Pharmaceuticals Inc.|||||||||||||||||||2017-02-18 17:44:14.31249|2017-02-18 17:44:14.31249
NCT00100321|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-28|2017-01-24|||December 21, 2004||2004-12-21|November 20, 2012|2012-11-20|November 20, 2012||2012-11-20|||||Observational|||Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study|Immunologic Studies of Tumors of the Pancreas|Terminated||N/A|25|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:14.392442|2017-02-18 17:44:14.392442
NCT00100308|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-28|2008-01-08|||July 2005||2005-07-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Unfractioned Heparin for Treatment of Sepsis|Unfractioned Heparin for Treatment of Sepsis: A Randomized Clinical Trial (The HETRASE Study)|Completed||Phase 3|319|Actual|Universidad de Antioquia||2|||f||||t||||||||||2017-02-18 17:44:14.47716|2017-02-18 17:44:14.47716
NCT00100295|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-28|2007-10-24|||February 2005||2005-02-01|October 2007|2007-10-01|November 2006|Actual|2006-11-01|||||Interventional|||Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)|Controlled Trial of an Herbal Treatment for Juvenile Attention Deficit Hyperactivity Disorder|Completed||Phase 2|59|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 17:44:14.581962|2017-02-18 17:44:14.581962
NCT00100282|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-27|2006-09-18|||May 2003||2003-05-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease|Single Dose Escalation Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer’s Disease|Completed||Phase 1|125||PRAECIS Pharmaceuticals Inc.|||||||||||||||||||2017-02-18 17:44:14.686384|2017-02-18 17:44:14.686384
NCT00100269|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-27|2006-05-01|||December 2004||2004-12-01|June 2005|2005-06-01|March 2006||2006-03-01|||||Interventional|||Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility|A Randomized Control Trial of the Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility|Completed||Phase 3|60||Repromed|||||f||||||||||||||2017-02-18 17:44:14.773601|2017-02-18 17:44:14.773601
NCT00100256|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-27|2014-12-17|||January 2004||2004-01-01|December 2014|2014-12-01|April 2005|Actual|2005-04-01|||||Interventional|||Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy|Open Label Study of Single Dose Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy|Completed||Phase 1|19|Actual|Bayer||1|||f||||||||||||||2017-02-18 17:44:14.885176|2017-02-18 17:44:14.885176
NCT00100243|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-27|2006-09-18|||May 2004||2004-05-01|September 2006|2006-09-01|September 2005||2005-09-01|||||Interventional|||Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy|Phase 2 Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy|Completed||Phase 2|22||PRAECIS Pharmaceuticals Inc.|||||||||||||||||||2017-02-18 17:44:14.997468|2017-02-18 17:44:14.997468
NCT00100230|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-27|2015-03-04|2014-08-25||September 2004||2004-09-01|March 2015|2015-03-01|August 2014|Actual|2014-08-01|May 2012|Actual|2012-05-01||Interventional||males with X-linked retinitis pigmentosa|DHA and X-Linked Retinitis Pigmentosa|Investigation of Effectiveness and Safety of High Dose Docosahexaenoic Acid (DHA) in X-Linked Retinitis Pigmentosa|Completed||Phase 2|78|Actual|Retina Foundation of the Southwest|A lower than expected event rate for the primary outcome measure was the major trial limitation.|2|||f||||t||||||||||2017-02-18 17:44:15.091921|2017-02-18 17:44:15.091921
NCT00100217|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-23|2017-01-24|||December 21, 2004||2004-12-21|June 25, 2010|2010-06-25|June 25, 2010||2010-06-25|||||Observational|||Evaluation of Patients With Critical Illness|Evaluation of Patients With Critical Illness: Intensive Care Training Protocol|Completed||N/A|1|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:15.638293|2017-02-18 17:44:15.638293
NCT00100204|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-23|2017-01-24|||December 21, 2004||2004-12-21|April 19, 2011|2011-04-19|April 19, 2011||2011-04-19|||||Observational|||Salivary Proteins in Disease and Health|Salivary Proteomics in Disease and Health|Completed||N/A|264|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:15.843857|2017-02-18 17:44:15.843857
NCT00100191|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-23|2005-06-23|||February 2002||2002-02-01|December 2004|2004-12-01|April 2006||2006-04-01|||||Interventional|||Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids|EMMY Trial: a Randomized Comparison of Uterine Artery Embolization and Hysterectomy for the Treatment of Symptomatic Uterine Fibroids|Completed||Phase 3|120||ZonMw: The Netherlands Organisation for Health Research and Development|||||f||||||||||||||2017-02-18 17:44:15.928904|2017-02-18 17:44:15.928904
NCT00100178|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-23|2016-07-07|2016-05-13||May 2004||2004-05-01|July 2016|2016-07-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial|New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial (Preservation of Pancreatic Production of Insulin Through Immunosuppression-POPPII #1)|Completed||Phase 2|126|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||||||||||||2017-02-18 17:44:16.034403|2017-02-18 17:44:16.034403
NCT00100165|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-23|2015-12-04|||January 2005||2005-01-01|December 2015|2015-12-01|December 2016|Anticipated|2016-12-01|December 2015|Anticipated|2015-12-01||Interventional|||Trial of DMXB-A in Schizophrenia|Phase 2 Trial of 3-2,4 Dimethoxybenzylidene Anabaseine in Schizophrenia|Recruiting||Phase 2|36|Anticipated|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:44:16.560563|2017-02-18 17:44:16.560563
NCT00100152|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-23|2015-05-25|||February 2005||2005-02-01|May 2015|2015-05-01|October 2006|Actual|2006-10-01|September 2006|Actual|2006-09-01||Interventional|||A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)|A Phase I Study of a Gamma Secretase Inhibitor for Adult and Pediatric Patients With Relapsed or Refractory Acute T-Cell Lymphoblastic Leukemia and Lymphoma|Terminated||Phase 1|50||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:44:16.670037|2017-02-18 17:44:16.670037
NCT00100139|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-23|2011-06-30|||November 2004||2004-11-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer|A Randomized Two-Period Crossover, Clinical Bioequivalence Study Comparing the Pharmacokinetics of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Formulation Versus Taxol® in Patients With Advanced Cancer|Completed||Phase 1|48||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 17:44:16.749812|2017-02-18 17:44:16.749812
NCT00100126|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-23|2006-10-23|||December 2004||2004-12-01|April 2005|2005-04-01|June 2005||2005-06-01|||||Interventional|||APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat|A Phase III, Investigator Blind, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of APC-231 Sprinkle QD for 7 Days vs Penicillin VK 10 mg/kg QID for 10 Days in Pediatric Patients With Streptococcus Pyogenes|Completed||Phase 3|500||Advancis Pharmaceutical Corporation|||||||||||||||||||2017-02-18 17:44:17.034753|2017-02-18 17:44:17.034753
NCT00100113|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-22|2017-01-10|||June 2004||2004-06-01|March 2005|2005-03-01|June 2005||2005-06-01|||||Interventional|||Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1|Study of Interactions Between GBR 12909 and Cocaine|Unknown status|Active, not recruiting|Phase 1|24||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:44:17.124943|2017-02-18 17:44:17.124943
NCT00100100|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-22|2017-01-11|||October 2004||2004-10-01|July 2008|2008-07-01|December 2006||2006-12-01|||||Interventional|||Modafinil for the Treatment of Cocaine Dependence - 1|Modafinil for the Treatment of Cocaine Dependence|Completed||Phase 2|210||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:44:17.240681|2017-02-18 17:44:17.240681
NCT00100087|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-22|2005-06-23|||October 2004||2004-10-01|January 2005|2005-01-01||||||||Interventional|||Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System|A Safety and Feasibility Study of the TheraSight(TM) Ocular Brachytherapy System for Treatment of Age-Related Macular Degeneration|Unknown status|Recruiting|Phase 1/Phase 2|30||Theragenics Corporation|||||||||||||||||||2017-02-18 17:44:17.351255|2017-02-18 17:44:17.351255
NCT00100074|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-22|2017-01-10|||September 2004||2004-09-01|December 2004|2004-12-01|April 2005||2005-04-01|||||Interventional|||To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1|Safety and Tolerability Study of Sublingual Lobeline|Unknown status|Active, not recruiting|Phase 1|8||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:44:17.459393|2017-02-18 17:44:17.459393
NCT00100061|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-22|2013-03-11|||May 2007||2007-05-01|March 2013|2013-03-01|July 2013|Anticipated|2013-07-01|July 2013|Anticipated|2013-07-01||Interventional|||Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)|Dose Response to Cranberry of Women With Recurrent UTIs|Unknown status|Active, not recruiting|Phase 2|350|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 17:44:17.546476|2017-02-18 17:44:17.546476
NCT00100048|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-22|2015-09-04|2010-01-21||January 2005||2005-01-01|September 2015|2015-09-01|July 2010|Actual|2010-07-01|October 2006|Actual|2006-10-01||Interventional|||A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)|Multicenter, Double-Blind, Randomized, Dose Ranging Study to Compare the Safety and Activity of MK0518 Plus Tenofovir and Lamivudine (3TC) Versus Efavirenz Plus Tenofovir and Lamivudine (3TC) in ART-Naive, HIV-Infected Patients|Completed||Phase 2|206|Actual|Merck Sharp & Dohme Corp.||10|||f||||f||||||||||2017-02-18 17:44:17.664318|2017-02-18 17:44:17.664318
NCT00100035|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-22|2008-04-21|||August 2004||2004-08-01|April 2008|2008-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Polarity Therapy for American Indian Caregivers of Dementia Patients|Polarity Therapy for Dementia Caregivers|Completed||Phase 1|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 17:44:20.095321|2017-02-18 17:44:20.095321
NCT00100009|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2017-01-24|||December 9, 2004||2004-12-09|December 20, 2006|2006-12-20|December 20, 2006||2006-12-20|||||Interventional|||Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration|Multi-Center, Randomized, Phase II/III Clinical Trial to Study the Effects of Preservative-Free Triamcinolone Acetonide as an Adjunct to Photodynamic Therapy in Participants With Neovascular Age-Related Macular Degeneration|Completed||Phase 3|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:20.184553|2017-02-18 17:44:20.184553
NCT00099996|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2008-03-03|||December 2004||2004-12-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia|A Study to Assess Adding Ezetimibe 30 mg to Ongoing Treatment With Ezetimibe 10 mg in Patients With Homozygous Sitosterolemia|Completed||Phase 3|3||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:20.296287|2017-02-18 17:44:20.296287
NCT00099983|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2014-08-05|2013-08-06||October 2006||2006-10-01|August 2014|2014-08-01|January 2011|Actual|2011-01-01|February 2010|Actual|2010-02-01||Interventional|CSP #504|"Valid diagnostic baseline data were collected on 267 patients randomized to receive risperidone (n=133) and placebo (n=134). The 29 patients with missing source documents as reported in Participant Flow were not included in any analyses."|Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder|CSP #504 - Risperidone Treatment for Military Service Related Chronic Post-Traumatic Stress Disorder|Completed||Phase 2|296|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:44:20.3845|2017-02-18 17:44:20.3845
NCT00099970|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2008-08-02|||December 2004||2004-12-01|August 2008|2008-08-01|March 2006||2006-03-01|||||Interventional|||Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy|Phase II Open-Label Study of Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemo|Completed||Phase 2|40||Facet Biotech|||||||||||||||||||2017-02-18 17:44:20.813363|2017-02-18 17:44:20.813363
NCT00099957|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2012-05-01|||September 2003||2003-09-01|May 2012|2012-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes|A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes|Completed||Phase 2|38||Novartis|||||||||||||||||||2017-02-18 17:44:20.915806|2017-02-18 17:44:20.915806
NCT00099944|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2012-05-03|||May 2004||2004-05-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes|Completed||Phase 3|515|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:44:21.192646|2017-02-18 17:44:21.192646
NCT00099931|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2012-05-04|||May 2004||2004-05-01|May 2012|2012-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes|Completed||Phase 3|254|Actual|Novartis|||||f||||||||||||||2017-02-18 17:44:21.297301|2017-02-18 17:44:21.297301
NCT00099918|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2012-05-04|||May 2004||2004-05-01|May 2012|2012-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|717|Actual|Novartis|||||f||||||||||||||2017-02-18 17:44:21.391827|2017-02-18 17:44:21.391827
NCT00099905|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2012-05-01|||April 2004||2004-04-01|May 2012|2012-05-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes|A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes|Completed||Phase 3|639|Actual|Novartis|||||||||||||||||||2017-02-18 17:44:21.49652|2017-02-18 17:44:21.49652
NCT00099892|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2012-05-01|||May 2004||2004-05-01|May 2012|2012-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes|Completed||Phase 3|544|Actual|Novartis|||||f||||||||||||||2017-02-18 17:44:21.591481|2017-02-18 17:44:21.591481
NCT00099879|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2010-02-27||2010-02-27||||August 2007|2007-08-01||||March 2006|Actual|2006-03-01||Interventional|||Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer|A Randomized, Two-Cohort Phase II Study of Two Doses of BMS-275183 Given on a Weekly Schedule in Patients With Pre-Treated Non-Small Cell Lung Cancer|Terminated||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:44:21.701964|2017-02-18 17:44:21.701964
NCT00099866|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2012-05-04|||January 2004||2004-01-01|May 2012|2012-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes|Completed||Phase 3|570|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:44:21.810666|2017-02-18 17:44:21.810666
NCT00099853|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2013-01-02||2012-12-28|May 2004||2004-05-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes|Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes|Completed||Phase 3|362|Actual|Novartis||3|||f||||||||||||||2017-02-18 17:44:21.921311|2017-02-18 17:44:21.921311
NCT00099840|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2007-04-24|||December 2004||2004-12-01|January 2006|2006-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Procalcitonin Guided Antibiotic Use in Acute Respiratory Tract Infections (PARTI)-Study|Procalcitonin Guided Antibiotic Use in Acute Respiratory Tract Infections in Primary Care - A Randomized Controlled Trial|Completed||N/A|400||University Hospital, Basel, Switzerland|||||f||||||||||||||2017-02-18 17:44:22.032853|2017-02-18 17:44:22.032853
NCT00099827|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2011-10-14|||October 2003||2003-10-01|October 2011|2011-10-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Teen Depression Awareness Project (TDAP)|Teen Depression Awareness Project- This Project Examines the Services Used by Teens Identified in Primary Care Settings With Depression|Completed||Phase 1|368|Actual|RAND|||||f||||f||||||||||2017-02-18 17:44:22.144295|2017-02-18 17:44:22.144295
NCT00099814|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2010-06-28|||March 2004||2004-03-01|June 2010|2010-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Periodontal Ligament Stress Level and Tooth Movement|Clinical/Numerical Study of the Effects of Periodontal Ligament Stress Level on the Rate Bodily Tooth Movement|Completed||Phase 1|20||University of Alberta, Graduate Orthodontic Program|||||f||||f||||||||||2017-02-18 17:44:22.264492|2017-02-18 17:44:22.264492
NCT00099801|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2014-01-14|||January 2005||2005-01-01|January 2014|2014-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant|Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant|Completed||Phase 3|||Novartis|||||||||||||||||||2017-02-18 17:44:22.347261|2017-02-18 17:44:22.347261
NCT00099788|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-21|2009-11-24|||October 2004||2004-10-01|November 2009|2009-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes|A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multinational, Clinical Trial to Evaluate the Efficacy and Safety of Ranolazine vs Placebo in Patients With Non-ST Segment Elevation Acute Coronary Syndromes|Completed||Phase 3|6560|Actual|Gilead Sciences||2|||f||||t||||||||||2017-02-18 17:44:22.43094|2017-02-18 17:44:22.43094
NCT00099775|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-18|2008-03-03|||December 2004||2004-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units|A Randomized Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting|Completed||Phase 3|1200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:22.555507|2017-02-18 17:44:22.555507
NCT00099762|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2017-01-24|||December 15, 2004||2004-12-15|September 2, 2009|2009-09-02||||September 2, 2009|Actual|2009-09-02||Observational|||Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia|Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:22.644364|2017-02-18 17:44:22.644364
NCT00099749|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2011-11-01|||November 2003||2003-11-01|November 2011|2011-11-01||||April 2006|Actual|2006-04-01||Interventional|||Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant|Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant|Completed||Phase 2/Phase 3|255||Novartis|||||||||||||||||||2017-02-18 17:44:22.727594|2017-02-18 17:44:22.727594
NCT00099736|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2011-11-01|||May 2003||2003-05-01|November 2011|2011-11-01||||October 2005|Actual|2005-10-01||Interventional|||Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant|Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant|Completed||Phase 3|684||Novartis|||||||||||||||||||2017-02-18 17:44:22.822824|2017-02-18 17:44:22.822824
NCT00099723|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2010-02-10|||October 2004||2004-10-01|December 2004|2004-12-01|December 2005|Anticipated|2005-12-01|||||Interventional|||The Effect of a Probiotic on Hepatic Steatosis|The Effect of a Probiotic on Hepatic Steatosis|Terminated||Phase 1|30|Anticipated|VSL Pharmaceuticals||||The hypothesis that probiotics would reduce hepatic steatosis in humans was not supported|||||||||||||||2017-02-18 17:44:22.953095|2017-02-18 17:44:22.953095
NCT00099710|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-17|2009-12-02|||July 2003||2003-07-01|December 2009|2009-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Curcumin in Patients With Mild to Moderate Alzheimer's Disease|A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Two Doses of Curcumin C3 Complex Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|33|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:44:23.043803|2017-02-18 17:44:23.043803
NCT00099450|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-14|2015-01-19|||December 2004||2004-12-01|January 2015|2015-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers|Single-Center, Open-Labeled Dose Escalation Followed by Randomized, Double-Blind, Placebo-Controlled Cohort Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers|Completed||Phase 1|48|Anticipated|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:44:23.312074|2017-02-18 17:44:23.312074
NCT00099437|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-13|2016-11-07|2010-02-23||February 2005||2005-02-01|November 2016|2016-11-01|January 2018|Anticipated|2018-01-01|February 2009|Actual|2009-02-01||Interventional|CONFIRM||Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.|A Randomised, Double-Blind, Parallel-group, Multicentre, Phase III Study Comparing the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 500 mg With Fulvestrant (FASLODEX™) 250 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy|Active, not recruiting||Phase 3|834|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:44:23.434237|2017-02-18 17:44:23.434237
NCT00099424|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-13|2008-06-04|||February 2004||2004-02-01|June 2008|2008-06-01|August 2005||2005-08-01|||||Interventional|||Exercise Training in Sarcoidosis (EXTRAS Study)|EXercise TRAining in Sarcoidosis (EXTRAS Study): A Prospective, Randomized, Controlled, Crossover Trial|Completed||N/A|30||University Hospital, Gasthuisberg|||||f||||||||||||||2017-02-18 17:44:24.309954|2017-02-18 17:44:24.309954
NCT00099411|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-13|2013-01-31|||January 2004||2004-01-01|January 2013|2013-01-01||||||||Observational|||Heart Muscle Viability and Remodeling in Individuals Post-Heart Attack|Myocardial Viability and Remodeling in the Occluded Artery Trial (OAT)-Ancillary to OAT|Unknown status|Active, not recruiting|N/A|200|Anticipated|Tufts Medical Center|||1||f||||t||||||||||2017-02-18 17:44:24.421953|2017-02-18 17:44:24.421953
NCT00099385|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-13|2012-02-15|||September 2004||2004-09-01|February 2012|2012-02-01|July 2010|Actual|2010-07-01|June 2010|Actual|2010-06-01||Interventional|||Comprehensive Elementary School Risk Prevention|Comprehensive Elementary School Risk Prevention|Completed||N/A|2620|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-02-18 17:44:24.513045|2017-02-18 17:44:24.513045
NCT00099372|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2013-09-27|||May 2004||2004-05-01|September 2013|2013-09-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse|Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse: The Extended Colpopexy and Urinary Reduction Efforts (E-CARE) Study|Terminated||N/A|215|Actual|NICHD Pelvic Floor Disorders Network|||2|resource and prioritization change as Network transition to a new funding cycle|f||||t||||||||||2017-02-18 17:44:24.612055|2017-02-18 17:44:24.612055
NCT00099359|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2012-10-26|2012-04-25||February 2004||2004-02-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission|Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission|Completed||Phase 3|1735|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||3|||f||||t||||||||||2017-02-18 17:44:24.947004|2017-02-18 17:44:24.947004
NCT00099346|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2015-06-16|||January 2005||2005-01-01|June 2015|2015-06-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001)|A Phase I/IIa Study Evaluating the Safety/Tolerability, Pharmacokinetics, and Efficacy of MK0457 Administered as a 5-Day Continuous Infusion in Patients With Advanced Colorectal Cancer and Other Solid Tumors|Terminated||Phase 1|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:44:26.161507|2017-02-18 17:44:26.161507
NCT00099333|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2015-02-20|||February 2004||2004-02-01|January 2015|2015-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents|An Exploratory Study of the Safety of Substituting Exenatide for Insulin in Patients With Type 2 Diabetes Who Have Been Using Insulin in Combination With Oral Antidiabetic Therapy|Completed||Phase 2|49|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:44:26.229012|2017-02-18 17:44:26.229012
NCT00099320|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2015-02-20|||May 2004||2004-05-01|January 2015|2015-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin|Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin|Completed||Phase 3|182|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:44:26.341069|2017-02-18 17:44:26.341069
NCT00099307|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2017-01-24|||December 8, 2004||2004-12-08|September 28, 2011|2011-09-28|September 28, 2011||2011-09-28|||||Observational|||Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis|An Exploratory Study on Detection of Cortical Damage in Patients With Multiple Sclerosis Using Magnetic Resonance Imaging|Completed||N/A|94|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:44:26.629609|2017-02-18 17:44:26.629609
NCT00099294|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2009-04-28|||September 2004||2004-09-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer|A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine|Completed||Phase 3|300||Threshold Pharmaceuticals|||||||||||||||||||2017-02-18 17:44:26.712816|2017-02-18 17:44:26.712816
NCT00099281|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2007-02-27|||May 2004||2004-05-01|February 2007|2007-02-01|June 2006||2006-06-01|||||Interventional|||DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer|A Phase III Study of DPPE Combined With Epirubicin and Cyclophosphamide vs Epirubicin and Cyclophosphamide Alone as First Line Treatment in Metastatic/Recurrent Breast Cancer|Terminated||Phase 3|700||YM BioSciences|||||||||||||||||||2017-02-18 17:44:27.092609|2017-02-18 17:44:27.092609
NCT00099268|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2012-04-19|2010-12-15||September 2004||2004-09-01|April 2012|2012-04-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|STRIDE-PD||Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy|A Long Term, Double-blind, Randomized, Parallel-group, Carbidopa/Levodopa Controlled, Multi-center Study to Evaluate the Effect of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy|Completed||Phase 3|747|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:44:27.198752|2017-02-18 17:44:27.198752
NCT00099255|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2014-12-17|||September 2004||2004-09-01|December 2014|2014-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma|A Phase II Multi-Dose Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma, Large Cell Transformation of Mycosis Fungoides, and Lymphomatoid Papulosis|Completed||Phase 2|40||Seattle Genetics, Inc.|||||||||||||||||||2017-02-18 17:44:28.250532|2017-02-18 17:44:28.250532
NCT00099242|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2007-12-17|||November 2003||2003-11-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease|Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease|Completed||Phase 3|1040||Novartis|||||||||||||||||||2017-02-18 17:44:28.35479|2017-02-18 17:44:28.35479
NCT00097162|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2006-06-23|||November 2004||2004-11-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Visual Cortex Stimulation in Patients With Amblyopia|Investigation of Visual Plasticity by a Direct Current Stimulation of Occipital Cortex in Adult Amblyopia|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:46:00.824751|2017-02-18 17:46:00.824751
NCT00099229|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2011-11-22|||November 2004||2004-11-01|November 2011|2011-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Tolerability of Licarbazepine 1000-2000mg/Day in the Treatment of Manic Episodes of Bipolar I Disorder Over 3 Weeks|Completed||Phase 3|320|Actual|Novartis|||||f||||||||||||||2017-02-18 17:44:28.510044|2017-02-18 17:44:28.510044
NCT00099216|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2011-11-16|||August 2001||2001-08-01|November 2011|2011-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia|Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia|Completed||Phase 3|708|Actual|Novartis|||||f||||||||||||||2017-02-18 17:44:28.622679|2017-02-18 17:44:28.622679
NCT00099203|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2016-08-23|||July 2005||2005-07-01|August 2016|2016-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease|A Randomized, Placebo-controlled, Double-blind Study of the Effect of Bondronat Compared With Zoledronic Acid on Pain in Patients With Malignant Bone Disease Experiencing Moderate to Severe Pain|Terminated||Phase 3|163|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:44:28.906262|2017-02-18 17:44:28.906262
NCT00099190|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2009-04-27|||December 2004||2004-12-01|April 2009|2009-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||ARQ 501 in Combination With Docetaxel in Patients With Cancer|A Phase Ib Safety and Pharmacokinetic Study of ARQ 501 in Combination With Docetaxol in Adult Patients With Locally Advanced or Metastatic Carcinoma|Completed||Phase 1|50||ArQule|||||||||||||||||||2017-02-18 17:44:29.082218|2017-02-18 17:44:29.082218
NCT00099177|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-10|2016-08-23|||August 2005||2005-08-01|August 2016|2016-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain|A Randomized, Double-blind Study of the Effect of Bondronat Compared With Zoledronic Acid on Pain in Patients With Malignant Bone Disease Experiencing Moderate to Severe Pain|Terminated||Phase 3|96|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:44:29.179983|2017-02-18 17:44:29.179983
NCT00099164|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2016-09-26|||April 2004||2004-04-01|September 2016|2016-09-01|September 2007|Actual|2007-09-01|August 2006|Actual|2006-08-01||Interventional|||Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)|A Randomized Trial of 17 Alpha-Hydroxyprogesterone Caproate for Prevention of Preterm Birth in Multifetal Gestation (STTARS)|Completed||Phase 3|795|Actual|The George Washington University Biostatistics Center||1|||f||||t||||||||Yes|The data will be shared after completion and publication of the main analyses in accordance with NIH policy. The dataset can be obtained by emailing mfmudatasets@bsc.gwu.edu.|2017-02-18 17:44:29.715193|2017-02-18 17:44:29.715193
NCT00099151|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2009-12-09|||March 2002||2002-03-01|December 2004|2004-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy|Metabolic Adaptations to Six Month Caloric Restriction|Completed||N/A|48||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:44:29.87049|2017-02-18 17:44:29.87049
NCT00099138|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2009-12-09|||March 2002||2002-03-01|February 2006|2006-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||CALERIE (Washington University): Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy|Caloric Restriction and Aging in Humans|Completed||Phase 1|48||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:44:29.970661|2017-02-18 17:44:29.970661
NCT00099125|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2014-01-23|||November 2004||2004-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|October 2006|Actual|2006-10-01||Interventional|||Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase II Study Of Radiation Therapy Plus Low Dose Temozolomide Followed By Temozolomide Plus Irinotecan For Glioblastoma Multiforme|Completed||Phase 2|170|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 17:44:30.078304|2017-02-18 17:44:30.078304
NCT00099112|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2015-04-29|||February 2004||2004-02-01|November 2005|2005-11-01||||||||Observational|||Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II|Transcriptional Profiling of the Epidermal Response to Solar-Simulated Ultraviolet Radiation|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:44:30.315283|2017-02-18 17:44:30.315283
NCT00099099|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2009-12-09|||March 2002||2002-03-01|February 2006|2006-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||CALERIE (Tufts) - Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy|Dietary Energy Restriction and Metabolic Aging in Humans|Completed||Phase 1|44||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:44:30.40906|2017-02-18 17:44:30.40906
NCT00099086|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2015-12-28|||July 2010||2010-07-01|December 2015|2015-12-01||||January 2011|Actual|2011-01-01||Interventional|||Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer|Phase I Trial of Concurrent Taxotere With Radiation Therapy and Hormonal Therapy For Clinically Localized High Risk Prostate Cancer|Active, not recruiting||Phase 1|20|Actual|Medical University of South Carolina||1|||f||||t||||||||||2017-02-18 17:44:30.500927|2017-02-18 17:44:30.500927
NCT00099060|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2014-01-24|||December 2004||2004-12-01|April 2012|2012-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme|A Phase I/II Study of GW572016 in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 17:44:30.635437|2017-02-18 17:44:30.635437
NCT00099047|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2016-12-28|2014-12-16||November 2004||2004-11-01|December 2016|2016-12-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional||Asymptomatic adult patients with a serum monoclonal protein >1g/dL from each of the participating centers between August 2005 and April 2008 were randomized to either celecoxib or placebo in a double-blind, 1:1 fashion|Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma|Biologic and Clinical Role of COX-2 Inhibitor (Celecoxib)in the Management of MGUS and Smoldering Myeloma|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)|No overall limitations or caveats for this trial.|2|||f||||t||||||||||2017-02-18 17:44:30.751205|2017-02-18 17:44:30.751205
NCT00097149|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2013-12-16|||May 2003||2003-05-01|December 2013|2013-12-01|May 2006|Actual|2006-05-01|||||Interventional|||Systematic Pediatric Care for Oral Clefts - South America|Systematic Pediatric Care for Oral Clefts - South America|Completed||N/A|696||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 17:46:00.914608|2017-02-18 17:46:00.914608
NCT00099021|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2016-12-28|2009-10-13||June 2003||2003-06-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|September 2008|Actual|2008-09-01||Interventional|||Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia|A Phase IIa Cancer Prevention Trial of the PPAR Gamma Agonist Pioglitazone in Oral Leukoplakia|Completed||Phase 2|21|Actual|National Cancer Institute (NCI)|"Study was closed prior to full accrual because results were very good and funding was discontinued (R-01 application was filed.)~Immunohistochemistry (Outcomes #4 through #12) were not done due to laboratory limitations of time."|1|||f||||||||||||||2017-02-18 17:44:31.340376|2017-02-18 17:44:31.340376
NCT00099008|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2013-05-17|||March 2004||2004-03-01|May 2013|2013-05-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women|Phase I Multiple Dose Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women|Completed||Phase 1|30|Actual|UNC Lineberger Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:44:31.649358|2017-02-18 17:44:31.649358
NCT00098995|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2013-06-25|||December 2004||2004-12-01|November 2006|2006-11-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer|A Phase I Study Of Tirapazamine In Combination With Radiation And Weekly Cisplatin In Patients With Locally Advanced Cervical Cancer|Completed||Phase 1|22|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:44:31.779621|2017-02-18 17:44:31.779621
NCT00098982|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2013-06-11|||September 2004||2004-09-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer|Phase I Study of PS-341 (VELCADE) in Combination With 5FU/LV Plus Oxaliplatin in Patients With Advanced Colorectal Cancer|Completed||Phase 1|16|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:44:31.874301|2017-02-18 17:44:31.874301
NCT00098969|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2012-12-13|||September 2004||2004-09-01|March 2010|2010-03-01||||||||Interventional|IRB 2004-535||UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants|Phase I Single-Dose Safety and Phamacokinetics Clinical Study of Resveratrol AKA IRB 2003-424|Completed||Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:44:31.986665|2017-02-18 17:44:31.986665
NCT00098956|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2015-08-10|2015-08-10||January 2005||2005-01-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer|A Phase II Study of UCN-01 in Combination With Topotecan in Patients With SCLC Who Relapsed or Progressed &gt;= 3 Months After Completing First-Line Platinum-Based Chemotherapy|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:32.201526|2017-02-18 17:44:32.201526
NCT00098943|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2012-09-20|||September 2004||2004-09-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||NGR-TNF in Treating Patients With Advanced Solid Tumors|Phase I Trial of NGR-TNF Administered Every 3 Weeks as a 1 Hour Intravenous Infusion in Patients With Solid Tumor|Completed||Phase 1|70|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:44:32.4545|2017-02-18 17:44:32.4545
NCT00098917|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2008-01-24|||February 2005||2005-02-01|April 2007|2007-04-01||||||||Interventional|||Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer|A Phase I Clinical Trial of Mature Autologous Dendritic Cells Loaded With Irradiated Autologous Tumor Cells for the Treatment of Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 1|15||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:44:32.561411|2017-02-18 17:44:32.561411
NCT00098891|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2013-01-23|||October 2004||2004-10-01|January 2013|2013-01-01||||March 2008|Actual|2008-03-01||Interventional|||MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas|A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275 (NSC 706995, IND 61,198), in Combination With 13-Cis-Retinoic Acid in Metastatic Progressive Cancer.|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:32.649024|2017-02-18 17:44:32.649024
NCT00098878|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2013-08-06|||March 2004||2004-03-01|July 2009|2009-07-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|SCOTROC 4: A Prospective, Multicentre, Randomised Trial Of Carboplatin Flat Dosing Vs Intrapatient Dose Escalation In First Line Chemotherapy Of Ovarian, Fallopian Tube And Primary Peritoneal Cancers|Completed||Phase 3|1300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:44:32.764959|2017-02-18 17:44:32.764959
NCT00098865|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2014-09-28|2012-12-15||September 2002||2002-09-01|September 2014|2014-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional||The analysis population represents all enrolled and treated patients.|Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma|A Phase II Pilot Study Of Thalidomide With Temozolomide In Patients With Relapsed Or Progressive Brain Tumors Or Neuroblastoma|Completed||Phase 2|15|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||||2017-02-18 17:44:32.945158|2017-02-18 17:44:32.945158
NCT00098852|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2014-01-03|||October 2004||2004-10-01|January 2009|2009-01-01||||June 2010|Anticipated|2010-06-01||Interventional|||Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer|A Pilot Study of Rosiglitazone in Patients With Incurable Differentiated Thyroid Cancer|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:33.260302|2017-02-18 17:44:33.260302
NCT00098839|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2016-03-24|2015-03-03||February 2005||2005-02-01|March 2016|2016-03-01||||April 2011|Actual|2011-04-01||Interventional||Ineligible patients (2) are not included in baseline population.|Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)|A Feasibility Pilot and Phase II Study Of Chemoimmunotherapy With Epratuzumab (IND #12034) for Children With Relapsed CD22-Positive Acute Lymphoblastic Leukemia (ALL)|Active, not recruiting||Phase 1/Phase 2|134|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 17:44:33.368231|2017-02-18 17:44:33.368231
NCT00098826|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2013-01-10|||December 2004||2004-12-01|January 2013|2013-01-01||||May 2008|Actual|2008-05-01||Interventional|||SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes|Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemias|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:39.863261|2017-02-18 17:44:39.863261
NCT00098813|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2014-05-13|2013-10-29||October 2004||2004-10-01|October 2013|2013-10-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine|A Phase II Study of Single Agent Depsipeptide (FK228) in Radioiodine (RAI)-Refractory Metastatic Non-medullary (Papillary, Follicular, and Hurthle Cell Variants) Thyroid Carcinoma|Completed||Phase 2|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:39.978882|2017-02-18 17:44:39.978882
NCT00098800|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2010-03-23|||October 2004||2004-10-01|November 2006|2006-11-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional|||Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries|A Multicenter Randomized Double-Blinded Trial for Chemoprevention of Ovarian Cancer: Modulation of Biomarkers and Spectral Properties Using Contrast Enhanced Ultrasound in High-Risk Women Using Fenretinide (4-HPR)|Completed||N/A|40|Anticipated|University of Arizona|||||||||||||||||||2017-02-18 17:44:40.259126|2017-02-18 17:44:40.259126
NCT00098787|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2015-10-06|2014-05-27||July 2005||2005-07-01|October 2015|2015-10-01|April 2016|Anticipated|2016-04-01|November 2013|Actual|2013-11-01||Interventional||Eligible and treated patients|Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer|Phase II Study of Treatment Selection Based Upon Tumor Thymidylate Synthase Expression in Previously Untreated Patients With Metastatic Colorectal Cancer|Active, not recruiting||Phase 2|247|Actual|Eastern Cooperative Oncology Group||3|||f||||t||||||||||2017-02-18 17:44:40.359896|2017-02-18 17:44:40.359896
NCT00098774|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2016-07-01|2014-06-26||October 2004||2004-10-01|July 2016|2016-07-01|September 2014|Actual|2014-09-01|January 2010|Actual|2010-01-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma|Intensive Chemotherapy And Immunotherapy In Patients With Newly Diagnosed Primary CNS Lymphoma|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:44:41.575588|2017-02-18 17:44:41.575588
NCT00098761|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-08|2011-06-29|||February 2005||2005-02-01|June 2011|2011-06-01|February 2008|Actual|2008-02-01|October 2006|Actual|2006-10-01||Interventional|||VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors|Phase I Study Of Cloretazine (VNP40101M) In Children With Recurrent, Progressive Or Refractory Primary Brain Tumors|Completed||Phase 1|42|Actual|Pediatric Brain Tumor Consortium||1|||f||||t||||||||||2017-02-18 17:44:42.445184|2017-02-18 17:44:42.445184
NCT00098748|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2010-11-19|2010-03-25||November 2004||2004-11-01|November 2010|2010-11-01|April 2009|Actual|2009-04-01|December 2005|Actual|2005-12-01||Interventional|||Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects|A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced, Non CCR5-Tropic HIV-1 Infected Subjects|Completed||Phase 2/Phase 3|190|Actual|ViiV Healthcare||3|||f||||t||||||||||2017-02-18 17:44:42.590036|2017-02-18 17:44:42.590036
NCT00098735|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2016-11-16|||April 2004||2004-04-01|November 2016|2016-11-01||||April 2006|Actual|2006-04-01||Interventional|||Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation|Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation|Completed||Phase 3|140||Novartis|||||||||||||||||||2017-02-18 17:44:44.158365|2017-02-18 17:44:44.158365
NCT00098722|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2012-04-16|2012-04-16||December 2004||2004-12-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2007|Actual|2007-04-01||Interventional|MOTIVATE 2||Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced HIV-1 Infected Subjects|Completed||Phase 2/Phase 3|474|Actual|ViiV Healthcare||3|||f||||t||||||||||2017-02-18 17:44:44.474997|2017-02-18 17:44:44.474997
NCT00098709|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2015-10-19|||May 2002||2002-05-01|October 2015|2015-10-01|February 2005||2005-02-01|||||Interventional|||Fetal Pulse Oximetry Trial (FOX)|A Randomized Clinical Trial of Fetal Pulse Oximetry|Terminated||Phase 3|10000||The George Washington University Biostatistics Center|||||||||||||||||||2017-02-18 17:44:47.616703|2017-02-18 17:44:47.616703
NCT00098683|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2014-02-11|||January 2005||2005-01-01|February 2014|2014-02-01|October 2009|Actual|2009-10-01|October 2007|Actual|2007-10-01||Interventional|||Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes|A Phase II Study Of Amifostine In Children With Myelodysplastic Syndrome|Completed||Phase 2|10|Actual|Children's Oncology Group|||||f||||t||||||||||2017-02-18 17:44:47.738|2017-02-18 17:44:47.738
NCT00098670|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2014-05-06|2012-11-05||October 2004||2004-10-01|December 2012|2012-12-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia|A Phase II Study of Fludarabine + Rituximab Induction Followed by Alemtuzumab (Campath-1H, NSC #715969, IND #10864) Administered Subcutaneously as Consolidation in Untreated Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|102|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:47.948997|2017-02-18 17:44:47.948997
NCT00098631|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2014-01-06|||October 2004||2004-10-01|January 2014|2014-01-01||||December 2006|Actual|2006-12-01||Interventional|||Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer|A Phase II Study Of GW572016 In Squamous Cell Carcinoma Of The Head And Neck (SCCHN)|Completed||Phase 2|88|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:48.915667|2017-02-18 17:44:48.915667
NCT00098618|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-07-01|||October 2004||2004-10-01|July 2013|2013-07-01||||January 2006|Actual|2006-01-01||Interventional|||Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer|A Phase 2 Study Of BAY 43-9006 In Combination With Interferon Alfa-2b In Metastatic Renal Cell Cancer|Terminated||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:49.023412|2017-02-18 17:44:49.023412
NCT00098605|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-06-04|||October 2004||2004-10-01|June 2013|2013-06-01||||September 2006|Actual|2006-09-01||Interventional|||Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases|A Phase 2 Study of GW572016 for Brain Metastases in Patients With HER2-Positive Breast Cancer|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:49.135319|2017-02-18 17:44:49.135319
NCT00098579|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-03-18|||October 2004||2004-10-01|March 2013|2013-03-01||||July 2011|Actual|2011-07-01||Interventional|||Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery|Phase I Trial of Doxorubicin and Alvocidib (Flavopiridol; NCI Supplied Agent, NSC 649890) in the Treatment of Metastatic Sarcoma|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:49.247249|2017-02-18 17:44:49.247249
NCT00098566|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2015-10-13|||December 2002||2002-12-01|October 2015|2015-10-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Observational|||Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Long-Term Follow-Up Study Evaluating the Efficacy and Delayed Toxicities of Radioiodinated Tositumomab (Anti-CD20 Antibody) Followed by Autologous Transplantation for Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|36|Actual|Fred Hutchinson Cancer Research Center|||1||f||||||||||||||2017-02-18 17:44:49.352434|2017-02-18 17:44:49.352434
NCT00098553|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2016-07-01|||April 2005||2005-04-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|July 2007|Actual|2007-07-01||Interventional|||Everolimus in Treating Patients With Stage IV Melanoma|Phase II Trial Of RAD-001 In Metastatic Malignant Melanoma|Completed||Phase 2|53|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:44:49.70849|2017-02-18 17:44:49.70849
NCT00098540|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2016-12-28|||December 2004||2004-12-01|December 2016|2016-12-01||||May 2007|Actual|2007-05-01||Interventional|||Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Study of the Raf Kinase Inhibitor BAY43-9006 in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:49.90796|2017-02-18 17:44:49.90796
NCT00098527|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-07-01|||October 2004||2004-10-01|July 2013|2013-07-01||||September 2005|Actual|2005-09-01||Interventional|||FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer|A Phase 2 Study of Single Agent Depsipeptide (FK228) in Gastric and Esophageal Cancers|Terminated||Phase 2|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:50.013448|2017-02-18 17:44:50.013448
NCT00098514|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2008-07-23|||October 2004||2004-10-01|January 2007|2007-01-01||||||||Interventional|||Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors|A Phase I Study Of PT523 In Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:44:50.145419|2017-02-18 17:44:50.145419
NCT00098501|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-06-03|||October 2004||2004-10-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors|A Phase 1 Trial of CCI-779 in Combination With EKB-569, an EGFR Inhibitor, in Patients With Solid Tumors|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:50.224122|2017-02-18 17:44:50.224122
NCT00098488|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-06-03|||April 2005||2005-04-01|June 2013|2013-06-01||||April 2008|Actual|2008-04-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia|A Phase 1 Study of 17-allylamino-17-demethoxygeldanamycin (17-AAG) (NSC 330507; IND 57,966) and Rituximab in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:50.326959|2017-02-18 17:44:50.326959
NCT00098475|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2016-12-21|2013-08-30||October 2004||2004-10-01|October 2016|2016-10-01||||November 2008|Actual|2008-11-01||Interventional|||Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma|A Randomized Phase III Study of CC-5013 Plus Dexamethasone Versus CC-5013 Plus Low Dose Dexamethasone in Multiple Myeloma With Thalidomide Plus Dexamethasone Salvage Therapy for Non-responders|Active, not recruiting||Phase 3|452|Actual|National Cancer Institute (NCI)||4|||f||||f||||||||||2017-02-18 17:44:50.714494|2017-02-18 17:44:50.714494
NCT00098462|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2012-10-02|||October 2004||2004-10-01|October 2012|2012-10-01||||||||Interventional|||Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase I/II Trial of ZD1839 (Iressa®) and Rapamycin (Rapamune) in Patients With Advanced Non Small Cell Lung Cancer|Withdrawn||Phase 1/Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||1||Withdrawn as study never opened|f||||||||||||||2017-02-18 17:44:52.696266|2017-02-18 17:44:52.696266
NCT00098436|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-07-17|||September 2004||2004-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|October 2006|Actual|2006-10-01||Interventional|||Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias|A Phase I Study Of Cloretazine™ (VNP40101M) And Temozolomide In Patients With Hematologic Malignancies|Completed||Phase 1|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:44:52.789202|2017-02-18 17:44:52.789202
NCT00098423|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-09-27|||November 2004||2004-11-01|September 2013|2013-09-01||||May 2009|Actual|2009-05-01||Interventional|||Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes|A Phase I And Pharmacological Trial Of 17-Allylamino -17-demethoxygeldanamycin (17-AAG) And Cytarabine In Refractory Leukemia And Myelodysplastic Syndrome|Completed||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:52.88013|2017-02-18 17:44:52.88013
NCT00098397|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-01-23|||February 2005||2005-02-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||FR901228 in Treating Patients With Metastatic Breast Cancer|A Phase II Study Of Single Agent Depsipeptide (FK228) In Breast Cancer|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:44:52.994761|2017-02-18 17:44:52.994761
NCT00098384|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2006-05-08|||June 2003||2003-06-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea|A Randomized, Double-Blind, Single Center, Comparative Dose Ranging Study of Rifaximin Vs. Placebo in the Prevention of Travelers' Diarrhea Due to Enteropathogenic Bacteria|Completed||Phase 2|220||DuPont, Hurbert L., MD|||||||||||||||||||2017-02-18 17:44:53.102907|2017-02-18 17:44:53.102907
NCT00098371|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2016-08-31|2015-07-14||April 2005||2005-04-01|August 2016|2016-08-01|November 2012|Actual|2012-11-01|June 2009|Actual|2009-06-01||Interventional|||Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia|A Phase II Study of Flavopiridol Administered as a 30 Minute Loading Dose Followed by a 4-Hour Continuous Infusion in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From CLL|Terminated||Phase 2|64|Actual|National Cancer Institute (NCI)||1||CTEP Initiated Action.|f||||||||||||||2017-02-18 17:44:53.205264|2017-02-18 17:44:53.205264
NCT00098358|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2007-02-05|||November 2004||2004-11-01|February 2007|2007-02-01|May 2005||2005-05-01|||||Interventional|||Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Proof of Concept Study of Zileuton IR in Patients With Moderate to Severe Facial Acne Vulgaris|Unknown status|Active, not recruiting|Phase 2|90||Critical Therapeutics|||||||||||||||||||2017-02-18 17:44:53.882227|2017-02-18 17:44:53.882227
NCT00098345|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2016-08-24|2011-04-27||November 2004||2004-11-01|August 2016|2016-08-01|December 2019|Anticipated|2019-12-01|February 2008|Actual|2008-02-01||Interventional|||Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer|An Open Label, Two Stage, Phase II Study to Evaluate the Efficacy and Tolerability of ZD6474 in Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Carcinoma.|Active, not recruiting||Phase 2|40|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:44:53.99096|2017-02-18 17:44:53.99096
NCT00098332|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-07|2013-07-09|||November 2004||2004-11-01|June 2007|2007-06-01|July 2011|Actual|2011-07-01|December 2010|Actual|2010-12-01||Interventional|||Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma|A Phase I, Multi-Center, Open-Label, Safety and Pharmacokinetic, Repeat-Dose Study of Oral Forodesine Hydrochloride in Patients With Refractory Cutaneous T-Cell Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:44:54.368834|2017-02-18 17:44:54.368834
NCT00098319|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-06|2013-12-16|||January 2004||2004-01-01|December 2013|2013-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Oral Cleft Prevention Trial in Brazil|Oral Cleft Prevention Trial in Brazil|Completed||Phase 3|2200|Anticipated|NICHD Global Network for Women's and Children's Health|||||f||||||||||||||2017-02-18 17:44:54.466699|2017-02-18 17:44:54.466699
NCT00098306|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-06|2012-04-02|2012-04-02||November 2004||2004-11-01|April 2012|2012-04-01|April 2011|Actual|2011-04-01|April 2007|Actual|2007-04-01||Interventional|MOTIVATE 1||Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced HIV-1 Infected Subjects.|Completed||Phase 2/Phase 3|601|Actual|ViiV Healthcare||3|||f||||t||||||||||2017-02-18 17:44:54.599273|2017-02-18 17:44:54.599273
NCT00098293|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-06|2013-08-07|2012-07-09||November 2004||2004-11-01|August 2013|2013-08-01|December 2012|Actual|2012-12-01|April 2007|Actual|2007-04-01||Interventional|MERIT||Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine|A Multicenter, Randomized, Double-Blind, Comparative Trial Of A Novel CCR5 Antagonist, UK-427,857, In Combination With Zidovudine/Lamivudine Versus Efavirenz In Combination With Zidovudine/Lamivudine For The Treatment Of Antiretroviral-Naive HIV-1 Infected Subjects|Completed||Phase 3|916|Actual|ViiV Healthcare|Following DSMB decision to discontinue maraviroc 300 mg once daily, inferential statistical analyses was performed between maraviroc 300 mg twice daily and efavirenz 600 mg once daily only. Data at Week 24 was not analyzed as planned in protocol.|3|||f||||t||||||||||2017-02-18 17:44:57.845405|2017-02-18 17:44:57.845405
NCT00098280|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2008-03-03|||December 2004||2004-12-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria|A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients|Completed||Phase 3|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:45:00.525279|2017-02-18 17:45:00.525279
NCT00098267|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2017-01-24|||December 2, 2004||2004-12-02|August 3, 2009|2009-08-03|August 3, 2009|Actual|2009-08-03|August 3, 2009|Actual|2009-08-03||Observational|||Collection of Dental Plaque and Saliva for Studies of Bacterial Colonization of Teeth|Collection of Dental Plaque and Saliva for Studies of Oral Microbial Colonization|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:45:00.610669|2017-02-18 17:45:00.610669
NCT00098254|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2012-04-03|2011-10-06||December 2004||2004-12-01|April 2012|2012-04-01|January 2011|Actual|2011-01-01|November 2009|Actual|2009-11-01||Interventional|||BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer|Phase II Study of Bay 43-9006 (Sorafenib) With Evaluation of RAS Signal Pathway in Patients With Relapsed Non-Small Cell Lung Cancer|Completed||Phase 2|37|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 17:45:00.702696|2017-02-18 17:45:00.702696
NCT00098241|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2011-06-15|||June 2000||2000-06-01|June 2011|2011-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients|Multicenter Trial of the Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients|Completed||Phase 3|45|Anticipated|Novartis|||||f||||||||||||||2017-02-18 17:45:01.448931|2017-02-18 17:45:01.448931
NCT00098228|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2011-10-24|||July 2004||2004-07-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Dose-Ranging Study in Patients With COPD|Completed||Phase 2|686|Actual|Novartis|||||||||||||||||||2017-02-18 17:45:01.563519|2017-02-18 17:45:01.563519
NCT00098215|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2005-11-09|||March 2001||2001-03-01|December 2004|2004-12-01|February 2006||2006-02-01|||||Interventional|||Pediatric Residency Training On Tobacco|Pediatric Residency Training on Tobacco|Unknown status|Recruiting|Phase 2|4000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:45:01.706924|2017-02-18 17:45:01.706924
NCT00098202|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2013-12-16|||March 2003||2003-03-01|December 2013|2013-12-01|April 2007|Actual|2007-04-01|||||Interventional|||Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala|Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala|Completed||Phase 3|420|Anticipated|NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 17:45:02.018042|2017-02-18 17:45:02.018042
NCT00097383|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-22|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer|A Phase 2 Study of Alimta and Epirubicin Administered Every 21 Days in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:45:02.139474|2017-02-18 17:45:02.139474
NCT00097123|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2014-07-29|||September 2002||2002-09-01|July 2014|2014-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||RCT of Misoprostol for Postpartum Hemorrhage in India|RCT of Misoprostol for Postpartum Hemorrhage in India|Completed||N/A|1600|Anticipated|NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 17:46:01.020057|2017-02-18 17:46:01.020057
NCT00097370|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-22|2016-05-09|2015-11-09||September 2004||2004-09-01|May 2016|2016-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome|An Open-Label Extension Study to Study MHE100185, to Evaluate Long-term Safety, Efficacy and Optimal Dosing Frequency of 750 mg Intravenous Mepolizumab in Subjects With Hypereosinophilic Syndromes|Terminated||Phase 3|78|Actual|GlaxoSmithKline||1||"Study terminated by sponsor (29 Sep 2010). Subjects eligible to continue mepolizumab treatment~   were transferred into the compassionate use program (MHE104317)"|f||||f||||||||||2017-02-18 17:45:02.2645|2017-02-18 17:45:02.2645
NCT00097357|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-22|2010-02-27||2010-02-27|October 2004||2004-10-01|November 2008|2008-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery|A Phase 2 Randomized, Double-Blinded (BMS-562247 and Enoxaparin), Active-Controlled (Enoxaparin and Warfarin), Parallel-Arm, Dose-Response Study of the Oral Factor Xa Inhibitor BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery|Completed||Phase 2/Phase 3|1238|Actual|Bristol-Myers Squibb||8|||f||||||||||||||2017-02-18 17:45:02.956561|2017-02-18 17:45:02.956561
NCT00097344|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-22|2007-08-21|||December 2004||2004-12-01|August 2007|2007-08-01|August 2006||2006-08-01|||||Interventional|||The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer|Phase 3 Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer|Terminated||Phase 3|842||Intarcia Therapeutics||||Identical study Biomed 777-CLP-029 did not meet superiority endpoint|f||||||||||||||2017-02-18 17:45:03.251136|2017-02-18 17:45:03.251136
NCT00097331|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-22|2015-04-10|||September 2004||2004-09-01|April 2015|2015-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis|A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Investigate the Efficacy and Safety of Three Months Administration of SB-683699 (150 - 1200mg Twice Daily) in Subjects With Relapsing Multiple Sclerosis|Completed||Phase 2|261|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:45:03.590223|2017-02-18 17:45:03.590223
NCT00097318|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-20|2017-01-24|||November 17, 2004||2004-11-17|April 8, 2011|2011-04-08|April 8, 2011|Actual|2011-04-08|||||Interventional|||Safety Study of Interferon Beta 1a to for Acute Stroke|Recombinant Human Interferon Beta-1a in Acute Ischemic Stroke: A Dose Escalation and Safety Study|Completed||Phase 1|60|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:45:03.696145|2017-02-18 17:45:03.696145
NCT00097305|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-19|2007-09-07|||September 2002||2002-09-01|August 2006|2006-08-01||||||||Interventional|||Body-Oriented Therapy for Sexual Abuse Recovery|Delving Intervention and Mindbody Integration|Completed||Phase 2|24||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:45:03.792687|2017-02-18 17:45:03.792687
NCT00097292|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-19|2016-09-04|||February 2004||2004-02-01|September 2016|2016-09-01|July 2019|Anticipated|2019-07-01|July 2019|Anticipated|2019-07-01||Observational|||Pathway to Prevention Study|Natural History Study of the Development of Type 1 Diabetes|Recruiting||N/A|75000|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||t||||||||||2017-02-18 17:45:03.883793|2017-02-18 17:45:03.883793
NCT00097279|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-19|2017-01-10|||August 2004||2004-08-01|January 2017|2017-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|ACTION||Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes|A Multicenter, Open-Label, Randomised Trial to Compare the Efficacy and Safety of NovoLog Mix 70/30 BID in Combination With Metformin and Pioglitazone to Metformin and Pioglitazone Alone in Insulin Naïve Subjects With Type 2 Diabetes|Completed||Phase 3|230|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:45:04.063236|2017-02-18 17:45:04.063236
NCT00097266|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-19|2013-11-07|||December 2004||2004-12-01|July 2010|2010-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study of Aripiprazole in Patients With Acute Bipolar Mania|A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder|Completed||Phase 3|615||Otsuka Pharmaceutical Development & Commercialization, Inc.||3|||f||||||||||||||2017-02-18 17:45:04.234481|2017-02-18 17:45:04.234481
NCT00097253|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-19|2010-02-12|2009-04-23||August 2005||2005-08-01|February 2010|2010-02-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||The Effects of Smell on Mood and Physical Responses|Psychoneuroimmunology and Mind-Body Medicine: Olfaction, Mood, and Physiological Responses|Completed||Phase 1|56|Actual|National Center for Complementary and Integrative Health (NCCIH)||3|||f||||t||||||||||2017-02-18 17:45:04.393928|2017-02-18 17:45:04.393928
NCT00098189|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2006-08-29|||July 2004||2004-07-01|August 2006|2006-08-01||||||||Observational|||Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis|A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis|Completed||Phase 2|||Novartis|||||||||||||||||||2017-02-18 17:45:07.569378|2017-02-18 17:45:07.569378
NCT00098163|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2012-05-03||||||May 2012|2012-05-01|May 2009|Actual|2009-05-01|||||Interventional|||Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers|A Phase I Study to Evaluate the Safety and Immunogenicity of ALVAC-HIV vCP1521 in Infants Born to HIV-1 Infected Women in Uganda|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:45:07.634026|2017-02-18 17:45:07.634026
NCT00098150|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2006-08-29|||July 2004||2004-07-01|August 2006|2006-08-01||||||||Observational|||Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis|A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Atopic Dermatitis|Completed||Phase 2|66||Novartis|||||||||||||||||||2017-02-18 17:45:07.744275|2017-02-18 17:45:07.744275
NCT00098137|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2012-09-10|||January 2005||2005-01-01|September 2012|2012-09-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation|Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation Trial (ANTIPAF Trial)|Completed||Phase 3|422|Actual|German Atrial Fibrillation Network||2|||f||||t||||||||||2017-02-18 17:45:07.803573|2017-02-18 17:45:07.803573
NCT00098124|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2007-12-18|||November 2004||2004-11-01|December 2007|2007-12-01|December 2006||2006-12-01|||||Interventional|||Study of Milnacipran for the Treatment of Fibromyalgia|A Phase III Pivotal, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Milnacipran for the Treatment of Fibromyalgia|Completed||Phase 3|1200||Forest Laboratories|||||||||||||||||||2017-02-18 17:45:07.916213|2017-02-18 17:45:07.916213
NCT00098111|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2014-02-19|||April 2005||2005-04-01|February 2014|2014-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease|A Double-Blinded, Randomized, Parallel Arm, Dose Ranging Study of IMURAN in Subjects With Active Crohn's Disease Requiring Treatment With Prednisone: A Crohn's Disease Optimal Range Dose of IMURAN Study (ACORDIS)|Terminated||Phase 3|31|Actual|Massachusetts General Hospital||3||Lack of recruitment|f||||||||||||||2017-02-18 17:45:10.818361|2017-02-18 17:45:10.818361
NCT00098098|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2012-08-22|||August 2004||2004-08-01|August 2012|2012-08-01|August 2005|Actual|2005-08-01|||||Interventional|||Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults|A Phase 1, Open-Label, Dose-Escalating Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults|Completed||Phase 1|44|Anticipated|DynPort Vaccine Company LLC, A CSC Company|||||||||||||||||||2017-02-18 17:45:10.936433|2017-02-18 17:45:10.936433
NCT00098085|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-03|2009-03-06|||September 2003||2003-09-01|March 2009|2009-03-01||||November 2007|Actual|2007-11-01||Interventional|||Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer|A Phase II Study of the Feasibility to Derive Autologous Vaccine (HSPPC-96) From Tumor Tissue for Clinical Administration in Patients With Resectable Non-Small Cell Lung Cancer|Completed||Phase 2|20||Agenus Inc.|||||||||||||||||||2017-02-18 17:45:11.029495|2017-02-18 17:45:11.029495
NCT00098072|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-02|2017-01-24|||November 30, 2004||2004-11-30|December 7, 2016|2016-12-07|July 8, 2009|Actual|2009-07-08|July 8, 2009|Actual|2009-07-08||Interventional|||Endothelial Cell Dysfunction in Pulmonary Hypertension|Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension: Biomarkers, Mechanisms of Disease and Novel Therapeutic Targets|Completed||Phase 1|27|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:45:11.133568|2017-02-18 17:45:11.133568
NCT00098059|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-02|2013-04-18|2009-02-02||February 2005||2005-02-01|April 2013|2013-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection|A Multicenter, Open-label, Single-arm, Two-step Study to Evaluate the Safety and Single-dose Pharmacokinetics of Famciclovir and Multiple-dose Safety After Administration of Famciclovir Oral Pediatric Formulation to Children 1 to 12 Years of Age With Herpes Simplex Infection|Completed||Phase 3|74|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:45:11.250662|2017-02-18 17:45:11.250662
NCT00098046|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-02|2007-09-25|||July 2005||2005-07-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection|Pharmacokinetics and Safety of Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection|Completed||Phase 3|76|Anticipated|Novartis|||||||||||||||||||2017-02-18 17:45:12.291178|2017-02-18 17:45:12.291178
NCT00098033|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-02|2015-03-24|||September 2002||2002-09-01|December 2004|2004-12-01|September 2005||2005-09-01|||||Interventional|||Investigation of Clofarabine in Acute Leukemias|Phase II Clinical and Pharmacodynamic Investigation of Clofarabine in Acute Leukemias|Completed||Phase 2|64||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 17:45:12.384553|2017-02-18 17:45:12.384553
NCT00098020|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2017-01-24|||November 26, 2004||2004-11-26|January 4, 2017|2017-01-04|June 27, 2016|Actual|2016-06-27|June 27, 2016|Actual|2016-06-27||Interventional|||Retinoids for Minimal Change Disease and Focal Segmental Glomerulosclerosis|Retinoids for Podocyte Disease|Completed||Phase 1/Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:45:12.472344|2017-02-18 17:45:12.472344
NCT00098007|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2011-11-01|||August 2004||2004-08-01|November 2011|2011-11-01||||January 2007|Actual|2007-01-01||Interventional|||A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients|Six-month, Multicenter, Randomized, Open-label Study of the Safety, Tolerability and Efficacy of Two Neoral Doses in Addition to Certican and Steroids in de Novo Heart Transplant Recipients|Completed||Phase 3|199|Actual|Novartis|||||||||||||||||||2017-02-18 17:45:12.58621|2017-02-18 17:45:12.58621
NCT00097994|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2014-05-19|||December 2004||2004-12-01|May 2014|2014-05-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Observational|||Does Menopause Matter?|Does Menopause Matter?|Completed||N/A|732|Actual|University of Pittsburgh|||1||f||||||||||||||2017-02-18 17:45:12.706634|2017-02-18 17:45:12.706634
NCT00097981|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2013-09-25|2008-10-02||January 2005||2005-01-01|September 2013|2013-09-01|October 2009|Actual|2009-10-01|October 2007|Actual|2007-10-01||Interventional|||A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma|A Randomized, Open-Label, Multi-Center Trial Comparing Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Subjects With Newly Diagnosed Multiple Myeloma|Completed||Phase 3|225|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-02-18 17:45:12.816888|2017-02-18 17:45:12.816888
NCT00097968|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2010-07-09|||August 2004||2004-08-01|July 2010|2010-07-01||||April 2005|Actual|2005-04-01||Interventional|||Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy|An Open-Label, Single Arm, Pilot Study of the Renal Safety of Everolimus in Addition to Neoral® in Cardiac Transplant Recipients With Established Allograft Vasculopathy|Completed||Phase 3|||Novartis|||||||||||||||||||2017-02-18 17:45:13.933616|2017-02-18 17:45:13.933616
NCT00097955|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2011-02-24|||October 2004||2004-10-01|February 2011|2011-02-01|April 2007||2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria|Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria|Completed||Phase 2|496||Novartis|||||f||||||||||||||2017-02-18 17:45:14.039797|2017-02-18 17:45:14.039797
NCT00097942|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2012-03-01|||August 2004||2004-08-01|March 2012|2012-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients|A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients With Persistent Residual Symptoms|Completed||Phase 2|138|Actual|Forest Laboratories|||||||||||||||||||2017-02-18 17:45:14.152366|2017-02-18 17:45:14.152366
NCT00097110|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2013-11-22|||July 2003||2003-07-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|||||Interventional|||RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil|RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil|Completed||Phase 3|734||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 17:46:01.133741|2017-02-18 17:46:01.133741
NCT00097929|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2015-10-30|||May 2005||2005-05-01|October 2015|2015-10-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)|A Phase II Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)|Completed||Phase 2|18|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:45:14.259566|2017-02-18 17:45:14.259566
NCT00097916|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2012-03-01|||September 2004||2004-09-01|March 2012|2012-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Non-Institutionalized Agitated Patients With Moderate to Severe Alzheimer's Disease|Completed||Phase 3|34|Actual|Forest Laboratories|||||||||||||||||||2017-02-18 17:45:14.35356|2017-02-18 17:45:14.35356
NCT00097903|ClinicalTrials.gov processed this data on February 17, 2017|2004-12-01|2017-01-07|||May 2004||2004-05-01|January 2017|2017-01-01|May 2013|Actual|2013-05-01|October 2011|Actual|2011-10-01||Interventional|||Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer|"Phase 1 Trial of Oral Karenitecin® in Patients With Solid Tumors"|Completed||Phase 1|32|Actual|BioNumerik Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 17:45:14.449169|2017-02-18 17:45:14.449169
NCT00097890|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2008-03-03|||November 2004||2004-11-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Replagal Enzyme Replacement Therapy for Adults With Fabry Disease|An Open Label Six-Month Maintenance Clinical Trial of Replagal Enzyme Replacement Therapy in Patients With Fabry Disease Who Have Completed TKT027|Completed||Phase 4|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:45:14.556792|2017-02-18 17:45:14.556792
NCT00097877|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2017-01-10|||January 2005||2005-01-01|January 2017|2017-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes|Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes|Completed||Phase 3|293|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:45:14.644972|2017-02-18 17:45:14.644972
NCT00097851|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2016-03-30|||February 2004||2004-02-01|March 2016|2016-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)|Phase II Trial of Docetaxel With PI-88 in Patients With Advanced Non-Small-Cell Lung Cancer|Completed||Phase 2|100||Medigen Biotechnology Corporation|||||||||||||||||||2017-02-18 17:45:15.094016|2017-02-18 17:45:15.094016
NCT00097838|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2012-06-27|||October 2004||2004-10-01|June 2012|2012-06-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults|A Phase I, Dose Escalation, Safety, and Immunogenicity Trial of an Alphavirus Replicon HIV-1 Subtype C Gag Vaccine (AVX101) in Healthy HIV-1 Uninfected Adult Participants|Completed||Phase 1|96|Actual|AlphaVax, Inc.||5|||f||||||||||||||2017-02-18 17:45:15.21364|2017-02-18 17:45:15.21364
NCT00097825|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2012-04-26|||April 2004||2004-04-01|April 2012|2012-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men|Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men|Completed||Phase 3|288||Novartis|||||||||||||||||||2017-02-18 17:45:15.345167|2017-02-18 17:45:15.345167
NCT00097812|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2012-04-26|||May 2004||2004-05-01|April 2012|2012-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid|A Study to Assess the Safety, Tolerability, and Efficacy of Switching Patients Currently on Oral Bisphosphonate to Zoledronic Acid|Completed||Phase 3|220||Novartis|||||||||||||||||||2017-02-18 17:45:15.455299|2017-02-18 17:45:15.455299
NCT00097799|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2016-11-29|||December 2004||2004-12-01|October 2013|2013-10-01||||August 2005|Actual|2005-08-01||Expanded Access|||Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection|An Open Label, Non-randomized Treatment Protocol of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Protease Inhibitor-experienced Patients With HIV-1 Infection (the Tipranavir Expanded Access Program)|Approved for marketing||N/A|||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:45:15.560691|2017-02-18 17:45:15.560691
NCT00097786|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2011-06-27|2011-01-14||January 2002||2002-01-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|Navigator||Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications|A Multinational, Randomized, Double-blind, Placebo-controlled, Forced-titration, 2 x 2 Factorial Design Study of the Efficacy and Safety of Long-term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects With Impaired Glucose Tolerance (IGT)|Completed||Phase 3|9306|Actual|Novartis||4|||f||||t||||||||||2017-02-18 17:45:16.155448|2017-02-18 17:45:16.155448
NCT00097773|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2014-01-28|2013-06-11||September 2004||2004-09-01|January 2014|2014-01-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|EPIC|Intent to Treat|Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis|Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa Airway Infection in Young Patients With Cystic Fibrosis|Completed||Phase 2|304|Actual|Seattle Children's Hospital||4|||f||||t||||||||||2017-02-18 17:45:24.76948|2017-02-18 17:45:24.76948
NCT00097760|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2009-06-17|||June 2003||2003-06-01|June 2009|2009-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis|Safety Study of Natalizumab in Combination With Glatiramer Acetate (GA)|Completed||Phase 2|110|Actual|Biogen||2|||f||||t||||||||||2017-02-18 17:45:26.369142|2017-02-18 17:45:26.369142
NCT00097747|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-30|2012-12-19|||August 2004||2004-08-01|December 2012|2012-12-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers|A Phase 1, Double-blind, Placebo-controlled, Dose Escalation Study of the Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers|Completed||Phase 1|28|Actual|Affymax||4|||f||||f||||||||||2017-02-18 17:45:26.483831|2017-02-18 17:45:26.483831
NCT00097734|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-29|2006-02-12|||July 2004||2004-07-01|February 2006|2006-02-01|June 2007||2007-06-01|||||Interventional|||Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis|A Prospective, Multicenter, Open-Label, Randomized Clinical Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis|Unknown status|Recruiting|Phase 4|540||Klinikum Hanover-Siloah Hospital|||||f||||||||||||||2017-02-18 17:45:26.600909|2017-02-18 17:45:26.600909
NCT00097721|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-29|2013-04-03|2012-01-09||September 2004||2004-09-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study of E7389 in Advanced/Metastatic Breast Cancer Patients|A Phase II Open Label Study of E7389 (Halichondrin B Analog) in Patients With Advanced/Metastatic Breast Cancer Previously Treated With Chemotherapy Including An Anthracycline and A Taxane|Completed||Phase 2|104|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 17:45:26.727483|2017-02-18 17:45:26.727483
NCT00097708|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-29|2014-10-01|2011-09-14||November 2004||2004-11-01|October 2014|2014-10-01|December 2005||2005-12-01|||||Interventional|||Experimental Medication For the Treatment of Generalized Anxiety Disorder|A Double-Blind, Placebo Controlled Trial of an Experimental Medication For the Treatment of Generalized Anxiety Disorder|Completed||Phase 3|511|Actual|Jazz Pharmaceuticals|||||||||||||||||||2017-02-18 17:45:27.731483|2017-02-18 17:45:27.731483
NCT00097695|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-26|2014-05-22|2011-01-24||August 2004||2004-08-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema|Randomized, Double Blind, Placebo-Controlled, Multicenter Study of a Subcutaneous Formulation of Icatibant for the Treatment of Hereditary Angioedema|Completed||Phase 3|84|Actual|Shire||4|||f||||f||||||||||2017-02-18 17:45:28.349708|2017-02-18 17:45:28.349708
NCT00097682|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2017-01-24|||November 18, 2004||2004-11-18|October 2, 2007|2007-10-02|October 2, 2007||2007-10-02|||||Observational|||Views of Cancer Patients Regarding Financial Conflicts of Interest|Ethics Study to Understand the Views of Cancer Patients Regarding Financial Conflicts of Interest in Research|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:45:28.8575|2017-02-18 17:45:28.8575
NCT00097669|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2010-02-24|||November 1998||1998-11-01|February 2010|2010-02-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||VITATOPS: A Study of VITAmins TO Prevent Stroke|VITATOPS - A Study of VITAmins TO Prevent Stroke|Completed||N/A|8000|Anticipated|VITATOPS||1|||f||||t||||||||||2017-02-18 17:45:28.952578|2017-02-18 17:45:28.952578
NCT00097656|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2011-01-03|||February 2004||2004-02-01|January 2011|2011-01-01|May 2010|Actual|2010-05-01|March 2010|Actual|2010-03-01||Interventional|||MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk|MOTOR: Maternal Oral Therapy to Reduce Obstetric Risk|Completed||Phase 3|1800|Actual|University of North Carolina, Chapel Hill||1|||f||||t||||||||||2017-02-18 17:45:32.072382|2017-02-18 17:45:32.072382
NCT00097643|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2008-08-12|||September 2000||2000-09-01|August 2008|2008-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Problem Solving/Physical Interventions and Aging|Problem Solving/Physical Interventions and Aging|Completed||Phase 3|273||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:45:32.184909|2017-02-18 17:45:32.184909
NCT00097630|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2009-12-09|||October 2003||2003-10-01|August 2008|2008-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||ABC Trial: Awakening and Breathing Controlled|Cognitive Impairment in the ICU: Evaluation and Outcomes|Completed||N/A|334||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:45:32.273019|2017-02-18 17:45:32.273019
NCT00097617|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2012-11-13|||March 2002||2002-03-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)|National Cooperative Growth Study (NCGS) of Nutropin AQ, Nutropin, and Protropin in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)|Completed||Phase 4|395|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:45:32.371278|2017-02-18 17:45:32.371278
NCT00097604|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2010-07-28|||September 2004||2004-09-01|December 2009|2009-12-01|April 2008|Actual|2008-04-01|April 2006|Actual|2006-04-01||Interventional|||Effects of Valerian on Sleep in Healthy Older Adults|Valerian for Sleep Disturbance in Healthy Older Adults|Completed||Phase 2|18|Actual|University of Washington||2|||f||||t||||||||||2017-02-18 17:45:32.45713|2017-02-18 17:45:32.45713
NCT00097591|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2010-08-25|2010-04-19||November 2004||2004-11-01|August 2010|2010-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention|A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention|Completed||Phase 3|13619|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 17:45:32.616767|2017-02-18 17:45:32.616767
NCT00097578|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2013-03-26|||March 2004||2004-03-01|March 2013|2013-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma|An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Adenocarcinoma|Completed||Phase 4|1953|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:45:38.623402|2017-02-18 17:45:38.623402
NCT00097565|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2015-02-27|||March 2004||2004-03-01|February 2015|2015-02-01|March 2014|Actual|2014-03-01|||||Observational|||An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma|The National Lymphocare Study: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma|Completed||Phase 4|2740|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:45:38.699653|2017-02-18 17:45:38.699653
NCT00097552|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2012-11-13|||May 1997||1997-05-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone|Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS)|Completed||Phase 4|1696|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:45:38.775398|2017-02-18 17:45:38.775398
NCT00097539|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2016-12-21|2016-10-13||October 1985||1985-10-01|December 2016|2016-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Observational||Safety evaluable population included all participants enrolled in the study.|National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin|Genentech National Cooperative Growth Study (NCGS) Post-Marketing Surveillance Program For Nutropin AQ® (Somatropin [rDNA Origin] Injection), Nutropin® (Somatropin [rDNA Origin] for Injection), and Protropin® (Somatrem for Injection)|Completed||Phase 4|65205|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:45:39.21802|2017-02-18 17:45:39.21802
NCT00097526|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2012-11-13|||April 2000||2000-04-01|November 2012|2012-11-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)|Bone Mineral Density in Adolescent Subjects With Growth Hormone Deficiency Who Are Completing Treatment With Nutropin AQ, Nutropin, or Protropin in the National Cooperative Growth Study (NCGS)|Completed||Phase 4|125|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:45:54.966949|2017-02-18 17:45:54.966949
NCT00097513|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2010-11-11|||February 2003||2003-02-01|November 2010|2010-11-01|June 2006|Actual|2006-06-01|||||Observational|||National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients|National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Subjects|Completed||Phase 4|||Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:45:55.048067|2017-02-18 17:45:55.048067
NCT00097500|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2015-03-19|2010-12-24||September 2004||2004-09-01|March 2015|2015-03-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes|A Phase 3, Randomized, Open Label, Comparator-Controlled, Parallel Group, Multicenter Study to Compare the Effects of Exenatide and Insulin Glargine on Beta Cell Function and Cardiovascular Risk Markers in Subjects With Type 2 Diabetes Treated With Metformin Who Have Not Achieved Target HbA1c|Completed||Phase 3|69|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:45:55.134819|2017-02-18 17:45:55.134819
NCT00097487|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-24|2005-06-23|||November 2000||2000-11-01|November 2004|2004-11-01|September 2004||2004-09-01|||||Observational|||A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane|Clinical Outcomes in Patients With HER2 Gene-Amplified Metastatic Breast Cancer Treated With First Line Herceptin in Combination With a Taxane: A Phase IV, Prospective, Community Based Study|Unknown status|Active, not recruiting|Phase 4|1000||Genentech, Inc.|||||f||||||||||||||2017-02-18 17:45:58.749208|2017-02-18 17:45:58.749208
NCT00097474|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-23|2017-01-24|||November 22, 2004||2004-11-22|July 29, 2016|2016-07-29|November 14, 2007|Actual|2007-11-14|November 14, 2007|Actual|2007-11-14||Interventional|||Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag|The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag|Completed||Phase 2|57|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-02-18 17:45:58.821327|2017-02-18 17:45:58.821327
NCT00097461|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-23|2017-01-24|||September 28, 2004||2004-09-28|July 21, 2016|2016-07-21||||||||Observational|||Revising Employee Benefits for the Sake of Health|Revising Employee Benefits for the Sake of Health|Completed||N/A|408|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:45:58.942561|2017-02-18 17:45:58.942561
NCT00097448|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-23|2013-02-27|2012-11-08||December 2004||2004-12-01|February 2013|2013-02-01|March 2011|Actual|2011-03-01|October 2009|Actual|2009-10-01||Interventional|SSNHL||Sudden Deafness Treatment Trial|Sudden Hearing Loss Multicenter Treatment Trial|Completed||Phase 3|255|Actual|Massachusetts Eye and Ear Infirmary||2|||f||||t||||||||||2017-02-18 17:45:59.046711|2017-02-18 17:45:59.046711
NCT00097435|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-23|2013-08-01|||October 2004||2004-10-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C|A Multi-Center, Randomized, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Albuferon (Recombinant Human Albumin-Interferon Alfa Fusion Protein) in Combination With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C|Completed||Phase 2|115|Actual|Human Genome Sciences Inc.|||||f||||||||||||||2017-02-18 17:45:59.576665|2017-02-18 17:45:59.576665
NCT00097422|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-23|2016-07-07|||November 2004||2004-11-01|July 2016|2016-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)|An Open-Label, Dose Ranging, Randomized Clinical Evaluation of OPT-80 in Patients With Clostridium Difficile-Associated Diarrhea (CDAD)|Completed||Phase 2|||Optimer Pharmaceuticals LLC|||||||||||||||||||2017-02-18 17:45:59.678111|2017-02-18 17:45:59.678111
NCT00097409|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-23|2010-10-01|||December 2004||2004-12-01|October 2010|2010-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer|A Phase II, Open-Label Study of Ispinesib in Subjects With Platinum/Taxane-Refractory or Resistant Relapsed Ovarian Cancer|Completed||Phase 2|35|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:45:59.975895|2017-02-18 17:45:59.975895
NCT00097396|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-23|2011-06-29|||November 2004||2004-11-01|June 2011|2011-06-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|||Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V|A Phase 1, Open-Label, Dose-Escalating Study to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant Plague Vaccine rF1V in Healthy Volunteers|Completed||Phase 1|40||DynPort Vaccine Company LLC, A CSC Company|||||f||||t||||||||||2017-02-18 17:46:00.107581|2017-02-18 17:46:00.107581
NCT00097240|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-19|2010-08-02|||January 2005||2005-01-01|August 2010|2010-08-01|September 2009|Actual|2009-09-01|||||Observational|FOLLOW||An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)|The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy|Completed||Phase 4|18|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:46:00.233777|2017-02-18 17:46:00.233777
NCT00097227|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-18|2010-04-08|||November 2004||2004-11-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|A Randomized Phase II Trial of Two Dose Schedules of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-small Cell Lung Cancer|Completed||Phase 2|165|Actual|ImClone LLC||2|||f||||f||||||||||2017-02-18 17:46:00.326156|2017-02-18 17:46:00.326156
NCT00097214|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-18|2010-04-08|||November 2004||2004-11-01|April 2010|2010-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)|A Phase II Trial of Carboplatin Plus Cetuximab for the Treatment of Stage IIIb/IV Non-Small Cell Lung Cancer|Completed||Phase 2|57|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 17:46:00.472463|2017-02-18 17:46:00.472463
NCT00097188|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-18|2014-02-28|||December 2004||2004-12-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis|A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab (Mabthera/Rituxan) in Adults With Relapsing Remitting Multiple Sclerosis|Completed||Phase 2|104|Actual|Genentech, Inc.|||||||||||||||||||2017-02-18 17:46:00.604695|2017-02-18 17:46:00.604695
NCT00097175|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2017-01-24|||November 10, 2004||2004-11-10|January 15, 2014|2014-01-15|January 15, 2014||2014-01-15|||||Observational|||Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders|The Effects of Mood and Tryptophan Depletion on the Neural Correlates of Affective Shifting in Mood Disorders|Completed||N/A|95|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:46:00.731212|2017-02-18 17:46:00.731212
NCT00097084|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2017-01-26|||September 2004||2004-09-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes|Efficacy and Safety Comparison of Insulin Detemir Plus Insulin Aspart Versus Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes|Completed||Phase 3|324|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:46:01.346024|2017-02-18 17:46:01.346024
NCT00097071|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2016-12-21|||October 2004||2004-10-01|December 2016|2016-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents|Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes|Completed||Phase 3|299|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:46:01.596036|2017-02-18 17:46:01.596036
NCT00097058|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2014-11-17|||August 2003||2003-08-01|November 2014|2014-11-01|November 2014|Actual|2014-11-01|November 2014|Actual|2014-11-01||Observational|||Estrogen Use in Protection From Cognitive Decline|Estrogen Use in Protection From Cognitive Decline|Completed||N/A|71|Anticipated|Stanford University|||2||f||||t||||||Samples With DNA|"~     whole blood serum urine~   "|||2017-02-18 17:46:01.936318|2017-02-18 17:46:01.936318
NCT00097045|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2007-08-21|||November 2004||2004-11-01|August 2007|2007-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C|Phase 2 Study of Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C|Completed||Phase 2|90||Intarcia Therapeutics|||||f||||||||||||||2017-02-18 17:46:02.042737|2017-02-18 17:46:02.042737
NCT00097032|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2011-05-20|||October 2004||2004-10-01|March 2010|2010-03-01|May 2005|Actual|2005-05-01|||||Interventional|||Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients|Differences in Cognitive Function Due to Acute Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Out-Patients.|Completed||Phase 3|30|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:46:02.134043|2017-02-18 17:46:02.134043
NCT00097019|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2014-03-12|||February 2005||2005-02-01|March 2014|2014-03-01|May 2006|Actual|2006-05-01|||||Interventional|||A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed|A Multicenter, Single-Arm, Phase II Trial of Bevacizumab in Subjects With Platinum-Resistant Epithelial Carcinoma of the Ovary or Primary Peritoneal Carcinoma for Whom Subsequent Doxil or Topotecan Therapy Has Failed|Completed||Phase 2|53||Genentech, Inc.|||||f||||||||||||||2017-02-18 17:46:02.240221|2017-02-18 17:46:02.240221
NCT00097006|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2016-04-14|||September 2004||2004-09-01|September 2009|2009-09-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Observational|||Retrovirus Epidemiology Donor Study-II (REDS-II)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:46:02.330207|2017-02-18 17:46:02.330207
NCT00096993|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2015-06-08|2015-05-26||January 2005||2005-01-01|June 2015|2015-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional||Safety population: All participants who received any amount of study treatment.|A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|A Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Pertuzumab (rhuMAb 2C4) in Combination With Gemcitabine and the Effect of Tumor-Based HER2 Activation in Subjects With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer|Completed||Phase 2|131|Actual|Genentech, Inc.||2|||f||||f||||||||||2017-02-18 17:46:02.418045|2017-02-18 17:46:02.418045
NCT00096980|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2013-06-19|||February 2001||2001-02-01|June 2013|2013-06-01|May 2004|Actual|2004-05-01|||||Interventional|||A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies|An Open Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneously Administered Efalizumab Used in Combination With Topical Psoriasis Therapies for Prolonged Maintenance Treatment|Completed||Phase 4|300||Genentech, Inc.|||||||||||||||||||2017-02-18 17:46:03.127701|2017-02-18 17:46:03.127701
NCT00096967|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2014-03-25|||October 2002||2002-10-01|March 2014|2014-03-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study|An Open-Label, Multicenter Extension Study of rhuMAb VEGF (Bevacizumab) in Subjects Treated in a Previous Genentech-Sponsored Cancer Study|Completed||Phase 3|100||Genentech, Inc.|||||||||||||||||||2017-02-18 17:46:03.192601|2017-02-18 17:46:03.192601
NCT00096954|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2011-11-03|2011-08-08||December 2005||2005-12-01|November 2011|2011-11-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|EXACT||A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)|A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)|Completed||Phase 4|333|Actual|Genentech, Inc.|This is a stand-alone study to fulfill one of the post-marketing commitments.|2|||f||||||||||||||2017-02-18 17:46:03.26176|2017-02-18 17:46:03.26176
NCT00096941|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2015-05-29|2015-05-27||May 2005||2005-05-01|May 2015|2015-05-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional||Safety population: Participants who received at least 1 dose of pertuzumab.|A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study|An Open-Label, Multicenter Extension Study of Pertuzumab (rhuMAb 2C4) in Subjects Treated With Pertuzumab in a Previous Genentech-Sponsored Phase II Cancer Study|Completed||Phase 2|3|Actual|Genentech, Inc.||1|||f||||||||||||||2017-02-18 17:46:03.629603|2017-02-18 17:46:03.629603
NCT00096928|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2015-07-01|||March 2005||2005-03-01|March 2011|2011-03-01|October 2009|Actual|2009-10-01|||||Observational|RESPONSE||A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)|Raptiva Epidemiologic Study of Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)|Completed||Phase 4|1846|Actual|Genentech, Inc.|||1||f||||||||||||||2017-02-18 17:46:03.848166|2017-02-18 17:46:03.848166
NCT00096915|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-17|2009-05-21|||October 2004||2004-10-01|May 2009|2009-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis|A Multicenter, Single-Arm Study Evaluating Once Monthly Darbepoetin Alfa Dosing in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis|Completed||Phase 3|110|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:46:04.375412|2017-02-18 17:46:04.375412
NCT00005343|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||January 1993||1993-01-01|May 2000|2000-05-01|December 1995||1995-12-01|||||Observational|||Social Support and CHD Risk Factors--A Community Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.655021|2017-02-18 18:15:06.655021
NCT00096902|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-16|2017-01-24|||November 8, 2004||2004-11-08|September 11, 2006|2006-09-11|September 11, 2006||2006-09-11|||||Interventional|||Non-Pharmacologic Therapy for Neurocardiogenic Syncope|Non-Pharmacologic Therapy for Neurocardiogenic Syncope|Completed||Phase 2|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:46:04.488778|2017-02-18 17:46:04.488778
NCT00096876|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-16|2008-06-09|||October 2004||2004-10-01|June 2008|2008-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients|Screening Evaluations for Neurologic Syndromes: Olfactory Testing in Relatives of Parkinson's Disease Patients|Completed||N/A|600|Anticipated|Institute for Neurodegenerative Disorders|||||f||||||||||||||2017-02-18 17:46:04.583983|2017-02-18 17:46:04.583983
NCT00096863|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-16|2016-01-28|||December 2004||2004-12-01|January 2016|2016-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||The MIND Study: Modifying the INcidence of Delirium|Delirium in the ICU: a Prospective, Randomized, Trial of Placebo vs. Haloperidol vs. Ziprasidone|Completed||Phase 2|102|Actual|Vanderbilt University||3|||f||||t||||||||||2017-02-18 17:46:04.675818|2017-02-18 17:46:04.675818
NCT00096850|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-16|2012-05-17||||||May 2012|2012-05-01|December 2007|Actual|2007-12-01|||||Interventional|||Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults|Safety, Tolerability, and Pharmacokinetic Interactions of Atazanavir and Rifampin in Healthy Volunteers|Completed||N/A|18|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:46:04.812487|2017-02-18 17:46:04.812487
NCT00096837|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-16|2006-06-07||||||June 2006|2006-06-01||||||||Interventional|||A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma|An Open-Label Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|25||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:46:04.953005|2017-02-18 17:46:04.953005
NCT00096824|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-15|2015-03-17|||February 2006||2006-02-01|March 2015|2015-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Observational|||A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175|International Neurological Study: A Stand Alone Study for Participants of A5175 (A Phase IV, Randomized, Open-Label Evaluation of the Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combination for Initial Treatment of HIV-1 Infected Individuals From Diverse Areas of the World)|Completed||N/A|860|Actual|AIDS Clinical Trials Group|||1||f||||t||||||||||2017-02-18 17:46:05.043525|2017-02-18 17:46:05.043525
NCT00096811|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-15|2016-09-20|||September 2003||2003-09-01|September 2016|2016-09-01|August 2008|Actual|2008-08-01|August 2008|Anticipated|2008-08-01||Expanded Access|||Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program|A Treatment Use Protocol of Entecavir in Subjects With Chronic Hepatitis B Infection Who Have Failed or Who Are Intolerant of Available Therapies|No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:46:05.163451|2017-02-18 17:46:05.163451
NCT00096798|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-15|2008-01-15|||September 2001||2001-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression|A Double-Blind, Placebo-Controlled Study of Ethyl Eicosapentanoic Acid (Ethyl-EPA) in Major Depressive Disorder|Completed||Phase 3|80|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:46:05.265512|2017-02-18 17:46:05.265512
NCT00096785|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-15|2010-08-04|2009-07-02||December 2004||2004-12-01|June 2010|2010-06-01|April 2008|Actual|2008-04-01|January 2006|Actual|2006-01-01||Interventional|||Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection|Randomized, Open-Label, Comparative Study to Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Naive Adults With Chronic Hepatitis B Infection|Completed||Phase 3|69|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 17:46:05.363634|2017-02-18 17:46:05.363634
NCT00096772|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-15|2014-05-16|||January 2005||2005-01-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Collection of Blood Samples From HIV Infected People|Collection and Use of Blood For Genetic and Other Related Analyses (The GENOMICS Protocol)|Completed||N/A|2502|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 17:46:06.154563|2017-02-18 17:46:06.154563
NCT00096759|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-15|2013-03-21|||November 2004||2004-11-01|March 2013|2013-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid Arthritis|Efficacy of CAM Interventions in Rheumatoid Arthritis|Completed||Phase 2/Phase 3|100|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 17:46:06.323117|2017-02-18 17:46:06.323117
NCT00096746|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-15|2011-04-12|||November 2004||2004-11-01|April 2011|2011-04-01|September 2006||2006-09-01|September 2006|Actual|2006-09-01||Observational|||Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects|An Exploratory Study of the Effect of the Atazanavir (ATV) I50L Mutation on Subsequent Treatment Response|Completed||N/A|200||Bristol-Myers Squibb|||2||f||||f||||||||||2017-02-18 17:46:06.414851|2017-02-18 17:46:06.414851
NCT00096733|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2012-12-07|||October 2004||2004-10-01|December 2012|2012-12-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|A2ALL-1||Adult-to-Adult Living Donor Liver Transplantation Study|Adult-to-Adult Living Donor Liver Transplantation Cohort Study|Completed||N/A|2470|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||f||||||Samples With DNA|"~     whole blood, serum, fixed tissue samples, frozen tissue samples~   "|||2017-02-18 17:46:06.547915|2017-02-18 17:46:06.547915
NCT00096720|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2010-09-28|||February 2004||2004-02-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease|Investigating Effects of Short-term Treatment With Pramipexole or Levodopa on [123I]B-CIT and SPECT Imaging in Early Parkinson's|Completed||Phase 2|112|Actual|Institute for Neurodegenerative Disorders||1|||f||||f||||||||||2017-02-18 17:46:06.749396|2017-02-18 17:46:06.749396
NCT00096707|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2009-04-28|||February 2004||2004-02-01|April 2009|2009-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors|Phase I Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) Alone and in Combination With Docetaxel in Subjects With Advanced Solid Malignancies|Completed||Phase 1|50|Anticipated|Threshold Pharmaceuticals|||||||||||||||||||2017-02-18 17:46:06.865256|2017-02-18 17:46:06.865256
NCT00096694|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2012-05-17||||||May 2012|2012-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women|A Pilot Study Evaluating the Effect of the Levonorgestrel-Releasing Intrauterine Device on Genital HIV Shedding in HIV-1-Infected Women|Completed||N/A|41||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:46:07.15146|2017-02-18 17:46:07.15146
NCT00096681|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2011-02-17|2011-01-14||February 2005||2005-02-01|February 2011|2011-02-01|February 2006|Actual|2006-02-01|August 2005|Actual|2005-08-01||Observational|||Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa|Protocol for Cross-Sectional Survey of Acid-Fast Bacilli (AFB) Smear Positive and/or Culture Positive Tuberculosis in the Masiphumelele Township|Completed||N/A|762|Actual|CIPRA SA|||1||f||||f||||||Samples With DNA|"~     Sputum samples~   "|||2017-02-18 17:46:07.269161|2017-02-18 17:46:07.269161
NCT00096668|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2009-06-02|||October 2004||2004-10-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer|A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(R) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) as Initial Treatment of Patients With Metastatic Breast Cancer|Completed||Phase 2|47|Actual|OncoGenex Technologies||1|||f||||||||||||||2017-02-18 17:46:07.47669|2017-02-18 17:46:07.47669
NCT00096655|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2011-05-16|||May 2002||2002-05-01|March 2010|2010-03-01|August 2007|Actual|2007-08-01|||||Interventional|||A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis|A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis|Completed||Phase 3|364|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:46:07.581222|2017-02-18 17:46:07.581222
NCT00096642|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2011-08-04|||June 2002||2002-06-01|August 2011|2011-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Cognitive Behavioral Therapy for Early-Onset Depression|Comprehensive Treatment for Depressed Youth: An Outcome Evaluation Study|Completed||N/A|30|Actual|Centre for Addiction and Mental Health||1|||f||||f||||||||||2017-02-18 17:46:07.681038|2017-02-18 17:46:07.681038
NCT00096629|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2016-03-28|||November 2003||2003-11-01|March 2016|2016-03-01|November 2017|Anticipated|2017-11-01|November 2017|Anticipated|2017-11-01||Interventional|||Vaccine Therapy in Treating Patients With Kidney Cancer|Injection of Renal Cell Carcinoma Patients With Human and Mouse Prostate Specific Membrane Antigen (PSMA) DNA: A Phase I Trial to Assess Safety and Immune Response|Active, not recruiting||Phase 1|15|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:46:07.792148|2017-02-18 17:46:07.792148
NCT00096616|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2013-10-31|||November 2004||2004-11-01|October 2013|2013-10-01||||March 2006|Actual|2006-03-01||Interventional|||Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma|A Single Dose, Randomized, Double-blind Crossover Comparison of Combivent CFC MDI and Albuterol HFA MDI in Patients With Moderate to Severe Persistent Asthma and Persistent Symptoms Despite Treatment With Inhaled Corticosteroids|Completed||Phase 2|113|Actual|Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:46:07.904134|2017-02-18 17:46:07.904134
NCT00096603|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-12|2014-03-19|||October 2002||2002-10-01|March 2014|2014-03-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g|An Open Label, Multicenter Study to Evaluate the Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g|Completed||Phase 3|450||Genentech, Inc.|||||||||||||||||||2017-02-18 17:46:08.013711|2017-02-18 17:46:08.013711
NCT00096590|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-11|2009-05-09|||November 2004||2004-11-01|June 2007|2007-06-01||||||||Observational|||Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery|Evaluation of a Novel Blood Test Hypercoagulability in Surgical Patients With Metastatic Carcinoma: A Pilot Study|Completed||N/A|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:46:08.085177|2017-02-18 17:46:08.085177
NCT00096564|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-10|2017-01-24|||November 9, 2004||2004-11-09|August 20, 2008|2008-08-20|August 20, 2008||2008-08-20|||||Observational|||Brain Activities Associated With Different Facial Expressions Using Blood Oxygenation Level Dependent Functional MRI|Functional MRI Study of Brain Activation With Observation of Facial Expressions|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:46:08.178497|2017-02-18 17:46:08.178497
NCT00096551|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2017-01-24|||November 1, 2004||2004-11-01|July 25, 2011|2011-07-25|July 25, 2011|Actual|2011-07-25|December 11, 2009|Actual|2009-12-11||Interventional|||A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy|A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer and Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy|Completed||Phase 1|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:46:08.253711|2017-02-18 17:46:08.253711
NCT00096538|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2015-10-21|2015-10-21||April 2004||2004-04-01|October 2015|2015-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma|Pilot Study Of Valganciclovir In Patients With Classic, Non-HIV-Associated Kaposi's Sarcoma|Completed||N/A|6|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:46:08.347825|2017-02-18 17:46:08.347825
NCT00096525|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-01-15|||July 2004||2004-07-01|January 2013|2013-01-01||||August 2005|Actual|2005-08-01||Interventional|||Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer|Phase II Trial of CC-5013 in Patients With Advanced Renal Cell Carcinoma With Either No Prior Treatment or One Prior Treatment Regimen|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:46:08.796793|2017-02-18 17:46:08.796793
NCT00096512|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-02-27|||October 2004||2004-10-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|Phase II Evaluation of BAY 43-9006 (NSC-724772) in Patients With Recurrent or Metastatic Head and Neck Cancer|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:08.904008|2017-02-18 17:46:08.904008
NCT00096499|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-01-24|||April 2005||2005-04-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel|A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Taxane-Resistant Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:09.020047|2017-02-18 17:46:09.020047
NCT00096486|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2015-12-15|2015-12-15||May 2004||2004-05-01|December 2015|2015-12-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer|A Phase I/II Trial of Fixed Doses of Daily Gefitinib With Escalating Doses of Daily RAD001 in Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|74|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:46:09.131275|2017-02-18 17:46:09.131275
NCT00096473|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2011-03-31|||January 2001||2001-01-01|March 2011|2011-03-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|||Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease|A 24 Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Donepezil Hydrochloride (E2020) in Patients With Severe Alzheimer's Disease Followed by a 12 Week Open-Label Extension Period|Completed||Phase 3|229|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:46:09.757141|2017-02-18 17:46:09.757141
NCT00096460|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-08-01|2011-08-16||August 2004||2004-08-01|August 2016|2016-08-01|March 2009|Actual|2009-03-01|March 2006|Actual|2006-03-01||Interventional|||Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)|Autologous Versus Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response (BMT CTN #0202)|Terminated||Phase 2/Phase 3|30|Actual|Medical College of Wisconsin||2||lower than anticipated accrual|f||||t||||||||Yes||2017-02-18 17:46:09.916232|2017-02-18 17:46:09.916232
NCT00096447|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2015-08-18|2015-06-03||November 2004||2004-11-01|January 2013|2013-01-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional||Eligible and treated patients.|Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation Of Lapatinib (GW572016) (NCI-Supplied Agent, NSC #727989) In The Treatment Of Persistent Or Recurrent Endometrial Carcinoma|Completed||Phase 2|31|Actual|National Cancer Institute (NCI)|The clinical trial was a two-stage design, accruing approximately 25 patients in each stage. Results from a planned interim futility analysis resulted in the early closure of the study. This study stopped early for lack of treatment efficacy.|1|||f||||||||||||||2017-02-18 17:46:10.509157|2017-02-18 17:46:10.509157
NCT00096434|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-10-07|||September 2004||2004-09-01|October 2013|2013-10-01||||June 2006|Actual|2006-06-01||Interventional|||Sorafenib in Treating Patients With Metastatic Breast Cancer|Phase II Trial of Raf Kinase Inhibitor BAY 43-9006 as Single Oral Agent in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane|Completed||Phase 2|42|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:10.901114|2017-02-18 17:46:10.901114
NCT00096421|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2006-10-24|||July 2003||2003-07-01|October 2006|2006-10-01|September 2006||2006-09-01|||||Interventional|||Tight Glycemic Control in Critical Care Patients|Tight Glycemic Control in Patients Hospitalized in a Medical-Surgery Intensive Care Unit: A Randomized Study|Completed||Phase 3|504||Hospital Pablo Tobón Uribe|||||f||||||||||||||2017-02-18 17:46:11.002891|2017-02-18 17:46:11.002891
NCT00096408|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-09-26|||October 2005||2005-10-01|September 2016|2016-09-01|December 2018|Anticipated|2018-12-01|April 2016|Actual|2016-04-01||Interventional|||Laparoscopic Approach to Cancer of the Endometrium|LACE - Laparoscopic Approach to Cancer of the Endometrium: An International Multicenter Randomized Phase 3 Clinical Trial|Active, not recruiting||Phase 3|760|Actual|Queensland Centre for Gynaecological Cancer||2|||f||||t||||||||Undecided||2017-02-18 17:46:11.182737|2017-02-18 17:46:11.182737
NCT00096395|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-06-11|||September 2004||2004-09-01|May 2013|2013-05-01||||February 2007|Actual|2007-02-01||Interventional|||Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer|A Phase 2 Study of BAY 43-9006 in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:11.507858|2017-02-18 17:46:11.507858
NCT00096382|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2015-10-06|2012-11-20||September 2004||2004-09-01|September 2015|2015-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma|Treatment of Patients With Metastatic Melanoma Using a Transplant of Autologous Lymphocytes Reactive With Tumor Following a Myeloablative Lymphocyte Depleting Regimen of Chemotherapy, Total Body Irradiation and Reconstitution With CD34+ Cells|Completed||Phase 2|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 17:46:11.632353|2017-02-18 17:46:11.632353
NCT00096369|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2008-05-23|||February 2002||2002-02-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer|An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer|Unknown status|Active, not recruiting|Phase 2|130|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:46:12.368646|2017-02-18 17:46:12.368646
NCT00096356|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2014-12-17|2014-09-08||August 2004||2004-08-01|December 2014|2014-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|CoQ10|All participants|Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer|A Randomized Double-Blind Placebo-Controlled Study Of Oral Coenzyme Q10 To Relieve Self-Reported Cancer Treatment Related Fatigue In Breast Cancer Patients|Completed||Phase 3|236|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 17:46:12.486537|2017-02-18 17:46:12.486537
NCT00096343|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-12-02|||October 2002||2002-10-01|November 2012|2012-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer|A Phase II Trial of Pre-Operative Taxol and Carboplatin in Women With Newly Diagnosed Locally Advanced Operable Breast Cancer|Completed||Phase 2|31|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 17:46:13.169339|2017-02-18 17:46:13.169339
NCT00096330|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2014-01-10|||September 2004||2004-09-01|January 2014|2014-01-01|March 2008|Actual|2008-03-01|February 2007|Actual|2007-02-01||Interventional|||Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer|Phase I Clinical Study of Folate|Completed||Phase 1|20|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:46:13.278752|2017-02-18 17:46:13.278752
NCT00096317|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2008-11-12|||March 2003||2003-03-01|January 2006|2006-01-01||||||||Interventional|||Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors|Effect Of Ketoconazole On The Pharmacokinetics Of BMS-247550 In Patients With Advanced Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:46:13.379955|2017-02-18 17:46:13.379955
NCT00096304|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2008-12-04|||June 2004||2004-06-01|November 2008|2008-11-01||||March 2008|Actual|2008-03-01||Interventional|||Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer|Phase I Trial of Epirubicin and Taxotere in Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:46:13.485343|2017-02-18 17:46:13.485343
NCT00096291|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-03-14|||February 2000||2000-02-01|March 2016|2016-03-01||||March 2005|Actual|2005-03-01||Interventional|||Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer|Neoadjuvant Chemotherapy in Palpable Breast Cancer: Evaluation of Physiologic, Radiologic, and Molecular Markers in Predicting Response|Active, not recruiting||Phase 2|62|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:46:13.575433|2017-02-18 17:46:13.575433
NCT00096278|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2014-05-16|2012-10-31||September 2004||2004-09-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|March 2009|Actual|2009-03-01||Interventional|||Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer|A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks With Bevacizumab to the Same Regimen Without Bevacizumab for the Treatment of Patients With Resected Stages II and III Carcinoma of the Colon|Completed||Phase 3|2710|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:46:13.698947|2017-02-18 17:46:13.698947
NCT00096265|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2014-05-05|2013-03-05||October 2004||2004-10-01|October 2011|2011-10-01|April 2012|Actual|2012-04-01|June 2011|Actual|2011-06-01||Interventional|||Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer|A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases|Terminated||Phase 3|126|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 17:46:14.449053|2017-02-18 17:46:14.449053
NCT00096239|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-12-18|||December 2004||2004-12-01|February 2005|2005-02-01|February 2005|Actual|2005-02-01|||||Interventional|||CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|Phase II Open-Label, Multi-Center Study of CP-547, 632, an Oral Tyrosine Kinase Inhibitor of VEGFR-2, in Subjects With Recurrent or Persistent Small-Volume Epithelial Ovarian Cancer, Primary Peritoneal Serous Cancer, or Fallopian Tube Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:46:15.73186|2017-02-18 17:46:15.73186
NCT00096226|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2015-11-14|2014-01-16||September 2004||2004-09-01|November 2015|2015-11-01||||April 2012|Actual|2012-04-01||Interventional||All eligible patients who started protocol treatment.|Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer|A Phase II Trial Of Neoadjuvant Therapy With Concurrent Chemotherapy And High Dose Radiotherapy Followed By Surgical Resection And Consolidative Therapy For Locally Advanced Non-Small Cell Lung Carcinoma|Completed||Phase 2|60|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 17:46:15.825434|2017-02-18 17:46:15.825434
NCT00096213|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2012-01-13|||December 2004||2004-12-01|January 2012|2012-01-01|August 2009|Actual|2009-08-01|April 2006|Actual|2006-04-01||Interventional|||S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone|A Phase II Surgical Trial Of Intralesional Resection Of Low-Grade Intracompartmental Chondrosarcoma Of Bone|Completed||Phase 2|60|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 17:46:16.356814|2017-02-18 17:46:16.356814
NCT00096200|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2015-04-14|2012-11-08||August 2004||2004-08-01|February 2014|2014-02-01||||August 2012|Actual|2012-08-01||Interventional|||Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|A Phase II Trial Of BAY 43-9006, A Novel Raf Kinase Inhibitor Plus Paclitaxel/Carboplatin In Women With Recurrent Platinum Sensitive Epithelial Ovarian, Peritoneal Or Fallopian Tube Cancer|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)|Principal Investigator did not collect data on secondary outcomes because not relevant.|2|||f||||||||||||||2017-02-18 17:46:16.496235|2017-02-18 17:46:16.496235
NCT00096187|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-04-10|||July 2005||2005-07-01|May 2007|2007-05-01||||July 2007||2007-07-01||Interventional|||Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy|A Phase II Trial of Pemetrexed (ALIMTA®, LY231514, IND #40061) as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Tumor|Terminated||Phase 2|55|Anticipated|Gynecologic Oncology Group|||||||||||||||||||2017-02-18 17:46:17.542068|2017-02-18 17:46:17.542068
NCT00096174|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2015-08-03|2011-02-28||December 2004||2004-12-01|August 2015|2015-08-01|July 2016|Anticipated|2016-07-01|July 2009|Actual|2009-07-01||Interventional|||Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck|Phase II Study of C225 (Erbitux or Cetuximab) in Combination With Cisplatin and Definitive Radiation in Unresectable Stage IV Squamous Cell Carcinoma of the Head and Neck|Active, not recruiting||Phase 2|69|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 17:46:17.665134|2017-02-18 17:46:17.665134
NCT00096161|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-02-29|||May 2003||2003-05-01|January 2016|2016-01-01||||February 2015|Actual|2015-02-01||Interventional|||Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant|Pentostatin and Donor Lymphocyte Infusion for Low Donor T-cell Chimerism After Hematopoietic Cell Transplantation - A Multi-center Trial|Active, not recruiting||Phase 2|37|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:46:18.060679|2017-02-18 17:46:18.060679
NCT00096148|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-01-23|||October 2004||2004-10-01|January 2013|2013-01-01||||November 2006|Actual|2006-11-01||Interventional|||Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|Randomized Phase II Trial of Idarubicin + Ara-C +/- Bevacizumab in Patients Age < 60 With Untreated Acute Myeloid Leukemia|Terminated||Phase 2|120|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 17:46:18.285295|2017-02-18 17:46:18.285295
NCT00096135|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-03-07|2015-07-10||November 2004||2004-11-01|July 2015|2015-07-01||||September 2013|Actual|2013-09-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes|Treatment of Late Isolated Extramedullary Relapse From Acute Lymphoblastic Leukemia (ALL) (Initial CR1≥ 18 Months)|Active, not recruiting||N/A|168|Actual|Children's Oncology Group|The COG SDC reviewed the NLM notification related to ct.gov AE/SAE reporting. The information in ‘Additional Description’ is accurate with respect to data supplied to ct.gov.COG plans to submit data AE/SAE data consistent with the text in this field.|2|||f||||t||||||||||2017-02-18 17:46:18.431364|2017-02-18 17:46:18.431364
NCT00096122|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2014-05-09|2011-06-13||September 2004||2004-09-01|June 2013|2013-06-01|February 2010|Actual|2010-02-01|September 2006|Actual|2006-09-01||Interventional|||Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia|PHASE I-II STUDY OF IDARUBICIN, CYTARABINE AND R115777 (TIPIFARNIB, ZARNESTRA; 702818; IND 58359), A FARNESYLTRANSFERASE INHIBITOR, IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIAS|Completed||Phase 1/Phase 2|95|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:22.386599|2017-02-18 17:46:22.386599
NCT00096109|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-11-18|2015-05-11||September 2005||2005-09-01|November 2016|2016-11-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Interventional|||Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer|A Phase II Clinical Trial of 17-Allyamino-17-Demethoxygeldanamycin (17-AAG) in Chemotherapy Refractory Metastatic Breast Cancer|Terminated||Phase 2|11|Actual|National Cancer Institute (NCI)|Because of the frequency of toxicities experienced by the pts & lack of response, study closed to accrual before all 17 planned pts were enrolled. It was proposed to analyze outcome by HER2 status,but no HER2 data was collected.|1||Closed to accrual before all 12 planned patients were enrolled.|f||||||||||||||2017-02-18 17:46:22.925897|2017-02-18 17:46:22.925897
NCT00096096|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2010-05-12|||August 2004||2004-08-01|May 2010|2010-05-01||||May 2006|Actual|2006-05-01||Interventional|||Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation|A Phase II Study of the Combination of Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-Versus-Host Disease|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:46:23.224798|2017-02-18 17:46:23.224798
NCT00096083|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-10-22|||September 2004||2004-09-01|October 2013|2013-10-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer|A Phase II Study Of Hepatic Arterial Infusion Of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion (PHP) For Unresectable Primary And Metastatic Cancers Of The Liver|Completed||Phase 2|56|Actual|Delcath Systems Inc.||1|||f||||||||||||||2017-02-18 17:46:23.337897|2017-02-18 17:46:23.337897
NCT00096070|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-07-15|||December 2004||2004-12-01|June 2013|2013-06-01||||April 2007|Actual|2007-04-01||Interventional|||Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer|Phase II Study of Oxaliplatin, Continuous 5-Fluorouracil and External Beam Radiation Followed by Gemcitabine in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:23.457149|2017-02-18 17:46:23.457149
NCT00096057|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-06-25|||May 2004||2004-05-01|April 2007|2007-04-01|December 2007|Actual|2007-12-01|||||Interventional|||Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer|An Open Label Phase I Study of Humanized Human Milk Fat Globule-1 (huHMFG1) Antibody in Patients With Locally Advanced or Metastatic Breast Cancer (TOPCAT)|Completed||Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:46:23.573344|2017-02-18 17:46:23.573344
NCT00096044|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-07-08|||March 2004||2004-03-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|CC-5013 Alone or in Combination With Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|45|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:46:23.658524|2017-02-18 17:46:23.658524
NCT00096031|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2012-04-04|2012-04-04||October 2004||2004-10-01|April 2012|2012-04-01|January 2010|Actual|2010-01-01|January 2008|Actual|2008-01-01||Interventional|||S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer|Cetuximab As Second Line Therapy In Patients With Metastatic Esophageal Cancer - Phase II|Completed||Phase 2|63|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:46:23.784634|2017-02-18 17:46:23.784634
NCT00096018|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-09-19|2013-01-28||May 2002||2002-05-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|November 2010|Actual|2010-11-01||Interventional||Treated Patients|Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia|A Phase I/II Study of Fludarabine Plus Thalidomide as Frontline Therapy for Newly Diagnosed Patients With Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|43|Actual|Roswell Park Cancer Institute|The study was stopped early due to low accrual.|1|||f||||t||||||||||2017-02-18 17:46:24.533991|2017-02-18 17:46:24.533991
NCT00096005|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2014-02-21|||November 2004||2004-11-01|October 2011|2011-10-01||||March 2010|Actual|2010-03-01||Interventional|||Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas|A Phase I Trial Of 17-Allylaminogeldanamycin (17-AAG) And PS341 In Advanced Malignancies|Terminated||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:25.344399|2017-02-18 17:46:25.344399
NCT00095992|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2011-09-26|||November 2004||2004-11-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|||SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer|A Phase II Study Of SB-715992 (NSC 727990) In Patients With Locally Advanced, Recurrent Or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|15|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 17:46:25.468056|2017-02-18 17:46:25.468056
NCT00095979|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2015-05-05|2015-05-05||May 2005||2005-05-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||Eligible and treated patients|Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Ixabepilone (BMS-247550) [NCI-Supplied Agent, NSC #710428]) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|52|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:25.56694|2017-02-18 17:46:25.56694
NCT00095966|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-07-01|||September 2004||2004-09-01|July 2013|2013-07-01||||September 2005|Actual|2005-09-01||Interventional|||Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase II Study of BAY 43-9006/Gemcitabine for Advanced Pancreatic Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:26.016119|2017-02-18 17:46:26.016119
NCT00095953|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-05-16|||November 2004||2004-11-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|September 2006|Actual|2006-09-01||Interventional|||SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma|A Phase II Study of SB-715992 (NSC 727990) in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 17:46:26.405456|2017-02-18 17:46:26.405456
NCT00095940|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2014-05-07|2011-08-02||October 2004||2004-10-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors|Molecular Biology and Phase II Study of Lapatinib (GW572016) in Pediatric Patients With Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma|Completed||Phase 1/Phase 2|52|Actual|National Cancer Institute (NCI)|Accrual to the Molecular Biology phase (MBP) was contingent upon accrual being open for the Phase II since some participants in the MBP could be counted in the phase II. The phase II enrolled rapidly thus limiting enrollment to the MBP.|1|||f||||||||||||||2017-02-18 17:46:26.528455|2017-02-18 17:46:26.528455
NCT00095927|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2017-01-03|||May 2003||2003-05-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Randomized Amifostine For SCCHN|Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|58|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 17:46:28.010507|2017-02-18 17:46:28.010507
NCT00095914|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2012-03-14|||September 2004||2004-09-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|May 2007|Actual|2007-05-01||Interventional|||Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Randomized, Crossover, Pharmacokinetic Study Of Paclitaxel (Taxol) And ABI-007 (A Cremophor EL-Free, Protein Stabilized, Nanoparticle Paclitaxel) In Patients With Advanced Solid Tumors|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:46:28.14788|2017-02-18 17:46:28.14788
NCT00095901|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2008-07-23|||June 2004||2004-06-01|December 2005|2005-12-01||||||||Interventional|||Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer|A Phase II Study Of Capecitabine In Previously Treated, Recurrent And/Or Metastatic Nasopharyngeal Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:46:28.245586|2017-02-18 17:46:28.245586
NCT00095888|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-01-15|||October 2004||2004-10-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer|A Phase II Trial Of Gemcitabine And Triapine In Refractory Metastatic Breast Cancer|Terminated||Phase 2|68|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:46:28.35292|2017-02-18 17:46:28.35292
NCT00095875|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-10-25|2013-05-15||August 2004||2004-08-01|October 2013|2013-10-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)|A Randomized Phase III Comparing Sequential Therapy With TPF/Chemoradiation (ST) To Cisplatinum-Based Chemoradiotherapy [PARADIGM TRIAL]|Completed||Phase 3|145|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||||2017-02-18 17:46:28.474052|2017-02-18 17:46:28.474052
NCT00095862|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-12-17|||November 2004||2004-11-01|October 2011|2011-10-01||||December 2014|Anticipated|2014-12-01||Interventional|||Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers|A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor|Suspended||Phase 1/Phase 2|24|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:28.924579|2017-02-18 17:46:28.924579
NCT00095836|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-11-03|||March 2003||2003-03-01|November 2016|2016-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy|A Phase II Study of ZD 1839 (IRESSA®) in Patients With Advanced Thyroid Cancer|Completed||Phase 2|38|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 17:46:29.025615|2017-02-18 17:46:29.025615
NCT00095823|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-11-22|||June 2004||2004-06-01|November 2013|2013-11-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Aripiprazole as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder.|Completed||Phase 3|1200||Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 17:46:29.14094|2017-02-18 17:46:29.14094
NCT00095810|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-11-07|||July 2003||2003-07-01|December 2010|2010-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease|An Open-Label Study of Aripiprazole to Evaluate the Safety and Tolerability in Patients With Psychosis Associated With Parkinson's Disease|Completed||Phase 4|50||Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||||||||||||2017-02-18 17:46:29.270683|2017-02-18 17:46:29.270683
NCT00095797|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-02-07|||October 2004||2004-10-01|February 2013|2013-02-01||||March 2007|Actual|2007-03-01||Interventional|||XK469R in Treating Patients With Refractory Hematologic Cancer|A Phase I Study of XK469R (NSC 698215) in Patients With Refractory Hematologic Malignancies|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:29.453892|2017-02-18 17:46:29.453892
NCT00095784|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2016-12-28|2014-07-09||September 2004||2004-09-01|December 2016|2016-12-01||||July 2008|Actual|2008-07-01||Interventional|||Decitabine in Treating Patients With Myelofibrosis|A Phase II Study of Decitabine in Myelofibrosis|Active, not recruiting||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:29.785917|2017-02-18 17:46:29.785917
NCT00095771|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2011-04-21|||November 2004||2004-11-01|April 2011|2011-04-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas|A Phase I Trial of Arsenic Trioxide in the Treatment of Infiltrating Gliomas of Childhood|Completed||Phase 1|36|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 17:46:30.325909|2017-02-18 17:46:30.325909
NCT00095758|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-11-22|||September 2004||2004-09-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder|A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder|Completed||Phase 3|1200||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:46:30.432024|2017-02-18 17:46:30.432024
NCT00094601|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-20|2017-01-24|||October 18, 2004||2004-10-18|January 22, 2008|2008-01-22|January 22, 2008||2008-01-22|||||Observational|||Relationship of Dopamine to Cognitive Function in Parkinson's Disease|Cognitive Function in Parkinson's Disease: Relationship to Cortical Dopamine Synthesis and Dopamine D1 Receptors|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:47:24.252641|2017-02-18 17:47:24.252641
NCT00095745|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-11-07|||September 2004||2004-09-01|April 2011|2011-04-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder|A Multicenter, Long-Term, Open-label, Study to Assess the Safety and Tolerability of Aripiprazole as an Adjunctive Therapy in the Treatment of Outpatients With Major Depressive Disorder|Completed||Phase 3|1002|Actual|Otsuka Pharmaceutical Development & Commercialization, Inc.||1|||f||||f||||||||||2017-02-18 17:46:30.577606|2017-02-18 17:46:30.577606
NCT00095732|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2014-10-15|||June 2004||2004-06-01|October 2014|2014-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency|A Phase 2, Randomized, Double Blind, Parallel Dose Ranging Study of Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency|Completed||Phase 2|129|Actual|Anthera Pharmaceuticals||3|||f||||t||||||||||2017-02-18 17:46:30.917459|2017-02-18 17:46:30.917459
NCT00095719|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-09|2013-11-07|||December 2003||2003-12-01|August 2008|2008-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia|A Safety & Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia|Completed||Phase 3|125||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 17:46:31.048043|2017-02-18 17:46:31.048043
NCT00095706|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2015-09-23|||June 2003||2003-06-01|September 2015|2015-09-01|January 2012|Actual|2012-01-01|April 2007|Actual|2007-04-01||Interventional|||Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)|Phase I/II Combined Biological Therapy of Breast Cancer Using Monoclonal Antibodies Directed Against HER2/Neu Proto-Oncogene and Vascular Endothelial Growth Factor|Completed||Phase 1/Phase 2|50|Anticipated|Translational Oncology Research International|||||f||||t||||||||||2017-02-18 17:46:31.173498|2017-02-18 17:46:31.173498
NCT00095693|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2014-01-15|||October 2004||2004-10-01|January 2014|2014-01-01|December 2011|Actual|2011-12-01|August 2005|Actual|2005-08-01||Interventional|||Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer|Phase II Study of BAY 43-9006 in Patients With Metastatic Thyroid Carcinoma|Terminated||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:31.296021|2017-02-18 17:46:31.296021
NCT00095680|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2010-10-21|||November 2004||2004-11-01|October 2010|2010-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma|A 24-week, Open-label Extension Study of the Efficacy, Safety, and Tolerability of Oral SCIO-469 in Treatment of Relapsed Refractory Patients With Multiple Myeloma|Completed||Phase 2|30|Actual|Scios, Inc.||2|||f||||||||||||||2017-02-18 17:46:31.422999|2017-02-18 17:46:31.422999
NCT00095667|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2013-05-07|||November 2004||2004-11-01|May 2013|2013-05-01||||November 2007|Actual|2007-11-01||Interventional|||Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer|A Phase 2 Study of GW572016 in Hormone Naive Recurrent or Metastatic Hormone Sensitive Prostate Cancer|Completed||Phase 2|41|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:31.529389|2017-02-18 17:46:31.529389
NCT00095654|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2009-11-09|||July 2001||2001-07-01|November 2009|2009-11-01|October 2006|Actual|2006-10-01|||||Interventional|||The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial|The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial|Completed||Phase 3|5000||Gerstein, Hertzel, MD|||||||||||||||||||2017-02-18 17:46:31.843191|2017-02-18 17:46:31.843191
NCT00095641|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2013-11-07||||||November 2013|2013-11-01||||||||Interventional|||S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer|S0225: Phase II Study of Adjuvant Low-Dose Capecitabine After Salvage Surgery in Patients With Locally Recurrent or Persistent Squamous Cell Carcinoma of the Head and Neck|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||||no longer studying this disease site|f||||t||||||||||2017-02-18 17:46:31.945648|2017-02-18 17:46:31.945648
NCT00095628|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2013-05-07|||January 2005||2005-01-01|May 2013|2013-05-01||||July 2010|Actual|2010-07-01||Interventional|||SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase 2 Study of SB-715992 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:32.039227|2017-02-18 17:46:32.039227
NCT00095589|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2009-02-26|||August 2004||2004-08-01|February 2009|2009-02-01||||June 2009|Anticipated|2009-06-01||Interventional|||Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer|Detection of Bladder Cancer by Microsatellite Analysis (MSA) of Urinary Sediment: Multi-Institutional Study|Unknown status|Active, not recruiting|N/A|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:46:32.169034|2017-02-18 17:46:32.169034
NCT00095576|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2015-10-05|2011-07-20||November 2004||2004-11-01|October 2015|2015-10-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Interventional|||Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase II Proof-of-Concept Study to Evaluate the Safety and Efficacy of a 3-Dose Regimen of the Merck Adenovirus Serotype 5 HIV-1 Gag/Pol/Nef Vaccine (MRK AD5 HIV-1 Gag/Pol/Nef) in Adults at High Risk of HIV-1 Infection|Terminated||Phase 2|3000|Actual|Merck Sharp & Dohme Corp.|The DSMB (Data & Safety Monitoring Board) reviewed interim data which demonstrated that the investigational vaccine was not effective, and all vaccinations were halted. Long term follow up was available for participants in V520-030.|2|||f||||t||||||||||2017-02-18 17:46:32.297881|2017-02-18 17:46:32.297881
NCT00095563|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2013-10-10|||September 2004||2004-09-01|October 2013|2013-10-01||||February 2009|Actual|2009-02-01||Interventional|||Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers|A Phase 2 Study of GW572016 in Recurrent and/or Metastatic Adenoid Cystic Carcinoma, and Other EGFR-and/or erbB2-expressing Malignant Tumors of the Salivary Glands|Completed||Phase 2|67|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:46:32.798415|2017-02-18 17:46:32.798415
NCT00095550|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2011-04-07||2010-02-15|October 2004||2004-10-01|August 2008|2008-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension|The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Patients With Moderate Hypertension|Completed||Phase 3|496|Anticipated|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 17:46:32.926284|2017-02-18 17:46:32.926284
NCT00005342|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||May 1993||1993-05-01|July 2000|2000-07-01|April 1997|Actual|1997-04-01|||||Observational|||Weight Set-Point and HDL Concentration in Runners||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.741551|2017-02-18 18:15:06.741551
NCT00095537|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2010-02-27|||March 2004||2004-03-01|October 2008|2008-10-01||||May 2006|Actual|2006-05-01||Interventional|||BMS-599626 in Patients With Advanced Solid Malignancies|Phase I Study of BMS-599626 in Patients With Advanced Solid Malignancies, Including Malignancies That Express HER2 at the Maximum Tolerated Dose and/or Recommended Phase II Dose|Completed||Phase 1|60||Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 17:46:33.166755|2017-02-18 17:46:33.166755
NCT00095524|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2013-11-07|||March 2004||2004-03-01|May 2008|2008-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder|A Multicenter, Randomized, Double-Blind Study on the Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|300||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||f||||||||||||||2017-02-18 17:46:33.276515|2017-02-18 17:46:33.276515
NCT00095511|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2013-11-07|||June 2004||2004-06-01|May 2008|2008-05-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Aripiprazole in Patients With Acute Mania|A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder|Completed||Phase 3|615||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||f||||||||||||||2017-02-18 17:46:33.542632|2017-02-18 17:46:33.542632
NCT00095498|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2014-01-10|2010-06-25||August 2004||2004-08-01|January 2014|2014-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis|A Randomized, Double-blind, Placebo-controlled, Multi-dose Phase 2 Study to Determine the Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis|Completed||Phase 2|227|Actual|Amgen||3|||f||||||||||||||2017-02-18 17:46:33.715259|2017-02-18 17:46:33.715259
NCT00095485|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-05|2008-03-03|||November 2004||2004-11-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Impact of Move to Clinical Research Center on Physical Activity of Employees|Impact of Move to CRC on Physical Activity of Employees|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:46:38.603406|2017-02-18 17:46:38.603406
NCT00095472|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-04|2017-01-24|||November 1, 2004||2004-11-01|December 7, 2015|2015-12-07|August 24, 2007|Actual|2007-08-24|August 24, 2007|Actual|2007-08-24||Interventional|||Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease|Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease|Completed||Phase 1|18|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:46:38.672257|2017-02-18 17:46:38.672257
NCT00095459|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-04|2017-01-24|||November 2, 2004||2004-11-02|April 23, 2014|2014-04-23|July 20, 2012|Actual|2012-07-20|November 1, 2005|Actual|2005-11-01||Interventional|||BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors|A Phase I Trial of BAY 43-9006 (Sorafenib) and Bevacizumab in Refractory Solid Tumors With Biologic and Proteomic Analysis|Completed||Phase 1|57|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:46:38.770184|2017-02-18 17:46:38.770184
NCT00095446|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-04|2017-01-02|||July 2004||2004-07-01|January 2017|2017-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes|An Open-Label, Multi Center, Clinical Trial: External Continuous Subcutaneous Infusion of Insulin Using Insulin Aspart (NovoLog®) in Subjects With Type 1 and Insulin Requiring Type 2 Diabetes|Completed||Phase 4|513|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:46:38.865635|2017-02-18 17:46:38.865635
NCT00095433|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-04|2014-03-25|||September 2002||2002-09-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)|An Extension Study to Evaluate the Safety and Tolerability of Multiple-Dose Intravitreal Injections of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration Who Have Completed the Treatment Phase of a Genentech-Sponsored Phase I or Phase I/II rhuFab V2 Study|Completed||Phase 3|100||Genentech, Inc.|||||f||||||||||||||2017-02-18 17:46:38.972575|2017-02-18 17:46:38.972575
NCT00095420|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-04|2013-05-13|||September 2003||2003-09-01|May 2013|2013-05-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Relationship Training for Children With Autism and Their Peers|Peer Related School Interventions in Autism|Completed||N/A|60|Actual|University of California, Los Angeles||4|||f||||t||||||||||2017-02-18 17:46:39.046838|2017-02-18 17:46:39.046838
NCT00095407|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-03|2017-01-24|||October 29, 2004||2004-10-29|December 29, 2011|2011-12-29|December 29, 2011||2011-12-29|||||Observational|||The Functional Anatomy of Personality Trait Knowledge: An fMRI Study|The Functional Anatomy of Personality Trait Knowledge: an fMRI Study|Completed||N/A|190|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:46:39.162424|2017-02-18 17:46:39.162424
NCT00095394|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-03|2011-04-07||2010-02-15|September 2004||2004-09-01|August 2008|2008-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension|The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Severe Hypertension|Completed||Phase 3|645|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:46:39.248735|2017-02-18 17:46:39.248735
NCT00095381|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-03|2012-01-18|||March 2004||2004-03-01|January 2012|2012-01-01|December 2007|Actual|2007-12-01|March 2007|Actual|2007-03-01||Interventional|||Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia|A Phase II, Multi-Center Open-Label, Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia With an Option of Long-Term Forodesine Hydrochloride (BCX-1777) Use|Completed||Phase 2|20||BioCryst Pharmaceuticals|||||f||||||||||||||2017-02-18 17:46:39.795016|2017-02-18 17:46:39.795016
NCT00095368|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-03|2006-12-06|||October 2004||2004-10-01|April 2005|2005-04-01|May 2005||2005-05-01|||||Interventional|||APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat|A Phase III, Randomized, Double-Blind, Double-Dummy Multicenter Study to Evaluate the Efficacy and Safety of 775 mg APC-111 MP Tablet QD for 7 Days vs Penicillin VK 250 mg QID for 10 Days in Patients With Streptococcus Pyogenes|Completed||Phase 3|500||Advancis Pharmaceutical Corporation|||||f||||||||||||||2017-02-18 17:46:39.906024|2017-02-18 17:46:39.906024
NCT00095355|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-02|2008-03-03|||October 2004||2004-10-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Effects of Lithium and Divalproex`on Brain-Derived Neurotrophic Factor in Huntington's Disease|Stimulation of Tyrosine Kinase and ERK Signaling Pathways in Huntington's Disease|Completed||Phase 2|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:46:39.9852|2017-02-18 17:46:39.9852
NCT00095342|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-02|2009-09-08||||||September 2009|2009-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study Evaluating TMI-005 in Active Rheumatoid Arthritis|A Double-Blind, Placebo-Controlled, Parallel, Randomized Study to Evaluate the Efficacy and Safety of 3 Oral Dose Levels of TMI-005 in Subjects With Active Rheumatoid Arthritis on a Background of Methotrexate|Completed||Phase 2|390|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:46:40.090618|2017-02-18 17:46:40.090618
NCT00095329|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-02|2016-09-20|||May 2003||2003-05-01|September 2016|2016-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor|A Phase I/II, Open-Label Pilot Trial to Evaluate the Safety of Rapamune (Sirolimus) in Patients With Multiple Sclerosis|Terminated||Phase 1/Phase 2|14|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Due to slow recruitment.|f||||t||||||||||2017-02-18 17:46:40.185873|2017-02-18 17:46:40.185873
NCT00095316|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-02|2014-12-04|||October 2004||2004-10-01|June 2006|2006-06-01|September 2006||2006-09-01|||||Interventional|||Caspofungin Study for Fungal Infections in Adults in Critical Care Settings|A Randomized, Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting|Terminated||Phase 3|1200|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:46:40.503664|2017-02-18 17:46:40.503664
NCT00095303|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-02|2015-06-10|2014-05-17||August 2004||2004-08-01|June 2015|2015-06-01|August 2011|Actual|2011-08-01|January 2008|Actual|2008-01-01||Interventional|BSFT|Main Study|Brief Strategic Family Therapy for Adolescent Drug Abusers|Brief Strategic Family Therapy for Adolescent Drug Abusers|Completed||Phase 3|480|Actual|University of Miami|Main Study: Low rates self-reported drug use leading to only examination of prevention of relapse/escalation of drug use Follow Up Study: Variability between the time of participation in main and follow up, so no direct casuality could be concluded|2|||f||||t||||||||||2017-02-18 17:46:40.62811|2017-02-18 17:46:40.62811
NCT00095290|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-02|2011-04-07||2010-02-15|September 2004||2004-09-01|September 2008|2008-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria|Irbesartan Versus Placebo in Combination With Standard Cardiovascular Protection ACE-I Therapy With Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk|Completed||Phase 4|400||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:46:41.855298|2017-02-18 17:46:41.855298
NCT00095277|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-02|2009-03-12|||October 2004||2004-10-01|March 2009|2009-03-01||||||||Interventional|||Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer|Completed||Phase 2|220||Amgen|||||||||||||||||||2017-02-18 17:46:42.036714|2017-02-18 17:46:42.036714
NCT00095264|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-02|2010-01-14|||October 2004||2004-10-01|January 2010|2010-01-01||||||||Interventional|||A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome|A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome|Completed||Phase 2|209||Amgen||1|||||||||||||||||2017-02-18 17:46:42.128629|2017-02-18 17:46:42.128629
NCT00095251|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2015-11-04|||August 2004||2004-08-01|November 2015|2015-11-01|December 2016|Anticipated|2016-12-01|August 2007|Actual|2007-08-01||Interventional|||MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status|A Randomized, Double-blind Trial in Ventilated ICU Patients Comparing Treatment With an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status|Active, not recruiting||Phase 2|100|Anticipated|Vanderbilt University||2|||f||||t||||||||||2017-02-18 17:46:42.222502|2017-02-18 17:46:42.222502
NCT00095238|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2015-03-18|2009-12-16||June 2002||2002-06-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)|Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)|Completed||Phase 3|4128|Actual|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:46:42.515051|2017-02-18 17:46:42.515051
NCT00095225|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2008-01-23|||July 2004||2004-07-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|||||Interventional|||A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)|A Phase II, Multicenter, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy (Docetaxel or Pemetrexed) or Tarceva (Erlotinib) Compared With Chemotherapy (Docetaxel or Pemetrexed) Alone for Treatment of Recurrent or Refractory Non-Small Cell Lung Cancer|Completed||Phase 2|122|Actual|Genentech, Inc.|||||||||||||||||||2017-02-18 17:46:46.871867|2017-02-18 17:46:46.871867
NCT00095212|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2010-04-09|2010-01-21||September 2004||2004-09-01|April 2010|2010-04-01|February 2009|Actual|2009-02-01|April 2008|Actual|2008-04-01||Interventional|||Androgen Effects in HIV-infected Women|Androgen Effects in HIV-infected Women|Completed||N/A|25|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:46:47.006322|2017-02-18 17:46:47.006322
NCT00095199|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2012-09-13|2012-06-19||January 2005||2005-01-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Interventional|||Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer|Randomized Phase III Study of Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer After Platinum-Based Therapy|Completed||Phase 3|939|Actual|Eli Lilly and Company||4|||f||||t||||||||||2017-02-18 17:46:47.723146|2017-02-18 17:46:47.723146
NCT00095186|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2008-04-08|||September 2004||2004-09-01|April 2008|2008-04-01|March 2007||2007-03-01|||||Interventional|||Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma|A Multi-Center, Phase 2, Open Label Study of Safety and Efficacy of Oral Recombinant Human Lactoferrin (rhLF) Monotherapy in Patients With Advanced Renal Cell Carcinoma (RCC), Who Have Failed at Least One Regimen of Systemic Therapy for RCC|Completed||Phase 2|40||Agennix|||||||||||||||||||2017-02-18 17:46:53.561322|2017-02-18 17:46:53.561322
NCT00095173|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2016-11-22|2016-09-22||December 2003||2003-12-01|November 2016|2016-11-01|November 2011|Actual|2011-11-01|June 2006|Actual|2006-06-01||Interventional||All treated participants in the Lead-In Phase (Period A)|BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis|A Phase III, Multi-Center, Multi-National, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of BMS-188667 in Children and Adolescents With Active Polyarticular Juvenile Rheumatoid Arthritis (JRA)|Completed||Phase 3|214|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 17:46:53.678935|2017-02-18 17:46:53.678935
NCT00095160|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2009-10-06|||October 2003||2003-10-01|October 2009|2009-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors|Phase I, Open Label Safety, Pharmacokinetic, and Pharmacodynamic Dose Escalation/De-escalation Study of 852A Administered Intravenously to Subjects With Refractory Solid Organ Tumors|Completed||Phase 1|42||Masonic Cancer Center, University of Minnesota|||||f||||||||||||||2017-02-18 17:46:55.1783|2017-02-18 17:46:55.1783
NCT00095147|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2015-03-04|2010-10-26||February 2005||2005-02-01|March 2015|2015-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis|A Phase IIIB, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Comparative Study of Abatacept or Infliximab in Combination With Methotrexate in Controlling Disease Activity in Subjects With Rheumatoid Arthritis Having an Inadequate Clinical Response to Methotrexate|Completed||Phase 3|431|Actual|Bristol-Myers Squibb||5|||f||||||||||||||2017-02-18 17:46:55.325164|2017-02-18 17:46:55.325164
NCT00095134|ClinicalTrials.gov processed this data on February 17, 2017|2004-11-01|2011-12-05|||October 2004||2004-10-01|December 2011|2011-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy|A Double-Blind Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy|Completed||Phase 3|630|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:46:59.395943|2017-02-18 17:46:59.395943
NCT00095121|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2012-05-16|2011-04-08||June 2004||2004-06-01|May 2012|2012-05-01|April 2010|Actual|2010-04-01|May 2006|Actual|2006-05-01||Interventional|||Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B|A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents (Age 2 to Less Than 18) With Chronic Hepatitis B|Completed||Phase 3|173|Actual|Gilead Sciences||2|||f||||||||||||||2017-02-18 17:46:59.558181|2017-02-18 17:46:59.558181
NCT00095108|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2009-03-06|||May 2004||2004-05-01|March 2009|2009-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer|A Phase 1 Open-Label Study of the Safety and Pharmacokinetics of Recombinant Human Interleukin-21 (rIL-21) in Subjects With Metastatic Melanoma or Metastatic Renal Cell Carcinoma|Completed||Phase 1|43|Actual|ZymoGenetics|||||f||||||||||||||2017-02-18 17:47:02.094841|2017-02-18 17:47:02.094841
NCT00095095|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2012-10-22|||October 2004||2004-10-01|March 2005|2005-03-01|May 2006||2006-05-01|||||Interventional|||Lumbar Interbody Fusion Using the Telamon® Peek™ Versus the Telamon® Hydrosorb™ Fusion Device|Lumbar Interbody Fusion Using The Telamon® Peek™ Versus The Telamon® Hydrosorb™ Fusion Device - A Prospective, Randomized Controlled Trial To Assess Surgical And Clinical Outcomes|Terminated||Phase 4|102||Medtronic|||||f||||||||||||||2017-02-18 17:47:02.206263|2017-02-18 17:47:02.206263
NCT00095082|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2017-01-26|||September 2004||2004-09-01|January 2017|2017-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes|Efficacy and Safety Comparison of Insulin Detemir Plus Insulin Aspart Versus Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes|Completed||Phase 3|447|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:47:02.32231|2017-02-18 17:47:02.32231
NCT00095069|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2015-01-13|||October 2004||2004-10-01|January 2015|2015-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)|A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Groups Efficacy and Safety Extension Study of MK0928 in the Treatment of Adult Outpatients With Primary Insomnia|Completed||Phase 3|600||H. Lundbeck A/S|||||f||||||||||||||2017-02-18 17:47:02.506557|2017-02-18 17:47:02.506557
NCT00095056|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2015-03-12|2010-06-22||October 2004||2004-10-01|March 2015|2015-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)|Sitagliptin Study in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency|Completed||Phase 3|91|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:47:02.597263|2017-02-18 17:47:02.597263
NCT00095043|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2016-11-16|||October 2004||2004-10-01|November 2016|2016-11-01||||June 2006|Actual|2006-06-01||Interventional|||Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)|A 12-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel Groups, Multicenter Long-Term Safety Study of MK0928 in the Treatment of Elderly Outpatients With Primary Insomnia|Completed||Phase 3|320||H. Lundbeck A/S|||||f||||||||||||||2017-02-18 17:47:03.398113|2017-02-18 17:47:03.398113
NCT00095030|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2010-09-10||2010-09-10|February 2004||2004-02-01|September 2007|2007-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone|A Phase 3, Randomized, Three-Arm, Double-blind, Active Controlled, Parallel Group, Multicenter Trial to Evaluate the Safety and Efficacy of Muraglitazar in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Subjects Wtih Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone|Completed||Phase 3|1752||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:47:03.499062|2017-02-18 17:47:03.499062
NCT00095017|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2015-07-29|||November 2004||2004-11-01|July 2015|2015-07-01||||||||Interventional|||Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)|A 4 Week Randomized, Placebo-Controlled, Parallel Group, Double-Blind Pilot Study to Assess the Safety and Efficacy of Etoricoxib 90 mg Versus Placebo in the Treatment of Cancer Pain|Withdrawn||Phase 2|0|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:47:04.018047|2017-02-18 17:47:04.018047
NCT00095004|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2015-11-19|||October 2004||2004-10-01|November 2015|2015-11-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)|A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild|Completed||Phase 3|167|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:47:04.115623|2017-02-18 17:47:04.115623
NCT00094991|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-29|2010-09-10||2010-09-10|May 2004||2004-05-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes|Mechanism of Action and Efficacy of Muraglitazar (BMS298585) in the Treatment of Type 2 Diabetic Patients|Completed||Phase 3|42||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:47:04.221821|2017-02-18 17:47:04.221821
NCT00094978|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-28|2017-01-24|||October 25, 2004||2004-10-25|May 20, 2013|2013-05-20|May 20, 2013|Actual|2013-05-20|May 20, 2013|Actual|2013-05-20||Interventional|||Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum|Phase I Study of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura, Thymus or Mediastinum|Terminated||Phase 1|23|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:47:04.332801|2017-02-18 17:47:04.332801
NCT00094965|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-28|2009-03-27|||September 2004||2004-09-01|March 2009|2009-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|FOLFOX4||Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function|Phase II Trial of Oxaliplatin in Combination With Bolus/Infusional 5FU/LV (FOLFOX4) in Patients With Advanced Gastrointestinal (GI) Cancers With Varying Degrees of Renal Impairment|Completed||Phase 2|43|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:47:04.445127|2017-02-18 17:47:04.445127
NCT00094952|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-28|2009-09-16|||April 2003||2003-04-01|September 2009|2009-09-01|March 2008||2008-03-01|||||Observational|||Biomarkers and Early Alzheimer's Disease|Biomarkers and Early Alzheimer's Disease|Unknown status|Recruiting|N/A|80|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:47:04.557068|2017-02-18 17:47:04.557068
NCT00094939|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-28|2009-12-10|||September 2003||2003-09-01|September 2009|2009-09-01|August 2008||2008-08-01|||||Observational|||Predictors of Cognitive Decline in Normal Aging|Predictors of Cognitive Decline in Normal Aging|Unknown status|Recruiting|N/A|170|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:47:04.668005|2017-02-18 17:47:04.668005
NCT00094926|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-28|2011-05-17|||May 2004||2004-05-01|April 2010|2010-04-01|February 2007|Actual|2007-02-01|||||Interventional|||A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.|A Prospective, Randomized, Double-blind, Placebo-controlled Study of the Effectiveness and Safety of RISPERDAL CONSTA Augmentation in Adult Patients With Frequently-relapsing Bipolar Disorder|Completed||Phase 3|275|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-02-18 17:47:04.759705|2017-02-18 17:47:04.759705
NCT00094913|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-28|2009-05-26|||May 2004||2004-05-01|July 2007|2007-07-01|April 2005||2005-04-01|||||Observational|||PET Changes in Alzheimer's Disease (AD)|Clinical Correlates of Longitudinal PET Changes in Alzheimer's Disease (AD)|Unknown status|Active, not recruiting|N/A|105|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:47:04.877788|2017-02-18 17:47:04.877788
NCT00094900|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-28|2014-01-30|2013-03-19||October 2004||2004-10-01|January 2014|2014-01-01|December 2010|Actual|2010-12-01|September 2010|Actual|2010-09-01||Interventional|||Interleukin-1 Trap to Treat Autoinflammatory Diseases|Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects With Autoinflammatory Diseases: A Therapeutic Approach to Study Pathogenesis|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)|"Secondary outcome analyses will be stratified based on primary outcome results - responders and non-responders.~1 subject with Familial Mediterranean Fever (FMF) was recruited but outcomes were not collected due to insufficient accrual of FMF cases."|1|||f||||||||||||||2017-02-18 17:47:05.008574|2017-02-18 17:47:05.008574
NCT00094887|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-28|2016-09-29|2009-12-04||October 2004||2004-10-01|September 2016|2016-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises|A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis|Completed||Phase 2|150|Actual|Mallinckrodt||2|||f||||t||||||||||2017-02-18 17:47:06.513627|2017-02-18 17:47:06.513627
NCT00094874|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-27|2005-06-23|||September 2004||2004-09-01|October 2004|2004-10-01|September 2005||2005-09-01|||||Interventional|||Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms|A Double-Blind, Randomized Study of Puncturing Versus Non-Puncturing Acupuncture for the Treatment of Interstitial Cystitis Symptoms|Unknown status|Recruiting|Phase 3|60||The Mary Elizabeth Groff Surgical Medical Research and Education Charitable Trust|||||f||||||||||||||2017-02-18 17:47:06.924951|2017-02-18 17:47:06.924951
NCT00094861|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-27|2014-12-11|2014-01-24||January 2005||2005-01-01|December 2014|2014-12-01|January 2014|Actual|2014-01-01|December 2007|Actual|2007-12-01||Interventional|||Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|A Phase 2 Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) in the Reduction of Dysphagia in Patients Receiving Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|100|Actual|Swedish Orphan Biovitrum||2|||f||||t||||||||||2017-02-18 17:47:07.01903|2017-02-18 17:47:07.01903
NCT00094848|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-27|2013-08-01|||June 2004||2004-06-01|August 2013|2013-08-01|May 2007|Actual|2007-05-01|December 2006|Actual|2006-12-01||Interventional|||Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)|A Multi-Center, Open-Label, Dose-Escalation Study to Evaluate the Safety, Efficacy, and Exposure to TRM-1 (Fully Human Monoclonal Antibody to the TRAIL-R1) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|||Human Genome Sciences Inc.|||||f||||||||||||||2017-02-18 17:47:10.895248|2017-02-18 17:47:10.895248
NCT00094835|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-27|2016-02-26|2010-08-13||January 2005||2005-01-01|February 2016|2016-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional||The analysis is based on the Safety Analysis Set which consists of all consented participants who received at least one dose of motesanib.|Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|An Open-label, Dose-finding Study to Evaluate the Safety and Pharmacokinetics (PK) of AMG 706 With Carboplatin/Paclitaxel, AMG 706 With Panitumumab and AMG 706 With Panitumumab and Carboplatin/Paclitaxel in the Treatment of Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|51|Actual|Amgen||3|||f||||||||||||||2017-02-18 17:47:11.00401|2017-02-18 17:47:11.00401
NCT00094822|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-27|2009-02-12|||July 2003||2003-07-01|February 2009|2009-02-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Observational|||Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)|Pegfilgrastim Given Same Day as or Day After Carboplatin and Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||N/A|90|Actual|Amgen|||2||f||||||||||||||2017-02-18 17:47:16.546922|2017-02-18 17:47:16.546922
NCT00093327|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2006-08-17|||September 2003||2003-09-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Acupuncture for Irritable Bowel Syndrome (IBS)|Acupuncture for Irritable Bowel Syndrome (IBS) Trial|Completed||Phase 2|287||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:47:55.600087|2017-02-18 17:47:55.600087
NCT00094809|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-26|2013-05-10|2010-12-16||February 2003||2003-02-01|May 2013|2013-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer|Chemotherapy Administered Every 2 Weeks With or Without a Single Injection of Pegfilgrastim as First or Second-Line Treatment in Subjects With Locally Advanced or Metastatic Colon Cancer|Completed||Phase 2|252|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:47:16.663649|2017-02-18 17:47:16.663649
NCT00094796|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-22|2017-01-24|||October 20, 2004||2004-10-20|September 3, 2008|2008-09-03|September 3, 2008||2008-09-03|||||Interventional|||Rosiglitazone to Reverse Metabolic Defects in Diabetes|Evaluation of Rosiglitazone in Reversing Metabolic Defects of Pre-Diabetes and Type 2 Diabetes Mellitus|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:47:17.942882|2017-02-18 17:47:17.942882
NCT00094783|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-22|2017-01-24|||October 20, 2004||2004-10-20|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Interventional|||MRI-Guided Balloon Angioplasty to Treat Blood Flow Blockage in the Legs|Real-Time MRI-Guided Percutaneous Intervention for Aorto-illac and Femoropopliteal, Artery Stenosis|Completed||Phase 1|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:47:18.037804|2017-02-18 17:47:18.037804
NCT00094770|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-22|2016-08-25|2009-09-24||September 2004||2004-09-01|August 2016|2016-08-01|May 2007|Actual|2007-05-01|May 2006|Actual|2006-05-01||Interventional|||An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)|A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK0431 Compared With Sulfonylurea Therapy in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Monotherapy|Completed||Phase 3|1172|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:47:18.129752|2017-02-18 17:47:18.129752
NCT00094757|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-22|2016-11-28|2010-06-22||October 2004||2004-10-01|November 2016|2016-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)|A Multicenter, Randomized, Double-Blind Study of MK0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 3|521|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 17:47:19.219001|2017-02-18 17:47:19.219001
NCT00094744|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-22|2010-09-08|||May 2001||2001-05-01|September 2010|2010-09-01|September 2003|Actual|2003-09-01|July 2003|Actual|2003-07-01||Interventional|||Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia|A Randomized Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia|Completed||Phase 3|175|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-02-18 17:47:19.952364|2017-02-18 17:47:19.952364
NCT00094731|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2009-12-09|||March 2001||2001-03-01|February 2006|2006-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||SeniorWISE: Improving Everyday Memory in At-Risk Elderly|Improving Everyday Memory in At-Risk Elderly|Completed||Phase 3|260||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:47:20.070412|2017-02-18 17:47:20.070412
NCT00094718|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2012-12-31|||February 2005||2005-02-01|December 2012|2012-12-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of West Nile/Dengue-4 3'delta30 Chimeric Virus Vaccine (WN/DEN4-3'delta30), a Live Attenuated Vaccine for West Nile Encephalitis|Completed||Phase 1|56|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 17:47:20.157863|2017-02-18 17:47:20.157863
NCT00094705|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2008-01-18|||January 2005||2005-01-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults|Phase 1 Study of the Safety and Immunogenicity of rDEN2/4delta30(ME), a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 2|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 17:47:20.276787|2017-02-18 17:47:20.276787
NCT00094692|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2010-03-23|||October 2002||2002-10-01|May 2007|2007-05-01|December 2005|Actual|2005-12-01|||||Interventional|||An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old|An Evaluation of Treatment of Amblyopia in 7 To <18 Year Olds|Completed||Phase 3|507||Jaeb Center for Health Research|||||f||||t||||||||||2017-02-18 17:47:20.593803|2017-02-18 17:47:20.593803
NCT00094679|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2010-09-08|||May 2001||2001-05-01|September 2010|2010-09-01|September 2002|Actual|2002-09-01|July 2002|Actual|2002-07-01||Interventional|ATS2B||Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia|A Randomized Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia|Completed||Phase 3|189|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-02-18 17:47:20.696443|2017-02-18 17:47:20.696443
NCT00094666|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2015-01-13|||November 2004||2004-11-01|January 2015|2015-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Elderly Patients With Primary Insomnia|Terminated||Phase 3|465||H. Lundbeck A/S|||||f||||||||||||||2017-02-18 17:47:20.805086|2017-02-18 17:47:20.805086
NCT00094653|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2011-06-29|2011-04-22||September 2004||2004-09-01|June 2011|2011-06-01|October 2009|Actual|2009-10-01|August 2009|Actual|2009-08-01||Interventional|||MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma|A Randomized, Double-Blind, Multicenter Study Comparing MDX-010 Monotherapy, MDX-010 in Combination With a Melanoma Peptide Vaccine, and Melanoma Vaccine Monotherapy in HLA-A2*0201-Positive Patients With Previously Treated Unresectable Stage III or IV Melanoma|Completed||Phase 3|1783|Actual|Bristol-Myers Squibb||3|||f||||t||||||||||2017-02-18 17:47:20.917386|2017-02-18 17:47:20.917386
NCT00094640|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||Pharmacokinetic Characterization of Intramuscular Olanzapine Depot||Completed||Phase 1|||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:47:23.997819|2017-02-18 17:47:23.997819
NCT00094627|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2015-01-13|||November 2004||2004-11-01|January 2015|2015-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Adult Patients With Primary Insomnia|Completed||Phase 3|465|Actual|H. Lundbeck A/S|||||f||||||||||||||2017-02-18 17:47:24.074324|2017-02-18 17:47:24.074324
NCT00094614|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-21|2010-03-24|||June 2002||2002-06-01|April 2006|2006-04-01|April 2003||2003-04-01|||||Interventional|||Trial Comparing Daily Atropine Versus Weekend Atropine|A Randomized Trial Comparing Daily Atropine Versus Weekend Atropine|Completed||Phase 4|168||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:47:24.162623|2017-02-18 17:47:24.162623
NCT00094575|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-20|2016-02-08|2013-09-16||October 2002||2002-10-01|February 2016|2016-02-01|April 2012|Actual|2012-04-01|October 2011|Actual|2011-10-01||Interventional|OVER||Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA)|CSP #498 - Open Versus Endovascular Repair (OVER) Trial for Abdominal Aortic Aneurysms|Completed||Phase 4|881|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:47:24.352257|2017-02-18 17:47:24.352257
NCT00094562|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-20|2008-04-21|||June 2004||2004-06-01|April 2008|2008-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss|AAFA™ Fish Oil Nutritional Supplementation to Maintain Body Weight in Patients With Disease-Related Weight Loss|Completed||Phase 2|60|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||||||t||||||||||2017-02-18 17:47:26.830999|2017-02-18 17:47:26.830999
NCT00094549|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-20|2007-01-24|||October 2004||2004-10-01|January 2007|2007-01-01|December 2006||2006-12-01|||||Interventional|||Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder|Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated With Bipolar I Disorder|Completed||Phase 4|500||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:47:26.94755|2017-02-18 17:47:26.94755
NCT00094536|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-20|2006-07-20|||April 2004||2004-04-01|July 2006|2006-07-01|March 2008||2008-03-01|||||Interventional|||Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System|A Study to Evaluate the Effectiveness of Extended Treatment Regimens With the Her Option® Cryoablation Therapy System for Treatment of Menorrhagia|Completed||Phase 4|76||American Medical Systems|||||||||||||||||||2017-02-18 17:47:27.078199|2017-02-18 17:47:27.078199
NCT00094523|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-20|2011-03-17|||December 2004||2004-12-01|March 2011|2011-03-01|June 2007|Actual|2007-06-01|||||Interventional|||Fosamprenavir Versus Other Protease Inhibitors|A Phase IIIB/IV, Open-label, Multi-center Trial to Evaluate the Safety, Tolerability, and Efficiency of HIV-1 Infected Subjects Switching Their Current Protease-inhibitor Therapies for a Fosamprenavir Therapy Over 48 Weeks|Completed||Phase 3|312|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:47:27.169742|2017-02-18 17:47:27.169742
NCT00094510|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-19|2017-01-24|||October 14, 2004||2004-10-14|September 3, 2010|2010-09-03|September 3, 2010||2010-09-03|||||Observational|||Effect of Gabapentin on GABA Concentration and Emotional Processing|The Effect of Gabapentin on Prefrontal GABA Concentration and Emotional Processing in Healthy Humans|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:47:27.296815|2017-02-18 17:47:27.296815
NCT00094497|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-19|2016-09-19|2016-09-19||June 2004||2004-06-01|September 2016|2016-09-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)|First International Randomized Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment|Completed||Phase 3|304|Actual|Collaborative Group for Adrenocortical Carcinoma Treatment||2|||f||||t||||||||||2017-02-18 17:47:27.509121|2017-02-18 17:47:27.509121
NCT00094484|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-19|2013-05-06|||October 2004||2004-10-01|May 2013|2013-05-01||||||||Interventional|||Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis|A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis|Completed||Phase 3|400||Amgen||1|||||||||||||||||2017-02-18 17:47:28.060272|2017-02-18 17:47:28.060272
NCT00094458|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-19|2016-12-15|2009-04-30||March 2005||2005-03-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|April 2008|Actual|2008-04-01||Interventional|||Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC|Multicenter, Randomized, Double-Blind, Active Controlled Trial Comparing REMICADE� (Infliximab) and REMICADE Plus Azathioprine to Azathioprine in the Treatment of Patients With Crohn's Disease Naive to Both Immunomodulators and Biologic Therapy|Completed||Phase 3|508|Actual|Centocor Ortho Biotech Services, L.L.C.||3|||f||||f||||||||||2017-02-18 17:47:28.364685|2017-02-18 17:47:28.364685
NCT00094445|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-18|2014-04-29|||November 2004||2004-11-01|April 2014|2014-04-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||Trial of Curcumin in Advanced Pancreatic Cancer|Phase II Trial of Curcumin in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:47:31.339614|2017-02-18 17:47:31.339614
NCT00094432|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-18|2013-11-07|||June 2004||2004-06-01|June 2008|2008-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode. CN138-146 LT is the 26-week Open Label Extension Phase of the Above Titled Protocol, CN138-146 ST.|Completed||Phase 3|650||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 17:47:31.456158|2017-02-18 17:47:31.456158
NCT00094419|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-18|2008-08-11|||November 2004||2004-11-01|August 2008|2008-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Complementary and Alternative Medicine Use in Low-Income African American and Caucasian Adults With Asthma|The Role of Complementary and Alternative Medicine (CAM), Folk Care and Faith-Based Approaches in the Home Management of Persistent Asthma in Low-Income African American and Caucasian Adults|Completed||N/A|50|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 17:47:31.601971|2017-02-18 17:47:31.601971
NCT00094406|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-16|2017-01-24|||October 13, 2004||2004-10-13|April 19, 2016|2016-04-19|March 11, 2010|Actual|2010-03-11|March 11, 2010|Actual|2010-03-11||Interventional|||Carbon Monoxide to Prevent Lung Inflammation|Effects of Inhaled Carbon Monoxide on Pulmonary Inflammatory Responses Following Endotoxin Instillation|Completed||Phase 1|35|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:47:31.68486|2017-02-18 17:47:31.68486
NCT00094393|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-16|2017-01-24|||October 12, 2004||2004-10-12|May 4, 2016|2016-05-04||||||||Observational|||Clinical Studies of Progeria|Clinical Investigations Into Hutchison-Gilford Progeria Syndrome|Completed||N/A|15|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:47:31.801499|2017-02-18 17:47:31.801499
NCT00093808|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2016-11-28|2016-11-28||August 2004||2004-08-01|November 2016|2016-11-01|May 2013|Actual|2013-05-01|December 2008|Actual|2008-12-01||Interventional|||Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer|Phase II Study of Capecitabine in Combination With Vinorelbine and Trastuzumab for the First- or Second-LineTreatment of HER2+ Metastatic Breast Cancer|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:47:46.32796|2017-02-18 17:47:46.32796
NCT00094380|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-16|2017-01-10|||September 2004||2004-09-01|January 2017|2017-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)|Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study|Completed||Phase 1/Phase 2|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||Yes|Participant level data and additional relevant materials are available to the public in 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools available to researchers; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal that makes data from the consortium's clinical trials publicly available.|2017-02-18 17:47:31.892873|2017-02-18 17:47:31.892873
NCT00094367|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-16|2010-09-29|||July 2004||2004-07-01|September 2010|2010-09-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)|See Detailed Description|Completed||Phase 3|900||GlaxoSmithKline||1|||||||||||||||||2017-02-18 17:47:32.04869|2017-02-18 17:47:32.04869
NCT00094354|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-16|2009-03-26|||October 2004||2004-10-01|January 2009|2009-01-01|April 2006|Actual|2006-04-01|March 2005|Actual|2005-03-01||Observational|||HIV Assessment in Fuyang, Anhui Province, China|A Qualitative Study for the Development of an Intervention Among HIV-Positive Former Plasma Donors (FPDs) in Fuyang, Anhui Province, China|Completed||N/A|111|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||f||||||||||2017-02-18 17:47:35.285154|2017-02-18 17:47:35.285154
NCT00094341|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-16|2008-12-04|||October 2004||2004-10-01|December 2008|2008-12-01||||||||Interventional|||Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes|An Open-Label, Randomized, Crossover Study to Assess Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes|Completed||Phase 4|215||Amgen|||||||||||||||||||2017-02-18 17:47:35.372253|2017-02-18 17:47:35.372253
NCT00094328|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-16|2016-11-07|2009-05-19||November 2004||2004-11-01|November 2016|2016-11-01|August 2017|Anticipated|2017-08-01|May 2008|Actual|2008-05-01||Interventional|BATT||Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]|An Open-label, Non-comparative, Multi-centre Study to Assess the Efficacy and Safety of Bicalutamide When Used in Combination With Anastrozole for the Treatment of Gonadotropin-independent Precocious Puberty in Boys With Testotoxicosis|Active, not recruiting||Phase 2|21|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 17:47:35.470419|2017-02-18 17:47:35.470419
NCT00094315|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2017-01-10|||September 2004||2004-09-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1|Cocaine Relapse Prevention II|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:47:36.103033|2017-02-18 17:47:36.103033
NCT00094302|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2015-02-11|2014-12-01||August 2006||2006-08-01|January 2014|2014-01-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|TOPCAT||Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function|Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)|Completed||Phase 3|3445|Actual|New England Research Institutes||2|||f||||t||||||||||2017-02-18 17:47:36.245604|2017-02-18 17:47:36.245604
NCT00094289|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2017-01-10|||August 2004||2004-08-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Interactions Between Cocaine and Ethanol and Disulfiram - 1|Interactions Between IV Cocaine and Ethanol and Oral Disulfiram|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:47:40.301046|2017-02-18 17:47:40.301046
NCT00094276|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2013-01-18|||September 2004||2004-09-01|January 2013|2013-01-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Intervention for Improving Asthma Care for Minority Children in Head Start|Improving Asthma Care for Minority Children in Head Start|Completed||Phase 3|336|Actual|Johns Hopkins University||4|||f||||t||||||||||2017-02-18 17:47:40.654066|2017-02-18 17:47:40.654066
NCT00094263|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2016-02-17|||September 2004||2004-09-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Long-Term Predictors of Morbidity in Older Age||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:47:40.765242|2017-02-18 17:47:40.765242
NCT00094250|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2016-07-28|||July 2006||2006-07-01|February 2009|2009-02-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||HEARTS: Heart, Exercise, and Resistance Training Study|More Effective Exercise Modalities in Older Congestive Heart Failure Patients|Withdrawn||N/A|200|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||||Study was closed due to administrative reasons; study did not enroll any participants.|f||||||||||||||2017-02-18 17:47:40.830866|2017-02-18 17:47:40.830866
NCT00094237|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2015-12-16|||September 2004||2004-09-01|December 2015|2015-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke|Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke|Completed||N/A|3200|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 17:47:40.920462|2017-02-18 17:47:40.920462
NCT00094211|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2009-02-13|||September 2004||2004-09-01|February 2009|2009-02-01|June 2009|Anticipated|2009-06-01|||||Observational|||Understanding the Impact of Neighborhood Type on Physical Activity in Older Adults|Neighborhood Impact on Physical Activity in Older Adults|Unknown status|Active, not recruiting|N/A|985|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||||||2017-02-18 17:47:40.996799|2017-02-18 17:47:40.996799
NCT00094198|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2008-08-20|||September 2003||2003-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Pharmacogenetics and Cardiovascular Events||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:47:41.083277|2017-02-18 17:47:41.083277
NCT00094185|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-15|2012-12-18|||May 2004||2004-05-01|December 2012|2012-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Clotting Genetic Variants, Hormones, and Venous Thrombosis||Completed||N/A|1000|Actual|University of Washington|||1||f||||||||||||||2017-02-18 17:47:41.154497|2017-02-18 17:47:41.154497
NCT00093353|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2010-10-14|||May 2004||2004-05-01|May 2009|2009-05-01||||July 2006|Actual|2006-07-01||Interventional|||N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma|A Phase I Study Of Oral Irinotecan, Temozolomide, Cefixime In Children With Recurrent/Resistant High-Risk Neuroblastoma|Completed||Phase 1|30|Anticipated|Children's Hospital Los Angeles|||||f||||t||||||||||2017-02-18 17:47:55.471549|2017-02-18 17:47:55.471549
NCT00094172|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-14|2014-06-04|2011-09-29||May 2005||2005-05-01|June 2014|2014-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|STAYCIS||Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Atorvastatin in Patients With Clinically Isolated Syndrome and High Risk of Conversion to Multiple Sclerosis (ITN020AI)|Completed||Phase 2|82|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:47:41.237354|2017-02-18 17:47:41.237354
NCT00094159|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-14|2007-05-09|||October 2004||2004-10-01|May 2007|2007-05-01||||||||Interventional|||Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors|Phase I Open-Label, Multicenter, Dose-Escalation Clinical Study of the Safety and Pharmacokinetic Profiles of Weekly Intravenous Administrations of SNS-595 in Patients With Advanced Malignancies|Completed||Phase 1|||Sunesis Pharmaceuticals|||||||||||||||||||2017-02-18 17:47:41.750917|2017-02-18 17:47:41.750917
NCT00094146|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-14|2009-09-21|||January 2002||2002-01-01|October 2004|2004-10-01|December 2002||2002-12-01|||||Interventional|||Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity||Completed||Phase 2|160||Novartis|||||||||||||||||||2017-02-18 17:47:41.830822|2017-02-18 17:47:41.830822
NCT00094133|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-14|2013-09-19|||April 2006||2006-04-01|September 2007|2007-09-01||||||||Interventional|||Hypnosis in Treating Hot Flashes in Breast Cancer Survivors|Hypnosis for Hot Flashes in Breast Cancer Survivors|Unknown status|Recruiting|N/A|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:47:41.915438|2017-02-18 17:47:41.915438
NCT00094120|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-11|2008-01-08|||October 2004||2004-10-01|November 2007|2007-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||"MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With Wet Age-Related Macular Degeneration (AMD)"|"Safety and Efficacy of MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With Wet Age-Related Macular Degeneration (AMD)"|Terminated||Phase 2|60||Genaera Corporation|||||||||||||||||||2017-02-18 17:47:42.025429|2017-02-18 17:47:42.025429
NCT00094107|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-11|2012-06-21|2012-02-25||December 2004||2004-12-01|June 2012|2012-06-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma|Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma|Completed||Phase 2|32|Actual|Pfizer|Population pharmacokinetic and plasma concentrations of soluble proteins were not presented, as the data was not available for the single study and data for all the axitinib (AG-013736) Phase 2 studies would be pooled together in a separate report.|1|||f||||t||||||||||2017-02-18 17:47:42.114372|2017-02-18 17:47:42.114372
NCT00094094|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-11|2012-06-21|2012-02-25||February 2005||2005-02-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer|Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 as Second- or Later- Line Treatment in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|32|Actual|Pfizer|Population pharmacokinetics and plasma concentrations of soluble proteins were not presented, as the data was not available for the single study and data for all the axitinib Phase 2 studies would be pooled together in a separate report.|1|||f||||||||||||||2017-02-18 17:47:42.580205|2017-02-18 17:47:42.580205
NCT00094081|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-11|2010-02-12|||October 2002||2002-10-01|February 2010|2010-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer|Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer|Completed||Phase 3|861|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:47:42.926206|2017-02-18 17:47:42.926206
NCT00094068|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-09|2008-03-03|||October 2004||2004-10-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Observational|||The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients|A Pilot Study to Detect the Effect of Sildenafil Citrate on Cerebral Blood Perfusion in Multiple Sclerosis Patients by Perfusion MRI|Completed||N/A|76||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:47:43.030563|2017-02-18 17:47:43.030563
NCT00094055|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-08|2012-06-21|2012-02-25||September 2004||2004-09-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer|Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer Who Are Refractory to or Not Suitable Candidates for 131 I Treatment|Completed||Phase 2|60|Actual|Pfizer|Population pharmacokinetics and plasma concentrations of soluble proteins were not presented, as the data was not available for the single study and data for all the axitinib (AG-013736) Phase 2 studies would be pooled together in a separate report.|1|||f||||f||||||||||2017-02-18 17:47:43.123461|2017-02-18 17:47:43.123461
NCT00094042|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-08|2010-01-26|||January 2002||2002-01-01|August 2008|2008-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Work and Iron Status Evaluation|Work and Iron Status Evaluation (WISE)|Completed||N/A|16000||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:47:43.846539|2017-02-18 17:47:43.846539
NCT00094029|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-08|2012-03-08|||September 2004||2004-09-01|March 2012|2012-03-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Expanded Access|||A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248|A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate|Approved for marketing||N/A|||Pfizer|||||||||f||||||||||2017-02-18 17:47:43.937282|2017-02-18 17:47:43.937282
NCT00094016|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-08|2014-05-09|||October 2004||2004-10-01|May 2014|2014-05-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children|Safety and Efficacy Evaluation of Two Doses of HFA-Propelled Beclomethasone Dipropionate (QVAR) Versus Placebo by Breath Operated and Metered Dose Inhalers in Mild to Moderate Asthmatic Children|Completed||Phase 3|440||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:47:44.162612|2017-02-18 17:47:44.162612
NCT00094003|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-08|2005-11-09|||September 2002||2002-09-01|November 2005|2005-11-01||||||||Interventional|||Study of NS-9 in Patients With Liver Metastases|A Phase I, Open-Label, Dose Escalation Study of Intravenously Administered NS-9 in Subjects With Liver Metastases From Various Primary Cancers|Completed||Phase 1|20||NS Pharma, Inc.|||||||||||||||||||2017-02-18 17:47:44.286419|2017-02-18 17:47:44.286419
NCT00093990|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2016-09-13|||January 2004||2004-01-01|September 2016|2016-09-01|October 2007|Actual|2007-10-01|||||Interventional|||Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)|A Randomized Study of Tipifarnib Versus Best Supportive Care (Including Hydroxyurea) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Subjects 70 Years or Older (Farnesyl Transferase Inhibition Global Human Trials AML 301 [F.I.G.H.T. AML 301])|Completed||Phase 3|457|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:47:44.371375|2017-02-18 17:47:44.371375
NCT00093977|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2013-05-22|||October 2004||2004-10-01|May 2013|2013-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease|An Open-label, Single-Arm Study to Assess the Safety of Darbepoetin Alfa Manufactured by a Serum Free Bioreactor Technology in Subjects With Chronic Kidney Disease|Completed||Phase 3|1100|Anticipated|Amgen||1|||f||||||||||||||2017-02-18 17:47:44.468512|2017-02-18 17:47:44.468512
NCT00093964|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2015-12-02|||October 2004||2004-10-01|December 2015|2015-12-01|December 2007|Actual|2007-12-01|April 2006|Actual|2006-04-01||Interventional|||Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)|A Multicenter, Open-label, Randomized, Uncontrolled, Phase IIa Trial in Subjects With Recurrent Glioblastoma Multiforme to Investigate the Clinical Activity, Safety, and Tolerability of Cilengitide (EMD 121,974) Administered as a Single Agent.|Completed||Phase 2|81|Actual|EMD Serono||2|||f||||f||||||||||2017-02-18 17:47:44.575461|2017-02-18 17:47:44.575461
NCT00093951|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2009-12-10|||April 2004||2004-04-01|February 2009|2009-02-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study of the Efficacy and Safety of SGS742 in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 2|280||National Institute on Aging (NIA)|||||||||||||||||||2017-02-18 17:47:44.705771|2017-02-18 17:47:44.705771
NCT00093938|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2010-01-12|||December 2004||2004-12-01|January 2010|2010-01-01||||||||Interventional|||Cranberry Juice for Preventing Bacteria in Urine During Pregnancy|Cranberry for Prevention of Bacteriuria in Pregnancy|Completed||Phase 1|360|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:47:44.852895|2017-02-18 17:47:44.852895
NCT00093925|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2014-05-05|||May 2004||2004-05-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|July 2006|Actual|2006-07-01||Interventional|ECLIPSE-NIC||Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)|Evaluation of Clevidipine in the Postoperative Treatment of Hypertension Assessing Safety Events (With Nicardipine as Active Comparator) (ECLIPSE-NIC)|Completed||Phase 3|739|Actual|The Medicines Company||2|||f||||t||||||||||2017-02-18 17:47:44.949988|2017-02-18 17:47:44.949988
NCT00093912|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2014-05-05|||June 2004||2004-06-01|May 2014|2014-05-01|November 2006|Actual|2006-11-01|October 2006|Actual|2006-10-01||Interventional|ECLISPE-SNP||Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)|Evaluation of Clevidipine in the Perioperative Treatment of Hypertension Assessing Safety Events (With Sodium Nitroprusside as Active Comparator) (ECLISPE-SNP)|Completed||Phase 3|739|Actual|The Medicines Company||2|||f||||t||||||||||2017-02-18 17:47:45.078395|2017-02-18 17:47:45.078395
NCT00093899|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2015-02-16|||November 2004||2004-11-01|February 2015|2015-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)|A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia|Completed||Phase 3|611|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:47:45.237657|2017-02-18 17:47:45.237657
NCT00093886|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-07|2014-05-05|||April 2004||2004-04-01|May 2014|2014-05-01|April 2005|Actual|2005-04-01|March 2005|Actual|2005-03-01||Interventional|ECLIPSE-NTG||Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)|Evaluation of Clevidipine in the Perioperative Treatment of Hypertension Assessing Safety Events (With Nitroglycerin as Active Comparator) (ECLIPSE-NTG)|Completed||Phase 3|629|Actual|The Medicines Company||2|||f||||t||||||||||2017-02-18 17:47:45.3517|2017-02-18 17:47:45.3517
NCT00093873|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-05-13|||July 2003||2003-07-01|May 2013|2013-05-01|December 2006|Actual|2006-12-01|February 2006|Actual|2006-02-01||Interventional|||Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors|A Phase 1, First in Human, Open-Label, Dose Finding Study Evaluating the Safety and Pharmacokinetics of AMG 706 in Subjects With Advanced Solid Tumors|Completed||Phase 1|71|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:47:45.502365|2017-02-18 17:47:45.502365
NCT00093860|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2008-03-03|||October 2004||2004-10-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance|Propranolol for Syncope With Sympathoadrenal Imbalance in Children|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:47:45.598324|2017-02-18 17:47:45.598324
NCT00093847|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2014-10-10|2012-04-25||May 2004||2004-05-01|October 2014|2014-10-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression|S-adenosyl Methionine (SAMe) Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for Treatment-Resistant Depression (TRD)|Completed||Phase 2|73|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:47:45.69184|2017-02-18 17:47:45.69184
NCT00093834|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2011-07-19|||January 2004||2004-01-01|April 2011|2011-04-01||||August 2008|Actual|2008-08-01||Interventional|||Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer|A Phase I Vaccine Safety and Chemotherapy Dose-Finding Trial of an Allogeneic GM-CSF-Secreting Breast Cancer Vaccine Given in a Specifically Timed Sequence With Immunomodulatory Doses of Cyclophosphamide and Doxorubicin|Completed||Phase 1|60|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:47:46.102959|2017-02-18 17:47:46.102959
NCT00093821|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-06-03|||September 2004||2004-09-01|June 2013|2013-06-01||||August 2007|Actual|2007-08-01||Interventional|||Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors|A Multicenter Phase I Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) in Patients With Recurrent/Refractory Pediatric Solid Tumors (Ewing's Sarcoma, Desmoplastic Small Round Cell Tumor, Osteosarcoma, Neuroblastoma, and Rhabdomyosarcoma) and Leukemia|Completed||Phase 1|70|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:47:46.214902|2017-02-18 17:47:46.214902
NCT00005341|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||February 1992||1992-02-01|January 2016|2016-01-01|January 1997||1997-01-01|||||Observational|||Blood Donation--Immune Sequelae and Recruitment||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-02-18 18:15:06.814316|2017-02-18 18:15:06.814316
NCT00093795|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2016-11-28|||October 2004||2004-10-01|August 2016|2016-08-01|June 2016|Actual|2016-06-01|March 2012|Actual|2012-03-01||Interventional|||Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer|A Phase III, Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Node-Positive Breast Cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC); Dose-Dense (DD) Doxorubicin/Cyclophosphamide Followed By DD Paclitaxel (DD AC→P); DD AC Followed By DD Paclitaxel Plus Gemcitabine (DD AC→PG)|Completed||Phase 3|4894|Actual|NSABP Foundation Inc||3|||f||||t||||||||||2017-02-18 17:47:47.141072|2017-02-18 17:47:47.141072
NCT00093782|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2016-12-14|2015-06-11||December 2003||2003-12-01|December 2016|2016-12-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional||Number of participants accrued|Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma|A Phase II Study of CCI-779 in Metastatic Neuroendocrine Carcinomas|Completed||Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:47:47.28939|2017-02-18 17:47:47.28939
NCT00093769|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2012-10-03|||August 2004||2004-08-01|October 2012|2012-10-01||||August 2005|Actual|2005-08-01||Interventional|||Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Study of VELCADE With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma|Completed||Phase 2|15|Actual|Jonsson Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:47:47.607303|2017-02-18 17:47:47.607303
NCT00093756|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2014-12-03|2013-11-25||September 2004||2004-09-01|November 2013|2013-11-01|May 2013|Actual|2013-05-01|January 2012|Actual|2012-01-01||Interventional|||Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer|Phase I/II Study of PS-341 in Combination With Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|52|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:47:47.75344|2017-02-18 17:47:47.75344
NCT00093743|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2016-03-01|||January 2000||2000-01-01|March 2016|2016-03-01||||September 2007|Actual|2007-09-01||Interventional|||Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia|Low-Dose Total Body Irradiation and Fludarabine Followed By Unrelated Donor Stem Cell Transplantation for Patients With Fanconi Anemia - A Multicenter Trial|Active, not recruiting||Phase 1|2|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:47:48.392429|2017-02-18 17:47:48.392429
NCT00093730|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2012-10-03|||August 2004||2004-08-01|October 2012|2012-10-01||||April 2006|Actual|2006-04-01||Interventional|||BMS-599626 in Treating Patients With Metastatic Solid Tumors|Phase I Study Of BMS-599626 In Patients With Advanced Solid Malignancies That Express Her2|Completed||Phase 1|9|Actual|Jonsson Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:47:48.52|2017-02-18 17:47:48.52
NCT00093704|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2015-10-01|||March 2005||2005-03-01|August 2012|2012-08-01||||July 2010|Actual|2010-07-01||Interventional|||Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma|EBV as Therapeutic Target: A Pilot Study of Inducing and Targeting EBV-TK in EBV-Positive Lymphomas by Combination of Bortezomib and Ganciclovir|Terminated||Phase 1|1|Actual|Jonsson Comprehensive Cancer Center||1||study could not recruit any more patients|f||||t||||||||||2017-02-18 17:47:48.718248|2017-02-18 17:47:48.718248
NCT00093678|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2015-10-06||||||October 2015|2015-10-01||||||||Interventional|||Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer|A Randomized, Double Blind, Placebo-Controlled Trial of Celecoxib in Patients With Advanced Cancer|Withdrawn||N/A|0|Actual|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 17:47:48.825937|2017-02-18 17:47:48.825937
NCT00093665|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-05-14|||November 2003||2003-11-01|October 2006|2006-10-01||||||||Interventional|||Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer|A Phase II Study Of Alternating Chemoradiotherapy For Nasopharyngeal Cancer Using Cisplatin And 5-Fluorouracil|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:47:48.924123|2017-02-18 17:47:48.924123
NCT00093652|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2015-10-05|||May 2003||2003-05-01|October 2015|2015-10-01||||May 2006|Actual|2006-05-01||Interventional|||Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer|ZD1839 (IRESSA®) With Oxaliplatin and Radiotherapy for Esophageal Carcinoma. A Phase I/II Study With Biologic Correlates|Terminated||Phase 1/Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 17:47:49.023151|2017-02-18 17:47:49.023151
NCT00093639|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-04-30|||August 2004||2004-08-01|April 2013|2013-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate|A Phase I-II, Study of RAD001 in Combination With Imatinib (Glivec®/Gleevec™) in Patients With Chronic Myelogenous Leukemia (CML) in Chronic Phase Who Are Not In Complete Cytogenetic Response to Imatinib-Alone at Study Entry|Completed||Phase 1/Phase 2|||Novartis|||||f||||||||||||||2017-02-18 17:47:49.120385|2017-02-18 17:47:49.120385
NCT00093626|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2015-05-18|||October 2004||2004-10-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|September 2007|Actual|2007-09-01||Interventional|||Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer|A Phase II Evaluation of BAY 43-9006 (Sorafenib, Nexavar®, NCI-Supplied Agent, NSC #724772) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|73|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:47:49.225319|2017-02-18 17:47:49.225319
NCT00093613|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2014-05-29|||December 2004||2004-12-01|December 2013|2013-12-01|December 2011|Actual|2011-12-01|October 2010|Actual|2010-10-01||Interventional|||Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma|A Phase I Trial of BAY 43-9006 for Patients With Recurrent or Progressive Malignant Glioma|Completed||Phase 1|47|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:47:49.334174|2017-02-18 17:47:49.334174
NCT00093600|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2015-03-09|||February 2004||2004-02-01|March 2015|2015-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase IB, Open-Label Study to Determine the Safety and Pharmacokinetics of Twice Daily Oral Dosing of PKC412 Administered in Combinations Sequentially and Concomitantly With Daunorubicin and Cytarabine for Standard Induction Therapy, and High Dose Cytarabine for Consolidation in Patients With Acute Myeloid Leukemia (AML)|Completed||Phase 1|69|Actual|Novartis||2|||f||||f||||||||||2017-02-18 17:47:49.448457|2017-02-18 17:47:49.448457
NCT00093587|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-11-05|||August 2004||2004-08-01|January 2006|2006-01-01||||||||Interventional|||Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia|Pilot Trial of Two Dose Levels of Thymoglobulin® as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor (MRD) Stem Cell Transplant With Cyclosporine (CsA) as Posttransplant Graft vs Host Disease (GvHD) Prophylaxis|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:47:49.564466|2017-02-18 17:47:49.564466
NCT00093561|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-06-25|||August 2004||2004-08-01|November 2006|2006-11-01|February 2006|Actual|2006-02-01|||||Interventional|||Lycopene in Preventing Prostate Cancer in Healthy Participants|Phase I Single Dose Pharmacokinetic Study of the Dietary Supplement Lycopene Delivered in Capsule Form to Healthy Male Volunteers Between 18 and 45 Years of Age|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:47:49.658073|2017-02-18 17:47:49.658073
NCT00093548|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2012-10-03||||||October 2012|2012-10-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer|A Phase I/II Trial Testing Immunization With AFP + GM-CSF Plasmid Prime And AFP Adenoviral Vector Boost In Patients With Hepatocellular Carcinoma (AFP Prime-Boost Protocol)|Withdrawn||Phase 1/Phase 2|0|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 17:47:49.743887|2017-02-18 17:47:49.743887
NCT00093522|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-12-18|||August 2004||2004-08-01|May 2007|2007-05-01||||||||Interventional|||Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer|A Phase II Pilot Study of Tumor-Loaded Dendritic Cells Alone or Following a Non-Myeloablative Conditioning Regimen in Patients With Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|28|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:47:49.822135|2017-02-18 17:47:49.822135
NCT00093509|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2014-08-29|||November 1999||1999-11-01|August 2014|2014-08-01|October 2009|Actual|2009-10-01|July 2007|Actual|2007-07-01||Interventional|||MRI Sarcoma Non Invasive Thermometry|Magnetic Resonance Based Non-Invasive Thermometry for Hyperthermic Treatment of Extremity Soft Tissue Sarcomas: A Multimodal Phase I/II Study|Completed||Phase 1/Phase 2|15|Actual|Duke University||1|||f||||f||||||||||2017-02-18 17:47:49.915179|2017-02-18 17:47:49.915179
NCT00093496|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2014-05-02|2013-03-22||October 2007||2007-10-01|October 2011|2011-10-01|March 2012|Actual|2012-03-01|April 2010|Actual|2010-04-01||Interventional|||Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer|A Phase II Trial Of Gemcitabine in Combination With 17-Allylaminogeldamycin (17-AAG) In Advanced Epithelial Ovarian And Primary Peritoneal Carcinoma|Completed||Phase 2|29|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:47:50.031717|2017-02-18 17:47:50.031717
NCT00093483|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2014-01-10|||April 2002||2002-04-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia|Arsenic Trioxide, High-Dose Cytarabine and Idarubicin Induction Therapy in Previously Untreated de Novo and Secondary Adult Acute Myeloid Leukemia Patients < 60 Years Old - A Phase I Study|Completed||Phase 1|61|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:47:53.362619|2017-02-18 17:47:53.362619
NCT00093470|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2016-11-14|2015-10-13||August 2004||2004-08-01|November 2016|2016-11-01||||February 2015|Actual|2015-02-01||Interventional||All randomized patients|Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission|A Phase III Randomized Study of Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subsequent Remission or in Remission After Primary Induction Failure or Patients Over Age 60 in First Remission|Active, not recruiting||Phase 3|144|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 17:47:53.486226|2017-02-18 17:47:53.486226
NCT00093457|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2011-09-27|||July 2004||2004-07-01|September 2011|2011-09-01|January 2011|Actual|2011-01-01|September 2006|Actual|2006-09-01||Interventional|||Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer|A Phase II Study Of BAY 43-9006 (NSC 724772; CTEP IND# 69,896) In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|28|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 17:47:54.375785|2017-02-18 17:47:54.375785
NCT00093444|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2012-03-14|||September 2004||2004-09-01|March 2012|2012-03-01|January 2010|Actual|2010-01-01|||||Interventional|||Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors|A Phase I Dose Escalation Study Of Heat Activated Liposome Delivery Of Doxorubicin And Radiofrequency Ablation Of Primary And Metastatic Tumors Of The Liver|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:47:54.48411|2017-02-18 17:47:54.48411
NCT00093418|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-01-14|||September 2004||2004-09-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia|Phase II Studies of Two Different Schedules and Two Different Doses of the Farnesyl Transferase Inhibitor R115777 (Tipifarnib, Zarnestra®, NSC-702818) for Previously Untreated Acute Myeloid Leukemia (AML) in Patients of Age 70 or Older|Completed||Phase 2|296|Actual|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 17:47:54.578047|2017-02-18 17:47:54.578047
NCT00093405|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2013-06-21|||August 2004||2004-08-01|November 2005|2005-11-01|November 2005|Actual|2005-11-01|||||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AAG)In Metastatic Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:47:54.688584|2017-02-18 17:47:54.688584
NCT00093379|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2014-03-12|2013-10-15||April 2004||2004-04-01|March 2014|2014-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer|A Phase II Study of Capecitabine (Xeloda)/Oxaliplatin (Eloxatin) With Concomitant Radiotherapy (XRT), XELOX/RT in Squamous Cell Carcinoma of the Anal Canal|Completed||Phase 2|20|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:47:54.784253|2017-02-18 17:47:54.784253
NCT00093366|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2011-11-28|||June 2004||2004-06-01|November 2011|2011-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes|Therapy of Advanced Stage Myelodysplastic Syndrome (MDS) With Arsenic Trioxide Given in Combination With Etanercept: A Phase I/II Study|Completed||Phase 1/Phase 2|32|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:47:55.373983|2017-02-18 17:47:55.373983
NCT00093314|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-06|2015-04-20|||October 2004||2004-10-01|January 2007|2007-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||HuMax-CD20 in Chronic Lymphocytic Leukemia|An Open-labeled, International, Multicenter, Dose Escalating, Phase I/II Trial of HuMax-CD20, a Fully Human Monoclonal Anti-CD20 Antibody, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Withdrawn||Phase 1/Phase 2|0|Actual|GlaxoSmithKline||||Acquired asset|||||||||||||||2017-02-18 17:47:55.681001|2017-02-18 17:47:55.681001
NCT00093301|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-05|2005-06-23|||October 2004||2004-10-01|October 2004|2004-10-01|April 2006||2006-04-01|||||Interventional|||Levosimendan Versus Dobutamine in Shock Patients|Efficacy of Levosimendan in the Critically Ill Patients With Unstable Hemodynamics (the LICI Study) - A Double Blind Randomized Pilot Study|Unknown status|Recruiting|Phase 2/Phase 3|40||Wentworth Area Health Services|||||f||||||||||||||2017-02-18 17:47:55.7607|2017-02-18 17:47:55.7607
NCT00093288|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-05|2013-08-29|||June 2004||2004-06-01|August 2013|2013-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Major Depressive Disorder In The Elderly|A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible Dose Study to Evaluate the Efficacy, Safety and Tolerability of Extended-release Bupropion Hydrochloride (150mg-300mg Once Daily) in Elderly Subjects With Major Depressive Disorder|Completed||Phase 3|364||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:47:55.851097|2017-02-18 17:47:55.851097
NCT00093275|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-05|2008-08-20|||October 2004||2004-10-01|August 2008|2008-08-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||HP184 in Chronic Spinal Cord Injury Subjects|A Phase II, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of HP184 Administered Orally Once Daily for Twenty-Four Weeks in Adult Subjects With Chronic Spinal Cord Injury (CSCI)|Completed||Phase 2|262|Actual|Sanofi|||||||||||||||||||2017-02-18 17:47:55.961733|2017-02-18 17:47:55.961733
NCT00093262|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-05|2014-05-07|||December 2003||2003-12-01|May 2014|2014-05-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|ESCAPE-2||Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)|Efficacy Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)|Completed||Phase 3|206|Actual|The Medicines Company||2|||||||t||||||||||2017-02-18 17:47:56.070836|2017-02-18 17:47:56.070836
NCT00093249|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-05|2014-08-21|||January 2004||2004-01-01|August 2014|2014-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|ESCAPE-1||Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)|Efficacy Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)|Completed||Phase 3|105|Actual|The Medicines Company||2|||f||||t||||||||||2017-02-18 17:47:56.208153|2017-02-18 17:47:56.208153
NCT00093236|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-05|2011-03-29|||September 2004||2004-09-01|March 2011|2011-03-01|April 2011|Anticipated|2011-04-01|November 2010|Anticipated|2010-11-01||Interventional|||Impact of Gum Infection on Heart Disease|Systemic Endothelial Consequences of Periodontal Disease|Unknown status|Active, not recruiting|Phase 2/Phase 3|160|Anticipated|Boston University||1|||f||||t||||||||||2017-02-18 17:47:56.355995|2017-02-18 17:47:56.355995
NCT00093223|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-04|2016-03-30|||September 2001||2001-09-01|March 2016|2016-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Safety Study of ABI-007 for In-Stent Restenosis|A Phase II Safety Study of Systemic Nanoparticle Paclitaxel (ABI-007)for In-Stent Restenosis|Completed||Phase 2|76|Actual|Celgene Corporation||2|||f||||t||||||||||2017-02-18 17:47:56.456277|2017-02-18 17:47:56.456277
NCT00093210|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-04|2007-12-03||||||December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B|A Double-Blind, Randomized, Crossover Evaluation of the Pharmacokinetics of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R); and an Open-Label Safety and Efficacy Evaluation of rFIX-R in Previously Treated Patients With Moderate to Severe (FIX:C≤2%) Hemophilia B|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:47:56.570339|2017-02-18 17:47:56.570339
NCT00093197|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-04|2011-08-31|||September 2004||2004-09-01|August 2011|2011-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack|Intracoronary KAI-9803 for Injection as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction|Completed||Phase 1/Phase 2|154|Actual|KAI Pharmaceuticals||5|||f||||t||||||||||2017-02-18 17:47:56.653156|2017-02-18 17:47:56.653156
NCT00093184|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-04|2006-02-08|||April 2004||2004-04-01|February 2006|2006-02-01|December 2005||2005-12-01|||||Interventional|||Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI|A Study Evaluating the Safety and Efficacy of Bivalirudin in the Management of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary PCI (BIAMI)|Completed||Phase 3|300||The Medicines Company|||||||||||||||||||2017-02-18 17:47:56.752356|2017-02-18 17:47:56.752356
NCT00093171|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-04|2009-08-20||||||August 2009|2009-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study Evaluating rFIX; BeneFIX® in Hemophilia B|An Open-label Safety and Efficacy Study of Recombinant Human Factor IX (rFIX; BeneFIX®) in Previously Treated Patients (PTPs) With Hemophilia B (FIX:C ≤2%)|Completed||Phase 3|23|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:47:56.84796|2017-02-18 17:47:56.84796
NCT00093158|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-04|2007-08-20|||August 2003||2003-08-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)|The ACUITY Trial: A Randomized Comparison of Angiomax (Bivalirudin) Versus Heparin (Unfractionated Heparin or Enoxaparin) in Patients Undergoing Early Invasive Management for Acute Coronary Syndromes Without ST-Segment Elevation|Completed||Phase 3|13800||The Medicines Company|||||||||||||||||||2017-02-18 17:47:56.929475|2017-02-18 17:47:56.929475
NCT00093145|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-04|2013-07-15|2013-05-07||June 2004||2004-06-01|July 2013|2013-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer|A Phase II Study of Weekly Dose-Dense Nanoparticle Paclitaxel (ABI-007), Carboplatin With Herceptin® As First-Line Therapy of Advanced HER-2 Positive Breast Cancer|Completed||Phase 2|32|Actual|Celgene||1|||f||||f||||||||||2017-02-18 17:47:57.018125|2017-02-18 17:47:57.018125
NCT00093132|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-01|2012-08-09||2012-08-09|August 2004||2004-08-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|January 2009|Actual|2009-01-01||Interventional|||Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy|A Phase 1/2 Study With Satraplatin and Simultaneous Radiation in Locally Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|20|Actual|Agennix||1||Sponsor decided to discontinue study drug development.|f||||||||||||||2017-02-18 17:47:57.897806|2017-02-18 17:47:57.897806
NCT00093119|ClinicalTrials.gov processed this data on February 17, 2017|2004-10-01|2009-06-11|||January 2004||2004-01-01|January 2006|2006-01-01||||||||Interventional|||Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma|A Phase II Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma|Completed||Phase 2|33||Celgene Corporation|||||||||||||||||||2017-02-18 17:47:57.991821|2017-02-18 17:47:57.991821
NCT00093093|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-30|2012-06-21|||June 2004||2004-06-01|June 2012|2012-06-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|VISER2||Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive|Randomized, Double-Blind, Multicenter Study to Compare the Safety and Efficacy of Viramidine to Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C|Completed||Phase 3|900||Valeant Pharmaceuticals International, Inc.|||||f||||||||||||||2017-02-18 17:47:58.083357|2017-02-18 17:47:58.083357
NCT00093080|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-30|2015-02-12|||October 2004||2004-10-01|February 2015|2015-02-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)|A Phase II Study of AP23573, An mTOR Inhibitor, in Patients With Advanced Sarcoma|Completed||Phase 2|216|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 17:47:58.301606|2017-02-18 17:47:58.301606
NCT00093067|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-30|2017-02-09|||March 2002||2002-03-01|February 2017|2017-02-01|February 2005|Actual|2005-02-01|November 2004|Actual|2004-11-01||Interventional|||Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus|A Phase 3, Multicenter, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of Daptomycin Compared to Conventional Therapy In the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to Staph Aureus|Completed||Phase 3|||Cubist Pharmaceuticals LLC|||||f||||||||||||||2017-02-18 17:47:58.414036|2017-02-18 17:47:58.414036
NCT00093054|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-30|2015-04-14||2015-04-14|November 2004||2004-11-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Interventional|||Cranberry Juice for Treatment of Urinary Tract Infections|Cranberry Juice and Urinary Tract Infections|Completed||Phase 2/Phase 3|319|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 17:47:58.524191|2017-02-18 17:47:58.524191
NCT00093041|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-30|2011-11-17|2011-09-12||December 2003||2003-12-01|November 2011|2011-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Zalutumumab in Head and Neck Cancer|An Open, Single Dose Escalation Study Followed by a Multiple Dose Extension of Anti-EGF Receptor Human Monoclonal Antibody (Zalutumumab) in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 1/Phase 2|28|Actual|Genmab|The study comprised a single-dose escalation part for assessment of safety and a repeat dose extension including 4 weekly infusions. Please see the referred publication by Bastholt at al 2007 for detailed results.|6|||f||||||||||||||2017-02-18 17:47:58.640347|2017-02-18 17:47:58.640347
NCT00093028|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-29|2010-07-01|||January 2004||2004-01-01|July 2010|2010-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II|UARK 2003-35, A Phase III Study of Bortezomib Versus Bortezomib in Two Doses in Combination With Revlimid™ for Patients Relapsing or Progressing on Total Therapy II (UARK 98-026)|Completed||Phase 3|315|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 17:47:59.668328|2017-02-18 17:47:59.668328
NCT00093015|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-28|2014-07-11|2010-08-06||August 2004||2004-08-01|July 2014|2014-07-01|August 2009|Actual|2009-08-01|July 2009|Actual|2009-07-01||Interventional|||Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)|Trial to Reduce Cardiovascular Events With Aranesp® Therapy|Completed||Phase 3|4038|Actual|Amgen|4047 subjects were enrolled, but before unblinding, all information from 9 subjects was excluded from two sites (3 and 6 subjects, respectively) that did not adhere to Good Clinical Practice guidelines. 4038 subjects were analyzed and reported.|2|||f||||||||||||||2017-02-18 17:47:59.807719|2017-02-18 17:47:59.807719
NCT00093002|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-28|2008-06-11|||June 2004||2004-06-01|June 2008|2008-06-01|July 2007|Actual|2007-07-01|||||Interventional|||Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer|A Randomized, Open-Label, Multicenter, Phase II Study Comparing the Effects on Proliferation and the Efficacy and Tolerability of Fulvestrant (FASLODEX®) 500 mg With Fulvestrant (FASLODEX®) 250 mg When Given as Neoadjuvant Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer (T2, 3, 4b, N0-3, M0).|Completed||Phase 2|179|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:48:03.386961|2017-02-18 17:48:03.386961
NCT00092989|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-28|2015-03-09|||July 2004||2004-07-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)|A Multicenter, Randomized, Double-Blind Study Comparing the Clinical Effects of Intravenous Montelukast With Placebo in Patients With Acute Asthma|Completed||Phase 3|650|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:48:03.529281|2017-02-18 17:48:03.529281
NCT00092976|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-28|2007-12-19|||February 2003||2003-02-01|May 2006|2006-05-01|July 2007|Actual|2007-07-01|||||Interventional|||Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery|A Phase IV Study of the Safety and Efficacy of ReFacto® (Moroctocog Alfa, B-Domain Deleted Recombinant Factor VIII) in Subjects With Hemophilia A Undergoing Major Surgery Monitored Using the Chromogenic Substrate Assay at the Local Laboratory|Completed||Phase 4|15|Anticipated|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:48:03.635725|2017-02-18 17:48:03.635725
NCT00092963|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-28|2015-11-03|||August 2004||2004-08-01|November 2015|2015-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)|A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild|Completed||Phase 3|529|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:03.729468|2017-02-18 17:48:03.729468
NCT00092950|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-24|2017-01-24|||September 23, 2004||2004-09-23|September 28, 2011|2011-09-28|December 7, 2009|Actual|2009-12-07|December 7, 2009|Actual|2009-12-07||Interventional|||Exercise in Women at Risk for Breast Cancer|A Pilot Study of a Three Month Intervention for Increasing Physical Activity in Sedentary Women at Risk for Breast Cancer|Completed||Phase 2|88|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:48:03.816474|2017-02-18 17:48:03.816474
NCT00092443|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-09-11|2009-05-19||September 2002||2002-09-01|September 2015|2015-09-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Dose Confirmation Efficacy Study (V260-007)|Study of the Efficacy, Safety, and Immunogenicity of V260 at Expiry|Completed||Phase 3|1312|Actual|Merck Sharp & Dohme Corp.|Safety has been reported in the literature.|2|||f||||||||||||||2017-02-18 17:48:16.191495|2017-02-18 17:48:16.191495
NCT00092937|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-24|2017-01-24|||September 23, 2004||2004-09-23|April 6, 2010|2010-04-06|April 6, 2010|Actual|2010-04-06|April 6, 2010|Actual|2010-04-06||Interventional|||Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant|Secondary Transplantation Using Moderate Dose Busulfan as Conditioning for a Patient With Partial Reconstitution Post Initial Allogeneic Transplantation|Completed||Phase 1|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:48:03.908005|2017-02-18 17:48:03.908005
NCT00092924|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-24|2013-08-01||||||August 2013|2013-08-01|March 2005|Actual|2005-03-01|January 2005|Actual|2005-01-01||Interventional|||Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)|A Phase 2, Multi-Center, Open-Label Study to Evaluate the Efficacy, Safety, and Tolerability of TRM-1 (Fully Human Monoclonal Antibody To TRAIL-R1) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer|Completed||Phase 2|||Human Genome Sciences Inc.|||||||||||||||||||2017-02-18 17:48:03.998716|2017-02-18 17:48:03.998716
NCT00092911|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-24|2009-08-18||||||August 2009|2009-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of a Flexible Dose of DVS-233 SR in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|244|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:48:04.085865|2017-02-18 17:48:04.085865
NCT00092898|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-16|||October 2004||2004-10-01|February 2015|2015-02-01|October 2005|Actual|2005-10-01|September 2005|Actual|2005-09-01||Interventional|||An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to An Ongoing Regimen of Ezetimibe 10 mg in Patients Homozygous Sitosterolemia|Completed||Phase 3|30|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:04.159732|2017-02-18 17:48:04.159732
NCT00092885|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-11-27|||March 2003||2003-03-01|November 2015|2015-11-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)|A Multicenter, Double-Blind, Randomized Study Investigating the Clinical Effect of Montelukast on Allergic Rhinitis in Patients With Seasonal Allergic Rhinitis and Chronic Asthma|Completed||Phase 3|831|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:04.25799|2017-02-18 17:48:04.25799
NCT00092872|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-01-29|||November 2003||2003-11-01|January 2015|2015-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of MK0557 in Obese Patients|Completed||Phase 3|359|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:04.352032|2017-02-18 17:48:04.352032
NCT00092859|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2016-12-30|||August 2003||2003-08-01|December 2016|2016-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of MK0557 in Obese Patients|Completed||Phase 3|1500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:04.436946|2017-02-18 17:48:04.436946
NCT00092846|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2016-11-17|||December 2002||2002-12-01|November 2016|2016-11-01||||September 2003|Actual|2003-09-01||Interventional|||A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)|A Consumer Use Study of OTC Lovastatin (CUSTOM): A 6-Month Consumer Behavior Study of the Lovastatin OTC Self-Management System|Completed||Phase 3|1000||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:04.506058|2017-02-18 17:48:04.506058
NCT00092833|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-03-16|||July 2002||2002-07-01|March 2015|2015-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)|An Open-Label, Worldwide, Treatment Use Study to Provide Ezetimibe 10 Mg/Day to Patients With Homozygous Familial Hypercholesterolemia or Homozygous Sitosterolemia|Terminated||Phase 3|49|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 17:48:04.602575|2017-02-18 17:48:04.602575
NCT00092820|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-16|||February 2001||2001-02-01|February 2015|2015-02-01|November 2004|Actual|2004-11-01|September 2001|Actual|2001-09-01||Interventional|||Sitosterolemia Extension Study (0653-004)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK0653 When Added to Current Regimen in Patients With Homozygous Sitosterolemia|Completed||Phase 3|58|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:04.716325|2017-02-18 17:48:04.716325
NCT00092807|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-16|||February 2001||2001-02-01|February 2015|2015-02-01|November 2004|Actual|2004-11-01|September 2001|Actual|2001-09-01||Interventional|||Sitosterolemia Extension Study (0653-003)(COMPLETED)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MK0653 When Added to Current Regimen in Patients With Homozygous Sitosterolemia - 1 Year Open-Label Extension|Completed||Phase 3|37|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:04.810767|2017-02-18 17:48:04.810767
NCT00092781|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-06-15|||March 2004||2004-03-01|June 2015|2015-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)|A 26-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind, 2-Part Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Patients With Osteoarthritis (Study 2)|Completed||Phase 3|500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:04.914545|2017-02-18 17:48:04.914545
NCT00092768|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-06-15|||March 2004||2004-03-01|June 2015|2015-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)|A 26-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind, 2-Part Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Patients With Osteoarthritis (Study 1)|Completed||Phase 3|500|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:05.007263|2017-02-18 17:48:05.007263
NCT00092755|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-06-29|||April 2003||2003-04-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||An Investigational Drug in Patients With Osteoarthritis (0663-073)|A 12-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Ibuprofen 2400 mg in Patients With Osteoarthritis (Study 2)|Completed||Phase 3|548|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:05.110497|2017-02-18 17:48:05.110497
NCT00092742|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-06-29|||February 2003||2003-02-01|June 2015|2015-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)|A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 75 mg b.i.d. in Patients With Rheumatoid Arthritis|Completed||Phase 3|4086|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:05.213031|2017-02-18 17:48:05.213031
NCT00092729|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-06-05|||June 2002||2002-06-01|June 2015|2015-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)|A Randomized, Placebo-and Active-Comparator-Controlled Study of Etoricoxib 120 mg in the Treatment of Primary Dysmenorrhea|Completed||Phase 3|129|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 17:48:05.323381|2017-02-18 17:48:05.323381
NCT00092716|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-10-30|||May 2002||2002-05-01|October 2015|2015-10-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)|A Multicenter, Double-Blind, Randomized, Parallel Group, 28-Week Study to Evaluate the Efficacy and Safety of Ezetimibe and Simvastatin Co-administration Versus Atorvastatin in Patients With Hypercholesteremia|Completed||Phase 3|655|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:05.418254|2017-02-18 17:48:05.418254
NCT00092703|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-05-26|||June 2002||2002-06-01|May 2015|2015-05-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)|A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 50 mg t.i.d. in Patients With Osteoarthritis|Completed||Phase 3|6000||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:05.49475|2017-02-18 17:48:05.49475
NCT00092690|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-16|||June 2003||2003-06-01|February 2015|2015-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)|A Multicenter, Double-Blind, Randomized, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Patients With Hypercholesterolemia|Completed||Phase 3|1902|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:05.584658|2017-02-18 17:48:05.584658
NCT00092677|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-24|2009-03-31||January 2001||2001-01-01|February 2015|2015-02-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effects of Ezetimibe + Simvastatin on Clinical Outcomes in Patients With Aortic Stenosis|Completed||Phase 3|1873|Actual|Merck Sharp & Dohme Corp.|It is important to note that several of the ischemic outcomes making up the composite ischemic endpoint can occur as a causal consequence of aortic stenosis progression itself, or in association with its standard treatment (aortic valve replacement).|2|||f||||||||||||||2017-02-18 17:48:05.954685|2017-02-18 17:48:05.954685
NCT00092664|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-17|||January 2003||2003-01-01|February 2015|2015-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)|"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Factorial Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patients With Primary Hypercholesterolemia"|Completed||Phase 3|1104|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:08.521625|2017-02-18 17:48:08.521625
NCT00092651|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-10-20|||September 2002||2002-09-01|October 2015|2015-10-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)|"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patients With Primary Hypercholesterolemia"|Completed||Phase 3|1398|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:08.620071|2017-02-18 17:48:08.620071
NCT00092638|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-17|||May 2003||2003-05-01|February 2015|2015-02-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Added to Existing Atorvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease.|Completed||Phase 3|450|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:08.719784|2017-02-18 17:48:08.719784
NCT00092625|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-10-30|||March 2003||2003-03-01|October 2015|2015-10-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Added to Existing Atorvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease.|Completed||Phase 3|442|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:08.814675|2017-02-18 17:48:08.814675
NCT00092612|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-16|||May 2003||2003-05-01|February 2015|2015-02-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Co-administered With Existing Simvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease.|Completed||Phase 3|372|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:08.914843|2017-02-18 17:48:08.914843
NCT00092599|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-10-29|||February 2003||2003-02-01|October 2015|2015-10-01|July 2004|Actual|2004-07-01|June 2004|Actual|2004-06-01||Interventional|||Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of Ezetimibe 10 mg or Placebo Co-administered With Existing Simvastatin 10 mg or 20 mg in Attaining Low-Density Lipoprotein Cholesterol Target Levels in Patients With Hypercholesterolemia and Coronary Heart Disease.|Completed||Phase 3|410|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:09.017831|2017-02-18 17:48:09.017831
NCT00092586|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-11-30|||September 2002||2002-09-01|November 2015|2015-11-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)|A Multi-center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe 10 mg/Day When Added to Ongoing Therapy With a Statin Versus Statin Therapy Alone, in Patients With Hypercholesterolemia Who Have Not Reached National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Target LDL-Cholesterol Level|Completed||Phase 3|2904|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:09.128238|2017-02-18 17:48:09.128238
NCT00092573|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-02-17|||April 2003||2003-04-01|February 2015|2015-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)|Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia|Completed||Phase 3|576|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:09.23929|2017-02-18 17:48:09.23929
NCT00092560|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-10-29|||December 2002||2002-12-01|October 2015|2015-10-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)|Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia|Completed||Phase 3|587|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:09.35202|2017-02-18 17:48:09.35202
NCT00092547|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2016-02-09|2009-11-03||October 2003||2003-10-01|February 2016|2016-02-01|June 2015|Actual|2015-06-01|November 2005|Actual|2005-11-01||Interventional|||A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)|A Safety and Immunogenicity Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Preadolescents and Adolescents (Base Study). A Long Term Immunogenicity, Safety, and Effectiveness Study of GARDASIL (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) Among Adolescents Who Received GARDASIL at 9-18 Years of Age (Extension Study).|Completed||Phase 3|1781|Actual|Merck Sharp & Dohme Corp.|The difference between the prior and final data is a minor change in the definition of the per-protocol immunogenicity population, which was applied down to the base study. Also, protocol violators were identified and excluded from the analysis.|3|||f||||f||||||||||2017-02-18 17:48:09.474538|2017-02-18 17:48:09.474538
NCT00092534|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2016-09-26|2009-07-20||June 2002||2002-06-01|September 2016|2016-09-01|January 2019|Anticipated|2019-01-01|July 2007|Actual|2007-07-01||Interventional|||Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015)|A Randomized, Worldwide, Placebo-Controlled, Double-Blind Study to Investigate the Safety Immunogenicity and Efficacy on the Incidence of HPV 16/18-Related CIN2/3 or Worse of the Quadrivalent HPV (Types 6, 11, 16, 18,) L1 Virus-Like Particle (VLP) Vaccine (V501, Gardasil) in 16- to 23-Year Old Women - The F.U.T.U.R.E. II Study (Females United to Unilaterally Reduce Endo/Ectocervical Disease)|Active, not recruiting||Phase 3|12167|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:48:10.851986|2017-02-18 17:48:10.851986
NCT00092521|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-23|2015-09-24|2009-08-03||December 2001||2001-12-01|September 2015|2015-09-01|January 2009|Actual|2009-01-01|July 2007|Actual|2007-07-01||Interventional|||Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)|A Study to Evaluate the Efficacy of Quadrivalent HPV Vaccine in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related CIN, AIS, and Cervical Cancer, and HPV 6-, 11-, 16-, and 18-Related External Genital Warts, Vulvar Intraepithelial Neoplasia Vaginal Intraepithelial Neoplasia, Vulvar Cancer, and Vaginal Cancer in 16- to 23-Year-Old Women|Completed||Phase 3|5759|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 17:48:11.735072|2017-02-18 17:48:11.735072
NCT00092508|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2007-06-19|||May 2004||2004-05-01|June 2007|2007-06-01|May 2007||2007-05-01|||||Interventional|||CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission|Phase 3, Multi-Center, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the Efficacy and Safety of 25 mg QD and 50 mg QD of OPC-6335 Oral Tablets and 800 mg BID of Asacol® in the Maintenance of Ulcerative Colitis Remission|Completed||Phase 3|1725|Anticipated|Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 17:48:12.827141|2017-02-18 17:48:12.827141
NCT00092495|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2014-12-29|2010-02-15||December 2002||2002-12-01|December 2014|2014-12-01|February 2009|Actual|2009-02-01|September 2004|Actual|2004-09-01||Interventional|||Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)|A Study to Demonstrate Immunogenicity and Tolerability of Gardasil (V501) Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Preadolescents, and To Determine End-Expiry Specifications for the Vaccine|Completed||Phase 3|3055|Actual|Merck Sharp & Dohme Corp.|Of note, the number of subjects who completed the Vaccination Period (N=1441) is slightly higher than that specified in the publication by Block, et al (2006; N=1430). The data provided here is based on final data.|4|||f||||||||||||||2017-02-18 17:48:12.954098|2017-02-18 17:48:12.954098
NCT00092482|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-05-12|||June 2002||2002-06-01|May 2015|2015-05-01|August 2008|Actual|2008-08-01|June 2004|Actual|2004-06-01||Interventional|||Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)|Immunogenicity and Safety of Gardasil (V501) Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Consistency Lots for 16- to 23-Year-Old Women With and Additional Immunogenicity Bridge to the Monovalent HPV 16 Vaccine Pilot Manufacturing Lot Study-The F.U.T.U.R.E. Study (Females United to Unilaterally Reduce Endo/Ectocervical Disease)|Completed||Phase 3|3882|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:14.547013|2017-02-18 17:48:14.547013
NCT00092469|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-10-06|||March 2002||2002-03-01|October 2015|2015-10-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)|A Registration Study of the Safety, Tolerability, and Immunogenicity of V441 in Healthy Infants in Taiwan|Completed||Phase 3|151||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:14.639543|2017-02-18 17:48:14.639543
NCT00092456|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-09-18|2009-06-19||May 2003||2003-05-01|September 2015|2015-09-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Consistency Lots Vaccine Study (V260-009)|Comparison of the Immunogenicity and Safety of Three Consistency Lots of V260 in Healthy Infants|Completed||Phase 3|793|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 17:48:14.955439|2017-02-18 17:48:14.955439
NCT00091494|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-09|2016-04-08|||September 2004||2004-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA||Completed||N/A|1000|Anticipated|University of Michigan|||1||f||||||||||||||2017-02-18 17:48:39.067717|2017-02-18 17:48:39.067717
NCT00092430|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-01-23|||September 2002||2002-09-01|January 2015|2015-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)|A Comparison of the Safety, Tolerability, and Immunogenicity of a Refrigerator-Stable Measles, Mumps, Rubella, and Varicella Combination Vaccine V221 (Refrigerated) Versus V221 (Frozen) in Healthy Children|Completed||Phase 3|1200||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:16.826635|2017-02-18 17:48:16.826635
NCT00092417|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-10-06|2010-05-12||October 2003||2003-10-01|October 2015|2015-10-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)|Evaluation of the Safety and Tolerability of a Higher Potency Dose of Varicella Zoster Virus Vaccine Live (Oka/Merck)Among Adults 50 Years of Age or Older|Completed||Phase 3|695|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:48:16.913462|2017-02-18 17:48:16.913462
NCT00092404|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-04-29|||December 2001||2001-12-01|April 2015|2015-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)|A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured With Recombinant Human Albumin (rHA) Versus V205C Manufactured With Pooled-Donor Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age|Completed||Phase 2|1210|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:17.38274|2017-02-18 17:48:17.38274
NCT00092391|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-10-22|||February 1999||1999-02-01|October 2015|2015-10-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)|A Study of M-M-R(TM) II at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age|Completed||Phase 3|1997|Actual|Merck Sharp & Dohme Corp.||3|||f||||||||||||||2017-02-18 17:48:17.472726|2017-02-18 17:48:17.472726
NCT00092378|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-04-09|||September 2003||2003-09-01|April 2015|2015-04-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)|A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Parallel-Group Study of Rofecoxib and Diclofenac Sodium in the Treatment of Post-Bunionectomy Surgery Pain|Completed||Phase 3|251|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:17.561905|2017-02-18 17:48:17.561905
NCT00092365|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-09-01|||April 2003||2003-04-01|September 2015|2015-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)|A Randomized, Placebo-Controlled, Parallel-Group, Double -Blind Study to Evaluate the Safety and Efficacy of Rofecoxib 12.5 mg and Celecoxib 200 mg in Patients With Osteoarthritis of the Knee|Completed||Phase 3|413|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:17.651862|2017-02-18 17:48:17.651862
NCT00092352|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-09-15|||April 2003||2003-04-01|September 2015|2015-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)|A Randomized, Placebo-Controlled, Parallel-Group, Double -Blind Study to Evaluate the Safety and Efficacy of Rofecoxib 12.5 mg and Celecoxib 200 mg in Patients With Osteoarthritis of the Knee|Completed||Phase 3|395|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:17.751313|2017-02-18 17:48:17.751313
NCT00092339|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-09-15|||August 2002||2002-08-01|September 2015|2015-09-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Effects of Rofecoxib 50 mg and Valdecoxib 40 mg in Patients With Postoperative Dental Pain|Completed||Phase 3|125|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:17.84773|2017-02-18 17:48:17.84773
NCT00092326|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2016-02-19|||June 2002||2002-06-01|February 2016|2016-02-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)|A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study to Evaluate the Efficacy of Rofecoxib and a Dosing Regimen of Oxycodone With Acetaminophen Over 24 Hours in Patients With Postoperative Dental Pain|Completed||Phase 3|269|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:17.943006|2017-02-18 17:48:17.943006
NCT00092313|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-11-24|||June 2002||2002-06-01|November 2015|2015-11-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)|A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Study to Evaluate the Efficacy of Rofecoxib and a Dosing Regimen of Oxycodone With Acetaminophen Over 24 Hours in Patients With Postoperative Dental Pain|Completed||Phase 3|271|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:18.051212|2017-02-18 17:48:18.051212
NCT00092300|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-07-31|||May 2002||2002-05-01|July 2015|2015-07-01||||September 2002|Actual|2002-09-01||Interventional|||A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)|A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Single Dose Study of the Effect of Rofecoxib 50 mg and Valdecoxib 20 mg in Patients With Postoperative Dental Pain|Completed||Phase 3|450||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:18.144844|2017-02-18 17:48:18.144844
NCT00092287|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2008-02-25|||July 2004||2004-07-01|February 2008|2008-02-01|October 2004|Actual|2004-10-01|||||Interventional|||Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome|A Phase III, Prospective, Multicenter, Randomized, Open, Parallel Group Comparison of Lanreotide Autogel® (90 and 120 mg) Administered by Deep Subcutaneous Injection Every Four Weeks, With Sandostatin LAR Depot (20 and 30 mg) Administered by Intramuscular Injection, Every Four Weeks for Six Months, in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome|Terminated||Phase 3|196||Ipsen|||||||||||||||||||2017-02-18 17:48:18.243485|2017-02-18 17:48:18.243485
NCT00092274|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-22|2015-04-20|||September 2004||2004-09-01|January 2005|2005-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma|An Open-label, International, Multicenter, Dose Escalating, Phase I/II Study of HuMax-CD20 in Patients With Relapsed or Refractory Follicular Lymphoma Grade I-II|Withdrawn||Phase 1/Phase 2|0|Actual|GlaxoSmithKline||||Acquired asset|||||||||||||||2017-02-18 17:48:18.3301|2017-02-18 17:48:18.3301
NCT00092235|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2017-01-24|||September 17, 2004||2004-09-17|September 26, 2016|2016-09-26||||||||Observational|||Factors Determining Outcomes in Patients With Graft-Versus-Host Disease|Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease|Recruiting||N/A|550|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:48:18.406265|2017-02-18 17:48:18.406265
NCT00092222|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2017-01-24|||September 17, 2004||2004-09-17|October 6, 2016|2016-10-06|October 1, 2020|Anticipated|2020-10-01|October 1, 2018|Anticipated|2018-10-01||Interventional|||Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity|Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease With Laboratory and Clinical Correlates of Disease Activity|Recruiting||Phase 2|55|Anticipated|National Institutes of Health Clinical Center (CC)||5|||f||||||||||||||2017-02-18 17:48:18.515156|2017-02-18 17:48:18.515156
NCT00092209|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2015-03-17|||April 2002||2002-04-01|March 2015|2015-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)|A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of the Anti-Hypertensive Efficacy and Safety of Losartan Monotherapy as Compared to HCTZ Monotherapy and to the Combination of Losartan and HCTZ in Japanese Patients With Essential Hypertension|Completed||Phase 3|840||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:18.658117|2017-02-18 17:48:18.658117
NCT00092196|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2016-11-20|||December 2002||2002-12-01|November 2016|2016-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)|Open-label Extension to: A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Moderately Emetogenic Chemotherapy|Completed||Phase 3|820|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:18.746523|2017-02-18 17:48:18.746523
NCT00092183|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2016-11-24|||October 2002||2002-10-01|November 2016|2016-11-01|February 2004|Actual|2004-02-01|December 2003|Actual|2003-12-01||Interventional|||An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)|A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Moderately Emetogenic Chemotherapy|Completed||Phase 4|866|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:18.838083|2017-02-18 17:48:18.838083
NCT00092170|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2017-02-16|||March 2002||2002-03-01|February 2017|2017-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)|A Prospective, Multicenter, Randomized, Open-Label, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of Ertapenem Sodium ( MK0826) Versus Ticarcillin/Clavulanate in the Treatment of Hospital-Acquired Pneumonia, Complicated Intra-Abdominal Infections, and Acute Pelvic Infections in Pediatric Patients|Completed||Phase 2|100||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:18.923804|2017-02-18 17:48:18.923804
NCT00092157|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2014-12-22|||May 2002||2002-05-01|December 2014|2014-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)|A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Tolerability and Efficacy of the Co-Administration of Simvastatin 20 mg/Day and Fenofibrate 160 mg/Day Compared to Simvastatin 20 mg/Day Alone for 12 Weeks of Treatment in Patients With Combined Hyperlipidemia-Simvastatin and Fenofibrate Efficacy Trial (SAFARI)|Completed||Phase 3|571|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:19.172732|2017-02-18 17:48:19.172732
NCT00092144|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2015-05-26|||February 2004||2004-02-01|May 2015|2015-05-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)|A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral MK0476 Vs Placebo During the Allergy Season in Patients With Seasonal Aeroallergen Sensitivity and Chronic Asthma Which is Also Active During Allergy Season|Completed||Phase 3|500|Anticipated|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:19.28144|2017-02-18 17:48:19.28144
NCT00092131|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2015-06-22|2009-09-24||June 2003||2003-06-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm|Completed||Phase 3|51|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:48:19.373927|2017-02-18 17:48:19.373927
NCT00092118|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2015-05-25|2009-09-10||October 2003||2003-10-01|May 2015|2015-05-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)|A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis|Completed||Phase 3|1992|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:48:19.840436|2017-02-18 17:48:19.840436
NCT00092105|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2015-09-02|||April 2002||2002-04-01|September 2015|2015-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)|A Multicenter, Double-Blind, Randomized, Crossover Study Investigating the Clinical Effect of Montelukast in Patients With Concomitant Asthma and Allergic Rhinitis Upon Controlled Exposure to Cat Allergen|Completed||Phase 3|58|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:20.415867|2017-02-18 17:48:20.415867
NCT00092092|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2015-06-25|||October 2002||2002-10-01|June 2015|2015-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)|A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, 2-Arm, 2X2 Crossover Study Comparing the Effects of Montelukast, Inhaled Budesonide, and Placebo on Lower Leg Growth in Children (Prepubertal, Tanner Stage I) With Mild Asthma|Completed||Phase 4|71|Actual|Merck Sharp & Dohme Corp.||4|||f||||f||||||||||2017-02-18 17:48:20.515972|2017-02-18 17:48:20.515972
NCT00091260|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2016-03-29|||January 2004||2004-01-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|July 2012|Actual|2012-07-01||Interventional|||CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis|A Phase II Trial of the Immunomodulatory Drug CC-5013 for Patients With AL Amyloidosis|Completed||Phase 2|82|Actual|Boston Medical Center||1|||f||||t||||||||||2017-02-18 17:48:42.282334|2017-02-18 17:48:42.282334
NCT00092079|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2014-11-07|||January 2004||2004-01-01|November 2014|2014-11-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)|A 15-Week, Double-Blind, Randomized, Active-Controlled, Multi-Center Study With 24-Week Extension to Evaluate the Safety, Tolerability, Efficacy of Alendronate 70 mg Plus Vitamin D3 2800 IU Combination Tablet in Men and Postmenopausal Women With Osteoporosis|Completed||Phase 3|652|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:20.62255|2017-02-18 17:48:20.62255
NCT00092066|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2014-11-07|||September 2003||2003-09-01|November 2014|2014-11-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)|A 15-Week, Double-Blind, Randomized, Active-Controlled, Multi-Center Study With 24-Week Extension to Evaluate the Safety, Tolerability, Efficacy of Alendronate 70 mg Plus Vitamin D3 2800 IU Combination Tablet in Men and Postmenopausal Women With Osteoporosis|Completed||Phase 3|717|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:20.719117|2017-02-18 17:48:20.719117
NCT00092053|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2016-01-06|||December 2004||2004-12-01|January 2016|2016-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study of Investigational Drug in Osteoporosis (MK-0217-908)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Persistence of the Effect of Oral Monthly Ibandronate on Bone Reception in Postmenopausal Women in Osteoporosis|Completed||Phase 3|203|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 17:48:20.811429|2017-02-18 17:48:20.811429
NCT00092040|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2015-02-26|||March 2003||2003-03-01|February 2015|2015-02-01|September 2005|Actual|2005-09-01|October 2004|Actual|2004-10-01||Interventional|||A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)|A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Risedronate on Bone Mineral Density in Postmenopausal Women With Osteoporosis; A 12 Month Extension to: A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Risedronate on Bone Mineral Density in Postmenopausal Women With Osteoporosis|Completed||Phase 3|936|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:20.918638|2017-02-18 17:48:20.918638
NCT00092027|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2015-06-09|||March 2003||2003-03-01|June 2015|2015-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)|A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Compare the Safety and Tolerability of an Oral Buffered Solution of Alendronate Sodium 70 mg Once-Weekly Versus Placebo for the Treatment of Osteoporosis in Postmenopausal Women|Completed||Phase 3|454|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:21.009011|2017-02-18 17:48:21.009011
NCT00092014|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2013-12-02|||September 2002||2002-09-01|December 2013|2013-12-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|FACT||A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)|A 12-Month Extension to: A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Once Weekly Alendronate and Risedronate on Bone Mineral Density in Postmenopausal Women With Osteoporosis|Completed||Phase 3|1053|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:48:21.098761|2017-02-18 17:48:21.098761
NCT00092001|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2008-10-15|||January 2005||2005-01-01|October 2008|2008-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer|A Phase 2 Efficacy And Safety Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|111|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:48:21.214903|2017-02-18 17:48:21.214903
NCT00091988|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-21|2010-03-02|||July 2004||2004-07-01|March 2010|2010-03-01|November 2007|Actual|2007-11-01|||||Interventional|||Program to Reduce Incontinence by Diet and Exercise (PRIDE)|Program to Reduce Incontinence by Diet and Exercise|Completed||N/A|330|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 17:48:21.341828|2017-02-18 17:48:21.341828
NCT00091975|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-20|2011-01-17|||August 2004||2004-08-01|July 2006|2006-07-01||||||||Interventional|||Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis|A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Evaluate the Safety and Efficacy of Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis|Completed||Phase 3|78||Abbott|||||||||||||||||||2017-02-18 17:48:21.464374|2017-02-18 17:48:21.464374
NCT00091962|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-20|2016-03-14|2016-01-25||August 2003||2003-08-01|March 2016|2016-03-01|December 2009|Actual|2009-12-01|June 2008|Actual|2008-06-01||Interventional|||Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery|Treatment of Depression Following Bypass Surgery|Completed||N/A|453|Actual|University of Pittsburgh|Selection bias if patients with severe depression were less likely to participate in our screening procedure. Also, the trial recruited just from one U.S. region.|3|||f||||t||||||||||2017-02-18 17:48:21.57876|2017-02-18 17:48:21.57876
NCT00091949|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-20|2016-09-09|2016-07-19||February 2005||2005-02-01|September 2016|2016-09-01|November 2015|Actual|2015-11-01|November 2015|Actual|2015-11-01||Interventional|IRIS||Insulin Resistance Intervention After Stroke Trial|Insulin Resistance Intervention After Stroke (IRIS) Trial|Completed||Phase 3|3876|Actual|Yale University||2|||f||||t||||||||Yes||2017-02-18 17:48:22.456615|2017-02-18 17:48:22.456615
NCT00091936|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-20|2010-03-26|||August 2009||2009-08-01|January 2007|2007-01-01||||||||Interventional|||Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings|Implementing Anti-Retroviral Therapy in Resource-Constrained Settings: A Randomized Controlled Trial to Assess the Effect of Integrated Tuberculosis and HIV Care on the Incidence of AIDS-Defining Conditions or Mortality in Subjects Co-Infected With Tuberculosis and HIV|Completed||N/A|592|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:48:23.416589|2017-02-18 17:48:23.416589
NCT00091923|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-20|2010-03-23|||February 2004||2004-02-01|September 2009|2009-09-01|December 2005|Actual|2005-12-01|||||Interventional|||Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children|A Randomized Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children 3 to <7 Years Old|Completed||Phase 3|268||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:48:23.523701|2017-02-18 17:48:23.523701
NCT00091910|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-19|2011-06-06|||September 2003||2003-09-01|April 2010|2010-04-01|June 2006|Actual|2006-06-01|||||Interventional|||Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)|A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Epoetin Alfa in Critically Ill Subjects|Completed||Phase 3|1460|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:48:23.634263|2017-02-18 17:48:23.634263
NCT00091897|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-18|2011-08-30|||September 2004||2004-09-01|August 2011|2011-08-01|May 2009|Actual|2009-05-01|July 2007|Actual|2007-07-01||Interventional|||Rituximab to Treat Stiff Person Syndrome|Efficacy of Rituximab in Patients With Stiff Person Syndrome With Anti-GAD Antibodies: A Randomized Placebo-Controlled Trial|Completed||Phase 2|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:48:23.732582|2017-02-18 17:48:23.732582
NCT00091884|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-17|2008-03-03|||July 2004||2004-07-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Efficacy of Elevated CD4 Counts on CMV Retinitis|Efficacy of Elevated CD4 Cell Counts on CMV Retinitis|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:48:23.856418|2017-02-18 17:48:23.856418
NCT00091871|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-17|2017-01-24|||September 14, 2004||2004-09-14|November 28, 2016|2016-11-28||||||||Observational|||A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression|A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:48:23.944354|2017-02-18 17:48:23.944354
NCT00091858|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-17|2013-05-06|||April 2004||2004-04-01|May 2013|2013-05-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer|Completed||Phase 3|1000||Amgen||2|||f||||||||||||||2017-02-18 17:48:24.055024|2017-02-18 17:48:24.055024
NCT00091845|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-17|2009-07-06|||November 2004||2004-11-01|July 2009|2009-07-01|November 2004|Actual|2004-11-01|||||Interventional|||An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease|An Exploratory Study of the Safety, Tolerability, Pharmacokinetics and Potential Effectiveness of AVI-4020 Injection in Patients Presenting With Presumptive Acute Neuroinvasive West Nile Virus (WNV) Disease|Terminated||Phase 1|50|Anticipated|Sarepta Therapeutics||||Due to limited pool of eligble WNV patients|||||||||||||||2017-02-18 17:48:24.166054|2017-02-18 17:48:24.166054
NCT00091832|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-17|2013-12-20|2010-12-09||September 2004||2004-09-01|December 2013|2013-12-01|October 2006|Actual|2006-10-01|November 2005|Actual|2005-11-01||Interventional|||Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer|A Randomized Active-controlled Study of AMG 162 in Breast Cancer Subjects With Bone Metastasis Who Have Not Previously Been Treated With Bisphosphonate Therapy.|Completed||Phase 2|255|Actual|Amgen||6|||f||||||||||||||2017-02-18 17:48:24.289548|2017-02-18 17:48:24.289548
NCT00091819|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-17|2010-12-10|2009-11-03||January 2005||2005-01-01|December 2010|2010-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|ATLAS1||Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus|A Phase 3, Randomized, Double Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram Positive Skin and Skin Structure Infections With a Focus on Patients With Infections Due to Methicillin-resistant Staphylococcus Aureus|Completed||Phase 3|862|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-02-18 17:48:29.931068|2017-02-18 17:48:29.931068
NCT00091806|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-17|2009-07-09|||August 2004||2004-08-01|July 2009|2009-07-01|October 2006|Actual|2006-10-01|April 2006|Actual|2006-04-01||Interventional|||Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors|An Open-Label, Clinical Trial Evaluating the Safety and Pharmacokinetics of Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors|Completed||Phase 1|86|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:48:33.693695|2017-02-18 17:48:33.693695
NCT00091793|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-17|2010-12-22|2009-12-22||August 2004||2004-08-01|December 2010|2010-12-01|March 2009|Actual|2009-03-01|February 2009|Actual|2009-02-01||Interventional|||Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis|A Randomized, Double-Blind Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis|Completed||Phase 3|332|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:48:33.802217|2017-02-18 17:48:33.802217
NCT00091780|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-16|2014-02-19|||September 2004||2004-09-01|February 2014|2014-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Epidemiology of Breast Arterial Calcification||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-02-18 17:48:34.650576|2017-02-18 17:48:34.650576
NCT00091767|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-16|2016-07-11|||September 2004||2004-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genetic Studies in Difficult to Treat Asthma: TENOR||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:48:34.720636|2017-02-18 17:48:34.720636
NCT00091754|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-16|2008-07-23|||September 2004||2004-09-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Atherosclerosis, Plaque and CVD in Communities||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:48:34.78997|2017-02-18 17:48:34.78997
NCT00091741|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-16|2009-07-21||||||September 2004|2004-09-01|October 2004|Actual|2004-10-01|||||Interventional|||Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects|A Phase I Pilot Study to Evaluate Safety and Efficacy of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects Who Are in Virologic Failure and Who Have Failed to Respond to Standard Antiretroviral Therapy|Completed||Phase 1|10|Anticipated|Georgetown University|||||||||||||||||||2017-02-18 17:48:34.857326|2017-02-18 17:48:34.857326
NCT00091728|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-16|2005-11-04|||September 1997||1997-09-01|September 2004|2004-09-01|August 2001||2001-08-01|||||Observational|||Hormonal Contraception and Risk of Chlamydia and Gonorrhea|Hormonal Contraception, Cervical Ectopy, and STDs|Terminated||Phase 4|1200||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:48:34.954433|2017-02-18 17:48:34.954433
NCT00091715|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-16|2011-08-26|||April 2004||2004-04-01|August 2011|2011-08-01|February 2011|Actual|2011-02-01|November 2006|Actual|2006-11-01||Interventional|||Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II|A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Mildly Symptomatic Pulmonary Arterial Hypertension (PAH)|Completed||Phase 3|185|Actual|Actelion||2|||f||||||||||||||2017-02-18 17:48:35.039309|2017-02-18 17:48:35.039309
NCT00091702|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-16|2012-05-16||||||May 2012|2012-05-01|January 2006|Actual|2006-01-01|||||Interventional|||Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents|A Phase I/II Randomized Trial of the Safety and Immunogenicity of Cold Adapted Influenza Vaccine (FluMist) in HIV-Infected Children and Adolescents|Completed||Phase 1/Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:48:35.17582|2017-02-18 17:48:35.17582
NCT00091689|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-15|2008-10-24|||September 2004||2004-09-01|October 2008|2008-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions||Completed||Phase 1|||Pfizer|||||||||||||||||||2017-02-18 17:48:35.335092|2017-02-18 17:48:35.335092
NCT00091676|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-15|2012-02-01|||January 2000||2000-01-01|February 2012|2012-02-01|December 2012|Anticipated|2012-12-01|December 2012|Anticipated|2012-12-01||Interventional|BiovaxID||Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma|Randomized Trial of Patient-Specific Vaccination With Conjugated Follicular Lymphoma-Derived Idiotype (FNHLId1) With Local GM-CSF in First Complete Remission|Unknown status|Active, not recruiting|Phase 3|629|Anticipated|Biovest International||2|||f||||t||||||||||2017-02-18 17:48:35.416445|2017-02-18 17:48:35.416445
NCT00091663|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-15|2014-02-28|||August 2004||2004-08-01|February 2014|2014-02-01|August 2005|Actual|2005-08-01|||||Interventional|||A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|A Multicenter, Open-Label, Phase IIIb Trial of Tarceva (Erlotinib Hydrochloride) in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|5000||Genentech, Inc.|||||||||||||||||||2017-02-18 17:48:35.53413|2017-02-18 17:48:35.53413
NCT00091650|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-14|2006-07-21|||March 2004||2004-03-01|July 2006|2006-07-01|November 2005||2005-11-01|||||Interventional|||Olanzapine in Patients With Borderline Personality Disorder|Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Flexible Dose Double-Blind Comparison With Placebo|Completed||Phase 3|300||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:48:35.973585|2017-02-18 17:48:35.973585
NCT00091637|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-14|2011-08-04|||April 2004||2004-04-01|August 2011|2011-08-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)|APEX-AMI - Pexelizumab in Conjunction With Angioplasty|Completed||Phase 3|5745|Actual|Procter and Gamble||2|||f||||t||||||||||2017-02-18 17:48:36.109771|2017-02-18 17:48:36.109771
NCT00091624|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-13|2016-11-30|||March 2003||2003-03-01|November 2016|2016-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)|A Phase I Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)|Completed||Phase 1|77|Actual|Celgene Corporation||1|||f||||f||||||||||2017-02-18 17:48:36.664581|2017-02-18 17:48:36.664581
NCT00091611|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-11|2012-10-25|||September 2004||2004-09-01|October 2012|2012-10-01|March 2008|Actual|2008-03-01|April 2006|Actual|2006-04-01||Interventional|||Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer|Phase II Study in Metastatic Renal Cell Cancer Using Cultured, Tumor-Reactive Lymphocytes and Interleukin-2|Terminated||Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||||This study was terminated due to low accrual.|f||||||||||||||2017-02-18 17:48:36.75926|2017-02-18 17:48:36.75926
NCT00091598|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-10|2010-03-04|||January 2004||2004-01-01|March 2010|2010-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)|ARIES 1 and ARIES 2: Ambrisentan in PAH - A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects With Pulmonary Arterial Hypertension|Completed||Phase 3|372||Gilead Sciences|||||t||||||||||||||2017-02-18 17:48:36.86171|2017-02-18 17:48:36.86171
NCT00091585|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-10|2007-05-09|||June 2004||2004-06-01|May 2007|2007-05-01|November 2006||2006-11-01|||||Interventional|||Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.|Phase I Open-Label, Multicenter, Dose-Escalation Clinical Study of the Initial Safety and Pharmacokinetic Profiles of Intravenous Administration of SNS-595 in Patients With Advanced Malignancies|Completed||Phase 1|||Sunesis Pharmaceuticals|||||||||||||||||||2017-02-18 17:48:37.185634|2017-02-18 17:48:37.185634
NCT00091572|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-10|2015-04-28|2008-12-19||October 2004||2004-10-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)|Extended Schedule, Escalated Dose Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma: A Randomized Phase III Study of the EORTC Melanoma Group|Completed||Phase 3|859|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:48:37.277516|2017-02-18 17:48:37.277516
NCT00091559|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-10|2015-04-09|||February 2005||2005-02-01|April 2015|2015-04-01|March 2006|Actual|2006-03-01|November 2005|Actual|2005-11-01||Interventional|||Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)|Phase IIb Multicenter Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Advanced Cutaneous T-cell Lymphoma|Completed||Phase 2|74|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:48:38.115661|2017-02-18 17:48:38.115661
NCT00091546|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-10|2016-02-01|||August 2003||2003-08-01|February 2016|2016-02-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||Genetic and Environmental Characteristics of Primary Pulmonary Hypertension|Genetic and Environmental Pathogenesis of PPH|Completed||N/A|3000|Actual|Vanderbilt University|||1||f||||f||||||Samples With DNA|"~     Specimens from 100 families affected by PPH~   "|Yes||2017-02-18 17:48:38.205927|2017-02-18 17:48:38.205927
NCT00091533|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-09|2017-01-24|||September 3, 2004||2004-09-03|September 2, 2008|2008-09-02|September 2, 2008||2008-09-02|||||Observational|||Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects|Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:48:38.293754|2017-02-18 17:48:38.293754
NCT00091520|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-09|2011-05-19|||April 2004||2004-04-01|March 2010|2010-03-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure|Follow-up Serial Infusions of Natrecor(Nesiritide) in the Management of Patients With Heart Failure-FUSION II|Completed||Phase 2|920|Actual|Scios, Inc.|||||||||||||||||||2017-02-18 17:48:38.367537|2017-02-18 17:48:38.367537
NCT00091507|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-09|2016-02-03|2012-11-13||November 2006||2006-11-01|February 2016|2016-02-01|August 2012|Actual|2012-08-01|August 2011|Actual|2011-08-01||Interventional|IMMEDIATE||IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.|Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care Trial|Completed||Phase 3|911|Actual|Tufts Medical Center||2|||f||||t||||||||||2017-02-18 17:48:38.465911|2017-02-18 17:48:38.465911
NCT00091481|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-09|2007-09-23|||June 2003||2003-06-01|September 2007|2007-09-01||||||||Interventional|||Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis|A Randomized, Active-Controlled, Double-Blind Multi-Center Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis|Completed||Phase 4|201|Actual|Abbott|||||||||||||||||||2017-02-18 17:48:39.149654|2017-02-18 17:48:39.149654
NCT00091468|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-09|2008-01-07|||September 2003||2003-09-01|January 2008|2008-01-01|July 2008|Anticipated|2008-07-01|July 2008|Anticipated|2008-07-01||Interventional|||Nicotine Treatment of Mild Cognitive Impairment (MCI)|Double-Blind Treatment of Mild Cognitive Impairment (MCI) With Transdermal Nicotine or Transdermal Placebo|Unknown status|Active, not recruiting|Phase 1|75|Anticipated|National Institute on Aging (NIA)||2|||f||||t||||||||||2017-02-18 17:48:39.261089|2017-02-18 17:48:39.261089
NCT00091442|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-08|2014-04-02|2009-12-15||September 2004||2004-09-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer|A Randomized Controlled Study of Docetaxel Monotherapy or Docetaxel and DOXIL for the Treatment of Advanced Breast Cancer|Completed||Phase 3|751|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||t||||||||||2017-02-18 17:48:39.591858|2017-02-18 17:48:39.591858
NCT00091429|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-08|2009-11-24|||August 2004||2004-08-01|November 2009|2009-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine|A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of Ranolazine SR at a Dose of 1000 mg Twice a Day in Patients With Chronic Angina Who Remain Symptomatic Despite Treatment With Amlodipine 10 mg Once a Day|Completed||Phase 3|500||Gilead Sciences|||||f||||||||||||||2017-02-18 17:48:40.433907|2017-02-18 17:48:40.433907
NCT00091416|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-08|2012-05-03||||||May 2012|2012-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052|A Phase I Clinical Trial to Evaluate the Safety of a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Administered to Healthy, HIV-1 Uninfected, Adult Participants Who Received DNA Plasmid Vaccine or Placebo in the HVTN 052 Clinical Trial|Completed||Phase 1|70|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:48:40.516253|2017-02-18 17:48:40.516253
NCT00091390|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2016-12-30|2014-10-31||July 2004||2004-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|January 2008|Actual|2008-01-01||Interventional||All eligible patients.|Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer|Phase II Trial Of Combined High Dose Rate Brachytherapy And External Beam Radiotherapy For Adenocarcinoma Of The Prostate|Completed||Phase 2|129|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 17:48:40.625044|2017-02-18 17:48:40.625044
NCT00091377|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2016-07-13|||August 2004||2004-08-01|July 2016|2016-07-01|March 2008|Actual|2008-03-01|December 2007|Actual|2007-12-01||Interventional|||Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|Multi-Center, Phase Ib/IIa Safety and Preliminary Efficacy Study of Phenoxodiol (Intravenous) as a Chemo-Sensitizing Agent for Cisplatin and Paclitaxel in Epithelial Ovarian Cancer or Primary Peritoneal Cancer, Platinum- and/or Taxane-Refractory or Resistant|Completed||Phase 1/Phase 2|65|Actual|MEI Pharma, Inc.||2|||f||||f||||||||||2017-02-18 17:48:40.938767|2017-02-18 17:48:40.938767
NCT00091351|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2016-07-01|||August 2004||2004-08-01|July 2016|2016-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis|A Phase III Randomized Study of Preoperative Radiation Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcomas (RPS)|Completed||Phase 3|370|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 17:48:41.066728|2017-02-18 17:48:41.066728
NCT00091338|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2015-04-29|||August 2004||2004-08-01|January 2005|2005-01-01||||||||Interventional|||Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma|"A Study of Subcutaneous CYT 99 007 (Interleukin-7) in Conjunction With Peptide Immunization in Patients With Metastatic Melanoma"|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:48:41.220194|2017-02-18 17:48:41.220194
NCT00091325|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2010-01-15|||October 2004||2004-10-01|January 2010|2010-01-01||||March 2005|Actual|2005-03-01||Interventional|||Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants|Phase I Drug Interaction Clinical Study of Polyphenon E|Completed||Phase 1|||University of Arizona|||||f||||||||||||||2017-02-18 17:48:41.411079|2017-02-18 17:48:41.411079
NCT00091312|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2009-02-06|||June 2004||2004-06-01|December 2006|2006-12-01||||||||Interventional|||Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer|Randomized Phase III Intergroup Trial in Resected Stage 2 (Dukes B) Colon Cancer: 6-Month Infusional 5FU-CPT11 (+/- Folinic Acid) Versus Observation - Determination of Biologic Predictive and Response Factors|Unknown status|Active, not recruiting|Phase 3|1976|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:48:41.502622|2017-02-18 17:48:41.502622
NCT00091299|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2015-10-01|||May 2004||2004-05-01|August 2012|2012-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors|An Open Label, Non Randomized , One Sequence, Add-On Study to Investigate the Effects of PTK787/ZK 222584 on the Pharmacokinetics and Pharmacodynamics of Warfarin at Steady-States in Cancer Patients|Completed||Phase 1|24|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:48:41.607588|2017-02-18 17:48:41.607588
NCT00091286|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2010-11-13|||March 2003||2003-03-01|October 2007|2007-10-01||||April 2011|Anticipated|2011-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer|Evaluation of the Immunogenicity of Vaccination With HER-2/Neu and CEA Derived Synthetic Peptides With GM-CSF-in-Adjuvant, in Patients With Stage IIB, III, or IV Colorectal Cancer|Unknown status|Active, not recruiting|N/A|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:48:41.719423|2017-02-18 17:48:41.719423
NCT00091273|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2014-05-19|2014-05-19||June 2004||2004-06-01|May 2014|2014-05-01|June 2007|Actual|2007-06-01|February 2006|Actual|2006-02-01||Interventional|||Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer|Evaluation of Safety and Immunogenicity of a Peptide Vaccine in Patients With Epithelial Ovarian or Primary Peritoneal Cancer|Completed||Phase 1|9|Actual|University of Virginia||1|||f||||t||||||||||2017-02-18 17:48:41.818631|2017-02-18 17:48:41.818631
NCT00091247|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2016-08-12|||December 2004||2004-12-01|August 2016|2016-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer|An Exploratory, Placebo-Controlled Trial of Prophylactic Tetracycline for Gefitinib-or Cetuximab-Induced Skin Rash (or Other Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Skin Rash)|Completed||N/A|130|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 17:48:42.399103|2017-02-18 17:48:42.399103
NCT00091234|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2012-07-23|||June 2004||2004-06-01|July 2012|2012-07-01||||December 2013|Anticipated|2013-12-01||Interventional|AML-19||Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|Gemtuzumab Ozogamicin (GO) Monotherapy Versus Standard Supportive Care for Previously Untreated AML in Elderly Patients Who Are Not Eligible for Intensive Chemotherapy: A Randomized Phase II/III Trial (AML-19) of the EORTC-LG and GIMEMA-ALWP|Unknown status|Recruiting|Phase 2/Phase 3|279|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||t||||||||||2017-02-18 17:48:42.582838|2017-02-18 17:48:42.582838
NCT00091195|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-03-18|||September 2004||2004-09-01|March 2013|2013-03-01||||March 2007|Actual|2007-03-01||Interventional|||Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer|A Phase II Study Of Single Agent Depsipeptide (FK228) In Recurrent, Platinum Sensitive Adeno-Carcinoma Of The Ovary Or Peritoneum|Terminated||Phase 2|51|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:48:42.742665|2017-02-18 17:48:42.742665
NCT00091182|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-06-04|||October 2004||2004-10-01|June 2013|2013-06-01||||February 2006|Actual|2006-02-01||Interventional|||Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment|A Phase II Study of Oxaliplatin in Children With Recurrent Solid Tumors|Completed||Phase 2|180|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:48:42.851338|2017-02-18 17:48:42.851338
NCT00091169|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2016-05-03|2016-02-02||November 2005||2005-11-01|May 2016|2016-05-01|May 2011|Actual|2011-05-01|March 2008|Actual|2008-03-01||Interventional||All randomized patients|Levocarnitine in Treating Fatigue in Cancer Patients|Phase III Randomized Placebo-Controlled Trial to Determine Efficacy of Levocarnitine for Fatigue in Patients With Cancer|Completed||Phase 3|376|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-02-18 17:48:42.974827|2017-02-18 17:48:42.974827
NCT00091156|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2012-07-13|||May 2004||2004-05-01|July 2012|2012-07-01||||July 2008|Actual|2008-07-01||Interventional|||Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Randomized Phase III Study of Follow Up With or Without Adjuvant Gefitinib (Iressa™) Following Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer|Terminated||Phase 3|598|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 17:48:43.547193|2017-02-18 17:48:43.547193
NCT00091143|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-04-02|||July 2004||2004-07-01|August 2009|2009-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma|A Pilot Trial of Therapeutic Vaccination With a Modified gp100 Melanoma Peptide (gp100:209-217(210M)), Montanide ISA 51, and KLH With Reconstitution After Chemotherapy to Induce Lymphopenia in Patients With Metastatic Melanoma|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:48:43.684049|2017-02-18 17:48:43.684049
NCT00091130|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-05-31|||September 2004||2004-09-01|March 2013|2013-03-01||||June 2007|Actual|2007-06-01||Interventional|||SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells|An Exploratory Study to Evaluate the Effect of HPV 16 Vaccine on the Reduction of Viral Load in HPV 16 Positive Women With Persistent Viral Infection, But Low Grade Disease (ASCUS/LSIL)|Completed||Phase 2|139|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:48:43.781053|2017-02-18 17:48:43.781053
NCT00091117|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-12-13|||July 2004||2004-07-01|December 2013|2013-12-01||||March 2013|Actual|2013-03-01||Interventional|||Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction|A Phase I Pharmacokinetic Study of PS-341 in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction for the CTEPSponsored Organ Dysfunction Working Group|Completed||Phase 1|80|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:48:43.894947|2017-02-18 17:48:43.894947
NCT00091104|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2012-03-14|||July 2004||2004-07-01|March 2012|2012-03-01|October 2010|Actual|2010-10-01|August 2010|Actual|2010-08-01||Interventional|||Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma|A Study in Metastatic Melanoma Using a Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 TCR-Gene Engineered Lymphocytes and Subsequent Peptide Immunization|Completed||Phase 1|136|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:48:44.016927|2017-02-18 17:48:44.016927
NCT00091091|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2017-02-13|||December 2004||2004-12-01|February 2017|2017-02-01||||June 27, 2011|Actual|2011-06-27||Observational|||Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma|Health-Related Outcomes For Hodgkin's Disease Survivors|Completed||N/A|530|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-02-18 17:48:44.121302|2017-02-18 17:48:44.121302
NCT00091078|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-06-04|||September 2005||2005-09-01|June 2013|2013-06-01||||July 2006|Actual|2006-07-01||Interventional|||Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery|A Phase IIA Study to Determine the Safety and Efficacy of A NCI-Supplied Agent: G3139 (NSC 683428, IND 58842) and Imatinib Mesylate in Patients With Refractory or Relapsed Gastrointestinal Stromal Tumor|Terminated||Phase 2|96|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:48:44.234468|2017-02-18 17:48:44.234468
NCT00091052|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-03-25|||July 2004||2004-07-01|May 2006|2006-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors|Contrast-Enhanced Radiotherapy With GM-CSF Immune Stimulation - Phase I/II Clinical Center Treatment Trial|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:48:44.344396|2017-02-18 17:48:44.344396
NCT00091039|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-06-18|||August 2004||2004-08-01|December 2005|2005-12-01|February 2006|Actual|2006-02-01|||||Interventional|||Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery|A Pilot Trial of a CEA/TRICOM-Based Vaccine in Combination With Combined Chemotherapy/Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)|Completed||N/A|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:48:44.426444|2017-02-18 17:48:44.426444
NCT00091026|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2014-04-28|2013-08-06||July 2004||2004-07-01|December 2012|2012-12-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||Four patients who never received treatment are excluded.|Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer|A Randomized Phase II Study of Bevacizumab (NSC# 704865) and Gemcitabine in Combination With Either Cetuximab (NSC# 714692) or OSI-774 (NSC# 718781) in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|143|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:48:44.610791|2017-02-18 17:48:44.610791
NCT00090987|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2014-08-27|2011-05-25||June 2005||2005-06-01|August 2014|2014-08-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma|A Phase II Trial Of Imatinib Mesylate (Gleevec) In Patients With HIV Related Kaposi's Sarcoma|Completed||Phase 2|30|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-02-18 17:48:45.359732|2017-02-18 17:48:45.359732
NCT00090974|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2009-08-19|||December 2004||2004-12-01|January 2006|2006-01-01||||||||Observational|||Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer|Quality Of Life Companion Study For JMA27 (NCIC-MA.27): A Randomized Phase III Trial Of Exemestane Versus Anastrozole With Or Without Celecoxib In Postmenopausal Women With Receptor Positive Primary Breast Cancer|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:48:45.694593|2017-02-18 17:48:45.694593
NCT00090961|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2012-10-31|||September 2004||2004-09-01|October 2012|2012-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer|A Randomized Trial Assessing the Effects of Exercise on Patients With Locally Advanced Lung Cancer Undergoing Curative Intent Combined Modality Therapy|Terminated||N/A|2|Actual|Southwest Oncology Group||2||Closed early due to poor accrual.|f||||f||||||||||2017-02-18 17:48:46.060689|2017-02-18 17:48:46.060689
NCT00090909|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-01-07|||June 2003||2003-06-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase II Study Of Gemcitabine, Cisplatin, and Dexamethasone In Patients With Relapsed Or Refractory Hodgkin Lymphoma|Completed||Phase 2|1|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 17:48:46.218004|2017-02-18 17:48:46.218004
NCT00090896|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2015-10-28|||April 2004||2004-04-01|August 2012|2012-08-01|October 2009|Actual|2009-10-01|July 2008|Actual|2008-07-01||Interventional|||CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery|A Phase I, Open Label, Study To Evaluate The Safety And Immune Function Effects Of CP-675,206 In Combination With MART-1 Peptide-Pulsed Dendritic Cells In Patients With Advanced Melanoma|Completed||Phase 1|18|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:48:46.311008|2017-02-18 17:48:46.311008
NCT00090870|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2012-04-26|||April 2002||2002-04-01|April 2012|2012-04-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Of Peg-Intron, GM-CSF And Thalidomide In Metastatic Renal Cell Carcinoma|Completed||Phase 2|25|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-02-18 17:48:46.420418|2017-02-18 17:48:46.420418
NCT00090857|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2009-04-10|||September 2000||2000-09-01|October 2007|2007-10-01||||||||Interventional|||Letrozole in Preventing Breast Cancer in Postmenopausal Women|A Pilot Study of Aromatase Inhibitors for Women at Increased Risk of Breast Cancer Based on Estradiol Levels|Completed||Phase 2|110|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:48:46.509104|2017-02-18 17:48:46.509104
NCT00090844|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-07|2013-01-23|2012-11-30||July 2004||2004-07-01|January 2013|2013-01-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer|Preservation of Ovarian Function in Young Women Treated With (Neo) Adjuvant Chemotherapy for Breast Cancer: A Randomized Trial Using the Gonadotropin-releasing Hormone (GnRH) Agonist (Triptorelin) During Chemotherapy|Terminated||Phase 2|49|Actual|University of South Florida|Study closed to accrual early due to futility|2||Early closure due to low accrual|f||||t||||||||||2017-02-18 17:48:46.606934|2017-02-18 17:48:46.606934
NCT00090831|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-03|2017-01-24|||August 31, 2004||2004-08-31|September 17, 2012|2012-09-17|September 17, 2012||2012-09-17|||||Observational|||Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion|Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion|Completed||N/A|91|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:48:47.313086|2017-02-18 17:48:47.313086
NCT00090818|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-03|2017-01-24|||September 1, 2004||2004-09-01|October 28, 2010|2010-10-28|October 28, 2010||2010-10-28|||||Observational|||Clinical Research Core Dental Screening Protocol|Clinical Research Core Dental Screening Protocol|Completed||N/A|441|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:48:47.396515|2017-02-18 17:48:47.396515
NCT00090779|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-03|2012-11-16|2012-07-02||January 2005||2005-01-01|November 2012|2012-11-01|May 2011|Actual|2011-05-01|July 2009|Actual|2009-07-01||Interventional|||Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV|The SETPOINT Study - A Randomized Study of the Effect of Immediate Treatment With Potent Antiretroviral Therapy Versus Observation With Treatment as Indicated in Newly Infected HIV-1 Infected Subjects: Does Early Therapy After the Virologic Setpoint?|Terminated||Phase 2|130|Actual|AIDS Clinical Trials Group||2||"The DSMB concluded that the findings regarding the primary analysis would persist and that no~   additional study goals would be achieved by continuing the study."|f||||t||||||||||2017-02-18 17:48:47.478467|2017-02-18 17:48:47.478467
NCT00090766|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-03|2016-09-14|2016-06-24||May 2004||2004-05-01|March 2016|2016-03-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional||Safety population included all participants who received at least one dose of valganciclovir|A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients|Safety and Pharmacokinetics of Valganciclovir Syrup Formulation in Pediatric Solid Organ Transplant Recipients|Completed||Phase 2/Phase 3|63|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:48:51.34374|2017-02-18 17:48:51.34374
NCT00088803|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2016-05-17|||August 2004||2004-08-01|May 2016|2016-05-01||||May 2016|Actual|2016-05-01||Observational|||DNA Variations in the Gene in Young Patients With Wilms' Tumor|The Incidence, Inheritance, and Prognostic Significance of Polymorphisms in the RASSF1A Gene in Children With Wilms Tumors|Completed||N/A|471|Anticipated|Children's Oncology Group|||1||f||||f||||||||||2017-02-18 17:49:57.237152|2017-02-18 17:49:57.237152
NCT00090753|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-03|2012-02-10|2011-12-01||October 2004||2004-10-01|February 2012|2012-02-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia|An Open-label, Multi-center Study to Document the Efficacy, Safety, and Tolerability of Long-term Administration of RO0503821 in Patients With Chronic Renal Anemia|Completed||Phase 3|1228|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:48:52.778115|2017-02-18 17:48:52.778115
NCT00090740|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-03|2013-01-23|||September 2004||2004-09-01|January 2013|2013-01-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|||Genetic Risk Factors for Severe Asthma|Genetic Risk Factors for Severe Asthma|Completed||N/A|600|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     40 mL blood~   "|||2017-02-18 17:48:55.475222|2017-02-18 17:48:55.475222
NCT00090727|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-02|2006-10-31|||August 2004||2004-08-01|April 2005|2005-04-01||||||||Interventional|||Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|A Phase 1, Open-Label, Dose-Escalation Study of AQ4N Administered Intravenously in Patients With Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1|45||Novacea|||||||||||||||||||2017-02-18 17:48:55.571591|2017-02-18 17:48:55.571591
NCT00090714|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-02|2006-04-18|||August 2004||2004-08-01|April 2006|2006-04-01||||||||Interventional|||To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter||Unknown status|Active, not recruiting|Phase 2|404||Corautus Genetics|||||||||||||||||||2017-02-18 17:48:55.656436|2017-02-18 17:48:55.656436
NCT00090701|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-02|2012-05-09|||September 2004||2004-09-01|May 2012|2012-05-01||||||||Interventional|||A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer|A Phase 2, Open-Label, Multicenter Study Of The GARFT Inhibitor AG2037 In Patients With MetastatIC Non Small Cell Lung Cancer Who Failed Two Or Three Prior Treatments|Withdrawn||Phase 2|0|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:48:55.766609|2017-02-18 17:48:55.766609
NCT00090688|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-02|2016-12-27|||August 2004||2004-08-01|January 2006|2006-01-01||||||||Interventional|||Phase 1 meCS6 + LT(R192G) Vaccine Study|Safety and Immunogenicity of Oral Microencapsulated CS6 Vaccine and LT(R192G) Adjuvant in Volunteers|Withdrawn||Phase 1|0|Actual|U.S. Army Medical Research and Materiel Command||||IND was terminated for being inactive for more than five years|||||||||||||||2017-02-18 17:48:55.848545|2017-02-18 17:48:55.848545
NCT00090675|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-02|2013-01-28|||January 2006||2006-01-01|January 2013|2013-01-01|November 2007|Anticipated|2007-11-01|November 2007|Anticipated|2007-11-01||Interventional|IMAC/Herbst||Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase IIIb Randomized, Double-Blind Study Comparing Maintenance ZD1839 (IRESSA®) or Placebo Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer|Withdrawn||Phase 3|0|Actual|AstraZeneca||||No patients randomised|||||||||||||||2017-02-18 17:48:55.932518|2017-02-18 17:48:55.932518
NCT00090662|ClinicalTrials.gov processed this data on February 17, 2017|2004-09-01|2017-01-24|||August 27, 2004||2004-08-27|December 1, 2016|2016-12-01||||||||Observational|||Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research|Collection of Peripheral Blood, Urine, Sputum, and Bone Marrow From Healthy Donors for Use in In Vitro Research|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:48:56.009152|2017-02-18 17:48:56.009152
NCT00090649|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-31|2009-08-18||||||August 2009|2009-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study Of DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|369|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:48:56.119711|2017-02-18 17:48:56.119711
NCT00090623|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-30|2013-06-19|||August 2004||2004-08-01|June 2013|2013-06-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)|A Phase IIIb, Multicenter, Randomized, Double Masked, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab in Subjects With Subfoveal Choroidal Neovascularization (CNV) With or Without Classic CNV Secondary to Age Related Macular Degeneration|Completed||Phase 3|180||Genentech, Inc.|||||||||||||||||||2017-02-18 17:48:56.198108|2017-02-18 17:48:56.198108
NCT00090610|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-27|2015-02-05|2012-11-21||October 2003||2003-10-01|December 2012|2012-12-01|October 2009|Actual|2009-10-01|March 2009|Actual|2009-03-01||Interventional|||Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer|Multicenter, Randomized, Phase II Comparative Study to Compare Efficacy & Safety of Taxotere®/Carboplatin Combination Therapy vs Sequential Therapy w/ Taxotere® Then Carboplatin as Second-line Treatment of Patients w/ Relapsed, Platinum-sensitive Ovarian Cancer|Completed||Phase 2|150|Actual|Duke University||2|||f||||t||||||||||2017-02-18 17:48:56.2967|2017-02-18 17:48:56.2967
NCT00090584|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-27|2013-05-08|2012-08-27||August 2004||2004-08-01|May 2013|2013-05-01|August 2006|Actual|2006-08-01|December 2005|Actual|2005-12-01||Interventional|BE-DRI||Behavior Enhances Drug Reduction of Incontinence (BE-DRI)|Behavior Enhances Drug Reduction of Incontinence|Completed||N/A|307|Actual|New England Research Institutes|Ony 68% of participants completed assigned treatment.|2|||f||||t||||||||||2017-02-18 17:48:57.047301|2017-02-18 17:48:57.047301
NCT00090571|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-27|2009-06-05|||October 1994||1994-10-01|June 2009|2009-06-01||||September 2009|Anticipated|2009-09-01||Observational|||Juvenile Rheumatoid Arthritis Research Registry|Research Registry for Juvenile Arthritis|Unknown status|Recruiting|N/A|200|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||f||||||Samples With DNA|"~     whole blood, serum, Pax gene~   "|||2017-02-18 17:48:57.708695|2017-02-18 17:48:57.708695
NCT00090558|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-27|2008-03-03|||August 2004||2004-08-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease|Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:48:57.804924|2017-02-18 17:48:57.804924
NCT00090545|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-27|2012-08-28|2012-07-23||August 2004||2004-08-01|August 2012|2012-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer|A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer|Completed||Phase 2|46|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 17:48:57.917499|2017-02-18 17:48:57.917499
NCT00090532|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2011-05-26|||January 2004||2004-01-01|May 2011|2011-05-01|August 2006|Actual|2006-08-01|||||Interventional|||A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration|A Phase 1/2, Randomized, Masked, Single and Multiple-Dose, Sequential Dose-Escalation Study of the Safety an Efficacy of AG-013958 in Subjects With Subfoveal Choroidal Neovascularization Associated With Age-related Macular Degeneration|Terminated||Phase 1/Phase 2|155||Pfizer||||This study was terminated due to a lack of efficacy.|||||||||||||||2017-02-18 17:48:58.712874|2017-02-18 17:48:58.712874
NCT00090519|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2016-08-25|2015-12-22||February 2004||2004-02-01|August 2016|2016-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Reduction in the Occurrence of Center-Involved Diabetic Macular Edema|Reduction in the Occurrence of Center-Involved Diabetic Macular Edema|Completed||Phase 3|731|Actual|Chromaderm, Inc.||2|||f||||f||||||||||2017-02-18 17:48:58.991281|2017-02-18 17:48:58.991281
NCT00090506|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2008-01-23|||July 2004||2004-07-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression|Yoga, Health, and Meditation|Completed||Phase 1|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:49:00.947151|2017-02-18 17:49:00.947151
NCT00090493|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2013-05-16|2013-01-25||June 2004||2004-06-01|May 2013|2013-05-01|May 2012|Actual|2012-05-01|July 2007|Actual|2007-07-01||Interventional|||Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma|UARK 2003-26, A Pilot Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combination With DTPACE Chemotherapy and Autologous Transplantation in Multiple Myeloma|Completed||Phase 2/Phase 3|4|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 17:49:01.03423|2017-02-18 17:49:01.03423
NCT00090480|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2009-06-30|||August 2004||2004-08-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Vaccine Treatment for Advanced Breast Cancer|A Phase I/II Study of an Antitumor Vaccination Using Alpha(1,3)Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Relapsed or Refractory Breast Cancer|Terminated||Phase 1/Phase 2|3|Actual|NewLink Genetics Corporation||1||Enrollment goals unable to be reached.|f||||f||||||||||2017-02-18 17:49:01.27984|2017-02-18 17:49:01.27984
NCT00090467|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2013-07-26|||August 2004||2004-08-01|July 2013|2013-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Biochemical and Genetic Markers of Hypertension in Women||Completed||N/A|1600|Actual|Brigham and Women's Hospital|||1||f||||||||||||||2017-02-18 17:49:01.393573|2017-02-18 17:49:01.393573
NCT00090454|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2008-07-23|||August 2004||2004-08-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Genetic Markers of CHD Risk in Men and Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:49:01.467021|2017-02-18 17:49:01.467021
NCT00090441|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2013-01-03|||August 2004||2004-08-01|December 2012|2012-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Risk Burden of Lipoprotein Metabolic Gene Haplotypes||Completed||N/A|4303|Actual|Intermountain Health Care, Inc.|||1||f||||f||||||||||2017-02-18 17:49:01.540154|2017-02-18 17:49:01.540154
NCT00090428|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2013-01-31|||January 2004||2004-01-01|January 2013|2013-01-01|February 2009|Actual|2009-02-01|October 2008|Actual|2008-10-01||Interventional|||Diet and Behavior in Young Children With Autism|Diet and Behavior in Young Children With Autism|Completed||Phase 1|21|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 17:49:01.616784|2017-02-18 17:49:01.616784
NCT00090415|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-26|2012-06-15|||April 2003||2003-04-01|June 2012|2012-06-01||||April 2008|Actual|2008-04-01||Interventional|||Early Characteristics of Autism|UW STAART Center of Excellence|Completed||Phase 1|48|Actual|University of Washington||2|||f||||f||||||||||2017-02-18 17:49:01.738497|2017-02-18 17:49:01.738497
NCT00090402|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2010-02-03|2009-12-02||April 2004||2004-04-01|January 2010|2010-01-01|February 2007||2007-02-01|||||Interventional|||Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease|Fish Oil and Alpha Lipoic Acid in Mild Alzheimer's Disease|Completed||Phase 1/Phase 2|39|Actual|Oregon Health and Science University||3|||f||||t||||||||||2017-02-18 17:49:01.858037|2017-02-18 17:49:01.858037
NCT00090389|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2008-01-23|||January 2005||2005-01-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Acupuncture for Women's Health Conditions|New England School of Acupuncture (NESA) Acupuncture Research Collaborative|Completed||Phase 1|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:49:02.396018|2017-02-18 17:49:02.396018
NCT00090376|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2008-11-06|||December 2003||2003-12-01|November 2008|2008-11-01||||||||Interventional|||Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy|Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 3 Arm, 12-Month Study to Evaluate the Effects of GPI 1485 on Erectile Function in Patients Undergoing Bilateral Nerve-Sparing Radical Retropubic Prostatectomy for Prostatic Carcinoma|Completed||Phase 2|240||Eisai Inc.|||||f||||||||||||||2017-02-18 17:49:02.484407|2017-02-18 17:49:02.484407
NCT00090363|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2013-01-03|2012-04-26||July 2004||2004-07-01|January 2013|2013-01-01|August 2011|Actual|2011-08-01|December 2008|Actual|2008-12-01||Interventional|||ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)|Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-centre Study to Assess ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)|Completed||Phase 2|447|Actual|AstraZeneca|‘Final analysis’ results (data cut-off 18th December 2008) should be considered in context with the longevity of the follow-up (median duration approximately 22 months) relative to only approximately 4 months median duration of study treatment.|3|||f||||||||||||||2017-02-18 17:49:02.613402|2017-02-18 17:49:02.613402
NCT00090337|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2013-03-06|||November 2003||2003-11-01|March 2013|2013-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer|Acupuncture for Pain and Dysfunction Following Neck Dissection: A Randomized, Controlled, Phase III Trial|Completed||Phase 3|73|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:49:04.153858|2017-02-18 17:49:04.153858
NCT00090324|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2013-01-03|||September 2004||2004-09-01|January 2013|2013-01-01|June 2007|Actual|2007-06-01|||||Interventional|ANCHOR 112||Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia|A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 3b Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets Compared With Placebo in Adolescents With Schizophrenia (Abbreviated)|Completed||Phase 3|249|Anticipated|AstraZeneca|||||f||||||||||||||2017-02-18 17:49:04.279863|2017-02-18 17:49:04.279863
NCT00090311|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2013-01-03|||July 2004||2004-07-01|January 2013|2013-01-01|July 2006|Actual|2006-07-01|||||Interventional|ANCHOR 149||Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania|A 3-wk, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase 3b Study of the Efficacy & Safety of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in the Treatment of Children & Adolescents With Bipolar I Mania (Abbreviated)|Completed||Phase 3|220|Actual|AstraZeneca|||||||||||||||||||2017-02-18 17:49:04.416056|2017-02-18 17:49:04.416056
NCT00090298|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2015-10-30|||April 2004||2004-04-01|October 2015|2015-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Lipid-Altering Efficacy and Safety of the Ezetimibe/Simvastatin Combination Tablet Versus Rosuvastatin in Patients With Primary Hypercholesterolemia|Completed||Phase 3|2815|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:49:04.541384|2017-02-18 17:49:04.541384
NCT00090285|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2017-02-07|2009-10-14||September 2004||2004-09-01|February 2017|2017-02-01|March 2017|Anticipated|2017-03-01|July 2009|Actual|2009-07-01||Interventional|||An Investigational Study of Gardasil™ (qHPV, V501) Vaccine in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)|An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men|Active, not recruiting||Phase 3|4065|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:49:04.646001|2017-02-18 17:49:04.646001
NCT00090272|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2017-02-16|||April 2002||2002-04-01|February 2017|2017-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)|A Prospective, Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Dose of Ertapenem Sodium (MK0826) Versus Cefotetan for the Prophylaxis of Surgical Site Infection Following Elective Colorectal Surgery|Completed||Phase 3|952|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:49:05.424933|2017-02-18 17:49:05.424933
NCT00090259|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2015-02-06|2010-06-30||December 2001||2001-12-01|February 2015|2015-02-01|May 2009|Actual|2009-05-01|March 2009|Actual|2009-03-01||Interventional|||Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)|A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment|Completed||Phase 3|3834|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:49:05.549389|2017-02-18 17:49:05.549389
NCT00090246|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2015-05-06|||May 2004||2004-05-01|May 2015|2015-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)|A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting|Completed||Phase 3|922|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:49:08.438073|2017-02-18 17:49:08.438073
NCT00090233|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2015-09-18|2009-06-29||January 2001||2001-01-01|September 2015|2015-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Rotavirus Efficacy and Safety Trial (REST)(V260-006)|Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants|Completed||Phase 3|69274|Actual|Merck Sharp & Dohme Corp.|70,301 participants randomized, 69,274 evaluated, when DSMB first recommended ending enrollment.|2|||f||||||||||||||2017-02-18 17:49:08.547556|2017-02-18 17:49:08.547556
NCT00090220|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2016-11-07|2009-10-30||June 2004||2004-06-01|November 2016|2016-11-01|November 2015|Actual|2015-11-01|May 2009|Actual|2009-05-01||Interventional||All randomized participants|A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)|Safety, Immunogenicity, and Efficacy of Gardasil (V501 (Human Papilloma Virus [Types 6, 11, 16, 18] Recombinant Vaccine) in Mid-Adult Women - The FUTURE III (Females United to Unilaterally Reduce Endo/Ectocervical Cancer) Study|Completed||Phase 3|3819|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:49:10.236913|2017-02-18 17:49:10.236913
NCT00090207|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2015-03-10|||January 2004||2004-01-01|March 2015|2015-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)|A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Safety, Tolerability and Efficacy of Aprepitant Regimen Compared to Ondansetron Regimen for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With High Dose Cisplatin in Cycle 1|Completed||Phase 4|477|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:49:15.226472|2017-02-18 17:49:15.226472
NCT00090194|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2017-01-10|||June 2003||2003-06-01|January 2017|2017-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%|Evaluation of Immune Globulin Intravenous (Human), 10%, Manufactured by Chromatography Process (IGIV-C, 10%), as an Agent to Reduce Anti-HLA Antibodies and Improve Transplantation Results in Cross Match Positive Living Donor Kidney Allograft Recipients|Terminated||Phase 2|56|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 17:49:15.314827|2017-02-18 17:49:15.314827
NCT00090181|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2015-11-27|||June 2004||2004-06-01|November 2015|2015-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)|A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain|Completed||Phase 4|401|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:49:15.453732|2017-02-18 17:49:15.453732
NCT00089999|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-18|2016-07-14|2014-08-18||June 2004||2004-06-01|July 2016|2016-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer|A Phase II, Open-Label, Randomized, Parallel-Group Multicenter Trial Comparing Two Schedules of GW572016 as First-Line Monotherapy in Patients With Advanced or Metastatic Breast Cancer|Completed||Phase 2|138|Actual|GlaxoSmithKline|||||f||||f||||||||||2017-02-18 17:49:24.243503|2017-02-18 17:49:24.243503
NCT00090168|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-25|2015-10-20|||January 2004||2004-01-01|October 2015|2015-10-01|November 2004|Actual|2004-11-01|October 2004|Actual|2004-10-01||Interventional|||Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)|A Multicenter Study to Assess the Cholesterol Lowering Level of Switching to an Investigational Drug Compared to Doubling the Dose of an Investigational Drug in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease|Completed||Phase 3|435|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:49:15.543409|2017-02-18 17:49:15.543409
NCT00090155|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-24|2015-07-09|||September 2003||2003-09-01|July 2015|2015-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)|A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting|Completed||Phase 3|805|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:49:15.63228|2017-02-18 17:49:15.63228
NCT00090142|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-24|2015-07-29|2009-09-22||May 2004||2004-05-01|July 2015|2015-07-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm|Completed||Phase 3|62|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:49:15.725979|2017-02-18 17:49:15.725979
NCT00090129|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-24|2013-10-21|||September 2004||2004-09-01|October 2013|2013-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis|A Multicentre, Randomised, Double-blind, Placebo Controlled Phase III Study of Subcutaneously Administered Onercept in the Treatment and Re-treatment of Subjects With Moderate to Severe Plaque Psoriasis|Terminated||Phase 3|854|Actual|EMD Serono||2||"The risk-benefit ratio for the use of onercept in this condition was not sufficiently~   favorable to justify continued development"|||||||||||||||2017-02-18 17:49:16.201824|2017-02-18 17:49:16.201824
NCT00090116|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-24|2012-03-01|||March 2003||2003-03-01|March 2012|2012-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease|A Randomized, Double-Blind,Placebo-Controlled Evaluation of the Safety and Efficacy of Neramexane Monotherapy in Patients With Moderate to Severe Dementia of the Alzheimer's Type|Completed||Phase 3|400||Forest Laboratories|||||||||||||||||||2017-02-18 17:49:16.623958|2017-02-18 17:49:16.623958
NCT00090103|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-24|2016-08-25|2010-02-26||November 2003||2003-11-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment|A Randomized, Double-blind, Parallel Group Study to Investigate the Efficacy and Safety of Treatment With Dutasteride (0.5mg) and Tamsulosin (0.4mg), Administered Once Daily for 4 Years, Alone and Combination, on the Improvement of Symptoms and Clinical Outcome in Men With Moderate to Severe Symptomatic Benign Prostatic Hyperplasia|Completed||Phase 3|4844|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 17:49:16.793111|2017-02-18 17:49:16.793111
NCT00090090|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-24|2008-01-08|||April 2004||2004-04-01|January 2008|2008-01-01|October 2006|Actual|2006-10-01|||||Interventional|||Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma|A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI 28090) In Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|114||Spectrum Pharmaceuticals, Inc|||||f||||f||||||||||2017-02-18 17:49:22.016562|2017-02-18 17:49:22.016562
NCT00090077|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-24|2006-02-24|||April 2004||2004-04-01|February 2006|2006-02-01||||||||Interventional|||Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults|A Phase I, Multicenter, Randomized, Parallel, Double-Blinded Dose Ranging, Placebo-Controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Four Oral Dosage Regimens of GW695634G Monotherapy Versus Placebo Over 10 Days in ART-Naive HIV-1 Infected Adults.|Completed||Phase 1|50||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:49:22.107774|2017-02-18 17:49:22.107774
NCT00090064|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-24|2015-11-12||2011-07-31|March 2004||2004-03-01|February 2014|2014-02-01|September 2010|Actual|2010-09-01|July 2010|Actual|2010-07-01||Interventional|||A Test of MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder|Phase II Clinical Trial Testing the Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Chronic Posttraumatic Stress Disorder|Completed||Phase 2|23|Actual|Multidisciplinary Association for Psychedelic Studies||2|||f||||t||||||||||2017-02-18 17:49:22.211311|2017-02-18 17:49:22.211311
NCT00090051|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-23|2013-05-29|2009-12-22||July 2003||2003-07-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|July 2008|Actual|2008-07-01||Interventional|||FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients|Open-label, Multicenter, Randomized, Comparative, Phase III Study to Evaluate the Efficacy and Safety of FCR vs. FC Alone in Previously Treated Patients With CD20 Positive B-cell CLL|Completed||Phase 3|552|Actual|Hoffmann-La Roche||2|||f||||t||||||||||2017-02-18 17:49:22.342586|2017-02-18 17:49:22.342586
NCT00090038|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-23|2009-10-16|||October 2003||2003-10-01|October 2009|2009-10-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma|A Multicenter Study to Evaluate the Effect of Rituximab (IDEC-102) on Primary Humoral Response, Recall Response, and Maintenance of Acquired Immunity to Specific Antigens|Completed||Phase 4|168|Actual|Biogen||2|||f||||f||||||||||2017-02-18 17:49:23.617656|2017-02-18 17:49:23.617656
NCT00090025|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-19|2009-01-13|||September 2004||2004-09-01|January 2009|2009-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors|A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery|Terminated||Phase 3|248|Actual|Helsinn Healthcare SA||2||Futility reasons after Independent Data Monitoring Committee interim analysis|f||||t||||||||||2017-02-18 17:49:23.94897|2017-02-18 17:49:23.94897
NCT00090012|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-18|2007-11-05|||July 2004||2004-07-01|November 2007|2007-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder|The Comparison of Efficacy and Safety of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder|Completed||Phase 4|340||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:49:24.113564|2017-02-18 17:49:24.113564
NCT00089986|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-18|2015-04-14|||September 2004||2004-09-01|April 2015|2015-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults|A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults|Completed||Phase 2|1415|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:49:25.239345|2017-02-18 17:49:25.239345
NCT00089973|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-18|2010-10-01|||June 2004||2004-06-01|October 2010|2010-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Study Of Ispinesib In Subjects With Breast Cancer|Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer|Completed||Phase 2|55|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:49:26.056359|2017-02-18 17:49:26.056359
NCT00089960|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-18|2013-04-25|||October 2004||2004-10-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2006|Actual|2006-06-01||Interventional|||Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)|An Open Label Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) Who Developed Progressive Disease or Relapsed While on Imatinib Mesylate|Completed||Phase 2|138|Actual|Amgen||1|||t||||||||||||||2017-02-18 17:49:26.155609|2017-02-18 17:49:26.155609
NCT00089947|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-18|2015-03-16|||June 2003||2003-06-01|March 2015|2015-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection|Randomized, Prospective, Phase 2 Study Comparing Thymoglobulin in a Rapid Discontinuation of Corticosteroids Protocol With Standard Corticosteroid Therapy in Living Donor Renal Transplantation Using Mycophenolate Mofetil and Tacrolimus Maintenance Therapy|Completed||Phase 2|150||Sanofi|||||||||||||||||||2017-02-18 17:49:26.270802|2017-02-18 17:49:26.270802
NCT00089921|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-17|2010-10-15|||July 2004||2004-07-01|October 2010|2010-10-01|October 2005|Actual|2005-10-01|||||Interventional|||SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate|A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469 in Subjects With Active Rheumatoid Arthritis Who Are Not Receiving DMARDs Other Than Hydroxychloroquine|Completed||Phase 2|302|Actual|Scios, Inc.||4|||f||||||||||||||2017-02-18 17:49:26.373055|2017-02-18 17:49:26.373055
NCT00089908|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-17|2008-01-17|||September 2004||2004-09-01|January 2008|2008-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults|Phase I Study of the Safety and Immunogenicity of rDEN1delta30, a Live Attenuated Virus Vaccine Candidate for the Prevention of Dengue Serotype 1|Completed||Phase 1|28|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||||2017-02-18 17:49:26.485655|2017-02-18 17:49:26.485655
NCT00089895|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-17|2015-09-01|2009-11-13||November 2004||2004-11-01|September 2015|2015-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)|Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients With Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS)|Completed||Phase 3|9406|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 17:49:26.797011|2017-02-18 17:49:26.797011
NCT00089882|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-17|2009-07-22|||May 2003||2003-05-01|July 2009|2009-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II|Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II|Completed||N/A|360||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:49:27.360028|2017-02-18 17:49:27.360028
NCT00089869|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-16|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia||Completed||Phase 1/Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:49:27.483254|2017-02-18 17:49:27.483254
NCT00089856|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-16|2008-11-03|||July 2004||2004-07-01|November 2008|2008-11-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer|A Phase III Randomized, Open-Label Study of CG1940 and CG8711 Versus Docetaxel and Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer Who Are Chemotherapy-Naïve|Terminated||Phase 3|626|Actual|Cell Genesys||2||Based on futility analysis showing <30% chance of meeting primary endpoint.|f||||||||||||||2017-02-18 17:49:27.57181|2017-02-18 17:49:27.57181
NCT00089843|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-16|2012-05-01|2011-11-09||June 2003||2003-06-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Bone Loss in Women With Anorexia Nervosa|IGF-1 and Bone Loss in Women Anorexia Nervosa|Completed||Phase 2/Phase 3|77|Actual|Massachusetts General Hospital||4|||f||||t||||||||||2017-02-18 17:49:27.922112|2017-02-18 17:49:27.922112
NCT00089830|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-16|2007-11-27|||August 2004||2004-08-01|November 2007|2007-11-01|May 2007|Actual|2007-05-01|||||Interventional|||"A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat Wet Age-Related Macular Degeneration"||Terminated||Phase 2|120||Genaera Corporation|||||||||||||||||||2017-02-18 17:49:28.499511|2017-02-18 17:49:28.499511
NCT00089804|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-13|2009-03-30|||October 2004||2004-10-01|March 2009|2009-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|ASPEN||Study of LJP 394 in Lupus Patients With History of Renal Disease|A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease|Terminated||Phase 3|943|Actual|La Jolla Pharmaceutical Company||3||Interim efficacy analysis indicated it would be futile to continue study.|f||||t||||||||||2017-02-18 17:49:28.590131|2017-02-18 17:49:28.590131
NCT00089791|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-13|2016-02-04|2010-07-02||August 2004||2004-08-01|February 2016|2016-02-01|July 2008|Actual|2008-07-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis|A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis Every 6 Months)|Completed||Phase 3|7808|Actual|Amgen||2|||f||||t||||||||||2017-02-18 17:49:29.114089|2017-02-18 17:49:29.114089
NCT00089583|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-06|2014-04-10|2012-02-24||July 2004||2004-07-01|April 2014|2014-04-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection|See Detailed Description|Completed||Phase 2|110|Actual|ViiV Healthcare||2|||t||||t||||||||||2017-02-18 17:49:38.68408|2017-02-18 17:49:38.68408
NCT00089778|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-12|2012-09-11|2012-06-25||August 2004||2004-08-01|September 2012|2012-09-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Vaccine Treatment of Kidney Cancer|Immunization of Patients With Renal Cancer Using HLA-A2 and HLA-A3-Binding Peptides From Fibroblast Growth Factors 5 (FGF-5)|Terminated||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||3||"Finding that fewer tumors than anticipated expressed FGF-5 led to the termination of accrual~   to cohorts A and B."|f||||f||||||||||2017-02-18 17:49:31.968249|2017-02-18 17:49:31.968249
NCT00089765|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-12|2017-01-24|||August 10, 2004||2004-08-10|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome|Pilot Study of Intravitreal Injection of Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:49:32.879959|2017-02-18 17:49:32.879959
NCT00089752|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-12|2009-05-22|||September 2003||2003-09-01|May 2009|2009-05-01|November 2008|Actual|2008-11-01|August 2008|Actual|2008-08-01||Interventional|||Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea|Impact of CPAP on Functional Outcomes in Milder Obstructive Sleep Apnea (CATNAP)|Completed||N/A|272|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 17:49:32.971654|2017-02-18 17:49:32.971654
NCT00089739|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-11|2017-01-24|||August 9, 2004||2004-08-09|October 28, 2008|2008-10-28|October 28, 2008||2008-10-28|||||Observational|||Immune Indicators of Uveitis|Use of Immune Cell Markers, Cytokines, Transcription Factors and Surface CD Markers as Markers of Ocular Inflammatory Activity|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:49:33.077663|2017-02-18 17:49:33.077663
NCT00089726|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-11|2007-12-18|||March 2003||2003-03-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)|A Phase II Randomized Study of GM-CSF Gene-Modified Autologous Tumor Vaccine (CG8123) With and Without Low-Dose Cyclophosphamide in Advanced Stage Non-Small Cell Lung Cancer|Completed||Phase 2|100||Cell Genesys|||||||||||||||||||2017-02-18 17:49:33.15866|2017-02-18 17:49:33.15866
NCT00089713|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-10|2010-02-05|||March 2004||2004-03-01|June 2005|2005-06-01||||||||Interventional|||Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)|Effect of ALT-711 in Combination With Fixed-Dose Hydrochlorothiazide Therapy on Systolic Blood Pressure in Hypertensive Patients|Terminated||Phase 2|392||Synvista Therapeutics, Inc|||||||||||||||||||2017-02-18 17:49:33.372027|2017-02-18 17:49:33.372027
NCT00089700|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-10|2005-06-23|||March 2004||2004-03-01|February 2005|2005-02-01||||||||Interventional|||TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1|A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Three-Arm Study of the Anti-CD4 Monoclonal Antibody TNX-355 With Optimized Background Therapy in Treatment-Experienced Subjects Infected With HIV-1|Unknown status|Active, not recruiting|Phase 2|80||Tanox|||||||||||||||||||2017-02-18 17:49:33.468239|2017-02-18 17:49:33.468239
NCT00089687|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-10|2017-01-10|||April 2004||2004-04-01|January 2005|2005-01-01|May 2005||2005-05-01|||||Interventional|||GBR 12909 Study in Cocaine Experienced African American Volunteers - 1|GBR 12909 Study in Cocaine Experienced African American Volunteers|Unknown status|Active, not recruiting|Phase 1|10||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:49:33.578289|2017-02-18 17:49:33.578289
NCT00089674|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-09|2016-02-22|2010-07-02||August 2004||2004-08-01|February 2016|2016-02-01|July 2010|Actual|2010-07-01|June 2008|Actual|2008-06-01||Interventional|||AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer|Completed||Phase 3|1468|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:49:33.684375|2017-02-18 17:49:33.684375
NCT00089661|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-09|2013-07-23|2009-12-22||October 2004||2004-10-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|June 2006|Actual|2006-06-01||Interventional|||AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer|Completed||Phase 3|252|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:49:35.412117|2017-02-18 17:49:35.412117
NCT00089648|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-09|2010-01-06|2009-11-16||December 2004||2004-12-01|January 2010|2010-01-01|March 2008|Actual|2008-03-01|January 2007|Actual|2007-01-01||Interventional|||SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma|A Phase 2 Study Of SU011248 In The Treatment Of Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma|Completed||Phase 2|61|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:49:35.975359|2017-02-18 17:49:35.975359
NCT00089635|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-09|2013-10-07|2010-08-06||August 2004||2004-08-01|October 2013|2013-10-01|December 2008|Actual|2008-12-01|May 2007|Actual|2007-05-01||Interventional|||ABX-EGF (Panitumumab) Monotherapy in Subjects With Metastatic Colorectal Cancer|A Phase 2 Multicenter Single Arm Clinical Trial of ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer Whose Tumors Express Low or Negative EGFr Levels of Immunohistochemistry Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy|Completed||Phase 2|203|Actual|Amgen||1|||f||||||||||||||2017-02-18 17:49:36.485771|2017-02-18 17:49:36.485771
NCT00089622|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-06|2017-01-24|||August 4, 2004||2004-08-04|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Interventional|||Lisuride Patch to Treat Parkinson's Disease|Transcutaneous Lisuride Therapy of Parkinson's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:49:37.040003|2017-02-18 17:49:37.040003
NCT00089609|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-06|2016-09-16|2012-10-12||August 2004||2004-08-01|September 2016|2016-09-01|January 2018|Anticipated|2018-01-01|December 2011|Actual|2011-12-01||Interventional|||Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer|A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients With Androgen-Independent Prostate Cancer|Active, not recruiting||Phase 2|73|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||No||2017-02-18 17:49:37.144984|2017-02-18 17:49:37.144984
NCT00089596|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-06|2007-04-11|||March 2004||2004-03-01|April 2007|2007-04-01|October 2006||2006-10-01|||||Interventional|||Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers|A Safety Study of Infusion of Ex Vivo Selectively Amplified Unrelated Cord Blood Stem Cells in Subjects With Hematological Malignancies Receiving Unrelated Cord Blood Transplantation|Completed||Phase 1/Phase 2|10||ViaCell|||||f||||||||||||||2017-02-18 17:49:38.562478|2017-02-18 17:49:38.562478
NCT00089570|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-06|2013-02-18|||June 2004||2004-06-01|February 2013|2013-02-01|September 2006|Actual|2006-09-01|March 2006|Actual|2006-03-01||Interventional|||Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III Study of Intravenous Terlipressin in Patients With Hepatorenal Syndrome Type 1|Completed||Phase 3|112|Actual|Orphan Therapeutics||2|||f||||t||||||||||2017-02-18 17:49:40.781766|2017-02-18 17:49:40.781766
NCT00089557|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-06|2005-06-23||||||September 2004|2004-09-01||||||||Interventional|||An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain|An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain|Terminated||Phase 2|||NeurogesX|||||||||||||||||||2017-02-18 17:49:40.92215|2017-02-18 17:49:40.92215
NCT00089544|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-06|2014-05-29|2013-03-13||June 2004||2004-06-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|March 2009|Actual|2009-03-01||Interventional||All eligible patients who started treatment.|Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall|A Pilot Phase II Study of Pre-Operative Radiation Therapy and Thalidomide (IND 48832; NSC 66847) for Low Grade Primary Soft Tissue Sarcoma or Pre-Operative MAID/Thalidomide/Radiation Therapy for High/Intermediate Grade Primary Soft Tissue Sarcoma of the Extremity or Body Wall|Terminated||Phase 2|23|Actual|National Cancer Institute (NCI)|This study closed early due to unacceptably high rate of thromboembolic events in Cohort A and due to low accrual in Cohort B. For this reason efficacy endpoints other than response to pre-operative therapy were not reported.|2|||f||||||||||||||2017-02-18 17:49:44.155822|2017-02-18 17:49:44.155822
NCT00089531|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2017-01-24|||August 2, 2004||2004-08-02|January 15, 2008|2008-01-15|January 15, 2008||2008-01-15|||||Interventional|||Candidate HIV Vaccine|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a 6-Plasmid Multiclade HIV-1 DNA Vaccine, VRC-HIVDNA016-00-VP, in Uninfected Adult Volunteers|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:49:44.747894|2017-02-18 17:49:44.747894
NCT00089518|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2015-03-05||||||August 2009|2009-08-01||||||||Interventional|||Optimal Treatment for Kidney Disease in HIV Infected Adults|A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of an Angiotensin Receptor Blocker (Valsartan) and Highly Active Antiretroviral Therapy (HAART) Versus HAART Alone for the Treatment of HIV-Associated Nephropathy|Withdrawn||Phase 3|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:49:44.859717|2017-02-18 17:49:44.859717
NCT00089505|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2016-01-04|2010-08-30||November 2006||2006-11-01|January 2016|2016-01-01|February 2011|Actual|2011-02-01|August 2010|Actual|2010-08-01||Interventional|OCTANE||NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission|Optimal Combination Therapy After Nevirapine Exposure|Completed||Phase 3|745|Actual|AIDS Clinical Trials Group||4|||f||||t||||||||||2017-02-18 17:49:45.070286|2017-02-18 17:49:45.070286
NCT00089492|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2016-11-01|||July 2004||2004-07-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients|A Phase II Open-label, Randomized, Active-controlled Study Comparing the Efficacy and Safety of Once Daily Enfuvirtide Dosing Versus the Currently Recommended Twice Daily Dosing in HIV-1 Infected Treatment-experienced Patients.|Completed||Phase 2|64|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:49:47.373827|2017-02-18 17:49:47.373827
NCT00089479|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2012-12-19|2011-03-31||August 2002||2002-08-01|December 2012|2012-12-01|May 2012|Actual|2012-05-01|June 2010|Actual|2010-06-01||Interventional|||A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer|A Randomized, Open-label Study of the Effect of Adjuvant Therapy With Adriamycin Plus Cytoxan Followed by Taxotere or Taxotere Plus Xeloda on Overall Survival in Female Patients With High-risk Breast Cancer|Completed||Phase 3|2611|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:49:47.496824|2017-02-18 17:49:47.496824
NCT00089466|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2012-10-26||2009-11-16|November 2004||2004-11-01|October 2012|2012-10-01|January 2009|Actual|2009-01-01|June 2006|Actual|2006-06-01||Interventional|||Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients|Phase IB/IIA Dose-Finding Safety and Activity Study of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor) in HIV-Infected Subjects|Completed||Phase 1/Phase 2|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||8|||f||||||||||||||2017-02-18 17:49:48.71439|2017-02-18 17:49:48.71439
NCT00089453|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2012-04-17|||September 2003||2003-09-01|April 2012|2012-04-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant|UARK 2003-18, A Phase II Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant in Relapsed Multiple Myeloma|Completed||Phase 1|10|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 17:49:48.836337|2017-02-18 17:49:48.836337
NCT00089440|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2017-01-10|||June 2004||2004-06-01|July 2005|2005-07-01|March 2005||2005-03-01|||||Interventional|||Assessment of Interactions Between Methamphetamine and Aripiprazole - 1|Assessment of Interactions Between IV Methamphetamine and Aripiprazole|Unknown status|Active, not recruiting|Phase 1|17||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:49:48.948211|2017-02-18 17:49:48.948211
NCT00089427|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-05|2011-06-30|||July 2004||2004-07-01|April 2011|2011-04-01||||July 2007|Actual|2007-07-01||Interventional|||IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma|Phase I Study of Convection Enhanced Delivery (CED) of IL13-PE38QQR Infusion After Resection Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma|Completed||Phase 1|24||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 17:49:49.033856|2017-02-18 17:49:49.033856
NCT00089414|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2016-11-02|2013-01-14||July 2004||2004-07-01|November 2016|2016-11-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives|The Treatment of Menstrually-Related Mood Disorders With Extended Versus Interrupted Oral Contraceptives|Terminated||Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)|Protocol terminated after receiving information from manufacturer (Pharma) that CDB-2914 crosses the blood-brain barrier, invalidating Arm #3 due to potential CNS effect of the compound on behavior. Data collected insufficient for analysis.|3||"Informed by manufacturer that CDB-2914 crosses blood-brain barrier invalidating Arm #3 of~   protocol."|f||||f||||||||||2017-02-18 17:49:49.132461|2017-02-18 17:49:49.132461
NCT00089401|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2012-05-11|||July 2004||2004-07-01|May 2012|2012-05-01|March 2008|Actual|2008-03-01|November 2006|Actual|2006-11-01||Interventional|||Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver|A Phase II Trial Of Isolated Hepatic Perfusion (IHP) With Melphalan For Subjects With Metastatic Unresectable Colorectal Cancers Of The Liver With Disease Refractory To First Line Systemic Chemotherapy|Completed||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:49:49.661751|2017-02-18 17:49:49.661751
NCT00089388|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-01-23|||July 2004||2004-07-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||Cilengitide in Treating Patients With Acute Myeloid Leukemia|A Phase 2 Study of EMD 121974 as Maintenance Therapy for Patinets With Acute Myeloid Leukemia in Complete Remission|Terminated||Phase 2|70|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 17:49:49.761266|2017-02-18 17:49:49.761266
NCT00089362|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-04-09|||July 2004||2004-07-01|April 2013|2013-04-01||||January 2008|Actual|2008-01-01||Interventional|||Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors|Phase 1 Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, NSC #707545) in Patients With Solid Tumors.|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:49:49.869756|2017-02-18 17:49:49.869756
NCT00089349|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-06-04|||July 2004||2004-07-01|June 2013|2013-06-01||||September 2006|Actual|2006-09-01||Interventional|||Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia|A Phase II Study of Campath-1H in Children With Acute Lymphoblastic Leukemia in Second or Greater Relapse or Twice Induction Failure|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:49:49.998054|2017-02-18 17:49:49.998054
NCT00089323|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2016-06-02|||January 2007||2007-01-01|June 2016|2016-06-01|April 2017|Anticipated|2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer|Bone Marrow Analysis In Early-Stage Breast Cancer|Active, not recruiting||N/A|1630|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-02-18 17:49:50.113699|2017-02-18 17:49:50.113699
NCT00089310|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2016-06-28|||September 2004||2004-09-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|February 2007|Actual|2007-02-01||Interventional|||Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer|Intraoperative Sentinel Node Mapping In Non-Small Cell Lung Cancer|Completed||N/A|46|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:49:50.541696|2017-02-18 17:49:50.541696
NCT00089297|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-02-07|2012-12-31||December 2004||2004-12-01|December 2012|2012-12-01|February 2011|Actual|2011-02-01|February 2010|Actual|2010-02-01||Interventional|||Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer|Phase II Evaluation of Cetuximab (C225) Combined With Induction Paclitaxel and Carboplatin Followed by C225, Paclitaxel, Carboplatin, and Radiation for Stage III/IV Operable Squamous Cancer of the Head and Neck|Completed||Phase 2|74|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 17:49:50.691983|2017-02-18 17:49:50.691983
NCT00089284|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2011-04-11|||September 2003||2003-09-01|April 2011|2011-04-01|April 2012|Anticipated|2012-04-01|December 2007|Actual|2007-12-01||Interventional|||Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL|A Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20 Positive Non-Hodgkin's Lymphoma (NHL): Combining 90-Yttrium- Zevalin and the Redox- Modulating Agent, Motexafin Gadolinium (MGd)|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 17:49:51.050967|2017-02-18 17:49:51.050967
NCT00089271|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-01-24|||July 2004||2004-07-01|January 2013|2013-01-01||||June 2010|Actual|2010-06-01||Interventional|||17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas|A Phase I Study Of 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin, (17-DMAG) (NSC 707545) In Patients With Advanced Solid Tumors|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:49:51.164309|2017-02-18 17:49:51.164309
NCT00089258|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-01-15|||July 2004||2004-07-01|January 2013|2013-01-01||||November 2006|Actual|2006-11-01||Interventional|||Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment|Phase II Study of Anti-GD2 3F8 Antibody and Biologic Response Modifiers for High-risk Neuroblastoma|Completed||Phase 2|74|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:49:51.282388|2017-02-18 17:49:51.282388
NCT00089245|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2016-11-07|||July 2004||2004-07-01|November 2016|2016-11-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer|Phase I Study Of Intrathecal Radioimmunotherapy Using I-8H9 For Central Nervous System/Leptomeningeal Neoplasms|Recruiting||Phase 1|120|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:49:51.379328|2017-02-18 17:49:51.379328
NCT00089219|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2014-11-18|||July 2003||2003-07-01|November 2014|2014-11-01||||May 2006|Actual|2006-05-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma|Vaccination With Multiple Synthetic Melanoma Peptides Recognized by Helper T-Cells in Patients With Advanced Melanoma|Completed||Phase 1/Phase 2|39|Actual|University of Virginia||3|||f||||t||||||||||2017-02-18 17:49:51.507228|2017-02-18 17:49:51.507228
NCT00089206|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2014-12-18|||August 2002||2002-08-01|December 2014|2014-12-01||||November 2005|Actual|2005-11-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery|Vaccination With Synthetic Melanoma Peptides Administered With GM-CSF-in-Adjuvant in Patients With Advanced Melanoma|Completed||Phase 2|7|Actual|University of Virginia||1|||f||||t||||||||||2017-02-18 17:49:51.638247|2017-02-18 17:49:51.638247
NCT00089193|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2014-12-18|||September 2003||2003-09-01|December 2014|2014-12-01||||February 2007|Actual|2007-02-01||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma|Evaluation of GM-CSF-in-Adjuvant and the Number of Vaccine Sites on Immunization With Multiple Synthetic Melanoma Peptides|Completed||Phase 2|||University of Virginia|||||f||||t||||||||||2017-02-18 17:49:51.729436|2017-02-18 17:49:51.729436
NCT00088816|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-09-16|||April 2003||2003-04-01|March 2008|2008-03-01||||March 2008|Anticipated|2008-03-01||Interventional|||S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer|Phase II Clinical Study of Preoperative S-1/CDDP Combination Chemotherapy in Patients With Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:49:57.043832|2017-02-18 17:49:57.043832
NCT00089180|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2015-12-03|||March 2004||2004-03-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant|A Phase IIb Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topical Bacteriophage T4 Endonuclease V in Renal Allograft Recipients With a History of Non-melanoma Skin Cancer|Completed||Phase 2|100|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:49:51.824219|2017-02-18 17:49:51.824219
NCT00089167|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-01-15|||May 2002||2002-05-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis|Risk Adapted Intravenous Melphalan and Adjuvant Thalidomide and Dexamethasone for Untreated Patients With Primary Systemic Amyloidosis|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:49:51.932577|2017-02-18 17:49:51.932577
NCT00089154|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-07-15|||August 2004||2004-08-01|June 2013|2013-06-01||||October 2005|Actual|2005-10-01||Interventional|||Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase II Study of Thrice Weekly Apolizumab in Patients With Chronic Lymphocytic Leukemia : CRC Master Protocol|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:49:52.044092|2017-02-18 17:49:52.044092
NCT00089141|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-05-01|2009-07-15||May 2004||2004-05-01|August 2009|2009-08-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)|A Randomized Study to Evaluate The Efficacy of Mycophenolate Mofetil Added to The Systemic Immunosuppressive Regimen First Used For Treatment of Chronic Graft-Versus-Host Disease|Terminated||Phase 3|151|Actual|Fred Hutchinson Cancer Research Center||2||Low probability of positive outcome|f||||t||||||||||2017-02-18 17:49:52.161393|2017-02-18 17:49:52.161393
NCT00089128|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2012-04-26|||November 2001||2001-11-01|April 2012|2012-04-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|||Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer|Phase II Study Of Gemcitabine And CPT-11 (Irinotecan) In Locally Advanced Or Metastatic Bladder Cancer|Completed||Phase 2|25|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-02-18 17:49:52.772082|2017-02-18 17:49:52.772082
NCT00089115|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-08-01|||July 2004||2004-07-01|February 2006|2006-02-01||||||||Interventional|||Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|Phase III, Randomized, Double Blind, Placebo-Controlled Trial of Favldand GM-CSF Versus Placebo and GM-CSF Following Rituximab in Subjects With Follicular B-Cell Non-Hodgkin's Lymphoma|Terminated||Phase 3|||National Cancer Institute (NCI)||||Withdrawn as company has shut down and filed for bankruptcy|f||||||||||||||2017-02-18 17:49:52.871611|2017-02-18 17:49:52.871611
NCT00089102|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2012-04-26|||September 2003||2003-09-01|April 2012|2012-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer|Phase II Study of Gemcitabine and CPT-11 (Irinotecan) in Unresectable or Metastatic Renal Cell Carcinoma|Completed||Phase 2|36|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-02-18 17:49:53.026878|2017-02-18 17:49:53.026878
NCT00089089|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-01-04|||September 2004||2004-09-01|January 2013|2013-01-01||||March 2008|Actual|2008-03-01||Interventional|||Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas|Phase I Study of Prolonged Low Dose Decitabine (5-Aza-Deoxycytidine, NSC #127716) in Patients With Biopsiable Advanced Cancers Refractory to Standard Therapy|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:49:53.12096|2017-02-18 17:49:53.12096
NCT00089076|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2014-05-22|2012-05-11||June 2004||2004-06-01|December 2012|2012-12-01|October 2009|Actual|2009-10-01|July 2008|Actual|2008-07-01||Interventional|||MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma|Phase I/II Study of Anti-CTLA-4 Monoclonal Antibody (MDX-010) in B-cell Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:49:53.239133|2017-02-18 17:49:53.239133
NCT00089063|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2015-04-14|||June 2004||2004-06-01|October 2013|2013-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma|A Randomized Phase II Continuation Booster Trial After A Vaccine Combining Tyrosinase/GP100/Mart-1 Peptides Emulsified With Montanide ISA 51 and ISA 51 VG With Or Without GM-CSF For Patients With Resected Stages IIB/C, III And IV Melanoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:49:53.882305|2017-02-18 17:49:53.882305
NCT00089050|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2011-11-28|||May 2004||2004-05-01|November 2011|2011-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia|A Phase II Trial Combining Gemtuzumab Ozogamicin (Mylotarg) With Cyclosporine for the Treatment of Relapsed Acute Myeloid Leukemia in Adults Over Age 60|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:49:53.999961|2017-02-18 17:49:53.999961
NCT00089037|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2011-07-13|||June 2003||2003-06-01|July 2011|2011-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation|A Phase I/II Study of Sirolimus in Addition to Tacrolimus and Methotrexate for the Prevention of Acute-Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation From Unrelated Donors|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:49:54.098388|2017-02-18 17:49:54.098388
NCT00089024|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2010-06-01|||February 2004||2004-02-01|June 2010|2010-06-01||||December 2013|Anticipated|2013-12-01||Interventional|||Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer|A Phase II Study Of Neo-Adjuvant Chemotherapy And Radiation In Patients With Locally Advanced Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|University of Nebraska||1|||f||||t||||||||||2017-02-18 17:49:54.208941|2017-02-18 17:49:54.208941
NCT00088829|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2016-04-06|||April 2001||2001-04-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|December 2015|Actual|2015-12-01||Interventional|||Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer|A Pilot Study to Establish a Standardized Protocol for Gene Microarray Analysis in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer: Identifying Factors Predictive of a Response to Paclitaxel|Terminated||Phase 2|22|Actual|Georgetown University||1||Investigator left institution|f||||f||||||||||2017-02-18 17:49:56.924749|2017-02-18 17:49:56.924749
NCT00089011|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2016-01-25|||April 2004||2004-04-01|January 2016|2016-01-01||||March 2014|Actual|2014-03-01||Interventional|||Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer|A Multi-Center Study of Nonmyeloablative Conditioning With TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies With Post Grafting Immunosuppression With Tacrolimus and Mycophenolate Mofetil|Active, not recruiting||Phase 2|150|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 17:49:54.321409|2017-02-18 17:49:54.321409
NCT00088998|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2016-12-05|||December 2004||2004-12-01|December 2016|2016-12-01|December 2010|Actual|2010-12-01|August 2006|Actual|2006-08-01||Interventional|||Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer|Phase II Trial Of Docetaxel With Capecitabine And Bevacizumab As First-Line Chemotherapy For Patients With Metastatic Breast Cancer|Completed||Phase 2|46|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:49:54.479124|2017-02-18 17:49:54.479124
NCT00088985|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2017-02-10|||January 2004||2004-01-01|February 2017|2017-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|NRR||Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer|Phase II Trial Evaluating The Efficacy Of A Multiepitope Dendritic Cell Vaccine Given With Trastuzumab And Vinorelbine For The Treatment Of Women With Metastatic Breast Cancer That Express HLA-A0201|Terminated||Phase 2|55|Actual|UNC Lineberger Comprehensive Cancer Center||1||Funding unavailable|f||||t||||||||||2017-02-18 17:49:54.581374|2017-02-18 17:49:54.581374
NCT00088972|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2015-09-28|2012-11-09||November 2004||2004-11-01|September 2015|2015-09-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women|Randomized Placebo-Controlled Biomarker Modulation Trial Using Celecoxib in Premenopausal Women at High Risk for Breast Cancer|Terminated||Phase 2|8|Actual|Southwest Oncology Group||2||Study closed due to poor accrual.|f||||t||||||||||2017-02-18 17:49:54.69204|2017-02-18 17:49:54.69204
NCT00088959|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2014-10-09|||December 2003||2003-12-01|April 2013|2013-04-01|November 2010|Actual|2010-11-01|January 2009|Actual|2009-01-01||Interventional|||Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase I Study of Erlotinib and Celecoxib in Former Smokers With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 17:49:55.069307|2017-02-18 17:49:55.069307
NCT00088946|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2015-10-28|||May 2004||2004-05-01|August 2012|2012-08-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer|Parallel, Randomized, Double-Blind, Placebo Controlled Phase II Adjuvant Studies of Erlotinib and Polyphenon E to Prevent the Recurrence and Progression of Tobacco-Related, Superficial Bladder Cancer|Completed||Phase 2|17|Actual|Jonsson Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 17:49:55.192202|2017-02-18 17:49:55.192202
NCT00088933|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2014-03-28|||June 2004||2004-06-01|March 2013|2013-03-01||||November 2007|Actual|2007-11-01||Interventional|||Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer|Randomized Single Institution Pilot Study of Vaccinia-CEA(6D)-TRICOM and Fowlpox-CEA(6D)-TRICOM With GM-CSF in Combination With Docetaxel in Patients With CEA-Bearing Cancers|Terminated||Phase 1|60|Actual|National Cancer Institute (NCI)||6|||f||||||||||||||2017-02-18 17:49:55.31547|2017-02-18 17:49:55.31547
NCT00088907|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2015-04-21|2015-03-20||August 2004||2004-08-01|July 2013|2013-07-01|August 2012|Actual|2012-08-01|May 2009|Actual|2009-05-01||Interventional||The primary population was eligible and treated patients in the study. All study results were based on the primary population except for adverse event results. In total, 136 patients enrolled on arm I, but 19 patients were ineligible/no protocol therapy. 134 patients entered arm II, 12 of them were not eligible/not starting protocol therapy.|Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer|Phase III Randomized, Placebo Controlled, Trial of Docetaxel Versus Docetaxel Plus ZD1839 (Iressa, Gefitinib) in Performance Status 2 or Previously Treated Patients With Recurrent or Metastatic Head and Neck Cancer|Terminated||Phase 3|270|Actual|National Cancer Institute (NCI)||2||"It was unlikely that the primary endpoint would be reached based on the fifth interim analysis~   results."|f||||t||||||||||2017-02-18 17:49:55.455042|2017-02-18 17:49:55.455042
NCT00088894|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-06-04|||June 2004||2004-06-01|June 2013|2013-06-01||||June 2006|Actual|2006-06-01||Interventional|||Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Randomized Phase III Trial Of Gemcitabine Plus Bevacizumab (NSC#704865 IND#7621) Versus Gemcitabine Plus Placebo In Patients With Advanced Pancreatic Cancer|Completed||Phase 3|590|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:49:56.117324|2017-02-18 17:49:56.117324
NCT00088881|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2015-02-17|2014-12-16||December 2004||2004-12-01|February 2015|2015-02-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional||Eligible and treated patients|Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma|A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for Patients With Previously Untreated Stages I and II CD20+ Diffuse Large Cell Non-Hodgkin's Lymphoma|Terminated||Phase 2|62|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 17:49:56.255632|2017-02-18 17:49:56.255632
NCT00088868|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2012-03-14|||June 2004||2004-06-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|March 2010|Actual|2010-03-01||Interventional|||17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma|A Phase I Study Of 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17DMAG) With Evaluation Of Hsp90 Client Proteins In Subjects With Solid Tumors And Lymphomas|Completed||Phase 1|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:49:56.697309|2017-02-18 17:49:56.697309
NCT00088855|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2017-01-31|||June 2004||2004-06-01|October 2016|2016-10-01||||October 2006|Actual|2006-10-01||Interventional|||Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma|Phase II Study of Bortezomib (PS-341) and Pegylated Liposomal Doxorubicin as Initial Therapy for Adult Patients With Symptomatic Multiple Myeloma|Active, not recruiting||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:49:56.788473|2017-02-18 17:49:56.788473
NCT00088790|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2011-01-25|||July 2004||2004-07-01|January 2011|2011-01-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||AZD5438 in Patients With Advanced Solid Malignancies|Phase I Study to Assess the Safety and Tolerability of AZD5438 in Patients With Advanced Solid Malignancies|Completed||Phase 1|||AstraZeneca|||||||||||||||||||2017-02-18 17:49:57.759543|2017-02-18 17:49:57.759543
NCT00088777|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2011-08-10|||January 2005||2005-01-01|August 2011|2011-08-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Nondrug Treatment Programs for Adults With Fibromyalgia|Behavioral Preparation for Treating Fibromyalgia|Completed||Phase 2|300|Anticipated|University of Utah||2|||f||||||||||||||2017-02-18 17:49:57.830412|2017-02-18 17:49:57.830412
NCT00088764|ClinicalTrials.gov processed this data on February 17, 2017|2004-08-04|2013-08-13|||February 2005||2005-02-01|August 2013|2013-08-01|June 2009|Actual|2009-06-01|April 2009|Actual|2009-04-01||Interventional|||Pain and Stress Management for People With Rheumatoid Arthritis|Disclosure and Skills Training for Rheumatoid Arthritis|Completed||Phase 2|280|Actual|Wayne State University||2|||f||||t||||||||||2017-02-18 17:49:57.939045|2017-02-18 17:49:57.939045
NCT00088751|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-31|2017-01-24|||July 23, 2004||2004-07-23|June 1, 2009|2009-06-01|June 1, 2009||2009-06-01|||||Observational|||Treatment Study of Frontotemporal Dementia|Treatment Study for Frontotemporal Dementia|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:49:58.049306|2017-02-18 17:49:58.049306
NCT00088738|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2017-01-24|||July 27, 2004||2004-07-27|September 10, 2008|2008-09-10|September 10, 2008||2008-09-10|||||Interventional|||Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ|Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F] SPA-RQ|Completed||Phase 1|84||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:49:58.134639|2017-02-18 17:49:58.134639
NCT00088712|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2017-01-24|||July 26, 2004||2004-07-26|September 2, 2016|2016-09-02||||||||Observational|||Event Related Potentials in Infants and Adults|Event Related Potentials From Infancy to Adulthood|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:49:58.228084|2017-02-18 17:49:58.228084
NCT00088699|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2017-01-24|||July 26, 2004||2004-07-26|November 22, 2016|2016-11-22|April 1, 2017|Anticipated|2017-04-01|April 1, 2017|Anticipated|2017-04-01||Interventional|||Rapid Antidepressant Effects of Ketamine in Major Depression|Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist|Recruiting||Phase 1/Phase 2|324|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:49:58.329312|2017-02-18 17:49:58.329312
NCT00088686|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2008-03-03|||July 2004||2004-07-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Capsaicin to Control Pain Following Third Molar Extraction|Evaluation of Vanilloid Receptor Inactivation for Preemptive Analgesia|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:49:58.449728|2017-02-18 17:49:58.449728
NCT00088673|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2007-02-27|||June 2004||2004-06-01|February 2007|2007-02-01||||||||Interventional|||Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease|A Phase III Study of the Efficacy and Safety of 3APS in Patients With Mild to Moderate Alzheimer’s Disease|Unknown status|Active, not recruiting|Phase 3|950||Bellus Health Inc|||||||||t||||||||||2017-02-18 17:49:58.540423|2017-02-18 17:49:58.540423
NCT00088660|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2006-02-07|||June 2004||2004-06-01|February 2006|2006-02-01||||||||Interventional|||PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen|A Phase III Randomized, Controlled Study to Evaluate the Safety and Efficacy of PANVAC™-VF in Combination With GM-CSF Versus Best Supportive Care or Palliative Chemotherapy in Patients With Metastatic (Stage IV) Adenocarcinoma of the Pancreas Who Have Failed a Gemcitabine-Containing Chemotherapy Regimen|Unknown status|Active, not recruiting|Phase 3|250||Therion Biologics Corporation|||||||||||||||||||2017-02-18 17:49:58.872181|2017-02-18 17:49:58.872181
NCT00088647|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2006-12-07||||||December 2006|2006-12-01||||||||Interventional|||Study Evaluating MST-997 in Advanced Malignant Solid Tumors|A Phase 1 Dose-Escalation Study of Intravenous MST-997 Formulated in Intralipid 20% Administered Weekly in Subjects With Advanced Malignant Solid Tumors|Terminated||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:49:59.015041|2017-02-18 17:49:59.015041
NCT00088634|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2016-03-10|2011-02-01||May 2004||2004-05-01|March 2016|2016-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia|A Double-blind Fixed-dose Study of Lurasidone (SM-13496) and Placebo in the Treatment of Schizophrenia|Completed||Phase 2|180|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 17:49:59.104241|2017-02-18 17:49:59.104241
NCT00088621|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2014-03-31|2011-02-11||July 2004||2004-07-01|March 2014|2014-03-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia|An Open-Label, Multicenter, Twelve-Month Study of Safety and Tolerability in the Treatment of Schizophrenia|Completed||Phase 2|61|Actual|Sunovion||1|||f||||f||||||||||2017-02-18 17:49:59.727064|2017-02-18 17:49:59.727064
NCT00088608|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2016-11-03|||April 2004||2004-04-01|November 2016|2016-11-01||||June 2006|Actual|2006-06-01||Interventional|||A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease|A Multicenter, Open Label Study to Assess the Safety and Efficacy of 600 µg SOM230, Administered Subcutaneously, b.i.d. in Patients With Cushing's Disease|Completed||Phase 2|26|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:49:59.990529|2017-02-18 17:49:59.990529
NCT00088595|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2012-05-29|2011-01-21||January 2004||2004-01-01|May 2012|2012-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors|An Open-label, Multicenter, Phase II Study Evaluating the Safety and Efficacy of Twice Daily Dosing of SOM230 in Patients With Metastatic Carcinoid Tumors|Completed||Phase 2|45|Actual|Novartis|No formal statistical comparisons were performed for this study. Summary statistics were provided to compare the different doses administered for the primary and secondary endpoints.|1|||f||||t||||||||||2017-02-18 17:50:00.105129|2017-02-18 17:50:00.105129
NCT00088582|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-30|2016-11-03|||March 2004||2004-03-01|November 2016|2016-11-01||||October 2005|Actual|2005-10-01||Interventional|||Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients|A Multicenter, Randomized, Crossover, Open Label Dose Finding Study to Compare the Safety, Efficacy and PK/PD Relationship of Multiple Doses of SOM230 and Sandostatin in Acromegalic Patients|Completed||Phase 2|62|Actual|Novartis||2|||f||||f||||||||||2017-02-18 17:50:00.604634|2017-02-18 17:50:00.604634
NCT00005340|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||September 1991||1991-09-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Hypertension in Blacks of West African Origin||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.884628|2017-02-18 18:15:06.884628
NCT00088556|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-29|2012-05-30|||August 2004||2004-08-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer|Phase 1-2a Dose-Ranging Study of the Triplet Combination of Carboplatin, Paclitaxel and TLK286 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|100|Actual|Telik||1|||f||||||||||||||2017-02-18 17:50:00.830895|2017-02-18 17:50:00.830895
NCT00088543|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-29|2015-03-16|||March 2004||2004-03-01|March 2015|2015-03-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant|Pilot Trial of Two Dose Levels of Thymoglobulin as Part of a Myeloablative-Conditioning for a Human Leukocyte Antigen (HLA) Identical Matched Related Donor (MRD) Stem Cell Transplant (SCT) With Cyclosporine (CSa) as Post-transplant Graft vs. Host Disease (GvHD) Prophylaxis|Completed||N/A|60|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:50:00.995999|2017-02-18 17:50:00.995999
NCT00088530|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-28|2013-05-20|||July 2004||2004-07-01|May 2013|2013-05-01|July 2010|Actual|2010-07-01|February 2010|Actual|2010-02-01||Interventional|||BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)|Pixantrone (BBR 2778) Versus Other Chemotherapeutic Agents for Third-line Single Agent Treatment of Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma: A Randomized, Controlled, Phase III Comparative Trial|Completed||Phase 3|140|Actual|CTI BioPharma||2|||f||||t||||||||||2017-02-18 17:50:01.124249|2017-02-18 17:50:01.124249
NCT00088517|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-27|2008-03-03|||July 2004||2004-07-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112|Whole Body Study of [11C]NNC-112 PET Imaging of Dopamine D1 Receptors|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:01.320728|2017-02-18 17:50:01.320728
NCT00088504|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-27|2007-12-17|||July 2004||2004-07-01|December 2007|2007-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C|A Phase 2b Study of Merimepodib in Combination With Pegylated Interferon Alfa-2a (Pegasys®) and Ribavirin in Subjects With Chronic Hepatitis C Non-Responsive to Prior Therapy With Pegylated Interferon Alfa and Ribavirin|Completed||Phase 2|315||Vertex Pharmaceuticals Incorporated|||||f||||||||||||||2017-02-18 17:50:01.539392|2017-02-18 17:50:01.539392
NCT00088491|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-26|2007-06-20|||June 2004||2004-06-01|June 2007|2007-06-01|October 2006|Actual|2006-10-01|||||Interventional|||Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia|A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia|Completed||Phase 3|1205|Actual|Eli Lilly and Company|||||||||||||||||||2017-02-18 17:50:01.69923|2017-02-18 17:50:01.69923
NCT00088478|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-26|2007-06-11|||June 2004||2004-06-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia|A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia|Completed||Phase 3|402|Actual|Eli Lilly and Company||4|||||||||||||||||2017-02-18 17:50:01.816721|2017-02-18 17:50:01.816721
NCT00088465|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-26|2011-12-09|2011-10-14||August 2004||2004-08-01|December 2011|2011-12-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder|An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder|Completed||Phase 3|931|Actual|Eli Lilly and Company||1|||f||||||||||||||2017-02-18 17:50:02.161752|2017-02-18 17:50:02.161752
NCT00088452|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-26|2017-02-03|||July 2004|Actual|2004-07-01|February 2017|2017-02-01|August 31, 2016|Actual|2016-08-31|January 2013|Actual|2013-01-01||Interventional|||Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study|Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study|Completed||Phase 3|453|Actual|Children's Hospital Medical Center, Cincinnati||3|||f||||t||||||||||2017-02-18 17:50:03.116282|2017-02-18 17:50:03.116282
NCT00088426|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2017-01-24|||January 16, 2004||2004-01-16|December 27, 2016|2016-12-27||||||||Observational|||Clinical and Genetic Studies on Holoprosencephaly|Clinical and Genetic Studies on Holoprosencephaly|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:03.28824|2017-02-18 17:50:03.28824
NCT00088413|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2017-01-26|||July 20, 2004||2004-07-20|September 26, 2016|2016-09-26|January 1, 2018|Anticipated|2018-01-01|January 1, 2018|Anticipated|2018-01-01||Interventional|||PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer|An Open Label Pilot Study to Evaluate the Safety and Tolerability of PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Combination With Sargramostim in Adults With Metastatic Carcinoma|Active, not recruiting||Phase 1|51|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||||||||||||2017-02-18 17:50:03.387544|2017-02-18 17:50:03.387544
NCT00088400|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2016-09-21|||July 2004||2004-07-01|September 2016|2016-09-01|November 2005||2005-11-01|||||Interventional|||Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors|A Phase III Multicenter Study of Intratumoral/Interstitial Therapy With TransMID Compared to Best Standard of Care in Patients With Progressive and/or Recurrent, Non-Resectable Glioblastoma Multiforme|Completed||Phase 3|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:03.50882|2017-02-18 17:50:03.50882
NCT00088387|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2008-03-03|||July 2004||2004-07-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Effect of Lithium and Divalproex in Alzheimer's Disease|Glycogen Synthetase Kinase 3 (GSK-3) Inhibition in Alzheimer's Disease|Completed||Phase 2|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:03.592173|2017-02-18 17:50:03.592173
NCT00088374|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2012-07-23|2011-05-24||July 2004||2004-07-01|July 2012|2012-07-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease|A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Von Hippel Lindau Disease and Renal Tumors|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)|Study did not meet accrual.|1|||f||||f||||||||||2017-02-18 17:50:03.687692|2017-02-18 17:50:03.687692
NCT00088361|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2008-03-03|||July 2004||2004-07-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Observational|||Effect of Respiratory Motion on Positron Emission Tomography Imaging|The Effects of Respiratory Motion on CT Based Attenuation Correction of Positron Emission Tomography Data: Liver and Heart Studies|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:04.046927|2017-02-18 17:50:04.046927
NCT00088348|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2017-01-24|||July 13, 2004||2004-07-13|August 20, 2008|2008-08-20|August 20, 2008||2008-08-20|||||Observational|||Screening for Research Subjects With Anterior Segment Diseases|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Anterior Segment Disease|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:04.12232|2017-02-18 17:50:04.12232
NCT00088335|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2008-03-03|||July 2004||2004-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Biological Markers in Parkinson's Disease|Investigation of Biomarkers in Parkinson's Disease|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:04.203577|2017-02-18 17:50:04.203577
NCT00088309|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2008-03-03|||June 2004||2004-06-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Effect of Tenofovir DF on Bone Metabolism in Children|Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of Its Effect on Bone Metabolism|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:04.289957|2017-02-18 17:50:04.289957
NCT00088296|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2017-01-24|||July 13, 2004||2004-07-13|October 18, 2007|2007-10-18|October 18, 2007||2007-10-18|||||Interventional|||Effects of Osteoarthritis Pain, Morphine, and Placebo on Neuroendocrine Function in Men|Effects of Osteoarthritis Pain, Morphine and Placebo on Neuro-Endocrine Function in Men|Completed||Phase 2|72||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:04.381595|2017-02-18 17:50:04.381595
NCT00088283|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2007-01-17|||May 2004||2004-05-01|January 2007|2007-01-01||||||||Interventional|||Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)|A Phase II Randomized, Dose-Ranging, Double-Masked, Multi-Center Trial, in Parallel Groups, Determining Safety, Efficacy and PK of Intravitreous Injections of Pegaptanib Sodium Compared to Sham Injection for 30 Weeks in Patients With Recent Vision Loss Due to Macular Edema Secondary to CRVO|Completed||Phase 2|90||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 17:50:04.472037|2017-02-18 17:50:04.472037
NCT00088270|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2006-02-17|||August 2004||2004-08-01|May 2004|2004-05-01|August 2005||2005-08-01|||||Interventional|||A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer|A Randomized, Open Label, Phase II Study of OSI-7904L Versus 5-FU/LV as First-Line Treatment in Patients With Unresectable, Locally Advanced or Metastatic Adenocarcinoma of the Biliary Tract|Completed||Phase 2|58||OSI Pharmaceuticals|||||||||||||||||||2017-02-18 17:50:04.581383|2017-02-18 17:50:04.581383
NCT00088257|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-23|2013-12-12|||August 2004||2004-08-01|December 2013|2013-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Observational|||Maternal Fatty Acids, Child Obesity, and Asthma Immunity|Maternal Fatty Acids, Child Obesity, and Asthma Immunity|Completed||N/A|411|Actual|Harvard Pilgrim Health Care|||1||f||||||||||||||2017-02-18 17:50:04.783305|2017-02-18 17:50:04.783305
NCT00088231|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-22|2012-01-19|||July 2004||2004-07-01|January 2012|2012-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP|Ph I/II Study of PTK 787 (Vatalanib) and Gleevec (Imatinib) in Patients With Refractory Acute Myelogenous Leukemia (AML), Agnogenic Myeloid Metaplasia (AMM), and Chronic Myelogenous Leukemia- Blastic Phase (CML-BP)|Completed||Phase 1/Phase 2|9|Actual|M.D. Anderson Cancer Center||2|||f||||||||||||||2017-02-18 17:50:04.860173|2017-02-18 17:50:04.860173
NCT00088218|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-22|2012-08-01|2009-09-25||July 2004||2004-07-01|April 2011|2011-04-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).|Randomized Phase II Study of Clofarabine Alone Versus Clofarabine in Combination With Low-Dose Cytarabine in Previously Untreated Patients >= 60 Years With AML and High-Risk MDS|Completed||Phase 2|95|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 17:50:04.978835|2017-02-18 17:50:04.978835
NCT00088205|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-22|2009-10-05||2009-06-10|March 2004||2004-03-01|October 2009|2009-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma|A Phase 2 Study of Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma|Completed||Phase 2|61|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 17:50:05.443515|2017-02-18 17:50:05.443515
NCT00088192|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-21|2005-08-29|||July 2004||2004-07-01|August 2005|2005-08-01||||||||Interventional|||Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)|An Open Label, Non-Comparative Protocol for Use of Intravitreous Pegaptanib Sodium Injection Every 6 Weeks in Patients With Exudative Age-Related Macular Degeneration (AMD)|Completed||N/A|||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 17:50:05.557969|2017-02-18 17:50:05.557969
NCT00088179|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-21|2017-02-15||2017-02-15|July 2004||2004-07-01|February 2017|2017-02-01||||October 2005|Actual|2005-10-01||Interventional|||Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)|A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)|Active, not recruiting||Phase 3|4000||Alexion Pharmaceuticals|||||||||||||||||||2017-02-18 17:50:05.862176|2017-02-18 17:50:05.862176
NCT00088166|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-20|2014-07-22|2011-10-13||May 2004||2004-05-01|July 2014|2014-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors|A Phase III Randomized, Double-Blind, Dexamethasone-Sparing Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Placebo for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Malignant Brain Tumor Who Require Chronic Administration of High-Dose Dexamethasone|Completed||Phase 3|200|Actual|Celtic Pharma Development Services||2|||f||||t||||||||||2017-02-18 17:50:06.200225|2017-02-18 17:50:06.200225
NCT00088153|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-20|2011-10-06|2011-07-06||July 2003||2003-07-01|September 2011|2011-09-01|June 2011|Actual|2011-06-01|February 2011|Actual|2011-02-01||Interventional|||Effects of Anorexia Nervosa on Bone Mass in Adolescents|Effects of Anorexia Nervosa on Peak Bone Mass|Completed||Phase 2/Phase 3|110|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:50:07.158983|2017-02-18 17:50:07.158983
NCT00088140|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-20|2012-08-09|||July 2004||2004-07-01|August 2012|2012-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients|A Dose Response Study of a Caspase Inhibitor in Hepatitis C Patients|Completed||Phase 2|204|Actual|Conatus Pharmaceuticals Inc.||4|||||||t||||||||||2017-02-18 17:50:07.651393|2017-02-18 17:50:07.651393
NCT00088114|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-20|2014-03-05|||January 2003||2003-01-01|March 2014|2014-03-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||STA-4783 and Paclitaxel for Treatment of Solid Tumors|A Phase I Trial of STA-4783 in Patients Receiving Paclitaxel for Treatment of Solid Tumors|Completed||Phase 1|50||Synta Pharmaceuticals Corp.|||||f||||||||||||||2017-02-18 17:50:07.876236|2017-02-18 17:50:07.876236
NCT00088101|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-20|2008-12-03|||February 2004||2004-02-01|December 2008|2008-12-01|December 2004||2004-12-01|||||Interventional|||STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors|Phase I Trial of STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematological Malignancies and Patients With Solid Tumors|Completed||Phase 1|42||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-02-18 17:50:07.949278|2017-02-18 17:50:07.949278
NCT00088088|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-20|2008-12-03|||March 2004||2004-03-01|December 2008|2008-12-01|March 2005||2005-03-01|||||Interventional|||STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)|A Phase I/II Trial of STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|86||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-02-18 17:50:08.027528|2017-02-18 17:50:08.027528
NCT00088075|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-19|2011-06-06|||August 2004||2004-08-01|January 2011|2011-01-01|December 2005|Actual|2005-12-01|||||Interventional|||Investigate Risperidone for the Treatment of Schizophrenia in Adolescents|A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Efficacy and Safety of Risperidone for the Treatment of Schizophrenia in Adolescents|Completed||Phase 3|160|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:50:08.118839|2017-02-18 17:50:08.118839
NCT00088062|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-19|2005-06-23|||February 2004||2004-02-01|May 2005|2005-05-01|November 2004||2004-11-01|||||Interventional|||STA-5326 in Crohn's Disease Patients|A Phase I/IIa Trial of STA-5326 in Crohn's Disease Patients With CDAI Scores of 220-450|Completed||Phase 1/Phase 2|48||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-02-18 17:50:08.226977|2017-02-18 17:50:08.226977
NCT00088049|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-19|2007-07-16|||October 2003||2003-10-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia|A Randomized Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia|Completed||Phase 4|560||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:50:08.325295|2017-02-18 17:50:08.325295
NCT00088036|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-19|2006-07-21|||February 2004||2004-02-01|July 2006|2006-07-01|January 2006||2006-01-01|||||Interventional|||Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder|Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Double-Blind Comparison With Placebo|Completed||Phase 3|450||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:50:08.442997|2017-02-18 17:50:08.442997
NCT00088023|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-19|2014-03-27|||March 2004||2004-03-01|March 2014|2014-03-01|December 2005||2005-12-01|||||Interventional|||Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness|A Phase I Study of PT-523 in Patients With Solid Tumors|Terminated||Phase 1|40||Spectrum Pharmaceuticals, Inc|||||||||||||||||||2017-02-18 17:50:08.552311|2017-02-18 17:50:08.552311
NCT00088010|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-19|2010-05-27||2010-05-27|June 2004||2004-06-01|May 2010|2010-05-01|November 2009|Actual|2009-11-01|June 2009|Actual|2009-06-01||Interventional|||Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer|Effects of Arzoxifene on Vertebral Fracture Incidence and on Invasive Breast Cancer Incidence in Postmenopausal Women With Osteoporosis or With Low Bone Density.|Completed||Phase 3|9369|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 17:50:08.645455|2017-02-18 17:50:08.645455
NCT00087997|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-19|2006-06-19|||July 2004||2004-07-01|June 2006|2006-06-01|October 2005||2005-10-01|||||Interventional|||A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas||Completed||Phase 2|80||Synta Pharmaceuticals Corp.|||||||||||||||||||2017-02-18 17:50:08.757936|2017-02-18 17:50:08.757936
NCT00087984|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-16|2013-02-14||2013-01-22|January 2004||2004-01-01|February 2013|2013-02-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||RNA-Loaded Dendritic Cell Cancer Vaccine|A Phase I/II Study To Examine The Safety, Feasibility, Immunological Response, And Measures Of Clinical Antitumor Activity After Administering Unselected, Autologous, Amplified Tumor Total RNA-Transfected, Dendritic Cell Vaccine (MB-002) To Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|26|Actual|Argos Therapeutics||1|||f||||||||||||||2017-02-18 17:50:08.869206|2017-02-18 17:50:08.869206
NCT00087958|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-16|2009-04-30|||August 2004||2004-08-01|April 2009|2009-04-01|April 2009|Actual|2009-04-01|February 2007|Actual|2007-02-01||Interventional|||Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment|Phase II Multi-Center, Open-Label, Non-Randomized Study of Intravenous RPR109881 Given Every 3 Weeks in Patients With Metastatic Breast Cancer Progressing After Therapy With Anthracyclines, Taxanes and Capecitabine|Completed||Phase 2|168|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:50:08.982027|2017-02-18 17:50:08.982027
NCT00087945|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-16|2013-10-04|||July 2004||2004-07-01|October 2013|2013-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Blood Levels of Abacavir in HIV Infected Adolescents|Abacavir Pharmacokinetics During Chronic Therapy in HIV-1 Infected Adolescents and Young Adults|Completed||N/A|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:50:11.825129|2017-02-18 17:50:11.825129
NCT00087932|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-15|2006-08-17|||September 2001||2001-09-01|August 2006|2006-08-01|August 2003||2003-08-01|||||Observational|||Socioeconomic Influences on Complementary and Alternative Medicine Use in Cancer Treatment|Socioeconomic Diversity of CAM Integration in Oncology|Completed||N/A|300||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:50:11.967005|2017-02-18 17:50:11.967005
NCT00087919|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-15|2008-07-01|||July 2004||2004-07-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Defining an Obesity QTL on Chromosome 3q||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:50:12.041225|2017-02-18 17:50:12.041225
NCT00087906|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-15|2015-12-22|||July 2004||2004-07-01|December 2015|2015-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Disability and Health Outcomes in COPD|Disability and Health Outcomes in COPD|Completed||N/A|1589|Actual|University of California, San Francisco|||1||f||||f||||||||No||2017-02-18 17:50:12.123195|2017-02-18 17:50:12.123195
NCT00087893|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-15|2013-09-26|||July 2004||2004-07-01|September 2013|2013-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Epidemiology of Vascular Inflammation & Atherosclerosis||Completed||N/A|931|Actual|University of Vermont|||1||f||||||||||||||2017-02-18 17:50:12.23231|2017-02-18 17:50:12.23231
NCT00087880|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-15|2017-01-11|||December 2002||2002-12-01|March 2016|2016-03-01|September 2009|Actual|2009-09-01|January 2005|Actual|2005-01-01||Interventional|||Maintaining Abstinence in Chronic Cigarette Smokers - 1|Maintaining Abstinence in Chronic Cigarette Smokers|Completed||Phase 2|407|Actual|National Institute on Drug Abuse (NIDA)||5|||f||||f||||||||||2017-02-18 17:50:12.310748|2017-02-18 17:50:12.310748
NCT00087867|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-14|2010-10-15|||June 2004||2004-06-01|October 2010|2010-10-01|September 2005|Actual|2005-09-01|||||Interventional|||Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma|An Open-label Study of the Efficacy, Safety, and Tolerability of Oral SCIO-469 in Treatment of Relapsed, Refractory Patients With Multiple Myeloma|Completed||Phase 2|62|Actual|Scios, Inc.||2|||f||||||||||||||2017-02-18 17:50:12.428102|2017-02-18 17:50:12.428102
NCT00087854|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-14|2008-04-21|||March 2004||2004-03-01|April 2008|2008-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of Individualized Amonafide to Treat Prostate Cancer|Dose-Defining Study of a NAT2 Phenotype-Based Dosing Regimen of Intravenous Amonafide L-Malate Administered Weekly in Men With Androgen-Independent Prostate Cancer (AIPC)|Completed||Phase 1/Phase 2|40||Xanthus Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:50:12.540179|2017-02-18 17:50:12.540179
NCT00087841|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-14|2008-01-15|||April 2002||2002-04-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Self-Hypnotic Relaxation Therapy During Invasive Procedures|Midcareer Development of Nonpharmacologic Analgesia|Completed||Phase 2|390||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:50:12.639317|2017-02-18 17:50:12.639317
NCT00087828|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-14|2006-08-16|||November 2000||2000-11-01|August 2006|2006-08-01|June 2005||2005-06-01|||||Interventional|||Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections|Cranberry Juice Metabolites in Urine|Completed||N/A|5||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:50:12.729266|2017-02-18 17:50:12.729266
NCT00087815|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-14|2013-12-17|||September 2003||2003-09-01|July 2007|2007-07-01|June 2005||2005-06-01|||||Interventional|||Hyperbaric Oxygen Therapy in Treating Patients With Radiation Necrosis of the Brain|Complimentary Hyperbaric Oxygen for Brain Radionecrosis|Unknown status|Active, not recruiting|N/A|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:50:15.609762|2017-02-18 17:50:15.609762
NCT00087802|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-13|2009-04-15|||March 2004||2004-03-01|April 2009|2009-04-01||||May 2007|Actual|2007-05-01||Interventional|||Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)|A Phase III Randomized Trial of Gemcitabine/Oxaliplatin (GEMOX) Versus Carboplatin/Paclitaxel (CP) as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|383|Actual|Sanofi||2|||f||||||||||||||2017-02-18 17:50:15.708946|2017-02-18 17:50:15.708946
NCT00087789|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-13|2016-10-27|||June 2004||2004-06-01|October 2016|2016-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease|A Phase I, Dose-Escalating Study to Assess the Safety and Tolerability of CERE-110 [Adeno-Associated Virus (AAV)-Based Vector-Mediated Delivery of Beta-Nerve Growth Factor (NGF)] in Subjects With Mild to Moderate Alzheimer's Disease|Completed||Phase 1|10|Actual|Sangamo Therapeutics||1|||f||||t||||||||||2017-02-18 17:50:15.860872|2017-02-18 17:50:15.860872
NCT00087776|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-13|2011-03-16|||October 2002||2002-10-01|March 2011|2011-03-01||||October 2007|Actual|2007-10-01||Interventional|||Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma|Phase III Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma|Completed||N/A|575|Anticipated|Luitpold Pharmaceuticals|||||||||||||||||||2017-02-18 17:50:15.948609|2017-02-18 17:50:15.948609
NCT00087763|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-13|2006-05-02|||March 2004||2004-03-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)|A Phase II Prospective, Randomized, Double-Masked, Sham-Controlled, Dose-Ranging, Multi-Center Trial to Assess the Effect of Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)|Completed||Phase 2|135||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 17:50:16.027594|2017-02-18 17:50:16.027594
NCT00087750|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-13|2017-01-10|||October 2003||2003-10-01|March 2005|2005-03-01||||||||Interventional|||Interaction Between Cocaine and Quetiapine - 1|Interaction Between IV Cocaine and Quetiapine|Unknown status|Active, not recruiting|Phase 1|12||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:50:16.101145|2017-02-18 17:50:16.101145
NCT00087737|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-13|2009-08-18||||||August 2009|2009-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|369|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:50:16.468545|2017-02-18 17:50:16.468545
NCT00087724|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2012-06-06|||July 2004||2004-07-01|June 2012|2012-06-01|September 2006|Actual|2006-09-01|||||Interventional|||A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of FK962 in Subjects With Mild to Moderate Alzheimer's Disease|Terminated||Phase 2|510||Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:50:16.551999|2017-02-18 17:50:16.551999
NCT00087711|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2016-11-21|||July 2004||2004-07-01|November 2016|2016-11-01|March 2008|Actual|2008-03-01|January 2007|Actual|2007-01-01||Interventional|||A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer|A Randomized Phase 3 Trial of ALIMTA and Cisplatin Versus GEMZAR and Cisplatin in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|1713|Actual|Eli Lilly and Company||2|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 17:50:16.724736|2017-02-18 17:50:16.724736
NCT00087698|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2009-05-01|2009-02-16||September 2003||2003-09-01|May 2009|2009-05-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma|A Multicenter Phase II Trial of Neo-Adjuvant Pemetrexed (Alimta) Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma|Completed||Phase 2|77|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 17:50:16.977989|2017-02-18 17:50:16.977989
NCT00087685|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2016-01-06|2015-12-01||June 2004||2004-06-01|January 2016|2016-01-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||RAD001 in Recurrent Endometrial Cancer Patients|A Phase II Study of RAD001 in Patients With Recurrent Endometrial Cancer|Completed||Phase 2|35|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:50:17.772899|2017-02-18 17:50:17.772899
NCT00087672|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2012-08-01|2009-09-15||July 2004||2004-07-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||A Phase II Study of CC-5013 in Myelofibrosis|Phase II Study of CC-5013 in Myelofibrosis|Completed||Phase 2|41|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:50:18.156891|2017-02-18 17:50:18.156891
NCT00087659|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2009-11-20|||December 2003||2003-12-01|November 2009|2009-11-01|May 2007|Actual|2007-05-01|||||Interventional|||A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy||Completed||N/A|||Novartis|||||||||||||||||||2017-02-18 17:50:18.449875|2017-02-18 17:50:18.449875
NCT00087646|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2015-12-10|2015-12-10||September 2003||2003-09-01|December 2015|2015-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional||Intent-to-treat analysis population (ITT) included, all participants randomized who received at least one dose of study medication.|REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy|A Randomized, Open-label Study of the Effect of PEGASYS Combined With Ribavirin on Sustained Virologic Response in Patients With Chronic Hepatitis C Who Did Not Respond to Previous Pegintron/Ribavirin Combination Therapy|Completed||Phase 4|948|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 17:50:18.574996|2017-02-18 17:50:18.574996
NCT00087633|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2010-12-22|2009-10-14||October 2004||2004-10-01|December 2010|2010-12-01|October 2008|Actual|2008-10-01|||||Interventional|||PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.|A Randomized, Open-label Study of Prophylactic Administration of PEGASYS Plus Ribavirin After Liver Transplantation on Hepatitis C Recurrence in Patients With Hepatitis C|Completed||Phase 4|115|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:50:20.158034|2017-02-18 17:50:20.158034
NCT00087620|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2017-02-02|||September 2004|Actual|2004-09-01|February 2017|2017-02-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer||Terminated||Phase 4|||Hoffmann-La Roche|||||||||||||||||||2017-02-18 17:50:20.600135|2017-02-18 17:50:20.600135
NCT00087607|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2016-05-24|2016-04-05||January 2004||2004-01-01|May 2016|2016-05-01|April 2006|Actual|2006-04-01|March 2006|Actual|2006-03-01||Interventional||Baseline characteristics were described for the Intent-to-Treat (ITT) Population, which included all participants who were randomized and received at least one dose of study medication (Pegylated interferon [PEG-IFN] or ribavirin).|Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).|A Prospective, Randomized, Open-label Study Evaluating the Viral Kinetics and Pharmacokinetics of Pegasys® Plus Copegus® and PEG-Intron® Plus Rebetol® in Interferon-naïve Patients With Chronic Hepatitis C.|Completed||Phase 4|385|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:50:20.993782|2017-02-18 17:50:20.993782
NCT00087594|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2016-02-04|2015-12-03||November 2003||2003-11-01|February 2016|2016-02-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional||Intent-to-treat (ITT) Population included all enrolled participants who received at least one dose of study medication.|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.|An Open-Label, Multi-Center, Randomized, Safety, Feasibility and Tolerability Pilot Study of Pegasys® (Peginterferon Alfa-2a) Plus Copegus® (Ribavirin) in Previous Intravenous Drug Users Who Are Currently Enrolled in a Methadone Maintenance Treatment Program.|Completed||Phase 4|48|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:50:22.093601|2017-02-18 17:50:22.093601
NCT00087581|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2016-11-03|||June 2004||2004-06-01|September 2016|2016-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation|An Open-Label, Prospective, Randomized, Controlled, Multi-Center Study Assessing Fixed Dose Versus Concentration Controlled Cellcept® Regimens for Patients Following a Single Organ Renal Transplantation in Combination With Full Dose and Reduced Dose Calcineurin Inhibitors|Completed||Phase 4|720|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:50:23.015662|2017-02-18 17:50:23.015662
NCT00087568|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2016-05-02|2016-02-03||January 2003||2003-01-01|May 2016|2016-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional||Intent-to-treat (ITT) Population included all enrolled participants who received at least one dose of study medication (Pegasys or ribavirin).|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin|An Open-label, Multicenter, Efficacy and Safety Study of Pegasys® Plus Ribavirin in Patients With Chronic HCV Infection Who Are Unable to Tolerate or Who Do Not Respond to 12 Weeks of Therapy With PEGIntron ® Plus Ribavirin|Completed||Phase 4|57|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:50:23.457013|2017-02-18 17:50:23.457013
NCT00087555|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-12|2012-01-20|2011-10-17||July 2004||2004-07-01|January 2012|2012-01-01|January 2006|Actual|2006-01-01|April 2005|Actual|2005-04-01||Interventional|||Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem(R) (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia|Completed||Phase 2|195|Actual|Jazz Pharmaceuticals||3|||f||||f||||||||||2017-02-18 17:50:24.213075|2017-02-18 17:50:24.213075
NCT00087542|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-09|2005-12-05|||March 2004||2004-03-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug||Completed||Phase 2|60||ACADIA Pharmaceuticals Inc.|||||||||||||||||||2017-02-18 17:50:25.216303|2017-02-18 17:50:25.216303
NCT00087529|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-09|2015-08-10|2015-08-10||June 2004||2004-06-01|August 2015|2015-08-01||||October 2007|Actual|2007-10-01||Interventional|OLYMPUS|Intent-to-Treat (ITT) Population: All randomized participants, with groups defined by treatment assigned at randomization.|A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis|A Phase II/III, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis|Completed||Phase 2/Phase 3|439|Actual|Genentech, Inc.||2|||f||||||||||||||2017-02-18 17:50:25.324717|2017-02-18 17:50:25.324717
NCT00086476|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2017-01-24|||June 29, 2004||2004-06-29|June 13, 2011|2011-06-13|June 13, 2011||2011-06-13|||||Observational|||Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles|Investigations of Megakaryocytes From Patients With Abnormal Platelet Vesicles|Completed||N/A|3|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:50.965677|2017-02-18 17:50:50.965677
NCT00087516|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-09|2015-06-08|2010-05-10||June 2004||2004-06-01|June 2015|2015-06-01|February 2007|Actual|2007-02-01|July 2005|Actual|2005-07-01||Interventional|||Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of MK0431 Monotherapy in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control|Completed||Phase 3|741|Actual|Merck Sharp & Dohme Corp.||4|||f||||||||||||||2017-02-18 17:50:25.942013|2017-02-18 17:50:25.942013
NCT00087503|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-09|2008-03-27|||April 2004||2004-04-01|March 2008|2008-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy|A Phase II Efficacy And Safety Study Intravenous Edotecarin In Patients With Advanced Gastric Cancer That Has Progressed Or Recurred After Prior Fluropyrimidine-Based Chemotherapy|Completed||Phase 2|28||Pfizer|||||f||||||||||||||2017-02-18 17:50:27.276356|2017-02-18 17:50:27.276356
NCT00087490|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-09|2012-06-29|2012-06-29||October 2004||2004-10-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)|Linezolid in the Treatment of Subjects With Complicated Skin and Soft Tissue Infections Proven to be Due to Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 4|1077|Actual|Pfizer|Comparing duration of intravenous (IV) therapy for linezolid (LZD) and vancomycin (VAN) in study, participants in LZD group had option to switch to oral therapy while those in VAN group had to remain on IV therapy until completion of study treatment.||||f||||||||||||||2017-02-18 17:50:27.409239|2017-02-18 17:50:27.409239
NCT00087477|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2005-08-26|||January 2004||2004-01-01|August 2005|2005-08-01|August 2004||2004-08-01|||||Interventional|||A Pilot Study of Pivanex in Patients With Malignant Melanoma|A Pilot Study of Pivanex, a Histone Deacetylase Inhibitor, in Patients With Malignant Melanoma|Terminated||Phase 1/Phase 2|14||Titan Pharmaceuticals|||||||||||||||||||2017-02-18 17:50:29.155013|2017-02-18 17:50:29.155013
NCT00087464|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Three Month Course of Anti-HIV Medications for People Recently Infected With HIV|Tenofovir, Emtricitabine, and Nevirapine for Recently HIV-Infected Subjects: Can Short-Course, Once Daily Therapy Reduce the Viral Load at 12 Months From Estimated Date of Infection?|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||||study was withdrawn before any participants were recruited and enrolled|||||||||||||||2017-02-18 17:50:29.439153|2017-02-18 17:50:29.439153
NCT00087451|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2015-08-18|||July 2004||2004-07-01|August 2015|2015-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)|A Phase I Sequential Ascending Dose Trial of AP23573 in Patients With Progressive or Recurrent Malignant Glioma|Completed||Phase 1|11|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:50:29.544623|2017-02-18 17:50:29.544623
NCT00087438|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2016-12-30|2014-02-25||May 2004||2004-05-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2010|Actual|2010-03-01||Interventional||All eligible patients who received protocol treatment.|Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer|A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients With Medically Inoperable Stage I/II Non-Small Cell Lung Cancer|Completed||Phase 2|59|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 17:50:29.645619|2017-02-18 17:50:29.645619
NCT00087425|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2015-04-29|||July 2004||2004-07-01|January 2007|2007-01-01||||October 2007|Actual|2007-10-01||Interventional|||Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|A Phase II Trial Of Bryostatin-1 In Combination With Rituximab In Rituximab-Refractory Indolent B-cell Non Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia|Completed||Phase 2|48|Anticipated|National Cancer Institute (NCI)||1|||||||||||||||||2017-02-18 17:50:30.001518|2017-02-18 17:50:30.001518
NCT00087412|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-02-27|||September 2004||2004-09-01|February 2013|2013-02-01||||July 2007|Actual|2007-07-01||Interventional|||S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer|Phase II Trial of OSI-774 (NSC-718781) in Patients With Advanced Non-Small Cell Lung Cancer and a Performance Status of 2|Completed||Phase 2|65|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:30.110611|2017-02-18 17:50:30.110611
NCT00087399|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2016-07-12|||November 2004||2004-11-01|July 2016|2016-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy|A Phase III Randomized, Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone|Completed||Phase 3|118|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:50:30.243487|2017-02-18 17:50:30.243487
NCT00087386|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-04-09|||June 2004||2004-06-01|April 2013|2013-04-01||||February 2007|Actual|2007-02-01||Interventional|||Tanespimycin in Treating Patients With Stage III-IV Melanoma|Phase II Trial of 17-N-allylamino-17-demethoxy Geldanamycin (17-AAG, NSC #330507) Diluted in EPL Diluent (NSC #704057) in Metastatic Melanoma Patients|Terminated||Phase 2|50|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:30.534572|2017-02-18 17:50:30.534572
NCT00087373|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-06-06|||June 2004||2004-06-01|December 2012|2012-12-01||||February 2006|Actual|2006-02-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Phase II Study of Intratumoral Injection of rF-TRICOMTM in Patients With Metastatic Melanoma Who Have Detectable Tumor Associated T Cells|Terminated||Phase 2|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:30.648832|2017-02-18 17:50:30.648832
NCT00087360|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-07-10|||November 2003||2003-11-01|July 2013|2013-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants|Providing Genetic And Environmental Cancer Risk Assessment In Primary Care|Completed||N/A|||Fox Chase Cancer Center|||||f||||f||||||||||2017-02-18 17:50:30.767764|2017-02-18 17:50:30.767764
NCT00087347|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-05-12|||September 2004||2004-09-01|May 2013|2013-05-01||||September 2006|Actual|2006-09-01||Observational|||Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer|An NCI-Sponsored Exploratory Study For Determining Optimum Timing For The Imaging Of Intravenous Superparamagnetic Particle Ferumoxytol (Code7228) For The Differentiation of Metastatic and Non Metastatic Lymph Nodes in Patients With Known Primary Cancer Scheduled For Possible Surgical Lymph Node Biopsy/Dissection|Completed||N/A|14|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:50:30.870808|2017-02-18 17:50:30.870808
NCT00087334|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-31|||January 2004||2004-01-01|January 2013|2013-01-01||||November 2005|Actual|2005-11-01||Interventional|||Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer|A Phase I/II Study of Capecitabine (XELODA®, Roche) Plus Oxaliplatin (Eloxatin®, Sanofi) Plus ZD 1893 (IRESSA®) in the Treatment of Metastatic Colorectal Cancer|Terminated||Phase 1/Phase 2|10|Actual|Roswell Park Cancer Institute||||Withdrawn due to poor/low accrual|f||||||||||||||2017-02-18 17:50:30.983798|2017-02-18 17:50:30.983798
NCT00087295|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2012-10-31|||June 2004||2004-06-01|October 2012|2012-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium|A Phase II Study of Depsipeptide (NSC-630176) In Patients With Advanced Transitional Cell Carcinoma Of The Urinary Tract Who Have Progressed After Receiving One Prior Chemotherapy Regimen For Advanced Disease|Terminated||Phase 2|6|Actual|Southwest Oncology Group||1||Permanently Closed Due to Poor Accrual|f||||f||||||||||2017-02-18 17:50:31.093433|2017-02-18 17:50:31.093433
NCT00087282|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-06-21|||June 2004||2004-06-01|May 2005|2005-05-01|July 2006|Actual|2006-07-01|||||Interventional|||Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer|A Non-Randomized Phase II Study of Sequential Irinotecan (CPT-11) And Flavopiridol In Patients With Advanced Hepatoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:50:31.204404|2017-02-18 17:50:31.204404
NCT00087269|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-06-04|||December 2004||2004-12-01|June 2013|2013-06-01||||April 2006|Actual|2006-04-01||Interventional|||Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection|Phase II Study to Evaluate the Tumor Biochemical Effects of the EGFR Tyrosine Kinase Inhibitor OSI-774 (Erlotinib) Administered Prior to Surgical Resection in Patients With Early Stage Non-Small Cell Lung Cancer|Terminated||Phase 2|110|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:31.300637|2017-02-18 17:50:31.300637
NCT00087256|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-04|||July 2004||2004-07-01|January 2013|2013-01-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer|Celecoxib Polyp Prevention Trial in Participants With Resected Stage I Colon Cancer|Terminated||Phase 3|18|Actual|NSABP Foundation Inc||2||For scientific, logistic, and administrative reasons.|f||||f||||||||||2017-02-18 17:50:31.43213|2017-02-18 17:50:31.43213
NCT00087217|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-24|||May 2004||2004-05-01|January 2013|2013-01-01||||June 2008|Actual|2008-06-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor|Phase I Study of 17- Allylamino-17 Demethoxygeldanamycin (17-AAG) in Combination With Paclitaxel in Advanced Solid Malignancies|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:31.553868|2017-02-18 17:50:31.553868
NCT00087204|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-22|||May 2004||2004-05-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia|A Phase I Study Of XL119 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphocytic Leukemia, Or Chronic Myeloid Leukemia In Blastic-Phase|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:31.672744|2017-02-18 17:50:31.672744
NCT00087191|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-15|||May 2004||2004-05-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer|Distribution Of The Photosensitizer Motexafin Lutetium And Hypoxia In Patients With Malignancies|Terminated||N/A|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:50:31.785777|2017-02-18 17:50:31.785777
NCT00087178|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2016-06-03|||May 2004||2004-05-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2014|Actual|2014-03-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer|A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer|Completed||Phase 3|2722|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 17:50:31.940126|2017-02-18 17:50:31.940126
NCT00087165|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2011-08-18|||January 2005||2005-01-01|November 2005|2005-11-01||||||||Interventional|||GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer|A Phase II Study of GTI-2040 in Combination With Docetaxel and Prednisone in Hormone-Refractory Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:50:33.049895|2017-02-18 17:50:33.049895
NCT00087152|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-05-12|2011-07-13||June 2004||2004-06-01|February 2013|2013-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer|Phase II Trial Of Imatinib Mesylate (Gleevec®) (NSC-716051) In Combination With Capecitabine (Xeloda®) (NSC-712807) In Metastatic Breast Cancer|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)|Two-stage design, but did not have enough confirmed responses after the first stage to launch the second stage.|1|||f||||f||||||||||2017-02-18 17:50:33.164667|2017-02-18 17:50:33.164667
NCT00087139|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-04-21|2012-11-25||September 2004||2004-09-01|April 2013|2013-04-01|February 2011|Actual|2011-02-01|April 2009|Actual|2009-04-01||Interventional|||Ixabepilone in Treating Patients With Metastatic Prostate Cancer|Phase II Study of a Weekly Schedule of BMS-247550 for Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|124|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:33.510776|2017-02-18 17:50:33.510776
NCT00087126|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2015-05-29|||February 2005||2005-02-01|May 2015|2015-05-01||||January 2010|Actual|2010-01-01||Interventional|||Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation of Weekly Topotecan Hydrochloride (Hycamtin®, NSC #609699) in the Treatment of Persistent or Recurrent Carcinoma of the Cervix|Completed||Phase 2|27|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 17:50:34.307021|2017-02-18 17:50:34.307021
NCT00087113|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-02-12|||August 2004||2004-08-01|February 2014|2014-02-01||||June 2006|Actual|2006-06-01||Interventional|||Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix|A Phase II Evaluation Of Pemetrexed (ALIMTA, LY231517, IND #40061) In the Treatment Of Recurrent Carcinoma Of The Cervix|Completed||Phase 2|||Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:50:34.446495|2017-02-18 17:50:34.446495
NCT00086073|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-22|2011-02-15|||August 1998||1998-08-01|November 2010|2010-11-01|January 2011|Actual|2011-01-01|||||Observational|PROGENI||Parkinson's Research: The Organized Genetics Initiative|Parkinson's Disease Collaborative Study of Genetic Linkage|Completed||N/A|1800|Anticipated|Indiana University|||1||f||||f||||||Samples With DNA|"~     blood sample~   "|||2017-02-18 17:51:03.711771|2017-02-18 17:51:03.711771
NCT00087100|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-02-12|||May 2006||2006-05-01|February 2014|2014-02-01||||August 2007|Actual|2007-08-01||Interventional|||Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer|A Phase II Evaluation Of Pemetrexed (ALIMTA, LY231514, IND #40061) In The Treatment Of Recurrent Or Persistent Endometrial Carcinoma|Completed||Phase 2|51|Anticipated|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 17:50:34.582837|2017-02-18 17:50:34.582837
NCT00087087|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-02-12|||July 2004||2004-07-01|February 2014|2014-02-01||||December 2006|Actual|2006-12-01||Interventional|||Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation Of Pemetrexed (ALIMTA LY231514, IND #40061) In The Treatment Of Recurrent Or Persistent Platinum-Resistant Ovarian Or Primary Peritoneal Carcinoma|Completed||Phase 2|51|Anticipated|Gynecologic Oncology Group|||||f||||t||||||||||2017-02-18 17:50:34.705199|2017-02-18 17:50:34.705199
NCT00087074|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-06-03|||June 2004||2004-06-01|June 2013|2013-06-01||||December 2005|Actual|2005-12-01||Interventional|||CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor|A Trial of CCI-779 in Patients With Soft Tissue Sarcoma.|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:37.63227|2017-02-18 17:50:37.63227
NCT00087061|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-07-17|||May 2004||2004-05-01|May 2005|2005-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma|Oral ST1481 in Adults With Malignant Glioma: A Phase I-II Clinical Trial|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:50:37.740478|2017-02-18 17:50:37.740478
NCT00087048|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2016-03-21|||April 2004||2004-04-01|March 2016|2016-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer|The Use Of Weekly Topotecan As Second Line Therapy In Small Cell Lung Cancer|Terminated||Phase 2|1|Actual|Case Comprehensive Cancer Center||1||Slow accrual|f||||t||||||||||2017-02-18 17:50:37.837458|2017-02-18 17:50:37.837458
NCT00087035|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2015-10-01|||May 2004||2004-05-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|June 2006|Actual|2006-06-01||Interventional|||Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer|Phase II Trial Of TAXOTERE + TARCEVA™ To Treat HRPC In Men ≥ 65 Years Of Age|Completed||Phase 2|1|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:50:37.940372|2017-02-18 17:50:37.940372
NCT00087022|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-01-28||2014-01-28|July 2004||2004-07-01|January 2014|2014-01-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer|A Randomized, Double Blind Phase III Study To Evaluate Adjuvant cG250 Treatment Versus Placebo In Patients With Clear Cell RCC And High Risk of Recurrence (ARISER)|Completed||Phase 3|864|Actual|Wilex||2|||f||||t||||||||||2017-02-18 17:50:38.060551|2017-02-18 17:50:38.060551
NCT00087009|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-03-18|||May 2004||2004-05-01|March 2013|2013-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation|Phase I Study of Oral ß-Glucan and Intravenous Rituximab Among Children and Adolescents With Relapsed CD20-Positive Lymphoma or Leukemia, or Post-Transplant Lymphoproliferative Disease|Terminated||Phase 1|3|Actual|Memorial Sloan Kettering Cancer Center||2||Lack of Accrual|f||||||||||||||2017-02-18 17:50:40.976816|2017-02-18 17:50:40.976816
NCT00086996|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-09-04|2012-03-05||September 2004||2004-09-01|September 2013|2013-09-01|August 2011|Actual|2011-08-01|August 2009|Actual|2009-08-01||Interventional|||S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction|Oxaliplatin (NSC-266046) Plus Protracted Infusion 5-Fluorouracil And Radiation For Potentially Curable Esophageal Cancer: A Phase II Trial With Molecular Correlates|Completed||Phase 2|98|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:50:41.102548|2017-02-18 17:50:41.102548
NCT00086983|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-09|||May 2004||2004-05-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors|A Phase I Study of XL119 (Rebeccamycin Analogue) in Combination With Oxaliplatin in Patients With Refractory Solid Tumors|Terminated||Phase 1|15|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:41.97715|2017-02-18 17:50:41.97715
NCT00086970|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-23|||June 2004||2004-06-01|January 2013|2013-01-01||||November 2005|Actual|2005-11-01||Interventional|||Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors|A Phase I Study Of BG In Combination With Ifosfamide For Advanced Solid Tumors|Terminated||Phase 1|32|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 17:50:42.083624|2017-02-18 17:50:42.083624
NCT00086957|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2015-10-01|||January 2004||2004-01-01|October 2015|2015-10-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer|Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma|Completed||Phase 1/Phase 2|31|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 17:50:42.193487|2017-02-18 17:50:42.193487
NCT00086944|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-23|||May 2004||2004-05-01|January 2013|2013-01-01||||July 2006|Actual|2006-07-01||Interventional|||Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase I/II Study of G3139 (Genasense) in Combination With RICE Chemotherapy in Relapsed B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:42.312768|2017-02-18 17:50:42.312768
NCT00086931|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-03-07|||September 2003||2003-09-01|March 2013|2013-03-01|May 2010|Actual|2010-05-01|May 2007|Actual|2007-05-01||Interventional|||Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum|A Phase I/II Study of Weekly Intravenous Oxaliplatin in Combination With Oral Daily Capecitabine and Radiation Therapy in the Neoadjuvant Treatment of Rectal Cancer|Completed||Phase 1/Phase 2|37|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:50:42.436404|2017-02-18 17:50:42.436404
NCT00086892|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-02-12|||June 2004||2004-06-01|February 2014|2014-02-01||||April 2006|Actual|2006-04-01||Interventional|||Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Cetuximab (C225, NSC #714692) in Combination With Carboplatin (NSC #241240) in the Treatment of Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|||Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 17:50:42.551041|2017-02-18 17:50:42.551041
NCT00086879|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2012-09-20|||May 2004||2004-05-01|September 2012|2012-09-01||||March 2006|Actual|2006-03-01||Interventional|||Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme|Randomized Phase II of TARCEVA™ (Erlotinib) Versus Temozolomide Or BCNU in Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|110|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:50:42.993971|2017-02-18 17:50:42.993971
NCT00086866|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2015-02-09|||May 2004||2004-05-01|February 2015|2015-02-01||||January 2007|Actual|2007-01-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery|Randomized, Open Phase II Study of Immunization With the Recombinant MAGE-3 Protein Combined With Adjuvant AS02B or AS15 in Patients With Unresectable and Progressive Metastatic Cutaneous Melanoma|Unknown status|Active, not recruiting|Phase 2|165|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:50:43.110401|2017-02-18 17:50:43.110401
NCT00086840|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-01-23|||May 2004||2004-05-01|January 2013|2013-01-01||||August 2005|Actual|2005-08-01||Interventional|||CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|A Phase II Study of CCI-779 in Patients With Relapsed, Refractory or Transformed Chronic Lymphocytic Leukemia|Terminated||Phase 2|60|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:50:43.241507|2017-02-18 17:50:43.241507
NCT00086827|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2014-04-09|||May 2004||2004-05-01|December 2012|2012-12-01||||November 2006|Actual|2006-11-01||Interventional|||Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer|A Phase II Study of Single Agent Depsipeptide (FK228) (NSC 630176; IND 51,810) in Relapsed Small Cell Lung Cancer|Completed||Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:50:43.348171|2017-02-18 17:50:43.348171
NCT00086801|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2016-06-30|||May 2004||2004-05-01|June 2016|2016-06-01|May 2011|Actual|2011-05-01|March 2007|Actual|2007-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma|Phase II Trial of Doxorubicin, Vinblastine, and Gemcitabine (AVG) Chemotherapy for Non-Bulky Stage I and II Hodgkin's Lymphoma|Completed||Phase 2|104|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:50:43.459016|2017-02-18 17:50:43.459016
NCT00086775|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-08-01|||July 2003||2003-07-01|October 2009|2009-10-01|October 2009|Actual|2009-10-01|June 2005|Actual|2005-06-01||Interventional|||Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia|Phase II Trial Comparing Combination Treatment With Fludarabine and Alemtuzumab to Fludarabine and Rituximab in Patients With B-Cell Chronic Lymphocytic Leukemia Requiring Treatment After First Line Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:50:43.623391|2017-02-18 17:50:43.623391
NCT00086762|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2016-04-28|||June 2004||2004-06-01|April 2016|2016-04-01||||June 2017|Anticipated|2017-06-01||Interventional|||Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors|Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Community Clinical Oncology Program|Active, not recruiting||N/A|474|Anticipated|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 17:50:43.730304|2017-02-18 17:50:43.730304
NCT00086749|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2012-07-10|||February 2003||2003-02-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer|A Prospective Study Of The Effect Of Tamoxifen On Breast Density In Premenopausal Women|Completed||Phase 1|53|Actual|Northwestern University|||1||f||||||||||||||2017-02-18 17:50:43.856906|2017-02-18 17:50:43.856906
NCT00086736|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2013-11-17|||November 2001||2001-11-01|July 2013|2013-07-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy|A Randomized, Placebo-Controlled Phase IIb Clinical Trial of 2-Difluoromethylornithine (DFMO) Versus Bicalutamide (CASODEX) Alone and in Combination in Patients With Prostate Cancer in the Period Prior to Radical Prostatectomy or Brachytherapy: Modulation of Tissue and Molecular Biomarkers in Human Prostate Tissue Serum|Completed||Phase 2|34|Actual|University of Alabama at Birmingham||4|||f||||t||||||||||2017-02-18 17:50:43.956567|2017-02-18 17:50:43.956567
NCT00086723|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2012-06-07||2011-02-18|July 2003||2003-07-01|June 2012|2012-06-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer|Phase I/II Trial of In Vivo Angiostatin Generation With Tissue Plasminogen Activator (tPA) and Captopril in Patients With Progressive, Metastatic Cancer|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 17:50:44.070814|2017-02-18 17:50:44.070814
NCT00086710|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-08|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||Study of Enfuvirtide in HIV-Positive Subjects|An Open-label, Randomized, Cross-over Study in HIV-Positive Subjects to Determine and Compare the Single-dose Pharmacokinetics of Enfuvirtide after a Single 90 mg SC Administration|Completed||Phase 1|26||Trimeris|||||||||||||||||||2017-02-18 17:50:44.176044|2017-02-18 17:50:44.176044
NCT00086684|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-07|2014-04-02|2012-05-31||September 2003||2003-09-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis|Randomized, Double-Blind, Placebo-Controlled, Parallel Group Evaluation of the Efficacy and Tolerability of Two Different Doses of ELMIRON for the Treatment of Interstitial Cystitis|Terminated||Phase 4|369|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3||"Interim Analysis showed that study continuation was futile. No safety concerns were raised~   during the trial."|f||||f||||||||||2017-02-18 17:50:44.268543|2017-02-18 17:50:44.268543
NCT00086671|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-07|2013-01-02||2011-08-24|April 2004||2004-04-01|January 2013|2013-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)|A 24-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Finding, Safety, Tolerability, and Efficacy Study of the Human Anti-IL-12 Antibody ABT-874 in Subjects With Multiple Sclerosis With a 24-Week Double-Blind, Active Extension Phase|Completed||Phase 2|215|Actual|AbbVie||3|||f||||t||||||||||2017-02-18 17:50:45.668868|2017-02-18 17:50:45.668868
NCT00005339|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||February 1992||1992-02-01|June 2000|2000-06-01|April 2004|Actual|2004-04-01|||||Observational|||Risk of Post Transfusion Hepatitis C Virus Infection||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:06.97852|2017-02-18 18:15:06.97852
NCT00086658|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-07|2015-04-16|||March 2004||2004-03-01|April 2015|2015-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)|A Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- Sparing Effects of Mepolizumab in Subjects With Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of Subjects With HES|Completed||Phase 2|86|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:50:45.826911|2017-02-18 17:50:45.826911
NCT00086645|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-07|2014-07-16|||April 2004||2004-04-01|July 2014|2014-07-01|April 2007|Actual|2007-04-01|October 2006|Actual|2006-10-01||Interventional|||Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)|Citalopram Treatment in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior|Completed||Phase 2|149|Actual|Boston University||2|||f||||t||||||||||2017-02-18 17:50:45.960213|2017-02-18 17:50:45.960213
NCT00086632|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-07|2007-12-13|||July 2004||2004-07-01|January 2006|2006-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment|An Open-Label, Phase II Study of Ovarex® MAb-B43.13 as an Adjuvant Treatment to Platinum-Based Front-Line Chemotherapy of Advanced Epithelial Carcinoma of Ovarian, Tubal, or Peritoneal Origin|Terminated||Phase 2|40||Unither Pharmaceuticals||||closed by sponser|||||||||||||||2017-02-18 17:50:46.092371|2017-02-18 17:50:46.092371
NCT00086619|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-07|2013-09-26|2012-06-07||May 2004||2004-05-01|September 2013|2013-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women|Evaluation of Factors That Affect Skeletal Responses to PTH|Completed||Phase 2|80|Actual|Massachusetts General Hospital||2|||f||||t||||||||||2017-02-18 17:50:46.168156|2017-02-18 17:50:46.168156
NCT00086606|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-06|2013-01-17|||June 2004||2004-06-01|January 2013|2013-01-01|April 2006|Actual|2006-04-01|||||Interventional|||A Safety and Efficacy Study of Xolair in Peanut Allergy|A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Oral Food Challenge Trial of Xolair (Omalizumab) in Peanut Allergy|Terminated||Phase 2|150||Genentech, Inc.|||||f||||||||||||||2017-02-18 17:50:46.588875|2017-02-18 17:50:46.588875
NCT00086593|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-06|2016-10-05|||May 2004||2004-05-01|October 2016|2016-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia|A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of a Flexible Dose of Lamotrigine Compared to Placebo as an Adjunctive Therapy to an Atypical Antipsychotic Agent(s) in Subjects With Schizophrenia|Completed||Phase 3|209|Actual|GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:50:46.673322|2017-02-18 17:50:46.673322
NCT00086580|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-06|2014-02-10|2011-06-13||July 2004||2004-07-01|February 2014|2014-02-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients|A Phase III Randomized Trial to Evaluate the Efficacy and Safety of Second-Line Therapy With Fludarabine Plus Alemtuzumab vs. Fludarabine Alone in Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 3|335|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 17:50:47.089778|2017-02-18 17:50:47.089778
NCT00086567|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-02|2017-01-24|||June 29, 2004||2004-06-29|September 26, 2016|2016-09-26||||||||Observational|||Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers|A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse|Completed||N/A|8|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:48.967698|2017-02-18 17:50:48.967698
NCT00086554|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-02|2017-01-24|||July 1, 2004||2004-07-01|January 8, 2010|2010-01-08|January 8, 2010||2010-01-08|||||Observational|||Collection of Specimens for Study of Inflammatory Bowel Disease|Procurement of Clinical Specimens for Immunologic or Genetic Studies in Inflammatory Bowel Diseases|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:49.077924|2017-02-18 17:50:49.077924
NCT00086541|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-02|2007-05-03|||June 2004||2004-06-01|May 2007|2007-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy|A Phase 3, Randomized, Open-Label Study of the Safety and Efficacy of Two Dose Levels of Interferon Alfacon-1 (Infergen, CIFN) Plus Ribavirin Administered Daily for 48 Weeks Versus No Treatment in Hepatitis C Infected Patients Who Are Nonresponders to Previous Pegylated Interferon Alfa Plus Ribavirin Therapy|Completed||Phase 3|515|Actual|Valeant Pharmaceuticals International, Inc.||3|||||||||||||||||2017-02-18 17:50:49.162783|2017-02-18 17:50:49.162783
NCT00086528|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-02|2011-10-17|||June 2004||2004-06-01|October 2011|2011-10-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors|A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors|Completed||Phase 1|41|Actual|Kadmon Corporation, LLC||1|||f||||t||||||||||2017-02-18 17:50:49.24593|2017-02-18 17:50:49.24593
NCT00086515|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-02|2015-04-27|2010-11-19||June 2004||2004-06-01|April 2015|2015-04-01|February 2007|Actual|2007-02-01|July 2005|Actual|2005-07-01||Interventional|||Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)|A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK0431 to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy|Completed||Phase 3|701|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:50:49.343827|2017-02-18 17:50:49.343827
NCT00086502|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-02|2016-02-04|2010-03-30||June 2004||2004-06-01|February 2016|2016-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus|A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK0431 to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Pioglitazone Therapy|Completed||Phase 3|353|Actual|Merck Sharp & Dohme Corp.||2|||f||||||||||||||2017-02-18 17:50:50.333762|2017-02-18 17:50:50.333762
NCT00086489|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2012-06-05|||August 2003||2003-08-01|June 2012|2012-06-01|May 2009|Actual|2009-05-01|May 2007|Actual|2007-05-01||Interventional|||CP-675,206 In Patients With Advanced Melanoma|Phase 1 Open Label, Non-Randomized, Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Immune Function Effects, And Efficacy Of Multiple Doses Of CP-675,206 In Patients With Advanced Melanoma, And Phase 2, Open Label, Randomized Study To Evaluate the Efficacy, Safety, Tolerability And Pharmacokinetics Of 2 Regimens Of CP-675,206 In Patients With Advanced Melanoma.|Completed||Phase 2|118|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:50:50.860326|2017-02-18 17:50:50.860326
NCT00086463|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2011-03-31|||June 2004||2004-06-01|March 2011|2011-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)|A Safety and Pilot Efficacy Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With PAH|Completed||Phase 2|60||Actelion|||||||||||||||||||2017-02-18 17:50:51.047494|2017-02-18 17:50:51.047494
NCT00086450|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2016-12-09|2016-09-13||April 2004||2004-04-01|December 2016|2016-12-01|December 2018|Anticipated|2018-12-01|July 2012|Actual|2012-07-01||Interventional|||Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM)|Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)|Active, not recruiting||Phase 3|1900|Actual|Icahn School of Medicine at Mount Sinai|Since the trial was not blinded, patients may have been treated differently on the basis of their surgical procedure.|2|||f||||t||||||||||2017-02-18 17:50:51.163652|2017-02-18 17:50:51.163652
NCT00086437|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2015-12-02|||July 2004||2004-07-01|December 2015|2015-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Observational|||Pharmacogenetics of Hypertriglyceridemia in Hispanics|Pharmacogenetics of Hypertriglyceridemia in Hispanics|Completed||N/A|274|Actual|University of California, Los Angeles|||1||f||||f||||||Samples With DNA|"~     Whole blood~   "|||2017-02-18 17:50:51.523749|2017-02-18 17:50:51.523749
NCT00086424|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2008-04-22|||July 2004||2004-07-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Epidemiology of Insulin Growth Factor (IGF) and Cardiovascular Events||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:50:51.600259|2017-02-18 17:50:51.600259
NCT00086411|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2014-01-24|2013-06-24||September 2003||2003-09-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|April 2008|Actual|2008-04-01||Interventional|||Comparing Smoking Treatment Programs for Lighter Smokers - 1|Comparing Smoking Treatment Programs for Lighter Smokers|Completed||Phase 2|260|Actual|University of Pennsylvania|Missing data from some early terminations from treatment (i.e., 2 or less visits) may reflect dissatisfaction with counseling assignment or medication effects.|4|||f||||t||||||||||2017-02-18 17:50:51.668842|2017-02-18 17:50:51.668842
NCT00086398|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2005-11-03|||September 2001||2001-09-01|November 2005|2005-11-01||||||||Interventional|||Psychotherapy Enhancement for Therapeutic Community (TC) Retention - 1|Psychotherapy Enhancement for TC Retention|Unknown status|Recruiting|Phase 2|100||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:50:52.15079|2017-02-18 17:50:52.15079
NCT00086385|ClinicalTrials.gov processed this data on February 17, 2017|2004-07-01|2015-03-03|2013-07-29||September 2001||2001-09-01|March 2015|2015-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Maintaining Nonsmoking: Older Smokers - 1|Maintaining Nonsmoking: Older Smokers|Completed||Phase 3|403|Actual|University of California, San Francisco|The limitations of this study include generalizability, as the population treated was relatively well-educated, willing to participate in research and to attend treatment sessions.|4|||f||||f||||||||||2017-02-18 17:50:52.234035|2017-02-18 17:50:52.234035
NCT00086372|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-30|2012-10-26|||July 2003||2003-07-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|||||Observational|||Long-term Follow-up of HIV Infected Patients Identified During Early Infection|Acute HIV Infection and Early Disease Research Program (AIEDRP) CORE01 Database|Completed||N/A|157|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:50:52.814621|2017-02-18 17:50:52.814621
NCT00086359|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-30|2014-12-22|||July 2004||2004-07-01|December 2014|2014-12-01|September 2007|Actual|2007-09-01|||||Interventional|||Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV|A Phase III Randomized Trial of the Safety and Antiretroviral Effects of Zidovudine/Lamivudine/Abacavir Versus Zidovudine/Lamivudine/Lopinavir/Ritonavir in the Prevention of Perinatal Transmission of HIV|Completed||Phase 3|19|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:50:52.928466|2017-02-18 17:50:52.928466
NCT00086346|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-30|2010-04-20|2009-07-06||December 2002||2002-12-01|April 2010|2010-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients|A Randomized, Open-Label, Comparative Evaluation of Conversion From Calcineurin Inhibitor Treatment to Sirolimus Treatment Versus Continued Calcineurin Inhibitor Treatment in Liver Allograft Recipients Undergoing Maintenance Therapy|Terminated||Phase 3|607|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||t||||||||||2017-02-18 17:50:53.071524|2017-02-18 17:50:53.071524
NCT00086333|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-30|2011-10-21|||July 2004||2004-07-01|October 2011|2011-10-01|December 2005|Actual|2005-12-01|||||Interventional|||FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma|A Phase II Study Using FDG-PET to Investigate the Dosing Schedule and Response of Combination SGN-15 (cBR96-Doxorubicin Immunoconjugate) and Docetaxel in Patients With Stage IV or Stage IIIB Non-Small Cell Lung Carcinoma Ineligible for Combined Modality Treatment With Curative Intent|Completed||Phase 2|30||Seattle Genetics, Inc.|||||||||||||||||||2017-02-18 17:50:54.424432|2017-02-18 17:50:54.424432
NCT00086320|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-30|2011-06-06|||March 2004||2004-03-01|April 2010|2010-04-01|August 2005|Actual|2005-08-01|||||Interventional|||A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.|A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Evaluating Paliperidone Extended Release Tablets in the Prevention of Recurrence in Subjects With Schizophrenia|Completed||Phase 3|111|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:50:54.51939|2017-02-18 17:50:54.51939
NCT00086307|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-29|2013-01-11|2012-06-07||June 2004||2004-06-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Lexapro and Pramipexole and to Treat Major Depression|Combining a Dopamine Agonist and Selective Serotonin Reuptake Inhibitor for Treatment of Depression: A Double-Blind, Randomized Study|Completed||Phase 2|39|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-02-18 17:50:54.624664|2017-02-18 17:50:54.624664
NCT00086294|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-29|2017-01-24|||June 25, 2004||2004-06-25|November 15, 2007|2007-11-15|November 15, 2007||2007-11-15|||||Interventional|||ACP-103 to Treat Parkinson's Disease|5HT2A/C Serotonin Blockade in Parkinson's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:50:55.249431|2017-02-18 17:50:55.249431
NCT00086060|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-22|2011-10-06|||May 2004||2004-05-01|October 2011|2011-10-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Pain Management Techniques for Fibromyalgia|Locus of Pain Control: Neural Substrates and Modifiability|Completed||Phase 1/Phase 2|97|Actual|University of Michigan||4|||f||||f||||||||||2017-02-18 17:51:03.87362|2017-02-18 17:51:03.87362
NCT00086281|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-29|2012-01-20|2011-11-11||November 2003||2003-11-01|January 2012|2012-01-01|November 2005|Actual|2005-11-01|June 2005|Actual|2005-06-01||Interventional|||Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients|Randomized, Placebo-Controlled Multicenter Trial of the Effects of Orally Administered Xyrem (Sodium Oxybate) and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients|Completed||Phase 4|60|Actual|Jazz Pharmaceuticals||4|||f||||f||||||||||2017-02-18 17:50:55.361849|2017-02-18 17:50:55.361849
NCT00086268|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-29|2013-04-15|||April 2004||2004-04-01|April 2013|2013-04-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|ZPACT||Non-small Cell Lung Cancer Study US75 (Z-PACT)||Completed||Phase 3|250|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:50:56.7808|2017-02-18 17:50:56.7808
NCT00086255|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-29|2017-01-11|||October 2002||2002-10-01|August 2008|2008-08-01|June 2004||2004-06-01|||||Interventional|||Tiagabine for the Treatment of Cocaine Dependence - 1|Tiagabine for the Treatment of Cocaine Dependence|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:50:57.056345|2017-02-18 17:50:57.056345
NCT00086242|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-28|2009-07-20||||||November 2006|2006-11-01||||||||Interventional|||Telephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stage I, Stage II, or Stage III Cervical Cancer|Stress-Immune Response and Cervical Cancer|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:50:57.158932|2017-02-18 17:50:57.158932
NCT00086229|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-28|2006-08-16|||April 2004||2004-04-01|August 2006|2006-08-01|January 2006||2006-01-01|||||Interventional|||Absorption and Distribution of Glucosamine and Chondroitin|A Pharmacokinetic Study of Glucosamine and Chondroitin|Completed||N/A|70||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:50:57.267191|2017-02-18 17:50:57.267191
NCT00086216|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-28|2007-12-20|||May 2004||2004-05-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma|An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Refractory or Relapsed Multiple Myeloma|Completed||Phase 1/Phase 2|30|Actual|Callisto Pharmaceuticals||1|||f||||f||||||||||2017-02-18 17:50:57.355243|2017-02-18 17:50:57.355243
NCT00086203|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-28|2015-03-24||||||August 2006|2006-08-01|September 2007||2007-09-01|||||Interventional|||Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)||Completed||Phase 2|||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 17:50:57.445852|2017-02-18 17:50:57.445852
NCT00086190|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-28|2013-01-03|2012-01-11||June 2005||2005-06-01|January 2013|2013-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|SAD-PD||Study of Antidepressants in Parkinson's Disease|Study of Antidepressants in Parkinson's Disease|Completed||Phase 3|115|Actual|University of Rochester||3|||f||||t||||||||||2017-02-18 17:50:57.557135|2017-02-18 17:50:57.557135
NCT00086177|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-25|2010-08-18|||April 2004||2004-04-01|August 2010|2010-08-01|March 2009|Actual|2009-03-01|January 2007|Actual|2007-01-01||Interventional|||Vaginal Progesterone to Reduce the Risk of Another Preterm Birth|A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy, Safety, and Tolerability of 8% Progesterone Vaginal Gel in Preventing Preterm Delivery in Pregnant Women at Increased-Risk for Preterm Delivery|Completed||Phase 3|636|Actual|Juniper Pharmaceuticals, Inc.||2|||f||||f||||||||||2017-02-18 17:51:02.516055|2017-02-18 17:51:02.516055
NCT00086164|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-25|2005-07-14|||May 2004||2004-05-01|July 2005|2005-07-01||||||||Interventional|||Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis|A Phase 1/2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Pilot Trial to Assess the Effect of Treatment of the Recipient Vein of a Polytetrafluoroethylene (PTFE) Vascular Access Graft With Two Concentrations of E2F Decoy as Compared to Placebo on Neointimal Hyperplasia and the Preservation of Graft Function in Patients With Chronic Renal Failure Requiring Hemodialysis|Terminated||Phase 1/Phase 2|||Anesiva, Inc.|||||||||||||||||||2017-02-18 17:51:02.676634|2017-02-18 17:51:02.676634
NCT00086151|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-25|2016-07-28|||July 2004||2004-07-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Identifying Low-Risk Patients With Pulmonary Embolism||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:51:02.776643|2017-02-18 17:51:02.776643
NCT00086138|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-25|2013-09-17|||July 2004||2004-07-01|September 2013|2013-09-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|DIADS-2||Depression in Alzheimer's Disease-2|Depression in Alzheimer's Disease (DIADS-2)|Completed||Phase 2/Phase 3|131|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 17:51:02.848693|2017-02-18 17:51:02.848693
NCT00086125|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-24|2015-08-18|||June 2004||2004-06-01|August 2015|2015-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)|A Phase II Study of AP23573, an mTOR Inhibitor, in Patients With Relapsed or Refractory Hematologic Malignancies|Completed||Phase 2|57|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 17:51:03.239369|2017-02-18 17:51:03.239369
NCT00086112|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-24|2012-07-19||||||July 2012|2012-07-01|June 2005|Actual|2005-06-01|||||Interventional|||Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.|A Double-blind, Randomized, Prospective Study to Evaluate Adjunctive Risperidone Versus Adjunctive Placebo in Generalized Anxiety Disorder Sub-optimally Responsive to Standard Psychotropic Therapy|Completed||Phase 3|301|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:51:03.382554|2017-02-18 17:51:03.382554
NCT00086099|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-23|2009-01-28|||July 2004||2004-07-01|January 2009|2009-01-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia|A Phase IB/II, Randomized, Open-Label, Multicenter Study Evaluating Whether the Addition of Amifostine (Ethyol®) Will Enable the Safe Increase in Dose Intensity of Idarubicin in Combination With Cytosine Arabinoside in Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia|Completed||Phase 1/Phase 2|54|Actual|MedImmune LLC||2|||f||||||||||||||2017-02-18 17:51:03.471543|2017-02-18 17:51:03.471543
NCT00086086|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-23|2017-02-07|||August 2003||2003-08-01|February 2017|2017-02-01||||||||Interventional|||Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Effects of Treatment With 2 Regimens of Subcutaneous Darbepoetin Alfa (Weight-based Dosing and Fixed Dosing) on Hemoglobin Concentration Response in Subjects With Symptomatic CHF and Anaemia|Completed||Phase 2|150||Amgen|||||||||||||||||||2017-02-18 17:51:03.600573|2017-02-18 17:51:03.600573
NCT00086047|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-22|2013-11-01|2011-08-12||July 2004||2004-07-01|October 2013|2013-10-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional|||Coping Skills Training for Adolescents With Fibromyalgia|Randomized Clinical Trial in Juvenile Fibromyalgia|Completed||Phase 3|114|Actual|Children's Hospital Medical Center, Cincinnati||2|||f||||t||||||||||2017-02-18 17:51:03.991899|2017-02-18 17:51:03.991899
NCT00086034|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-21|2007-05-11||||||May 2007|2007-05-01||||||||Interventional|||Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma|Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|Completed||Phase 2|35||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:51:04.379591|2017-02-18 17:51:04.379591
NCT00086021|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-21|2007-06-08|||February 2002||2002-02-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Acupuncture for the Treatment of Chronic Daily Headaches|Acupuncture for the Treatment of Chronic Daily Headaches|Completed||N/A|74||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:51:04.48753|2017-02-18 17:51:04.48753
NCT00085995|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-18|2017-01-24|||June 15, 2004||2004-06-15|April 27, 2016|2016-04-27||||||||Observational|||Progression of Spinal Fusion in Ankylosing Spondylitis|Progression of Spinal Fusion in Ankylosing Spondylitis|Recruiting||N/A|75|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:04.577897|2017-02-18 17:51:04.577897
NCT00085982|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-18|2017-01-24|||July 24, 2003||2003-07-24|September 23, 2016|2016-09-23|January 1, 2030|Anticipated|2030-01-01|January 1, 2030|Anticipated|2030-01-01||Interventional|||Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance|Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance|Recruiting||Phase 2|20|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:51:04.692605|2017-02-18 17:51:04.692605
NCT00085969|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-18|2015-02-19|||September 2003||2003-09-01|January 2015|2015-01-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus|A Phase 2, Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|99|Actual|AstraZeneca||6|||f||||f||||||||||2017-02-18 17:51:04.806522|2017-02-18 17:51:04.806522
NCT00085956|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-18|2007-03-07|||April 2004||2004-04-01|March 2007|2007-03-01|February 2007||2007-02-01|||||Interventional|||Effects of Arzoxifene on Bone Mass and the Uterus|Effects of Arzoxifene on Bone Mineral Density and Endometrial Histology in Postmenopausal Women.|Completed||Phase 3|300||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:51:05.200729|2017-02-18 17:51:05.200729
NCT00085943|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-17|2011-05-12|||May 2004||2004-05-01|May 2011|2011-05-01||||||||Interventional|||KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks|See Detailed Description|Completed||Phase 3|866||GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:51:05.293903|2017-02-18 17:51:05.293903
NCT00085930|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-17|2016-10-13|||April 2003||2003-04-01|October 2016|2016-10-01|December 2021|Anticipated|2021-12-01|January 2010|Actual|2010-01-01||Interventional|NESTLES||Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients|Administration of Peripheral Blood T-Cells and EBV Specific CTLs Transduced to Express GD-2 Specific Chimeric T Cell Receptors to Patients With Neuroblastoma|Active, not recruiting||Phase 1|19|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:51:05.54607|2017-02-18 17:51:05.54607
NCT00085917|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-16|2011-06-21|2010-04-12||June 2004||2004-06-01|June 2011|2011-06-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|PIFNPK||Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients|A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Twice-Weekly Peginterferon Alpha 2a and Ribavirin Induction Therapy for Chronic Hepatitis C in Patients Who Are Coinfected With HIV-1|Completed||Phase 2|29|Actual|National Institutes of Health Clinical Center (CC)|Small number of enrolled participants|2|||f||||f||||||||||2017-02-18 17:51:05.652014|2017-02-18 17:51:05.652014
NCT00085904|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-16|2008-10-09|||April 2004||2004-04-01|October 2008|2008-10-01||||||||Interventional|||Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas|A Phase I, Dose-Escalation Study to Assess the Safety and Pharmacokinetics of SB- 485232 Administered as Five Daily Intravenous Infusions Repeated Every 28 Days in Adult Patients With Solid Tumors and Lymphomas|Completed||Phase 1|12|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:51:06.100855|2017-02-18 17:51:06.100855
NCT00085891|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-16|2009-03-24|||June 2004||2004-06-01|March 2009|2009-03-01|September 2005|Actual|2005-09-01|||||Interventional|||Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia|A 6-Week, Multicenter, Double-Blind, Double-Dummy, Randomized Comparison of the Efficacy and Safety of Sustained-Release Formulation Quetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Acutely Ill Patients With Schizophrenia|Completed||Phase 3|535||AstraZeneca|||||||||||||||||||2017-02-18 17:51:06.191425|2017-02-18 17:51:06.191425
NCT00085878|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-16|2008-10-15|||January 2003||2003-01-01|October 2008|2008-10-01||||||||Interventional|||Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors|A Phase I, Dose Escalation Study to Assess the Safety and Pharmacokinetics of SB- 485232 Administered as Daily Subcutaneous Injections in Adult Patients With Solid Tumors|Completed||Phase 1|25|Actual|GlaxoSmithKline|||||||||||||||||||2017-02-18 17:51:06.314165|2017-02-18 17:51:06.314165
NCT00085865|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-15|2008-03-03|||June 2004||2004-06-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Observational|||Serotonin Transporters in Alcoholism|PET Evaluation of Serotonin Transporters Using [C-11] DASB in Alcoholism|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:06.396689|2017-02-18 17:51:06.396689
NCT00085852|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-15|2008-02-27|||April 2005||2005-04-01|February 2008|2008-02-01|June 2007|Actual|2007-06-01|October 2006|Actual|2006-10-01||Interventional|||US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation|Phase 1 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Heterogeneous Emphysema|Completed||Phase 1|6|Actual|Aeris Therapeutics||1|||f||||t||||||||||2017-02-18 17:51:06.491277|2017-02-18 17:51:06.491277
NCT00085839|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-15|2012-08-06|2011-03-28||February 2004||2004-02-01|August 2012|2012-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2|A Randomized Phase II Study of Single Agent Erlotinib [Tarceva (TM), OSI-774] Versus Standard Chemotherapy in Patients With Previously Untreated Advanced NSCLC and a Poor Performance Status|Completed||Phase 2|103|Actual|Astellas Pharma Inc||2|||f||||f||||||||||2017-02-18 17:51:06.612827|2017-02-18 17:51:06.612827
NCT00085826|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-15|2011-10-18|||April 2001||2001-04-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|||||Interventional|||A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients|A Phase III, Randomized, Double-Blind, Multi-Center Study of the Efficacy of Taxotere (Docetaxel) in Combination With Aptosyn (Exisulind) Versus Taxotere (Docetaxel) and Placebo in Non-Small Cell Lung Cancer (NSCLC) Patients After Failure of Prior Platinum-Based Chemotherapy|Completed||Phase 3|600||Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:51:07.249624|2017-02-18 17:51:07.249624
NCT00085813|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2010-10-01|||December 2003||2003-12-01|October 2010|2010-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer|A Phase II, Open-Label Study of Ispinesib in Subjects With Locally Advanced or Metastatic Platinum-Refractory or Platinum-Relapsed Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|70||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:51:07.713805|2017-02-18 17:51:07.713805
NCT00085800|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2008-04-22|||May 2004||2004-05-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Dietary Fiber and Cardiovascular Inflammatory Markers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:51:07.824009|2017-02-18 17:51:07.824009
NCT00085787|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2012-09-28|||June 2004||2004-06-01|September 2012|2012-09-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||A Study of ARRY-142886 in Patients With Advanced Cancer||Completed||Phase 1|57|Actual|Array BioPharma||1|||f||||||||||||||2017-02-18 17:51:07.888131|2017-02-18 17:51:07.888131
NCT00085774|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2015-03-19|||June 2004||2004-06-01|March 2015|2015-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma|A Single-Dose Efficacy Comparison of Albuterol Hydrofluoroalkane (HFA) Breath-operated Inhaler (BOI) (Volare Easi-Breathe™) and Albuterol HFA Meter Dose Inhaler (MDI) (Volare™) in Adolescents and Adults With Exercise-Induced Bronchospasm|Completed||Phase 3|24|Actual|Teva Pharmaceutical Industries||3|||f||||f||||||||||2017-02-18 17:51:07.976518|2017-02-18 17:51:07.976518
NCT00085761|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2008-03-04||||||March 2008|2008-03-01||||||||Interventional|||Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy|An International, Multicenter, Randomized, Double-Blind, 12-Week Controlled Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy|Terminated||Phase 3|||NeurogesX||||Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes|||||||||||||||2017-02-18 17:51:08.085716|2017-02-18 17:51:08.085716
NCT00085748|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2011-06-06|||August 2004||2004-08-01|November 2010|2010-11-01|May 2005|Actual|2005-05-01|||||Interventional|||Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia|A Randomized, 6-Week Double-Blind, Placebo-Controlled Study With an Optional 24-Week Open-Label Extension to Evaluate the Safety and Tolerability of Flexible Doses of Paliperidone Extended Release in the Treatment of Geriatric Patients With Schizophrenia|Completed||Phase 3|114|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:51:08.167186|2017-02-18 17:51:08.167186
NCT00085735|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2017-02-09|||April 2004||2004-04-01|February 2017|2017-02-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma|A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial|Completed||Phase 3|549|Actual|Children's Oncology Group||6|||f||||||||||||||2017-02-18 17:51:08.281793|2017-02-18 17:51:08.281793
NCT00085722|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2015-10-09|||July 2004||2004-07-01|October 2015|2015-10-01|May 2016|Anticipated|2016-05-01|November 2008|Actual|2008-11-01||Interventional|||Joint Injections for Osteoarthritic Knee Pain|The Efficacy of Prolotherapy in Osteoarthritic Knee Pain|Active, not recruiting||Phase 1/Phase 2|111|Anticipated|University of Wisconsin, Madison||3|||f||||t||||||||||2017-02-18 17:51:08.638818|2017-02-18 17:51:08.638818
NCT00085709|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-14|2015-09-25|2012-06-05||July 2004||2004-07-01|September 2015|2015-09-01|August 2014|Actual|2014-08-01|March 2010|Actual|2010-03-01||Interventional|||S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML|A Phase III Study of the Addition of Gemtuzumab Ozogamicin (Mylotarg®) During Induction Therapy Versus Standard Induction With Daunomycin and Cytosine Arabinoside Followed by Consolidation and Subsequent Randomization to Post-Consolidation Therapy With Gemtuzumab Ozogamicin (Mylotarg®) or No Additional Therapy For Patients Under Age 61 With Previously Untreated De Novo Acute Myeloid Leukemia (AML)|Completed||Phase 3|637|Actual|Southwest Oncology Group||4|||f||||t||||||||||2017-02-18 17:51:08.785797|2017-02-18 17:51:08.785797
NCT00085696|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-11|2008-02-07|||May 2004||2004-05-01|February 2008|2008-02-01||||April 2006|Actual|2006-04-01||Interventional|||VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma|A Phase 2 Study of VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma|Completed||Phase 2|66||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:51:10.921108|2017-02-18 17:51:10.921108
NCT00085683|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2008-03-03|||June 2004||2004-06-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Herpes Virus-6 and Epilepsy|Human Herpesvirus-6 and Its Effect on the GABA/Glutamate Balance in the Cerebrospinal Fluid and in the Brain From Patients With Epilepsy|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:11.013742|2017-02-18 17:51:11.013742
NCT00085670|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2017-01-24|||June 9, 2004||2004-06-09|October 6, 2016|2016-10-06||||||||Observational|||Cytokine Gene Polymorphisms in Bone Marrow Failure|Cytokine Gene Polymorphisms in Bone Marrow Failure|Completed||N/A|79|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:11.174531|2017-02-18 17:51:11.174531
NCT00085657|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2017-01-24|||June 9, 2004||2004-06-09|May 21, 2009|2009-05-21|May 21, 2009||2009-05-21|||||Observational|||Brain Electrical Stimulation to Enhance Recovery After Stroke|Enhancement of Rehabilitative Treatment-Dependent Functional Recovery After Stroke by Transcranial Direct Current Stimulation (tDCS)|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:11.278233|2017-02-18 17:51:11.278233
NCT00085436|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-04-24|2013-04-24||December 2003||2003-12-01|October 2011|2011-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC|A Phase II Study Of Autologous Tumor/DC Vaccine (DC Vaccine) Combined With Interleukin-2 (IL-2) And Interferon-α-2a (IFNα-2a) In Patients With Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 2|18|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||f||||||||||2017-02-18 17:51:16.064235|2017-02-18 17:51:16.064235
NCT00085644|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2011-04-18|2009-11-30||January 2004||2004-01-01|April 2011|2011-04-01|July 2009|Actual|2009-07-01|December 2004|Actual|2004-12-01||Interventional|ATLAS||Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis|A Phase 3 Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis|Completed||Phase 3|315|Actual|Abbott|Interim results are shown for subjects after 12 weeks for efficacy parameters and 24 weeks for safety parameters. Subjects who discontinued the study before Week 12 and subjects with missing values were classified as nonresponders for efficacy.|2|||f||||f||||||||||2017-02-18 17:51:11.569061|2017-02-18 17:51:11.569061
NCT00085631|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-07-10|2013-04-10||March 2003||2003-03-01|July 2013|2013-07-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer|An International Multi Center Phase III Study of Chemoradiotherapy Versus Chemoradiotherapy Plus Hyperthermia for Locally Advanced Cervical Cancer|Terminated||Phase 3|101|Actual|Duke University|There are integrity issues with the currently available data, involving international institutions, in that several pieces of information relating to patient accrual and outcomes cannot be verified.|2||Study was closed because of slow accrual|f||||f||||||||||2017-02-18 17:51:13.21218|2017-02-18 17:51:13.21218
NCT00085579|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-12-11|||March 2004||2004-03-01|December 2012|2012-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase II Study of Maintenance Biotherapy With Interleukin-2 and Granulocyte-Macrophage Colony Stimulating Factor in Patients With Metastatic Melanoma With a Partial Response or Stable Disease After Systemic Therapy|Withdrawn||Phase 2|0|Actual|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:51:13.510408|2017-02-18 17:51:13.510408
NCT00085566|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-12-15|2015-12-15||March 2004||2004-03-01|December 2015|2015-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer|A Phase I/II Trial to Assess the Tolerability of RAD 001 With Gefitinib in Patients With Glioblastoma Multiforme and Prostate Cancer and Efficacy in Patients With Castrate Metastatic Prostate Cancer|Completed||Phase 1/Phase 2|61|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:51:13.598213|2017-02-18 17:51:13.598213
NCT00085553|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2017-01-31|||May 2004||2004-05-01|December 2016|2016-12-01||||May 2008|Actual|2008-05-01||Interventional|||Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors|Phase I Trial of R115777 and OSI-774 in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|29|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:14.405543|2017-02-18 17:51:14.405543
NCT00085540|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-11-15|2016-09-23||January 2005||2005-01-01|November 2016|2016-11-01|March 2009|Actual|2009-03-01|December 2008|Actual|2008-12-01||Interventional||two patients were removed from the analysis due to one withdrawing consent and one was deemed ineligible.|FR901228 in Treating Patients With Recurrent High-Grade Gliomas|A Phase I-II Trial of Depsipeptide in Patients With Recurrent High-Grade Gliomas|Completed||Phase 1/Phase 2|50|Actual|National Cancer Institute (NCI)|Dose escalation was terminated after 2 dose levels because PK parameters of romidepsin in pts receiving EIAEDs were similar to those reported in Adults not receiving CYP34A inducing drugs, we wanted to avoid the expected dose limiting toxicity.|2|||f||||t||||||||No||2017-02-18 17:51:14.531483|2017-02-18 17:51:14.531483
NCT00085527|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-09-04|||May 2005||2005-05-01|September 2013|2013-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer|A Phase II Study Of Depsipeptide In Patients With Relapsed Or Refractory Ovarian Carcinoma|Withdrawn||Phase 2|0|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 17:51:15.0448|2017-02-18 17:51:15.0448
NCT00085501|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-10-30|||July 2004||2004-07-01|October 2012|2012-10-01|July 2011|Actual|2011-07-01|August 2007|Actual|2007-08-01||Interventional|||S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Selection Design Trial Of Concurrent Chemotherapy + Cetuximab Vs. Chemotherapy Followed By Cetuximab In Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|242|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 17:51:15.17513|2017-02-18 17:51:15.17513
NCT00085488|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-01-30|||February 2004||2004-02-01|October 2005|2005-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|En Vivo Matured Dendritic Cell Therapy in Patients With Melanoma|Completed||Phase 1|||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 17:51:15.471423|2017-02-18 17:51:15.471423
NCT00085475|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-09-20|||April 2004||2004-04-01|September 2012|2012-09-01||||April 2007|Actual|2007-04-01||Interventional|||Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma|Phase II Study of Glivec (Imatinib) in Locally Advanced and/or Metastatic Soft Tissue Sarcomas Expressing the t(17;22)(q22;q13) Translocation Resulting in a COL1A1/PDGF-beta Fusion Protein i.e. DermatoFibroSarcoma Protuberans (DFSP) and Giant Cell Fibroblastoma (GCF)|Completed||Phase 2|17|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:51:15.568637|2017-02-18 17:51:15.568637
NCT00085462|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-06-21|||May 2004||2004-05-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|May 2007|Actual|2007-05-01||Interventional|||Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma|Treatment of Patients With Metastatic Melanoma by Lymphodepleting Conditioning Followed by Infusion of TCR-Gene Engineered Lymphocytes and Subsequent Fowlpox gp100 Vaccination|Completed||Phase 1|61|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:51:15.68258|2017-02-18 17:51:15.68258
NCT00085449|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-07-01|||May 2006||2006-05-01|July 2016|2016-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer|A Trial of Reduced Intensity Conditioning and Transplantation of Haplotype Mismatched and KIR Class I Epitope-Mismatched Highly Purified CD34 Cells|Completed||Phase 1/Phase 2|56|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:51:15.90354|2017-02-18 17:51:15.90354
NCT00005338|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1991||1991-08-01|December 2004|2004-12-01|August 2004|Actual|2004-08-01|||||Observational|||Homocysteine and Progression of Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.043241|2017-02-18 18:15:07.043241
NCT00085423|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-04-09|2012-01-26||February 2004||2004-02-01|April 2013|2013-04-01|February 2010|Actual|2010-02-01|December 2008|Actual|2008-12-01||Interventional|||Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma|"High Dose Interleukin-2 (IL-2) Therapy In Lymphodepleted Primed Patients With Metastatic Melanoma"|Completed||Phase 2|20|Actual|Dartmouth-Hitchcock Medical Center|This was the first stage of a two-stage phase II study and continuation to next stage required 4 of 18 particpant having an objective response. Only 3 objective responses were noted and the study was terminated at stage 1.|1|||f||||t||||||||||2017-02-18 17:51:16.399222|2017-02-18 17:51:16.399222
NCT00085410|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-01-11|||January 2004||2004-01-01|January 2013|2013-01-01||||April 2009|Actual|2009-04-01||Interventional|||Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder|Phase II and Pharmacodynamic Study of PS-341 in Patients With Unresectable or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:51:16.670637|2017-02-18 17:51:16.670637
NCT00085397|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2009-02-06|||March 2004||2004-03-01|April 2008|2008-04-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Randomized Phase II Study of Immunization Against Melanoma Comparing Autologous Dendritic Cells Pulsed With gp100 Peptide to Autologous Dendritic Cells Fused With Autologous Tumor Cells|Unknown status|Recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:51:16.77708|2017-02-18 17:51:16.77708
NCT00085384|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-08-01|||July 2002||2002-07-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|November 2005|Actual|2005-11-01||Interventional|||PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer|A Phase I/II Study to Evaluate the Optimum Dose of Pegylated-Interferon (PEG INTRON) in Patients With Platinum Resistant Ovarian, Peritoneal or Fallopian Tube Cancer|Terminated||Phase 1/Phase 2|30|Actual|M.D. Anderson Cancer Center||3||Terminated due to slow accrual.|f||||f||||||||||2017-02-18 17:51:16.886848|2017-02-18 17:51:16.886848
NCT00085371|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-10-07|||July 2004||2004-07-01|October 2013|2013-10-01||||July 2006|Actual|2006-07-01||Interventional|||Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas|A Phase II Study Of Triapine For Advanced Adenocarcinoma Of The Pancreas|Completed||Phase 2|116|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:17.004778|2017-02-18 17:51:17.004778
NCT00085358|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-03-18|||May 2004||2004-05-01|March 2013|2013-03-01||||May 2011|Actual|2011-05-01||Interventional|||Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)|A Phase I Trial of Intravenous Paclitaxel, Intraperitoneal Carboplatin and Intraperitoneal Paclitaxel or Intravenous Docetaxel, Intraperitoneal Carboplatin and Intraperitoneal Paclitaxel or Intravenous Paclitaxel, Intraperitoneal Carboplatin, Intraperitoneal Paclitaxel and CTEP-Supplied Agent Bevacizumab (NSC 704865, IND 7921) in Patients With Previously Untreated Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:17.119327|2017-02-18 17:51:17.119327
NCT00085345|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-07-09||||||July 2006|2006-07-01||||||||Interventional|||Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma|Phase II Study of Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients With Relapsed or Refractory Multiple Myeloma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:51:17.258071|2017-02-18 17:51:17.258071
NCT00085332|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-01-10|||July 2004||2004-07-01|January 2014|2014-01-01||||December 2005|Actual|2005-12-01||Interventional|||Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)|A Phase II Evaluation of Weekly Docetaxel (NSC #628503) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||t||||||||||2017-02-18 17:51:17.36786|2017-02-18 17:51:17.36786
NCT00085306|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-10-01|||April 2004||2004-04-01|October 2015|2015-10-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma|Phase II Trial Of Interferon-B In Patients With Metastatic Cutaneous Melanoma And Metastatic Ocular Melanoma|Completed||Phase 2|21|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:51:20.443376|2017-02-18 17:51:20.443376
NCT00085293|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-08-20|2014-08-20||May 2004||2004-05-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|January 2014|Actual|2014-01-01||Interventional||Participants who received at least one dose of therapy.|Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131|Phase II Study of Decitabine in Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Radioiodine|Completed||Phase 2|12|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 17:51:20.548842|2017-02-18 17:51:20.548842
NCT00085280|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-03-28|||September 2004||2004-09-01|January 2013|2013-01-01||||October 2006|Actual|2006-10-01||Interventional|||Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Pilot Study to Determine if Downstream Markers of EGFR Linked Signaling Pathways Predict Response to OSI-774 (Erlotinib) in the First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer|Completed||N/A|129|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:20.845807|2017-02-18 17:51:20.845807
NCT00085254|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-01-28|2015-05-05||April 2005||2005-04-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional||pt had undergone previous surgery and had histological diagnosis of glioblastoma. All pt 18 years or older and KPS greater or equal to 60%|Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Safety Run-in/Randomized Phase II Trial of EMD 121974 in Conjunction With Concomitant and Adjuvant Temozolomide With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1/Phase 2|112|Actual|National Cancer Institute (NCI)|Study is safety run-in / phase 2 study. Pre-defined doses in safety run-in, 500, 1000 & 2000mg. Safety run-in is under an assumption of low probability of DLT with these dosages. NO actual MTD was defined in the safety run in, all doses were safe.|3|||f||||t||||||||||2017-02-18 17:51:20.960948|2017-02-18 17:51:20.960948
NCT00084929|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-10-07|||February 2005||2005-02-01|October 2013|2013-10-01||||September 2008|Actual|2008-09-01||Interventional|ACRIN 6664||Computed Tomographic Colonography in Screening Healthy Participants for Colorectal Cancer|National CT Colonography Trial|Completed||Phase 2/Phase 3|2607|Actual|American College of Radiology Imaging Network||1|||f||||t||||||||||2017-02-18 17:51:24.889565|2017-02-18 17:51:24.889565
NCT00085228|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-09-20|||April 2004||2004-04-01|September 2012|2012-09-01||||January 2006|Actual|2006-01-01||Interventional|||Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate|Randomized Phase II Trial of Docetaxel (Taxotere) and Oblimersen (Antisense Oligonucleotide Directed to BCL-2) Versus Taxotere Alone in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2|116|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:51:22.132574|2017-02-18 17:51:22.132574
NCT00085202|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-01-29|2013-11-04||August 2003||2003-08-01|January 2016|2016-01-01|September 2018|Anticipated|2018-09-01|December 2016|Anticipated|2016-12-01||Interventional||Participants had a diagnosis of medulloblastoma, supratentorial primitive neuroectodermal tumor (PNET), PNET variants (ependymoblastoma, pineoblastoma, CNS neuroblastoma), or atypical teratoid rhabdoid tumor (ATRT).|Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor|Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor|Active, not recruiting||Phase 3|416|Actual|St. Jude Children's Research Hospital|The study is ongoing. Participant flow and adverse events will be updated as additional outcomes are reported.|2|||f||||f||||||||||2017-02-18 17:51:22.267967|2017-02-18 17:51:22.267967
NCT00085189|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-05-20|||May 2004||2004-05-01|May 2014|2014-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma|A PHASE II TRIAL OF A VACCINE COMBINING MULTIPLE CLASS I PEPTIDES WITH MONTANIDE ISA 51 OR ISA 51 VG AND CpG ADJUVANT 7909 FOR PATIENTS WITH RESECTED STAGES IIC/III AND IV MELANOMA|Completed||Phase 2|42|Actual|University of Southern California||2|||f||||||||||||||2017-02-18 17:51:22.807657|2017-02-18 17:51:22.807657
NCT00085176|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-01-29|||May 2004||2004-05-01|January 2014|2014-01-01|January 2011|Actual|2011-01-01|September 2009|Actual|2009-09-01||Observational|||Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia|Neurobehavioral Outcomes in Childhood Acute Lymphoblastic Leukemia. A Limited Non-Therapeutic Study|Completed||N/A|286|Actual|Children's Oncology Group|||1||f||||t||||||||||2017-02-18 17:51:22.93693|2017-02-18 17:51:22.93693
NCT00085163|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-10-19|||March 2004||2004-03-01|October 2015|2015-10-01||||November 2005|Actual|2005-11-01||Interventional|||Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon|Multicenter, Double-Blind, Placebo-Controlled Randomized Phase III Study of Adjuvant Therapy With Celecoxib in Combination With Chemotherapy in Patients With Curatively Resected Stage III Colon Cancer|Completed||Phase 3|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:51:23.34365|2017-02-18 17:51:23.34365
NCT00085150|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-04-29|||April 2004||2004-04-01|February 2007|2007-02-01||||||||Interventional|||LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma|Pediatric Phase I Trial of LMB-2 for Refractory CD25-Positive Leukemias and Lymphomas|Completed||Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:51:23.485267|2017-02-18 17:51:23.485267
NCT00085124|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01||||June 2007|Actual|2007-06-01||Interventional|||Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia|A Phase III Study of Daunorubicin and Cytarabine +/- G3139 (Genasense, Oblimersen Sodium, NSC #683428, IND #58842), a BCL2 Antisense Oligodeoxynucleotide, in Previously Untreated Patients With Acute Myeloid Leukemia (AML) &gt; / = 60 Years|Completed||Phase 3|500|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:51:23.59272|2017-02-18 17:51:23.59272
NCT00085111|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01||||October 2005|Actual|2005-10-01||Interventional|||Bevacizumab in Treating Young Patients With Refractory Solid Tumors|A Phase I Study of Bevacizumab in Refractory Solid Tumors|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:23.714719|2017-02-18 17:51:23.714719
NCT00085098|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-09-14|2013-06-07||January 2007||2007-01-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2009|Actual|2009-05-01||Interventional|||Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor|Radiotherapy Alone Versus Chemotherapy Followed By Response-Based Radiotherapy For Newly Diagnosed Primary CNS Germinoma|Active, not recruiting||Phase 3|24|Actual|Children's Oncology Group|Study closed early due to slow accrual. Analysis plans were not carried out (lack of statistical precision compromised the ability to draw appropriate conclusions). Reported Primary Outcome Measure data reflects data collection through May 2009.|2|||f||||t||||||||||2017-02-18 17:51:23.826139|2017-02-18 17:51:23.826139
NCT00085059|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-07-17|||April 2004||2004-04-01|July 2012|2012-07-01||||October 2006|Actual|2006-10-01||Interventional|||Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma|Early Phase II Study On BNCT In Metastatic Malignant Melanoma Using The Boron Carrier BPA|Terminated||Phase 2|4|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 17:51:24.417777|2017-02-18 17:51:24.417777
NCT00085020|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-10-01|||March 2004||2004-03-01|August 2012|2012-08-01|February 2005|Actual|2005-02-01|December 2004|Actual|2004-12-01||Interventional|||GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu|A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Trastuzumab [Herceptin†]|Completed||Phase 1|13|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 17:51:24.526943|2017-02-18 17:51:24.526943
NCT00084981|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-09-27|||April 2004||2004-04-01|September 2013|2013-09-01||||February 2013|Actual|2013-02-01||Interventional|||Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer|A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Non-Small Cell Lung Cancer|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:24.665317|2017-02-18 17:51:24.665317
NCT00084942|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-01-11|||October 2002||2002-10-01|January 2012|2012-01-01|November 2006|Actual|2006-11-01|May 2004|Actual|2004-05-01||Interventional|||Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder|A Phase II Study of Gemcitabine in Combination With Capecitabine in Advanced Cholangiocarcinoma|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 17:51:24.781806|2017-02-18 17:51:24.781806
NCT00005337|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1991||1991-04-01|March 2005|2005-03-01|March 1995|Actual|1995-03-01|||||Observational|||Hostility and Coronary Risk--Role of Weak Vagal Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.121079|2017-02-18 18:15:07.121079
NCT00084916|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-01-22|||April 2004||2004-04-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase|A Phase II Study Of CCI-779 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Or Chronic Myeloid Leukemia In Blastic-Phase|Completed||Phase 2|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:25.034292|2017-02-18 17:51:25.034292
NCT00084903|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-08-01|||April 1998||1998-04-01|August 2012|2012-08-01|February 2009|Actual|2009-02-01|July 2007|Actual|2007-07-01||Interventional|||Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears|Pathological Correlation of Colposcopically Directed Biopsies to Fluorescence EEM of the Normal Human Cervix|Completed||N/A|1070|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:51:25.157515|2017-02-18 17:51:25.157515
NCT00084890|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2017-01-18|||November 2003||2003-11-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|March 2007|Actual|2007-03-01||Interventional|||Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix|Weekly Docetaxel and Carboplatin in Patients With Recurrent Squamous Carcinoma of the Cervix: A Phase I/II Study|Terminated||Phase 1|15|Actual|Wake Forest University Health Sciences||1||slow accrual|f||||f||||||||||2017-02-18 17:51:25.289272|2017-02-18 17:51:25.289272
NCT00084877|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-05-15|||March 2004||2004-03-01|May 2013|2013-05-01||||July 2008|Actual|2008-07-01||Interventional|||Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Triapine® in Combination With Irinotecan in Refractory Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:25.399795|2017-02-18 17:51:25.399795
NCT00084864|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-09-09|||September 2002||2002-09-01|September 2016|2016-09-01|May 2010|Actual|2010-05-01|February 2010|Actual|2010-02-01||Interventional|||Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate|A Pilot Trial of Calcitriol in Localized Prostate Cancer: Investigation of Biologic Effects and Potential Intermediate Endpoints|Terminated||Phase 2|25|Actual|Roswell Park Cancer Institute||6||sample size is too small to draw a conclusion|f||||t||||||||||2017-02-18 17:51:25.782842|2017-02-18 17:51:25.782842
NCT00084838|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-12-18|2012-12-14||February 2003||2003-02-01|December 2015|2015-12-01|March 2013|Actual|2013-03-01|February 2008|Actual|2008-02-01||Interventional|||Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT|A Phase II Study of Intrathecal and Systemic Chemotherapy With Radiation Therapy for Children With Central Nervous System Atypical Teratoid/Rhabdoid Tumor (AT/RT) Tumor|Completed||Phase 2|25|Actual|Dana-Farber Cancer Institute|None. Trial was completed.|1|||f||||t||||||||||2017-02-18 17:51:25.908319|2017-02-18 17:51:25.908319
NCT00084825|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-10-24|||May 2003||2003-05-01|October 2012|2012-10-01|June 2008|Actual|2008-06-01|July 2006|Actual|2006-07-01||Interventional|||Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008|Crossover From Docetaxel and Placebo to Docetaxel and Imatinib in Patients With Androgen-Independent Prostate Cancer With Bone Metastases: Extension Trial to ID03-0008|Completed||Phase 2|23|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:51:26.398345|2017-02-18 17:51:26.398345
NCT00084812|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-03-21|||March 2004||2004-03-01|March 2013|2013-03-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study of Safingol Administered With Cisplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|43|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:51:26.522049|2017-02-18 17:51:26.522049
NCT00084799|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-06-15|||February 2004||2004-02-01|June 2015|2015-06-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer|A Multiple-Dose Targeting Study of hu3S193 in Patients With Small Cell Lung Cancer|Completed||Phase 1|||Ludwig Institute for Cancer Research|||||f||||f||||||||||2017-02-18 17:51:26.636728|2017-02-18 17:51:26.636728
NCT00084786|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-01-15|||March 2004||2004-03-01|January 2013|2013-01-01||||July 2006|Actual|2006-07-01||Interventional|||Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors|A Phase I Dose Escalation of ZD1839 (Iressa®) (Days 1 and 2) and Docetaxel (Day 3) Every 3 Weeks in Patients With an Advanced Solid Tumor|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:51:26.728546|2017-02-18 17:51:26.728546
NCT00084773|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-12-21|||March 2004||2004-03-01|December 2015|2015-12-01|March 2010|Actual|2010-03-01|January 2007|Actual|2007-01-01||Interventional|||Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer|A Pilot Clinical Trial of Preoperative Cetuximab With Concurrent Continuous Infusion Fluorouracil and Pelvic Radiation in Patients With Local-Regionally Advanced Rectal Cancer|Completed||N/A|28|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:51:26.812001|2017-02-18 17:51:26.812001
NCT00084747|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-02-17|2016-01-20||June 2004||2004-06-01|February 2016|2016-02-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional|||Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma|Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation With VELCADE Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma|Completed||Phase 1/Phase 2|30|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:51:26.924657|2017-02-18 17:51:26.924657
NCT00084734|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-01-10|||May 2002||2002-05-01|January 2014|2014-01-01|December 2009|Actual|2009-12-01|November 2009|Actual|2009-11-01||Interventional|||Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacokinetics Study of Docetaxel in Combination With Capecitabine and Cisplatin in Solid Tumors|Completed||Phase 1|61|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:51:27.189211|2017-02-18 17:51:27.189211
NCT00084721|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-01-30|||March 2005||2005-03-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer|A Phase I Study of Irinotecan in Combination With Fixed Dose Celecoxib in Patients With Advanced Colorectal Cancer|Completed||Phase 1|2|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 17:51:27.28567|2017-02-18 17:51:27.28567
NCT00084708|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-01-10|||November 2002||2002-11-01|January 2014|2014-01-01|May 2007|Actual|2007-05-01|October 2006|Actual|2006-10-01||Interventional|||Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors|A Phase I Study of Intravenous (IV) Calcitriol in Combination With ZD1839 (IRESSA®) in Refractory Solid Tumors|Completed||Phase 1|53|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:51:27.392428|2017-02-18 17:51:27.392428
NCT00084695|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-01-09|||September 2003||2003-09-01|October 2008|2008-10-01||||December 2012|Anticipated|2012-12-01||Interventional|||Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases|The Use Of Umbilical Cord Blood As A Source Of Hematopoietic Stem Cells|Unknown status|Recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 17:51:27.486036|2017-02-18 17:51:27.486036
NCT00084682|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-04-29|2015-04-29||April 2004||2004-04-01|May 2013|2013-05-01|March 2012|Actual|2012-03-01|November 2008|Actual|2008-11-01||Interventional|||Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|A Phase II Study of Single Agent Depsipeptide (FK228; NSC 630176; IND 51,810) in Patients With Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|14|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:51:27.62911|2017-02-18 17:51:27.62911
NCT00084669|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2010-04-27|||May 2004||2004-05-01|April 2010|2010-04-01|March 2010|Actual|2010-03-01|October 2007|Actual|2007-10-01||Interventional|||Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer|Targeting Insomnia to Enhance Hot Flush Treatment in Women Receiving Therapy for Breast Cancer or Breast Cancer Risk-Reduction|Completed||N/A|119|Anticipated|Massachusetts General Hospital|||||f||||||||||||||2017-02-18 17:51:27.87658|2017-02-18 17:51:27.87658
NCT00084656|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2010-04-23|||May 2004||2004-05-01|April 2010|2010-04-01||||October 2009|Actual|2009-10-01||Interventional|||Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma|An Extended Dosing, Two-phase Study of MDX-010 as Monotherapy or in Combination With Tyrosinase/gp100/MART-1 Peptides Emulsified With Montanide ISA 51 VG in the Treatment of Subjects With Resected Stage III or Stage IV Melanoma|Completed||Phase 2|75|Actual|Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 17:51:27.976655|2017-02-18 17:51:27.976655
NCT00084643|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-03-26|||May 2004||2004-05-01|January 2013|2013-01-01||||April 2008|Actual|2008-04-01||Interventional|||GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors|A Phase I Study of GTI-2040 in Combination With Oxaliplatin and Capecitabine in Patients With Advanced Metastatic Solid Tumors|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:28.084285|2017-02-18 17:51:28.084285
NCT00084630|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-02-27|||May 2004||2004-05-01|February 2013|2013-02-01||||July 2007|Actual|2007-07-01||Interventional|||Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans|A Phase II Study of Imatinib (NSC-716051) in Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:28.196279|2017-02-18 17:51:28.196279
NCT00084617|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2015-04-15|2015-04-15||March 2004||2004-03-01|July 2013|2013-07-01|December 2008|Actual|2008-12-01|October 2008|Actual|2008-10-01||Interventional|||Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma|Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma|Completed||Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:28.306485|2017-02-18 17:51:28.306485
NCT00084604|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-06-03|||April 2004||2004-04-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|A Multicenter, Open-Label, Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma|Completed||Phase 2|47|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:28.615265|2017-02-18 17:51:28.615265
NCT00084591|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2010-02-11|||December 2003||2003-12-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer|Phase I Study of Preoperative Intensity Modulated Radiation Therapy (IMRT) With Incorporated Boost and Oral Capecitabine in Locally Advanced Rectal Cancer|Completed||Phase 1|||Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 17:51:28.75133|2017-02-18 17:51:28.75133
NCT00084578|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-07-12|||March 2004||2004-03-01|July 2013|2013-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder|A Randomized Trial of Celecoxib and Rosiglitazone, Alone and in Combination, in Patients With Early Stage Non-Invasive Bladder Carcinoma Undergoing Cystoscopic Surveillance and in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy|Withdrawn||N/A|0|Actual|Fox Chase Cancer Center||||Withdrawn due to drug toxicity|f||||f||||||||||2017-02-18 17:51:29.104479|2017-02-18 17:51:29.104479
NCT00084565|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-07-09|||November 2003||2003-11-01|July 2013|2013-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer|Phase II Study of the Activity of Weekly Paclitaxel, Topotecan Plus Oral Estramustine Phosphate in Metastatic Hormone-Refractory Prostate Carcinoma|Withdrawn||Phase 2|0|Actual|Fox Chase Cancer Center||||Study was never activated at Fox Chase Cancer Center.|f||||f||||||||||2017-02-18 17:51:29.19857|2017-02-18 17:51:29.19857
NCT00084552|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-03-01|||December 2003||2003-12-01|March 2016|2016-03-01||||August 2013|Actual|2013-08-01||Interventional|||Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer|Outcomes Following Intensity Modulated Radiation Therapy With And Without Erectile Tissue Dose Sparing For Favorable To Intermediate Risk Prostate Cancer|Active, not recruiting||Phase 3|200|Anticipated|Fox Chase Cancer Center||2|||f||||f||||||||||2017-02-18 17:51:29.292324|2017-02-18 17:51:29.292324
NCT00083707|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-27|2010-07-01|||January 1999||1999-01-01|July 2010|2010-07-01|February 2003||2003-02-01|||||Interventional|||Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia|UARK 99-006, A Phase II Pilot Study of Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia|Completed||Phase 2|40||University of Arkansas|||||||||||||||||||2017-02-18 17:51:55.419086|2017-02-18 17:51:55.419086
NCT00084539|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-03-01|||November 2003||2003-11-01|March 2016|2016-03-01||||November 2005|Actual|2005-11-01||Interventional|||Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer|Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy (IMRT) With Incorporated Boost in Early Stage Breast Cancer|Completed||Phase 2|78|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-02-18 17:51:29.398668|2017-02-18 17:51:29.398668
NCT00084526|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2010-02-11|||November 2003||2003-11-01|February 2010|2010-02-01|February 2007|Actual|2007-02-01|||||Interventional|||Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer|Evaluation of Daily CT Scans Using CT on Rails for Localization in the Treatment of Prostate Cancer|Completed||Phase 1/Phase 2|40|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 17:51:29.504763|2017-02-18 17:51:29.504763
NCT00084513|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2010-02-11|||August 2004||2004-08-01|February 2010|2010-02-01|March 2007|Actual|2007-03-01|||||Interventional|||Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer|Phase I of Trastuzumab and Imatinib Mesylate (Gleevec®, Formerly Known as STI-571) in Patients With Recurrent or Metastatic Her-2/Neu Expressing Cancer|Completed||Phase 1|18|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 17:51:29.602992|2017-02-18 17:51:29.602992
NCT00084487|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-05-07|2013-11-12||April 2004||2004-04-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional||One patient died prior to start of treatment and is not included on any data analysis.|Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy|"Phase II Trial of XL119 (Rebeccamycin Analogue) in Relapsed Sensitive Small Cell Lung Cancer"|Terminated||Phase 2|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:29.717629|2017-02-18 17:51:29.717629
NCT00084461|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-06-03|||March 2004||2004-03-01|June 2013|2013-06-01||||October 2004|Actual|2004-10-01||Interventional|||Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors|Phase II Study of Depsipeptide in Metastatic Neuroendocrine Tumors|Terminated||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:51:30.136508|2017-02-18 17:51:30.136508
NCT00084448|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-07-08|||April 2004||2004-04-01|June 2005|2005-06-01||||May 2005|Actual|2005-05-01||Interventional|||Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation of Weekly Paclitaxel (NSC #673089) and Celecoxib (Celebrex®, NSC #719627) in the Treatment of Recurrent or Persistent Platinum-Resistant Epithelial Ovarian or Primary Peritoneal Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 17:51:30.249935|2017-02-18 17:51:30.249935
NCT00084435|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-06-13|||July 2005||2005-07-01|June 2012|2012-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|S0217||S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer|Adjuvant Chemo-RT With Cisplatin (NSC-119875) and Docetaxel (NSC-628503) After Complete Resection of Locally Advanced (Stage III and IV) Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||1||Poor accrual and suspension of head and neck committee|f||||f||||||||||2017-02-18 17:51:30.362335|2017-02-18 17:51:30.362335
NCT00084422|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-08-28|||August 2003||2003-08-01|August 2014|2014-08-01|February 2011|Actual|2011-02-01|September 2009|Actual|2009-09-01||Interventional|||N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma|A Phase I Study Of CEP-701 In Patients With Refractory Neuroblastoma (IND # 67,722)|Completed||Phase 1|47|Actual|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-02-18 17:51:30.517008|2017-02-18 17:51:30.517008
NCT00084409|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2014-05-05|2012-11-26||November 2001||2001-11-01|May 2014|2014-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease|A Randomized Phase II Chemoprevention Study of Iloprost Versus Placebo in Patients at High Risk for Lung Cancer|Completed||Phase 2|152|Actual|University of Colorado, Denver||2|||f||||t||||||||||2017-02-18 17:51:30.636856|2017-02-18 17:51:30.636856
NCT00084396|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-09-23|||October 2003||2003-10-01|September 2016|2016-09-01|September 2016|Actual|2016-09-01|March 2007|Actual|2007-03-01||Interventional|||Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer|A Phase 2 Trial Of 4 Months Preoperative Letrozole 2.5 mg Daily For Postmenopausal Women With Estrogen Receptor Positive And/Or Progesterone Receptor Positive T2, T3, T4a-c, N0-2, M0 Breast Cancer- Novel Biomarkers for Aromatase Inhibitor Therapy|Completed||Phase 2|115|Actual|Washington University School of Medicine||1|||f||||t||||||||||2017-02-18 17:51:31.254783|2017-02-18 17:51:31.254783
NCT00084383|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-07-17|2013-03-01||January 2002||2002-01-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|December 2005|Actual|2005-12-01||Interventional|||Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas|A Safety and Efficacy Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected With the GM-CSF Gene in Combination With Adjuvant Chemoradiotherapy for the Treatment of Adenocarcinoma of the Pancreas|Completed||Phase 2|60|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:51:31.380126|2017-02-18 17:51:31.380126
NCT00084370|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2013-08-21|||June 2002||2002-06-01|August 2013|2013-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy|Molecular Alterations in Human Ovarian Epithelium Induced by Chemopreventive Agents in Patients at Elevated Inherited Risk of Ovarian Cancer: A Controlled Pilot Study in Ovarian Cancer Chemoprevention|Withdrawn||N/A|0|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 17:51:31.641054|2017-02-18 17:51:31.641054
NCT00084344|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2012-05-17||2011-02-16|April 2003||2003-04-01|May 2012|2012-05-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women|A Prospective, Randomized, Placebo-Controlled Trial of the Effects of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women|Completed||N/A|||Northwestern University|||||f||||t||||||||||2017-02-18 17:51:31.759094|2017-02-18 17:51:31.759094
NCT00083694|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-27|2010-07-01|||August 1998||1998-08-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia|UARK, 98-032, Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia|Completed||Phase 2|25||University of Arkansas|||||||||||||||||||2017-02-18 17:51:55.516028|2017-02-18 17:51:55.516028
NCT00084318|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-10|2016-12-30|2016-06-14||April 2004||2004-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2009|Actual|2009-03-01||Interventional||Eligible patients who started protocol treatment and did not withdraw consent.|Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck|A Phase II Randomized Trial Of Surgery Followed By Chemoradiotherapy Plus Cetuximab For Advanced Squamous Cell Carcinoma Of The Head and Neck|Completed||Phase 2|238|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 17:51:31.867833|2017-02-18 17:51:31.867833
NCT00084305|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-09|2017-01-24|||June 9, 2004||2004-06-09|September 26, 2016|2016-09-26||||||||Observational|||Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis|Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:33.225999|2017-02-18 17:51:33.225999
NCT00084292|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-09|2013-05-28|||June 2004||2004-06-01|May 2013|2013-05-01|December 2020|Anticipated|2020-12-01|December 2020|Anticipated|2020-12-01|12 Months|Observational [Patient Registry]|||Database for Stroke in Infants and Children|International Pediatric Stroke Study|Recruiting||N/A|12000|Anticipated|The Hospital for Sick Children|||1||f||||f||||||||||2017-02-18 17:51:33.330611|2017-02-18 17:51:33.330611
NCT00084279|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-09|2009-07-01|||April 2004||2004-04-01|July 2009|2009-07-01|April 2006|Actual|2006-04-01|||||Interventional|||CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)|Safety and Tolerability of Consensus Interferon-Alpha (CIFN) Plus Interferon Gamma-1b (IFN-γ 1b) With or Without Ribavirin (RBV) in the Treatment of Patients With Chronic Hepatitis C Who Are Non-Responders to PEG-IFN-a (2a or 2b) Plus RBV|Completed||Phase 2|81|Actual|InterMune||1|||f||||||||||||||2017-02-18 17:51:33.440391|2017-02-18 17:51:33.440391
NCT00084266|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-09|2012-01-30|2011-03-10||October 2004||2004-10-01|January 2012|2012-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|ZEPHYR||Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)|Linezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus|Completed||Phase 4|1225|Actual|Pfizer|EOS visit window of 15-21 days after last dose as specified in protocol was expanded during blinded evaluability assessments and prior to database lock and unblinding to 7-30 days after last dose in order to better fit the actual study visit days.|2|||f||||f||||||||||2017-02-18 17:51:33.581664|2017-02-18 17:51:33.581664
NCT00084253|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-09|2010-03-04||2010-03-04|June 2004||2004-06-01|June 2008|2008-06-01||||August 2006|Actual|2006-08-01||Interventional|||Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients|Phase IV Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients|Completed||Phase 4|200|Anticipated|Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:51:39.35631|2017-02-18 17:51:39.35631
NCT00084240|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-09|2008-10-30|||March 2004||2004-03-01|October 2008|2008-10-01|April 2005|Actual|2005-04-01|||||Interventional|||Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia|A Phase 2/3, Randomized, Comparative, Double Blind Trial Of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia|Terminated||Phase 2/Phase 3|32|Actual|Pfizer||||See Detailed Description|||||||||||||||2017-02-18 17:51:39.466679|2017-02-18 17:51:39.466679
NCT00084227|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-09|2011-05-10|||July 2004||2004-07-01|May 2011|2011-05-01|July 2005|Actual|2005-07-01|||||Interventional|||Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America|A Phase Ii/Iii, Randomized, Double Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America|Completed||Phase 2/Phase 3|244|Actual|Pfizer|||||||||||||||||||2017-02-18 17:51:39.550911|2017-02-18 17:51:39.550911
NCT00084214|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-09|2014-03-05|||May 2004||2004-05-01|December 2008|2008-12-01||||||||Interventional|||STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma|A Two-Stage Trial of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|103||Synta Pharmaceuticals Corp.|||||f||||||||||||||2017-02-18 17:51:39.633887|2017-02-18 17:51:39.633887
NCT00084201|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-08|2006-11-28|||July 2006||2006-07-01|November 2006|2006-11-01|June 2007||2007-06-01|||||Interventional|||Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections|Cranberry: Interactions With Anti-Infectious Agents|Completed||N/A|18||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:51:39.769859|2017-02-18 17:51:39.769859
NCT00084188|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-08|2017-01-11|||May 2004||2004-05-01|October 2016|2016-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1|HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs|Completed||Phase 3|541||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:51:39.860079|2017-02-18 17:51:39.860079
NCT00084175|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-08|2017-01-11|||April 2004||2004-04-01|October 2016|2016-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1|HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs|Completed||Phase 3|630||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:51:39.953606|2017-02-18 17:51:39.953606
NCT00084162|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-08|2017-01-24|||March 30, 2004||2004-03-30|March 17, 2010|2010-03-17|March 17, 2010||2010-03-17|||||Observational|||Neurocardiac Control in Major Depression|Neurocardiac Control in Major Depression|Completed||N/A|41|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:40.325983|2017-02-18 17:51:40.325983
NCT00084149|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-07|2013-07-26|||February 2004||2004-02-01|July 2013|2013-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection|A Randomized Phase II Study of the Safety, Immunologic, and Virologic Effects of Cyclosporine A in Conjunction With Trizivir(R) and Kaletra(R) Versus Trizivir(R) and Kaletra(R) Alone During Primary HIV-1 Infection|Completed||Phase 2|16|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:51:40.421333|2017-02-18 17:51:40.421333
NCT00083681|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-27|2010-07-01|||June 1998||1998-06-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse|UARK 98-018, A Randomized Phase II Trial of DCEP or DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse in Patients With Multiple Myeloma|Completed||Phase 2|180||University of Arkansas|||||||||||||||||||2017-02-18 17:51:55.626795|2017-02-18 17:51:55.626795
NCT00084136|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-07|2015-06-01|2011-07-13||May 2005||2005-05-01|June 2015|2015-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|PEARLS||Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings|Randomized, Open-Label Evaluation of Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combinations for Initial Treatment of HIV-1 Infected Persons From Resource-Limited Settings (PEARLS) Trial|Completed||Phase 4|1571|Actual|AIDS Clinical Trials Group||3|||f||||t||||||||||2017-02-18 17:51:40.568723|2017-02-18 17:51:40.568723
NCT00084123|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-07|2009-07-09|||September 2002||2002-09-01|July 2009|2009-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Healing Touch and Relaxation Therapies in Cervical Cancer Patients|Healing Touch in Advanced Cervical Cancer Patients: Immune Effects and Mechanisms|Completed||Phase 2|60|Actual|National Center for Complementary and Integrative Health (NCCIH)||3|||f||||t||||||||||2017-02-18 17:51:42.742929|2017-02-18 17:51:42.742929
NCT00084110|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-07|2006-08-17|||August 1993||1993-08-01|August 2006|2006-08-01|September 2000||2000-09-01|||||Observational|||Use of Complementary and Alternative Medicine Among Older Mexican Americans|Complementary Alternative Medicine|Terminated||N/A|3000||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:51:42.852062|2017-02-18 17:51:42.852062
NCT00084097|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-05|2017-01-24|||June 2, 2004||2004-06-02|December 23, 2008|2008-12-23|February 5, 2007||2007-02-05|||||Interventional|||Omalizumab to Treat Eosinophilic Gastroenteritis|Pilot Study of Omalizumab in Eosinophilic Gastroenteritis|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:51:42.939116|2017-02-18 17:51:42.939116
NCT00084084|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-05|2014-03-25|2013-08-01||June 2004||2004-06-01|March 2014|2014-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Replagal Enzyme Replacement Therapy for Children With Fabry Disease|An Open Label Clinical Trial of Replagal Enzyme Replacement Therapy In Children With Fabry Disease Who Have Completed Study TKT023 or Who Are Naive to Enzyme Replacement Therapy|Completed||Phase 2|17|Actual|Shire||2|||f||||f||||||||||2017-02-18 17:51:43.048414|2017-02-18 17:51:43.048414
NCT00084071|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-04|2012-07-12|||May 2004||2004-05-01|July 2012|2012-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia|Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) for the Treatment of Patients With Severe Community-Acquired Pneumonia|Completed||Phase 3|2136|Actual|Novartis|||||f||||||||||||||2017-02-18 17:51:43.949337|2017-02-18 17:51:43.949337
NCT00084058|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-04|2012-05-17||||||May 2012|2012-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV|A Phase I/II Safety, Tolerability, and Pharmacokinetic Study of High Dose Lopinavir/Ritonavir With or Without Saquinavir in HIV-Infected Pediatric Subjects Previously Treated With Protease Inhibitors|Completed||Phase 1/Phase 2|26|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:51:44.188913|2017-02-18 17:51:44.188913
NCT00084045|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-04|2012-10-26|||November 2004||2004-11-01|October 2012|2012-10-01|December 2006|Actual|2006-12-01|||||Interventional|||Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission|Mother Infant Rapid Intervention at Delivery (MIRIAD)|Completed||N/A|283|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:51:44.309623|2017-02-18 17:51:44.309623
NCT00084032|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-04|2012-10-26||||||October 2012|2012-10-01||||||||Interventional|||Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV|A Randomized, Multicenter Trial to Determine Whether Induction Therapy Followed by Treatment Interruption is Superior to Induction Therapy Alone in the Treatment of Primary HIV Infection (PHI): The Structured Treatment Interruption (STI) Study|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:51:44.421865|2017-02-18 17:51:44.421865
NCT00084019|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-04|2014-06-02|||July 2004||2004-07-01|June 2014|2014-06-01|May 2006|Actual|2006-05-01|||||Interventional|||Atazanavir/Ritonavir Maintenance Therapy|A Prospective, Open-Label, Pilot Trial of Regimen Simplification to Atazanavir/Ritonavir Alone as Maintenance Antiretroviral Therapy After Sustained Virologic Suppression|Completed||N/A|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:51:44.532736|2017-02-18 17:51:44.532736
NCT00083993|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-04|2011-11-07|||May 2004||2004-05-01|November 2011|2011-11-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer|A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study of Oral CCI-779 Administered in Combination With Letrozole vs. Letrozole Alone as First Line Hormonal Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer|Terminated||Phase 3|1236||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:51:44.655701|2017-02-18 17:51:44.655701
NCT00083980|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-04|2012-10-18|||June 2002||2002-06-01|August 2006|2006-08-01|August 2004|Actual|2004-08-01|June 2004|Actual|2004-06-01||Interventional|||Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)|KAVA KAVA in Generalized Anxiety: A Double-Blind Trial|Terminated||Phase 2|16|Actual|National Center for Complementary and Integrative Health (NCCIH)||3||European reports of liver toxicity from kava meant that the study had to stop|f||||f||||||||||2017-02-18 17:51:44.974703|2017-02-18 17:51:44.974703
NCT00083967|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-03|2015-04-09|||June 2004||2004-06-01|April 2015|2015-04-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment|A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Rhegmatogenous Retinal Detachment|Terminated||Phase 2|23|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:51:45.085763|2017-02-18 17:51:45.085763
NCT00083954|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-03|2013-01-03|||June 2004||2004-06-01|January 2013|2013-01-01|August 2005|Actual|2005-08-01|||||Interventional|||Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression|A Confirmatory Multicenter, Double-blind, Randomized, Placebo Controlled Study of the Use of Quetiapine Fumarate (SEROQUEL) in the Treatment of Patients With Bipolar Depression|Completed||Phase 3|530||AstraZeneca|||||||||||||||||||2017-02-18 17:51:45.411111|2017-02-18 17:51:45.411111
NCT00083941|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-03|2011-06-28|||August 2004||2004-08-01|June 2011|2011-06-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer|Clinical Trial Phase II (Single Centre Study) : A Preliminary Study of the Safety, Immunogenicity, and Clinical Efficacy of TroVax Given in Conjunction With Interleukin 2 (IL-2) in the Treatment of Stage IV Renal Cell Cancer|Completed||Phase 2|25|Anticipated|Oxford BioMedica||1|||f||||||||||||||2017-02-18 17:51:45.537168|2017-02-18 17:51:45.537168
NCT00083928|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-03|2013-01-22|||May 2004||2004-05-01|January 2013|2013-01-01|December 2006|Actual|2006-12-01|February 2006|Actual|2006-02-01||Interventional|||Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels|A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Å6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy|Completed||Phase 2|60|Anticipated|Ångstrom Pharmaceuticals|||||||||||||||||||2017-02-18 17:51:45.635481|2017-02-18 17:51:45.635481
NCT00083915|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-03|2011-07-07|2011-07-07||June 2001||2001-06-01|July 2011|2011-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||DTPACE Followed by Tandem Transplant With MEL 200 Versus MEL/DTPACE Hybrid and DTPACE Consolidation|UARK 2001-12, A Phase III Study of DTPACE Followed by Tandem Transplant With MEL 200 Versus MEL/DTPACE Hybrid and DTPACE Consolidation in Patients With Active Multiple Myeloma|Completed||Phase 3|97|Actual|University of Arkansas||2|||f||||f||||||||||2017-02-18 17:51:45.743634|2017-02-18 17:51:45.743634
NCT00083902|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-03|2010-07-01|||June 1998||1998-06-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy|UARK 98-025, A Randomized Phase II Trial of Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy for Low-Risk Post Transplantation Relapse in Patients With Multiple Myeloma|Completed||Phase 2|190||University of Arkansas|||||||||||||||||||2017-02-18 17:51:46.173293|2017-02-18 17:51:46.173293
NCT00083889|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-03|2010-01-19|2009-09-16||August 2004||2004-08-01|January 2010|2010-01-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma|A Phase 3, Randomized Study Of SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 3|750|Actual|Pfizer||2|||f||||t||||||||||2017-02-18 17:51:46.318795|2017-02-18 17:51:46.318795
NCT00083876|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2010-07-01|||September 1998||1998-09-01|July 2010|2010-07-01|November 2007|Actual|2007-11-01|||||Interventional|||D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma|UARK 98-035, A Phase III Study of D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma|Completed||Phase 3|500||University of Arkansas|||||f||||||||||||||2017-02-18 17:51:53.374295|2017-02-18 17:51:53.374295
NCT00083863|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2013-08-08|||June 2004||2004-06-01|August 2013|2013-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Framingham: Inflammation, Genes & Cardiovascular Disease||Completed||N/A|7374|Actual|Boston University|||2||f||||||||||||||2017-02-18 17:51:53.473615|2017-02-18 17:51:53.473615
NCT00083850|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2016-07-28|||June 2004||2004-06-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Genetics and Cardiovascular Reactivity in Young Twins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:51:53.570078|2017-02-18 17:51:53.570078
NCT00083837|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2016-07-11|||May 2004||2004-05-01|April 2008|2008-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Gene-Specific Responses to Exercise in Discordant Twins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:51:53.644135|2017-02-18 17:51:53.644135
NCT00083824|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2016-04-19|||March 2004||2004-03-01|April 2016|2016-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Estrogen, HDL, and Coronary Heart Disease in Women|Estrogen, HDL, and Coronary Heart Disease in Women|Completed||Phase 2/Phase 3|309|Actual|Tufts University||3|||f||||f||||||||||2017-02-18 17:51:53.722744|2017-02-18 17:51:53.722744
NCT00083811|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2016-08-05|||January 2004||2004-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||HYPGENE-Genetics Fitness Obesity & Risk of Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:51:53.858693|2017-02-18 17:51:53.858693
NCT00083798|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2016-08-18|||September 2003||2003-09-01|August 2016|2016-08-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland||Completed||N/A|2843|Actual|University of Pennsylvania|||1||f||||||||||Samples With DNA|"~     Samples with DNA~   "|||2017-02-18 17:51:54.032696|2017-02-18 17:51:54.032696
NCT00083785|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2007-04-10|||May 2004||2004-05-01|April 2007|2007-04-01||||||||Interventional|||Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases|Safety and Effectiveness of Treating Cancers With the Litx™ System and Chemotherapy. Section A: Phase II Safety and Effectiveness Study in Patients With Liver Metastases From Colorectal Cancer|Completed||Phase 2|25||Light Sciences LLC|||||||||||||||||||2017-02-18 17:51:54.119691|2017-02-18 17:51:54.119691
NCT00083772|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-02|2012-07-27|||May 2004||2004-05-01|July 2012|2012-07-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Use of Nesiritide in the Management of Acute Diastolic Heart Failure|The Use of Nesiritide in the Management of Acute Diastolic Heart Failure|Terminated||Phase 4|20|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:51:54.410164|2017-02-18 17:51:54.410164
NCT00083759|ClinicalTrials.gov processed this data on February 17, 2017|2004-06-01|2016-07-14|2009-01-27||May 2004||2004-05-01|April 2009|2009-04-01||||February 2005|Actual|2005-02-01||Interventional|||Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate|A Phase II, Multicenter, Double-blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Intravenous Natalizumab (300 mg) in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Receiving Concomitant Treatment With Methotrexate (MTX)|Terminated||Phase 2|299|Actual|Biogen|The study was terminated prematurely on 28 February 2005. The biological effect seen with natalizumab was not sufficient to warrant further development in RA.|2||"The biological effect seen with natalizumab was not sufficient to warrant further development~   in RA."|||||||||||||||2017-02-18 17:51:54.540061|2017-02-18 17:51:54.540061
NCT00083733|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-29|2017-01-24|||May 27, 2004||2004-05-27|November 17, 2010|2010-11-17|November 17, 2010||2010-11-17|||||Observational|||Genetic and Protein Profiling in Normal and Cancerous Breast Tissue|Procurement of Normal Breast Tissue and Metastatic Breast Cancer Tissue for Molecular Profiling|Completed||N/A|216|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:54.95419|2017-02-18 17:51:54.95419
NCT00083720|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-28|2011-05-19|2009-04-16||October 2004||2004-10-01|May 2011|2011-05-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy|A Phase II Multicenter Study of Erbitux (Cetuximab) in Patients With Refractory, EGFR-Negative Metastatic Colorectal Carcinoma|Completed||Phase 2|87|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 17:51:55.045037|2017-02-18 17:51:55.045037
NCT00083252|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|||Study of Talabostat and Cisplatin in Advanced Melanoma||Completed||Phase 2|||Point Therapeutics|||||||||||||||||||2017-02-18 17:52:01.727679|2017-02-18 17:52:01.727679
NCT00083668|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-27|2011-06-06|||April 2004||2004-04-01|March 2010|2010-03-01|May 2005|Actual|2005-05-01|||||Interventional|||Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia|A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 3 Fixed Dosages of Paliperidone Extended Release (ER) Tablets and Olanzapine, With Open-label Extension, in the Treatment of Patients With Schizophrenia|Completed||Phase 3|619|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:51:55.736667|2017-02-18 17:51:55.736667
NCT00083642|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-27|2017-01-24|||May 25, 2004||2004-05-25|June 13, 2008|2008-06-13|June 13, 2008||2008-06-13|||||Observational|||Observational Learning in Stroke Patients|Neural Correlates of Observational Motor Learning in Chronic Stroke Patients|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:55.834385|2017-02-18 17:51:55.834385
NCT00083629|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-27|2008-03-03|||May 2004||2004-05-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Use of [18F]FECNT in Positron Emission Tomography|PET Whole Body Biodistribution and Test Retest Brain Imaging Studies Using a Dopamine Transporter Ligand [18F]FECNT|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:55.9147|2017-02-18 17:51:55.9147
NCT00083616|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-26|2013-12-10|2010-08-06||March 2004||2004-03-01|December 2013|2013-12-01|December 2008|Actual|2008-12-01|May 2007|Actual|2007-05-01||Interventional|||Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy|A Phase 2 Multicenter Single Arm Clinical Trial of ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy|Completed||Phase 2|185|Actual|Amgen||1|||f||||t||||||||||2017-02-18 17:51:56.028541|2017-02-18 17:51:56.028541
NCT00083603|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-26|2013-08-21|||September 2004||2004-09-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|||||Interventional|||Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults|A Phase I Trial to Evaluate the Safety and Immunogenicity of rMVA-HIV (rMVA-HIV Env/Gag + rMVA-HIV Tat/Rev/Nef-RT) and rFPV-HIV (rFPV-HIV Env/Gag + rFPV-HIV Tat/Rev/Nef-RT) Vaccines, Alone or in Combination, in Healthy, Vaccinia Naive HIV-1 Negative Participants|Completed||Phase 1|150|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||16|||f||||||||||||||2017-02-18 17:51:56.790128|2017-02-18 17:51:56.790128
NCT00083590|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-26|2008-02-19|||April 2004||2004-04-01|February 2008|2008-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Huperzine A in Alzheimer's Disease|A Multi-Center, Double-Blind, Placebo-Controlled Therapeutic Trial to Determine Whether Natural Huperzine A Improves Cognitive Function|Completed||Phase 2|150|Anticipated|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:51:56.935622|2017-02-18 17:51:56.935622
NCT00083577|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-25|2010-07-01|||February 1998||1998-02-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma|UARK 98-003, A Phase II Pilot Study of Anti-Angiogenesis Therapy Using Thalidomide in Patients With Multiple Myeloma|Completed||Phase 2|250||University of Arkansas|||||||||||||||||||2017-02-18 17:51:57.05817|2017-02-18 17:51:57.05817
NCT00083564|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-25|2009-03-30|||March 2004||2004-03-01|March 2009|2009-03-01||||||||Interventional|||Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma|A Randomized Multicenter Study to Compare the Safety and Efficacy of 166Ho-DOTMP Plus Melphalan to Melphalan Alone as Conditioning for Autologous Peripheral Blood Stem Cell Transplant in Subjects With Primary Refractory Multiple Myeloma|Terminated||Phase 3|240||Poniard Pharmaceuticals||||For business reasons|||||||||||||||2017-02-18 17:51:57.154221|2017-02-18 17:51:57.154221
NCT00083551|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-25|2015-10-21|2015-08-24||August 1998||1998-08-01|October 2015|2015-10-01|August 2014|Actual|2014-08-01|August 2014|Actual|2014-08-01||Interventional|||UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy|UARK 98-026, Total Therapy II - A Phase III Study for Newly Diagnosed Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy|Completed||Phase 3|668|Actual|University of Arkansas||2|||f||||t||||||||||2017-02-18 17:51:57.286456|2017-02-18 17:51:57.286456
NCT00083538|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-25|2010-07-06|||February 2001||2001-02-01|July 2010|2010-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally|UARK 2000-46, A Phase II Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally in Multiple Myeloma Patients|Completed||Phase 2|40|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 17:51:58.463805|2017-02-18 17:51:58.463805
NCT00083525|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-25|2008-01-21|||May 2004||2004-05-01|January 2008|2008-01-01||||||||Interventional|||Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies||Completed||Phase 1|33|Anticipated|Wilex|||||||||||||||||||2017-02-18 17:51:58.567408|2017-02-18 17:51:58.567408
NCT00083512|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-25|2017-01-24|||May 21, 2004||2004-05-21|September 26, 2016|2016-09-26||||||||Observational|||Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme|Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:58.727842|2017-02-18 17:51:58.727842
NCT00083499|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-25|2017-01-24|||May 24, 2004||2004-05-24|December 8, 2016|2016-12-08||||||||Observational|||Mutations in Genes Associated With Pentalogy of Cantrell|Mutations in Genes Associated With Pentalogy of Cantrell|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:58.840017|2017-02-18 17:51:58.840017
NCT00083486|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-24|2011-04-25|||February 2004||2004-02-01|April 2011|2011-04-01|October 2004|Actual|2004-10-01|||||Interventional|||Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy||Terminated||Phase 3|||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:51:59.135447|2017-02-18 17:51:59.135447
NCT00083473|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-24|2005-08-26|||May 2004||2004-05-01|August 2005|2005-08-01|April 2005||2005-04-01|||||Interventional|||A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia|A Pilot Study of Pivanex, a Histone Deacetylase Inhibitor, in Patients With Chronic Lymphocytic Leukemia|Terminated||Phase 2|28||Titan Pharmaceuticals|||||||||||||||||||2017-02-18 17:51:59.226797|2017-02-18 17:51:59.226797
NCT00083239|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|||Study of Talabostat in Advanced Melanoma||Completed||Phase 2|||Point Therapeutics|||||||||||||||||||2017-02-18 17:52:01.819209|2017-02-18 17:52:01.819209
NCT00083460|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-24|2010-07-30|||December 2001||2001-12-01|July 2010|2010-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Study of Combination PS-341 and Thalidomide in Multiple Myeloma|UARK 2001-37, A Phase I Exploratory Study of Combination PS-341 and Thalidomide in Refractory Multiple Myeloma|Completed||Phase 1|86|Actual|University of Arkansas||2|||f||||t||||||||||2017-02-18 17:51:59.31181|2017-02-18 17:51:59.31181
NCT00083447|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-24|2009-01-06|||May 2004||2004-05-01|January 2008|2008-01-01|June 2007|Anticipated|2007-06-01|March 2006|Actual|2006-03-01||Interventional|||Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme|A Phase III Multicenter Study of Intratumoral/Interstitial Therapy With TransMID™ Compared to Best Standard of Care in Patients With Progressive and/or Recurrent, Non-Resectable Glioblastoma Multiforme|Withdrawn||Phase 3|323||Xenova Biomedix||||This study has been withdrawn because the drug would not meet trial criteria for efficacy|f||||||||||||||2017-02-18 17:51:59.432339|2017-02-18 17:51:59.432339
NCT00083434|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-24|2011-04-25|||February 2004||2004-02-01|April 2011|2011-04-01|October 2004|Actual|2004-10-01|||||Interventional|||Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy||Terminated||Phase 3|||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||This study was stopped because of an inadequate rate of enrollment.|||||t||||||||||2017-02-18 17:51:59.560699|2017-02-18 17:51:59.560699
NCT00083421|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-24|2012-06-12|||June 2004||2004-06-01|June 2012|2012-06-01|July 2007|Actual|2007-07-01|||||Interventional|||Effects of ONO-2506PO in Patients With Alzheimer's Disease|Effects of ONO-2506PO in Patients With Alzheimer's Disease|Completed||Phase 2|647|Actual|Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 17:51:59.651983|2017-02-18 17:51:59.651983
NCT00083408|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-24|2010-07-01|||March 1998||1998-03-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide|UARK 99-016, A Phase II Trial of Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide in Patients With Multiple Myeloma and Poor Hematopoietic Stem Cell Reserve|Completed||Phase 2|20||University of Arkansas|||||||||||||||||||2017-02-18 17:51:59.826618|2017-02-18 17:51:59.826618
NCT00083395|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-22|2008-03-03|||May 2004||2004-05-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy|Utility of Isoproterenol Challenge Test to Detect Disease in Patients With Incomplete Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:51:59.924377|2017-02-18 17:51:59.924377
NCT00083382|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-21|2015-06-05|2015-06-05||December 1998||1998-12-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide|UARK 98-036, A Phase II Trial of Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide in Patients With Smoldering/Indolent Myeloma|Completed||Phase 2|83|Actual|University of Arkansas||1|||f||||f||||||||||2017-02-18 17:52:00.015792|2017-02-18 17:52:00.015792
NCT00083369|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-21|2013-11-16|||September 2002||2002-09-01|November 2013|2013-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Genetic and Environmental Determinants of Triglycerides (GOLDN)||Completed||N/A|1327|Actual|University of Alabama at Birmingham|||1||f||||||||||||||2017-02-18 17:52:00.398212|2017-02-18 17:52:00.398212
NCT00083356|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-21|2008-03-03|||May 2004||2004-05-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Bradykinin Receptors and Pain|Bradykinin-1 Receptor and Kinin Induction in a Clinical Model of Tissue Injury|Completed||Phase 2|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:00.485565|2017-02-18 17:52:00.485565
NCT00083343|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-20|2015-12-30|||May 2004||2004-05-01|December 2015|2015-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)|A Multicenter, Open, Noncomparative Study to Estimate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in the Treatment of Adults With Invasive Candida Infections (Excluding Patients With Candidemia as the Sole Site of Infection)|Completed||Phase 2|48|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:52:00.580226|2017-02-18 17:52:00.580226
NCT00083330|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-20|2017-01-24|||May 18, 2004||2004-05-18|October 1, 2009|2009-10-01|October 1, 2009|Actual|2009-10-01|October 1, 2009|Actual|2009-10-01||Interventional|||Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers|Completed||Phase 1|36||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:52:00.676237|2017-02-18 17:52:00.676237
NCT00083317|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-19|2017-01-24|||May 15, 2004||2004-05-15|January 4, 2012|2012-01-04|January 4, 2012||2012-01-04|||||Observational|||Role of the Brain in Making Economic Decisions|The Role of the Prefrontal Cortex in Economic Decision-Making in Reciprocal Trust Games Using Functional Hyperscanning Neuroimaging|Completed||N/A|127|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:00.983886|2017-02-18 17:52:00.983886
NCT00083304|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-18|2013-05-08|||February 2004||2004-02-01|May 2013|2013-05-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|ENRICH||Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer|A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy With Supplemental Oxygen, With or Without Concurrent RSR13 (Efaproxiral), in Women With Brain Metastases From Breast Cancer|Completed||Phase 3|368|Actual|Spectrum Pharmaceuticals, Inc||2|||f||||t||||||||||2017-02-18 17:52:01.072809|2017-02-18 17:52:01.072809
NCT00083291|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-18|2008-03-03|||May 2004||2004-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Helicobacter Pylori and Dry Eye|Pilot Study of Helicobacter Pylori and Ocular Surface Disease|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:01.413406|2017-02-18 17:52:01.413406
NCT00083278|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-17|2012-04-26|||May 2003||2003-05-01|April 2012|2012-04-01|February 2006|Actual|2006-02-01|||||Interventional|||Study of MDX-010 in Stage IV Breast Cancer|A Phase II Study of MDX-010 in Patients With Stage IV Adenocarcinoma of the Breast|Completed||Phase 2|33|Actual|Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 17:52:01.509288|2017-02-18 17:52:01.509288
NCT00083265|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-15|2017-01-24|||May 10, 2004||2004-05-10|July 1, 2016|2016-07-01||||||||Observational|||Genetic Causes of Panic Disorder|Association Between Adenosine Receptor Gene Polymorphisms and Physiological Responses to Caffeine in Subjects With Panic Disorder and Healthy Controls|Completed||N/A|117|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:01.620264|2017-02-18 17:52:01.620264
NCT00083226|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2014-10-24|2014-10-24||March 2004||2004-03-01|January 2014|2014-01-01|August 2012|Actual|2012-08-01|February 2011|Actual|2011-02-01||Interventional||The primary population was the 38 eligible and treated patients|Doxorubicin and Bortezomib in Treating Patients With Liver Cancer|A Phase II Trial of Bortezomib Plus Doxorubicin in Hepatocellular Carcinoma|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 17:52:01.895089|2017-02-18 17:52:01.895089
NCT00083213|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2016-06-01|||January 2004||2004-01-01|June 2016|2016-06-01||||May 2008|Actual|2008-05-01||Interventional|||Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma|An Open Label, Sequential Cohort Dose-Escalation Safety, Tolerability and Pharmacokinetic Study of VEGF Trap Administered Intravenously in Patients With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|25|Actual|Regeneron Pharmaceuticals||1|||f||||||||||||||2017-02-18 17:52:02.416815|2017-02-18 17:52:02.416815
NCT00083187|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-07-17|||November 2005||2005-11-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|January 2007|Actual|2007-01-01||Interventional|||VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia|A Phase II Study of VNP40101M For Patients With Acute Myelogenous Leukemia Or High-Risk Myelodysplasia|Completed||Phase 2|230|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:52:02.528792|2017-02-18 17:52:02.528792
NCT00083174|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2016-10-21|2012-11-07||February 2004||2004-02-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2010|Actual|2010-11-01||Interventional|||Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer|A Phase III Randomized Study of Exemestane Versus Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer|Active, not recruiting||Phase 3|4560|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 17:52:02.650583|2017-02-18 17:52:02.650583
NCT00083161|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2012-09-01|||June 2003||2003-06-01|September 2012|2012-09-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Pilot Study of a Combination of Standard Etoposide/Cisplatin and Metronomic Cyclophosphamide in Patients With Newly Diagnosed Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|8|Actual|Gundersen Lutheran Health System||1|||f||||f||||||||||2017-02-18 17:52:03.47342|2017-02-18 17:52:03.47342
NCT00083148|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2011-03-07|||November 2002||2002-11-01|March 2011|2011-03-01|September 2006|Actual|2006-09-01|March 2005|Actual|2005-03-01||Interventional|||Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer|Phase I Study of Irinotecan Followed by Capecitabine in Patients With Advanced Breast Carcinoma|Completed||Phase 1|12|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:52:03.596819|2017-02-18 17:52:03.596819
NCT00083135|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2010-10-14|||March 2004||2004-03-01|May 2009|2009-05-01||||February 2006|Actual|2006-02-01||Interventional|||N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation|I-MIBG Escalating Dose Rapid Sequence Double Infusion Followed By Autologous Stem Cell Infusion For Refractory Neuroblastoma|Completed||Phase 1|18|Anticipated|Children's Hospital Los Angeles|||||f||||t||||||||||2017-02-18 17:52:03.699652|2017-02-18 17:52:03.699652
NCT00083122|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2014-05-06|2013-03-22||April 2004||2004-04-01|April 2013|2013-04-01|May 2012|Actual|2012-05-01|July 2010|Actual|2010-07-01||Interventional|||Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer|Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:52:03.817595|2017-02-18 17:52:03.817595
NCT00083109|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2015-05-22|||March 2004||2004-03-01|January 2013|2013-01-01|March 2008|Actual|2008-03-01|December 2005|Actual|2005-12-01||Interventional|||Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer|Phase I/II Trial Of Low Dose Suramin (CI-1003, NSC#34936) And 5-Fluorouracil In Patients With Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 1/Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:04.293055|2017-02-18 17:52:04.293055
NCT00083096|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2015-02-09|||March 2004||2004-03-01|February 2015|2015-02-01||||June 2009|Actual|2009-06-01||Interventional|||Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas|Phase I Study Of SCH66336 (Lonafarnib), A Farnesyl Protein Transferase Inhibitor In Combination With Temozolomide In Gliomas|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:52:04.410069|2017-02-18 17:52:04.410069
NCT00083083|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2011-02-26|||March 2005||2005-03-01|October 2007|2007-10-01||||June 2006|Anticipated|2006-06-01||Interventional|||Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer|Positron Emission Tomography Pre- and Post-treatment Assessment For Locally Advanced Non-Small Cell Lung Carcinoma|Unknown status|Active, not recruiting|Phase 2|250|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:04.516709|2017-02-18 17:52:04.516709
NCT00083070|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2014-02-18|||March 2004||2004-03-01|February 2014|2014-02-01|June 2008|Actual|2008-06-01|September 2004|Actual|2004-09-01||Interventional|||Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia|A Phase I Trial Of Temozolomide In Pediatric Patients With Refractory/Recurrent Leukemias|Completed||Phase 1|16|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:52:04.664675|2017-02-18 17:52:04.664675
NCT00083057|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2012-03-14|||May 2004||2004-05-01|March 2012|2012-03-01|November 2010|Actual|2010-11-01|October 2010|Actual|2010-10-01||Interventional|||Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck|A Pilot Phase I Dose Escalation Study Of The EGFR Tyrosine Kinase Inhibitor Gefitinib (Iressa) Combined With Paclitaxel (Taxol) And External Beam Radiation Therapy In Patients With Advanced Squamous Cell Carcinoma Of The Head And Neck (SCCHN)|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:52:04.789195|2017-02-18 17:52:04.789195
NCT00083044|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2012-04-24|||October 2003||2003-10-01|April 2012|2012-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy|Surrogate Endpoints in Prevention Studies and Ductal Lavage|Withdrawn||Phase 2|0|Actual|Northwestern University|||1|Funding ended and will not be renewed|f||||f||||||||||2017-02-18 17:52:05.008687|2017-02-18 17:52:05.008687
NCT00005336|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||April 1991||1991-04-01|April 2000|2000-04-01|September 1996||1996-09-01|||||Observational|||Dietary Treatment of Hyperlipidemia in Women vs. Men||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:07.202558|2017-02-18 18:15:07.202558
NCT00083031|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2009-02-06|||November 2002||2002-11-01|September 2005|2005-09-01||||||||Interventional|||Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer|Metronomic Chemotherapy in Combination With Bevacizumab for Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:05.106879|2017-02-18 17:52:05.106879
NCT00083018|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-08-23|||September 2003||2003-09-01|December 2005|2005-12-01||||||||Interventional|||Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer|Evaluation Of The Role Of Nipple Aspiration, Ductal Lavage And Duct Endoscopy At The Time Of Surgery In Patients With Breast Cancer|Unknown status|Recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:05.202574|2017-02-18 17:52:05.202574
NCT00083005|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2012-03-14|||March 2004||2004-03-01|March 2012|2012-03-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate|A Phase II Trial Combining Estramustine, Docetaxel And Thalidomide In Patients With Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:05.301211|2017-02-18 17:52:05.301211
NCT00082979|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-08-23|||October 2003||2003-10-01|December 2005|2005-12-01||||||||Interventional|||Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer|Evaluation of the Role of Duct Endoscopy in the Assessment of Cellular Atypia Within Breast Duct Fluid in High-Risk Women Carrying BRCA1/2 or p53 Gene Mutations|Unknown status|Recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:05.412786|2017-02-18 17:52:05.412786
NCT00082966|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2015-12-03|||March 2004||2004-03-01|June 2013|2013-06-01||||March 2007|Actual|2007-03-01||Interventional|||Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase II Study of PS-341 (Bortezomib) in Patients With Relapsed or Refractory Hodgkin's Lymphoma|Completed||Phase 2|43|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:05.508482|2017-02-18 17:52:05.508482
NCT00082940|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2017-01-17|||August 2002||2002-08-01|June 2013|2013-06-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|||Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia|A Phase II Study of ONTAK® (Denileukin Diftitox, DABIL-2) in Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 17:52:05.618478|2017-02-18 17:52:05.618478
NCT00082927|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-06-25|||April 2003||2003-04-01|June 2009|2009-06-01|July 2011|Actual|2011-07-01|||||Interventional|||Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain|A Multicentre Randomised Trial Of Single Dose Radiotherapy Compared To Ibandronate For Localised Metastatic Bone Pain|Completed||Phase 3|580|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:05.724617|2017-02-18 17:52:05.724617
NCT00082914|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-06-18|||March 2004||2004-03-01|December 2005|2005-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer|Phase II Evaluation of Denileukin Diftitox in Patients With Metastatic Melanoma or Metastatic Kidney Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:06.061925|2017-02-18 17:52:06.061925
NCT00082888|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2016-10-27|2011-11-02||March 2004||2004-03-01|October 2016|2016-10-01||||May 2009|Actual|2009-05-01||Interventional|||Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma|Phase II Evaluation of FTI (R115777) in Treatment of Relapsed and Refractory Lymphoma|Active, not recruiting||Phase 2|93|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:06.164252|2017-02-18 17:52:06.164252
NCT00082875|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-06-04|||March 2004||2004-03-01|June 2013|2013-06-01||||July 2006|Actual|2006-07-01||Interventional|||Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma|A Phase 2 Study of EMD 121974 (Cilengitide, NSC 707544) in Patients With Metastatic Melanoma|Terminated||Phase 2|56|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:52:06.580349|2017-02-18 17:52:06.580349
NCT00082862|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2012-02-10|||July 2002||2002-07-01|December 2008|2008-12-01||||November 2012|Anticipated|2012-11-01||Interventional|||Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer|A Phase II Clinical Trial of a Timing/Schedule Optimized Combined-Modality Regimen: Cisplatin + Metronomic Low-Dose Interferon-α (IFN-α) Followed by Gemcitabine HCl (GEMZAR) in Combination With Mild, Fever-Range Whole-Body Hyperthermia (FR-WBH) in Patients With Advanced, Inoperable Pancreatic Cancer|Unknown status|Recruiting|Phase 2|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:06.690781|2017-02-18 17:52:06.690781
NCT00082836|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-01-15|||December 2004||2004-12-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma|A Pilot Study of Radiolabeled Indium-111 and Yttrium-90 Ibritumomab Tiuxetan in Primary CNS Lymphoma|Completed||N/A|10|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:52:06.798212|2017-02-18 17:52:06.798212
NCT00082823|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2016-06-01|||January 2004||2004-01-01|June 2016|2016-06-01||||May 2008|Actual|2008-05-01||Interventional|||Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma|An Open-Label, Long-Term, Safety and Tolerability Study of VEGF Trap Administered Intravenously in Patients With Advanced Solid Tumors or Lymphoma|Completed||Phase 1|25|Actual|Regeneron Pharmaceuticals||1|||f||||||||||||||2017-02-18 17:52:06.891601|2017-02-18 17:52:06.891601
NCT00082810|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2015-08-03|2015-05-04||March 2004||2004-03-01|October 2013|2013-10-01|September 2008|Actual|2008-09-01|July 2008|Actual|2008-07-01||Interventional|||Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer|A Phase II Trial of Tipifarnib (R115777, Zarnestra™) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Hormone Receptor-Positive Breast Cancer|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:52:07.00445|2017-02-18 17:52:07.00445
NCT00082797|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2010-01-28|||February 2005||2005-02-01|January 2010|2010-01-01||||May 2007|Actual|2007-05-01||Interventional|||High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase II Study Of Systemic High-Dose Methotrexate For The Treatment Of Glioblastoma Multiforme In Newly Diagnosed Patients With Measurable Disease|Completed||Phase 2|36|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 17:52:07.323614|2017-02-18 17:52:07.323614
NCT00082784|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2014-12-22|||March 2004||2004-03-01|October 2014|2014-10-01|September 2014|Actual|2014-09-01|October 2012|Actual|2012-10-01||Interventional|||Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms|Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol NSC 649890) in Patients With Recurrent or Refractory Indolent B-Cell Neoplasms|Completed||Phase 1|93|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:07.499324|2017-02-18 17:52:07.499324
NCT00082758|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2015-01-27|2013-12-02||August 2005||2005-08-01|January 2015|2015-01-01|May 2012|Actual|2012-05-01|February 2008|Actual|2008-02-01||Interventional|||hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma|A Phase II Study Of hu14.18-IL2 In Children With Recurrent Or Refractory Neuroblastoma|Completed||Phase 2|39|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 17:52:07.640267|2017-02-18 17:52:07.640267
NCT00082745|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2016-10-24|||March 2004||2004-03-01|October 2016|2016-10-01||||January 2100|Anticipated|2100-01-01||Observational|||Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors|Key Adverse Events After Childhood Cancer|Recruiting||N/A|8100|Anticipated|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"~     peripheral blood or buccal sample~   "|||2017-02-18 17:52:08.637855|2017-02-18 17:52:08.637855
NCT00082732|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2012-10-18|||July 2002||2002-07-01|October 2012|2012-10-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer|Impact of Dietary Intervention in Men With Hormone Refractory Prostate Cancer|Completed||Phase 1|56|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 17:52:09.43043|2017-02-18 17:52:09.43043
NCT00082719|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2015-05-12|||December 2003||2003-12-01|May 2015|2015-05-01|January 2015|Actual|2015-01-01|January 2015|Actual|2015-01-01||Interventional|||Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium|Modulation of Death Effector Expression By Short-Term Exposure to Low-Dose Interferon|Completed||Phase 1|33|Actual|M.D. Anderson Cancer Center||4|||f||||t||||||||||2017-02-18 17:52:09.545803|2017-02-18 17:52:09.545803
NCT00082706|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2016-12-19|||April 2003||2003-04-01|December 2016|2016-12-01||||February 2018|Anticipated|2018-02-01||Interventional|||Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant|Phase II Trial of 5-FU, Leucovorin, Gemcitabine, and Cisplatin for Adenocarcinomas of the Urothelial Tract and Urachal Remnant|Active, not recruiting||Phase 2|46|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:52:09.677201|2017-02-18 17:52:09.677201
NCT00082667|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-02-22|||October 2002||2002-10-01|February 2013|2013-02-01|June 2005|Actual|2005-06-01|July 2004|Actual|2004-07-01||Interventional|||Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast|EGFR Pathway Modulation In Patients With Ductal Carcinoma In Situ Of The Breast|Terminated||Phase 2|1|Actual|Vanderbilt-Ingram Cancer Center||||PI left VICC|f||||t||||||||||2017-02-18 17:52:09.805593|2017-02-18 17:52:09.805593
NCT00082654|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2010-09-17|||March 2002||2002-03-01|September 2010|2010-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients|Emotional Needs of Caregivers and Patient/Spouse Couples During Hematopoietic Stem Cell Transplantation (HSCT)|Completed||N/A|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:52:09.913547|2017-02-18 17:52:09.913547
NCT00082641|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-14|2013-05-14|||January 2004||2004-01-01|May 2013|2013-05-01||||December 2014|Anticipated|2014-12-01||Interventional|||Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant Radiation Therapy in Treating Women With p53-Overexpressing Stage III Breast Cancer|1) Adenovirus p53 Infected DC Vaccine For Breast Cancer, 2) Translation of Biotechnology Into the Clinic|Unknown status|Active, not recruiting|Phase 1/Phase 2|24|Actual|University of Nebraska||2|||f||||t||||||||||2017-02-18 17:52:10.035932|2017-02-18 17:52:10.035932
NCT00082628|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-13|2014-06-16|||May 2004||2004-05-01|June 2014|2014-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients|A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Serostim®, r-hGH in the Treatment and Maintenance of Human Immunodeficiency HIV-Associated Adipose Redistribution Syndrome, or HARS|Completed||Phase 3|569|Actual|EMD Serono|||||f||||||||||||||2017-02-18 17:52:10.152002|2017-02-18 17:52:10.152002
NCT00082615|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-13|2017-01-24|||May 11, 2004||2004-05-11|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Neurophysiological Markers in Patients With Craniofacial Dystonia and Their Relatives|Neurophysiological Markers in Patients With Craniofacial Dystonia and Their Relatives|Completed||N/A|210||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:10.269094|2017-02-18 17:52:10.269094
NCT00082602|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-12|2011-05-19|||May 2004||2004-05-01|April 2009|2009-04-01|April 2005|Actual|2005-04-01|||||Interventional|||Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease|Galantamine ER Open Label Rapid Dose Escalation Trial in Alzheimer's Disease|Completed||Phase 3|83|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 17:52:10.36218|2017-02-18 17:52:10.36218
NCT00082589|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-12|2008-05-22|||April 2004||2004-04-01|April 2007|2007-04-01|March 2006||2006-03-01|||||Interventional|REMODEL||The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure|A Randomized, Double-Blind, Multi-Center,Study Evaluating the Effects of Eplerenone Versus Placebo on Ventricular Remodeling in Patient's With Left Ventricular Systolic Dysfunction (EF Less Than or Equal to 35%) and Mild to Moderate Heart Failure|Completed||Phase 4|250||Pfizer|||||||||||||||||||2017-02-18 17:52:10.461454|2017-02-18 17:52:10.461454
NCT00082576|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-12|2011-05-10|||June 2004||2004-06-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa|A Phase II/III, Randomized, Double-Blind, Comparative Trial Of Azithromycin Plus Chloroquine Versus Mefloquine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Africa|Completed||Phase 2/Phase 3|238|Actual|Pfizer|||||||||||||||||||2017-02-18 17:52:10.602043|2017-02-18 17:52:10.602043
NCT00082563|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-12|2011-04-25|||August 2004||2004-08-01|April 2011|2011-04-01|November 2004|Actual|2004-11-01|||||Interventional|||Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum|A Phase II, Randomized, Comparative Trial Of Azithromycin In Combination With Chloroquine Versus Chloroquine In The Eradication Of Asymptomatic Plasmodium Falciparum Infection In Semi-Immune Adults|Terminated||Phase 2|14|Actual|Pfizer|||||||||||||||||||2017-02-18 17:52:10.700965|2017-02-18 17:52:10.700965
NCT00082550|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-12|2017-01-24|||May 10, 2004||2004-05-10|April 9, 2007|2007-04-09|April 9, 2007||2007-04-09|||||Observational|||Serotonin Transporters in Obsessive-Compulsive-Related Disorders|PET Imaging of Monoamine Transporters in OCD-related Disorders|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:10.793523|2017-02-18 17:52:10.793523
NCT00082537|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-11|2015-09-07|||April 2004||2004-04-01|September 2015|2015-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)|A Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Versus (Amphotericin B) Liposome for Injection as Empirical Therapy in Pediatric Patients With Persistent Fever and Neutropenia|Completed||Phase 2|100|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:52:10.882197|2017-02-18 17:52:10.882197
NCT00082524|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-11|2014-12-18|||April 2004||2004-04-01|December 2014|2014-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)|A Multicenter, Open-Label, Noncomparative Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in Children With Documented Candida or Aspergillus Infections|Completed||Phase 2|50|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:52:10.976918|2017-02-18 17:52:10.976918
NCT00082511|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-11|2008-01-10|||July 2003||2003-07-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids|A Multi-Center, Open-Label Study to Assess the Durability and Safety of the Prevention of Bone Loss by Treatment With GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids|Completed||Phase 3|114|Actual|Genelabs Technologies||4|||f||||f||||||||||2017-02-18 17:52:11.064968|2017-02-18 17:52:11.064968
NCT00082498|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-11|2014-07-22|||May 2004||2004-05-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|December 2005|Actual|2005-12-01||Interventional|||Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients|Phase II, Randomized, Double-Blind Study of the Safety and Efficacy of Vicriviroc (An Orally Administered HIV-1 Entry Inhibitor) in HIV-Infected, Treatment-Experienced Subjects|Completed||Phase 2|119|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:52:11.179537|2017-02-18 17:52:11.179537
NCT00082485|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-11|2017-01-11|||June 2004||2004-06-01|August 2016|2016-08-01||||July 2006|Actual|2006-07-01||Interventional|||Baclofen for the Treatment of Cocaine Dependence - 1|Multi-Center Trial of Baclofen for the Treatment of Cocaine Dependence|Completed||Phase 2|160|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-02-18 17:52:11.316945|2017-02-18 17:52:11.316945
NCT00082472|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-11|2006-04-14|||January 2004||2004-01-01|April 2006|2006-04-01||||||||Interventional|||Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)|Phase I/II Study of Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Locally Advanced or Metastatic Unresectable Non Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|30||Zivena|||||||||||||||||||2017-02-18 17:52:11.430872|2017-02-18 17:52:11.430872
NCT00082459|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-10|2012-09-06|||July 2002||2002-07-01|September 2012|2012-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma|A Randomized Phase II Study Investigating the Route of Administration of Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma|Terminated||Phase 2|40||Agenus Inc.||||Lack of enrollment|||||||||||||||2017-02-18 17:52:11.522202|2017-02-18 17:52:11.522202
NCT00082446|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-10|2014-12-18|||May 2004||2004-05-01|September 2008|2008-09-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combination Study With MVA BN and Dryvax|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of MVA-BN in a Dose Response Regimen Followed by Administration of Dryvax in Healthy Adult Volunteers|Completed||Phase 1|91|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||6|||f||||||||||||||2017-02-18 17:52:11.601565|2017-02-18 17:52:11.601565
NCT00082433|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-07|2016-02-09|2009-05-01||November 2003||2003-11-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer|A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane|Completed||Phase 3|1221|Actual|R-Pharm||2|||f||||t||||||||||2017-02-18 17:52:11.843023|2017-02-18 17:52:11.843023
NCT00082420|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-06|2010-01-12|||September 2004||2004-09-01|January 2010|2010-01-01|November 2005|Actual|2005-11-01|||||Observational|||Retinol Equivalence of Plant Carotenoids in Children||Completed||N/A|32|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||||||||||||2017-02-18 17:52:17.151164|2017-02-18 17:52:17.151164
NCT00082407|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-06|2015-03-19|2009-07-16||November 2003||2003-11-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional||IIT population|Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin|Efficacy of Exenatide (AC2993, Synthetic Exendin-4, LY2148568) Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin|Completed||Phase 3|505|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:52:17.250075|2017-02-18 17:52:17.250075
NCT00082394|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-06|2010-09-29|||April 2004||2004-04-01|September 2010|2010-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV|See Detailed Description|Completed||Phase 4|280|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 17:52:17.961228|2017-02-18 17:52:17.961228
NCT00082381|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-06|2015-03-19|2009-07-16||June 2003||2003-06-01|March 2015|2015-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin|Effect of AC2993 (Synthetic Exendin-4) Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin|Completed||Phase 3|551|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:52:18.383402|2017-02-18 17:52:18.383402
NCT00080613|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer|Phase II Study of Neoadjuvant and Adjuvant Exemestane in Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer|Withdrawn||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:45.065121|2017-02-18 17:52:45.065121
NCT00082368|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2015-05-07|2015-04-15||May 2004||2004-05-01|May 2015|2015-05-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Interventional|||PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy|A Pilot Study of Tc-94m Sestamibi PET MDR Imaging|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)|The lack of flexibility around patient chemotherapy schedules made the protocol difficult to conduct. Future studies should make imaging integral to the treatment protocol .|1|||f||||f||||||||||2017-02-18 17:52:19.025481|2017-02-18 17:52:19.025481
NCT00082355|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-06|2014-10-31|2011-02-08||May 2004||2004-05-01|October 2014|2014-10-01|October 2014|Actual|2014-10-01|March 2010|Actual|2010-03-01||Interventional|||Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins|"The Treatment of Deep Vein Thrombosis (DVT) of the Lower Extremities With Low-Dose Alteplase: a Pilot Study"|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)|Small trial of 30 patients does not have statistical power to prove clinical safety (expected to be <1 %)|1|||f||||f||||||||||2017-02-18 17:52:19.361127|2017-02-18 17:52:19.361127
NCT00082342|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-06|2012-11-22|2012-08-31||March 2003||2003-03-01|November 2012|2012-11-01||||February 2009|Actual|2009-02-01||Interventional|||Transcranial Direct Current Stimulation to Treat Symptoms of Parkinson's Disease|Transcranial Direct Current Stimulation for the Treatment of Parkinson's Disease|Completed||Phase 2|25|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 17:52:19.63151|2017-02-18 17:52:19.63151
NCT00082329|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-06|2014-04-01|2014-04-01||May 2004||2004-05-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers|Peripheral Blood Hematopoietic Progenitor Cell Mobilization Using Granulocyte Colony Stimulating Factor (G-CSF) Combined With AMD3100 Mozobil (Plerixafor) in Healthy Volunteers|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 17:52:20.119417|2017-02-18 17:52:20.119417
NCT00082316|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-05|2008-01-03||||||January 2008|2008-01-01||||||||Interventional|||Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain|A Randomized, Open-Label Study of the Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain|Completed||Phase 2|||NeurogesX|||||||||||||||||||2017-02-18 17:52:20.365314|2017-02-18 17:52:20.365314
NCT00082303|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-05|2006-08-16|||July 2002||2002-07-01|August 2006|2006-08-01||||||||Interventional|||Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin’s Lymphoma|Music Imagery for Patients in Protected Environments|Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:52:20.723398|2017-02-18 17:52:20.723398
NCT00082290|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-05|2015-12-17|||May 2003||2003-05-01|December 2015|2015-12-01||||February 2011|Actual|2011-02-01||Interventional|||Massage Therapy in Treating Patients With Cancer Pain|Massage for the Treatment of Pain in Cancer: A Randomized Phase II Study|Completed||Phase 2|92|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 17:52:20.800955|2017-02-18 17:52:20.800955
NCT00082277|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-05|2011-01-25|||April 2004||2004-04-01|January 2011|2011-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|SABRE||Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer|A Multicentre Phase III/IV Study, of the Effects of Risedronate Sodium (ACTONEL™, 35mg/Week, Oral) on Bone, in Postmenopausal Women, With Hormone-receptor-positive Early Breast Cancer, Treated With Anastrozole (ARIMIDEX™, 1mg/Day Oral) With Risk of Fragility Fracture (High-risk Fragility Fracture-open-label, Non-comparative Stratum; Moderate-risk of Fragility Fracture-randomised, Double-blind Stratum; Low-risk of Fragility Fracture - Open-label, Non-comparative Stratum)Abbreviated|Completed||Phase 4|237|Actual|AstraZeneca||3|||f||||||||||||||2017-02-18 17:52:20.906159|2017-02-18 17:52:20.906159
NCT00082251|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-03|2006-10-31||||||October 2006|2006-10-01||||||||Interventional|||Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST|Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST|Completed||Phase 3|||Kos Pharmaceuticals|||||||||||||||||||2017-02-18 17:52:21.056871|2017-02-18 17:52:21.056871
NCT00082238|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-03|2010-03-01|||March 2003||2003-03-01|March 2010|2010-03-01||||||||Interventional|||Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)|Increased Gluconeogenesis is One Cause of CFRD|Completed||N/A|60|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:52:21.147405|2017-02-18 17:52:21.147405
NCT00082225|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-03|2017-02-03|||October 2003||2003-10-01|February 2017|2017-02-01|January 2008|Actual|2008-01-01|February 2006|Actual|2006-02-01||Interventional|ACDAL||LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)|Administration of LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody to Patients With Relapsed EBV-Positive Hodgkin's or Non-Hodgkin's Lymphoma|Terminated||Phase 1|4|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:52:21.218641|2017-02-18 17:52:21.218641
NCT00082212|ClinicalTrials.gov processed this data on February 17, 2017|2004-05-03|2010-04-08|||November 2004||2004-11-01|April 2010|2010-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|A Phase II Trial of Single-agent Cetuximab Dose Escalated to Rash in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Terminated||Phase 2|25|Actual|ImClone LLC||1||Due to lack of sufficient efficacy.|f||||f||||||||||2017-02-18 17:52:21.327355|2017-02-18 17:52:21.327355
NCT00082199|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-30|2013-11-07|||April 2004||2004-04-01|July 2008|2008-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study of Aripiprazole in Subjects With Alcoholism|A Randomized, Multicenter, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Aripiprazole in the Maintenance of Abstinence From Alcohol in Subjects With Alcoholism|Completed||Phase 4|400||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 17:52:21.444551|2017-02-18 17:52:21.444551
NCT00082186|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-30|2010-02-11|||July 2003||2003-07-01|February 2010|2010-02-01|November 2007|Actual|2007-11-01|February 2007|Actual|2007-02-01||Interventional|||The Effect of Tracleer® on Male Fertility|TRACLEER® (Bosentan) Pulmonary Arterial Hypertension A Multicenter, Open-label, Single-arm Safety Study to Investigate the Effects of Chronic TRACLEER® Treatment on Testicular Function in Male Patients With Pulmonary Arterial Hypertension|Completed||Phase 4|22|Actual|Actelion||1|||f||||||||||||||2017-02-18 17:52:21.557447|2017-02-18 17:52:21.557447
NCT00080600|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2017-01-24|||April 6, 2004||2004-04-06|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Brain Physiology in Polio Survivors|Central Motor Physiology in Polio Survivors|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:45.172144|2017-02-18 17:52:45.172144
NCT00082173|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-30|2013-03-26|2013-03-26||October 2004||2004-10-01|March 2013|2013-03-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Interventional||125 had 8-week data (moxifloxacin n=64, ethambutol n=61)|Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis|Phase 2 Randomized Trial of a Moxifloxacin-Containing Regimen For Treatment of Smear-Positive Pulmonary Tuberculosis in Adults With and Without HIV Infection|Completed||Phase 2|170|Actual|Johns Hopkins University||2|||f||||t||||||||||2017-02-18 17:52:21.672541|2017-02-18 17:52:21.672541
NCT00082160|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-30|2006-08-03|||July 2001||2001-07-01|August 2006|2006-08-01|June 2005||2005-06-01|||||Observational|||Brain Imaging Technology to Examine the Effects of Meditation|fMRI Investigation of Meditation|Completed||N/A|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:52:22.067942|2017-02-18 17:52:22.067942
NCT00082147|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-30|2017-01-24|||April 28, 2004||2004-04-28|July 21, 2016|2016-07-21|February 21, 2007|Actual|2007-02-21|||||Interventional|||Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer|A Prospective Histopathologic Study of Dynamic Contrast Enhanced MRI for Prostate Cancer Delineation and Characterization With the APT-MRI System|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:52:22.16788|2017-02-18 17:52:22.16788
NCT00082134|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-29|2015-03-04||||||March 2015|2015-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel|A Phase II Study of ILX651 Administered Intravenously Daily for Five Consecutive Days Every 21 Days in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel|Completed||Phase 2|40||Sanofi|||||||||||||||||||2017-02-18 17:52:22.280517|2017-02-18 17:52:22.280517
NCT00082121|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-29|2007-07-19|||April 2004||2004-04-01|July 2007|2007-07-01|December 2005||2005-12-01|||||Interventional|||Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery||Completed||Phase 2|300||Avant Immunotherapeutics|||||||||||||||||||2017-02-18 17:52:22.379331|2017-02-18 17:52:22.379331
NCT00082108|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-29|2016-08-26|||September 2000||2000-09-01|August 2016|2016-08-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Observational|||Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry|National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Patients and Family Members|Recruiting||N/A|3000|Anticipated|University of Rochester|||1||f||||f||||||||||2017-02-18 17:52:22.482899|2017-02-18 17:52:22.482899
NCT00082095|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-29|2014-10-08|||April 2004||2004-04-01|October 2014|2014-10-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older|A Randomized, Open-Label Trial Comparing Treatment With Either Pegylated Liposomal Doxorubicin or Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer in Women 60 Years and Older|Terminated||Phase 3|62|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2||"The study was terminated due to poor recruitment (after enrolling 62 of planned 300 patients~   in 20 months"|f||||f||||||||||2017-02-18 17:52:22.594091|2017-02-18 17:52:22.594091
NCT00082082|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-28|2008-01-08||||||January 2008|2008-01-01||||||||Interventional|||A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma|A Trial of Thymalfasin With Trans Arterial Chemo-Embolization (TACE) in the Treatment of Adult Patients With Unresectable Hepatocellular Carcinoma: A Phase II Trial|Completed||Phase 2|||SciClone Pharmaceuticals|||||||||||||||||||2017-02-18 17:52:22.737848|2017-02-18 17:52:22.737848
NCT00082069|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-28|2015-04-28|||April 2004||2004-04-01|April 2015|2015-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Invaplex 50 Vaccine Dose-Ranging|Safety and Immunogenicity Study of an Intranasal Shigella Flexneri 2a Invaplex 50 Vaccine|Completed||Phase 1|32|Actual|U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-02-18 17:52:22.813934|2017-02-18 17:52:22.813934
NCT00082043|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-28|2017-01-24|||March 31, 2004||2004-03-31|February 5, 2016|2016-02-05|March 6, 2014|Actual|2014-03-06|March 6, 2014|Actual|2014-03-06||Interventional|||Dutasteride to Treat Women With Menstrually Related Mood Disorders|The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women With Menstrual-Related Mood Disorders and Controls|Completed||Phase 1|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 17:52:22.911071|2017-02-18 17:52:22.911071
NCT00082030|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-28|2017-01-24|||April 19, 2004||2004-04-19|November 18, 2011|2011-11-18|November 18, 2011||2011-11-18|||||Observational|||Function of Catecholamines in the Brain During Depression|Neural Correlates of Depressive Symptoms and Reward Related Mechanisms Following AMPT Depletion in Remitted Depressed Patients Off Treatment and Healthy Controls|Completed||N/A|71|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:23.023449|2017-02-18 17:52:23.023449
NCT00082017|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-28|2012-07-26|2012-06-06||April 2004||2004-04-01|June 2012|2012-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas|Phase II Study of UCN-01 in Relapsed or Refractory Systemic Anaplastic Large Cell and Mature T-Cell Lymphomas|Completed||Phase 2|20|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 17:52:23.116141|2017-02-18 17:52:23.116141
NCT00081991|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-28|2008-03-03|||April 2004||2004-04-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Dynamic Light Scattering for Studying Lens Aging and Cataract Formation|A Cross Sectional Clinical Study of Human Lens Aging and Cataract Formation, in Vivo, Using Dynamic Light Scattering (DLS)|Completed||N/A|267||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:23.677149|2017-02-18 17:52:23.677149
NCT00081978|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-28|2010-04-26|||March 2004||2004-03-01|April 2010|2010-04-01|October 2005|Actual|2005-10-01|||||Interventional|||TMC125-C223: TMC125 in HIV-1 Infected Subjects|A Randomized, Controlled, Partially Blinded Phase IIb Dose-Finding Trial of TMC125 in HIV-1 Infected Subjects With Documented Genotypic Evidence of Resistance to Currently Available NNRTIs and With at Least Three Primary PI Mutations|Completed||Phase 2|211|Actual|Tibotec Pharmaceuticals, Ireland|||||||||||||||||||2017-02-18 17:52:23.957085|2017-02-18 17:52:23.957085
NCT00081965|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-27|2012-12-11||||||December 2012|2012-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Acupuncture in Treating Hot Flashes in Women With Breast Cancer|Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients: A Randomized Controlled Trial|Completed||N/A|80|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:52:24.063447|2017-02-18 17:52:24.063447
NCT00081952|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-27|2013-03-21|||October 2003||2003-10-01|March 2013|2013-03-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Amino Acid Therapy for Hot Flashes in Postmenopausal Women|Amino Acid Therapy for Hot Flashes/Postmenopausal Women|Completed||Phase 1/Phase 2|15||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 17:52:24.156836|2017-02-18 17:52:24.156836
NCT00081939|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-27|2015-09-18|2015-09-18||January 2004||2004-01-01|September 2015|2015-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||UARK 2003-33, Total Therapy III|A Phase 2 Study Incorporating Bone Marrow Microenvironment (ME) Co-Targeting Bortezomib Into Tandem Melphalan-Based Autotransplants With DT PACE for Induction/Consolidation and Thalidomide + Dexamethasone for Maintenance|Completed||Phase 2|303|Actual|University of Arkansas||1|||f||||t||||||||||2017-02-18 17:52:24.262668|2017-02-18 17:52:24.262668
NCT00081926|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-26|2009-11-20|||October 2003||2003-10-01|November 2009|2009-11-01|March 2007||2007-03-01|||||Interventional|||Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia||Completed||Phase 4|112||Novartis|||||||||||||||||||2017-02-18 17:52:24.99064|2017-02-18 17:52:24.99064
NCT00081913|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-26|2008-01-23|||January 2004||2004-01-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|March 2006|Actual|2006-03-01||Interventional|||Stem Cell Study for Patients With Heart Disease|Injection of Autologous CD34-Positive Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia|Completed||Phase 1|24||Losordo, Douglas, M.D.|||||||||||||||||||2017-02-18 17:52:25.094612|2017-02-18 17:52:25.094612
NCT00081900|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-26|2015-04-09|||March 2004||2004-03-01|April 2015|2015-04-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care|A Phase 1/2 Study of DENSPM (N1, N11-diethylnorspermine) in Patients With Unresectable Hepatocellular Carcinoma|Terminated||Phase 1/Phase 2|38|Actual|Sanofi||1||"This study was terminated early by Genzyme because there were insufficient data to support~   clinical benefit to HCC patients on the study."|f||||t||||||||||2017-02-18 17:52:25.191818|2017-02-18 17:52:25.191818
NCT00081887|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-23|2012-07-31|||May 2004||2004-05-01|July 2012|2012-07-01|June 2007|Actual|2007-06-01|May 2007|Actual|2007-05-01||Interventional|||Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia|Phase I Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia|Terminated||Phase 1|8|Actual|M.D. Anderson Cancer Center||1||low accrual|f||||f||||||||||2017-02-18 17:52:25.312035|2017-02-18 17:52:25.312035
NCT00081874|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-23|2012-03-20|||April 2004||2004-04-01|March 2012|2012-03-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma|Phase I/II Study of RAD001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia in Blastic-Phase, Agnogenic Myeloid Metaplasia, Chronic Lymphocytic Leukemia, T-Cell Leukemia, or Mantle Cell Lymphoma|Completed||Phase 1/Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:52:25.427969|2017-02-18 17:52:25.427969
NCT00081861|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-23|2012-04-02|2009-03-05||March 2004||2004-03-01|April 2012|2012-04-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma|A Phase II Study of Avastin Plus Rituximab for Patients With Relapsed and Chemotherapy- or Rituxan-Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|13|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:52:25.545527|2017-02-18 17:52:25.545527
NCT00081848|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-22|2017-01-24|||April 20, 2004||2004-04-20|January 25, 2012|2012-01-25|August 23, 2007|Actual|2007-08-23|August 23, 2007|Actual|2007-08-23||Interventional|||Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors|A Pilot Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis in Adults With CEA Positive Solid Tumors|Completed||Phase 1|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:52:25.791179|2017-02-18 17:52:25.791179
NCT00081835|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-22|2017-01-24|||April 19, 2004||2004-04-19|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Evaluation and Treatment of Eye Complications of Vaccinia Vaccination|Evaluation and Treatment of Ocular Complications of Vaccinia Vaccination: Suitability of NP-016 Vaccinia Immune Globulin (VIG) for Sight-Threatening Conditions [VIG31]|Completed||Phase 2|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:25.883868|2017-02-18 17:52:25.883868
NCT00081822|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-21|2012-04-18|||January 2004||2004-01-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|April 2009|Actual|2009-04-01||Interventional|||Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia|A Phase I Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia|Completed||Phase 1|23|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 17:52:25.977457|2017-02-18 17:52:25.977457
NCT00081809|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-20|2012-09-06|||March 2000||2000-03-01|September 2012|2012-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma|A Phase II Trial of Active Specific Immunotherapy in Patients With Indolent Lymphoma Using Autologous Lymphoma-Derived Heat Shock Protein-Peptide Complex (HSPPC-96)|Completed||Phase 2|35||Agenus Inc.|||||f||||||||||||||2017-02-18 17:52:26.09179|2017-02-18 17:52:26.09179
NCT00081796|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-20|2008-08-20|||April 2004||2004-04-01|August 2008|2008-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer|A Randomized, Open-Label, Phase III Study of RPR109881 IV Every 3 Weeks Versus Capecitabine (Xeloda) Tablets Twice Daily for 2 Weeks in 3-Week Cycles in Patients With Metastatic Breast Cancer Progressing After Taxanes and Anthracycline Therapy|Completed||Phase 3|438|Actual|Sanofi||2|||||||||||||||||2017-02-18 17:52:26.194024|2017-02-18 17:52:26.194024
NCT00081783|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-20|2005-06-23|||March 2004||2004-03-01|March 2005|2005-03-01||||||||Interventional|||Xcellerated T CellsTM for Non-Hodgkin’s Lymphoma (NHL) Patients|A Phase II Study of Xcellerated T CellsTM in Patients With Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma (NHL)|Unknown status|Recruiting|Phase 2|40||Xcyte Therapies|||||||||||||||||||2017-02-18 17:52:26.731175|2017-02-18 17:52:26.731175
NCT00081770|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-20|2015-03-31|2008-11-03||March 2004||2004-03-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)|Comparison of PEG-Intron 1.5µg/kg/wk Plus REBETOL vs PEG-Intron 1µg/kg/wk Plus REBETOL vs PEGASYS 180µg/wk Plus COPEGUS in Previously Untreated Adult Subjects With Chronic Hepatitis C Infected With Genotype 1|Completed||Phase 3|4469|Actual|Merck Sharp & Dohme Corp.||3|||f||||t||||||||||2017-02-18 17:52:26.853813|2017-02-18 17:52:26.853813
NCT00081757|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-19|2010-07-01|||September 1998||1998-09-01|July 2010|2010-07-01|May 2005||2005-05-01|||||Interventional|||An Open Protocol for the Compassionate Use of Thalidomide|An Open Protocol For The Compassionate Use of Thalidomide For Patients With Advanced Or Refractory Malignancies|Completed||Phase 1/Phase 2|250||University of Arkansas|||||||||||||||||||2017-02-18 17:52:28.424553|2017-02-18 17:52:28.424553
NCT00081744|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-19|2013-02-07|||November 2002||2002-11-01|February 2013|2013-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects|A Multicenter, Double-Blind, Randomized Comparison Study Of the Efficacy and Safety of Tigecycline to Imipenem/ Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Subjects|Completed||Phase 3|850|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:52:28.519171|2017-02-18 17:52:28.519171
NCT00081731|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-19|2015-09-18|2013-12-09||April 2004||2004-04-01|September 2015|2015-09-01|September 2013|Actual|2013-09-01|September 2013|Actual|2013-09-01||Interventional|CORAL||Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions|Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)|Completed||Phase 3|947|Actual|Baim Institute for Clinical Research|Patients could be enrolled in the trial with renal artery stenosis > = 60%. Didn't include patients with fibromuscular dysplasia. Some screened and deemed to be eligible were not enrolled because of physician preference.|2|||f||||t||||||||||2017-02-18 17:52:28.604384|2017-02-18 17:52:28.604384
NCT00081705|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-19|2016-07-28|||March 2004||2004-03-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Estrogen Receptor Variants, HDL, and Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:52:29.122094|2017-02-18 17:52:29.122094
NCT00081692|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-19|2013-08-05|||January 2004||2004-01-01|August 2013|2013-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Longitudinal Cardiac Outcomes and Body Composition|Longitudinal Cardiac Outcomes and Body Composition|Completed||N/A|715|Actual|Virginia Commonwealth University|||1||f||||f||||||None Retained|"~     Only receiving data~   "|||2017-02-18 17:52:29.198961|2017-02-18 17:52:29.198961
NCT00081679|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-19|2014-04-15|||June 2004||2004-06-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||SES, Health Behaviors and CVD Among Vietnam-Era Twins||Completed||N/A|||The Miriam Hospital|||||f||||||||||||||2017-02-18 17:52:29.279419|2017-02-18 17:52:29.279419
NCT00081666|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-19|2016-07-28|||July 2004||2004-07-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Logical Analysis of Data and Cardiac Surgery Risk||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:52:29.349443|2017-02-18 17:52:29.349443
NCT00081653|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-19|2015-08-07|2008-12-22||May 2004||2004-05-01|August 2015|2015-08-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional||Intent -To - Treat (ITT) population: All participants who were randomized into this study, received at least one dose of the trial medication, and had at least one follow-up efficacy data point (BMD or serum C-terminal peptide cross-links of Collagen Type I [CTX]).|A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva|Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549|Completed||Phase 4|719|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:52:29.682327|2017-02-18 17:52:29.682327
NCT00081640|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-16|2009-12-22||||||November 2006|2006-11-01||||||||Interventional|||Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India|Phase I Safety and Acceptability Study of the Investigational Vaginal Microbicide PRO 2000/5 Gel (P)|Completed||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:52:30.612596|2017-02-18 17:52:30.612596
NCT00081627|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2007-11-26|||April 2004||2004-04-01|November 2007|2007-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Clinical Trial in Patients With Metastatic Colorectal Cancer|COFU: A Multi-Center Phase II Clinical Trial to Evaluate the Safety and Efficacy of Weekly Treatment With CoFactor and 5-Fluorouracil in Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|48||Mast Therapeutics, Inc.|||||f||||||||||||||2017-02-18 17:52:30.70555|2017-02-18 17:52:30.70555
NCT00081614|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2014-05-14|||March 2004||2004-03-01|May 2014|2014-05-01|July 2005|Actual|2005-07-01|||||Interventional|||A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma|A Phase II, Multicenter, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Tarceva (Erlotinib Hydrochloride) in Combination With Avastin (Bevacizumab) Versus Avastin Alone for Treatment of Metastatic Renal Cell Carcinoma|Completed||Phase 2|100||Genentech, Inc.|||||||||||||||||||2017-02-18 17:52:30.790924|2017-02-18 17:52:30.790924
NCT00081601|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2012-08-22|||March 2004||2004-03-01|August 2012|2012-08-01|June 2005|Actual|2005-06-01|May 2005|Actual|2005-05-01||Interventional|||Study of CEP-701 in Treatment of Prostate Cancer|An Open-Label Phase 2 Study of Oral CEP-701 in Patients With Asymptomatic Hormone-Refractory Cancer With Rising Prostate Specific Antigen|Completed||Phase 2|30||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 17:52:30.899687|2017-02-18 17:52:30.899687
NCT00081588|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2014-06-19|||November 2003||2003-11-01|June 2014|2014-06-01|December 2008|Actual|2008-12-01|September 2005|Actual|2005-09-01||Interventional|||An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.|An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.|Completed||Phase 2|555|Actual|Tibotec Pharmaceuticals, Ireland||1|||f||||t||||||||||2017-02-18 17:52:30.993001|2017-02-18 17:52:30.993001
NCT00081575|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2013-02-07|||January 2004||2004-01-01|February 2013|2013-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia|A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Intravenous Tigecycline Vs Intravenous Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia|Completed||Phase 3|434|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:52:31.172159|2017-02-18 17:52:31.172159
NCT00081562|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2008-02-19|||September 1999||1999-09-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Genetics of Ankylosing Spondylitis|Family Studies of the Genetics of Ankylosing Spondylitis|Completed||N/A|1600||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 17:52:31.262676|2017-02-18 17:52:31.262676
NCT00081549|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies|A Phase I/II Study of Aroplatin and Gemcitabine In Subjects With Unresectable, Locally Advanced And/Or Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|111||Aronex Pharmaceuticals|||||||||||||||||||2017-02-18 17:52:31.34598|2017-02-18 17:52:31.34598
NCT00081536|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies|A Phase I/II Study of Aroplatin and Capecitabine in Subjects With Unresectable Local Recurrence or Distant Metastases of Colorectal Cancer Refractory to 5-FU/Leucovorin and Irinotecan|Unknown status|Active, not recruiting|Phase 1/Phase 2|105||Aronex Pharmaceuticals|||||||||||||||||||2017-02-18 17:52:31.424193|2017-02-18 17:52:31.424193
NCT00081523|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-15|2017-02-15|||April 13, 2004||2004-04-13|February 13, 2017|2017-02-13||||||||Observational|||Natural History of Sickle Cell Disease|Studies of the Natural History of Sickle Cell Disease|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:31.4992|2017-02-18 17:52:31.4992
NCT00081510|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-14|2015-03-26||2009-04-17|December 2003||2003-12-01|March 2015|2015-03-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)|A Randomized Double-Blind Phase-2 Study of Anastrozole Plus Lonafarnib (SCH 66336) or Anastrozole Plus Placebo for the Treatment of Subjects With Advanced Breast Cancer|Completed||Phase 2|110|Actual|Merck Sharp & Dohme Corp.||2|||f||||f||||||||||2017-02-18 17:52:31.609856|2017-02-18 17:52:31.609856
NCT00081497|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-14|2015-03-13|2008-12-17||January 2004||2004-01-01|March 2015|2015-03-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease|Multi-Center, Open-Label Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease That Previously Participated in the AGAL-008-00 Study|Completed||Phase 4|67|Actual|Sanofi|No valid conclusions can be made from the predefined primary efficacy analysis. The sponsor believes that it is more statistically appropriate to compare placebo patients with Fabrazyme patients as they were randomized in the original Phase 4 trial.|1|||f||||||||||||||2017-02-18 17:52:31.849421|2017-02-18 17:52:31.849421
NCT00081484|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-13|2016-11-01|||June 2004||2004-06-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients|A Randomized, Open-label Study of the Effect of Maintenance Mircera Administered With Pre-filled Syringes on Hemoglobin Levels in Anemic Dialysis Patients With Chronic Kidney Disease|Completed||Phase 3|336|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:52:33.801359|2017-02-18 17:52:33.801359
NCT00081471|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-13|2016-11-01|||June 2004||2004-06-01|November 2016|2016-11-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis|A Randomized, Open-label Study of the Effect of Subcutaneous Mircera on Hemoglobin Level/Correction in Non-dialysis Patients With Chronic Kidney Disease|Completed||Phase 3|324|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:52:33.994841|2017-02-18 17:52:33.994841
NCT00081458|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-13|2015-11-10|2010-09-24||April 2004||2004-04-01|September 2014|2014-09-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional||84 subjects were initially randomized; however, one subject never received study therapy. As a result, the total participant who started flow period is 83.|Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome|A Study of the Efficacy and Safety of Teduglutide in Subjects With Parenteral Nutrition-Dependent Short Bowel Syndrome|Completed||Phase 3|84|Actual|Shire||3|||f||||t||||||||||2017-02-18 17:52:34.320514|2017-02-18 17:52:34.320514
NCT00081432|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-10|2017-01-24|||April 9, 2004||2004-04-09|April 27, 2010|2010-04-27|April 27, 2010||2010-04-27|||||Observational|||Language and Emotional Function in Patients With Temporal Lobe Epilepsy|Functional MRI (fMRI) and Diffusion Tensor Imaging (DTI) in Temporal Lobe Epilepsy|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:35.266299|2017-02-18 17:52:35.266299
NCT00081419|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-10|2017-01-24|||April 8, 2004||2004-04-08|January 12, 2009|2009-01-12|January 12, 2009||2009-01-12|||||Observational|||Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder|Timing of Voluntary Movement in Patients With Tourette Syndrome and Chronic Tic Disorder Using EEG and Surface EMG|Completed||N/A|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:35.347032|2017-02-18 17:52:35.347032
NCT00081406|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-09|2014-03-05|||July 2000||2000-07-01|March 2005|2005-03-01||||||||Interventional|||Individual and Family Therapy for Children With Anxiety Disorders|Child and Family Therapy for Anxiety-Disordered Youth|Completed||Phase 2/Phase 3|150||Temple University|||||f||||||||||||||2017-02-18 17:52:35.615314|2017-02-18 17:52:35.615314
NCT00081380|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-09|2008-12-19|||March 2004||2004-03-01|December 2008|2008-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder|Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo as Adjunct to Mood Stabilizers (Lithium or Divalproex) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)|Completed||Phase 3|710||AstraZeneca|||||||||||||||||||2017-02-18 17:52:35.701793|2017-02-18 17:52:35.701793
NCT00081367|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-09|2014-06-09|||February 2004||2004-02-01|June 2014|2014-06-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Community-Based Cognitive Therapy for Suicide Attempters|Community-Based Cognitive Therapy for Suicide Attempters|Completed||Phase 3|140|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 17:52:35.879446|2017-02-18 17:52:35.879446
NCT00081354|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-09|2017-01-31|||April 6, 2004||2004-04-06|February 24, 2016|2016-02-24||||||||Observational|||Early Detection of Barrett's Esophagus|Barrett's Esophagus Early Detection Study|Completed||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:35.979083|2017-02-18 17:52:35.979083
NCT00081341|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-08|2010-02-12||||||February 2010|2010-02-01|December 2002|Actual|2002-12-01|||||Observational|||Cognition, Steroids, and Imaging in Cushings Disease|Cognition, Steroids, and Imaging in Cushings Disease|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:52:36.07282|2017-02-18 17:52:36.07282
NCT00081328|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-08|2014-12-08|2014-09-26||May 2004||2004-05-01|December 2014|2014-12-01|February 2014|Actual|2014-02-01|February 2011|Actual|2011-02-01||Interventional|TODAY|Age 10–17 years with T2D according to American Diabetes Association criteria for less than 2 years, body mass index (BMI) >=85th percentile, negative diabetes autoantibodies, fasting c-peptide >0.6 ng/mL, and an adult caregiver willing to actively support study participation.|Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)|Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Clinical Trial|Completed||Phase 3|699|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 17:52:36.141438|2017-02-18 17:52:36.141438
NCT00081315|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2007-08-20|||November 2003||2003-11-01|August 2007|2007-08-01|August 2006|Actual|2006-08-01|||||Interventional|||Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer|Phase II, Randomized, Double-Blind, Multicenter Trial of Subcutaneous Amifostine (Ethyol®) Versus Placebo in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer|Completed||Phase 2|130||MedImmune LLC|||||||||||||||||||2017-02-18 17:52:37.798034|2017-02-18 17:52:37.798034
NCT00081302|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2015-11-14|||March 2004||2004-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|December 2005|Actual|2005-12-01||Interventional|||Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer|A Phase II Study Of Cetuximab (C225) In Combination With Chemoradiation In Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 17:52:37.925402|2017-02-18 17:52:37.925402
NCT00081289|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-12-30|2013-05-23||March 2004||2004-03-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|May 2011|Actual|2011-05-01||Interventional||All eligible patients enrolled after the protocol ammendment.|Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer|Randomized Phase II Trial Of Neoadjuvant Combined Modality Therapy For Locally Advanced Rectal Cancer|Completed||Phase 2|146|Actual|Radiation Therapy Oncology Group|The study was temporarily closed to accrual due to excessive GI AEs in the first 35 pts. The protocol was amended to adjust the chemotherapy and the study reopened (treatment descriptions reflect the revision).|2|||f||||t||||||||||2017-02-18 17:52:38.052478|2017-02-18 17:52:38.052478
NCT00081276|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-01-23|||July 2005||2005-07-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation Of Triapine (NCI-Supplied Agent: NSC #663249, IND #68338) In Combination With Cisplatin (Commercially Available: NSC # 119875) In The Treatment Of Recurrent Or Persistent Platinum-Resistant Ovarian Or Primary Peritoneal Carcinoma|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:39.138469|2017-02-18 17:52:39.138469
NCT00081263|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2014-08-08|||June 2005||2005-06-01|August 2014|2014-08-01||||January 2100|Anticipated|2100-01-01||Interventional|||Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia|A RANDOMIZED DOUBLE-BLIND PHASE II TRIAL OF CELECOXIB, A COX-2 INHIBITOR, IN THE TREATMENT OF PATIENTS WITH CERVICAL INTRAEPITHELIAL NEOPLASIA 2/3 or 3 (CIN 2/3 or 3)|Active, not recruiting||Phase 2|130|Anticipated|Gynecologic Oncology Group||2|||f||||t||||||||||2017-02-18 17:52:39.250113|2017-02-18 17:52:39.250113
NCT00081250|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-07-01|||December 2004||2004-12-01|July 2016|2016-07-01||||December 2007|Actual|2007-12-01||Interventional|||Creatine in Treating Patients With Cancer-Associated Weight Loss|Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss|Active, not recruiting||Phase 3|300|Anticipated|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 17:52:39.413818|2017-02-18 17:52:39.413818
NCT00081237|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-06-11|||February 2004||2004-02-01|June 2013|2013-06-01||||August 2005|Actual|2005-08-01||Interventional|||OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer|A Phase I Study of OSI-7904L In Combination With Oxaliplatin In Patients With Advanced Colo-Rectal Cancer|Completed||Phase 1|15|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:52:39.887522|2017-02-18 17:52:39.887522
NCT00081224|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-12-14|||December 2004||2004-12-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|February 2006|Actual|2006-02-01||Interventional|||Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum|A Phase II Trial Of Celecoxib (Celebrex) And Capecitabine (Xeloda) Combined With Pelvic Irradiation As Neoadjuvant Treatment Of Stage II or III Adenocarcinoma Of The Rectum|Terminated||Phase 2|3|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 17:52:39.992867|2017-02-18 17:52:39.992867
NCT00081211|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-01-23|||April 2004||2004-04-01|January 2013|2013-01-01||||July 2004|Actual|2004-07-01||Interventional|||Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck|A Phase I Study Of PV701 In Patients With Head And Neck Squamous Cell Carcinoma|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:52:40.107176|2017-02-18 17:52:40.107176
NCT00081172|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-07-09|||January 2004||2004-01-01|April 2006|2006-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate|A Phase II Trial Of Lu Radiolabeled Monoclonal Antibody HuJ591-GS (Lu-J591) In Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:40.404325|2017-02-18 17:52:40.404325
NCT00081159|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-09-22|2016-09-22||July 2004||2004-07-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases|A Randomized Phase II Study Of Bone-Targeted Therapy In Advanced Androgen-Dependent Prostate Cancer|Completed||Phase 2|80|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 17:52:40.501892|2017-02-18 17:52:40.501892
NCT00081133|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia|A Phase I/II Study to Determine Safety and Efficacy of Arsenic Trioxide (Trisneox™) in Combination With Imatinib (STI571, Gleevec™) in Patients With Chronic Myelogenous Leukemia in Accelerated or Blastic Phase Disease or Ph+ Acute Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:52:40.979687|2017-02-18 17:52:40.979687
NCT00081107|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-06-04|||December 2003||2003-12-01|June 2013|2013-06-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy|A Phase II Study of KOS-862, Administered Intravenously Weekly for 3 Weeks Every 4 Weeks, in Patients With Non-Small Cell Lung Cancer Who Have Progressed Following Initial Therapy for Advanced or Metastatic Disease|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:52:41.079613|2017-02-18 17:52:41.079613
NCT00081094|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-04-22|||September 2003||2003-09-01|April 2013|2013-04-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|||Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer|Detection of Hepatocellular Carcinoma by Positron Emission Tomography With C-Acetate-11 and F-fluorodeoxyglucose-18|Completed||N/A|31|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 17:52:41.167703|2017-02-18 17:52:41.167703
NCT00081068|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-01-07|||January 2004||2004-01-01|January 2013|2013-01-01||||||||Interventional|||Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia|Phase II Study of Campath-1H in Lymphoplasmacytic Lymphoma (Waldenstrom's Macroglobulinemia)|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 17:52:41.266299|2017-02-18 17:52:41.266299
NCT00081055|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2014-12-03||||||December 2014|2014-12-01||||||||Interventional|||OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies|A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OTI-010 in Subjects Who Receive HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies|Withdrawn||Phase 2|0|Actual|Mesoblast, Ltd.|||||f||||||||||||||2017-02-18 17:52:41.376236|2017-02-18 17:52:41.376236
NCT00081042|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-12-18|||February 2004||2004-02-01|May 2005|2005-05-01|January 2010|Actual|2010-01-01|||||Interventional|||ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma|An Open-Label, Multicenter, Phase II Trial of ABI-007 (A Cremophor® -Free, Protein Stabilized, Nanoparticle Paclitaxel) in Previously Treated Patients With Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:41.487129|2017-02-18 17:52:41.487129
NCT00081029|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2011-03-22|||January 2004||2004-01-01|March 2008|2008-03-01||||January 2013|Anticipated|2013-01-01||Interventional|||Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia|A Multicentre Randomised Study Of Parotid Sparing Intensity Modulated Radiotherapy Versus Conventional Radiotherapy In Patients With Head And Neck Cancer|Unknown status|Active, not recruiting|Phase 3|84|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:41.582591|2017-02-18 17:52:41.582591
NCT00081003|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2014-07-22|||November 2003||2003-11-01|December 2005|2005-12-01||||||||Interventional|||Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer|The Intraduct Environment: A Novel Approach to Risk Assessment of Women With a Family History of Breast Cancer|Completed||N/A|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:41.688362|2017-02-18 17:52:41.688362
NCT00080990|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-12-13|||February 2004||2004-02-01|December 2013|2013-12-01||||April 2009|Actual|2009-04-01||Interventional|||Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Oxaliplatin and Fluorouracil/Leucovorin in Patients With Advanced Solid Tumors|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:41.78316|2017-02-18 17:52:41.78316
NCT00080977|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-12-18|||June 1998||1998-06-01|June 2005|2005-06-01||||||||Interventional|||High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2|Treatment of Patients With Metastatic Renal Cell Carcinoma Who Have Failed Low Dose Intensity Interleukin-2 With High-Dose Intravenous Recombinant Interleukin-2|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:52:41.90275|2017-02-18 17:52:41.90275
NCT00080951|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-12-05|||March 2004||2004-03-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|April 2005|Actual|2005-04-01||Interventional|||Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer|Phase II Trial Of Irinotecan + 5-Fluorouracil + Leucovorin + Oxaliplatin As First-Line Treatment For Metastatic Colorectal Cancer|Completed||Phase 2|14|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 17:52:41.995273|2017-02-18 17:52:41.995273
NCT00080938|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-02-12|2010-12-30||October 2005||2005-10-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|August 2008|Actual|2008-08-01||Interventional|||Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer|A Phase II Study of Temozolomide and Radiation Therapy in Patients With Brain Metastasis From Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|26|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 17:52:42.107658|2017-02-18 17:52:42.107658
NCT00080925|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2012-03-07|||February 2004||2004-02-01|March 2012|2012-03-01|December 2010|Actual|2010-12-01|||||Interventional|||T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies|T-Cell Depleted, Reduced-Intensity Allogeneic Stem Cell Transplantation From Haploidentical Related Donors For Hematologic Malignancies|Completed||Phase 1|20|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:52:42.402095|2017-02-18 17:52:42.402095
NCT00080912|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2015-02-11|2015-02-11||January 2004||2004-01-01|February 2015|2015-02-01|January 2014|Actual|2014-01-01|September 2012|Actual|2012-09-01||Interventional|||Single-Fraction Compared With Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases|A Phase III International Randomized Trial Of Single Versus Multiple Fractions For Re-Irradiation Of Painful Bone Metastases|Completed||Phase 3|850|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 17:52:42.513235|2017-02-18 17:52:42.513235
NCT00080899|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2015-02-19|2015-02-19||June 2004||2004-06-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer|A Phase II Trial of Fenretinide (4-HPR) in Biochemically Recurrent, Hormone Naive Prostate Cancer|Completed||Phase 2|23|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:52:42.826156|2017-02-18 17:52:42.826156
NCT00080886|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-12-13|||May 2002||2002-05-01|December 2013|2013-12-01|January 2015|Anticipated|2015-01-01|November 2005|Actual|2005-11-01||Interventional|||Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma|A Phase II Trial Of BEAM/Rituximab/Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Patients With CD20 Positive Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|68|Actual|University of Nebraska||1|||f||||t||||||||||2017-02-18 17:52:43.089758|2017-02-18 17:52:43.089758
NCT00080873|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-01-05|||April 2004||2004-04-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|November 2006|Actual|2006-11-01||Interventional|||Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation|A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation|Completed||N/A|195|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 17:52:43.198145|2017-02-18 17:52:43.198145
NCT00080860|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2012-03-07|||February 2004||2004-02-01|March 2012|2012-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer|Efficacy Of Sentinel Lymph Node Biopsy And Primary Tumor Gene Expression Profiling To Detect Axillary Lymph Node Metastases After Neoadjuvant Chemotherapy For Breast Cancer|Completed||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:43.471331|2017-02-18 17:52:43.471331
NCT00080847|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-01-04|||March 2004||2004-03-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab, or Rituximab and G3139 Phosphorothioate Oligonucleotide (BCL-2 Antisense - NSC-683428) Therapy for Young Patients (< Age 60) With Advanced Stage Diffuse Large B-Cell NHL of Low and Low-Intermediate IPI Risk|Terminated||Phase 2|160|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:52:43.568096|2017-02-18 17:52:43.568096
NCT00080834|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2012-05-15|||February 2004||2004-02-01|May 2012|2012-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma|A Phase II Study Of Oral DJ-927 Administered As A Single Dose Every Three Weeks To Patients With Advanced Or Metastatic Adenocarcinoma Of The Colon Or Rectum|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:52:43.694805|2017-02-18 17:52:43.694805
NCT00080808|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2012-07-27|||August 2001||2001-08-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|July 2006|Actual|2006-07-01||Interventional|||Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer|A Randomized Phase II Trial Evaluating the Importance of Early Erectile Dysfunction Rehabilitation and Unilateral Autologous Sural Nerve Sparing Radical Prostatectomy Clinically Localized Prostate Cancer|Completed||Phase 2|111|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 17:52:43.796413|2017-02-18 17:52:43.796413
NCT00080795|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2012-10-18|||July 2001||2001-07-01|October 2012|2012-10-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium|Phase II Trial of Neoadjuvant, Multi-Agent Chemotherapy For Locally Advanced Urothelial Cancer|Completed||Phase 2|65|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:52:43.920025|2017-02-18 17:52:43.920025
NCT00080782|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2012-07-27|||February 2002||2002-02-01|August 2010|2010-08-01|January 2005|Actual|2005-01-01|April 2004|Actual|2004-04-01||Interventional|||Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases|A Randomized Phase II Trial of Bone-Targeted Therapy Consisting of Strontium-89 and Doxorubicin With or Without Celecoxib in Androgen-Independent Prostate Cancer|Terminated||Phase 2|14|Actual|M.D. Anderson Cancer Center||2||Low accrual due to competing trial.|f||||f||||||||||2017-02-18 17:52:44.022684|2017-02-18 17:52:44.022684
NCT00080756|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-07-12|||February 2004||2004-02-01|July 2016|2016-07-01||||September 2017|Anticipated|2017-09-01||Interventional|||Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease|Biomarkers, Breast Density And Risk Reduction Perspectives In BRCA Carriers|Active, not recruiting||Phase 2|11|Actual|City of Hope Medical Center||2|||f||||f||||||||||2017-02-18 17:52:44.155451|2017-02-18 17:52:44.155451
NCT00080743|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2009-08-04|||January 2004||2004-01-01|August 2009|2009-08-01|November 2005|Actual|2005-11-01|April 2005|Actual|2005-04-01||Interventional|||Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer|ZD1839 (IRESSA) In Tamoxifen-Resistant Metastatic Breast Cancer|Completed||Phase 2|2|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 17:52:44.271028|2017-02-18 17:52:44.271028
NCT00080678|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2012-10-10|||May 2003||2003-05-01|October 2012|2012-10-01|March 2008|Actual|2008-03-01|August 2005|Actual|2005-08-01||Interventional|||Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases|Randomized Double-Blind Phase II Trial of Docetaxel and Imatinib Versus Docetaxel and Placebo in Metastatic Androgen-Independent Prostate Cancer (AIPC) With Bone Metastases|Completed||Phase 2|116|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 17:52:44.582871|2017-02-18 17:52:44.582871
NCT00080665|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-11-04|||December 2003||2003-12-01|November 2016|2016-11-01|January 2011|Actual|2011-01-01|January 2007|Actual|2007-01-01||Interventional|||Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Phase I Study Of Weekly Taxotere (Docetaxel) And Gleevec (STI571, Imatinib Mesylate, CGP 57148B) In Locally Advanced Or Metastatic Breast Cancer|Completed||Phase 1|12|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 17:52:44.71194|2017-02-18 17:52:44.71194
NCT00080639|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2013-08-01|||June 2003||2003-06-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||CA-125 in Screening Patients at High Risk for Ovarian Cancer|Specialized Program Of Research Excellence (SPORE) In Ovarian Cancer/Cancer Genetics Network Collaborative Ovarian Cancer Screening Pilot Trial In High Risk Women|Withdrawn||Phase 2|0|Actual|University of Alabama at Birmingham|||1|Terminated for administrative reasons and becuase there were no enrollments|f||||t||||||||||2017-02-18 17:52:44.836348|2017-02-18 17:52:44.836348
NCT00080626|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2016-11-04|||July 2003||2003-07-01|November 2016|2016-11-01|June 2017|Anticipated|2017-06-01|April 2006|Actual|2006-04-01||Interventional|||Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer|A Pilot Study Assessing Patterns of Response or Resistance to Preoperative Dose Dense Docetaxel in Women With Newly Diagnosed Breast Cancer|Active, not recruiting||Phase 2|19|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 17:52:44.934948|2017-02-18 17:52:44.934948
NCT00080587|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2008-03-03|||April 2004||2004-04-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Atherosclerosis in the Coronary and Carotid Arteries|Atherosclerosis in the Coronary and Carotid Arteries: Correlations Between Coronary IVUS, Carotid Ultrasound, and Carotid MRI|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:45.267864|2017-02-18 17:52:45.267864
NCT00080574|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2008-03-03|||April 2004||2004-04-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients|The Effects of Thyroid Hormone on Cytochrome P450 and P-Glycoprotein Activity in Thyroid Cancer Patients|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:45.358402|2017-02-18 17:52:45.358402
NCT00080548|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2017-01-24|||April 6, 2004||2004-04-06|January 6, 2009|2009-01-06|January 6, 2009||2009-01-06|||||Observational|||Timing of Voluntary Movement in Patients With Schizophrenia|Timing of Voluntary Movement in Patients With Schizophrenia Using EEG and Surface EMG|Completed||N/A|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:45.456109|2017-02-18 17:52:45.456109
NCT00080535|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-07|2012-09-24|2012-09-24||April 2004||2004-04-01|September 2012|2012-09-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas|A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Cutaneous T-Cell Lymphomas|Completed||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 17:52:45.545749|2017-02-18 17:52:45.545749
NCT00080522|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-06|2007-09-17|||February 2005||2005-02-01|August 2007|2007-08-01|January 2007|Actual|2007-01-01|||||Interventional|||Strategies for Delivering Anti-HIV Therapy in South Africa|Safeguard the Household: A Study of HIV Antiretroviral Therapy Treatment Strategies Appropriate for a Resource Poor Country|Completed||N/A|813||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:52:45.945658|2017-02-18 17:52:45.945658
NCT00080509|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-05|2010-02-02|||December 2003||2003-12-01|November 2009|2009-11-01|November 2004||2004-11-01|||||Interventional|||Effectiveness of KOS-862 in the Treatment of Lung Cancer|A Phase 2 Study of KOS-862, Administered Intravenously Weekly for 3 Weeks Every 4 Weeks, in Patients With Non-Small Cell Lung Cancer Who Have Progressed Following Initial Therapy for Advanced or Metastatic Disease|Terminated||Phase 2|85||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 17:52:46.06139|2017-02-18 17:52:46.06139
NCT00080496|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-05|2008-07-31|||July 2003||2003-07-01|July 2008|2008-07-01|December 2006|Actual|2006-12-01|||||Interventional|||Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia|A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Tigecycline Vs Imipenem/Cilastatin For The Treatment Of Subjects With Nosocomial Pneumonia|Completed||Phase 3|430||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:52:46.134906|2017-02-18 17:52:46.134906
NCT00080483|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-05|2014-06-12|2013-12-12||March 2004||2004-03-01|December 2013|2013-12-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Testosterone and Growth Hormone for Bone Loss in Men|Will Testosterone and Growth Hormone Improve Bone Structure?|Completed||Phase 2|35|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 17:52:46.247685|2017-02-18 17:52:46.247685
NCT00080470|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-01|2013-10-25|2013-04-11||June 2003||2003-06-01|October 2013|2013-10-01|December 2012|Actual|2012-12-01|July 2008|Actual|2008-07-01||Interventional|||An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence|Battery Powered Bion Clinical Investigation: An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence|Completed||Phase 3|148|Actual|Boston Scientific Corporation|This study was limited by poor adherence to the clinical protocol and by incomplete data recovery. Analysis of efficacy-related endpoints was not possible.|2|||f||||f||||||||||2017-02-18 17:52:46.665522|2017-02-18 17:52:46.665522
NCT00080457|ClinicalTrials.gov processed this data on February 17, 2017|2004-04-01|2007-11-08|||May 2003||2003-05-01|November 2007|2007-11-01|January 2005|Actual|2005-01-01|||||Interventional|||Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium (Thelin™) Treatment With an Open-Label Bosentan Arm in Patients With Pulmonary Arterial Hypertension (PAH)|Completed||Phase 3|240||Encysive Pharmaceuticals|||||||||||||||||||2017-02-18 17:52:47.020272|2017-02-18 17:52:47.020272
NCT00080444|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-31|2014-08-04|||April 2004||2004-04-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|September 2006|Actual|2006-09-01||Interventional|||Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Emetogenic Chemotherapy in Adolescent Patients|Completed||Phase 3|50|Actual|Merck Sharp & Dohme Corp.||3|||f||||f||||||||||2017-02-18 17:52:47.233556|2017-02-18 17:52:47.233556
NCT00080431|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-30|2017-01-24|||March 26, 2004||2004-03-26|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Interventional|||Daclizumab to Treat HIV-Infected Patients|An Open Label Trial to Assess Safety and Tolerability of Daclizumab in HIV-Infected Individuals|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:47.34741|2017-02-18 17:52:47.34741
NCT00080418|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-30|2011-06-30|||July 2003||2003-07-01|June 2011|2011-06-01|June 2010|Actual|2010-06-01|July 2005|Actual|2005-07-01||Interventional|||Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer|Phase I Study of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Formulation in Patients With Advanced Cancer|Completed||Phase 1|40||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 17:52:47.431867|2017-02-18 17:52:47.431867
NCT00080405|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-30|2009-03-26|||March 2004||2004-03-01|March 2009|2009-03-01||||June 2005|Actual|2005-06-01||Interventional|||Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma|Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma|Completed||Phase 1|40||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:52:47.547806|2017-02-18 17:52:47.547806
NCT00080392|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-30|2017-01-24|||March 27, 2004||2004-03-27|December 29, 2011|2011-12-29|December 29, 2011|Actual|2011-12-29|||||Interventional|||EW-A-401 to Treat Intermittent Claudication|Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication|Completed||Phase 1|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:52:47.622617|2017-02-18 17:52:47.622617
NCT00080158|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-24|2013-11-01|||March 2004||2004-03-01|July 2008|2008-07-01|June 2007|Actual|2007-06-01|||||Interventional|||Treatment of Adolescent Suicide Attempters (TASA)||Completed||Phase 2/Phase 3|120||New York State Psychiatric Institute|||||f||||||||||||||2017-02-18 17:52:56.053378|2017-02-18 17:52:56.053378
NCT00080366|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-27|2007-04-03|||March 2004||2004-03-01|March 2007|2007-03-01|March 2007||2007-03-01|||||Interventional|||Octanol to Treat Essential Tremor|Treatment Efficacy of 1-Octanol Compared to Placebo in Adults With Essential Tremor|Completed||Phase 2|14||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:47.711156|2017-02-18 17:52:47.711156
NCT00080353|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-27|2012-06-12|||March 2004||2004-03-01|June 2012|2012-06-01|December 2008|Actual|2008-12-01|December 2007|Actual|2007-12-01||Interventional|||Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma|Phase II Study in Metastatic Melanoma Using Lymphocytes Reactive With the gp100 Antigen and Immunization Using a Recombinant rF-gp100P209 Virus Encoding a gp100 Peptide Following a Nonmyeloablative Lymphocyte Depleting Regimen|Completed||Phase 2|58|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:47.79484|2017-02-18 17:52:47.79484
NCT00080340|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-26|2008-01-10||||||March 2006|2006-03-01|May 2005||2005-05-01|||||Interventional|||Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Phase 3 Randomized Study of TLK286 (Telcyta) Versus Gefitinib (Iressa) as Third-Line Therapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|520||Telik|||||||||||||||||||2017-02-18 17:52:47.895885|2017-02-18 17:52:47.895885
NCT00080327|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-26|2013-11-07|||November 2003||2003-11-01|August 2008|2008-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia|A Placebo-Controlled Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia|Completed||Phase 4|370||Otsuka Pharmaceutical Development & Commercialization, Inc.||4|||f||||||||||||||2017-02-18 17:52:51.515468|2017-02-18 17:52:51.515468
NCT00080314|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-26|2013-11-07|||January 2004||2004-01-01|June 2008|2008-06-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode|Completed||Phase 3|400||Otsuka Pharmaceutical Development & Commercialization, Inc.||2|||f||||||||||||||2017-02-18 17:52:51.630229|2017-02-18 17:52:51.630229
NCT00080301|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-26|2016-02-09|2009-05-01||September 2003||2003-09-01|February 2016|2016-02-01|March 2008|Actual|2008-03-01|November 2006|Actual|2006-11-01||Interventional|||Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer|A Phase III Trial of Novel Epothilone BMS-247550 Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With or Resistant to an Anthracycline and Who Are Taxane Resistant|Completed||Phase 3|752|Actual|R-Pharm||2|||f||||t||||||||||2017-02-18 17:52:51.786242|2017-02-18 17:52:51.786242
NCT00080288|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-25|2013-07-12|2009-06-01||March 2004||2004-03-01|July 2013|2013-07-01|December 2004||2004-12-01|||||Interventional|||Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD|A 12 Week, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CEP 10953 (150 mg) as Treatment for Adults With Excessive Sleepiness Associated With Chronic Shift Work Sleep Disorder|Completed||Phase 3|254|Actual|Teva Pharmaceutical Industries||2|||||||||||||||||2017-02-18 17:52:54.105738|2017-02-18 17:52:54.105738
NCT00080275|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-25|2006-10-31|||March 2004||2004-03-01|October 2006|2006-10-01||||||||Interventional|||Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)|An Open-Label Evaluation of the Safety and Efficacy of a Combination of Niacin ER and Simvastatin in Patients With Dyslipidemia (OCEANS)|Completed||Phase 3|600||Kos Pharmaceuticals|||||||||||||||||||2017-02-18 17:52:54.529918|2017-02-18 17:52:54.529918
NCT00080262|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-25|2017-01-27|||February 2004||2004-02-01|January 2017|2017-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)|Phase II Study of Novel Epothilone (BMS-247550) in Patients With MBC Who Are Refractory to an Anthracycline, a Taxane, and Capecitabine|Completed||Phase 2|125||R-Pharm||1|||f||||||||||||||2017-02-18 17:52:54.611097|2017-02-18 17:52:54.611097
NCT00080236|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-24|2012-08-08|||November 2003||2003-11-01|August 2012|2012-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation|Safety, Tolerability and Efficacy Study of a Caspase Inhibitor, IDN-6556, in Patients Undergoing Orthotopic Liver Transplantation (OLT)|Completed||Phase 2|99|Actual|Conatus Pharmaceuticals Inc.||4|||f||||t||||||||||2017-02-18 17:52:54.762226|2017-02-18 17:52:54.762226
NCT00080223|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-24|2016-02-10|2016-02-10||August 2003||2003-08-01|February 2016|2016-02-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional||All treated participants|Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis|An Open-Label, Phase 2 Study of the Safety of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis|Completed||Phase 2|83|Actual|Genentech, Inc.||1|||f||||f||||||||||2017-02-18 17:52:55.176691|2017-02-18 17:52:55.176691
NCT00080210|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-24|2013-05-31|||March 2004||2004-03-01|May 2013|2013-05-01|February 2005||2005-02-01|||||Interventional|||A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy|A Phase II Study of Multiple Doses of Intravenous Puricase in Subjects With Hyperuricemia and Refractory Gout|Completed||Phase 2|40||Savient Pharmaceuticals|||||||||||||||||||2017-02-18 17:52:55.651351|2017-02-18 17:52:55.651351
NCT00080197|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-24|2006-10-10|||February 2004||2004-02-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients|An Open-Label Phase II Study of E7070 in Metastatic Breast Cancer Patients Previously Treated With an Anthracycline, a Taxane, and Capecitabine|Completed||Phase 2|250||Eisai Inc.|||||||||||||||||||2017-02-18 17:52:55.741616|2017-02-18 17:52:55.741616
NCT00080184|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-24|2006-08-16|||December 2003||2003-12-01|August 2006|2006-08-01|May 2006||2006-05-01|||||Interventional|||Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia|Effectiveness of EEG Biofeedback in the Treatment of Fibromyalgia|Completed||Phase 1/Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:52:55.862535|2017-02-18 17:52:55.862535
NCT00080171|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-24|2009-03-31|||February 2004||2004-02-01|March 2009|2009-03-01|October 2015|Anticipated|2015-10-01|October 2015|Anticipated|2015-10-01||Observational|||Osteoarthritis Initiative (OAI): A Knee Health Study|Osteoarthritis Initiative (OAI): A Knee Health Study|Unknown status|Active, not recruiting|N/A|5000|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||||||||Samples With DNA|"~     Blood, urine~   "|||2017-02-18 17:52:55.95497|2017-02-18 17:52:55.95497
NCT00080145|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-24|2013-08-15|||February 2004||2004-02-01|August 2013|2013-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders|Risperidone and Behavioral Therapy in Treatment of Children and Adolescents With Autistic Disorder|Completed||N/A|124|Actual|Yale University||2|||f||||t||||||||||2017-02-18 17:52:56.159422|2017-02-18 17:52:56.159422
NCT00080132|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-23|2005-06-23|||October 2004||2004-10-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy|An Open-Label, Dose-Escalating Efficacy and Safety Study of Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy|Terminated||Phase 2|50||Medical Research Laboratories International|||||||||||||||||||2017-02-18 17:52:56.272216|2017-02-18 17:52:56.272216
NCT00080119|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-23|2011-02-10|2010-07-01||February 2004||2004-02-01|February 2011|2011-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV|A Randomized, Double Blind, Placebo Controlled Trial to Determine the Efficacy of Isoniazid (INH) in Preventing Tuberculosis Disease and Latent Tuberculosis Infection Among Infants With Perinatal Exposure to HIV|Terminated||Phase 2/Phase 3|1354|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|"DSMB recommended stopping study due to futility: no compelling reason to enroll additional infants or to continue to treat participants with the blinded study medication. Week 192 analyses not done as <4% (26%) of HIVpos (HIVneg) reached wk 192"|4||Data Safety Monitoring Board (DSMB) recommended stopping study due to futility|f||||t||||||||||2017-02-18 17:52:56.373907|2017-02-18 17:52:56.373907
NCT00080106|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-23|2013-07-01||2009-08-12|June 2004||2004-06-01|July 2013|2013-07-01|May 2011|Actual|2011-05-01|September 2007|Actual|2007-09-01||Interventional|||Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients|A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Antiretroviral Effect of Immunization With the MRK Ad5 HIV-1 Gag Vaccine in HIV-1 Infected Individuals Who Interrupt Antiretroviral Therapy|Completed||Phase 2|114|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:52:59.110404|2017-02-18 17:52:59.110404
NCT00080093|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-23|2008-09-25|||January 2006||2006-01-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|October 2007|Actual|2007-10-01||Interventional|||Increasing Condom Use in People at Risk for HIV Infection|Increasing Condom Use With a Stage-Matched Intervention|Unknown status|Active, not recruiting|N/A|534|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:52:59.259862|2017-02-18 17:52:59.259862
NCT00080080|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-23|2007-06-07||||||June 2007|2007-06-01||||||||Interventional|||Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer|Phase 2 Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||Point Therapeutics|||||||||||||||||||2017-02-18 17:52:59.366079|2017-02-18 17:52:59.366079
NCT00080067|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-23|2017-01-24|||March 22, 2004||2004-03-22|February 23, 2009|2009-02-23|February 23, 2009||2009-02-23|||||Observational|||Rhythm Perception and Generation|fMRI Study on Mechanism of Rhythm Perception and Generation|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:52:59.449307|2017-02-18 17:52:59.449307
NCT00080054|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-22|2009-04-02||||||January 2007|2007-01-01||||||||Interventional|||A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas|Phase I Trial of Motexafin Gadolinium (MGd) in Combination With Temozolomide for Treatment of Malignant Gliomas|Completed||Phase 1|24||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:52:59.526866|2017-02-18 17:52:59.526866
NCT00080041|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-22|2007-05-11||||||May 2007|2007-05-01||||||||Interventional|||Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors|Phase I Trial of Motexafin Gadolinium (MGd) and Docetaxel Administered at 3-Week Intervals for Advanced Solid Tumors|Completed||Phase 1|20||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:52:59.605877|2017-02-18 17:52:59.605877
NCT00080028|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-22|2007-05-04||||||May 2007|2007-05-01||||||||Interventional|||Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer|Phase I Trial of Motexafin Gadolinium and Chemoradiation in Locally Advanced, Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 1|18||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 17:52:59.693498|2017-02-18 17:52:59.693498
NCT00080015|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-19|2009-07-23|||March 2004||2004-03-01|July 2009|2009-07-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)|A Phase II Open Label Study Investigating the Activity of Diflomotecan (BN80915) Administered at the Fixed Dose of 7mg as a 20 Minute Intravenous Infusion Once Every 3 Weeks in Patients With Sensitive Small Cell Lung Cancer (SCLC) Who Have Failed First-line Treatment With a Platinum Based Regimen.|Completed||Phase 2|40||Ipsen|||||f||||||||||||||2017-02-18 17:52:59.786466|2017-02-18 17:52:59.786466
NCT00080002|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-19|2012-09-05|||December 2003||2003-12-01|March 2005|2005-03-01||||||||Interventional|||Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction|Effectiveness and Safety Study of Pegamotecan (PEG-Camptothecin) in Patients With Locally Advanced or Metastatic Cancer of the Stomach or Gastroesophageal Junction Who Have Relapsed or Progressed Following a Previous Chemotherapy Treatment|Terminated||Phase 2|||Enzon Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:52:59.868242|2017-02-18 17:52:59.868242
NCT00079989|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-19|2013-02-07|||December 2003||2003-12-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms|A Phase 3, Open-label, Noncomparative Study of Tigecycline for the Treatment of Subjects With Selected Serious Infections Due to Resistant Gram-negative Organisms Such as Enterobacter Species, Acinetobacter Baumannii, and Klebsiella Pneumoniae|Completed||Phase 3|115|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:52:59.938494|2017-02-18 17:52:59.938494
NCT00079976|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-19|2013-02-07|||October 2003||2003-10-01|February 2013|2013-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)|A Clinical Research Study to Evaluate the Safety and Efficacy of Tigecycline in the Treatment of Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)|Completed||Phase 3|174|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:53:00.03331|2017-02-18 17:53:00.03331
NCT00079963|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-18|2016-03-21|||April 2004||2004-04-01|March 2016|2016-03-01|December 2017|Anticipated|2017-12-01|December 2008|Actual|2008-12-01||Interventional|||Gender, Obesity, C-Reactive Protein, and Oxidative Stress|Gender, Obesity, C-Reactive Protein, and Oxidative Stress|Active, not recruiting||N/A|396|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 17:53:00.163783|2017-02-18 17:53:00.163783
NCT00079950|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-18|2012-09-05|||August 2003||2003-08-01|September 2012|2012-09-01||||||||Interventional|||Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma||Suspended||Phase 2|||Enzon Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 17:53:00.29061|2017-02-18 17:53:00.29061
NCT00079937|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-18|2012-04-09|2010-12-03||April 2004||2004-04-01|April 2012|2012-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma|A 1 Year, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Evaluation of Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Persistent, Inadequately Controlled Allergic Asthma|Completed||Phase 3|628|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:53:00.387561|2017-02-18 17:53:00.387561
NCT00079924|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-18|2007-05-23|||November 2004||2004-11-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Effects of Teriparatide in Postmenopausal Women With Osteoporosis|Effects of Teriparatide in Postmenopausal Women With Osteoporosis Previously Treated With Alendronate or Raloxifene|Completed||Phase 4|200||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:53:01.118008|2017-02-18 17:53:01.118008
NCT00079911|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-18|2010-09-28|||March 2004||2004-03-01|September 2010|2010-09-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons|An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons With CD4+ Lymphocyte Count <100 Cells/mm3.|Terminated||Phase 4|162||GlaxoSmithKline|||||||||||||||||||2017-02-18 17:53:01.211955|2017-02-18 17:53:01.211955
NCT00079898|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-18|2008-01-23|||July 2002||2002-07-01|January 2008|2008-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Effect of Acupuncture on Human Brain Activity|Modulatory Effect of Acupuncture on Human Brain Activity|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:53:01.447407|2017-02-18 17:53:01.447407
NCT00079885|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-18|2013-02-07|||November 2003||2003-11-01|February 2013|2013-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia|A Phase 3, Multicenter, Randomized, Double-Blind, Comparative Study Of The Efficacy And Safety Of Tigecycline Vs Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia|Completed||Phase 3|430|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 17:53:01.517585|2017-02-18 17:53:01.517585
NCT00079872|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-17|2007-11-05|||February 2004||2004-02-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer|A Randomized Phase 2 Trial of ALIMTA Plus a Comparator Versus Leucovorin Modulated Fluorouracil Plus a Comparator in First Line Treatment of Locally Advanced or Metastatic Colorectal Cancer|Completed||Phase 2|120||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:53:01.608467|2017-02-18 17:53:01.608467
NCT00079859|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-17|2005-06-23|||October 2003||2003-10-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy|Safety and Efficacy Study of Implitapide Compared With Placebo in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy|Terminated||Phase 2|120||Medical Research Laboratories International|||||||||||||||||||2017-02-18 17:53:01.713388|2017-02-18 17:53:01.713388
NCT00079846|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-17|2005-06-23|||September 2003||2003-09-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy|Safety and Efficacy Study of Implitapide Compared With Placebo in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy|Terminated||Phase 2|60||Medical Research Laboratories International|||||||||||||||||||2017-02-18 17:53:01.80072|2017-02-18 17:53:01.80072
NCT00079833|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-16|2010-11-18|||November 2003||2003-11-01|November 2010|2010-11-01|July 2005|Actual|2005-07-01|||||Interventional|||Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome|A Phase III, Multicenter, Open-Label Study To Evaluate the Control of Gastric Acid Secretion With Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome For 12 Months|Completed||Phase 3|25||AstraZeneca|||||||||||||||||||2017-02-18 17:53:01.883086|2017-02-18 17:53:01.883086
NCT00079820|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-15|2014-01-09|||April 2004||2004-04-01|January 2014|2014-01-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults|The Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine, in Adults Without Previous Smallpox Vaccination|Completed||Phase 1|110|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 17:53:01.980815|2017-02-18 17:53:01.980815
NCT00079807|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-15|2008-04-21|||September 2003||2003-09-01|April 2008|2008-04-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Painful HIV Neuropathy and Alpha-Lipoic Acid|Painful HIV Neuropathy: Treatment With Alpha-Lipoic Acid|Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:53:02.1134|2017-02-18 17:53:02.1134
NCT00079794|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-15|2008-01-23|||September 2001||2001-09-01|January 2008|2008-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Iscar for Supplemental Care in Stage IV Lung Cancer|Iscar for Supplemental Care in Stage IV Lung Cancer|Completed||Phase 2|36||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 17:53:02.405314|2017-02-18 17:53:02.405314
NCT00079781|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-12|2013-12-23|2013-11-06||January 2004||2004-01-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|May 2006|Actual|2006-05-01||Interventional||Date of birth was not provided for 5 subjects (4 in the Open Label Group and 1 in the Treatment Group), therefore baseline characteristics calculations requiring age/DOB were derived using an N = 60.|RNS® System Feasibility Study|RNS® System Feasibility Clinical Investigation|Completed||Phase 2|70|Actual|NeuroPace||3|||f||||t||||||||||2017-02-18 17:53:02.503006|2017-02-18 17:53:02.503006
NCT00079768|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-12|2010-06-16|||March 2004||2004-03-01|January 2009|2009-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Alemtuzumab to Treat Sporadic Inclusion Body Myositis|Effects of a T Cell-Depleting Monoclonal Antibody, Alemtuzumab, in Patients With Inclusion Body Myositis: A Pilot Clinicopathological Study|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:53:03.689616|2017-02-18 17:53:03.689616
NCT00079755|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-12|2014-12-17|||February 2004||2004-02-01|December 2014|2014-12-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma|A Phase II Multi-Dose Study of SGN-30 (Anti-CD30 mAb) in Patients With Refractory or Recurrent Hodgkin's Disease or Anaplastic Large Cell Lymphoma|Completed||Phase 2|80||Seattle Genetics, Inc.|||||||||||||||||||2017-02-18 17:53:03.796927|2017-02-18 17:53:03.796927
NCT00079742|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-11|2008-06-05|||September 2003||2003-09-01|June 2008|2008-06-01|May 2007|Actual|2007-05-01|||||Interventional|||A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis|A Phase II, Multicenter, Randomized, Controlled, Open-Label Study of the Safety and Efficacy of Nutropin AQ [Somatropin (DNA Origin) Injection] for the Treatment of Growth Restriction in Children With Cystic Fibrosis|Completed||Phase 2|68|Actual|Genentech, Inc.|||||||||||||||||||2017-02-18 17:53:03.914532|2017-02-18 17:53:03.914532
NCT00079729|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-11|2012-10-26|||April 2004||2004-04-01|October 2012|2012-10-01|July 2004|Actual|2004-07-01|||||Observational|||Directly Observed Therapy in HIV Infected Adolescent Focus Groups|Directly Observed Therapy (DOT) in HIV-Infected Adolescents: Part A-Focus Groups|Completed||N/A|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:53:03.997761|2017-02-18 17:53:03.997761
NCT00079716|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-11|2014-12-17|||March 2004||2004-03-01|December 2014|2014-12-01|November 2007|Actual|2007-11-01|August 2007|Actual|2007-08-01||Interventional|||Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma|A Phase I, Multi-Dose Study of SGN-40 (Anti-huCD40 mAb) in Patients With Refractory or Recurrent Multiple Myeloma|Completed||Phase 1|44|Actual|Seattle Genetics, Inc.||1|||f||||f||||||||||2017-02-18 17:53:04.109083|2017-02-18 17:53:04.109083
NCT00079703|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-10|2016-07-28|||September 2002||2002-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Diet, Genetics, and CVD Risk Factor Response in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:53:04.239994|2017-02-18 17:53:04.239994
NCT00079690|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-10|2016-07-28|||September 2002||2002-09-01|May 2009|2009-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Genetic Epidemiology of Blood Pressure Intervention||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:53:04.313925|2017-02-18 17:53:04.313925
NCT00079677|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-10|2013-07-12|2009-06-01||March 2004||2004-03-01|July 2013|2013-07-01|October 2004||2004-10-01|||||Interventional|||Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of CEP-10953 (150 mg/Day) as Treatment for Adults With Residual Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|263|Actual|Teva Pharmaceutical Industries||2|||||||||||||||||2017-02-18 17:53:04.386275|2017-02-18 17:53:04.386275
NCT00079664|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-10|2013-09-30|||September 2001||2001-09-01|September 2013|2013-09-01|July 2003|Actual|2003-07-01|March 2002|Actual|2002-03-01||Interventional|||Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults|Tai Chi Training and Sleep Enhancement in the Elderly|Completed||Phase 1|100||Oregon Research Institute|||||f||||f||||||||||2017-02-18 17:53:04.871245|2017-02-18 17:53:04.871245
NCT00079651|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-10|2013-11-21|||December 2002||2002-12-01|November 2013|2013-11-01|July 2005|Actual|2005-07-01|April 2005|Actual|2005-04-01||Interventional|||Montessori-Based Activities for Elderly Persons With Dementia|Programming for Dementia: Maximizing Abilities|Completed||Phase 2/Phase 3|300||Menorah Park|||||f||||t||||||||||2017-02-18 17:53:04.961812|2017-02-18 17:53:04.961812
NCT00079638|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-10|2006-10-31|||April 2004||2004-04-01|October 2006|2006-10-01|May 2005||2005-05-01|||||Interventional|||Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL|Comparative Efficacy Evaluation of Lipid Levels When Treated With Niaspan and Statin or Other Lipid-Modifying Therapies|Completed||Phase 4|300||Kos Pharmaceuticals|||||||||||||||||||2017-02-18 17:53:05.06271|2017-02-18 17:53:05.06271
NCT00079625|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2017-01-24|||March 5, 2004||2004-03-05|August 9, 2013|2013-08-09|August 9, 2013|Actual|2013-08-09|August 9, 2013|Actual|2013-08-09||Interventional|||Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer|Allogeneic Breast Protocol 2: Phase I Trial of T Cell Exchange With Th2/Tc2 Cells for Allogeneic Stem Cell Transplantation After Reduced Intensity Conditioning for Metastatic Breast Cancer|Completed||Phase 1|22|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:53:05.160014|2017-02-18 17:53:05.160014
NCT00079612|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2014-12-18|||September 2002||2002-09-01|December 2014|2014-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer|Randomized Discontinuation Study of BAY 43-9006 in Patients With Advanced Refractory Cancer.|Completed||Phase 2|501|Actual|Bayer||2|||f||||||||||||||2017-02-18 17:53:05.260276|2017-02-18 17:53:05.260276
NCT00079599|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2008-09-02|||November 2002||2002-11-01|September 2008|2008-09-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||L-Carnitine to Treat Fatigue in AIDS Patients|Phase II Developmental Study on Fatigue in AIDS Patients|Completed||Phase 2|44|Actual|National Institute of Nursing Research (NINR)||2|||f||||t||||||||||2017-02-18 17:53:05.381903|2017-02-18 17:53:05.381903
NCT00079586|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2012-01-04|||April 2004||2004-04-01|January 2012|2012-01-01|November 2004|Actual|2004-11-01|||||Interventional|||Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)|A Study Comparing Angiomax (Bivalirudin) to Heparin With Protamine Reversal in Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass (CPB)|Completed||Phase 3|150|Actual|The Medicines Company||2|||f||||||||||||||2017-02-18 17:53:05.485493|2017-02-18 17:53:05.485493
NCT00079573|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2006-08-16|||July 2002||2002-07-01|August 2006|2006-08-01|June 2004||2004-06-01|||||Interventional|||Comparison of Popular Weight Loss Diets|Benefits & Risks of Popular Weight Loss Diets|Completed||Phase 2|300||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:53:05.58254|2017-02-18 17:53:05.58254
NCT00079560|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2017-01-10|||December 2001||2001-12-01|October 2008|2008-10-01|August 2005|Actual|2005-08-01|August 2004|Actual|2004-08-01||Interventional|||Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS|THC and Marijuana--Effects in Individuals With HIV/AIDS|Completed||Phase 1/Phase 2|30|Actual|National Institute on Drug Abuse (NIDA)||1|||t||||f||||||||||2017-02-18 17:53:05.682139|2017-02-18 17:53:05.682139
NCT00079547|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2013-06-28|||April 2003||2003-04-01|January 2008|2008-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||The Safety and Effectiveness of Low and High Carbohydrate Diets|The Safety and Efficacy of Low and High Carbohydrate Diets|Completed||Phase 4|307|Actual|Temple University||2|||f||||t||||||||||2017-02-18 17:53:05.774109|2017-02-18 17:53:05.774109
NCT00079534|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2006-08-16|||December 2000||2000-12-01|August 2006|2006-08-01|December 2003||2003-12-01|||||Interventional|||Distant Healing for HIV/AIDS|"Distant Healing Efforts for AIDS by Nurses and Healers"|Completed||N/A|150||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:53:05.876926|2017-02-18 17:53:05.876926
NCT00079521|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2006-08-16|||March 2003||2003-03-01|August 2006|2006-08-01|April 2006||2006-04-01|||||Interventional|||Therapeutic Touch for Wrist Fractures in Postmenopausal Women|The Effect of Therapeutic Touch on Bone Formation in Postmenopausal Women After Wrist Fracture|Completed||Phase 2|125||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:53:05.958032|2017-02-18 17:53:05.958032
NCT00079508|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-09|2011-11-08|||April 2004||2004-04-01|November 2011|2011-11-01||||October 2005|Actual|2005-10-01||Interventional|HIT/TS||Angiomax in Patients With HIT/HITTS Type II Undergoing CPB|A Phase III Study of Angiomax (Bivalirudin) in Patients With HIT/HITTS Type II Undergoing Cardiac Surgery on Cardiopulmonary Bypass (CPB)|Completed||Phase 3|125|Actual|The Medicines Company||1|||f||||||||||||||2017-02-18 17:53:06.040252|2017-02-18 17:53:06.040252
NCT00079495|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2008-03-20|||July 2003||2003-07-01|September 2007|2007-09-01|April 2005||2005-04-01|||||Interventional|||Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of NBI-5788 in Patients With Relapsing Multiple Sclerosis|Completed||Phase 2|150||Neurocrine Biosciences|||||||||||||||||||2017-02-18 17:53:06.252491|2017-02-18 17:53:06.252491
NCT00079482|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-07-19||2013-08-27|October 2003||2003-10-01|July 2016|2016-07-01|January 2010|Actual|2010-01-01|March 2009|Actual|2009-03-01||Interventional|||Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)|A Randomized, Open-Label Study of Oral CEP-701 Administered in Sequence With Standard Chemotherapy to Patients With Relapsed Acute Myeloid Leukemia (AML) Expressing FLT-3 Activating Mutations|Completed||Phase 2|224|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 17:53:06.339647|2017-02-18 17:53:06.339647
NCT00079469|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2012-03-07|||February 2004||2004-02-01|March 2012|2012-03-01|August 2004|Actual|2004-08-01|||||Interventional|||Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke|Contingency Management to Enhance Smoking Cessation for Cancer Survivors: A Proof of Concept Trial|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:06.530972|2017-02-18 17:53:06.530972
NCT00079456|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-10-10|||February 2004||2004-02-01|October 2013|2013-10-01||||February 2007|Actual|2007-02-01||Interventional|||Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Trial of CCI-779 in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:06.610982|2017-02-18 17:53:06.610982
NCT00079443|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-06-28|||January 2004||2004-01-01|June 2013|2013-06-01||||September 2005|Actual|2005-09-01||Interventional|||FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma|A Phase II Study of Single Agent Depsipeptide (NSC 630176) Followed by a Phase I Study of Rituximab/Fludarabine Combination With an Escalating Dose of Depsipeptide in Relapsed or Refractory Low Grade B Cell Lymphomas|Terminated||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:06.912208|2017-02-18 17:53:06.912208
NCT00079430|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2014-06-18|||June 2004||2004-06-01|June 2014|2014-06-01||||May 2011|Actual|2011-05-01||Interventional|||Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Dose-Escalating Phase I Study With an Expanded Cohort to Assess the Feasibility of Intraperitoneal Carboplatin (NSC #214240) and Intravenous Paclitaxel (NSC # 673089) and Intravenous Paclitaxel, Intraperitoneal Carboplatin and NCI Supplied Intravenous Bevacizumab (NSC #704865) in Patients With Previously Untreated Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma|Completed||Phase 1|113|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:07.026207|2017-02-18 17:53:07.026207
NCT00079417|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-03-14|2013-12-23||December 2005||2005-12-01|March 2016|2016-03-01||||January 2010|Actual|2010-01-01||Interventional|||Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma|Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma|Active, not recruiting||Phase 3|28|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:53:07.171617|2017-02-18 17:53:07.171617
NCT00079404|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-06-03|||March 2004||2004-03-01|June 2013|2013-06-01||||May 2006|Actual|2006-05-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia|A Phase I Study of 17-AAG in Relapsed/Refractory Pediatric Patients With Solid Tumors or Leukemia|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:07.488899|2017-02-18 17:53:07.488899
NCT00079391|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2015-10-05|2011-04-20||January 2004||2004-01-01|June 2014|2014-06-01|September 2011|Actual|2011-09-01|December 2008|Actual|2008-12-01||Interventional|||Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies|Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peri-transplant Cyclosporine on Chimerism|Completed||Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 17:53:07.594829|2017-02-18 17:53:07.594829
NCT00079378|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-09-27|||February 2004||2004-02-01|September 2013|2013-09-01||||May 2011|Actual|2011-05-01||Interventional|||Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Selected Hematologic Malignancies|Completed||Phase 1|84|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:07.943493|2017-02-18 17:53:07.943493
NCT00079170|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-06-18|||January 2004||2004-01-01|October 2006|2006-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Pilot Study to Evaluate the Influence of Garlic on the Pharmacokinetics of Docetaxel in Patients With Metastatic Breast Cancer|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:19.295585|2017-02-18 17:53:19.295585
NCT00079365|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-12-03|||May 2001||2001-05-01|May 2005|2005-05-01||||||||Interventional|||Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas|A Randomized Trial Comparing 5-Fluorouracil, External Beam Radiation, and Gemcitabine With or Without P Radiopharmaceutical Therapy As A First Line Therapy in Patients With Locally/Regionally Advanced Non-Resectable Adenocarcinoma of the Pancreas|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:08.06603|2017-02-18 17:53:08.06603
NCT00079352|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-01-24|||April 2004||2004-04-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors|A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:08.163288|2017-02-18 17:53:08.163288
NCT00079339|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2014-04-29|2010-04-30||January 2004||2004-01-01|December 2012|2012-12-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma|Phase I/II Trial of R115777 and XRT in Pediatric Patients With Newly Diagnosed Non-Disseminated Intrinsic Diffuse Brainstem Gliomas|Completed||Phase 1/Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:08.290589|2017-02-18 17:53:08.290589
NCT00079326|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2014-05-29|2013-11-04||January 2004||2004-01-01|January 2013|2013-01-01|October 2010|Actual|2010-10-01|July 2008|Actual|2008-07-01||Interventional|||Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer|A Phase 2 Study of Trastuzumab in Combination With BMS-247550 in Women With Metastatic Breast Cancer|Terminated||Phase 2|39|Actual|National Cancer Institute (NCI)||1||Slow accrual.|f||||||||||||||2017-02-18 17:53:09.2333|2017-02-18 17:53:09.2333
NCT00079313|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2017-01-24|||January 14, 2004||2004-01-14|September 23, 2011|2011-09-23|October 25, 2010|Actual|2010-10-25|December 30, 2006|Actual|2006-12-30||Interventional|||Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia|A Pilot Study of the Safety and Efficacy of Imatinib in Reducing Monocytosis or Leukocytosis in Patients With Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia, Respectively|Completed||Phase 2|7|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:53:09.595484|2017-02-18 17:53:09.595484
NCT00079300|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-04-25|||January 2004||2004-01-01|April 2013|2013-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer|Double-Blind, Vehicle-Controlled Study to Evaluate Apoptosis in Basal Cell Carcinoma Treated With Aldara™ (Imiquimod) Cream, 5% Applied Once or Twice a Day|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:09.798536|2017-02-18 17:53:09.798536
NCT00079287|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-09-16|||March 2001||2001-03-01|April 2005|2005-04-01|November 2008|Actual|2008-11-01|||||Interventional|||Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:09.895578|2017-02-18 17:53:09.895578
NCT00079274|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2015-01-23|2013-12-05||February 2004||2004-02-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer|A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer|Completed||Phase 3|3397|Actual|National Cancer Institute (NCI)|Accrual to arms A and D terminated early based on the results of the planned 2nd interim analysis. Sample sizes limit statistical conclusions for data from the irinotecan treated patients as those treatment arms were discontinued early in the study.|7|||f||||t||||||||||2017-02-18 17:53:10.076683|2017-02-18 17:53:10.076683
NCT00079261|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2012-09-20|||January 2004||2004-01-01|September 2012|2012-09-01||||March 2007|Actual|2007-03-01||Interventional|||Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma|Gem-CHOP: A Randomized Phase II Study of Gemcitabine Combined With CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|25|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:53:18.496632|2017-02-18 17:53:18.496632
NCT00079248|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2009-05-09|||March 2002||2002-03-01|June 2005|2005-06-01||||||||Interventional|||Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer|UK Trial Of Hormone Replacement Therapy (HRT) In Women With A History Of Early Stage Breast Cancer|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:18.605343|2017-02-18 17:53:18.605343
NCT00079235|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-07-15|||February 2004||2004-02-01|June 2013|2013-06-01||||June 2007|Actual|2007-06-01||Interventional|||CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of the mTOR Inhibitor, CCI-779 in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:18.690566|2017-02-18 17:53:18.690566
NCT00079222|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-01-07|||November 2003||2003-11-01|January 2013|2013-01-01||||April 2005|Actual|2005-04-01||Interventional|||Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation|Randomized Trial Of Safety And Tolerability Of Intravenous/Oral Voriconazole Versus Intravenous/Oral Itraconazole For Long-Term Antifungal Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplant Recipients|Completed||N/A|||Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 17:53:18.79701|2017-02-18 17:53:18.79701
NCT00079183|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2012-03-13|||April 2002||2002-04-01|March 2012|2012-03-01||||July 2009|Actual|2009-07-01||Interventional|||Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond To Prior Treatment|A Phase II Clinical Trial to Evaluate the Safety and Efficacy of Sirolimus for Secondary Treatment of Chronic Graft-versus-Host Disease|Completed||Phase 2|44|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 17:53:19.177025|2017-02-18 17:53:19.177025
NCT00005335|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||May 1991||1991-05-01|July 2004|2004-07-01|March 2002|Actual|2002-03-01|||||Observational|||Genetic Epidemiology of Lipoprotein-Lipid Levels||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.278661|2017-02-18 18:15:07.278661
NCT00079157|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2009-07-29|||February 2004||2004-02-01|July 2009|2009-07-01||||May 2008|Anticipated|2008-05-01||Interventional|||Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer|Phase I Study Of Telomerase Peptide Vaccination For Patients With Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 1|28|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:19.392208|2017-02-18 17:53:19.392208
NCT00079144|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-06-18|||January 2004||2004-01-01|May 2005|2005-05-01|August 2005|Actual|2005-08-01|||||Interventional|||Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma|Treatment Of Patients With Metastatic Melanoma Using Nonmyeloablative But Lymphocyte Depleting Regimen Followed By The Administration Of In Vitro Sensitized Lymphocytes Reactive With ESO-1 Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:19.491426|2017-02-18 17:53:19.491426
NCT00079131|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-06-03|||January 2004||2004-01-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||Oblimersen in Treating Patients With Merkel Cell Carcinoma|A Phase II Study of G3139 (Genasense ™) in Patients With Merkel Cell Carcinoma|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:19.588026|2017-02-18 17:53:19.588026
NCT00079118|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-12-09|||April 2004||2004-04-01|December 2016|2016-12-01|December 2010|Actual|2010-12-01|February 2007|Actual|2007-02-01||Interventional|||Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer|Phase II Trial of Weekly Irinotecan and Docetaxel in Refractory Metastatic Breast Cancer|Completed||Phase 2|70|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:53:19.700825|2017-02-18 17:53:19.700825
NCT00079105|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2015-10-07|||January 2004||2004-01-01|October 2015|2015-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years|A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years; Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Treating Older Patients With Hodgkin's Lymphoma|Completed||Phase 2|175|Actual|Newcastle-upon-Tyne Hospitals NHS Trust||2|||f||||t||||||||||2017-02-18 17:53:20.164022|2017-02-18 17:53:20.164022
NCT00079092|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2009-08-20|||January 2004||2004-01-01|August 2009|2009-08-01||||||||Interventional|||Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma|A Phase II Trial Of Thalidomide And Procarbazine In Adults With Recurrent/Progressive Gliomas|Completed||Phase 2|55|Anticipated|Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 17:53:20.327856|2017-02-18 17:53:20.327856
NCT00079079|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-11-25|||October 2003||2003-10-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|September 2008|Actual|2008-09-01||Interventional|||Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor|A Phase II Study of Cisplatin and Gemcitabine in Patients With Locally Advanced/Recurrent or Metastatic Malignant Salivary Gland Tumors|Completed||Phase 2|34|Anticipated|Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-02-18 17:53:20.431292|2017-02-18 17:53:20.431292
NCT00079066|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-10-31|||August 2003||2003-08-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|March 2006|Actual|2006-03-01||Interventional|||Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer|A Phase III Randomized Study of Cetuximab (Erbitux™, C225) and Best Supportive Care Versus Best Supportive Care in Patients With Pretreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Positive Colorectal Carcinoma|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 17:53:20.544804|2017-02-18 17:53:20.544804
NCT00079053|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-11-25|||November 2003||2003-11-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|A Phase I Study of Adjuvant OSI-774 (Tarceva®) in Patients Following Combined Chemo-Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|20|Anticipated|Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-02-18 17:53:20.882764|2017-02-18 17:53:20.882764
NCT00079040|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2014-04-28|2009-11-19||January 2006||2006-01-01|December 2012|2012-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer|A Phase II Study of Cisplatin Plus Etoposide (PE) Plus Bevacizumab (NSC #704865) for Previously Untreated Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|65|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:20.996316|2017-02-18 17:53:20.996316
NCT00079027|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-12-17|||April 2004||2004-04-01|May 2007|2007-05-01||||||||Interventional|||Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)|A Randomized Clinical Trial Evaluating the Benefits of Doxorubicin Chemoembolization Versus Systemic Doxorubicin in Patients With Unresectable, Advanced Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 3|280|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:21.370648|2017-02-18 17:53:21.370648
NCT00079014|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-05-15|||January 2004||2004-01-01|May 2013|2013-05-01||||July 2008|Actual|2008-07-01||Interventional|||3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors|A Phase I Study of Triapine® in Combination With Doxorubicin in Refractory Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:21.497049|2017-02-18 17:53:21.497049
NCT00079001|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-10-27|2014-10-27||January 2004||2004-01-01|October 2016|2016-10-01|October 2014|Actual|2014-10-01|July 2012|Actual|2012-07-01||Interventional|||Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases|A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone|Completed||Phase 3|645|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:53:21.631625|2017-02-18 17:53:21.631625
NCT00078754|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-05|2014-12-29|2014-02-19||May 2003||2003-05-01|December 2014|2014-12-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder|Fluoxetine and Divalproex: Treatment Correlates in IED|Completed||Phase 2|90|Actual|University of Chicago||3|||f||||t||||||||||2017-02-18 17:53:26.319645|2017-02-18 17:53:26.319645
NCT00078988|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2015-05-06|||October 2004||2004-10-01|May 2015|2015-05-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas|A Phase III Randomized Trial for the Treatment of Pediatric High Grade Gliomas at First Recurrence With a Single High Dose Chemotherapy and Autologous Stem Cell Transplant Versus Three Courses of Intermediate Dose Chemotherapy With Peripheral Blood Stem Cell (PBSC) Support|Completed||Phase 3|1|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 17:53:23.57035|2017-02-18 17:53:23.57035
NCT00078975|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-06-21|||April 2004||2004-04-01|June 2016|2016-06-01||||January 2009|Actual|2009-01-01||Interventional|||3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer|A Phase II Study of Triapine in Combination With Gemcitabine in Recurrent/Unresectable/Metastatic Pancreatic Carcinoma|Completed||Phase 2|26|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 17:53:23.750452|2017-02-18 17:53:23.750452
NCT00078962|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-01-23|||January 2004||2004-01-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Pharmacokinetics and Pharmacodynamic Study of GTI2040 in Combination With Gemcitabine in Patients With Solid Tumors|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:23.854527|2017-02-18 17:53:23.854527
NCT00078949|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-03-16|2014-09-17||August 2003||2003-08-01|April 2015|2015-04-01|December 2016|Anticipated|2016-12-01|May 2013|Actual|2013-05-01||Interventional||ITT population|Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase III Study Of Gemcitabine, Dexamethasone, And Cisplatin Compared To Dexamethasone, Cytarabine, And Cisplatin Plus/Minus Rituximab [(R)-GDP vs (R)-DHAP] As Salvage Chemotherapy For Patients With Relapsed Or Refractory Aggressive Histology Non-Hodgkin's Lymphoma Prior To Autologous Stem Cell Transplant And Followed By Maintenance Rituximab Versus Observation|Active, not recruiting||Phase 3|619|Actual|Canadian Cancer Trials Group||4|||f||||t||||||||||2017-02-18 17:53:23.965374|2017-02-18 17:53:23.965374
NCT00078923|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2014-03-04|||November 2001||2001-11-01|March 2014|2014-03-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate|Phase II Clinical Trial of Soy Isoflavones Prior to Radical Prostatectomy|Completed||Phase 2|32|Actual|Barbara Ann Karmanos Cancer Institute||4|||f||||t||||||||||2017-02-18 17:53:24.887395|2017-02-18 17:53:24.887395
NCT00078910|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2013-06-21|||August 2003||2003-08-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer|A Prospective Phase II Study of Preoperative, Controlled Exisulind Therapy Initiated Prior to Radical Prostatectomy: Effect on Apoptosis|Completed||Phase 2|130|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:24.996419|2017-02-18 17:53:24.996419
NCT00078897|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-05-18|||January 2001||2001-01-01|November 2015|2015-11-01|July 2016|Anticipated|2016-07-01|October 2015|Actual|2015-10-01||Interventional|||Selenium for Prevention of Adenomatous Colorectal Polyps|Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence|Active, not recruiting||Phase 3|1800|Anticipated|University of Arizona||2|||f||||t||||||||||2017-02-18 17:53:25.279295|2017-02-18 17:53:25.279295
NCT00078858|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-03-01|||September 2003||2003-09-01|March 2016|2016-03-01||||January 2006|Actual|2006-01-01||Interventional|||Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant|Prolonged Mycophenolate Mofetil and Truncated Cyclosporine Postgrafting Immunosuppression to Reduce Life-Threatening GVHD After Unrelated Donor Peripheral Blood Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-Center Trial|Active, not recruiting||Phase 1/Phase 2|37|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:53:25.406331|2017-02-18 17:53:25.406331
NCT00078845|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2012-10-16|||May 2004||2004-05-01|October 2012|2012-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors|Phase II Trial Of Subcutaneous Amifostine For Reversal Of Persistent Paclitaxel-Induced Peripheral Neuropathy|Completed||Phase 2|24|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:53:25.569066|2017-02-18 17:53:25.569066
NCT00078832|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-08|2016-08-05|||September 2003||2003-09-01|August 2016|2016-08-01|January 2022|Anticipated|2022-01-01|December 2013|Actual|2013-12-01||Interventional|IBIS II||Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer|International Breast Cancer Intervention Study|Active, not recruiting||Phase 3|3864|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-02-18 17:53:25.702665|2017-02-18 17:53:25.702665
NCT00078819|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-05|2013-07-26|||August 2004||2004-08-01|July 2013|2013-07-01|June 2007|Actual|2007-06-01|February 2006|Actual|2006-02-01||Interventional|||Etanercept (Enbrel®) in Psoriasis - Pediatrics|Placebo-controlled Multicenter Study With Etanercept to Determine Safety and Efficacy in Pediatric Subjects With Plaque Psoriasis (PEDS)|Completed||Phase 3|211|Actual|Amgen||2|||f||||||||||||||2017-02-18 17:53:25.896223|2017-02-18 17:53:25.896223
NCT00078806|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-05|2009-04-30|||June 2001||2001-06-01|April 2009|2009-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis|Phase 3 Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis|Terminated||Phase 3|75|Anticipated|Amgen||2||the study was terminated because of slow enrollment|f||||||||||||||2017-02-18 17:53:26.004272|2017-02-18 17:53:26.004272
NCT00078793|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-05|2013-05-10|||June 2000||2000-06-01|May 2013|2013-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|||Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis|Phase IV Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis|Completed||N/A|600|Actual|Amgen|||1||f||||||||||||||2017-02-18 17:53:26.109378|2017-02-18 17:53:26.109378
NCT00078767|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-05|2013-11-20|||April 2001||2001-04-01|November 2013|2013-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Pharmacologic Treatment of PTSD in Sexually Abused Children||Completed||Phase 3|60||Allegheny Singer Research Institute|||||f||||||||||||||2017-02-18 17:53:26.217493|2017-02-18 17:53:26.217493
NCT00078741|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-05|2015-08-07|||January 2004||2004-01-01|December 2007|2007-12-01|September 2007|Actual|2007-09-01|March 2006|Actual|2006-03-01||Interventional|||Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness|CBT for PTSD and SMI in Community Mental Health Centers|Completed||Phase 2|60||Medical University of South Carolina|||||f||||||||||||||2017-02-18 17:53:26.858234|2017-02-18 17:53:26.858234
NCT00078728|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-05|2014-03-18|2013-10-24||September 2003||2003-09-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Family-Based Prevention Program for Childhood Anxiety|Family-Based Prevention for Childhood Anxiety|Completed||N/A|40|Actual|Johns Hopkins University|Of the 40 participants in the study, no adverse events occured or were reported.|2|||f||||t||||||||||2017-02-18 17:53:26.956289|2017-02-18 17:53:26.956289
NCT00078715|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-04|2012-08-16|2012-06-07||March 2004||2004-03-01|August 2012|2012-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Rapid Antidepressant Effects of Yohimbine in Major Depression|An Investigation of a Pharmacologic Strategy to Bring About Rapid (Next Day) Antidepressant Effects|Completed||Phase 2|11|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 17:53:27.339739|2017-02-18 17:53:27.339739
NCT00078689|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-04|2017-01-24|||March 3, 2004||2004-03-03|July 18, 2008|2008-07-18|July 18, 2008||2008-07-18|||||Interventional|||Daclizumab and Sirolimus to Treat Uveitis|Combination Daclizumab/Sirolimus Therapy For the Induction of Immune Tolerance in Non-Infectious Intermediate and Posterior Uveitis|Completed||Phase 1|6||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:53:27.6239|2017-02-18 17:53:27.6239
NCT00078663|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-03|2017-01-24|||March 2, 2004||2004-03-02|August 16, 2011|2011-08-16|August 16, 2011|Actual|2011-08-16|December 28, 2007|Actual|2007-12-28||Interventional|||Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients|The Effect of a Systemic Oral Care Program on Reducing Exposure to Oropharyngeal Pathogens in Critically III Patients|Completed||Phase 3|800|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:53:27.718396|2017-02-18 17:53:27.718396
NCT00078637|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-03|2014-12-19|||January 2004||2004-01-01|December 2014|2014-12-01|February 2007|Actual|2007-02-01|August 2006|Actual|2006-08-01||Interventional|||Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma|Phase I and Pharmacokinetic Study of E7820 After Oral Administration to Patients With Malignancy|Completed||Phase 1|37|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:53:27.806651|2017-02-18 17:53:27.806651
NCT00078624|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-03|2013-01-23|||April 2004||2004-04-01|January 2013|2013-01-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Knee Stability Training for Knee Osteoarthritis (OA)|Knee Stability Training in Individuals With Knee Osteoarthritis|Completed||Phase 2|231|Actual|University of Pittsburgh||2|||f||||f||||||||||2017-02-18 17:53:27.877706|2017-02-18 17:53:27.877706
NCT00078611|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2016-06-14|||March 2004||2004-03-01|March 2012|2012-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease|A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous Antegren(TM) (Natalizumab) in Subjects With Moderately to Severely Active Crohn's Disease With Elevated C-Reactive Protein|Completed||Phase 3|462||Biogen|||||||||||||||||||2017-02-18 17:53:27.984595|2017-02-18 17:53:27.984595
NCT00078598|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2005-11-08|||April 2004||2004-04-01|October 2004|2004-10-01||||||||Interventional|||A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma|A Multi-Center, Randomized, Phase III Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 3|506||Corixa Corporation|||||||||||||||||||2017-02-18 17:53:28.285245|2017-02-18 17:53:28.285245
NCT00078585|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2005-07-07|||November 2003||2003-11-01|July 2005|2005-07-01||||||||Interventional|||PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy|A Phase II Randomized, Double Blind, Controlled Study to Evaluate the Safety and Efficacy of PROSTVAC®-VF/TRICOM™ in Combination With GM-CSF in Patients With Androgen-Independent Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|120||Therion Biologics Corporation|||||||||||||||||||2017-02-18 17:53:28.377925|2017-02-18 17:53:28.377925
NCT00078572|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2010-12-09|||March 2004||2004-03-01|December 2010|2010-12-01|February 2010|Actual|2010-02-01|April 2006|Actual|2006-04-01||Interventional|||Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer|A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) Versus Capecitabine in Women With Refractory Advanced or Metastatic Breast Cancer|Completed||Phase 3|408|Actual|GlaxoSmithKline||2|||f||||t||||||||||2017-02-18 17:53:28.500936|2017-02-18 17:53:28.500936
NCT00078559|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2012-07-25|2012-04-13||November 2003||2003-11-01|July 2012|2012-07-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults|Campath-1H/Tacrolimus/Sirolimus Withdrawal in Renal Transplantation (ITN013ST)|Completed||Phase 1/Phase 2|10|Actual|University of Wisconsin, Madison|The absence of a control group in this pilot trial precludes any comparison between alemtuzumab-induced patients with further minimization and patients with more conventional immunosuppressive approaches, and is a limitation of the current study|1|||f||||t||||||||||2017-02-18 17:53:28.617928|2017-02-18 17:53:28.617928
NCT00078546|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2012-07-27|||September 2003||2003-09-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|CLANC||EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)|Administration of EBV-Specific Cytotoxic T Lymphocytes Following CD45 Antibody to Patients With EBV Positive Nasopharyngeal Carcinoma|Completed||Phase 1|12|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:53:29.657474|2017-02-18 17:53:29.657474
NCT00078533|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2014-10-06|||April 2004||2004-04-01|June 2014|2014-06-01|June 2011|Actual|2011-06-01|July 2010|Actual|2010-07-01||Interventional|VICTA||Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant|Virus Specific Cytotoxic T-Lymphocytes for the Treatment of CMV After Allogeneic Stem Cell Transplant: A Dose-Finding Trial|Completed||Phase 1|26|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:53:29.770732|2017-02-18 17:53:29.770732
NCT00078520|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2010-04-21|||January 2003||2003-01-01|March 2010|2010-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|CLIPA||Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells|Treatment of Chronic Lymphocytic B-Leukemia (B-CLL) With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (CLIPA)|Completed||Phase 1|21|Anticipated|Baylor College of Medicine||1|||t||||t||||||||||2017-02-18 17:53:29.879943|2017-02-18 17:53:29.879943
NCT00078507|ClinicalTrials.gov processed this data on February 17, 2017|2004-03-01|2010-02-02|||December 2001||2001-12-01|February 2010|2010-02-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Sensory Re-Training Following Facial Surgery for Correction of Facial Skeletal Disharmony|Sensory Re-Training Following Orthognathic Surgery|Completed||Phase 3|186|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 17:53:29.99712|2017-02-18 17:53:29.99712
NCT00078494|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-27|2008-03-03|||February 2004||2004-02-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer|Phase I/II Trial of Latent Membrane Protein (LMP) - 2 Immunization for the Assessment of the Natural History and the Immunization-Induced Immunological Response in Patients at High Risk for Recurrence of Anaplastic Nasopharyngeal Cancer|Completed||Phase 1|99||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:30.106688|2017-02-18 17:53:30.106688
NCT00078481|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-27|2008-03-03|||February 2004||2004-02-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia|Phase 1B Clinical Trial to Establish the Safety and Tolerability of a Multiple-Dose Regimen of Idebenone Administered to Patients With Friedreich's Ataxia|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:30.192573|2017-02-18 17:53:30.192573
NCT00078468|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-27|2006-11-08|||December 2003||2003-12-01|August 2006|2006-08-01|September 2004||2004-09-01|||||Interventional|||Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment|A Phase 2 Open-Label Multicenter Study Of The Garft Inhibitor AG2037 In Patients With Metastatic Colorectal Cancer Who Failed Treatment With A 5-Fluorouracil/Leucovorin Regimen.|Completed||Phase 2|56||Pfizer|||||f||||||||||||||2017-02-18 17:53:30.286824|2017-02-18 17:53:30.286824
NCT00078455|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-25|2015-03-04|||December 2003||2003-12-01|March 2015|2015-03-01|August 2005|Actual|2005-08-01|||||Interventional|||Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma|A Phase II Study of ILX651 Administered Intravenously Daily for Five Consecutive Days Once Every 3 Weeks in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma|Completed||Phase 2|||Sanofi|||||||||||||||||||2017-02-18 17:53:30.371667|2017-02-18 17:53:30.371667
NCT00078442|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-25|2009-08-06|||May 2006||2006-05-01|August 2009|2009-08-01||||January 2007|Actual|2007-01-01||Interventional|||Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People|A Phase II Open-Label Pilot Trial of the Antiretroviral Activity, Safety, and Tolerability of Pegylated Interferon Alfa-2A (40KD) [PegasysTM] in HIV-1 Infected Subjects|Completed||Phase 2|12|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:53:30.45707|2017-02-18 17:53:30.45707
NCT00078429|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-25|2008-07-23|||July 2003||2003-07-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Molecular Epidemiology of Myocardial Infarction and Stroke in Older Adults - Ancillary to CHS||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:53:30.570688|2017-02-18 17:53:30.570688
NCT00078403|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-24|2016-11-30|2010-11-05||July 2004||2004-07-01|November 2016|2016-11-01|February 2009|Actual|2009-02-01|May 2007|Actual|2007-05-01||Interventional||All Arm A, B and C participants.|Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)|Suppressive Long-Term Antiviral Management of Hepatitis C Virus (HCV) and HIV-1 Coinfected Subjects (SLAM-C)|Completed||Phase 2|333|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 17:53:30.651544|2017-02-18 17:53:30.651544
NCT00078390|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-24|2005-06-23|||February 2003||2003-02-01|December 2004|2004-12-01||||||||Interventional|||Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer|A Phase I/II Study of the Safety, Pharmacokinetic Interaction and Efficacy of S-3304 in Combination With Standard Therapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.|Unknown status|Active, not recruiting|Phase 1/Phase 2|90||Shionogi|||||||||||||||||||2017-02-18 17:53:32.096845|2017-02-18 17:53:32.096845
NCT00078377|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-24|2013-07-12|2009-06-01||March 2004||2004-03-01|July 2013|2013-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy|A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of CEP-10953 (150 and 250 mg/Day) as Treatment for Adults With Excessive Sleepiness Associated With Narcolepsy|Completed||Phase 3|196|Actual|Teva Pharmaceutical Industries||3|||||||||||||||||2017-02-18 17:53:32.190234|2017-02-18 17:53:32.190234
NCT00078364|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-23|2008-03-03|||February 2004||2004-02-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Pain Pathways in the Brain|Imaging Neural Mechanisms Underlying Pain Modulation|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:32.830175|2017-02-18 17:53:32.830175
NCT00078351|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-23|2008-03-03|||February 2004||2004-02-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Synvisc to Treat Osteoarthritis of the Temporomandibular Joint|The Effects of Viscosupplementation Using Synvisc in Symptomatic Osteoarthritis of the Temporomandibular Joint|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:32.916194|2017-02-18 17:53:32.916194
NCT00078338|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-23|2014-08-05|||March 2004||2004-03-01|April 2011|2011-04-01|September 2007|Actual|2007-09-01|||||Interventional|||Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis|Phase IV, Multicenter, Open Label, Randomized Study of Rebif® 44 mcg Administered Three Times Per Week by Subcutaneous Injection Compared With Copaxone® 20 mg Administered Daily by Subcutaneous Injection in the Treatment of Relapsing Remitting Multiple Sclerosis|Completed||Phase 4|764|Actual|EMD Serono|||||f||||||||||||||2017-02-18 17:53:33.00886|2017-02-18 17:53:33.00886
NCT00078325|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-23|2013-07-12|2009-06-01||February 2004||2004-02-01|July 2013|2013-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)|A 12 Week, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of CEP 10953 (150 and 250 mg/Day) as Treatment for Adults With Residual Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome|Completed||Phase 3|395|Actual|Teva Pharmaceutical Industries||3|||||||f||||||||||2017-02-18 17:53:36.102508|2017-02-18 17:53:36.102508
NCT00078130|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-19|2017-01-11|||July 2003||2003-07-01|October 2016|2016-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1|Bup/Nx - Facilitated Rehab for Opioid Dependent Adolescents|Completed||Phase 3|223||National Institute on Drug Abuse (NIDA)|||||||||t||||||||||2017-02-18 17:53:39.045555|2017-02-18 17:53:39.045555
NCT00078312|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-23|2013-07-12|2009-06-01||January 2004||2004-01-01|July 2013|2013-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder|A 12-Month, Open-Label, Flexible-Dosage (100 to 250 mg/Day) Study of the Safety and Efficacy of CEP-10953 in the Treatment of Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (With an Open-Ended Extension Period)|Completed||Phase 3|328|Actual|Teva Pharmaceutical Industries|||||||||f||||||||||2017-02-18 17:53:36.634313|2017-02-18 17:53:36.634313
NCT00078299|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-20|2008-03-03|||February 2004||2004-02-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Evaluation of the Age-Related Eye Disease Study (AREDS) Clinical Lens Grading System|Evaluation of the Age-Related Eye Disease Study (AREDS) Clinical Lens Grading System|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:37.193883|2017-02-18 17:53:37.193883
NCT00078286|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-20|2013-01-23|2009-05-11||November 2003||2003-11-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|March 2008|Actual|2008-03-01||Interventional|SADHART-CHF||Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure|Safety and Efficacy of Sertraline for Depression CHF|Completed||Phase 2/Phase 3|469|Actual|Duke University|NFS may have limited our ability to detect effect of sertraline on depression scores. Dropout rate was higher than expected. A 12-week duration of therapy may have been insufficient to show potential effects of sertraline on clinical outcomes.|2|||f||||t||||||||||2017-02-18 17:53:37.2753|2017-02-18 17:53:37.2753
NCT00078273|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-20|2013-12-10|||July 2003||2003-07-01|December 2013|2013-12-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Indicated Prevention With At-Risk Gamblers|Indicated Prevention With At-Risk Gamblers|Completed||Phase 2|225|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 17:53:37.681211|2017-02-18 17:53:37.681211
NCT00078260|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-20|2016-11-21|||December 2003||2003-12-01|November 2016|2016-11-01|April 2008|Actual|2008-04-01|October 2006|Actual|2006-10-01||Interventional|||A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer|A Randomized Phase 3 Study of Two Doses of Alimta in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy|Completed||Phase 3|589|Actual|Eli Lilly and Company||2|||f||||t||||||||Yes|"Lilly provides access to the individual patient data from studies on approved medicines and indications as defined by the sponsor specific information on ClinicalStudyDataRequest.com.~This access is provided in a timely fashion after the primary publication is accepted. Researchers need to have an approved research proposal submitted through ClinicalStudyDataRequest.com. Access to the data will be provided in a secure data sharing environment after signing a data sharing agreement."|2017-02-18 17:53:37.795711|2017-02-18 17:53:37.795711
NCT00078247|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-20|2010-08-10|||October 2004||2004-10-01|August 2010|2010-08-01||||||||Interventional|||Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis|Delaying HIV Disease Progression With Punctuated Antiretroviral Therapy in HIV-Associated Tuberculosis|Completed||Phase 3|350|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:53:37.89649|2017-02-18 17:53:37.89649
NCT00078234|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-20|2011-11-04|||November 2003||2003-11-01|May 2009|2009-05-01|September 2010|Actual|2010-09-01|September 2008|Actual|2008-09-01||Interventional|||Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia|A Pilot Study of Genasense® (G3139, Oblimersen Sodium, Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated Subjects With Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|25|Actual|Genta Incorporated||1|||f||||||||||||||2017-02-18 17:53:38.005907|2017-02-18 17:53:38.005907
NCT00078221|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-20|2008-05-08|||August 1999||1999-08-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)||Unknown status|Active, not recruiting|Phase 3|180||OccuLogix|||||||||||||||||||2017-02-18 17:53:38.093488|2017-02-18 17:53:38.093488
NCT00078208|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-19|2017-01-24|||February 18, 2004||2004-02-18|August 19, 2010|2010-08-19|August 19, 2010||2010-08-19|||||Observational|||Exhaled Breath Condensate as a Measure of Airway Inflammation in Children With Asthma|Exhaled Breath Condensate as a Measurement of Airway Inflammation in Children With Asthma|Completed||N/A|128|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:38.204329|2017-02-18 17:53:38.204329
NCT00078195|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-19|2016-10-14|||April 2003||2003-04-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies|Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered With Omalizumab, an Anti-IgE Monoclonal Antibody (ITN019AD)|Completed||Phase 2|168||National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in: 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts; and 2.) TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research data sharing portal.|2017-02-18 17:53:38.289311|2017-02-18 17:53:38.289311
NCT00078182|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-19|2016-12-13||||||May 2005|2005-05-01||||||||Interventional|||Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia|Study of Daily Oral Tenofovir (Tenofovir Disoproxil Fumarate) to Prevent HIV-1 Infection Among Sex Workers in Cambodia|Withdrawn||Phase 2/Phase 3|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:53:38.417185|2017-02-18 17:53:38.417185
NCT00078169|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-19|2017-01-11|||November 2003||2003-11-01|October 2016|2016-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Motivational Enhancement for Spanish Speaking Individuals - 1|Motivational Enhancement for Spanish Speaking Individuals|Completed||Phase 3|463||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:53:38.508855|2017-02-18 17:53:38.508855
NCT00078156|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-19|2017-01-11|||January 2004||2004-01-01|October 2016|2016-10-01|October 2005||2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Women's Treatment for Trauma and Substance Use Disorders - 1|Women's Treatment for Trauma and Substance Use Disorders|Completed||Phase 3|409||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:53:38.598169|2017-02-18 17:53:38.598169
NCT00078143|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-19|2017-01-11|||October 2003||2003-10-01|October 2016|2016-10-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1|Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users|Completed||Phase 3|200||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:53:38.942826|2017-02-18 17:53:38.942826
NCT00078117|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-19|2017-01-11|||June 2003||2003-06-01|April 2010|2010-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1|Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules|Completed||Phase 3|516||National Institute on Drug Abuse (NIDA)|||||||||t||||||||||2017-02-18 17:53:39.14291|2017-02-18 17:53:39.14291
NCT00078104|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-18|2008-03-03|||February 2004||2004-02-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Prostanoid Levels After Medication to Prevent Pain Following Third Molar (Wisdom Tooth) Extraction|Proinflammatory Gene Expression and Prostanoid Levels in a Clinical Model of Tissue Injury|Completed||Phase 2|148||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:39.246454|2017-02-18 17:53:39.246454
NCT00078091|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-18|2017-01-24|||February 17, 2004||2004-02-17|February 5, 2016|2016-02-05|February 5, 2016||2016-02-05|||||Observational|||Genetics and Clinical Characteristics of Bardet-Biedl Syndrome|Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics|Terminated||N/A|194|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:39.331367|2017-02-18 17:53:39.331367
NCT00078078|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-18|2017-01-24|||February 17, 2004||2004-02-17|October 20, 2016|2016-10-20||||||||Observational|||Clinical and Laboratory Study of Methylmalonic Acidemia|Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:39.423178|2017-02-18 17:53:39.423178
NCT00078065|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-18|2005-11-10|||November 2003||2003-11-01|March 2005|2005-03-01|June 2004||2004-06-01|||||Interventional|||Xcellerated T CellsTM in Patients With Multiple Myeloma|A Randomized Phase II Study of Xcellerated T CellsTM With or Without Prior Fludarabine Therapy in Patients With Multiple Myeloma|Completed||Phase 2|30||Xcyte Therapies|||||||||||||||||||2017-02-18 17:53:39.526006|2017-02-18 17:53:39.526006
NCT00078052|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-17|2013-03-18|||September 2003||2003-09-01|March 2013|2013-03-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Genetic Markers of Coronary Heart Disease in Type 2 Diabetes||Completed||N/A|120000|Actual|Harvard School of Public Health|||1||f||||||||||Samples With DNA|"~     Plasma and buffy coat~   "|||2017-02-18 17:53:39.621244|2017-02-18 17:53:39.621244
NCT00078039|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-17|2011-06-06|||March 2004||2004-03-01|April 2010|2010-04-01|January 2005|Actual|2005-01-01|||||Interventional|||Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia|Randomized, Double-blind, Placebo- and Active-controlled Parallel Group, Dose-response Study to Evaluate the Efficacy and Safety of 3 Fixed Dosages of Paliperidone Extended Release (6, 9, and 12 mg/Day) and Olanzapine (10 mg/Day) With Open-label Extension in Treatment of Schizophrenia|Completed||Phase 3|630|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:53:39.784047|2017-02-18 17:53:39.784047
NCT00078026|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-16|2014-02-04|||August 2003||2003-08-01|February 2014|2014-02-01|December 2004||2004-12-01|||||Interventional|||An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass|A Phase I/II Randomized Study of the Short-Term Effects of APOMINE vs Placebo in Postmenopausal Women With Osteoporosis or Low Bone Mass|Terminated||Phase 1/Phase 2|60||Sanofi|||||||||||||||||||2017-02-18 17:53:39.885682|2017-02-18 17:53:39.885682
NCT00078013|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-13|2005-06-23|||April 2003||2003-04-01|March 2005|2005-03-01|August 2004||2004-08-01|||||Interventional|||MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients|A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Examine the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Standard Therapy With Primary PCI in Patients Diagnosed as Having an ST Elevation Acute Myocardial Infarction|Completed||Phase 2|414||Mitsubishi Tanabe Pharma Corporation|||||||||||||||||||2017-02-18 17:53:39.997087|2017-02-18 17:53:39.997087
NCT00078000|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-13|2008-11-24|||March 2004||2004-03-01|November 2008|2008-11-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.|A Phase 2 Study Of The Efficacy And Safety Of SU011248 In Patients With Metastatic Breast Cancer|Completed||Phase 2|64|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:53:40.07582|2017-02-18 17:53:40.07582
NCT00077987|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-13|2007-01-09|||December 2003||2003-12-01|October 2005|2005-10-01|April 2005||2005-04-01|||||Interventional|||Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.|A Phase II Study Of SU011248 In Patients With Metastatic Colorectal Cancer Who Have Previously Failed Treatment With Irinotecan, Oxaliplatin, And A Fluoropyrimidine, With And Without Bevacizumab|Completed||Phase 2|84||Pfizer|||||f||||||||||||||2017-02-18 17:53:40.1762|2017-02-18 17:53:40.1762
NCT00077974|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-13|2010-10-08|2009-09-25||February 2004||2004-02-01|October 2010|2010-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.|A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma|Completed||Phase 2|106|Actual|Pfizer||1|||f||||t||||||||||2017-02-18 17:53:40.268649|2017-02-18 17:53:40.268649
NCT00077961|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-13|2015-03-25|||December 2003||2003-12-01|March 2015|2015-03-01||||February 2006|Actual|2006-02-01||Interventional|||Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL|Phase I/II Study of Rituximab Plus CAMPATH in Patients With Previously Treated Relapsed or Refractory Low-Grade Follicular, CD20-positive, B-cell Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|49||Sanofi|||||||||||||||||||2017-02-18 17:53:41.226746|2017-02-18 17:53:41.226746
NCT00077948|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-13|2014-01-08|||July 2003||2003-07-01|January 2014|2014-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure|A Phase III, Randomized, Double-Blind, Double Placebo-Controlled, Multicenter, Three Parallel Group Study of Enoximone Plus Extended-Release Metoprolol Succinate in Advanced CHF Subjects Previously Intolerant to Beta-Blocker Treatment|Terminated||Phase 3|175||Gilead Sciences||3|||f||||||||||||||2017-02-18 17:53:41.335533|2017-02-18 17:53:41.335533
NCT00077935|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-13|2011-06-06|||November 2003||2003-11-01|February 2004|2004-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Civamide in OA of the Knee(s)|An Open-Label Multicenter Study Evaluating the Safety of Civamide Cream 0.075% as a Treatment in Subjects With Osteoarthritis of the Knee(s)|Completed||Phase 3|351|Actual|Winston Laboratories||1|||f||||f||||||||||2017-02-18 17:53:41.448629|2017-02-18 17:53:41.448629
NCT00074672|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-17|2017-01-24|||December 12, 2003||2003-12-12|April 14, 2009|2009-04-14|April 14, 2009||2009-04-14|||||Observational|||Relationship Between Sensory and Motor Systems in Restless Leg Syndrome|Sensorimotor Gating Studies in Restless Legs Syndrome|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:12.141465|2017-02-18 17:55:12.141465
NCT00077922|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2012-10-17|2012-10-17||February 2004||2004-02-01|October 2012|2012-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia|A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia|Completed||Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 17:53:41.577632|2017-02-18 17:53:41.577632
NCT00077909|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2017-01-24|||February 10, 2004||2004-02-10|May 5, 2016|2016-05-05||||||||Observational|||Study of Lung Proteins in Patients With Pneumonia|Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage From Patients With Lung Infiltrates|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:41.998983|2017-02-18 17:53:41.998983
NCT00077896|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2008-03-03|||February 2004||2004-02-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Direct Current Brain Polarization in Frontotemporal Dementia|Direct Current Brain Polarization in Frontotemporal Dementia|Completed||Phase 1|6||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:42.101202|2017-02-18 17:53:42.101202
NCT00077883|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2011-07-21|||February 2004||2004-02-01|June 2005|2005-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Cisplatin as First-Line Therapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|50|Anticipated|Telik||1|||f||||||||||||||2017-02-18 17:53:42.187156|2017-02-18 17:53:42.187156
NCT00077870|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2009-09-01|||February 2004||2004-02-01|September 2009|2009-09-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis|A Randomized, Placebo-Controlled, Multicenter, Blinded Phase I/II Study of the Safety of Escalating Doses of Ocrelizumab (PRO70769) in Subjects With Moderate to Severe Rheumatoid Arthritis Receiving Stable Doses of Concomitant Methotrexate|Completed||Phase 1/Phase 2|237||Genentech, Inc.|||||f||||||||||||||2017-02-18 17:53:42.287031|2017-02-18 17:53:42.287031
NCT00077857|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2013-03-27|2013-02-13||July 2003||2003-07-01|March 2013|2013-03-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer|A Randomized, Open-label Study of the Effect of Different Dosing Regimens of Xeloda® in Combination With Taxotere® on Disease Progression in Patients With Locally Advanced and/or Metastatic Breast Cancer|Completed||Phase 2|470|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:53:42.382509|2017-02-18 17:53:42.382509
NCT00077844|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2011-01-10|||January 2004||2004-01-01|January 2011|2011-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)|An International Phase 2-3, Stratified, Randomized, Open-label, Parallel-group Clinical Trial to Evaluate the Safety and Efficacy of a Single Intravenous Bolus of Enoxaparin Versus Intravenous Unfractionated Heparin in Patients Undergoing Non-emergent Percutaneous Coronary Intervention|Completed||Phase 2/Phase 3|3532|Anticipated|Sanofi|||||f||||||||||||||2017-02-18 17:53:43.065663|2017-02-18 17:53:43.065663
NCT00077831|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2015-07-19|||September 2001||2001-09-01|July 2015|2015-07-01|June 2015|Actual|2015-06-01|April 2014|Actual|2014-04-01||Observational|CILP||Child and Infant Learning Project|Neurobehavioral Correlates of Craniosynostosis|Completed||N/A|535|Actual|Seattle Children's Hospital|||1||f||||f||||||||||2017-02-18 17:53:43.142229|2017-02-18 17:53:43.142229
NCT00077818|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2009-10-14|||June 2002||2002-06-01|October 2009|2009-10-01||||February 2005|Actual|2005-02-01||Interventional|||Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)|A Prospective, Open-label, Randomized, Parallel-group Investigation to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome|Completed||Phase 4|||Sanofi|||||t||||||||||||||2017-02-18 17:53:43.246719|2017-02-18 17:53:43.246719
NCT00077805|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2011-01-10|||August 2003||2003-08-01|January 2011|2011-01-01||||July 2006|Actual|2006-07-01||Interventional|||PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)|An Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolism in Patients Following Acute Ischemic Stroke|Completed||Phase 4|||Sanofi|||||f||||||||||||||2017-02-18 17:53:43.337167|2017-02-18 17:53:43.337167
NCT00077792|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2009-04-17|||October 2002||2002-10-01|April 2009|2009-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)|A Randomized, Double-Blind, Double-Dummy , Parallel Group, Multinational, Clinical Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients With Acute ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic Therapy|Completed||Phase 3|20506|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:53:43.722664|2017-02-18 17:53:43.722664
NCT00077779|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2007-09-23|||July 2003||2003-07-01|September 2007|2007-09-01||||||||Interventional|CHARM||Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease|A Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease|Completed||Phase 3|854|Actual|Abbott|||||||||||||||||||2017-02-18 17:53:43.865408|2017-02-18 17:53:43.865408
NCT00077766|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2016-09-16|2016-07-27||March 2004||2004-03-01|November 2015|2015-11-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional||The safety population was defined as all participants who received at least one dose of RO0503821 or darbepoetin alfa and had a safety follow-up, whether withdrawn prematurely or not. There were 4 participants who were excluded from the safety population as they did not receive the study medication.|A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.|A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.|Completed||Phase 3|313|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:53:44.011755|2017-02-18 17:53:44.011755
NCT00074243|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2015-04-29|||December 2003||2003-12-01|November 2006|2006-11-01||||||||Interventional|||CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas|A Phase I Trial Of CC-8490 For The Treatment Of Patients With Recurrent/Refractory High-Grade Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:55:18.692142|2017-02-18 17:55:18.692142
NCT00077753|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-12|2011-01-10|||February 2002||2002-02-01|January 2011|2011-01-01|February 2007|Actual|2007-02-01|October 2006|Actual|2006-10-01||Interventional|||EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization|A Double-Blind, Placebo-Controlled, Parallel, Multicenter Study on Extended VTE Prophylaxis in Acutely Ill Medical Patients With Prolonged Immobilization|Completed||Phase 4|4726||Sanofi|||||||||||||||||||2017-02-18 17:53:45.013505|2017-02-18 17:53:45.013505
NCT00077727|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-11|2011-05-20|||March 2003||2003-03-01|April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.|A Study of Galantamine HBr as an Adjunctive Treatment to Atypical Antipsychotic Medications in Outpatients With Schizophrenia and Associated Cognitive Deficits.|Completed||Phase 3|107|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:53:45.121145|2017-02-18 17:53:45.121145
NCT00077714|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-11|2011-06-06|||January 2004||2004-01-01|April 2010|2010-04-01|January 2005|Actual|2005-01-01|||||Interventional|||Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia|A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 2 Fixed Dosages of Paliperidone Extended Release Tablets and Olanzapine, With Open-label Extension, in the Treatment of Patients With Schizophrenia|Completed||Phase 3|12|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:53:45.221211|2017-02-18 17:53:45.221211
NCT00077688|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2009-06-02|||November 2003||2003-11-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|||||Interventional|||TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium|A Phase 2 Multicenter Evaluation of the Safety and Efficacy of TOCOSOL(TM) Paclitaxel (S-8184 Paclitaxel Injectable Emulsion) in Patients With Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|44||OncoGenex Technologies|||||f||||||||||||||2017-02-18 17:53:45.317538|2017-02-18 17:53:45.317538
NCT00077675|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2010-05-13|2009-12-02||February 2004||2004-02-01|May 2010|2010-05-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|FAST2||Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)|A Phase 2, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Standard Therapy for Treatment of Complicated Gram-Positive Skin and Skin Structure Infections (Gram Positive cSSSI)|Completed||Phase 2|201|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||t||||||||||2017-02-18 17:53:45.42149|2017-02-18 17:53:45.42149
NCT00077662|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2015-05-04|||March 2004||2004-03-01|May 2015|2015-05-01|January 2006|Actual|2006-01-01|May 2005|Actual|2005-05-01||Observational|||A Prospective, Observational Study in Patients With Late-Onset Pompe Disease|A Prospective, Observational Study in Patients With Late-Onset Pompe Disease|Completed||N/A|61|Actual|Sanofi|||1||f||||||||||||||2017-02-18 17:53:46.319661|2017-02-18 17:53:46.319661
NCT00077649|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-03-21|2016-02-03||January 2004||2004-01-01|March 2016|2016-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional||The ITT [intent to treat] population which consisted of all participants who were randomized and received at least one dose of either of the study medication|A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).|Randomized, Multicenter, Double-blind, Phase IV Pilot Study Evaluating the Effect of PEGASYS Doses of 180 ug or 270 ug in Combination With Copegus Doses of 1200 mg or 1600 mg on Viral Kinetics, Virological Response, Pharmacokinetics, and Safety in Interferon-naïve Patients With Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Body Weight Greater Than 85 kg|Completed||Phase 4|188|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 17:53:46.48998|2017-02-18 17:53:46.48998
NCT00077636|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-01-22|2015-12-15||December 2003||2003-12-01|January 2016|2016-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.|A Randomized, Open-label Study of the Effect of PEGASYS and Ribavirin Combination Therapy on Sustained Virologic Response in Interferon-naïve Patients With Chronic Hepatitis C Genotype 2 or 3 Infection|Completed||Phase 4|1469|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:53:48.049357|2017-02-18 17:53:48.049357
NCT00077623|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-04-26|2016-03-24||March 2004||2004-03-01|April 2016|2016-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional||The analysis was done on safety population which included all participants who received at least one dose of study drug.|A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.|A Randomized, Controlled, Open-Label, Multi- Center, Parallel-Group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Subcutaneously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis|Completed||Phase 3|572|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:53:51.913364|2017-02-18 17:53:51.913364
NCT00077610|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-11-23|2016-01-29||February 2004||2004-02-01|September 2016|2016-09-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional||The safety population included all participants who received at least one dose of RO0503821 or Epoetin, and a safety follow-up, whether withdrawn prematurely or not.|A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients|A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis.|Completed||Phase 3|673|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 17:53:54.101479|2017-02-18 17:53:54.101479
NCT00077597|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-11-01|||February 2004||2004-02-01|November 2016|2016-11-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||A Study of Mircera for the Treatment of Anemia in Dialysis Patients|A Randomized, Open-label Study of the Effect of Intravenous Mircera on Hemoglobin Level/Correction in Dialysis Patients With Chronic Kidney Disease|Completed||Phase 3|182|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:53:56.068791|2017-02-18 17:53:56.068791
NCT00077584|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-10-26|||October 2003||2003-10-01|October 2016|2016-10-01|May 2005|Actual|2005-05-01|March 2005|Actual|2005-03-01||Interventional|RAPIDS-2||Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma|A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Effect of Bosentan on Healing and Prevention of Ischemic Digital Ulcers in Patients With Systemic Sclerosis|Completed||Phase 3|188|Actual|Actelion||2|||f||||||||||||||2017-02-18 17:53:56.223191|2017-02-18 17:53:56.223191
NCT00077558|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2010-03-09|||January 2004||2004-01-01|March 2010|2010-03-01||||||||Interventional|||3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome|A Phase I Trial Of Sequential Administration Of Triapine (3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone) Followed By Fludarabine In Adults With Relapsed And Refractory Leukemias And Myelodysplasias|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 17:53:56.36629|2017-02-18 17:53:56.36629
NCT00077545|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-10-07|||January 2004||2004-01-01|October 2013|2013-10-01||||March 2007|Actual|2007-03-01||Interventional|||3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction|A Phase II Study Of Triapine In Combination With Cisplatin Esophageal Carcinoma|Completed||Phase 2|39|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:56.474534|2017-02-18 17:53:56.474534
NCT00077532|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2012-06-21|||March 2004||2004-03-01|June 2012|2012-06-01|February 2008|Actual|2008-02-01|January 2007|Actual|2007-01-01||Interventional|||Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma|A Study of Intra-Patient Escalating Doses of MDX-010 Given Alone or in Combination With Two gp100 Peptides Emulsified With Montanide ISA-51 in the Treatment of Patients With Stage IV Melanoma|Completed||Phase 2|179|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:53:56.586481|2017-02-18 17:53:56.586481
NCT00077519|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2009-02-06|||January 2004||2004-01-01|April 2007|2007-04-01||||||||Interventional|||Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer|A Phase I Trial of the Farnesyltransferase Inhibitor, R115777 (NSC# 702818) and Radiotherapy in Patients With Locally Advanced Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:53:56.698223|2017-02-18 17:53:56.698223
NCT00077493|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2007-12-21|||January 2004||2004-01-01|December 2007|2007-12-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma|Pediatric Phase I Trial of BL22 for Refractory CD22-Positive Leukemias and Lymphomas|Suspended||Phase 1|95|Anticipated|MedImmune LLC||4||protocol development and Amended protocol revision|f||||f||||||||||2017-02-18 17:53:56.784782|2017-02-18 17:53:56.784782
NCT00077467|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-06-04|||January 2004||2004-01-01|June 2013|2013-06-01||||March 2006|Actual|2006-03-01||Interventional|||Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia|A Phase I Study of PS-341 (Velcade, Bortezomib) in Pediatric Patients With Refractory/Recurrent Leukemias|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:56.893176|2017-02-18 17:53:56.893176
NCT00077454|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-06-04|||February 2004||2004-02-01|June 2013|2013-06-01||||September 2007|Actual|2007-09-01||Interventional|||Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors|A Phase I Study of Single Agent OSI-774 (Tarceva) (NSC# 718781, IND# 63383) Followed by OSI-774 With Temozolomide for Patients With Selected Recurrent/Refractory Solid Tumors, Including Brain Tumors|Completed||Phase 1|95|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:57.018674|2017-02-18 17:53:57.018674
NCT00077441|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-06-03|||April 2005||2005-04-01|June 2013|2013-06-01||||June 2006|Actual|2006-06-01||Interventional|||Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)|Phase II Trial of PS-341 in Patients With Hepatocellular Carcinoma|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:57.145938|2017-02-18 17:53:57.145938
NCT00077428|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-01-23|||June 2004||2004-06-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck|Phase II Trial of PS-341 (NSC 681239) Followed by the Addition of Doxorubicin at Progression in Advanced Adenoid Cystic Carcinoma of the Head and Neck|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:57.257768|2017-02-18 17:53:57.257768
NCT00077415|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-05-14|||April 2004||2004-04-01|August 2006|2006-08-01|February 2008|Actual|2008-02-01|January 2008|Actual|2008-01-01||Interventional|||3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer|A Randomized Phase II Study Of Triapine® Alone Versus Triapine and Gemcitabine As Second-Line Treatment Of Advanced Non-Small-Cell-Lung Cancer In Patients Who Had Prior Gemcitabine With Evaluation Of The Effect Of Triapine® On Gemcitabine Pharmacokinetics and Cellular Uptake In Peripheral Mononuclear Cells|Completed||Phase 2|31|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:53:57.382847|2017-02-18 17:53:57.382847
NCT00077402|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-05-14|||November 2003||2003-11-01|December 2006|2006-12-01|February 2011|Actual|2011-02-01|January 2011|Actual|2011-01-01||Interventional|||Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer|A Phase 2 Study Of Fenretinide In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:57.494813|2017-02-18 17:53:57.494813
NCT00077389|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2014-06-23|||January 2004||2004-01-01|December 2009|2009-12-01||||||||Interventional|||Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma|Intensified Pre-Operative Chemotherapy And Radical Surgery For High Risk Hepatoblastoma|Unknown status|Active, not recruiting|Phase 2|57|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:57.60556|2017-02-18 17:53:57.60556
NCT00077376|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2014-05-02|2011-03-04||March 2005||2005-03-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|March 2009|Actual|2009-03-01||Interventional|||Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer|A Phase II Trial of Trastuzumab Plus Weekly Ixabepilone(BMS-247550) and Carboplatin in Patients With HER2/Neu-Positive Metastatic Breast Cancer|Completed||Phase 2|61|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:58.02354|2017-02-18 17:53:58.02354
NCT00077363|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-02-26|||May 2004||2004-05-01|February 2013|2013-02-01||||February 2007|Actual|2007-02-01||Interventional|||Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer|A Phase II Trial of Capecitabine in Combination With the Farnesyltransferase Inhibitor, R115777 (Tipifarnib, Zarnestra) in Patients With Metastatic Breast Cancer|Completed||Phase 2|70|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:58.426492|2017-02-18 17:53:58.426492
NCT00077350|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-02-26|||July 2004||2004-07-01|February 2013|2013-02-01||||April 2005|Actual|2005-04-01||Interventional|||A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer|A Phase II Trial of Triapine® (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:53:58.53162|2017-02-18 17:53:58.53162
NCT00077337|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-06-21|||April 2004||2004-04-01|November 2005|2005-11-01|April 2006|Actual|2006-04-01|||||Interventional|||FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer|Phase II Trial of Depsipeptide (NSC-630176) in Colorectal Cancer Patients Who Have Received Either One or Two Prior Chemotherapy Regimens for Metastatic or Locally Advanced, Unresectable Disease|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:53:58.658493|2017-02-18 17:53:58.658493
NCT00077324|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-07-01|||February 2004||2004-02-01|July 2016|2016-07-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Observational|||Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions|Use Of Proteomic Analysis Of Serum Samples For Detection Of Non-Small Cell Lung Cancer|Completed||N/A|1000|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 17:53:58.859773|2017-02-18 17:53:58.859773
NCT00077311|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-06-28|||August 2004||2004-08-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|July 2006|Actual|2006-07-01||Interventional|||Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Randomized Study Of Dose-Dense Docetaxel And Cisplatin Every Two Weeks With Pegfilgrastim And Darbepoetin Alfa With And Without The Chemoprotector BNP7787 In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|160|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 17:53:59.054038|2017-02-18 17:53:59.054038
NCT00077298|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2015-04-14|||December 2003||2003-12-01|December 2012|2012-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer|A Randomized Phase II Study of Bevacizumab in Combination With Cetuximab Plus Irinotecan, or in Combination With Cetuximab Alone, in Irinotecan-Refractory Colorectal Cancer|Completed||Phase 2|70|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:53:59.383056|2017-02-18 17:53:59.383056
NCT00077285|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-11-01|||October 2003||2003-10-01|November 2016|2016-11-01|October 2017|Anticipated|2017-10-01|October 2017|Anticipated|2017-10-01||Interventional|||Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma|A Pilot Phase II Trial Of Irinotecan Plus Carboplatin, And Irinotecan Maintenance Therapy (High-Risk Patients Only), Integrated Into The Upfront Therapy Of Newly Diagnosed Patients With Intermediate - And High-Risk Rhabdomyosarcoma|Active, not recruiting||Phase 2|65|Anticipated|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:53:59.50446|2017-02-18 17:53:59.50446
NCT00077259|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-01-15|||October 2003||2003-10-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer|A Phase II Study Of KOS-862 (Epothilone D), Administered Intravenously Weekly For 3 Weeks Every 4 Weeks, In The Second-Line Treatment Of Patients With Advanced Or Metastatic Colorectal Carcinoma (CRC)|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:53:59.632578|2017-02-18 17:53:59.632578
NCT00077246|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-11-05|||September 2003||2003-09-01|December 2009|2009-12-01||||October 2008|Actual|2008-10-01||Interventional|||ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer|An Open-Label, Phase I/II Trial Of ABI-007 (A CREMOPHOR® El-Free, Protein Stabilized, Nanoparticle Paclitaxel) Administered Weekly In Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|64|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:53:59.724432|2017-02-18 17:53:59.724432
NCT00077233|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-07-01|||December 2003||2003-12-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|December 2006|Actual|2006-12-01||Interventional|||FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum|A Phase II Trial Of Irinotecan /5-FU/ Leucovorin Or Oxaliplatin /5-FU / Leucovorin With And Without Cetuximab (C225) For Patients With Untreated Metastatic Adenocarcinoma Of The Colon or Rectum|Completed||Phase 2|238|Actual|Alliance for Clinical Trials in Oncology||4|||f||||f||||||||||2017-02-18 17:53:59.83463|2017-02-18 17:53:59.83463
NCT00077220|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2009-02-06|||June 2002||2002-06-01|May 2007|2007-05-01||||||||Interventional|||Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer|Phase III Randomised Study Of Adjuvant Paclitaxel And Carboplatin (TAXOL-PARAPLATINE) With Concomittant Radiotherapy In Patients With Stage II or III Non-Metastatic Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:00.266318|2017-02-18 17:54:00.266318
NCT00077207|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2014-06-30|2014-01-08||July 2004||2004-07-01|June 2014|2014-06-01|December 2013|Actual|2013-12-01|March 2010|Actual|2010-03-01||Interventional|||Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma|A Pilot Study Using Carboplatin, Vincristine And Temozolomide For Children ≤ 10 Years With Progressive/Symptomatic Low-Grade Gliomas|Completed||N/A|66|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:54:00.469417|2017-02-18 17:54:00.469417
NCT00077194|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-02-08|||January 2004||2004-01-01|February 2005|2005-02-01||||December 2005|Actual|2005-12-01||Interventional|||FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Study Of Depsipeptide, A Histone Deacetylase Inhibitor, In Relapsed Or Refractory Mantle Cell Or Diffuse Large Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:54:01.059809|2017-02-18 17:54:01.059809
NCT00077181|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-01-23|||January 2004||2004-01-01|January 2013|2013-01-01||||July 2008|Actual|2008-07-01||Interventional|||3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies|A Phase I Study of Triapine in Combination With High Dose Ara-C (Hi-DAC) in Patients With Advanced Hematologic Malignancies|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:54:01.174185|2017-02-18 17:54:01.174185
NCT00071656|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-08-06|||September 2002||2002-09-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I|Psychosocial Treatment for ADHD Inattentive Type I|Completed||N/A|60||University of California, San Francisco|||||f||||||||||||||2017-02-18 17:56:10.741595|2017-02-18 17:56:10.741595
NCT00077168|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2009-02-06|||April 2004||2004-04-01|October 2007|2007-10-01||||September 2017|Anticipated|2017-09-01||Interventional|||Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole|Randomised Trial Testing Observation (No Radiotherapy) Against Radiotherapy In Women With Low-Risk Completely Excised ER Positive Ductal Carcinoma In Situ (DCIS) Of The Breast On Adjuvant Endocrine Therapy|Active, not recruiting||Phase 2|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:01.299433|2017-02-18 17:54:01.299433
NCT00077155|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-01-23|||December 2003||2003-12-01|January 2013|2013-01-01||||June 2010|Actual|2010-06-01||Interventional|||Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study Of Continuous Infusion EMD 121974 In Patients With Solid Tumors|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:54:01.431385|2017-02-18 17:54:01.431385
NCT00077142|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2012-07-27|||April 2001||2001-04-01|July 2012|2012-07-01|August 2005|Actual|2005-08-01|July 2005|Actual|2005-07-01||Interventional|||TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)|Phase I/II Dose Escalation, Pharmacokinetic, Safety, and Efficacy Study of Oral TAC-101 in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|37|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:54:01.551772|2017-02-18 17:54:01.551772
NCT00077129|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2010-01-26|||September 2004||2004-09-01|January 2010|2010-01-01||||August 2006|Actual|2006-08-01||Interventional|||Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer|Phase II Trial Of Paclitaxel Plus Carboplatin In Patients With Metastatic Or Locally Advanced Collecting Duct Renal Cell Cancer|Completed||Phase 2|22|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 17:54:01.675193|2017-02-18 17:54:01.675193
NCT00077116|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2012-07-13|||November 2003||2003-11-01|July 2012|2012-07-01||||November 2006|Actual|2006-11-01||Interventional|||Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome|Idarubicin and Ara-C in Combination With Gemtuzumab-Ozogamicin (IAGO) for Young Untreated Patients, Without an HLA Identical Sibling, With High Risk MDS or AML Developing After a Preceding Period With MDS During 6 Months Duration: A Phase II Study|Completed||Phase 2|31|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:54:01.818105|2017-02-18 17:54:01.818105
NCT00077103|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2010-06-09|||November 2003||2003-11-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|February 2007|Actual|2007-02-01||Interventional|||Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer|Phase II Trial of Combined Modality Combretastatin A-4 Phosphate (CA4P)-Based Therapy for Patients With Newly Diagnosed Anaplastic Thyroid Cancer [Induction Chemotherapy With Doxorubicin/Cisplatin; Combined Modality Therapy With CA4P and Radiation; Followed by 2 Cycles of CA4P Consolidation]|Terminated||Phase 1/Phase 2|4|Actual|Case Comprehensive Cancer Center||1||slow accrual|f||||t||||||||||2017-02-18 17:54:01.929207|2017-02-18 17:54:01.929207
NCT00077090|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2013-12-17|||April 2004||2004-04-01|September 2007|2007-09-01||||||||Interventional|||Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer|Randomized Phase II Trial Of Hyperbaric Oxygen Therapy In Patients With Chronic Arm Lymphoedema After Radiotherapy For Cancer|Unknown status|Active, not recruiting|Phase 2|63|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:02.177421|2017-02-18 17:54:02.177421
NCT00077077|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2012-05-15|||February 2004||2004-02-01|May 2012|2012-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Study Of The Combination Of Oral DJ-927 And Capecitabine In Patients With Advanced Solid Tumors|Completed||Phase 1|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:54:02.273217|2017-02-18 17:54:02.273217
NCT00077064|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2015-03-26|||June 2003||2003-06-01|March 2015|2015-03-01||||September 2008|Actual|2008-09-01||Interventional|||Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy|A Phase II Randomized Trial With Captopril In Patients Who Have Received Radiation Therapy +/- Chemotherapy For Stage II-IIIB Non-Small Cell Lung Cancer, Stage I Central Non-Small Cell Lung Cancer, Or Limited-Stage Small-Cell Lung Cancer|Active, not recruiting||Phase 2|81|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 17:54:02.380322|2017-02-18 17:54:02.380322
NCT00077051|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-10|2016-12-14|||April 2004||2004-04-01|December 2016|2016-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)|Translational Phase I Trial of Escalating Doses of 5-Chloro-2'-Deoxycytidine (CldC) With a Fixed Dose of Tetrahydrouridine Combined With a Fixed Dose of Cisplatin Concomitant With Definitive Radiation in Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity and Oropharynx|Completed||Phase 1|1|Actual|University of Miami||1|||f||||||||||||||2017-02-18 17:54:02.568092|2017-02-18 17:54:02.568092
NCT00077038|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-09|2017-01-24|||February 6, 2004||2004-02-06|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||Brain Activity in Visual-Motor Behavior|Modulation of the Visual Information Processing in the Human Parieto-Frontal Network as Studied by a Frequency Tagging Technique During Visuomotor Tracking|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:02.877121|2017-02-18 17:54:02.877121
NCT00077025|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-09|2014-07-15|||January 2004||2004-01-01|July 2014|2014-07-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|||Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer|Phase II Multicenter, Double-Blind, Randomized Trial Comparing Anastrozole (ZD1033, Arimidex™)-Placebo to the Combination Anastrozole-ZD1839 (Gefitinib, IRESSA™) in Postmenopausal Patients With Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) Metastatic Breast Cancer|Completed||Phase 2|174|Anticipated|AstraZeneca||2|||f||||f||||||||||2017-02-18 17:54:02.965282|2017-02-18 17:54:02.965282
NCT00076076|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-13|2016-12-01|||December 2003||2003-12-01|September 2016|2016-09-01|June 2005|Actual|2005-06-01|||||Interventional|||The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)|The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma|Completed||Phase 3|822||AstraZeneca|||||f||||||||||||||2017-02-18 17:54:24.618544|2017-02-18 17:54:24.618544
NCT00077012|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-09|2012-05-22|||March 2003||2003-03-01|May 2012|2012-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia|A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Transurethral Photodynamic Therapy With QLT0074 for Benign Prostatic Hyperplasia|Completed||Phase 1/Phase 2|||QLT Inc.|||||f||||||||||||||2017-02-18 17:54:03.134385|2017-02-18 17:54:03.134385
NCT00076999|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-09|2014-04-25|2011-06-27||November 2003||2003-11-01|April 2014|2014-04-01||||June 2010|Actual|2010-06-01||Interventional|||Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children|Multiple-dose, Open-label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination With Low-dose Ritonavir in HIV-infected Pediatric Patients|Completed||Phase 1|115|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 17:54:03.26689|2017-02-18 17:54:03.26689
NCT00076986|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-06|2011-06-02|||February 2004||2004-02-01|June 2011|2011-06-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme|PRECISE - Phase III Randomized Evaluation of Convection Enhanced Delivery of IL13-PE38QQR Compared to GLIADEL® Wafer With Survival Endpoint in Glioblastoma Multiforme Patients at First Recurrence|Completed||Phase 3|300||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 17:54:06.153122|2017-02-18 17:54:06.153122
NCT00076973|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-06|2016-01-21|||August 2003||2003-08-01|January 2016|2016-01-01|October 2006|Actual|2006-10-01|June 2006|Actual|2006-06-01||Interventional|||An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)|A Randomized, 2-Period, Multicenter, Dble-Blind, Parallel-Group Study Comparing Effects of 2 Doses of MK0476 and Placebo in the Tx of Respiratory Symptoms Associated w/ Respiratory Syncytial Virus-Induced Bronchiolitis in Children 3 to 24 Mths|Completed||Phase 3|1125|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:54:06.295142|2017-02-18 17:54:06.295142
NCT00076960|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-06|2016-12-12|||October 2003||2003-10-01|January 2016|2016-01-01||||July 2017|Anticipated|2017-07-01||Expanded Access|||Compassionate Use of Stanate (TM) [Stannsoporfin]|Compassionate Use of Stannsoporfin as an Adjuvant to Phototherapy to Reduce the Need for Exchange Transfusions|No longer available||N/A|||InfaCare Pharmaceuticals Corporation|||||||||||||||||||2017-02-18 17:54:06.386098|2017-02-18 17:54:06.386098
NCT00076947|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-06|2008-03-20|||August 2003||2003-08-01|March 2005|2005-03-01||||||||Interventional|||Safety of the EnvPro HIV Vaccine in Healthy Volunteers|Evaluation of Tolerability and Safety of a Recombinant Purified HIV Envelope Vaccine|Completed||Phase 1|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:54:06.475673|2017-02-18 17:54:06.475673
NCT00076934|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-06|2014-06-04|||January 2003||2003-01-01|June 2014|2014-06-01|February 2006|Actual|2006-02-01|||||Interventional|||Safety of RG2077 in Patients With Multiple Sclerosis|A Phase I Study: Safety of RG2077 (CTLA4-IgG4m) in Patients With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||t||||||||||2017-02-18 17:54:06.567509|2017-02-18 17:54:06.567509
NCT00076921|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-06|2013-04-08|||September 2002||2002-09-01|April 2013|2013-04-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Epidemiology & Intervention Research for Tobacco Control|Research on China Tobacco Control Epidemiology and Intervention|Completed||N/A|15705|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||f||||||None Retained|"~     No bio-specimens collected. Sampled nicotine from buildings only.~   "|||2017-02-18 17:54:06.677768|2017-02-18 17:54:06.677768
NCT00076869|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-05|2015-01-12|||January 2003||2003-01-01|January 2015|2015-01-01|August 2005|Actual|2005-08-01|September 2004|Actual|2004-09-01||Interventional|||MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)|A Multicenter, Open, Noncomparative Study to Estimate the Safety, Tolerability, and Efficacy of MK0991 in Combination With Amphotericin B, Lipid Formulations of Amphotericin B, or Azoles in the Treatment of Invasive Aspergillus Infection in Adults Who Are Refractory to or Intolerant of Standard Therapy|Completed||Phase 2|55|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:54:06.755728|2017-02-18 17:54:06.755728
NCT00076856|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-04|2015-04-30|||March 2004||2004-03-01|April 2015|2015-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)|A Randomized, Open-Label Phase 2 Study of Temozolomide Added to Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone for the Treatment of Brain Metastasis From Non-Small Cell Lung Cancer|Completed||Phase 2|95|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:54:06.847947|2017-02-18 17:54:06.847947
NCT00076843|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2017-01-24|||January 29, 2004||2004-01-29|October 6, 2016|2016-10-06|May 31, 2017|Anticipated|2017-05-31|May 31, 2017|Anticipated|2017-05-31||Interventional|||Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis|Phase I/II Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-Beta-1 Monoclonal Antibody Directed Toward the IL-2/IL-15R-Beta Subunit (CD122) That Blocks IL-15 Action|Recruiting||Phase 1|18|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:54:09.91647|2017-02-18 17:54:09.91647
NCT00076830|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2017-01-24|||February 2, 2004||2004-02-02|January 13, 2016|2016-01-13||||||||Observational|||Evaluation and Treatment of Patients With Connective Tissue Disease|Screening and Diagnosis of Patients With Connective Tissue Disorders|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:10.020503|2017-02-18 17:54:10.020503
NCT00076817|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-03|2012-10-26|||June 2006||2006-06-01|October 2012|2012-10-01|September 2008|Actual|2008-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm|A Phase I Double Blind Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of the Aventis Pasteur ALVAC-HIV (vCP205) Administered to the Groin Area Versus the Deltoid Area|Completed||Phase 1|18|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:54:10.11787|2017-02-18 17:54:10.11787
NCT00076804|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-03|2015-03-09|2010-06-01||February 2005||2005-02-01|March 2015|2015-03-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Helping HIV Infected Patients in South Africa Adhere to Drug Regimens|DOT-HAART for HIV-Infected South African Adults|Terminated||Phase 2|274|Actual|Johns Hopkins University|Intervention was stopped at 12 months, transition phase did not ensure that participants developed a set of adherence strategies to replace DOT-ART. Low incidence of AIDS-defining illness and death limit our ability to make final conclusions|2||DSMB stopped trial for futility|f||||t||||||||||2017-02-18 17:54:10.222142|2017-02-18 17:54:10.222142
NCT00076791|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-03|2013-07-05|||March 2004||2004-03-01|July 2013|2013-07-01|March 2011|Actual|2011-03-01|March 2010|Actual|2010-03-01||Interventional|||Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants|A Phase I Study of the Safety, Tolerance, and Pharmacokinetics of Tenofovir Disoproxil Fumarate (TDF) and the Combination of TDF Plus Emtricitabine in HIV-1 Infected Pregnant Women and Their Infants|Completed||Phase 1|66|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:54:10.672174|2017-02-18 17:54:10.672174
NCT00076752|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-02|2014-06-13|2014-03-25||January 2004||2004-01-01|June 2014|2014-06-01|October 2013|Actual|2013-10-01|October 2013|Actual|2013-10-01||Interventional|||Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus|A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Systemic Lupus Erythematosus|Completed||Phase 2|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 17:54:10.811322|2017-02-18 17:54:10.811322
NCT00076739|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-02|2017-01-24|||February 2, 2004||2004-02-02|December 12, 2011|2011-12-12|December 12, 2011||2011-12-12|||||Observational|||Study of Brain Function During Cognitive Tasks|Examining Associative Relations in Structured Event Complexes Using Functional Neuroimaging|Completed||N/A|452|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:11.553709|2017-02-18 17:54:11.553709
NCT00076726|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-02|2011-05-16|||November 2003||2003-11-01|April 2010|2010-04-01|July 2005|Actual|2005-07-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis|A Randomized, Double-Masked, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Infliximab in Subjects With Giant Cell Arteritis|Terminated||Phase 2|44|Actual|Centocor, Inc.||||"Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative~   glucocorticosteroid dosage"|||||t||||||||||2017-02-18 17:54:11.625767|2017-02-18 17:54:11.625767
NCT00076713|ClinicalTrials.gov processed this data on February 17, 2017|2004-02-02|2013-02-11|||April 2000||2000-04-01|February 2013|2013-02-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|APSCORE||Antiphospholipid Syndrome Collaborative Registry (APSCORE)|Antiphospholipid Syndrome Collaborative Registry (APSCORE)|Completed||N/A|860|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||Samples With DNA|"~     Serum, plasma, genomic DNA~   "|||2017-02-18 17:54:11.726558|2017-02-18 17:54:11.726558
NCT00076700|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-31|2008-03-03|||January 2004||2004-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Enhanced Tactile Memory in the Blind|Enhanced Tactile Memory in the Blind|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:11.820846|2017-02-18 17:54:11.820846
NCT00076687|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-29|2011-08-30|2011-07-28||October 2003||2003-10-01|August 2011|2011-08-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function||Completed||Phase 2|155|Actual|Allergan||3|||f||||||||||||||2017-02-18 17:54:11.910185|2017-02-18 17:54:11.910185
NCT00076674|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-28|2016-09-21|||January 2004||2004-01-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Levetiracetam Treatment of L-dopa Induced Dyskinesias|Levetiracetam Treatment of L-dopa Induced Dyskinesias|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:12.460203|2017-02-18 17:54:12.460203
NCT00076648|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-28|2006-07-31||||||July 2006|2006-07-01||||||||Interventional|||Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting|A Phase III, Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception From Informed Consent Requirements Designed to Evaluate the Safety and Efficacy of Poly SFH-P Injection [Polymerized Human Hemoglobin (Pyridoxylated), PolyHeme(R)] When Used to Treat Patients in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Prehospital Setting|Unknown status|Active, not recruiting|Phase 3|||Northfield Laboratories|||||||||||||||||||2017-02-18 17:54:12.553558|2017-02-18 17:54:12.553558
NCT00076635|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-28|2007-11-02|||November 2003||2003-11-01|November 2007|2007-11-01|April 2007|Actual|2007-04-01|||||Interventional|||An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF|An Open-Label Study of the Safety of Subcutaneous Recombinant Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis|Terminated||Phase 3|91|Actual|InterMune||1||program discontinued based on GIPF-007 results|f||||f||||||||||2017-02-18 17:54:12.653953|2017-02-18 17:54:12.653953
NCT00076622|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-28|2013-04-25|||November 2003||2003-11-01|April 2013|2013-04-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Medication Treatment for Depression in Nursing Home Residents|Drug Treatment of Depression in the Nursing Home Aged|Completed||Phase 4|94|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 17:54:12.747759|2017-02-18 17:54:12.747759
NCT00076609|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-27|2007-03-27|||October 2003||2003-10-01|March 2007|2007-03-01||||||||Interventional|||Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma|A Phase I/II Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|31||PhytoCeutica|||||||||||||||||||2017-02-18 17:54:13.111556|2017-02-18 17:54:13.111556
NCT00076596|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-26|2017-01-24|||January 23, 2004||2004-01-23|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Brain Control of Movements in Cerebral Palsy|Brain Reorganization in Cerebral Palsy|Completed||N/A|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:13.210401|2017-02-18 17:54:13.210401
NCT00076583|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-26|2008-03-03|||January 2004||2004-01-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Spinal Reflexes in Motor Skill Learning|Motor Skill Learning: Spinal Reflexes|Completed||N/A|22||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:13.300297|2017-02-18 17:54:13.300297
NCT00076570|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-26|2013-08-12|2013-08-07||January 2004||2004-01-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional||Baseline analysis was performed using the patients who finished study.|Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation|Depletion Induction With Rabbit Anti-Thymocyte Globulin, Followed by Two Approaches Toward Monotherapy Immunosuppression in Kidney Transplant Recipients|Completed||Phase 2|31|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 17:54:13.386418|2017-02-18 17:54:13.386418
NCT00076557|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-26|2007-04-02|||January 2004||2004-01-01|January 2004|2004-01-01||||||||Interventional|||Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B|A Phase I Safety Study in Subjects With Severe Hemophilia B (Factor IX Deficiency) Using Adeno-Associated Viral Vector to Deliver the Gene for Human Factor IX Into the Liver|Terminated||Phase 1/Phase 2|15||Avigen|||||||||||||||||||2017-02-18 17:54:13.852038|2017-02-18 17:54:13.852038
NCT00076544|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-26|2015-12-10|||February 2004||2004-02-01|December 2015|2015-12-01||||March 2005|Actual|2005-03-01||Interventional|||Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain|An Open-Label, Long-Term, Multi-Center, Intrathecal Ziconotide (PRIALT) Effectiveness and Safety Trial (ZEST) in Patients With Chronic Severe Pain|Completed||Phase 3|300||Elan Pharmaceuticals|||||||||||||||||||2017-02-18 17:54:13.935712|2017-02-18 17:54:13.935712
NCT00075426|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-02-11|||November 2002||2002-11-01|February 2013|2013-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Pilot Phase II Protocol Of Arsenic Trioxide (Trisenox) In Subjects With Advanced Non-Small Cell Carcinoma Of The Lung|Completed||Phase 2|30|Anticipated|The University of Texas Medical Branch, Galveston|||||f||||||||||||||2017-02-18 17:54:14.079866|2017-02-18 17:54:14.079866
NCT00075413|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2015-09-30|||November 2002||2002-11-01|September 2015|2015-09-01||||July 2005|Actual|2005-07-01||Interventional|||Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer|A Pilot Phase II Protocol Of Arsenic Trioxide (TRISENOX) In Subjects With Advanced Carcinoma Of The Breast|Withdrawn||Phase 2|0|Actual|The University of Texas Medical Branch, Galveston||||Unable to identify qualified subjects willing to participate in this study|f||||||||||||||2017-02-18 17:54:14.171439|2017-02-18 17:54:14.171439
NCT00075400|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2015-05-06|2015-05-06||January 2004||2004-01-01|March 2014|2014-03-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional||Eligible and treated patients.|Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer|A Phase II Evaluation of Gleevec(TM) (NCI-Supplied Agent: STI571 [Imatinib Mesylate], NSC# 716051) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus|Completed||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:54:14.268376|2017-02-18 17:54:14.268376
NCT00075387|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-11-17|||March 2003||2003-03-01|November 2016|2016-11-01|April 2019|Anticipated|2019-04-01|April 2018|Anticipated|2018-04-01||Interventional|||Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors|Phase II Clinical Trial of Patients With High-Grade Glioma Treated With Intra-Arterial Carboplatin-Based Chemotherapy, Randomized to Treatment With or Without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant Against Severe Thrombocytopenia|Recruiting||Phase 2|60|Anticipated|OHSU Knight Cancer Institute||2|||f||||t||||||||||2017-02-18 17:54:14.656194|2017-02-18 17:54:14.656194
NCT00075374|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2014-01-15|||October 2003||2003-10-01|January 2014|2014-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Multicenter, Randomized Phase II Study of Two Schedules of Taxotere (Weekly Versus Every 3 Weeks) in Elderly or Poor Performance (ECOG PS 2), Chemotherapy-Naive Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|6|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:54:14.810236|2017-02-18 17:54:14.810236
NCT00075348|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2012-03-14|||December 2003||2003-12-01|March 2012|2012-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome|Genetic Mutation Analysis In A VHL Population|Completed||N/A|260|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:14.915324|2017-02-18 17:54:14.915324
NCT00075335|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-08|2012-12-08|||January 2004||2004-01-01|July 2012|2012-07-01|August 2012|Actual|2012-08-01|August 2012|Actual|2012-08-01||Interventional|||AMD3100 to Mobilize Stem Cells for Donation|Peripheral Blood Hematopoietic Progenitor Cell Mobilization With AMD 3100 in Healthy Volunteers Previously Mobilized With G-CSF|Completed||Phase 2|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:54:15.011529|2017-02-18 17:54:15.011529
NCT00075296|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-08|2017-01-24|||January 5, 2004||2004-01-05|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression|FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:15.121173|2017-02-18 17:54:15.121173
NCT00075283|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-08|2005-06-23|||November 2002||2002-11-01|January 2004|2004-01-01||||||||Interventional|||Walking Therapy In Hemiparetic Stroke Patients Using Robotic-Assisted Treadmill Training|Gait Restoration In Hemiparetic Stroke Patients Using Goal-Directed, Robotic-Assisted, Treadmill Training|Unknown status|Recruiting|Phase 1|50||U.S. Department of Education|||||f||||||||||||||2017-02-18 17:54:15.211397|2017-02-18 17:54:15.211397
NCT00075270|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-07|2015-04-16|2013-03-14||January 2004||2004-01-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|October 2006|Actual|2006-10-01||Interventional|||Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer|A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Phase III Study of Oral GW572016 in Combination With Paclitaxel in Subjects Previously Untreated or Advanced or Metastatic Breast Cancer|Completed||Phase 3|580|Actual|GlaxoSmithKline||2|||f||||f||||||||||2017-02-18 17:54:15.32793|2017-02-18 17:54:15.32793
NCT00075257|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-07|2009-08-18||||||August 2009|2009-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of DVS-233 SR For Prevention Of Depressive Relapse In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|603|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:54:17.659797|2017-02-18 17:54:17.659797
NCT00075244|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-06|2008-03-03|||January 2004||2004-01-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Alternative Dosing and Regimen of Replagal to Treat Fabry Disease|A Phase I-II Pharmacokinetic/Pharmacodynamic Study of Replagal to Assess the Effects of Alternative Dose and Regimen in Patients With Fabry Disease|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:17.995187|2017-02-18 17:54:17.995187
NCT00076531|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-26|2008-01-24|||December 2003||2003-12-01|January 2008|2008-01-01||||November 2004|Actual|2004-11-01||Interventional|||Clinical Trial for Prostate Cancer||Completed||Phase 3|||Oakwood Laboratories, LLC|||||||||||||||||||2017-02-18 17:54:18.082864|2017-02-18 17:54:18.082864
NCT00074711|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2016-07-05|2012-07-03||August 2004||2004-08-01|July 2016|2016-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Adding Phosphorus to Osteoporosis Drug Treatment|Bone Sparing by Calcium Salts With and Without Extra Phosphorus|Completed||Phase 2|241|Actual|Creighton University||2|||f||||f||||||||||2017-02-18 17:55:11.497749|2017-02-18 17:55:11.497749
NCT00076518|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-26|2012-05-17||||||May 2012|2012-05-01|September 2005|Actual|2005-09-01|||||Interventional|||The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)|A Phase II Trial of the Effect of Combination Therapy With Fish Oil Supplement and Fenofibrate on Triglyceride (TG) Levels in Subjects on Highly Active Antiretroviral Therapy (HAART) Who Are Not Responding to Either Fish Oil or Fenofibrate Alone|Completed||Phase 2|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:54:18.161145|2017-02-18 17:54:18.161145
NCT00076505|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-23|2017-01-24|||January 14, 2004||2004-01-14|November 30, 2006|2006-11-30|November 30, 2006||2006-11-30|||||Observational|||Cell Studies of Parkinson's Disease|Bioenergetic Function in Parkinson's Disease|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:18.270158|2017-02-18 17:54:18.270158
NCT00076492|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-23|2012-10-31|||January 2004||2004-01-01|October 2012|2012-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485|A Multi-center, Double-blind, Pilot Study of CoQ10 and GPI 1485 in Subjects With Early Untreated Parkinson's Disease|Completed||Phase 2|195||University of Rochester|||||f||||||||||||||2017-02-18 17:54:18.350703|2017-02-18 17:54:18.350703
NCT00076479|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-22|2008-03-03|||January 2004||2004-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Role of the Right Brain in Recovery of Language Function in Chronic Stroke||Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:18.45531|2017-02-18 17:54:18.45531
NCT00076466|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-22|2017-01-24|||January 22, 2004||2004-01-22|January 14, 2009|2009-01-14|January 14, 2009||2009-01-14|||||Observational|||Brain Changes Associated With Learning a Motor Task|Changes in Intracortical Inhibitory Processes Are Associated With the Development of Implicit Learning of a Motor Task|Completed||N/A|72||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:18.550546|2017-02-18 17:54:18.550546
NCT00076453|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-22|2011-09-26|||June 2003||2003-06-01|September 2011|2011-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||A Study of Orthotic Shoe Inserts for Controlling Osteoarthritic Knee Pain|Clinical Effects of Altered Biomechanics in Knee Osteoarthritis|Completed||N/A|100|Actual|Rush University Medical Center||2|||f||||f||||||||||2017-02-18 17:54:18.63044|2017-02-18 17:54:18.63044
NCT00076440|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-22|2009-12-10|||December 2003||2003-12-01|March 2007|2007-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study|Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study|Completed||Phase 2|90||National Institute on Aging (NIA)|||||||||||||||||||2017-02-18 17:54:18.733118|2017-02-18 17:54:18.733118
NCT00076427|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-21|2017-01-24|||January 14, 2004||2004-01-14|June 9, 2015|2015-06-09|June 9, 2015||2015-06-09|||||Observational|||Leukapheresis for Research on HCV-Coinfected Patients|Evaluation of Clinical, Virologic and Immunologic Factors That Contribute to the Pathogenesis of Chronic Hepatitis C and Its Complications|Completed||N/A|327|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:18.840423|2017-02-18 17:54:18.840423
NCT00076414|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-21|2008-03-03|||January 2004||2004-01-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||The Effect of Lopinavir/Ritonavir on Endothelial Function|The Effect of Lopinavir/Ritonavir on Endothelial Function in Normal Volunteers|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:18.941765|2017-02-18 17:54:18.941765
NCT00076401|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-21|2014-06-25||||||June 2014|2014-06-01||||||||Interventional|||A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)|Phase II Trial of Motexafin Gadolinium (MGd) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 2|27||Pharmacyclics LLC.|||||f||||||||||||||2017-02-18 17:54:19.023971|2017-02-18 17:54:19.023971
NCT00076388|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-21|2011-05-12|||February 2004||2004-02-01|May 2011|2011-05-01|October 2007|Actual|2007-10-01|March 2007|Actual|2007-03-01||Interventional|||Iressa Versus Docetaxel (Taxotere)|A Randomized, Open-Label, Parallel Group, International, Multicenter, Phase III Study of Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non-Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy|Completed||Phase 3|1440||AstraZeneca|||||||||||||||||||2017-02-18 17:54:19.124719|2017-02-18 17:54:19.124719
NCT00076375|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-21|2005-06-23|||November 2003||2003-11-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Two Concentrations of Nanocrystalline Silver Cream (NPI) Applied Twice Daily in Adults With Mild to Moderate Atopic Dermatitis|Completed||Phase 2|180||Nucryst Pharmaceuticals|||||||||||||||||||2017-02-18 17:54:19.386068|2017-02-18 17:54:19.386068
NCT00076362|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-21|2011-09-08|||March 2004||2004-03-01|September 2011|2011-09-01||||July 2005|Actual|2005-07-01||Interventional|||Pediatric Hypothalamic Obesity||Completed||Phase 4|60|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:54:19.628758|2017-02-18 17:54:19.628758
NCT00076349|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-20|2014-05-08|||April 2004||2004-04-01|May 2014|2014-05-01|March 2008|Actual|2008-03-01|December 2005|Actual|2005-12-01||Interventional|||SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)|A Multi-Center Phase II Study to Investigate the Safety and Activity of SDX-105 (Bendamustine) in Combination With Rituximab in Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|66|Actual|Teva Pharmaceutical Industries||1|||f||||||||||||||2017-02-18 17:54:19.731104|2017-02-18 17:54:19.731104
NCT00076336|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-20|2011-08-04|2011-01-03||December 2003||2003-12-01|August 2011|2011-08-01||||December 2009|Actual|2009-12-01||Interventional|||Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis|Randomized, Double-Blind Trial of Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis|Completed||Phase 3|232|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:54:19.863045|2017-02-18 17:54:19.863045
NCT00076323|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-20|2010-07-26|||December 2003||2003-12-01|July 2010|2010-07-01|November 2006|Actual|2006-11-01|||||Interventional|||A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency|A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency|Completed||N/A|14||Walter Reed Army Institute of Research (WRAIR)|||||f||||||||||||||2017-02-18 17:54:20.853831|2017-02-18 17:54:20.853831
NCT00074698|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-18|2007-12-10||||||December 2007|2007-12-01|May 2004||2004-05-01|||||Interventional|||Safety and Tolerability Study of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis|A Phase 1 Study of the Safety, Pharmacokinetics, and Biologic Activity of Escalating Doses of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis|Completed||Phase 1|27||FibroGen|||||f||||||||||||||2017-02-18 17:55:11.967845|2017-02-18 17:55:11.967845
NCT00076310|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-20|2016-10-24|||January 2004||2004-01-01|October 2016|2016-10-01|February 2017|Anticipated|2017-02-01|February 2007|Actual|2007-02-01||Interventional|||OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer|A Phase II Study of OSI-774 in Combination With Cisplatin and Docetaxel in Metastatic or Recurrent Head and Neck Squamous Cell Cancer|Active, not recruiting||Phase 2|50|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:54:20.945473|2017-02-18 17:54:20.945473
NCT00076284|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-16|2008-03-03|||January 2004||2004-01-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||GW873140 to Treat HIV-1 Infected Adults|A Phase II, Double-Blind RAndomized, Placebo-Controlled Study to Evaluate the Antiviral Activity, Safety, Tolerability, and Pharmacokinetics of GW873130 for 10 Days in HIV-1 Infected Adults|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:21.071469|2017-02-18 17:54:21.071469
NCT00076271|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-16|2017-01-24|||January 14, 2004||2004-01-14|October 28, 2008|2008-10-28|October 28, 2008||2008-10-28|||||Observational|||Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye Diseases|Evaluation and Treatment of Pediatric, Developmental and Genetic Eye Diseases|Completed||N/A|350||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:21.159715|2017-02-18 17:54:21.159715
NCT00076258|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-16|2016-10-14|2015-11-17||April 2003||2003-04-01|October 2016|2016-10-01|August 2007|Actual|2007-08-01|October 2006|Actual|2006-10-01||Interventional|TREAD||Adding Exercise to Antidepressant Medication Treatment for Depression|Treatment With Exercise Augmentation for Depression (TREAD)|Completed||N/A|126|Actual|University of Texas Southwestern Medical Center||2|||f||||t||||||||||2017-02-18 17:54:21.249417|2017-02-18 17:54:21.249417
NCT00076245|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-16|2014-06-24|2014-02-24||November 2002||2002-11-01|June 2014|2014-06-01|November 2005|Actual|2005-11-01|February 2004|Actual|2004-02-01||Interventional|||Cognitive Behavioral Therapy for the Treatment of Seasonal Affective Disorder (SAD)|Cognitive Behavioral Approaches to Seasonal Depression|Completed||Phase 1|61|Actual|Henry M. Jackson Foundation for the Advancement of Military Medicine||4|||f||||f||||||||||2017-02-18 17:54:21.786136|2017-02-18 17:54:21.786136
NCT00076232|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-15|2010-12-29|||April 2005||2005-04-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|June 2007|Actual|2007-06-01||Interventional|||A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes|A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir for the Reduction of HIV Acquisition Among High-Risk HSV-2 Seropositive, HIV Seronegative Individuals|Completed||Phase 3|3682|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:54:22.402038|2017-02-18 17:54:22.402038
NCT00076219|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-15|2013-08-16|2013-06-12||October 2003||2003-10-01|August 2013|2013-08-01|July 2008|Actual|2008-07-01|September 2007|Actual|2007-09-01||Interventional|ATN||Acute Renal Failure Trial Network (ATN) Study|CSP #530 - Intensive vs. Conventional Renal Support in Acute Renal Failure|Completed||Phase 3|1124|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 17:54:22.51627|2017-02-18 17:54:22.51627
NCT00076206|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-15|2015-12-07|||December 2003||2003-12-01|December 2015|2015-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy|A Double-Blind, Parallel, Placebo-Controlled, Randomized Study to Evaluate the Efficacy and Safety of 3 Different Oral Dose Levels (1, 2, And 4 Mg) of CCI-779 in Subjects With Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy|Terminated||Phase 2|||Wyeth is now a wholly owned subsidiary of Pfizer||4|||||||||||||||||2017-02-18 17:54:23.381847|2017-02-18 17:54:23.381847
NCT00076180|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-14|2017-01-24|||January 6, 2004||2004-01-06|September 23, 2016|2016-09-23|November 12, 2010|Actual|2010-11-12|November 12, 2010|Actual|2010-11-12||Interventional|||Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia|Phase I Open-Label Single-Dose Study of Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward the IL-2R/IL-15R-Beta Subunit (CD122) in T Cell Large Granular Lymphocytic Leukemia|Completed||Phase 1|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:54:23.464348|2017-02-18 17:54:23.464348
NCT00076154|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-14|2014-04-18|||January 2003||2003-01-01|April 2014|2014-04-01|September 2009|Actual|2009-09-01|September 2007|Actual|2007-09-01||Observational|ALS Registry||National Registry of Veterans With Amyotrophic Lateral Sclerosis and DNA Bank|CSP #500A - National Registry of Veterans With Amyotrophic Lateral Sclerosis|Completed||N/A|2121|Actual|VA Office of Research and Development|||1||f||||f||||||Samples With DNA|"~     DNA samples or blood or mouthwash were collected in veterans' homes by nurses.~   "|||2017-02-18 17:54:23.570163|2017-02-18 17:54:23.570163
NCT00076141|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-14|2017-02-02|||January 1, 2002|Actual|2002-01-01|February 2017|2017-02-01|January 2021|Anticipated|2021-01-01|January 1, 2014|Actual|2014-01-01||Observational|ACTIVE Health||Relatively Healthy Male Veterans Observed Over Time to See What Types of Diseases Develop|CSP #499A - Selenium and Vitamin E Cancer Prevention Trial - COHORT|Active, not recruiting||N/A|991|Actual|VA Office of Research and Development|||1||f||||f||||||Samples With DNA|"~     PE and buffy coat~   "|No||2017-02-18 17:54:23.673728|2017-02-18 17:54:23.673728
NCT00076115|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-14|2011-06-06|||December 2003||2003-12-01|April 2010|2010-04-01|December 2005|Actual|2005-12-01|||||Interventional|||Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents|Research on the Effectiveness of Risperidone in Bipolar Disorder in Adolescents and Children (REACH): A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Risperidone for the Treatment of Acute Mania in Bipolar I Disorder|Completed||Phase 3|13|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:54:23.764741|2017-02-18 17:54:23.764741
NCT00076102|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-13|2013-03-11|2012-01-04||January 2004||2004-01-01|March 2013|2013-03-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas|Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas|Completed||Phase 2|36|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 17:54:23.860712|2017-02-18 17:54:23.860712
NCT00076089|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-13|2016-12-01|||December 2003||2003-12-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)|Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. A 52-week, Multicenter, Double-blind Study With 500 mcg Roflumilast Once Daily Versus Placebo.|Completed||Phase 3|1100||AstraZeneca|||||f||||||||||||||2017-02-18 17:54:24.485763|2017-02-18 17:54:24.485763
NCT00005334|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1991||1991-07-01|June 2000|2000-06-01|June 1995|Actual|1995-06-01|||||Observational|||Effects of Personality and Context on Recovery From Coronary Artery Bypass||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.355187|2017-02-18 18:15:07.355187
NCT00076063|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-13|2015-03-12|||March 2004||2004-03-01|March 2015|2015-03-01|March 2007|Actual|2007-03-01|||||Interventional|||A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines|A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC Prime/LIPO-5 Boost in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1/Phase 2|174|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-02-18 17:54:24.745437|2017-02-18 17:54:24.745437
NCT00076050|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-13|2016-10-12|2013-06-26||September 2003||2003-09-01|October 2016|2016-10-01|June 2009|Actual|2009-06-01|March 2009|Actual|2009-03-01||Interventional|SPARE||Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms|Bone Sparing Effects of Soy Phytoestrogens in Menopause|Completed||Phase 3|248|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 17:54:24.877583|2017-02-18 17:54:24.877583
NCT00076037|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-13|2015-03-03|||April 2004||2004-04-01|March 2015|2015-03-01|June 2006|Actual|2006-06-01|||||Interventional|||Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a CTL Multi-Epitope Peptide HIV Vaccine Formulated With RC529-SE, With or Without GM-CSF, in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|96|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:54:25.313886|2017-02-18 17:54:25.313886
NCT00076024|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-12|2012-06-21|2012-02-25||February 2004||2004-02-01|June 2012|2012-06-01|November 2008|Actual|2008-11-01|January 2007|Actual|2007-01-01||Interventional|||AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer|Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study Of AG-013736 In Combination With Docetaxel Versus Docetaxel Alone In Patients With Metastatic Breast Cancer Preceded By A Phase 1 Evaluation Of The Combination|Completed||Phase 1/Phase 2|174|Actual|Pfizer|Analysis of TTP (Phase 2, Double-blind) was performed with both discontinuation due to lack of efficacy (LOE) considered a progression and not considered a progression event. Latter was considered primary analysis and former a sensitivity analysis.|2|||f||||t||||||||||2017-02-18 17:54:25.43591|2017-02-18 17:54:25.43591
NCT00076011|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-12|2012-06-20|2012-02-25||October 2003||2003-10-01|June 2012|2012-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma|Phase 2 Study of AG 013736 as Second-Line Treatment in Patients With Metastatic Renal Cell Cancer|Completed||Phase 2|52|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:54:27.096514|2017-02-18 17:54:27.096514
NCT00075998|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-12|2009-07-01|||December 2003||2003-12-01|July 2009|2009-07-01|May 2007|Actual|2007-05-01|||||Interventional|||The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)|A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (The INSPIRE Trial)|Terminated||Phase 3|826|Actual|InterMune||1||test drug showed lack of benefit at interim analysis|f||||t||||||||||2017-02-18 17:54:27.827129|2017-02-18 17:54:27.827129
NCT00075985|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-12|2009-01-20|||May 2000||2000-05-01|April 2007|2007-04-01|April 2006||2006-04-01|||||Observational|||Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist|CSP #716B - The 80+ Hemorrhagic Cohort Study|Completed||N/A|700||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:54:27.929932|2017-02-18 17:54:27.929932
NCT00075972|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-12|2015-06-25|||March 2003||2003-03-01|June 2015|2015-06-01|March 2006||2006-03-01|||||Interventional|||Mood and Smoking: A Comparison of Smoking Cessation Treatments|CSP #725 - Mood and Smoking: A Comparison of Smoking Cessation Treatments|Completed||N/A|128||VA Office of Research and Development|||||f||||||||||||||2017-02-18 17:54:28.02426|2017-02-18 17:54:28.02426
NCT00075959|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-12|2013-01-03|||August 2004||2004-08-01|January 2013|2013-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke|CHANT (Cerebral Hemorrhage And NXY Treatment) A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter, Phase IIb Study to Assess the Safety and Tolerability of Intravenous Infusion of NXY-059 in Adult Patients With Acute Intracerebral Hemorrhage (ICH)|Completed||Phase 2|600||AstraZeneca|||||||||||||||||||2017-02-18 17:54:28.104372|2017-02-18 17:54:28.104372
NCT00075946|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-12|2015-06-03|2015-02-09||November 2003||2003-11-01|June 2015|2015-06-01|September 2023|Anticipated|2023-09-01|September 2013|Actual|2013-09-01||Interventional||As the primary analysis only includes randomized patients, the baseline characteristics were provided among patients who were correctly randomized to one of the two arms for maintenance therapy.|Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma|Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens For Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma|Active, not recruiting||Phase 3|545|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-02-18 17:54:28.265055|2017-02-18 17:54:28.265055
NCT00075933|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-12|2009-04-27|||September 2003||2003-09-01|April 2009|2009-04-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ARQ 501 in Subjects With Cancer|A Phase I Clinical, Pharmacokinetic Study of ARQ 501 in Subjects With Advanced Solid Tumors|Completed||Phase 1|80||ArQule|||||f||||||||||||||2017-02-18 17:54:29.705573|2017-02-18 17:54:29.705573
NCT00075920|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-11|2017-01-24|||January 8, 2004||2004-01-08|October 17, 2007|2007-10-17|October 17, 2007||2007-10-17|||||Observational|||Technical Development of Strain Rate Echocardiography|Technical Development of Strain Rate Echocardiography|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:54:29.776331|2017-02-18 17:54:29.776331
NCT00075907|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-10-04|||July 2004||2004-07-01|October 2013|2013-10-01|September 2006|Actual|2006-09-01|||||Interventional|||Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents|A Comparative Trial of Protease-Containing and Protease-Sparing HAART Regimens in HIV-Infected Adolescents With an Evaluation of Therapeutic Drug Monitoring|Completed||Phase 3|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:54:29.856763|2017-02-18 17:54:29.856763
NCT00075894|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2009-01-10|||March 2004||2004-03-01|August 2006|2006-08-01||||||||Interventional|||Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas|A Phase I/II, Open-Label, Non-Randomized, Multicenter, Single Agent Study Of Intravenous SDX-102 For The Treatment Of Patients With MTAP-Deficient High Grade Recurrent Malignant Gliomas|Completed||Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:29.98221|2017-02-18 17:54:29.98221
NCT00075881|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2014-05-29|2012-03-08||January 2004||2004-01-01|March 2014|2014-03-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma|Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:54:30.083495|2017-02-18 17:54:30.083495
NCT00075868|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2015-11-14|||December 2003||2003-12-01|November 2015|2015-11-01||||August 2006|Actual|2006-08-01||Interventional|||Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer|A Randomized, Double Blind, Placebo-Controlled Phase III Study To Determine The Efficacy Of Sandostatin LAR® Depot (Octreotide Acetate) In Preventing Or Reducing The Severity Of Chemoradiation-Induced Diarrhea In Patients With Anal Or Rectal Cancer|Completed||Phase 3|233|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 17:54:30.560669|2017-02-18 17:54:30.560669
NCT00075855|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-07-12|||April 2004||2004-04-01|July 2016|2016-07-01|October 2007|Actual|2007-10-01|May 2007|Actual|2007-05-01||Interventional|||Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors|The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study|Completed||Phase 3|150|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:54:30.793467|2017-02-18 17:54:30.793467
NCT00075842|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-12-02|||August 2003||2003-08-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|March 2007|Actual|2007-03-01||Interventional|||(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy|"The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer A Phase III Randomized, Placebo-Controlled, Double-Blind Study"|Completed||Phase 3|227|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:54:30.921814|2017-02-18 17:54:30.921814
NCT00075829|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-08-03|2014-12-17||December 2003||2003-12-01|August 2016|2016-08-01|March 2013|Actual|2013-03-01|June 2012|Actual|2012-06-01||Interventional||Analysis is based on intention-to-treat data. Primary analysis of the clinical trial focused on patients meeting protocol criteria of standard risk multiple myeloma.|Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)|A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy vs Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients With Multiple Myeloma (BMT CTN #0102)|Completed||Phase 3|710|Actual|National Heart, Lung, and Blood Institute (NHLBI)||3|||f||||f||||||||Yes|Findings will be published in a manuscript|2017-02-18 17:54:31.066366|2017-02-18 17:54:31.066366
NCT00075816|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-08-01|2015-01-22||January 2004||2004-01-01|August 2016|2016-08-01|April 2014|Actual|2014-04-01|April 2013|Actual|2013-04-01||Interventional||All randomized patients were included in primary, intention-to-treat analysis.|Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)|A Phase III Randomized, Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell With Marrow Transplantation From Human Leukocyte Antigen (HLA) Compatible Unrelated Donors (BMT CTN #0201)|Completed||Phase 3|551|Actual|Medical College of Wisconsin||2|||f||||t||||||||Yes||2017-02-18 17:54:35.152707|2017-02-18 17:54:35.152707
NCT00075803|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-08-01|2013-02-22||November 2003||2003-11-01|August 2016|2016-08-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)|A Randomized Double-blind Trial of Fluconazole Versus Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Patients (BMT CTN #0101)|Completed||Phase 3|600|Actual|Medical College of Wisconsin||2|||f||||t||||||||Yes||2017-02-18 17:54:39.786482|2017-02-18 17:54:39.786482
NCT00075777|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2014-08-27|||February 2005||2005-02-01|August 2014|2014-08-01|February 2008|Actual|2008-02-01|July 2007|Actual|2007-07-01||Interventional|||Valproic Acid in Treating Patients With Kaposi's Sarcoma|A Pilot Trial Of Valproic Acid In Patients With Kaposi's Sarcoma|Completed||N/A|19|Actual|AIDS Malignancy Consortium||1|||f||||||||||||||2017-02-18 17:54:40.809486|2017-02-18 17:54:40.809486
NCT00075764|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2014-05-08|||April 2004||2004-04-01|May 2014|2014-05-01|October 2014|Anticipated|2014-10-01|December 2012|Actual|2012-12-01||Interventional|||S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer|Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 3|690|Anticipated|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 17:54:40.951476|2017-02-18 17:54:40.951476
NCT00075751|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-02-27|||January 2004||2004-01-01|February 2013|2013-02-01||||July 2007|Actual|2007-07-01||Interventional|||Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer|A Phase II Trial of Gemcitabine, Carboplatin and PS-341 (NSC-681239) in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|99|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:54:41.877111|2017-02-18 17:54:41.877111
NCT00075738|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2008-07-23|||October 2003||2003-10-01|July 2007|2007-07-01||||||||Interventional|||Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer|Phase II Study Of 5FU-Irinotecan-Cisplatin As First-Line Treatment In Patients With Metastatic Carcinoma Of The Esophagus|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:41.988881|2017-02-18 17:54:41.988881
NCT00075725|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-08-15|2015-07-10||December 2003||2003-12-01|July 2016|2016-07-01||||December 2010|Actual|2010-12-01||Interventional|||Dexamethasone Compared With Prednisone During Induction Therapy and MTX With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia|High Risk B-Precursor Acute Lymphoblastic Leukemia|Active, not recruiting||Phase 3|3154|Actual|Children's Oncology Group|The COG SDC reviewed the NLM notification related to ct.gov AE/SAE reporting. The information in ‘Additional Description’ is accurate with respect to data supplied to ct.gov.COG plans to submit data AE/SAE data consistent with the text in this field.|12|||f||||t||||||||||2017-02-18 17:54:42.369072|2017-02-18 17:54:42.369072
NCT00075712|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-08-09|||September 2003||2003-09-01|May 2007|2007-05-01||||||||Interventional|||Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer|A Randomized Feasibility Trial to Determine the Impact of Timing of Surgery and Chemotherapy in Newly Diagnosed Patients With Advanced Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Carcinoma|Completed||Phase 2/Phase 3|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:51.031685|2017-02-18 17:54:51.031685
NCT00075699|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-08-06|||September 2003||2003-09-01|June 2008|2008-06-01||||||||Interventional|||Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma|A Randomized Controlled Trial of Active Symptom Control With or Without Chemotherapy in the Treatment of Patients With Malignant Pleural Mesothelioma|Completed||Phase 3|840|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:51.29917|2017-02-18 17:54:51.29917
NCT00075686|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2015-11-16|||January 2004||2004-01-01|November 2015|2015-11-01|April 2009|Actual|2009-04-01|May 2007|Actual|2007-05-01||Interventional|||S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer|A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (IMC-C225) Versus Gemcitabine As First-Line Therapy Of Patients With Advanced Pancreas Cancer|Completed||Phase 3|766|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 17:54:51.422904|2017-02-18 17:54:51.422904
NCT00075673|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2011-07-21|||November 2003||2003-11-01|July 2011|2011-07-01|February 2005|Actual|2005-02-01|September 2004|Actual|2004-09-01||Interventional|||Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer|A Phase I Study of Weekly Administration of Oral Navelbine in Combination With the COX-2 Inhibitor Celebrex in Relapsed and/or Metastatic Breast Cancer|Terminated||Phase 1|6|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:54:52.616839|2017-02-18 17:54:52.616839
NCT00075660|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2010-11-07|||January 2004||2004-01-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma|A Phase II Study of Triapine (NSC 663249) in Previously Untreated Patients With Recurrent Renal Cell Carcinoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 17:54:52.71896|2017-02-18 17:54:52.71896
NCT00075647|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-01-16|||December 2003||2003-12-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|Phase II Trial of CCI-779 in Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:54:52.811951|2017-02-18 17:54:52.811951
NCT00075634|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-09-27|||December 2003||2003-12-01|September 2013|2013-09-01||||September 2007|Actual|2007-09-01||Interventional|||Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma|A Phase I Study of Decitabine (NSC# 127716, IND# 50733) in Combination With Doxorubicin and Cyclophosphamide in the Treatment of Relapsed or Refractory Solid Tumors|Completed||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:54:52.940267|2017-02-18 17:54:52.940267
NCT00075621|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-03-29|||August 2000||2000-08-01|March 2016|2016-03-01|May 2018|Anticipated|2018-05-01|June 2005|Actual|2005-06-01||Interventional|||Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis|A Phase II Trial of Tandem Transplantation in AL Amyloidosis|Active, not recruiting||Phase 2|62|Actual|Boston Medical Center||1|||f||||f||||||||||2017-02-18 17:54:53.068036|2017-02-18 17:54:53.068036
NCT00075608|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-12-02|2014-08-20||August 2001||2001-08-01|December 2016|2016-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis|Phase II Trial of Second Autologous Transplantation in AL Amyloidosis|Terminated||Phase 2|12|Actual|Boston Medical Center||1||poor accrual|f||||t||||||||No||2017-02-18 17:54:53.187218|2017-02-18 17:54:53.187218
NCT00075595|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2009-01-03|||June 2002||2002-06-01|August 2007|2007-08-01||||||||Interventional|||Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer|Phase II Study of 5FU/Folinic Acid and Irinotecan as Second or Third Line Treatment in Patients With Metastatic, Unresectable, Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:53.470056|2017-02-18 17:54:53.470056
NCT00075582|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-11-02|2013-12-16||September 2004||2004-09-01|October 2016|2016-10-01||||September 2012|Actual|2012-09-01||Interventional|||Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma|Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients With Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma|Active, not recruiting||Phase 3|390|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 17:54:53.717477|2017-02-18 17:54:53.717477
NCT00075569|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2010-01-27|||March 2004||2004-03-01|January 2006|2006-01-01||||||||Interventional|||SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia|SGN-00101 (HspE7) Immunotherapy Of CIN III|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:54:54.875695|2017-02-18 17:54:54.875695
NCT00075556|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2009-02-06|||January 2002||2002-01-01|May 2008|2008-05-01||||||||Interventional|||Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma|Phase II Study Of Radiotherapy And Capecitabine As Pre-Operative Treatment In Patients With Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:54.972618|2017-02-18 17:54:54.972618
NCT00075543|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2008-07-23|||July 2003||2003-07-01|July 2007|2007-07-01||||||||Interventional|||Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer|Phase I-II Study Of Docetaxel And Oxaliplatine In Patients With Stage III-IV Ovarian Epithelial Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:55.090334|2017-02-18 17:54:55.090334
NCT00075517|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2008-07-23|||September 2003||2003-09-01|July 2007|2007-07-01||||||||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Study Of Gemcitabine And Docetaxel In Patients With Inoperable Stage IIIB Or IIIB or IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:55.1907|2017-02-18 17:54:55.1907
NCT00075504|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2015-08-31|2015-05-19||November 2003||2003-11-01|May 2013|2013-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer|A Phase II Study of Triapine in Combination With Gemcitabine in Adenocarcinoma of the Biliary Ducts and Gall Bladder|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:54:55.306589|2017-02-18 17:54:55.306589
NCT00075491|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-01-23|||December 2003||2003-12-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme|A Phase II Evaluation With Correlative Studies Of Fenretinide (NSC 374551-4HPR) As A Single Agent In The Treatment Of Adult Patients With Recurrent Glioblastoma Multiforme|Terminated||Phase 2|42|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 17:54:55.762985|2017-02-18 17:54:55.762985
NCT00005333|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||January 1991||1991-01-01|August 2004|2004-08-01|August 2001|Actual|2001-08-01|||||Observational|||Epidemic Hypertension in Nigerian Workers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.425345|2017-02-18 18:15:07.425345
NCT00075478|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2016-02-02|2014-04-16||October 2003||2003-10-01|February 2016|2016-02-01||||February 2014|Actual|2014-02-01||Interventional||The randomization will be stratified on institution, disease risk (indolent vs. aggressive), and prior conventional HCT and will be balanced (blocked) over time.|Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer|A Multi-center Phase III Study Comparing Nonmyeloablative Conditioning With TBI Versus Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies|Active, not recruiting||Phase 3|87|Actual|Fred Hutchinson Cancer Research Center||2|||f||||t||||||||||2017-02-18 17:54:55.876605|2017-02-18 17:54:55.876605
NCT00075465|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2008-07-23|||April 2001||2001-04-01|July 2007|2007-07-01||||||||Interventional|||Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach|Phase II Study of Docetaxel and Epirubicine as First-Line Treatment in Patients With Advanced or Metastatic Adenocarcinoma of the Stomach|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:56.499998|2017-02-18 17:54:56.499998
NCT00075452|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2008-07-23|||November 2003||2003-11-01|May 2007|2007-05-01||||||||Interventional|||Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma|Phase III Randomized Study Of Gemcitabine Versus Gemcitabine-Oxaliplatine In Patients With Locally Advanced Or Metastatic Pancreatic Carcinoma|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:54:56.729613|2017-02-18 17:54:56.729613
NCT00075439|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-09|2013-06-03|||December 2003||2003-12-01|June 2013|2013-06-01||||May 2007|Actual|2007-05-01||Interventional|||Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors|A Phase II Trial of ZD1839 (Iressa®) in Metastatic Neuroendocrine Tumors|Completed||Phase 2|90|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:54:56.864221|2017-02-18 17:54:56.864221
NCT00075231|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-06|2006-09-28|||December 2003||2003-12-01|September 2006|2006-09-01||||||||Interventional|||A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects|A Randomized, Open-Label Study Exploring a Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects|Completed||Phase 2|150||Abbott|||||||||||||||||||2017-02-18 17:54:56.981205|2017-02-18 17:54:56.981205
NCT00075218|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-06|2009-08-31|2009-05-06||December 2003||2003-12-01|August 2009|2009-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Of SU011248 In The Treatment Of Patients With Imatinib Mesylate (Gleevec Tm, Glivec)-Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor|Completed||Phase 3|361|Actual|Pfizer|Duration of Tumor Response could not be reliably estimated at the time of analysis.|2|||f||||t||||||||||2017-02-18 17:54:57.109264|2017-02-18 17:54:57.109264
NCT00075205|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-05|2017-01-24|||December 31, 2003||2003-12-31|June 2, 2010|2010-06-02|March 15, 2007|Actual|2007-03-15|March 15, 2007|Actual|2007-03-15||Interventional|||Rimonabant to Reduce Alcohol Consumption|Clinical Trial of the Cannabinoid CB1 Receptor Antagonist, SR141716 (Rimonabant), to Reduce Voluntary Ethanol Drinking in Healthy, Non-Treatment Seeking Individuals Who Consume Between 20 and 50 Drinks Per Week|Completed||Phase 2|54|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:55:00.840815|2017-02-18 17:55:00.840815
NCT00075192|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-05|2012-06-05|||March 2004||2004-03-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|||||Interventional|||CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer|A Phase 1, Open Label, Non-Randomized, Dose Escalation Study to Evaluate the Safety of CP-675,206 in Combination With Neoadjuvant Androgen Ablation and a Phase 2, Open Label, Randomized Study to Evaluate the Efficacy of CP-675,206 in Combination With Neoadjuvant Androgen Ablation and Androgen Ablation Alone in Patients With High Risk Prostate Cancer|Completed||Phase 1/Phase 2|8|Actual|AstraZeneca|||||f||||||||||||||2017-02-18 17:55:00.93717|2017-02-18 17:55:00.93717
NCT00075179|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-05|2012-07-31|||January 2004||2004-01-01|July 2012|2012-07-01|March 2006|Actual|2006-03-01|May 2005|Actual|2005-05-01||Interventional|||Natrecor in Pulmonary Hypertension|Phase IV, Open Labeled Study to Test the Effectiveness of Nesiritide in Reversing Pulmonary Hypertension in Patients Who Will be Undergoing CardioThoracic Surgery|Terminated||Phase 4|7|Actual|M.D. Anderson Cancer Center||1||Low accrual.|f||||f||||||||||2017-02-18 17:55:01.044644|2017-02-18 17:55:01.044644
NCT00075166|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-02|2008-03-03|||December 2003||2003-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors|A Prospective, Randomized Trial Comparing Surgery Versus Radiosurgery for the Treatment of Metastatic Brain Tumors|Completed||Phase 4|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:01.154719|2017-02-18 17:55:01.154719
NCT00075153|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-02|2014-04-21|||September 2001||2001-09-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Quality of Life in Children With HIV Infection|Quality of Life in Children With HIV Infection|Completed||N/A|1993|Actual|Rutgers, The State University of New Jersey|||1||f||||f||||||||||2017-02-18 17:55:01.246899|2017-02-18 17:55:01.246899
NCT00075140|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-02|2009-01-15|||September 2001||2001-09-01|January 2009|2009-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||Family Health After Predictive Huntington Disease (HD) Testing|Family Health After Predictive Huntington Disease Testing|Completed||Phase 3|422|Actual|National Institute of Nursing Research (NINR)|||1||f||||f||||||||||2017-02-18 17:55:01.329825|2017-02-18 17:55:01.329825
NCT00075114|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-02|2015-01-14|||September 2000||2000-09-01|January 2015|2015-01-01|April 2006|Actual|2006-04-01|February 2002|Actual|2002-02-01||Interventional|||Prevent Inability To Control Urination|Promoting Self -Care to Prevent Urinary Incontinence|Completed||Phase 3|417|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 17:55:01.424752|2017-02-18 17:55:01.424752
NCT00075101|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-02|2008-08-14|||September 2000||2000-09-01|August 2008|2008-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Sleep, Fatigue, and Dexamethosone in Children With Leukemia|Sleep, Fatigue, and Dexamethosone in Childhood Cancer|Completed||Phase 3|134|Anticipated|National Institute of Nursing Research (NINR)||1|||f||||f||||||||||2017-02-18 17:55:01.531485|2017-02-18 17:55:01.531485
NCT00074685|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-18|2009-04-28|||September 1994||1994-09-01|April 2009|2009-04-01||||||||Observational|||National Registry for Ichthyosis and Related Disorders|Research Registry for Inherited Disorders of Keratinization|Unknown status|Active, not recruiting|N/A|610|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||f||||||Samples With DNA|"~     Histology, DNA from participating enrollees~   "|||2017-02-18 17:55:12.046544|2017-02-18 17:55:12.046544
NCT00075088|ClinicalTrials.gov processed this data on February 17, 2017|2004-01-02|2015-05-15|2013-06-08||September 2003||2003-09-01|May 2015|2015-05-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Tele-Electrocardiography in Emergency Cardiac Care|Tele-electrocardiography in Emergency Cardiac Care|Completed||Phase 3|794|Actual|University of California, San Francisco|Sample size was not powered to detect a statistically significant difference in survival between patients with and without a prehospital ECG|2|||f||||t||||||||||2017-02-18 17:55:01.862661|2017-02-18 17:55:01.862661
NCT00075075|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-31|2017-01-24|||December 23, 2003||2003-12-23|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Interventional|||Infliximab to Treat Non-Infectious Scleritis|Pilot Study of the Evaluation of Infliximab in the Treatment of Non-Infectious Scleritis|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:02.368605|2017-02-18 17:55:02.368605
NCT00075062|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-31|2008-08-20||||||May 2006|2006-05-01||||||||Observational|||A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials|Characteristics of Baseline Mucosal Indices of Injury and Inflammation in Men For Use in Rectal Microbicide Trials|Completed||N/A|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:55:02.459657|2017-02-18 17:55:02.459657
NCT00075049|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-31|2014-08-20|||December 2003||2003-12-01|August 2014|2014-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria|Dbl-Blind, Rand Phase 1/2a Human Challenge Study, to Eval Safety, Reactogenicity, Immunogenicity and Preliminary Efficacy After Sporozoite Challenge/Rechallenge of Vaccines Containing RTS,S|Completed||Phase 1/Phase 2|104||U.S. Army Medical Research and Materiel Command|||||f||||||||||||||2017-02-18 17:55:02.551835|2017-02-18 17:55:02.551835
NCT00075036|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-30|2017-01-24|||December 24, 2003||2003-12-24|August 1, 2016|2016-08-01||||||||Observational|||Patient-Provider Trust Among Individuals With End-Stage Kidney Disease|Exploring Patient-Provider Trust Among Individuals With End-Stage Renal Disease|Completed||N/A|68|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:02.643085|2017-02-18 17:55:02.643085
NCT00075023|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-30|2015-10-29|2015-10-29||December 2003||2003-12-01|October 2015|2015-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional||The sample size for the proof of concept study was calculated by using the data for aphthous ulcer percentage healing (personal communication with investigator) with topical thalidomide gel at 0 mg and 20 mg. This gave a total sample size of 60 using an alpha level = .05, beta = -.20 and a 2-tailed test. Assuming drop out rate of 10%, total is 66.|Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis|Evaluation of Efficacy and Mechanisms of Topical Thalidomide for Chronic Graft-Versus-Host-Disease Related Stomatitis|Terminated||Phase 2|10|Actual|National Institutes of Health Clinical Center (CC)|Small sample size due to difficult enrollment|2||unable to enroll adequate subjects|f||||t||||||||||2017-02-18 17:55:02.739993|2017-02-18 17:55:02.739993
NCT00075010|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-29|2012-06-08|||January 2004||2004-01-01|June 2012|2012-06-01|November 2006|Actual|2006-11-01|March 2005|Actual|2005-03-01||Interventional|||Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes|Phase I/II Study of 5-aza-2'-Deoxycytidine and Valproic Acid in Patients With Relapsed/Refractory Leukemia or Myelodysplastic Syndromes|Completed||Phase 1/Phase 2|54|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 17:55:03.094577|2017-02-18 17:55:03.094577
NCT00074997|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-28|2016-06-17||2013-03-15|December 2002||2002-12-01|June 2016|2016-06-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection|A Randomized Phase II, Double-Blind, Controlled Trial to Evaluate the Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced With Placebo or an Anti-HIV-1 Ribozyme (OZ1) in Patients With HIV-1 Infection|Completed||Phase 2|1|Actual|Janssen-Cilag Pty Ltd||2|||f||||t||||||||||2017-02-18 17:55:03.215677|2017-02-18 17:55:03.215677
NCT00074984|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-24|2013-12-02|2010-07-21||February 2001||2001-02-01|December 2013|2013-12-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease|Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Fabrazyme on Progression of Renal Disease and Significant Clinical Events in Patients With Fabry Disease|Completed||Phase 4|82|Actual|Sanofi||2|||f||||t||||||||||2017-02-18 17:55:03.351035|2017-02-18 17:55:03.351035
NCT00074971|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-24|2013-12-02|||October 1999||1999-10-01|December 2013|2013-12-01|December 2004||2004-12-01|||||Interventional|||A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease|A Multi-center, Open-Label Extension Study of the Safety and Efficacy of Recombinant Human a-Galactosidase A (r-haGAL) Replacement in Patients With Fabry Disease|Completed||Phase 3|58||Sanofi|||||||||||||||||||2017-02-18 17:55:08.161881|2017-02-18 17:55:08.161881
NCT00074958|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-24|2015-03-13|2009-03-03||October 2002||2002-10-01|March 2015|2015-03-01|July 2005|Actual|2005-07-01|May 2005|Actual|2005-05-01||Interventional|||A Study of Fabrazyme in Pediatric Patients With Fabry Disease|A Multi-center, Phase 2, Open-Label Study of Fabrazyme (Recombinant Human a-Galactosidase A) Replacement Therapy in Pediatric Patients With Fabry Disease|Completed||Phase 2|16|Actual|Sanofi|The trial was not powered to demonstrate clinical benefit.|1|||f||||||||||||||2017-02-18 17:55:08.300614|2017-02-18 17:55:08.300614
NCT00074945|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-23|2017-01-24|||December 19, 2003||2003-12-19|February 28, 2013|2013-02-28|February 28, 2013||2013-02-28|||||Observational|||Obesity and Fatty Acid Flux Comparison Trials|A Comparison of Free Fatty Acid Flux in African Americans and Caucasians|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:08.629896|2017-02-18 17:55:08.629896
NCT00074932|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-23|2014-02-04|||November 2004||2004-11-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease|Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease|Completed||N/A|9|Actual|Sanofi||1|||t||||||||||||||2017-02-18 17:55:08.712389|2017-02-18 17:55:08.712389
NCT00074919|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-23|2014-02-04|||December 2003||2003-12-01|February 2014|2014-02-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Expanded Access|||Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease|Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease|Approved for marketing||N/A|||Sanofi|||||||||||||||||||2017-02-18 17:55:08.810565|2017-02-18 17:55:08.810565
NCT00074906|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-23|2012-05-04|||November 2003||2003-11-01|January 2012|2012-01-01|June 2008|Actual|2008-06-01|March 2008|Actual|2008-03-01||Interventional|||Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)|Venticute in Patients With Pneumonia or Aspiration of Gastric Contents Leading to Intubation, Ventilation, and Severe Oxygenation Impairment: A Randomized, Multinational, Multicenter, Parallel Group, Double Blind, Control Group Study|Completed||Phase 3|1200|Anticipated|Takeda||1|||f||||t||||||||||2017-02-18 17:55:08.890784|2017-02-18 17:55:08.890784
NCT00074893|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-23|2006-03-06|||November 2003||2003-11-01|March 2006|2006-03-01|February 2004||2004-02-01|||||Interventional|||Protective Brace to Prevent Hand and Arm Injuries|Shock Absorbing Brace for Study of Upper Extremity Musculoskeletal Disorders|Completed||N/A|15||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 17:55:09.32776|2017-02-18 17:55:09.32776
NCT00074880|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-22|2008-03-03|||December 2003||2003-12-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||The Role of Heart Stiff and Weak Atrium on Exercise Capacity in Patients With Hypertrophic Cardiomyopathy|The Role of Atrio-Ventricular Coupling in Exercise Tolerance in Non-Obstructive Hypertrophic Cardiomyopathy|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:09.412085|2017-02-18 17:55:09.412085
NCT00074867|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-22|2006-11-06|||October 2003||2003-10-01|July 2006|2006-07-01|September 2004||2004-09-01|||||Interventional|||Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer|A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Recurrent Or Persistent Small-Volume Epithelial Ovarian Cancer, Primary Peritoneal Serous Cancer, Or Fallopian Tube Cancer|Completed||Phase 2|29||Pfizer|||||f||||||||||||||2017-02-18 17:55:09.489896|2017-02-18 17:55:09.489896
NCT00074854|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-22|2006-11-08|||May 2002||2002-05-01|July 2006|2006-07-01|March 2005||2005-03-01|||||Interventional|||A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy|A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy (Paclitaxel And Carboplatin) Vs. Chemotherapy Alone For The Treatment Of Advanced Stage Non-Small Cell Lung Cancer.|Completed||Phase 1/Phase 2|87||Pfizer|||||f||||||||||||||2017-02-18 17:55:09.584971|2017-02-18 17:55:09.584971
NCT00074841|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-22|2011-05-09|||September 2003||2003-09-01|May 2011|2011-05-01|January 2005|Actual|2005-01-01|||||Interventional|||Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India|A Phase II/III, Randomized, Comparative Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in India|Completed||Phase 2/Phase 3|230|Actual|Pfizer|||||||||||||||||||2017-02-18 17:55:09.830768|2017-02-18 17:55:09.830768
NCT00074828|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2008-03-27|||December 2003||2003-12-01|March 2008|2008-03-01|May 2005|Actual|2005-05-01|||||Interventional|||New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery|A Comparison of the Oral Anticoagulant LY517717 Difumarate to Subcutaneous Enoxaparin for the Prevention of Venous Thromboembolic Events (VTE) Post-Total Hip Replacement (THR) and Post-Total Knee Replacement (TKR) Surgery|Completed||Phase 2|511|Actual|Eli Lilly and Company||2|||||||||||||||||2017-02-18 17:55:09.924246|2017-02-18 17:55:09.924246
NCT00074815|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2014-07-23|2012-11-15||September 2003||2003-09-01|November 2012|2012-11-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Treatment of Obsessive Compulsive Disorder in Children|Treatment of Pediatric OCD for SRI Partial Responders|Completed||Phase 3|124|Actual|Duke University||3|||f||||t||||||||||2017-02-18 17:55:10.030585|2017-02-18 17:55:10.030585
NCT00074802|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2016-03-08|||December 2003||2003-12-01|September 2008|2008-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder|CBT Augmentation of Paroxetine for Social Anxiety|Completed||Phase 3|153|Actual|Temple University||2|||f||||t||||||||||2017-02-18 17:55:10.519294|2017-02-18 17:55:10.519294
NCT00074789|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2013-06-20|||June 2003||2003-06-01|June 2013|2013-06-01|January 2009|Actual|2009-01-01|September 2008|Actual|2008-09-01||Interventional|||Reducing Symptoms of Depression in Low-Income Mothers|Reducing Depressive Symptoms in Low-Income Mothers|Completed||Phase 2|226|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 17:55:10.632451|2017-02-18 17:55:10.632451
NCT00074776|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2012-07-19|||May 2003||2003-05-01|July 2012|2012-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Acute Treatment of Bipolar II Depression|Acute Treatment of Bipolar II Depression|Completed||Phase 3|102|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 17:55:10.73808|2017-02-18 17:55:10.73808
NCT00074763|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2012-08-01|||July 2003||2003-07-01|August 2012|2012-08-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets|Randomized Crossover Study Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets|Terminated||Phase 3|4|Actual|M.D. Anderson Cancer Center||1||Terminated due to low recruitment.|f||||f||||||||||2017-02-18 17:55:10.852748|2017-02-18 17:55:10.852748
NCT00074750|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2012-02-20|||December 2003||2003-12-01|February 2012|2012-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)|A Phase I Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)|Terminated||Phase 1|7|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-02-18 17:55:10.960647|2017-02-18 17:55:10.960647
NCT00074737|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2014-09-16|||April 2004||2004-04-01|September 2014|2014-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML|Open Label, Phase II Dosing Study of Ara-C Chemotherapy in Combination With EL625 and Idarubicin in Refractory and Relapsed Acute Myelogenous Leukemia (AML)|Completed||Phase 2|53|Actual|Eleos, Inc.||3|||f||||f||||||||||2017-02-18 17:55:11.251508|2017-02-18 17:55:11.251508
NCT00074724|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-19|2013-04-16|||May 2003||2003-05-01|April 2013|2013-04-01|April 2016|Anticipated|2016-04-01|December 2008|Actual|2008-12-01||Interventional|DECIPHER||Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization|Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization|Unknown status|Active, not recruiting|N/A|319|Actual|Medstar Health Research Institute||2|||f||||t||||||||||2017-02-18 17:55:11.38514|2017-02-18 17:55:11.38514
NCT00005332|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2008-01-25|||September 1991||1991-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Antihypertensive Drug/Gene Interactions and CV Events||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.500135|2017-02-18 18:15:07.500135
NCT00074646|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-17|2007-01-02|||December 2003||2003-12-01|January 2007|2007-01-01|June 2005||2005-06-01|||||Interventional|||Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas|Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas|Completed||Phase 1|36||Celgene|||||||||||||||||||2017-02-18 17:55:12.219781|2017-02-18 17:55:12.219781
NCT00074633|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-17|2010-01-12|||January 2000||2000-01-01|January 2010|2010-01-01||||||||Interventional|||"Evaluating Health at Every Size(HAES) as an Alternative Obesity Treatment Model"|"Evaluating Health at Every Size(HAES) as an Alternative Obesity Treatment Model"|Completed||N/A|79||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:55:12.291933|2017-02-18 17:55:12.291933
NCT00074620|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-17|2007-10-04|||November 2003||2003-11-01|October 2007|2007-10-01|January 2006||2006-01-01|||||Interventional|||A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis|A Randomised, Multicenter, Open-Label, Parallel Group Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Unfractionated Heparin as Anticoagulant Treatment in Patients Undergoing Haemodialysis Via an Arteriovenous Graft|Completed||Phase 2|260||Speedel Pharma Ltd.|||||||||f||||||||||2017-02-18 17:55:12.365246|2017-02-18 17:55:12.365246
NCT00074607|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-16|2012-11-09|||December 2001||2001-12-01|November 2012|2012-11-01|April 2007|Actual|2007-04-01|July 2005|Actual|2005-07-01||Interventional|||Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine|Intrathecal Gemcitabine Therapy for Neoplastic Meningitis: A Phase I and Pharmacokinetic Study|Terminated||Phase 1|10|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:55:12.453988|2017-02-18 17:55:12.453988
NCT00074581|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-16|2016-11-03|2016-09-09||February 2005||2005-02-01|November 2016|2016-11-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Interventional|||Preventing Sexual Transmission of HIV With Anti-HIV Drugs|A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care Versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples|Completed||Phase 3|3526|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:55:12.584212|2017-02-18 17:55:12.584212
NCT00074568|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-16|2016-01-04|||September 2000||2000-09-01|January 2016|2016-01-01||||January 2022|Anticipated|2022-01-01||Observational|Registry||Scleroderma Registry|Scleroderma Family Registry and DNA Repository|Recruiting||N/A|5000|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||2||f||||f||||||Samples With DNA|"~     Serum, Plasma, DNA~   "|||2017-02-18 17:55:14.201566|2017-02-18 17:55:14.201566
NCT00074555|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-16|2016-01-05|||January 2001||2001-01-01|January 2016|2016-01-01|March 2012|Actual|2012-03-01|December 2011|Actual|2011-12-01||Observational|CLEAR||Registry for African Americans With Early Rheumatoid Arthritis|Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)|Completed||N/A|357|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||f||||||Samples With DNA|"~     serum, DNA~   "|||2017-02-18 17:55:14.330419|2017-02-18 17:55:14.330419
NCT00074542|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-15|2007-02-20|||September 2002||2002-09-01|October 2005|2005-10-01|January 2005||2005-01-01|||||Interventional|||An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease|A Phase III Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Multi-Centre Study to Assess the Efficacy and Safety of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease|Completed||Phase 3|364||Tillotts Pharma AG|||||||||||||||||||2017-02-18 17:55:14.431572|2017-02-18 17:55:14.431572
NCT00074529|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-15|2015-07-23|||October 2003||2003-10-01|July 2015|2015-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in Slowing the Progression of Alzheimer's Disease|Completed||Phase 2|512|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:55:14.552406|2017-02-18 17:55:14.552406
NCT00074516|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-12|2017-01-24|||December 10, 2003||2003-12-10|June 11, 2014|2014-06-11|June 11, 2014||2014-06-11|||||Observational|||Kidney Transplantation in Patients With Cystinosis|Renal Transplantation in Recipients With Nephropathic Cystinosis|Completed||N/A|11|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:14.640539|2017-02-18 17:55:14.640539
NCT00074503|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-12|2017-01-24|||December 12, 2003||2003-12-12|July 13, 2010|2010-07-13|July 13, 2010||2010-07-13|||||Observational|||PET Imaging of DHA Metabolism|Positron Emission Tomography Imaging of Incorporation of Docosahexaenoic Acid (DHA) From Plasma Into Human Brain|Completed||N/A|85|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:14.729117|2017-02-18 17:55:14.729117
NCT00074490|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-02-09|||December 11, 2003||2003-12-11|February 3, 2017|2017-02-03|December 31, 2022|Anticipated|2022-12-31|December 31, 2021|Anticipated|2021-12-31||Interventional|||Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers|Allogeneic HSCT Without Preparative Chemotherapy or With Low-Intensity Preparative Chemotherapy Using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome|Active, not recruiting||Phase 2|377|Actual|National Institutes of Health Clinical Center (CC)||6|||f||||||||||||||2017-02-18 17:55:14.806487|2017-02-18 17:55:14.806487
NCT00074477|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-12|2011-05-20|||October 2003||2003-10-01|April 2010|2010-04-01|July 2004|Actual|2004-07-01|||||Interventional|||Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 50 and 100 Mg-eq of Paliperidone Palmitate in Patients With Schizophrenia|Completed||Phase 2|250|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:55:14.957727|2017-02-18 17:55:14.957727
NCT00074464|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-12|2013-05-03|||August 2003||2003-08-01|May 2013|2013-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Cholesterol Homeostasis in Framingham Offspring Study||Completed||N/A|3378|Actual|Tufts University|||1||f||||f||||||||||2017-02-18 17:55:15.053987|2017-02-18 17:55:15.053987
NCT00074451|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-12|2008-08-20|||September 2003||2003-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Genomewide Search for Loci Underlying Metabolic Syndrome||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:55:15.145838|2017-02-18 17:55:15.145838
NCT00073177|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-17|2016-10-24|||November 2003||2003-11-01|September 2016|2016-09-01||||||||Interventional|||Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)|A 24 Week, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Roflumilast (250 mcg or 500 mcg) Daily in Patients With Asthma|Completed||Phase 3|819||AstraZeneca|||||f||||||||||||||2017-02-18 17:55:37.436751|2017-02-18 17:55:37.436751
NCT00074438|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-12|2013-05-07|||June 2003||2003-06-01|May 2013|2013-05-01|July 2011|Actual|2011-07-01|September 2004|Actual|2004-09-01||Interventional|||Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis|Randomized, Multifactorial, Double-blind, Parallel-group, Dose-ranging Study of the Efficacy and Safety of Rituximab (MabThera®/Rituxan®) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis|Completed||Phase 2|465|Actual|Genentech, Inc.||9|||f||||||||||||||2017-02-18 17:55:15.223286|2017-02-18 17:55:15.223286
NCT00074425|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-11|2013-07-05||2009-08-24|January 2005||2005-01-01|July 2013|2013-07-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women|Phase II/IIb Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and 0.5% PRO 2000/5 Gel (P) for the Prevention of HIV Infection in Women|Completed||Phase 2|3101|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 17:55:15.335769|2017-02-18 17:55:15.335769
NCT00074412|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-11|2013-07-05|2013-05-30||January 2007||2007-01-01|July 2013|2013-07-01|November 2011|Actual|2011-11-01|September 2011|Actual|2011-09-01||Interventional|||Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding|A Phase III Trial to Determine the Efficacy and Safety of an Extended Regimen of Nevirapine in Infants Born to HIV-Infected Women to Prevent Vertical HIV Transmission During Breastfeeding|Completed||Phase 3|2026|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|The rate of maternal highly active antiretroviral therapy use was higher than expected in our study. Thus there were fewer infant infections which decreased the power to detect differences in HIV transmission risks between study groups.|2|||f||||||||||||||2017-02-18 17:55:15.467287|2017-02-18 17:55:15.467287
NCT00074399|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-11|2009-08-06|||February 2001||2001-02-01|August 2009|2009-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV|Nevirapine (NVP) Use to Prevent Maternal-Infant HIV Transmission: A Randomized Clinical Trial of Two Doses of NVP Compared to Six Weeks of NVP for the Prevention of Maternal-Infant HIV Transmission in the Breastfeeding Infant|Completed||Phase 3|775|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 17:55:16.715918|2017-02-18 17:55:16.715918
NCT00074386|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-11|2014-01-16|||October 2003||2003-10-01|January 2014|2014-01-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|||Kidney and Liver Transplantation in People With HIV|Solid Organ Transplantation in HIV: Multi-Site Study|Completed||N/A|275|Actual|University of California, San Francisco|||1||f||||t||||||Samples Without DNA|"~     Whole Blood, serum, PBMC, kidney and liver biopsy slides, saliva, spleen tissue~   "|||2017-02-18 17:55:16.840106|2017-02-18 17:55:16.840106
NCT00074373|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-11|2016-10-17|||September 1994||1994-09-01|October 2016|2016-10-01|January 2020|Anticipated|2020-01-01|January 2020|Anticipated|2020-01-01||Observational|||The Research Registry for Neonatal Lupus|The Research Registry for Neonatal Lupus|Recruiting||N/A|500|Anticipated|New York University School of Medicine|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 17:55:16.980138|2017-02-18 17:55:16.980138
NCT00074360|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2017-01-24|||December 9, 2003||2003-12-09|December 17, 2012|2012-12-17|December 17, 2012||2012-12-17|||||Observational|||The Effect of Ethanol on Brain Activity|The Effect of Ethanol on Cerebral Blood Flow as Measured by Functional Magnetic Resonance Imaging and the Development of Conditioned Response to Ethanol Administration|Completed||N/A|107|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:17.148515|2017-02-18 17:55:17.148515
NCT00074334|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2009-10-20|||May 2004||2004-05-01|October 2009|2009-10-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma|A Phase I/II Study Of A Recombinant Chimeric Protein Composed Of Transforming Growth Factor (TGF)-a And A Mutated Pseudomonas Exotoxin Termed PE38 (TP-38) In Pediatric Patients With Recurrent Or Progressive Supratentorial High Grade Gliomas|Terminated||Phase 1/Phase 2|3|Actual|Pediatric Brain Tumor Consortium||||Drug company withdrawal of support for investigational agent in this indication.|f||||t||||||||||2017-02-18 17:55:17.237903|2017-02-18 17:55:17.237903
NCT00074321|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2013-06-05|||November 2003||2003-11-01|June 2013|2013-06-01||||July 2010|Actual|2010-07-01||Interventional|||Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors|A Phase I And Pharmacogenetic Study Of CPT-11, Oxaliplatin, And Capecitabine In Patients With Solid Tumors|Completed||Phase 1|84|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:17.596336|2017-02-18 17:55:17.596336
NCT00074308|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2016-10-25|||October 2003||2003-10-01|October 2016|2016-10-01||||July 2009|Actual|2009-07-01||Interventional|||Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers|A Phase I/II Study Of Imatinib Mesylate And Bevacizumab In Patients With Advanced Melanoma And Other Advanced Cancers|Completed||Phase 1/Phase 2|64|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:17.719251|2017-02-18 17:55:17.719251
NCT00074295|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-07-20|||March 2004||2004-03-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer|Phase II Trial of CG8123, an Autologous Cancer Vaccine (GVAX), in Patients With Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)|Terminated||Phase 2|19|Actual|Southwest Oncology Group||1||closed due to lack of availability of vaccine|f||||t||||||||||2017-02-18 17:55:17.850729|2017-02-18 17:55:17.850729
NCT00074282|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-11-09|||December 2004||2004-12-01|November 2012|2012-11-01||||October 2014|Anticipated|2014-10-01||Interventional|||Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia|Phase II Trial of Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Lenalidomide for Previously Treated Relapsed or Refractory Patients With Chronic Lymphocytic Leukemia|Unknown status|Recruiting|Phase 2|110|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:17.981703|2017-02-18 17:55:17.981703
NCT00074269|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2014-12-02|2014-05-29||July 2003||2003-07-01|November 2014|2014-11-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional||This is a pilot study. The original planned target accrual was 15 male or female patients age 18-60 but due to poor enrollment the study was closed to accrual early after 5 patients had been enrolled.|Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Metastatic Breast Cancer|Pilot Study Of Allogeneic Peripheral Blood Progenitor Cell Transplantation In Patients With Chemotherapy-Refractory Or Poor-Prognosis Metastatic Breast Cancer|Terminated||Phase 2|5|Actual|University of California, San Diego|Terminated early due to small numbers of subjects enrolled on study|1||Terminated early due to poor enrollment|f||||t||||||||||2017-02-18 17:55:18.456325|2017-02-18 17:55:18.456325
NCT00074230|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2015-05-11|||July 2003||2003-07-01|May 2015|2015-05-01|March 2014|Actual|2014-03-01|March 2014|Actual|2014-03-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma|Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With RNAs Encoding for Mage-3, MelanA, and Survivin Antigens|Completed||Phase 1/Phase 2|82|Actual|University Hospital Erlangen||1|||f||||||||||||||2017-02-18 17:55:18.802953|2017-02-18 17:55:18.802953
NCT00074204|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2010-08-13|||October 2003||2003-10-01|August 2010|2010-08-01|April 2008|Actual|2008-04-01|August 2005|Actual|2005-08-01||Interventional|||Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase III Study of Delayed vs. Immediate Second-Line Therapy With Docetaxel After Gemcitabine + Carboplatin in Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|17|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:55:19.099653|2017-02-18 17:55:19.099653
NCT00074191|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-05-24|||January 2000||2000-01-01|February 2011|2011-02-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|Protocol-A||Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma|Combination Chemotherapy (Methotrexate, Procarbazine And CCNU), Intraventricular Cytarabine And Methotrexate, +/- Intra-Ocular Chemotherapy For Patients With Primary Central Nervous System Lymphoma|Completed||Phase 2|1|Actual|OHSU Knight Cancer Institute|||||f||||t||||||||||2017-02-18 17:55:19.222163|2017-02-18 17:55:19.222163
NCT00074178|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-05-24|||January 2000||2000-01-01|June 2010|2010-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|Protocol-B||Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma|Combination Chemotherapy (Methotrexate, Cyclophosphamide, And Etoposide Phosphate) Delivered In Conjunction With Osmotic Blood-Brain Barrier Disruption (BBBD), With Intraventricular Cytarabine +/- Intra-Ocular Chemotherapy, In Patients With Primary Central Nervous System Lymphoma|Completed||Phase 2|22|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 17:55:19.331087|2017-02-18 17:55:19.331087
NCT00074165|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2011-11-21|2011-10-10||January 2003||2003-01-01|November 2011|2011-11-01|December 2010|Actual|2010-12-01|June 2010|Actual|2010-06-01||Interventional|||Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen|A Phase II Trial Involving Patients With Recurrent PCNSL Treated With Carboplatin/BBBD, by Adding Rituxan (Rituximab), An Anti CD-20 Antibody, To The Treatment Regimen|Terminated||Phase 2|17|Actual|OHSU Knight Cancer Institute||1||Lack of accrual|f||||t||||||||||2017-02-18 17:55:19.448316|2017-02-18 17:55:19.448316
NCT00074152|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2016-07-29|2015-04-07||July 2002||2002-07-01|July 2016|2016-07-01|December 2016|Anticipated|2016-12-01|February 2014|Actual|2014-02-01||Interventional|CALOR||Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer|A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer|Active, not recruiting||Phase 3|162|Actual|International Breast Cancer Study Group|Small sample size|2|||f||||t||||||||||2017-02-18 17:55:19.756088|2017-02-18 17:55:19.756088
NCT00074139|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2014-03-04|||September 2003||2003-09-01|March 2014|2014-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer|A Pharmacokinetic Interaction Study Of Docetaxel (Taxotere) 75 mg/mIV On The Combination Therapy Doxorubicin (50 mg/m) And Cyclophosphamide (50 mg/m) In The Treatment Of Advanced Breast Cancer|Withdrawn||Phase 1|0|Actual|Case Comprehensive Cancer Center||||No patients were enrolled|f||||t||||||||||2017-02-18 17:55:21.062216|2017-02-18 17:55:21.062216
NCT00074100|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2013-05-29|||August 2003||2003-08-01|August 2004|2004-08-01|September 2004|Actual|2004-09-01|||||Interventional|||Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy|Amonafide: Individual Phenotype-Adjusted Chemotherapy for Women With Metastatic Breast Cancer Who Have Progressed Despite Prior Chemotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:21.172949|2017-02-18 17:55:21.172949
NCT00074087|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2015-07-16|||October 2003||2003-10-01|July 2015|2015-07-01|September 2010|Actual|2010-09-01|July 2009|Actual|2009-07-01||Interventional|||Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides|Phase II Clinical Trial With Caelyx Mono-Chemotherapy in Patients With Advanced Mycosis Fungoides Stage IIb, IVa and IVb With or Without Previous Chemotherapy|Completed||Phase 2|49|Actual|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||||||||||||2017-02-18 17:55:21.263229|2017-02-18 17:55:21.263229
NCT00074074|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-07-13|||October 2003||2003-10-01|July 2012|2012-07-01||||December 2006|Actual|2006-12-01||Interventional|||Infliximab in Treating Patients With Myelodysplastic Syndrome|Randomized Phase II Trial With Infliximab (Remicade) in Patients With Myelodysplastic Syndrome and a Relatively Low Risk of Developing Acute Leukemia|Completed||Phase 2|46|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:55:21.382997|2017-02-18 17:55:21.382997
NCT00074048|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2010-06-17|||October 2003||2003-10-01|June 2010|2010-06-01|July 2008|Actual|2008-07-01|April 2007|Actual|2007-04-01||Interventional|||BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia|Phase II Trial Of BL22 Immunotoxin In Hairy Cell Leukemia|Completed||Phase 2|36|Actual|MedImmune LLC||1|||f||||f||||||||||2017-02-18 17:55:21.710826|2017-02-18 17:55:21.710826
NCT00074035|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2016-06-24|||December 2003||2003-12-01|June 2016|2016-06-01||||August 2008|Actual|2008-08-01||Interventional|||Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease|A Phase II Trial Of Intravenous Pentostatin For The Treatment Of Patients With Refractory Chronic Graft-Versus-Host Disease|Active, not recruiting||Phase 2|39|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:55:21.828101|2017-02-18 17:55:21.828101
NCT00074022|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2013-01-23|||October 2003||2003-10-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors|A Phase I/2 Study of GTI-2040 Combined With Docetaxel In Metastatic Or Unresectable Locally Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:21.959892|2017-02-18 17:55:21.959892
NCT00073151|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-17|2007-11-28|||September 2003||2003-09-01|November 2007|2007-11-01|January 2006|Actual|2006-01-01|||||Interventional|||A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer|A Phase II Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Refractory to Taxane Regimens|Completed||Phase 2|30|Anticipated|Abbott||1|||f||||f||||||||||2017-02-18 17:55:37.698288|2017-02-18 17:55:37.698288
NCT00074009|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-02-11|||October 2003||2003-10-01|December 2009|2009-12-01||||April 2005|Actual|2005-04-01||Interventional|||Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma|A Multicenter, Open-Label, Two-Stage, Phase II Study Of PS-341 (LDP-341, NSC # 681239) In Patients With Unresectable Or Metastatic Gastric Adenocarcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:22.082723|2017-02-18 17:55:22.082723
NCT00073983|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-02-08|2011-03-15||October 2006||2006-10-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|January 2010|Actual|2010-01-01||Interventional|||Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma|Phase II Study Of Sequential Gemcitabine Followed By Docetaxel For Recurrent Ewing's Sarcoma, Osteosarcoma, Or Unresectable Or Locally Recurrent Chondrosarcoma [SARC Study]|Completed||Phase 2|54|Actual|Sarcoma Alliance for Research through Collaboration|Since this design did not specify a rule for declaring the treatment as “active” a direct comparison to a standard 2 stage phase 2 design is not appropriate.|1|||f||||t||||||||||2017-02-18 17:55:22.190414|2017-02-18 17:55:22.190414
NCT00073970|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-05-21|||April 2003||2003-04-01|May 2012|2012-05-01|January 2006|Actual|2006-01-01|June 2005|Actual|2005-06-01||Interventional|||Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy|A Trial Of COX-2 Inhibitors In PSA Recurrence After Definitive Radiation Or Radical Prostatectomy For Prostate Cancer|Terminated||Phase 2|37|Actual|UNC Lineberger Comprehensive Cancer Center||1||Study stopped due to increased cardiovascular risks associated with Celebrex|f||||t||||||||||2017-02-18 17:55:22.57438|2017-02-18 17:55:22.57438
NCT00073957|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2009-07-07|||December 2003||2003-12-01|July 2009|2009-07-01||||June 2010|Anticipated|2010-06-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Zevalin And Rituxan For The Treatment Of Relapsed Or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Unknown status|Recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:22.683973|2017-02-18 17:55:22.683973
NCT00073944|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2013-05-29|||April 2003||2003-04-01|July 2004|2004-07-01||||January 2005|Actual|2005-01-01||Interventional|||BCX-1777 in Treating Patients With Refractory Cancer|Phase I Pharmacology Study Of Oral And Intravenous BCX-1777 In Patients With Refractory T-Cell And Non-T-Cell Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:22.791287|2017-02-18 17:55:22.791287
NCT00073931|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2015-02-03|||October 1999||1999-10-01|February 2015|2015-02-01|July 2014|Actual|2014-07-01|May 2007|Actual|2007-05-01||Interventional|||Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial Evaluating: Radioiodinated Anti-B1 (Anti-CD20) Antibody With Autologous Stem Cell Transplantation For Relapsed Or Refractory Non-Hodgkin's Lymphoma In Patients 60 Years Of Age And Older|Completed||Phase 2|25|Actual|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 17:55:22.890685|2017-02-18 17:55:22.890685
NCT00073918|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2016-12-02|2016-12-02||February 1999||1999-02-01|December 2016|2016-12-01||||July 2014|Actual|2014-07-01||Interventional|||Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial Evaluating The Efficacy of Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide Followed by Autologous Transplantation, for Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|111|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 17:55:23.025501|2017-02-18 17:55:23.025501
NCT00073905|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-06-02|||April 2003||2003-04-01|June 2012|2012-06-01|January 2009|Actual|2009-01-01|June 2006|Actual|2006-06-01||Interventional|||Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer|Capecitabine And Gemcitabine In Patients With Advanced Or Metastatic Biliary Tract Cancer, A Multicenter Phase II Trial|Completed||Phase 2|44|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 17:55:23.425151|2017-02-18 17:55:23.425151
NCT00073892|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2016-08-29|||January 2004||2004-01-01|August 2016|2016-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma|A Phase I/II Study Of PI-88 In Advanced Malignancies (Phase I), And In Advanced Melanoma(Phase II)|Completed||Phase 1/Phase 2|44|Actual|Medigen Biotechnology Corporation||1|||f||||||||||||Undecided||2017-02-18 17:55:23.543883|2017-02-18 17:55:23.543883
NCT00073879|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2015-01-27|||April 2003||2003-04-01|January 2015|2015-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation|Allogeneic Adoptive Immunochemotherapy For Treatment Of Renal Cell Carcinoma|Completed||N/A|||Baylor College of Medicine|||||f||||||||||||||2017-02-18 17:55:23.654045|2017-02-18 17:55:23.654045
NCT00073866|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2012-07-10||2011-02-16|June 2003||2003-06-01|July 2012|2012-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase I/II Trial Of Weekly Irinotecan And Docetaxel With The Addition Of Celecoxib In Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 17:55:23.75289|2017-02-18 17:55:23.75289
NCT00073853|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-10|2009-08-27|||September 2003||2003-09-01|March 2006|2006-03-01||||||||Interventional|||Autologous Incubated Macrophages for Patients With Complete Spinal Cord Injuries|A Phase II Multicenter, Randomized-Controlled Study to Evaluate the Safety and Efficacy of Autologous Incubated Macrophages for the Treatment of Patients With Complete Spinal Cord Injuries|Suspended||Phase 2|61||Proneuron Biotechnologies|||||||||||||||||||2017-02-18 17:55:23.855312|2017-02-18 17:55:23.855312
NCT00073840|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-09|2012-02-21|||December 2002||2002-12-01|February 2012|2012-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma|An Efficacy and Safety Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 3|386|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 17:55:23.962615|2017-02-18 17:55:23.962615
NCT00073827|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-09|2012-02-21|||May 2002||2002-05-01|February 2012|2012-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma|An Efficacy and Safety Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 3|445|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 17:55:24.140918|2017-02-18 17:55:24.140918
NCT00073814|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-09|2012-02-21|||December 2002||2002-12-01|February 2012|2012-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma|An Efficacy, Safety, and Tolerability Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma|Completed||Phase 3|80|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 17:55:24.465387|2017-02-18 17:55:24.465387
NCT00073801|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-08|2017-02-15|||December 3, 2003||2003-12-03|September 6, 2016|2016-09-06||||||||Observational|||Pelvic Pain in Women With Endometriosis|The Neural Immune Mechanisms and Genetic Influences on Chronic Pelvic Pain in Women With Endometriosis|Completed||N/A|78|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:24.627934|2017-02-18 17:55:24.627934
NCT00073788|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-08|2014-05-30|||September 2003||2003-09-01|May 2014|2014-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Wounded Spirits, Ailing Hearts: Post-Traumatic Stress Disorder and Cardiovascular Disease in Indians|Wounded Spirits, Ailing Hearts: Post-Traumatic Stress Disorder and Cardiovascular Disease in Indians|Completed||N/A|267|Actual|University of Colorado, Denver|||2||f||||f||||||||||2017-02-18 17:55:24.758318|2017-02-18 17:55:24.758318
NCT00073775|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-08|2013-08-08|||September 2003||2003-09-01|August 2013|2013-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Epidemiology of Stress and the Metabolic Syndrome|Epidemiology of Stress and the Metabolic Syndrome|Completed||N/A|3075|Actual|University of Florida|||1||f||||f||||||Samples With DNA|"~     DNA, blood~   "|||2017-02-18 17:55:24.847476|2017-02-18 17:55:24.847476
NCT00073762|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-04|2009-08-18||||||August 2009|2009-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Two Fixed Doses (200 Mg, Or 400 Mg) Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|375|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:55:25.122979|2017-02-18 17:55:25.122979
NCT00073749|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-04|2013-02-14|||August 2003||2003-08-01|February 2013|2013-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma|A Phase 1 Study Of CMC-544 Administered As A Single Agent In Subjects With B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1|80|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:55:25.197503|2017-02-18 17:55:25.197503
NCT00073736|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-03|2011-08-10|||September 2003||2003-09-01|August 2011|2011-08-01||||July 2007|Actual|2007-07-01||Interventional|||Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma|A Phase 1/2 Open-Label Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous Infusion of MB07133 in Subjects With Unresectable Hepatocellular Carcinoma and Child-Pugh Class A Liver Function|Completed||Phase 1/Phase 2|28|Actual|Ligand Pharmaceuticals||5|||f||||f||||||||||2017-02-18 17:55:25.321164|2017-02-18 17:55:25.321164
NCT00073723|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-03|2016-12-14|||December 2003||2003-12-01|December 2016|2016-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer|An Open-label, Phase I/II Trial of ABI-007 (A Cremophor EL-Free, Protein Stabilized, Nanoparticle, Paclitaxel) Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|75||Celgene Corporation|||||f||||||||||||||2017-02-18 17:55:25.442986|2017-02-18 17:55:25.442986
NCT00073710|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-03|2006-07-31|||September 2004||2004-09-01|July 2006|2006-07-01||||||||Interventional|||Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium|A Phase IV, Single-Center, Active-Controlled Cross-Over Pilot Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium|Completed||Phase 4|30||Abbott|||||||||||||||||||2017-02-18 17:55:25.543586|2017-02-18 17:55:25.543586
NCT00073697|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-02|2012-01-10|||May 2003||2003-05-01|January 2012|2012-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Treatment of Depression in Adults|Depression: The Search for Treatment-Relevant Phenotypes|Completed||Phase 4|290|Actual|University of Pittsburgh||3|||f||||||||||||||2017-02-18 17:55:25.639278|2017-02-18 17:55:25.639278
NCT00073684|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-02|2014-05-06|||August 2003||2003-08-01|May 2014|2014-05-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Optimal Treatment Strategies for Sexually Abused Children|Young Sexually Abused Children: Optimal CBT Strategies|Completed||Phase 3|210|Actual|Rowan University||4|||f||||t||||||||||2017-02-18 17:55:25.752393|2017-02-18 17:55:25.752393
NCT00073671|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-02|2013-03-26|||March 2003||2003-03-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|March 2006|Actual|2006-03-01||Interventional|||Prevention of Depression in At-Risk Adolescents|Prevention of Depression in At-Risk Adolescents|Completed||N/A|316|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 17:55:25.852164|2017-02-18 17:55:25.852164
NCT00073658|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-02|2014-03-07|||January 2000||2000-01-01|March 2014|2014-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Treating Behavioral Disturbances in Individuals With Dementia|Continuation Pharmacotherapy for Agitation of Dementia|Completed||Phase 2|137||University of Pittsburgh|||||f||||||||||||||2017-02-18 17:55:25.965226|2017-02-18 17:55:25.965226
NCT00073645|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-02|2013-08-19|||July 2002||2002-07-01|August 2013|2013-08-01|July 2008|Actual|2008-07-01|December 2007|Actual|2007-12-01||Interventional|||Family and Peer Involvement in the Treatment of Anxiety Disorders in Children|Therapy Specificity and Mediation in Family and Group CBT|Completed||Phase 1|241|Actual|Florida International University||2|||f||||t||||||||||2017-02-18 17:55:26.064923|2017-02-18 17:55:26.064923
NCT00073632|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-02|2013-11-05|||May 2002||2002-05-01|September 2008|2008-09-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Acceptance-Based Treatment for Generalized Anxiety Disorder|Developing a New Therapy for GAD: Acceptance-Based CBT|Completed||Phase 1|50|Actual|University of Massachusetts, Boston|||||f||||f||||||||||2017-02-18 17:55:26.175519|2017-02-18 17:55:26.175519
NCT00073619|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-02|2016-06-22|||December 2001||2001-12-01|June 2016|2016-06-01|July 2011|Actual|2011-07-01|July 2007|Actual|2007-07-01||Interventional|||Preventing Anxiety Disorders in Urban Youth|Community Violence and Youth: Preventing Anxiety Disorders|Completed||N/A|200|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||f||||||||No|There is no plan to make individual participant data available.|2017-02-18 17:55:26.288127|2017-02-18 17:55:26.288127
NCT00073606|ClinicalTrials.gov processed this data on February 17, 2017|2003-12-01|2017-01-24|||December 1, 2003||2003-12-01|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Observational|||Spinal Cord Plasticity|Intraspinal Plasticity Associated With Locomotor Learning|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:26.400109|2017-02-18 17:55:26.400109
NCT00073593|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-26|2011-11-08|||August 2003||2003-08-01|November 2011|2011-11-01||||May 2004|Actual|2004-05-01||Interventional|OPCAB||Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB|A Study Comparing Angiomax (Bivalirudin) to Heparin With Protamine Reversal in Patients Undergoing Coronary Artery Bypass (OPCAB) Surgery|Completed||Phase 3|150|Actual|The Medicines Company||2|||f||||||||||||||2017-02-18 17:55:26.4774|2017-02-18 17:55:26.4774
NCT00073580|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-26|2011-11-08|||October 2003||2003-10-01|November 2011|2011-11-01||||September 2005|Actual|2005-09-01||Interventional|||Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)|Angiomax in Patients With HIT/HITTS Type II Undergoing Off-PUMP CABG|Unknown status|Active, not recruiting|Phase 3|88|Actual|The Medicines Company||1|||f||||||||||||||2017-02-18 17:55:26.578859|2017-02-18 17:55:26.578859
NCT00073554|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-24|2009-12-16|||June 2003||2003-06-01|November 2006|2006-11-01||||||||Interventional|||Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion|A Phase 2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Activity of Alfimeprase in Patients With Acute Peripheral Arterial Occlusion|Completed||Phase 2|100||ARCA Biopharma, Inc.|||||||||||||||||||2017-02-18 17:55:26.679657|2017-02-18 17:55:26.679657
NCT00073541|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-24|2017-01-19|||April 2003||2003-04-01|January 2017|2017-01-01|August 2004|Actual|2004-08-01|March 2004|Actual|2004-03-01||Interventional|||A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer|An Open-Label Phase II Study in Subjects With Recurrent EGFR-Positive Ovarian Cancer to Investigate the Safety and Efficacy of EMD 72000 Administered as a Single Agent|Completed||Phase 2|38|Actual|EMD Serono|||||||||||||||||||2017-02-18 17:55:26.759527|2017-02-18 17:55:26.759527
NCT00073528|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-24|2016-04-04|2012-04-19||December 2003||2003-12-01|April 2016|2016-04-01|December 2016|Anticipated|2016-12-01|June 2008|Actual|2008-06-01||Interventional|||Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer|A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study Comparing GW572016 and Letrozole Versus Letrozole in Subjects With Estrogen/Progesterone Receptor-Positive Advanced or Metastatic Breast Cancer|Active, not recruiting||Phase 3|1286|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:55:26.875039|2017-02-18 17:55:26.875039
NCT00073515|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-21|2010-02-02||||||June 2005|2005-06-01||||||||Interventional|||Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices|A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Alfimeprase for Restoring Function in Occluded Central Venous Catheters|Completed||Phase 2|115||ARCA Biopharma, Inc.|||||||||||||||||||2017-02-18 17:55:29.336984|2017-02-18 17:55:29.336984
NCT00073502|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-21|2006-02-17|||October 2003||2003-10-01|October 2003|2003-10-01|October 2003||2003-10-01|||||Interventional|||Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer|A Phase II Study of Single Agent OSI-7904L In Patients With Locally Advanced or Metastatic Adenocarcinoma Of the Stomach or Gastroesophageal Junction|Completed||Phase 2|43||OSI Pharmaceuticals|||||||||||||||||||2017-02-18 17:55:29.410567|2017-02-18 17:55:29.410567
NCT00073489|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-21|2011-10-14|||May 2001||2001-05-01|October 2011|2011-10-01|December 2003|Actual|2003-12-01|||||Interventional|||A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)|A Pilot Trial of OSI-461 in Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|23||Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:55:29.486422|2017-02-18 17:55:29.486422
NCT00073476|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-21|2006-06-20|||September 2003||2003-09-01|June 2006|2006-06-01|February 2005||2005-02-01|||||Interventional|||A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke|A Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of a 72-Hour Infusion of CP-101,606 in Subjects With Acute Ischemic Stroke.|Terminated||Phase 2|300||Pfizer|||||||||||||||||||2017-02-18 17:55:29.589793|2017-02-18 17:55:29.589793
NCT00073463|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-21|2008-01-24|||June 2003||2003-06-01|January 2008|2008-01-01|October 2005||2005-10-01|||||Interventional|||Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis|A Multicenter, Double-Blind, Placebo Controlled, Phase II Study of Aerosolized tgAAVCF for the Treatment of Cystic Fibrosis|Terminated||Phase 2/Phase 3|100||Targeted Genetics Corporation|||||f||||||||||||||2017-02-18 17:55:29.81627|2017-02-18 17:55:29.81627
NCT00073450|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-20|2015-04-20|||September 2003||2003-09-01|April 2015|2015-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)|An Open-Label Phase 2 Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck|Terminated||Phase 2|15|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 17:55:29.9029|2017-02-18 17:55:29.9029
NCT00073437|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-20|2011-05-16|||October 2003||2003-10-01|April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||A Study of Infliximab in Patients With Sarcoidosis|A Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety and Efficacy of Infliximab (Remicade�) in Subjects With Chronic Sarcoidosis With Pulmonary Involvement.|Completed||Phase 3|139|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:55:29.980336|2017-02-18 17:55:29.980336
NCT00073424|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-20|2013-05-31|||January 2004||2004-01-01|May 2013|2013-05-01|October 2006|Actual|2006-10-01|||||Observational|||Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents|Cognitive, Behavioral, and Psychosocial Correlates of Medication Adherence in Children and Adolescents With HIV-1 Infection|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:55:30.092266|2017-02-18 17:55:30.092266
NCT00073411|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-20|2007-07-30|||November 2003||2003-11-01|July 2007|2007-07-01|May 2005|Actual|2005-05-01|||||Interventional|||Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression|Duloxetine Versus Escitalopram and Placebo in the Treatment of Patients With Major Depression|Completed||Phase 3|675||Eli Lilly and Company|||||f||||f||||||||||2017-02-18 17:55:30.212769|2017-02-18 17:55:30.212769
NCT00073398|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-19|2015-06-25||2015-04-07|November 2003||2003-11-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|November 2012|Actual|2012-11-01||Interventional|||Vaccine Treatment for Advanced Non-Small Cell Lung Cancer|A Phase I/II Study of Tergenpumatucel-L (HyperAcute Lung) an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Refractory or Recurrent Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|54|Actual|NewLink Genetics Corporation||1|||f||||f||||||||||2017-02-18 17:55:30.318979|2017-02-18 17:55:30.318979
NCT00073164|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-17|2006-08-02|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia|A Study of the Safety and Efficacy of Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia|Completed||Phase 2|400||Abbott|||||||||||||||||||2017-02-18 17:55:37.577826|2017-02-18 17:55:37.577826
NCT00073385|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-19|2005-08-26|||September 2003||2003-09-01|August 2005|2005-08-01|October 2004||2004-10-01|||||Interventional|||Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer|A Randomized Trial of Pivanex Plus Docetaxel or Docetaxel Monotherapy in Patients With Chemotherapy Resistant Advanced Non-Small Cell Carcinoma of the Lung (NSCLC)|Completed||Phase 2|225||Titan Pharmaceuticals|||||||||||||||||||2017-02-18 17:55:30.442464|2017-02-18 17:55:30.442464
NCT00073372|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-19|2011-05-16|||October 2003||2003-10-01|June 2010|2010-06-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)|Abciximab (ReoPro) in Acute Ischemic Stroke: A Phase III, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled Trial.|Terminated||Phase 3|808|Actual|Centocor, Inc.||||"Based on the data and observed benefit-risk profile, the trial's independent oversight~   committee recommended that enrollment not resume."|||||t||||||||||2017-02-18 17:55:30.542168|2017-02-18 17:55:30.542168
NCT00073359|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-19|2014-05-19|||February 2003||2003-02-01|November 2005|2005-11-01|June 2005||2005-06-01|||||Interventional|||Effects of Therapist Behavior on the Treatment of Depressed Adolescents|Engagement and Alliance in CBT for Depressed Adolescents|Unknown status|Active, not recruiting|Phase 1/Phase 2|40||University of Denver|||||f||||||||||||||2017-02-18 17:55:30.637667|2017-02-18 17:55:30.637667
NCT00073346|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-19|2013-06-19|||September 2003||2003-09-01|June 2013|2013-06-01|August 2006||2006-08-01|||||Interventional|||Treatment of Compulsive Hoarding|Treatment of Compulsive Hoarding|Completed||Phase 1|52||Boston University|||||f||||||||||||||2017-02-18 17:55:30.715869|2017-02-18 17:55:30.715869
NCT00073333|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-19|2013-07-01|2013-05-14||December 2002||2002-12-01|July 2013|2013-07-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia|Social Phobia: Assessment and Treatment of Social Skills|Completed||N/A|379|Actual|Milton S. Hershey Medical Center||3|||f||||f||||||||||2017-02-18 17:55:30.809378|2017-02-18 17:55:30.809378
NCT00073320|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-19|2010-04-26|||August 2003||2003-08-01|April 2010|2010-04-01|May 2004|Actual|2004-05-01|||||Interventional|||Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia|Pharmacokinetics, Tolerability, and Safety of Paliperidone After Repeated Intramuscular Injection of Paliperidone Palmitate in the Arm or the Buttock of Subjects With Schizophrenia|Completed||Phase 3|88|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:55:31.250871|2017-02-18 17:55:31.250871
NCT00073307|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-19|2014-01-08|2011-08-02||November 2003||2003-11-01|January 2014|2014-01-01|April 2010|Actual|2010-04-01|September 2006|Actual|2006-09-01||Interventional|||Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer|A Phase III Randomized Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer.|Completed||Phase 3|903|Actual|Bayer|Per final PFS data (N=769) study unblinded; placebo-randomized subjects switched to sorafenib ~31May2005 (N=216) that diluted final OS, sorafenib treatment effect. Final ITT, N=903, reported safety data include additional data and cleaning.|2|||f||||t||||||||||2017-02-18 17:55:31.35321|2017-02-18 17:55:31.35321
NCT00073294|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-18|2010-01-14||||||January 2010|2010-01-01||||||||Interventional|||Insulin Resistance and Insulin Secretion|Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity|Completed||N/A|200|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:55:36.634016|2017-02-18 17:55:36.634016
NCT00073281|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-18|2010-01-14|||August 2003||2003-08-01|January 2010|2010-01-01|December 2004||2004-12-01|||||Interventional|||Islet Transplantation for Patients With Type 1 Diabetes|Islet Transplantation for Patients With Type 1 Diabetes and Stable Renal Allografts Using Steroid Sparing Immunosuppression|Completed||Phase 1|10||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:55:36.71138|2017-02-18 17:55:36.71138
NCT00073268|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-18|2010-01-14|||December 2002||2002-12-01|January 2010|2010-01-01|June 2007||2007-06-01|||||Interventional|||Prevention of Type 2 Diabetes Mellitus in Children|Prevention of Type 2 Diabetes Mellitus in Children|Completed||Phase 1|300|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:55:36.798357|2017-02-18 17:55:36.798357
NCT00073255|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-18|2010-01-14|||June 2003||2003-06-01|January 2010|2010-01-01|December 2005||2005-12-01|||||Interventional|||Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)|Evaluation of Tolerability, Safety, and Pharmacokinetics of hOKT3g1 (Ala-Ala)|Completed||Phase 1|12||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 17:55:36.879186|2017-02-18 17:55:36.879186
NCT00073242|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-18|2015-06-03|||July 2000||2000-07-01|June 2015|2015-06-01|July 2015|Anticipated|2015-07-01|July 2015|Anticipated|2015-07-01||Interventional|||Low-Dose Leptin and the Formerly-Obese|Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese|Recruiting||Phase 3|25|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 17:55:36.951145|2017-02-18 17:55:36.951145
NCT00073229|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-18|2008-09-25|||July 2000||2000-07-01|September 2008|2008-09-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Observational|||Immune Function of Infants With HIV|Killer Cells and Viral Load in Vertical HIV Infection|Completed||N/A|80|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||f||||||||||2017-02-18 17:55:37.060208|2017-02-18 17:55:37.060208
NCT00073216|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-18|2012-05-03||||||May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Clade B Gag DNA/PLG and Env DNA/PLG Microparticles Vaccine and a Clade B Recombinant, Oligomeric gp140/MF59 Adjuvant Vaccine in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|96|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:55:37.155962|2017-02-18 17:55:37.155962
NCT00073203|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-17|2009-08-27||||||May 2004|2004-05-01|May 2004||2004-05-01|||||Interventional|||A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder|A 6- Week, Randomized, Double-Blind, Parallel-Group, Active-and Placebo-Controlled Trial to Assess the Efficacy of R228060 in Adult Subjects With Major Depressive Disorder (MDD)|Completed||Phase 2|488||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:55:37.260698|2017-02-18 17:55:37.260698
NCT00073190|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-17|2013-12-13|||September 2003||2003-09-01|December 2013|2013-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Patient- and Physician-Based Osteoporosis Education|Randomized Controlled Testing of Osteoporosis Education|Completed||Phase 1|30000||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 17:55:37.338338|2017-02-18 17:55:37.338338
NCT00073125|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-17|2007-08-13|||May 2003||2003-05-01|August 2007|2007-08-01||||||||Interventional|||Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma|A Phase II Randomized Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma|Completed||Phase 2|103|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:55:37.99941|2017-02-18 17:55:37.99941
NCT00073112|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-17|2007-11-28|||August 2003||2003-08-01|November 2007|2007-11-01|September 2006|Actual|2006-09-01|||||Interventional|||A Study of ABT-751 in Patients With Renal Cell Cancer|A Phase 2 Study of ABT-751 in Subjects With Refractory Colorectal Carcinoma|Completed||Phase 2|60||Abbott||1|||f||||f||||||||||2017-02-18 17:55:38.111787|2017-02-18 17:55:38.111787
NCT00073099|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-14|2017-01-24|||November 14, 2003||2003-11-14|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Observational|||Digital Photography to Evaluate Dry Eye|Digital Image Based Determination of Ocular Surface Vital Dye Staining|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:38.221034|2017-02-18 17:55:38.221034
NCT00073086|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-14|2017-01-24|||November 5, 2003||2003-11-05|December 27, 2010|2010-12-27|December 27, 2010||2010-12-27|||||Observational|||Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)|Clinical Evaluation and Management of Persons With Severe Acute Respiratory Syndrome (SARS)|Withdrawn||N/A|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:38.315183|2017-02-18 17:55:38.315183
NCT00073073|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-14|2016-04-11|2016-04-11||November 2003||2003-11-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||Patients who were treated|Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer|A Trial of Exemestane in Postmenopausal Women With DCIS or at High Risk for Invasive Breast Cancer|Completed||Phase 2|46|Actual|Georgetown University||1|||f||||f||||||||||2017-02-18 17:55:38.58741|2017-02-18 17:55:38.58741
NCT00073060|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-14|2017-01-24|||November 13, 2003||2003-11-13|March 23, 2016|2016-03-23||||||||Observational|||Citrate Effects and Bone Density in Long-Term Apheresis Donors|Citrate Effects and Bone Density Studies in Long-Term Apheresis Donors|Completed||N/A|273|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:38.903521|2017-02-18 17:55:38.903521
NCT00073047|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-14|2009-07-17|||April 2003||2003-04-01|July 2009|2009-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis|A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study of Intravenous Daclizumab in Patients With Moderate-to-severe Ulcerative Colitis|Completed||Phase 2|150||Facet Biotech|||||||||||||||||||2017-02-18 17:55:38.999987|2017-02-18 17:55:38.999987
NCT00073034|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-14|2013-02-20|||January 2004||2004-01-01|February 2013|2013-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of 3 Fixed Doses of EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy|Terminated||Phase 2|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:55:39.143348|2017-02-18 17:55:39.143348
NCT00073021|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-13|2015-06-01|2011-03-25||September 2000||2000-09-01|June 2015|2015-06-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis|A Double-Blind, Randomized, 6-Week, Parallel-Group Design Clinical Trial to Assess Safety and Efficacy of Asacol 4.8 g/Day (800 mg Tablet) Versus Asacol 2.4 g/Day (400 mg Tablet) for the Treatment of Moderately Active Ulcerative Colitis|Completed||Phase 3|386|Actual|Warner Chilcott||2|||f||||f||||||||||2017-02-18 17:55:39.227042|2017-02-18 17:55:39.227042
NCT00073008|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-13|2011-03-17|2009-06-15||November 2003||2003-11-01|March 2011|2011-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer|A Phase 2 Multicenter Trial Comparing Two Schedules of GW572016 as First or Second Line Monotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer With Either Bronchioloalveolar Carcinoma or No Smoking History|Terminated||Phase 2|131|Actual|GlaxoSmithKline|Based on interim analysis and predefined stopping rules for futility, the study was discontinued due to lack of efficacy. At that time, no additional participants were added; enrolled participants could continue on treatment, following the protocol.|1||"Based on interim analysis at the end of Stage 1, and predefined stopping rules for futility,~   further enrollment was stopped due to lack of efficacy"|f||||t||||||||||2017-02-18 17:55:40.044|2017-02-18 17:55:40.044
NCT00072995|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-13|2013-01-29|||September 2003||2003-09-01|January 2013|2013-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Preventing Obesity Using Novel Dietary Strategies|Preventing Overweight Using Novel Dietary Strategies (Pounds Lost)|Completed||N/A|811||Brigham and Women's Hospital|||||f||||t||||||||||2017-02-18 17:55:41.100405|2017-02-18 17:55:41.100405
NCT00072982|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-13|2008-08-22|||November 2006||2006-11-01|August 2008|2008-08-01|November 2008|Anticipated|2008-11-01|May 2008|Actual|2008-05-01||Interventional|||Treatment of Rheumatoid Arthritis With Marine and Botanical Oils|Treatment of Rheumatoid Arthritis With Marine and Botanical Oils|Unknown status|Active, not recruiting|Phase 3|156|Actual|National Center for Complementary and Integrative Health (NCCIH)||3|||f||||t||||||||||2017-02-18 17:55:41.19149|2017-02-18 17:55:41.19149
NCT00072969|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-12|2008-03-03|||November 2003||2003-11-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)|A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)|Completed||Phase 2|132||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:41.509544|2017-02-18 17:55:41.509544
NCT00072956|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-12|2008-03-03|||November 2003||2003-11-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Observational|||The Physiology of Tricks|The Physiology of Tricks|Completed||N/A|49||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:41.604799|2017-02-18 17:55:41.604799
NCT00072943|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-12|2012-03-09|||March 2002||2002-03-01|March 2012|2012-03-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease|A Phase II, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) Administered to Patients With Moderate to Severe Crohn's Disease|Completed||Phase 2|175||Facet Biotech|||||f||||||||||||||2017-02-18 17:55:41.684389|2017-02-18 17:55:41.684389
NCT00072930|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-12|2008-01-11|||December 2003||2003-12-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|April 2007|Anticipated|2007-04-01||Interventional|||MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer|Phase II, Randomized, Open-Label, Two-Arm, Multicenter Study of MEDI-522, a HuMA Directed Against the Human Alpha V Beta 3 Integrin, in Combination With Docetaxel, Prednisone, and Zoledronic Acid in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 2|150||MedImmune LLC||2|||f||||||||||||||2017-02-18 17:55:41.805641|2017-02-18 17:55:41.805641
NCT00072917|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-12|2010-01-15|||October 2003||2003-10-01|January 2010|2010-01-01|June 2008||2008-06-01|||||Observational|||The Effects of Overfeeding on Obesity-Prone (OP) and Obesity-Resistant (OR) Women|The Effects of Overfeeding on Obesity-Prone (OP) and Obesity-Resistant (OR) Women|Completed||N/A|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||Samples With DNA|"~     Blood and urine~   "|||2017-02-18 17:55:41.988227|2017-02-18 17:55:41.988227
NCT00072904|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-12|2012-02-27|||June 2001||2001-06-01|February 2012|2012-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Diabetes Therapy to Improve BMI and Lung Function in CF|Diabetes Therapy to Improve BMI and Lung Function in CF|Completed||Phase 3|108|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||||||||||||2017-02-18 17:55:42.070859|2017-02-18 17:55:42.070859
NCT00072891|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-12|2010-02-12||||||February 2010|2010-02-01|December 2005|Actual|2005-12-01|||||Interventional|||Improving Medication Adherence in Comorbid Conditions||Completed||N/A|400||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:55:42.1879|2017-02-18 17:55:42.1879
NCT00072865|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-12|2007-01-24|||June 2003||2003-06-01|January 2007|2007-01-01|September 2005||2005-09-01|||||Interventional|||Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer|A Phase II Study of Alimta and Carboplatin in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:55:42.274037|2017-02-18 17:55:42.274037
NCT00072852|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-11|2008-10-15|||November 2003||2003-11-01|October 2008|2008-10-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine|Phase II Trial of Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine|Completed||Phase 2|134|Actual|Pfizer|||||f||||||||||||||2017-02-18 17:55:42.378859|2017-02-18 17:55:42.378859
NCT00072839|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-11|2015-11-10|||October 2003||2003-10-01|January 2015|2015-01-01|September 2005|Actual|2005-09-01|July 2005|Actual|2005-07-01||Interventional|||Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease|A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease|Completed||Phase 2|100|Actual|Shire||4|||f||||f||||||||||2017-02-18 17:55:42.543949|2017-02-18 17:55:42.543949
NCT00072826|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-10|2017-01-24|||November 4, 2003||2003-11-04|December 7, 2015|2015-12-07|August 24, 2007|Actual|2007-08-24|August 24, 2007|Actual|2007-08-24||Interventional|||Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease|Atorvastatin Therapy To Improve Endothelial Function in Sickle Cell Disease|Completed||Phase 1|44|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:55:42.694257|2017-02-18 17:55:42.694257
NCT00072813|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-10|2017-01-24|||November 10, 2003||2003-11-10|November 12, 2009|2009-11-12||||November 12, 2009|Actual|2009-11-12||Observational|||MRI in Autosomal Dominant Partial Epilepsy With Auditory Features|MRI in Autosomal Dominant Partial Epilepsy With Auditory Features|Completed||N/A|72||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:42.793755|2017-02-18 17:55:42.793755
NCT00072800|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-10|2008-03-03|||November 2003||2003-11-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Classification of Cerebral Palsy Subtypes|Classification of Cerebral Palsy Subtypes|Completed||N/A|115||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:42.874108|2017-02-18 17:55:42.874108
NCT00072787|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-10|2009-08-06|||October 2003||2003-10-01|August 2009|2009-08-01|May 2006|Actual|2006-05-01|March 2006|Actual|2006-03-01||Interventional|||Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer|A Phase I/II, Open-Label, Nonrandomized, Dose-Finding Safety, Tolerance, Pharmacokinetic, and Efficacy Study of Orally Administered S-1 in Combination With Cisplatin in Patients With Advanced Gastric Cancer|Completed||Phase 1/Phase 2|41||Taiho Oncology, Inc.|||||||||||||||||||2017-02-18 17:55:42.961945|2017-02-18 17:55:42.961945
NCT00072774|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-10|2009-08-18||||||August 2009|2009-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Three Fixed Doses (100 Mg, 200 Mg, Or 400 Mg) Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|480|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:55:43.058689|2017-02-18 17:55:43.058689
NCT00072761|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-10|2016-01-07|2015-05-04||December 2004||2004-12-01|January 2016|2016-01-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|SIT||Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial|Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial|Completed||Phase 3|196|Actual|Washington University School of Medicine|The SIT Trial results are not directly applicable to all children with SCA. Those who were on hydroxyurea therapy for severe disease, had abnormally elevated TCDs, were receiving blood transfusion for stroke prevention or had epilepsy were excluded.|2|||f||||t||||||||||2017-02-18 17:55:43.134528|2017-02-18 17:55:43.134528
NCT00072748|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-10|2009-08-20||||||August 2009|2009-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Study Evaluating EKB-569 in Advanced Colorectal Cancer||Completed||Phase 2|63|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:55:43.65019|2017-02-18 17:55:43.65019
NCT00072735|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-07|2017-01-24|||November 6, 2003||2003-11-06|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Improvement of Use Dependent Plasticity in Chronic Stroke Patients|Improvement of Use Dependent Plasticity in Chronic Stroke Patients|Completed||Phase 1|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:43.728943|2017-02-18 17:55:43.728943
NCT00072722|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-07|2006-12-18|||September 2003||2003-09-01|December 2006|2006-12-01|April 2005||2005-04-01|||||Interventional|||Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)|Phase II Randomized Open-Label, Two-Arm Study of Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)|Completed||Phase 2|36||Celgene|||||||||||||||||||2017-02-18 17:55:43.81237|2017-02-18 17:55:43.81237
NCT00072709|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-07|2011-11-22|||September 2003||2003-09-01|November 2011|2011-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)|A Randomized, Double-Blind, Placebo-Controlled, Stratified, Parallel-Group, Multicenter, Dose-Ranging Study Evaluating Four Oral Doses of TCH346 (1.0, 2.5, 7.5 and 15 mg) Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis|Completed||Phase 2|551|Actual|Novartis|||||f||||||||||||||2017-02-18 17:55:43.88834|2017-02-18 17:55:43.88834
NCT00072683|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-07|2007-01-24|||April 2003||2003-04-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||“SALT Trial” Study of Ascending Levels of Tolvaptan in Hyponatremia|Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia|Completed||Phase 3|240||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 17:55:43.984012|2017-02-18 17:55:43.984012
NCT00072670|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-07|2014-04-07|||January 2004||2004-01-01|April 2014|2014-04-01|November 2008|Actual|2008-11-01|September 2008|Actual|2008-09-01||Interventional|||A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer|Phase 2 Study of Yondelis in Men With Advanced Prostate Carcinoma|Completed||Phase 2|59|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||3|||f||||t||||||||||2017-02-18 17:55:44.212437|2017-02-18 17:55:44.212437
NCT00072657|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-07|2013-04-01|||February 2004||2004-02-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis|Behavioral Treatments for Rheumatoid Arthritis|Completed||N/A|106|Actual|University of California, Los Angeles||3|||f||||||||||||||2017-02-18 17:55:44.32475|2017-02-18 17:55:44.32475
NCT00072644|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-06|2017-01-24|||October 30, 2003||2003-10-30|June 17, 2008|2008-06-17|June 17, 2008||2008-06-17|||||Observational|||Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-infected Patients Receiving Single-Dose Prednisone|Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-infected Patients Receiving Single-Dose Prednisone|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:44.432723|2017-02-18 17:55:44.432723
NCT00072631|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-05|2015-06-12|||August 2003||2003-08-01|June 2015|2015-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer|A Phase II, Open-label, Intra-patient Dose-escalation Study of Erlotinib in Patients With Advanced Non-small Cell Lung Cancer Who Have Failed Prior Chemotherapy|Completed||Phase 2|43|Actual|Astellas Pharma Inc||1|||f||||f||||||||||2017-02-18 17:55:44.515084|2017-02-18 17:55:44.515084
NCT00072618|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-05|2011-10-18|||October 2001||2001-10-01|October 2011|2011-10-01|August 2003|Actual|2003-08-01|||||Interventional|||Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients|A Phase I/II Multi-Center Study of Weekly Taxotere (Docetaxel) in Combination With Aptosyn (Exisulind) in Non-Small Cell Lung Cancer (NSCLC) Patients Who Have Failed a Prior Platinum-Containing Regimen|Completed||Phase 1/Phase 2|52||Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:55:44.622078|2017-02-18 17:55:44.622078
NCT00072605|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2017-01-24|||October 30, 2003||2003-10-30|August 22, 2007|2007-08-22|August 22, 2007||2007-08-22|||||Interventional|||Experimental Ebola Vaccine Trial|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiple Strain Ebola DNA Plasmid Vaccine, VRC-EBODNA012-00-VP, in Adult Volunteers|Completed||Phase 1|27||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:44.700701|2017-02-18 17:55:44.700701
NCT00072592|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2008-03-03|||October 2003||2003-10-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies|An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:44.784792|2017-02-18 17:55:44.784792
NCT00072579|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2017-01-17|||May 2003||2003-05-01|June 2013|2013-06-01|December 2007|Actual|2007-12-01|April 2006|Actual|2006-04-01||Interventional|||Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment|Phase II Study of GM-CSF in Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML) Who Are Not in Complete Cytogenetic Remission After Initial Therapy|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 17:55:44.876217|2017-02-18 17:55:44.876217
NCT00072566|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2015-05-08|2015-04-14||December 2003||2003-12-01|December 2012|2012-12-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer|Phase II Clinical Trial of Bevacizumab (NSC 704865) and Low Dose Oral Cyclophosphamide in Recurrent Ovarian Cancer, Primary Peritoneal Carcinoma|Completed||Phase 2|70|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:45.193604|2017-02-18 17:55:45.193604
NCT00072553|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2009-02-06|||September 2003||2003-09-01|May 2007|2007-05-01||||||||Interventional|||Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer|A Phase II Of An Optimized LV-5FU-Oxaliplatin Strategy With Celebrex In Metastatic Colorectal Cancer, Optimox2-Celecoxib Study|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:45.75588|2017-02-18 17:55:45.75588
NCT00072540|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-11-07||||||November 2013|2013-11-01||||||||Interventional|||S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix|S0212: Phase IIb Randomized Study of Celecoxib in Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||||drug issues|f||||t||||||||||2017-02-18 17:55:45.864116|2017-02-18 17:55:45.864116
NCT00072527|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2016-07-01|||November 2003||2003-11-01|July 2016|2016-07-01|January 2013|Actual|2013-01-01|June 2007|Actual|2007-06-01||Interventional|||Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Induction Cisplatin/Irinotecan Followed By Combination Carboplatin, Etoposide And Chest Radiotherapy In Limited Stage Small Cell Lung Cancer: A Phase II Study|Completed||Phase 2|78|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:55:45.962885|2017-02-18 17:55:45.962885
NCT00071643|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-07-01|||September 2002||2002-09-01|July 2013|2013-07-01||||November 2008|Actual|2008-11-01||Interventional|||Preventing Post-Stroke Depression|Prevention of Post-Stroke Depression - Treatment Strategy|Unknown status|Active, not recruiting|Phase 3|201|Anticipated|University of Iowa||3|||f||||||||||||||2017-02-18 17:56:10.824299|2017-02-18 17:56:10.824299
NCT00072514|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-11-25|||August 2003||2003-08-01|November 2013|2013-11-01||||July 2008|Actual|2008-07-01||Interventional|||Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies|A Phase II Study Evaluating the Efficacy of Gemcitabine, Carboplatin, and Dexamethasone and Rituximab for Previously Treated Lymphoid Malignancies|Completed||Phase 2|54|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 17:55:46.182673|2017-02-18 17:55:46.182673
NCT00072501|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2012-10-27|||April 2004||2004-04-01|February 2006|2006-02-01||||April 2012|Actual|2012-04-01||Interventional|||Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer|Screening Breast Ultrasound in High-Risk Women|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:46.308065|2017-02-18 17:55:46.308065
NCT00072488|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2010-06-05|||October 2004||2004-10-01|October 2007|2007-10-01||||December 2005|Anticipated|2005-12-01||Interventional|||Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma|Whole-Body MRI in the Evaluation of Pediatric Malignancies|Unknown status|Active, not recruiting|N/A|226|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:46.424616|2017-02-18 17:55:46.424616
NCT00072475|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2016-07-01|2014-05-22||December 2003||2003-12-01|July 2016|2016-07-01|June 2014|Actual|2014-06-01|November 2008|Actual|2008-11-01||Interventional||Of the 155 participants recruited, 2 participants cancelled prior to starting treatment; 7 were determined to have AML at registration and 4 had diagnosis other than MDS. Thus 142 participants were evaluable for response|Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes|A Phase II Study of an Oral VEGF Receptor Tyrosine Kinase Inhibitor (PTK787/ZK222584) (IND #66370, NSC #719335) in Myelodysplastic Syndrome (MDS)|Completed||Phase 2|155|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:55:46.554054|2017-02-18 17:55:46.554054
NCT00072462|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2015-08-21|||September 2003||2003-09-01|August 2015|2015-08-01|January 2022|Anticipated|2022-01-01|February 2017|Anticipated|2017-02-01||Interventional|IBIS-II DCIS||Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ|International Breast Cancer Intervention Study II (IBIS-II) (DCIS)|Active, not recruiting||Phase 3|2980|Actual|Queen Mary University of London||2|||f||||t||||||||||2017-02-18 17:55:47.395942|2017-02-18 17:55:47.395942
NCT00072449|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-06-14|2013-06-14||May 2004||2004-05-01|June 2013|2013-06-01|June 2010|Actual|2010-06-01|March 2009|Actual|2009-03-01||Interventional|||Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma|A Phase II Study Of Anti-CD20 Monoclonal Antibody (Rituximab) Therapy For Patients With Refractory Or Relapsed Primary CNS Lymphoma (PCNSL)|Terminated||Phase 2|12|Actual|Sidney Kimmel Comprehensive Cancer Center|Study terminated early due to slow accrual and lack of resources and priority due to NCI mandate of combining two consortia. Unable to fully analyze the data, or objectives, not enough patients. Not able to do statistics|1||slow accrual and lack of resources and priority due to combining 2 consortia|f||||||||||||||2017-02-18 17:55:50.559478|2017-02-18 17:55:50.559478
NCT00072436|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-07-01|||September 2003||2003-09-01|July 2013|2013-07-01||||March 2009|Actual|2009-03-01||Interventional|||Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors|A Phase I Trial of Gemcitabine Followed by a Short Infusion of Flavopiridol in Patients With Solid Tumors|Completed||Phase 1|58|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:55:50.884982|2017-02-18 17:55:50.884982
NCT00072410|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2009-02-06|||June 2003||2003-06-01|August 2005|2005-08-01||||||||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer|Single-Dose, Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Humanized Monoclonal Antibody 3S193 (90Y-hu3S193) in Patients With Advanced Ovarian Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:51.273749|2017-02-18 17:55:51.273749
NCT00072384|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-06-18|||April 2007||2007-04-01|June 2013|2013-06-01||||February 2013|Actual|2013-02-01||Interventional|||Systemic Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy in Treating Children With Intraocular Retinoblastoma|A Single Arm Trial of Systemic And Subtenon Chemotherapy For Groups C And D Intraocular Retinoblastoma|Completed||Phase 3|30|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:55:51.367436|2017-02-18 17:55:51.367436
NCT00072358|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2016-10-10|||July 2003||2003-07-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2017|Anticipated|2017-12-01||Interventional|||Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma|Phase II Study of Anti-GD2 3F8 Antibody and GM-CSF for High-Risk Neuroblastoma|Active, not recruiting||Phase 2|340|Anticipated|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:55:51.502794|2017-02-18 17:55:51.502794
NCT00072345|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-01-17|||July 2003||2003-07-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma|A Phase II Study of Temozolomide, Thalidomide, and Lomustine in the Treatment of Advanced Melanoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:55:51.626551|2017-02-18 17:55:51.626551
NCT00072332|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-12-18|||August 2003||2003-08-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2005|Actual|2005-12-01||Interventional|||Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I Dose Escalation Study of Edotecarin (PHA-782615) and Cisplatin in Adult Patients With Advanced/Metastatic Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:51.739082|2017-02-18 17:55:51.739082
NCT00072319|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-03-01|||August 2003||2003-08-01|March 2013|2013-03-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer|Pilot Study of Epirubicin and Cyclophosphamide Followed by Paclitaxel at 10-11 Days Interval for Women With Early Breast Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:55:51.824975|2017-02-18 17:55:51.824975
NCT00072293|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2016-04-12|2016-02-26||December 2001||2001-12-01|April 2016|2016-04-01|December 2021|Anticipated|2021-12-01|November 2011|Actual|2011-11-01||Interventional|23-01|Intention-to-treat|Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases|A Randomized Trial Of Axillary Dissection Versus No Axillary Dissection For Patients With Clinically Node Negative Breast Cancer And Micrometastases In The Sentinel Node|Active, not recruiting||Phase 3|934|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-02-18 17:55:51.928943|2017-02-18 17:55:51.928943
NCT00072280|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2014-09-16|2013-09-23||November 2004||2004-11-01|September 2014|2014-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma|A Pilot Phase II Study for Children With Infantile Fibrosarcoma|Terminated||Phase 2|7|Actual|Children's Oncology Group|Study closed early due to slow accrual. Analysis plans were not carried out (lack of statistical precision compromised the ability to draw appropriate conclusions). Reported Primary Outcome Measure data reflects data collection through March 2008.|2||Due to poor accrual|f||||t||||||||||2017-02-18 17:55:52.36019|2017-02-18 17:55:52.36019
NCT00072267|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2015-07-22|||January 2004||2004-01-01|July 2015|2015-07-01||||April 2005|Actual|2005-04-01||Interventional|||UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase II Study of UCN-01 in Combination With Topotecan in Patients With Advanced Ovarian Cancer|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 17:55:53.368165|2017-02-18 17:55:53.368165
NCT00072228|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Phase I Study of Soblidotin and Gemcitabine in Patients With Locally Advanced or Metastatic Solid Tumors|Withdrawn||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:53.463562|2017-02-18 17:55:53.463562
NCT00072215|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2016-07-01|||April 2004||2004-04-01|July 2016|2016-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors|A Randomized Phase III Study of Paclitaxel, Ifosfamide and Cisplatin Versus Vinblastine, Ifosfamide and Cisplatin as Second-Line Therapy for Patients With Relapsed/Resistant Germ Cell Tumors|Terminated||Phase 3|1|Actual|Alliance for Clinical Trials in Oncology||2||poor accrual|f||||t||||||||||2017-02-18 17:55:53.546232|2017-02-18 17:55:53.546232
NCT00072189|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2015-02-17|2015-02-17||November 2003||2003-11-01|October 2013|2013-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase II Study of UCN-01 in Metastatic Melanoma|A Phase II Study of UCN-01 in Metastatic Melanoma|Terminated||Phase 2|17|Actual|National Cancer Institute (NCI)|Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results|1||Early termination for discouraging results|f||||||||||||||2017-02-18 17:55:53.744674|2017-02-18 17:55:53.744674
NCT00072176|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2015-02-05|2015-02-05||May 2004||2004-05-01|March 2014|2014-03-01|August 2009|Actual|2009-08-01|May 2009|Actual|2009-05-01||Interventional||All patients received treatment|Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer|A Phase II Study of CCI-779 in Patients With Metastatic and/or Locally Advanced Recurrent Endometrial Cancer|Completed||Phase 2|62|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:54.069159|2017-02-18 17:55:54.069159
NCT00072163|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-01-15|||October 2003||2003-10-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma|A Phase II Study Of Temozolomide And Thalidomide In Patients With Metastatic Melanoma In The Brain|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:54.590572|2017-02-18 17:55:54.590572
NCT00072150|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-06-04|||October 2003||2003-10-01|June 2013|2013-06-01||||March 2006|Actual|2006-03-01||Interventional|||Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma|Phase II Trial of PS-341 (Bortezomib) in Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:54.693245|2017-02-18 17:55:54.693245
NCT00072137|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2014-12-22|||October 2003||2003-10-01|August 2013|2013-08-01|November 2010|Actual|2010-11-01|December 2009|Actual|2009-12-01||Interventional|||Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy|Phase I Study of Intravesical Recombinant Fowlpox - GM-CSF (rF-GM-CSF) and/or Recombinant Fowlpox-TRICOM (rF-TRICOM) in Patients With Bladder Carcinoma Scheduled for Cystectomy|Terminated||Phase 1|21|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 17:55:54.800154|2017-02-18 17:55:54.800154
NCT00072124|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-06-18|||September 2003||2003-09-01|January 2005|2005-01-01|May 2005|Actual|2005-05-01|||||Interventional|||Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma|A Prospective Random Assignment Trial Comparing Complete Metastasectomy to Chemotherapy for Selected Patients With Stage IV Melanoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:54.917681|2017-02-18 17:55:54.917681
NCT00072111|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2015-04-29|||September 2003||2003-09-01|April 2006|2006-04-01||||||||Interventional|||Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene|Phase I Study of Anakinra Mediated Tumor Regression and Angiogenesis Inhibition in Subjects With Cancers Producing Interleukin-1|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:54.999047|2017-02-18 17:55:54.999047
NCT00072098|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2017-01-10|||September 2003||2003-09-01|January 2017|2017-01-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer|Phase I Trial Of Adenoviral Vector Delivery Of The Human Interleukin-12 cDNA By Intratumoral Injection In Patients With Metastatic Colorectal Cancer To The Liver|Terminated||Phase 1|22|Actual|Icahn School of Medicine at Mount Sinai||1||limited funding|f||||t||||||||||2017-02-18 17:55:55.305555|2017-02-18 17:55:55.305555
NCT00072085|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-06-18|||September 2003||2003-09-01|May 2005|2005-05-01|July 2006|Actual|2006-07-01|||||Interventional|||Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma|Immunization Of Patients With Metastatic Melanoma Using A Recombinant GP100 Protein (184V) And A Class I Restricted Peptide From The GP100 Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:55.410336|2017-02-18 17:55:55.410336
NCT00072072|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-09-19|||August 2003||2003-08-01|January 2006|2006-01-01|January 2006|Actual|2006-01-01|||||Interventional|||Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase I Trial Of A COX-2 Inhibitor (Celecoxib) In Combination With An EGFR Inhibitor (OSI-774) In Metastatic Non-Small Cell Lung Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:55.505182|2017-02-18 17:55:55.505182
NCT00071630|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-11-06|||September 2002||2002-09-01|September 2008|2008-09-01|August 2005||2005-08-01|||||Interventional|||Therapeutic Processes and Treatment Outcome in Adolescents With Anxiety Disorders|Process as a Predictor of Outcomes in CBT for Youth|Completed||Phase 4|130||Temple University|||||f||||||||||||||2017-02-18 17:56:10.934443|2017-02-18 17:56:10.934443
NCT00072059|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-07-17|||July 2003||2003-07-01|January 2005|2005-01-01|February 2005|Actual|2005-02-01|||||Interventional|||Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer|An Open Label, Randomized, Multicenter, Phase II Study To Determine Hemoglobin Dose Response, Safety And Pharmacokinetic Profile Of Ro 50-3821 Given Subcutaneously Once Weekly Or Once Every 3 Weeks To Anemic Patients With Stage IIIB or IV Non-Small Cell Lung Carcinoma Receiving Antineoplastic Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:55.598182|2017-02-18 17:55:55.598182
NCT00072046|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2016-07-01|||October 2003||2003-10-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|January 2004|Actual|2004-01-01||Interventional|||Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)|A Randomized Phase III Trial Of Interferon Alfa-2B Or Interferon Alfa-2B Plus Bevacizumab In Patients With Advanced Renal Carcinoma|Completed||Phase 3|732|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:55:55.999471|2017-02-18 17:55:55.999471
NCT00072033|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2012-06-02|||March 2003||2003-03-01|June 2012|2012-06-01|May 2010|Actual|2010-05-01|March 2003|Actual|2003-03-01||Interventional|||Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer|Docetaxel and Cisplatin Chemo- and Radiochemotherapy Followed by Surgery in Patients With Locally Advanced Esophageal Cancer - A Multicenter Phase II Trial|Completed||Phase 2|66|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 17:55:57.063993|2017-02-18 17:55:57.063993
NCT00072020|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-08-01|||August 2003||2003-08-01|January 2006|2006-01-01||||||||Interventional|||Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer|Does Adjuvant Zoledronic Acid Reduce Recurrence in Patients With High Risk Localized Breast Cancer?|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:57.192103|2017-02-18 17:55:57.192103
NCT00072007|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2012-05-14|||June 2002||2002-06-01|May 2012|2012-05-01|October 2010|Actual|2010-10-01|March 2003|Actual|2003-03-01||Interventional|||Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL|2-CDA and Rituximab as Remission Induction and Rituximab as In Vivo Purging Prior to Peripheral Stem Cell Mobilization in Patients With Chronic Lymphocytic Leukemia (CLL) - A Prospective Multicenter Phase II Trial|Completed||Phase 2|43|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 17:55:57.298148|2017-02-18 17:55:57.298148
NCT00071994|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-02-26|||February 2004||2004-02-01|February 2013|2013-02-01||||May 2005|Actual|2005-05-01||Interventional|||Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)|A Phase II Study of ZD1839 (Iressa, Gefitinib, NSC 715055) in Advanced Unresectable Hepatocellular Carcinoma|Completed||Phase 2|59|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:57.424693|2017-02-18 17:55:57.424693
NCT00071981|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2015-10-06|2012-11-24||March 2005||2005-03-01|October 2015|2015-10-01|January 2014|Actual|2014-01-01|August 2011|Actual|2011-08-01||Interventional|||Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma|A Randomized Phase II Trial of Multi-Epitope Vaccination With Melanoma Peptides For Cytotoxic T Cells And Helper T Cells For Patients With Metastatic Melanoma|Completed||Phase 2|175|Actual|Eastern Cooperative Oncology Group||4|||f||||f||||||||||2017-02-18 17:55:57.549114|2017-02-18 17:55:57.549114
NCT00071968|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-01-07|||August 2003||2003-08-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse|An Open-Label Study Of Exploratory Pharmacogenomics And Pharmacologic Effects Of Neoadjuvant Oral CCI-779 In Newly Diagnosed Prostate Cancer Patients Undergoing Radical Prostatectomy Who Have A High Risk Of Relapse|Completed||Phase 2|15|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 17:55:58.415999|2017-02-18 17:55:58.415999
NCT00071955|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-12-18|||March 2003||2003-03-01|January 2006|2006-01-01|January 2009|Actual|2009-01-01|||||Interventional|||Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma|A Phase II Study to Evaluate Safety and Efficacy of Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH and GM-CSF Following the Anti-CD20 Antibody, Rituximab, in Previously Treated Patients With Follicular Non-Hodgkin's Lymphoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:58.638827|2017-02-18 17:55:58.638827
NCT00071942|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-12-10|||October 2003||2003-10-01|December 2013|2013-12-01||||November 2007|Actual|2007-11-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Breast Cancer|A Phase I Trial of An Admixture of Recombinant Vaccinia Virus That Express DF3/MUC1 and rV-TRICOM (B7.ICAM-1, and LFA-3) in Patients With Metastatic Adenocarcinoma of The Breast|Terminated||Phase 1|22|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:55:58.742201|2017-02-18 17:55:58.742201
NCT00071929|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2013-06-20|||November 1999||1999-11-01|September 2004|2004-09-01|September 2007|Actual|2007-09-01|||||Interventional|||Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer|Phase II Evaluation of Oxaliplatin in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:55:58.854076|2017-02-18 17:55:58.854076
NCT00071916|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-04|2010-10-28|||March 2001||2001-03-01|March 2010|2010-03-01|June 2010|Anticipated|2010-06-01|||||Observational|||Racial Difference in HCV/Host Interactions|African American Response to Therapy for Hepatitis C|Unknown status|Recruiting|N/A|260|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     Blood. No liver biopsies will be performed specifically for inclusion into the tissue~     repository. Only slides or paraffin tissue blocks of previously performed liver biopsies~     will be included in the tissue repository.~   "|||2017-02-18 17:55:58.974491|2017-02-18 17:55:58.974491
NCT00071903|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-03|2017-01-24|||October 30, 2003||2003-10-30|July 18, 2008|2008-07-18|July 18, 2008||2008-07-18|||||Observational|||The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study|The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study|Completed||N/A|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:59.068416|2017-02-18 17:55:59.068416
NCT00071682|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-05-13|||October 2007||2007-10-01|May 2013|2013-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Evaulation of Interaction Between Herbal Products and Anticoagulants|Early Identification of Adverse Reactions to Herbs|Withdrawn||N/A|0|Actual|University of California, San Francisco|||||f||||f||||||||||2017-02-18 17:56:10.581877|2017-02-18 17:56:10.581877
NCT00071890|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-03|2010-09-13|2010-09-13||October 2003||2003-10-01|September 2010|2010-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|ILIADE||Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx|Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Anti-Retroviral TX in HIV Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm(3) Who Have Received Anti-Retroviral TX|Completed||Phase 2|148|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 17:55:59.158926|2017-02-18 17:55:59.158926
NCT00071877|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-03|2008-03-03|||October 2003||2003-10-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease|A Clinical Trial of Replagal Enzyme Replacement Therapy in Children Ages 7 - 17 Years With Fabry Disease|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:55:59.832629|2017-02-18 17:55:59.832629
NCT00071851|ClinicalTrials.gov processed this data on February 17, 2017|2003-11-03|2015-04-09|||December 2003||2003-12-01|April 2015|2015-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults|A Phase IB Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP, Administered at 2 Different Dosing Schedules, in HIV-1-Uninfected Adult Participants|Completed||Phase 1/Phase 2|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:55:59.914307|2017-02-18 17:55:59.914307
NCT00071838|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-31|2017-01-24|||October 30, 2003||2003-10-30|August 16, 2011|2011-08-16|August 16, 2011|Actual|2011-08-16|October 4, 2007|Actual|2007-10-04||Interventional|||Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis|Zenapax (Daclizumab) Admin to Pts With Multiple Sclerosis (ZAP MS): Effect of Intravenously Admin Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (Daclizumab) on Inflammatory Activity in the Central Nervous System|Completed||Phase 2|16|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:56:00.032352|2017-02-18 17:56:00.032352
NCT00071812|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-31|2013-08-01|2012-02-27||December 2003||2003-12-01|August 2013|2013-08-01|December 2005|Actual|2005-12-01|January 2005|Actual|2005-01-01||Interventional|||A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)|A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)|Completed||Phase 2|283|Actual|Human Genome Sciences Inc.||4|||f||||t||||||||||2017-02-18 17:56:00.149408|2017-02-18 17:56:00.149408
NCT00071799|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-31|2010-08-24|2010-03-02||November 2003||2003-11-01|August 2010|2010-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care|A Multicenter, Randomized, Open-label, Parallel-group, Phase 3 Trial of Subcutaneous Azacitidine Plus Best Supportive Care Versus Conventional Care Regimens Plus Best Supportive Care for the Treatment of Myelodysplastic Syndromes (MDS)|Completed||Phase 3|358|Actual|Celgene||2|||f||||t||||||||||2017-02-18 17:56:01.452803|2017-02-18 17:56:01.452803
NCT00071786|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-30|2017-01-24|||August 20, 2003||2003-08-20|September 28, 2016|2016-09-28||||||||Observational|||Family Study of Affective and Anxiety Spectrum Disorders|Family Study of Affective and Anxiety Spectrum Disorders|Recruiting||N/A|3775|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:04.577591|2017-02-18 17:56:04.577591
NCT00071773|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-30|2016-08-25|||July 2003||2003-07-01|August 2016|2016-08-01|February 2008|Actual|2008-02-01|November 2005|Actual|2005-11-01||Interventional|Laser||A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema|A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema|Completed||Phase 2|263|Actual|Jaeb Center for Health Research||2|||f||||f||||||||||2017-02-18 17:56:04.795861|2017-02-18 17:56:04.795861
NCT00071760|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-30|2016-11-28|2012-03-02||October 2003||2003-10-01|November 2016|2016-11-01|June 2021|Anticipated|2021-06-01|July 2011|Actual|2011-07-01||Interventional|||Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects|A 48 Week, Phase II, Open-label, 2-cohort, Multicenter Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Antiviral Activity of GW433908 and GW433908/RTV When Administered to HIV-1 Infected Protease Inhibitor (PI) Naive and PI-experienced Pediatric Subjects Aged 4 Weeks to <2 Years.|Active, not recruiting||Phase 2|75|Actual|ViiV Healthcare||2|||f||||t||||||||||2017-02-18 17:56:04.935192|2017-02-18 17:56:04.935192
NCT00071747|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-30|2016-08-30|||August 2003||2003-08-01|August 2016|2016-08-01|January 2005|Actual|2005-01-01|||||Interventional|||Clinical Study Of Schizophrenia in Both Men and Women|A Multi-Center, Double Blind, Placebo-controlled, Randomized, Parallel Group Evaluation of the Efficacy of a Flexible Dose of Lamotrigine Versus Placebo As Add-On Therapy In Schizophrenia|Completed||Phase 3|176||GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:56:09.028939|2017-02-18 17:56:09.028939
NCT00071734|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2008-03-03|||October 2003||2003-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Brain Activation During Simple Vocal Behaviors|Brain Activation During Simple Vocal Behaviors|Completed||N/A|37||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:09.147971|2017-02-18 17:56:09.147971
NCT00071721|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2014-09-15|2010-07-06||October 2003||2003-10-01|September 2014|2014-09-01|December 2009|Actual|2009-12-01|February 2009|Actual|2009-02-01||Interventional|||Valproate in Dementia (VALID)|A Randomized, Double-Blind, Placebo-Controlled Trial of Valproate to Attenuate the Progression of Alzheimer's Disease (AD)|Completed||Phase 3|313|Actual|Alzheimer's Disease Cooperative Study (ADCS)||2|||f||||t||||||||||2017-02-18 17:56:09.23289|2017-02-18 17:56:09.23289
NCT00071708|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2008-07-30||||||July 2008|2008-07-01||||||||Expanded Access|||Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial|Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial|No longer available||N/A|||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:56:10.394706|2017-02-18 17:56:10.394706
NCT00071695|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2007-05-17|||July 2003||2003-07-01|May 2007|2007-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Duloxetine vs. Active Comparator in the Treatment of Patients With Depression|Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder|Completed||Phase 4|320||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:56:10.493294|2017-02-18 17:56:10.493294
NCT00071617|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-11-08|||November 2002||2002-11-01|November 2013|2013-11-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Youth-Nominated Support Team Intervention for Suicidal Adolescents|Youth Support Team Intervention for Suicidal Adolescents|Completed||Phase 2|448|Actual|University of Michigan||2|||f||||t||||||||||2017-02-18 17:56:11.015911|2017-02-18 17:56:11.015911
NCT00071604|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-05-03|||September 2002||2002-09-01|April 2008|2008-04-01|May 2007||2007-05-01|||||Interventional|||Medication Adherence in Older People With Psychosis|Medication Adherence in Older Psychotic People|Unknown status|Active, not recruiting|N/A|240|Anticipated|Veterans Medical Research Foundation|||||f||||||||||||||2017-02-18 17:56:11.119021|2017-02-18 17:56:11.119021
NCT00071591|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-06-13|||July 2001||2001-07-01|June 2013|2013-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Rehabilitative Training for Older People With Schizophrenia|Functional Skills Training for Late Life Schizophrenia|Completed||Phase 2|240||University of California, San Diego|||||f||||||||||||||2017-02-18 17:56:11.289309|2017-02-18 17:56:11.289309
NCT00071578|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-29|2013-06-26|||October 2003||2003-10-01|June 2013|2013-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Comparing Two Group Therapy Treatments for Binge Eating Disorder|Comparison of Dialectical Behavior Therapy and Supportive Therapy for Binge Eating Disorder|Completed||N/A|101|Actual|Stanford University||2|||f||||t||||||||||2017-02-18 17:56:11.566528|2017-02-18 17:56:11.566528
NCT00071565|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-28|2015-08-17|||September 2002||2002-09-01|August 2015|2015-08-01|May 2015|Actual|2015-05-01|May 2015|Actual|2015-05-01||Observational|||Familial Intracranial Aneurysm Study II|Familial Intracranial Aneurysm Study II|Completed||N/A|5875|Actual|University of Cincinnati|||1||f||||f||||||Samples With DNA|"~     blood sample~   "|||2017-02-18 17:56:11.677082|2017-02-18 17:56:11.677082
NCT00071552|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-28|2014-05-09|||January 2004||2004-01-01|May 2014|2014-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients|Evaluation of Clinical Efficacy of HFA-Propelled Beclomethasone Dipropionate Metered-Dose Inhaler Versus Fluticasone Propionate Multidose Dry Powder Inhaler on Small Airways in Poorly Controlled Asthmatic Adolescent and Adult Patients|Terminated||Phase 4|49|Actual|Teva Pharmaceutical Industries||2||Very poor enrollment|f||||f||||||||||2017-02-18 17:56:11.793152|2017-02-18 17:56:11.793152
NCT00071539|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-28|2012-01-18|||October 2003||2003-10-01|January 2012|2012-01-01|July 2006|Actual|2006-07-01|January 2006|Actual|2006-01-01||Interventional|||Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors||Completed||Phase 2|56|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 17:56:11.883739|2017-02-18 17:56:11.883739
NCT00071526|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-27|2017-01-24|||October 24, 2003||2003-10-24|October 26, 2016|2016-10-26||||||||Observational|||Urinary Vitamin C Loss in Diabetic Subjects|Urinary Vitamin C Loss in Subjects With and Without Diabetes|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:11.980994|2017-02-18 17:56:11.980994
NCT00071513|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-24|2016-07-07|2015-12-06||March 2003||2003-03-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|CAST-T/HSTS|All participants.|Middle School to High School Transition Project: Depression and Substance Abuse Prevention|Middle School to High School Transition Project|Completed||Phase 1|497|Actual|University of Washington|"A significant limitation of this trial was the brief nature of the comparison condition, the Brief Intervention group; findings might reflect dose rather than content of the CAST-T/HSTS intervention."|2|||f||||f||||||||No|Add data has been de-identified. De-identified data is available to share.|2017-02-18 17:56:12.113313|2017-02-18 17:56:12.113313
NCT00071500|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-24|2008-09-25|||October 2003||2003-10-01|September 2008|2008-09-01|June 2009|Anticipated|2009-06-01|June 2007|Actual|2007-06-01||Interventional|||An Electronic Pillbox for People With HIV|A Novel Technology to Improve HIV Medication Compliance|Unknown status|Active, not recruiting|Phase 1|75|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 17:56:12.552656|2017-02-18 17:56:12.552656
NCT00071487|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-24|2013-08-01|2012-02-27||October 2003||2003-10-01|August 2013|2013-08-01|June 2006|Actual|2006-06-01|August 2005|Actual|2005-08-01||Interventional|||Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)|A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B™ Antibody (Monoclonal Anti-BLyS Antibody) in Subjects With Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|449|Actual|Human Genome Sciences Inc.||4|||f||||t||||||||||2017-02-18 17:56:12.68392|2017-02-18 17:56:12.68392
NCT00071474|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-23|2007-01-22|||August 2003||2003-08-01|January 2007|2007-01-01|May 2005||2005-05-01|||||Interventional|||Shamanic Healing for Women With Temporomandibular Joint Disorders (TMDs)||Completed||Phase 1|25||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:56:14.799552|2017-02-18 17:56:14.799552
NCT00071461|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-23|2012-02-22||2010-02-11|August 2003||2003-08-01|February 2012|2012-02-01|May 2010|Actual|2010-05-01|September 2005|Actual|2005-09-01||Interventional|BUILD 1||Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Idiopathic Pulmonary Fibrosis, Open Label Extension|Completed||Phase 2/Phase 3|158|Actual|Actelion||2|||f||||t||||||||||2017-02-18 17:56:14.904826|2017-02-18 17:56:14.904826
NCT00071448|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-23|2016-12-21|||June 2002||2002-06-01|December 2016|2016-12-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population|Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes|Completed||Phase 3|378|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:56:15.049612|2017-02-18 17:56:15.049612
NCT00071435|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-22|2008-03-03|||October 2003||2003-10-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Observational|||Brain Function in Primary Lateral Sclerosis|Movement Related Cortical Potentials in Primary Lateral Sclerosis|Completed||N/A|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:15.23397|2017-02-18 17:56:15.23397
NCT00071422|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-22|2014-07-10|||October 2003||2003-10-01|August 2011|2011-08-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes|A Randomized, Double-blind, Placebo-controlled, Rising-dose, Multicenter Study to Evaluate the Efficacy and Safety of 90 Days of 300 or 600 mg Daily Subcutaneous Injections of INGAP Peptide in Insulin-using Type 2 Diabetes Mellitus Patients|Completed||Phase 2|126|Actual|Exsulin Corporation||3|||f||||||||||||||2017-02-18 17:56:15.318865|2017-02-18 17:56:15.318865
NCT00071409|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-22|2014-07-10|||October 2003||2003-10-01|August 2011|2011-08-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes|A Randomized, Double-blind, Placebo-controlled, Rising Dose, Multicenter Study to Evaluate the Efficacy and Safety of 90 Days of 300 or 600 mg Daily Subcutaneous Injections of INGAP Peptide in Type I Diabetes Mellitus Patients|Completed||Phase 2|63|Actual|Exsulin Corporation||3|||f||||f||||||||||2017-02-18 17:56:15.430971|2017-02-18 17:56:15.430971
NCT00071396|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-21|2012-08-01|2009-09-25||October 2002||2002-10-01|August 2012|2012-08-01|August 2007|Actual|2007-08-01|September 2006|Actual|2006-09-01||Interventional|||Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders|Continuous Infusion Followed by Subcutaneous Injection of Campath-1H Plus Rituximab in the Treatment of CD52- and CD20-Positive Refractory or Relapsed Chronic Lymphoid Disorders|Completed||Phase 2|48|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:56:15.53269|2017-02-18 17:56:15.53269
NCT00071383|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-20|2008-03-03|||October 2003||2003-10-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Observational|||Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2|Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2|Completed||N/A|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:15.768737|2017-02-18 17:56:15.768737
NCT00071370|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-20|2008-03-03|||October 2003||2003-10-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Activating Effects of Sleep Deprivation on Synchronized MEG-EEG Recordings of Epilepsy Patients With Non-Diagnostic EEG|Activating Effects of Sleep Deprivation On Synchronized MEG-EEG Recordings Of Epilepsy Patients With Non-Diagnostic EEG|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:15.855588|2017-02-18 17:56:15.855588
NCT00071357|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-20|2008-03-03|||October 2003||2003-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer|Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer|Completed||N/A|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:15.943038|2017-02-18 17:56:15.943038
NCT00071344|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-20|2008-03-03|||October 2003||2003-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Analysis of Brain Metastasis in Patients With Lung Cancer|Analysis of Brain Metastasis in Patients With Lung Cancer|Completed||N/A|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:16.034488|2017-02-18 17:56:16.034488
NCT00071331|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-20|2012-05-02|||September 2003||2003-09-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan|Protocol 156-03-236: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized With Worsening Congestive Heart Failure|Completed||Phase 3|3600||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 17:56:16.21966|2017-02-18 17:56:16.21966
NCT00071305|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-17|2017-01-24|||October 17, 2003||2003-10-17|October 6, 2009|2009-10-06||||October 6, 2009|Actual|2009-10-06||Observational|||Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings|Non-Invasive Seizure Localization in Patients With Medically Refractory Localization Related Epilepsy: Synchronized MEG-EEG Recordings|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:17.319123|2017-02-18 17:56:17.319123
NCT00071292|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-17|2008-03-05|||July 2003||2003-07-01|March 2008|2008-03-01|March 2005||2005-03-01|||||Interventional|||Meditation-Based Stress Reduction in Rheumatoid Arthritis|Mindfulness Meditation-Based Stress Reduction in Relieving Symptoms Associated With Rheumatoid Arthritis|Completed||Phase 2|80||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:56:17.412585|2017-02-18 17:56:17.412585
NCT00071279|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-16|2011-04-05|||November 2003||2003-11-01|April 2011|2011-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis|The Van Gogh-extension Trial, a Multicenter, International, Randomized, Double-blind, Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous SR34006 With Placebo in the Long-term Prevention of Symptomatic Venous Thromboembolism in Patients With Symptomatic Pulmonary Embolism or Deep-vein Thrombosis Who Completed 6 Months of Treatment With Vitamin K Antagonist or SR34006|Completed||Phase 3|1215|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:56:17.51228|2017-02-18 17:56:17.51228
NCT00071266|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-16|2006-10-31|||October 2003||2003-10-01|October 2006|2006-10-01||||||||Interventional|||The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC|The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - a Matrix Design|Completed||Phase 3|870||Kos Pharmaceuticals|||||||||||||||||||2017-02-18 17:56:17.671523|2017-02-18 17:56:17.671523
NCT00071253|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-16|2006-08-02|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness|A Randomized, Double-Blind Study of Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness|Terminated||Phase 4|180||Abbott|||||||||||||||||||2017-02-18 17:56:17.781177|2017-02-18 17:56:17.781177
NCT00071240|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-16|2009-08-14|||October 2002||2002-10-01|August 2009|2009-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Growth Hormone to Increase Immune Function in People With HIV|The Use of Recombinant Growth Hormone to Enhance T-Cell Production in Adults Infected With HIV-1|Completed||Phase 2|22|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:56:17.885023|2017-02-18 17:56:17.885023
NCT00071227|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-15|2017-01-24|||October 15, 2003||2003-10-15|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders|Pilot Study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:18.000066|2017-02-18 17:56:18.000066
NCT00071019|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2008-01-24|||September 2003||2003-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Dietary Fatty Acids, PPAR Activated Genes, and CHD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:56:20.945407|2017-02-18 17:56:20.945407
NCT00071214|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-15|2006-07-07|||September 2003||2003-09-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis|A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate Efficacy of StaphVAX, a Bivalent Staphylococcus Aureus Glycoconjugate Vaccine in Adults on Hemodialysis|Completed||Phase 3|3600||Nabi Biopharmaceuticals|||||||||||||||||||2017-02-18 17:56:18.084427|2017-02-18 17:56:18.084427
NCT00071201|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-15|2013-10-14|||June 2003||2003-06-01|October 2013|2013-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B|A Multi-Center Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Varying Degrees of Renal Impairment|Completed||Phase 3|48||Gilead Sciences|||||||||||||||||||2017-02-18 17:56:18.297053|2017-02-18 17:56:18.297053
NCT00071188|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-14|2016-08-24|||February 2004||2004-02-01|August 2016|2016-08-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|A Randomized, Partially Blinded, Phase II Study to Assess the Safety, Tolerability and Efficacy of ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 2|||Sanofi|||||f||||||||||||||2017-02-18 17:56:18.392309|2017-02-18 17:56:18.392309
NCT00071175|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-14|2015-10-13|||October 1995||1995-10-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|September 2012|Actual|2012-09-01||Observational|LFRR||Lupus Genetics Studies|Lupus Genetic Studies; Lupus Family Registry & Repository|Completed||N/A|3460|Actual|Oklahoma Medical Research Foundation|||1||f||||f||||||Samples With DNA|"~     DNA, sera, plasma, cell lines~   "|||2017-02-18 17:56:18.510737|2017-02-18 17:56:18.510737
NCT00071162|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-14|2009-03-31|||September 1999||1999-09-01|March 2009|2009-03-01||||||||Observational|||Genetics of Fibromyalgia|Fibromyalgia Family Study Registry|Unknown status|Active, not recruiting|N/A|560|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||1||f||||f||||||Samples With DNA|"~     DNA, whole blood~   "|||2017-02-18 17:56:18.608198|2017-02-18 17:56:18.608198
NCT00071149|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-14|2006-08-17|||November 2001||2001-11-01|July 2006|2006-07-01|April 2004||2004-04-01|||||Observational|||Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis|Consistency of Traditional Chinese Medicine Rheumatoid Arthritis Diagnosis and Herbal Prescriptions|Completed||N/A|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:56:18.701472|2017-02-18 17:56:18.701472
NCT00071136|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-13|2007-01-24|||December 2003||2003-12-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Phase 1/2 Dose-Escalating Study of Biweekly Alimta and Gemcitabine in Patients With Advanced Cancer|Completed||Phase 1/Phase 2|48||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:56:18.802519|2017-02-18 17:56:18.802519
NCT00071123|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-10|2017-01-24|||October 9, 2003||2003-10-09|November 15, 2010|2010-11-15|November 15, 2010||2010-11-15|||||Observational|||Evaluating Brain Responses to Facial Expressions in Major Depressive Disorder|The Functional Neuroanatomy of Emotion Regulation in Major Depressive Disorder (MDD)|Completed||N/A|172|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:18.893181|2017-02-18 17:56:18.893181
NCT00071110|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-10|2009-12-04|2009-03-27||March 2004||2004-03-01|December 2009|2009-12-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Electroacupuncture for Major Depression|Electroacupuncture for Major Depression: A Pilot Study|Completed||Phase 2|57|Actual|National Center for Complementary and Integrative Health (NCCIH)|Four participants were excluded from the analyses because of a protocol violation. In the Sham Acupuncture group, the acupuncturist placed unelectrified needles in GV-20 and Yin tang points instead of placing them laterally.|2|||f||||||||||||||2017-02-18 17:56:18.978837|2017-02-18 17:56:18.978837
NCT00071097|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-10|2016-09-19|||October 2003||2003-10-01|September 2016|2016-09-01|November 2007|Actual|2007-11-01|February 2005|Actual|2005-02-01||Interventional|||TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients|A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose Response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.|Completed||Phase 2|330|Actual|Tibotec Pharmaceuticals, Ireland||5|||f||||t||||||||||2017-02-18 17:56:19.640983|2017-02-18 17:56:19.640983
NCT00071084|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-10|2012-12-05|||May 2003||2003-05-01|November 2012|2012-11-01||||June 2004|Actual|2004-06-01||Interventional|||Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.||Completed||Phase 2|22|Actual|Emergent Product Development Seattle LLC||1|||f||||||||||||||2017-02-18 17:56:19.807476|2017-02-18 17:56:19.807476
NCT00071071|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-10|2012-12-05|||April 2003||2003-04-01|December 2012|2012-12-01||||May 2004|Actual|2004-05-01||Interventional|||Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.||Completed||Phase 2|25|Actual|Emergent Product Development Seattle LLC||1|||f||||||||||||||2017-02-18 17:56:19.899463|2017-02-18 17:56:19.899463
NCT00071058|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2012-09-12|2012-08-13||October 2003||2003-10-01|September 2012|2012-09-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer|A Study of Combination Chemotherapy & Surgical Resection in the Tx of Adrenocortical Cancer: Mitotane & Continuous Infusion Doxorubicin, Vincristine & Etoposide w/the P-glycoprotein Antagonist, Tariquidar (XR9576), Before & After Surgical Resection|Completed||Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 17:56:19.994853|2017-02-18 17:56:19.994853
NCT00071045|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2017-01-24|||October 7, 2003||2003-10-07|November 1, 2016|2016-11-01||||||||Observational|||Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members|Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples From Patients With Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:20.427298|2017-02-18 17:56:20.427298
NCT00071032|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2014-08-14|2014-08-14||July 2003||2003-07-01|August 2014|2014-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|FOCUS|Randomized subjects|Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease|Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)|Completed||Phase 3|2016|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-02-18 17:56:20.527916|2017-02-18 17:56:20.527916
NCT00071006|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2012-05-31|2012-02-25||September 2003||2003-09-01|May 2012|2012-05-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)|Phase 2 Study Of AG-013736 In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)|Completed||Phase 2|12|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 17:56:21.028012|2017-02-18 17:56:21.028012
NCT00070993|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2006-08-03|||December 2002||2002-12-01|August 2006|2006-08-01|May 2006||2006-05-01|||||Interventional|||Creatine for the Treatment of Amyotrophic Lateral Sclerosis|Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis|Completed||Phase 2|110||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 17:56:21.522658|2017-02-18 17:56:21.522658
NCT00070980|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2006-08-17|||March 2003||2003-03-01|July 2006|2006-07-01|November 2004||2004-11-01|||||Interventional|||Massage to Increase Well-Being and Immune Function in Dominican Children Infected With HIV|Massage to Enhance Well-Being in HIV-Positive Dominican Children|Completed||N/A|54||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:56:21.612969|2017-02-18 17:56:21.612969
NCT00070967|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2006-08-17|||September 2001||2001-09-01|July 2006|2006-07-01|February 2005||2005-02-01|||||Interventional|||Acupuncture to Improve Quality of Life in Patients With Advanced Cancer|Effects of Acupuncture on Pain, Nausea, Quality of Life|Completed||Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:56:21.692309|2017-02-18 17:56:21.692309
NCT00070954|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2011-06-27|||February 2003||2003-02-01|August 2008|2008-08-01|March 2005|Actual|2005-03-01|January 2005|Actual|2005-01-01||Interventional|||Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)|Ginkgo Biloba for ECT-induced Memory Deficits|Terminated||Phase 1/Phase 2|50|Anticipated|Medical University of South Carolina||2|||f||||||||||||||2017-02-18 17:56:21.77334|2017-02-18 17:56:21.77334
NCT00070941|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2016-06-02|2013-05-03||July 2003||2003-07-01|June 2016|2016-06-01|October 2010|Actual|2010-10-01|June 2010|Actual|2010-06-01||Interventional|||SAM-e for the Treatment of Depression in Patients With Parkinson's Disease|SAM-e Treatment of Depression in Parkinson's Disease.|Completed||Phase 2/Phase 3|29|Actual|New York University School of Medicine||3|||f||||t||||||||||2017-02-18 17:56:21.882919|2017-02-18 17:56:21.882919
NCT00070928|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2006-07-25|||September 2000||2000-09-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Valerian to Improve Sleep in Patients With Parkinson's Disease|Polysomnographic Assessment of Alternative Treatments for Sleep Disturbance in Parkinson's Disease|Completed||Phase 2|80||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:56:22.415122|2017-02-18 17:56:22.415122
NCT00070915|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2011-06-28|||September 2000||2000-09-01|June 2011|2011-06-01|June 2003||2003-06-01|||||Interventional|||Massage, Meditation, and Tai Chi for Chronic Lower Back Pain|Relaxation-Related CAM Therapies for Chronic Back Pain|Completed||N/A|120||Group Health Cooperative|||||f||||||||||||||2017-02-18 17:56:22.695381|2017-02-18 17:56:22.695381
NCT00070902|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2006-08-16|||June 2000||2000-06-01|August 2006|2006-08-01|October 2002||2002-10-01|||||Interventional|||Using MRI Scans to Evaluate Spinal Manipulation|The Effects of Positioning and Adjusting on the Z Joint|Completed||Phase 1|64||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:56:22.767815|2017-02-18 17:56:22.767815
NCT00070889|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-09|2006-08-17|||September 1999||1999-09-01|July 2006|2006-07-01|August 2004||2004-08-01|||||Observational|||Brain Cell Injury in Patients With A First Episode of Psychosis|Oxidative Cell Injury: First Episode Psychotic Patients|Completed||N/A|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:56:22.857022|2017-02-18 17:56:22.857022
NCT00070876|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-08|2013-04-01|||August 2002||2002-08-01|April 2013|2013-04-01|August 2008|Actual|2008-08-01|August 2005|Actual|2005-08-01||Interventional|||Psychosocial Training for Pediatric Health Care Providers|Trial of Psychosocial Training for Pediatric Generalists|Completed||N/A|350||Johns Hopkins Bloomberg School of Public Health|||||f||||f||||||||||2017-02-18 17:56:22.932889|2017-02-18 17:56:22.932889
NCT00070863|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-08|2013-08-19|||June 2002||2002-06-01|August 2013|2013-08-01||||December 2005|Actual|2005-12-01||Interventional|||Treatment for Men Who Are Abusive to Their Partners|Behavior Therapy for Partner Violent Men|Unknown status|Active, not recruiting|Phase 1|60||University of Maryland, Baltimore County|||||f||||||||||||||2017-02-18 17:56:23.029434|2017-02-18 17:56:23.029434
NCT00070850|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-08|2007-06-28|||April 2001||2001-04-01|August 2005|2005-08-01|July 2005||2005-07-01|||||Observational|||Prenatal Screening For Smith-Lemli-Opitz Syndrome|The Feasibility of Screening for Smith-Lemli-Opitz Syndrome|Completed||Phase 2|1800||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:56:23.114736|2017-02-18 17:56:23.114736
NCT00070837|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-08|2007-07-12|||October 2003||2003-10-01|July 2007|2007-07-01|October 2004||2004-10-01|||||Interventional|||MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer|A Phase 1/2 Dose Escalation Trial of Multiple Doses of MLN2704 (DM1 Conjugated Monoclonal Antibody MLN591) in Subjects With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 1/Phase 2|46||Millennium Pharmaceuticals, Inc.|||||t||||||||||||||2017-02-18 17:56:23.206092|2017-02-18 17:56:23.206092
NCT00070824|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-08|2007-09-06|||January 2004||2004-01-01|September 2007|2007-09-01|April 2007|Actual|2007-04-01|||||Interventional|||Functional Brain Imaging - Acupuncture and Osteoarthritis|Functional Brain Imaging - Acupuncture and Osteoarthritis|Completed||Phase 2/Phase 3|16|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 17:56:23.28212|2017-02-18 17:56:23.28212
NCT00070811|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-08|2013-07-02|||August 2001||2001-08-01|July 2013|2013-07-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Observational|||Assessing the Results of Lip Surgery in Patients With Cleft Lip and Palate|Functional Outcomes of Cleft Lip and Lip Revision Surgery|Completed||Phase 2/Phase 3|127|Actual|University of North Carolina, Chapel Hill|||3||f||||f||||||||||2017-02-18 17:56:23.412348|2017-02-18 17:56:23.412348
NCT00070785|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-07|2017-01-24|||October 6, 2003||2003-10-06|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations|Comprehensive Epitope Mapping of the Epstein-Barr Virus Latent Membrane Protein-2 in Ethnically Diverse Populations|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:23.533789|2017-02-18 17:56:23.533789
NCT00070759|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-07|2017-01-24|||October 6, 2003||2003-10-06|October 2, 2006|2006-10-02|October 2, 2006||2006-10-02|||||Interventional|||Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis|Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study|Completed||Phase 2|6||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:23.617621|2017-02-18 17:56:23.617621
NCT00070746|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-07|2014-07-29|||June 2003||2003-06-01|July 2014|2014-07-01|July 2005||2005-07-01|||||Observational|||Perinatal Infections in Pakistan|Perinatal Infections and Pregnancy Outcomes in Pakistan: A Collaborative Research Project in Partnership With the University of Alabama, USA|Completed||N/A|1500||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 17:56:23.718645|2017-02-18 17:56:23.718645
NCT00070733|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-07|2005-11-04|||August 2003||2003-08-01|October 2003|2003-10-01|June 2005||2005-06-01|||||Interventional|||The Effect of 5-Alpha Reductase on Testosterone in Men|The Role of 5-Alpha Reductase in Mediating Testosterone Actions|Unknown status|Recruiting|Phase 3|184||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:56:23.829916|2017-02-18 17:56:23.829916
NCT00070720|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-07|2013-12-16|||September 2003||2003-09-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|||||Interventional|||Improving Perinatal Care in Latin America|Clustered Trial for Improving Perinatal Care in Uruguay/Argentina|Completed||Phase 4|21780||NICHD Global Network for Women's and Children's Health|||||f||||t||||||||||2017-02-18 17:56:23.921626|2017-02-18 17:56:23.921626
NCT00070707|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-07|2015-06-29|||April 2003||2003-04-01|June 2015|2015-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Efficacy and Safety of Nasonex vs. Placebo in Subjects With SAR and Concomitant Asthma (Study P03280)||Terminated||Phase 4|188|Actual|Merck Sharp & Dohme Corp.||||Recruitment challenges.|||||||||||||||2017-02-18 17:56:24.032524|2017-02-18 17:56:24.032524
NCT00070694|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-06|2008-03-03|||September 2003||2003-09-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression|An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907 in Combination With Escitalopram in Treatment Resistant Depression|Completed||Phase 2|96||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:24.10801|2017-02-18 17:56:24.10801
NCT00070681|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-06|2016-07-28|||September 2003||2003-09-01|April 2009|2009-04-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Outcomes of Sleep Disorders in Older Men||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:56:24.195599|2017-02-18 17:56:24.195599
NCT00070668|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-06|2008-08-20|||September 2003||2003-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Inflammatory Genomics in Human Carotid Artery Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:56:24.27452|2017-02-18 17:56:24.27452
NCT00070655|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-06|2011-04-05|||September 2003||2003-09-01|April 2011|2011-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)|The AMADEUS Trial, A Multicenter, Randomized, Open-label, Assessor Blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Idraparinux (SR34006) With Adjusted-dose Oral Vitamin-K Antagonists in the Prevention of Thromboembolic Events in Patients With Atrial Fibrillation|Completed||Phase 3|4673|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:56:24.341994|2017-02-18 17:56:24.341994
NCT00070642|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-06|2009-02-09|||December 2003||2003-12-01|February 2009|2009-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||CPG 7909 Injection in Melanoma|ProMune™ (CPG 7909 Injection) With or Without Chemotherapy for the Treatment of Stage III b/c or IV Melanoma: A Randomized, Multi-Center, Open Label, Parallel Group, Active-Controlled, Phase II/III Study|Completed||Phase 2|184|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 17:56:24.510421|2017-02-18 17:56:24.510421
NCT00070629|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-06|2009-02-09|||May 2003||2003-05-01|February 2009|2009-02-01|July 2007|Actual|2007-07-01|||||Interventional|||CPG 7909 Injection in Non-Small Cell Lung Cancer|Promune™ (CPG 7909 Injection) In Combination With Chemotherapy In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer, A Randomized, Multi-Center, Controlled, Phase 2 Study|Completed||Phase 2|116|Actual|Pfizer||2|||f||||||||||||||2017-02-18 17:56:24.617368|2017-02-18 17:56:24.617368
NCT00070616|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-06|2014-10-23|||December 2001||2001-12-01|October 2014|2014-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support|An Open-label Study of the Pharmacokinetics (PK) of Recombinant Human Keratinocyte Growth Factor (Palifermin; rHuKGF) in Subjects With Hematologic Malignancies Undergoing Total Body Irradiation and High-dose Chemotherapy Followed by Peripheral Blood Progenitor Cell (PBPC) Transplantation|Completed||Phase 1|25|Actual|Swedish Orphan Biovitrum||2|||||||||||||||||2017-02-18 17:56:24.747694|2017-02-18 17:56:24.747694
NCT00070590|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-06|2010-02-11||2010-02-11|July 2003||2003-07-01|February 2010|2010-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis|Completed||Phase 2/Phase 3|132||Actelion|||||||||||||||||||2017-02-18 17:56:24.855187|2017-02-18 17:56:24.855187
NCT00070577|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2017-01-24|||September 29, 2003||2003-09-29|May 3, 2011|2011-05-03|May 3, 2011||2011-05-03|||||Observational|||Influence of Age and Sex on Alcohol Metabolism and Acute Responses|Influence of Age and Sex on Alcohol Metabolism and Acute Responses|Completed||N/A|65|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:24.966458|2017-02-18 17:56:24.966458
NCT00070564|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2015-09-15|||November 2003||2003-11-01|September 2015|2015-09-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer|Phase III Trial of Continuous Schedule AC + G vs. Q 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node-Negative Breast Cancer|Active, not recruiting||Phase 3|3250|Anticipated|Southwest Oncology Group||6|||f||||t||||||||||2017-02-18 17:56:25.073668|2017-02-18 17:56:25.073668
NCT00070551|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-06-03|||September 2003||2003-09-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia|A Phase I Study of GTI2040 (NSC 722929; IND 67368) in Combination With High-dose Cytarabine in Refractory or Relapsed Acute Myeloid Leukemia (AML)|Completed||Phase 1|51|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:56:26.093473|2017-02-18 17:56:26.093473
NCT00069212|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-17|2017-01-24|||September 16, 2003||2003-09-16|September 17, 2012|2012-09-17|September 17, 2012||2012-09-17|||||Observational|||Psychobiological Mechanisms of Resilience to Trauma|Psychobiological Mechanisms of Resilience to Trauma|Completed||N/A|210|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:52.359309|2017-02-18 17:56:52.359309
NCT00070538|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-07-17|||June 2003||2003-06-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|September 2004|Actual|2004-09-01||Interventional|||VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies|A Phase I Study Of VNP40101M And Cytarabine For Patients With Hematologic Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:26.208948|2017-02-18 17:56:26.208948
NCT00070525|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-10-07|||November 2003||2003-11-01|October 2013|2013-10-01||||September 2006|Actual|2006-09-01||Interventional|||Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma|A Phase II Study of R115777 (Zarnestra) (NSC # 702818, IND# 58,359) in Children With Recurrent or Progressive: High Grade Glioma, Medulloblastoma/PNET or Brainstem Glioma|Completed||Phase 2|90|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:56:26.305644|2017-02-18 17:56:26.305644
NCT00070499|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2016-12-08|2012-06-05||August 2004||2004-08-01|October 2016|2016-10-01||||November 2010|Actual|2010-11-01||Interventional|||Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia|A Phase IIb Study of Molecular Responses to Imatinib, at Standard or Increased Doses, or Dasatinib (BMS-354825) (NSC-732517) for Previously Untreated Patients With Chronic Myelogenous Leukemia (CML) in Chronic Phase|Active, not recruiting||Phase 2|406|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 17:56:26.430085|2017-02-18 17:56:26.430085
NCT00070486|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2016-06-28|||December 2003||2003-12-01|June 2016|2016-06-01|May 2011|Actual|2011-05-01|December 2006|Actual|2006-12-01||Interventional|||Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer|Randomized Phase II Study of Eicosanoid Pathway Modulators and Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|140|Actual|Alliance for Clinical Trials in Oncology||3|||f||||f||||||||||2017-02-18 17:56:30.809832|2017-02-18 17:56:30.809832
NCT00070473|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2014-02-19|||October 2003||2003-10-01|February 2014|2014-02-01|June 2008|Actual|2008-06-01|March 2006|Actual|2006-03-01||Interventional|||Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors|A Phase I Study of Pemetrexed (LY231514, Alimta) in Children and Adolescents With Recurrent Solid Tumors|Completed||Phase 1|33|Actual|Children's Oncology Group|||||||||t||||||||||2017-02-18 17:56:33.768006|2017-02-18 17:56:33.768006
NCT00070447|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2014-01-27|||November 2003||2003-11-01|October 2004|2004-10-01|June 2006|Actual|2006-06-01|||||Interventional|||Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma|Phase II Study of Rituximab (NSC 687451) + CHOP Followed by 90Y-Ibritumomab Tiuxetan (NSC 710085) in Patients With Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:33.894479|2017-02-18 17:56:33.894479
NCT00070434|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2012-06-05|||August 2004||2004-08-01|June 2012|2012-06-01||||February 2006|Actual|2006-02-01||Interventional|||S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum|A Phase II Feasibility Translational Research Trial of Induction Chemotherapy Followed by Concomitant Chemoradiation in Patients With Clinical T4 Rectal Cancer|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group||3||poor accrual|f||||t||||||||||2017-02-18 17:56:34.359292|2017-02-18 17:56:34.359292
NCT00070421|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-05-14|||April 2003||2003-04-01|December 2004|2004-12-01|January 2005|Actual|2005-01-01|||||Interventional|||Study of @neWorld: A Virtual Community for Children With Cancer|@neWorld: A Virtual Community For Kids With Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:34.477532|2017-02-18 17:56:34.477532
NCT00070382|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2015-10-01|||August 2003||2003-08-01|August 2012|2012-08-01||||November 2003|Actual|2003-11-01||Interventional|||Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer|A Randomized, Open-Label, Multicenter Study Of Darbepoetin Alfa Administered Once Every Two Weeks (Q2W) Compared With rHuEPO Administered Once Every Week (QW) For The Treatment Of Anemia In Subjects With Non-Myeloid Malignancies Receiving Multiple Chemotherapy|Completed||Phase 3|14|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:56:34.570495|2017-02-18 17:56:34.570495
NCT00070343|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2014-01-03|||August 2003||2003-08-01|November 2004|2004-11-01||||||||Interventional|||Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301|Continuation Protocol For G3139 (Bcl-2 Antisense Oligonucleotide) And Dacarbazine In Patients With Malignant Melanoma Who Responded To This Combination In Protocol GM301|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:34.715482|2017-02-18 17:56:34.715482
NCT00070317|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2015-06-03|||June 2004||2004-06-01|June 2015|2015-06-01||||January 2013|Actual|2013-01-01||Interventional|||Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer|Lymphatic Mapping and Sentinel Node Identification in Patients With Stage1B1 Cervical Carcinoma|Terminated||N/A|102|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:56:34.802149|2017-02-18 17:56:34.802149
NCT00070304|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-07-25|||July 2004||2004-07-01|July 2013|2013-07-01||||September 2007|Actual|2007-09-01||Interventional|||Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma|A Phase II Study Of Weekly Gemcitabine And Vinorelbine In Children With Recurrent Or Refractory Hodgkin's Disease|Completed||Phase 2|33|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:56:34.945249|2017-02-18 17:56:34.945249
NCT00070291|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-02-12|2013-01-07||September 2005||2005-09-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|March 2009|Actual|2009-03-01||Interventional|||Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma|A Phase II Study of Cyclosporine in the Treatment of Angioimmunoblastic T-Cell Lymphoma|Terminated||Phase 2|4|Actual|Eastern Cooperative Oncology Group||1||Slow accrual.|f||||f||||||||||2017-02-18 17:56:35.467246|2017-02-18 17:56:35.467246
NCT00070278|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-08-06|||January 2005||2005-01-01|January 2009|2009-01-01||||September 2007|Actual|2007-09-01||Interventional|||Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer|A Phase III Randomized Neoadjuvant Study of Sequential Epirubicin/Cyclophosphamide and Paclitaxel + - Gemcitabine in Poor Risk Early Breast Cancer|Unknown status|Active, not recruiting|Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:35.744721|2017-02-18 17:56:35.744721
NCT00069199|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-17|2008-03-03|||September 2003||2003-09-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Optical Coherence Tomography Comparative Study|Optical Coherence Tomography Comparative Study|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:52.444649|2017-02-18 17:56:52.444649
NCT00070265|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-01-23|||August 2003||2003-08-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer|A Multi-Institutional Phase II Trial Of Neoadjuvant Capecitabine (XELODA) And Oxaliplatin (ELOXATIN) For Resectable Colorectal Metastases In The Liver|Terminated||Phase 2|80|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:56:35.84799|2017-02-18 17:56:35.84799
NCT00070252|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2015-05-01|||September 2003||2003-09-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|February 2006|Actual|2006-02-01||Interventional|||Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer|Phase Ib/II Neoadjuvant Trial of the Farnesyltransferase Inhibitor, R115777 With Docetaxel and Capecitabine for Patients With Stage IIIA or IIIB Breast Cancer|Completed||Phase 1/Phase 2|53|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:56:35.961128|2017-02-18 17:56:35.961128
NCT00070239|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-12-13|||August 2003||2003-08-01|December 2013|2013-12-01||||June 2006|Actual|2006-06-01||Interventional|||Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies|A Phase I Clinical, Pharmacokinetic and Pharmacodynamic Study of Flavopiridol in Patients With Refractory Solid Tumors and Hematologic Malignancies|Terminated||Phase 1|100|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:56:36.083919|2017-02-18 17:56:36.083919
NCT00070213|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-09-16|||September 2003||2003-09-01|June 2011|2011-06-01||||||||Interventional|||Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer|Drug Treatment for Bowel Cancer: Making the Best Choices When a Milder Treatment is Needed|Unknown status|Active, not recruiting|Phase 3|460|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:36.20208|2017-02-18 17:56:36.20208
NCT00070200|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2014-02-12|||March 2004||2004-03-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|September 2006|Actual|2006-09-01||Interventional|||Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma|A Pilot Induction Regimen Incorporating Topotecan for Treatment of Newly Diagnosed High Risk Neuroblastoma|Completed||Phase 1|31|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:56:36.317352|2017-02-18 17:56:36.317352
NCT00070187|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-10-16|||November 2003||2003-11-01|October 2013|2013-10-01||||June 2005|Actual|2005-06-01||Interventional|||Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma|A Phase II/III Study of Immunomodulation After High Dose Myeloablative Therapy With Autologous Stem Cell Rescue for Refractory/Relapsed Hodgkin Disease|Completed||Phase 2/Phase 3|24|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 17:56:36.471256|2017-02-18 17:56:36.471256
NCT00070174|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2014-02-19|||December 2003||2003-12-01|February 2014|2014-02-01|December 2013|Actual|2013-12-01|September 2006|Actual|2006-09-01||Interventional|||Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy|Treatment of Newly Diagnosed Childhood Acute Myeloid Leukemia (AML) Using Intensive MRC-Based Therapy and Gemtuzumab Ozogamicin (GMTZ): A COG Pilot Study|Completed||Phase 2|350|Actual|Children's Oncology Group|||||f||||t||||||||||2017-02-18 17:56:36.680886|2017-02-18 17:56:36.680886
NCT00070161|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2017-01-17|||July 2001||2001-07-01|November 2016|2016-11-01|August 2012|Actual|2012-08-01|May 2005|Actual|2005-05-01||Interventional|||Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor|Donepezil and EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases|Completed||Phase 2|68|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-02-18 17:56:37.198586|2017-02-18 17:56:37.198586
NCT00070148|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2016-12-20|||March 2004||2004-03-01|April 2013|2013-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer|A Phase III Randomized Study Comparing The Effects Of Oxandrolone (Oxandrin) And Megestrol Acetate (Megace) On Lean Body Mass, Weight, Body Fat, And Quality Of Life In Patients With Solid Tumors And Weight Loss Receiving Chemotherapy|Completed||Phase 3|155|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||Undecided||2017-02-18 17:56:37.30232|2017-02-18 17:56:37.30232
NCT00070135|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2016-07-01|||January 2004||2004-01-01|July 2016|2016-07-01||||December 2016|Anticipated|2016-12-01||Interventional|||Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission|A Phase II Study Of Allogeneic Transplant For Older Patients With AML In First Morphologic Complete Remission Using A Non-Myeloablative Preparative Regimen|Active, not recruiting||Phase 2|61|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 17:56:37.443072|2017-02-18 17:56:37.443072
NCT00070122|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-01-24|||April 2004||2004-04-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer|A Phase III Trial of Modified FOLFOX6 Versus CAPOX, With Bevacizumab (NSC-704865) or Placebo, as First-Line Therapy in Patients With Previously Untreated Advanced Colorectal Cancer|Terminated||Phase 3|2200|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 17:56:37.591924|2017-02-18 17:56:37.591924
NCT00070109|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2014-09-16|2013-12-09||January 2008||2008-01-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|October 2010|Actual|2010-10-01||Interventional|||Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors|A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas|Completed||Phase 2|50|Actual|Children's Oncology Group||5|||f||||t||||||||||2017-02-18 17:56:37.72805|2017-02-18 17:56:37.72805
NCT00070096|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-06-21|||August 2003||2003-08-01|April 2006|2006-04-01|June 2007|Actual|2007-06-01|||||Interventional|||Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors|A Phase II Study of BMS-247550 In Advanced Germ Cell Tumor Patients - THERAPEUTIC/DIAGNOSTIC PROTOCOL|Completed||Phase 2|29|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:56:38.964868|2017-02-18 17:56:38.964868
NCT00005331|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1988||1988-09-01|July 2000|2000-07-01|February 1995|Actual|1995-02-01|||||Observational|||Providers for Smoking Prevention Programs||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.579323|2017-02-18 18:15:07.579323
NCT00070083|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2009-04-04|||July 2003||2003-07-01|June 2005|2005-06-01||||||||Interventional|||Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma|A Phase I Study Of G3139 Antisense Oligonucleotide (Oblimersen) In Combination With CHOP And Rituximab In Untreated Advanced Stage Diffuse Large B Cell Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:39.052828|2017-02-18 17:56:39.052828
NCT00070070|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-07-18|||May 2003||2003-05-01|July 2013|2013-07-01||||April 2006|Actual|2006-04-01||Interventional|||Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder|NY-ESO-1 Protein Immunization of Post-Cystectomy Patients With Transitional Cell Carcinomas Expressing NY-ESO-1 or LAGE-1 Antigen|Completed||Phase 1|||Ludwig Institute for Cancer Research|||||f||||||||||||||2017-02-18 17:56:39.141215|2017-02-18 17:56:39.141215
NCT00070057|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2016-12-28|||April 2003||2003-04-01|December 2016|2016-12-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer|An Exploratory, Open-Label Phase I Pharmacodynamic Study of COX-2 Inhibition With Celecoxib (Celebrex) and Aromatase Activity in Breast Cancer|Completed||Phase 1|75|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 17:56:39.22762|2017-02-18 17:56:39.22762
NCT00070031|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-12-18|||June 2003||2003-06-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|April 2006|Actual|2006-04-01||Interventional|||Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy|A Phase II Study of Intravenous Edotecarin (PHA-782615) in Patients With Anthracycline- and Taxane-Refractory or Chemoresistant Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:39.336474|2017-02-18 17:56:39.336474
NCT00070018|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2016-04-20|2012-03-05||February 2004||2004-02-01|April 2016|2016-04-01|November 2018|Anticipated|2018-11-01|November 2010|Actual|2010-11-01||Interventional|||S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma|Evaluation of CHOP Plus Involved Field Radiotherapy Followed by Yttrium-90 Ibritumomab Tiuxetan for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High-Risk Localized, Aggressive Histologies of Non-Hodgkin Lymphoma, Phase II|Active, not recruiting||Phase 2|46|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 17:56:39.443168|2017-02-18 17:56:39.443168
NCT00070005|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2013-08-06|||June 2002||2002-06-01|April 2007|2007-04-01||||||||Interventional|||J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal Adenocarcinoma|A Phase III Randomised Study Of J-Pouch Coloanal Anastomosis Versus Side-To-End Coloanal Anastomosis After Preoperative Radiotherapy And Total Mesorectal Excision In Patients With Mid And Distal Rectal Cancer|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:40.082301|2017-02-18 17:56:40.082301
NCT00069992|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2012-10-05|||December 2001||2001-12-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|September 2006|Actual|2006-09-01||Interventional|MPDMDSBMT||Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML|Safety And Efficacy of Sub-Myeloablative Allogeneic Stem Cell Transplantation For Patients With Myeloproliferative Disorder (MPD), Myelodysplastic Syndrome (MDS), Acute Myelogenous Leukemia (AML) or Chronic Myelogenous Leukemia|Terminated||Phase 2|7|Actual|Baylor College of Medicine||1||Closed due to competing protocols|f||||t||||||||||2017-02-18 17:56:40.176763|2017-02-18 17:56:40.176763
NCT00069966|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2009-07-04|||April 2003||2003-04-01|November 2004|2004-11-01||||||||Interventional|||Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse|A Phase II Trial of BBR 2778 in Combination With Cytarabine, Methylprednisolone and Cisplatin (BSHAP) as Salvage in Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:56:40.296745|2017-02-18 17:56:40.296745
NCT00069953|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2016-12-30|2014-10-14||September 2003||2003-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|March 2007|Actual|2007-03-01||Interventional||All eligible patients.|Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Study Of Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus|Completed||Phase 2|43|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 17:56:40.42598|2017-02-18 17:56:40.42598
NCT00069940|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2010-12-26|||December 2000||2000-12-01|December 2010|2010-12-01|August 2008|Actual|2008-08-01|August 2006|Actual|2006-08-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor|A Phase I Study Of Vaccination With Telomerase Peptide Plus GM-CSF|Completed||Phase 1|||Dana-Farber Cancer Institute|||||f||||t||||||||||2017-02-18 17:56:40.825953|2017-02-18 17:56:40.825953
NCT00069927|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-03|2014-01-31|||August 2003||2003-08-01|January 2014|2014-01-01|September 2006|Actual|2006-09-01|June 2006|Actual|2006-06-01||Interventional|||Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression|Adderall-XR Versus Concerta For Cancer Treatment-Related Neurocognitive Sequelae And Depression In Pediatric Patients: A Randomized Phase II Study|Terminated||Phase 2|12|Actual|University of South Florida||2||Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility|f||||t||||||||||2017-02-18 17:56:40.929366|2017-02-18 17:56:40.929366
NCT00069914|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-02|2008-03-03|||September 2003||2003-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Immune Response to Influenza Vaccine in HIV-Infected Individuals|Immune Response to Influenza Vaccination in HIV-Infected Individuals|Completed||N/A|165||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:41.049558|2017-02-18 17:56:41.049558
NCT00069901|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-02|2008-09-18|||February 2003||2003-02-01|September 2008|2008-09-01|September 2006|Actual|2006-09-01|November 2005|Actual|2005-11-01||Interventional|||Phase II CT-2103/Carboplatin in Ovarian Cancer|CT-2103/Carboplatin for Patients With Newly Diagnosed Stage III or IV Ovarian or Primary Peritoneal Cancer: A Phase 2 Study|Completed||Phase 2|82|Actual|CTI BioPharma||1|||||||||||||||||2017-02-18 17:56:41.128413|2017-02-18 17:56:41.128413
NCT00069888|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-02|2011-06-07|||November 2001||2001-11-01|June 2011|2011-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy|A Multicenter, Open-Label, Phase II Trial of Adjuvant Taxotere in Patients At High Risk of Relapse Following Prostatectomy|Completed||Phase 2|83|Actual|Sanofi|||||f||||||||||||||2017-02-18 17:56:41.230818|2017-02-18 17:56:41.230818
NCT00069875|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-02|2007-12-17|||September 2003||2003-09-01|December 2007|2007-12-01|December 2005||2005-12-01|||||Interventional|||A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer|Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study of Gemcitabine-Cisplatin Combined With Two Different Doses of LY293111 or Placebo in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer|Completed||Phase 2|195||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:56:41.315717|2017-02-18 17:56:41.315717
NCT00069862|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-02|2015-03-04|||September 2003||2003-09-01|March 2015|2015-03-01|November 2005|Actual|2005-11-01|||||Interventional|||Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia|Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia|Completed||Phase 1/Phase 2|25||Sanofi|||||||||||||||||||2017-02-18 17:56:41.52769|2017-02-18 17:56:41.52769
NCT00069849|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-01|2006-08-31|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease|A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease|Terminated||Phase 2|64||Abbott|||||||||||||||||||2017-02-18 17:56:41.608784|2017-02-18 17:56:41.608784
NCT00069836|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-01|2016-08-31|||October 2003||2003-10-01|August 2016|2016-08-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.|A 24 Week, Randomised, Double Blind, Parallel Study to Compare the Change in HbA1c With AVANDAMET® (8.0mg / 2.0g) Plus Insulin to Placebo Plus Insulin, in Subjects With Type 2 Diabetes Starting Insulin Therapy|Completed||Phase 3|272|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:56:41.706388|2017-02-18 17:56:41.706388
NCT00069823|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-01|2012-12-17|2010-05-14||September 2003||2003-09-01|December 2012|2012-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study of Acid Reflux in Asthma|The Study of Acid Reflux in Asthma|Completed||Phase 3|403|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-02-18 17:56:42.09967|2017-02-18 17:56:42.09967
NCT00069810|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-01|2009-07-16|||August 2003||2003-08-01|July 2009|2009-07-01|December 2010|Anticipated|2010-12-01|December 2010|Anticipated|2010-12-01||Observational|||Role of Chronic Kidney Disease in Cardiovascular Disease|Oxidative Stress in Chronic Kidney Disease|Withdrawn||N/A|200|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||1|The study is not a clinical trial.|f||||f||||||Samples With DNA|"~     EDTA tube of whole blood~   "|||2017-02-18 17:56:43.39439|2017-02-18 17:56:43.39439
NCT00069797|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-01|2013-01-14|||September 2003||2003-09-01|January 2013|2013-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Epidemiology of Coronary Heart Disease in Men Aged 40 and Over|Epidemiology of Coronary Heart Disease in Men Aged 40 and Over|Completed||N/A|1027|Actual|University of Pittsburgh|||1||f||||||||||Samples With DNA|"~     Blood samples (serum and plasma), buffy coat for DNA~   "|||2017-02-18 17:56:43.485796|2017-02-18 17:56:43.485796
NCT00069784|ClinicalTrials.gov processed this data on February 17, 2017|2003-10-01|2013-01-24|2012-12-18||August 2003||2003-08-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|ORIGIN||The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)|A Multicenter, International Randomized, 2x2 Factorial Design Study to Evaluate the Effects of Lantus (Insulin Glargine) Versus Standard Care, and of Omega-3 Fatty Acids Versus Placebo, in Reducing Cardiovascular Morbidity and Mortality in High Risk People With Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes Mellitus: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)|Completed||Phase 3|12537|Actual|Sanofi||4|||f||||t||||||||||2017-02-18 17:56:43.614843|2017-02-18 17:56:43.614843
NCT00069758|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-30|2014-05-08|||September 2003||2003-09-01|May 2014|2014-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma|A Multi-Center Phase II Study to Investigate the Safety and Activity of SDX-105 (Bendamustine) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab|Completed||Phase 2|72||Teva Pharmaceutical Industries|||||||||||||||||||2017-02-18 17:56:45.148703|2017-02-18 17:56:45.148703
NCT00069745|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-30|2012-08-01||2012-03-22|September 2003||2003-09-01|August 2012|2012-08-01|March 2007|Actual|2007-03-01|January 2006|Actual|2006-01-01||Interventional|||Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen|A Multi-National Phase III Study of Satraplatin Plus Prednisone or Placebo Plus Prednisone in Patients With Hormone Refractory Prostate Cancer Previously Treated With One Cytotoxic Chemotherapy Regimen|Completed||Phase 3|||Agennix|||||f||||||||||||||2017-02-18 17:56:45.245137|2017-02-18 17:56:45.245137
NCT00069732|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-30|2010-02-11||||||February 2010|2010-02-01||||||||Interventional|||Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss|Pilot of Two CAM Treatments for Maintenance of Weight Loss|Terminated||Phase 2|90||Kaiser Permanente|||||f||||||||||||||2017-02-18 17:56:45.724881|2017-02-18 17:56:45.724881
NCT00069719|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-30|2008-08-04|||February 1999||1999-02-01|August 2008|2008-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients|Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients|Completed||Phase 2|||Alcon Research|||||||||||||||||||2017-02-18 17:56:45.807509|2017-02-18 17:56:45.807509
NCT00069706|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-30|2012-02-11|||July 2003||2003-07-01|February 2012|2012-02-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients|Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients|Completed||Phase 2|118|Actual|Alcon Research||5|||f||||||||||||||2017-02-18 17:56:45.877668|2017-02-18 17:56:45.877668
NCT00069693|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2017-01-24|||September 26, 2003||2003-09-26|August 5, 2008|2008-08-05|August 5, 2008||2008-08-05|||||Observational|||Evaluation of Chronic Orthostatic Intolerance|Clinical Laboratory Evaluation of Chronic Orthostatic Intolerance|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:45.973084|2017-02-18 17:56:45.973084
NCT00069680|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2017-02-16|||September 25, 2003||2003-09-25|September 26, 2016|2016-09-26||||||||Observational|||Genetic Analysis of Gray Platelet Syndrome|Genetic Analysis of Gray Platelet Syndrome|Completed||N/A|123|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:46.063565|2017-02-18 17:56:46.063565
NCT00069654|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2017-01-24|||September 25, 2003||2003-09-25|May 18, 2009|2009-05-18||||May 18, 2009|Actual|2009-05-18||Interventional|||Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease|Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients With Coronary Artery Disease|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:56:46.157155|2017-02-18 17:56:46.157155
NCT00069641|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2015-04-27|2014-01-16||September 2003||2003-09-01|January 2014|2014-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional||Intent-to-treat (ITT) population included all randomized participants.|Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)|A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II|Completed||Phase 2/Phase 3|96|Actual|Shire||3|||f||||t||||||||||2017-02-18 17:56:46.267467|2017-02-18 17:56:46.267467
NCT00069628|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2016-09-02|||July 2003||2003-07-01|September 2016|2016-09-01|November 2004||2004-11-01|||||Interventional|||Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer|DirecNet Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer in the Management of Type 1 Diabetes in Children|Completed||Phase 4|200||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:56:47.474521|2017-02-18 17:56:47.474521
NCT00069615|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2016-09-02|||February 2003||2003-02-01|September 2016|2016-09-01|June 2003||2003-06-01|||||Interventional|||Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children|DirecNet Pilot Study to Evaluate the GlucoWatch G2 Biographer in the Management of Type 1 Diabetes in Children|Completed||Phase 4|15||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:56:47.584783|2017-02-18 17:56:47.584783
NCT00069602|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2016-09-02|||August 2002||2002-08-01|September 2016|2016-09-01|November 2002||2002-11-01|||||Interventional|||Assessing Continuous Glucose Monitors in Healthy Children|DirecNet Pilot Study to Assess the Accuracy of Continuous Glucose Monitors in Normal Children|Completed||Phase 4|20||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:56:47.691076|2017-02-18 17:56:47.691076
NCT00069589|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2017-02-15|||November 2001||2001-11-01|November 2016|2016-11-01|November 2099|Anticipated|2099-11-01|November 2099|Anticipated|2099-11-01||Observational|NAAR||Alopecia Areata Registry|Alopecia Areata Registry and Immunogenetic Mechanisms|Active, not recruiting||N/A|3100|Anticipated|M.D. Anderson Cancer Center|||1||f||||f||||||Samples With DNA|"~     DNA will be analyzed to learn the link between gene markers of traites of alopecia areata.~     Sera will be used to analyse cytokins. Lymphocytes will be used for the creation of B-cell~     lines.~   "|||2017-02-18 17:56:47.795197|2017-02-18 17:56:47.795197
NCT00069576|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2015-10-19|||October 2002||2002-10-01|October 2015|2015-10-01|October 2013|Actual|2013-10-01|November 2007|Actual|2007-11-01||Interventional|GDM||Gestational Diabetes Mellitus Trial (GDM)|A Randomized Clinical Trial of Treatment for Mild Gestational Diabetes Mellitus|Completed||N/A|1889|Actual|The George Washington University Biostatistics Center||2|||f||||t||||||||||2017-02-18 17:56:47.896152|2017-02-18 17:56:47.896152
NCT00069563|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2005-06-23|||September 1995||1995-09-01|October 2003|2003-10-01|September 2000||2000-09-01|||||Interventional|||Improving Mental Health Services for Economically Disadvantaged Children: Training Teachers|John F. Kennedy Center for Mental Retardation: Parent Vs. Teacher-Training in Children's Mental Health Services|Completed||N/A|93||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:56:48.022123|2017-02-18 17:56:48.022123
NCT00069550|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2005-06-23|||September 2004||2004-09-01|December 2004|2004-12-01|June 2008||2008-06-01|||||Interventional|||Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome|Pathogenesis of Rett Syndrome: Natural History and Treatment|Unknown status|Recruiting|Phase 3|90||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-02-18 17:56:48.105275|2017-02-18 17:56:48.105275
NCT00069537|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2016-09-02|||May 2002||2002-05-01|September 2016|2016-09-01|November 2002||2002-11-01|||||Interventional|||Continuous Glucose Monitors for Children With Diabetes Mellitus|DirecNet Inpatient Study to Test the Accuracy of Continuous Blood Glucose Monitoring Devices in Children With Type 1 Diabetes|Completed||Phase 4|90||Jaeb Center for Health Research|||||f||||||||||||||2017-02-18 17:56:48.1894|2017-02-18 17:56:48.1894
NCT00069524|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2007-09-25|||June 2004||2004-06-01|September 2007|2007-09-01|May 2006|Actual|2006-05-01|||||Interventional|||Antihyperlipidemic Effects of Oyster Mushrooms|Antihyperlipidemic Effects of Oyster Mushrooms|Completed||Phase 1/Phase 2|20||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 17:56:48.299597|2017-02-18 17:56:48.299597
NCT00069511|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-29|2005-06-23|||July 2003||2003-07-01|June 2004|2004-06-01|December 2004||2004-12-01|||||Interventional|||12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.||Unknown status|Active, not recruiting|Phase 2|72||Unither Pharmaceuticals|||||||||||||||||||2017-02-18 17:56:48.384643|2017-02-18 17:56:48.384643
NCT00069498|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-26|2007-05-24|||October 1999||1999-10-01|July 2006|2006-07-01||||||||Interventional|||Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients|Impact of Co-Receptor and HIV Viral Burden on Gut Mucosa|Completed||Phase 1|14||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:56:48.577177|2017-02-18 17:56:48.577177
NCT00069485|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-26|2007-09-17|||December 1995||1995-12-01|July 2007|2007-07-01||||||||Observational|||Resistance to HIV Infection|Evaluation of HIV-Specific Immunological and Virological Responses of HIV-1 Multiply-Exposed Seronegative Individuals|Unknown status|Recruiting|N/A|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:56:48.671007|2017-02-18 17:56:48.671007
NCT00069472|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-25|2015-09-09|||October 2002||2002-10-01|September 2015|2015-09-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Observational|NARAC||Genetic Registry for Rheumatoid Arthritis|Genetics of Rheumatoid Arthritis Registry|Completed||N/A|1062|Actual|Northwell Health|||1||f||||f||||||Samples With DNA|"~     DNA, plasma, serum and cells~   "|||2017-02-18 17:56:48.75514|2017-02-18 17:56:48.75514
NCT00069459|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-25|2017-02-06|||September 2003||2003-09-01|February 2017|2017-02-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Seasonal Affective Depression (SAD) Study|A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up Phase|Completed||Phase 2|250||GlaxoSmithKline||1|||||||||||||||||2017-02-18 17:56:48.856162|2017-02-18 17:56:48.856162
NCT00069446|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-25|2006-12-08||||||December 2006|2006-12-01||||||||Interventional|||A Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers|An Exploratory, Double-Blind, Randomized, Placebo Controlled Study Evaluating Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Chronic, Diabetic Foot Ulcers|Completed||Phase 1|50||Genentech, Inc.|||||f||||||||||||||2017-02-18 17:56:48.999361|2017-02-18 17:56:48.999361
NCT00069433|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-24|2013-09-23|||April 2001||2001-04-01|September 2013|2013-09-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Enhancing the Outcome of Skills Training for People With Schizophrenia|Skills Training for Schizophrenia: Enhancing Outcomes|Completed||N/A|60||New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 17:56:49.28609|2017-02-18 17:56:49.28609
NCT00069420|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-24|2013-12-30|||September 2003||2003-09-01|December 2013|2013-12-01|May 2007|Actual|2007-05-01|January 2007|Actual|2007-01-01||Interventional|||Cognitive Motivational Behavior Therapy for Gamblers|Cognitive-Motivational Behavior Therapy for Gamblers|Completed||Phase 1|40||University at Albany|||||f||||f||||||||||2017-02-18 17:56:49.38512|2017-02-18 17:56:49.38512
NCT00069407|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-24|2014-12-12|||February 2003||2003-02-01|December 2014|2014-12-01|December 2006|Actual|2006-12-01|May 2006|Actual|2006-05-01||Interventional|||Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major Depression|Comparing Three Electrode Placements to Optimize ECT|Completed||N/A|230|Actual|Rutgers, The State University of New Jersey||3|||f||||t||||||||||2017-02-18 17:56:49.477667|2017-02-18 17:56:49.477667
NCT00069381|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-24|2013-03-27|||April 2002||2002-04-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Treatment for Women With Post-Traumatic Stress Disorder Related to Childhood Abuse|Skills Training, Exposure, and Their Combination in Childhood Abuse PTSD|Completed||N/A|144|Actual|New York University School of Medicine||1|||f||||||||||||||2017-02-18 17:56:49.596136|2017-02-18 17:56:49.596136
NCT00069368|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-24|2014-09-25|||July 2003||2003-07-01|September 2014|2014-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence|ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence|Completed||N/A|2161|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||f||||||||||2017-02-18 17:56:49.695969|2017-02-18 17:56:49.695969
NCT00069355|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-23|2008-03-03|||September 2003||2003-09-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Propranolol for the Treatment of Acute Stress Disorder|Propranolol For the Treatment of Acute Stress Disorder|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:49.77968|2017-02-18 17:56:49.77968
NCT00069342|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-23|2017-01-24|||September 15, 2003||2003-09-15|April 8, 2016|2016-04-08||||||||Observational|||Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases|Health Beliefs and Health Behavior Practices Among Minorities With Rheumatic Diseases|Completed||N/A|140|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:49.870346|2017-02-18 17:56:49.870346
NCT00069329|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-22|2016-10-07|2016-05-06||September 2003||2003-09-01|October 2016|2016-10-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease|A Long-Term Outcome Study With the IL-1 Receptor Antagonist Anakinra/Kineret in Patients With Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) A Therapeutic Approach to Study the Pathogenesis of This Disease|Terminated||Phase 1/Phase 2|43|Actual|National Institutes of Health Clinical Center (CC)|Data reported is on 26 patients who completed their 3 year assessment and 20 of these patients also completed their 5 year assessment.|1||data submitted for Food and Drug Administration (FDA) approval|f||||f||||||||Yes|with Swedish Orphan Biovitrum Inc (SOBI)|2017-02-18 17:56:49.991471|2017-02-18 17:56:49.991471
NCT00069316|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-22|2017-01-24|||September 22, 2003||2003-09-22|February 18, 2011|2011-02-18|June 27, 2007|Actual|2007-06-27|June 27, 2007|Actual|2007-06-27||Interventional|||Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease|A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (Omr-IgG-am) Containing High Anti-West Nile Virus Antibody Titers in Patients With, or at High Risk for Progression to West Nile Virus(WNV)|Completed||Phase 2|2|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:56:50.80794|2017-02-18 17:56:50.80794
NCT00069303|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-22|2017-01-24|||September 16, 2003||2003-09-16|February 18, 2011|2011-02-18|February 18, 2011||2011-02-18|||||Observational|||Natural History of West Nile Virus Infection|Investigation of the Natural History of West Nile Virus Infection in Patients With Recently Acquired West Nile Fever or Neuroinvasive Disease|Completed||N/A|110|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:50.901215|2017-02-18 17:56:50.901215
NCT00069277|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-19|2012-04-06|2012-01-09||August 2003||2003-08-01|April 2012|2012-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Study of E7389 Administered Once Every 3 Weeks In Patients With Advanced Solid Tumors|A Phase I Dose-Finding Study of E7389 (Halichondrin B Analog) Administered Once Every Three Weeks in Patients With Advanced Solid Tumors|Completed||Phase 1|21|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:56:50.989784|2017-02-18 17:56:50.989784
NCT00069264|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-19|2011-11-16|2011-11-16||September 2003||2003-09-01|November 2011|2011-11-01|July 2005|Actual|2005-07-01|March 2005|Actual|2005-03-01||Interventional|||Study of E7389 in Patients With Advanced Solid Tumors|A Phase I Dose-Finding Study of E7389 (Halichondrin B Analog) in Patients With Advanced Solid Tumors|Completed||Phase 1|33|Actual|Eisai Inc.||1|||f||||||||||||||2017-02-18 17:56:51.289092|2017-02-18 17:56:51.289092
NCT00069251|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-18|2017-01-11|||July 2003||2003-07-01|July 2008|2008-07-01|June 2005||2005-06-01|||||Interventional|||Bupropion for the Treatment of Methamphetamine Dependence - 1|Bupropion for the Treatment of Methamphetamine Dependence|Completed||Phase 2|150||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 17:56:51.604|2017-02-18 17:56:51.604
NCT00069238|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-17|2016-08-01|2015-10-07||September 2003||2003-09-01|August 2016|2016-08-01|March 2018|Anticipated|2018-03-01|June 2009|Actual|2009-06-01||Interventional|||Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas|Phase 2 Trial of Alemtuzumab and Dose-Adjusted Epoch in Chemotherapy Naive Aggressive T and NK-Cell Lymphomas|Active, not recruiting||Phase 2|31|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 17:56:51.702812|2017-02-18 17:56:51.702812
NCT00069225|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-17|2008-03-03|||September 2003||2003-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Brain Structure and Function Before and After Treatment for Post-Traumatic Stress Disorder|Cerebral Structure and Function Before and After Pharmacological and Psychological Treatment for PTSD|Completed||N/A|95||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:56:52.281111|2017-02-18 17:56:52.281111
NCT00069186|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-17|2005-06-23|||June 2003||2003-06-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis|A Phase III, Multi-Center, Double-Blind, Placebo Controlled, Randomized Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis|Unknown status|Active, not recruiting|Phase 3|107||The Avicena Group|||||||||||||||||||2017-02-18 17:56:52.532754|2017-02-18 17:56:52.532754
NCT00069173|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-16|2005-06-23|||July 2000||2000-07-01|June 2003|2003-06-01||||||||Interventional|||Preventing Osteoporosis in Adolescent Girls|Prevention of Osteoporosis Among Sedentary Adolescent Females|Unknown status|Recruiting|Phase 1|250||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:56:52.636713|2017-02-18 17:56:52.636713
NCT00069160|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-15|2012-09-12|2011-06-30||September 2003||2003-09-01|September 2012|2012-09-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer|A Clinical Trial of the P-Glycoprotein Antagonist, Tariquidar (XR9576), in Combination With Docetaxel in Patients With Lung, Ovarian, Renal and Cervical Cancer: Analysis of the Interaction Between Tariquidar and Docetaxel|Completed||Phase 2|48|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 17:56:52.723038|2017-02-18 17:56:52.723038
NCT00069134|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-15|2015-01-27|||June 2003||2003-06-01|January 2015|2015-01-01|March 2016|Anticipated|2016-03-01|March 2016|Anticipated|2016-03-01||Interventional|||Study of Antioxidants and Oxidants in Malnourished Children|Glutathione Homeostasis and Oxidant Damage in Kwashiorkor|Unknown status|Recruiting|Phase 1|84|Anticipated|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:56:53.428903|2017-02-18 17:56:53.428903
NCT00069121|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-15|2013-08-13|2011-03-31||January 2003||2003-01-01|August 2013|2013-08-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer|A Randomized, Open-label Study of the Effect of Intermittent Xeloda in Combination With Eloxatin, Versus Fluorouracil/Leucovorin, on Disease-free Survival in Patients Who Have Undergone Surgery for Colon Cancer.|Completed||Phase 3|1886|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:56:56.535244|2017-02-18 17:56:56.535244
NCT00069108|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-15|2016-03-03|2016-01-27||July 2003||2003-07-01|March 2016|2016-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional||All participants with written informed consent who were randomized to one of the two study arms were included in the Intent-to-treat (ITT) population. Participants in this population were analyzed according to the arm to which they were randomized|A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer|"An Open-Label Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) (XELOX) Versus Bolus and Continuous Infusion Fluorouracil/ Intravenous Leucovorin With Intravenous Oxaliplatin (Q2W) (FOLFOX4) as Treatment for Patients With Metastatic Colorectal Cancer Who Have Received Prior Treatment With CPT-11 in Combination With 5-FU/LV as First Line Therapy"|Completed||Phase 3|627|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 17:56:58.496584|2017-02-18 17:56:58.496584
NCT00069095|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-15|2016-08-26|2015-12-11||July 2003||2003-07-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|January 2006|Actual|2006-01-01||Interventional||Baseline characteristics were described for the Intent-to-treat (ITT) population.This population included all randomized participants who provided written informed consent.|A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer|"A 2x2 Factorial Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) (XELOX) With/Without Intravenous Bevacizumab (Q3W) Versus Bolus and Continuous Infusion Fluorouracil/Intravenous Leucovorin With Intravenous Oxaliplatin (Q2W) (FOLFOX-4) With/Without Intravenous Bevacizumab (Q2W) as First-line Treatment for Patients With Metastatic Colorectal Cancer"|Completed||Phase 3|2035|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 17:56:59.774225|2017-02-18 17:56:59.774225
NCT00069082|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-15|2011-06-08|||August 2003||2003-08-01|June 2011|2011-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Intranasal Civamide for Episodic Cluster Headache|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache|Completed||Phase 3|2|Actual|Winston Laboratories||2|||f||||||||||||||2017-02-18 17:57:03.769731|2017-02-18 17:57:03.769731
NCT00069069|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2017-01-24|||September 10, 2003||2003-09-10|October 6, 2016|2016-10-06|November 20, 2025|Anticipated|2025-11-20|November 20, 2025|Anticipated|2025-11-20||Interventional|||E-Selectin Nasal Instillation to Prevent Secondary Stroke|Induction of Mucosal Tolerance to Human E-Selectin for the Secondary Prevention of Stroke|Not yet recruiting||Phase 1|58|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:57:04.079449|2017-02-18 17:57:04.079449
NCT00069056|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-13|2017-01-24|||September 10, 2003||2003-09-10|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema|A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema|Completed||Phase 1|4||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:04.203931|2017-02-18 17:57:04.203931
NCT00069030|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-12|2012-11-07|||December 2003||2003-12-01|November 2012|2012-11-01|December 2006|Actual|2006-12-01|||||Interventional|||Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the HIV-1 DNA Vaccine VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade Env) With the Plasmid Cytokine Adjuvant VRC-ADJDNA004-IL2-VP (IL-2/Ig)|Completed||Phase 1|70|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:57:04.293102|2017-02-18 17:57:04.293102
NCT00069017|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-12|2007-11-26|||September 2003||2003-09-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate|A Phase II, Randomized, Double-Blind Study to Evaluate the Effects of MEDI-522, a Humanized MAb to Integrin Alpha V Beta 3, On Disease Activity and Progression of Joint Damage in Pts With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate|Completed||Phase 2|300|Actual|MedImmune LLC||2|||f||||||||||||||2017-02-18 17:57:04.409179|2017-02-18 17:57:04.409179
NCT00069004|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-12|2014-01-06|||October 2003||2003-10-01|January 2014|2014-01-01|August 2005|Actual|2005-08-01|||||Observational|||A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth|Prevalence of Morphologic and Metabolic Abnormalities in Vertically HIV-Infected and Uninfected Children and Youth|Completed||N/A|450||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:57:04.549904|2017-02-18 17:57:04.549904
NCT00068991|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-12|2015-05-29||||||September 2008|2008-09-01|June 2007||2007-06-01|||||Interventional|||HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China|A Cluster-Randomized Trial to Evaluate the Efficacy of a Combined Individual- and Community-Based Behavioral Intervention to Improve Quality of Life for HIV-Positive Villagers in Rural China (China CIPRA Project 2)|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||f||||||||||2017-02-18 17:57:04.685778|2017-02-18 17:57:04.685778
NCT00068978|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-12|2007-09-17|||April 2003||2003-04-01|August 2007|2007-08-01||||||||Observational|||Analysis of Immune Responses to HIV Vaccines|Flow Cytometry Study of T Cell Responses to HIV Vaccines|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:57:04.79552|2017-02-18 17:57:04.79552
NCT00068952|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-12|2008-03-27|||August 2003||2003-08-01|March 2008|2008-03-01|March 2006||2006-03-01|||||Interventional|||Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme|A Phase III, Randomized, Open-Label Study Of IV Edotecarin Vs Temozolomide Or Carmustine (BCNU) Or Lomustine (CCNU) In Patients With Glioblastoma Multiforme At First Relapse After Alkylator-Based (NEO) Adjuvant Chemotherapy|Completed||Phase 3|118||Pfizer|||||f||||||||||||||2017-02-18 17:57:04.892178|2017-02-18 17:57:04.892178
NCT00068926|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-11|2017-01-24|||September 3, 2003||2003-09-03|June 29, 2011|2011-06-29|June 29, 2011||2011-06-29|||||Observational|||VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases|VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases|Completed||N/A|958|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:05.242853|2017-02-18 17:57:05.242853
NCT00068913|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2005-06-23|||March 2000||2000-03-01|September 2004|2004-09-01||||||||Interventional|||Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome|Investigation of Clinical Syndromes Associated With mtDNA Point Mutations: MELAS/DCA Clinical Trial|Unknown status|Active, not recruiting|Phase 2|35||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-02-18 17:57:05.32482|2017-02-18 17:57:05.32482
NCT00068900|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2015-04-29|||November 2003||2003-11-01|April 2015|2015-04-01|February 2004|Actual|2004-02-01|January 2004|Actual|2004-01-01||Observational|||FFA Metabolism in Different Types of Human Obesity|FFA Metabolism in Different Types of Human Obesity|Withdrawn||N/A|0|Actual|Mayo Clinic||||NOT A CLINICAL TRIAL|f||||||||||||||2017-02-18 17:57:05.409179|2017-02-18 17:57:05.409179
NCT00068887|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2015-04-29|||September 1999||1999-09-01|April 2015|2015-04-01|December 2005||2005-12-01|||||Observational|||Regional Fatty Acid Metabolism in Humans|Regional Fatty Acid Metabolism in Humans|Withdrawn||N/A|0|Actual|Mayo Clinic||||NOT A CLINICAL TRIAL|f||||||||||||||2017-02-18 17:57:05.478887|2017-02-18 17:57:05.478887
NCT00068874|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2009-04-08|||April 2004||2004-04-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Improving Quality of Life for African American Female Adolescents With Lupus|Predictors of Adaptation and a Cognitive Behavioral Intervention for African American Adolescents With Lupus|Completed||Phase 2|120|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||3|||f||||t||||||||||2017-02-18 17:57:05.548885|2017-02-18 17:57:05.548885
NCT00068861|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2007-09-28|||November 2002||2002-11-01|September 2005|2005-09-01|February 2006|Actual|2006-02-01|||||Interventional|||Treatment of Infertility in Women With Polycystic Ovary Syndrome|Pregnancy in Polycystic Ovary Syndrome: A 30 Week Double-Blind Randomized Trial of Clomiphene Citrate, Metformin XR, and Combined Clomiphene Citrate/Metformin XR For the Treatment of Infertility in Women With Polycystic Ovary Syndrome|Completed||Phase 3|678||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-02-18 17:57:05.657431|2017-02-18 17:57:05.657431
NCT00068848|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2007-04-09|||February 2003||2003-02-01|April 2007|2007-04-01|March 2005||2005-03-01|||||Interventional|||Quick Start Approach to Birth Control Pills|RCT of a Novel Oral Contraceptive Initiation Method|Completed||Phase 4|2000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:05.759404|2017-02-18 17:57:05.759404
NCT00068835|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2005-06-23|||June 2000||2000-06-01|November 2004|2004-11-01|May 2005||2005-05-01|||||Interventional|||Using fMRI to Evaluate Instructional Programs for Children With Developmental Dyslexia|Remediation in Developmental Dyslexia|Unknown status|Active, not recruiting|N/A|160||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:05.860739|2017-02-18 17:57:05.860739
NCT00068822|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2012-09-24|2012-08-07||April 2003||2003-04-01|September 2012|2012-09-01|September 2009|Actual|2009-09-01|August 2009|Actual|2009-08-01||Interventional|||Vertebroplasty for the Treatment of Fractures Due to Osteoporosis|Investigational Vertebroplasty Efficacy and Safety Trial (INVEST)|Completed||Phase 3|131|Actual|Mayo Clinic|The possible role of the placebo effect on outcomes remains unclear. Crossover at 1 month was allowed, which complicated the interpretation of between-group outcome differences. Other medical treatments received were not compared to study groups.|2|||f||||t||||||||||2017-02-18 17:57:05.958146|2017-02-18 17:57:05.958146
NCT00068809|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-02-29|||July 2003||2003-07-01|February 2016|2016-02-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||4-Day-A-Week Treatment Plan for HIV Infected Adolescents|Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression|Completed||Phase 4|31|Actual|Westat||1|||f||||t||||||||||2017-02-18 17:57:06.796304|2017-02-18 17:57:06.796304
NCT00068783|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-02-27|||October 2003||2003-10-01|February 2013|2013-02-01||||June 2007|Actual|2007-06-01||Interventional|||S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer|A Phase II Trial of STI-571/Imatinib (Gleevec®) (NSC-716051) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:57:06.91911|2017-02-18 17:57:06.91911
NCT00068770|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2015-03-17|2012-11-19||October 2003||2003-10-01|March 2015|2015-03-01|May 2006|Actual|2006-05-01|May 2005|Actual|2005-05-01||Interventional|||Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT|A Pharmacokinetic Study of the Interaction Between Celecoxib and Anticonvulsant Drugs in Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Radiation Therapy|Terminated||Phase 2|35|Actual|Sidney Kimmel Comprehensive Cancer Center|Study ended early when results from another study became available documenting Temozolomide (TMZ) and radiation improved survival, we felt it was unethical to continue this study, our study did not include TMZ.|2||EORTC trail showed TMZ & RT conferred significant survivial in this population|f||||t||||||||||2017-02-18 17:57:07.035325|2017-02-18 17:57:07.035325
NCT00068757|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2012-09-11|||August 2003||2003-08-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer|Phase I Study of Lonafarnib (SCH66336) in Combination With Herceptin Plus Paclitaxel in HER 2 NEU Overexpressing Breast Cancer|Completed||Phase 1|23|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:57:07.594714|2017-02-18 17:57:07.594714
NCT00068744|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2012-09-20|||July 2003||2003-07-01|September 2012|2012-09-01||||November 2007|Actual|2007-11-01||Interventional|||Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer|Continuous Fluorouracil Plus Mitomycin C Versus Mitomycin C Plus Cisplatin As Chemotherapy Combination In Combined Radiochemotherapy For Locally Advanced Anal Cancer. A Phase II-III Study|Terminated||Phase 2/Phase 3|88|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 17:57:07.719307|2017-02-18 17:57:07.719307
NCT00068731|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-07-12|||January 2004||2004-01-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|February 2007|Actual|2007-02-01||Interventional|||Lycopene in Treating Patients With Metastatic Prostate Cancer|A Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA Elevation|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 17:57:07.848417|2017-02-18 17:57:07.848417
NCT00068718|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-07-25|||May 2003||2003-05-01|July 2016|2016-07-01||||May 2013|Actual|2013-05-01||Interventional|||Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant|Donor Lymphocyte Infusion for the Treatment of Malignancy After Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning - A Multi-center Trial|Active, not recruiting||Phase 1/Phase 2|32|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:57:07.972753|2017-02-18 17:57:07.972753
NCT00068692|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-02-26|||October 2003||2003-10-01|February 2013|2013-02-01||||January 2100|Anticipated|2100-01-01||Interventional|||Comparison of Adjuvant Chemotherapy Regimens in Treating Patients With Stage II or Stage III Rectal Cancer Who Are Receiving Radiation Therapy and Fluorouracil Before or After Surgery|Intergroup Randomized Phase III Study of Postoperative Irinotecan, 5-Fluorouracil and Leucovorin vs. Oxaliplatin, 5-Fluorouracil and Leucovorin vs. 5-Fluorouracil and Leucovorin for Patients With Stage II or III Rectal Cancer Receiving Either Preoperative Radiation and 5-Fluorouracil or Postoperative Radiation and 5-Fluorouracil|Terminated||Phase 3|3000|Actual|National Cancer Institute (NCI)||6||Administratively complete.|f||||||||||||||2017-02-18 17:57:08.08607|2017-02-18 17:57:08.08607
NCT00068666|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-12-14|||January 2004||2004-01-01|December 2016|2016-12-01|March 2010|Actual|2010-03-01|March 2005|Actual|2005-03-01||Interventional|||Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System|A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System|Terminated||Phase 2|41|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:57:08.365375|2017-02-18 17:57:08.365375
NCT00068653|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-04-25|||June 2003||2003-06-01|April 2013|2013-04-01|May 2008|Actual|2008-05-01|October 2007|Actual|2007-10-01||Interventional|||Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer|Phase II Study of the Combination of ZD1839 (Iressa) and Celecoxib in Patients With Platinum Refractory Non-Small Cell Lung Cance|Completed||Phase 2|27|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 17:57:08.512331|2017-02-18 17:57:08.512331
NCT00068614|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2014-02-04|||July 2003||2003-07-01|February 2014|2014-02-01||||October 2005|Actual|2005-10-01||Interventional|||HER-2 Protein Vaccine in Treating Women With Breast Cancer|A Phase I Trial Evaluating The Safety Of Intramuscular Injections Of HER-2 Protein AUTOVAC (PX104.1.6) In Patients With Breast Cancer|Completed||Phase 1|||Case Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 17:57:08.624787|2017-02-18 17:57:08.624787
NCT00068601|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-10-28|||October 2003||2003-10-01|October 2016|2016-10-01|September 2016|Actual|2016-09-01|January 2014|Actual|2014-01-01||Interventional|||S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer|Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer|Completed||Phase 3|257|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 17:57:08.723362|2017-02-18 17:57:08.723362
NCT00068588|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2014-10-24|2014-09-25||October 2003||2003-10-01|January 2013|2013-01-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer|A Phase 2 Study of GTI-2040 (NSC 722929) in Combination With Capecitabine in Metastatic Breast Cancer|Completed||Phase 2|24|Actual|National Cancer Institute (NCI)|In the first stage of the two stage Optimum design, following the dose escalation step, 3 of 15 patients responded for a response rate of 20%. A response rate of less than 25% would not warrant further study.|1|||f||||||||||||||2017-02-18 17:57:08.876254|2017-02-18 17:57:08.876254
NCT00068575|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2012-02-13|2012-01-23||May 2002||2002-05-01|February 2012|2012-02-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer|A Phase II Trial of Pancreaticoduodenectomy Plus Postoperative Cisplatin, Interferon Alfa-2b, and 5-FU Combined With Radiation Treatment for Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:57:09.603405|2017-02-18 17:57:09.603405
NCT00068549|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2014-12-23|||October 2003||2003-10-01|December 2014|2014-12-01||||January 2008|Actual|2008-01-01||Interventional|||Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer|A Phase I Study of Whole Pelvic Radiation Therapy With Concomitant Cisplatin and Gemcitabine Chemotherapy in Patients With Cervical Carcinoma (Stages I-IV) Limited to the Pelvis|Completed||Phase 1|13|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:57:09.861883|2017-02-18 17:57:09.861883
NCT00068523|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2010-06-10|||June 2003||2003-06-01|June 2010|2010-06-01||||March 2004|Actual|2004-03-01||Interventional|||Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies|Immunomodulation by Ultraviolet B-Irradiation (UVB) to Facilitate Allogeneic Stem Cell Transplantation for Treatment of Hematologic Malignancies|Completed||N/A|10|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:57:09.991115|2017-02-18 17:57:09.991115
NCT00067652|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01|November 2003||2003-11-01|||||Interventional|||Improving Body Image in Middle Schoolers||Completed||Phase 1|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:23.954295|2017-02-18 17:57:23.954295
NCT00068510|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2015-09-30|||June 2003||2003-06-01|August 2013|2013-08-01|September 2012|Actual|2012-09-01|September 2012|Actual|2012-09-01||Interventional|||Vaccine Therapy in Treating Patients With Malignant Glioma|Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas|Completed||Phase 1|28|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:57:10.110391|2017-02-18 17:57:10.110391
NCT00068497|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-01-11|||August 2003||2003-08-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer|Single Agent ZD-1839 (NSC-715055, IND-61187) in Patients With Advanced Head and Neck Carcinoma or Non-Small Cell Lung Cancer Aged 75 Years and Older (and in a Cohort of Patients 50 Years Old and Younger)|Completed||N/A|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:57:10.218836|2017-02-18 17:57:10.218836
NCT00068484|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-01-31|||July 2003||2003-07-01|January 2013|2013-01-01||||February 2006|Actual|2006-02-01||Interventional|||A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies|A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:57:10.351792|2017-02-18 17:57:10.351792
NCT00068471|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-06-18|||July 2003||2003-07-01|April 2004|2004-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Anidulafungin in Treating Immunocompromised Children With Neutropenia|Phase I-II Study of the Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children With Neutropenia|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:10.463646|2017-02-18 17:57:10.463646
NCT00068458|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2017-01-18|||September 2003||2003-09-01|April 2013|2013-04-01|January 2005|Actual|2005-01-01|January 2004|Actual|2004-01-01||Interventional|||Survival TRaining for ENhancing Total Health (STRENGTH)|A Phase II Randomized Study to Assess the Feasibility of Distance Medicine Based Exercise and Dietary Approaches to Prevent Body Composition Change Occurring During Adjuvant Chemotherapy for Early Stage Breast Cancer|Completed||Phase 2|39|Actual|Wake Forest University Health Sciences||3|||f||||t||||||||||2017-02-18 17:57:10.563979|2017-02-18 17:57:10.563979
NCT00068445|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-07-12|||February 2004||2004-02-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|May 2006|Actual|2006-05-01||Interventional|||Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer|The Efficacy of Lamotrigine in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double Blind, Placebo-Controlled Trial|Completed||Phase 3|131|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:57:10.687609|2017-02-18 17:57:10.687609
NCT00068432|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2012-01-09|||December 2003||2003-12-01|January 2012|2012-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer|A Phase II Trial of Gemcitabine and Celecoxib as First-Line Treatment for Patients With Advanced Metastatic Pancreatic Cancer|Completed||Phase 2|28|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:57:10.820551|2017-02-18 17:57:10.820551
NCT00068419|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-03-21|2013-10-07||February 2004||2004-02-01|March 2016|2016-03-01||||August 2010|Actual|2010-08-01||Interventional|||Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor|A Phase II Study of Sulindac and Tamoxifen in Patients With Desmoid Tumors That Are Recurrent or Not Amenable to Standard Therapy|Active, not recruiting||Phase 2|70|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:57:10.943149|2017-02-18 17:57:10.943149
NCT00068406|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2012-09-02|||January 2005||2005-01-01|September 2009|2009-09-01||||December 2010|Actual|2010-12-01||Interventional|||Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva|A Phase II Trial of Radiation Therapy and Weekly Cisplatin Chemotherapy for the Treatment of Locally-Advanced Squamous Cell Carcinoma of the Vulva|Completed||Phase 2|58|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:57:11.339534|2017-02-18 17:57:11.339534
NCT00068393|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-01-04|2012-11-30||December 2003||2003-12-01|January 2013|2013-01-01|May 2011|Actual|2011-05-01|June 2009|Actual|2009-06-01||Interventional|||Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma|Phase II Trial of Doxorubicin and Gemcitabine in Metastatic Renal Cell Carcinoma With Sarcomatoid Features|Completed||Phase 2|39|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 17:57:11.679294|2017-02-18 17:57:11.679294
NCT00068380|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2014-10-01|2014-07-21||March 2004||2004-03-01|July 2013|2013-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer|A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer|Completed||Phase 2|17|Actual|National Cancer Institute (NCI)|In the first stage none of the 17 patients responded (CR/PR) to treatment. Due to budget constraints and recent reprioritizations, CTEP closed the study to accrual.|1|||f||||||||||||||2017-02-18 17:57:12.2664|2017-02-18 17:57:12.2664
NCT00068367|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2012-01-13|||December 2003||2003-12-01|January 2012|2012-01-01|August 2009|Actual|2009-08-01|July 2007|Actual|2007-07-01||Interventional|||S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor|U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II|Completed||Phase 2|24|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:57:12.57841|2017-02-18 17:57:12.57841
NCT00068341|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2015-10-29|||July 2003||2003-07-01|June 2014|2014-06-01||||November 2013|Actual|2013-11-01||Interventional|||Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer|Neoadjuvant Treatment and Molecular Characterization of Locally Advanced Breast Cancer|Completed||Phase 2|80|Actual|Jonsson Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 17:57:12.792854|2017-02-18 17:57:12.792854
NCT00068328|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-07-01|||August 2003||2003-08-01|July 2016|2016-07-01||||December 2006|Actual|2006-12-01||Observational|||Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer|Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer|Active, not recruiting||N/A|1360|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 17:57:12.926806|2017-02-18 17:57:12.926806
NCT00068315|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-09-27|||July 2003||2003-07-01|September 2013|2013-09-01||||December 2008|Actual|2008-12-01||Interventional|||Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|A Phase I Trial of PS-341 and Fludarabine for Relapsed and Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia|Completed||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:57:13.127105|2017-02-18 17:57:13.127105
NCT00068302|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2015-03-11|||January 2003||2003-01-01|July 2013|2013-07-01|July 2013|Actual|2013-07-01|April 2009|Actual|2009-04-01||Interventional|||Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma|A Phase I Trial Of Sirolimus In Relapsed/Refractory Leukemia And Non-Hodgkin's Lymphoma|Terminated||Phase 1|10|Actual|Children's Hospital of Philadelphia||1||Recruiting/enrolling participants halted prematurely but potentially will resume|f||||t||||||||||2017-02-18 17:57:13.256237|2017-02-18 17:57:13.256237
NCT00068289|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2013-06-21|||September 2003||2003-09-01|August 2004|2004-08-01|July 2007|Actual|2007-07-01|||||Interventional|||Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy|A Phase II Trial of PS-341 (NSC-681239) in Patients With Platinum-Treated Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:13.376917|2017-02-18 17:57:13.376917
NCT00068276|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2017-01-17|||July 2003||2003-07-01|June 2013|2013-06-01|September 2006|Actual|2006-09-01|June 2005|Actual|2005-06-01||Interventional|||Cholecalciferol in Treating Patients With Myelodysplastic Syndrome|Orthomolecular Vitamin D3 in Low-Risk Myelodysplastic Syndrome: An Open-Label Clinical Trial|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 17:57:13.698362|2017-02-18 17:57:13.698362
NCT00068263|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-12-30|||August 2003||2003-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|June 2005|Actual|2005-06-01||Interventional|||3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection|A Phase I/II Trial to Evaluate Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma|Completed||Phase 1/Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 17:57:13.797164|2017-02-18 17:57:13.797164
NCT00068250|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-12-30|||July 2003||2003-07-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma|Phase I/II Study Of Pre-Irradiation Chemotherapy With Methotrexate, Rituximab, And Temozolomide And Post -Irradiation Temozolomide For Primary Central Nervous System Lymphoma|Completed||Phase 1/Phase 2|60|Actual|Radiation Therapy Oncology Group||4|||f||||t||||||||||2017-02-18 17:57:13.910242|2017-02-18 17:57:13.910242
NCT00068237|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2016-12-30|2013-10-29||August 2003||2003-08-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|January 2008|Actual|2008-01-01||Interventional||All eligible patients who started study treatment.|Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer|A Phase II Study Of Submandibular Salivary Gland Transfer To The Submental Space Prior To Start Of Radiation Treatment For Prevention Of Radiation-Induced Xerostomia In Head And Neck Cancer Patients|Completed||Phase 2|49|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 17:57:14.060488|2017-02-18 17:57:14.060488
NCT00068224|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-10|2017-02-16|||September 4, 2003||2003-09-04|November 14, 2016|2016-11-14||||||||Observational|||Clinical and Molecular Investigations Into Ciliopathies|Clinical and Molecular Investigations Into Ciliopathies|Active, not recruiting||N/A|290|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:14.555737|2017-02-18 17:57:14.555737
NCT00068211|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-09|2015-03-04|||August 2003||2003-08-01|March 2015|2015-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma|A Phase II Study of ILX651 Administered Intravenously Daily for Five Consecutive Days Once Every 3 Weeks in Patients With Inoperable Locally Advanced or Metastatic Melanoma.|Completed||Phase 2|||Sanofi|||||||||||||||||||2017-02-18 17:57:14.660297|2017-02-18 17:57:14.660297
NCT00068198|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-09|2010-08-26||||||May 2006|2006-05-01|November 2004||2004-11-01|||||Interventional|||Human Immune Responses Smallpox|Evaluation of Human Immune Response to Smallpox Vaccine (Vaccinia Virus)|Completed||Phase 1|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:57:14.758693|2017-02-18 17:57:14.758693
NCT00068185|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-09|2009-12-09|||August 2003||2003-08-01|December 2009|2009-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||A Study of the Pharmacokinetics of Black Cohosh|Interactions Between SERMs, Soy and Black Cohosh|Terminated||Phase 1|12|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||||PI left institution, study did not continue, funding stopped|f||||t||||||||||2017-02-18 17:57:14.832382|2017-02-18 17:57:14.832382
NCT00068172|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-09|2016-03-30|||July 2001||2001-07-01|March 2016|2016-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study of PI-88 in Patients With Advanced Melanoma|A Phase I/II Study of PI-88 in Advanced Malignancies (Phase I), and in Advanced Melanoma (Phase II)|Completed||Phase 1/Phase 2|88||Medigen Biotechnology Corporation|||||f||||||||||||||2017-02-18 17:57:14.927349|2017-02-18 17:57:14.927349
NCT00068159|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-09|2017-01-24|||September 3, 2003||2003-09-03|December 23, 2016|2016-12-23||||||||Observational|||Cardiac Function in Patients With Hereditary Hemochromatosis|Characterization of Cardiac Function in Subjects With Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I|Active, not recruiting||N/A|66|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:15.031958|2017-02-18 17:57:15.031958
NCT00068146|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-09|2017-01-24|||September 19, 2002||2002-09-19|November 26, 2012|2012-11-26|November 26, 2012||2012-11-26|||||Observational|||Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma|Study of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Evaluation of the Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-Associated Lymphoma|Completed||N/A|77|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:15.142389|2017-02-18 17:57:15.142389
NCT00068133|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-08|2005-06-23|||June 2003||2003-06-01|May 2005|2005-05-01|June 2005||2005-06-01|||||Interventional|||Trial of VLTS-589 in Subjects With Intermittent Claudication|A Phase II Multicenter, Double-Blind, Placebo-Controlled, Trial of VLTS-589 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease|Completed||Phase 2|100||Valentis|||||||||||||||||||2017-02-18 17:57:15.253109|2017-02-18 17:57:15.253109
NCT00068120|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-08|2010-01-12||||||January 2010|2010-01-01||||||||Observational|||ORWH:SCOR - Sex/Gender Factors Affecting Women's Health|ORWH:SCOR - Sex/Gender Factors Affecting Women's Health|Completed||N/A|200|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:15.362403|2017-02-18 17:57:15.362403
NCT00005330|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1985||1985-09-01|April 2002|2002-04-01|April 2001|Actual|2001-04-01|||||Observational|||Framingham Children's Study - Food and Exercise Habits in Framingham Study Descendents||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.648178|2017-02-18 18:15:07.648178
NCT00068107|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-06|2015-03-19|2015-03-12||September 2003||2003-09-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Dosing Study of Replagal in Patients With Fabry Disease|Study of Weekly Dosing Regimens of Replagal in Patients With Fabry Disease With Incomplete Clinical Response to Long-Term Therapy|Completed||Phase 2|13|Actual|Baylor Research Institute|Small number of subjects. Single group with comparison to baseline data.|1|||f||||f||||||||||2017-02-18 17:57:15.449994|2017-02-18 17:57:15.449994
NCT00068094|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-05|2006-08-16|||July 2005||2005-07-01|August 2006|2006-08-01|February 2006||2006-02-01|||||Interventional|||The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics|The Effect of a Probiotic on Hepatic Steatosis|Terminated||Phase 1/Phase 2|30||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 17:57:15.999904|2017-02-18 17:57:15.999904
NCT00068081|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-05|2008-03-04||||||September 2007|2007-09-01||||||||Interventional|||Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|A Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|Completed||Phase 3|150||NeurogesX|||||||||||||||||||2017-02-18 17:57:16.107531|2017-02-18 17:57:16.107531
NCT00068068|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-04|2006-09-18|||October 2003||2003-10-01|September 2006|2006-09-01||||||||Interventional|||Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases|Safety and Efficacy of Treating Refractory Cancers With the Litx™ System: Phase II Safety and Efficacy Study in Patients With Liver Metastases From Colorectal Cancer That Have Failed Chemotherapy|Completed||Phase 2|25||Light Sciences LLC|||||||||||||||||||2017-02-18 17:57:16.204741|2017-02-18 17:57:16.204741
NCT00068055|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-04|2011-02-03|||September 2003||2003-09-01|July 2009|2009-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||IVIG - West Nile Encephalitis: Safety and Efficacy|A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (OMR-IGG-AM) Containing High Anti-West Nile Virus Antibody Titers in Patients With, or at High Risk for Progression to West Nile Virus (WNV) Encephalitis and/or Myelitis|Completed||Phase 1/Phase 2|62|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 17:57:16.311491|2017-02-18 17:57:16.311491
NCT00068042|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-04|2008-04-03|||April 2003||2003-04-01|April 2008|2008-04-01|May 2006|Actual|2006-05-01|||||Interventional|||A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly|A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly|Completed||Phase 4|100||Pfizer|||||||||||||||||||2017-02-18 17:57:16.614494|2017-02-18 17:57:16.614494
NCT00068029|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-04|2008-04-03|||October 2003||2003-10-01|April 2008|2008-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Pegvisomant And Sandostatin LAR Combination Study|A Randomized, Parallel Group, Three-Arm Study To Evaluate Treatment With A Combination Of Pegvisomant Plus Sandostatin Lar, Pegvisomant (Alone), And Sandostatin Lar (Alone) In Patients With Acromegaly|Completed||Phase 4|75||Pfizer|||||||||||||||||||2017-02-18 17:57:16.764797|2017-02-18 17:57:16.764797
NCT00068003|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-04|2017-02-03|||August 22, 2003||2003-08-22|December 13, 2016|2016-12-13||||||||Observational|||Harvesting Cells for Experimental Cancer Treatments|Cell Harvest and Preparation for Surgery Branch Adoptive Cell Therapy Protocols|Enrolling by invitation||N/A|1792|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:16.912851|2017-02-18 17:57:16.912851
NCT00067990|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-03|2016-08-23|||December 2002||2002-12-01|August 2016|2016-08-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Angiotensin II Blockade for Chronic Allograft Nephropathy|Angiotensin II Blockade for the Prevention of Cortical Interstitial Expansion and Graft Loss in Kidney Transplant Recipients|Completed||Phase 4|153|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 17:57:17.023412|2017-02-18 17:57:17.023412
NCT00067977|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-03|2005-11-02||||||November 2005|2005-11-01||||||||Interventional|||Clinical Trial to Slow the Progression of ADPKD||Unknown status|Not yet recruiting|N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:17.149908|2017-02-18 17:57:17.149908
NCT00067964|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-03|2010-01-12||||||January 2010|2010-01-01||||||||Interventional|||Diet and Physical Activity Interactions in Obesity||Completed||N/A|90||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:17.244598|2017-02-18 17:57:17.244598
NCT00067951|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-03|2017-01-16|||October 2003||2003-10-01|January 2017|2017-01-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics|An Open-label Trial to Evaluate the Safety and Efficacy of Fixed Dose Rosiglitazone/Metformin Combination Therapy in Poorly-controlled Subjects With Type 2 Diabetes Mellitus|Completed||Phase 3|190|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:57:17.316167|2017-02-18 17:57:17.316167
NCT00067938|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-03|2016-08-31|||August 2003||2003-08-01|August 2016|2016-08-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Bipolar Study in Adults at Least 18 Years of Age|Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness.|Completed||Phase 4|1200|Actual|GlaxoSmithKline||1|||f||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:57:20.451809|2017-02-18 17:57:20.451809
NCT00067925|ClinicalTrials.gov processed this data on February 17, 2017|2003-09-03|2010-10-18|||September 2000||2000-09-01|August 2003|2003-08-01|June 2002||2002-06-01|||||Interventional|||A School-Based Osteoporosis Prevention Program for Adolescent Girls|Incorporating More Physical Activity and Calcium in Teens (IMPACT): A School-Based Osteoporosis Prevention Program for Adolescent Girls|Completed||Phase 1|718||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:21.130565|2017-02-18 17:57:21.130565
NCT00067912|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-29|2007-05-17|||April 2003||2003-04-01|May 2007|2007-05-01|March 2004|Actual|2004-03-01|||||Interventional|||Duloxetine vs. Active Comparator for the Treatment of Depression|Duloxetine Versus Venlafaxine Extended Release in the Treatment of Major Depressive Disorder|Completed||Phase 4|480||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:57:21.212751|2017-02-18 17:57:21.212751
NCT00067899|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-29|2013-06-17|||September 2000||2000-09-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Oxidative Stress and Vitamin E Requirements|Oxidative Stress and Vitamin E Requirements|Completed||Phase 2|99||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||f||||||||||2017-02-18 17:57:21.298645|2017-02-18 17:57:21.298645
NCT00067886|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-29|2016-04-12|||March 2003||2003-03-01|April 2016|2016-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Matrix Metalloproteinases and Diabetic Nephropathy|Matrix Metalloproteinases and Diabetic Nephropathy|Completed||N/A|330|Actual|Arkansas Children's Hospital Research Institute|||1||f||||f||||||||||2017-02-18 17:57:21.385115|2017-02-18 17:57:21.385115
NCT00067873|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-29|2010-01-12|||December 2000||2000-12-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Exercise Training in Obesity-prone Black and White Women|Exercise Training in Obesity-prone Black and White Women|Completed||N/A|231||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:21.457969|2017-02-18 17:57:21.457969
NCT00067860|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-29|2016-05-12|||October 1996||1996-10-01|May 2016|2016-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Diet/Growth Factor Mechanisms of Gut Adaptation|Diet/Growth Factor Mechanisms of Gut Adaptation|Completed||Phase 2|27|Actual|Emory University|||||||||||||||||||2017-02-18 17:57:21.5351|2017-02-18 17:57:21.5351
NCT00067847|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-28|2010-01-12|||July 2003||2003-07-01|January 2010|2010-01-01|May 2004||2004-05-01|||||Interventional|||Evaluation of California's SB 19 Pupil Nutrition Act||Completed||N/A|5020||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:21.626972|2017-02-18 17:57:21.626972
NCT00067834|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-28|2015-12-22|||November 2003||2003-11-01|December 2015|2015-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Electromagnetic Treatment For Bone Loss After Forearm Fracture|Feasibility and Dosing Study of Bone Density Changes With and Without PEMF Following Immobilization of the Forearm|Completed||Phase 1/Phase 2|80||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 17:57:21.713564|2017-02-18 17:57:21.713564
NCT00067821|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-28|2017-01-24|||August 26, 2003||2003-08-26|September 23, 2016|2016-09-23||||||||Observational|||Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity|A Comparative Study of Pediatric CNS Tumor Activity as Assessed by [18]F-FDG PET Imaging and Proton Magnetic Resonance Spectroscopic Imaging ([1]H-MRSI)|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:21.868817|2017-02-18 17:57:21.868817
NCT00067808|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-27|2012-08-01|2009-09-25||October 2003||2003-10-01|August 2012|2012-08-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)|Phase II Randomized Study of Three Different Schedules of Low-Dose Decitabine (5-AZA-2'-Deoxycytidine) in Myelodysplastic Syndrome (MDS)|Completed||Phase 2|128|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 17:57:22.169643|2017-02-18 17:57:22.169643
NCT00067795|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-27|2010-11-19||||||November 2010|2010-11-01||||||||Observational|||Evaluating Immune Function Tests in People With HIV|"HIV Antigen-Specific Immune Responses - A Comparison of Alternative In Vitro Assays From Subjects Characterized as Either Stable HAART or Efficient Immune Control"|Completed||N/A|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:57:22.780844|2017-02-18 17:57:22.780844
NCT00067782|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-27|2011-04-07||2010-01-28|December 2002||2002-12-01|January 2010|2010-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy||Completed||Phase 3|||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 17:57:22.874498|2017-02-18 17:57:22.874498
NCT00067769|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-27|2015-12-04|||October 2003||2003-10-01|June 2014|2014-06-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Internet-based Treatment of Early Childhood Fecal Incontinence|Treatment of Early Childhood Constipation/Encopresis|Completed||N/A|91|Actual|University of Virginia||2|||f||||f||||||||||2017-02-18 17:57:23.004104|2017-02-18 17:57:23.004104
NCT00067756|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-26|2014-01-02|||November 2001||2001-11-01|April 2013|2013-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?|"4 Phenyl Butyrate Mediated Secretion Rescue in Alpha 1-Antitrypsin Deficient Individuals"|Completed||Phase 2|12|Actual|University of Florida||1|||f||||t||||||||||2017-02-18 17:57:23.12152|2017-02-18 17:57:23.12152
NCT00067743|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-26|2007-12-28|||August 2003||2003-08-01|December 2006|2006-12-01|August 2007|Actual|2007-08-01|October 2004|Actual|2004-10-01||Interventional|CRPS||A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)|A Multicenter, Open-Label Study to Evaluate the Preliminary Safety and Efficacy of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)|Completed||Phase 2|40|Actual|Celgene||1|||f||||t||||||||||2017-02-18 17:57:23.242302|2017-02-18 17:57:23.242302
NCT00067730|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2007-12-03|||March 2003||2003-03-01|December 2007|2007-12-01|October 2003|Actual|2003-10-01|||||Interventional|||A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation|A Safety Evaluation of Xigris Drotrecogin Alfa Activated in Hematopoietic Stem Cell Transplant Patients With Severe Sepsis|Completed||Phase 4|7|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 17:57:23.373203|2017-02-18 17:57:23.373203
NCT00067717|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2014-10-17|||November 2003||2003-11-01|October 2014|2014-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Distance Healing in Wound Healing|Placebo Effects in Distance Healing of Wounds|Completed||Phase 1/Phase 2|72|Actual|California Pacific Medical Center Research Institute||3|||f||||t||||||||||2017-02-18 17:57:23.486309|2017-02-18 17:57:23.486309
NCT00067704|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2015-10-09|||February 2004||2004-02-01|October 2015|2015-10-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Emotional Disclosure in HIV|Efficacy of an Emotional Disclosure Intervention in HIV|Completed||N/A|283|Actual|University of Miami||2|||f||||f||||||||||2017-02-18 17:57:23.588626|2017-02-18 17:57:23.588626
NCT00067691|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2006-08-16|||November 2001||2001-11-01|August 2006|2006-08-01|November 2003||2003-11-01|||||Interventional|||Acupuncture for Shortness of Breath in Cancer Patients|Acupuncture for Shortness of Breath in Cancer Patients|Completed||N/A|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:23.694486|2017-02-18 17:57:23.694486
NCT00067678|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2006-08-16|||July 2001||2001-07-01|August 2006|2006-08-01|June 2003||2003-06-01|||||Interventional|||Soy Protein in Early Diabetic Nephropathy|Soy Protein in Early Diabetic Nephropathy|Completed||Phase 1/Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:23.777812|2017-02-18 17:57:23.777812
NCT00067665|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2011-03-25|||August 2003||2003-08-01|January 2011|2011-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Hypertension in Hemodialysis|Hypertension in Hemodialysis|Completed||N/A|150|Anticipated|Indiana University||2|||f||||f||||||||||2017-02-18 17:57:23.864605|2017-02-18 17:57:23.864605
NCT00067639|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2012-07-31|||December 2003||2003-12-01|July 2012|2012-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma|Pegfilgrastim (Neulasta) for Mobilization of Peripheral Blood Progenitor Cells (PBPC) in Patients With Multiple Myeloma|Completed||Phase 2|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:57:24.02079|2017-02-18 17:57:24.02079
NCT00067626|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2010-10-14|||April 2005||2005-04-01|October 2010|2010-10-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes|Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes|Completed||Phase 2|60|Anticipated|Griffin Hospital||2|||f||||t||||||||||2017-02-18 17:57:24.130937|2017-02-18 17:57:24.130937
NCT00067613|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2015-06-03|||March 2001||2001-03-01|June 2015|2015-06-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|Benchmarking||Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia|Randomized Controlled Trial of Benchmarking to Reduce Bronchopulmonary Dysplasia to Reduce Bronchopulmonary Dysplasia|Completed||N/A|4095|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-02-18 17:57:24.251946|2017-02-18 17:57:24.251946
NCT00067600|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2014-10-28|||August 2000||2000-08-01|October 2014|2014-10-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Improving Bone Health in Adolescent Girls: The Youth Osteoporosis and Understanding Total Health (YOUTH) Study|Lifestyle Changes to Increase Bone Density in Teen Girls|Completed||Phase 1|228||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:24.663169|2017-02-18 17:57:24.663169
NCT00067587|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2016-02-29|||July 2003||2003-07-01|February 2016|2016-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Observational|||Metabolic Abnormalities in HIV Infected and Uninfected Young Women|Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women|Completed||N/A|300|Actual|Westat|||5||f||||t||||||||||2017-02-18 17:57:24.745706|2017-02-18 17:57:24.745706
NCT00067574|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-25|2016-07-13|||July 2003||2003-07-01|July 2016|2016-07-01||||||||Interventional|||Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents|Structured Treatment Interruption as an Autovaccination Approach to Enhance Immune Based HIV-1 Control in an Adolescent/Young Adult Population|Withdrawn||Phase 2|0|Actual|Westat||||"The study was never opened for enrollment; concept became irrelevant as other study results~   became available."|f||||||||||||||2017-02-18 17:57:24.85185|2017-02-18 17:57:24.85185
NCT00067561|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-21|2015-04-15|||June 2003||2003-06-01|April 2015|2015-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy|A Twelve-Week, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 0.5 mg QD, 1 mg QD and 1 mg BID of Alosetron in Female Subjects With Severe Diarrhea-predominant IBS Who Have Failed Conventional Therapy|Completed||Phase 3|702|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:57:24.955524|2017-02-18 17:57:24.955524
NCT00067548|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-21|2009-08-20||||||August 2009|2009-08-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer|A Phase 2 Study of EKB-569 in Subjects With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|44|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:57:25.227382|2017-02-18 17:57:25.227382
NCT00067535|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-21|2017-01-11|||June 2003||2003-06-01|February 2009|2009-02-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|||Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1|Potential Interactions Between IV Cocaine and RPR 102681|Completed||Phase 1|16|Actual|National Institute on Drug Abuse (NIDA)||2|||||||||||||||||2017-02-18 17:57:25.318986|2017-02-18 17:57:25.318986
NCT00067522|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-21|2007-06-28|||January 2002||2002-01-01|September 2005|2005-09-01||||||||Interventional|||Preventing Unplanned Pregnancies in HIV Infected Zambian Couples|Family Planning Promotion to Prevent Unplanned Pregnancies in HIV Infected Zambian Couples|Unknown status|Active, not recruiting|N/A|5000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:25.412137|2017-02-18 17:57:25.412137
NCT00067509|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-21|2005-06-23|||June 2001||2001-06-01|July 2003|2003-07-01|May 2004||2004-05-01|||||Interventional|||Emergency Contraception (ECP): Reducing Unintended Pregnancies|A Second Chance With Emergency Contraception (ECP): Reducing Unintended Pregnancy|Completed||Phase 4|1100||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:25.498276|2017-02-18 17:57:25.498276
NCT00067496|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-20|2008-08-26|||August 2003||2003-08-01|May 2005|2005-05-01|August 2006||2006-08-01|||||Interventional|||Modafinil to Treat Fatigue in Post-Polio Syndrome|Modafinil in the Treatment of Fatigue in Post-Polio Syndrome|Terminated||Phase 3|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:25.598614|2017-02-18 17:57:25.598614
NCT00067483|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-20|2017-01-24|||August 15, 2003||2003-08-15|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Pilot Study: Dynamic Light Scattering Device for Studying Early Changes in Cataract|Pilot Study on the Use of the NASA-NEI Dynamic Light Scattering (DLS) Device in Detecting Lens Changes in the Other Eye of Patients With Pre-Senile Cataracts|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:25.687285|2017-02-18 17:57:25.687285
NCT00067470|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-20|2009-12-18|2009-02-04||September 2003||2003-09-01|December 2009|2009-12-01|March 2004||2004-03-01|||||Interventional|||Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI||Completed||Phase 3|39|Actual|BioMarin Pharmaceutical||2|||||||||||||||||2017-02-18 17:57:25.78165|2017-02-18 17:57:25.78165
NCT00067457|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-20|2015-04-15|||June 2003||2003-06-01|April 2015|2015-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy|A 12-Week, Randomized, Double-Blind, Placebo- Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects With Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy|Completed||Phase 3|700|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:57:26.6659|2017-02-18 17:57:26.6659
NCT00067444|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-19|2016-08-30|||June 2003||2003-06-01|August 2016|2016-08-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Depression Study In Elderly Patients|A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Evaluating the Efficacy and Safety of Paroxetine CR in Elderly Outpatients Diagnosed With Major Depressive Disorder|Completed||Phase 3|560|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:57:27.225394|2017-02-18 17:57:27.225394
NCT00067431|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-19|2006-08-02|||July 2003||2003-07-01|August 2006|2006-08-01||||||||Interventional|||A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children|A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children|Terminated||Phase 3|300||Abbott|||||||||||||||||||2017-02-18 17:57:27.36768|2017-02-18 17:57:27.36768
NCT00067418|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-18|2008-03-03|||August 2003||2003-08-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Light Scattering Spectroscopy to Determine Brain Tumors|Spectroscopic Determination of Brain Tumor Cells|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:27.467998|2017-02-18 17:57:27.467998
NCT00067405|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-18|2008-04-21|||June 2004||2004-06-01|April 2008|2008-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia|Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia|Completed||Phase 1/Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 17:57:27.555803|2017-02-18 17:57:27.555803
NCT00067392|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-15|2010-11-08|||November 2003||2003-11-01|July 2008|2008-07-01|May 2009|Anticipated|2009-05-01|April 2008|Anticipated|2008-04-01||Interventional|||Evaluation of Implants Placed Immediately or Delayed Into Extraction Sites|Prospective Evaluation of Immediate Temporized Implants|Unknown status|Active, not recruiting|Phase 3|90|Anticipated|Louisiana State University Health Sciences Center in New Orleans||1|||f||||||||||||||2017-02-18 17:57:27.649201|2017-02-18 17:57:27.649201
NCT00067379|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-15|2010-06-09|||April 2003||2003-04-01|June 2010|2010-06-01|June 2009|Anticipated|2009-06-01|June 2009|Anticipated|2009-06-01||Interventional|||Early Orthodontic Intervention Under Medicaid|Early Orthodontic Intervention Under Medicaid|Unknown status|Active, not recruiting|Phase 1|150|Anticipated|University of Washington||1|||f||||t||||||||||2017-02-18 17:57:27.747053|2017-02-18 17:57:27.747053
NCT00067366|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-15|2011-09-19|||October 2003||2003-10-01|September 2011|2011-09-01|September 2011|Actual|2011-09-01|October 2008|Actual|2008-10-01||Interventional|||Brief Treatment for Temporomandibular Pain|Brief Focused Treatment for TMD: Mechanisms of Action|Completed||Phase 1/Phase 2|116|Actual|UConn Health||2|||f||||||||||||||2017-02-18 17:57:27.847391|2017-02-18 17:57:27.847391
NCT00067353|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-15|2010-05-06|||November 2003||2003-11-01|May 2010|2010-05-01|August 2005|Actual|2005-08-01|July 2005|Actual|2005-07-01||Interventional|||Yakima Head Start Fluoride Varnish Study|Fluoride Varnish Trial in High Caries Preschoolers|Completed||Phase 3|500||University of Washington|||||f||||t||||||||||2017-02-18 17:57:27.950858|2017-02-18 17:57:27.950858
NCT00067340|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-15|2015-05-29|||April 2003||2003-04-01|April 2010|2010-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Caries Transmission Prevention in Alaska Native Infants|Northwest Alaska Center to Reduce Oral Health Disparity Project 2: Caries Transmission Prevention in Alaska Native Infants|Terminated||Phase 3|250|Anticipated|University of Washington||2||Unable to recruit sufficient number of subjects|f||||t||||||||||2017-02-18 17:57:28.052223|2017-02-18 17:57:28.052223
NCT00067327|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-15|2006-03-16|||February 2002||2002-02-01|March 2006|2006-03-01|September 2005||2005-09-01|||||Interventional|||Treatment of Multiple Sclerosis Using Over the Counter Inosine|Treatment of Multiple Sclerosis Using Over the Counter Inosine|Completed||Phase 2|30||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 17:57:28.149186|2017-02-18 17:57:28.149186
NCT00067314|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-15|2012-01-13|||June 2003||2003-06-01|January 2012|2012-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy|A Phase II Study Of Intravenous Edotecarin (PHA-782615) In Patients With Anthracycline- And Taxane Resistant Metastatic Breast Cancer|Completed||Phase 2|65||Pfizer|||||f||||||||||||||2017-02-18 17:57:28.236679|2017-02-18 17:57:28.236679
NCT00067301|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-14|2008-01-23|||September 2003||2003-09-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||PUFA Augmentation in Treatment of Major Depression|PUFA Augmentation in Treatment of Major Depression|Completed||Phase 3|60||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 17:57:28.357088|2017-02-18 17:57:28.357088
NCT00067288|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-14|2006-08-16|||May 2002||2002-05-01|August 2006|2006-08-01|March 2006||2006-03-01|||||Interventional|||Meaning-Centered Psychotherapy in Advanced Cancer|Meaning-Centered Psychotherapy in Advanced Cancer|Completed||Phase 2|118||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:28.449432|2017-02-18 17:57:28.449432
NCT00067275|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-13|2017-01-24|||August 8, 2003||2003-08-08|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Observational|||The Effect of Dopamine on Motor Skills Training|Dopamine Release in Use-Dependent Plasticity in Health and Disease|Completed||N/A|98||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:28.551005|2017-02-18 17:57:28.551005
NCT00067262|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-13|2006-08-02|||March 2003||2003-03-01|August 2006|2006-08-01||||||||Interventional|||An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents|A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Depakote ER for the Treatment of Bipolar Disorder in Children and Adolescents|Completed||Phase 3|150||Abbott|||||||||||||||||||2017-02-18 17:57:28.635173|2017-02-18 17:57:28.635173
NCT00067249|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-13|2007-02-26|||April 2001||2001-04-01|February 2007|2007-02-01|September 2001||2001-09-01|||||Observational|||Women's Use of Alternative Medicine: A Multiethnic Study||Completed||N/A|3200||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:28.735972|2017-02-18 17:57:28.735972
NCT00067236|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-13|2011-09-27|2011-08-03||September 2003||2003-09-01|September 2011|2011-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Study of Oral PG-116800 Following a Heart Attack|A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral PG-116800 Following a Heart Attack|Completed||Phase 2|253|Actual|Procter and Gamble||2|||f||||f||||||||||2017-02-18 17:57:28.810945|2017-02-18 17:57:28.810945
NCT00067223|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-12|2017-01-24|||August 5, 2003||2003-08-05|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Observational|||Studying Use-Dependent Plasticity|Bi-hemispheric Plasticity Elicited By Unilateral Finger Motor Training|Completed||N/A|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:29.379159|2017-02-18 17:57:29.379159
NCT00067210|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-12|2017-01-24|||August 11, 2003||2003-08-11|June 13, 2008|2008-06-13|May 22, 2007||2007-05-22|||||Interventional|||Reducing Seizure Frequency Using Cooling of the Head and Neck|Cooling of the Head and Neck to Reduce Seizure Frequency: A Pilot Study|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:29.712335|2017-02-18 17:57:29.712335
NCT00067197|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-12|2017-01-24|||August 11, 2003||2003-08-11|July 17, 2008|2008-07-17|July 17, 2008||2008-07-17|||||Observational|||Improving Motor Learning in Stroke Patients|Modulation of Motor Learning in Chronic Stroke Patients by Transcranial DC Stimulation|Completed||N/A|76||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:29.806738|2017-02-18 17:57:29.806738
NCT00067184|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-12|2015-03-30|||September 2002||2002-09-01|February 2013|2013-02-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Observational|||Fetal Neurobehavioral Development in Methadone Maintained Pregnancies|Methadone, Buprenorphine and Fetal Development|Completed||N/A|157|Actual|Johns Hopkins University|||1||f||||f||||||||||2017-02-18 17:57:29.890368|2017-02-18 17:57:29.890368
NCT00067171|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-12|2017-01-11|||January 2003||2003-01-01|October 2016|2016-10-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Telephone Enhancement Procedure for Continuing Care - 1|Telephone Enhancement Procedure (TELE) for Continuing Care|Completed||Phase 3|339||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:57:29.99894|2017-02-18 17:57:29.99894
NCT00067158|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-12|2017-01-11|||April 2003||2003-04-01|April 2010|2010-04-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1|Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy|Completed||Phase 3|585||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 17:57:30.096997|2017-02-18 17:57:30.096997
NCT00067145|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-11|2010-01-12||||||January 2010|2010-01-01||||||||Interventional|||Computer Intervention for Prevention of Weight Regain||Completed||Phase 3|300||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:30.219544|2017-02-18 17:57:30.219544
NCT00067132|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-11|2010-01-12|||March 2003||2003-03-01|January 2010|2010-01-01||||||||Interventional|||Adjuvant Nutrition for Critically Ill Trauma Patients||Completed||Phase 1|100|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:30.306124|2017-02-18 17:57:30.306124
NCT00067119|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-11|2010-03-02|||January 2003||2003-01-01|March 2010|2010-03-01|February 2008|Actual|2008-02-01|January 2003|Actual|2003-01-01||Interventional|||Vascular Access Clinical Trials Data Coordinating Center|1) Clopidogrel Prevention of Early AV Fistula Thrombosis (IND 64169) 2) Aggrenox Prevention of Access Stenosis (IND 64,202)|Completed||Phase 3|1284|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||t||||||||||2017-02-18 17:57:30.400725|2017-02-18 17:57:30.400725
NCT00067106|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-11|2015-05-15|||July 2003||2003-07-01|September 2014|2014-09-01|March 2009|Actual|2009-03-01|March 2007|Actual|2007-03-01||Observational|||Antiviral Therapy and HIV in the Female Genital Tract|Antiviral Therapy and HIV in the Genital Tract of Women|Completed||N/A|130|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||f||||||Samples With DNA|"~     Blood and genital tract collection~   "|||2017-02-18 17:57:30.523961|2017-02-18 17:57:30.523961
NCT00067093|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-11|2011-04-05|||May 2003||2003-05-01|April 2011|2011-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)||Completed||Phase 3|1452|Actual|Sanofi|||||||||||||||||||2017-02-18 17:57:30.63282|2017-02-18 17:57:30.63282
NCT00067080|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-11|2016-11-16|||May 2003||2003-05-01|November 2016|2016-11-01||||July 2007|Actual|2007-07-01||Interventional|||Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions|A Randomized, Open Label, Phase II Study on Safety and Efficacy of Long Term Treatment of ICL670 Relative to Deferoxamine in Sickle Cell Disease Patients With Transfusional Hemosiderosis|Completed||Phase 2|195|Actual|Novartis||1|||f||||||||||||||2017-02-18 17:57:30.764416|2017-02-18 17:57:30.764416
NCT00067067|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-08|2008-03-03|||August 2003||2003-08-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Investigating Endothelial Precursor Cells (EPCs)|Circulating Endothelial Progenitor Cells in Gliomas|Completed||N/A|84||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:30.921642|2017-02-18 17:57:30.921642
NCT00067054|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-08|2017-02-14|||August 6, 2003||2003-08-06|January 26, 2017|2017-01-26||||||||Observational|||Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies|VRC 200: A Multicenter Specimen Collection Protocol to Obtain Human Biological Samples for Research Studies|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:31.009386|2017-02-18 17:57:31.009386
NCT00067041|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-08|2013-03-05|||March 2003||2003-03-01|March 2013|2013-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft|A Randomized Placebo-Controlled, 12-Week Multicenter Study of the Safety and Efficacy of Remodulin in Patients With Critical Limb Ischemia Following an Autogenous Vein Infrainguinal Bypass Graft|Terminated||Phase 2/Phase 3|30||United Therapeutics|||||f||||||||||||||2017-02-18 17:57:31.135389|2017-02-18 17:57:31.135389
NCT00067028|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-08|2013-06-17|||December 2003||2003-12-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML|A Prospective Randomized Phase I/II Study of Clofarabine (Clo) and Ara-C vs Clo and Ida vs Clo Plus Ida and Ara-C in Patients With First Relapse or First Salvage of Primary Refractory AML; and High-Grade MDS(>/= 10% Blasts); or CML in Myeloid Blasts Phase as Front Line Therapy or in First Salvage.|Completed||Phase 2|166|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 17:57:31.225116|2017-02-18 17:57:31.225116
NCT00067015|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-08|2015-12-21|||May 2003||2003-05-01|December 2015|2015-12-01|September 2008|Actual|2008-09-01|October 2004|Actual|2004-10-01||Interventional|||Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer|Phase III Randomized Trial Study Comparing the Outcome of High-Dose IMRT (86.4 GY) Alone With IMRT to 75.6 GY Plus Neoadjuvant/Adjuvant Androgen Deprivation in Patients With High Grade Intermediate Risk and Unfavorable Risk Prostate Cancer|Completed||Phase 3|3|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 17:57:31.359664|2017-02-18 17:57:31.359664
NCT00067002|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-08|2016-07-15|||April 2003||2003-04-01|July 2016|2016-07-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Interventional|||Randomized Double Cord Blood Transplant Study|Randomized Trial of Unmanipulated Versus Expanded Cord Blood|Completed||Phase 2|110|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 17:57:31.475902|2017-02-18 17:57:31.475902
NCT00065858|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2016-08-17|||September 2001||2001-09-01|August 2016|2016-08-01|April 2005||2005-04-01|||||Interventional|||Effectiveness of BufferGel as a Vaginal Contraceptive|A Randomized, Controlled Trial of the Efficacy, Safety, and Acceptability of BufferGel|Completed||Phase 2/Phase 3|975||Health Decisions|||||||||||||||||||2017-02-18 17:57:53.419884|2017-02-18 17:57:53.419884
NCT00066989|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-08|2012-05-10|||July 2003||2003-07-01|May 2012|2012-05-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates|A Double Blind, Randomized, Multicenter Stratified Study to Assess the Safety of an Intravenous Staphylococcus Aureus Immune Globulin (Human) [Altastaph] in Low-Birth-Weight-Neonates|Completed||Phase 2|200||Nabi Biopharmaceuticals|||||f||||||||||||||2017-02-18 17:57:31.605375|2017-02-18 17:57:31.605375
NCT00066976|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-07|2017-01-24|||August 5, 2003||2003-08-05|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Studying Fetal Breathing Patterns|Classification of Fetal Breathing Patterns in the Maturing Upper Airway: Spectral Waveform Analysis of Amniotic Fluid Flow Dynamics in Normal Development, Polyhydramnios, and Oligohydramnios|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:31.69773|2017-02-18 17:57:31.69773
NCT00066963|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-07|2014-04-30|2011-04-05||October 2002||2002-10-01|April 2014|2014-04-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Fluoride Varnish Randomized Clinical Trial|Comprehensive Oral Health Center for Discovery: New Strategies for Enhancing Tissue Integrity and Repair Early Childhood Caries: Prevention and Treatment Outcomes|Completed||Phase 3|376|Actual|University of California, San Francisco|In a protocol deviation, children received placebo varnish for 10 months; this would be expected to bias the study toward the null of no difference among groups. The study did not address FV efficacy for children with extant or past caries.|3|||f||||t||||||||||2017-02-18 17:57:31.782008|2017-02-18 17:57:31.782008
NCT00066950|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-07|2014-04-30|||March 2003||2003-03-01|April 2014|2014-04-01|August 2005|Actual|2005-08-01|July 2005|Actual|2005-07-01||Interventional|||Prevention Management Model for Early Childhood Caries (MAYA Project)|Prevention Management Model for Early Childhood Caries|Completed||Phase 3|361|Actual|University of California, San Francisco||2|||f||||t||||||||||2017-02-18 17:57:32.273707|2017-02-18 17:57:32.273707
NCT00066937|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-07|2010-06-25|||November 2002||2002-11-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)|Pain Management in Temporomandibular Joint Disorders|Completed||Phase 2|214|Anticipated|Johns Hopkins University||1|||f||||t||||||||||2017-02-18 17:57:32.389535|2017-02-18 17:57:32.389535
NCT00066924|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-07|2005-06-23|||September 2003||2003-09-01|May 2005|2005-05-01|June 2004||2004-06-01|||||Observational|||Spirituality, Religiosity, and Immune Functioning||Completed||N/A|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:32.487812|2017-02-18 17:57:32.487812
NCT00066911|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2017-01-24|||August 2, 2003||2003-08-02|November 5, 2009|2009-11-05||||November 5, 2009|Actual|2009-11-05||Observational|||Brain Mapping of Voice Control|Functional Brain Mapping of Laryngeal Sensorimotor Control in Voice Disorders|Completed||N/A|174||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:32.571245|2017-02-18 17:57:32.571245
NCT00066898|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2006-09-29|||June 2003||2003-06-01|September 2006|2006-09-01|December 2006||2006-12-01|||||Interventional|||ARISE – Aggressive Reduction of Inflammation Stops Events|“Reduction of Vascular Inflammation and Coronary Atherosclerosis With AGI-1067, a V-Protectant, Reduces Cardiovascular Events in Patients With Coronary Artery Disease”|Unknown status|Active, not recruiting|Phase 3|6000||AtheroGenics|||||||||||||||||||2017-02-18 17:57:32.668745|2017-02-18 17:57:32.668745
NCT00066885|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2007-05-03|||June 2003||2003-06-01|May 2007|2007-05-01|December 2005||2005-12-01|||||Interventional|||Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer|A Phase 1/2 Multicenter, Open Label, Dose Ranging Study of DN-101 and Taxotere® in Patients With Advanced (Stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Previous Therapy With Platinum-Based Chemotherapy|Completed||Phase 1/Phase 2|80||Novacea|||||||||||||||||||2017-02-18 17:57:36.008574|2017-02-18 17:57:36.008574
NCT00066872|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-09-16|||October 2002||2002-10-01|September 2009|2009-09-01|April 2010|Actual|2010-04-01|||||Interventional|||Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer|A Randomized Controlled Trial of Excisional Surgery Versus Imiquimod 5% Cream for Nodular and Superficial Basal Cell Carcinoma|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:36.127165|2017-02-18 17:57:36.127165
NCT00066859|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2016-12-20|||March 2004||2004-03-01|November 2016|2016-11-01|November 2005|Actual|2005-11-01|April 2005|Actual|2005-04-01||Interventional|||Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression|A Phase III Double-Blind Randomized Trial Comparing Sertraline (Zoloft) And Hypericum Perforatum (St. John's Wort) In Cancer Patients With Mild To Moderate Depression|Completed||Phase 3|2|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||No||2017-02-18 17:57:36.227198|2017-02-18 17:57:36.227198
NCT00066846|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-06-18|||August 2003||2003-08-01|April 2004|2004-04-01|July 2007|Actual|2007-07-01|||||Interventional|||Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy|A Multicenter Study of the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin®) Plus 5-Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancers That Have Progressed After Standard Chemotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:36.347825|2017-02-18 17:57:36.347825
NCT00066807|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2016-09-26|2016-03-11||August 2003||2003-08-01|September 2016|2016-09-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|PERCHE||Premenopausal Endocrine Responsive Chemotherapy Trial|A Phase III Trial Evaluating the Role of Chemotherapy as Adjuvant Therapy for Premenopausal Women With Endocrine Responsive Breast Cancer Who Receive Endocrine Therapy|Terminated||Phase 3|29|Actual|International Breast Cancer Study Group|Trial terminated early due to poor accrual. Adverse event data is available ONLY for selected Grade 3-5 AEs for chemotherapy arm. 25 of 29 patients were co-enrolled in TEXT (IBCSG 25-02), which reports AEs and outcomes of endocrine therapy.|2||Poor accrual, patients were followed until completion of 5 yrs treatment|f||||t||||||||||2017-02-18 17:57:36.746093|2017-02-18 17:57:36.746093
NCT00066794|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2015-03-05|||July 2004||2004-07-01|March 2015|2015-03-01|January 2010|Actual|2010-01-01|February 2007|Actual|2007-02-01||Interventional|||S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|A Phase II Study Of Induction With Daunorubicin, Cytarabine, And Cyclosporine All By Continuous IV Infusion For Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) In Patients Of Age 56 Or Older|Completed||Phase 2|69|Actual|Southwest Oncology Group||1|||f||||||||||||||2017-02-18 17:57:37.13481|2017-02-18 17:57:37.13481
NCT00066781|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2016-08-12|||February 2004||2004-02-01|August 2016|2016-08-01|March 2009|Actual|2009-03-01|April 2008|Actual|2008-04-01||Interventional|||Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary|A Phase II Study Of Gemcitabine (GEMZAR) And Irinotecan (CPT-11) In Previously Untreated Patients With Measurable Disease With Unknown Primary Carcinoma|Completed||Phase 2|31|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 17:57:37.349433|2017-02-18 17:57:37.349433
NCT00066768|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-06-03|||July 2003||2003-07-01|June 2013|2013-06-01||||March 2008|Actual|2008-03-01||Interventional|||Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer|A Pilot Study of Low Dose Suramin as Modulator of Docetaxel and Gemcitabine in Patients With Previously Treated Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:57:37.472454|2017-02-18 17:57:37.472454
NCT00066742|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2014-04-29|2012-06-14||September 2003||2003-09-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer|A Phase II Study of Tirapazamine (NSC-130181)/Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:57:37.594505|2017-02-18 17:57:37.594505
NCT00066729|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2011-04-23|||May 2003||2003-05-01|December 2009|2009-12-01||||July 2006|Actual|2006-07-01||Interventional|||Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase I Study Of NY-ESO-1b Peptide Plus Montanide ISA-51 In Patients With Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer Expressing NY-ESO-1 or LAGE-1|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:38.335585|2017-02-18 17:57:38.335585
NCT00066716|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2009-12-07|||June 2003||2003-06-01|December 2009|2009-12-01||||May 2007|Actual|2007-05-01||Interventional|||Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus|A Phase II Study Of Preoperative Celecoxib/Paclitaxel/Carboplatin For Squamous Cell And Adenocarcinoma Of The Esophagus|Completed||Phase 2|39|Actual|Weill Medical College of Cornell University||1|||f||||f||||||||||2017-02-18 17:57:38.429869|2017-02-18 17:57:38.429869
NCT00066703|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2016-09-26|2015-07-14||August 2003||2003-08-01|September 2016|2016-09-01|June 2020|Anticipated|2020-06-01|June 2014|Actual|2014-06-01||Interventional|TEXT|Intention-to-treat population excludes 12 patients who immediately withdrew consent, were at a non-adherent center, or had inadequate documentation of informed consent.|Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer|A Phase III Trial Evaluating The Role Of Exemestane Plus GnRH Analogue As Adjuvant Therapy For Premenopausal Women With Endocrine Responsive Breast Cancer|Active, not recruiting||Phase 3|2672|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-02-18 17:57:38.562679|2017-02-18 17:57:38.562679
NCT00066690|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2016-07-29|2015-07-14||August 2003||2003-08-01|July 2016|2016-07-01||||December 2031|Anticipated|2031-12-01||Interventional|SOFT|Intention-to-treat population, excludes 19 patients who immediately withdrew consent.|Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer|A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women With Endocrine Responsive Breast Cancer|Active, not recruiting||Phase 3|3066|Actual|International Breast Cancer Study Group||3|||f||||t||||||||||2017-02-18 17:57:40.126533|2017-02-18 17:57:40.126533
NCT00066677|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-06-18|||October 2003||2003-10-01|May 2013|2013-05-01|April 2009|Actual|2009-04-01|November 2008|Actual|2008-11-01||Interventional|||Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer|Phase II and Coagulation Study of rhuMAb-VEGF With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|46|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 17:57:42.680906|2017-02-18 17:57:42.680906
NCT00066664|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2012-03-14|||June 2003||2003-06-01|March 2012|2012-03-01|March 2010|Actual|2010-03-01|December 2007|Actual|2007-12-01||Interventional|||Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin|Characterization of Serum Proteomic Patterns in Neoplastic and Inflammatory Skin Disease|Completed||N/A|423|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:42.769869|2017-02-18 17:57:42.769869
NCT00066651|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2015-04-29|||July 2003||2003-07-01|February 2006|2006-02-01||||||||Interventional|||Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors|Phase I Study Of SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin In Advanced Malignancies: I.V. Infusion QOD Dosing|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:57:42.864071|2017-02-18 17:57:42.864071
NCT00066638|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2015-03-16|||June 2003||2003-06-01|December 2012|2012-12-01|March 2011|Actual|2011-03-01|May 2007|Actual|2007-05-01||Interventional|||FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase 2 Study of Depsipeptide in Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:57:42.96234|2017-02-18 17:57:42.96234
NCT00066625|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-01-31|||July 2003||2003-07-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer|A Phase I and Pharmacokinetic Study of Oxaliplatin (Eloxatin™) in Combination With Bortezomib (PS-341, Velcade™) in Patients With Advanced Malignancy|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:57:43.075581|2017-02-18 17:57:43.075581
NCT00066612|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2012-10-31|||July 2003||2003-07-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|August 2007|Actual|2007-08-01||Interventional|||S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy|Phase II Study of Irinotecan in Patients With Advanced Transitional Cell Carcinoma of the Urothelium|Completed||Phase 2|45|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:57:43.184274|2017-02-18 17:57:43.184274
NCT00066599|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-06-18|||June 2003||2003-06-01|July 2004|2004-07-01|June 2004|Actual|2004-06-01|||||Interventional|||Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy|An Open-Label, Intravenous To Oral Switch, Multiple Dose, Multi-Center Study To Investigate The Pharmacokinetics, Safety And Tolerability Of Voriconazole In Hospitalized Children Aged 2 - <12 Years Who Require Treatment For The Prevention Of Systemic Fungal Infection|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:43.296249|2017-02-18 17:57:43.296249
NCT00066586|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-05-30|||August 2001||2001-08-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|April 2006|Actual|2006-04-01||Interventional|||Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer|A Randomized Study Of The Effect Of Exemestane (Aromasin) Versus Placebo On Breast Density In Postmenopausal Women At Increased Risk For Development Of Breast Cancer|Completed||N/A|98|Actual|Canadian Cancer Trials Group||2|||f||||||||||||||2017-02-18 17:57:43.407473|2017-02-18 17:57:43.407473
NCT00066573|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2014-05-14|2014-04-16||June 2003||2003-06-01|May 2014|2014-05-01|March 2011|Actual|2011-03-01|April 2010|Actual|2010-04-01||Interventional|||Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer|A Randomized Phase III Trial Of Exemestane Versus Anastrozole In Postmenopausal Women With Receptor Positive Primary Breast Cancer|Completed||Phase 3|7576|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 17:57:43.52427|2017-02-18 17:57:43.52427
NCT00066547|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-12-03|||May 2003||2003-05-01|August 2004|2004-08-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy|An Open Label Phase I/II Study of Humanized Human Milk Fat Globule-1 (THEREX) in Patients With Locally Advanced or Metastatic Breast Cancer Following Prior Anthracycline and Taxane Therapy|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:44.093317|2017-02-18 17:57:44.093317
NCT00066508|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-01-07|||May 2003||2003-05-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy|A Phase II Study Of PS-341 (VELCADE) In Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Completed||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 17:57:44.186929|2017-02-18 17:57:44.186929
NCT00066482|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-10-15|||July 2004||2004-07-01|October 2013|2013-10-01||||April 2007|Actual|2007-04-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors|Pilot Study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children With High Risk Malignant Germ Cell Tumors|Completed||N/A|19|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:57:44.290549|2017-02-18 17:57:44.290549
NCT00066469|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2016-09-14|2013-09-17||April 2004||2004-04-01|September 2016|2016-09-01||||October 2009|Actual|2009-10-01||Interventional|||Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation|Phase II Study of Cyclophosphamide, Prednisone and Rituximab (CPR) in Children, Adolescents and Young Adults With B-lymphocyte Antigen CD20 (CD20) Positive Post-Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplantation (SOT)|Active, not recruiting||Phase 2|55|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:57:44.717446|2017-02-18 17:57:44.717446
NCT00066456|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2016-02-10|||September 2003||2003-09-01|February 2016|2016-02-01||||July 2010|Actual|2010-07-01||Interventional|||Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer|A Phase I Study Using Low Dose Abdominal Radiotherapy as A Docetaxel Chemosensitizer for Recurrent , Persistent Or Advanced Ovarian, Peritoneal Or Fallopian Tube Cancer|Completed||Phase 1|13|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:57:45.190554|2017-02-18 17:57:45.190554
NCT00066443|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2015-11-02|||February 2003||2003-02-01|January 2014|2014-01-01|January 2014|Actual|2014-01-01|January 2014|Actual|2014-01-01||Interventional|||Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer|A Phase I/II Study Of Increasing Doses Of Epirubicin And Docetaxel Plus Pegfilgrastim For Locally Advanced Or Inflammatory Breast Cancer|Completed||Phase 1/Phase 2|93|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 17:57:45.308993|2017-02-18 17:57:45.308993
NCT00066430|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2014-09-16|||September 2003||2003-09-01|September 2014|2014-09-01|April 2006|Actual|2006-04-01|September 2004|Actual|2004-09-01||Interventional|||Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia|Infrared Coagulator For Treatment Of High Grade Squamous Intraepithelial Neoplasia (HSIL) in the Anal Canal In HIV Infected Individuals: A Pilot Study|Completed||Phase 1|18|Actual|AIDS Malignancy Consortium||1|||f||||f||||||||||2017-02-18 17:57:45.429847|2017-02-18 17:57:45.429847
NCT00066417|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-04-30||||||November 2006|2006-11-01|January 2007|Actual|2007-01-01|||||Interventional|||Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia|Pilot Study Of T-Cell-Depleted Peripheral Blood Stem Cell Transplantation From Partially Matched Related Donors For Patients With High-Risk Leukemia|Terminated||Phase 2|51|Anticipated|National Cancer Institute (NCI)||||Trial was withdrawn for drug availability issues.|f||||||||||||||2017-02-18 17:57:45.538329|2017-02-18 17:57:45.538329
NCT00066404|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2010-08-07|||April 2003||2003-04-01|December 2005|2005-12-01||||||||Interventional|||Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions|A Phase I Clinical Trial of Intrapleural Adenoviral-Mediated Interferon-beta (IFN-ß) Gene Transfer for Pleural Malignancies|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:45.649216|2017-02-18 17:57:45.649216
NCT00066391|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2012-09-20|||June 2003||2003-06-01|September 2012|2012-09-01||||January 2006|Actual|2006-01-01||Interventional|||Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer|Phase II Study of Irinotecan (CPT 11) and Cisplatin (CDDP) in Metastatic or Locally Advanced Penile Carcinoma|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:57:45.746031|2017-02-18 17:57:45.746031
NCT00066378|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-10-23|||May 2003||2003-05-01|October 2013|2013-10-01||||August 2007|Actual|2007-08-01||Interventional|||Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer|An EORTC Randomized, Double Blind, Placebo-Controlled, Phase II Multi-Center Trial Of Anastrozole (Arimidex) In Combination With ZD 1839 (Iressa) Or Placebo In Patients With Advanced Breast Cancer|Completed||Phase 2|71|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 17:57:45.997123|2017-02-18 17:57:45.997123
NCT00066365|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2015-03-17|2015-02-11||July 2004||2004-07-01|March 2015|2015-03-01|December 2013|Actual|2013-12-01|July 2010|Actual|2010-07-01||Interventional|||Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma|A Phase II Study of Aerosolized GM-CSF (NSC# 613795, IND# 11042) in Patients With First Pulmonary Recurrence of Osteosarcoma|Completed||Phase 2|49|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 17:57:46.159669|2017-02-18 17:57:46.159669
NCT00066352|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2015-07-22|||September 2003||2003-09-01|July 2015|2015-07-01||||September 2003|Actual|2003-09-01||Interventional|||Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter|A Phase II Study of PS-341 in Advanced or Metastatic Urothelial Cancer (Transitional Cell Cancer of the Bladder, Ureter, and Renal Pelvis)|Completed||Phase 2|||University Health Network, Toronto|||||||||||||||||||2017-02-18 17:57:47.323681|2017-02-18 17:57:47.323681
NCT00066339|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2012-07-17|||May 2003||2003-05-01|July 2012|2012-07-01||||January 2004|Actual|2004-01-01||Interventional|||Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy|An IDBBC Single Arm Phase II Trial Evaluating The Activity Of Iressa (ZD1839) In Metastatic Breast Cancer Patients Pretreated With An Antiestrogen And A Non-Steroidal Aromatase Inhibitor (Anastrozole Or Letrozole)|Completed||Phase 2|44|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:57:47.446386|2017-02-18 17:57:47.446386
NCT00066326|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2013-04-03|||June 2003||2003-06-01|April 2013|2013-04-01|September 2005|Actual|2005-09-01|October 2004|Actual|2004-10-01||Interventional|||Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia|Phase I Study Of The Combination Of 17-AAG And Imatinib Mesylate (Gleevec) In Patients With Blastic Phase, Accelerated Phase Of Chronic Mesylate Leukemia (CML) Or Patients With Chronic Phase CML Who Have Not Achieved A Cytogenetic Response With Imatinib Mesylate|Completed||Phase 1|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 17:57:47.548484|2017-02-18 17:57:47.548484
NCT00066313|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2016-08-23|||May 2003||2003-05-01|August 2016|2016-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||ZD6474 in Treating Patients With Small Cell Lung Cancer|A Phase II Study Of ZD6474 Or Placebo In Small Cell Lung Cancer Patients Who Have Complete Or Partial Response To Induction Chemotherapy +/- Radiation Therapy|Completed||Phase 2|||Sanofi|||||||||||||||||||2017-02-18 17:57:47.649654|2017-02-18 17:57:47.649654
NCT00066274|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2009-01-10|||May 2002||2002-05-01|May 2005|2005-05-01||||||||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer|Randomized Phase II Study Evaluating Three Chemotherapies: [Irinotecan + Oxaliplatin (Irinox)], [Irinotecan + LV5FU2] and [Oxaliplatin + LV5FU2] as First Intention Treatment in Subjects With Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:57:47.774123|2017-02-18 17:57:47.774123
NCT00066248|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2014-01-31|||June 2003||2003-06-01|January 2014|2014-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment|The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia|Completed||Phase 2|70|Actual|University of South Florida||2|||f||||t||||||||||2017-02-18 17:57:47.88754|2017-02-18 17:57:47.88754
NCT00066222|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-06|2014-12-10|2014-12-10||June 2003||2003-06-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|May 2012|Actual|2012-05-01||Interventional||Eligible patients who started protocol treatment.|Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|A Phase II Study Of Accelerated High Dose Thoracic Irradiation With Concurrent Chemotherapy For Patients With Limited Small Cell Lung Cancer|Completed||Phase 2|72|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 17:57:48.080399|2017-02-18 17:57:48.080399
NCT00066209|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-05|2017-01-24|||August 4, 2003||2003-08-04|May 24, 2007|2007-05-24|May 24, 2007||2007-05-24|||||Observational|||Investigating Severe Acute Respiratory Syndrome (SARS)|An Investigation of the Inflammatory Response in Severe Acute Respiratory Syndrome (SARS)|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:48.654288|2017-02-18 17:57:48.654288
NCT00066196|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-05|2008-01-14|||August 2003||2003-08-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|April 2007|Anticipated|2007-04-01||Interventional|||Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma|A Phase II, Randomized, Open-Label Study Evaluating The Antitumor Activity Of MEDI-522, A Humanized Monoclonal Antibody Directed Against The Human Alpha V Beta 3 Integrin, ± Dacarbazine In Patients With Metastatic Melanoma|Completed||Phase 2|110||MedImmune LLC||2|||f||||f||||||||||2017-02-18 17:57:48.73669|2017-02-18 17:57:48.73669
NCT00066183|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-04|2008-03-03|||August 2003||2003-08-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Studying Phosphorus Metabolism|Studies in Phosphorus Metabolism|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:57:48.862053|2017-02-18 17:57:48.862053
NCT00066170|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-04|2011-12-21|2011-10-21||April 2003||2003-04-01|December 2011|2011-12-01|November 2004|Actual|2004-11-01|July 2004|Actual|2004-07-01||Interventional|||Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy|Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate) and Modafinil With Placebo in Treatment of Daytime Sleepiness in Narcolepsy|Completed||Phase 3|231|Actual|Jazz Pharmaceuticals||4|||f||||f||||||||||2017-02-18 17:57:48.95332|2017-02-18 17:57:48.95332
NCT00066157|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-04|2015-10-01|||September 2001||2001-09-01|September 2010|2010-09-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Alzheimer's Disease: Therapeutic Potential of Estrogen|Alzheimer's Disease: Therapeutic Potential of Estrogen|Completed||Phase 2/Phase 3|42|Actual|University of Wisconsin, Madison||4|||f||||t||||||||||2017-02-18 17:57:50.360598|2017-02-18 17:57:50.360598
NCT00066144|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-04|2007-10-11|||April 2003||2003-04-01|October 2007|2007-10-01|April 2006|Actual|2006-04-01|||||Interventional|||Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms|Black Cohosh and Red Clover Efficacy for the Relief of Menopausal Symptoms|Completed||Phase 2|112|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 17:57:50.481522|2017-02-18 17:57:50.481522
NCT00066131|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-04|2015-07-24|||March 2003||2003-03-01|July 2015|2015-07-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|OPT||Obstetrics and Periodontal Therapy (OPT) Study|Effects of Periodontal Therapy on Preterm Birth|Completed||Phase 3|823|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 17:57:50.570738|2017-02-18 17:57:50.570738
NCT00066118|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-04|2010-09-02|||August 1996||1996-08-01|September 2010|2010-09-01|February 2011|Anticipated|2011-02-01|July 2005|Actual|2005-07-01||Interventional|||Health Effects of Silver-Mercury Dental Fillings|The Casa Pia Study of the Health Effects of Dental Amalgam in Children.|Unknown status|Active, not recruiting|Phase 3|507||University of Washington|||||f||||||||||||||2017-02-18 17:57:50.686931|2017-02-18 17:57:50.686931
NCT00066092|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-04|2008-02-20|||April 2003||2003-04-01|February 2008|2008-02-01|October 2004|Actual|2004-10-01|March 2004|Actual|2004-03-01||Interventional|||Pegfilgrastim PBPC Mobilization Study|Randomized, Double-Blind Study of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Pegfilgrastim or Filgrastim for Autologous Transplantation in Subjects With Hodgkin's or Non-Hodgkin's Lymphoma.|Completed||Phase 2|41|Actual|Amgen||3|||f||||||||||||||2017-02-18 17:57:50.794949|2017-02-18 17:57:50.794949
NCT00066079|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2008-08-04|||August 2003||2003-08-01|August 2008|2008-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Home Based Massage and Relaxation for Sickle Cell Pain|Home Based Massage and Relaxation for Sickle Cell Pain|Completed||Phase 2|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 17:57:50.903523|2017-02-18 17:57:50.903523
NCT00066066|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2013-03-06|2012-12-11||July 2003||2003-07-01|March 2013|2013-03-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers|Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers|Completed||Phase 2|146|Actual|The Forsyth Institute||3|||f||||f||||||||||2017-02-18 17:57:50.989563|2017-02-18 17:57:50.989563
NCT00066053|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2011-08-04|||January 2003||2003-01-01|May 2007|2007-05-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||"Periodontitis and Cardiovascular Events or PAVE"|Periodontal Intervention for Cardiac Events: A Pilot Trial|Completed||N/A|303|Actual|University at Buffalo||2|||f||||t||||||||||2017-02-18 17:57:51.606078|2017-02-18 17:57:51.606078
NCT00066040|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2012-07-16|||January 2001||2001-01-01|July 2012|2012-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Prevention of Transmission of Bacteria That Cause Cavities From Mothers to Their Children|Prevention of Transmission of Mutans Streptococci From Mother to Child|Completed||N/A|280||New York University|||||f||||t||||||||||2017-02-18 17:57:51.721037|2017-02-18 17:57:51.721037
NCT00066027|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2015-12-01|||June 2002||2002-06-01|December 2015|2015-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effects of Low-Dose Doxycycline on Oral Bone Loss|Low-Dose Doxycycline Effects on Osteopenic Bone Loss|Completed||Phase 3|128|Actual|University of Nebraska||2|||f||||t||||||||||2017-02-18 17:57:51.825794|2017-02-18 17:57:51.825794
NCT00066014|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2012-02-21|||November 1998||1998-11-01|January 2010|2010-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Clinical Investigation of Mandibular Implant Overdenture|Clinical Investigation of Mandibular Implant Overdenture|Completed||Phase 2|30|Actual|Virginia Commonwealth University||1|||f||||t||||||||||2017-02-18 17:57:52.067345|2017-02-18 17:57:52.067345
NCT00066001|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2010-11-08|||December 2002||2002-12-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|December 2007|Actual|2007-12-01||Interventional|||Microbial Associations in Periodontal Health and Disease|The Effect of Systemically Administered Metronidazole Alone and in Combination With Professional Supragingival Plaque Removal on Plaque Composition|Completed||Phase 2|154|Actual|The Forsyth Institute||1|||f||||f||||||||||2017-02-18 17:57:52.169492|2017-02-18 17:57:52.169492
NCT00065988|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2010-04-27|||September 1997||1997-09-01|August 2005|2005-08-01|March 2005||2005-03-01|||||Interventional|||The Children's Amalgam Trial|Health Effects of Dental Amalgams in Children|Completed||Phase 3|534||New England Research Institutes|||||f||||||||||||||2017-02-18 17:57:52.279236|2017-02-18 17:57:52.279236
NCT00065975|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2006-08-16|||April 2002||2002-04-01|August 2006|2006-08-01|December 2002||2002-12-01|||||Interventional|||Physical CAM Therapies for Chronic Low Back Pain|Physical CAM Therapies for Chronic Low Back Pain|Completed||Phase 2|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:52.368589|2017-02-18 17:57:52.368589
NCT00065962|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2005-06-23|||June 1999||1999-06-01|June 2003|2003-06-01|May 2000||2000-05-01|||||Interventional|||Secretin for the Treatment of Autism|Multisite Controlled Secretin Trial in Autism|Completed||Phase 3|85||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:52.458211|2017-02-18 17:57:52.458211
NCT00065949|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2005-06-23|||August 1987||1987-08-01|May 2003|2003-05-01|February 2003||2003-02-01|||||Interventional|||Magnesium Sulfate to Prevent Brain Injury in Premature Infants|Magnesium Prevention of Brain Injury in Preterm Infants|Unknown status|Active, not recruiting|Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:52.56884|2017-02-18 17:57:52.56884
NCT00065936|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2005-06-23|||July 1997||1997-07-01|May 2003|2003-05-01|June 2002||2002-06-01|||||Interventional|||Self-Injury: Diagnosis and Treatment|Behavioral and Biochemical Mechanisms of Self-Injury|Unknown status|Active, not recruiting|Phase 3|37||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:52.680546|2017-02-18 17:57:52.680546
NCT00065923|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2013-04-30|||July 2002||2002-07-01|August 2010|2010-08-01||||December 2005|Actual|2005-12-01||Interventional|||Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome|Topiramate Effects on SIB in Prader-Willi Syndrome|Completed||N/A|10|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:52.786539|2017-02-18 17:57:52.786539
NCT00065910|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2007-06-28|||September 2001||2001-09-01|June 2003|2003-06-01|January 2006||2006-01-01|||||Interventional|||Improving Attention Skills of Children With Autism|A Joint Attention Intervention With Caregivers and Their Children With Autism|Completed||Phase 1/Phase 2|30||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:52.878421|2017-02-18 17:57:52.878421
NCT00065897|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2005-06-23|||September 1996||1996-09-01|June 2003|2003-06-01|August 2000||2000-08-01|||||Interventional|||Prenatal Testing: Amniocentesis Versus Transabdominal Chorionic Villus Sampling (TA CVS)|Randomized Trial of 11-14 Week Amniocentesis and Transabdominal Chorionic Villus Sampling (TA CVS)|Completed||N/A|6400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:52.965224|2017-02-18 17:57:52.965224
NCT00065884|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2005-06-23||||||June 2003|2003-06-01||||||||Interventional|||Valproate Response in Aggressive Autistic Adolescents|Valproate Response in Aggressive Autistic Adolescents|Unknown status|Recruiting|Phase 3|30||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:53.041701|2017-02-18 17:57:53.041701
NCT00065871|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2007-04-05|||June 2003||2003-06-01|November 2004|2004-11-01|February 2006||2006-02-01|||||Interventional|||The Direct Access Study: Access to Hormonal Birth Control Through Community Pharmacies|Improving Contraceptive Practice and Delivery Through Community Pharmacists: The Direct Access Study|Unknown status|Active, not recruiting|N/A|250||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:53.312805|2017-02-18 17:57:53.312805
NCT00065845|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2011-01-09|||April 2002||2002-04-01|October 2010|2010-10-01|April 2007|Actual|2007-04-01|March 2007|Actual|2007-03-01||Interventional|CARE||Colpopexy and Urinary Reduction Efforts (CARE) Protocol|CARE: A Randomized Trial of Colpopexy and Urinary Reduction Efforts|Completed||Phase 3|322|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 17:57:53.515312|2017-02-18 17:57:53.515312
NCT00065832|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2015-06-02|||July 1993||1993-07-01|October 2004|2004-10-01|June 2002||2002-06-01|||||Interventional|||Reading Problems in Children Living in Urban Areas|Early Interventions for Children With Reading Problems|Completed||Phase 3|1400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:53.642048|2017-02-18 17:57:53.642048
NCT00065819|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2005-06-23|||September 1996||1996-09-01|June 2003|2003-06-01|August 1999||1999-08-01|||||Interventional|||HIV Symptom Management Program for African American Mothers|HIV Symptom Management With African American Mothers|Completed||Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:57:53.730869|2017-02-18 17:57:53.730869
NCT00065806|ClinicalTrials.gov processed this data on February 17, 2017|2003-08-01|2013-07-15|2013-02-11||September 2003||2003-09-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Test the Safety and Efficacy of Lipitor (Atorvastatin) in Reducing the Progression of Carotid IMT in Early Childhood SLE|Completed||Phase 3|221|Actual|Duke University||2|||f||||t||||||||||2017-02-18 17:57:53.828563|2017-02-18 17:57:53.828563
NCT00065793|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2015-01-30|||July 2003||2003-07-01|January 2015|2015-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||VLDL and LDL Particle Types as Coronary Heart Disease Risk Factors||Completed||N/A|1478|Actual|Brigham and Women's Hospital|||1||f||||||||||||||2017-02-18 17:57:54.700975|2017-02-18 17:57:54.700975
NCT00065780|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2013-10-25|||August 2003||2003-08-01|October 2013|2013-10-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Ventricular Size and Value Calcification Measures by Computed Tomography - Ancillary to MESA||Completed||N/A|6814|Actual|Los Angeles Biomedical Research Institute|||1||f||||||||||||||2017-02-18 17:57:54.778744|2017-02-18 17:57:54.778744
NCT00065767|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2015-10-01|||September 2001||2001-09-01|September 2010|2010-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease|Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease|Completed||Phase 2/Phase 3|20||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 17:57:54.852439|2017-02-18 17:57:54.852439
NCT00065754|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2011-09-16|||September 2003||2003-09-01|August 2011|2011-08-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Brain Imaging and Pain in Irritable Bowel Syndrome|Brain Imaging and Pain: Analysis of Placebo Analgesia|Completed||N/A|50||University of Florida|||||f||||f||||||||||2017-02-18 17:57:54.947972|2017-02-18 17:57:54.947972
NCT00065741|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2007-03-21|||September 2003||2003-09-01|March 2007|2007-03-01|March 2006||2006-03-01|||||Interventional|||Botanical/Drug Interactions in HIV: Glucuronidation|Botanical/Drug Interactions in HIV: Glucuronidation|Completed||Phase 1|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:55.038754|2017-02-18 17:57:55.038754
NCT00065728|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2013-09-04||2012-11-27|June 2003||2003-06-01|May 2009|2009-05-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD|An Open Label Evaluation of Long Term Efficacy and Safety of Posterior Juxtascleral Injections of Anecortave Acetate 15 mg in Patients With Subfoveal Exudative Age-Related Macular Degeneration (AMD)|Terminated||Phase 3|111|Actual|Alcon Research||1||Management decision|f||||||||||||||2017-02-18 17:57:55.129905|2017-02-18 17:57:55.129905
NCT00065715|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2014-12-03|||September 2003||2003-09-01|December 2014|2014-12-01|April 2013|Actual|2013-04-01|August 2008|Actual|2008-08-01||Interventional|PEP||Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)|"Placebo: Physician or Pill? A Randomized Trial in a Common Cold Model Funded by NIH NCCAM Under RFA The Placebo Effect in Clinical Practice"|Completed||Phase 3|719|Actual|University of Wisconsin, Madison||4|||f||||t||||||||||2017-02-18 17:57:55.240543|2017-02-18 17:57:55.240543
NCT00065702|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2006-08-17|||October 2000||2000-10-01|August 2006|2006-08-01|September 2002||2002-09-01|||||Interventional|||Biomarkers of Homeopathy in Fibromyalgia||Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:55.351418|2017-02-18 17:57:55.351418
NCT00065689|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-31|2006-07-24|||March 2003||2003-03-01|July 2006|2006-07-01|September 2005||2005-09-01|||||Interventional|||High Intensity Light Therapy in Alzheimer's Disease|High Intensity Light Therapy in Alzheimer's Disease|Completed||Phase 3|107||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:55.426251|2017-02-18 17:57:55.426251
NCT00065676|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-30|2017-01-24|||July 25, 2003||2003-07-25|August 29, 2016|2016-08-29|December 17, 2025|Anticipated|2025-12-17|||||Interventional|||Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes|Inhibition of Intestinal Glucose Absorption by the Bioflavonoid Quercetin in the Obese and in Obese Type 2 Diabetics|Recruiting||Phase 2|100|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:57:55.507667|2017-02-18 17:57:55.507667
NCT00065663|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-30|2007-11-16|||August 2002||2002-08-01|November 2007|2007-11-01|December 2004||2004-12-01|||||Interventional|||Gene Therapy to Improve Wound Healing in Patients With Diabetes|Growth Factor Gene Therapy for Wound Healing|Completed||Phase 1|21||Tissue Repair Company|||||||||||||||||||2017-02-18 17:57:55.613241|2017-02-18 17:57:55.613241
NCT00065650|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-30|2015-04-14|||July 2003||2003-07-01|April 2015|2015-04-01|January 2004||2004-01-01|||||Interventional|||Pilot Study of Vedic Medicine for Type 2 Diabetes||Completed||Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:55.700916|2017-02-18 17:57:55.700916
NCT00065637|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-29|2013-02-04|||December 2003||2003-12-01|February 2013|2013-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Once Weekly Parathyroid Hormone for Osteoporosis|PTH Once Weekly Research (POWR)|Completed||Phase 3|50||University of California, San Francisco||2|||f||||||||||||||2017-02-18 17:57:55.942934|2017-02-18 17:57:55.942934
NCT00065624|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-29|2007-09-28|||November 2003||2003-11-01|September 2007|2007-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Antioxidant Functions of Lipoic Acid|Antioxidant Functions of Lipoic Acid|Completed||Phase 2|16||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:57:56.048208|2017-02-18 17:57:56.048208
NCT00065611|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-28|2011-09-20|2011-09-20||July 2003||2003-07-01|September 2011|2011-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Steroid Treatment for Kidney Disease|Pulse Dexamethasone Over 48 Weeks for Podocyte Disease|Completed||Phase 3|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:57:56.157196|2017-02-18 17:57:56.157196
NCT00065585|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-28|2014-02-25|||April 2004||2004-04-01|February 2014|2014-02-01|June 2007|Actual|2007-06-01|September 2006|Actual|2006-09-01||Interventional|||Efficacy of Acupuncture for Chronic Low Back Pain|Efficacy of Acupuncture for Chronic Low Back Pain|Completed||Phase 3|640||Group Health Cooperative||4|||f||||t||||||||||2017-02-18 17:57:56.630427|2017-02-18 17:57:56.630427
NCT00065572|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-28|2011-01-25|||August 2003||2003-08-01|January 2011|2011-01-01|February 2004|Anticipated|2004-02-01|February 2004|Anticipated|2004-02-01||Interventional|||Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)||Suspended||Phase 2|||AstraZeneca|||||||||||||||||||2017-02-18 17:57:56.733766|2017-02-18 17:57:56.733766
NCT00065559|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-28|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01|December 2004||2004-12-01|||||Interventional|||Treatment of Diabetic Nephropathy||Terminated||N/A|30||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:57:56.823575|2017-02-18 17:57:56.823575
NCT00065546|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-28|2012-01-05|||June 2007||2007-06-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|September 2009|Actual|2009-09-01||Interventional|||Human Requirements for the Nutrient Choline|Human Requirements for the Nutrient Choline|Completed||N/A|43|Actual|University of North Carolina, Chapel Hill||3|||f||||t||||||||||2017-02-18 17:57:56.911932|2017-02-18 17:57:56.911932
NCT00065533|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-28|2007-06-21|||May 2003||2003-05-01|June 2007|2007-06-01|June 2005|Actual|2005-06-01|||||Interventional|||Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer|Study of Two Doses of ALIMTA (Pemetrexed) as First Line Chemotherapy for Advanced Breast Cancer|Completed||Phase 2|92|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 17:57:57.21828|2017-02-18 17:57:57.21828
NCT00065507|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-28|2013-06-17|2010-02-25||August 2003||2003-08-01|June 2013|2013-06-01|May 2013|Actual|2013-05-01|October 2008|Actual|2008-10-01||Interventional|||Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation|Comparison of the Efficacy and Safety of Entecavir Versus Adefovir in Subjects Chronically Infected With Hepatitis B Virus and Evidence of Hepatic Decompensation|Completed||Phase 3|195|Actual|Bristol-Myers Squibb||2|||f||||f||||||||||2017-02-18 17:57:57.344924|2017-02-18 17:57:57.344924
NCT00065468|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-24|2012-09-24|2012-03-22||July 2003||2003-07-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|June 2006|Actual|2006-06-01||Interventional|ARCC||Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma|A Phase 3, Three-Arm, Randomized, Open-Label Study Of Interferon Alfa Alone, CCI-779 Alone, And The Combination Of Interferon Alfa And CCI-779 In First-Line Poor-Prognosis Subjects With Advanced Renal Cell Carcinoma.|Completed||Phase 3|626|Actual|Pfizer|Efficacy data was not collected or analyzed after the primary analysis was completed.|3|||f||||t||||||||||2017-02-18 17:57:59.506742|2017-02-18 17:57:59.506742
NCT00065455|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-23|2017-01-24|||July 17, 2003||2003-07-17|May 6, 2009|2009-05-06|May 6, 2009||2009-05-06|||||Interventional|||Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa|Pilot Study on the Effect of Vitamin A Supplementation on Cone Function in Retinitis Pigmentosa|Completed||Phase 1|11||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:58:01.383161|2017-02-18 17:58:01.383161
NCT00065442|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-23|2010-09-02|2010-05-28||July 2003||2003-07-01|September 2010|2010-09-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy|A Randomized, Double Blind, Placebo Controlled Phase 3 Trial of Immunotherapy With Autologous Antigen Presenting Cells Loading With PA2024 (Provenge(R), APC8015) in Men With Metastatic Androgen Independent Prostatic Adenocarcinoma|Completed||Phase 3|512|Actual|Dendreon||2|||f||||||||||||||2017-02-18 17:58:01.48676|2017-02-18 17:58:01.48676
NCT00065429|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-23|2012-07-09|2011-08-03||April 2003||2003-04-01|July 2012|2012-07-01|December 2008|Actual|2008-12-01|November 2008|Actual|2008-11-01||Interventional|||Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer|A Phase I, Open-Label, Dose Escalation Study of Weekly Dosing With BB-10901, Followed by a Phase II Efficacy Expansion|Completed||Phase 1/Phase 2|64|Actual|ImmunoGen, Inc.||7|||f||||f||||||||||2017-02-18 17:58:02.396932|2017-02-18 17:58:02.396932
NCT00065416|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-22|2005-06-23||||||October 2004|2004-10-01||||||||Interventional|||Evaluating Therapeutic Massage for Chronic Neck Pain||Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:58:03.245923|2017-02-18 17:58:03.245923
NCT00065403|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-22|2006-08-16|||February 2004||2004-02-01|August 2006|2006-08-01|September 2005||2005-09-01|||||Interventional|||Acupuncture for Irritable Bowel Syndrome||Completed||Phase 1/Phase 2|260||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:58:03.324112|2017-02-18 17:58:03.324112
NCT00065390|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2008-03-03|||July 2003||2003-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome|Pilot (Phase I-II) Study of Pyrimethamine (Daraprim) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)|Completed||Phase 1|8||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:03.402148|2017-02-18 17:58:03.402148
NCT00065377|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2006-06-23|||July 2003||2003-07-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People|An Exploratory Study of the Effects of Oral Glucosamine Administration on Insulin Sensitivity and Capillary Recruitment in Normal and Obese Subjects|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:03.492109|2017-02-18 17:58:03.492109
NCT00065364|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2005-06-23|||May 2000||2000-05-01|October 2004|2004-10-01||||||||Interventional|||Improving Brain Development in Medically Healthy Premature Infants|Neurodevelopment and Experience: Behavior, Quantitative EEG and MRI|Completed||N/A|90||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:03.579971|2017-02-18 17:58:03.579971
NCT00065351|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2016-11-21|||July 2003||2003-07-01|November 2016|2016-11-01|March 2007|Actual|2007-03-01|October 2006|Actual|2006-10-01||Interventional|||Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma|A Multicenter, Open-label Study to Determine the Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma|Completed||Phase 2|222|Actual|Celgene Corporation||1|||f||||f||||||||||2017-02-18 17:58:03.668117|2017-02-18 17:58:03.668117
NCT00065325|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2015-02-23|||August 2003||2003-08-01|February 2015|2015-02-01|September 2014|Actual|2014-09-01|June 2006|Actual|2006-06-01||Interventional|EFECT||The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer|A Randomized, Double Blind, Multicenter Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX™) vs. Exemestane (AROMASIN™) in Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer With Disease Progression After Prior Non-Steroidal Aromatase Inhibitor (AI) Therapy|Completed||Phase 3|694|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 17:58:06.820185|2017-02-18 17:58:06.820185
NCT00065312|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:58:07.083139|2017-02-18 17:58:07.083139
NCT00065299|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2005-06-23|||May 1984||1984-05-01|May 2000|2000-05-01|April 2000||2000-04-01|||||Interventional|||Low Phenylalanine Diet for Mothers With Phenylketonuria (PKU)|Effects of Maternal Phenylketonuria (PKU) on Pregnancy Outcome|Completed||N/A|572||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:07.472922|2017-02-18 17:58:07.472922
NCT00065286|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2005-06-23|||December 1996||1996-12-01|June 2003|2003-06-01|November 1999||1999-11-01|||||Observational|||Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation|Movement Dynamic Analyses of Akathisia|Completed||Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:07.567027|2017-02-18 17:58:07.567027
NCT00065273|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-21|2005-06-23|||July 1998||1998-07-01|June 2003|2003-06-01|June 2001||2001-06-01|||||Interventional|||Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay|Severe Aberrant Behavior Among Persons With Mental Retardation. Project III: Behavioral Selectivity of Atypical Neuroleptic Drugs: Effects on Cognitive and Social Behaviors|Completed||Phase 3|50||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:07.657071|2017-02-18 17:58:07.657071
NCT00065260|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-18|2016-02-03|2016-02-03||July 2003||2003-07-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|December 2014|Actual|2014-12-01||Interventional|||Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia|A Randomized Trial of Immunosuppression in Aplastic Anemia Patients With Refractory Pancytopenia or Suboptimal Hematologic Response After h-ATG/CsA Treatment|Completed||Phase 2|54|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 17:58:07.758635|2017-02-18 17:58:07.758635
NCT00065247|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-18|2005-06-23|||June 1999||1999-06-01|June 2003|2003-06-01|May 2004||2004-05-01|||||Interventional|||The BONES Project: Building Healthy Bones in Children|Beat Osteoporosis: Nourish and Exercise Skeletons (BONES)|Unknown status|Active, not recruiting|N/A|1500||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:08.133865|2017-02-18 17:58:08.133865
NCT00065234|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-18|2006-08-16|||September 2003||2003-09-01|August 2006|2006-08-01|May 2006||2006-05-01|||||Interventional|||Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)|Acupuncture to Prevent Postoperative Paralytic Ileus|Suspended||Phase 2|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:58:08.217381|2017-02-18 17:58:08.217381
NCT00065221|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-18|2008-01-24|||June 2003||2003-06-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Ginger Control of Chemotherapy Induced Nausea and Vomiting|Trial of Encapsulated Ginger as a Treatment for Chemotherapy-Induced Nausea and Vomiting|Completed||Phase 2|180|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:58:08.299784|2017-02-18 17:58:08.299784
NCT00065208|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-18|2012-09-20|||April 2005||2005-04-01|September 2012|2012-09-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Reiki/Energy Healing in Prostate Cancer|Effects of Energy Healing on Prostate Cancer|Completed||Phase 1/Phase 2|79|Actual|The Cleveland Clinic||3|||f||||t||||||||||2017-02-18 17:58:08.383981|2017-02-18 17:58:08.383981
NCT00065195|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-18|2008-01-23|||November 2003||2003-11-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||REST: Reducing End-of-Life Symptoms With Touch|Efficacy of Massage at the End of Life|Completed||Phase 2|440||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:58:08.491481|2017-02-18 17:58:08.491481
NCT00065182|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-17|2015-04-13|||August 2003||2003-08-01|April 2015|2015-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer|An Open-Label, Multicenter, Randomized, Phase III Study Comparing Combination IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Advanced (IIIB/IV) Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|408||GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:58:08.596363|2017-02-18 17:58:08.596363
NCT00065169|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-17|2015-12-02|||November 2000||2000-11-01|December 2015|2015-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs|Anti-Inflammation in AD: PET Imaging Supplement|Completed||N/A|138||University of California, Los Angeles|||||f||||||||||||||2017-02-18 17:58:09.029069|2017-02-18 17:58:09.029069
NCT00065156|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-17|2011-10-05|2009-08-31||June 2003||2003-06-01|October 2011|2011-10-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality|A Multicenter, Single-arm, Open-label Study of the Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion-dependent Subjects With Myelodysplastic Syndromes Associated With a Del(5q) Cytogenetic Abnormality.|Completed||Phase 2|148|Actual|Celgene||1|||f||||f||||||||||2017-02-18 17:58:09.129818|2017-02-18 17:58:09.129818
NCT00065143|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-17|2012-01-20|||June 2003||2003-06-01|January 2012|2012-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome|A Phase II Study of Clofarabine in Combination With Cytarabine (Ara-C) in Patients >/= 50 Years With Newly Diagnosed and Previously Untreated Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) (>/= 10% Bone Marrow Blasts)|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-02-18 17:58:09.929102|2017-02-18 17:58:09.929102
NCT00065130|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-17|2016-12-21|||April 2000||2000-04-01|December 2016|2016-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes|Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Basal/Bolus Therapy for Patients With Gestational Diabetes|Completed||Phase 3|27|Actual|Novo Nordisk A/S|||||f||||f||||||||||2017-02-18 17:58:10.027792|2017-02-18 17:58:10.027792
NCT00065117|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-17|2011-01-25|||September 2003||2003-09-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.||Terminated||Phase 2|180||AstraZeneca|||||||||||||||||||2017-02-18 17:58:10.132392|2017-02-18 17:58:10.132392
NCT00065104|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-17|2006-08-16|||October 2000||2000-10-01|August 2006|2006-08-01|April 2003||2003-04-01|||||Interventional|||Dehydroepiandrosterone Effects on HIV-1 Replication|Dehydroepiandrosterone Effects on HIV-1 Replication|Completed||Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 17:58:10.223017|2017-02-18 17:58:10.223017
NCT00065078|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2005-09-09|||June 2003||2003-06-01|September 2005|2005-09-01|July 2005||2005-07-01|||||Interventional|||Providing Birth Control Through Home Health Visits|Effectiveness of Nurse Home Contraceptive Dispensing|Unknown status|Active, not recruiting|N/A|600||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:10.311044|2017-02-18 17:58:10.311044
NCT00065065|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2015-12-04|2014-07-10||September 2002||2002-09-01|December 2015|2015-12-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Trial of Rosiglitazone for Ulcerative Colitis|A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis|Completed||Phase 2|105|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 17:58:10.39395|2017-02-18 17:58:10.39395
NCT00065052|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2010-01-12|||September 2002||2002-09-01|January 2010|2010-01-01|May 2007|Actual|2007-05-01|||||Interventional|||Modifying the Home Television Watching Environment|Modifying the Home Television Watching Environment|Completed||N/A|70|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||1|||f||||t||||||||||2017-02-18 17:58:10.99127|2017-02-18 17:58:10.99127
NCT00065039|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01||||||||Interventional|||Wise Mind: Environmental Approach for Obesity Prevention||Completed||Phase 1|1000|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:11.273847|2017-02-18 17:58:11.273847
NCT00065026|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01||||||||Interventional|||Increasing Physical Activity Levels in Low-Income Women|Environmental Approaches to Reducing Obesity: Increasing Physical Activity Levels in Low-Income Women|Completed||N/A|150|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:11.34095|2017-02-18 17:58:11.34095
NCT00065013|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2010-06-23|||March 2003||2003-03-01|January 2010|2010-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Strength Training Following Gastric Bypass for Obesity|Strength Training Following Gastric Bypass for Obesity|Completed||Phase 2|24|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||f||||||||||2017-02-18 17:58:11.406314|2017-02-18 17:58:11.406314
NCT00065000|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2010-01-12||||||January 2010|2010-01-01|August 2003||2003-08-01|||||Interventional|||Impact of Non-Commercialism Policy in Seattle Schools||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:11.493619|2017-02-18 17:58:11.493619
NCT00064987|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2014-04-01|||April 2001||2001-04-01|April 2014|2014-04-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional|||Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism|Role of FSH in Human Gonadal Development|Terminated||Phase 2|14|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1||Recruitment was at a standstill. We are currently preparing our results for publication.|f||||t||||||||||2017-02-18 17:58:11.568715|2017-02-18 17:58:11.568715
NCT00064974|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2013-04-03|||June 2003||2003-06-01|April 2013|2013-04-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes|A Multicenter, Single-Arm, Open-Label Study of the Efficacy and Safety of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes|Completed||Phase 2|215|Actual|Celgene||1|||f||||t||||||||||2017-02-18 17:58:11.686843|2017-02-18 17:58:11.686843
NCT00064961|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-16|2009-12-09|||March 2000||2000-03-01|December 2009|2009-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Obesity Prevention After Smoking Cessation in Menopause||Completed||N/A|100||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:58:11.923328|2017-02-18 17:58:11.923328
NCT00064935|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-15|2005-06-23|||April 1999||1999-04-01|May 2003|2003-05-01|February 2002||2002-02-01|||||Interventional|||Endometrial Biopsy in Infertile Patients|Utility of the Endometrial Biopsy in the Evaluation of the Luteal Phase|Completed||Phase 3|880||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:12.017934|2017-02-18 17:58:12.017934
NCT00064922|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-15|2017-01-11|||January 2002||2002-01-01|May 2008|2008-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Incentive Programs for Female Substance Abusers Who Smoke - 3|Incentive Programs for Female Substance Abusers Who Smoke|Completed||Phase 2/Phase 3|90||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 17:58:12.107492|2017-02-18 17:58:12.107492
NCT00064909|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2008-03-03|||July 2003||2003-07-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Observational|||MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis|Using MR Perfusion Imaging and Hypercapnia to Study Angiogenesis in Multiple Sclerosis Patients|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:12.189798|2017-02-18 17:58:12.189798
NCT00064896|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2017-01-24|||July 11, 2003||2003-07-11|November 14, 2016|2016-11-14|June 1, 2018|Anticipated|2018-06-01|June 1, 2018|Anticipated|2018-06-01||Interventional|||Technical Development of Cardiovascular Magnetic Resonance Imaging|Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging|Recruiting||Phase 1|140|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:58:12.269962|2017-02-18 17:58:12.269962
NCT00064883|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2017-01-24|||July 10, 2003||2003-07-10|September 23, 2016|2016-09-23||||||||Observational|||Radiation Therapy and the Natural History of Childhood Cancers|The Natural History of Childhood Malignancies Treated With Radiation Therapy|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:12.381158|2017-02-18 17:58:12.381158
NCT00064870|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2016-11-04|||June 2002||2002-06-01|November 2016|2016-11-01|July 2021|Anticipated|2021-07-01|July 2021|Anticipated|2021-07-01||Observational|NCRAD||Alzheimer's Disease Genetics Study|National Cell Repository for Alzheimer's Disease (NCRAD)|Recruiting||N/A|3000|Anticipated|Indiana University|||1||f||||f||||||Samples With DNA|"~     blood samples~   "|||2017-02-18 17:58:12.480825|2017-02-18 17:58:12.480825
NCT00064857|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2008-04-21|||August 2003||2003-08-01|April 2008|2008-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors|Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors|Completed||Phase 2|26||National Center for Complementary and Integrative Health (NCCIH)|||||||||t||||||||||2017-02-18 17:58:12.581738|2017-02-18 17:58:12.581738
NCT00064844|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2013-03-08|2013-01-31||August 2002||2002-08-01|March 2013|2013-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Combination Nicotine Replacement for Alcoholic Smokers|Combination Nicotine Replacement for Alcoholic Smokers|Completed||Phase 4|96|Actual|Yale University||2|||f||||f||||||||||2017-02-18 17:58:12.671959|2017-02-18 17:58:12.671959
NCT00064831|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2007-12-06|||July 2003||2003-07-01|December 2007|2007-12-01|February 2007|Actual|2007-02-01|||||Interventional|||Black Cohosh Extract in Postmenopausal Breast Health|The Effect of Black Cohosh Extract on the Human Breast|Completed||Phase 1/Phase 2|73||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 17:58:13.016289|2017-02-18 17:58:13.016289
NCT00063778|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-07|2012-06-27|||July 2003||2003-07-01|June 2012|2012-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa|A Phase I Safety and Immunogenicity Trial of an Alphavirus Replicon HIV Subtype C Gag Vaccine (AVX101, Alphavax, Inc.) in Healthy HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|48|Actual|AlphaVax, Inc.||3|||f||||||||||||||2017-02-18 17:58:13.110311|2017-02-18 17:58:13.110311
NCT00063765|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-03|2008-03-03|||June 2003||2003-06-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye|A Phase I Study of NT-501-10 and NT-501-6A.02, Implants of Encapsulated Human NTC-210 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Patients With Retinitis Pigmentosa|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:13.243854|2017-02-18 17:58:13.243854
NCT00063752|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-03|2005-06-23|||July 2003||2003-07-01|April 2005|2005-04-01|March 2005||2005-03-01|||||Interventional|||Safety Study of PI-0824 to Treat Pemphigus Vulgaris|An Open-Label, Dose-Escalation, Phase I Clinical Study to Assess the Safety of PI-0824 in Patient With Pemphigus Vulgaris Requiring Daily Corticosteroid Therapy|Completed||Phase 1|15||Peptimmune|||||||||||||||||||2017-02-18 17:58:13.334069|2017-02-18 17:58:13.334069
NCT00063726|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-02|2012-01-12|||April 2002||2002-04-01|January 2012|2012-01-01|July 2005|Actual|2005-07-01|May 2005|Actual|2005-05-01||Interventional|||A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039|An International, Non-Comparative, Open-Label Study of PS-341 Administered to Patients With Multiple Myeloma Who Experienced Relapsed or Progressive Disease After Receiving at Least Four Previous Treatment Regimens or Experienced Progressive Disease After Receiving Dexamethasone in Millennium Protocol M34101-039|Completed||Phase 3|600||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 17:58:13.426251|2017-02-18 17:58:13.426251
NCT00063713|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-02|2008-02-07|||June 2003||2003-06-01|February 2008|2008-02-01||||December 2005|Actual|2005-12-01||Interventional|||VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma|A Phase 2 Study of VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma|Completed||Phase 2|152||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 17:58:13.585667|2017-02-18 17:58:13.585667
NCT00062894|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2007-09-13|||April 2003||2003-04-01|September 2007|2007-09-01|April 2007||2007-04-01|||||Interventional|||Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab|A Multi-Center Study to Examine the Pharmacokinetics, Whole Body and Organ Dosimetry, and Biodistribution of Fission-Derived Iodine I 131 Tositumomab for Patients With Previously Untreated or Relapsed Follicular or Transformed Follicular Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|12|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:58:13.964524|2017-02-18 17:58:13.964524
NCT00062881|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2006-08-21|||June 1990||1990-06-01|April 2005|2005-04-01|September 2005||2005-09-01|||||Interventional|||Intrathecal Mafosfamide|Phase I Study of Intrathecal Mafosfamide|Completed||Phase 1|65||Baylor College of Medicine|||||||||||||||||||2017-02-18 17:58:14.073428|2017-02-18 17:58:14.073428
NCT00062868|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2017-02-03|||April 2007||2007-04-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2017|Anticipated|2017-04-01||Interventional|ALCI||LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma|Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma (ALCI)|Active, not recruiting||Phase 1|89|Anticipated|Baylor College of Medicine||3|||f||||t|t|f||||||||2017-02-18 17:58:14.173905|2017-02-18 17:58:14.173905
NCT00064818|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|September 2003||2003-09-01|||||Observational|||Acupuncture Needling on Connective Tissue by Ultrasound|Acupuncture Needling on Connective Tissue by Ultrasound|Completed||N/A|46||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:58:14.298483|2017-02-18 17:58:14.298483
NCT00064805|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-14|2014-08-13|||August 2002||2002-08-01|April 2014|2014-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Therapy for Reading Problems in Adults After Brain Injury|Cognitively-based Treatments of Acquired Dyslexias|Completed||N/A|58|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:14.376208|2017-02-18 17:58:14.376208
NCT00064792|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-11|2014-06-04|2012-07-30||July 2003||2003-07-01|June 2014|2014-06-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||Simvastatin Therapy in Smith-Lemli-Opitz Syndrome|Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome|Completed||Phase 2|23|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 17:58:14.485853|2017-02-18 17:58:14.485853
NCT00064779|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-11|2011-06-02|||July 2003||2003-07-01|June 2011|2011-06-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma|Pilot Imaging Study to Assess the Distribution of IL13-PE38QQR Cytotoxin Infusions in Patients With Recurrent, Resectable, Supratentorial Malignant Glioma|Completed||Phase 1|18||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 17:58:14.912742|2017-02-18 17:58:14.912742
NCT00064766|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-11|2005-06-23|||February 2003||2003-02-01|May 2003|2003-05-01|February 2005||2005-02-01|||||Interventional|||Norplant and Irregular Bleeding/Spotting|A Prospective Randomized Clinical Trial of Doxycycline 20mg Twice a Day Versus Placebo on the Bleeding and Spotting in Women After Insertion of a Levonorgestrel Implant (Norplant) Protocol #2002-1|Unknown status|Recruiting|Phase 4|50||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||||||||||||||||2017-02-18 17:58:15.003703|2017-02-18 17:58:15.003703
NCT00064753|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-11|2015-10-26|2015-10-26||May 2002||2002-05-01|October 2015|2015-10-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|FAVORIT|7273 patients were screened, of whom 2056 and 2054 were randomized to high-dose and low-dose multivitamins, respectively; 34% did not meet eligibility cutpoints for tHey and Cer, and 9% were not enrolled for other reasons. Baseline characteristics were well balanced between treatment groups overall and within country.|Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)|Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)|Completed||Phase 2/Phase 3|4110|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|The B-vitamin pathway for reducing tHcy may not be the optimal one for reducing CVD risk. Also, the duration of follow-up may not have been sufficient to identify a lagged impact on modification of CVD risk.|2|||f||||t||||||||||2017-02-18 17:58:15.110695|2017-02-18 17:58:15.110695
NCT00064740|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-11|2006-08-16|||July 2003||2003-07-01|August 2006|2006-08-01|March 2006||2006-03-01|||||Interventional|||Relaxation Response With Acupuncture for HIV Patients|Relaxation Response With Acupuncture for HIV Patients|Completed||Phase 2|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:58:16.081144|2017-02-18 17:58:16.081144
NCT00064727|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2017-01-24|||July 9, 2003||2003-07-09|April 11, 2007|2007-04-11|April 11, 2007||2007-04-11|||||Interventional|||Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II Diabetes|Attenuating Insulin Resistance as a Therapeutic Target in the Management of Heart Failure|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:16.170119|2017-02-18 17:58:16.170119
NCT00064714|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2015-02-23||2010-08-13|July 2003||2003-07-01|January 2015|2015-01-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes|Effect of AC 2993 (Synthetic Exendin-4) - Administered Alone or in Combination With Daclizumab - on Islet Function in Patients With Type I Diabetes|Completed||Phase 2|47|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 17:58:16.288632|2017-02-18 17:58:16.288632
NCT00064701|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2013-11-12|2013-07-25||June 2003||2003-06-01|November 2013|2013-11-01|March 2009|Actual|2009-03-01|March 2005|Actual|2005-03-01||Interventional||Full analysis set; all randomized patients who received at least one dose of study drug.|Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients|A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (Cyclosporine)/MMF in de Novo Kidney Transplant Recipients|Completed||Phase 3|668|Actual|Astellas Pharma Inc|Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.|3|||f||||t||||||||||2017-02-18 17:58:16.442707|2017-02-18 17:58:16.442707
NCT00064688|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2015-09-08|||July 2003||2003-07-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genomic Dissection of a QTL Affecting the Lipid Profile|Genomic Dissection of a QTL Affecting the Lipid Profile|Withdrawn||N/A|0|Actual|Medical College of Wisconsin|||1|This protocol was created to support work as part of an NIH-funded study.|f||||f||||||Samples With DNA|"~     DNA~   "|||2017-02-18 17:58:19.816293|2017-02-18 17:58:19.816293
NCT00064675|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2013-04-04|||July 2003||2003-07-01|April 2013|2013-04-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genetics of Cardiovascular Reactivity in Black Youth|Genetics of Cardiovascular Reactivity in Black Youth|Completed||N/A|500|Actual|University of Tennessee|||1||f||||||||||Samples With DNA|"~     buccal specimens stored at Med Coll Wisconsin~   "|||2017-02-18 17:58:19.886017|2017-02-18 17:58:19.886017
NCT00064662|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2013-05-08|2012-03-26||February 2002||2002-02-01|May 2013|2013-05-01|March 2010|Actual|2010-03-01|June 2006|Actual|2006-06-01||Interventional|SISTEr||Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence|Randomized Clinical Trial of the Burch Modified Tanagho and Autologous Fascia Sling Procedures for Women With Predominantly Stress Urinary Incontinence|Completed||Phase 2/Phase 3|655|Actual|New England Research Institutes|Patients received care at tertiary care centers which could limit the generalizability of the findings. Patients and providers were aware of treatment assignment which could lead to assessment bias.|2|||f||||f||||||||||2017-02-18 17:58:19.965731|2017-02-18 17:58:19.965731
NCT00064649|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2010-01-12|||April 2004||2004-04-01|January 2010|2010-01-01|June 2006|Actual|2006-06-01|||||Interventional|MIST||Minimally Invasive Surgical Therapy for BPH|Minimally Invasive Surgical Therapy Consortium for Benign Prostatic Hyperplasia|Terminated||Phase 3|49|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3||Inability to recruit required sample size.|f||||t||||||||||2017-02-18 17:58:20.423254|2017-02-18 17:58:20.423254
NCT00064636|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2005-06-23|||December 2002||2002-12-01|September 2003|2003-09-01||||||||Interventional|||Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors|A Phase I, Open Label, Dose Escalation Study of PS-341 Plus Docetaxel in Treatment-Naive or Previously Treated Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors|Terminated||Phase 1|46||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:58:20.526253|2017-02-18 17:58:20.526253
NCT00064623|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2008-03-04|||August 2003||2003-08-01|March 2008|2008-03-01|November 2005||2005-11-01|||||Interventional|||Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy|A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Painful HIV-Associated Distal Symmetrical Polyneuropathy|Completed||Phase 3|300||NeurogesX|||||||||||||||||||2017-02-18 17:58:20.601013|2017-02-18 17:58:20.601013
NCT00064610|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2008-02-07|||December 2002||2002-12-01|February 2008|2008-02-01||||December 2004|Actual|2004-12-01||Interventional|||Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer|A Phase I/II, Open Label, Dose Escalation Study to Determine the Tolerance and Preliminary Activity of PS-341 Plus Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer Requiring Chemotherapy|Completed||Phase 1/Phase 2|102||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:58:20.999688|2017-02-18 17:58:20.999688
NCT00064597|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-10|2005-06-23|||December 1987||1987-12-01|June 2003|2003-06-01|December 2003||2003-12-01|||||Observational|||Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood|National Institute of Child Health and Human Development Fetal Cell Isolation Study (NIFTY)|Unknown status|Active, not recruiting|N/A|3500||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:21.089458|2017-02-18 17:58:21.089458
NCT00064584|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-09|2009-03-23|||May 2002||2002-05-01|March 2009|2009-03-01|July 2005|Actual|2005-07-01|January 2005|Actual|2005-01-01||Interventional|||Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)|Tolerability and PK/PD of Multiple Oral Doses of CT53518 in Patients With Acute Myelogenous Leukemia|Completed||Phase 1|60||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:58:21.182531|2017-02-18 17:58:21.182531
NCT00064571|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-09|2006-04-21|||October 2002||2002-10-01|April 2006|2006-04-01|October 2005||2005-10-01|||||Interventional|||Surgery for Vocal Cord Paralysis|Medialization Vs Reinnervation for Vocal Cord Paralysis|Terminated||Phase 3|300||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-02-18 17:58:21.28106|2017-02-18 17:58:21.28106
NCT00064558|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2016-10-05|||July 2003||2003-07-01|October 2016|2016-10-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genetic Determinants of Sudden Cardiac Death|Genetic Determinants of Sudden Cardiac Death|Completed||N/A|2500|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 17:58:21.375876|2017-02-18 17:58:21.375876
NCT00064545|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-12-11|||July 2003||2003-07-01|December 2012|2012-12-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Gene-by-Smoking Interactions and Risk of Atherosclerosis - Ancillary to ARIC||Completed||N/A|1500|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 17:58:21.458972|2017-02-18 17:58:21.458972
NCT00064532|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2014-12-02|||July 2003||2003-07-01|November 2013|2013-11-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA||Completed||N/A|6173|Actual|Northwestern University|||1||f||||||||||||||2017-02-18 17:58:21.543496|2017-02-18 17:58:21.543496
NCT00064519|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-09-22|||July 2003||2003-07-01|September 2015|2015-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Genetics of CRP in Families With Myocardial Infarction||Completed||N/A|1406|Actual|Medical College of Wisconsin|||1||f||||f||||||Samples With DNA|"~     i.) Blood: A blood sample (30 cc, ~2 tablespoons) will be drawn. This will take place in the~     catheterization lab at the end of the catheterization procedure or by using standard~     venipuncture technique during a clinic visit or at community outreach events when feasible.~      ii.) Buccal Swab: The participant uses specially prepared cotton swabs (called buccal swabs)~     to rub in a circular motion on the inside of both cheeks. The swabs collect cheek cells that~     can be processed to obtain DNA.~      iii.) Saliva: A saliva sample is obtained by having the participant spit in a special vial~     specifically designed for genetic testing. The participant will continue to spit into the~     vial until it contains 2 ml (about 1 teaspoon) of saliva.~   "|||2017-02-18 17:58:21.622093|2017-02-18 17:58:21.622093
NCT00064506|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-01-13|||July 2003||2003-07-01|January 2015|2015-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Observational|||Gene-Environment Interactions in Complex Disease|Gene-Environment Interactions in Complex Disease|Completed||N/A|15792|Actual|The University of Texas Health Science Center, Houston|||1||f||||f||||||||||2017-02-18 17:58:21.709771|2017-02-18 17:58:21.709771
NCT00064493|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2008-07-01|||June 2003||2003-06-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Modeling DNA Diversity in Reverse Cholesterol Transport||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:58:21.788266|2017-02-18 17:58:21.788266
NCT00064480|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2008-04-22|||July 2003||2003-07-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Black Pooling Project||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:58:21.865161|2017-02-18 17:58:21.865161
NCT00064467|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2017-01-18|||June 2003||2003-06-01|January 2017|2017-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Lethargic Depression Study|An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms|Completed||Phase 3|268||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:58:21.937563|2017-02-18 17:58:21.937563
NCT00064454|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-05-09|||May 2003||2003-05-01|May 2012|2012-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis|FACTS II: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Efficacy and Safety of OPC-6535 Tablets in the Treatment of Subjects With Active Ulcerative Colitis|Completed||Phase 3|375||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 17:58:22.068892|2017-02-18 17:58:22.068892
NCT00064441|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-05-09|||May 2003||2003-05-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis|FACTS I: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Efficacy and Safety of OPC-6535 Tablets in the Treatment of Subjects With Active Ulcerative Colitis|Completed||Phase 3|375||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 17:58:22.391935|2017-02-18 17:58:22.391935
NCT00064428|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2016-09-22|||August 2003||2003-08-01|September 2016|2016-09-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction|An International Randomized Study Evaluating the Efficacy and Safety of Fondaparinux Versus Control Therapy in a Broad Range of Patients With ST Segment Elevation Acute Myocardial Infarction.|Completed||Phase 3|12092|Actual|GlaxoSmithKline||4|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:58:22.489265|2017-02-18 17:58:22.489265
NCT00064415|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-02-21|||June 2002||2002-06-01|February 2012|2012-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD|A Multicenter, Open-Label, Randomized, Active-Controlled, Parallel Group Chronic Safety Study of (R,R)-Formoterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|799|Actual|Sunovion||2|||f||||t||||||||||2017-02-18 17:58:22.61965|2017-02-18 17:58:22.61965
NCT00064402|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-02-21|||April 2002||2002-04-01|February 2012|2012-02-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD|A Double-Blind, Double-Dummy, Randomized, Placebo- and Active-Controlled, Multicenter, Parallel-Group Study of (R,R)-Formoterol in the Treatment of Subjects With Chronic Obstructive Pulmonary Disease|Completed||Phase 3|741|Actual|Sunovion||5|||f||||t||||||||||2017-02-18 17:58:23.012515|2017-02-18 17:58:23.012515
NCT00064389|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-02-21|||January 2003||2003-01-01|February 2012|2012-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma|Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma|Completed||Phase 3|746|Actual|Sunovion||2|||f||||f||||||||||2017-02-18 17:58:23.209428|2017-02-18 17:58:23.209428
NCT00064376|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2008-07-23|||May 2003||2003-05-01|September 2004|2004-09-01||||||||Interventional|||Paricalcitol in Treating Patients With Myelodysplastic Syndrome|A Phase II Trial Of Paricalcitol In Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:58:23.424222|2017-02-18 17:58:23.424222
NCT00064363|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-03-07|||June 2003||2003-06-01|March 2012|2012-03-01|February 2007|Actual|2007-02-01|||||Interventional|||Talampanel in Treating Patients With Recurrent High-Grade Glioma|A Phase II Trial Of Talampanel In Patients With Recurrent High-Grade Gliomas|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:58:23.520591|2017-02-18 17:58:23.520591
NCT00064350|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-11-25|2012-03-08||May 2004||2004-05-01|November 2015|2015-11-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer|A Double Blind Phase II Study of BAY 43-9006 in Patients With Non-Small Cell Lung Cancer Who Have Failed at Least Two Prior Chemotherapy Regimens|Completed||Phase 2|342|Actual|Eastern Cooperative Oncology Group||3|||f||||t||||||||||2017-02-18 17:58:23.647387|2017-02-18 17:58:23.647387
NCT00064337|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-04-01|||January 2004||2004-01-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|May 2012|Actual|2012-05-01||Interventional|||S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis|S0115, A Phase II Trial Evaluating Modified High Dose Melphalan (100 mg/m) And Autologous Peripheral Blood Stem Cell Supported Transplant (SCT) For High Risk Patients With Multiple Myeloma And/Or Light Chain Amyloidosis (AL Amyloidosis) (A BMT Study)|Active, not recruiting||Phase 2|100|Anticipated|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:58:25.25343|2017-02-18 17:58:25.25343
NCT00064324|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-06-03|||June 2003||2003-06-01|June 2013|2013-06-01||||November 2005|Actual|2005-11-01||Interventional|||Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma|A Phase II Study of Perifosine in Soft Tissue Sarcoma|Completed||Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:25.408468|2017-02-18 17:58:25.408468
NCT00064311|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-03-07|||June 2003||2003-06-01|March 2012|2012-03-01|September 2004|Actual|2004-09-01|||||Interventional|||Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation|A Phase I-II Safety, Tolerability And Pharmacokinetic Study Of Ravuconazole For Prophylaxis Of Invasive Fungal Infections In Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 1/Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:25.514351|2017-02-18 17:58:25.514351
NCT00064298|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-04-03|||January 2004||2004-01-01|April 2013|2013-04-01|April 2009|Actual|2009-04-01|October 2008|Actual|2008-10-01||Interventional|||Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer|A Phase II Randomized Placebo Controlled, Double Blinded Trial To Evaluate The Effects Of Fruit And Vegetable Extracts On Intermediate Biomarkers In Head And Neck Cancer Patients|Completed||Phase 3|132|Actual|Wake Forest University Health Sciences||2|||f||||t||||||||||2017-02-18 17:58:25.621862|2017-02-18 17:58:25.621862
NCT00064285|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2010-04-30|||June 2003||2003-06-01|April 2010|2010-04-01||||||||Interventional|||Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer|Phase I Study Of Flavopiridol In Combination With Imatinib Mesylate (STI571, Gleevec) In Bcr/Abl+ Hematological Malignancies|Completed||Phase 1|22|Actual|Virginia Commonwealth University||1|||||||f||||||||||2017-02-18 17:58:25.757645|2017-02-18 17:58:25.757645
NCT00064272|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2016-10-20|||May 2003||2003-05-01|October 2016|2016-10-01||||May 2007|Actual|2007-05-01||Interventional|IRB 2003-551||UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer|Phase II Trial Of Encapsulized Ginger As A Treatment For Chemotherapy-Induced Nausea and Vomiting AKA IRB 2003-213|Completed||Phase 2|180|Anticipated|University of Michigan Cancer Center||3|||f||||||||||||||2017-02-18 17:58:25.868168|2017-02-18 17:58:25.868168
NCT00064259|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-06-10|2015-06-10||June 2003||2003-06-01|May 2013|2013-05-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional||Total number of participants at different dose levels of Oblimersen (3, 5, or 7 mg/kg/d) in combination with 5-FU (1000 mg/m2/d or 750 mg/m2/d) and Cisplatin (100 mg/m2 or 75 mg/m2)|A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer|A Phase I/II Study of Oblimersen in Combination With Cisplatin and Fluorouracil in Patients With Advanced Esophageal, Gastro-Esophageal Junction and Gastric Cancer|Terminated||Phase 1/Phase 2|15|Actual|National Cancer Institute (NCI)||1||Discontinued development of G3139 (oblimersen)|f||||t||||||||||2017-02-18 17:58:25.976909|2017-02-18 17:58:25.976909
NCT00064246|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-01-24|||July 2003||2003-07-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder|A Phase I/II Study: Zevalin Radioimmunotherapy for Patients With Post Transplant Lymphoproliferative Disease Following Solid Organ Transplantation|Completed||Phase 1/Phase 2|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:26.275938|2017-02-18 17:58:26.275938
NCT00064233|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-10-01|||November 2003||2003-11-01|August 2012|2012-08-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate|A Phase I Dose-Escalation Study To Determine The Safety, Pharmacokinetics, And Pharmacodynamics Of BMS-354825 In The Treatment Of Patients With Chronic Phase Chronic Myelogenous Leukemia Who Have Hematologic Resistance To Imatinib Mesylate (Gleevec|Completed||Phase 1|42|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 17:58:26.39345|2017-02-18 17:58:26.39345
NCT00064220|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-05-15|||April 2003||2003-04-01|May 2012|2012-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma|A Phase II Study of Intravenous TZT-1027, Administered Weekly Times Two, Every Three Weeks, to Patients With Advanced or Metastatic Soft Tissue Sarcomas (STS) With Prior Exposure to Anthracycline-Based Chemotherapy|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:58:26.499036|2017-02-18 17:58:26.499036
NCT00064207|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-09-20|||May 2003||2003-05-01|September 2012|2012-09-01||||January 2007|Actual|2007-01-01||Interventional|||Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer|Randomized Phase II/III Study Comparing Gemcitabine Followed by Gemcitabine Plus Concomitant Radiation (50.4 Gy) Versus Control After Curative Pancreaticoduodenectomy for Pancreatic Head Cancer|Completed||Phase 2/Phase 3|97|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:58:26.606272|2017-02-18 17:58:26.606272
NCT00064194|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2016-11-25|||November 2001||2001-11-01|March 2010|2010-03-01|April 2008|Actual|2008-04-01|||||Interventional|||Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia|A Double-Blind, Placebo-Controlled, Randomized Study Of Combination Vitamin E, Selenium And Soy Protein Product In Subjects With High Grade Prostatic Intraepithelial Neoplasia|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 17:58:26.874683|2017-02-18 17:58:26.874683
NCT00064181|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2012-09-20|||May 2003||2003-05-01|September 2012|2012-09-01||||January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer|Irinotecan Combined With Infusional 5-FU/Folinic Acid or Capecitabine and the Role of Celecoxib in Patients With Metastatic Colorectal Cancer|Completed||Phase 3|86|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:58:26.975773|2017-02-18 17:58:26.975773
NCT00064142|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-06-04|||May 2003||2003-05-01|June 2013|2013-06-01||||December 2006|Actual|2006-12-01||Interventional|||Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma|A Phase II Trial of Topical Halofuginone in Patients With HIV Related Kaposi's Sarcoma|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:58:27.103448|2017-02-18 17:58:27.103448
NCT00064129|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2017-01-31|||May 2003||2003-05-01|October 2016|2016-10-01||||January 2011|Actual|2011-01-01||Interventional|||Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer|A Phase I Study of Repetitive Dosing of Anti-CTLA-4 Antibody (Ipilimumab) in Combination With GM-CSF in Patients With Metastatic, Androgen-Independent Prostate Cancer|Active, not recruiting||Phase 1|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:27.208894|2017-02-18 17:58:27.208894
NCT00064116|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2014-06-23|||May 2001||2001-05-01|June 2014|2014-06-01|January 2014|Actual|2014-01-01|December 2010|Actual|2010-12-01||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|Randomized Intergroup Trial of First Line Treatment for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma With a CHOP-Like Chemotherapy Regimen With or Without the Anti-CD20 Antibody Rituximab (IDEC-C2B8)|Completed||Phase 3|824|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 17:58:27.323078|2017-02-18 17:58:27.323078
NCT00064103|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-01-22|||June 2003||2003-06-01|January 2013|2013-01-01||||August 2007|Actual|2007-08-01||Interventional|||Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx|Clinical Protocol for Wild Type p53 Gene Induction in Premalignancies of Squamous Epithelium of the Oral Cavity and Oral Pharynx Via an Adenoviral Vector [NCI Supplied Agent Ad-p53, (INGN 201) (Advexin®) NSC 683550, IND# 7135]|Completed||Phase 1/Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:27.648772|2017-02-18 17:58:27.648772
NCT00064090|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-07-17|||March 2003||2003-03-01|August 2008|2008-08-01|January 2008|Actual|2008-01-01|September 2004|Actual|2004-09-01||Interventional|||3-AP and Cytarabine in Treating Patients With Hematologic Cancer|A Phase I Study of Triapine and Cytarabine in Patients With Hematologic Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:58:27.751744|2017-02-18 17:58:27.751744
NCT00064077|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-05-27|||May 2003||2003-05-01|May 2015|2015-05-01||||January 2011|Actual|2011-01-01||Interventional|||Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix|A Randomized Phase III Trial Of Paclitaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Versus Topotecan Plus Cisplatin In Stage IVB, Recurrent Or Persistent Carcinoma of the Cervix|Completed||Phase 3|513|Actual|Gynecologic Oncology Group||4|||f||||||||||||||2017-02-18 17:58:27.839586|2017-02-18 17:58:27.839586
NCT00064064|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-11-05|||January 2003||2003-01-01|August 2004|2004-08-01|August 2008|Actual|2008-08-01|||||Interventional|||3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer|A Phase II Study of Triapine in Combination With Gemcitabine in Patients With Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:58:27.988245|2017-02-18 17:58:27.988245
NCT00064051|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-08-01|||January 2003||2003-01-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2006|Actual|2006-08-01||Interventional|||3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer|A Phase II Study of Triapine in Combination With Gemcitabine in Patients With Pancreatic Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:58:28.076838|2017-02-18 17:58:28.076838
NCT00064038|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-03-05|2012-11-19||November 2004||2004-11-01|March 2015|2015-03-01|May 2012|Actual|2012-05-01|October 2008|Actual|2008-10-01||Interventional|||S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma|Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients With Previously Untreated Multiple Myeloma|Completed||Phase 3|198|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 17:58:28.187332|2017-02-18 17:58:28.187332
NCT00064025|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2016-03-17|2014-01-31||April 2004||2004-04-01|March 2016|2016-03-01||||September 2010|Actual|2010-09-01||Interventional|||Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus|A Phase II Pilot Investigation Of The Relationship Of Short Term Depo-Provera (Medroxyprogesterone Acetate) Exposure To The Morphologic , Biochemical, And Molecular Changes In Primary Endometroid Adenocarcinoma of the Uterine Corpus|Completed||Phase 2|75|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:58:29.424117|2017-02-18 17:58:29.424117
NCT00064012|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-03-18|||May 2003||2003-05-01|March 2013|2013-03-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer|A Randomized, Multicenter, Open-Label, Phase II Study Of VELCADE Alone Or VELCADE Plus Docetaxel In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|4|Actual|University of Wisconsin, Madison||2|||f||||||||||||||2017-02-18 17:58:29.729351|2017-02-18 17:58:29.729351
NCT00063999|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2016-10-26|||August 2003||2003-08-01|October 2016|2016-10-01||||June 2013|Actual|2013-06-01||Interventional|||Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer|Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF Versus Carboplatin/Paclitaxel in Patients With Stage III &Amp; IV or Recurrent Endometrial Cancer|Active, not recruiting||Phase 3|1331|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-02-18 17:58:29.999015|2017-02-18 17:58:29.999015
NCT00063986|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-02-07|2012-11-29||March 2004||2004-03-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|December 2010|Actual|2010-12-01||Interventional|||Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer|Minimally Invasive Esophagectomy (MIE): A Multicenter Feasibility Study|Completed||Phase 2|110|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 17:58:31.110686|2017-02-18 17:58:31.110686
NCT00063973|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-09-27|||July 2003||2003-07-01|September 2013|2013-09-01||||March 2008|Actual|2008-03-01||Interventional|||Cilengitide in Treating Children With Refractory Primary Brain Tumors|Phase I Study of Cilengitide (EMD 121974) in Children With Refractory Brain Tumors|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:31.789398|2017-02-18 17:58:31.789398
NCT00063960|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2016-07-01|||August 2003||2003-08-01|July 2016|2016-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer|A Phase II Trial Of Toxicity Assessment In Two Cohorts Of Patients (Resection Alone Or Ablation With Or Without Resection Of Hepatic Metastases From Colorectal Cancer) Treated With Adjuvant Hepatic Arterial Infusion (HAI) FUDR Plus Systemic CPT-11|Completed||Phase 2|94|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:58:31.906473|2017-02-18 17:58:31.906473
NCT00063947|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-06-03|||May 2003||2003-05-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer|A Phase I Study of OSI-774 in Combination With Gemcitabine and Radiation in Locally Advanced, Non-Operable Pancreatic Cancer|Completed||Phase 1|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:32.033183|2017-02-18 17:58:32.033183
NCT00063934|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2014-05-06|2012-07-10||May 2003||2003-05-01|December 2012|2012-12-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer|A Phase 1/2 Study of Bcl-2 Antisense Oligonucleotide G3139 in Combination With Doxorubicin and Docetaxel in Metastatic and Locally Advanced Breast Cancer|Terminated||Phase 1/Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:32.151488|2017-02-18 17:58:32.151488
NCT00063895|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2013-01-08|||April 2003||2003-04-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck|A Pharmacogenetic and Pharmacodynamic Study of Erlotinib (OSI-774) Toxicity in Patients With Advanced Solid Tumors|Completed||Phase 1/Phase 2|80|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:32.429629|2017-02-18 17:58:32.429629
NCT00063882|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-08|2015-12-11|||June 2003||2003-06-01|December 2015|2015-12-01||||January 2017|Anticipated|2017-01-01||Interventional|||Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer|A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma|Active, not recruiting||Phase 3|588|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 17:58:32.554245|2017-02-18 17:58:32.554245
NCT00063869|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-07|2009-09-03||||||September 2009|2009-09-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis|A Double-blind, Parallel, Placebo-controlled, Randomized Study of the Efficacy and Safety of Etanercept in Patients With Idiopathic Pulmonary Fibrosis.|Completed||Phase 2|88|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:58:32.945541|2017-02-18 17:58:32.945541
NCT00063856|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-07|2012-02-09|||July 2003||2003-07-01|May 2007|2007-05-01|June 2004||2004-06-01|||||Interventional|||Dressing Preparations for Smallpox|A Comparison of Dressing Preparations for Smallpox Vaccination Sites With a Focus Upon the Risk of Secondary Transmission of Vaccinia Virus|Completed||Phase 1/Phase 2|102|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:58:33.024308|2017-02-18 17:58:33.024308
NCT00063843|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-07|2010-08-26|||July 2003||2003-07-01|May 2006|2006-05-01|August 2005||2005-08-01|||||Interventional|||Anthrax-rPA: Safety, Tolerability, Immunogenicity|A Phase I, Dose-Escalating Study to Assess the Safety, Tolerability, and Immunogenicity of Recombinant Anthrax Protective Antigen Vaccine (rPA) Administered in Two Intramuscular Doses to Healthy Adults|Completed||Phase 1|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:58:33.109117|2017-02-18 17:58:33.109117
NCT00063830|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-07|2007-10-15||||||October 2007|2007-10-01||||||||Interventional|||ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.|ISIS 2302-CS27, Phase 2, Double-Blinded, Controlled Study of Four Dosing Regimens of Alicaforsen (ISIS 2302) Enema, an Antisense Inhibitor of ICAM-1, for the Treatment of Patients With Mild to Moderate Active Ulcerative Colitis|Completed||Phase 2|||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:58:33.387803|2017-02-18 17:58:33.387803
NCT00063817|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-07|2017-01-10|||June 2003||2003-06-01|January 2017|2017-01-01|July 2009|Actual|2009-07-01|January 2009|Actual|2009-01-01||Interventional|||Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant|Renal Allograft Tolerance Through Mixed Chimerism (ITN010ST)|Completed||Phase 1|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||Yes|Data access is provided in TrialShare, the Immune Tolerance Network (ITN) Clinical Trials Research Portal that makes data from the consortium's clinical trials publicly available.|2017-02-18 17:58:33.474348|2017-02-18 17:58:33.474348
NCT00063804|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-07|2012-05-17||||||May 2012|2012-05-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men|A Phase 1, Dose-Rising Study of AMD11070 in HIV-Seronegative Men to Assess the Safety and Pharmacokinetics After Single or Multiple Doses|Completed||Phase 1|44|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||||||||||||||||2017-02-18 17:58:33.601081|2017-02-18 17:58:33.601081
NCT00063791|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-07|2007-02-13||||||July 2003|2003-07-01||||||||Expanded Access|||A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE|An Open-Labeled, Randomized Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE in Patients With Relapsed Multiple Myeloma Who Have Failed Four or More Lines of Therapy|No longer available||Phase 2|1000||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:58:33.714537|2017-02-18 17:58:33.714537
NCT00063700|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-02|2010-01-12|||September 2002||2002-09-01|January 2010|2010-01-01|July 2005||2005-07-01|||||Interventional|||Impact of Non-Commercialism Policy in Seattle Schools|Impact of Non-Commercialism Policy in Seattle Schools|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:33.801835|2017-02-18 17:58:33.801835
NCT00063687|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-02|2005-08-03|||March 2003||2003-03-01|July 2003|2003-07-01|June 2005||2005-06-01|||||Interventional|||Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure|A Phase II-III Prospective, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oxypurinol Added to Standard Therapy in Patients With NYHA Class III-IV Congestive Heart Failure|Completed||Phase 2/Phase 3|400||Cardiome Pharma|||||||||||||||||||2017-02-18 17:58:33.87567|2017-02-18 17:58:33.87567
NCT00063674|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-02|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01||||||||Interventional|||Type 2 Diabetes Primary Prevention for At Risk Girls||Completed||Phase 2/Phase 3|240|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:33.96753|2017-02-18 17:58:33.96753
NCT00063661|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-02|2008-03-03|||June 2003||2003-06-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Observational|||Studying Automatic Movements in Patients With Parkinson's Disease|A Neuroimaging Study of Automatic Movements in Patients With Parkinson's Disease|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:34.041511|2017-02-18 17:58:34.041511
NCT00063648|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-01|2010-01-12|||May 2002||2002-05-01|January 2010|2010-01-01|December 2007||2007-12-01|||||Interventional|||Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant||Completed||Phase 1|50||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:34.122605|2017-02-18 17:58:34.122605
NCT00063635|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-01|2012-08-27|2012-06-26||September 2005||2005-09-01|August 2012|2012-08-01|February 2010|Actual|2010-02-01|September 2009|Actual|2009-09-01||Interventional|TONIC||Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)|Clinical Research Network in Nonalcoholic Steatohepatitis: Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)|Completed||Phase 3|173|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 17:58:34.20938|2017-02-18 17:58:34.20938
NCT00063622|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-01|2012-08-27|2012-06-14||January 2005||2005-01-01|August 2012|2012-08-01|September 2009|Actual|2009-09-01|June 2009|Actual|2009-06-01||Interventional|PIVENS||Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)|Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)|Completed||Phase 3|247|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 17:58:35.037402|2017-02-18 17:58:35.037402
NCT00063609|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-01|2009-11-20|||April 2003||2003-04-01|November 2009|2009-11-01|April 2005||2005-04-01|||||Interventional|||The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy|The Effect of Zoledronic Acid Compared to Placebo on Bone Mineral Density in Patients Undergoing Androgen Deprivation Therapy|Completed||Phase 4|200||Novartis|||||||||||||||||||2017-02-18 17:58:35.602819|2017-02-18 17:58:35.602819
NCT00063596|ClinicalTrials.gov processed this data on February 17, 2017|2003-07-01|2005-06-23|||January 2000||2000-01-01|November 2004|2004-11-01|May 2004||2004-05-01|||||Interventional|||Vitamin A Supplementation in Preterm Infants|Vitamin A Therapy in Preterm Infants: Vaccine Response|Unknown status|Active, not recruiting|N/A|220||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:35.72013|2017-02-18 17:58:35.72013
NCT00063583|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-30|2009-11-03|||June 2003||2003-06-01|November 2009|2009-11-01|March 2009|Actual|2009-03-01|November 2007|Actual|2007-11-01||Interventional|||Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes|Pirfenidone: A Novel Anti-Scarring Therapy for Diabetic Nephropathy|Completed||Phase 1/Phase 2|77|Actual|Sharma, Kumar, M.D.||3|||f||||t||||||||||2017-02-18 17:58:35.806006|2017-02-18 17:58:35.806006
NCT00063570|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-30|2009-05-12|2009-01-27||July 2003||2003-07-01|May 2009|2009-05-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy|Phase II Trial of Alimta (Pemetrexed) and Gemzar (Gemcitabine) in Metastatic Breast Cancer Patients Who Have Received Prior Taxane Therapy|Completed||Phase 2|73|Actual|Eli Lilly and Company||2|||f||||||||||||||2017-02-18 17:58:36.043465|2017-02-18 17:58:36.043465
NCT00063557|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-30|2016-04-08|||June 2003||2003-06-01|January 2008|2008-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Neighborhoods and CVD Risk in a Multiethnic Cohort - Ancillary to MESA||Completed||N/A|||University of Michigan|||||f||||||||||||||2017-02-18 17:58:37.095195|2017-02-18 17:58:37.095195
NCT00063544|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-30|2016-05-24|||May 2003||2003-05-01|May 2016|2016-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Physical Activity and Childhood Obesity|Physical Activity and Childhood Obesity|Withdrawn||N/A|0|Actual|University of Bristol|||1|CI left institution|f||||f||||||||||2017-02-18 17:58:37.354266|2017-02-18 17:58:37.354266
NCT00063531|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-30|2014-03-01|||June 2003||2003-06-01|March 2014|2014-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Observational|||Comparison of Two Methods to Diagnose Coronary Artery Disease|Coronary Disease Detection by Thallium SPECT and Fast CT|Completed||N/A|650|Actual|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"~     Blood~   "|||2017-02-18 17:58:37.432627|2017-02-18 17:58:37.432627
NCT00063518|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-30|2013-09-09|||April 2003||2003-04-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Monitoring Trends in Venous Thromboembolism|Incidence Rates, Clinical Profile, and Outcomes of Patients With Venous Thromboembolism|Completed||N/A|||University of Massachusetts, Worcester|||||f||||f||||||||||2017-02-18 17:58:37.521891|2017-02-18 17:58:37.521891
NCT00063505|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-30|2014-04-22|||December 2002||2002-12-01|April 2014|2014-04-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Genes of Hypertension in African Americans|Genes of Hypertension in African Americans|Completed||N/A|5000|Actual|Medical College of Wisconsin|||1||f||||f||||||Samples With DNA|"~     Blood cells and DNA~   "|||2017-02-18 17:58:37.598674|2017-02-18 17:58:37.598674
NCT00063492|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-30|2013-07-23|||January 2003||2003-01-01|July 2013|2013-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Angiotensinogen Gene and Human Hypertension||Completed||N/A|||University of Utah|||||f||||||||||||||2017-02-18 17:58:37.678968|2017-02-18 17:58:37.678968
NCT00063453|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-26|2013-09-19|||August 2003||2003-08-01|September 2013|2013-09-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Supplemental Selenium and Vitamin E and Pulmonary Function|The Respiratory Ancillary Study (RAS) to SELECT|Completed||Phase 3|2920|Actual|Cornell University||4|||f||||t||||||||||2017-02-18 17:58:37.8434|2017-02-18 17:58:37.8434
NCT00063440|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-26|2013-02-06|||June 2003||2003-06-01|February 2013|2013-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Epidemiology of Carotid IMT Progression in MESA - Ancillary Study||Completed||N/A|5610|Actual|Tufts Medical Center|||1||f||||||||||||||2017-02-18 17:58:37.94932|2017-02-18 17:58:37.94932
NCT00063427|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-26|2009-08-20||||||August 2009|2009-08-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Study Evaluating MAC-321 in Colorectal Cancer|A Phase 2, Open-Label Study of MAC-321 Administered Intravenously as a Single Agent for the Treatment of Advanced Colorectal Cancer|Completed||Phase 2|45|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:58:38.028868|2017-02-18 17:58:38.028868
NCT00063414|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2007-10-15||||||October 2007|2007-10-01||||||||Interventional|||ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis|ISIS 2302-CS22, Phase II, Double-Blinded, Active-Controlled Study of Alicaforsen (ISIS 2302) Enema, an Antisense Inhibitor of ICAM-1, for the Treatment of Patients With Mild to Moderate Active Ulcerative Colitis (Left-Sided Colitis or Pancolitis With Left Sided Disease Flare)|Completed||Phase 2|||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:58:38.108415|2017-02-18 17:58:38.108415
NCT00063401|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2010-04-07|||September 2003||2003-09-01|April 2010|2010-04-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer|A Phase II Study of Cetuximab (C225)/Paclitaxel/Carboplatin for the Initial Treatment of Advanced Stage Ovarian, Primary Peritoneal, and Fallopian Tube Cancer|Completed||Phase 2|39|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 17:58:38.183193|2017-02-18 17:58:38.183193
NCT00063388|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2010-04-08|||May 2003||2003-05-01|April 2010|2010-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer|A Phase II Trial of Cetuximab (C225) as Therapy for Recurrent Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|66|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 17:58:38.300817|2017-02-18 17:58:38.300817
NCT00063375|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2013-10-24|||January 2002||2002-01-01|October 2013|2013-10-01||||February 2007|Actual|2007-02-01||Interventional|||Interactive Computer Treatment for Panic Disorder|Interactive Computer Treatment for Panic Disorder|Completed||Phase 1|60|Anticipated|Florida State University|||||f||||||||||||||2017-02-18 17:58:38.439155|2017-02-18 17:58:38.439155
NCT00063362|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2016-10-03|2013-11-04||February 2002||2002-02-01|October 2016|2016-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Combination Therapy for the Treatment of Bipolar Disorders|Combination Therapy in Bipolar Rapid Cycling|Terminated||Phase 3|49|Actual|University Hospitals Cleveland Medical Center||2||Funding Expiration|f||||t||||||||||2017-02-18 17:58:38.520705|2017-02-18 17:58:38.520705
NCT00063336|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2013-11-07|||December 2001||2001-12-01|May 2009|2009-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Treatment Response to Rehabilitation in Patients With Schizophrenia|Treatment Response to Rehabilitation in Schizophrenia|Completed||N/A|46|Actual|Hartford Hospital||2|||f||||||||||||||2017-02-18 17:58:38.977621|2017-02-18 17:58:38.977621
NCT00063323|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2017-01-11|||August 2000||2000-08-01|January 2010|2010-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Maintenance Treatment for Abstinent Smokers|Maintenance Treatment for Prevention of Smoking Relapse|Completed||Phase 3|589|Actual|National Institute on Drug Abuse (NIDA)||4|||f||||t||||||||||2017-02-18 17:58:39.078098|2017-02-18 17:58:39.078098
NCT00063310|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2009-12-10|||March 2003||2003-03-01|February 2006|2006-02-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation|Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN)|Completed||Phase 2|90||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:58:39.195659|2017-02-18 17:58:39.195659
NCT00063297|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-25|2009-08-27|||May 2003||2003-05-01|December 2003|2003-12-01|October 2003||2003-10-01|||||Interventional|||Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia||Completed||Phase 2|180||Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:58:39.294269|2017-02-18 17:58:39.294269
NCT00063284|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-24|2017-01-24|||June 18, 2003||2003-06-18|April 15, 2009|2009-04-15|April 15, 2009||2009-04-15|||||Interventional|||Investigating the Safety of srTMS in the Treatment of Parkinson's Disease|Safety Study of the Super Rapid Transcranial Magnetic Stimulation in Patients With Parkinson's Disease|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:58:39.397898|2017-02-18 17:58:39.397898
NCT00063258|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-24|2016-04-05|2010-08-25||June 2003||2003-06-01|April 2016|2016-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer|Phase II Randomized Open-Label Trial of the EGFR Tyrosine Kinase Inhibitor OSI-774 (Tarceva™) in Combination With Paclitaxel and Carboplatin Prior to Surgery in Resectable Stage IIIA (N2) and IIIB (T4 N2) NSCLC: A Clinical Outcome and Biological Endpoint Trial|Terminated||Phase 2|5|Actual|M.D. Anderson Cancer Center|Despite active study recruitment and screening for this study, only 5 subjects were enrolled out of the planned 40 subjects. Of the 5 subjects enrolled, only 1 patient was evaluable for response assessment. The study was subsequently terminated.|2||Low accrual rate|f||||t||||||||||2017-02-18 17:58:39.488808|2017-02-18 17:58:39.488808
NCT00063245|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-23|2008-03-03|||June 2003||2003-06-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Stimulating Deep Brain Regions With a Magnetic Stimulator|Noninvasive Stimulation of Human Deep Brain Regions With a Magnetic Stimulator|Completed||N/A|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:39.806631|2017-02-18 17:58:39.806631
NCT00063232|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-23|2011-06-21|2011-03-14||June 2003||2003-06-01|June 2011|2011-06-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Treating Nonalcoholic Steatohepatitis (NASH) With Metformin|Treatment of Nonalcoholic Steatohepatitis With Metformin|Completed||Phase 2|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:58:39.894963|2017-02-18 17:58:39.894963
NCT00060580|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-07|2008-03-03|||May 2003||2003-05-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Raman Scattering Spectroscopy to Measure Macular Pigment|Measurement of Macular Pigment With Resonant Raman Backscattering Spectroscopy|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:22.671642|2017-02-18 17:59:22.671642
NCT00063219|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-23|2009-08-20||||||August 2009|2009-08-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy|A Phase 2, Open-label Study of MAC-321 Administered Intravenously as a Single Agent for the Treatment of Non-small Cell Lung Cancer Refractory to Platinum-based Therapy|Completed||Phase 2|48|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:58:40.225535|2017-02-18 17:58:40.225535
NCT00063206|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-23|2009-08-18||||||August 2009|2009-08-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder|A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of a Flexible Dose of DVS-233 SR in Adult Outpatients With Major Depressive Disorder|Completed||Phase 3|247|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 17:58:40.30804|2017-02-18 17:58:40.30804
NCT00063193|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-23|2016-01-19|||May 2003||2003-05-01|January 2016|2016-01-01|July 2005|Actual|2005-07-01|May 2005|Actual|2005-05-01||Interventional|||National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial|A Multi-center, Double-blind, Pilot Study of Minocycline and Creatine in Subjects With Early Untreated Parkinson's Disease|Completed||Phase 2|195||University of Rochester|||||f||||t||||||||||2017-02-18 17:58:40.376658|2017-02-18 17:58:40.376658
NCT00063180|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-20|2017-01-24|||June 19, 2003||2003-06-19|April 20, 2009|2009-04-20|April 20, 2009||2009-04-20|||||Observational|||Evaluating the Remote Effects of Stroke With MRI and PET Scans|Remote Effects of Stroke on Cerebral Metabolism. Evaluation With Positron Emission Tomography and Proton Magnetic Resonance Spectroscopy|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:40.467996|2017-02-18 17:58:40.467996
NCT00063154|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-20|2015-06-08|2015-05-26||July 2003||2003-07-01|June 2015|2015-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional||Safety population: All participants who received any amount of pertuzumab.|Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy|A Phase II, Open-label, Multicenter Study to Evaluate the Effect of Tumor-based HER2 Activation on the Efficacy of rhuMAb 2C4 (Pertuzumab) in Subjects With Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|51|Actual|Genentech, Inc.||1|||f||||f||||||||||2017-02-18 17:58:40.561446|2017-02-18 17:58:40.561446
NCT00063141|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-20|2010-04-08|||April 2003||2003-04-01|April 2010|2010-04-01|October 2007|Actual|2007-10-01|June 2006|Actual|2006-06-01||Interventional|||Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer|Revised Protocol 07 to Protocol CA225006 - A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Carcinoma|Completed||Phase 3|1302|Actual|ImClone LLC||2|||f||||||||||||||2017-02-18 17:58:40.972477|2017-02-18 17:58:40.972477
NCT00063128|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-20|2007-12-20|||April 2003||2003-04-01|December 2007|2007-12-01|April 2004|Actual|2004-04-01|||||Interventional|||Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.|Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus|Completed||Phase 2|119|Actual|Eli Lilly and Company||2|||||||f||||||||||2017-02-18 17:58:41.488742|2017-02-18 17:58:41.488742
NCT00063115|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2017-01-24|||June 16, 2003||2003-06-16|July 2, 2008|2008-07-02|July 2, 2008||2008-07-02|||||Observational|||Using fMRI to Understand the Roles of Brain Areas for Fine Hand Movements|Event-Related fMRI Analysis of Patients With Ideomotor Apraxia During Transitive and Intransitive Hand Gesturing|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:41.636477|2017-02-18 17:58:41.636477
NCT00063102|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2007-11-28|||November 2002||2002-11-01|November 2007|2007-11-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.|A Phase II Study of ABT-751 in Patients With Breast Cancer Refractory to Taxane Regimens|Completed||Phase 2|40||Abbott||1|||f||||f||||||||||2017-02-18 17:58:41.717712|2017-02-18 17:58:41.717712
NCT00063089|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2012-05-10|||September 2002||2002-09-01|May 2012|2012-05-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever|Initial Safety and Pharmacokinetics Trial of Immune Globulin to Staphylococcus Aureus Capsule Polysaccharide (Altastaph) in Subjects With S. Aureus Bacteremia and Persistent Fever|Completed||Phase 1/Phase 2|40|Actual|Nabi Biopharmaceuticals||2|||f||||||||||||||2017-02-18 17:58:41.80992|2017-02-18 17:58:41.80992
NCT00063076|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2012-08-01|||May 2003||2003-05-01|August 2012|2012-08-01|May 2007|Actual|2007-05-01|October 2006|Actual|2006-10-01||Interventional|||Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata|A Two Stage Phase II Randomized Bilateral Comparison of Topical Targretin® Gel 1% in Alopecia Areata|Completed||Phase 2/Phase 3|46|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 17:58:41.914782|2017-02-18 17:58:41.914782
NCT00063063|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2016-12-08|||January 1987||1987-01-01|December 2016|2016-12-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|GDB||Generic Database of Very Low Birth Weight Infants|Generic Database: A Survey of Morbidity and Mortality in Very Low Birth Weight Infants|Recruiting||N/A|80000|Anticipated|NICHD Neonatal Research Network|||1||f||||f||||||||||2017-02-18 17:58:42.041159|2017-02-18 17:58:42.041159
NCT00063050|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2011-11-14|||April 2000||2000-04-01|November 2011|2011-11-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Osteoporosis Prevention: Changes to Exercise and Diet in Children|Healthy Children Healthy Families|Completed||Phase 2|155|Actual|San Diego State University|||||f||||f||||||||||2017-02-18 17:58:42.261246|2017-02-18 17:58:42.261246
NCT00063037|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2005-06-23|||June 1999||1999-06-01|May 2003|2003-05-01|May 2005||2005-05-01|||||Interventional|||Building Better Bones in Children|Building Better Bones in Children|Unknown status|Active, not recruiting|N/A|139||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:42.364828|2017-02-18 17:58:42.364828
NCT00063024|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2005-06-23|||June 1999||1999-06-01|May 2003|2003-05-01|May 2004||2004-05-01|||||Interventional|||Program to Prevent Osteoporosis in Girls|Behavioral Strategies to Prevent Osteoporosis in Girls|Unknown status|Active, not recruiting|Phase 3|322||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:42.450695|2017-02-18 17:58:42.450695
NCT00063011|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-19|2005-06-23|||May 1998||1998-05-01|May 2003|2003-05-01||||||||Interventional|||Bone Development in Adolescent Girls: Effects of Calcium and Exercise|Calcium and Exercise Effect on Pubertal Bone Gain|Unknown status|Active, not recruiting|Phase 1/Phase 2|107||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:42.540674|2017-02-18 17:58:42.540674
NCT00062972|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-18|2011-05-20|||September 1999||1999-09-01|May 2011|2011-05-01|August 2002||2002-08-01|||||Interventional|||Improving Memory in Patients With Multiple Sclerosis|Interventions to Improve Memory in Patients With Multiple Sclerosis|Withdrawn||Phase 3|60|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||||Study terminated/withdrawn|f||||||||||||||2017-02-18 17:58:42.780611|2017-02-18 17:58:42.780611
NCT00062959|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-18|2005-06-23|||June 1994||1994-06-01|May 2003|2003-05-01|June 2000||2000-06-01|||||Interventional|||Preventing Problem Behavior Among Middle School Students|Preventing Problem Behaviors Among Middle School Students|Completed||N/A|2768||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:42.870083|2017-02-18 17:58:42.870083
NCT00062946|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2017-01-24|||June 17, 2003||2003-06-17|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Interventional|||PET Imaging of Dopamine in Healthy Study Participants|PET Imaging of Dopamine D2 Receptors and Extracellular Dopamine With (18F)Fallypride, D-amphetamine, and Alpha-Methyl-Para-Tyrosine in Healthy Subjects|Completed||Phase 2|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:42.951133|2017-02-18 17:58:42.951133
NCT00062933|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2012-08-17|||June 2003||2003-06-01|August 2012|2012-08-01|March 2008|Actual|2008-03-01|September 2007|Actual|2007-09-01||Interventional|||A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma|A Phase II Study of Isolated Hepatic Perfusion (IHP) With Melphalan Followed by Temozolomide for Subjects With Unresectable Hepatic Metastases From Ocular Melanoma|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:43.036273|2017-02-18 17:58:43.036273
NCT00062907|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2006-12-05|||May 2003||2003-05-01|November 2004|2004-11-01||||||||Interventional|||Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer|Phase I Open-Label Dose Escalation Trial Evaluating The Safety And Immunogenicity Of Sequential Administration Of Recombinant DNA And Adenovirus Expressing L523S Protein In Patients With Early Stage Non-Small Cell Lung Cancer|Unknown status|Recruiting|Phase 1|9||Corixa Corporation|||||||||||||||||||2017-02-18 17:58:43.115049|2017-02-18 17:58:43.115049
NCT00062855|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2012-10-26|||November 1997||1997-11-01|October 2012|2012-10-01|March 2006|Actual|2006-03-01|August 2001|Actual|2001-08-01||Interventional|CYCHE||Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma|Phase I Study of Chemokine and Cytokine Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using an Adenoviral Vector (CYCHE)|Completed||Phase 1|9|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:58:43.192033|2017-02-18 17:58:43.192033
NCT00062842|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2007-04-09|||November 1998||1998-11-01|April 2007|2007-04-01|May 2005||2005-05-01|||||Interventional|||Study of Irinotecan in Children|Pediatric Phase I and Pharmacokinetic Study of Irinotecan|Completed||Phase 1|25||Baylor College of Medicine|||||||||||||||||||2017-02-18 17:58:43.294321|2017-02-18 17:58:43.294321
NCT00062829|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-17|2014-09-24|||September 1998||1998-09-01|September 2014|2014-09-01|September 2005|Actual|2005-09-01|September 2000|Actual|2000-09-01||Interventional|||Young Driver Intervention Study: Preventing Motor Vehicle Crashes|Young Driver Intervention Study: Preventing Motor Vehicle Crashes Among Young Drivers|Completed||N/A|3743|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-02-18 17:58:43.373391|2017-02-18 17:58:43.373391
NCT00062816|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-16|2007-10-15|||May 2004||2004-05-01|October 2007|2007-10-01||||||||Interventional|||Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs||Completed||Phase 1/Phase 2|22||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 17:58:43.469743|2017-02-18 17:58:43.469743
NCT00062803|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-16|2009-04-28|||June 2003||2003-06-01|April 2009|2009-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism|The Van Gogh-PE Trial, a Multicenter, International, Randomized, Open-Label, Assessor-Blind, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Weekly Subcutaneous SR34006 With the Combination of (LMW)Heparin and Vitamin K Antagonist (VKA) in the Treatment of Acute Symptomatic Pulmonary Embolism|Completed||Phase 3|||Sanofi|||||||||||||||||||2017-02-18 17:58:43.585249|2017-02-18 17:58:43.585249
NCT00062790|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-16|2016-09-13|||October 2003||2003-10-01|September 2016|2016-09-01|July 2005|Actual|2005-07-01|||||Interventional|||Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels|Effects of Dutasteride on Intraprostatic Dihydrotestosterone (DHT) Levels|Completed||Phase 4|50||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 17:58:43.889734|2017-02-18 17:58:43.889734
NCT00062777|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-13|2017-01-24|||June 12, 2003||2003-06-12|June 16, 2011|2011-06-16|June 16, 2011||2011-06-16|||||Observational|||The Framingham Study: Examining DNA Markers and Links to Diseases|A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study|Completed||N/A|330|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:44.000996|2017-02-18 17:58:44.000996
NCT00062764|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-12|2012-12-14|2011-03-01||June 2003||2003-06-01|December 2012|2012-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Treating Nonalcoholic Steatohepatitis With Pioglitazone|Long-Term Treatment of Nonalcoholic Steatohepatitis With Pioglitazone|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)|"A major limitation of this study was the lack of a concurrently followed control group.~Another important shortcoming of this study was that patients were treated for 48 weeks only."|1|||f||||f||||||||||2017-02-18 17:58:44.075769|2017-02-18 17:58:44.075769
NCT00062751|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-12|2011-04-13|2010-10-27||December 2002||2002-12-01|April 2011|2011-04-01|October 2009|Actual|2009-10-01|April 2005|Actual|2005-04-01||Interventional|||Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms|A Phase 2 Randomized Open-Label Study Of Letrozole In Combination With Two Dose Levels And Schedules Of Oral Temsirolimus (CCI-779), Or Letrozole Alone, In Postmenopausal Women With Locally Advanced Or Metastatic Breast Cancer|Completed||Phase 2|108|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|Clinical development of oral temsirolimus for treatment of locally advanced or metastatic breast cancer was terminated by Wyeth based on the results of a phase 3 clinical study with the combination temsirolimus and letrozole.|3|||f||||f||||||||||2017-02-18 17:58:44.461013|2017-02-18 17:58:44.461013
NCT00062738|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-12|2015-10-27|2012-12-05||June 2003||2003-06-01|October 2015|2015-10-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Treatment of Depression in Parkinson's Disease Trial|Treatment of Depression in Patients With Parkinson's Disease|Completed||Phase 2|52|Actual|Rutgers, The State University of New Jersey|This was only an eight week trial with relatively few participants.|3|||f||||t||||||||||2017-02-18 17:58:52.230496|2017-02-18 17:58:52.230496
NCT00062712|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-11|2017-01-24|||June 9, 2003||2003-06-09|March 22, 2007|2007-03-22|March 22, 2007||2007-03-22|||||Interventional|||Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients|Induction of Donor Specific Immunologic Hyporesponsiveness With Thymoglobulin, Sirolimus and Donor Bone Marrow Infusion|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:52.760601|2017-02-18 17:58:52.760601
NCT00062699|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-11|2006-07-31|||April 2003||2003-04-01|July 2006|2006-07-01||||||||Interventional|||Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis|A Phase IV, Prospective, Randomized, Active-Controlled, Double-Blind, Double-Dummy, Multi-Center Study to Evaluate the Survival Benefits of Zemplar Relative to Calcijex in Subjects With Stage V Chronic Kidney Disease on Hemodialysis|Terminated||Phase 4|2200||Abbott|||||||||||||||||||2017-02-18 17:58:52.848402|2017-02-18 17:58:52.848402
NCT00062686|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-11|2015-04-14|||November 2003||2003-11-01|April 2015|2015-04-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||GW572016 For Treatment Of Refractory Metastatic Breast Cancer|An Open-Label, Multicenter, Single Arm Phase II Study of Oral GW572016 as Single Agent Therapy in Subjects With Advanced or Metastatic Breast Cancer Who Have Progressed While Receiving HERCEPTIN-Containing Regimens|Completed||Phase 2|200||GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:58:53.254709|2017-02-18 17:58:53.254709
NCT00062673|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-10|2007-05-17|||March 2003||2003-03-01|May 2007|2007-05-01|July 2004|Actual|2004-07-01|||||Interventional|||Study of Duloxetine in Elderly Patients With Major Depressive Disorder|Duloxetine Versus Placebo in the Treatment of Elderly Patients With Major Depressive Disorder|Completed||Phase 3|311||Eli Lilly and Company|||||f||||f||||||||||2017-02-18 17:58:53.348163|2017-02-18 17:58:53.348163
NCT00062660|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-10|2016-11-29|||May 2003||2003-05-01|July 2014|2014-07-01|April 2014|Actual|2014-04-01|April 2014|Actual|2014-04-01||Expanded Access|||Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection|An Open Label Safety Study to Evaluate the Safety of Tipranavir Plus Ritonavir When Used in Combination With Other Agents for the Treatment of Patients With HIV Infection Who Have Failed and/or Are Intolerant to Combination Antiretroviral Therapy and Have Limited Treatment Options|Approved for marketing||N/A|||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 17:58:53.456205|2017-02-18 17:58:53.456205
NCT00062647|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2011-03-30|2009-12-02||August 2003||2003-08-01|March 2011|2011-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|ASSURE||Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia|A Phase 2, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Televancin (TD-6424) for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia|Completed||Phase 2|60|Actual|Theravance Biopharma Antibiotics, Inc.||2|||f||||f||||||||||2017-02-18 17:58:53.83304|2017-02-18 17:58:53.83304
NCT00062634|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2005-06-23|||June 2003||2003-06-01|October 2004|2004-10-01|August 2005||2005-08-01|||||Interventional|||Education Program to Promote Female Condom Use|Female Condom Intervention Trial|Unknown status|Recruiting|N/A|400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:58:54.59293|2017-02-18 17:58:54.59293
NCT00062621|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2013-02-01|||June 2003||2003-06-01|February 2013|2013-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure|Combined HLA-matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With Renal Failure|Completed||Phase 1|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:58:54.685442|2017-02-18 17:58:54.685442
NCT00062608|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2010-01-12||||||January 2010|2010-01-01||||||||Interventional|||Written Self-disclosure for Youth Abdominal Pain|RCT of Written Self-disclosure for Youth Abdominal Pain|Completed||Phase 2/Phase 3|160|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:58:54.979748|2017-02-18 17:58:54.979748
NCT00062595|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2016-05-16|||September 2000||2000-09-01|May 2016|2016-05-01|October 2004||2004-10-01|||||Interventional|||Vitamin K and Bone Turnover in Postmenopausal Women|Vitamin K and Bone Turnover in Postmenopausal Women|Completed||Phase 3|375||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 17:58:55.057391|2017-02-18 17:58:55.057391
NCT00062582|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2016-11-22|||June 2003||2003-06-01|September 2016|2016-09-01||||||||Interventional|||Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)|A 24 Week, Placebo-Controlled, Randomized, Parallel Group Study Comparing Roflumilast 500 mcg Daily vs Placebo on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|1000||AstraZeneca|||||f||||||||||||||2017-02-18 17:58:55.155372|2017-02-18 17:58:55.155372
NCT00062569|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2009-03-10|||September 2002||2002-09-01|March 2009|2009-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Bathing Persons With Alzheimer's Disease aT Home (The BATH Study)|Reminiscence During Bathing Persons With Alzheimer's Disease at Home|Completed||N/A|90|Actual|National Institute of Nursing Research (NINR)||2|||f||||f||||||||||2017-02-18 17:58:55.309757|2017-02-18 17:58:55.309757
NCT00062556|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2006-10-31|||January 2003||2003-01-01|October 2006|2006-10-01|March 2006||2006-03-01|||||Interventional|||Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication|Effect of Niacin ER/Lovastatin on Peak Walking Time and Claudication Onset Time in Patients With Intermittent Claudication|Completed||Phase 3|366||Kos Pharmaceuticals|||||||||||||||||||2017-02-18 17:58:55.424879|2017-02-18 17:58:55.424879
NCT00062543|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2012-08-01|||May 2002||2002-05-01|August 2012|2012-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Hepatic Artery Infusion of CD34+ Cells|Hepatic Artery Infusion of CD34+ Cells, Isolated by the Isolex 300i Device, in Stem Cell Transplant Recipients With Hepatic Failure Due to Veno-occlusive Disease|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:58:55.51903|2017-02-18 17:58:55.51903
NCT00062530|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-09|2008-09-25||||||September 2008|2008-09-01||||||||Interventional|||Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers|Development of an Oral Prime-Boost AIDS Vaccine to Elicit Broadly Neutralizing Antibodies Against HIV-1|Unknown status|Not yet recruiting|Phase 1|38|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:58:55.625215|2017-02-18 17:58:55.625215
NCT00062309|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2016-03-01|||June 2002||2002-06-01|March 2016|2016-03-01||||May 2006|Actual|2006-05-01||Interventional|||Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer|A Phase III Intensity Modulated Radiotherapy Dose Escalation Trial for Prostate Cancer Using Hypofractionation|Completed||Phase 3|307|Actual|Fox Chase Cancer Center||2|||f||||f||||||||||2017-02-18 17:58:58.232507|2017-02-18 17:58:58.232507
NCT00062517|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-06|2017-01-24|||June 5, 2003||2003-06-05|September 21, 2016|2016-09-21|September 21, 2016||2016-09-21|||||Observational|||Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning|Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning|Completed||N/A|497|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:55.730167|2017-02-18 17:58:55.730167
NCT00062504|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-06|2011-05-20|||July 2003||2003-07-01|May 2011|2011-05-01|April 2006|Actual|2006-04-01|January 2006|Actual|2006-01-01||Interventional|||Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas|A Phase II Trial of Talampanel in Patients With Recurrent High-Grade Gliomas.|Terminated||Phase 2|30|Actual|Teva Pharmaceutical Industries||3|||f||||||||||||||2017-02-18 17:58:55.82109|2017-02-18 17:58:55.82109
NCT00062491|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-06|2017-01-09|||May 2002||2002-05-01|January 2017|2017-01-01|November 2005|Actual|2005-11-01|June 2003|Actual|2003-06-01||Interventional|||Study of Karenitecin (BNP1350) to Treat Malignant Melanoma|Phase 2 Trial of Karenitecin (BNP1350) in Patients With Malignant Melanoma|Completed||Phase 2|46|Actual|BioNumerik Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 17:58:55.907859|2017-02-18 17:58:55.907859
NCT00062478|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-06|2017-01-09|||October 2001||2001-10-01|October 2015|2015-10-01||||August 2002|Actual|2002-08-01||Interventional|||Study of Karenitecin (BNP1350) in Patients With Brain Tumors|Phase 2 Treatment of Adults With Primary Malignant Glioma With Karenitecin|Completed||Phase 2|40|Actual|BioNumerik Pharmaceuticals, Inc.||1|||f||||f||||||||||2017-02-18 17:58:55.993197|2017-02-18 17:58:55.993197
NCT00062465|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2008-03-03|||June 2003||2003-06-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine|A 24-Week, Double Blind, Randomized Study to Determine the Effects of 24 Weeks of Dosing With Tripterygium Wilfordii Hook F (TwHF) or Sulfasalazine, in Subjects With Active Rheumatoid Arthritis|Completed||Phase 2|157||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:56.0907|2017-02-18 17:58:56.0907
NCT00062452|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2010-01-12|||May 2002||2002-05-01|January 2010|2010-01-01|July 2005|Actual|2005-07-01|April 2005|Actual|2005-04-01||Observational|||Esophageal Motility and Airway Defenses Among Infants|Esophageal Motility and Airway Defenses Among Infants|Completed||N/A|65|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||1||f||||t||||||||||2017-02-18 17:58:56.175069|2017-02-18 17:58:56.175069
NCT00062439|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-10-30|2012-11-15||July 2003||2003-07-01|October 2013|2013-10-01|December 2010|Actual|2010-12-01|December 2010|Actual|2010-12-01||Interventional|||S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors|A Phase II Trial of Induction Chemoradiotherapy With Cisplatin/Etoposide Followed by Surgical Resection, Followed by Docetaxel, for Non-Small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors)|Completed||Phase 2|46|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:58:56.288815|2017-02-18 17:58:56.288815
NCT00062426|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-11-05|||May 2003||2003-05-01|April 2004|2004-04-01|February 2011|Actual|2011-02-01|||||Interventional|||Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer|A Randomized, Prospective Study Comparing Three Regimens Of Eloxatin ™ Plus Fluoropyrimidine For Evaluation Of Safety And Tolerability In First Line Treatment Of Patients With Advanced Colorectal Cancer (Tree Study)|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:58:57.392269|2017-02-18 17:58:57.392269
NCT00062400|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-10-23|||May 2003||2003-05-01|October 2013|2013-10-01||||June 2008|Actual|2008-06-01||Interventional|||Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer|A Survey of the Breast International Group (B.I.G.) to Assess the Attitude of Patients Aged Less Than 35 Years, With Early Breast Cancer, Toward the Risk of Loss of Fertility Related to Adjuvant Therapies|Completed||N/A|385|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:58:57.545195|2017-02-18 17:58:57.545195
NCT00062387|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-05-31|||May 2003||2003-05-01|October 2004|2004-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Study Of Perifosine In Patients With Recurrent Or Metastatic Head And Neck Cancer|Terminated||Phase 2|46|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:58:57.689465|2017-02-18 17:58:57.689465
NCT00062374|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-06-03|||June 2003||2003-06-01|June 2013|2013-06-01||||June 2011|Actual|2011-06-01||Interventional|||Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction|An Evaluation of Preoperative Chemotherapy With Irinotecan and Cisplatin for Advanced, But Resectable Gastric Cancer: A Coordinated Multidisciplinary, Multicenter Study Linking Functional Imaging, Genomic Expression Profiles and Histopathology|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:57.817361|2017-02-18 17:58:57.817361
NCT00062348|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2012-01-19|||April 2003||2003-04-01|January 2012|2012-01-01||||December 2007|Actual|2007-12-01||Interventional|||Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases|B-Uptake In Different Tumours Using The Boron Compounds BSH And BPA|Completed||Phase 1|27|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:58:57.937522|2017-02-18 17:58:57.937522
NCT00062335|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2012-09-20|||April 2003||2003-04-01|September 2012|2012-09-01||||February 2006|Actual|2006-02-01||Interventional|||High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer|A Phase I Study On The Feasibility Of High Dose Three Dimensional Conformal Radiotherapy In Patients With Inoperable And Locally Advanced Non Small Cell Lung Cancer|Terminated||Phase 1|14|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 17:58:58.044123|2017-02-18 17:58:58.044123
NCT00062322|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2010-02-11|||February 2003||2003-02-01|February 2010|2010-02-01|October 2009|Actual|2009-10-01|||||Interventional|||Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer|Phase I Study of Preoperative Chemo/Radiation (Concurrent Irinotecan/Cisplatin/RT) Followed by Surgery in Limited Stage Small Cell Lung Cancer (SCLC-LS)|Completed||Phase 1|||Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 17:58:58.143129|2017-02-18 17:58:58.143129
NCT00005329|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||May 1992||1992-05-01|March 2005|2005-03-01|March 1997|Actual|1997-03-01|||||Observational|||Protein S and Myocardial Infarction||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.719808|2017-02-18 18:15:07.719808
NCT00062296|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-07-10|||March 2003||2003-03-01|July 2013|2013-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Phase II Study of Epirubicin and Rituximab in Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma and CLL|Completed||Phase 2|5|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-02-18 17:58:58.342522|2017-02-18 17:58:58.342522
NCT00062283|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-06-25|||March 2003||2003-03-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2005|Actual|2005-12-01||Interventional|||Alanosine in Treating Patients With Cancer|A Phase II, Open-Label, Non-Randomized, Multicenter, Single Agent Study of Intravenous SDX-102 for the Treatment of Patients With MTAP-Deficient Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:58:58.444419|2017-02-18 17:58:58.444419
NCT00062270|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2015-10-06|||May 2003||2003-05-01|September 2015|2015-09-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer|Neoadjuvant Chemoradiotherapy (Gemcitabine/Cisplatin and Taxotere) With or Without Co-Administration of ZD 1839 (Iressa) for Stage IIIA (N2) and Selective Stage IIIB Non-Small Cell Lung Cancer: Phase I-II Study|Completed||Phase 1/Phase 2|||University of Alabama at Birmingham|||||f||||t||||||||||2017-02-18 17:58:58.547181|2017-02-18 17:58:58.547181
NCT00062257|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-05-14|||June 2003||2003-06-01|March 2005|2005-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer|A Phase II Study of Irofulven as First Line Therapy in Recurrent or Metastatic Gastric Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:58:58.659797|2017-02-18 17:58:58.659797
NCT00062244|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-06-03|||May 2003||2003-05-01|June 2013|2013-06-01||||June 2007|Actual|2007-06-01||Interventional|||Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia|Phase I/II Study of G3139 (Genasense) in Patients With Waldenstrom's Macroglobulinemia|Completed||Phase 1/Phase 2|58|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:58:58.87515|2017-02-18 17:58:58.87515
NCT00062231|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2012-09-20|||April 2002||2002-04-01|September 2012|2012-09-01||||October 2006|Actual|2006-10-01||Interventional|||Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer|Oral Empirical Therapy of Fever in Low-Risk Neutropenic Cancer Patients: A Prospective, Double-Blind, Randomized, Multicenter Trial Comparing Monotherapy (Single Daily Dose Moxifloxacin) With Combination Therapy (Ciprofloxacin Plus Amoxicillin/Clavulanic Acid)|Terminated||N/A|351|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 17:58:58.997624|2017-02-18 17:58:58.997624
NCT00062205|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2010-02-05|||June 2002||2002-06-01|February 2010|2010-02-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor|Phase II Trial of Gleevec (STI571) in Therapy of Ewing's Family of Tumors and Desmoplastic Small Round Cell Tumors|Completed||Phase 2|40|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-02-18 17:58:59.14907|2017-02-18 17:58:59.14907
NCT00062179|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2015-10-01|||March 2003||2003-03-01|August 2012|2012-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer|A Randomized Double Blind Phase II Study of Preoperative Celecoxib/Paclitaxel/Carboplatin for Stage IIIA Non-Small Cell Lung Cancer|Completed||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 17:58:59.240029|2017-02-18 17:58:59.240029
NCT00062166|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2017-01-24|||April 10, 2003||2003-04-10|November 29, 2016|2016-11-29||||||||Observational|||Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease|Evaluation of the Natural History and Management of Pancreatic Lesions Associated With Von Hippel-Lindau|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:58:59.353668|2017-02-18 17:58:59.353668
NCT00062140|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2010-09-20|||April 2003||2003-04-01|September 2010|2010-09-01|July 2004|Actual|2004-07-01|||||Interventional|||Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer|A Phase I Trial Of Total Body Irradiation, Cyclophosphamide Dose-Adjustment Based On Its Metabolism, And Hematopoietic Stem Cell Transplantation For Patients With Hematological Malignancy|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 17:58:59.460964|2017-02-18 17:58:59.460964
NCT00062127|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-01-23|||April 2003||2003-04-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors|A Phase I Pharmacokinetic Interaction Study of Irinotecan (NSC616348) and Thalidomide (NSC66847) in Patients With Advanced Solid Tumors|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:58:59.558276|2017-02-18 17:58:59.558276
NCT00062114|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2016-07-01|||April 2004||2004-04-01|July 2016|2016-07-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Study To Evaluate The Safety And Efficacy Of Zevalin (IND # BB IND 4850) Therapeutic Regimen In Patients With Transformed CD20 + B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|84|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:58:59.670132|2017-02-18 17:58:59.670132
NCT00062101|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-06-05|||January 2004||2004-01-01|June 2013|2013-06-01||||January 2006|Actual|2006-01-01||Interventional|||Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer|A Phase II Study of OSI 774 (IND Number 63383) in Combination With Celecoxib (Celebrex, Pharmacia) as Second-Line Therapy in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:59:00.05911|2017-02-18 17:59:00.05911
NCT00062075|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2015-12-03|||May 2003||2003-05-01|April 2013|2013-04-01||||March 2007|Actual|2007-03-01||Interventional|||Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Phase 2 Study of Depsipeptide in Patients With Relapsed or Refractory AML|Completed||Phase 2|47|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:00.205033|2017-02-18 17:59:00.205033
NCT00061867|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-05-29|||March 2003||2003-03-01|July 2005|2005-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer|A Dose Escalation, Pharmacokinetics, and Safety Study of Doxorubicin Encapsulated in Temperature Sensitive Liposomes Released Through Microwave Therapy in the Treatment of Prostate Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:05.397908|2017-02-18 17:59:05.397908
NCT00062062|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2016-12-12|||October 2004||2004-10-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|August 2006|Actual|2006-08-01||Interventional|||Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer|Parallel Phase II Trials of ZD1839 (Iressa) Alone or Weekly Carboplatin and Paclitaxel Followed by ZD1839 (Iressa) (Oncologists Must Choose) for Metastatic Non-Small Cell Lung Cancer in Patients > or = 65 Years of Age|Completed||Phase 2|65|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 17:59:00.326873|2017-02-18 17:59:00.326873
NCT00062049|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2012-03-07|||April 2003||2003-04-01|March 2012|2012-03-01|May 2011|Actual|2011-05-01|||||Interventional|||Interleukin-7 in Treating Patients With Refractory Solid Tumors|"A Phase I Study of Subcutaneous CYT 99 007 (Interleukin-7) in Patients With Refractory Non Hematologic Malignancy"|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:59:00.602493|2017-02-18 17:59:00.602493
NCT00062036|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2017-01-24|||June 2003||2003-06-01|March 2012|2012-03-01|September 2008|Actual|2008-09-01|February 2007|Actual|2007-02-01||Interventional|||Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma|Tumor Infiltrating Lymphocytes (TIL Cells) Transduced With An Interleukin-2 (SBIL-2) Gene Following The Administration Of A Nonmyeloablative But Lymphocyte Depleting Regimen in Metastatic Melanoma|Completed||Phase 1/Phase 2|33|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:59:00.688567|2017-02-18 17:59:00.688567
NCT00062023|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2012-07-27|||June 2003||2003-06-01|July 2012|2012-07-01|May 2006|Actual|2006-05-01|April 2005|Actual|2005-04-01||Interventional|||Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer|Phase II Study Of Colorectal ACF Screening, Regression And Prevention In High Risk Participants|Terminated||Phase 2|12|Actual|M.D. Anderson Cancer Center||4||Study closed by the NCI.|f||||t||||||||||2017-02-18 17:59:00.79549|2017-02-18 17:59:00.79549
NCT00062010|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2015-10-06|2012-12-01||February 2004||2004-02-01|December 2012|2012-12-01|August 2012|Actual|2012-08-01|May 2011|Actual|2011-05-01||Interventional|||Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer|Interferon Alpha (NSC# 377523) Plus 13-Cis-Retinoic Acid Modulation Of BCL-2 Plus Paclitaxel For Recurrent Small Cell Lung Cancer|Completed||Phase 2|37|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 17:59:00.92983|2017-02-18 17:59:00.92983
NCT00061997|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2010-02-01|||May 2003||2003-05-01|November 2005|2005-11-01||||||||Interventional|||Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers|A Phase I Study Of The Safety Of Myo-Inositol As A Chemopreventive Agent|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:01.487892|2017-02-18 17:59:01.487892
NCT00061984|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2014-10-24|||April 2003||2003-04-01|October 2014|2014-10-01|July 2012|Actual|2012-07-01|May 2010|Actual|2010-05-01||Interventional|||Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma|Randomised Trial Of Single Agent Doxorubicin Versus Doxorubicin Plus Ifosfamide In The First Line Treatment Of Advanced Or Metastatic Soft Tissue Sarcoma|Completed||Phase 3|455|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 17:59:01.574785|2017-02-18 17:59:01.574785
NCT00061958|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-01-22|||June 2003||2003-06-01|January 2013|2013-01-01||||April 2005|Actual|2005-04-01||Interventional|||Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Study of Arsenic Trioxide (NSC 706363) in Patients With Advanced Adenocarcinoma of the Esophagus or Gastroesophageal Junction|Terminated||Phase 2|50|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:59:01.715296|2017-02-18 17:59:01.715296
NCT00061945|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2014-03-20|2013-12-05||June 2003||2003-06-01|December 2013|2013-12-01|October 2012|Actual|2012-10-01|December 2007|Actual|2007-12-01||Interventional|||Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia|A Phase I/II Dose Escalation Study of Subcutaneous Campath-1H (NSC #715969, IND #10864) During Intensification Therapy in Adults With Untreated Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1/Phase 2|302|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:02.040841|2017-02-18 17:59:02.040841
NCT00061932|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2015-05-15|2015-05-15||April 2003||2003-04-01|June 2013|2013-06-01|November 2013|Actual|2013-11-01|December 2009|Actual|2009-12-01||Interventional|||Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach|A Phase II Study of PS-341 Alone or in Combination With Irinotecan in Patients With Adenocarcinoma of the Gastroesophageal Junction (GEJ) or Stomach|Completed||Phase 2|41|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 17:59:03.71708|2017-02-18 17:59:03.71708
NCT00061919|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2012-03-15|||April 2003||2003-04-01|March 2012|2012-03-01|July 2007|Actual|2007-07-01|February 2007|Actual|2007-02-01||Interventional|||Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer|A Phase III Randomized, Double Blind, Placebo Controlled Trial Of Carboplatin/Etoposide With Or Without Thalidomide In Small Cell Lung Cancer (Study 12)|Completed||Phase 3|724|Actual|University College, London||2|||f||||t||||||||||2017-02-18 17:59:04.275209|2017-02-18 17:59:04.275209
NCT00061906|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2014-02-10|||January 2003||2003-01-01|February 2014|2014-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer|Phase II Study Of Celecoxib In Metastatic Differentiated Thyroid Carcinoma|Completed||Phase 2|25|Actual|Ohio State University Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:59:04.391982|2017-02-18 17:59:04.391982
NCT00061893|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2014-09-16|2013-01-17||April 2004||2004-04-01|September 2014|2014-09-01|December 2013|Actual|2013-12-01|April 2008|Actual|2008-04-01||Interventional|||Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors|A Pilot Study of Low-Dose Antiangiogenic Chemotherapy in Combination With Standard Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma Family of Tumors|Completed||Phase 2|38|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 17:59:04.538418|2017-02-18 17:59:04.538418
NCT00061880|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2013-05-29|||February 2003||2003-02-01|July 2004|2004-07-01|January 2008|Actual|2008-01-01|January 2005|Actual|2005-01-01||Interventional|||BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma|Phase 1-2 Multi-Center Study of Intravenous BCX-1777 in Patients With Refractory Cutaneous T-Cell Lymphoma (CTCL)|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:05.303638|2017-02-18 17:59:05.303638
NCT00061854|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2012-05-15|||April 2003||2003-04-01|May 2012|2012-05-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II Study Of Intravenous TZT-1027, Administered Weekly Times Two, Every Three Weeks, To Patients With Progressive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) Following Treatment With Platinum-Based Chemotherapy|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 17:59:05.488693|2017-02-18 17:59:05.488693
NCT00061841|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2010-01-12||||||January 2010|2010-01-01||||||||Interventional|||Medical College of Georgia FitKid Project||Completed||Phase 2|685|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:05.584162|2017-02-18 17:59:05.584162
NCT00061828|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-05|2016-09-28|||May 2004||2004-05-01|September 2016|2016-09-01|May 2019|Anticipated|2019-05-01|May 2019|Anticipated|2019-05-01||Observational|PROBE||Biliary Atresia Research Consortium|Childhood Liver Disease Research and Education Network (CHILDREN): A Prospective Database of Infants With Cholestasis|Recruiting||N/A|1000|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||2||f||||t||||||Samples With DNA|"~     Samples of blood, urine and liver tissue samples will be collected for research purposes.~   "|Yes|The data will be transferred to NIDDK at the end of the study.|2017-02-18 17:59:05.655845|2017-02-18 17:59:05.655845
NCT00061815|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-04|2010-04-08|||March 2003||2003-03-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|December 2004|Actual|2004-12-01||Interventional|||Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer|A Phase 3 Randomized Multicenter Study of Cetuximab, Oxaliplatin, 5-Fluorouracil, and Leucovorin vs. Oxaliplatin, 5-Fluorouracil, and Leucovorin in Subjects With Previously Treated Metastatic, EGFR-Positive Colorectal Carcinoma|Completed||Phase 3|102|Actual|ImClone LLC||2|||f||||f||||||||||2017-02-18 17:59:05.816665|2017-02-18 17:59:05.816665
NCT00061802|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-04|2012-02-06|||June 2003||2003-06-01|February 2012|2012-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder|A Randomized, Double Blind Study to Evaluate the Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder|Completed||Phase 4|225|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 17:59:05.968872|2017-02-18 17:59:05.968872
NCT00061789|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-04|2008-03-03|||February 2003||2003-02-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Interventional|||Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia|SPECT Imaging of Alpha 4 Beta 2 Nicotinic Acetylcholine Receptors Using [(123)I]5-I-A-85380 in Schizophrenia|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:06.07896|2017-02-18 17:59:06.07896
NCT00061776|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-03|2008-03-04||||||March 2008|2008-03-01||||||||Interventional|||NGX-4010 for the Treatment of Postherpetic Neuralgia|A Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Postherpetic Neuralgia|Completed||Phase 2/Phase 3|300||NeurogesX|||||||||||||||||||2017-02-18 17:59:06.164036|2017-02-18 17:59:06.164036
NCT00061763|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-03|2011-03-02|||May 2003||2003-05-01|March 2011|2011-03-01||||November 2004|Actual|2004-11-01||Interventional|||Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias|Phase II Study of Safety & Efficacy of Deferasirox Given for 1 Year in Patients With Chronic Anemias and Transfusional Hemosiderosis Unable to be Treated With Deferoxamine|Completed||Phase 2|175|Actual|Novartis|||||||||||||||||||2017-02-18 17:59:06.450726|2017-02-18 17:59:06.450726
NCT00061750|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-03|2012-04-18|||May 2003||2003-05-01|April 2012|2012-04-01||||November 2004|Actual|2004-11-01||Interventional|||Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions|A Randomized, Comparative, Open Label Phase III Trial on Efficacy & Safety of Long-term Treatment With ICL670 Compared to Deferoxamine in Beta-thalassemia Patients With Transfusional Hemosiderosis|Completed||Phase 3|595|Actual|Novartis||2|||f||||||||||||||2017-02-18 17:59:06.552277|2017-02-18 17:59:06.552277
NCT00061737|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-03|2010-01-12|||January 2003||2003-01-01|January 2010|2010-01-01||||||||Observational|||Quality of Life in Pediatric Inflammatory Bowel Disease||Completed||N/A|350|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:06.665157|2017-02-18 17:59:06.665157
NCT00061308|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-23|2013-03-01|||December 2002||2002-12-01|March 2013|2013-03-01||||September 2004|Actual|2004-09-01||Interventional|||Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer|An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer|Completed||Phase 2|75||GlaxoSmithKline|||||f||||||||||||||2017-02-18 17:59:06.744723|2017-02-18 17:59:06.744723
NCT00061295|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-23|2005-06-23|||March 1999||1999-03-01|March 2003|2003-03-01|February 2004||2004-02-01|||||Interventional|||Treadmill Training With Body Weight Support in Patients With Spinal Cord Injury|Body Weight Supported Ambulation Training After Spinal Cord Injury|Unknown status|Recruiting|Phase 1|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:06.861391|2017-02-18 17:59:06.861391
NCT00061282|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-23|2016-01-26|||September 2002||2002-09-01|January 2016|2016-01-01|June 2018|Anticipated|2018-06-01|June 2018|Anticipated|2018-06-01||Interventional|CAPTURE||Clotrimazole Enemas for Pouchitis in Children and Adults|Clotrimazole Enemas for Pouchitis in Children and Adults|Suspended||Phase 1/Phase 2|40|Anticipated|Boston Children’s Hospital||3||Funding Horizon|f||||t||||||||||2017-02-18 17:59:06.947027|2017-02-18 17:59:06.947027
NCT00061269|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-22|2010-01-12|||September 2003||2003-09-01|January 2010|2010-01-01||||||||Interventional|||Videoendoscopic Drainage of Infected Pancreatic Collections||Completed||Phase 2|40|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:07.051896|2017-02-18 17:59:07.051896
NCT00061256|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-22|2009-08-06||||||August 2009|2009-08-01|September 2006|Actual|2006-09-01|||||Interventional|||The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Once-Weekly Alendronate in HIV-Infected Subjects With Decreased Bone Mineral Density Receiving Calcium and Vitamin D|Completed||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:59:07.130907|2017-02-18 17:59:07.130907
NCT00061243|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-22|2008-09-25|||April 2004||2004-04-01|December 2005|2005-12-01|April 2010|Anticipated|2010-04-01|April 2005|Actual|2005-04-01||Interventional|||Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults|A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Multi-Gene, Polyvalent HIV-1 DNA Plasmid Prime/Env Protein Boost Vaccine Formulation, DP6-001 in Healthy Volunteers|Unknown status|Active, not recruiting|Phase 1|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-02-18 17:59:07.452641|2017-02-18 17:59:07.452641
NCT00061230|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-22|2005-06-23|||March 2003||2003-03-01|April 2003|2003-04-01|March 2006||2006-03-01|||||Interventional|||Relaxation Training to Decrease Pain and Improve Function in Adolescents With Cerebral Palsy|Efficacy of Relaxation Training|Unknown status|Recruiting|N/A|60||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:07.564797|2017-02-18 17:59:07.564797
NCT00061217|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-22|2005-06-23|||April 2001||2001-04-01|October 2004|2004-10-01|March 2005||2005-03-01|||||Interventional|||Prosthetic Limbs After Leg Amputation: Alternative Method of Socket Design|Comparison of Rectified and Unrectified Amputee Sockets|Unknown status|Active, not recruiting|Phase 2|59||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:07.651832|2017-02-18 17:59:07.651832
NCT00061204|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2008-03-03|||May 2003||2003-05-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Observational|||Magnetic Resonance Imaging of the Brain in Emotional Processing|Functional Neuroimaging of Social Cognitive and Emotional Processing: Technical and Cognitive Issues|Completed||N/A|38||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:07.760383|2017-02-18 17:59:07.760383
NCT00061178|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2016-10-18||||||October 2016|2016-10-01||||||||Interventional|||Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma|Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy & Safety of rhuMAb VEGF in Previously Treated Metastatic Renal Cell Carcinoma|Withdrawn||Phase 3|0|Actual|Genentech, Inc.||||No patients were enrolled, study cancelled before start|||||||||||||||2017-02-18 17:59:07.838749|2017-02-18 17:59:07.838749
NCT00061165|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2010-01-12|||February 2003||2003-02-01|January 2010|2010-01-01||||||||Interventional|||Obesity Prevention in African American School Children||Completed||N/A|900|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:07.902586|2017-02-18 17:59:07.902586
NCT00061152|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2007-09-12||||||September 2007|2007-09-01||||||||Interventional|||Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy|An Open-Label Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy|Unknown status|Active, not recruiting|Phase 2|||NeurogesX|||||||||||||||||||2017-02-18 17:59:07.980046|2017-02-18 17:59:07.980046
NCT00061139|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2005-06-23|||September 2002||2002-09-01|April 2003|2003-04-01|September 2006||2006-09-01|||||Interventional|||Constraint-Based Therapy to Improve Motor Function in Children With Cerebral Palsy|Randomized Controlled Trial of Pediatric CI Therapy|Unknown status|Recruiting|Phase 2|52||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:08.063153|2017-02-18 17:59:08.063153
NCT00061126|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2005-06-23|||April 2003||2003-04-01|September 2004|2004-09-01||||||||Interventional|||ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body|A Clinical Trial Evaluating the Safety and Efficacy of ABX-EGF in Patients With Hormone Resistant Prostate Cancer With or Without Metastasis|Completed||Phase 2|50||Abgenix|||||||||||||||||||2017-02-18 17:59:08.149864|2017-02-18 17:59:08.149864
NCT00061113|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2017-01-11|||February 2001||2001-02-01|September 2008|2008-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Substance Dependent Teens - Impact of Treating Depression Study 1 - 1|Substance Dependent Teens - Impact of Treating Depression Study 1|Completed||Phase 4|126|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 17:59:08.231697|2017-02-18 17:59:08.231697
NCT00061100|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2015-03-30|||October 1999||1999-10-01|March 2015|2015-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||HIV Counseling Intervention for Methadone-Maintained Patients - 2|HIV Counseling Intervention for Methadone-Maintained Patients|Completed||Phase 1|50|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 17:59:08.352175|2017-02-18 17:59:08.352175
NCT00061087|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2012-10-24|||February 1998||1998-02-01|October 2012|2012-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1|Treatment of Adult ADHD in Methadone Patients|Completed||Phase 2/Phase 3|115|Actual|New York State Psychiatric Institute||3|||f||||t||||||||||2017-02-18 17:59:08.470496|2017-02-18 17:59:08.470496
NCT00061074|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2015-12-01|||March 1993||1993-03-01|December 2015|2015-12-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Tobacco Cessation in Postmenopausal Women (Part II) - 2|The Effects of ERT on Appetitive Behavior and Withdrawal in Short-term Smoking Cessation in Postmenopausal Females on Transdermal Nicotine Replacement|Completed||Phase 1|1|Actual|University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-02-18 17:59:08.597647|2017-02-18 17:59:08.597647
NCT00061724|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-03|2010-01-12||||||January 2010|2010-01-01||||||||Observational|||Medical and Surgical Treatment of Esophageal Reflux||Completed||N/A|175|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:08.680146|2017-02-18 17:59:08.680146
NCT00061711|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-03|2009-12-09|||July 2000||2000-07-01|December 2009|2009-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Alternative Therapies for Menopause: A Randomized Trial||Completed||N/A|355||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:59:08.750935|2017-02-18 17:59:08.750935
NCT00061698|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-03|2015-06-11|||April 2002||2002-04-01|June 2015|2015-06-01|December 2008|Actual|2008-12-01|August 2008|Actual|2008-08-01||Interventional|||Treatment for Depressed Preadolescent Girls|CBT vs CBT Plus Parent Training for Girls With Depression|Completed||Phase 1|153|Actual|University of Texas at Austin||3|||f||||f||||||||||2017-02-18 17:59:08.837773|2017-02-18 17:59:08.837773
NCT00061672|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-02|2007-08-13|||April 2003||2003-04-01|August 2007|2007-08-01||||||||Interventional|||Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma|A Phase II Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma|Completed||Phase 2|67|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:59:08.932564|2017-02-18 17:59:08.932564
NCT00060593|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-07|2008-03-03|||May 2003||2003-05-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Observational|||MRI Study of Self-Perception of Postural Stability|Self-Perception of Postural Stability: Event-Related fMRI Study|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:22.593911|2017-02-18 17:59:22.593911
NCT00061659|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-02|2007-11-28|||May 2003||2003-05-01|November 2007|2007-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma|A Phase II Randomized Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma|Completed||Phase 2|88|Actual|Abbott||2|||f||||f||||||||||2017-02-18 17:59:09.044196|2017-02-18 17:59:09.044196
NCT00061646|ClinicalTrials.gov processed this data on February 17, 2017|2003-06-02|2007-08-10|||March 2003||2003-03-01|August 2007|2007-08-01||||||||Interventional|||Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)|A Phase II Single-Arm Study Evaluating the Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 2|25|Actual|Abbott||1||"Enrollment suspended based upon interim analysis; subjects allowed to stay on study until~   disease progression."|f||||f||||||||||2017-02-18 17:59:09.139332|2017-02-18 17:59:09.139332
NCT00061633|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-30|2010-01-27|2009-12-02||June 2003||2003-06-01|January 2010|2010-01-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|FAST||Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)|A Phase 2, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Standard Therapy for Treatment of Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)|Completed||Phase 2|169|Actual|Theravance Biopharma Antibiotics, Inc.||2|||||||t||||||||||2017-02-18 17:59:09.236884|2017-02-18 17:59:09.236884
NCT00061620|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-30|2012-07-27|||September 2001||2001-09-01|July 2012|2012-07-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies|Phase I Study of Continuous Infusion Schedule of (E)-2'-Deoxy-2'-(Fluoromethylene) Cytidine (Tezacitabine, FMdC) in Hematologic Malignancies|Completed||Phase 1|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:59:10.087119|2017-02-18 17:59:10.087119
NCT00061607|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-29|2017-01-24|||May 19, 2003||2003-05-19|March 28, 2016|2016-03-28||||||||Observational|||Measuring Levels of SMN in Blood Samples of SMA Patients|SMN Levels in Peripheral Blood Samples of SMA Patients and the Effects of Pharmacological Compounds In Vitro|Completed||N/A|73|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:10.206249|2017-02-18 17:59:10.206249
NCT00061594|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-29|2014-03-18|||May 2003||2003-05-01|March 2014|2014-03-01|September 2006|Actual|2006-09-01|||||Interventional|||A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration|A Phase III, Multicenter, Randomized, Double Masked, Active Treatment-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne) Photodynamic Therapy in Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration|Completed||Phase 3|426||Genentech, Inc.|||||f||||||||||||||2017-02-18 17:59:10.297777|2017-02-18 17:59:10.297777
NCT00061581|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-29|2017-01-24|||May 19, 2003||2003-05-19|July 14, 2016|2016-07-14|December 28, 2007|Actual|2007-12-28|December 28, 2007|Actual|2007-12-28||Interventional|||Experimental Bone Marrow Transplant Protocol|Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies Effect of Irradiated Donor Lymphocytes on Chimerism|Completed||Phase 2|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:59:10.582743|2017-02-18 17:59:10.582743
NCT00061568|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-29|2017-01-24|||May 19, 2003||2003-05-19|January 3, 2017|2017-01-03|January 31, 2018|Anticipated|2018-01-31|January 31, 2018|Anticipated|2018-01-31||Interventional|||Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias|Nonmyeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease (SCD) and Beta-Thalassemia|Recruiting||Phase 2|124|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:59:10.681272|2017-02-18 17:59:10.681272
NCT00061542|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-28|2016-11-16|||January 2003||2003-01-01|August 2008|2008-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension|Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension|Completed||Phase 3|105|Actual|Alcon Research||3|||||||||||||||||2017-02-18 17:59:10.795596|2017-02-18 17:59:10.795596
NCT00061529|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-28|2008-08-04|||January 2003||2003-01-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension|A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-02-18 17:59:10.900902|2017-02-18 17:59:10.900902
NCT00061516|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-28|2016-11-16|||January 2003||2003-01-01|August 2008|2008-08-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension|Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension|Completed||Phase 3|78|Actual|Alcon Research||2|||||||||||||||||2017-02-18 17:59:10.979106|2017-02-18 17:59:10.979106
NCT00061503|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-28|2008-08-04|||April 2003||2003-04-01|August 2008|2008-08-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension|A Double-Masked, Placebo-Controlled, Paired Comparison Study of the Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension|Completed||Phase 4|||Alcon Research|||||||||||||||||||2017-02-18 17:59:11.092124|2017-02-18 17:59:11.092124
NCT00061490|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-28|2008-02-29|||September 2002||2002-09-01|February 2008|2008-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||The Effect of Weight Loss and Exercise on Knee Osteoarthritis|The Impact of Weight Loss and Exercise on Knee Osteoarthritis|Completed||N/A|160|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||2|||f||||t||||||||||2017-02-18 17:59:11.180119|2017-02-18 17:59:11.180119
NCT00061477|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-28|2007-01-24|||December 2002||2002-12-01|January 2007|2007-01-01|September 2006||2006-09-01|||||Interventional|||Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma|ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma: A Phase II Clinical Trial|Completed||Phase 2|48||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:59:11.471634|2017-02-18 17:59:11.471634
NCT00061464|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-28|2007-01-24|||February 2003||2003-02-01|January 2007|2007-01-01|February 2006||2006-02-01|||||Interventional|||Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.|ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase II Clinical Trial|Completed||Phase 2|48||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:59:11.572031|2017-02-18 17:59:11.572031
NCT00061451|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-28|2010-12-20|||December 2002||2002-12-01|December 2010|2010-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial|ALIMTA Plus Gemcitabine as Front-line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer: A Phase II Clinical Trial|Completed||Phase 2|48||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:59:11.670716|2017-02-18 17:59:11.670716
NCT00061438|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-27|2010-11-17|||February 2003||2003-02-01|November 2010|2010-11-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died|A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis|Completed||Phase 4|240||AstraZeneca|||||||||||||||||||2017-02-18 17:59:11.769764|2017-02-18 17:59:11.769764
NCT00061425|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-27|2009-01-08|||August 2000||2000-08-01|January 2009|2009-01-01||||November 2007|Actual|2007-11-01||Interventional|||Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgG|Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immuno-LL2: Treatment With 90Y-hLL2 IgG|Completed||Phase 1/Phase 2|||Immunomedics, Inc.|||||f||||f||||||||||2017-02-18 17:59:11.872398|2017-02-18 17:59:11.872398
NCT00061412|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-27|2006-09-27|||December 1995||1995-12-01|September 2006|2006-09-01|November 2005||2005-11-01|||||Interventional|||Comprehensive Program to Improve Reading and Writing Skills in At-Risk and Dyslexic Children|Learning Disabilities: Links to Schools and Biology|Completed||N/A|2500||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:11.955695|2017-02-18 17:59:11.955695
NCT00061399|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-27|2014-10-28|||July 2002||2002-07-01|April 2007|2007-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Prospective Memory in Children With Traumatic Brain Injury|Prospective Memory in Normal and Head-Injured Children|Completed||N/A|178||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:12.057136|2017-02-18 17:59:12.057136
NCT00061386|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-27|2005-09-09|||March 2001||2001-03-01|September 2005|2005-09-01|March 2004||2004-03-01|||||Interventional|||Improving Health in Low Income Women Following the Birth of a Child|Reducing Disease Risk in Low Income Postpartum Women|Completed||N/A|680||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:12.130924|2017-02-18 17:59:12.130924
NCT00061373|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-23|2012-12-27|2012-12-27||May 2003||2003-05-01|December 2012|2012-12-01|July 2011|Actual|2011-07-01|December 2009|Actual|2009-12-01||Interventional|CATALIST||Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)|Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)|All patients enrolled were dosed with aspirin and tinzaparin. None of the patients received iv eptifibatide. The study was closed prior to dosing with eptifibatide due to slow recruitment over the 5-year trial period.|2|||f||||t||||||||||2017-02-18 17:59:12.230477|2017-02-18 17:59:12.230477
NCT00061360|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-23|2017-01-24|||May 19, 2003||2003-05-19|August 25, 2016|2016-08-25|September 8, 2015|Actual|2015-09-08|May 31, 2006|Actual|2006-05-31||Interventional|||Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia|A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects With Severe Aplastic Anemia|Completed||Phase 2|77|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:59:12.817219|2017-02-18 17:59:12.817219
NCT00061347|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-23|2017-01-24|||May 21, 2003||2003-05-21|September 23, 2016|2016-09-23|April 4, 2011|Actual|2011-04-04|May 31, 2004|Actual|2004-05-31||Interventional|||Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment|Trans-Rectal Placement of Prostatic Fiducial Markers Under MR-Guidance in Patients Receiving External Beam Radiotherapy for Prostate Cancer: A Pilot Study|Completed||Phase 1|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 17:59:12.924227|2017-02-18 17:59:12.924227
NCT00061334|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-23|2017-01-24|||May 7, 2003||2003-05-07|December 29, 2011|2011-12-29|December 29, 2011||2011-12-29|||||Observational|||Investigating the Cognitive Processes That Underlie Social Knowledge and Behavior|Social Knowledge Representation in the Human Prefrontal Cortex|Completed||N/A|222|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:13.039496|2017-02-18 17:59:13.039496
NCT00061321|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-23|2008-07-30|||August 2002||2002-08-01|August 2007|2007-08-01|September 2007|Actual|2007-09-01|April 2007|Actual|2007-04-01||Interventional|SWEN||Daily Nevirapine to Prevent Mother to Infant Transmission of HIV|Prevention of Maternal to Infant HIV Transmission in India|Completed||Phase 3|770|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 17:59:13.126866|2017-02-18 17:59:13.126866
NCT00061061|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-21|2015-12-01|||March 1997||1997-03-01|December 2015|2015-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Tobacco Cessation in Postmenopausal Women (Part I) - 1|The Effects of ERT on Appetitive Behavior and Withdrawal in Short-term Smoking Cessation Compared to Smoking ad Lib in Postmenopausal Female Smokers.|Completed||Phase 4|0||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-02-18 17:59:13.250839|2017-02-18 17:59:13.250839
NCT00061048|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-20|2012-10-26|2011-05-17||May 2003||2003-05-01|October 2012|2012-10-01|July 2012|Actual|2012-07-01|July 2009|Actual|2009-07-01||Interventional|||Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma|Phase II Study of the Efficacy and Toxicity of Campath-1H in the Therapy of Adult T-Cell Leukemia|Completed||Phase 2|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 17:59:13.34741|2017-02-18 17:59:13.34741
NCT00061035|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-20|2008-08-26|||April 2003||2003-04-01|August 2008|2008-08-01||||||||Interventional|||Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma|A Phase 1, Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma|Completed||Phase 1|18|Anticipated|Cosmo Bioscience|||||||||||||||||||2017-02-18 17:59:13.732843|2017-02-18 17:59:13.732843
NCT00005328|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-01-16|||April 1980||1980-04-01|January 2013|2013-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Antecedents of the Type A Behavior Pattern||Completed||N/A|184|Actual|University of Pittsburgh|||1||f||||||||||||||2017-02-18 18:15:07.79417|2017-02-18 18:15:07.79417
NCT00061022|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-20|2010-11-10|||May 2003||2003-05-01|November 2010|2010-11-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke|SAINT (Stroke - Acute Ischemic - NXY Treatment) A Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter, Phase IIb/III Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke|Completed||Phase 3|3200||AstraZeneca|||||||||||||||||||2017-02-18 17:59:13.844656|2017-02-18 17:59:13.844656
NCT00061009|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-19|2008-03-03|||May 2003||2003-05-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Hypnosis in Autonomic Function|Relationship of Autonomic Function to Hypnotic Susceptibility|Completed||N/A|93||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:14.299079|2017-02-18 17:59:14.299079
NCT00060996|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-19|2013-03-05|||February 2003||2003-02-01|March 2013|2013-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures|A Randomized Placebo-Controlled, 12-Week Multicenter Study of the Safety and Efficacy of Continuous or Daily Administration of Remodulin® (Treprostinil Sodium) Injection in Patients With CLI With No Planned Revascularization Procedures|Terminated||Phase 3|30||United Therapeutics|||||f||||||||||||||2017-02-18 17:59:14.390899|2017-02-18 17:59:14.390899
NCT00060983|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-16|2005-06-23|||May 1998||1998-05-01|May 2003|2003-05-01|April 2002||2002-04-01|||||Interventional|||Improving Gait in Patients With Spinal Cord Injuries|Effects of Sensory Motor Input on Gait in SCI (Spinal Cord Injured) Subjects|Completed||Phase 2|36||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:14.501274|2017-02-18 17:59:14.501274
NCT00060970|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-16|2005-06-23|||September 1995||1995-09-01|March 2003|2003-03-01|August 2000||2000-08-01|||||Observational|||Evaluating Muscle Function After Ankle Surgery|Restoration of Muscle Function During Rehabilitation|Completed||N/A|30||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:14.593656|2017-02-18 17:59:14.593656
NCT00060957|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-16|2016-09-23|||July 1997||1997-07-01|May 2011|2011-05-01||||June 2002|Actual|2002-06-01||Interventional|||Botulinum Toxin (BOTOX) for Cerebral Palsy|Botulinum Toxin for Spasticity in Cerebral Palsy|Completed||Phase 2|40||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:14.686075|2017-02-18 17:59:14.686075
NCT00060944|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-16|2014-08-28|2014-01-14||May 2003||2003-05-01|August 2014|2014-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer|A Randomized, Multicenter, Open-label Study of Yondelis (ET-743 Ecteinascidin) Administered by 2 Different Schedules (Weekly for 3 of 4 Weeks vs. q3 Weeks) in Subjects With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma Following Treatment With an Anthracycline and Ifosfamide|Completed||Phase 2|271|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||f||||||||||2017-02-18 17:59:17.749096|2017-02-18 17:59:17.749096
NCT00060931|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-15|2015-04-13|||June 2001||2001-06-01|April 2015|2015-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension|A Randomized, Double-Blind, Multicenter Study Comparing the Effects of Carvedilol and Metoprolol on Glycemic Control in Hypertensive Patients With Type II Diabetes Mellitus.|Completed||Phase 4|501|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:59:18.969026|2017-02-18 17:59:18.969026
NCT00060918|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-15|2015-04-14|||June 2001||2001-06-01|June 2012|2012-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension|A Randomized, Double-Blind, Multicenter Study Comparing the Glycemic Control Characteristics of Carvedilol and Metoprolol in Hypertensive Patients With Type II Diabetes Mellitus.|Completed||Phase 4|1210||GlaxoSmithKline|||||||||f||||||||||2017-02-18 17:59:19.188704|2017-02-18 17:59:19.188704
NCT00060905|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-15|2006-08-02|||January 2003||2003-01-01|August 2006|2006-08-01||||||||Interventional|||An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder|An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder|Completed||Phase 3|370||Abbott|||||||||||||||||||2017-02-18 17:59:19.322916|2017-02-18 17:59:19.322916
NCT00060892|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-15|2008-01-09|||April 2003||2003-04-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|||Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia|A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Leg Ischemia|Completed||Phase 2|104|Actual|AnGes||4|||f||||t||||||||||2017-02-18 17:59:19.698434|2017-02-18 17:59:19.698434
NCT00060866|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-14|2008-03-03|||May 2003||2003-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance|Propranolol for Syncope With Sympathoadrenal Imbalance|Completed||Phase 4|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:19.824303|2017-02-18 17:59:19.824303
NCT00060853|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-14|2008-03-03|||May 2003||2003-05-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Observational|||Magnetic Resonance Imaging of the Brain in Social and Emotional Reasoning|Reasoning About Social and Economic Knowledge: Identifying the Role of the Human Prefrontal Cortex Using Functional Neuroimaging|Completed||N/A|330||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:19.91235|2017-02-18 17:59:19.91235
NCT00060840|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-14|2016-07-22|2010-08-25||July 2003||2003-07-01|July 2016|2016-07-01|July 2008|Actual|2008-07-01|June 2008|Actual|2008-06-01||Interventional|||The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation|The Effects of Nitric Oxide for Inhalation During Left Ventricular Assist Device (LVAD) Implantation|Completed||Phase 2|150|Actual|Mallinckrodt||2|||f||||t||||||||||2017-02-18 17:59:19.99327|2017-02-18 17:59:19.99327
NCT00060827|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-14|2014-10-28||||||March 2004|2004-03-01||||||||Observational|||Measuring Head Impacts in Sports|Head Impact Recording Technology for Field Applications|Withdrawn||Phase 2|0|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||f||||||||||2017-02-18 17:59:20.467622|2017-02-18 17:59:20.467622
NCT00060814|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-14|2017-01-11|||June 2002||2002-06-01|October 2016|2016-10-01|December 2002|Actual|2002-12-01|September 2002|Actual|2002-09-01||Interventional|||Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients|Pilot Study Examining the Effects of Combined Pharmacotherapy (Zyban/NRT)/Behavioral Treatment on Smoking Cessation Among MMT Patients.|Completed||Phase 2|28|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||f||||||||||2017-02-18 17:59:20.558927|2017-02-18 17:59:20.558927
NCT00060801|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-13|2013-10-30|||May 2003||2003-05-01|October 2013|2013-10-01||||July 2004|Actual|2004-07-01||Interventional|||Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients|A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult (75 mg, 150 mg) and Pediatric (75 mg) Cystic Fibrosis Patients|Terminated||Phase 2|420||Boehringer Ingelheim|||||||||||||||||||2017-02-18 17:59:20.660711|2017-02-18 17:59:20.660711
NCT00060788|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-13|2006-03-06|||September 2001||2001-09-01|March 2006|2006-03-01|December 2005||2005-12-01|||||Observational|||Antisocial Behavior: Passing From Parent to Child to Grandchild|Intergenerational Transmission of Antisocial Behavior|Unknown status|Recruiting|N/A|663||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:20.790424|2017-02-18 17:59:20.790424
NCT00060775|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-12|2017-01-24|||May 9, 2003||2003-05-09|December 28, 2016|2016-12-28||||||||Observational|||The Psychobiology of Childhood Temperament|The Psychobiology of Temperament: An fMRI Study|Recruiting||N/A|1010|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:20.882291|2017-02-18 17:59:20.882291
NCT00060762|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-12|2014-05-14|||April 2002||2002-04-01|May 2014|2014-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Effectiveness of Binge Eating Disorder Treatments|Effectiveness of Psychological Treatments for BED|Completed||Phase 4|205|Actual|Stanford University||3|||f||||t||||||||||2017-02-18 17:59:20.994513|2017-02-18 17:59:20.994513
NCT00060749|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-09|2017-01-24|||May 5, 2003||2003-05-05|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Interventional|||Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy|Investigation of the Effect of Dietary Docosahexaenoic Acid (DHA) Supplementation on Macular Function in Subjects With Autosomal Dominant Stargardt-Like and Autosomal Recessive Stargardt Macular Dystrophy|Completed||Phase 1|22||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:21.116734|2017-02-18 17:59:21.116734
NCT00060736|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-09|2017-01-24|||May 5, 2003||2003-05-05|April 27, 2016|2016-04-27|April 27, 2016||2016-04-27|||||Observational|||The Effects of Estrogen Withdrawal on Mood Symptoms in Women|The Effects of Acute Withdrawal of Estradiol on Mood Symptoms in Women With Perimenopausal Depression|Completed||N/A|60|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:21.202991|2017-02-18 17:59:21.202991
NCT00060723|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-09|2016-12-03|||August 1999||1999-08-01|December 2016|2016-12-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Observational|||Behavioral Effects of Obstructive Sleep Apnea in Children|Behavioral Effect of Obstructive Sleep Apnea in Children|Completed||N/A|106|Actual|University of Michigan|||2||f||||f||||||||||2017-02-18 17:59:21.296313|2017-02-18 17:59:21.296313
NCT00060710|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-09|2011-10-14|||January 2003||2003-01-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|||||Interventional|||CP-461 in the Treatment of Patients With Advanced Melanoma|Phase II Study of CP-461 in the Treatment of Patients With Advanced Melanoma|Terminated||Phase 2|35||Astellas Pharma Inc|||||||||||||||||||2017-02-18 17:59:21.390173|2017-02-18 17:59:21.390173
NCT00060697|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-09|2005-06-23|||December 2000||2000-12-01|May 2003|2003-05-01|May 2005||2005-05-01|||||Interventional|||A Mother's Role in Delaying Onset of Sexual Activity in Her Children|Family Intervention to Promote Health in Children|Unknown status|Recruiting|Phase 2|1300||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:21.466256|2017-02-18 17:59:21.466256
NCT00060684|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-09|2015-01-15|||December 2001||2001-12-01|September 2008|2008-09-01|May 2007|Actual|2007-05-01|January 2005|Actual|2005-01-01||Interventional|||Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma|A Phase I Trial of BBR 2778 in Combination With Fludarabine, Dexamethasone and Rituximab in the Treatment of Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma|Completed||Phase 1|30||CTI BioPharma|||||||||||||||||||2017-02-18 17:59:21.550018|2017-02-18 17:59:21.550018
NCT00060671|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-09|2015-01-15|||January 2005||2005-01-01|May 2013|2013-05-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma|An Open-Label, Randomized, Phase III Comparative Trial of BBR 2778 + Rituximab Versus Rituximab in the Treatment of Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma (NHL)|Terminated||Phase 3|800||CTI BioPharma|||||f||||||||||||||2017-02-18 17:59:21.662304|2017-02-18 17:59:21.662304
NCT00060658|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-08|2008-03-03|||May 2003||2003-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Magnetic Resonance Imaging of Calculus Problem Solving|Functional Neuroimaging of Calculus Problem Solving|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:21.869259|2017-02-18 17:59:21.869259
NCT00060645|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-08|2015-08-26|||May 2003||2003-05-01|August 2015|2015-08-01|February 2009|Actual|2009-02-01|May 2006|Actual|2006-05-01||Interventional|||Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)|A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily x 5 Administration of AP23573, an mTOR Inhibitor, in Patients With Refractory or Advanced Malignancies|Completed||Phase 1|33|Actual|Merck Sharp & Dohme Corp.||1|||f||||||||||||||2017-02-18 17:59:22.136217|2017-02-18 17:59:22.136217
NCT00060632|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-08|2015-08-26|||April 2003||2003-04-01|August 2015|2015-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)|A Phase I, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Weekly Administration of AP23573, an mTOR Inhibitor, in Patients With Refractory or Advanced Malignancies|Completed||Phase 1|46|Actual|Merck Sharp & Dohme Corp.||6|||f||||||||||||||2017-02-18 17:59:22.24881|2017-02-18 17:59:22.24881
NCT00060619|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-08|2005-06-23|||May 1999||1999-05-01|March 2003|2003-03-01|June 2004||2004-06-01|||||Interventional|||Migraine and Recurrent Abdominal Pain in Children|Treatment of Recurrent Pain Syndromes in Children|Unknown status|Recruiting|N/A|180|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:22.370771|2017-02-18 17:59:22.370771
NCT00060606|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-08|2015-10-19|||February 2003||2003-02-01|October 2015|2015-10-01|November 2014|Actual|2014-11-01|February 2014|Actual|2014-02-01||Interventional|MOMS||Management of Myelomeningocele Study (MOMS)|Myelomeningocele Repair Randomized Trial|Completed||N/A|183|Actual|The George Washington University Biostatistics Center||2|||f||||t||||||||||2017-02-18 17:59:22.469609|2017-02-18 17:59:22.469609
NCT00005327|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-15|||April 1993||1993-04-01|August 2004|2004-08-01|March 1998||1998-03-01|||||Observational|||Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center||Completed||N/A|||University of Southern California|||||f||||||||||||||2017-02-18 18:15:07.88092|2017-02-18 18:15:07.88092
NCT00060567|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-07|2013-06-05|||March 2003||2003-03-01|June 2013|2013-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Dose-Finding Study of E7070 in Combination With Irinotecan|Phase I Dose-Finding Study of E7070 in Combination With Irinotecan|Completed||Phase 1|88|Actual|Eisai Inc.||3|||f||||||||||||||2017-02-18 17:59:22.7558|2017-02-18 17:59:22.7558
NCT00060554|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-07|2009-11-02|||April 2003||2003-04-01|November 2009|2009-11-01||||||||Interventional|||A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)||Withdrawn||Phase 2|300||Schering-Plough||||"Drug sold to Sanofi-Aventis who sold it to GSK; OBS no longer owns study and does not have~   data."|||||||||||||||2017-02-18 17:59:22.874535|2017-02-18 17:59:22.874535
NCT00060541|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-07|2017-01-24|||May 5, 2003||2003-05-05|December 6, 2016|2016-12-06||||||||Observational|||Evaluation and Treatment of Neurosurgical Disorders|Evaluation and Treatment of Neurosurgical Disorders|Recruiting||N/A|1600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:22.985088|2017-02-18 17:59:22.985088
NCT00060528|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-07|2012-06-05|2011-11-30||May 2003||2003-05-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|October 2009|Actual|2009-10-01||Interventional|||Sequential Vaccinations in Prostate Cancer Patients|A Phase I/II Pilot Study of Sequential Vaccinations With rFowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM) Alone, or in Combination With rVaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM), and the Role of GM-CSF, in Men With Prostate Cancer|Completed||Phase 1/Phase 2|32|Actual|National Institutes of Health Clinical Center (CC)||4|||f||||f||||||||||2017-02-18 17:59:23.091303|2017-02-18 17:59:23.091303
NCT00060515|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-07|2005-08-04||||||August 2005|2005-08-01||||||||Interventional|||RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease|An Open-Label Dose-Escalation Phase I Study to Asses the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RG2133 (2',3',5'-Tri-O-Acetyluridine) in the Treatment of Inherited Mitochondrial Diseases|Terminated||Phase 1|12||Repligen Corporation|||||||||||||||||||2017-02-18 17:59:23.795565|2017-02-18 17:59:23.795565
NCT00060502|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-07|2011-05-16|||April 2003||2003-04-01|April 2010|2010-04-01|February 2006|Actual|2006-02-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia|A Phase II, Multicenter, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Anti-TNF a Monoclonal Antibody (Infliximab) to Treat Cancer-Related Cachexia in Subjects With Pancreatic Cancer.|Completed||Phase 2|73|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 17:59:23.866404|2017-02-18 17:59:23.866404
NCT00060489|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2011-01-25|||September 2002||2002-09-01|January 2011|2011-01-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression||Completed||Phase 3|||AstraZeneca|||||||||||||||||||2017-02-18 17:59:23.967748|2017-02-18 17:59:23.967748
NCT00060476|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2015-09-15|||January 2003||2003-01-01|September 2015|2015-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Rofecoxib in Decreasing the Risk of Prostate Cancer (ViP Study)|Completed||Phase 3|15000|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 17:59:24.074555|2017-02-18 17:59:24.074555
NCT00060463|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2005-06-23|||October 2002||2002-10-01|October 2004|2004-10-01|October 2005||2005-10-01|||||Interventional|||Increased Access to Emergency Contraceptive Pills|Increased Access to Emergency Contraceptive Pills|Unknown status|Active, not recruiting|N/A|1490||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:24.174163|2017-02-18 17:59:24.174163
NCT00060450|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-09-08|||August 2001||2001-08-01|September 2016|2016-09-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation|Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation|Terminated||Phase 3|84|Actual|Mallinckrodt||2||Slow Enrollment|f||||f||||||||||2017-02-18 17:59:24.254321|2017-02-18 17:59:24.254321
NCT00060437|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-06-18|||October 2003||2003-10-01|April 2004|2004-04-01|April 2004|Actual|2004-04-01|||||Interventional|||Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer|A Phase II Trial Of Oral Perifosine In Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:24.365323|2017-02-18 17:59:24.365323
NCT00060424|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-07-18|||March 2003||2003-03-01|July 2016|2016-07-01||||September 2010|Actual|2010-09-01||Interventional|||Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia|Allogeneic Hematopoietic Stem Cell Transplantation With Nonmyeloablative Conditioning for Patients With Chronic Lymphocytic Leukemia - A Multi-center Trial|Active, not recruiting||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 17:59:24.464263|2017-02-18 17:59:24.464263
NCT00060411|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-09-27|||June 2003||2003-06-01|September 2013|2013-09-01||||July 2007|Actual|2007-07-01||Interventional|||A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer|A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:24.590941|2017-02-18 17:59:24.590941
NCT00060398|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2009-05-09|||June 2004||2004-06-01|July 2006|2006-07-01||||June 2006|Actual|2006-06-01||Interventional|||Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer|Study Of Epoetin Alfa Vs Epoetin Alfa With Dexamethasone In Hormone Refractory Prostate Cancer Patients: Impact On Fatigue, Anemia, Functional Status And Quality Of Life|Completed||Phase 3|282|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:24.720213|2017-02-18 17:59:24.720213
NCT00060385|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2012-09-20|||March 2003||2003-03-01|September 2012|2012-09-01||||August 2004|Actual|2004-08-01||Interventional|||Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma|Diffuse Large B Cell And Peripheral T Cell Non-Hodgkin's Lymphomas (NHL) In The Elderly. Influence Of Prolonged Oral Etoposide Added To CHOP Combination Chemotherapy In Patients With Good Physiological Status. An EORTC Randomized Phase II-III Trial Including Geriatric Assessment And Quality Of Life|Terminated||Phase 2/Phase 3|3|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 17:59:25.233391|2017-02-18 17:59:25.233391
NCT00060372|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-03-26|||April 2003||2003-04-01|March 2013|2013-03-01||||April 2008|Actual|2008-04-01||Interventional|||Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer|CTLA-4 Blockade With MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 1|21|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:25.345849|2017-02-18 17:59:25.345849
NCT00060359|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2015-05-07|||April 2003||2003-04-01|May 2015|2015-05-01||||January 2009|Actual|2009-01-01||Interventional|||Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer|A Dose-Escalating Phase I Study With an Expanded Cohort to Assess the Feasibility of CT-2103 and Carboplatin (NSC #214240) in Patients With Previously Untreated Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma|Completed||Phase 1|32|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 17:59:25.474972|2017-02-18 17:59:25.474972
NCT00060346|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-02-11|2013-01-10||June 2004||2004-06-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|December 2011|Actual|2011-12-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia|Phase II Pilot Study Of Rituximab Plus CHOP In Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia|Terminated||Phase 2|16|Actual|Eastern Cooperative Oncology Group||1||slow accrual|f||||f||||||||||2017-02-18 17:59:25.613281|2017-02-18 17:59:25.613281
NCT00060333|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-08-12|||July 2003||2003-07-01|August 2016|2016-08-01||||June 2011|Actual|2011-06-01||Interventional|||Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma|Phase II Trial Evaluating Resection Followed By Adjuvant Radiation Therapy (RT) For Patients With Desmoplastic Melanoma|Active, not recruiting||Phase 2|60|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 17:59:26.171663|2017-02-18 17:59:26.171663
NCT00060320|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-07-12|||October 2003||2003-10-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer|A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes|Completed||Phase 3|132|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:59:26.313651|2017-02-18 17:59:26.313651
NCT00060307|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-02-27|||May 2003||2003-05-01|February 2013|2013-02-01||||May 2007|Actual|2007-05-01||Interventional|||Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer|A Phase II Study of OSI-774 (NSC-718781) in Patients With Locally Advanced or Metastatic Papillary Histology Renal Cell Cancer|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:26.431677|2017-02-18 17:59:26.431677
NCT00060294|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-01-07|||April 2003||2003-04-01|January 2013|2013-01-01||||June 2004|Actual|2004-06-01||Interventional|||Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia|Phase I Study of Zevalin (90Y-Ibritumomab Tiuxetan) in Waldenstrom's Macroglobulinemia (Lymphoplasmacytic Lymphoma)|Terminated||Phase 1|||Jonsson Comprehensive Cancer Center||||no accrual|f||||t||||||||||2017-02-18 17:59:26.545208|2017-02-18 17:59:26.545208
NCT00060268|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2011-03-07|||January 1997||1997-01-01|March 2011|2011-03-01|June 2004|Actual|2004-06-01|September 2003|Actual|2003-09-01||Interventional|||Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors|A Phase I/II Trial for Treatment of Obstructive Esophageal Tumors by Photodynamic Therapy (PDT) Using 2-(1-Hydroxyethyl)-2-Devinylpyropheophorbide-a (HPPH)|Completed||Phase 1/Phase 2|11|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:59:26.644329|2017-02-18 17:59:26.644329
NCT00060255|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-05-07|||December 1991||1991-12-01|May 2013|2013-05-01|February 2013|Actual|2013-02-01|August 2006|Actual|2006-08-01||Interventional|||High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors|Autologous Blood and Marrow Transplantation for Hematologic Malignancy and Selected Solid Tumors|Completed||Phase 2|451|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 17:59:26.727198|2017-02-18 17:59:26.727198
NCT00060242|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2010-06-10|||February 2003||2003-02-01|June 2010|2010-06-01|January 2008|Actual|2008-01-01|February 2007|Actual|2007-02-01||Interventional|||Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer|Phase II Trial Of Combretastatin A-4 Phosphate (CA4P) In Advanced Anaplastic Carcinoma Of The Thyroid|Completed||Phase 2|26|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:59:26.837398|2017-02-18 17:59:26.837398
NCT00060203|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2014-01-14|||December 2002||2002-12-01|January 2014|2014-01-01|April 2004|Actual|2004-04-01|March 2003|Actual|2003-03-01||Interventional|||Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma|A Phase I/II Study of the Safety and Efficacy of Brostallicin (PNU-166196A) in Adult Patients With Multiple Myeloma That Has Progressed on Prior Chemotherapy|Completed||Phase 1/Phase 2|3|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 17:59:27.135305|2017-02-18 17:59:27.135305
NCT00060151|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-09-19|||December 2002||2002-12-01|April 2006|2006-04-01|June 2009|Actual|2009-06-01|||||Interventional|||GW786034 in Treating Patients With Advanced Solid Tumors|A Phase I, Open Label, Multiple Dose, Dose Escalation Study OF GW786034 In Patients With Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:27.24857|2017-02-18 17:59:27.24857
NCT00060138|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-05-13|||November 2002||2002-11-01|May 2013|2013-05-01||||September 2004|Actual|2004-09-01||Interventional|||Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases|A Phase I-II, 24-Week, Multi-Center, Double-Blind, Randomized, Dose-Ranging Study To Evaluate The Safety And Efficacy Of A Humanized Monoclonal Antibody To PTHrP Versus Zoledronic Acid In Patients With Breast Cancer Metastatic To Bone|Completed||Phase 1/Phase 2|||Chugai Pharmaceutical|||||f||||||||||||||2017-02-18 17:59:27.339974|2017-02-18 17:59:27.339974
NCT00060125|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-06-04|||May 2003||2003-05-01|June 2013|2013-06-01||||June 2006|Actual|2006-06-01||Interventional|||Tipifarnib in Treating Patients With Metastatic Malignant Melanoma|PHASE II TRIAL OF R115777 IN PATIENTS WITH METASTATIC MALIGNANT MELANOMA|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:27.435103|2017-02-18 17:59:27.435103
NCT00060112|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-01-24|||March 2003||2003-03-01|January 2013|2013-01-01||||December 2009|Actual|2009-12-01||Interventional|||Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma|A Phase I Study of Oblimersen (Genasense™, G3139) in Combination With Gemcitabine in Advanced Malignancies|Terminated||Phase 1|15|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 17:59:27.545301|2017-02-18 17:59:27.545301
NCT00060099|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-11-05|||May 2003||2003-05-01|March 2005|2005-03-01||||||||Interventional|||SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia|Phase II Randomized, Double-Blinded Trial Of SGN-00101 (HSP-E7) For Treatment Of CIN II/III|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:27.662046|2017-02-18 17:59:27.662046
NCT00060086|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-09-30|||March 2003||2003-03-01|September 2016|2016-09-01||||December 2017|Anticipated|2017-12-01||Interventional|||Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer|Phase II Study Evaluating Pomegranate Juice In Patients With Recurrent Adenocarcinoma Of The Prostate|Active, not recruiting||Phase 2|40|Anticipated|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 17:59:27.745752|2017-02-18 17:59:27.745752
NCT00060021|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2015-04-29|||March 2003||2003-03-01|April 2004|2004-04-01||||||||Interventional|||Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation|A Randomized, Placebo-Controlled, Blinded Study Of Acupuncture Therapy In Mucositis-Related Pain In Patients Undergoing Hematopoietic Stem Cell Transplantation|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:27.860559|2017-02-18 17:59:27.860559
NCT00060008|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2014-04-03|2014-04-01||April 2002||2002-04-01|April 2014|2014-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma|Novel Imaging Modalities For Plexiform Neurofibromas|Terminated||N/A|18|Actual|Children's Hospital of Philadelphia|The sample size was modest. It is possible that with increased sample size, if the correlation estimate holds, it will become statistically significant.|1||Study was closed early due to poor accrual.|f||||f||||||||||2017-02-18 17:59:27.964141|2017-02-18 17:59:27.964141
NCT00059995|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-05-29|||January 2003||2003-01-01|November 2009|2009-11-01|November 2009|Actual|2009-11-01|October 2007|Actual|2007-10-01||Interventional|||MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma|Phase I/II Open Label, Dose-Escalating Study of MDX-060 Administered Weekly for 4 Weeks in Patients With Refractory/Relapsed CD30 Lymphoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:28.184229|2017-02-18 17:59:28.184229
NCT00059982|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-06-21|||July 2003||2003-07-01|August 2004|2004-08-01|August 2005|Actual|2005-08-01|||||Interventional|||Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer|Phase II Trial Of Perifosine In Locally Advanced, Unresectable Or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:28.272233|2017-02-18 17:59:28.272233
NCT00059943|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-01-15|||September 2002||2002-09-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer|Pharmacokinetics of Weekly Docetaxel in Patients Age 65 and Older With Metastatic Breast or Lung Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:59:28.368786|2017-02-18 17:59:28.368786
NCT00059930|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-09-26|||January 2003||2003-01-01|September 2016|2016-09-01|June 2017|Anticipated|2017-06-01|June 2017|Anticipated|2017-06-01||Interventional|||Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer|A Phase I Study Of Hepatic Arterial Infusion With Floxuridine And Dexamethasone In Combination With Intravenous Oxaliplatin Plus 5-Fluorouracil And Leucovorin As Adjuvant Treatment After Resection Of Hepatic Metastases From Colorectal Cancer|Active, not recruiting||Phase 1|38|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:59:28.476277|2017-02-18 17:59:28.476277
NCT00059917|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-05-29|||January 2003||2003-01-01|April 2005|2005-04-01|May 2005|Actual|2005-05-01|||||Interventional|||Polyglutamate Camptothecin in Treating Patients With Advanced Cancer|Phase I Study of CT-2106 in Patients With Advanced Malignancy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:28.596374|2017-02-18 17:59:28.596374
NCT00059904|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-07-17|||January 2003||2003-01-01|July 2004|2004-07-01|June 2004|Actual|2004-06-01|||||Interventional|||Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma|An Open-Labeled, Phase II Study of Rituximab in Combination With Recombinant IL-2 for Relapsed or Refractory Non-Hodgkin's Lymphoma of Intermediate- or High-Grade Histology|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:28.699632|2017-02-18 17:59:28.699632
NCT00059891|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-02-26|||January 2003||2003-01-01|February 2013|2013-02-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer|Total Anorectal Reconstruction With The American Medical Systems, Inc. Acticon Neosphincter Prosthesis After Abdominoperineal Resection|Completed||N/A|4|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:59:28.791438|2017-02-18 17:59:28.791438
NCT00059878|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-06-17|||August 2003||2003-08-01|July 2004|2004-07-01|January 2005|Actual|2005-01-01|||||Interventional|||Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections|A Prospective, Randomized, Double-Blind, Multicenter Pilot Study Of The Safety And Efficacy Of Interferon Gamma- 1b (IFN-y 1b) Plus Voriconazole Versus Placebo Plus Voriconazole In The Treatment Of Invasive Aspergillosis And Other Filamentous Fungal Infections|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:28.900932|2017-02-18 17:59:28.900932
NCT00059865|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-12-05|||January 2004||2004-01-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer|Phase I/II Trial Of Gemcitabine And ALIMTA In Patients With Measurable Or Evaluable, Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Or Vater) And Gallbladder Carcinoma|Completed||Phase 1/Phase 2|68|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:59:28.991773|2017-02-18 17:59:28.991773
NCT00059852|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-12-05|||June 2003||2003-06-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|August 2006|Actual|2006-08-01||Interventional|||Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane|A Phase II Study of OSI-774 (Tarceva) and Gemcitabine for Patients With Metastatic Breast Cancer|Completed||Phase 2|61|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:59:29.149546|2017-02-18 17:59:29.149546
NCT00059124|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-17|2013-07-10|||March 2003||2003-03-01|July 2013|2013-07-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||Aortic Calcium: Epidemiology and Progression -- Ancillary to MESA|Aortic Calcium: Epidemiology and Progression|Completed||N/A|1980|Actual|University of California, San Diego|||1||f||||f||||||||||2017-02-18 17:59:43.128849|2017-02-18 17:59:43.128849
NCT00059839|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2014-09-10|2013-06-28||November 2003||2003-11-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|December 2009|Actual|2009-12-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma|A Phase III Trial of Treatment of Advanced-Stage Anaplastic Large Cell Lymphoma (ALCL) With Standard APO (Doxorubicin, Prednisone, Vincristine) Versus Consolidation With a Regimen Including Vinblastine|Completed||Phase 3|129|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 17:59:29.286602|2017-02-18 17:59:29.286602
NCT00059826|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2016-12-05|||March 2003||2003-03-01|December 2016|2016-12-01|February 2011|Actual|2011-02-01|July 2007|Actual|2007-07-01||Interventional|||Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer|A Phase II Study of Interferon-Based Adjuvant Chemoradiation in Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 2|89|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 17:59:30.578213|2017-02-18 17:59:30.578213
NCT00059813|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-08-23|||August 2003||2003-08-01|August 2013|2013-08-01||||June 2005|Actual|2005-06-01||Interventional|||Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer|A Phase II Trial of G3139 (Genasense) Anti-Bcl-2 Antisense Oligonucleotide Plus Alpha-Interferon in Metastatic Renal Cancer|Completed||Phase 2|41|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:30.71452|2017-02-18 17:59:30.71452
NCT00059800|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2013-06-25|||May 2002||2002-05-01|December 2005|2005-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Boron Neutron Capture Therapy in Treating Patients With Melanoma|A Phase II Trial For Neutron Capture Therapy In Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:30.827499|2017-02-18 17:59:30.827499
NCT00059787|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2015-10-29|2015-04-29||April 2003||2003-04-01|May 2013|2013-05-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma|Phase II Study of Erlotinib Plus Carboplatin and Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:59:30.922019|2017-02-18 17:59:30.922019
NCT00059761|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-06|2015-11-14|||March 2003||2003-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|March 2009|Actual|2009-03-01||Interventional|||Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Phase I Study of Irinotecan and Cisplatin in Combination With Twice Daily Thoracic Radiotherapy (45 Gy) or Once Daily Thoracic Radiotherapy (70 Gy) for Patients With Limited Stage Small Cell Lung Cancer|Completed||Phase 1|36|Actual|Radiation Therapy Oncology Group||6|||f||||t||||||||||2017-02-18 17:59:31.250957|2017-02-18 17:59:31.250957
NCT00059748|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-05|2017-01-24|||April 30, 2003||2003-04-30|September 22, 2016|2016-09-22||||||||Observational|||Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID / CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)|Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, CRMO, Still s Disease, Behcet s Disease, and Other Undifferentiated Autoinflammatory Diseases)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:31.423259|2017-02-18 17:59:31.423259
NCT00059735|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-05|2008-02-29|||May 2002||2002-05-01|February 2008|2008-02-01|December 2003|Actual|2003-12-01|||||Interventional|||A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma|A Phase II Study of E7070 in Patients With Progressive Inoperable and/or Metastatic Renal Cell Carcinoma (RCC)|Completed||Phase 2|30|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 17:59:31.524122|2017-02-18 17:59:31.524122
NCT00059722|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-02|2016-08-22|||May 2003||2003-05-01|August 2016|2016-08-01|June 2007|Actual|2007-06-01|||||Interventional|||This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.|A Phase II, Randomized Double-blind, 2-part, Multicenter Study to Compare the Efficacy of ZD6474 With the Efficacy of ZD1839 (Iressa™) in Subjects With Locally Advanced or Metastatic (IIIB/IV) Non-small Cell Lung Cancer After Failure of First-line Platinum-based Chemotherapy and to Assess the Activity of ZD6474 in Subjects Following Failure of Treatment With ZD1839.|Completed||Phase 2|160||Sanofi|||||||||||||||||||2017-02-18 17:59:31.620275|2017-02-18 17:59:31.620275
NCT00059709|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-02|2007-04-02|||August 2000||2000-08-01|January 2006|2006-01-01||||||||Interventional|||Learning to Resolve Family Conflict|Understanding and Learning How to Resolve Family Conflict|Completed||N/A|360||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:31.766963|2017-02-18 17:59:31.766963
NCT00059696|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-01|2016-09-23|||December 1999||1999-12-01|May 2011|2011-05-01||||November 2004|Actual|2004-11-01||Interventional|||Treatment for Movement Problems in Elderly Stroke Patients|A Treatment for Excess Motor Disability in the Aged|Completed||Phase 2|80|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:31.844128|2017-02-18 17:59:31.844128
NCT00059683|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-01|2014-09-29|||January 2003||2003-01-01|September 2014|2014-09-01|October 2009|Actual|2009-10-01|November 2007|Actual|2007-11-01||Interventional|||Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women|Vaginal Ultrasound Cerclage Trial|Completed||N/A|300|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||t||||||||||2017-02-18 17:59:31.941814|2017-02-18 17:59:31.941814
NCT00059670|ClinicalTrials.gov processed this data on February 17, 2017|2003-05-01|2010-01-12||||||January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia|Comparison of Two Therapies for UES Dysphagia|Completed||N/A|204||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:32.058734|2017-02-18 17:59:32.058734
NCT00059657|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-29|2006-05-17|||August 2001||2001-08-01|May 2006|2006-05-01|November 2005||2005-11-01|||||Interventional|||Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease|A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of CirculaseTM in Conjunction With Peripheral Revascularization for the Treatment of Critical Leg Ischemia|Completed||Phase 3|280||Mitsubishi Tanabe Pharma Corporation|||||||||||||||||||2017-02-18 17:59:32.153145|2017-02-18 17:59:32.153145
NCT00059644|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-29|2005-06-23|||July 2001||2001-07-01|June 2005|2005-06-01|June 2004||2004-06-01|||||Interventional|||Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease|A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of CirculaseTM for the Treatment of Critical Leg Ischemia|Terminated||Phase 3|560||Mitsubishi Tanabe Pharma Corporation|||||||||||||||||||2017-02-18 17:59:32.264565|2017-02-18 17:59:32.264565
NCT00059631|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-29|2015-06-19|||March 2003||2003-03-01|June 2015|2015-06-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone|Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone in Patients With Advanced Androgen-Independent Prostate Cancer (AI-PCa)|Completed||Phase 1|42|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:59:32.371237|2017-02-18 17:59:32.371237
NCT00059618|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-29|2012-08-01|||April 2003||2003-04-01|August 2012|2012-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer|A Phase I Study Evaluating the Safety and Tolerability of PS-341(Bortezomib)and Carboplatin in Patients With Platinum- and Taxane-Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer|Completed||Phase 1|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:59:32.485439|2017-02-18 17:59:32.485439
NCT00059605|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-29|2012-02-21|||March 2003||2003-03-01|February 2012|2012-02-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer|Phase I Study Of Intravenous DOTAP:Cholesterol-Fus1 Liposome Complex (DOTAP:Chol-fus1) In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy|Completed||Phase 1|32|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 17:59:32.599487|2017-02-18 17:59:32.599487
NCT00059592|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-29|2005-06-23|||May 1998||1998-05-01|May 2005|2005-05-01||||||||Interventional|||Valacyclovir in Immunocompromised Children|Valacyclovir in Immunocompromised Children|Completed||Phase 1|30||Baylor College of Medicine|||||||||||||||||||2017-02-18 17:59:32.703124|2017-02-18 17:59:32.703124
NCT00059579|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-29|2017-01-24|||April 24, 2003||2003-04-24|November 12, 2010|2010-11-12|November 12, 2010||2010-11-12|||||Observational|||Brain Regulation of Emotions in People With Depression and Anhedonia|Functional MRI Study of Brain Mechanism Mediating Anhedonia in Major Depression|Completed||N/A|163|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:32.776928|2017-02-18 17:59:32.776928
NCT00059553|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-28|2009-06-17|||May 2000||2000-05-01|August 2005|2005-08-01|January 2005||2005-01-01|||||Interventional|||Retraining Walking After Spinal Cord Injury|Activity-Dependent Plasticity After Spinal Cord Injury|Unknown status|Active, not recruiting|Phase 2/Phase 3|16||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:32.872595|2017-02-18 17:59:32.872595
NCT00059540|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-28|2016-09-20|||May 1993||1993-05-01|September 2016|2016-09-01|March 2011|Actual|2011-03-01|March 1995|Actual|1995-03-01||Observational|MLS||The Maternal Lifestyle Study (MLS)|The Maternal Lifestyle Study|Completed||Phase 4|11811|Actual|NICHD Neonatal Research Network|||1||f||||t||||||||||2017-02-18 17:59:33.090911|2017-02-18 17:59:33.090911
NCT00059527|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-28|2014-10-28|||March 1999||1999-03-01|August 2005|2005-08-01|May 2003||2003-05-01|||||Interventional|||Healthy Youth Places: A Program to Promote Nutrition and Physical Activity in Adolescents|Youth Environments Promoting Nutrition and Activity|Completed||Phase 4|2000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:33.2207|2017-02-18 17:59:33.2207
NCT00059514|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-28|2013-10-08|||May 2000||2000-05-01|April 2003|2003-04-01|April 2005||2005-04-01|||||Interventional|||Tobacco Use Among Arab American Youth|Arab American Youth: Tobacco Use and Intervention|Unknown status|Recruiting|N/A|4000|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:33.314022|2017-02-18 17:59:33.314022
NCT00059501|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-26|2008-03-03|||April 2003||2003-04-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Postural Control in the Elderly|Cortical Control of Postural Stability in the Elderly|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:33.404168|2017-02-18 17:59:33.404168
NCT00059475|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-26|2012-10-17|2012-03-30||April 2003||2003-04-01|October 2012|2012-10-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Peptide Vaccination for Patients at High Risk for Recurrent Melanoma|Randomized Comparison of Peptide Immunization in Patients at High Risk for Recurrence of Melanoma|Completed||Phase 2|138|Actual|National Institutes of Health Clinical Center (CC)||8|||f||||f||||||||||2017-02-18 17:59:33.491167|2017-02-18 17:59:33.491167
NCT00059462|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-25|2014-12-18|||December 2002||2002-12-01|December 2014|2014-12-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection|Phase I/II Randomized, Double Blind, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Subcutaneous Bay 50-4798 Administration in Patients With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to Patients on HAART Alone.|Completed||Phase 1/Phase 2|56|Actual|Bayer||2|||f||||||||||||||2017-02-18 17:59:35.330924|2017-02-18 17:59:35.330924
NCT00059449|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-25|2010-01-12||||||January 2010|2010-01-01||||||||Observational|||Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis|Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis|Completed||N/A|372|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:35.448475|2017-02-18 17:59:35.448475
NCT00059436|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-25|2016-09-23|||October 1999||1999-10-01|May 2011|2011-05-01||||September 2004|Actual|2004-09-01||Interventional|||Mental Effort and Muscle Strength|Mental-effort Effect on Large Muscle Strengthening|Completed||Phase 1|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:35.523436|2017-02-18 17:59:35.523436
NCT00059423|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-25|2017-01-24|||April 22, 2003||2003-04-22|August 11, 2016|2016-08-11||||||||Observational|||Natural History Study for BEN|Natural History and Molecular Characterization of Benign Ethnic Neutropenia in Individuals of African Descent|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:35.614564|2017-02-18 17:59:35.614564
NCT00059410|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-24|2009-12-10|||January 2003||2003-01-01|February 2008|2008-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Observational|||Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II|Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II|Completed||N/A|210||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:59:35.722189|2017-02-18 17:59:35.722189
NCT00059397|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-24|2010-03-17|||April 2003||2003-04-01|March 2010|2010-03-01||||||||Observational|||Hepatitis C: Grading and Staging by MR|Hepatitis C: Grading and Staging by MR|Completed||N/A|80|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:35.817254|2017-02-18 17:59:35.817254
NCT00059384|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-23|2008-09-16|||January 2003||2003-01-01|July 2007|2007-07-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Alternative Dosing Strategy for Anti-HIV Drugs|Concentration-Controlled Antiretroviral Therapy in Persons Experiencing Persistent Viremia|Completed||Phase 4|66||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 17:59:35.895707|2017-02-18 17:59:35.895707
NCT00059371|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-23|2008-05-28|||February 2002||2002-02-01|September 2007|2007-09-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Male Circumcision and HIV Rates in Kenya|Trial of Male Circumcision to Reduce HIV Incidence|Completed||Phase 3|2887|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||f||||||||||2017-02-18 17:59:35.993748|2017-02-18 17:59:35.993748
NCT00059358|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-23|2009-08-06|||September 2001||2001-09-01|August 2009|2009-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Zidovudine Levels in HIV Infected Patients Being Treated for HCV|Pharmacological Interactions Between Zidovudine and Ribavirin in HCV-HIV Co-Infected Patients Treated With Rebetron or Peg-Intron Plus Ribavirin|Completed||Phase 1/Phase 2|16|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 17:59:36.10662|2017-02-18 17:59:36.10662
NCT00059345|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-23|2013-11-15|||September 2002||2002-09-01|November 2013|2013-11-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Interaction Between Patient and Healthcare Provider: Response to Acupuncture in Knee Osteoarthritis|The Impact of Patient-Provider Interaction on Response to Acupuncture|Completed||N/A|639|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 17:59:36.226208|2017-02-18 17:59:36.226208
NCT00059332|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-23|2015-07-24|2015-06-09||January 2005||2005-01-01|June 2015|2015-06-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|FAST-MAG||Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial|Field Administration of Stroke Therapy-Magnesium Trial: A Randomized, Double-Blind, Placebo Controlled Trial of Neuroprotective Magnesium Sulfate Therapy for Acute Stroke Initiated Within 2 Hours of Onset by Paramedics in the Field|Completed||Phase 3|1700|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 17:59:36.369052|2017-02-18 17:59:36.369052
NCT00059319|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-23|2007-05-18|||January 1999||1999-01-01|May 2007|2007-05-01||||||||Interventional|||Reduced Manipulation of the Aorta and Neurobehavioral Outcome Trial||Completed||Phase 3|300||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 17:59:37.976726|2017-02-18 17:59:37.976726
NCT00059306|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-23|2013-04-02|||February 2003||2003-02-01|April 2013|2013-04-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|SPS3||Secondary Prevention of Small Subcortical Strokes Trial|Secondary Prevention of Small Subcortical Strokes (SPS3) Trial|Completed||Phase 3|3020|Actual|University of British Columbia||2|||f||||t||||||||||2017-02-18 17:59:38.063342|2017-02-18 17:59:38.063342
NCT00059293|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-22|2008-07-23|||September 2002||2002-09-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 17:59:38.235297|2017-02-18 17:59:38.235297
NCT00059280|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-22|2014-02-04|||April 2003||2003-04-01|July 2006|2006-07-01|September 2005|Actual|2005-09-01|June 2005|Actual|2005-06-01||Interventional|||A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease|An Open-label, Multicenter, Multinational Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Acid Alpha-glucosidase Treatment in Patients Less Than 6 Months Old With Infantile-onset Pompe Disease|Completed||Phase 2/Phase 3|16|Actual|Sanofi||1|||f||||||||||||||2017-02-18 17:59:38.33933|2017-02-18 17:59:38.33933
NCT00059267|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-22|2010-01-12|||June 2001||2001-06-01|January 2010|2010-01-01||||||||Observational|||Prevention of Recurrent Hepatitis B After Liver Transplantation|Prevention of Recurrent Hepatitis B After Liver Transplantation|Completed||N/A|500||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:38.457714|2017-02-18 17:59:38.457714
NCT00059254|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-22|2010-01-12|||September 2000||2000-09-01|January 2010|2010-01-01|April 2005||2005-04-01|||||Interventional|||Differential Metabolism of Dietary Fatty Acids|Differential Metabolism of Dietary Fatty Acids|Completed||Phase 1|44||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:38.533512|2017-02-18 17:59:38.533512
NCT00059241|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-22|2005-06-23|||July 2000||2000-07-01|April 2003|2003-04-01||||||||Interventional|||"The Reach For Health Program: Delaying Sexual Activity in Children"|Reach For Health--Middle Childhood Risk Prevention Study|Unknown status|Recruiting|Phase 2|1200||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:38.618946|2017-02-18 17:59:38.618946
NCT00059228|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-22|2017-01-24|||April 17, 2003||2003-04-17|November 15, 2016|2016-11-15|November 15, 2016|Actual|2016-11-15|November 15, 2016|Actual|2016-11-15||Interventional|||Clinical Trial of Estrogen for Postpartum Depression|The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness|Terminated||Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 17:59:38.702341|2017-02-18 17:59:38.702341
NCT00059215|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-21|2010-05-21|2010-04-19||April 2003||2003-04-01|May 2010|2010-05-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)|A Double-Blind, Randomized, Multicenter, Dose-Ranging Trial of CS-747 Compared With Clopidogrel in Subjects Undergoing Percutaneous Coronary Intervention|Completed||Phase 2|905|Actual|Eli Lilly and Company||4|||f||||f||||||||||2017-02-18 17:59:38.817968|2017-02-18 17:59:38.817968
NCT00059202|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-21|2013-10-31||||||October 2013|2013-10-01||||||||Interventional|||Trial of High-dose Urso in Primary Sclerosing Cholangitis|Multicentered Randomized Trial of High-dose Urso in Primary Sclerosing Cholangitis|Completed||Phase 2/Phase 3|150||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:42.874509|2017-02-18 17:59:42.874509
NCT00059189|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-19|2008-03-03|||April 2003||2003-04-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Brain Plasticity of Verbal Memory in the Blind|Cross-Modal Plasticity of Verbal Memory in the Blind|Completed||N/A|85||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:42.97511|2017-02-18 17:59:42.97511
NCT00059137|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-18|2008-03-03|||April 2003||2003-04-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Observational|||Breathing Cycle Biofeedback During Computed Tomography Procedures|Respiratory Cycle Biofeedback During CT Guided Procedures|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:43.058689|2017-02-18 17:59:43.058689
NCT00059046|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-16|2008-03-03|||April 2003||2003-04-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Brain Imaging of Serotonin Transporters in the Brain|Kinetic Studies in Whole Body and Brain of [11C]DASB PET Imaging of Serotonin Transporters|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:43.35233|2017-02-18 17:59:43.35233
NCT00059033|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-16|2017-01-24|||April 10, 2003||2003-04-10|October 6, 2016|2016-10-06||||||||Observational|||Evaluation of Primary Chronic Autonomic Failure|Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure|Recruiting||N/A|435|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:43.436454|2017-02-18 17:59:43.436454
NCT00059020|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-16|2008-03-03|||April 2003||2003-04-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Observational|||The Role of Gene Changes in Brain Tumor Formation and Growth|EGF Polymorphisms and Gliomagenesis|Completed||N/A|344||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:43.530893|2017-02-18 17:59:43.530893
NCT00058994|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-15|2012-11-28|||March 2003||2003-03-01|August 2008|2008-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD|An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-related Macular Degeneration|Completed||Phase 3|||Alcon Research|||||f||||f||||||||||2017-02-18 17:59:43.616587|2017-02-18 17:59:43.616587
NCT00058981|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-15|2009-03-18|||October 2002||2002-10-01|March 2009|2009-03-01|May 2007|Actual|2007-05-01|March 2007|Actual|2007-03-01||Interventional|||Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Tolerability as Well as the Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in LADA Subjects|Terminated||Phase 2|100||DeveloGen Israel, Ltd.|||||||||||||||||||2017-02-18 17:59:43.972139|2017-02-18 17:59:43.972139
NCT00058968|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-15|2007-05-16|||October 2002||2002-10-01|May 2007|2007-05-01|March 2005|Actual|2005-03-01|||||Interventional|||A Study for the Treatment of Painful Diabetic Neuropathy|Duloxetine Versus Placebo in the Treatment of Patients With Painful Diabetic Neuropathy|Completed||Phase 3|660||Eli Lilly and Company|||||||||||||||||||2017-02-18 17:59:44.05762|2017-02-18 17:59:44.05762
NCT00058955|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-15|2008-09-09|||August 2003||2003-08-01|September 2008|2008-09-01|March 2005||2005-03-01|||||Interventional|||Physiological, Behavioral and Subjective Effects of Drugs (GHB)|Physiological, Behavioral and Subjective Effects of Drugs (GHB)|Completed||Phase 1|20|Anticipated|Orphan Medical||4|||f||||f||||||||||2017-02-18 17:59:44.158236|2017-02-18 17:59:44.158236
NCT00058942|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-15|2009-12-09|||January 2000||2000-01-01|November 2006|2006-11-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||A Trial of Tap Water Treatment in the Elderly|A Randomized Trial of Tap Water Treatment in the Elderly|Completed||N/A|810||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:59:44.274233|2017-02-18 17:59:44.274233
NCT00058929|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-14|2013-03-05|||October 2002||2002-10-01|March 2013|2013-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension|A Multicenter, Randomized, Parallel Placebo-Controlled Study of the Safety and Efficacy of Subcutaneous Remodulin® Therapy After Transition From Flolan® in Patients With Pulmonary Arterial Hypertension|Completed||Phase 4|39||United Therapeutics|||||f||||f||||||||||2017-02-18 17:59:44.372849|2017-02-18 17:59:44.372849
NCT00058903|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-14|2010-01-12|||April 2003||2003-04-01|January 2010|2010-01-01|March 2005||2005-03-01|||||Interventional|||Treatment of Cholestatic Pruritus With Sertraline|Treatment of Cholestatic Pruritus With Sertraline|Completed||Phase 2|40|Anticipated|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 17:59:44.467386|2017-02-18 17:59:44.467386
NCT00058890|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-14|2010-03-17|||November 2000||2000-11-01|March 2010|2010-03-01|January 2004||2004-01-01|||||Interventional|||Gabapentin to Treat Itch in Patients With Liver Disease|Study of Gabapentin for the Pruritus of Cholestasis|Completed||Phase 3|30||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:44.552476|2017-02-18 17:59:44.552476
NCT00058877|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-14|2010-03-17||||||March 2010|2010-03-01||||||||Observational|||Familial Aggregation of Barrett's Esophagus|Familial Aggregation of Barrett's Esophagus|Unknown status|Active, not recruiting|N/A|650||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 17:59:44.6568|2017-02-18 17:59:44.6568
NCT00058864|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-14|2009-02-26|||September 2001||2001-09-01|February 2009|2009-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The HIP Impact Protection Program (HIP PRO)|Trochanteric Padding to Prevent Hip Fractures|Completed||N/A|546||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 17:59:44.73047|2017-02-18 17:59:44.73047
NCT00058851|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-14|2009-08-17|||January 2003||2003-01-01|August 2009|2009-08-01|November 2007|Actual|2007-11-01|||||Interventional|||Massage Therapy for Breast Cancer Treatment-Related Swelling of the Arms|Massage Therapy for Breast Cancer-Related Lymphedema|Completed||Phase 2|88|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 17:59:44.812405|2017-02-18 17:59:44.812405
NCT00058838|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-14|2006-06-06|||April 2003||2003-04-01|June 2006|2006-06-01|September 2004||2004-09-01|||||Interventional|||Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease|A Phase III, Double-Blind, Placebo-Controlled, Fixed-Dose Response Study Comparing the Efficacy and Safety of Sumanirole Versus Placebo in Patients With Early Parkinson's Disease.|Completed||Phase 3|854||Pfizer|||||||||||||||||||2017-02-18 17:59:44.912548|2017-02-18 17:59:44.912548
NCT00058825|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2016-09-20|2015-09-23||August 2000||2000-08-01|September 2016|2016-09-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|HIMSUM||Stem Cell Transplant for Hematologic Diseases|Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients With Hematologic Diseases Using Haploidentical Family Donors and Sub-Myeloablative Conditioning With Campath 1H|Terminated||Phase 1/Phase 2|27|Actual|Baylor College of Medicine||1||Slow accrual due to practice changes meant study would take too long to finish|f||||t||||||||||2017-02-18 17:59:45.217631|2017-02-18 17:59:45.217631
NCT00058812|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2015-01-27|||May 1993||1993-05-01|January 2015|2015-01-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|ETNA||Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts|Administration of EBV Specific Cytotoxic T Lymphocytes to Recipients of Mismatched-Related or Phenotypically Similar Unrelated Donor Marrow Grafts|Completed||Phase 1|69|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:59:45.788039|2017-02-18 17:59:45.788039
NCT00058799|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2010-07-27|||June 1999||1999-06-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine|Treatment of High Risk Acute Leukemia With CD40 Ligand and IL-2 Gene Modified Autologous Skin Fibroblasts and Tumor Cells|Completed||Phase 1|11|Actual|Baylor College of Medicine||1|||t||||f||||||||||2017-02-18 17:59:45.892861|2017-02-18 17:59:45.892861
NCT00058786|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2012-05-21|||December 2002||2002-12-01|May 2012|2012-05-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|CLIMAT||Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells|Treatment of Chronic Lymphocytic B-Leukemia (B-CLL) With Human IL-2 Gene Modified and Human CD40 Ligand-Expressing Autologous Tumor Cells|Completed||Phase 1|9|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:59:45.990364|2017-02-18 17:59:45.990364
NCT00058773|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2012-11-05|||January 1996||1996-01-01|November 2012|2012-11-01|August 2006|Actual|2006-08-01|April 2002|Actual|2002-04-01||Interventional|ANGELA||Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease|Administration of Autologous Neomycin Resistant Gene Marked EBV Specific Cytotoxic T-Lymphocytes as Therapy for Patients Receiving Autologous Bone Marrow Transplant for Relapsed EBV-Positive Lymphoma.|Terminated||Phase 1|5|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 17:59:46.089393|2017-02-18 17:59:46.089393
NCT00058760|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2005-06-23|||February 2001||2001-02-01|March 2003|2003-03-01|January 2006||2006-01-01|||||Interventional|||Delaying Sexual Activity in African American Adolescent Girls|A Randomized Controlled Trial of the NIA Intervention|Unknown status|Recruiting|Phase 1|240||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 17:59:46.196881|2017-02-18 17:59:46.196881
NCT00058747|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2012-09-06|||March 2003||2003-03-01|September 2012|2012-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™|Phase II Exploratory Study Of AG-858 Plus Gleevec™ In Patients With Chronic Myelogenous Leukemia (CML) In Chronic Phase Who Are Cytogenetically Positive After Treatment With Gleevec™|Terminated||Phase 2|40||Agenus Inc.||||Business decision of the sponsor|||||||||||||||2017-02-18 17:59:46.279881|2017-02-18 17:59:46.279881
NCT00058734|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2007-08-23|||November 2000||2000-11-01|August 2007|2007-08-01||||||||Interventional|||Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients|Immune Responses to Antigen-Bearing Dendritic Cells in HIV-Infected Individuals|Completed||Phase 1|5|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 17:59:46.388139|2017-02-18 17:59:46.388139
NCT00058721|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2008-03-03|||April 2003||2003-04-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease|SPECT Evaluation of Nicotinic Cholinergic Receptors in Parkinson's Disease|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:46.483964|2017-02-18 17:59:46.483964
NCT00058695|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2017-01-24|||April 4, 2003||2003-04-04|October 21, 2015|2015-10-21|October 21, 2015||2015-10-21|||||Observational|||Genetic Factors in Age-Related Macular Degeneration|Evaluation of Single Nucleotide Polymorphism (SNP) in Patients With and Subjects Without Age-Related Macular Degeneration (AMD)|Terminated||N/A|477|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:46.569532|2017-02-18 17:59:46.569532
NCT00058682|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-11|2008-03-03|||April 2003||2003-04-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Anidulafungin Versus Fluconazole in the Treatment of Candidemia|A Phase III, Double Blind, Randomized, Multi-Center Study of the Safety and Efficacy of Anidulafungin VS. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis and Prevention of Complications|Completed||Phase 3|248||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 17:59:46.663096|2017-02-18 17:59:46.663096
NCT00058669|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-10|2016-01-04|||March 2003||2003-03-01|January 2016|2016-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Observational|||CVD Risk Factors and Sexual Identity in Women|CVD Risk Factors and Sexual Identity in Women|Completed||N/A|1174|Actual|University of Pittsburgh|||1||f||||f||||||Samples Without DNA|"~     urine, plasma,~   "|||2017-02-18 17:59:46.752743|2017-02-18 17:59:46.752743
NCT00058656|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-08|2006-11-20|||March 2003||2003-03-01|January 2005|2005-01-01||||||||Interventional|||Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients|A Phase I/II Study of Xcellerated T Cells(tm) in Patients With Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 1/Phase 2|18||Xcyte Therapies|||||||||||||||||||2017-02-18 17:59:46.832093|2017-02-18 17:59:46.832093
NCT00058617|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-08|2017-02-13|||January 1996||1996-01-01|February 2017|2017-02-01|July 2014|Actual|2014-07-01|August 2011|Actual|2011-08-01||Interventional|||Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL|Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma|Completed||Phase 1|13|Actual|Baylor College of Medicine||1|||f||||t|t|f||||||||2017-02-18 17:59:46.924772|2017-02-18 17:59:46.924772
NCT00058604|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-08|2009-04-09|||January 2001||2001-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|EUCLID||Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).|Autologous EBV Specific CTLs for Prophylaxis and Therapy of EBV Lymphoma Post Solid Organ Transplant|Completed||Phase 1|14|Anticipated|Baylor College of Medicine||1|||t||||t||||||||||2017-02-18 17:59:47.035173|2017-02-18 17:59:47.035173
NCT00058591|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-08|2009-04-09|||January 2000||2000-01-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|SCAEBV||Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)|Autologous EBV Specific CTLs for Therapy of Severe Chronic EBV Infection|Completed||Phase 1|18|Anticipated|Baylor College of Medicine||1|||t||||t||||||||||2017-02-18 17:59:47.121008|2017-02-18 17:59:47.121008
NCT00058578|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-08|2007-04-09|||June 1999||1999-06-01|April 2007|2007-04-01|June 2004||2004-06-01|||||Interventional|||Stem Cell Transplant to Treat Patients With Systemic Sclerosis|Autologous T-Cell Depleted Peripheral Blood Stem Cell Transplantation for the Treatment of Selected Patients With Systemic Sclerosis|Completed||Phase 1|24||Baylor College of Medicine|||||||||||||||||||2017-02-18 17:59:47.213027|2017-02-18 17:59:47.213027
NCT00058318|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-10-31|||December 2004||2004-12-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|May 2007|Actual|2007-05-01||Interventional|||S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer|A Phase II Study of IV Gemcitabine and Oral Capecitabine in Patients With Advanced Renal Cell Cancer|Completed||Phase 2|43|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 17:59:49.926722|2017-02-18 17:59:49.926722
NCT00058552|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-08|2015-06-02|2015-06-02|||||June 2015|2015-06-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional||All the participants who received at least 1 dose of study drug were included in the analysis.|A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer|A Phase II, Open-label, Multicenter Study to Evaluate the Effect of Tumor-based HER2 Activation on the Efficacy of rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced, Refractory or Recurrent Ovarian Cancer|Completed||Phase 2|129|Actual|Genentech, Inc.|||||||||||||||||||2017-02-18 17:59:47.305899|2017-02-18 17:59:47.305899
NCT00058539|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-08|2015-06-02|2015-06-02||April 2003||2003-04-01|June 2015|2015-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional||All the participants who received at least 1 dose of study drug were included in the analysis.|Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer|A Phase II, Open-Label, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Omnitarg (Pertuzumab) in Subjects With Castration-Resistant Prostate Cancer|Completed||Phase 2|42|Actual|Genentech, Inc.|||||||||||||||||||2017-02-18 17:59:48.082804|2017-02-18 17:59:48.082804
NCT00058526|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-07-18|||March 2003||2003-03-01|July 2013|2013-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer|A Multicenter Phase I Open-label Dose-escalation Vaccine Trial of dHER2 Protein With AS15 Adjuvant in HER2-overexpressing Patients With High-risk Breast Cancer|Completed||Phase 1|61|Actual|GlaxoSmithKline||4|||f||||||||||||||2017-02-18 17:59:48.410343|2017-02-18 17:59:48.410343
NCT00058487|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-07-17|||December 2001||2001-12-01|October 2006|2006-10-01|January 2007|Actual|2007-01-01|||||Interventional|||Epirubicin and Thalidomide in Treating Patients With Liver Cancer|A Phase II Study Of Epirubicin And Thalidomide In Unresectable Or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:48.524822|2017-02-18 17:59:48.524822
NCT00058474|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-03-22|||July 2004||2004-07-01|March 2016|2016-03-01|May 2016|Anticipated|2016-05-01|August 2013|Actual|2013-08-01||Interventional|||Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer|A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine With or Without Oxaliplatin With Preoperative Radiation Therapy And Continuous Intravenous Infusion Of 5-Fluorouracil With or Without Oxaliplatin In The Treatment Of Patients With Operable Carcinoma Of The Rectum|Active, not recruiting||Phase 3|1608|Actual|NSABP Foundation Inc||4|||f||||t||||||||||2017-02-18 17:59:48.631184|2017-02-18 17:59:48.631184
NCT00058461|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-10-07|||November 2003||2003-11-01|October 2013|2013-10-01||||March 2007|Actual|2007-03-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia|A Phase II Study of Rituximab (IND #7028) and Ifosfamide, Carboplatin and Etoposide (ICE) Chemotherapy in Children With Recurrent/Refractory B-cell (CD20+) Non-Hodgkin Lymphoma and B-cell Acute Lymphoblastic Leukemia|Terminated||Phase 2|82|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:48.755576|2017-02-18 17:59:48.755576
NCT00058448|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-04-16|||October 2004||2004-10-01|April 2013|2013-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)|Phase II Study Of Weekly Docetaxel In Patients With Advanced Epidermoid Carcinoma Of The Penis|Terminated||Phase 2|1|Actual|Southwest Oncology Group||1||Study terminated due to poor patient recruitment.|f||||f||||||||||2017-02-18 17:59:48.879378|2017-02-18 17:59:48.879378
NCT00058435|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-06-04|||December 2002||2002-12-01|June 2013|2013-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|Phase I Trial of the Monoclonal Anti-Idiotype Antibody ACA125 in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 17:59:49.036286|2017-02-18 17:59:49.036286
NCT00058422|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-03-01|||February 2003||2003-02-01|March 2016|2016-03-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma|A Phase II Study of R-CHOP and Ibritumomab Tiuxetan (Zevalin) for Elderly Patients With Previously Untreated Diffuse Large B-Cell Lymphoma|Active, not recruiting||Phase 2|65|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:59:49.148996|2017-02-18 17:59:49.148996
NCT00058396|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-05-29|||October 2002||2002-10-01|December 2009|2009-12-01||||October 2004|Actual|2004-10-01||Interventional|||Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma|Phase I Study Of IDEC-152 (Anti-CD23 Monoclonal Antibody) In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:49.279902|2017-02-18 17:59:49.279902
NCT00058370|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-12-12|||February 2003||2003-02-01|December 2016|2016-12-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma|A Trial Of Radioimmunotherapy, Reduced-Dose External Beam Craniospinal Radiation Therapy With IMRT Boost, And Chemotherapy For Patients With Standard-Risk Medulloblastoma|Active, not recruiting||N/A|6|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 17:59:49.383409|2017-02-18 17:59:49.383409
NCT00058357|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-06-27|||May 2004||2004-05-01|June 2016|2016-06-01|July 2007|Actual|2007-07-01|July 2006|Actual|2006-07-01||Interventional|||Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery|The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study|Completed||Phase 3|30|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:59:49.504523|2017-02-18 17:59:49.504523
NCT00058331|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-07-15|||June 2003||2003-06-01|July 2016|2016-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Epoetin Alfa in Treating Anemia in Patients With Solid Tumors|A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer|Completed||Phase 3|365|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 17:59:49.791741|2017-02-18 17:59:49.791741
NCT00057655|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2015-12-01|||January 2002||2002-01-01|December 2015|2015-12-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Observational|||Behavioral Health Services for Women Receiving Public Assistance|Access to Behavioral Health Services for Women on TANF|Withdrawn||N/A|0|Actual|University of Pennsylvania||||lack of funding|f||||f||||||||||2017-02-18 18:00:05.051582|2017-02-18 18:00:05.051582
NCT00058305|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-01-09|||March 2003||2003-03-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation|A Phase II Study of Bryostatin 1 and Vincristine in Patients With Low or Intermediate Grade Non-Hodgkin's Lymphoma Progressing or Relapsing After a Prior Autologous Bone Marrow or Stem Cell Transplant|Completed||Phase 2|28|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:50.039275|2017-02-18 17:59:50.039275
NCT00058292|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-05-31|||April 2000||2000-04-01|May 2012|2012-05-01|March 2009|Actual|2009-03-01|June 2006|Actual|2006-06-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I Trial Combining IDEC-Y2B8 And High-Dose Beam Chemotherapy With Hematopoietic Progenitor Cell Transplant In Patients With Relapsed Or Refractory B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1|44|Actual|Northwestern University||1|||f||||||||||||||2017-02-18 17:59:50.154493|2017-02-18 17:59:50.154493
NCT00058279|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-06-18|||February 2003||2003-02-01|August 2006|2006-08-01|August 2006|Actual|2006-08-01|||||Interventional|||Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma|MDX-CTLA4 Combined With IL-2 for Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 17:59:50.548007|2017-02-18 17:59:50.548007
NCT00058266|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-07-10||2011-05-19|December 2002||2002-12-01|July 2012|2012-07-01|September 2009|Actual|2009-09-01|November 2006|Actual|2006-11-01||Interventional|||Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy|A Phase II Study Of Genistein In Patients With Localized Prostate Cancer (Molecular Correlates of Soy In Humans)|Terminated||Phase 2|36|Actual|Northwestern University||2||Data Monitoring Committee cited poor accrual.|f||||t||||||||||2017-02-18 17:59:50.651176|2017-02-18 17:59:50.651176
NCT00058253|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2014-06-16|||February 2003||2003-02-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|January 2008|Actual|2008-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AAG, NSC# 330507) in Combination With Docetaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:59:50.76464|2017-02-18 17:59:50.76464
NCT00058240|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2014-06-06|||April 2003||2003-04-01|November 2012|2012-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma|A Dose-Escalation Study of Flavopiridol (NSC 649890) Administered as a 30 Minute Loading Dose Followed by a 4-Hour Infusion in Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)|Completed||Phase 1/Phase 2|84|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:50.881717|2017-02-18 17:59:50.881717
NCT00058227|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-06-03|||April 2003||2003-04-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma|A Phase I Study of Flavopiridol, Fludarabine and Rituximab in Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma|Completed||Phase 1|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:50.998372|2017-02-18 17:59:50.998372
NCT00058214|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2015-02-09|2015-02-09||March 2003||2003-03-01|February 2013|2013-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Perifosine in Treating Patients With Recurrent Prostate Cancer|A Phase II Trial of Perifosine (IND 58,156; NSC# 639966) in Biochemically Recurrent, Hormone Sensitive Prostate Cancer|Terminated||Phase 2|25|Actual|National Cancer Institute (NCI)|Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results.|1||Did not meet interim stopping criteria for continuation to the second stage.|f||||||||||||||2017-02-18 17:59:51.124008|2017-02-18 17:59:51.124008
NCT00058201|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-12-17|||July 2001||2001-07-01|May 2008|2008-05-01|September 2010|Actual|2010-09-01|April 2008|Actual|2008-04-01||Interventional|||Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer|European Study Group For Pancreatic Cancer - Trial 3|Completed||Phase 3|1030|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 17:59:51.404917|2017-02-18 17:59:51.404917
NCT00058188|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-10-21|||March 2003||2003-03-01|October 2016|2016-10-01|December 2017|Anticipated|2017-12-01|December 2016|Anticipated|2016-12-01||Interventional|||Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation|A Phase III Randomized Study of Zolendronate Bisphosphonate Therapy for the Prevention of Bone Loss in Men With Prostate Cancer Receiving Long-Term Androgen Deprivation|Active, not recruiting||Phase 3|70|Anticipated|Northwestern University||2|||f||||t||||||||||2017-02-18 17:59:51.549411|2017-02-18 17:59:51.549411
NCT00058149|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2011-09-20|||March 2003||2003-03-01|April 2004|2004-04-01||||July 2006|Actual|2006-07-01||Interventional|||Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:51.668719|2017-02-18 17:59:51.668719
NCT00058123|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2014-08-11|||March 2003||2003-03-01|August 2014|2014-08-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|||Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma|A Phase II Trial of Poly ICLC in Patients With Recurrent Anaplastic Glioma|Completed||Phase 2|46|Anticipated|Sidney Kimmel Comprehensive Cancer Center||1|||f||||||||||||||2017-02-18 17:59:51.829263|2017-02-18 17:59:51.829263
NCT00058097|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-04-08|||August 2003||2003-08-01|April 2013|2013-04-01||||January 2007|Actual|2007-01-01||Interventional|||Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study of R115777 for the Treatment of Adults With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|54|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:51.944739|2017-02-18 17:59:51.944739
NCT00058084|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-01-14|||March 2003||2003-03-01|January 2013|2013-01-01||||September 2008|Actual|2008-09-01||Interventional|||Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer|A Randomized Phase II Study Of BMS 247550 Or Mitoxantrone And Prednisone In Patients With Taxane Resistant Hormone Refractory Prostate Cancer|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:59:52.055026|2017-02-18 17:59:52.055026
NCT00058071|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-07-08|||March 2003||2003-03-01|July 2007|2007-07-01||||December 2007|Actual|2007-12-01||Interventional|||Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer|A Randomized Phase III Trial of Amifostine vs. No Treatment for Platinum Induced Peripheral Neuropathy|Completed||Phase 3|100|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 17:59:52.187389|2017-02-18 17:59:52.187389
NCT00058058|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-10-23|||February 2001||2001-02-01|April 2004|2004-04-01||||March 2007|Actual|2007-03-01||Interventional|||Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer|MRI Evaluation Of The Contralateral Breast In Women With Recent Diagnosis Of Breast Cancer|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:52.350133|2017-02-18 17:59:52.350133
NCT00058045|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-01-30|||August 2002||2002-08-01|January 2013|2013-01-01||||November 2003|Actual|2003-11-01||Interventional|||Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer|A Phase I Study Of Low-Dose Subcutaneous Interleukin 2 (IL-2) And Stem Cell Factor (r-metHuSCF) For Patients With AIDS And AIDS-Associated Malignancy|Completed||Phase 1|1|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 17:59:52.454751|2017-02-18 17:59:52.454751
NCT00058032|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-12-03|||February 2003||2003-02-01|September 2005|2005-09-01|March 2009|Actual|2009-03-01|||||Interventional|||CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women|United Kingdom Collaborative Trial Of Ovarian Cancer Screening|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 17:59:52.537614|2017-02-18 17:59:52.537614
NCT00058019|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2014-05-07|2013-08-19||February 2003||2003-02-01|October 2011|2011-10-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase II Study of Epothilone B Analog BMS-247550 (NSC 710428) in Patients With Relapsed Aggressive Non-Hodgkin's Lymphomas|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 17:59:52.631713|2017-02-18 17:59:52.631713
NCT00058006|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-06-07|||September 2002||2002-09-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer|Pilot Randomized Trial Of Adjuvant Celecoxib In Patients With Early Stage Head And Neck And Non-Small Cell Lung Cancers|Completed||Phase 2|||Northwestern University|||||f||||||||||||||2017-02-18 17:59:53.231152|2017-02-18 17:59:53.231152
NCT00057993|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-06-07||2011-02-16|July 2002||2002-07-01|June 2012|2012-06-01|August 2004||2004-08-01|August 2004||2004-08-01||Interventional|||Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer|Phase II Study Of Herceptin And Exemestane For Treatment Of Postmenopausal Women With Metastatic Hormone-Responsive, HER2/NEU Positive Breast Cancer|Withdrawn||Phase 2|0|Actual|Northwestern University||||"Unable to accrue subjects to the study after 2 years - closed per request by Data Monitoring~   Committee."|f||||t||||||||||2017-02-18 17:59:53.322963|2017-02-18 17:59:53.322963
NCT00057980|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-06-07||2011-02-18|October 2002||2002-10-01|June 2012|2012-06-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma|Phase I/II Study of Epirubicin and Celecoxib for Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|8|Actual|Northwestern University|||||f||||t||||||||||2017-02-18 17:59:53.40929|2017-02-18 17:59:53.40929
NCT00057967|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-02-23|||July 2000||2000-07-01|February 2016|2016-02-01|August 2018|Anticipated|2018-08-01|August 2017|Anticipated|2017-08-01||Interventional|||Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome|Phase II Trial Of Campath-1H In Patients With Relapsed/Refractory Advanced Mycosis Fungoides or Sezary Syndrome|Active, not recruiting||Phase 2|37|Anticipated|Northwestern University||1|||f||||t||||||||||2017-02-18 17:59:53.508064|2017-02-18 17:59:53.508064
NCT00057954|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-02-11|2013-01-07||June 2005||2005-06-01|February 2013|2013-02-01|May 2011|Actual|2011-05-01|April 2008|Actual|2008-04-01||Interventional|||Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma|A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplantation for the Treatment of Relapsed Non-Hodgkin and Hodgkin Lymphoma|Terminated||Phase 2|6|Actual|Eastern Cooperative Oncology Group||1||Slow accrual|f||||f||||||||||2017-02-18 17:59:53.62199|2017-02-18 17:59:53.62199
NCT00057941|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2014-04-22|2011-04-11||September 2003||2003-09-01|January 2013|2013-01-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional|||Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer|A Randomized Phase II Trial of Combination Anastrozole (NSC #719344) Plus ZD1839 (Iressa, NSC #715055, IND #61187) and of Combination Fulvestrant (NSC #719276) Plus ZD1839 in the Treatment of Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer|Completed||Phase 2|148|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 17:59:54.219155|2017-02-18 17:59:54.219155
NCT00057928|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-06-11|||April 2003||2003-04-01|June 2012|2012-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer|Phase III Randomized Trial of Cisplatin/Paclitaxel Versus Cisplatin/Gemcitabine in Recurrent, Persistent or Metastatic Carcinoma of the Cervix|Withdrawn||Phase 3|0|Actual|Southwest Oncology Group||||lack of accrual|f||||t||||||||||2017-02-18 17:59:54.813252|2017-02-18 17:59:54.813252
NCT00057915|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2014-09-04|||September 2003||2003-09-01|September 2014|2014-09-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer|A Phase I Study of Active Immunotherapy With CAP-1 (6D) and CMVpp65 Peptide-Pulsed, Autologous Dendritic Cells Produced in the Aastromreplicell Cell Production System in Patients With Stage IV CEA Expressing Malignancies|Completed||Phase 1|4|Actual|Duke University||1|||f||||f||||||||||2017-02-18 17:59:55.040917|2017-02-18 17:59:55.040917
NCT00057889|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2012-03-14|||February 2003||2003-02-01|March 2012|2012-03-01|February 2008|Actual|2008-02-01|October 2007|Actual|2007-10-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer|A Phase II Open-Label Study of Single Agent MDX-010 for the Treatment of IL-2 Refractory or IL-2 Ineligible Patients With Stage IV Renal Cancer|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 17:59:55.147818|2017-02-18 17:59:55.147818
NCT00057876|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-02-11|2011-02-28||April 2003||2003-04-01|February 2013|2013-02-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer|A Randomized Phase III Study Of Gemcitabine In Combination With Radiation Therapy Versus Gemcitabine Alone In Patients With Localized, Unresectable Pancreatic Cancer|Completed||Phase 3|74|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-02-18 17:59:55.259737|2017-02-18 17:59:55.259737
NCT00057863|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2015-10-16|2015-10-16||January 2003||2003-01-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer|A Phase II Study of Oxaliplatin in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Cervical Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:56.028374|2017-02-18 17:59:56.028374
NCT00057850|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-02-08|||January 2002||2002-01-01|April 2003|2003-04-01||||July 2003|Actual|2003-07-01||Interventional|||BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Phase I/II Trial of the Epothilone B Analogue BMS 247550 (NSC 710428)/Cisplatin in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 17:59:59.230157|2017-02-18 17:59:59.230157
NCT00057837|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-01-11|2013-01-11||March 2004||2004-03-01|January 2013|2013-01-01|August 2012|Actual|2012-08-01|January 2012|Actual|2012-01-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Randomized Phase II Study: Sequencing Topoisomerase Inhibitors for Extensive Stage Small Cell Lung Cancer (SCLC): Topotecan Sequenced With Etoposide/Cisplatin, and Irinotecan/Cisplatin Sequenced With Etoposide|Completed||Phase 2|140|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 17:59:59.336837|2017-02-18 17:59:59.336837
NCT00057811|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2014-09-10|2014-01-21||June 2004||2004-06-01|September 2014|2014-09-01|July 2014|Actual|2014-07-01|October 2009|Actual|2009-10-01||Interventional|||Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma|A Pilot Study To Determine The Toxicity Of The Addition Of Rituximab To The Induction And Consolidation Phases And The Addition Of Rasburicase To The Reduction Phase In Children With Newly Diagnosed Advanced B-Cell Leukemia/Lymphoma Treated With LMB/FAB Therapy|Completed||Phase 2|97|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:00:00.270064|2017-02-18 18:00:00.270064
NCT00057798|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2011-03-07|||March 2000||2000-03-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|May 2003|Actual|2003-05-01||Interventional|||Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery|Molecular And Genetic Changes In Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) Following Neoadjuvant Chemotherapy With Vinorelbine And Gemcitabine - Phase II Study|Completed||Phase 2|21|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:00:01.419171|2017-02-18 18:00:01.419171
NCT00057785|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-12-30|2014-10-08||February 2003||2003-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|February 2007|Actual|2007-02-01||Interventional||All eligible patients|Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer|A Phase II Study Of Intensity Modulated Radiation Therapy (IMRT) +/- Chemotherapy For Nasopharyngeal Cancer|Completed||Phase 2|68|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:00:01.743951|2017-02-18 18:00:01.743951
NCT00057759|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2015-11-14|||January 2003||2003-01-01|November 2015|2015-11-01||||December 2006|Actual|2006-12-01||Interventional|||Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer|Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life|Completed||N/A|115|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:00:02.175045|2017-02-18 18:00:02.175045
NCT00057746|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2016-04-18|2016-04-18||February 2003||2003-02-01|April 2016|2016-04-01|November 2013|Actual|2013-11-01|May 2009|Actual|2009-05-01||Interventional|||Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer|A Phase II Randomized Trial Of Two Dose Schedules For Delivering Prophylactic Cranial Irradiation For Patients With Limited Disease Small Cell Lung Cancer|Completed||Phase 2|265|Actual|Radiation Therapy Oncology Group|The number of inevaluable patients at one year (e.g., patients dying prior to 1 year, patients not completing the neurocognitive battery at 1 year) was greater than anticipated.|3|||f||||t||||||||||2017-02-18 18:00:02.354376|2017-02-18 18:00:02.354376
NCT00057733|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2013-05-29|||February 2003||2003-02-01|April 2005|2005-04-01|June 2006|Actual|2006-06-01|April 2005|Actual|2005-04-01||Interventional|||Stress Management Training in Patients Undergoing Radiation Therapy for Cancer|Stress Management Training For Patients Undergoing Radiotherapy|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:03.404335|2017-02-18 18:00:03.404335
NCT00057720|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-07|2011-07-21|||June 2003||2003-06-01|May 2006|2006-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer|Phase 3 Randomized Study of TLK286 (Telcyta) Versus Doxil/Caelyx or Hycamtin as Third-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-1 (Assessment of Survival In Solid Tumors-1)]|Completed||Phase 3|440||Telik|||||f||||||||||||||2017-02-18 18:00:03.515153|2017-02-18 18:00:03.515153
NCT00057707|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-05|2017-01-24|||March 26, 2003||2003-03-26|December 20, 2016|2016-12-20|May 1, 2017|Anticipated|2017-05-01|May 1, 2017|Anticipated|2017-05-01||Interventional|||Effects of Modafinil on Brain Function in Patients With Schizophrenia|Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype|Active, not recruiting||Phase 1|176|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:00:04.034586|2017-02-18 18:00:04.034586
NCT00057694|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-05|2008-03-03|||April 2003||2003-04-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Observational|||The Value of Genetic Information to Adult Adopted Individuals|Genetic Information: Exploring the Value to Adult Adoptees|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:04.141573|2017-02-18 18:00:04.141573
NCT00057681|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2013-03-27|2012-05-29||February 2003||2003-02-01|March 2013|2013-03-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|TEAM||Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents|Treatment of Early Age Mania (TEAM) Study|Completed||Phase 3|379|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 18:00:04.222976|2017-02-18 18:00:04.222976
NCT00057668|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2013-11-18|||September 2001||2001-09-01|August 2006|2006-08-01|August 2006||2006-08-01|||||Interventional|||Preventing Behavior Problems in Children With ADHD|Prevention of Behavioral Deficits in Young ADHD Children|Unknown status|Active, not recruiting|Phase 2|200||Lehigh University|||||f||||||||||||||2017-02-18 18:00:04.956218|2017-02-18 18:00:04.956218
NCT00005326|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||January 1988||1988-01-01|December 2004|2004-12-01|March 2004|Actual|2004-03-01|||||Observational|||Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:07.954316|2017-02-18 18:15:07.954316
NCT00057642|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2013-08-16|||September 2002||2002-09-01|September 2008|2008-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Improving Retention of Hispanics Receiving Antidepressant Therapy|Improving Hispanic Retention in Antidepressant Therapy|Completed||N/A|50|Actual|New York State Psychiatric Institute||1|||f||||f||||||||||2017-02-18 18:00:05.140884|2017-02-18 18:00:05.140884
NCT00057629|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2015-11-12|||January 2002||2002-01-01|November 2015|2015-11-01|August 2009|Actual|2009-08-01|August 2008|Actual|2008-08-01||Interventional|||Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault|Effectiveness of Treatment for PTSD in Community Agencies|Completed||Phase 2/Phase 3|187|Actual|University of Pennsylvania||2|||f||||t||||||||||2017-02-18 18:00:05.263994|2017-02-18 18:00:05.263994
NCT00057616|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2016-11-30|||October 2002||2002-10-01|November 2016|2016-11-01|December 2004||2004-12-01|||||Interventional|||Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.|Multicenter, Randomized, Double-blind, Placebo-controlled Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma Whose Disease Has Progressed on Treatment With DTIC, IL-2, or IFN Based Therapy|Completed||Phase 3|274||Celgene Corporation|||||||||||||||||||2017-02-18 18:00:05.378391|2017-02-18 18:00:05.378391
NCT00057603|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2011-11-08|||January 2001||2001-01-01|November 2011|2011-11-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Deep Brain Stimulation for Treatment-Resistant Obsessive Compulsive Disorder|Pilot Study of DBS for Treatment-Refractory OCD|Completed||N/A|6|Actual|University of Florida||1|||f||||f||||||||||2017-02-18 18:00:05.522321|2017-02-18 18:00:05.522321
NCT00057590|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2013-05-03|||March 2003||2003-03-01|May 2013|2013-05-01||||||||Interventional|||Outreach and Treatment for Depression in the Labor Force|Outreach and Treatment for Depression in the Labor Force|Completed||N/A|590||Harvard Medical School|||||f||||||||||||||2017-02-18 18:00:05.63008|2017-02-18 18:00:05.63008
NCT00057577|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2015-04-01|2013-12-18||October 2002||2002-10-01|April 2015|2015-04-01|March 2014|Actual|2014-03-01|July 2012|Actual|2012-07-01||Interventional|CPT3|All participants met criteria for Major Depressive Disorder (MDD) with exclusions only for psychosis and selected personality disorders|Prevention of Recurrence in Depression With Drugs and CT|Prevention of Recurrence in Depression With Drugs and CT|Completed||Phase 4|452|Actual|Vanderbilt University||2|||f||||t||||||||||2017-02-18 18:00:05.719254|2017-02-18 18:00:05.719254
NCT00057564|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2015-09-09|||February 2003||2003-02-01|September 2015|2015-09-01|August 2013|Actual|2013-08-01|April 2006|Actual|2006-04-01||Interventional|||A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma|A Multicenter, Randomized, Parallel-group , Double Blind, Placebo-controlled Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma|Completed||Phase 3|470|Actual|Celgene||2|||f||||t||||||||||2017-02-18 18:00:06.421264|2017-02-18 18:00:06.421264
NCT00057551|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2016-05-03|2015-04-07||April 2003||2003-04-01|May 2016|2016-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|REVAMP||Research Evaluating the Value of Augmenting Medication With Psychotherapy|CBASP Augmentation for Treatment of Chronic Depression|Completed||Phase 4|491|Actual|Weill Medical College of Cornell University||3|||f||||t||||||||No||2017-02-18 18:00:06.647108|2017-02-18 18:00:06.647108
NCT00057538|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-04|2006-08-16|||May 2003||2003-05-01|August 2006|2006-08-01|May 2003||2003-05-01|||||Interventional|||Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV|Curb, Alter, Lower, or Manage Stress in HIV: CALMS-HIV|Completed||Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:00:07.066306|2017-02-18 18:00:07.066306
NCT00057525|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-03|2011-06-29|||April 2003||2003-04-01|June 2011|2011-06-01|August 2004|Actual|2004-08-01|April 2004|Actual|2004-04-01||Interventional|||A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults|A Phase 1 Study of Safety and Immunogenicity of E. Coli-Derived Recombinant Protective Antigen (rPA), a New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults|Completed||Phase 1|70|Actual|DynPort Vaccine Company LLC, A CSC Company||2|||f||||t||||||||||2017-02-18 18:00:07.163885|2017-02-18 18:00:07.163885
NCT00057512|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-03|2016-02-20|||January 2003||2003-01-01|January 2006|2006-01-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck|Open-Label Phase 1 Dose Escalation Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck|Completed||Phase 1|9|Actual|Erimos Pharmaceuticals||1|||f||||f||||||||No||2017-02-18 18:00:07.502146|2017-02-18 18:00:07.502146
NCT00057499|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-03|2017-02-06|||March 2003||2003-03-01|February 2017|2017-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics|Autoantigen Vaccination in Human Type 1 Newly Diagnosed Diabetes Mellitus|Completed||Phase 1|12|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Data access is provided to the public in : 1.) the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts that also provides data analysis tools available to researchers; and 2.) TrialShare, the Immune Tolerance Network (ITN) portal.|2017-02-18 18:00:07.595251|2017-02-18 18:00:07.595251
NCT00057486|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-02|2016-12-13|||September 1997||1997-09-01|March 2003|2003-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients|A Pilot, Proof-of-Concept, Dose-Escalating Trial of Recombinant Human Interleukin-12 (rhIL-12) Versus Placebo Along With Paromomycin and Azithromycin for Chronic Cryptosporidiosis in AIDS|Terminated||Phase 1/Phase 2|2||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:00:07.709481|2017-02-18 18:00:07.709481
NCT00057473|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-02|2011-04-07||2010-02-03|February 2003||2003-02-01|April 2011|2011-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors||Completed||Phase 2|||Bristol-Myers Squibb||2|||f||||||||||||||2017-02-18 18:00:07.799072|2017-02-18 18:00:07.799072
NCT00057460|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-02|2008-03-03|||April 2003||2003-04-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity|Effects of AMPA Receptor Blockade on Human Cortical Excitability - A Pilot Study|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:08.01677|2017-02-18 18:00:08.01677
NCT00005325|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-07-15|||February 1996||1996-02-01|July 2014|2014-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR||Completed||N/A|||Boston University|||||f||||||||||||||2017-02-18 18:15:08.02302|2017-02-18 18:15:08.02302
NCT00057447|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-01|2007-10-30|||March 2003||2003-03-01|October 2007|2007-10-01|June 2004|Actual|2004-06-01|||||Interventional|||Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients|Phase I/II Study of the Safety of Subcutaneous Interferon Gamma-1b Combined With Rituximab in Patients With Low Grade/Follicular Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|24|Actual|InterMune||1||administrative reasons|f||||||||||||||2017-02-18 18:00:08.101836|2017-02-18 18:00:08.101836
NCT00057434|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-01|2007-09-17|||September 1998||1998-09-01|August 2007|2007-08-01||||||||Interventional|||Vitamin A Therapy for Tuberculosis|Adjunct Vitamin A Therapy for Tuberculosis and HIV/AIDS|Completed||Phase 3|1140||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:00:08.186914|2017-02-18 18:00:08.186914
NCT00057421|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-01|2007-09-17|||November 1998||1998-11-01|August 2007|2007-08-01|September 2002||2002-09-01|||||Interventional|||Tuberculosis in HIV Infected Patients in Uganda|Impact of Tuberculosis on HIV Infection in Uganda|Completed||Phase 2|190||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:00:08.283777|2017-02-18 18:00:08.283777
NCT00057408|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-01|2015-03-24|||May 2003||2003-05-01|September 2011|2011-09-01|September 2005||2005-09-01|||||Interventional|||A Controlled Study of Olanzapine in Children With Autism|A Controlled Study of Olanzapine in Children With Autism|Completed||Phase 2|78|Anticipated|FDA Office of Orphan Products Development||2|||f||||t||||||||||2017-02-18 18:00:08.379744|2017-02-18 18:00:08.379744
NCT00057395|ClinicalTrials.gov processed this data on February 17, 2017|2003-04-01|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies|A Phase I/II Study of Aroplatin™ in Patients With Advanced Solid Malignancies|Unknown status|Active, not recruiting|Phase 1/Phase 2|40||Aronex Pharmaceuticals|||||||||||||||||||2017-02-18 18:00:08.49579|2017-02-18 18:00:08.49579
NCT00057382|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-31|2005-06-23|||March 2003||2003-03-01|September 2004|2004-09-01||||||||Interventional|||T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients||Terminated||Phase 2/Phase 3|750||Tularik|||||||||||||||||||2017-02-18 18:00:08.775593|2017-02-18 18:00:08.775593
NCT00057369|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-31|2005-06-23|||February 2001||2001-02-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Interventional|||Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections|Phase II, Randomized, Open-Label, Multi-Center Study to Evaluate the Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections With Suspected or Confirmed Gram-Positive Bacterial Pathogens|Unknown status|Active, not recruiting|Phase 2|88||Vicuron Pharmaceuticals|||||||||||||||||||2017-02-18 18:00:08.941238|2017-02-18 18:00:08.941238
NCT00057356|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-31|2014-04-30|||November 2002||2002-11-01|April 2014|2014-04-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure|A Randomized, Double-blind, Placebo-controlled, Dose-ranging Pilot Study Evaluating the Efficacy and Safety of YM087 in Patients With Decompensated Chronic Heart Failure|Completed||Phase 2|170|Actual|Cumberland Pharmaceuticals||4|||f||||f||||||||||2017-02-18 18:00:09.023405|2017-02-18 18:00:09.023405
NCT00057343|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-31|2006-09-08|||March 2003||2003-03-01|September 2006|2006-09-01||||||||Interventional|||Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma|A Prospectively Randomized, Phase III, Multicenter, Controlled Trial to Evaluate the Safety and Efficacy of the Zevalin Therapeutic Regimen Plus Rituxan Compared With Rituxan Alone in Patients With Relapsed or Refractory Follicular NHL|Terminated||Phase 3|400||Biogen|||||||||||||||||||2017-02-18 18:00:09.162192|2017-02-18 18:00:09.162192
NCT00057330|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-31|2016-09-29|2011-09-29||January 2003||2003-01-01|March 2013|2013-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||HerpeVac Trial for Young Women|A Double-Blind, Randomized, Controlled Phase III Study to Assess the Prophylactic Efficacy and Safety of gD-Alum/MPL Vaccine in the Prevention of Genital Herpes Disease in Young Women Who Are HSV-1 and -2 Seronegative|Completed||Phase 3|8323|Actual|GlaxoSmithKline|Out of the 8323 subjects enrolled and vaccinated, 7850 subjects were followed throughout the study, e. a. for safety and adverse event assessment (4488 in the Herpes Simplex Virus Group and 3662 in the Havrix Group).|2|||f||||||||||||||2017-02-18 18:00:09.319887|2017-02-18 18:00:09.319887
NCT00057317|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-31|2016-08-23|||December 2001||2001-12-01|August 2016|2016-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus|A Phase II, Randomized, Double-blind, Placebo-controlled Dose-ranging Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|||Hoffmann-La Roche|||||||||||||||||||2017-02-18 18:00:10.39697|2017-02-18 18:00:10.39697
NCT00057304|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-31|2005-06-23||||||November 2004|2004-11-01||||||||Interventional|||Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus|A Phase II Randomized, Double-Blind, Dose-Ranging Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus|Completed||Phase 2|||Hoffmann-La Roche|||||||||||||||||||2017-02-18 18:00:10.5722|2017-02-18 18:00:10.5722
NCT00057291|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-31|2014-10-28|||April 2000||2000-04-01|December 2004|2004-12-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Effect of Improving Caregiving on Early Mental Health|Effect of Improving Caregiving on Early Mental Health|Completed||N/A|1521|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||1|||f||||f||||||||||2017-02-18 18:00:10.793987|2017-02-18 18:00:10.793987
NCT00057278|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-28|2007-12-14|||March 2003||2003-03-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Gabapentin in Fibromyalgia Trial (GIFT)|Gabapentin in Fibromyalgia Trial (GIFT)|Completed||Phase 2/Phase 3|150||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-02-18 18:00:10.890403|2017-02-18 18:00:10.890403
NCT00057265|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-28|2015-03-19|||February 2003||2003-02-01|March 2015|2015-03-01||||April 2006|Actual|2006-04-01||Interventional|||A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B|A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B|Completed||Phase 3|||Novartis|||||||||||||||||||2017-02-18 18:00:11.183983|2017-02-18 18:00:11.183983
NCT00057252|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||March 7, 2003||2003-03-07|March 17, 2016|2016-03-17||||||||Observational|||Development of Computer-aided Detection and Diagnosis From Imaging Techniques|Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Radiologic Images|Completed||N/A|66169|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:11.284797|2017-02-18 18:00:11.284797
NCT00057239|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2010-10-01|||March 2003||2003-03-01|October 2010|2010-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder|A Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Evaluating the Efficacy, Safety and Tolerability of Two Doses (20mg and 60mg) of a Once-Daily Oral Formulation of GW353162 in Subjects With Major Depressive Disorder for a Treatment Period of Eight Weeks|Completed||Phase 2|546||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:00:11.397154|2017-02-18 18:00:11.397154
NCT00057226|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-15|||March 2003||2003-03-01|April 2015|2015-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose Study Evaluating Efficacy, Safety, and Tolerability of Once-Daily Oral GW353162 (40-60mg) Versus Placebo in Subjects With Major Depressive Disorder Over an Eight-Week Treatment Period.|Completed||Phase 2|365|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 18:00:11.526588|2017-02-18 18:00:11.526588
NCT00057213|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-15|||March 2003||2003-03-01|April 2015|2015-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder|A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible-Dose Study Evaluating Efficacy, Safety, and Tolerability of Once-Daily Oral GW353162 (20-40-60mg) Versus Placebo in Subjects With Major Depressive Disorder Over an Eight-Week Treatment Period.|Completed||Phase 2|367|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 18:00:11.660971|2017-02-18 18:00:11.660971
NCT00057200|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|January 2005|Actual|2005-01-01|||||Interventional|||Evaluating Telehealth Home Care for Elderly Veterans With Congestive Heart Failure|Evaluating Telehealth Home Care for Elderly Veterans With Congestive Heart Failure|Completed||N/A|198|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:11.792924|2017-02-18 18:00:11.792924
NCT00057187|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|January 2005|Actual|2005-01-01|||||Interventional|||Improving Substance Abuse Treatment Aftercare Adherence and Outcome|Improving Substance Abuse Treatment Aftercare Adherence and Outcome|Completed||N/A|157|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:11.904402|2017-02-18 18:00:11.904402
NCT00057174|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|June 2004|Actual|2004-06-01|||||Interventional|||Economic Impact of Guidelines for Gastroesophageal Reflux Disease|Economic Impact of Guidelines for Gastroesophageal Reflux Disease|Completed||N/A|484|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:12.016394|2017-02-18 18:00:12.016394
NCT00057161|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|June 2004|Actual|2004-06-01|||||Interventional|||Homelessness Prevention: Psychiatric Care With Representative Payeeship|Homelessness Prevention: Psychiatric Care With Representative Payeeship|Completed||N/A|240|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:12.126686|2017-02-18 18:00:12.126686
NCT00057148|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06|||February 2003||2003-02-01|March 2006|2006-03-01|June 2005|Actual|2005-06-01|||||Interventional|||Massage After Surgery To Help Treat Post-Operative Pain|Acute Post-Operative Pain Management Using Massage As Adjuvant Therapy|Completed||N/A|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:12.236288|2017-02-18 18:00:12.236288
NCT00057135|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06|||November 2002||2002-11-01|April 2007|2007-04-01|September 2006|Actual|2006-09-01|||||Interventional|||Improving Antipsychotic Adherence Among Patients With Serious Mental Illness|Improving Antipsychotic Adherence Among Patients With Schizophrenia|Completed||N/A|150|Anticipated|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 18:00:12.350403|2017-02-18 18:00:12.350403
NCT00057122|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2012-10-19|||September 2002||2002-09-01|October 2012|2012-10-01|June 2009|Actual|2009-06-01|November 2008|Actual|2008-11-01||Interventional|||Tuberculosis Prevention for HIV Infected Adults|Novel TB Prevention Regimens for HIV-Infected Adults|Completed||Phase 3|1148|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 18:00:12.476838|2017-02-18 18:00:12.476838
NCT00057109|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06||||||December 2005|2005-12-01|June 2005|Actual|2005-06-01|||||Observational|||Health Values and Spirituality in Veterans With HIV/AIDS|Health Values and Spirituality in Veterans With HIV/AIDS|Completed||N/A|100|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:00:12.595852|2017-02-18 18:00:12.595852
NCT00057096|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|March 2004|Actual|2004-03-01|||||Interventional|||Onsite Versus Referral Models of Primary Care for Substance Abusing Patients|Onsite Versus Referral Models of Primary Care for Substance Abusing Patients|Completed||N/A|800|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:12.689687|2017-02-18 18:00:12.689687
NCT00057083|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06|||March 2003||2003-03-01|February 2008|2008-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Effect of Telemedicine on Physician-Patient Communication|Effect of Telemedicine on Physician-Patient Communication|Completed||N/A|221|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:12.790109|2017-02-18 18:00:12.790109
NCT00057070|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06|||October 2001||2001-10-01|February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET|Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET|Completed||N/A|1900|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:13.123741|2017-02-18 18:00:13.123741
NCT00057057|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06||||||February 2007|2007-02-01|March 2005|Actual|2005-03-01|||||Interventional|||Telephone Intervention in Heart Failure Patients|Randomized Trial of a Telephone Intervention in Heart Failure Patients|Completed||N/A|438|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:13.235802|2017-02-18 18:00:13.235802
NCT00057044|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-27|2015-04-06|||October 2001||2001-10-01|February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||From Research to Practice - Lipid Management for Low HDL-Cholesterol|From Research to Practice - Lipid Management for Low HDL-Cholesterol|Completed||N/A|11700|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:00:13.346857|2017-02-18 18:00:13.346857
NCT00057031|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2006-10-31|||November 2002||2002-11-01|February 2005|2005-02-01|March 2004||2004-03-01|||||Interventional|||Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)|A Phase 2, Multicenter, Open Label Study of the Safety and Efficacy of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome|Unknown status|Active, not recruiting|Phase 2|46||Novacea|||||||||||||||||||2017-02-18 18:00:13.459404|2017-02-18 18:00:13.459404
NCT00057018|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2016-09-23|||April 2000||2000-04-01|May 2011|2011-05-01|January 2006||2006-01-01|March 2005|Actual|2005-03-01||Interventional|||Improving Arm Mobility and Use After Stroke|The Extremity Constraint Induced Therapy Evaluation (EXCITE) Trial|Completed||Phase 3|229||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:00:13.5532|2017-02-18 18:00:13.5532
NCT00057005|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2010-01-19|||February 2003||2003-02-01|November 2009|2009-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|ADVL||Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation|Phase I Study of Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation (ADVL)|Completed||Phase 1|24|Anticipated|Baylor College of Medicine||1|||t||||t||||||||||2017-02-18 18:00:13.692783|2017-02-18 18:00:13.692783
NCT00056992|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2015-03-24|||September 2002||2002-09-01|September 2002|2002-09-01|October 2003||2003-10-01|||||Interventional|||Testing of ADI-PEG in Hepatocellular Carcinoma|Phase II Testing of ADI-PEG in Hepatocellular Carcinoma|Completed||Phase 2|34||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:00:13.802794|2017-02-18 18:00:13.802794
NCT00056979|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2015-09-21|||June 2002||2002-06-01|September 2015|2015-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases|Anti-CD45 (YTH-24 & YTH 54) and ANTI-CD52 (CAMPATH-1H) Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases|Terminated||Phase 1/Phase 2|2|Actual|Baylor College of Medicine||1|||f||||||||||||||2017-02-18 18:00:13.869093|2017-02-18 18:00:13.869093
NCT00056966|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2012-06-27|||November 2002||2002-11-01|June 2012|2012-06-01|December 2006|Actual|2006-12-01|May 2005|Actual|2005-05-01||Interventional|||Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases|Phase I/II Study of CD45 Antibodies and Alemtuzumab Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases|Completed||Phase 1/Phase 2|24|Actual|Baylor College of Medicine||2|||f||||t||||||||||2017-02-18 18:00:13.978918|2017-02-18 18:00:13.978918
NCT00056953|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2005-07-27|||September 1999||1999-09-01|July 2005|2005-07-01|November 2004||2004-11-01|||||Interventional|||Peer Mentors for Adolescents in HIV Affected Families|Peer Mentors for Early Adolescents in HIV-Affected Families|Completed||Phase 2|160||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:00:14.100846|2017-02-18 18:00:14.100846
NCT00056940|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2007-04-23|||September 2001||2001-09-01|April 2007|2007-04-01|July 2006|Actual|2006-07-01|||||Interventional|||Prevention of Violent Behavior Among Children|Randomized Controlled Trial to Prevent Child Violence|Completed||N/A|6600||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||t||||||||||2017-02-18 18:00:14.189059|2017-02-18 18:00:14.189059
NCT00056927|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2006-09-29|||September 1997||1997-09-01|July 2005|2005-07-01|August 2002||2002-08-01|||||Interventional|||Anti-Smoking Program for Parents: Effects on Child Smoking|Preventing Initiation of Smoking by Children|Completed||N/A|1007||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:00:14.278211|2017-02-18 18:00:14.278211
NCT00056914|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2017-01-24|||March 21, 2003||2003-03-21|January 5, 2010|2010-01-05|January 5, 2010||2010-01-05|||||Observational|||Development of Techniques for Use in MRI With a Magnetic Field of 7 Tesla|Development of 7 Tesla MRI Methodology for Anatomical Functional and Spectroscopic Imaging of the Brain|Completed||N/A|102|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:14.362429|2017-02-18 18:00:14.362429
NCT00056901|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2017-01-24|||March 21, 2003||2003-03-21|November 4, 2016|2016-11-04||||||||Observational|||Screening Evaluation for Women With Postpartum Depression|A Screening Protocol to Evaluate Women With Postpartum-Related Mood and Behavioral Disorders|Recruiting||N/A|650|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:14.550516|2017-02-18 18:00:14.550516
NCT00056888|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-26|2017-01-24|||March 21, 2003||2003-03-21|February 17, 2009|2009-02-17|February 17, 2009||2009-02-17|||||Observational|||Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders|Neurophysiological Studies in Patients With Psychogenic Movement Disorders|Completed||N/A|115||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:14.654029|2017-02-18 18:00:14.654029
NCT00056875|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-25|2015-03-24|||September 2002||2002-09-01|February 2006|2006-02-01|June 2005||2005-06-01|||||Interventional|||Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants|Safety and Efficacy of Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants|Completed||Phase 1/Phase 2|50||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:00:14.732938|2017-02-18 18:00:14.732938
NCT00056862|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-25|2013-11-13|2010-11-12||March 2003||2003-03-01|November 2013|2013-11-01|June 2010|Actual|2010-06-01|January 2010|Actual|2010-01-01||Interventional|||Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3|Low Dose Peginterferon and Ribavirin Therapy for Patients With Chronic Hepatitis C Infected With Genotype 2 or 3|Completed||Phase 4|58|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:00:14.820488|2017-02-18 18:00:14.820488
NCT00056849|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-25|2017-01-24|||March 20, 2003||2003-03-20|March 3, 2016|2016-03-03||||||||Observational|||Genetic Determinants of Ankylosing Spondylitis Severity|Genetic Determinants of Ankylosing Spondylitis Severity - Cross Sectional Study|Completed||N/A|134|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:15.439299|2017-02-18 18:00:15.439299
NCT00056836|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-24|2014-05-14|||March 2003||2003-03-01|May 2014|2014-05-01|December 2005|Actual|2005-12-01|||||Interventional|||A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration|A Phase III, Multicenter, Randomized, Double Masked, Sham Injection-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) in Subjects With Minimally Classic or Occult Subfoveal Neovascular Age-Related Macular Degeneration|Completed||Phase 3|720||Genentech, Inc.|||||||||||||||||||2017-02-18 18:00:15.533682|2017-02-18 18:00:15.533682
NCT00056823|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-24|2013-06-19|||March 2003||2003-03-01|June 2013|2013-06-01|December 2005|Actual|2005-12-01|||||Interventional|||Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)|A Phase I/II, Single-Masked, Multicenter Study of the Safety, Tolerability, and Efficacy of Multiple-Dose Intravitreal Injections of rhuFab V2 in Combination With Verteporfin (Visudyne(R)) Photodynamic Therapy in Subjects With Neovascular Age Related Macular Degeneration|Completed||Phase 1/Phase 2|168||Genentech, Inc.|||||||||||||||||||2017-02-18 18:00:15.616425|2017-02-18 18:00:15.616425
NCT00056810|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-24|2015-03-24|||September 2002||2002-09-01|May 2006|2006-05-01|May 2005||2005-05-01|||||Interventional|||Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine|Assessment of Chronic GBS Improvement With Use of 4-AP|Completed||Phase 2|30||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:00:15.701499|2017-02-18 18:00:15.701499
NCT00056797|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-24|2016-12-13|||March 2002||2002-03-01|July 2007|2007-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV|A Randomized Controlled Study Testing the Efficacy of Immunotherapies to Control Plasma HIV RNA Concentrations Upon Interruption of Highly Active Antiretroviral Therapy (HAART).|Completed||Phase 2|92||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:00:15.802864|2017-02-18 18:00:15.802864
NCT00056784|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-22|2017-01-24|||March 20, 2003||2003-03-20|June 17, 2014|2014-06-17|June 17, 2014||2014-06-17|||||Observational|||The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation|The Pathogenesis of Chronic Graft Failure After Kidney Transplantation|Completed||N/A|134|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:15.903841|2017-02-18 18:00:15.903841
NCT00056771|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-22|2017-01-24|||March 18, 2003||2003-03-18|May 25, 2016|2016-05-25|May 25, 2016||2016-05-25|||||Observational|||Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts|Clinical and Molecular Studies in Families With Congenital or Hereditary Cataracts|Completed||N/A|873|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:15.990655|2017-02-18 18:00:15.990655
NCT00056758|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-21|2007-08-23|||February 2003||2003-02-01|August 2007|2007-08-01||||||||Interventional|||HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs|Randomized Phase I Evaluation of Immunization With Highly Conserved HIV-1 Derived Peptides and Influenza Matrix Peptide in HIV-1-Infected Subjects on Highly Active Antiretroviral Therapy (HAART) Using Autologous Dendritic Cells Derived From Adherent Monocytic Precursors|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:00:16.102097|2017-02-18 18:00:16.102097
NCT00056745|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-21|2007-09-17||||||July 2007|2007-07-01||||||||Interventional|||Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines|The Role of Immunization Site in Eliciting Mucosal Immunity|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:00:16.200111|2017-02-18 18:00:16.200111
NCT00056719|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-21|2017-01-24|||March 17, 2003||2003-03-17|July 19, 2016|2016-07-19||||||||Observational|||Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study|Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study|Recruiting||N/A|999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:16.287341|2017-02-18 18:00:16.287341
NCT00056706|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-21|2008-03-03|||March 2003||2003-03-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Ischemic Nerve Block to Improve Hand Function in Stroke Patients|Improved Function in the Paretic Hand of Chronic Stroke Patients by Transient Deafferentation of the Intact Upper Extremity|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:19.457877|2017-02-18 18:00:19.457877
NCT00056693|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-20|2008-07-18|||April 2003||2003-04-01|July 2008|2008-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment With SU11248 in Patients With Neuroendocrine Tumors|A Phase II Study Of The Efficacy And Safety Of SU011248 In Patients With Advanced Unresectable Neuroendocrine Tumor|Completed||Phase 2|107|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 18:00:19.558434|2017-02-18 18:00:19.558434
NCT00056680|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-20|2007-06-19|||July 2001||2001-07-01|May 2007|2007-05-01|December 2006|Actual|2006-12-01|||||Interventional|||Three-Part Program for Parents With Premature Infants|Adult Attachment and Intervention Efficacy With Preterms|Completed||N/A|173|Actual|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||2|||f||||f||||||||||2017-02-18 18:00:19.688392|2017-02-18 18:00:19.688392
NCT00056667|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-20|2014-01-15|||July 2001||2001-07-01|January 2014|2014-01-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Relaxation Response Training for the Treatment of Rheumatoid Arthritis|Relaxation Response, Somatic Style and Rheumatoid Arthritis|Completed||Phase 4|168|Actual|Brigham and Women's Hospital||3|||f||||f||||||||||2017-02-18 18:00:19.792699|2017-02-18 18:00:19.792699
NCT00056654|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-20|2008-09-16|||March 2003||2003-03-01|September 2008|2008-09-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer|Pharmacokinetic, Safety and Efficacy Study of a Six-Month Depot Formulation of Leuprolide in Subjects With Prostatic Carcinoma|Completed||N/A|164|Actual|Abbott||1|||f||||f||||||||||2017-02-18 18:00:19.906993|2017-02-18 18:00:19.906993
NCT00056641|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-19|2013-11-13|||January 2003||2003-01-01|November 2013|2013-11-01||||January 2004|Actual|2004-01-01||Interventional|||Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients|An Open Label, Randomized, Parallel-group Pharmacokinetics Trial of Tipranavir / Ritonavir (TPV/RTV), Alone or in Combination With RTV-boosted Saquinavir (SQV), Amprenavir (APV), or Lopinavir (LPV), Plus an Optimized Background Regimen, in Multiple Antiretroviral (ARV) Experienced Patients.|Completed||Phase 2|328||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 18:00:20.13804|2017-02-18 18:00:20.13804
NCT00056628|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-19|2006-09-11|||January 2001||2001-01-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||COGNIShunt® System for Alzheimer's Disease|Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System|Completed||Phase 3|250||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:00:20.56179|2017-02-18 18:00:20.56179
NCT00056602|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-19|2017-01-24|||March 17, 2003||2003-03-17|March 1, 2016|2016-03-01||||||||Observational|||Clinically Important Changes in Rheumatoid Arthritis|Clinically Important Changes in Rheumatoid Arthritis|Completed||N/A|192|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:20.650683|2017-02-18 18:00:20.650683
NCT00056589|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-18|2017-01-10|||March 2003||2003-03-01|January 2017|2017-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency|A Phase 1 Escalating Dose Study of the Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor XIII Deficiency|Completed||Phase 1|11|Actual|Novo Nordisk A/S||1|||f||||f||||||||||2017-02-18 18:00:20.763676|2017-02-18 18:00:20.763676
NCT00056576|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-18|2011-07-14|||February 2002||2002-02-01|July 2011|2011-07-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy|A Double-Blind, Randomized, Multicenter, Parallel Group Study to Establish Dose-Response, Safety, and Efficacy of Zonegran (Zonisamide) as Monotherapy in Patients With Newly Diagnosed Epilepsy|Completed||Phase 3|165||Eisai Inc.|||||||||||||||||||2017-02-18 18:00:20.872835|2017-02-18 18:00:20.872835
NCT00056563|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-18|2014-04-24|2013-05-20||April 2002||2002-04-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial|CSP #468 Phase I - A Comparison of Best Medical Therapy and Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus for the Treatment of Parkinson's Disease|Completed||Phase 3|255|Actual|VA Office of Research and Development|A limitation of this study is that the STN and GPi cases are pooled into a single DBS group. When the study was planned, it was thought that differences between STN and GPi at six months would be small, which was tested during the study analysis.|2|||f||||t||||||||||2017-02-18 18:00:20.992123|2017-02-18 18:00:20.992123
NCT00056550|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-17|2012-09-17|2012-03-19||December 2002||2002-12-01|August 2012|2012-08-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|rhAT||Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.|A Study to Assess the Incidence of Deep Vein Thrombosis (DVT) Following Prophylactic Intravenous Administration of Recombinant Human Antithrombin(rhAT) to Hereditary Antithrombin (AT) Deficient Patients in High Risk Situations.|Completed||Phase 3|14|Actual|rEVO Biologics||1|||f||||f||||||||||2017-02-18 18:00:21.809113|2017-02-18 18:00:21.809113
NCT00056537|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-16|2014-08-26|||April 2003||2003-04-01|August 2014|2014-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer|An Open-Label, Phase I, Repeat Dose-Escalation Study of ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer|Completed||Phase 1|44|Actual|Active Biotech AB||1|||f||||f||||||||||2017-02-18 18:00:22.166539|2017-02-18 18:00:22.166539
NCT00056524|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-15|2016-07-13|||February 2003||2003-02-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)|An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.|Completed||Phase 3|600|Anticipated|Avanir Pharmaceuticals|||||||||||||||||||2017-02-18 18:00:22.286426|2017-02-18 18:00:22.286426
NCT00056511|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-14|2006-08-16|||May 2002||2002-05-01|August 2006|2006-08-01|April 2005||2005-04-01|||||Interventional|||Comparing Effects of 3 Sources of Garlic on Cholesterol Levels|Comparing Effects of 3 Sources of Garlic on Serum Lipids|Completed||Phase 2/Phase 3|220||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 18:00:22.425685|2017-02-18 18:00:22.425685
NCT00056498|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-14|2015-04-10|2009-03-23||December 2001||2001-12-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine|Clozapine Treatment of Schizophrenic Patients|Completed||Phase 4|65|Actual|University of Maryland||2|||f||||t||||||||||2017-02-18 18:00:22.525134|2017-02-18 18:00:22.525134
NCT00056485|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-14|2013-11-05|||April 2002||2002-04-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Treatment of Depression in Nursing Homes|Behavioral Intervention for Depression in Nursing Homes|Completed||Phase 1|40||University of Louisville|||||f||||||||||||||2017-02-18 18:00:22.953945|2017-02-18 18:00:22.953945
NCT00056472|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-14|2013-06-26|2009-06-16||January 2003||2003-01-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|STOP-PD||Study of Pharmacotherapy of Psychotic Depression|Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression|Completed||Phase 3|259|Actual|Weill Medical College of Cornell University||2|||f||||t||||||||||2017-02-18 18:00:23.058813|2017-02-18 18:00:23.058813
NCT00056459|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-13|2009-11-18|||February 2003||2003-02-01|November 2009|2009-11-01||||January 2007|Actual|2007-01-01||Interventional|||Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.|A Randomized, Double-blind, Placebo-controlled, Phase Lll Study in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Who Are Receiving First-line Chemotherapy With Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo|Completed||Phase 3|1168|Actual|Novartis||2|||f||||||||||||||2017-02-18 18:00:23.550351|2017-02-18 18:00:23.550351
NCT00056446|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-13|2016-01-26|||January 2003||2003-01-01|January 2016|2016-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer|A Randomized, Double-blind, Placebo-controlled, Phase III Study of Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo in Patients With Previously Treated Metastatic Adenocarcinoma of the Colon or Rectum|Completed||Phase 3|855|Actual|Novartis||2|||f||||f||||||||||2017-02-18 18:00:24.152902|2017-02-18 18:00:24.152902
NCT00056433|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-12|2017-01-24|||March 10, 2003||2003-03-10|December 7, 2015|2015-12-07|December 27, 2006|Actual|2006-12-27|December 27, 2006|Actual|2006-12-27||Interventional|||Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia|Evaluation of Potential Synergy of Combining Hydroxyurea With Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients With Sickle Cell Anemia|Completed||Phase 1|39|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:00:24.516672|2017-02-18 18:00:24.516672
NCT00056420|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-12|2017-01-24|||March 10, 2003||2003-03-10|January 22, 2009|2009-01-22|January 22, 2009||2009-01-22|||||Observational|||Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement|Spatiotemporal Dynamics of Cortical Connectivity Involved in Tics and Voluntary Movements in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder: An EEG Study|Completed||N/A|54||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:24.620558|2017-02-18 18:00:24.620558
NCT00056186|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-07|2008-03-03|||March 2003||2003-03-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Observational|||Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling|Exploration of Transitional Life Events in Individuals With Friedreich's Ataxia: Implications for Genetic Counseling|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:34.470271|2017-02-18 18:00:34.470271
NCT00056407|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-11|2016-08-17|2010-02-01||March 2003||2003-03-01|August 2016|2016-08-01|April 2009|Actual|2009-04-01|January 2009|Actual|2009-01-01||Interventional|REDUCE||"REDUCE - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk"|A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer|Completed||Phase 3|8231|Actual|GlaxoSmithKline||2|||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 18:00:25.063154|2017-02-18 18:00:25.063154
NCT00056394|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-11|2014-07-11|||February 2003||2003-02-01|November 2013|2013-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Coping Skills Training for Early Rheumatoid Arthritis|Coping Skills Training for Early Rheumatoid Arthritis|Completed||N/A|105|Actual|Duke University||3|||f||||t||||||||||2017-02-18 18:00:29.288153|2017-02-18 18:00:29.288153
NCT00056381|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-11|2008-10-17|||July 2003||2003-07-01|October 2008|2008-10-01|June 2004|Actual|2004-06-01|||||Interventional|||Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17|Phase I/II Study of the Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children With Fever and Neutropenia|Completed||Phase 1/Phase 2|25|Actual|Pfizer|||||||||||||||||||2017-02-18 18:00:29.460271|2017-02-18 18:00:29.460271
NCT00056368|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-11|2008-10-17|||March 2003||2003-03-01|October 2008|2008-10-01|October 2004|Actual|2004-10-01|||||Interventional|||The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis|A Phase III, Double-Blind, Randomized, Multi-Center, Study of the Safety and Efficacy of Anidulafungin vs. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis and Prevention of Complications.|Completed||Phase 3|256|Actual|Pfizer|||||||||||||||||||2017-02-18 18:00:29.548212|2017-02-18 18:00:29.548212
NCT00056355|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-10|2008-03-03|||March 2003||2003-03-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease|A Single Arm Study of Extracorporeal Photoimmune Therapy With Uvadex For Corticosteroid Sparing in Patients With Corticosteroid-Dependent Crohn's Disease Who May Also Be Refractory or Intolerant to Immunosuppressants and/or Anti-Tumor Necrosis Factor Agen|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:29.654871|2017-02-18 18:00:29.654871
NCT00056329|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-10|2012-05-02|||April 2002||2002-04-01|May 2012|2012-05-01|May 2012|Anticipated|2012-05-01|May 2012|Anticipated|2012-05-01||Interventional|||Vitamin E in Aging Persons With Down Syndrome|Multicenter Vitamin E Trial in Aging Persons With Down Syndrome|Unknown status|Active, not recruiting|Phase 3|350|Actual|New York State Institute for Basic Research||2|||f||||t||||||||||2017-02-18 18:00:29.742556|2017-02-18 18:00:29.742556
NCT00056316|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-10|2014-06-04|2008-10-23||January 2002||2002-01-01|June 2014|2014-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Reducing Depression in Dementia Caregivers|Reducing Depression in Dementia Caregivers|Completed||Phase 1/Phase 2|74|Actual|University of Missouri, St. Louis||2|||f||||t||||||||||2017-02-18 18:00:29.878225|2017-02-18 18:00:29.878225
NCT00056303|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-10|2016-12-19|||December 2002||2002-12-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2016|Actual|2016-12-01||Interventional|||Mental Health Services for Foster and Adopted Children|Specialized Mental Health Services for Foster Infants|Completed||Phase 1|220|Actual|University of Delaware||2|||f||||t||||||||No||2017-02-18 18:00:33.261096|2017-02-18 18:00:33.261096
NCT00056290|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-10|2010-11-10|||December 2002||2002-12-01|November 2010|2010-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||VEGF Gene Transfer for Diabetic Neuropathy|p.VGI.1 (VEGF2) Gene Transfer for Diabetic Neuropathy|Completed||Phase 1/Phase 2|60|Anticipated|Losordo, Douglas, M.D.||2|||t||||t||||||||||2017-02-18 18:00:33.368323|2017-02-18 18:00:33.368323
NCT00056277|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-10|2011-03-25|||February 2003||2003-02-01|March 2011|2011-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Bipolar Disorder Study for Men and Women|A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose, 8-Week Evaluation of the Efficacy and Safety of Lamotrigine in the Treatment of Bipolar Disorder Patients Currently Experiencing a Major Depressive Episode|Completed||Phase 3|260|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 18:00:33.471444|2017-02-18 18:00:33.471444
NCT00056264|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-07|2011-05-16|||December 2002||2002-12-01|April 2010|2010-04-01|December 2004|Actual|2004-12-01|||||Interventional|||A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group, Dose Finding Study Evaluating the Safety and Efficacy of Infliximab Administration in Symptomatic Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)|Completed||Phase 3|234|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 18:00:33.568581|2017-02-18 18:00:33.568581
NCT00056251|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-07|2005-06-23|||January 2003||2003-01-01|January 2004|2004-01-01|August 2003||2003-08-01|||||Interventional|||Interstitial Cystitis|A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of RTX Topical Solution in Patients With Interstitial Cystitis|Completed||Phase 2|150||ICOS Corporation|||||||||||||||||||2017-02-18 18:00:33.661901|2017-02-18 18:00:33.661901
NCT00056238|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-07|2005-06-23|||February 2003||2003-02-01|March 2003|2003-03-01||||||||Interventional|||Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy|A Phase II Pilot Study of the Safety, Tolerability and Pharmacokinetics of Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy|Completed||Phase 2|30||Bellus Health Inc|||||||||||||||||||2017-02-18 18:00:33.85641|2017-02-18 18:00:33.85641
NCT00056225|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-07|2009-06-10|||January 2003||2003-01-01|June 2009|2009-06-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)|High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)|Completed||Phase 3|340|Actual|National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:00:33.950928|2017-02-18 18:00:33.950928
NCT00056212|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-07|2006-08-17|||July 2002||2002-07-01|July 2006|2006-07-01|October 2004||2004-10-01|||||Interventional|||Evaluating Yoga for Chronic Low Back Pain|Evaluating Yoga for Chronic Low Back Pain|Completed||N/A|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:00:34.291757|2017-02-18 18:00:34.291757
NCT00056199|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-07|2008-03-03|||March 2003||2003-03-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome|Pilot Study of Intravitreal Injection of EYE001 (Anti-VEGF Pegylated Aptamer) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:34.374701|2017-02-18 18:00:34.374701
NCT00056173|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2008-01-04|||March 2002||2002-03-01|January 2008|2008-01-01||||December 2004|Actual|2004-12-01||Interventional|||Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma|A Phase I/II Study of GTI-2040 and Capecitabine Combination Therapy in Patients With Advanced or Metastatic Renal Cell Carcinoma (mRCC)|Completed||Phase 1/Phase 2|43|Anticipated|Aptose Biosciences Inc.|||||||||||||||||||2017-02-18 18:00:34.550794|2017-02-18 18:00:34.550794
NCT00056160|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2016-11-21|2009-12-24||January 2003||2003-01-01|November 2016|2016-11-01|October 2008|Actual|2008-10-01|November 2005|Actual|2005-11-01||Interventional|||CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma|A Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma|Completed||Phase 3|353|Actual|Celgene Corporation|Analyses for efficacy had data cutoff dates of 07 Jun 2005 and a data cutoff date of 23 Jul 2008 for overall survival. Only safety data were collected for 6 subjects ongoing beyond the 23 Jul 2008 data cutoff date.|2|||f||||t||||||||||2017-02-18 18:00:34.668369|2017-02-18 18:00:34.668369
NCT00056147|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2015-01-28|||April 2003||2003-04-01|January 2015|2015-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease|Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study of INS37217 Inhalation Solution in Subjects With Mild to Moderate Cystic Fibrosis Lung Disease|Completed||Phase 2|90|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:00:36.079492|2017-02-18 18:00:36.079492
NCT00056134|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-09-16|||October 2002||2002-10-01|September 2013|2013-09-01|May 2012|Actual|2012-05-01|October 2011|Actual|2011-10-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|Vaccination of HLA-A1 and/or -A2+ Stage III or IV Melanoma Patients With Tumor Peptide-Loaded Autologous Dendritic Cells With Prior Depletion of CD25-Positive Cells Using Denileukin Difitox (ONTAK)|Completed||Phase 1/Phase 2|23|Actual|University Hospital Erlangen||1|||f||||f||||||||||2017-02-18 18:00:36.184499|2017-02-18 18:00:36.184499
NCT00056095|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2009-02-06|||December 2002||2002-12-01|December 2006|2006-12-01||||||||Interventional|||Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer|Phase II Trial in Intrafamilial Allogeneic Cell Transplant in Patients With Metastatic Kidney Cancer|Unknown status|Recruiting|Phase 2|170|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:36.289923|2017-02-18 18:00:36.289923
NCT00056082|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2017-02-13|||January 2003||2003-01-01|February 2017|2017-02-01|July 2013|Actual|2013-07-01|July 2008|Actual|2008-07-01||Interventional|||Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women|A Study to Identify Biomarker Modulation by a Cyclooxygenase-2 (COX-2) Inhibitor in Breast Tissue of Premenopausal Women at High Risk for Estrogen Receptor Negative (ERN) Breast Cancer|Completed||Phase 2|110|Actual|University of Kansas Medical Center||1|||f||||f||||||||No|Global results will be published|2017-02-18 18:00:36.415655|2017-02-18 18:00:36.415655
NCT00056069|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2015-05-06|||December 2002||2002-12-01|May 2015|2015-05-01|March 2010|Actual|2010-03-01|January 2010|Actual|2010-01-01||Interventional|||Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia|Differences in Parental Caregiving Demands in Childhood Acute Lymphoblastic Leukemia by Length of Infusion Therapy|Completed||N/A|172|Actual|Children's Oncology Group||1|||f||||f||||||||||2017-02-18 18:00:36.531917|2017-02-18 18:00:36.531917
NCT00056056|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2012-06-19|||January 2003||2003-01-01|June 2012|2012-06-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides|A Randomized, Open-Label Phase III Trial to Evaluate the Efficacy and Safety of Bexarotene (Targretin) Capsules Combined With PUVA, Compared to PUVA Treatment Alone in Patients With Mycosis Fungoides|Terminated||Phase 3|93|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2||poor accrual|f||||t||||||||||2017-02-18 18:00:36.774528|2017-02-18 18:00:36.774528
NCT00056030|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2017-01-20|||December 2004|Actual|2004-12-01|January 2017|2017-01-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer|A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum|Completed||Phase 2|73|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:00:36.920748|2017-02-18 18:00:36.920748
NCT00056004|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-04-25|||June 2003||2003-06-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|September 2006|Actual|2006-09-01||Interventional|||Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia|Phase II Trial Of Zileuton In Persons With Bronchial Dysplasia|Completed||Phase 2|38|Actual|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:00:37.449082|2017-02-18 18:00:37.449082
NCT00055991|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-02-04|||September 2001||2001-09-01|February 2013|2013-02-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Bexarotene in Preventing Breast Cancer in Women at Genetic Risk|A Multicenter Randomized Double-Blind Trial Of Targretin Capsules Modifying Immunophenotypic Markers Related To Breast Cancer Progression In Breast Tissue From Genetically Identified High Risk Patients|Completed||Phase 1|87|Actual|Baylor Breast Care Center||2|||f||||t||||||||||2017-02-18 18:00:37.552842|2017-02-18 18:00:37.552842
NCT00055978|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2011-06-16|||October 2002||2002-10-01|June 2011|2011-06-01|May 2009|Actual|2009-05-01|March 2008|Actual|2008-03-01||Interventional|||Celecoxib in Preventing Lung Cancer in Former Heavy Smokers|Lung Cancer Chemoprevention With Celecoxib In Ex-Smokers|Completed||Phase 2|112|Actual|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 18:00:37.669468|2017-02-18 18:00:37.669468
NCT00055965|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-09-19|||November 2002||2002-11-01|January 2009|2009-01-01||||August 2006|Actual|2006-08-01||Interventional|||Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin|A Pragmatic, Randomised Study To Compare The Hospitalisation Rates Of Two Platinum-Based Outpatient Regimens (Gemcitabine/Cisplatin vs. Gemcitabine/Carboplatin) In Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:37.782798|2017-02-18 18:00:37.782798
NCT00055731|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2012-02-23|||November 2002||2002-11-01|April 2008|2008-04-01||||||||Interventional|||Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse|Phase III Randomized Study Of Adjuvant Hormonal Therapy With And Without Docetaxel And Estramustine In Patients With Advanced Prostate Cancer Or With A High Risk Of Relapse|Unknown status|Active, not recruiting|Phase 3|250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:39.920977|2017-02-18 18:00:39.920977
NCT00055952|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2012-05-15|||January 2003||2003-01-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor|A Phase II Study Of Intravenous DX-8951f (EXATECAN MESYLATE) Administered Daily For Five Days Every Three Weeks To Pediatric And Young Adult Patients With Ewing's Sarcoma (ES), Primitive Neuroectodermal Tumor (PNET), Or Desmoplastic Small Round Cell Tumor (DSRCT)|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:00:37.876835|2017-02-18 18:00:37.876835
NCT00055939|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2012-05-15|||January 2003||2003-01-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma|A Phase II Study Of Intravenous DX-8951f (EXATECAN MESYLATE) Administered Daily For Five Days Every Three Weeks To Pediatric Patients With Relapsed Or Refractory Rhabdomyosarcoma|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:00:37.985153|2017-02-18 18:00:37.985153
NCT00055926|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2015-10-28|||January 2003||2003-01-01|August 2012|2012-08-01|May 2005|Actual|2005-05-01|December 2004|Actual|2004-12-01||Interventional|||CP-724,714 in Treating Patients With Metastatic Breast Cancer|A Phase I Safety and Pharmacokinetic/Pharmacodynamic Study of CP-724, 714 In Patients With Metastatic HER2-Overexpressing Breast Cancer|Completed||Phase 1|9|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:00:38.089855|2017-02-18 18:00:38.089855
NCT00055913|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2014-02-11|||March 2003||2003-03-01|December 2012|2012-12-01||||September 2007|Actual|2007-09-01||Interventional|||Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase I/II Study Of Bevacizumab (rhuMAb VEGF) In Combination With OSI-774 For Patients With Recurrent Or Metastatic Cancer Of The Head And Neck|Completed||Phase 1/Phase 2|58|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:00:38.197431|2017-02-18 18:00:38.197431
NCT00055887|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-05-08|||November 2002||2002-11-01|May 2013|2013-05-01||||||||Interventional|||Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Phase III Randomized, Open-Label Comparative Study of Induction Chemotherapy Followed by Thoracic Radiation Therapy With Supplemental Oxygen, With or Without Concurrent RSR13 (Efaproxiral), in Patients With Locally Advanced Unresectable (Stage IIIA/IIIB) Non-Small Cell Lung Cancer|Withdrawn||Phase 3|0|Actual|Spectrum Pharmaceuticals, Inc||||Study never started. No patients were enrolled.|f||||||||||||||2017-02-18 18:00:38.321998|2017-02-18 18:00:38.321998
NCT00055874|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-08-09|||June 2002||2002-06-01|November 2011|2011-11-01||||December 2016|Anticipated|2016-12-01||Interventional|||Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia|Treatment Optimization Trial in Chronic Myeloid Leukemia (CML) - Randomized Controlled Comparison of Imatinib vs. Imatinib/Interferon-alpha vs. Imatinib/Low-Dose AraC vs. Interferon-alpha Standard Therapy and Determination of the Role of Allografting in Newly Diagnosed Chronic Phase|Unknown status|Recruiting|Phase 3|1600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:38.451791|2017-02-18 18:00:38.451791
NCT00055861|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-06-03|||July 2002||2002-07-01|June 2013|2013-06-01||||August 2006|Actual|2006-08-01||Interventional|||Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer|PHASE 2 STUDY OF BEVACIZUMAB IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH ADVANCED BREAST CANCER|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:00:38.633136|2017-02-18 18:00:38.633136
NCT00055848|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2016-07-12|||December 2001||2001-12-01|July 2015|2015-07-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Observational|||Genetic Study of Familial Factors in Patients With Colon Cancer|Familial Factors in the Development of Colon Cancer|Completed||N/A|600|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 18:00:38.748313|2017-02-18 18:00:38.748313
NCT00055835|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-01-30|||November 2002||2002-11-01|January 2013|2013-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium|Phase II Evaluation of Carboplatin, Paclitaxel and Gemcitabine Followed by Concurrent Cisplatin and Radiation Therapy in Patients With Locally Advanced or Recurrent Urothelial Malignancy|Completed||Phase 2|7|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:00:38.863495|2017-02-18 18:00:38.863495
NCT00055822|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2012-07-03|||October 2002||2002-10-01|July 2012|2012-07-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer|A Phase I/II Study of Oblimersen Sodium (G3139, Genasense) in Combination With Oxaliplatin, 5FU and Leucovorin (FOLFOX4) Regimen in Advanced Colorectal Cancer|Completed||Phase 1/Phase 2|16|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:00:39.342861|2017-02-18 18:00:39.342861
NCT00055809|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-01-22|||January 2003||2003-01-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors|Phase II Study Of Bevacizumab And PEG Interferon Alpha-2b (PEG Intron) In Patients With Metastatic, Or Unresectable Carcinoid Tumors|Completed||Phase 2|44|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:00:39.468324|2017-02-18 18:00:39.468324
NCT00055783|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-05-14|||July 2002||2002-07-01|April 2003|2003-04-01|April 2003|Actual|2003-04-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma|A Phase II Study of Hu1D10 in Recurrent Hodgkin's Disease|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:39.58549|2017-02-18 18:00:39.58549
NCT00055770|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-11-21|||October 2002||2002-10-01|November 2013|2013-11-01||||December 2006|Actual|2006-12-01||Interventional|||Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer|A Phase I and Phase II Study of OSI-774 in Combination With Docetaxel in Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|45|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:00:39.676989|2017-02-18 18:00:39.676989
NCT00055757|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-06-03|||October 2003||2003-10-01|June 2013|2013-06-01||||April 2004|Actual|2004-04-01||Interventional|||Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Phase II Trial of R115777, a Farnesyl Transferase Inhibitor, in Combination With Gemcitabine and Cisplatin in Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:00:39.802126|2017-02-18 18:00:39.802126
NCT00055718|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-12-17|||November 2001||2001-11-01|May 2006|2006-05-01|January 2010|Actual|2010-01-01|||||Interventional|||Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy|A Pilot Study of Silymarin During Maintenance Therapy in Children With Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:40.063945|2017-02-18 18:00:40.063945
NCT00055705|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2011-04-23|||January 2003||2003-01-01|August 2004|2004-08-01||||||||Interventional|||PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer|A Phase I Clinical Trial To Assess The Safety And Efficacy Of Intraperitoneal PV701 Administrations In Patients With Advanced Or Recurrent Malignancy Largely Confined To The Peritoneal Cavity|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:40.163443|2017-02-18 18:00:40.163443
NCT00055692|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2016-01-29|2015-08-25||February 2003||2003-02-01|December 2012|2012-12-01|December 2009|Actual|2009-12-01|January 2008|Actual|2008-01-01||Interventional|||Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer|Bevacizumab (RhuMAB-VEGF) In Hepatocellular Cancer For Patients With Unresectable Tumor (Without Invasion Of The Main Portal Vein Or Metastatic Disease) A Phase II Study|Completed||Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 18:00:40.249854|2017-02-18 18:00:40.249854
NCT00055679|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-06-17|||August 2002||2002-08-01|June 2013|2013-06-01|June 2013|Actual|2013-06-01|June 2012|Actual|2012-06-01||Interventional|||Combination Chemotherapy in Treating Women With Stage I Breast Cancer|Phase III Randomized Study Of Adjuvant Fluourouracil, Epirubicin And Cyclophosphamide, In Women With Stage I Breast Cancer|Completed||Phase 3|1512|Actual|UNICANCER||2|||f||||t||||||||||2017-02-18 18:00:40.572362|2017-02-18 18:00:40.572362
NCT00055666|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2011-03-07|||March 2001||2001-03-01|March 2011|2011-03-01|April 2006|Actual|2006-04-01|February 2005|Actual|2005-02-01||Interventional|||Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract|Compassionate Use Of Oral Beclomethasone Dipropionate For Treatment Of Gastrointestinal Graft Versus Host Disease|Completed||N/A|51|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:00:40.758948|2017-02-18 18:00:40.758948
NCT00055653|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2011-03-03|||January 2003||2003-01-01|March 2011|2011-03-01|September 2005|Actual|2005-09-01|September 2003|Actual|2003-09-01||Interventional|||Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders|Unrelated Umbilical Cord Blood As An Alternate Source Of Stem Cells Transplantation|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:00:40.853007|2017-02-18 18:00:40.853007
NCT00055640|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2010-06-09|||October 2002||2002-10-01|June 2010|2010-06-01|March 2006|Actual|2006-03-01|April 2005|Actual|2005-04-01||Interventional|||Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma|Molecular Risk Guided Treatment Of Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|9|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:00:40.996116|2017-02-18 18:00:40.996116
NCT00055614|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2013-06-25|||May 2002||2002-05-01|April 2007|2007-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|Phase I Study of Oral Topotecan as Consolidation for Patients With Mullerian Origin Tumors (Ovary, Tube, Peritoneum)|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:00:41.107809|2017-02-18 18:00:41.107809
NCT00055601|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2016-06-30|2016-06-30||December 2002||2002-12-01|June 2016|2016-06-01||||October 2010|Actual|2010-10-01||Interventional||All eligible patients who started protocol treatment.|Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer|A Phase II Randomized Trial for Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery and BID Irradiation Plus Either Paclitaxel and Cisplatin or 5-Fluorouracil and Cisplatin Followed by Selective Bladder Preservation and Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy|Active, not recruiting||Phase 2|97|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:00:41.198458|2017-02-18 18:00:41.198458
NCT00055588|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2017-01-24|||March 4, 2003||2003-03-04|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Interventional|||Nervous System Function in Normal Volunteers During Cycling Training|Spinal Substrates of Training-Dependent Improvements in Locomotor Function|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:41.804842|2017-02-18 18:00:41.804842
NCT00055575|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-06|2017-01-24|||February 27, 2003||2003-02-27|February 2, 2015|2015-02-02|February 2, 2015|Actual|2015-02-02|February 2, 2015|Actual|2015-02-02||Interventional|||Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies|Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies|Terminated||N/A|197|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:00:41.90906|2017-02-18 18:00:41.90906
NCT00055562|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-05|2005-06-23|||January 2003||2003-01-01|May 2004|2004-05-01|December 2004||2004-12-01|||||Interventional|||Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma|Multicenter, Randomized, Controlled, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma Whose Disease Has Progressed on Treatment With DTIC, IL-2 or IFN Based Therapy|Completed||Phase 2/Phase 3|274||Celgene|||||||||||||||||||2017-02-18 18:00:42.098842|2017-02-18 18:00:42.098842
NCT00055549|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-05|2017-01-24|||March 4, 2003||2003-03-04|November 13, 2009|2009-11-13|November 13, 2009|Actual|2009-11-13|November 13, 2009|Actual|2009-11-13||Interventional|||Dextromethorphan to Treat Patients With Voice Spasms|The Effects of an NMDA-Receptor Antagonist in Idiopathic Voice Disorders|Completed||Phase 1|65||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:00:42.404949|2017-02-18 18:00:42.404949
NCT00055536|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-04|2016-06-14|||April 2002||2002-04-01|March 2012|2012-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease|A Phase II, Multi-Center, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of Intravenous Antegren (Natalizumab) in Crohn's Disease Subjects Concurrently Receiving Remicade (Infliximab) and Not in Remission|Completed||Phase 2|60||Biogen|||||||||||||||||||2017-02-18 18:00:42.492374|2017-02-18 18:00:42.492374
NCT00055523|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-04|2006-08-11|||April 2002||2002-04-01|August 2006|2006-08-01||||||||Interventional|||A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease|A Phase II Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease|Completed||Phase 2|300||Abbott|||||||||||||||||||2017-02-18 18:00:42.593081|2017-02-18 18:00:42.593081
NCT00055510|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-04|2005-06-23||||||February 2004|2004-02-01||||||||Interventional|||A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.||Completed||Phase 2/Phase 3|||Chugai Pharma USA|||||||||||||||||||2017-02-18 18:00:42.728815|2017-02-18 18:00:42.728815
NCT00055497|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-03|2011-04-07|2009-12-15||August 2002||2002-08-01|April 2011|2011-04-01|December 2008|Actual|2008-12-01|January 2005|Actual|2005-01-01||Interventional|CLASSICII||Remission in Subjects With Crohn's Disease, 1 Year Phase|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Maintenance of Clinical Remission in Subjects With Crohn's Disease|Completed||Phase 3|276|Actual|Abbott||4|||f||||f||||||||||2017-02-18 18:00:42.856738|2017-02-18 18:00:42.856738
NCT00055484|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-03|2015-12-10|||March 2002||2002-03-01|December 2015|2015-12-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache|A Double-Blind, Randomized, Multicenter, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150 mg and 300 mg Per Day and Placebo in Subjects With Migraine Headache|Completed||Phase 2|204||Elan Pharmaceuticals|||||||||||||||||||2017-02-18 18:00:44.387214|2017-02-18 18:00:44.387214
NCT00055471|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-03|2012-10-23|2011-03-29||June 2003||2003-06-01|October 2012|2012-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer||Completed||Phase 2|22|Actual|AstraZeneca|One patient received one dose of 22.5 mg and was dose reduced to 15 mg thereafter. This patient was classified into the 15 mg dose group, except for the single dose pharmacokinetic results (not posted).|3|||f||||||||||||||2017-02-18 18:00:44.486765|2017-02-18 18:00:44.486765
NCT00055445|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-03|2006-08-17|||November 2003||2003-11-01|July 2006|2006-07-01|April 2006||2006-04-01|||||Interventional|||IdB 1016 Treatment for Hepatitis C Disease|IdB 1016 in Hepatitis C|Completed||Phase 1/Phase 2|45||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 18:00:45.297967|2017-02-18 18:00:45.297967
NCT00055432|ClinicalTrials.gov processed this data on February 17, 2017|2003-03-03|2006-09-13||||||September 2006|2006-09-01||||||||Interventional|||Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer||Terminated||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:00:45.392366|2017-02-18 18:00:45.392366
NCT00055419|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-28|2010-04-08|||February 2003||2003-02-01|April 2010|2010-04-01|August 2004|Actual|2004-08-01|July 2004|Actual|2004-07-01||Interventional|||A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer|A Phase II Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer|Completed||Phase 2|744|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 18:00:45.54401|2017-02-18 18:00:45.54401
NCT00055393|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-28|2016-05-14|||July 2002||2002-07-01|May 2016|2016-05-01|April 2006|Actual|2006-04-01|May 2005|Actual|2005-05-01||Interventional|||Bupropion in the Treatment of Pathological Gambling|Bupropion Versus Placebo in the Treatment of Pathological Gambling|Completed||N/A|80|Actual|University of Iowa||2|||f||||f||||||||No|There is no plan to share individual participant data.|2017-02-18 18:00:45.877697|2017-02-18 18:00:45.877697
NCT00055380|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-28|2008-03-03|||February 2003||2003-02-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients|Molecular, Genetic, and Biochemical Effects Of Novel Therapies In Buccal Mucosal Cells|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:45.977054|2017-02-18 18:00:45.977054
NCT00055367|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-26|2016-06-14|||April 2002||2002-04-01|March 2012|2012-03-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease|A Phase II, International, Multicenter, Open Label Study of the Safety, Tolerability and Effectiveness of Three Intravenous Infusions of Antegren (Natalizumab) in Adolescents With Moderately to Severely Active Crohn's Disease|Completed||Phase 2|30||Biogen|||||||||||||||||||2017-02-18 18:00:46.059623|2017-02-18 18:00:46.059623
NCT00055354|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-26|2006-08-17|||September 2002||2002-09-01|July 2006|2006-07-01|May 2004||2004-05-01|||||Interventional|||Acupuncture for the Treatment of Post-Traumatic Stress Disorder (PTSD)|Acupuncture Diagnosis and Treatment of DSM-IV PTSD|Completed||N/A|90||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:00:46.16107|2017-02-18 18:00:46.16107
NCT00055341|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-25|2008-07-29|||March 2002||2002-03-01|December 2006|2006-12-01|June 2005||2005-06-01|||||Interventional|||Treatment of Hepatitis C in Hemophilic Patients With HIV|A Prospective Multicenter, Phase II, Open Label, Controlled Trial Evaluating the Response of Hepatitis C Virus (HCV) to Pegylated Interferon Alpha-2A and Ribavirin in Hemophilic Patients With and Without Coinfection With the Human Immunodeficiency Virus (HIV)|Completed||Phase 2|22||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:00:46.24256|2017-02-18 18:00:46.24256
NCT00055328|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-25|2013-09-06|||December 2002||2002-12-01|August 2008|2008-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Treatment for Depression in the Primary Care Setting|Problem-Solving Treatment for Primary Care Depression|Completed||Phase 4|300||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 18:00:46.332742|2017-02-18 18:00:46.332742
NCT00055315|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-25|2013-07-25|||July 2002||2002-07-01|July 2013|2013-07-01|April 2007|Actual|2007-04-01|||||Interventional|||Treatment for Borderline Personality Disorder|A Cognitive Group Treatment for Borderline Outpatients|Completed||N/A|160||University of Iowa|||||f||||||||||||||2017-02-18 18:00:46.415448|2017-02-18 18:00:46.415448
NCT00055302|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-25|2015-08-31|||August 2002||2002-08-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|February 2006|Actual|2006-02-01||Interventional|||Arimidex in McCune Albright Syndrome|An Open-label Study Evaluating the Safety and Efficacy of Anastrozole™ (ARIMIDEX) in the Treatment of Precocious Puberty in Girls With McCune-Albright Syndrome|Completed||Phase 2|40|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 18:00:46.499482|2017-02-18 18:00:46.499482
NCT00055289|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-22|2008-03-03|||February 2003||2003-02-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Brain Use of Sensory Information to Generate Movement|Role of Multimodal Areas for Sensory-To-Motor Processing|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:46.615143|2017-02-18 18:00:46.615143
NCT00055263|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-21|2009-07-24|||March 2002||2002-03-01|February 2003|2003-02-01||||||||Interventional|||A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies|A Phase I, Open Label, Dose Escalation Study of a New Formulation of Calcitriol (DN-101) for Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Malignancies|Completed||Phase 1|60||Novacea|||||||||||||||||||2017-02-18 18:00:46.687476|2017-02-18 18:00:46.687476
NCT00055250|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-21|2007-01-24|||January 2003||2003-01-01|January 2007|2007-01-01|October 2005||2005-10-01|||||Interventional|||A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer|A Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of Gemcitabine Plus LY293111 Compared to Gemcitabine Plus Placebo in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Completed||Phase 2|130||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:00:46.770328|2017-02-18 18:00:46.770328
NCT00055237|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-21|2012-07-30|2012-06-19||February 2003||2003-02-01|July 2012|2012-07-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients|Phase II Study of Intravenous Recombinant Humanized Anti-Vascular Endothelial Cell Growth Factor Antibody (Bevacizumab) in Classical (HIV-Negative) and in AIDS-Associated Kaposi's Sarcoma|Completed||Phase 2|19|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:00:46.865996|2017-02-18 18:00:46.865996
NCT00055224|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-21|2017-01-24|||February 13, 2003||2003-02-13|December 22, 2016|2016-12-22||||||||Observational|||Expectation of Unpleasant Events in Anxiety Disorders|Predictability and Aversive Expectancies in Anxiety and Depressive Disorders|Recruiting||N/A|1191|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:47.402559|2017-02-18 18:00:47.402559
NCT00055198|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-20|2016-07-13|||December 2002||2002-12-01|July 2016|2016-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria|A Compassionate Use Protocol for Intravenous Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria That Cannot be Adequately Treated With Currently Available Therapy|Terminated||Phase 3|75||Cubist Pharmaceuticals LLC||||Study terminated due to low enrollment|||||||||||||||2017-02-18 18:00:47.507531|2017-02-18 18:00:47.507531
NCT00055185|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-20|2008-10-02|||April 2003||2003-04-01|October 2008|2008-10-01|June 2005|Actual|2005-06-01|||||Interventional|||Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients||Completed||Phase 2|24||Progenics Pharmaceuticals, Inc.||2|||f||||||||||||||2017-02-18 18:00:47.59302|2017-02-18 18:00:47.59302
NCT00055172|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-20|2017-01-24|||February 14, 2003||2003-02-14|June 15, 2016|2016-06-15||||||||Observational|||Genetic Basis of Immunodeficiency|The Determination of Genetic Basis Of Immunodeficiency|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:47.680515|2017-02-18 18:00:47.680515
NCT00055159|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-20|2017-01-24|||February 19, 2003||2003-02-19|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Interventional|||Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins|Treatment of Jugular, Subclavian, and/or Innominate Vein Thrombosis With Low Dose Recombinant Tissue Plasminogen Activator Plus Anticoagulation|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:47.785884|2017-02-18 18:00:47.785884
NCT00055146|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-19|2009-04-16|||March 2003||2003-03-01|April 2009|2009-04-01|May 2006|Actual|2006-05-01|March 2006|Actual|2006-03-01||Interventional|||Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)|A Multicenter, Phase II Study of ONTAK (Denileukin Diftitox) in Patients With Previously-Treated Chronic Lymphocytic Leukemia|Completed||Phase 2|41|Anticipated|Eisai Inc.|||||f||||||||||||||2017-02-18 18:00:47.878746|2017-02-18 18:00:47.878746
NCT00055133|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-19|2008-07-26|||September 2002||2002-09-01|July 2008|2008-07-01|December 2004||2004-12-01|||||Interventional|||A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis|A Phase 2 Open-Label Clinical Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis|Completed||Phase 2|50||Angiotech Pharmaceuticals|||||||||||||||||||2017-02-18 18:00:47.984875|2017-02-18 18:00:47.984875
NCT00055120|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-19|2014-10-14|||March 2003||2003-03-01|October 2014|2014-10-01|August 2007|Actual|2007-08-01|September 2006|Actual|2006-09-01||Interventional|||When to Start Anti-HIV Drugs in Patients With Opportunistic Infections|A Phase IV Study of Antiretroviral Therapy for HIV Infected Adults Presenting With Acute Opportunistic Infections: Immediate Versus Deferred Initiation of Antiretroviral Therapy|Completed||Phase 4|283|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:00:48.074892|2017-02-18 18:00:48.074892
NCT00055107|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-19|2012-02-14||||||February 2012|2012-02-01|May 2006|Actual|2006-05-01|||||Interventional|||Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children|A Phase I/II Open Label Study of Nitazoxanide (NTZ) for the Treatment of Cryptosporidium Parvum in HIV Infected Infants, Children, and Adolescents|Completed||Phase 1/Phase 2|6|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:00:48.222189|2017-02-18 18:00:48.222189
NCT00055094|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-19|2005-06-23|||July 1999||1999-07-01|April 2004|2004-04-01||||||||Observational|||Treatment of Acute HIV Infection to Preserve Immune Function|Immune Control of HIV Replication|Completed||N/A|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:00:48.342337|2017-02-18 18:00:48.342337
NCT00055081|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-19|2013-12-05|||July 2002||2002-07-01|December 2013|2013-12-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||The Impact of Family CTI on Homeless Children|The Impact of Family CTI on Homeless Children|Completed||N/A|320|Actual|Nathan Kline Institute for Psychiatric Research||1|||f||||f||||||||||2017-02-18 18:00:48.431234|2017-02-18 18:00:48.431234
NCT00055068|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-19|2014-05-06|||March 2002||2002-03-01|February 2008|2008-02-01|February 2006||2006-02-01|||||Interventional|||Family Based Treatment of Early Childhood Obsessive Compulsive Disorder|Family Based Treatment of Early Childhood OCD|Completed||Phase 3|38|Anticipated|Rhode Island Hospital|||||f||||||||||||||2017-02-18 18:00:48.555163|2017-02-18 18:00:48.555163
NCT00055055|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-15|2017-01-24|||February 13, 2003||2003-02-13|November 21, 2016|2016-11-21||||||||Observational|||Study of Families With Twins or Siblings Discordant for Rheumatic Disorders|Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders|Recruiting||N/A|1550|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:48.639495|2017-02-18 18:00:48.639495
NCT00055042|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-15|2008-03-03|||February 2003||2003-02-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Interventional|||Laser and Antioxidant Treatment of Diabetic Macular Edema|Laser and Antioxidant Treatment of Diabetic Macular Edema|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:48.746784|2017-02-18 18:00:48.746784
NCT00055029|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-15|2017-01-24|||February 12, 2003||2003-02-12|August 1, 2016|2016-08-01||||||||Observational|||Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis|X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:48.958406|2017-02-18 18:00:48.958406
NCT00055016|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-15|2017-01-24|||February 13, 2003||2003-02-13|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Registry of Fabry Disease - A Multicenter Observational Study|Registry of Fabry Disease: A Multicenter, Longitudinal Observational Study|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:49.059271|2017-02-18 18:00:49.059271
NCT00055003|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-15|2017-01-24|||February 13, 2003||2003-02-13|November 18, 2010|2010-11-18|November 18, 2010||2010-11-18|||||Observational|||Effect of Hydrocortisone on the Brain|Effects of Hydrocortisone Infusion on Processing of Facially Expressed Emotion During Functional Magnetic Resonance Imaging|Completed||N/A|80|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:49.150005|2017-02-18 18:00:49.150005
NCT00054990|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-15|2008-03-03|||February 2003||2003-02-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Effects of Antiepileptic Drugs on Brain Excitability|The Effects Of Antiepileptic Drugs On Cortical Excitability|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:00:49.258038|2017-02-18 18:00:49.258038
NCT00054977|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-14|2012-03-09|||February 2003||2003-02-01|March 2012|2012-03-01|September 2006|Actual|2006-09-01|April 2005|Actual|2005-04-01||Interventional|||Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors|A Phase I Open-Label Study to Evaluate the Safety and Tolerability of Escalating Doses of GM-CT-01 in the Presence and Absence of 5-Fluorouracil (5-FU) in Subjects With Advanced Solid Tumors|Completed||Phase 1|40|Actual|Galectin Therapeutics Inc.||1|||f||||f||||||||||2017-02-18 18:00:49.342324|2017-02-18 18:00:49.342324
NCT00054964|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-14|2017-02-03|||March 2003||2003-03-01|February 2017|2017-02-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique|Comparison of Single-dose Efficacy of Albuterol-HFA-BOI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability|Completed||Phase 2|14|Actual|Teva Pharmaceutical Industries||2|||f||||f||||||||||2017-02-18 18:00:49.44636|2017-02-18 18:00:49.44636
NCT00054951|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-13|2005-06-23|||June 2001||2001-06-01|September 2003|2003-09-01||||||||Interventional|||Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads|A Phase I/II, Open Label, Multicenter, Single-Arm, Safety and Efficacy Study of Doxorubicin Hydrochloride Adsorbed to Magnetic Targeted Carriers (MTC-DOX) Administered by Intrahepatic Delivery (Via Hepatic Artery Catheterization) for the Treatment of Patients With Unresectable Hepatocellular Carcinoma.|Unknown status|Active, not recruiting|Phase 1/Phase 2|30||FeRx|||||||||||||||||||2017-02-18 18:00:49.559768|2017-02-18 18:00:49.559768
NCT00054938|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-13|2013-12-23|||March 2003||2003-03-01|December 2013|2013-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)|A Randomized Controlled Trial of Strategies for the Prevention of Accelerated Atherosclerosis in Systemic Lupus Erythematosus - A Pilot Study|Completed||Phase 2|150||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 18:00:49.64096|2017-02-18 18:00:49.64096
NCT00054925|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-13|2012-03-06|||January 2003||2003-01-01|March 2012|2012-03-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|WLM||Weight Loss Maintenance (WLM)|Weight Loss Maintenance (WLM)|Completed||N/A|1685|Actual|Duke University||2|||f||||t||||||||||2017-02-18 18:00:49.75073|2017-02-18 18:00:49.75073
NCT00054912|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-12|2008-04-07|||February 2003||2003-02-01|April 2004|2004-04-01||||||||Interventional|||An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer|An Open Label, Multi-Center Safety and Tolerance Study of EP2101 Peptide Vaccine in Patients With Stage III Colon Cancer|Completed||Phase 1|18||Epimmune|||||||||||||||||||2017-02-18 18:00:49.842316|2017-02-18 18:00:49.842316
NCT00054899|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-12|2010-03-23|||January 2003||2003-01-01|April 2004|2004-04-01||||||||Interventional|||An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer|An Open Label, Multi-center Safety and Tolerance Study of EP2101 Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|18||Epimmune|||||||||||||||||||2017-02-18 18:00:49.945885|2017-02-18 18:00:49.945885
NCT00054886|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-12|2007-05-04|||January 2003||2003-01-01|July 2006|2006-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer|Phase II Study Of Single-Agent SU011248 In The Second-Line Treatment Of Patients With Metastatic Renal Cell Carcinoma|Completed||Phase 2|63||Pfizer|||||f||||||||||||||2017-02-18 18:00:50.237816|2017-02-18 18:00:50.237816
NCT00054873|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-12|2006-07-10|||November 2003||2003-11-01|June 2006|2006-06-01|December 2004||2004-12-01|||||Interventional|||Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer||Completed||Phase 2|||Chiron Corporation|||||||||||||||||||2017-02-18 18:00:50.355356|2017-02-18 18:00:50.355356
NCT00054860|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-11|2015-04-13||||||April 2015|2015-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults|A Phase I Dose-Escalation Clinical Trial to Evaluate the Safety and Immunogenicity of the EP HIV-1090 DNA Vaccine in Healthy, HIV-1-Uninfected Adult Participants|Completed||Phase 1|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:00:50.488777|2017-02-18 18:00:50.488777
NCT00054847|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-11|2014-04-18|2014-01-31||February 2003||2003-02-01|April 2014|2014-04-01|February 2010|Actual|2010-02-01|February 2009|Actual|2009-02-01||Interventional|||Radial Artery Versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery|CSP #474 - Radial Artery vs. Saphenous Vein Grafts in Coronary Artery Bypass Surgery (Radial Artery)|Completed||N/A|733|Actual|VA Office of Research and Development|There was more disease in the radial artery grafts at 1 week and at 1 year. There is more spasm or string sign in radial artery grafts. Study was conducted predominantly in men. Data show lower vein graft patency when endoscopic harvesting was used.|2|||f||||t||||||||||2017-02-18 18:00:50.625733|2017-02-18 18:00:50.625733
NCT00054834|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-11|2008-01-08|||March 2003||2003-03-01|January 2008|2008-01-01||||||||Interventional|||Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma|A Phase I Clinical Trial of Radiolabeled Immunotherapy With Humanized LL2 in Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma|Terminated||Phase 1|27||Immunomedics, Inc.||||lack of accrual|||||||||||||||2017-02-18 18:00:52.749453|2017-02-18 18:00:52.749453
NCT00054821|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-11|2013-08-02|||November 2002||2002-11-01|August 2013|2013-08-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Prevention of Post-Traumatic Osteoarthritis (OA)|Pathogenesis-Prevention of Post-Traumatic Osteoarthritis (OA): Effects of Distraction and Motion on OA|Completed||N/A|56|Anticipated|University of Iowa||2|||f||||t||||||||||2017-02-18 18:00:52.82032|2017-02-18 18:00:52.82032
NCT00054808|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-10|2006-02-07|||June 2002||2002-06-01|February 2006|2006-02-01||||||||Interventional|||Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Multicenter Study of Gallium Nitrate in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|40||Genta Incorporated|||||||||||||||||||2017-02-18 18:00:52.926534|2017-02-18 18:00:52.926534
NCT00054795|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-10|2007-05-04||||||May 2007|2007-05-01||||||||Interventional|||Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)|Randomized Phase III Trial of Xcytrin® (Motexafin Gadolinium) Injection for the Treatment of Brain Metastases in Patients With Non-Small Cell Lung Cancer Undergoing Whole Brain Radiation Therapy|Completed||Phase 3|550||Pharmacyclics LLC.|||||||||||||||||||2017-02-18 18:00:53.016986|2017-02-18 18:00:53.016986
NCT00054769|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-10|2008-09-16|||March 2002||2002-03-01|July 2007|2007-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||Diagnosing Tuberculosis in HIV Infected Children in Peru|Diagnostics For AIDS-Related Pediatric TB, Peru|Completed||N/A|760||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:00:53.201712|2017-02-18 18:00:53.201712
NCT00054756|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-07|2017-02-04|||February 6, 2003||2003-02-06|June 30, 2016|2016-06-30|February 3, 2017|Actual|2017-02-03|February 3, 2017|Actual|2017-02-03||Interventional|||Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities|Study of Thyrotropin Releasing Hormone in Patients With Thyroid or Pituitary Abnormalities|Completed||Phase 2|157|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:00:53.284117|2017-02-18 18:00:53.284117
NCT00054743|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-07|2017-01-24|||February 6, 2003||2003-02-06|April 28, 2011|2011-04-28|April 28, 2011|Actual|2011-04-28|||||Interventional|||Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States|Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations|Completed||Phase 4|24|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:00:53.39486|2017-02-18 18:00:53.39486
NCT00054730|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-07|2005-06-23|||June 2002||2002-06-01|February 2005|2005-02-01||||||||Interventional|||Effects of CX516 on Functioning in Fragile X Syndrome and Autism|Effects of Ampakine CX516 (Ampalex®) on Functioning in Fragile X Syndrome and Autism|Completed||Phase 2|||RespireRx|||||||||||||||||||2017-02-18 18:00:53.489669|2017-02-18 18:00:53.489669
NCT00054717|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-07|2014-06-23|2009-09-09||January 2003||2003-01-01|April 2014|2014-04-01||||September 2008|Actual|2008-09-01||Interventional||Safety Set, all patients treated with at least one dose of study drug|Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)|Randomized, Open-label, Comparative Safety and Efficacy Study of Tipranavir Boosted With Low-dose Ritonavir (TPV/RTV) Verses Genotypically-defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-experienced Patients.|Completed||Phase 3|630|Actual|Boehringer Ingelheim||2|||f||||||||||||||2017-02-18 18:00:53.589869|2017-02-18 18:00:53.589869
NCT00054704|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-06|2016-05-17|2015-12-10||February 2003||2003-02-01|May 2016|2016-05-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||All participants randomized.|Riluzole to Treat Depression in Bipolar Disorder|An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression|Terminated||Phase 2|20|Actual|National Institutes of Health Clinical Center (CC)|The study was terminated due to results suggesting the active drug was leading to worse outcomes than placebo.|2||Placebo was better than active drug.|f||||t||||||||No||2017-02-18 18:00:59.982269|2017-02-18 18:00:59.982269
NCT00054691|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-06|2015-02-24|2015-01-28||May 2004||2004-05-01|February 2015|2015-02-01|October 2012|Actual|2012-10-01|October 2012|Actual|2012-10-01||Interventional||Out of 40 participants, 2 participants had unmeasurable disease and 1 participant was noncompliant.|ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin|A Phase II Study of ZD1839 (Iressa), Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor, in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Skin|Completed||Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:01:00.649956|2017-02-18 18:01:00.649956
NCT00054678|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-06|2007-10-11|||February 2003||2003-02-01|October 2007|2007-10-01|October 2007|Anticipated|2007-10-01|||||Interventional|||MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)|A Phase I, Open-Label, Non-Randomized, Dose Escalation, Multi Center Study to Assess the Safety and Cardiovascular Effects of Autologous Skeletal Myoblast Implantation by a Transendocardial Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s) With Previous Placement of ICD|Unknown status|Active, not recruiting|Phase 1|20||Bioheart, Inc.|||||f||||||||||||||2017-02-18 18:01:00.97416|2017-02-18 18:01:00.97416
NCT00054665|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2012-08-10|2012-06-25||February 2003||2003-02-01|August 2012|2012-08-01|July 2009|Actual|2009-07-01|September 2008|Actual|2008-09-01||Interventional|||PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma|PS-341 and PS-341 + Epoch Chemotherapy and Molecular Profiling in Relapsed or Refractory Diffuse Large B-Cell Lymphomas|Completed||Phase 2|50|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:01:01.09072|2017-02-18 18:01:01.09072
NCT00054652|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2008-03-03|||February 2003||2003-02-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Observational|||Survey of Sensory and Motor Tricks in Focal Dystonia|Survey of Sensory and Motor Tricks in Focal Dystonia|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:01.830481|2017-02-18 18:01:01.830481
NCT00054639|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2014-05-13|2011-01-24||January 2003||2003-01-01|March 2013|2013-03-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma|A Phase II Study of G3139 (Bcl-2 Antisense) And Rituximab in Patients With Recurrent B-cell Non-Hodgkinâs Lymphomas|Completed||Phase 2|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:01.909004|2017-02-18 18:01:01.909004
NCT00054626|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-12-17|||September 2001||2001-09-01|November 2008|2008-11-01||||June 2008|Anticipated|2008-06-01||Interventional|||Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer|Phase III Study Of Adjuvant Cisplatin-Gemcitabine Vs. Observation After Radical Cystectomy In High-Risk Bladder Cancer|Unknown status|Active, not recruiting|Phase 3|700|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:02.187931|2017-02-18 18:01:02.187931
NCT00054613|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2016-07-22|||June 2002||2002-06-01|July 2016|2016-07-01|March 2004||2004-03-01|||||Interventional|||Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease|A Randomized Single-Blind Study of Extracorporeal Photoimmune Therapy With UVADEX in Conjunction With Standard Therapy Alone for the Treatment of Patients With Corticosteroid-Refractory, Corticosteroid-Dependent, or Corticosteroid-Intolerant Chronic Graft-versus-Host Disease|Completed||Phase 2|72||Mallinckrodt|||||||||||||||||||2017-02-18 18:01:02.728208|2017-02-18 18:01:02.728208
NCT00054600|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2016-05-23|||June 2002||2002-06-01|May 2016|2016-05-01|June 2004||2004-06-01|||||Interventional|||Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease|A Study of Extracorporeal Photopheresis With UVADEX in the Setting of a Standard Myeloablative Conditioning Regimen for the Prevention of Graft-versus-Host Disease in Patients Undergoing an Allogeneic Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant|Completed||Phase 2|60||Mallinckrodt|||||||||||||||||||2017-02-18 18:01:02.851994|2017-02-18 18:01:02.851994
NCT00054587|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-07-18|||June 2001||2001-06-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|June 2009|Actual|2009-06-01||Interventional|||Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer|Randomized And Multicentric Opened Phase III Study Evaluating The Concomitant Administration Of Docetaxel 75MG/M2 and Epirubicine 75MG/M2 Versus FEC 100 In Non Metastatic With Positive Lymphatic Nodes Breast Cancer Subjects, And The Sequential Addition Of Herceptin In (HER2+++) And (HER2++ And FISH+) Subjects|Completed||Phase 3|3010|Actual|UNICANCER||2|||f||||t||||||||||2017-02-18 18:01:02.984157|2017-02-18 18:01:02.984157
NCT00054574|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2012-08-02|||November 2002||2002-11-01|August 2012|2012-08-01|February 2004|Actual|2004-02-01|September 2003|Actual|2003-09-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer|A Clinical Trial Evaluating The Safety And Efficacy Of ABX-EGF In Patients With Hormone Resistant Prostate Cancer With Elevated PSA Without Metastasis|Completed||Phase 2|||Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:01:03.15766|2017-02-18 18:01:03.15766
NCT00054561|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2009-02-06|||August 2003||2003-08-01|May 2004|2004-05-01||||December 2004|Actual|2004-12-01||Interventional|||Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Phase III Randomized Study of Adjuvant Biologic Therapy in Patients With Stages III/IV Head and Neck Squamous Cell Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:03.25562|2017-02-18 18:01:03.25562
NCT00054548|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-05-15|||October 2002||2002-10-01|May 2013|2013-05-01||||May 2008|Actual|2008-05-01||Interventional|||Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors|A Phase I Study of Antisense Bcl-2 Oligonucleotide (G3139) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:03.43701|2017-02-18 18:01:03.43701
NCT00054535|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-06-18|||January 2003||2003-01-01|July 2004|2004-07-01|September 2004|Actual|2004-09-01|||||Interventional|||Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma|Treatment Of Patients With Metastatic Melanoma Using Recombinant Vaccinia And Fowlpox Viruses Encoding The Tyrosine Antigen In Combination With Interleukin-2|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:03.547853|2017-02-18 18:01:03.547853
NCT00054522|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2011-03-07|||April 2002||2002-04-01|March 2011|2011-03-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy|Calcitriol + Dexamethasone in Early, Recurrent Prostate Cancer Following Local Therapy, A Phase I/II Trial|Completed||Phase 2|15|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:01:03.645021|2017-02-18 18:01:03.645021
NCT00054496|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2014-01-09|||August 2002||2002-08-01|December 2006|2006-12-01||||||||Interventional|||Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme|Phase II Study Trial Of Tarceva In Patients With Recurrent/Progressive Glioblastoma Multiforme|Unknown status|Recruiting|Phase 2|73|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:03.744615|2017-02-18 18:01:03.744615
NCT00054483|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-05-15|||January 2003||2003-01-01|May 2013|2013-05-01||||September 2009|Actual|2009-09-01||Interventional|||Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction|A Phase I Pharmacokinetic Study of PS341 in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction for the CTEP-Sponsored Organ Dysfunction Working Group|Completed||Phase 1|69|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:03.851393|2017-02-18 18:01:03.851393
NCT00054470|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2012-06-27|||December 2002||2002-12-01|June 2012|2012-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer|A Phase II Evaluation Of The Efficacy And Safety Of R115777 (NSC702818) A Non-Peptidomimetic Farnesyl Transferase Inhibitor, And Trastuzumab In Patients With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:01:03.968507|2017-02-18 18:01:03.968507
NCT00054457|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2016-12-09|||September 2003||2003-09-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|February 2007|Actual|2007-02-01||Interventional|||Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction|A Phase II Study Of Docetaxel And Capecitabine In Patients With Measurable Metastatic Adenocarcinoma Of The Stomach And Gastroesophageal Junction|Completed||Phase 2|46|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:01:04.064633|2017-02-18 18:01:04.064633
NCT00054444|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2014-12-29|||September 2007||2007-09-01|December 2014|2014-12-01||||January 2012|Actual|2012-01-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer|A PHASE I STUDY OF PELVIC RADIATION THERAPY WITH CONCOMITANT WEEKLY CISPLATIN AND TOPOTECAN CHEMOTHERAPY IN PATIENTS WITH CERVICAL CARCINOMA WITHOUT EXTRA-PELVIC METASTASIS|Completed||Phase 1|11|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:01:04.366675|2017-02-18 18:01:04.366675
NCT00054431|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-01-22|||January 2003||2003-01-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia|Phase II Study of Imatinib Mesylate (Gleevec, STI-571) (NSC#716051) and Decitabine (5-AZA-2'-Deoxycitidine) (NSC#127716), in Chronic Myelogenous Leukemia in Accelerated and Blastic Phases|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:04.502356|2017-02-18 18:01:04.502356
NCT00054418|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2016-07-12|||March 2003||2003-03-01|July 2016|2016-07-01|May 2008|Actual|2008-05-01|April 2007|Actual|2007-04-01||Interventional|||Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer|A Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of Risedronate (Actonel) For Prevention Of Bone Loss In Premenopausal Women Undergoing Chemotherapy For Primary Breast Carcinoma|Completed||Phase 3|216|Actual|Alliance for Clinical Trials in Oncology||2|||f||||||||||||||2017-02-18 18:01:04.625569|2017-02-18 18:01:04.625569
NCT00053521|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2016-11-04|||January 2003||2003-01-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Observational|||Genetic Epidemiology of CVD Risk Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:01:21.354272|2017-02-18 18:01:21.354272
NCT00054405|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-04-08|||December 2002||2002-12-01|April 2013|2013-04-01||||May 2009|Actual|2009-05-01||Interventional|||Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma|A Phase I Investigation of IL-12 (NSC 672423)/Pulse IL-2 (Aldesleukin) in Children With Persistent and/or Refractory Neuroblastoma (13623)|Terminated||Phase 1|40|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:01:05.143096|2017-02-18 18:01:05.143096
NCT00054392|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-07-10|||September 2001||2001-09-01|July 2013|2013-07-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer|A Randomized, Phase III Multicenter Trial Of Gemcitabine In Combination With Carboplatin Or Paclitaxel Plus Carboplatin In Patients With Metastatic (Stage IIIB, IV) Non-Small Cell Lung Cancer|Withdrawn||Phase 3|0|Actual|Fox Chase Cancer Center||||Not opened at Fox Chase Cancer Center|f||||||||||||||2017-02-18 18:01:05.287953|2017-02-18 18:01:05.287953
NCT00054353|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2016-12-13|||October 2002||2002-10-01|December 2016|2016-12-01||||October 2009|Actual|2009-10-01||Interventional|||Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma|Reduced-Intensity Allogeneic HSC Transplantation From HLA-Matched Related and Unrelated Donors for Patients With Multiple Myeloma - A Multi-Center Trial|Active, not recruiting||Phase 1/Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:01:05.458863|2017-02-18 18:01:05.458863
NCT00054340|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2010-05-12|||October 2002||2002-10-01|May 2010|2010-05-01|September 2006|Actual|2006-09-01|||||Interventional|||Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder|Conditioning With Targeted Busulfan, Cyclophosphamide and Thymoglobulin for Allogeneic Marrow or Peripheral Blood Stem Cell (PBSC) Transplantation for Myelodysplasia and Myeloproliferative Disorders|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:01:05.597415|2017-02-18 18:01:05.597415
NCT00054327|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-06-19|2013-04-30||November 2000||2000-11-01|June 2013|2013-06-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer|Hematopoietic Stem Cell Transplantation Using Bone Marrow Or Peripheral Blood Stem Cells From Matched, Unrelated, Volunteer Donors|Completed||Phase 2|34|Actual|Case Comprehensive Cancer Center||6|||f||||t||||||||||2017-02-18 18:01:05.706348|2017-02-18 18:01:05.706348
NCT00054314|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-01-30|||March 2002||2002-03-01|January 2013|2013-01-01||||April 2003|Actual|2003-04-01||Interventional|||BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer|An Uncontrolled, Phase II Study Evaluating Anti-Tumor Efficacy and Safety of BAY 59-8862 in Patients With Taxane Resistant Non-Small Cell Lung Carcinoma (NSCLC)|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:01:07.128082|2017-02-18 18:01:07.128082
NCT00054301|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2010-06-10|||November 2002||2002-11-01|June 2010|2010-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer|Intraoperative Radiation Therapy to the Tumor Bed for Boost Treatment After Lumpectomy Prior to Whole Breast Radiation in Breast Conservation Candidates|Completed||Phase 2|2|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:01:07.207863|2017-02-18 18:01:07.207863
NCT00054288|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2014-01-10|||August 2001||2001-08-01|January 2014|2014-01-01|June 2009|Actual|2009-06-01|May 2003|Actual|2003-05-01||Interventional|||Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors|Escalating Irinotecan (CPT-11) Administered 24 Hours Prior To Gemcitabine In Patients With Refractory Solid Tumors|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:01:07.315128|2017-02-18 18:01:07.315128
NCT00054275|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2016-02-15|2012-02-21||December 2002||2002-12-01|February 2016|2016-02-01|November 2012|Actual|2012-11-01|April 2010|Actual|2010-04-01||Interventional|||Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer|A Phase II Study Of The Weekly Administration Of Docetaxel In Combination With The Epidermal Growth Factor Receptor Inhibitor OSI-774 In Recurrent And/Or Metastatic Breast Cancer|Completed||Phase 2|39|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:01:07.416218|2017-02-18 18:01:07.416218
NCT00054262|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-07-17|||November 2002||2002-11-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|March 2004|Actual|2004-03-01||Interventional|||T900607 in Treating Patients With Unresectable Liver Cancer|A Phase II Study Of Intravenous T900607-Sodium In Subjects With Chemotherapy-Naive Unresectable Hepatocellular Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:07.924613|2017-02-18 18:01:07.924613
NCT00054249|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-07-17|||September 2002||2002-09-01|September 2010|2010-09-01|September 2010|Actual|2010-09-01|October 2004|Actual|2004-10-01||Interventional|||T900607 in Treating Patients With Gastroesophageal Junction Cancer|A Phase II Study Of Intravenous T900607-Sodium In Subjects With Previously Treated Gastric Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:08.023449|2017-02-18 18:01:08.023449
NCT00054236|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2012-09-11|||May 2002||2002-05-01|September 2012|2012-09-01|March 2011|Actual|2011-03-01|March 2011|Actual|2011-03-01||Interventional|||Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia|Pilot Study Of Multiple Umbilical Cord Blood Unit Transplantation Following Non-Myeloablative Conditioning In Patients With Hematologic Disorders Or Severe Aplastic Anemia|Completed||Phase 1|55|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:01:08.112915|2017-02-18 18:01:08.112915
NCT00054223|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2012-03-14|||January 2003||2003-01-01|March 2012|2012-03-01|November 2005|Actual|2005-11-01|||||Interventional|||Study of Decision Making in Patients Participating in Phase I Clinical Trials|Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients|Completed||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:08.246706|2017-02-18 18:01:08.246706
NCT00054210|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2008-07-23|||January 2003||2003-01-01|July 2004|2004-07-01||||||||Interventional|||Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|CT-2103/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of PS = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:08.348946|2017-02-18 18:01:08.348946
NCT00054197|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2011-02-23|||January 2003||2003-01-01|July 2004|2004-07-01||||||||Interventional|||Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|CT-2103 vs Gemcitabine or Vinorelbine for the Treatment of PS = 2 Patients With Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:08.469138|2017-02-18 18:01:08.469138
NCT00054184|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-07-29|||January 2003||2003-01-01|July 2013|2013-07-01||||December 2013|Anticipated|2013-12-01||Interventional|||Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer|CT-2103 vs Docetaxel for the Second-Line Treatment of Non-Small Cell Lung Cancer (NSCLC): A Phase III Study|Unknown status|Active, not recruiting|Phase 3|350|Anticipated|CTI BioPharma||1|||f||||||||||||||2017-02-18 18:01:08.792247|2017-02-18 18:01:08.792247
NCT00054171|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-01-30|||February 1999||1999-02-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia|A Pilot Study of Short (1-2.5 h), Medium (4-6 h) and Long (18-24 h) Applications of 20% Topical ALA-PDT for Photodynamic Therapy of Cutaneous T and B Cell Lymphomas and Cutaneous Infiltrates of Early CLL|Completed||Phase 2|1|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:01:08.981567|2017-02-18 18:01:08.981567
NCT00054158|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-01-30|||August 2004||2004-08-01|January 2013|2013-01-01||||April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma|A Phase II Study of VAD (Vincristine, Adriamycin, Dexamethasone) Plus Thalidomide (Low Dose) as Frontline Therapy for Newly Diagnosed Patients With Multiple Myeloma (MM)|Completed||Phase 2|24|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:01:09.09431|2017-02-18 18:01:09.09431
NCT00054145|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2015-07-22|||June 2003||2003-06-01|July 2015|2015-07-01||||April 2007|Actual|2007-04-01||Interventional|||Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer|A Phase 2 Study Of Perifosine In Metastatic Or Advanced Breast Cancer|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 18:01:09.208183|2017-02-18 18:01:09.208183
NCT00054132|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2015-12-16|||December 2002||2002-12-01|December 2015|2015-12-01||||April 2015|Actual|2015-04-01||Interventional|||Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer|A Phase II Study of OSI-774 in Combination With Bevacizumab in Patients With Stage IV Breast Cancer|Completed||Phase 2|39|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 18:01:09.321805|2017-02-18 18:01:09.321805
NCT00054119|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2014-12-29|||January 2003||2003-01-01|December 2014|2014-12-01||||July 2008|Actual|2008-07-01||Interventional|||Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Karenitecin in the Third-Line Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|27|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:01:09.468446|2017-02-18 18:01:09.468446
NCT00054106|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2010-11-07|||December 2002||2002-12-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer|A Phase I Study Of Combination Neoadjuvant Hormone Therapy And Weekly OGX-011 (Clusterin Antisense Oligonucleotide) Prior To Radical Prostatectomy In Patients With Localized Prostate Cancer|Completed||Phase 1|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:01:09.597851|2017-02-18 18:01:09.597851
NCT00054067|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-04-10|||February 2003||2003-02-01|April 2013|2013-04-01||||April 2005|Actual|2005-04-01||Interventional|||Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix|Treatment of Patients With Stage IB2 Carcinoma of the Cervix: A Randomized Comparison of Radical Hysterectomy and Tailored Chemo-Radiation Versus Primary Chemo-Radiation|Terminated||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:01:09.704143|2017-02-18 18:01:09.704143
NCT00054054|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2011-07-21|||April 2003||2003-04-01|July 2011|2011-07-01||||November 2007|Actual|2007-11-01||Interventional|||S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Docetaxel (NSC-628503), Cisplatin (NSC-119875), And 5-Fluorouracil (NSC-19893) Induction Chemotherapy Followed By Accelerated Fractionation/Concomitant Boost Radiation And Concurrent Single Agent Cisplatin (NSC-119875), In Patients With Advanced Squamous Cell Head And Neck Cancer|Completed||Phase 2|||Southwest Oncology Group|||||f||||f||||||||||2017-02-18 18:01:09.854317|2017-02-18 18:01:09.854317
NCT00054041|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-01-23|||June 2004||2004-06-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia|Phase II Evaluation Of SGN-00101 (HSP-E7) Fusion Protein In Women With Cervical Intraepithelial Neoplasia 3, CIN 3|Completed||Phase 2|84|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:01:10.082108|2017-02-18 18:01:10.082108
NCT00054028|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2015-03-03|2014-11-17||December 2002||2002-12-01|February 2015|2015-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer|A Phase I/II Study of Suramin in Combination With Paclitaxel in Advanced (Stage IIIB or IV) Metastatic Breast Cancer|Completed||Phase 1/Phase 2|31|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:10.226722|2017-02-18 18:01:10.226722
NCT00054015|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-11-05|||December 2002||2002-12-01|April 2004|2004-04-01|January 2008|Actual|2008-01-01|||||Interventional|||3-AP in Treating Patients With Advanced Prostate Cancer|A Phase II Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) in Patients With Advanced Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:11.152479|2017-02-18 18:01:11.152479
NCT00054002|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2011-02-25|||March 1999||1999-03-01|February 2011|2011-02-01|December 2010|Actual|2010-12-01|June 2006|Actual|2006-06-01||Interventional|||Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma|Surgery and Intracavitary Photodynamic Therapy (PDT) for the Treatment of Malignant Pleural Mesothelioma; The Use of Light Delivery Fibers With Large Diffusers|Completed||Phase 2|12|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:01:11.23276|2017-02-18 18:01:11.23276
NCT00053989|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2017-01-04|||January 2002||2002-01-01|January 2017|2017-01-01||||January 2017|Actual|2017-01-01||Interventional|||Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Aplastic Anemia|Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies and Aplastic Anemia|Active, not recruiting||Phase 2|41|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:01:11.335392|2017-02-18 18:01:11.335392
NCT00053976|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2017-01-19|||January 2001||2001-01-01|January 2017|2017-01-01|November 2004|Actual|2004-11-01|November 2003|Actual|2003-11-01||Interventional|||Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease|Treatment of Acute Graft vs. Host Disease With Steroids Plus Daclizumab (Zenapax) or Placebo|Completed||Phase 3|105|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 18:01:11.572192|2017-02-18 18:01:11.572192
NCT00053963|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-01-15|||September 2002||2002-09-01|January 2013|2013-01-01||||February 2006|Actual|2006-02-01||Interventional|||FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia|A PHASE I STUDY OF DEPSIPEPTIDE (NSC#630176, IND# 51810) IN PEDIATRIC PATIENTS WITH REFRACTORY SOLID TUMORS AND LEUKEMIAS|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:11.697798|2017-02-18 18:01:11.697798
NCT00053950|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-04-08|||December 2002||2002-12-01|April 2013|2013-04-01||||March 2007|Actual|2007-03-01||Interventional|||Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma|A Phase I Study of High-dose Pyrazoloacridine (PZA) (NSC 366140) Supported With Autologous Hematopoietic Stem Cell Rescue in Children With Recurrent or Resistant Neuroblastoma (IND # 36325)|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 18:01:11.809439|2017-02-18 18:01:11.809439
NCT00053937|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2015-04-29|||December 2002||2002-12-01|April 2004|2004-04-01||||||||Interventional|||Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas|Phase I Trial Of Pirfenidone In Children With Neurofibromatosis Type 1 And Plexiform Neurofibromas|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:01:11.9369|2017-02-18 18:01:11.9369
NCT00053924|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2015-07-22|||May 2003||2003-05-01|July 2015|2015-07-01||||May 2006|Actual|2006-05-01||Interventional|||Perifosine in Treating Patients With Advanced Pancreatic Cancer|A Phase 2 Study Of Perifosine As Second Line Therapy For Advanced Pancreatic Carcinoma|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 18:01:12.038899|2017-02-18 18:01:12.038899
NCT00053911|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2014-12-14|||November 2002||2002-11-01|December 2014|2014-12-01||||April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer|Randomized And Multicentric Phase III Study Evaluating The Benefit By Using A Chemotherapy With FEC 100 And Docetaxel In Non Metastatic Breast Cancer Which Has Relapsed After A Conservative Surgery|Terminated||Phase 3|||UNICANCER|||||f||||||||||||||2017-02-18 18:01:12.127883|2017-02-18 18:01:12.127883
NCT00053898|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2016-06-08|||January 2003||2003-01-01|June 2016|2016-06-01|May 2016|Actual|2016-05-01|March 2015|Actual|2015-03-01||Interventional|||Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy|A Clinical Trial Comparing Anastrozole With Tamoxifen in Postmenopausal Patients With Ductal Carcinoma in Situ (DCIS) Undergoing Lumpectomy With Radiation Therapy|Completed||Phase 3|3104|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 18:01:12.286077|2017-02-18 18:01:12.286077
NCT00053885|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2016-06-30|||July 2003||2003-07-01|June 2016|2016-06-01|June 2006|Actual|2006-06-01|July 2005|Actual|2005-07-01||Interventional|||PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma|A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:01:16.645021|2017-02-18 18:01:16.645021
NCT00053872|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2014-06-23|||February 2003||2003-02-01|February 2007|2007-02-01||||||||Interventional|||Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma|A Prospective Randomised Controlled Trial Of Hyperfractionated Versus Conventionally Fractionated Radiotherapy In Standard Risk Medulloblastoma|Unknown status|Active, not recruiting|Phase 3|316|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:16.828234|2017-02-18 18:01:16.828234
NCT00053846|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2015-10-27|2014-08-20||November 2002||2002-11-01|October 2015|2015-10-01|January 2011|Actual|2011-01-01|November 2010|Actual|2010-11-01||Interventional|||Buspirone in Reducing Shortness of Breath in Patients With Cancer|Buspirone in Reducing Shortness of Breath in Patients With Cancer|Completed||Phase 2/Phase 3|432|Actual|University of Rochester||2|||f||||t||||||||||2017-02-18 18:01:16.940111|2017-02-18 18:01:16.940111
NCT00053833|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-11-07|||April 2003||2003-04-01|November 2013|2013-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|S0025: Phase II Trial Of Irinotecan (CAMPTOSAR) For Patients With Platinum And Taxane Refractory Ovarian, Peritoneal Or Fallopian Tube Cancer|Terminated||Phase 2|2|Actual|Southwest Oncology Group||1||lack of accrual|f||||t||||||||||2017-02-18 18:01:18.172807|2017-02-18 18:01:18.172807
NCT00053820|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2013-12-18|||July 2002||2002-07-01|August 2006|2006-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer|A Randomized Controlled Trial of Interferon-alpha, Interleukin-2 and 5-Fluorouracil vs. Interferon-alpha Alone in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 3|670|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:18.376645|2017-02-18 18:01:18.376645
NCT00053807|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2012-09-20|||February 1998||1998-02-01|September 2012|2012-09-01||||January 2004|Actual|2004-01-01||Interventional|||Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer|Adjuvant Interleukin-2, Interferon-alpha and 5-Fluorouracil for Patients With High Risk of Relapse After Surgical Treatment for Renal Cell Carcinoma|Completed||Phase 3|96|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:01:18.496559|2017-02-18 18:01:18.496559
NCT00053794|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2010-11-07|||May 2003||2003-05-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma|A Phase II Study Of Perifosine (D-21266) In Patients With Previously Untreated Metastatic Or Locally Advanced Soft Tissue Sarcoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:01:18.62184|2017-02-18 18:01:18.62184
NCT00053781|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2010-11-07|||June 2003||2003-06-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma|A Phase II Study Of Perifosine (D-21266) In Previously Untreated Patients With Metastatic Or Recurrent Malignant Melanoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:01:18.719874|2017-02-18 18:01:18.719874
NCT00053768|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-05|2009-02-06|||April 2002||2002-04-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma|Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Prognoses|Unknown status|Active, not recruiting|Phase 3|552|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:18.833647|2017-02-18 18:01:18.833647
NCT00053742|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-04|2008-03-03|||February 2003||2003-02-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox|A Phase I/II Clinical Trial of Modified Vaccinia Virus Ankara (MVA) to Evaluate Its Safety, Immunogenicity and Protective Efficacy Against Dryvax® (Registered Trademark) Challenge in Vaccinia-Immune Individuals|Completed||Phase 1|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:19.384348|2017-02-18 18:01:19.384348
NCT00053716|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-04|2007-03-06|||February 2003||2003-02-01|March 2004|2004-03-01|August 2003||2003-08-01|||||Interventional|||Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease|Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease|Unknown status|Recruiting|Phase 2|12||Endovasc|||||||||||||||||||2017-02-18 18:01:19.477384|2017-02-18 18:01:19.477384
NCT00053703|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-04|2014-02-07|2013-09-16||February 2002||2002-02-01|February 2014|2014-02-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|TEOSS|We are referring to the population of participants who had baseline assessment, took at least one dose of trial medication, and had at least one post-baseline assessment. There were 3 randomized subjects, on in each treatment group, who did not take at least one dose of study medication and are not included.|Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)|Treatment of Schizophrenia and Related Disorders in Children and Adolescents|Completed||Phase 4|116|Actual|University of North Carolina, Chapel Hill|The most significant weakness of this study was the sample size, which was sufficient only to detect large differences across the three treatments and limited our ability to identify predictors of response or adverse effects.|3|||f||||t||||||||||2017-02-18 18:01:19.565006|2017-02-18 18:01:19.565006
NCT00053690|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-04|2013-09-09|||January 2002||2002-01-01|February 2009|2009-02-01|December 2004||2004-12-01|||||Interventional|||Treatment of Post Traumatic Stress Disorder in Patients With Other Mental Illnesses|Cognitive-Behavioral Treatment of PTSD in SMI Clients|Completed||N/A|88||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 18:01:20.251795|2017-02-18 18:01:20.251795
NCT00053677|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-04|2014-08-21|||December 2002||2002-12-01|August 2014|2014-08-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Drug Treatment for Pathologic Gambling Disorder|Naltrexone Treatment in Pathologic Gambling Disorder|Completed||Phase 3|156||University of Chicago|||||f||||||||||||||2017-02-18 18:01:20.334772|2017-02-18 18:01:20.334772
NCT00053651|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-04|2013-08-20|||September 2001||2001-09-01|August 2013|2013-08-01||||||||Interventional|||Prevention of Postpartum Depression in Low-Income Women|Depression Intervention for Poor Pregnant Women|Completed||Phase 1|250||Butler Hospital|||||f||||t||||||||||2017-02-18 18:01:20.429774|2017-02-18 18:01:20.429774
NCT00053638|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-04|2010-10-01|||February 2003||2003-02-01|October 2010|2010-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy|A Phase III, Randomized, Open-label, Multicenter Study of the Safety and Efficacy of Efavirenz Versus Tenofovir When Administered in Combination With the Abacavir/Lamivudine Fixed-dose Combination Tablet as a Once-daily Regimen in Antiretroviral-naive HIV-1 Infected Subjects.|Completed||Phase 3|345||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:01:20.516135|2017-02-18 18:01:20.516135
NCT00053625|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-04|2015-04-02|||June 1999||1999-06-01|April 2015|2015-04-01|June 2009|Actual|2009-06-01|December 2008|Actual|2008-12-01||Interventional|||Deep Brain Stimulation for Parkinson's Disease Trial|Deep Brain Stimulation for Parkinson's Disease Trial|Completed||Phase 3|123|Actual|University of Minnesota - Clinical and Translational Science Institute||4|||f||||t||||||||||2017-02-18 18:01:20.679377|2017-02-18 18:01:20.679377
NCT00053612|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-03|2016-12-13||||||August 2007|2007-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission|Prevention of HIV Shedding in Women - Trial of Vitamin A|Completed||Phase 2|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:01:20.787332|2017-02-18 18:01:20.787332
NCT00053599|ClinicalTrials.gov processed this data on February 17, 2017|2003-02-03|2009-07-24|||December 2002||2002-12-01|June 2009|2009-06-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Slow the Progression of Alzheimer's Disease|Completed||Phase 3|400||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:01:20.864873|2017-02-18 18:01:20.864873
NCT00053573|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-31|2014-02-04|||February 2003||2003-02-01|February 2014|2014-02-01|November 2006|Actual|2006-11-01|July 2006|Actual|2006-07-01||Interventional|||rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)|An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of rhGAA Treatment in Patients Greater Than 6 Months and Less Than or Equal to 36 Months Old With Infantile-Onset GSD-II|Completed||Phase 1/Phase 2|20|Actual|Sanofi||1|||f||||||||||||||2017-02-18 18:01:20.998352|2017-02-18 18:01:20.998352
NCT00053560|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2007-12-26|||December 2002||2002-12-01|November 2004|2004-11-01|August 2004||2004-08-01|||||Interventional|||To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids|A Randomized, Double-Blind, Multi-Center, Placebo- Controlled Study to Assess Prevention of Bone Loss by Treatment With GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids|Unknown status|Active, not recruiting|Phase 3|155||Genelabs Technologies|||||f||||||||||||||2017-02-18 18:01:21.101009|2017-02-18 18:01:21.101009
NCT00053547|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2006-07-31|||January 2002||2002-01-01|July 2006|2006-07-01||||||||Interventional|||Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis|Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis|Completed||Phase 4|28||Abbott|||||||||||||||||||2017-02-18 18:01:21.199176|2017-02-18 18:01:21.199176
NCT00053534|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2014-02-19|||January 2003||2003-01-01|February 2014|2014-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Heart Failure in the Community||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-02-18 18:01:21.28468|2017-02-18 18:01:21.28468
NCT00053508|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2014-01-17|||September 2002||2002-09-01|January 2014|2014-01-01|September 2003|Actual|2003-09-01|March 2003|Actual|2003-03-01||Interventional|||Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination|The Effect of Dose On Safety, Tolerability, and Immunogenicity of ACAM1000 Smallpox Vaccine in Adults Without Previous Smallpox Vaccination A Phase 2, Randomized, Double-Blind, Dose-Response Study|Terminated||Phase 2|274|Actual|Sanofi||4||CDC's decision to down-select vaccine development to single candidate, ACAM2000|f||||t||||||||||2017-02-18 18:01:21.68434|2017-02-18 18:01:21.68434
NCT00053495|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2012-05-07|2011-01-03||January 2003||2003-01-01|May 2012|2012-05-01|November 2003|Actual|2003-11-01|June 2003|Actual|2003-06-01||Interventional|||Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination|The Effect of Dose On Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults Without Previous Smallpox Vaccination|Completed||Phase 2|353|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 18:01:21.806565|2017-02-18 18:01:21.806565
NCT00053482|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2012-05-07|2011-01-03||January 2003||2003-01-01|May 2012|2012-05-01|October 2003|Actual|2003-10-01|April 2003|Actual|2003-04-01||Interventional|||Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults|The Effect of Dose on Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults With Previous Smallpox Vaccination|Completed||Phase 2|357|Actual|Sanofi||5|||f||||t||||||||||2017-02-18 18:01:22.970572|2017-02-18 18:01:22.970572
NCT00053469|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2017-01-24|||January 28, 2003||2003-01-28|March 30, 2015|2015-03-30|March 30, 2015||2015-03-30|||||Observational|||Infant s Examination and Manipulation of Objects|Early Learning and Development Project|Completed||N/A|350|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:24.095577|2017-02-18 18:01:24.095577
NCT00053456|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-30|2008-03-03|||January 2003||2003-01-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||The Effect of Exercise on Stem Cell Mobilization and Heart Function in Patients Undergoing Cardiac Rehabilitation|Stem Cell Mobilization For Improvement in Vascular Function and Myocardial Perfusion in Patients Undergoing Cardiac Rehabilitation|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:24.17738|2017-02-18 18:01:24.17738
NCT00053443|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-29|2016-12-13||||||December 2005|2005-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens|Compliance Enhancement In HIV/AIDS Patients|Completed||Phase 2|156||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:01:24.25082|2017-02-18 18:01:24.25082
NCT00053430|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-29|2009-08-06|||April 2001||2001-04-01|August 2009|2009-08-01|February 2006|Actual|2006-02-01|August 2005|Actual|2005-08-01||Interventional|||Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People|Pharmacologic T Cell Costimulation In HIV Disease|Completed||Phase 2|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:01:24.332334|2017-02-18 18:01:24.332334
NCT00053417|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-29|2011-08-03|2011-05-16||February 2003||2003-02-01|August 2011|2011-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis|Double-Blind, Placebo-Controlled, 20-Week, Parallel Group Study to Evaluate Safety, Tolerability and Activity of Oral Fampridine-SR in Subjects With Multiple Sclerosis|Completed||Phase 2|206|Actual|Acorda Therapeutics||4|||||||||||||||||2017-02-18 18:01:24.446594|2017-02-18 18:01:24.446594
NCT00053404|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-28|2008-09-25|||March 2003||2003-03-01|September 2008|2008-09-01|December 2008|Anticipated|2008-12-01|December 2006|Actual|2006-12-01||Observational|||Immunologic Control of Drug Resistant HIV|Observational Study of HIV Infected Adults With Detectable Plasma HIV-1 RNA Levels Between 200 and 10,000 Copies/mL While Receiving Stable Antiretroviral Therapy|Unknown status|Active, not recruiting|N/A|50|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood collection~   "|||2017-02-18 18:01:25.37733|2017-02-18 18:01:25.37733
NCT00053391|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2015-05-11|||October 2002||2002-10-01|May 2015|2015-05-01|June 2007|Actual|2007-06-01|June 2005|Actual|2005-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|Vaccination Of HLA-A1 And/Or -A2+ Stage III or IV Melanoma Patients With Tumor Peptide - Loaded Autologous Dendritic Cells That Are Generated In The Absence Or Presence Of CD40 Ligand|Completed||Phase 1/Phase 2|62|Actual|University Hospital Erlangen|||||f||||f||||||||||2017-02-18 18:01:25.470166|2017-02-18 18:01:25.470166
NCT00053378|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2006-07-31|||January 2002||2002-01-01|July 2006|2006-07-01||||||||Interventional|||A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects|A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects|Completed||Phase 2|45||Abbott|||||||||||||||||||2017-02-18 18:01:25.562045|2017-02-18 18:01:25.562045
NCT00053365|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2014-04-29|2013-08-12||June 2003||2003-06-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Interventional||This is the number of eligible and evaluable participants.|Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation Of Irofulven (IND #55804, NSC #683863) In The Treatment Of Recurrent Or Persistent Platinium-Sensitive Ovarian Or Primary Peritoneal Cancer|Completed||Phase 2|61|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:25.663474|2017-02-18 18:01:25.663474
NCT00053352|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2016-05-06|||November 2003||2003-11-01|May 2016|2016-05-01||||October 2013|Actual|2013-10-01||Interventional|||Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors|A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors|Active, not recruiting||Phase 3|302|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:01:26.048894|2017-02-18 18:01:26.048894
NCT00053339|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2016-07-11||||||July 2016|2016-07-01||||||||Interventional|||Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer|Phase III Randomized Study of Trastuzumab (Herceptin) With or Without Tamoxifen in Women With Progressive, Stage IV, Estrogen or Progesterone Receptor- and HER2/Neu-Positive Breast Cancer|Withdrawn||Phase 3|0|Actual|Alliance for Clinical Trials in Oncology||2||The study was not activated.|f||||f||||||||||2017-02-18 18:01:26.457717|2017-02-18 18:01:26.457717
NCT00053326|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2013-10-07|||May 2003||2003-05-01|October 2013|2013-10-01||||March 2006|Actual|2006-03-01||Interventional|||Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma|A Phase II Study of Fenretinide (NSC# 374551, IND# 40294) in Children With Recurrent/Resistant High Risk Neuroblastoma|Completed||Phase 2|70|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:26.563792|2017-02-18 18:01:26.563792
NCT00053300|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2010-06-09|||August 2002||2002-08-01|June 2010|2010-06-01|April 2010|Actual|2010-04-01|November 2005|Actual|2005-11-01||Interventional|||Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Daily Thalidomide in Extensive Stage Small Cell Lung Cancer Patients Achieving a Complete or Partial Response to Induction Chemotherapy|Completed||Phase 2|30|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:01:26.67365|2017-02-18 18:01:26.67365
NCT00053287|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2010-06-09|||September 2002||2002-09-01|June 2010|2010-06-01|March 2007|Actual|2007-03-01|January 2007|Actual|2007-01-01||Interventional|||Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS|Phase II Study of Fludarabine, Carboplatin, and Topotecan With Thalidomide for Patients With Relapsed/Refractory or High Risk Acute Myelogenous Leukemia, Chronic Myeloid Leukemia and Advanced Myelodysplastic Syndromes|Completed||Phase 2|42|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:01:26.778644|2017-02-18 18:01:26.778644
NCT00053261|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2013-05-24|||July 2003||2003-07-01|June 2005|2005-06-01||||January 2007|Actual|2007-01-01||Observational|||Vaginal Changes and Sexual Function in Patients With Cervical Cancer|Vaginal Length, Elasticity, Lubrication And Sexual Function In Women With Stage IB2 Cervix Carcinoma|Completed||N/A|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:01:26.885835|2017-02-18 18:01:26.885835
NCT00053248|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2012-05-24|||October 2002||2002-10-01|June 2010|2010-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A Phase I/II Study To Determine The Safety, Tolerability, And Anti-Leukemic Effects of Trisenox (Arsenic Trioxide) In Combination With Gleevec (STI571) In Patients With Resistant Chronic Myelogenous Leukemia In Chronic Phase|Completed||Phase 1/Phase 2|16|Actual|OHSU Knight Cancer Institute|||||f||||t||||||||||2017-02-18 18:01:26.989499|2017-02-18 18:01:26.989499
NCT00053235|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2015-05-29|||November 2002||2002-11-01|May 2015|2015-05-01||||August 2010|Actual|2010-08-01||Observational|||Research Study in Patients With Advanced Ovarian Epithelial Cancer|A Pilot Study to Correlate DNA Sequence Copy Number Abnormalities With Outcome in Patients With Advanced Epithelial Ovarian Cancer|Withdrawn||N/A|0|Actual|Gynecologic Oncology Group|||1||f||||||||||||||2017-02-18 18:01:27.102371|2017-02-18 18:01:27.102371
NCT00053222|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2013-09-04|||February 2003||2003-02-01|September 2013|2013-09-01|July 2007|Actual|2007-07-01|January 2005|Actual|2005-01-01||Interventional|||Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine|A Phase II Study Of Arsenic Trioxide In Patients With Adenocarcinoma Of The Pancreas Refractory To Gemcitabine|Completed||Phase 2|13|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:01:27.216433|2017-02-18 18:01:27.216433
NCT00053209|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2012-11-30|||April 2004||2004-04-01|November 2012|2012-11-01|May 2009|Actual|2009-05-01|September 2007|Actual|2007-09-01||Interventional|||Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium|Phase II Trial Of Pemetrexed Disodium And Gemcitabine In Advanced Urothelial Cancer|Completed||Phase 2|46|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 18:01:27.557969|2017-02-18 18:01:27.557969
NCT00053196|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2016-06-30|||December 2002||2002-12-01|June 2016|2016-06-01|August 2010|Actual|2010-08-01|November 2006|Actual|2006-11-01||Interventional|||Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer|Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation For Patients With Disease Relapse Or Myelodysplasia After Prior Autologous Transplantation|Completed||Phase 2|82|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:01:27.797391|2017-02-18 18:01:27.797391
NCT00053183|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2009-02-06|||October 2003||2003-10-01|July 2004|2004-07-01||||||||Interventional|||Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I Brachytherapy Dose Escalation Using The GliaSite RTS In Newly Diagnosed Glioblastoma Multiforme In Conjunction With External Beam Radiation Therapy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:27.941967|2017-02-18 18:01:27.941967
NCT00053157|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2013-01-30|||June 2002||2002-06-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia|Use Of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) To Mobilize Donor Peripheral Blood Stem Cells Along With GM-CSF Administration Post Allogeneic Transplant - A Pilot Study|Completed||N/A|10|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:01:28.048888|2017-02-18 18:01:28.048888
NCT00053144|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2011-03-07|||November 1999||1999-11-01|March 2011|2011-03-01|March 2003|Actual|2003-03-01|February 2003|Actual|2003-02-01||Interventional|||Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia|Irinotecan And Cytarabine In Refractory or Relapsed Acute Myeloid Leukemia And In Chronic Myelogenous Leukemia In Myeloid Blast Transformation: Efficacy And In Vitro Correlates|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:01:28.154691|2017-02-18 18:01:28.154691
NCT00053131|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2011-03-07|||January 1999||1999-01-01|March 2011|2011-03-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|High Dose Cytarabine And Mitoxantrone Therapy For Relapsed And Refractory Acute Myeloid And Lymphocytic Leukemia: Effects Of GM-CSF Versus G-CSF On Dendritic Cells And Leukemia Associated Antigen-Specific T-Lymphocytes|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:01:28.250898|2017-02-18 18:01:28.250898
NCT00053118|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2011-02-25|||March 2002||2002-03-01|February 2011|2011-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer|High Dose Carboplatin Combined With Oral VP-16 In The Treatment Of Pediatric CNS Malignancies|Completed||Phase 1|1|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:01:28.349092|2017-02-18 18:01:28.349092
NCT00053105|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2009-07-04|||February 2002||2002-02-01|March 2003|2003-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase I Trial of BBR 2778 in Combination With Cytarabine, Methylprednisolone and Cisplatin in the Treatment of Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:28.469278|2017-02-18 18:01:28.469278
NCT00052507|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2015-07-22|||January 2003||2003-01-01|July 2015|2015-07-01||||August 2005|Actual|2005-08-01||Interventional|||Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer|A Phase II Study Of PS-341 In Patients With Metastatic Colorectal Cancer|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 18:01:34.396751|2017-02-18 18:01:34.396751
NCT00053092|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2013-12-17|||October 2002||2002-10-01|June 2007|2007-06-01|February 2009|Actual|2009-02-01|||||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma|National Mantle Cell Lymphoma Trial - Phase II Randomized Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma|Completed||Phase 2|82|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:28.563786|2017-02-18 18:01:28.563786
NCT00053053|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2016-12-06|||December 2002||2002-12-01|October 2013|2013-10-01|February 2009|Actual|2009-02-01|March 2005|Actual|2005-03-01||Interventional|||Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer|A Double-Blind Study Of Nutritional Intervention For The Treatment Of Cancer Cachexia Using Juven® Nutritional Supplement|Completed||Phase 3|472|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:01:28.674023|2017-02-18 18:01:28.674023
NCT00053040|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2010-09-23|||October 2005||2005-10-01|September 2010|2010-09-01||||||||Interventional|||Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas|Phase I/II Trial Of Intracerebral IL13-PE38QQR Infusions In Pediatric Patients With Recurrent Malignant Glioma|Withdrawn||Phase 1/Phase 2|0|Actual|Pediatric Brain Tumor Consortium||1||Withdrawal of pharmaceutical company support for the investigational drug|f||||t||||||||||2017-02-18 18:01:29.351486|2017-02-18 18:01:29.351486
NCT00053027|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2016-12-05|||February 2003||2003-02-01|December 2016|2016-12-01|November 2009|Actual|2009-11-01|January 2006|Actual|2006-01-01||Interventional|||Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma|Phase II Trial of Rituximab and 2-Chlorodeoxyadenosine (2-CDA) in Newly Diagnosed Mantle Cell Lymphoma (MCL)|Completed||Phase 2|30|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:01:29.486344|2017-02-18 18:01:29.486344
NCT00053014|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2015-03-05|2013-01-02||April 2003||2003-04-01|March 2015|2015-03-01|June 2006|Actual|2006-06-01|June 2005|Actual|2005-06-01||Interventional|||S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia|S0125, A Phase II Study Of Chimerism-Mediated Immunotherapy (CMI) Using Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation In Older Patients With Acute Myeloid Leukemia (AML) In First Complete Remission (A BMT Study)|Terminated||Phase 2|5|Actual|Southwest Oncology Group||1||Poor accrual|f||||t||||||||||2017-02-18 18:01:29.60304|2017-02-18 18:01:29.60304
NCT00053001|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-27|2013-06-25|||June 2001||2001-06-01|October 2007|2007-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome|A Phase II Study on the Effectiveness of Thalomid (Thalidomide) Combined With Procrit (Erythropoietin) for the Treatment of Anemia in Patients With Low and Intermediate Risk-1 (IPSS Score Less Than or Equal to 1.5) Myelodysplastic Syndromes|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:29.930471|2017-02-18 18:01:29.930471
NCT00052962|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-26|2012-11-16|2012-09-04||January 2003||2003-01-01|November 2012|2012-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis|A Prospective Random Assignment Trial to Study Operative Debulking and Systemic Chemotherapy With or Without Intra-and Peri-Operative Intraperitoneal Chemotherapy for Subjects With Peritoneal Carcinomatosis From Low Grade Gastrointestinal Adenocarcinoma|Completed||Phase 3|30|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 18:01:30.044588|2017-02-18 18:01:30.044588
NCT00052949|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-10-07|||May 2003||2003-05-01|October 2013|2013-10-01||||October 2007|Actual|2007-10-01||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer|Phase II Trial of STI571 in Patients With Relapsed Small Cell Lung Cancer|Completed||Phase 2|91|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:30.72052|2017-02-18 18:01:30.72052
NCT00052936|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2010-03-11|||January 2001||2001-01-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma|Randomised Study Comparing 6 And 8 Cycles Of Chemotherapy With CHOP ( Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) At 14-Day Intervals (CHOP-14), Both With Or Without The Monoclonal Anti-CD20 Antibody Rituximab In Patients Aged 61 To 80 Years With Aggressive Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|1580|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:30.833579|2017-02-18 18:01:30.833579
NCT00052923|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2009-02-06|||March 2003||2003-03-01|June 2006|2006-06-01||||June 2006|Actual|2006-06-01||Interventional|||Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma|Randomized Phase III Trial Of Rituximab (NSC #687451) And Autologous Stem Cell Transplantation For B Cell Diffuse Large Cell Lymphoma|Completed||Phase 3|427|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:01:31.095969|2017-02-18 18:01:31.095969
NCT00052910|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2016-06-17|||December 2002||2002-12-01|June 2016|2016-06-01||||June 2012|Actual|2012-06-01||Interventional|||Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer|Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma|Active, not recruiting||Phase 3|546|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:01:31.20523|2017-02-18 18:01:31.20523
NCT00052897|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-02-08|||December 2002||2002-12-01|April 2004|2004-04-01||||July 2005|Actual|2005-07-01||Interventional|||SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia|A Phase I/II Trial of SGN-00101 in the Treatment of High-Grade Anal Intraepithelial Neoplasia (AIN) in HIV-Positive Individuals|Completed||Phase 1/Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:32.239681|2017-02-18 18:01:32.239681
NCT00052884|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2012-11-30|||October 2003||2003-10-01|November 2012|2012-11-01|March 2011|Actual|2011-03-01|September 2007|Actual|2007-09-01||Interventional|||Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation|A Phase I Study of Amifostine Followed by High-Dose Escalation of Melphalan With Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis|Terminated||Phase 1|8|Actual|Eastern Cooperative Oncology Group||1||Slow accrual and changes in clinical practice|f||||f||||||||||2017-02-18 18:01:32.352182|2017-02-18 18:01:32.352182
NCT00052845|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2016-06-30|||November 2002||2002-11-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|January 2006|Actual|2006-01-01||Interventional|||Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer|Completed||Phase 2|80|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:01:32.482118|2017-02-18 18:01:32.482118
NCT00052832|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2015-09-30|||September 2002||2002-09-01|September 2015|2015-09-01||||July 2005|Actual|2005-07-01||Interventional|||Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia|Phase II Study of Doxercalciferol for the Treatment of Myelodysplastic Syndromes|Completed||Phase 2|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:01:32.785335|2017-02-18 18:01:32.785335
NCT00052780|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-09-27|||October 2002||2002-10-01|September 2013|2013-09-01||||November 2007|Actual|2007-11-01||Interventional|||Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors|Phase I Trial of Temozolomide and O6-Benzylguanine in Pediatric Patients With Recurrent Brain Tumors|Completed||Phase 1|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:32.883822|2017-02-18 18:01:32.883822
NCT00052754|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2012-09-20|||October 2002||2002-10-01|September 2012|2012-09-01||||October 2005|Actual|2005-10-01||Interventional|||Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma|Phase II Study Of Iressa (ZD 1839) In Locally Advanced And/Or Metastatic Synovial Sarcoma Expressing HER1/EGFR1|Completed||Phase 2|48|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:01:33.0068|2017-02-18 18:01:33.0068
NCT00052728|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-06-18|||December 2002||2002-12-01|May 2005|2005-05-01|July 2006|Actual|2006-07-01|||||Interventional|||Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer|A Phase II Trial Of Tipifarnib (R15777, ZARNESTRA) In Combination With Tamoxifen In Subjects With Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:33.134445|2017-02-18 18:01:33.134445
NCT00052715|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2009-02-06|||November 2002||2002-11-01|March 2005|2005-03-01||||April 2008|Actual|2008-04-01||Interventional|||Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Trial Of Poly-ICLC For Glioblastoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:33.225362|2017-02-18 18:01:33.225362
NCT00052689|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-10-07|||December 2002||2002-12-01|October 2013|2013-10-01||||October 2007|Actual|2007-10-01||Interventional|||Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer|A Randomized Phase II Trial of PS-341 and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|88|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:01:33.314214|2017-02-18 18:01:33.314214
NCT00052676|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-05-14|||October 2002||2002-10-01|September 2007|2007-09-01|May 2007|Actual|2007-05-01|||||Interventional|||Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer|French Randomized Sentinel Node Multicentric Study|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:33.422111|2017-02-18 18:01:33.422111
NCT00052637|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-10-22|||September 2001||2001-09-01|October 2013|2013-10-01||||May 2002|Actual|2002-05-01||Interventional|||Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer|An Open, Comparative, Within Patient, Controlled Phase III, Multicenter Study Of HEXVIX Fluorescence Cystoscopy And White Light Cystoscopy In the Detection Of Carcinoma In Situ In Patients With Bladder Cancer|Completed||Phase 3|||Photocure|||||f||||f||||||||||2017-02-18 18:01:33.522108|2017-02-18 18:01:33.522108
NCT00052624|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2009-02-06|||July 2002||2002-07-01|April 2004|2004-04-01||||||||Interventional|||Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma|A Phase I Multicenter Trial Of Intratumoral/Interstitial Therapy With HN66000, NC66000 (TransMID) In Patients Between 5 and 18 Years Of Age With Progressive Or Recurrent Glioblastoma Multiforme Or Anaplastic Astrocytoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:33.616328|2017-02-18 18:01:33.616328
NCT00052611|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2008-07-23|||June 2002||2002-06-01|January 2005|2005-01-01||||||||Interventional|||Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia|Celecoxib In Biomarker Modulation Of Oral Precancerous Lesions: A Pilot Study|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:33.699158|2017-02-18 18:01:33.699158
NCT00052598|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2017-02-13||2017-02-13|September 2002||2002-09-01|February 2017|2017-02-01|June 2011|Actual|2011-06-01|November 2009|Actual|2009-11-01||Interventional|||Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant|Phase I/II Study of Adoptive Immunotherapy With CD8+ Proteinase 3 (Myeloblastin)-Specific CTL Clones for HLA-A2+ Patients With Relapse or Progression of Disease After Allogeneic Hematopoietic Stem Cell Transplant for High Risk Myeloid Leukemias|Terminated||Phase 1/Phase 2|7|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 18:01:33.805331|2017-02-18 18:01:33.805331
NCT00052585|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-01-15|||October 2002||2002-10-01|January 2013|2013-01-01||||November 2004|Actual|2004-11-01||Interventional|||Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer|A Phase II Trial Of IRESSA (NSC 715055, IND 61187) In Combination With 5-FU/LV/ CPT-11 In Patients With Advanced Or Recurrent Colorectal Cancer|Terminated||Phase 2|50|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:01:33.921027|2017-02-18 18:01:33.921027
NCT00052572|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-06-21|||October 2002||2002-10-01|April 2006|2006-04-01|July 2007|Actual|2007-07-01|||||Interventional|||Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders|A Multicenter Phase II Study Of BMS 247550 (Epothilone B Analogue) In Indolent Lymphoproliferative Disorders|Completed||Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:01:34.037857|2017-02-18 18:01:34.037857
NCT00052559|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-06-04|||August 2002||2002-08-01|June 2013|2013-06-01||||April 2003|Actual|2003-04-01||Interventional|||Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer|A Phase I Study Of The Antiangiogenic Agent Bevacizumab In Combination With 5-Fluourouracil And External Beam Radiation Therapy In Rectal Cancer|Completed||Phase 1|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:34.145967|2017-02-18 18:01:34.145967
NCT00052520|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-07-03|||September 2002||2002-09-01|July 2013|2013-07-01|June 2013|Actual|2013-06-01|April 2011|Actual|2011-04-01||Interventional|||Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation|Phase I/II Study of Adoptive Immunotherapy With CD8+ WT1-Specific CTL Clones for Patients With Advanced MDS, CML, AML or ALL After Allogeneic Hematopoietic Stem Cell Transplant|Completed||Phase 1/Phase 2|37|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 18:01:34.261567|2017-02-18 18:01:34.261567
NCT00052494|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2015-07-22|||April 2003||2003-04-01|July 2015|2015-07-01||||February 2009|Actual|2009-02-01||Interventional|||Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase I Study Of STI 571 (Gleevec) In Combination With Cisplatin/Irinotecan In Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 1|9|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 18:01:34.49683|2017-02-18 18:01:34.49683
NCT00052481|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2016-07-01|||September 2002||2002-09-01|July 2016|2016-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Observational|||Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer|Health-Related Quality Of Life In Patients With Low Risk, Localized Prostate Cancer Randomized To Radical Prostatectomy Or Brachytherapy|Completed||N/A|500|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 18:01:34.59652|2017-02-18 18:01:34.59652
NCT00052468|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2014-06-24|||August 2002||2002-08-01|June 2014|2014-06-01|January 2011|Actual|2011-01-01|July 2009|Actual|2009-07-01||Interventional|AGO-OVAR9||Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer|A Multi-National Randomized Phase-III GCIG Intergroup-Study Comparing 1st-line Chemotherapy With Gemcitabine/Paclitaxel/Carboplatin vs Paclitaxel/Carboplatin In Previously Untreated Patients With Epithelial Ovarian Cancer FIGO Stages I-IV|Completed||Phase 3|1742|Actual|AGO Study Group||2|||f||||t||||||||||2017-02-18 18:01:37.497037|2017-02-18 18:01:37.497037
NCT00052455|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-12-17|||October 2002||2002-10-01|May 2007|2007-05-01|September 2010|Actual|2010-09-01|||||Interventional|||Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma|A Prospective Randomised Trial Comparing Temozolomide With PCV In The Treatment Of Recurrent WHO Astrocytic Tumours Grades III And IV|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:37.654519|2017-02-18 18:01:37.654519
NCT00052442|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-12-03|||August 2002||2002-08-01|December 2009|2009-12-01||||March 2009|Actual|2009-03-01||Interventional|||10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma|A Phase II Study of 10-Propargyl-10-Deazaaminopterin (PDX) in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphomas and Hodgkin's Disease|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:37.754366|2017-02-18 18:01:37.754366
NCT00052429|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2016-01-22|2015-12-15||September 2002||2002-09-01|January 2016|2016-01-01|November 2010|Actual|2010-11-01|November 2010|Actual|2010-11-01||Interventional|||High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer|Phase I/II Study of Dose-Painting Using Intensity Modulated Radiation Therapy Plus Chemotherapy in Patients With Stage II-IVB Nasopharyngeal Carcinoma|Completed||Phase 1/Phase 2|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:01:37.846506|2017-02-18 18:01:37.846506
NCT00052416|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-06-25|||October 2002||2002-10-01|April 2003|2003-04-01|January 2003|Actual|2003-01-01|||||Interventional|||Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Thalidomide in Indolent Non-Hodgkin's Lymphoma: A Feasibility Study|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:38.140423|2017-02-18 18:01:38.140423
NCT00052403|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2014-01-15|||February 2002||2002-02-01|January 2014|2014-01-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors|Phase I Study of Monoclonal Antibody Anti-Anb3 Integrin in Patients With Advanced Solid Tumors|Withdrawn||Phase 1|0|Actual|Barbara Ann Karmanos Cancer Institute||1||Study was not successful at recruiting particpants|f||||t||||||||||2017-02-18 18:01:38.241837|2017-02-18 18:01:38.241837
NCT00052390|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-06-21|||October 2002||2002-10-01|February 2004|2004-02-01|October 2005|Actual|2005-10-01|||||Interventional|||Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma|A Multi-Institutional, Open-Label, Phase II Study Of Doxorubicin And Bevacizumab (Anti-VEFG Monoclonal Antibody, NSC 704865) For Patients With Advanced Or Metastatic Soft-Tissue Sarcoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:38.329548|2017-02-18 18:01:38.329548
NCT00052377|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-01-15|||September 2002||2002-09-01|January 2013|2013-01-01||||June 2005|Actual|2005-06-01||Interventional|||Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides|A Phase II Open-Label Study Of Recombinant Human Interleukin-12 (NSC 672423) In Mycosis Fungoides (MF) Patients With Cross-Over To Phase I Evaluation Of Escalating Doses Of Interleukin-2 (NSC 373364) Administered With Interleukin-12|Terminated||Phase 1/Phase 2|46|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:01:41.237649|2017-02-18 18:01:41.237649
NCT00052364|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-06-17|||September 2002||2002-09-01|June 2013|2013-06-01||||January 2006|Actual|2006-01-01||Interventional|||Oxaliplatin in Treating Patients With Liver Cancer|A Phase II Study of Oxaliplatin in Hepatocellular Cancer|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:41.348665|2017-02-18 18:01:41.348665
NCT00052351|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-06-17|||September 2002||2002-09-01|May 2003|2003-05-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer|A Pilot Study Of Sequential Vaccinations With Recombinant Vaccinia-CEA(6D)-TRICOM, And Recombinant Fowlpox-CEA(6D)-TRICOM (B7.1/ICIAM-1/LFA-3) With Sargramostim (GM-CSF), In Conjunction With Standard Adjuvant Chemotherapy In High Risk Breast Cancer Patients Status Post Surgery With 4+ Or More Lymph Nodes And CEA Expressing Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:41.458311|2017-02-18 18:01:41.458311
NCT00052338|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-01-22|||September 2002||2002-09-01|January 2013|2013-01-01||||May 2004|Actual|2004-05-01||Interventional|||Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|A Phase I Study Of PS-341 In Combination With Gemcitabine And Carbloplatin In Selected Stage IIIB Or IV Non-Small Cell Lung Cancer|Completed||Phase 1|34|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:41.559376|2017-02-18 18:01:41.559376
NCT00052325|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-12-17|||October 2002||2002-10-01|July 2005|2005-07-01||||||||Interventional|||Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy|Iscar For Supplemental Care In Advanced Non-Small Cell Lung Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:01:41.674472|2017-02-18 18:01:41.674472
NCT00052091|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-22|2013-09-20|||September 2002||2002-09-01|September 2013|2013-09-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Therapy for Depressed Elders With Thought Problems|PST in Geriatric Depression With Executive Dysfunction|Completed||Phase 3|221|Actual|University of California, San Francisco||2|||f||||||||||||||2017-02-18 18:01:44.224366|2017-02-18 18:01:44.224366
NCT00052312|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2012-09-20|||September 2002||2002-09-01|September 2012|2012-09-01||||September 2006|Actual|2006-09-01||Interventional|||Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer|Randomized Trial Of Adriamycin (A) Cisplatin (P) Chemotherapy Versus Paclitaxel (T) Adriamycin (A) And Cisplatin (P) In Patients With Metastatic/Relapsed Or Locally Advanced Inoperable Endometrial Cancer|Completed||Phase 2|141|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:01:41.978088|2017-02-18 18:01:41.978088
NCT00052299|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2012-08-24|||September 2002||2002-09-01|August 2012|2012-08-01|February 2012|Actual|2012-02-01|January 2008|Actual|2008-01-01||Interventional|AML-17||Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia|Gemtuzumab Ozogamicin (GO) Combined With Standard Intensive Chemotherapy Versus Standard Intensive Chemotherapy Alone For Induction/Consolidation In Patients 61-75 Years Old With Previously Untreated AML: A Randomized Phase III Trial (AML-17) Of The EORTC-LG and the GIMEMA-ALWP|Completed||Phase 3|472|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 18:01:42.121113|2017-02-18 18:01:42.121113
NCT00052286|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2016-02-05|||September 2002||2002-09-01|February 2016|2016-02-01|August 2010|Actual|2010-08-01|July 2006|Actual|2006-07-01||Interventional|||Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer|A Pilot Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Adult Brain Tumor Patients|Completed||N/A|29|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:01:42.5589|2017-02-18 18:01:42.5589
NCT00052273|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2015-10-28|||December 2002||2002-12-01|August 2012|2012-08-01|October 2005|Actual|2005-10-01|November 2004|Actual|2004-11-01||Interventional|||LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors|A Phase I Dose Escalation Study With Oral LY317615 in Combination With Capecitabine in Advanced Cancer Patients|Completed||Phase 1|16|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:01:42.669624|2017-02-18 18:01:42.669624
NCT00052221|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2016-04-05|||May 2003||2003-05-01|October 2012|2012-10-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy|A Placebo Controlled Trial Of Short-Term, High-Dose Epoetin Alfa In Advanced Cancer Outpatients With Mild Fatigue|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:01:42.777507|2017-02-18 18:01:42.777507
NCT00052208|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2013-06-11|||March 2002||2002-03-01|May 2013|2013-05-01||||June 2005|Actual|2005-06-01||Interventional|||Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme|A Phase I/II Study of an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), ZD 1839 (Iressa), [NSC #715055] With Radiation Therapy in Glioblastoma Multiforme|Completed||Phase 1/Phase 2|158|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:01:42.89203|2017-02-18 18:01:42.89203
NCT00052195|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2016-02-17|||September 2001||2001-09-01|February 2016|2016-02-01|May 2009|Actual|2009-05-01|December 2008|Actual|2008-12-01||Interventional|||Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People|DARDAR Health Project (Disseminated Tuberculosis and HIV Infection)|Completed||Phase 2/Phase 3|1975|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 18:01:43.005944|2017-02-18 18:01:43.005944
NCT00052182|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2007-10-22|||October 2002||2002-10-01|September 2007|2007-09-01||||||||Interventional|||Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients|A Single Center Phase I Safety and Immunogenicity Study of Epimmune HIV-1 CTL Epitope-Based DNA Vaccine (EP HIV-1090) for Immunotherapy of HIV-1 Infected Individuals Receiving Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 1|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:01:43.117771|2017-02-18 18:01:43.117771
NCT00052169|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-24|2007-12-13|||January 2003||2003-01-01|December 2007|2007-12-01|September 2006|Actual|2006-09-01|||||Interventional|||Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer|A Phase 2, Multi-Center Trial of ZD1839 (IRESSA) in Combination With Docetaxel as First-Line Treatment in Patients With Advanced Breast Cancer|Completed||Phase 2|33|Actual|NSABP Foundation Inc||1|||f||||f||||||||||2017-02-18 18:01:43.225724|2017-02-18 18:01:43.225724
NCT00052156|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-23|2005-06-23||||||April 2005|2005-04-01||||||||Interventional|||Vaccine Therapy for Patients With Stage IV Melanoma|A Phase III Randomized Double-Blind Pivotal Trial of Immunotherapy With a Polyvalent Melanoma Vaccine, CancerVax™ Vaccine Plus BCG Versus Placebo Plus BCG as a Post-Surgical Treatment for Stage IV Melanoma|Unknown status|Active, not recruiting|Phase 3|670||CancerVax Corporation|||||||||||||||||||2017-02-18 18:01:43.339459|2017-02-18 18:01:43.339459
NCT00052143|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-23|2009-04-15|||July 1999||1999-07-01|February 2008|2008-02-01|July 2010|Anticipated|2010-07-01|July 2010|Anticipated|2010-07-01||Observational|PHAROS||Prospective Huntington At Risk Observational Study|Prospective Huntington At Risk Observational Study (PHAROS)|Unknown status|Active, not recruiting|N/A|1001|Actual|Huntington Study Group|||1||f||||t||||||Samples With DNA|"~     Blood sample~   "|||2017-02-18 18:01:43.491121|2017-02-18 18:01:43.491121
NCT00052130|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-22|2005-06-23||||||September 2004|2004-09-01||||||||Interventional|||Vaccine Therapy for Patients With Stage III Melanoma|Phase III Randomized Double-Blind Pivotal Trial of Immunotherapy With BCG Plus a Polyvalent Melanoma Vaccine, CancerVax™ Vaccine Versus BCG Plus a Placebo as a Post-Surgical Treatment for Stage III Melanoma|Unknown status|Active, not recruiting|Phase 3|1118||CancerVax Corporation|||||||||||||||||||2017-02-18 18:01:43.889023|2017-02-18 18:01:43.889023
NCT00052117|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-22|2007-10-05|||January 2003||2003-01-01|October 2007|2007-10-01|May 2005||2005-05-01|||||Interventional|||Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens|A Phase 2, Randomized, Double-Blind, Dose-Ranging Study Of Capravirine (AG1549) In Combination With Kaletra (Trademark) and At Least 2 Nucleoside Reverse Transcriptase Inhibitors in Hiv-Infected Subjects Who Have Failed Antiretroviral Regimens Containing Protease Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Nucleoside Reverse Transcriptase Inhibitors|Completed||Phase 2|300||Pfizer|||||||||||||||||||2017-02-18 18:01:44.062581|2017-02-18 18:01:44.062581
NCT00052104|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-22|2013-08-07|||December 2001||2001-12-01|March 2008|2008-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Telephone-Based Support for Caregivers of Patients With Dementia|A Telephone Intervention for Dementia Caregivers|Completed||Phase 2/Phase 3|85||Rhode Island Hospital|||||f||||||||||||||2017-02-18 18:01:44.146086|2017-02-18 18:01:44.146086
NCT00005324|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-09-27|||January 1992||1992-01-01|May 2000|2000-05-01|November 1996|Actual|1996-11-01|||||Observational|||Genetic and Epidemiologic Studies of Premature Coronary Artery Disease - SCOR in Arteriosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:08.09597|2017-02-18 18:15:08.09597
NCT00052078|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-22|2008-10-20|||January 2003||2003-01-01|October 2008|2008-10-01|March 2008|Anticipated|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Child and Adolescent Anxiety Disorders (CAMS)|Child/Adolescent Anxiety Multimodal Treatment Study|Unknown status|Active, not recruiting|Phase 3|488|Actual|National Institute of Mental Health (NIMH)||4|||f||||||||||||||2017-02-18 18:01:44.343144|2017-02-18 18:01:44.343144
NCT00052065|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-21|2011-07-21|||February 2003||2003-02-01|June 2011|2011-06-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer|Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer|Completed||Phase 1/Phase 2|28||Telik|||||f||||||||||||||2017-02-18 18:01:44.468217|2017-02-18 18:01:44.468217
NCT00052052|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-21|2007-11-02|||September 2002||2002-09-01|November 2007|2007-11-01|September 2004|Actual|2004-09-01|||||Interventional|||An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)|An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis.|Completed||Phase 2|210|Actual|InterMune||1|||f||||||||||||||2017-02-18 18:01:44.548611|2017-02-18 18:01:44.548611
NCT00052039|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-21|2007-11-02|||April 2002||2002-04-01|November 2007|2007-11-01|June 2002|Actual|2002-06-01|||||Interventional|||A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone|A Randomized, Double-Blind, Three-Arm, Phase IIIb Study Comparing the Safety and Efficacy of Interferon Gamma-1b Alone, IFN-Gamma 1b With Azathioprine, and Azathioprine Alone in Patients With Idiopathic Pulmonary Fibrosis Receiving Prednisone|Terminated||Phase 3|0|Actual|InterMune||1||Study design changes were needed based on GIPF-001 results|f||||||||||||||2017-02-18 18:01:44.636756|2017-02-18 18:01:44.636756
NCT00052026|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-21|2008-12-24|||May 2000||2000-05-01|December 2008|2008-12-01|July 2006|Actual|2006-07-01|June 2005|Actual|2005-06-01||Interventional|||Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure|A Multicenter, Placebo-Controlled, 8-Month Study of the Effect of Twice Daily Carvedilol in Children With Congestive Heart Failure Due to Systemic Ventricular Systolic Dysfunction|Completed||Phase 3|161|Actual|Shaddy, Robert, M.D.||3|||f||||t||||||||||2017-02-18 18:01:44.730965|2017-02-18 18:01:44.730965
NCT00052013|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-21|2011-02-16|||February 2003||2003-02-01|February 2011|2011-02-01||||June 2006|Actual|2006-06-01||Interventional|||Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584|A Phase II Open-Label Study of Oral, Continuous, Once Daily PTK787/ZK 222584 in Patients With Von Hippel-Lindau Disease (VHL) and Hemangioblastoma (HB)|Completed||Phase 2|11|Actual|Novartis||1|||f||||||||||||||2017-02-18 18:01:44.886742|2017-02-18 18:01:44.886742
NCT00052000|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-21|2007-02-28|||November 2002||2002-11-01|February 2007|2007-02-01||||||||Interventional|||A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer|A Phase 1 Single Ascending Dose Trial of MLN2704 (DM1 Conjugated Monoclonal Antibody MLN591) in Subjects With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 1|29||Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 18:01:44.990489|2017-02-18 18:01:44.990489
NCT00051987|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-21|2008-02-07|||December 2002||2002-12-01|February 2008|2008-02-01||||March 2004|Actual|2004-03-01||Interventional|||Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma|A Randomized, Multicenter, Open-Label, Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma|Completed||Phase 2|175||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 18:01:45.08523|2017-02-18 18:01:45.08523
NCT00051974|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-21|2008-02-07|||December 2002||2002-12-01|February 2008|2008-02-01||||September 2004|Actual|2004-09-01||Interventional|||Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer|A Randomized, Multicenter, Open-Label, Phase 2 Study of VELCADE Alone or VELCADE Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|155||Millennium Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 18:01:45.188852|2017-02-18 18:01:45.188852
NCT00051961|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-17|2017-01-24|||January 14, 2003||2003-01-14|October 18, 2007|2007-10-18|October 18, 2007||2007-10-18|||||Observational|||Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome|Effects of Dopaminergic Agonist Treatment on Spinal Cord Excitability in Restless Legs Syndrome|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:45.286998|2017-02-18 18:01:45.286998
NCT00051948|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-17|2011-07-21|||January 2003||2003-01-01|February 2007|2007-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer|Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer|Completed||Phase 1/Phase 2|28||Telik|||||f||||||||||||||2017-02-18 18:01:45.367332|2017-02-18 18:01:45.367332
NCT00051935|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-17|2014-02-04|||January 2003||2003-01-01|February 2014|2014-02-01|October 2003|Actual|2003-10-01|April 2003|Actual|2003-04-01||Interventional|||A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II|Open-Label, Pilot Study of the Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Human Acid Alpha-Glucosidase (rhGAA) as Enzyme Replacement Therapy in Siblings With Glycogen Storage Disease Type II (GSD-II).|Completed||Phase 2|2|Actual|Sanofi||1|||f||||||||||||||2017-02-18 18:01:45.452253|2017-02-18 18:01:45.452253
NCT00051922|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-17|2011-06-06|||October 1997||1997-10-01|June 2011|2011-06-01|June 2009|Actual|2009-06-01|July 2006|Actual|2006-07-01||Interventional|||Development of a New HIV Vaccine|Evaluation of the Safety of a Polyvalent Vaccinia Virus HIV-1 Envelope Recombinant Vaccine (PolyEnv1) in Healthy Adults|Completed||Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:01:45.556476|2017-02-18 18:01:45.556476
NCT00051909|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-17|2006-07-18|||November 2002||2002-11-01|July 2006|2006-07-01|June 2003||2003-06-01|||||Interventional|||Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease|Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease|Completed||Phase 2|200||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:01:45.667731|2017-02-18 18:01:45.667731
NCT00051896|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-17|2017-01-10|||August 2002||2002-08-01|March 2005|2005-03-01||||||||Interventional|||Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1|Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers|Unknown status|Active, not recruiting|Phase 1|24||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 18:01:45.743691|2017-02-18 18:01:45.743691
NCT00051883|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-17|2017-01-11|||December 1999||1999-12-01|October 2016|2016-10-01|February 2005|Actual|2005-02-01|||||Observational|||Chemical Dependency and Smoking Cessation: Patient's Views - 1|Chemical Dependency and Smoking Cessation: Patient's Views|Completed||Phase 4|125|Actual|National Institute on Drug Abuse (NIDA)|||1||f||||f||||||||||2017-02-18 18:01:45.830356|2017-02-18 18:01:45.830356
NCT00051870|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2008-03-03|||January 2003||2003-01-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Brain Encoding for Memory|Role of the Prefrontal Cortex in Successful Memory Encoding|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:46.170211|2017-02-18 18:01:46.170211
NCT00051857|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2017-02-02|||January 14, 2003||2003-01-14|December 14, 2016|2016-12-14||||||||Observational|||MRI Study of Musculoskeletal Function|Virtual Functional Anatomy (VFA)|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:46.251953|2017-02-18 18:01:46.251953
NCT00051844|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2011-05-09|||August 2002||2002-08-01|May 2011|2011-05-01|November 2004|Actual|2004-11-01|||||Interventional|||Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen|A Double Blind- Randomized, Placebo-controlled Study of Two Doses of Capravirine (AG1549) in Combination With Viracept and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Infected Patients Who Failed an Initial Nonnucleoside Reverse Transcriptase Inhibitor Containing Regimen|Completed||Phase 2|179|Actual|Pfizer|||||||||||||||||||2017-02-18 18:01:46.356029|2017-02-18 18:01:46.356029
NCT00051831|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2015-05-29|||October 2003||2003-10-01|May 2015|2015-05-01|May 2008|Actual|2008-05-01|December 2007|Actual|2007-12-01||Interventional|||Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults|A Pilot Study to Measure the Clearance of Replication-Competent HIV-1 in Resting Memory CD4+ Cells in HIV-1-Infected Subjects Who Receive Enfuvirtide Plus Oral Combination Antiretroviral Therapy|Completed||N/A|19|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:01:46.508258|2017-02-18 18:01:46.508258
NCT00051818|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2016-02-08|||September 2000||2000-09-01|December 2005|2005-12-01|July 2003|Actual|2003-07-01|May 2003|Actual|2003-05-01||Interventional|||Immune and Viral Outcomes of HIV-1 Therapy Interruption|Immune and Viral Outcomes of HIV-1 Therapy Interruption|Completed||Phase 1|20|Actual|The Wistar Institute||2|||f||||t||||||||||2017-02-18 18:01:46.655076|2017-02-18 18:01:46.655076
NCT00051805|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2007-09-17|||August 2002||2002-08-01|August 2007|2007-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Promoting Adherence to Anti-HIV Drug Regimens|Promoting Adherence to Antiretroviral Regimens|Completed||N/A|119||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:01:46.752456|2017-02-18 18:01:46.752456
NCT00051792|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2006-08-16|||January 2003||2003-01-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)|Efficacy of Yoga for Self-Management of Dyspnea in COPD|Completed||Phase 1/Phase 2|36||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:01:46.851599|2017-02-18 18:01:46.851599
NCT00051779|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2005-06-23||||||February 2004|2004-02-01||||||||Interventional|||An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer|A 24-Week Blinded Study Conducted at Multiple Centers, Evaluating the Safety and Effectiveness of Various Doses of the Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) When Randomly Assigned to Patients With Breast Cancer That Has Metastasized to Bone|Completed||Phase 1|||Chugai Pharma USA|||||||||||||||||||2017-02-18 18:01:46.933118|2017-02-18 18:01:46.933118
NCT00051766|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2005-06-23||||||May 2005|2005-05-01||||||||Interventional|||Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs|A Computer-Based HIV Medication Adherence Intervention|Terminated||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:01:47.057774|2017-02-18 18:01:47.057774
NCT00051753|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-16|2011-01-07|||November 2002||2002-11-01|January 2011|2011-01-01|May 2005|Actual|2005-05-01|||||Interventional|||Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media|A Multicenter, Randomized, Comparative Study to Evaluate the Efficacy and Safety of Levofloxacin in the Treatment of Children Who Have Recurrent and/or Persistent Acute Otitis Media|Completed||Phase 3|1643|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:01:47.142546|2017-02-18 18:01:47.142546
NCT00051740|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-15|2013-04-05|||February 2002||2002-02-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Treating Thought Problems in Patients With Schizophrenia|Compensating for Cognitive Deficits in Schizophrenia|Completed||N/A|120|Anticipated|The University of Texas Health Science Center at San Antonio||2|||f||||||||||||||2017-02-18 18:01:47.23639|2017-02-18 18:01:47.23639
NCT00051727|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-15|2012-01-06|||October 2002||2002-10-01|January 2012|2012-01-01||||||||Interventional|||Prevention of School Dropout for Mexican American Adolescents|Preventive Intervention for Mexican American Adolescents|Completed||Phase 2|480||Arizona State University|||||f||||||||||||||2017-02-18 18:01:47.541041|2017-02-18 18:01:47.541041
NCT00051714|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-15|2013-07-12|||March 1997||1997-03-01|July 2013|2013-07-01||||December 2012|Actual|2012-12-01||Interventional|||Early Prevention of Conduct Problems|Early Primary Prevention of Conduct Problems|Completed||Phase 4|1050|Actual|New York University School of Medicine||1|||f||||||||||||||2017-02-18 18:01:47.622625|2017-02-18 18:01:47.622625
NCT00051701|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-15|2015-03-04|||December 2002||2002-12-01|March 2015|2015-03-01|August 2005|Actual|2005-08-01|||||Interventional|||Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma|Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|61||Sanofi|||||||||||||||||||2017-02-18 18:01:47.721184|2017-02-18 18:01:47.721184
NCT00051688|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-15|2006-07-10|||June 2003||2003-06-01|July 2006|2006-07-01|August 2004||2004-08-01|||||Interventional|||Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer||Terminated||Phase 2|||Chiron Corporation|||||||||||||||||||2017-02-18 18:01:47.834557|2017-02-18 18:01:47.834557
NCT00051675|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-14|2005-06-23|||July 2002||2002-07-01|September 2004|2004-09-01|September 2003||2003-09-01|||||Interventional|||Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas|An Open-Label, Multi-Dose, Phase I, Dose-Escalating Study of a Subcutaneously Administered Human-Engineered Monoclonal Antibody, ING-1(heMAb), in Subjects With Advanced Adenocarcinomas|Completed||Phase 1|30||XOMA (US) LLC|||||||||||||||||||2017-02-18 18:01:47.918027|2017-02-18 18:01:47.918027
NCT00051246|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-07|2014-01-23|||January 2002||2002-01-01|January 2014|2014-01-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Group Therapy for Postpartum Depression|Relational Group Intervention for Postpartum Depression|Completed||N/A|147|Actual|University of Wisconsin, Madison||2|||f||||t||||||||||2017-02-18 18:01:54.854718|2017-02-18 18:01:54.854718
NCT00051662|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-14|2005-06-23||||||September 2004|2004-09-01|February 2004||2004-02-01|||||Interventional|||Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Efficacy and Pharmacokinetics of Efalizumab in Subjects With Psoriatic Arthritis|Completed||Phase 1|45||XOMA (US) LLC|||||||||||||||||||2017-02-18 18:01:48.00893|2017-02-18 18:01:48.00893
NCT00051636|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-14|2012-05-09|2012-04-05||January 2001||2001-01-01|May 2012|2012-05-01|April 2011|Actual|2011-04-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period|Randomized, Double-blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget's Disease of Bone Using Risedronate as a Comparator, Including an Extended Observational Period|Completed||Phase 3|172|Actual|Novartis||2|||f||||||||||||||2017-02-18 18:01:48.084658|2017-02-18 18:01:48.084658
NCT00051623|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-14|2011-05-16|||May 2003||2003-05-01|March 2010|2010-03-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis|A Multicenter, Randomized, Double-blind Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab) for the Treatment of Patients With Psoriatic Arthritis|Completed||Phase 3|70|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 18:01:48.694427|2017-02-18 18:01:48.694427
NCT00051597|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-13|2011-10-07||||||October 2011|2011-10-01|August 2003|Actual|2003-08-01|||||Interventional|||A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies|A Phase I/II Multi-Dose Study of SGN-30 in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies|Completed||Phase 1/Phase 2|70||Seattle Genetics, Inc.|||||||||||||||||||2017-02-18 18:01:48.791138|2017-02-18 18:01:48.791138
NCT00051584|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-13|2011-10-21||||||October 2011|2011-10-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer|A Phase II Study of SGN-15 (cBR96 - Doxorubicin Immunoconjugate) Combined With Gemzar® Versus Single-Agent Gemzar® in Patients With Advanced Ovarian Cancer|Terminated||Phase 2|60||Seattle Genetics, Inc.|||||||||||||||||||2017-02-18 18:01:48.879657|2017-02-18 18:01:48.879657
NCT00051571|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-13|2011-10-21||||||October 2011|2011-10-01|October 2003|Actual|2003-10-01|||||Interventional|||Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma|A Phase II Study Using SGN-15 (cBR96-Doxorubicin Immunoconjugate) in Combination With Docetaxel for the Treatment of Advanced Stage or Recurrent Non-Small Cell Lung Carcinoma|Completed||Phase 2|60||Seattle Genetics, Inc.|||||||||||||||||||2017-02-18 18:01:48.958751|2017-02-18 18:01:48.958751
NCT00051558|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-13|2009-02-13|2009-01-14||November 2002||2002-11-01|February 2009|2009-02-01|January 2008|Actual|2008-01-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis|Comparison of the Effects of Teriparatide With Those of Alendronate Sodium on Lumbar Spine Bone Mineral Density in Glucocorticoid-Induced Osteoporosis|Completed||Phase 3|428|Actual|Eli Lilly and Company||2|||f||||f||||||||||2017-02-18 18:01:49.332259|2017-02-18 18:01:49.332259
NCT00051545|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-13|2007-02-21|||November 1999||1999-11-01|April 2005|2005-04-01|June 2004||2004-06-01|||||Interventional|||Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma|Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5 ug) or Placebo in Prolonging Time to Relapse Following Intended Curative Resection or Percutaneous Ablative Treatment for Hepatocellular Carcinoma|Terminated||Phase 3|608||LEO Pharma|||||||||||||||||||2017-02-18 18:01:51.198868|2017-02-18 18:01:51.198868
NCT00051532|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-13|2007-03-05|||September 1999||1999-09-01|April 2005|2005-04-01|May 2004||2004-05-01|||||Interventional|||Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma|Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma. Efficacy of Seocalcitol (EB 1089) Enteric-Coated Capsules (5ug) or Placebo in the Treatment of Patients With Hepatocellular Carcinoma Not Amenable to Curative Treatment|Terminated||N/A|700||LEO Pharma|||||||||||||||||||2017-02-18 18:01:51.308691|2017-02-18 18:01:51.308691
NCT00051519|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-10|2017-01-24|||January 9, 2003||2003-01-09|June 25, 2009|2009-06-25|December 1, 2007|Actual|2007-12-01|December 1, 2007|Actual|2007-12-01||Observational|||Screening HIV-Infected Patients for Vaccine Studies|Screening HIV-Infected Subjects for Vaccine Research Studies|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:51.418729|2017-02-18 18:01:51.418729
NCT00051506|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-10|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:01:51.500871|2017-02-18 18:01:51.500871
NCT00051493|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-10|2006-07-18|||April 2002||2002-04-01|July 2006|2006-07-01|December 2002||2002-12-01|||||Interventional|||ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.|ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.|Completed||Phase 2|50||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:01:51.58469|2017-02-18 18:01:51.58469
NCT00051480|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-10|2011-05-11||||||May 2011|2011-05-01||||||||Interventional|||Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer|A Single Arm, Phase II Study of TNFerade™ Biologic Gene Therapy + Radiation + 5-FU and Cisplatin in Locally Advanced, Resectable, Esophageal Cancer|Completed||Phase 2|||GenVec|||||||||||||||||||2017-02-18 18:01:51.662974|2017-02-18 18:01:51.662974
NCT00051467|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-10|2012-02-22||||||May 2011|2011-05-01||||||||Interventional|||A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer|A Randomized, Phase II/III, Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-line Treatment of Unresectable Locally Advanced Pancreatic Cancer|Completed||Phase 3|||GenVec|||||||||||||||||||2017-02-18 18:01:51.755039|2017-02-18 18:01:51.755039
NCT00051454|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-10|2007-08-23|||March 2003||2003-03-01|August 2007|2007-08-01|February 2005||2005-02-01|||||Interventional|||Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults|A Randomised, Placebo-Controlled, Double-Blind, Phase I/IIa Clinical Trial to Evaluate the Safety and Immunogenicity of a Candidate Prophylactic DNA Prime-rFPV Boost HIV Vaccination Strategy|Completed||Phase 1/Phase 2|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:01:51.866203|2017-02-18 18:01:51.866203
NCT00051233|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-07|2014-06-26|||January 2003||2003-01-01|June 2014|2014-06-01|January 2005||2005-01-01|||||Interventional|||Treatment of Schizophrenia Through Internet-Based Psychoeducation|Schizophrenia Patient and Family Continuity of Care|Completed||Phase 2|40||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:01:54.963039|2017-02-18 18:01:54.963039
NCT00051441|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-09|2011-05-17||||||April 2010|2010-04-01|February 2005|Actual|2005-02-01|||||Interventional|||Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx|A Double-Blind, Randomized, Vehicle-Controlled Study Comparing the Safety and Efficacy of Benzydamine HCl 0.15% Oral Rinse Including a Separate Open-Label Standard of Care Arm in Subjects With Radiation-Induced Mucositis|Completed||Phase 3|605|Actual|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.|||||||||||||||||||2017-02-18 18:01:52.235037|2017-02-18 18:01:52.235037
NCT00051428|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-09|2006-08-16|||January 2003||2003-01-01|August 2006|2006-08-01|February 2005||2005-02-01|||||Interventional|||The Efficacy of Reiki in the Treatment of Fibromyalgia|The Efficacy of Reiki in the Treatment of Fibromyalgia|Completed||Phase 1|100||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:01:52.33356|2017-02-18 18:01:52.33356
NCT00051415|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-09|2006-08-17|||January 2003||2003-01-01|July 2006|2006-07-01|January 2005||2005-01-01|||||Interventional|||Safety and Effectiveness of Flaxseed for Reducing High Cholesterol|A Double Blind, Randomized, Placebo Controlled Trial of Flaxseed in Patients With Hypercholesterolemia|Completed||Phase 2/Phase 3|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:01:52.43392|2017-02-18 18:01:52.43392
NCT00051402|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-09|2007-10-24|||December 2002||2002-12-01|October 2007|2007-10-01|August 2007|Actual|2007-08-01|||||Interventional|||Phytoestrogens and Memory Decline in Menopause|Phytoestrogens and Cognition in Menopause|Completed||Phase 2|96||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:01:52.525319|2017-02-18 18:01:52.525319
NCT00051389|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-09|2016-02-17|||February 2002||2002-02-01|January 2008|2008-01-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||ACE Inhibition and Novel Cardiovascular Risk Factors||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:01:52.61626|2017-02-18 18:01:52.61626
NCT00051376|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-09|2016-02-17|||September 2001||2001-09-01|November 2005|2005-11-01|August 2006|Actual|2006-08-01|||||Interventional|||Vascular Interaction With Age in Myocardial Infarction||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:01:52.703617|2017-02-18 18:01:52.703617
NCT00051363|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-09|2016-10-06|2016-02-29||September 2002||2002-09-01|October 2016|2016-10-01|September 2008|Actual|2008-09-01|August 2008|Actual|2008-08-01||Interventional|APPLES||Apnea Positive Pressure Long-Term Efficacy Study|APPLES: Apnea Positive Pressure Long-Term Efficacy Study|Completed||Phase 3|1105|Actual|Stanford University|There are study sample limitations because although participants with severe OSA were included, those who had the lowest oxygen saturation, a history of sleepiness-related accidents, or major cardiovascular comorbidities were excluded.|2|||f||||t||||||||Yes|Only in de-identified format to researchers|2017-02-18 18:01:52.789794|2017-02-18 18:01:52.789794
NCT00051350|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-09|2008-04-22|||May 2002||2002-05-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||OmniHeart Trial: Macronutrients and Cardiovascular Risk||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:01:53.858714|2017-02-18 18:01:53.858714
NCT00051337|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-08|2008-03-03|||January 2003||2003-01-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders|The Physiology of Paroxysmal Hyperkinetic Movement Disorders: A SPECT Study|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:53.945884|2017-02-18 18:01:53.945884
NCT00051324|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-08|2016-10-27|||August 2002||2002-08-01|October 2016|2016-10-01|August 2017|Anticipated|2017-08-01|August 2017|Anticipated|2017-08-01||Observational|PREDICT-HD||Neurobiological Predictors of Huntington's Disease (PREDICT-HD)|Neurobiological Predictors of Huntington's Disease Trial|Active, not recruiting||N/A|1500|Anticipated|University of Iowa|||1||f||||f||||||Samples With DNA|"~     Cerebral spinal fluid acquired and retained since 2012.~      Plasma retained from 2000-2007. Urine, plasma and cell lines to be acquired and retained~     2008-2013.~   "|||2017-02-18 18:01:54.036168|2017-02-18 18:01:54.036168
NCT00051311|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-08|2017-01-24|||January 3, 2003||2003-01-03|September 25, 2014|2014-09-25|September 25, 2014|Actual|2014-09-25|September 25, 2014|Actual|2014-09-25||Interventional|||Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers|A Pilot Study of EPOCH-F/R Induction Chemotherapy and Reduced-Intensity, HLA-Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation, With Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory or Relapsed Hematologic Malignancies|Completed||Phase 2|62|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:01:54.173573|2017-02-18 18:01:54.173573
NCT00051298|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-07|2007-06-11|||November 2002||2002-11-01|June 2007|2007-06-01|April 2005|Actual|2005-04-01|||||Interventional|||Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia|Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia|Completed||Phase 3|107|Actual|Eli Lilly and Company||2|||||||||||||||||2017-02-18 18:01:54.273822|2017-02-18 18:01:54.273822
NCT00051285|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-07|2014-01-08|||February 2002||2002-02-01|January 2014|2014-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||"ESSENTIAL-The Studies of Oral Enoximone Therapy in Advanced Heart Failure"|ESSENTIAL Protocol No. My-021 and Protocol No. My-026, Each Titled: A Phase III, Randomized, Double-Blind, Multicenter, Parallel Group, Placebo-Controlled Study of Oral Enoximone vs. Placebo in Advanced Chronic Heart Failure Subjects|Terminated||Phase 3|1800||Gilead Sciences||2|||f||||||||||||||2017-02-18 18:01:54.387753|2017-02-18 18:01:54.387753
NCT00051272|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-07|2011-03-28|||January 2003||2003-01-01|March 2011|2011-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Effects Of Antidepressants On Sexual Functioning In Adults|A Multicenter, Double-blind Randomized Placebo-controlled Comparison of the Effects on Sexual Functioning of Extended-release Bupropion Hydrochloride (300-450mg) and Escitalopram (10-20mg) in Outpatients With Moderate to Severe Major Depression Over an Eight-Week Treatment Period|Completed||Phase 3|425|Actual|GlaxoSmithKline||1|||||||||||||||||2017-02-18 18:01:54.49655|2017-02-18 18:01:54.49655
NCT00051259|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-07|2010-10-01|||January 2003||2003-01-01|October 2010|2010-10-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Effects of Antidepressants on Sexual Functioning|A Multicenter, Double-Blind, Randomized, Placebo Controlled Comparison of the Effects on Sexual Functioning of Extended-Release Bupropion Hydrochloride (300-450mg) and Escitalopram (10-20mg) in Outpatients With Moderate to Severe Major Depression Over an Eight-Week Treatment Period|Completed||Phase 3|420||GlaxoSmithKline||1|||||||||||||||||2017-02-18 18:01:54.72713|2017-02-18 18:01:54.72713
NCT00051220|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-07|2013-06-06|||October 2001||2001-10-01|June 2013|2013-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment for Specific Phobias in Children|One-Session Treatment for Specific Phobias in Children|Completed||Phase 1/Phase 2|150|Actual|Virginia Polytechnic Institute and State University|||||f||||||||||||||2017-02-18 18:01:55.054163|2017-02-18 18:01:55.054163
NCT00051207|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-07|2013-06-21|||November 2002||2002-11-01|December 2007|2007-12-01|August 2005|Actual|2005-08-01|||||Interventional|||Therapy for Depression With Co-occurring Panic or Anxiety Symptoms|Interpersonal Psychotherapy for Depression With Co-occurring Panic and Anxiety Symptoms (IPT-PS)|Completed||Phase 1/Phase 2|36||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:01:55.133275|2017-02-18 18:01:55.133275
NCT00051194|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2012-04-12|||September 2002||2002-09-01|March 2006|2006-03-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension|A 6-week Safety and Efficacy Study of Combination IOP-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension.|Completed||Phase 2|||Alcon Research|||||||||||||||||||2017-02-18 18:01:55.213769|2017-02-18 18:01:55.213769
NCT00051181|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2008-08-04|||January 2000||2000-01-01|August 2008|2008-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma|A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-02-18 18:01:55.30088|2017-02-18 18:01:55.30088
NCT00051168|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2011-10-02|2010-03-22||January 2006||2006-01-01|April 2010|2010-04-01||||March 2009|Actual|2009-03-01||Interventional|||A Long-term Safety Study of Once-daily Travatan|A Long-term Safety Study of Once-daily TRAVATAN|Completed||Phase 3|502|Actual|Alcon Research||1|||f||||||||||||||2017-02-18 18:01:55.392697|2017-02-18 18:01:55.392697
NCT00050440|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-09|2013-01-07|||July 2002||2002-07-01|January 2013|2013-01-01|July 2004|Actual|2004-07-01|||||Interventional|||Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma|A Phase 2 Study of ET-743 as Second-Line Therapy in Subjects With Persistent or Recurrent Endometrial Carcinoma|Completed||Phase 2|50|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 18:01:55.966028|2017-02-18 18:01:55.966028
NCT00050427|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-09|2011-04-26|||December 2002||2002-12-01|April 2011|2011-04-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer|A Phase 2 Study of ET-743 in Subjects With Advanced Breast Cancer|Completed||Phase 2|53|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-02-18 18:01:56.113609|2017-02-18 18:01:56.113609
NCT00050414|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-09|2013-01-09|||October 2002||2002-10-01|January 2013|2013-01-01|September 2005|Actual|2005-09-01|||||Interventional|||A Study of Trabectedin in Patients With Advanced Ovarian Cancer|Phase 2 Study of Efficacy and Safety of Trabectedin in Subjects With Advanced Ovarian Cancer|Completed||Phase 2|147|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||f||||f||||||||||2017-02-18 18:01:56.231297|2017-02-18 18:01:56.231297
NCT00050401|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-08|2013-01-03|||July 2002||2002-07-01|January 2013|2013-01-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support|Impact of Aggressive Empiric Antibiotic Therapy on the Emergence of Antimicrobial Resistance During the Treatment of Ventilator-associated Pneumonia|Completed||Phase 3|500||AstraZeneca|||||||||||||||||||2017-02-18 18:01:56.351402|2017-02-18 18:01:56.351402
NCT00050388|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-06|2008-06-20||||||June 2008|2008-06-01|June 2002||2002-06-01|||||Interventional|||Phase II Trial of Allovectin-7® for Head and Neck Cancer|Phase II Study of the Safety and Efficacy of Allovectin-7® Immunotherapy for the Treatment of Primary, Resectable Squamous Cell Carcinoma of the Oral Cavity or Oropharynx|Completed||Phase 3|||Vical|||||||||||||||||||2017-02-18 18:01:56.442159|2017-02-18 18:01:56.442159
NCT00050375|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-05|2007-12-13|||December 2002||2002-12-01|June 2006|2006-06-01|December 2007|Actual|2007-12-01|||||Interventional|||Clinical Trial for Ovarian Cancer (OvaRex®)|A Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of Intravenous OvaRex® MAb-B43.13 as Post Chemotherapy Consolidation for Epithelial Carcinoma of Ovarian, Tubal or Peritoneal Origin|Terminated||Phase 3|354||Unither Pharmaceuticals||||Study closed by sponser|||||||||||||||2017-02-18 18:01:56.547199|2017-02-18 18:01:56.547199
NCT00050362|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-04|2008-03-03|||December 2002||2002-12-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction|Evaluation of a Long-Acting Local Anesthesia (Bupivacaine) and a Selective COX-2 Inhibitor (Rofecoxib) in Suppression of Central Sensitization|Completed||Phase 2|136||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:56.704969|2017-02-18 18:01:56.704969
NCT00050349|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-04|2013-03-07|||July 2002||2002-07-01|March 2013|2013-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||EPO906 in Carcinoid and Other Neuroendocrine Tumors|EPO906 Therapy in Patients With Metastatic Carcinoid Tumors and Other Neuroendocrine Tumors|Completed||Phase 2|33|Actual|Novartis||1|||f||||||||||||||2017-02-18 18:01:56.794358|2017-02-18 18:01:56.794358
NCT00050336|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-04|2015-08-26|||December 2002||2002-12-01|August 2015|2015-08-01|March 2004|Actual|2004-03-01|February 2004|Actual|2004-02-01||Interventional|||Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)|A Phase 3 Randomized Study of Lonafarnib in Combination With Paclitaxel and Carboplatin vs. Placebo in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer|Terminated||Phase 3|702|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:01:56.901322|2017-02-18 18:01:56.901322
NCT00050323|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-04|2015-03-04|||November 2002||2002-11-01|March 2015|2015-03-01|March 2004|Actual|2004-03-01|||||Interventional|||Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer|Phase 1/2 Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusion in Patients With AJCC Stage IV Renal Cell Carcinoma|Completed||Phase 1/Phase 2|30||Sanofi|||||||||||||||||||2017-02-18 18:01:56.989415|2017-02-18 18:01:56.989415
NCT00050310|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-03|2017-01-24|||February 27, 2002||2002-02-27|October 21, 2016|2016-10-21||||||||Observational|||Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients|Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:57.068386|2017-02-18 18:01:57.068386
NCT00050284|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-03|2010-11-05||||||November 2010|2010-11-01||||||||Observational|||Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection|Predictors of Immunologic and Clinical Progression in Subjects With CD4+ Cell Counts Greater Than 350 Cells/mm3 Who Discontinue Antiretroviral Therapy|Completed||N/A|158||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:01:57.269581|2017-02-18 18:01:57.269581
NCT00050271|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-03|2012-05-17||||||May 2012|2012-05-01|January 2007|Actual|2007-01-01|||||Interventional|||Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy|An Open-Label, Dose-Escalation Pilot Study of Acetyl-L-Carnitine for the Treatment of Dideoxynucleoside-Associated Distal Symmetric Peripheral Neuropathy|Completed||N/A|27|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:01:57.385729|2017-02-18 18:01:57.385729
NCT00050245|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-02|2017-01-24|||November 27, 2002||2002-11-27|October 17, 2007|2007-10-17|October 17, 2007||2007-10-17|||||Interventional|||Rituximab to Treat Neuropathy With Anti-MAG Antibodies|Safety, Tolerability, and Efficacy of Rituximab in Patients With Anti-Glycoconjugate Antibody-Mediated Demyelinating Neuropathy: A Double-Blind Placebo-Controlled Randomized Trial|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:57.622832|2017-02-18 18:01:57.622832
NCT00050232|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-02|2016-07-13|||December 2002||2002-12-01|July 2016|2016-07-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients||Completed||Phase 3|96||Avanir Pharmaceuticals|||||f||||f||||||||||2017-02-18 18:01:57.714704|2017-02-18 18:01:57.714704
NCT00050219|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-29|2008-03-03|||November 2002||2002-11-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Observational|||Role of Dopamine in Response to Alcohol|Striatal Dopamine and Alcohol Risk|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:57.817532|2017-02-18 18:01:57.817532
NCT00050206|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-26|2007-06-11|||November 2002||2002-11-01|June 2007|2007-06-01|May 2005|Actual|2005-05-01|||||Interventional|||Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder|Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder|Completed||Phase 4|130||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:01:57.911633|2017-02-18 18:01:57.911633
NCT00050193|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-25|2017-01-24|||November 22, 2002||2002-11-22|March 10, 2014|2014-03-10|March 10, 2014||2014-03-10|||||Observational|||Cause and Natural Course of Pediatric-Onset Mastocytosis|Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis|Completed||N/A|103|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:01:57.995505|2017-02-18 18:01:57.995505
NCT00050180|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-25|2017-01-24|||November 22, 2002||2002-11-22|May 3, 2012|2012-05-03|August 24, 2007|Actual|2007-08-24|August 24, 2007|Actual|2007-08-24||Interventional|||Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers|Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers|Completed||Phase 4|81|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:01:58.085349|2017-02-18 18:01:58.085349
NCT00050167|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-25|2011-08-25|2011-07-07||November 2002||2002-11-01|August 2011|2011-08-01|August 2011|Actual|2011-08-01|July 2008|Actual|2008-07-01||Interventional|||Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer|Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer|Completed||Phase 1|603|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:01:58.188767|2017-02-18 18:01:58.188767
NCT00050154|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-22|2010-04-23|||July 2002||2002-07-01|April 2010|2010-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)|An Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of the Farnesyl-Transferase Inhibitor ZARNESTRA(tm) (R115777) in Subjects With High-Risk Myelodysplastic Syndrome (MDS)|Completed||Phase 2|82|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:01:58.576474|2017-02-18 18:01:58.576474
NCT00051155|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2008-08-04|||January 2001||2001-01-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)|A 6-Week Safety and Efficacy Study of TRAVATAN Compared to XALCOM in Subjects With Open-Angle Glaucoma or Ocular Hypertension.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-02-18 18:01:58.660333|2017-02-18 18:01:58.660333
NCT00051142|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2008-08-04|||February 2001||2001-02-01|August 2008|2008-08-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)|A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma or Ocular Hypertension|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-02-18 18:01:58.742909|2017-02-18 18:01:58.742909
NCT00051129|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2012-11-27||2012-11-27|January 2007||2007-01-01|August 2008|2008-08-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)|An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-Related Macular Degeneration.|Completed||Phase 3|291|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 18:01:58.823004|2017-02-18 18:01:58.823004
NCT00051116|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2009-09-22|||May 2002||2002-05-01|September 2009|2009-09-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma|A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma|Completed||Phase 2|100|Actual|Celgene|||||f||||f||||||||||2017-02-18 18:01:58.916361|2017-02-18 18:01:58.916361
NCT00051103|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2015-04-14|||October 2002||2002-10-01|April 2015|2015-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.|An Open-Label, Multicenter, Single Arm Phase II Study of Oral GW572016 as Single Agent Therapy in Subjects With Advanced or Metastatic Breast Cancer Who Have Progressed While Receiving Herceptin Containing Regimens|Completed||Phase 2|||GlaxoSmithKline|||||f||||||||||||||2017-02-18 18:01:59.015031|2017-02-18 18:01:59.015031
NCT00051090|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV|Multicenter, Pilot Study of Telbivudine (LdT) Anti-HBV Treatment Prior to the Initiation of Highly Active Antiretroviral Therapy Containing Lamivudine in Subjects Coinfected With HBV and HIV|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:01:59.133722|2017-02-18 18:01:59.133722
NCT00051077|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-03|2012-05-16||||||May 2012|2012-05-01||||||||Interventional|||Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)|A Phase II Study of Adefovir Dipivoxil, Pegylated Interferon Alfa-2A, and Ribavirin Treatment in HBV and HCV Infected Subjects With HIV Disease|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:01:59.245632|2017-02-18 18:01:59.245632
NCT00051051|ClinicalTrials.gov processed this data on February 17, 2017|2003-01-02|2007-05-03|||December 2002||2002-12-01|September 2006|2006-09-01|May 2005|Actual|2005-05-01|||||Interventional|||A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer|A Phase II, Randomized, Open-Label Study of Single Agent CI-1033 in Patients With Metastatic Breast Cancer|Completed||Phase 2|168||Pfizer|||||f||||||||||||||2017-02-18 18:01:59.338176|2017-02-18 18:01:59.338176
NCT00051038|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-31|2011-04-07||2010-01-29|September 2002||2002-09-01|August 2007|2007-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients|A Phase II Study of the Safety and Efficacy of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients Who Have Hepatitis B Viremia While Being Treated With Lamivudine|Completed||Phase 2/Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:02:02.485876|2017-02-18 18:02:02.485876
NCT00051025|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-31|2012-07-07|2011-07-07||May 2000||2000-05-01|July 2012|2012-07-01|September 2006|Actual|2006-09-01|January 2001|Actual|2001-01-01||Interventional|||Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)|A Randomized, Multicenter, Phase II Evaluation of ONTAK (Denileukin Diftitox) in Patients With Previously Treated, Indolent, B-Cell, Non-Hodgkin's Lymphoma|Completed||Phase 2|9|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 18:02:02.581107|2017-02-18 18:02:02.581107
NCT00051012|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-31|2008-02-29|||September 1995||1995-09-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|October 2006|Actual|2006-10-01||Interventional|||Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients|A Multicenter Open-Label Study to Evaluate the Safety and Efficacy of DAB389IL-2 in Cutaneous T-Cell Lymphoma (CTCL) Patients Following Protocol 93-04-10, Protocol 93-04-11, or Protocol 92-04-01 or Who Meet the Requirements for Protocol 93-04-11 Except Have Biopsy-Documented CTCL That Does Not Express CD25|Completed||Phase 4|86||Eisai Inc.|||||f||||||||||||||2017-02-18 18:02:03.131799|2017-02-18 18:02:03.131799
NCT00050999|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-31|2008-02-29|||June 1995||1995-06-01|February 2008|2008-02-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients|A Multicenter Phase III Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy of Two Dose Levels of DAB389IL-2 (9 and 18 Mcg/kg/Day) in Cutaneous T-Cell Lymphoma (CTCL) Patients With Stage Ia-III Disease Who, Following Less Than or Equal to 3 Previous Therapies, Have Recurrent or Persistent Disease That Has Been Biopsy-Documented to Express CD25|Completed||Phase 4|195||Eisai Inc.|||||f||||||||||||||2017-02-18 18:02:03.531804|2017-02-18 18:02:03.531804
NCT00050986|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-31|2012-07-27|2009-09-25||December 2002||2002-12-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme|Phase I/II Evaluation Temozolomide and Farnesyl Transferase Inhibitor ZARNESTRA (R115777) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme|Completed||Phase 1/Phase 2|55|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:02:03.668983|2017-02-18 18:02:03.668983
NCT00050973|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-31|2013-05-13||||||July 2008|2008-07-01|March 2005|Actual|2005-03-01|November 2004|Actual|2004-11-01||Interventional|||Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer|Randomized Phase III Trial Comparing Targretin Capsules/Cisplatin/Vinorelbine Versus Cisplatin/Vinorelbine in Chemotherapy-Naive Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|623|Actual|Eisai Inc.|||||f||||||||||||||2017-02-18 18:02:03.984929|2017-02-18 18:02:03.984929
NCT00050960|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-31|2012-07-07|2010-07-23||May 2002||2002-05-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|July 2004|Actual|2004-07-01||Interventional|||Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer|Randomized Phase III Trial Comparing Targretin Capsules/Carboplatin/Paclitaxel Versus Carboplatin/Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 3|612|Actual|Eisai Inc.||2|||f||||||||||||||2017-02-18 18:02:04.183424|2017-02-18 18:02:04.183424
NCT00050947|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-30|2011-11-22|||July 2002||2002-07-01|November 2011|2011-11-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Pediatric Epilepsy Study|A Multicenter, Rater-blind, Randomized, Age-stratified, Parallel-group Study Comparing Two Doses of Oxcarbazepine as Monotherapy in Pediatric Patients With Inadequately-controlled Partial Seizures.|Completed||Phase 3|94|Actual|Novartis|||||f||||||||||||||2017-02-18 18:02:05.395835|2017-02-18 18:02:05.395835
NCT00050934|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-30|2011-11-22|||June 2002||2002-06-01|November 2011|2011-11-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Pediatric Epilepsy Study|A Multicenter, Rater-blind, Randomized, Age-stratified, Parallel-group Study Comparing Two Doses of Oxcarbazepine as Adjunctive Therapy in Pediatric Patients With Inadequately-controlled Partial Seizures.|Completed||Phase 3|132|Actual|Novartis|||||f||||||||||||||2017-02-18 18:02:05.518221|2017-02-18 18:02:05.518221
NCT00050921|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-30|2012-05-16||||||May 2012|2012-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs|Improving Immune Reconstitution With Growth Hormone in HIV-infected Subjects With Incomplete CD4+ Lymphocyte Restoration on Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:02:05.63874|2017-02-18 18:02:05.63874
NCT00050908|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-30|2013-07-26||||||July 2013|2013-07-01|May 2007|Actual|2007-05-01|||||Observational|||Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs|Endothelial Function in HIV-Infected Subjects Prior To and After Starting a Potent Antiretroviral Regimen|Completed||N/A|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:02:05.753015|2017-02-18 18:02:05.753015
NCT00050895|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-30|2012-05-17||||||May 2012|2012-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients|A Phase III, Randomized, Open-Label Comparison of Lopinavir/Ritonavir Plus Efavirenz Versus Lopinavir/Ritonavir Plus 2 NRTIs Versus Efavirenz Plus 2 NRTIs as Initial Therapy for HIV-1 Infection|Completed||Phase 3|775||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:02:05.856727|2017-02-18 18:02:05.856727
NCT00050882|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-29|2005-06-23||||||February 2004|2004-02-01||||||||Interventional|||Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis|A 12-Week Study Conducted at Multiple Centers, Blinded to Both the Patient and Doctor, Evaluating for Safety and Effectiveness Two Dosages of an Investigational Agent (GM-611) Versus a Placebo, That Are Randomly Assigned to Patients With Diabetic Gastroparesis|Completed||Phase 2|||Chugai Pharma USA|||||||||||||||||||2017-02-18 18:02:06.305326|2017-02-18 18:02:06.305326
NCT00050869|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-27|2017-01-24|||December 23, 2002||2002-12-23|November 15, 2007|2007-11-15|November 15, 2007||2007-11-15|||||Observational|||Learning a Motor Task Through Observation|Encoding a Motor Memory by Action Observation|Completed||N/A|56||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:06.455502|2017-02-18 18:02:06.455502
NCT00050856|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-23|2008-03-03|||November 2002||2002-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection|Multicenter, Open-Label, Early Acces Program of Fuzeon (Enfuvirtide T-20/Ro 29,9800, HIV-1 Fusion Inhibitor) in Combination With Free Choice Antiretroviral Regimen to Assess Serious Adverse Events, Serious AIDS-Defining Events, and Tolerability in Patient|Completed||Phase 3|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:06.53974|2017-02-18 18:02:06.53974
NCT00050843|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-23|2005-06-23|||August 2001||2001-08-01|May 2004|2004-05-01|February 2004||2004-02-01|||||Interventional|||A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes||Completed||Phase 3|220||Celgene|||||||||||||||||||2017-02-18 18:02:06.634299|2017-02-18 18:02:06.634299
NCT00050830|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-20|2006-11-06|||January 2003||2003-01-01|January 2006|2006-01-01|November 2005||2005-11-01|||||Interventional|||A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer|A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|163||Pfizer|||||f||||||||||||||2017-02-18 18:02:06.757709|2017-02-18 18:02:06.757709
NCT00050817|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-20|2012-04-20|||October 2002||2002-10-01|April 2012|2012-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)|A Phase III, Multicenter, Multinational, Randomized, Parallel Group, Double-blind Trial of Clopidogrel Versus Placebo in High-risk Patients Aged 45 Years and Older, at Risk of Atherothrombotic Events, and Who Are Receiving Background Therapy Including Low-dose ASA.|Completed||Phase 3|15603|Actual|Sanofi|||||f||||||||||||||2017-02-18 18:02:06.905814|2017-02-18 18:02:06.905814
NCT00050804|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-19|2008-03-03|||December 2002||2002-12-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Evaluation of Stress Disorders|Efficacy of an SSRI in Acute Stress Disorder and PTSD|Completed||Phase 4|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:07.048279|2017-02-18 18:02:07.048279
NCT00050791|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-19|2010-10-18|||March 2001||2001-03-01|October 2010|2010-10-01|June 2009|Actual|2009-06-01|November 2006|Actual|2006-11-01||Interventional|||Effects of Leptin Treatment on Weight Loss|Leptin Treatment for Prevention of the Metabolic and Endocrine Sequelae of a Decreased Caloric Intake: Studies of Patients on a Very Low Calorie Diet|Completed||Phase 2|40|Anticipated|Rockefeller University||2|||f||||f||||||||||2017-02-18 18:02:07.142274|2017-02-18 18:02:07.142274
NCT00050778|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-19|2015-01-06|2008-11-03||December 2002||2002-12-01|January 2015|2015-01-01|January 2010|Actual|2010-01-01|September 2007|Actual|2007-09-01||Interventional||FAS population included all randomized participants who had correct diagnosis of MS at entry. One participant was included in safety but excluded from efficacy analysis as initial multiple sclerosis diagnosis was incorrect.|A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis|A Phase II, Randomized, Open-Label, Three-Arm Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Subcutaneous Interferon Beta-1a (Rebif®) in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis|Completed||Phase 2|334|Actual|Sanofi||3|||f||||t||||||||||2017-02-18 18:02:07.270967|2017-02-18 18:02:07.270967
NCT00050765|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-18|2006-03-06|||August 2006||2006-08-01|March 2006|2006-03-01|August 2006||2006-08-01|||||Interventional|||Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection|A Phase I Multi-Center Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation in Patients With a Previous MI and Placement of an ICD Requiring De Novo Coronary Artery Bypass Graft Therapy|Unknown status|Not yet recruiting|Phase 1|15||Bioheart, Inc.|||||||||||||||||||2017-02-18 18:02:09.340928|2017-02-18 18:02:09.340928
NCT00050752|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2017-01-24|||December 17, 2002||2002-12-17|November 8, 2016|2016-11-08||||||||Observational|||Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer|Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:09.433783|2017-02-18 18:02:09.433783
NCT00050726|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2013-11-19|||May 2001||2001-05-01|November 2013|2013-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2|Substudies of ESPRIT: ESPRIT Influenza Vaccine Substudy (FLUVAC) and ESPRIT Tetanus-Pneumococcal Vaccine Substudy (TEPVAC)|Completed||Phase 2|620||National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:02:09.549577|2017-02-18 18:02:09.549577
NCT00050713|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2017-01-24|||December 17, 2002||2002-12-17|July 7, 2015|2015-07-07|August 27, 2007|Actual|2007-08-27|August 27, 2007|Actual|2007-08-27||Interventional|||Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy|Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:02:09.649216|2017-02-18 18:02:09.649216
NCT00050700|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2017-01-24|||December 16, 2002||2002-12-16|May 14, 2010|2010-05-14|May 14, 2010||2010-05-14|||||Observational|||Brain Imaging in Depression|Muscarinic Cholinergic Receptor Imaging in Depression|Completed||N/A|107|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:09.752268|2017-02-18 18:02:09.752268
NCT00050687|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2011-01-21||2011-01-11|June 2001||2001-06-01|November 2006|2006-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies|A Randomized, Serum Level-targeted Study Investigating the Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Patients With Various Refractory Malignancies|Terminated||Phase 1/Phase 2|||Titan Pharmaceuticals|||||||||||||||||||2017-02-18 18:02:09.848838|2017-02-18 18:02:09.848838
NCT00050674|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2012-12-26|||November 2001||2001-11-01|December 2012|2012-12-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma|Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma|Completed||Phase 2|40|Actual|Schwartzberg, Lee, M.D.||1|||f||||f||||||||||2017-02-18 18:02:09.933881|2017-02-18 18:02:09.933881
NCT00050661|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2009-03-24|||October 1997||1997-10-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|April 2004|Actual|2004-04-01||Interventional|||To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris|Use of Humanized CD25 (Anti-TAC) Monoclonal Antibody/ Placebo to Prevent Relapse of Psoriasis Vulgaris Following NBUVB Therapy|Completed||Phase 1/Phase 2|6|Actual|Rockefeller University||2|||f||||f||||||||||2017-02-18 18:02:10.04159|2017-02-18 18:02:10.04159
NCT00050648|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2009-03-12|||October 1997||1997-10-01|March 2009|2009-03-01|April 2008|Actual|2008-04-01|September 2004|Actual|2004-09-01||Interventional|||To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris|Use of Humanized CD25 (Anti-TAC) Monoclonal Antibody and Cyclosporine for the Treatment of Active Psoriasis.|Completed||Phase 1/Phase 2|20|Actual|Rockefeller University||3|||f||||f||||||||||2017-02-18 18:02:10.154978|2017-02-18 18:02:10.154978
NCT00050635|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-17|2009-11-18|||December 2002||2002-12-01|November 2009|2009-11-01|July 2003||2003-07-01|||||Interventional|||STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea||Completed||Phase 4|150||Novartis|||||f||||||||||||||2017-02-18 18:02:10.273381|2017-02-18 18:02:10.273381
NCT00050622|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-16|2016-08-08|2016-05-31||September 2001||2001-09-01|August 2016|2016-08-01|June 2005|Actual|2005-06-01|August 2004|Actual|2004-08-01||Interventional|||Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)|ADHD Treatment: Comparative and Combined Dosage Effects|Completed||N/A|154|Actual|Florida International University|Highly structured environment and direct observational measures were used. Additional study in natural school and home settings will be necessary.|12|||f||||f||||||||Yes||2017-02-18 18:02:10.390637|2017-02-18 18:02:10.390637
NCT00050609|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-16|2007-11-16|||February 2003||2003-02-01|November 2007|2007-11-01|September 2003|Actual|2003-09-01|||||Interventional|||Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying|A Randomized, Double-Blind, Placebo-Controlled, Parallel Study of IC351 (LY450190) in Patients With Diabetic Gastroparesis|Completed||Phase 2|2|Actual|Eli Lilly and Company||3|||f||||f||||||||||2017-02-18 18:02:11.243591|2017-02-18 18:02:11.243591
NCT00050596|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-16|2011-06-23|||November 2002||2002-11-01|June 2011|2011-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer|A Randomized Study Comparing 4 Monthly Doses of MDX-010 (CTLA-4) as a Single Agent or Used in Combination With a Single Dose of Docetaxel in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:02:11.575221|2017-02-18 18:02:11.575221
NCT00050583|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-16|2014-01-10|||February 2001||2001-02-01|January 2014|2014-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Treatment of Medically Unexplained Physical Ailments (Somatization Disorder)|Treatment of Somatization in Primary Care|Completed||Phase 3|172|Actual|Rutgers, The State University of New Jersey||2|||f||||f||||||||||2017-02-18 18:02:11.673288|2017-02-18 18:02:11.673288
NCT00050570|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-16|2015-04-02|||February 2001||2001-02-01|April 2015|2015-04-01||||April 2012|Actual|2012-04-01||Interventional|||Reducing Eating Disorder Risk Factors|Interventions to Reduce Eating Disorder Risk Factors|Completed||N/A|206|Actual|Stanford University||1|||f||||||||||||||2017-02-18 18:02:11.776182|2017-02-18 18:02:11.776182
NCT00050557|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-13|2012-05-02|||July 2001||2001-07-01|May 2012|2012-05-01|December 2006|Actual|2006-12-01|September 2006|Actual|2006-09-01||Interventional|||Family Psychoeducation for Children With Mood Disorders|Family Psychoeducation: Efficacy in Child Mood Disorders|Completed||Phase 1|165|Actual|Ohio State University||2|||f||||f||||||||||2017-02-18 18:02:11.863077|2017-02-18 18:02:11.863077
NCT00050531|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-12|2016-05-09|||April 2003||2003-04-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|April 2007|Actual|2007-04-01||Interventional|||High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)|Randomized Trial of Therapy of Early Phase Chronic Myelogenous Leukemia With High-Dose Imatinib Mesylate (Gleevec) Alone or in Combination With Peg-Alpha Interferon (PEG-Intron) and Sargramostim (GM-CSF)|Completed||Phase 3|94|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 18:02:11.963294|2017-02-18 18:02:11.963294
NCT00050518|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-11|2010-08-26||||||March 2010|2010-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||APSV in Vaccinia Naive Adults|A Multicenter, Double-Blind, Randomized Study of the Safety and Efficacy of Aventis Pasteur's Smallpox Vaccine, USP (APSV) in Vaccinia-Naive Adults.|Completed||Phase 2|444||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:02:12.081094|2017-02-18 18:02:12.081094
NCT00050505|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-10|2014-12-04|||October 2002||2002-10-01|July 2009|2009-07-01|December 2003|Actual|2003-12-01|||||Interventional|||Expanded Dryvax Dilution Study in Previously Vaccinated Adults|A Multicenter, Double Blind, Randomized Dose-response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults|Completed||Phase 2|927|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 18:02:12.181161|2017-02-18 18:02:12.181161
NCT00050492|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-09|2017-01-24|||December 6, 2002||2002-12-06|September 19, 2006|2006-09-19|September 19, 2006||2006-09-19|||||Observational|||Biological Markers in Retinal Vasculitis|Identification of Biological Markers in Retinal Vasculitis|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:12.290039|2017-02-18 18:02:12.290039
NCT00050479|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-09|2006-07-18|||December 2002||2002-12-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Laser and Medical Treatment of Diabetic Macular Edema|Preliminary Multi-Center Assessment of Laser and Medical Treatment of Diabetic Macular Edema|Completed||Phase 3|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:12.367362|2017-02-18 18:02:12.367362
NCT00050466|ClinicalTrials.gov processed this data on February 17, 2017|2002-12-09|2008-03-03|||December 2002||2002-12-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Dynamic Light Scattering and Keratoscopy for Corneal Examination|A Pilot Study Using the Dynamic Light Scattering Device (DLS) Combined With Keratoscopy on the Cornea in Vivo|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:12.451927|2017-02-18 18:02:12.451927
NCT00050141|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-22|2013-01-31|||September 2002||2002-09-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|October 2005|Actual|2005-10-01||Interventional|||Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer|A Randomised, Blinded, Phase 2 Study of Letrozole Plus the Farnesyl Transferase Inhibitor ZARNESTRA TM (R115777) and Letrozole Plus Placebo in the Treatment of Advanced Breast Cancer After Antiestrogen Therapy.|Completed||Phase 2|121|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:02:12.536131|2017-02-18 18:02:12.536131
NCT00050128|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-21|2017-01-24|||November 18, 2002||2002-11-18|October 24, 2007|2007-10-24|October 24, 2007||2007-10-24|||||Interventional|||Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation|Repetitive Transcranial Magnetic Stimulation in Chronic Stroke Patients. Dose Effect on Motor Cortex Excitability, Motor Performance, and Safety Using Different Stimulation Parameters|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:12.657357|2017-02-18 18:02:12.657357
NCT00050115|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-21|2017-01-24|||November 16, 2002||2002-11-16|April 11, 2016|2016-04-11||||||||Observational|||Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia|Collection of Blood, Stool, Bone Marrow and/or Tissue Samples From Subjects With Hepatitis-Associated Aplastic Anemia|Completed||N/A|9|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:12.743796|2017-02-18 18:02:12.743796
NCT00050102|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-21|2011-01-20||2011-01-12|October 2002||2002-10-01|January 2011|2011-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma|A Randomized Study Comparing MDX-010 (CTLA-4) Alone or in Combination With DTIC in the Treatment of Patients With Chemotherapy Naїve Metastatic Melanoma.|Completed||Phase 2|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:02:13.002397|2017-02-18 18:02:13.002397
NCT00050089|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-20|2015-04-03|2013-09-11||January 2001||2001-01-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|OPTIMA|HIV-positive patients with a CD4 count <=300 cells/ul who had prior anti-retroviral treatment failure requiring retreatment|CSP #512 - Options in Management With Anti-Retrovirals|CSP #512 - Options in Management With Anti-Retrovirals (OPTIMA), Management of Patients With HIV Infection for Whom First and Second-line Highly Active Anti-Retroviral Therapy Has Failed|Completed||N/A|368|Actual|VA Office of Research and Development||4|||f||||f||||||||||2017-02-18 18:02:13.117971|2017-02-18 18:02:13.117971
NCT00050076|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-20|2012-01-31|||August 2002||2002-08-01|January 2012|2012-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.|A Phase II, Double-Blind, Randomized, Exploratory, Placebo-Controlled Study of Efficacy, Safety, and Tolerability of MCC-135 Comparing QD vs BID Doses in Subjects With Congestive Heart Failure, NYHA Class II/III|Completed||Phase 2|204|Actual|Takeda||4|||f||||f||||||||||2017-02-18 18:02:16.572854|2017-02-18 18:02:16.572854
NCT00050063|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-20|2012-05-17||||||May 2012|2012-05-01|May 2004|Actual|2004-05-01|||||Observational|||Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs|A Rollover Study of A5058s: A Phase II Trial to Evaluate the Ability of Vaccine-Induced Helper and CTL Responses to Control Viremia in the Absence of Antiretroviral Therapy|Completed||N/A|78||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:02:16.725439|2017-02-18 18:02:16.725439
NCT00050050|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-20|2014-05-23|||September 2001||2001-09-01|May 2014|2014-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder|CBT for Residual ADHD Symptoms in Adults|Completed||Phase 1|40|Actual|Massachusetts General Hospital|||||f||||f||||||||||2017-02-18 18:02:16.835929|2017-02-18 18:02:16.835929
NCT00050037|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-20|2013-04-10|||April 2001||2001-04-01|April 2013|2013-04-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Cognitive Therapy for Binge-Eating Disorder|Cognitive Therapy Via CD-Rom for Binge-Eating Disorder|Completed||N/A|60|Actual|University of North Carolina, Chapel Hill||3|||f||||f||||||||||2017-02-18 18:02:16.927626|2017-02-18 18:02:16.927626
NCT00050024|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-19|2017-01-24|||November 13, 2002||2002-11-13|September 17, 2008|2008-09-17|September 17, 2008||2008-09-17|||||Observational|||Transcranial Magnetic Stimulation and Electrical Stimulation of Nerves to Study Focal Dystonia|The Effect of Peripheral Heterotopic Stimulation on Cortical Excitability in Dystonia|Completed||N/A|38||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:17.219213|2017-02-18 18:02:17.219213
NCT00050011|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-18|2014-02-21|2013-12-04||September 2002||2002-09-01|February 2014|2014-02-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy|An Open-Label, Randomized, Multicenter Study to Evaluate the Use of Zoledronic Acid in the Prevention of Cancer Treatment-Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Letrozole as Adjuvant Therapy|Completed||Phase 3|602|Actual|Novartis||2|||f||||f||||||||||2017-02-18 18:02:17.31478|2017-02-18 18:02:17.31478
NCT00049998|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-18|2013-03-01|||October 2001||2001-10-01|March 2013|2013-03-01||||April 2004|Actual|2004-04-01||Interventional|||Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer|An Open-Label, Multicentre, Randomised, Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non Small Cell Lung Cancer|Completed||Phase 3|760||GlaxoSmithKline||1|||||||||||||||||2017-02-18 18:02:18.351882|2017-02-18 18:02:18.351882
NCT00049985|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-18|2009-08-06|||July 2002||2002-07-01|August 2009|2009-08-01||||||||Interventional|||Heart Failure and Anemia|A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Impact of Subcutaneous (SC) Darbepoetin Alfa Treatment on Exercise Tolerance in Subjects With Symptomatic Heart Failure (CHF) and Anemia.|Completed||Phase 2|300||Amgen||1|||||||||||||||||2017-02-18 18:02:18.697121|2017-02-18 18:02:18.697121
NCT00049972|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-18|2010-10-04|||September 2002||2002-09-01|October 2010|2010-10-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Major Depressive Disorder Study In Adults|An Open Label Study Assessing Paxil CR (Paroxetine CR) in Patients With Major Depressive Disorder Who Discontinued Treatment With Selective Serotonin Reuptake Inhibitors or a Selective Serotonin/Norepinephrine Reuptake Inhibitor Due to Intolerability|Completed||Phase 4|646||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:02:18.785465|2017-02-18 18:02:18.785465
NCT00049959|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-15|2011-03-01||2011-03-01||||March 2011|2011-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.|A Randomized, Placebo-Controlled, Masked, Multicenter Phase III Study Of Photodynamic Therapy With Verteporfin For Injection (VFI) For The Treatment Of Multiple Basal Cell Carcinoma|Terminated||Phase 3|||QLT Inc.|||||||||||||||||||2017-02-18 18:02:18.942362|2017-02-18 18:02:18.942362
NCT00049946|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-15|2013-02-11|||October 2002||2002-10-01|February 2013|2013-02-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Schizophrenia Study In Adults|A Multicenter, Double-Blind, Double-Dummy, Placebo-Controlled, Randomized, Parallel Group Evaluation of the Efficacy and Safety of a Fixed-Dose of Talnetant Versus Placebo Versus Risperidone in Subjects With Schizophrenia|Completed||Phase 2|231||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:02:19.21962|2017-02-18 18:02:19.21962
NCT00049933|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2012-12-18|||September 2002||2002-09-01|December 2012|2012-12-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Hormone Replacement Therapy and Prothrombotic Variants||Completed||N/A|1000|Actual|University of Washington|||1||f||||||||||||||2017-02-18 18:02:19.345244|2017-02-18 18:02:19.345244
NCT00049920|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2016-07-28|||September 2002||2002-09-01|October 2008|2008-10-01|September 2008|Actual|2008-09-01|May 2006|Actual|2006-05-01||Observational|||The ARIC MRI Study|The ARIC Neurocognitive Longitudinal Study|Completed||N/A|1134|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||Samples With DNA|"~     Plasma and DNA~   "|||2017-02-18 18:02:19.431668|2017-02-18 18:02:19.431668
NCT00049907|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2016-02-17|||September 2002||2002-09-01|January 2006|2006-01-01|August 2004|Actual|2004-08-01|||||Observational|||Cardiac and Renal Disease Study (CARDS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:02:19.509748|2017-02-18 18:02:19.509748
NCT00049894|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2016-02-17|||September 2002||2002-09-01|October 2005|2005-10-01|August 2004|Actual|2004-08-01|||||Observational|||Predictors of Recurrent Stroke in the PROGRESS Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:02:19.581504|2017-02-18 18:02:19.581504
NCT00049881|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2016-02-17|||April 2002||2002-04-01|January 2005|2005-01-01|March 2004|Actual|2004-03-01|||||Observational|||Genetic Determinants:Low HDL, High Triglycerides, Obesity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:02:19.65334|2017-02-18 18:02:19.65334
NCT00049868|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2016-01-11|||September 2002||2002-09-01|January 2006|2006-01-01|August 2005||2005-08-01|||||Observational|||Enhanced Linkage Maps From Family-Based Genetics Studies||Completed||N/A|||Rutgers University|||||f||||||||||||||2017-02-18 18:02:19.72249|2017-02-18 18:02:19.72249
NCT00049855|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2014-04-15|||September 2002||2002-09-01|April 2014|2014-04-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Novel Approaches in Linkage Analysis for Complex Traits||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-02-18 18:02:19.791909|2017-02-18 18:02:19.791909
NCT00049842|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2015-09-24|2010-10-07||October 2002||2002-10-01|September 2015|2015-09-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)|PEG-Intron(TM) Maintenance Therapy vs. an Untreated Control Group for Prevention of Progression of Fibrosis in Adult Subjects With Chronic Hepatitis C With Hepatic Fibrosis (METAVIR Fibrosis Score of F2 or F3), Who Failed Therapy With PEG-Intron Plus REBETOL(R) (in Protocol No. P02370)|Completed||Phase 3|540|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 18:02:19.877736|2017-02-18 18:02:19.877736
NCT00049829|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2011-11-01|||January 2002||2002-01-01|November 2011|2011-11-01||||June 2006|Actual|2006-06-01||Interventional|||HORIZON-PFT: Pivotal Fracture Trial|HORIZON-PFT: Pivotal Fracture Trial|Completed||Phase 3|7700||Novartis|||||||||||||||||||2017-02-18 18:02:20.69527|2017-02-18 18:02:20.69527
NCT00049816|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-14|2013-05-16|||October 2002||2002-10-01|May 2013|2013-05-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Aerobic Exercise Intervention for Knee Osteoarthritis|Aerobic Exercise Intervention for Knee Osteoarthritis|Completed||N/A|306|Actual|Mayo Clinic||3|||f||||||||||||||2017-02-18 18:02:20.84072|2017-02-18 18:02:20.84072
NCT00049803|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-13|2005-06-23|||December 2000||2000-12-01|July 2004|2004-07-01|April 2004||2004-04-01|||||Interventional|||Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients|Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate) With Placebo for the Treatment of Narcolepsy|Completed||Phase 3|200||Orphan Medical|||||||||||||||||||2017-02-18 18:02:20.952448|2017-02-18 18:02:20.952448
NCT00049790|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-13|2009-01-08||||||January 2009|2009-01-01|December 2004||2004-12-01|||||Interventional|||Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer||Completed||Phase 2|||CASI Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 18:02:21.077858|2017-02-18 18:02:21.077858
NCT00049777|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-13|2007-01-24|||December 2002||2002-12-01|January 2007|2007-01-01|August 2005||2005-08-01|||||Interventional|||A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)|A Randomized, Double-Blind, Placebo-Controlled Trial of Prophylactic Heparin in Patients With Severe Sepsis and Higher Disease Severity Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)|Completed||Phase 4|2000||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:02:21.162461|2017-02-18 18:02:21.162461
NCT00049764|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-13|2007-11-15|||November 2002||2002-11-01|November 2007|2007-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis|Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis|Completed||Phase 3|474|Actual|Eli Lilly and Company||2|||f||||t||||||||||2017-02-18 18:02:21.251834|2017-02-18 18:02:21.251834
NCT00049751|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-13|2006-08-13|||September 2002||2002-09-01|August 2006|2006-08-01||||||||Interventional|||Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis|A Multicenter Study of the Safety of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis|Completed||Phase 3|3000||Abbott|||||||||||||||||||2017-02-18 18:02:21.529556|2017-02-18 18:02:21.529556
NCT00049738|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2017-01-24|||October 29, 2002||2002-10-29|November 15, 2016|2016-11-15||||||||Observational|||Screening for Childhood-Onset Psychotic Disorders|Screening, Evaluation, Diagnosis, Treatment Optimization and Follow-up for Childhood Onset Psychotic Disorders|Active, not recruiting||N/A|123|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:21.65979|2017-02-18 18:02:21.65979
NCT00049725|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2008-03-03|||November 2002||2002-11-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Daclizumab to Treat Chronic Immune Thrombocytopenia|A Study of Daclizumab in Chronic Immune Thrombocytopenia (ITP)|Completed||Phase 2|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:21.755481|2017-02-18 18:02:21.755481
NCT00049712|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2015-07-22|||October 2002||2002-10-01|July 2015|2015-07-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma|A Phase I Study Of Medi 522 In Patients With Advanced Tumors|Completed||Phase 1|||University of Wisconsin, Madison|||||||||||||||||||2017-02-18 18:02:21.839581|2017-02-18 18:02:21.839581
NCT00049699|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-07-17|||October 2002||2002-10-01|March 2004|2004-03-01|January 2008|Actual|2008-01-01|||||Interventional|||VNP40101M in Treating Patients With Advanced or Metastatic Cancer|A Phase I Trial of VNP40101M, a Novel Alkylating Agent, Administered Weekly for Patients With Advanced or Metastatic Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:02:21.938556|2017-02-18 18:02:21.938556
NCT00049686|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-07-17|||April 2002||2002-04-01|September 2003|2003-09-01|January 2008|Actual|2008-01-01|||||Interventional|||VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome|A Phase I Trial Of VNP40101M, A Novel Alkylating Agent, For Patients With Hematologic Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:02:22.218132|2017-02-18 18:02:22.218132
NCT00049673|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2015-10-05|||September 2002||2002-09-01|September 2013|2013-09-01|September 2013|Actual|2013-09-01|February 2010|Actual|2010-02-01||Interventional|||Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Randomized Phase III Study Of Thalidomide And Prednisone As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients With Multiple Myeloma|Completed||Phase 3|332|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:02:22.31198|2017-02-18 18:02:22.31198
NCT00049660|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2012-07-17|||September 2002||2002-09-01|July 2012|2012-07-01||||December 2004|Actual|2004-12-01||Interventional|||Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer|A Randomized Phase II-III Trial Evaluating the Efficacy of Capecitabine and Vinorelbine in Anthracycline and Taxane Pre-Treated Metastatic Breast Cancer|Terminated||Phase 2/Phase 3|47|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:02:22.450499|2017-02-18 18:02:22.450499
NCT00049634|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2010-09-14|||January 2002||2002-01-01|September 2010|2010-09-01||||February 2007|Actual|2007-02-01||Interventional|||Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder|A Phase I/II Study of Immunologically Engineered rhG-CSF Mobilized Peripheral Blood Stem Cells (PBSC) for Allogeneic Transplant From HLA Identical, Related Donors for Treatment of Myeloid Malignancies|Completed||Phase 1/Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 18:02:22.582295|2017-02-18 18:02:22.582295
NCT00049608|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-06-17|||July 2002||2002-07-01|April 2007|2007-04-01|August 2011|Actual|2011-08-01|||||Interventional|||Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors|A Phase I Study Of The Effect Of Mistletoe Extract, A Complementary Medicine Botanical, On Pharmacokinetics, Pharmacodynamics And Safety Of Gemcitabine In Patients With Advanced Solid Tumors|Terminated||Phase 1|51|Anticipated|National Cancer Institute (NCI)||||Principal investigator [PI] has left institution.|f||||||||||||||2017-02-18 18:02:22.689408|2017-02-18 18:02:22.689408
NCT00049595|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-02-05|||August 2002||2002-08-01|February 2016|2016-02-01||||January 2010|Actual|2010-01-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma|BEACOPP (4 Cycles Escalated + 4 Cycles Baseline) Versus ABVD (8 Cycles) In Stage III & IV Hodgkin's Lymphoma|Active, not recruiting||Phase 3|552|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 18:02:22.801571|2017-02-18 18:02:22.801571
NCT00049582|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-09-27|||September 2002||2002-09-01|September 2013|2013-09-01||||June 2010|Actual|2010-06-01||Interventional|||Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia|Phase I Study of 5-Aza-2'-Deoxycytidine (Decitabine) as a Biologic Modifier of Retinoid Responsive Genes in Patients With High-Risk Myelodysplastic Syndromes and Acute Myelogenous Leukemia (De-novo, Relapsed or Secondary)|Terminated||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:02:23.111657|2017-02-18 18:02:23.111657
NCT00049569|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-10-07|||January 2003||2003-01-01|October 2013|2013-10-01||||March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia|Intensive Induction Therapy for Children With Acute Lymphoblastic Leukemia (ALL) Who Experience a Bone Marrow Relapse|Completed||N/A|126|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:02:23.240441|2017-02-18 18:02:23.240441
NCT00049556|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-06-18|||October 2002||2002-10-01|January 2006|2006-01-01|August 2006|Actual|2006-08-01|||||Interventional|||Gefitinib in Treating Patients With Cervical Cancer|Phase II Pilot Study of Clinical Activity and Proteomic Pathway Profiling of the EGFR Inhibitor, ZD1839 (Iressa; Gefitinib), in Patients With Epithelial Ovarian Cancer or Cervical Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:02:23.385418|2017-02-18 18:02:23.385418
NCT00049543|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2014-12-19|2014-12-19||September 2002||2002-09-01|March 2014|2014-03-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery|A Phase III Prospective Randomized, Double-Blind, Placebo-Controlled Trial of the Epidermal Growth Factor Receptor Antagonist, ZD1839 (IRESSA) in Completely Resected Primary Stage IB, II and IIIA Non-Small Cell Lung Cancer|Completed||Phase 3|503|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 18:02:23.499334|2017-02-18 18:02:23.499334
NCT00049530|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2015-10-06|2014-01-30||September 2003||2003-09-01|May 2014|2014-05-01|June 2014|Actual|2014-06-01|August 2012|Actual|2012-08-01||Interventional||The primary analysis population was all eligible (meeting all eligibility criteria listed in protocol) and treated patients (receiving at least one dose of the protocol therapy). All baseline analysis and efficacy endpoints are based on the primary population (n=29).|PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma|Phase II Study of Low Dose Peginterferon Alfa-2b in Patients With Metastatic Melanoma Over-Expressing Basic Fibroblast Growth Factor|Completed||Phase 2|32|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 18:02:24.350287|2017-02-18 18:02:24.350287
NCT00049517|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-12-01|2013-01-10||December 2002||2002-12-01|December 2016|2016-12-01|January 2019|Anticipated|2019-01-01|March 2009|Actual|2009-03-01||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia|A Phase III Trial in Adult Acute Myeloid Leukemia: Daunorubicin Dose-Intensification Prior to Risk-Allocated Autologous Stem Cell Transplantation|Active, not recruiting||Phase 3|657|Actual|Eastern Cooperative Oncology Group||6|||f||||t||||||||||2017-02-18 18:02:24.823893|2017-02-18 18:02:24.823893
NCT00049504|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2014-02-27|||January 2002||2002-01-01|February 2014|2014-02-01|February 2014|Actual|2014-02-01|March 2011|Actual|2011-03-01||Interventional|||Fludarabine Phosphate, Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil, Total-Body Irradiation, and Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer|Nonmyeloablative Hematopoietic Stem Cell Transplantation for Patients With High-Risk Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Phase II Trial of Combined Immunosuppression Before and After Transplantation|Completed||Phase 2|53|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 18:02:25.628756|2017-02-18 18:02:25.628756
NCT00049465|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2010-09-17|||August 1998||1998-08-01|September 2010|2010-09-01||||February 2005|Actual|2005-02-01||Interventional|||Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer|Multi-Site Randomized Clinical Trial Comparing Standard Recovery Preparation to Extended Recovery Preparation to Enhance Long Term Function After Marrow or Stem Cell Transplant|Completed||N/A|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:02:28.563142|2017-02-18 18:02:28.563142
NCT00049452|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2014-01-03|||December 2001||2001-12-01|April 2007|2007-04-01|August 2008|Actual|2008-08-01|||||Interventional|||Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer|A Randomized, Placebo Controlled Trial Of Zoledronic Acid For The Prevention Of Bone Loss In Premenopausal Women With Early Stage Breast Cancer|Completed||Phase 3|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:02:28.679327|2017-02-18 18:02:28.679327
NCT00049439|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2010-06-09|||March 1998||1998-03-01|June 2010|2010-06-01|February 2008|Actual|2008-02-01|October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma|Dose-Modified Oral Combination Chemotherapy In Patients With Aids-Related Non-Hodgkin's Lymphoma In The United States And Africa|Completed||Phase 2|54|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:02:28.785625|2017-02-18 18:02:28.785625
NCT00049413|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2011-05-10|||June 2002||2002-06-01|May 2011|2011-05-01|December 2005|Actual|2005-12-01|December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma|Pentostatin, Cyclophosphamide And Rituximab (PCR) For B-Cell Chronic Lymphocytic Leukemia (CLL) And Small B-Cell Lymphocytic Lymphoma (SLL): Four Phase II Trials With Patient Stratification Based On Prior Therapy|Completed||Phase 2|||Hoag Memorial Hospital Presbyterian|||||f||||f||||||||||2017-02-18 18:02:28.890557|2017-02-18 18:02:28.890557
NCT00049400|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2015-04-01|||October 2003||2003-10-01|April 2015|2015-04-01|December 2007|Actual|2007-12-01|September 2006|Actual|2006-09-01||Interventional|||S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction|A Phase I Pharmacokinetic Study Of Epothilone B Analogue BMS-247550 (NSC 710428D) In Patients With Advanced Malignancies And Varying Levels Of Liver Dysfunction|Completed||Phase 1|78|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:02:29.009296|2017-02-18 18:02:29.009296
NCT00049387|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2015-04-14|||September 2002||2002-09-01|December 2013|2013-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma|Phase I Trial of R115777 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1|19|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:02:29.160704|2017-02-18 18:02:29.160704
NCT00049374|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2009-09-23|||September 2002||2002-09-01|September 2009|2009-09-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Study Of Genasense In Combination With Thalidomide And Dexamethasone In Relapsed And Refractory Multiple Myeloma|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-02-18 18:02:29.2763|2017-02-18 18:02:29.2763
NCT00049361|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2009-08-20|||January 2004||2004-01-01|August 2009|2009-08-01||||||||Interventional|||Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases|A Phase II Study Of Whole-Brain Radiation Therapy With Thalidomide And Temozolomide In Patients With Newly Diagnosed Brain Metastases|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:02:32.192024|2017-02-18 18:02:32.192024
NCT00049348|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2010-11-12|||May 2003||2003-05-01|June 2005|2005-06-01||||October 2005|Actual|2005-10-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer|A Randomized Phase II Study Of Gemcitabine Plus Radiotherapy Vs. Gemcitabine, 5-Fluorouracil And Cisplatin Followed By Radiotherapy And 5-Fluoraracil For Patients With Locally Advanced, Potentially Resectable Pancreatic Adenocarcinoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:02:32.295038|2017-02-18 18:02:32.295038
NCT00049335|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-01-02|||February 2003||2003-02-01|January 2013|2013-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed|Protocol For Assessment Of Capecitabine For Advanced Colorectal Cancer In Patients Aged 70 Years And Older (And In A Cohort Of Patients Younger Than 60 Years)|Completed||Phase 2|29|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:02:32.817284|2017-02-18 18:02:32.817284
NCT00049322|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-02-17|2016-01-20||June 2003||2003-06-01|February 2016|2016-02-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery|A Phase II Study Of rhuMAb VEGF (BEVACIZUMAB) In Patients With Hepatocellular Carcinoma Receiving Chemoembolization|Completed||Phase 2|30|Actual|Jonsson Comprehensive Cancer Center|Size of study limits any strong conclusions regarding efficacy.Since this study was first designed and implemented, there have been many advances in the field, including confirmation of proof of principal for anti-angiogenic agents in advanced HCC.|2|||f||||t||||||||||2017-02-18 18:02:33.037673|2017-02-18 18:02:33.037673
NCT00049309|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-04-09|||January 2003||2003-01-01|February 2013|2013-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer|Prostate Cancer: Impact Of Fat And Flaxseed - Modified Diets|Completed||Phase 2|161|Actual|Duke University||4|||f||||t||||||||||2017-02-18 18:02:33.477759|2017-02-18 18:02:33.477759
NCT00049296|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2010-06-10|||July 2002||2002-07-01|June 2010|2010-06-01|January 2006|Actual|2006-01-01|December 2004|Actual|2004-12-01||Interventional|||Thalidomide and Docetaxel in Treating Patients With Advanced Cancer|Phase I Pharmacokinetic Trial of Thalidomide and Docetaxel: A Regimen Based on Anti-Angiogenic Therapeutic Principles|Completed||Phase 1|26|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:02:33.587168|2017-02-18 18:02:33.587168
NCT00049283|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2014-06-05|||September 2002||2002-09-01|January 2013|2013-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer|A Phase I Study of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, OSI-774, in Combination With Docetaxel and Radiation in Locally Advanced Squamous Cell Cancer of the Head and Neck|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:02:33.712352|2017-02-18 18:02:33.712352
NCT00049257|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2015-10-01|2011-04-28||October 2002||2002-10-01|August 2012|2012-08-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of Paclitaxel and Carboplatin in the Treatment of Hormone-Refractory Prostate Cancer (HRPC)|Completed||Phase 2|58|Actual|Jonsson Comprehensive Cancer Center|The major weakness of the study is, it is a single-arm non-comparative study. With the small sample size of 58 participants who received treatment, the study does not have the statistical power to make categorical assessments or statements.|1|||f||||t||||||||||2017-02-18 18:02:34.111907|2017-02-18 18:02:34.111907
NCT00049244|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2017-01-27|||September 2002||2002-09-01|January 2017|2017-01-01||||||||Interventional|||BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer|A Phase I Study of BMS-247550 in Combination With Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With a Taxane and an Anthracycline|Active, not recruiting||Phase 1|||R-Pharm|||||f||||||||||||||2017-02-18 18:02:34.498577|2017-02-18 18:02:34.498577
NCT00049231|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-06-21|||June 2003||2003-06-01|June 2005|2005-06-01|August 2005|Actual|2005-08-01|||||Interventional|||EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer|Evaluation of Hypoxia by EF5 (NSC#684681) Binding in Cervix Cancer|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:02:34.595962|2017-02-18 18:02:34.595962
NCT00049218|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2014-05-08|||April 2003||2003-04-01|May 2014|2014-05-01|May 2014|Actual|2014-05-01|June 2007|Actual|2007-06-01||Interventional|||Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase I-II Trial Using Dendritic Cells Transduced With An Adenoviral Vector Containing The p53 Gene To Immunize Patients With Extensive Stage Small Cell Lung Cancer After Standard Chemotherapy|Completed||Phase 1/Phase 2|56|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:02:34.695711|2017-02-18 18:02:34.695711
NCT00049192|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-06-03|||November 2002||2002-11-01|June 2013|2013-06-01||||November 2005|Actual|2005-11-01||Interventional|||Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A PHASE II STUDY OF G3139 (GENASENSE™, NSC # 683428 IND # 58842) + IMATINIB MESYLATE (GLEEVEC®, STI571) IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA|Completed||Phase 2|43|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:02:34.804452|2017-02-18 18:02:34.804452
NCT00049179|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2015-03-05|||April 2003||2003-04-01|March 2015|2015-03-01|October 2010|Actual|2010-10-01|December 2005|Actual|2005-12-01||Interventional|||S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia|A Phase II Study of Gemtuzumab Ozogamicin (Mylotarg) and Standard Dose ARA-C for Patients With Relapsed Acute Myeloid Leukemia (AML)|Completed||Phase 2|33|Actual|Southwest Oncology Group||1|||f||||||||||||||2017-02-18 18:02:34.929726|2017-02-18 18:02:34.929726
NCT00049166|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-09-27|||October 2002||2002-10-01|September 2013|2013-09-01||||July 2007|Actual|2007-07-01||Interventional|||Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer|A Phase I Study of OSI-774 in Combination With Standard Fractionation Radiation Therapy in Patients With Oral Cavity or Oropharyngeal Cancer Stage II or III and in Combination With Standard Fractionation Radiation Therapy and Low Dose Daily Cisplatin in Patients With Oral Cavity or Oropharyngeal Cancer Stage III and IV|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:02:35.182605|2017-02-18 18:02:35.182605
NCT00049140|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2014-07-24|||August 2002||2002-08-01|February 2013|2013-02-01||||October 2004|Actual|2004-10-01||Interventional|||EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer|Pilot Study of the Relationship Between EF5 Uptake and Concentration of Oxygen-Related Metabolites in Head and Neck Cancer|Completed||Phase 2|8|Actual|Duke University||1|||f||||||||||||||2017-02-18 18:02:35.297245|2017-02-18 18:02:35.297245
NCT00049127|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-07-19|2013-11-25||June 2003||2003-06-01|July 2016|2016-07-01||||August 2011|Actual|2011-08-01||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor|Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma|Active, not recruiting||Phase 1/Phase 2|64|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:02:35.424883|2017-02-18 18:02:35.424883
NCT00049114|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-06-05|||February 2003||2003-02-01|June 2013|2013-06-01||||January 2007|Actual|2007-01-01||Interventional|||Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer|A Phase I-II Study of R115777 (ZARNESTRA) Plus Doxorubicin and Cyclophosphamide in Patients With Locally Advanced Breast Cancer and Metastatic Breast Cancer|Completed||Phase 2|62|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:02:37.098607|2017-02-18 18:02:37.098607
NCT00049101|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-06-21|||August 2002||2002-08-01|April 2004|2004-04-01|August 2004|Actual|2004-08-01|||||Interventional|||Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer|A Phase I/II Study Of OSI-774 In Combination With Oxaliplatin, And 5-Fluourouracil In Patients With Metastatic Colorectal Carcinoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:02:37.215187|2017-02-18 18:02:37.215187
NCT00048633|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-04|2012-05-22|||November 2001||2001-11-01|May 2012|2012-05-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer||Completed||Phase 2|30||QLT Inc.||1|||f||||||||||||||2017-02-18 18:02:46.106161|2017-02-18 18:02:46.106161
NCT00049088|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-01-23|||August 2002||2002-08-01|January 2013|2013-01-01||||February 2009|Actual|2009-02-01||Interventional|||Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors|A Phase 1 Study of PS-341 in Combination With Docetaxel in Patients With Advanced Solid Tumors|Terminated||Phase 1|24|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:02:37.308061|2017-02-18 18:02:37.308061
NCT00049075|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-11-25|||August 2002||2002-08-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|July 2005|Actual|2005-07-01||Interventional|||Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia|A Phase II Study of Oral Fludarabine Phosphate in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|128|Actual|Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-02-18 18:02:37.421006|2017-02-18 18:02:37.421006
NCT00049062|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-02-19|||September 2002||2002-09-01|February 2013|2013-02-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer|A Phase II And Biologic Correlative Study Investigating ARIMIDEX In Combination With IRESSA (ZD1839) In Post-Menopausal Patients With Estrogen Receptor-Positive Metastatic Breast Carcinoma Who Have Previously Failed Hormonal Therapy|Completed||Phase 2|||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 18:02:37.544611|2017-02-18 18:02:37.544611
NCT00049036|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2014-04-28|2011-05-23||March 2003||2003-03-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|A Randomized Phase II Trial of EPOCH Given Either Concurrently or Sequentially With Rituximab in Patients With Intermediate- or High-Grade HIV-Associated B-cell Non-Hodgkin's Lymphoma|Completed||Phase 2|106|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:02:37.908643|2017-02-18 18:02:37.908643
NCT00049023|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-06-17|||January 2002||2002-01-01|June 2016|2016-06-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Interventional|||Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors|A Phase I, Open Label, Maximum Tolerated Dose-Finding Study to Evaluate the Safety and Tolerability of 90Y-DOTA-tyr3-Octreotide Administered by Intravenous Infusion to Children With Refractory Somatostatin-Receptor Positive Tumors|Completed||Phase 1|27|Actual|University of Iowa||1|||f||||t||||||||||2017-02-18 18:02:38.576139|2017-02-18 18:02:38.576139
NCT00049010|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-06-30|||September 2002||2002-09-01|June 2016|2016-06-01|October 2009|Actual|2009-10-01|March 2006|Actual|2006-03-01||Interventional|||Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma|Prospective Study of Melastatin Expression in Predicting the Risk for Developing Local Regional Metastases of Primary Melanoma|Completed||N/A|314|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:02:38.704792|2017-02-18 18:02:38.704792
NCT00048997|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-12-30|2014-09-30||September 2002||2002-09-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|December 2008|Actual|2008-12-01||Interventional||All eligible patients with consent.|Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer|A Phase III Comparison Of Prophylactic Cranial Irradiation (PCI) Versus Observation In Patients With Locally Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|356|Actual|Radiation Therapy Oncology Group|This study stopped accrual early due to unmet accrual goals.|2|||f||||t||||||||||2017-02-18 18:02:38.843133|2017-02-18 18:02:38.843133
NCT00048984|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2013-06-20|||January 2003||2003-01-01|June 2013|2013-06-01||||February 2013|Actual|2013-02-01||Observational|||Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma|A Groupwide Biology and Banking Study for Ewing Sarcoma|Completed||N/A|637|Actual|Children's Oncology Group|||1||f||||f||||||Samples With DNA|"~     Paraffin-embedded blocks of tumor tissue or slides of tumor tissue, and blood specimens~   "|||2017-02-18 18:02:39.194911|2017-02-18 18:02:39.194911
NCT00048971|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-07-01|||April 2002||2002-04-01|July 2016|2016-07-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|||Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy|A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin|Completed||N/A|308|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     blood specimens~   "|||2017-02-18 18:02:39.303128|2017-02-18 18:02:39.303128
NCT00048958|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2016-05-04|||June 1984||1984-06-01|May 2016|2016-05-01||||January 2100|Anticipated|2100-01-01||Observational|||Cytogenetic Studies in Acute Leukemia and Multiple Myeloma|Cytogenetic Studies in Acute Leukemia and Multiple Myeloma: Companion to CALGB Treatment Studies For Previously Untreated Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) or Multiple Myeloma (MM) Patients|Active, not recruiting||N/A|9000|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     Institutions must submit patient samples (eg, bone marrow and peripheral blood) at~     diagnosis, at complete remission, and at the time of relapse to the Alliance-Approved~     Institutional Cytogeneticist.~   "|||2017-02-18 18:02:39.492515|2017-02-18 18:02:39.492515
NCT00048945|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-12|2017-02-16|||January 2002|Actual|2002-01-01|February 2017|2017-02-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B||Completed||Phase 3|820|Actual|Hoffmann-La Roche|||||||||||||||||||2017-02-18 18:02:40.042748|2017-02-18 18:02:40.042748
NCT00048932|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-11|2011-11-15|2011-04-01||December 2002||2002-12-01|November 2011|2011-11-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis||Completed||Phase 3|1795|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 18:02:40.212177|2017-02-18 18:02:40.212177
NCT00048906|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-08|2008-03-03|||November 2002||2002-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Alpha-Galactosidase A Replacement Therapy for Fabry Disease|A Safety and Pharmacokinetic Study of Replagal Enzyme Replacement Therapy in Patients With Fabry Disease|Completed||Phase 2|3||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:42.340925|2017-02-18 18:02:42.340925
NCT00048646|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-04|2014-09-17|||May 2002||2002-05-01|September 2014|2014-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Progesterone Treatment of Blunt Traumatic Brain Injury|ProTECT: Single Center, Phase II (Pilot), Double Blind, 4:1 Randomized, Placebo Controlled Clinical Trial for Progesterone Treatment of Moderate and Severe Blunt TBI|Completed||Phase 1/Phase 2|100|Actual|Emory University||2|||f||||t||||||||||2017-02-18 18:02:45.983348|2017-02-18 18:02:45.983348
NCT00048893|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-08|2012-03-20|2011-10-25||November 2002||2002-11-01|March 2012|2012-03-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer|A Multicenter Phase I-II Study of Tumor Vaccine Following Chemotherapy in Patients With Metastatic Breast Cancer Untreated With Chemo/Radiation in the Previous 18 Months: Vaccine-Induced Bias of T-Cell Repertoire Reconstitution After T-Cell Re-Infusion|Terminated||Phase 1/Phase 2|37|Actual|National Institutes of Health Clinical Center (CC)|The study was closed to accrual due to very poor enrollment. No meaningful data analysis was possible on the small number of accrued subjects, so none was done.|1||The study was closed to accrual due to very poor enrollment.|f||||t||||||||||2017-02-18 18:02:42.426027|2017-02-18 18:02:42.426027
NCT00048880|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-08|2017-01-24|||November 5, 2002||2002-11-05|March 5, 2010|2010-03-05|July 2, 2008|Actual|2008-07-02|July 2, 2008|Actual|2008-07-02||Interventional|||Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein|Phase I Study of HeFi-1 in Refractory CD30-Positive Malignancy|Completed||Phase 1|9|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:02:43.118764|2017-02-18 18:02:43.118764
NCT00048854|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-08|2016-01-11|||September 2001||2001-09-01|January 2016|2016-01-01|January 2008|Actual|2008-01-01|June 2007|Actual|2007-06-01||Interventional|||Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder|Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder|Completed||Phase 1/Phase 2|66|Actual|Yale University||2|||f||||t||||||||||2017-02-18 18:02:43.225245|2017-02-18 18:02:43.225245
NCT00048841|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-08|2010-03-01|||May 2002||2002-05-01|March 2010|2010-03-01|December 2005|Actual|2005-12-01|||||Interventional|||Prevention of Osteoporosis in Men With Prostate Cancer|Prevention of Osteoporosis in Men With Prostate Cancer|Completed||Phase 3|112||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:02:43.338804|2017-02-18 18:02:43.338804
NCT00048828|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-08|2013-07-01|||October 2001||2001-10-01|July 2013|2013-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Treating Drug-Resistant Childhood Schizophrenia|Treating Refractory Childhood Schizophrenia|Completed||Phase 4|41|Actual|Northwell Health||2|||f||||||||||||||2017-02-18 18:02:43.430036|2017-02-18 18:02:43.430036
NCT00048815|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-08|2009-03-10|||February 2003||2003-02-01|October 2008|2008-10-01||||||||Interventional|||Drug Therapy to Treat Minor Depression|Pharmacotherapy for Minor Depression|Completed||N/A|300||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:02:43.543268|2017-02-18 18:02:43.543268
NCT00048802|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-08|2014-01-21|||August 2002||2002-08-01|January 2014|2014-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Treatment and Outcome of Early Onset Bipolar Disorder|Treatment and Outcome of Early Onset Bipolar Disorder|Completed||Phase 4|40||Northwell Health|||||f||||||||||||||2017-02-18 18:02:43.636286|2017-02-18 18:02:43.636286
NCT00048789|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-07|2017-01-24|||November 4, 2002||2002-11-04|January 29, 2009|2009-01-29|January 29, 2009||2009-01-29|||||Interventional|||Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease|Treatment of Chronic Graft Versus Host Disease With Extracorporeal Photopheresis|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:02:43.736944|2017-02-18 18:02:43.736944
NCT00048776|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-07|2005-07-14|||October 2001||2001-10-01|July 2005|2005-07-01|June 2003||2003-06-01|||||Interventional|||Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon||Completed||Phase 4|75||Otsuka America Pharmaceutical|||||||||||||||||||2017-02-18 18:02:43.830755|2017-02-18 18:02:43.830755
NCT00048763|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-07|2005-07-14|||October 2001||2001-10-01|July 2005|2005-07-01|June 2003||2003-06-01|||||Interventional|||Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon||Completed||Phase 4|75||Otsuka America Pharmaceutical|||||||||||||||||||2017-02-18 18:02:43.927798|2017-02-18 18:02:43.927798
NCT00048750|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-06|2012-03-26|||January 2003||2003-01-01|March 2008|2008-03-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU|A Phase 3, Randomized,Double-Blind, Comparative Study of Micafungin (FK463) Versus Placebo as Preemptive Prophylactic Antifungal Therapy in Patients in the Intensive Care Unit|Terminated||Phase 3|104|Actual|Astellas Pharma Inc||2||Inadequate enrollment|f||||t||||||||||2017-02-18 18:02:44.026919|2017-02-18 18:02:44.026919
NCT00048737|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-06|2013-06-11|2013-04-22||October 2002||2002-10-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional|||Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies|Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies|Completed||Phase 1/Phase 2|70|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:02:44.186838|2017-02-18 18:02:44.186838
NCT00048724|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-06|2015-03-26|2009-04-23||June 2002||2002-06-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)|PEG-Intron as Maintenance Therapy vs. an Untreated Control Group in Adult Subjects With Compensated Cirrhosis (METAVIR F4), Secondary to Chronic Hepatitis C, Who Have Failed to Respond to Therapy With Any Alpha Interferon Plus Ribavirin|Completed||Phase 3|631|Actual|Merck Sharp & Dohme Corp.||2|||f||||t||||||||||2017-02-18 18:02:44.481987|2017-02-18 18:02:44.481987
NCT00048711|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-06|2009-08-24|||March 2002||2002-03-01|August 2009|2009-08-01|June 2006|Actual|2006-06-01|||||Interventional|||Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI|Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI|Completed||Phase 2|||BioMarin Pharmaceutical|||||||||||||||||||2017-02-18 18:02:45.485245|2017-02-18 18:02:45.485245
NCT00048698|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-05|2008-03-03|||November 2002||2002-11-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Effects of Direct Current Brain Stimulation on Cognition|A Phase I Trial of Focal DC Brain Polarization|Completed||Phase 1|170||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:45.573327|2017-02-18 18:02:45.573327
NCT00048685|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-05|2008-03-03|||November 2002||2002-11-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Study of Oral Bacteria in Patients With Dry Mouth|Incidence and Frequency of Cariogenic Microflora in Patients With Clinical Xerostomia and Autoimmune Disease|Completed||N/A|44||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:02:45.650533|2017-02-18 18:02:45.650533
NCT00048672|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-05|2016-01-19|||March 2001||2001-03-01|January 2016|2016-01-01|August 2013|Actual|2013-08-01|November 2002|Actual|2002-11-01||Interventional|||Therapy of Early Chronic Phase CML With Gleevec|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Gleevec (STI571)|Completed||Phase 2|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:02:45.737055|2017-02-18 18:02:45.737055
NCT00048620|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-04|2006-11-02|||September 2000||2000-09-01|November 2006|2006-11-01|November 2005||2005-11-01|||||Interventional|||Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI|Double-Blind,2 Dose Group Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI|Completed||Phase 1|||BioMarin Pharmaceutical|||||||||||||||||||2017-02-18 18:02:46.201268|2017-02-18 18:02:46.201268
NCT00048607|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-04|2015-03-10|||July 2002||2002-07-01|March 2015|2015-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)|A Double-Blind, Multicenter, Placebo and Active-Controlled, Acute Extension Study of 2 Doses of MK-0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|600|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:02:46.283297|2017-02-18 18:02:46.283297
NCT00048594|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-04|2015-03-10|||January 2002||2002-01-01|March 2015|2015-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)|A Double-Blind, Placebo-Controlled, Multicenter Study of the Long-Term Efficacy of MK0869 in the Maintenance of Antidepressant Effect in Patients With Major Depressive Disorder|Completed||Phase 3|800|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:02:46.381392|2017-02-18 18:02:46.381392
NCT00048581|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-02|2011-11-14|2011-04-07||December 2002||2002-12-01|November 2011|2011-11-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.|A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BMS-188667 in Subjects With Active Rheumatoid Arthritis on Background Disease Modifying Anti-Rheumatic Drugs (DMARDS) Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy|Completed||Phase 3|738|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 18:02:49.584785|2017-02-18 18:02:49.584785
NCT00048568|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-02|2011-10-26|2011-03-28||December 2002||2002-12-01|October 2011|2011-10-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate|A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy With Methotrexate Versus Methotrexate Alone in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate|Completed||Phase 3|1250|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 18:02:55.302804|2017-02-18 18:02:55.302804
NCT00048555|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-01|2013-09-12|||November 2002||2002-11-01|January 2011|2011-01-01|November 2010|Actual|2010-11-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma|A Phase I/II Trial of IDEC-114 (Anti-CD80 Monoclonal Antibody) in Combination With Rituxan® for Patients With Relapsed or Refractory, Follicular Lymphoma|Completed||Phase 1/Phase 2|90|Actual|Biogen||1|||f||||f||||||||||2017-02-18 18:03:07.128565|2017-02-18 18:03:07.128565
NCT00048542|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-01|2011-08-18|2009-12-07||September 2002||2002-09-01|August 2011|2011-08-01|June 2010|Actual|2010-06-01|January 2005|Actual|2005-01-01||Interventional|||Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)|A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis|Completed||Phase 3|171|Actual|Abbott||8|||f||||t||||||||||2017-02-18 18:03:07.263424|2017-02-18 18:03:07.263424
NCT00048529|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-01|2005-06-23|||September 2002||2002-09-01|April 2004|2004-04-01||||||||Interventional|||Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus||Suspended||Phase 2|70||Tularik|||||||||||||||||||2017-02-18 18:03:09.327139|2017-02-18 18:03:09.327139
NCT00048516|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-01|2006-07-31|||February 2002||2002-02-01|July 2006|2006-07-01||||||||Interventional|||Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)|Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)|Completed||Phase 3|68||Abbott|||||||||||||||||||2017-02-18 18:03:09.418407|2017-02-18 18:03:09.418407
NCT00048503|ClinicalTrials.gov processed this data on February 17, 2017|2002-11-01|2010-04-23|||June 2002||2002-06-01|April 2010|2010-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older|An Open-label, Phase 2 Study of the Farnesyl Transferase Inhibitor ZARNESTRA (R115777) as Post-consolidation Therapy for Acute Myeloid Leukemia (AML) in Patients Age 60 Years and Older.|Completed||Phase 2|88|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:03:09.522083|2017-02-18 18:03:09.522083
NCT00048490|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-31|2008-03-03|||October 2002||2002-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Transcranial Magnetic Stimulation to Treat Epilepsy|Drug-Refractory Neocortical Epilepsy: rTMS Treatment|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:09.700407|2017-02-18 18:03:09.700407
NCT00048477|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-31|2008-03-03|||October 2002||2002-10-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Effects of Nitrite on Blood Vessel Dilation in Normal Volunteers|Determination of Nitrite as a Source of Bioactive Nitric Oxide in Human Subjects|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:09.782551|2017-02-18 18:03:09.782551
NCT00048464|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-31|2006-11-06|||October 2002||2002-10-01|March 2005|2005-03-01||||||||Interventional|||T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant|A Phase I/II Study of Xcellerated T Cells After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma|Unknown status|Active, not recruiting|Phase 1/Phase 2|35||Xcyte Therapies|||||||||||||||||||2017-02-18 18:03:10.075938|2017-02-18 18:03:10.075938
NCT00048451|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-31|2006-07-31|||February 2002||2002-02-01|July 2006|2006-07-01||||||||Interventional|||Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)|Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)|Completed||Phase 3|68||Abbott|||||||||||||||||||2017-02-18 18:03:10.187269|2017-02-18 18:03:10.187269
NCT00048438|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-31|2006-08-10|||February 2002||2002-02-01|August 2006|2006-08-01||||||||Interventional|||Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)|Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)|Completed||Phase 3|68||Abbott|||||||||||||||||||2017-02-18 18:03:10.285793|2017-02-18 18:03:10.285793
NCT00048425|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-31|2006-12-14|||September 2002||2002-09-01|December 2006|2006-12-01|December 2004||2004-12-01|||||Interventional|||Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.|Randomized, Multicenter Evaluation of Intravenous Levosimendan Efficacy Versus Placebo in the Short Term Treatment of Decompensated Chronic Heart Failure: the REVIVE II Study.|Completed||Phase 3|600||Abbott|||||||||||||||||||2017-02-18 18:03:10.400028|2017-02-18 18:03:10.400028
NCT00048412|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-30|2007-04-09|||June 2000||2000-06-01|April 2007|2007-04-01||||||||Interventional|||Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H|Phase I/II Study of Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancy, Using MHC Identical or Near Identical Donors and Sub-Myeloablative Conditioning With CAMPATH 1H (DIMSUM)|Completed||Phase 1/Phase 2|40||Baylor College of Medicine|||||||||||||||||||2017-02-18 18:03:10.667678|2017-02-18 18:03:10.667678
NCT00048399|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-30|2007-04-09|||December 2000||2000-12-01|April 2007|2007-04-01||||||||Interventional|||Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H|Phase I/II Study of Allogeneic Stem Cell Transplantation For Patients With Graft Failure Following Allogeneic Transplantation Using MHC Identical or Near Identical Donors and Submyeloablative Conditioning With CAMPATH 1H (CAMGRAFT)|Terminated||Phase 1/Phase 2|40||Baylor College of Medicine|||||||||||||||||||2017-02-18 18:03:10.91276|2017-02-18 18:03:10.91276
NCT00048386|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-30|2012-07-26|||November 1999||1999-11-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|December 2004|Actual|2004-12-01||Interventional|CYCHE2||Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy|A Pilot Study of Gene Modified Autologous Neuroblastoma Vaccine for the Post-Chemotherapy Treatment of High-Risk Neuroblastoma|Completed||Phase 1|13|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 18:03:11.006362|2017-02-18 18:03:11.006362
NCT00048373|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-30|2006-08-22|||October 2001||2001-10-01|August 2006|2006-08-01|April 2004||2004-04-01|||||Interventional|||Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL|Treatment of Resistant Langerhans Cell Histiocytosis With Etanercept (ENBREL, IMMUNEX, SEATTLE)|Completed||Phase 2|20||Baylor College of Medicine|||||||||||||||||||2017-02-18 18:03:11.107455|2017-02-18 18:03:11.107455
NCT00048360|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-30|2013-02-11|||October 2002||2002-10-01|February 2013|2013-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults|An 8-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Comparison of Extended-Release Bupropion Hydrochloride 300-450 mg/Day to Assess the Efficacy, Safety, and Effects on Health Outcomes in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder|Completed||Phase 3|162||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:03:11.212203|2017-02-18 18:03:11.212203
NCT00048347|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-29|2010-08-30|2010-07-06||October 2002||2002-10-01|August 2010|2010-08-01|May 2010|Actual|2010-05-01|June 2008|Actual|2008-06-01||Interventional|||Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis|An Open-Label, Pilot Study of Type I Interferon (AVONEX) Treatment of Ulcerative Colitis|Completed||Phase 2|18|Actual|National Institutes of Health Clinical Center (CC)|While this study was designed as a proof-of-concept pilot trial to correlate changes in IL-13 and other cytokines with clinical response, efficacy was measured. The efficacy estimate is limited by the open-label design.|1|||f||||f||||||||||2017-02-18 18:03:11.331513|2017-02-18 18:03:11.331513
NCT00048334|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-29|2017-01-24|||October 26, 2002||2002-10-26|January 7, 2014|2014-01-07|April 1, 2010|Actual|2010-04-01|April 1, 2010|Actual|2010-04-01||Interventional|||Depsipeptide to Treat Thyroid and Other Advanced Cancers|Phase I Trial of Romidepsin Given on Days One, Three, and Five in Patients With Thyroid and Other Advanced Cancers|Completed||Phase 1|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:03:11.569538|2017-02-18 18:03:11.569538
NCT00048321|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-29|2007-10-15|||January 2002||2002-01-01|October 2007|2007-10-01||||||||Interventional|||ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis|ISIS 104838-CS7, A Double-Blind, Placebo-Controlled, Randomized Trial of the Safety, Efficacy and Pharmacokinetic Profile of ISIS 104838 (TNF-Alpha Antisense Oligonucleotide) Subcutaneous Injections in Active Rheumatoid Arthritis Patients|Completed||Phase 2|160||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 18:03:11.664346|2017-02-18 18:03:11.664346
NCT00048308|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-29|2017-02-15|||January 2002||2002-01-01|February 2017|2017-02-01||||||||Interventional|||Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass||Active, not recruiting||Phase 3|3000||Alexion Pharmaceuticals|||||||||||||||||||2017-02-18 18:03:11.979131|2017-02-18 18:03:11.979131
NCT00048295|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-29|2005-06-23|||May 2002||2002-05-01|April 2004|2004-04-01||||||||Interventional|||Alicaforsen (ISIS 2302) in Patients With Active Crohn’s Disease|ISIS 2302-CS21, Phase 3 Double-Masked, Placebo-Controlled Study of Alicaforsen (ISIS 2302), an Antisense Inhibitor of ICAM-1, for the Treatment of Patients With Active Crohn’s Disease|Unknown status|Active, not recruiting|Phase 3|150||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 18:03:12.270368|2017-02-18 18:03:12.270368
NCT00048282|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-29|2010-05-13||||||January 2006|2006-01-01||||||||Observational|||HIV Prevention Preparedness Study|HIV Prevention Preparedness Study|Completed||N/A|1200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:03:12.373649|2017-02-18 18:03:12.373649
NCT00048256|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-28|2008-03-03|||October 2002||2002-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates|Exploring the Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates|Completed||N/A|57||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:12.472857|2017-02-18 18:03:12.472857
NCT00048230|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-28|2012-01-12|||June 2002||2002-06-01|January 2012|2012-01-01|December 2004|Actual|2004-12-01|July 2004|Actual|2004-07-01||Interventional|||PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|An International, Multi-Center, Randomized, Open-Label Study of PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 3|620|Actual|Millennium Pharmaceuticals, Inc.|||||f||||||||||||||2017-02-18 18:03:12.551229|2017-02-18 18:03:12.551229
NCT00048217|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-28|2005-06-23||||||July 2004|2004-07-01||||||||Interventional|||A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102||Unknown status|Active, not recruiting|Phase 1/Phase 2|||Trimeris|||||||||||||||||||2017-02-18 18:03:12.726279|2017-02-18 18:03:12.726279
NCT00048022|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2005-06-23||||||May 2005|2005-05-01||||||||Interventional|||Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma||Completed||Phase 2|||Hoffmann-La Roche|||||||||||||||||||2017-02-18 18:03:20.994384|2017-02-18 18:03:20.994384
NCT00048204|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-28|2016-09-22|||November 2002||2002-11-01|September 2016|2016-09-01||||||||Interventional|||A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder|An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Fixed-Dose Study Comparing the Efficacy and Safety of GW597599B or Paroxetine to Placebo in Moderately to Severely Depressed Patients With Major Depressive Disorder|Completed||Phase 2|372|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 18:03:12.798217|2017-02-18 18:03:12.798217
NCT00048165|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2016-05-04|2016-05-04||August 1999||1999-08-01|May 2016|2016-05-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional||The randomized population included all participants who were randomized into the study, whether they received the study drug or not.|A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation|A Double-Blind, Placebo -Controlled, Randomized Study to Assess the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation.|Completed||Phase 4|434|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 18:03:13.035539|2017-02-18 18:03:13.035539
NCT00048152|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2016-11-01|||December 2000||2000-12-01|November 2016|2016-11-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients|A Randomized, Open-label Study Comparing the Effects of Low-dose Cyclosporine vs Cyclosporine Withdrawal on Renal Function in Kidney Transplant Patients Treated With CellCept and Daclizumab|Completed||Phase 3|539|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 18:03:14.609173|2017-02-18 18:03:14.609173
NCT00048139|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2016-11-01|||October 2001||2001-10-01|November 2016|2016-11-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer|An Open-label Study of the Effect of Intermittent Xeloda in Combination With Irinotecan on Treatment Response in Patients With Advanced and/or Metastatic Colorectal Cancer|Completed||Phase 2|52|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 18:03:14.738354|2017-02-18 18:03:14.738354
NCT00048126|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2016-11-01|||July 2001||2001-07-01|November 2016|2016-11-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer|An Open-label Study of the Effect of Continuous Xeloda Therapy in Combination With Irinotecan on Treatment Response in Patients With Advanced and/or Metastatic Colorectal Cancer|Completed||Phase 2|57|Actual|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 18:03:14.84361|2017-02-18 18:03:14.84361
NCT00048113|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2007-10-15|||September 2001||2001-09-01|October 2007|2007-10-01||||||||Interventional|||Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease|ISIS 2302-CS20, Phase 3 Double-Masked, Placebo-Controlled Study of Alicaforsen (ISIS 2302), an Antisense Inhibitor of ICAM-1, for the Treatment of Patients With Active Crohn's Disease|Completed||Phase 3|150||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 18:03:14.948523|2017-02-18 18:03:14.948523
NCT00048100|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2012-08-22|||February 2001||2001-02-01|August 2012|2012-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes|Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes for Therapy of Relapsed Leukemia After Allogeneic Stem Cell Therapy|Terminated||Phase 1|2|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-02-18 18:03:15.056259|2017-02-18 18:03:15.056259
NCT00048087|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2012-07-27|||August 2002||2002-08-01|July 2012|2012-07-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Iressa/Docetaxel in Non-Small-Cell Lung Cancer|A Phase II Study of ZD1839 (Iressa), Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor, in Combination With Docetaxel in Patients With Recurrent or Metastatic Advanced Non-Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-02-18 18:03:15.522407|2017-02-18 18:03:15.522407
NCT00048074|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2016-01-04|2016-01-04||June 2002||2002-06-01|January 2016|2016-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional||Safety Population: All participants who were randomized and had at least one dose of study drug, whether withdrawn prematurely or not, and who had at least one follow-up data point were included.|DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis|A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis|Completed||Phase 3|1395|Actual|Hoffmann-La Roche||3|||f||||||||||||||2017-02-18 18:03:15.650049|2017-02-18 18:03:15.650049
NCT00048061|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2016-04-22|2016-02-05||April 2002||2002-04-01|April 2016|2016-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional||The safety population consisted of all participants who were randomized and received at least one dose of the study medication, and who have at least one follow-up data point.|MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis|Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis|Completed||Phase 3|1609|Actual|Hoffmann-La Roche||4|||f||||||||||||||2017-02-18 18:03:17.460879|2017-02-18 18:03:17.460879
NCT00048048|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2015-10-01|||March 2002||2002-03-01|October 2015|2015-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.|A Randomized, Open-label Study of the Effect of Different Dosing Intervals of Subcutaneous Mircera on Hemoglobin Level/Correction in Patients With Chronic Renal Anemia|Completed||Phase 2|65|Actual|Hoffmann-La Roche||9|||f||||||||||||||2017-02-18 18:03:19.678961|2017-02-18 18:03:19.678961
NCT00048035|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-24|2016-10-26|2016-05-03||March 2002||2002-03-01|October 2016|2016-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional||The Intent-to-Treat (ITT) population was used for the analysis. It was defined as all randomized participants.|A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia|An Open-label, Multicenter, Randomized Study to Determine Dose Conversion Factors at Different Frequencies of Administration After Switching From Maintenance Treatment With Intravenous Epoetin Alfa to Maintenance Treatment With Intravenous RO0503821 in Hemodialysis Patients With Chronic Renal Anemia.|Completed||Phase 2|91|Actual|Hoffmann-La Roche||6|||f||||||||||||||2017-02-18 18:03:19.811834|2017-02-18 18:03:19.811834
NCT00047983|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-23|2017-01-10||||||January 2017|2017-01-01|April 2004|Actual|2004-04-01|||||Interventional|||Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients|A Randomized Trial of Immunomodulating Diets With Arginine and Omega-3 Fatty Acids in Renal Transplant Recipients|Completed||Early Phase 1|75|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 18:03:21.391998|2017-02-18 18:03:21.391998
NCT00047970|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-23|2015-04-14|||August 2003||2003-08-01|November 2012|2012-11-01|April 2015|Actual|2015-04-01|August 2009|Actual|2009-08-01||Observational|||The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer|The Sister Study: Genetic and Environmental Risk Factors for Breast Cancer|Completed||N/A|50884|Actual|National Institute of Environmental Health Sciences (NIEHS)|||||f||||f||||||||||2017-02-18 18:03:21.536414|2017-02-18 18:03:21.536414
NCT00047957|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-22|2008-03-03|||October 2002||2002-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Brain Inhibition of Muscle Movement in Normal Volunteers|The Effect of Peripheral Homotopic and Heterotopic Stimulation on Cortical Excitability|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:21.620439|2017-02-18 18:03:21.620439
NCT00047944|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-22|2017-01-24|||October 12, 2002||2002-10-12|October 27, 2016|2016-10-27|October 27, 2016||2016-10-27|||||Observational|||MRI Study of Brain Activity and Risk for Depression in Adolescents|Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging|Completed||N/A|88|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:21.707391|2017-02-18 18:03:21.707391
NCT00047931|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-22|2017-01-24|||October 17, 2002||2002-10-17|May 5, 2009|2009-05-05|May 5, 2009||2009-05-05|||||Interventional|||HIV-1 Vaccine Test in Uninfected Adult Volunteers|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA009-00-VP in Uninfected Adult Volunteers|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:03:21.802785|2017-02-18 18:03:21.802785
NCT00047918|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-22|2008-03-03|||October 2002||2002-10-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing|Investigation of Hematologic Parameters in Mastocytosis and Idiopathic Anaphylaxis|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:21.893355|2017-02-18 18:03:21.893355
NCT00047905|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-22|2008-03-03|||October 2002||2002-10-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Pilot Study of the Process of Prenatal Genetic Counseling|The Process of Prenatal Genetic Counseling Using a Simulated Client - A Pilot Study|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:21.973045|2017-02-18 18:03:21.973045
NCT00047879|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2011-09-19|2011-05-24||October 2002||2002-10-01|September 2011|2011-09-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas|A Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults With Recurrent High-Grade Gliomas|Completed||Phase 2|7|Actual|National Institutes of Health Clinical Center (CC)|Registered 7 out of 64 participants and they came off study for progressive disease around 3-4 months after starting the study.|2|||f||||f||||||||||2017-02-18 18:03:22.057418|2017-02-18 18:03:22.057418
NCT00047866|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-22|2017-01-24|||October 12, 2002||2002-10-12|June 25, 2010|2010-06-25|June 25, 2010||2010-06-25|||||Observational|||Brain Function in Response to Motivational Stimuli|Brain Activation in Response to Motivational and Affective Stimuli: Pharmacological Manipulations|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:22.738757|2017-02-18 18:03:22.738757
NCT00047853|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-22|2017-01-24|||October 11, 2002||2002-10-11|December 19, 2016|2016-12-19||||||||Observational|||Brain Changes in Fear|fMRI Investigation of Explicit Cue and Contextual Fear|Recruiting||N/A|1430|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:22.820239|2017-02-18 18:03:22.820239
NCT00047840|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-18|2016-08-24|||October 2002||2002-10-01|August 2016|2016-08-01|September 2006|Actual|2006-09-01|||||Interventional|||This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.|A Randomized, Double-blind, Multicenter, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 in Combination With Docetaxel (TAXOTERE™) in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-based Chemotherapy.|Completed||Phase 2|129||Sanofi|||||f||||||||||||||2017-02-18 18:03:22.921085|2017-02-18 18:03:22.921085
NCT00047827|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-18|2014-08-19|||December 2002||2002-12-01|August 2014|2014-08-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis|A Phase 2, Open-Label, Non-Comparative Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) as First-Line Therapy in the Treatment of Invasive Aspergillosis|Terminated||Phase 2|2|Actual|Astellas Pharma Inc||1||Inadequate enrollment|f||||f||||||||||2017-02-18 18:03:23.038361|2017-02-18 18:03:23.038361
NCT00047814|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-18|2011-12-08|||October 2002||2002-10-01|December 2011|2011-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection|A Multiple Rising-Dose Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection|Completed||Phase 2|48||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:03:23.208941|2017-02-18 18:03:23.208941
NCT00047801|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-18|2011-07-21|||October 2002||2002-10-01|June 2011|2011-06-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer|Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel (Taxotere) in Platinum-Resistant Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|28||Telik|||||f||||||||||||||2017-02-18 18:03:23.316614|2017-02-18 18:03:23.316614
NCT00047788|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-18|2016-08-22|||October 2002||2002-10-01|August 2016|2016-08-01|May 2004|Actual|2004-05-01|||||Interventional|||Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer|A Phase Two Study of ZD6474 in Patients With Relapsed Multiple Myeloma|Completed||Phase 2|30||Sanofi|||||||||||||||||||2017-02-18 18:03:23.405625|2017-02-18 18:03:23.405625
NCT00047775|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-18|2005-06-23|||May 2001||2001-05-01|October 2004|2004-10-01|August 2004||2004-08-01|||||Interventional|||African-American Heart Failure Trial||Completed||Phase 4|1100||Nitromed|||||||||||||||||||2017-02-18 18:03:23.504914|2017-02-18 18:03:23.504914
NCT00047762|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-16|2005-06-23|||October 2002||2002-10-01|November 2004|2004-11-01||||||||Interventional|||Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer|Open-Label, Multicenter, Dose-Escalation Study in Subjects w/Advanced Colorectal Cancer to Evaluate the Safety, Efficacy, and Pharmacokinetics of Tarceva in Combination w/5-Fluorouracil, Leucovorin, and Irinotecan and of Bevacizumab in Combination w/Tarceva, 5-Fluorouracil, Leucovorin, and Irinotecan|Completed||Phase 1|||Genentech, Inc.|||||||||||||||||||2017-02-18 18:03:23.589233|2017-02-18 18:03:23.589233
NCT00047749|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-16|2015-12-10|||August 2002||2002-08-01|December 2015|2015-12-01|June 2003||2003-06-01|||||Interventional|||Prialt (Ziconotide) In Severe Chronic Pain|A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults With Severe Chronic Pain|Completed||Phase 3|220||Elan Pharmaceuticals|||||||||||||||||||2017-02-18 18:03:23.667342|2017-02-18 18:03:23.667342
NCT00047736|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-16|2013-06-19|||July 2001||2001-07-01|June 2013|2013-06-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer|A Phase III, Randomized, Double Blind, Multicenter Trial of Tarceva (Erlotinib) Plus Chemotherapy (Carboplatin and Paclitaxel) Versus Chemotherapy Alone in Patients With Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy|Completed||Phase 3|||Genentech, Inc.|||||||||||||||||||2017-02-18 18:03:24.053605|2017-02-18 18:03:24.053605
NCT00047723|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-16|2007-12-18|||January 2003||2003-01-01|December 2007|2007-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Minocycline to Treat Amyotrophic Lateral Sclerosis||Completed||Phase 3|400||National Institute of Neurological Disorders and Stroke (NINDS)|||||||||||||||||||2017-02-18 18:03:24.144592|2017-02-18 18:03:24.144592
NCT00047710|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-14|2012-07-31|||September 2002||2002-09-01|July 2012|2012-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer|A Phase I Trial of Concurrent RHUMAB VEGF (BEVACIZUMAB) and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 1|48|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:03:24.27329|2017-02-18 18:03:24.27329
NCT00047697|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-11|2008-10-13|||October 2002||2002-10-01|October 2008|2008-10-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Drug Treatment for Autism|Donepezil HCl: Treating Cognitive Deficits in Autism|Completed||Phase 2|40||National Institute of Mental Health (NIMH)||2|||f||||||||||||||2017-02-18 18:03:24.396242|2017-02-18 18:03:24.396242
NCT00047684|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-11|2013-09-09|||November 2001||2001-11-01|September 2008|2008-09-01|November 2002||2002-11-01|||||Interventional|||Brief Integrative Therapy for Post-Traumatic Stress Disorder|Development and Initial Evaluation of Brief Integrative Therapy for PTSD|Completed||N/A|20||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 18:03:24.498231|2017-02-18 18:03:24.498231
NCT00047671|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-11|2009-08-03|||June 2002||2002-06-01|August 2009|2009-08-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Ethnic Variations in Antidepressant Response|Ethnic Variations in Antidepressant Response|Completed||Phase 4|400|Anticipated|National Institute of Mental Health (NIMH)||1|||f||||t||||||||||2017-02-18 18:03:24.585722|2017-02-18 18:03:24.585722
NCT00047658|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-09|2007-11-02|||November 2001||2001-11-01|November 2007|2007-11-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Biology, and Clinical Effects of Interferon Gamma-1b Administered Subcutaneously to Patients With IPF Followed by an Open-Label Extension|Completed||Phase 2|32|Actual|InterMune||1|||f||||||||||||||2017-02-18 18:03:24.690656|2017-02-18 18:03:24.690656
NCT00047645|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-09|2007-11-01|||April 2000||2000-04-01|November 2007|2007-11-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)|A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis|Completed||Phase 3|330|Actual|InterMune||1|||f||||||||||||||2017-02-18 18:03:24.971931|2017-02-18 18:03:24.971931
NCT00047632|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-09|2007-10-30|||October 2001||2001-10-01|October 2007|2007-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer|Interferon Gamma-1b in Combination With Chemotherapy (Carboplatin/Paclitaxel) for First Line Therapy of Advanced Ovarian or Primary Peritoneal Carcinoma.|Terminated||Phase 3|847|Actual|InterMune||1||futility|f||||||||||||||2017-02-18 18:03:25.062874|2017-02-18 18:03:25.062874
NCT00047619|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-09|2015-09-10|2015-07-08||June 2002||2002-06-01|September 2015|2015-09-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Enhancement of Pressure Healing With Pulsatile Lavage|Enhancement of Pressure Healing With Pulsatile Lavage|Completed||Phase 2|28|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:03:25.162858|2017-02-18 18:03:25.162858
NCT00047606|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2012-08-16|||August 2002||2002-08-01|August 2008|2008-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32|Phase 4 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Caucasian and Japanese Subjects C-02-32.|Terminated||Phase 4|84|Actual|Alcon Research||||Management Decision|||||||||||||||2017-02-18 18:03:25.458912|2017-02-18 18:03:25.458912
NCT00047593|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2008-08-04|||January 2000||2000-01-01|August 2008|2008-08-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98|Phase 3 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Japanese Subjects C-01-98.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-02-18 18:03:25.53339|2017-02-18 18:03:25.53339
NCT00047580|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2015-12-10|||June 2002||2002-06-01|December 2015|2015-12-01|September 2002||2002-09-01|||||Interventional|||Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.|A Multicenter, Open-Label, Randomized, 4-Way Crossover Trial of the Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex (Tizanidine Hydrochloride) Tablets Taken Under Fed and Fasted Conditions in Patients With Moderate to Severe Spasticity|Completed||Phase 3|120||Elan Pharmaceuticals|||||||||||||||||||2017-02-18 18:03:25.615553|2017-02-18 18:03:25.615553
NCT00047567|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2015-12-10|||July 2002||2002-07-01|December 2015|2015-12-01|July 2002||2002-07-01|||||Interventional|||Open-label Adjunctive Zonisamide for Bipolar Disorder||Terminated||Phase 4|20||Elan Pharmaceuticals|||||||||||||||||||2017-02-18 18:03:25.711096|2017-02-18 18:03:25.711096
NCT00047554|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2013-05-13|||May 2003||2003-05-01|May 2013|2013-05-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Observational|||Study of TRAVATAN in Subjects With Iris Pigmentation Changes|A Five-Year, Multicenter, Commercial Label Safety Study of TRAVATAN® 0.004% in Patients With TRAVATAN-Induced Iris Pigmentation Changes|Terminated||Phase 4|336|Actual|Alcon Research|||1|Study objectives met|f||||||||||||||2017-02-18 18:03:25.787705|2017-02-18 18:03:25.787705
NCT00047541|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2008-08-04|||February 2001||2001-02-01|August 2008|2008-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70|Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-70.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-02-18 18:03:25.897257|2017-02-18 18:03:25.897257
NCT00047528|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2008-08-04|||January 2001||2001-01-01|August 2008|2008-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41|Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients (C-02-41).|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-02-18 18:03:25.974613|2017-02-18 18:03:25.974613
NCT00047515|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2008-08-04|||January 2001||2001-01-01|August 2008|2008-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69|Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients C-01-69.|Completed||Phase 3|||Alcon Research|||||||||||||||||||2017-02-18 18:03:26.055966|2017-02-18 18:03:26.055966
NCT00047502|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2012-02-20|||November 2002||2002-11-01|February 2012|2012-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia|Phase I Study of Lonafarnib (SCH66336) and Gleevec (Imatinib Mesylate) in Chronic Myelogenous Leukemia (CML)|Completed||Phase 1|23|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 18:03:26.137079|2017-02-18 18:03:26.137079
NCT00047489|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2012-02-20|||December 2002||2002-12-01|February 2012|2012-02-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Study of ABT-751 in Patients With Refractory Hematologic Malignancies|A Phase I Study of ABT-751 in Patients With Refractory Hematologic Malignancies|Completed||Phase 1|32|Actual|M.D. Anderson Cancer Center|||||||||||||||||||2017-02-18 18:03:26.255334|2017-02-18 18:03:26.255334
NCT00047476|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-08|2005-06-23|||June 2002||2002-06-01|May 2004|2004-05-01|March 2004||2004-03-01|||||Interventional|||D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients|Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of d-MPH in the Treatment of Fatigue and Neurobehavioral Impairment Related to Chemotherapy in Adult Cancer Patients|Completed||Phase 2|160||Celgene|||||||||||||||||||2017-02-18 18:03:26.345891|2017-02-18 18:03:26.345891
NCT00047463|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-07|2016-07-20|2009-11-18||September 2002||2002-09-01|July 2016|2016-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Effects of Treating Obstructive Sleep Apnea in Epilepsy|Effects of Treating Obstructive Sleep Apnea in Epilepsy|Completed||Phase 2|68|Actual|Vanderbilt University|Being a pilot study with a relatively small sample size, we were unable to isolate the effects of specific medications or seizure types on the presence of sleep apnea.|2|||f||||t||||||||||2017-02-18 18:03:26.452958|2017-02-18 18:03:26.452958
NCT00047450|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-04|2013-08-06|||September 2001||2001-09-01|August 2013|2013-08-01|September 2007|Actual|2007-09-01|September 2006|Actual|2006-09-01||Interventional|||Antidepressant Treatment in Older Adults With Schizophrenia|Citalopram Augmentation in Older Patients With Schizophrenia|Completed||N/A|212|Actual|Veterans Medical Research Foundation||2|||f||||t||||||||||2017-02-18 18:03:26.891858|2017-02-18 18:03:26.891858
NCT00047437|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-03-20|||April 2003||2003-04-01|March 2013|2013-03-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure|Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)|Completed||Phase 3|2331|Actual|Duke University||2|||f||||t||||||||||2017-02-18 18:03:27.014526|2017-02-18 18:03:27.014526
NCT00047424|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2009-02-04|||September 2002||2002-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Stop Atherosclerosis in Native Diabetics Study (SANDS)|Stop Atherosclerosis in Native Diabetics Study (SANDS)|Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:03:27.318466|2017-02-18 18:03:27.318466
NCT00047411|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2008-03-06|||September 2002||2002-09-01|March 2008|2008-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|HAT||Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest|Home Automatic External Defibrillator Trial -- HAT|Completed||Phase 3|7001|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 18:03:27.403761|2017-02-18 18:03:27.403761
NCT00047385|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2014-05-02|2012-05-30||August 2002||2002-08-01|October 2012|2012-10-01|October 2010|Actual|2010-10-01|October 2010|Actual|2010-10-01||Interventional|NLST||National Lung Screening Trial (NLST) Screening|National Lung Screening Trial A Randomized Trial Comparing Low-dose Helical CT With Chest Xray for Lung Cancer|Completed||Phase 3|53454|Actual|National Cancer Institute (NCI)|"NLST utilized institutions with special expertise. The healthy volunteer effect may apply. Scanners are now more technologically advanced. Ongoing LDCT screening may reduce the rate of lung cancer deaths more than three rounds done in NLST."|2|||f||||t||||||||||2017-02-18 18:03:27.514507|2017-02-18 18:03:27.514507
NCT00047346|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-01-22|||August 2002||2002-08-01|January 2013|2013-01-01||||December 2005|Actual|2005-12-01||Interventional|||Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction|A Dose-Finding, Safety, And Pharmacokinetic Study Of The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor OSI-774 (NSC 718781) In Patients With Unresectable Hepatocellular Carcinoma And Moderate Hepatic Dysfunction|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:28.320069|2017-02-18 18:03:28.320069
NCT00047333|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-01-22|||August 2002||2002-08-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed|A Phase 2 Open-Label Study Of OSI-774 (NSC 718781) In Unresectable Hepatocellular Carcinoma|Terminated||Phase 2|80|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:03:28.445495|2017-02-18 18:03:28.445495
NCT00005300|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-12|||October 1988||1988-10-01|May 2000|2000-05-01|June 1995||1995-06-01|||||Observational|||Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.222085|2017-02-18 18:15:10.222085
NCT00047320|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2016-09-27|2014-01-15||January 2004||2004-01-01|September 2016|2016-09-01||||February 2009|Actual|2009-02-01||Interventional|||Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors|A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT|Active, not recruiting||Phase 2|104|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:03:28.571957|2017-02-18 18:03:28.571957
NCT00047307|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-06-03|||August 2002||2002-08-01|June 2013|2013-06-01||||August 2008|Actual|2008-08-01||Interventional|||Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer|A Phase 1 Study of Alvocidib (Flavopiridol) in Combination With Radiation in Locally Advanced, Non-Operable Pancreatic and Extrahepatic Bile Duct Cancers|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:29.142314|2017-02-18 18:03:29.142314
NCT00047294|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2009-02-06|||April 2002||2002-04-01|May 2005|2005-05-01||||||||Interventional|||Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study Of Temozolomide, Thalidomide And Celecoxib In Patients With Newly Diagnosed Glioblastoma Multiforme In The Post-Radiation Setting|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:29.261158|2017-02-18 18:03:29.261158
NCT00047281|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2008-11-22|||March 2002||2002-03-01|November 2004|2004-11-01||||||||Interventional|||Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma|Trial Of Oral Thalidomide, Celecoxib, Etoposide And Cyclophosphamide In Adult Patients With Relapsed Or Progressive Malignant Gliomas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:29.387037|2017-02-18 18:03:29.387037
NCT00047268|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-09-16|||July 1998||1998-07-01|July 2007|2007-07-01||||||||Interventional|||Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome|Prospective Study of the Diagnosis and Treatment of Myelodysplastic Syndromes (MDS) in Childhood|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:29.478845|2017-02-18 18:03:29.478845
NCT00047255|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2016-02-11|||May 2002||2002-05-01|February 2016|2016-02-01|April 2010|Actual|2010-04-01|January 2006|Actual|2006-01-01||Interventional|||Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer|A Multicenter Phase III Randomized Trial Comparing Docetaxel (Taxotere) and Trastuzumab (Herceptin) With Docetaxel (Taxotere), Carboplatin and Trastuzumab (Herceptin) as First Line Chemotherapy for Patients With Advanced Breast Cancer Containing the HER2 Gene Amplification|Completed||Phase 3|263|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:03:29.573752|2017-02-18 18:03:29.573752
NCT00047242|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2010-08-05|||August 2002||2002-08-01|August 2010|2010-08-01||||February 2006|Actual|2006-02-01||Interventional|||UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors|The Pharmacokinetic and Safety Profile of UCN-01 in Combination With Irinotecan in Solid Tumors (Primarily Lung, Ovarian and GI Cancers)|Completed||Phase 1|30|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||||||||||||||||2017-02-18 18:03:29.701923|2017-02-18 18:03:29.701923
NCT00047229|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2009-04-04|||October 2002||2002-10-01|August 2005|2005-08-01||||January 2009|Actual|2009-01-01||Interventional|||Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)|A Phase II Study of G3139 in Combination With Doxorubicin in Advanced Hepatocellular Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:29.786294|2017-02-18 18:03:29.786294
NCT00047216|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2015-07-22|||November 2002||2002-11-01|July 2015|2015-07-01||||March 2006|Actual|2006-03-01||Interventional|||Tipifarnib in Treating Patients With Recurrent Bladder Cancer|A Phase II Study of R115777 (Zarnestra) in Superficial Transitional Cell Carcinoma of Bladder|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 18:03:29.885393|2017-02-18 18:03:29.885393
NCT00047203|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-01-15|||September 2002||2002-09-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma|A Phase II Study of Flavopiridol in Patients With Relapsed and Refractory Multiple Myeloma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:29.991839|2017-02-18 18:03:29.991839
NCT00047190|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-06-03|||August 2002||2002-08-01|June 2013|2013-06-01||||April 2007|Actual|2007-04-01||Interventional|||Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia|A Phase II Trial of R115777 in Myelofibrosis With Myeloid Metaplasia (MMM)|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:30.102247|2017-02-18 18:03:30.102247
NCT00047177|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2009-10-14|||October 2002||2002-10-01|October 2009|2009-10-01|July 2007|Actual|2007-07-01|August 2004|Actual|2004-08-01||Interventional|||Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor|A Phase II Study of Oxaliplatin in Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumors and Atypical Teratoid Rhabdoid Tumors|Completed||Phase 2|43|Actual|Pediatric Brain Tumor Consortium|||||f||||t||||||||||2017-02-18 18:03:30.212829|2017-02-18 18:03:30.212829
NCT00047164|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2016-09-23|||September 2002||2002-09-01|March 2012|2012-03-01|November 2010|Actual|2010-11-01|September 2010|Actual|2010-09-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy|A Pilot Study of Ipilimumab (MDX-CTLA4, MDX-010) in Lymphoma|Completed||Phase 1|89|Actual|National Institutes of Health Clinical Center (CC)||1|||||||||||||||||2017-02-18 18:03:30.323477|2017-02-18 18:03:30.323477
NCT00047138|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2014-06-23|||January 2001||2001-01-01|June 2009|2009-06-01||||||||Interventional|||Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor|Nephroblastoma (Wilms Tumour) Clinical Trial And Study|Unknown status|Recruiting|Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:30.436102|2017-02-18 18:03:30.436102
NCT00047125|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2012-06-19|||July 2002||2002-07-01|June 2012|2012-06-01||||July 2004|Actual|2004-07-01||Interventional|||Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor|Randomized Phase III Study On The Selection Of The Target Volume In Postoperative Radiotherapy For Cervical Lymph Node Metastases Of Squamous Cell Carcinoma From And Unknown Primary (CUP)|Completed||Phase 3|600|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-02-18 18:03:30.682341|2017-02-18 18:03:30.682341
NCT00047112|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2016-05-27|||May 2002||2002-05-01|May 2016|2016-05-01|September 2010|Actual|2010-09-01|September 2010|Actual|2010-09-01||Interventional|||Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer|Randomized Study of Pre-Operative Radio-Chemotherapy Versus Surgery Alone in Thoracic Esophageal Cancer Deemed to be Resectable|Completed||Phase 3|195|Actual|Federation Francophone de Cancerologie Digestive||2|||f||||||||||||||2017-02-18 18:03:31.303287|2017-02-18 18:03:31.303287
NCT00047099|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-05-29|||August 2001||2001-08-01|December 2002|2002-12-01|March 2012|Actual|2012-03-01|February 2012|Actual|2012-02-01||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer|A Randomized Phase III Trial Comparing FEC-Chemotherapy vs. EC-Doc-Chemotherapy in Patients With Primary Breast Cancer|Completed||Phase 3|446|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:31.523424|2017-02-18 18:03:31.523424
NCT00047073|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2012-07-27|||July 2002||2002-07-01|July 2012|2012-07-01|October 2007|Actual|2007-10-01|June 2005|Actual|2005-06-01||Interventional|||Sirolimus in Treating Patients With Glioblastoma Multiforme|A Modified Phase I/II Trial Of Rapamycin In Patients With Glioblastoma Multiforme|Completed||Phase 1/Phase 2|13|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:03:31.651753|2017-02-18 18:03:31.651753
NCT00047060|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2017-01-24|||July 30, 2002||2002-07-30|April 15, 2016|2016-04-15|December 30, 2017|Anticipated|2017-12-30|December 30, 2017|Anticipated|2017-12-30||Interventional|||Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome|A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning With Campath-1H|Recruiting||Phase 1|50|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:03:31.782947|2017-02-18 18:03:31.782947
NCT00047047|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-06-03|||August 2002||2002-08-01|June 2013|2013-06-01||||September 2007|Actual|2007-09-01||Interventional|||Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors|A Phase I Trial Of Gemcitabine, 17-Allylaminogeldanamycin (17-AAG) And Cisplatin In Advanced Solid Tumor Patients|Completed||Phase 1|78|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:31.898939|2017-02-18 18:03:31.898939
NCT00047034|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-01-04|||August 2002||2002-08-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||E7389 in Treating Patients With Advanced Solid Tumors|Phase I Trial of E7389 (Halichondrin B Analog) (NSC# 707389) in Patients With Advanced Solid Tumors|Completed||Phase 1|31|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:32.004346|2017-02-18 18:03:32.004346
NCT00047021|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2010-06-10|||November 2001||2001-11-01|June 2010|2010-06-01|September 2005|Actual|2005-09-01|August 2005|Actual|2005-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma|A Pilot Study Of Cytarabine And High-Dose Mitoxantrone For Relapsed Or Refractory Hematologic Malignancies|Completed||Phase 2|3|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:03:32.107852|2017-02-18 18:03:32.107852
NCT00047008|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2015-11-11|2014-07-28||July 2002||2002-07-01|November 2015|2015-11-01||||June 2010|Actual|2010-06-01||Interventional||Eligible patients who did not withdraw consent.|Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer|A Phase III Trial of Concurrent Radiation and Chemotherapy for Advanced Head and Neck Carcinomas|Active, not recruiting||Phase 3|743|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:03:32.226369|2017-02-18 18:03:32.226369
NCT00046995|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-09-19|||May 2001||2001-05-01|November 2002|2002-11-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Colon Cancer|5-Fluorouracil-Leucovorin With or Without Carboplatin as Adjuvant Treatment for Primary Dukes B2-C Colon Cancer; Chronomodulated Versus Standard Administration. A Multicenter Randomized Phase III Trial of the GRECCR-Belgium (Study 03).|Unknown status|Active, not recruiting|Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:33.15282|2017-02-18 18:03:33.15282
NCT00046969|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-05-29|||July 2002||2002-07-01|March 2007|2007-03-01|June 2007|Actual|2007-06-01|||||Interventional|||Epoetin Beta in Treating Anemia in Patients With Cervical Cancer|Management Of Anemia Under RadioChemotherapy (MARCH): An Open, Randomized Multicenter Study Of The Effect Of NeoRecormon On Treatment Outcome In Patients With Advanced Cervical Cancer Stage IIB -IVA Treated With Primary Simultaneous Radiochemotherapy (Radiotherapy Plus Cisplatin)|Completed||Phase 4|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:33.252691|2017-02-18 18:03:33.252691
NCT00046943|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2011-02-18|||September 2002||2002-09-01|September 2003|2003-09-01||||June 2007|Actual|2007-06-01||Interventional|||Atrasentan in Treating Patients With Prostate Cancer|A Phase III Extension Study to Evaluate the Safety of 10 mg Atrasentan in Men With Hormone-Refractory Prostate Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:33.363748|2017-02-18 18:03:33.363748
NCT00046930|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2015-06-01|2010-08-17||July 2002||2002-07-01|June 2015|2015-06-01||||June 2009|Actual|2009-06-01||Interventional|||Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia|A Randomized, Placebo-Controlled, Double Blind, Trial of the Administration of the MDR Modulator, Zosuquidar Trihydrochloride (LY335979), During Conventional Induction and Post-Remission Therapy in Patients Greater Than 60 Years of Age With Newly Diagnosed Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation or High-Risk Refractory Anemia With Excess Blasts|Completed||Phase 3|449|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-02-18 18:03:33.461179|2017-02-18 18:03:33.461179
NCT00046917|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2014-02-21|||July 2002||2002-07-01|October 2011|2011-10-01||||March 2010|Actual|2010-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Irinotecan (CPT-11) and Cisplatin in Patients With Advanced Solid Tumors|Completed||Phase 1|13|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:38.211347|2017-02-18 18:03:38.211347
NCT00046904|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2011-05-04|||May 2003||2003-05-01|May 2011|2011-05-01||||September 2007|Actual|2007-09-01||Interventional|||Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer|Phase III Placebo-Controlled, Randomized, Double-Blind Comparison Of Etanercept (Enbrel) Versus Placebo For The Treatment Of Cancer-Associated Weight Loss And Anorexia|Completed||Phase 3|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:03:38.34217|2017-02-18 18:03:38.34217
NCT00046709|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-01|2013-10-09|||September 2002||2002-09-01|October 2013|2013-10-01|October 2004|Actual|2004-10-01|||||Interventional|||Marijuana for Cancer Pain|Marijuana in Combination With Opioids for Cancer Pain: A Pilot Study|Terminated||Phase 1/Phase 2|16||Center for Medicinal Cannabis Research||||Discontinued due to non-enrollment.|||||||||||||||2017-02-18 18:03:41.636218|2017-02-18 18:03:41.636218
NCT00046891|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2016-07-01|2015-02-25||December 2002||2002-12-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|October 2006|Actual|2006-10-01||Interventional|||EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer|The Use of Ginkgo Biloba For The Prevention Of Chemotherapy-Related Cognitive Dysfunction|Completed||Phase 3|226|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:03:38.474137|2017-02-18 18:03:38.474137
NCT00046878|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-03-26||||||March 2013|2013-03-01|August 2002|Actual|2002-08-01|||||Interventional|||Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme|Phase 2 Trial of BCNU Plus O6-Benzylguanine (NSC 637037) in the Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme|Withdrawn||Phase 2|0|Actual|Duke University|||||f||||||||||||||2017-02-18 18:03:39.572215|2017-02-18 18:03:39.572215
NCT00046865|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2012-10-05|||October 2002||2002-10-01|October 2012|2012-10-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer|Treatment of Chemotherapy-Induced Nausea With Acupressure: A Phase III Trial|Completed||Phase 3|57|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 18:03:39.659088|2017-02-18 18:03:39.659088
NCT00046852|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2009-09-23|||December 2001||2001-12-01|September 2009|2009-09-01|February 2008|Actual|2008-02-01|November 2004|Actual|2004-11-01||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma|High-Dose Therapy and Autologous Blood Stem Cell Transplantation (ASCT) Followed by Post-Transplant Immunotherapy With Costimulated Autologous T-Cells in Conjunction With Pneumococcal Conjugate Vaccine Immunization for Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|||University of Maryland|||||f||||||||||||||2017-02-18 18:03:39.766502|2017-02-18 18:03:39.766502
NCT00046839|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2015-11-14|2014-01-28||July 2002||2002-07-01|November 2015|2015-11-01||||September 2011|Actual|2011-09-01||Interventional||Eligible patients who started protocol treatment.|Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer|A Phase I/II Trial of a COX-2 Inhibitor, Celebrex (Celecoxib), [National Screening Committee# 719627] With Limited Field Radiation for Intermediate Prognosis Patients With Locally Advanced Non-Small Cell Lung Cancer, With Analysis of Prognostic Factors|Completed||Phase 1/Phase 2|21|Actual|Radiation Therapy Oncology Group|This study stopped accrual early with 21 subjects accrued out of 128 planned, therefore only the phase I and phase II primary outcomes were reported.|3|||f||||t||||||||||2017-02-18 18:03:39.984838|2017-02-18 18:03:39.984838
NCT00046826|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2013-04-02|||September 2001||2001-09-01|January 2006|2006-01-01|October 2009|Actual|2009-10-01|June 2007|Actual|2007-06-01||Interventional|||Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy|A Phase II Clinical Trial of Taxotere, Emcyt and Thalidomide (TET) for the Treatment of Hormone-Refractory Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:40.410127|2017-02-18 18:03:40.410127
NCT00046813|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2017-01-11|||August 2001||2001-08-01|August 2008|2008-08-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1|High-Dose Versus Regular-Dose Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder|Terminated||Phase 4|100||National Institute on Drug Abuse (NIDA)||||Interim data analysis showed no effect between treatment groups|f||||||||||||||2017-02-18 18:03:40.519013|2017-02-18 18:03:40.519013
NCT00046800|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2011-10-18|||September 2002||2002-09-01|October 2011|2011-10-01|March 2003|Actual|2003-03-01|||||Interventional|||Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer|A Randomized, Open Label Phase II Study of OSI-211 vs Topotecan in Patients With Advanced and/or Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|80||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:03:40.820332|2017-02-18 18:03:40.820332
NCT00046787|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-03|2011-10-18|||September 2002||2002-09-01|October 2011|2011-10-01|February 2003|Actual|2003-02-01|||||Interventional|||Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer|Phase II Study to Determine the Efficacy of OSI-211 (Liposomal Lurtotecan) Given on Days 1, 2 & 3 Every 3 Weeks in Patients With Recurrent Small Cell Lung Cancer|Completed||Phase 2|47||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:03:40.918467|2017-02-18 18:03:40.918467
NCT00046774|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-02|2017-01-24|||September 2, 2002||2002-09-02|April 13, 2016|2016-04-13|July 2, 2007|Actual|2007-07-02|January 1, 2007|Actual|2007-01-01||Interventional|||Monoclonal Antibody Treatment for Systemic Lupus Erythematosus|A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients With Systemic Lupus Erythematosus|Completed||Phase 1|23|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:03:41.021536|2017-02-18 18:03:41.021536
NCT00046761|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-02|2012-10-10|||November 2002||2002-11-01|October 2012|2012-10-01||||May 2005|Actual|2005-05-01||Interventional|||A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke|A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke|Terminated||Phase 2/Phase 3|1320||Ono Pharmaceutical Co. Ltd|||||f||||||||||||||2017-02-18 18:03:41.138817|2017-02-18 18:03:41.138817
NCT00046748|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-02|2011-10-24|||December 2001||2001-12-01|October 2011|2011-10-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma|Ph III, 28-wk, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess Efficacy, Safety, Tolerability of SC Omalizumab in Adults and Adolescents w/ Severe Persist. Allergic Asthma & Are Inadequately Controlled Despite GINA (2002) Step 4 Tx|Completed||Phase 3|484|Actual|Novartis|||||||||||||||||||2017-02-18 18:03:41.369095|2017-02-18 18:03:41.369095
NCT00046735|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-02|2016-11-22|||June 2002||2002-06-01|November 2016|2016-11-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Phase 1 Study OF CDC-501 in Patients With Solid Tumors|A Single-Center, Open-Label, Between-Patient, Dose-Escalation Phase 1 Study of CDC-501 In Patients With Solid Tumors|Completed||Phase 1|24|Actual|Celgene Corporation||1|||f||||||||||||||2017-02-18 18:03:41.442138|2017-02-18 18:03:41.442138
NCT00046722|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-01|2007-06-12|||January 2003||2003-01-01|June 2007|2007-06-01|April 2005||2005-04-01|||||Interventional|||Marijuana for HIV-Related Peripheral Neuropathy|Effects of Marijuana on Neuropathic Pain in HIV-Related Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.|Completed||Phase 1/Phase 2|50||Center for Medicinal Cannabis Research|||||||||||||||||||2017-02-18 18:03:41.545143|2017-02-18 18:03:41.545143
NCT00005253|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||January 1990||1990-01-01|January 2006|2006-01-01|January 2000||2000-01-01|||||Observational|||Proarrhythmic Medicines and Primary Cardiac Arrest||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:17.435977|2017-02-18 18:15:17.435977
NCT00046696|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-01|2015-05-19|||May 2001||2001-05-01|May 2015|2015-05-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.|A Phase I and Pharmacokinetic Study of NM-3 Administered Orally Once or Twice Daily on Five Consecutive Days and Repeated Weekly for Six Weeks Every Eight Weeks in Patients With Advanced Solid Tumors.|Completed||Phase 1|32||Sanofi|||||||||||||||||||2017-02-18 18:03:41.721995|2017-02-18 18:03:41.721995
NCT00046683|ClinicalTrials.gov processed this data on February 17, 2017|2002-10-01|2016-07-27|||July 2001||2001-07-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|||||Interventional|||Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia|A Phase III Study to Evaluate the Efficacy and Safety of Front-Line Therapy With Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 3|284||Sanofi|||||||||||||||||||2017-02-18 18:03:41.814924|2017-02-18 18:03:41.814924
NCT00046670|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2014-03-04|||September 2002||2002-09-01|March 2014|2014-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Sleep Disordered Breathing, APOE, and Lipid Metabolism||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 18:03:41.932951|2017-02-18 18:03:41.932951
NCT00046657|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2016-07-28|||September 2002||2002-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Longitudinal Study of Neighborhood Predictors of CVD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:03:42.008868|2017-02-18 18:03:42.008868
NCT00046644|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2014-04-16|||June 2002||2002-06-01|April 2014|2014-04-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial||Completed||N/A|||Nemours Children's Clinic|||||f||||||||||||||2017-02-18 18:03:42.076617|2017-02-18 18:03:42.076617
NCT00046631|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2014-03-11|||August 2002||2002-08-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|TAAG2||Community Characteristics and Physical Activity Among Adolescent Girls - Ancillary to TAAG|Community Characteristics and Physical Activity Among Adolescent Girls|Completed||N/A|1556|Actual|RAND|||1||f||||f||||||||||2017-02-18 18:03:42.140058|2017-02-18 18:03:42.140058
NCT00046618|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2014-02-19|||July 2002||2002-07-01|February 2014|2014-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Mapping Novel Disease Genes for Dilated Cardiomyopathy||Completed||N/A|||Mayo Clinic|||||f||||||||||||||2017-02-18 18:03:42.356767|2017-02-18 18:03:42.356767
NCT00046605|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2008-07-23|||August 2002||2002-08-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:03:42.440816|2017-02-18 18:03:42.440816
NCT00046592|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2016-02-17|||August 2002||2002-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Mechanisms of Disability in Peripheral Arterial Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:03:42.51651|2017-02-18 18:03:42.51651
NCT00046579|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2016-07-28|||August 2002||2002-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Psychosocial Determinants of Nutrient Intake in Girls||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:03:42.584115|2017-02-18 18:03:42.584115
NCT00046566|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2013-11-25|||July 2002||2002-07-01|November 2013|2013-11-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Protein Supplements to Treat High Blood Pressure|Clinical Trial of Dietary Protein on Blood Pressure|Completed||Phase 3|280|Actual|Tulane University Health Sciences Center||3|||f||||t||||||||||2017-02-18 18:03:42.650393|2017-02-18 18:03:42.650393
NCT00046553|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2008-03-03|||September 2002||2002-09-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Brain Receptor Function in Post-Traumatic Stress Disorder|Glucocorticoid and Mineralocorticoid Receptor Function in Post Traumatic Stress Disorder|Completed||N/A|97||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:42.75945|2017-02-18 18:03:42.75945
NCT00046540|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2011-06-30|||October 2002||2002-10-01|June 2011|2011-06-01|November 2010|Actual|2010-11-01|August 2007|Actual|2007-08-01||Interventional|||Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer||Completed||Phase 1|40||INSYS Therapeutics Inc|||||f||||||||||||||2017-02-18 18:03:42.849479|2017-02-18 18:03:42.849479
NCT00046527|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2006-07-12|||June 2001||2001-06-01|October 2004|2004-10-01||||||||Interventional|||Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer|A Controlled, Randomized, Phase III, Multicenter, Open Label Study of ABI-007(a Cremophor Free, Protein Stabilized, Nanoparticle Paclitaxel) and Taxol in Patients With Metastatic Breast Cancer|Completed||Phase 3|460||Celgene Corporation|||||||||||||||||||2017-02-18 18:03:42.936363|2017-02-18 18:03:42.936363
NCT00046514|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2016-12-14|||June 2001||2001-06-01|December 2016|2016-12-01||||||||Interventional|||ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer|A Phase II Clinical Trial of ABI-007 (A Cremophor-Free, Protein Stabilized, Nanoparticle Paclitaxel)Administered Weekly in Taxol Resistant Patients With Metastatic Breast Cancer|Completed||Phase 2|100||Celgene Corporation|||||||||||||||||||2017-02-18 18:03:43.023921|2017-02-18 18:03:43.023921
NCT00046501|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2011-01-10|||November 2002||2002-11-01|January 2011|2011-01-01||||February 2005|Actual|2005-02-01||Interventional|||Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents|Morning LANTUS v. Intermediate-acting Insulin 2x/Day as Basal Insulin in a Multiple Daily Inj. w/ Humalog in Adolescents w/ Type 1 Diabetes Mellitus: an Active-controlled, Open, Randomized, Gender-stratified, Two-arm, Parallel-group Study|Completed||Phase 3|250||Sanofi|||||f||||||||||||||2017-02-18 18:03:43.113443|2017-02-18 18:03:43.113443
NCT00046488|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2013-09-12|||September 2002||2002-09-01|May 2010|2010-05-01|March 2010|Actual|2010-03-01|April 2004|Actual|2004-04-01||Interventional|||Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)|A Phase I Multicenter, Dose-Escalation Study of IDEC-152 (Anti-CD23 Monoclonal Antibody) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 1|70|Actual|Biogen||1|||f||||t||||||||||2017-02-18 18:03:43.205964|2017-02-18 18:03:43.205964
NCT00046475|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2015-05-13|2015-04-24||January 2002||2002-01-01|November 2007|2007-11-01|October 2004|Actual|2004-10-01|||||Interventional||The intent-to-treat (ITT) population, defined as all patients who were randomly assigned to treatment in the study and have at least one post-randomization Orthostatic Hypotension Questionnaire (OHQ) measurement.|A Study for Patients With Neurogenic Orthostatic Hypotension|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Patients With Neurogenic Orthostatic Hypotension|Completed||Phase 4|140|Actual|Shire|||||||||||||||||||2017-02-18 18:03:43.520387|2017-02-18 18:03:43.520387
NCT00046462|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2011-01-10|||November 2001||2001-11-01|January 2011|2011-01-01|December 2004|Actual|2004-12-01|November 2004|Actual|2004-11-01||Interventional|||Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment|Substituting Lantus®(Insulin Glargine[rDNAorigin]Inj) for a Thiazolidinedione vs. a 3rd Oral Agent as add-on Therapy in Patients Failing a Thiazolidinedione & Sulfonylurea or Metformin Combination|Completed||Phase 3|240||Sanofi|||||f||||||||||||||2017-02-18 18:03:44.36416|2017-02-18 18:03:44.36416
NCT00046449|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2015-06-02|||September 2002||2002-09-01|June 2015|2015-06-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Prevention of Seasonal Affective Disorder||Completed||Phase 3|||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:03:44.478554|2017-02-18 18:03:44.478554
NCT00046436|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2013-05-31||||||May 2013|2013-05-01|March 2004|Actual|2004-03-01|||||Observational|||Rapid HIV Tests for Women Late in Pregnancy and During Labor|Mother-Infant Rapid Intervention at Delivery (MIRIAD)|Terminated||N/A|7500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:03:44.616984|2017-02-18 18:03:44.616984
NCT00046423|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-30|2016-11-23|||April 2000||2000-04-01|November 2016|2016-11-01||||||||Interventional|||A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies|A Phase I Trial of ABI-007 Administered Weekly for Three Doses Every 4 Weeks in Patients With Advanced Non-hematologic Malignancies|Completed||Phase 1|20||Celgene Corporation|||||||||||||||||||2017-02-18 18:03:44.703969|2017-02-18 18:03:44.703969
NCT00046410|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-27|2017-01-24|||September 25, 2002||2002-09-25|November 15, 2007|2007-11-15|November 15, 2007||2007-11-15|||||Observational|||Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting|Assessing the Risk of New Ischemic Brain Lesions With On- Versus Off-Pump Coronary Artery Bypass Grafting|Completed||N/A|340||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:44.809281|2017-02-18 18:03:44.809281
NCT00046397|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-27|2008-03-03|||September 2002||2002-09-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||Phase I Trial of Smallpox Vaccine|A Phase I/II Clinical Trial of Modified Vaccinia Virus Ankara (MVA) to Evaluate Its Safety, Dosing Schedule, Immunogenicity and Protective Efficacy Against Dryvax Challenge in Vaccinia-Naive Individuals|Completed||Phase 1|195||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:44.9|2017-02-18 18:03:44.9
NCT00046384|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-27|2013-11-07|||June 2002||2002-06-01|September 2007|2007-09-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:03:44.99771|2017-02-18 18:03:44.99771
NCT00046371|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-27|2008-01-22|||August 2002||2002-08-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|||||Interventional|||Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients|Open-Label, Phase II Trial of Immunological Response Rate, Safety, and Tolerability of THERATOPE® Vaccine in Subjects With Metastatic Breast Cancer Undergoing Treatment With Aromatase Inhibitors or Faslodex®|Completed||Phase 2|||Oncothyreon Canada Inc.|||||f||||||||||||||2017-02-18 18:03:45.088981|2017-02-18 18:03:45.088981
NCT00046358|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-26|2008-03-03|||September 2002||2002-09-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Interventional|||The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease|The Effect of Short-Term Statin and NSAID Treatment on CSF Beta-Amyloid|Completed||Phase 4|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:45.184271|2017-02-18 18:03:45.184271
NCT00046345|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-26|2011-04-13|||May 2002||2002-05-01|April 2011|2011-04-01|July 2003||2003-07-01|||||Expanded Access|||Atazanavir for HIV Infected Individuals: An Early Access Program||No longer available||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:03:45.28229|2017-02-18 18:03:45.28229
NCT00046332|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-26|2013-02-20|||June 2002||2002-06-01|February 2013|2013-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients|A Phase II, Randomized, Placebo-controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Four Oral Doses of S-1360 Versus Placebo Over 10 Days in ART-naive HIV-1 Infected Adults.|Completed||Phase 2|100||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:03:45.617401|2017-02-18 18:03:45.617401
NCT00046319|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-26|2009-04-15|||September 2002||2002-09-01|April 2009|2009-04-01|June 2003||2003-06-01|||||Interventional|||Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension|A Phase II, Randomized, Double-Blind, Dose-Controlled, Dose-Ranging, Multicenter Study of BSF 208075 Evaluating Exercise Capacity in Patients With Moderate to Severe Pulmonary Arterial Hypertension|Completed||Phase 2|60||Gilead Sciences|||||||||||||||||||2017-02-18 18:03:45.923419|2017-02-18 18:03:45.923419
NCT00046306|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-26|2013-01-11||||||January 2013|2013-01-01|August 2005|Actual|2005-08-01|||||Interventional|||Nevada Environmental Tobacco Smoke and Health Study||Completed||Phase 3|375||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:03:46.051995|2017-02-18 18:03:46.051995
NCT00046293|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-25|2017-01-24|||September 24, 2002||2002-09-24|April 8, 2011|2011-04-08|July 20, 2007|Actual|2007-07-20|July 20, 2007|Actual|2007-07-20||Interventional|||ReoPro and Retavase to Treat Acute Stroke|ReoPro Retavase Reperfusion of Stroke Safety Study-Imaging Evaluation With Computed Tomography (ROSIE-CT)|Completed||Phase 2|72|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:03:46.146642|2017-02-18 18:03:46.146642
NCT00046280|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-24|2012-11-02||||||November 2005|2005-11-01||||||||Observational|||HIV Infection in Homosexual and Bisexual Men||Unknown status|Active, not recruiting|N/A|1100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:03:46.258857|2017-02-18 18:03:46.258857
NCT00046267|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-24|2011-02-28||||||May 2006|2006-05-01||||December 2006|Actual|2006-12-01||Interventional|||Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients|A Pilot Study of the Safety, Efficacy, and Tolerability of Extended-Release Niacin (Niaspan) for the Treatment of Elevated Non-HDL Cholesterol and Elevated Triglycerides in HIV-Infected Subjects|Completed||N/A|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:03:46.35794|2017-02-18 18:03:46.35794
NCT00046254|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-24|2012-05-01|||February 2002||2002-02-01|May 2012|2012-05-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture||Completed||Phase 3|2127||Novartis|||||||||||||||||||2017-02-18 18:03:46.495612|2017-02-18 18:03:46.495612
NCT00005252|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||January 1990||1990-01-01|August 2004|2004-08-01|December 1992|Actual|1992-12-01|||||Observational|||Physicians' Health Study: Study of Low Cardiovascular Disease Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.515531|2017-02-18 18:15:17.515531
NCT00046241|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-24|2017-01-20|||September 2002|Actual|2002-09-01|January 2017|2017-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Prevention of Seasonal Affective Disorder|A 7 Month, Multicenter, Randomized, Double-blind, Placebo-controlled Comparison of 150-300mg/Day of Extended-release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Affective Disorder in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up Phase|Completed||Phase 3|300||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:03:46.609969|2017-02-18 18:03:46.609969
NCT00046228|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-24|2014-07-25|2009-03-26||August 2002||2002-08-01|July 2014|2014-07-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)|A Muticenter, Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy and Safety of Reteplease and Abciximab Combination Therapy With Abciximab Alone Administered Early or Just Prior to Primary Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.|Completed||Phase 3|2461|Actual|Centocor, Inc.|Some AEs were collected separately per protocol and are reported as “Other Pre-Specified Outcomes Measures”.|3|||f||||||||||||||2017-02-18 18:03:46.765973|2017-02-18 18:03:46.765973
NCT00046215|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-21|2008-03-03|||September 2002||2002-09-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||Transcranial Magnetic Stimulation to Study Imagination of Movement|Effect of Transcranial Magnetic Stimulation to Dorsal Premotor Cortex on Motor Imagination|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:49.017006|2017-02-18 18:03:49.017006
NCT00046202|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-21|2017-02-14|||September 18, 2002||2002-09-18|January 24, 2017|2017-01-24||||||||Observational|||Study of Inborn Errors of Cholesterol Synthesis and Related Disorders|Investigations Into Inborn Errors of Cholesterol Synthesis and Related Disorders|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:49.092374|2017-02-18 18:03:49.092374
NCT00046189|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-21|2017-01-24|||September 18, 2002||2002-09-18|September 23, 2016|2016-09-23||||||||Observational|||Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum|Cancer Risk in Xeroderma Pigmentosum Heterozygotes|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:49.190142|2017-02-18 18:03:49.190142
NCT00046176|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-20|2011-06-02|||August 2002||2002-08-01|May 2011|2011-05-01||||||||Interventional|||A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients|A Phase III, 48-Week, Open-Label, Randomized, Multicenter Study of the Safety and Efficacy of the Abacavir/Lamivudine Fixed-Dose Combination Tablet Administered QD Versus Abacavir + Lamivudine Administered BID in Combination With a PI or NNRTI in Antiretroviral Experienced Patients.|Completed||Phase 3|240||GlaxoSmithKline|||||||||f||||||||||2017-02-18 18:03:49.309101|2017-02-18 18:03:49.309101
NCT00046163|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-20|2007-11-02|||September 2002||2002-09-01|November 2007|2007-11-01|August 2003|Actual|2003-08-01|||||Interventional|||A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension|A Phase IV, Multi-Center, Double-Blind, Parallel Group, Randomized, Placebo-Controlled Study to Assess the Clinical Benefit of Three Doses of Midodrine Hydrochloride (ProAmatine®) in Subjects With Neurogenic Orthostatic Hypotension|Terminated||Phase 4|150||Shire||||Study was terminated due to poor enrollment|||||||||||||||2017-02-18 18:03:49.464068|2017-02-18 18:03:49.464068
NCT00046150|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-20|2008-06-18|||May 2002||2002-05-01|June 2008|2008-06-01|December 2002|Actual|2002-12-01|||||Interventional|||12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.|12-Week, Multinational, Multicenter, Controlled, Open, 1:1 Randomized, Parallel Clinical Trial Comparing the Safety of HMR1964 and Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion (CSII) in Subjects With Type 1 Diabetes Mellitus|Completed||Phase 3|59|Actual|Sanofi|||||||||||||||||||2017-02-18 18:03:49.546587|2017-02-18 18:03:49.546587
NCT00046137|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-20|2006-07-19||||||July 2006|2006-07-01||||||||Interventional|||Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis||Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:03:49.631896|2017-02-18 18:03:49.631896
NCT00046124|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-20|2006-09-01||||||September 2006|2006-09-01||||||||Observational|||Organophosphate Pesticides and Human Reproductive Health||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:03:49.83782|2017-02-18 18:03:49.83782
NCT00046111|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-19|2015-04-13|||September 2001||2001-09-01|April 2015|2015-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors|A Study to Determine the Bioequivalence of an Oral Formulation of Topotecan Containing the Drug Substance Manufactured by New Process Relative to the Current Study Formulation of Topotecan in Patients With Advanced Solid Tumors|Completed||Phase 1|1|Actual|GlaxoSmithKline||1|||f||||||||||||||2017-02-18 18:03:49.902019|2017-02-18 18:03:49.902019
NCT00046085|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-19|2016-09-08|||March 2001||2001-03-01|September 2016|2016-09-01|November 2006|Actual|2006-11-01|December 2005|Actual|2005-12-01||Interventional|||Online Family Support and Education for Schizophrenia|Online Family Support and Education for Schizophrenia|Completed||N/A|42|Actual|University of California, Los Angeles||2|||f||||f||||||||||2017-02-18 18:03:50.007408|2017-02-18 18:03:50.007408
NCT00046072|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-19|2005-12-08|||October 2001||2001-10-01|December 2005|2005-12-01|April 2005||2005-04-01|||||Interventional|||A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis|A Double-Blind, Placebo-Controlled Study of E5564, A Lipid A Antagonist, Administered by Twice Daily Infusions in Patients With Severe Sepsis|Completed||Phase 2|300||Eisai Inc.|||||||||||||||||||2017-02-18 18:03:50.114344|2017-02-18 18:03:50.114344
NCT00046059|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-18|2017-01-31|||February 1, 2000||2000-02-01|September 26, 2016|2016-09-26||||||||Observational|||Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)|Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)|Completed||N/A|3481|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:50.21585|2017-02-18 18:03:50.21585
NCT00046033|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-18|2011-02-28||||||May 2005|2005-05-01||||March 2003|Actual|2003-03-01||Interventional|||Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance|A Phase II, Randomized, Open-Label Study Comparing Fixed-Dose Versus Concentration-Adjusted Lopinavir/Ritonavir Therapy in HIV-Infected Subjects on Salvage Therapy|Completed||Phase 2|118||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:03:50.307156|2017-02-18 18:03:50.307156
NCT00045734|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-11|||February 2003||2003-02-01|January 2013|2013-01-01||||December 2009|Actual|2009-12-01||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Meningioma|Phase II Trial of STI571 (NSC 716051) in Patients With Recurrent Meningioma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:53.430176|2017-02-18 18:03:53.430176
NCT00046020|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-18|2009-08-13|||August 2000||2000-08-01|August 2009|2009-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Study Evaluating Venlafaxine ER in Recurrent Depression|An Acute and Continuation Phase Study of the Comparative Efficacy Study of Venlafaxine ER (Effexor® XR) and Fluoxetine (Prozac®) in Achieving and Sustaining Remission (Wellness) in Patients With Recurrent Unipolar Major Depression; Followed by a Long Term Randomized, Placebo-Controlled Maintenance Treatment Study in Patients Treated Initially With Venlafaxine ER|Completed||Phase 4|1096|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:03:50.403425|2017-02-18 18:03:50.403425
NCT00045994|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-17|2009-07-28|||August 2001||2001-08-01|August 2007|2007-08-01|June 2003|Actual|2003-06-01|January 2002|Actual|2002-01-01||Interventional|||The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling|Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SILVER Study|Completed||Phase 2|180||Synvista Therapeutics, Inc|||||||||||||||||||2017-02-18 18:03:50.491609|2017-02-18 18:03:50.491609
NCT00045981|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-17|2010-03-25|||October 2001||2001-10-01|August 2007|2007-08-01|August 2006|Actual|2006-08-01|May 2003|Actual|2003-05-01||Interventional|||The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)|Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: The SAPPHIRE Study|Completed||Phase 2|450||Synvista Therapeutics, Inc|||||||||||||||||||2017-02-18 18:03:50.57236|2017-02-18 18:03:50.57236
NCT00045968|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-17|2016-10-12|||December 2006||2006-12-01|October 2016|2016-10-01||||November 2016|Anticipated|2016-11-01||Interventional|GBM||Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer|A Phase III Clinical Trial Evaluating DCVax®-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen For The Treatment Of Glioblastoma Multiforme (GBM)|Active, not recruiting||Phase 3|348|Anticipated|Northwest Biotherapeutics||2|||f||||t||||||||||2017-02-18 18:03:50.842037|2017-02-18 18:03:50.842037
NCT00045955|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-17|2008-08-20|||February 2002||2002-02-01|August 2008|2008-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Long-Term Safety Performance of Fexofenadine in Asthma|A Multicenter, Open-Label, Randomized, Parallel Groups Study to Assess the Long-Term Safety Performance of Fexofenadine Compared to Montelukast in Subjects With Asthma|Completed||Phase 3|1200|Anticipated|Sanofi|||||||||||||||||||2017-02-18 18:03:51.050693|2017-02-18 18:03:51.050693
NCT00045942|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-16|2016-02-19|||January 2002||2002-01-01|February 2016|2016-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||PKC412 in Patients With Acute Myeloid Leukemia and Patients With Myelodysplastic Syndrome With Either Wild Type or Mutated FLT3|An Open-label, Phase I/II Trial of PKC412 in Patients With Acute Myeloid Leukemia and Patients With Myelodysplastic Syndrome With Either Wild Type or Mutated FLT3|Completed||Phase 2|20|Actual|Novartis||1|||f||||f||||||||||2017-02-18 18:03:51.14804|2017-02-18 18:03:51.14804
NCT00045916|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-13|2013-08-09|||February 2001||2001-02-01|October 2008|2008-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Optimizing Electroconvulsive Therapy for Depression|Optimization of Electroconvulsive Therapy|Completed||Phase 4|340|Actual|New York State Psychiatric Institute||6|||f||||||||||||||2017-02-18 18:03:51.259116|2017-02-18 18:03:51.259116
NCT00045903|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-13|2014-04-22|||August 2000||2000-08-01|October 2012|2012-10-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|Aug1||Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder|CBT Augmentation for SRI Pharmacotherapy in OCD|Completed||N/A|136|Actual|New York State Psychiatric Institute||2|||f||||t||||||||||2017-02-18 18:03:51.385719|2017-02-18 18:03:51.385719
NCT00045877|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-12|2006-02-02||||||February 2006|2006-02-01||||||||Interventional|||Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments||Completed||Phase 2/Phase 3|||Chiron Corporation|||||||||||||||||||2017-02-18 18:03:51.500522|2017-02-18 18:03:51.500522
NCT00045864|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-12|2006-02-02||||||February 2006|2006-02-01||||||||Interventional|||Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.||Completed||Phase 2|||Chiron Corporation|||||||||||||||||||2017-02-18 18:03:51.644059|2017-02-18 18:03:51.644059
NCT00045838|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-10|2015-09-30|||August 2002||2002-08-01|September 2015|2015-09-01|April 2003|Actual|2003-04-01|April 2003|Anticipated|2003-04-01||Interventional|||HIV-1 Vaccine Test in Uninfected Adult Volunteers|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA006-00-VP, In Uninfected Adult Volunteers|Withdrawn||Phase 1|0|Actual|National Institutes of Health Clinical Center (CC)||||The study product was revised. PI withdrew the study without enrolling participants..|f||||||||||||||2017-02-18 18:03:51.943825|2017-02-18 18:03:51.943825
NCT00045812|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-10|2008-03-03|||March 2001||2001-03-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate SCH-58235 in Homozygous Sitosterolemia|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:03:52.032093|2017-02-18 18:03:52.032093
NCT00045799|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-09|2014-04-24|||May 2002||2002-05-01|April 2014|2014-04-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill|Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill|Completed||Phase 3|354|Actual|Valeant Pharmaceuticals International, Inc.||2|||f||||f||||||||||2017-02-18 18:03:52.117845|2017-02-18 18:03:52.117845
NCT00045786|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-09|2005-06-23|||October 2001||2001-10-01|May 2004|2004-05-01|November 2005||2005-11-01|||||Interventional|||Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes||Completed||Phase 2|39||Celgene|||||||||||||||||||2017-02-18 18:03:52.262832|2017-02-18 18:03:52.262832
NCT00045773|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-09|2016-08-29|||April 2001||2001-04-01|August 2016|2016-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Observational|||Treatment Outcome of Vascular Depression|Treatment Outcome of Vascular Depression|Completed||N/A|208|Actual|University of Pennsylvania|||1||f||||f||||||||||2017-02-18 18:03:52.340497|2017-02-18 18:03:52.340497
NCT00045760|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-09|2006-07-18|||September 2002||2002-09-01|July 2006|2006-07-01||||||||Interventional|||The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis||Completed||Phase 4|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:03:52.67591|2017-02-18 18:03:52.67591
NCT00045747|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-21|||July 2002||2002-07-01|August 2004|2004-08-01|September 2004|Actual|2004-09-01|||||Interventional|||UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer|Phase II Study of UCN-01 in Combination With Fluorouracil in Advanced Pancreatic Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:53.33666|2017-02-18 18:03:53.33666
NCT00045721|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2009-10-15|||March 2003||2003-03-01|October 2009|2009-10-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma|Phase I Trial of GLIADEL and O(6)-Benzylguanine in Pediatric Patients With Recurrent Malignant Gliomas|Terminated||Phase 1|3|Actual|Pediatric Brain Tumor Consortium||||Poor accrual|f||||t||||||||||2017-02-18 18:03:53.545079|2017-02-18 18:03:53.545079
NCT00045708|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-04-08|||October 2002||2002-10-01|April 2013|2013-04-01||||November 2008|Actual|2008-11-01||Interventional|||A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas|A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-grade Gliomas|Completed||Phase 1/Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:53.657873|2017-02-18 18:03:53.657873
NCT00045695|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-05-16|||August 2002||2002-08-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|March 2006|Actual|2006-03-01||Interventional|||Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia|A Phase II Study Of PS-341 (NSC 681239) In Patients With Untreated Or Relapsed Waldenstrom's Macroglobulinemia|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 18:03:53.764386|2017-02-18 18:03:53.764386
NCT00045682|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2014-12-29|||September 2002||2002-09-01|December 2014|2014-12-01||||January 2008|Actual|2008-01-01||Interventional|||CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of CT-2103 in the Third-Line Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|78|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:03:53.880083|2017-02-18 18:03:53.880083
NCT00045669|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2012-06-11|||July 2002||2002-07-01|June 2012|2012-06-01|January 2005|Actual|2005-01-01|January 2004|Actual|2004-01-01||Interventional|||Imatinib Mesylate in Treating Patients With Salivary Gland Cancer|A Phase 2 Study Of Imatinib Mesylate In Adenoid Cystic, Lymphoepithelioma-Like And Myoepithelial Salivary Gland Carcinomas|Completed||Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 18:03:54.187398|2017-02-18 18:03:54.187398
NCT00045630|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-04-16|2012-11-15||January 2003||2003-01-01|April 2013|2013-04-01|December 2011|Actual|2011-12-01|May 2008|Actual|2008-05-01||Interventional|||S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium|A Sequential Approach to the Treatment of Muscle Invasive, Non-Metastatic Urothelial Carcinoma of the Bladder: A Phase II Trial of Neoadjuvant Gemcitabine, Paclitaxel and Carboplatin With Molecular Correlates|Completed||Phase 2|77|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:03:54.328728|2017-02-18 18:03:54.328728
NCT00045617|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2012-06-11|||January 2003||2003-01-01|June 2012|2012-06-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer|A Phase II Trial of Patients With Limited Stage Small Cell Lung Cancer Treated With Thoracic Radiation Therapy and Chemotherapy With Cisplatin/Etoposide Followed by Cisplatin/Etoposide and Anti-Idiotype Monoclonal Antibody Vaccines|Terminated||Phase 2|9|Actual|Southwest Oncology Group||1||Closed due to lack of drug availability.|f||||t||||||||||2017-02-18 18:03:54.934247|2017-02-18 18:03:54.934247
NCT00045604|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2008-07-23|||July 2002||2002-07-01|April 2004|2004-04-01||||||||Interventional|||Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase I Study of Imatinib (Gleevec) in Combination With Irinotecan and Cisplatin in Extensive Stage Small Cell Lung Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:55.141138|2017-02-18 18:03:55.141138
NCT00045591|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2017-01-09|||February 2003||2003-02-01|January 2017|2017-01-01|January 2010|Actual|2010-01-01|August 2005|Actual|2005-08-01||Interventional|||Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer|Evaluation Of Novel Therapeutic Agents (Celecoxib: NSC # 719627) Against Breast Cancer: An Innovative Randomized Phase II Trial Design|Terminated||Phase 2|39|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:03:55.244081|2017-02-18 18:03:55.244081
NCT00045565|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-04-08|||October 2002||2002-10-01|April 2013|2013-04-01||||November 2008|Actual|2008-11-01||Interventional|||Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma|Phase I Study of Combined Radiotherapy and Arsenic Trioxide for the Treatment of Newly Diagnosed Malignant Glioma|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:03:55.543094|2017-02-18 18:03:55.543094
NCT00045539|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-21|||October 2002||2002-10-01|December 2005|2005-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma|A Phase II Study of Methotrexate and Thiotepa Chemotherapy for Patients With Newly Diagnosed Primary CNS Lymphoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:55.653696|2017-02-18 18:03:55.653696
NCT00045526|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-03|||June 2002||2002-06-01|June 2013|2013-06-01||||February 2007|Actual|2007-02-01||Interventional|||Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer|Phase II Study Of OSI-774 In Advanced Esophageal Cancer|Completed||Phase 2|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:55.756714|2017-02-18 18:03:55.756714
NCT00045513|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2015-07-22|||June 2002||2002-06-01|July 2015|2015-07-01||||December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma|Phase I/II Study Of UCN-01 In Combination With Fludarabine In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma|Completed||Phase 1/Phase 2|||University Health Network, Toronto|||||f||||||||||||||2017-02-18 18:03:55.86893|2017-02-18 18:03:55.86893
NCT00045500|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2015-04-29|||June 2002||2002-06-01|August 2005|2005-08-01||||January 2010|Actual|2010-01-01||Interventional|||UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma|A Phase I Trial Of UCN-01 And Prednisone In Patients With Refractory Solid Tumors And Lymphomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:03:55.961734|2017-02-18 18:03:55.961734
NCT00045487|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-12-09|2013-05-07||June 2002||2002-06-01|December 2013|2013-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|OSI-774||Erlotinib in Treating Patients With Advanced Kidney Cancer|A Phase II, Pharmacokinetic And Biologic Correlative Study of OSI-774, An EGFR Tyrosine Kinase Inhibitor, In Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|41|Actual|The University of Texas Health Science Center at San Antonio|The PI/responsible party left this institution. Additional records for completion of results entries is not available at our institution. NCI transferred the PRS record to this institution >4.5 years after the PIs left employment.|1|||f||||f||||||||||2017-02-18 18:03:56.066231|2017-02-18 18:03:56.066231
NCT00045474|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2009-02-06|||October 2002||2002-10-01|April 2003|2003-04-01||||||||Interventional|||Brachytherapy in Treating Patients With Recurrent Malignant Glioma|Phase I Brachytherapy Dose Escalating Study Using the Proxima Therapeutics, Inc. GliaSite RTS in Patients With Recurrent Malignant Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:56.294919|2017-02-18 18:03:56.294919
NCT00045461|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-08-06|||June 2000||2000-06-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|A Randomized Phase II/III Trial Comparing Carboplatin-Ifosfamide (IC)-Chemotherapy Vs. IC-Chemotherapy Combined With Extreme Whole Body Hyperthermia In Patients With Recurrence Of Epithelial Ovarian Carcinoma: DOLPHIN-1-STUDY|Unknown status|Recruiting|Phase 2/Phase 3|241|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:56.58317|2017-02-18 18:03:56.58317
NCT00045448|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-05-29|||April 2002||2002-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|Single Center Open-Label Non-Comparative Phase I Dose Finding Study Of Weekly Flavopiridol In Combination With Weekly Docetaxel In Patients With Advanced Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:56.709749|2017-02-18 18:03:56.709749
NCT00045435|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2016-01-19|||April 2002||2002-04-01|January 2016|2016-01-01||||June 2009|Actual|2009-06-01||Interventional|||Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission|Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation From HLA Matched Related Donors for Treatment of Older Patients With De Novo or Secondary Acute Myeloid Leukemia in First Complete Remission|Active, not recruiting||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:03:56.793331|2017-02-18 18:03:56.793331
NCT00045422|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A Phase II Open Label Study to Determine Safety and Efficacy of Interferon-alpha in Combination With Imantinib Mesylate (Gleevec) in Patients With Chronic Phase Chronic Myelogenous Leukemia Who Have Not Achieved a Complete Cytogenetic Response to Gleevec as a Single Agent|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:03:56.920269|2017-02-18 18:03:56.920269
NCT00045396|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-01-08|||June 2002||2002-06-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS)|A Phase II Study of the Farnesyltransferase Inhibitor ZARNESTRA (Tipifarnib, R115777, NSC #702818, IND #58,359) in Complete Remission Following Induction and/or Consolidation Chemotherapy in Adults With Poor-Risk Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplasia (MDS).|Completed||Phase 2|44|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:57.014091|2017-02-18 18:03:57.014091
NCT00045370|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer|A Phase I Study of the Safety, Tolerability, and Antitumor Activity of Escalating Doses of Intravenous CCI-779 Given in Combination With Escalating Doses of Interferon-Alpha to Patients With Advanced Renal Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:03:57.123882|2017-02-18 18:03:57.123882
NCT00045357|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2010-09-20|||November 2001||2001-11-01|September 2010|2010-09-01|August 2008|Actual|2008-08-01|||||Interventional|||Biological Therapy in Treating Patients With Metastatic Melanoma|Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD4+ Antigen-Specific T Cell Clones for Patients With Metastatic Melanoma|Completed||Phase 1|18|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:03:57.304342|2017-02-18 18:03:57.304342
NCT00045331|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-18|||August 2002||2002-08-01|October 2004|2004-10-01|October 2007|Actual|2007-10-01|||||Interventional|||Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer|Are the Proteomic Profiles of Serum and Urine Predictivefor Clinical Outcome After Definitive Radiotherapy for Localized Prostate Cancer? A Preliminary Cohort Study|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:57.389847|2017-02-18 18:03:57.389847
NCT00045318|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-07-09|||May 2002||2002-05-01|April 2003|2003-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction|A Phase I Study of DX-8951f (Exatecan Mesylate for Injection) in Patients With Renal Dysfunction|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:57.471952|2017-02-18 18:03:57.471952
NCT00045305|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2015-01-15|2015-01-09||May 2005||2005-05-01|January 2015|2015-01-01|September 2014|Actual|2014-09-01|February 2014|Actual|2014-02-01||Interventional||eligible and treated patients|Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes|A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplant for the Treatment of Myelodysplastic Syndromes|Completed||Phase 2|17|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 18:03:57.573784|2017-02-18 18:03:57.573784
NCT00045292|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2010-09-17|||April 2002||2002-04-01|September 2010|2010-09-01|October 2004|Actual|2004-10-01|||||Interventional|||Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation|A Phase III Multicenter Study of Cytomegalovirus Prophylaxis With Valacyclovir for the Prevention of Serious Fungal and Bacterial Infections Among Cytomegalovirus Seronegative Recipients of Cytomegalovirus Seropositive Sx Stem Cell Transplants|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:03:58.02319|2017-02-18 18:03:58.02319
NCT00045279|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer|Phase II Trial of PEG-Intron in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:03:58.134675|2017-02-18 18:03:58.134675
NCT00045266|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2016-06-01|||April 2002||2002-04-01|June 2016|2016-06-01||||February 2007|Actual|2007-02-01||Interventional|||VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma|An Open-Label, Long Term, Safety, and Tolerability Study of VEGF Trap in Patients With Incurable, Relapsed or Refractory Solid Tumors or Lymphoma|Completed||Phase 1|||Regeneron Pharmaceuticals|||||f||||||||||||||2017-02-18 18:03:58.230557|2017-02-18 18:03:58.230557
NCT00045227|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-18|||August 2002||2002-08-01|December 2003|2003-12-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer|A Pilot Trial of Pox Vector PSA Vaccine With Concurrent Docetaxel Versus Pox Vector Vaccine Followed by Docetaxel in Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:03:58.324647|2017-02-18 18:03:58.324647
NCT00045201|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2017-01-31|||June 2002||2002-06-01|November 2016|2016-11-01||||June 2009|Actual|2009-06-01||Interventional|||Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors|Phase I Trial of OSI-774 and CPT-11 in Patients With Advanced Solid Tumors|Active, not recruiting||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:58.417556|2017-02-18 18:03:58.417556
NCT00045188|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-01-22|||August 2002||2002-08-01|January 2013|2013-01-01||||July 2004|Actual|2004-07-01||Interventional|||Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer|Phase II Trial of STI571 in Metastatic Breast Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:03:58.525249|2017-02-18 18:03:58.525249
NCT00045175|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2016-06-21|||June 2002||2002-06-01|June 2016|2016-06-01||||June 2013|Actual|2013-06-01||Interventional|||UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer|A Phase I Study of UCN-01 in Combination With Topotecan in Patients With Solid Tumors|Completed||Phase 1|33|Actual|University Health Network, Toronto||1|||f||||||||||||||2017-02-18 18:03:58.629412|2017-02-18 18:03:58.629412
NCT00045162|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-07-03|2013-04-16||November 2002||2002-11-01|July 2013|2013-07-01|December 2009|Actual|2009-12-01|March 2008|Actual|2008-03-01||Interventional||Eleven ineligible patients on the cisplatin + irinotecan arm, and eight ineligible patients on the cisplatin + etoposide arm were excluded from the analysis.|S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer|Randomized Phase III Trial of Cisplatin and Irinotecan (NSC-616348) Versus Cisplatin and Etoposide in Patients With Extensive Stage Small Cell Lung Cancer (E-SCLC)|Completed||Phase 3|671|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:03:58.763302|2017-02-18 18:03:58.763302
NCT00045149|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2010-05-05|||October 2002||2002-10-01|May 2010|2010-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Biological Therapy in Treating Patients With Metastatic Melanoma|Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen Specific T Cell Clones Targeting Cancer Testis Antigens for Patients With Metastatic Melanoma|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:04:00.597275|2017-02-18 18:04:00.597275
NCT00045136|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2009-04-02|||January 2002||2002-01-01|April 2009|2009-04-01||||January 2003|Actual|2003-01-01||Interventional|||Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Multicenter Dosimetry Trial to Evaluate Radiation Absorbed Dose From Holmium-166-DOTMP in Patients With Multiple Myeloma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:00.687807|2017-02-18 18:04:00.687807
NCT00045123|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-12-17|||February 2002||2002-02-01|February 2004|2004-02-01||||||||Interventional|||R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence|Phase IIB, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Efficacy of MPC-7869 in Delaying the Systemic Progression of Prostate Cancer in Patients With Intermediate to High Risk of Recurrence With Rising PSA Levels After Prostatectomy, Prostatectomy and Radiotherapy or Radiotherapy Alone for Localized Disease|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:00.891217|2017-02-18 18:04:00.891217
NCT00045110|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2014-07-09|||August 2002||2002-08-01|July 2014|2014-07-01||||December 2010|Actual|2010-12-01||Interventional|||Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma|A Phase I/II Trial of OSI-774 in Patients With Recurrent Malignant Gliomas and Malignant Gliomas Post Radiation Therapy|Unknown status|Active, not recruiting|Phase 1/Phase 2|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:04:01.031124|2017-02-18 18:04:01.031124
NCT00045097|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-06-18|||May 2002||2002-05-01|January 2007|2007-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Phase II Clinical Trial Of BMS-247550 (NSC 710428), An Epothilone B Analog, In Patients With Breast Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:04:01.146278|2017-02-18 18:04:01.146278
NCT00045045|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-12-17|||May 2002||2002-05-01|September 2002|2002-09-01|July 2007|Actual|2007-07-01|||||Interventional|||Positron Emission Tomography in Detecting Testicle Cancer|A Study Of 18 FDG PET In The Prediction Of Relapse In Patients With A Clinical Stage I Non-Seminomatous Germ Cell Tumor|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:01.247738|2017-02-18 18:04:01.247738
NCT00045032|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2012-06-04|||December 2001||2001-12-01|March 2012|2012-03-01|September 2015|Anticipated|2015-09-01|September 2015|Anticipated|2015-09-01||Interventional|||Trastuzumab in Treating Women With Primary Breast Cancer|HERA: A Randomised Three-Arm Multi-Centre Comparison Of 1 Year And 2 Years Of Herceptin Versus No Herceptin In Women With HER2-Positive Primary Breast Cancer Who Have Completed Adjuvant Chemotherapy|Unknown status|Active, not recruiting|Phase 3|5043|Anticipated|Hoffmann-La Roche||1|||f||||||||||||||2017-02-18 18:04:01.35092|2017-02-18 18:04:01.35092
NCT00045019|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2012-08-24|||May 2002||2002-05-01|August 2012|2012-08-01|March 2005|Actual|2005-03-01|June 2004|Actual|2004-06-01||Observational|||Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care|An International Field-Testing Study Of The Reliability And Validity Of A Patient Satisfaction Module (QLQ-SAT32) Assessing Cancer Patients' Perception Of The Quality Of Care Received Within The Hospital|Completed||N/A|795|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||||||2017-02-18 18:04:04.63626|2017-02-18 18:04:04.63626
NCT00045006|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-05-29|||July 2001||2001-07-01|October 2003|2003-10-01|July 2008|Actual|2008-07-01|December 2005|Actual|2005-12-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer|Phase I Clinical Trial of Oral Suberoylanilide Hydroxamic Acid - SAHA (MSK390) in Patients With Advanced Solid Tumors and Hematologic Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:04.741724|2017-02-18 18:04:04.741724
NCT00044577|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-30|2011-03-17|||July 2002||2002-07-01|March 2011|2011-03-01||||||||Interventional|||New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects|See Detailed Description|Completed||Phase 3|166||GlaxoSmithKline|||||||||f||||||||||2017-02-18 18:04:08.838228|2017-02-18 18:04:08.838228
NCT00044993|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-05-29|||February 2002||2002-02-01|July 2004|2004-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer|Phase II, Single Arm, Single Institution Clinical Trial of Docetaxel and Doxorubicin in Combination With Local Administration of INGN 201 (Ad5CMV-p53) in Locally Advanced Breast Cancer (LABC)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:04.844048|2017-02-18 18:04:04.844048
NCT00044980|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2014-07-11|||July 2002||2002-07-01|November 2012|2012-11-01|December 2006|Actual|2006-12-01|September 2005|Actual|2005-09-01||Interventional|||Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer|Fresh Start: Promoting Health in Prostate Cancer Survivors|Completed||N/A|||Duke University|||||f||||t||||||||||2017-02-18 18:04:04.934591|2017-02-18 18:04:04.934591
NCT00044967|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2016-07-01|||May 2002||2002-05-01|July 2016|2016-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Observational|||Genetic Study of Young Patients With Colorectal Cancer|A Prospective Study Of The Prognostic Significance Of Microsatellite Instability In Patients With Early Age-Of-Onset Colorectal Cancer|Completed||N/A|651|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 18:04:05.050264|2017-02-18 18:04:05.050264
NCT00044954|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2009-02-06|||November 2001||2001-11-01|February 2005|2005-02-01||||||||Interventional|||Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Low Dose Total-Body Irradiation And Fludarabine Followed By HLA Matched Allogeneic Stem Cell Transplantation For Hematologic Malgnancies - A Multi-Center Study|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:05.488587|2017-02-18 18:04:05.488587
NCT00044928|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2013-02-07|||July 2002||2002-07-01|February 2013|2013-02-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection|Randomized, Open-label, Comparative Study of Zosyn (Pip/Tazo [12g/1.5g]) Administered by Daily 24hr Continuous Infusion vs Zosyn (Pip/Tazo) [3g/0.375g]) q6h for the Treatment of Hospitalized Patients With Complicated Intra-abdominal Infection|Completed||Phase 4|262|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 18:04:05.605539|2017-02-18 18:04:05.605539
NCT00044915|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2009-06-09|||December 2000||2000-12-01|June 2009|2009-06-01|September 2004|Actual|2004-09-01|||||Interventional|||Repinotan in Patients With Acute Ischemic Stroke|A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic / Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke|Completed||Phase 2|782|Actual|Bayer||2|||f||||||||||||||2017-02-18 18:04:05.695965|2017-02-18 18:04:05.695965
NCT00044902|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2007-12-20||||||December 2007|2007-12-01||||||||Interventional|||Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)||Completed||Phase 2|||Amgen|||||||||||||||||||2017-02-18 18:04:05.922431|2017-02-18 18:04:05.922431
NCT00044889|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-06|2014-03-17|||May 2002||2002-05-01|March 2014|2014-03-01|March 2003|Actual|2003-03-01|||||Interventional|||Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia|A Phase II, Open-Label Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia|Completed||Phase 2|40||Sanofi|||||||||||||||||||2017-02-18 18:04:06.000238|2017-02-18 18:04:06.000238
NCT00044876|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-05|2017-01-24|||September 2, 2002||2002-09-02|October 1, 2015|2015-10-01|October 1, 2015|Actual|2015-10-01|June 16, 2007|Actual|2007-06-16||Interventional|||Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist|Treatment of Leiomyomata With the Selective Progesterone Receptor Modulator CDB-2914|Completed||Phase 2|56|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:04:06.102027|2017-02-18 18:04:06.102027
NCT00044863|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-05|2011-02-21|||August 2002||2002-08-01|February 2011|2011-02-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma|A Phase II Multicenter Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|250|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 18:04:06.197579|2017-02-18 18:04:06.197579
NCT00044837|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-05|2015-06-03||||||June 2003|2003-06-01||||||||Interventional|||Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women|A Phase I, Pharmacokinetic Study of Hormone Replacement Therapy in HIV-1-Infected, Postmenopausal Women on Nelfinavir, Lopinavir/Ritonavir, or Efavirenz|Terminated||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:04:06.307277|2017-02-18 18:04:06.307277
NCT00044824|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-05|2008-08-20|||February 2002||2002-02-01|August 2008|2008-08-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma|A Multicenter, Double-Blind, Randomized, Parallel Groups Placebo-Controlled Study to Assess the Efficacy and Safety of Fexofenadine 120mg BID in Subjects With Mild to Moderate Persistent Asthma|Completed||Phase 3|1000|Anticipated|Sanofi|||||||||||||||||||2017-02-18 18:04:06.404124|2017-02-18 18:04:06.404124
NCT00044811|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-05|2008-08-20|||March 2002||2002-03-01|August 2008|2008-08-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma|A Multicenter, Double-Blind, Randomized, Parallel Groups Placebo-Controlled Study to Assess the Efficacy and Safety of Fexofenadine 120mg BID in Subjects With Mild to Moderate Persistent Asthma|Completed||Phase 3|1000|Anticipated|Sanofi|||||||||||||||||||2017-02-18 18:04:06.779268|2017-02-18 18:04:06.779268
NCT00044798|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-04|2013-09-26|||September 2001||2001-09-01|September 2013|2013-09-01|August 2008|Actual|2008-08-01|March 2007|Actual|2007-03-01||Interventional|rtms||Magnetic Stimulation Therapy for Treating Vascular Depression|Vascular Depression and Magnetic Stimulation Therapy|Completed||Phase 3|132|Anticipated|University of Iowa||2|||f||||t||||||||||2017-02-18 18:04:06.883862|2017-02-18 18:04:06.883862
NCT00044785|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-04|2005-06-23|||August 2002||2002-08-01|May 2005|2005-05-01|March 2004||2004-03-01|||||Interventional|||Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors|A Phase I Study of Escalating Doses of CPT-11 and 5fluorouracil (5FU) Plus PN401 With a Fixed Dose of Leucovorin in Patients With Solid Tumor Malignancies.|Terminated||Phase 1|24||Wellstat Therapeutics|||||||||||||||||||2017-02-18 18:04:06.993156|2017-02-18 18:04:06.993156
NCT00044772|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-04|2009-08-13|||November 2001||2001-11-01|August 2009|2009-08-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Study Evaluating Venlafaxine ER in Patients With Panic Disorder|A Double-blind, Placebo-controlled, Parallel-group Comparison of Venlafaxine Extended-release Capsules and Paroxetine in Outpatients With Panic Disorder|Completed||Phase 3|653|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:04:07.069185|2017-02-18 18:04:07.069185
NCT00044759|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-04|2007-10-08||||||October 2007|2007-10-01|January 2003|Actual|2003-01-01|||||Interventional|||Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma|A Randomized, Open-Label, Multi-Center, Comparative Study of the Efficacy and Safety of Piperacillin/Tazobactam to Cefepime for the Empiric Treatment of Neutropenic Fever in Patients With a Hematologic Malignancy or Lymphoma|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:04:07.146662|2017-02-18 18:04:07.146662
NCT00044746|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-04|2013-02-07|||October 2000||2000-10-01|February 2013|2013-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections|An Open-label, Randomized Study Comparing the Efficacy and Safety of Piperacillin/Tazobactam and Ampicillin/Sulbactam Administered Intravenously in the Empirical Treatment of Foot Infections in Diabetic Inpatients|Completed||Phase 4|314|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 18:04:07.272304|2017-02-18 18:04:07.272304
NCT00044733|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-04|2006-05-17|||March 2000||2000-03-01|May 2006|2006-05-01|September 2004||2004-09-01|||||Interventional|||Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant|A Dose-Finding Study of the Safety of Gemtuzumab Ozogamicin as Single Agent Treatment of Patients With Relapsed Acute Myelogenous Leukemia After Autologous or Allogenic Hematopoietic Stem Cell Transplant (HSCT)|Completed||Phase 2|38||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:04:07.360283|2017-02-18 18:04:07.360283
NCT00044720|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-04|2009-08-17||||||August 2009|2009-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients|An Open-label, Concentration Controlled, Randomized, 12 Month Study of Prograf + Rapamune + Cor|Completed||Phase 4|484|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:04:07.458442|2017-02-18 18:04:07.458442
NCT00044707|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2015-05-20|||August 2002||2002-08-01|May 2015|2015-05-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide||Completed||Phase 2|24|Actual|AstraZeneca||2|||f||||||||||||||2017-02-18 18:04:07.551587|2017-02-18 18:04:07.551587
NCT00044694|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2015-02-19|||August 2002||2002-08-01|January 2015|2015-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus|A Phase 2, Randomized, Triple-Blind, Placebo-Controlled, Short-Term, Dose-Response Study to Examine the Effect on Glucose Control and Safety and Tolerability of AC2993 Given Two Times a Day in Subjects With Type 2 Diabetes Mellitus|Completed||Phase 2|156|Actual|AstraZeneca||8|||f||||f||||||||||2017-02-18 18:04:07.663486|2017-02-18 18:04:07.663486
NCT00044681|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2011-05-17|||October 2002||2002-10-01|November 2010|2010-11-01|March 2004|Actual|2004-03-01|||||Interventional|||A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression|A Study to Evaluate the Efficacy, Safety and Maintenance Effect of Risperidone Augmentation of SSRI Monotherapy in Young and Older Adult Patients With Unipolar Treatment-Resistant Depression|Completed||Phase 3|258|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:04:07.821155|2017-02-18 18:04:07.821155
NCT00044668|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2015-02-19|||August 2002||2002-08-01|January 2015|2015-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination|An Open-Label Study to Examine the Long-Term Effect on Glucose Control (HbA1c) and Safety of AC2993 Given Two Times a Day to Subjects With Type 2 Diabetes Treated With Metformin, a Sulfonylurea, or Metformin and Sulfonylurea Combination|Completed||Phase 3|155|Actual|AstraZeneca||1|||f||||f||||||||||2017-02-18 18:04:07.911297|2017-02-18 18:04:07.911297
NCT00044655|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2016-03-28|2013-09-27||July 2001||2001-07-01|March 2016|2016-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Switching Medication to Treat Schizophrenia|Effectiveness of Switching Antipsychotic Medications|Completed||Phase 4|219|Actual|Icahn School of Medicine at Mount Sinai||2|||f||||t||||||||||2017-02-18 18:04:08.021037|2017-02-18 18:04:08.021037
NCT00044642|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2013-12-05|||December 2000||2000-12-01|December 2013|2013-12-01|July 2007|Actual|2007-07-01|||||Interventional|||Lorazepam-Induced Toxicity in the Aged|Long-Term Lorazepam Use and Acute Toxicity in the Aged|Completed||Phase 4|90|Anticipated|Nathan Kline Institute for Psychiatric Research|||||f||||||||||||||2017-02-18 18:04:08.393515|2017-02-18 18:04:08.393515
NCT00044629|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2013-09-12|||September 2001||2001-09-01|September 2013|2013-09-01|August 2006||2006-08-01|||||Interventional|||Combined Behavioral/Pharmacological Therapy for Insomnia|Combined Behavioral/Pharmacological Therapy for Insomnia|Completed||Phase 2|162|Actual|Duke University||3|||f||||||||||||||2017-02-18 18:04:08.49197|2017-02-18 18:04:08.49197
NCT00044616|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2015-10-02|||February 2001||2001-02-01|December 2013|2013-12-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Relapse Prevention for Bipolar Type-II Disorder|Relapse Prevention of Bipolar Type-II Disorder|Completed||Phase 4|180||University of Pennsylvania|||||f||||||||||||||2017-02-18 18:04:08.59708|2017-02-18 18:04:08.59708
NCT00044603|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2014-10-14|||February 2000||2000-02-01|October 2014|2014-10-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS.|Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS|Completed||N/A|505|Actual|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||f||||||Samples With DNA|"~     Biologic samples were collected from the mothers and their children as follows: maternal~     blood (30-35 ml) within 1 day postpartum and umbilical cord blood (30 - 60 ml) collected by~     delivery room staff immediately after the cord was cut. Members of the research staff~     transported the samples to the laboratory immediately. The buffy coat, packed red blood~     cells, and plasma samples were separated and stored at -70°C and then shipped to Columbia~     University. Placental tissue and meconium were also collected. The placental tissue and~     meconium were sent to Columbia and stored for future analysis under separate funding.~   "|||2017-02-18 18:04:08.678153|2017-02-18 18:04:08.678153
NCT00044590|ClinicalTrials.gov processed this data on February 17, 2017|2002-09-03|2015-10-05|||September 2000||2000-09-01|April 2015|2015-04-01|November 2015|Anticipated|2015-11-01|November 2015|Anticipated|2015-11-01||Observational|||Parkinson's Diseases Susceptibility Genes and Pesticides|Parkinson's Diseases Susceptibility Genes and Pesticides|Recruiting||N/A|1200|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:08.75439|2017-02-18 18:04:08.75439
NCT00044564|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-30|2014-12-18|||December 2001||2001-12-01|December 2014|2014-12-01|January 2003|Actual|2003-01-01|||||Interventional|||Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma|An Uncontrolled Phase II, Multi Center Trial Evaluating Antitumor Efficacy and Safety of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|54|Actual|Bayer||1|||||||||||||||||2017-02-18 18:04:09.309055|2017-02-18 18:04:09.309055
NCT00044551|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-30|2013-10-10|||February 2002||2002-02-01|October 2013|2013-10-01|July 2003|Actual|2003-07-01|||||Interventional|||Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma|An Open Phase II, Multi Center Trial of BAY 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|29|Actual|Bayer||1|||f||||||||||||||2017-02-18 18:04:09.442936|2017-02-18 18:04:09.442936
NCT00044538|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-30|2009-06-19|||December 2001||2001-12-01|June 2009|2009-06-01|June 2004|Actual|2004-06-01|||||Interventional|||Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients|An Uncontrolled, Phase II Study Evaluating Anti-Tumor Efficacy and Safety of BAY 59-8862 in Patients With Taxane Resistant Non-Small Cell Lung Carcinoma (NSCLC)|Completed||Phase 2|102|Actual|Bayer||1|||f||||||||||||||2017-02-18 18:04:09.569592|2017-02-18 18:04:09.569592
NCT00044525|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-30|2014-12-18|||April 2002||2002-04-01|December 2014|2014-12-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients|An Uncontrolled Phase II Study Evaluating the Efficacy and Safety of Intravenous BAY59-8862 in Patients With Taxane-Resistant Metastatic Breast Cancer|Completed||Phase 2|82|Actual|Bayer||1|||f||||||||||||||2017-02-18 18:04:09.698136|2017-02-18 18:04:09.698136
NCT00044512|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-30|2014-03-26|2009-02-20||August 2002||2002-08-01|March 2014|2014-03-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma|A Phase II Multicenter Uncontrolled Trial of Sorafenib (BAY43-9006) in Patients With Advanced Hepatocellular Carcinoma|Completed||Phase 2|137|Actual|Bayer|Subjects had advanced disease and were heavily pretreated. National Cancer Institute-Common Toxicity Criteria (NCI-CTC) was translated to Medical Dictionary for Regulatory Activities (MedDRA) for System Organ Class (SOC) only.|1|||f||||f||||||||||2017-02-18 18:04:09.826782|2017-02-18 18:04:09.826782
NCT00044486|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-29|2015-08-14|||July 2002||2002-07-01|August 2015|2015-08-01|April 2005|Actual|2005-04-01|December 2004|Actual|2004-12-01||Interventional|||Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)|A Randomized Controlled Trial of Posaconazole (SCH 56592) vs. Standard Azole Therapy for the Prevention of Invasive Fungal Infections Among High-Risk Neutropenic Patients|Completed||Phase 3|602|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:04:10.410313|2017-02-18 18:04:10.410313
NCT00044473|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-29|2011-06-06|||November 2002||2002-11-01|January 2011|2011-01-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to Treat|An Open-Label Study of Levofloxacin to Evaluate Bacteriologic Outcome in the Treatment of Children Who Are at Risk for Acute Otitis Media That is Difficult to Treat|Completed||Phase 3|206|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:04:10.519705|2017-02-18 18:04:10.519705
NCT00044460|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-29|2016-09-22|||May 2002||2002-05-01|September 2016|2016-09-01||||||||Interventional|||Efficacy and Safety In Poorly Controlled Type 2 Diabetics|A 24-week Randomized, Double-Blind, Parallel-Group, Multicenter Study to Demonstrate the Efficacy and Safety of Two Different Rosiglitazone Dosing Regimens, 4mg OD and 8mg OD, in Poorly-Controlled Drug Naive Patients With Type 2 Diabetes Mellitus|Active, not recruiting||Phase 4|142||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 18:04:10.615116|2017-02-18 18:04:10.615116
NCT00044447|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-28|2008-06-18|||May 2001||2001-05-01|June 2008|2008-06-01|September 2002|Actual|2002-09-01|||||Interventional|||Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione|A Double-Blind, Placebo-Controlled, Parallel Group Comparison Study to Evaluate the Role of the Addition of Amaryl to NIDDM Patients Not Responding to Maximum Dose Metformin and Thiazolidinedione Therapy|Completed||Phase 3|170|Actual|Sanofi|||||||||||||||||||2017-02-18 18:04:10.707614|2017-02-18 18:04:10.707614
NCT00044434|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-28|2008-01-25|||May 2002||2002-05-01|January 2008|2008-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Bupropion as a Smoking Cessation Aid in Alcoholics|Bupropion as a Smoking Cessation Aid in Alcoholics|Completed||Phase 4|200||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:04:10.798365|2017-02-18 18:04:10.798365
NCT00044421|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-28|2007-11-05|||July 2002||2002-07-01|November 2007|2007-11-01|October 2006|Actual|2006-10-01|||||Interventional|||Treatment of Peripheral Neuropathy in Patients With Diabetes|LY333531 Treatment of Peripheral Neuropathy in Patients With Diabetes|Completed||Phase 3|400||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:04:10.87591|2017-02-18 18:04:10.87591
NCT00044408|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-28|2016-07-25|||July 2002||2002-07-01|July 2016|2016-07-01|October 2005|Actual|2005-10-01|||||Interventional|||Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes|LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes|Completed||Phase 3|200||Chromaderm, Inc.|||||||||||||||||||2017-02-18 18:04:11.03856|2017-02-18 18:04:11.03856
NCT00044395|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-28|2007-11-05|||July 2002||2002-07-01|November 2007|2007-11-01|October 2005|Actual|2005-10-01|||||Interventional|||Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes|LY333531 Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes|Completed||Phase 3|200||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:04:11.154666|2017-02-18 18:04:11.154666
NCT00044382|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-27|2009-06-16|||February 2002||2002-02-01|June 2009|2009-06-01||||January 2007|Actual|2007-01-01||Interventional|||Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome|A Phase II Open Label Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome|Completed||Phase 2|25||Celgene|||||f||||t||||||||||2017-02-18 18:04:11.533261|2017-02-18 18:04:11.533261
NCT00044369|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-27|2006-09-01|||May 2000||2000-05-01|September 2006|2006-09-01|April 2005||2005-04-01|||||Observational|||Role of the Toxic Metal Cadmium in the Mechanism Producing Infertility With a Varicocele|Increased Testicular Cd2+ & Infertility With Varicocele ( a Varicose Vein in the Scrotum)|Completed||N/A|400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:11.61191|2017-02-18 18:04:11.61191
NCT00044356|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-26|2011-07-05|||February 2001||2001-02-01|July 2011|2011-07-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||Phase II Trial of Allovectin-7® for Metastatic Melanoma|A Phase II Study of High-Dose Allovectin-7® in Patients With Advanced Metastatic Melanoma|Completed||Phase 2|133|Actual|Vical|||||f||||f||||||||||2017-02-18 18:04:11.698419|2017-02-18 18:04:11.698419
NCT00044343|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-26|2014-07-09|||September 2002||2002-09-01|July 2014|2014-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin|An Open-Label, Multicenter, Phase II Study of Oral Lapatinib (GW572016) as Single Agent, Second-Line Therapy in Subjects With Metastatic Colorectal Cancer Who Have Progressed on First-Line Therapy With 5-Fluorouracil in Combination With Irinotecan or Oxaliplatin|Completed||Phase 2|80|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 18:04:11.809986|2017-02-18 18:04:11.809986
NCT00044317|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-26|2005-06-23||||||August 2002|2002-08-01||||||||Observational|||Health Effects of Particulate Acids in Late Adolescence||Completed||N/A|1500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:11.963478|2017-02-18 18:04:11.963478
NCT00044304|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-24|2017-01-24|||August 22, 2002||2002-08-22|April 18, 2016|2016-04-18|January 1, 2025|Anticipated|2025-01-01|September 1, 2024|Anticipated|2024-09-01||Interventional|||Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome|Efficacy of Imatinib Mesylate in Reducing Eosinophilia in Patients With Myeloproliferative and/or Steroid-Refractory Hypereosinophilic Syndrome|Recruiting||Phase 2|50|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:04:12.031205|2017-02-18 18:04:12.031205
NCT00044291|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-23|2015-07-29|||June 2002||2002-06-01|July 2015|2015-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer||Completed||Phase 3|865|Actual|Intarcia Therapeutics||2|||f||||||||||||||2017-02-18 18:04:12.147645|2017-02-18 18:04:12.147645
NCT00044278|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-23|2017-01-16|||September 2000||2000-09-01|January 2017|2017-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Pediatric Epilepsy Study in Subjects 1-24 Months|An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)|Completed||Phase 2|197|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 18:04:12.337318|2017-02-18 18:04:12.337318
NCT00044265|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-23|2012-06-06|||July 2002||2002-07-01|June 2012|2012-06-01|November 2004||2004-11-01|||||Interventional|||Treatment of Pediatric Hypertension With Altace Trial|A Dose Escalation, Randomized, Double-blind Withdrawal Study of the Efficacy, Dose-response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents|Completed||Phase 4|310||Pfizer|||||||||||||||||||2017-02-18 18:04:12.52629|2017-02-18 18:04:12.52629
NCT00044252|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-22|2017-01-24|||July 26, 2002||2002-07-26|January 22, 2008|2008-01-22|January 22, 2008||2008-01-22|||||Observational|||Role of Hormones in Susceptibility to Seizures in Women With Epilepsy|Role of Serum Gonadal and Neuroactive Steroids in the Seizure Susceptibility of Women With Catamenial Epilepsy|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:12.637297|2017-02-18 18:04:12.637297
NCT00044239|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-22|2017-01-24|||August 20, 2002||2002-08-20|May 18, 2010|2010-05-18|May 18, 2010||2010-05-18|||||Observational|||Characterization of Childhood-Onset Obsessive-Compulsive Disorder|The Characterization of Childhood Onset Obsessive Compulsive Disorder and the PANDAS Subgroup|Completed||N/A|49|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:12.717004|2017-02-18 18:04:12.717004
NCT00044226|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-22|2005-06-23|||April 2002||2002-04-01|August 2002|2002-08-01|October 2002||2002-10-01|||||Interventional|||A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia|Unknown status|Recruiting|Phase 2|350||Milkhaus Laboratory|||||||||||||||||||2017-02-18 18:04:12.810642|2017-02-18 18:04:12.810642
NCT00044213|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-22|2013-08-30|2013-08-30||September 2003||2003-09-01|August 2013|2013-08-01|August 2012|Actual|2012-08-01|October 2011|Actual|2011-10-01||Interventional|||Trial to Assess Chelation Therapy (TACT)|Trial to Assess Chelation Therapy (TACT)|Completed||Phase 3|1708|Actual|Mt. Sinai Medical Center, Miami||4|||f||||t||||||||||2017-02-18 18:04:12.908876|2017-02-18 18:04:12.908876
NCT00044200|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-21|2017-01-24|||January 10, 2000||2000-01-10|June 12, 2015|2015-06-12|June 12, 2015||2015-06-12|||||Observational|||Positron Emission Tomography (PET) to Study Brain Signaling|Positron Emission Tomography Imaging of Activation-Induced Signal Transduction in Human Brain|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:13.49251|2017-02-18 18:04:13.49251
NCT00044187|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-21|2006-07-18|||April 2001||2001-04-01|July 2006|2006-07-01|September 2003||2003-09-01|||||Interventional|||The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder|The Assessment of a Anti-Obesity Agent for the Treatment of Olanzapine-Associated Weight Gain in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder and Bipolar I Disorder|Completed||Phase 4|130||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:04:13.594355|2017-02-18 18:04:13.594355
NCT00044174|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-20|2017-01-24|||August 15, 2002||2002-08-15|October 17, 2016|2016-10-17||||||||Observational|||Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants|Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants|Completed||N/A|850|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:13.704839|2017-02-18 18:04:13.704839
NCT00044148|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-20|2017-01-30|||July 16, 2002|Actual|2002-07-16|January 2017|2017-01-01|April 28, 2004|Actual|2004-04-28|April 28, 2004|Actual|2004-04-28||Interventional|||The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes|The Effect of LY333531 on Albuminuria in Patients With Type 2 Diabetes A Pilot Clinical Trial|Completed||Phase 2|||Chromaderm, Inc.|||||f|||||t|f||||||||2017-02-18 18:04:13.797497|2017-02-18 18:04:13.797497
NCT00044135|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-20|2005-06-23|||August 2002||2002-08-01|November 2002|2002-11-01||||||||Interventional|||A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.|A Phase II, Randomized, Partially-Blinded Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of 12 Weeks of Treatment with Clevudine (10 mg, 30 mg or 50 mg QD) in Patients Infected with Hepatitis B Virus.|Unknown status|Active, not recruiting|Phase 2|30||Triangle Pharmaceuticals|||||f||||||||||||||2017-02-18 18:04:13.903001|2017-02-18 18:04:13.903001
NCT00044122|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-17|2017-01-24|||August 16, 2002||2002-08-16|September 29, 2016|2016-09-29||||||||Observational|||Study of Factors Regulating Mast Cell Proliferation|Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:13.993895|2017-02-18 18:04:13.993895
NCT00044109|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-17|2006-06-23|||August 2002||2002-08-01|June 2006|2006-06-01|June 2006||2006-06-01|||||Interventional|||Magnets in the Treatment of Sciatica|Static Magnets In The Treatment of Sciatica|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:14.100825|2017-02-18 18:04:14.100825
NCT00044096|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2017-01-24|||August 15, 2002||2002-08-15|September 17, 2013|2013-09-17|September 17, 2013||2013-09-17|||||Observational|||Psychopharmacology of Fear-Potentiated Startle in Humans|Psychopharmacology of Fear-Potentiated Startle in Humans|Completed||N/A|225|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:14.193459|2017-02-18 18:04:14.193459
NCT00044083|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2016-08-31|||August 2002||2002-08-01|June 2016|2016-06-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|||Clinical Trial of Tolcapone for Cognition in Schizophrenia|Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype|Completed||Phase 2|213|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:04:14.534702|2017-02-18 18:04:14.534702
NCT00044070|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2006-03-31|||December 2000||2000-12-01|March 2006|2006-03-01|January 2003||2003-01-01|||||Interventional|||A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients|A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Effects of YM872 on Lesion Volume as Measured by Diffusion, Perfusion, and FLAIR Magnetic Resonance Imaging in Patients With Acute Ischemic Stroke|Completed||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:04:14.647085|2017-02-18 18:04:14.647085
NCT00044057|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2006-03-31|||December 2000||2000-12-01|March 2006|2006-03-01|January 2003||2003-01-01|||||Interventional|||A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)|A Multicenter, Stratified, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Neurologic Function and Disability in Patients With Acute Ischemic Stroke Given Tissue Plasminogen Activator Plus YM872 or Tissue Plasminogen Activator Plus Placebo|Completed||Phase 2|||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:04:14.853173|2017-02-18 18:04:14.853173
NCT00044044|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2014-03-31|2011-02-01||July 2002||2002-07-01|March 2014|2014-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia|A 6-Week, Double-Blind, Randomized, Fixed-Dose, Parallel-Group Study of the Efficacy and Safety of Three Dose Levels of SM-13496 Compared to Placebo and Haloperidol in Patients With Schizophrenia Who Are Experiencing an Acute Exacerbation of Symptoms|Completed||Phase 2|356|Actual|Sunovion||5|||f||||f||||||||||2017-02-18 18:04:15.094235|2017-02-18 18:04:15.094235
NCT00044031|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2014-04-16|||February 2001||2001-02-01|April 2014|2014-04-01|October 2007|Actual|2007-10-01|April 2004|Actual|2004-04-01||Interventional|||Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma|Prospective, Randomized, Controlled, Double-Blind, Multi-National, Multi-Center Study of G17DT Immunogen in Combination With Gemcitabine Versus Placebo in Combination With Gemcitabine in Previously Untreated Subjects With Locally Advanced (Nonresectable Stage II and III), Recurrent Disease Following Primary Resection, or Metastatic (Stage IV) Adenocarcinoma of the Pancreas (Protocol No. PC4)|Completed||Phase 3|394|Actual|Cancer Advances Inc.||2|||t||||f||||||||||2017-02-18 18:04:15.899453|2017-02-18 18:04:15.899453
NCT00044018|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2009-09-22|||April 2002||2002-04-01|September 2009|2009-09-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma|An Open-Label Study to Evaluate the Efficacy and Safety of Two CDC-501 Dose Regimens When Used Alone or in Combination With Dexamethasone for the Treatment Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|102|Actual|Celgene|||||f||||f||||||||||2017-02-18 18:04:15.987917|2017-02-18 18:04:15.987917
NCT00044005|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2014-03-31|2011-02-16||September 2002||2002-09-01|March 2014|2014-03-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Safety and Tolerability Study of Drug to Treat Schizophrenia|A Randomized, Open-Label, Dose-Blinded, Multicenter, 6-Month Study of Safety and Tolerability of 3 Dose Levels of SM-13496 (Lurasidone) in Patients With Schizophrenia|Completed||Phase 2|98|Actual|Sunovion||3|||f||||f||||||||||2017-02-18 18:04:16.08662|2017-02-18 18:04:16.08662
NCT00043992|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-16|2006-09-01|||July 2001||2001-07-01|September 2006|2006-09-01||||||||Observational|||Outdoor Allergen Exposure, Sensitivity, and Acute Asthma||Completed||N/A|1000||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:16.567607|2017-02-18 18:04:16.567607
NCT00043979|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-15|2013-09-12|2013-04-03||August 2002||2002-08-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|April 2012|Actual|2012-04-01||Interventional|||Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas|Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas|Completed||Phase 2|60|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:04:16.733227|2017-02-18 18:04:16.733227
NCT00043966|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-15|2006-07-26|||July 2002||2002-07-01|July 2006|2006-07-01||||||||Interventional|||Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects|A Randomized, Open-Label Study of 800 Mg Lopinavir/200 Mg Ritonavir QD in Combination With Tenofovir and Emtricitabine Vs. 400 Mg Lopinavir /100 Mg Ritonavir BID in Combination With Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects|Completed||Phase 3|200||Abbott|||||||||||||||||||2017-02-18 18:04:20.709745|2017-02-18 18:04:20.709745
NCT00043953|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-15|2007-09-26|||August 2002||2002-08-01|September 2007|2007-09-01||||||||Interventional|||Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects|A Phase II Study of Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects|Completed||Phase 2|30|Actual|Abbott||2|||f||||f||||||||||2017-02-18 18:04:20.841726|2017-02-18 18:04:20.841726
NCT00043940|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2011-09-15|||April 1999||1999-04-01|September 2011|2011-09-01||||February 2003|Actual|2003-02-01||Interventional|||Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)|Anticoagulant Therapy With Bivalirudin in the Performance of PCI in Patients With Heparin-Induced Thrombocytopenia|Completed||Phase 3|50|Actual|The Medicines Company||1|||f||||||||||||||2017-02-18 18:04:21.200811|2017-02-18 18:04:21.200811
NCT00043927|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2013-08-20|||April 2001||2001-04-01|August 2013|2013-08-01||||January 2004|Actual|2004-01-01||Interventional|||Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults|An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin as Treatment for Chemotherapy-naive Patients With Extensive Disease-Small Cell Lung Cancer.|Completed||Phase 3|760||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:04:21.298686|2017-02-18 18:04:21.298686
NCT00043914|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2016-09-22|||January 2002||2002-01-01|September 2016|2016-09-01||||||||Interventional|||Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy|A Multicenter, Open-Label Conversion of Valproate Monotherapy to Lamotrigine Monotherapy in Patients With Epilepsy|Completed||Phase 4|72||GlaxoSmithKline|||||f||||||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 18:04:21.577907|2017-02-18 18:04:21.577907
NCT00043901|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2013-08-20|||December 2000||2000-12-01|August 2013|2013-08-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects Wtih Primary Generalized Tonic-Clonic Seizures|Completed||Phase 4|141|Actual|GlaxoSmithKline|||||f||||||||||||||2017-02-18 18:04:21.678519|2017-02-18 18:04:21.678519
NCT00043888|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2013-02-11|||January 2002||2002-01-01|February 2013|2013-02-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR|A Phase IIIb/IV, Randomized, Open Label, Multicenter, Pilot Trial to Explore the Safety and Tolerability of GW433908 +/- Ritonavir (1400mg Twice Daily or 700mg/100mg Twice Daily) When Used in Combination With a Zidovudine-containing Regimen (TRIZIVIR or COMBIVIR Twice Daily) Over a 24 Week Period in Antiretroviral Therapy Naive HIV-1 Infected Subjects.|Completed||Phase 3|60||GlaxoSmithKline|||||||||||||||||||2017-02-18 18:04:21.829019|2017-02-18 18:04:21.829019
NCT00043875|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2016-09-13|||May 2000||2000-05-01|September 2016|2016-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Pediatric Epilepsy Trial in Subjects 1-24 Months|A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)|Completed||Phase 2|177|Actual|GlaxoSmithKline|||||||||f||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 18:04:22.210667|2017-02-18 18:04:22.210667
NCT00043862|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2013-03-01|||August 2002||2002-08-01|March 2013|2013-03-01||||November 2005|Actual|2005-11-01||Interventional|(SCLC)||The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)|A Phase II Trial of Twice Daily Oral Topotecan as a Radiation Sensitizer With Twice Daily Radiotherapy for Newly Diagnosed Small Cell Lung Cancer|Completed||Phase 2|60|Actual|GlaxoSmithKline|||||||||f||||||||||2017-02-18 18:04:22.383665|2017-02-18 18:04:22.383665
NCT00043849|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2009-12-10|||July 2002||2002-07-01|August 2006|2006-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)|Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)|Completed||Phase 4|60||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:04:22.514729|2017-02-18 18:04:22.514729
NCT00043836|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2009-09-01|||July 2002||2002-07-01|August 2007|2007-08-01|October 2005|Actual|2005-10-01|February 2003|Actual|2003-02-01||Interventional|||The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure|A Pilot Study Of ALT-711 In Elderly Patients With Isolated Diastolic Heart Failure: The DIAMOND Study|Completed||Phase 2|20||Synvista Therapeutics, Inc|||||||||||||||||||2017-02-18 18:04:22.64116|2017-02-18 18:04:22.64116
NCT00043823|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2012-04-18|||August 2002||2002-08-01|April 2012|2012-04-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer|Safety and Efficacy of Recombinant Humanized Monoclonal Anti-VEGF Antibody rhuMAb VEGF and EGFR Tyrosine Kinase Inhibitor OSI-774 for Locally Advanced or Metastatic Non-Squamous Cell NSCLC in Patients Who Have Been Previously Treated|Completed||Phase 1/Phase 2|41|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:04:22.730742|2017-02-18 18:04:22.730742
NCT00043810|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-14|2012-07-27|||July 2002||2002-07-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Study of Gelonin Purging of Autologous Stem Cells for Transplantation|Dose Finding Study of Gelonin Purging of Autologous Stem Cells for Transplantation of Patients With AML/MDS in First or Subsequent Remission|Terminated||Phase 1/Phase 2|3|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:04:22.850037|2017-02-18 18:04:22.850037
NCT00043797|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-13|2005-06-23||||||December 2002|2002-12-01||||||||Interventional|||Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy||Unknown status|Active, not recruiting|Phase 2|||The Institute for Diabetes Discovery, LLC|||||||||||||||||||2017-02-18 18:04:22.976731|2017-02-18 18:04:22.976731
NCT00043784|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-13|2008-09-15|||August 2001||2001-08-01|September 2008|2008-09-01||||February 2005|Actual|2005-02-01||Interventional|||SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes|A Prospective, Randomized, Open-Label, Multicenter Study in Patients Presenting With Acute Coronary Syndromes (ACS)|Completed||Phase 3|8000||Sanofi|||||f||||||||||||||2017-02-18 18:04:23.075154|2017-02-18 18:04:23.075154
NCT00043771|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-13|2005-06-23|||May 2002||2002-05-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Interventional|||Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients|Multi-Center, Double-Blind Study to Compare the Effects of 30mg Qd Versus 15 Mg Bid of Tolvaptan in Congestive Heart Failure Patients|Completed||Phase 2|40||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:04:23.17316|2017-02-18 18:04:23.17316
NCT00043758|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-13|2005-06-23|||July 2002||2002-07-01|June 2005|2005-06-01|July 2004||2004-07-01|||||Interventional|||Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients||Completed||Phase 2|170||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:04:23.261162|2017-02-18 18:04:23.261162
NCT00043745|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-13|2013-02-06|||March 2003||2003-03-01|February 2013|2013-02-01||||April 2008|Actual|2008-04-01||Interventional|SIRBL||Bone Response to Soy Isoflavones in Women|Bone Response to Soy Isoflavones in Women|Completed||Phase 2|224|Actual|Iowa State University||3|||f||||t||||||||||2017-02-18 18:04:23.377697|2017-02-18 18:04:23.377697
NCT00043732|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-12|2010-04-26||||||April 2010|2010-04-01|September 2003|Actual|2003-09-01|||||Interventional|||Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study of SCIO-469 in Patients in Active Rheumatoid Arthritis Receiving Methotrexate|Completed||Phase 2|120|Actual|Scios, Inc.|||||||||||||||||||2017-02-18 18:04:23.480781|2017-02-18 18:04:23.480781
NCT00043719|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-12|2009-01-29|||July 2002||2002-07-01|January 2009|2009-01-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women|Prevention of Postmenopausal Bone Loss With Nitric Oxide|Completed||Phase 3|200||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-02-18 18:04:23.562431|2017-02-18 18:04:23.562431
NCT00043706|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-12|2015-03-04||||||March 2015|2015-03-01|September 2003|Actual|2003-09-01|||||Interventional|||Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis|A Phase 1/2 Double Blind, Placebo Controlled, Randomized, Dose Ranging, Repeat Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of CAT-192 Human Anti-TGF-Beta1 Monoclonal Antibody in Patients With Early Stage Diffuse Systemic Sclerosis|Completed||Phase 1/Phase 2|||Sanofi|||||||||||||||||||2017-02-18 18:04:23.655714|2017-02-18 18:04:23.655714
NCT00043693|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-12|2012-08-07|||April 2002||2002-04-01|August 2012|2012-08-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Family Intervention for Mental Illness and Substance Abuse|Family Intervention for SMI and Substance Use Disorder|Completed||N/A|108|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||||||||||||2017-02-18 18:04:23.737184|2017-02-18 18:04:23.737184
NCT00043680|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-10|2008-03-03|||August 2002||2002-08-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy|Multi-Center Randomized Phase I/II Trial to Study the Effects of Cyclooxygenase-2 Inhibition on the Response to Photodynamic Therapy in Patients With Age-Related Macular Degeneration|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:23.847292|2017-02-18 18:04:23.847292
NCT00043667|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-10|2008-03-03|||August 2002||2002-08-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis|Evaluation of Subcutaneous Daclizumab Treatments in Patients With Non-Infectious Sight-Threatening Uveitis: A Multicenter, Open-Label, Phase II Study|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:23.931983|2017-02-18 18:04:23.931983
NCT00043654|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2017-01-24|||August 7, 2002||2002-08-07|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Interventional|||Clinical Trial of Mifepristone for Bipolar Depression|Antiglucocorticoid Therapy in Bipolar Depression With Mifepristone (RU486)|Completed||Phase 2|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:24.289535|2017-02-18 18:04:24.289535
NCT00043641|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2017-01-24|||July 26, 2002||2002-07-26|February 7, 2013|2013-02-07|February 7, 2013||2013-02-07|||||Observational|||HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)|HIV Expression in Patients With Viral Loads Suppressed on HAART|Completed||N/A|73|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:24.396639|2017-02-18 18:04:24.396639
NCT00043628|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2008-03-03|||August 2002||2002-08-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Stem Cell Mobilization to Treat Chest Pain and Shortness of Breath in Patients With Coronary Artery Disease|Stem Cell Mobilization as Therapy for Chronic Myocardial Ischemia in Patients With Coronary Artery Disease|Completed||Phase 2|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:24.486117|2017-02-18 18:04:24.486117
NCT00043615|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2017-01-24|||July 29, 2002||2002-07-29|April 10, 2012|2012-04-10|April 10, 2012||2012-04-10|||||Observational|||Collection of Blood, Bone Marrow, Tumor or Tissue Samples|Acquisition of Blood, Bone Marrow, Tumor, or Tissue Samples|Completed||N/A|74|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:24.584172|2017-02-18 18:04:24.584172
NCT00043602|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2013-09-25|||September 2001||2001-09-01|September 2013|2013-09-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Clinician Managed Interpersonal Psychotherapy|Clinician Managed Interpersonal Psychotherapy|Completed||Early Phase 1|140|Actual|University of Iowa||2|||f||||f||||||||||2017-02-18 18:04:24.672788|2017-02-18 18:04:24.672788
NCT00043589|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2013-12-03|||June 2002||2002-06-01|December 2013|2013-12-01|December 2007|Actual|2007-12-01|December 2006|Actual|2006-12-01||Interventional|||Memory and Mental Health in Aging|Memory and Mental Health in Aging|Completed||N/A|200||Stanford University|||||f||||f||||||||||2017-02-18 18:04:24.776338|2017-02-18 18:04:24.776338
NCT00043576|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2009-03-10|||August 2002||2002-08-01|February 2005|2005-02-01|December 2005||2005-12-01|||||Interventional|||ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere|A Phase 2/3 Multicenter, Randomized, Double Blind Study of Docetaxel (Taxotere) Plus DN-101 or Placebo in Androgen Independent Prostate Cancer (AIPC)|Unknown status|Active, not recruiting|Phase 2/Phase 3|250||Novacea|||||||||||||||||||2017-02-18 18:04:24.878834|2017-02-18 18:04:24.878834
NCT00043563|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2015-12-15|||January 2001||2001-01-01|December 2015|2015-12-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Cognitive Behavioral Treatment of Pediatric Trichotillomania|Cognitive Behavioral Treatment of Pediatric Trichotillomania|Completed||N/A|24|Actual|University of Pennsylvania|||||f||||t||||||||||2017-02-18 18:04:25.064251|2017-02-18 18:04:25.064251
NCT00043550|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2012-06-12|||November 2001||2001-11-01|June 2012|2012-06-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Treatments for Depression: Drug Versus Psychotherapy|Efficacy of Dynamic Therapy Versus Selective Serotonin Reuptake Inhibitor for Depression|Completed||Phase 3|156|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 18:04:25.163575|2017-02-18 18:04:25.163575
NCT00043537|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2013-07-31|||April 2001||2001-04-01|July 2013|2013-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Treatment of Childhood Social Phobia|Treatment of Childhood Social Phobia|Completed||Phase 3|139|Actual|University of Central Florida||3|||f||||t||||||||||2017-02-18 18:04:25.287962|2017-02-18 18:04:25.287962
NCT00043511|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2012-05-03||||||May 2012|2012-05-01|April 2003|Actual|2003-04-01|||||Interventional|||Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults|A Phase I Trial to Evaluate the Safety and Immunogenicity of the HIV-1 pGA2/JS2 Plasmid DNA Vaccine Given Intramuscularly (IM) in HIV-1 Uninfected Adults|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:04:25.404514|2017-02-18 18:04:25.404514
NCT00043498|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-09|2014-10-14|||August 1997||1997-08-01|October 2014|2014-10-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Observational|||Health Effects of Early-Life Exposure to Urban Pollutants in Minority Children|Health Effects of Early-Life Exposure to Urban Pollutants in Minority Children|Completed||N/A|727|Actual|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||t||||||Samples With DNA|"~     We collected maternal urine during the third trimester of pregnancy, maternal blood at~     delivery, umbilical cord blood, meconium, blood and urine from the child at ages 24, 36, and~     60 months.~   "|||2017-02-18 18:04:25.519452|2017-02-18 18:04:25.519452
NCT00043472|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||August 1, 2002||2002-08-01|November 25, 2016|2016-11-25||||||||Observational|||Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk|Prospective Study of Prophylactic Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer|Completed||N/A|40|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:25.609967|2017-02-18 18:04:25.609967
NCT00043459|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-08|2005-06-23|||July 2002||2002-07-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.||Terminated||Phase 2|35||Tularik|||||||||||||||||||2017-02-18 18:04:25.718171|2017-02-18 18:04:25.718171
NCT00043446|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-08|2005-06-23|||July 2002||2002-07-01|April 2004|2004-04-01||||||||Interventional|||Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.||Unknown status|Active, not recruiting|Phase 2|35||Tularik|||||||||||||||||||2017-02-18 18:04:25.803146|2017-02-18 18:04:25.803146
NCT00043433|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-08|2005-06-23|||July 2002||2002-07-01|April 2004|2004-04-01||||||||Interventional|||Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.||Unknown status|Active, not recruiting|Phase 2|35||Tularik|||||||||||||||||||2017-02-18 18:04:25.884656|2017-02-18 18:04:25.884656
NCT00043420|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-08|2009-02-11|||January 2003||2003-01-01|February 2009|2009-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||CPG 7909 in Patients With Cutaneous T-Cell Lymphoma|A Phase I/II Open Label, Multi-Center Study For The Evaluation Of Pf-3512676 (CPG 7909) In Patients With Stage Ib To Iva Cutaneous T-Cell Lymphoma|Completed||Phase 1/Phase 2|42|Actual|Pfizer||8|||f||||f||||||||||2017-02-18 18:04:25.988426|2017-02-18 18:04:25.988426
NCT00043407|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-08|2009-02-11|||March 2002||2002-03-01|February 2009|2009-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||CPG 7909 in Patients Wih Stage IV Renal Cell Cancer|A Phase I/II, Open Label, Multi-Center Study For The Evaluation Of CPG 7909 In Patients With Stage Iv Renal Cell Carcinoma|Completed||Phase 1/Phase 2|42|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 18:04:26.107598|2017-02-18 18:04:26.107598
NCT00043394|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-08|2009-03-11|||September 2002||2002-09-01|March 2009|2009-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer|A Phase I/II Open Label, Multi-Center, Dose-Escalation Study Of Subcutaneous CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer|Completed||Phase 2|16|Actual|Pfizer||4|||f||||f||||||||||2017-02-18 18:04:26.214233|2017-02-18 18:04:26.214233
NCT00043381|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-08|2013-01-22|||April 2001||2001-04-01|June 2011|2011-06-01|April 2003|Actual|2003-04-01|November 2002|Actual|2002-11-01||Interventional|||Decitabine Versus Supportive Care in Adults With Advanced-stage MDS|A Randomized, Open-label, Phase III Trial of Decitabine (5-aza-2'Deoxycytidine) Versus Supportive Care in Adults With Advanced-stage Myelodysplastic Syndrome|Completed||Phase 3|160||Astex Pharmaceuticals|||||f||||||||||||||2017-02-18 18:04:26.360268|2017-02-18 18:04:26.360268
NCT00043368|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-08|2009-03-11|||September 2002||2002-09-01|March 2009|2009-03-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)|A Continuation Study Of PF-3512676 (CPG 7909) Injection In Patients With Metastatic Or Recurrent Malignancies Who Have Stable Disease Or Who Have Responded To Pf-3512676 Injection Therapy|Completed||Phase 2|31|Actual|Pfizer||1|||f||||f||||||||||2017-02-18 18:04:26.48084|2017-02-18 18:04:26.48084
NCT00043355|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-07|2007-10-30|||December 2000||2000-12-01|October 2007|2007-10-01|February 2003|Actual|2003-02-01|||||Interventional|||Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection|A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Safety and Efficacy of Inhaled Interferon Gamma-1b With Antimycobacterials in Previously Treated or Mod-to-Sev Pulmonary Mycobacterium Avium Complex Infection|Terminated||Phase 2|100|Actual|InterMune||1||Futility|f||||||||||||||2017-02-18 18:04:26.615972|2017-02-18 18:04:26.615972
NCT00043342|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-07|2007-10-29|||April 2002||2002-04-01|October 2007|2007-10-01|March 2003|Actual|2003-03-01|||||Interventional|||Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis|A Phase I/II Study of Interferon Gamma-1b by Subcutaneous Injection for the Treatment of Patients With Cystic Fibrosis|Completed||Phase 1/Phase 2|51|Actual|InterMune||1|||f||||||||||||||2017-02-18 18:04:26.704719|2017-02-18 18:04:26.704719
NCT00043329|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-07|2007-10-30|||January 2002||2002-01-01|October 2007|2007-10-01|September 2005|Actual|2005-09-01|||||Observational|||Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis|Post-Marketing Surveillance Study of Actimmune (Interferon Gamma-1b) in Patients With Severe Malignant Osteopetrosis|Completed||Phase 4|6|Actual|InterMune|||1||f||||||||||||||2017-02-18 18:04:26.793734|2017-02-18 18:04:26.793734
NCT00043316|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-07|2007-10-29|||February 2001||2001-02-01|October 2007|2007-10-01|October 2002|Actual|2002-10-01|||||Interventional|||Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis|A Phase I/II Study of Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis|Completed||Phase 1/Phase 2|66|Actual|InterMune||1|||f||||||||||||||2017-02-18 18:04:26.881962|2017-02-18 18:04:26.881962
NCT00043303|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-07|2007-10-29|||September 2001||2001-09-01|October 2007|2007-10-01|November 2003|Actual|2003-11-01|||||Interventional|||Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis|A Multicenter Study of the Safety and Anti-Fibrotic Efficacy of Interferon-Gamma 1b (Actimmune) in Patients With Severe Lever Fibrosis or Compensated Cirrhosis Due to Hepatitis C.|Completed||Phase 2|502|Actual|InterMune||1|||f||||||||||||||2017-02-18 18:04:26.976116|2017-02-18 18:04:26.976116
NCT00043277|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-07|2006-01-31|||August 2002||2002-08-01|January 2006|2006-01-01|December 2004||2004-12-01|||||Interventional|||Study Of Angiomax In Infants Under Six Months With Thrombosis|Pilot Dose Finding And Efficacy Study Of Angiomax® (Bivalirudin) As Primary Anticoagulation In Infants Under Six Months With Thrombosis|Completed||Phase 2|25||The Medicines Company|||||||||||||||||||2017-02-18 18:04:27.06446|2017-02-18 18:04:27.06446
NCT00043264|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-07|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis|Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis|Completed||Phase 2|40||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:04:27.147664|2017-02-18 18:04:27.147664
NCT00043238|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-07|2015-04-13||||||April 2015|2015-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||Mohawk Culture, Behavior, Toxicant Exposure and Health|Mohawk Culture, Behavior, Toxicant Exposure and Health|Completed||N/A|220|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:27.500813|2017-02-18 18:04:27.500813
NCT00043225|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||June 19, 2001||2001-06-19|September 2, 2016|2016-09-02||||||||Observational|||The Role of Bacteria and Genetic Variations in Cystic Fibrosis|Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:27.586192|2017-02-18 18:04:27.586192
NCT00043212|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-06|2013-04-30||||||April 2013|2013-04-01||||||||Interventional|||Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.|A Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial Evaluating DCVax(tm)-Prostate, Autologous Dendritic Cells Loaded With Recombinant PSMA for the Treatment of Metastatic Hormone Refractory Prostate Cancer|Withdrawn||Phase 3|0|Actual|Northwest Biotherapeutics||||Redirection of company goals|f||||||||||||||2017-02-18 18:04:27.702425|2017-02-18 18:04:27.702425
NCT00043199|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-06|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies|A Phase II Study of Aroplatin in Subjects With Recurrent, Unresectable and Metastatic Colorectal Cancer Refractory to 5-Fluorouracil (5-FU)/Leucovorin or Capecitabine, and Irinotecan|Unknown status|Active, not recruiting|Phase 2|40||Aronex Pharmaceuticals|||||||||||||||||||2017-02-18 18:04:27.818087|2017-02-18 18:04:27.818087
NCT00043186|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-06|2013-09-06|2009-12-22||May 2002||2002-05-01|September 2013|2013-09-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density|A Randomized, Double-Blind, Placebo-controlled, Multi-dose Phase 2 Study to Determine the Efficacy, Safety and Tolerability of AMG 162 in the Treatment of Postmenopausal Women With Low Bone Mineral Density|Completed||Phase 2|412|Actual|Amgen||9|||f||||||||||||||2017-02-18 18:04:27.944507|2017-02-18 18:04:27.944507
NCT00043147|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-05-29|||April 2002||2002-04-01|December 2004|2004-12-01|January 2005|Actual|2005-01-01|||||Interventional|||Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease|A Phase III, Randomized, Placebo-Controlled, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Oral Beclomethasone 17, 21-Dipropionate (BDP) in Conjunction With Ten Days of High-Dose Prednisone Therapy in the Treatment of Patients With Grade II Graft vs. Host Disease With Gastrointestinal Symptoms|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:33.84641|2017-02-18 18:04:33.84641
NCT00043134|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2010-04-10|||May 2002||2002-05-01|April 2008|2008-04-01||||May 2008|Anticipated|2008-05-01||Interventional|||Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome|Intravenous Low-Dose Decitabine Versus Supportive Care in Elderly Patients With Primary Myelodysplastic Syndrome (MDS) (>10% Blasts or High-Risk Cytogenetics), Secondary MDS or Chronic Myelomonocytic Leukemia (CMML) Who Are Not Eligible for Intensive Therapy: An EORTC-German MDS Study Group Randomized Phase III Study|Unknown status|Active, not recruiting|Phase 3|220|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:33.941928|2017-02-18 18:04:33.941928
NCT00043121|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-12-10|||June 2002||2002-06-01|December 2013|2013-12-01||||August 2008|Actual|2008-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery|A Phase I Study of Oxaliplatin, 5-Fluorouracil, and Leucovorin in Combination With Oral Capecitabine in Patients With Advanced Malignancy|Completed||Phase 1|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:04:34.39034|2017-02-18 18:04:34.39034
NCT00043108|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2016-11-23|||July 2002||2002-07-01|November 2016|2016-11-01||||December 2006|Actual|2006-12-01||Interventional|||Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|Trimodality Protocol for the Treatment of Locally Advanced, Potentially Resectable Non-Small Cell Lung Cancer Targeting|Active, not recruiting||Phase 2|57|Anticipated|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 18:04:34.503769|2017-02-18 18:04:34.503769
NCT00043095|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2008-07-23|||June 2002||2002-06-01|April 2005|2005-04-01||||||||Interventional|||BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors|A Phase I Trial of BMS 247550 (NSC# 710428) and Gemcitabine in Patients With Advanced Solid Tumor Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:34.601512|2017-02-18 18:04:34.601512
NCT00043082|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2015-10-23|||August 2002||2002-08-01|October 2015|2015-10-01|July 2011|Actual|2011-07-01|June 2007|Actual|2007-06-01||Interventional|||S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer|A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy|Completed||Phase 3|61|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:04:34.702672|2017-02-18 18:04:34.702672
NCT00043069|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2016-12-05|||November 2002||2002-11-01|December 2016|2016-12-01|January 2010|Actual|2010-01-01|June 2006|Actual|2006-06-01||Interventional|||Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer|Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study|Completed||Phase 3|71|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-02-18 18:04:34.9055|2017-02-18 18:04:34.9055
NCT00043043|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-06-18|||May 2003||2003-05-01|November 2004|2004-11-01|October 2007|Actual|2007-10-01|||||Interventional|||Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia|Rectal Abberant Crypt Foci And Other Intermediate Biomarkers For Sporadic Colorectal Neoplasia: Cross-Sectional Prevelance And Modulation By Celecoxib|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:35.337535|2017-02-18 18:04:35.337535
NCT00043030|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2012-03-14|||June 2002||2002-06-01|March 2012|2012-03-01|May 2009|Actual|2009-05-01|December 2006|Actual|2006-12-01||Interventional|||Evaluating Patient Participation in Phase I Clinical Trials|Survey Of Patient's Motivations, Perceptions, And Expectations In Phase I Clinical Trials|Completed||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:35.432766|2017-02-18 18:04:35.432766
NCT00043017|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-10-07|||May 2002||2002-05-01|October 2013|2013-10-01|March 2011|Actual|2011-03-01|May 2005|Actual|2005-05-01||Interventional|ACRIN 6657||Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer|Contrast-Enhanced Breast MRI For Evaluation Of Patients Undergoing Neoadjuvant Treatment For Locally-Advanced Breast Cancer (I-SPY 1/ACRIN 6657)|Completed||Phase 2|356|Actual|American College of Radiology Imaging Network||1|||f||||t||||||||||2017-02-18 18:04:35.52124|2017-02-18 18:04:35.52124
NCT00043004|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2012-09-20|||May 2002||2002-05-01|September 2012|2012-09-01||||June 2007|Actual|2007-06-01||Interventional|||Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer|CLOCC Trial (Chemotherapy + Local Ablation Versus Chemotherapy) Randomized Phase II Study Of Local Treatment Of Liver Metastases By Radiofrequency Combined With Chemotherapy Versus Chemotherapy Alone In Patients With Unresectable Colorectal Liver Metastases|Terminated||Phase 2|119|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:04:35.661652|2017-02-18 18:04:35.661652
NCT00042991|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2014-05-15|2011-02-09||July 2002||2002-07-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|February 2010|Actual|2010-02-01||Interventional|||Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas|Phase I/II Trial of Gefitinib and Radiation in Pediatric Patients Newly Diagnosed With Brain Stem Tumors or Incompletely Resected Supratentorial Malignant Gliomas With Phase II Limited to Brain Stem Tumors|Completed||Phase 1/Phase 2|69|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:04:36.026072|2017-02-18 18:04:36.026072
NCT00042978|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-01-11|||April 2003||2003-04-01|January 2013|2013-01-01||||May 2005|Actual|2005-05-01||Interventional|||Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer|A Randomized Phase II Study Of Carboplatin And Etoposide With Or Without G3139 (NSC #683428, IND #58842) In Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:04:37.755193|2017-02-18 18:04:37.755193
NCT00042965|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2016-07-12|||October 2002||2002-10-01|July 2016|2016-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Of Capecitabine Plus Gemcitabine For Metastatic Renal Cell Carcinoma|Completed||Phase 2|60|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:04:37.869219|2017-02-18 18:04:37.869219
NCT00042952|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-01-15|||June 2002||2002-06-01|January 2013|2013-01-01||||October 2003|Actual|2003-10-01||Interventional|||Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer|A Phase II Study Of Imatinib Mesylate (Gleevec, Formerly Known As STI571; IND 61,135, NSC #716051) In Patients With Refractory Seminoma|Terminated||Phase 2|32|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:04:38.159806|2017-02-18 18:04:38.159806
NCT00042939|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-04-02|2011-06-21||July 2003||2003-07-01|December 2012|2012-12-01|August 2009|Actual|2009-08-01|June 2009|Actual|2009-06-01||Interventional|||Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer|Phase II Trial of Irinotecan/Docetaxel for Advanced Pancreatic Cancer, With Randomization Between Irinotecan/Docetaxel and Irinotecan/Docetaxel Plus C225 a Monoclonal Antibody to the Epidermal Growth Factor Receptor (EGF-r)|Completed||Phase 2|94|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 18:04:38.276495|2017-02-18 18:04:38.276495
NCT00042926|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2016-12-05|||May 2002||2002-05-01|December 2016|2016-12-01|November 2010|Actual|2010-11-01|May 2007|Actual|2007-05-01||Interventional|||Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer|A Trial Of Lymphatic Mapping And Sentinel Node Lymphadenectomy For Patients With T1 or T2 Clinically N0 Oral Cavity Squamous Cell Carcinoma|Completed||N/A|161|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:04:38.867669|2017-02-18 18:04:38.867669
NCT00042913|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-12-18|||May 2002||2002-05-01|September 2003|2003-09-01||||||||Interventional|||Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma|A Phase 2 Open Label, Randomized, Dose And Schedule Finding, Clinical Trial Of Immunotherapy With AMG 412 In Subjects With Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:38.975815|2017-02-18 18:04:38.975815
NCT00042900|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Pyroxamide in Treating Patients With Advanced Cancer|A Phase I Clinical And Pharmacological Study Of Pyroxamide (NSC 696085) In Patients With Advanced Malignancies|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:04:39.285532|2017-02-18 18:04:39.285532
NCT00042887|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2012-09-20|||May 2002||2002-05-01|September 2012|2012-09-01||||May 2004|Actual|2004-05-01||Interventional|||Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer|Chemoresection With 4 Weekly Intravesical Instillations Of Mitomycin C Versus Transurethral Resection (TUR) Followed By One Single Immediate Instillation Of Mitomycin C In Single, Small, Papillary Stage Ta, T1 Bladder Tumors: A Prospective Randomized Phase III Trial|Terminated||Phase 3|58|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:04:39.404715|2017-02-18 18:04:39.404715
NCT00042874|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-06-03|||May 2002||2002-05-01|June 2013|2013-06-01||||January 2009|Actual|2009-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study of Alvocidib (Flavopiridol) Administered With Irinotecan (CPT-11) and Fluorouracil/Leucovorin in Patients With Advanced Solid Tumors|Completed||Phase 1|77|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:04:39.510338|2017-02-18 18:04:39.510338
NCT00042861|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2015-04-29|||August 2002||2002-08-01|April 2003|2003-04-01||||||||Interventional|||UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Pharmacologic Trial Of Infusional UCN-01 Given With A Weekly Schedule Of 5-Fluorouracil And Leucovorin|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:39.624121|2017-02-18 18:04:39.624121
NCT00042848|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2015-10-13|||August 2002||2002-08-01|October 2015|2015-10-01|October 2007|Actual|2007-10-01|April 2007|Actual|2007-04-01||Interventional|||Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer|Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of The Effect Of Modafinil On Fatigue In Cancer Patients Receiving Chemotherapy|Completed||Phase 3|837|Anticipated|University of Rochester|||||f||||t||||||||||2017-02-18 18:04:39.723889|2017-02-18 18:04:39.723889
NCT00042835|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-01-31|||May 2002||2002-05-01|January 2013|2013-01-01||||December 2008|Actual|2008-12-01||Interventional|||Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer|A Phase I Study Of OSI-774 (NSC #718781)-Based Multimodality Therapy For Inoperable Stage III Non Small Cell Lung Cancer|Terminated||Phase 1|48|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 18:04:39.865057|2017-02-18 18:04:39.865057
NCT00042822|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2011-05-14|||May 2002||2002-05-01|December 2009|2009-12-01||||March 2005|Actual|2005-03-01||Interventional|||FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma|A Pilot Study Of FR901228, Or Depsipeptide (NSC #630176) For Adult Patients With Advanced Hematologic Cancers|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:39.994963|2017-02-18 18:04:39.994963
NCT00042809|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-01-23|||May 2002||2002-05-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors|Phase I Study To Determine The Safety, Tolerance And Preliminary Antineoplastic Activity Of Combined EGFR (erbB1) And HER2 (erbB2) Blockade, With OSI-774 And Trastuzumab, In Combination With Weekly Paclitaxel|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:04:40.092084|2017-02-18 18:04:40.092084
NCT00042796|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-01-22|||December 2002||2002-12-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|A Phase I Study Of Decitabine (DAC) (IND # 50733) In Children With Relapsed Or Refractory Acute Leukemia|Terminated||Phase 1|21|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:04:40.218712|2017-02-18 18:04:40.218712
NCT00042783|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2013-06-21|||September 2002||2002-09-01|April 2004|2004-04-01|March 2006|Actual|2006-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|A Phase II Trial Of A D1/3-MAGE3-HIS Fusion Protein (NSC-719274) With Adjuvant SBAS02B (NSC-719275) For Patients With Stage IV, M1a or M1b Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:40.33428|2017-02-18 18:04:40.33428
NCT00042770|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2016-07-01|||May 2002||2002-05-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|February 2005|Actual|2005-02-01||Interventional|||Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer|Phase III Comparison of Catheter Based Therapy of Pleural Effusions in Cancer Patients (Optimal Pleural Effusion Control, OPEC)|Completed||Phase 3|67|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:04:40.434996|2017-02-18 18:04:40.434996
NCT00042731|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2012-09-21|||July 2002||2002-07-01|September 2012|2012-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy|A Randomized Pilot Clinical Trial Of The Action Of Isoflavones And Lycopene In Localized Prostate Cancer: Administration Prior To Radical Prostatectomy|Completed||N/A|79|Actual|H. Lee Moffitt Cancer Center and Research Institute||3|||f||||f||||||||||2017-02-18 18:04:40.543907|2017-02-18 18:04:40.543907
NCT00042718|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2010-04-26|||November 2001||2001-11-01|April 2010|2010-04-01|August 2003|Actual|2003-08-01|||||Interventional|||A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.||Completed||Phase 3|659|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 18:04:40.663651|2017-02-18 18:04:40.663651
NCT00042705|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2015-04-13|||May 2000||2000-05-01|April 2015|2015-04-01|May 2012|Actual|2012-05-01|May 2012|Actual|2012-05-01||Observational|||Asthma Severity in Children and Environmental Agents||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:40.753326|2017-02-18 18:04:40.753326
NCT00042120|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2014-09-26|||April 2001||2001-04-01|August 2009|2009-08-01||||July 2011|Actual|2011-07-01||Observational|FAME||Farming and Movement Evaluation Study (FAME)|Pesticides and Risk in the Agricultural Health Study|Completed||N/A|520|Actual|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:40.829297|2017-02-18 18:04:40.829297
NCT00042107|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2014-09-26|||September 2000||2000-09-01|July 2002|2002-07-01|June 2005||2005-06-01|||||Observational|||Molecular Epidemiology of Parkinson's Disease||Completed||N/A|2022|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:40.918072|2017-02-18 18:04:40.918072
NCT00042094|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-23|2011-06-29|||March 2002||2002-03-01|June 2011|2011-06-01|March 2003||2003-03-01|||||Interventional|||Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®|A Phase 1 Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation (Take Rate) of a Cell-Cultured Smallpox Vaccine (CCSV) Compared to a Calf Lymph Vaccine (Dryvax®)|Completed||Phase 1|350||DynPort Vaccine Company LLC, A CSC Company|||||||||||||||||||2017-02-18 18:04:41.182144|2017-02-18 18:04:41.182144
NCT00042081|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-22|2006-05-04|||July 2002||2002-07-01|July 2005|2005-07-01|February 2005||2005-02-01|||||Interventional|||Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures|A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment With CGT003 of Coronary Vein Grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures|Completed||Phase 3|3000||Anesiva, Inc.|||||||||||||||||||2017-02-18 18:04:41.27249|2017-02-18 18:04:41.27249
NCT00042068|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-22|2013-10-31|||June 2002||2002-06-01|October 2013|2013-10-01|July 2003||2003-07-01|||||Interventional|||A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis|A Multi-center, Double-Blind, Randomized, Parallel-Group Trial to Compare the Efficacy and Safety of Three Doses of Meloxicam (7.5, 15, and 22.5 mg) and Placebo in Patients With Rheumatoid Arthritis|Completed||Phase 3|1000||Boehringer Ingelheim|||||f||||||||||||||2017-02-18 18:04:41.727817|2017-02-18 18:04:41.727817
NCT00042055|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-22|2011-10-14|||July 2002||2002-07-01|October 2011|2011-10-01|September 2003|Actual|2003-09-01|||||Interventional|||CP-461 for the Treatment of Crohn's Disease|A Phase II Pilot Study of CP-461 in the Treatment of Moderately to Severely Active Crohn's Disease|Completed||Phase 2|30||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:04:41.979416|2017-02-18 18:04:41.979416
NCT00042042|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-22|2005-06-23||||||July 2002|2002-07-01||||||||Interventional|||Screening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic|Screening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic|Unknown status|Recruiting|N/A|400||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:04:42.076563|2017-02-18 18:04:42.076563
NCT00042029|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-22|2015-08-07|||June 2002||2002-06-01|August 2015|2015-08-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)|A Double-Blind, Multicenter, Placebo-Controlled Study of MK0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|324|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:04:42.154768|2017-02-18 18:04:42.154768
NCT00042016|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-19|2009-10-12|||July 2002||2002-07-01|June 2005|2005-06-01||||||||Interventional|||Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)|A Phase II, Multicenter Study of Decitabine (5-aza-2'Deoxycytidine) in Chronic Myelogenous Leukemia Chronic Phase Refractory to Imatinib Mesylate (STI 571)|Completed||Phase 2|40||Astex Pharmaceuticals|||||||||||||||||||2017-02-18 18:04:42.241187|2017-02-18 18:04:42.241187
NCT00042003|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-19|2013-01-22|||July 2002||2002-07-01|June 2008|2008-06-01||||December 2004|Actual|2004-12-01||Interventional|||Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)|A Phase II, Multicenter Study of Decitabine (5-aza-2'Deoxycytidine) in Chronic Myelogenous Leukemia Blast Phase Refractory to Imatinib Mesylate (STI 571)|Completed||Phase 2|40||Astex Pharmaceuticals|||||f||||f||||||||||2017-02-18 18:04:42.33191|2017-02-18 18:04:42.33191
NCT00041990|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-19|2007-12-12|||July 2002||2002-07-01|December 2007|2007-12-01||||||||Interventional|||Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)|A Phase II, Multicenter Study of Decitabine (5-Aza-2'Deoxycytidine) in Chronic Myelogenous Leukemia Accelerated Phase Refractory to Imatinib Mesylate (STI 571)|Completed||Phase 2|40||Astex Pharmaceuticals|||||||||||||||||||2017-02-18 18:04:42.427302|2017-02-18 18:04:42.427302
NCT00041977|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-19|2005-06-23|||June 2002||2002-06-01|November 2003|2003-11-01||||||||Interventional|||Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets [Periostat(R)] Administered Twice Daily for the Treatment of Acne Rosacea|Completed||Phase 3|150||CollaGenex Pharmaceuticals|||||||||||||||||||2017-02-18 18:04:42.521401|2017-02-18 18:04:42.521401
NCT00041964|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-19|2012-07-23||||||July 2012|2012-07-01||||||||Observational|||A Study of HIV Levels During Pregnancy and After Childbirth|A Prospective Observational Study of Virologic and Immunologic Changes in HIV-Infected Women During the Postpartum Period|Completed||N/A|129||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:04:42.615863|2017-02-18 18:04:42.615863
NCT00042692|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-05|2006-03-22|||March 2001||2001-03-01|March 2006|2006-03-01|March 2002||2002-03-01|||||Observational|||Catechol Thioethers in Parkinson's Disease||Completed||N/A|20||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:42.743353|2017-02-18 18:04:42.743353
NCT00042679|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-02|2006-07-18|||June 2002||2002-06-01|July 2006|2006-07-01||||||||Interventional|||A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.|A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.|Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:04:42.803776|2017-02-18 18:04:42.803776
NCT00042666|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-02|2009-10-16||2009-10-16|June 2002||2002-06-01|October 2009|2009-10-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.|A Phase 2 Evaluation of Oral LY317615 in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma|Completed||Phase 2|55|Actual|Eli Lilly and Company||1|||f||||f||||||||||2017-02-18 18:04:42.893537|2017-02-18 18:04:42.893537
NCT00042653|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-02|2013-05-06|||May 2002||2002-05-01|May 2013|2013-05-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis|A Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of an Oral Calcimimetic Agent (AMG 073) in Secondary Hyperparathyroidism of Chronic Kidney Disease (Hemodialysis and Peritoneal Dialysis)|Completed||Phase 3|380|Anticipated|Amgen||2|||f||||||||||||||2017-02-18 18:04:42.984397|2017-02-18 18:04:42.984397
NCT00042627|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-01|2017-01-24|||July 30, 2002||2002-07-30|June 25, 2007|2007-06-25|June 25, 2007||2007-06-25|||||Observational|||Prevalence and Risk of Cataracts in Granulocyte Donors|Prevalence and Risks for Posterior Subcapsular Cataracts in Volunteer Granulocytapheresis Donors|Completed||N/A|252||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:43.084579|2017-02-18 18:04:43.084579
NCT00042614|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-01|2017-01-24|||July 30, 2002||2002-07-30|October 25, 2016|2016-10-25||||||||Observational|||Study of Heart Transplant Rejection|Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy|Recruiting||N/A|482|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:43.274427|2017-02-18 18:04:43.274427
NCT00042601|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-01|2015-10-20|||July 2002||2002-07-01|October 2015|2015-10-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Evaluation of the Effect of Pramlintide on Satiety and Food Intake|A Single Center, Randomized, Double-blind, Placebo-controlled, Two-period, Crossover Study Evaluating the Acute Effect of Pramlintide on Satiety and Food Intake in Normal-weight and Obese Non-diabetic Subjects and in Insulin Treated Subjects With Type 1 and Type 2 Diabetes Mellitus|Completed||Phase 2|51|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 18:04:43.372294|2017-02-18 18:04:43.372294
NCT00042588|ClinicalTrials.gov processed this data on February 17, 2017|2002-08-01|2005-06-23|||May 2002||2002-05-01|January 2004|2004-01-01||||||||Interventional|||A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis|A Phase 2 Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis|Completed||Phase 2|||ICOS Corporation|||||||||||||||||||2017-02-18 18:04:43.462847|2017-02-18 18:04:43.462847
NCT00042575|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-31|2006-07-18|||June 2002||2002-06-01|July 2006|2006-07-01|August 2002||2002-08-01|||||Interventional|||Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression|Protocol F1J-US-HMBY Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression|Completed||Phase 3|120||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:04:43.542243|2017-02-18 18:04:43.542243
NCT00042445|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-30|2006-09-01|||August 2000||2000-08-01|September 2006|2006-09-01|July 2005||2005-07-01|||||Observational|||Brain Neoplasms, Leukemia and Petrochemical Exposures||Completed||N/A|1456||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:53.719977|2017-02-18 18:04:53.719977
NCT00042562|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-31|2006-07-18|||December 2002||2002-12-01|July 2006|2006-07-01|December 2003||2003-12-01|||||Interventional|||Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression|Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:04:43.625927|2017-02-18 18:04:43.625927
NCT00042549|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-31|2005-06-23|||May 2002||2002-05-01|June 2003|2003-06-01||||||||Interventional|||Lithotripsy for the Treatment of Gallstones|Biliary Lithotripsy in Combination With Actigall Versus Actigall Monotherapy for the Treatment of Symptomatic Cholesterol Gallstones|Terminated||Phase 4|184||Medstone International|||||||||||||||||||2017-02-18 18:04:43.722108|2017-02-18 18:04:43.722108
NCT00042536|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-31|2008-03-03|||July 2002||2002-07-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Observational|||Effects of Yohimbine and Naltrexone on Sexual Function|Effects of Alpha-2 Adrenergic and Opiate Receptor Blockade on Sexual Function in Healthy Male Volunteers|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:44.015008|2017-02-18 18:04:44.015008
NCT00042523|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-31|2008-03-03|||July 2002||2002-07-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus|Role of the Antibody Against NR2 Glutamate Receptor in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus|Completed||N/A|61||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:44.103547|2017-02-18 18:04:44.103547
NCT00042510|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-31|2014-08-27|||August 2000||2000-08-01|August 2014|2014-08-01|July 2004|Actual|2004-07-01|February 2003|Actual|2003-02-01||Interventional|||Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer|Open-Label,Multicenter Study of G17DT Immunogen in Combination w/ Cisplatin and 5-FU in Subjects w/ Metastatic or Locally Recurrent Gastric or Gastroesophageal Cancer Previously Untreated With Chemotherapy.|Completed||Phase 2|103|Actual|Cancer Advances Inc.||1|||f||||f||||||||||2017-02-18 18:04:44.196435|2017-02-18 18:04:44.196435
NCT00042497|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-30|2005-06-23|||July 2002||2002-07-01|September 2002|2002-09-01||||||||Interventional|||Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma|A Phase II, Multicenter, Open-Labeled Study of Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma|Suspended||Phase 2|60||Anosys|||||||||||||||||||2017-02-18 18:04:44.287958|2017-02-18 18:04:44.287958
NCT00041951|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-19|2016-05-31|||December 1998||1998-12-01|May 2016|2016-05-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Observational|||Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study|Search for Genes Influencing Childhood Absence Epilepsy Study|Completed||N/A|185|Actual|Icahn School of Medicine at Mount Sinai|||2||f||||f||||||Samples With DNA|"~     saliva~   "|||2017-02-18 18:04:44.549027|2017-02-18 18:04:44.549027
NCT00041938|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-19|2014-08-29|2013-01-03||October 2002||2002-10-01|August 2014|2014-08-01|July 2014|Actual|2014-07-01|August 2011|Actual|2011-08-01||Interventional|WARCEF||Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial|Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial|Completed||Phase 3|2305|Actual|Columbia University||2|||f||||t||||||||||2017-02-18 18:04:44.66034|2017-02-18 18:04:44.66034
NCT00041925|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-18|2005-07-14|||November 2001||2001-11-01|July 2005|2005-07-01|November 2004||2004-11-01|||||Interventional|||Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures|A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment With CGT003 of Peripheral Vein Grafts in Patients Undergoing Peripheral Arterial Bypass Graft Procedures|Completed||Phase 2/Phase 3|1400||Anesiva, Inc.|||||||||||||||||||2017-02-18 18:04:45.829544|2017-02-18 18:04:45.829544
NCT00041899|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-18|2008-03-03|||May 2002||2002-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914|Pharmacokinetic Comparison of Two Preparations of the Selective Progesterone Receptor Modular CDB2914|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:46.155494|2017-02-18 18:04:46.155494
NCT00041886|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-18|2008-03-03|||July 2002||2002-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Radiofrequency Ablation of Painful Soft Tissue Neoplasms|Radiofrequency Ablation of Painful Soft Tissue Neoplasms|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:46.239798|2017-02-18 18:04:46.239798
NCT00041860|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-18|2005-06-23||||||July 2002|2002-07-01||||||||Interventional|||Modulation of Benzene Metabolism by Exposure to Environment||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:46.320552|2017-02-18 18:04:46.320552
NCT00041093|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-12-07|||June 2002||2002-06-01|December 2016|2016-12-01||||October 2008|Actual|2008-10-01||Interventional|||Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation Of Docetaxel (NSC #628503) In The Treatment Of Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix|Completed||Phase 2|27|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:04:46.394953|2017-02-18 18:04:46.394953
NCT00041080|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2014-04-29|2013-07-09||February 2003||2003-02-01|January 2013|2013-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional||"Description of population is based on eligible patients.~1 patient not included in characteristics due to ineligible primary tumor site."|Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Randomized Study Of Tamoxifen Versus Thalidomide (NSC# 66847) In Patients With Biochemical-Recurrence-Only Epithelial Ovarian Cancer, Cancer Of The Fallopian Tube, And Primary Peritoneal Carcinoma After First Line Chemotherapy|Completed||Phase 3|139|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:04:46.509794|2017-02-18 18:04:46.509794
NCT00041067|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-05-20|2012-11-15||September 2002||2002-09-01|May 2013|2013-05-01|January 2012|Actual|2012-01-01|January 2008|Actual|2008-01-01||Interventional|||S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer|Docetaxel (NSC-628503) And Vinorelbine (NSC-608210) Plus Filgrastim (NSC-614629) With Weekly Trastuzumab (NSC-688097) For HER-2 Positive, Stage IV Breast Cancer|Completed||Phase 2|76|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:04:47.065084|2017-02-18 18:04:47.065084
NCT00041054|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-12-05|||June 2002||2002-06-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|August 2004|Actual|2004-08-01||Interventional|||Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer|Completed||Phase 2|41|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:04:50.47007|2017-02-18 18:04:50.47007
NCT00041041|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-02-19|||June 2002||2002-06-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation Of Gleevec (Imatinib Mesylate) (IND #61135, NSC #716051) In The Treatment Of Persistent Or Recurrent Epithelial Ovarian Or Primary Peritoneal Carcinoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:04:50.932324|2017-02-18 18:04:50.932324
NCT00041028|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2015-04-30|||May 2002||2002-05-01|September 2006|2006-09-01|April 2014|Actual|2014-04-01|September 2007|Actual|2007-09-01||Interventional|||EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer|Pilot Phase II Research Study of EF5 to Measure Tumor Hypoxia in Patients With Non-Small Cell Lung Cancer|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:04:51.045197|2017-02-18 18:04:51.045197
NCT00041015|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2014-01-08|||September 2001||2001-09-01|January 2014|2014-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment For Chemotherapy-Naive Patients With Extensive Disease - Small Cell Lung|Completed||Phase 3|4|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:04:51.136985|2017-02-18 18:04:51.136985
NCT00040989|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer|Phase II Study of BAY 56-3722 in Patients With Recurrent, Unresectable, or Metastatic Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:51.250936|2017-02-18 18:04:51.250936
NCT00040950|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-12-18|||March 2002||2002-03-01|July 2003|2003-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Multi-Center, Phase I, Open Label, Two Arm, Non-Randomized, Dose-Escalation, Study Of The Safety And Tolerability Of CPG 7909 In Patients Receiving Rituxan For Relapsed Or Refractory B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:04:51.373056|2017-02-18 18:04:51.373056
NCT00040937|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-10-26|2012-10-31||June 2002||2002-06-01|October 2016|2016-10-01|October 2015|Actual|2015-10-01|October 2008|Actual|2008-10-01||Interventional|||S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma|A Phase II Trial Of Thalidomide/Dexamethasone Induction Followed By Tandem Melphalan Transplant And Prednisone/Thalidomide Maintenance (A BMT Study)|Completed||Phase 2|147|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:04:51.497056|2017-02-18 18:04:51.497056
NCT00040911|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-05-29|||April 2005||2005-04-01|May 2013|2013-05-01|January 2011|Actual|2011-01-01|October 2009|Actual|2009-10-01||Interventional|||Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma|A Randomized Study Of Electroacupuncture Treatment For Delayed Chemotherapy-Induced Nausea And Vomiting In Patients With Pediatric Solid Tumors|Completed||N/A|17|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:04:52.415192|2017-02-18 18:04:52.415192
NCT00040898|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-01-17|||January 2001||2001-01-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed|Sho-Saiko-To After Ablation for Non-Resectable Hepatocellular Carcinoma (HCC): A Phase II Trial With Historical Control|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:04:52.537866|2017-02-18 18:04:52.537866
NCT00040885|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-12-05|||October 2002||2002-10-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|February 2006|Actual|2006-02-01||Interventional|||Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)|Docetaxel And Infliximab/Placebo In Non-Small Cell Lung Cancer (NSCLC) Patients Greater Than Or Equal To 65 Years Of Age Or In NSCLC Patients With Poor Performance Status: A Double-Blind Randomized, Placebo-Controlled Trial To Prevent And Treat Wasting, Anorexia, And Asthenia In Chemotherapy-Naive And Previously-Treated Patients|Completed||Phase 3|67|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:04:52.633834|2017-02-18 18:04:52.633834
NCT00040872|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-03-06|||June 2000||2000-06-01|March 2013|2013-03-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Multiple Therapies in Treating Patients With Advanced Neuroblastoma|N8: Dose-Intensive Chemotherapy Plus Biologics in the Treatment of Neuroblastoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:04:52.934432|2017-02-18 18:04:52.934432
NCT00040859|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-12-05|||September 2002||2002-09-01|December 2016|2016-12-01|April 2008|Actual|2008-04-01|January 2005|Actual|2005-01-01||Interventional|||Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer|A Phase II Study of Oxaliplatin and Capecitabine in Patients With Measurable Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:04:53.299429|2017-02-18 18:04:53.299429
NCT00042484|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-30|2015-04-13||||||April 2015|2015-04-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Community Organizing Network for Environmental Health||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:53.418076|2017-02-18 18:04:53.418076
NCT00042471|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-30|2015-09-22|||June 2002||2002-06-01|August 2015|2015-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Evaluation of the Bioavailability of Pramlintide||Completed||Phase 2|75|Actual|AstraZeneca||1|||f||||||||||||||2017-02-18 18:04:53.494125|2017-02-18 18:04:53.494125
NCT00042458|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-30|2015-09-22|||April 2002||2002-04-01|August 2015|2015-08-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control|A Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Investigate the Safety of Pramlintide Treatment Employing Pramlintide Dose-Titration Followed by Insulin Dose Optimization in Subjects With Type 1 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Intensive Insulin Therapy|Completed||Phase 3|296|Actual|AstraZeneca||2|||f||||f||||||||||2017-02-18 18:04:53.598792|2017-02-18 18:04:53.598792
NCT00042432|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-29|2013-05-09|2010-11-04||June 2002||2002-06-01|May 2013|2013-05-01|August 2003|Actual|2003-08-01|March 2003|Actual|2003-03-01||Interventional|||Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients|A Study of an Investigational Medication for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients|Completed||Phase 2|54|Actual|Amgen||2|||f||||||||||||||2017-02-18 18:04:53.815158|2017-02-18 18:04:53.815158
NCT00042419|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-29|2006-09-01|||March 2002||2002-03-01|September 2006|2006-09-01|July 2003||2003-07-01|||||Observational|||Work and Health Disparities Among Rural Women||Completed||N/A|150||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:54.346018|2017-02-18 18:04:54.346018
NCT00042406|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-29|2012-12-05|||September 2002||2002-09-01|December 2012|2012-12-01||||September 2002|Actual|2002-09-01||Interventional|||Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-alpha Blocker|A Double-Blind, Placebo-Controlled, Randomized, Parallel Group Clinical Trial of Anti-CD4 Receptor Human Monoclonal Antibody (HuMax-CD4) in Patients With Active RA Failing Treatment With Methotrexate and TNF-alpha Blocking Agents|Terminated||Phase 2/Phase 3|75|Actual|Emergent Product Development Seattle LLC||3|||f||||||||||||||2017-02-18 18:04:54.421471|2017-02-18 18:04:54.421471
NCT00042393|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-27|2014-01-03||||||January 2014|2014-01-01||||||||Expanded Access|||An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options|A Phase 3b, Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B Who Have Limited Treatment Options|Approved for marketing||Phase 3|||Gilead Sciences|||||||||||||||||||2017-02-18 18:04:54.580275|2017-02-18 18:04:54.580275
NCT00042380|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2008-03-03|||July 2002||2002-07-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Interventional|||Examination of a Soy-Based Supplement for Major Depression|A Phase 2A Study of Soy Isoflavones in the Treatment of Major Depression|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:54.667399|2017-02-18 18:04:54.667399
NCT00042367|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2012-02-10|||April 2000||2000-04-01|February 2012|2012-02-01|June 2006|Actual|2006-06-01|December 2005|Actual|2005-12-01||Interventional|BB'98||Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors|Pilot Study of Systemic and Intrathecal Chemotherapy Followed by Conformal Radiation for Infants With Brain Tumors|Completed||N/A|119|Actual|Baylor College of Medicine||1|||f||||t||||||||||2017-02-18 18:04:54.755834|2017-02-18 18:04:54.755834
NCT00042354|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2015-03-04|||May 2002||2002-05-01|March 2015|2015-03-01|August 2004|Actual|2004-08-01|||||Interventional|||Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients|A Phase II, Open Label Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myelogenous Leukemia|Completed||Phase 2|40||Sanofi|||||||||||||||||||2017-02-18 18:04:54.863251|2017-02-18 18:04:54.863251
NCT00042341|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2014-03-17|||May 2002||2002-05-01|March 2014|2014-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)|A Phase II, Open Label Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia|Completed||Phase 2|60||Sanofi|||||||||||||||||||2017-02-18 18:04:54.977004|2017-02-18 18:04:54.977004
NCT00042328|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2015-08-20|||August 2001||2001-08-01|August 2015|2015-08-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients|A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients|Completed||Phase 2|30||Baylor College of Medicine|||||f||||t||||||||||2017-02-18 18:04:55.087491|2017-02-18 18:04:55.087491
NCT00042315|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2012-05-22|||June 2002||2002-06-01|May 2012|2012-05-01|June 2003||2003-06-01|June 2003||2003-06-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)||Terminated||Phase 3|490||QLT Inc.|||||f||||||||||||||2017-02-18 18:04:55.170397|2017-02-18 18:04:55.170397
NCT00042302|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2012-05-22|||June 2002||2002-06-01|May 2012|2012-05-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)||Terminated||Phase 3|540||QLT Inc.|||||f||||||||||||||2017-02-18 18:04:55.2435|2017-02-18 18:04:55.2435
NCT00042289|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2017-02-06|||March 2003||2003-03-01|February 2017|2017-02-01||||June 2018|Anticipated|2018-06-01||Interventional|||Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy|Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and Postpartum|Recruiting||Phase 4|1786|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||5|||f||||||||||||||2017-02-18 18:04:55.319062|2017-02-18 18:04:55.319062
NCT00042276|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-26|2017-01-24|||July 14, 2002||2002-07-14|March 15, 2013|2013-03-15|March 15, 2013||2013-03-15|||||Observational|||The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time|The Natural History of Upper Trapezius Myofascial Trigger Points: Comparison of Local and Remote Tissue Milieu in Normal Muscle, Latent and Active Myofascial Trigger Points Over Time|Completed||N/A|88|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:04:55.897794|2017-02-18 18:04:55.897794
NCT00042263|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-25|2006-09-01|||April 2002||2002-04-01|September 2006|2006-09-01||||||||Observational|||Healthy Environments Partnership|Social and Physical Environments and Health Disparities|Completed||N/A|1000||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:55.986201|2017-02-18 18:04:55.986201
NCT00042250|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2012-01-20|||May 1992||1992-05-01|January 2012|2012-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||IUdR/BUdR Cell Cycle Labelling|Cell Cycle Kinetics in Vivo in Patients With Hematologic Malignancies Studied by Iododeoxyuridine and Bromodeoxyuridine Labelling|Completed||N/A|28|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-02-18 18:04:56.054094|2017-02-18 18:04:56.054094
NCT00042237|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2013-08-20|||September 2001||2001-09-01|August 2013|2013-08-01||||||||Interventional|||Treatment of Depressed Women Who Have Been Sexually Abused|Treatment of Women With Depression and Sexual Abuse|Completed||Phase 1|24||Butler Hospital|||||f||||||||||||||2017-02-18 18:04:56.153602|2017-02-18 18:04:56.153602
NCT00042224|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2015-09-15|2015-04-09||December 2000||2000-12-01|September 2015|2015-09-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Electroconvulsive Therapy in Clozapine Refractory Schizophrenia|ECT in Clozapine Refractory Schizophrenia|Completed||Phase 1/Phase 2|39|Actual|Northwell Health||2|||f||||t||||||||||2017-02-18 18:04:56.243547|2017-02-18 18:04:56.243547
NCT00042211|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2014-01-07|||February 2001||2001-02-01|February 2008|2008-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Preventing Depression in Patients With Macular Degeneration|Preventing Depression in Macular Degeneration|Completed||Phase 3|206|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 18:04:56.62505|2017-02-18 18:04:56.62505
NCT00042198|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2013-07-01|||December 2001||2001-12-01|July 2013|2013-07-01|August 2006|Actual|2006-08-01|December 2005|Actual|2005-12-01||Interventional|||Treatment of Depression After Coronary Bypass Surgery|Treatment of Depression After Coronary Bypass Surgery|Completed||N/A|123|Actual|Washington University School of Medicine||3|||f||||t||||||||||2017-02-18 18:04:56.73502|2017-02-18 18:04:56.73502
NCT00042185|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2013-09-26|||February 2001||2001-02-01|September 2013|2013-09-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Eating Disorder Prevention Programs|Austin Body Acceptance Study|Completed||N/A|450||University of Texas at Austin||4|||f||||||||||||||2017-02-18 18:04:56.84921|2017-02-18 18:04:56.84921
NCT00042172|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2014-02-27|||June 2002||2002-06-01|February 2014|2014-02-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Treatment for Early Memory Loss|Cognitive Enhancers Explored With PET Imaging|Completed||Phase 4|40||University of Iowa|||||f||||||||||||||2017-02-18 18:04:56.953536|2017-02-18 18:04:56.953536
NCT00042159|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2013-08-02|||July 2002||2002-07-01|August 2013|2013-08-01|June 2004|Actual|2004-06-01|July 2003|Actual|2003-07-01||Interventional|||Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations|TMS Intervention Development for Auditory Hallucinations|Completed||N/A|50|Actual|Yale University||1|||f||||t||||||||||2017-02-18 18:04:57.050557|2017-02-18 18:04:57.050557
NCT00042146|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2013-05-17|||December 2001||2001-12-01|May 2013|2013-05-01||||||||Interventional|||Behavioral and Pharmacological Treatment for Insomnia|Behavioral and Pharmacological Treatment for Insomnia|Completed||Phase 4|160||Laval University|||||f||||||||||||||2017-02-18 18:04:57.157015|2017-02-18 18:04:57.157015
NCT00042133|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-24|2015-04-13|||April 2001||2001-04-01|April 2015|2015-04-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Socio-economic Status and Age-related Disability in a Biracial Community||Completed||N/A|6000|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:57.242836|2017-02-18 18:04:57.242836
NCT00041847|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-18|2015-04-14|||July 2001||2001-07-01|April 2015|2015-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Observational|||Gene-Environment Interaction in Prostate Cancer|Gene-Environment Interaction in Prostate Cancer|Completed||N/A|881|Actual|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:57.313504|2017-02-18 18:04:57.313504
NCT00041834|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-18|2005-06-23|||September 2000||2000-09-01|July 2002|2002-07-01|August 2003||2003-08-01|||||Observational|||Geographic Modeling of Traffic and Asthma Rates||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:57.380623|2017-02-18 18:04:57.380623
NCT00041821|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-18|2006-03-22|||September 2000||2000-09-01|March 2006|2006-03-01||||||||Interventional|||Nasal Irritation Study: Individual Factors in Nasal Irritant Sensitivity|Individual Factors in Nasal Irritant Sensitivity|Completed||N/A|64||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:04:57.458918|2017-02-18 18:04:57.458918
NCT00041808|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-17|2005-06-23|||July 2001||2001-07-01|February 2003|2003-02-01|April 2003||2003-04-01|||||Interventional|||Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver|A Phase I/II Single Dose Trial to Determine The Safety, Tolerance, Pharmacokinetic Profile, and Preliminary Activity of Intrahepatic Delivery (Via Hepatic Artery Catheterization) of Doxorubicin Hydrochloride Adsorbed to Magnetic Targeted Carriers ( MTC-DOX) in Patients With Metastatic Cancer to the Liver .|Completed||Phase 1/Phase 2|20||FeRx|||||||||||||||||||2017-02-18 18:04:57.543901|2017-02-18 18:04:57.543901
NCT00041795|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-16|2005-06-23|||January 2002||2002-01-01|July 2002|2002-07-01||||||||Interventional|||Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy|A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Neotrofin to Treat Patients With Sensory or Motor Neuropathy Caused by Chemotherapy for Cancer|Completed||Phase 2|50||NeoTherapeutics|||||||||||||||||||2017-02-18 18:04:57.631498|2017-02-18 18:04:57.631498
NCT00041782|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-16|2012-07-27|||October 2000||2000-10-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients|Outpatient Treatment Of Deep Venous Thrombosis (DVT) Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients|Terminated||Phase 2|26|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 18:04:57.71658|2017-02-18 18:04:57.71658
NCT00041769|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-16|2010-07-12|||June 2002||2002-06-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|April 2007|Actual|2007-04-01||Interventional|||Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor|A Phase II Randomized Controlled Trial Evaluating the Impact of Therapeutic Drug Monitoring (TDM) on Virologic Response to a Salvage Regimen in Subjects With a Normalized Inhibitory Quotient (NIQ) Less Than or Equal to 1 to One or More Protease Inhibitors|Completed||Phase 3|360||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:04:57.834809|2017-02-18 18:04:57.834809
NCT00041756|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-16|2011-11-07|2011-08-03||July 2002||2002-07-01|November 2011|2011-11-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis|Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis|Completed||Phase 2|395|Actual|Procter and Gamble||5|||f||||f||||||||||2017-02-18 18:04:57.993089|2017-02-18 18:04:57.993089
NCT00041743|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-16|2010-01-12|||July 2002||2002-07-01|January 2010|2010-01-01|December 2007|Actual|2007-12-01|||||Interventional|||Treatment of Binge Eating Disorder|Treatment of Binge Eating Disorder|Completed||N/A|200||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:04:59.128543|2017-02-18 18:04:59.128543
NCT00041730|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-15|2009-09-29|||July 2002||2002-07-01|October 2004|2004-10-01||||||||Interventional|||Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma|Phase II Trial of Rituxan(R) Plus FavId(TM) (Tumor-Specific Idiotype-KLH) and GM-CSF Immunotherapy in Patients With Grade 1 or 2 Follicular B-Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|90||Favrille|||||||||||||||||||2017-02-18 18:04:59.45922|2017-02-18 18:04:59.45922
NCT00041275|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-09-19|||May 2002||2002-05-01|September 2002|2002-09-01|August 2011|Actual|2011-08-01|June 2007|Actual|2007-06-01||Interventional|||Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery|Randomized Double Blind Trial Of Megestrol Acetate Versus Placebo For The Treatment Of Inoperable Hepatocellular Carcinoma|Completed||Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:04.00295|2017-02-18 18:05:04.00295
NCT00041717|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-12|2013-04-25|2013-02-26||July 2002||2002-07-01|April 2013|2013-04-01|May 2004|Actual|2004-05-01|February 2004|Actual|2004-02-01||Interventional|||Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury|Double-Blind, Placebo-Controlled, 12-Week Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Moderate to Severe Spasticity Resulting From Chronic, Incomplete Spinal Cord Injury|Completed||Phase 3|213|Actual|Acorda Therapeutics||2|||f||||t||||||||||2017-02-18 18:04:59.569503|2017-02-18 18:04:59.569503
NCT00041704|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-12|2008-10-17|||August 2002||2002-08-01|October 2008|2008-10-01|August 2004|Actual|2004-08-01|||||Interventional|||The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)|A Phase 2 Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis.|Completed||Phase 2|19|Actual|Pfizer|||||f||||||||||||||2017-02-18 18:05:00.187916|2017-02-18 18:05:00.187916
NCT00041691|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-12|2005-06-23||||||January 2003|2003-01-01||||||||Interventional|||Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery|A Phase I, Single Dose Escalating Study to Investigate the Tolerability, Pharmacokinetics and Dosimetry of 90 Y-Humanized MN-14 IgG in Colorectal Cancer Patients With Limited Residual Disease After Primary or Salvage Surgery|Terminated||Phase 1|30||Immunomedics, Inc.|||||||||||||||||||2017-02-18 18:05:00.289657|2017-02-18 18:05:00.289657
NCT00041678|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-12|2013-11-07|||January 2000||2000-01-01|September 2007|2007-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:05:00.369715|2017-02-18 18:05:00.369715
NCT00041665|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-11|2013-05-06||||||May 2013|2013-05-01||||||||Interventional|||Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy|A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Recombinant Human Keratinocyte Growth Factor for Reduction of Mucositis in Patients With Hematologic Malignancies Undergoing Total Body Irradiation and High-dose Chemotherapy With Autologous PBPC Transplantation|Completed||Phase 3|||Amgen|||||||||||||||||||2017-02-18 18:05:00.458339|2017-02-18 18:05:00.458339
NCT00041652|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-11|2005-10-21|||February 2000||2000-02-01|October 2005|2005-10-01|June 2003||2003-06-01|||||Interventional|||Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer|A Phase I/II Clinical Trial of Immunotherapy With Humanized MN-14 IgG in Recurrent, Metastatic, Unresectable Colorectal and Breast Carcinomas|Completed||Phase 1/Phase 2|30||Immunomedics, Inc.|||||||||||||||||||2017-02-18 18:05:00.556873|2017-02-18 18:05:00.556873
NCT00041639|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-11|2005-06-23|||January 2000||2000-01-01|January 2004|2004-01-01|December 2003||2003-12-01|||||Interventional|||Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer|A Phase I/II Study of Radioimmunotherapy With 90Y-Humanized MN-14 IgG Administered as a Single Dose to Patients With Refractory Advanced/Metastatic Pancreatic Carcinoma|Completed||Phase 1/Phase 2|75||Immunomedics, Inc.|||||||||||||||||||2017-02-18 18:05:00.638533|2017-02-18 18:05:00.638533
NCT00041626|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-11|2007-09-10||||||September 2007|2007-09-01||||||||Interventional|||Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone||Unknown status|Recruiting|Phase 3|||Introgen Therapeutics|||||||||||||||||||2017-02-18 18:05:00.735329|2017-02-18 18:05:00.735329
NCT00041613|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-11|2008-03-28||||||March 2008|2008-03-01||||||||Interventional|||Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate||Unknown status|Recruiting|Phase 3|||Introgen Therapeutics|||||||||||||||||||2017-02-18 18:05:00.818429|2017-02-18 18:05:00.818429
NCT00041600|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-11|2014-06-27|||April 1996||1996-04-01|June 2014|2014-06-01|February 2019|Anticipated|2019-02-01|February 2019|Anticipated|2019-02-01||Observational|||Human Epilepsy Genetics--Neuronal Migration Disorders Study|Human Epilepsy Genetics--Neuronal Migration Disorders Study|Recruiting||N/A|3500|Anticipated|Harvard University Faculty of Medicine|||1||f||||f||||||Samples With DNA|"~     whole blood, DNA~   "|||2017-02-18 18:05:00.902186|2017-02-18 18:05:00.902186
NCT00041587|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-10|2011-06-02|||July 2002||2002-07-01|June 2011|2011-06-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma|Pre-operative IL13-PE38QQR Infusion in Patients With Recurrent or Progressive Supratentorial Malignant Glioma: A Phase I/II Study|Completed||Phase 1/Phase 2|80||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 18:05:01.013863|2017-02-18 18:05:01.013863
NCT00041574|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-10|2016-09-08|||April 2002||2002-04-01|September 2016|2016-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide|Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases|Terminated||Phase 2|7|Actual|Mallinckrodt||1||Closed for lack of enrollment|f||||t||||||||||2017-02-18 18:05:01.110535|2017-02-18 18:05:01.110535
NCT00041561|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-10|2016-07-22|||January 2002||2002-01-01|July 2016|2016-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics|The Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) In Pediatrics|Terminated||Phase 3|55|Actual|Mallinckrodt||2||Study stopped due to poor enrollment|f||||t||||||||||2017-02-18 18:05:01.222309|2017-02-18 18:05:01.222309
NCT00041548|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-10|2016-10-18|||May 2002||2002-05-01|October 2016|2016-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation|Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation|Terminated||Phase 1/Phase 2|7|Actual|Mallinckrodt||2||slow enrollment|f||||t||||||||||2017-02-18 18:05:01.347779|2017-02-18 18:05:01.347779
NCT00041535|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-09|2017-01-24|||July 5, 2002||2002-07-05|March 3, 2008|2008-03-03|March 21, 2007||2007-03-21|||||Interventional|||OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease|A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:01.46652|2017-02-18 18:05:01.46652
NCT00041262|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-08-09|||November 2004||2004-11-01|March 2007|2007-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Esophageal Cancer|A Prospective Randomized Trial Comparing Standard Chemotherapy Followed By Resection Versus Infusional Chemotherapy In Patients With Resectable Adenocarcinoma Of The Oesophagus|Unknown status|Recruiting|Phase 3|1300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:04.126454|2017-02-18 18:05:04.126454
NCT00041509|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-09|2011-06-30|||January 2002||2002-01-01|June 2011|2011-06-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|TEMPEST||ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)|ThromboEMbolism Prevention Efficacy and Safety Trial (TEMPEST): A Double-blind Four-week Study to Assess the Efficacy, Safety, and Tolerability of SB-424323 in the Extended Prophylaxis of Patients Following Total Hip Arthroplasty|Completed||Phase 2|343|Actual|GlaxoSmithKline||3|||||||f||||||||||2017-02-18 18:05:01.55894|2017-02-18 18:05:01.55894
NCT00041496|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-09|2014-08-07|||November 2001||2001-11-01|August 2014|2014-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Prevention Of Recurrence Of Atrial Fibrillation|A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Safety and Efficacy of SB 207266 in Patients With Symptomatic Persistent Atrial Fibrillation (AF)|Completed||Phase 2|520|Actual|GlaxoSmithKline||2|||f||||||||||||||2017-02-18 18:05:01.664906|2017-02-18 18:05:01.664906
NCT00041483|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-09|2014-06-30|||June 2002||2002-06-01|July 2008|2008-07-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD|Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD|Completed||Phase 3|530|Actual|Alcon Research||2|||f||||||||||||||2017-02-18 18:05:01.776555|2017-02-18 18:05:01.776555
NCT00041470|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-09|2012-09-13|||March 2001||2001-03-01|September 2012|2012-09-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial|Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial|Completed||Phase 1/Phase 2|40|Actual|University of Washington||1|||f||||f||||||||||2017-02-18 18:05:01.886158|2017-02-18 18:05:01.886158
NCT00041457|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2015-08-05|||July 2002||2002-07-01|August 2015|2015-08-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Epidemiology of Venous Thromboembolism||Completed||N/A|||Brigham and Women's Hospital|||4||f||||||||||||||2017-02-18 18:05:01.996046|2017-02-18 18:05:01.996046
NCT00041444|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-02-05|||June 2002||2002-06-01|February 2016|2016-02-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Observational|MESA-Eye||Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study|Multi-Ethnic Study of Atherosclerosis-Eye Study|Completed||N/A|6176|Actual|University of Wisconsin, Madison|||1||f||||||||||||||2017-02-18 18:05:02.109738|2017-02-18 18:05:02.109738
NCT00041431|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-05-12|||December 2001||2001-12-01|May 2005|2005-05-01|December 2003|Actual|2003-12-01|||||Interventional|||Estrogen, Cytokines and Heart Failure in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:05:02.218161|2017-02-18 18:05:02.218161
NCT00041418|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Cardiac MR of Subclinical CVD: Impact of Age||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:05:02.300994|2017-02-18 18:05:02.300994
NCT00041405|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-05-12|||July 2001||2001-07-01|July 2005|2005-07-01|June 2005|Actual|2005-06-01|||||Observational|||Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:05:02.369102|2017-02-18 18:05:02.369102
NCT00041392|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-07-25|2012-08-05||December 2001||2001-12-01|April 2012|2012-04-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|POINT||Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery|PeriOperative Interventional Neuroprotection Trial (POINT)|Completed||Phase 2|389|Actual|Duke University||2|||f||||||||||||||2017-02-18 18:05:02.448343|2017-02-18 18:05:02.448343
NCT00041379|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-12-17|||March 2002||2002-03-01|December 2005|2005-12-01||||||||Interventional|||Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia|Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With Waldenstrom's Macroglobulinemia|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:02.881184|2017-02-18 18:05:02.881184
NCT00041353|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-07-10||||||July 2013|2013-07-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer|Breast Cancer Biomarkers Based on Fine Needle Aspirates|Withdrawn||N/A|0|Actual|Fox Chase Cancer Center||||Study was not activated at Fox Chase Cancer Center|f||||f||||||||||2017-02-18 18:05:02.96991|2017-02-18 18:05:02.96991
NCT00041340|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-01-22|||May 2002||2002-05-01|January 2013|2013-01-01||||July 2006|Actual|2006-07-01||Interventional|||Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer|Phase II Study Of Gleevec (Imatinib Mesylate Formerly Known As(STI571) (NSC #716051) In Patients With Colorectal Cancer Stage IV|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:03.052878|2017-02-18 18:05:03.052878
NCT00041327|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-02-01|||October 2002||2002-10-01|February 2016|2016-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma|Phase II Trial Of Induction Therapy With EPOCH Chemotherapy And Maintenance Therapy With Combivir/Interferon ALPHA-2a For HTLV-1 Associated T-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|19|Actual|AIDS Malignancy Consortium||1|||f||||||||||||||2017-02-18 18:05:03.157805|2017-02-18 18:05:03.157805
NCT00041314|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2009-06-06|||August 2002||2002-08-01|August 2002|2002-08-01||||July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer|A Phase II Trial Of Carboplatin And Gemcitabine With Exisulind In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:03.278482|2017-02-18 18:05:03.278482
NCT00041301|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2012-08-24|||March 2002||2002-03-01|August 2012|2012-08-01|November 2005|Actual|2005-11-01|December 2004|Actual|2004-12-01||Observational|||Assessing Quality of Life of Patients With Prostate Cancer|An International Field Study Of The Reliability And Validity Of The EORTC QLQ-C30 And A Disease-Specific Questionnaire Module (QLQ-PR25) For Assessing Quality Of Life Of Patients With Prostate Cancer|Completed||N/A|625|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||||||2017-02-18 18:05:03.721642|2017-02-18 18:05:03.721642
NCT00041288|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2009-02-06|||October 2001||2001-10-01|March 2003|2003-03-01||||||||Interventional|||Comparison of Fludarabine Plus Total-Body Irradiation With Combination Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:03.880349|2017-02-18 18:05:03.880349
NCT00041249|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2012-07-17|||May 2002||2002-05-01|July 2012|2012-07-01||||January 2004|Actual|2004-01-01||Interventional|||Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma|Efficacy And Safety Study Of Brostallicin In Patients With Locally Advanced Or Metastatic Soft Tissue Sarcoma Failing One Prior Chemotherapy Treatment|Completed||Phase 2|64|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:05:04.231944|2017-02-18 18:05:04.231944
NCT00041236|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2012-07-17|||May 2002||2002-05-01|July 2012|2012-07-01||||December 2004|Actual|2004-12-01||Interventional|||Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma|Exatecan As Second-Line Treatment In Advanced Adult Soft Tissue Sarcoma: A Phase II - Study Of The EORTC Soft Tissue And Bone Sarcoma Group|Completed||Phase 2|39|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:05:04.352921|2017-02-18 18:05:04.352921
NCT00041223|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-11-05|||September 2002||2002-09-01|September 2002|2002-09-01||||||||Interventional|||IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer|Double-Blind, Placebo-Controlled, Randomized Phase II Trial of IH636 Grape Seed Proanthocyanidin Extract (GSPE) in Patients With Adverse Effects of High Dose Breast Radiotherapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:04.466117|2017-02-18 18:05:04.466117
NCT00041210|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-09-19|||October 2001||2001-10-01|April 2009|2009-04-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma|Protocol for a Randomized Phase III Study of the Stanford V Regimen, Compared With ABVD for the Treatment of Advanced Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 3|850|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:04.613727|2017-02-18 18:05:04.613727
NCT00041197|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-07-15|||June 2002||2002-06-01|June 2013|2013-06-01||||April 2007|Actual|2007-04-01||Interventional|||Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery|A Phase III Randomized Double-Blind Study of Adjuvant STI571 (Gleevec™) Versus Placebo in Patients Following the Resection of Primary Gastrointestinal Stromal Tumor (GIST)|Completed||Phase 3|732|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:05:04.768978|2017-02-18 18:05:04.768978
NCT00041171|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-07-11||||||July 2016|2016-07-01||||||||Interventional|||Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery|Phase III Randomized Study of Hypericum Perforatum (St. John's Wort) Combined With Docetaxel in Patients With Unresectable Solid Tumors|Withdrawn||Phase 3|0|Actual|Alliance for Clinical Trials in Oncology||3||The study was not activated.|f||||||||||||||2017-02-18 18:05:04.887546|2017-02-18 18:05:04.887546
NCT00041132|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2012-10-03|2012-03-05||September 2002||2002-09-01|October 2012|2012-10-01|June 2011|Actual|2011-06-01|November 2007|Actual|2007-11-01||Interventional|||S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma|Pilot Trial of Hyper-CVAD and Methotrexate/ARA C Plus Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|56|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:05:05.005765|2017-02-18 18:05:05.005765
NCT00041119|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-08-11|||May 2002||2002-05-01|August 2016|2016-08-01||||April 2012|Actual|2012-04-01||Interventional|||Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer|Cyclophosphamide And Doxorubicin (CA) (4 VS 6 Cycles) Versus Paclitaxel (4 VS 6 Cycles) As Adjuvant Therapy For Breast Cancer in Women With 0-3 Positive Axillary Lymph Nodes:A 2X2 Factorial Phase III Randomized Study|Active, not recruiting||Phase 3|4646|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-02-18 18:05:05.428233|2017-02-18 18:05:05.428233
NCT00041106|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-06-04|||May 2002||2002-05-01|June 2013|2013-06-01||||July 2007|Actual|2007-07-01||Interventional|||Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer|Phase II Study Of Cisplatin, Gemcitabine, And ZD 1839 (IRESSA) (IND #61187; NSC 715055) For The Treatment Of Advanced Urothelial Tract Carcinoma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:09.364312|2017-02-18 18:05:09.364312
NCT00040846|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2016-01-05|||November 2001||2001-11-01|January 2016|2016-01-01||||December 2009|Actual|2009-12-01||Interventional|||Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies|Campath® [Alemtuzumab] Dose Escalation, Low-Dose TBI and Fludarabine Followed by HLA Class I Mismatched Donor Stem Cell Transplantation for Patients With Hematologic Malignancies - A Multi-Center Trial|Active, not recruiting||Phase 2|60|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:05:09.486811|2017-02-18 18:05:09.486811
NCT00040833|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-06-04|||February 2002||2002-02-01|June 2013|2013-06-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer|Acupuncture for the Treatment of Pancreatic Cancer Pain: A Single Arm Phase II Study|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:05:09.636351|2017-02-18 18:05:09.636351
NCT00040820|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2011-03-03|||January 2002||2002-01-01|March 2011|2011-03-01|March 2004|Actual|2004-03-01|August 2003|Actual|2003-08-01||Interventional|||Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer|A Treatment Access Program With Oxaliplatin for Previously Treated Colorectal Cancer Patients|Completed||N/A|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:05:09.717762|2017-02-18 18:05:09.717762
NCT00040807|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2009-07-29|||October 2002||2002-10-01|November 2004|2004-11-01||||April 2005|Actual|2005-04-01||Interventional|||Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer|Phase II Trial Of Weekly Irinotecan And Docetaxel In Recurrent Or Metastatic Head And Neck Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:09.80919|2017-02-18 18:05:09.80919
NCT00040794|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-06-04|||May 2002||2002-05-01|June 2013|2013-06-01||||March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer|ZD1839 (NSC #715055, IND #61187) With Induction Paclitaxel And Carboplatin Followed By Either Radiation Or Concomitant Radiation With Weekly Paclitaxel And Carboplatin In Stage III Non-Small Cell Lung Cancer, A Phase II Study|Completed||Phase 2|144|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:05:09.952502|2017-02-18 18:05:09.952502
NCT00005251|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||January 1990||1990-01-01|June 2000|2000-06-01|March 1995|Actual|1995-03-01|||||Observational|||Genetic Analysis of Familial Hypertrophic Cardiomyopathy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.591271|2017-02-18 18:15:17.591271
NCT00040781|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-01-22|||June 2002||2002-06-01|January 2013|2013-01-01||||October 2004|Actual|2004-10-01||Interventional|||Gefitinib in Treating Children With Refractory Solid Tumors|A Phase I Study Of ZD1839 (Iressa TM), An Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, In Children With Refractory Solid Tumors|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:10.344339|2017-02-18 18:05:10.344339
NCT00040768|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-01-15|||April 2002||2002-04-01|January 2013|2013-01-01||||March 2006|Actual|2006-03-01||Interventional|||Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer|A Phase II Study Of PS-341 In Metastatic Non-Small Cell Lung Cancer|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:05:10.452623|2017-02-18 18:05:10.452623
NCT00040755|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-01-31|||May 2002||2002-05-01|January 2013|2013-01-01||||July 2006|Actual|2006-07-01||Interventional|||BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|Randomized Phase II Trial of BMS-275291 (NSC 713763, IND 62573) in Hormone Refractory Prostate Cancer|Completed||Phase 2|68|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:05:10.581055|2017-02-18 18:05:10.581055
NCT00040742|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2015-10-13|2014-07-10||March 2003||2003-03-01|October 2015|2015-10-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|||Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer|A Phase II/III Randomized, Controlled Clinical Trial Of Ginger (Zingiber Officinale) For Nausea Caused By Chemotherapy For Cancer|Completed||Phase 2/Phase 3|745|Actual|University of Rochester|Two main weaknesses of the study, which should be controlled for in future studies, were not controlling for chemotherapy regimens (i.e., high versus low emetogenic regimens) or the severity level of nausea before enrollment.|4|||f||||t||||||||||2017-02-18 18:05:10.705657|2017-02-18 18:05:10.705657
NCT00040729|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2015-04-24|||March 2002||2002-03-01|May 2003|2003-05-01||||||||Observational|||Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C|Retrospective Analysis Of Promoter Polymorphism Of UGT1A1 Gene In Cancer Patients Enrolled On Clinical Trials With Flavopiridol At National Cancer Institute To Assess The Pharmacokinetics And Pharmacodynamics Of Flavopiridol|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:12.140862|2017-02-18 18:05:12.140862
NCT00040690|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2013-12-18|||November 2008||2008-11-01|May 2007|2007-05-01|December 2008|Actual|2008-12-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia|A Clinicopathological Study In Burkitts's And Burkitt-Like Non-Hodgkin's Lymphoma|Completed||Phase 2|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:12.228977|2017-02-18 18:05:12.228977
NCT00040677|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-08|2011-07-13||2011-07-07|February 2002||2002-02-01|July 2011|2011-07-01|January 2004|Actual|2004-01-01|November 2003|Actual|2003-11-01||Interventional|||A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.|A Phase II, Multicenter, Twelve-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Efficacy and Safety of ICA-17043 With or Without Hydroxyurea Therapy in Patients With Sickle Cell Anemia|Completed||Phase 2|90|Actual|Icagen||3|||f||||t||||||||||2017-02-18 18:05:12.340334|2017-02-18 18:05:12.340334
NCT00040664|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-05|2011-01-24|2009-08-06||July 2002||2002-07-01|January 2011|2011-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years|See Detailed Description|Completed||Phase 2|69|Actual|GlaxoSmithKline||3|||f||||||||||||||2017-02-18 18:05:12.48864|2017-02-18 18:05:12.48864
NCT00040651|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-05|2007-12-19|||July 2002||2002-07-01|December 2007|2007-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients|Transplantation With T-Cell Depleted Autologous Peripheral Stem Cells for Severe Systemic Sclerosis: A Phase I Dose Escalation Study|Terminated||Phase 1|15||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-02-18 18:05:13.596738|2017-02-18 18:05:13.596738
NCT00040638|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-02|2011-07-21|||July 2002||2002-07-01|June 2011|2011-06-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer||Completed||Phase 2|40||Telik|||||f||||||||||||||2017-02-18 18:05:13.694659|2017-02-18 18:05:13.694659
NCT00040625|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-02|2007-03-14||||||March 2007|2007-03-01||||||||Expanded Access|||ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.||Approved for marketing||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:05:13.764661|2017-02-18 18:05:13.764661
NCT00040599|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-01|2008-01-08|||January 2000||2000-01-01|January 2008|2008-01-01|January 2004||2004-01-01|||||Interventional|||Safety Study of 90Y-hMN14 to Treat Colorectal Cancer|A Phase I/II Study of Radioimmunotherapy With 90Y-Humanized MN-14 IgG Administered as a Single Dose to Patients With Refractory Metastatic/Recurrent Colorectal Carcinomas|Completed||Phase 1/Phase 2|72||Immunomedics, Inc.|||||||||||||||||||2017-02-18 18:05:13.845988|2017-02-18 18:05:13.845988
NCT00040586|ClinicalTrials.gov processed this data on February 17, 2017|2002-07-01|2007-01-19||||||July 2002|2002-07-01||||||||Interventional|||Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2|Phase II Trial of Monoclonal Antibody J591 in Combination With Low-Dose Interleukin-2 in Patients With Recurrent Prostate Cancer|Completed||Phase 2|||BZL Biologics|||||||||||||||||||2017-02-18 18:05:13.937599|2017-02-18 18:05:13.937599
NCT00040573|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-29|2009-03-30|||June 2002||2002-06-01|March 2009|2009-03-01|August 2003||2003-08-01|||||Interventional|||Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.|A Phase I/II Open Label, Single Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients With Recurrent High-Grade Glioma.|Completed||Phase 1/Phase 2|18||TransMolecular|||||||||||||||||||2017-02-18 18:05:14.023707|2017-02-18 18:05:14.023707
NCT00040560|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-28|2005-06-23||||||January 2003|2003-01-01||||||||Interventional|||Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer||Unknown status|Active, not recruiting|Phase 1|||Copharos|||||||||||||||||||2017-02-18 18:05:14.121886|2017-02-18 18:05:14.121886
NCT00040547|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-28|2015-02-16|||June 2001||2001-06-01|February 2015|2015-02-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED)|Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors|Completed||Phase 1|29|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:05:14.19902|2017-02-18 18:05:14.19902
NCT00040534|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-28|2015-02-13|||January 2001||2001-01-01|February 2015|2015-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)||Terminated||Phase 1|22|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:05:14.281551|2017-02-18 18:05:14.281551
NCT00040521|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-27|2013-02-07|||April 2002||2002-04-01|September 2005|2005-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study Evaluating rhIL-11 in Active Crohn's Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Orally Administered Recombinant Human Interleukin-11 (rhIL-11) for the Treatment of Patients With Active Crohn's Disease|Completed||Phase 2|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:05:14.357626|2017-02-18 18:05:14.357626
NCT00040508|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2008-03-03|||June 2002||2002-06-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Sirolimus for Focal Segmental Glomerulosclerosis|Sirolimus for Focal Segmental Glomerulosclerosis|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:14.449935|2017-02-18 18:05:14.449935
NCT00040495|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2013-02-07|||April 2001||2001-04-01|February 2013|2013-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage|An Efficacy and Safety Study of Intravenous Pantoprazole in the Prevention of Recurrent Peptic Ulcer Bleeding After Successful Hemostasis|Completed||Phase 3|149|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 18:05:14.54008|2017-02-18 18:05:14.54008
NCT00040482|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2007-04-09|||April 1999||1999-04-01|April 2007|2007-04-01|August 2005||2005-08-01|||||Interventional|||High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis|Intensive Immunosuppression Followed by Rescue With CD34 Selected, T Cell Depleted, Leukopheresis Products in Patients With Multiple Sclerosis|Completed||Phase 2|10||Baylor College of Medicine|||||||||||||||||||2017-02-18 18:05:14.623356|2017-02-18 18:05:14.623356
NCT00040469|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2007-04-09|||August 2000||2000-08-01|April 2007|2007-04-01||||||||Interventional|||Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies|Allogeneic Bone Marrow Transplant From HLA Identical Related Donors for Patients With High Risk Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, Hemoglobin SB0/+ Thalassemia, or Homozygous B0/+ Thalassemia or Severe Variants of B0/+ Thalassemia|Terminated||Phase 2|15||Baylor College of Medicine|||||||||||||||||||2017-02-18 18:05:14.71453|2017-02-18 18:05:14.71453
NCT00040456|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2012-11-15|||January 2001||2001-01-01|November 2012|2012-11-01|May 2006|Actual|2006-05-01|||||Interventional|||Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate|The Effect of Oral Magnesium Pidolate on Incidence of Painful Crises in Patients With Hemoglobin SC Disease|Terminated||Phase 2|12|Actual|Baylor College of Medicine||2||Lack of accrual|f||||t||||||||||2017-02-18 18:05:14.81136|2017-02-18 18:05:14.81136
NCT00040443|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2005-06-23|||April 2002||2002-04-01|February 2005|2005-02-01|March 2003||2003-03-01|||||Interventional|||Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.|Efficacy And Safety Of CX516 (900 Mg t.i.d.) In Elderly Participants With Mild Cognitive Impairment. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group 4-Week Study.|Completed||Phase 2|160||RespireRx|||||||||||||||||||2017-02-18 18:05:14.921972|2017-02-18 18:05:14.921972
NCT00040430|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2005-06-23||||||January 2003|2003-01-01||||||||Interventional|||Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer||Unknown status|Active, not recruiting|Phase 1|||Copharos|||||||||||||||||||2017-02-18 18:05:15.008713|2017-02-18 18:05:15.008713
NCT00040417|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2007-04-09|||August 2000||2000-08-01|April 2007|2007-04-01||||||||Interventional|||Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies|Allo SCT From HLA Haploidentical Related Donors Using Sub-Myeloablative Conditioning For Patients With High Risk Hemoglobinopathies: Hemo SS, Hemo SC, Hemo SB0/+ Thalassemia, Homozygous B0/+ Thalassemia or Severe B0/+ Thalassemia Variants|Terminated||Phase 2|15||Baylor College of Medicine|||||||||||||||||||2017-02-18 18:05:15.088318|2017-02-18 18:05:15.088318
NCT00040404|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2012-05-08||2012-05-03|March 2002||2002-03-01|May 2012|2012-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Efficacy and Safety of CEP-1347 in Patients With Parkinson's Disease|Terminated||Phase 2/Phase 3|806|Actual|Teva Pharmaceutical Industries||4||Unlikely to provide evidence of significant effect|f||||t||||||||||2017-02-18 18:05:15.186115|2017-02-18 18:05:15.186115
NCT00040391|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-26|2016-11-30|||June 2002||2002-06-01|November 2016|2016-11-01||||||||Interventional|||A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer|A Phase II, Randomized, Open-label, Controlled, Dose-elevation, Multicenter Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer|Terminated||Phase 2|||Celgene Corporation|||||||||||||||||||2017-02-18 18:05:15.619802|2017-02-18 18:05:15.619802
NCT00040378|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-25|2013-02-21|||May 2002||2002-05-01|February 2013|2013-02-01|August 2014|Anticipated|2014-08-01|January 2014|Anticipated|2014-01-01||Interventional|||Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)|Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)|Unknown status|Active, not recruiting|Phase 3|10400|Anticipated|University of Kentucky||4|||f||||t||||||||||2017-02-18 18:05:15.74591|2017-02-18 18:05:15.74591
NCT00040365|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-25|2012-04-26|2012-01-13||June 2002||2002-06-01|April 2012|2012-04-01|June 2011|Actual|2011-06-01|May 2010|Actual|2010-05-01||Interventional|||Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer|Amifostine as a Rectal Protector During External Beam Radiotherapy for Prostate Cancer: A Phase II Study|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 18:05:15.980074|2017-02-18 18:05:15.980074
NCT00040352|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-25|2017-02-08|||June 20, 2002||2002-06-20|February 6, 2017|2017-02-06||||||||Observational|||Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma|Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:16.432999|2017-02-18 18:05:16.432999
NCT00040339|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-24|2007-12-26|||May 2002||2002-05-01|December 2007|2007-12-01|July 2005|Actual|2005-07-01|||||Interventional|||Hypothermia to Treat Severe Brain Injury|The National Acute Brain Injury Study: Hypothermia II (NABISH II)|Completed||N/A|42||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:05:16.537437|2017-02-18 18:05:16.537437
NCT00040326|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-24|2010-02-22|||July 2002||2002-07-01|February 2010|2010-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|ERSET||Early Surgical Intervention to Treat Epilepsy|Early Randomized Surgical Epilepsy Trial|Completed||Phase 3|200|Anticipated|University of California, Los Angeles||2|||f||||t||||||||||2017-02-18 18:05:16.632016|2017-02-18 18:05:16.632016
NCT00040313|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-24|2006-05-02|||October 2002||2002-10-01|May 2006|2006-05-01|February 2005||2005-02-01|||||Interventional|||Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula|A Phase II Randomized, Controlled, Double-Masked, Dose-Finding, Multi-Center, Comparative Trial, in Parallel Groups, to Establish the Safety and Preliminary Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer), Given Every 6 Weeks for 12 to 30 Weeks to Patients With Clinically Significant Diabetic Macular Edema (CSME) Involving the Center of the Macula|Completed||Phase 2|0||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 18:05:16.748741|2017-02-18 18:05:16.748741
NCT00040300|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-24|2005-07-18|||June 2002||2002-06-01|July 2005|2005-07-01|December 2002||2002-12-01|||||Interventional|||A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males||Completed||Phase 1|18||Pharmasset|||||||||||||||||||2017-02-18 18:05:16.816693|2017-02-18 18:05:16.816693
NCT00040287|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-24|2007-05-16|||January 1999||1999-01-01|May 2007|2007-05-01||||||||Interventional|||Theory-Based Interventions for Smoking and Obesity (Challenge) Trial||Completed||Phase 3|1778||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:05:16.893043|2017-02-18 18:05:16.893043
NCT00040274|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-24|2005-07-18||||||July 2005|2005-07-01||||||||Interventional|||A Study of DPC 817 in HIV-Infected Males|A Placebo-Controlled, Dose-Escalation Study in HIV-1 Infected Subjects to Characterize the Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of DPC 817|Completed||Phase 1|30||Pharmasset|||||||||||||||||||2017-02-18 18:05:16.980377|2017-02-18 18:05:16.980377
NCT00040261|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-22|2008-03-03|||June 2002||2002-06-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Clinical Trial of Memantine for Major Depression|An Investigation of the Antidepressant Efficacy of Memantine, an NMDA Antagonist With Neurotrophic Properties in Major Depression|Completed||Phase 3|112||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:17.06689|2017-02-18 18:05:17.06689
NCT00040248|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-22|2008-03-03|||June 2002||2002-06-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Daclizumab to Treat Wegener's Granulomatosis|A Randomized Trial Examining the Use of Daclizumab in Wegener's Granulomatosis|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:17.168622|2017-02-18 18:05:17.168622
NCT00040235|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-22|2008-03-03|||June 2002||2002-06-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Magnesium Effects in Apheresis|Citrate Effects and Role of Prophylactic Magnesium Administration During Large-Volume Leukapheresis|Completed||Phase 3|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:17.264788|2017-02-18 18:05:17.264788
NCT00040222|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-22|2017-01-24|||June 20, 2002||2002-06-20|September 23, 2016|2016-09-23||||||||Observational|||Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer|Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer|Active, not recruiting||N/A|377|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:17.346525|2017-02-18 18:05:17.346525
NCT00040209|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-21|2008-03-03|||June 2002||2002-06-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||JP-1730 to Treat Parkinson's Disease|Alpha-2 Adrenergic Antagonist Treatment of Parkinson's Disease|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:17.453844|2017-02-18 18:05:17.453844
NCT00040196|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-21|2017-01-24|||June 19, 2002||2002-06-19|July 9, 2009|2009-07-09|July 9, 2009|Actual|2009-07-09|July 9, 2009|Actual|2009-07-09||Observational|||How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance|Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements|Completed||N/A|133||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:17.542085|2017-02-18 18:05:17.542085
NCT00040183|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-21|2015-06-12|||October 2001||2001-10-01|June 2015|2015-06-01|September 2004|Actual|2004-09-01|||||Interventional|||OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.|A Randomized Placebo Controlled Study of OSI-774 (Tarceva (TM)) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer|Completed||Phase 3|569|Actual|Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:05:17.631796|2017-02-18 18:05:17.631796
NCT00040170|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-21|2006-10-31|||May 2002||2002-05-01|October 2006|2006-10-01||||||||Interventional|||Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer|Randomized Multicenter Phase II Study Evaluating Two Dosing Schedules of TG4010(MVA-MUC1-IL2) in Patients With Adenocarcinoma of the Prostate|Terminated||Phase 2|50||Transgene|||||||||||||||||||2017-02-18 18:05:17.85595|2017-02-18 18:05:17.85595
NCT00040157|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-21|2015-12-29||||||December 2015|2015-12-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.|A Phase 2 Trial of 4 Weeks of ACH-126,443 in Comparison With Continued Lamivudine in Stable Triple Antiretroviral Combination Therapy in HIV-Infected Subjects With Modestly Detectable Viral Load|Terminated||Phase 2|60||Achillion Pharmaceuticals||||Safety concerns|||||||||||||||2017-02-18 18:05:18.217673|2017-02-18 18:05:18.217673
NCT00040144|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-21|2009-08-18|||July 2002||2002-07-01|August 2009|2009-08-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B|A Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Safety and Efficacy of 12 Weeks Oral Treatment With ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B|Terminated||Phase 2|85||Achillion Pharmaceuticals||||Safety concerns|||||||||||||||2017-02-18 18:05:18.318064|2017-02-18 18:05:18.318064
NCT00040131|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-20|2015-10-30|||January 2002||2002-01-01|October 2015|2015-10-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED)||Terminated||Phase 2|316|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:05:18.428377|2017-02-18 18:05:18.428377
NCT00040105|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-19|2012-07-31|||October 2002||2002-10-01|July 2012|2012-07-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia|Phase I Study of Zarnestra (R115777.USA30) and Gleevec (Imatinib Mesylate) in Chronic Phase Chronic Myelogenous Leukemia (CML)|Completed||Phase 1|26|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:18.520175|2017-02-18 18:05:18.520175
NCT00040066|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-18|2017-01-10|||May 2002||2002-05-01|September 2004|2004-09-01|August 2003||2003-08-01|||||Interventional|||Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1|Development of Human Laboratory Study Model of Cocaine Relapse Prevention|Unknown status|Active, not recruiting|Phase 1|32||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 18:05:18.716201|2017-02-18 18:05:18.716201
NCT00040053|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-18|2017-01-11|||June 2002||2002-06-01|July 2008|2008-07-01|February 2004|Actual|2004-02-01|||||Interventional|||Ondansetron for the Treatment of Methamphetamine Dependence - 1|Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence.|Completed||Phase 2|154||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:05:18.804697|2017-02-18 18:05:18.804697
NCT00040040|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-18|2017-01-10|||June 2002||2002-06-01|August 2003|2003-08-01|September 2003||2003-09-01|||||Interventional|||Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1|Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion|Unknown status|Active, not recruiting|Phase 1|20||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:05:18.902357|2017-02-18 18:05:18.902357
NCT00040027|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-18|2008-01-08|||April 2002||2002-04-01|January 2008|2008-01-01||||||||Interventional|||Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin||Completed||Phase 3|500||SciClone Pharmaceuticals|||||||||||||||||||2017-02-18 18:05:18.991838|2017-02-18 18:05:18.991838
NCT00040014|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-18|2012-02-14|||June 2002||2002-06-01|February 2012|2012-02-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women|Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women With Advanced Breast Cancer Having Progressed on Tamoxifen.|Terminated||Phase 2|100||Pfizer|||||f||||||||||||||2017-02-18 18:05:19.123005|2017-02-18 18:05:19.123005
NCT00039195|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2016-06-29|2015-12-15||November 2006||2006-11-01|June 2016|2016-06-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma|Risk-Adapted Therapy for Patients With Untreated Age-Adjusted International Prognostic Index II or III Diffuse Large B Cell Lymphoma|Completed||Phase 2|98|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:05:19.220682|2017-02-18 18:05:19.220682
NCT00039182|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-01-23|||May 2002||2002-05-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung|A Phase II Study of Oral EGFR Tyrosine Kinase Inhibitor OSI-774 (NSC-718781) in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:19.500066|2017-02-18 18:05:19.500066
NCT00039169|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2008-07-23|||December 2001||2001-12-01|January 2008|2008-01-01||||||||Interventional|||BAY 59-8862 in Treating Patients With Advanced Kidney Cancer|An Uncontrolled Phase II Multi-Center Trial Evaluating Anti-Tumor Efficacy and Safety of BAY 59-8862 in Patients With Advanced Renal Cell Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:19.62472|2017-02-18 18:05:19.62472
NCT00039156|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2008-07-23|||January 2002||2002-01-01|January 2004|2004-01-01||||||||Interventional|||BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma|An Open Phase II Multi-Center Trial of BAY 59-8862 in Patients With Aggressive Refractory Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:19.736867|2017-02-18 18:05:19.736867
NCT00039130|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2016-07-01|2014-10-16||May 2002||2002-05-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|September 2010|Actual|2010-09-01||Interventional|||Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia|Phase II Study Of Rituximab And Short Duration, High Intensity Chemotherapy With G-CSF Support In Previously Untreated Patients With Burkitt Lymphoma/Leukemia|Completed||Phase 2|105|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:05:19.859929|2017-02-18 18:05:19.859929
NCT00039117|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2015-12-03|||April 2002||2002-04-01|June 2013|2013-06-01||||September 2003|Actual|2003-09-01||Interventional|||Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia|A Phase I Study of G3139 ( NSC # 683428) in Combination With Cytarabine and Daunorubicin in Previously Untreated Patients With Acute Myeloid Leukemia (AML)&gt;= 60 Years of Age|Completed||Phase 1|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:20.612231|2017-02-18 18:05:20.612231
NCT00039104|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-06-04|||April 2002||2002-04-01|June 2013|2013-06-01||||January 2005|Actual|2005-01-01||Interventional|||Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer|A Phase II, Open-Label, Randomized Trial of Zoledronic Acid (Zometa™) and BMS-275291 (NSC#713763) in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:05:20.722553|2017-02-18 18:05:20.722553
NCT00039091|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-01-09|||March 2002||2002-03-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer|Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 (Anti-CTLA-4) Humanized Monoclonal Antibody (MDX-CTLA-4 NSC# 732442, Previously 720801) in Patients Previously Vaccinated With GM-CSF-Based Autologous Tumor Vaccines (CTEP Protocol Number P-5708) and Patients With Acute Myelogenous Leukemia/ Myelodysplasia, and Non-Small Cell Lung Cancer Who Have Not Received a Prior Vaccine|Terminated||Phase 1|48|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:20.831778|2017-02-18 18:05:20.831778
NCT00039078|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2009-12-23|||August 2000||2000-08-01|December 2008|2008-12-01||||||||Interventional|||Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery|The Use of TheraSphere® for the Treatment of Unresectable Hepatocellular Carcinoma|Unknown status|Recruiting|Phase 2|500|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:20.941331|2017-02-18 18:05:20.941331
NCT00039052|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-07-17|||January 2002||2002-01-01|March 2003|2003-03-01|July 2008|Actual|2008-07-01|May 2003|Actual|2003-05-01||Interventional|||Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer|An Open Label, Multiple-Dose, Sequential Dose-Escalation Study of NBI-3001 in Patients With Recurrent or Unresponsive Solid Tumors Known to Over-Express IL-4 Receptors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:21.030676|2017-02-18 18:05:21.030676
NCT00039039|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-12-17|||February 2000||2000-02-01|August 2006|2006-08-01||||||||Interventional|||Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer|Phase III Randomized Study of Paclitaxel and Carboplatin or Cisplatin Followed by Radiotherapy With or Without Concurrent Paclitaxel in Patients With Unresectable Stage III Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:21.116904|2017-02-18 18:05:21.116904
NCT00039026|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2015-02-23|||February 2002||2002-02-01|January 2015|2015-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea|A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects With Type 2 Diabetes Mellitus Treated With a Sulfonylurea Alone|Completed||Phase 3|377|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 18:05:21.514987|2017-02-18 18:05:21.514987
NCT00039013|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2015-02-23|||March 2002||2002-03-01|January 2015|2015-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin|A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects With Type 2 Diabetes Mellitus Treated With Metformin Alone|Completed||Phase 3|336|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 18:05:21.790425|2017-02-18 18:05:21.790425
NCT00039000|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2012-09-06|||March 2002||2002-03-01|September 2012|2012-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma|A Phase III Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus Physician's Choice Including Interleukin-2 and/or Dacarbazine/Temozolomide-based Therapy and/or Complete Tumor Resection in Stage IV Melanoma|Completed||Phase 3|350||Agenus Inc.|||||f||||||||||||||2017-02-18 18:05:22.060955|2017-02-18 18:05:22.060955
NCT00040001|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-18|2005-06-23||||||February 2003|2003-02-01||||||||Interventional|||Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation||Completed||Phase 2|||Aderis Pharmaceuticals|||||||||||||||||||2017-02-18 18:05:22.236921|2017-02-18 18:05:22.236921
NCT00039988|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-18|2016-09-20|||November 2001||2001-11-01|September 2016|2016-09-01|November 2007|Actual|2007-11-01|March 2006|Actual|2006-03-01||Interventional|||Treatment of Multiple Sclerosis With Copaxone and Albuterol|Treatment of Multiple Sclerosis With Copaxone (Glatiramer Acetate) and Albuterol|Completed||N/A|40|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||Yes|Data access including but not limited to participant level data, is available to the public in the Immunology Database and Analysis Portal (ImmPort), a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 18:05:22.310364|2017-02-18 18:05:22.310364
NCT00039975|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-18|2012-05-17||||||May 2012|2012-05-01|April 2004|Actual|2004-04-01|||||Interventional|||Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers|Evaluation of Potential Pharmacokinetic Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:05:22.438231|2017-02-18 18:05:22.438231
NCT00039962|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-17|2008-01-08|||May 2002||2002-05-01|January 2008|2008-01-01||||||||Interventional|||Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin||Completed||Phase 3|500||SciClone Pharmaceuticals|||||||||||||||||||2017-02-18 18:05:22.596624|2017-02-18 18:05:22.596624
NCT00039936|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-17|2010-01-12|||February 2002||2002-02-01|January 2010|2010-01-01||||||||Interventional|||Treatment of Binge Eating Disorder||Completed||N/A|180||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:05:22.725133|2017-02-18 18:05:22.725133
NCT00039923|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-14|2008-03-03|||June 2002||2002-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria|A Pilot Study to Determine if Transfer of Gpi-Linked Proteins Occurs Following Transfusion of Red Cells to Patients With Paroxysmal Nocturnal Hemoglobinuria|Completed||N/A|7||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:22.804123|2017-02-18 18:05:22.804123
NCT00039910|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-14|2007-05-03|||July 2000||2000-07-01|September 2006|2006-09-01|March 2003|Actual|2003-03-01|||||Interventional|||Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia|Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia in Recurrent or Refractory Non-Burkitt's, Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease Receiving DHAP (Dexamethasone, High-Dose Cytarabine and Cisplatin) Chemotherapy|Completed||Phase 3|240||Pfizer|||||f||||||||||||||2017-02-18 18:05:22.885704|2017-02-18 18:05:22.885704
NCT00039884|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-13|2005-06-23|||September 2001||2001-09-01|June 2002|2002-06-01|March 2003||2003-03-01|||||Interventional|||Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?|Phase II Study of NESP (Novel Erythropoiesis Stimulating Protein) During Concurrent Chemo-Radiation for the Treatment of Cervical Carcinoma.|Unknown status|Active, not recruiting|Phase 2|64||Mirhashemi, Ramin, M.D.|||||||||||||||||||2017-02-18 18:05:23.012398|2017-02-18 18:05:23.012398
NCT00039871|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-13|2015-03-26|2008-09-29||May 2002||2002-05-01|March 2015|2015-03-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)|PEG-Intron Plus REBETOL for the Treatment of Subjects With Chronic Hepatitis C Who Failed to Respond to Previous Combination Therapy (Any Alpha Interferon Treatment in Combination With Ribavirin)|Completed||Phase 3|2333|Actual|Merck Sharp & Dohme Corp.||1|||f||||t||||||||||2017-02-18 18:05:23.176294|2017-02-18 18:05:23.176294
NCT00039858|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-13|2007-01-10|||September 2003||2003-09-01|January 2007|2007-01-01|March 2006||2006-03-01|||||Interventional|||Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin|Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin|Completed||Phase 4|24||Encysive Pharmaceuticals|||||||||||||||||||2017-02-18 18:05:26.586934|2017-02-18 18:05:26.586934
NCT00039845|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-12|2017-01-24|||June 7, 2002||2002-06-07|April 20, 2009|2009-04-20|April 20, 2009||2009-04-20|||||Observational|||MRI Language Studies in Young Children|fMRI Languages Studies In Young Children|Completed||N/A|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:26.681546|2017-02-18 18:05:26.681546
NCT00039832|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-12|2011-09-19|||March 2002||2002-03-01|September 2011|2011-09-01|May 2008|Actual|2008-05-01|April 2007|Actual|2007-04-01||Interventional|||ReoPro and Retavase to Restore Brain Blood Flow After Stroke|ReoPro Retavase Reperfusion of Stroke Safety Study - Imaging Evaluation|Completed||Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 18:05:26.774061|2017-02-18 18:05:26.774061
NCT00039819|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-11|2008-03-03|||June 2002||2002-06-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||Nerve Stimulation to Modify a Spinal Reflex|Plasticity of Reciprocal Inhibition|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:26.89145|2017-02-18 18:05:26.89145
NCT00039793|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-11|2006-08-17|||March 2001||2001-03-01|July 2006|2006-07-01|March 2004||2004-03-01|||||Interventional|||Massage Therapy for Cancer-Related Fatigue|Massage Therapy for Cancer-Related Fatigue|Completed||Phase 2|45||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:05:26.971959|2017-02-18 18:05:26.971959
NCT00039780|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-10|2017-01-09|||September 2001||2001-09-01|January 2017|2017-01-01|September 2014|Actual|2014-09-01|October 2006|Actual|2006-10-01||Interventional|||Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel|BNP7787 vs. Placebo for Prevention of Paclitaxel Neurotoxicity: A Double-Blind Multicenter Randomized Phase 3 Trial in Patients With Metastatic Breast Cancer|Completed||Phase 3|764|Actual|BioNumerik Pharmaceuticals, Inc.||2|||f||||t||||||||||2017-02-18 18:05:27.070045|2017-02-18 18:05:27.070045
NCT00039767|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-07|2008-03-03|||May 2002||2002-05-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices|Heparin vs. Lepirudin Flushes in Preventing Withdrawal Occlusion of Tunneled, Open-Ended Venous Access Devices: A Blinded, Randomized, Clinical Trial|Completed||Phase 2|340||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:27.183354|2017-02-18 18:05:27.183354
NCT00039754|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-07|2009-01-19|||March 2002||2002-03-01|January 2009|2009-01-01||||||||Interventional|||A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma|A Multicenter Dosimetry Trial to Evaluate Radiation Absorbed Dose From Holmium-166-DOTMP in Patients With Multiple Myeloma|Terminated||Phase 1/Phase 2|||Poniard Pharmaceuticals||||business reasons|||||||||||||||2017-02-18 18:05:27.273948|2017-02-18 18:05:27.273948
NCT00039741|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-07|2015-10-26|2011-12-19||August 2002||2002-08-01|November 2014|2014-11-01|March 2010|Actual|2010-03-01|August 2009|Actual|2009-08-01||Interventional|||Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children|A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age|Completed||Phase 2/Phase 3|266|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 18:05:27.359936|2017-02-18 18:05:27.359936
NCT00039715|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2008-03-03|||June 2002||2002-06-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Observational|||Effects of Hydrocortisone in Patients With Post-Traumatic Stress Disorder|Effect of Hydrocortisone Infusion on Hippocampal Glucose Metabolism, Neuropsychological Test Performance and Reexperiencing Symptoms in Patients With Post-Traumatic Stress Disorder (PTSD)|Completed||N/A|93||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:32.367837|2017-02-18 18:05:32.367837
NCT00039702|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2008-03-03|||June 2002||2002-06-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Observational|||Brain Imaging in Alzheimer's Disease|SPECT Imaging of Alpha4beta2 Nicotinic Acetylcholine Receptors Using [123I]5-I-A-85380 in Alzheimer's Disease|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:32.452924|2017-02-18 18:05:32.452924
NCT00039689|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2017-02-14|||May 20, 2002||2002-05-20|February 13, 2017|2017-02-13||||||||Observational|||Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients|Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-Infected Patients|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:32.540489|2017-02-18 18:05:32.540489
NCT00039676|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2017-02-08|||June 19, 2002||2002-06-19|February 6, 2017|2017-02-06||||||||Observational|||Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer|Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:32.645393|2017-02-18 18:05:32.645393
NCT00039663|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2008-03-03|||May 2002||2002-05-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Endothelial Dysfunction as a Risk Factor in HIV Study|Endothelial Dysfunction as a Risk Factor in HIV Study|Completed||Phase 1|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:32.758284|2017-02-18 18:05:32.758284
NCT00039650|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2008-03-03|||May 2002||2002-05-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Pilot Study: Effects of G-CSF on T Cell Function|Pilot Study of the Effects of G-CSF on T Cell Function|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:05:32.855137|2017-02-18 18:05:32.855137
NCT00039624|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2017-01-24|||May 31, 2002||2002-05-31|October 11, 2016|2016-10-11|June 28, 2010|Actual|2010-06-28|July 29, 2004|Actual|2004-07-29||Interventional|||Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer|A Phase II Study of MR-Guided High Dose Rate Brachytherapy Boosts For Prostate Cancer|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:05:32.935147|2017-02-18 18:05:32.935147
NCT00039611|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-06-18|||May 2002||2002-05-01|July 2002|2002-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|Oxaliplatin (NSC 266046) in Combination With 5-Fluorouracil and Leucovorin (FOLFOX4) for Patients Who Have Not Received Prior Chemotherapy for Advanced Colorectal Cancer|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:33.048047|2017-02-18 18:05:33.048047
NCT00039585|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2015-04-29|||May 2002||2002-05-01|February 2007|2007-02-01||||February 2006|Actual|2006-02-01||Interventional|||Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor|Phase II Clinical Trial With Proteomic Profiling Of Imatinib Mesylate (Gleevec; STI571), A PDGFR And C-Kit Inhibitor, In Patients With Refractory Or Relapsed Epithelial Ovarian Cancer, Fallopian Tube And Primary Peritoneal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:05:33.159359|2017-02-18 18:05:33.159359
NCT00039572|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-06-25|||May 2002||2002-05-01|July 2002|2002-07-01|January 2005|Actual|2005-01-01|||||Interventional|||Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain|A Phase I/II Trial For Neutron Capture Therapy In Glioblastoma Multiforme And Intracranial Melanoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:33.350907|2017-02-18 18:05:33.350907
NCT00039559|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-06-07|||May 2002||2002-05-01|June 2013|2013-06-01|December 2014|Anticipated|2014-12-01|December 2013|Anticipated|2013-12-01||Interventional|||Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer|Ovarian Cancer Screening Pilot Trial in High Risk Women|Unknown status|Active, not recruiting|N/A|2430|Anticipated|Massachusetts General Hospital||1|||f||||t||||||||||2017-02-18 18:05:33.437163|2017-02-18 18:05:33.437163
NCT00039546|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-08-06|||August 2001||2001-08-01|May 2005|2005-05-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery|'tAnGo', A Phase III Randomised Trial Of Gemcitabine In Paclitaxel-Containing, Epirubicin-Based, Adjuvant Chemotherapy For ER/PgR-Poor, Early Stage, Breast Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:33.546641|2017-02-18 18:05:33.546641
NCT00039520|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2014-05-05|||January 2002||2002-01-01|May 2014|2014-05-01|July 2008|Actual|2008-07-01|June 2004|Actual|2004-06-01||Interventional|||Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer|A Phase II Trial Of Exisulind With Docetaxel In Patients With Metastatic Adenocarcinoma Of The Breast|Completed||Phase 2|10|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-02-18 18:05:33.677808|2017-02-18 18:05:33.677808
NCT00039507|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2010-02-11|||June 2002||2002-06-01|February 2010|2010-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer|Pilot Study: Radiofrequency Ablation Of Resectable Non-Small Cell Lung Cancer|Completed||Phase 2|||Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 18:05:33.774316|2017-02-18 18:05:33.774316
NCT00039494|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-08-01|||December 2002||2002-12-01|August 2013|2013-08-01||||July 2007|Actual|2007-07-01||Interventional|||Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors|A Pilot and Phase II Study of OSI-774 and Temozolomide in Combination With Radiation Therapy in Glioblastoma Multiforme|Completed||Phase 2|171|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:33.866806|2017-02-18 18:05:33.866806
NCT00039481|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-01-16|||November 2002||2002-11-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors|A Phase I Trial Of G3139 (BCL-2 Antisense, NSC# 683428, IND# 58842) Combined With Cytotoxic Chemotherapy In Relapsed Childhood Solid Tumors|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:34.380331|2017-02-18 18:05:34.380331
NCT00039468|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2011-10-26|||March 2002||2002-03-01|October 2011|2011-10-01|February 2008|Actual|2008-02-01|September 2007|Actual|2007-09-01||Interventional|||Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy|A Phase II Study Of Thalidomide And CPT-11 (IRINOTECAN) Following Radiotherapy For Glioblastoma Multiforme|Completed||Phase 2|26|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 18:05:34.51863|2017-02-18 18:05:34.51863
NCT00039455|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-01-31|||April 2002||2002-04-01|January 2013|2013-01-01||||December 2004|Actual|2004-12-01||Interventional|||Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer|A Phase I Study of Herceptin/Flavopiridol in HER-2 Positive Metastatic Breast Cancer|Terminated||Phase 1|50|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:05:34.635373|2017-02-18 18:05:34.635373
NCT00039442|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2016-12-07|||April 2002||2002-04-01|December 2016|2016-12-01||||December 2005|Actual|2005-12-01||Interventional|||Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation Of Capecitabine (NSC #712807) In The Treatment Of Persistent Or Recurrent Non-Squamous Cell Carcinoma Of The Cervix|Completed||Phase 2|21|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:05:34.751878|2017-02-18 18:05:34.751878
NCT00039429|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2010-01-26|||May 2003||2003-05-01|January 2010|2010-01-01||||April 2006|Actual|2006-04-01||Interventional|||Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer|A Phase II Trial Evaluating Atrasentan In Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|180|Anticipated|Eastern Cooperative Oncology Group|||||||||f||||||||||2017-02-18 18:05:34.870863|2017-02-18 18:05:34.870863
NCT00039416|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2014-02-24|||April 2002||2002-04-01|December 2012|2012-12-01||||August 2007|Actual|2007-08-01||Interventional|||Imatinib Mesylate in Treating Patients With Myelofibrosis|A Phase II Study Of Gleevec (Imatinib Mesylate Formerly Known as STI-571) In Patients With Myelofibrosis|Completed||Phase 2|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:35.162|2017-02-18 18:05:35.162
NCT00039403|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-01-22|||April 2002||2002-04-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer|A Phase I Study Of UCN-01 In Combination With Gemcitabine In Unresectable Or Metastatic Pancreatic Carcinoma|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:35.280259|2017-02-18 18:05:35.280259
NCT00039390|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-01-24|||April 2002||2002-04-01|January 2013|2013-01-01||||May 2007|Actual|2007-05-01||Interventional|||Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors|A Phase I Trial of ZD1839 With Capecitabine in Patients With Advanced Solid Tumors (Formerly a Phase I Trial of ZD1839 With Capecitabine and Celecoxib)|Completed||Phase 1|41|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:05:35.415973|2017-02-18 18:05:35.415973
NCT00039377|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2014-11-13|2013-11-27||April 2002||2002-04-01|June 2014|2014-06-01|February 2014|Actual|2014-02-01|April 2012|Actual|2012-04-01||Interventional|||Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|A Phase II Trial of Sequential Chemotherapy, Imatinib Mesylate (Gleevec, STI571) (NSC # 716051), and Transplantation for Adults With Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia by the CALGB and SWOG|Completed||Phase 2|58|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 18:05:35.838903|2017-02-18 18:05:35.838903
NCT00039364|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2012-07-23|||March 2002||2002-03-01|July 2012|2012-07-01||||August 2004|Actual|2004-08-01||Interventional|||Imatinib Mesylate in Treating Patients With Gliomas|Open Label Phase II Study On STI571 (Glivec) Administered As A Daily Oral Treatment In Gliomas|Completed||Phase 2|112|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:05:37.124353|2017-02-18 18:05:37.124353
NCT00039351|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2012-09-20|||March 2002||2002-03-01|September 2012|2012-09-01||||January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma|Diffuse Large B Cell And Peripheral T-Cell Non-Hodgkin's Lymphoma In The Frail Elderly. Progressive And Cautious Treatment Strategy In Poor Status Patients. A Phase II Trial With Emphasis On Geriatric Assessment And Quality Of Life|Completed||Phase 2|32|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:05:37.229312|2017-02-18 18:05:37.229312
NCT00039338|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2016-12-02|||March 2002||2002-03-01|December 2016|2016-12-01||||July 2019|Anticipated|2019-07-01||Interventional|||Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer|Randomized Phase III Study Of Neoadjuvant Chemotherapy Followed By Surgery Vs. Concomitant Radiotherapy And Chemotherapy In FIGO Ib2, IIa>4 cm or IIb Cervical Cancer|Active, not recruiting||Phase 3|686|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||t||||||||||2017-02-18 18:05:37.337576|2017-02-18 18:05:37.337576
NCT00039325|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2015-10-01|||March 2002||2002-03-01|July 2012|2012-07-01|June 2009|Actual|2009-06-01|September 2005|Actual|2005-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma|A Phase I/II Trial Testing Mart-1 Genetic Immunization In Malignant Melanoma|Completed||Phase 1/Phase 2|28|Actual|Jonsson Comprehensive Cancer Center||5|||f||||t||||||||||2017-02-18 18:05:37.465752|2017-02-18 18:05:37.465752
NCT00039312|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2012-07-27|||December 1999||1999-12-01|July 2012|2012-07-01|April 2010|Actual|2010-04-01|August 2003|Actual|2003-08-01||Interventional|||Comparison of Screening Tests in Detecting Cervical Neoplasia|Multi-Institutional Prospective Cohort Study For The Comparison Of Different Primary Screening Strategies For The Detection Of Cervical Neoplasia|Completed||N/A|15|Actual|Jonsson Comprehensive Cancer Center|||||f||||f||||||||||2017-02-18 18:05:37.84491|2017-02-18 18:05:37.84491
NCT00039299|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-04-02|||March 2002||2002-03-01|June 2003|2003-06-01|June 2003|Actual|2003-06-01|||||Interventional|||Biological Therapy in Treating Patients With Prostate Cancer|A Phase I Safety Study Of Xcellerate In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:37.953151|2017-02-18 18:05:37.953151
NCT00039286|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2015-12-23|||October 2001||2001-10-01|December 2015|2015-12-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer|A Pilot Study To Assess The Utility Of 18F-Fluorodeoxyglucose Positron Emission Tomography (PET) In The Pre-Operative Evaluation Of Patients With Primary And Recurrent Breast Carcinoma|Completed||Phase 1|118|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:05:38.042088|2017-02-18 18:05:38.042088
NCT00039273|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-01-07|||July 2002||2002-07-01|January 2013|2013-01-01||||May 2003|Actual|2003-05-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer|An Open Label Phase II Clinical Trial To Evaluate The Safety And Efficacy Of ABX-EGF In Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|44|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:05:38.160754|2017-02-18 18:05:38.160754
NCT00039234|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2013-12-17|||September 2002||2002-09-01|December 2003|2003-12-01||||||||Interventional|||Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver|A Phase III, Multi-Center Controlled Trial With Stratified Randomization Comparing The Efficacy Of Interleukin-2 (IL-2) Plus Histamine Dihydrochloride (HDC) Versus IL-2 Alone To Increase The Duration Of Survival In Patients With AJCC Stage IV Malignant Melanoma With Hepatic Metastasis|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:05:38.257609|2017-02-18 18:05:38.257609
NCT00039208|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2012-07-12|||February 2002||2002-02-01|July 2012|2012-07-01||||August 2005|Actual|2005-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Colorectal Cancer|Time Finding Study of Chronomodulated Irinotecan, 5 Fluorouracil, Leucovorin and Oxaliplatin as First or Second Chemotherapy Line Against Metastatic Colorectal Cancer|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:05:38.374543|2017-02-18 18:05:38.374543
NCT00038987|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-06|2010-08-26|||May 2002||2002-05-01|December 2003|2003-12-01|August 2002||2002-08-01|||||Interventional|||Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT|A Phase I/II Study to Evaluate the Safety and Preliminary Efficacy of Various Concentrations of Aventis Pasteur's Smallpox Vaccine, USP (APSV) in Vaccinia-naive Adults|Completed||Phase 1/Phase 2|330||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:05:38.510864|2017-02-18 18:05:38.510864
NCT00038974|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2011-03-15|||August 2002||2002-08-01|March 2011|2011-03-01||||||||Interventional|||Hepatitis C Antiviral Resistance in African-Americans|Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)|Completed||Phase 3|400||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 18:05:38.596917|2017-02-18 18:05:38.596917
NCT00038961|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2016-08-31|||November 2001||2001-11-01|August 2016|2016-08-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).|A Multicenter, Randomized, Double-blind, Parallel Group Trial to Demonstrate the Efficacy of Fondaparinux Sodium in Association With Intermittent Pneumatic Compression (IPC) Versus IPC Used Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdomi|Completed||Phase 3|1309|Actual|GlaxoSmithKline||2|||f||||t||||||||Yes|Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.|2017-02-18 18:05:38.686189|2017-02-18 18:05:38.686189
NCT00038948|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2010-04-22|2009-05-29||January 2002||2002-01-01|April 2010|2010-04-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients|A Randomized, Open-label, Comparative Evaluation of Conversion From Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients|Completed||Phase 3|830|Actual|Wyeth is now a wholly owned subsidiary of Pfizer||2|||f||||t||||||||||2017-02-18 18:05:38.818681|2017-02-18 18:05:38.818681
NCT00038727|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-04|2014-06-16|||September 2002||2002-09-01|June 2014|2014-06-01|January 2015|Anticipated|2015-01-01|October 2013|Actual|2013-10-01||Interventional|DPPOS||Diabetes Prevention Program Outcomes Study|Diabetes Prevention Program Outcomes Study|Unknown status|Active, not recruiting|Phase 3|2776|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||3|||f||||t||||||||||2017-02-18 18:05:41.861885|2017-02-18 18:05:41.861885
NCT00038935|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2008-04-18||||||April 2008|2008-04-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A|A Single Dose, Randomized, Double-Blind, 2-Period Crossover Study in Patients With Hemophilia A to Evaluate the Pharmacokinetics of B-Domain Deleted Recombinant Human Factor VIII (BDDrFVIII) Manufactured by the Current Process (ReFacto) and by an Albumin Free Manufacturing Process (ReFacto AF)|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:05:39.932908|2017-02-18 18:05:39.932908
NCT00038922|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2006-05-17||||||May 2006|2006-05-01||||||||Interventional|||Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating, Safety and Exploratory Pharmacogenomic Study of Orally Administered Recombinant Human Interleukin Eleven (rhIL-11) in Patients With Mild to Moderate Left-Sided Ulcerative Colitis|Terminated||Phase 1|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:05:40.015301|2017-02-18 18:05:40.015301
NCT00038909|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2013-02-07|||September 1994||1994-09-01|February 2013|2013-02-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Study Evaluating ReFacto in Hemophilia A|Factor VIII Mutation Testing Program in Previously Untreated Patients (PUPs) With Hemophilia A Participating in ReFacto® Study|Completed||N/A|103|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 18:05:40.094553|2017-02-18 18:05:40.094553
NCT00038896|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2009-08-13|||April 2001||2001-04-01|August 2009|2009-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study Evaluating Venlafaxine ER in Adults With Panic Disorder|A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder|Completed||Phase 3|343|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:05:40.166383|2017-02-18 18:05:40.166383
NCT00038883|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-07-27|||April 2001||2001-04-01|July 2012|2012-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies|Campath-1H Snd Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies|Completed||N/A|19|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:40.250253|2017-02-18 18:05:40.250253
NCT00038870|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-08-02|||January 2001||2001-01-01|August 2012|2012-08-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes|Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 18:05:40.376487|2017-02-18 18:05:40.376487
NCT00038857|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-08-07|2012-06-21||September 2001||2001-09-01|August 2012|2012-08-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Interventional|||Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases|Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases|Completed||Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:40.486314|2017-02-18 18:05:40.486314
NCT00038844|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2011-10-31|||June 2001||2001-06-01|October 2011|2011-10-01|September 2010|Actual|2010-09-01|December 2007|Actual|2007-12-01||Interventional|||Safety and Efficacy of Campath in Nonmyeloablative Transplantation|Safety and Efficacy of Campath in Nonmyeloablative Transplantation|Completed||N/A|65|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:40.743244|2017-02-18 18:05:40.743244
NCT00038831|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-07-31|||May 2001||2001-05-01|July 2012|2012-07-01|October 2006|Actual|2006-10-01|March 2005|Actual|2005-03-01||Interventional|||Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS|Phase I/II Evaluation of Safety and Activity of Mylotarg Plus Melphalan and Fludarabine as Preparative Therapy for Older or Medically Infirm Patients Undergoing Allogeneic Bone Marrow and Peripheral Blood Stem Cell Transplantation|Completed||Phase 1/Phase 2|47|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:41.115928|2017-02-18 18:05:41.115928
NCT00038818|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-08-22|||May 2001||2001-05-01|August 2012|2012-08-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation|CD8 Depleted Donor Lymphocyte Infusions for Patients With Relapse Or Residual Disease Following Allogeneic Stem Cell Transplantation|Terminated||N/A|3|Actual|M.D. Anderson Cancer Center||1||Low accrual.|f||||f||||||||||2017-02-18 18:05:41.245175|2017-02-18 18:05:41.245175
NCT00038805|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-07-27|||May 2001||2001-05-01|July 2012|2012-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)|Allogeneic Stem Cell Transplantation Using Mylotarg (CMA-676) Plus Nonmyeloablative Chemotherapy in Older or Medically Infirm Patients With High-Risk Acute Leukemia (ALL), Chronic Myelogenous Leukemia (CML) or Myelodysplastic Syndrome (MDS)|Terminated||Phase 2/Phase 3|3|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:41.342211|2017-02-18 18:05:41.342211
NCT00038792|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-08-01|||October 2000||2000-10-01|August 2012|2012-08-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD|A Phase I/II Trial of Recombinant Human Keratinocyte Growth Factor (rHuKFG) for the Treatment of Steroid Refractory Gastrointestinal Acute Graft-versus-host Disease (aGvHD)|Terminated||Phase 1/Phase 2|7|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||t||||||||||2017-02-18 18:05:41.451951|2017-02-18 18:05:41.451951
NCT00038779|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-08-03|||August 1996||1996-08-01|August 2012|2012-08-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States|Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States|Terminated||N/A|7|Actual|M.D. Anderson Cancer Center||1||Lack of Accrual|f||||f||||||||||2017-02-18 18:05:41.559863|2017-02-18 18:05:41.559863
NCT00038766|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-05|2012-08-22|||June 2002||2002-06-01|August 2012|2012-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|CD02||CNI-1493 for Treatment of Moderate to Severe Crohn's Disease|A Randomized, Double-Blind, Placebo-controlled Study of CNI-1493 for Treatment of Moderate to Severe Crohn's Disease|Terminated||Phase 2|33|Actual|Ferring Pharmaceuticals||3||Unable to enroll into study.|f||||f||||||||||2017-02-18 18:05:41.645012|2017-02-18 18:05:41.645012
NCT00038753|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-04|2009-10-15||||||October 2009|2009-10-01||||||||Interventional|||Vision In Preschoolers Study (VIP Study)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:05:41.769116|2017-02-18 18:05:41.769116
NCT00038714|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-04|2007-06-26|||November 2001||2001-11-01|June 2007|2007-06-01|January 2004||2004-01-01|||||Interventional|||A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis|A Phase II Trial of SGN-00101 In The Treatment of Pediatric Recurrent Respiratory Papillomatosis|Completed||Phase 2|27|Anticipated|Nventa Biopharmaceuticals Corporation|||||||||||||||||||2017-02-18 18:05:41.995306|2017-02-18 18:05:41.995306
NCT00038701|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-04|2012-07-27|||August 2000||2000-08-01|July 2012|2012-07-01|May 2004|Actual|2004-05-01|July 2002|Actual|2002-07-01||Interventional|||Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas|Phase II Study of Gemcitabine-Based Chemoradiation and TNP-470 for Patients With Locally Advanced, Nonmetastatic Adenocarcinoma of the Pancreas|Terminated||Phase 2|6|Actual|M.D. Anderson Cancer Center||1||Slow accrual.|f||||f||||||||||2017-02-18 18:05:42.084557|2017-02-18 18:05:42.084557
NCT00038688|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-04|2009-10-29||||||March 2006|2006-03-01||||||||Interventional|||A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts|A Phase III Randomized Study to Evaluate the Efficacy of a Network-Oriented Peer Education Intervention for the Prevention of HIV Transmission Among Injection Drug Users and Their Network Members|Completed||Phase 3|2610||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:05:42.181721|2017-02-18 18:05:42.181721
NCT00038675|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-04|2013-12-10|||June 2001||2001-06-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate|Therapy of Hypereosinophilic Syndrome, Polycythemia Vera, Atypical CML or CMML With Platelet Derived Growth Factor (PDGF-R) Fusion Genes, or Mastocytosis With Imatinib Mesylate (STI571)|Completed||N/A|125|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 18:05:42.273364|2017-02-18 18:05:42.273364
NCT00038662|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-03|2006-08-10|||May 2002||2002-05-01|August 2006|2006-08-01||||||||Interventional|||Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure|A Phase 2 Study Evaluating the Safety and Efficacy of Atrasentan (ABT-627) in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure|Completed||Phase 2|200||Abbott|||||||||||||||||||2017-02-18 18:05:42.391215|2017-02-18 18:05:42.391215
NCT00038649|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-03|2013-12-06|||June 2001||2001-06-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Higher-Dose Gleevec (STI571)|Terminated||Phase 2|117|Actual|M.D. Anderson Cancer Center||1||Sponsor discontinued providing study drug.|f||||t||||||||||2017-02-18 18:05:42.514077|2017-02-18 18:05:42.514077
NCT00038636|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-03|2006-08-13|||September 2000||2000-09-01|August 2006|2006-08-01||||||||Interventional|||A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors|A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors|Completed||Phase 3|36||Abbott|||||||||||||||||||2017-02-18 18:05:42.626418|2017-02-18 18:05:42.626418
NCT00038623|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-03|2011-10-31|||April 2002||2002-04-01|October 2011|2011-10-01|February 2010|Actual|2010-02-01|December 2007|Actual|2007-12-01||Interventional|||Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma|A Phase II Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma|Completed||Phase 2|35|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:42.715306|2017-02-18 18:05:42.715306
NCT00038610|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-03|2015-08-19|2015-08-19||March 2001||2001-03-01|August 2015|2015-08-01|July 2014|Actual|2014-07-01|July 2014|Actual|2014-07-01||Interventional|||Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia|Phase II Study of Hyper-CVAD Plus Imatinib Mesylate (Gleevec, STI571) for Philadelphia-Positive Acute Lymphocytic Leukemia|Completed||Phase 2|54|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:42.833881|2017-02-18 18:05:42.833881
NCT00038597|ClinicalTrials.gov processed this data on February 17, 2017|2002-06-03|2012-01-20|||April 2001||2001-04-01|January 2012|2012-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)|Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)|Completed||Phase 2|13|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-02-18 18:05:43.139747|2017-02-18 18:05:43.139747
NCT00038584|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2012-07-31|||June 1999||1999-06-01|July 2012|2012-07-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer|A Phase IB Study of Oral Administration of SCH 66336 Preoperatively in Patients With Head and Neck Squamous Cell Cancer Scheduled for Definitive Therapy|Completed||Phase 1|37|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:43.227516|2017-02-18 18:05:43.227516
NCT00038571|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2012-07-27|||May 2002||2002-05-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy|Phase II Study of Proteasome Inhibitor PS-341 For Patients With Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 18:05:43.302811|2017-02-18 18:05:43.302811
NCT00038558|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2012-07-27|||November 2001||2001-11-01|July 2012|2012-07-01|March 2005|Actual|2005-03-01|February 2004|Actual|2004-02-01||Interventional|||Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy|Prophylactic Use of Filgrastim SD/01 In Patients With Hodgkin's Disease Receiving ABVD Chemotherapy|Completed||Phase 3|25|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 18:05:43.431447|2017-02-18 18:05:43.431447
NCT00038545|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2012-01-20|||May 2001||2001-05-01|January 2012|2012-01-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma|A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Patients With Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|25|Actual|M.D. Anderson Cancer Center|||||f||||f||||||||||2017-02-18 18:05:43.555946|2017-02-18 18:05:43.555946
NCT00038337|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2009-01-20|||April 2001||2001-04-01|May 2002|2002-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Improving Functional Health Literacy in Older Veterans|Improving Functional Health Literacy in Older Veterans|Completed||Phase 2|240|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:05:54.597996|2017-02-18 18:05:54.597996
NCT00038532|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2008-03-29|||April 2001||2001-04-01|July 2006|2006-07-01||||||||Interventional|||Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART|An Open Label, Phase II Study of Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART|Completed||Phase 2|24||Abbott|||||||||||||||||||2017-02-18 18:05:43.65174|2017-02-18 18:05:43.65174
NCT00038519|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2006-07-27|||April 2001||2001-04-01|July 2006|2006-07-01||||||||Interventional|||Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor|An Open Label, Phase II Study of Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra (Lopinavir/Ritonavir) as Their Second Protease Inhibitor.|Completed||Phase 2/Phase 3|16||Abbott|||||||||||||||||||2017-02-18 18:05:43.798728|2017-02-18 18:05:43.798728
NCT00038506|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2015-04-06|||March 2002||2002-03-01|October 2010|2010-10-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure|A Phase IV, Open-label, Multicenter Study of Treatment With TRIZIVIR (Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg) Twice Daily and Tenofovir 300mg Once-daily for 48 Weeks in HIV-infected Subjects Experiencing Early Virologic Failure (ZIAGEN Intensification Protocol)|Completed||Phase 4|100||ViiV Healthcare||1|||||||||||||||||2017-02-18 18:05:44.048312|2017-02-18 18:05:44.048312
NCT00038493|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2012-01-20|||September 2001||2001-09-01|January 2012|2012-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme|Phase II Evaluation Temozolomide and Farnesyl Transferase Inhibitor (SCH66336) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme|Terminated||Phase 2|23|Actual|M.D. Anderson Cancer Center||||Lack of Accrual|f||||f||||||||||2017-02-18 18:05:44.175237|2017-02-18 18:05:44.175237
NCT00038480|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2012-05-17||||||May 2012|2012-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants|A Phase I/II Study of Lopinavir/Ritonavir in HIV-1 Infected Infants Less Than 6 Months of Age|Completed||Phase 1|31|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:05:44.275198|2017-02-18 18:05:44.275198
NCT00038467|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-31|2014-04-21|2014-03-05||February 1998||1998-02-01|April 2014|2014-04-01|March 2013|Actual|2013-03-01|June 2003|Actual|2003-06-01||Interventional|IES|Intent-to-treat (ITT) population included all participants assigned to the treatment group to which they were randomized, irrespective of the treatment they actually received.|Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer|Randomized Double-Blind Trial In Postmenopausal Women With Primary Breast Cancer Who Have Received Adjuvant Tamoxifen For 2-3 Years, Comparing Subsequent Adjuvant Exemestane Treatment With Further Tamoxifen|Completed||Phase 3|4740|Actual|Pfizer|Other AEs included both SAEs and AEs. Non-SAE could not be presented separately for this study as AEs were collected in clinical database where SAE flags were not collected.|2|||f||||t||||||||||2017-02-18 18:05:44.633185|2017-02-18 18:05:44.633185
NCT00038454|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2005-06-23||||||April 2003|2003-04-01||||||||Interventional|||Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery|A Phase II, Randomized, Single-Blind, Controlled Clinical Trial to Evaluate the Efficacy and Safety of Hemolink[Tm] (o-Raffinose Cross-Linked Human Hemoglobin) in Subjects Undergoing Primary Coronary Artery Bypass Grafting Surgery|Suspended||Phase 2/Phase 3|180||Hemosol|||||||||||||||||||2017-02-18 18:05:53.383561|2017-02-18 18:05:53.383561
NCT00038441|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2012-07-27|||September 1995||1995-09-01|July 2012|2012-07-01|August 2005|Actual|2005-08-01|February 2003|Actual|2003-02-01||Interventional|||Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas|Phase I Trial of Intratumoral Injection of DTI-015 for Recurrent Malignant Gliomas|Completed||Phase 1/Phase 2|39|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:53.501044|2017-02-18 18:05:53.501044
NCT00038428|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2011-07-21|||June 2001||2001-06-01|June 2011|2011-06-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer||Completed||Phase 2|40||Telik||1|||f||||||||||||||2017-02-18 18:05:53.602973|2017-02-18 18:05:53.602973
NCT00038415|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2012-08-01|||December 2001||2001-12-01|August 2012|2012-08-01|January 2005|Actual|2005-01-01|July 2004|Actual|2004-07-01||Interventional|||A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach|A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach|Terminated||Phase 1/Phase 2|2|Actual|M.D. Anderson Cancer Center||1||Vaccine unavailable.|f||||t||||||||||2017-02-18 18:05:53.673088|2017-02-18 18:05:53.673088
NCT00038402|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2012-07-19|||April 2001||2001-04-01|July 2012|2012-07-01|July 2011|Actual|2011-07-01|November 2004|Actual|2004-11-01||Interventional|||Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer|Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer|Completed||Phase 3|74|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:53.775105|2017-02-18 18:05:53.775105
NCT00038389|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2012-07-27|||January 2002||2002-01-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|October 2004|Actual|2004-10-01||Interventional|||Study of Vioxx and Radiation Therapy for Brainstem Glioma|Phase I Study of Vioxx and Radiation Therapy for Brainstem Glioma|Terminated||Phase 1|8|Actual|M.D. Anderson Cancer Center||1||Unavailability of study drug.|f||||f||||||||||2017-02-18 18:05:53.903914|2017-02-18 18:05:53.903914
NCT00038376|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2012-07-27|||May 1990||1990-05-01|July 2012|2012-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies|Phase II Study of Interferon Alpha and Isotretinoin in Patients With T-Cell Malignancies|Terminated||Phase 2|60|Anticipated|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:54.280836|2017-02-18 18:05:54.280836
NCT00038363|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2009-01-20|||April 2001||2001-04-01|May 2002|2002-05-01|March 2004|Actual|2004-03-01|||||Interventional|||Comparison of Subacute and Hospital Based Rehabilitation Care|Comparison of Subacute and Hospital Based Rehabilitation Care|Completed||Phase 2|260|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:05:54.403299|2017-02-18 18:05:54.403299
NCT00038350|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2008-05-05|||January 2002||2002-01-01|May 2008|2008-05-01|March 2006|Actual|2006-03-01|January 2006|Actual|2006-01-01||Interventional|||Effects of Age and Age-Related Diseases on Swallowing|Effects of Age and Age-Related Diseases on Swallowing|Completed||Phase 2|60|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:05:54.486626|2017-02-18 18:05:54.486626
NCT00038311|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-30|2015-04-30|||September 2000||2000-09-01|April 2015|2015-04-01|March 2003|Actual|2003-03-01|||||Interventional|||Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia|Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Administered to Patients With High-Risk Sarcoma Receiving Intensive Chemotherapy (Adriamycin and Ifosfamide (AI))|Completed||Phase 3|120||Pfizer|||||f||||||||||||||2017-02-18 18:05:54.673818|2017-02-18 18:05:54.673818
NCT00038298|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2011-01-20|||April 2002||2002-04-01|January 2011|2011-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Assess the Efficacy, Safety and Tolerability of AMG 719 in Subjects With Rheumatoid Arthritis Receiving Methothrexate|Completed||Phase 2|53|Actual|Amgen||4|||f||||||||||||||2017-02-18 18:05:54.76428|2017-02-18 18:05:54.76428
NCT00038285|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2009-01-20|||April 2002||2002-04-01|May 2002|2002-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)|Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:05:54.859646|2017-02-18 18:05:54.859646
NCT00038272|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2012-05-17||||||May 2012|2012-05-01|April 2006|Actual|2006-04-01|||||Interventional|||A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection|A Phase I/II Randomized, Double-Blind, Placebo-Controlled Pilot Study of Beta-D-2,6-diaminopurine Dioxolane (DAPD) Versus DAPD Plus Mycophenolate Mofetil (MMF) in Treatment-Experienced Subjects|Completed||Phase 2|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:05:54.939926|2017-02-18 18:05:54.939926
NCT00038259|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2012-05-09||||||May 2012|2012-05-01|May 2006|Actual|2006-05-01|||||Interventional|||Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy|An Exploratory, Open-Label, Randomized Trial to Evaluate the Ability of Interleukin-2 (IL-2) to Enhance HIV-Specific Immunity and Influence the Time to Virologic Relapse Following Withdrawal of Potent Antiretroviral Therapy|Completed||N/A|21||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:05:55.047158|2017-02-18 18:05:55.047158
NCT00038246|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2013-05-31|||October 2000||2000-10-01|May 2013|2013-05-01|December 2004|Actual|2004-12-01|February 2004|Actual|2004-02-01||Interventional|||Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma|Phase I/II Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma (AI-PCa)|Completed||Phase 1/Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 18:05:55.154678|2017-02-18 18:05:55.154678
NCT00038233|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2012-07-27|||May 1999||1999-05-01|July 2012|2012-07-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Thalidomide for Multiple Myeloma|Thalidomide for Multiple Myeloma|Completed||Phase 3|27|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 18:05:55.275522|2017-02-18 18:05:55.275522
NCT00038220|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2006-07-26|||July 2000||2000-07-01|July 2006|2006-07-01||||||||Interventional|||Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients|A Phase I/II, Open Label Study to Evaluate the Ability of Combination Therapy With ABT-378/Ritonavir (Kaletra), Lamivudine (Epivir), Efavirenz (Sustiva)and Tenofovir DF to Completely Suppress Viral Replication in Subjects Infected With HIV-1|Completed||Phase 2|40||Abbott|||||||||||||||||||2017-02-18 18:05:55.396949|2017-02-18 18:05:55.396949
NCT00038207|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2012-07-27|||June 2000||2000-06-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|September 2004|Actual|2004-09-01||Interventional|||Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies|Phase II Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies|Completed||Phase 2|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:55.490798|2017-02-18 18:05:55.490798
NCT00038194|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2012-07-31|||October 2001||2001-10-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer|Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer|Completed||Phase 1|28|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:55.604642|2017-02-18 18:05:55.604642
NCT00038181|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2012-07-31|||October 2000||2000-10-01|July 2012|2012-07-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer|A Tolerance and Efficacy Trial of Preoperative Thalidomide Treatment Followed by Radical Retropubic Prostatectomy (RRP) in Select Patients With Locally Advanced Prostate Cancer|Completed||Phase 2|18|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:55.716193|2017-02-18 18:05:55.716193
NCT00038168|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2012-07-31|||June 2000||2000-06-01|July 2012|2012-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma|Phase I/II Study of Intravenous Estramustine Phosphate Combined With Taxol in Patients With Hormone Refractory Adenocarcinoma of the Prostate|Completed||Phase 1/Phase 2|14|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:55.802058|2017-02-18 18:05:55.802058
NCT00038155|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2010-09-22|||May 2002||2002-05-01|September 2010|2010-09-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|STAGE||Rehabilitation for Older Adults From Acute Medical Conditions|Rehabilitation for Older Adults From Acute Medical Conditions|Completed||Phase 2|10|Actual|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:05:55.906836|2017-02-18 18:05:55.906836
NCT00038142|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2016-03-03|||November 1997||1997-11-01|March 2016|2016-03-01|March 2016|Actual|2016-03-01|March 2016|Actual|2016-03-01||Interventional|||Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients|Randomized Phase II Study of Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) With or Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma|Terminated||Phase 2|46|Actual|M.D. Anderson Cancer Center||2||Low Accrual|f||||t||||||||||2017-02-18 18:05:56.001453|2017-02-18 18:05:56.001453
NCT00038129|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2013-06-17|||May 2002||2002-05-01|June 2013|2013-06-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||SPRINT - Randomized Trial of Tibial Fracture Fixation|Study to Prospectively Evaluate Reamed Intramedullary Nails in Tibial Shaft Fractures (SPRINT)|Completed||N/A|1200|Anticipated|University of Minnesota - Clinical and Translational Science Institute||2|||f||||f||||||||||2017-02-18 18:05:56.126758|2017-02-18 18:05:56.126758
NCT00038116|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2013-02-04|||May 1995||1995-05-01|March 2010|2010-03-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Embryonic Dopamine Cell Implants for Parkinson's Disease|Embryonic Dopamine Cell Implants for Parkinson's Disease: A Double-Blind Study|Completed||Phase 3|40|Actual|University of Colorado, Denver||2|||f||||||||||||||2017-02-18 18:05:56.317906|2017-02-18 18:05:56.317906
NCT00038103|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-29|2010-02-11|2009-03-27||January 2002||2002-01-01|February 2010|2010-02-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen|Open-Label, Multicentre, Controlled Study Of Exemestane (Aromasin®) With Or Without Celecoxib (Celebrex®) In Postmenopausal Women With Advanced Breast Cancer (ABC) Having Progressed On Tamoxifen|Completed||Phase 2|111|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 18:05:56.642058|2017-02-18 18:05:56.642058
NCT00038090|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-28|2012-07-31|||September 2001||2001-09-01|July 2012|2012-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Thalidomide-Dexamethasone for Multiple Myeloma|Thalidomide-Dexamethasone for Multiple Myeloma|Completed||Phase 2/Phase 3|83|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:57.513035|2017-02-18 18:05:57.513035
NCT00038077|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-28|2010-11-17|||August 2001||2001-08-01|November 2010|2010-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Reversal of Ventricular Remodeling With Toprol-XL||Completed||Phase 3|300||AstraZeneca|||||||||||||||||||2017-02-18 18:05:57.633477|2017-02-18 18:05:57.633477
NCT00038064|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-28|2008-09-11|||January 2002||2002-01-01|September 2008|2008-09-01|April 2004|Actual|2004-04-01|October 2003|Actual|2003-10-01||Interventional|||Anemia in Patients With a Non-Myeloid Malignancy|A Randomized, Open-Label Study of Darbepoetin Alfa (Novel Erythropoiesis Stimulation Protein, NESP) and rHuEPO for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 3|707|Actual|Amgen||2|||f||||||||||||||2017-02-18 18:05:57.75281|2017-02-18 18:05:57.75281
NCT00038051|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2013-04-01|||May 1999||1999-05-01|April 2013|2013-04-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Interventional|||Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies|Phase I Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies|Completed||Phase 1|28|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 18:05:57.861317|2017-02-18 18:05:57.861317
NCT00038038|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2012-07-31|||January 1994||1994-01-01|July 2012|2012-07-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole|Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole|Withdrawn||N/A|0|Actual|M.D. Anderson Cancer Center||1||No participants enrolled, study terminated.|f||||f||||||||||2017-02-18 18:05:57.980008|2017-02-18 18:05:57.980008
NCT00038025|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2012-08-01|||September 1994||1994-09-01|August 2012|2012-08-01|November 2006|Actual|2006-11-01|August 2006|Actual|2006-08-01||Interventional|||A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies|A Phase II Study of Deoxycoformycin (DCF) in Lymphoid Malignancies|Completed||Phase 2|60|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:58.096936|2017-02-18 18:05:58.096936
NCT00038012|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2012-07-31|||September 1999||1999-09-01|July 2012|2012-07-01|June 2004|Actual|2004-06-01|October 2002|Actual|2002-10-01||Interventional|||rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin|A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopreserved With Thrombosol and 2% DMSO in Patients With Gynecologic Malignancy Receiving Carboplatin|Completed||N/A|31|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:58.208464|2017-02-18 18:05:58.208464
NCT00037999|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2009-01-20|||April 2001||2001-04-01|May 2002|2002-05-01|March 2004|Actual|2004-03-01|||||Interventional|||The Effect of Testosterone Supplementation on Rehabilitation Outcomes|The Effect of Testosterone Supplementation on Rehabilitation Outcomes|Completed||Phase 2|60|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:05:58.314005|2017-02-18 18:05:58.314005
NCT00037986|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2009-02-09|||July 2001||2001-07-01|February 2009|2009-02-01|June 2004|Actual|2004-06-01|May 2004|Actual|2004-05-01||Interventional|||Functioning, Disability, and Quality of Life in the Adult Hearing Impaired|Functioning, Disability, and Quality of Life in the Adult Hearing Impaired|Completed||Phase 2|330|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:05:58.39676|2017-02-18 18:05:58.39676
NCT00037973|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2010-09-15|||August 2000||2000-08-01|September 2010|2010-09-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Effect of Ventilation-Feedback Training on Exercise Performance in COPD|Effects of Ventilation-Feedback Training on Exercise Performance in COPD|Completed||Phase 2|108|Anticipated|VA Office of Research and Development||3|||f||||f||||||||||2017-02-18 18:05:58.584512|2017-02-18 18:05:58.584512
NCT00037960|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2009-01-20|||June 2001||2001-06-01|May 2002|2002-05-01|June 2004|Actual|2004-06-01|||||Interventional|||Automated Constraint-Induced Therapy for Restoring Movement After Stroke|Automated Constraint-Induced Therapy for Restoring Movement After Stroke|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:05:58.699406|2017-02-18 18:05:58.699406
NCT00037947|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2008-06-02|||October 2001||2001-10-01|June 2008|2008-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Auditory Function in Patients With and Without Multiple Sclerosis|Auditory Function in Patients With and Without Multiple Sclerosis|Completed||Phase 2|300|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:05:58.981744|2017-02-18 18:05:58.981744
NCT00037934|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2011-10-06|||April 2002||2002-04-01|October 2011|2011-10-01|December 2004|Actual|2004-12-01|September 2004|Actual|2004-09-01||Interventional|||Robotic Upper-Limb Neurorehabilitation in Chronic Stroke Patient|Evaluation of Robotic Upper Extremity Neuro-Rehabilitation|Completed||Phase 2|30|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:05:59.070963|2017-02-18 18:05:59.070963
NCT00037921|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2010-05-05|||January 2001||2001-01-01|May 2010|2010-05-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||UTI Prophylaxis Using Bacterial Interference Following SCI|UTI Prophylaxis Using Bacterial Interference Following SCI|Completed||Phase 2|40|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:05:59.163707|2017-02-18 18:05:59.163707
NCT00037908|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2009-01-20|||October 2000||2000-10-01|May 2002|2002-05-01|September 2003|Actual|2003-09-01|||||Interventional|||Effects of Strength Training on Upper-Limb Function in Post-Stroke Hemiparesis|Effects of Strength Training on Upper-Limb Function in Post-Stroke Hemiparesis|Completed||Phase 2|60|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:05:59.266937|2017-02-18 18:05:59.266937
NCT00037895|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2009-01-20|||January 2001||2001-01-01|May 2002|2002-05-01|December 2003|Actual|2003-12-01|||||Interventional|||Stroke Rehabilitation Outcomes With Supported Treadmill Ambulation Training|Stroke Rehabilitation Outcomes With Supported Treadmill Ambulation Training|Completed||Phase 2|48|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:05:59.353878|2017-02-18 18:05:59.353878
NCT00037882|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2012-07-31|||February 2001||2001-02-01|July 2012|2012-07-01|December 2003|Actual|2003-12-01|October 2003|Actual|2003-10-01||Interventional|||PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or Intron|A Phase II Study of SCH 54031 (Peg Interferon Alpha-2B/PEG-Intron) in Subjects With Interferon-Refractory Chronic Myelogenous Leukemia|Terminated||Phase 2|1|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:59.447165|2017-02-18 18:05:59.447165
NCT00037869|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-24|2012-07-31|||November 2001||2001-11-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors|High Dose I-131 Metaiodobenzylguanidine (MIBG) Therapy for Metastatic Neuroendocrine Tumors|Completed||Phase 3|15|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:05:59.56259|2017-02-18 18:05:59.56259
NCT00037843|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-23|2012-02-20|||December 1988||1988-12-01|February 2012|2012-02-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening|Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening|Completed||Phase 3|114|Actual|M.D. Anderson Cancer Center||1|||f||||||||||||||2017-02-18 18:05:59.665076|2017-02-18 18:05:59.665076
NCT00037830|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-22|2012-12-18|2011-07-13||November 1999||1999-11-01|December 2012|2012-12-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||GM1 Ganglioside Effects on Parkinson's Disease|The Study of GM1 Ganglioside, A Potential New Parkinson's Disease Medication|Completed||Phase 2|94|Actual|Thomas Jefferson University||3|||f||||f||||||||||2017-02-18 18:05:59.76344|2017-02-18 18:05:59.76344
NCT00037817|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-21|2017-01-24|||May 17, 2002||2002-05-17|November 30, 2016|2016-11-30|November 9, 2009|Actual|2009-11-09|October 8, 2008|Actual|2008-10-08||Interventional|||Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies|Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies|Completed||Phase 1|34|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||||||||||||2017-02-18 18:06:00.560319|2017-02-18 18:06:00.560319
NCT00037804|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-21|2009-08-13||||||August 2009|2009-08-01||||||||Interventional|||Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction||Completed||Phase 1|||Pfizer|||||||||||||||||||2017-02-18 18:06:00.678882|2017-02-18 18:06:00.678882
NCT00037791|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-21|2006-11-08|||December 1999||1999-12-01|September 2006|2006-09-01|September 2002||2002-09-01|||||Interventional|||Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia|Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia in Patients Receiving Myelosuppressive Treatment Regimens Requiring Platelet Transfusion Support.|Completed||Phase 3|180||Pfizer|||||f||||||||||||||2017-02-18 18:06:00.764019|2017-02-18 18:06:00.764019
NCT00037778|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2016-08-29|||September 2001||2001-09-01|August 2016|2016-08-01|February 2013|Actual|2013-02-01|February 2013|Actual|2013-02-01||Observational|||Genetic Modifiers of Cystic Fibrosis: Sibling Study|Genetic Modifiers of Cystic Fibrosis: Sibling Study|Completed||N/A|3459|Actual|Johns Hopkins University|||1||f||||f||||||Samples With DNA|"~     Blood samples~   "|||2017-02-18 18:06:00.864169|2017-02-18 18:06:00.864169
NCT00037765|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2016-10-24|||September 2001||2001-09-01|October 2016|2016-10-01|July 2017|Anticipated|2017-07-01|July 2017|Anticipated|2017-07-01||Observational|||Gene Modifiers of Cystic Fibrosis Lung Disease|Gene Modifiers of Cystic Fibrosis Lung Disease|Active, not recruiting||N/A|600|Anticipated|University of North Carolina, Chapel Hill|||1||f||||f||||||||||2017-02-18 18:06:00.964598|2017-02-18 18:06:00.964598
NCT00037752|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2014-05-20|||September 2002||2002-09-01|May 2014|2014-05-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|SUCCESS||Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates|Use of Sibutramine in Smoking Cessation|Completed||N/A|436|Actual|University of Tennessee||2|||f||||t||||||||||2017-02-18 18:06:01.077664|2017-02-18 18:06:01.077664
NCT00037739|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2016-01-19|||April 2001||2001-04-01|January 2016|2016-01-01|March 2004||2004-03-01|||||Observational|||Chronic Obstructive Pulmonary Disease Gene Localization||Completed||N/A|||University of Utah|||||f||||||||||||||2017-02-18 18:06:01.188843|2017-02-18 18:06:01.188843
NCT00037726|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2015-12-21|||April 2001||2001-04-01|December 2005|2005-12-01|March 2004||2004-03-01|||||Observational|||Antibiotics in Infancy--Risk Factor for Childhood Asthma||Completed||N/A|||Augusta University|||||f||||||||||||||2017-02-18 18:06:01.255708|2017-02-18 18:06:01.255708
NCT00037713|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2010-04-07|||September 1998||1998-09-01|April 2010|2010-04-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG|The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG|Completed||Phase 3|515|Actual|ImClone LLC||2|||f||||f||||||||||2017-02-18 18:06:01.332495|2017-02-18 18:06:01.332495
NCT00037700|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2009-11-25|||May 2001||2001-05-01|December 2007|2007-12-01|December 2002||2002-12-01|||||Interventional|||Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis||Completed||Phase 2|||Swedish Orphan Biovitrum|||||||||||||||||||2017-02-18 18:06:01.441|2017-02-18 18:06:01.441
NCT00037687|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2005-06-23|||April 2001||2001-04-01|January 2003|2003-01-01|December 2004||2004-12-01|||||Interventional|||Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis|A Phase 3 Study to Demonstrate the Safety and Efficacy of Recombinant Platelet-Activating Factor Acetylhydrolase (rPAF-AH, Pafase®) for Reducing 28 Day All Cause Mortality in Patients With Severe Sepsis|Terminated||Phase 3|2500||ICOS Corporation|||||||||||||||||||2017-02-18 18:06:01.745651|2017-02-18 18:06:01.745651
NCT00037674|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-20|2011-05-17|||January 2001||2001-01-01|January 2011|2011-01-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder|A Randomized, Double-Blind, Multicenter, Placebo-Controlled 12-Week Study of the Safety and Efficacy of Two Doses of Topiramate for the Treatment of Acute Manic or Mixed Episodes in Patients With Bipolar I Disorder With an Optional Open-Label Extension|Completed||Phase 3|434|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:06:01.83461|2017-02-18 18:06:01.83461
NCT00037661|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-18|2015-10-01|||April 2002||2002-04-01|October 2015|2015-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye|Double-Masked, Randomized, Placebo-Controlled Study of Efficacy Parameter Following Administration of INS365 Ophthalmic Solution or Placebo in a Controlled Adverse Environment (CAE) Chamber in Subjects With Non-Sjogren's Associated Dry Eye|Completed||Phase 3|222|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:01.925521|2017-02-18 18:06:01.925521
NCT00037648|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2009-11-25|||July 2000||2000-07-01|February 2008|2008-02-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Juvenile Rheumatoid Arthritis|A Randomized, Multi-center, Blinded, Placebo-controlled Study With an Open-label Run-in Period to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daily, Single, Subcutaneous Injections of r-metHuIL-1ra (Anakinra) in Polyarticular-Course Juvenile Rheumatoid Arthritis|Completed||Phase 2|86|Actual|Swedish Orphan Biovitrum||2|||f||||||||||||||2017-02-18 18:06:02.000498|2017-02-18 18:06:02.000498
NCT00037635|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2013-05-06|||December 2001||2001-12-01|May 2013|2013-05-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients|A Phase 3 Study to Assess the Efficacy and Safety of an Oral Calcimimetic Agent (AMG 073) in Secondary Hyperparathyroidism of End Stage Renal Disease Treated With Hemodialysis|Completed||Phase 3|400|Anticipated|Amgen||2|||f||||||||||||||2017-02-18 18:06:02.104238|2017-02-18 18:06:02.104238
NCT00037622|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2009-08-18||||||August 2009|2009-08-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.|An Open-Label Treatment Protocol to Provide Continued ACH-126,443 to Subjects of Previous Achillion-Sponsored Phase 1 and 2 Studies in Chronic Hepatitis B Infection|Terminated||N/A|100||Achillion Pharmaceuticals||||Safety concerns from other studies.|||||||||||||||2017-02-18 18:06:02.215688|2017-02-18 18:06:02.215688
NCT00037609|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2012-10-22|||January 2001||2001-01-01|October 2012|2012-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients|Phase I-II Study to Evaluate Safety, Efficacy and Pharmacokinetic Interactions Between Capecitabine (XELODA) and Exisulind (APTOSYN) in Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|35|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:06:02.305061|2017-02-18 18:06:02.305061
NCT00037596|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2013-02-11|||August 2000||2000-08-01|February 2013|2013-02-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia|A Dose Ranging Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) Given in Combination With Cytarabine in Relapsed or Refractory Patients and Alder De Novo Patients With Acute Myeloid Leukemia.|Completed||Phase 2|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:06:02.433584|2017-02-18 18:06:02.433584
NCT00037583|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2009-08-20||||||August 2009|2009-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia|A Dose-Ranging Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (go) Given in Combination With Cytarabine and Daunorubicin in Relapsed or Refractory Patients and in Younger de Novo Patients With Acute Myeloid Leukemia (AML)|Completed||Phase 2|69|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:06:02.511474|2017-02-18 18:06:02.511474
NCT00037570|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2013-02-07|||November 2000||2000-11-01|February 2013|2013-02-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage|A Randomized Study of the Effect of Intravenous Pantoprazole on Gastric pH After Successful Hemostasis in Patients With Bleeding Peptic Ulcer|Completed||Phase 2|12|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 18:06:02.581301|2017-02-18 18:06:02.581301
NCT00037557|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2007-12-18|||September 2002||2002-09-01|December 2007|2007-12-01|November 2007|Actual|2007-11-01|||||Interventional|||Study Evaluating rFIX; BeneFIX in Severe Hemophilia B|An Open-Label, Single-Arm, Safety and Efficacy Study of Recombinant Human Factor IX (rFIX; BeneFIX®) in Children Less Than 6 Years of Age With Severe Hemophilia B|Completed||Phase 3|20||Wyeth is now a wholly owned subsidiary of Pfizer|||||f||||||||||||||2017-02-18 18:06:02.753862|2017-02-18 18:06:02.753862
NCT00037544|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2008-04-18||||||April 2008|2008-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Study Evaluating ReFacto AF in Severe Hemophilia A|An Open-Label Study to Characterize the Safety and Efficacy of BDDrFVIII Manufactured by the Albumin Free Process (ReFacto AF) in the Treatment of Previously Treated Patients (PTP) With Severe Hemophilia A|Completed||Phase 3|||Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:06:03.044047|2017-02-18 18:06:03.044047
NCT00037531|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2009-08-17||||||August 2009|2009-08-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients|An Open-label Extension Study of the Safety of Long-term Administration of Sirolimus (Rapamune™) in Solid Organ Transplant Recipients|Completed||Phase 3|769|Actual|Wyeth is now a wholly owned subsidiary of Pfizer|||||||||||||||||||2017-02-18 18:06:03.133051|2017-02-18 18:06:03.133051
NCT00037518|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2013-05-06|||April 2001||2001-04-01|May 2013|2013-05-01||||||||Interventional|||A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer|An Assessment of the Calcimimetic Agent AMG 073 for the Treatment of Subjects With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism.|Completed||Phase 4|46||Amgen||1|||||||||||||||||2017-02-18 18:06:03.242855|2017-02-18 18:06:03.242855
NCT00037505|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Major Depression and Inflammatory Risk Markers for Coronary Heart Disease|Major Depression and Inflammatory Risk Markers for Coronary Heart Disease|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:06:03.338085|2017-02-18 18:06:03.338085
NCT00037492|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2007-05-21||||||May 2007|2007-05-01||||||||Interventional|||Families In Recovery From Stroke Trial (F.I.R.S.T.)|Psychological Intervention in Stroke Recovery|Completed||Phase 3|291||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:06:03.425917|2017-02-18 18:06:03.425917
NCT00037479|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-17|2005-12-06|||December 1999||1999-12-01|December 2005|2005-12-01||||||||Interventional|||Brain Imaging and Retreatment Study of Persistent Lyme Disease|PET and MRI Imaging of Persistent Lyme Encephalopathy|Completed||Phase 2|65||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:06:03.52019|2017-02-18 18:06:03.52019
NCT00037466|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-03-01|||September 2000||2000-09-01|February 2005|2005-02-01|November 2002|Actual|2002-11-01|August 2001|Actual|2001-08-01||Observational|||Relation of Diet to Serum Homocysteine Level in Youths|Relation of Diet to Serum Homocysteine Level in Youths|Completed||N/A|2445|Actual|Boston Children’s Hospital|||1||f||||f||||||||No|Data Sharing was not required at the time the study was conducted.|2017-02-18 18:06:03.621235|2017-02-18 18:06:03.621235
NCT00037453|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-03-15|||April 2001||2001-04-01|August 2004|2004-08-01|March 2003|Actual|2003-03-01|||||Observational|||Analysis of Sex Hormones and Lipoproteins in Young Males||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:03.717654|2017-02-18 18:06:03.717654
NCT00037440|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2014-12-01|||September 2001||2001-09-01|December 2014|2014-12-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Genetic Epidemiology of Change in CVD Risk Factors|Genetic Epidemiology of Change in CVD Risk Factors (HL70568-1)|Completed||N/A|1735|Actual|The University of Texas Health Science Center, Houston|||2||f||||f||||||||||2017-02-18 18:06:03.992516|2017-02-18 18:06:03.992516
NCT00037427|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-03-15|||September 2001||2001-09-01|May 2005|2005-05-01|July 2004|Actual|2004-07-01|||||Observational|||Airway Responses Following Chlorine Gas Exposure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:04.094796|2017-02-18 18:06:04.094796
NCT00037414|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-08-19|||September 2001||2001-09-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Joint Determinants of Bone Density and CVD Calcification||Completed||N/A|||University of Maryland|||||f||||||||||||||2017-02-18 18:06:04.161403|2017-02-18 18:06:04.161403
NCT00037401|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-02-17|||September 2001||2001-09-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Postprandial Lipemia and Endothelial Function in ACCORD- Ancillary to ACCORD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:04.237359|2017-02-18 18:06:04.237359
NCT00037388|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-07-28|||July 2004||2004-07-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:04.504097|2017-02-18 18:06:04.504097
NCT00037375|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-02-17|||July 2001||2001-07-01|February 2005|2005-02-01|June 2003|Actual|2003-06-01|||||Observational|||Physical Activity, Body Composition, and Prevalent Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:04.582721|2017-02-18 18:06:04.582721
NCT00037362|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Measuring Sensitivity to Nonignorability||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:04.655527|2017-02-18 18:06:04.655527
NCT00037349|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-02-17|||March 2001||2001-03-01|January 2005|2005-01-01|February 2004|Actual|2004-02-01|||||Observational|||Heart Rate Recovery and Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:04.725318|2017-02-18 18:06:04.725318
NCT00037336|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2014-03-14|||September 2001||2001-09-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Atherosclerosis in Rheumatoid Arthritis||Completed||N/A|||Vanderbilt University|||||f||||||||||||||2017-02-18 18:06:04.803331|2017-02-18 18:06:04.803331
NCT00037323|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-03-15|||May 2001||2001-05-01|May 2004|2004-05-01|October 2003|Actual|2003-10-01|||||Observational|||Framingham Offspring Study: Psychosocial Risk Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:04.887967|2017-02-18 18:06:04.887967
NCT00037310|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-07-28|||April 2001||2001-04-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||New CVD Risk Factors for Lowered Cognitive Functioning||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:04.955777|2017-02-18 18:06:04.955777
NCT00037297|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-07-28|||July 2001||2001-07-01|January 2008|2008-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||Epidemiology of Cardiovascular Disease in Diabetes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:05.029965|2017-02-18 18:06:05.029965
NCT00037284|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-07-11|||July 2001||2001-07-01|July 2008|2008-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Behavioral and Immunological Factors in Coronary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:05.120656|2017-02-18 18:06:05.120656
NCT00037271|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-02-17|||April 2001||2001-04-01|August 2004|2004-08-01|March 2003|Actual|2003-03-01|||||Observational|||Genome Scan for Obesity in a Multi-Ethnic Sample||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:05.195735|2017-02-18 18:06:05.195735
NCT00037258|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2014-03-28|||September 2001||2001-09-01|March 2014|2014-03-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women||Completed||N/A|||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 18:06:05.262516|2017-02-18 18:06:05.262516
NCT00037245|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-02-08|||September 2001||2001-09-01|December 2005|2005-12-01|July 2005||2005-07-01|||||Observational|||Androgens and Subclinical Atherosclerosis in Young Women - Ancillary to CARDIA||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:06:05.345325|2017-02-18 18:06:05.345325
NCT00037232|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2016-03-15|||April 2001||2001-04-01|May 2005|2005-05-01|March 2005|Actual|2005-03-01|||||Observational|||Failure Time Methods for Family Disease Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:05.42297|2017-02-18 18:06:05.42297
NCT00037219|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2008-10-17|||August 2001||2001-08-01|October 2008|2008-10-01|November 2002|Actual|2002-11-01|||||Interventional|||The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.|A Phase 2, Open-Label, Randomized, Dose-Ranging Study of the Safety and Efficacy of Intravenous Anidulafungin (VER002) in the Treatment of Patients With Invasive Candidiasis|Completed||Phase 2|120|Actual|Pfizer|||||f||||||||||||||2017-02-18 18:06:05.498812|2017-02-18 18:06:05.498812
NCT00037206|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2008-10-17|||May 2002||2002-05-01|October 2008|2008-10-01|February 2003|Actual|2003-02-01|||||Interventional|||A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).|An Open Label Non-Comparative Study of the Safety and Efficacy of Intravenous Anidulafungin Plus AmBisome® [(Amphotericin B) Liposome for Injection] as a Treatment for Invasive Aspergillosis.|Completed||Phase 2/Phase 3|30|Actual|Pfizer|||||f||||||||||||||2017-02-18 18:06:05.57891|2017-02-18 18:06:05.57891
NCT00037180|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2008-09-25|||April 2002||2002-04-01|September 2008|2008-09-01|January 2003|Actual|2003-01-01|||||Interventional|||For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy|Phase II, Randomized, Double-Blind, Multicenter Trial Of Celecoxib Vs Placebo For The Prevention Of Diarrhea Associated With CPT-11/5fu/LV Chemotherapy In Patients With Previously Untreated Metastatic Colorectal Cancer|Terminated||Phase 2|212||Pfizer|||||f||||||||||||||2017-02-18 18:06:05.755319|2017-02-18 18:06:05.755319
NCT00037167|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2009-04-08|||September 2001||2001-09-01|April 2009|2009-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Effects of Exercise Poles on Older Adults During Exercise Walking|Impact of Running Poles on Older Adult Exercise Walking|Completed||Phase 1/Phase 2|150||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:06:05.885891|2017-02-18 18:06:05.885891
NCT00037154|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2010-01-12|||August 1999||1999-08-01|January 2010|2010-01-01|December 2002||2002-12-01|||||Interventional|||Saw Palmetto Extract in Benign Prostatic Hyperplasia|Saw Palmetto Extract In Benign Prostatic Hyperplasia|Completed||Phase 3|224||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 18:06:05.97715|2017-02-18 18:06:05.97715
NCT00037141|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-15|2007-10-04|||March 2002||2002-03-01|June 2004|2004-06-01|March 2004||2004-03-01|||||Interventional|||Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)|Evaluation of the Safety and Tolerability of Transurethral Alcohol Injection for the Treatment of BPH (Enlarged Prostate)|Completed||Phase 1/Phase 2|150||American Medical Systems|||||||||||||||||||2017-02-18 18:06:06.078653|2017-02-18 18:06:06.078653
NCT00037128|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-16|2005-12-08|||March 1998||1998-03-01|May 2004|2004-05-01||||||||Interventional|||Study of GL701 in Men With Systemic Lupus Erythematosus||Unknown status|Active, not recruiting|Phase 3|40||Genelabs Technologies|||||||||||||||||||2017-02-18 18:06:06.152114|2017-02-18 18:06:06.152114
NCT00037115|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-15|2009-11-20|||May 2002||2002-05-01|November 2009|2009-11-01||||||||Interventional|||Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.|An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results.|Withdrawn||Phase 4|20|Anticipated|MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute||||Lack of funding|||||||||||||||2017-02-18 18:06:06.227739|2017-02-18 18:06:06.227739
NCT00037102|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-15|2009-06-16|||July 2001||2001-07-01|November 2003|2003-11-01|December 2003||2003-12-01|||||Interventional|MTX01||Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis|An Open Label Study of the Safety and Efficacy of Combination Therapy With AVONEX and Bi-Monthly High Dose Intravenous Methotrexate With Leucovorin Rescue in the Treatment of Multiple Sclerosis|Completed||Phase 4|16|Actual|MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute||1|||||||||||||||||2017-02-18 18:06:06.317517|2017-02-18 18:06:06.317517
NCT00037089|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-14|2005-06-23||||||January 2005|2005-01-01||||||||Interventional|||A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer||Unknown status|Active, not recruiting|Phase 2|||Edelman, Martin, M.D.|||||||||||||||||||2017-02-18 18:06:06.403145|2017-02-18 18:06:06.403145
NCT00037076|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-14|2012-10-30||||||October 2012|2012-10-01|July 2003|Actual|2003-07-01|||||Observational|||Prevalence of Hepatitis C Virus Infection in HIV-Infected Children|Hepatitis C Prevalence in Perinatally Infected HIV-Positive Children Enrolled in PACTG 219C|Completed||N/A|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:06:06.485188|2017-02-18 18:06:06.485188
NCT00037063|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-14|2015-06-03||||||June 2003|2003-06-01||||||||Interventional|||A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs|A Pilot Study of the Efficacy of a Combination of Antioxidants and B Vitamins in Preventing the Recurrence of Hyperlactatemia in Subjects Who Have Limited Antiretroviral Options|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:06:06.6135|2017-02-18 18:06:06.6135
NCT00037050|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-14|2009-09-11|||April 2002||2002-04-01|September 2009|2009-09-01|July 2005|Actual|2005-07-01|||||Interventional|||Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria|Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram-Positive Bloodstream Infections|Completed||Phase 3|739|Actual|Pfizer|||||||||||||||||||2017-02-18 18:06:06.714723|2017-02-18 18:06:06.714723
NCT00037037|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-12-17|||October 2001||2001-10-01|May 2004|2004-05-01||||||||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma|A Phase I Study of Peptide Based Vaccine Therapy in Patients With High-Risk or Metastatic Melanoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:06.81677|2017-02-18 18:06:06.81677
NCT00037024|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2014-07-11|||April 2002||2002-04-01|November 2012|2012-11-01|October 2004|Actual|2004-10-01|February 2004|Actual|2004-02-01||Interventional|||Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer|Project LEAD: Promoting Health Among Populations With Early Stage Cancers|Completed||N/A|||Duke University|||||f||||t||||||||||2017-02-18 18:06:06.910165|2017-02-18 18:06:06.910165
NCT00037011|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-01-17|||November 2001||2001-11-01|January 2013|2013-01-01||||January 2005|Actual|2005-01-01||Interventional|||Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma|Phase I Study of Oral Beta-Glucan and Intravenous Anti-GD2 Monoclonal Antibody 3F8 Among Patients With Metastatic Neuroblastoma|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:06:07.013078|2017-02-18 18:06:07.013078
NCT00036998|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-11-05|||August 2001||2001-08-01|July 2004|2004-07-01||||||||Interventional|||Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer|A Randomized Pivotal Clinical Trial In Breast Cancer Patients Of Pre-Operative Focal Microwave Thermotherapy Treatment For Early-Stage Breast Disease In Intact Breast|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:07.109782|2017-02-18 18:06:07.109782
NCT00036985|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-12-18|||August 2001||2001-08-01|July 2004|2004-07-01||||||||Interventional|||Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer|A Randomized Pivotal Clinical Trial To Assess The Efficacy Of Pre-operative Focused Microwave Thermotherapy Treatment Combined With Pre-operative Chemotherapy For Cytoreduction Of Advanced Breast Cacer In Intact Breast|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:07.201635|2017-02-18 18:06:07.201635
NCT00036972|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-06-25|||November 2001||2001-11-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|January 2005|Actual|2005-01-01||Interventional|||Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma|Phase I Study to Assess the Histologic Effect and Safety of Pre-Operative and Post-Operative Infusions of IL13-PE38QQR Cytotoxin in Patients With Recurrent Resectable Supratentorial Malignant Glioma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:07.292329|2017-02-18 18:06:07.292329
NCT00036959|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2012-03-14|||March 2002||2002-03-01|March 2012|2012-03-01|February 2010|Actual|2010-02-01|February 2010|Actual|2010-02-01||Interventional|||ABT-751 in Treating Young Patients With Refractory Solid Tumors|Phase I Trial and Pharmacokinetic Study of ABT-751, an Orally Bioavailable Tubulin Binding Agent, on a 7 Day and 21 Day Dosing Schedule in Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|90|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 18:06:07.379442|2017-02-18 18:06:07.379442
NCT00036946|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2016-06-01|||November 2001||2001-11-01|June 2016|2016-06-01||||March 2002|Actual|2002-03-01||Interventional|||VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma|An Open-Label, Sequential Cohort Dose-Escalation Safety, Tolerability And Pharmacokinetic Study Of VEGF Trap In Patients With Incurable, Relapsed Or Refractory Solid Tumors Or Lymphoma|Completed||Phase 1|||Regeneron Pharmaceuticals|||||f||||||||||||||2017-02-18 18:06:07.551885|2017-02-18 18:06:07.551885
NCT00036933|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-03-22|||March 2002||2002-03-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer|Vaccination Of Prostate Cancer Patients With A Bivalent Vaccine Containing MUC-2 Glycopeptide And Globo H Conjugates Plus The Immunological Adjuvant QS21|Completed||Phase 1|9|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:06:07.873077|2017-02-18 18:06:07.873077
NCT00036920|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-06-25|||January 2002||2002-01-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|August 2002|Actual|2002-08-01||Interventional|||TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase II Study Of TLK286 For The Treatment Of Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:07.998355|2017-02-18 18:06:07.998355
NCT00036894|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2015-04-29|||March 2002||2002-03-01|November 2003|2003-11-01||||||||Interventional|||CC-5013 in Treating Patients With Recurrent Glioma|A Phase I Trial Of A Thalidomide Analog, CC-5013, For The Treatment Of Patients With Recurrent High-Grade Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:08.109301|2017-02-18 18:06:08.109301
NCT00036881|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2016-07-12|||May 2002||2002-05-01|July 2016|2016-07-01|June 2007|Actual|2007-06-01|April 2007|Actual|2007-04-01||Interventional|||Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer|Phase III Double-Blind, Placebo-Controlled Randomized Comparison Of Zinc Sulfate Versus Placebo For The Prevention Of Altered Taste In Patients With Head And Neck Cancer During Radiation|Completed||Phase 3|173|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:06:08.219123|2017-02-18 18:06:08.219123
NCT00036868|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-06-06|||February 2002||2002-02-01|June 2013|2013-06-01||||June 2009|Actual|2009-06-01||Interventional|||Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer|A Randomized Phase II Study Of CMF Alone And In Combination With Anti c-erbB2 Antibody (Herceptin) In Women With c-erbB2 Positive Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|90|Actual|European Organisation for Research and Treatment of Cancer - EORTC||1|||f||||||||||||||2017-02-18 18:06:08.330929|2017-02-18 18:06:08.330929
NCT00036855|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-01-16|||June 2002||2002-06-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma|A Phase I Study Of Yttrium-Ibritumomab Tiuxetan (90Y Zevalin, Yttrium (90)-Anti-CD20, NSC # 710085) Preceded By Rituximab In Children With Recurrent/Refractory CD20 Positive Lymphoma|Terminated||Phase 1|36|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 18:06:08.473691|2017-02-18 18:06:08.473691
NCT00036842|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-06-21|||April 2002||2002-04-01|August 2004|2004-08-01|June 2007|Actual|2007-06-01|||||Interventional|||Arsenic Trioxide in Treating Men With Germ Cell Cancer|Phase II Study Of Arsenic Trioxide In Patients With Refractory Germ Cell Malignancies|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:08.605398|2017-02-18 18:06:08.605398
NCT00036829|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-07-17|||March 2002||2002-03-01|March 2003|2003-03-01|April 2003|Actual|2003-04-01|||||Interventional|||Improving Pain Management in Patients With Nonhematologic Cancer|Improving Pain Management in Cancer Care|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:08.822129|2017-02-18 18:06:08.822129
NCT00036816|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2012-09-20|||February 2002||2002-02-01|September 2012|2012-09-01||||February 2003|Actual|2003-02-01||Interventional|||Vaccine Therapy in Treating Patients With Melanoma of the Eye|Randomized Phase III Study Of Adjuvant Immunization With The NA17.A2 And Melanoma Differentiation Peptites In HLA-A2 Patients With Primary Ocular Melanoma At High Risk Of Relapse|Terminated||Phase 3|13|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:06:08.915037|2017-02-18 18:06:08.915037
NCT00036790|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2015-09-30|||February 2002||2002-02-01|September 2015|2015-09-01||||October 2005|Actual|2005-10-01||Interventional|||Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer|An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:06:09.018549|2017-02-18 18:06:09.018549
NCT00036777|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-06-28|||March 2002||2002-03-01|June 2013|2013-06-01||||October 2004|Actual|2004-10-01||Interventional|||UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors|A Phase 1 Study of UCN-01 in Combination With Carboplatin in Advanced Solid Tumors|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:06:09.154342|2017-02-18 18:06:09.154342
NCT00036764|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-01-24|||February 2002||2002-02-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||BMS-247550 in Treating Patients With Stage IV Melanoma|A Phase II Study Of Epothilone B Analog BMS 247550 (NSC # 710428) In Stage IV Malignant Melanoma|Completed||Phase 2|88|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:06:09.277624|2017-02-18 18:06:09.277624
NCT00036114|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2013-11-07|||March 2000||2000-03-01|April 2011|2011-04-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:06:22.303656|2017-02-18 18:06:22.303656
NCT00036751|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-01-23|||April 2002||2002-04-01|January 2013|2013-01-01||||August 2007|Actual|2007-08-01||Interventional|||Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Trial Of STI571 For The Treatment Of Platinum And Taxane Refractory Stage III And IV Epithelial Ovarian Cancer And Primary Peritoneal Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:06:09.406009|2017-02-18 18:06:09.406009
NCT00036738|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2016-07-18|||July 2001||2001-07-01|July 2016|2016-07-01||||October 2018|Anticipated|2018-10-01||Interventional|||Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib|Allogeneic Nonmyeloablative Hematopoietic Stem Cell Transplant for Patients With BCR-ABL Tyrosine Kinase Inhibitor Responsive Ph+ Acute Leukemia - a Multi-Center Trial|Active, not recruiting||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:06:09.52372|2017-02-18 18:06:09.52372
NCT00036712|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2013-09-19|||January 2002||2002-01-01|June 2009|2009-06-01||||August 2009|Anticipated|2009-08-01||Interventional|||Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation|A Multiinstitutional Trial To Evaluate The Prophylactic Use Of NASA-Developed Light Emitting Diodes For The Prevention Of Oral Mucositis In Bone Marrow Transplant Patients|Unknown status|Recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:09.673443|2017-02-18 18:06:09.673443
NCT00036686|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2012-09-21|||December 2002||2002-12-01|September 2012|2012-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy|A Clinical Trial of the Action of Isoflavones in Breast Neoplasia: Administration Prior to Mastectomy or Lumpectomy-A Pilot Study|Terminated||N/A|1|Actual|H. Lee Moffitt Cancer Center and Research Institute||2||low accrual|f||||f||||||||||2017-02-18 18:06:09.772785|2017-02-18 18:06:09.772785
NCT00036660|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2010-11-07|||August 2001||2001-08-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||SarCNU in Treating Patients With Recurrent Malignant Glioma|A Phase II Study of SarCNU (NSC 364432) in Patients With Malignant Glioma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:06:09.886263|2017-02-18 18:06:09.886263
NCT00036647|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2015-06-12|||October 2001||2001-10-01|June 2015|2015-06-01|January 2003|Actual|2003-01-01|||||Interventional|||OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer|A Randomized Placebo Controlled Study of OSI-774 (Erlotinib HCl, Tarceva[TM]) in Patients With Incurable Stage IIIB/IV Non-small Cell Lung Cancer Who Have Failed Standard Therapy for Advanced or Metastatic Disease|Completed||Phase 3|731|Actual|Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:06:09.989199|2017-02-18 18:06:09.989199
NCT00036634|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-13|2014-01-13|||March 2002||2002-03-01|January 2014|2014-01-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients|A Phase 1/2, Randomized, Double-Blind, Active Controlled, Dose Escalation Study of the Safety, Tolerance, Pharmacokinetic,, and Antiviral Activity of GS-7340-02 in Antiretroviral-Naive Patients Who Are Chronically Infected With HIV-1|Completed||Phase 1/Phase 2|30|Actual|Gilead Sciences||3|||f||||||||||||||2017-02-18 18:06:10.244573|2017-02-18 18:06:10.244573
NCT00036621|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-11|2010-02-27||2010-02-27||||August 2007|2007-08-01||||September 2002|Actual|2002-09-01||Interventional|||A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy||Terminated||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:06:10.362873|2017-02-18 18:06:10.362873
NCT00036608|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2011-04-07||2010-01-28|January 2002||2002-01-01|January 2010|2010-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine||Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:06:10.46925|2017-02-18 18:06:10.46925
NCT00036595|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2008-03-03|||May 2002||2002-05-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Observational|||Functional Coupling of Cortico-Cortical and Cortico-Muscular Connections During Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control|Functional Coupling Of Cortico-Cortical and Cortico-Muscular Connections During Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:10.590115|2017-02-18 18:06:10.590115
NCT00036582|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2008-03-03|||May 2002||2002-05-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents|Clozapine vs Placebo In Treatment-Refractory Bipolar Disorder In Children And Adolescents|Completed||Phase 3|116||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:10.670597|2017-02-18 18:06:10.670597
NCT00036569|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2012-01-10|2011-09-20||May 2002||2002-05-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas|A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron (TM)) in Children With Diffuse Pontine Gliomas|Completed||Phase 2|32|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 18:06:10.764268|2017-02-18 18:06:10.764268
NCT00036556|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2007-08-13|||June 2001||2001-06-01|August 2007|2007-08-01||||||||Interventional|||Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer|A Phase III, Randomized Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer|Completed||Phase 3|941|Actual|Abbott||2|||f||||||||||||||2017-02-18 18:06:14.145268|2017-02-18 18:06:14.145268
NCT00036543|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2006-08-10|||May 2001||2001-05-01|August 2006|2006-08-01||||||||Interventional|||A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer|A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of 10 Mg Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer|Completed||Phase 3|1000||Abbott|||||||||||||||||||2017-02-18 18:06:14.755516|2017-02-18 18:06:14.755516
NCT00036517|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2005-06-23|||February 2002||2002-02-01|September 2004|2004-09-01|March 2003||2003-03-01|||||Interventional|||Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer|A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose Escalation, Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer|Terminated||Phase 1/Phase 2|30||PhytoCeutica|||||||||||||||||||2017-02-18 18:06:15.337078|2017-02-18 18:06:15.337078
NCT00036504|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2010-10-12|||August 2001||2001-08-01|October 2010|2010-10-01|August 2002||2002-08-01|||||Interventional|||Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin|Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients New to Insulin Therapy Who Were Inadequately Controlled on Oral Agents|Completed||Phase 4|100||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:15.443983|2017-02-18 18:06:15.443983
NCT00036491|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2016-02-12|||January 2001||2001-01-01|February 2016|2016-02-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Anti-CD20 in Systemic Lupus Erythematosus|An Open-Label Safety and Efficacy Study of an Anti-CD20 Antibody (Rituximab, Rituxan®) for Anti-B Cell Therapy in the Treatment of Systemic Lupus Erythematosus|Completed||Phase 1/Phase 2|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||t||||||||||2017-02-18 18:06:15.551148|2017-02-18 18:06:15.551148
NCT00036478|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2017-01-18||||||October 2004|2004-10-01||||||||Observational|||Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients|Pilot Study to Evaluate the Use of Phosphorus P31 Nuclear Magnetic Resonance Spectroscopy as a Non-Invasive Means to Evaluate Mitochondrial Dysfunction in HIV-Infected Subjects|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:06:15.681719|2017-02-18 18:06:15.681719
NCT00036465|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2013-07-26||||||July 2013|2013-07-01|September 2005|Actual|2005-09-01|||||Interventional|||Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads|A Phase II, Randomized, Controlled, Pilot Study of Antiretroviral Switch at Lower Versus Higher HIV-1 RNA Levels in Subjects Experiencing Virologic Relapse on a Current HAART Regimen|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:06:15.772368|2017-02-18 18:06:15.772368
NCT00036452|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2012-05-17||||||May 2012|2012-05-01|January 2006|Actual|2006-01-01|||||Interventional|||A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation|A Randomized, Phase II, Open Label Study to Compare Twice Daily and Once Daily Potent Antiretroviral Therapy and to Compare Self-Administered Therapy and Therapy Administered Under Direct Observation|Completed||Phase 2|402|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:06:15.887008|2017-02-18 18:06:15.887008
NCT00036439|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-10|2011-05-16|||February 2002||2002-02-01|March 2010|2010-03-01|January 2007|Actual|2007-01-01|||||Interventional|||A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis|A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients With Active Ulcerative Colitis|Completed||Phase 3|364|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 18:06:16.018121|2017-02-18 18:06:16.018121
NCT00036426|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-09|2005-06-23|||March 2001||2001-03-01|October 2004|2004-10-01||||||||Interventional|||Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma|Phase II Study of FavId (Tumor-Specific Idiotype-KLH) and Soluble GM-CSF Immunotherapy in Patients With Stable or Progressive Grade 1 and 2 Follicular B-Cell Lymphomas|Unknown status|Active, not recruiting|Phase 2|22||Favrille|||||||||||||||||||2017-02-18 18:06:16.113827|2017-02-18 18:06:16.113827
NCT00036413|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-09|2011-11-22|||January 2002||2002-01-01|November 2011|2011-11-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis|A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Safety and Dose-ranging Study of Three Oral Doses (0.5 mg, 2.5 mg and 10 mg Once Daily) of TCH346 in Patients With Amyotrophic Lateral Sclerosis.|Completed||Phase 2|44|Actual|Novartis|||||f||||||||||||||2017-02-18 18:06:16.21427|2017-02-18 18:06:16.21427
NCT00036400|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-09|2011-06-08|||December 2001||2001-12-01|April 2010|2010-04-01|December 2003|Actual|2003-12-01|||||Interventional|||Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery|A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing Preoperative Chemoradiation Followed by Surgery|Completed||Phase 3|60|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:06:16.298257|2017-02-18 18:06:16.298257
NCT00036387|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-09|2011-05-18||||||May 2010|2010-05-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.|A Randomized, Double-blind Trial of the Safety of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis on Standard Disease-modifying Anti-Rheumatic Drug Background Therapy.|Completed||Phase 3|347|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 18:06:16.385613|2017-02-18 18:06:16.385613
NCT00036374|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-09|2011-05-16|||October 2001||2001-10-01|April 2010|2010-04-01|December 2006|Actual|2006-12-01|||||Interventional|||A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis|A Randomized, Double-Blind Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate for the Treatment of Patients With Polyarticular Juvenile Rheumatoid Arthritis|Completed||Phase 3|123|Actual|Centocor, Inc.|||||||||||||||||||2017-02-18 18:06:16.491536|2017-02-18 18:06:16.491536
NCT00035607|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2013-05-09|||December 2001||2001-12-01|May 2013|2013-05-01|April 2003|Actual|2003-04-01|December 2002|Actual|2002-12-01||Interventional|||Chemotherapy Related Anemia|A Randomized, Open-label, Multicenter Study of Subcutaneous and Intravenous Administration of Darbepoetin Alfa (Novel Erythropoiesis Stimulating Protein, NESP) for the Treatment of Anemia in Subjects With Non-myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 2|120|Actual|Amgen||2|||f||||||||||||||2017-02-18 18:06:16.585837|2017-02-18 18:06:16.585837
NCT00036361|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2013-11-07|||July 2002||2002-07-01|September 2007|2007-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Broad Effectiveness: Study With Aripiprazole|Broad Effectiveness: Study With Aripiprazole|Completed||Phase 3|444||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:06:16.954299|2017-02-18 18:06:16.954299
NCT00036348|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2013-11-07|||March 2000||2000-03-01|September 2007|2007-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Study of Aripiprazole in Patients With a History of Bipolar Disorder||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:06:17.052221|2017-02-18 18:06:17.052221
NCT00036335|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2006-07-18|||March 2002||2002-03-01|July 2006|2006-07-01|January 2003||2003-01-01|||||Interventional|||Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain|Duloxetine Hydrochloride (LY248686) Protocol F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain|Completed||Phase 3|286||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:17.163191|2017-02-18 18:06:17.163191
NCT00036309|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2006-07-18|||May 2002||2002-05-01|July 2006|2006-07-01|July 2003||2003-07-01|||||Interventional|||Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder|Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:17.274335|2017-02-18 18:06:17.274335
NCT00036296|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2011-04-11|||December 2006||2006-12-01|October 2009|2009-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Effects of Talampanel on Patients With Advanced Parkinson's Disease|Effects of Talampanel on Patients With Advanced Parkinson's Disease Who Have Been on Sinemet for More Than 5 Years and Have Dyskinesia (Abnormal Involuntary Movements)|Completed||Phase 1/Phase 2|22|Actual|Teva Pharmaceutical Industries||2|||f||||||||||||||2017-02-18 18:06:17.355606|2017-02-18 18:06:17.355606
NCT00036283|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2008-09-25|||November 2000||2000-11-01|September 2008|2008-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Chemoprevention of Oral Premalignant Lesions|Clinical Protocol For A Phase II Double-Blind, Placebo-Controlled, Randomized Study Of Celecoxib (Sc-58635) In Oral Premalignant Lesions, Investigator IND|Completed||Phase 2|42||Pfizer|||||f||||||||||||||2017-02-18 18:06:17.443698|2017-02-18 18:06:17.443698
NCT00036270|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2015-10-06|2009-10-30||August 2001||2001-08-01|October 2015|2015-10-01|February 2011|Actual|2011-02-01|October 2008|Actual|2008-10-01||Interventional|TEAM||Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane|Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen For 2.5- 3 Years Followed By Exemestane (Aromasin) For A Total Of 5 Years As Adjuvant Therapy For Postmenopausal, Receptor Positive, Node Negative or Node Positive Breast Cancer Patients|Completed||Phase 3|9779|Actual|Pfizer|Overall Survival was reported as number of events which otherwise reported as time.|2|||f||||t||||||||||2017-02-18 18:06:17.585858|2017-02-18 18:06:17.585858
NCT00036257|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2011-10-14|||March 2002||2002-03-01|October 2011|2011-10-01|April 2003|Actual|2003-04-01|||||Interventional|||Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia||Completed||Phase 1|15||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:06:20.328877|2017-02-18 18:06:20.328877
NCT00036244|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2005-08-04|||April 2002||2002-04-01|August 2005|2005-08-01|January 2004||2004-01-01|||||Interventional|||Synthetic Human Secretin in Children With Autism|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism|Completed||Phase 3|||Repligen Corporation|||||||||||||||||||2017-02-18 18:06:20.420288|2017-02-18 18:06:20.420288
NCT00036231|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2005-11-17|||April 2002||2002-04-01|August 2005|2005-08-01||||||||Interventional|||Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism and Gastrointestinal Dysfunction|Terminated||Phase 3|||Repligen Corporation|||||||||||||||||||2017-02-18 18:06:20.505992|2017-02-18 18:06:20.505992
NCT00036218|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2006-06-06|||December 2001||2001-12-01|June 2006|2006-06-01|April 2003||2003-04-01|||||Interventional|||Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.|A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Comparing the Efficacy, Safety, and Tolerability of Sumanirole Versus Placebo or Ropinirole in Patients With Early Parkinson's Disease.|Completed||Phase 3|600||Pfizer|||||||||||||||||||2017-02-18 18:06:20.577365|2017-02-18 18:06:20.577365
NCT00036205|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2007-01-17|||August 2000||2000-08-01|January 2007|2007-01-01|December 2004||2004-12-01|||||Interventional|||Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease|Open-Label, Long Term, Flexible Dose Study Of Safety, Tolerability, And Therapeutic Response In Patients With Parkinson's Disease.|Terminated||Phase 3|984||Pfizer|||||||||||||||||||2017-02-18 18:06:21.046852|2017-02-18 18:06:21.046852
NCT00036192|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2011-12-08|||February 2002||2002-02-01|December 2011|2011-12-01|March 2006|Actual|2006-03-01|||||Interventional|||Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea|A Randomized, Double-Blind, Placebo-Controlled Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea|Completed||Phase 2|200||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:06:21.241345|2017-02-18 18:06:21.241345
NCT00036179|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2015-06-12|||February 1999||1999-02-01|June 2015|2015-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis|An Open-Label, Non-Comparative Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis|Completed||Phase 2|75|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-02-18 18:06:21.565658|2017-02-18 18:06:21.565658
NCT00036166|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2015-06-12|||January 1999||1999-01-01|June 2015|2015-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Study of FK463 for the Treatment of Invasive Aspergillosis|An Open-Label, Non-Comparative Study of FK463 for the Treatment of Invasive Aspergillosis|Completed||Phase 2|326|Actual|Astellas Pharma Inc|||||f||||||||||||||2017-02-18 18:06:21.68106|2017-02-18 18:06:21.68106
NCT00036153|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2012-03-26|||March 2002||2002-03-01|December 2011|2011-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis|A Randomized, Double-Blind Study to Assess the Efficacy of Tacrolimus (Prograf®)+ Methotrexate Vs. Placebo + Methotrexate in the Treatment of Rheumatoid Arthritis in Patients With Partial Response to Methotrexate|Completed||Phase 3|210||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:06:21.801636|2017-02-18 18:06:21.801636
NCT00036140|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-08|2005-06-23||||||March 2004|2004-03-01||||||||Interventional|||Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma||Completed||Phase 1|||Pfizer|||||||||||||||||||2017-02-18 18:06:21.930813|2017-02-18 18:06:21.930813
NCT00036127|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2013-11-07|||April 2002||2002-04-01|September 2007|2007-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders||Completed||Phase 2/Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:06:22.202967|2017-02-18 18:06:22.202967
NCT00036101|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2013-11-07|||February 2002||2002-02-01|September 2007|2007-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder||Completed||Phase 3|||Otsuka Pharmaceutical Development & Commercialization, Inc.|||||||||||||||||||2017-02-18 18:06:22.429479|2017-02-18 18:06:22.429479
NCT00036088|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2006-07-18|||August 2001||2001-08-01|July 2006|2006-07-01|July 2002||2002-07-01|||||Interventional|||Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia||Completed||Phase 4|530||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:22.549426|2017-02-18 18:06:22.549426
NCT00036075|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2011-10-14|||August 2001||2001-08-01|October 2011|2011-10-01|December 2005|Actual|2005-12-01|||||Interventional|||Study Using CP-461 to Treat Advanced Prostate Cancer||Completed||Phase 2|25||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:06:22.692334|2017-02-18 18:06:22.692334
NCT00036062|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2006-07-18|||August 2001||2001-08-01|July 2006|2006-07-01|December 2002||2002-12-01|||||Interventional|||A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury|A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury|Completed||Phase 1/Phase 2|600||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:22.780952|2017-02-18 18:06:22.780952
NCT00036036|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2011-10-14|||July 2001||2001-07-01|October 2011|2011-10-01|July 2003|Actual|2003-07-01|||||Interventional|||Study of CP-461 in Patients With Advanced Renal Cell Cancer|Phase II Study of CP-461 in Patients With Advanced Renal Cell Cancer|Completed||Phase 2|14||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:06:22.959942|2017-02-18 18:06:22.959942
NCT00036023|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2009-05-07||||||May 2009|2009-05-01||||||||Interventional|||Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies|A Randomized, Open-Label, Dose-Timing Study of Darbepoetin Alfa Administered Once Every 3 Weeks (Q3W) by Subcutaneous (SC) Injection for Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy|Completed||Phase 2|||Amgen||1|||||||||||||||||2017-02-18 18:06:23.038994|2017-02-18 18:06:23.038994
NCT00035997|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2009-11-20|||April 2002||2002-04-01|November 2009|2009-11-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis|An Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Mineral Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis|Completed||Phase 4|261|Actual|Novartis|||||||||||||||||||2017-02-18 18:06:23.127436|2017-02-18 18:06:23.127436
NCT00035984|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2015-02-23|||May 2002||2002-05-01|January 2015|2015-01-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus|A Phase 3, Randomized, Triple-Blind, Parallel-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Twice Daily in Subjects With Type 2 Diabetes Mellitus Treated With Metformin and a Sulfonylurea|Completed||Phase 3|734|Actual|AstraZeneca||4|||f||||f||||||||||2017-02-18 18:06:23.410464|2017-02-18 18:06:23.410464
NCT00035971|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||EVA: Evista Alendronate Comparison||Completed||Phase 4|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:23.818474|2017-02-18 18:06:23.818474
NCT00035958|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-07|2013-07-31|||August 2002||2002-08-01|July 2013|2013-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis|Toward Improved Understanding of Pathogenesis and Treatment of Childhood Onset Dermatomyositis|Terminated||Phase 2/Phase 3|75||Children's Hospital Medical Center, Cincinnati||||"Incorporating the recommendations of the NIH-formed DSMB in the study procedures would make~   the project budget over the limit for this funding mechanism."|||||||||||||||2017-02-18 18:06:23.98247|2017-02-18 18:06:23.98247
NCT00035945|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2007-10-15||||||October 2007|2007-10-01||||||||Interventional|||ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections||Completed||Phase 2|||Ionis Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 18:06:24.080005|2017-02-18 18:06:24.080005
NCT00035932|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2010-11-29|2010-10-14||November 2001||2001-11-01|November 2010|2010-11-01|March 2009|Actual|2009-03-01|July 2003|Actual|2003-07-01||Interventional|||Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV|Phase III Open Label Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV|Completed||Phase 3|571|Actual|Bristol-Myers Squibb||3|||t||||f||||||||||2017-02-18 18:06:24.178955|2017-02-18 18:06:24.178955
NCT00035919|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2014-05-20|||November 2002||2002-11-01|May 2014|2014-05-01|October 2003||2003-10-01|||||Interventional|||Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver|Tumor Site Specific Phase I Evaluation of Safety of Hepatic Arterial Infusion of a Matrix-Targeted Retroviral Vector Bearing a Dominant Negative Cyclin G1 Construct as Intervention for Colorectal Carcinoma Metastatic to Liver|Withdrawn||Phase 1/Phase 2|0|Actual|University of Southern California||||Never received final IRB approval for amendments, so never opened officially|f||||||||||||||2017-02-18 18:06:26.952471|2017-02-18 18:06:26.952471
NCT00035906|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2011-05-27|||October 2001||2001-10-01|May 2011|2011-05-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Research Study in Patients With Persistent Macular Edema|Research Study in Patients With Persistent Macular Edema Due to Diabetic Retinopathy, Retinal Vein Occlusion, Uveitis, or Irvine-Gass Syndrome|Completed||Phase 2|315|Actual|Allergan|||||f||||||||||||||2017-02-18 18:06:27.034301|2017-02-18 18:06:27.034301
NCT00035893|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2013-04-16|||May 2001||2001-05-01|April 2013|2013-04-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART|The Role of Ampligen in Strategic Therapeutic Intervention (STI) of Highly Active Anti-Retroviral Therapy (HAART): A Multi-Center, Randomized, Controlled Study of Ampligen Potentiation of the HAART-Free Interval.|Completed||Phase 2|40|Actual|Hemispherx Biopharma||2|||f||||f||||||||||2017-02-18 18:06:27.13178|2017-02-18 18:06:27.13178
NCT00035880|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2005-06-23|||October 1999||1999-10-01|July 2003|2003-07-01|June 2003||2003-06-01|||||Interventional|||Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease|A Phase II/III, Multicenter, Open Label, Randomized Clinical Trial Evaluating ABX-CBL When Compared to Atgam as Second Line Therapy in Patients With Steroid Resistant Acute Graft Versus Host Disease|Completed||Phase 2/Phase 3|95||Abgenix|||||||||||||||||||2017-02-18 18:06:27.244674|2017-02-18 18:06:27.244674
NCT00005250|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||January 1990||1990-01-01|November 2001|2001-11-01|December 1992|Actual|1992-12-01|||||Observational|||Linkage Study of Long QT Syndrome In An Amish Kindred||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.666448|2017-02-18 18:15:17.666448
NCT00035867|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2008-05-30|||April 2002||2002-04-01|June 2005|2005-06-01|May 2007|Actual|2007-05-01|||||Interventional|||Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome|Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome|Completed||Phase 1/Phase 2|65||Telik|||||||||||||||||||2017-02-18 18:06:27.321443|2017-02-18 18:06:27.321443
NCT00035854|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2009-08-13|||February 2002||2002-02-01|August 2009|2009-08-01|May 2004|Actual|2004-05-01|||||Interventional|||New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)|Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children|Completed||Phase 3|13|Actual|Pfizer|||||||||||||||||||2017-02-18 18:06:27.41574|2017-02-18 18:06:27.41574
NCT00035841|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2011-07-21|||April 2002||2002-04-01|June 2011|2011-06-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Phase 2 Study of TLK286 in Metastatic Breast Cancer|Phase 2 Study of TLK286 in Metastatic Breast Cancer|Completed||Phase 2|60||Telik|||||f||||||||||||||2017-02-18 18:06:27.532219|2017-02-18 18:06:27.532219
NCT00035828|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2005-06-23|||December 2001||2001-12-01|July 2003|2003-07-01|December 2002||2002-12-01|||||Interventional|||A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD||Completed||Phase 2|150||Abgenix|||||||||||||||||||2017-02-18 18:06:27.619807|2017-02-18 18:06:27.619807
NCT00035815|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2013-02-13|2009-11-17||June 2003||2003-06-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|August 2007|Actual|2007-08-01||Interventional|||Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial|Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS)|Completed||Phase 3|330|Actual|Mayo Clinic||2|||f||||t||||||||||2017-02-18 18:06:27.713773|2017-02-18 18:06:27.713773
NCT00035802|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-06|2011-06-23|||January 2002||2002-01-01|June 2011|2011-06-01|April 2002|Actual|2002-04-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder|A Randomized, Double-Blind, Multicenter, Placebo-Controlled 4-Week Study of the Safety and Efficacy of Topiramate in Adolescents With Acute Manic or Mixed Episodes of Bipolar I Disorder, With an Optional 6-Month Open-Label Extension|Completed||Phase 3|13|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-02-18 18:06:28.196727|2017-02-18 18:06:28.196727
NCT00035789|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-05|2011-04-07||2010-01-28|November 2001||2001-11-01|January 2010|2010-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen||Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:06:28.305707|2017-02-18 18:06:28.305707
NCT00035776|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2016-03-15|||January 2001||2001-01-01|January 2006|2006-01-01|December 2005|Actual|2005-12-01|||||Observational|||Blood Factors and Peripheral Arterial Disease Outcomes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:28.420875|2017-02-18 18:06:28.420875
NCT00035763|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2016-03-23|||October 2001||2001-10-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Pain in Sickle Cell Epidemiologic Study|Pain in Sickle Cell Epidemiologic Study|Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-02-18 18:06:28.496316|2017-02-18 18:06:28.496316
NCT00035750|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2016-01-28|||September 2001||2001-09-01|January 2016|2016-01-01|August 2005||2005-08-01|||||Observational|||Risk Factors for Atherogenesis in Type 1 Diabetes||Completed||N/A|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:06:28.565928|2017-02-18 18:06:28.565928
NCT00035737|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2014-02-20|||May 2002||2002-05-01|February 2014|2014-02-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Vascular Function in the Framingham Third Generation||Completed||N/A|||Boston University|||||f||||||||||||||2017-02-18 18:06:28.63741|2017-02-18 18:06:28.63741
NCT00035724|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2016-07-28|||April 2002||2002-04-01|May 2009|2009-05-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Monitoring Community Trends in Heart Failure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:28.821155|2017-02-18 18:06:28.821155
NCT00035711|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2016-03-15|||September 2001||2001-09-01|November 2005|2005-11-01|August 2004|Actual|2004-08-01|||||Observational|||VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:28.899741|2017-02-18 18:06:28.899741
NCT00035698|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2009-01-30|||December 2001||2001-12-01|January 2009|2009-01-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Epidemiological and Genetic Studies of Body Mass Index||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:28.97894|2017-02-18 18:06:28.97894
NCT00035685|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2016-02-17|||December 2001||2001-12-01|January 2008|2008-01-01|November 2006|Actual|2006-11-01|||||Observational|||Exposure of Children With Asthma to Household Environmental Tobacco Smoke||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:29.048393|2017-02-18 18:06:29.048393
NCT00035672|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2008-04-22|||March 2002||2002-03-01|April 2008|2008-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Genetic Predictors of Incident Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:06:29.121221|2017-02-18 18:06:29.121221
NCT00035659|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2015-10-26|||April 2002||2002-04-01|October 2015|2015-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Longitudinal Study of the Menopause and Fat Patterning||Completed||N/A|868|Actual|Rush University Medical Center|||1||f||||||||||||||2017-02-18 18:06:29.194206|2017-02-18 18:06:29.194206
NCT00035633|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-04|2011-04-07||2010-01-28|December 2001||2001-12-01|January 2010|2010-01-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen||Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:06:29.27206|2017-02-18 18:06:29.27206
NCT00035620|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2010-02-25|||April 2000||2000-04-01|February 2010|2010-02-01|April 2007|Actual|2007-04-01|January 2007|Actual|2007-01-01||Interventional|||Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy|A Study of Single Dose Per Cycle Filgrastim-SD/01 as an Adjunct to VAdriaC/IE Chemotherapy in Pediatric Sarcoma Patients|Completed||Phase 2|44|Actual|Amgen||2|||f||||||||||||||2017-02-18 18:06:29.389836|2017-02-18 18:06:29.389836
NCT00035594|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2013-05-07|||February 2002||2002-02-01|May 2013|2013-05-01|June 2004|Actual|2004-06-01|February 2004|Actual|2004-02-01||Interventional|||Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy|A Double-Blind, Placebo-Controlled, Multicenter, Randomized Study Evaluating the Prophylactic Use of Pegfilgrastim on the Incidence of Febrile Neutropenia in Subjects With Advanced Breast Cancer Treated With Single Agent Docetaxel|Completed||Phase 3|928||Amgen||2|||f||||||||||||||2017-02-18 18:06:29.489747|2017-02-18 18:06:29.489747
NCT00035581|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2013-04-16|||May 2001||2001-05-01|April 2013|2013-04-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART|A Multi-Center, Randomized, Controlled Study of the Biological Actions of Ampligen as an Adjunct to HAART in HIV Disease|Terminated||Phase 2|16|Actual|Hemispherx Biopharma||2|||f||||f||||||||||2017-02-18 18:06:29.600453|2017-02-18 18:06:29.600453
NCT00035568|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2011-04-07||2010-02-15|February 2002||2002-02-01|April 2011|2011-04-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes||Completed||Phase 4|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:06:29.708766|2017-02-18 18:06:29.708766
NCT00035555|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2013-11-27|2013-09-04||March 2001||2001-03-01|November 2013|2013-11-01|July 2012|Actual|2012-07-01|January 2004|Actual|2004-01-01||Interventional||Baseline characteristics are provided for all patients who were randomized and received transplants; participant flow is provided for all randomized participants who received treatment.|Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney|Phase II/III, Open-Label, Randomized, Controlled, Multiple-Dose Study of Efficacy and Safety of BMS-224818 (Belatacept) as Part of a Quadruple Drug Regimen in First Renal Transplant Recipients|Completed||Phase 2|230|Actual|Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 18:06:29.819757|2017-02-18 18:06:29.819757
NCT00035542|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2011-04-07||2010-02-15|December 2001||2001-12-01|April 2011|2011-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.||Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:06:35.114365|2017-02-18 18:06:35.114365
NCT00035529|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2010-12-02||2010-09-03|November 2001||2001-11-01|December 2010|2010-12-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis|A Phase II,Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Preliminary Efficacy, Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-Remitting Multiple Sclerosis|Terminated||Phase 2|||Bristol-Myers Squibb||3|||f||||||||||||||2017-02-18 18:06:35.241861|2017-02-18 18:06:35.241861
NCT00035516|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2016-02-09|||February 2001||2001-02-01|February 2016|2016-02-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy||Completed||Phase 2|||R-Pharm|||||||||||||||||||2017-02-18 18:06:35.352129|2017-02-18 18:06:35.352129
NCT00035503|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2013-02-20|||January 2002||2002-01-01|February 2013|2013-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Multicenter Trial For Patients With Acute Crohn's Disease||Completed||Phase 2|||Teva Pharmaceutical Industries|||||f||||||||||||||2017-02-18 18:06:35.448196|2017-02-18 18:06:35.448196
NCT00035490|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2011-09-30|||September 2001||2001-09-01|September 2011|2011-09-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators|Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators|Completed||Phase 3|633|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 18:06:35.543103|2017-02-18 18:06:35.543103
NCT00035477|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2011-09-30|||September 2000||2000-09-01|September 2011|2011-09-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation|Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation|Completed||Phase 3|446|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 18:06:36.061842|2017-02-18 18:06:36.061842
NCT00035464|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2011-09-30|||December 2000||2000-12-01|September 2011|2011-09-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.|Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients|Completed||Phase 3|431|Actual|Forest Laboratories||2|||f||||f||||||||||2017-02-18 18:06:36.400639|2017-02-18 18:06:36.400639
NCT00035451|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2011-09-30|||February 2001||2001-02-01|September 2011|2011-09-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.|Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.|Completed||Phase 3|658|Actual|Forest Laboratories||3|||f||||f||||||||||2017-02-18 18:06:36.606744|2017-02-18 18:06:36.606744
NCT00035438|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2006-08-03|||May 2002||2002-05-01|August 2006|2006-08-01|September 2003||2003-09-01|||||Interventional|||St. John’s Wort Vs. Placebo in Obsessive-Compulsive Disorder.|St. John’s Wort Vs. Placebo in Obsessive-Compulsive Disorder.|Completed||Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:37.038821|2017-02-18 18:06:37.038821
NCT00035425|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2009-11-30|||November 2001||2001-11-01|November 2009|2009-11-01|November 2002|Actual|2002-11-01|||||Interventional|||Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection|A Randomized, Double-Blind Trial Comparing Linezolid To Vancomycin In The Empiric Treatment Of Febrile Neutropenic Oncology Patients With Suspected Gram-Positive Infections|Completed||Phase 3|120|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 18:06:37.127881|2017-02-18 18:06:37.127881
NCT00035412|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2006-08-17|||December 2001||2001-12-01|July 2006|2006-07-01|August 2004||2004-08-01|||||Interventional|||St. John's Wort Versus Placebo in Social Phobia|St. John's Wort Versus Placebo in Social Phobia|Completed||Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:37.292333|2017-02-18 18:06:37.292333
NCT00035399|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-03|2008-08-11|||March 2002||2002-03-01|August 2008|2008-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Efficacy of Acupuncture With Physical Therapy for Knee Osteo-Arthritis|Efficacy of Acupuncture With Physical Therapy for Knee Osteo-Arthritis|Completed||Phase 3|300|Anticipated|National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 18:06:37.386918|2017-02-18 18:06:37.386918
NCT00035386|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2008-03-03|||April 2002||2002-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study|Trans-Right Ventricular Approach to Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Feasibility Study|Completed||Phase 2|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:37.479037|2017-02-18 18:06:37.479037
NCT00035373|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2017-01-24|||April 19, 2002||2002-04-19|April 29, 2015|2015-04-29|April 29, 2015||2015-04-29|||||Observational|||Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols|Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute (NCI) Clinical Research Protocols|Terminated||N/A|767|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:37.568456|2017-02-18 18:06:37.568456
NCT00035360|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2015-10-07|||March 2002||2002-03-01|October 2015|2015-10-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Phase III PEG-Intron in HIV-infected Patients (Study P00738)|Phase 3 Study of PEG-Intron in Heavily Treatment-experienced, HIV-infected Patients|Completed||Phase 3|49|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:37.658072|2017-02-18 18:06:37.658072
NCT00035347|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-04-25|||January 2001||2001-01-01|April 2011|2011-04-01|June 2002|Actual|2002-06-01|||||Interventional|||Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia|A Randomized, Multicenter, Open Label Trial Comparing Intravenous Zithromax® (Azithromycin) Plus Intravenous Rocephin® (Ceftriaxone) Followed By Oral Zithromax® (Azithromycin) With Intravenous Levaquin® (Levofloxacin) Followed By Oral Levaquin® (Levofloxacin) For The Treatment Of Moderate To Severely Ill Hospitalized Subjects With Community-Acquired Pneumonia|Completed||Phase 4|219|Actual|Pfizer||2|||f||||f||||||||||2017-02-18 18:06:37.742433|2017-02-18 18:06:37.742433
NCT00035334|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2006-02-13|||October 2001||2001-10-01|February 2006|2006-02-01|December 2004||2004-12-01|||||Interventional|||Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis|A Phase II/III Study of the Safety and Efficacy of NC-503 in Patients Suffering From Secondary (AA) Amyloidosis|Completed||Phase 2/Phase 3|150||Bellus Health Inc|||||||||||||||||||2017-02-18 18:06:37.885212|2017-02-18 18:06:37.885212
NCT00035321|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2006-07-21|||April 2002||2002-04-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression|The Study of Olanzapine Plus Fluoxetine in Combination for Treatment-Resistant Depression Without Psychotic Features|Completed||Phase 3|600||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:38.007451|2017-02-18 18:06:38.007451
NCT00035308|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2006-09-22||||||December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Safety and Efficacy Trial of LJP 394 in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease|Completed||Phase 3|330||La Jolla Pharmaceutical Company|||||||||||||||||||2017-02-18 18:06:38.254626|2017-02-18 18:06:38.254626
NCT00035295|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2015-08-07|||November 2001||2001-11-01|August 2015|2015-08-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)|A Double-Blind, Multicenter, Placebo-and Active-Controlled Acute and Extension Study of 2 Doses of MK-0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|584|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:06:38.427671|2017-02-18 18:06:38.427671
NCT00035282|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2015-02-06|||September 2001||2001-09-01|February 2015|2015-02-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)|A Double-Blind, Placebo- and Active-Controlled Acute and Extension Study of MK0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|450|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:06:38.515357|2017-02-18 18:06:38.515357
NCT00035269|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-04-25|||December 2001||2001-12-01|April 2011|2011-04-01|May 2003|Actual|2003-05-01|||||Interventional|||New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)|Linezolid in the Treatment of Penicillin-Resistant Streptococcus Pneumoniae Pneumonia: An Open-Label, Non-Comparator Study|Completed||Phase 3|230|Actual|Pfizer|||||||||||||||||||2017-02-18 18:06:38.800374|2017-02-18 18:06:38.800374
NCT00035256|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2007-05-11|||October 2001||2001-10-01|May 2007|2007-05-01|July 2005|Actual|2005-07-01|||||Interventional|||Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis|Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis|Completed||Phase 4|330||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:38.947756|2017-02-18 18:06:38.947756
NCT00035243|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2012-04-16|||April 2002||2002-04-01|April 2012|2012-04-01||||August 2003|Actual|2003-08-01||Interventional|||EPO906 Therapy in Patients With Advanced Kidney Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Renal Cancer|Completed||Phase 2|53|Actual|Novartis||1|||f||||||||||||||2017-02-18 18:06:39.040929|2017-02-18 18:06:39.040929
NCT00035230|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-06-06|||July 2001||2001-07-01|January 2011|2011-01-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder|A Randomized, Double-Blind, Multicenter, Placebo-Controlled 12-Week Study of the Safety and Efficacy of Topiramate in Patients With Acute Manic or Mixed Episodes of Bipolar I Disorder With an Optional Open-Label Extension|Completed||Phase 3|338|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:06:39.15106|2017-02-18 18:06:39.15106
NCT00035217|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program|Follow-Up Study for Men Diagnoses With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:06:39.239724|2017-02-18 18:06:39.239724
NCT00035204|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-06-06||||||April 2010|2010-04-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease|A Double-blind, Randomized Pilot Study to Evaluate the Effects of Galantamine and Donepezil on Sleep and Attention and Gastrointestinal (GI) Tolerance in Patients With Mild to Moderate Alzheimer's Disease (AD)|Completed||Phase 4|63|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||1|||||||||||||||||2017-02-18 18:06:39.314148|2017-02-18 18:06:39.314148
NCT00034970|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2006-08-17|||April 2002||2002-04-01|July 2006|2006-07-01|December 2003||2003-12-01|||||Interventional|||Mindfulness-Based Art Therapy for Cancer Patients|Mindfulness-Based Art Therapy for Cancer Patients|Completed||N/A|114||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:41.23784|2017-02-18 18:06:41.23784
NCT00035191|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-06-06|||October 2001||2001-10-01|November 2010|2010-11-01|September 2003|Actual|2003-09-01|||||Interventional|||A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia|A Randomized 26-Week, Double-Blind, Placebo Controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia|Completed||Phase 3|254|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:06:39.405927|2017-02-18 18:06:39.405927
NCT00035178|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2005-06-23|||May 2002||2002-05-01|December 2003|2003-12-01|November 2002||2002-11-01|||||Interventional|||Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis|Pharmacokinetics and Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease (ESRD) Patients Undergoing Hemodialysis|Completed||Phase 4|12||Encysive Pharmaceuticals|||||||||||||||||||2017-02-18 18:06:39.505844|2017-02-18 18:06:39.505844
NCT00035165|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2012-04-24|||March 2002||2002-03-01|April 2012|2012-04-01||||May 2003|Actual|2003-05-01||Interventional|||EPO906 Therapy in Patients With Advanced Melanoma|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Melanoma|Completed||Phase 2|51|Actual|Novartis||1|||f||||||||||||||2017-02-18 18:06:39.591783|2017-02-18 18:06:39.591783
NCT00035152|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2016-09-16|||June 2000||2000-06-01|September 2016|2016-09-01|December 2004||2004-12-01|||||Interventional|||Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer|A Multicenter, Randomized Trial for Stage IIIB or IV NSCLC Comparing Weekly Taxol(Paclitaxel) and Carboplatin(Paraplatin) Regimen Versus Standard Taxol and Carboplatin Administered Every Three Weeks, Followed by Weekly Taxol.|Completed||Phase 3|444||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:06:39.702087|2017-02-18 18:06:39.702087
NCT00035139|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery|Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery|Completed||Phase 4|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:06:39.84443|2017-02-18 18:06:39.84443
NCT00035126|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2017-02-07|||January 2002|Actual|2002-01-01|February 2017|2017-02-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||EPO906 Therapy in Patients With Advanced Breast Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Breast Cancer|Completed||Phase 2|46|Actual|Novartis||1|||f||||||||||||||2017-02-18 18:06:39.935359|2017-02-18 18:06:39.935359
NCT00035113|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2017-02-07|||January 2002||2002-01-01|February 2017|2017-02-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||EPO906 Therapy in Patients With Prostate Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Androgen-independent Prostate Cancer|Completed||Phase 2|48|Actual|Novartis|||||f||||||||||||||2017-02-18 18:06:40.046317|2017-02-18 18:06:40.046317
NCT00035100|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2012-04-13|||September 2001||2001-09-01|April 2012|2012-04-01||||June 2003|Actual|2003-06-01||Interventional|||EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer|Completed||Phase 2|54|Actual|Novartis||1|||f||||||||||||||2017-02-18 18:06:40.156342|2017-02-18 18:06:40.156342
NCT00035087|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2013-12-03|||May 2002||2002-05-01|December 2013|2013-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||EPO906 Therapy in Patients With Advanced Colorectal Cancer|An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Colorectal Cancer|Completed||Phase 2|62|Actual|Novartis|||||f||||||||||||||2017-02-18 18:06:40.271018|2017-02-18 18:06:40.271018
NCT00035074|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease|A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel Disease|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:06:40.369483|2017-02-18 18:06:40.369483
NCT00035061|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:40.447823|2017-02-18 18:06:40.447823
NCT00035048|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2015-03-10|||November 2001||2001-11-01|March 2015|2015-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)|A Double-Blind, Placebo-Controlled, Multicenter Study of the Long-Term Efficacy of MK0869 in the Maintenance of Antidepressant Effect in Geriatric Outpatients With Major Depressive Disorder|Completed||Phase 3|540|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:06:40.556696|2017-02-18 18:06:40.556696
NCT00035035|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.|A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:40.655|2017-02-18 18:06:40.655
NCT00035022|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2006-01-12|||August 2001||2001-08-01|February 2005|2005-02-01|March 2004||2004-03-01|||||Interventional|||Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas|Phase I-II Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive (High Grade) T-Cell Malignancies|Completed||Phase 1/Phase 2|71||BioCryst Pharmaceuticals|||||||||||||||||||2017-02-18 18:06:40.972264|2017-02-18 18:06:40.972264
NCT00035009|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2015-08-07|||September 2001||2001-09-01|August 2015|2015-08-01|March 2004|Actual|2004-03-01|December 2003|Actual|2003-12-01||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)|A Double-Blind, Multicenter, Placebo- and Active-Controlled Acute and Extension Study of MK0869 in the Treatment of Patients With Major Depressive Disorder With Melancholic Features|Completed||Phase 3|468|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:06:41.052781|2017-02-18 18:06:41.052781
NCT00034983|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2008-07-31|||October 2001||2001-10-01|July 2008|2008-07-01|April 2004|Actual|2004-04-01|||||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869|A Worldwide, Multicenter, Double-Blind, Parallel, Active-Controlled, Long-Term Safety Study of MK0869 in Outpatients With Major Depressive Disorder|Completed||Phase 3|900|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:06:41.141101|2017-02-18 18:06:41.141101
NCT00034944|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2015-05-29|||January 2002||2002-01-01|May 2015|2015-05-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)|A Double-Blind, Multicenter, Placebo Controlled, Acute and Extension Study of 2 Doses of MK0869 in the Treatment of Patients With Major Depressive Disorder|Completed||Phase 3|495|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:41.430294|2017-02-18 18:06:41.430294
NCT00034918|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2016-08-22|||May 2002||2002-05-01|August 2016|2016-08-01|November 2003|Actual|2003-11-01|||||Interventional|||This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer|An Open-label, Multicenter Phase II Study to Assess the Response of Subjects With Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy With or Without Capecitabine to ZD6474 (100-mg or 300-mg Daily Oral Dose).|Completed||Phase 2|44||Sanofi|||||||||||||||||||2017-02-18 18:06:41.523098|2017-02-18 18:06:41.523098
NCT00034905|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2013-01-03|||July 2001||2001-07-01|January 2013|2013-01-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||A Comparison of Seroquel vs. Risperidone in Schizophrenia||Completed||Phase 4|||AstraZeneca|||||||||||||||||||2017-02-18 18:06:41.606285|2017-02-18 18:06:41.606285
NCT00034892|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2013-01-03|||March 2002||2002-03-01|January 2013|2013-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||CAFE Comparison of Atypicals in First Episode of Psychosis|Efficacy and Tolerability of Olanzapine, Quetiapine and Risperidone in the Treatment of First Episode Psychosis: A Randomized Double Blind 52-Week Comparison|Completed||Phase 3|||AstraZeneca|||||||||||||||||||2017-02-18 18:06:41.952637|2017-02-18 18:06:41.952637
NCT00034879|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2013-01-03|||August 2000||2000-08-01|January 2013|2013-01-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Iressa Expanded Access Program (EAP)|An Expanded Access Clinical Program With ZD1839 (IRESSA®) for Patients With Advanced Non-small Cell Lung Cancer (NSCLC)|Completed||Phase 3|||AstraZeneca|||||t||||f||||||||||2017-02-18 18:06:42.105888|2017-02-18 18:06:42.105888
NCT00034866|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2005-09-19|||April 2002||2002-04-01|September 2005|2005-09-01|October 2002||2002-10-01|||||Interventional|||Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals|Double-Blind, Randomized, Dose Optimization Trial of Three Doses of Tipranavir Boosted With Low Dose Ritonavir (TPV/RTV) in Multiple Antiretroviral Drug-Experienced Subjects.|Completed||Phase 2|165||Boehringer Ingelheim|||||||||||||||||||2017-02-18 18:06:42.975115|2017-02-18 18:06:42.975115
NCT00034853|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2013-10-31|||December 2000||2000-12-01|October 2013|2013-10-01||||June 2003|Actual|2003-06-01||Interventional|||Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)|A 12 Week Double-blind Randomized Trial, With a 12 Week Open-label Extension, to Investigate the Efficacy and Safety of Meloxicam Oral Suspension Administered Once Daily and Naproxen Oral Suspension Administered Twice Daily in Children With Juvenile Rheumatoid Arthritis|Completed||Phase 3|180|Anticipated|Boehringer Ingelheim|||||f||||||||||||||2017-02-18 18:06:45.945987|2017-02-18 18:06:45.945987
NCT00034840|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2013-10-31|||October 2001||2001-10-01|October 2013|2013-10-01|August 2002||2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose|A Prospective, Randomized, Double-Blind, Forced Titration Trial to Compare the Efficacy of MICARDIS® (Telmisartan 80 mg p.o. Once Daily) and Diovan® (Valsartan 160 mg p.o. Once Daily) Using Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Hypertension After Missing One Dose|Completed||Phase 4|490||Boehringer Ingelheim|||||||||||||||||||2017-02-18 18:06:46.085784|2017-02-18 18:06:46.085784
NCT00034827|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2007-05-03|||January 2002||2002-01-01|July 2006|2006-07-01|May 2003|Actual|2003-05-01|||||Interventional|||A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer|A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer, or Pancreatic Cancer|Completed||Phase 2|172||Pfizer|||||f||||||||||||||2017-02-18 18:06:46.225493|2017-02-18 18:06:46.225493
NCT00034814|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-03-15|||January 2002||2002-01-01|March 2011|2011-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Multicenter Trial for Adults With Partial Seizures|Efficacy and Safety of Talampanel as Adjunctive Therapy in Patients With Partial Seizures: A Phase II Clinical Trial.|Completed||Phase 2|190|Actual|Teva Pharmaceutical Industries||6|||f||||||||||||||2017-02-18 18:06:49.177207|2017-02-18 18:06:49.177207
NCT00034801|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2006-07-18|||September 2001||2001-09-01|July 2006|2006-07-01|March 2003||2003-03-01|||||Interventional|||Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia|A Controlled Trial of Olanzapine Versus Active Comparator in the Treatment of Schizophrenic and Schizoaffective Subjects With Comorbid Depression|Completed||Phase 4|378||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:49.273379|2017-02-18 18:06:49.273379
NCT00034788|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-06-06|||December 2000||2000-12-01|March 2010|2010-03-01|February 2004|Actual|2004-02-01|||||Interventional|||A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX|A Multicenter Clinical Evaluation of the Efficacy and Safety of REGRANEX Gel in the Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers|Terminated||Phase 3|84|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||||Slow recruitment; Study did not address safety concern raised by European Medicines Agency|||||f||||||||||2017-02-18 18:06:49.376242|2017-02-18 18:06:49.376242
NCT00034775|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-01-07|||August 2001||2001-08-01|January 2011|2011-01-01|October 2002|Actual|2002-10-01|||||Interventional|||A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.|Open-Label Trial Exploring A Switching Regimen From Oral Neuroleptics, Other Than Risperidone, To Risperidone Depot Microspheres|Completed||Phase 3|141|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:06:49.478387|2017-02-18 18:06:49.478387
NCT00034762|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-01-31|||December 2000||2000-12-01|January 2011|2011-01-01|January 2003|Actual|2003-01-01|||||Interventional|||Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease|Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer's Disease.|Completed||Phase 3|473|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:06:49.572737|2017-02-18 18:06:49.572737
NCT00034749|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-06-06|||April 2001||2001-04-01|March 2010|2010-03-01|March 2006|Actual|2006-03-01|||||Interventional|||The Efficacy and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia|The Efficacy and Safety of Risperidone in Adolescents With Schizophrenia: a Comparison of Two Dose Ranges of Risperidone|Completed||Phase 3|279|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:06:49.666057|2017-02-18 18:06:49.666057
NCT00034736|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-02|2011-06-06|||August 2002||2002-08-01|December 2010|2010-12-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study to Compare the Efficacy and Safety of Levofloxacin in the Treatment of Children With Community-acquired Pneumonia in the Hospital or Outpatient Setting|A Multicenter, Randomized, Open-Label, Comparative Study to Compare the Efficacy and Safety of Levofloxacin and Standard of Care Therapy in the Treatment of Children With Community-Acquired Pneumonia in the Hospitalized or Outpatient Setting|Completed||Phase 3|691|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|||||||||||||||||||2017-02-18 18:06:49.75863|2017-02-18 18:06:49.75863
NCT00034723|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2008-03-03|||April 2002||2002-04-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis|MRI Investigation Of The CNS In HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:49.848659|2017-02-18 18:06:49.848659
NCT00034710|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2006-02-06|||March 2002||2002-03-01|February 2006|2006-02-01|October 2002||2002-10-01|||||Interventional|||Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain|A Double-Blind Controlled Pilot Study of High-Dose Capsaicin Patches in the Treatment of Pain Associated With Postherpetic Neuralgia|Completed||Phase 2|42||NeurogesX|||||||||||||||||||2017-02-18 18:06:50.210492|2017-02-18 18:06:50.210492
NCT00034697|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2015-01-28|||June 2001||2001-06-01|January 2015|2015-01-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)|A Phase II Study of Temozolomide (SCH 52365) in Subjects With Brain Metastasis From Non-Small-Cell Lung Cancer|Completed||Phase 2|60||Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:50.312234|2017-02-18 18:06:50.312234
NCT00034684|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2015-06-16|||July 2001||2001-07-01|June 2015|2015-06-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)|Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia|Completed||Phase 1/Phase 2|132|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:50.397667|2017-02-18 18:06:50.397667
NCT00034671|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2015-12-30|||January 2001||2001-01-01|December 2015|2015-12-01|March 2002|Actual|2002-03-01|November 2001|Actual|2001-11-01||Interventional|||PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)|Phase II Study of Safety, Tolerance, Efficacy, and Pharmacokinetics of Posaconazole (SCH 56592) for the Treatment of Invasive Fungal Infections in Immunocompromised Hosts|Completed||Phase 2|98|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:50.487223|2017-02-18 18:06:50.487223
NCT00034658|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2015-09-10|||December 1998||1998-12-01|September 2015|2015-09-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)|Open Label, Treatment Protocol for the Safety and Efficacy of Posaconazole (SCH 56592) in the Treatment of Invasive Fungal Infections|Completed||Phase 3|336|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:50.585292|2017-02-18 18:06:50.585292
NCT00034645|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2015-07-10|||January 1999||1999-01-01|July 2015|2015-07-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease||Completed||Phase 3|600|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:50.66972|2017-02-18 18:06:50.66972
NCT00034632|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2015-08-11|||April 2001||2001-04-01|August 2015|2015-08-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)|Open Label, Treatment Protocol for the Safety and Efficacy of Posaconazole (SCH 56592) in the Treatment of Invasive Fungal Infections|Completed||Phase 3|||Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:06:50.755383|2017-02-18 18:06:50.755383
NCT00034619|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:50.850506|2017-02-18 18:06:50.850506
NCT00034606|ClinicalTrials.gov processed this data on February 17, 2017|2002-05-01|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||Comparing 3 Schedules of Alimta Plus Gemzar||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:50.946749|2017-02-18 18:06:50.946749
NCT00034593|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-30|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium||Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:51.027476|2017-02-18 18:06:51.027476
NCT00034580|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-30|2006-07-18|||August 2001||2001-08-01|July 2006|2006-07-01|August 2002||2002-08-01|||||Interventional|||Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder|Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed|Completed||Phase 4|326||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:51.112925|2017-02-18 18:06:51.112925
NCT00034567|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-30|2007-09-14||||||September 2007|2007-09-01||||||||Observational|||Healthy Aging and Memory Study|Alzheimer's Disease Prevention Instrument Protocol|Completed||N/A|650||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:06:51.211931|2017-02-18 18:06:51.211931
NCT00034554|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-30|2010-04-08|||March 2002||2002-03-01|December 2009|2009-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Study of gp75 Vaccine in Patients With Stage III and IV Melanoma|Phase I Study of gp75 DNA Vaccine in Patients With AJCC Stage III and IV Melanoma|Completed||Phase 1|31|Actual|ImClone LLC||5|||f||||f||||||||||2017-02-18 18:06:51.329455|2017-02-18 18:06:51.329455
NCT00034541|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-30|2010-04-08|||December 2000||2000-12-01|April 2010|2010-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer|Phase Ib/IIa Study of an Anti-Epidermal Growth Factor Receptor (EGFr) Antibody Cetuximab in Combination With Carboplatin-Paclitaxel in Patients With Chemotherapy-Naive Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|32|Actual|ImClone LLC||1|||f||||f||||||||||2017-02-18 18:06:51.454488|2017-02-18 18:06:51.454488
NCT00034528|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-30|2013-04-30|||September 2001||2001-09-01|April 2013|2013-04-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia|Allogeneic Stem Cell Transplantation Following Nonmyeloablative Chemotherapy in Patients With Hemoglobinopathies|Terminated||Phase 2|2|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Due to slow recruitment|f||||||||||||||2017-02-18 18:06:51.654747|2017-02-18 18:06:51.654747
NCT00034515|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-29|2015-02-13|||June 2001||2001-06-01|February 2015|2015-02-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||A Study in Adult and Pediatric Patients With Cystic Fibrosis|Ph 1b/2a Study to Assess Levels of INS37217 and Placebo Treatment With Maximum Tolerated Dose Administered by Inhalation Via the Pari LC Star Nebulizer in Adult and Pediatric CF Patients|Completed||Phase 1/Phase 2|63|Actual|Merck Sharp & Dohme Corp.|||||||||||||||||||2017-02-18 18:06:51.96675|2017-02-18 18:06:51.96675
NCT00034502|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-29|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.||Completed||Phase 1/Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:52.064236|2017-02-18 18:06:52.064236
NCT00034489|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-29|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.|A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.|Completed||Phase 2|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:52.154153|2017-02-18 18:06:52.154153
NCT00034476|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-29|2006-07-18|||October 2001||2001-10-01|July 2006|2006-07-01|October 2002||2002-10-01|||||Interventional|||A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis|A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis|Completed||Phase 1/Phase 2|466||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:52.250826|2017-02-18 18:06:52.250826
NCT00034463|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-29|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer|A Phase 1 Trial of ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer|Completed||Phase 1|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:52.410586|2017-02-18 18:06:52.410586
NCT00034450|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-29|2006-08-17|||January 2002||2002-01-01|March 2006|2006-03-01|August 2004||2004-08-01|||||Interventional|||Developmental Study on Fatigue in Cancer|Developmental Study on Fatigue in Cancer|Completed||Phase 2|140||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:52.491576|2017-02-18 18:06:52.491576
NCT00034437|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-27|2008-03-03|||April 2002||2002-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Immune Response to Cytomegalovirus|Measurement of Cytomegalovirus (CMV)-Specific T Lymphocytes in CMV-Seropositive Normal Volunteers.|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:52.580795|2017-02-18 18:06:52.580795
NCT00034424|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-27|2017-01-24|||April 24, 2002||2002-04-24|January 3, 2017|2017-01-03||||||||Observational|||Cause of Familial Testicular Cancer|Multidisciplinary Etiologic Study of Familial Testicular Cancer|Recruiting||N/A|1750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:52.656479|2017-02-18 18:06:52.656479
NCT00034398|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-26|2017-01-24|||April 24, 2002||2002-04-24|March 11, 2010|2010-03-11|March 11, 2010||2010-03-11|||||Observational|||Study of GABA-A Receptors in the Generation of Tics in Patients With Tourette's Syndrome|Evaluation of Density and Pattern of Distribution of GABA A Receptors in Brain of Patients With Tourette's Syndrome Studied With PET Using [11C] Flumazenil|Completed||N/A|26|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:52.766013|2017-02-18 18:06:52.766013
NCT00034385|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2017-01-24|||April 24, 2002||2002-04-24|August 20, 2008|2008-08-20|October 30, 2009|Actual|2009-10-30|January 30, 2007|Actual|2007-01-30||Interventional|||Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients|Pharmacokinetics of Valganciclovir in Kidney and Kidney/Pancreas Transplant Recipients|Completed||Phase 4|12||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:06:52.847447|2017-02-18 18:06:52.847447
NCT00034372|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-26|2007-12-13|||September 2000||2000-09-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma||Terminated||Phase 2|102||Unither Pharmaceuticals||||closed by sponser|||||||||||||||2017-02-18 18:06:52.946985|2017-02-18 18:06:52.946985
NCT00034359|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-26|2014-02-18|||February 2002||2002-02-01|February 2014|2014-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection|A Double-Blind, Randomized Trial of Antiviral Activity and Safety of 12 Weeks Oral Treatment With ACH-126,443 (Beta-L-Fd4C) in Treatment-Naive HBV-Infected Adults|Completed||Phase 2|79|Actual|Achillion Pharmaceuticals|||||||||||||||||||2017-02-18 18:06:53.045234|2017-02-18 18:06:53.045234
NCT00034346|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-25|2007-12-20|||January 2002||2002-01-01|December 2007|2007-12-01||||||||Interventional|||ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)|A Two Part, Multiple Dose Clinical Trial of the Safety and Efficacy of ABX-EGF in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|194||Amgen|||||||||||||||||||2017-02-18 18:06:53.158303|2017-02-18 18:06:53.158303
NCT00034333|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-25|2005-06-23|||March 2002||2002-03-01|May 2004|2004-05-01||||||||Interventional|||Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer|Study of Doxorubicin Hydrochloride Adsorbed to Magnetic Targeted Carriers (MTC-DOX) Administered by Intrahepatic Delivery Versus Intravenous Doxorubicin for Treatment of Patients With Unresectable Hepatocellular Carcinoma|Terminated||Phase 2/Phase 3|240||FeRx|||||||||||||||||||2017-02-18 18:06:53.267133|2017-02-18 18:06:53.267133
NCT00034307|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-24|2005-06-23||||||May 2002|2002-05-01||||||||Interventional|||Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension|A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension|Unknown status|Active, not recruiting|Phase 2/Phase 3|180||ICOS-Texas Biotechnology|||||||||||||||||||2017-02-18 18:06:53.378655|2017-02-18 18:06:53.378655
NCT00034294|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-24|2015-03-04|||February 2002||2002-02-01|March 2015|2015-03-01|July 2003|Actual|2003-07-01|||||Interventional|||A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea|A Randomized, Double-Blind Study of GT160-246 Versus Vancomycin in Patients With C. Difficile-Associated Diarrhea|Completed||Phase 2|300||Sanofi|||||||||||||||||||2017-02-18 18:06:53.494971|2017-02-18 18:06:53.494971
NCT00034281|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-24|2012-01-31|||June 2002||2002-06-01|January 2012|2012-01-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2|A Phase I, Open-Label, Dose Escalating, Multiple Dose Study to Determine the Safety, Tolerability, Maximum Tolerated Dose and Pharmacokinetics of Oral TAK-165 Administered Once Daily to Subjects With Tumors Known to Express HER2.|Completed||Phase 1|16|Actual|Takeda||1|||f||||f||||||||||2017-02-18 18:06:53.953749|2017-02-18 18:06:53.953749
NCT00034268|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-24|2006-07-18|||March 2002||2002-03-01|July 2006|2006-07-01||||||||Interventional|||A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer|A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:54.067892|2017-02-18 18:06:54.067892
NCT00034255|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-24|2005-06-23|||December 2001||2001-12-01|June 2003|2003-06-01||||||||Interventional|||Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients|Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients|Completed||Phase 1/Phase 2|62||GMP Endotherapeutics|||||||||||||||||||2017-02-18 18:06:54.268513|2017-02-18 18:06:54.268513
NCT00034242|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-24|2008-03-03|||April 2002||2002-04-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration|The Efficacy of High-Dose Intravenous Immunoglobulin Therapy In Patients With Cerebellar Degeneration: A Double Blind, Placebo Controlled Trial|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:54.546626|2017-02-18 18:06:54.546626
NCT00034229|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-24|2008-03-03|||April 2002||2002-04-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Interventional|||Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression|A Double-Blind Randomized Placebo-Controlled Trial of Felbamate in Treatment Resistant Bipolar Depression|Completed||Phase 2|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:54.643928|2017-02-18 18:06:54.643928
NCT00034216|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-24|2017-01-24|||April 18, 2002||2002-04-18|December 30, 2016|2016-12-30||||||||Observational|||Collection of Blood From Patients With Cancer|Biospecimen Acquisition From Human Subjects|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:54.744979|2017-02-18 18:06:54.744979
NCT00034203|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-23|2005-06-23|||April 2002||2002-04-01|September 2004|2004-09-01|August 2003||2003-08-01|||||Interventional|||Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.||Completed||Phase 2|||XOMA (US) LLC|||||||||||||||||||2017-02-18 18:06:54.861234|2017-02-18 18:06:54.861234
NCT00034190|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-23|2009-06-02|||March 2002||2002-03-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma|A Phase IIa Multicenter Evaluation of The Safety And Efficacy of Weekly Administration of S-8184 Paclitaxel Injectable Emulsion In Second Line Treatment of Patients With Stage III or IV Colorectal Adenocarcinoma|Completed||Phase 2|28|Actual|OncoGenex Technologies||1|||f||||||||||||||2017-02-18 18:06:54.987923|2017-02-18 18:06:54.987923
NCT00034177|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-23|2009-06-02|||April 2002||2002-04-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium|Safety And Efficacy Of Weekly Administration Of S-8184 Paclitaxel Injectable Emulsion In Second Line Treatment Of Patients With Locally Advanced, Metastatic, Or Recurrent Transitional Cell Carcinoma Of The Urothelium|Completed||Phase 2|27|Actual|OncoGenex Technologies||1|||f||||||||||||||2017-02-18 18:06:55.078333|2017-02-18 18:06:55.078333
NCT00034164|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-23|2009-06-02|||April 2002||2002-04-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer|A Phase IIA Multicenter Evaluation of the Safety and Efficacy of Weekly Administration of S-8184 Paclitaxel Injectable Emulsion in Second Line Treatment of Patients With Relapsed Stage IIIB OR IV Non Small Cell Lung Cancer|Completed||Phase 2|52|Actual|OncoGenex Technologies||1|||f||||f||||||||||2017-02-18 18:06:55.168284|2017-02-18 18:06:55.168284
NCT00034151|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-23|2009-06-02|||March 2002||2002-03-01|June 2009|2009-06-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer|A Phase IIA Evaluation of Safety and Efficacy of Weekly S-8184 Paclitaxel Injectable Emulsion in Second Line Treatment of Stage III or IV Platinum Resistant Ovarian Cancer or Primary Peritoneal Carcinoma|Completed||Phase 2|52|Actual|OncoGenex Technologies||1|||f||||||||||||||2017-02-18 18:06:55.271035|2017-02-18 18:06:55.271035
NCT00034138|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-23|2007-12-13|||March 2002||2002-03-01|December 2007|2007-12-01|December 2007|Actual|2007-12-01|||||Interventional|||A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma||Terminated||Phase 1/Phase 2|24||Unither Pharmaceuticals||||closed by sponser|||||||||||||||2017-02-18 18:06:55.350615|2017-02-18 18:06:55.350615
NCT00034125|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-23|2006-07-18||||||July 2006|2006-07-01||||||||Interventional|||Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.|a Phase 3 Randomized Double Blind Evaluation of LY353381 Compared With Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.|Completed||Phase 3|||Eli Lilly and Company|||||||||||||||||||2017-02-18 18:06:55.441985|2017-02-18 18:06:55.441985
NCT00034112|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-22|2006-08-17|||April 2001||2001-04-01|July 2006|2006-07-01|March 2002||2002-03-01|||||Interventional|||Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease|Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:55.53862|2017-02-18 18:06:55.53862
NCT00034086|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-22|2012-05-17||||||May 2012|2012-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Study of Anti-HIV Therapy Intensification|Immunologic Consequences of Antiretroviral Therapy Intensification in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315/375|Completed||N/A|22||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:06:55.631518|2017-02-18 18:06:55.631518
NCT00034073|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-20|2017-01-24|||April 18, 2002||2002-04-18|April 16, 2009|2009-04-16|April 16, 2009||2009-04-16|||||Observational|||Magnetic Resonance Imaging in Children and Adults Using Arterial Spin Tagging Techniques|Quantitative fMRI in Children and Adults Using Arterial Spin Tagging Techniques|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:55.737366|2017-02-18 18:06:55.737366
NCT00034060|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-19|2008-03-03|||April 2002||2002-04-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept|Suppression of the Growth Hormone/ Insulin-Like Growth Factor-1 (GH/IGF-1) Axis in Women With Rheumatoid Arthritis|Completed||Phase 2|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:55.814033|2017-02-18 18:06:55.814033
NCT00034047|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-19|2008-01-23|||September 2002||2002-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Endometriosis : Traditional Medicine vs Hormone Therapy|Endometriosis : Traditional Medicine vs Hormone Therapy|Completed||Phase 1/Phase 2|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:55.908068|2017-02-18 18:06:55.908068
NCT00034034|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-19|2007-01-04|||June 2002||2002-06-01|January 2007|2007-01-01|August 2006||2006-08-01|||||Interventional|||Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer|An Intervention to Improve End-of-Life Symptom Distress|Completed||Phase 1|105||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:56.006861|2017-02-18 18:06:56.006861
NCT00034021|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-19|2006-08-17|||June 2002||2002-06-01|July 2006|2006-07-01|September 2004||2004-09-01|||||Interventional|||Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction|Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:56.102459|2017-02-18 18:06:56.102459
NCT00034008|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-19|2006-08-17|||July 2003||2003-07-01|July 2006|2006-07-01|July 2004||2004-07-01|||||Interventional|||Efficacy of Healing Touch in Stressed Neonates|Efficacy of Healing Touch in Stressed Neonates|Completed||Phase 2|13||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:56.201594|2017-02-18 18:06:56.201594
NCT00033995|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-18|2017-01-24|||April 17, 2002||2002-04-17|February 17, 2009|2009-02-17|February 17, 2009||2009-02-17|||||Observational|||Study of Tics in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder|Study of Tics in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder With [15O]H2O PET in Awake and in Sleep States|Completed||N/A|46||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:56.292086|2017-02-18 18:06:56.292086
NCT00033982|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-18|2017-01-24|||April 11, 2002||2002-04-11|February 20, 2007|2007-02-20|February 20, 2007||2007-02-20|||||Interventional|||Posaconazole to Treat Invasive Fungal Infections|Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections|Completed||Phase 3|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:56.384837|2017-02-18 18:06:56.384837
NCT00033969|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-17|2017-01-24|||April 15, 2002||2002-04-15|October 23, 2014|2014-10-23|October 23, 2014||2014-10-23|||||Observational|||Study of Proteins Associated With Complex Regional Pain Syndrome|Complex Regional Pain Syndrome Proteomics Study|Terminated||N/A|120|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:56.495882|2017-02-18 18:06:56.495882
NCT00033956|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-17|2005-06-23|||December 2001||2001-12-01|May 2002|2002-05-01||||||||Interventional|||Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2|Phase I/II Open Label Dose Escalation and Double-Blind, Placebo-Controlled Evaluation of M40403, for the Prevention of the Dose Limiting Toxicities of High Dose IV Bolus IL-2 Treatment of Metastatic Melanoma or Renal Cell Carcinoma.|Suspended||Phase 1/Phase 2|48||MetaPhore Pharmaceuticals|||||||||||||||||||2017-02-18 18:06:56.584258|2017-02-18 18:06:56.584258
NCT00033943|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-16|2005-06-23|||January 2001||2001-01-01|October 2002|2002-10-01|September 2002||2002-09-01|||||Interventional|||Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative Colitis|A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Two Dosage Levels of OP2000 (75 Mg and 125 Mg) Administered Once Daily by Subcutaneous Injection for the Treatment of Active Ulcerative Colitis|Completed||Phase 2/Phase 3|270||Incara Pharmaceuticals|||||||||||||||||||2017-02-18 18:06:56.672123|2017-02-18 18:06:56.672123
NCT00033917|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-12|2013-02-20|2013-01-08||September 1989||1989-09-01|February 2013|2013-02-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial|Randomized Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial|Completed||Phase 3|630|Actual|Yale University||2|||f||||||||||||||2017-02-18 18:06:57.054982|2017-02-18 18:06:57.054982
NCT00033904|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-12|2012-09-06|||June 2000||2000-06-01|September 2012|2012-09-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer|A Multi-Center, Randomized Phase III Study of Adjuvant Oncophage® Versus Observation in Subjects With High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma|Completed||Phase 3|650||Agenus Inc.|||||||||||||||||||2017-02-18 18:06:57.438533|2017-02-18 18:06:57.438533
NCT00033891|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-11|2017-01-24|||April 5, 2002||2002-04-05|March 18, 2016|2016-03-18|May 20, 2010|Actual|2010-05-20|July 31, 2007|Actual|2007-07-31||Interventional|||Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis|A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab in Patients With Dermatomyositis and Polymyositis|Completed||Phase 2|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:06:57.610885|2017-02-18 18:06:57.610885
NCT00033878|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-11|2007-03-27|||November 2001||2001-11-01|March 2007|2007-03-01|June 2006|Actual|2006-06-01|||||Interventional|||Study of Noni in Cancer Patients|Phase I Study of Noni in Cancer Patients|Completed||Phase 1|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:57.723298|2017-02-18 18:06:57.723298
NCT00033865|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-11|2015-04-27|||April 2001||2001-04-01|April 2015|2015-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Yoga as a Treatment for Insomnia|Yoga as a Treatment for Insomnia|Completed||Phase 2|48|Anticipated|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||||||||||||2017-02-18 18:06:57.812548|2017-02-18 18:06:57.812548
NCT00033852|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-11|2008-03-05|||April 2002||2002-04-01|March 2008|2008-03-01|May 2004||2004-05-01|||||Interventional|||Treatment of Depression With Massage in HIV|Treatment of Depression With Massage in HIV|Completed||Phase 2|90||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:06:57.945251|2017-02-18 18:06:57.945251
NCT00033839|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-11|2011-06-08|||January 2002||2002-01-01|June 2011|2011-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache|Completed||Phase 3|60||Winston Laboratories|||||f||||||||||||||2017-02-18 18:06:58.03632|2017-02-18 18:06:58.03632
NCT00033826|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-10|2013-05-23|||April 2002||2002-04-01|May 2013|2013-05-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Observational|||Role of Fat Tissue in Vitamin D Metabolism|The Role of Adipose Tissue in Vitamin D Metabolism|Completed||N/A|41|Actual|Tufts University|||1||f||||f||||||||||2017-02-18 18:06:58.150126|2017-02-18 18:06:58.150126
NCT00033787|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2017-01-24|||April 5, 2002||2002-04-05|June 8, 2009|2009-06-08|April 30, 2005|Actual|2005-04-30|April 30, 2005|Actual|2005-04-30||Observational|||Serotonin Function During Depression|Tryptophan Depletion PET Study in Remitted Depressed Subjects and Healthy Controls, and GABA MRS Study in Remitted and Currently Depressed Subjects and Healthy Controls|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:58.321767|2017-02-18 18:06:58.321767
NCT00033774|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2017-01-24|||April 5, 2002||2002-04-05|November 4, 2016|2016-11-04||||||||Observational|||Stem Cell Collection for Adult Volunteers|Peripheral Blood Stem Cell Collection From Adult Volunteers|Recruiting||N/A|99999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:06:58.406767|2017-02-18 18:06:58.406767
NCT00033748|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-07-15|||December 2001||2001-12-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|March 2007|Actual|2007-03-01||Interventional|||Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver|Sequential Phase II Study of the Anti-Idiotype Monoclonal Antibody Vaccine CeaVac and TriAb in Patients With Minimal Metastatic Colorectal Cancer|Completed||Phase 2|56|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:06:58.506922|2017-02-18 18:06:58.506922
NCT00033735|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2012-12-20|||January 2000||2000-01-01|December 2012|2012-12-01||||June 2003|Actual|2003-06-01||Interventional|||Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer|Phase III Trial Of Irofulven Vs. 5-Fluorouracil In Patients With Gemcitabine-Refractory Advanced Pancreatic Adenocarcinoma|Completed||Phase 3|158|Actual|Eisai Inc.||2|||f||||t||||||||||2017-02-18 18:06:58.708115|2017-02-18 18:06:58.708115
NCT00033722|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2014-01-03|||February 2002||2002-02-01|November 2002|2002-11-01||||||||Interventional|||Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Multicenter Study Of Lometrexol Sodium And Folic Acid In Subjects With Previously Treated Stage IIIB or IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:58.817724|2017-02-18 18:06:58.817724
NCT00033709|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2014-01-03|||March 2002||2002-03-01|May 2005|2005-05-01||||||||Interventional|||Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma|A Phase II Study of Combination Therapy of a Protracted Oral Schedule of Temozolomide and Thalidomide as First-Line or Subsequent Therapy for Patients With Metastatic, Locally Advanced or Unresectable Leiomyosarcoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:58.9137|2017-02-18 18:06:58.9137
NCT00033696|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-07-15|||September 2001||2001-09-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Paclitaxel/Topotecan/Etoposide (EtopoTax) Induction Followed by Consolidation Chemoradiotherapy for Limited Stage Small Cell Lung Cancer: A Phase II Study|Completed||Phase 2|65|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:06:59.012668|2017-02-18 18:06:59.012668
NCT00033683|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2009-02-06|||February 2001||2001-02-01|June 2005|2005-06-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Resected Breast Cancer|A Randomised Trial Of Standard Anthracycline-Based Chemotherapy With Fluorouracil, Epirubicin And Cyclophosphamide (FEC) Or Epirubicin And CMF (Epi-CMF) Versus FEC Followed By Sequential Docetaxel As Adjuvant Treatment For Women With Early Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:06:59.177009|2017-02-18 18:06:59.177009
NCT00033657|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2012-11-30|2011-06-21||May 2002||2002-05-01|November 2012|2012-11-01|October 2009|Actual|2009-10-01|September 2009|Actual|2009-09-01||Interventional|||Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer|Randomized Phase II Study of Preoperative Combined Modality Paclitaxel / Cisplatin / RT or Irinotecan / Cisplatin / RT Followed by Postoperative Chemotherapy With the Same Agents in Operable Adenocarcinoma of the Esophagus|Completed||Phase 2|97|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 18:06:59.349561|2017-02-18 18:06:59.349561
NCT00033644|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-04-10|||March 2002||2002-03-01|September 2004|2004-09-01||||October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus|A Phase II Evaluation of DMAP Plus GM-CSF in the Treatment of Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:07:00.44299|2017-02-18 18:07:00.44299
NCT00033631|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-12-16|2016-12-16||March 2002||2002-03-01|December 2016|2016-12-01||||April 2014|Actual|2014-04-01||Interventional||All eligible patients who did not withdraw consent|Radiation Therapy in Treating Patients With Stage II Prostate Cancer|A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer|Active, not recruiting||Phase 3|1532|Actual|Radiation Therapy Oncology Group|The data monitoring committee (DMC) recommended early reporting of the trial when the third interim analysis futility boundary was crossed.|2|||f||||t||||||||||2017-02-18 18:07:00.582686|2017-02-18 18:07:00.582686
NCT00033618|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-02-26|||November 2002||2002-11-01|February 2013|2013-02-01||||January 2007|Actual|2007-01-01||Interventional|||Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck|A Randomized Phase II Study of BMS-247550 (NSC #710428) Given Daily x 5 Days Every 3 Weeks or Weekly in Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|144|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:07:01.214931|2017-02-18 18:07:01.214931
NCT00033605|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-07-12|||April 2002||2002-04-01|July 2016|2016-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis|Phase III Double-Blind Study Of Depot Octreotide Versus Placebo In The Prevention Of Acute Diarrhea In Patients Receiving Pelvic Radiation Therapy|Completed||Phase 3|130|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:07:01.336317|2017-02-18 18:07:01.336317
NCT00033592|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-07-12|||February 2002||2002-02-01|July 2016|2016-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking|Phase III Trial Comparing Nicotine Inhaler Versus Bupropion Versus Nicotine Inhaler Plus Bupropion For Smoking Cessation Efficacy And Relapse Prevention|Completed||Phase 3|1708|Actual|Alliance for Clinical Trials in Oncology||15|||f||||f||||||||||2017-02-18 18:07:01.461784|2017-02-18 18:07:01.461784
NCT00005249|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1989||1989-09-01|April 2000|2000-04-01|August 1991|Actual|1991-08-01|||||Observational|||Epidemiology of Blood Pressure, Insulin, Salt Transport||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.729299|2017-02-18 18:15:17.729299
NCT00033566|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2011-03-03|||October 2001||2001-10-01|March 2011|2011-03-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||S-3304 in Treating Patients With Advanced Solid Tumors|A Phase I Study of S-3304 in Patients With Solid Tumors|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:07:01.611594|2017-02-18 18:07:01.611594
NCT00033553|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-07-15|||March 2002||2002-03-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer|Induction/Concurrent Chemotherapy and Dose-Escalated Three Dimensional Thoracic Radiation for Patients With Stage III Non Small Cell Lung Cancer: A Randomized Phase II Study|Completed||Phase 2|69|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:07:01.708555|2017-02-18 18:07:01.708555
NCT00033540|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2012-09-24|2012-06-14||September 2003||2003-09-01|September 2012|2012-09-01|July 2011|Actual|2011-07-01|April 2008|Actual|2008-04-01||Interventional|||S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma|A Phase II Trial of Gemcitabine (NSC-613327) and Capecitabine (NSC-712807) in Patients With Unresectable or Metastatic Gallbladder or Cholangiocarcinoma|Completed||Phase 2|57|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:07:01.999993|2017-02-18 18:07:01.999993
NCT00033527|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-11-05||||||September 2002|2002-09-01||||||||Interventional|||INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer|A Double-Blinded, Placebo-Controlled, Parallel Group Study Of Uridine 5'-Triphosphate (UTP) Solution For Inhalation As An Adjunct In The Diagnosis Of Lung Cancer By Sputum Cytology|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:05.584792|2017-02-18 18:07:05.584792
NCT00033514|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-03-11|2016-02-11||August 2001||2001-08-01|February 2016|2016-02-01|December 2011|Actual|2011-12-01|December 2011|Actual|2011-12-01||Interventional||enrolled subjects|Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression|Phase I/II Study Of Herceptin Combined With OSI-774 In The First-Line Treatment Of Metastatic Breast Cancer Associated With HER2/Neu Overexpression|Completed||Phase 1/Phase 2|27|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:07:05.670858|2017-02-18 18:07:05.670858
NCT00033488|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-12-17|||September 2000||2000-09-01|June 2007|2007-06-01|March 2010|Actual|2010-03-01|||||Interventional|||Screening Women at High Genetic Risk for Ovarian Cancer|The UK Familial Ovarian Cancer Screening Study|Completed||N/A|5000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:06.542369|2017-02-18 18:07:06.542369
NCT00033475|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-12-18|||March 2001||2001-03-01|June 2002|2002-06-01||||||||Interventional|||Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation|Cytotoxic T Cell Therapy for Post Transplant Lymphoproliferative Disease: Randomized Controlled Trial in Transplant Recipients|Unknown status|Active, not recruiting|Phase 3|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:06.644843|2017-02-18 18:07:06.644843
NCT00033462|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-06-03|||March 2002||2002-03-01|June 2013|2013-06-01||||November 2006|Actual|2006-11-01||Interventional|||Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer|A Phase II Trial of OSI-774 in Patients With Hepatocellular or Biliary Carcinoma|Completed||Phase 2|78|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:06.756866|2017-02-18 18:07:06.756866
NCT00033449|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-01-24|||February 2002||2002-02-01|January 2013|2013-01-01||||April 2010|Actual|2010-04-01||Interventional|||Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer|A Phase I Study Of ZD 1839 In Combination With Radiation And Chemotherapy In Locally Advanced Squamous Cell Carcinoma Of The Head And Neck|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:07:06.874288|2017-02-18 18:07:06.874288
NCT00033436|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-09-19|||October 2000||2000-10-01|December 2002|2002-12-01|November 2008|Actual|2008-11-01|||||Interventional|||Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer|A Multicenter Randomized Trial of Radical Radiotherapy With Carbogen in the Radical Treatment of Locally Advanced Bladder Cancer|Completed||Phase 3|330|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:06.996063|2017-02-18 18:07:06.996063
NCT00033423|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-12-12|||August 2001||2001-08-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Phase I, Multicenter, Open Label, Dose Escalation Of 90Y-Zevalin Radioimmunotherapy Using A Modified Treatment Regimen For Relapsed Or Refractory CD20+ B-Cell (Follicular/Transformed) Non-Hodgkin's Lymphoma|Terminated||Phase 1|18|Actual|University of Alabama at Birmingham||5|||f||||t||||||||||2017-02-18 18:07:07.112677|2017-02-18 18:07:07.112677
NCT00033410|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2009-02-06|||March 2002||2002-03-01|September 2006|2006-09-01||||||||Interventional|||Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|A Phase I Study Of Tirapazamine (NSC 130181) Paclitaxel And Carboplatin With Concurrent Radiation Followed By Tirapazamine/Paclitaxel/Carboplatin Consolidation For Stage III Non-Small Cell Lung Cancer|Completed||Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:07:07.24329|2017-02-18 18:07:07.24329
NCT00033397|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-08-11|||February 2002||2002-02-01|August 2016|2016-08-01||||May 2012|Actual|2012-05-01||Interventional|||Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery|Contrast-Enhanced Breast MRI, MRS, And Correlative Science Studies To Characterize Tumor Response In Patients Undergoing Neoadjuvant Treatment For Locally Advanced Breast Cancer|Active, not recruiting||N/A|384|Anticipated|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:07:07.331232|2017-02-18 18:07:07.331232
NCT00033384|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-04-10|||February 2002||2002-02-01|December 2002|2002-12-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer|A Multicenter Phase 2 Study of CI-1040 In Patients With Advanced Nonsmall-Cell Lung Cancer, Breast Cancer, Colon Cancer Or Pancreatic Cancer|Completed||Phase 2|||University of Alabama at Birmingham|||||f||||t||||||||||2017-02-18 18:07:07.458532|2017-02-18 18:07:07.458532
NCT00032942|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||April 2001||2001-04-01|July 2008|2008-07-01||||October 2004|Actual|2004-10-01||Interventional|||Lofexidine for Opiate Withdrawal - 1|A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal|Completed||Phase 3|66||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:07:13.61932|2017-02-18 18:07:13.61932
NCT00033371|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-12-28|2015-01-26||December 2001||2001-12-01|December 2016|2016-12-01|December 2014|Actual|2014-12-01|April 2009|Actual|2009-04-01||Interventional||According to the protocol, a patient needed to receive at least 80% of intended overall dose AND at least 80% dose during the final 60 days of the study to qualify as evaluable. One participant was randomized to Arm II but withdrew prior to receiving any treatment.|Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis|A Two-Arm Phase II Chemoprevention Trial in Adenomatous Polyposis Coli Patients|Terminated||Phase 2|112|Actual|National Cancer Institute (NCI)|Following reports of COX-2 inhibitor-associated cardiovascular toxicities, trial suspended from December 17, 2004 to March 18, 2005 pending reevaluation of cardiovascular risks, only two sites resumed the trial.|2||Slow recruitment.|f||||t||||||||||2017-02-18 18:07:07.564317|2017-02-18 18:07:07.564317
NCT00033358|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-05-02|||February 2002||2002-02-01|April 2013|2013-04-01||||October 2007|Actual|2007-10-01||Interventional|||Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer|Modulation Of Putative Surrogate Endpoint Biomarkers In Endometrial Biopsies From Women With HNPCC|Completed||Phase 2|52|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:07:09.054252|2017-02-18 18:07:09.054252
NCT00033345|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-08-17|||January 2002||2002-01-01|August 2016|2016-08-01||||July 2008|Actual|2008-07-01||Interventional|||Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer|Multiple Daily Dose Phase I Safety And Pharmacokinetic Clinical Study Of Indole-3-Carbinol|Completed||Phase 1|17|Actual|University of Kansas Medical Center||1|||f||||||||||||||2017-02-18 18:07:09.18146|2017-02-18 18:07:09.18146
NCT00033332|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2014-04-02|||April 2002||2002-04-01|November 2005|2005-11-01|June 2006|Actual|2006-06-01|March 2006|Actual|2006-03-01||Interventional|||Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma|A Randomized Phase III Trial Of Thalidomide (NSC # 66847) Plus Dexamethasone Versus Dexamethasone In Newly Diagnosed Multiple Myeloma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:09.30273|2017-02-18 18:07:09.30273
NCT00033319|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-09-16|||May 1997||1997-05-01|December 2002|2002-12-01||||||||Interventional|||Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps|UKCAP Trial: A Multi-Center Double Blind Randomised Controlled Trial Of Aspirin And/Or Folate Supplementation For the Prevention Of Recurrent Colorectal Adenomas|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:09.494069|2017-02-18 18:07:09.494069
NCT00033306|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-08-01|||February 2002||2002-02-01|August 2013|2013-08-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||BMS-247550 in Treating Patients With Metastatic Colorectal Cancer|A Phase II Study Of Epothilone Analog BMS-247550 In Patients With Metastatic Colorectal Cancer Previously Treated With A Fluoropyrimidine And Irinotecan|Terminated||Phase 2|2|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 18:07:09.626625|2017-02-18 18:07:09.626625
NCT00033293|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2016-08-09|2016-01-28||March 2004||2004-03-01|June 2015|2015-06-01|June 2014|Actual|2014-06-01|December 2013|Actual|2013-12-01||Interventional|||Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma|A Pilot Study Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone|Completed||Phase 3|53|Actual|Children's Oncology Group|The COG SDC reviewed the NLM notification related to ct.gov AE/SAE reporting. The information in ‘Additional Description’ is accurate with respect to data supplied to ct.gov.COG plans to submit data AE/SAE data consistent with the text in this field.|2|||f||||t||||||||||2017-02-18 18:07:09.784567|2017-02-18 18:07:09.784567
NCT00033280|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2015-12-11|||July 2002||2002-07-01|December 2015|2015-12-01||||April 2005|Actual|2005-04-01||Interventional|||Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas|A Phase II Trial Of Pre-Irradiation And Concurrent Temozolomide In Patients With Newly Diagnosed Anaplastic Oligodendrogliomas And Mixed Anaplastic Oligoastrocytomas|Active, not recruiting||Phase 2|42|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:07:10.8673|2017-02-18 18:07:10.8673
NCT00033267|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2014-04-02|||April 2002||2002-04-01|December 2012|2012-12-01|February 2008|Actual|2008-02-01|February 2006|Actual|2006-02-01||Interventional|||CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma|A Phase II Study of CCI-779 in Previously Treated Patients With Mantle Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:11.015992|2017-02-18 18:07:11.015992
NCT00033254|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2013-06-05|||March 2002||2002-03-01|June 2013|2013-06-01||||May 2006|Actual|2006-05-01||Interventional|||Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases|A Phase III Study of Conventional Radiation Therapy Plus Thalidomide (NSC#66847) Versus Conventional Radiation Therapy for Multiple Brain Metastases|Completed||Phase 3|332|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:07:11.132571|2017-02-18 18:07:11.132571
NCT00033241|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2015-06-12|||June 2001||2001-06-01|June 2015|2015-06-01|April 2004|Actual|2004-04-01|||||Interventional|||Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors|A Phase Ib Multicenter Trial To Determine The Safety, Tolerance And Preliminary Antineoplastic Activity Of Gemcitabine Administered In Combination With Escalating Oral Doses Of OSI-774 To Patient Cohorts With Recently Diagnosed, Gemcitabine-Naive, Advanced Pancreatic Carcinoma Or Other Potentially Responsive Malignancies|Completed||Phase 1|||Astellas Pharma Inc|||||||||||||||||||2017-02-18 18:07:11.25186|2017-02-18 18:07:11.25186
NCT00033228|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2011-05-11|||January 2002||2002-01-01|May 2011|2011-05-01|April 2003|Actual|2003-04-01|March 2003|Actual|2003-03-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|A Phase I/II Pilot Study Of Intranodal Delivery Of A Plasmid DNA (Synchrovax SEM Vaccine) In Stage IV Melanoma Patients|Completed||Phase 1/Phase 2|19|Actual|Mannkind Corporation||3|||||||f||||||||||2017-02-18 18:07:11.371477|2017-02-18 18:07:11.371477
NCT00033215|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2005-06-23|||November 2001||2001-11-01|November 2003|2003-11-01|October 2003||2003-10-01|||||Interventional|||A Phase 1 Study of S-3304 in Patients With Solid Tumors|A Phase 1 Study of S-3304 in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|28||Shionogi|||||||||||||||||||2017-02-18 18:07:11.486206|2017-02-18 18:07:11.486206
NCT00033202|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-09|2009-06-02|||March 2002||2002-03-01|June 2009|2009-06-01|February 2005|Actual|2005-02-01|||||Interventional|||This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor|Phase I Study of Oral ST1481 Administered Once Weekly Every 3 Out 4 Weeks in Patients With Advanced Solid Malignancies.|Completed||Phase 1|30|Anticipated|Sigma-Tau Research, Inc.|||||||||||||||||||2017-02-18 18:07:11.570311|2017-02-18 18:07:11.570311
NCT00033163|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-08|2012-05-17||||||May 2012|2012-05-01|May 2005|Actual|2005-05-01|||||Interventional|||A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV|A Randomized, Phase II, Controlled Trial Comparing the Efficacy of Adefovir Dipivoxil and Tenofovir Disoproxil Fumarate for the Treatment of Lamivudine-Resistant Hepatitis B Virus in Subjects Who Are Co-Infected With HIV|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:07:11.84203|2017-02-18 18:07:11.84203
NCT00033150|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-08|2006-04-21|||June 2002||2002-06-01|April 2006|2006-04-01|January 2005||2005-01-01|||||Interventional|||A Comparison of Language Intervention Programs|A Comparison of Language Intervention Programs|Completed||Phase 3|216||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-02-18 18:07:11.963729|2017-02-18 18:07:11.963729
NCT00033137|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-24|||April 3, 2002||2002-04-03|October 19, 2016|2016-10-19||||||||Observational|||Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer|The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:12.062146|2017-02-18 18:07:12.062146
NCT00033124|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-10|||July 2001||2001-07-01|August 2003|2003-08-01|June 2002||2002-06-01|||||Interventional|||A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1|Behavioral Trial for the Treatment of Methamphetamine Dependence|Unknown status|Active, not recruiting|Phase 2|50||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:07:12.187135|2017-02-18 18:07:12.187135
NCT00033111|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||June 2001||2001-06-01|October 2016|2016-10-01|April 2004|Actual|2004-04-01|||||Interventional|||A Study of Cabergoline for the Treatment of Cocaine Dependence - 1|Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence|Completed||Phase 2|140|Actual|National Institute on Drug Abuse (NIDA)||2|||||||t||||||||||2017-02-18 18:07:12.29639|2017-02-18 18:07:12.29639
NCT00033098|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-10|||November 2001||2001-11-01|August 2003|2003-08-01|May 2002||2002-05-01|||||Interventional|||Cocaine-Metyrapone Interaction Study - 1|Cocaine-Metyrapone Interaction Study|Unknown status|Active, not recruiting|Phase 1|12||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:07:12.410704|2017-02-18 18:07:12.410704
NCT00033085|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||May 2001||2001-05-01|July 2008|2008-07-01|December 2002||2002-12-01|||||Interventional|||Ondansetron for the Treatment of Cocaine Dependence - 1|Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence|Completed||Phase 2|60||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:07:12.505106|2017-02-18 18:07:12.505106
NCT00033072|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-10|||September 2001||2001-09-01|November 2003|2003-11-01|October 2002||2002-10-01|||||Interventional|||Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1|Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 18:07:12.595897|2017-02-18 18:07:12.595897
NCT00033059|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-10|||July 2001||2001-07-01|August 2003|2003-08-01|March 2002||2002-03-01|||||Interventional|||Assessment of Potential Interactions Between Cocaine and Tolcapone - 1|Assessment of Potential Interactions Between Intravenous Cocaine and Tolcapone|Unknown status|Active, not recruiting|Phase 1|16||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:07:12.684097|2017-02-18 18:07:12.684097
NCT00033046|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-10|||June 2001||2001-06-01|May 2004|2004-05-01|April 2002||2002-04-01|||||Interventional|||Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1|Safety Evaluation of Cocaine Treatment Medication Modafinil: Interactions With Intravenous Cocaine|Unknown status|Active, not recruiting|Phase 1|12||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 18:07:12.773367|2017-02-18 18:07:12.773367
NCT00033033|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||July 2001||2001-07-01|August 2008|2008-08-01|May 2003||2003-05-01|||||Interventional|||Reserpine for the Treatment of Cocaine Dependence - 1|Phase 2, Double-Blind, Placebo-Controlled Trial of Reserpine for the Treatment of Cocaine Dependence|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:07:12.88216|2017-02-18 18:07:12.88216
NCT00033020|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||April 2001||2001-04-01|April 2010|2010-04-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1|Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics|Completed||Phase 3|390||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 18:07:12.97887|2017-02-18 18:07:12.97887
NCT00033007|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||April 2001||2001-04-01|April 2010|2010-04-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1|Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics|Completed||Phase 3|440||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 18:07:13.088109|2017-02-18 18:07:13.088109
NCT00032994|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||April 2001||2001-04-01|April 2010|2010-04-01|October 2002||2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1|Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse|Completed||Phase 3|422||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 18:07:13.192825|2017-02-18 18:07:13.192825
NCT00032981|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||May 2001||2001-05-01|April 2010|2010-04-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1|Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse|Completed||Phase 3|561||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 18:07:13.298591|2017-02-18 18:07:13.298591
NCT00032968|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||January 2001||2001-01-01|April 2010|2010-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1|Buprenorphine/Naloxone Versus Clonidine For Out-patient Opiate Detoxification|Completed||Phase 3|341||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 18:07:13.403924|2017-02-18 18:07:13.403924
NCT00032955|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||February 2001||2001-02-01|April 2010|2010-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1|Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification|Completed||Phase 3|163||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 18:07:13.511278|2017-02-18 18:07:13.511278
NCT00032929|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-11|||March 2001||2001-03-01|May 2009|2009-05-01||||December 2002|Actual|2002-12-01||Interventional|||Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1|Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence|Completed||Phase 3|269|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-02-18 18:07:13.984425|2017-02-18 18:07:13.984425
NCT00032916|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2017-01-10|||June 2001||2001-06-01|April 2004|2004-04-01|December 2002||2002-12-01|||||Interventional|||Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1|Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers|Unknown status|Active, not recruiting|Phase 1|24||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:07:14.108647|2017-02-18 18:07:14.108647
NCT00032903|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2009-06-02|||March 2002||2002-03-01|June 2009|2009-06-01|October 2005|Actual|2005-10-01|||||Interventional|||This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.|Oral ST1481 in Adults With Malignant Glioma: a Phase I-II Clinical Trial|Completed||Phase 1/Phase 2|59|Anticipated|Sigma-Tau Research, Inc.|||||||||||||||||||2017-02-18 18:07:14.200123|2017-02-18 18:07:14.200123
NCT00032890|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-05|2009-01-20|||April 2000||2000-04-01|November 2006|2006-11-01|February 2004||2004-02-01|||||Interventional|||Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)|Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)|Completed||Phase 3|1588||VA Office of Research and Development|||||||||||||||||||2017-02-18 18:07:14.278316|2017-02-18 18:07:14.278316
NCT00032877|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-04|2008-03-03|||April 2002||2002-04-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||Genetic Analysis of Fraser Syndrome and Fryns Syndrome|Molecular Genetic Analysis of Fraser Syndrome and Fryns Syndrome|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:14.396876|2017-02-18 18:07:14.396876
NCT00032864|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-04|2009-01-20|||January 1997||1997-01-01|February 2003|2003-02-01|September 2000||2000-09-01|||||Observational|||Clinical Trial of Footwear in Patients With Diabetes|Clinical Trial of Footwear in Patients With Diabetes|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:07:14.49994|2017-02-18 18:07:14.49994
NCT00032838|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-03|2008-03-03|||March 2002||2002-03-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Effects of Stress Hormones on Emotion and Cognition|The Effects of Cortisol and Norepinephrine Modulation on Emotional and Nonemotional Processing|Completed||N/A|170||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:14.568867|2017-02-18 18:07:14.568867
NCT00032825|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-03|2017-01-24|||March 19, 2002||2002-03-19|May 4, 2012|2012-05-04|June 13, 2011|Actual|2011-06-13|||||Interventional|||Ketoconazole Plus Docetaxel to Treat Prostate Cancer|A Phase I Trial of High Dose Ketoconazole Plus Weekly Docetaxel in Metastatic Androgen Independent Prostate Cancer|Completed||Phase 1|480|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:07:14.666454|2017-02-18 18:07:14.666454
NCT00032812|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-03|2008-03-03|||March 2002||2002-03-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Observational|||The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease|Motor Memory: Study of the Role of Dopamine in Healthy Subjects and Patients With Parkinson's Disease Using PET and EEG|Completed||N/A|64||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:14.771995|2017-02-18 18:07:14.771995
NCT00032799|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-03|2016-06-14|||December 2001||2001-12-01|March 2012|2012-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease|A Phase 3 International, Multicenter, Double-blind, Placebo-controlled Study of the Safety, Efficacy, and Tolerability of Intravenous Antegren (Natalizumab) in Subjects With Moderate to Severely Active Crohn's Disease|Completed||Phase 3|905|Actual|Biogen|||||||||||||||||||2017-02-18 18:07:14.865694|2017-02-18 18:07:14.865694
NCT00032786|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-03|2016-06-14|||March 2002||2002-03-01|March 2012|2012-03-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease|A Phase 3, International, Multicenter, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Intravenous Antegren (Natalizumab) in Maintaining Clinical Response and Remission in Subjects With Crohn's Disease|Completed||Phase 3|||Biogen|||||||||||||||||||2017-02-18 18:07:14.963745|2017-02-18 18:07:14.963745
NCT00032773|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-02|2009-10-12||||||June 2005|2005-06-01||||||||Interventional|||Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD|A Sequentially Adaptive, Open Label, Dose-finding, Phase I/II Trial of Pentostatin in the Treatment of Steroid-refractory Acute Graft Versus Host Disease (aGvHD)|Terminated||Phase 1/Phase 2|36||Astex Pharmaceuticals|||||||||||||||||||2017-02-18 18:07:15.05543|2017-02-18 18:07:15.05543
NCT00032760|ClinicalTrials.gov processed this data on February 17, 2017|2002-04-01|2007-09-28|||March 2002||2002-03-01|September 2007|2007-09-01|March 2004|Actual|2004-03-01|||||Interventional|||Meditation-Based Treatment for Binge Eating Disorder|Meditation-Based Treatment for Binge Eating Disorder|Completed||Phase 2/Phase 3|160||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:15.145662|2017-02-18 18:07:15.145662
NCT00032747|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-29|2008-06-16|||August 2001||2001-08-01|June 2008|2008-06-01|February 2003|Actual|2003-02-01|||||Interventional|||Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Effects of Vasopressin V2 Receptor Antagonist on Clinical Improvement in Patients With Severe Chronic Heart Failure|Completed||Phase 2|338|Actual|Sanofi|||||||||||||||||||2017-02-18 18:07:15.26366|2017-02-18 18:07:15.26366
NCT00032734|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-29|2008-06-16|||June 2001||2001-06-01|June 2008|2008-06-01|July 2003|Actual|2003-07-01|||||Interventional|||Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation, Multicenter Study Evaluating the Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion.|Completed||Phase 2|35|Actual|Sanofi|||||||||||||||||||2017-02-18 18:07:15.38712|2017-02-18 18:07:15.38712
NCT00032721|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-29|2006-08-17|||March 2002||2002-03-01|July 2006|2006-07-01|September 2003||2003-09-01|||||Interventional|||The Use of Reiki for Patients With Advanced AIDS|The Use of Reiki for Patients With Advanced AIDS|Completed||Phase 2|146||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:15.498363|2017-02-18 18:07:15.498363
NCT00032708|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-28|2010-08-26|||April 2004||2004-04-01|May 2006|2006-05-01|November 2004||2004-11-01|||||Interventional|||Dryvax Dilution-Prev Vacc Adults|A Double Blind, Randomized Dose Response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:07:15.592363|2017-02-18 18:07:15.592363
NCT00032682|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2008-03-03|||March 2002||2002-03-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Observational|||Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or Narcotics|A Pilot Study Evaluating the Assessment Process for Constipation in Pediatric Oncology Patients Who Are Receiving Vinca Alkaloids and/or Narcotics|Completed||N/A|34||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:15.768038|2017-02-18 18:07:15.768038
NCT00032669|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2008-03-03|||March 2002||2002-03-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children|Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children|Completed||Phase 1|34||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:15.853721|2017-02-18 18:07:15.853721
NCT00032656|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2006-08-17|||February 2001||2001-02-01|July 2006|2006-07-01|December 2003||2003-12-01|||||Observational|||Adolescents' Use of Complementary and Alternative Medicine|Adolescents' Use of Complementary and Alternative Medicine|Completed||N/A|1400||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:15.939937|2017-02-18 18:07:15.939937
NCT00032643|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2013-11-04|||June 2004||2004-06-01|November 2013|2013-11-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)|CSP #526 - A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)|Terminated||Phase 2|150|Anticipated|VA Office of Research and Development||1||Funding support withdrawn (much slower than expected enrollment)|f||||f||||||||||2017-02-18 18:07:16.039996|2017-02-18 18:07:16.039996
NCT00032630|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2014-04-18|2013-08-08||April 2002||2002-04-01|April 2014|2014-04-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|ROOBY||Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass|CSP #517 - Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass|Completed||Phase 3|2203|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 18:07:16.163696|2017-02-18 18:07:16.163696
NCT00032617|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2010-09-22|||August 2002||2002-08-01|September 2010|2010-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||A Randomized Clinical Trial of Cognitive-Behavioral Treatment for Post-Traumatic Stress Disorders in Women|CSP #494 - A Randomized Clinical Trial of Cognitive-Behavioral Treatment for PTSD in Women (PTSD)|Completed||Phase 3|284|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 18:07:16.60887|2017-02-18 18:07:16.60887
NCT00032591|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2014-03-18|2013-06-12||August 2003||2003-08-01|March 2014|2014-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|THINRS|3745 participants were screened for participation|The Home INR Study|CSP #481 - The Home INR Study (THINRS)|Completed||Phase 4|2922|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 18:07:16.739315|2017-02-18 18:07:16.739315
NCT00032578|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2009-01-20|||January 2000||2000-01-01|June 2006|2006-06-01||||||||Observational|||VA Genetic Tissue Banking|CSP #478 (FeAST-DNA), Genetic Tissue Banking in VA Clinical Research: A Cooperative Studies Program Demonstration Project|Completed||N/A|1000||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:07:18.056328|2017-02-18 18:07:18.056328
NCT00032565|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2010-09-22|||November 2002||2002-11-01|September 2010|2010-09-01|March 2008|Actual|2008-03-01|July 2007|Actual|2007-07-01||Observational|EQUIC||EQUIC-SM: Enhancing Quality of Informed Consent|CSP #476SM - Enhancing Quality of Informed Consent (EQUIC-SM) Self-Monitoring|Completed||N/A|836|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:07:18.140941|2017-02-18 18:07:18.140941
NCT00032552|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2010-03-23|||April 1999||1999-04-01|March 2010|2010-03-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Enhancing Quality of Informed Consent (EQUIC-DP) Developmental Phase|CSP #476DP - Enhancing Quality of Informed Consent (EQUIC-DP) Developmental Phase|Completed||N/A|632|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:07:18.254783|2017-02-18 18:07:18.254783
NCT00032539|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-27|2012-03-14|||April 1999||1999-04-01|March 2012|2012-03-01|April 1999|Actual|1999-04-01|April 1999|Actual|1999-04-01||Observational|||EQUIC-CC: Enhancing Quality of Informed Consent - Customized Consent|CSP #476CC - Enhancing Quality of Informed Consent (EQUIC-CC) Customized Consent|Completed||N/A|240|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:07:18.37772|2017-02-18 18:07:18.37772
NCT00032526|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-25|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Classical Conditioning to Treat Allergic Airway Diseases|Classical Conditioning to Treat Allergic Airway Diseases|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:07:18.489151|2017-02-18 18:07:18.489151
NCT00032513|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-22|2017-01-24|||March 15, 2002||2002-03-15|August 11, 2016|2016-08-11||||||||Observational|||Genetic Studies of Chronic Active Epstein-Barr Disease|Genetic Studies of Chronic Active Epstein-Barr Virus Infection|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:18.565454|2017-02-18 18:07:18.565454
NCT00032500|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-22|2006-08-17|||September 2001||2001-09-01|July 2006|2006-07-01|May 2004||2004-05-01|||||Interventional|||Evaluation of Echinacea for the Common Cold|Evaluation of Echinacea in a Human Rhinovirus Challenge|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:18.677003|2017-02-18 18:07:18.677003
NCT00032487|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-21|2014-03-07|2013-09-10||December 2000||2000-12-01|March 2014|2014-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|VADT||Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)|CSP #465 - Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)|Completed||Phase 3|1791|Actual|VA Office of Research and Development|Our study had several limitations. Since we were studying veterans, the patients were predominantly men, and extrapolation of our findings to women must be done with caution.Changes in therapeutic agents have occurred since the design of our protocol|2|||f||||t||||||||||2017-02-18 18:07:18.783681|2017-02-18 18:07:18.783681
NCT00032474|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-21|2006-08-17|||December 2001||2001-12-01|July 2006|2006-07-01|May 2005||2005-05-01|||||Interventional|||Ginkgo Biloba Extract and the Insulin Resistance Syndrome|Ginkgo Biloba Extract and the Insulin Resistance Syndrome|Completed||Phase 1/Phase 2|150||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:19.360034|2017-02-18 18:07:19.360034
NCT00032461|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-20|2009-01-20|||November 1998||1998-11-01|March 2007|2007-03-01|April 2001||2001-04-01|||||Observational|||Compare the Medical Conditions of Gulf War Veterans to Non-Deployed Veterans|National Health Survey of Gulf War Era Veterans and Their Families - Phase III Physical Examinations|Completed||N/A|2000||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:07:19.451512|2017-02-18 18:07:19.451512
NCT00032448|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-20|2011-04-13|||October 1998||1998-10-01|April 2011|2011-04-01|June 2004|Actual|2004-06-01|December 2003|Actual|2003-12-01||Interventional|||Does Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients?|CSP #456 - Tension Free Inguinal Hernia Repair: Comparison of Open and Laparoscopic Surgical Techniques|Completed||Phase 3|2200|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:07:19.53071|2017-02-18 18:07:19.53071
NCT00032435|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-20|2010-10-14|||May 2001||2001-05-01|October 2010|2010-10-01|September 2006|Actual|2006-09-01|August 2006|Actual|2006-08-01||Interventional|||Homocysteine Study (HOST)|CSP #453 - Homocysteinemia in Kidney and Endstage Renal Disease Study (HOST)|Completed||Phase 3|2003|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:07:19.657954|2017-02-18 18:07:19.657954
NCT00032422|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-20|2006-08-17|||July 2001||2001-07-01|July 2006|2006-07-01|June 2003||2003-06-01|||||Interventional|||Acupuncture in Cardiovascular Disease|Acupuncture in Cardiovascular Disease|Completed||Phase 2|200||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:19.816365|2017-02-18 18:07:19.816365
NCT00032409|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-20|2006-08-17|||August 2001||2001-08-01|July 2006|2006-07-01|June 2004||2004-06-01|||||Interventional|||The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant Recipients|The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant Recipients|Completed||Phase 2|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:19.915004|2017-02-18 18:07:19.915004
NCT00031278|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-28|2011-05-26|||October 2001||2001-10-01|May 2011|2011-05-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer|A Phase I/II Open Label, Multi-Center Study For The Evaluation Of The Combination Of CpG 7909 And Herceptin® In Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|12|Actual|Pfizer||4|||||||||||||||||2017-02-18 18:07:19.999845|2017-02-18 18:07:19.999845
NCT00031265|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-28|2005-10-11|||October 1998||1998-10-01|October 2005|2005-10-01||||||||Interventional|||Efficacy of a Family Telephone Intervention for Stroke||Completed||Phase 2|290||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:07:20.132828|2017-02-18 18:07:20.132828
NCT00031252|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-27|2013-06-24|||January 2001||2001-01-01|June 2013|2013-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Observational|||Neighborhood-Level Influences on All-Cause Mortality||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 18:07:20.225346|2017-02-18 18:07:20.225346
NCT00031239|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-27|2016-07-28|||September 2001||2001-09-01|May 2009|2009-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:07:20.301396|2017-02-18 18:07:20.301396
NCT00031226|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-27|2014-03-12|||September 2004||2004-09-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Biomarkers of Oxidative Stress in LOOK AHEAD - Ancillary to LOOK AHEAD||Completed||N/A|||Arizona State University|||||f||||||||||||||2017-02-18 18:07:20.37446|2017-02-18 18:07:20.37446
NCT00031213|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-27|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEAD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:07:20.44484|2017-02-18 18:07:20.44484
NCT00031200|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-27|2016-07-28|||September 2001||2001-09-01|January 2008|2008-01-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Observational|||MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEAD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:07:20.510446|2017-02-18 18:07:20.510446
NCT00031187|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-27|2011-10-21|||October 2000||2000-10-01|October 2011|2011-10-01|July 2003|Actual|2003-07-01|||||Interventional|||Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer|Phase II Study of SGN-15 (cBR96 - Doxorubicin Immunoconjugate) Combined With Taxotere in Patients With Hormone Refractory Prostate Carcinoma|Completed||Phase 2|160||Seattle Genetics, Inc.|||||||||||||||||||2017-02-18 18:07:20.588651|2017-02-18 18:07:20.588651
NCT00031174|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-26|2017-01-24|||February 21, 2002||2002-02-21|April 22, 2016|2016-04-22||||||||Observational|||Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy Volunteers|Collection Of Blood Components Using Apheresis From Patients With Rheumatic or Kidney Diseases and Healthy Volunteers|Recruiting||N/A|10000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:20.698609|2017-02-18 18:07:20.698609
NCT00031161|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-26|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|September 2005||2005-09-01|||||Interventional|||Prevention of Dichloroacetate Toxicity|Prevention of Dichloroacetate Toxicity|Completed||N/A|30|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:07:20.810017|2017-02-18 18:07:20.810017
NCT00031148|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-26|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|August 2003||2003-08-01|||||Interventional|||Keratinocyte Growth Factor to Prevent Acute GVHD|Phase I/II Trial of Keratinocyte Growth Factor (rHuKGF) to Prevent Acute GVHD in 6/6 HLA=BMT Recipients|Completed||Phase 1/Phase 2|72||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:07:20.899179|2017-02-18 18:07:20.899179
NCT00031135|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-26|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|September 2005||2005-09-01|||||Interventional|||Total Parenteral Nutrition-Associated Liver Disease|Prevention of TPN-Associated Hepatic Steatosis: A Placebo Controlled Trial|Terminated||Phase 2|48|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:07:20.983862|2017-02-18 18:07:20.983862
NCT00032396|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-20|2006-05-25|||November 2001||2001-11-01|December 2002|2002-12-01||||||||Interventional|||"A Study to Evaluate Retisert in the Treatment of Patients With the Wet Form of Age-Related Macular Degeneration"||Unknown status|Active, not recruiting|Phase 2|||Control Delivery Systems|||||||||||||||||||2017-02-18 18:07:21.070589|2017-02-18 18:07:21.070589
NCT00032383|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-20|2007-01-19|||April 2001||2001-04-01|July 2006|2006-07-01|April 2003||2003-04-01|||||Interventional|||Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System|Complementary/Alternative Medicine for Vestibulopathy|Completed||Phase 1/Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:21.227395|2017-02-18 18:07:21.227395
NCT00032370|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-19|2015-06-25|||August 1997||1997-08-01|June 2015|2015-06-01|May 2004|Actual|2004-05-01|February 2004|Actual|2004-02-01||Interventional|CARP||Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality|CSP #411 - The Coronary Artery Revascularization Prophylaxis (CARP) Trial|Completed||N/A|510|Actual|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:07:21.321425|2017-02-18 18:07:21.321425
NCT00032357|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-19|2013-01-18|||May 1999||1999-05-01|January 2013|2013-01-01|September 2005|Actual|2005-09-01|April 2005|Actual|2005-04-01||Interventional|FeAST||Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?|CSP #410 - The Iron (Fe) and Atherosclerosis Study (FeAST)|Completed||Phase 3|1277|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 18:07:21.453396|2017-02-18 18:07:21.453396
NCT00032344|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-18|2010-11-19|||October 1993||1993-10-01|November 2010|2010-11-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps|CSP #380 - Prospective Evaluation of Risk Factors for Large (> 1 CM) Colonic Adenomas in Asymptomatic Subjects|Completed||Phase 3|3200|Actual|VA Office of Research and Development||1|||f||||t||||||||||2017-02-18 18:07:21.600321|2017-02-18 18:07:21.600321
NCT00032331|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-18|2009-01-20|||January 1999||1999-01-01|January 2004|2004-01-01|June 2003||2003-06-01|||||Interventional|||(PET) Imaging in the Management of Patients With Solitary Pulmonary Nodules|18/F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET) IMAGING IN THE MANAGEMENT OF PATIENTS WITH SOLITARY PULMONARY NODULES|Completed||Phase 3|500||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:07:21.724004|2017-02-18 18:07:21.724004
NCT00032305|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-14|2012-03-06|||March 2002||2002-03-01|March 2012|2012-03-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Research Study in Patients With Severe Ulcerative Colitis|A Phase I, Dose-Escalation, Pilot Study of Visilizumab in Patients With Severe Ulcerative Colitis That is Refractory to Corticosteroids|Completed||Phase 2/Phase 3|20||Facet Biotech|||||f||||||||||||||2017-02-18 18:07:21.803512|2017-02-18 18:07:21.803512
NCT00032292|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-14|2012-03-09|||March 2002||2002-03-01|March 2012|2012-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease|A Phase I/II, Open-Label, Dose-Escalation, Pilot Study to Evaluate Safety and Preliminary Efficacy of Visilizumab as Primary Therapy for Acute Graft-Versus-Host Disease After Hematopoietic Cell Transplantation|Completed||Phase 1/Phase 2|34||Facet Biotech|||||f||||||||||||||2017-02-18 18:07:21.893008|2017-02-18 18:07:21.893008
NCT00032279|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-15|2005-06-23|||March 2002||2002-03-01|October 2003|2003-10-01||||||||Interventional|||Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease|A Phase II, Multicenter Clinical Trial Evaluating the Use of Humanized Monoclonal Anti-CD3 Antibody Visilizumab(Nuvion) as Second-line Therapy for Glucocorticoid-Refractory, Acute Graft-Versus-Host Disease|Unknown status|Active, not recruiting|Phase 2|80||Facet Biotech|||||||||||||||||||2017-02-18 18:07:24.934285|2017-02-18 18:07:24.934285
NCT00032240|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-12|2013-06-02|||February 2002||2002-02-01|June 2013|2013-06-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Shoe Inserts for Treating Osteoarthritis of the Knee|Randomized Trial of a Wedged Insole for Treatment of Osteoarthritis of the Knee|Completed||Phase 3|90||Boston University|||||f||||||||||||||2017-02-18 18:07:25.039948|2017-02-18 18:07:25.039948
NCT00032227|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-12|2013-05-04|||August 2002||2002-08-01|May 2013|2013-05-01|April 2008|Actual|2008-04-01|April 2007|Actual|2007-04-01||Interventional|||Carpal Tunnel Syndrome: Diagnosis and Treatment Trial|Carpal Tunnel Syndrome: Diagnosis and Treatment Trial|Completed||N/A|116|Actual|University of Washington||2|||f||||||||||||||2017-02-18 18:07:25.124676|2017-02-18 18:07:25.124676
NCT00032201|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-09|2017-01-24|||March 6, 2002||2002-03-06|December 3, 2014|2014-12-03|December 3, 2014||2014-12-03|||||Observational|||Cell Lines From High-Risk Breast Tissue|Establishment of Normal High Risk Breast Epithelial Cell Cultures, and A High Risk Cell Line and Tissue Repository From Breast Tissue From Women at High Risk of Breast Cancer|Completed||N/A|43|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:25.235577|2017-02-18 18:07:25.235577
NCT00032188|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-01-23|||January 2002||2002-01-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer|A Randomized Phase II Study Of Interluekin-2 In Combination With Three Different Doses Of Bryostatin In Patients With Renal Cell Carcinoma|Completed||Phase 2|65|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:07:25.32092|2017-02-18 18:07:25.32092
NCT00032175|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-06-25|||April 2002||2002-04-01|April 2007|2007-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase III Multicenter Randomized Clinical Trial Comparing Gemcitabine Alone Or In Combination With Capecitabine For The Treatment Of Patients With Advanced Pancreatic Cancer|Completed||Phase 3|508|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:25.434699|2017-02-18 18:07:25.434699
NCT00032162|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2012-05-29|||August 2001||2001-08-01|May 2012|2012-05-01||||May 2005|Actual|2005-05-01||Interventional|||Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer|Phase I/II Trial, Dose Finding Combination Chemotherapy With PegLiposomal Doxorubicin (PLD) And Carboplatin In Patients With Gynecologic Tumors|Completed||Phase 1/Phase 2|63|Actual|AGO Study Group||1|||f||||t||||||||||2017-02-18 18:07:25.55584|2017-02-18 18:07:25.55584
NCT00032149|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-09-19|||October 2001||2001-10-01|March 2007|2007-03-01||||||||Interventional|||Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma|Pilot Study Of PMitCEBO Plus G-CSF In Good-Prognosis HIV-Related Lymphoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:25.960169|2017-02-18 18:07:25.960169
NCT00032136|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-08-01|||December 2001||2001-12-01|March 2007|2007-03-01|April 2009|Actual|2009-04-01|||||Interventional|||Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer|An Open Label, Randomized Multicenter Comparative Trial Of 5 Years Adjuvant Exemestane Treatment Versus 5 Years Adjuvant Tamoxifen Treatment In Postmenopausal Women With Early Breast Cancer|Completed||Phase 3|4400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:26.062268|2017-02-18 18:07:26.062268
NCT00032123|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-06-21|||June 2002||2002-06-01|October 2003|2003-10-01|May 2006|Actual|2006-05-01|||||Interventional|||Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer|A Phase II Study Of OSI-774 (NSC 718781) In Unresectable Or Metastatic Adenocarcinoma Of The Stomach And Gastroesophageal Junction|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:26.173689|2017-02-18 18:07:26.173689
NCT00032110|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2015-04-14|||January 2002||2002-01-01|January 2013|2013-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer|A Phase II Study of OSI-774 in Metastatic Colorectal Cancer|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:26.384713|2017-02-18 18:07:26.384713
NCT00032097|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2009-02-06|||April 2002||2002-04-01|January 2004|2004-01-01||||||||Interventional|||Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain|A Phase I Trial To Evaluate Repetitive Intravenous Doses Of Gadolinium-Texaphyrin As A Radiosensitizer In Patients With Glioblastoma Multi Forme|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:26.496477|2017-02-18 18:07:26.496477
NCT00032084|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-03-08|||January 2002||2002-01-01|March 2013|2013-03-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery|Smoking Cessation Intervention (Including Bupropion-Zyban Versus Placebo) for Completely Resected Stage I and II Non-Small Cell Lung Cancer Survivors Who Are Current Smokers|Terminated||Phase 3|10|Actual|Southwest Oncology Group||2||This study was closed early due to poor accrual|f||||t||||||||||2017-02-18 18:07:26.597109|2017-02-18 18:07:26.597109
NCT00032058|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2011-02-18|||June 2003||2003-06-01|April 2005|2005-04-01||||June 2006|Actual|2006-06-01||Interventional|||Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer|MR Imaging And MR Spectroscopic Imaging Of Prostate Cancer Prior To Radical Prostatectomy: A Prospective Multi-Institutional Clinicopathological Study|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:27.161576|2017-02-18 18:07:27.161576
NCT00032045|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-06-18|||January 2002||2002-01-01|March 2003|2003-03-01|August 2006|Actual|2006-08-01|||||Interventional|||Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma|An Open-label Study Of MDX-010 In Combination With gp100 Peptides Emulsified With Montanide ISA 51 In The Treatment Of Patients With Stage IV Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:07:27.266073|2017-02-18 18:07:27.266073
NCT00032032|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-11-30|||May 2002||2002-05-01|November 2016|2016-11-01|January 2010|Actual|2010-01-01|January 2008|Actual|2008-01-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|Phase I/II Study Of Concurrent Chemotherapy And Escalating Doses Of Radiotherapy (RT) For Unresectable Non-Small Cell Lung Cancer (NSCLC) Using A New RT Paradigm|Completed||Phase 1|69|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:07:27.368386|2017-02-18 18:07:27.368386
NCT00032019|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-07-15|||February 2002||2002-02-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|Phase II Study Of Dose-Adjusted Epoch-Rituximab (EPOCH-R) Chemotherapy For Patients With Previously Untreated Aggressive CD20+ B-Cell Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|78|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:07:27.544769|2017-02-18 18:07:27.544769
NCT00032006|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-07-12|||February 2002||2002-02-01|July 2016|2016-07-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer|A Trial Of Neoadjuvant Androgen Supression And Dose Escalation Transperineal Ultrasound-Guided Brachytherapy For Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:07:27.756126|2017-02-18 18:07:27.756126
NCT00031993|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-01-16|||March 2002||2002-03-01|January 2013|2013-01-01||||November 2005|Actual|2005-11-01||Interventional|||Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix|A Phase II Evaluation Of OSI-774 (NSC #718781) In The Treatment Of Persistent or Recurrent Squamous Cell Carcinoma Of The Cervix|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:27.865729|2017-02-18 18:07:27.865729
NCT00031980|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-07-01|||March 2002||2002-03-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer|Phase II Study of Cyclosporine in T-Cell Large Granular Lymphocytic Leukemia|Completed||Phase 2|30|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:07:27.973488|2017-02-18 18:07:27.973488
NCT00031967|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-11-18|||May 2002||2002-05-01|November 2013|2013-11-01||||March 2004|Actual|2004-03-01||Interventional|||Melatonin and Radiation Therapy in Treating Patients With Brain Metastases|A Randomized Phase II Study of A.M. and P.M. Melatonin for Brain Metastasis in RPA Class II Patients|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:07:28.086454|2017-02-18 18:07:28.086454
NCT00031954|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2015-12-22|||August 2001||2001-08-01|December 2015|2015-12-01||||April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|A Phase II Study Of Paclitaxel, Carboplatin And Gemcitabine In Previously Untreated Patients With Epithelial Ovarian Carcinoma FIGO Stage IIB-IV|Completed||Phase 2|105|Actual|AGO Study Group||1|||f||||||||||||||2017-02-18 18:07:28.696907|2017-02-18 18:07:28.696907
NCT00031941|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2012-03-14|||April 2002||2002-04-01|March 2012|2012-03-01|April 2009|Actual|2009-04-01|September 2007|Actual|2007-09-01||Interventional|||CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy|A Multidose Phase I Study of Oral CC5013, a Thalidomide Derivative, in Patients With Refractory Metastatic Cancer|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 18:07:28.824311|2017-02-18 18:07:28.824311
NCT00031928|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2015-04-29|||January 2002||2002-01-01|November 2003|2003-11-01||||||||Interventional|||Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors|Phase I Study of Intrathecal Mafosfamide|Completed||Phase 1|3000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:28.930544|2017-02-18 18:07:28.930544
NCT00031915|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-06-17|||June 2002||2002-06-01|October 2003|2003-10-01|May 2007|Actual|2007-05-01|||||Interventional|||Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma|Phase II Trial of Gleevec (Formerly Known as STI571) in Patients With Soft Tissue and Bone Sarcomas: A Multi-Disciplinary Trial of the North American Sarcoma Study Group of the Connective Tissue Oncology Society|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:29.031304|2017-02-18 18:07:29.031304
NCT00031902|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-09-19|||October 2001||2001-10-01|February 2003|2003-02-01||||||||Interventional|||Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma|Rituxumab Combined With Chemotherapy (PVB) For Poor Prognosis HIV-Related Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:29.139654|2017-02-18 18:07:29.139654
NCT00031889|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2012-05-14|||August 2001||2001-08-01|May 2012|2012-05-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer|A Randomized Phase II Trial of Exemestane With and Without Bicalutamide as Second Line Therapy After Failure of Androgen Suppression in Advanced Prostate Cancer|Completed||Phase 2|5|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 18:07:29.241319|2017-02-18 18:07:29.241319
NCT00031876|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2012-05-14|||May 2000||2000-05-01|May 2012|2012-05-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer|Phase I/II Trial of Capecitabine With Weekly Paclitaxel for Advanced Breast Cancer|Completed||Phase 1/Phase 2|34|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 18:07:29.356302|2017-02-18 18:07:29.356302
NCT00031863|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-08-01|||February 2001||2001-02-01|June 2002|2002-06-01|September 2007|Actual|2007-09-01|||||Interventional|||Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer|Phase III, Randomized, Double Blind, Placebo Controlled Study of Rofecoxib in Colorectal Cancer Patients Following Adjuvant Chemotherapy|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:29.460068|2017-02-18 18:07:29.460068
NCT00031850|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-06-25|||March 2000||2000-03-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer|A Randomized Trial Of Raloxifene Plus Zoladex For Prevention Of Breast Cancer|Completed||N/A|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:29.569181|2017-02-18 18:07:29.569181
NCT00031837|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2015-10-13|||October 2002||2002-10-01|October 2015|2015-10-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer|A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer|Terminated||Phase 3|400|Anticipated|University of Rochester||1|||f||||||||||||||2017-02-18 18:07:29.665434|2017-02-18 18:07:29.665434
NCT00031824|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2014-02-12|||April 2002||2002-04-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|May 2005|Actual|2005-05-01||Interventional|||Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease|Phase III Trial of Hydroxychloroquine + Standard Therapy for Chronic Graft-Versus-Host Disease|Completed||Phase 3|82|Actual|Children's Oncology Group|||||f||||t||||||||||2017-02-18 18:07:29.799971|2017-02-18 18:07:29.799971
NCT00031811|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2012-05-24|||March 2001||2001-03-01|June 2010|2010-06-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer|Breast Cancer Survivors: Exercise and Raloxifene|Completed||N/A|80|Actual|OHSU Knight Cancer Institute|||||f||||||||||||||2017-02-18 18:07:30.000893|2017-02-18 18:07:30.000893
NCT00031798|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2017-01-18|||April 2002||2002-04-01|August 2009|2009-08-01|May 2006|Actual|2006-05-01|March 2005|Actual|2005-03-01||Interventional|||Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors|A Phase III, Double-Blind, Prospective Randomized Clinical Trial of the Effect of D-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy|Terminated||Phase 3|||Wake Forest University Health Sciences||||low accrual; loss of funding|f||||||||||||||2017-02-18 18:07:30.093445|2017-02-18 18:07:30.093445
NCT00031785|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2009-08-20|||September 2000||2000-09-01|August 2009|2009-08-01||||||||Interventional|||Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer|A Phase III, Double-Blind, Randomized Study of the Effect of Megestrol Acetate on Weight and Health Related Quality of Life in Lung Cancer Patients Receiving Thoracic Radiation Therapy|Completed||Phase 3|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:07:30.462051|2017-02-18 18:07:30.462051
NCT00031772|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-02-12|||July 1998||1998-07-01|February 2013|2013-02-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer|Enhancing Well-Being During Breast Cancer Recurrence. SWOG Study S9832.|Completed||N/A|322|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:07:30.560219|2017-02-18 18:07:30.560219
NCT00031759|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-07-12|||June 1999||1999-06-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|July 2004|Actual|2004-07-01||Interventional|||Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia|Phase II Topical Immunomodulatory Therapy With Imiquimod for the Chemoprevention of Recurrent and High-Grade Cervical Intraepithelial Neoplasia (CIN)|Completed||Phase 2|57|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:07:30.803681|2017-02-18 18:07:30.803681
NCT00031746|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-07-15|||February 2000||2000-02-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels|Effects of Dietary Soy on Biomarkers of Prostate Cancer: A Prospective Phase II Study|Completed||Phase 2|26|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:07:30.92716|2017-02-18 18:07:30.92716
NCT00031733|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2014-05-20|||February 2002||2002-02-01|May 2014|2014-05-01|November 2007|Actual|2007-11-01|December 2004|Actual|2004-12-01||Interventional|||Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma|A Phase II Randomized Trial of a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With Interleukin-12 With Alum or GM-CSF for Patients With Resected Stages IIB/C, III and IV Melanoma|Completed||Phase 2|60|Actual|University of Southern California|||||f||||t||||||||||2017-02-18 18:07:31.044721|2017-02-18 18:07:31.044721
NCT00031720|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-07-12|||March 2002||2002-03-01|July 2016|2016-07-01|November 2013|Actual|2013-11-01|April 2006|Actual|2006-04-01||Interventional|||Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease|Phase II Study of Soy Protein to Treat Vasomotor Symptoms in Postmenopausal Women Taking Tamoxifen|Completed||Phase 2|112|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:07:31.14522|2017-02-18 18:07:31.14522
NCT00031707|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-07-12|||March 2000||2000-03-01|July 2016|2016-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite|Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Megestrol Acetate (Megace) Versus an N-3 Fatty Acid (EPA) Enriched Nutritional Supplement Versus Both for the Treatment of Cancer Cachexia and Anorexia|Completed||Phase 3|429|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-02-18 18:07:31.283021|2017-02-18 18:07:31.283021
NCT00031694|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2015-04-08|2015-04-08||January 2002||2002-01-01|May 2013|2013-05-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer|A Phase II Study of Sequential Paclitaxel and Bryostatin-1 for Patients With Advanced Pancreatic Cancer|Completed||Phase 2|19|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 18:07:31.454475|2017-02-18 18:07:31.454475
NCT00031681|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-09-27|||December 2001||2001-12-01|September 2013|2013-09-01||||January 2011|Actual|2011-01-01||Interventional|||7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)|A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II)|Completed||Phase 1|41|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:31.735668|2017-02-18 18:07:31.735668
NCT00031668|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-11-11|||January 2001||2001-01-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|||||Interventional|||Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation|A Phase III Study of Involved Field Radiation Therapy (IFRT) in Patients With Histologically Aggressive Non-Hodgkin's Lymphoma Following High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT)|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:07:31.869941|2017-02-18 18:07:31.869941
NCT00031655|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2012-12-05|||September 2001||2001-09-01|December 2012|2012-12-01|November 2012|Actual|2012-11-01|August 2006|Actual|2006-08-01||Interventional|||Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission|Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation From HLA Matched Unrelated Donors for Treatment of Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission - A Multicenter Trial|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:07:31.980519|2017-02-18 18:07:31.980519
NCT00031642|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-12-13|||January 2002||2002-01-01|December 2013|2013-12-01|March 2008|Actual|2008-03-01|November 2005|Actual|2005-11-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma That Has Relapsed After High-Dose Chemotherapy and Autologous Stem Cell Transplantation|Phase I/II Study of IDEC-Y2B8 (Zevalin) for Post Transplant Relapses of B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 1/Phase 2|26|Actual|University of Nebraska||1|||f||||f||||||||||2017-02-18 18:07:32.121784|2017-02-18 18:07:32.121784
NCT00031629|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2016-12-07|||January 2005||2005-01-01|December 2016|2016-12-01||||July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus|A Phase II Evaluation of Docetaxel and Gemcitabine Plus G-CSF in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Completed||Phase 2|51|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:07:32.234896|2017-02-18 18:07:32.234896
NCT00031616|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2013-12-17|||December 2001||2001-12-01|April 2004|2004-04-01||||||||Interventional|||NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer|A Phase I/II Study Of NB1011 Administered Intravenously Daily For 5 Days Every 4 Weeks In Fluoropyrimidine-Resistant Metastatic Or Relapsed Colorectal Cancers|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:32.370013|2017-02-18 18:07:32.370013
NCT00031590|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2015-09-30|||April 2001||2001-04-01|September 2015|2015-09-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma|Study Of Reduced Dose Craniospinal Radiotherapy (1800 cGy) And Chemotherapy In Children With Newly-Diagnosed Standard-Risk Posterior Fossa Primitive Neuro-ectodermal Tumor (PNET/Medulloblastoma)|Terminated||Phase 2|30|Actual|Children's Hospital of Philadelphia||1||The study was terminated prematurely due to slow accrual.|f||||t||||||||||2017-02-18 18:07:32.459472|2017-02-18 18:07:32.459472
NCT00031577|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2015-03-17|||August 1999||1999-08-01|January 2014|2014-01-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma|A Phase I Study Of Taxol And Involved Field Radiation Therapy For Newly Diagnosed Intrinsic Gliomas Of Childhood|Terminated||Phase 1|11|Actual|Children's Hospital of Philadelphia||||"Administrative closure 9/22/2006. Decline in enrollment at CHOP. due to competing protocols~   with new agents."|f||||||||||||||2017-02-18 18:07:32.595837|2017-02-18 18:07:32.595837
NCT00031564|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-08|2012-09-26|||May 2000||2000-05-01|September 2012|2012-09-01|June 2012|Actual|2012-06-01|June 2005|Actual|2005-06-01||Interventional|||Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2|Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 for Patients With Stage IV Renal Cell Carcinoma|Completed||Phase 2|49|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:07:32.688417|2017-02-18 18:07:32.688417
NCT00031551|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-07|2015-11-24|2015-11-24||March 2002||2002-03-01|November 2015|2015-11-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|||Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury|Evaluation of Efficacy and Mechanisms of an Anti-Inflammatory Intervention for Chemotherapy Related Mucosal Injury|Terminated||Phase 2|27|Actual|National Institutes of Health Clinical Center (CC)||3||It was not feasible to recruit required sample size from two clinical sites.|f||||t||||||||||2017-02-18 18:07:32.820726|2017-02-18 18:07:32.820726
NCT00031538|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2017-01-24|||March 1, 2002||2002-03-01|April 29, 2015|2015-04-29|April 29, 2015||2015-04-29|||||Observational|||Genetic Analysis of Brain Tumors|A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative|Terminated||N/A|480|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:33.644985|2017-02-18 18:07:33.644985
NCT00031512|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2013-02-28||2011-07-20|June 2001||2001-06-01|August 2012|2012-08-01|September 2012|Actual|2012-09-01|September 2010|Actual|2010-09-01||Interventional|||Pleconaril Enteroviral Sepsis Syndrome|A Double-Blind, Placebo-Controlled, Virologic Efficacy Trial of Pleconaril in the Treatment of Neonates With Enteroviral Sepsis Syndrome|Completed||Phase 2|61|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:07:33.747922|2017-02-18 18:07:33.747922
NCT00030004|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-29|2006-08-17|||May 2000||2000-05-01|July 2006|2006-07-01|April 2001||2001-04-01|||||Interventional|||Pilot Study of Spinal Manipulation for Chronic Neck Pain|Pilot Study of Spinal Manipulation for Chronic Neck Pain|Terminated||Phase 1|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:53.1927|2017-02-18 18:07:53.1927
NCT00031499|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2013-04-25|||June 2000||2000-06-01|April 2013|2013-04-01|March 2009|Actual|2009-03-01|August 2007|Actual|2007-08-01||Interventional|||Azithromycin/Bicillin Syphilis|A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for the Treatment of Early Syphilis|Completed||Phase 3|593|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:07:34.14535|2017-02-18 18:07:34.14535
NCT00031486|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2012-05-10|2012-03-15||September 2000||2000-09-01|October 2011|2011-10-01|February 2011|Actual|2011-02-01|June 2010|Actual|2010-06-01||Interventional|||Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir|A Phase III Double-Blind, Placebo-Controlled Trial of Long Term Therapy of Herpes Simplex Encephalitis (HSE): An Evaluation of Valacyclovir (CASG-204)|Completed||Phase 3|91|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:07:34.2909|2017-02-18 18:07:34.2909
NCT00031473|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2010-08-26|||November 1997||1997-11-01|December 2003|2003-12-01|March 2003||2003-03-01|||||Interventional|||Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients|A Randomized Phase III Study to Evaluate the Safety and Efficacy of Ribavirin Inhaled Solution in Preventing Progression of Upper Respiratory Tract Respiratory Syncytial Virus Infection to RSV Pneumonia in Blood and Bone Marrow Transplant (BMT) Recipient|Terminated||Phase 3|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:07:35.645829|2017-02-18 18:07:35.645829
NCT00031460|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2012-05-10|2009-04-02||December 1997||1997-12-01|October 2009|2009-10-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates|A Placebo-Controlled Phase III Evaluation of Suppressive Therapy With Oral Acyclovir Suspension Following Neonatal Herpes Simplex Virus Infections Involving the Central Nervous System|Completed||Phase 3|46|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:07:35.758142|2017-02-18 18:07:35.758142
NCT00031447|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2012-05-10|2009-04-01||August 1999||1999-08-01|November 2009|2009-11-01|April 2008|Actual|2008-04-01|February 2008|Actual|2008-02-01||Interventional|||Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth|A Placebo-Controlled Phase III Evaluation of Suppressive Therapy With Oral Acyclovir Suspension Following Neonatal Herpes Simplex Virus Infections Limited to the Skin, Eye, and Mouth|Completed||Phase 3|29|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:07:36.298346|2017-02-18 18:07:36.298346
NCT00031434|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2011-02-03|||July 2002||2002-07-01|July 2009|2009-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Valganciclovir in Congenital CMV Infants|A Phase I/II Pharmacokinetic and Pharmacodynamic Evaluation of Oral Valganciclovir in Neonates With Symptomatic Congenital Cytomegalovirus (CMV) Infection (CASG 109)|Completed||Phase 1/Phase 2|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:07:36.88842|2017-02-18 18:07:36.88842
NCT00031421|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-06|2011-08-11|||September 2001||2001-09-01|July 2008|2008-07-01|November 2005||2005-11-01|||||Observational|||Neonatal CMV-Ganciclovir Follow-up Study|A Follow-up Assessment of Subjects Who Received Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) During the Phase I/II Study to Evaluate the Safety and Efficacy of Ganciclovir Treatment for Congenital Cytomegalovirus (CMV) Infections|Completed||N/A|8||National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||||||2017-02-18 18:07:37.013313|2017-02-18 18:07:37.013313
NCT00031408|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-05|2017-01-24|||March 2002||2002-03-01|January 2017|2017-01-01|December 2018|Anticipated|2018-12-01|December 2018|Anticipated|2018-12-01||Observational|||Consent for Use of Stored Patient Specimens for Future Testing|Plan for Obtaining Informed Consent to Use Stored Human Biological Materials (HBM) for Currently Unspecified Analyses|Recruiting||N/A|30000|Anticipated|AIDS Clinical Trials Group|||1||f||||t||||||Samples With DNA|"~     Blood and tissue samples~   "|||2017-02-18 18:07:37.105148|2017-02-18 18:07:37.105148
NCT00031395|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-04|2009-05-20|||September 1999||1999-09-01|May 2009|2009-05-01|June 2007|Actual|2007-06-01|||||Interventional|||Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children|Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT)|Completed||Phase 3|122|Actual|University of Cincinnati||4|||f||||t||||||||||2017-02-18 18:07:40.192699|2017-02-18 18:07:40.192699
NCT00031382|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-02|2008-03-03|||February 2002||2002-02-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Imaging Study of Automatic Movements|A Neuroimaging Study of Automatic Movements|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:40.30564|2017-02-18 18:07:40.30564
NCT00031369|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-02|2017-01-24|||February 27, 2002||2002-02-27|March 10, 2015|2015-03-10|March 10, 2015||2015-03-10|||||Observational|||Brain Anatomy in Dystonia|In Vivo Mapping Of Structural and Biochemical Abnormalities In Patients With Primary Focal Dystonia|Terminated||N/A|189|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:40.37942|2017-02-18 18:07:40.37942
NCT00031343|ClinicalTrials.gov processed this data on February 17, 2017|2002-03-02|2008-03-03|||February 2002||2002-02-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin|A Randomized, Controlled Study to Assess the Impact of Highly Active Antiretroviral Therapy to Hepatitis C Therapy in Patients Coinfected With HIV-1 and Treated With Peginterferon Alpha-2b and Ribavirin|Completed||Phase 2|128||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:40.467215|2017-02-18 18:07:40.467215
NCT00031317|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-28|2008-03-03|||February 2002||2002-02-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression|Combined Treatment With A Benzodiazepine (Clonazepam) And A Selective Serotonin Reuptake Inhibitor (Paroxetine) For Rapid Treatment Of Panic Disorder With Depression|Completed||Phase 4|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:40.550405|2017-02-18 18:07:40.550405
NCT00031304|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-28|2017-01-24|||February 27, 2002||2002-02-27|April 8, 2013|2013-04-08|April 8, 2013||2013-04-08|||||Observational|||Screening Protocol for HIV Vaccine Studies|Screening Subjects for HIV Vaccine Research Studies|Completed||N/A|1324|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:40.643451|2017-02-18 18:07:40.643451
NCT00031291|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-28|2008-03-03|||February 2002||2002-02-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin|Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:40.727055|2017-02-18 18:07:40.727055
NCT00029991|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-29|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|July 2005||2005-07-01|||||Interventional|||Extract of Ginkgo Biloba (EGB 761) and Vascular Function|Extract of Ginkgo Biloba (Egb 761) and Vascular Function|Completed||Phase 1/Phase 2|100||National Center for Complementary and Integrative Health (NCCIH)|||||||||||||||||||2017-02-18 18:07:53.277216|2017-02-18 18:07:53.277216
NCT00031122|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-26|2010-10-04|||September 2000||2000-09-01|May 2009|2009-05-01|September 2012|Anticipated|2012-09-01|September 2011|Anticipated|2011-09-01||Observational|SBRR||Study of Genetic Risk Factors for Spina Bifida and Anencephaly|The Spina Bifida Research Resource|Unknown status|Active, not recruiting|N/A|1100|Anticipated|Office of Rare Diseases (ORD)|||1||f||||f||||||Samples With DNA|"~     DNA extracted from whole blood, saliva, buccal swab, and/or amniocytes~   "|||2017-02-18 18:07:40.814331|2017-02-18 18:07:40.814331
NCT00031109|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-25|2012-05-03||||||May 2012|2012-05-01|May 2005|Actual|2005-05-01|||||Interventional|||The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys|An Open-Label, Passive Antibody Trial to Assess Efficacy in the Pathogenic SHIV-89.6P Macaque Model of Human Antibodies Generated by a Candidate HIV-1 Vaccine in a Phase I Clinical Trial|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:07:41.183441|2017-02-18 18:07:41.183441
NCT00031096|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-21|2014-02-23|||January 2002||2002-01-01|February 2014|2014-02-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne|A 12-week, Randomized, Double-blind, Multicenter Study Comparing the Clinical Efficacy and Safety of Azelaic Acid 15% Gel (SH H 655 BA) With Its Vehicle (SH H 655 PBA) in Patients With Mild to Moderate Acne.|Completed||Phase 3|879|Actual|Bayer||2|||f||||||||||||||2017-02-18 18:07:41.294313|2017-02-18 18:07:41.294313
NCT00031083|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-20|2012-06-07|||January 2002||2002-01-01|November 2004|2004-11-01|March 2004||2004-03-01|||||Interventional|||Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas|A Multi-center, Open Label, Two Part, Dose Escalation Study to Determine the Tolerability of Interferon-Beta Gene Transfer (BG00001) in the Treatment of Recurrent or Progressive Grade III and Grade IV Gliomas|Suspended||Phase 1|35||Biogen|||||||||||||||||||2017-02-18 18:07:41.432632|2017-02-18 18:07:41.432632
NCT00031070|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-20|2015-03-05||||||August 2006|2006-08-01|December 2006|Actual|2006-12-01|||||Interventional|||Increasing HAART-Induced Immune Restoration With Cyclosporine|Augmenting the Magnitude of HAART-Induced Immune Restoration With the Use of Cyclosporine|Completed||Phase 2|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:07:41.521915|2017-02-18 18:07:41.521915
NCT00031057|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-20|2011-02-25||||||November 2004|2004-11-01||||March 2003|Actual|2003-03-01||Interventional|||Vitamin B Therapy for Hyperlactatemia|A Pilot Study of Oral B Vitamin Therapy for Asymptomatic or Mildly Symptomatic Hyperlactatemia in Patients on NRTIs|Completed||N/A|225||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:07:41.644462|2017-02-18 18:07:41.644462
NCT00031044|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-20|2012-05-17||||||May 2012|2012-05-01|November 2004|Actual|2004-11-01|||||Interventional|||Adding New Drugs for HIV Infected Patients Failing Current Therapy|A Randomized Phase I/II Placebo-controlled Study of Amdoxovir (DAPD) Versus Placebo Together With Enfuvirtide (T-20) Plus Optimized Background Therapy for HIV-Infected Subjects Failing Current Therapy|Completed||Phase 1/Phase 2|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:07:41.757473|2017-02-18 18:07:41.757473
NCT00031031|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-20|2007-11-26|||June 2001||2001-06-01|November 2007|2007-11-01|November 2002|Actual|2002-11-01|||||Interventional|||Kanglaite Injection Phase I Study|Phase I Study of KLT in Patients With Solid Tumors Refractory to Standard Therapy|Completed||Phase 1|16|Actual|KangLaiTe USA|||||||||||||||||||2017-02-18 18:07:41.890657|2017-02-18 18:07:41.890657
NCT00031018|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-20|2008-02-04||||||February 2008|2008-02-01||||||||Interventional|||Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha|Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha|Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:07:41.984664|2017-02-18 18:07:41.984664
NCT00031005|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-20|2008-03-03|||February 2002||2002-02-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Interventional|||Stem Cell Transplantation to Treat Leukocyte Adhesion Deficiency|Treatment of Leukocyte Adhesion Deficiency With Allogeneic Stem Cell Transplantation|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:42.096849|2017-02-18 18:07:42.096849
NCT00030992|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-20|2012-08-13|2012-06-06||February 2002||2002-02-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|January 2009|Actual|2009-01-01||Interventional|||BMS 247550 to Treat Kidney Cancer|A Phase II Clinical Trial of BMS-247550 (NSC 710428), an Epothilone B Analog, in Renal Cell Carcinoma|Completed||Phase 2|102|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 18:07:42.204363|2017-02-18 18:07:42.204363
NCT00030979|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-15|2008-03-03|||February 2002||2002-02-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Donepezil to Treat Dementia in Parkinson's Disease|Donepezil for Dementia in Parkinson's Disease: A Randomized, Double Blinded Placebo Controlled Crossover Trial|Completed||Phase 4|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:43.025519|2017-02-18 18:07:43.025519
NCT00030966|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-15|2009-06-17|||January 2002||2002-01-01|June 2009|2009-06-01|December 2005|Actual|2005-12-01|April 2005|Actual|2005-04-01||Interventional|||Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Natalizumab, When Added to Avonex® (Interferon Beta-1a), in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|1200|Actual|Biogen||2|||f||||t||||||||||2017-02-18 18:07:43.123109|2017-02-18 18:07:43.123109
NCT00030953|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2017-01-24|||February 11, 2002||2002-02-11|February 3, 2015|2015-02-03|February 3, 2015||2015-02-03|||||Observational|||Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome|Evaluation of Tourette's Syndrome With Multimetabolite H-Magnetic Resonance Spectroscopy at 3T|Completed||N/A|100|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:43.325452|2017-02-18 18:07:43.325452
NCT00030940|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2017-01-24|||February 11, 2002||2002-02-11|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Cause, Development, and Progression of Stiff-Person Syndrome|Natural History and Immunopathogenesis of Stiff Person Syndrome (SPS)|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:43.413567|2017-02-18 18:07:43.413567
NCT00030914|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2016-07-12|||April 2002||2002-04-01|July 2016|2016-07-01|September 2006|Actual|2006-09-01|February 2006|Actual|2006-02-01||Interventional|||Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women|Phase III Comparison of Depomedroxyprogesterone Acetate (DPROV) to Venlafaxine for Managing Hot Flashes|Completed||Phase 3|227|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-02-18 18:07:43.499746|2017-02-18 18:07:43.499746
NCT00030901|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-01-02|2012-11-19||February 2000||2000-02-01|January 2013|2013-01-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate|L-Selenium-Based Chemoprevention Of Prostate Cancer Among Men With High Grade Prostatic Intraepithelial Neoplasia|Completed||Phase 3|619|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:07:43.665984|2017-02-18 18:07:43.665984
NCT00030888|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2014-01-03|||December 2002||2002-12-01|December 2003|2003-12-01||||||||Interventional|||UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer|A Phase 2 Study Of UCN-01 In Advanced Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:44.409887|2017-02-18 18:07:44.409887
NCT00030875|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2010-11-07|||July 2002||2002-07-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||Bortezomib in Treating Patients With Mantle Cell Lymphoma|A Phase II Study Of PS-341 (NSC 681239) In Patients With Untreated Or Relapsed Mantle Cell Lymphoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:07:44.504087|2017-02-18 18:07:44.504087
NCT00030862|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-06-04|||October 2001||2001-10-01|June 2013|2013-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus|Phase II Single-Arm Trial Of CPT-11 (Irinotecan HC1; Camptosar Injection)/Cisplatin In Patients With Advanced Esophageal Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:07:44.614077|2017-02-18 18:07:44.614077
NCT00030849|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-04-02|||October 2001||2001-10-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|September 2004|Actual|2004-09-01||Interventional|||Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma|Phase II Trial Of Oral Bexarotene (Targretin) Combined With Interferon Alfa-2b (Intron-A) For Patients With Cutaneous T-Cell Lymphoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:44.710423|2017-02-18 18:07:44.710423
NCT00030823|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2015-11-24|2015-10-23||March 2001||2001-03-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence|Vaccination Of High Risk Breast Cancer Patients With Heptavalent Antigen - Keyhole Limpet Hemocyanin Conjugate Plus The Immunological Adjuvant QS21|Completed||N/A|14|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:07:44.818772|2017-02-18 18:07:44.818772
NCT00030810|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2012-05-14|||September 2001||2001-09-01|May 2012|2012-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC|Preoperative Chemoradiotherapy In Non-Small Cell Lung Cancer (NSCLC) Patients With Operable Stage IIIB Disease: A Prospective Phase II Trial|Completed||Phase 2|46|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 18:07:45.078409|2017-02-18 18:07:45.078409
NCT00030797|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2012-05-14|||February 2001||2001-02-01|May 2012|2012-05-01|December 2003|Actual|2003-12-01|May 2002|Actual|2002-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer|A Randomized Phase II Trial Of Capecitabine And Different Schedules Of Irinotecan As First Line Treatment For Advanced Or Metastatic Colorectal Cancer|Completed||Phase 2|75|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 18:07:45.258056|2017-02-18 18:07:45.258056
NCT00030784|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2012-09-20|||November 2001||2001-11-01|September 2012|2012-09-01||||March 2005|Actual|2005-03-01||Interventional|||Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma|Phase I Study To Determine The Safety Of Caelyx (Doxorubin HCI, Pegylated Liposomal) In Combination With Ifosfamide In Previously Untreated Adult Patients With Advanced And/Or Metastatic Soft Tissues Sarcomas|Completed||Phase 1|28|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:07:45.562237|2017-02-18 18:07:45.562237
NCT00030771|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2016-04-14|||April 2001||2001-04-01|April 2016|2016-04-01|December 2020|Anticipated|2020-12-01|October 2013|Actual|2013-10-01||Interventional|||Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients|Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial|Active, not recruiting||Phase 3|232|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||No||2017-02-18 18:07:45.660226|2017-02-18 18:07:45.660226
NCT00030758|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-08-06|||October 2001||2001-10-01|June 2007|2007-06-01||||||||Interventional|||Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer|G-CSF (Filgrastim) or Pegfilgrastim Secondary Prophylaxis In The Adjuvant Chemotherapy Of Early Breast Cancer|Unknown status|Active, not recruiting|Phase 4|816|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:45.801829|2017-02-18 18:07:45.801829
NCT00030745|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2012-05-14|||June 2000||2000-06-01|May 2012|2012-05-01|August 2003|Actual|2003-08-01|May 2003|Actual|2003-05-01||Interventional|||Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung|Preoperative Chemotherapy Of Potentially Resectable Mesothelioma Of The Pleura|Completed||Phase 2|61|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 18:07:45.934136|2017-02-18 18:07:45.934136
NCT00030732|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2012-05-14|||June 2001||2001-06-01|May 2012|2012-05-01|April 2008|Actual|2008-04-01|June 2004|Actual|2004-06-01||Interventional|||Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer|Gemcitabine Plus Capecitabine Versus Gemcitabine Alone In Advanced Pancreatic Cancer. A Randomized Phase III Trial|Completed||Phase 3|319|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 18:07:46.040435|2017-02-18 18:07:46.040435
NCT00030719|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2014-06-23|||December 2001||2001-12-01|August 2010|2010-08-01||||||||Interventional|||Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma|High Risk Neuroblastoma Study 1 Of Siop-Europe|Unknown status|Recruiting|Phase 3|175|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:46.180691|2017-02-18 18:07:46.180691
NCT00030706|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2008-07-23|||November 2004||2004-11-01|February 2006|2006-02-01||||||||Interventional|||Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer|Phase II Study Of Epothilone B Analogue BMS-247550 In Relapse And/Or Refractory Stage III Or IV Ovarian Epithelial Cancer, Following Front-Line Treatment With Platinum Plus Taxane-Based Chemotherapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:46.343365|2017-02-18 18:07:46.343365
NCT00030693|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-01-23|||December 2001||2001-12-01|January 2013|2013-01-01||||April 2010|Actual|2010-04-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Solid Tumors|Intra-Lesional rF-B7.1 Versus rF-Tricom Vaccine In The Treatment Of Metastatic Cancer|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 18:07:46.435452|2017-02-18 18:07:46.435452
NCT00030680|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-08-26|||November 2001||2001-11-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Interventional|||Radiation Therapy in Treating Patients With Aggressive Fibromatoses|Phase II Pilot Study Of Moderate Dose Radiotherapy For Inoperable Aggressive Fibromatoses|Completed||Phase 2|44|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:07:46.547947|2017-02-18 18:07:46.547947
NCT00030667|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2015-04-14|||May 2002||2002-05-01|December 2013|2013-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood|A Phase II Study of Gleevec (Imatinib Mesylate, NSC 716051 Formerly STI571) in Children With Refractory or Relapsed Solid Tumors|Completed||Phase 2|100|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:46.679465|2017-02-18 18:07:46.679465
NCT00030654|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2015-12-11|||October 2002||2002-10-01|December 2015|2015-12-01||||February 2005|Actual|2005-02-01||Interventional|||Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer|A Phase III Randomized Study of Patients With High Risk, Hormone-Naive Prostate Cancer: Androgen Blockade With 4 Cycles of Immediate Chemotherapy Versus Androgen Blockade With Delayed Chemotherapy|Active, not recruiting||Phase 3|21|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:07:46.811375|2017-02-18 18:07:46.811375
NCT00030641|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2014-01-03|||October 2001||2001-10-01|September 2003|2003-09-01||||||||Interventional|||Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer|Randomized Study of Docetaxel Versus Docetaxel Plus Genasense™ (G3139; Bcl-2 Antisense Oligonucleotide) in Patients With Previously Treated Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:47.032738|2017-02-18 18:07:47.032738
NCT00030628|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2016-07-06|||December 2001||2001-12-01|July 2016|2016-07-01|October 2014|Actual|2014-10-01|March 2005|Actual|2005-03-01||Interventional|||Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases|A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases|Completed||Phase 3|480|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:07:47.170501|2017-02-18 18:07:47.170501
NCT00030615|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-02-06|||December 2001||2001-12-01|February 2013|2013-02-01||||September 2008|Actual|2008-09-01||Interventional|||Decitabine in Treating Patients With Advanced Solid Tumors|A Phase I Study Of The Toxicities, Biologic And Clinical Effects Of Daily 5 Aza 2'Deoxycytidine (DAC), NSC 127716 (IND 50733) For Four Weeks In Patients With Advanced Malignancies|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:47.327584|2017-02-18 18:07:47.327584
NCT00030602|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2009-02-06||||||March 2002|2002-03-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer|A Phase 2 Study Of Prostate Specific Antigen-3 (PSA-3) (NSC # 694155) With Montanide (NSC #675756) Vaccination In Patients With Prostate Cancer Recurrent|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:47.433739|2017-02-18 18:07:47.433739
NCT00030589|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-12-17|||February 2001||2001-02-01|October 2003|2003-10-01||||||||Interventional|||Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma|A Muliticenter, Dose-Reandomized Evaluation Of Targretin Capsules Plus PUVA In Patients With Stage IB - IIA Cutaneous T-Cell Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:47.513166|2017-02-18 18:07:47.513166
NCT00030576|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2016-04-13|||November 2001||2001-11-01|April 2016|2016-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase I/II Study Of OSI-774 In Combination With Cisplatin In Patients With Recurrent Or Metastatic Squamous Cell Cancer Of The Head And Neck|Completed||Phase 1/Phase 2|51|Actual|University Health Network, Toronto||1|||f||||t||||||||No||2017-02-18 18:07:47.892452|2017-02-18 18:07:47.892452
NCT00030563|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2012-11-28|||May 2001||2001-05-01|November 2012|2012-11-01|October 2005|Actual|2005-10-01|October 2004|Actual|2004-10-01||Interventional|||Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver|A Phase II Study Of Adjuvant Intravenous Irinotecan Following Resection With Or Without Radiofrequency Ablation (RFA), Of Hepatic Metastases From Colorectal Carcinoma|Completed||Phase 2|||University of Washington|||||f||||||||||||||2017-02-18 18:07:48.006479|2017-02-18 18:07:48.006479
NCT00030550|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-01-30|||September 2001||2001-09-01|January 2013|2013-01-01||||June 2003|Actual|2003-06-01||Interventional|||Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome|A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial Assessing The Safety And Efficacy Of Thalidomide (THALOMID) For The Treatment Of Anemia In Red Blood Cell Transfusion-Dependent Patients With Myelodysplastic Syndromes|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:07:48.111786|2017-02-18 18:07:48.111786
NCT00030537|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-06-17|||November 2001||2001-11-01|October 2002|2002-10-01|March 2003|Actual|2003-03-01|||||Interventional|||Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Pilot Study to Evaluate Epidermal Growth Factor Receptor Signaling After Treatment With Oral OSI-774 in Patients With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:48.211091|2017-02-18 18:07:48.211091
NCT00030524|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2012-10-26|||January 2002||2002-01-01|October 2012|2012-10-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer|A Phase II Clinical, Biological and Pharmacological Study of ZD1839 in Patients With Advanced Colorectal Carcinoma Refractory to 5-Fluorouracil (5-FU) and Irinotecan Chemotherapy|Completed||Phase 2|||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 18:07:48.313712|2017-02-18 18:07:48.313712
NCT00030511|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2012-07-13|||October 2001||2001-10-01|July 2012|2012-07-01||||July 2003|Actual|2003-07-01||Interventional|||Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer|A Phase II Study of Chronomodulated Preoperative Infusional Chemoradiation for Biliary Tract Cancer|Terminated||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:07:48.422537|2017-02-18 18:07:48.422537
NCT00030498|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-01-15|||December 2001||2001-12-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction|Phase I Study of OSI-774 (NSC 718781) for Solid Tumors in Patients With Hepatic or Renal Dysfunction|Completed||Phase 1|75|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:48.524505|2017-02-18 18:07:48.524505
NCT00030485|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2014-01-24|||January 2002||2002-01-01|January 2011|2011-01-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer|A Phase II Study of OSI-774 (NSC 718781) in Patients With Locally Advanced and/or Metastatic Carcinoma of the Endometrium|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:48.655347|2017-02-18 18:07:48.655347
NCT00030472|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-04-10|||December 2001||2001-12-01|September 2004|2004-09-01||||October 2006|Actual|2006-10-01||Interventional|||Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix|A Phase II Evaluation of Liposomal Doxorubicin (Doxil) in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:07:48.762833|2017-02-18 18:07:48.762833
NCT00030459|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-08-06|||November 2000||2000-11-01|May 2003|2003-05-01||||||||Interventional|||Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma|Randomized Feasibility Study Of Active Symptom Control With Or Without Chemotherapy In The Treatment Of Patients With Mesothelioma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:48.873895|2017-02-18 18:07:48.873895
NCT00030446|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2010-11-07|||January 2002||2002-01-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Study Of OSI-774 (NSC 718781) Given In Combination With Carboplatin In Patients With Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:07:48.98851|2017-02-18 18:07:48.98851
NCT00030433|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-02-12|||January 2002||2002-01-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|February 2007|Actual|2007-02-01||Interventional|||S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial Of Gemcitabine (NSC-613327) And Irinotecan (NSC-616348) In Patients With Untreated Extensive Stage Small Cell Lung Cancer (SCLC)|Completed||Phase 2|85|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:07:49.105482|2017-02-18 18:07:49.105482
NCT00030420|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-04-25|||October 2001||2001-10-01|April 2013|2013-04-01|February 2008|Actual|2008-02-01|May 2004|Actual|2004-05-01||Interventional|||Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer|Evaluation Of Celecoxib In Combination With Docetaxel In The Treatment Of Advanced Non-Small Cell Lung Cancer Patients Previously Treated With Platinum Based Chemotherapy|Completed||Phase 2|24|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 18:07:49.317451|2017-02-18 18:07:49.317451
NCT00030407|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-04-25|||October 2001||2001-10-01|April 2013|2013-04-01|April 2009|Actual|2009-04-01|September 2005|Actual|2005-09-01||Interventional|||Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer|Evaluation Of Celecoxib In Combination With Weekly Docetaxel In Elderly (70 Years) Or Poor Performance Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|34|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-02-18 18:07:49.452785|2017-02-18 18:07:49.452785
NCT00030394|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-01-16|||September 2002||2002-09-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia|A Phase II Study of Gleevec in Ph+ Chronic Phase Chronic Myelogenous Leukemia|Completed||Phase 2|64|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:49.591113|2017-02-18 18:07:49.591113
NCT00030381|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-01-15|||December 2001||2001-12-01|January 2013|2013-01-01||||January 2003|Actual|2003-01-01||Interventional|||Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis|Phase I Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)|Terminated||Phase 1|22|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:07:49.713727|2017-02-18 18:07:49.713727
NCT00030368|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-06-03|||November 2001||2001-11-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Study of PS-341 in Combination With Paclitaxel in Metastatic Solid Tumors|Completed||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:49.825461|2017-02-18 18:07:49.825461
NCT00030355|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-03-21||||||September 2007|2007-09-01||||||||Interventional|||Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia|A Phase I/II Open-Label Study Of The Intravenous Administration Of Homoharringtonine (CGX-635) Salvage Therapy For The Treatment Of Refractory Acute Promyelocytic Leukemia|Withdrawn||Phase 1/Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:49.937241|2017-02-18 18:07:49.937241
NCT00030342|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-06-25|||November 2001||2001-11-01|October 2008|2008-10-01|January 2008|Actual|2008-01-01|October 2007|Actual|2007-10-01||Interventional|||Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer|A Phase I/II Study Of Interleukin-12-Primed Activated T Cells In Combination With 5FU, GM-CSF And Interferon Alfa-2b In Metastatic Renal Cell Carcinoma Or Colorectal Carcinoma|Completed||Phase 1/Phase 2|60|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:07:50.037612|2017-02-18 18:07:50.037612
NCT00030303|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2011-06-04|||January 2001||2001-01-01|March 2003|2003-03-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia|A Feasibility And Toxicity Study Of Vaccination With HSP70 For The Treatment Of Chronic Myelogenous Leukemia In Chronic Phase|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:50.147778|2017-02-18 18:07:50.147778
NCT00030290|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-07-09|||October 2001||2001-10-01|December 2008|2008-12-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Interventional|||Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate|Feasibility Study for Organ Confined Prostate Cancer Treatment With HIFU Using SONABLATE System|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:50.238571|2017-02-18 18:07:50.238571
NCT00030277|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2013-07-09|||October 2001||2001-10-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|October 2007|Actual|2007-10-01||Interventional|||High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer|Feasibility Study for Locally Recurrent Prostate Cancer Treatment With HIFU Using the SONABLATE System|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:50.324569|2017-02-18 18:07:50.324569
NCT00030264|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-14|2016-06-01|||February 2001||2001-02-01|June 2016|2016-06-01|March 2016|Actual|2016-03-01|December 2013|Actual|2013-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas|Vinblastine/Methotrexate For Severe Progressive Plexiform Neurofibromas: A Phase II Study|Completed||Phase 2|25|Actual|Children's Hospital of Philadelphia||1|||f||||t||||||||||2017-02-18 18:07:50.413638|2017-02-18 18:07:50.413638
NCT00030238|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-12|2017-01-24|||February 6, 2002||2002-02-06|October 28, 2014|2014-10-28|December 14, 2007|Actual|2007-12-14|December 14, 2007|Actual|2007-12-14||Interventional|||Supplemental Calcium in Overweight People|Supplemental Calcium in Overweight Out-Patients|Completed||Phase 3|540|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 18:07:50.538521|2017-02-18 18:07:50.538521
NCT00030225|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-11|2012-07-24|||January 2002||2002-01-01|July 2012|2012-07-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure|Phase 2 Evaluation of the Vitagen Extracorporeal Liver Assist Device (ELAD) System in the Management of the Patients With Fulminant Hepatic Failure|Completed||Phase 2|19|Actual|Vital Therapies, Inc.||2|||f||||t||||||||||2017-02-18 18:07:50.651257|2017-02-18 18:07:50.651257
NCT00030212|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-07|2017-01-24|||February 4, 2002||2002-02-04|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Immune Abnormalities in Sporadic Inclusion Body Myositis|Study of Immune Dysregulation in Patients With Sporadic Inclusion Body Myositis (s-IBM)|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:50.774633|2017-02-18 18:07:50.774633
NCT00030199|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-07|2008-03-03|||February 2002||2002-02-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Brain Control of Blinking|Cortical Control of Voluntary Blinking|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:50.856622|2017-02-18 18:07:50.856622
NCT00030186|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-07|2012-08-14||2012-05-03|January 2002||2002-01-01|August 2012|2012-08-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation|An Open-Label Study of CEP-701 in Patients With Refractory, Relapsed, or Poor Risk Acute Myeloid Leukemia Expressing FLT-3 Activating Mutations|Completed||Phase 2|37|Actual|Teva Pharmaceutical Industries||3|||f||||||||||||||2017-02-18 18:07:50.940075|2017-02-18 18:07:50.940075
NCT00030173|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-07|2009-01-07|||October 2001||2001-10-01|January 2009|2009-01-01|June 2003|Actual|2003-06-01|||||Interventional|||A Trial to Evaluate Epothilone D in Patients With Advanced Solid Tumors|A Phase 1, Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Epothilone D in Patients With Advanced Solid Tumors|Completed||Phase 1|45||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:07:51.041523|2017-02-18 18:07:51.041523
NCT00030160|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-07|2010-01-12|||April 2002||2002-04-01|January 2010|2010-01-01|July 2005||2005-07-01|||||Interventional|||Strength Training for Obesity Prevention|Strength Training for Obesity Prevention|Completed||Phase 2|160||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:07:51.121984|2017-02-18 18:07:51.121984
NCT00030147|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-06|2016-07-18|2016-06-02||February 2002||2002-02-01|July 2016|2016-07-01|June 2015|Actual|2015-06-01|June 2015|Actual|2015-06-01||Interventional|||Raloxifene and Rimostil for Perimenopause-Related Depression|The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression|Completed||Phase 4|65|Actual|National Institutes of Health Clinical Center (CC)|Two participants signed the consent but were not started (did not meet inclusion criteria.) Early termination of Rimostil treatment arm limits the generalizability of treatment response in this arm.|4|||f||||f||||||||No||2017-02-18 18:07:51.205917|2017-02-18 18:07:51.205917
NCT00030134|ClinicalTrials.gov processed this data on February 17, 2017|2002-02-02|2008-03-03|||January 2002||2002-01-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||Data Collection in Women With Fabry Disease|A Study to Collect Normative Data in Female Patients With Fabry Disease|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:52.367371|2017-02-18 18:07:52.367371
NCT00030121|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-31|2008-02-19|||December 1999||1999-12-01|February 2008|2008-02-01||||||||Interventional|||Carperitide in Acute Respiratory Distress Syndrome (ARDS)|A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Evaluation of the Safety and Efficacy of Carperitide Infusion in Patients With ARDS|Completed||Phase 2|||Suntory Pharmaceutical|||||||||||||||||||2017-02-18 18:07:52.454616|2017-02-18 18:07:52.454616
NCT00030108|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-30|2012-03-14|||November 2001||2001-11-01|March 2012|2012-03-01|April 2010|Actual|2010-04-01|March 2010|Actual|2010-03-01||Interventional|||Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy|Phase I Trial and Pharmacokinetic Study of BMS-247550 (NSC 710428, Ixabepilone), an Epothilone B Analog, in Pediatric Patients With Refractory Solid Tumors and Leukemias|Completed||Phase 1|30|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 18:07:52.530476|2017-02-18 18:07:52.530476
NCT00030095|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-30|2015-04-29|||September 2001||2001-09-01|July 2006|2006-07-01||||||||Interventional|||2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors|A Phase I Trial Of 2-Methoxyestradiol (2ME2), (NSC-659853) An Angiogenesis Inhibitor, In Patients With Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:07:52.64637|2017-02-18 18:07:52.64637
NCT00030082|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-30|2015-04-29|||July 2001||2001-07-01|July 2004|2004-07-01||||||||Interventional|||Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer|A Phase I Study of Hepatic Arterial Infusion of Escalating Dose Melphalan With Venous Filtration for Metastatic Unresectable Cancers of the Liver|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:07:52.736942|2017-02-18 18:07:52.736942
NCT00030069|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-30|2016-01-14|||September 2001||2001-09-01|January 2016|2016-01-01|May 2009|Actual|2009-05-01|September 2007|Actual|2007-09-01||Interventional|||Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes|Calcitriol and Dexamethasone for Myelodysplastic Syndromes|Completed||Phase 2|32|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 18:07:52.835506|2017-02-18 18:07:52.835506
NCT00030056|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-30|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|December 2005||2005-12-01|||||Interventional|||GM-CSF in Patients With Pulmonary Alveolar Proteinosis|Trial of GM-CSF for Alveolar Proteinosis|Terminated||Phase 2|48|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:07:52.942502|2017-02-18 18:07:52.942502
NCT00030043|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-30|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|August 2003||2003-08-01|||||Interventional|||An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors|Penetrating Auditory Brainstem Implant for Neurofibromatosis 2|Completed||Phase 1|10||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:07:53.030208|2017-02-18 18:07:53.030208
NCT00029965|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-27|2017-02-03|||January 23, 2002||2002-01-23|November 15, 2016|2016-11-15||||||||Observational|||Nervous System Degeneration in Glycosphingolipid Storage Disorders|Investigation of Neurodegeneration in the Glycosphingolipid Storage Disorders|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:53.450438|2017-02-18 18:07:53.450438
NCT00029952|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-26|2008-03-03|||July 1993||1993-07-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Observational|||Long Term Post Operative Follow-Up of Cushing Syndrome|Long-Term Post-Operative Follow-Up of Cushing Syndrome|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:53.556691|2017-02-18 18:07:53.556691
NCT00029939|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-26|2017-01-24|||January 22, 2002||2002-01-22|November 23, 2010|2010-11-23|November 23, 2010||2010-11-23|||||Observational|||Brain Activity During Production of Movement|Real-Time Analysis of Scalp Electroencephalography and Magnetoencephalography During Production of Human Voluntary Movement|Completed||N/A|140|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:53.638913|2017-02-18 18:07:53.638913
NCT00029926|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-26|2008-03-03|||January 2002||2002-01-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Observational|||Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity|A Pilot Study of F-18FDG Positron Emission Tomography (PET) to Assess the Distribution of Activated Lymphocytes in Systemic Lupus Erythematosus (SLE)|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:53.724047|2017-02-18 18:07:53.724047
NCT00029913|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-24|2010-08-31|||April 2002||2002-04-01|August 2010|2010-08-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Observational|||A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials|A Multi-Site Evaluation of Virologic, Immunologic, and Clinical Natural History of Participants Enrolled in Phase I and Phase II HIV-1 Vaccine Protocols or HIV-1 Vaccine Preparedness Cohorts Who Develop HIV-1 Infection Subsequent to Trial Enrollment|Completed||N/A|54|Anticipated|HIV Vaccine Trials Network|||1||f||||||||||||||2017-02-18 18:07:53.816939|2017-02-18 18:07:53.816939
NCT00029900|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-24|2015-03-24|||September 2001||2001-09-01|January 2002|2002-01-01|August 2003||2003-08-01|||||Interventional|||ADI-PEG in Patients With Metastatic Melanoma|Phase I Testing of ADI-PEG in Metastatic Melanoma|Completed||Phase 1|15||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:07:53.952041|2017-02-18 18:07:53.952041
NCT00029874|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-24|2015-03-24|||September 2001||2001-09-01|December 2004|2004-12-01|August 2003||2003-08-01|||||Interventional|||Minocycline in Patients With Huntington's Disease|Minocycline Dosing and Safety in Huntington's Disease|Completed||Phase 1/Phase 2|63||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:07:54.03552|2017-02-18 18:07:54.03552
NCT00029861|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-23|2009-04-17|||August 2001||2001-08-01|April 2009|2009-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Obese Patients With or Without Comorbidities (RIO-North America)|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing and Prevention of Weight Regain Effects and Safety in Obese Patients With or Without Comorbidities|Completed||Phase 3|3045|Actual|Sanofi|||||f||||||||||||||2017-02-18 18:07:54.123772|2017-02-18 18:07:54.123772
NCT00029848|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-23|2009-04-17|||October 2001||2001-10-01|April 2009|2009-04-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|RIO-Diabetes||Obese Patients With Type 2 Diabetes|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety in Obese Patients With Type 2 Diabetes|Completed||Phase 3|1045|Actual|Sanofi|||||f||||||||||||||2017-02-18 18:07:54.265991|2017-02-18 18:07:54.265991
NCT00029835|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-23|2009-04-17|||September 2001||2001-09-01|April 2009|2009-04-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|RIO-Lipids||Obese Patients With Untreated Dyslipidemias|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study of Weight-Reducing Effect and Safety in Obese Patients With Untreated Dyslipidemias|Completed||Phase 3|1033|Actual|Sanofi|||||f||||||||||||||2017-02-18 18:07:54.411163|2017-02-18 18:07:54.411163
NCT00029822|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-23|2008-06-06|||May 2001||2001-05-01|June 2008|2008-06-01|March 2005|Actual|2005-03-01|||||Interventional|||Clinical Trial in Males With BPH (Enlarged Prostate)|Long-Term, Efficacy and Safety of Alfuzosin 10 MG OD on the Risk of Acute Urinary Retention and the Need for Surgery in Patients With BPH. A Two Year, Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Study.|Completed||Phase 3|1522|Actual|Sanofi|||||||||||||||||||2017-02-18 18:07:54.620666|2017-02-18 18:07:54.620666
NCT00029809|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-23|2006-08-17||||||July 2006|2006-07-01||||||||Interventional|||Chinese Exercise Modalities in Parkinson's Disease|Chinese Exercise Modalities in Parkinson's Disease|Completed||Phase 1/Phase 2|40||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:54.771174|2017-02-18 18:07:54.771174
NCT00029796|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-23|2013-03-21||||||March 2013|2013-03-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Isoflavones and Acute-phase Response in Chronic Renal Failure|Isoflavones and Acute-phase Response in Chronic Renal Failure|Completed||Phase 2|52||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:54.853326|2017-02-18 18:07:54.853326
NCT00029783|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-23|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|June 2005||2005-06-01|||||Interventional|||Efficacy of Distant Healing in Glioblastoma Treatment|Efficacy of Distant Healing in Glioblastoma Treatment|Completed||Phase 2|150||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:54.930928|2017-02-18 18:07:54.930928
NCT00029770|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-23|2008-01-23|||September 2001||2001-09-01|January 2008|2008-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Chiropractic Care, Medication, and Self-Care for Neck Pain|Chiropractic Care, Medication, and Self-Care for Neck Pain|Completed||Phase 2|270||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:55.009069|2017-02-18 18:07:55.009069
NCT00029757|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-22|2005-11-04||||||December 2003|2003-12-01||||||||Interventional|||Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women|Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women|Completed||N/A|15||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:07:55.085567|2017-02-18 18:07:55.085567
NCT00029744|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-21|2012-10-29|||April 2003||2003-04-01|October 2012|2012-10-01|May 2007|Actual|2007-05-01|||||Observational|||A Study to Prepare for Future HIV Vaccine Studies|An HIV Vaccine Preparedness Study|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:07:55.16319|2017-02-18 18:07:55.16319
NCT00029731|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-21|2015-03-24|||August 2001||2001-08-01|January 2002|2002-01-01|July 2005||2005-07-01|||||Interventional|||Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients|Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease|Completed||Phase 2|30|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:07:55.254017|2017-02-18 18:07:55.254017
NCT00029718|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-14|2017-01-24|||January 16, 2002||2002-01-16|November 18, 2011|2011-11-18|November 18, 2011||2011-11-18|||||Observational|||Interhemispheric Interactions Associated With Performance of Voluntary Movements in Patients With Stroke Motor Disability|Interhemispheric Interactions Associated With Performance of Voluntary Movements in Patients With Stroke Motor Disability|Completed||N/A|57|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:58.325171|2017-02-18 18:07:58.325171
NCT00029692|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-18|2006-07-24|||March 2002||2002-03-01|July 2006|2006-07-01|March 2005||2005-03-01|||||Interventional|||Effects of Ginseng and Ginkgo on Drug Disposition in Man|Effects of Ginseng and Ginkgo on Drug Disposition in Man|Completed||Phase 2|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:58.406494|2017-02-18 18:07:58.406494
NCT00029679|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-18|2006-08-16|||September 2000||2000-09-01|August 2006|2006-08-01|July 2005||2005-07-01|||||Interventional|||Borage Oil and Ginkgo Biloba (EGb 761) in Asthma|Borage Oil and Ginkgo Biloba (EGb 761) in Asthma|Completed||Phase 1/Phase 2|280||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:58.480636|2017-02-18 18:07:58.480636
NCT00029666|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-17|2008-03-03|||January 2002||2002-01-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease|Placebo Controlled Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:58.557746|2017-02-18 18:07:58.557746
NCT00029653|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-16|2008-03-03|||January 2002||2002-01-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Effect of Transcranial Magnetic Stimulation on Free Will|The Effect of Transcranial Magnetic Stimulation on Free Will|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:58.644091|2017-02-18 18:07:58.644091
NCT00029640|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-16|2008-03-03|||January 2002||2002-01-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||The Treatment of Children and Adolescents With Treatment-Resistant Depression|Clinical and Neurochemical Effects of Pharmacologic Treatment in Pediatric Depression|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:58.717898|2017-02-18 18:07:58.717898
NCT00029627|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-16|2008-03-03|||January 2002||2002-01-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Observational|||Brain Receptors in Sympathetic Nervous System Regulation|Alpha(2)-Adrenoreceptor (AR) Subtype Polymorphisms and Physiological Responses to Alpha(2)-AR Agonist and Antagonist Drugs|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:58.796159|2017-02-18 18:07:58.796159
NCT00029614|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-16|2010-04-27|||May 2006||2006-05-01|April 2010|2010-04-01|July 2007|Actual|2007-07-01|||||Interventional|||Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD|Psychopharmacology of Adolescents With AUD and ADHD|Completed||Phase 2|24|Anticipated|University of Pittsburgh|||||f||||||||||||||2017-02-18 18:07:58.879898|2017-02-18 18:07:58.879898
NCT00029601|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-15|2008-03-03|||January 2002||2002-01-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Observational|||Surround Inhibition in Patients With Dystonia|The Study of Surround Inhibition in Patients With Dystonia|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:58.962474|2017-02-18 18:07:58.962474
NCT00029588|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-15|2017-01-24|||January 11, 2002||2002-01-11|June 20, 2016|2016-06-20||||||||Observational|||Reward-Related Processes and Brain Function|Reward-Related Processes and Brain Function|Completed||N/A|241|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:59.038381|2017-02-18 18:07:59.038381
NCT00029575|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-15|2008-03-03|||January 2002||2002-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Interventional|||Magnetic Resonance Imaging of Narrowed Arteries|Intravascular Narrow Field Magnetic Resonance Arterial Wall Imaging|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:59.126389|2017-02-18 18:07:59.126389
NCT00029536|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-15|2010-07-20|||October 2000||2000-10-01|July 2010|2010-07-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Progesterone vs Placebo Therapy for Women With Epilepsy|Phase 3 Study of Progesterone vs Placebo Therapy|Completed||Phase 3|462|Actual|Beth Israel Deaconess Medical Center||2|||f||||t||||||||||2017-02-18 18:07:59.210046|2017-02-18 18:07:59.210046
NCT00029523|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-15|2007-02-27|||April 2001||2001-04-01|February 2007|2007-02-01|November 2004||2004-11-01|||||Interventional|||DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor|A Randomized Clinical Study to Determine the Patient Benefit and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis|Completed||Phase 4|100||Pacira Pharmaceuticals, Inc|||||||||||||||||||2017-02-18 18:07:59.609003|2017-02-18 18:07:59.609003
NCT00029510|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-14|2006-08-17|||May 2002||2002-05-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Magnesium and Asthma - Clinical Trials|Magnesium and Asthma - Clinical Trials|Completed||Phase 2|240||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:59.72663|2017-02-18 18:07:59.72663
NCT00029497|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-14|2013-03-21||||||March 2013|2013-03-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Sham Device, Pill Placebo or Treatment For Arm Pain|Sham Device, Pill Placebo or Treatment For Arm Pain|Completed||Phase 2|240||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:59.804104|2017-02-18 18:07:59.804104
NCT00029484|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-11|2006-08-17||||||July 2006|2006-07-01||||||||Interventional|||Tai Chi Chih and Varicella Zoster Immunity|Tai Chi Chih and Varicella Zoster Immunity|Completed||Phase 2|70||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:07:59.903184|2017-02-18 18:07:59.903184
NCT00029458|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-11|2008-03-03|||January 2002||2002-01-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Interventional|||Clozapine for Treatment-Resistant Mania|A Double Blind Study Examining the Efficacy of Clozapine and a Study of the Pathophysiology in Treatment Resistant Mania|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:07:59.987167|2017-02-18 18:07:59.987167
NCT00029445|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-11|2017-01-24|||January 2, 2002||2002-01-02|August 11, 2016|2016-08-11||||||||Observational|||Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors|Evaluation of Viral Factors and Immune Parameters to Study HIV-Specific Immunity|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:00.077288|2017-02-18 18:08:00.077288
NCT00029406|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-10|2015-12-15|||April 2001||2001-04-01|December 2015|2015-12-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|TRIPPS||Transfusion Infections Pediatric Prospective Study (TRIPPS)|Transfusion Infections Pediatric Prospective Study (TRIPPS)|Completed||N/A|600|Actual|Children's Research Institute|||1||f||||f||||||Samples Without DNA|"~     Whole blood and plasma samples~   "|||2017-02-18 18:08:00.18361|2017-02-18 18:08:00.18361
NCT00029393|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-10|2016-07-28|||August 2001||2001-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Induction of Stable Chimerism for Sickle Cell Anemia||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:08:00.293174|2017-02-18 18:08:00.293174
NCT00029380|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-10|2016-07-28|||January 1999||1999-01-01|September 2008|2008-09-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia|Sibling Donor Cord Blood Banking and Transplantation|Completed||Phase 2|30|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:08:00.379114|2017-02-18 18:08:00.379114
NCT00029341|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-10|2008-07-29||||||January 2005|2005-01-01||||||||Interventional|||A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body|A Phase II Study to Demonstrate That Therapy With Efavirenz (EFV) and Other Antiretroviral Drugs Can Be Interrupted Without Selecting for EFV-Resistant Virus, and Relation to Kinetics of Drug Elimination|Completed||Phase 2|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:08:00.496602|2017-02-18 18:08:00.496602
NCT00029328|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-10|2015-03-24|||September 2001||2001-09-01|November 2001|2001-11-01|September 2003||2003-09-01|||||Interventional|||Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation|Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation|Completed||Phase 1/Phase 2|15||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:08:00.588828|2017-02-18 18:08:00.588828
NCT00029315|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-10|2015-03-24|||September 2001||2001-09-01|December 2001|2001-12-01|September 2004||2004-09-01|||||Interventional|||Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage|Intraventricular Rt-PA Pharmacokinetic and Pharmacodynamic Study|Completed||Phase 2|30|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:08:00.674297|2017-02-18 18:08:00.674297
NCT00029302|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2017-01-24|||December 10, 2001||2001-12-10|December 24, 2008|2008-12-24|December 24, 2008||2008-12-24|||||Observational|||Brain Control of Bimanual (Both Hands) Movements|Brain Areas Involved in Temporal Linkage of Bilateral Movements|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:00.767768|2017-02-18 18:08:00.767768
NCT00029289|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2006-08-16|||April 2001||2001-04-01|August 2006|2006-08-01|October 2002||2002-10-01|||||Interventional|||Effects of Lutein in Retinitis Pigmentosa|Effects of Lutein in Retinitis Pigmentosa|Completed||Phase 1/Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:00.84578|2017-02-18 18:08:00.84578
NCT00029276|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2006-08-16|||August 2000||2000-08-01|August 2006|2006-08-01|April 2005||2005-04-01|||||Interventional|||Magnetic Stimulation for Parkinson Disease|Transcranial Magnetic Stimulation For Treatment Of Depression In Parkinson's Disease|Completed||Phase 1|50||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:00.930407|2017-02-18 18:08:00.930407
NCT00029263|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2006-08-17|||August 2001||2001-08-01|July 2006|2006-07-01|May 2004||2004-05-01|||||Interventional|||Screening Herbs for Drug Interactions|R-21 Project: Screening Herbs for Drug Interference|Completed||Phase 2|140||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:01.016085|2017-02-18 18:08:01.016085
NCT00029250|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2013-03-21|||November 2001||2001-11-01|March 2013|2013-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Garlic in Hyperlipidemia Caused by HAART|Phase II, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study on the Effects of Garlic on Hyperlipidemia Induced by HAART in HIV-positive Individuals|Withdrawn||Phase 2|0|Actual|National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:01.104131|2017-02-18 18:08:01.104131
NCT00029237|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2006-08-17|||September 2000||2000-09-01|August 2006|2006-08-01|May 2005||2005-05-01|||||Interventional|||Alternative Stress Management Approaches in HIV Disease|Alternative Stress Management Approaches in HIV Disease|Completed||Phase 3|392||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:01.213912|2017-02-18 18:08:01.213912
NCT00029224|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2012-01-30|||October 2001||2001-10-01|January 2012|2012-01-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions|A Prospective, Multicenter, Open-label Clinical Evaluation of the Effect of IV Zoledronic Acid 4mg on PAIN, QUALITY OF LIFE and TIME IN INFUSION CHAIR in Breast Cancer, Multiple Myeloma, and Prostate Cancer Patients With Cancer-related Bone Lesions|Completed||Phase 4|500||Novartis|||||f||||||||||||||2017-02-18 18:08:01.310867|2017-02-18 18:08:01.310867
NCT00029211|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2006-08-17|||April 2000||2000-04-01|August 2006|2006-08-01|March 2003||2003-03-01|||||Interventional|||A Trial of Echinacea in Children|A Randomized Controlled Trial of Echinacea in Children|Completed||Phase 3|600||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:01.681495|2017-02-18 18:08:01.681495
NCT00029198|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-09|2014-04-09|||April 2003||2003-04-01|April 2014|2014-04-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Preterm Infants' Weight Gain Following Massage Therapy|Preterm Infants' Weight Gain Following Massage Therapy|Completed||Phase 3|139|Actual|University of Miami||2|||f||||t||||||||||2017-02-18 18:08:01.773904|2017-02-18 18:08:01.773904
NCT00029185|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-08|2015-03-24|||September 2001||2001-09-01|October 2001|2001-10-01|September 2007||2007-09-01|||||Interventional|||Study of Dehydrex in Patients With Corneal Erosion|Topical Dehydrex in Treating Recurrent Corneal Erosion|Completed||N/A|300|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:08:01.884756|2017-02-18 18:08:01.884756
NCT00029172|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-08|2009-12-31|2009-08-03||May 1999||1999-05-01|December 2009|2009-12-01|December 2005|Actual|2005-12-01|||||Interventional|||Treatment for Post-Stroke Depression|Treatment for Post-Stroke Depression|Completed||Phase 4|188|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 18:08:01.979835|2017-02-18 18:08:01.979835
NCT00028548|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2014-04-24|||January 2002||2002-01-01|April 2014|2014-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||XK469 in Treating Patients With Advanced Solid Tumors|Phase I Study of R(+)-XK469 (NSC 698215) Given Daily, Days 1-5, Repeated Every Three Weeks in Patients With Advanced Malignancies|Completed||Phase 1|22|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 18:08:09.647346|2017-02-18 18:08:09.647346
NCT00029159|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-08|2012-06-04|||November 1992||1992-11-01|June 2012|2012-06-01|June 2012|Actual|2012-06-01|January 2007|Actual|2007-01-01||Interventional|||The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome|The Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate and Cognitive Function of Growth Hormone-treated Girls With Turner Syndrome|Completed||Phase 3|200|Actual|Thomas Jefferson University||2|||f||||t||||||||||2017-02-18 18:08:02.207577|2017-02-18 18:08:02.207577
NCT00029146|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-08|2012-03-24|2012-01-17||July 2002||2002-07-01|March 2012|2012-03-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|COSS||Carotid Occlusion Surgery Study|Carotid Occlusion Surgery Study|Terminated||Phase 3|700|Actual|University of North Carolina, Chapel Hill||2||Pre-specified futility boundary was reached.|f||||t||||||||||2017-02-18 18:08:02.33951|2017-02-18 18:08:02.33951
NCT00029133|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-08|2005-06-23|||February 2000||2000-02-01|August 2003|2003-08-01||||||||Interventional|||Hypothermia During Intracranial Aneurysm Surgery Trial||Completed||Phase 3|1000||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:08:03.028751|2017-02-18 18:08:03.028751
NCT00029120|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-05|2017-01-24|||December 18, 2001||2001-12-18|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder|MRI Contrast Imaging in the Evaluation and Follow-up of Patients With Memory Disorder and Healthy Controls|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:03.115864|2017-02-18 18:08:03.115864
NCT00029107|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-05|2012-04-10|2011-10-26||December 2001||2001-12-01|April 2012|2012-04-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis|Rituximab (Anti-CD20) for the Treatment of Hepatitis C Associated Cryoglobulinemic Vasculitis|Completed||Phase 2|47|Actual|National Institutes of Health Clinical Center (CC)|The study was not blinded. In addition, the study was limited to patients who had failed antiviral therapy.|2|||f||||f||||||||||2017-02-18 18:08:03.201443|2017-02-18 18:08:03.201443
NCT00029068|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2008-03-03|||January 2002||2002-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||Cortical Excitability in Obsessive-Compulsive and Related Disorders|Studies of Cortical Excitability in Obsessive-Compulsive Disorder, Related Disorder and Healthy Volunteers Using Paired-Pulse Transcranial Magnetic Stimulation|Completed||N/A|145||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:03.598582|2017-02-18 18:08:03.598582
NCT00029042|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2008-08-26|||January 2002||2002-01-01|August 2008|2008-08-01|October 2005|Actual|2005-10-01|||||Interventional|||Infliximab to Treat Children With Juvenile Rheumatoid Arthritis|A Randomized Double Blind Controlled Intra-Patient Dose Escalation Phase II Trial of Infliximab in Pediatric Patients With Refractory Juvenile Rheumatoid Arthritis|Terminated||Phase 2|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:03.678722|2017-02-18 18:08:03.678722
NCT00029029|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2016-04-18|||October 2000||2000-10-01|January 2016|2016-01-01||||October 2002|Actual|2002-10-01||Interventional|||Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases|RF Ablation of Painful Metastases Involving Bone|Active, not recruiting||Phase 2|||Mayo Clinic|||||f||||||||||||||2017-02-18 18:08:03.759651|2017-02-18 18:08:03.759651
NCT00029003|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-02-27|||December 2001||2001-12-01|February 2013|2013-02-01||||December 2004|Actual|2004-12-01||Interventional|||Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Trial of Chronic Oral ZD1839 (Iressa®) (NSC-715055) in Both Previously-Untreated and Previously-Treated Patients With Selected Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)|Completed||Phase 2|90|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:03.856995|2017-02-18 18:08:03.856995
NCT00028990|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2012-03-08|||December 2001||2001-12-01|January 2010|2010-01-01|May 2009|Actual|2009-05-01|November 2006|Actual|2006-11-01||Interventional|||Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer|A Randomized Phase III Tial Of Paclitaxel Versus Paclitaxel Plus Bevacizumab (rhuMAb VEGF) As First-Line Therapy For Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 3|722|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-02-18 18:08:03.969422|2017-02-18 18:08:03.969422
NCT00028977|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2012-09-13|||August 2001||2001-08-01|September 2012|2012-09-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Herbal Therapy in Treating Women With Metastatic Breast Cancer|A Pilot Safety, Feasibility, Efficacy And Correlative (Phase I/II) Study Assessing Herba Scutellaria Barbatae (HSB) For Metastatic Breast Cancer|Completed||Phase 1/Phase 2|21|Actual|University of California, San Francisco|||||f||||||||||||||2017-02-18 18:08:04.152666|2017-02-18 18:08:04.152666
NCT00028964|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2011-02-20|||February 2001||2001-02-01|February 2011|2011-02-01|February 2005|Actual|2005-02-01|||||Interventional|||Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer|A Randomized, Double Blind, Pacebo-Controlled Study to Assess The Feasibility, Toxicity And Efficacy (Phase I/II) Of A Chinese Herbal Therapy (CHT) For Symptom Management In Women Undergoing Chemotherapy For Stage I/II/III Breast Cancer|Completed||Phase 1/Phase 2|||University of California, San Francisco|||||f||||||||||||||2017-02-18 18:08:04.248925|2017-02-18 18:08:04.248925
NCT00028951|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-07-08|||January 2003||2003-01-01|December 2005|2005-12-01||||December 2005|Actual|2005-12-01||Interventional|||Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva|A Phase III Clinical Trial Use of TISSEEL VH Fibrin Sealant to Reduce Lymphedema Incidence After Inguinal Lymph Node Dissection Performed in the Management of Vulvar Malignancies|Completed||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:08:04.347063|2017-02-18 18:08:04.347063
NCT00028938|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2009-08-20|||January 2002||2002-01-01|August 2009|2009-08-01||||||||Interventional|||Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer|A Phase III Randomized Trial Evaluating the Effect of Epoetin Alfa (Procrit) on Local Control in Patients Undergoing Concurrent Chemotherapy and Radiation Therapy for Non-Small Cell Lung Cancer|Completed||Phase 3|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:08:04.763148|2017-02-18 18:08:04.763148
NCT00028925|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2016-12-05|||November 2001||2001-11-01|December 2016|2016-12-01|August 2008|Actual|2008-08-01|November 2005|Actual|2005-11-01||Interventional|||Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF (Filgrastim) Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|27|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:08:04.859593|2017-02-18 18:08:04.859593
NCT00028912|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2011-04-23|||November 2001||2001-11-01|April 2004|2004-04-01||||||||Interventional|||Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|Phase I Trial of Bortezomib (NSC 681239, IND#58443) and Carboplatin in Recurrent or Progressive Epithelial Ovarian Cancer or Primary Peritoneal Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:04.997797|2017-02-18 18:08:04.997797
NCT00028899|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2014-02-18|||July 2002||2002-07-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|September 2006|Actual|2006-09-01||Interventional|||Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes|A Dose Finding Study of the Safety of Gemtuzumab Ozogamicin Combined With Conventional Chemotherapy for Patients With Relapsed or Refractory Acute Myeloid Leukemia|Completed||Phase 1|47|Actual|Children's Oncology Group|||||||||t||||||||||2017-02-18 18:08:05.109785|2017-02-18 18:08:05.109785
NCT00028886|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-09-16|||March 2001||2001-03-01|October 2012|2012-10-01||||||||Interventional|||Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma|A Randomized Phase III Study On The Effect Of Thalidomide Combined With Adriamycin, Dexamethasone (AD) And High Dose Melphalan In Patients With Multiple Myeloma|Unknown status|Active, not recruiting|Phase 3|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:05.299244|2017-02-18 18:08:05.299244
NCT00028873|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2012-07-17|||September 2001||2001-09-01|July 2012|2012-07-01||||June 2002|Actual|2002-06-01||Interventional|||R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy|An EORTC-IDBBC/ECSG Phase II Study Evaluating The Role Of The Multi-Drug Resistance (MDR) Reversor, R101933, In Patients With Taxane Refractory Metastatic Breast Cancer|Completed||Phase 2|35|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:08:05.43166|2017-02-18 18:08:05.43166
NCT00028860|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-07-09|||October 2001||2001-10-01|August 2004|2004-08-01|October 2004|Actual|2004-10-01|||||Interventional|||Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer|A Phase II Trial Of Adjuvant Chemotherapy For High Risk Transitional Cell Carcinoma Of The Urothelium|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:05.521534|2017-02-18 18:08:05.521534
NCT00028847|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-09-16|||April 2001||2001-04-01|August 2011|2011-08-01||||||||Interventional|||Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia|A Dose-ranging Phase I/II Study of STI571 in Combination With Cytarabin in Patients With First Chronic Phase Chronic Myeloid Leukemia|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:05.612744|2017-02-18 18:08:05.612744
NCT00028834|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-01-23|||February 2002||2002-02-01|January 2013|2013-01-01||||December 2004|Actual|2004-12-01||Interventional|||Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer|A Phase II Trial Of Bevacizumab (NSC#704865) Plus Gemcitabine In Patients With Advanced Pancreatic Cancer|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:05.741011|2017-02-18 18:08:05.741011
NCT00028821|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-01-15|||January 2002||2002-01-01|January 2013|2013-01-01||||April 2006|Actual|2006-04-01||Interventional|||2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacologic Study of 2-Methoxyestradiol in Patients With Advanced Solid Tumors|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:05.856641|2017-02-18 18:08:05.856641
NCT00028795|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2014-02-19|||December 2002||2002-12-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|September 2007|Actual|2007-09-01||Interventional|||Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma|A Phase II Study of Temozolomide in the Treatment of Children With High Grade Glioma|Completed||Phase 2|170|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:08:05.973461|2017-02-18 18:08:05.973461
NCT00028782|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-01-15|||October 2001||2001-10-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer|The Detection of Tumor Hypoxia and Vascularity in Patients Undergoing Intraperitoneal Photodynamic Therapy|Terminated||N/A|80|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:08:06.612183|2017-02-18 18:08:06.612183
NCT00028769|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-06-12|2012-11-15||December 2001||2001-12-01|June 2013|2013-06-01|July 2011|Actual|2011-07-01|June 2010|Actual|2010-06-01||Interventional|||S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer|Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination With Hormone Therapy in Patients With High-Risk Metastatic Adenocarinoma of the Prostate|Completed||Phase 2|41|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:08:06.731142|2017-02-18 18:08:06.731142
NCT00028756|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2016-08-01|||October 2001||2001-10-01|August 2016|2016-08-01|July 2014|Actual|2014-07-01|January 2014|Actual|2014-01-01||Interventional|||Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium|Randomized Phase III Trial Comparing Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients With pT3-pT4, and/or N+M0 Transitional Cell Carcinoma (TCC) of the Bladder|Completed||Phase 3|285|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 18:08:07.347611|2017-02-18 18:08:07.347611
NCT00028743|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-10-31|||August 2001||2001-08-01|December 2012|2012-12-01|January 2013|Actual|2013-01-01|October 2007|Actual|2007-10-01||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer|A Phase III Study of Cisplatin Plus Topotecan Followed by Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Carboplatin as First Line Chemotherapy in Women With Newly Diagnosed Advanced Epithelial Ovarian Cancer|Completed||Phase 3|819|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:08:07.512048|2017-02-18 18:08:07.512048
NCT00028535|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-06-03|||November 2001||2001-11-01|June 2013|2013-06-01||||February 2009|Actual|2009-02-01||Interventional|||Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors|Phase I Trial of Interleukin-12 in Combination With Paclitaxel Plus Herceptin in Patients With Her2-positive Malignancies|Completed||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:09.74557|2017-02-18 18:08:09.74557
NCT00028730|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2015-12-21|||August 2001||2001-08-01|December 2015|2015-12-01|June 2008|Actual|2008-06-01|July 2006|Actual|2006-07-01||Interventional|||Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer|Phase II Trial of T-Cell Depleted Hematopoietic Stem Cell Transplants (SBA-E-BM) From HLA Compatible Related or Unrelated Donors After a Myeloablative Preparative Regimen of Hyperfractionated TBI, Thiotepa and Cyclophosphamide (TBI/Thio/cy) for Treatment of Patients Less Than or Equal to 18 Years With Lymphohematopoietic Disorders|Completed||Phase 2|25|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:08:07.672199|2017-02-18 18:08:07.672199
NCT00028717|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-09-16|||February 2001||2001-02-01|November 2007|2007-11-01||||||||Interventional|||Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma|A Randomized Phase III Study Of Chimeric Anti-CD20 Monoclonal Antibody (Rituximab) With 2-Weekly CHOP Chemotherapy In Elderly Patients With Intermediate Or High-Risk Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:07.798048|2017-02-18 18:08:07.798048
NCT00028704|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2012-07-17|||October 2001||2001-10-01|July 2012|2012-07-01||||December 2003|Actual|2003-12-01||Interventional|||Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy|Conservative Local Treatment Versus Mastectomy After Induction Chemotherapy In Locally Advanced Breast Cancer: A Randomized Phase III Study|Terminated||Phase 3|26|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:08:07.922131|2017-02-18 18:08:07.922131
NCT00028691|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-09-16|||December 2002||2002-12-01|January 2002|2002-01-01||||||||Interventional|||Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma|Chlorambucil Versus 2x2 Gy Involved Field Radiotherapy in Stage III/IV Previously Untreated Follicular Lymphoma Patients. A Prospective, Randomized Phase III Clinical Trial|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:08.033976|2017-02-18 18:08:08.033976
NCT00028678|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2010-01-26|||May 2002||2002-05-01|January 2010|2010-01-01||||July 2006|Actual|2006-07-01||Interventional|||Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme|A Phase II Study to Evaluate the Effect of Dalteparin and Radiation Therapy on Survival Compared to the RTOG RPA Database and on Thromboembolic Events in Patients With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||||||f||||||||||2017-02-18 18:08:08.145195|2017-02-18 18:08:08.145195
NCT00028665|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2010-06-09|||June 2000||2000-06-01|June 2010|2010-06-01||||March 2005|Actual|2005-03-01||Interventional|||Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma|Randomized Phase II Trial of B-Lymphocyte Purging of Autologous Peripheral Blood Progenitor Cells in Patients With B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|37|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:08:08.257219|2017-02-18 18:08:08.257219
NCT00028652|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2015-09-30|||January 2002||2002-01-01|September 2015|2015-09-01||||||||Interventional|||Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases|Treament of Spontaneous Tumor Metastases With IL-12 DNA (NSC #709933): A Phase IB Trial|Terminated||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:08:08.377092|2017-02-18 18:08:08.377092
NCT00028639|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2011-07-01||2011-07-01|August 2001||2001-08-01|July 2011|2011-07-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||PS-341 in Treating Women With Metastatic Breast Cancer|A Phase II Study of the Proteasome Inhibitor PS-341 (NSC 681 239) in Patients With Metastatic Breast Cancer|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:08:08.460353|2017-02-18 18:08:08.460353
NCT00028626|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-06-04|||August 2001||2001-08-01|June 2013|2013-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer|Clinical Efficacy And Biologic Effects Of Preoperative Portal Vein Embolization In Patients With Colorectal Liver Metastases|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:08:08.549333|2017-02-18 18:08:08.549333
NCT00028613|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2014-01-08|||March 2001||2001-03-01|January 2014|2014-01-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma|Phase I Safety Study Of 131I-Lym-1 For The Treatment Of Previously Treated Diffuse Large B-Cell Lymphoma|Completed||Phase 1|2|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:08:08.634424|2017-02-18 18:08:08.634424
NCT00028600|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2016-07-01|||November 2001||2001-11-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|June 2006|Actual|2006-06-01||Interventional|||Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma|Autologous Followed By Non-Myeloablative Allogeneic Transplant For Multiple Myeloma|Completed||Phase 2|60|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:08:08.817782|2017-02-18 18:08:08.817782
NCT00028587|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-01-15|||December 2001||2001-12-01|January 2013|2013-01-01||||April 2006|Actual|2006-04-01||Interventional|||PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacologic Study of the Proteasome Inhibitor PS-341 in Combination With Paclitaxel and Carboplatin in Patients With Advanced Malignancies|Completed||Phase 1|96|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:08:08.951563|2017-02-18 18:08:08.951563
NCT00028574|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2016-06-27|||December 2001||2001-12-01|June 2016|2016-06-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer|A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men|Completed||Phase 3|223|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-02-18 18:08:09.06638|2017-02-18 18:08:09.06638
NCT00028561|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-01-16|||October 2001||2001-10-01|January 2013|2013-01-01||||February 2007|Actual|2007-02-01||Interventional|||BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors|A Phase I Study of Epothilone B Analog BMS 247550 in Combination With Carboplatin in Recurrent and/or Refractory Solid Tumors|Terminated||Phase 1|45|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:08:09.540421|2017-02-18 18:08:09.540421
NCT00028522|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-12-13|||December 2001||2001-12-01|December 2013|2013-12-01||||September 2009|Actual|2009-09-01||Interventional|||R(+)XK469 in Treating Patients With Advanced Neuroblastoma|Phase I Study Of R(+)XK469 In Patients With Advanced Neuroblastoma|Completed||Phase 1|85|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:09.857732|2017-02-18 18:08:09.857732
NCT00028509|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2014-02-11|||July 2002||2002-07-01|February 2014|2014-02-01||||July 2011|Actual|2011-07-01||Observational|||Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201|Assessment of Clinical and Neuroradiologic Evidence of Methotrexate Leukoencephalopathy in Children Treated on POG 9605 and 9201|Completed||N/A|66|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-02-18 18:08:09.963721|2017-02-18 18:08:09.963721
NCT00028496|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2013-01-24|||November 2001||2001-11-01|January 2013|2013-01-01||||November 2005|Actual|2005-11-01||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer|Phase I Study of a Recombinant Fowl Pox Vaccine rF-CEA (6D)/TRICOM Alone or With GM-CSF in Patients With Advanced CEA Expressing Adenocarinomas|Completed||Phase 1|48|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:10.085928|2017-02-18 18:08:10.085928
NCT00028483|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2011-10-21|||October 2000||2000-10-01|October 2011|2011-10-01|April 2003|Actual|2003-04-01|||||Interventional|||Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer|A Phase II Study Using SGN-15 (cBR96 - Doxorubicin Immunoconjugate) in Combination With Taxotere for the Treatment of Metastatic or Recurrent Breast Carcinoma|Terminated||Phase 2|||Seattle Genetics, Inc.|||||||||||||||||||2017-02-18 18:08:10.2106|2017-02-18 18:08:10.2106
NCT00028431|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2014-05-20|||August 2001||2001-08-01|May 2014|2014-05-01|June 2005|Actual|2005-06-01|January 2003|Actual|2003-01-01||Interventional|||Novel Adjuvants for Peptide-Based Melanoma Vaccines|An Open Label Study of MDX-CTLA4 in Combination With Tyrosinase/gp100/MART-1 Peptides Emulsified With Montanide ISA 51 in the Treatment of Patients With Resected Stage III or IV Melanoma|Completed||Phase 1|19|Actual|University of Southern California|||||||||||||||||||2017-02-18 18:08:10.298055|2017-02-18 18:08:10.298055
NCT00028418|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2015-03-24|||February 1999||1999-02-01|November 2001|2001-11-01|March 2004||2004-03-01|||||Interventional|||Clofarabine in Chronic Lymphocytic Leukemia|Phase I Study of CL-F-ARA-A in Solid and Hematologic Malignancies|Completed||Phase 1|100||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:08:10.389888|2017-02-18 18:08:10.389888
NCT00028405|ClinicalTrials.gov processed this data on February 17, 2017|2002-01-04|2005-06-23|||November 2001||2001-11-01|March 2003|2003-03-01|December 2002||2002-12-01|||||Interventional|||Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors|A Multicenter Phase I Safety and Tolerability Study of the Oncolux System for Intratumoral Delivery of Non-Coherent Light for the Photoactivation of LS 11 in Patients With Refractory Solid Tumors|Completed||Phase 1|48||Light Sciences LLC|||||||||||||||||||2017-02-18 18:08:10.480472|2017-02-18 18:08:10.480472
NCT00028379|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-27|2008-03-03|||December 2001||2001-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Enhancement of Use-Dependent Plasticity by Somatosensory Stimulation in Chronic Stroke|Enhancement of Use-Dependent Plasticity by Somatosensory Stimulation in Chronic Stroke|Completed||N/A|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:10.611362|2017-02-18 18:08:10.611362
NCT00028366|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-27|2012-08-15||||||August 2012|2012-08-01|July 2005|Actual|2005-07-01|||||Interventional|||Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People|A Randomized, Comparative Study of Lopinavir/Ritonavir Versus GW433908 and Ritonavir Versus Lopinavir/Ritonavir and GW433908 (In Combination With Tenofovir Disoproxil Fumarate and One or Two Nucleoside Reverse Transcriptase Inhibitors) in HIV-1-Infected Subjects With Virologic Treatment Failure|Completed||N/A|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:08:10.695289|2017-02-18 18:08:10.695289
NCT00028353|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-22|2013-11-13|||April 2001||2001-04-01|November 2013|2013-11-01|July 2003||2003-07-01|||||Interventional|||A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)||Completed||Phase 2|500||GTx|||||||||||||||||||2017-02-18 18:08:10.850015|2017-02-18 18:08:10.850015
NCT00028340|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-21|2017-02-15|||December 12, 2001||2001-12-12|February 7, 2017|2017-02-07||||||||Observational|||High-Risk Breast Duct Epithelium|Characterization of High Risk Breast Duct Epithelium by Cytology, Breast Duct Endoscopy, and cDNA Gene Expression Profile|Recruiting||N/A|184|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:10.961051|2017-02-18 18:08:10.961051
NCT00028327|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-20|2011-02-28||||||July 2004|2004-07-01||||July 2004|Actual|2004-07-01||Interventional|||Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care|Randomized Study to Evaluate Immediate Potent Antiretroviral Therapy for HIV-Infected Subjects With CD4 Cell Counts Less Than 350 Cells/mm3 Admitted to Intensive Care Areas With an AIDS-Defining Illness, Pneumonia, or Sepsis|Completed||Phase 3|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:08:11.068063|2017-02-18 18:08:11.068063
NCT00028314|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-20|2013-07-26|||March 2002||2002-03-01|July 2013|2013-07-01|March 2005|Actual|2005-03-01|||||Interventional|||Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients|A Restrictively Randomized, Open-Label, Controlled, Pilot Study of the Effect of a Thymidine Analogue Substitution or Change to a Nucleoside-Sparing Regimen on Peripheral Fat Wasting|Completed||N/A|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:08:11.180032|2017-02-18 18:08:11.180032
NCT00028301|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-20|2010-09-10||2010-09-10|February 2001||2001-02-01|September 2010|2010-09-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)|A Randomized Open-label Study of the Antiviral Efficacy and Safety of Atazanavir Versus Lopinavir/Ritonavir(LPV/RTV), Each in Combination With Two Nucleosides in Subjects Who Have Experienced Virologic Failure With Prior Protease Inhibitor-Containing HAART Regimen(s)|Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:08:11.310209|2017-02-18 18:08:11.310209
NCT00028288|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-19|2012-03-09|||September 2001||2001-09-01|March 2012|2012-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Study of Daclizumab in Patients With Chronic, Persistent Asthma|A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Daclizumab in Patients With Chronic, Persistent Asthma|Completed||Phase 2|120||Facet Biotech|||||f||||||||||||||2017-02-18 18:08:11.50205|2017-02-18 18:08:11.50205
NCT00028275|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-18|2008-03-03|||December 2001||2001-12-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Gamma Interferon Therapy for Chronic Hepatitis C|Pilot Studies of Gamma Interferon Therapy for Chronic Hepatitis C|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:11.605161|2017-02-18 18:08:11.605161
NCT00027391|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-05|2015-03-24|||September 2001||2001-09-01|November 2001|2001-11-01|August 2004||2004-08-01|||||Interventional|||Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)|Clinical Trials of Albuterol and Oxandrolone in FSH Dystrophy|Completed||N/A|160||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:08:24.025079|2017-02-18 18:08:24.025079
NCT00028262|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-17|2016-09-21|2015-01-09||February 2001||2001-02-01|September 2016|2016-09-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis|A Combination Therapy With Cystagon and N-Acetylcysteine for INCL Patients|Completed||Phase 4|10|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 18:08:11.695102|2017-02-18 18:08:11.695102
NCT00028249|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-17|2008-03-03|||December 2001||2001-12-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Process and Outcomes of Pain Management|A Randomized Study Evaluating the Process and Outcomes of the Pain and Palliative Care Team Intervention|Completed||N/A|298||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:12.068718|2017-02-18 18:08:12.068718
NCT00028236|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-17|2017-01-24|||December 10, 2001||2001-12-10|July 25, 2011|2011-07-25|July 25, 2011|Actual|2011-07-25|July 25, 2011|Actual|2011-07-25||Interventional|||Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)|Ex Vivo Retroviral Gene Transfer For Treatment of X-Linked Severe Combined Immunodeficiency (XSCID)|Completed||Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:08:12.142025|2017-02-18 18:08:12.142025
NCT00028210|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-17|2008-03-03|||December 2001||2001-12-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Enhanced Tactile (Touch) Spatial Acuity in Upper Limb Amputees|Enhancement of Tactile Spatial Acuity in Upper Limb Amputees|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:12.232391|2017-02-18 18:08:12.232391
NCT00028197|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-17|2008-03-03|||December 2001||2001-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Comparison of Externally and Self-Initiated Movements|Comparison of Externally and Self-Initiated Movements|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:12.309636|2017-02-18 18:08:12.309636
NCT00028184|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-17|2008-03-03|||December 2001||2001-12-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Observational|||Role of the Intact Hemisphere in Recovery of Motor Function After Stroke|Role of the Intact Hemisphere in Recovery of Motor Function After Stroke|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:12.382916|2017-02-18 18:08:12.382916
NCT00028171|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-17|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing|Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:08:12.460489|2017-02-18 18:08:12.460489
NCT00028158|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-17|2005-06-23|||December 2001||2001-12-01|December 2001|2001-12-01|October 2003||2003-10-01|||||Interventional|||Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer|An Open-Label Phase Ib/II Study of the Safety, Tolerability and Efficacy of G207, a Genetically Engineered Herpes Simplex Type-1 Virus, Administered Intracerebrally to Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|65||MediGene|||||||||||||||||||2017-02-18 18:08:12.529243|2017-02-18 18:08:12.529243
NCT00028145|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-13|2014-10-08|||October 2002||2002-10-01|October 2014|2014-10-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Observational|||Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission|Perinatal Core Protocol|Completed||N/A|3090|Actual|International Maternal Pediatric Adolescent AIDS Clinical Trials Group|||1||f||||t||||||Samples With DNA|"~     Blood and amniotic fluid~   "|||2017-02-18 18:08:12.818631|2017-02-18 18:08:12.818631
NCT00028132|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-13|2012-02-16||||||February 2012|2012-02-01|December 2005|Actual|2005-12-01|||||Interventional|||Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel|Phase I Safety and Acceptability Study of the Vaginal Microbicide Agent PMPA Gel|Completed||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:08:13.045185|2017-02-18 18:08:13.045185
NCT00028119|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-13|2014-08-18|||August 2002||2002-08-01|August 2010|2010-08-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||HIV Incidence and Participation Retention in Pune, India|HPTN HIV Incidence and Participant Retention Protocol, Pune, India|Completed||N/A|1070||HIV Prevention Trials Network|||2||f||||||||||||||2017-02-18 18:08:13.156077|2017-02-18 18:08:13.156077
NCT00028106|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-11|2017-01-24|||December 5, 2001||2001-12-05|August 21, 2008|2008-08-21|January 8, 2007||2007-01-08|||||Interventional|||131MIBG to Treat Malignant Pheochromocytoma|(131)I-Metaiodobenzylguanidine Treatment of Malignant Pheochromocytoma|Completed||Phase 2|32||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:08:13.250221|2017-02-18 18:08:13.250221
NCT00028093|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-11|2013-09-04|2011-05-26||December 2001||2001-12-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|June 2010|Actual|2010-06-01||Interventional|||Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C With and Without Renal Disease|Completed||Phase 4|50|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:08:13.353662|2017-02-18 18:08:13.353662
NCT00028080|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-11|2017-01-24|||November 21, 2001||2001-11-21|December 16, 2016|2016-12-16||||||||Observational|||Evaluation, Treatment, and Follow-up of Patients With Lyme Disease|Evaluation, Treatment and Follow up of Patients With Lyme Disease|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:14.044477|2017-02-18 18:08:14.044477
NCT00028067|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-10|2011-04-28||2011-04-13|August 2001||2001-08-01|April 2011|2011-04-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor|A Phase III Study Comparing the Antiviral Efficacy and Safety of Atazanavir With Nelfinavir: Each in Combination With Dual Nucleoside Therapy in HIV-Infected Subjects Who Have Failed a Regimen Not Containing a Protease Inhibitor|Terminated||Phase 3|500||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:08:14.189053|2017-02-18 18:08:14.189053
NCT00028028|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-02-27|||February 2002||2002-02-01|February 2013|2013-02-01||||January 2007|Actual|2007-01-01||Interventional|||CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Randomized, Phase II ECOG Trial of Two Dose Levels of CCI-779 in Patients With Extensive-Stage Small Cell Lung Cancer Who Have Responding or Stable Disease After Induction Chemotherapy|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:08:14.371351|2017-02-18 18:08:14.371351
NCT00028015|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2010-11-07|||October 2001||2001-10-01|March 2010|2010-03-01||||||||Interventional|||SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer|A Phase II Study of Second-Line SarCNU (NSC 364432) in Patients With Recurrent/Metastatic Colorectal Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:08:14.484649|2017-02-18 18:08:14.484649
NCT00028002|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2014-05-07|2012-11-29||February 2002||2002-02-01|November 2012|2012-11-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor|A Phase II Trial of Neoadjuvant/Adjuvant STI-571 (Gleevec NSC #716051) for Primary and Recurrent Operable Malignant GIST Expressing the KIT Receptor Tyrosine Kinase (CD117)|Completed||Phase 2|63|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:14.596165|2017-02-18 18:08:14.596165
NCT00027989|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-12-17|||December 2001||2001-12-01|April 2004|2004-04-01||||||||Interventional|||Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer|An Open-Label, Single-Arm, Phase II Study of Liposomal Doxorubicin (Doxil) and Gemcitabine in the Treatment of Women With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:14.927907|2017-02-18 18:08:14.927907
NCT00027976|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-08-01|||December 2001||2001-12-01|November 2012|2012-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses|A Phase II/III Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Celecoxib In Subjects With Actinic Keratoses|Withdrawn||Phase 2/Phase 3|0|Actual|University of Alabama at Birmingham||3|||f||||t||||||||||2017-02-18 18:08:15.027585|2017-02-18 18:08:15.027585
NCT00027963|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2016-07-01|||February 2002||2002-02-01|July 2016|2016-07-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy|The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial|Completed||Phase 3|100|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:08:15.147244|2017-02-18 18:08:15.147244
NCT00027937|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2010-05-12|||August 2001||2001-08-01|May 2010|2010-05-01|November 2007|Actual|2007-11-01|||||Interventional|||Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma|A Phase II Study Of Mobilization Chemotherapy With GMCSF And GCSF Followed By High Dose Therapy Combined With IL2 Activated Autologous Peripheral Blood Stem Cells Followed By Sequential IL2 Therapy As Treatment For Solid Tumors And Lymphoma|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:08:15.364712|2017-02-18 18:08:15.364712
NCT00027924|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2010-03-31|||October 2001||2001-10-01|March 2010|2010-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome|Fludarabine And Busulfan As Conditioning For Patients With Chronic Myeloid Leukemia Or Myelodysplastic Syndrome Transplanted With Hematopoietic Stem Cells From HLA-Compatible Related Or Unrelated Donors|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:08:15.475502|2017-02-18 18:08:15.475502
NCT00027911|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-02-13|||April 2001||2001-04-01|February 2013|2013-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma|A Pilot Study of NY-ESO-1 Immunization in Patients With NY-ESO-1/LAGE Antigen Expressing Cancer|Terminated||Phase 1|||Columbia University||||Departure of PI|f||||||||||||||2017-02-18 18:08:15.568715|2017-02-18 18:08:15.568715
NCT00027898|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-02-06|||January 2002||2002-01-01|February 2013|2013-02-01||||January 2006|Actual|2006-01-01||Interventional|||Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I Study of PS-341 (NSC 681239), Carboplatin, and Etoposide in Patients With Advanced Solid Tumors Refractory to Standard Therapy|Completed||Phase 1|27|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:15.658113|2017-02-18 18:08:15.658113
NCT00027885|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-06-14|||November 2001||2001-11-01|June 2013|2013-06-01|August 2010|Actual|2010-08-01|December 2005|Actual|2005-12-01||Interventional|||Phase II Bevacizumab + Tax In Advanced Breast Cancer|A Randomized Phase II Study of Bevacizumab in Combination With Docetaxel in Locally Advanced Breast Cancer|Completed||Phase 2|49|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:08:15.771725|2017-02-18 18:08:15.771725
NCT00027872|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-03-22|||October 2001||2001-10-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|July 2007|Actual|2007-07-01||Interventional|||Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia|A Phase II Study of Farnesyl Transferase Inhibitor R115777 (Zarnestra) (R115777 ( Zarnestra), Tipifarnib, R115777, NSC #702818) in Elderly Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia|Completed||Phase 2|125|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:16.11052|2017-02-18 18:08:16.11052
NCT00027859|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2010-01-26|||May 2003||2003-05-01|January 2010|2010-01-01||||December 2004|Actual|2004-12-01||Interventional|||Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer|A Phase III Randomized Trial for Evaluating Second Line Hormonal Therapy (Ketoconazole/Hydrocortisone) Versus Paclitaxel/Estramustine Combination Chemotherapy on Progression Free Survival in Asymptomatic Patients With a Rising PSA After Hormonal Therapy for Prostate Cancer|Completed||Phase 3|||Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-02-18 18:08:16.221286|2017-02-18 18:08:16.221286
NCT00027846|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2015-03-03|||August 2003||2003-08-01|March 2015|2015-03-01||||January 2010|Actual|2010-01-01||Interventional|||Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma|A Phase II Trial of Conformal Radiation Therapy for Pediatric Patients With Localized Ependymoma, Chemotherapy Prior to Second Surgery for Incompletely Resected Ependymoma and Observation for Completely Resected, Differentiated, Supratentorial Ependymoma|Active, not recruiting||Phase 2|378|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 18:08:19.590442|2017-02-18 18:08:19.590442
NCT00027833|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2014-01-03|||December 2001||2001-12-01|September 2003|2003-09-01||||||||Interventional|||Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer|Pilot Phase II Study of Safety and Immunogenicity of an ALVAC-CEA/B7.1 Vaccine Administered With Chemotherapy, Alone or in Combination With Tetanus Toxoid, as Compared to Chemotherapy Alone, in Patients With Metastatic Colorectal Adenocarcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:20.148068|2017-02-18 18:08:20.148068
NCT00027378|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-04|2013-06-17|2012-02-08||July 2001||2001-07-01|June 2013|2013-06-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|FIDAA||Pharmacological Intervention Project (Fluoxetine)|Pharmacological Intervention Project (Fluoxetine)|Completed||Phase 2|50|Actual|University of Pittsburgh|Limited sample size; efficacy of CBT/MET Therapy|2|||f||||f||||||||||2017-02-18 18:08:24.117462|2017-02-18 18:08:24.117462
NCT00027820|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2016-12-13|||August 2001||2001-08-01|December 2016|2016-12-01||||September 2004|Actual|2004-09-01||Interventional|||Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer|Low-Dose TBI and Fludarabine Followed by Nonmyeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation Using Enhanced Postgrafting Immunosuppression for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial|Active, not recruiting||Phase 1/Phase 2|106|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:08:20.272185|2017-02-18 18:08:20.272185
NCT00027807|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2016-02-15|||October 2001||2001-10-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|September 2010|Actual|2010-09-01||Interventional|||Biological Therapy in Treating Women With Stage IV Breast Cancer|Treatment of Stage IV Breast Cancer With OKT3 x Herceptin Armed Activated T Cells, Low Dose IL-2, And GM-CSF (Phase I Only as of 4-22-09 as Per IRB Approval Date)|Completed||Phase 1|6|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 18:08:20.420895|2017-02-18 18:08:20.420895
NCT00027794|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2012-09-20|||September 2001||2001-09-01|September 2012|2012-09-01||||January 2005|Actual|2005-01-01||Interventional|||Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer|Radical Prostatectomy for Locally Advanced Prostate Cancer. A Feasibility Study|Completed||Phase 2|40|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:08:20.555522|2017-02-18 18:08:20.555522
NCT00027781|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2012-07-23|||August 2001||2001-08-01|July 2012|2012-07-01||||March 2003|Actual|2003-03-01||Interventional|||MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy|Open Label Phase II Study of MEN-10755 Administered Every 3 Weeks in Patients With Progressive Hormone Refractory Prostate Cancer|Completed||Phase 2|37|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:08:20.653842|2017-02-18 18:08:20.653842
NCT00027768|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-09-19|||June 2001||2001-06-01|June 2007|2007-06-01||||||||Interventional|||Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer|Randomised Trial of Adjuvant Hepatic Intra-Arterial Iodine-131-Lipiodol Following Curative Resection of Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:20.758873|2017-02-18 18:08:20.758873
NCT00027742|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-06-04|||May 2001||2001-05-01|June 2013|2013-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma|A Phase II Study of Temozolomide (Temodar) and Peglated Interferon Alfa-2B (PEGIntron) in the Treatment of Advanced Melanoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:08:20.87304|2017-02-18 18:08:20.87304
NCT00027729|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-06-04|||June 2001||2001-06-01|June 2013|2013-06-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer|Phase I/II Study of MEDI-522, A Humanized Monoclonal Antibody Directed Against the Human Alpha V Beta 3 Integrin, in Patients With Irinotecan-Refractory Advanced Colorectal Cancer|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:08:20.963995|2017-02-18 18:08:20.963995
NCT00027716|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-06-04|||October 2001||2001-10-01|June 2013|2013-06-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma|A Multi-Institutional, Open-Label, Two-Group, Phase II Study of PS-341 (LDP-341, NSC #681239) in Patients With Advanced or Metastatic Sarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:08:21.0584|2017-02-18 18:08:21.0584
NCT00027703|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2014-02-10|||October 2001||2001-10-01|December 2012|2012-12-01||||May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma|A Double Blind, Placebo Controlled Randomized Phase II Trial Of Gemcitabine And Cisplatin With Or Without The VEGF Inhibitor Bevacizumab (NSC #704865) In Patients With Malignant Mesotheloma|Completed||Phase 2|106|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:08:21.154862|2017-02-18 18:08:21.154862
NCT00027690|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2015-03-13|||June 2002||2002-06-01|December 2012|2012-12-01|July 2013|Actual|2013-07-01|September 2004|Actual|2004-09-01||Interventional|||Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer|A Phase II Trial of ZD 1839 (IRESSA) (NSC #715055) in the Treatment of Persistent or Recurrent Endometrial Carcinoma|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:21.275996|2017-02-18 18:08:21.275996
NCT00027677|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2012-07-23|||August 2001||2001-08-01|July 2012|2012-07-01||||February 2004|Actual|2004-02-01||Interventional|||Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors|Phase I Study To Determine The Safety Of Halofuginone In Patients With A Solid Progressive Tumor|Completed||Phase 1|25|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:08:21.656582|2017-02-18 18:08:21.656582
NCT00027664|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-08-06|||February 2001||2001-02-01|March 2002|2002-03-01||||||||Interventional|||Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer|Interferon Alpha In Combination With Thalidomide In The Treatment Of Metastatic Renal Cell Carcinoma A Randomized Phase II Study|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:21.748352|2017-02-18 18:08:21.748352
NCT00027638|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-06-17|||March 2001||2001-03-01|June 2013|2013-06-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors|Phase II Trial Of Thalidomide In Patients With Low Grade Neuroendocrine Tumors (Carcinoid and Islet Cell Cancers)|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:08:21.838293|2017-02-18 18:08:21.838293
NCT00027625|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2008-12-13|||January 2002||2002-01-01|September 2003|2003-09-01||||||||Interventional|||Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma|A Phase I Study Of ZD 1839 And Temozolomide For The Treatment Of Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:21.932295|2017-02-18 18:08:21.932295
NCT00027612|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2016-12-05|||July 2002||2002-07-01|December 2016|2016-12-01|July 2009|Actual|2009-07-01|October 2006|Actual|2006-10-01||Interventional|||Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme|Pilot And Phase II Trial Of Irinotecan And Radiation Followed By Irinotecan And BCNU In Glioblastoma Multiforme Patients|Completed||Phase 1/Phase 2|58|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:08:22.042375|2017-02-18 18:08:22.042375
NCT00027599|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2013-02-08|||December 2001||2001-12-01|December 2003|2003-12-01||||July 2007|Actual|2007-07-01||Interventional|||APC8015 and Bevacizumab in Treating Patients With Prostate Cancer|A Phase II Study Of Prostatic Acid Phosphatase-Pulsed Dendritic Cells (Provenge) In Combination With Bevacizumab In Patients With Serologic Progression Of Prostate Cancer After Definitive Local Therapy|Completed||Phase 2|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:22.149051|2017-02-18 18:08:22.149051
NCT00027586|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2012-07-27|||September 2001||2001-09-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Imatinib Mesylate in Treating Patients With Metastatic Melanoma|Phase II Trial of Gleevec (Imatinib Mesylate, STI-571) in Metastatic Melanoma|Completed||Phase 2|22|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:08:22.251065|2017-02-18 18:08:22.251065
NCT00027573|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2016-07-12|||October 2001||2001-10-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer|Adoptive Immunotherapy by Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Carcinoma: A Phase II Study|Completed||Phase 2|36|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:08:22.373623|2017-02-18 18:08:22.373623
NCT00027560|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2012-12-03|2012-11-27||July 2001||2001-07-01|December 2012|2012-12-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer|Phase II Trial Of Non-Myeloablative Regimen Combining Melphalan, Fludarabine, And Anti-CD52 Monoclonal Antibody (CAMPATH-1H) Followed By An Unmodified Hematopoietic Cell Transplant From An HLA Compatible Related Or Unrelated Donor For Treatment Of Lymphohematopoietic Malignancies|Completed||Phase 2|51|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:08:22.507878|2017-02-18 18:08:22.507878
NCT00027547|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2011-11-28|||July 2001||2001-07-01|November 2011|2011-11-01|July 2004|Actual|2004-07-01|||||Interventional|||Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia|Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation From HLA Matched Sibling Donors For Treatment Of Patients With High Risk Acute Lymphocytic Leukemia In Complete Remission|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:08:22.830777|2017-02-18 18:08:22.830777
NCT00027534|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2014-09-04|||January 2002||2002-01-01|September 2014|2014-09-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer|A Phase I Study Of Active Immunotherapy With Autologous Dendritic Cells Infected With CEA-6D Expressing Fowlpox -Tricom In Patients With Advanced Or Metastatic Malignancies Expressing CEA|Completed||Phase 1|14|Actual|Duke University||1|||f||||f||||||||||2017-02-18 18:08:22.933804|2017-02-18 18:08:22.933804
NCT00027521|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2012-09-17|||December 2000||2000-12-01|September 2012|2012-09-01||||||||Interventional|||Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer|Phase I Study: Electroporation Therapy With Bleomycin For The Treatment Of Pancreatic Cancer|Withdrawn||Phase 1|0|Actual|Ichor Medical Systems Incorporated||||Program terminated|f||||||||||||||2017-02-18 18:08:23.059247|2017-02-18 18:08:23.059247
NCT00027508|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2015-02-23|||July 2001||2001-07-01|June 2013|2013-06-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma|Phase II Study Of ET-743 In Patients With Unresectable Malignant Pleural Mesothelioma|Terminated||Phase 2|||PharmaMar||||Enrolment halted prematurely and not resumed. 2 patients enrolled. No data was obtained.|f||||||||||||||2017-02-18 18:08:23.213897|2017-02-18 18:08:23.213897
NCT00027495|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2012-12-19|||December 2001||2001-12-01|December 2012|2012-12-01|September 2007|Actual|2007-09-01|February 2004|Actual|2004-02-01||Interventional|||Curcumin for the Prevention of Colon Cancer|Phase I Pharmacokinetic Trial of Curcuminoids Administered in a Capsule Formulation|Completed||Phase 1|||University of Michigan Cancer Center|||||f||||t||||||||||2017-02-18 18:08:23.302019|2017-02-18 18:08:23.302019
NCT00027482|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2017-01-24|||December 4, 2001||2001-12-04|August 27, 2008|2008-08-27|August 27, 2008||2008-08-27|||||Observational|||Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers|Studies of Specific Immune Responses in HIV-Infected and HIV-Uninfected Volunteers|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:23.39391|2017-02-18 18:08:23.39391
NCT00027469|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2008-03-03|||December 2001||2001-12-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Interventional|||MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal Artery|Evidence of Procedural Embolism Complicating Renal Artery Stenting|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:23.476554|2017-02-18 18:08:23.476554
NCT00027456|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-07|2008-03-03|||November 2001||2001-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Leptin to Treat Severe Insulin Resistance - Pilot Study|Efficacy of Leptin in Severe Insulin Resistance: A Pilot Study|Completed||Phase 2|2||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:23.562388|2017-02-18 18:08:23.562388
NCT00027443|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-05|2015-03-24|||August 2001||2001-08-01|October 2001|2001-10-01|July 2007||2007-07-01|||||Interventional|||Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis|Giant Cell Myocarditis Treatment Trial Pilot Study|Completed||N/A|40|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:08:23.653878|2017-02-18 18:08:23.653878
NCT00027430|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-05|2015-03-24|||September 2001||2001-09-01|November 2001|2001-11-01|December 2004||2004-12-01|||||Interventional|||Androgen Replacement Therapy in Women With Hypopituitarism|TheraDerm Administration in Women With Hypopituitarism|Completed||N/A|50|Anticipated|FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:08:23.739299|2017-02-18 18:08:23.739299
NCT00027417|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-05|2013-08-01|||April 2001||2001-04-01|August 2013|2013-08-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Study of Triostat in Infants During Heart Surgery|Triostat in Children During CardioPulmonary Bypass (CPB)|Completed||Phase 3|195|Actual|Seattle Children's Hospital||2|||f||||t||||||||||2017-02-18 18:08:23.82484|2017-02-18 18:08:23.82484
NCT00027404|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-05|2015-03-24|||September 2001||2001-09-01|November 2002|2002-11-01|August 2005||2005-08-01|||||Interventional|||Study of Fluoxetine in Adults With Autistic Disorder|Fluoxetine vs Placebo in Adult Autistic Disorder|Completed||N/A|48||FDA Office of Orphan Products Development|||||||||||||||||||2017-02-18 18:08:23.92653|2017-02-18 18:08:23.92653
NCT00005248|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1989||1989-08-01|May 2002|2002-05-01|July 1992|Actual|1992-07-01|||||Observational|||Adiposity and Fat Patterning in Black Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.791761|2017-02-18 18:15:17.791761
NCT00027365|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-04|2012-05-03||||||May 2012|2012-05-01|June 2003|Actual|2003-06-01|||||Interventional|||An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV|A Phase I Safety and Immunogenicity Trial of a Combination Vaccine (NefTat and gp120w61d) Formulated With AS02A (GlaxoSmithKline Biologicals) Given Intramuscularly in HIV-1 Uninfected Adult Participants|Completed||Phase 1|84||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:08:24.795514|2017-02-18 18:08:24.795514
NCT00027352|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-04|2009-11-24||||||December 2008|2008-12-01||||||||Observational|||A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)|A Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)|Completed||N/A|6000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:08:24.93401|2017-02-18 18:08:24.93401
NCT00027339|ClinicalTrials.gov processed this data on February 17, 2017|2001-12-04|2012-05-17||||||May 2012|2012-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV|A Phase II Study of the Predictive Value of Pharmacokinetic-Adjusted Phenotypic Susceptibility (C12h/IC50) on Antiretroviral Response to Ritonavir-Enhanced Protease Inhibitors in Subjects With Failure of Previous Protease Inhibitor-Based Regimens|Completed||Phase 2|53|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:08:25.257325|2017-02-18 18:08:25.257325
NCT00027326|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2017-01-24|||December 5, 2001||2001-12-05|December 30, 2016|2016-12-30||||||||Observational|||Collection of Blood and Urine From Patients Undergoing Radiation Therapy|Collection of Peripheral Blood and/or Urine From Patients Undergoing Radiation Therapy|Recruiting||N/A|450|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:25.373723|2017-02-18 18:08:25.373723
NCT00027300|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-30|2017-01-05|||November 2001||2001-11-01|January 2017|2017-01-01|January 2005|Actual|2005-01-01|November 2004|Actual|2004-11-01||Interventional|||Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis|A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Natalizumab in Subjects With Relapsing-Remitting Multiple Sclerosis|Completed||Phase 3|900|Actual|Biogen||2|||f||||t||||||||||2017-02-18 18:08:25.482626|2017-02-18 18:08:25.482626
NCT00027287|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-29|2008-03-03|||November 2001||2001-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Laser and Medical Treatment of Diabetic Macular Edema|Preliminary Assessment of Laser and Medical Treatment of Diabetic Macular Edema|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:25.650974|2017-02-18 18:08:25.650974
NCT00027274|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-29|2017-02-14|||November 28, 2001||2001-11-28|February 8, 2017|2017-02-08||||||||Observational|||Cancer in Inherited Bone Marrow Failure Syndromes|Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:25.743493|2017-02-18 18:08:25.743493
NCT00027261|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-29|2012-05-15||||||May 2012|2012-05-01|December 2005|Actual|2005-12-01|||||Interventional|||Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults|A Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of High-Dose Live Recombinant Canarypox ALVAC-HIV Vaccine (vCP1452) in Healthy, HIV-1 Uninfected Adult Participants|Completed||Phase 1|110|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:08:25.858266|2017-02-18 18:08:25.858266
NCT00027248|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-29|2005-09-12|||September 2000||2000-09-01|September 2005|2005-09-01|July 2003||2003-07-01|||||Interventional|||Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections|Phase III, Randomized, Open-Label Study to Assess the Safety and Efficacy of Topical Administration of MBI 226 1.0% Gel Versus Standard Medical Care in Patients Undergoing Non-Cuffed, Short-Term Arterial and/or Central Venous Catheterization|Completed||Phase 3|1400||BioWest Therapeutics Inc|||||||||||||||||||2017-02-18 18:08:25.973963|2017-02-18 18:08:25.973963
NCT00027235|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-28|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Popcorn Lung: the Discovery of a New Disease|Popcorn Lung: the Discovery of a New Disease|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:08:26.070393|2017-02-18 18:08:26.070393
NCT00027222|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-28|2005-06-23|||October 2001||2001-10-01|December 2003|2003-12-01||||||||Interventional|||The Early Treatment for Retinopathy of Prematurity Study (ETROP)|The Early Treatment for Retinopathy of Prematurity Study (ETROP)|Unknown status|Active, not recruiting|Phase 2/Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:08:26.133162|2017-02-18 18:08:26.133162
NCT00027209|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-28|2006-05-12||||||November 2005|2005-11-01||||||||Interventional|||Hormone Replacement in Menopausal Women With Epilepsy||Completed||Phase 2|125||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:08:26.505641|2017-02-18 18:08:26.505641
NCT00027196|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-27|2008-03-03|||April 1998||1998-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease|Clinical Correlates of Molecular Defects in Familial Cardiomyopathy|Completed||N/A|9999999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:26.598247|2017-02-18 18:08:26.598247
NCT00027183|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-27|2017-01-24|||February 4, 1998||1998-02-04|August 15, 2016|2016-08-15||||||||Observational|||Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa|Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa|Recruiting||N/A|225|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:26.683365|2017-02-18 18:08:26.683365
NCT00027170|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-27|2017-01-24|||November 16, 2001||2001-11-16|December 27, 2016|2016-12-27||||||||Observational|||Technical Development of Cardiovascular Magnetic Resonance Imaging|Technical Development of Cardiovascular Magnetic Resonance Imaging|Recruiting||N/A|8325|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:26.787054|2017-02-18 18:08:26.787054
NCT00027157|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-27|2008-03-03|||April 2000||2000-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Determination of Variances in Exhaled Nitric Oxide Output in Normal Healthy Male Volunteers Consuming High and Low Nitrate/Nitrite Diets|The Determination of Variances in Exhaled Nitric Oxide Output in Normal Healthy Male Volunteers Consuming High and Low Nitrate/Nitrite Diets|Completed||N/A|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:26.898903|2017-02-18 18:08:26.898903
NCT00027144|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-27|2005-06-23|||December 2000||2000-12-01|November 2001|2001-11-01|October 2002||2002-10-01|||||Interventional|||Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase|A Feasibility and Toxicity Study of Vaccination With HSP70 for the Treatment of Chronic Myelogenous Leukemia in the Chronic Phase|Completed||Phase 1|10||UConn Health|||||||||||||||||||2017-02-18 18:08:26.977091|2017-02-18 18:08:26.977091
NCT00027131|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-27|2008-10-07|||December 2000||2000-12-01|October 2008|2008-10-01|October 2002||2002-10-01|||||Interventional|||Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70|Vaccination Against High Risk Breast Cancer With Autologous Tumor-Derived Heat Shock Protein 70-Peptide Complexes (HSP70)|Terminated||Phase 1/Phase 2|15||UConn Health||||difficulty with accrual|||||||||||||||2017-02-18 18:08:27.064113|2017-02-18 18:08:27.064113
NCT00027118|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-20|2017-01-24|||November 16, 2001||2001-11-16|August 17, 2016|2016-08-17|August 17, 2016||2016-08-17|||||Observational|||Morbidity After Diagnosis and Treatment of Breast Cancer Patients|A Prospective (Cohort) Study to Identify Factors Affecting Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer: A Multi-Institutional Study Between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the Walter Reed National Military Medical Center (WRNMMC) Breast Care Center (BCC)|Completed||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:27.162347|2017-02-18 18:08:27.162347
NCT00027105|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-20|2017-01-24|||November 16, 2001||2001-11-16|August 17, 2016|2016-08-17|August 17, 2016||2016-08-17|||||Observational|||Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer|Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer: A Multi-Institutional Study Between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the Walter Reed National Military Medical Center (WRNMMC) Breast Care Center|Completed||N/A|165|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:27.25725|2017-02-18 18:08:27.25725
NCT00027092|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-20|2008-08-06||||||February 2004|2004-02-01||||||||Observational|||Use of a Test That Evaluates How the Body Handles Insulin and Glucose|AACTG Modified Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT) for the Assessment of Insulin Sensitivity: A Substudy of A5079|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:08:27.352218|2017-02-18 18:08:27.352218
NCT00027079|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-20|2007-12-07|||September 2001||2001-09-01|December 2007|2007-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)||Completed||Phase 2|360||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:08:27.44603|2017-02-18 18:08:27.44603
NCT00027066|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-20|2011-06-16|||June 1993||1993-06-01|June 2011|2011-06-01|November 2001|Actual|2001-11-01|June 2000|Actual|2000-06-01||Interventional|||Warfarin Versus Aspirin Recurrent Stroke Study|A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke|Completed||Phase 3|2206||Columbia University||2|||f||||f||||||||||2017-02-18 18:08:27.521662|2017-02-18 18:08:27.521662
NCT00027053|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-19|2010-05-11|||June 2002||2002-06-01|March 2006|2006-03-01|June 2006|Actual|2006-06-01|January 2006|Actual|2006-01-01||Interventional|SIESTA||Trazodone for Sleep Disturbance in Early Alcohol Recovery|Trazodone for Sleep Disturbance - Early Alcohol Recovery|Completed||Phase 2|173|Actual|Rhode Island Hospital||2|||f||||f||||||||||2017-02-18 18:08:27.631712|2017-02-18 18:08:27.631712
NCT00027040|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-16|2015-01-15||||||October 2012|2012-10-01|June 2005|Actual|2005-06-01|||||Interventional|||A Study of Decreased Mental Function Associated With HIV|HIV-Associated Cognitive Impairment and Oxidative Stress: An In Vivo Proton Magnetic Resonance Spectroscopy Study of Cerebral Injury|Completed||N/A|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:08:27.736294|2017-02-18 18:08:27.736294
NCT00027027|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-15|2015-07-24|2015-06-26||November 2001||2001-11-01|July 2015|2015-07-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional||The baseline analysis population included all participants that were enrolled into one of the 5 treatment groups.|Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors|A Phase I, Open-Label, Multicenter, Dose-Escalation Study of the Safety and Pharmacokinetics of a Recombinant Humanized Antibody to Her2 (rhuMAb 2C4) Administered Every 3 Weeks to Subjects With Advanced Solid Malignancies|Completed||Phase 1|21|Actual|Genentech, Inc.||5|||f||||||||||||||2017-02-18 18:08:27.853674|2017-02-18 18:08:27.853674
NCT00027014|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-15|2007-02-07|||September 2001||2001-09-01|July 2006|2006-07-01|May 2005||2005-05-01|||||Interventional|||Herb-Opioid Interactions|Herb-Opioid Interactions|Completed||Phase 4|54||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:29.179984|2017-02-18 18:08:29.179984
NCT00027001|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-15|2006-08-17|||September 2000||2000-09-01|July 2006|2006-07-01|June 2003||2003-06-01|||||Interventional|||Qigong Therapy For Heart Device Patients|Qigong Therapy for Heart Device Patients|Completed||N/A|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:29.263297|2017-02-18 18:08:29.263297
NCT00026988|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-15|2006-08-17|||October 2001||2001-10-01|July 2006|2006-07-01|June 2006||2006-06-01|||||Interventional|||Creatine Therapy for Huntington's Disease|Creatine Therapy for Huntington's Disease|Completed||Phase 1/Phase 2|64||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:29.341747|2017-02-18 18:08:29.341747
NCT00026975|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-15|2006-08-17|||September 2000||2000-09-01|August 2006|2006-08-01|August 2005||2005-08-01|||||Interventional|||Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients|Clinical Outcomes Modeling for Laryngectomy Surgery Patients and Efficacy of Hyperbaric Oxygen Therapy|Completed||Phase 2|150||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:29.42676|2017-02-18 18:08:29.42676
NCT00026962|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||September 1999||1999-09-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Effects of Raloxifene on Hormone Levels|Assessment of the Effects of Raloxifene on Salivary Estradiol and Progesterone Levels|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:29.507395|2017-02-18 18:08:29.507395
NCT00026949|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||August 1999||1999-08-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Study of Etoposide in Breast Cancer Patients|Pharmacokinetics of Etoposide in Patients With Breast Cancer Receiving High-Dose Etoposide|Completed||N/A|33||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:29.596454|2017-02-18 18:08:29.596454
NCT00026936|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||May 1999||1999-05-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning|A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning|Completed||Phase 2|140||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:29.675475|2017-02-18 18:08:29.675475
NCT00026923|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||January 1999||1999-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||A Phase II Evaluation of Telesurgery Systems|A Phase II Evaluation of Telesurgery Systems|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:29.760412|2017-02-18 18:08:29.760412
NCT00026910|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||July 1998||1998-07-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma|Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.096481|2017-02-18 18:08:30.096481
NCT00026897|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||December 1997||1997-12-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer|Trafficking of Indium-111-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.176888|2017-02-18 18:08:30.176888
NCT00026884|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||July 10, 1997||1997-07-10|November 8, 2016|2016-11-08||||||||Observational|||Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease|Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.257955|2017-02-18 18:08:30.257955
NCT00026871|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||July 1997||1997-07-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System|Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.366109|2017-02-18 18:08:30.366109
NCT00026858|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||October 1994||1994-10-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Interventional|||Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts|Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.445798|2017-02-18 18:08:30.445798
NCT00026832|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||October 4, 2001||2001-10-04|November 27, 2012|2012-11-27|November 27, 2012||2012-11-27|||||Observational|||Examination of Brain Serotonin Receptors in Patients With Mood Disorders|Serotonin1A Receptor and Serotonin Transporter Imaging In Mood Disorders|Completed||N/A|214|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.536153|2017-02-18 18:08:30.536153
NCT00026819|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||November 2001||2001-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction|Pre-Emptive Analgesic Effects of a Selective COX-2 Inhibitor (Rofecoxib) in the Oral Surgery Model|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.63552|2017-02-18 18:08:30.63552
NCT00026806|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||July 2001||2001-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Long-Term Survival With HIV: Psychological and Behavioral Factors Associated With the Transition From Adolescence to Young Adulthood|Long-Term Survival With HIV: A Study of the Psychological and Behavioral Factors Associated With the Transition From Adolescence To Young Adulthood|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.735719|2017-02-18 18:08:30.735719
NCT00026793|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||April 23, 2001||2001-04-23|September 23, 2016|2016-09-23||||||||Observational|||Assessment of Blood Vessel Density in Kaposi s Sarcoma Lesions|Protocol to Assess Vascularity in Kaposi's Sarcoma Lesions Utilizing Non-Invasive Imaging Techniques|Enrolling by invitation||N/A|29|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.846526|2017-02-18 18:08:30.846526
NCT00026780|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-02-10|||April 18, 2001||2001-04-18|December 5, 2016|2016-12-05||||||||Observational|||Eligibility Screening for a NCI Pediatric Oncology Branch Research Study|Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols|Enrolling by invitation||N/A|1416|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:30.957646|2017-02-18 18:08:30.957646
NCT00026767|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||April 9, 2001||2001-04-09|July 17, 2012|2012-07-17|July 17, 2012||2012-07-17|||||Observational|||Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients|Surveillance of Invasive Fungal Infections in Bone Marrow/Stem Cell and Solid Organ Transplantation Recipients and Other Immunocompromised Patients: A Prospective Study|Completed||N/A|217|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.069583|2017-02-18 18:08:31.069583
NCT00026754|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||March 21, 2001||2001-03-21|November 1, 2016|2016-11-01||||||||Observational|||Screening Patients for NCI Protocol Eligibility|Eligibility Screening and Tissue Procurement for the National Cancer Institute Center for Cancer Research Clinical Protocols|Recruiting||N/A|15000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.151899|2017-02-18 18:08:31.151899
NCT00026741|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||March 2001||2001-03-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Research in Skin Inflammation|Expression of Chemokine and Chemokine Receptors in Skin in a Model of Delayed-Type Hypersensitivity|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.254417|2017-02-18 18:08:31.254417
NCT00026728|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||February 2001||2001-02-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States|The Seroprevalence of Kaposi's Sarcoma Herpesvirus in the United States|Completed||N/A|20169||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.339926|2017-02-18 18:08:31.339926
NCT00026715|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||June 2000||2000-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Evaluation of New Test Method to Measure Kidney Function|Validation of Fast Methods to Measure Glomerular Filtration Rate|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.424054|2017-02-18 18:08:31.424054
NCT00026702|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||April 6, 2000||2000-04-06|August 24, 2016|2016-08-24||||||||Observational|||Search for New Methods to Detect Acute Renal Failure|Search for Novel Methods to Detect Acute Renal Failure|Recruiting||N/A|640|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.515066|2017-02-18 18:08:31.515066
NCT00026689|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||July 24, 2000||2000-07-24|November 10, 2016|2016-11-10||||||||Observational|||Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols|Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.626497|2017-02-18 18:08:31.626497
NCT00026676|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2008-03-03|||May 2000||2000-05-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine|Retrospective Analysis of HIV-1 RNA Levels in Pediatric HIV-Infected Patients Treated With Didanosine|Completed||N/A|82||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.73824|2017-02-18 18:08:31.73824
NCT00026663|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||February 11, 2000||2000-02-11|September 23, 2016|2016-09-23||||||||Observational|||Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance|Collection of Blood, Fluid, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer or Normal Volunteers|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.823276|2017-02-18 18:08:31.823276
NCT00026650|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-24|||February 4, 2000||2000-02-04|November 30, 2016|2016-11-30||||||||Observational|||Follow Up of Patients Treated With Radiotherapy|Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:31.933867|2017-02-18 18:08:31.933867
NCT00026637|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-14|2017-01-18|||August 2001||2001-08-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||Depression and Health Outcomes in Refractory Epilepsy|Depression and Health Outcomes in Refractory Epilepsy|Terminated||Phase 3|140|Actual|Columbia University||2||The PI left Columbia in 2008. No research related activity has taken place since then.|f||||t|t|f|||f|||No||2017-02-18 18:08:32.046135|2017-02-18 18:08:32.046135
NCT00026624|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-12|2012-05-16||||||May 2012|2012-05-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC|A Phase I/II Study to Evaluate the Safety and Immunogenicity of the Subcutaneous Administration of ALVAC-HIV vCP1452 Infected Autologous Dendritic Cells Versus the Subcutaneous Administration of ALVAC-HIV vCP1452 To HIV-Infected Subjects|Completed||Phase 1|||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:08:32.170026|2017-02-18 18:08:32.170026
NCT00026611|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-12|2010-08-26||||||March 2010|2010-03-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults|A Multicenter, Double-Blind, Randomized Dose-Response Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults|Completed||Phase 2|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:08:32.267302|2017-02-18 18:08:32.267302
NCT00026598|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-10|2008-03-03|||October 2001||2001-10-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease|Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:32.355117|2017-02-18 18:08:32.355117
NCT00026585|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-10|2017-01-24|||November 9, 2001||2001-11-09|May 20, 2008|2008-05-20|November 2, 2007||2007-11-02|||||Interventional|||Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder|A Double-Blind Study Examining the Efficacy of the Protein Kinase C Inhibitor Tamoxifen in the Treatment of Acute Mania|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:32.434154|2017-02-18 18:08:32.434154
NCT00026559|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-10|2017-02-07|||June 26, 2001||2001-06-26|January 25, 2017|2017-01-25||||||||Observational|||Effects of Arousal and Stress in Anxiety|Effects of Arousal and Stress on Classical Conditioning|Recruiting||N/A|1427|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:32.525703|2017-02-18 18:08:32.525703
NCT00026546|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2017-01-24|||November 5, 2001||2001-11-05|June 2, 2016|2016-06-02||||||||Observational|||Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers|A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control|Completed||N/A|189|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:32.632625|2017-02-18 18:08:32.632625
NCT00026533|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2011-07-07|||June 2001||2001-06-01|July 2011|2011-07-01|December 2005|Actual|2005-12-01|November 2003|Actual|2003-11-01||Interventional|||Thalidomide in Treating Patients With Thyroid Cancer|Phase II Trial of Thalidomide for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas and Medullary Thyroid Carcinomas|Completed||Phase 2|||University of Kentucky|||||f||||f||||||||||2017-02-18 18:08:32.7321|2017-02-18 18:08:32.7321
NCT00026520|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-06-20|||November 2001||2001-11-01|April 2003|2003-04-01|April 2006|Actual|2006-04-01|||||Interventional|||Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma|Evaluation of Interferon Alpha-2b and Thalidomide in Patients With Disseminated Malignant Melanoma, Phase II|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:32.829918|2017-02-18 18:08:32.829918
NCT00026494|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2015-12-15|2015-12-15||July 2001||2001-07-01|December 2015|2015-12-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Interventional|||Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases|A Phase I/II Trial Of Temozolomide And Vinorelbine For Patients With Recurrent Brain Metastases|Completed||Phase 1/Phase 2|49|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:08:33.137446|2017-02-18 18:08:33.137446
NCT00026468|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-07-23|||July 1999||1999-07-01|July 2013|2013-07-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Interventional|||Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis|Chemoprevention of Duodenal Polyps in Familial Adenomatous Polyposis|Withdrawn||Phase 2/Phase 3|0|Actual|University of Utah||1||Principle Investigator has left the University.|f||||||||||||||2017-02-18 18:08:33.886171|2017-02-18 18:08:33.886171
NCT00026442|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-12-17|||November 2001||2001-11-01|April 2004|2004-04-01||||||||Interventional|||Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer|A Pilot Trial Of Two Different Doses Of Capecitabine (XELODA) In Patients With Advanced And/Or Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:33.978164|2017-02-18 18:08:33.978164
NCT00026429|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-12-17|||January 2001||2001-01-01|February 2002|2002-02-01||||||||Interventional|||Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma|A Multicenter Phase II Evaluation Of ONTAK (DENILEUKINDIFTITOX) In Patients With Low Or Intermediate Grade-B-Cell Non-Hodgkin's Lymphoma Who Have Been Treated Previously With A Monoclonal Antibody Or Who Are Not Candidates For Monoclonal Antibody Therapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:34.090459|2017-02-18 18:08:34.090459
NCT00026416|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2014-01-03|||October 2001||2001-10-01|October 2003|2003-10-01||||||||Interventional|||Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma|Phase II Study of Low-Dose Interferon Alfa 2B (Schering Plough) Plus Thalidomide (Celgene) for Patients With Resected High-Risk Soft Tissue Sarcoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:34.391779|2017-02-18 18:08:34.391779
NCT00026403|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2016-07-12|||September 2001||2001-09-01|July 2016|2016-07-01|July 2009|Actual|2009-07-01|June 2007|Actual|2007-06-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer|A Phase II Study of Gemcitabine, Cisplatin and Radiation Therapy in Patients With Locally Advanced Pancreatic Cancer|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:08:34.49503|2017-02-18 18:08:34.49503
NCT00026377|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-09-04|||November 2001||2001-11-01|September 2013|2013-09-01|April 2003|Actual|2003-04-01|March 2002|Actual|2002-03-01||Interventional|||SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer|A Phase I Study Of SU5416 With Androgen Ablation And Radiation In Patients With Intermediate and Advanced Stage Prostate Cancer|Completed||Phase 1|3|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:08:34.651246|2017-02-18 18:08:34.651246
NCT00026364|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-03-19|||November 2001||2001-11-01|September 2002|2002-09-01||||December 2006|Actual|2006-12-01||Interventional|||ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer|A Phase I Study Of ZD1839 (Iressa) In Combination With Irinotecan, Leucovorin, And 5-Fluorouracil In Previously Untreated, Stage IV Colorectal Cancer|Completed||Phase 1|22|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:34.765695|2017-02-18 18:08:34.765695
NCT00026351|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-02-01|||December 2000||2000-12-01|July 2002|2002-07-01|June 2003|Actual|2003-06-01|||||Interventional|||Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Phase II Multicenter Trial Of Pentostatin and Rituximab In Patients With Previously Treated and Untreated Low Grade B-Cell Non-Hodgkin's Lymphoma (NHL) Including Chronic Lymphocytic Leukemia (CLL)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:34.885061|2017-02-18 18:08:34.885061
NCT00026338|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2011-09-28|||August 2001||2001-08-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|September 2004|Actual|2004-09-01||Interventional|||Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer|A Randomized Placebo Controlled Study Of OSI-774 (TARCEVA) Plus Gemcitabine In Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer|Completed||Phase 3|569|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:08:34.998843|2017-02-18 18:08:34.998843
NCT00026312|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2016-12-01|||October 2001||2001-10-01|November 2016|2016-11-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma|Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue|Completed||Phase 3|1449|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 18:08:35.331713|2017-02-18 18:08:35.331713
NCT00026299|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-09-04|||September 2001||2001-09-01|September 2013|2013-09-01|February 2005|Actual|2005-02-01|December 2002|Actual|2002-12-01||Interventional|||Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer|A Phase I/ Randomized Phase II Trial Of Oxaliplatin (NSC #266046) With Or Without ZD 1839 (NSC # 715055) In Patients With Advanced Colorectal Carcinoma|Completed||Phase 1/Phase 2|14|Actual|University of Chicago||3|||f||||f||||||||||2017-02-18 18:08:35.767905|2017-02-18 18:08:35.767905
NCT00026286|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2009-05-09|||September 2000||2000-09-01|March 2008|2008-03-01||||August 2002|Actual|2002-08-01||Interventional|||Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer|A Phase III Prospective, Randomized, Double-Blind Clinical Trial of Hormone Replacement Therapy In Postmenopausal Women With A History Of Node-Negative Or Ductal Carcinoma In Situ Who Are Receiving Adjuvant Tamoxifen|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:35.920858|2017-02-18 18:08:35.920858
NCT00026273|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2012-08-06|||January 2001||2001-01-01|August 2012|2012-08-01||||September 2004|Actual|2004-09-01||Interventional|||Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer|Multicenter Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone As Adjuvant Treatment Of Stage III Colon Cancer|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 18:08:36.0371|2017-02-18 18:08:36.0371
NCT00026260|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-06-20||||||June 2007|2007-06-01|October 2003|Actual|2003-10-01|||||Interventional|||SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer|A Phase II Evaluation of SU5416 (NSC 696819) in Persistent or Recurrent Squamous Cell Carcinoma of the Cervix|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:36.155254|2017-02-18 18:08:36.155254
NCT00026247|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2011-04-07|||November 2001||2001-11-01|March 2006|2006-03-01||||February 2011|Actual|2011-02-01||Interventional|||Radiofrequency Ablation in Treating Patients With Bone Metastases|A Phase I/II Study of Percutaneous Radiofrequency Ablation of Bone Metastases Using CT Guidance|Completed||Phase 1/Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:36.235435|2017-02-18 18:08:36.235435
NCT00026234|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-07-15|||February 2002||2002-02-01|June 2013|2013-06-01||||January 2006|Actual|2006-01-01||Interventional|||Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver|A Phase II Trial Evaluating Multiple Metastasectomy Combined With Hepatic Artery Infusion Of Floxuridine (FUDR) And Dexamethasone (DXM), Alternating With Systemic Oxaliplatin (OXAL) And Capecitabine (CAPCIT) For Colorectal Carcinoma Metastatic To The Liver|Completed||Phase 2|75|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:36.335482|2017-02-18 18:08:36.335482
NCT00026221|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2016-02-18|2015-12-16||November 2001||2001-11-01|February 2016|2016-02-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma|A Phase 2 Study of Bevacizumab and Interferon-Alpha-2b in Metastatic Malignant Melanoma|Completed||Phase 2|57|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:08:36.455707|2017-02-18 18:08:36.455707
NCT00005247|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1989||1989-08-01|May 2000|2000-05-01|July 1992|Actual|1992-07-01|||||Observational|||Nutritional Determinants of Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.860851|2017-02-18 18:15:17.860851
NCT00026208|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2016-11-22|||June 2001||2001-06-01|November 2016|2016-11-01|March 2017|Anticipated|2017-03-01|March 2017|Anticipated|2017-03-01||Interventional|||Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma|Risk Adapted Stanford V-C With Radiotherapy for Clinical Stage I and IIA Favorable Hodgkin's Disease: The G5 Study|Active, not recruiting||Phase 2|80|Anticipated|Stanford University||1|||f||||||||||||||2017-02-18 18:08:36.984726|2017-02-18 18:08:36.984726
NCT00026195|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2016-07-01|||September 2001||2001-09-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Irinotecan in Treating Aging Patients With Solid Tumors|Clinical Pharmacology In The Elderly: Prospective Evaluation Of The Pharmacokinetics, Pharmacogenetics And Pharmacodynamics Of CPT-11 And Aging|Completed||Phase 1|140|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:08:37.090556|2017-02-18 18:08:37.090556
NCT00026182|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-08-23|||October 2001||2001-10-01|August 2013|2013-08-01||||February 2005|Actual|2005-02-01||Interventional|||Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma|Randomized Phase II Study Of Interleukin-12 In Combination With Rituximab In Patients With Non-Hodgkin's Lymphoma|Completed||Phase 2|99|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:08:40.201436|2017-02-18 18:08:40.201436
NCT00026169|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-01-09|||September 2001||2001-09-01|January 2013|2013-01-01||||April 2005|Actual|2005-04-01||Interventional|||Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure|A Phase I Pharmacokinetic Study of STI571 in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction for the CTEP-Sponsored Organ Dysfunction Working Group|Completed||Phase 1|69|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:40.319136|2017-02-18 18:08:40.319136
NCT00026156|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-02-12|||November 2001||2001-11-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|July 2004|Actual|2004-07-01||Interventional|||S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer|Phase II Trial of Sequential Vinorelbine and Docetaxel in Advanced Non-Small Cell Lung Cancer Patients Age Seventy and Older, or With Performance Status 2|Completed||Phase 2|125|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:08:40.436323|2017-02-18 18:08:40.436323
NCT00026143|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-06-04|||October 2001||2001-10-01|June 2013|2013-06-01||||July 2004|Actual|2004-07-01||Interventional|||Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma|Phase II Trial of Interleukin-12 (NSC #672423, IND #6798) Followed by Interferon Alfa-2B in Patients With Metastatic Malignant Melanoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:40.896576|2017-02-18 18:08:40.896576
NCT00026130|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2016-07-15|||September 2001||2001-09-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer|A Phase II Trial of Gemcitabine, 5-Fluorouracil and Radiation Therapy in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|81|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:08:41.012801|2017-02-18 18:08:41.012801
NCT00026117|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2016-07-12|||August 2001||2001-08-01|July 2016|2016-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer|Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer|Completed||Phase 3|88|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:08:41.214566|2017-02-18 18:08:41.214566
NCT00026104|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-06-05|||November 2001||2001-11-01|June 2013|2013-06-01||||August 2006|Actual|2006-08-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer|A Randomized Phase II Trial of Weekly Gemcitabine, Paclitaxel and External Irradiation (50.4 GY) Followed by the Farnesyl Transferase Inhibitor R115777 (NSC #702818) for Locally Advanced Pancreatic Cancer|Completed||Phase 2|154|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:08:41.335467|2017-02-18 18:08:41.335467
NCT00026091|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-03-22|||September 2001||2001-09-01|February 2013|2013-02-01||||March 2004|Actual|2004-03-01||Interventional|||Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer|Phase II Trial of Fenretinide (NSC 374551) in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:41.455633|2017-02-18 18:08:41.455633
NCT00026078|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2013-08-06|||March 2001||2001-03-01|November 2006|2006-11-01||||||||Interventional|||Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer|Docetaxel (DTX) - Ifosfamide (IFX) As First Line Chemotherapy In Metastatic Breast Cancer|Unknown status|Recruiting|Phase 2|42|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:41.562394|2017-02-18 18:08:41.562394
NCT00026065|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-09|2007-09-28|||February 2000||2000-02-01|August 2006|2006-08-01|March 2006||2006-03-01|||||Interventional|||Hypertension: Prediction of Biofeedback Success|Hypertension: Prediction of Biofeedback Success|Completed||Phase 1|60||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:41.667319|2017-02-18 18:08:41.667319
NCT00026052|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-08|2008-03-03|||November 2001||2001-11-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Riluzole to Treat Major Depression|An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent With Neurotrophic Properties in Major Depression|Completed||Phase 2|31||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:41.763006|2017-02-18 18:08:41.763006
NCT00026039|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-07|2006-05-12|||December 1993||1993-12-01|November 2005|2005-11-01||||||||Interventional|||Women's Estrogen for Stroke Trial (WEST)||Completed||Phase 3|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:08:41.851515|2017-02-18 18:08:41.851515
NCT00026026|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-06|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Linkage and Identification of (a) Candidate Gene(s) for Tooth Disorders|Linkage and Identification of (a) Candidate Gene(s) for Tooth Disorders|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:08:41.943211|2017-02-18 18:08:41.943211
NCT00026013|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-05|2006-08-17|||January 2002||2002-01-01|July 2006|2006-07-01|January 2004||2004-01-01|||||Interventional|||Effects of St. John's Wort on the Effectiveness of Oral Contraceptives|Effects of Hypericum Perforatum on Effectiveness of Oral Contraceptives|Completed||N/A|25||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:08:42.289251|2017-02-18 18:08:42.289251
NCT00026000|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-02|2008-03-03|||November 2001||2001-11-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Brain Activation in Vocal and Motor Tics|Brain Activation in Motor and Vocal Tics in Patients With Tourette's Syndrome or Chronic Motor or Vocal Tic Disorder Using Blood Oxygenation Level Dependent Functional MRI|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:42.376274|2017-02-18 18:08:42.376274
NCT00025987|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-02|2008-03-03|||November 2001||2001-11-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Temperature Response to a Head-Neck Cooling System|Thermal Responses In Normal Volunteers To Head-Neck Cooling|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:42.459234|2017-02-18 18:08:42.459234
NCT00025974|ClinicalTrials.gov processed this data on February 17, 2017|2001-11-02|2017-01-24|||October 31, 2001||2001-10-31|July 21, 2008|2008-07-21|July 21, 2008||2008-07-21|||||Observational|||Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder|Serotonin 1A Receptor Imaging and Benzodiazepine Receptor Imaging in Panic Disorder and Posttraumatic Stress Disorder|Completed||N/A|230||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:42.544824|2017-02-18 18:08:42.544824
NCT00025935|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-31|2017-02-02|||October 29, 2001||2001-10-29|January 13, 2017|2017-01-13||||||||Observational|||Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder|Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth|Recruiting||N/A|1350|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:42.635626|2017-02-18 18:08:42.635626
NCT00025922|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-31|2008-03-03|||October 2001||2001-10-01|October 2003|2003-10-01|October 2003||2003-10-01|||||Observational|||Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load|Influenza Vaccine in HIV Infection: Immunologic Responses and Effect on HIV Viral Load|Completed||N/A|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:42.748315|2017-02-18 18:08:42.748315
NCT00025909|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-31|2008-03-03|||October 2001||2001-10-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||Intermittent vs. Continuous HAART to Treat Chronic HIV Infection|A Randomized, Controlled Trial of Short Cycle Intermittent Versus Continuous HAART for the Treatment of Chronic HIV Infection|Completed||Phase 3|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:42.828446|2017-02-18 18:08:42.828446
NCT00025896|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-31|2014-11-12|||May 2001||2001-05-01|November 2014|2014-11-01|September 2002|Actual|2002-09-01|||||Interventional|||Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease|A Prospective Multinational, Multicenter, Clinical Trial of the Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase (rhGAA) in Cross-Reacting Immunologic Material-Positive Patients With Classical Infantile Pompe Disease|Completed||Phase 2|8||Sanofi|||||||||||||||||||2017-02-18 18:08:42.920873|2017-02-18 18:08:42.920873
NCT00025883|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-27|2016-08-12|2016-03-01||October 2001||2001-10-01|August 2016|2016-08-01|February 2015|Actual|2015-02-01|February 2015|Actual|2015-02-01||Interventional|||Leptin to Treat Lipodystrophy|Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy|Completed||Phase 2|103|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||Yes||2017-02-18 18:08:43.002708|2017-02-18 18:08:43.002708
NCT00025870|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-27|2017-01-24|||October 25, 2001||2001-10-25|June 23, 2016|2016-06-23|June 23, 2016||2016-06-23|||||Observational|||Studies of Children With Metabolic and Other Genetic Disorders|Studies of Pediatric Patients With Metabolic or Other Genetic Disorders|Completed||N/A|1090|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:43.904025|2017-02-18 18:08:43.904025
NCT00025857|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-26|2017-01-24|||October 22, 2001||2001-10-22|June 29, 2012|2012-06-29|June 29, 2012||2012-06-29|||||Observational|||Brain Function in Mentally Ill Adolescents|Adolescent Medial Temporal Lobe Function in Health and Illness|Completed||N/A|105|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:43.994646|2017-02-18 18:08:43.994646
NCT00025844|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-26|2017-01-24|||October 22, 2001||2001-10-22|April 10, 2012|2012-04-10|April 10, 2012||2012-04-10|||||Observational|||Fear Conditioning Using Computer-Generated Virtual Reality|Fear Conditioning Using Computer-Generated Virtual Reality|Completed||N/A|202|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:44.080262|2017-02-18 18:08:44.080262
NCT00025831|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-26|2008-03-03|||October 2001||2001-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Biological Specimen Collection for Laboratory Methods Development and Training Purposes|Biological Specimen Collection for Laboratory Methods Development and for Training Purposes|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:44.158791|2017-02-18 18:08:44.158791
NCT00025818|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-26|2011-05-27|||May 2001||2001-05-01|May 2011|2011-05-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome||Completed||Phase 3|290|Actual|Allergan|||||f||||||||||||||2017-02-18 18:08:44.239183|2017-02-18 18:08:44.239183
NCT00025805|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-25|2017-01-24|||October 23, 2001||2001-10-23|June 13, 2008|2008-06-13|June 13, 2008||2008-06-13|||||Interventional|||G-CSF to Treat Crohn's Disease|Granulocyte-Colony Stimulating Factor Treatment for Crohn's Disease: A Pilot Study Assessing Immune and Clinical Response|Completed||Phase 1|23||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:44.331744|2017-02-18 18:08:44.331744
NCT00025792|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-24|2008-03-03|||October 2001||2001-10-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Clinical Trial of Pramipexole in Bipolar Depression|An Investigation of the Antidepressant Efficacy of a Dopamine Agonist With Neurotrophic Properties in Bipolar Disorder|Completed||Phase 2|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:44.422984|2017-02-18 18:08:44.422984
NCT00025779|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-23|2009-07-24|||October 2001||2001-10-01|August 2008|2008-08-01||||November 2003|Actual|2003-11-01||Interventional|||Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders|Methylphenidate for Hyperactivity and Impulsiveness in Children and Adolescents With Pervasive Developmental Disorders|Completed||N/A|60||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:08:44.515903|2017-02-18 18:08:44.515903
NCT00025766|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-22|2013-11-25|||September 2001||2001-09-01|November 2013|2013-11-01|December 2011|Actual|2011-12-01|April 2006|Actual|2006-04-01||Interventional|TOSCA-2||Angioplasty and Heart Stents to Treat Individuals With an Occluded Artery Following a Heart Attack|TOSCA-2: An Angiographic Substudy (Ancillary) of the Occluded Artery Trial (OAT)|Completed||Phase 4|380|Actual|University Health Network, Toronto||2|||f||||t||||||||||2017-02-18 18:08:44.62498|2017-02-18 18:08:44.62498
NCT00025753|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-19|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution|Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:08:44.728695|2017-02-18 18:08:44.728695
NCT00025740|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-16|2008-03-03|||October 2001||2001-10-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Interventional|||Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder|Combined Treatment With a Benzodiazepine (Clonazepam) and a Selective Serotonin Reuptake Inhibitor (Paroxetine) for Rapid Treatment of Posttraumatic Stress Disorder (PTSD)|Completed||Phase 4|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:44.801971|2017-02-18 18:08:44.801971
NCT00025727|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-15|2005-06-23|||May 2001||2001-05-01|June 2002|2002-06-01||||||||Interventional|||Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure|A Phase III, Randomized, Multicenter, Parallel Group, Open-Label, Three Arm Study to Compare the Efficacy and Safety of Two Dosing Regimens of GW433908/Ritonavir (700mg/100mg Twice Daily or 1400mg/200mg Once Daily) Versus Lopinavir/Ritonavir (400mg/100mg Twice Daily) for 48 Weeks in Protease Inhibitor Experienced HIV-Infected Adults Experiencing Virological Failure|Unknown status|Active, not recruiting|Phase 3|330||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:08:44.893223|2017-02-18 18:08:44.893223
NCT00025714|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2017-01-24|||October 9, 2001||2001-10-09|November 22, 2016|2016-11-22||||||||Observational|||Study of Specimens Obtained During Epilepsy Surgery|Research Study of Specimens Obtained During Epilepsy Surgery|Recruiting||N/A|120|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:45.277378|2017-02-18 18:08:45.277378
NCT00025701|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2017-01-24|||October 9, 2001||2001-10-09|October 4, 2010|2010-10-04|October 4, 2010||2010-10-04|||||Observational|||EEG and EMG Studies of Hand Dystonia|EEG Study of Movement-Related Center-Surround Organization in Hand Dystonia|Completed||N/A|75|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:45.38684|2017-02-18 18:08:45.38684
NCT00025688|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2008-07-23|||January 2001||2001-01-01|September 2006|2006-09-01||||||||Interventional|||Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer|A Randomized, Phase II Trial of Weekly Taxol (Paclitaxel) Versus Weekly Taxol Plus Paraplatin (Carboplatin) as First-Line Chemotherapy in Patients Age 65 Years or Older With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:45.471412|2017-02-18 18:08:45.471412
NCT00025675|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2012-05-18|||January 2002||2002-01-01|May 2012|2012-05-01||||June 2009|Actual|2009-06-01||Interventional|||Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors|ZD1839 FOR Treatment Of Recurrent Or Progressive Malignant Astrocytoma Or Glioblastoma And Recurrent Or Progressive Meningioma: A Phase II Study With A Phase I Component For Patients Receiving EIAEDs|Completed||Phase 2|105|Actual|Sidney Kimmel Comprehensive Cancer Center||2|||f||||||||||||||2017-02-18 18:08:45.596224|2017-02-18 18:08:45.596224
NCT00025662|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2016-09-21|2011-04-20||May 2001||2001-05-01|September 2016|2016-09-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS|"Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA: Reducing GVHD Risk Associated With Matched, Nonmyeloablative, Stem Cell Transplant for Hematologic Malignancies in Older Adults"|Completed||Phase 2|23|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 18:08:45.7253|2017-02-18 18:08:45.7253
NCT00025649|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-09-16|||July 1999||1999-07-01|December 2001|2001-12-01|March 2009|Actual|2009-03-01|||||Interventional|||Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma|European Infant Neuroblastoma Study - Stage 2, 3, 4, and 4S; MYCN Amplified Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:46.058446|2017-02-18 18:08:46.058446
NCT00025636|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-09-16|||July 2001||2001-07-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma|A Randomized Trial Of BEAM Plus PBSCT Versus Single Agent High-Dose Therapy Followed By BEAM Plus PBSCT In Patients With Relapsed Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 3|220|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:46.183035|2017-02-18 18:08:46.183035
NCT00025623|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-09-16|||July 1999||1999-07-01|December 2002|2002-12-01|March 2009|Actual|2009-03-01|||||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma|European Infant Neuroblastoma Study - Stage 4 With Bone, Lung, Pleura or CNS Involvement; MYCN Not Amplified|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:46.338067|2017-02-18 18:08:46.338067
NCT00025610|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-09-16|||July 1999||1999-07-01|November 2001|2001-11-01|March 2009|Actual|2009-03-01|||||Interventional|||Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma|European Infant Neuroblastoma Study - Stage 4S and Stage 4 (No Bone, Lung, Pleura or CNS); MYCN Not Amplified|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:46.446829|2017-02-18 18:08:46.446829
NCT00025597|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-09-16|||July 1999||1999-07-01|November 2001|2001-11-01|February 2011|Actual|2011-02-01|||||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.|European Infant Neuroblastoma Study - Unresectable Tumors (MYCN Not Amplified)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:46.553015|2017-02-18 18:08:46.553015
NCT00025584|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-01-22|||August 2001||2001-08-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||PS-341 in Treating Women With Metastatic Breast Cancer|Phase II Trial Of PS-341 In Metastatic Breast Cancer|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:46.664317|2017-02-18 18:08:46.664317
NCT00025571|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2011-03-03|||June 2001||2001-06-01|March 2011|2011-03-01|October 2004|Actual|2004-10-01|October 2002|Actual|2002-10-01||Interventional|||Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer|A Phase I Study of Photodynamic Therapy (PDT) Using 2-(1-hexyloxyethyl)-2 Devinyl Pyropheophorbide-a (HPPH) for Treatment of Early Stage Lung Cancer - A Dose Ranging Study|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:08:46.776021|2017-02-18 18:08:46.776021
NCT00025558|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2011-03-25|||October 2000||2000-10-01|March 2011|2011-03-01||||May 2007|Actual|2007-05-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer|Dose Escalation of Temozolomide in Combination With Thiotepa and Carboplatin With Autologous Stem Cell Rescue in Patients With Malignant Brain Tumors With Minimal Residual Disease|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:08:46.867011|2017-02-18 18:08:46.867011
NCT00025545|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2010-05-12|||March 1996||1996-03-01|May 2010|2010-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>|A Phase II Trial to Evaluate the Use of G-CSF-Mobilized Peripheral Blood Progenitor Cells as Hematopoietic Rescue in Patients With Acute Leukemia Undergoing Allografting From an Unrelated Donor|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:08:46.962201|2017-02-18 18:08:46.962201
NCT00025532|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2012-09-13|||April 2001||2001-04-01|September 2012|2012-09-01||||||||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer|A Pre-Phase I Biodistribution Study Of hCC^CH2 Labeled With 131 Iodine In Patients With Gastrointestinal Adenocarcinomas|Withdrawn||Phase 1|0|Actual|University of California, San Francisco|||||f||||||||||||||2017-02-18 18:08:47.065348|2017-02-18 18:08:47.065348
NCT00025519|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-07-10|||June 2001||2001-06-01|July 2013|2013-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer|Submyeloablative Allogeneic Blood Stem Cell Transplantation With HLA Identical Donor Lymphocyte Infusions From Matched Related and Matched Unrelated Donors for Treatment of Metastatic Renal Cell Carcinoma|Withdrawn||Phase 2|0|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-02-18 18:08:47.160253|2017-02-18 18:08:47.160253
NCT00025506|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2015-05-07|2015-05-07||September 2001||2001-09-01|December 2013|2013-12-01|January 2013|Actual|2013-01-01|January 2013|Actual|2013-01-01||Interventional||Eligible and treated patients.|Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus|A Phase II Evaluation of Thalidomide (NSC #66847) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 18:08:47.258708|2017-02-18 18:08:47.258708
NCT00025493|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-01-22|||October 2001||2001-10-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2007|Actual|2007-06-01||Interventional|||S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer|Single Agent Docetaxel for Metastatic Breast Cancer in Patients Aged 70 Years and Older (and in a Cohort of Patients Younger Than 60 Years)|Terminated||Phase 2|27|Actual|Southwest Oncology Group||1||poor accrual|f||||t||||||||||2017-02-18 18:08:47.853042|2017-02-18 18:08:47.853042
NCT00025480|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2009-02-06|||August 2001||2001-08-01|April 2007|2007-04-01||||||||Interventional|||Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Phase I Trial of Farnesyltransferase Inhibitor, R115777 (NSC # 702818) and Radiotherapy in Patients With Non-Small Cell Lung Cancer|Completed||Phase 1|12|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:08:47.959816|2017-02-18 18:08:47.959816
NCT00025467|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-01-23|||September 2001||2001-09-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Thalidomide (NSC #66847, IND 48832) in the Treatment of Recurrent of Persistent Endometrial Carcinoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:48.328024|2017-02-18 18:08:48.328024
NCT00025454|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2010-02-05|||August 2001||2001-08-01|February 2010|2010-02-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||R115777 in Treating Patients With Advanced Solid Tumors|Phase I Trial of R115777 (NSA 702818) in Advanced Malignant Solid Tumors|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:08:48.444226|2017-02-18 18:08:48.444226
NCT00025441|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-12-03|||November 1998||1998-11-01|November 2001|2001-11-01|March 2010|Actual|2010-03-01|||||Interventional|||Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors|MMT 98 Study For Metastatic Disease Rhabdomyosarcoma And Other Malignant Soft Tissue Sarcoma Of Childhood|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:48.548326|2017-02-18 18:08:48.548326
NCT00025428|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-12-03|||December 2000||2000-12-01|November 2006|2006-11-01|November 2013|Actual|2013-11-01|||||Interventional|||Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma|Treatment Of Children Over The Age Of 1 Year With Unresectable Localized Neuroblastoma Without MYCN Amplification|Completed||Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:48.694494|2017-02-18 18:08:48.694494
NCT00025415|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-02-06|||August 2001||2001-08-01|February 2013|2013-02-01||||January 2005|Actual|2005-01-01||Interventional|||Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction|A Phase I Pharmacokinetic Study of STI571 in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:48.815193|2017-02-18 18:08:48.815193
NCT00025402|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-12-17|||July 1997||1997-07-01|July 2002|2002-07-01||||||||Interventional|||Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia|Randomized Multicenter Treatment Optimization Study In Chronic Myeloid Leukemia (CML) Interferon-a Vs. Allogeneic Stem Cell Transplantation Vs. High-Dose Chemotherapy Followed By Autografting And Interferon-a Maintainance In Early Chronic Phase|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:48.957995|2017-02-18 18:08:48.957995
NCT00025389|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-02-08|||November 2001||2001-11-01|February 2013|2013-02-01|August 2007|Actual|2007-08-01|December 2005|Actual|2005-12-01||Interventional|||Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer|A Phase 2 Study Of Neoadjuvant rhuMAb VEGF (Bevacizumab) In Combination With Paclitaxel And Carboplatin In Surgically Resectable Non-Small Cell Lung Cancer|Completed||Phase 2|8|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:08:49.265404|2017-02-18 18:08:49.265404
NCT00025376|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-09-04|||October 2001||2001-10-01|September 2013|2013-09-01|March 2006|Actual|2006-03-01|September 2002|Actual|2002-09-01||Interventional|||PS-341 in Treating Patients With Metastatic Kidney Cancer|A Phase II Trial of PS-341 in Patients With Renal Cell Cancer|Completed||Phase 2|23|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 18:08:49.386955|2017-02-18 18:08:49.386955
NCT00025363|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-01-16|||November 2001||2001-11-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma|A Groupwide Randomized Phase II Window Study of Two Different Schedules of Irinotecan in Combination With Vincristine And Pilot Assessment of Safety and Efficacy of Tirapazamine Combined With Multiagent Chemotherapy for First Relapse or Progressive Disease in Rhabdomyosarcoma and Related Tumors|Completed||Phase 2|150|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:08:49.514517|2017-02-18 18:08:49.514517
NCT00025350|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-06-20|||October 2001||2001-10-01|January 2006|2006-01-01|June 2006|Actual|2006-06-01|||||Interventional|||Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer|A Randomized Phase II Trial of Two Dose Levels of ZD1839 (Iressa) (NSC 715055, IND 61187) in Patients With Recurrent Colorectal Adenocarcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:49.663476|2017-02-18 18:08:49.663476
NCT00025337|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-01-23|||September 2001||2001-09-01|January 2013|2013-01-01||||April 2007|Actual|2007-04-01||Interventional|||Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated|Phase III Trial of Bevacizumab (NSC 704865), Oxaliplatin (NSC 266046), Fluorouracil and Leucovorin Versus Oxaliplatin, Fluorouracil and Leucovorin Versus Bevacizumab Alone in Previously Treated Patients With Advanced Colorectal Cancer|Completed||Phase 3|880|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:08:49.776526|2017-02-18 18:08:49.776526
NCT00025324|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-12-17|||December 2000||2000-12-01|December 2004|2004-12-01||||||||Interventional|||Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors|Clinical Correlative Studies In Primary Central Nervous System Germ Cell Tumors: The Third International CNS Germ Cell Tumor Study Group Protocol|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:49.900122|2017-02-18 18:08:49.900122
NCT00025311|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2012-11-08|||May 2001||2001-05-01|March 2003|2003-03-01||||October 2003|Actual|2003-10-01||Interventional|||Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain|A Phase I Study Of Seven Day Continuous Intrathecal/Intraventricular Infusion Of Topotecan For Patients With Recurrent, Progressive Or Refractory Leptomingeal Disease|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:08:50.005258|2017-02-18 18:08:50.005258
NCT00025298|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2012-09-20|||July 2001||2001-07-01|September 2012|2012-09-01||||October 2002|Actual|2002-10-01||Interventional|||Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx|A Feasibility Study Of Primary Chemotherapy Followed By Concomitant Chemoradiation With And Without Amifostine In Patients With Locally Advanced Undifferentiated Nasopharyngeal Cancer (UNPC)|Terminated||Phase 2|5|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:08:50.103394|2017-02-18 18:08:50.103394
NCT00025285|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2009-08-21|||November 2001||2001-11-01|August 2009|2009-08-01||||||||Interventional|||Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Study of Carboplatin, Irinotecan, and Thalidomide in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:08:50.220961|2017-02-18 18:08:50.220961
NCT00025272|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2009-08-20|||November 2001||2001-11-01|August 2009|2009-08-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Study of Sequential Topotecan-Carboplatin-Etoposide in Patients With Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:08:50.317442|2017-02-18 18:08:50.317442
NCT00025259|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2016-05-27|||September 2002||2002-09-01|May 2016|2016-05-01||||March 2012|Actual|2012-03-01||Interventional|||Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease|A Phase III Groupwide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate Risk Hodgkin Disease|Completed||Phase 3|1734|Actual|Children's Oncology Group||7|||f||||||||||||||2017-02-18 18:08:50.433581|2017-02-18 18:08:50.433581
NCT00025246|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-02-19|||September 2001||2001-09-01|January 2013|2013-01-01||||November 2007|Actual|2007-11-01||Interventional|||Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery|A Phase II Study of Adjuvant STI571 (Gleevec TM) Therapy in Patients Following Completely Resected High-risk Primary GastroIntestinal Stromal Tumor (GIST)|Completed||Phase 2|89|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:51.113688|2017-02-18 18:08:51.113688
NCT00025233|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2015-06-10|2015-06-10||April 2002||2002-04-01|January 2013|2013-01-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional||Eligible and treated patients.|Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix|A Phase II Trial of Bevacizumab (rhuMAB VEGF) (NSC #704865) in the Treatment of Persistent and Recurrent Squamous Cell Carcinoma of the Cervix (Group A)|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:51.250609|2017-02-18 18:08:51.250609
NCT00025220|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2015-03-13|||September 2001||2001-09-01|December 2012|2012-12-01|July 2008|Actual|2008-07-01|April 2003|Actual|2003-04-01||Interventional|||Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus|A Phase II Evaluation of Thalidomide (NSC #66847) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:51.721422|2017-02-18 18:08:51.721422
NCT00025207|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-01-15|||September 2001||2001-09-01|January 2013|2013-01-01||||February 2006|Actual|2006-02-01||Interventional|||Gefitinib in Treating Patients With Malignant Mesothelioma|A Phase II Study Of ZD 1839 (NSC 715055, IND 61187) In Patients With Malignant Mesothelioma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:51.843582|2017-02-18 18:08:51.843582
NCT00025194|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-06-20|||July 2001||2001-07-01|November 2005|2005-11-01|July 2006|Actual|2006-07-01|||||Interventional|||Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer|A Phase I And Randomized Phase 2 Trial Of Epothilone B Analogue BMS 247550 (NSC # 710428) Administered Every 21 Days With Or Without Oral Estramustine Phosphate In Patients With Androgen Independent Prostate Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:51.952973|2017-02-18 18:08:51.952973
NCT00025181|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2014-05-20|||October 2001||2001-10-01|May 2014|2014-05-01|June 2005|Actual|2005-06-01|January 2003|Actual|2003-01-01||Interventional|||Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery|An Open-label Study Of MDX-CTLA4 In Combination With Tyrosinase/gp100/MART-1 Peptides Emulsified With Montanide ISA 51 In The Treatment Of Patients With Resected Stage III Or Stage IV Melanoma|Completed||Phase 1|19|Actual|University of Southern California|||||f||||t||||||||||2017-02-18 18:08:52.053785|2017-02-18 18:08:52.053785
NCT00025168|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2009-08-20|||November 2001||2001-11-01|August 2009|2009-08-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer|Phase II Trial Of Induction Gemcitabine/CPT-11 Followed By Twice-Weekly Infusion Gemcitabine And Concurrent External Beam Radiation For The Treatment Of Locally Advanced Pancreatic Cancer|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:08:52.161574|2017-02-18 18:08:52.161574
NCT00025155|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2015-06-17|2015-04-29||July 2002||2002-07-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||Patients who were eligible and received any study treatment.|Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy|A Phase II Evaluation of Epothilone-B BMS 247550 (NSC # 710428) in the Treatment of Recurrent or Persistent Platinum and Paclitaxel Refractory Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|51|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:52.271402|2017-02-18 18:08:52.271402
NCT00025142|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-05-14|||July 2001||2001-07-01|February 2005|2005-02-01|November 2006|Actual|2006-11-01|||||Interventional|||Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer|A Study of ZD1839 (Iressa) in Combination With Oxaliplatin, 5-Fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Malignancies (Phase I) and Advanced Colorectal Cancers (Phase II)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:52.691836|2017-02-18 18:08:52.691836
NCT00025129|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-07-17|||March 2001||2001-03-01|March 2004|2004-03-01|May 2004|Actual|2004-05-01|||||Interventional|||VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas|A Phase I Trial of VNP4010M, A Novel Alkylating Agent for Patients With Advanced or Metastatic Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:52.790531|2017-02-18 18:08:52.790531
NCT00025116|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2010-11-07|||April 2001||2001-04-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|A Randomized Phase II Study Of ZD1839 (IRESSA) In Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:08:52.889237|2017-02-18 18:08:52.889237
NCT00025103|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-08-01|||May 2001||2001-05-01|June 2009|2009-06-01||||November 2008|Anticipated|2008-11-01||Interventional|||Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney|Protocol For The Treatment Of Relapsed And Refractory Wilms Tumour And Clear Cell Sarcoma Of The Kidney (CCSK)|Unknown status|Active, not recruiting|Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:52.984084|2017-02-18 18:08:52.984084
NCT00025090|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-08-23|||March 2001||2001-03-01|March 2007|2007-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer|Second UK Phase III Anal Cancer Trial: A Trial of Chemoradiation and Maintenance Therapy for Patients With Anal Cancer|Completed||Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:53.185663|2017-02-18 18:08:53.185663
NCT00025077|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-08-01|||January 2000||2000-01-01|June 2007|2007-06-01|April 2011|Actual|2011-04-01|||||Interventional|||Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors|Treatment Of Recurrent Central Nervous System Primitive Neuroectodermal Tumors (PNETs) In Children And Adolescents A Strategy Including The Use Of High Dose Thiotepa And High Dose Carboplatin|Completed||Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:53.293304|2017-02-18 18:08:53.293304
NCT00025064|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-08-06|||January 2000||2000-01-01|December 2002|2002-12-01||||||||Interventional|||Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma|Protocol For The Treatment Of Children And Adolescents With Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 2|260|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:53.411766|2017-02-18 18:08:53.411766
NCT00025051|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-03-21||||||December 2006|2006-12-01||||||||Interventional|||Celecoxib in Preventing Skin Cancer|A Phase II, Double-Blind, Placebo-Controlled Clinical Trial To Assess Celecoxib As A Chemopreventive Agent Inhibiting UV-Induced Erythema And Cutaneous Carcinogenesis As Assessed Through Surrogate Biological Markers In Biopsied Skin After Exposure Of Skin In Normal Volunteers Ages 20-60 Years Old With Fitzpatrick Type I, II, III And IV Skin To UV-Radiation From Artificial Light Sources|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:53.532226|2017-02-18 18:08:53.532226
NCT00025038|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-04-10|||June 2001||2001-06-01|January 2013|2013-01-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia|Phase II Window Evaluation of the Farnesyl Transferase Inhibitor (R115777) Followed by 13-CIS Retinoic Acid, Cytosine Arabinoside and Fludarabine Plus Hematopoietic Stem Cell Transplantation in Children With Juvenile Myelomonocytic Leukemia|Completed||Phase 2|100|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:08:53.629749|2017-02-18 18:08:53.629749
NCT00025025|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2016-07-01|||October 2001||2001-10-01|July 2016|2016-07-01|June 2009|Actual|2009-06-01|June 2009|Actual|2009-06-01||Observational|||Screening Tests in Detecting Colorectal Cancer|Colorectal Cancer Screening: Fecal Blood vs. DNA|Completed||N/A|4482|Actual|Alliance for Clinical Trials in Oncology|||2||f||||f||||||||||2017-02-18 18:08:56.746271|2017-02-18 18:08:56.746271
NCT00025012|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-11|2013-06-17|||June 1991||1991-06-01|November 2007|2007-11-01|February 2004|Actual|2004-02-01|||||Interventional|||Isotretinoin in Preventing Skin Cancer|Use Of Isotretinion For Prevention Of Skin Cancer In Patients With Xeroderma Pigmentosum Or Nevoid Basal Cell Carcinoma Syndrome|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:08:56.917294|2017-02-18 18:08:56.917294
NCT00024986|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-10|2008-03-03|||October 2001||2001-10-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Tenofovir Disoproxil Fumarate to Treat Pediatric HIV|A Phase I Study of Tenofovir Disoproxil Fumarate (PMPA Prodrug), A Novel Nucleotide Analog Reverse Transcriptase Inhibitor in Children With HIV Infection|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:57.086417|2017-02-18 18:08:57.086417
NCT00024960|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-09|2017-01-24|||October 3, 2001||2001-10-03|October 29, 2010|2010-10-29|October 29, 2010||2010-10-29|||||Observational|||Dopamine Function in Developmental Stuttering|Assessment of Pre- and Post-Synaptic Dopamine Function in Developmental Stuttering Using 11C-Raclopride and Positron Emission Tomography|Completed||N/A|12|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:57.177637|2017-02-18 18:08:57.177637
NCT00024934|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-09|2016-09-21|||October 2001||2001-10-01|September 2016|2016-09-01|August 2004||2004-08-01|||||Interventional|||B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency|A Phase I Dose Escalation Study of B-Lymphocyte Stimulator (BLyS) Administered Subcutaneously in Patients With Selective IgA Deficiency|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:57.258603|2017-02-18 18:08:57.258603
NCT00024921|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-05|2013-09-05||||||December 2003|2003-12-01||||||||Observational|||The Genetics of Kidneys in Diabetes (GoKinD) Study|The Genetics of Kidneys in Diabetes (GoKinD) Study|Completed||N/A|2100|Anticipated|National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:08:57.33709|2017-02-18 18:08:57.33709
NCT00024908|ClinicalTrials.gov processed this data on February 17, 2017|2001-10-04|2017-01-24|||October 1, 2001||2001-10-01|April 7, 2010|2010-04-07|April 7, 2010||2010-04-07|||||Observational|||Test of A Model of Representational Knowledge Stored in the Human Prefrontal Cortex|Testing A Model of the Representational Knowledge Stored in the Human Prefrontal Cortex|Completed||N/A|949|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:57.675206|2017-02-18 18:08:57.675206
NCT00024843|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-28|2016-05-12|||September 1999||1999-09-01|August 2004|2004-08-01|August 2003|Actual|2003-08-01|||||Observational|||Family Based Interventions: Preschool Children and Parent||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:08:57.75875|2017-02-18 18:08:57.75875
NCT00024830|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-28|2016-03-15|||September 1999||1999-09-01|October 2005|2005-10-01|August 2002|Actual|2002-08-01|||||Observational|||Peer-Based Skills Training to Enhance Teen Weight Loss||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:08:57.834576|2017-02-18 18:08:57.834576
NCT00024817|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-28|2016-07-14|||September 1999||1999-09-01|August 2004|2004-08-01|August 2002|Actual|2002-08-01|||||Observational|||Energy Expenditure, Diet and Body Fat in Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:08:57.926994|2017-02-18 18:08:57.926994
NCT00024804|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-28|2017-01-24|||September 25, 2001||2001-09-25|September 6, 2016|2016-09-06||||||||Observational|||Evaluation and Treatment of Skeletal Diseases|Evaluation and Treatment of Bone and Mineral Disorders|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:58.002137|2017-02-18 18:08:58.002137
NCT00024791|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-27|2008-03-03|||September 2001||2001-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Eye-Hand Coordination in Children With Spastic Diplegia|Neurophysiology of Motor Disorders in Spastic Diplegia|Completed||N/A|144||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:58.111275|2017-02-18 18:08:58.111275
NCT00024687|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-24|2014-11-13|||November 2000||2000-11-01|November 2014|2014-11-01||||||||Interventional|||Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses||Withdrawn||Phase 1|0|Actual|INSYS Therapeutics Inc||||Support withdrawn - Study continued by NCI - see record NCT00006981|||||||||||||||2017-02-18 18:08:58.201235|2017-02-18 18:08:58.201235
NCT00024674|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-24|2014-11-13|||February 2001||2001-02-01|November 2014|2014-11-01||||||||Interventional|||Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days||Withdrawn||Phase 1|0|Actual|INSYS Therapeutics Inc||||Support withdrawn - Study continued by NCI - see record NCT00006981|||||||||||||||2017-02-18 18:08:58.285262|2017-02-18 18:08:58.285262
NCT00024661|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-24|2011-04-12|||March 2001||2001-03-01|April 2011|2011-04-01|October 2004||2004-10-01|||||Interventional|||Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors|Study to Determine the Maximum Tolerated Dose of Liposome-Encapsulated C-RAF Antisense Oligodeoxynucleotide (LErafAON) in Patients With Advanced Solid Tumors|Completed||Phase 1|30||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 18:08:58.37251|2017-02-18 18:08:58.37251
NCT00024648|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-24|2011-04-12|||March 2001||2001-03-01|April 2011|2011-04-01|December 2004||2004-12-01|||||Interventional|||Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies|Phase I Study to Determine the Maximum Tolerated Dose of LErafAON in Combination With Radiotherapy in Patients With Advanced Malignancies|Completed||Phase 1|25||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 18:08:58.461329|2017-02-18 18:08:58.461329
NCT00024635|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-23|2017-01-26|||September 20, 2001||2001-09-20|January 12, 2017|2017-01-12||||||||Observational|||Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers|The Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers|Recruiting||N/A|16000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:58.562463|2017-02-18 18:08:58.562463
NCT00024622|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-23|2017-01-24|||September 17, 2001||2001-09-17|November 2, 2016|2016-11-02||||||||Observational|||PET Scanning in Parkinson s Disease|Positron Emission Tomography (PET) Scanning in Dopamine Disorders: Parkinson's Disease and Schizophrenia|Recruiting||N/A|460|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:58.671483|2017-02-18 18:08:58.671483
NCT00024596|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-21|2015-12-21|||September 2001||2001-09-01|December 2015|2015-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)||Completed||N/A|3389|Actual|Washington University School of Medicine|||2||f||||||||||Samples With DNA|"~     Stored DNA, lymphoblasts~   "|||2017-02-18 18:08:58.772996|2017-02-18 18:08:58.772996
NCT00024583|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-21|2016-02-17|||September 2001||2001-09-01|January 2008|2008-01-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Prenatal Nutrition and Adult Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:08:58.857988|2017-02-18 18:08:58.857988
NCT00024570|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-20|2014-11-12|||November 2000||2000-11-01|November 2014|2014-11-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma|Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma: Phase I/II Study|Completed||Phase 1/Phase 2|60||INSYS Therapeutics Inc|||||f||||||||||||||2017-02-18 18:08:58.930439|2017-02-18 18:08:58.930439
NCT00024557|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-20|2011-06-02|||June 2001||2001-06-01|June 2011|2011-06-01|July 2007|Actual|2007-07-01|June 2006|Actual|2006-06-01||Interventional|||Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients|Phase I Study to Assess the Histologic Effect and Safety of Pre-Operative and Post-Operative Infusions of IL13-PE38QQR Cytotoxin in Patients With Recurrent Resectable Supratentorial Malignant Glioma|Completed||Phase 1|40||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 18:08:59.021943|2017-02-18 18:08:59.021943
NCT00024544|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-19|2012-03-06|||August 2001||2001-08-01|March 2012|2012-03-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Pilot Study in Patients With Symptomatic Steroid-Naive Asthma|A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma|Completed||Phase 2|120||Facet Biotech|||||f||||||||||||||2017-02-18 18:08:59.105799|2017-02-18 18:08:59.105799
NCT00024531|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-19|2006-11-08|||October 2000||2000-10-01|November 2006|2006-11-01|August 2004||2004-08-01|||||Interventional|||Lipitor as a Treatment for Alzheimer's Disease|Effect of the HMG-CoA Reductase Inhibitor Atorvastatin Calcium, Lipitor, in the Treatment of Alzheimer's Disease|Completed||Phase 2|98||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:08:59.202609|2017-02-18 18:08:59.202609
NCT00024518|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-19|2013-11-18|||September 2001||2001-09-01|November 2013|2013-11-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||Interferon-Alpha for Diabetes Mellitus Type 1|"Ingested Interferon-Alpha: Prolongation or Permanence of the Honeymoon Phase in Newly Diagnosed Diabetes Mellitus"|Completed||Phase 2|57|Actual|The University of Texas Health Science Center, Houston||3|||f||||f||||||||||2017-02-18 18:08:59.296162|2017-02-18 18:08:59.296162
NCT00024505|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-18|2013-01-15|||September 2001||2001-09-01|January 2013|2013-01-01|July 2010|Actual|2010-07-01|July 2010|Actual|2010-07-01||Observational|||Multidisciplinary Study of Right Ventricular Dysplasia|Multidisciplinary Study of Right Ventricular Dysplasia|Completed||N/A|320|Actual|University of Arizona|||1||f||||t||||||Samples With DNA|"~     Blood~   "|||2017-02-18 18:08:59.702483|2017-02-18 18:08:59.702483
NCT00024492|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-17|2011-06-02|||August 2001||2001-08-01|August 2004|2004-08-01|June 2004||2004-06-01|||||Interventional|||Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer||Completed||Phase 1|40||INSYS Therapeutics Inc|||||||||||||||||||2017-02-18 18:08:59.823294|2017-02-18 18:08:59.823294
NCT00024479|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-14|2017-01-24|||September 6, 2001||2001-09-06|November 25, 2016|2016-11-25||||||||Observational|||Natural History of Rheumatic Diseases in Minority Communities|Studies of the Natural History of Rheumatic Disease in Minority Communities|Recruiting||N/A|100000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:08:59.905538|2017-02-18 18:08:59.905538
NCT00024466|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2014-05-01|||March 2001||2001-03-01|May 2014|2014-05-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma|Vaccination In Peripheral Stem Cell Transplant Setting For Multiple Myeloma: The Use Of Autologous Tumor Cells/An Allo PSCT|Completed||Phase 1/Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:09:00.014492|2017-02-18 18:09:00.014492
NCT00024453|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-08-06|||February 1999||1999-02-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|||Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter|The Use of Teicoplanin in the Treatment of Septicaemia Caused by Coagulase-Negative Staphylococci - A Randomized Study Comparing Bolus Injection With Infused and/or Line-Locked Teicoplanin|Unknown status|Active, not recruiting|N/A|1360|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:00.124567|2017-02-18 18:09:00.124567
NCT00024440|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2014-01-03|||July 2001||2001-07-01|October 2003|2003-10-01|February 2007|Actual|2007-02-01|||||Interventional|||Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia|Randomized Study Of Fludarabine And Cyclophosphamide With Or Without Genasense (Bcl-2 Antisense Oligonucleotide) In Subjects With Relapsed Or Refractory Chronic Lymphocytic Leukemia|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:00.247641|2017-02-18 18:09:00.247641
NCT00024427|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2012-06-27|||February 2001||2001-02-01|May 2010|2010-05-01||||February 2006|Actual|2006-02-01||Interventional|||Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer|An Open Label, Randomized, Controlled, Phase III, Multi-center, Clinical Trial Of PN401 With High Dose 5-Fluorouracil (5FU) Versus Gemcitabine For Treatment Of Patients With Advanced Pancreatic Cancer|Completed||Phase 3|250|Actual|Wellstat Therapeutics||1|||f||||f||||||||||2017-02-18 18:09:00.383623|2017-02-18 18:09:00.383623
NCT00024414|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2008-07-23|||April 2001||2001-04-01|March 2003|2003-03-01||||||||Interventional|||DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer|Phase II Open-Label Study of Taxoprexin (DHA-Paclitaxel) Injection by 2-Hour Intravenous Infusion in Patients With Metastatic Hormone-Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:00.529828|2017-02-18 18:09:00.529828
NCT00024401|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2008-07-23|||May 2001||2001-05-01|June 2002|2002-06-01||||||||Interventional|||DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer|Phase II Open-Label Study of Taxoperxin (DHA-Paclitacel) Injection by 2-Hour Intravenous Infusion in Patients With Metastatic Cancer of the Colon/Rectum|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:00.633301|2017-02-18 18:09:00.633301
NCT00024388|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2008-07-23|||April 2001||2001-04-01|June 2002|2002-06-01||||||||Interventional|||Chemotherapy in Treating Patients With Metastatic Kidney Cancer|Phase II Open-Label Study of Taxoprexin (DHA-Paclitaxel) Injection by 2-Hour Intravenous Infusion In Patients With Metastatic, Locally Advanced, or Unresectable Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:00.728591|2017-02-18 18:09:00.728591
NCT00024375|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2009-02-17|||June 2001||2001-06-01|March 2003|2003-03-01||||||||Interventional|||DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer|Phase II Open-Label Study of Taxoperxin (DHA-Paclitaxel) Injection by 2 Hour Intravenous Infusion in Patients With Metastatic Cancer of the Pancreas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:00.828932|2017-02-18 18:09:00.828932
NCT00023543|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-07|2013-06-18|||September 2001||2001-09-01|June 2013|2013-06-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Reduction of Triglycerides in Women on Hormone Replacement Therapy|Reduction of Triglycerides in Women on HRT|Completed||Phase 2|508|Actual|University of Pittsburgh||1|||f||||||||||||||2017-02-18 18:09:13.871026|2017-02-18 18:09:13.871026
NCT00024362|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2008-07-23|||May 2001||2001-05-01|April 2007|2007-04-01||||||||Interventional|||BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery|A Phase II Trial of BBR 3464 as First Line Treatment in Patients With Inoperable, Locally Advanced or Metastatic Adenocarcinoma of the Pancreas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:00.928585|2017-02-18 18:09:00.928585
NCT00024349|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-12-17|||June 2001||2001-06-01|May 2007|2007-05-01|April 2012|Actual|2012-04-01|||||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer|2X2 Factorial Randomized Phase III Study Comparing Standard Versus Reduced Volume Radiotherapy With and Without Synchronous Chemotherapy in Muscle Invasive Bladder Cancer|Completed||Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:01.033421|2017-02-18 18:09:01.033421
NCT00024336|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-08-06|||August 1999||1999-08-01|December 2006|2006-12-01||||||||Interventional|||Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma|Treatment of Children With Newly Diagnosed Diffuse Pontine Gliomas Using Conventional Radiotherapy and High Dose Tamoxifen|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:01.165532|2017-02-18 18:09:01.165532
NCT00024323|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-07-17|||March 2001||2001-03-01|November 2002|2002-11-01|June 2003|Actual|2003-06-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) Administered Daily x 5 in Combination With Cisplatin|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:01.275314|2017-02-18 18:09:01.275314
NCT00024310|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-09-16|||September 2001||2001-09-01|November 2002|2002-11-01||||||||Interventional|||Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Trial of Lometrexol Sodium and Paclitaxel Adminsitered Intravenously Every 21 Days in Conjunction With Oral Folic Acid in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:01.360008|2017-02-18 18:09:01.360008
NCT00024297|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-08-06|||October 1999||1999-10-01|December 2002|2002-12-01|February 2009|Actual|2009-02-01|||||Interventional|||Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters|A Multicenter Prospective Randomized Controlled Trial of Thrombosis Prophylaxis With Warfarin in Cancer Patients With Central Venous Catheters|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:01.457621|2017-02-18 18:09:01.457621
NCT00024284|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-04-03|||June 2001||2001-06-01|April 2013|2013-04-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors|A Phase I Study Of Carboplatin And Irinotecan In Patients 1-21 Years Of Age With Refractory Solid Tumors|Completed||Phase 1|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:09:01.576889|2017-02-18 18:09:01.576889
NCT00024271|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2014-01-03|||May 2001||2001-05-01|January 2004|2004-01-01||||||||Interventional|||Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer|Phase II Trial Of Combined Resection, Intraperitoneal Chemotherapy, And Whole Abdominal Radiation For Treatment Of Peritoneal Mesothelioma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:01.935619|2017-02-18 18:09:01.935619
NCT00024258|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2015-10-22|2015-10-22||March 2001||2001-03-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors|Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors|Completed||Phase 2|22|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:09:02.048831|2017-02-18 18:09:02.048831
NCT00024245|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-06-25|||May 2001||2001-05-01|March 2003|2003-03-01|April 2003|Actual|2003-04-01|||||Interventional|||10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors|Phase I and Clinical Pharamcologic Study of 10-Propargyl-10-Deazaaminopterin (PDX) in Combination With Probenecid in Adults With Advanced Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:02.364018|2017-02-18 18:09:02.364018
NCT00024232|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-06-17|||June 2001||2001-06-01|June 2013|2013-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer|Pilot Trial of Humanized Monoclonal Antibody J591 in Patients With Progressive Androgen-Independent Prostate Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:09:02.459221|2017-02-18 18:09:02.459221
NCT00024206|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-01-22|||July 2001||2001-07-01|January 2013|2013-01-01||||July 2003|Actual|2003-07-01||Interventional|||SU6668 in Treating Patients With Advanced Solid Tumors|A Phase I Surrogate Endpoint Trial of SU6668 in Patients With Incurable Solid Tumors|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:02.557084|2017-02-18 18:09:02.557084
NCT00024193|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-08-06|||April 1999||1999-04-01|November 2001|2001-11-01||||||||Interventional|||Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma|A Study Of The Treatment Of Metastatic Neuroblastoma In Children More Than One Year Of Age At Diagnosis|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:02.670787|2017-02-18 18:09:02.670787
NCT00024180|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-01-30|||January 2002||2002-01-01|November 2002|2002-11-01|August 2006|Actual|2006-08-01|||||Interventional|||FR901228 in Treating Patients With Hematologic Cancer|A Phase I Study of Depsipeptide in Selected Hematologic Malignancies (NSC 630176)|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:02.773865|2017-02-18 18:09:02.773865
NCT00024167|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2016-02-19|2016-01-22||April 2002||2002-04-01|February 2016|2016-02-01||||September 2014|Actual|2014-09-01||Interventional||Of the 265 participants enrolled - 133 participants received only induction treatment and 127 were randomized to either the Sr-89 treatment arm or the no Sr-89 treatment arm. 5 participants never received any treatment.|Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer|A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer|Terminated||Phase 3|265|Actual|M.D. Anderson Cancer Center||4||Terminated due to slow accrual|f||||t||||||||||2017-02-18 18:09:02.882387|2017-02-18 18:09:02.882387
NCT00023530|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-07|2016-02-17|||September 2001||2001-09-01|July 2006|2006-07-01|August 2006|Actual|2006-08-01|||||Interventional|||Blood and Marrow Transplant Clinical Research Network|Blood and Marrow Transplant Clinical Research Network|Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:09:13.984086|2017-02-18 18:09:13.984086
NCT00024154|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-01-23|||February 2002||2002-02-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer|A Phase I/II Trial of Herceptin and ZD1839 (Iressa, NSC #715055, IND#61187) in Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu (erbB-2)|Completed||Phase 2|132|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:03.73627|2017-02-18 18:09:03.73627
NCT00024141|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2011-03-03|||May 2001||2001-05-01|March 2011|2011-03-01|January 2003|Actual|2003-01-01|September 2002|Actual|2002-09-01||Interventional|||Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors|5-Flourouracil Preceded by Irinotecan In Patients With Advanced Solid Tumors: A Pilot Study|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:09:03.852881|2017-02-18 18:09:03.852881
NCT00024128|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2016-02-01|||August 2001||2001-08-01|February 2016|2016-02-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma|Delayed Donor Leukocyte Infusions in Patients Receiving Allogeneic PBSC Following Conditioning With Non-myeloablative Regimen for AIDS-Related Lymphoma (NHL and HD)|Withdrawn||Phase 2|0|Actual|AIDS Malignancy Consortium||1||Withdrawn prior to initiation.|f||||||||||||||2017-02-18 18:09:03.940985|2017-02-18 18:09:03.940985
NCT00024115|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2015-04-27||||||December 2006|2006-12-01||||||||Interventional|||BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Phase I Study of Recombinant BL22 Immunotoxin in Patients With CD22-Positive B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Withdrawn||Phase 1|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:04.031948|2017-02-18 18:09:04.031948
NCT00024102|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2016-07-12|2012-11-20||September 2001||2001-09-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|May 2008|Actual|2008-05-01||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer|A Randomized Trial of Adjuvant Chemotherapy With Standard Regimens, Cyclophosphamide, Methotrexate and Fluorouracil - (CMF) or Doxorubicin and Cyclophosphamide - (AC), Versus Capecitabine in Women 65 Years and Older With Node Positive or Node-Negative Breast Cancer|Completed||Phase 3|633|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:09:04.148232|2017-02-18 18:09:04.148232
NCT00024089|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-02-08|||July 2001||2001-07-01|November 2005|2005-11-01||||March 2006|Actual|2006-03-01||Interventional|||Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer|A Phase II Study of ZD 1839 (Iressa) in Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:05.842468|2017-02-18 18:09:05.842468
NCT00024076|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2015-10-28|||May 2000||2000-05-01|July 2012|2012-07-01||||December 2006|Actual|2006-12-01||Interventional|||Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer|Radiofrequency Ablation of Pulmonary Malignancy|Completed||Phase 2|30|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:09:05.949302|2017-02-18 18:09:05.949302
NCT00024063|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-12-18||||||April 2007|2007-04-01||||||||Interventional|||SU006668 in Treating Patients With Advanced Solid Tumors|A Phase I Study Of SU006668 Via Twice Daily Oral Administration Under Fed Conditions In Patients With Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:06.062036|2017-02-18 18:09:06.062036
NCT00024050|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2010-05-12|||February 2001||2001-02-01|May 2010|2010-05-01|August 2007|Actual|2007-08-01|||||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome|"Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation for the Treatment of Less Advanced Myelodysplasi"|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:09:06.155498|2017-02-18 18:09:06.155498
NCT00024037|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2010-06-15|||April 1995||1995-04-01|June 2010|2010-06-01|December 2002|Actual|2002-12-01|||||Interventional|||Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation|A Phase II/III Blinded Randomized Trial to Determine the Efficacy of Low Energy Diode Laser Therapy (650 nm or 780 nm) to Prevent Oral Mucositis Following Bone Marrow Transplantation|Completed||Phase 2/Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:09:06.247492|2017-02-18 18:09:06.247492
NCT00024024|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-02-08|||August 2001||2001-08-01|April 2008|2008-04-01||||August 2003|Actual|2003-08-01||Interventional|||BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma|A Phase I-II Trial Of BMS-275291 In Patients With HIV-Related Kaposi's Sarcoma|Completed||Phase 1/Phase 2|59|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:06.326519|2017-02-18 18:09:06.326519
NCT00024011|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-01-15|||July 2001||2001-07-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||PS-341 in Treating Patients With Metastatic Malignant Melanoma|A Phase II Study of PS-341 in the Treatment of Metastatic Malignant Melanoma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:06.428116|2017-02-18 18:09:06.428116
NCT00023998|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-02-01|||July 2001||2001-07-01|January 2013|2013-01-01|May 2007||2007-05-01|November 2005|Actual|2005-11-01||Interventional|||Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma|A Groupwide Phase II Study of Trastuzumab (Herceptin) in Metastatic Osteosarcoma Patients With Tumors That Overexpress HER2|Completed||Phase 2|80|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:06.533023|2017-02-18 18:09:06.533023
NCT00023985|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2011-03-03|||January 2001||2001-01-01|March 2011|2011-03-01|August 2003|Actual|2003-08-01|July 2003|Actual|2003-07-01||Interventional|||Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer|Vaccination With Autologous Tumor Lysate-Pulsed Dendritic Cells - Phase I|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:09:06.67271|2017-02-18 18:09:06.67271
NCT00023972|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2012-05-15|||July 2001||2001-07-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Randomized, Open-Label, Multicenter Phase III Study Comparing the Efficacy and Safety of a Combination of Intravenous DX-8951f (Exatecan Mesylate) Plus Gemcitabine to Gemcitabine Alone in Patients With Locally Advanced or Metastatic Cancer of the Exocrine Pancreas Who Have Not Received Prior Chemotherapy|Completed||Phase 3|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:09:06.762367|2017-02-18 18:09:06.762367
NCT00023504|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-07|2017-01-24|||September 3, 2001||2001-09-03|December 22, 2016|2016-12-22||||||||Observational|||Antibody Production in Immune Disorders|Evaluation of Immune Response to Vaccines in Primary Immune Disorders|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:14.102751|2017-02-18 18:09:14.102751
NCT00023959|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-02-06|||July 2001||2001-07-01|February 2013|2013-02-01||||March 2010|Actual|2010-03-01||Interventional|||Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer|A Phase I Study Of Bevacizumab (Recombinant Humanized Monoclonal Antibody To Vascular Endothelial Growth Factor) In Addition To Flourouracil And Hydroxyurea As Initial Chemotherapy With Concomitant Radiotherapy (B-FHX) For Poor Prognosis Head And Neck Cancer|Completed||Phase 1|39|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:07.203009|2017-02-18 18:09:07.203009
NCT00023946|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2014-05-13|||August 2001||2001-08-01|December 2012|2012-12-01|November 2009|Actual|2009-11-01|July 2005|Actual|2005-07-01||Interventional|||BMS-247550 in Treating Patients With Liver or Gallbladder Cancer|A Phase II Trial Of The Epothilone B Analog BMS-247550 (NSC 710428D) In Patients With Hepatobiliary Cancer|Terminated||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:07.338746|2017-02-18 18:09:07.338746
NCT00023933|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-01-24|||October 2001||2001-10-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer|Phase I Trial of 131I-HuCC49^CH2 for Colon Cancer|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:07.453523|2017-02-18 18:09:07.453523
NCT00023920|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-01-22|||July 2001||2001-07-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia|A Phase II Study of Bevacizumab (rhuMab VEGF, NSC 704865), Idarubicin and Cytarabine in Patients With Chronic Myeloid Leukemia in Blast Phase|Terminated||Phase 2|60|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:09:07.56626|2017-02-18 18:09:07.56626
NCT00023907|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-04-10|||July 2001||2001-07-01|May 2004|2004-05-01||||April 2006|Actual|2006-04-01||Interventional|||Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum and Paclitaxel-Resistant Ovarian or Primary Peritoneal Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:09:07.68387|2017-02-18 18:09:07.68387
NCT00023894|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-06-20|||July 2001||2001-07-01|May 2004|2004-05-01|February 2006|Actual|2006-02-01|||||Interventional|||Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer|A Phase II Evaluation of Flavopiridol (NSC# 649890) in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:07.838115|2017-02-18 18:09:07.838115
NCT00023881|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2012-10-05|||July 2001||2001-07-01|October 2012|2012-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Bortezomib in Treating Patients With Chronic Myelogenous Leukemia|Phase II Study of a Proteasome Inhibitor, PS-341 (NSC 681239) in Chronic Myelogenous Leukemia (CML) in Chronic or Accelerated Phase|Completed||Phase 2|7|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:09:07.984179|2017-02-18 18:09:07.984179
NCT00023868|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2009-01-03|||November 2001||2001-11-01|December 2003|2003-12-01||||||||Interventional|||Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver|A Randomized Phase I/III Study Of Systematic Chemotherapy With Or Without Hepatic Chemoembolization For Liver-Dominant Metastatic Adenocarcinoma Of The Colon And Rectum|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:08.078895|2017-02-18 18:09:08.078895
NCT00023855|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2015-09-30|||June 2001||2001-06-01|September 2015|2015-09-01||||October 2003|Actual|2003-10-01||Interventional|||PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacodynamic Study of Proteasome Inhibitor, PS-341, in Combination With Doxorubicin in Patients With Advanced Solid Tumors|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:09:08.184958|2017-02-18 18:09:08.184958
NCT00023842|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2012-09-20|||June 2001||2001-06-01|September 2012|2012-09-01||||February 2005|Actual|2005-02-01||Interventional|||BCG With or Without Mitomycin in Treating Patients With Bladder Cancer|A Randomized Phase II Trial of Sequential Chemo-Immunotherapy Versus Immunotherapy Alone in Carcinoma in Situ of the Urinary Bladder|Completed||Phase 2|97|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:09:08.28164|2017-02-18 18:09:08.28164
NCT00023829|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-11-12|||August 2001||2001-08-01|November 2013|2013-11-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer|Phase III Randomized Study of Adjuvant Therapy for High Risk pT3N0 Prostate Cancer|Completed||Phase 3|67|Actual|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-02-18 18:09:08.408965|2017-02-18 18:09:08.408965
NCT00023816|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-09-19||||||December 2001|2001-12-01||||||||Interventional|||Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma|Third Phase I and Pharmacokinetic Study Of FB-642 Administered Orally To Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:08.549746|2017-02-18 18:09:08.549746
NCT00023790|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2011-08-23|||August 2001||2001-08-01|August 2011|2011-08-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin|Phase I Trial of PC 4-PDT (NSC 676418) for Cutaneous Malignancies|Terminated||Phase 1|3|Actual|Case Comprehensive Cancer Center||1||slow accrual|f||||t||||||||||2017-02-18 18:09:08.642422|2017-02-18 18:09:08.642422
NCT00023777|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2015-03-05|||August 2001||2001-08-01|March 2015|2015-03-01|April 2008|Actual|2008-04-01|June 2003|Actual|2003-06-01||Interventional|||S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia|A Phase II Study Of Daunomycin And ARA-C, Both Given By Continous IV Infusion For Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) In Patients Of Age 56 Or Older|Completed||Phase 2|71|Actual|Southwest Oncology Group||1|||f||||||||||||||2017-02-18 18:09:08.774057|2017-02-18 18:09:08.774057
NCT00023764|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2015-11-02|2013-10-23||June 2001||2001-06-01|December 2012|2012-12-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Bortezomib in Treating Patients With Lymphoproliferative Disorders|Phase II Study of PS-341 in Low Grade Lymphoproliferative Disorders|Completed||Phase 2|103|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:09.132836|2017-02-18 18:09:09.132836
NCT00023283|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-30|2008-12-30||||||December 2008|2008-12-01||||||||Interventional|||Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1|Counseling Conditions for Thrice Weekly Buprenorphine in a Primary Care Clinic|Unknown status|Not yet recruiting|Phase 2|0|Anticipated|National Institute on Drug Abuse (NIDA)||3|||f||||||||||||||2017-02-18 18:09:21.039022|2017-02-18 18:09:21.039022
NCT00023751|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2016-07-01|||July 2001||2001-07-01|July 2016|2016-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer|A Phase II Study of Local Excision Alone or Local Excision Plus Adjuvant Chemoradiation Therapy for Small Distal Rectal Cancers|Completed||Phase 2|320|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:09:09.556886|2017-02-18 18:09:09.556886
NCT00023738|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-06-20|||August 2001||2001-08-01|December 2010|2010-12-01|October 2003|Actual|2003-10-01|||||Interventional|||Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma|A Phase I/II Study Of Neoadjuvant Chemotherapy, Angiogenesis Inhibitor SU5416 (NSC # 696819; A TK Inhibitor Anti-Angionesises Compound), And Radiation Therapy In The Management Of High Risk, High-Grade, Soft Tissue Sarcomas Of The Extremities And Body Wall|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:10.061266|2017-02-18 18:09:10.061266
NCT00023725|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-06-20|||August 2001||2001-08-01|August 2007|2007-08-01|October 2003|Actual|2003-10-01|||||Interventional|||Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma|A Randomized Phase I/II Study Of Preoperative Radiotherapy With/Without SUGEN 5416 (NSC # 696819; A TK Inhibitor Anti-Angiogenesis Compound) In The Management Of Low To Intermediate Grade Soft Tissue Sarcoma Of The Trunk or Extremity|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:10.401517|2017-02-18 18:09:10.401517
NCT00023712|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2014-04-29|2013-09-17||July 2004||2004-07-01|December 2012|2012-12-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional||Cohort 1: 2 participants were not eligible/evaluable after enrollment. Cohort 2: 1 participant was not eligible/evaluable after enrollment.|Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Bortezomib (Velcade™, PS-341, NSC #681239, IND #58443) in the Treatment of Persistent or Recurrent Platinum-Sensitive Epithelial Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|58|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:10.857222|2017-02-18 18:09:10.857222
NCT00023699|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-06-20|||August 2001||2001-08-01|August 2003|2003-08-01|May 2006|Actual|2006-05-01|||||Interventional|||Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Trial of ZD1839 (Iressa) (NSC# 715055) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:11.791413|2017-02-18 18:09:11.791413
NCT00023686|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2016-07-01|||October 2001||2001-10-01|July 2016|2016-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer|A Randomized Trial of Radical Prostatectomy Versus Brachytherapy for Patients With T1c or T2a N0 M0 Prostate Cancer|Completed||Phase 3|190|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:09:11.96549|2017-02-18 18:09:11.96549
NCT00023673|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2015-11-14|2014-02-12||July 2001||2001-07-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|January 2009|Actual|2009-01-01||Interventional||Eligible patients who started protocol treatment.|Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer|A Phase I/II Dose Intensification Study Using Three Dimensional Conformal Radiation Therapy And Concurrent Chemotherapy For Patients With Inoperable, Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|63|Actual|Radiation Therapy Oncology Group|This study was originally designed to escalate 3DRT via increasing doses per fraction. However, due to excessive toxicity at dose level 1 (75.25 Gy, 2.15 Gy/fraction), the protocol was amended in January 2003 to de-escalate 3DRT dose.|4|||f||||||||||||||2017-02-18 18:09:12.140837|2017-02-18 18:09:12.140837
NCT00023660|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-11-18|||August 2001||2001-08-01|November 2013|2013-11-01||||January 2005|Actual|2005-01-01||Interventional|||Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer|A Phase I/II Study Of COX-2 Inhibitor, CELEBREX (CELECOXIB), And Chemoradiation In Patients With Locally Advanced Cervical Cancer|Completed||Phase 1/Phase 2|84|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:09:12.893254|2017-02-18 18:09:12.893254
NCT00023647|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2012-07-09|||July 2000||2000-07-01|July 2012|2012-07-01|November 2002|Actual|2002-11-01|April 2002|Actual|2002-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|A Phase I Dose-Ranging Safety Study Using Intranodal Delivery of a Plasmid DNA (Synchrotope TA2M) in Adult Stage IV Melanoma Patients|Completed||Phase 1|26|Actual|Mannkind Corporation||3|||f||||f||||||||||2017-02-18 18:09:13.025153|2017-02-18 18:09:13.025153
NCT00023634|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2015-03-05|||June 2001||2001-06-01|March 2015|2015-03-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer|An Early Phase Study of an EGFRvIII Peptide Based Vaccine in Patients With EGFRvIII Expressing Cancers|Terminated||Phase 1|14|Actual|Southwest Oncology Group||2||lack of accrual|f||||t||||||||||2017-02-18 18:09:13.136247|2017-02-18 18:09:13.136247
NCT00023621|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-13|2013-06-25|||February 2001||2001-02-01|July 2007|2007-07-01|July 2007|Actual|2007-07-01|||||Interventional|||Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome|A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Celecoxib in Subjects With Basal Cell Nevus Syndrome|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:13.379709|2017-02-18 18:09:13.379709
NCT00023595|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-11|2016-07-22|||January 2002||2002-01-01|July 2016|2016-07-01|December 2015|Actual|2015-12-01|December 2015|Actual|2015-12-01||Interventional|STICH||Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease|Surgical Treatment for Ischemic Heart Failure (STICH)|Completed||Phase 3|2136|Actual|Duke University||3|||f||||t||||||||||2017-02-18 18:09:13.482557|2017-02-18 18:09:13.482557
NCT00023582|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-10|2008-08-07||||||November 2006|2006-11-01||||||||Observational|||HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru|HIV Prevalence, Incidence and HSV-2 Prevalence Among High-Risk MSM in Lima, Peru|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:09:13.607139|2017-02-18 18:09:13.607139
NCT00023569|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-08|2008-03-03|||September 2001||2001-09-01|September 2003|2003-09-01|September 2003||2003-09-01|||||Observational|||Electrical Stimulation to Improve Hand Function in Patients With Chronic Stroke|Cortical Motor Reorganization in Chronic Stroke Following EMG Triggered NMES Therapy|Completed||N/A|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:13.691651|2017-02-18 18:09:13.691651
NCT00023491|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-07|2008-03-03|||September 2001||2001-09-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells|Assessment of the Potential of Hematopoietic Stem Cells to Transdifferentiate Into Salivary Gland and Oral Mucosal Epithelial Cells in Adult Bone Marrow Transplant Patients|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:14.203876|2017-02-18 18:09:14.203876
NCT00023465|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging|Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging|Unknown status|Recruiting|N/A|10||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:09:14.289915|2017-02-18 18:09:14.289915
NCT00023452|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2015-07-30|2012-08-15||June 2001||2001-06-01|July 2015|2015-07-01|September 2013|Actual|2013-09-01|October 2010|Actual|2010-10-01||Interventional|PREVENT TB||Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection|TBTC Study 26: Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months Versus Daily Isoniazid for 9 Months for the Treatment of Latent Tuberculosis Infection|Completed||Phase 3|8595|Actual|Centers for Disease Control and Prevention||2|||f||||t||||||||||2017-02-18 18:09:14.387683|2017-02-18 18:09:14.387683
NCT00023439|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2011-08-02|||May 2000||2000-05-01|June 2011|2011-06-01||||||||Observational|||TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment|Study of the Performance of Several Nucleic Acid Amplification Methodologies in the Diagnosis and Management of Active TB|Completed||N/A|300|Anticipated|Centers for Disease Control and Prevention|||1||f||||||||||||||2017-02-18 18:09:18.28594|2017-02-18 18:09:18.28594
NCT00023426|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2005-09-09|||July 1999||1999-07-01|September 2005|2005-09-01|February 2003||2003-02-01|||||Interventional|||TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis|TBTC Study 25:A Prospective, Randomized, Double-Blind Study of the Tolerability of Higher Doses of Rifapentine|Completed||Phase 2|150||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 18:09:18.393837|2017-02-18 18:09:18.393837
NCT00023413|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2012-06-04|||November 1999||1999-11-01|June 2012|2012-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz|TBTC Study 23C: Intensive Pharmacokinetic Study of Intermittent Rifabutin and Isoniazid With Daily Efavirenz in Combination With Two Nucleoside Analogs for Treatment of HIV and Tuberculosis Co-infections|Completed||Phase 2|20||Centers for Disease Control and Prevention|||||f||||||||||||||2017-02-18 18:09:18.514586|2017-02-18 18:09:18.514586
NCT00023400|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2005-09-01|||February 2000||2000-02-01|September 2005|2005-09-01|February 2002||2002-02-01|||||Interventional|||TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB|TBTC Study 23B:Intensive Pharmacokinetics of the Nelfinavir Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen|Completed||Phase 4|20||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 18:09:18.629702|2017-02-18 18:09:18.629702
NCT00023387|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2005-09-09|||March 2000||2000-03-01|September 2005|2005-09-01|May 2001||2001-05-01|||||Interventional|||TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine|Intensive Pharmacokinetic Study of Three Doses of Rifapentine (600, 900 and 1200mg) During Continuation Phase Therapy of Tuberculosis in HIV-Negative Adults|Completed||N/A|36||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 18:09:19.011731|2017-02-18 18:09:19.011731
NCT00023374|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2011-08-02|||August 2000||2000-08-01|June 2011|2011-06-01|December 2010|Actual|2010-12-01|December 2006|Actual|2006-12-01||Interventional|||TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance|TBTC Study 24: A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance|Completed||N/A|98|Actual|Centers for Disease Control and Prevention||1|||f||||t||||||||||2017-02-18 18:09:19.133754|2017-02-18 18:09:19.133754
NCT00023361|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2005-09-01|||February 1999||1999-02-01|September 2005|2005-09-01|February 2003||2003-02-01|||||Interventional|||TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen|TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen|Completed||N/A|215||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 18:09:19.266814|2017-02-18 18:09:19.266814
NCT00023348|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2005-09-09|||July 1999||1999-07-01|September 2005|2005-09-01|November 2002||2002-11-01|||||Interventional|||TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB|TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in USPHS Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen|Completed||Phase 2/Phase 3|150||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 18:09:19.396566|2017-02-18 18:09:19.396566
NCT00023335|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-06|2005-09-01|||April 1995||1995-04-01|September 2005|2005-09-01|March 2001||2001-03-01|||||Interventional|||TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis|TBTC Study 22: Efficacy and Safety of Once-Weekly Rifapentine and Isoniazid Compared to Efficacy and Safety of Once-Weekly Rifapentine and Isoniazid Compared to Twice-Weekly Rifampin and Isoniazid in the Continuation Phase of Therapy for Pulmonary Tuberculosis|Completed||Phase 3|1000||Centers for Disease Control and Prevention|||||||||||||||||||2017-02-18 18:09:19.526363|2017-02-18 18:09:19.526363
NCT00023322|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-03|2013-07-09|2013-04-15||August 2001||2001-08-01|July 2013|2013-07-01|October 2012|Actual|2012-10-01|May 2012|Actual|2012-05-01||Interventional|||Pegylated Interferon to Treat Chronic Hepatitis D|Treatment of Chronic Delta Hepatitis With Pegylated Interferon|Completed||Phase 2|13|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 18:09:19.638214|2017-02-18 18:09:19.638214
NCT00023309|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-03|2016-09-22|2011-07-07||August 2001||2001-08-01|July 2014|2014-07-01|August 2013|Actual|2013-08-01|April 2010|Actual|2010-04-01||Interventional|||Lamivudine and Adefovir to Treat Chronic Hepatitis B|Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B|Completed||Phase 2|41|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:09:19.977127|2017-02-18 18:09:19.977127
NCT00023296|ClinicalTrials.gov processed this data on February 17, 2017|2001-09-03|2017-01-24|||July 27, 2001||2001-07-27|November 9, 2015|2015-11-09|November 9, 2015|Actual|2015-11-09|November 2, 2006|Actual|2006-11-02||Interventional|||Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension|Inhaled Nitric Oxide and Transfusion Therapy for Patients With Sickle Cell Anemia and Secondary Pulmonary Hypertension|Completed||Phase 1|59|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:09:20.931232|2017-02-18 18:09:20.931232
NCT00023244|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-29|2016-10-19|||January 2001||2001-01-01|October 2016|2016-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Steroid Withdrawal in Pediatric Kidney Transplant Recipients|A Double-Blind Randomized Trial of Steroid Withdrawal in Sirolimus- and Cyclosporine-Treated Primary Transplant Recipients|Terminated||Phase 2|274|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2||"Effective August 13, 2004: Unanticipated high incidence of post-transplant lymphoproliferative~   disorder"|f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 18:09:21.148069|2017-02-18 18:09:21.148069
NCT00023231|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-29|2016-10-19|||February 2001||2001-02-01|October 2016|2016-10-01|August 2006|Actual|2006-08-01|August 2004|Actual|2004-08-01||Interventional|||Pediatric Kidney Transplant Without Calcineurin Inhibitors|Calcineurin Inhibitor Sparing Protocol in Living Donor Pediatric Kidney Transplantation|Completed||N/A|35|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 18:09:21.302349|2017-02-18 18:09:21.302349
NCT00023218|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-29|2015-03-05||||||June 2003|2003-06-01||||||||Interventional|||Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis|Effect of Change to a Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimen of Efavirenz (EFV) and Lopinavir/Ritonavir (LPV/r) on Liver Histology in HIV-1-Infected Individuals With Lactic Acidemia and Persistent Alanine Aminotransferase (ALT) Elevations on NRTI-Containing Antiretroviral Therapy|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:09:21.425845|2017-02-18 18:09:21.425845
NCT00023205|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-29|2013-12-23|||November 2002||2002-11-01|December 2013|2013-12-01|December 2006|Actual|2006-12-01|August 2006|Actual|2006-08-01||Interventional|||Impact of Literacy Level on Patient Education and Health Among People With Arthritis|Literacy in Arthritis Management: A Randomized Controlled Clinical Trial of a Novel Education Intervention|Completed||Phase 2|134|Actual|Brigham and Women's Hospital||2|||f||||||||||||||2017-02-18 18:09:21.520981|2017-02-18 18:09:21.520981
NCT00023192|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-29|2008-03-03|||August 2001||2001-08-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care|Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care|Completed||Phase 3|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:21.631889|2017-02-18 18:09:21.631889
NCT00023166|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-24|2005-06-23|||May 2001||2001-05-01|March 2004|2004-03-01|May 2002||2002-05-01|||||Interventional|||Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas|Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas|Terminated||Phase 1|||Enzon Pharmaceuticals, Inc.|||||||||||||||||||2017-02-18 18:09:21.721234|2017-02-18 18:09:21.721234
NCT00023153|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-24|2008-03-03|||August 2001||2001-08-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection|Studies of the Addition of Adefovir Dipivoxil to Lamivudine for the Treatment of Chronic Hepatitis B: A Randomized, Double-Blind, Placebo Controlled Study in HIV-Infected Patients and an Open-Label Study in HIV-Negative Subjects|Completed||Phase 3|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:21.791175|2017-02-18 18:09:21.791175
NCT00023140|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-22|2015-04-13|||July 1999||1999-07-01|April 2015|2015-04-01|June 2002|Actual|2002-06-01|May 2002|Actual|2002-05-01||Observational|||Collaborative Study of 1,3 Butadiene Biomarkers|Collaborative Study of 1,3 Butadiene Biomarkers|Completed||N/A|80||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:09:21.886181|2017-02-18 18:09:21.886181
NCT00022087|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-07-15|||December 2001||2001-12-01|July 2016|2016-07-01|February 2009|Actual|2009-02-01|March 2007|Actual|2007-03-01||Interventional|||Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer|Phase III Trial of Intravenous Zoledronic Acid (Zometa) in the Prevention of Bone Loss in Localized Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure|Completed||Phase 3|439|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:09:21.958126|2017-02-18 18:09:21.958126
NCT00022074|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-10-13|||July 2001||2001-07-01|October 2015|2015-10-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Gabapentin For the Control of Hot Flashes in Women With Breast Cancer|Control of Vasomotor Symptoms in Women Treated for Breast Cancer|Completed||N/A|||University of Rochester|||||f||||||||||||||2017-02-18 18:09:22.192465|2017-02-18 18:09:22.192465
NCT00022048|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-05-14|||August 2001||2001-08-01|October 2004|2004-10-01|November 2004|Actual|2004-11-01|||||Interventional|||Bevacizumab in Treating Patients With Myelodysplastic Syndrome|Safety and Efficacy Trial of Bevacizumab: Anti-VEGF Humanized Monoclonal Antibody (NSC 704865) Therapy for Myelodysplastic Syndrome (MDS)|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:22.308753|2017-02-18 18:09:22.308753
NCT00022035|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-01-30|||August 2000||2000-08-01|January 2013|2013-01-01||||November 2002|Actual|2002-11-01||Interventional|||Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia|Influenza Vaccine Immunogenicity in Children During and After Therapy for Acute Lymphoblastic Leukemia|Completed||N/A|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:09:22.415907|2017-02-18 18:09:22.415907
NCT00022022|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-12-17|||December 2000||2000-12-01|April 2006|2006-04-01||||||||Interventional|||Docetaxel in Treating Patients With Non-Small Cell Lung Cancer|Docetaxel In Second-Line Treatment Of Advanced Non-Small-Cell Lung Cancer - The Distal Study|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:22.503583|2017-02-18 18:09:22.503583
NCT00022009|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-09-19|||July 2001||2001-07-01|October 2002|2002-10-01||||||||Interventional|||Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|Phase I/II Randomized Trial Comparing Two Treatment Schedules Of Gemcitabine In Poor Prognosis Status Patients With Advanced Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:22.87635|2017-02-18 18:09:22.87635
NCT00021476|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-16|2013-08-09|||May 2001||2001-05-01|August 2013|2013-08-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Preventing Chronic Whiplash Pain|Preventing Chronic Whiplash Pain: Biobehavioral Approach|Completed||Phase 3|300||University of Washington|||||f||||||||||||||2017-02-18 18:09:42.874757|2017-02-18 18:09:42.874757
NCT00021996|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-07-17|||January 2001||2001-01-01|February 2002|2002-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Valdecoxib in Treating Chronic Pain in Cancer Patients|Clinical Protocol for a Randomized Double-Blind, Placebo-Controlled Comparison of the Analgesic Activity of Valdecoxib (SC-65872) 40mg BID as Add-On Therapy to Opioid Medication in Patients With Chronic Cancer Pain|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:22.974622|2017-02-18 18:09:22.974622
NCT00021983|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-04-28|||December 1998||1998-12-01|January 2006|2006-01-01||||||||Interventional|||Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia|Phase I Study of BL22, a Recombinant Immunotoxin for Treatment of CD22+ Leukemias and Lymphomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:23.062089|2017-02-18 18:09:23.062089
NCT00021970|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-02-29|||April 2001||2001-04-01|February 2016|2016-02-01|March 2005||2005-03-01|||||Observational|||Modifying Oxidative Damage in WAVE - Ancillary to WAVE||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:09:23.154381|2017-02-18 18:09:23.154381
NCT00021957|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-02-17|||April 2001||2001-04-01|May 2005|2005-05-01|March 2005|Actual|2005-03-01|||||Observational|||ESCAPE Mechanistic Substudies - Ancillary to ESCAPE||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:09:23.220804|2017-02-18 18:09:23.220804
NCT00023127|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-22|2006-03-22||||||March 2006|2006-03-01||||||||Interventional|||Reducing Indoor Allergen Exposures in Northern Manhattan and the South Bronx||Completed||N/A|40||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:09:23.288632|2017-02-18 18:09:23.288632
NCT00023114|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-22|2006-09-01|||September 2000||2000-09-01|September 2006|2006-09-01|September 2001||2001-09-01|||||Observational|||p450 Mediated Lung Toxicity||Completed||N/A|10||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:09:23.365379|2017-02-18 18:09:23.365379
NCT00023101|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-22|2006-03-22|||August 1996||1996-08-01|March 2006|2006-03-01||||||||Observational|||Lead, Endocrine Disruption and Reproductive Outcomes||Completed||N/A|800||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:09:23.425246|2017-02-18 18:09:23.425246
NCT00023088|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-22|2017-01-24|||April 13, 1994||1994-04-13|July 9, 2008|2008-07-09|July 9, 2008||2008-07-09|||||Observational|||Screening Study for the Department of Rehabilitation Medicine|Rehabilitation Medicine Screening Protocol|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:23.483909|2017-02-18 18:09:23.483909
NCT00023075|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-22|2008-03-03|||August 2001||2001-08-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Observational|||Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis|Nuclear Magnetic Spectroscopy for the Evaluation of Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:23.562177|2017-02-18 18:09:23.562177
NCT00023062|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-22|2008-03-03|||August 2001||2001-08-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Observational|||Transcranial Magnetic Stimulation in Parkinson's Disease|TMS Measures in Parkinson's Disease|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:23.646124|2017-02-18 18:09:23.646124
NCT00023049|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-21|2017-01-24|||August 17, 2001||2001-08-17|August 31, 2016|2016-08-31||||||||Observational|||Genetic Analysis of Hereditary Disorders of Hearing and Balance|Genetic Analysis of Hereditary Disorders of Hearing and Balance|Recruiting||N/A|750|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:23.723755|2017-02-18 18:09:23.723755
NCT00023036|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-21|2017-01-24|||August 17, 2001||2001-08-17|August 15, 2016|2016-08-15||||||||Observational|||Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts|Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:23.827338|2017-02-18 18:09:23.827338
NCT00023023|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-18|2017-01-24|||August 15, 2001||2001-08-15|August 12, 2016|2016-08-12||||||||Observational|||Study of Transfusion-Transmitted Infections|A Prospective Study of Transfusion-Transmitted Infections|Recruiting||N/A|2800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:23.937974|2017-02-18 18:09:23.937974
NCT00023010|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-18|2017-01-24|||August 15, 2001||2001-08-15|December 13, 2010|2010-12-13|December 13, 2010||2010-12-13|||||Observational|||Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)|Follow-Up of a Phase-I Gene Therapy Trial of Patients With Leukocyte Adherence Deficiency|Completed||N/A|2|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:24.045617|2017-02-18 18:09:24.045617
NCT00022997|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-17|2017-01-24|||August 15, 2001||2001-08-15|April 29, 2016|2016-04-29||||||||Observational|||Study of Taste Deficits|Studies of Deficits in the Sense of Taste|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:24.128902|2017-02-18 18:09:24.128902
NCT00022984|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-17|2008-03-03|||August 2001||2001-08-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Technology Dependency and Health-Related Quality of Life|Toward a Theory of Technology Dependency and Health Related Quality of Life (HRQL): A Test of a Model in Patients With an Implantable Cardioverter Defibrillator|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:24.232193|2017-02-18 18:09:24.232193
NCT00022971|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-17|2017-01-24|||August 15, 2001||2001-08-15|September 23, 2016|2016-09-23|January 22, 2010|Actual|2010-01-22|January 22, 2010|Actual|2010-01-22||Interventional|||Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia|Combination Antibody Therapy With Apolizumab (1D10) and Rituximab (CD20) in Relapsed Lymphoma and CLL|Completed||Phase 1|35|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:09:24.322208|2017-02-18 18:09:24.322208
NCT00022958|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-16|2005-06-23|||September 1998||1998-09-01|August 2004|2004-08-01||||||||Interventional|||Expanded Access Study of Iodine-131 Anti-B1 Antibody|Expanded Access Study of Iodine-131 Anti-B1 Antibody for Relapsed/Refractory Low-Grade and Transformed Low-Grade Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|N/A|||Corixa Corporation|||||||||||||||||||2017-02-18 18:09:24.440701|2017-02-18 18:09:24.440701
NCT00022945|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-16|2005-06-23||||||January 2005|2005-01-01||||||||Interventional|||Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma|Phase II Study Of Iodine-131 Anti-B1 Antibody Plus CHOP For Patients With Previously Untreated Mantle Cell Lymphoma|Completed||Phase 2|||Corixa Corporation|||||||||||||||||||2017-02-18 18:09:24.524934|2017-02-18 18:09:24.524934
NCT00022932|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-16|2005-06-23|||January 2000||2000-01-01|September 2004|2004-09-01||||||||Interventional|||Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP|Phase II Multicenter Study of Iodine-131 Anti-B1 Antibody Consolidation For Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Following First-Line CHOP|Unknown status|Active, not recruiting|Phase 2|||Corixa Corporation|||||||||||||||||||2017-02-18 18:09:24.621414|2017-02-18 18:09:24.621414
NCT00022919|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-16|2008-03-03|||August 2001||2001-08-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods|Analysis of Prostate Cancer Short-Term Cultures Utilizing Molecular Cytogenetic Methods|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:24.710165|2017-02-18 18:09:24.710165
NCT00022906|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-15|2005-06-23|||May 1999||1999-05-01|August 2004|2004-08-01||||||||Interventional|||Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement|Phase I, Dose-Escalation Study of Iodine-131 Anti-B1 Antibody For Patients With Previously Treated Non-Hodgkin's Lymphoma With More Than 25% Bone Marrow Involvement|Unknown status|Active, not recruiting|Phase 1|24||Corixa Corporation|||||||||||||||||||2017-02-18 18:09:24.789857|2017-02-18 18:09:24.789857
NCT00022893|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-15|2005-06-23||||||August 2004|2004-08-01||||||||Interventional|||Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma|Retreatment Study of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti-B1 Antibody.|Unknown status|Active, not recruiting|N/A|||Corixa Corporation|||||||||||||||||||2017-02-18 18:09:24.877941|2017-02-18 18:09:24.877941
NCT00022880|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-15|2005-06-23|||July 1999||1999-07-01|August 2004|2004-08-01||||||||Interventional|||Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia|A Phase I, Dose-Escalation, Open-Label, Multicenter Study of Iodine-131, Anti-B1 Antibody for Intermediate- and High-Risk B-Cell Chronic Lymphocytic Leukemia|Unknown status|Active, not recruiting|Phase 1|30||Corixa Corporation|||||||||||||||||||2017-02-18 18:09:24.973025|2017-02-18 18:09:24.973025
NCT00022867|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-14|2015-07-23|||May 2001||2001-05-01|July 2015|2015-07-01|November 2006|Actual|2006-11-01|January 2005|Actual|2005-01-01||Interventional|||Encouraging Calcium Absorption and Bone Formation During Early Puberty|Optimization of Calcium Absorption and Bone Formation During Early Puberty|Completed||Phase 1/Phase 2|100||Baylor College of Medicine|||||f||||t||||||||||2017-02-18 18:09:25.06048|2017-02-18 18:09:25.06048
NCT00022854|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-14|2013-05-02|||May 2001||2001-05-01|May 2013|2013-05-01|January 2005|Actual|2005-01-01|||||Interventional|||Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction|Outcomes After ACL Reconstruction: The Effect of Femoral Nerve Block Analgesia|Completed||Phase 4|270|Actual|University of Pittsburgh||3|||f||||t||||||||||2017-02-18 18:09:25.163242|2017-02-18 18:09:25.163242
NCT00022841|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-14|2007-12-14||||||December 2007|2007-12-01|September 2005|Actual|2005-09-01|||||Interventional|||Prevention of Steroid-Induced Osteoporosis in Children|Prevention of Steroid-Induced Osteoporosis in Children|Terminated||Phase 1/Phase 2|40||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||||Inadequate eligible subjects to expect sufficient numbers to analyse outcomes.|||||||||||||||2017-02-18 18:09:25.279599|2017-02-18 18:09:25.279599
NCT00022828|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-14|2007-01-02|||January 2003||2003-01-01|October 2006|2006-10-01|January 2006||2006-01-01|||||Observational|||3-D Laser Imaging to Analyze Neck Movement|3-D Laser Imaging for Cervical Spine Motion Analysis|Unknown status|Active, not recruiting|Phase 1|134||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:09:25.367328|2017-02-18 18:09:25.367328
NCT00022815|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-14|2008-04-11|||June 2002||2002-06-01|April 2008|2008-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Management of Compartment Syndrome With Ultrafiltration|Management of Compartment Syndrome With Ultrafiltration|Completed||Phase 1|10||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:09:25.452024|2017-02-18 18:09:25.452024
NCT00022802|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-14|2009-04-07|||December 2002||2002-12-01|April 2009|2009-04-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Image Guided System for Orthopaedic Surgery|Image Guided Surgical System for Orthopaedic Trauma|Terminated||Phase 2|40||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||||Grant expired|f||||||||||||||2017-02-18 18:09:25.529743|2017-02-18 18:09:25.529743
NCT00022789|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-14|2014-03-12|||August 2001||2001-08-01|March 2014|2014-03-01|November 2006|Actual|2006-11-01|June 2006|Actual|2006-06-01||Observational|||Prevalence of Sleep-Disordered Breathing in Children|Prevalence of Sleep Disordered Breathing in Children|Completed||N/A|700|Actual|Milton S. Hershey Medical Center|||1||f||||f||||||||||2017-02-18 18:09:25.612889|2017-02-18 18:09:25.612889
NCT00022776|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-13|2013-02-26|||September 2000||2000-09-01|February 2013|2013-02-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Surgical Versus Nonsurgical Treatment for Spinal Stenosis|Randomized Clinical Trial of Treatment for Spinal Stenosis|Completed||Phase 3|178|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 18:09:25.698033|2017-02-18 18:09:25.698033
NCT00022763|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-11|2016-01-19|2015-12-04||August 2001||2001-08-01|January 2016|2016-01-01||||December 2004|Actual|2004-12-01||Interventional|||T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents|A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents|Completed||Phase 2|52|Actual|Hoffmann-La Roche||1|||||||||||||||||2017-02-18 18:09:25.816391|2017-02-18 18:09:25.816391
NCT00022750|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2010-01-14|||October 2000||2000-10-01|January 2010|2010-01-01|May 2005||2005-05-01|||||Interventional|||Randomized Trial of Health Events Costs in Diabetic Blacks|Project Sugar 2: Health Events Costs in Diabetic Blacks|Completed||N/A|800||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:09:26.625817|2017-02-18 18:09:26.625817
NCT00022737|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2014-02-26|||October 2002||2002-10-01|November 2012|2012-11-01||||October 2006|Actual|2006-10-01||Interventional|||Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia|A Children's Oncology Group Pilot Study for the Treatment of Very High Risk Acute Lymphoblastic Leukemia in Children and Adolescents (Imatinib (STI571, GLEEVEC) NSC#716051)|Completed||Phase 3|220|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:26.718433|2017-02-18 18:09:26.718433
NCT00022724|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2008-11-22|||December 2001||2001-12-01|January 2005|2005-01-01||||||||Interventional|||CCI-779 in Treating Patients With Malignant Glioma|Phase I/II Trial Of CCI-779 In Patients With Malignant Glioma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:26.876932|2017-02-18 18:09:26.876932
NCT00022711|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-07-10|||January 2002||2002-01-01|July 2013|2013-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer|A Phase II Study of Temozolomide (SCH 52365) in the Treatment of Patients With Relapsed Small Cell Lung Cancer|Completed||Phase 2|7|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-02-18 18:09:26.98068|2017-02-18 18:09:26.98068
NCT00022698|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-03-16|2016-03-16||May 2001||2001-05-01|February 2005|2005-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional||The All Patients Population included participants who received at least one dose of study drug in Cohort 1 or Cohort 2.|Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer|A Phase II Study of Oral Xeloda (Capecitabine) in Combination With Intravenous Irinotecan for Patients With Locally Advanced and/or Metastatic Colorectal Cancer|Completed||Phase 2|67|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 18:09:27.120881|2017-02-18 18:09:27.120881
NCT00022685|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-12-18|||September 2001||2001-09-01|April 2003|2003-04-01||||||||Interventional|||Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma|A Phase III Clinical Trial of Immunotherapy With Humanized LL2 IgG (Epratuzumab) in Patients With Low-Grade Follicular, B-Cell Non-Hodgkin's Lymphoma Refractory to Rituxan (Rituximab)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:27.838979|2017-02-18 18:09:27.838979
NCT00022672|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-06-07|2013-04-02||January 2001||2001-01-01|June 2013|2013-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer|A Randomized, Open-label Study of the Effect of Herceptin Plus Arimidex Compared With Arimidex Alone on Progression-free Survival in Patients With HER2-positive and Hormone-receptor Positive Metastatic Breast Cancer|Completed||Phase 3|208|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 18:09:27.950689|2017-02-18 18:09:27.950689
NCT00022659|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-04-23|2015-04-23||April 2002||2002-04-01|December 2012|2012-12-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional||Eligible and treated patients.|Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase II Evaluation of Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) (NSC #704865) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma|Completed||Phase 2|64|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:28.866519|2017-02-18 18:09:28.866519
NCT00022646|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-12-05|||August 2001||2001-08-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|November 2003|Actual|2003-11-01||Interventional|||Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer|A Phase II Clinical Trial Evaluating Three Schedules Of ALIMTA Plus Gemcitabine As Frontline Chemotherapy For Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|157|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-02-18 18:09:29.587693|2017-02-18 18:09:29.587693
NCT00022633|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-07-08|2012-11-26||July 2001||2001-07-01|July 2016|2016-07-01|July 2011|Actual|2011-07-01|June 2008|Actual|2008-06-01||Interventional||All eligible patients who started treatment were included in the analysis|S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract|Protocol for Assessment of Gemcitabine and Paclitaxel for Metastatic Urothelial Cancer in Patients Aged 70 Years or Older (and in a Cohort of Patients Younger Than 60 Years)|Terminated||Phase 2|65|Actual|Southwest Oncology Group||1||Permanently Closed Due to Poor Accrual|f||||f||||||||||2017-02-18 18:09:29.740061|2017-02-18 18:09:29.740061
NCT00022620|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2012-09-20|||June 2001||2001-06-01|September 2012|2012-09-01||||October 2002|Actual|2002-10-01||Interventional|||Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer|Phase II Study On Paclitaxel In Recurrent Uterine Papillary Serous Carcinoma (UPSC)|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:09:30.502321|2017-02-18 18:09:30.502321
NCT00022607|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-06-20|||January 2002||2002-01-01|October 2004|2004-10-01|May 2006|Actual|2006-05-01|||||Interventional|||Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma|Phase II Randomized Trial of Bevacizumab Versus Bevacizumab and Thalidomide for Relapsed/Refractory Multiple Myeloma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:30.597527|2017-02-18 18:09:30.597527
NCT00022594|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2012-07-23|||May 2001||2001-05-01|July 2012|2012-07-01||||August 2002|Actual|2002-08-01||Interventional|||Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer|Phase II Study Of NX 211 (Liposomal Lurtotecan) Given As An IV Bolus Injection On Days 1 and 8 Every 3 Weeks In Patients With Metastatic Or Loco-Regional Recurrent Squamous Cell Carcinoma Of The Head and Neck With Target Lesions Within Previously Irradiated Fields Or Outside Previously Irradiated Fields|Completed||Phase 2|50|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:09:30.688159|2017-02-18 18:09:30.688159
NCT00022581|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-01-04|||July 2001||2001-07-01|January 2013|2013-01-01||||December 2004|Actual|2004-12-01||Interventional|||Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial of Thalidomide (NSC #66847, IND #48832) for Patients With Relapsed or Refractory Low Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|45|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:30.805336|2017-02-18 18:09:30.805336
NCT00022568|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-12-17|||August 2001||2001-08-01|December 2003|2003-12-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|A Phase I Trial of Intra Lesional rV-Tricom Vaccine in the Treatment of Malignant Melanoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:30.911023|2017-02-18 18:09:30.911023
NCT00022555|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-01-24|||November 2001||2001-11-01|January 2013|2013-01-01||||July 2003|Actual|2003-07-01||Interventional|||Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma|A Phase I Trial of Combination Bryostatin-1 and Vincristine in HIV-Related B-cell Neoplasms|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:31.007116|2017-02-18 18:09:31.007116
NCT00022542|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-04-14|||June 2001||2001-06-01|December 2012|2012-12-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma|A Phase II Study of Epothilone B Analog (BMS-247550) in Advanced Soft Tissue Sarcomas|Terminated||Phase 2|26|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:31.123111|2017-02-18 18:09:31.123111
NCT00022529|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-01-24|||July 2001||2001-07-01|January 2013|2013-01-01||||January 2004|Actual|2004-01-01||Interventional|||BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors|Phase I Study of Intravenous BMS-214662 FTI (NSC# 710086) and Herceptin (NSC# 688097) Weekly in Patients With Advanced Malignancies|Completed||Phase 1|28|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:31.233941|2017-02-18 18:09:31.233941
NCT00022516|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-08-05|2015-11-06||November 2000||2000-11-01|August 2016|2016-08-01|August 2016|Actual|2016-08-01|January 2015|Actual|2015-01-01||Interventional|22-00|Patients who started overall study|Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer|"Low-dose Cytotoxics as Anti-angiogenesis Treatment Following Adjuvant Induction Chemotherapy for Patients With ER-negative and PgR-negative Breast Cancer"|Completed||Phase 3|1086|Actual|International Breast Cancer Study Group|This trial collected only Grade 3 or higher Adverse Events.|2|||f||||t||||||||||2017-02-18 18:09:31.348093|2017-02-18 18:09:31.348093
NCT00022490|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-12-08|2012-06-06||June 2001||2001-06-01|December 2015|2015-12-01|July 2011|Actual|2011-07-01|May 2011|Actual|2011-05-01||Interventional|||Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia|A Phase II Study To Determine The Anti-Leukemic Effects Of STI571 In Combination With Ara-C In Patients With Chronic Myelogenous Leukemia In Chronic Phase|Terminated||Phase 2|24|Actual|OHSU Knight Cancer Institute|Study was terminated, therefore the 12 month response data was not analyzed.|1|||f||||t||||||||||2017-02-18 18:09:31.803685|2017-02-18 18:09:31.803685
NCT00022477|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-09-04|||September 2001||2001-09-01|September 2013|2013-09-01|December 2004|Actual|2004-12-01|October 2002|Actual|2002-10-01||Interventional|||BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer|A Phase II Study Of Epothilone B Analog BMS-247550 (NSC 710428D) In Patients With Advanced Colorectal Carcinoma|Completed||Phase 2|24|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:09:32.038716|2017-02-18 18:09:32.038716
NCT00022464|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-06-03|||June 2001||2001-06-01|June 2015|2015-06-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||CCI-779 in Treating Patients With Metastatic Melanoma|A Phase II Study Of CCI-779 (NSC 683864) In Metastatic Melanoma|Completed||Phase 2|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:09:32.183697|2017-02-18 18:09:32.183697
NCT00022451|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2012-03-14|||June 2001||2001-06-01|March 2012|2012-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Tipifarnib in Treating Young Patients With Refractory Leukemia|A Phase I Trial and Pharmacokinetic Study of R115777 in Pediatric Patients With Refractory Leukemia|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:32.289466|2017-02-18 18:09:32.289466
NCT00022438|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-06-17|||June 2001||2001-06-01|July 2004|2004-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment|Immunization of HLA-0201 Positive Patients With Metastatic Melanoma Using a Peptide From Tyrosinase-related Protein 2 (TRP-2)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:32.73138|2017-02-18 18:09:32.73138
NCT00022425|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-12-17|||June 2001||2001-06-01|September 2003|2003-09-01||||||||Interventional|||Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy|Multiple-Dose Phase I and Pharmacokinetic Trial of Perillyl Alcohol|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:32.831644|2017-02-18 18:09:32.831644
NCT00022412|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-10-10|||August 2001||2001-08-01|October 2016|2016-10-01|August 2008|Actual|2008-08-01|February 2006|Actual|2006-02-01||Interventional|||Doxercalciferol Before Surgery in Treating Localized Prostate Cancer|Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN|Completed||Phase 2|60|Anticipated|University of Wisconsin, Madison||2|||f||||f||||||||||2017-02-18 18:09:32.940767|2017-02-18 18:09:32.940767
NCT00022399|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2011-02-18|||September 2001||2001-09-01|October 2004|2004-10-01||||||||Interventional|||Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer|A Randomized, Placebo-Controlled Trial Of Celecoxib In Men Pre-Prostatectomy For Clinically Localized Adenocarcinoma Of The Prostate: Evaluation Of Drug-Specific Biomarker Modulation|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:33.06456|2017-02-18 18:09:33.06456
NCT00022386|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-07-17||||||May 2002|2002-05-01|April 2004|Actual|2004-04-01|||||Interventional|||Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer|An Open-Label Study of PROCRIT (Epoetin Alfa) in Women Undergoing Adjuvant Chemotherapy for Stage I, II, or III Breast Cancer|Completed||Phase 4|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:33.16655|2017-02-18 18:09:33.16655
NCT00022373|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2014-10-14|||December 2000||2000-12-01|November 2001|2001-11-01||||||||Interventional|||Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer|A Multinational, Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial to Determine the Efficacy and Safety of IB-367 Rinse in Reducing the Severity of Oral Mucositis in Patients Receiving Radiotherapy for Head and Neck Malignancy|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:33.256735|2017-02-18 18:09:33.256735
NCT00022360|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-06-17|||May 2001||2001-05-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Taurolidine in Treating Patients With Recurrent or Progressive Glioma|An Open-Label Dose-Ranging Study of the Safety of Taurolidine 2% Solution Administered Intravenously to Patients With Recurrent or Progressive High Grade Glioma|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:09:33.357947|2017-02-18 18:09:33.357947
NCT00022347|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-06-25|||May 2001||2001-05-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|April 2004|Actual|2004-04-01||Interventional|||TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase II Study of TLK 286 in Platinum Resistant Advanced Epithelial Ovarian Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:33.449742|2017-02-18 18:09:33.449742
NCT00022334|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-10-28|||January 2001||2001-01-01|July 2012|2012-07-01|October 2008|Actual|2008-10-01|December 2004|Actual|2004-12-01||Interventional|||Vaccine Therapy in Treating Patients With Liver Cancer|A Phase I/II Trial Testing Immunization With Dendritic Cells Pulsed With Four AFP Peptides in Patients With Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|33|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:09:33.546582|2017-02-18 18:09:33.546582
NCT00022321|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-12-18|||September 2001||2001-09-01|June 2002|2002-06-01||||||||Interventional|||Gemtuzumab in Treating Patients With Myelodysplastic Syndrome|A Randomized Study Of The Safety And Efficacy Of Two Dose Schedules Of Gemcituzumab Ozogamicin In Patients With Intermediate-2 Or High-Risk Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:33.654944|2017-02-18 18:09:33.654944
NCT00022308|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-08-30|||January 1999||1999-01-01|August 2013|2013-08-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|Phase I Trial of Radical Thoracic Radiation, Weekly CPT-11 (Irinotecan) and Cisplatin in Locally Advanced Non-Small Cell Lung Carcinoma|Completed||Phase 1|||Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 18:09:33.745327|2017-02-18 18:09:33.745327
NCT00022295|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-03-25|||August 2001||2001-08-01|March 2007|2007-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Phenoxodiol in Treating Patients With Refractory Solid Tumors|Phase IB Study of Phenoxodiol Given by Constant Intravenous Infusion in Patients With Solid Neoplasms (With the Exception of Breast Cancer) Whose Tumors Are Refractory to Standard Therapy|Completed||Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:33.856518|2017-02-18 18:09:33.856518
NCT00022282|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-02-27|||April 2001||2001-04-01|February 2008|2008-02-01||||March 2007|Actual|2007-03-01||Interventional|||AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma|Neovastat (AE-941) in Refractory and Early Relapse Multiple Myeloma Patients|Completed||Phase 2|||AEterna Zentaris|||||f||||||||||||||2017-02-18 18:09:33.945979|2017-02-18 18:09:33.945979
NCT00022256|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-06-17|||April 2001||2001-04-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|An Open-Label Phase II Trial to Evaluate the Safety and Pharmacokinetics of Motexafin Gadolinium and Cranial Irradiation in the Treatment of Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:09:34.031782|2017-02-18 18:09:34.031782
NCT00022243|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2014-01-03|||October 2000||2000-10-01|May 2002|2002-05-01||||||||Interventional|||T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy|A Phase II, Open Label Study Of T138067-Sodium In A Second-Line Setting In Non-Small-Cell Lung Cancer Patients With Locally Advanced Or Metastatic Disease Who Have Failed First-Line Therapy With a Taxane|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:34.137953|2017-02-18 18:09:34.137953
NCT00022230|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-05-04|||January 2000||2000-01-01|May 2015|2015-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer|Combination of Chemotherapy With Taxol, Adriamycin, and Cytoxan (TAC), Multiple Infusions of Activated T Cells (ATC), Interleukin-2 (IL-2) and GM-CSF for High Risk Breast Cancer With and Without Her2/Neu Overexpression. (Phase I/II)|Withdrawn||Phase 1/Phase 2|0|Actual|Roger Williams Medical Center||1||PI left Institution|f||||t||||||||||2017-02-18 18:09:34.228889|2017-02-18 18:09:34.228889
NCT00022217|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-12-17|||November 2000||2000-11-01|February 2002|2002-02-01||||||||Interventional|||Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer|A Phase II Activity And Safety Study Of IntraDose (Cisplatin/Epinephrine Injectable Gel) When Given In Combination With Systematic Chemotherapy Paclitaxel And Carboplatin In The Treatment Of Patients With Squamous Cell Carcinoma Of The Head And Neck At First Relapse|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:34.341423|2017-02-18 18:09:34.341423
NCT00022204|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-11-05|||January 2000||2000-01-01|May 2007|2007-05-01||||||||Interventional|||Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer|Double-Blind, Placebo-Controlled, Randomised Trial Of Alpha-Tocopherol And Oxpentifylline In Patients With Radiation Fibrosis|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:34.447116|2017-02-18 18:09:34.447116
NCT00022191|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-06-11|||May 2001||2001-05-01|June 2013|2013-06-01||||June 2004|Actual|2004-06-01||Interventional|||Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer|Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients With Metastatic or Locally Advanced Urothelial Cancer Without Prior Systemic Therapy|Completed||Phase 3|608|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:09:34.567674|2017-02-18 18:09:34.567674
NCT00022178|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-09-19|||December 1998||1998-12-01|February 2002|2002-02-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin|An Open Label Prospective Randomised Study Comparing The Use Of Vincristine, Adriamycin And Cyclophosphamide (VAC) Versus Epirubicin, Cisplatin And Continuous 5-Flourouracil (ECF) In Patients With Unknown Primary Carcinoma (UPC)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:34.919904|2017-02-18 18:09:34.919904
NCT00022165|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2015-08-10|||October 1999||1999-10-01|August 2015|2015-08-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Selenium in the Prevention of Cancer|Prevention Of Cancer By Intervention With Selenium|Completed||N/A|501|Actual|University of Surrey||4|||f||||f||||||||||2017-02-18 18:09:35.007959|2017-02-18 18:09:35.007959
NCT00022152|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-07-01|||November 2001||2001-11-01|July 2016|2016-07-01|August 2007|Actual|2007-08-01|March 2006|Actual|2006-03-01||Interventional|||Vinorelbine in Treating Older Women With Stage IV Breast Cancer|Phase II Trial of Oral Vinorelbine for the Treatment of Metastatic Breast Cancer in Patients >65 Years of Age: A Trial of Efficacy, Toxicity, and Patients' Perceived Preference for Oral Therapy|Completed||Phase 2|25|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:09:35.109952|2017-02-18 18:09:35.109952
NCT00022139|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-12-05|||January 2002||2002-01-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|July 2005|Actual|2005-07-01||Interventional|||Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction|A Phase II Trial of Preoperative Radiation and Chemotherapy (Paclitaxel, Carboplatin, and Continuous Infusion 5-FU) for Locally Advanced Esophageal Cancer|Completed||Phase 2|56|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:09:35.313549|2017-02-18 18:09:35.313549
NCT00022126|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2014-02-18|||November 2002||2002-11-01|February 2014|2014-02-01|April 2006|Actual|2006-04-01|January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia|A Study of Modified Augmented BFM Therapy for Infants With Acute Lymphoblastic Leukemia|Completed||Phase 2|6|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:09:35.481613|2017-02-18 18:09:35.481613
NCT00022113|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2013-01-24|||May 2001||2001-05-01|January 2013|2013-01-01||||May 2005|Actual|2005-05-01||Interventional|||EMD 121974 in Treating Patients With Advanced Solid Tumors|A Phase I Study of EMD 121974 in Patients With Advanced Solid Tumors|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:35.670305|2017-02-18 18:09:35.670305
NCT00021944|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-07-28|||April 2001||2001-04-01|January 2008|2008-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:09:38.712779|2017-02-18 18:09:38.712779
NCT00021931|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-03-15|||April 2001||2001-04-01|July 2005|2005-07-01|March 2005|Actual|2005-03-01|||||Observational|||Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:09:38.80207|2017-02-18 18:09:38.80207
NCT00021918|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-02-17|||April 2001||2001-04-01|October 2005|2005-10-01|June 2004|Actual|2004-06-01|||||Observational|||Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:09:38.883585|2017-02-18 18:09:38.883585
NCT00021905|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2008-07-23|||July 2002||2002-07-01|July 2008|2008-07-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Atrial Fibrillation Incidence, Risk Factors and Genetics||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:09:38.958442|2017-02-18 18:09:38.958442
NCT00021892|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2014-02-20|||June 2001||2001-06-01|February 2014|2014-02-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Ventricular Matrix Remodeling: Correlates and Prognosis||Completed||N/A|||Boston University|||||f||||||||||||||2017-02-18 18:09:39.023859|2017-02-18 18:09:39.023859
NCT00021879|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-10|2016-02-17|||March 2001||2001-03-01|January 2008|2008-01-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Visceral Adiposity and CVD Risk in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:09:39.097394|2017-02-18 18:09:39.097394
NCT00021866|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-08|2013-11-08|||September 2000||2000-09-01|September 2013|2013-09-01|August 2012|Actual|2012-08-01|August 2010|Actual|2010-08-01||Observational|||Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy|Neurodevelopmental Effects of Antiepileptic Drugs II: the NEAD Study|Completed||N/A|331|Actual|Emory University|||4||f||||t||||||Samples With DNA|"~     Venous blood for AED levels Cord Blood for G6PD, Homocysteine Saliva for drug metabolizing~     enzymes, antioxidant enzymes, DNA repair enzymes, drug membrane transporter proteins and~     folate-related genes~   "|||2017-02-18 18:09:39.171378|2017-02-18 18:09:39.171378
NCT00021853|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-08|2008-03-03|||August 2001||2001-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||Motor Training to Treat Hand Dystonia|Motor Training as Treatment of Focal Hand Dystonia|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:39.316703|2017-02-18 18:09:39.316703
NCT00021840|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-07|2014-08-01|||July 2001||2001-07-01|August 2014|2014-08-01|July 2011|Actual|2011-07-01|July 2011|Actual|2011-07-01||Observational|||Genetic Epidemiology of Asthma in Costa Rica|Genetic Epidemiology of Asthma in Costa Rica|Completed||N/A|4245|Actual|Brigham and Women's Hospital|||1||f||||f||||||Samples With DNA|"~     Blood (and its components, e.g., serum, WBC, etc.)~   "|||2017-02-18 18:09:39.400603|2017-02-18 18:09:39.400603
NCT00021827|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-04|2010-03-01|||June 1999||1999-06-01|March 2010|2010-03-01|December 2001||2001-12-01|||||Interventional|||PTHrP and Osteoporosis|Pathophysiology of PTH-related Protein in Humans.|Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:09:39.505308|2017-02-18 18:09:39.505308
NCT00021814|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-04|2010-01-12|||December 1995||1995-12-01|January 2010|2010-01-01|March 1998||1998-03-01|||||Interventional|||Medical Therapy of Prostatic Symptoms (MTOPS)||Completed||Phase 3|2931||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 18:09:39.852959|2017-02-18 18:09:39.852959
NCT00021801|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-04|2010-03-01|||March 2000||2000-03-01|March 2010|2010-03-01|September 2000||2000-09-01|||||Interventional|||Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen|Pathways to Tolerance in Human Islet Transplantation|Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:09:39.97765|2017-02-18 18:09:39.97765
NCT00021788|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-04|2010-07-07|||July 2000||2000-07-01|July 2010|2010-07-01|December 2001||2001-12-01|||||Interventional|||Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression|Immunomodulation for Islet Transplantation in Diabetes|Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:09:40.063904|2017-02-18 18:09:40.063904
NCT00021775|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-04|2013-12-31|||April 2002||2002-04-01|December 2013|2013-12-01|February 2004|Actual|2004-02-01|||||Observational|||HIV Prevention Preparedness Study in Russia, China, and India|HIV Prevention Preparedness Study|Completed||N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:09:40.159084|2017-02-18 18:09:40.159084
NCT00021762|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-04|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV|A Pilot Phase II Evaluation of the Effects on HIV Replication of Immunization With a gp120-Depleted, Inactivated Whole Virus Vaccine Combined With Exposures to Replicating Autologous HIV by Scheduled Treatment Interruptions, a Rollover Study of A5057|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:09:40.248783|2017-02-18 18:09:40.248783
NCT00021749|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-03|2009-11-10|||January 2001||2001-01-01|November 2009|2009-11-01||||January 2003|Actual|2003-01-01||Interventional|||Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia|Phase I-II Multicenter Study of Genasense (Bcl-2 Antisense Oligonucleotide) in Patients With Advanced Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|40|Actual|Genta Incorporated||1|||f||||f||||||||||2017-02-18 18:09:40.337008|2017-02-18 18:09:40.337008
NCT00021736|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-03|2005-06-23|||July 2001||2001-07-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Phase II/III Study of Anti-VEGF in Neovascular AMD|Phase II/III Randomized, Double-Masked, Trial, to Establish the Safety and Efficacy of Intravitreal Injections of EYE001 (Anti-VEGF Pegylated Aptamer) Given Every 6 Weeks for 54 Weeks, in Patients With Exudative AMD).|Completed||Phase 2/Phase 3|540||Eyetech Pharmaceuticals|||||||||||||||||||2017-02-18 18:09:40.429676|2017-02-18 18:09:40.429676
NCT00021723|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-02|2009-09-22|||September 2001||2001-09-01|November 2001|2001-11-01|September 2003||2003-09-01|||||Interventional|||Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease||Terminated||Phase 2|375||JANSSEN Alzheimer Immunotherapy Research & Development, LLC|||||||||||||||||||2017-02-18 18:09:40.512654|2017-02-18 18:09:40.512654
NCT00021710|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-02|2008-03-03|||July 2001||2001-07-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Motor Learning in Stroke Patients and Healthy Volunteers|Motor Learning: Behavioral and Physiologic Studies in Normal Volunteers and Stroke Patients|Completed||N/A|78||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:40.609607|2017-02-18 18:09:40.609607
NCT00021697|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-01|2016-07-13|||January 2001||2001-01-01|July 2016|2016-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS|A Double-Blind Controlled, Multicenter Phase II/III Study to Assess the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect in Patients With Amyotrophic Lateral Sclerosis|Completed||Phase 3|100||Avanir Pharmaceuticals|||||||||||||||||||2017-02-18 18:09:40.692926|2017-02-18 18:09:40.692926
NCT00021671|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-31|2012-02-13||||||February 2012|2012-02-01|November 2004|Actual|2004-11-01|||||Interventional|||Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission|Phase III Trial of Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission|Completed||Phase 3|3720||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:09:40.798844|2017-02-18 18:09:40.798844
NCT00021658|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-30|2014-09-26|||October 1999||1999-10-01|July 2014|2014-07-01|September 2003||2003-09-01|||||Interventional|||Effects of Pesticide Exposure on Neurodevelopment/Growth/Respiratory Health||Completed||N/A|550||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:09:40.9036|2017-02-18 18:09:40.9036
NCT00021645|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-26|2008-03-03|||July 2001||2001-07-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Vitamin E to Treat Uveitis-Associated Macular Edema|Randomized Masked Study to Evaluate the Use of Vitamin E in the Treatment of Uveitis-Associated Macular Edema|Completed||Phase 1|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:40.990382|2017-02-18 18:09:40.990382
NCT00021632|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-26|2015-05-15||||||July 2013|2013-07-01||||||||Observational|||Effects of Ribavirin on Zidovudine or Stavudine|Pharmacokinetic Evaluation of the Effects of Ribavirin (RBV) on Zidovudine (ZDV) or Stavudine (d4T) Triphosphate (TP) Formation|Completed||N/A|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:09:41.081323|2017-02-18 18:09:41.081323
NCT00021580|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-24|2005-06-23||||||April 2004|2004-04-01||||||||Interventional|||"Modification of the Edmonton Protocol to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the Edmonton Protocol to Kidney Transplant Recipients"|"Modification of the Edmonton Protocol to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the Edmonton Protocol to Kidney Transplant Recipients (Project 1 of JDFI Washington University Center for Islet Transplantation)"|Unknown status|Active, not recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:09:41.191266|2017-02-18 18:09:41.191266
NCT00021567|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-24|2008-03-03|||July 2001||2001-07-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections|A Randomized, Double-Blinded, Placebo-Controlled, Phase II Study of the Safety and Efficacy of Inhaled Interferon Gamma-1b With Antimycobacterial in Previously Treated or Moderate to Severe Pulmonary Mycobacterium Avium Complex (MAC) Infection|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:41.269621|2017-02-18 18:09:41.269621
NCT00021554|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-21|2005-06-23||||||May 2002|2002-05-01||||||||Interventional|||T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs|A Phase III Open-Label, Randomized, Active-Controlled Study Assessing the Efficacy and Safety of T-20 (HIV-1 Fusion Inhibitor) in Combination With an Optimized Background Regimen, Versus Optimized Background Regimen Alone, in Patients With Prior Experience and/or Prior Documented Resistance to Each of the Three Classes of Approved Antiretrovirals (Nucleoside Reverse Transcriptase, Non-Nucleoside Reverse Transcriptase and Protease Inhibitors)|Completed||Phase 3|525||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:09:41.35577|2017-02-18 18:09:41.35577
NCT00021541|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-19|2012-09-24|2012-03-30||July 2001||2001-07-01|September 2012|2012-09-01|November 2010|Actual|2010-11-01|March 2010|Actual|2010-03-01||Interventional|||R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas|A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas|Completed||Phase 2|62|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 18:09:41.755671|2017-02-18 18:09:41.755671
NCT00021528|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-20|2009-09-24|||July 2001||2001-07-01|September 2006|2006-09-01|September 2006||2006-09-01|||||Interventional|||Sequenced Treatment Alternatives to Relieve Depression (STAR*D)|Sequenced Treatment Alternatives to Relieve Depression|Completed||Phase 4|4000||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:09:42.527537|2017-02-18 18:09:42.527537
NCT00021502|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-18|2009-08-13|||March 2001||2001-03-01|August 2009|2009-08-01|May 2004|Actual|2004-05-01|August 2003|Actual|2003-08-01||Interventional|||Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)|A Phase 3, Multi-Center, Randomized, Placebo Controlled Study of PHP When Administered by Continuous Infusion in Patients With Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)|Completed||Phase 3|1000||Apex Bioscience|||||||||||||||||||2017-02-18 18:09:42.695812|2017-02-18 18:09:42.695812
NCT00021489|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-18|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment|A Phase I/II Study of the Safety, Tolerability, and Antiretroviral Activity of Mycophenolate Mofetil As an Adjunct to Abacavir Therapy in HIV-Infected Subjects With Treatment Failure and Extensive Prior Antiretroviral Exposure|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:09:42.779356|2017-02-18 18:09:42.779356
NCT00021463|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-14|2011-02-24||||||January 2003|2003-01-01||||February 2002|Actual|2002-02-01||Interventional|||Changing to Nonprotease Inhibitor Treatment to Improve Side Effects|Phase II, Randomized, Open-Label Study of Switching to Protease Inhibitor-Sparing Regimens for Improvement of Metabolic Abnormalities|Completed||Phase 2|342||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:09:42.98908|2017-02-18 18:09:42.98908
NCT00021450|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-13|2016-09-01|||April 2001||2001-04-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|April 2008|Actual|2008-04-01||Interventional|||Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer|Three Dimensional Conformal Radiotherapy / Intensity Modulated Radiotherapy Alone Vs Three Dimensional Conformal Therapy / Intensity Modulated Radiotherapy Plus Adjuvant Hormonal Therapy In Localized T1b-c, T2a, N0, M0 Prostatic Carcinoma. A Phase III Randomized Study|Completed||Phase 3|819|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:09:43.112887|2017-02-18 18:09:43.112887
NCT00021437|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Biological Significance of the Bloom's Syndrome Protein|Biological Significance of the Bloom's Syndrome Protein|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:09:43.254855|2017-02-18 18:09:43.254855
NCT00021424|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-29|||June 2001||2001-06-01|August 2002|2002-08-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer|Phase I/Pilot Study of Intralesional Immunotherapy With A Recombinant Avipox Virus Engineered To Express A Triad Of Co-Stimulatory Molecules In Patients With Advanced Squamous Cell Carcinoma Of The Head And Neck|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:43.325063|2017-02-18 18:09:43.325063
NCT00021398|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2016-11-22|||July 1996||1996-07-01|November 2016|2016-11-01||||July 2001|Actual|2001-07-01||Interventional|||Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer|Phase II Study: Hyperfractionated Pre-Op Chemo-Radiation for Locally Advanced Rectal Cancer|Active, not recruiting||Phase 2|23|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-02-18 18:09:43.419818|2017-02-18 18:09:43.419818
NCT00021385|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-12-17|||May 2001||2001-05-01|May 2002|2002-05-01||||||||Interventional|||Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer|A Phase IIA Trial of Continuous Five Day Infusions of MSI-1256F (Squalamine Lactate) Plus Carboplatin for Therapy of Refractory and Resistant Stage III and IV Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:43.542345|2017-02-18 18:09:43.542345
NCT00021372|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-07-09|||February 1996||1996-02-01|July 2013|2013-07-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Phase II Study of Paclitaxel and Estramustine Phosphate in Patients With Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 2|25|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-02-18 18:09:43.633456|2017-02-18 18:09:43.633456
NCT00021359|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-07-09|||August 1999||1999-08-01|July 2013|2013-07-01|October 2005|Actual|2005-10-01|July 2000|Actual|2000-07-01||Interventional|||Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma|A Phase II Trial of Dexamethasone and 13-cis-Retinoic Acid as First-Line Treatment for Multiple Myeloma|Completed||Phase 2|17|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-02-18 18:09:43.74561|2017-02-18 18:09:43.74561
NCT00021346|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-04-16|||November 1997||1997-11-01|April 2013|2013-04-01|March 2002|Actual|2002-03-01|July 2001|Actual|2001-07-01||Interventional|||Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors|Phase I Evaluation Of Carboplatin And Gemcitabine|Completed||Phase 1|8|Actual|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 18:09:43.855452|2017-02-18 18:09:43.855452
NCT00021333|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-04-16|||September 1999||1999-09-01|April 2013|2013-04-01|May 2008|Actual|2008-05-01|April 2006|Actual|2006-04-01||Interventional|||Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer|Phase II Evaluation Of Paclitaxel And Cisplatin In Combination With Split Course Hyperfractionated Radiation Therapy And Granulocyte-Colony Stimulating Factor In Previously Irradiated Patients With Locally Recurrent Carcinoma Of The Head And Neck, And Lung|Completed||Phase 2|29|Actual|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 18:09:43.938674|2017-02-18 18:09:43.938674
NCT00021320|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2014-05-07|||May 2000||2000-05-01|May 2014|2014-05-01|April 2009|Actual|2009-04-01|January 2004|Actual|2004-01-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer|Phase II Evaluation Of Paclitaxel, Cisplatin And 5-Fluorouracil Given In Combination With Radiation Therapy Prior To Surgery In Patients With Resectable Esophageal Cancer|Completed||Phase 2|21|Actual|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 18:09:44.309909|2017-02-18 18:09:44.309909
NCT00021307|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-07-10||||||July 2013|2013-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme|Phase I/II Trial Of Temozolomide And Carboplatin In Recurrent Glioblastoma Multiforme|Withdrawn||Phase 1/Phase 2|0|Actual|Fox Chase Cancer Center||||Study not activated.|f||||f||||||||||2017-02-18 18:09:44.403439|2017-02-18 18:09:44.403439
NCT00021294|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2010-03-23|||May 2001||2001-05-01|June 2002|2002-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis|Phase IIB Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Safety and Efficacy of Topical Difluoromethylornithine (DFMO) With and Without a Topical Corticosteroid Cream (Triamcinolone 0.1%) in the Therapy of Actinic Keratoses (AK) on the Forearms|Completed||Phase 2|||University of Arizona|||||f||||||||||||||2017-02-18 18:09:44.489029|2017-02-18 18:09:44.489029
NCT00021281|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-12-18|||December 2000||2000-12-01|September 2001|2001-09-01||||||||Interventional|||Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer|A Phase III, Randomized, Open-Label Multicenter, International Study Comparing The Combination Of SU5416/Irinotecan/5-Fluorouracil/Leucovorin Versus Irinotecan/Fluorouracil/Leucovorin Alone As First-Line Therapy Of Patient With Previously Untreated Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:44.589725|2017-02-18 18:09:44.589725
NCT00021268|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-08-01|||April 2001||2001-04-01|October 2002|2002-10-01||||||||Interventional|||Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer|Phase I Study Of Tocladesine In Patients With Colorectal Carcinoma Following Therapy With 5-FU And Irinotecan|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:44.684682|2017-02-18 18:09:44.684682
NCT00021255|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2016-09-26|2016-06-15||April 2001||2001-04-01|September 2016|2016-09-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional||Intent-To-Treat (ITT) population included all randomized participants.|Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer|Multicenter Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed By Docetaxel (AC-T) With Doxorubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab (Herceptin)(AC-TH) and With Docetaxel, Carboplatin and Trastuzumab (TCH) In The Adjuvant Treatment Of Node Positive and High Risk Node Negative Patients With Operable Breast Cancer Containing The HER2 Alteration|Completed||Phase 3|3222|Actual|Sanofi||3|||f||||||||||||||2017-02-18 18:09:44.78885|2017-02-18 18:09:44.78885
NCT00021242|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2014-08-07|||August 2002||2002-08-01|August 2014|2014-08-01|September 2006|Actual|2006-09-01|March 2006|Actual|2006-03-01||Interventional|||Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia|A Phase II Study of Docetaxel (Taxotere) (NSC# 628503, IND# 59,761) in Children With Refractory Leukemias|Completed||Phase 2|12|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:09:45.922669|2017-02-18 18:09:45.922669
NCT00021229|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2014-07-25|2010-02-09||May 2001||2001-05-01|February 2013|2013-02-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma|A Phase I/II Trial Of STI571 In Children With Newly Diagnosed Poor Prognosis Brainstem Gliomas And Recurrent Intracranial Malignant Gliomas|Terminated||Phase 1/Phase 2|85|Actual|National Cancer Institute (NCI)|The phase II component of the trial was terminated because of poor accrual. Only one patient enrolled to the phase II component and did not receive the investigational drug.|1||Poor accrual|f||||t||||||||||2017-02-18 18:09:46.545899|2017-02-18 18:09:46.545899
NCT00021216|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-14|||November 2001||2001-11-01|December 2013|2013-12-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Bortezomib in Treating Children With Advanced Solid Tumors|A Phase I Study Of PS-341 In Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:47.604391|2017-02-18 18:09:47.604391
NCT00021164|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-17|||May 2001||2001-05-01|April 2004|2004-04-01|May 2004|Actual|2004-05-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Cancer|Immunization of HLA-A*0201 Patients With Metastatic Cancer Using a Peptide Epitope From the Telomerase Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:47.719554|2017-02-18 18:09:47.719554
NCT00021151|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2014-01-07|||January 2000||2000-01-01|January 2014|2014-01-01|May 2002|Actual|2002-05-01|April 2001|Actual|2001-04-01||Interventional|||Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia|CAMPATH-1H Compassionate Treatment In Patients With PLL Who Have Failed At Least One Prior Regimen And CLL Patients Who Have Failed Fludarabine Therapy|Completed||N/A|2|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:09:47.810115|2017-02-18 18:09:47.810115
NCT00021138|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-05-14|||April 2001||2001-04-01|March 2011|2011-03-01|March 2004|Actual|2004-03-01|||||Interventional|||Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking|Computerized Scheduling of Nicotine Inhaler Use|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:47.915302|2017-02-18 18:09:47.915302
NCT00021125|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-25|||July 2000||2000-07-01|December 2002|2002-12-01|June 2007|Actual|2007-06-01|||||Interventional|||Radiation Therapy in Treating Patients With Head and Neck Cancer|A Randomized Controlled Trial Of CHARTWEL (a Continuous Hyperfractionated Accelerated Radiotherapy Schedule) Versus Conventional Radiotherapy In Post-Operative Head And Neck Cancer Patients|Completed||Phase 3|460|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:48.020978|2017-02-18 18:09:48.020978
NCT00021112|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-07-17|||April 2001||2001-04-01|July 2012|2012-07-01||||October 2002|Actual|2002-10-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer|Surgical Treatment Of Stage IIIB Non-Small Cell Lung Cancer After Induction-Chemoradiotherapy|Terminated||Phase 2|5|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:09:48.114599|2017-02-18 18:09:48.114599
NCT00021099|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-01-23|||June 2001||2001-06-01|January 2013|2013-01-01||||August 2007|Actual|2007-08-01||Interventional|||Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer|A Phase II Study Of Epothilone B Analogue BMS-247550 (NSC #710428) q21 Days In Advanced Carcinoma Of The Urothelium|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:48.214027|2017-02-18 18:09:48.214027
NCT00021073|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-12-10|||May 2001||2001-05-01|December 2013|2013-12-01||||April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|Phase I Study of Flavopiridol in Combination With 5-Fluorouracil, Leucovorin and Irinotecan in Patients With Advanced Malignancies|Completed||Phase 1|90|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:48.323424|2017-02-18 18:09:48.323424
NCT00021060|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-02-26|||August 2002||2002-08-01|February 2013|2013-02-01||||September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer|Randomized Phase II/III Trial of Paclitaxel Plus Carboplatin With or Without Bevacizumab (NSC #704865) in Patients With Advanced Nonsquamous NSCLC|Completed||Phase 2/Phase 3|842|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:09:48.438971|2017-02-18 18:09:48.438971
NCT00021047|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-07|||July 2001||2001-07-01|March 2012|2012-03-01|June 2004|Actual|2004-06-01|||||Interventional|||Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor|A Phase I/II Trial of Epirubicin, Carboplatin & Capecitabine in Adult Cancer Patients|Completed||Phase 1/Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:48.562953|2017-02-18 18:09:48.562953
NCT00021034|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-17|||March 2001||2001-03-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|Phase I Trial of Taurolidine After Positive Second Look Surgery for Recurrent Ovarian Epithelial, Fallopian Tube and Primary Peritoneal Cancers|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:09:48.667128|2017-02-18 18:09:48.667128
NCT00021021|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-03-25|||September 2001||2001-09-01|May 2002|2002-05-01|February 2004|Actual|2004-02-01|||||Interventional|||RPI.4610 in Treating Patients With Metastatic Kidney Cancer|A Phase II, Open-Label, Multicenter Trial of Angiozyme in Subjects With Metastatic Renal Cell Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:48.753106|2017-02-18 18:09:48.753106
NCT00021008|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-12-18||||||September 2001|2001-09-01||||||||Interventional|||ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer|A Phase II Open, Multicenter Trial to Assess the Activity and Tolerability of ZD0473 Given Intravenously as Second-line Therapy to Patients With Non-Small Lung Cancer Who Have Failed One Prior Platinum Based Chemotherapy Regimen|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:48.833475|2017-02-18 18:09:48.833475
NCT00020995|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-09-19|||August 2001||2001-08-01|May 2004|2004-05-01|January 2010|Actual|2010-01-01|||||Interventional|||Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer|Effects of a Low Fat Diet on Serum Factors and Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:48.905686|2017-02-18 18:09:48.905686
NCT00020969|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2011-05-12|||March 2001||2001-03-01|September 2004|2004-09-01||||||||Interventional|||Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes|Phase Two Multicenter Study Of Arsenic Trioxide In Patients With Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:49.003715|2017-02-18 18:09:49.003715
NCT00020943|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2016-07-15|||June 2001||2001-06-01|July 2016|2016-07-01|September 2009|Actual|2009-09-01|December 2006|Actual|2006-12-01||Interventional|||Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma|A Phase II Study Of Intensive Induction Chemotherapy Followed By Autologous Stem Cell Transplantation Plus Immunotherapy For Mantle Cell Lymphoma|Completed||Phase 2|79|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:09:49.110737|2017-02-18 18:09:49.110737
NCT00020930|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2009-12-03|||March 2001||2001-03-01|December 2009|2009-12-01||||August 2002|Actual|2002-08-01||Interventional|||Cetuximab in Treating Patients With Stage IV Colorectal Cancer|Phase II Study of an Anti-Epidermal Growth Factor Receptor (EGFR) Antibody, Cetuximab, in Patients With Irinotecan-Refractory, Stage IV Colorectal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:49.597141|2017-02-18 18:09:49.597141
NCT00020917|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-17|||February 2001||2001-02-01|June 2013|2013-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer|Pilot Study of an Anti-Epidermal Growth Factor Receptor (EGFR) Antibody, Cetuximab, in Combination With Irinotecan, Fluorouracil, and Leucovorin, and in Patients With Newly Diagnosed Stage IV Colorectal Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:09:49.687914|2017-02-18 18:09:49.687914
NCT00020904|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-17|||February 2001||2001-02-01|June 2013|2013-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||BMS-247550 in Treating Women With Metastatic Breast Cancer|A Phase II Study of Epothilone B Analog BMS-247550 in Patients With Taxane-Resistant Metastatic Breast Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:09:49.78806|2017-02-18 18:09:49.78806
NCT00020891|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-01-17|||March 2001||2001-03-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy|The Use Of Multiple CT Scans To Reduce Target Positioning Errors In Patients Undergoing External Beam Radiotherapy Treatment For Prostate Cancer|Completed||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:09:49.888948|2017-02-18 18:09:49.888948
NCT00020878|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2016-03-02|||March 2001||2001-03-01|March 2016|2016-03-01|May 2009|Actual|2009-05-01|November 2002|Actual|2002-11-01||Interventional|||Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers|Celecoxib for Chemoprevention of Primary Lung Cancer|Completed||Phase 2|21|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:09:49.979993|2017-02-18 18:09:49.979993
NCT00020865|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-12-18|||September 2001||2001-09-01|May 2007|2007-05-01||||||||Interventional|||Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia|Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Levofloxacin With That of Cefepime in the Treatment of Fever and Neutropenia - Phase IIIB|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:50.095165|2017-02-18 18:09:50.095165
NCT00020852|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-05-29|||May 2001||2001-05-01|May 2004|2004-05-01|July 2004|Actual|2004-07-01|||||Interventional|||Cryosurgery in Treating Women With Breast Lesions|Evaluation of Freezing Tumors in the Treatment of Breast Cancer Safety Study - 1-Probe CRYOcare Surgical System for Breast Tumor Ablation|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:50.208243|2017-02-18 18:09:50.208243
NCT00020839|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-09-20|||April 2001||2001-04-01|September 2012|2012-09-01||||May 2003|Actual|2003-05-01||Interventional|||Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain|Temozolomide Versus Temozolomide + Whole Brain Radiation In Stage IV Melanoma Patients With Asymptomatic Brain Metastases|Terminated||Phase 3|23|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:09:50.296753|2017-02-18 18:09:50.296753
NCT00020826|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-08-24|||April 2001||2001-04-01|August 2012|2012-08-01|January 2004|Actual|2004-01-01|May 2003|Actual|2003-05-01||Observational|||Assessing Quality of Life of Patients With Stomach Cancer|An International Field Study Of The Reliability And Validity Of The EORTC QLQ-C30 And A Disease-Specific Questionnaire Module (The QLQ-STO22) In Assessing The Quality Of Life Of Patients With Gastric Cancer|Completed||N/A|267|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||||||2017-02-18 18:09:50.421489|2017-02-18 18:09:50.421489
NCT00020800|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-01-07|||September 2001||2001-09-01|January 2013|2013-01-01||||April 2003|Actual|2003-04-01||Interventional|||Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia|Phase II Study of Combination Rituxan (Rituximab, Mabthera) and Fludarabine Therapy in Lymphoplasmacytic Lymphoma (Waldenstrom's Macroglobulinemia)|Completed||Phase 2|7|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:09:50.536326|2017-02-18 18:09:50.536326
NCT00020787|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-09-30|||July 2001||2001-07-01|July 2012|2012-07-01|December 2002|Actual|2002-12-01|January 2002|Actual|2002-01-01||Interventional|||Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer|An Open Label, Sequential Multi-Center Multi Dose Study Of G17T Immunogen In Combination With Cisplatin (CDDP) And 5-Fluorouracil (5-FU) In Subjects With Metastatic Or Locally Recurrent Gastric Or Gastroesophageal Cancer Previously Untreated With Chemotherapy For Advanced Disease (Stage IV)|Completed||Phase 3|8|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:09:50.642871|2017-02-18 18:09:50.642871
NCT00020774|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-10-28|||October 1998||1998-10-01|July 2012|2012-07-01||||January 2003|Actual|2003-01-01||Interventional|||SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer|A Phase IB Clinical Study Of The Farnesyltransferase Inhibitor SCH 66336 And Gemcitabine In Patients With Resectable Primary Liver Neoplasms|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:09:50.759616|2017-02-18 18:09:50.759616
NCT00020761|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-10-28|||April 2000||2000-04-01|July 2012|2012-07-01|August 2005|Actual|2005-08-01|December 2002|Actual|2002-12-01||Interventional|||Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach|A Phase II Study Of Irinotecan (Camptosar) And Paclitaxel (Taxol) In Patients With Adenocarcinoma Of The Upper Gastrointestinal Tract|Completed||Phase 2|51|Actual|Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:09:50.849392|2017-02-18 18:09:50.849392
NCT00020748|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2011-03-23|||August 2000||2000-08-01|January 2005|2005-01-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer|A Phase I Study of Epirubicin in Combination With Irinotecan in Patients With Advanced Cancer|Completed||Phase 1|||Georgetown University|||||f||||f||||||||||2017-02-18 18:09:50.960937|2017-02-18 18:09:50.960937
NCT00020735|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-12-01|||April 2001||2001-04-01|December 2015|2015-12-01|June 2009|Actual|2009-06-01|January 2005|Actual|2005-01-01||Interventional|||Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer|A Phase II Randomized Controlled Clinical Trial Of The Antiestrogen GTx-006 In Subjects With Prostate Cancer|Completed||Phase 2|45|Actual|University of Pittsburgh||2|||f||||t||||||||||2017-02-18 18:09:51.057101|2017-02-18 18:09:51.057101
NCT00020722|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2016-02-15|2015-02-09||August 2007||2007-08-01|February 2016|2016-02-01|March 2013|Actual|2013-03-01|March 2013|Actual|2013-03-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer|Treatment of Stage IV Breast Cancer With Activated T Cells After Peripheral Blood Stem Cell Transplant (Pilot Phase II)|Terminated||Phase 2|7|Actual|Barbara Ann Karmanos Cancer Institute|Not enough funding to finish study, cost of immunotherapy infusions for the stem cell transplant portion & of infusions for targeted T cell therapy were limited due to lack of funding, trial was converted into a proof-of-principle or concept trial.|1||Lack of funding to continue study.|f||||t||||||||||2017-02-18 18:09:51.171555|2017-02-18 18:09:51.171555
NCT00020709|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-02-26|||June 2001||2001-06-01|February 2013|2013-02-01||||February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery|A Phase III Trial of Cisplatin/Etoposide/Radiotherapy With Consolidation Docetaxel Followed by Maintenance Therapy With ZD1839 (NSC-715055) or Placebo in Patients With Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer|Completed||Phase 3|840|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:09:51.411416|2017-02-18 18:09:51.411416
NCT00020696|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-01-07|||June 2001||2001-06-01|March 2008|2008-03-01||||April 2006|Actual|2006-04-01||Interventional|||Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation of Tirapazamine (NSC #130181, IND #46,525) in Combination With Cisplatin in Recurrent Platinum Sensitive Ovarian or Primary Peritoneal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:51.535157|2017-02-18 18:09:51.535157
NCT00020683|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-10-07|||March 2003||2003-03-01|October 2013|2013-10-01||||November 2005|Actual|2005-11-01||Interventional|||A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma|A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma|Terminated||Phase 2|70|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:09:51.838356|2017-02-18 18:09:51.838356
NCT00020670|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2009-02-06|||January 2001||2001-01-01|August 2003|2003-08-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia|A Phase I Study of Vaccination With Autologous CD40-Activated Acute Lymphoblastic Leukemia Cells|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:51.945159|2017-02-18 18:09:51.945159
NCT00020657|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-10-13|||July 2001||2001-07-01|October 2015|2015-10-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer|Treatment of Delayed Nausea: What Works Best?|Completed||Phase 3|||University of Rochester|||||f||||||||||||||2017-02-18 18:09:52.043318|2017-02-18 18:09:52.043318
NCT00020644|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-08-06|||March 2000||2000-03-01|April 2004|2004-04-01||||||||Interventional|||Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer|Phase I Study of Continuous Infusion Gemcitabine|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:52.165166|2017-02-18 18:09:52.165166
NCT00020631|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-17|||October 2001||2001-10-01|April 2004|2004-04-01|October 2007|Actual|2007-10-01|||||Interventional|||Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer|A Pilot Study Of Pirfenidone For The Treatment Of Radiation-Induced Fibrosis|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:52.251093|2017-02-18 18:09:52.251093
NCT00020618|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-07-17|||March 2001||2001-03-01|February 2002|2002-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain|An Open Label, Randomized, Multicenter, Crossover, Phase II Study to Compare Pain Relief Following Morphine Administration Via AERxPMS vs Orally in Cancer Patients Experiencing Opioid-Sensitive Breakthrough Pain|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:52.345567|2017-02-18 18:09:52.345567
NCT00020605|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2009-05-09|||May 2000||2000-05-01|October 2001|2001-10-01||||||||Interventional|||Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIB Study of Oral Naloxone for the Treatment of Opioid-Induced Constipation in Patients With Chronic, Non-Malignant Pain or Malignant Pain|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:52.431818|2017-02-18 18:09:52.431818
NCT00020579|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-14|||March 2001||2001-03-01|March 2012|2012-03-01|October 2008|Actual|2008-10-01|April 2008|Actual|2008-04-01||Interventional|||MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study of an Oral Histone Deacetylase Inhibitor, MS-275, in Refractory Solid Tumors and Lymphomas|Completed||Phase 1|75|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 18:09:52.521303|2017-02-18 18:09:52.521303
NCT00020566|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2014-06-23|||February 2001||2001-02-01|June 2012|2012-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma|European Ewing Tumour Working Initiative of National Groups Ewing Tumour Studies 1999 (EURO-E.W.I.N.G.99)|Unknown status|Recruiting|Phase 3|1200|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:09:52.859304|2017-02-18 18:09:52.859304
NCT00020553|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-09-19|||August 2000||2000-08-01|October 2006|2006-10-01||||||||Interventional|||Video Support Program For Families With a Parent Newly Diagnosed With Cancer|We Can Cope: Family Support When A Parent Has Cancer|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.104524|2017-02-18 18:09:53.104524
NCT00020540|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-29|||March 2001||2001-03-01|April 2002|2002-04-01||||||||Interventional|||Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer|Treatment Of Patients With Metastatic Melanoma And Renal Cancer With A Combination Of Flt3L And CD40L|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.189312|2017-02-18 18:09:53.189312
NCT00020527|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-17|||March 2001||2001-03-01|March 2003|2003-03-01|June 2003|Actual|2003-06-01|||||Interventional|||Caspofungin Acetate in Treating Children With Fever and Neutropenia|A Multicenter, Open, Non-Comparative, Sequential Dose-Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Separate Doses of MK-0991 in Children With New Onset Fever and Neutropenia|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.285733|2017-02-18 18:09:53.285733
NCT00020501|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-07|||March 2001||2001-03-01|March 2012|2012-03-01|January 2005|Actual|2005-01-01|||||Interventional|||Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver|A Phase III Prospective Random Assignment Trial of Regional and Systemic Chemotherapy With or Without Initial Isolated Hepatic Perfusion for Patients With Metastatic Unresectable Colorectal Cancers of the Liver|Completed||Phase 3|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:53.392033|2017-02-18 18:09:53.392033
NCT00020488|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-29|||February 2001||2001-02-01|September 2003|2003-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors|A Phase I & Pharmacologic Trial Of Sequential Irinotecan As A 24-Hour IV Infusion, Leucovorin, & Flurouracil As A 48-Hour IV Infusion In Adult Cancer Patients|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.497528|2017-02-18 18:09:53.497528
NCT00020475|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-08-14|||February 2001||2001-02-01|July 2002|2002-07-01|March 2007|Actual|2007-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye|Phase II Study of gp100:209-217 (210M) Antigen and MART-1:26-35 (27L) Antigen Emulsified in Montanide ISA-51 in Patients With Metastatic Ocular Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.583062|2017-02-18 18:09:53.583062
NCT00020462|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-29|||February 2001||2001-02-01|December 2008|2008-12-01||||||||Interventional|||Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma|Active Specific Immunotherapy for Follicular Lymphomas With Liposomes Containing Tumor-Derived Antigen and IL-2|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.673688|2017-02-18 18:09:53.673688
NCT00020449|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-18|||January 2001||2001-01-01|March 2004|2004-03-01|May 2004|Actual|2004-05-01|||||Interventional|||Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma|A Phase II Study of Liposomal Doxorubicin and Interleukin-12 in AIDS-Associated Kaposi's Sarcoma Followed by Chronic Administration of Interleukin-12|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.769636|2017-02-18 18:09:53.769636
NCT00020410|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-29|||February 2001||2001-02-01|September 2003|2003-09-01||||||||Interventional|||Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer|Phase I Study Of Yttrium 90-labeled Monoclonal Antibody B3 With Autologous Stem Cell Support For Metastatic Breast Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.869841|2017-02-18 18:09:53.869841
NCT00020397|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-18|||November 2000||2000-11-01|January 2005|2005-01-01|July 2005|Actual|2005-07-01|||||Interventional|||Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma|Immunization Of HLA-A*0201 or HLA-DPB1*04 Patients With Metastatic Melanoma Using Epitopes From The ESO-1 Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:53.967344|2017-02-18 18:09:53.967344
NCT00020371|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2015-04-27|||September 2000||2000-09-01|May 2005|2005-05-01||||||||Interventional|||BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy|Phase I Study of BMS-247550 in Patients With Refractory Neoplasms|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:54.07411|2017-02-18 18:09:54.07411
NCT00020358|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-18|||September 2000||2000-09-01|March 2003|2003-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy in Treating Patients With Melanoma|Randomized Comparison of Three Schedules of Peptide Immunization in Patients With Stage II or III, or Completely Resected Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:54.173463|2017-02-18 18:09:54.173463
NCT00020345|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2012-03-07|||September 2000||2000-09-01|March 2012|2012-03-01|March 2002|Actual|2002-03-01|||||Interventional|||Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas|Phase II Study of Neoadjuvant Intraperitoneal Gemcitabine and Intravenous Gemcitabine With Radiotherapy Followed by Surgery and Adjuvant Intraperitoneal Gemcitabine, Intravenous Gemcitabine, and Fluorouracil in Patients With Advanced Adenocarcinoma of the Pancreas|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:54.275655|2017-02-18 18:09:54.275655
NCT00020332|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-14|||October 2000||2000-10-01|July 2002|2002-07-01|March 2003|Actual|2003-03-01|||||Interventional|||Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer|A Phase I/II Trial of Docetaxel Followed by Infusional Flavopiridol Over 72 Hours in Patients With Previously Treated Locally Advanced or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:54.368901|2017-02-18 18:09:54.368901
NCT00020267|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2015-04-27|||July 2000||2000-07-01|May 2002|2002-05-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Cancer|Phase I Randomized Study of MAGE-12 Peptide Vaccine in Patients With Refractory Metastatic Cancer Expressing MAGE-12 Antigen|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:54.470724|2017-02-18 18:09:54.470724
NCT00020254|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||June 2000||2000-06-01|April 2003|2003-04-01||||October 2004|Actual|2004-10-01||Interventional|||Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer|A Randomized Phase II Study of Either Immunotherapy With a Regimen of Recombinant Pox Viruses That Express PSA/B7.1 Plus Adjuvant GM-CSF and IL2 or Hormone Therapy With Nilutamide in Patients With Hormone Refractory Prostate Cancer and No Radiographic Evidence of Disease|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:54.581597|2017-02-18 18:09:54.581597
NCT00020202|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-08-14|||June 2000||2000-06-01|June 2006|2006-06-01|March 2007|Actual|2007-03-01|||||Interventional|||FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer|Phase II Study of FR901228 in Patients With Refractory or Progressive Small Cell or Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:54.692495|2017-02-18 18:09:54.692495
NCT00020189|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-17|||June 2000||2000-06-01|August 2004|2004-08-01|August 2004|Actual|2004-08-01|||||Interventional|||Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Trial of Daily Bolus Flavopiridol for Five Consecutive Days in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:54.790175|2017-02-18 18:09:54.790175
NCT00020176|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-18|||June 2000||2000-06-01|November 2004|2004-11-01|August 2007|Actual|2007-08-01|||||Interventional|||Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer|Allogeneic Breast Protocol 1: T-Cell Depleted Allogeneic Blood Stem Cell Transplantation Using an Immunoablative Conditioning Regimen in Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:09:54.887697|2017-02-18 18:09:54.887697
NCT00020150|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||June 2000||2000-06-01|August 2004|2004-08-01||||||||Interventional|||Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors|Phase I Trial and Pharmacokinetic Study of Temozolomide and O6-Benzylguanine in Childhood Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:54.990462|2017-02-18 18:09:54.990462
NCT00020124|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-14|||June 2000||2000-06-01|March 2012|2012-03-01|December 2002|Actual|2002-12-01|||||Interventional|||Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs|Phase I and Clinical Pharmacologic Study of Inhaled Doxorubicin in Adults With Advanced Solid Tumors Affecting the Lungs|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:55.083813|2017-02-18 18:09:55.083813
NCT00020111|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||March 2000||2000-03-01|February 2005|2005-02-01||||||||Interventional|||Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma|Phase I Trial and Pharmacokinetic Study of Arsenic Trioxide in Pediatric Patients With Refractory Leukemia or Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:55.170377|2017-02-18 18:09:55.170377
NCT00020098|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-28|||June 2000||2000-06-01|March 2012|2012-03-01|September 2001|Actual|2001-09-01|||||Interventional|||Complementary or Alternative Medicine Practices Used by Women at Increased Risk for Breast Cancer|Use of Complementary or Alternative Medicine Practices by Women at Increased Risk for Breast Cancer|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:55.305452|2017-02-18 18:09:55.305452
NCT00020072|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||March 2000||2000-03-01|March 2003|2003-03-01||||||||Interventional|||Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells|Gene Expression Analysis in Cutaneous T-Cell Lymphoma|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:55.382581|2017-02-18 18:09:55.382581
NCT00020046|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2012-03-14|||December 1999||1999-12-01|March 2012|2012-03-01|September 2003|Actual|2003-09-01|||||Interventional|||Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer|Phase II Randomized Study of Docetaxel With or Without Thalidomide in Patients With Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:55.471404|2017-02-18 18:09:55.471404
NCT00020007|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||December 1999||1999-12-01|January 2006|2006-01-01||||||||Interventional|||Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery|A Phase I Study of Isolated Lung Perfusion With Paclitaxel and Moderate Hyperthermia in Patients With Unresectable Pulmonary Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:55.695449|2017-02-18 18:09:55.695449
NCT00019994|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-17|||October 1999||1999-10-01|March 2003|2003-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using a Class II Restricted Peptide From the GP100 Antigen and Class I Restricted Peptides From the GP100 and MART-1 Antigens|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:55.782084|2017-02-18 18:09:55.782084
NCT00019968|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2012-03-14|||August 1999||1999-08-01|March 2012|2012-03-01|March 2002|Actual|2002-03-01|||||Interventional|||Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg|Phase II Randomized Study of Isolated Limb Perfusion Using Melphalan With or Without Tumor Necrosis Factor in Patients With Unresectable High Grade Soft Tissue Sarcomas of the Extremity|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:55.871795|2017-02-18 18:09:55.871795
NCT00019955|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||March 2000||2000-03-01|September 2005|2005-09-01||||||||Interventional|||Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)|A Phase II Study to Evaluate Radiofrequency Ablation of Renal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:55.953339|2017-02-18 18:09:55.953339
NCT00019929|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-18|||August 2000||2000-08-01|November 2005|2005-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer|Phase II Trial of Individualized Mutant p53 Peptide-Pulsed Cultured Autologous Dendritic Cells in the Adjuvant Treatment of Patients With Locally Advanced Non-Small Cell Lung Cancer After Standard Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:09:56.048428|2017-02-18 18:09:56.048428
NCT00019916|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||June 2000||2000-06-01|December 2005|2005-12-01|July 2006|Actual|2006-07-01|||||Interventional|||Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer|Vaccine Therapy With Tumor Specific p53 Peptides in Adult Patients With Adenocarcinoma of the Breast or Ovary|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:09:56.156103|2017-02-18 18:09:56.156103
NCT00019890|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2013-06-19||||||June 2001|2001-06-01|March 2007|Actual|2007-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma|Phase II Randomized Study of CD34+ Derived or Peripheral Monocyte Derived Dendritic Cells Pulsed With MART-1 and gp100 Melanoma Antigens in Patients With High Risk Stage III or Completely Resected Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:56.251871|2017-02-18 18:09:56.251871
NCT00019864|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-06-04|||March 2000||2000-03-01|October 2007|2007-10-01|October 2011|Actual|2011-10-01|December 2006|Actual|2006-12-01||Interventional|||Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma|Osteosarcoma: Outcome of Therapy Based on Histologic Response. A Collaborative Effort of the POB/NCI, Texas Children's Hospital and University of Oklahoma.|Terminated||Phase 2|100|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:56.330861|2017-02-18 18:09:56.330861
NCT00019838|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||July 1999||1999-07-01|February 2005|2005-02-01||||||||Interventional|||UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia|Phase I and Pharmacokinetic Study of UCN-01 and Fludarabine in Relapsed or Refractory Low-Grade Lymphoid Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:09:56.427611|2017-02-18 18:09:56.427611
NCT00019825|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||October 1999||1999-10-01|July 2004|2004-07-01||||||||Interventional|||Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura|Phase I Study of Decitabine Mediated Induction of Tumor Antigen and Tumor Suppressor Gene Expression in Lung Cancer Patients|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:56.517126|2017-02-18 18:09:56.517126
NCT00019812|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-21|||August 1999||1999-08-01|April 2003|2003-04-01|February 2004|Actual|2004-02-01|||||Interventional|||Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2|Study of Trastuzumab (Herceptin) and Paclitaxel in Patients With HER2-Overexpressing Metastatic Breast Cancer|Completed||Phase 2|55|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:56.805384|2017-02-18 18:09:56.805384
NCT00019786|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-21|||August 1999||1999-08-01|March 2012|2012-03-01|January 2006|Actual|2006-01-01|||||Interventional|||Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases|A Phase II Study of Isolated Hepatic Perfusion (IHP) With Melphalan for Metastatic Unresectable Cancers of the Liver|Completed||Phase 2|67|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:56.903102|2017-02-18 18:09:56.903102
NCT00019773|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||July 1999||1999-07-01|April 2003|2003-04-01||||||||Interventional|||Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer|Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:57.033051|2017-02-18 18:09:57.033051
NCT00019760|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2012-03-21|||April 1999||1999-04-01|March 2012|2012-03-01|March 2002|Actual|2002-03-01|||||Interventional|||Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver|Phase II Study of Isolated Hepatic Perfusion With Melphalan Followed By Postoperative Hepatic Arterial Chemotherapy in Patients With Unresectable Colorectal Cancer Metastatic to the Liver|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:57.142594|2017-02-18 18:09:57.142594
NCT00019747|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-10-06|2012-09-25||August 1999||1999-08-01|September 2015|2015-09-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer|A Phase II Trial of Oral Thalidomide as an Adjuvant Agent Following Metastasectomy in Patients With Recurrent Colorectal Cancer|Terminated||Phase 2|39|Actual|National Institutes of Health Clinical Center (CC)||2||DSMB recommended closure of the protocol due to slow accrual.|f||||t||||||||||2017-02-18 18:09:57.259752|2017-02-18 18:09:57.259752
NCT00019734|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||July 1999||1999-07-01|May 2007|2007-05-01|May 2003|Actual|2003-05-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using Recombinant Fowlpox and Vaccinia Viruses Encoding the Tyrosinase Antigen|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:57.932277|2017-02-18 18:09:57.932277
NCT00019721|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-18|||April 1999||1999-04-01|August 2002|2002-08-01|June 2003|Actual|2003-06-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using MART-1 and GP100 Peptides Modified to Increase Binding to HLA-0201|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:58.021104|2017-02-18 18:09:58.021104
NCT00019708|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-12-13|||June 1999||1999-06-01|December 2013|2013-12-01||||April 2010|Actual|2010-04-01||Interventional|||Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|A Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (AAG, NSC 330507) in Adult Patients With Solid Tumors|Terminated||Phase 1|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:09:58.121934|2017-02-18 18:09:58.121934
NCT00019695|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2014-04-21|||March 1999||1999-03-01|March 2004|2004-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer|Phase II Randomized Study of High-Dose Ketoconazole With or Without Alendronate Sodium in Patients With Androgen-Independent Metastastic Adenocarinoma of the Prostate|Terminated||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:58.235593|2017-02-18 18:09:58.235593
NCT00019682|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2014-12-05|||December 1999||1999-12-01|December 2012|2012-12-01||||May 2011|Actual|2011-05-01||Interventional|||Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma|A Phase III Multi-Institutional Randomized Study of Immunization With the gp100: 209-217 (210M) Peptide Followed by High Dose IL-2 vs. High Dose IL-2 Alone in Patients With Metastatic Melanoma|Completed||Phase 3|185|Actual|National Cancer Institute (NCI)||2|||f||||t||||||||||2017-02-18 18:09:58.328962|2017-02-18 18:09:58.328962
NCT00019669|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||October 1999||1999-10-01|August 2004|2004-08-01|October 2007|Actual|2007-10-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using a Recombinant Fowlpox Virus Encoding a GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:58.457703|2017-02-18 18:09:58.457703
NCT00019656|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||August 1999||1999-08-01|August 2004|2004-08-01||||||||Interventional|||Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer|A Phase I Trial of Oral Perifosine With Different Loading Schedules in Patients With Refractory Neoplasms|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:58.547198|2017-02-18 18:09:58.547198
NCT00019643|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-02|2012-03-28|||August 1999||1999-08-01|March 2012|2012-03-01|April 2007|Actual|2007-04-01|||||Observational|||Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer|Prospective Study of Potential Factors Affecting Weight in Breast Cancer Patients Receiving Adjuvant Chemotherapy|Terminated||N/A|26|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:58.645699|2017-02-18 18:09:58.645699
NCT00019630|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2015-04-27|||July 1999||1999-07-01|June 2002|2002-06-01||||||||Interventional|||Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors|Phase I Study of Doxorubicin HCl Liposome in Pediatric Patients With Refractory Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:58.726559|2017-02-18 18:09:58.726559
NCT00019604|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2016-12-07|2014-04-01||August 1998||1998-08-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer|The Use of Radiofrequency Ablation to Treat Hepatic Neoplasms|Terminated||Phase 2|44|Actual|National Institutes of Health Clinical Center (CC)|Adverse event data is available but the format is uninterpretable.|1||Principal investigator left the institution.|f||||f||||||||No||2017-02-18 18:09:58.828776|2017-02-18 18:09:58.828776
NCT00019591|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||March 1999||1999-03-01|November 2005|2005-11-01|November 2005|Actual|2005-11-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer|A Phase I/II Trial of Vaccination With Mutant Ras Peptide-Pulsed Dendritic Cells in the Treatment of HLA A2.1 Positive Patients With Colorectal Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:09:59.225692|2017-02-18 18:09:59.225692
NCT00019578|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2012-03-21|||November 1998||1998-11-01|March 2012|2012-03-01|May 2002|Actual|2002-05-01|||||Interventional|||Stereotactic Radiosurgery in Treating Patients With Brain Tumors|Phase I Pilot Study of Stereotaxic Radiosurgery in Patients With Intracranial Neoplasms|Completed||Phase 1|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:59.436499|2017-02-18 18:09:59.436499
NCT00019565|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2016-09-23|||October 1998||1998-10-01|September 2016|2016-09-01||||August 2008|Actual|2008-08-01||Interventional|||PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy|The Use of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Assess the Effects of Anti-neoplastic Therapy on Tumor Associated Vasculature|Completed||Phase 1|53|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:59.525829|2017-02-18 18:09:59.525829
NCT00019552|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||September 1998||1998-09-01|January 2002|2002-01-01|April 2004|Actual|2004-04-01|||||Interventional|||Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer|A Phase II Study of MGI-114 in Patients With Recurrent or Persistent Epithelial Ovarian Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:59.609857|2017-02-18 18:09:59.609857
NCT00019539|ClinicalTrials.gov processed this data on February 17, 2017|2009-01-09|2013-06-19|||November 1998||1998-11-01|October 2004|2004-10-01|November 2004|Actual|2004-11-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer|Phase II Randomized Study of Monoclonal Antibody VEGF in Patients With Unresectable Advanced Renal Cell Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:59.703877|2017-02-18 18:09:59.703877
NCT00019513|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-21|||August 1998||1998-08-01|March 2012|2012-03-01|June 2004|Actual|2004-06-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas|A Phase I Study of Weekly Gemcitabine in Combination With Infusional 5-Fluorouracil and Oral Calcium Leucovorin in Adult Cancer Patients|Completed||Phase 1|108|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:09:59.789803|2017-02-18 18:09:59.789803
NCT00019500|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-18|||December 1998||1998-12-01|April 2009|2009-04-01|June 2005|Actual|2005-06-01|||||Interventional|||Raloxifene in Preventing Breast Cancer in Premenopausal Women|A Randomized Phase II Trial of Two Doses of Raloxifene in Pre-Menopausal Women at High Risk For Developing Invasive Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:59.8908|2017-02-18 18:09:59.8908
NCT00019487|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||November 1998||1998-11-01|March 2003|2003-03-01|May 2003|Actual|2003-05-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Treatment of Patients With Metastatic Melanoma Using Cloned Peripheral Blood Lymphocytes Sensitized In Vitro to the gp209-2M Immunodominant Peptide|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:09:59.983924|2017-02-18 18:09:59.983924
NCT00019474|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2009-02-06|||March 1998||1998-03-01|April 2007|2007-04-01||||||||Interventional|||Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer|Phase II Trial of 2-Fluorouracil Recombinant Alpha-2a-Interferon and Intravenous Hydroxyurea With Filigrastim in Patients With Refractory GI Malignancies Grant Application Title: Parenteral Hydroxyurea: A Modulator in Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:00.081479|2017-02-18 18:10:00.081479
NCT00019461|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||April 1998||1998-04-01|June 2003|2003-06-01|October 2007|Actual|2007-10-01|||||Interventional|||Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Trial of Orally Administered CAI for Patients With Persistent or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:00.184542|2017-02-18 18:10:00.184542
NCT00019448|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2013-06-19|||September 1998||1998-09-01|September 2001|2001-09-01|March 2007|Actual|2007-03-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Phase II Study of DNA Encoding the gp100 Antigen Alone or in Combination With Interleukin-2 in Patients With Recurrent Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:00.286081|2017-02-18 18:10:00.286081
NCT00019435|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||May 1998||1998-05-01|April 2007|2007-04-01||||||||Interventional|||LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors|Phase I Study of LMB-9, a Recombinant Disulfide Stabilized Immunotoxin for Advanced Carcinomas That Express Lewis Y Antigen|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:00.383401|2017-02-18 18:10:00.383401
NCT00019422|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-08-14|||March 1998||1998-03-01|April 2003|2003-04-01|April 2003|Actual|2003-04-01|||||Interventional|||Lobradimil and Carboplatin in Treating Children With Brain Tumors|A Phase II Trial of Intravenous Cereport (RMP-7) and Carboplatin in Childhood Brain Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:00.501912|2017-02-18 18:10:00.501912
NCT00019409|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-21|||October 1999||1999-10-01|March 2012|2012-03-01|July 2001|Actual|2001-07-01|||||Interventional|||Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia|A Randomized Study of Two Methods of CNS Prophylaxis in Patients With Acute Lymphoblastic Leukemia|Withdrawn||Phase 3|0|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:03.769469|2017-02-18 18:10:03.769469
NCT00019396|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2013-06-19|||February 1998||1998-02-01|May 2006|2006-05-01|March 2007|Actual|2007-03-01|||||Interventional|||flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer|Phase II Study of Flt3 Ligand Alone or in Combination With Melanoma Peptide Immunization in Patients With Metastatic Melanoma or Renal Cell Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:03.881443|2017-02-18 18:10:03.881443
NCT00019383|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||January 1998||1998-01-01|June 2003|2003-06-01|June 2003|Actual|2003-06-01|||||Interventional|||Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma|Immunization of Patients With Metastatic Melanoma Using Immunodominant Peptides From the Tyrosinase Protein or Tyrosinase Related Protein-1 (TRP1)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:03.977068|2017-02-18 18:10:03.977068
NCT00019357|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||June 1998||1998-06-01|August 2001|2001-08-01||||||||Interventional|||Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy|Cellular Immunotherapy With Autologous T Lymphocytes Stimulated With the Patient's Tumor-Specific Mutated Ras Peptides|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:04.073943|2017-02-18 18:10:04.073943
NCT00019344|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||August 1997||1997-08-01|May 2002|2002-05-01||||||||Interventional|||Flavopiridol in Treating Patients With Refractory Cancer|A Phase I Trial of Daily Bolus Flavopiridol for Five Consecutive Days in Patients With Refractory Neoplasms|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:04.443439|2017-02-18 18:10:04.443439
NCT00019331|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||October 1997||1997-10-01|April 2004|2004-04-01|May 2007|Actual|2007-05-01|||||Interventional|||Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors|Vaccine Therapy With Tumor Specific Mutated Ras Peptides and IL-2 or GM-CSF for Adult Patients With Solid Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:04.5523|2017-02-18 18:10:04.5523
NCT00019318|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||August 1997||1997-08-01|October 2001|2001-10-01||||||||Interventional|||Depsipeptide in Treating Patients With Solid Tumors|Phase I Trial of a Four Hour Infusion of Depsipeptide (NSC630176) Given on Days 1 and 5 of a 21 Day Cycle in Patients With Refractory Neoplasms|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:04.674051|2017-02-18 18:10:04.674051
NCT00019240|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||November 1996||1996-11-01|November 2007|2007-11-01|April 2004|Actual|2004-04-01|||||Interventional|||Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection|PHASE II PROTOCOL WITH LABORATORY CORRELATES OF 1-[(S)-3-HYDROXY-2-(PHOSPHOMETHOXY)PROPYL]CYTOSINE DIHYDRATE(CIDOFOVIR) IN PATIENTS WITH KAPOSI'S SARCOMA (KS)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:04.774794|2017-02-18 18:10:04.774794
NCT00019227|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||October 1996||1996-10-01|March 2003|2003-03-01|July 2006|Actual|2006-07-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Leukemia|PHASE I/II STUDY OF TAC-EXPRESSING ADULT T-CELL LEUKEMIA (ATL) WITH YTTRIUM-90 (90Y)-RADIOLABELED HUMANIZED ANTI-TAC AND CALCIUM-DTPA|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:04.883934|2017-02-18 18:10:04.883934
NCT00019214|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-18|||April 1997||1997-04-01|January 2005|2005-01-01|July 2006|Actual|2006-07-01|||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma|Phase I/II Study in Patients With Metastatic Melanoma of Immunization With Dendritic Cells Presenting Epitopes Derived From The Melanoma Associated Antigens MART-1 and gp 100|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:04.978461|2017-02-18 18:10:04.978461
NCT00019201|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||August 1996||1996-08-01|February 2000|2000-02-01||||||||Interventional|||Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer|PILOT STUDY OF THE CORRELATION BETWEEN THE FINDINGS OF ATYPICAL/MALIGNANT CELLS IN SPUTUM AND FLUORESCENCE BRONCHOSCOPY IN PATIENTS AT RISK FOR LUNG CANCER OF THE LIFE IMAGING SYSTEM AND WHITE LIGHT BRONCHOSCOPY|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.066834|2017-02-18 18:10:05.066834
NCT00019188|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2013-06-19|||January 1997||1997-01-01|April 2004|2004-04-01|March 2007|Actual|2007-03-01|||||Interventional|||Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma|Phase I/II Pilot Study of Interleukin-12 in Patients With AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.173097|2017-02-18 18:10:05.173097
NCT00019175|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||August 1996||1996-08-01|April 2003|2003-04-01||||||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma|PHASE I TRIAL IN PATIENTS WITH METASTATIC MELANOMA OF IMMUNIZATION WITH A RECOMBINANT FOWLPOX VIRUS ENCODING THE GP100 MELANOMA ANTIGEN|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.284783|2017-02-18 18:10:05.284783
NCT00019136|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||February 1997||1997-02-01|December 2003|2003-12-01||||||||Interventional|||Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer|TREATMENT OF PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER USING ANTI-CD3 STIMULATED PERIPHERAL BLOOD LYMPHOCYTES TRANSDUCED WITH A GENE ENCODING A CHIMERIC T-CELL RECEPTOR REACTIVE WITH FOLATE BINDING PROTEIN|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.380525|2017-02-18 18:10:05.380525
NCT00019123|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-08-14|||April 1996||1996-04-01|November 2007|2007-11-01|April 2004|Actual|2004-04-01|||||Interventional|||Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma|A PHASE II STUDY OF ORAL THALIDOMIDE FOR PATIENTS WITH HIV INFECTION AND KAPOSI'S SARCOMA|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.478055|2017-02-18 18:10:05.478055
NCT00018330|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2004||2004-03-01|||||Interventional|||Genetics, Metabolism and Weight Loss in Older, Obese Veterans|Genetics, Metabolism and Weight Loss in Older, Obese Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.065394|2017-02-18 18:10:14.065394
NCT00019110|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||November 1995||1995-11-01|November 1999|1999-11-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer|VACCINE THERAPY AND DETECTION OF IMMUNOLOGIC RESPONSES WITH HUMAN PAPILLOMAVIRUS 16 E6 AND E7 PEPTIDES IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED CERVICAL CANCER|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.577671|2017-02-18 18:10:05.577671
NCT00019097|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2013-06-19|||July 1995||1995-07-01|May 2006|2006-05-01|March 2007|Actual|2007-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With Multiple Myeloma|Phase II Study of Autologous Myeloma-Derived Immunoglobulin Idiotype Conjugated to Keyhole Limpet Hemocyanin Plus Sargramostim (GM-CSF) in Patients With Multiple Myeloma Undergoing Second Autologous Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.681833|2017-02-18 18:10:05.681833
NCT00019084|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-19|||February 1996||1996-02-01|April 2007|2007-04-01|May 2003|Actual|2003-05-01|||||Interventional|||Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer|VACCINE THERAPY WITH TUMOR SPECIFIC MUTATED P53 OR RAS PEPTIDES ALONE OR IN COMBINATION WITH CELLULAR IMMUNOTHERAPY WITH PEPTIDE ACTIVATED LYMPHOCYTES (PAL CELLS) ALONG WITH SUBCUTANEOUS IL-2|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.779555|2017-02-18 18:10:05.779555
NCT00019071|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||March 1995||1995-03-01|May 2002|2002-05-01||||||||Interventional|||Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma|A PHASE I STUDY OF 2-CHLORODEOXYADENOSINE AND RADIATION FOR THE TREATMENT OF HIGH GRADE GLIOMA (CDX)|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.870995|2017-02-18 18:10:05.870995
NCT00019058|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-28|||April 1995||1995-04-01|December 2001|2001-12-01||||||||Interventional|||Radiation Therapy in Treating Patients With Glioblastoma|A PHASE I STUDY OF COMBINED RADIATION RESPONSE MODIFIERS EMPLOYING HYDROXYUREA AND PENTOXIFYLLINE FOR TREATMENT OF GLIOBLASTOMA|Completed||Phase 1|34|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:05.987112|2017-02-18 18:10:05.987112
NCT00019032|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-27|||March 1996||1996-03-01|April 2004|2004-04-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia|PHASE I STUDY OF T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA USING THE MIK-BETA 1 MONOCLONAL ANTIBODY DIRECTED TOWARD THE IL-2R BETA SUBUNIT|Completed||Phase 1|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:06.078231|2017-02-18 18:10:06.078231
NCT00019019|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-03-14|||October 1994||1994-10-01|March 2012|2012-03-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas|A PHASE I STUDY OF THE COMBINATION OF CAI AND PACLITAXEL IN ADULT PATIENTS WITH REFRACTORY CANCERS OR LYMPHOMA|Completed||Phase 1|70|Anticipated|National Institutes of Health Clinical Center (CC)|||||||||||||||||||2017-02-18 18:10:06.177587|2017-02-18 18:10:06.177587
NCT00019006|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2015-04-27|||March 1995||1995-03-01|May 2005|2005-05-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer|Phase I Pilot Study of Vaccine Therapy With Tumor-Specific Mutated Ras Peptides in the Adjuvant Setting in Patients With Colorectal, Pancreatic, or Lung Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:06.5739|2017-02-18 18:10:06.5739
NCT00018967|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2015-04-29|||November 1993||1993-11-01|April 2007|2007-04-01||||April 2007|Actual|2007-04-01||Interventional|||Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate|A Trial of Carboxypeptidase-G2 (CPDG2) For The Management of Patients With Intrathecal Methotrexate Overdose|Completed||N/A|10|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:10:06.683942|2017-02-18 18:10:06.683942
NCT00018954|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2012-02-16|||October 1992||1992-10-01|February 2012|2012-02-01|October 2002|Actual|2002-10-01|||||Interventional|||Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma|PILOT MULTINATIONAL PROTOCOLS IN ACUTE LYMPHOBLASTIC LEUKEMIA AND DIFFUSE NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:06.886585|2017-02-18 18:10:06.886585
NCT00018941|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-11|2013-06-14|||April 1991||1991-04-01|March 2003|2003-03-01|May 2003|Actual|2003-05-01|||||Interventional|||Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|Phase III Randomized Study of Intravenous Low Dose Versus Intravenous High Dose Versus Subcutaneous Interleukin-2 for Metastatic Renal Cell Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:07.010954|2017-02-18 18:10:07.010954
NCT00018902|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-10|2014-03-11|||January 2001||2001-01-01|March 2014|2014-03-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|TORDIA||Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)|Treatment of SSRI-Resistant Depression in Adolescents (TORDIA)|Completed||Phase 2/Phase 3|334|Actual|University of Pittsburgh||4|||||||t||||||||||2017-02-18 18:10:07.100743|2017-02-18 18:10:07.100743
NCT00018889|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-07|2017-01-24|||July 6, 2001||2001-07-06|November 2, 2016|2016-11-02||||||||Observational|||Phenotype/Genotype Correlations in Movement Disorders|Phenotype/Genotype Correlations in Movement Disorders|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:07.254422|2017-02-18 18:10:07.254422
NCT00018876|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-05|2013-06-06|||October 2000||2000-10-01|March 2006|2006-03-01|October 2002||2002-10-01|||||Interventional|||Low-Dose Radiation to Prevent Complications of Back Surgery|Radiotherapy to Prevent Fibrosis After Lumbar Laminectomy|Completed||Phase 1|46||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:10:07.382082|2017-02-18 18:10:07.382082
NCT00018863|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-05|2013-11-01|||April 2001||2001-04-01|October 2006|2006-10-01||||March 2006|Actual|2006-03-01||Interventional|||Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)|Methylphenidate Efficacy and Safety in ADHD Preschoolers|Unknown status|Active, not recruiting|Phase 3|165||New York State Psychiatric Institute|||||||||||||||||||2017-02-18 18:10:07.484579|2017-02-18 18:10:07.484579
NCT00018850|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||June 1998||1998-06-01|December 2004|2004-12-01|June 2003||2003-06-01|||||Interventional|||5HT3 Antagonism and Auditory Gating in Schizophrenia|5HT3 Antagonism and Auditory Gating in Schizophrenia|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:07.606531|2017-02-18 18:10:07.606531
NCT00018837|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|December 2004|2004-12-01|March 2001||2001-03-01|||||Interventional|||Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome|Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:07.693773|2017-02-18 18:10:07.693773
NCT00018824|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-09-21|||October 1999||1999-10-01|September 2009|2009-09-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Treating Alcohol Use In Older Adults With Depression|The Treatment of Late Life Major Depression Complication by Alcohol|Completed||Phase 4|74|Actual|VA Office of Research and Development||2|||f||||||||||||||2017-02-18 18:10:07.77171|2017-02-18 18:10:07.77171
NCT00018811|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2003|2003-12-01|March 2003||2003-03-01|||||Interventional|||Psychological Assessment and Treatment of Chronic Benign Headache|Psychological Assessment and Treatment of Chronic Benign Headache|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:07.895334|2017-02-18 18:10:07.895334
NCT00018798|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 2000||2000-04-01|December 2004|2004-12-01|April 2003||2003-04-01|||||Observational|||Post-Traumatic Stress Disorder (PTSD) Symptom Study|Longitudinal Evaluation of Chronic Combat-Related PTSD|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:08.186907|2017-02-18 18:10:08.186907
NCT00018785|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants|Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:08.262275|2017-02-18 18:10:08.262275
NCT00018772|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|April 2003||2003-04-01|||||Observational|||Risk Factors for Venous Thromboembolism|2779 Epidemiology of Genetic and Acquired Risk Factors for Venous Thrombosis|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:08.340693|2017-02-18 18:10:08.340693
NCT00018759|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||March 2001||2001-03-01|December 2004|2004-12-01|October 2003||2003-10-01|||||Interventional|||Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients|Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:08.417701|2017-02-18 18:10:08.417701
NCT00018746|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||July 1999||1999-07-01|December 2004|2004-12-01|July 2001||2001-07-01|||||Interventional|||Transcranial Magnetic Stimulation in Depression|Efficacy of Threshold vs. Subthreshold TMS in the Treatment of Depression|Completed||Phase 1|||VA Office of Research and Development|||||||||||||||||||2017-02-18 18:10:08.499997|2017-02-18 18:10:08.499997
NCT00018733|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||September 1996||1996-09-01|December 2004|2004-12-01|December 2001||2001-12-01|||||Interventional|||Biological Aspects of Depression and Antidepressant Drugs|Biological Aspects of Depression and Antidepressant Drugs|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:08.583871|2017-02-18 18:10:08.583871
NCT00018720|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1996||1996-04-01|December 2004|2004-12-01|December 2000||2000-12-01|||||Observational|||Regulation of Sterol Homeostasis|Regulation of Sterol Homeostasis|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:08.679289|2017-02-18 18:10:08.679289
NCT00018707|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2003||2003-03-01|||||Observational|||Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress|Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:08.755289|2017-02-18 18:10:08.755289
NCT00018694|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2013-10-11|||October 1999||1999-10-01|October 2013|2013-10-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Cholestanol in Humans|Biologic Significance of Cholestanol in Man|Withdrawn||N/A|0|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:10:08.834884|2017-02-18 18:10:08.834884
NCT00018681|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|December 2004|2004-12-01|January 2002||2002-01-01|||||Observational|||Regulation of Human Intestinal Bile Acid Transport in Health and Disease|Regulation of Human Intestinal Bile Acid Transport in Health and Disease|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:08.943746|2017-02-18 18:10:08.943746
NCT00018668|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 2000||2000-10-01|December 2004|2004-12-01|September 2004||2004-09-01|||||Interventional|||Antipsychotic Response in Schizophrenia|Psychopharmacologic Aspects of Motor Slowing in Schizophrenia|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:09.302728|2017-02-18 18:10:09.302728
NCT00018655|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2014-12-09|||April 2000||2000-04-01|December 2014|2014-12-01|September 2012|Actual|2012-09-01|September 2009|Actual|2009-09-01||Interventional|||Integrated Intervention for Substance Abusers With Depressive Disorders|Integrated Intervention for Substance Abusers With Depressive Disorders|Terminated||Phase 2|276|Actual|VA Office of Research and Development||2||"PI has been contacted numerous times for an update, with no response. ORD requested a close~   out of this project. 10/2011"|f||||t||||||||||2017-02-18 18:10:09.395237|2017-02-18 18:10:09.395237
NCT00018642|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1997||1997-04-01|December 2004|2004-12-01|March 2002||2002-03-01|||||Interventional|||Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder|Predicting the Optimal Pharmacotherapy for Outpatients With Schizophrenia|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:09.527324|2017-02-18 18:10:09.527324
NCT00018629|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-05|||May 2000||2000-05-01|September 2008|2008-09-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Cognitive - Behavioral Therapy|Rehabilitation of Older Patients With Schizophrenia|Completed||Phase 2|76|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:10:09.609804|2017-02-18 18:10:09.609804
NCT00018616|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-09-21|||October 1999||1999-10-01|September 2009|2009-09-01|January 2005|Actual|2005-01-01|January 2004|Actual|2004-01-01||Interventional|||Improving Compliance With Metformin|Improving Compliance With Metformin|Completed||Phase 2|79|Actual|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:10:09.705912|2017-02-18 18:10:09.705912
NCT00018603|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||November 1999||1999-11-01|December 2004|2004-12-01|October 2002||2002-10-01|||||Interventional|||Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)|Guanfacine for the Treatment of PTSD|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:09.810913|2017-02-18 18:10:09.810913
NCT00018395|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||August 1997||1997-08-01|December 2004|2004-12-01|June 2002||2002-06-01|||||Observational|||Cardiovascular Mortality Associated With Abnormal Calcium Metabolism|Cardiovascular Mortality Associated With Abnormal Calcium Metabolism|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:09.898634|2017-02-18 18:10:09.898634
NCT00016679|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-24|2008-03-03|||May 2001||2001-05-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Interventional|||1-Octanol to Treat Essential Tremor|Dose Finding Study of 1-Octanol in Essential Tremor|Completed||Phase 1|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:09.971883|2017-02-18 18:10:09.971883
NCT00018590|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||January 2001||2001-01-01|December 2004|2004-12-01||||||||Observational|||Center for the Study of Vascular Disease in Hispanic and Native Americans|Center for the Study of Vascular Disease in Hispanic and Native Americans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.054195|2017-02-18 18:10:10.054195
NCT00018577|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2008-04-02|||October 2000||2000-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Observational|||The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men|The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.13218|2017-02-18 18:10:10.13218
NCT00018564|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 2000||2000-10-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Novel Therapies for Essential Tremor|Novel Therapies for Essential Tremor|Completed||Phase 3|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.220175|2017-02-18 18:10:10.220175
NCT00018551|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Chemoprevention With Folic Acid|3389 Colorectal Adenoma: Chemoprevention With Folic Acid|Completed||Phase 2|||VA Office of Research and Development|||||||||||||||||||2017-02-18 18:10:10.306419|2017-02-18 18:10:10.306419
NCT00018538|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Interventional|||Calcifidol Therapy in Men With Cancer|Calcifidol Therapy in Men With Cancer|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.386973|2017-02-18 18:10:10.386973
NCT00018525|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 2000||2000-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Interventional|||Lung Volume Reductions Surgery (LVRS) Study|Effects of Lung Volume Reduction Surgery in the Treatment of Severe Emphysema|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.460801|2017-02-18 18:10:10.460801
NCT00018512|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2004||2004-09-01|||||Interventional|||Biological Specifications for Denture Designs|Biological Specifications for Denture Designs|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.53819|2017-02-18 18:10:10.53819
NCT00018499|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|October 2001||2001-10-01|||||Observational|||Genotype Influence on Recovery After Traumatic Brain Injury|The Influence of APOE Genotype on Recovery After Traumatic Brain Injury|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.623859|2017-02-18 18:10:10.623859
NCT00018486|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2004||2004-03-01|||||Observational|||Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans|Epidemiology of Hearing Loss in Diabetic and Non-Diabetic Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.708494|2017-02-18 18:10:10.708494
NCT00018473|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2004||2004-03-01|||||Observational|||Gene-Environment Interactions in Alzheimer's Disease|Gene-Environment Interactions in Alzheimer's Disease|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.77461|2017-02-18 18:10:10.77461
NCT00018460|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1999||1999-04-01|December 2004|2004-12-01|March 2002||2002-03-01|||||Interventional|||Anticoagulation, Vitamins, and Endothelial Function|Anticoagulation, Vitamins, and Endothelial Function|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:10.850693|2017-02-18 18:10:10.850693
NCT00018447|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||November 1998||1998-11-01|December 2004|2004-12-01|October 2003||2003-10-01|||||Interventional|||Combination Osteogenic Therapy in Established Osteoporosis|Combination Osteogenic Therapy in Established Osteoporosis|Completed||Phase 2|||VA Office of Research and Development|||||||||||||||||||2017-02-18 18:10:10.945813|2017-02-18 18:10:10.945813
NCT00018434|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2015-06-25|||July 1998||1998-07-01|June 2015|2015-06-01|June 2001||2001-06-01|||||Observational|||The Epidemiology of Infection With Vancomycin-Resistant Enterococci|The Epidemiology of Infection With Vancomycin-Resistant Enterococci|Completed||N/A|||VA Office of Research and Development|||1||f||||||||||||||2017-02-18 18:10:11.035465|2017-02-18 18:10:11.035465
NCT00018421|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||July 1997||1997-07-01|December 2004|2004-12-01|June 2001||2001-06-01|||||Interventional|||Effects of Exercise on Patients With Hemiparetic Stroke|Effects of Exercise on Patients With Hemiparetic Stroke|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:11.118258|2017-02-18 18:10:11.118258
NCT00018408|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2001||2001-09-01|||||Observational|||Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)|Genetic Mechanisms of Chronic Obstructive Pulmonary Disease|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:11.199523|2017-02-18 18:10:11.199523
NCT00017147|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-01-28|||September 2001||2001-09-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|May 2006|Actual|2006-05-01||Interventional|||S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma|A Phase III Study of Radiation Therapy (RT) and O6-Benzylguanine (O6-BG) Plus BCNU Versus RT and BCNU Alone for Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma|Completed||Phase 3|183|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:10:11.287794|2017-02-18 18:10:11.287794
NCT00017134|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-07|||September 2002||2002-09-01|November 2006|2006-11-01||||December 2006|Actual|2006-12-01||Interventional|||Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk|An Exploratory Evaluation of Fenretinide (4-HPR) as a Chemopreventive Agent for Ovarian Carcinoma|Terminated||N/A|71|Anticipated|Gynecologic Oncology Group||||Withdrawn due to poor accrual|||||||||||||||2017-02-18 18:10:11.57833|2017-02-18 18:10:11.57833
NCT00017121|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2016-07-01|||May 2002||2002-05-01|July 2016|2016-07-01|November 2012|Actual|2012-11-01|November 2012|Actual|2012-11-01||Interventional|||Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung|Dose Finding Study of Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung|Completed||Phase 1|40|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:10:11.775163|2017-02-18 18:10:11.775163
NCT00017108|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2008-07-23|||March 2001||2001-03-01|June 2004|2004-06-01||||||||Interventional|||Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia|Low Dose Chlorambucil Maintenance Vs. No Treatment Following High-Dose Chlorambucil Induction In Patients With Advanced B-Chronic Lymphocytic Leukemia. A Randomized Phase III Study Of The EORTC LG (CLL-3)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:12.171601|2017-02-18 18:10:12.171601
NCT00017095|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-10-23|||March 2001||2001-03-01|October 2013|2013-10-01||||November 2006|Actual|2006-11-01||Interventional|||Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer|First Prospective Intergroup Translational Research Trial Assessing the Potential Predictive Value of p53 Using a Functional Assay in Yeast in Patients With Locally Advanced/Inflammatory or Large Operable Breast Cancer Prospectively Randomised to a Taxane Versus a Non Taxane Regimen|Completed||Phase 3|1856|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 18:10:12.28104|2017-02-18 18:10:12.28104
NCT00017082|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-25|||April 2001||2001-04-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|June 2003|Actual|2003-06-01||Interventional|||Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer|A Multicenter, Phase II Study Of Oxaliplatin Single Agent As Third-Line Treatment Of Metastatic Colorectal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:12.463782|2017-02-18 18:10:12.463782
NCT00017069|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2008-11-16|||February 2001||2001-02-01|April 2004|2004-04-01||||||||Interventional|||Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma|CTI 1060: A Phase II Clinical Trial of Arsenic Trioxide and Dexamethasone as Therapy for Relapsed or Refractory Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:12.57601|2017-02-18 18:10:12.57601
NCT00017056|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-17|||February 2001||2001-02-01|June 2013|2013-06-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy|A Phase II Study Of Epothilone Analog BMS-247550 In Patients With Metastatic Gastric Adenocarcinoma Previously Treated With A Fluoropyrimidine And/Or Platinum|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:12.686137|2017-02-18 18:10:12.686137
NCT00017043|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-04-03|||February 2001||2001-02-01|April 2013|2013-04-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy|A Phase II Study of Epothilone Analog BMS-247550 in Patients With Metastatic Gastric Adenocarcinoma Previously Treated With a Taxane|Completed||Phase 2|||Bristol-Myers Squibb||1|||f||||||||||||||2017-02-18 18:10:12.78698|2017-02-18 18:10:12.78698
NCT00017030|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-25|||February 2001||2001-02-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|January 2003|Actual|2003-01-01||Interventional|||Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma|Phase II Study of ET-743 Given as a Three Hour Intravenous Infusion in Patients With Advanced and/or Metastatic Soft Tissue Sarcoma Previously Treated With Chemotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:12.882836|2017-02-18 18:10:12.882836
NCT00017017|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-05-29|||February 2001||2001-02-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|February 2003|Actual|2003-02-01||Interventional|||CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer|A Phase I/II Trial fo Intravenous CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:12.989797|2017-02-18 18:10:12.989797
NCT00017004|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2014-12-29|||August 2001||2001-08-01|December 2014|2014-12-01||||January 2010|Actual|2010-01-01||Interventional|||Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia|Phase III Trial to Evaluate the Efficacy of Maintaining Hemoglobin Levels Above 120 g/l With Erythropoietin Versus Above 100 g/l Without Erythropoietin in Anemic Patients Receiving Concurrent Radiation and Cisplatin for Cervical Cancer|Completed||Phase 3|114|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-02-18 18:10:13.082539|2017-02-18 18:10:13.082539
NCT00016991|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-19|||June 2001||2001-06-01|October 2009|2009-10-01|April 2005|Actual|2005-04-01|||||Interventional|||ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse|A Phase II Study of ZD 1839 (NSC 715055) for Patients With First Relapse Glioblastoma Multiforme|Completed||Phase 2|||Duke University|||||f||||||||||||||2017-02-18 18:10:13.217767|2017-02-18 18:10:13.217767
NCT00016978|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-02-04|||April 2001||2001-04-01|August 2007|2007-08-01||||June 2007|Actual|2007-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan|A Phase II Study of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), and Leucovorin (CF) in Patients With Metastatic Colorectal Carcinoma Previously Treated With Irinotecan (CPT-11)|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:13.326855|2017-02-18 18:10:13.326855
NCT00016965|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-20|||July 2001||2001-07-01|April 2003|2003-04-01|April 2006|Actual|2006-04-01|||||Interventional|||BMS-247550 in Treating Patients With Advanced Pancreatic Cancer|A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) Every 21 Days in Patients With Advanced Pancreas Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:13.526589|2017-02-18 18:10:13.526589
NCT00018382|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|March 2003||2003-03-01|||||Interventional|||Insulin, Neurogenetics and Memory in Alzheimer's Disease|Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:13.722559|2017-02-18 18:10:13.722559
NCT00018369|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||December 2000||2000-12-01|December 2004|2004-12-01|April 2004||2004-04-01|||||Observational|||Age-Related Changes in Stress Hormone Regulation|Mechanism of Aging-Related Changes in (HPA) Hydrocortisone Corticotropin Feedback Function|Completed||Phase 4|||VA Office of Research and Development|||||||||||||||||||2017-02-18 18:10:13.803154|2017-02-18 18:10:13.803154
NCT00018356|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2011-06-22|||January 1999||1999-01-01|June 2011|2011-06-01|August 2006|Actual|2006-08-01|July 2006|Actual|2006-07-01||Interventional|||Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly|Physiologic Effects of PRMS & Testosterone in the Debilitated Elderly|Completed||Phase 4|88|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:10:13.883559|2017-02-18 18:10:13.883559
NCT00018343|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|December 2004|2004-12-01|March 2001||2001-03-01|||||Interventional|||Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen|Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:13.986299|2017-02-18 18:10:13.986299
NCT00017823|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-13|2010-04-20||||||April 2001|2001-04-01||||||||Interventional|||Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients|The Acupressure Study|Completed||Phase 1|||National Institute of Nursing Research (NINR)|||||f||||||||||||||2017-02-18 18:10:23.257675|2017-02-18 18:10:23.257675
NCT00018317|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 2000||2000-10-01|December 2004|2004-12-01|December 2005||2005-12-01|||||Interventional|||Resistance Training and Diet in Patients With Chronic Renal Failure|Resistance Training and Diet in Patients With Chronic Renal Failure|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.148456|2017-02-18 18:10:14.148456
NCT00018304|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20||||||December 2004|2004-12-01||||||||Observational|||Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow|Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow|Completed||Phase 1|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.23409|2017-02-18 18:10:14.23409
NCT00018291|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||January 2001||2001-01-01|December 2004|2004-12-01|January 2005||2005-01-01|||||Interventional|||Specific Interventions for Agitation in Alzheimer's Disease|Specific Interventions for Agitation in Alzheimer's Disease|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.304401|2017-02-18 18:10:14.304401
NCT00018278|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1998||1998-10-01|December 2004|2004-12-01|September 2001||2001-09-01|||||Interventional|||Electrophysiologic Measures of Treatment Response in Alzheimer Disease|Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease|Completed||Phase 4|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.382125|2017-02-18 18:10:14.382125
NCT00018265|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2003||2003-09-01|||||Interventional|||Fitness and Daily Function in Adults|Oxygen Kinetics, Mobility Task Performance, and Task Training in Older Adults|Completed||Phase 3|140||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.463568|2017-02-18 18:10:14.463568
NCT00018252|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1997||1997-04-01|June 2001|2001-06-01|March 2000||2000-03-01|||||Interventional|||The Effect of Exercise Training on Mental Stress-Induced Silent Ischemia|The Effect of Exercise Training on Mental Stress-Induced Silent Ischemia|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.552118|2017-02-18 18:10:14.552118
NCT00018239|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||October 1999||1999-10-01|December 2004|2004-12-01|September 2002||2002-09-01|||||Interventional|||Aging and Cellular Mechanism for Insulin Action After Exercise Training|Aging and Cellular Mechanism for Insulin Action After Exercise Training|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.628266|2017-02-18 18:10:14.628266
NCT00018226|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|December 2004|2004-12-01|March 2001||2001-03-01|||||Interventional|||Effect Of Case Management Following Discharge From Methadone Treatment|Enhanced Outreach Counseling Following Methadone Treatment Discharge|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.701332|2017-02-18 18:10:14.701332
NCT00018213|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||April 1998||1998-04-01|September 2007|2007-09-01|March 2001||2001-03-01|||||Interventional|||Naltrexone and Patch for Smokers|Naltrexone and Nicotine Replacement Effects on Cue Reactivity of Smokers|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:14.777313|2017-02-18 18:10:14.777313
NCT00018200|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2012-06-04|||April 1999||1999-04-01|June 2012|2012-06-01|March 2004|Actual|2004-03-01|December 2003|Actual|2003-12-01||Interventional|||Effect of Antidepressants on Back Pain|Efficacy of Antidepressants in Chronic Back Pain|Completed||Phase 2|130|Actual|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 18:10:14.853883|2017-02-18 18:10:14.853883
NCT00016952|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2016-12-05|||April 2001||2001-04-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|April 2004|Actual|2004-04-01||Interventional|||Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer|Phase II Study in Patients With Metastatic Colorectal Carcinoma Previously Treated With Oxaliplatin (OXAL) or a Combination of Irinotecan (CPT-11) and OXAL|Completed||Phase 2|19|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:10:14.962736|2017-02-18 18:10:14.962736
NCT00016939|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-20|||May 2001||2001-05-01|January 2008|2008-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer|A Phase II Study of Flavopiridol 1 Hour Bolus Days 1-3 Q 21 Days in Patients With Advanced Renal Cell Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:15.371982|2017-02-18 18:10:15.371982
NCT00016926|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-05-24|||April 2001||2001-04-01|May 2004|2004-05-01||||July 2007|Actual|2007-07-01||Interventional|||Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer|A Limited Access Phase II Trial Of Capecitabine In Advanced, Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:10:15.60518|2017-02-18 18:10:15.60518
NCT00016913|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2016-07-01|2015-07-31||May 2001||2001-05-01|July 2016|2016-07-01|May 2008|Actual|2008-05-01|July 2007|Actual|2007-07-01||Interventional|||Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer|Phase II Study Of Neo-Adjuvant Paclitaxel, Estramustine And Carboplatin (TEC) Plus Androgen Ablation Prior To Radiation Therapy In Patients With Poor Prognosis Localized Prostate Cancer|Completed||Phase 2|34|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:10:15.723433|2017-02-18 18:10:15.723433
NCT00016900|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-17|||December 2000||2000-12-01|June 2013|2013-06-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus|A Phase II Multicenter Study of the Efficacy and Safety Study of PNU-93914 (Liposome Encapsulated Paclitaxel) in Patients With Advanced Esophageal Cancer Previously Exposed to Chemotherapy|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:16.153419|2017-02-18 18:10:16.153419
NCT00016887|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-09-16|||December 2000||2000-12-01|August 2003|2003-08-01||||||||Interventional|||Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma|Treatment of Mantle Cell Lymphomas at Advanced Stages: Prospective Randomized Comparison of Myeloablative Radiochemotherapy Followed by Blood Stem Cell Transplantation Versus Maintenance With Interferon Alpha in First Remission After Initial Cytoreductive Chemotherapy With an Anthracycline Containing Combination|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:16.257103|2017-02-18 18:10:16.257103
NCT00016874|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-07-17|||December 2000||2000-12-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer|A Phase I Study Of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) In Combination With Cisplatin And Paclitaxel In Patients With Advanced And Metastatic Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:16.37079|2017-02-18 18:10:16.37079
NCT00016861|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-25|||September 1998||1998-09-01|November 2004|2004-11-01|January 2005|Actual|2005-01-01|||||Interventional|||Irinotecan in Treating Children With Refractory or Progressive Solid Tumors|Pediatric Phase I and Pharmacokinetic Study of Irinotecan|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:16.473213|2017-02-18 18:10:16.473213
NCT00016848|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2008-03-03|||June 2001||2001-06-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||Effects of Dietary Carbohydrate and Fat on Hormones|The Effects of Dietary Carbohydrate and Fat on Hormone Regulators of Body Composition and Reproduction|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:16.570327|2017-02-18 18:10:16.570327
NCT00016835|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-05|2007-10-05|||April 2001||2001-04-01|October 2007|2007-10-01|October 2008|Anticipated|2008-10-01|||||Interventional|||Treating Periodontal Infection: Effects on Glycemic Control in People With Type 2 Diabetes|Treating Periodontal Infection: Effects on Glycemic Control|Unknown status|Active, not recruiting|Phase 2|45||National Institute of Dental and Craniofacial Research (NIDCR)|||||f||||t||||||||||2017-02-18 18:10:16.664699|2017-02-18 18:10:16.664699
NCT00016796|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-02|2008-03-03|||May 2001||2001-05-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Language Stimuli Screening in Children|Language Stimuli Screening in Children|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:16.760647|2017-02-18 18:10:16.760647
NCT00016783|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-02|2013-10-04||||||October 2013|2013-10-01|October 2006|Actual|2006-10-01|||||Observational|||Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV|Intensification of HIV-Specific CD4 and CD8 Activity by Cycling Highly Active Antiretroviral Therapy (HAART) in Pediatric/Adolescent Patients With Less Than 50 HIV RNA Copies/ml|Completed||N/A|39||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:10:16.844935|2017-02-18 18:10:16.844935
NCT00016744|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-31|2009-01-08|||September 2001||2001-09-01|January 2009|2009-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)|A Pilot Trial of Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous Cystic Fibrosis Patients|Completed||Phase 1/Phase 2|12|Actual|Children's Hospital of Philadelphia||2|||f||||t||||||||||2017-02-18 18:10:16.957935|2017-02-18 18:10:16.957935
NCT00016731|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-31|2017-02-14|||May 25, 2001||2001-05-25|January 24, 2017|2017-01-24||||||||Observational|||Adolescence, Puberty, and Emotion Regulation|Adolescence, Puberty, Hormones, and Emotion Regulation: An fMRI Study|Completed||N/A|300|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:17.061931|2017-02-18 18:10:17.061931
NCT00016718|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-31|2013-05-03||2010-01-20|August 2001||2001-08-01|May 2013|2013-05-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Interventional|||Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs|An Open-Label Study to Evaluate the Safety, Tolerance, Antiviral Activity, and Pharmacokinetics of Emtricitabine in Combination With Efavirenz and Didanosine in a Once-Daily Regimen in HIV Infected, Antiretroviral Therapy Naive or Very Limited Antiretroviral Exposed Pediatric Subjects|Completed||Phase 1/Phase 2|43|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:10:17.154905|2017-02-18 18:10:17.154905
NCT00016692|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-24|2006-04-26||||||April 2001|2001-04-01||||||||Interventional|||Safety and Tolerability of Z-100 in Patients With Early HIV Infection|A Phase 1b Multicenter Double-Blind, Placebo-Controlled, Randomized Study on the Safety and Tolerability of Z-100 in Early HIV-1 Infected Patients|Terminated||Phase 1|||Zeria Pharmaceutical|||||||||||||||||||2017-02-18 18:10:17.281689|2017-02-18 18:10:17.281689
NCT00018187|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||November 1998||1998-11-01|May 2007|2007-05-01|June 2001||2001-06-01|||||Interventional|||Combinations of Pharmacologic Smoking Cessation Treatments|Combinations of Pharmacologic Smoking Cessation Treatments|Completed||Phase 1|||VA Office of Research and Development|||||||||||||||||||2017-02-18 18:10:17.369886|2017-02-18 18:10:17.369886
NCT00018174|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-02-26|||February 1998||1998-02-01|February 2009|2009-02-01|January 2005|Actual|2005-01-01|January 2003|Actual|2003-01-01||Interventional|||Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers|Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers|Completed||Phase 3|247|Actual|VA Office of Research and Development||2|||f||||||||||||||2017-02-18 18:10:17.464637|2017-02-18 18:10:17.464637
NCT00018161|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2009-01-20|||January 1997||1997-01-01|September 2007|2007-09-01|June 2001||2001-06-01|||||Interventional|||Treatment to Quit Smoking|Combined Pharmacologic/Behavioral Treatment for Smoking Cessation|Completed||Phase 2|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:10:17.655139|2017-02-18 18:10:17.655139
NCT00018148|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2010-09-14|||April 1998||1998-04-01|September 2010|2010-09-01|January 2003|Actual|2003-01-01|December 2002|Actual|2002-12-01||Interventional|||Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation|Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation|Completed||Phase 2|158|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 18:10:17.738237|2017-02-18 18:10:17.738237
NCT00018135|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals|Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:10:17.836566|2017-02-18 18:10:17.836566
NCT00018122|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2005-06-27||||||December 2003|2003-12-01||||||||Observational|||Patterns and Natural History of Insulin Secretion in Islet Cell Transplant Recipients and Controls|Patterns and Natural History of Insulin Secretion in Islet Cell Transplant Recipients and Controls (Project 2 of JDFI Washington University Center for Islet Transplantation, KS Polonsky, PI)|Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:10:17.922195|2017-02-18 18:10:17.922195
NCT00018109|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-03|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)|A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)|Completed||Phase 3|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:10:17.998076|2017-02-18 18:10:17.998076
NCT00018096|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-02|2008-05-05|||June 2001||2001-06-01|May 2008|2008-05-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||The Genetics of Environmental Asthma|The Genetics of Environmental Asthma|Completed||N/A|176|Actual|National Institute of Environmental Health Sciences (NIEHS)||1|||f||||f||||||||||2017-02-18 18:10:18.068245|2017-02-18 18:10:18.068245
NCT00018083|ClinicalTrials.gov processed this data on February 17, 2017|2001-07-02|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen|Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:10:18.170952|2017-02-18 18:10:18.170952
NCT00018070|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-30|2017-01-24|||June 28, 2001||2001-06-28|August 30, 2006|2006-08-30|August 30, 2006||2006-08-30|||||Interventional|||Identification and Treatment of Feeder Vessels in Macular Degeneration|Feasibility Study of the Identification and Treatment of Feeder-Vessels of Choroidal Neovascularization in Age-Related Macular Degeneration|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:18.258108|2017-02-18 18:10:18.258108
NCT00018057|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-29|2017-01-24|||June 26, 2001||2001-06-26|January 12, 2017|2017-01-12||||||||Observational|||Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes|Fluoxetine's Effects on Attention and Emotional Memory in Anxious and Depressed Youth and Adults|Recruiting||N/A|2530|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:18.345212|2017-02-18 18:10:18.345212
NCT00018044|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-28|2017-01-24|||June 27, 2001||2001-06-27|September 9, 2016|2016-09-09||||||||Observational|||Study of Mycobacterial Infections|Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections|Recruiting||N/A|800|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:18.456736|2017-02-18 18:10:18.456736
NCT00018031|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-27|2014-09-25|2013-01-18||June 2001||2001-06-01|September 2014|2014-09-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|HEPCPR||Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients|A Non-Randomized, Open Label, Study to Assess Hepatitis C Viral Kinetics in Predicting the Clinical Response in Patients With Hepatitis C Infection Coinfected With HIV-1 Treated With Peginterferon Alpha-2b and Ribavirin|Completed||Phase 2|36|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:10:18.556472|2017-02-18 18:10:18.556472
NCT00018018|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-27|2017-01-24|||June 20, 2001||2001-06-20|September 17, 2014|2014-09-17|September 17, 2014|Actual|2014-09-17|||||Interventional|||Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency|Treatment of SCID Due to ADA Deficiency With Autologous Cord Blood or Bone Marrow CD34+ Cells Transduced With a Human ADA Gene|Completed||Phase 1|8|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:10:21.802068|2017-02-18 18:10:21.802068
NCT00018005|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-26|2012-10-19|||June 2001||2001-06-01|October 2012|2012-10-01|June 2007|Actual|2007-06-01|||||Interventional|HART||A Self-Management Intervention for Mild to Moderate Heart Failure|Heart Failure Adherence and Retention Trial (HART)|Completed||Phase 3|902|Actual|Rush University Medical Center||1|||f||||t||||||||||2017-02-18 18:10:21.907423|2017-02-18 18:10:21.907423
NCT00017992|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-23|2005-06-23||||||March 2003|2003-03-01||||||||Interventional|||Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV|An Open-Label Study of a Once Daily Dose of Emtricitabine in Combination With Other Antiretroviral Agents in HIV-Infected Pediatric Patients|Unknown status|Recruiting|Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:10:22.002676|2017-02-18 18:10:22.002676
NCT00017979|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-23|2008-03-03|||June 2001||2001-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Study of Brain Control of Movement|Effect of Volitional Inhibition on Cortical Inhibitory Mechanisms|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:22.101861|2017-02-18 18:10:22.101861
NCT00017966|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-23|2008-03-03|||June 2001||2001-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Brain Excitability During Self-Paced Voluntary Movements|Cortical Excitability During Self-Paced Voluntary Movements|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:22.18383|2017-02-18 18:10:22.18383
NCT00017953|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-21|2016-11-04|||June 2001||2001-06-01|November 2016|2016-11-01|January 2021|Anticipated|2021-01-01|January 2021|Anticipated|2021-01-01||Interventional|LookAHEAD||Look AHEAD: Action for Health in Diabetes|Look AHEAD: Action for Health in Diabetes|Active, not recruiting||N/A|5145|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||Yes|We plan to share data sets through the NIDDK repository, baseline data sets are currently available. Outcome data will be available approximately 1 year after the study is over.|2017-02-18 18:10:22.279557|2017-02-18 18:10:22.279557
NCT00017940|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-20|2009-12-10||||||July 2005|2005-07-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Gene Therapy for Alzheimer's Disease Clinical Trial|A Phase I Study of Ex Vivo Nerve Growth Factor Gene Therapy for Alzheimer's Disease|Completed||Phase 1|8||National Institute on Aging (NIA)|||||||||||||||||||2017-02-18 18:10:22.413224|2017-02-18 18:10:22.413224
NCT00017927|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-20|2008-03-03|||June 2001||2001-06-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Interventional|||A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome|A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome|Completed||Phase 3|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:22.516312|2017-02-18 18:10:22.516312
NCT00017914|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-19|2017-01-24|||June 8, 1994||1994-06-08|October 27, 2016|2016-10-27||||||||Observational|||Adult and Juvenile Myositis|Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies|Recruiting||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:22.893189|2017-02-18 18:10:22.893189
NCT00017875|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-15|2008-03-03|||June 2001||2001-06-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Transcranial Magnetic Stimulation (TMS) Studies of Dystonia|Neurophysiological Studies of Focal and Generalized Forms of Dystonia Using Transcranial Magnetic Stimulation (TMS)|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:22.997579|2017-02-18 18:10:22.997579
NCT00017862|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-15|2008-03-03|||June 2001||2001-06-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Interventional|||Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome|A Pilot Phase II Study of the Efficacy of Humanized Anti-IL5 Antibody (SCH55700) in Reducing Eosinophilia in Patients With Hypereosinophilic Syndrome or Eosinophilic Gastroenteritis Refractory to or Intolerant of Conventional Therapy|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:23.085539|2017-02-18 18:10:23.085539
NCT00017836|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-15|2014-05-28|||June 2001||2001-06-01|May 2014|2014-05-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Mechanisms Linking Depression to Cardiovascular Risk||Completed||N/A|||Emory University|||||f||||||||||||||2017-02-18 18:10:23.182243|2017-02-18 18:10:23.182243
NCT00017797|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-12|2006-08-03||||||August 2006|2006-08-01||||||||Observational|||Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women|Evaluation of Metabolic Complications Associated With Antiretroviral Medications in HIV-1-Infected Pregnant Women|Completed||N/A|160||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:10:23.425851|2017-02-18 18:10:23.425851
NCT00017784|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-11|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection|Open-Label Safety Study of Valganciclovir in Patients With CMV Retinitis and AIDS Who Have Complications Due to IV Treatment|Unknown status|Active, not recruiting|Phase 3|500||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:10:23.560952|2017-02-18 18:10:23.560952
NCT00017771|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-11|2013-07-26|||June 2001||2001-06-01|July 2013|2013-07-01|July 2004|Actual|2004-07-01|||||Observational|||Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs|A Pathophysiologic Study of Development of Distal Symmetrical Polyneuropathy in Individuals With Advanced HIV-1 Infection and Prior Antiretroviral Exposure|Completed||N/A|100|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood collection~   "|||2017-02-18 18:10:23.662713|2017-02-18 18:10:23.662713
NCT00017758|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-11|2006-03-13||||||February 2004|2004-02-01||||||||Interventional|||The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs|The Effect of Efavirenz and Nelfinavir on the Pharmacokinetics of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:10:23.768712|2017-02-18 18:10:23.768712
NCT00017745|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-08|2017-01-24|||June 1, 2001||2001-06-01|May 10, 2007|2007-05-10|May 10, 2007||2007-05-10|||||Observational|||Phenotype/Genotype Correlations in Neuromuscular Disorders|Phenotype/Genotype Correlations in Inherited Myopathies|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:23.873623|2017-02-18 18:10:23.873623
NCT00017732|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-08|2008-03-03|||June 2001||2001-06-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Estimation of the Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans|Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:23.957109|2017-02-18 18:10:23.957109
NCT00017719|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-08|2013-11-25|||May 2002||2002-05-01|November 2013|2013-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy|Randomized Trial of Protease Inhibitor-Including vs. Protease Inhibitor-Sparing Regimens for Women Who Initiate Therapy of HIV Infection During Pregnancy|Completed||Phase 3|440||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:10:24.042164|2017-02-18 18:10:24.042164
NCT00017706|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-07|2010-01-12||||||January 2010|2010-01-01|May 2001||2001-05-01|||||Interventional|||Effectiveness of Primary Care Physicians in Delivering Weight Control Counseling|Treatment of Obesity in the Primary Care Setting|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:10:24.203988|2017-02-18 18:10:24.203988
NCT00017693|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-07|2016-03-03|||May 1998||1998-05-01|March 2016|2016-03-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Recombinant Human IL-4 Receptor Used in Treatment of Asthma|Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma|Completed||Phase 2|62|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 18:10:24.572446|2017-02-18 18:10:24.572446
NCT00017680|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2008-06-06|||July 1999||1999-07-01|June 2008|2008-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis|Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in|Completed||Phase 2|25||Office of Rare Diseases (ORD)||1|||f||||||||||||||2017-02-18 18:10:24.689395|2017-02-18 18:10:24.689395
NCT00017654|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2005-06-23|||April 2001||2001-04-01|October 2003|2003-10-01||||||||Interventional|||Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia||Unknown status|Active, not recruiting|N/A|3||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:10:24.789247|2017-02-18 18:10:24.789247
NCT00017641|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2005-06-23|||April 2001||2001-04-01|November 2003|2003-11-01||||||||Interventional|||Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus||Unknown status|Active, not recruiting|Phase 1|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:10:24.902566|2017-02-18 18:10:24.902566
NCT00017628|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2005-06-23|||April 2001||2001-04-01|July 2004|2004-07-01||||||||Interventional|||Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis||Completed||Phase 1|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:10:24.99747|2017-02-18 18:10:24.99747
NCT00017602|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2014-01-03|||December 2000||2000-12-01|August 2003|2003-08-01|April 2009|Actual|2009-04-01|||||Interventional|||Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma|Randomized Phase III Study of Dexamethasone With or Without Genasense (Bcl-2 Antisense Oligonucleotide) in Patients With Relapsed or Refractory Multiple Myeloma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:25.109264|2017-02-18 18:10:25.109264
NCT00017589|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2014-01-03|||December 2000||2000-12-01|April 2003|2003-04-01|May 2006|Actual|2006-05-01|||||Interventional|||Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia|Phase II Study of Genasense (Bcl-2 Antisense) Combined With Mylotarg (Gemtuzumab Ozogamicin) in Elderly Patients With Relapsed Acute Myeloid Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:25.22528|2017-02-18 18:10:25.22528
NCT00017576|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2012-05-24|||December 2000||2000-12-01|September 2009|2009-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy|Phase II Study of Calcitrol Enhanced Carboplatin in Hormone Refractory Prostate Cancer|Completed||Phase 2|19|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 18:10:25.320837|2017-02-18 18:10:25.320837
NCT00017563|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2016-02-11|2011-05-31||September 2000||2000-09-01|February 2016|2016-02-01||||May 2010|Actual|2010-05-01||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer|Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer|Completed||Phase 2|57|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 18:10:25.423454|2017-02-18 18:10:25.423454
NCT00017550|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2009-02-06|||August 2001||2001-08-01|March 2003|2003-03-01||||||||Interventional|||Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome|An Open Label, Prospective, Stratified, Randomized, Controlled, Multi-Center, Phase IIB Study of the Impact of Thymoglobulin Therapy on Transfusion Needs of Patients With Early Myelodysplastic Syndrome (MDS)|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:25.678433|2017-02-18 18:10:25.678433
NCT00017537|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-08-02|||March 2000||2000-03-01|November 2012|2012-11-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer|Phase IB Trial of Active Specific Immunotherapy With MVF-HER-2(628-647) and CRL1005 Copolymer Adjuvant in Patients With Metastatic Cancer|Withdrawn||Phase 1|0|Actual|University of Alabama at Birmingham||5|||f||||t||||||||||2017-02-18 18:10:25.798823|2017-02-18 18:10:25.798823
NCT00017524|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-12-12|||March 2001||2001-03-01|November 2012|2012-11-01|November 2004|Actual|2004-11-01|||||Interventional|||AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors|A Phase I Dose-Escalation Study of AG2037 Administered Once Weekly for Three Weeks to Patients With Advanced Cancer|Completed||Phase 1|22|Actual|University of Alabama at Birmingham|||||f||||t||||||||||2017-02-18 18:10:25.898602|2017-02-18 18:10:25.898602
NCT00017511|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2012-05-15|||June 2001||2001-06-01|May 2012|2012-05-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer|A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region|Completed||Phase 3|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:10:25.989436|2017-02-18 18:10:25.989436
NCT00017498|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2012-09-20|||February 2001||2001-02-01|September 2012|2012-09-01||||April 2003|Actual|2003-04-01||Interventional|||Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck|Phase II Study On Gemcitabine In Recurrent Or Metastatic Adenoid Cystic Carcinoma Of The Head And Neck|Completed||Phase 2|21|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:10:26.173751|2017-02-18 18:10:26.173751
NCT00017485|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2011-03-03|||January 2000||2000-01-01|March 2011|2011-03-01|January 2007|Actual|2007-01-01|December 2006|Actual|2006-12-01||Interventional|||Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer|A Phase I Study Of Photodynamic Therapy (PDT) For The Treatment Of Basal Cell Carcinoma (BCC): A Drug/Light Dose Finding Study Utilizing 2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A (HPPH-PHOTOCLOR)|Completed||Phase 1|6|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:10:26.28425|2017-02-18 18:10:26.28425
NCT00017472|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-03|||April 2001||2001-04-01|June 2013|2013-06-01||||April 2006|Actual|2006-04-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia|Phase I Study of Thrice Weekly Hu1D10*in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Acute Leukemia|Completed||Phase 1|35|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:26.375005|2017-02-18 18:10:26.375005
NCT00017459|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-08-01|||July 2000||2000-07-01|February 2010|2010-02-01|February 2004|Actual|2004-02-01|||||Interventional|||Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|The International Tirazone Triple Trial (i3T): A Phase III, Randomized Efficacy And Safety Study Of The Combination Chemotherapy With Tirapazamine+Cisplatin+Vinorelbine Versus Cisplatin+Vinorelbine In Subjects With Inoperable, Previously Untreated, Non-Small Cell Lung Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:26.487169|2017-02-18 18:10:26.487169
NCT00017446|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2014-01-03|||October 2000||2000-10-01|September 2002|2002-09-01||||||||Interventional|||CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma|Phase II Evaluation Of CP4071 In Previously Treated Advanced Sarcomas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:26.881396|2017-02-18 18:10:26.881396
NCT00017433|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2008-11-16|||January 2001||2001-01-01|June 2002|2002-06-01||||||||Interventional|||Arsenic Trioxide in Treating Patients With Multiple Myeloma|Phase II Study of Arsenic Trioxide in Patients With Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:26.974545|2017-02-18 18:10:26.974545
NCT00017407|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2009-02-06|||October 2000||2000-10-01|December 2006|2006-12-01||||||||Interventional|||Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer|A Prospective, Randomized, Open-Label, Phase III Trial of Chemotherapy With Carboplatin And Paclitaxel, Versus Carboplatin And Paclitaxel In Combination With ISIS-3521, An Antisense Inhibitor Of Protein Kinase C Alpha In Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:27.070372|2017-02-18 18:10:27.070372
NCT00017394|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-01-16|||March 2001||2001-03-01|January 2013|2013-01-01||||September 2007|Actual|2007-09-01||Interventional|||Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer|A Phase II Study of Bevacizumab in Combination With Vinorelbine in Stage IV Breast Cancer|Completed||Phase 2|56|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:27.172043|2017-02-18 18:10:27.172043
NCT00017381|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-01-08|||April 2001||2001-04-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma|Dose Finding Study of IDEC-Y2B8 With Autologous Stem Cell Support|Completed||Early Phase 1|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:27.292251|2017-02-18 18:10:27.292251
NCT00017368|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2014-02-12|||April 2001||2001-04-01|February 2014|2014-02-01|January 2012|Actual|2012-01-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma|A Pilot Study Of Tandem High Dose Chemotherapy With Stem Cell Rescue Following Induction Therapy In Children With High Risk Neuroblastoma|Completed||Phase 2|42|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:10:27.428823|2017-02-18 18:10:27.428823
NCT00017355|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-09-16|||April 2001||2001-04-01|March 2003|2003-03-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Mature Dendritic Cell Immunotherapy Of Metastatic Melanoma- A Phase I Trial|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:27.575762|2017-02-18 18:10:27.575762
NCT00017342|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2010-02-26|||July 2001||2001-07-01|February 2010|2010-02-01|June 2005|Actual|2005-06-01|September 2004|Actual|2004-09-01||Interventional|||Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia|Phase II Study Of Bryostatin 1 (NSC 339555) And High-Dose 1-B-D-Arabinofuranosylcytosine (HiDAC) In Patients With Refractory Leukemia|Completed||Phase 2|||Virginia Commonwealth University|||||f||||t||||||||||2017-02-18 18:10:27.6698|2017-02-18 18:10:27.6698
NCT00017329|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2009-12-13|||April 2001||2001-04-01|December 2009|2009-12-01||||April 2004|Actual|2004-04-01||Interventional|||PS-341 in Treating Patients With Metastatic Kidney Cancer|Phase II Trial of PS341 (NSC 681239) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:27.776723|2017-02-18 18:10:27.776723
NCT00017316|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-02-08|||March 2001||2001-03-01|August 2002|2002-08-01||||September 2003|Actual|2003-09-01||Interventional|||Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma|A Phase II, Pharmacologic and Biologic Study of Escalating Doses of Thalidomide (NSC #66847) Administered Orally Once a Day in Combination With a Fixed Dose of SU5416 (NSC #696819) in Patients With Metastatic Melanoma|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:27.881524|2017-02-18 18:10:27.881524
NCT00017303|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-11-05|||January 2001||2001-01-01|February 2002|2002-02-01||||||||Interventional|||Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer|A Phase II Trial Of IM862 Combined With Paclitaxel And Carboplatin In Newly Diagnosed Advanced Epithelial Ovarian Or Primary Peritoneal Carcinoma Followed By IM862 Consolidation Therapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:27.996492|2017-02-18 18:10:27.996492
NCT00017290|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-12-03|||November 2000||2000-11-01|August 2002|2002-08-01||||||||Interventional|||Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma|A Phase III Trial To Evaluate The Safety And Efficacy Of Specific Immunotherapy, Recombinant Idiotype Conjugated To KLH With GM-CSF, Compared To Non-Specific Immunotherapy, KLH With GM-CSF, In Patients With Follicular Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:28.115081|2017-02-18 18:10:28.115081
NCT00017277|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2012-09-20|||March 2001||2001-03-01|September 2012|2012-09-01||||April 2003|Actual|2003-04-01||Interventional|||Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer|A Phase III Double-Blind, Randomized, Placebo-Controlled Study of Erythropoietin When Used as an Adjuvant to Radiation Therapy in Patients With Head and Neck Squamous Cell Carcinoma|Terminated||Phase 3|47|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:10:28.259003|2017-02-18 18:10:28.259003
NCT00017264|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2009-01-10|||June 2002||2002-06-01|August 2004|2004-08-01||||||||Interventional|||Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma|A Phase I Evaluation of the Safety and Pharmacokinetics of ABT-627 in Adults With Recurrent Malignant Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:28.394647|2017-02-18 18:10:28.394647
NCT00017251|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-01-23|||April 2001||2001-04-01|January 2013|2013-01-01||||January 2004|Actual|2004-01-01||Interventional|||Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer|A Phase I Study Of Genasense, A Bcl-2 Antisense Oligonucleotide, Combined With Carboplatin And Etoposide In Patients With Small Cell Lung Cancer|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:28.504282|2017-02-18 18:10:28.504282
NCT00017238|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-01-10|||February 2002||2002-02-01|January 2013|2013-01-01||||November 2008|Actual|2008-11-01||Interventional|||KRN5500 in Treating Patients With Solid Tumors|A Phase I Trial of KRN5500 (NSC 650426) Given as a 72 Hour Continuous IV Infusion Every 21 Days in Patients With Solid Tumors|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:28.621773|2017-02-18 18:10:28.621773
NCT00017225|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-08-01|||May 1997||1997-05-01|August 2002|2002-08-01|February 2002|Actual|2002-02-01|||||Interventional|||Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma|Neuroblastoma Study Phase II Study of Various Therapies in Patients With Neuroblastoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:28.741255|2017-02-18 18:10:28.741255
NCT00017212|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2012-05-15|||April 2001||2001-04-01|May 2012|2012-05-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||DX-8951f in Treating Patients With Metastatic Stomach Cancer|A Phase II Study Of Intravenous Exatecan Mesylate (DX-891F) Administered Daily For Five Days Every Three Weeks To Patients With Previously Untreated Metastatic Gastric Cancer|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:10:28.947798|2017-02-18 18:10:28.947798
NCT00017199|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-01-30|||April 2001||2001-04-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors|Phase II Study of PS-341 in Metastatic Neuroendocrine Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:29.057277|2017-02-18 18:10:29.057277
NCT00017186|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2016-12-05|||July 2001||2001-07-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|August 2004|Actual|2004-08-01||Interventional|||Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma|Phase II Study of Gemcitabine and Epirubicin for the Treatment of Mesothelioma|Completed||Phase 2|69|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:10:29.156521|2017-02-18 18:10:29.156521
NCT00017173|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2012-06-12|||February 2003||2003-02-01|June 2012|2012-06-01|July 2011|Actual|2011-07-01|May 2007|Actual|2007-05-01||Interventional|||S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat|Phase II Trial Of Surgery With Perioperative RPR/INGN 201 (Ad5CMV-p53) Gene Therapy Followed By Chemoradiotherapy For Advanced, Resectable Squamous Cell Carcinoma Of The Oral Cavity, Oropharynx, Larynx, and Pharynx|Terminated||Phase 2|13|Actual|Southwest Oncology Group||1||Terminated for poor accrual.|f||||f||||||||||2017-02-18 18:10:29.299107|2017-02-18 18:10:29.299107
NCT00017160|ClinicalTrials.gov processed this data on February 17, 2017|2001-06-06|2013-06-25||||||June 2013|2013-06-01||||||||Interventional|||Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma|Phase II Study of Neoadjuvant Doxorubicin and Ifosfamide, Radiotherapy, and Surgical Resection in Patients With Primary or Recurrent Retroperitoneal Sarcoma|Withdrawn||Phase 2|0|Actual|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:10:29.443204|2017-02-18 18:10:29.443204
NCT00016666|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-23|2017-01-24|||May 21, 2001||2001-05-21|January 19, 2007|2007-01-19|January 19, 2007||2007-01-19|||||Interventional|||Clinical Trial of Propranolol for Seasonal Affective Disorder|Treatment of Winter Depression With Pharmacological Suppression of Melatonin Secretion|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:30.057506|2017-02-18 18:10:30.057506
NCT00016653|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-21|2011-10-26|||June 2000||2000-06-01|October 2011|2011-10-01|December 2006||2006-12-01|||||Interventional|||Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy|A Multicenter Randomized Placebo-controlled Double-blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy|Completed||Phase 2/Phase 3|48||Cooperative International Neuromuscular Research Group|||||||||||||||||||2017-02-18 18:10:30.16777|2017-02-18 18:10:30.16777
NCT00016627|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-19|2016-02-17|||August 2000||2000-08-01|November 2005|2005-11-01|July 2005|Actual|2005-07-01|||||Observational|||Linkage Study in Familial Pulmonary Fibrosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:10:30.277372|2017-02-18 18:10:30.277372
NCT00016601|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-18|2012-10-31|||June 2001||2001-06-01|October 2012|2012-10-01|May 2004|Actual|2004-05-01|||||Interventional|||Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women|An Open-Label, Non-Randomized Study of Pharmacokinetic Interactions Between Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) and Selected Protease Inhibitor (PI) and Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) Therapies Among HIV-Infected Women|Completed||N/A|76||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:10:30.365517|2017-02-18 18:10:30.365517
NCT00016588|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-17|2005-06-23|||May 2001||2001-05-01|May 2002|2002-05-01||||||||Interventional|||Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs|An Open-Label Study to Assess the Anti-HIV-1 Activity of Tenofovir Disoproxil Fumarate (TDF) in Antiretroviral-Naive Patients Who Are Chronically Infected With HIV-1|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:10:30.502782|2017-02-18 18:10:30.502782
NCT00016562|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-16|2017-01-24|||May 13, 2001||2001-05-13|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Cause and Pathogenesis of Neurometabolic Disorders|The Etiology and Pathogenesis of Neurometabolic Disorders|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:30.611791|2017-02-18 18:10:30.611791
NCT00016549|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-16|2017-01-24|||May 13, 2001||2001-05-13|April 6, 2012|2012-04-06|January 29, 2007|Actual|2007-01-29|January 29, 2007|Actual|2007-01-29||Interventional|||Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer|A Pilot Study to Evaluate Angiogenesis After Treatment With Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients With Inflammatory Breast Cancer or Locally Advanced Breast Cancer|Completed||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:10:30.701762|2017-02-18 18:10:30.701762
NCT00016536|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-16|2012-04-03||||||April 2012|2012-04-01|May 1997|Actual|1997-05-01|||||Interventional|||Effects of BufferGel and PRO 2000/5 Gel in Men|Male Tolerance Study of BufferGel and PRO 2000/5 Gel (P)|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:10:30.809265|2017-02-18 18:10:30.809265
NCT00016523|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-14|2015-06-03|||January 2001||2001-01-01|June 2015|2015-06-01|May 2006|Actual|2006-05-01|September 2003|Actual|2003-09-01||Interventional|Preemie iNO||Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure|Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure|Terminated||Phase 3|420|Actual|NICHD Neonatal Research Network||2||Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm|f||||t||||||||||2017-02-18 18:10:30.920579|2017-02-18 18:10:30.920579
NCT00016510|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-12|2008-03-03|||May 2001||2001-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Differences in Brain Processing of First and Second Languages (Korean and English)|Differences of Verbal Working Memory and Translation Systems Between First and Second Languages: a Functional MRI Study|Completed||N/A|63||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:31.079605|2017-02-18 18:10:31.079605
NCT00016497|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-10|2006-04-21|||February 1997||1997-02-01|April 2006|2006-04-01|January 2007||2007-01-01|||||Interventional|||Adenoidectomy for Otitis Media in 2-3 Year Old Children|Adenoidectomy for Otitis Media in 2-3 Year Old Children|Terminated||Phase 3|||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-02-18 18:10:31.164895|2017-02-18 18:10:31.164895
NCT00016471|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-07|2005-06-23|||March 2001||2001-03-01|November 2003|2003-11-01|February 2002||2002-02-01|||||Observational|||A Genetic Analysis of Usher Syndrome in Ashkenazi Jews|A Genetic Analysis of Usher Syndrome in Ashkenazi Jews|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:10:31.276813|2017-02-18 18:10:31.276813
NCT00016458|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2008-09-02|||June 2000||2000-06-01|September 2008|2008-09-01||||||||Interventional|||Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:10:31.358191|2017-02-18 18:10:31.358191
NCT00016445|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2008-09-08|||February 2001||2001-02-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of Growth Hormone in Children With Cystic Fibrosis||Completed||Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:10:31.448613|2017-02-18 18:10:31.448613
NCT00016432|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2011-04-18|||May 2001||2001-05-01|April 2011|2011-04-01|February 2011|Actual|2011-02-01|October 2003|Actual|2003-10-01||Interventional|||Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen|A Randomized Trial Evaluating The Effect Of Exemestane In Clinical Stage T1-3 N0-1 M0 Postmenopausal Breast Cancer Patients Completing At Least Five Years Of Tamoxifen Therapy|Completed||Phase 3|1598|Actual|NSABP Foundation Inc||2|||f||||||||||||||2017-02-18 18:10:31.565045|2017-02-18 18:10:31.565045
NCT00016419|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2015-03-05|||August 2001||2001-08-01|March 2015|2015-03-01|January 2007|Actual|2007-01-01|July 2003|Actual|2003-07-01||Interventional|||S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome|A Phase II Study of Anti-Thymocyte Globulin and Cyclosporine for Patients With Myelodysplastic Syndrome (MDS)|Completed||Phase 2|130|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-02-18 18:10:31.842886|2017-02-18 18:10:31.842886
NCT00016029|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-03-20|||August 2000||2000-08-01|September 2003|2003-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer|Prospective Comparison of Air Contrast Barium Enema (ACBE), Computed Tomographic Colonography (Virtual Colonoscopy) and Colonoscopy for Evaluation of the Colon in Patients With Fecal Occult Blood|Terminated||N/A|775|Actual|Duke University|||||f||||||||||||||2017-02-18 18:10:39.555362|2017-02-18 18:10:39.555362
NCT00016406|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-23|||May 2001||2001-05-01|January 2013|2013-01-01|February 2012|Actual|2012-02-01|September 2006|Actual|2006-09-01||Interventional|||S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer|A Comparative Randomized Study of Standard Doxorubicin and Cyclophosphamide Followed by Weekly Paclitaxel Vs. Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF Followed by Weekly Paclitaxel As Neoadjuvant Therapy For Inflammatory and Locally Advanced Breast Cancer|Completed||Phase 3|399|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:10:32.358913|2017-02-18 18:10:32.358913
NCT00016393|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-06-20|||June 2001||2001-06-01|February 2004|2004-02-01|April 2006|Actual|2006-04-01|||||Interventional|||BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) (IND 59699) Administered Every 21 Days in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:32.858261|2017-02-18 18:10:32.858261
NCT00016380|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2016-11-25|||February 2001||2001-02-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|April 2004|Actual|2004-04-01||Interventional|||Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen|A Randomized Phase III Double-Blind Study Of Ondansetron And Dexamethasone Versus Ondansetron And Placebo In The Prophylaxis Of Radiation-Induced Emesis|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-02-18 18:10:32.978523|2017-02-18 18:10:32.978523
NCT00016367|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2012-07-27|||May 2001||2001-05-01|July 2012|2012-07-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|Phase II Multidose, Single Arm, Multicenter Clinical Trial of Cisplatin and Gemcitabine in Combination With Recombinant Humanized Anti-p185HER2 Monoclonal Antibody (Herceptin) in Patients Who Have Untreated p185HER2 Overexpressing Advanced Local Stage (Stage IIIb Pleural Effusion Only) and Metastatic (Stage IV) Non-Small Cell Lung Cancer|Completed||Phase 2|22|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:10:33.105637|2017-02-18 18:10:33.105637
NCT00016354|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-03-18|2012-06-11||March 2001||2001-03-01|March 2013|2013-03-01|September 2006|Actual|2006-09-01|August 2004|Actual|2004-08-01||Interventional|||Benzoylphenylurea in Treating Patients With Advanced Solid Tumors|Phase I Study of Continuous Weekly Dosing of Dimethyl Benzoylphenylurea (BPU) in Patients With Solid Tumors Not Responding to Conventional Therapy|Completed||Phase 1|19|Actual|Sidney Kimmel Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:10:33.237394|2017-02-18 18:10:33.237394
NCT00016341|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-04-10|||May 2001||2001-05-01|June 2007|2007-06-01||||October 2003|Actual|2003-10-01||Interventional|||Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer|Randomized Phase III Crossover Trial of Chemotherapy (Doxorubicin/Cisplatin/Paclitaxel and G-CSF) Versus Hormonal Therapy (Tamoxifen/Megestrol Acetate) in Patients With Stage III & IV or Recurrent Endometrial Cancer|Terminated||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:10:33.547387|2017-02-18 18:10:33.547387
NCT00016328|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-07-17|||May 2001||2001-05-01|June 2013|2013-06-01||||August 2005|Actual|2005-08-01||Interventional|||CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme|A Phase II Study of CCI-779 in Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|33|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:33.765706|2017-02-18 18:10:33.765706
NCT00016315|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2015-11-14|||May 2001||2001-05-01|November 2015|2015-11-01|June 2010|Actual|2010-06-01|January 2009|Actual|2009-01-01||Interventional|||Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer|A Phase I Study of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Radiation Therapy Followed by Adjuvant Chemotherapy for Patients With Favorable Prognosis Inoperable Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 1|35|Actual|Radiation Therapy Oncology Group||13|||f||||t||||||||||2017-02-18 18:10:33.879814|2017-02-18 18:10:33.879814
NCT00016302|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-15|||April 2001||2001-04-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia|The Use of Modified BFM +/- Compound 506U78 (Nelarabine) (NSC# 686673, IND #52611) in an Intensive Chemotherapy Regimen for the Treatment of T-Cell Leukemia|Completed||N/A|100|Actual|National Cancer Institute (NCI)||6|||f||||||||||||||2017-02-18 18:10:34.027768|2017-02-18 18:10:34.027768
NCT00016289|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-22|||July 2001||2001-07-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer|Phase II Study of Intraperitoneal Recombinant Human Interleukin-12 (rhIL-12) in Patients With Peritoneal Carcinomatosis (Residual Disease < 1cm) Associated With Ovarian Epithelial Cancer or Primary Peritoneal Carcinoma|Completed||Phase 2|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:34.202613|2017-02-18 18:10:34.202613
NCT00016276|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-15|||May 2001||2001-05-01|January 2013|2013-01-01||||March 2005|Actual|2005-03-01||Interventional|||Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer|A 2X2X2 Factorial Randomized Phase III Trial Of Multimodality Therapy Comparing 4 Cycles Of Doxorubicin And Cyclophosphamide With Or Without Dexrazoxane (AC+/-Z) Followed By 12 Weeks Of Weekly Paclitaxel With Or Without Trastuzumab (T+/-H) Followed By Local Therapy Followed By 40 Weeks Of Weekly Trastuzumab Or None In Women With HER-2+ STAGE IIIA, IIIB OR REGIONAL STAGE IV BREAST CANCER|Terminated||Phase 3|396|Actual|National Cancer Institute (NCI)||8||Administratively complete.|f||||||||||||||2017-02-18 18:10:34.311959|2017-02-18 18:10:34.311959
NCT00016263|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2014-01-03|||July 2000||2000-07-01|October 2002|2002-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma|Randomized Study Of Dacarbazine Versus Dacarbazine Plus G3139 (Bcl-2 Antisense Oligonucleotide) In Patients With Advanced Malignant Melanoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:37.437736|2017-02-18 18:10:37.437736
NCT00016250|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-06-17|||December 2000||2000-12-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer|A Randomized Phase II Study of Two Shcedules of Ro 31-7453 in Patients With Metastatic (Dukes' D) Colorectal Carcinoma (CRC) Who Have Failed Both Fluoropyrimidine and Irinotecan Chemotherapy|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:37.520569|2017-02-18 18:10:37.520569
NCT00016237|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-10-22|||December 2000||2000-12-01|June 2002|2002-06-01||||||||Interventional|||Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment|Phase I Dose-Escalation Study of the Pharmacokinetic, Safety, Tolerability, and Biologic Activity of huKS-IL-2 Administered Daily as a 1-Hour Intravenous Infusion for Five Consecutive Days for Treatment of Refractory Epithelial Cancer|Completed||Phase 1|||EMD Serono|||||f||||||||||||||2017-02-18 18:10:37.618426|2017-02-18 18:10:37.618426
NCT00016224|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-06-17|||January 2001||2001-01-01|June 2013|2013-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer|Phase II Trial of Thalidomide in Patients With Ovarian Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:37.704033|2017-02-18 18:10:37.704033
NCT00016211|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2012-09-20|||February 2001||2001-02-01|September 2012|2012-09-01||||March 2006|Actual|2006-03-01||Interventional|||Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer|Prophylactic Cranial Irradiation In Extensive Disease Small Cell Lung Cancer|Completed||Phase 3|287|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:10:37.80852|2017-02-18 18:10:37.80852
NCT00016198|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-06-25|||May 2001||2001-05-01|December 2010|2010-12-01|December 2010|Actual|2010-12-01|April 2003|Actual|2003-04-01||Interventional|||Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer|A Randomized, Multicenter, Phase II Study Of Bolus/Infusion 5-FU/LV (de Gramont Regimen) Versus Oxaliplatin And Bolus/Infusion 5-FU/LV (de Gramont Regimen) As Third-Line Treatment Of Patients With Metastatic Colorectal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:37.971119|2017-02-18 18:10:37.971119
NCT00016185|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-04-03|||March 2001||2001-03-01|April 2013|2013-04-01|December 2005|Actual|2005-12-01|February 2003|Actual|2003-02-01||Interventional|||Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors|Phase I Study Of Flavopiridol And Docetaxel (Taxotere) In Patients With Advanced Cancers|Completed||Phase 1|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:10:38.417294|2017-02-18 18:10:38.417294
NCT00016172|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-06-17|||November 2000||2000-11-01|June 2013|2013-06-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma|A Phase I Study of ZD0473 and Doxil in Patients With Advanced Refractory Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:38.513346|2017-02-18 18:10:38.513346
NCT00016159|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-15|||November 2000||2000-11-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia|Phase II Study Of Combined Modality Postremission Therapy As Determined By Molecular Response (Adaptive Regulation) In The Treatment Of Acute Promyelocytic Leukemia (APL)|Completed||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:38.617516|2017-02-18 18:10:38.617516
NCT00016146|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-03-18|||July 2000||2000-07-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer|Vaccination Of Prostate Cancer Patients With A Bivalent Vaccine Containing MUC-2 Glycopeptide And Globo H Conjugates: A Dose-Escalating Trial Studying The Immunogenicity And Safety Of The Immunological Adjuvant GPI-0100|Completed||Phase 1|34|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:10:38.724846|2017-02-18 18:10:38.724846
NCT00016133|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-05-29|||March 2001||2001-03-01|July 2004|2004-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery|A Non-Randomized Multicenter Phase I/II Study Of Active Specific Immunotherapy In Patients With Stage II and Stage III Colon Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:38.837626|2017-02-18 18:10:38.837626
NCT00016107|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-06-04|||June 2001||2001-06-01|June 2013|2013-06-01||||February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer|A Phase II Study Of Estramustine, Docetaxel, And Bevacizumab (IND # 7921, NSC # 704865) In Men With Hormone Refractory Prostate Cancer|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:38.934523|2017-02-18 18:10:38.934523
NCT00016094|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-28|||April 2001||2001-04-01|January 2013|2013-01-01|September 2008|Actual|2008-09-01|August 2005|Actual|2005-08-01||Interventional|||S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma|Bevacizumab (rhuMab VEGF) (NSC-704865) Therapy for Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:39.050903|2017-02-18 18:10:39.050903
NCT00016081|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2010-03-26|||March 1998||1998-03-01|March 2010|2010-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation|A Randomized Phase III Study To Evaluate The Safety And Efficacy Or Ribavirin Inhaled Solution In Preventing Progression Of Upper Respiratory Tract Respiratory Syncytial Virus (RSV) Infection To RSV Pneumonia In Blood And Bone Marrow Transplant (BMT) Recipients|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:10:39.162312|2017-02-18 18:10:39.162312
NCT00016068|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2010-05-14|||January 2001||2001-01-01|May 2010|2010-05-01|September 2007|Actual|2007-09-01|||||Interventional|||Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation|A Phase III Multicenter Study Of Valganciclovir For The Prevention Of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation|Completed||Phase 3|184|Anticipated|Fred Hutchinson Cancer Research Center|||||||||||||||||||2017-02-18 18:10:39.255635|2017-02-18 18:10:39.255635
NCT00016055|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-09-19|||November 2000||2000-11-01|November 2006|2006-11-01||||||||Interventional|||Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma|Interleukin 12-Primed Activated T Cells As Therapy For Patients With Metastatic Melanoma (Phase I)|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:39.365072|2017-02-18 18:10:39.365072
NCT00016042|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-09-19|||January 2001||2001-01-01|October 2001|2001-10-01||||||||Interventional|||Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer|Interleukin 12-Primed Activated T Cells For Patients With Metastatic Renal Cell Carcinoma Or Colorectal Carcinoma (Phase I)|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:39.460401|2017-02-18 18:10:39.460401
NCT00016016|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-10-07|||February 2001||2001-02-01|October 2013|2013-10-01||||November 2006|Actual|2006-11-01||Interventional|||Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia|A Phase I/II Study of Flavopiridol (NSC 649890, IND 46,211) in Timed Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Poor-Risk Acute Leukemias|Completed||Phase 1/Phase 2|53|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:39.664068|2017-02-18 18:10:39.664068
NCT00015990|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-23|||April 2001||2001-04-01|January 2013|2013-01-01||||February 2007|Actual|2007-02-01||Interventional|||Thalidomide in Treating Patients With Myelodysplastic Syndrome|Phase II Study of Thalidomide in the Treatment of Myelodysplastic Syndromes in Adults: A Clinical and Biologic Study|Completed||Phase 2|29|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:39.770077|2017-02-18 18:10:39.770077
NCT00015977|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2014-03-06|||November 2001||2001-11-01|March 2014|2014-03-01|January 2005|Actual|2005-01-01|March 2003|Actual|2003-03-01||Interventional|||Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Phase II Study of Immunization With PSMA Peptide-Pulsed Autologous PBMC Plus rhIL-12 in Patients With Metastatic Prostate Cancer|Completed||Phase 2|13|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:10:39.879935|2017-02-18 18:10:39.879935
NCT00015964|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-09-04|||March 2001||2001-03-01|September 2013|2013-09-01|July 2005|Actual|2005-07-01|September 2001|Actual|2001-09-01||Interventional|||ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck|A Phase II Stdy of ZD 1839 in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|51|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:10:40.262586|2017-02-18 18:10:40.262586
NCT00015951|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2009-09-23|||April 2001||2001-04-01|September 2009|2009-09-01|March 2004|Actual|2004-03-01|April 2003|Actual|2003-04-01||Interventional|||Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers|A Phase II Study of the Recombinant Human Monoclonal Anti-Vascular Endothelial Growth Factor Antibody (rhuMAB VEGF) Bevacizumab (NSC #704865, IND # 7,921) Administered in Times Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Refractory and Relapsed Acute Myelogenous Leukemias (AMLs)|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-02-18 18:10:40.389546|2017-02-18 18:10:40.389546
NCT00015938|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-23|||May 2001||2001-05-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|February 2005|Actual|2005-02-01||Interventional|||S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer|Docetaxel And Vinorelbine Plus Filgrastim For HER-2 Negative, Stage IV Breast Cancer|Completed||Phase 2|95|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:10:40.507637|2017-02-18 18:10:40.507637
NCT00015925|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2010-03-09|||February 2001||2001-02-01|March 2010|2010-03-01||||||||Interventional|||MS-275 in Treating Patients With Hematologic Cancer|Phase I Clinical-Labratory Study of the Histone Deacetylase (HDA) Inhibitor MS-275 in Adults With Refractory and Relapsed Hematologic Malignancies|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:10:40.71264|2017-02-18 18:10:40.71264
NCT00015912|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-24|||July 2001||2001-07-01|January 2013|2013-01-01||||September 2003|Actual|2003-09-01||Interventional|||Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Clinical And Biologic Study Of The Combination Of Low Dose Interferon-Alpha And Thalidomide (NSC #66847) For Patients With Relapsed Or Refractory Low-Grade Follicular Lymphoma|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:10:40.810316|2017-02-18 18:10:40.810316
NCT00015899|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2009-10-13|||January 2002||2002-01-01|October 2009|2009-10-01|March 2007|Actual|2007-03-01|September 2005|Actual|2005-09-01||Interventional|||SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors|Phase I Trial Of Escalating Oral Doses Of SCH 66336 In Pediatric Patients With Refractory Or Recurrent Brain Tumors|Completed||Phase 1|53|Actual|Pediatric Brain Tumor Consortium|||||f||||t||||||||||2017-02-18 18:10:40.924367|2017-02-18 18:10:40.924367
NCT00015886|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2012-07-12|||January 1997||1997-01-01|July 2012|2012-07-01|July 2009|Actual|2009-07-01|May 2002|Actual|2002-05-01||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery|Docetaxel (Taxotere) and 5-Fluorouracil As Second- Or Third-Line Chemotherapy In Women With Metastatic Breast Cancer|Completed||Phase 2|25|Actual|Wake Forest University Health Sciences||1|||f||||t||||||||||2017-02-18 18:10:41.040128|2017-02-18 18:10:41.040128
NCT00015873|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2014-02-14|||May 1999||1999-05-01|February 2014|2014-02-01|December 2009|Actual|2009-12-01|February 2006|Actual|2006-02-01||Interventional|||Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia|International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic Leukemia|Completed||Phase 3|350|Anticipated|Dutch Childhood Oncology Group||2|||f||||t||||||||||2017-02-18 18:10:41.145345|2017-02-18 18:10:41.145345
NCT00015860|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-06-20|||May 2001||2001-05-01|September 2003|2003-09-01|October 2003|Actual|2003-10-01|||||Interventional|||STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia|A Phase I/II Trial of STI-571 and Chemotherapy in Lymphoid Blast Crisis of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoid Leukemia|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:41.306127|2017-02-18 18:10:41.306127
NCT00015847|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2012-07-12|2012-06-06||April 2001||2001-04-01|June 2012|2012-06-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia|A Phase I/II Dose-Finding Study to Determine the Safety, Tolerability, and Anti-Leukemic Effects of STI571 (NSC 716051) in Combination With Interferon-alpha in Patients With Chronic Myelogenous Leukemia in Chronic Phase|Terminated||Phase 2|25|Actual|OHSU Knight Cancer Institute|Early termination; 12 month follow-up was not carried out.|1|||f||||t||||||||||2017-02-18 18:10:41.405986|2017-02-18 18:10:41.405986
NCT00015834|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-01-23|||May 2001||2001-05-01|January 2013|2013-01-01||||April 2003|Actual|2003-04-01||Interventional|||STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia|A Phase I/II Trial of STI571 and High-Dose Cytarabine in Myeloid Blast Crisis of Chronic Myeloid Leukemia|Completed||Phase 1/Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:41.669406|2017-02-18 18:10:41.669406
NCT00015821|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2013-10-07|||May 2000||2000-05-01|October 2013|2013-10-01||||December 2007|Actual|2007-12-01||Interventional|||Thalidomide in Treating Patients With Myelofibrosis|A Pilot Study of Thalidomide as an Inhibitor of Angiogenesis in the Treatment of Myelofibrosis With Myeloid Metaplasia (MMM)|Completed||Phase 2|43|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:41.77732|2017-02-18 18:10:41.77732
NCT00015808|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-06|2006-07-11|||May 2001||2001-05-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Safety Study of Idebenone to Treat Friedreich's Ataxia|Phase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenone in Children, Adolescents, and Adults With Friedreich's Ataxia|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:41.884175|2017-02-18 18:10:41.884175
NCT00015795|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-04|2008-03-03|||May 2001||2001-05-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Interventional|||Study of Air Stream in Voice Production|Laryngeal Resistance in Abductor Spasmodic Dysphonia|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:41.975785|2017-02-18 18:10:41.975785
NCT00015782|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-04|2017-01-24|||April 27, 2001||2001-04-27|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||The Natural History and Pathogenesis of Mucolipidosis Type IV|The Natural History and Pathogenesis of Mucolipidosis Type IV|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:42.055858|2017-02-18 18:10:42.055858
NCT00015769|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-04|2008-03-03|||April 2001||2001-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness|Pilot Evaluation of Levetiracetam (Keppra® (Registered Trademark)) in Bipolar Illness|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:42.206946|2017-02-18 18:10:42.206946
NCT00015756|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-04|2017-01-24|||May 2, 2001||2001-05-02|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Tissue Collection From People With Cystic Fibrosis|Tissue Collection Protocol for Individuals With Cystic Fibrosis|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:42.490476|2017-02-18 18:10:42.490476
NCT00015717|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-02|2008-03-03|||April 2001||2001-04-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Magnetic Resonance Imaging to Investigate Silent Strokes During Neck and Skull Angioplasty|Silent Cerebral Ischemia After Cervico-Cranial Angioplasty Detected by Diffusion-Weighted MRI|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:42.580076|2017-02-18 18:10:42.580076
NCT00015704|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-01|2012-05-21||||||May 2012|2012-05-01|November 2004|Actual|2004-11-01|||||Interventional|||Effect of Interleukin-2 on HIV Treatment Interruption|An Open-Label, Pilot Study Utilizing CD4 T-Cell Counts Lower Than 350 Cells/mm3 as the Threshold for Restarting Therapy With Potent Antiretroviral Therapy With or Without Interleukin-2 to Determine the Effect of Pulse Therapy on the Characteristics of Treatment Interruptions|Completed||N/A|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:10:42.661353|2017-02-18 18:10:42.661353
NCT00015691|ClinicalTrials.gov processed this data on February 17, 2017|2001-05-01|2013-07-19||||||July 2013|2013-07-01||||January 2006|Actual|2006-01-01||Interventional|||Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities|A Randomized, Double-Blind, Placebo-Controlled Study of Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Subjects With Hyperinsulinemia and Elevated Waist/Hip Ratio|Completed||N/A|105||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:10:42.783546|2017-02-18 18:10:42.783546
NCT00015678|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-28|2008-03-03|||April 2001||2001-04-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Observational|||Effects of Flumazenil on Brain Excitability|Effects of Flumazenil on Cortical Excitability in Humans|Completed||N/A|7||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:42.924215|2017-02-18 18:10:42.924215
NCT00015665|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-28|2008-03-03|||April 2001||2001-04-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections|Open-Label, Non-Comparative Protocol for the Emergency Use of Voriconazole in Patients With Life Threatening, Invasive Mycoses Who Are Failing on Currently Available Antifungal Agents|Completed||Phase 3|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:43.010081|2017-02-18 18:10:43.010081
NCT00015652|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-26|2012-05-21||||||May 2012|2012-05-01|March 2005|Actual|2005-03-01|||||Interventional|||Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection|A Pilot Study of Low Dose Interleukin-2 (IL-2) With the Addition of Pegylated Interferon (PEG-IFN Alfa-2b) and Ribavirin (RBV) for the Treatment of Hepatitis C Infection in Subjects With HIV Coinfection|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:10:43.10045|2017-02-18 18:10:43.10045
NCT00015639|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-25|2008-03-03|||April 2001||2001-04-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus|Identification of Donors of CD36-Deficient Platelets Among Individuals on the NIH Campus|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:43.207579|2017-02-18 18:10:43.207579
NCT00015626|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-24|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)|A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)|Completed||Phase 2|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:10:43.303465|2017-02-18 18:10:43.303465
NCT00015613|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-23|2005-11-02|||August 1998||1998-08-01|September 2002|2002-09-01|September 2001||2001-09-01|||||Observational|||Farm Work & Preterm Low Birthweight Among Hispanic Women|Study of Hispanic Acculturation Reproduction and the Environment (SHARE)|Completed||N/A|1500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:43.384212|2017-02-18 18:10:43.384212
NCT00015600|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-23|2006-03-22|||October 1997||1997-10-01|March 2006|2006-03-01|September 2002||2002-09-01|||||Interventional|||Community-Based Environmental Health Intervention|Community-Based Environmental Health Intervention|Completed||N/A|500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:43.46757|2017-02-18 18:10:43.46757
NCT00015587|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-23|2016-10-11|||April 1995||1995-04-01|October 2016|2016-10-01|July 2016|Actual|2016-07-01|July 2016|Actual|2016-07-01||Observational|CCLS||Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)|Chemical Exposures and Leukemia Risks and Childhood Leukemia and Environmental Exposure|Completed||N/A|3523|Actual|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||f||||||Samples With DNA|"~     pre-treatment peripheral blood and bone marrow saliva~   "|||2017-02-18 18:10:43.592495|2017-02-18 18:10:43.592495
NCT00015574|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-20|2006-09-01|||September 1998||1998-09-01|September 2006|2006-09-01|September 2004||2004-09-01|||||Observational|||Air Pollution and Implantable Cardioverter Defibrillators||Completed||N/A|500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:43.719978|2017-02-18 18:10:43.719978
NCT00015548|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-20|2015-06-16|||March 2001||2001-03-01|February 2009|2009-02-01|October 2004||2004-10-01|||||Interventional|||CATIE-Alzheimer's Disease Trial|Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial)|Completed||N/A|450||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:10:43.912375|2017-02-18 18:10:43.912375
NCT00014547|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2008-07-23|||November 2000||2000-11-01|January 2002|2002-01-01||||||||Interventional|||BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment|Phase II Study Of BBR 3464 As Treatment In Patients With Sensitive Or Refractory Small Cell Lung Cancer After One Prior Chemotherapy Regimen|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:44.051359|2017-02-18 18:10:44.051359
NCT00014534|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2016-07-12|||March 2004||2004-03-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Bladder Cancer|Phase III Study Comparing Sequential Chemotherapy (AG-ITP) To Cisplatin And Gemcitabine As Adjuvant Treatment After Cystectomy For Transitional Cell Carcinoma Of The Bladder|Completed||Phase 3|42|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:10:44.175081|2017-02-18 18:10:44.175081
NCT00014521|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2008-07-23|||January 2002||2002-01-01|February 2005|2005-02-01||||||||Interventional|||Karenitecin in Treating Patients With Recurrent Malignant Glioma|Phase I Evaluation Of The Safety Of Karenitecin In The Treatment Of Recurrent Malignant Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:44.831995|2017-02-18 18:10:44.831995
NCT00014508|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2009-02-25|||April 2001||2001-04-01|November 2005|2005-11-01||||February 2007|Actual|2007-02-01||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase II Trial Of Autologous Stem Cell Transplant Followed By Mini-Allogeneic Stem Cell Transplant In Lieu Of Standard Allogeneic Bone Marrow Transplantation For Treatment Of Multiple Myeloma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:44.93107|2017-02-18 18:10:44.93107
NCT00014495|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2015-12-17|2015-12-17||November 2000||2000-11-01|December 2015|2015-12-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer|Phase I/II Trial Of Sequential Therapy With Cytarabine And Bismuth-213-Labeled HuM195 (Humanized Anti-CD33) In Patients With Advanced Myeloid Malignancies|Completed||Phase 1/Phase 2|32|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:10:45.067173|2017-02-18 18:10:45.067173
NCT00014482|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-06-17|||December 2000||2000-12-01|June 2013|2013-06-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation|Music Therapy for Distress During Autologous Stem Cell Transplantation: A Randomized Trial|Completed||N/A|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:45.687733|2017-02-18 18:10:45.687733
NCT00014469|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-03-06|||December 2000||2000-12-01|March 2013|2013-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer|A Phase II Trial of IV Busulfan (Busulfex) and Melphalan as a Preparatory Regimen Prior to Allogeneic Bone Marrow Transplantation for the Treatment of Advanced and High Risk Hematologic Malignancies|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:45.798169|2017-02-18 18:10:45.798169
NCT00014456|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-08-27|||March 2000||2000-03-01|August 2013|2013-08-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors|A Dose-Escalation Trial Of The Combination Of Docetaxel, Gemcitabine And Filgrastim (NEUPOGEN) For The Treatment Of Patients With Advanced Solid Tumors|Completed||Phase 1|35|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 18:10:45.909906|2017-02-18 18:10:45.909906
NCT00014443|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2008-07-23|||August 2000||2000-08-01|January 2006|2006-01-01||||||||Interventional|||Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma|A Pilot Study Of Hycamtin (Topotecan) And Thalomid (Thalidomide) In Patients With Recurrent Malignant Gliomas|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:46.04777|2017-02-18 18:10:46.04777
NCT00014430|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-03-12|||November 1999||1999-11-01|November 2002|2002-11-01||||September 2002|Actual|2002-09-01||Interventional|||Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer|Phase I Clinical Trial Of Vinorelbine (Navelbine) And Trastuzumab (Herceptin) In Patients With Carcinoma Of The Breast Or Non-Small Cell Lung Cancer And HER-2/NEU Overexpression|Completed||Phase 1|13|Actual|Dartmouth-Hitchcock Medical Center||1|||f||||||||||||||2017-02-18 18:10:46.145575|2017-02-18 18:10:46.145575
NCT00014404|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-01-15|||October 2000||2000-10-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||Celecoxib in Treating Patients With Precancerous Lesions of the Mouth|Phase II Double-Blind, Placebo Controlled, Randomized Study Of Celecoxib, A Selective COX-2 Inhibitor, In Oral Premalignant Lesions|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:46.248997|2017-02-18 18:10:46.248997
NCT00014391|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2010-03-31|||February 1999||1999-02-01|March 2010|2010-03-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation|A Randomized Double-Blind Placebo-Controlled Phase III Study To Evaluate The Safety And Efficacy Of Palivizumab Combined With Aerosolized Ribavirin Compared To Ribavirin Alone To Treat RSV Pneumonia In Patients With Bone Marrow Transplants (BMT)|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:10:46.354769|2017-02-18 18:10:46.354769
NCT00014378|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2015-12-17|||October 2000||2000-10-01|December 2015|2015-12-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors|A Phase I Study Of The Chinese Herb Huanglian (Coptis Chinesis) In Patients With Advanced Solid Tumors|Completed||Phase 1|34|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:10:46.476273|2017-02-18 18:10:46.476273
NCT00014365|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-06-17|||October 2000||2000-10-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Ro 31-7453 in Treating Patients With Metastatic Solid Tumors|The Food-Effect Bioavailability Study of Ro 31-7453, a Novel Cell Cycle Inhibitor, in Stable Patient Volunteers With Solid Tumors|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:46.575433|2017-02-18 18:10:46.575433
NCT00014352|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-01-15|||September 2000||2000-09-01|January 2013|2013-01-01||||March 2003|Actual|2003-03-01||Interventional|||Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer|Phase II Trial Of Sequential Estramustine/Paclitaxel Followed By Doxorubicin/Ketoconazole In Patients With Androgen-Independent Prostate Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:10:46.659022|2017-02-18 18:10:46.659022
NCT00014339|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-12-17|||March 2000||2000-03-01|November 2007|2007-11-01||||||||Interventional|||Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma|A Randomized, Phase III, Placebo-Controlled Multicenter Study to Demonstrate the Effectiveness and Safety of the Combination Enzyme Tablet (Wobe-Mugos E) as Adjuvant Therapy to Standard of Care Treatment in Patients With Stages II or III Multiple Myeloma|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:46.746565|2017-02-18 18:10:46.746565
NCT00014326|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2012-07-13|||January 2001||2001-01-01|July 2012|2012-07-01||||March 2009|Actual|2009-03-01||Interventional|||Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma|A Phase III Randomized Study On Low-Dose Total Body Irradiation And Involved Field Radiotherapy In Patients With Localized, Stages I and II, Low Grade Non-Hodgkin's Lymphoma|Terminated||Phase 3|204|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:10:46.859495|2017-02-18 18:10:46.859495
NCT00014313|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2012-09-20|||January 2001||2001-01-01|September 2012|2012-09-01||||December 2002|Actual|2002-12-01||Interventional|||Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor|A Phase II Study to Evaluate the Role of Weekly Cisplatin With Oral Etoposide in Ewing's Sarcoma and Primitive Neuroectodermal Tumor (PNET) With Bone and/or Bone Marrow Metatstatic Disease|Terminated||Phase 2|3|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:10:46.969919|2017-02-18 18:10:46.969919
NCT00015483|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-20|2006-09-01||||||September 2006|2006-09-01||||||||Observational|||Hematotoxic Effects of Particulate Exposure|Hematotoxic Effects of Benzene and Doxorubicin|Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:47.062931|2017-02-18 18:10:47.062931
NCT00015470|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-19|2017-01-24|||April 16, 2001||2001-04-16|May 10, 2007|2007-05-10|May 10, 2007||2007-05-10|||||Observational|||Diagnostic Evaluation of Patients With Neuromuscular Disease|Diagnostic Evaluation of Patients With Neuromuscular Diseases|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:47.127439|2017-02-18 18:10:47.127439
NCT00015457|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2013-03-14|2013-03-14||April 2001||2001-04-01|March 2013|2013-03-01||||April 2009|Actual|2009-04-01||Interventional|||Amlodipine Plus Botulinum Toxin for Focal Dystonia|Trial of Amlodipine Combined With Botulinum Toxin Injections for Focal Dystonia|Completed||Phase 2|16|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:10:47.198669|2017-02-18 18:10:47.198669
NCT00015444|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-24|||April 11, 2001||2001-04-11|October 5, 2016|2016-10-05||||||||Observational|||Screening and Natural History: Primary Lateral Sclerosis and Related Disorders|Screening and Natural History: Primary Lateral Sclerosis and Related Disorders|Active, not recruiting||N/A|189|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:47.462029|2017-02-18 18:10:47.462029
NCT00015431|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-24|||April 16, 2001||2001-04-16|July 10, 2013|2013-07-10|July 10, 2013||2013-07-10|||||Observational|||Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms|The Immune Basis for the Gastrointestinal Complications of Common Variable Immunodeficiency|Completed||N/A|30|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:47.817351|2017-02-18 18:10:47.817351
NCT00015340|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11|||August 1999||1999-08-01|August 2016|2016-08-01|September 2001|Actual|2001-09-01|August 2001|Actual|2001-08-01||Interventional|||Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14|Buprenorphine/Nx Treatment of Heroin Dependence-A Compassionate Use Study|Completed||Phase 4|582|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||||||||||||2017-02-18 18:10:47.906729|2017-02-18 18:10:47.906729
NCT00015301|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2015-06-02||||||December 2002|2002-12-01||||||||Interventional|||Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11|Methylphenidate Raclopride PET Test|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.022102|2017-02-18 18:10:48.022102
NCT00015288|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11|||November 1996||1996-11-01|August 1998|1998-08-01||||||||Interventional|||Buprenorphine and Naloxone Combination Study - 10|PK0496 Pharmacokinetics of Buprenorphine|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.129898|2017-02-18 18:10:48.129898
NCT00015275|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11||||||December 2002|2002-12-01||||||||Interventional|||Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9|Pathophysiological Subtyping of Abnormalities in Cocaine Dependence|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.222338|2017-02-18 18:10:48.222338
NCT00015249|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11|||February 1997||1997-02-01|June 1998|1998-06-01|May 1998|Actual|1998-05-01|April 1998|Actual|1998-04-01||Interventional|||Prepulse Inhibition of Startle in Cocaine Dependence - 7|Prepulse Inhibition of Startle in Cocaine Dependence (Human)|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.316009|2017-02-18 18:10:48.316009
NCT00015236|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11|||March 1997||1997-03-01|June 1998|1998-06-01||||||||Interventional|||Modeling Impaired Judgement in Cocaine Abusers - 6|Modeling Impaired Judgement in Cocaine Abusers|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.418372|2017-02-18 18:10:48.418372
NCT00015223|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-13|||June 1997||1997-06-01|October 2012|2012-10-01|August 1999|Actual|1999-08-01|July 1999|Actual|1999-07-01||Interventional|||Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5|Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.511722|2017-02-18 18:10:48.511722
NCT00015210|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2015-07-29|||February 1997||1997-02-01|July 2015|2015-07-01||||May 1999|Actual|1999-05-01||Interventional|||Nefazodone in the Treatment of Cocaine Dependence and Depression - 4|Efficacy of Nefazodone in Cocaine Dependent Subjects|Completed||Phase 2|69|Actual|Boston Medical Center||2|||f||||||||||||||2017-02-18 18:10:48.612724|2017-02-18 18:10:48.612724
NCT00015171|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-13|||April 1996||1996-04-01|January 1999|1999-01-01|June 1997|Actual|1997-06-01|May 1997|Actual|1997-05-01||Interventional|||Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1|CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence|Completed||Phase 3|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.735917|2017-02-18 18:10:48.735917
NCT00015132|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11|||March 1999||1999-03-01|March 1999|1999-03-01|November 2000|Actual|2000-11-01|September 2000|Actual|2000-09-01||Interventional|||Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9|CREST-II: Tiagabine, Sertraline, or Donepezil vs. Unmatched Placebo|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.841317|2017-02-18 18:10:48.841317
NCT00015106|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11|||November 1997||1997-11-01|February 1999|1999-02-01|February 1999|Actual|1999-02-01|January 1999|Actual|1999-01-01||Interventional|||Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7|CREST-I: Resperine, Gabapentin, or Lamotrigine vs. Placebo|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:48.938119|2017-02-18 18:10:48.938119
NCT00015080|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-13|||May 1995||1995-05-01|December 1996|1996-12-01|July 1996|Actual|1996-07-01|June 1996|Actual|1996-06-01||Interventional|||Naltrexone in Treatment of Cocaine Dependence - 5|Naltrexone in Treatment of Cocaine Dependence|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:49.043573|2017-02-18 18:10:49.043573
NCT00015067|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11|||December 1997||1997-12-01|October 1998|1998-10-01||||||||Interventional|||Cocaine-Methylphendidate Interaction Study - 4|Cocaine-Methylphendidate Interaction Study|Completed||Phase 1|8||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:49.141292|2017-02-18 18:10:49.141292
NCT00015054|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-13|||September 1998||1998-09-01|February 1999|1999-02-01|November 1999|Actual|1999-11-01|October 1999|Actual|1999-10-01||Interventional|||Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3|MPD04961-Methylphendidate Treatment of Cocaine Dependent ADHD Patients|Completed||Phase 2|20||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:49.237958|2017-02-18 18:10:49.237958
NCT00015041|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-11|||November 1996||1996-11-01|July 1998|1998-07-01|July 1998|Actual|1998-07-01|June 1998|Actual|1998-06-01||Interventional|||Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2|PK 0396 - Buprenorphine Dose Escalation Trial|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:49.340779|2017-02-18 18:10:49.340779
NCT00015028|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-18|2017-01-13|||November 1996||1996-11-01|November 1996|1996-11-01|January 1997|Actual|1997-01-01|December 1996|Actual|1996-12-01||Interventional|||Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1|CS1008A Efficacy/Safety Trial of Buprenorphine/Naloxone|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:10:49.432557|2017-02-18 18:10:49.432557
NCT00015015|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-17|2006-09-01|||December 1994||1994-12-01|September 2006|2006-09-01|October 2002||2002-10-01|||||Observational|||Dichloroacetate Kinetics, Metabolism and Toxicology||Completed||N/A|100||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:49.522347|2017-02-18 18:10:49.522347
NCT00015002|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-17|2016-09-29|||March 2000||2000-03-01|September 2016|2016-09-01|March 2007|Actual|2007-03-01|May 2006|Actual|2006-05-01||Interventional|BEARS||Repeat Antenatal Steroids Trial|A Randomized Placebo-Controlled Trial of Antenatal Corticosteroid Regimens|Terminated||Phase 3|486|Actual|The George Washington University Biostatistics Center||1||Concerns regarding neonatal data|f||||t||||||||Yes|The data will be shared after completion and publication of the main analyses in accordance with NIH policy. The dataset can be obtained by emailing mfmudatasets@bsc.gwu.edu|2017-02-18 18:10:49.594268|2017-02-18 18:10:49.594268
NCT00014989|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-17|2016-09-26|||December 1997||1997-12-01|September 2016|2016-09-01|June 2007|Actual|2007-06-01|February 2007|Actual|2007-02-01||Interventional|BEAM||Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)|Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)|Completed||Phase 3|2136|Actual|The George Washington University Biostatistics Center||1|||f||||t||||||||Yes|The data will be shared after completion and publication of the main analyses in accordance with NIH policy. The dataset can be obtained by email at mfmudatasets@bsc.gwu.edu.|2017-02-18 18:10:49.727999|2017-02-18 18:10:49.727999
NCT00014976|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-17|2017-01-24|||April 13, 2001||2001-04-13|November 1, 2010|2010-11-01|November 1, 2010||2010-11-01|||||Observational|||Physiologic Studies of Spasticity|Spasticity: Physiologic Studies|Completed||N/A|48|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:49.854801|2017-02-18 18:10:49.854801
NCT00014963|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-16|2006-03-22||||||March 2006|2006-03-01||||||||Observational|||Biomarkers of Benzene Exposure in Inner City Residents||Completed||N/A|90||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:49.931736|2017-02-18 18:10:49.931736
NCT00014950|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-14|2010-03-01||||||March 2010|2010-03-01||||||||Interventional|||Benefits and Risks of Newborn Screening for Cystic Fibrosis|Pulmonary Benefits of Cystic Fibrosis Neonatal Screening|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:10:50.014012|2017-02-18 18:10:50.014012
NCT00014937|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-14|2013-07-26||||||July 2013|2013-07-01||||December 2004|Actual|2004-12-01||Interventional|||Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen|A Randomized, Controlled Trial of Two Potent, Simplified Regimens Utilizing A Protease Inhibitor-Sparing Regimen Versus A Nucleoside-Sparing Regimen for HIV-Infected Subjects Who Participated in ACTG 388 or Who Responded to A First Potent Combination Regimen and Have 200 or Less HIV-1 RNA Copies/ml|Completed||N/A|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:10:50.106094|2017-02-18 18:10:50.106094
NCT00014911|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-13|2014-06-04|2012-09-13||April 2001||2001-04-01|June 2014|2014-06-01|August 2010|Actual|2010-08-01|June 2005|Actual|2005-06-01||Interventional|||Islet Transplantation for Type 1 Diabetes|Islet Transplantation for Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression (ITN005CT)|Completed||Phase 2|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:10:50.265164|2017-02-18 18:10:50.265164
NCT00014898|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-12|2005-06-23|||June 1999||1999-06-01|March 2001|2001-03-01|May 2002||2002-05-01|||||Observational|||Attention Deficit Disorder and Exposure to Lead||Completed||N/A|500||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:50.796132|2017-02-18 18:10:50.796132
NCT00014885|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-12|2006-03-22|||September 1998||1998-09-01|March 2006|2006-03-01|August 2001||2001-08-01|||||Observational|||Bone Lead Levels and College Achievement Scores||Completed||N/A|750||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:50.866215|2017-02-18 18:10:50.866215
NCT00014872|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-11|2014-01-09|||May 2001||2001-05-01|January 2014|2014-01-01|April 2008|Actual|2008-04-01|April 2008|Actual|2008-04-01||Observational|||Genetic Epidemiology and Energy Metabolism in Black Girls||Completed||N/A|600|Actual|University of New Mexico|||1||f||||||||||||||2017-02-18 18:10:50.926079|2017-02-18 18:10:50.926079
NCT00014859|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-11|2015-06-01|||June 2001||2001-06-01|June 2015|2015-06-01|June 2019|Anticipated|2019-06-01|June 2015|Actual|2015-06-01|4 Weeks|Observational [Patient Registry]|||Epidemiology of Surfactant Protein-B Deficiency|Epidemiology of Surfactant Protein-B Deficiency|Recruiting||N/A|5000|Anticipated|Washington University School of Medicine|||2||f||||f||||||Samples With DNA|"~     DNA and tracheal aspirate samples~   "|||2017-02-18 18:10:51.010791|2017-02-18 18:10:51.010791
NCT00014833|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-11|2016-04-09|||March 2001||2001-03-01|April 2016|2016-04-01|February 2006|Actual|2006-02-01|February 2006|Actual|2006-02-01||Observational|||Life Course Socioeconomic Status, Social Context and Cardiovascular Disease||Completed||N/A|15872|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||Yes|Data shared through LOINCC and directly by request to the PI|2017-02-18 18:10:51.127367|2017-02-18 18:10:51.127367
NCT00014820|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-11|2015-12-17|||March 2001||2001-03-01|December 2015|2015-12-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Occupation and Asthma in an Urban Low Income Population|Occupation and Asthma in an Urban Low Income Population|Completed||N/A|800|Actual|New York University School of Medicine|||3||f||||||||||||||2017-02-18 18:10:51.464714|2017-02-18 18:10:51.464714
NCT00014807|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-11|2006-09-01|||July 2000||2000-07-01|September 2006|2006-09-01|June 2005||2005-06-01|||||Interventional|||Reducing Pesticide Exposure in Minority Families|Reducing Pesticide Exposure in Minority Families|Completed||N/A|1000||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:10:51.545473|2017-02-18 18:10:51.545473
NCT00014794|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-11|2008-03-03|||April 2001||2001-04-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis Patients|H215O Positron Emission Tomography (PET) in the Assessment of Synovial Blood Flow in Rheumatoid Arthritis Patients|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:51.62618|2017-02-18 18:10:51.62618
NCT00014781|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2009-03-10|||February 2001||2001-02-01|March 2009|2009-03-01||||||||Observational|||Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis||Completed||N/A|39|Anticipated|Office of Rare Diseases (ORD)|||||f||||t||||||||||2017-02-18 18:10:51.715254|2017-02-18 18:10:51.715254
NCT00014768|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2005-06-23|||February 2001||2001-02-01|March 2002|2002-03-01||||||||Observational|||Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis||Terminated||N/A|36||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:10:51.802577|2017-02-18 18:10:51.802577
NCT00014755|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2005-06-23|||December 1997||1997-12-01|April 2001|2001-04-01||||||||Interventional|||Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis||Completed||Phase 1|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:10:51.900783|2017-02-18 18:10:51.900783
NCT00014742|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2015-03-24||||||April 2001|2001-04-01|April 2004||2004-04-01|||||Interventional|||Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease||Completed||Phase 3|72|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:10:52.010508|2017-02-18 18:10:52.010508
NCT00014729|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2015-03-24|||October 2000||2000-10-01|May 2001|2001-05-01|September 2002||2002-09-01|||||Interventional|||Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa||Completed||Phase 1|20||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:10:52.099326|2017-02-18 18:10:52.099326
NCT00014690|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-08-01|||March 2001||2001-03-01|December 2004|2004-12-01|February 2004|Actual|2004-02-01|||||Interventional|||ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer|A Phase II, Open, Randomized Multicenter Trial to Assess the Efficacy and Tolerability of Intravenous ZD9331 Given as Monotherapy (at Two Doses) or in Combination With Topotecan, in Patients With Ovarian Cancer Refractory or Recurrent After Failing Platinum and Paclitaxel in Combination|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:52.183337|2017-02-18 18:10:52.183337
NCT00014677|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-07-17|||March 2001||2001-03-01|June 2002|2002-06-01|July 2008|Actual|2008-07-01|September 2002|Actual|2002-09-01||Interventional|||NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme|A Randomized, Dose-Ranging, Safety and Tolerability Study of NBI-3001 Administered by Continuous Intratumoral Infusion Followed by Surgical Resection in Patients With Recurrent Glioblastoma Multiforme|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:52.275626|2017-02-18 18:10:52.275626
NCT00014664|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-12-17|||October 2000||2000-10-01|September 2002|2002-09-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II, Open-Label, Randomized, Multicenter Trial To Evaluate The Preliminary Safety And Efficacy of Hu1D10 In Patients With Relapsed Or Refractory Grades I, II, or III B-Cell Non-Hodgkin's Lymphoma (Including Follicular, Small Lymphocytic And Marginal Zone/MALT)|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:52.372701|2017-02-18 18:10:52.372701
NCT00014651|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2010-08-06|||March 2001||2001-03-01|August 2010|2010-08-01|April 2002|Actual|2002-04-01|March 2001|Actual|2001-03-01||Interventional|||Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection|Vapreotide in Pancreas Surgery: A Double-Blind, Placebo-Controlled, Randomized Study of Vapreotide to Prevent Post-Surgical Complications in Patients Undergoing Elective Pancreatic Resection Grant Application Title: Vapreotide to Prevent Complications of Pancreatic Resection|Terminated||Phase 3|||Mayo Clinic||||"Teminated by the DSMB because there are no differences between the control group and the~   Vapreotide group"|f||||||||||||||2017-02-18 18:10:52.474742|2017-02-18 18:10:52.474742
NCT00014638|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-02-20|||January 2001||2001-01-01|February 2013|2013-02-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer|Open Label, Multicenter Trial Of Femera (Letrozole) 2.5 mg As First-line Therapy In Postmenopausal Women With Metastatic Breast Cancer Relapsing Following Adjuvant Tamoxifen Therapy|Completed||Phase 4|||Novartis|||||f||||||||||||||2017-02-18 18:10:52.597515|2017-02-18 18:10:52.597515
NCT00014625|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2012-07-23|||February 2001||2001-02-01|July 2012|2012-07-01||||November 2001|Actual|2001-11-01||Interventional|||E7070 in Treating Patients With Stage IV Melanoma|Open Label Phase II Study Of E7070 In Patients With Metastatic Melanoma (Stage IV)|Completed||Phase 2|28|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:10:52.717985|2017-02-18 18:10:52.717985
NCT00014612|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-10-28|||February 2001||2001-02-01|October 2013|2013-10-01|March 2013|Actual|2013-03-01|November 2010|Actual|2010-11-01||Interventional|AMAROS||Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer|After Mapping Of The Axilla: Radiotherapy Or Surgery|Completed||Phase 3|4813|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 18:10:52.83276|2017-02-18 18:10:52.83276
NCT00014599|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2012-09-20|||February 2001||2001-02-01|September 2012|2012-09-01||||February 2005|Actual|2005-02-01||Interventional|||Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva|Phase II Clinical Trial On Taxol As Single Agent In Locally Advanced And/Or Metastatic Or Recurrent Vulva Cancer Not Amenable For Surgery And/Or Radiotherapy|Completed||Phase 2|31|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:10:52.986144|2017-02-18 18:10:52.986144
NCT00014586|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2012-09-20|||January 2001||2001-01-01|September 2012|2012-09-01||||February 2003|Actual|2003-02-01||Interventional|||Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer|Randomized Phase III Step-Up Study On Initial Antiandrogen Monotherapy In Comparison With Watchful Waiting In Asymptomatic T1-3 Any G (Any Gleason) NO or Nx M0 Prostate Cancer Patients Without Local Treatment With Curative Intent|Terminated||Phase 3|110|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:10:53.100322|2017-02-18 18:10:53.100322
NCT00014573|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-04-05|||August 1998||1998-08-01|April 2013|2013-04-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer|Phase II Trial Of High Dose Cyclophosphamide, Cisplatin And Carmustine With Stem Cell Reconstitution Followed By Specific Cellular Therapy In Patients With Recurrent Or Refractory Brain Tumors|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-02-18 18:10:53.200832|2017-02-18 18:10:53.200832
NCT00014560|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2015-10-12|2013-04-02||September 2000||2000-09-01|April 2013|2013-04-01||||February 2003||2003-02-01||Interventional|||Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Phase I Trial Of Intravenous Bispecific Antibody (4G7XH22) In Patients With Refractory Or Relapsed Non-Hodgkin's Lymphoma Or Chronic Lymphocytic Leukemia (CLL)|Terminated||Phase 1|3|Actual|Dartmouth-Hitchcock Medical Center|This study was prematurely ended by the sponsor Medarex (supplier of BsAb) due to toxicities experienced at other sites on unrelated trials leading to the decision that Medarex would not be manufacturing the investigational product (BsAb).|1||"Medarex (supplier of BsAb) stopped study due to toxicities experienced at other sites on~   unrelated trials halting manufacturing of BsAb"|f||||||||||||||2017-02-18 18:10:53.304803|2017-02-18 18:10:53.304803
NCT00014300|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2012-09-20|||January 2001||2001-01-01|September 2012|2012-09-01||||September 2001|Actual|2001-09-01||Interventional|||Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme|Open Label Phase II Study On Glufosfamide Administered As A 60 Minute Infusion Every 3 Weeks In Recurrent Glioblastoma Multiforme|Completed||Phase 2|32|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:10:53.523853|2017-02-18 18:10:53.523853
NCT00014287|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-12-18|||September 2000||2000-09-01|December 2013|2013-12-01||||||||Interventional|||Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer|Intravesical Gemcitabine Therapy for BCG-Refractory Superficial Bladder Cancer: A Phase I and Pharmacokinetic Study|Withdrawn||Phase 1|0|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 18:10:53.644052|2017-02-18 18:10:53.644052
NCT00014274|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-06-11|||January 2001||2001-01-01|June 2013|2013-06-01||||March 2008|Actual|2008-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium|Randomized Phase II/III Study Assessing Gemcitabine/Carboplatin And Methotrexate/Carboplatin/Vinblastine In Previously Untreated Patients With Advanced Urothelial Cancer Ineligible For Cisplatin Based Chemotherapy|Completed||Phase 2/Phase 3|238|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:10:53.730153|2017-02-18 18:10:53.730153
NCT00014261|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-03-15|||October 2000||2000-10-01|March 2013|2013-03-01||||November 2002|Actual|2002-11-01||Interventional|||Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors|A Phase-I Study Of Cyclical Oral Administration Of Temozolomide In Combination With PEG12000-Interferon Alfa-2B In Patients With Refractory And/Or Advanced Solid Tumors|Completed||Phase 1|||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 18:10:53.859947|2017-02-18 18:10:53.859947
NCT00014248|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-03-15|||October 2000||2000-10-01|March 2013|2013-03-01||||November 2002|Actual|2002-11-01||Interventional|||Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors|A Phase I Study And Pharmacokinetics Of Adenosine 5'- Triphosphate (ATP) When Administered By Intravenous Infusion On A Multiple Weekly Dose Schedule To Patients With Advanced Malignancies (Solid Tumors)|Completed||Phase 1|||Dartmouth-Hitchcock Medical Center|||||f||||||||||||||2017-02-18 18:10:53.947247|2017-02-18 18:10:53.947247
NCT00014235|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2016-11-28|||December 2000||2000-12-01|November 2016|2016-11-01||||February 2005|Actual|2005-02-01||Interventional|||Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies|Nonmyeloablative PBSC Allografting From HLA Matched Related Donors Using Fludarabine and/or Low Dose TBI With Disease-Risk Based Immunosuppression|Active, not recruiting||N/A|160|Anticipated|Fred Hutchinson Cancer Research Center||2|||f||||||||||||||2017-02-18 18:10:54.119731|2017-02-18 18:10:54.119731
NCT00014222|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2014-03-17|||December 2000||2000-12-01|March 2014|2014-03-01|March 2014|Actual|2014-03-01|October 2006|Actual|2006-10-01||Interventional|||Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer|A Phase III Adjuvant Trial Of Sequenced EC + Filgrastim + Epoetin Alfa Followed By Paclitaxel Versus Sequenced AC Followed By Paclitaxel Versus CEF As Therapy For Premenopausal Women And Early Postmenopausal Women Who Have Had Potentially Curative Surgery For Node Positive Or High Risk Node Negative Breast Cancer|Completed||Phase 3|2104|Actual|Canadian Cancer Trials Group||3|||f||||t||||||||||2017-02-18 18:10:54.275369|2017-02-18 18:10:54.275369
NCT00013975|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-04|2008-03-03|||March 2001||2001-03-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Endothelial Progenitor Cells and Risk Factors for Coronary Artery Disease|Endothelial Progenitor Cells and Risk Factors for Coronary Artery Disease|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:59.946946|2017-02-18 18:10:59.946946
NCT00014209|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2016-11-25|||December 2000||2000-12-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|July 2002|Actual|2002-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma That Has Not Responded to Previous Treatment|A Phase II Study Of Gemcitabine, Dexamethasone, And Cisplatin (GDP) In Patients With Either Hodgkin's Disease Or Aggressive Histology Non-Hodgkin's Lymphoma Which Is Relapsed Or Refractory|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-02-18 18:10:54.468954|2017-02-18 18:10:54.468954
NCT00014196|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-02-12|||March 2001||2001-03-01|February 2013|2013-02-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer|Phase II Trial of Concurrent Cisplatin/Docetaxel and Radiotherapy Followed by Consolidation Docetaxel in Stage IIIB Non-Small Cell Lung Cancer|Terminated||Phase 2|33|Actual|Southwest Oncology Group||1||This study was closed early due to poor accrual.|f||||f||||||||||2017-02-18 18:10:57.478171|2017-02-18 18:10:57.478171
NCT00014183|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2009-09-23|||January 2001||2001-01-01|September 2009|2009-09-01|August 2005|Actual|2005-08-01|May 2002|Actual|2002-05-01||Interventional|||ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer|A Phase II Study Of ZD1839 (NSC #715055) In Renal Cell Carcinoma Stage IV And Renal Cell Carcinoma Recurrent|Completed||Phase 2|||University of Maryland|||||f||||||||||||||2017-02-18 18:10:57.781723|2017-02-18 18:10:57.781723
NCT00014170|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-07-15|||March 2001||2001-03-01|June 2013|2013-06-01||||July 2003|Actual|2003-07-01||Interventional|||Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study Of ZD1839 (NSC 715055) In Newly Diagnosed Patients With Glioblastoma (Grade 4 Astrocytoma)|Completed||Phase 2|92|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:10:57.868394|2017-02-18 18:10:57.868394
NCT00014144|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2012-10-05|||February 2001||2001-02-01|October 2012|2012-10-01|December 2007|Actual|2007-12-01|May 2003|Actual|2003-05-01||Interventional|||S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract|Evaluation of ZD1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II|Completed||Phase 2|31|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:10:57.980371|2017-02-18 18:10:57.980371
NCT00014131|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2016-05-25|||November 2001||2001-11-01|June 2014|2014-06-01||||December 2009|Actual|2009-12-01||Interventional|||Vaccine Therapy in Treating Patients With Kidney Cancer|Vaccine Biotherapy Of Cancer: Autologous Tumor Cells And Dendritic Cells As Active Specific Immunotherapy In Patients With Stage IV Renal Cell Carcinoma|Terminated||Phase 1/Phase 2|9|Actual|Caladrius Biosciences, Inc.||1|||f||||f||||||||||2017-02-18 18:10:58.458722|2017-02-18 18:10:58.458722
NCT00014118|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2015-10-06|||March 2001||2001-03-01|October 2015|2015-10-01|May 2009|Actual|2009-05-01|March 2007|Actual|2007-03-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer|A Phase II Trial OF Chemoradiation For Organ Preservation In Resectable Stage III or IV Squamous Cell Carcinomas Of The Larynx Or Oropharynx|Completed||Phase 2|||Eastern Cooperative Oncology Group||1|||f||||||||||||||2017-02-18 18:10:58.57479|2017-02-18 18:10:58.57479
NCT00014105|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-12-03|||December 2000||2000-12-01|May 2002|2002-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme|Phase I/II Trial of Temozolomide and Carboplatin in Recurrent Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:58.736949|2017-02-18 18:10:58.736949
NCT00014092|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-03-25|||December 1999||1999-12-01|March 2004|2004-03-01|December 2003|Actual|2003-12-01|||||Interventional|||Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery|Treatment of Patients With Metastatic Malignant Melanoma With Chemobiotherapy With Temozolomide, GM-CSF, IL2, and Interferon Alfa-2b Phase II Trial|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:10:58.832481|2017-02-18 18:10:58.832481
NCT00014079|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2016-07-12|||September 1997||1997-09-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|July 2003|Actual|2003-07-01||Observational|||Genetic Markers in Patients With Colorectal Cancer|Clinical Significance of Genetic Markers in Colon Cancer|Completed||N/A|675|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||||||2017-02-18 18:10:58.932655|2017-02-18 18:10:58.932655
NCT00014066|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2013-02-04|||March 1993||1993-03-01|February 2013|2013-02-01||||February 2004|Actual|2004-02-01||Interventional|||Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer|A Phase I Study of Photodynamic Therapy (PDT) Combined With High Dose Rate (HDR) Brachytherapy for Patients With Obstructive Bronchogenic Carcinoma|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:10:59.038354|2017-02-18 18:10:59.038354
NCT00014053|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-10|2008-07-29||||||June 2003|2003-06-01||||||||Observational|||A Study of Immune System Activity in Healthy Adults|A Study of Immune Function in Healthy Adults Aged 18-30 and 45 and Older|Completed||N/A|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:10:59.136285|2017-02-18 18:10:59.136285
NCT00014040|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-07|2008-03-03|||April 2001||2001-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients With Coronary Artery Disease|Nitric Oxide Inhalation Therapy for Myocardial Ischemia in Patients With Coronary Artery Disease|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:10:59.227174|2017-02-18 18:10:59.227174
NCT00014027|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-07|2017-01-24|||April 4, 2001||2001-04-04|July 13, 2010|2010-07-13|April 11, 2008|Actual|2008-04-11|April 11, 2008|Actual|2008-04-11||Interventional|||Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress|Polyunsaturated Fatty Acids and the Neurochemistry of Cardiovascular and Behavioral Responses in Aggressive Alcoholics|Completed||Phase 1|97|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:10:59.318392|2017-02-18 18:10:59.318392
NCT00014014|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-07|2013-10-04||||||October 2013|2013-10-01|August 2002|Actual|2002-08-01|||||Interventional|||Zidovudine and Lamivudine Given Once Versus Twice Daily|A Phase I Pharmacokinetic Study of Once Versus Twice Daily Dosing With Zidovudine and Lamivudine|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:10:59.407597|2017-02-18 18:10:59.407597
NCT00014001|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-06|2015-06-16|||December 2000||2000-12-01|October 2006|2006-10-01|December 2004||2004-12-01|||||Interventional|||CATIE- Schizophrenia Trial|Comparative Effectiveness of Antipsychotic Medications in Patients With Schizophrenia (CATIE Schizophrenia Trial)|Completed||Phase 4|1600||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:10:59.791237|2017-02-18 18:10:59.791237
NCT00013923|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-02|2009-12-10||||||August 2003|2003-08-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease|A Nutritional Brain Metabolic Enhancer for Alzheimer Disease|Completed||Phase 2|40||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:11:00.328335|2017-02-18 18:11:00.328335
NCT00013910|ClinicalTrials.gov processed this data on February 17, 2017|2001-04-02|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes|NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes|Completed||Phase 1|30||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:00.424488|2017-02-18 18:11:00.424488
NCT00013897|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-31|2011-04-28||2011-04-13|February 2001||2001-02-01|April 2011|2011-04-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine|A Phase III Study Comparing the Antiviral Efficacy and Safety of BMS-232632 With Efavirenz; Each in Combination With Fixed Dose Zidovudine-Lamivudine|Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:11:00.50778|2017-02-18 18:11:00.50778
NCT00013884|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-31|2008-03-03|||March 2001||2001-03-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||HIV Maintenance Therapy With T-20 During HAART Interruption|A Pilot Study to Evaluate the Ability of Maintenance Therapy With the HIV Fusion Inhibitor T20 to Prevent Rebound of Plasma HIV RNA Following an Interruption of HAART|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:00.715007|2017-02-18 18:11:00.715007
NCT00013871|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-31|2013-11-25||||||November 2013|2013-11-01|November 2004|Actual|2004-11-01|||||Interventional|||Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs|Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Treated With Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:11:00.804629|2017-02-18 18:11:00.804629
NCT00013858|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-30|2015-04-13|||January 1997||1997-01-01|April 2015|2015-04-01|August 2011|Actual|2011-08-01|August 2011|Actual|2011-08-01||Observational|||Environmental Contaminants and Infant Development||Completed||N/A|280|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:00.932246|2017-02-18 18:11:00.932246
NCT00013845|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-30|2017-01-24|||March 28, 2001||2001-03-28|January 19, 2017|2017-01-19||||||||Observational|||Evaluation and Treatment of Patients With Epilepsy|Evaluation and Treatment of Patients With Epilepsy|Recruiting||N/A|21500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:01.012599|2017-02-18 18:11:01.012599
NCT00013832|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-30|2017-01-24|||March 28, 2001||2001-03-28|April 11, 2007|2007-04-11|April 11, 2007||2007-04-11|||||Observational|||Study of Tongue Pressures|Effect of Task on Oral Pressure Dynamics During Swallowing|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:01.109169|2017-02-18 18:11:01.109169
NCT00013819|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-29|2015-04-13|||February 1997||1997-02-01|April 2015|2015-04-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Observational|||Exposure, Dose, Body Burden and Health Effects of Lead|Exposure, Dose, Body Burden and Health Effects of Lead|Completed||N/A|944||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:01.182593|2017-02-18 18:11:01.182593
NCT00013806|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-29|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study|CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study|Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:01.247933|2017-02-18 18:11:01.247933
NCT00013793|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-29|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Ultrasound and Motivational Enhancement for Prenatal Smoking Cessation|Ultrasound and Motivational Enhancement for Prenatal Smoking Cessation|Completed||N/A|30||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:01.323227|2017-02-18 18:11:01.323227
NCT00013780|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-29|2006-03-22|||July 1998||1998-07-01|March 2006|2006-03-01|June 2003||2003-06-01|||||Observational|||Ozone Exposure and Dose Delivered to Human Lungs||Completed||N/A|50||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:01.663904|2017-02-18 18:11:01.663904
NCT00013767|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-29|2015-04-13|||June 1999||1999-06-01|April 2015|2015-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Community Based Prevention/Control Project|Child Environmental Health Center--Reducing Pesticide Exposure in Children of Farmworkers|Completed||N/A|400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:01.743989|2017-02-18 18:11:01.743989
NCT00013754|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-29|2015-04-13|||March 2001||2001-03-01|April 2015|2015-04-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Observational|||Pesticide Exposure Pathways for Farmworker Children|Child Environmental Health Center--Reducing Pesticide Exposure in Children of Farmworkers (UW IRB 96-6567-C02, FENSKE, 6/15/00-6/14/01)|Completed||N/A|40|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:01.823237|2017-02-18 18:11:01.823237
NCT00013741|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-28|2012-05-23||||||February 2003|2003-02-01||||||||Interventional|||The MI-HEART Project||Completed||N/A|55||National Library of Medicine (NLM)|||||f||||||||||||||2017-02-18 18:11:01.903244|2017-02-18 18:11:01.903244
NCT00013728|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-28|2006-03-22|||September 2000||2000-09-01|March 2006|2006-03-01|October 2003||2003-10-01|||||Observational|||Asthma & Exposure to Peaks in Particulate Air Pollution||Completed||N/A|24||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:01.993264|2017-02-18 18:11:01.993264
NCT00013715|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-28|2008-08-08|||September 1999||1999-09-01|August 2008|2008-08-01|August 2003||2003-08-01|||||Observational|||Ozone and Rhinovirus-Induced Disease in Asthmatics||Completed||N/A|60|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:02.062622|2017-02-18 18:11:02.062622
NCT00013702|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-28|2008-03-03|||March 2001||2001-03-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients|Adefovir Dipivoxil for the Treatment of Hepatitis B in Human Immunodeficiency Virus Infected Patients With Decompensated Hepatitis B Liver Disease and a Hepatitis B Viral Load of at Least 1.0 X 10(6) (Copies/mL) Despite 52 Weeks of Lamivudine Therapy|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:02.140106|2017-02-18 18:11:02.140106
NCT00013689|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-28|2008-03-03|||March 2001||2001-03-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome|Pilot Study of Pyrimethamine and Sulfadoxine (Fansidar) for the Treatment of Individuals With the Autoimmune Lymphoproliferative Syndrome (ALPS)|Completed||Phase 1|8||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:02.233967|2017-02-18 18:11:02.233967
NCT00013663|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-27|2012-11-01||||||June 2006|2006-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load|A Randomized Controlled Study Testing the Efficacy of Immunotherapies to Control Plasma HIV RNA Concentrations Upon Interruption of Highly Active Antiretroviral Therapy|Completed||Phase 2|92||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:11:02.327682|2017-02-18 18:11:02.327682
NCT00013650|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-27|2017-01-24|||March 22, 2001||2001-03-22|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Interventional|||Effects of an Anti-Inflammatory Drug in Alzheimer's Disease|Pilot Study of Immunomodulatory Versus Antiinflammatory Therapy in Alzheimer's Disease|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:02.432888|2017-02-18 18:11:02.432888
NCT00013637|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-26|2006-09-01|||September 1998||1998-09-01|September 2006|2006-09-01|August 2003||2003-08-01|||||Observational|||Lead Exposure, Genetics, and Osteoporosis Epidemiology||Completed||N/A|650||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:02.526221|2017-02-18 18:11:02.526221
NCT00013624|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-24|2008-03-03|||March 2001||2001-03-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Riluzole to Treat Parkinson's Disease|Effect of Antiglutamatergic Treatment in Parkinson's Disease|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:02.593319|2017-02-18 18:11:02.593319
NCT00013611|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-24|2011-08-02|2010-11-08||March 2001||2001-03-01|August 2011|2011-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|SILCAAT||Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)|A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients With Low CD4+ Counts Under Active Antiretroviral Therapy (SILCAAT Amendment 4)|Completed||Phase 3|1695|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||||2017-02-18 18:11:02.699824|2017-02-18 18:11:02.699824
NCT00013598|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-24|2008-03-03|||March 2001||2001-03-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Interventional|||Treatment of Nonalcoholic Steatohepatitis With Pioglitazone|Treatment of Nonalcoholic Steatohepatitis With Pioglitazone|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:03.716399|2017-02-18 18:11:03.716399
NCT00013585|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-22|2012-05-17||||||May 2012|2012-05-01|December 2005|Actual|2005-12-01|||||Interventional|||"Safety and Effectiveness of the Selegiline Patch for Decreased Mental Function in HIV Patients"|Phase II, Placebo-Controlled, Double-Blind Study of the Selegiline Transdermal System (STS) in the Treatment of HIV-Associated Cognitive Impairment|Completed||Phase 2|127|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:11:03.805485|2017-02-18 18:11:03.805485
NCT00013572|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-21|2005-06-23||||||March 2003|2003-03-01||||||||Interventional|||HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults|A Phase I Study of Aventis Pasteur Live Recombinant ALVAC-HIV (vCP205, HIV-1 Env/Gag/Pol) in Seronegative Adults Administered (1) Subcutaneously Via Ex Vivo Transfected, Autologous Dendritic Cells, (2) Intradermally, or (3) Intramuscularly|Unknown status|Active, not recruiting|Phase 1|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:11:03.919953|2017-02-18 18:11:03.919953
NCT00013559|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-20|2017-01-24|||March 13, 2001||2001-03-13|September 26, 2016|2016-09-26||||||||Observational|||Natural History Study of Smith-Magenis Syndrome|Natural History Study of the Clinical and Molecular Manifestations of Smith-Magenis Syndrome (SMS)|Recruiting||N/A|700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:04.009737|2017-02-18 18:11:04.009737
NCT00013546|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-20|2008-03-03|||March 2001||2001-03-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Hormone Replacement Therapy to Treat Turner Syndrome|Turner Syndrome: Hormone Replacement Therapy|Completed||Phase 2|92||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:04.122197|2017-02-18 18:11:04.122197
NCT00013533|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-20|2017-01-24|||March 14, 2001||2001-03-14|May 7, 2015|2015-05-07|May 7, 2015|Actual|2015-05-07|March 1, 2008|Actual|2008-03-01||Interventional|||Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies|Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies|Completed||Early Phase 1|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:11:04.211331|2017-02-18 18:11:04.211331
NCT00013520|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-16|2012-05-17||||||May 2012|2012-05-01|June 2005|Actual|2005-06-01|||||Interventional|||Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection|Phase III, Randomized, Double-Blind Comparison of Three Protease Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection|Completed||Phase 3|1125||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:11:04.323974|2017-02-18 18:11:04.323974
NCT00013507|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||January 1999||1999-01-01|January 2001|2001-01-01|December 2002|Actual|2002-12-01|||||Interventional|||Effects of Functional Incidental Training in VA NHCU Residents|Effects of Functional Incidental Training in VA NHCU Residents|Completed||Phase 2|24|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:04.771279|2017-02-18 18:11:04.771279
NCT00013494|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||July 1999||1999-07-01|March 2006|2006-03-01|June 2003|Actual|2003-06-01|||||Interventional|||Video-Based Functional Performance and Assessment Following Stroke|Video-Based Functional Performance and Assessment Following Stroke|Completed||Phase 2|30||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:04.854646|2017-02-18 18:11:04.854646
NCT00013481|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-11-09|||January 2000||2000-01-01|November 2009|2009-11-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Coordination of Hemiparetic Movement After Post-Stroke Rehabilitation|Coordination of Hemiparetic Movement After Post-Stroke Rehabilitation|Completed||Phase 2|70|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:11:04.943358|2017-02-18 18:11:04.943358
NCT00013468|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||August 2000||2000-08-01|January 2001|2001-01-01|August 2003|Actual|2003-08-01|||||Observational|||Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss|Early Diagnosis of Steroid-Responsive & No-Responsive Hearing Loss|Completed||Phase 2|50|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.03661|2017-02-18 18:11:05.03661
NCT00013455|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||August 2000||2000-08-01|May 2002|2002-05-01|August 2003|Actual|2003-08-01|||||Interventional|||Quantifying Auditory Perceptual Learning Following Hearing Aid Fitting|Quantifying Auditory Perceptual Learning Following Hearing Aid Fitting|Completed||Phase 2|48|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.119689|2017-02-18 18:11:05.119689
NCT00013442|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||January 2000||2000-01-01|January 2001|2001-01-01|December 2002|Actual|2002-12-01|||||Observational|||AERs in Aphasia: Severity and Improvement|AERs in Aphasia: Severity and Improvement|Completed||Phase 2|20||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.217509|2017-02-18 18:11:05.217509
NCT00013429|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||January 2000||2000-01-01|January 2001|2001-01-01|September 2003|Actual|2003-09-01|||||Interventional|||Evaluation of Eye Movement Tracking Systems for Visual Rehabilitation|Evaluation of Eye Movement Tracking Systems for Visual Rehabilitation|Completed||Phase 2|100||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.309319|2017-02-18 18:11:05.309319
NCT00013416|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||October 1999||1999-10-01|January 2001|2001-01-01|September 2002|Actual|2002-09-01|||||Interventional|||Measurement and Prediction of Outcomes of Amplification|Measurement and Prediction of Outcomes of Amplification|Completed||Phase 2|120||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.396735|2017-02-18 18:11:05.396735
NCT00013403|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-06-25|||April 1999||1999-04-01|June 2015|2015-06-01|March 2002|Actual|2002-03-01|||||Interventional|||The Impact of Rehabilitation on Quality of Life in Visually Impaired|The Impact of Rehabilitation on Quality of Life in Visually Impaired|Completed||Phase 2|300||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.483866|2017-02-18 18:11:05.483866
NCT00013390|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2011-05-17|||October 1999||1999-10-01|May 2011|2011-05-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Evaluation of Treatment Methods for Clinically Significant Tinnitus|Evaluation of Treatment Methods for Clinically Significant Tinnitus|Completed||Phase 2|200|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:11:05.563622|2017-02-18 18:11:05.563622
NCT00013377|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||April 1999||1999-04-01|January 2001|2001-01-01|March 2002|Actual|2002-03-01|||||Interventional|||Predictors of Driving Performance and Successful Mobility - Rehabilitation in Patients With Medical Eye Condition|Predictors of Driving Performance and Successful Mobility - Rehabilitation in Patients With Medical Eye Condition|Completed||Phase 2|30||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.666427|2017-02-18 18:11:05.666427
NCT00013364|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||April 1998||1998-04-01|January 2001|2001-01-01|March 2001|Actual|2001-03-01|||||Observational|||Effects of Stimulus Validity on Speech Recognition|Effects of Stimulus Validity on Speech Recognition|Completed||Phase 2|80||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.74984|2017-02-18 18:11:05.74984
NCT00013351|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||April 1998||1998-04-01|January 2001|2001-01-01|March 2001|Actual|2001-03-01|||||Observational|||Restricted Useful Field View as a Risk Factor in Older Adults|Restricted Useful Field View as a Risk Factor in Older Adults|Completed||Phase 2|150||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.829204|2017-02-18 18:11:05.829204
NCT00013338|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||January 2000||2000-01-01|January 2001|2001-01-01|December 2002|Actual|2002-12-01|||||Interventional|||Supported Treadmill Ambulation Training After Spinal Cord Injury|Supported Treadmill Ambulation Training After Spinal Cord Injury|Completed||Phase 2|40||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.904477|2017-02-18 18:11:05.904477
NCT00013325|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||October 1999||1999-10-01|January 2001|2001-01-01|September 2002|Actual|2002-09-01|||||Observational|||Cardiac Disease and the Electrocardiogram in SCI Patients|Cardiac Disease and the Electrocardiogram in SCI Patients|Completed||Phase 2|800||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:05.981766|2017-02-18 18:11:05.981766
NCT00013312|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||April 1999||1999-04-01|January 2001|2001-01-01|March 2001|Actual|2001-03-01|||||Interventional|||Effects of Acute SCI on Colonic Motility & Tone|Effects of Acute SCI on Colonic Motility & Tone|Completed||Phase 2|12||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:06.065788|2017-02-18 18:11:06.065788
NCT00013299|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||October 2000||2000-10-01|January 2001|2001-01-01|April 2001|Actual|2001-04-01|||||Interventional|||Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3|Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3|Completed||Phase 2|427||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:06.153076|2017-02-18 18:11:06.153076
NCT00013286|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||October 1999||1999-10-01|January 2001|2001-01-01|September 2002|Actual|2002-09-01|||||Observational|||A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk|A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk|Completed||Phase 2|750||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:06.242097|2017-02-18 18:11:06.242097
NCT00013273|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-01-20|||January 1999||1999-01-01|January 2001|2001-01-01|December 2001|Actual|2001-12-01|||||Interventional|||Physical Conditioning in Management of Chronic Venous Insufficiency|Physical Conditioning in Management of Chronic Venous Insufficiency|Completed||Phase 2|60||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:06.336184|2017-02-18 18:11:06.336184
NCT00013260|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|July 2000|Actual|2000-07-01|||||Interventional|||An Integrated Model of Primary Care in Mental Health|An Integrated Model of Primary Care in Mental Health|Completed||N/A|271|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:06.427108|2017-02-18 18:11:06.427108
NCT00013247|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2002|Actual|2002-12-01|||||Interventional|||Facilitating Shared Decisionmaking About Prostate Cancer Screening|Facilitating Shared Decisionmaking About Prostate Cancer Screening|Completed||N/A|1152|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:06.527846|2017-02-18 18:11:06.527846
NCT00013234|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||Health Services Implications of a Teledermatology Consult System|Health Services Implications of a Teledermatology Consult System|Completed||N/A|260|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:06.638514|2017-02-18 18:11:06.638514
NCT00013221|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2000|Actual|2000-03-01|||||Interventional|||Exercise Effect on Aerobic Capacity and QOL in Heart Failure|Exercise Effect on Aerobic Capacity and QOL in Heart Failure|Completed||Phase 4|84|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:06.748566|2017-02-18 18:11:06.748566
NCT00013195|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|June 2000|Actual|2000-06-01|||||Interventional|||Nurse Counseling for Physical Activity in Primary Care Patients|Nurse Counseling for Physical Activity in Primary Care Patients|Completed||N/A|210|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:06.955084|2017-02-18 18:11:06.955084
NCT00013182|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|June 2001|Actual|2001-06-01|||||Interventional|||Effect of Activity on Sleep of Cognitively-Impaired Veterans|Effect of Activity on Sleep of Cognitively-Impaired Veterans|Completed||N/A|90|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:07.057483|2017-02-18 18:11:07.057483
NCT00013169|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2002|Actual|2002-09-01|||||Interventional|||Patient-Centered Alternative to Psychiatric Hospitalization for Veterans|Patient-Centered Alternative to Psychiatric Hospitalization for Veterans|Completed||N/A|220|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:07.151657|2017-02-18 18:11:07.151657
NCT00013156|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2000|Actual|2000-03-01|||||Interventional|||Cost-Effectiveness of Lung Volume Reduction Surgery|Cost-Effectiveness of Lung Volume Reduction Surgery|Completed||Phase 2|92|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:07.247644|2017-02-18 18:11:07.247644
NCT00013143|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06|||June 2001||2001-06-01|February 2007|2007-02-01|January 2003|Actual|2003-01-01|||||Interventional|||Patient Profiling and Provider Feedback to Reduce Adverse Drug Events|Patient Profiling and Provider Feedback to Reduce Adverse Drug Events|Completed||N/A|1200|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:07.342072|2017-02-18 18:11:07.342072
NCT00013130|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|February 2001|Actual|2001-02-01|||||Interventional|||Ambulatory Care Quality Improvement (ACQUIP)|Ambulatory Care Quality Improvement (ACQUIP)|Completed||Phase 2|62487|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:07.437025|2017-02-18 18:11:07.437025
NCT00013117|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||November 2007|2007-11-01|December 2002|Actual|2002-12-01|||||Interventional|||Computer-Assisted Access to Specialist Expertise|Computer-Assisted Access to Specialist Expertise|Completed||N/A|10000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:07.554933|2017-02-18 18:11:07.554933
NCT00013104|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||January 2005|2005-01-01|September 2002|Actual|2002-09-01|||||Observational|||Implementation of Ischemic Heart Disease Clinical Practice Guidelines|Implementation of Ischemic Heart Disease Clinical Practice Guidelines|Completed||N/A|50|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:11:07.648604|2017-02-18 18:11:07.648604
NCT00013091|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06|||October 1997||1997-10-01|May 2009|2009-05-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Treatment of Depression in Patients With PTSD|Treatment of Depression in Patients With PTSD|Completed||N/A|120|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:07.744381|2017-02-18 18:11:07.744381
NCT00013078|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||June 2005|2005-06-01|June 2001|Actual|2001-06-01|||||Interventional|||Safe-Grip Fall/Injuries Intervention: A Randomized Trial|Safe-Grip Fall/Injuries Intervention: A Randomized Trial|Completed||N/A|210|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:07.840177|2017-02-18 18:11:07.840177
NCT00013065|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||January 2005|2005-01-01|December 2003|Actual|2003-12-01|||||Observational|||A Medication Adherence Intervention for HIV Infected Veterans|A Medication Adherence Intervention for HIV Infected Veterans|Completed||N/A|210|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:11:07.937639|2017-02-18 18:11:07.937639
NCT00013052|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2002|Actual|2002-09-01|||||Interventional|||Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program|Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program|Completed||N/A|2068|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:08.029297|2017-02-18 18:11:08.029297
NCT00013039|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|February 2001|Actual|2001-02-01|||||Interventional|||Computerized Guidelines Enhanced by Symptoms and History: Clinical Effects|Computerized Guidelines Enhanced by Symptoms and History: Clinical Effects|Completed||N/A|1000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:08.126763|2017-02-18 18:11:08.126763
NCT00013026|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2004|Actual|2004-03-01|||||Interventional|||Trial of a Tailored Message Program to Implement CHF Guidelines|Trial of a Tailored Message Program to Implement CHF Guidelines|Completed||N/A|700|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:08.223104|2017-02-18 18:11:08.223104
NCT00013013|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|August 2001|Actual|2001-08-01|||||Interventional|||A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline|A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline|Completed||Phase 4|4000|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:08.310092|2017-02-18 18:11:08.310092
NCT00013000|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2000|Actual|2000-09-01|||||Interventional|||A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines|A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines|Completed||N/A|400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:08.394406|2017-02-18 18:11:08.394406
NCT00012987|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2002|Actual|2002-12-01|||||Interventional|||Implementing Guidelines for Smoking Cessation: A Randomized Trial of Evidence-Based Quality Improvement|Implementing Guidelines for Smoking Cessation: A Randomized Trial of Evidence-Based Quality Improvement|Completed||N/A|2500|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:08.499584|2017-02-18 18:11:08.499584
NCT00012974|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06|||November 2005||2005-11-01|December 2005|2005-12-01|May 2007|Actual|2007-05-01|||||Interventional|||Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas|Innovative Strategies for Implementing New CHF Guideline Recommendations|Completed||Phase 1/Phase 2|60|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:08.862337|2017-02-18 18:11:08.862337
NCT00012961|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||January 2005|2005-01-01|March 2003|Actual|2003-03-01|||||Observational|||Improving Health Services for Veterans With Schizophrenia|Improving Health Services for Veterans With Schizophrenia|Completed||N/A|300|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:11:08.972324|2017-02-18 18:11:08.972324
NCT00012948|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2004|Actual|2004-09-01|||||Interventional|||Centralized Telephone Outreach to Assist Smoking Cessation Among Veterans|Centralized Telephone Outreach to Assist Smoking Cessation Among Veterans|Completed||Phase 4|800|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.054571|2017-02-18 18:11:09.054571
NCT00012935|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2001|Actual|2001-12-01|||||Interventional|||Treatment Decision Intervention for Veterans With Prostate Cancer|Treatment Decision Intervention for Veterans With Prostate Cancer|Completed||N/A|100|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.147497|2017-02-18 18:11:09.147497
NCT00012922|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|April 2003|Actual|2003-04-01|||||Interventional|||Low Literacy Intervention for Colorectal Cancer Screening|Low Literacy Intervention for Colorectal Cancer Screening|Completed||N/A|2400|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.248825|2017-02-18 18:11:09.248825
NCT00012909|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||November 2007|2007-11-01|March 2004|Actual|2004-03-01|||||Interventional|||Development and Evaluation of a Hormone Replacement Therapy Decision-Aid|Development and Evaluation of a Hormone Replacement Therapy Decision-Aid|Completed||N/A|150|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.343867|2017-02-18 18:11:09.343867
NCT00012896|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2004|Actual|2004-09-01|||||Interventional|||Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines|Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines|Completed||N/A|320|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.444592|2017-02-18 18:11:09.444592
NCT00012883|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2001|Actual|2001-12-01|||||Interventional|||Home Walking Exercise Training in Advanced Heart Failure|Home Walking Exercise Training in Advanced Heart Failure|Completed||N/A|110|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.535918|2017-02-18 18:11:09.535918
NCT00012870|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2002|Actual|2002-03-01|||||Interventional|||Effect of Behavioral Management on Quality of Life in Heart Failure|Effect of Behavioral Management on Quality of Life in Heart Failure|Completed||N/A|116|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.634281|2017-02-18 18:11:09.634281
NCT00012857|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2001|Actual|2001-03-01|||||Interventional|||Pain Management and Behavioral Outcomes in Patients With Dementia|Pain Management and Behavioral Outcomes in Patients With Dementia|Completed||Phase 2|66|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.747666|2017-02-18 18:11:09.747666
NCT00012844|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 1999|Actual|1999-12-01|||||Interventional|||Redesigning Patient Handling Tasks to Prevent Nursing Back Injuries|Redesigning Patient Handling Tasks to Prevent Nursing Back Injuries|Completed||N/A|134|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:09.855063|2017-02-18 18:11:09.855063
NCT00012831|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||December 2005|2005-12-01|June 2001|Actual|2001-06-01|||||Observational|||Nurse Managed Clinic for Dementia Patients and Family Caregivers|Nurse Managed Clinic for Dementia Patients and Family Caregivers|Completed||N/A|120|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:11:09.952793|2017-02-18 18:11:09.952793
NCT00012818|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2003|Actual|2003-09-01|||||Interventional|||Efficacy and Cost Effectiveness of Relaxation and Response to CHF|Efficacy and Cost Effectiveness of Relaxation and Response to CHF|Completed||N/A|90|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.040783|2017-02-18 18:11:10.040783
NCT00012805|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|March 2001|Actual|2001-03-01|||||Interventional|||Effectiveness and Cost Impact of a Telecommunications System in COPD|Effectiveness and Cost Impact of a Telecommunications System in COPD|Completed||Phase 4|300|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.14511|2017-02-18 18:11:10.14511
NCT00012792|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||December 2005|2005-12-01|December 2000|Actual|2000-12-01|||||Interventional|||Randomized Controlled Trial of Exercise Training in Patients With COPD|Randomized Controlled Trial of Exercise Training in Patients With COPD|Completed||Phase 3|130|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.256795|2017-02-18 18:11:10.256795
NCT00012779|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||June 2005|2005-06-01|March 2003|Actual|2003-03-01|||||Interventional|||Effectiveness of a Health Education Program in a Primary Care Setting|Effectiveness of a Health Education Program in a Primary Care Setting|Completed||Phase 2|288|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.36909|2017-02-18 18:11:10.36909
NCT00012766|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||December 2005|2005-12-01|March 2001|Actual|2001-03-01|||||Interventional|||Effectiveness of Team Treatment of Depression in Primary Care|Effectiveness of Team Treatment of Depression in Primary Care|Completed||Phase 2|360|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.479823|2017-02-18 18:11:10.479823
NCT00012753|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 1999|Actual|1999-12-01|||||Interventional|||Automated Calls With Nurse Follow-Up to Improve Diabetes Ambulatory Care|Automated Calls With Nurse Follow-Up to Improve Diabetes Ambulatory Care|Completed||Phase 3|272|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.592851|2017-02-18 18:11:10.592851
NCT00012740|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||December 2005|2005-12-01|September 2001|Actual|2001-09-01|||||Interventional|||A Casefinding and Referral System for Older Veterans Within Primary Care|A Casefinding and Referral System for Older Veterans Within Primary Care|Completed||N/A|792|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.704148|2017-02-18 18:11:10.704148
NCT00012727|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||July 2005|2005-07-01|August 2001|Actual|2001-08-01|||||Interventional|||Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment|Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment|Completed||Phase 2|236|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.802213|2017-02-18 18:11:10.802213
NCT00012714|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|June 2000|Actual|2000-06-01|||||Interventional|||Evaluation of Subacute Rehabilitative Care|Evaluation of Subacute Rehabilitative Care|Completed||Phase 2|180|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:10.90023|2017-02-18 18:11:10.90023
NCT00012701|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||July 2005|2005-07-01|June 2003|Actual|2003-06-01|||||Observational|||Measuring HIV Quality of Care|Measuring HIV Quality of Care|Completed||N/A|1600|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:11:10.993051|2017-02-18 18:11:10.993051
NCT00012675|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2012-05-23||||||May 2012|2012-05-01|December 2003|Actual|2003-12-01|||||Observational|||Developing and Implementing a Quality Measure for Glycemic Control|Developing and Implementing a Quality Measure for Glycemic Control|Withdrawn||N/A|0|Actual|VA Office of Research and Development|||1|This study was withdrawn prior to enrollment.|f||||f||||||||||2017-02-18 18:11:11.202385|2017-02-18 18:11:11.202385
NCT00012662|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|December 2002|Actual|2002-12-01|||||Interventional|||Disease Management and Educational Intervention Outcomes in High-Risk Diabetics|Disease Management and Educational Intervention Outcomes in High-Risk Diabetics|Completed||N/A|1800|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:11.297789|2017-02-18 18:11:11.297789
NCT00012649|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||January 2005|2005-01-01|May 2003|Actual|2003-05-01|||||Observational|||Improving Diabetes Care Via Telephone Assessment and Patient Education|Improving Diabetes Care Via Telephone Assessment and Patient Education|Completed||N/A|480|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:11:11.409407|2017-02-18 18:11:11.409407
NCT00012636|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||February 2007|2007-02-01|September 2000|Actual|2000-09-01|||||Interventional|||Guidelines for Drug Therapy of Hypertension: Closing the Loop|Guidelines for Drug Therapy of Hypertension: Closing the Loop|Completed||N/A|36|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:11.52221|2017-02-18 18:11:11.52221
NCT00012623|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||April 2015|2015-04-01|March 2002|Actual|2002-03-01|||||Observational|||Improving Service Delivery Through Access Points|Improving Service Delivery Through Access Points|Completed||N/A|39481|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:11:11.642693|2017-02-18 18:11:11.642693
NCT00012610|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||April 2015|2015-04-01|September 2000|Actual|2000-09-01|||||Interventional|||Efficacy of Telepsychiatry in the Treatment of Depression|Efficacy of Telepsychiatry in the Treatment of Depression|Completed||N/A|119|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:11.741649|2017-02-18 18:11:11.741649
NCT00012597|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2015-04-06||||||April 2015|2015-04-01|September 2000|Actual|2000-09-01|||||Interventional|||Pressure Ulcer Assessment Via Telemedicine|Pressure Ulcer Assessment Via Telemedicine|Completed||N/A|128|Anticipated|VA Office of Research and Development||1|||f||||f||||||||||2017-02-18 18:11:11.853112|2017-02-18 18:11:11.853112
NCT00012584|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-14|2009-06-23|||November 2000||2000-11-01|June 2009|2009-06-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Treatment of Youth With ADHD and Anxiety|A Treatment Study of Youth With Comorbid Attention Deficit Hyperactivity Disorder (ADHD) and Anxiety Disorders|Completed||N/A|120||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:11:11.96333|2017-02-18 18:11:11.96333
NCT00012558|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-13|2007-05-03|||September 1998||1998-09-01|April 2007|2007-04-01|September 2005||2005-09-01|||||Interventional|||Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)|Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)|Completed||N/A|5000||National Institute of Mental Health (NIMH)|||||||||||||||||||2017-02-18 18:11:12.060216|2017-02-18 18:11:12.060216
NCT00012545|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-10|2017-01-24|||March 8, 2001||2001-03-08|October 31, 2016|2016-10-31||||||||Observational|||Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease|Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:12.194968|2017-02-18 18:11:12.194968
NCT00012519|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-10|2012-05-17||||||May 2012|2012-05-01|July 2005|Actual|2005-07-01|||||Interventional|||Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment|A Phase I/II Trial of Ritonavir and Indinavir in Children Failing Other Antiretroviral Therapy|Completed||Phase 1/Phase 2|29|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:11:12.2984|2017-02-18 18:11:12.2984
NCT00012506|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-10|2005-06-23||||||March 2001|2001-03-01||||||||Interventional|||The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis||Unknown status|Recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:11:12.40781|2017-02-18 18:11:12.40781
NCT00012493|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-09|2006-09-01|||October 1999||1999-10-01|September 2006|2006-09-01|December 2002||2002-12-01|||||Observational|||Cardiac Vulnerability in Potentially Susceptible Patients||Completed||N/A|100||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:12.489886|2017-02-18 18:11:12.489886
NCT00012480|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-09|2015-04-14|||August 2002||2002-08-01|April 2015|2015-04-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm|Human Sperm Zona Acceptor: Environmental Effects|Completed||N/A|400|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:12.574543|2017-02-18 18:11:12.574543
NCT00012467|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-09|2009-05-29|||January 2000||2000-01-01|May 2009|2009-05-01|July 2001|Actual|2001-07-01|||||Interventional|||Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis|A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase II Study of the Safety and Antifungal Activity of Subcutaneous Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) in Conjunction With Standard Therapy in Patients With Acute Cryptococcal Meningitis|Completed||Phase 2|60||InterMune|||||f||||||||||||||2017-02-18 18:11:12.669|2017-02-18 18:11:12.669
NCT00012454|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-09|2010-05-03|||March 2001||2001-03-01|May 2010|2010-05-01|February 2004||2004-02-01|||||Interventional|||E-Selectin Nasal Spray to Prevent Stroke Recurrence|Induction of Mucosal Tolerance to E-Selectin for the Secondary Prevention of Stroke|Terminated||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:12.779757|2017-02-18 18:11:12.779757
NCT00012441|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-06|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Comparison of Daily Nocturnal Hemodialysis With Daily Hemodialysis|Comparison of Daily Nocturnal Hemodialysis With Daily Hemodialysis|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:12.865875|2017-02-18 18:11:12.865875
NCT00011583|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2008-03-10|||January 2000||2000-01-01|March 2008|2008-03-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Robot Assisted Upper Limb Neuro-Rehabilitation|Robot Assisted Upper Limb Neuro-Rehabilitation|Completed||Phase 2|60|Anticipated|VA Office of Research and Development||2|||f||||||||||||||2017-02-18 18:11:12.936233|2017-02-18 18:11:12.936233
NCT00011570|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2008-04-25|||April 1998||1998-04-01|April 2008|2008-04-01|November 2007|Actual|2007-11-01|October 2005|Actual|2005-10-01||Interventional|||Electrical Control of Bladder in Spinal Cord Injury Patients|Electrical Control of Bladder in Spinal Cord Injury Patients|Completed||Phase 2|18|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:11:13.028436|2017-02-18 18:11:13.028436
NCT00011544|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2009-01-20|||January 1998||1998-01-01|January 2001|2001-01-01|December 2000|Actual|2000-12-01|||||Interventional|||Physical Performance Measures for Manual Wheelchair Users|Physical Performance Measures for Manual Wheelchair Users|Completed||Phase 2|120||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:13.197434|2017-02-18 18:11:13.197434
NCT00011531|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2009-02-05|||January 2000||2000-01-01|January 2001|2001-01-01|December 2001|Actual|2001-12-01|||||Interventional|||Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing|Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing|Completed||Phase 2|120|Anticipated|VA Office of Research and Development||1|||f||||||||||||||2017-02-18 18:11:13.271911|2017-02-18 18:11:13.271911
NCT00011518|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2006-03-22|||October 1997||1997-10-01|March 2006|2006-03-01|July 2001||2001-07-01|||||Observational|||Bladder Cancer Case Control Study of Arsenic in Water||Completed||N/A|600||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:13.360003|2017-02-18 18:11:13.360003
NCT00011505|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2008-03-03|||February 2001||2001-02-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Interventional|||Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia|Investigation of G-CSF-Induced Stem Cell Mobilization Potential in Patients With Diamond-Blackfan Anemia|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:13.431154|2017-02-18 18:11:13.431154
NCT00011492|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2017-01-26|||February 21, 2001||2001-02-21|January 6, 2017|2017-01-06||||||||Observational|||Patient Evaluation for Head and Neck Surgery Branch Studies|Evaluation for NIDCD Head & Neck Surgery Branch Clinical Research Protocols|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:13.518143|2017-02-18 18:11:13.518143
NCT00011479|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2012-05-17||||||May 2012|2012-05-01|August 2002|Actual|2002-08-01|||||Interventional|||Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents|Single Dose Pharmacokinetic Study of Abacavir in HIV-Infected Children and Adolescents|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:11:13.623844|2017-02-18 18:11:13.623844
NCT00011466|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-21|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder|Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:14.004088|2017-02-18 18:11:14.004088
NCT00010309|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2014-01-03|||November 2000||2000-11-01|July 2002|2002-07-01||||||||Interventional|||Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma|Phase I/II Trial Investigating The Safety And Immunogenicity Of Adenoviruses Encoding The Melan-A/MART-1 And gp 100 Melanoma Antigens Administered Intradermally To Patients With Stage II-IV Melanoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:14.084124|2017-02-18 18:11:14.084124
NCT00012428|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-06|2015-04-13|||September 1999||1999-09-01|April 2015|2015-04-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Observational|||Prenatal PCB Exposure|Prenatal PCB Exposure and Cognitive Development|Completed||N/A|224||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:14.180998|2017-02-18 18:11:14.180998
NCT00012389|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-12-18|||December 2000||2000-12-01|October 2002|2002-10-01|October 2008|Actual|2008-10-01|||||Interventional|||Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer|A Multicenter, Open-Label, Randomized, Two-Arm Study of Irinotecan (CPT-11) Versus the Combination of Oxaliplatin + Irinotecan (CPT-11) as Second-Line Treatment of Metastatic Colorectal Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:14.252837|2017-02-18 18:11:14.252837
NCT00012376|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-01-08|||March 2001||2001-03-01|January 2013|2013-01-01||||January 2010|Actual|2010-01-01||Interventional|||Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer|Dose Finding Study of Bryostatin-1 and GM-CSF in Refractory Myeloid Malignancies|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:14.541546|2017-02-18 18:11:14.541546
NCT00012363|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2012-06-12|||April 2001||2001-04-01|June 2012|2012-06-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus|Gemcitabine Plus Irinotecan in Patients With Esophageal Cancer, Phase II|Completed||Phase 2|61|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:11:14.673909|2017-02-18 18:11:14.673909
NCT00012350|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2012-10-22|||January 2001||2001-01-01|October 2012|2012-10-01|January 2010|Actual|2010-01-01|September 2003|Actual|2003-09-01||Interventional|||Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma|Phase II Evaluation of FTI (R115777) (NSC 702818) in Treatment of Advanced Multiple Myeloma|Completed||Phase 2|44|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:11:14.904706|2017-02-18 18:11:14.904706
NCT00012337|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-06-20|||January 2001||2001-01-01|March 2002|2002-03-01|March 2004|Actual|2004-03-01|||||Interventional|||ZD 1839 in Treating Patients With Metastatic Kidney Cancer|A Trial of ZD1839 (Iressa) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:15.040438|2017-02-18 18:11:15.040438
NCT00012324|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-06-25|||September 2000||2000-09-01|October 2005|2005-10-01|November 2005|Actual|2005-11-01|||||Interventional|||Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer|A Phase III Randomized Controlled Study Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma (HCC) Treated With THYMITAQ to Patients Treated With Doxorubicin|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:15.141923|2017-02-18 18:11:15.141923
NCT00012311|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2014-01-03|||January 2000||2000-01-01|September 2001|2001-09-01||||||||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer|Multi-Cycle High-Dose Chemotherapy Versus Optimized Conventionally-Dosed Chemotherapy in Patients With Metastatic Breast Cancer: A Phase II Prospective Randomized Trial|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:15.316058|2017-02-18 18:11:15.316058
NCT00012298|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2015-11-04|2015-11-04||April 2001||2001-04-01|December 2012|2012-12-01|April 2010|Actual|2010-04-01|April 2010|Actual|2010-04-01||Interventional|||Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Phase I/II Study of Two Sequential Doses of IDEC-Y2B8 in Patients With Relapsed Low-Grade and Follicular Non-Hodgkin's Lymphoma|Terminated||Phase 1/Phase 2|81|Actual|National Cancer Institute (NCI)||1||Trial completed prematurely.|f||||||||||||||2017-02-18 18:11:15.43619|2017-02-18 18:11:15.43619
NCT00012259|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-05-30|||October 2000||2000-10-01|May 2013|2013-05-01||||February 2002|Actual|2002-02-01||Interventional|||Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia|A Phase II Study Of Troxatyl In Patients With CML Blastic Phase Disease|Completed||Phase 2|31|Actual|Shire||1|||f||||||||||||||2017-02-18 18:11:16.947931|2017-02-18 18:11:16.947931
NCT00012246|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-05-15|||July 2002||2002-07-01|May 2013|2013-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract|A Trial Of Vaccination With The Carcinoembryonic Antigen (CEA) Peptide Cap 1-6D With Montanide ISA 51 Adjuvant Or Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) In HLA-A2+ Patients With CEA Producing Adenocarcinomas Of Gastrointestinal (GI) Tract Origin|Terminated||Phase 2|7|Actual|The University of Texas Medical Branch, Galveston||||Administratively Terminated|f||||||||||||||2017-02-18 18:11:17.081391|2017-02-18 18:11:17.081391
NCT00012220|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2016-07-12|||January 2001||2001-01-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|June 2004|Actual|2004-06-01||Interventional|||Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas|A Randomized Phase II Study Of Gemcitabine/Cisplatin, Gemcitabine/Docetaxel, Gemcitabine/Irinotecan, Or Fixed Dose Rate Infusion Gemcitabine In Patients With Metastic Pancreatic Cancer|Completed||Phase 2|259|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-02-18 18:11:17.187003|2017-02-18 18:11:17.187003
NCT00012207|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2010-08-20|||September 2000||2000-09-01|August 2010|2010-08-01|July 2010|Actual|2010-07-01|||||Interventional|||Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase I Study To Evaluate The Safety Of Cellular Immunotherapy Using Genetically Modified Autologous Cd20-Specific Cd8+ T Cell Clones For Patients With Relapsed Cd20+ Indolent Lymphomas|Completed||Phase 1|12|Anticipated|Fred Hutchinson Cancer Research Center|||||||||t||||||||||2017-02-18 18:11:20.400093|2017-02-18 18:11:20.400093
NCT00012194|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-07-08|||March 2001||2001-03-01|July 2013|2013-07-01||||January 2007|Actual|2007-01-01||Interventional|||7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors|Phase I Dose Escalation Study of UCN-01 (NSC 638850) Plus Cisplatin in Advanced Malignant Solid Tumors|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:20.521139|2017-02-18 18:11:20.521139
NCT00012181|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-07-01|||April 2001||2001-04-01|July 2013|2013-07-01||||January 2005|Actual|2005-01-01||Interventional|||Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas|A PHASE I STUDY OF FLAVOPIRIDOL (NSC# 649890; IND# 46211) IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC SOLID TUMORS OR LYMPHOMAS|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:20.635082|2017-02-18 18:11:20.635082
NCT00012168|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2016-03-10|||May 1999||1999-05-01|March 2016|2016-03-01||||July 2003|Actual|2003-07-01||Interventional|||Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat|Lymphoscintigraphy Assisted Molecular Staging of Head and Neck Cancer|Completed||N/A|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:11:20.749225|2017-02-18 18:11:20.749225
NCT00012155|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-06-25|||October 2000||2000-10-01|November 2002|2002-11-01|December 2009|Actual|2009-12-01|November 2002|Actual|2002-11-01||Interventional|||Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver|A Phase I, Open-Label, Dose-Escalating Study Of The Safety, Tolerability, And Anti-Tumor Activity Of A Single Intrahepatic Arterial Injection Of Genetically Engineered Herpes Simplex Virus, NV1020, In Subjects With Adenocarcinoma Of The Colon With Metastasis To The Liver|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:20.842519|2017-02-18 18:11:20.842519
NCT00012142|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-06-20|||September 2000||2000-09-01|May 2002|2002-05-01|March 2004|Actual|2004-03-01|||||Interventional|||CCI-779 in Treating Patients With Prostate Cancer|Randomized, Double-Blind, Placebo-Controlled, Phase II Study Of Intravenous CCI-779 Administered Weekly To Patients With Androgen-Independent Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:20.928103|2017-02-18 18:11:20.928103
NCT00012129|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2016-03-10|||September 1998||1998-09-01|March 2016|2016-03-01||||May 2001|Actual|2001-05-01||Interventional|||Chemotherapy in Treating Patients With Breast Cancer|Phase I/II Clinical and Pharmacological Study of Liposomal Annamycin in Anthracycline-Resistant Breast Cancer|Completed||Phase 1/Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:11:21.022549|2017-02-18 18:11:21.022549
NCT00012116|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2015-10-28|||October 2000||2000-10-01|July 2012|2012-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain|Temozolomide For Patients With Cerebral Metastases Who Have Failed Radiation Therapy|Completed||Phase 2|4|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 18:11:21.115753|2017-02-18 18:11:21.115753
NCT00012103|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2011-03-25|||September 1999||1999-09-01|March 2011|2011-03-01||||December 2001|Actual|2001-12-01||Interventional|||Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer|Prevention and Early Detection of Lung Cancer in Women|Completed||N/A|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:11:21.226294|2017-02-18 18:11:21.226294
NCT00012090|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-06-17|||September 2000||2000-09-01|June 2013|2013-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum|A Phase II Trial Of Oral Bicalutamide With Subcutaneous Goserelin In Patients With Epithelial Ovarian, Fallopian Tube, Or Peritoneal Carcinoma In Second Or Greater Remission|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:11:21.31283|2017-02-18 18:11:21.31283
NCT00012064|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2014-01-27|||July 2000||2000-07-01|August 2013|2013-08-01|April 2011|Actual|2011-04-01|April 2011|Actual|2011-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma|Vaccine Biotherapy of Cancer: Tumor Cells and Dendritic Cells as Active Specific Immunotherapy of Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|56|Actual|Caladrius Biosciences, Inc.||1|||f||||f||||||||||2017-02-18 18:11:21.405262|2017-02-18 18:11:21.405262
NCT00012051|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-08-09|||September 2000||2000-09-01|March 2007|2007-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|A Randomised Phase III Study On The Effect Of The Chimeric Anti-CD20 Monoclonal Antibody (Mabthera) During Sequential Chemotherapy Followed By Autologous Stem Cell Transplantation In Patients With Relapse B-Cell Non-Hodgkin Lymphoma(HOVON 44 STUDY)|Completed||Phase 3|340|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:21.607939|2017-02-18 18:11:21.607939
NCT00012038|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-06-20|||July 2001||2001-07-01|September 2003|2003-09-01|October 2003|Actual|2003-10-01|||||Interventional|||Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors|A Phase I/II Trial Of MGI114 For Treatment Of Patients With Recurrent Malignant Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:21.940422|2017-02-18 18:11:21.940422
NCT00012025|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2016-07-01|||May 2001||2001-05-01|July 2016|2016-07-01|August 2008|Actual|2008-08-01|March 2006|Actual|2006-03-01||Interventional|||ICI 182780 in Treating Women With Metastatic Breast Cancer|Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy|Completed||Phase 2|80|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:11:22.051004|2017-02-18 18:11:22.051004
NCT00012012|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2014-12-24|2014-12-24||August 2001||2001-08-01|December 2014|2014-12-01|June 2010|Actual|2010-06-01|September 2007|Actual|2007-09-01||Interventional||All eligible patients.|Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer|A Two Part Phase I/II Study Of Extended Field External Irradiation And Intracavitary Brachytherapy Combined With Chemotherapy And Amifostine In Carcinoma Of The Cervix With Positive Para-Aortic Or High Common Iliac Lymph Nodes|Completed||Phase 1/Phase 2|45|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:11:22.202479|2017-02-18 18:11:22.202479
NCT00011999|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2015-11-14|||March 2001||2001-03-01|November 2015|2015-11-01|June 2010|Actual|2010-06-01|February 2004|Actual|2004-02-01||Interventional|||Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer|Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck|Completed||Phase 2|70|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:11:22.691807|2017-02-18 18:11:22.691807
NCT00011986|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2016-03-17|2014-02-18||January 2001||2001-01-01|March 2016|2016-03-01||||March 2010|Actual|2010-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer|A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma|Completed||Phase 3|3882|Actual|Gynecologic Oncology Group||5|||f||||||||||||||2017-02-18 18:11:23.331739|2017-02-18 18:11:23.331739
NCT00011973|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-04-03|||December 2000||2000-12-01|April 2013|2013-04-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Chemotherapy in Treating Patients With Advanced Kidney Cancer|A Phase Two Study Of Fenretinide In Renal Cell Cancer|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:11:24.709804|2017-02-18 18:11:24.709804
NCT00011960|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2015-11-14|||May 2001||2001-05-01|November 2015|2015-11-01||||May 2006|Actual|2006-05-01||Interventional|||Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery|A Randomized Phase II Comparison Of Two Cisplatin-Paclitaxel Containing Chemoradiation Regimens In Resected Gastric Cancers|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:11:24.808814|2017-02-18 18:11:24.808814
NCT00011934|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2014-04-16|||May 1998||1998-05-01|April 2014|2014-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia|Granulocyte-Macrophage Colony Stimulating Factor (Rhu-GM-CSF) and Autologous Bone Marrow Transplantation for Chronic Myeloid Leukemia|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:11:25.253227|2017-02-18 18:11:25.253227
NCT00011921|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2013-09-16|||September 1997||1997-09-01|March 2003|2003-03-01||||||||Interventional|||Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer|Phase III Randomized Trial of Sequential High-Dose Chemotherapy Versus Standard Chemotherapy for the Treatment of Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|430|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:25.355264|2017-02-18 18:11:25.355264
NCT00011908|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-03|2008-03-03|||February 2001||2001-02-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Interventional|||Humanized LL2IGG to Treat Systemic Lupus Erythematosus|A Phase I Clinical Trial of Immunotherapy With Humanized LL2 IgG (Epratuzumab) in Patients With Systemic Lupus Erythematosus|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:25.461424|2017-02-18 18:11:25.461424
NCT00011895|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-02|2005-06-23|||February 2001||2001-02-01|March 2002|2002-03-01||||||||Interventional|||Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|A Phase IV Multicenter Study of the Efficacy and Safety of 48-Week Induction Treatment With TRIZIVIR (Abacavir 300 Mg/Lamivudine 150 Mg/Zidovudine 300 Mg Combination Tablet BID) With Efavirenz (600 Mg QD) Followed by 48-Week Randomized, Open-Label, Maintenance Treatment With TRIZIVIR With or Without Efavirenz in HIV-1 Infected Antiretroviral Therapy Naive Subjects|Unknown status|Active, not recruiting|Phase 4|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:11:25.550439|2017-02-18 18:11:25.550439
NCT00011856|ClinicalTrials.gov processed this data on February 17, 2017|2001-03-01|2008-03-03|||February 2001||2001-02-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Genetic Analysis of Familial Brain Aneurysms|Linkage Analysis of Familial Intracranial Aneurysms|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:25.687749|2017-02-18 18:11:25.687749
NCT00011843|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-28|2017-01-24|||February 22, 2001||2001-02-22|February 4, 2009|2009-02-04|February 4, 2009||2009-02-04|||||Observational|||Molecular Analysis of Microphthalmia/Anophthalmia|Molecular Analysis of Microphthalmia/Anophthalmia and Related Disorders|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:25.770693|2017-02-18 18:11:25.770693
NCT00011830|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-28|2008-03-03|||February 2001||2001-02-01|February 2006|2006-02-01|February 2006||2006-02-01|||||Interventional|||Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission|A Pilot Study of G-CSF Induced Stem Cell Mobilization Potential in Patients With Relapsed Severe Aplastic Anemia|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:25.853989|2017-02-18 18:11:25.853989
NCT00011817|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-28|2017-01-24|||February 21, 2001||2001-02-21|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||Evaluation and Treatment of Patients With Inherited Eye Diseases|Evaluation and Treatment Protocol for Potential Research Subjects With Inherited Ophthalmic Diseases|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:25.93952|2017-02-18 18:11:25.93952
NCT00011791|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-28|2017-01-24|||February 22, 2001||2001-02-22|May 10, 2011|2011-05-10|May 10, 2011||2011-05-10|||||Observational|||Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia|Catecholamine Reserve and Exercise Tolerance in Subjects With Congenital Adrenal Hyperplasia and Healthy Controls|Completed||N/A|61|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:26.100585|2017-02-18 18:11:26.100585
NCT00011778|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-28|2017-01-24|||February 22, 2001||2001-02-22|February 8, 2013|2013-02-08|February 8, 2013|Actual|2013-02-08|August 26, 2010|Actual|2010-08-26||Interventional|||PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck|A Phase I Study of Concomitant Therapy With Proteasome Inhibitor PS-341 and Radiation in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|25|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:11:26.187696|2017-02-18 18:11:26.187696
NCT00011765|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-28|2017-01-24|||February 22, 2001||2001-02-22|June 2, 2010|2010-06-02|February 26, 2007|Actual|2007-02-26|February 26, 2007|Actual|2007-02-26||Interventional|||Effect of Fluoxetine (Prozac) on Domestic Violence|The Effect of Fluoxetine on Measures of Domestic Violence|Completed||Phase 2|104|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:11:26.286192|2017-02-18 18:11:26.286192
NCT00011752|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-28|2008-03-03|||February 2001||2001-02-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Serotonin in Alcoholism|Effects of Acute Plasma Tryptophan Depletion on Serotonin Receptor Occupancy and Binding Affinity Using PET in Healthy and Alcoholic Human Subjects|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:26.416887|2017-02-18 18:11:26.416887
NCT00011739|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-27|2009-01-20|||November 1997||1997-11-01|February 2003|2003-02-01|September 2001||2001-09-01|||||Observational|||A Prospective Cohort Study of MR Abnormalities and Back Pain Risk|A Prospective Cohort Study of MR Abnormalities and Back Pain Risk|Completed||N/A|150||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:26.506024|2017-02-18 18:11:26.506024
NCT00011726|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-27|2006-03-22|||August 1996||1996-08-01|March 2006|2006-03-01|December 2002||2002-12-01|||||Observational|||Lead Mobilization & Bone Turnover in Pregnancy/Lactation||Completed||N/A|1000||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:26.596962|2017-02-18 18:11:26.596962
NCT00011713|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-27|2016-09-20|||October 1999||1999-10-01|September 2016|2016-09-01|April 2019|Anticipated|2019-04-01|April 2019|Anticipated|2019-04-01||Observational|EARTH||Environment and Reproductive Health; Human Exposure to Bisphenol A, Phthalates and Fertility and Pregnancy Outcomes|Human Exposure to Bisphenol A, Phthalates and Fertility, Pregnancy Outcomes.|Recruiting||N/A|2401|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||1||f||||f||||||Samples With DNA|"~     Whole blood, urine, semen, follicular fluid, amniotic fluid~   "|||2017-02-18 18:11:26.659775|2017-02-18 18:11:26.659775
NCT00011700|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-26|2015-04-13|||January 1999||1999-01-01|April 2015|2015-04-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Stachybotrys Induced Hemorrhage in the Developing Lung||Completed||N/A|50|Anticipated|National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:26.785492|2017-02-18 18:11:26.785492
NCT00011687|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-26|2006-03-22|||September 1999||1999-09-01|March 2006|2006-03-01|September 2003||2003-09-01|||||Observational|||Study for Future Families|US Study of Semen Quality in Partners of Pregnant Women|Completed||N/A|2400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:26.869755|2017-02-18 18:11:26.869755
NCT00011674|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-26|2006-03-22|||May 1997||1997-05-01|March 2006|2006-03-01|May 2001||2001-05-01|||||Observational|||Early Exposure to Lead and Adolescent Development||Completed||N/A|300||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:26.936801|2017-02-18 18:11:26.936801
NCT00011661|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-26|2006-09-01|||June 2000||2000-06-01|September 2006|2006-09-01|August 2005||2005-08-01|||||Interventional|||Social Network Based Intervention to Reduce Lead Exposure Among Native American Children||Completed||N/A|400||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:27.008667|2017-02-18 18:11:27.008667
NCT00011648|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-24|2017-01-24|||February 8, 2001||2001-02-08|September 12, 2016|2016-09-12||||||||Observational|||Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia|Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients With Sickle Cell Anemia|Recruiting||N/A|1200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:27.20502|2017-02-18 18:11:27.20502
NCT00011635|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-24|2008-03-03|||February 2001||2001-02-01|December 2000|2000-12-01|June 2001||2001-06-01|||||Interventional|||The Effect of Milk Thistle on the Pharmacokinetics of Indinavir|The Effect of Milk Thistle on the Pharmacokinetics of Indinavir|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:27.322241|2017-02-18 18:11:27.322241
NCT00011622|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor|Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:27.405012|2017-02-18 18:11:27.405012
NCT00011609|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2009-01-20|||August 2000||2000-08-01|January 2001|2001-01-01|November 2001|Actual|2001-11-01|||||Interventional|||Clinical Evaluation of a Wheelchair Mounted Robotic Arm|Clinical Evaluation of a Wheelchair Mounted Robotic Arm|Completed||Phase 2|30||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:27.482726|2017-02-18 18:11:27.482726
NCT00011596|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-22|2009-01-20|||August 2000||2000-08-01|January 2001|2001-01-01|August 2003|Actual|2003-08-01|||||Interventional|||FNS and Weight Support Treadmill Training for Gait Component Restoration|FNS and Weight Support Treadmill Training for Gait Component Restoration|Completed||Phase 2|36|Anticipated|VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:27.569182|2017-02-18 18:11:27.569182
NCT00011453|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-21|2005-06-23|||July 1998||1998-07-01|July 2002|2002-07-01|June 2001||2001-06-01|||||Observational|||Protection Against Benzene Toxicity|NQO1 in Protection Against Benzene Toxicity|Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:27.648813|2017-02-18 18:11:27.648813
NCT00011440|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-20|2006-03-22|||December 1998||1998-12-01|March 2006|2006-03-01|August 2002||2002-08-01|||||Observational|||Pollutant Altered Allergic Responses|Markers of Pollutant Altered Allergic Responses|Completed||N/A|20||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:27.714886|2017-02-18 18:11:27.714886
NCT00009672|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2017-01-24|||January 30, 2001||2001-01-30|December 12, 2006|2006-12-12|December 12, 2006||2006-12-12|||||Interventional|||Pain Treatment for Sciatica|Morphine, Nortriptyline and Their Combination in Sciatica Treatment|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:45.994206|2017-02-18 18:11:45.994206
NCT00011414|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-17|2017-01-24|||February 15, 2001||2001-02-15|January 13, 2016|2016-01-13|January 13, 2016|Actual|2016-01-13|November 28, 2007|Actual|2007-11-28||Interventional|||Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors|Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination With Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients With Refractory Solid Tumors Including Brain Tumors|Completed||Phase 1|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:11:27.786878|2017-02-18 18:11:27.786878
NCT00011388|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-16|2006-03-22||||||March 2006|2006-03-01||||||||Observational|||Reproductive Effects of Pesticide, PCB and Mercury Exposure in Laotian Immigrants|Organochlorine Compounds and Menstrual Cycle Function|Completed||N/A|50||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:27.896927|2017-02-18 18:11:27.896927
NCT00011375|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-16|2008-03-03|||February 2001||2001-02-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||Rolipram to Treat Multiple Sclerosis|Safety, Tolerability & Effects of Rolipram on Inflammatory Activity in the Central Nervous System in Multiple Sclerosis. A Phase II, Open Label Crossover Trial Using MRI as an Outcome Measure|Completed||Phase 2|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:27.963986|2017-02-18 18:11:27.963986
NCT00011362|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-15|2015-06-03|||September 1992||1992-09-01|June 2015|2015-06-01|April 1994|Actual|1994-04-01|January 1994|Actual|1994-01-01||Interventional|Dexamethasone||Dexamethasone Therapy in VLBW Infants at Risk of CLD|Randomized Clinical Trial of Dexamethasone Therapy in Very-Low-Birth-Weight Infants at Risk for Chronic Lung Disease (CLD)|Completed||Phase 3|371|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-02-18 18:11:28.050715|2017-02-18 18:11:28.050715
NCT00011349|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-15|2013-04-11|||January 2001||2001-01-01|April 2013|2013-04-01|January 2010|Actual|2010-01-01|June 2006|Actual|2006-06-01||Observational|||Early Stage Prostate Cancer Cohort|CSP #719B - Prospective Cohort of Early Stage Prostate Cancer|Completed||N/A|1116|Actual|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:11:28.384897|2017-02-18 18:11:28.384897
NCT00011336|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-15|2009-01-20|||July 1998||1998-07-01|February 2003|2003-02-01|June 2002||2002-06-01|||||Observational|||Determine the Association Between the Level of SCI With Chronic Respiratory Symptoms, Measures of Pulmonary Function, and Respiratory Illness.|Prospective Cohort Study of Respiratory Function and Illness in Chronic SCI|Completed||N/A|400||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:28.496366|2017-02-18 18:11:28.496366
NCT00011323|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-15|2009-01-20|||June 1998||1998-06-01|February 2003|2003-02-01|January 2001||2001-01-01|||||Observational|||Determining the Risk Factors Such as Smoking, Alcohol, and Caffeine and Their Association With Osteoporosis in Men|Prevalence and Determinants of Osteoporosis in Male Veterans|Completed||N/A|1000||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:28.571428|2017-02-18 18:11:28.571428
NCT00011310|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-15|2006-09-01|||March 1999||1999-03-01|September 2006|2006-09-01|February 2002||2002-02-01|||||Observational|||Cardiopulmonary Effects of Particulate Exposure||Completed||N/A|||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:28.647402|2017-02-18 18:11:28.647402
NCT00011297|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-15|2006-10-20||||||October 2006|2006-10-01|December 2005||2005-12-01|||||Interventional|||Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal|Alcohol Research Center - Treatment and Implications|Completed||Phase 2|160||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:11:28.727076|2017-02-18 18:11:28.727076
NCT00011284|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-15|2005-06-23||||||September 2002|2002-09-01|November 2001||2001-11-01|||||Observational|||Mechanisms of Inflammatory Liver Injury||Completed||N/A|50||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:28.817275|2017-02-18 18:11:28.817275
NCT00011258|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-14|2009-01-20|||March 1997||1997-03-01|January 2004|2004-01-01|September 2003||2003-09-01|||||Observational|||Paraoxonase and LDL Oxidation in Carotid Artery Disease|Paraoxonase and LDL Oxidation in Carotid Artery Disease|Completed||N/A|1000||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:11:28.895878|2017-02-18 18:11:28.895878
NCT00011245|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-14|2017-01-24|||February 8, 2001||2001-02-08|May 18, 2011|2011-05-18|May 18, 2011||2011-05-18|||||Observational|||Study and Surgical Treatment of Syringomyelia|Establishing the Pathophysiology of Primary Spinal Syringomyelia|Completed||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:28.970766|2017-02-18 18:11:28.970766
NCT00011206|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-13|2014-03-14|||January 2001||2001-01-01|March 2014|2014-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Mortality Follow-Up and Analyses of Men in the MRFIT||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||f||||||||||2017-02-18 18:11:29.056165|2017-02-18 18:11:29.056165
NCT00011193|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-13|2012-05-25|||January 2001||2001-01-01|May 2012|2012-05-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|DREW||Dose-Response to Exercise in Women Aged 45-75 Years (DREW)|Dose-response to Exercise in Women Aged 45-75 Years (DREW)|Completed||N/A|464|Actual|Pennington Biomedical Research Center|||4||f||||t||||||Samples With DNA|"~     whole blood~   "|||2017-02-18 18:11:29.15031|2017-02-18 18:11:29.15031
NCT00011180|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-13|2012-12-05|||April 2001||2001-04-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Risk Factors for Venous Thromboembolism in the Community|Subtherapeutic Heparin Anticoagulation as a Predictor of Recurrent Venous Thromboembolism: A Population-Based Cohort Study|Completed||N/A|385|Actual|Mayo Clinic|||2||f||||f||||||Samples With DNA|"~     Plasma and genomic DNA~   "|||2017-02-18 18:11:29.280144|2017-02-18 18:11:29.280144
NCT00011167|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-13|2016-02-05|||March 2001||2001-03-01|February 2016|2016-02-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Observational|||Retinal Arteriolar Abnormalities and CV Mortality||Completed||N/A|1380|Actual|University of Wisconsin, Madison|||1||f||||f||||||||||2017-02-18 18:11:29.373173|2017-02-18 18:11:29.373173
NCT00011154|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-12|2006-03-22|||September 1996||1996-09-01|March 2006|2006-03-01|August 2002||2002-08-01|||||Observational|||Exogenous Toxicants and Genetic Susceptibility in ALS||Completed||N/A|525||National Institute of Environmental Health Sciences (NIEHS)|||||f||||||||||||||2017-02-18 18:11:29.457239|2017-02-18 18:11:29.457239
NCT00011141|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-12|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency|Lactobacillus Plantarum as Therapy for NK-T Cell Deficiency|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:29.520195|2017-02-18 18:11:29.520195
NCT00010881|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Oregon Center for Complementary and Alternative Medicine in Neurological Disorders|Oregon Center for Complementary and Alternative Medicine in Neurological Disorders|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:31.271069|2017-02-18 18:11:31.271069
NCT00011128|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-10|2015-05-15||||||May 2004|2004-05-01||||||||Interventional|||Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment|Phase III Evaluation of the Role of Temporary Cessation of Antiretroviral Treatment and Resistance Testing-Based Selection of Antiretroviral Drugs in the Virologic Response to Salvage Therapy for Heavily Treatment-Experienced HIV-Infected Individuals Failing Current Antiretroviral Therapy|Withdrawn||Phase 3|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:11:29.594197|2017-02-18 18:11:29.594197
NCT00011115|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-09|2010-01-12|||September 2001||2001-09-01|January 2010|2010-01-01|May 2003||2003-05-01|||||Interventional|||Motivations for Weight Loss|Weight Loss Motivations and Long-term Weight Loss|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:11:29.71323|2017-02-18 18:11:29.71323
NCT00011102|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-09|2010-01-12|||February 2001||2001-02-01|January 2010|2010-01-01|December 2001||2001-12-01|||||Interventional|||Prevention of Weight Gain|Prevention of Weight Gain in Women Aged 25 Through 44|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:11:29.791195|2017-02-18 18:11:29.791195
NCT00011089|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-09|2005-06-23|||February 2001||2001-02-01|November 2001|2001-11-01||||||||Interventional|||Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations|US Expanded Access Program of Tenofovir Disoproxil Fumarate in the Treatment of HIV-1 Infected Patients Who Have Limited Treatment Options|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:11:29.883795|2017-02-18 18:11:29.883795
NCT00011076|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-09|2008-03-03|||February 2001||2001-02-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Pirfenidone to Treat Hypertrophic Cardiomyopathy|Double-Blind Placebo-Controlled Study of Pirfenidone, A Novel Anti-Fibrotic Drug in Symptomatic Patients With Hypertrophic Cardiomyopathy (HCM) Associated With Left Ventricular Diastolic Function|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:29.966893|2017-02-18 18:11:29.966893
NCT00011063|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-09|2008-03-03|||February 2001||2001-02-01|January 2001|2001-01-01|April 2001||2001-04-01|||||Interventional|||Effect of Ginkgo Biloba on Phenytoin Elimination|Evaluation of the Effect of Ginkgo Biloba on Phenytoin Pharmacokinetics|Completed||Phase 1|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:30.06412|2017-02-18 18:11:30.06412
NCT00011050|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-09|2008-07-29|||January 2001||2001-01-01|November 2004|2004-11-01||||||||Observational|||Effects of Storage on Lactate in Blood Samples|Effects of Storage on Plasma Lactate Determinations|Completed||N/A|13||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:11:30.148879|2017-02-18 18:11:30.148879
NCT00011037|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-08|2012-05-17||||||May 2012|2012-05-01|July 2004|Actual|2004-07-01|||||Interventional|||ALVAC-HIV vCP1452 Alone and Combined With MN rgp120|A Multisite Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of ALVAC-HIV vCP1452 Alone and Combined With MN rgp120|Completed||Phase 2|160|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||3|||f||||||||||||||2017-02-18 18:11:30.228407|2017-02-18 18:11:30.228407
NCT00011024|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-08|2006-08-17|||September 1998||1998-09-01|August 2006|2006-08-01|June 2004||2004-06-01|||||Interventional|||Prospective Studies of the Use of Self Hypnosis, Acupuncture and Osteopathic Manipulation on Muscle Tension in Children With Spastic Cerebral Palsy|Prospective Studies of the Use of Self Hypnosis, Acupuncture and Osteopathic Manipulation on Muscle Tension in Children With Spastic Cerebral Palsy|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:30.340563|2017-02-18 18:11:30.340563
NCT00011011|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-08|2013-07-30|||February 2001||2001-02-01|July 2013|2013-07-01|October 2006|Actual|2006-10-01|||||Interventional|||Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV|A Randomized Phase I/II Pilot Study of Intermittent Withdrawal of Antiretroviral Therapy as an Immunization Strategy and Double-Blinded Immunization With ALVAC-HIV vCP1452 in Subjects With Persistent CD4+ Cell Counts Greater Than 400 Cells/mm3 and Plasma HIV-1 RNA Levels Less Than 50 Copies/ml|Completed||Phase 1/Phase 2|94|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:11:30.42289|2017-02-18 18:11:30.42289
NCT00010998|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Yoga: Effect on Attention in Aging & Multiple Sclerosis|Yoga: Effect on Attention in Aging & Multiple Sclerosis|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:30.533806|2017-02-18 18:11:30.533806
NCT00010985|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-03-05|||September 1999||1999-09-01|March 2008|2008-03-01|August 2003||2003-08-01|||||Interventional|||Usual Care Vs Choice of Alternative Rx: Low Back Pain|Usual Care Vs Choice of Alternative Rx: Low Back Pain|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:30.619333|2017-02-18 18:11:30.619333
NCT00010972|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17||||||August 2006|2006-08-01||||||||Interventional|||Use of Acupuncture for Dental Pain: Testing a Model|Use of Acupuncture for Dental Pain: Testing a Model|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:30.702779|2017-02-18 18:11:30.702779
NCT00010959|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2007-03-01|||February 2001||2001-02-01|March 2007|2007-03-01|February 2002||2002-02-01|||||Interventional|||Single-Dose Study of Black Cohosh and Red Clover|A Phase I Single-Dose Pharmacokinetic Study of Black Cohosh and Red Clover in Healthy Menopausal Women 45-59 Years of Age|Completed||Phase 1|30||National Center for Complementary and Integrative Health (NCCIH)|||||f||||f||||||||||2017-02-18 18:11:30.770678|2017-02-18 18:11:30.770678
NCT00010946|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-03-05|||September 1998||1998-09-01|March 2008|2008-03-01|August 2003||2003-08-01|||||Interventional|||Acupuncture Safety/Efficacy in Knee Osteoarthritis|Acupuncture Safety/Efficacy in Knee Osteoarthritis|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:30.854777|2017-02-18 18:11:30.854777
NCT00010933|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-16|||September 1998||1998-09-01|August 2006|2006-08-01|June 2004||2004-06-01|||||Interventional|||Treatment of Functional Abdominal Pain in Children: Evaluation of Relaxation/Guided Imagery and Chamomile Tea as Therapeutic Modalities|Treatment of Functional Abdominal Pain in Children: Evaluation of Relaxation/Guided Imagery and Chamomile Tea as Therapeutic Modalities|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:30.933515|2017-02-18 18:11:30.933515
NCT00010920|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Preventing Cognitive Decline With Alternative Therapies|Preventing Cognitive Decline With Alternative Therapies|Completed||Phase 3|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:31.011129|2017-02-18 18:11:31.011129
NCT00010855|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-08-04|||September 1997||1997-09-01|August 2008|2008-08-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Nonpharmacologic Analgesia for Invasive Procedures|Nonpharmacologic Analgesia for Invasive Procedures|Completed||Phase 2/Phase 3|390||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:31.436327|2017-02-18 18:11:31.436327
NCT00010842|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|December 2004||2004-12-01|||||Interventional|||Natural Antioxidants in the Treatment of Multiple Sclerosis|Natural Antioxidants in the Treatment of Multiple Sclerosis|Completed||Phase 1/Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:31.523454|2017-02-18 18:11:31.523454
NCT00010829|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||January 2001||2001-01-01|August 2006|2006-08-01|December 2005||2005-12-01|||||Interventional|||Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors|Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:31.604318|2017-02-18 18:11:31.604318
NCT00010816|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1998||1998-09-01|August 2006|2006-08-01|June 2003||2003-06-01|||||Interventional|||Herbal Treatment of Hepatitis C in Methadone Maintained Patients|Herbal Treatment of Hepatitis C in Methadone Maintained Patients|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:31.702707|2017-02-18 18:11:31.702707
NCT00010803|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-03-11|2009-03-27||October 2000||2000-10-01|March 2013|2013-03-01|July 2011|Actual|2011-07-01|April 2008|Actual|2008-04-01||Interventional|||Ginkgo Biloba Prevention Trial in Older Individuals|Ginkgo Biloba Prevention Trial in Older Individuals|Completed||Phase 3|3069|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 18:11:31.822706|2017-02-18 18:11:31.822706
NCT00010777|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|March 2004||2004-03-01|||||Interventional|||Fibromyalgia: A Randomized Controlled Trial of a Mind/Body Intervention|Fibromyalgia: A Randomized Controlled Trial of a Mind/Body Intervention|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:32.547463|2017-02-18 18:11:32.547463
NCT00010764|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-03-05|||September 2000||2000-09-01|March 2008|2008-03-01|July 2002||2002-07-01|||||Interventional|||Efficacy of Acupuncture in the Treatment of Fibromyalgia|Efficacy of Acupuncture in the Treatment of Fibromyalgia|Completed||Phase 1|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:32.635262|2017-02-18 18:11:32.635262
NCT00010751|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1998||1998-09-01|August 2006|2006-08-01|June 2004||2004-06-01|||||Interventional|||Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors|Chronic Diabetic Painful Neuropathy and Cardiovascular Risk Factors in NIDDM: An Alternative Approach.|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:32.717667|2017-02-18 18:11:32.717667
NCT00010738|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|July 2006|2006-07-01|August 2002||2002-08-01|||||Interventional|||Effects of Meditation on Mechanism of Coronary Heart Disease|Effects of Meditation on Mechanism of Coronary Heart Disease|Completed||Phase 2|145||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:32.811159|2017-02-18 18:11:32.811159
NCT00010725|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2010-01-11|||September 1999||1999-09-01|January 2010|2010-01-01|August 2004|Actual|2004-08-01|||||Interventional|||Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks|Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks|Completed||Phase 2|138||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 18:11:32.888759|2017-02-18 18:11:32.888759
NCT00010712|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|July 2005||2005-07-01|||||Interventional|||Effects of Black Cohosh on Menopausal Hot Flashes|Effects of Black Cohosh on Menopausal Hot Flashes|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:32.976284|2017-02-18 18:11:32.976284
NCT00010699|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-03-21||||||March 2013|2013-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Effect of High Dose Vitamin E on Carotid Atherosclerosis|Effect of High Dose Vitamin E on Carotid Atherosclerosis|Completed||Phase 2|120||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.059289|2017-02-18 18:11:33.059289
NCT00010686|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17||||||August 2006|2006-08-01|December 2005||2005-12-01|||||Interventional|||Dietary Phytoestrogens and Bone Metabolism|Dietary Phytoestrogens and Bone Metabolism|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.154573|2017-02-18 18:11:33.154573
NCT00010647|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-16|||August 1999||1999-08-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Cost-Effectiveness of and Long-Term Outcomes Following Acupuncture Treatment for Osteoarthritis of the Knee|Cost-Effectiveness of and Long-Term Outcomes Following Acupuncture Treatment for Osteoarthritis of the Knee|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.25387|2017-02-18 18:11:33.25387
NCT00010634|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Complementary Naturopathic Medicine for Periodontitis|Complementary Naturopathic Medicine for Periodontitis|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.346467|2017-02-18 18:11:33.346467
NCT00010621|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Complementary Medicine Approaches to TMD Pain Management|Complementary Medicine Approaches to TMD Pain Management|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.430814|2017-02-18 18:11:33.430814
NCT00010608|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2009-12-04|||October 1999||1999-10-01|December 2009|2009-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women|Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women|Completed||Phase 2|196|Actual|National Center for Complementary and Integrative Health (NCCIH)||2|||f||||t||||||||||2017-02-18 18:11:33.509766|2017-02-18 18:11:33.509766
NCT00010530|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2009-12-04|||September 1999||1999-09-01|December 2009|2009-12-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks|Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks|Completed||Phase 1|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||t||||||||||2017-02-18 18:11:33.613887|2017-02-18 18:11:33.613887
NCT00010491|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-03-05|||September 1999||1999-09-01|March 2008|2008-03-01|August 2003||2003-08-01|||||Interventional|||Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients|Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.870356|2017-02-18 18:11:33.870356
NCT00010478|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2006-08-17||||||July 2006|2006-07-01||||||||Interventional|||Acupuncture and Hypertension|Acupuncture and Hypertension-Efficacy and Mechanisms|Completed||N/A|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:33.958314|2017-02-18 18:11:33.958314
NCT00010465|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-03-21||||||March 2013|2013-03-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Nervous System Manipulation and Botanicals for the Treatment of Recurrent Ear Infections in Children|Osteopathic Manipulation and Echinacea for the Treatment of Recurrent Ear Infections in Children|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:34.037781|2017-02-18 18:11:34.037781
NCT00010452|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2015-03-24|||April 2000||2000-04-01|January 2008|2008-01-01|November 2007|Actual|2007-11-01|June 2006|Actual|2006-06-01||Interventional|||Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations|Treatment of Cystic Hygroma (Lymphangiomas) in Children- Picibanil(OK432) Sclerotherapy-Multicenter Trial|Completed||Phase 2/Phase 3|150|Actual|FDA Office of Orphan Products Development||1|||f||||||||||||||2017-02-18 18:11:34.145222|2017-02-18 18:11:34.145222
NCT00010439|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2010-10-21|2009-06-03||September 2000||2000-09-01|October 2010|2010-10-01|November 2008|Actual|2008-11-01|October 2003|Actual|2003-10-01||Interventional|||Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis|A Non-Randomized, Open-Label, Prospective, Non-Controlled, 12-Month Clinical Trial to Determine the Effects of Alendronate 35 or 70 mg/Week Depending Upon Body Weight, in Children and Adolescent With IJO|Completed||Phase 2|10|Actual|Medical University of South Carolina||1|||f||||t||||||||||2017-02-18 18:11:34.261358|2017-02-18 18:11:34.261358
NCT00010426|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2015-03-24|||December 1999||1999-12-01|April 2001|2001-04-01|February 2001||2001-02-01|||||Interventional|||Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis||Completed||N/A|30||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:11:34.504718|2017-02-18 18:11:34.504718
NCT00010413|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-10-01|||April 1999||1999-04-01|October 2008|2008-10-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus||Completed||Phase 2|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:11:34.58622|2017-02-18 18:11:34.58622
NCT00010400|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2005-06-23|||April 1997||1997-04-01|July 2004|2004-07-01||||||||Interventional|||Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome||Completed||N/A|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:11:34.670426|2017-02-18 18:11:34.670426
NCT00010387|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-09-08|||March 1999||1999-03-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease||Completed||Phase 2|32||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:11:34.764585|2017-02-18 18:11:34.764585
NCT00010374|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-09-15|||February 2000||2000-02-01|September 2008|2008-09-01|October 2008|Anticipated|2008-10-01|October 2008|Anticipated|2008-10-01||Interventional|||Electrical Activation of The Diaphragm for Ventilatory Assist|Multi-Center Pivotal Study of NeuRx RA/4 Ventilatory Assist Device|Unknown status|Active, not recruiting|N/A|50|Anticipated|Synapse Biomedical||2|||f||||||||||||||2017-02-18 18:11:34.856396|2017-02-18 18:11:34.856396
NCT00010361|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2014-12-08|||November 2000||2000-11-01|August 2006|2006-08-01||||April 2007|Actual|2007-04-01||Interventional|||Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:11:34.963753|2017-02-18 18:11:34.963753
NCT00010348|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2009-05-13|||November 2000||2000-11-01|May 2009|2009-05-01|December 2015|Anticipated|2015-12-01|December 2010|Anticipated|2010-12-01||Interventional|||Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and Mycophenolate Mofetil in High Risk-Patients With Human Immunodeficiency Virus-1|Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Unknown status|Recruiting|Phase 2|20|Anticipated|Office of Rare Diseases (ORD)||1|||f||||t||||||||||2017-02-18 18:11:35.050345|2017-02-18 18:11:35.050345
NCT00010335|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2015-03-04|||November 2000||2000-11-01|March 2015|2015-03-01|May 2011|Actual|2011-05-01|July 2010|Actual|2010-07-01||Interventional|||Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders|A Pilot Study of High-Dose Immunosuppression Followed by Infusion of CD34-Selected Autologous or Syngeneic Peripheral Blood Stem Cells for Treatment of Refractory Autoimmune Disorders|Completed||Phase 1|6|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:11:35.165036|2017-02-18 18:11:35.165036
NCT00010322|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2014-03-24|||October 2000||2000-10-01|March 2014|2014-03-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer|Phase III Study of Atamestane Plus Toremifene in Metastatic Breast Cancer|Terminated||Phase 3|||Intarcia Therapeutics||||Withdrawn due to change in standard of care - new protocol required|f||||f||||||||||2017-02-18 18:11:35.272066|2017-02-18 18:11:35.272066
NCT00010283|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2010-03-31|||July 2000||2000-07-01|March 2010|2010-03-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon|Oral Beclomethasone Dipropionate Capsules for Treatment of Intestinal Graft-Versus-Host Disease: Compassionate Use in Patients With Contraindictions to High-Dose Immunosuppressive Therapy|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:11:35.363996|2017-02-18 18:11:35.363996
NCT00009048|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-23|2008-03-03|||January 2001||2001-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Interventional|||EMD 128130 for the Treatment of Parkinson's Disease|Effect of Serotoninergic Treatment in Parkinson's Disease|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:48.322531|2017-02-18 18:11:48.322531
NCT00010270|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-12-18|||April 2001||2001-04-01|January 2007|2007-01-01||||||||Interventional|||LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer|A Phase I Study Of LMB-9, A Recombinant Disulfide Stabilized Anti-Lewis Y Immonutoxin Administered By 5-Days Continuous Infusion For Patients With Colorectal Adenocarcinoma|Unknown status|Active, not recruiting|Phase 1|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:35.484828|2017-02-18 18:11:35.484828
NCT00010257|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2015-10-07|2012-09-17||February 2001||2001-02-01|June 2013|2013-06-01|August 2012|Actual|2012-08-01|November 2008|Actual|2008-11-01||Interventional|||Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma|Phase II Study Of Carboplatin Plus Paclitaxel Treatment Of Advanced Thymoma Or Thymic Carcinoma|Completed||Phase 2|46|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 18:11:35.589806|2017-02-18 18:11:35.589806
NCT00010244|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2011-02-18|||September 1999||1999-09-01|January 2011|2011-01-01||||||||Interventional|||Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer|Conformational, Curative Ratiotherapy For Prostate Cancer (NO, N-): Phase III Multicenter Study Of The Contribution To Survival Without Clinical Or Biological Change With A Dose Variation Of 15% (80 Gy VS 70 Gy)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:36.228625|2017-02-18 18:11:36.228625
NCT00010231|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2015-03-27|||June 1999||1999-06-01|March 2015|2015-03-01|November 2002|Actual|2002-11-01|August 2002|Actual|2002-08-01||Interventional|||Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|Phase I Study Of Oral, 1,25 Dihydroxycholecalciferol (Calcitriol) + Dexamethasone In Hormone-refractory Prostate Cancer|Completed||Phase 1|22|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 18:11:36.335458|2017-02-18 18:11:36.335458
NCT00010218|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2016-07-15|||April 2001||2001-04-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|April 2003|Actual|2003-04-01||Interventional|||Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer|Phase II Trial Of Karenitecin (IND 57250) In Patients With Relapsed or Refractory Non-small Cell Lung Cancer|Completed||Phase 2|55|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:11:36.440222|2017-02-18 18:11:36.440222
NCT00010205|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-01-24|||December 2000||2000-12-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Benzoylphenylurea in Treating Patients With Advanced Cancer|Phase I Trial Of Benzoylphenylurea (NSC#639829) In Advanced Malignancy|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:11:36.794087|2017-02-18 18:11:36.794087
NCT00010192|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-06-05|||December 2000||2000-12-01|June 2013|2013-06-01||||January 2003|Actual|2003-01-01||Interventional|||Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer|A Phase I Trial Of Rituximab And Interleukin-2|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:36.897059|2017-02-18 18:11:36.897059
NCT00010179|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2010-11-07|||June 2000||2000-06-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer|Randomized Phase II Study Of NX 211 Given By Two Different Intravenous Schedules In Advanced And/Or Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:11:37.02749|2017-02-18 18:11:37.02749
NCT00010166|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2009-08-20|||December 2000||2000-12-01|August 2009|2009-08-01||||||||Interventional|||Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas|Phase II Trial Of Adjuvant 2'2'-Difluoro-2'-Deoxycytidine (Gemcitabine) And External Beam Radiation For The Treatment Of Resectable Pancreatic Cancer|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:11:37.145916|2017-02-18 18:11:37.145916
NCT00010153|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2012-07-18|||November 2000||2000-11-01|July 2012|2012-07-01||||October 2001|Actual|2001-10-01||Interventional|||ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer|"A Double-Blind Phase III Clinical Trial to Compare the Effects of a Pre-Operatively Administered Single Dose of Faslodex (Long-Acting ICI 182.780) With Placebo on Tumor Recurrence in Pre- and Postmenopausal Women Treated for Operable First Primary Breast Cancer"|Terminated||Phase 3|||European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:11:37.249408|2017-02-18 18:11:37.249408
NCT00010140|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-12-17|||August 1997||1997-08-01|September 2005|2005-09-01||||||||Interventional|||Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer|A Multicenter Randomized Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin in Node Positive Postmenopausal Breast Cancer Patients|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:37.357912|2017-02-18 18:11:37.357912
NCT00010127|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-03-19|||November 2000||2000-11-01|December 2008|2008-12-01|March 2003|Actual|2003-03-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer|A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA|Terminated||Phase 1|3|Actual|Duke University|||||||||||||||||||2017-02-18 18:11:37.468995|2017-02-18 18:11:37.468995
NCT00010114|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2011-07-19|||March 2001||2001-03-01|July 2011|2011-07-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Observational|||Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children|Gene Expression Profiling of Infant Embryonal Central Nervous System Tumors by Microarray Gene Chip Analysis: Angiogenesis, Invasion and Metastasis|Completed||N/A|83|Actual|Pediatric Brain Tumor Consortium|||1||f||||f||||||||||2017-02-18 18:11:37.569081|2017-02-18 18:11:37.569081
NCT00010101|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2011-07-19|||March 2001||2001-03-01|July 2011|2011-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Observational|||Genetic Study of Brain Tumors in Young Children|INI1 Mutation Analysis and Expression Profiling of Embryonal CNS Tumors|Terminated||N/A|38|Actual|Pediatric Brain Tumor Consortium|||1|Poor accrual|f||||f||||||Samples With DNA|"~     Tumor samples~   "|||2017-02-18 18:11:37.680723|2017-02-18 18:11:37.680723
NCT00010088|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2009-02-06|||January 1999||1999-01-01|April 2007|2007-04-01||||||||Interventional|||Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct|Study Of Gemcitabine, Leukovorin, And Fluorouracil Used To Treat Locally Advanced And Metastatic Pancreatic And Biliary Adenocarcinomas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:37.785053|2017-02-18 18:11:37.785053
NCT00008346|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2011-04-26|||October 2001||2001-10-01|December 2003|2003-12-01||||||||Interventional|||Screening and Diagnostic Trial to Compare the Effectiveness of Two Types of Mammography in Detecting Breast Cancer in Women|Digital VS. Screen-Film Mammography|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:53.19455|2017-02-18 18:11:53.19455
NCT00010075|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-07-23|||January 2000||2000-01-01|June 2003|2003-06-01||||||||Interventional|||Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer|Study Of The Survival Without Degradation To The Quality Of Life During Chemotherapy For Metastatic Breast Cancer In Women|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:37.953907|2017-02-18 18:11:37.953907
NCT00010062|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2009-02-06|||October 2000||2000-10-01|April 2007|2007-04-01||||||||Interventional|||Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer|Study Of Post-Operative Concomitant Radio-Chemotherapy With A Continuous Infusion Of Flourouracil For Adjuvant Treatment Of Resected Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:38.056013|2017-02-18 18:11:38.056013
NCT00010049|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2010-07-31|||November 2002||2002-11-01|December 2003|2003-12-01||||||||Interventional|||Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma|Phase I/II Trial of STI571 (NSC 716051) in Patients With Recurrent Malignant Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:38.189106|2017-02-18 18:11:38.189106
NCT00010036|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2011-03-25|||May 1999||1999-05-01|March 2011|2011-03-01||||October 2001|Actual|2001-10-01||Interventional|||Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme|A Phase I/II Trial of CPT-11 With Carboplatin in Patients With Glioblastoma Multiforme Prior to Radiation Therapy|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:11:38.305031|2017-02-18 18:11:38.305031
NCT00010023|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2011-04-04|||August 2000||2000-08-01|April 2011|2011-04-01||||August 2007|Actual|2007-08-01||Interventional|||Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined With Intravenous Cisplatin in Patients With Advanced Cancer of the Digestive System|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:11:38.40493|2017-02-18 18:11:38.40493
NCT00010010|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2016-03-10|||June 2000||2000-06-01|March 2016|2016-03-01||||May 2001|Actual|2001-05-01||Interventional|||Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer|A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:11:38.511136|2017-02-18 18:11:38.511136
NCT00009997|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2011-03-25|||March 1999||1999-03-01|March 2011|2011-03-01||||January 2004|Actual|2004-01-01||Interventional|||Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer|Herceptin and Paclitaxel in Locally Advanced Breast Cancer With Her-2 Overexpression|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:11:38.599905|2017-02-18 18:11:38.599905
NCT00009984|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-06-05|||March 2002||2002-03-01|June 2013|2013-06-01||||November 2006|Actual|2006-11-01||Interventional|||Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer|Randomized Phase II Study of Thalidomide Versus Thalidomide Plus Fludarabine for Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine|Terminated||Phase 2|70|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:11:38.694165|2017-02-18 18:11:38.694165
NCT00009971|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-02-08|||November 2000||2000-11-01|October 2003|2003-10-01||||September 2005|Actual|2005-09-01||Interventional|||Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer|Phase II Trial Of Fenretinide (NSC-374551; IND-40, 294) In Patients With Relapsed Small Cell Lung Cancer|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:38.810663|2017-02-18 18:11:38.810663
NCT00009958|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-05-15|||November 2000||2000-11-01|May 2013|2013-05-01||||April 2010|Actual|2010-04-01||Interventional|||Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer|A Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM (B7.1/ICAM/LFA-3) Alone, and in Combination With Vaccinia-CEA(6D)-TRICOM, and the Role of GM-CSF, in Patients With CEA Expressing Carcinomas|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:11:38.913173|2017-02-18 18:11:38.913173
NCT00009945|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2014-04-02|||January 2001||2001-01-01|April 2014|2014-04-01|December 2012|Actual|2012-12-01|March 2011|Actual|2011-03-01||Interventional|||Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer|A Clinical Trial Comparing Adjuvant Clodronate Therapy vs Placebo in Early-Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Hormonal Therapy or No Therapy|Completed||Phase 3|3323|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 18:11:39.038738|2017-02-18 18:11:39.038738
NCT00009932|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-05-14|||January 2001||2001-01-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Solid Tumors|A Phase I Study Of Fenretinide Combined With Paclitaxel And Cisplatin For The Treatment Of Refractory Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:39.166529|2017-02-18 18:11:39.166529
NCT00009919|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-01-22|||December 2000||2000-12-01|January 2013|2013-01-01||||June 2003|Actual|2003-06-01||Interventional|||SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment|Phase II Study of SU5416 (NSC 696819) for Patients With Progressive Metastatic Renal Cancer Failing Prior Biologic Therapy or 5-Fluorouracil Containing Regimens|Terminated||Phase 2|50|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:11:39.259546|2017-02-18 18:11:39.259546
NCT00009906|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2014-12-19|||December 2000||2000-12-01|June 2014|2014-06-01|November 2014|Actual|2014-11-01|May 2007|Actual|2007-05-01||Interventional|||Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor|Phase III Randomized, Intergroup Trial Assessing the Clinical Activity Of STI-571 at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST) Expressing the Kit Receptor Tyrosine Kinase (CD117)|Terminated||Phase 3|748|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:11:39.376431|2017-02-18 18:11:39.376431
NCT00009893|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2016-12-05|||May 2001||2001-05-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer|Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma|Completed||Phase 2|42|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:11:39.747476|2017-02-18 18:11:39.747476
NCT00009880|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-07-17|||April 2001||2001-04-01|July 2004|2004-07-01||||July 2006|Actual|2006-07-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach|Non-Operative Therapy Of Local-Regional Carcinoma Of The Esophagus: A Randomizd Phase II Study Of Two Paclitaxel-Based Chemoradiotherapy Regimens|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:11:39.875479|2017-02-18 18:11:39.875479
NCT00009867|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-06-03|||December 2000||2000-12-01|June 2013|2013-06-01||||June 2004|Actual|2004-06-01||Interventional|||Arsenic Trioxide in Treating Patients With Urothelial Cancer|A PHASE II STUDY OF ARSENIC TRIOXIDE (NSC #706363, IND #57974) IN UROTHELIAL CANCER|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:40.025224|2017-02-18 18:11:40.025224
NCT00009854|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-11-05|||June 2000||2000-06-01|March 2003|2003-03-01||||||||Interventional|||Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm|Phase I/II Study of Intratumoral Injection of DTI-015 Prior to Tumor Resection in Patients With Recurrent Malignant Glioma or Metastatic Neoplasm to Brain|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:40.134041|2017-02-18 18:11:40.134041
NCT00009841|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2016-02-11|||March 1999||1999-03-01|June 2002|2002-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Gene Therapy in Treating Patients With Advanced Head and Neck Cancer|Phase I Trial Of Intratumoral EGFR Antisense DNA And DC-Chol Liposomes In Advanced Oral Squamous Cell Carcinoma|Completed||Phase 1|13|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 18:11:40.223165|2017-02-18 18:11:40.223165
NCT00009828|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-12-18|||December 1999||1999-12-01|December 2013|2013-12-01||||||||Interventional|||Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors|Phase I Study Of Weekly Paclitaxel In Combination With ORZEL (UFT + Leucovorin) For Advanced Non-Hematological Malignancies|Withdrawn||Phase 1|0|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 18:11:43.334071|2017-02-18 18:11:43.334071
NCT00009815|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-12-18|||December 1999||1999-12-01|December 2013|2013-12-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I Study Of Oral Etoposide In Combination With ORZEL (UFT + Leucovorin) For Advanced Non-Hematological Malignancies|Withdrawn||Phase 1|0|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 18:11:43.421554|2017-02-18 18:11:43.421554
NCT00009802|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-12-18|||June 1998||1998-06-01|December 2013|2013-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors|A Phase I Trial Of Oral Calcitriol [1,25-(OH)2D3] And Paclitaxel In Advanced Solid Tumors|Completed||Phase 1|45|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 18:11:43.507087|2017-02-18 18:11:43.507087
NCT00009789|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2016-07-12|||December 2000||2000-12-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|June 2007|Actual|2007-06-01||Interventional|||Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction|Accelerated Conformal Radiotherapy for Stage I Non-Small Cell Lung Cancer in Patients With Pulmonary Dysfunction: A Phase I Study|Completed||Phase 1|39|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:11:43.593445|2017-02-18 18:11:43.593445
NCT00009776|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-09-19|||March 2001||2001-03-01|October 2001|2001-10-01||||||||Interventional|||Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma|Combined Modality Radioimmunotherapy For Non-Hodgkin's Lymphoma With Three Cycles Of 90Y-DOTA-peptide-Lym-1, Paclitaxel and Cyclosporin A|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:43.720796|2017-02-18 18:11:43.720796
NCT00009763|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-09-19|||March 2001||2001-03-01|November 2003|2003-11-01||||||||Interventional|||Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer|Combined Modality Radioimmunotherapy For Metastatic Breast Adenocarcinoma With Two Cycles Of Escalating Dose 90Y-DOTA-peptide-m170 and Fixed, Low Dose Paclitaxel With Blood Stem Cell Support And Cyclosporin For HAMA Suppression|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:43.813577|2017-02-18 18:11:43.813577
NCT00009750|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-09-19|||March 2001||2001-03-01|November 2003|2003-11-01||||||||Interventional|||Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Combined Modality Radioimmunotherapy For Hormone Refractory Metastatic Prostate Cancer With Two Cycles Of Escalating Dose 90Y-DOTA-Peptide-m170 And Fixed, Low Dose Paclitaxel With Blood Stem Cell Support And Cyclosporin For HAMA Suppression|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:43.915992|2017-02-18 18:11:43.915992
NCT00009737|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2016-05-16|2016-05-16||November 1998||1998-11-01|May 2016|2016-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional||All randomized population included all participants who were randomized to one of the two treatment arms, regardless of whether they received any study medication.|A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer|An Open-Label Randomized Phase III Study Comparing Xeloda (Capecitabine) With IV Bolus 5-Fluorouracil in Combination With Low-Dose Leucovorin as Adjuvant Chemotherapy in Patients Who Underwent Surgery for Dukes C Colon Cancer|Completed||Phase 3|1987|Actual|Hoffmann-La Roche||2|||f||||||||||||||2017-02-18 18:11:44.034012|2017-02-18 18:11:44.034012
NCT00009711|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-04-29|||March 1996||1996-03-01|April 2013|2013-04-01|August 2005|Actual|2005-08-01|August 2004|Actual|2004-08-01||Observational|||Study of Lung Function in Children Who Have Undergone Bone Marrow Transplantation|The Impact of Pediatric Marrow Transplantation on Late Pulmonary Function|Completed||N/A|280|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:11:45.315856|2017-02-18 18:11:45.315856
NCT00009698|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2013-06-27|||March 1998||1998-03-01|June 2013|2013-06-01|September 2005|Actual|2005-09-01|June 2001|Actual|2001-06-01||Interventional|||Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia|IL-2 Infusion in AML Patients After Autologous Bone Marrow Transplant: A Pediatric Oncology Group Wide Phase I Trial|Completed||Phase 1|1|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:11:45.669231|2017-02-18 18:11:45.669231
NCT00009685|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-03-03|||January 2001||2001-01-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||HIV-1 Vaccine Test in Uninfected Adult Volunteers|Evaluation of an HIV-1 DNA Vaccine Encoding a Modified Gag-Pol Protein in Uninfected Adult Volunteers|Completed||Phase 1|21||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:45.909265|2017-02-18 18:11:45.909265
NCT00009659|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-02|2008-03-03|||January 2001||2001-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause|Biologic Activity of a Selective Progesterone Receptor Modulator, CDB-2914, in Post-Menopausal Women|Completed||Phase 2|58||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:46.089538|2017-02-18 18:11:46.089538
NCT00009646|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-01|2015-06-03|||November 1993||1993-11-01|June 2015|2015-06-01|March 2001|Actual|2001-03-01|March 1999|Actual|1999-03-01||Interventional|TIPP||Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)|Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)|Completed||Phase 3|1202|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-02-18 18:11:46.173732|2017-02-18 18:11:46.173732
NCT00009633|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-01|2016-08-23|||January 1993||1993-01-01|August 2016|2016-08-01|March 2021|Anticipated|2021-03-01|March 2021|Anticipated|2021-03-01||Observational|FU||Follow-up Visit of High Risk Infants|Follow-up Visit of High Risk Infants|Recruiting||Phase 4|68000|Anticipated|NICHD Neonatal Research Network|||1||f||||f||||||||||2017-02-18 18:11:46.311018|2017-02-18 18:11:46.311018
NCT00009620|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-01|2015-06-03|||February 1993||1993-02-01|June 2015|2015-06-01|February 1997|Actual|1997-02-01|February 1995|Actual|1995-02-01||Interventional|Phenobarbital||Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage|Randomized Clinical Trial of Antenatal Phenobarbital in the Prevention of Neonatal Intracranial Hemorrhage|Completed||Phase 3|610|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-02-18 18:11:46.537699|2017-02-18 18:11:46.537699
NCT00009594|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-01|2006-08-17|||September 1999||1999-09-01|August 2006|2006-08-01|July 2004||2004-07-01|||||Interventional|||Alternative Medicine Approaches for Women With Temporomandibular Disorders|Alternative Medicine Approaches for Women With Temporomandibular Disorders|Completed||Phase 2|||National Center for Complementary and Integrative Health (NCCIH)|||||f||||||||||||||2017-02-18 18:11:46.680017|2017-02-18 18:11:46.680017
NCT00009581|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-01|2008-03-03|||January 2001||2001-01-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Interventional|||Nitric Oxide to Improve Blood Flow in Sickle Cell Disease|Targeted Delivery of Nitric Oxide by Hemoglobin to Improve Regional Blood Flow in Sickle Cell Disease|Completed||Phase 2|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:46.762712|2017-02-18 18:11:46.762712
NCT00009568|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-01|2008-03-03|||January 2001||2001-01-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Platelet Function in Patients Treated With SSRI and Non-SSRI Antidepressants|Platelet Dysfunction in Patients Treated With SSRI Versus Non-SSRI Antidepressants|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:46.855726|2017-02-18 18:11:46.855726
NCT00009555|ClinicalTrials.gov processed this data on February 17, 2017|2001-02-01|2012-05-17||||||May 2012|2012-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat|A Prospective, Multicenter, Randomized, Placebo-Controlled Trial of Physiologic Testosterone Supplementation for HIV-Positive Men With Mildly to Moderately Reduced Serum Testosterone Levels and Abdominal Obesity|Completed||Phase 4|86||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:11:46.94239|2017-02-18 18:11:46.94239
NCT00009542|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-27|2008-03-03|||January 2001||2001-01-01|January 2001|2001-01-01|April 2001||2001-04-01|||||Interventional|||Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan|Evaluation of the Effect of Kava on Drug Metabolism Enzymes and EEG Measured Beta Amplitude|Completed||Phase 4|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:47.060418|2017-02-18 18:11:47.060418
NCT00009529|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-27|2009-10-15||||||October 2009|2009-10-01||||||||Observational|||The Contact Lens and Myopia Progression (CLAMP) Study||Completed||N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:11:47.148279|2017-02-18 18:11:47.148279
NCT00009256|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-25|2017-01-24|||April 13, 2000||2000-04-13|March 3, 2009|2009-03-03|March 3, 2009||2009-03-03|||||Observational|||Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy|Analysis of HIV Genetic Variation in Patients Prior to Initiation of Highly Active Antiretroviral Therapy|Completed||N/A|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:47.228954|2017-02-18 18:11:47.228954
NCT00009243|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-24|2017-01-24|||January 19, 2001||2001-01-19|October 5, 2016|2016-10-05||||||||Observational|||Natural History of Stroke: Cause and Development|Evaluation, Pathogenesis, and Treatment of Patients With or at Risk for Cerebrovascular Disease (A Natural History/Disease Pathogenesis Protocol)|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:47.323588|2017-02-18 18:11:47.323588
NCT00009230|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-23|2015-12-02|||June 2000||2000-06-01|December 2015|2015-12-01||||June 2005|Actual|2005-06-01||Interventional|||Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial||Suspended||Phase 3|||University of California, Los Angeles||||Funding|f||||||||||||||2017-02-18 18:11:47.691251|2017-02-18 18:11:47.691251
NCT00009217|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-23|2016-05-23|||January 1999||1999-01-01|February 2012|2012-02-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Treatment of Behavioral Symptoms in Alzheimer's Disease|Treatment of Behavioral Symptoms in Alzheimer's Disease|Completed||Phase 4|44|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 18:11:47.791302|2017-02-18 18:11:47.791302
NCT00009204|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-23|2013-06-18|||September 1995||1995-09-01|June 2013|2013-06-01|April 2002|Actual|2002-04-01|April 2000|Actual|2000-04-01||Interventional|SPAD||Serotonergic Pharmacotherapy for Agitation of Dementia|Serotonergic Pharmacotherapy for Agitation of Dementia|Completed||Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:11:47.91981|2017-02-18 18:11:47.91981
NCT00009191|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-23|2013-09-17|||November 2005||2005-11-01|September 2013|2013-09-01|November 2007|Actual|2007-11-01|November 2006|Actual|2006-11-01||Interventional|||The Depression in Alzheimer's Disease Study (DIADS)||Completed||Phase 4|||Johns Hopkins University|||||f||||||||||||||2017-02-18 18:11:48.016673|2017-02-18 18:11:48.016673
NCT00009178|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-23|2010-01-12|||March 1998||1998-03-01|January 2010|2010-01-01|December 2001||2001-12-01|||||Interventional|||Treatment of Bulimia Nervosa in a Primary Care Setting||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:11:48.104544|2017-02-18 18:11:48.104544
NCT00009061|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-23|2005-06-23|||November 2000||2000-11-01|March 2002|2002-03-01||||||||Interventional|||Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs|A Randomized, Open-Label, Two Arm Trial to Compare the Safety and Antiviral Efficacy of GW433908/Ritonavir QD to Nelfinavir BID When Used in Combination With Abacavir and Lamivudine for 48 Weeks in Antiretroviral Therapy Naive HIV-1 Infected Subjects|Unknown status|Active, not recruiting|Phase 3|624||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:11:48.200956|2017-02-18 18:11:48.200956
NCT00009035|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-23|2017-01-24|||January 19, 2001||2001-01-19|December 1, 2016|2016-12-01||||||||Observational|||Natural History of Patients With Brain and Spinal Cord Tumors|Evaluation of the Natural History of Patients With Tumors of the Central Nervous System|Recruiting||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:48.424858|2017-02-18 18:11:48.424858
NCT00009009|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-20|2008-03-03|||January 2001||2001-01-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Kidney Transplant for HIV-Infected Patients in Renal Failure|Renal Allotransplantation for Treatment of End Stage Renal Disease in the Setting of Human Immunodeficiency Virus (HIV) Infection|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:48.535948|2017-02-18 18:11:48.535948
NCT00008892|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-18|2017-01-24|||January 12, 2001||2001-01-12|January 31, 2007|2007-01-31|January 31, 2007||2007-01-31|||||Observational|||Brain Imaging in Children With AD/HD|Anatomic MRI Brain Imaging of White Matter in Children|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:48.632895|2017-02-18 18:11:48.632895
NCT00008866|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-18|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy|A Phase II, Double-Blind, Randomized Study to Determine the Effect of Adding Delayed Versus Immediate Hydroxyurea to a Genotypic Based, ddI-Containing, Three-Drug Antiretroviral Regimen on the Recovery of Total CD4+ T-Cell Counts and Suppression of Plasma Viral Load in Advanced HIV-1 Infected Subjects Failing a First or Second Triple Combination Therapy|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:11:48.71449|2017-02-18 18:11:48.71449
NCT00008853|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-18|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines|Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines|Completed||Phase 1|65||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:11:48.805046|2017-02-18 18:11:48.805046
NCT00008840|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-18|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia|A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia|Completed||N/A|866||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:11:48.894267|2017-02-18 18:11:48.894267
NCT00008827|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-17|2010-01-12|||September 2000||2000-09-01|January 2010|2010-01-01|April 2001||2001-04-01|||||Interventional|||The Use of the Internet to Facilitate Weight Loss and Maintenance.|The Use of the Internet to Facilitate Weight Loss and Maintenance.|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:11:48.967528|2017-02-18 18:11:48.967528
NCT00008814|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Functional Magnetic Resonance Imaging in Infants|Functional Magnetic Resonance Imaging (fMRI) in Infants|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:49.04472|2017-02-18 18:11:49.04472
NCT00008801|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-16|2005-10-31||||||December 2003|2003-12-01||||||||Interventional|||hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure|hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:49.115821|2017-02-18 18:11:49.115821
NCT00008788|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Osteoporosis in Children and Adults Following Liver Transplantation|Osteoporosis in Children and Adults Following Liver Transplantation|Unknown status|Active, not recruiting|N/A|40||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:49.205261|2017-02-18 18:11:49.205261
NCT00008775|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-16|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Pressure Support Ventilation During CF Exacerbations|Pressure Support Ventilation During CF Exacerbations: A Randomized, Controlled Trial|Suspended||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:49.279619|2017-02-18 18:11:49.279619
NCT00008762|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Bone Health of People With Cystic Fibrosis|Bone Health of People With Cystic Fibrosis|Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:49.351918|2017-02-18 18:11:49.351918
NCT00008749|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus|Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus|Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:49.428405|2017-02-18 18:11:49.428405
NCT00008736|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-16|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Electrogastrography (EGC) in Premature Infants With Feeding Intolerance|Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide|Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:11:49.494093|2017-02-18 18:11:49.494093
NCT00008697|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-13|2013-04-11|||November 1998||1998-11-01|April 2013|2013-04-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia|A Phase I/II Trial of Infusional Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia|Completed||Phase 1/Phase 2|13|Actual|Washington University School of Medicine||2|||f||||f||||||||||2017-02-18 18:11:49.573537|2017-02-18 18:11:49.573537
NCT00008554|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-13|2005-06-23|||November 2000||2000-11-01|July 2001|2001-07-01||||||||Interventional|||Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy|A Phase III, Randomised, Multicenter, Parallel, Open-Label Study to Compare the Efficacy, Safety, and Tolerability of GW433908 (1400 Mg Bid) and Nelfinavir (1250 Mg Bid) Over 48 Weeks in Antiretroviral Therapy Naive HIV-1 Infected Adults|Unknown status|Active, not recruiting|Phase 3|210||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:11:49.68321|2017-02-18 18:11:49.68321
NCT00008541|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-13|2017-01-24|||January 2, 2001||2001-01-02|March 6, 2009|2009-03-06|March 6, 2009||2009-03-06|||||Observational|||Evaluation and Treatment of Patients With Corneal and External Diseases|Evaluation and Treatment of Corneal and External Diseases and Anterior Segment Disorders|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:49.796427|2017-02-18 18:11:49.796427
NCT00008528|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-12|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs|A Phase III Open-Label, Randomized, Active-Controlled Study Assessing the Efficacy and Safety of T-20 (HIV-1 Fusion Inhibitor) in Combination With an Optimized Background Regimen, Versus Optimized Background Therapy Alone, in Patients With Prior Experience and/or Prior Documented Resistance to Each of the Three Classes of Approved Antiretrovirals (Nucleoside Reverse Transcriptase, Non-Nucleoside Reverse Transcriptase and Protease Inhibitors)|Completed||Phase 3|525||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:11:49.878654|2017-02-18 18:11:49.878654
NCT00008515|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-12|2008-03-03|||January 2001||2001-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Fluocinolone Implant to Treat Macular Degeneration|A Randomized, Prospective Study of Sustained-Release Fluocinolone Acetonide Implant for Choroidal Neovascularization Associated With Age-Related Macular Degeneration|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:50.002457|2017-02-18 18:11:50.002457
NCT00008502|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-12|2017-01-26|||January 9, 2001||2001-01-09|January 6, 2017|2017-01-06||||||||Observational|||Genetic Analysis of Familial Keloids|Genetic Analysis of Familial Keloids|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:50.086788|2017-02-18 18:11:50.086788
NCT00008489|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-30|2005-12-08||||||January 2002|2002-01-01||||||||Interventional|||Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults|A Randomized Open-Label Trial Comparing the Tolerability of Videx EC Capsules to Videx Tablets in Adults With HIV Infection|Unknown status|Active, not recruiting|Phase 3|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:11:50.186959|2017-02-18 18:11:50.186959
NCT00008476|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-09|2008-03-03|||January 2001||2001-01-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Interventional|||Capsaicin to Control Pain Following Third Molar Extraction|Evaluation of Vanilloid Receptor Inactivation for Preemptive Analgesia|Completed||Phase 2|162||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:11:50.279942|2017-02-18 18:11:50.279942
NCT00008463|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-09|2013-06-07|||November 2000||2000-11-01|June 2013|2013-06-01|August 2006||2006-08-01|||||Interventional|||A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)|A Prospective, Multicenter, Phase II/III, Open-Label, Controlled, Randomized Trial Evaluating the Efficacy, Safety, and Tolerability of Interferon-alfa-2a Plus Ribavirin Versus PEG-interferon-alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus (HCV) Infection in Individuals Co-Infected With Human Immunodeficiency Virus-1 (HIV-1)|Completed||Phase 2|132||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:11:50.369302|2017-02-18 18:11:50.369302
NCT00008450|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2016-07-06|||August 1997||1997-08-01|July 2016|2016-07-01||||October 2011|Actual|2011-10-01||Interventional|||Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant|Induction of Mixed Hematopoietic Chimerism in Patients With Severe Combined Immunodeficiency Disorders Using Allogeneic Bone Marrow and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Active, not recruiting||Phase 1|6|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:11:50.49161|2017-02-18 18:11:50.49161
NCT00008437|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2012-06-29|||December 2000||2000-12-01|June 2012|2012-06-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer|Pilot Study of MR-Guided Focused Ultrasound for Tissue Coagulation in Women With Breast Cancer: MR Imaging and Histopathic Correlation, An Assessment or Target Accuracy and Patient Acceptance|Completed||Phase 2|||InSightec|||||f||||f||||||||||2017-02-18 18:11:50.606532|2017-02-18 18:11:50.606532
NCT00008424|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2014-05-02|||October 2000||2000-10-01|May 2014|2014-05-01|September 2006|Actual|2006-09-01|September 2005|Actual|2005-09-01||Interventional|||Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants|A Phase I Study of Irinotecan in Patients With Refractory Solid Tumors Who Are Concomitantly Receiving Anticonvulsants|Completed||Phase 1|7|Actual|Children's Oncology Group|||||f||||t||||||||||2017-02-18 18:11:50.95625|2017-02-18 18:11:50.95625
NCT00008411|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2012-07-27|||December 1999||1999-12-01|July 2012|2012-07-01|January 2007|Actual|2007-01-01|March 2006|Actual|2006-03-01||Interventional|||Docetaxel in Treating Patients With Metastatic Breast Cancer|Phase III Study Comparing the Use of Docetaxel on a Every Three-Week vs. Weekly Schedule in the Treatment of Patients With Metastatic Breast Cancer|Completed||Phase 3|90|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:11:51.11147|2017-02-18 18:11:51.11147
NCT00008398|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-11-18|||October 2000||2000-10-01|November 2013|2013-11-01||||March 2004|Actual|2004-03-01||Interventional|||Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer|A Phase III Study to Test the Efficacy and Safety of GM-CSF to Reduce the Severity and Duration of Mucosal Injury and Pain (Mucositis) Associated With Curative Radiation Therapy in Head and Neck Cancer Patients|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:11:51.241455|2017-02-18 18:11:51.241455
NCT00008385|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2016-03-31|2016-02-02||October 2000||2000-10-01|March 2016|2016-03-01|November 2019|Anticipated|2019-11-01|June 2011|Actual|2011-06-01||Interventional||All randomized patients|Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer|Phase III Chemoprevention Trial Of Selenium Supplementation In Persons With Resected Stage I Non-Small Cell Lung Cancer|Terminated||Phase 3|1772|Actual|Eastern Cooperative Oncology Group||2||The trial was stopped based on futility analysis results in November 2009.|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-02-18 18:11:51.614045|2017-02-18 18:11:51.614045
NCT00008372|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2011-10-18|||December 2000||2000-12-01|October 2011|2011-10-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer|Phase II Trial Of CQS (NSC 339004) In Platinum-Refractory Small Cell Lung Cancer|Completed||Phase 2|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:11:52.967726|2017-02-18 18:11:52.967726
NCT00008359|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-01-17|||August 2000||2000-08-01|January 2013|2013-01-01||||March 2003|Actual|2003-03-01||Interventional|||Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment|A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia|Completed||Phase 3|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:11:53.069399|2017-02-18 18:11:53.069399
NCT00008333|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2016-07-12|||April 2001||2001-04-01|July 2016|2016-07-01|July 2007|Actual|2007-07-01|March 2004|Actual|2004-03-01||Interventional|||Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Oral Vinorelbine For The Treatment Of Metastatic Non-Small Cell Lung Cancer In Patients More Than Or Equal To 65 Years Of Age: A Phase II Trial of Efficacy and Patients Perceived Preference for Oral Therapy|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:11:53.324877|2017-02-18 18:11:53.324877
NCT00008320|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2016-12-02|||January 2001||2001-01-01|December 2016|2016-12-01|October 2009|Actual|2009-10-01|April 2002|Actual|2002-04-01||Interventional|||Ceramide Cream in Treating Women With Cutaneous Breast Cancer|A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer|Completed||Phase 2|26|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:11:53.546583|2017-02-18 18:11:53.546583
NCT00008307|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2014-01-03|||April 1998||1998-04-01|April 2006|2006-04-01||||||||Interventional|||Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders|Non-Ablative Chemotherapeutic Conditioning Before Allogeneic Stem Cell Transplantation|Unknown status|Active, not recruiting|Phase 2|52|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:53.677111|2017-02-18 18:11:53.677111
NCT00008294|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-01-17|||August 2000||2000-08-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer|A Phase I Study Of Hepatic Arterial Infusion With Floxuridine And Dexamethasone In Combination With Intravenous Oxaliplatin Plus 5-Fluorouracil And Leucovorin In Patients With Unresectable Hepatic Metastases From Colorectal Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:11:53.803403|2017-02-18 18:11:53.803403
NCT00008281|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2014-01-03|||October 2000||2000-10-01|April 2002|2002-04-01||||||||Interventional|||Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer|A Multicenter, Open-Label, Randomized, Three-Arm Study Of 5-Fluorouracil (5-FU) Plus Leucovorin (LV) Or Oxaliplatin Or A Combination Of (5-Fu) LV + Oxaliplatin As Second-Line Treatment Of Metastatic Colorectal Carcinoma|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:53.912241|2017-02-18 18:11:53.912241
NCT00008268|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-06-17|||August 2000||2000-08-01|June 2013|2013-06-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma|A Phase II Study Of Blood Stem Cell Mobilization With Intravenous Melphalan (60 MG/M2) + G-CSF In Patients With Multiple Myeloma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:11:54.139715|2017-02-18 18:11:54.139715
NCT00008255|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-06-25|||August 2000||2000-08-01|May 2001|2001-05-01|May 2004|Actual|2004-05-01|||||Interventional|||INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer|Evaluation Of Uridine 5-Triphosphate Solution For Inhalation (UTP) As An Adjunct In The Diagnosis Of Lung Cancer By Sputum Cytology|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:54.234559|2017-02-18 18:11:54.234559
NCT00008242|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-03-06|||August 2000||2000-08-01|March 2013|2013-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Interventional|||Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma|A Phase II Clinical Trial Of Thalidomide, Adramycin And Dexamethasone (TAD) As Initial Therapy For The Treatment Of Multiple Myeloma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:11:54.321097|2017-02-18 18:11:54.321097
NCT00008229|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2010-09-17|||August 2000||2000-08-01|September 2010|2010-09-01|September 2001|Actual|2001-09-01|||||Interventional|||Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase III Multicenter, Randomized, Open-Label Trial Evaluating High Dose Melphalan Plus Holmium-166-DOTMP Versus High Dose Melphalan Alone When Given In Conjuction With Peripheral Blood Stem Cell Transplantation In Patients With Multiple Myeloma|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:11:54.418436|2017-02-18 18:11:54.418436
NCT00008216|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2014-06-05|||July 1996||1996-07-01|June 2014|2014-06-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01|36 Months|Observational [Patient Registry]|||Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer|The Use Of Peripheral Blood Stem Cells For Allogeneic Transplantation|Terminated||Phase 2|48|Actual|Columbia University|||1|Poor enrollment|f||||f||||||Samples Without DNA|"~     Standard bloodwork that would be required for transplantation patients~   "|||2017-02-18 18:11:54.513177|2017-02-18 18:11:54.513177
NCT00008203|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-02-01|||May 1996||1996-05-01|May 2003|2003-05-01|May 2008|Actual|2008-05-01|December 2005|Actual|2005-12-01||Interventional|||Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer|High-Dose Chemotherapy Followed By Autologous Hematopoietic Stem Cell Support And One Of Two Regimens Aimed At Modifying Immune Reconstitution In Women With High Risk Stage 2 And Stage 3 Breast Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:54.640783|2017-02-18 18:11:54.640783
NCT00008190|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-02-01|||March 1999||1999-03-01|April 2004|2004-04-01|May 2008|Actual|2008-05-01|November 2005|Actual|2005-11-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia|High Dose Chemotherapy And Autologous Peripheral Blood Stem Cell Rescue For High Risk Acute Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:54.73399|2017-02-18 18:11:54.73399
NCT00008177|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2016-11-14|||July 1999||1999-07-01|November 2016|2016-11-01||||March 2009|Actual|2009-03-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes|A Phase I Study Combining Escalating Doses of Radiolabeled BC8 (Anti-CD45) Antibody With Fludarabine, Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil to Establish Mixed or Full Donor Chimerism for Elderly Patients With Advanced Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome|Active, not recruiting||Phase 1|79|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:11:57.83119|2017-02-18 18:11:57.83119
NCT00007579|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2008-10-16|||February 1998||1998-02-01|February 2003|2003-02-01||||||||Observational|||To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population.|Prostate Cancer Case-Control Study: Black Versus White: VA Versus Private Sector|Completed||N/A|||VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:12:06.520407|2017-02-18 18:12:06.520407
NCT00008164|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-12-17|||January 1997||1997-01-01|January 2007|2007-01-01||||||||Interventional|||Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia|Transplantation Using Umbilical Cord And Placental Blood|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:57.95401|2017-02-18 18:11:57.95401
NCT00008151|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2010-03-31|||October 2000||2000-10-01|March 2010|2010-03-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome|Gemtuzumab Ozogamicin (GO), Fludarabine, And Low-Dose TBI Followed By Donor Stem Cell Transplantation For Patients With Advanced Acute Myeloid Leukemia Or Myelodysplastic Syndrome|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:11:58.066063|2017-02-18 18:11:58.066063
NCT00008138|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2015-12-08|2012-06-13||March 2001||2001-03-01|December 2015|2015-12-01|November 2009|Actual|2009-11-01|September 2009|Actual|2009-09-01||Interventional|S0009||S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer|Phase II Evaluation Of Neoadjuvant Chemotherapy, Interval Debulking Followed By Intraperitoneal Chemotherapy In Women With Stage III And IV Epithelial Ovarian Cancer, Fallopian Tube Cancer Or Primary Peritoneal Cancer|Completed||Phase 2|62|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:11:58.163688|2017-02-18 18:11:58.163688
NCT00008125|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2016-01-14|||March 1998||1998-03-01|January 2016|2016-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors|Phase I Study Of Gemcitabine, Docetaxel And Carboplatin, With And Without Filrastim Support, Combination Chemotherapy In Patients With Advanced Non-Hematological Malignancies|Completed||Phase 1|25|Actual|University of Pittsburgh|||||f||||||||||||||2017-02-18 18:11:58.556464|2017-02-18 18:11:58.556464
NCT00008112|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-08-06|||June 2000||2000-06-01|October 2002|2002-10-01||||||||Interventional|||Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer|Feasibility Study of the Combination of Radiotherapy, Chemotherapy and Hyperthermia for the Treatment of Stage IIB-III-IVA Cervical Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:58.647063|2017-02-18 18:11:58.647063
NCT00008099|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2016-01-19|||May 1998||1998-05-01|January 2016|2016-01-01|February 2004|Actual|2004-02-01|March 2001|Actual|2001-03-01||Interventional|||Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer|Phase I Dose Escalation Trial of a 100 aa Synthetic Mucin Peptide Admixed With SB-AS2 as Adjuvant in Locally Advanced and Resected Pancreatic Cancer|Completed||Phase 1|25|Actual|University of Pittsburgh||1|||f||||t||||||||||2017-02-18 18:11:59.008176|2017-02-18 18:11:59.008176
NCT00008086|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-12-18|||January 1996||1996-01-01|December 2013|2013-12-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Subcutaneous And/Or Oral Calcitriol [(1,25-COH)2D3] and Carboplatin in Advanced Solid Tumors|Completed||Phase 1|||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:11:59.109623|2017-02-18 18:11:59.109623
NCT00008073|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-12-18|||January 1996||1996-01-01|December 2013|2013-12-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Octreotide and Doxorubicin in Treating Patients With Advanced Cancer|Phase I Study Of Octreotide Acetate (Sandostatin) (SMS) As A Biomodulator Of Doxorubicin (DOX)|Completed||Phase 1|||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:11:59.206226|2017-02-18 18:11:59.206226
NCT00008060|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-12-18|||May 2000||2000-05-01|March 2002|2002-03-01|December 2003|Actual|2003-12-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer|Fluorouracil, Oxaliplatin and Irinotecan: Use and Sequencing: A Randomized Trial to Assess the Role of Irinotecan and Oxaliplatin in Advanced Colorectal Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:59.302476|2017-02-18 18:11:59.302476
NCT00008047|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2009-02-06|||August 1999||1999-08-01|February 2001|2001-02-01||||||||Interventional|||Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus|Multicentre Phase II Study Of Concomitant Radio-Chemotherapy Associating Continuous Infusion 5-FU With Hydroxyuree Via Bone Marrow With Or Without Paclitaxel In Treatment Of Inoperable Epidermoid Carcinoma Of Esophagus|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:59.400946|2017-02-18 18:11:59.400946
NCT00008034|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2012-07-17|||February 2000||2000-02-01|July 2012|2012-07-01||||December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer|A Phase I Study Of Cyclophoshamide And Epirubicin In Combination With Capecitabine (XELODA) (CEX) As Primary Treatment Of Locally Advanced/Inflammatory Or Large Operable Breast Cancer|Completed||Phase 1|15|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:11:59.507997|2017-02-18 18:11:59.507997
NCT00008021|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-08-06|||February 2001||2001-02-01|December 2002|2002-12-01||||||||Interventional|||Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma|A Phase I Study of 90Y-DOTA-Peptide-Lym-1 With Peripheral Blood Stem Cell Support, Paclitaxel And Cyclosporin A In Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:11:59.603907|2017-02-18 18:11:59.603907
NCT00008008|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-02-01|||September 1997||1997-09-01|July 2007|2007-07-01|May 2008|Actual|2008-05-01|June 2005|Actual|2005-06-01||Interventional|||Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma|CAMP 013:- Tandem Thiotepa Regimen For Selected Malignant Gliomas:1) Primary Or Recurrent Glioblastoma Multiforme (GBM); and 2) Recurrent Anaplastic Astrocytomas (AA), Oligodendrogliomas (O), Oligoastrocytomas (OA), Ependymomas And Primitive Neuroectodermal Tumors (PNET) That Have Either Progressed After Primary Therapy Or Are Refractory To Standard Chemotherapy|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:59.703551|2017-02-18 18:11:59.703551
NCT00007995|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-02-01|||July 1999||1999-07-01|July 2007|2007-07-01|May 2008|Actual|2008-05-01|November 2007|Actual|2007-11-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis|Phase 2 Study Of High Dose Chemotherapy Followed By Autologous Hematopoietic Stem Cell Support In Patients With Multiple Myeloma And Primary Light Chain Amyloidosis|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:59.808232|2017-02-18 18:11:59.808232
NCT00007982|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-02-01|||April 1999||1999-04-01|July 2007|2007-07-01|May 2008|Actual|2008-05-01|February 2005|Actual|2005-02-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer|CAMP 004A - Phase 2 Study Of Intensive Chemotherapy (BET) For Selected Categories Of Malignant Central Nervous System Tumor|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:11:59.912694|2017-02-18 18:11:59.912694
NCT00007969|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-11-05|||October 2000||2000-10-01|August 2008|2008-08-01||||||||Interventional|||Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase 1/2 Uncontrolled, Open Label Study Of Photodynamic Vaccination In Patients With Stage III/IV Malignant Melanoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:00.025257|2017-02-18 18:12:00.025257
NCT00007956|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2015-04-29|||November 2000||2000-11-01|February 2002|2002-02-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma|A Phase I Study Of Therapy With Mono-dgA-RFB4 In Patients With Relapsed And Refractory CD22+ B-Cell Lymphoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:00.126769|2017-02-18 18:12:00.126769
NCT00007943|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2009-08-20|||September 2000||2000-09-01|August 2009|2009-08-01||||||||Interventional|||Gemcitabine in Treating Patients With Advanced Colorectal Cancer|A Phase II Study Of Twenty-Four Hour Infusion Gemcitabine For Advanced Colorectal Cancer|Completed||Phase 2|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:12:00.230497|2017-02-18 18:12:00.230497
NCT00007930|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-08-23|||August 1999||1999-08-01|December 2006|2006-12-01||||||||Interventional|||Comparison of Two Types of Surgery in Treating Patients With Rectal Cancer|Randomized Trial of Wide Mesorectal Excision Versus Total Mesorectal Excision for Mid Rectal Cancer|Unknown status|Recruiting|Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:00.317671|2017-02-18 18:12:00.317671
NCT00007917|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-02-27|||January 2001||2001-01-01|February 2013|2013-02-01|October 2010|Actual|2010-10-01|September 2010|Actual|2010-09-01||Interventional|||Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors|A Phase I Trial Of Gemcitabine Followed By Flavopiridol In Patients With Solid Tumors|Completed||Phase 1|58|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:12:00.411312|2017-02-18 18:12:00.411312
NCT00007904|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2012-09-28|||July 2000||2000-07-01|September 2012|2012-09-01|September 2012|Actual|2012-09-01|June 2006|Actual|2006-06-01||Interventional|||Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes|A Phase II Study Of Safety And Tolerability Of Adjuvant Chemotherapy With Continuous Infusion Paclitaxel And Dose Intense Cyclophosphamide And Hematopoietic Growth Factor Support Followed By Doxorubicin For Stage II-IIIA Breast Cancer Involving Greater Than or Equal to 10 Lymph Nodes|Completed||Phase 2|16|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:12:00.527328|2017-02-18 18:12:00.527328
NCT00007891|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-05-14|||June 1997||1997-06-01|September 2004|2004-09-01|October 2004|Actual|2004-10-01|||||Interventional|||Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer|Phase I Study of 90-Y-Humanized-BrE-3 Followed by Autologous Hematopoietic Progenitor Cell Support in Patients With Metastatic Breast Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:00.855069|2017-02-18 18:12:00.855069
NCT00007878|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-12-10|||September 2000||2000-09-01|December 2013|2013-12-01||||January 2008|Actual|2008-01-01||Interventional|||Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery|A Phase I Study of PS-341 in Combination With 5-FU/LV in Solid Tumors|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:12:00.949981|2017-02-18 18:12:00.949981
NCT00007865|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2010-06-25|||September 2000||2000-09-01|June 2010|2010-06-01|April 2008|Actual|2008-04-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial of Ifosfamide, Carboplatin, and Etoposide (ICE) Chemotherapy in Combination With Rituximab as Salvage Therapy|Completed||Phase 2|||University of Nebraska|||||f||||f||||||||||2017-02-18 18:12:01.057713|2017-02-18 18:12:01.057713
NCT00007852|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2012-03-23|||September 2000||2000-09-01|March 2012|2012-03-01|January 2011|Actual|2011-01-01|January 2002|Actual|2002-01-01||Interventional|||Rituximab and Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Trial of Rituxan and BEAM High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Transplant for Lymphoma|Completed||Phase 2|44|Actual|University of Nebraska||1|||f||||f||||||||||2017-02-18 18:12:01.233027|2017-02-18 18:12:01.233027
NCT00007839|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-12-17|||August 2000||2000-08-01|April 2010|2010-04-01||||||||Interventional|||Beta Alethine in Treating Patients With Low-Grade Lymphoma|Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With B-Cell Lymphoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:01.570938|2017-02-18 18:12:01.570938
NCT00007826|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2013-09-19|||April 2000||2000-04-01|February 2005|2005-02-01||||||||Interventional|||Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer|A Phase I/II Trial of an Allogeneic Cell Based Vaccine and an Anti-Idiotypic Antibody Vaccine Approach for Metastatic Adenocarcinoma of the Colon or Rectum|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:01.674488|2017-02-18 18:12:01.674488
NCT00007813|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-06|2009-02-06|||May 1995||1995-05-01|December 2007|2007-12-01||||||||Interventional|||Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors|TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT/REFRACTORY SOLID TUMORS WITH HIGH DOSE ETOPOSIDE AND CARBOPLATIN PLUS ESCALATING DOSE CYCLOPHOSPHAMIDE, FOLLOWED BY HEMATOPOIETIC RESCUE USING AUTOLOGOUS CD34+ SELECTED BLOOD STEM CELLS: A PILOT STUDY|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:01.772071|2017-02-18 18:12:01.772071
NCT00007800|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-05|2010-01-12|||May 2000||2000-05-01|January 2010|2010-01-01|May 2002||2002-05-01|||||Interventional|||NEW DAY: Nutrition, Exercise, Weight Loss, Diabetes And You|Obesity Treatment and NIDDM in Black and White Women|Completed||Phase 2|218||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:12:01.881395|2017-02-18 18:12:01.881395
NCT00007540|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-01-20|||April 1998||1998-04-01|February 2003|2003-02-01|September 2000||2000-09-01|||||Observational|||Study of Prostate Cancer in Black and White U.S. Veterans|Study of Prostate Cancer in Black and White U.S. Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:12:06.618632|2017-02-18 18:12:06.618632
NCT00007787|ClinicalTrials.gov processed this data on February 17, 2017|2001-01-04|2013-01-18|||April 2000||2000-04-01|January 2013|2013-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants|Evaluation of Antibody Plus Delayed CSA vs CSA in Determining Delayed Graft Function in Cadaver Transplant Recipients|Completed||N/A|350|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:12:01.97274|2017-02-18 18:12:01.97274
NCT00007774|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-02-03|||March 1998||1998-03-01|February 2009|2009-02-01||||June 2001|Actual|2001-06-01||Interventional|||To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia|CSP #451 - The Clinical and Economic Impact of Olanzapine in the Treatment of Schizophrenia|Completed||Phase 4|600|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:12:02.092895|2017-02-18 18:12:02.092895
NCT00007761|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-09-22|||July 1997||1997-07-01|September 2009|2009-09-01||||December 2003|Actual|2003-12-01||Interventional|||Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.|CSP #430 - Reducing The Efficacy-Effectiveness Gap In Bipolar Disorder|Completed||Phase 3|382|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:12:02.222238|2017-02-18 18:12:02.222238
NCT00007748|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2015-06-25|||March 1999||1999-03-01|June 2015|2015-06-01|August 2001||2001-08-01|||||Interventional|||Exercise and Behavioral Therapy Trial (EBT).|CSP#470 - A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans With Gulf War Illnesses|Completed||Phase 3|1064||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:12:02.354083|2017-02-18 18:12:02.354083
NCT00007735|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-01-20|||January 1999||1999-01-01|February 2007|2007-02-01|October 2001||2001-10-01|||||Interventional|||Antibiotic Treatment of Gulf War Veterans' Illnesses|CSP #475 - Persian Gulf - Antibiotic Treatment Trial of Gulf War Veterans' Illnesses|Completed||Phase 3|450||VA Office of Research and Development|||||||||||||||||||2017-02-18 18:12:02.482133|2017-02-18 18:12:02.482133
NCT00007722|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-10-07|||July 2000||2000-07-01|October 2009|2009-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Observational|||Amyotrophic Lateral Sclerosis (ALS) Gulf War Study|CSP #500 - An Epidemiological Investigation Into the Occurrence of Amyotrophic Lateral Sclerosis (ALS) Among Gulf War Veterans|Completed||N/A|135|Actual|VA Office of Research and Development|||1||f||||f||||||Samples With DNA|"~     DNA samples of blood or mouthwash were collected in veterans' homes by nurses.~   "|||2017-02-18 18:12:02.601129|2017-02-18 18:12:02.601129
NCT00007709|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2011-02-02|||January 1998||1998-01-01|February 2011|2011-02-01||||||||Observational|||To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI).|CSP #706D - HIV Seroprevalence and Risks in Veterans With Severe Mental Illness|Completed||N/A|||VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:12:02.709886|2017-02-18 18:12:02.709886
NCT00007696|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2011-02-02|||April 1998||1998-04-01|February 2011|2011-02-01||||||||Observational|||Finding Diabetes Mellitus Among Veterans|CSP #705D - Screening for Diabetes Mellitus in Veterans|Completed||N/A|1276|Anticipated|VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:12:02.805558|2017-02-18 18:12:02.805558
NCT00007683|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2011-06-14|||October 1998||1998-10-01|June 2011|2011-06-01|December 2004|Actual|2004-12-01|July 2003|Actual|2003-07-01||Interventional|||Warfarin and Antiplatelet Therapy in Chronic Heart Failure|CSP #442 - Warfarin and Antiplatelet Therapy Study in Patients With Congestive Heart Failure (WATCH)|Completed||Phase 3|1587|Anticipated|VA Office of Research and Development||3|||f||||t||||||||||2017-02-18 18:12:04.00534|2017-02-18 18:12:04.00534
NCT00007670|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-01-20|||January 1998||1998-01-01|February 2007|2007-02-01|March 2003||2003-03-01|||||Interventional|||Does Gabapentin and Lamotriginel Have Significantly Fewer Side-Effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly.|CSP #428 - Treatment of Seizures in the Elderly Population|Completed||Phase 3|720||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:12:04.273292|2017-02-18 18:12:04.273292
NCT00007657|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-06-12|||December 1998||1998-12-01|June 2009|2009-06-01|June 2006|Actual|2006-06-01|||||Interventional|||Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation|CSP #424 - Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation|Completed||Phase 3|3260|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:12:04.652323|2017-02-18 18:12:04.652323
NCT00007644|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2014-04-24|2013-08-15||November 1994||1994-11-01|April 2014|2014-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|PIVOT||Prostate Cancer Intervention Versus Observation Trial (PIVOT)|CSP #407 - Prostate Cancer Intervention Versus Observation Trial (PIVOT): A Randomized Trial Comparing Radical Prostatectomy Versus Palliative Expectant Management for the Treatment of Clinically Localized Prostate Cancer|Completed||Phase 3|731|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 18:12:04.812209|2017-02-18 18:12:04.812209
NCT00007631|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-01-29|||March 1998||1998-03-01|January 2009|2009-01-01|July 2006|Actual|2006-07-01|November 2004|Actual|2004-11-01||Interventional|||Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer|CSP #402 - VA Topical Tretinoin Chemoprevention Trial|Completed||Phase 3|1131|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 18:12:06.065684|2017-02-18 18:12:06.065684
NCT00007618|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2011-02-02|||January 1998||1998-01-01|February 2011|2011-02-01||||||||Observational|||The Identification of Prognostic Factors of Late Stage Disease, Particularly Those That Are Modifiable, That Might Explain the Worsened Prognosis With Colorectal Cancer Among Veterans.|CSP #707D - Colorectal Cancer-Risk Factors for Advanced Disease|Completed||N/A|||VA Office of Research and Development|||1||f||||f||||||||||2017-02-18 18:12:06.183837|2017-02-18 18:12:06.183837
NCT00007605|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2011-06-13|||April 1998||1998-04-01|June 2011|2011-06-01|December 2003|Actual|2003-12-01|October 2002|Actual|2002-10-01||Interventional|||Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm|CSP #399 - The Effects of Antiarrhythmic Therapy in Maintaining Stability of Sinus Rhythm in Atrial Fibrillation|Completed||Phase 3|706|Anticipated|VA Office of Research and Development||2|||f||||f||||||||||2017-02-18 18:12:06.275221|2017-02-18 18:12:06.275221
NCT00007592|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-01-20|||June 1989||1989-06-01|February 2003|2003-02-01||||||||Observational|||Hypertension Screening and Treatment Program|VA HYPERTENSION SCREENING AND TREATMENT PROGRAM (PILOT STUDY)|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:12:06.421971|2017-02-18 18:12:06.421971
NCT00006513|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-20|2016-03-15|||September 2000||2000-09-01|January 2006|2006-01-01|August 2004|Actual|2004-08-01|||||Observational|||Assessing the Occupation Burden in COPD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:27.761926|2017-02-18 18:12:27.761926
NCT00007527|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-01-20|||August 1999||1999-08-01|February 2003|2003-02-01|January 2002||2002-01-01|||||Interventional|||Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice|A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence|Completed||Phase 4|600||VA Office of Research and Development|||||||||||||||||||2017-02-18 18:12:06.701499|2017-02-18 18:12:06.701499
NCT00007514|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2009-01-20|||March 2000||2000-03-01|February 2003|2003-02-01|February 2001||2001-02-01|||||Observational|||Investigate Olfactory Functioning as a Possible Proxy for Neurotoxic Exposure in Cohorts of Deployed and Non-Deployed Gulf War-Era Veterans.|Olfactory Functioning in Gulf War Veterans|Completed||N/A|||VA Office of Research and Development|||||f||||||||||||||2017-02-18 18:12:06.792556|2017-02-18 18:12:06.792556
NCT00007501|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-29|2013-07-02|||November 1998||1998-11-01|July 2013|2013-07-01|February 2011|Actual|2011-02-01|April 2004|Actual|2004-04-01||Interventional|SPS||Shingles Prevention Study|CSP #403 - Trial of Varicella Zoster Vaccine for the Prevention of Herpes Zoster and Its Complications|Completed||Phase 3|38456|Actual|VA Office of Research and Development||2|||f||||t||||||||||2017-02-18 18:12:06.868344|2017-02-18 18:12:06.868344
NCT00007488|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-23|2013-11-19|||November 2000||2000-11-01|November 2013|2013-11-01|August 2004|Actual|2004-08-01|||||Observational|||HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs|Virologic Studies in Compartmental Samples From HIV-Infected Subjects Changing or Initiating Potent Antiretroviral Therapy|Completed||N/A|164||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:07.013303|2017-02-18 18:12:07.013303
NCT00007475|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-22|2016-02-08|2015-06-19||December 2000||2000-12-01|February 2016|2016-02-01|June 2014|Actual|2014-06-01|June 2014|Actual|2014-06-01||Interventional|||Permeability Factor in Focal Segmental Glomerulosclerosis|Permeability Factor in Focal Segmental Glomerulosclerosis|Completed||Phase 1/Phase 2|15|Actual|National Institutes of Health Clinical Center (CC)|Note: definitive FSGS Permeability Factor (FPF) assays still in development. Data/samples transferred to the NIH-CC Glomerulosclerosis Consolidation protocol: focus on cardiotrophin like cytokine 1 & antibodies to a panel of podocyte proteins as FPF.|1|||f||||f||||||||||2017-02-18 18:12:07.123058|2017-02-18 18:12:07.123058
NCT00007449|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-19|2005-06-23||||||June 2002|2002-06-01||||||||Interventional|||Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors|A Phase II, Open Label, Multicenter Study to Assess the Safety and Efficacy of 100 Mg DPC 083 Once Daily in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Subjects Who Are Failing Treatment With a Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimen|Unknown status|Active, not recruiting|Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:12:07.942923|2017-02-18 18:12:07.942923
NCT00007436|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-19|2005-06-23||||||July 2001|2001-07-01||||||||Interventional|||The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients|A Phase 3, Open-Label, Multicenter Study of the Safety of Tenofovir Disoproxil Fumarate Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients|Unknown status|Active, not recruiting|Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:12:08.054315|2017-02-18 18:12:08.054315
NCT00007423|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-19|2012-05-16||||||May 2012|2012-05-01|September 2001|Actual|2001-09-01|||||Interventional|||Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda|A Phase I Study of the Safety and Immunogenicity of Live Recombinant ALVAC-HIV vCP205 in HIV-1 Uninfected Adult Volunteers in Uganda|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:08.164695|2017-02-18 18:12:08.164695
NCT00007410|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-19|2016-07-28|||September 2000||2000-09-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Genetic Architecture of Plasma T-PA and PAI-1||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:08.275213|2017-02-18 18:12:08.275213
NCT00007397|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-19|2016-05-12|||February 2000||2000-02-01|December 2005|2005-12-01|January 2004|Actual|2004-01-01|||||Observational|||Age, Risk Factors for CVD and Cognitive Functioning||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:08.351521|2017-02-18 18:12:08.351521
NCT00007384|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-19|2016-02-17|||July 2000||2000-07-01|January 2008|2008-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Longitudinal LDL-C Studies in Black and White Families||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:08.416503|2017-02-18 18:12:08.416503
NCT00007371|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-19|2016-09-22|||September 1999||1999-09-01|January 2005|2005-01-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Observational|||Hepatitis C in Clinically Discordant Hemophilic Siblings|Hepatitis C in Clinically Discordant Hemophilic Siblings|Completed||N/A|||University of North Carolina, Chapel Hill|||||f||||f||||||||No||2017-02-18 18:12:08.497425|2017-02-18 18:12:08.497425
NCT00007358|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-19|2016-03-10|||October 2000||2000-10-01|March 2016|2016-03-01|October 2008|Actual|2008-10-01|April 2007|Actual|2007-04-01||Interventional|||Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus|Study of Dexamethasone in Neonatal Lupus Congenital Heart Block; PRIDE (PR Interval and Dexamethasone Evaluation) in Congenital Heart Block|Completed||N/A|150|Anticipated|New York University School of Medicine||1|||f||||||||||||||2017-02-18 18:12:08.577687|2017-02-18 18:12:08.577687
NCT00007345|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2016-03-25|2016-01-14||December 2000||2000-12-01|March 2016|2016-03-01|December 2016|Anticipated|2016-12-01|January 2015|Actual|2015-01-01||Interventional||Although 7 cohorts were written in the protocol, the cohorts were consolidated for submission to the Food and Drug Administration (FDA) into the peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) groups, thus they are presented in this format.|Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma|Phase II Trial of Depsipeptide in Patients With Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma|Active, not recruiting||Phase 2|131|Actual|National Institutes of Health Clinical Center (CC)|7 cohorts were consolidated for submission to the Food and Drug Administration (FDA) into the peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) groups, thus they are presented in this format.|2|||f||||f||||||||||2017-02-18 18:12:08.966351|2017-02-18 18:12:08.966351
NCT00007332|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2012-05-16||||||May 2012|2012-05-01|April 2003|Actual|2003-04-01|||||Interventional|||Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B|A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of a Combined Regimen Using ALVAC vCP1452 and AIDSVAX B/B|Completed||Phase 2|330||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:10.033931|2017-02-18 18:12:10.033931
NCT00007319|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2008-09-16||||||May 2006|2006-05-01||||||||Observational|||Carotid Artery Thickness in HIV Infected and Uninfected Adults|Carotid Artery Intima-Media Thickness in HIV-Infected and Uninfected Adults: A Pilot Study|Completed||N/A|132||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:10.159828|2017-02-18 18:12:10.159828
NCT00007306|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2007-01-02|||January 2000||2000-01-01|March 2003|2003-03-01|April 2005||2005-04-01|||||Interventional|||Treatment of Psoriasis With Parathyroid Hormone|Evaluation of the Therapeutic Efficacy & Safety of Topical Administration of Parathyroid Hormone (PTH) in Psoriasis|Completed||Phase 1/Phase 2|40||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-02-18 18:12:10.257275|2017-02-18 18:12:10.257275
NCT00007293|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2007-01-02|||August 2000||2000-08-01|February 2003|2003-02-01|July 2002||2002-07-01|||||Interventional|||Scalp Psoriasis Treatment With a Fiber Optic Comb|Phototherapy of Psoriasis of the Scalp With a UV-B Emitting Fiber Optic Comb|Completed||Phase 1/Phase 2|30||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:12:10.358635|2017-02-18 18:12:10.358635
NCT00007280|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2013-08-01|||October 2000||2000-10-01|April 2008|2008-04-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Bioengineered Skin and Wound Healing|Mechanisms of Bioengineered Skin in Human Wounds|Completed||Phase 1|50|Actual|Roger Williams Medical Center||1|||f||||||||||||||2017-02-18 18:12:10.444221|2017-02-18 18:12:10.444221
NCT00007267|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2008-02-29|||June 2001||2001-06-01|February 2008|2008-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Psychological Treatments for Scleroderma|Psychosocial Interventions for Scleroderma|Completed||Phase 2|89|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||3|||f||||f||||||||||2017-02-18 18:12:10.541376|2017-02-18 18:12:10.541376
NCT00007254|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2013-05-17|||March 2000||2000-03-01|May 2013|2013-05-01|February 2003||2003-02-01|||||Interventional|||Morphine Gel for Bedsores|Morphine-Infused Gel for Pressure Ulcer Analgesia|Completed||Phase 1/Phase 2|75||University of Kansas Medical Center|||||f||||||||||||||2017-02-18 18:12:10.654642|2017-02-18 18:12:10.654642
NCT00007241|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-16|2007-01-02|||September 2001||2001-09-01|February 2003|2003-02-01|July 2002||2002-07-01|||||Interventional|||Muscle Strengthening Device for Knee Osteoarthritis|Osteoarthritic Knee Isometric Exerciser for Home Use|Completed||Phase 2|92||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:12:10.743322|2017-02-18 18:12:10.743322
NCT00007228|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-15|2008-03-03|||December 2000||2000-12-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Heart and Skeletal Muscle Problems in Neuroacanthocytosis|Characterization of Cardiac and Skeletal Myopathy, Risk Evaluation, and Phenotype-Genotype Correlation in Patients With Neuroacanthocytosis|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:10.842001|2017-02-18 18:12:10.842001
NCT00007215|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-15|2008-03-03|||December 2000||2000-12-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Dynamic Light Scattering Device (DLS) Study of Age-Related Changes in the Lens and Cataracts|A Study of Age-Related Changes in the Human Lens and Cataracts In Vivo Using Dynamic Light Scattering Device (DLS) Combined With Keratoscopy|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:10.922562|2017-02-18 18:12:10.922562
NCT00007202|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-15|2013-09-20||||||September 2013|2013-09-01|October 2006|Actual|2006-10-01|||||Interventional|||Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients|A Pilot Open-Label Phase II Clinical Trial to Evaluate the Safety and Efficacy of a Compact Three Drug Antiretroviral Treatment Regimen for Subjects With Acute HIV-1 Infection or Recent HIV-1 Seroconversion|Completed||Phase 2|55|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:12:11.022616|2017-02-18 18:12:11.022616
NCT00007189|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-14|2016-10-18|||January 2001||2001-01-01|October 2016|2016-10-01||||May 2007|Actual|2007-05-01||Interventional|||Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)|Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)|Completed||Phase 3|2625||Seattle Institute for Biomedical and Clinical Research|||||f||||||||||||||2017-02-18 18:12:11.134106|2017-02-18 18:12:11.134106
NCT00007163|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-09|2008-03-03|||December 2000||2000-12-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Interventional|||Monoclonal Antibody Treatment of Crohn's Disease|A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Safety Study of Two Parallel Dose Levels of Subcutaneously Administered Human Monoclonal Antibody to Interleukin-12 (J695) in Patients With Active Crohn's Disease|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:11.249448|2017-02-18 18:12:11.249448
NCT00007150|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-09|2017-02-10|||December 6, 2000||2000-12-06|September 29, 2016|2016-09-29||||||||Observational|||Treatment of Hemochromatosis|Studies of Phlebotomy Therapy in Hereditary Hemochromatosis|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:11.342541|2017-02-18 18:12:11.342541
NCT00007137|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-09|2017-01-24|||December 5, 2000||2000-12-05|April 11, 2007|2007-04-11|April 11, 2007||2007-04-11|||||Observational|||Structure and Function of the Human Tongue|Task-Induced Physiological and Biomechanical Changes of the In Vivo Human Tongue|Completed||N/A|165||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:11.460106|2017-02-18 18:12:11.460106
NCT00007124|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-07|2008-03-03|||December 2000||2000-12-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Observational|||Ketogenic Diet in Lafora Disease|A Trial of Ketogenic Diet in Lafora Disease|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:11.545523|2017-02-18 18:12:11.545523
NCT00007111|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-07|2015-12-21|||April 1992||1992-04-01|January 2005|2005-01-01|April 2002||2002-04-01|||||Observational|||Children's Activity and Nutrition III||Completed||N/A|||Augusta University|||||f||||||||||||||2017-02-18 18:12:11.628994|2017-02-18 18:12:11.628994
NCT00007098|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-07|2016-12-06|||May 1995||1995-05-01|December 2016|2016-12-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Influence of Insulin on BP Change During Adolescence||Completed||N/A|2|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||||Undecided||2017-02-18 18:12:11.711019|2017-02-18 18:12:11.711019
NCT00007085|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-07|2016-07-28|||September 2000||2000-09-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:11.786712|2017-02-18 18:12:11.786712
NCT00007072|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2005-06-23|||November 2000||2000-11-01|October 2003|2003-10-01||||||||Interventional|||Phase II Study of Azacitidine and Phenylbutyrate in Patients With Thalassemia Major||Terminated||Phase 2|24||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:12:11.860978|2017-02-18 18:12:11.860978
NCT00007059|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2005-06-23|||June 1998||1998-06-01|December 2003|2003-12-01||||||||Interventional|||Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation|Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation|Completed||N/A|20||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:11.944726|2017-02-18 18:12:11.944726
NCT00007046|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2005-06-23|||August 2000||2000-08-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:12.029786|2017-02-18 18:12:12.029786
NCT00007033|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2009-01-21|||October 2000||2000-10-01|April 2002|2002-04-01||||||||Interventional|||Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease||Completed||N/A|25||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:12.105889|2017-02-18 18:12:12.105889
NCT00007020|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2015-04-15||2013-05-21|January 1992||1992-01-01|April 2015|2015-04-01|December 2009|Actual|2009-12-01|December 2009|Actual|2009-12-01||Interventional|||Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid|"Investigation in the Pathogenesis of Liver Disease in Patients With Inborn Errors of Bile Acid Metabolism. This Study Was Previously Registered by the NCRR and Identified as NCRR-M01RR08084-0009"|Completed||Phase 3|79|Actual|Retrophin, Inc.||1|||f||||f||||||||||2017-02-18 18:12:12.195085|2017-02-18 18:12:12.195085
NCT00007007|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2015-03-26|||November 2000||2000-11-01|March 2015|2015-03-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases|A Feasibility Study of Neurocognitive Evaluation in Patients Treated for Brain Metastases|Completed||N/A|59|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:12:12.377085|2017-02-18 18:12:12.377085
NCT00006994|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2015-11-17|||November 2001||2001-11-01|November 2015|2015-11-01|April 2006|Actual|2006-04-01|April 2005|Actual|2005-04-01||Interventional|||S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat|S9908, A Double-Blind, Placebo-Controlled Trial To Study The Efficacy And Safety Of L-Glutamine (In AES0014 Delivery Vehicle) Upon Radiation Therapy-Induced Oral Mucositis In Head and Neck Cancer Patients, Phase III|Terminated||Phase 3|23|Actual|Southwest Oncology Group||2||Withdrawn due to drug availability and funding|f||||t||||||||||2017-02-18 18:12:12.932416|2017-02-18 18:12:12.932416
NCT00006981|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2015-04-29|||December 2000||2000-12-01|May 2005|2005-05-01||||||||Interventional|||Immunotoxin Therapy in Treating Patients With Advanced Cancer|Phase I Study Of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion X 10 Days|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:13.335494|2017-02-18 18:12:13.335494
NCT00006968|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-01-07|||September 2000||2000-09-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer|Non-Myeloablative Chemotherapy Followed By Related Allogeneic Stem Cell Rescue In Patients With Advanced Renal Cell Carcinoma|Completed||Phase 1/Phase 2|4|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:12:13.43644|2017-02-18 18:12:13.43644
NCT00006942|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-08-23|||October 2000||2000-10-01|August 2013|2013-08-01||||March 2004|Actual|2004-03-01||Interventional|||Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Trial of Bryostatin in Combination With Cisplatin in Patients With Recurrent or Persistent Epithelial Ovarian Cancer|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:12:13.526812|2017-02-18 18:12:13.526812
NCT00006929|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-06-03|||September 2000||2000-09-01|June 2013|2013-06-01||||November 2007|Actual|2007-11-01||Interventional|||Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase I/II Study of Carboplatin / Paclitaxel / Suramin Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|82|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:12:13.642543|2017-02-18 18:12:13.642543
NCT00006916|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2015-11-14|2013-06-12||June 2001||2001-06-01|November 2015|2015-11-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme|A Phase II Trial Of Conventional Radiation Therapy Followed By Intratumoral Bleomycin Delivered Using A Refillable, Sustained Release Device (IND# 46,592) For The Treatment Of Supratentorial Glioblastoma|Terminated||Phase 2|19|Actual|Radiation Therapy Oncology Group|This study stopped accrual early due unmet targeted accrual goals with 19 subjects accrued out of 72 planned. No efficacy analyses were performed since the small number of patients would not have provided meaningful results.|1||Low accrual|f||||t||||||||||2017-02-18 18:12:13.792703|2017-02-18 18:12:13.792703
NCT00006903|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2015-05-29|2014-05-20||August 2004||2004-08-01|May 2015|2015-05-01||||November 2010|Actual|2010-11-01||Interventional||Total number of eligible and treated participants by estrogen receptor status in metastatic tumor|Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer|Phase II Study of Faslodex In Recurrent/Metastatic Endometrial Cancer|Active, not recruiting||Phase 2|67|Actual|Gynecologic Oncology Group|Accrual was discontinued after completion of the first stage of accrual due to lack of study drug activity.|1|||f||||t||||||||||2017-02-18 18:12:14.275741|2017-02-18 18:12:14.275741
NCT00006890|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2011-09-27|||July 2000||2000-07-01|September 2011|2011-09-01|December 2008|Actual|2008-12-01|May 2002|Actual|2002-05-01||Interventional|||Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Randomized Phase II Dose Finding Study Of Thalidomide And Prednisone As Maintenance Therapy Following Autologous Stem Cell Transplant In Patients With Multiple Myeloma|Completed||Phase 2|67|Actual|Canadian Cancer Trials Group||1|||f||||t||||||||||2017-02-18 18:12:14.709639|2017-02-18 18:12:14.709639
NCT00006877|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2014-01-06|||July 2000||2000-07-01|February 2001|2001-02-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer|A Phase II Study Of Temozolomide In The Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer|Completed||Phase 2|30|Actual|Case Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:12:14.896726|2017-02-18 18:12:14.896726
NCT00006512|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-20|2016-01-19|||September 2000||2000-09-01|January 2016|2016-01-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Characterizing a 5P-Linked BHR Susceptibility Locus||Completed||N/A|||University of Chicago|||||f||||||||||||||2017-02-18 18:12:27.830428|2017-02-18 18:12:27.830428
NCT00006864|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2014-01-08|||July 2000||2000-07-01|January 2014|2014-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|Interleukin-2 In An Alternative Dose (The Iliad Trial): Treatment Of Patients With Metastatic Renal Cell Carcinoma With Low Dose Proleukin|Completed||Phase 4|||Case Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:12:14.992699|2017-02-18 18:12:14.992699
NCT00006825|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2011-03-25|||July 2000||2000-07-01|March 2011|2011-03-01||||July 2004|Actual|2004-07-01||Interventional|||Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer|A Safety Study Of Doxil And Herceptin In Patients With Advanced Her-2 Overexpressing Breast Cancer|Completed||Phase 1/Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:12:15.083807|2017-02-18 18:12:15.083807
NCT00006812|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-04-10|||March 2001||2001-03-01|November 2005|2005-11-01||||July 2005|Actual|2005-07-01||Interventional|||Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer|Phase II Evaluation Of Capecitabine In Recurrent Platinum-Sensitive Ovarian Or Primary Peritoneal Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:12:15.172142|2017-02-18 18:12:15.172142
NCT00006799|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2009-08-20|||October 2000||2000-10-01|August 2009|2009-08-01||||||||Interventional|||Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer|A Phase III, Double-Blind, Randomized Study Of The Effect Of Megestrol Acetate On Weight And Health Related Quality Of Life In Head And Neck Cancer Patients Receiving Radiation Therapy|Completed||Phase 3|||Wake Forest University Health Sciences|||||f||||||||||||||2017-02-18 18:12:15.290504|2017-02-18 18:12:15.290504
NCT00006786|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-06-20|||November 2000||2000-11-01|September 2006|2006-09-01|September 2006|Actual|2006-09-01|||||Interventional|||Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer|Phase II Trial of Fluorouracil (5-FU), Leucovorin (LV), Irinotecan (CPT-11) and Bevacizumab (Anti-VEGF) in Previously Untreated Patients With Advanced Colorectal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:15.390026|2017-02-18 18:12:15.390026
NCT00006773|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-01-23|||May 2001||2001-05-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Bortezomib in Treating Patients With Recurrent Glioma|Phase I Evaluation of the Safety of PS 341 in the Treatment of Recurrent Gliomas|Terminated||Phase 1|42|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:12:15.6797|2017-02-18 18:12:15.6797
NCT00006760|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-07-25|||May 2001||2001-05-01|July 2013|2013-07-01|March 2012|Actual|2012-03-01|July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma|A Pilot Study of Re-Induction Chemotherapy With Ifosfamide, and Vinorelbine (IV) in Children With Refractory/Relapsed Hodgkin's Disease|Completed||Phase 2|66|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:12:15.789164|2017-02-18 18:12:15.789164
NCT00006747|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2016-07-15|||November 2000||2000-11-01|July 2016|2016-07-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma|Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma|Completed||Phase 2|4|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:12:16.21347|2017-02-18 18:12:16.21347
NCT00006734|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-05-16|||May 2001||2001-05-01|May 2013|2013-05-01||||August 2006|Actual|2006-08-01||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor|Trial of Chemotherapy Intensification Through Compression in Ewing's Sarcoma and Related Tumors|Completed||Phase 3|587|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:12:16.392228|2017-02-18 18:12:16.392228
NCT00006721|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2016-04-21|2012-11-02||March 2001||2001-03-01|April 2016|2016-04-01||||September 2011|Actual|2011-09-01||Interventional|||S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma|A Phase III Trial of CHOP Plus Rituximab vs CHOP Plus Iodine-131-Labeled Monoclonal Anti-B1 Antibody (Tositumomab) for Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas|Active, not recruiting||Phase 3|571|Actual|Southwest Oncology Group||3|||f||||t||||||||||2017-02-18 18:12:16.800431|2017-02-18 18:12:16.800431
NCT00006708|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-04-08|||October 2000||2000-10-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2002|Actual|2002-11-01||Interventional|||S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Randomized Phase III Trial of ICE Chemotherapy With or Without Rituximab for the Treatment of Relapsed or Refractory CD20 Expressing Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients Not Suitable for High Dose Therapy and PBSCT|Terminated||Phase 3|7|Actual|Southwest Oncology Group||2||lack of accrual|f||||t||||||||||2017-02-18 18:12:18.649302|2017-02-18 18:12:18.649302
NCT00006695|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2015-05-26|||April 2000||2000-04-01|May 2015|2015-05-01|December 2014|Actual|2014-12-01|September 2005|Actual|2005-09-01||Interventional|||Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|BEAM Plus Iodine-131 Anti-B1 Antibody and Autologous Hematopoietic Stem Cell Transplantation for Treatment of Recurrent Diffuse Large B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|50|Actual|University of Nebraska||1|||f||||||||||||||2017-02-18 18:12:18.951557|2017-02-18 18:12:18.951557
NCT00006682|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2008-07-23|||February 2000||2000-02-01|May 2001|2001-05-01||||||||Interventional|||Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer|An Open-Label Phase II Study of Navelbine (Vinorelbine Tartrate) and Taxotere (Docetaxel) as First-Line Therapy for Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:19.074911|2017-02-18 18:12:19.074911
NCT00006669|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2009-02-06|||September 1999||1999-09-01|May 2001|2001-05-01||||||||Interventional|||Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma|Phase II Trial of EPOCH and Rituxan Combined Therapy in Patients With Refractory or Relapsed CD20 Positive Intermediate Grade B-Cell Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:19.163575|2017-02-18 18:12:19.163575
NCT00006656|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2013-11-05|||June 2000||2000-06-01|August 2003|2003-08-01||||||||Interventional|||Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme|A Phase I/II Study of the Safety and Tolerability of DTI-015 in Patients With Recurrent Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:19.256399|2017-02-18 18:12:19.256399
NCT00006643|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2008-07-29||||||June 2003|2003-06-01||||||||Observational|||Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus|Use of Single Photon Emission Computed Tomography (SPECT) as a Noninvasive Alternative to Liver Biopsies in Assessing Liver Involvement in Subjects Coinfected With HIV and Hepatitis C Virus (HCV)|Completed||N/A|44||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:19.36272|2017-02-18 18:12:19.36272
NCT00006630|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2012-05-11||||||May 2012|2012-05-01||||||||Interventional|||Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection|Open-Label, Multi-Site Study for the Administration of Vaccinia Immune Globulin (Human) To Subjects Who Experience Complications From Vaccinia Virus Vaccinations or To Unprotected Individuals Accidentally Exposed To Vaccinia Virus or Related Orthopox Viruses [During HIV Vaccine Research]|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:12:19.449413|2017-02-18 18:12:19.449413
NCT00006617|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2015-05-14||||||December 2004|2004-12-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients|An Open-Label, Single Center Trial to Evaluate the Efficacy and Safety of Quadruple Chemotherapy (Zidovudine, EPIVIR, 1592U89, and 141W94) in Subjects Infected With HIV-1 (GW QUAD)|Completed||N/A|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:19.544844|2017-02-18 18:12:19.544844
NCT00006604|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-06|2016-03-07|2016-01-29||November 2000||2000-11-01|March 2016|2016-03-01|September 2014|Actual|2014-09-01|October 2011|Actual|2011-10-01||Interventional||"Participants accrued and treated at the dose ultimately selected for their groups.~NOTE: (1) Final Dose not established for Grps 1, 2; (2) Grp 5a started with n=12, but (1) participant inadvertently enrolled,never received ATV, final n=11; (3) Grp 8 started with n=15, but (1) participant inadvertently enrolled, never received ATV, final n=14."|Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents|Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS 232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and -Experienced HIV-Infected Infants, Children, and Adolescents|Completed||Phase 1/Phase 2|195|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||9|||f||||f||||||||||2017-02-18 18:12:19.671956|2017-02-18 18:12:19.671956
NCT00006591|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-01|2005-06-23||||||December 2004|2004-12-01||||||||Interventional|||Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment|The Safety and Efficacy of a Ritonavir-Enhanced Agenerase Regimen as Salvage Therapy in HIV-Infected Individuals|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:12:26.366102|2017-02-18 18:12:26.366102
NCT00006578|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-01|2015-03-05||||||June 2003|2003-06-01||||||||Interventional|||Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication|Evaluation of the Relationship Between Immunologic Recovery After Highly Active Antiretroviral Therapy and the Ability to Mobilize CD34+ Stem Cells Following G-CSF Administration|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:26.484951|2017-02-18 18:12:26.484951
NCT00006565|ClinicalTrials.gov processed this data on February 17, 2017|2000-12-01|2016-02-17|||September 2000||2000-09-01|October 2008|2008-10-01|April 2004|Actual|2004-04-01|March 2003|Actual|2003-03-01||Interventional|||Randomized Trial to Reduce Environmental Tobacco Smoke in Children With Asthma|Randomized Trial to Reduce Environmental Tobacco Smoke in Children With Asthma|Completed||Phase 3|225|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||f||||||||||2017-02-18 18:12:26.577808|2017-02-18 18:12:26.577808
NCT00006552|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-28|2016-03-15|||September 1999||1999-09-01|May 2005|2005-05-01|August 2002|Actual|2002-08-01|||||Observational|||Adherence to Antihypertensive Therapy--Data Analyses||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:26.685712|2017-02-18 18:12:26.685712
NCT00006539|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-28|2016-03-15|||September 1999||1999-09-01|March 2005|2005-03-01|August 2004|Actual|2004-08-01|||||Observational|||Thrombotic, Inflammatory & Gene Markers of CVD in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:26.766174|2017-02-18 18:12:26.766174
NCT00006526|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-28|2016-03-15|||July 1999||1999-07-01|August 2004|2004-08-01|May 2003|Actual|2003-05-01|||||Observational|||Coronary Calcification Progression Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:26.842737|2017-02-18 18:12:26.842737
NCT00006519|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-23|2006-07-10|||November 2000||2000-11-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Interventional|||Capravirine to Treat Children With HIV Infection|A Phase I Study of Capravirine (AG 1549), a Novel Non-Nucleoside Reverse Transcriptase Inhibitor in Children With HIV Infection|Completed||Phase 1|96||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:26.909694|2017-02-18 18:12:26.909694
NCT00006518|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-22|2017-02-01|||November 17, 2000||2000-11-17|January 27, 2017|2017-01-27||||||||Observational|||Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer|Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:27.00231|2017-02-18 18:12:27.00231
NCT00006517|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-22|2015-06-02|||September 1998||1998-09-01|November 2005|2005-11-01|April 2004|Actual|2004-04-01|June 2003|Actual|2003-06-01||Interventional|||Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)|Light and Ion Therapy for Seasonal Affective Disorder|Completed||N/A|150|Actual|New York State Psychiatric Institute||5|||f||||f||||||||||2017-02-18 18:12:27.112975|2017-02-18 18:12:27.112975
NCT00006516|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-21|2016-09-23|||September 1999||1999-09-01|May 2011|2011-05-01||||August 2004|Actual|2004-08-01||Interventional|||Home Stimulation for Brain-Asphyxiated Infants|Neuroplasticity of Brain-Asphyxiated Infants: Efficacy of Intervention|Completed||Phase 2|120|Anticipated|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:27.319896|2017-02-18 18:12:27.319896
NCT00006515|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-21|2017-01-24|||November 16, 2000||2000-11-16|November 18, 2011|2011-11-18|November 18, 2011||2011-11-18|||||Observational|||Late Effects of Treatment for Sarcomas in Children|Late Effects of Treatment in Survivors of Pediatric Sarcomas|Completed||N/A|39|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:27.606105|2017-02-18 18:12:27.606105
NCT00006514|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-20|2016-02-17|||September 2000||2000-09-01|July 2005|2005-07-01|August 2004|Actual|2004-08-01|||||Observational|||Multivariate Risk of CVD in Diverse Populations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:27.692828|2017-02-18 18:12:27.692828
NCT00006509|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-17|2015-03-05||||||March 2015|2015-03-01|June 2007|Actual|2007-06-01|||||Interventional|||A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years|A Phase I/II Safety and Immunogenicity Evaluation of a Prime/Boost Vaccine Using ALVAC-HIV (vCP 1452) With Recombinant gp160 LAI/MN-2 in HIV-Infected Subjects Treated With Antiretroviral Therapy for a Minimum of 2 Years|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:12:28.062688|2017-02-18 18:12:28.062688
NCT00006508|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-18|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Disorders of Systemic Glucose Balance||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:28.15657|2017-02-18 18:12:28.15657
NCT00006507|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-04|2007-01-16|||March 1999||1999-03-01|December 2004|2004-12-01|February 2002||2002-02-01|||||Interventional|||Occupational Therapy to Treat Children Who Over or Under React to Their Environment|Occupational Therapy (OT) Outcomes: Children With Sensory Modulation Disorders|Completed||Phase 2|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:28.229401|2017-02-18 18:12:28.229401
NCT00006506|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-17|2012-06-13|||November 2000||2000-11-01|June 2012|2012-06-01||||||||Observational|||Data Distribution Procedures for NHLBI Data Repository|National Heart, Lung, and Blood Institute Data Repository|Completed||N/A|0||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:28.332254|2017-02-18 18:12:28.332254
NCT00006505|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-17|2017-01-24|||November 15, 2000||2000-11-15|May 20, 2016|2016-05-20|June 1, 2020|Anticipated|2020-06-01|June 30, 2002|Actual|2002-06-30||Interventional|||Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression|Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression|Active, not recruiting||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:12:28.406691|2017-02-18 18:12:28.406691
NCT00006504|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2016-03-15|||August 2000||2000-08-01|August 2004|2004-08-01|July 2002|Actual|2002-07-01|||||Observational|||Flavonoids and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:28.514385|2017-02-18 18:12:28.514385
NCT00006503|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2014-04-29|||August 2000||2000-08-01|April 2008|2008-04-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Prevalence & Progression of Subclinical Atherosclerosis||Completed||N/A|||Rush University Medical Center|||||f||||||||||||||2017-02-18 18:12:28.58687|2017-02-18 18:12:28.58687
NCT00006502|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2016-02-26|||September 2000||2000-09-01|July 2005|2005-07-01|June 2005|Actual|2005-06-01|||||Observational|||Myocardial Perfusion, Risk Factors, and Coronary Calcium||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:28.660607|2017-02-18 18:12:28.660607
NCT00006501|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2015-12-21|||January 2003||2003-01-01|December 2015|2015-12-01|February 2012|Actual|2012-02-01|December 2009|Actual|2009-12-01||Observational|||Prognostic Significance of T Wave Alternans|The Prevalence and Prognostic Significance of T Wave Alternans in Patients With Severe Congestive Heart Failture|Completed||N/A|549|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 18:12:28.737188|2017-02-18 18:12:28.737188
NCT00006500|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2016-06-22|||April 2000||2000-04-01|June 2016|2016-06-01|March 2002||2002-03-01|||||Observational|||Trends in Trans-Fatty Acid Intake Between 1980 and 1997||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:12:28.840775|2017-02-18 18:12:28.840775
NCT00006499|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2016-03-15|||June 2000||2000-06-01|July 2004|2004-07-01|April 2004|Actual|2004-04-01|||||Observational|||Genetics of Hypertension and Its Intermediate Phenotypes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:28.907135|2017-02-18 18:12:28.907135
NCT00006498|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2016-03-15|||September 2000||2000-09-01|January 2006|2006-01-01|August 2005|Actual|2005-08-01|||||Observational|||Chronic Life Stress and Incident Asthma in Adult Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:28.972129|2017-02-18 18:12:28.972129
NCT00006497|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2008-08-20|||September 2000||2000-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Long-Term Effects of Subclinical CAD on Cardiac Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:29.039905|2017-02-18 18:12:29.039905
NCT00006496|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-16|2017-01-13|||February 2000||2000-02-01|January 2017|2017-01-01|December 2017|Anticipated|2017-12-01|August 2017|Anticipated|2017-08-01||Observational|||Molecular Epidemiology of ARDS|Molecular Epidemiology of Acute Respiratory Distress Syndrome|Recruiting||N/A|4000|Anticipated|Massachusetts General Hospital|||1||f||||f||||||Samples With DNA|"~     Blood will be collected for DNA extraction and plasma cytokine measurements~   "|No||2017-02-18 18:12:29.235392|2017-02-18 18:12:29.235392
NCT00006495|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-15|2013-07-19||||||July 2013|2013-07-01|September 2004|Actual|2004-09-01|||||Interventional|||Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452|Augmentation of HIV-Specific Helper and CTL Responses Through Therapeutic Vaccination in Individuals Receiving Potent Suppressive Antiretroviral Therapies|Completed||Phase 1|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:29.353783|2017-02-18 18:12:29.353783
NCT00006494|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-14|2017-01-24|||November 7, 2000||2000-11-07|September 6, 2011|2011-09-06|September 6, 2011||2011-09-06|||||Observational|||Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs|An Assessment of the Relationship Between Antiretroviral Drug Genotype/Phenotype (IC50) and Antiretroviral Activity in HIV-Infected, Drug-Experienced Patients With Suboptimal Suppression of Plasma Viral Load|Completed||N/A|14|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:29.45807|2017-02-18 18:12:29.45807
NCT00006493|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-14|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia||Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:29.546556|2017-02-18 18:12:29.546556
NCT00006492|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-09|2008-03-03|||November 2000||2000-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Observational|||Gluten-Free Diet in Patients With Gluten Sensitivity and Cerebellar Ataxia|Open Label Controlled Trial of Gluten-Free Diet in Patients With Gluten-Sensitivity and Cerebellar Ataxia|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:29.618779|2017-02-18 18:12:29.618779
NCT00006490|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-08|2008-09-24||||||July 2004|2004-07-01||||||||Observational|||A Comparison of Two Tests for Anti-HIV Drug Resistance|HIV-1 Resistance Testing During Antiretroviral Failure: Comparison of Sequencing Versus Phenotyping|Completed||N/A|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:29.706673|2017-02-18 18:12:29.706673
NCT00006489|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-08|2012-07-03|||December 2000||2000-12-01|February 2011|2011-02-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)|Naltrexone and Cognitive-Behavioral Therapy for Patients With Alcoholism and Post-Traumatic Stress Disorder|Completed||Phase 4|167|Actual|University of Pennsylvania||4|||f||||t||||||||||2017-02-18 18:12:29.831529|2017-02-18 18:12:29.831529
NCT00006488|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-08|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease||Completed||Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:29.936166|2017-02-18 18:12:29.936166
NCT00006487|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2012-10-03|||October 2000||2000-10-01|October 2012|2012-10-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer|A Phase I Study Of Tirapazamine/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer|Completed||Phase 1|30|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:12:30.204299|2017-02-18 18:12:30.204299
NCT00006486|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-01-15|||October 2000||2000-10-01|January 2013|2013-01-01||||October 2005|Actual|2005-10-01||Interventional|||Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer|A Phase II Randomized Discontinuation Trial Of Carboxyaminoimidazole (CAI, NSC 609974) In Metastatic Renal Carcinoma|Completed||Phase 2|335|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:12:30.417679|2017-02-18 18:12:30.417679
NCT00006485|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2009-12-13|||September 2000||2000-09-01|June 2003|2003-06-01||||December 2003|Actual|2003-12-01||Interventional|||Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors|An Open-Labeled, Non-Randomized Phase I Study Of Flavopiridol Administered With Irinotecan (CPT-11) In Patients With Advanced Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:30.533653|2017-02-18 18:12:30.533653
NCT00006484|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-06-20|||November 2000||2000-11-01|January 2002|2002-01-01|April 2006|Actual|2006-04-01|||||Interventional|||Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Randomized Phase III Trial Of Carboplatin And Paclitaxel Plus Tirapazamine Versus Carboplatin And Paclitaxel In Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:30.630171|2017-02-18 18:12:30.630171
NCT00006483|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2016-07-12|||October 2000||2000-10-01|July 2016|2016-07-01|January 2013|Actual|2013-01-01|January 2003|Actual|2003-01-01||Interventional|||Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung|A Phase II Study Of Aerosolized GM-CSF In The Treatment Of Metastatic Renal Cell Carcinoma To The Lung|Completed||Phase 2|27|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:12:30.830114|2017-02-18 18:12:30.830114
NCT00006482|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-04-10|||October 2000||2000-10-01|May 2004|2004-05-01||||April 2006|Actual|2006-04-01||Interventional|||Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix|A Phase II Evaluation Of Gemcitabine And Cisplatin In Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:12:30.955612|2017-02-18 18:12:30.955612
NCT00006481|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-11-18|||October 2000||2000-10-01|November 2013|2013-11-01||||August 2002|Actual|2002-08-01||Interventional|||Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer|A Phase III Comparison of Biafine to Declared Institutional Preference for Radiation Induced Skin Toxicity in Patients Undergoing Radiation Therapy for Advanced Squamous Cell Carcinomas of the Head and Neck|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:12:31.09371|2017-02-18 18:12:31.09371
NCT00006480|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2010-09-17|||May 2000||2000-05-01|September 2010|2010-09-01|March 2005|Actual|2005-03-01|||||Interventional|||Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma|Phase I Study to Evaluate the Safety of Cellular Immunotherapy for Recurrent/Refractory Neuroblastoma Using Genetically-Modified Autologous CD8+ T Cell Clones|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:12:31.771294|2017-02-18 18:12:31.771294
NCT00006479|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2011-04-15|||September 2000||2000-09-01|December 2000|2000-12-01||||||||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer|Pre- and Post-Operative Chemotherapy With Oxaliplatin 5FU/LV Versus Surgery Alone in Resectable Liver Metastases From Colorectal Origin - Phase III Study|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:31.879927|2017-02-18 18:12:31.879927
NCT00006478|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2011-03-01|2010-10-19||September 2000||2000-09-01|March 2011|2011-03-01|April 2008|Actual|2008-04-01|March 2008|Actual|2008-03-01||Interventional|||Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma|Pilot Trial to Evaluate Immune Response Using Idiotype Vaccines Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Follicular Lymphoma|Terminated||Phase 2|19|Actual|University of Nebraska|The Sponsor Genitope suspend development of MyVax in light of the decision made by the FDA March 6, 2008, therefore this trial was halted prematurely leaving insufficient data to analyze.|1||"Genitope suspend development of MyVax in light of the decision made by the Food and Drug~   Administration (FDA) March 6, 2008"|f||||||||||||||2017-02-18 18:12:32.114647|2017-02-18 18:12:32.114647
NCT00006477|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2012-07-17|||September 2000||2000-09-01|July 2012|2012-07-01||||June 2004|Actual|2004-06-01||Interventional|||Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors|Phase I Clinical Trial of Recombinant Viscumin (rVISCUMIN, rMISTLETOE LECTIN, rML) Administered Twice Weekly by the Subcutanous Route in Patients With Solid Tumors After Failure of Standard Therapy|Completed||Phase 1|26|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:12:32.345826|2017-02-18 18:12:32.345826
NCT00006476|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-06-25|||October 2000||2000-10-01|March 2007|2007-03-01|October 2007|Actual|2007-10-01|||||Interventional|||Suramin in Treating Patients With Recurrent Bladder Cancer|A Phase I Study of Intravesicular Suramin in Recurrent Superficial Bladder Cancer|Completed||Phase 1|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:32.438923|2017-02-18 18:12:32.438923
NCT00006475|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-02-20|||September 2000||2000-09-01|February 2013|2013-02-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis|An Open-Label Study to Determine the Efficacy and Safety of STI571 in Patients With Chronic Myeloid Leukemia in Blast Crisis|Completed||Phase 2|||Novartis|||||f||||||||||||||2017-02-18 18:12:32.538596|2017-02-18 18:12:32.538596
NCT00006474|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-06-19|||March 2001||2001-03-01|February 2013|2013-02-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma|Phase I Trial of Temodar Plus O6-Benzylguanine (O6-BG) (NSC 637037) in the Treatment of Patients With Newly Diagnosed (Part 1) or Recurrent/Progressive (Parts 1 and 2) Cerebral Anaplastic Gliomas|Completed||Phase 1|||Duke University|||||f||||f||||||||||2017-02-18 18:12:32.649105|2017-02-18 18:12:32.649105
NCT00006473|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-01-22|||September 2000||2000-09-01|January 2013|2013-01-01||||February 2006|Actual|2006-02-01||Interventional|||Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Phase II Study of Oxaliplatin in Relapsed and Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|72|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:12:32.759373|2017-02-18 18:12:32.759373
NCT00006472|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2009-02-06|||January 2000||2000-01-01|February 2002|2002-02-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer|Esophageal Cancer: A Phase II Study of Paclitaxel, Carboplatin and 5-Fluorouracil With Simultaneous Radiotherapy Followed by Surgical Resection|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:32.872846|2017-02-18 18:12:32.872846
NCT00006471|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2012-07-27|||September 2000||2000-09-01|July 2012|2012-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Study of Fenretinide in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|11|Actual|M.D. Anderson Cancer Center||1|||f||||t||||||||||2017-02-18 18:12:32.966673|2017-02-18 18:12:32.966673
NCT00006470|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-08-09|||March 2001||2001-03-01|August 2013|2013-08-01||||December 2004|Actual|2004-12-01||Interventional|||Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery|Phase II Study of Postoperative Adjuvant Immunotherapy and Radiation in Patients With Completely Resected Stage II and Stage IIIA Non-Small Cell Lung Cancer|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:12:33.099568|2017-02-18 18:12:33.099568
NCT00006469|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2009-02-06|||August 1999||1999-08-01|May 2006|2006-05-01||||||||Interventional|||Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer|Phase II Trial of Concurrent Paclitaxel, Carboplatin and External Beam Radiotherapy Followed by Surgical Resection in Stage IIIA (N2) Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:33.708268|2017-02-18 18:12:33.708268
NCT00006468|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2009-01-10|||January 2000||2000-01-01|December 2000|2000-12-01||||||||Interventional|||Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer|Phase III Study of An Optimized LV-5FU-Oxaliplatin Regimen in Metastatic Colorectal Cancer. C99-1.|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:33.816384|2017-02-18 18:12:33.816384
NCT00006467|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2016-07-01|||February 2001||2001-02-01|July 2016|2016-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas|Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:12:33.907296|2017-02-18 18:12:33.907296
NCT00006466|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-12-17|||August 2000||2000-08-01|September 2002|2002-09-01||||||||Interventional|||Beta Alethine in Treating Patients With Myeloma|Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With Myeloma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:34.042865|2017-02-18 18:12:34.042865
NCT00006465|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2010-06-10|||December 2000||2000-12-01|June 2010|2010-06-01|April 2005|Actual|2005-04-01|November 2003|Actual|2003-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I Study of Oxaliplatin (NSC# 266046), Irinotecan, and Capecitabine in Patients With Solid Tumors|Completed||Phase 1|22|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:12:34.152861|2017-02-18 18:12:34.152861
NCT00006464|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2010-01-13|||March 2001||2001-03-01|January 2010|2010-01-01|June 2008|Actual|2008-06-01|January 2005|Actual|2005-01-01||Interventional|||UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors|Phase I Dose Escalation Study of UCN-01 (NSC 638850) Plus Cisplatin in Advanced Malignant Solid Tumors|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:12:34.259571|2017-02-18 18:12:34.259571
NCT00006463|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2014-02-19|||October 2000||2000-10-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||Ecteinascidin 743 in Treating Children With Refractory Solid Tumors|Phase I Study of ET-743 in Pediatric Refractory Solid Tumors|Completed||Phase 1|13|Actual|Children's Oncology Group||2|||f||||f||||||||||2017-02-18 18:12:34.359326|2017-02-18 18:12:34.359326
NCT00006462|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2014-02-18|||April 2001||2001-04-01|February 2014|2014-02-01|September 2006|Actual|2006-09-01|August 2003|Actual|2003-08-01||Interventional|||Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia|A Phase II Study of Gemcitabine (NSC #613327) in Children With Relapsed Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia|Completed||Phase 2|32|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:12:34.547439|2017-02-18 18:12:34.547439
NCT00006461|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-08-07|||October 2000||2000-10-01|August 2013|2013-08-01||||September 2007|Actual|2007-09-01||Interventional|||Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor|Systemic Chemotherapy, Second Look Surgery and Conformal Radiation Therapy Limited to the Posterior Fossa and Primary Site for Children &gt;/= to 8 Months and &lt;3 Years With Non-metastatic Medulloblastoma: A Children&Apos;s Oncology Group Phase III Study|Completed||Phase 3|82|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:12:35.209713|2017-02-18 18:12:35.209713
NCT00006460|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-12-03|||August 2000||2000-08-01|May 2002|2002-05-01||||||||Interventional|||Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I/II Trial of Conformal Radiotherapy and Hyperbaric Oxygen for Patients With Newly Diagnosed Glioblastoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:35.325548|2017-02-18 18:12:35.325548
NCT00006459|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2012-06-06|||July 2000||2000-07-01|April 2002|2002-04-01|October 2005|Actual|2005-10-01|||||Interventional|||Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer|Phase III Study of Gemcitabine Plus Paclitaxel Versus Paclitaxel in Patients With Unresectable, Locally Recurrent or Metastatic Breast Cancer|Completed||Phase 3|||Eli Lilly and Company|||||f||||||||||||||2017-02-18 18:12:35.407224|2017-02-18 18:12:35.407224
NCT00006458|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2009-02-28|||August 2000||2000-08-01|October 2001|2001-10-01||||||||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer|Phase I Non-Myeloablative Trial With 90Y-Humanized MN-14 (Anti-CEA) Antibody for Relapsed or Refractory Advanced Non-Small Cell Lung Cancer (NSCLC)|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:35.530302|2017-02-18 18:12:35.530302
NCT00006457|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2012-06-07|||August 2000||2000-08-01|June 2012|2012-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Oltipraz in the Prevention of Lung Cancer in People Who Smoke|Clinical Phase I Multiple-Dose Safety Research Study of Oltipraz in Smokers|Completed||Phase 1|||Northwestern University|||||f||||||||||||||2017-02-18 18:12:35.623806|2017-02-18 18:12:35.623806
NCT00006456|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2010-02-23|||February 1999||1999-02-01|February 2010|2010-02-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid Tumors|Fractionated Stereotactic Body Radiosurgery for Extracranial Tumors|Completed||Phase 2|26|Actual|Virginia Commonwealth University|||||f||||f||||||||||2017-02-18 18:12:35.718222|2017-02-18 18:12:35.718222
NCT00006455|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2011-08-25|||December 1999||1999-12-01|August 2011|2011-08-01||||||||Interventional|||Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma|International Protocol for the Treatment of Childhood Anaplastic Large Cell Lymphoma|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:35.805399|2017-02-18 18:12:35.805399
NCT00006454|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2015-12-22|||December 1999||1999-12-01|December 2015|2015-12-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer|Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan|Completed||Phase 3|||AGO Study Group|||||f||||t||||||||||2017-02-18 18:12:35.926162|2017-02-18 18:12:35.926162
NCT00006453|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2015-12-22|||September 1999||1999-09-01|December 2015|2015-12-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy|A Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy|Completed||Phase 3|||AGO Study Group|||||f||||t||||||||||2017-02-18 18:12:36.06244|2017-02-18 18:12:36.06244
NCT00006452|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2011-06-27|||April 1999||1999-04-01|June 2011|2011-06-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme|A Phase I Trial to Evaluate Repetitive Intravenous Doses of Gadolinium-Texaphyrin as a Radiosensitizer in Patients With Glioblastoma Multiforme|Completed||Phase 1|18|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:12:36.252447|2017-02-18 18:12:36.252447
NCT00006451|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2012-11-06|||April 1996||1996-04-01|November 2012|2012-11-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Leukemia|T-cell Depletion In Unrelated Donor Marrow Transplantation|Withdrawn||Phase 3|0|Actual|Masonic Cancer Center, University of Minnesota||||Withdrawn due to no accrual|f||||t||||||||||2017-02-18 18:12:36.343623|2017-02-18 18:12:36.343623
NCT00006450|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-07|2008-03-03|||November 2000||2000-11-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors|Phase II Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Progressive or Recurrent CNS Malignancy|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:39.432801|2017-02-18 18:12:39.432801
NCT00006449|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2010-05-11|||September 2000||2000-09-01|May 2010|2010-05-01|July 2006||2006-07-01|||||Interventional|||Post-Treatment Effects of Naltrexone|Post-Treatment Effects of Naltrexone|Completed||Phase 4|160||Indiana University|||||f||||||||||||||2017-02-18 18:12:39.519094|2017-02-18 18:12:39.519094
NCT00006448|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-04|2016-09-23|||August 1996||1996-08-01|March 2003|2003-03-01||||July 2001|Actual|2001-07-01||Interventional|||Treatment of Chronic Pain After Spinal Cord Injury (SCI) or Amputation|Spinal Cord Injury (SCI) and Amputation Pain Prevention and Treatment|Completed||N/A|400||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:39.590026|2017-02-18 18:12:39.590026
NCT00006447|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-04|2016-09-23|||September 1997||1997-09-01|May 2011|2011-05-01||||August 2002|Actual|2002-08-01||Interventional|||Supporting Traumatic Brain Injury (TBI) Caregivers||Completed||Phase 2|64||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:39.676522|2017-02-18 18:12:39.676522
NCT00006446|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-04|2007-02-21|||July 1996||1996-07-01|April 2003|2003-04-01|June 2001||2001-06-01|||||Interventional|||Preventing Problems in Children's Social Behavior|John F. Kennedy Center for Mental Retardation at Vanderbilt University: Preventing Problems in Children's Social Behavior|Completed||N/A|180||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:39.758362|2017-02-18 18:12:39.758362
NCT00006445|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-04|2007-02-21||||||March 2003|2003-03-01||||||||Interventional|||Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters|First and 2nd Trimester Evaluation of the Risk of Aneuploidy|Unknown status|Active, not recruiting|N/A|38000||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:39.844664|2017-02-18 18:12:39.844664
NCT00006444|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2013-11-19|||November 2000||2000-11-01|November 2013|2013-11-01|August 2005|Actual|2005-08-01|||||Observational|||The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women|Assessment of Prevalence and Persistence of Human Papillomavirus (HPV) DNA in HIV-Infected Women Who Are Antiretroviral Naive and Have Initiated HAART|Completed||N/A|160||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:39.956719|2017-02-18 18:12:39.956719
NCT00006443|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2011-03-01||||||January 2005|2005-01-01||||October 2003|Actual|2003-10-01||Interventional|||Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection|Evaluating Responses to Antiretroviral Drugs in Cells and Tissues (The ERADICATE Study): Comprehensive Comparisons of Viral and Cellular Dynamics Among Previously-Untreated Subjects With Acute HIV Infection (Seroconversion Syndrome) or Recently Acquired HIV Infection Versus the Early, Middle, and Advanced Stages of Seropositive HIV Infection|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:40.347084|2017-02-18 18:12:40.347084
NCT00006442|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2008-07-29||||||January 2005|2005-01-01||||||||Observational|||The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients|Quantitative Assessment of Viral and Lymphocyte Dynamics in Blood and Lymphoreticular Tissues of HIV-1 Infected Patients Treated With Antiretroviral Agents|Completed||N/A|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:40.441159|2017-02-18 18:12:40.441159
NCT00006441|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2015-03-05|||February 2003||2003-02-01|April 2014|2014-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV|A Single Center, Randomized Open Label Study of Initial Interleukin-2 Compared to Delayed Interleukin-2 When Added to Zidovudine, 3TC and Nelfinavir In Order to Modulate Immune Function and to Sustain Suppression of HIV-1 Replication Among Those Persons With Primary or Early HIV Infection|Completed||N/A|398|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:12:40.521316|2017-02-18 18:12:40.521316
NCT00006440|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2016-10-27|||March 2000||2000-03-01|October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||A Test of Behavioral Intervention for Women at High Risk for HIV Infection|Feasibility Study of a Behavioral Intervention for Women at Persistent High Risk for HIV Infection|Completed||N/A|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:40.654323|2017-02-18 18:12:40.654323
NCT00006439|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-04|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Effects of Home Visits on Medication Adherence in Children and Youth With HIV||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:40.742603|2017-02-18 18:12:40.742603
NCT00006438|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2005-06-23|||January 1997||1997-01-01|March 2000|2000-03-01|December 1999||1999-12-01|||||Interventional|||How Shoes With Rocker Soles Affect Walking|Rocker Sole Kinetics and Kinematics|Completed||N/A|46||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:40.817436|2017-02-18 18:12:40.817436
NCT00006437|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2008-03-03|||October 2000||2000-10-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||Pathophysiology of Chronic Wounds|Pathophysiology of Chronic Wounds: Collection of Blood From Healthy Volunteers|Completed||N/A|999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:40.906229|2017-02-18 18:12:40.906229
NCT00006436|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2017-01-24|||October 30, 2000||2000-10-30|December 29, 2016|2016-12-29|March 31, 2021|Anticipated|2021-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection|Short-Course EPOCH-Rituximab in Untreated CD-20+ HIV-Associated Lymphomas|Recruiting||Phase 2|80|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:12:40.993474|2017-02-18 18:12:40.993474
NCT00006435|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2017-01-24|||October 26, 2000||2000-10-26|July 7, 2016|2016-07-07||||||||Observational|||Study of Plexiform Neurofibromas in Neurofibromatosis Type 1|Natural History of Plexiform in Neurofibromatosis Type I|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:41.123302|2017-02-18 18:12:41.123302
NCT00006434|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Tumor Lysate Pulsed-Dendritic Cell Vaccines After High-Dose Chemotherapy for Non-Hodgkin's Lymphoma||Completed||Phase 3|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:41.21894|2017-02-18 18:12:41.21894
NCT00006433|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2005-06-23|||January 2000||2000-01-01|November 2001|2001-11-01||||||||Interventional|||Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer||Unknown status|Recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:41.29557|2017-02-18 18:12:41.29557
NCT00006432|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2007-06-22|||January 2000||2000-01-01|June 2007|2007-06-01||||||||Interventional|||Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:41.37146|2017-02-18 18:12:41.37146
NCT00006431|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA||Unknown status|Active, not recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:41.444144|2017-02-18 18:12:41.444144
NCT00006430|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-03|2005-06-23||||||February 2002|2002-02-01||||||||Interventional|||A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA||Unknown status|Active, not recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:41.522432|2017-02-18 18:12:41.522432
NCT00006429|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-01|2016-09-23|||March 1999||1999-03-01|May 2011|2011-05-01|February 2004||2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Treadmill Training for Spinal Cord Injury|Locomotor Therapy Trial for Spinal Cord Injury|Completed||Phase 2|200||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:41.600304|2017-02-18 18:12:41.600304
NCT00006428|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-01|2012-12-14|||August 1996||1996-08-01|March 2003|2003-03-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Chronic Pain in Spinal Cord Injury|Management of Chronic Pain in Rehabilitation Project I - Management of Chronic Pain in Persons With Spinal Cord Injury|Completed||Phase 4|100||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:41.701618|2017-02-18 18:12:41.701618
NCT00006427|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-01|2016-09-23|||August 1996||1996-08-01|May 2011|2011-05-01||||July 2001|Actual|2001-07-01||Interventional|||Chronic Pain After Amputation|Management of Chronic Pain in Rehabilitation Project II Management of Chronic Pain in Persons With Amputation|Completed||Phase 4|125||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:41.806099|2017-02-18 18:12:41.806099
NCT00006426|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-01|2005-06-23|||August 1998||1998-08-01|March 2003|2003-03-01|May 2003||2003-05-01|||||Interventional|||Achilles Tendon Lengthening in Patients With Diabetes to Prevent Foot Ulcers|Controlled Clinical Trial Comparing the Effect of an Achilles Tendon Lengthening Procedure and Casting to Casting Alone for the Treatment of Neuropathic Forefoot Plantar Ulcers in Patients With Diabetes Mellitus|Completed||Phase 1|60||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:12:41.914941|2017-02-18 18:12:41.914941
NCT00006425|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-31|2017-01-24|||October 26, 2000||2000-10-26|November 16, 2016|2016-11-16||||||||Observational|||Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study|Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Pilot Study|Completed||N/A|20|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:42.007334|2017-02-18 18:12:42.007334
NCT00006424|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-28|2008-03-03|||October 2000||2000-10-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Study of Brain Changes Shaped by Experience|fMRI and Spectroscopy Studies of Cortical Plasticity at 1.5 and 3 Tesla|Completed||N/A|153||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:42.094773|2017-02-18 18:12:42.094773
NCT00006422|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-27|2008-03-03|||October 2000||2000-10-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Evaluation and Treatment of Pediatric Eye Diseases|Evaluation and Treatment Protocol for Patients With Pediatric Eye Diseases and Strabismus|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:42.17528|2017-02-18 18:12:42.17528
NCT00006421|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-27|2017-01-24|||October 24, 2000||2000-10-24|September 23, 2016|2016-09-23||||||||Observational|||Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study|Breast Imaging Screening Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-up Study|Completed||N/A|200|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:42.52084|2017-02-18 18:12:42.52084
NCT00006420|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-26|2016-02-03|||August 2000||2000-08-01|February 2016|2016-02-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|MHS||Minnesota Heart Survey - Mortality and Morbidity|Study of Trends of Cardiovascular Disease in a Metropolitan Area.|Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||1||f||||||||||||||2017-02-18 18:12:42.620429|2017-02-18 18:12:42.620429
NCT00006419|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-26|2016-03-15|||July 2000||2000-07-01|May 2005|2005-05-01|June 2004|Actual|2004-06-01|||||Observational|||Diet and Chronic Obstructive Pulmonary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:42.710005|2017-02-18 18:12:42.710005
NCT00006418|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-25|2014-04-01|||September 2003||2003-09-01|November 2005|2005-11-01|August 2007||2007-08-01|||||Observational|||Molecular Genetics of Schizophrenia||Completed||N/A|10800|Anticipated|NorthShore University HealthSystem|||||f||||||||||||||2017-02-18 18:12:42.785784|2017-02-18 18:12:42.785784
NCT00006417|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-24|2008-03-03|||October 2000||2000-10-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Interventional|||Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease|HLA-Matched, Peripheral Blood Stem Cell Transplantation Using Low Intensity Conditioning to Treat Patients With Chronic Granulomatous Disease Who Are Actively Infected|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:42.89584|2017-02-18 18:12:42.89584
NCT00006415|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-19|2015-03-05||||||March 2015|2015-03-01||||||||Observational|||A Study of Patients Who Recently Have Been Infected With HIV|Evaluation of Subjects With Primary or Early Human Immunodeficiency Virus (HIV) Infection|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:42.990264|2017-02-18 18:12:42.990264
NCT00006414|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-17|2008-03-03|||October 2000||2000-10-01|March 2006|2006-03-01|March 2006||2006-03-01|||||Observational|||Hand Exercise and Upper Arm Anesthesia to Improvements Hand Function in Chronic Stroke Patients|Improvements of Hand Function in Chronic Stroke Related to Upper Arm Anesthesia|Completed||N/A|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:43.074215|2017-02-18 18:12:43.074215
NCT00006413|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-17|2017-01-24|||October 13, 2000||2000-10-13|December 14, 2006|2006-12-14|December 14, 2006||2006-12-14|||||Interventional|||Stem Cell Transplantation to Treat Systemic Mastocytosis|Low Intensity Preparative Regimen Followed by HLA-Matched, Mobilized Peripheral Blood Stem Cell Transplantation for Systemic Mastocytosis|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:43.156425|2017-02-18 18:12:43.156425
NCT00006412|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-13|2013-07-19||||||July 2013|2013-07-01|May 2003|Actual|2003-05-01|||||Interventional|||Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids|A Prospective, Multicenter, Randomized Trial Comparing the Efficacy and Safety of Fenofibrate Versus Pravastatin in HIV-Infected Subjects With Lipid Abnormalities|Completed||Phase 3|630||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:43.242166|2017-02-18 18:12:43.242166
NCT00006411|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-13|2010-03-23|||July 2002||2002-07-01|April 2008|2008-04-01|July 2013|Anticipated|2013-07-01|December 2007|Actual|2007-12-01||Interventional|CDS||Cornea Donor Study|Cornea Donor Study|Unknown status|Active, not recruiting|N/A|1101|Actual|National Eye Institute (NEI)||2|||f||||t||||||||||2017-02-18 18:12:43.407725|2017-02-18 18:12:43.407725
NCT00006409|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2015-06-29|2010-02-17||September 2000||2000-09-01|June 2015|2015-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|TAAG||Trial of Activity for Adolescent Girls (TAAG)|Trial of Activity for Adolescent Girls (TAAG)|Completed||Phase 2|8727|Actual|University of North Carolina, Chapel Hill||2|||f||||t||||||||||2017-02-18 18:12:43.534624|2017-02-18 18:12:43.534624
NCT00006408|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2014-03-27|||August 2000||2000-08-01|March 2014|2014-03-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Hypertension in Black Americans: A Life Course Approach||Completed||N/A|||Duke University|||||f||||f||||||||||2017-02-18 18:12:44.280437|2017-02-18 18:12:44.280437
NCT00006407|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2016-03-15|||September 2000||2000-09-01|March 2005|2005-03-01|July 2004|Actual|2004-07-01|||||Observational|||Sex Steroid Hormones and Risk of CHD in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:44.351619|2017-02-18 18:12:44.351619
NCT00006406|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2016-03-15|||August 2000||2000-08-01|December 2005|2005-12-01|July 2005|Actual|2005-07-01|||||Observational|||Amino Acids in Urine, Diet, and Blood Pressure: International Population Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:44.414589|2017-02-18 18:12:44.414589
NCT00006405|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2008-01-18|||April 2002||2002-04-01|January 2008|2008-01-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||APEX: Adiposity Prevention by Exercise in Black Girls||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:44.487276|2017-02-18 18:12:44.487276
NCT00006401|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2015-10-05|||September 2000||2000-09-01|October 2015|2015-10-01|October 2007|Actual|2007-10-01|September 2005|Actual|2005-09-01||Interventional|||Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants|Inhaled NO for the Prevention of Chronic Lung Disease|Completed||Phase 3|793|Anticipated|University of Colorado, Denver||2|||f||||||||||||||2017-02-18 18:12:44.80059|2017-02-18 18:12:44.80059
NCT00006400|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-12|2011-04-15||2011-04-07|August 2000||2000-08-01|April 2011|2011-04-01|September 2009|Actual|2009-09-01|September 2009|Actual|2009-09-01||Interventional|||Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia|Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG)|Completed||Phase 3|191|Actual|National Heart, Lung, and Blood Institute (NHLBI)||2|||f||||t||||||||||2017-02-18 18:12:44.928796|2017-02-18 18:12:44.928796
NCT00006399|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-18|2009-01-13|||September 1999||1999-09-01|January 2009|2009-01-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease|Estrogen Modulation Effects on Cholinergic Function in Normal Post-Menopausal Women and Patients With Alzheimer's Disease|Completed||Phase 2|45||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:12:45.06878|2017-02-18 18:12:45.06878
NCT00006398|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-05|2010-01-12|||August 1993||1993-08-01|January 2010|2010-01-01|March 1998||1998-03-01|||||Interventional|||Prevention of Esophageal Varices by Beta-Adrenergic Blockers|Randomized, Double-Blind Study of Timolol (A Nonselective Beta-Adrenergic Blocker) vs Placebo to Prevent Complications of Hepatic Portal Hypertension in Patients With Cirrhosis|Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:12:45.468482|2017-02-18 18:12:45.468482
NCT00006397|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-10|2005-06-23|||August 2000||2000-08-01|June 2001|2001-06-01||||||||Interventional|||Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs|A Study of the Combination of Indinavir, Ritonavir, Enteric-Coated ddI and d4T In Nucleoside and Non-Nucleoside Reverse Transcriptase Inhibitor Experienced Patients: An Open-Label Study Investigating Differences Between Women and Men|Unknown status|Active, not recruiting|Phase 3|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:12:45.579641|2017-02-18 18:12:45.579641
NCT00006396|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-10|2012-02-13||||||February 2012|2012-02-01|November 2004|Actual|2004-11-01|||||Interventional|||Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns|A Phase III Placebo-Controlled Trial to Determine the Efficacy of Oral AZT and the Efficacy of Oral Nevirapine for the Prevention of Vertical Transmission of HIV-1 Infection in Pregnant Ugandan Women and Their Neonates|Completed||Phase 3|1500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:45.699601|2017-02-18 18:12:45.699601
NCT00006395|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-07|2008-03-03|||October 2000||2000-10-01|September 2000|2000-09-01|April 2001||2001-04-01|||||Interventional|||Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers|Evaluation of the Effect of St. John's Wort on Single Dose Carbamazepine Pharmacokinetics in Normal Healthy Volunteers|Completed||Phase 4|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:45.809452|2017-02-18 18:12:45.809452
NCT00006394|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2005-06-23|||April 1997||1997-04-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone Deficiency||Completed||N/A|72||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:45.89756|2017-02-18 18:12:45.89756
NCT00006393|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2005-06-23|||July 1998||1998-07-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis|Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic Sclerosis|Unknown status|Recruiting|N/A|80||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:45.999637|2017-02-18 18:12:45.999637
NCT00006392|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2015-10-23|2012-06-12||July 2001||2001-07-01|October 2015|2015-10-01|September 2012|Actual|2012-09-01|May 2011|Actual|2011-05-01||Interventional|SELECT||S0000 Selenium and Vitamin E in Preventing Prostate Cancer|Selenium and Vitamin E Cancer Prevention Trial (SELECT) for Prostate Cancer|Completed||Phase 3|35533|Actual|Southwest Oncology Group||4|||f||||t||||||||||2017-02-18 18:12:46.0985|2017-02-18 18:12:46.0985
NCT00006391|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2011-04-04|||August 2000||2000-08-01|April 2011|2011-04-01||||November 2004|Actual|2004-11-01||Interventional|||Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer|A Phase I Dose-Finding Study of Oxaliplatin (NSC #266046) Combined With Continuous Infusion Topotecan Hydrochloride as Chemotherapy for Patients With Previously Treated Ovarian Cancer|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:12:48.084286|2017-02-18 18:12:48.084286
NCT00006390|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2010-01-26|||February 2001||2001-02-01|January 2010|2010-01-01||||December 2004|Actual|2004-12-01||Interventional|||Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia|Phase II Study of Campath-1H (NSC #950010) and Peripheral Blood Stem Cell Transplant for Patients With Chronic Lymphocytic Leukemia|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||||||f||||||||||2017-02-18 18:12:48.17828|2017-02-18 18:12:48.17828
NCT00006389|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2014-09-26|2014-09-26||October 2000||2000-10-01|October 2013|2013-10-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer|A Phase II Combination Trial of Bryostatin-1 and Cisplatin in the Treatment of Metastatic Gastric Cancer|Completed||Phase 2|12|Actual|National Cancer Institute (NCI)|Of 12 pts accrued\treated, none responded. The initial phase accrual goal was 15, but given the 12 non-responders, we determined the probability of 3 future pts all responding (stochastic curtailed sampling) at 2.7%. Decided to terminate the trial.|1|||f||||||||||||||2017-02-18 18:12:48.284128|2017-02-18 18:12:48.284128
NCT00006388|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2015-11-14|||December 2000||2000-12-01|November 2015|2015-11-01||||October 2003|Actual|2003-10-01||Interventional|||Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme|A Phase II Trial of High Dose Tamoxifen For The Treatment of Newly Diagnosed Supratentorial Glioblastoma Multiforme (GBM)|Completed||Phase 2|77|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:12:48.593847|2017-02-18 18:12:48.593847
NCT00006387|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-07-10|||October 2000||2000-10-01|July 2013|2013-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer|A Phase I Study of RAS Peptide Vaccination in Patients With Advanced Pancreatic or Colorectal Adenocarcinoma|Completed||Phase 1|7|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-02-18 18:12:49.239057|2017-02-18 18:12:49.239057
NCT00006386|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2015-11-14|||March 2001||2001-03-01|November 2015|2015-11-01|February 2009|Actual|2009-02-01|November 2004|Actual|2004-11-01||Interventional|||Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme|A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boosts For Supratentorial Glioblastoma Multiforme|Completed||Phase 2|80|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:12:49.341936|2017-02-18 18:12:49.341936
NCT00006385|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2011-11-05|||September 2000||2000-09-01|December 2002|2002-12-01||||October 2006|Actual|2006-10-01||Interventional|||Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma|Phase II Evaluation of Immunization With an HLA-A2 Multi-Epitope Peptide Vaccine Containing MART-1 (NSC #672643), gp100 (NSC #683472), and Tyrosinase (NSC #699048) Peptides Alone or in Combination With GM-CSF, IFN Alpha-2b, or GM-CSF + IFN Alpha-2b in Patients With Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:50.064844|2017-02-18 18:12:50.064844
NCT00006384|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2011-10-18|||November 2000||2000-11-01|October 2011|2011-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer|Phase II Trial of SU5416 and Interferon Alfa 2B in Unresectable or Metastatic Renal Cell Carcinoma|Completed||Phase 2|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:12:50.209757|2017-02-18 18:12:50.209757
NCT00006383|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-11-05|||June 2000||2000-06-01|December 2002|2002-12-01|August 2009|Actual|2009-08-01|||||Interventional|||Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma|Pivotal Phase II Multicenter Study of Vincristine Sulfate Liposomes Injection in Diffuse Large B-Cell Non-Hodgkin's Lymphoma That is Refractory or Relapsed After Second-Line Combination Chemotherapy Revised Title Per 03/01 SR Pivotal Phase II Multicenter Study of Vincristine Sulfate Liposomes Injection in Aggressive Non-Hodgkin's Lymphoma That is Refractory to or Relapsed After Second-Line Combination Chemotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:50.312343|2017-02-18 18:12:50.312343
NCT00006382|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2015-05-01|||August 2000||2000-08-01|June 2010|2010-06-01|December 2002|Actual|2002-12-01|||||Interventional|||Lung Screening Study|Lung Screening Study|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:50.417286|2017-02-18 18:12:50.417286
NCT00006381|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-12-18|||June 2000||2000-06-01|December 2003|2003-12-01|February 2004|Actual|2004-02-01|||||Interventional|||Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer|Phase II Study of Celecoxib in HER-2/Neu Overexpressing Metastatic Breast Cancer Patients Who Have Failed Recombinant Humanized Anti-p 185HER Monoclonal Antibody Trastuzumab (HERCEPTIN)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:50.517201|2017-02-18 18:12:50.517201
NCT00006380|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-06-17|||September 2000||2000-09-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer|Phase I Evaluation of 131I-J591 Murine Monoclonal Antibody in Patients With Progressive Androgen-Independent Prostate Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:12:50.612072|2017-02-18 18:12:50.612072
NCT00006379|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2011-12-07|||June 2000||2000-06-01|December 2011|2011-12-01|October 2011|Actual|2011-10-01|January 2004|Actual|2004-01-01||Interventional|||Non-Ablative Allo HSCT For Hematologic Malignancies or SAA|Purine-Analog-Containing Non-Myeloablative Allogeneic Stem Cell Transplantation for Treatment of Hematologic Malignancies and Severe Aplastic Anemia|Completed||Phase 2|58|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:12:50.711786|2017-02-18 18:12:50.711786
NCT00006378|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2014-01-08|||December 1999||1999-12-01|January 2014|2014-01-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer|Phase II Randomized Study of Taxol (PACLITAXEL), Paraplatin (Carboplatin), and Radiation Therapy for Locally Advanced Inoperable Non-Small Cell Lung Cancer|Completed||Phase 2|5|Actual|Case Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:12:50.844013|2017-02-18 18:12:50.844013
NCT00006377|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-06-17|||June 2000||2000-06-01|June 2013|2013-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer|Phase II Study of Sequential Administration of Doxorubicin, Paclitaxel, and Carboplatin in Patients With Advanced and Recurrent Endometrial Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:12:50.94582|2017-02-18 18:12:50.94582
NCT00006376|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-12-03|||March 2000||2000-03-01|June 2005|2005-06-01|May 2005|Actual|2005-05-01|||||Interventional|||R115777 in Treating Patients With Advanced Bladder Cancer|A Phase II Trial of R115777, an Oral Farnesyltransferase Inhibitor (FTI) in Previously Untreated Patients With Advanced Urothelial Tract Transitional Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:51.046253|2017-02-18 18:12:51.046253
NCT00006375|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-06-17|||June 2000||2000-06-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||LY293111 in Treating Patients With Advanced Solid Tumors|A Phase I Clinical and Pharmacokinetic Evaluation of LY293111 in Patients With Solid Tumors (Protocol H6H-MC-JEAI)|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:12:51.141035|2017-02-18 18:12:51.141035
NCT00006374|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2014-01-14|||October 1999||1999-10-01|January 2014|2014-01-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer|An Open-Label, Multicenter, Randomized, Phase II Study of Topotecan/Paclitaxel vs Etoposide/Cisplatin as First-Line Therapy for Patients With Extensive Disease Small Cell Lung Cancer|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||||Slow accrual|f||||t||||||||||2017-02-18 18:12:51.235028|2017-02-18 18:12:51.235028
NCT00006373|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-06-03|||February 2000||2000-02-01|June 2013|2013-06-01|December 2011|Actual|2011-12-01|October 2006|Actual|2006-10-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma|A Phase II Study of Intensive-Dose Topotecan, Ifosfamide/Mesna and Etoposide (Vepesid)(TIME) Followed by Autologous Stem Cell Rescue in High Risk Lymphoma|Completed||Phase 2|27|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:12:51.330663|2017-02-18 18:12:51.330663
NCT00006324|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-02|2008-08-06|||December 1999||1999-12-01|November 2006|2006-11-01|December 2002||2002-12-01|||||Interventional|||Hormonal Birth Control and the Risk of Acquiring HIV|Hormonal Contraception and the Risk of HIV Acquisition|Completed||N/A|6360||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:57.548204|2017-02-18 18:12:57.548204
NCT00006372|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2010-06-09|||February 2000||2000-02-01|June 2010|2010-06-01|February 2005|Actual|2005-02-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I Trial of Combination Pegylated Liposomal Doxorubicin (Doxil), Vinorelbine, and Gemcitabine|Completed||Phase 1|10|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:12:51.445153|2017-02-18 18:12:51.445153
NCT00006371|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-09-25|||May 2000||2000-05-01|September 2012|2012-09-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||"A Phase II Trial of Early Medical Adrenalectomy for D0.5 Prostate Cancer"|"A Phase II Trial of Early Medical Adrenalectomy for D0.5 Prostate Cancer"|Terminated||Phase 2|2|Actual|H. Lee Moffitt Cancer Center and Research Institute||2||low accrual|f||||f||||||||||2017-02-18 18:12:51.546806|2017-02-18 18:12:51.546806
NCT00006370|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-04-30|||July 2000||2000-07-01|April 2013|2013-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer|A Phase II, Open-label, Multi-Center Study to Evaluate the Efficacy of 90Y-SMT 487 Administered Intravenously to Patients With Refractory Small Cell Lung or Advanced Metastatic Breast Cancer Expressing Somatostatin Receptors as Determined by OctreoScan Scintigraphy|Completed||Phase 2|275|Actual|Novartis|||||f||||||||||||||2017-02-18 18:12:51.671273|2017-02-18 18:12:51.671273
NCT00006369|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-11-05|||June 2000||2000-06-01|October 2001|2001-10-01||||||||Interventional|||ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer|A Phase II, Randomized, Double-Masked, Multicenter Study of Two Dose Levels of ERA-923 for the Treatment of Metastatic Breast Cancer in Postmenopausal Women Who Have Failed Tamoxifen Therapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:51.762122|2017-02-18 18:12:51.762122
NCT00006368|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-04-30|||January 1998||1998-01-01|April 2013|2013-04-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer|A Phase I, Open-Label, Maximum Tolerated Single-Cycle and Four-Cycle Dose-Finding Study to Evaluation the Safety and Tolerability of 90Y-SMT 487 Administered by Intravenous Infusion to Subjects With Refractory Somatostatin-Receptor Positive Tumors|Completed||Phase 1|60|Actual|Novartis|||||f||||||||||||||2017-02-18 18:12:51.856473|2017-02-18 18:12:51.856473
NCT00006367|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2010-06-15|||May 2000||2000-05-01|June 2010|2010-06-01|January 2004|Actual|2004-01-01|||||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis|Autologous Peripheral Blood Stem Cell Mobilization and Transplantation for Myelofibrosis|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:12:51.962482|2017-02-18 18:12:51.962482
NCT00006366|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-07-17|||February 2001||2001-02-01|December 2002|2002-12-01||||December 2003|Actual|2003-12-01||Interventional|||Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum|Randomized Phase II Trial of Preoperative Combined Modality Chemoradiation for Distal Rectal Cancer|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:12:52.195851|2017-02-18 18:12:52.195851
NCT00006365|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2014-01-23|||November 2000||2000-11-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|December 2006|Actual|2006-12-01||Interventional|||External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer|A Phase II Study of External Beam Radiation Therapy Combined With Permanent Source Brachytherapy for Intermediate Risk Clinically Localized Adenocarcinoma of the Prostate|Completed||Phase 2|138|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:12:52.738572|2017-02-18 18:12:52.738572
NCT00006364|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-01-22|||November 1999||1999-11-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia|Phase I and Pilot Study of Subcutaneous Homoharringtonine in Chronic Myelogenous Leukemia|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:12:53.121949|2017-02-18 18:12:53.121949
NCT00006363|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-06-03|||November 2000||2000-11-01|June 2013|2013-06-01||||June 2005|Actual|2005-06-01||Interventional|||Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia|Phase III Randomized Study of Induction Chemotherapy With or Without MDR-Modulation With PSC-833 (NSC # 648265, IND # 41121) Followed by Cytogenetic Risk-Adapted Intensification Therapy Followed by Immunotherapy With rIL-2 (NSC # 373364, IND # 1969) vs. Observation in Previously Untreated Patients With AML &lt; 60 Years|Completed||Phase 3|720|Actual|National Cancer Institute (NCI)||7|||f||||||||||||||2017-02-18 18:12:53.239485|2017-02-18 18:12:53.239485
NCT00006362|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2011-08-01|||November 1999||1999-11-01|August 2011|2011-08-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||PS-341 in Treating Patients With Advanced Cancer|A Phase I and Pharmacologic Study of the Proteasome Inhibitor PS-341 in Patients With Advanced Solid Tumors and B-cell Lymphoproliferative Disorders|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:12:53.396741|2017-02-18 18:12:53.396741
NCT00006361|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2009-12-03|||December 2000||2000-12-01|December 2002|2002-12-01||||January 2003|Actual|2003-01-01||Interventional|||SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck|A Phase II Trial of SU5416 (NSC #696819) in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:53.492143|2017-02-18 18:12:53.492143
NCT00006360|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2016-12-30|||February 2001||2001-02-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2005|Actual|2005-11-01||Interventional|||Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer|Conformal and Intensity Modulated Irradiation for Oropharyngeal Cancer|Completed||Phase 1/Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:12:53.5888|2017-02-18 18:12:53.5888
NCT00006359|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2016-07-15|||September 2000||2000-09-01|July 2016|2016-07-01|March 2012|Actual|2012-03-01|October 2007|Actual|2007-10-01||Interventional|||Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer|Phase II Trial of Androgen Suppression for 6 Months Combined With External Beam Radiotherapy (EBRT) With Brachytherapy (BT) Boost for Intermediate Risk Prostate Cancer|Completed||Phase 2|63|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:12:53.710019|2017-02-18 18:12:53.710019
NCT00006358|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2008-07-23|||May 2000||2000-05-01|October 2006|2006-10-01||||||||Interventional|||Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor|Phase II Evaluation of Temozolomide (SCH52365) and Thalidomide for the Treatment of Recurrent and Progressive Glioblastoma Multiforme|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:53.955724|2017-02-18 18:12:53.955724
NCT00006357|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-09-20|||August 2000||2000-08-01|September 2012|2012-09-01||||April 2001|Actual|2001-04-01||Interventional|||STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma|Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma|Completed||Phase 1/Phase 2|91|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:12:54.066487|2017-02-18 18:12:54.066487
NCT00006356|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-09-20|||August 2000||2000-08-01|September 2012|2012-09-01||||October 2002|Actual|2002-10-01||Interventional|||Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer|A Randomized Phase III Study for the Treatment of Recurrent Epithelial Ovarian Cancer: Chemotherapy Alone Versus Chemotherapy Followed by Secondary Cytoreductive Surgery in Patients With a Treatment-Free Interval of More Than 12 Months|Terminated||Phase 3|38|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:12:54.184892|2017-02-18 18:12:54.184892
NCT00006355|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-05-01|||May 2000||2000-05-01|May 2012|2012-05-01|October 2006|Actual|2006-10-01|October 2004|Actual|2004-10-01||Interventional|||Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme|Phase I/II Study of Pyrazoloacridine (PZA) in Adults With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 1/Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:12:54.289396|2017-02-18 18:12:54.289396
NCT00006354|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-07-23|||August 2000||2000-08-01|July 2012|2012-07-01||||March 2003|Actual|2003-03-01||Interventional|||Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy|Phase I Clinical Trial of Recombinant Viscumin (rViscumin, rMistletoe Lectin, rML) Administered Twice Weekly By The Intravenous Route In Patients With Solid Tumors After Failure of Standard Therapy|Completed||Phase 1|41|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:12:54.399572|2017-02-18 18:12:54.399572
NCT00006353|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-09-20|||July 2000||2000-07-01|September 2012|2012-09-01||||March 2002|Actual|2002-03-01||Interventional|||Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme - A Randomized Phase III Study|Completed||Phase 3|575|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:12:54.484427|2017-02-18 18:12:54.484427
NCT00006352|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-07-17|||September 1999||1999-09-01|July 2012|2012-07-01||||October 2002|Actual|2002-10-01||Interventional|||Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer|The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG|Completed||Phase 3|453|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:12:54.7995|2017-02-18 18:12:54.7995
NCT00006351|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-09-20|||June 2000||2000-06-01|September 2012|2012-09-01||||December 2001|Actual|2001-12-01||Interventional|||SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract|Phase II Study on SCH 66336 (Farnesyl Protein Transferase Inhibitor) and Gemcitabine as Second Line Treatment in Advanced Metastatic Urothelial Cancer - EORTC Study 16997|Completed||Phase 2|34|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:12:54.908399|2017-02-18 18:12:54.908399
NCT00006350|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2009-02-06|||April 2000||2000-04-01|January 2002|2002-01-01||||||||Interventional|||Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies After a Non-Myeloablative Conditioning Regimen From HLA-Matched Sibling Donors|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:55.018069|2017-02-18 18:12:55.018069
NCT00006349|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2016-07-12|||February 2001||2001-02-01|July 2016|2016-07-01|January 2007|Actual|2007-01-01|January 2005|Actual|2005-01-01||Interventional|||Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer|An Exploratory Trial of Donepezil and Vitamin E to Prevent Cognitive Dysfunction in Patients With Small Cell Lung Cancer (SCLC) After Cancer Treatment Which Includes Prophylatic Cranial Irradiation (PCI)|Completed||Phase 3|9|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:12:55.13214|2017-02-18 18:12:55.13214
NCT00006348|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2016-07-01|||October 2000||2000-10-01|July 2016|2016-07-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment|Phase III, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Ondansetron in the Control of Chronic Nausea and Vomiting Not Due to Antineoplastic Therapy in Patients With Advanced Cancer|Completed||Phase 3|100|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:12:55.286286|2017-02-18 18:12:55.286286
NCT00006347|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2009-02-28|||August 2000||2000-08-01|April 2003|2003-04-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer|Phase I Non-Myeloablative Trial With 90Y-Humanized MN-14 (Anti-CEA) Antibody for Relapsed or Refractory Small Cell Lung Cancer (SCLC)|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:55.441221|2017-02-18 18:12:55.441221
NCT00006346|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-07-09|||August 2000||2000-08-01|March 2010|2010-03-01|September 2003|Actual|2003-09-01|||||Interventional|||Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer|Stress Reduction For Breast Cancer in Women 55 Years of Age or Older: Enhancing Quality of Life and Survival|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:55.541058|2017-02-18 18:12:55.541058
NCT00006345|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-05-29|||November 1999||1999-11-01|November 2001|2001-11-01|March 2004|Actual|2004-03-01|||||Interventional|||Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma|An Evaluation of Corticosteroid Pretreatment in Cutaneous T-Cell Lymphoma Patients Receiving Ontak (Denileukin Difitox)|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:12:55.635715|2017-02-18 18:12:55.635715
NCT00006344|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2015-05-15|||May 2000||2000-05-01|May 2015|2015-05-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer|A Randomized, Phase III Dose Response Study of Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Lung|Withdrawn||Phase 3|0|Actual|Virginia Commonwealth University||||PI left institution|f||||f||||||||||2017-02-18 18:12:55.746122|2017-02-18 18:12:55.746122
NCT00006343|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-12-30|||June 2000||2000-06-01|December 2012|2012-12-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia|A Phase III Study of STI571 Versus Interferon-a (IFN-a) Combined With Cytarabine (Ara-C) in Patients With Newly Diagnosed Previously Untreated Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)|Completed||Phase 3|||Novartis|||||f||||f||||||||||2017-02-18 18:12:55.839907|2017-02-18 18:12:55.839907
NCT00006342|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2015-10-13|||January 1997||1997-01-01|June 2013|2013-06-01|January 2001|Actual|2001-01-01|September 2000|Actual|2000-09-01||Observational|||Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor|Analyses of Mutations Associated With Secondary Leukemia or Non-Hodgkin's Lymphoma in Patients Treated for Hodgkin's Disease or Childhood Brain Tumors|Completed||N/A|19|Actual|Duke University|||1||f||||||||||||||2017-02-18 18:12:55.947602|2017-02-18 18:12:55.947602
NCT00006341|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2016-01-29|||June 1997||1997-06-01|January 2016|2016-01-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer|Efficacy of Implant-Supported Maxillofacial Prostheses|Completed||Phase 2|46|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||No||2017-02-18 18:12:56.04256|2017-02-18 18:12:56.04256
NCT00006340|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2013-07-25|||December 1994||1994-12-01|July 2013|2013-07-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus|A PHASE I TRIAL OF BUTYRATE AND GANCICLOVIR IN EBV-ASSOCIATED MALIGNANCIES|Completed||Phase 1|||Boston Medical Center|||||f||||||||||||||2017-02-18 18:12:56.133932|2017-02-18 18:12:56.133932
NCT00006339|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection|A Prospective Randomized Open-Label Clinical Trial to Evaluate the Comparative Efficacy and Safety of a Potent Antiretroviral Treatment Regimen With or Without Hydroxyurea for Subjects With Acute HIV-1 Infection or Recent HIV-1 Seroconversion|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:56.250296|2017-02-18 18:12:56.250296
NCT00006337|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2008-03-03|||October 2000||2000-10-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||KW-6002 to Treat Parkinson's Disease|Adenosine A2A Blockade With KW-6002 in Parkinson's Disease|Completed||Phase 2|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:56.338454|2017-02-18 18:12:56.338454
NCT00006336|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2008-03-03|||September 2000||2000-09-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Sensory Training to Treat Focal Dystonia|Sensory Training for Treatment of Focal Dystonia|Completed||N/A|22||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:56.427215|2017-02-18 18:12:56.427215
NCT00006335|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2017-01-24|||September 26, 2000||2000-09-26|September 23, 2009|2009-09-23||||September 25, 2008|Actual|2008-09-25||Observational|||Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID|Decisions of Female Adolescents About Carrier Testing in Families With X-Linked Severe Combined Immunodeficiency (XSCID)|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:56.505463|2017-02-18 18:12:56.505463
NCT00006334|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2017-01-24|||September 26, 2000||2000-09-26|July 8, 2014|2014-07-08|July 8, 2014||2014-07-08|||||Observational|||Turner Syndrome: Genotype and Phenotype|Turner Syndrome: Genotype and Phenotype|Completed||N/A|1017|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:56.594627|2017-02-18 18:12:56.594627
NCT00006333|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2017-01-24|||September 26, 2000||2000-09-26|November 25, 2016|2016-11-25||||||||Observational|||Study of Arthritis and Related Conditions|Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:56.681879|2017-02-18 18:12:56.681879
NCT00006332|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate||Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:56.774465|2017-02-18 18:12:56.774465
NCT00006331|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2005-06-27||||||December 2003|2003-12-01||||||||Observational|||Prospective Controlled Study of Posttransplant Diabetes||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:56.844906|2017-02-18 18:12:56.844906
NCT00006330|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:56.926757|2017-02-18 18:12:56.926757
NCT00006329|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Comparison of Two Methods of Parathyroidectomy for Primary Hyperparathyroidism||Completed||Phase 2/Phase 3|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:57.002166|2017-02-18 18:12:57.002166
NCT00006328|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-04|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:12:57.199141|2017-02-18 18:12:57.199141
NCT00006327|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-02|2005-06-23|||March 1999||1999-03-01|June 2003|2003-06-01|August 2000||2000-08-01|||||Interventional|||Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand|A Phase III Trial to Determine the Efficacy of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand|Completed||Phase 3|2500||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:12:57.266609|2017-02-18 18:12:57.266609
NCT00006326|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-02|2005-06-23|||August 2000||2000-08-01|July 2002|2002-07-01||||||||Interventional|||Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir|A Randomized, Open-Label Study to Evaluate 3 Salvage Regimens in HIV-Infected Subjects Experiencing Virologic Failure on an Initial HAART Regimen Containing Nelfinavir|Terminated||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:12:57.355138|2017-02-18 18:12:57.355138
NCT00006325|ClinicalTrials.gov processed this data on February 17, 2017|2000-10-02|2012-05-18||||||May 2012|2012-05-01|March 2004|Actual|2004-03-01|||||Interventional|||Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children|Safety, Tolerability, Antiviral Activity, and Pharmacokinetics of PEG-Intron in HIV-1 Infected Children|Completed||Phase 1|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:12:57.443737|2017-02-18 18:12:57.443737
NCT00006320|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-30|2008-03-03|||September 2000||2000-09-01|July 2004|2004-07-01|July 2004||2004-07-01|||||Interventional|||Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women|Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:57.870529|2017-02-18 18:12:57.870529
NCT00006319|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-30|2017-02-10|||September 24, 2000||2000-09-24|October 12, 2016|2016-10-12||||||||Observational|||Molecular and Clinical Studies of Primary Immunodeficiency Diseases|Molecular and Clinical Studies of Primary Immunodeficiency Diseases|Enrolling by invitation||N/A|256|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:57.962532|2017-02-18 18:12:57.962532
NCT00006318|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-30|2008-03-03|||September 2000||2000-09-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||Role of Prostaglandins in the Regulation of Brain Blood Flow|Role of Prostaglandins in the Control of Cerebral Blood Flow During Hypercapnia and Functional Activation in Humans|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:12:58.047888|2017-02-18 18:12:58.047888
NCT00006316|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2008-07-30||||||February 2004|2004-02-01||||||||Observational|||Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs|Discontinuation of Antifungal Therapy for Histoplasmosis Following Immunologic Response to Antiretroviral Therapy|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:12:58.130352|2017-02-18 18:12:58.130352
NCT00006315|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-05-12|||September 1999||1999-09-01|May 2005|2005-05-01|August 2004|Actual|2004-08-01|||||Observational|||Dose/Response of Exercise on Long Term Weight Loss||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:58.233924|2017-02-18 18:12:58.233924
NCT00006314|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-05-12|||July 1999||1999-07-01|January 2006|2006-01-01|June 2004|Actual|2004-06-01|||||Observational|||Cytomegalovirus Spread and Reactivation in Blood Cells||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:58.315158|2017-02-18 18:12:58.315158
NCT00006313|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-05-12|||June 1999||1999-06-01|September 2002|2002-09-01|June 2000|Actual|2000-06-01|||||Observational|||Hormone Therapy Effects on CVD Risk Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:58.387009|2017-02-18 18:12:58.387009
NCT00006312|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-01-14|||July 1999||1999-07-01|January 2016|2016-01-01|May 2003||2003-05-01|||||Observational|||Hemochromatosis--Genetic Prevalence and Penetrance||Completed||N/A|||University of Rochester|||||f||||||||||||||2017-02-18 18:12:58.449107|2017-02-18 18:12:58.449107
NCT00006311|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-02-17|||June 1999||1999-06-01|January 2006|2006-01-01|May 2004|Actual|2004-05-01|||||Observational|||Anxiety and Vagal Control of the Heart in Coronary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:58.516255|2017-02-18 18:12:58.516255
NCT00006310|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-03-08|||April 1999||1999-04-01|March 2016|2016-03-01|March 2004||2004-03-01|||||Observational|||KSHV Infection in Blood Donors From Texas|KSHV Seroprevalence in Hospital Patients From San Antonio|Completed||N/A|||The University of Texas Health Science Center at San Antonio|||||f||||f||||||||No||2017-02-18 18:12:58.588973|2017-02-18 18:12:58.588973
NCT00006309|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-02-17|||September 1999||1999-09-01|December 2004|2004-12-01|August 2002|Actual|2002-08-01|||||Observational|||Pooling of Cohort Studies on Diet & Coronary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:58.665207|2017-02-18 18:12:58.665207
NCT00006308|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2014-05-07|||September 1999||1999-09-01|May 2014|2014-05-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Observational|||Observational Cohort Study of Sodium, Weight and Cardiovascular Disease|Observational Cohort Study of Sodium, Weight and Cardiovascular Disease|Completed||N/A|||Brigham and Women's Hospital|||||f||||f||||||||||2017-02-18 18:12:58.733946|2017-02-18 18:12:58.733946
NCT00006307|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-02-17|||August 2000||2000-08-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Epidemiology of Body Mass Index Rebound||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:58.810289|2017-02-18 18:12:58.810289
NCT00006306|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-02-26|||September 1999||1999-09-01|January 2006|2006-01-01|August 2004|Actual|2004-08-01|||||Observational|||Effects of Chronic Ozone Exposure on Lung Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:12:58.878709|2017-02-18 18:12:58.878709
NCT00006305|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-28|2016-01-12|2011-01-27||September 2000||2000-09-01|January 2016|2016-01-01|March 2009|Actual|2009-03-01|November 2008|Actual|2008-11-01||Interventional|BARI2D||Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes|Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes|Completed||Phase 3|2368|Actual|University of Pittsburgh||4|||f||||t||||||||||2017-02-18 18:12:58.947814|2017-02-18 18:12:58.947814
NCT00006304|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-27|2013-10-04||||||October 2013|2013-10-01|May 2002|Actual|2002-05-01|||||Observational|||Long-Term Effects of HIV Exposure and Infection in Children|Pediatric Late Outcomes Protocol|Completed||N/A|4150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:02.699985|2017-02-18 18:13:02.699985
NCT00006301|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-27|2017-01-24|||September 24, 2000||2000-09-24|March 24, 2015|2015-03-24|March 24, 2015||2015-03-24|||||Observational|||Immune Response to Hepatitis C Virus|Evaluation of the Immune Response in Humans After Exposure to Hepatitis C Virus|Completed||N/A|46|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:03.156036|2017-02-18 18:13:03.156036
NCT00006300|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-27|2008-03-03|||April 2000||2000-04-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Observational|||Oral Manifestations of Aplastic Anemia|Oral Manifestations of Aplastic Anemia|Completed||N/A|146||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:03.249291|2017-02-18 18:13:03.249291
NCT00006299|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-27|2008-03-03|||December 1999||1999-12-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Celebrex for Pain Relief After Oral Surgery|In Vivo Selectivity of Cyclooxygenase Inhibitors in the Oral Surgery Model|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:03.340587|2017-02-18 18:13:03.340587
NCT00006298|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-26|2008-09-24||||||July 2004|2004-07-01||||||||Observational|||Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa|Virological and Immunological Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa|Completed||N/A|125||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:03.440562|2017-02-18 18:13:03.440562
NCT00006297|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-25|2016-02-17|||September 2000||2000-09-01|October 2005|2005-10-01|July 2005|Actual|2005-07-01|||||Observational|||Risk Factors for CV Disease in a Dialysis Cohort||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:13:03.528371|2017-02-18 18:13:03.528371
NCT00006292|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-23|2008-03-03|||September 2000||2000-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Infliximab for the Treatment of Early Rheumatoid Arthritis|Randomized Double Blind Active Treatment Controlled Trial of the Anti-TNF-Alpha Antibody Infliximab in Patients With Erosive Rheumatoid Arthritis|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:03.854126|2017-02-18 18:13:03.854126
NCT00006291|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-22|2012-05-17||||||May 2012|2012-05-01|October 2005|Actual|2005-10-01|||||Interventional|||Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination|A Phase II, Randomized, Partially Blinded Trial of Combinations of Potent Antiretroviral Therapy, HIV-Specific Immunizations, and Cycles of Interleukin-2 to Promote Efficient Control of Viral Replication|Completed||Phase 2|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:13:03.946605|2017-02-18 18:13:03.946605
NCT00006290|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-21|2008-09-24||||||June 2003|2003-06-01||||||||Observational|||Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs|Perceived Changes in Body Habitus and Body Image Among HIV+ Persons Currently Receiving or Recently Discontinuing Combination Antiretroviral Therapy|Completed||N/A|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:04.06926|2017-02-18 18:13:04.06926
NCT00006289|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-21|2016-12-12|2013-06-04||September 2000||2000-09-01|December 2016|2016-12-01|June 2012|Actual|2012-06-01|June 2012|Actual|2012-06-01||Interventional||Clinical evaluation includes blood chemistries (acute care, hepatic panel, and mineral panel) as well as measurements of pain (including allodynia, hyperalgesia, and hyperpathia), edema, autonomic dysfunction (altered skin color, temperature, or sudomotor activity) and extent of movement disorders.|Neurotropin to Treat Chronic Neuropathic Pain|Neurotropin for Acute Dental Pain and for Chronic Neuropathic Pain|Terminated||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)|Because of the difficulty in patient recruitment, the interim analysis was performed for the first 16 patients (target was 30). The results are inconclusive due to large variations in pain scores associated with insufficient the number of patients.|2||difficulty in the recruitment of patients|f||||f||||||||||2017-02-18 18:13:04.155322|2017-02-18 18:13:04.155322
NCT00006286|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-14|2014-04-16|||September 1998||1998-09-01|November 2005|2005-11-01|March 2004||2004-03-01|||||Interventional|||Treatment for Adolescents With Depression Study (TADS)|Treatment for Adolescents With Depression Study (TADS)|Completed||Phase 3|432||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:13:04.657704|2017-02-18 18:13:04.657704
NCT00006285|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-16|2017-01-24|||September 14, 2000||2000-09-14|June 8, 2009|2009-06-08|April 1, 2002|Actual|2002-04-01|April 1, 2002|Actual|2002-04-01||Observational|||Use of Transcranial Magnetic Stimulation (TMS) and Magnetic Resonance Imaging (MRI) to Study Visual Attention|Transcranial Magnetic Stimulation Studies of Visual Attention|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:04.769187|2017-02-18 18:13:04.769187
NCT00006280|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2010-03-01|||February 2000||2000-02-01|March 2010|2010-03-01|February 2002||2002-02-01|||||Interventional|||A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis|A Phase II Multicenter Randomized Trial of Tobramycin for Inhalation in Young Children With Cystic Fibrosis|Completed||Phase 2|98||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:04.847305|2017-02-18 18:13:04.847305
NCT00006279|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-14|2012-02-13||||||February 2012|2012-02-01|May 2005|Actual|2005-05-01|||||Interventional|||The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months|Phase I/II Study to Assess the Safety and Plasma Concentrations of Nevirapine Given Daily, Twice a Week or Weekly as Prophylaxis in Breastfeeding Infants From Birth to 6 Months|Completed||Phase 1|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:05.19866|2017-02-18 18:13:05.19866
NCT00006278|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-14|2008-03-03|||September 2000||2000-09-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Observational|||Study of Cushing's Syndrome Not Related to ACTH Production|The Molecular and Cellular Etiology of ACTH-Independent Adrenal Disease|Completed||N/A|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:05.314512|2017-02-18 18:13:05.314512
NCT00006276|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-14|2008-03-03|||September 2000||2000-09-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Micellar Paclitaxel to Treat Severe Psoriasis|A Pilot Open-Label Single-Dose Study Using Intravenous Micellar Paclitaxel for Patients With Severe Psoriasis|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:05.397484|2017-02-18 18:13:05.397484
NCT00006275|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||July 2000||2000-07-01|September 2000|2000-09-01|July 2000||2000-07-01|||||Interventional|||Study of Topical Calcitriol in Children With Psoriasis||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:05.495889|2017-02-18 18:13:05.495889
NCT00006274|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||March 1997||1997-03-01|December 2003|2003-12-01||||||||Observational|||Study of Energy Requirements in Critically Ill Newborns|Study of Energy Requirements in Critically Ill Newborns|Unknown status|Recruiting|N/A|60||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:05.578369|2017-02-18 18:13:05.578369
NCT00006273|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||June 1996||1996-06-01|December 2003|2003-12-01||||||||Observational|||Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis|Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis|Unknown status|Active, not recruiting|N/A|60||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:05.667504|2017-02-18 18:13:05.667504
NCT00006272|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||August 1994||1994-08-01|December 2003|2003-12-01||||||||Observational|||Study of Energy Expenditure in Infants With Ventricular Septal Defects|Study of Energy Expenditure in Infants With Ventricular Septal Defects|Unknown status|Recruiting|N/A|20||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:05.750358|2017-02-18 18:13:05.750358
NCT00006271|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||January 1997||1997-01-01|December 2003|2003-12-01||||||||Observational|||Phase I/II Study of Neuroendocrine Dysfunction in Patients With Closed Head Injuries||Unknown status|Active, not recruiting|N/A|100||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:05.833798|2017-02-18 18:13:05.833798
NCT00006270|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||February 1998||1998-02-01|December 2003|2003-12-01||||||||Observational|||Study of the Approximate Entropy of Adrenocorticotropic Hormone and Cortisol Secretion in Patients With Head Injury||Unknown status|Active, not recruiting|N/A|32||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:05.927392|2017-02-18 18:13:05.927392
NCT00006269|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2012-05-24|||December 1999||1999-12-01|May 2012|2012-05-01||||December 1999|Actual|1999-12-01||Interventional|||Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer|A Prospective, Randomized Trial of Sandostatin LAR Depot for the Prevention of Irinotecan-Induced Diarrhea in Patients With Metastatic Colorectal Cancer|Terminated||Phase 3|89|Actual|Novartis|||||f||||||||||||||2017-02-18 18:13:06.025808|2017-02-18 18:13:06.025808
NCT00006268|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-06-20|||October 2000||2000-10-01|March 2005|2005-03-01|March 2005|Actual|2005-03-01|||||Interventional|||Immunotoxin Therapy in Treating Patients With Malignant Glioma|Interstitial Infusion of IL 13-PE38QQR Cytotoxin in Recurrent Malignant Glioma: Phase I/II Study|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:06.138817|2017-02-18 18:13:06.138817
NCT00006267|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-07-08||||||May 2004|2004-05-01||||May 2006|Actual|2006-05-01||Interventional|||Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Evaluation Of 9-Nitro-Camptothecin In The Third-Line Treatment Of Recurrent Ovarian Or Primary Peritoneal Cancer|Withdrawn||Phase 2|0|Actual|Gynecologic Oncology Group||||Never activated.|f||||||||||||||2017-02-18 18:13:06.249221|2017-02-18 18:13:06.249221
NCT00006265|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2016-07-12|||March 2001||2001-03-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|December 2004|Actual|2004-12-01||Interventional|||Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|A Dose Escalation And Phase II Study Of Gemtuzumab Ozogamicin (CMA-676; Mylotarg) With High-Dose Cytarabine For Patients With Refractory Or Relapsed Acute Myeloid Leukemia (AML)|Completed||Phase 2|60|Actual|Alliance for Clinical Trials in Oncology||4|||f||||f||||||||||2017-02-18 18:13:06.342609|2017-02-18 18:13:06.342609
NCT00006264|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2016-02-01|||July 2000||2000-07-01|February 2016|2016-02-01|July 2003|Actual|2003-07-01|March 2003|Actual|2003-03-01||Interventional|||Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma|A Phase II Trial Of Induction Therapy With Zidovudine, Interleukin-2, And Ganciclovir In The Treatment Of HIV Positive Primary Central Nervous System Lymphoma|Completed||Phase 2|||AIDS Malignancy Consortium|||||f||||||||||||||2017-02-18 18:13:06.55252|2017-02-18 18:13:06.55252
NCT00006263|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2015-08-03|||November 1997||1997-11-01|August 2015|2015-08-01||||||||Interventional|||Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma|Phase II Trial of Temozolomide, Carboplatin and Neupogen in High-Grade Gliomas, Both Newly-Diagnosed and Recurrent|Withdrawn||Phase 2|0|Actual|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:13:06.664608|2017-02-18 18:13:06.664608
NCT00006262|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2012-06-07||2011-02-16|July 2000||2000-07-01|June 2012|2012-06-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer|A Phase 2 Study of BMY-27557-14 (a Rebeccamycin Analog) in Patients With Ovarian Cancer|Terminated||Phase 2|||Northwestern University||||Unable to accrue patients to the study.|f||||t||||||||||2017-02-18 18:13:06.773889|2017-02-18 18:13:06.773889
NCT00006261|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2010-06-09|||May 2000||2000-05-01|June 2010|2010-06-01||||||||Interventional|||Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer|Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:13:06.865902|2017-02-18 18:13:06.865902
NCT00006260|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2010-06-09|||May 1997||1997-05-01|June 2010|2010-06-01||||January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer|A Phase II Study Of An OutPatient Three Day VIP Regimen With Oral Mesna For Metastatic Breast Cancer|Completed||Phase 2|36|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:13:06.965718|2017-02-18 18:13:06.965718
NCT00006259|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2010-06-09|||January 2000||2000-01-01|June 2010|2010-06-01|February 2005|Actual|2005-02-01|November 2001|Actual|2001-11-01||Interventional|||Stereotactic Radiation Therapy in Treating Patients With Brain Metastases|A Phase II Trial of Radiosurgery Alone for Brain Metastases in Elderly Patients or Patients With Poor Performance Status|Completed||Phase 2|10|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:13:07.069422|2017-02-18 18:13:07.069422
NCT00006258|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-07-17|||November 1997||1997-11-01|December 2004|2004-12-01|January 2005|Actual|2005-01-01|||||Interventional|||Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma|Dose Intensive Chemotherapy for Patients Greater Than or Equal To 10 Years of Age With Newly Diagnosed High Stage Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumors (PNET) and Ependymoma: A Feasibility Study of an Intensive Induction Chemotherapy Regimen Followed by Standard Irradiation|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:07.166158|2017-02-18 18:13:07.166158
NCT00006257|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2010-01-11|||November 2000||2000-11-01|January 2010|2010-01-01||||||||Interventional|||SU5416 and Paclitaxel in Treating Patients With Advanced Cancer|Phase I Trial of SU5416 in Combination With Weekly Paclitaxel in Patients With Advanced Malignancies|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:13:07.271732|2017-02-18 18:13:07.271732
NCT00006256|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2016-09-15|||June 2000||2000-06-01|September 2016|2016-09-01|August 2017|Anticipated|2017-08-01|November 2005|Actual|2005-11-01||Interventional|||Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer|Concurrent Taxol (Paclitaxel) and Definitive Breast Radiation Therapy in Early Stage Breast Cancer Following Four Cycles of Adriamycin/Cytoxan Chemotherapy|Active, not recruiting||Phase 2|44|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:13:07.36762|2017-02-18 18:13:07.36762
NCT00006255|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2010-06-09|||April 2000||2000-04-01|June 2010|2010-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases|A Phase II Study of Magnetic Resonance Guided and Monitored Interstitial Thermal Radiofrequency Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases|Completed||Phase 2|17|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:13:07.482907|2017-02-18 18:13:07.482907
NCT00006254|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-07-17|||May 2000||2000-05-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||VNP20009 in Treating Patients With Advanced Solid Tumors|A Phase I Trial of a Live, Genetically Modified Salmonella Typhimurium (VNP20009) for the Treatment of Cancer by Intravenous Administration|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:07.590511|2017-02-18 18:13:07.590511
NCT00006252|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2016-07-15|||February 2001||2001-02-01|July 2016|2016-07-01|October 2011|Actual|2011-10-01|January 2007|Actual|2007-01-01||Interventional|||Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma|Minimal Ablation and Cellular Immune Therapy of Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Low-Grade Non-Hodgkin's Lymphoma, and Mantle Cell Lymphoma With Allogeneic Donor Stem Cells|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:13:08.052355|2017-02-18 18:13:08.052355
NCT00006251|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2016-08-01|||May 2000||2000-05-01|August 2016|2016-08-01||||September 2005|Actual|2005-09-01||Interventional|||Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer|Induction of Mixed Hematopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Active, not recruiting||Phase 1/Phase 2|21|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:13:08.210461|2017-02-18 18:13:08.210461
NCT00006250|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-09-19|||May 2000||2000-05-01|March 2007|2007-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma|Randomized Trial of MCD Versus FMD in Untreated Advanced Follicular Lymphoma|Unknown status|Active, not recruiting|Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:08.376456|2017-02-18 18:13:08.376456
NCT00006249|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2015-02-09|||June 2000||2000-06-01|February 2015|2015-02-01||||August 2003|Actual|2003-08-01||Interventional|||Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma|PEG-Intron Observation After Regional Lymph Node Dissection in AJCC Stage III (TxN1-2MO) Melanoma Patients: a Randomized Phase III Trial|Unknown status|Active, not recruiting|Phase 3|1258|Actual|European Organisation for Research and Treatment of Cancer - EORTC||2|||f||||||||||||||2017-02-18 18:13:08.546978|2017-02-18 18:13:08.546978
NCT00006248|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-04-08|||November 2000||2000-11-01|April 2013|2013-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Evaluation of Three Hour Infusion of Paclitaxel Plus Cisplatin and 5-Fluorouracil in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|78|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:13:08.780082|2017-02-18 18:13:08.780082
NCT00006247|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2009-10-13|||August 2000||2000-08-01|October 2009|2009-10-01|March 2006|Actual|2006-03-01|July 2003|Actual|2003-07-01||Interventional|||SU5416 in Treating Children With Recurrent or Progressive Brain Tumors|A Phase I Study of SU5416 in Pediatric Patients With Recurrent or Progressive Poor Prognosis Brain Tumors|Terminated||Phase 1|33|Actual|Pediatric Brain Tumor Consortium||||The pharmaceutical company discontinued further development of SU5416.|f||||t||||||||||2017-02-18 18:13:08.993935|2017-02-18 18:13:08.993935
NCT00006246|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2009-10-06|||November 2000||2000-11-01|October 2009|2009-10-01||||May 2003|Actual|2003-05-01||Interventional|||Busulfan in Treating Children and Adolescents With Refractory CNS Cancer|Phase I Study of Intrathecal Spartaject-Busulfan in Children With Neoplastic Meningitis|Completed||Phase 1|28|Actual|Pediatric Brain Tumor Consortium|||||||||t||||||||||2017-02-18 18:13:09.115401|2017-02-18 18:13:09.115401
NCT00006245|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-06-20|||July 2000||2000-07-01|April 2004|2004-04-01|August 2007|Actual|2007-08-01|||||Interventional|||Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel|Phase II Trial of Flavopiridol and Paclitaxel in Patients With Paclitaxel-Refractory Esophageal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:09.267925|2017-02-18 18:13:09.267925
NCT00006244|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2016-06-01|||February 2000||2000-02-01|June 2016|2016-06-01||||April 2016|Actual|2016-04-01||Interventional|||Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma|Immunotherapy for Autologous/Syngeneic Peripheral Blood Stem Cell (PBSC) Transplant Patients as Treatment for Advanced Multiple Myeloma|Completed||Phase 2|36|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 18:13:09.380268|2017-02-18 18:13:09.380268
NCT00006243|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-01-24|||October 2000||2000-10-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma|Melanoma Vaccines: Differentiation Antigen Peptides (MART-1:27-35, Tyrosinase and Gp-100) as Immune Targets|Completed||N/A|30|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:13:09.510378|2017-02-18 18:13:09.510378
NCT00006242|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-01-31|||July 2000||2000-07-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||BMS-214662 in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Farnesyltransferase Inhibitor BMS-214662 (NSC 710086) Escalating to a 24 Hour Continuous Intravenous Infusion in Patients With Solid Tumors|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:09.633291|2017-02-18 18:13:09.633291
NCT00006241|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2011-11-28|||March 2000||2000-03-01|November 2011|2011-11-01|October 2000|Actual|2000-10-01|||||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma|A Pivotal Study to Determine the Safety and Efficacy of Using B-Cell High Density Microparticles (BCell-HDM) to Deplete B-Cells From Peripheral Blood Stem Cell Collections Without Compromising the Time to Neutrophil and Platelet Engraftment in Patients With Relapsed Low or Intermediate Grade B-Cell Non-Hodgkin's Lymphoma Given Autologous Peripheral Blood Stem Cell Transplants After High-Dose Chemotherapy|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:13:09.732281|2017-02-18 18:13:09.732281
NCT00006240|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2015-04-27|||October 2000||2000-10-01|November 2002|2002-11-01|August 2001|Actual|2001-08-01|||||Interventional|||Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia|A Pilot Study of Phenylbutyrate, Dexamethasone and GM-CSF in Refractory or Relapsed t(8;21) Acute Myeloid Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:09.826113|2017-02-18 18:13:09.826113
NCT00006239|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2010-03-09|||December 2000||2000-12-01|March 2010|2010-03-01||||||||Interventional|||Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer|A Phase I, Dose-Finding Trial of Sodium Phenylbutrate (NSC 657802) in Combination With All Trans-retinoic Acid (ATRA, NSC 122758) in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:13:09.924025|2017-02-18 18:13:09.924025
NCT00006237|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2015-03-05|2012-08-20||August 2000||2000-08-01|March 2015|2015-03-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma|Phase III Trial of High Dose Interferon Alfa 2-b Versus Cisplatin, Vinblastine, DTIC Plus IL-2 and Interferon in Patients With High Risk Melanoma|Completed||Phase 3|432|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:13:10.033243|2017-02-18 18:13:10.033243
NCT00006235|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-07-08||||||February 2006|2006-02-01||||February 2006|Actual|2006-02-01||Interventional|||Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase I Trial of Combination Carboplatin and Lipsomal Doxorubicin (Doxil) In Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer|Completed||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:13:11.262448|2017-02-18 18:13:11.262448
NCT00006234|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2011-11-30|||November 2001||2001-11-01|November 2011|2011-11-01|March 2006|Actual|2006-03-01|||||Interventional|||Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone|A Phase I/II Study of 166Ho-DOTMP With Peripheral Blood Progenitor Cell Support for Refractory or Recurrent Ewing's Sarcoma Family of Tumors With Bone Disease|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:13:11.340836|2017-02-18 18:13:11.340836
NCT00006233|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2011-11-28|||January 2000||2000-01-01|November 2011|2011-11-01|December 2003|Actual|2003-12-01|||||Interventional|||Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma|Phase II Trial of Non-Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation Using Fludarabine, Low-Dose TBI, and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil (MMF) Followed by Donor Lymphocyte Infusion in Selected Patients With Metastatic Melanoma|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:13:11.434026|2017-02-18 18:13:11.434026
NCT00006232|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-05-14|||October 1996||1996-10-01|March 2007|2007-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma|A Randomized Trial Comparing Z-Dex With VAD as Induction Therapy for Patients With Multiple Myeloma|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:11.529166|2017-02-18 18:13:11.529166
NCT00006231|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-12-18|||February 1998||1998-02-01|October 2000|2000-10-01|December 2002|Actual|2002-12-01|||||Interventional|||Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma|A Randomized Study to Assess Whether Radiotherapy Prevents Skin Lumps at Sites Where Needles or Tubes Have Been Inserted in Patients With Malignant Mesothelioma|Completed||Phase 3|44|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:11.643446|2017-02-18 18:13:11.643446
NCT00006230|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2012-09-20|||May 2000||2000-05-01|September 2012|2012-09-01||||April 2003|Actual|2003-04-01||Interventional|||Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer|"Open Label Phase II Study on RFS 2000 (9-Nitro-camptothecin, 9-NC) Administered as a 5 Days On-2 Days Off Oral Treatment in Advanced Ovarian Cancer"|Completed||Phase 2|51|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:13:11.751369|2017-02-18 18:13:11.751369
NCT00006229|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-11-11|||April 2000||2000-04-01|August 2011|2011-08-01|February 2009|Actual|2009-02-01|December 2003|Actual|2003-12-01||Interventional|||Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer|A Phase II/III Double Blind Randomized Trial of BMS-275291 vs. Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-small Cell Lung Cancer|Completed||Phase 2/Phase 3|774|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:13:11.866867|2017-02-18 18:13:11.866867
NCT00006228|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-10-07|||July 2000||2000-07-01|October 2013|2013-10-01||||July 2003|Actual|2003-07-01||Interventional|||Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer|Phase II Trial of Anti-HER-2 Monoclonal Antibody Trastuzumab (Herceptin) in Combination With Low Dose Interleukin-2 (Proleukin) in Metastatic Breast Cancer Patients Who Have Previously Failed Trastuzumab|Completed||Phase 2|37|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:12.035193|2017-02-18 18:13:12.035193
NCT00006227|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2016-03-16|||November 2000||2000-11-01|March 2016|2016-03-01||||July 2013|Actual|2013-07-01||Interventional|||Paclitaxel in Treating Patients With Ovarian Stromal Cancer|Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy|Active, not recruiting||Phase 2|31|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:13:12.14725|2017-02-18 18:13:12.14725
NCT00006226|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-10-07|||September 2000||2000-09-01|October 2013|2013-10-01||||December 2007|Actual|2007-12-01||Interventional|||Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia|A Phase II Trial of Thalidomide in Patients With Relapsed Chronic Lymphocytic Leukemia|Completed||Phase 2|41|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:12.643817|2017-02-18 18:13:12.643817
NCT00006225|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2012-05-31||2011-02-18|November 1999||1999-11-01|May 2012|2012-05-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer|Ex Vivo Expanded Megakaryocytes for Supportive Care of Breast Cancer Patients: A Phase I/II Study|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||||||||||||2017-02-18 18:13:12.765907|2017-02-18 18:13:12.765907
NCT00006224|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-04-10|||September 2000||2000-09-01|June 2005|2005-06-01||||April 2005|Actual|2005-04-01||Interventional|||Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix|Evaluation of Gemcitabine in Persistent or Recurrent Non-Squamous Cell Carcinoma of the Cervix|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:13:12.892889|2017-02-18 18:13:12.892889
NCT00006223|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-06-20|||July 2000||2000-07-01|September 2006|2006-09-01|January 2007|Actual|2007-01-01|||||Interventional|||flt3L in Treating Patients With Acute Myeloid Leukemia|A Phase III Study of Flt3 Ligand (Flt3L) Therapy in Acute Myeloid Leukemia (AML) Patients in Remission|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:13.032058|2017-02-18 18:13:13.032058
NCT00006222|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-05-31|||September 2000||2000-09-01|April 2001|2001-04-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma|A Phase I Trial of EMD 121974 in Patients With HIV Related Kaposi's Sarcoma|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:13:13.181143|2017-02-18 18:13:13.181143
NCT00006221|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-02-08|||November 2000||2000-11-01|July 2004|2004-07-01||||June 2005|Actual|2005-06-01||Interventional|||BMS-247550 in Treating Patients With Advanced Cancers|A Phase I Study of BMS-247550 (NSC 710428) Given Weekly X 3 Every 4 Weeks in Patients With Advanced Malignancies|Completed||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:13.293609|2017-02-18 18:13:13.293609
NCT00006220|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-02-04|||June 1999||1999-06-01|February 2013|2013-02-01|February 2002|Actual|2002-02-01|November 2000|Actual|2000-11-01||Interventional|||Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy|Arsenic Trioxide Alone or With ATRA (Vesanoid) for Resistant Hematologic Malignancy|Terminated||Phase 1/Phase 2|5|Actual|Washington University School of Medicine||3||Study drug became commercially available.|f||||||||||||||2017-02-18 18:13:13.412062|2017-02-18 18:13:13.412062
NCT00006219|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2011-08-02|||August 2000||2000-08-01|August 2011|2011-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma|A Phase II Clinical Trial of Dehydroepiandrosterone and Biaxin in Monoclonal Gammopathy of Undetermined and Borderline Significance|Completed||Phase 2|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:13:13.535141|2017-02-18 18:13:13.535141
NCT00006218|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-07-17|||May 2000||2000-05-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||3-AP in Treating Patients With Advanced Cancer|A Phase I Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) in Cancer Patients Using a 96-Hour Intravenous Continuous Infusion|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:13.639676|2017-02-18 18:13:13.639676
NCT00006216|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-09-19|||August 1997||1997-08-01|July 2001|2001-07-01||||||||Interventional|||Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma|Treatment of Malignant Pleural Mesothelioma With Gene Modified Cancer Cell Lines|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:13.741866|2017-02-18 18:13:13.741866
NCT00006215|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-12-18|||October 1999||1999-10-01|December 2001|2001-12-01||||||||Interventional|||Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Phase II Study of Docetaxel and Vinorelbine in Advanced Non-Small Cell Lung Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:13.853927|2017-02-18 18:13:13.853927
NCT00006214|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2016-07-12|||August 2000||2000-08-01|July 2016|2016-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate|Short-Term Chemoprevention Trial in Men With Prostatic Intraepithelial Neoplasia Using Flutamide as an Androgen Deprivation Agent|Completed||Phase 2|63|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:13:13.982191|2017-02-18 18:13:13.982191
NCT00006213|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01||||October 2002|Actual|2002-10-01||Interventional|||BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia|Phase I Study of Farnesyl Transferase Inhibitor BMS-214662 (NSC 710086) in Acute Leukemias, Myelodysplastic Syndromes (RAEB and RAEB-T) and Chronic Myeloid Leukemia in Blast Phase|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:14.120563|2017-02-18 18:13:14.120563
NCT00006212|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-09-16|||November 1999||1999-11-01|February 2001|2001-02-01||||||||Interventional|||Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer|Phase I Study of Interstitial Colloidal 32P Integrated With External Radiation Therapy and Chemotherapy in the Treatment of Non-Resectable or Medically Inoperable Non-Small Cell Carcinoma of the Lung|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:14.229326|2017-02-18 18:13:14.229326
NCT00006211|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||February 2000||2000-02-01|March 2001|2001-03-01|April 2001||2001-04-01|||||Interventional|||A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments|A Double-Blind, Randomized, Placebo-Controlled Study of Capravirine (AG1549) in Combination With VIRACEPT and Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Subjects Who Failed an Initial Nonnucleoside Reverse Transcriptase Inhibitor Containing Regimen|Completed||Phase 2|350||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:13:14.31806|2017-02-18 18:13:14.31806
NCT00006209|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||June 2000||2000-06-01|June 2001|2001-06-01||||||||Interventional|||A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs|A Phase I Open-Label Dose Escalation Trial of Tucaresol in HIV-1 Infected Subjects Taking Potent Antiretroviral Therapy|Unknown status|Active, not recruiting|Phase 1|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:13:14.408173|2017-02-18 18:13:14.408173
NCT00006208|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2005-06-23|||August 2000||2000-08-01|June 2006|2006-06-01||||||||Interventional|||A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs|A Randomized, Double-Blind, Equivalence Trial Comparing Emtricitabine to Stavudine Within a Triple Drug Combination Containing Didanosine Plus Efavirenz in Antiretroviral-Drug Naive HIV-1 Infected Patients|Unknown status|Active, not recruiting|Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:13:14.487353|2017-02-18 18:13:14.487353
NCT00006207|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2008-07-29||||||June 2003|2003-06-01||||||||Interventional|||Safety and Tolerability of the Vaginal Gel PRO 2000/5|A Phase I Multicenter Dose Escalation Safety and Acceptability Study of the Investigational Vaginal Microbicide Agent PRO 2000/5 Gel (P)|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:14.704627|2017-02-18 18:13:14.704627
NCT00006206|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2010-04-30|||August 1997||1997-08-01|November 2007|2007-11-01|May 2006|Actual|2006-05-01|||||Interventional|||COMBINE (Acamprosate/Naltrexone)|COMBINE: Effect of Combined Pharmacotherapies and Behavioral Interventions|Completed||Phase 3|1375||University of North Carolina, Chapel Hill|||||||||||||||||||2017-02-18 18:13:14.794214|2017-02-18 18:13:14.794214
NCT00006205|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-03-14|||March 2005||2005-03-01|March 2013|2013-03-01|December 2013|Anticipated|2013-12-01|June 2013|Anticipated|2013-06-01||Interventional|||Alcohol Dependency Study: Combining Medication Treatment for Alcoholism|Combining Medications Treatment for Alcoholism|Unknown status|Recruiting|Phase 2|320|Anticipated|University of Virginia||4|||f||||t||||||||||2017-02-18 18:13:14.89861|2017-02-18 18:13:14.89861
NCT00006204|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2007-12-07|||March 2000||2000-03-01|December 2007|2007-12-01|January 2006|Actual|2006-01-01|||||Interventional|||Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)|Combined Pharmacotherapy in Depressed Alcoholics|Completed||Phase 4|106||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:13:15.031264|2017-02-18 18:13:15.031264
NCT00006202|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-09|2008-03-03|||September 2000||2000-09-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Lutein for Age-Related Macular Degeneration|Dose Ranging Study of Lutein Supplementation in Persons Over Age 60|Completed||Phase 2|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:15.200718|2017-02-18 18:13:15.200718
NCT00006200|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-09|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Thalidomide and Dacarbazine for Metastatic Melanoma||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:15.292898|2017-02-18 18:13:15.292898
NCT00006199|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-09|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)||Unknown status|Recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:15.369299|2017-02-18 18:13:15.369299
NCT00006198|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-09|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:15.442382|2017-02-18 18:13:15.442382
NCT00006196|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-07|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||The Relationship Between Vitamin D, Fingernail Thickness and Bone Density||Completed||Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:15.524074|2017-02-18 18:13:15.524074
NCT00006195|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-07|2006-10-11||||||December 2003|2003-12-01||||||||Interventional|||Glucose Regulation During Risperidone and Olanzapine Treatment||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:18.639919|2017-02-18 18:13:18.639919
NCT00006194|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-07|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Effects of Exercise on Markers of Inflammation in Skeletal Muscle in Elderly Hip Fracture Patients||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:18.725503|2017-02-18 18:13:18.725503
NCT00006193|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-07|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Effectiveness of Atkins Diet for Weight Loss||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:18.801976|2017-02-18 18:13:18.801976
NCT00006192|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-31|2016-07-28|||August 2000||2000-08-01|May 2009|2009-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Genetics of Coronary Artery Disease in Alaskan Natives (GOCADAN)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:13:18.872899|2017-02-18 18:13:18.872899
NCT00006191|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-29|2008-03-03|||August 2000||2000-08-01|August 2000|2000-08-01|June 2001||2001-06-01|||||Observational|||Effect of Levetiracetam on Brain Excitability|Effects of Levetiracetam on Cortical Excitability in Humans|Completed||N/A|14||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:18.949813|2017-02-18 18:13:18.949813
NCT00006190|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-25|2010-03-01|||November 2000||2000-11-01|March 2010|2010-03-01|November 2001||2001-11-01|||||Interventional|||A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy|The Study of Mechanisms of Lipodystrophy in HIV-Infected Patients|Completed||Phase 4|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:19.036945|2017-02-18 18:13:19.036945
NCT00006188|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-26|2017-01-24|||August 19, 2000||2000-08-19|July 25, 2008|2008-07-25|July 25, 2008||2008-07-25|||||Observational|||Evaluation and Treatment of Patients With Inflammatory Eye Diseases|Evaluation and Treatment Protocol for Patients With Intraocular Inflammatory Disease (Uveitis)|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:19.1352|2017-02-18 18:13:19.1352
NCT00006187|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-25|2009-12-10||||||October 2003|2003-10-01|June 2005|Anticipated|2005-06-01|June 2005|Anticipated|2005-06-01||Interventional|||The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease||Terminated||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:13:19.223375|2017-02-18 18:13:19.223375
NCT00006186|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-25|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Autologous Fresh Whole Blood and Coagulation Following Cardiopulmonary Bypass in Infants||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:19.335577|2017-02-18 18:13:19.335577
NCT00006185|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-22|2010-03-01|||September 1999||1999-09-01|March 2010|2010-03-01|August 2003||2003-08-01|||||Interventional|||Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome|Cellular Mechanisms for Metabolic Dysfunction in HIV|Completed||Phase 1|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:19.412216|2017-02-18 18:13:19.412216
NCT00006184|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-23|2014-03-24|2012-12-13||August 2000||2000-08-01|March 2014|2014-03-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma|Active Immunization of Sibling Stem Cell Transplant Donors Against Purified Myeloma Protein of the Stem Cell Recipient With Multiple Myeloma in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation|Completed||Phase 2|20|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:13:19.789629|2017-02-18 18:13:19.789629
NCT00006183|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-21|2016-07-28|||July 2000||2000-07-01|March 2008|2008-03-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Comparison of Hematocrit Levels in Infant Heart Surgery|Hematocrit Strategy in Infant Heart Surgery|Completed||Phase 3|120||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:13:20.652024|2017-02-18 18:13:20.652024
NCT00006182|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-21|2016-02-17|||July 2000||2000-07-01|October 2005|2005-10-01|February 2006|Actual|2006-02-01|||||Interventional|||Stroke Prevention in Sickle Cell Anemia (STOP 2)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:13:20.753944|2017-02-18 18:13:20.753944
NCT00006181|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-19|2014-01-06|||April 1999||1999-04-01|March 2003|2003-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|PHLAME||Promoting Healthy Lifestyles Among Firefighters|PHLAME: Promoting Healthy Lifestyles: Alternative Models' Effects|Completed||Phase 2|600||Oregon Health and Science University|||||f||||||||||||||2017-02-18 18:13:20.831946|2017-02-18 18:13:20.831946
NCT00006180|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-17|2017-01-24|||August 10, 2000||2000-08-10|January 19, 2007|2007-01-19|January 19, 2007||2007-01-19|||||Interventional|||Bone Loss in Premenopausal Women With Depression|The P.O.W.E.R. STUDY (Premenopause, Osteopenia/Osteoporosis, Women, Alendronate, Depression)|Completed||Phase 4|220||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:20.939551|2017-02-18 18:13:20.939551
NCT00006178|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-15|2010-06-16|2010-01-14||August 2000||2000-08-01|June 2010|2010-06-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection|Sirolimus Monotherapy to Optimize Activation Induced Cell Death (AICD) in Renal Transplants Following Lymphocyte Depletion Induction With Thymoglobulin|Completed||Phase 2|12|Actual|National Institutes of Health Clinical Center (CC)|Optimal dose of RATG remains to be determined. Whether other depleting agents are as effective as RATG is unclear.|1|||f||||||||||||||2017-02-18 18:13:21.028804|2017-02-18 18:13:21.028804
NCT00006177|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-12|2017-01-24|||August 9, 2000||2000-08-09|November 22, 2016|2016-11-22||||||||Observational|||Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study|The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents With Bipolar Disorder|Recruiting||N/A|2300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:21.297699|2017-02-18 18:13:21.297699
NCT00006176|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-12|2017-01-24|||August 10, 2000||2000-08-10|August 4, 2009|2009-08-04|August 4, 2009|Actual|2009-08-04|August 4, 2009|Actual|2009-08-04||Observational|||Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies|Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy With Neuroserpin Inclusion Bodies|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:21.407332|2017-02-18 18:13:21.407332
NCT00006175|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-12|2008-03-03|||August 2000||2000-08-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Observational|||Cyclooxygenase Levels Following Surgery to Remove Third Molars (Wisdom Teeth)|Cytokine Responses to Acute Inflammation in the Oral Surgery Model|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:21.49642|2017-02-18 18:13:21.49642
NCT00006174|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-11|2017-01-24|||August 3, 2000||2000-08-03|May 18, 2009|2009-05-18|May 18, 2009||2009-05-18|||||Interventional|||Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome|Effects of the Aromatase Inhibitor Letrozole on Pubertal Progression and Indices of Bone Turnover in Girls With Precocious Puberty and McCune-Albright Syndrome (MAS)|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:13:21.858711|2017-02-18 18:13:21.858711
NCT00006173|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-11|2008-03-03|||August 2000||2000-08-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Observational|||Magnetic Resonance Imaging for Evaluating Kidney Function|Assessment of Renal Artery Stenosis and Renovascular Hypertension by Contrast Enhanced Magnetic Resonance Imaging: A Pilot Study|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:21.946745|2017-02-18 18:13:21.946745
NCT00006172|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-11|2014-09-30|||April 2000||2000-04-01|March 2008|2008-03-01|February 2004|Actual|2004-02-01|July 2003|Actual|2003-07-01||Interventional|||Clinical Trials of Two Non-drug Treatments for Chronic Depression|Light and Negative Ion Treatment for Chronic Depression|Completed||N/A|32|Actual|New York State Psychiatric Institute||3|||f||||f||||||||||2017-02-18 18:13:22.038115|2017-02-18 18:13:22.038115
NCT00006171|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-10|2017-01-24|||August 7, 2000||2000-08-07|June 29, 2012|2012-06-29|June 29, 2012||2012-06-29|||||Observational|||Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma|A Study of the Effects of Potent Anti-HIV Therapy on Parameters Hypothesized to be Related to the Pathogenesis of Kaposi's Sarcoma (KS) in HIV-Infected Individuals|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:22.163873|2017-02-18 18:13:22.163873
NCT00006170|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-09|2016-06-22|2013-06-18||September 2000||2000-09-01|June 2016|2016-06-01|September 2010|Actual|2010-09-01|December 2009|Actual|2009-12-01||Interventional|||Bupropion and Weight Control for Smoking Cessation - 1|Bupropion and Weight Control for Smoking Cessation|Completed||Phase 4|349|Actual|University of Pittsburgh||4|||f||||f||||||||No||2017-02-18 18:13:22.250575|2017-02-18 18:13:22.250575
NCT00006169|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-03-01|||June 1996||1996-06-01|March 2010|2010-03-01|November 1999||1999-11-01|||||Interventional|||Behavioral Treatment of Weight Gain in CF|Behavioral Treatment of Weight Gain in CF|Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:22.916317|2017-02-18 18:13:22.916317
NCT00006168|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-01-12|||January 1994||1994-01-01|January 2010|2010-01-01|March 2004||2004-03-01|||||Interventional|||Ursodiol-Methotrexate for Primary Biliary Cirrhosis||Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:22.996388|2017-02-18 18:13:22.996388
NCT00006167|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-01-12|||January 1998||1998-01-01|January 2010|2010-01-01|August 2000||2000-08-01|||||Interventional|||Nutrition Intervention in AIDS Wasting||Completed||Phase 4|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:23.145085|2017-02-18 18:13:23.145085
NCT00006166|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-01-12|||March 1997||1997-03-01|January 2010|2010-01-01|October 2001||2001-10-01|||||Interventional|||North American Study for the Treatment of Refractory Ascites (NASTRA)|The North American Study for the Treatment of Refractory Ascites (NASTRA) Clinical Trial|Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:23.22838|2017-02-18 18:13:23.22838
NCT00006165|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-03-01||||||March 2010|2010-03-01||||||||Interventional|||Native Hawaiian Diabetes Intervention Program|Cultural-based Diabetes Program for Native Hawaiians|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:23.307985|2017-02-18 18:13:23.307985
NCT00006164|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-01-12|2009-06-09||June 2000||2000-06-01|January 2010|2010-01-01|October 2009|Actual|2009-10-01|April 2007|Actual|2007-04-01||Interventional|HALT-C||Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment|Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)|Completed||Phase 3|1050|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||2|||f||||t||||||||||2017-02-18 18:13:23.403803|2017-02-18 18:13:23.403803
NCT00006163|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-03-01|||September 1997||1997-09-01|March 2010|2010-03-01|June 1999||1999-06-01|||||Interventional|||Computer-assisted Diabetes Self-management Interventions||Completed||Phase 4|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:24.09876|2017-02-18 18:13:24.09876
NCT00006162|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-03-01|||October 1994||1994-10-01|March 2010|2010-03-01|April 1999||1999-04-01|||||Interventional|||Lifestyle Interventions to Reduce Diabetes Risk|Interventions to Reduce Diabetic Risk in Japanese Americans|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:24.175751|2017-02-18 18:13:24.175751
NCT00006161|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-01-12|||December 1996||1996-12-01|January 2010|2010-01-01|December 2003||2003-12-01|||||Interventional|||Decompression Intervention of Variceal Rebleeding Trial (DIVERT)|Decompression Intervention of Variceal Rebleeding Trial|Completed||Phase 3|140||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:24.254295|2017-02-18 18:13:24.254295
NCT00006159|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-02-12|||March 1994||1994-03-01|February 2010|2010-02-01|January 2004|Actual|2004-01-01|||||Interventional|||Family-Centered Diabetes Project|Family-Centered Diabetes Project for Pueblo Native Americans|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:24.403032|2017-02-18 18:13:24.403032
NCT00006158|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-02-12|||September 1998||1998-09-01|February 2010|2010-02-01|December 2004|Actual|2004-12-01|||||Interventional|||AIDS Wasting in Women: Anabolic Effects of Testosterone||Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:24.487788|2017-02-18 18:13:24.487788
NCT00006157|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2010-01-12|||July 1996||1996-07-01|January 2010|2010-01-01|March 2001||2001-03-01|||||Interventional|||Treatment of Functional Bowel Disorders|Multicenter Trial of Functional Bowel Disorders|Completed||Phase 3|300||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:13:24.842284|2017-02-18 18:13:24.842284
NCT00006156|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-09|2013-03-28|2013-03-28||August 2000||2000-08-01|March 2013|2013-03-01|January 2012|Actual|2012-01-01|January 2012|Actual|2012-01-01||Interventional|||Feasibility Study for Development of an Early Test for Ovarian Failure|FSH-Stimulated Inhibin B as a Marker for Early Ovarian Insufficiency|Completed||N/A|49|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 18:13:24.938467|2017-02-18 18:13:24.938467
NCT00006155|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-09|2008-03-03|||August 2000||2000-08-01|June 2000|2000-06-01|April 2001||2001-04-01|||||Interventional|||SU5416 and Carboplatin to Treat Ovarian Cancer|A Phase I Study of SU5416, an Antiangiogenesis Agent, in Combination With Carboplatin in Patients With Platinum-Refractory Ovarian Cancer|Completed||Phase 1|33||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:25.460288|2017-02-18 18:13:25.460288
NCT00006154|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-07|2013-09-04||||||September 2013|2013-09-01||||||||Interventional|||A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection|Randomized, Controlled, Open Label, Multi-Center Phase III Trial Comparing the Safety and Antiviral Activity of a Protease-Containing Regimen (d4T/ddI/IDV/RTV) Versus a Protease-Sparing Regimen (d4T/ddI/EFV) and the Ability of Interleukin-2 to Purge HIV From Latent Stores in Patients With Acute/Early HIV Infection|Completed||Phase 3|165|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:13:25.548565|2017-02-18 18:13:25.548565
NCT00006153|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-07|2008-07-29||||||June 2003|2003-06-01||||||||Interventional|||Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination|A Multicenter, Double-Blind, Phase I, Adjuvant Controlled Study to Evaluate the Effect of Remune (HIV-1 Immunogen) Compared to IFA, in Combination With Fully Suppressive Antiviral Drug Therapy on HIV-1-Specific Immunogenicity in Subjects With Acute or Primary HIV-1 Infection|Terminated||Phase 1|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:25.675052|2017-02-18 18:13:25.675052
NCT00006152|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-07|2012-05-17||||||May 2012|2012-05-01|August 2002|Actual|2002-08-01|||||Interventional|||A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment|A Phase II, Restrictively Randomized, Open-Label, Pilot Study of Treatment Intensification of Early Virologic Failure|Completed||Phase 2|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:13:25.763896|2017-02-18 18:13:25.763896
NCT00006151|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2015-12-01|2013-06-24||May 1999||1999-05-01|December 2015|2015-12-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Combining a Smoke Ending Aid With Behavioral Treatment - 1|Combining a Smoke Ending Aid With Behavioral Treatment|Completed||N/A|60|Actual|University of Pennsylvania||2|||f||||f||||||||||2017-02-18 18:13:25.875211|2017-02-18 18:13:25.875211
NCT00006150|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2017-01-24|||August 3, 2000||2000-08-03|November 22, 2016|2016-11-22||||||||Observational|||Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection|Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:26.245245|2017-02-18 18:13:26.245245
NCT00006148|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-08|2008-03-03|||August 2000||2000-08-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Observational|||Spleen Size in Peripheral Blood Stem Cell Donors|Spleen Size in Peripheral Blood Stem Cell Donors|Completed||N/A|49||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:26.347879|2017-02-18 18:13:26.347879
NCT00006146|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-07|2010-08-26|||August 2000||2000-08-01|November 2005|2005-11-01|September 2000||2000-09-01|||||Interventional|||Half-Dose Flu Vaccine Study in Healthy Adults|Evaluation of the Immunogenicity of Low Dose Trivalent Inactivated Influenza Vaccine in Healthy Adults|Completed||Phase 2|840||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:26.423747|2017-02-18 18:13:26.423747
NCT00006145|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-07|2013-07-08|||August 2000||2000-08-01|July 2013|2013-07-01|February 2006|Actual|2006-02-01|||||Interventional|||Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV|A Phase III, Prospective, Randomized, Double-Blind Trial of Valganciclovir Pre-Emptive Therapy for Cytomegalovirus (CMV) Viremia as Detected by Plasma CMV DNA PCR Assay|Completed||Phase 3|350||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:13:26.508364|2017-02-18 18:13:26.508364
NCT00006144|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-07|2013-11-06|||October 2000||2000-10-01|November 2013|2013-11-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of HIV-Disease Development in Aging|A Phase II Exploratory Study Examining Immunologic and Virologic Indices in Two Age-Differentiated Cohorts of HIV-Infected Subjects to Explore the Basis of Accelerated HIV-Disease Progression Associated With Aging|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:26.671887|2017-02-18 18:13:26.671887
NCT00006143|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-07|2012-05-17||||||May 2012|2012-05-01|July 2002|Actual|2002-07-01|||||Interventional|||Growth Hormone Treatment of Children With HIV-Associated Growth Failure|A Randomized, Open-Label Study of Recombinant Human Growth Hormone (r-hGH) in Children With HIV-Associated Growth Failure|Completed||N/A|102||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:13:26.815084|2017-02-18 18:13:26.815084
NCT00006142|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||December 1983||1983-12-01|August 2000|2000-08-01||||||||Interventional|||Study of a Phenylalanine Restricted Diet During Pregnancy to Prevent Symptoms in Offspring of Patients With Phenylketonuria||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:26.926103|2017-02-18 18:13:26.926103
NCT00006138|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||June 1998||1998-06-01|October 2000|2000-10-01|August 2000||2000-08-01|||||Observational|||Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major||Completed||N/A|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:27.004667|2017-02-18 18:13:27.004667
NCT00006132|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||June 1997||1997-06-01|December 2003|2003-12-01||||||||Interventional|||Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System||Unknown status|Recruiting|Phase 3|132||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:27.56501|2017-02-18 18:13:27.56501
NCT00006131|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2007-05-22|||January 1997||1997-01-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster||Completed||N/A|66|Anticipated|National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:27.955385|2017-02-18 18:13:27.955385
NCT00006130|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2017-02-14|||June 1999||1999-06-01|February 2017|2017-02-01||||||||Interventional|||Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease|Randomized Study of Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease|Completed||N/A|50||Children's Hospital & Research Center Oakland|||||f||||||||||||||2017-02-18 18:13:28.044804|2017-02-18 18:13:28.044804
NCT00006129|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||June 2000||2000-06-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Testosterone and Progressive Resistance Exercise in Men With Burn Injury||Unknown status|Recruiting|N/A|60||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:28.141773|2017-02-18 18:13:28.141773
NCT00006128|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||July 1998||1998-07-01|December 2003|2003-12-01||||||||Observational|||Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries||Unknown status|Recruiting|N/A|374||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:28.224665|2017-02-18 18:13:28.224665
NCT00006127|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2005-06-23|||April 2000||2000-04-01|October 2003|2003-10-01||||||||Interventional|||Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia||Unknown status|Active, not recruiting|Phase 1|21||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:28.302958|2017-02-18 18:13:28.302958
NCT00006126|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2015-11-10|||September 1999||1999-09-01|November 2015|2015-11-01|April 2001||2001-04-01|April 2001||2001-04-01||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery|Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients With Incurable Solid Tumors: A Phase I Study|Withdrawn||Phase 1|0|Actual|Northwestern University||||Unable to accrue subjects.|f||||||||||||||2017-02-18 18:13:28.400266|2017-02-18 18:13:28.400266
NCT00006125|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2016-07-12|||July 2000||2000-07-01|July 2016|2016-07-01||||August 2006|Actual|2006-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma|A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|||Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:13:28.515662|2017-02-18 18:13:28.515662
NCT00006124|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-02-12|||June 2000||2000-06-01|January 2013|2013-01-01|April 2008|Actual|2008-04-01|March 2006|Actual|2006-03-01||Interventional|||Celecoxib in Treating Patients With Bladder Cancer|Phase IIb/III Chemoprevention Trial of Celecoxib to Prevent Recurrence of Superficial Bladder Cancer|Completed||Phase 2/Phase 3|152|Anticipated|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 18:13:28.703185|2017-02-18 18:13:28.703185
NCT00006123|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2009-02-06|||July 2000||2000-07-01|December 2006|2006-12-01||||||||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer|Autotransplantation and Her 2 Neu Antibody Immunotherapy in Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:28.812907|2017-02-18 18:13:28.812907
NCT00006122|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-07-13|||June 2000||2000-06-01|July 2012|2012-07-01||||January 2002|Actual|2002-01-01||Interventional|||Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia|Gemtuzumab Ozogamicin (CMA-676) Followed or Not by Intensive Chemotherapy as Initial Treatment for Elderly Patients With Acute Myeloid Leukemia: An EORTC-LG Pilot Phase II Study|Completed||Phase 2|106|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:13:28.905434|2017-02-18 18:13:28.905434
NCT00006121|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-07-23|||May 2000||2000-05-01|July 2012|2012-07-01||||May 2002|Actual|2002-05-01||Interventional|||Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy|Phase II Study of Oxaliplatin Single Agent in Patients With Metastatic Breast Cancer After Failure of Anthracycline/Taxane Based Chemotherapy|Terminated||Phase 2|18|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:13:29.029369|2017-02-18 18:13:29.029369
NCT00006120|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2008-07-23|||May 2000||2000-05-01|March 2006|2006-03-01||||||||Interventional|||Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer|Phase II Randomized Study of Two Different Schedules of Docetaxel or Paclitaxel for Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:29.141563|2017-02-18 18:13:29.141563
NCT00006119|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2008-07-23|||July 1999||1999-07-01|December 2004|2004-12-01||||||||Interventional|||Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma|Phase II Study of Hydroxyurea for the Treatment of Recurrent and/or Nonoperable Meningioma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:29.269186|2017-02-18 18:13:29.269186
NCT00006118|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2008-07-23|||July 1999||1999-07-01|November 2001|2001-11-01||||||||Interventional|||Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer|First Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma of the Bladder With a Combination of Cisplatin-Paclitaxel-Gemcitabine|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:29.371622|2017-02-18 18:13:29.371622
NCT00006117|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2009-10-29|||September 1999||1999-09-01|October 2009|2009-10-01||||||||Interventional|||Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|Phase II Study of Gemcitabine Plus Oxaliplatin in Patients With Locally Advanced or Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:29.473693|2017-02-18 18:13:29.473693
NCT00006086|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2010-09-08|||June 2000||2000-06-01|September 2002|2002-09-01||||February 2003|Actual|2003-02-01||Interventional|||BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer|Phase I Study of BMS-188797 in Combination With Carboplatin in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:33.232211|2017-02-18 18:13:33.232211
NCT00006116|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2008-07-23|||April 1999||1999-04-01|November 2000|2000-11-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|First Line Treatment of Stage IIIb/IV Non Small Cell (NSC) Lung Cancer With a Bimonthly Administration of a Combination of Cisplatin-Gemcitabine|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:29.585131|2017-02-18 18:13:29.585131
NCT00006115|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2009-01-10|||April 1999||1999-04-01|January 2002|2002-01-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer|Alternation of FOLFOX6 (Oxaliplatin - Leucovorin - Fluorouracil) and FOLFIRI (Irinotecan - Leucovorin - Fluorouracil) as Second Line Treatment of Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:29.718906|2017-02-18 18:13:29.718906
NCT00006114|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2011-02-26|||May 1999||1999-05-01|September 2000|2000-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|First Line Treatment of Metastatic Hormone Refractory Prostate Cancer With a Combination of Novantrone-Navelbine|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:29.822469|2017-02-18 18:13:29.822469
NCT00006113|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2014-05-20|||June 1999||1999-06-01|May 2014|2014-05-01|April 2006|Actual|2006-04-01|May 2003|Actual|2003-05-01||Interventional|||Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase II Trial of a MART-1/gp100/Tyrosinase Peptide-Pulsed Dendritic Cell Vaccine Treated With CD40 Ligand/Gamma Interferon With Subcutaneous IL-2 for Patients With Metastatic Melanoma|Terminated||Phase 2|25|Actual|University of Southern California||||Lack of efficacy|f||||t||||||||||2017-02-18 18:13:29.922652|2017-02-18 18:13:29.922652
NCT00006112|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2011-04-23|||January 1996||1996-01-01|May 2001|2001-05-01||||||||Interventional|||Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer|Randomized Therapeutic Study Comparing Tumor Resection Followed Immediately by Intraperitoneal Chemotherapy and Systemic Chemotherapy VS Systemic Chemotherapy Alone for the Treatment of Colorectal Cancer Metastatic to the Peritoneum|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:30.030201|2017-02-18 18:13:30.030201
NCT00006111|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2009-02-06|||April 1999||1999-04-01|May 2002|2002-05-01||||||||Interventional|||Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract|Multicenter Study of the Quality of Life of Patients With Invasive Urothelial Cancer Treated With Conservative Surgery Followed by Cisplatin, Fluorouracil and Radiotherapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:30.124182|2017-02-18 18:13:30.124182
NCT00006110|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2016-01-20|||December 1998||1998-12-01|January 2016|2016-01-01|April 2013|Actual|2013-04-01|March 2012|Actual|2012-03-01||Interventional|NRR||Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer|Nonrandomized Ph II Study of Multimodality Therapy for Stg IIB, IIIA/B, or Initially Presenting Stg IV Breast Cancer w/ Four Cycles of AC Followed by 12 Weeks of Single Agent Paclitaxel w/ or w/o Herceptin Followed by Local Therapy Followed by Weekly Herceptin or No Additional Therapy|Completed||Phase 2|85|Actual|UNC Lineberger Comprehensive Cancer Center||4|||f||||t||||||||||2017-02-18 18:13:30.225388|2017-02-18 18:13:30.225388
NCT00006108|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-02-03|||August 1999||1999-08-01|February 2012|2012-02-01|July 2002|Actual|2002-07-01|September 2001|Actual|2001-09-01||Interventional|||Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer|A Phase II Trial of Xeloda, Every Three Week Taxol and Herceptin in Metastatic Breast Cancer|Completed||Phase 1/Phase 2|||UNC Lineberger Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:13:30.360378|2017-02-18 18:13:30.360378
NCT00006107|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2009-02-06|||March 2000||2000-03-01|January 2004|2004-01-01||||||||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Taxotere Plus Concurrent Concomitant Boost Radiotherapy For Squamous Cell Cancer of the Head and Neck (TAXT-XRT)|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:30.458023|2017-02-18 18:13:30.458023
NCT00006106|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-07-09|||July 1999||1999-07-01|December 2006|2006-12-01||||||||Interventional|||ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer|Phase I Study of Intraarterial ONYX-015 in Combination With Intravenous Cisplatin and Fluorouracil in Patients With Advanced Squamous Cell Cancer of the Head and Neck|Withdrawn||Phase 1|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:30.55069|2017-02-18 18:13:30.55069
NCT00006105|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-09-04|||June 2000||2000-06-01|September 2013|2013-09-01|September 2006|Actual|2006-09-01|November 2004|Actual|2004-11-01||Interventional|||Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer|Phase II Trial of Adjuvant Gemcitabine Plus Cisplatin With Amifostine Cytoprotection in Patients With Locally Advanced Bladder Cancer|Completed||Phase 2|37|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:13:30.652314|2017-02-18 18:13:30.652314
NCT00006104|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-08-10|||September 1998||1998-09-01|August 2012|2012-08-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer|A Multi-Institutional Phase II Pilot Trial With Weekly Docetaxel and Herceptin as First or Second Line Therapy for HER2/Neu Overexpressing Metastatic Breast Cancer|Completed||Phase 2|46|Actual|Vanderbilt-Ingram Cancer Center|||||f||||t||||||||||2017-02-18 18:13:30.775244|2017-02-18 18:13:30.775244
NCT00006103|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2016-07-01|||July 2000||2000-07-01|July 2016|2016-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Colorectal Cancer|Interracial Study of CPT-11 (Irinotecan) Pharmacokinetics in 5-Fluorouracil Refractory Colorectal Cancer: A Population Pharmacokinetic/Pharmacodynamic Study of CPT-11|Completed||Phase 3|400|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:13:30.880997|2017-02-18 18:13:30.880997
NCT00006102|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-02-04|||July 2000||2000-07-01|November 2010|2010-11-01||||June 2006|Actual|2006-06-01||Interventional|||Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma|A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors|Completed||Phase 2|200|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:30.984649|2017-02-18 18:13:30.984649
NCT00006085|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-12-18|||June 2000||2000-06-01|December 2001|2001-12-01||||||||Interventional|||CP-609,754 in Treating Patients With Advanced Solid Tumors|Phase I Open-Label Study of the Safety, Toleration and Pharmacokinetics of CP-609,754, a Farnesyl Transferase Inhibitor, in Subjects With Advanced Malignant Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:33.325511|2017-02-18 18:13:33.325511
NCT00006101|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2016-03-23|||October 1998||1998-10-01|March 2016|2016-03-01|December 2012|Actual|2012-12-01|December 2012|Actual|2012-12-01||Interventional|||Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer|Randomized Placebo-Controlled, Double-Blind Phase IIb Chemoprevention Trial of Difluoromethylornithine in Brothers and First Cousin Males of Familial Prostate Cancer Probands|Completed||Phase 2|140|Actual|University of California, Irvine||2|||f||||t||||||||No||2017-02-18 18:13:31.645752|2017-02-18 18:13:31.645752
NCT00006100|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-12-17|||April 2000||2000-04-01|May 2005|2005-05-01||||||||Interventional|||Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma|A Phase I Pilot Trial to Evaluate the Toxicity of Epstein-Barr Virus Specific T-Lymphocytes or Peripheral Blood Mononuclear Cells for the Treatment of Relapsed/Refractory Hodgkin's Disease|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:31.758475|2017-02-18 18:13:31.758475
NCT00006099|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2009-02-06|||May 2000||2000-05-01|June 2002|2002-06-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer|Pilot Trial of Humanized 3S193 Monoclonal Antibody (hu3S193) in Presurgical Patients With Ovarian Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:31.854889|2017-02-18 18:13:31.854889
NCT00006098|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-06-17|||April 2000||2000-04-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||PS-341 in Treating Patients With Hematologic Cancer|A Phase I Study of PS-341 in Patients With Hematologic Malignancies|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:13:31.950363|2017-02-18 18:13:31.950363
NCT00006097|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2010-09-21|||August 1999||1999-08-01|May 2001|2001-05-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia|CC-1088 Therapy for Chronic Lymphocytic Leukemia: A Phase I/II Trial|Completed||Phase 1/Phase 2|||Boston Medical Center|||||f||||t||||||||||2017-02-18 18:13:32.055716|2017-02-18 18:13:32.055716
NCT00006096|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-06-07|||March 2001||2001-03-01|June 2007|2007-06-01||||January 2003|Actual|2003-01-01||Interventional|||Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva|A Randomized Study of Adjuvant Radiation Treatment Versus Radiation and Chemotherapy in Patients With Vulvar Cancer and Involved Nodes|Terminated||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:13:32.156162|2017-02-18 18:13:32.156162
NCT00006095|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2014-02-20|||July 2000||2000-07-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy|A Trial of Irinotecan (NSC# 616348) Plus Vincristine in Children With Solid Tumors|Completed||Phase 1|20|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:13:32.286441|2017-02-18 18:13:32.286441
NCT00006094|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-01-15|||July 2000||2000-07-01|January 2013|2013-01-01||||October 2006|Actual|2006-10-01||Interventional|||Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum|A Phase I/II Study of Preoperative Oxaliplatin (NSC# 266046), 5-Fluorouracil, and External Beam Radiation Therapy in Locally Advanced Rectal Cancer|Completed||Phase 1/Phase 2|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:32.430168|2017-02-18 18:13:32.430168
NCT00006093|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-06-20|||September 2000||2000-09-01|April 2003|2003-04-01|October 2006|Actual|2006-10-01|||||Interventional|||EMD 121974 in Treating Patients With Progressive or Recurrent Glioma|A Phase I/II Trial of EMD 121974 for Treatment of Patients With Recurrent Anaplastic Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:32.550611|2017-02-18 18:13:32.550611
NCT00006092|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-09-25|||August 2000||2000-08-01|September 2012|2012-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia|A Phase II Study of Arsenic Trioxide for Induction Therapy of Adult Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia and Previously Untreated Chronic Myeloid Leukemia With Blast Crisis|Terminated||Phase 2|2|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||low accrual|f||||f||||||||||2017-02-18 18:13:32.65096|2017-02-18 18:13:32.65096
NCT00006091|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-10-05|||June 2000||2000-06-01|October 2012|2012-10-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment|Arsenic Trioxide Therapy for Interferon Alpha Refractory or Intolerant Chronic Phase Chronic Myelogenous Leukemia|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||No enrollment.|f||||f||||||||||2017-02-18 18:13:32.76201|2017-02-18 18:13:32.76201
NCT00006090|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-10-05|||June 2000||2000-06-01|October 2012|2012-10-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia|Phase II Study of Arsenic Trioxide (NSC #706363) Therapy for Fludarabine Refractory or Relapsed Chronic Lymphocytic Leukemia|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||No enrollment.|f||||f||||||||||2017-02-18 18:13:32.844088|2017-02-18 18:13:32.844088
NCT00006089|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2014-01-10|||March 2001||2001-03-01|January 2014|2014-01-01||||September 2007|Actual|2007-09-01||Interventional|||Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer|A Phase II Evaluation of Trastuzumab (MoAb HER2) in Patients With Advanced, Recurrent or Persistent Endometrial Carcinoma With or Without Prior Chemotherapy|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:32.930063|2017-02-18 18:13:32.930063
NCT00006088|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-09-19|||June 2000||2000-06-01|November 2000|2000-11-01||||||||Interventional|||Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors|A Phase I Absolute Bioavailability Study of Oral NAVELBINE (Vinorelbine Tartrate) in Patients With Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:33.042299|2017-02-18 18:13:33.042299
NCT00006087|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2009-02-06|||November 1999||1999-11-01|December 2007|2007-12-01||||||||Interventional|||Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer|A Randomized Prospective Study Comparing Annual Chest X-Rays to Annual Spiral Chest CT Scanning in Patients at High-Risk for the Development of Lung Cancer|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:33.134949|2017-02-18 18:13:33.134949
NCT00005246|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1989||1989-08-01|May 2000|2000-05-01|July 1991|Actual|1991-07-01|||||Observational|||Epidemiology of Insulin and Dehydroepiandrosterone Sulfate and Coronary Heart Disease Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.930713|2017-02-18 18:15:17.930713
NCT00006084|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-12-18|||February 2001||2001-02-01|November 2001|2001-11-01||||||||Interventional|||Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia|Phase II, Open-Label Study of HuM195 (Humanized Anti-CD33 Monoclonal Antibody) Administered to Patients With Acute Myelogenous Leukemia (AML) Who Are Documented Regimen Failures (RF) of the Control Arm of Study 195-301|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:33.41528|2017-02-18 18:13:33.41528
NCT00006083|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2015-10-01|||April 2000||2000-04-01|July 2012|2012-07-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter|A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Fragmin (5,000 IU Subcutaneously) in Preventing Catheter-Related Complications When Given Daily to Cancer Patients With Central Venous Catheters|Completed||Phase 3|||Jonsson Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:13:33.505721|2017-02-18 18:13:33.505721
NCT00006082|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-09-20|||May 2000||2000-05-01|September 2012|2012-09-01||||August 2002|Actual|2002-08-01||Interventional|||Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer|"Open Label Phase II Study on RFS 2000 (9-Nitro-Camptothecin, 9-NC) Administered as a 5 Days On - 2 Days Off Oral Treatment in Advanced Small Cell Lung Cancer"|Completed||Phase 2|38|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:13:33.713343|2017-02-18 18:13:33.713343
NCT00006081|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-07-27|||June 2000||2000-06-01|July 2012|2012-07-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer|A Phase II Study of Bryostatin-1 (NSC 339555) Plus Paclitaxel in Patients With Metastatic or Unresectable Locally Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction|Completed||Phase 2|37|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:13:33.800359|2017-02-18 18:13:33.800359
NCT00006080|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2008-11-22|||November 2000||2000-11-01|September 2005|2005-09-01||||||||Interventional|||Fenretinide in Treating Patients With Recurrent Malignant Glioma|Phase II Evaluation of Fenretinide NSC (374551) as a Single Agent in the Treatment of Adult Patients With Recurrent Malignant Glioma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:33.914862|2017-02-18 18:13:33.914862
NCT00006079|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2012-07-27|||June 2000||2000-06-01|July 2012|2012-07-01|April 2004|Actual|2004-04-01|February 2003|Actual|2003-02-01||Interventional|||Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia|A Randomized Double-Blind Study of Alpha-Difluromethylornithine (DFMO) Versus Placebo in Patients With Cervical Intraepithelial Neoplasia (CIN) Grade 2-3|Completed||Phase 2|150|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 18:13:34.024185|2017-02-18 18:13:34.024185
NCT00006078|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2013-06-25|||June 2000||2000-06-01|December 2004|2004-12-01|January 2005|Actual|2005-01-01|||||Interventional|||Lycopene In Preventing of Prostate Cancer|Single Dose Pharmacokinetic Study of Lycopene Delivered in a Well Defined Food-Based Lycopene Delivery System (Tomato Paste-oil Mixture) in Healthy Male Volunteers Between 18 and 45 Years of Age|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:34.16421|2017-02-18 18:13:34.16421
NCT00006077|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-04|2008-03-03|||August 2000||2000-08-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Interventional|||Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease|Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:34.252137|2017-02-18 18:13:34.252137
NCT00006076|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-28|2017-01-24|||July 26, 2000||2000-07-26|June 29, 2010|2010-06-29|June 29, 2010||2010-06-29|||||Observational|||Genetic Studies of Tone Deafness|Genetic Studies of Tune Deafness|Completed||N/A|968|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:34.338335|2017-02-18 18:13:34.338335
NCT00006075|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-27|2008-09-26||||||June 2004|2004-06-01|August 2007|Actual|2007-08-01|||||Interventional|||A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies|Phase IIA Study of Tolerance and Safety of Differing Concentrations of Chlorhexidine, for Peripartum Vaginal and Infant Washes, to Prevent Mother to Infant HIV-1 Transmission|Completed||Phase 2|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:34.416581|2017-02-18 18:13:34.416581
NCT00006073|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-25|2017-01-24|||July 19, 2000||2000-07-19|August 31, 2016|2016-08-31|August 31, 2016||2016-08-31|||||Observational|||Endocrine Studies in Health and Disease|Endocrine Studies in Health and Disease|Terminated||N/A|3090|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:34.511774|2017-02-18 18:13:34.511774
NCT00006072|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-25|2005-06-23||||||July 2000|2000-07-01||||||||Interventional|||A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:34.606165|2017-02-18 18:13:34.606165
NCT00006071|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-21|2008-03-03|||July 2000||2000-07-01|July 2000|2000-07-01|March 2001||2001-03-01|||||Observational|||Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol|Effects of Rosiglitazone on Endothelium-Dependent Vasodilation and on Endothelin Activity in Patients With Essential Hypertension and in Patients With Hypercholesterolemia|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:34.6703|2017-02-18 18:13:34.6703
NCT00006070|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-18|2008-03-03|||July 2000||2000-07-01|May 2004|2004-05-01|May 2004||2004-05-01|||||Interventional|||Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction|Safety and Efficacy of a TNF Receptor Fusion Protein for Injury-Induced Inflammation and Sequelae|Completed||Phase 2|86||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:37.73586|2017-02-18 18:13:37.73586
NCT00006068|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-18|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Does Islet Transplantation Eliminate Hypoglycemia?||Unknown status|Not yet recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:37.83762|2017-02-18 18:13:37.83762
NCT00006066|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-14|2012-05-17||||||May 2012|2012-05-01|June 2006|Actual|2006-06-01|||||Interventional|||Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems|Phase I/II Trial of Subcutaneous IL-2 With Highly Active Antiretroviral Therapy in HIV-Infected Children With Immunosuppression|Completed||Phase 1|92||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:13:37.907446|2017-02-18 18:13:37.907446
NCT00005222|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1988||1988-04-01|April 2000|2000-04-01|March 1996|Actual|1996-03-01|||||Observational|||Decline in Cardiovascular Mortality: Framingham 1950-1984||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.998227|2017-02-18 18:15:19.998227
NCT00006064|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-16|2014-10-28|||June 2000||2000-06-01|October 2014|2014-10-01|February 2005|Actual|2005-02-01|||||Observational|||The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children|Effect of Antiretroviral Therapy on Body Composition in HIV-Infected Children|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:13:38.018374|2017-02-18 18:13:38.018374
NCT00006063|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2005-06-23|||July 1999||1999-07-01|July 2000|2000-07-01|August 1999||1999-08-01|||||Interventional|||Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis||Completed||N/A|24||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:38.105783|2017-02-18 18:13:38.105783
NCT00006062|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-11|2008-03-03|||July 2000||2000-07-01|June 2000|2000-06-01|May 2001||2001-05-01|||||Interventional|||Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction|Phase I Study of Oxaliplatin in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:38.185727|2017-02-18 18:13:38.185727
NCT00006061|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2005-06-23|||January 2000||2000-01-01|July 2000|2000-07-01|January 2000||2000-01-01|||||Interventional|||Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency||Completed||N/A|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:38.275612|2017-02-18 18:13:38.275612
NCT00006060|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-03-10|||April 1999||1999-04-01|March 2009|2009-03-01||||||||Observational|||Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis||Unknown status|Recruiting|N/A|100||Office of Rare Diseases (ORD)|||||f||||t||||||||||2017-02-18 18:13:38.356066|2017-02-18 18:13:38.356066
NCT00006059|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2005-06-23|||January 1997||1997-01-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of Familial Epilepsy||Completed||N/A|898||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:38.443565|2017-02-18 18:13:38.443565
NCT00006058|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2005-06-23|||September 1996||1996-09-01|December 2003|2003-12-01||||||||Observational|||Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns|Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns|Completed||N/A|200||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:38.517893|2017-02-18 18:13:38.517893
NCT00006057|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2005-06-23|||December 1999||1999-12-01|April 2002|2002-04-01||||||||Observational|||Diagnostic and Screening Study of Genetic Disorders||Completed||N/A|50||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:13:38.596251|2017-02-18 18:13:38.596251
NCT00006056|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2005-06-23|||March 2000||2000-03-01|October 2003|2003-10-01||||||||Interventional|||Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders||Unknown status|Active, not recruiting|N/A|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:38.938083|2017-02-18 18:13:38.938083
NCT00006055|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2005-06-23|||March 2000||2000-03-01|October 2003|2003-10-01||||||||Interventional|||Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases||Unknown status|Active, not recruiting|N/A|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:39.038691|2017-02-18 18:13:39.038691
NCT00006054|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-10-14|||March 2000||2000-03-01|October 2003|2003-10-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies||Terminated||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:13:39.145898|2017-02-18 18:13:39.145898
NCT00006053|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-16|||June 2000||2000-06-01|January 2013|2013-01-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa|A Study to Determine the Safety and Efficacy of STI571 in Patients With Chronic Myeloid Leukemia Who Are Hematologically or Cytogenetically Resistant or Refractory to Interferon-Alpha, or Intolerant of, Interferon-Alpha|Completed||Phase 2|||Novartis|||||f||||f||||||||||2017-02-18 18:13:39.253564|2017-02-18 18:13:39.253564
NCT00006052|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2014-01-30|||June 2000||2000-06-01|January 2014|2014-01-01||||June 2003|Actual|2003-06-01||Interventional|||STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia|A Study to Determine the Efficacy and Safety of STI571 in Patients With Chronic Myeloid Leukemia in Accelerated Phase|Completed||Phase 2|||Novartis|||||f||||f||||||||||2017-02-18 18:13:39.362801|2017-02-18 18:13:39.362801
NCT00006051|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-02-06|||February 1999||1999-02-01|November 2001|2001-11-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer|Combination Chemotherapy Concurrent With Postoperative Radiotherapy Epidermoid Carcinoma of the Head and Neck at High Risk of Recurrence - Study of Feasibility|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:39.459123|2017-02-18 18:13:39.459123
NCT00006050|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-02-06|||January 1999||1999-01-01|September 2005|2005-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver|Chemotherapy Intra-Arterial Hepatic With Oxaliplatin Combined With Leucovorin Calcium and Fluorouracil IV|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:39.562686|2017-02-18 18:13:39.562686
NCT00006049|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-12-18|||May 2000||2000-05-01|July 2001|2001-07-01||||||||Interventional|||ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer|A Randomized, Double-Blind, Phase III Comparative Trial of 2 Doses of ZD1839 (IRESSA) in Combination With Paclitaxel and Carboplatin Versus Placebo in Combination With Paclitaxel and Carboplatin in Chemotherapy-Naive Patients With Advanced (Stage III or IV) Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:39.66695|2017-02-18 18:13:39.66695
NCT00006048|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-12-18|||May 2000||2000-05-01|July 2001|2001-07-01||||||||Interventional|||ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer|A Randomized, Double Blind, Phase III Comparative Trial of 2 Doses of ZD1839 (IRESSA) in Combination With Gemcitabine and Cisplatin Versus Placebo in Combination With Gemcitabine and Cisplatin in Chemotherapy Naive Patients With Advanced (Stage III or IV) Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:39.766502|2017-02-18 18:13:39.766502
NCT00006047|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-09-25|||June 2000||2000-06-01|September 2012|2012-09-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide|Phase I Study of Combination Therapy With Oral 9-Nitrocamptothecin and Oral Etoposide|Completed||Phase 1|44|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:13:39.857496|2017-02-18 18:13:39.857496
NCT00006046|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-02-06|||January 2000||2000-01-01|March 2003|2003-03-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer|Phase I Study of Humanized 3S193 (Anti-Lewis-Y) Antibody in Patients With Advanced Colorectal Carcinoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:39.965907|2017-02-18 18:13:39.965907
NCT00006045|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-11-05|||March 2000||2000-03-01|February 2010|2010-02-01||||||||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia|Phase III, Randomized, Multicenter Study to Assess the Efficacy and Safety of HuM195 (Recombinant Humanized Anti-CD33 Monoclonal Antibody) in Combination With Standardized Chemotherapy Compared to Standardized Chemotherapy Alone in the Treatment of Patients With Refractory or First-Relapsed Acute Myelogenous Leukemia (AML)|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:40.061937|2017-02-18 18:13:40.061937
NCT00006044|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-17|||February 2000||2000-02-01|January 2013|2013-01-01||||February 2005|Actual|2005-02-01||Interventional|||Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy|A Phase I Trial of Testosterone in Patients With Progressive Androgen-Independent Prostate Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:13:40.200609|2017-02-18 18:13:40.200609
NCT00006043|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-04|||February 2000||2000-02-01|June 2013|2013-06-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin|Phase II Trial of Temozolomide in Patients With Cisplatin-Refractory Germ Cell Tumors|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:13:40.295261|2017-02-18 18:13:40.295261
NCT00006042|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-03-09|||December 1999||1999-12-01|March 2010|2010-03-01||||||||Interventional|||Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Non-Myeloablative Allogeneic Bone Marrow Transplantation for Hematologic Malignancies Using Haploidentical Donors: A Phase I Trial of Pre-Transplant Cyclophosphamide|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:13:40.386928|2017-02-18 18:13:40.386928
NCT00006041|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-17|||February 2000||2000-02-01|June 2013|2013-06-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer|Vaccination of Patients Who Have Ovarian, Fallopian Tube or Peritoneal Cancer With Glycosylated MUC-1-KLH Conjugate Plus the Immunological Adjuvant QS-21|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:13:40.502454|2017-02-18 18:13:40.502454
NCT00006040|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-17|||April 2000||2000-04-01|June 2013|2013-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia|Phase I Study of Yttrium-90 Labeled HuM195 Combined With Etoposide as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients With Advanced Myelodysplastic Syndrome and Refractory Leukemia|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:13:40.855094|2017-02-18 18:13:40.855094
NCT00006039|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-17|||December 1999||1999-12-01|June 2013|2013-06-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma|Phase II Study of Weekly Administered High-Dose Pegylated Interferon Alfa-2B (PEGIntron) in Advanced Stage Low Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:13:40.946319|2017-02-18 18:13:40.946319
NCT00006038|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-17|||February 2000||2000-02-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer|A Phase II Trial of Neoadjuvant Cisplatin-Fluorouracil-Docetaxel Chemotherapy, Surgery, and Intraperitoneal (IP) Floxuridine (FUdR) Plus Leucovorin in Patients With Locally Advanced Gastric Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:13:41.046034|2017-02-18 18:13:41.046034
NCT00006037|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2014-05-20|||November 1999||1999-11-01|May 2014|2014-05-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer|Phase II Randomized Placebo-Controlled Double-Blinded Study With 5-FU vs. 5-FU With IM862 With Cross-Over to CPT-11 vs. CPT-11 With IM862|Terminated||Phase 2|18|Actual|University of Southern California||||Drug not available|f||||t||||||||||2017-02-18 18:13:41.152772|2017-02-18 18:13:41.152772
NCT00006036|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-11-07|||April 2000||2000-04-01|March 2010|2010-03-01|December 2009||2009-12-01|||||Interventional|||Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I Study of NX 211 in Combination With Cisplatin Given as an IV Infusion Days 1, 2, and 3 Every 3 Weeks in Patients With Solid Tumors|Completed||Phase 1|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:13:41.264145|2017-02-18 18:13:41.264145
NCT00006035|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-09-16|||June 2000||2000-06-01|November 2000|2000-11-01||||||||Interventional|||Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma|An Open Label Lesion Controlled Study of Electroporation Therapy (EPT) for the Treatment of Cutaneous Metastatic Melanoma Using the Genetronics, Inc. Medpulser System and Bleomycin|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:41.379936|2017-02-18 18:13:41.379936
NCT00006034|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-14|||June 1998||1998-06-01|January 2006|2006-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer|A Randomized, Multicenter Phase III Trial Evaluating the Efficacy and Safety of BCI-ImmuneActivator Versus Adriamycin in BCG Refractory or Intolerant Patients With Carcinoma in Situ With or Without Resected Superficial Papillary Bladder Cancer|Completed||Phase 3|||National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:13:41.474091|2017-02-18 18:13:41.474091
NCT00006033|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-29|||June 2000||2000-06-01|January 2001|2001-01-01|June 2004|Actual|2004-06-01|||||Interventional|||Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer|Protocol IL-2001: A Multi-Center, Open-Label, Randomized Study of the Efficacy and Safety of Multiple Intratumoral Injections of hIl-2 Plasmid (1.8 mg) Formulated With DOTMA/Cholesterol [Ratio 1:0.5(-/+)] Liposomes in Patients With Unresctable or Recurrent/Refractory Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:41.575417|2017-02-18 18:13:41.575417
NCT00006032|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-12-10|||March 2000||2000-03-01|December 2012|2012-12-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer|A Phase II Study of Intensive-Dose Topotecan, Ifosfamide/Mesna and Etoposide (TIME) Followed by Autologous Stem Cell Rescue in Metastatic Breast Cancer|Terminated||Phase 2|||H. Lee Moffitt Cancer Center and Research Institute||||low accrual|f||||f||||||||||2017-02-18 18:13:41.677246|2017-02-18 18:13:41.677246
NCT00006031|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-09-24|||November 1999||1999-11-01|September 2012|2012-09-01|July 2006|Actual|2006-07-01|July 2001|Actual|2001-07-01||Interventional|||Comparison of Two Types of Biopsy in Patients With Breast Lesions|Randomized Prospective Trial Comparing Radioactive Seed Localized Breast Biopsy to Needle Localized Breast Biopsy|Completed||N/A|117|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-02-18 18:13:41.774348|2017-02-18 18:13:41.774348
NCT00006030|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-08-06|||January 1992||1992-01-01|December 2006|2006-12-01||||||||Interventional|||Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer|Protocol of a Randomized Trial for the Management of Small Well-Differentiated and Special Type Carcinomas of the Breast|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:41.883124|2017-02-18 18:13:41.883124
NCT00006029|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-07-12|||July 2000||2000-07-01|July 2016|2016-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease|Completed||Phase 1/Phase 2|91|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:13:41.983395|2017-02-18 18:13:41.983395
NCT00006028|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-24|||January 2001||2001-01-01|March 2003|2003-03-01||||January 2007|Actual|2007-01-01||Interventional|||Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy|Evaluation of Gemcitabine and Cisplatin in Recurrent, Platinum Resistant and Refractory Ovarian Cancer|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:13:42.176062|2017-02-18 18:13:42.176062
NCT00006027|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-08-09|||August 2000||2000-08-01|August 2013|2013-08-01||||June 2004|Actual|2004-06-01||Interventional|||Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer|A Phase III Study of Adjuvant Postoperative Irradiation With or Without Cisplatin/Taxol Chemotherapy Following TAH/BSO for Patients With Endometrial Cancer|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:13:42.307311|2017-02-18 18:13:42.307311
NCT00006026|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-09-20|||May 2000||2000-05-01|September 2012|2012-09-01||||October 2001|Actual|2001-10-01||Interventional|||Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract|"Open Label Phase II Study on RFS 2000 (9-Nitro-Camptothecin, 9-NC) Administered as a 5 Days On-2 Days Off Oral Treatment in Advanced/Metastatic Urothelial Tract Tumors"|Completed||Phase 2|21|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:13:42.434561|2017-02-18 18:13:42.434561
NCT00006025|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2008-11-22|||November 2000||2000-11-01|August 2004|2004-08-01||||May 2008|Actual|2008-05-01||Interventional|||Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma|Phase I-II Trial of CPT-11 and Temozolomide (Temodar) in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:42.546481|2017-02-18 18:13:42.546481
NCT00006024|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2014-02-11|||November 2000||2000-11-01|February 2014|2014-02-01|September 2006|Actual|2006-09-01|January 2005|Actual|2005-01-01||Interventional|||Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma|A Phase I Study of Temozolomide and CCNU in Pediatric Patients With Newly Diagnosed Incompletely Resected Non-Brainstem High-Grade Gliomas|Completed||Phase 1|32|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:13:42.656035|2017-02-18 18:13:42.656035
NCT00006023|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-05-14|||March 2000||2000-03-01|May 2012|2012-05-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Master Protocol for Metastatic Hormone-Resistant Prostatic Carcinoma - Phase II Trials - Protocol 5: Capecitabine|Completed||Phase 2|||Swiss Group for Clinical Cancer Research|||||f||||t||||||||||2017-02-18 18:13:43.2561|2017-02-18 18:13:43.2561
NCT00006022|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2015-12-10|||September 2000||2000-09-01|December 2015|2015-12-01|January 2004|Actual|2004-01-01|October 2003|Actual|2003-10-01||Interventional|||Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer|Phase IA/IB Trial of Modulation of the Biological Response to Interleukin-2 (IL-2) With Bryostatin 1 (BRYO; NSC 339555)|Completed||Phase 1|17|Actual|Virginia Commonwealth University||3|||f||||t||||||||||2017-02-18 18:13:43.352241|2017-02-18 18:13:43.352241
NCT00006021|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-12-14|||June 2000||2000-06-01|December 2016|2016-12-01|March 2007|Actual|2007-03-01|May 2006|Actual|2006-05-01||Interventional|||Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma|Phase I/II Trial of Arsenic Trioxide (As2O3) With Ascorbic Acid in the Treatment of Relapsed/Refractory Multiple Myeloma|Completed||Phase 1/Phase 2|22|Actual|University of Miami||1|||||||t||||||||||2017-02-18 18:13:43.455383|2017-02-18 18:13:43.455383
NCT00006020|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2015-03-05|||July 2000||2000-07-01|March 2015|2015-03-01|July 2004|Actual|2004-07-01|June 2004|Actual|2004-06-01||Interventional|||S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia|A Phase II Trial of 506U78 (IND 52611) in Patients With Relapsed or Refractory Non T-cell Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 2|35|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-02-18 18:13:43.570201|2017-02-18 18:13:43.570201
NCT00006019|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-20|||May 2000||2000-05-01|October 2002|2002-10-01|August 2003|Actual|2003-08-01|||||Interventional|||Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer|Pilot Study of Sodium Phenylbutyrate Plus Azacytidine|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:43.781295|2017-02-18 18:13:43.781295
NCT00006018|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-06-10|||July 2000||2000-07-01|June 2010|2010-06-01|April 2002|Actual|2002-04-01|December 2001|Actual|2001-12-01||Interventional|||Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors|Phase I Study of BMS-214662 and Paclitaxel in Patients With Advanced Malignancies|Completed||Phase 1|5|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:13:43.877948|2017-02-18 18:13:43.877948
NCT00006017|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-06-09|||May 2000||2000-05-01|June 2010|2010-06-01|January 2005|Actual|2005-01-01|July 2003|Actual|2003-07-01||Interventional|||Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer|A Randomized Phase II Trial of Two Different Schedules of Administration of Rebeccamycin Analog in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|42|Actual|Case Comprehensive Cancer Center||2|||f||||t||||||||||2017-02-18 18:13:43.971362|2017-02-18 18:13:43.971362
NCT00006016|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2015-04-14|||May 2000||2000-05-01|January 2013|2013-01-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery|An Evaluation of Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer|Completed||Phase 2|75|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:44.083784|2017-02-18 18:13:44.083784
NCT00006015|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-01|||May 2000||2000-05-01|June 2011|2011-06-01|February 2003|Actual|2003-02-01|December 2002|Actual|2002-12-01||Interventional|||Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer|Phase II Study Evaluating the Combination of 5-Fluorouracil, Leucovorin, Oxaliplatin, and Herceptin in the Treatment of Patients With Metastatic Colorectal Cancer Who Have Progressed After 5-FU and/or Irinotecan-Containing Therapy|Terminated||Phase 2|26|Actual|National Cancer Institute (NCI)||1||lack of sufficient accrual|f||||t||||||||||2017-02-18 18:13:44.194244|2017-02-18 18:13:44.194244
NCT00006014|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-31|||August 2000||2000-08-01|February 2009|2009-02-01|February 2009|Actual|2009-02-01|February 2007|Actual|2007-02-01||Interventional|||SU5416 in Treating Patients With Malignant Mesothelioma|A Phase II Trial of SU5416 (NSC# 696819) in Patients With Malignant Mesothelioma|Completed||Phase 2|45|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:44.357548|2017-02-18 18:13:44.357548
NCT00006013|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-07-10|||June 2000||2000-06-01|July 2013|2013-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma|Phase II Trial of SU5416 as Treatment for Refractory/Relapsed Multiple Myeloma|Completed||Phase 2|21|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-02-18 18:13:44.46771|2017-02-18 18:13:44.46771
NCT00006012|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-07-01|||February 2001||2001-02-01|July 2016|2016-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer|Completed||Phase 1/Phase 2|73|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:13:44.563691|2017-02-18 18:13:44.563691
NCT00006011|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2015-04-30|2014-05-20||July 2000||2000-07-01|April 2015|2015-04-01||||March 2010|Actual|2010-03-01||Interventional||Total number of eligible participants.|Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer|A Randomized Phase III Study of Tumor Volume Directed Pelvic Plus or Minus Para-Aortic Irradiation Followed by Cisplatin and Doxorubicin or Cisplatin, Doxorubicin and Paclitaxel for Advanced Endometrial Carcinoma|Completed||Phase 3|659|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-02-18 18:13:45.063343|2017-02-18 18:13:45.063343
NCT00006010|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-12-05|||September 2001||2001-09-01|December 2016|2016-12-01|April 2008|Actual|2008-04-01|May 2004|Actual|2004-05-01||Interventional|||Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer|Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma|Completed||Phase 2|25|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:13:45.55357|2017-02-18 18:13:45.55357
NCT00006009|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-14|||April 2001||2001-04-01|April 2003|2003-04-01|October 2003|Actual|2003-10-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma|A Phase I, Multiple Dose Escalation Trial of Intravenous Humanized Anti-CD3 Antibody (HuM291) in Patients With CD3+ T-cell Lymphomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:45.685672|2017-02-18 18:13:45.685672
NCT00006008|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-20|||June 2000||2000-06-01|August 2002|2002-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia|A Phase II Trial of Arsenic Trioxide (NSC #706363) for Relapsed or Refractory Acute Lymphoblastic Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:45.784731|2017-02-18 18:13:45.784731
NCT00006007|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-12-05|||December 2000||2000-12-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|March 2004|Actual|2004-03-01||Interventional|||LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer|A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:13:45.966779|2017-02-18 18:13:45.966779
NCT00006006|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-02-08|||August 2000||2000-08-01|September 2003|2003-09-01||||March 2005|Actual|2005-03-01||Interventional|||Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed|Thalidomide for Unresectable Hepatocellular Cancer With Optional Interferon Alpha-2a Upon Disease Progression|Completed||Phase 2|38|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:46.101503|2017-02-18 18:13:46.101503
NCT00006005|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-20|||September 2000||2000-09-01|August 2004|2004-08-01|August 2006|Actual|2006-08-01|||||Interventional|||Thalidomide in Treating Patients With Gynecologic Sarcomas|Phase II Study of Thalidomide (NSC #66847) in Patients With Sarcomas of Gynecologic Origin|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:46.20465|2017-02-18 18:13:46.20465
NCT00006004|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-08-16|||May 2000||2000-05-01|August 2013|2013-08-01||||January 2005|Actual|2005-01-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer|A Randomized Phase II Trial of Paclitaxel-Carboplatin or Gemicitabine-Cisplatin in ECOG Performance Status 2 Non-Small Cell Lung Cancer Patients|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:13:46.303117|2017-02-18 18:13:46.303117
NCT00006003|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-23|||July 2000||2000-07-01|January 2013|2013-01-01||||July 2003|Actual|2003-07-01||Interventional|||SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated|A Phase II Trial of SU5416 (NSC #696819) in Patients With Metastatic Melanoma|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:13:46.415592|2017-02-18 18:13:46.415592
NCT00006002|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-09-04|||June 2000||2000-06-01|September 2013|2013-09-01|January 2006|Actual|2006-01-01|September 2002|Actual|2002-09-01||Interventional|||SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of SU5416 (NSC# 686819) in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|36|Actual|University of Chicago||2|||f||||f||||||||||2017-02-18 18:13:46.53512|2017-02-18 18:13:46.53512
NCT00006001|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-31|||August 2000||2000-08-01|February 2009|2009-02-01|August 2009|Actual|2009-08-01|February 2007|Actual|2007-02-01||Interventional|||SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer|Phase II Trial of SU5416 (NSC #696819) in Patients With Advanced Colorectal Cancer|Terminated||Phase 2|37|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:13:46.669323|2017-02-18 18:13:46.669323
NCT00006000|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-30|||August 2000||2000-08-01|January 2002|2002-01-01|March 2004|Actual|2004-03-01|||||Interventional|||SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors|Phase I Study of SU5416 in Combination With CPT-11 and Cisplatin in Patients With Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:46.783304|2017-02-18 18:13:46.783304
NCT00005999|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-20|||April 2000||2000-04-01|March 2002|2002-03-01|May 2003|Actual|2003-05-01|||||Interventional|||Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer|A Phase II Study of Arsenic Trioxide (NSC #706363) in Patients With Advanced Cervical Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:46.866564|2017-02-18 18:13:46.866564
NCT00005998|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-10-09|||January 2000||2000-01-01|October 2012|2012-10-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease|Autologous Transplantation for Non-Hodgkin's Lymphoma and Hodgkin's Disease Using Retrovirally Marked Peripheral Blood Progenitor Cells Obtained After In Vivo Mobilization Using Hematopoietic Cytokines Plus Chemotherapy|Withdrawn||Phase 2|0|Actual|Masonic Cancer Center, University of Minnesota||||Withdrawn because study never enrolled patients|f||||t||||||||||2017-02-18 18:13:46.955553|2017-02-18 18:13:46.955553
NCT00005997|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-06-09|||April 1999||1999-04-01|June 2010|2010-06-01|November 2005|Actual|2005-11-01|April 2005|Actual|2005-04-01||Interventional|||Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer|Phase II and Pharmacokinetic Trial of Rebeccamycin Analog in Hepatobiliary Cancers|Terminated||Phase 2|72|Actual|Case Comprehensive Cancer Center||1||slow accrual for Cohort II|f||||t||||||||||2017-02-18 18:13:47.052068|2017-02-18 18:13:47.052068
NCT00005996|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-12-18||||||September 2000|2000-09-01||||||||Interventional|||SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors|A Phase I Study of SU5416 in Combination With Gemcitabine/Cisplatin in Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:47.161409|2017-02-18 18:13:47.161409
NCT00005995|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-03-04|||October 2000||2000-10-01|February 2008|2008-02-01||||March 2007|Actual|2007-03-01||Interventional|||AE-941 in Treating Patients With Metastatic Kidney Cancer|AE-941 (NEOVASTAT) Versus Placebo in Metastatic Renal Cell Carcinoma Patients Who Are Refractory to Immunotherapy|Completed||Phase 3|||AEterna Zentaris|||||f||||||||||||||2017-02-18 18:13:47.241675|2017-02-18 18:13:47.241675
NCT00005994|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-03-04|||August 2000||2000-08-01|March 2013|2013-03-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy|Patient Information and Antiemetic Drug Efficacy|Completed||N/A|||University of Rochester|||||f||||||||||||||2017-02-18 18:13:47.334792|2017-02-18 18:13:47.334792
NCT00005993|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-10-09|||May 1999||1999-05-01|October 2012|2012-10-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer|Immunotherapy With Subcutaneous Il-2 and Stem Cell Factor (SCF) for Patients With Lymphoma or Breast Cancer After Autologous Transplantation|Terminated||Phase 1|||Masonic Cancer Center, University of Minnesota|||||f||||t||||||||||2017-02-18 18:13:47.4301|2017-02-18 18:13:47.4301
NCT00005992|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-08-06|||December 2000||2000-12-01|May 2002|2002-05-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Phase I Clinical Trial of Recombinant Prostate Specific Membrane Antigen (rPSMA)-Loaded Mature Autologous Dendritic Cells (CapPVax) for the Treatment of Metastatic Horomone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:47.533055|2017-02-18 18:13:47.533055
NCT00005991|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-10-05|||April 2000||2000-04-01|October 2012|2012-10-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer|Phase I/II Study of Gemcitabine and Doxil Combination Chemotherapy in Patients With Advanced Solid Tumors (Phase I)/Breast Cancer (Phase II)|Completed||Phase 2|76|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:13:47.625432|2017-02-18 18:13:47.625432
NCT00005990|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-11-08|||August 2000||2000-08-01|January 2006|2006-01-01||||September 2006|Actual|2006-09-01||Interventional|||R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors|Phase I and Pharmacokinetic Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:13:47.727259|2017-02-18 18:13:47.727259
NCT00005989|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2011-08-02|||November 2002||2002-11-01|August 2011|2011-08-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer|A Phase II Study of Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:13:47.820095|2017-02-18 18:13:47.820095
NCT00005988|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-05-16|||February 2000||2000-02-01|May 2009|2009-05-01||||||||Interventional|||Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy|A Phase I Open-Label, Safety Study of Haploidentical Bone Marrow Transplantation (BMT) After Ex Vivo Treatment of Bone Marrow With Anti-B7.1 and Anti-B7.2 Antibodies|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:47.914545|2017-02-18 18:13:47.914545
NCT00005973|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01||||July 2004|Actual|2004-07-01||Interventional|||BMS-214662 in Treating Patients With Solid Tumors|Phase I Study of Farnesyl Transferase Inhibitor BMS-214662 (NSC 710086D) in Solid Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:50.212218|2017-02-18 18:13:50.212218
NCT00005987|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-10-09|||August 2000||2000-08-01|October 2012|2012-10-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma|Autologous Transplantation for Multiple Myeloma: A Research Study of Multiple Myeloma Using Chemotherapy Plus Growth Factor Primed Peripheral Blood Stem Cells Followed by Autologous Transplantation and Post-Transplant Immunotherapy|Terminated||Phase 2|87|Actual|Masonic Cancer Center, University of Minnesota||||Withdrawn because treatment guidelines changed|f||||t||||||||||2017-02-18 18:13:48.031172|2017-02-18 18:13:48.031172
NCT00005986|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2011-07-13|||August 2000||2000-08-01|July 2011|2011-07-01||||September 2004|Actual|2004-09-01||Interventional|||Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia|Autologous Transplantation for Chronic Myelogenous Leukemia Using Retrovirally Marked Peripheral Blood Progenitor Cells Obtained After In Vivo Cyclophosphamide/G-CSF Priming|Terminated||Phase 2|||Masonic Cancer Center, University of Minnesota||1||Principal investigator left the university.|f||||||||||||||2017-02-18 18:13:48.126073|2017-02-18 18:13:48.126073
NCT00005985|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-10-16|||August 2000||2000-08-01|October 2012|2012-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma|Primed Peripheral Blood Stem Cell Autologous Transplantation for Lymphoma and Hodgkin's Disease|Completed||Phase 2|213|Actual|Masonic Cancer Center, University of Minnesota|||||f||||t||||||||||2017-02-18 18:13:48.504594|2017-02-18 18:13:48.504594
NCT00005984|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2011-05-25|||August 2000||2000-08-01|May 2011|2011-05-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia|Autologous Marrow Transplantation for Chronic Myelogenous Leukemia Using Stem Cells Obtained After In Vivo Cyclophosphamide/G-CSF Priming|Terminated||Phase 2|22|Actual|Masonic Cancer Center, University of Minnesota||1||Study terminated as principal investigator [PI] left the university.|f||||t||||||||||2017-02-18 18:13:48.638599|2017-02-18 18:13:48.638599
NCT00005983|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-22|||June 2000||2000-06-01|January 2013|2013-01-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer|Randomized Trial of Post-Mastectomy Radiotherapy in Stage II Breast Cancer in Women With One to Three Positive Axillary Nodes Phase III|Terminated||Phase 3|98|Actual|Southwest Oncology Group||2||due to lack of accrual|f||||t||||||||||2017-02-18 18:13:48.766102|2017-02-18 18:13:48.766102
NCT00005982|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01||||July 2004|Actual|2004-07-01||Interventional|||506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma|Phase II Study of 506U78 (NSC #686673) in Patients With Previously Treated Cutaneous T-Cell Lymphoma|Terminated||Phase 2|35|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:13:48.878731|2017-02-18 18:13:48.878731
NCT00005981|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-06-09|||June 2000||2000-06-01|June 2010|2010-06-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer|Phase II Trial of O6Benzylguanine and BCNU in Patients With Colon and Rectal Carcinoma|Completed||Phase 2|13|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:13:48.991293|2017-02-18 18:13:48.991293
NCT00005980|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-07-17|||April 2000||2000-04-01|July 2012|2012-07-01||||July 2002|Actual|2002-07-01||Interventional|||Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer|A Randomized Phase II Study of Two Different Schedules of Caelyx in Metastatic Breast Cancer|Completed||Phase 2|116|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:13:49.106801|2017-02-18 18:13:49.106801
NCT00005979|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-02-03|||February 1998||1998-02-01|September 2000|2000-09-01||||||||Interventional|||Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer|Phase III Randomized Study of Intensive Adjuvant Chemotherapy for Resected Colon Cancer at High Risk of Recurrence|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:49.232709|2017-02-18 18:13:49.232709
NCT00005978|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-10-14|||May 2000||2000-05-01|May 2009|2009-05-01||||December 2004|Actual|2004-12-01||Interventional|||N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma|Dose Escalation Study of 131 I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma - A Phase I Study|Completed||Phase 1|||New Approaches to Neuroblastoma Therapy Consortium|||||f||||t||||||||||2017-02-18 18:13:49.376294|2017-02-18 18:13:49.376294
NCT00005977|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-08-19|||September 2000||2000-09-01|August 2013|2013-08-01|September 2006|Actual|2006-09-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia|A Pilot Study of Dose Intensification of Methotrexate in Patients With Advanced-Stage (III/IV) Small Non-Cleaved Cell Non-Hodgkins Lymphoma and B-Cell All|Completed||Phase 3|83|Actual|Children's Oncology Group||5|||f||||t||||||||||2017-02-18 18:13:49.50921|2017-02-18 18:13:49.50921
NCT00005976|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-31|||May 2000||2000-05-01|September 2003|2003-09-01|April 2007|Actual|2007-04-01|December 2006|Actual|2006-12-01||Interventional|||Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma|Phase I/II Trial of Pyrazoloacridine and Carboplatin in Patients With Recurrent Glioma|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:13:49.812433|2017-02-18 18:13:49.812433
NCT00005975|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2015-11-17|||April 1998||1998-04-01|November 2015|2015-11-01|March 2002|Actual|2002-03-01|September 2001|Actual|2001-09-01||Interventional|||S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer|A Phase III Trial of Placebo Versus Megestrol Acetate 20 MG/Day Versus Megestrol Acetate 40 MG/Day as Treatment for Symptoms of Ovarian Failure in Women Treated for Breast Cancer: SWOG Study S9626|Completed||Phase 3|288|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:13:49.942869|2017-02-18 18:13:49.942869
NCT00005974|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2011-09-27|||July 2000||2000-07-01|September 2011|2011-09-01|September 2008|Actual|2008-09-01|November 2002|Actual|2002-11-01||Interventional|||Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma|A Phase II Study of Flavopiridol (HMR 1275; NSC 649890) in Patients With Previously Untreated Metastatic or Locally Advanced Soft Tissue Sarcoma|Completed||Phase 2|18|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 18:13:50.058606|2017-02-18 18:13:50.058606
NCT00005972|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-07-12|||May 2000||2000-05-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|October 2006|Actual|2006-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer|Phase II Trial of Gemcitabine/Irinotecan as Second Line Therapy for Small Cell Lung Cancer|Completed||Phase 2|73|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:13:50.32317|2017-02-18 18:13:50.32317
NCT00005971|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-11-07|||July 2000||2000-07-01|March 2010|2010-03-01|December 2009|Actual|2009-12-01|||||Interventional|||Flavopiridol in Treating Patients With Metastatic Malignant Melanoma|A Phase II Study of Flavopiridol (HMR 1275; NSC 649890) in Patients With Previously Untreated Metastatic Malignant Melanoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:13:50.553703|2017-02-18 18:13:50.553703
NCT00005970|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2017-02-02|||May 2000||2000-05-01|December 2016|2016-12-01||||May 2020|Anticipated|2020-05-01||Interventional|||Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer|Phase III Trial of Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Paclitaxel With or Without Trastuzumab as Adjuvant Treatment for Women With HER-2 Over-Expressing or Amplified Node Positive or High-Risk Node Negative Breast Cancer|Active, not recruiting||Phase 3|3000|Anticipated|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 18:13:50.690751|2017-02-18 18:13:50.690751
NCT00005969|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-02-17|||September 1999||1999-09-01|February 2012|2012-02-01||||January 2001|Actual|2001-01-01||Interventional|||Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease|Phase II Study of ATRAGEN (Liposomal Tretinoin) in Patients With Relapsed or Refractory Hodgkin's Disease|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Study withdrawn.|f||||f||||||||||2017-02-18 18:13:53.945493|2017-02-18 18:13:53.945493
NCT00005968|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-28|||November 1999||1999-11-01|December 2002|2002-12-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Irofulven in Treating Patients With Stage IV Melanoma|A Multicenter Phase II Trial of MGI-114 in Patients With Stage IV Malignant Melanoma|Completed||Phase 2|||University of Colorado, Denver|||||f||||f||||||||||2017-02-18 18:13:54.326203|2017-02-18 18:13:54.326203
NCT00005967|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-02-08|||August 2000||2000-08-01|October 2004|2004-10-01||||April 2004|Actual|2004-04-01||Interventional|||Tipifarnib in Treating Patients With Advanced Hematologic Cancer|A Dose Finding Study of R115777 (NSC 702818) in Patients With Advanced Hematologic Malignancies|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:54.428497|2017-02-18 18:13:54.428497
NCT00005966|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-02-04|||October 2000||2000-10-01|September 2002|2002-09-01||||March 2006|Actual|2006-03-01||Interventional|||Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer|Phase III Randomized Trial of Interferon-Alfa2b Alone Versus Interferon-Alfa2b Plus Thalidomide in Patients With Previously Untreated Metastatic or Unresectable Renal Cell Carcinoma|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:54.549257|2017-02-18 18:13:54.549257
NCT00005965|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-07-09|||August 2000||2000-08-01|July 2004|2004-07-01|April 2004|Actual|2004-04-01|||||Interventional|||Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix|Phase II Clinical Trial of Bryostatin-1, NSC 339555, and Cisplatin in Patients With Recurrent and/or Advanced Inoperable Squamous Cell, Adeno or Adenosquamous Cell Carcinoma of the Cervix|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:54.6628|2017-02-18 18:13:54.6628
NCT00005964|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-07-12|||May 2000||2000-05-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|Randomized Phase II Study of Dose-Adjusted EPOCH vs. NHL-15 Chemotherapy for Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:13:54.770186|2017-02-18 18:13:54.770186
NCT00005963|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-12-05|||November 2000||2000-11-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|October 2002|Actual|2002-10-01||Interventional|||Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer|Phase II Trial of Docetaxel and Carboplatin as First-Line Therapy for Metastatic Breast Cancer|Completed||Phase 2|53|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:13:54.93645|2017-02-18 18:13:54.93645
NCT00005962|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-08-16|||July 2000||2000-07-01|August 2013|2013-08-01|June 2007|Actual|2007-06-01|October 2005|Actual|2005-10-01||Interventional|||Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia|A Phase II Randomized Trial of Immunologic and Chemotherapeutic Agents for Treatment of Patients With Relapsed or Refractory Acute Myelogenous Leukemia|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:13:55.061384|2017-02-18 18:13:55.061384
NCT00005961|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-02-08|||June 2000||2000-06-01|April 2003|2003-04-01||||December 2005|Actual|2005-12-01||Interventional|||O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma|A Phase II Trial of O6-Benzylguanine (NSC 637037) and BCNU (Carmustine) in Patients With Metatstatic Melanoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:55.491148|2017-02-18 18:13:55.491148
NCT00005960|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-12-03|||October 1999||1999-10-01|January 2001|2001-01-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study of Doxorubicin and Cyclophosphamide With Sequential Docetaxel in Patients With Hormone-Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:55.612301|2017-02-18 18:13:55.612301
NCT00005959|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-12-03|||December 1999||1999-12-01|June 2002|2002-06-01||||||||Interventional|||Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma|Phase II Trial of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated Intermediate or High Grade Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:55.718412|2017-02-18 18:13:55.718412
NCT00005958|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-12-03|||October 1999||1999-10-01|October 2001|2001-10-01||||||||Interventional|||Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer|Treatment of Patients With Transitional-Cell Carcinoma of the Urothelial Tract With Gemcitabine, Docetaxel and Filgrastim|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:55.845937|2017-02-18 18:13:55.845937
NCT00005957|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-05-09|2016-04-05||April 2000||2000-04-01|May 2016|2016-05-01|December 2016|Anticipated|2016-12-01|October 2014|Actual|2014-10-01||Interventional||Intention-to-treat|Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer|A Phase III Study of Regional Radiation Therapy in Early Breast Cancer|Active, not recruiting||Phase 3|1832|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:13:55.953859|2017-02-18 18:13:55.953859
NCT00005956|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2014-07-07|||February 2000||2000-02-01|March 2013|2013-03-01|July 2002|Actual|2002-07-01|August 2001|Actual|2001-08-01||Interventional|||Biological Therapy in Treating Patients With Advanced Cancer|A Pilot Study of Active Immunotherapy With HER2/Neu Intracellular Domain (ICD) Protein-Pulsed, Autologous, Cultured Dendritic Cells in Patients With No Evidence of Disease After Standard Treatment for HER2/Neu Expressing Malignancies|Completed||N/A|3|Actual|Duke University||1|||f||||f||||||||||2017-02-18 18:13:56.366613|2017-02-18 18:13:56.366613
NCT00005955|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-19|||August 2000||2000-08-01|October 2009|2009-10-01|September 2002|Actual|2002-09-01|||||Interventional|||Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors|Phase II Treatment of Children With Newly Diagnosed Malignant Central Nervous System Tumors With Temozolomide Prior to Radiation Therapy|Completed||Phase 2|||Duke University|||||f||||||||||||||2017-02-18 18:13:56.47726|2017-02-18 18:13:56.47726
NCT00005954|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-19|||August 2000||2000-08-01|October 2009|2009-10-01|June 2003|Actual|2003-06-01|||||Interventional|||Temozolomide in Treating Patients With Brain Metastases|Phase II Treatment of Adults With Brain Metastases With Temodar|Completed||Phase 2|||Duke University|||||f||||||||||||||2017-02-18 18:13:56.576136|2017-02-18 18:13:56.576136
NCT00005952|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-06-19|||August 2000||2000-08-01|February 2013|2013-02-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors|A Phase I/II Trial of Temodar in Pediatric Patients and Young Adults With High-Risk or Recurrent Solid Tumors|Completed||Phase 1/Phase 2|30|Anticipated|Duke University|||||f||||f||||||||||2017-02-18 18:13:56.672604|2017-02-18 18:13:56.672604
NCT00005951|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2014-08-20|||August 2000||2000-08-01|February 2013|2013-02-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma|Phase I Treatment of Adults With Primary Malignant Glioma With Irinotecan (CPT-11) (NSC- #6616348) Plus Temodar (NSC #362856)|Completed||Phase 1|||Duke University|||||f||||||||||||||2017-02-18 18:13:56.782876|2017-02-18 18:13:56.782876
NCT00005950|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01||||October 2004|Actual|2004-10-01||Interventional|||506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma|Phase II Study of 506U78 (NSC #686673) for Patients With Relapsed or Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma|Terminated||Phase 2|111|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:13:56.87833|2017-02-18 18:13:56.87833
NCT00005949|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-15|||March 2001||2001-03-01|January 2013|2013-01-01||||March 2006|Actual|2006-03-01||Interventional|||Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma|Phase II Study of Melanoma Vaccine (NSC #683472/675756, IND #6123) and Low-Dose, Subcutaneous Interleukin-2 in Advanced Melanoma|Completed||Phase 2|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:56.990874|2017-02-18 18:13:56.990874
NCT00005948|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-03-31|||January 2000||2000-01-01|March 2010|2010-03-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia|A Pilot Study of High Dose Busulfan Combined With IL2/GM-CSF Activated Autologous/Syngeneic PBSC, Sequential IL2/GM-CSF Therapy and Alpha Interferon Maintenance Therapy as Treatment of CML|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:13:57.107326|2017-02-18 18:13:57.107326
NCT00005947|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-10-08|2010-05-28||November 1999||1999-11-01|October 2010|2010-10-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Randomized, Double Blind, Placebo Controlled Trial of Immunotherapy With Autologous Antigen-Loaded Dendritic Cells (Provenge) for Asymptomatic Metastatic Hormome-Refractory Prostate Cancer|Completed||Phase 3|127|Actual|Dendreon||2|||f||||||||||||||2017-02-18 18:13:57.202063|2017-02-18 18:13:57.202063
NCT00005946|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2009-02-06|||October 2000||2000-10-01|July 2007|2007-07-01||||||||Interventional|||Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation|A Pilot Study of Combined Chemotherapy and Donor Lymphocyte Infusion for Hematologic Malignancies in Relapse After Allogeneic Bone Marrow Transplantation|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:58.045581|2017-02-18 18:13:58.045581
NCT00005945|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-02-19|||June 2000||2000-06-01|February 2016|2016-02-01|June 2008|Actual|2008-06-01|November 2007|Actual|2007-11-01||Interventional|||Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia|Escalating Dose Intravenous Methotrexate Without Leucovorin Rescue Versus Oral Methotrexate and Single Versus Double Delayed Intensification for Children With Standard Risk Acute Lymphoblastic Leukemia|Completed||Phase 3|3054|Actual|Children's Oncology Group||7|||f||||t||||||||||2017-02-18 18:13:58.15236|2017-02-18 18:13:58.15236
NCT00005944|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2011-04-23|||November 1999||1999-11-01|June 2007|2007-06-01||||||||Interventional|||Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer|Study of Second Look Surgery With or Without Chemotherapy Intraperitoneally, in the Event of Risk of Intraperitoneal Recurrence|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:58.454466|2017-02-18 18:13:58.454466
NCT00005943|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-05-28|||February 2000||2000-02-01|October 2001|2001-10-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Gene Therapy in Treating Patients With Metastatic Melanoma|A Phase I Study Using Direct Combination DNA Injections for the Immunotherapy of Metastatic Melanoma|Completed||Phase 1|||University of Colorado, Denver|||||f||||t||||||||||2017-02-18 18:13:58.568235|2017-02-18 18:13:58.568235
NCT00005942|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-01-22|||March 2000||2000-03-01|January 2013|2013-01-01||||December 2000|Actual|2000-12-01||Interventional|||Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy|Phase II Trial of Liposomal Daunorubicin (Daunoxome) and SU5416 (NSC 696819) in Patients With AML, RAEB, RAEB-T or CMML in Transformation Refractory to One Course of Induction Chemotherapy|Completed||Phase 1/Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:13:58.665259|2017-02-18 18:13:58.665259
NCT00005941|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2010-03-31|||November 1999||1999-11-01|March 2010|2010-03-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer|Phase II Pilot Trial of Non-Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation Using Fludarabine, Low Dose TBI and Post-Transplant Cyclosporine and Mycophenolate Mofetil Followed by Donor Lymphocyte Infusion for Therapy of Advanced or Metastatic Human Papilloma Virus (HPV) - Associated Cervical Carcinoma Refractory to Standard Therapy|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:13:58.77354|2017-02-18 18:13:58.77354
NCT00005940|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2016-11-14|||October 1999||1999-10-01|November 2016|2016-11-01||||January 2006|Actual|2006-01-01||Interventional|||Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission|Phase II Study of Radiolabeled BC8 (Anti-CD45) Antibody Combined With Busulfan and Cyclophosphamide as Treatment for Acute Myelogenous Leukemia in First Remission Followed by HLA-Identical Related Peripheral Blood Stem Cell Transplantation|Active, not recruiting||Phase 2|18|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 18:13:58.870275|2017-02-18 18:13:58.870275
NCT00005939|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2013-11-05|||November 1999||1999-11-01|February 2001|2001-02-01||||||||Interventional|||Brachytherapy in Treating Patients With Recurrent Prostate Cancer|Phase I/II Study of Interstitial Colloidal 32P for Locally Recurrent Prostate Cancer Failing Radiation|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:13:58.997759|2017-02-18 18:13:58.997759
NCT00005938|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-05|2012-05-15|||March 2000||2000-03-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||DX-8951f in Treating Patients With Biliary Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Biliary Tree Cancer (Cholangiocarcinoma and Gallbladder Cancer)|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:13:59.080638|2017-02-18 18:13:59.080638
NCT00005937|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-06|2014-10-20|2010-04-02||June 2000||2000-06-01|October 2014|2014-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Interventional|||Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia|A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)|Completed||Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 18:13:59.176661|2017-02-18 18:13:59.176661
NCT00005936|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-06|2008-03-03|||June 2000||2000-06-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Collection of Liver Tissue for Virologic Studies|Collection of Liver Tissue for Virologic Studies|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:59.410878|2017-02-18 18:13:59.410878
NCT00005935|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-06|2008-03-03|||June 2000||2000-06-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia|A Randomized Trial for the Treatment of Relapsing Aplastic Anemia With Mycophenolate Mofetil (MMF) and Cyclosporine (CSA)|Completed||Phase 2|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:59.487475|2017-02-18 18:13:59.487475
NCT00005934|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-06|2008-03-03|||June 2000||2000-06-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Interventional|||5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia|A Pilot Study of 5-Azacytidine and Oral Sodium Phenylbutyrate in Severe Thalassemia|Completed||Phase 2|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:59.845932|2017-02-18 18:13:59.845932
NCT00005933|ClinicalTrials.gov processed this data on February 17, 2017|2000-07-04|2008-03-03|||June 2000||2000-06-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders|Cognitive Function in Leukocyte Disorders|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:13:59.935141|2017-02-18 18:13:59.935141
NCT00005931|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-30|2005-06-23||||||December 2000|2000-12-01||||||||Interventional|||SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment|A Multicenter, Open-Label, Phase II Study of SU5416 in Patients With Therapy-Refractory Cutaneous AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:14:00.020131|2017-02-18 18:14:00.020131
NCT00005928|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-28|2008-03-03|||June 2000||2000-06-01|February 2002|2002-02-01|February 2002||2002-02-01|||||Interventional|||Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation|Effects of Angiotensin Converting Enzyme Inhibitor Therapy on Vascular Inflammation and Compliance|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:00.102975|2017-02-18 18:14:00.102975
NCT00005927|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-28|2017-01-24|||June 23, 2000||2000-06-23|December 22, 2016|2016-12-22||||||||Observational|||Study of Adrenal Gland Tumors|Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:00.204052|2017-02-18 18:14:00.204052
NCT00005926|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-28|2008-03-03|||June 2000||2000-06-01|June 2000|2000-06-01|December 2000||2000-12-01|||||Interventional|||Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas|A Phase II Trial of Gemcitabine, Herceptin, and Radiation for Regionally Confined Adenocarcinoma of the Pancreas|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:00.315121|2017-02-18 18:14:00.315121
NCT00005925|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-24|2017-01-24|||June 23, 2000||2000-06-23|December 24, 2014|2014-12-24|March 31, 2020|Anticipated|2020-03-31|||||Interventional|||Brain Infusion of Muscimol to Treat Epilepsy|Trial of Intracerebral Infusion in Patients With Medically Intractable Epilepsy|Terminated||Phase 1|3|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:14:00.409143|2017-02-18 18:14:00.409143
NCT00005924|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-24|2017-01-24|||June 23, 2000||2000-06-23|February 2, 2010|2010-02-02|February 2, 2010||2010-02-02|||||Observational|||Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus|Persistence of Epstein-Barr Virus in Vivo|Completed||N/A|41|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:00.510361|2017-02-18 18:14:00.510361
NCT00005842|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-02-08|||June 2000||2000-06-01|April 2007|2007-04-01||||February 2004|Actual|2004-02-01||Interventional|||Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer|A Phase I, Pharmacokinetic, and Biologic Correlative Study of R115777 (NSC 702818) and Herceptin in Patients With Advanced Cancer|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:00.599027|2017-02-18 18:14:00.599027
NCT00005841|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2014-05-20|||June 2000||2000-06-01|May 2014|2014-05-01|October 2002|Actual|2002-10-01|December 2000|Actual|2000-12-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase I Trial of a Vaccine Combining Tyrosinase/GP100/Mart-1 Peptides Emulsified With Montanide ISA 51 With ProGP for Patients With Resected Stages III and IV Melanoma|Terminated||Phase 1|15|Actual|University of Southern California||||Toxicity/Side Effects|f||||t||||||||||2017-02-18 18:14:00.722064|2017-02-18 18:14:00.722064
NCT00005840|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2014-12-29|||July 2000||2000-07-01|December 2014|2014-12-01||||July 2009|Actual|2009-07-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer|Phase I Trial of the Treatment of Advanced Endometrial Cancer With Concurrent Weekly Paclitaxel and Cisplatin and Whole Abdominal Radiation Therapy|Completed||Phase 1|35|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:14:00.828068|2017-02-18 18:14:00.828068
NCT00005839|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2015-06-03|||August 2000||2000-08-01|June 2015|2015-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor|A Phase I Study of Oxaliplatin in Combination With Capecitabine in Metastatic/Recurrent Solid Tumors|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:14:00.944351|2017-02-18 18:14:00.944351
NCT00005838|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-22|||March 2000||2000-03-01|January 2013|2013-01-01||||February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery|Multicenter, Open-Ended, Double-Blind, Placebo-Controlled, Phase III Study of AE-941 in Addition to Combined Modality Treatment (Chemotherapy/Radiotherapy) for Locally Advanced Unresectable Non-Small Cell Lung Cancer|Completed||Phase 3|756|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:14:01.231521|2017-02-18 18:14:01.231521
NCT00005837|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-06-20|||February 2000||2000-02-01|July 2004|2004-07-01|June 2004|Actual|2004-06-01|||||Interventional|||Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer|Phase II Evaluation of Oxaliplatin in Persistent or Recurrent Squamous Cell Carcinoma of the Cervix|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:01.379279|2017-02-18 18:14:01.379279
NCT00005836|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-06-20|||February 2000||2000-02-01|March 2003|2003-03-01|July 2004|Actual|2004-07-01|||||Interventional|||Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy|Phase II Evaluation of Oxaliplatin in Recurrent, Platinum Resistant and Refractory Ovarian Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:01.551319|2017-02-18 18:14:01.551319
NCT00005835|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-08-27|||August 2001||2001-08-01|June 2016|2016-06-01|April 2016|Actual|2016-04-01|December 2014|Actual|2014-12-01||Interventional|BSO||N99-02: Melphalan and Buthionine Sulfoximine|Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BSO) Autologous Stem Cell Support for Resistant or Recurrent High-Risk Neuroblastoma (IND 69-112)|Completed||Phase 1|30|Anticipated|New Approaches to Neuroblastoma Therapy Consortium||1|||f||||t||||||||||2017-02-18 18:14:01.728864|2017-02-18 18:14:01.728864
NCT00005834|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2015-03-05|||April 2000||2000-04-01|March 2015|2015-03-01|November 2007|Actual|2007-11-01|November 2003|Actual|2003-11-01||Interventional|||S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma|A Phase III Trial of Dexamethasone, Cyclophosphamide, Etoposide, Cisplatin (DCEP) and G-CSF With or Without Thalidomide (NSC #66847) as Salvage Therapy for Patients With Refractory Multiple Myeloma|Terminated||Phase 3|19|Actual|Southwest Oncology Group||2||poor accrual|f||||t||||||||||2017-02-18 18:14:01.855926|2017-02-18 18:14:01.855926
NCT00005833|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-06-12|||June 2000||2000-06-01|June 2012|2012-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||S9923 R115777 in Treating Patients With Advanced Colorectal Cancer|A Phase II Trial of R115777 (NSC #702818) in Patients With Advanced Colorectal Cancer|Completed||Phase 2|62|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:14:02.085364|2017-02-18 18:14:02.085364
NCT00005832|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2015-11-16|||June 2000||2000-06-01|November 2015|2015-11-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer|A Phase II Trial of R115777 (NSC #702818) in Patients With Advanced Pancreas Cancer|Completed||Phase 2|58|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:14:02.21174|2017-02-18 18:14:02.21174
NCT00005831|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-11|||March 2000||2000-03-01|January 2013|2013-01-01||||August 2004|Actual|2004-08-01||Interventional|||Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer|Phase II Evaluation of Trastuzumab (Herceptin), Paclitaxel, Carboplatin, and Gemcitabine in the Treatment of Advanced Urothelial Cancer|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:02.346234|2017-02-18 18:14:02.346234
NCT00005830|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2014-12-29|||July 2000||2000-07-01|December 2014|2014-12-01||||July 2009|Actual|2009-07-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer|Phase I Toxicity Trial of Doxorubicin-Cisplatin Followed by Whole Abdominal Irradiation for Advanced Endometrial Carcinoma|Completed||Phase 1|31|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:14:02.458958|2017-02-18 18:14:02.458958
NCT00005829|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-12-05|||February 2000||2000-02-01|December 2016|2016-12-01|April 2008|Actual|2008-04-01|October 2002|Actual|2002-10-01||Interventional|||Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia|Phase II Study of Gemcitabine for Relapsed B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|22|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:14:02.57353|2017-02-18 18:14:02.57353
NCT00005828|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-07-12|||December 2000||2000-12-01|July 2016|2016-07-01|June 2008|Actual|2008-06-01|March 2003|Actual|2003-03-01||Interventional|||Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of Green Tea Extract in the Treatment of Androgen-Independent Metastatic Prostate Cancer|Completed||Phase 2|54|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:14:02.950291|2017-02-18 18:14:02.950291
NCT00005827|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-04-20|||December 1999||1999-12-01|April 2012|2012-04-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer|Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical Study of Genistein in Normal Volunteers and in Prostate Neoplasia (Multiple Dose Safety and Pharmacokinetic Clinical Study of Genistein in Prostate Neoplasia)|Withdrawn||Phase 1|0|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:14:03.079533|2017-02-18 18:14:03.079533
NCT00005826|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-09-20|||March 2000||2000-03-01|September 2012|2012-09-01||||September 2000|Actual|2000-09-01||Interventional|||Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme|"Open Label Phase II Study on RFS 2000 (9-Nitro-Camptothecin, 9-NC) Administered as a 5 Days On-2 Days Off Oral Treatment in Glioblastoma Multiforme"|Completed||Phase 2|17|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:14:03.174702|2017-02-18 18:14:03.174702
NCT00005825|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-17|||September 1998||1998-09-01|July 2003|2003-07-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Trans Retinoic Acid (Vesanoid) With Chemotherapy in Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:03.280698|2017-02-18 18:14:03.280698
NCT00005824|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-02-01|||November 2000||2000-11-01|February 2016|2016-02-01|April 2006|Actual|2006-04-01|July 2004|Actual|2004-07-01||Interventional|||Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma|Pilot Study of the Safety and Feasibility of Autologous Peripheral Blood Stem Cell Transplantation for Patients With Relapsed AIDS-Related Lymphoma|Completed||Phase 2|||AIDS Malignancy Consortium|||||f||||||||||||||2017-02-18 18:14:03.366406|2017-02-18 18:14:03.366406
NCT00005823|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-17|||December 1998||1998-12-01|September 2006|2006-09-01|December 2007|Actual|2007-12-01|||||Interventional|||Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome|A Randomized Trial for Patients With Acute Myeloid Leukemia or High Risk Myelodysplatic Syndrome Aged 60 or Over|Completed||Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:03.460587|2017-02-18 18:14:03.460587
NCT00005822|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2010-06-10|||April 2000||2000-04-01|June 2010|2010-06-01|October 2003|Actual|2003-10-01|December 2002|Actual|2002-12-01||Interventional|||SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer|A Phase I Pharmacokinetic, Pharmacodynamic, and Clinical Study of the Combination of the Angiogenesis Inhibitor SU5416 and Doxorubicin in Inflammatory Breast Cancer|Completed||Phase 1|21|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:14:03.583391|2017-02-18 18:14:03.583391
NCT00005821|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-11-05|||December 1998||1998-12-01|March 2003|2003-03-01||||||||Interventional|||Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer|Sentinel Lymph Node Biopsy in the Assessment of Axillary Nodal Status in Operable Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:03.693831|2017-02-18 18:14:03.693831
NCT00005923|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-23|2005-06-23||||||November 2001|2001-11-01||||||||Observational|||The Effect of Estrogen and Progesterone Levels on Knee and Ankle Joint Laxity||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:03.778968|2017-02-18 18:14:03.778968
NCT00005922|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-22|2013-09-20|||August 2000||2000-08-01|September 2013|2013-09-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Conditioning, the Placebo Effect, and Psoriasis|Role of Conditioning in the Pharmacotherapy of Psoriasis|Completed||N/A|138|Actual|University of Rochester||3|||f||||t||||||||||2017-02-18 18:14:03.858667|2017-02-18 18:14:03.858667
NCT00005921|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-19|2005-06-23||||||June 2000|2000-06-01||||||||Interventional|||A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis|An Open, Serial-Panel, Multiple-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of L-743,872 in Patients With Candida Esophagitis|Completed||N/A|18||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:14:03.980479|2017-02-18 18:14:03.980479
NCT00005920|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-19|2005-06-23||||||June 2000|2000-06-01||||||||Interventional|||Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole|A Multiclinic, Double-Blind, Randomized, Dose-Comparison Study to Evaluate the Safety, Tolerability, and Efficacy of L-743,872 in the Treatment of Fluconazole-Unresponsive Oropharyngeal Candidiasis in Adults|Terminated||Phase 2|70||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:14:04.065082|2017-02-18 18:14:04.065082
NCT00005919|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-17|2008-03-03|||June 2000||2000-06-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Observational|||Cause of Pigment Dispersion Syndrome|Etiology of Pigment Dispersion Syndrome (PDS)|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:04.153503|2017-02-18 18:14:04.153503
NCT00005918|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-15|2011-04-28||2011-04-13|June 2000||2000-06-01|April 2011|2011-04-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients|The Safety and Antiviral Efficacy of Stavudine Extended Release Formulation as Compared to Stavudine Immediate Release Formulation, Each as Part of Potent Antiretroviral Combination Therapy|Completed||Phase 3|730||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:14:04.236446|2017-02-18 18:14:04.236446
NCT00005917|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-16|2017-02-14|||June 13, 2000||2000-06-13|January 26, 2017|2017-01-26||||||||Observational|||Study of Chediak-Higashi Syndrome|Investigations Into Chediak-Higashi Syndrome and Related Disorders|Recruiting||N/A|60|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:04.416391|2017-02-18 18:14:04.416391
NCT00005916|ClinicalTrials.gov processed this data on February 17, 2017|2006-06-30|2017-01-24|||June 13, 2000||2000-06-13|December 22, 2005|2005-12-22|December 22, 2005|Actual|2005-12-22|||||Interventional|||PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer|A Randomized Phase II Study of a PSA-Based Vaccine in Patients With Localized Prostate Cancer Receiving Standard Radiotherapy|Completed||Phase 2|48|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:14:04.52664|2017-02-18 18:14:04.52664
NCT00005915|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-15|2013-09-28||||||September 2013|2013-09-01|June 2004|Actual|2004-06-01|||||Observational|||A Comparison of Two Anti-HIV Treatment Plans|A Randomized Study of a Prescribed 4-Month Structured Treatment Interruption (STI) Followed by Initiation of a New Antiretroviral Regimen Versus Immediate Initiation of a New Antiretroviral Regimen in HIV-Infected Patients With Multidrug Resistant (MDR) Virus|Completed||N/A|480||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:14:04.622809|2017-02-18 18:14:04.622809
NCT00005914|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-15|2009-12-16|||October 1999||1999-10-01|February 2009|2009-02-01|September 2003||2003-09-01|||||Observational|||Genetics of Recurrent Early-Onset Depression||Completed||N/A|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:14:04.735751|2017-02-18 18:14:04.735751
NCT00005889|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||October 1999||1999-10-01|December 2003|2003-12-01||||||||Interventional|||Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion|Study of Gluconeogenesis in Very Low Birth Weight Infants Receiving Total Parenteral Nutrition|Unknown status|Recruiting|N/A|96||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:07.88601|2017-02-18 18:14:07.88601
NCT00005912|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-14|2008-03-03|||June 2000||2000-06-01|June 2000|2000-06-01|January 2001||2001-01-01|||||Interventional|||Voriconazole to Prevent Systemic Fungal Infections in Children|An Open Intravenous Multiple Dose, Multi-Center Study to Investigate the Pharmacokinetics, Safety and Toleration of Voriconazole in Children Aged 2-12 Years Who Require Treatment for the Prevention of Systemic Fungal Infection|Completed||Phase 1|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:04.826807|2017-02-18 18:14:04.826807
NCT00005911|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-13|2008-03-03|||June 2000||2000-06-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Magnetic Resonance Imaging to Study the Normal Eye|Refinement of the Magnetic Resonance Imaging Technique for the Study of the Normal Eye, Particularly the Lens and Cataract|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:04.922807|2017-02-18 18:14:04.922807
NCT00005910|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-13|2008-03-03|||June 2000||2000-06-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Interventional|||Laparoscopy to Remove Pancreatic Tumors (Insulinomas)|Use of Laparoscopy for Localization and Resection of Insulinomas of the Pancreas|Completed||N/A|23||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:05.006784|2017-02-18 18:14:05.006784
NCT00005909|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-13|2017-01-24|||June 9, 2000||2000-06-09|October 7, 2016|2016-10-07||||||||Observational|||Study of Alkaptonuria|Clinical, Biochemical, and Molecular Investigations Into Alkaptonuria|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:05.094072|2017-02-18 18:14:05.094072
NCT00005908|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-13|2013-03-13|2012-02-14||June 2000||2000-06-01|March 2013|2013-03-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Interventional|||Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer|A Pilot Trial of Sequential Primary (Neoadjuvant) Combination Chemotherapy With Docetaxel/Capecitabine (TX) and Doxorubicin/Cyclophosphamide (AC) in Primary Breast Cancer With Evaluation of Chemotherapy Effects on Gene Expression|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:14:05.205199|2017-02-18 18:14:05.205199
NCT00005907|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-09|2008-03-03|||June 2000||2000-06-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Comparison of Immune Response to Booster Vaccines in Blood Transplant Patients and Healthy Volunteers|Evaluation of Hepatitis B Surface Antigen-Specific and Tetanus Toxoid-Specific Lymphocytes|Completed||N/A|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:05.694779|2017-02-18 18:14:05.694779
NCT00005906|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-09|2010-04-29|2010-02-26||June 2000||2000-06-01|April 2010|2010-04-01||||April 2008|Actual|2008-04-01||Interventional|||Treatment With Octreotide in Patients With Lymphangioleiomyomatosis|Treatment With Octreotide in Patients With Lymphangioleiomyomatosis|Completed||Phase 2|4|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 18:14:05.770425|2017-02-18 18:14:05.770425
NCT00005905|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-09|2008-03-03|||June 2000||2000-06-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Leptin to Treat Lipodystrophy|Efficacy of Leptin Replacement in Treatment of Lipodystrophy|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:06.02627|2017-02-18 18:14:06.02627
NCT00005903|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-07|2008-03-03|||June 2000||2000-06-01|May 2005|2005-05-01|May 2005||2005-05-01|||||Interventional|||Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy|Dose-Escalation Trial of Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor for the Treatment of PSP|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:06.106638|2017-02-18 18:14:06.106638
NCT00005902|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-06|2017-01-24|||June 4, 2000||2000-06-04|October 5, 2016|2016-10-05||||||||Observational|||Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease|A Prospective Natural History Study of VHL Patients With CNS Hemangioblastomas|Active, not recruiting||N/A|250|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:06.203613|2017-02-18 18:14:06.203613
NCT00005901|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-06|2016-02-01|2015-11-24||June 2000||2000-06-01|February 2016|2016-02-01|March 2015|Actual|2015-03-01|May 2014|Actual|2014-05-01||Interventional|||Pamidronate to Treat Osteogenesis Imperfecta in Children|A Trial of Pamidronate in Children With Osteogenesis Imperfecta|Completed||Phase 3|34|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 18:14:06.294144|2017-02-18 18:14:06.294144
NCT00005900|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||August 1999||1999-08-01|October 2003|2003-10-01||||||||Observational|||Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation||Unknown status|Active, not recruiting|N/A|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:14:06.941314|2017-02-18 18:14:06.941314
NCT00005898|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||February 2000||2000-02-01|July 2004|2004-07-01||||||||Interventional|||Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia||Completed||Phase 1/Phase 2|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:14:07.296313|2017-02-18 18:14:07.296313
NCT00005896|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||March 2000||2000-03-01|March 2001|2001-03-01||||||||Interventional|||Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia||Unknown status|Active, not recruiting|Phase 1|6||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:14:07.38718|2017-02-18 18:14:07.38718
NCT00005893|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||June 2000||2000-06-01|July 2004|2004-07-01||||||||Interventional|||Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:14:07.472205|2017-02-18 18:14:07.472205
NCT00005892|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||March 2000||2000-03-01|July 2004|2004-07-01||||||||Interventional|||Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:14:07.575081|2017-02-18 18:14:07.575081
NCT00005891|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||March 2000||2000-03-01|July 2004|2004-07-01||||||||Interventional|||Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:14:07.68889|2017-02-18 18:14:07.68889
NCT00005890|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2005-06-23|||March 1996||1996-03-01|December 2003|2003-12-01||||||||Interventional|||Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock||Completed||N/A|56||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:07.779896|2017-02-18 18:14:07.779896
NCT00005887|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-05-08|||February 2000||2000-02-01|May 2013|2013-05-01||||||||Interventional|||Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases|A Phase III, Randomized, Open-Label, Comparative Study of Standard Whole Brain Radiation Therapy With or Without RSR13 in Patients With Brain Metastases|Completed||Phase 3|||Spectrum Pharmaceuticals, Inc|||||f||||||||||||||2017-02-18 18:14:08.093844|2017-02-18 18:14:08.093844
NCT00005886|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2017-01-12|||July 2000||2000-07-01|January 2017|2017-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer|A Phase IB Randomized Study of an Antiestrogen in Women With Newly Diagnosed Breast Cancer|Completed||Phase 1|||University of Kansas Medical Center|||||f||||||||||||||2017-02-18 18:14:08.289574|2017-02-18 18:14:08.289574
NCT00005884|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2015-09-30||||||September 2015|2015-09-01||||December 2000|Actual|2000-12-01||Interventional|||Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer|Chemoprevention of Skin Cancers With DFMO: A Controlled, Randomized Clinical Trial|Completed||Phase 3|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:14:08.407628|2017-02-18 18:14:08.407628
NCT00005883|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2011-03-25||||||March 2011|2011-03-01||||April 2001|Actual|2001-04-01||Interventional|||Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke|A Phase I - Part B Multiple Dose Trial of Phenethyl Isothiocyanate|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:14:08.494447|2017-02-18 18:14:08.494447
NCT00005882|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-28|||June 2000||2000-06-01|January 2013|2013-01-01|December 2011|Actual|2011-12-01|June 2008|Actual|2008-06-01||Interventional|||Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients With Benign Colorectal Polyps|A Phase II Clinical Trial of a Randomized, Double-Blind, Placebo Controlled Clinical Trial of DFMO and Sulindac Against Various Endpoints of Colorectal Pathobiology in a Cohort of Individuals at Increased Risk of Colorectal Carcinoma|Completed||Phase 2|324|Actual|University of California, Irvine||2|||f||||t||||||||||2017-02-18 18:14:08.575282|2017-02-18 18:14:08.575282
NCT00005881|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-08-22|||April 2000||2000-04-01|August 2013|2013-08-01|September 2006|Actual|2006-09-01|March 2003|Actual|2003-03-01||Observational|||Quality of Life in Children Treated for Cancer|Assessment of Health/Quality of Life in Survivors of Childhood Cancer|Completed||N/A|538|Actual|Children's Oncology Group|||1||f||||f||||||||||2017-02-18 18:14:08.696667|2017-02-18 18:14:08.696667
NCT00005880|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2008-07-23|||July 2000||2000-07-01|July 2007|2007-07-01||||||||Interventional|||Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia|A Phase II Trial of Inhaled Budesonide (Pulmicort Turbuhaler) in Persons With Dysplasia of the Bronchial Epithelium|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:08.833012|2017-02-18 18:14:08.833012
NCT00005879|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-05-11|||August 2000||2000-08-01|May 2016|2016-05-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||LY353381 in Preventing Breast Cancer in Women With Hyperplasia|A Phase II Clinical Trial of a Selective Estrogen Receptor Modulator (LY353381*HCl) in High Risk Women With Fine Needle Aspiration Cytologic Evidence of Hyperplasia|Completed||Phase 2|199|Actual|University of Kansas Medical Center||2|||f||||f||||||||No|Global results will be published.|2017-02-18 18:14:08.949418|2017-02-18 18:14:08.949418
NCT00005878|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-10-12|||July 2000||2000-07-01|October 2016|2016-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus|Chemoprevention for Barrett's Esophagus Trial (CBET)|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:14:09.060843|2017-02-18 18:14:09.060843
NCT00005877|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||September 1999||1999-09-01|April 2002|2002-04-01||||||||Interventional|||Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer|Phase II and Pharmacokinetic Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) in Patients With Advanced Colorectal Cancer Who Have Failed Previous 5-FU Based Chemotherapy|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.189404|2017-02-18 18:14:09.189404
NCT00005876|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||April 2000||2000-04-01|June 2002|2002-06-01||||||||Interventional|||Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery|A Phase II Study of RFS 2000 (Rubitecan, 9-Nitro-Camptothecin, 9-NC) in Patients With Advanced Gastric Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.280744|2017-02-18 18:14:09.280744
NCT00005875|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||January 1999||1999-01-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Nitrocamptothecin in Treating Patients With Metastatic Melanoma|Phase II Evaluation of RFS 2000 (9-Nitro-Camptothecin, 9NC) in Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.372073|2017-02-18 18:14:09.372073
NCT00005874|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||June 1999||1999-06-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas|Phase II Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) in Patients With Soft-Tissue Sarcomas|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.460409|2017-02-18 18:14:09.460409
NCT00005873|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||September 1999||1999-09-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer|Phase II Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) in Patients With Relapsed Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.542594|2017-02-18 18:14:09.542594
NCT00005872|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||May 1999||1999-05-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer|Phase II Study of RFS 2000 in Relapsed NSCLC|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.624159|2017-02-18 18:14:09.624159
NCT00005871|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||November 1998||1998-11-01|June 2007|2007-06-01||||||||Interventional|||Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer|Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) Versus 5-Fluorouracil (5-FU) in Pancreatic Cancer Patients That Have Progressive Disease Following Gemcitabine HCl Treatment|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.714632|2017-02-18 18:14:09.714632
NCT00005870|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||March 1999||1999-03-01|June 2007|2007-06-01||||||||Interventional|||Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas|Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) Versus Most Appropriate Therapy in Refractory Pancreatic Cancer Patients|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.802741|2017-02-18 18:14:09.802741
NCT00005869|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-03|||November 1998||1998-11-01|June 2007|2007-06-01||||||||Interventional|||Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer|Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) Versus Gemcitabine HCl in Chemonaive Pancreatic Cancer Patients|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:09.898818|2017-02-18 18:14:09.898818
NCT00005868|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-07-17|||March 2000||2000-03-01|July 2012|2012-07-01||||August 2002|Actual|2002-08-01||Interventional|||Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer|Taxotere and Cisplatin as Induction Chemotherapy in Patients With Stage IIIa N2 Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 2|47|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:14:09.981397|2017-02-18 18:14:09.981397
NCT00005867|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-06-25|||January 1998||1998-01-01|March 2007|2007-03-01|August 2007|Actual|2007-08-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma|Phase III Trial Comparing CHOP ot PMitCEBO in Good Risk Patients With Histologically Aggresive Non Hodgkin's Lymphoma|Completed||Phase 3|310|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:10.096238|2017-02-18 18:14:10.096238
NCT00005866|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2015-03-05|||February 2000||2000-02-01|March 2015|2015-03-01|March 2006|Actual|2006-03-01|March 2004|Actual|2004-03-01||Interventional|||S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia|A Phase III Randomized Study Comparing Busulfan-Total Body Irradiation Versus Cyclophosphamide-Total Body Irradiation Preparative Regimen in Patients With Advanced Myelodysplastic Syndrome (MDS) or MDS-Related Acute Myeloid Leukemia (AML) Undergoing HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation, (A BMT Study)|Completed||Phase 3|240|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-02-18 18:14:10.313013|2017-02-18 18:14:10.313013
NCT00005865|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2014-01-03|||April 2000||2000-04-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer|A Research Study Evaluating Oral and Intravenous NAVELBINE as a Single Agent for the Treatment of Chemotherapy-Naive Subjects With Inoperable Stage IIIb or Stage IV Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:10.482656|2017-02-18 18:14:10.482656
NCT00005864|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-30|||April 2000||2000-04-01|September 2002|2002-09-01|February 2004|Actual|2004-02-01|||||Interventional|||Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer|A Phase II Study of Chloroquinoxaline Sulfonamide (CQS) in Colorectal Cancer Stage IV|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:13.658057|2017-02-18 18:14:13.658057
NCT00005863|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-18|||August 1998||1998-08-01|January 2006|2006-01-01|December 2004|Actual|2004-12-01|||||Interventional|||Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia|Protocol for Patients With High Risk (Resistant, Refractory, Relapsed or Adverse Cytogenetic) AML|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:13.752938|2017-02-18 18:14:13.752938
NCT00005862|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-02-08|||October 2000||2000-10-01|April 2002|2002-04-01||||July 2004|Actual|2004-07-01||Interventional|||SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas|A Phase II Trial of SU5416 (NSC #696819) in Previously Treated Patients With Advanced, Metastatic and/or Locally Recurrent Soft Tissue Sarcomas|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:13.859756|2017-02-18 18:14:13.859756
NCT00005861|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-06-07|||May 2000||2000-05-01|August 2002|2002-08-01||||August 2005|Actual|2005-08-01||Interventional|||Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer|Evaluation of Doxil as First-Line Therapy of Advanced or Recurrent Endometrial Carcinoma|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:14:13.959915|2017-02-18 18:14:13.959915
NCT00005860|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2011-04-23|||April 2000||2000-04-01|May 2002|2002-05-01||||||||Interventional|||Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum|A Phase I Study of Intraperitoneal Oxaliplatin Alone and in Combination With Intraperitoneal Floxuridine and Leucovorin in Patients With Advanced Metastatic Cancer Confined to the Peritoneal Cavity|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:14.065112|2017-02-18 18:14:14.065112
NCT00005859|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2008-07-23|||August 2000||2000-08-01|April 2004|2004-04-01||||||||Interventional|||Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma|Phase I/II Trial of R115777 in Patients With Recurrent Malignant Glioma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:14.178289|2017-02-18 18:14:14.178289
NCT00005858|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-02-08|||April 2000||2000-04-01|March 2003|2003-03-01||||April 2003|Actual|2003-04-01||Interventional|||LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer|Phase I Study of LMB-9, a Recombinant Disulfide Stabilized Anti-Lewis Y Immunotoxin Admistered by Continuous Infusion|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:14.28521|2017-02-18 18:14:14.28521
NCT00005857|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2011-10-18|||August 2000||2000-08-01|October 2011|2011-10-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy|Randomized Phase II Trial of Herceptin (NSC 688097) and Weekly Docetaxel (NSC 628503) in Androgen-Independent (Horomone Refractory) Adenocarcinoma of the Prostate (CaP)|Completed||Phase 2|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:14:14.396888|2017-02-18 18:14:14.396888
NCT00005856|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-23|||December 2000||2000-12-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase I/II Trial of Oxaliplatin as Neoadjuvant Treatment in Adults With Newly Diagnosed Glioblastoma Multiforme|Terminated||Phase 1/Phase 2|59|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:14:14.502833|2017-02-18 18:14:14.502833
NCT00005855|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-06-20|||July 2000||2000-07-01|December 2003|2003-12-01|October 2006|Actual|2006-10-01|||||Interventional|||Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma|A Phase I/II Study to Evaluate the Safety and Tolerance of Escalating Doses of RSR13 Administered With a Fixed Dose of BCNU Every Six Weeks in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:14.888827|2017-02-18 18:14:14.888827
NCT00005854|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2011-11-28|||December 1999||1999-12-01|November 2011|2011-11-01|October 2000|Actual|2000-10-01|||||Interventional|||Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Transplantation of HLA Haploidentical Marrow Cells After Ex Vivo Exposure to Recipient Alloantigen in Presence of CTLA4-Ig - A Phase II Study of Tolerance Induction in Donor T Cells by Blockade of the CD80/CD86:CD28 Costimulatory Signal|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:14:14.999378|2017-02-18 18:14:14.999378
NCT00005853|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2010-03-31|||December 1999||1999-12-01|March 2010|2010-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Biological Therapy in Treating Patients With Myelodysplastic Syndrome|Therapy of Myelodysplastic Syndrome (MDS) With Antithymocyte Globulin (ATG) and TNFR:Fc|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:14:15.107778|2017-02-18 18:14:15.107778
NCT00005852|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-12-10|||June 1996||1996-06-01|December 2012|2012-12-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant|Allogeneic Bone Marrow Transplantation for Marrow Failure States|Terminated||Phase 2|||H. Lee Moffitt Cancer Center and Research Institute||||low accrual|f||||f||||||||||2017-02-18 18:14:15.214174|2017-02-18 18:14:15.214174
NCT00005851|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-07-06|||February 2000||2000-02-01|July 2016|2016-07-01||||July 2004|Actual|2004-07-01||Interventional|||Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer|Phase I/II Study of HLA-Matched Non-Myeloablative Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation as Treatment for Patients With Metastatic Renal Cell Carcinoma. A Multi-Center Trial.|Active, not recruiting||Phase 1/Phase 2|11|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:14:15.318681|2017-02-18 18:14:15.318681
NCT00005850|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-07-01|||August 2001||2001-08-01|July 2016|2016-07-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer|Fluoxetine in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC): A Phase II Pilot Study to Improve Quality of Life During Chemotherapy|Completed||Phase 2|21|Actual|Alliance for Clinical Trials in Oncology||1|||f||||||||||||||2017-02-18 18:14:15.448263|2017-02-18 18:14:15.448263
NCT00005849|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-02-08|||April 2000||2000-04-01|February 2013|2013-02-01|November 2003|Actual|2003-11-01|September 2002|Actual|2002-09-01||Interventional|||Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer|Phase II Study of Bryostatin-1 in Combination With Paclitaxel for Non-Small Cell Lung Cancer|Completed||Phase 2|15|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:14:15.608996|2017-02-18 18:14:15.608996
NCT00005848|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-07-10|||April 2000||2000-04-01|July 2013|2013-07-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|Phase II Trial of R115777 (NSC 702818) an Inhibitor of Farnesyl Protein Transferase, in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|7|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-02-18 18:14:15.72744|2017-02-18 18:14:15.72744
NCT00005847|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2010-01-26|||January 2001||2001-01-01|January 2010|2010-01-01||||July 2004|Actual|2004-07-01||Interventional|||Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Randomized Phase II Trial of Mitoxantrone, Estramustine and Navelbine or 13-cis Retinoic Acid, Interferon and Paclitaxel in Patients With Metatstatic Hormone Refractory Prostate Cancer|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:14:15.831653|2017-02-18 18:14:15.831653
NCT00005846|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2011-06-04|||June 2000||2000-06-01|July 2005|2005-07-01||||||||Interventional|||Tipifarnib in Treating Patients With Myeloproliferative Disorders|Phase I/II Study of the Farnesyltransferase Inhibitor R115777 (NSC 702818) in Patients With Myeloproliferative Disorders|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:15.947334|2017-02-18 18:14:15.947334
NCT00005845|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-13|||June 2002||2002-06-01|December 2013|2013-12-01||||September 2009|Actual|2009-09-01||Interventional|||Tipifarnib in Treating Patients With Myelodysplastic Syndromes|Phase I Study of the Farnesyl Transferase Inhibitor R115777 (NSC #702818) in Patients With Myelodysplastic Syndrome|Completed||Phase 1|65|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:16.039906|2017-02-18 18:14:16.039906
NCT00005844|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-10-22|||April 2000||2000-04-01|October 2012|2012-10-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Oxaliplatin in Treating Children With Advanced Solid Tumors|A Phase I Study of Oxaliplatin in Children With Solid Tumors|Completed||Phase 1|26|Actual|St. Jude Children's Research Hospital|||||f||||f||||||||||2017-02-18 18:14:16.149701|2017-02-18 18:14:16.149701
NCT00005843|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-02-08|||May 2000||2000-05-01|April 2007|2007-04-01||||September 2004|Actual|2004-09-01||Interventional|||R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer|Phase II Trial of R115777 (NSC-702818), an Inhibitor of Farnesyl Protein Transferase, in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:16.246942|2017-02-18 18:14:16.246942
NCT00005820|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-07-12|||May 2000||2000-05-01|July 2016|2016-07-01|September 2006|Actual|2006-09-01|September 2004|Actual|2004-09-01||Interventional|||Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer|Completed||Phase 2|35|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:14:16.427993|2017-02-18 18:14:16.427993
NCT00005819|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2010-06-09|||April 2000||2000-04-01|June 2010|2010-06-01|August 2006|Actual|2006-08-01|May 2005|Actual|2005-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Fenretinide in Combination With Paclitaxel and Cisplatin|Completed||Phase 1|21|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:14:16.783703|2017-02-18 18:14:16.783703
NCT00005818|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-22|||March 2000||2000-03-01|January 2013|2013-01-01||||March 2003|Actual|2003-03-01||Interventional|||SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer|A Phase I/II Study of Escalating Doses of SU5416 (NSC 696819) in Combination With CPT-11 in Patients With Advanced Colorectal Carcinoma|Completed||Phase 1/Phase 2|68|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:16.880773|2017-02-18 18:14:16.880773
NCT00005817|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-31|||March 2000||2000-03-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer|A Randomized Phase 2 Study of Rebeccamycin Analog in Advanced Breast Cancer|Completed||Phase 2|42|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:14:16.995946|2017-02-18 18:14:16.995946
NCT00005816|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-03-19|||February 2000||2000-02-01|December 2008|2008-12-01|August 2002|Actual|2002-08-01|||||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer|Active Immunotherapy of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA|Completed||Phase 1|15|Actual|Duke University|||||f||||||||||||||2017-02-18 18:14:17.100491|2017-02-18 18:14:17.100491
NCT00005815|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-06-17|||December 1999||1999-12-01|June 2013|2013-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma|A Phase I/II Study of Temozolamide and Thalidomide in the Treatment of Advanced Melanoma|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:17.199798|2017-02-18 18:14:17.199798
NCT00005814|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-06-17|||December 1999||1999-12-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer|Phase II Study of C225 in Combination With Cisplatin and Standard/Delayed Accelerated Hyperfractionated Radiation Therapy in Patients With Advanced Head & Neck Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:17.304882|2017-02-18 18:14:17.304882
NCT00005813|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2011-10-26|||March 1997||1997-03-01|October 2011|2011-10-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme|A Phase I Trial of Intratumoral Bispecific Antibody and Activated Monocytes in Patients With Recurrent or Refractory Glioblastoma Multiforme|Completed||Phase 1|||Dartmouth-Hitchcock Medical Center|||||f||||t||||||||||2017-02-18 18:14:17.403057|2017-02-18 18:14:17.403057
NCT00005812|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-05-13|||January 2000||2000-01-01|May 2013|2013-05-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma|A Pilot Phase II Trial of Temozolomide in Leptomeningeal Metastases|Terminated||Phase 2|12|Actual|Dartmouth-Hitchcock Medical Center||1||No objective response documented, protocol terminated after 12 patients.|f||||t||||||||||2017-02-18 18:14:17.511744|2017-02-18 18:14:17.511744
NCT00005811|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-02-20|||April 2000||2000-04-01|February 2013|2013-02-01|February 2009|Actual|2009-02-01|April 2006|Actual|2006-04-01||Interventional|||Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment|A Phase II Study of Intrathecal Topotecan (NSC #609699) in Patients With Refractory Meningeal Malignancies|Completed||Phase 2|77|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:17.62578|2017-02-18 18:14:17.62578
NCT00005810|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-07-12|||March 2000||2000-03-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Study of Estramustine, Docetaxel, and Carboplatin With G-CSF Support in Men With Hormone Refractory Prostate Cancer|Completed||Phase 2|40|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:14:17.749519|2017-02-18 18:14:17.749519
NCT00005809|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-02-01|||July 2000||2000-07-01|February 2013|2013-02-01|January 2003|Actual|2003-01-01|October 2000|Actual|2000-10-01||Interventional|ACRIN 6656||Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia|Computerized Tomographic Colonography: Performance Evaluation in a Multicenter Setting|Completed||N/A|||American College of Radiology Imaging Network|||||f||||t||||||||||2017-02-18 18:14:17.873992|2017-02-18 18:14:17.873992
NCT00005808|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-02-06|||December 2000||2000-12-01|February 2013|2013-02-01||||April 2004|Actual|2004-04-01||Interventional|||Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia|Phase I Study Photodynamic Therapy Using Lutrin (Lutetium Texaphyrin) in the Treatment of Patients With Cervical Intraepithelial Neoplasia|Terminated||Phase 1|54|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 18:14:17.982774|2017-02-18 18:14:17.982774
NCT00005807|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2008-07-23|||July 2000||2000-07-01|September 2003|2003-09-01||||||||Interventional|||BMS-247550 in Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer|A Phase I Scientific Exploratory Study of Epothilone B Analog (BMS-247550; NSC #710428) in Patients With Solid Tumors and Gynecological Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:18.101867|2017-02-18 18:14:18.101867
NCT00005806|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-06-17|||September 1999||1999-09-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer|A Pilot Trial of Daily Oral ZD1839 (Iressa) With Standard Doses of Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:18.199365|2017-02-18 18:14:18.199365
NCT00005805|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-17|||December 1999||1999-12-01|January 2013|2013-01-01||||June 2000|Actual|2000-06-01||Interventional|||St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer|Does Hypericum Reduce Fatigue in Cancer Patients on Chemotherapy? A Randomized, Double-Blind, Placebo-Controlled Clinical Trial|Completed||Phase 3|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:18.295037|2017-02-18 18:14:18.295037
NCT00005804|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2010-03-31|||October 1999||1999-10-01|March 2010|2010-03-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Treatment of Patients With Hematological Malignancies Using Marrow Transplantation From Unrelated Donors Incompatible for One HLA Locus Antigen|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:14:18.413363|2017-02-18 18:14:18.413363
NCT00005803|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-02-23|||September 1999||1999-09-01|February 2016|2016-02-01||||January 2016|Actual|2016-01-01||Interventional|||Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma|A Phase I/II Study of Autologous Stem Cell Transplantation Followed by Nonmyeloablative Allogeneic Stem Cell Transplantation for Patients With Relapsed or Refractory Lymphoma - A Multi-center Trial|Active, not recruiting||Phase 1/Phase 2|80|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:14:18.524958|2017-02-18 18:14:18.524958
NCT00005802|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2010-03-31|||June 1999||1999-06-01|March 2010|2010-03-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia|Chemotherapy (CT) Followed by Donor Lymphocyte Infusion (DLI) Plus Interleukin 2 (IL-2) for Patients With Relapse Acute Myeloid or Lymphoid Leukemia After Allogeneic Hematopoietic Transplant|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:14:18.690793|2017-02-18 18:14:18.690793
NCT00005801|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-11-14|||November 1999||1999-11-01|September 2001|2001-09-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia|A Phase II Study of Allografting to Establish Mixed or Full Donor Chimerism as Consolidative Immunotherapy for Older Patients With AML in Complete Remission Using Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil|Completed||Phase 2|||University of Colorado, Denver|||||f||||||||||||||2017-02-18 18:14:18.790683|2017-02-18 18:14:18.790683
NCT00005800|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-09-24|||April 1999||1999-04-01|September 2012|2012-09-01|May 2012|Actual|2012-05-01|January 2006|Actual|2006-01-01||Interventional|||Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer|A Phase II Neoadjuvant Trial of Sequential Doxorubicin and Docetaxel for the Treatment of Stage III Breast Cancer Measuring STAT Activation as a Predictor of Response to Therapy|Completed||Phase 2|45|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:18.881439|2017-02-18 18:14:18.881439
NCT00005799|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-10-10|||November 1999||1999-11-01|October 2016|2016-10-01||||July 2002|Actual|2002-07-01||Interventional|||Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer|Low-Dose TBI and Fludarabine Followed by Unrelated Donor Stem Cell Transplantation for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial|Active, not recruiting||N/A|55|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 18:14:18.994501|2017-02-18 18:14:18.994501
NCT00005798|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-10-24|||July 1995||1995-07-01|October 2012|2012-10-01|July 2007|Actual|2007-07-01|August 2001|Actual|2001-08-01||Interventional|CTC||Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer|A Phase II Study of Cyclophosphamide, Thiotepa, and Carboplatin (CTC) as a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Patients With Breast Cancer|Completed||Phase 2|209|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:19.140817|2017-02-18 18:14:19.140817
NCT00005797|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-10-24|||March 1993||1993-03-01|October 2012|2012-10-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Bone Marrow Transplant in Treating Patients With Hematologic Cancers|Allogeneic Bone Marrow Transplantation for Hematologic Malignancies: A Treatment Approach Based on Risk of Relapse and Toxicity|Completed||Phase 2|125|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-02-18 18:14:19.249245|2017-02-18 18:14:19.249245
NCT00005796|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2015-03-23|||February 2000||2000-02-01|March 2015|2015-03-01|December 2011|Actual|2011-12-01|June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors|A Pilot Study of Dose-Intensified Procarbazine, CCNU, Vincristine (PCV) for Poor Prognosis Pediatric and Adult Brain Tumors Utilizing Fibronectin-Assisted, Retroviral-Mediated Modification of CD34+ Peripheral Blood Cells With O6-Methylguanine DNA Methyltransferase|Completed||Phase 1|10|Actual|Indiana University||1|||f||||t||||||||||2017-02-18 18:14:19.645466|2017-02-18 18:14:19.645466
NCT00005795|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-06-07||2011-02-16|February 2000||2000-02-01|June 2012|2012-06-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia|Phase II Trial of Arsenic Trioxide in Relapsed and Refractory Acute Myeloid Leukemia, Secondary Leukemia, and/or Newly-Diagnosed Patients Greater Than or Equal to 65 Years Old|Completed||Phase 2|11|Actual|Northwestern University|||||f||||t||||||||||2017-02-18 18:14:19.762145|2017-02-18 18:14:19.762145
NCT00005794|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2015-10-15|||February 2000||2000-02-01|October 2015|2015-10-01|July 2003|Actual|2003-07-01|||||Interventional|||Perifosine in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Perifosine on a Loading Dose/Maintenance Dose Schedule in Patients With Advanced Cancer|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:14:19.861286|2017-02-18 18:14:19.861286
NCT00005793|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-09-24|||July 1999||1999-07-01|September 2012|2012-09-01|November 2006|Actual|2006-11-01|July 2006|Actual|2006-07-01||Interventional|||A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide|A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide (DATE) for De Novo AML: In the Treatment of Young Patients Ages 16-59|Completed||Phase 1/Phase 2|41|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:19.94981|2017-02-18 18:14:19.94981
NCT00005792|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2016-12-28|||June 1998||1998-06-01|December 2016|2016-12-01|November 2017|Anticipated|2017-11-01|July 2006|Actual|2006-07-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Study of Intensive-Dose Melphalan, Topotecan, and VP-16 Phosphate (MTV) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma|Active, not recruiting||Phase 1|131|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:20.075353|2017-02-18 18:14:20.075353
NCT00005791|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-12-18|||October 1999||1999-10-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|July 2002|Actual|2002-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Phase I Trial of Irinotecan, Cisplatin, and Fluorouracil in Patients With Advanced Solid Tumor Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:20.192239|2017-02-18 18:14:20.192239
NCT00005790|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-06-08|||April 1996||1996-04-01|June 2012|2012-06-01|May 1999||1999-05-01|May 1999||1999-05-01||Interventional|||Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors|Perfusion Magnetic Resonance Imaging of Brain Tumors: Correlation With Indicators of Angiogenesis|Withdrawn||N/A|0|Actual|Northwestern University||||Unable to accrue subjects.|f||||||||||||||2017-02-18 18:14:20.281402|2017-02-18 18:14:20.281402
NCT00005788|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-05-31||2011-07-01|April 1997||1997-04-01|May 2012|2012-05-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome|Phase II Trial of Subcutaneous Injections of Interleukin-2 for the Treatment of Mycosis Fungoides or the Sezary Syndrome|Terminated||Phase 2|||Northwestern University||||Low/inadequate rate of accrual.|f||||t||||||||||2017-02-18 18:14:20.37694|2017-02-18 18:14:20.37694
NCT00005787|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-05-31|||September 1999||1999-09-01|May 2012|2012-05-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma|Ex Vivo Expanded Peripheral Blood Mononuclear Cells for the Elimination of Neutropenia Associated With High Dose Chemotherapy|Terminated||Phase 1|3|Actual|Northwestern University||||Per PI due to poor/inadequate accrual.|f||||t||||||||||2017-02-18 18:14:20.481696|2017-02-18 18:14:20.481696
NCT00005786|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2013-01-31|||January 2001||2001-01-01|January 2013|2013-01-01||||November 2004|Actual|2004-11-01||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia|A Pilot Study of Arsenic Trioxide in the Treatment of Relapsed and Refractory Indolent Lymphomas|Terminated||N/A|25|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:14:20.58123|2017-02-18 18:14:20.58123
NCT00005785|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-03|2008-03-03|||September 1999||1999-09-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer|Low Intensity Non-Myeloablative Preparative Conditioning Followed by Transplantation of Genetically Modified HLA-Matched Peripheral Blood Hematopoietic Precursor Cells (PBPC) for Hematologic Malignancies in HIV Positive Adults|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:20.705387|2017-02-18 18:14:20.705387
NCT00005784|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-03|2017-01-24|||May 31, 2000||2000-05-31|August 8, 2008|2008-08-08|August 8, 2008||2008-08-08|||||Observational|||Evaluation and Treatment of Patients With Retinal Disease|Evaluation and Treatment Protocol for Patients With Retinal Disease|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:20.797273|2017-02-18 18:14:20.797273
NCT00005783|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-03|2008-03-03|||March 2000||2000-03-01|February 2000|2000-02-01|October 2000||2000-10-01|||||Interventional|||A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders|A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:20.883615|2017-02-18 18:14:20.883615
NCT00005782|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-03|2008-03-03|||January 2000||2000-01-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Mobilization and Handling of Stem Cells for Transplant From Healthy Volunteers With Sickle Cell Trait|Leukapheresis of Volunteers With Sickle Cell Trait to Evaluate Mobilization of Stem Cells With Granulocyte Colony-Stimulating Factor and Stem Cell Collection and Storage for Allogeneic Transplantation|Completed||Phase 3|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:20.976174|2017-02-18 18:14:20.976174
NCT00005781|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-03|2008-03-03|||May 2000||2000-05-01|May 2000|2000-05-01|September 2000||2000-09-01|||||Observational|||Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles|Digital Imaging as a Tool for Assessing the Prevalence of Atypical Nevi, Psoriasis and Hand Dermatitis: A Validation Study in Preparation for NHANES IV, Dermatology Section|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:21.062314|2017-02-18 18:14:21.062314
NCT00005780|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-03|2017-01-24|||June 1, 2000||2000-06-01|October 25, 2016|2016-10-25|June 1, 2018|Anticipated|2018-06-01|August 31, 2005|Actual|2005-08-31||Interventional|||Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma|Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma|Active, not recruiting||Phase 2|26|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:14:21.150347|2017-02-18 18:14:21.150347
NCT00005779|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-03|2012-05-17||||||May 2012|2012-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy|A Phase I, Limited-Center, Sequential Cohort Trial of HIV Vaccine (Polyvalent Peptide Vaccine C4-V3) in Conjunction With Interleukin-12 in Subjects With Maximal Suppression of HIV Replication and CD4 Count > 400 Cells/mm3|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:14:21.268674|2017-02-18 18:14:21.268674
NCT00005778|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-03|2008-11-05|||January 2000||2000-01-01|November 2008|2008-11-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide|Randomized Trial of High-Dose IV Cyclophosphamide Versus Monthly IV Cyclophosphamide|Completed||Phase 3|100|Anticipated|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||1|||f||||||||||||||2017-02-18 18:14:21.374147|2017-02-18 18:14:21.374147
NCT00005777|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2015-06-03|||February 1998||1998-02-01|June 2015|2015-06-01|September 2002|Actual|2002-09-01|September 1998|Actual|1998-09-01||Interventional|SAVE||Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)|Randomized Trial of Minimal Ventilator Support and Early Corticosteroid Therapy to Increase Survival Without Chronic Lung Disease in Extremely-Low-Birth-Weight Infants|Terminated||Phase 3|220|Actual|NICHD Neonatal Research Network||4||"The trial was halted because of unanticipated nonrespiratory adverse events related to~   dexamethasone therapy."|f||||t||||||||||2017-02-18 18:14:21.495815|2017-02-18 18:14:21.495815
NCT00005776|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2015-06-03|||October 1995||1995-10-01|June 2015|2015-06-01|May 1998|Actual|1998-05-01|May 1996|Actual|1996-05-01||Interventional|NINOS||Inhaled Nitric Oxide Study for Respiratory Failure in Newborns|The Randomized Inhaled Nitric Oxide Study (NINOS) in Full-Term and Nearly Full-Term Infants With Hypoxic Respiratory Failure|Terminated||Phase 3|235|Actual|NICHD Neonatal Research Network||2||Results showed statistically significant benefit in the experimental group|f||||t||||||||||2017-02-18 18:14:21.651937|2017-02-18 18:14:21.651937
NCT00005775|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2015-06-03|||July 1999||1999-07-01|June 2015|2015-06-01|August 2001|Actual|2001-08-01|December 2000|Actual|2000-12-01||Interventional|Glutamine||Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants|Randomized Controlled Trial of Parenteral Glutamine Supplementation for Extremely-Low-Birth-Weight (ELBW) Infants|Completed||Phase 3|1433|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-02-18 18:14:21.80623|2017-02-18 18:14:21.80623
NCT00005774|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2015-06-03|||May 2000||2000-05-01|June 2015|2015-06-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|Surfactant 2||Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants|Early Surfactant Followed by Nasal CPAP to Reduce the Use of Mechanical Ventilation Without Additional Morbidity in Infants 1250- 2000 Grams With RDS|Terminated||Phase 3|61|Actual|NICHD Neonatal Research Network||2||The trial was stopped after 7 months for lack of recruitment.|f||||t||||||||||2017-02-18 18:14:21.960927|2017-02-18 18:14:21.960927
NCT00005773|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2015-06-03|||August 1998||1998-08-01|June 2015|2015-06-01|August 2003|Actual|2003-08-01|May 2001|Actual|2001-05-01||Interventional|Early iNO||Early Inhaled Nitric Oxide for Respiratory Failure in Newborns|Early Inhaled Nitric Oxide Therapy in Term and Near Term Infants With Respiratory Failure|Terminated||Phase 3|302|Actual|NICHD Neonatal Research Network||2||Halted after 3 years because of a persistent decline in enrollment|f||||t||||||||||2017-02-18 18:14:22.106128|2017-02-18 18:14:22.106128
NCT00005772|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2015-06-03|||October 1999||1999-10-01|June 2015|2015-06-01|July 2010|Actual|2010-07-01|May 2003|Actual|2003-05-01||Interventional|||Whole-Body Cooling for Birth Asphyxia in Term Infants|Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants|Completed||Phase 3|208|Actual|NICHD Neonatal Research Network||2|||f||||t||||||||||2017-02-18 18:14:22.260912|2017-02-18 18:14:22.260912
NCT00005771|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||The Use of Real Time Ultrasound Feedback in Teaching Abdominal Hollowing Exercises||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:22.407524|2017-02-18 18:14:22.407524
NCT00005770|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2005-06-23||||||November 2001|2001-11-01||||||||Observational|||Investigation of the Effect of Acupuncture Needling on Connective Tissue Using Ultrasound Elastography||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:22.485913|2017-02-18 18:14:22.485913
NCT00005769|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:22.554795|2017-02-18 18:14:22.554795
NCT00005768|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women||Unknown status|Recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:22.625726|2017-02-18 18:14:22.625726
NCT00005767|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Dynamic Aspects of Amino Acid Metabolism||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:22.694832|2017-02-18 18:14:22.694832
NCT00005766|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis||Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:22.770647|2017-02-18 18:14:22.770647
NCT00005765|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-01|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Behavioral Economics of Human Drug Self-Administration||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:22.846161|2017-02-18 18:14:22.846161
NCT00005764|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-30|2005-06-23|||May 2000||2000-05-01|June 2001|2001-06-01||||||||Interventional|||A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients|Glaxo Wellcome Trial to Assess the Regression of Hyperlactatemia and to Evaluate the Regression of Established Lipodystrophy in HIV-1-Positive Subjects (TARHEEL)|Completed||Phase 4|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:14:23.185907|2017-02-18 18:14:23.185907
NCT00005763|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||December 1984||1984-12-01|June 2000|2000-06-01|April 1997|Actual|1997-04-01|||||Observational|||INTERSALT: International Study of Sodium, Potassium, and Blood Pressure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:23.311647|2017-02-18 18:14:23.311647
NCT00005762|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-07-19|||March 2001||2001-03-01|July 2013|2013-07-01|May 2004|Actual|2004-05-01|||||Interventional|||Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers|Pharmacokinetic Interaction Studies of Amprenavir (APV), Efavirenz (EFV), and a Second Protease Inhibitor in HIV-Seronegative Volunteers|Completed||N/A|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:14:23.402061|2017-02-18 18:14:23.402061
NCT00005761|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-26|2017-01-24|||May 23, 2000||2000-05-23|December 7, 2010|2010-12-07|December 7, 2010||2010-12-07|||||Observational|||Blood Factors and Diabetic Retinopathy|Study of Association of Serum Factors With Diabetic Retinopathy|Completed||N/A|173|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:23.513306|2017-02-18 18:14:23.513306
NCT00005760|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-26|2008-03-03|||May 2000||2000-05-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 Diabetes|A Pilot Study of the Metabolic Effects of Large Volume Liposuction in Overweight Women With Hyperinsulinemia, Impaired Glucose Tolerance and/or Type 2 Diabetes|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:23.59583|2017-02-18 18:14:23.59583
NCT00005758|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-23|2012-05-21||||||May 2012|2012-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination|A Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Effect of Immunization With an HIV Immunogen on the Time to Virologic Relapse in Individuals Receiving Potent, Suppressive Antiretroviral Therapies|Completed||Phase 3|472||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:14:23.688336|2017-02-18 18:14:23.688336
NCT00005757|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-11-23|||September 1997||1997-09-01|November 2016|2016-11-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Observational|||Racial Variation in ACE--Genetic and Physiologic Bases||Completed||N/A|293|Actual|Vanderbilt University|||8||f||||||||||||||2017-02-18 18:14:23.806854|2017-02-18 18:14:23.806854
NCT00005756|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-12|||August 1999||1999-08-01|January 2016|2016-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Epidemiology of Coronary Calcification in the Elderly||Completed||N/A|||University of Pittsburgh|||||f||||t||||||||Yes||2017-02-18 18:14:23.892487|2017-02-18 18:14:23.892487
NCT00005755|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||May 1999||1999-05-01|January 2006|2006-01-01|April 2003|Actual|2003-04-01|||||Observational|||Community Based Study on Occupational Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:23.971711|2017-02-18 18:14:23.971711
NCT00005754|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-06-08|||September 1999||1999-09-01|June 2015|2015-06-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Observational|||Coronary Artery Calcification in Type 1 Diabetes||Completed||N/A|1420|Actual|University of Colorado, Denver|||1||f||||f||||||||||2017-02-18 18:14:24.04134|2017-02-18 18:14:24.04134
NCT00005753|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||June 1997||1997-06-01|February 2005|2005-02-01|May 2002|Actual|2002-05-01|||||Observational|||Pharmacological and Behavioral Treatment of Insomnia||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:24.135248|2017-02-18 18:14:24.135248
NCT00005739|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-21|||September 1995||1995-09-01|December 2015|2015-12-01|December 2015|Actual|2015-12-01|December 2004|Actual|2004-12-01||Observational|||Behavioral Interventions for Control of TB|Behavioral Interventions for Control of Tuberculosis|Completed||N/A|145|Actual|Columbia University|||2||f||||f||||||||||2017-02-18 18:14:25.148854|2017-02-18 18:14:25.148854
NCT00005738|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-11|||September 1995||1995-09-01|May 2002|2002-05-01|August 2001||2001-08-01|||||Observational|||Promoting Adherence to TB Regimens in Latino Adolescents||Completed||N/A|||San Diego State University|||||f||||||||||||||2017-02-18 18:14:25.266508|2017-02-18 18:14:25.266508
NCT00005737|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1995||1995-09-01|April 2004|2004-04-01|August 1999|Actual|1999-08-01|||||Observational|||Tuberculosis Prophylaxis in the Homeless--A Controlled Trial||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:25.346039|2017-02-18 18:14:25.346039
NCT00005736|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1995||1995-09-01|July 2004|2004-07-01|September 2002||2002-09-01|||||Observational|||Interventions to Improve Asthma Management/Prevention at School||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:25.443142|2017-02-18 18:14:25.443142
NCT00005735|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1995||1995-09-01|July 2004|2004-07-01|October 2002|Actual|2002-10-01|||||Observational|||Controlling Asthma at School||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:25.525343|2017-02-18 18:14:25.525343
NCT00005734|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1995||1995-09-01|March 2005|2005-03-01|September 2002||2002-09-01|||||Observational|||Intervention to Improve Asthma Management/Prevention||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:25.602385|2017-02-18 18:14:25.602385
NCT00005678|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||July 1984||1984-07-01|May 2000|2000-05-01|April 1996||1996-04-01|||||Observational|||Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:25.682069|2017-02-18 18:14:25.682069
NCT00005677|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-12|||August 1980||1980-08-01|January 2016|2016-01-01|January 2013|Actual|2013-01-01|December 2011|Actual|2011-12-01||Observational|||Percutaneous Transluminal Coronary Angioplasty (PTCA) Registries I, II, and III and the Dynamic Registry|Dynamic Evaluation of Coronary Intervention|Completed||N/A|4290|Actual|University of Pittsburgh|||1||f||||t||||||||||2017-02-18 18:14:25.762942|2017-02-18 18:14:25.762942
NCT00005676|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-03-03|||April 2000||2000-04-01|March 2014|2014-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||High Density Lipoprotein Subspecies and Coronary Disease|High Density Lipoprotein Subspecies and Coronary Disease|Completed||N/A|2700|Actual|Tufts University|||1||f||||f||||||||||2017-02-18 18:14:25.881684|2017-02-18 18:14:25.881684
NCT00005675|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-26|2010-05-24|||April 2000||2000-04-01|March 2008|2008-03-01||||May 2005|Actual|2005-05-01||Interventional|||Oral Type I Collagen for Relieving Scleroderma|Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma|Completed||Phase 2|168|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||2|||t||||t||||||||||2017-02-18 18:14:25.976624|2017-02-18 18:14:25.976624
NCT00005674|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-26|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]||Completed||Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:26.129517|2017-02-18 18:14:26.129517
NCT00005673|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-24|2008-03-03|||May 2000||2000-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Interventional|||Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs|Safety and Pharmacokinetic Study of Capravirine. Part I. Pharmacokinetics of Capravirine in HIV-Negative Volunteers. Part II. Antiviral Activity of Capravirine, Efavirenz, and Abacavir in HIV-Infected Patients|Completed||Phase 1|46||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:26.210731|2017-02-18 18:14:26.210731
NCT00005671|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-24|2008-03-03|||May 2000||2000-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Quality of Life in Patients With Chronic Ischemic Heart Disease|Quality of Life in Chronic Ischemic Heart Disease With Left Ventricular Dysfunction|Completed||N/A|105||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:26.29359|2017-02-18 18:14:26.29359
NCT00005669|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-19|2015-04-21|2010-04-07||May 2000||2000-05-01|April 2015|2015-04-01|May 2011|Actual|2011-05-01|August 2009|Actual|2009-08-01||Interventional|||Metformin to Treat Obesity in Children With Insulin Resistance|Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children With Insulin Resistance|Completed||Phase 2|100|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 18:14:26.382455|2017-02-18 18:14:26.382455
NCT00005668|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-18|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma|A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma|Completed||Phase 2|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:14:26.848357|2017-02-18 18:14:26.848357
NCT00005667|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-19|2005-06-23||||||November 2001|2001-11-01||||||||Observational|||Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of Colonization||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:26.930424|2017-02-18 18:14:26.930424
NCT00005666|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-19|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:27.002924|2017-02-18 18:14:27.002924
NCT00005665|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-19|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||"Ingested Interferon Alpha: Prolongation or Permanence of the Honeymoon Phase in Newly Diagnosed Type 1 Diabetes Mellitus"||Unknown status|Active, not recruiting|Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:27.072544|2017-02-18 18:14:27.072544
NCT00005664|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-17|2017-01-24|||May 9, 2000||2000-05-09|December 28, 2016|2016-12-28||||||||Observational|||Evaluation of Patients With Endocrine-Related Conditions|Evaluation of Patients With Endocrine-Related Conditions|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:27.146873|2017-02-18 18:14:27.146873
NCT00005733|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1993||1993-09-01|September 2002|2002-09-01|March 1997||1997-03-01|||||Observational|||Develop and Implement Asthma Controlling Strategies (2)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:27.254098|2017-02-18 18:14:27.254098
NCT00005713|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-22|||August 1990||1990-08-01|December 2015|2015-12-01|February 1997|Actual|1997-02-01|February 1997|Actual|1997-02-01||Observational|||Childhood Asthma Program in NYC Health Department Clinics|Improving Care for Minority Children With Asthma: Professional Education in Public Health Clinics|Completed||N/A|1000|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 18:14:28.965478|2017-02-18 18:14:28.965478
NCT00005712|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||August 1990||1990-08-01|January 2016|2016-01-01|July 1996||1996-07-01|||||Observational|||Self Management Education Asthma||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-02-18 18:14:29.066537|2017-02-18 18:14:29.066537
NCT00005711|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-06|||August 1990||1990-08-01|May 2016|2016-05-01|July 2009|Actual|2009-07-01|July 2008|Actual|2008-07-01||Interventional|||Intervention for Hispanic Children With Asthma|Intervention for Hispanic Children With Asthma|Completed||N/A|145|Actual|The University of Texas Health Science Center at San Antonio||2|||f||||f||||||||No||2017-02-18 18:14:29.148742|2017-02-18 18:14:29.148742
NCT00005710|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-06-22|||July 1990||1990-07-01|June 2016|2016-06-01|June 1995||1995-06-01|||||Observational|||Recycling of Chronic Smokers to Sustained Abstinence||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:14:29.245234|2017-02-18 18:14:29.245234
NCT00005709|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1993||1993-09-01|June 2001|2001-06-01|August 1998|Actual|1998-08-01|||||Observational|||Lipoprotein Metabolism in Hypertensive African-Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:29.316301|2017-02-18 18:14:29.316301
NCT00005708|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|July 2000|2000-07-01|August 1997|Actual|1997-08-01|||||Observational|||Improving Adherence to Interventions for Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:29.39295|2017-02-18 18:14:29.39295
NCT00005707|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-08|||September 1993||1993-09-01|December 2015|2015-12-01|August 1998||1998-08-01|||||Observational|||Improving Hypertension Care for Inner City Minorities||Completed||N/A|||Baylor College of Medicine|||||f||||||||||||||2017-02-18 18:14:29.46481|2017-02-18 18:14:29.46481
NCT00005706|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|May 2002|2002-05-01|August 1998|Actual|1998-08-01|||||Observational|||Urban African-American Community Hypertension Control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:29.537628|2017-02-18 18:14:29.537628
NCT00005705|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1992||1992-09-01|September 2002|2002-09-01|June 1996|Actual|1996-06-01|||||Observational|||Adherence in the Childhood Asthma Management Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:29.614782|2017-02-18 18:14:29.614782
NCT00005704|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-26|||July 1991||1991-07-01|July 2000|2000-07-01|June 1997||1997-06-01|||||Observational|||Pharmacologic Intervention for Postcessation Weight Gain||Completed||N/A|||University of Memphis|||||f||||||||||||||2017-02-18 18:14:29.772869|2017-02-18 18:14:29.772869
NCT00005703|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1995||1995-07-01|March 2005|2005-03-01|July 1998|Actual|1998-07-01|||||Observational|||Hemostasis in Sickle Cell Disease--Infancy to Adulthood||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:29.845515|2017-02-18 18:14:29.845515
NCT00005702|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-29|||May 1996||1996-05-01|February 2016|2016-02-01|April 2000||2000-04-01|||||Observational|||Promoting Smoking Cessation in Hospital Patients||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:14:29.913623|2017-02-18 18:14:29.913623
NCT00005701|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1994||1994-07-01|April 2000|2000-04-01|June 1997|Actual|1997-06-01|||||Observational|||Acute Cardiac Ischemia in Women in the ACI/TIPI Trial||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:29.985117|2017-02-18 18:14:29.985117
NCT00005700|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|May 2001|2001-05-01|August 1998|Actual|1998-08-01|||||Observational|||Fat Reduction Intervention Trial in African-Americans||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.058864|2017-02-18 18:14:30.058864
NCT00005699|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-10|||September 1993||1993-09-01|February 2016|2016-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|||Improving Hypertension Control in the Inner City|Improving Hypertension Control in the Inner City|Completed||N/A|2000|Actual|Medical College of Wisconsin|||2||f||||f||||||||Undecided|to be published|2017-02-18 18:14:30.127929|2017-02-18 18:14:30.127929
NCT00005698|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|July 2000|2000-07-01|August 1997|Actual|1997-08-01|||||Observational|||IN CONTROL--Hypertension Reduction in Inner City Seattle||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.212582|2017-02-18 18:14:30.212582
NCT00005697|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||January 1993||1993-01-01|April 2001|2001-04-01|December 1996||1996-12-01|||||Observational|||Intervention for Resistant Pregnant Smokers||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.284236|2017-02-18 18:14:30.284236
NCT00005696|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||January 1994||1994-01-01|May 2005|2005-05-01|December 1996|Actual|1996-12-01|||||Observational|||Early Atherosclerosis Change in Two Clinical Trials||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.352322|2017-02-18 18:14:30.352322
NCT00005695|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-21|||January 1995||1995-01-01|April 2002|2002-04-01|December 1997||1997-12-01|||||Observational|||Physical Training and Blood Pressure in High Risk Youths||Completed||N/A|||Augusta University|||||f||||||||||||||2017-02-18 18:14:30.430333|2017-02-18 18:14:30.430333
NCT00005694|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1992||1992-07-01|July 2000|2000-07-01|June 1996|Actual|1996-06-01|||||Observational|||Worksites, Occupational Nurses and Cholesterol Change||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.506624|2017-02-18 18:14:30.506624
NCT00005693|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||April 1992||1992-04-01|July 2000|2000-07-01|March 1995|Actual|1995-03-01|||||Observational|||Computer Assisted Instruction Weight Management for Low Literacy Populations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.56966|2017-02-18 18:14:30.56966
NCT00005692|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1992||1992-04-01|March 2005|2005-03-01|November 2002|Actual|2002-11-01|||||Observational|||Inflammation Markers Over Time in Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.629328|2017-02-18 18:14:30.629328
NCT00005691|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1992||1992-09-01|July 2001|2001-07-01|August 1996|Actual|1996-08-01|||||Observational|||Psychosocial Risk Factors for Coronary Heart Disease in Swedish Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.715614|2017-02-18 18:14:30.715614
NCT00005690|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1991||1991-08-01|January 2005|2005-01-01|November 2000|Actual|2000-11-01|||||Observational|||Improving Outcomes and Quality of Life After CABG||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:30.784456|2017-02-18 18:14:30.784456
NCT00005683|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||December 1986||1986-12-01|January 2016|2016-01-01|November 1997||1997-11-01|||||Observational|||Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children||Completed||N/A|||University of Rochester|||||f||||||||||||||2017-02-18 18:14:31.297138|2017-02-18 18:14:31.297138
NCT00005682|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1988||1988-09-01|May 2000|2000-05-01|August 1994|Actual|1994-08-01|||||Observational|||Aplastic Anemia Epidemiology: Incidence and Case-control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:31.361252|2017-02-18 18:14:31.361252
NCT00005681|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||August 1989||1989-08-01|October 2005|2005-10-01|July 2001|Actual|2001-07-01|||||Observational|||Vascular Basis for the Treatment of Ischemia||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:31.436171|2017-02-18 18:14:31.436171
NCT00005680|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||September 1993||1993-09-01|January 2008|2008-01-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Observational|||Whitehall II - Social and Occupational Influences On Health and Illness||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:31.508441|2017-02-18 18:14:31.508441
NCT00005679|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||June 1985||1985-06-01|January 2008|2008-01-01|July 1993|Actual|1993-07-01|July 1993|Actual|1993-07-01||Observational|||Pathobiological Determinants of Atherosclerosis in Youth (PDAY)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:31.689212|2017-02-18 18:14:31.689212
NCT00005663|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-11|2005-06-23|||June 1999||1999-06-01|July 2001|2001-07-01||||||||Interventional|||A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients|An International, Randomized, Double-Blind, Placebo-Controlled Study of Valacyclovir for the Suppression of Recurrent Ano-Genital HSV Infections in HIV-Infected Subjects|Unknown status|Active, not recruiting|Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:14:31.781112|2017-02-18 18:14:31.781112
NCT00005660|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-12|2008-03-03|||October 1977||1977-10-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases|The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases|Completed||N/A|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:31.883956|2017-02-18 18:14:31.883956
NCT00005658|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-09|2008-03-03|||May 2000||2000-05-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Glycine to Treat Psychotic Disorders in Children|Childhood Onset Psychotic Disorders: An Open Trial With the Amino Acid Glycine|Completed||Phase 2|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:31.964851|2017-02-18 18:14:31.964851
NCT00005657|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-06|2017-01-24|||May 4, 2000||2000-05-04|April 19, 2011|2011-04-19|April 19, 2011||2011-04-19|||||Observational|||Genetics of Hepatitis C Virus Infection|Immunogenetics of Hepatitis C Virus Infection|Completed||N/A|870|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:32.06033|2017-02-18 18:14:32.06033
NCT00005655|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-04|2017-01-24|||April 28, 2000||2000-04-28|September 23, 2016|2016-09-23|October 6, 2010|Actual|2010-10-06|October 6, 2010|Actual|2010-10-06||Interventional|||Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer|A Phase I Investigation of IL-12/Pulse IL-2 in Adults With Advanced Solid Tumors|Completed||Phase 1|39|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:14:32.1411|2017-02-18 18:14:32.1411
NCT00005654|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2005-06-23|||January 2000||2000-01-01|April 2000|2000-04-01||||||||Interventional|||Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome||Completed||N/A|88||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:14:32.256511|2017-02-18 18:14:32.256511
NCT00005652|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2008-09-08|||December 2000||2000-12-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:14:32.337219|2017-02-18 18:14:32.337219
NCT00005650|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2005-06-23|||February 2000||2000-02-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of Patients With Primary Ciliary Dyskinesia|Genetic Study of Patients With Primary Ciliary Dyskinesia|Completed||N/A|180||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:35.362419|2017-02-18 18:14:35.362419
NCT00005649|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2008-07-23|||July 1998||1998-07-01|December 2006|2006-12-01||||||||Interventional|||Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer|An Open-Label Combination Study of Capecitabine and Standard Paclitaxel Therapy as First or Second Line Therapy in Women With Metastatic Breast Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:35.457425|2017-02-18 18:14:35.457425
NCT00005648|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2011-05-17|||November 1999||1999-11-01|October 2010|2010-10-01|November 2003|Actual|2003-11-01|||||Interventional|||Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer|A Phase III, Double-Blind, Placebo Controlled Trial of Gemcitabine Plus Placebo Versus Gemcitabine Plus R115777 in Patients With Advanced Pancreatic Cancer|Completed||Phase 3|688|Actual|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||2|||f||||||||||||||2017-02-18 18:14:35.548474|2017-02-18 18:14:35.548474
NCT00005647|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2010-06-09|||May 2000||2000-05-01|June 2010|2010-06-01|October 2003|Actual|2003-10-01|December 2002|Actual|2002-12-01||Interventional|||SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck|A Phase I Pharmacokinetic, Pharmacodynamic, and Clinical Study of the Combination of the Angiogenesis Inhibitor SU5416 and Paclitaxel in Recurrent or Metastatic Carcinoma of the Head and Neck|Completed||Phase 1|12|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:14:35.6541|2017-02-18 18:14:35.6541
NCT00005646|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2016-07-12|||April 2000||2000-04-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|January 2004|Actual|2004-01-01||Interventional|||Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive Stage Small Cell Lung Cancer|Completed||Phase 2|36|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:14:35.759395|2017-02-18 18:14:35.759395
NCT00005645|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2014-01-03|||May 1999||1999-05-01|February 2001|2001-02-01||||||||Interventional|||ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment|Phase II Trial of ILX295501 Administered Orally Once Weekly x 3 Repeated Every 6 Weeks in Patients With Stage III/IV Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:35.869927|2017-02-18 18:14:35.869927
NCT00005644|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-09-29|||May 2000||2000-05-01|July 2002|2002-07-01||||February 2003|Actual|2003-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function|Phase II Trial of Paclitaxel Plus Gemcitabine in Patients With Advanced Urothelial Carcinoma With Renal Insufficiency|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:35.95685|2017-02-18 18:14:35.95685
NCT00005643|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-07|||May 2000||2000-05-01|November 2005|2005-11-01||||March 2005|Actual|2005-03-01||Interventional|||Chemotherapy in Treating Patients With Sarcoma of the Uterus|Evaluation of Doxil in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:14:36.062554|2017-02-18 18:14:36.062554
NCT00005642|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2010-06-09|||May 2000||2000-05-01|June 2010|2010-06-01|November 2005|Actual|2005-11-01|December 2002|Actual|2002-12-01||Interventional|||SU5416 in Treating Patients With Advanced Solid Tumors|A Phase I Pharmacodynamic Trial of SU5416 (NSC 696819)|Completed||Phase 1|19|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:14:36.467423|2017-02-18 18:14:36.467423
NCT00005641|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-12-10|||September 1997||1997-09-01|December 2012|2012-12-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation|T-Cell Depletion for Graft-Versus-Host Disease (GVHD) Prevention in High Risk Matched and Mismatched Allogeneic Bone Marrow Transplantation|Terminated||Phase 2|||H. Lee Moffitt Cancer Center and Research Institute||||low study accrual|f||||f||||||||||2017-02-18 18:14:36.573125|2017-02-18 18:14:36.573125
NCT00005640|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-09-24|||June 1999||1999-06-01|September 2012|2012-09-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer|Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer: A Feasibility Study|Completed||N/A|17|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:36.703415|2017-02-18 18:14:36.703415
NCT00005639|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2010-03-13|||June 2000||2000-06-01|December 2005|2005-12-01||||||||Interventional|||Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment|A Phase I Dose Escalation to Maximally Tolerated Dose Trial of 5-Azacytidine (5 AC, NSC 102816) in Combination With Sodium Phenylbutyrate (PB, NSC 657802) in Patients With Refractory Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:14:36.815247|2017-02-18 18:14:36.815247
NCT00005638|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-17|||October 1999||1999-10-01|June 2013|2013-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer|Phase I Trial of Combined Modality Irinotecan, Cisplatin, and Concurrent Radiation Therapy for Patients With Locally Advanced Esophageal Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:36.924805|2017-02-18 18:14:36.924805
NCT00005637|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-04-02|||December 1999||1999-12-01|March 2003|2003-03-01|December 2009|Actual|2009-12-01|June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma|A Phase I Study of Extended Low Dose Temozolomide (SCH 52365, Temodar (R)) and Carmustine (BCNU) in the Treatment of Malignant Gliomas After Radiation Therapy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:37.020169|2017-02-18 18:14:37.020169
NCT00005636|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-17|||November 1999||1999-11-01|June 2013|2013-06-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery|A Single-Blind Randomized Phase III Trial of MTA Plus Cisplatin Versus Cisplatin in Patients With Malignant Pleural Mesothelioma|Completed||Phase 3|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:37.112185|2017-02-18 18:14:37.112185
NCT00005635|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-08-16|||January 2000||2000-01-01|August 2013|2013-08-01||||November 2001|Actual|2001-11-01||Interventional|||Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2|A Phase II Trial to Investigate the Pharmacokinetics, Safety, and Tolerability of Herceptin Administered Subcutaneously in Combination With Paclitaxel in Women With HER2 Overexpressing Metastatic Breast Cancer|Completed||Phase 2|||Genentech, Inc.|||||f||||||||||||||2017-02-18 18:14:37.205795|2017-02-18 18:14:37.205795
NCT00005634|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy|Phase I Clinical and Pharmacological Study of Suberoylanilide Hydroxamic Acid- SAHA (MSK390) in Patients With Advanced Solid Tumors|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:37.288055|2017-02-18 18:14:37.288055
NCT00005633|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-18|||June 1999||1999-06-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma|Vaccination of Melanoma Patients With Tyrosinase YMD and gp100 IMD-Javelin Fusion Peptides/HSP70 Complexes: A Trial Comparing the Immunogenicity of Three Doses|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:37.377788|2017-02-18 18:14:37.377788
NCT00005632|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-01-30|||June 1999||1999-06-01|January 2013|2013-01-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer|Vaccination of Prostate Cancer Patients With MUC-1-KLH Conjugate Plus the Immunological Adjuvant QS21: A Trial Examining the Immunogenicity of MUC-1 Glycopeptide Conjugate|Completed||Phase 1|27|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:14:37.467081|2017-02-18 18:14:37.467081
NCT00005631|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-18|||November 1999||1999-11-01|June 2013|2013-06-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma|Cytoreduction and Stem Cell Mobilization With Rituximab and ICE for Patients With Refractory or Relapsed CD20+ B-Cell IGL Eligible for ASCT: The RICE Protocol|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:37.561178|2017-02-18 18:14:37.561178
NCT00005630|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-18|||July 1999||1999-07-01|June 2013|2013-06-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer|Vaccination of Non-Small Cell Lung Cancer Patients Against Mutated K-Ras: A Pilot Trial|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:37.65631|2017-02-18 18:14:37.65631
NCT00005629|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2015-09-30|||July 1999||1999-07-01|July 2012|2012-07-01|June 2002|Actual|2002-06-01|May 2002|Actual|2002-05-01||Interventional|||Vaccine Therapy in Treating Patients With Liver Cancer|Phase I/II Trial Testing Alpha Fetoprotein (AFP) Peptide Immunization in Hepatocellular Carcinoma|Completed||Phase 1/Phase 2|6|Actual|Jonsson Comprehensive Cancer Center||3|||f||||t||||||||||2017-02-18 18:14:37.770428|2017-02-18 18:14:37.770428
NCT00005628|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-18|||November 1999||1999-11-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma|A Phase II Trial of Active Specific Immunotherapy in Patients With Recurrent Soft Tissue Sarcoma Using Autologous Tumor-derived Heat Shock Protein-Peptide Complex (HSPPC-96)|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:37.877775|2017-02-18 18:14:37.877775
NCT00005627|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-07-17|||March 1999||1999-03-01|April 2003|2003-04-01|April 2003|Actual|2003-04-01|||||Interventional|||Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase I Study of Estramustine, Taxotere and Carboplatin (ETP) in Patients With Horomone Refractory Prostate Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:37.9608|2017-02-18 18:14:37.9608
NCT00005626|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-09-24|||February 1998||1998-02-01|September 2012|2012-09-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)|Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11) in Newly Diagnosed and Relapsed Indolent Lymphoproliferative Malignancies|Completed||Phase 2|10|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:38.055211|2017-02-18 18:14:38.055211
NCT00005625|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-18|||December 1999||1999-12-01|June 2013|2013-06-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma|Phase II Study of ET-743 Therapy in Metastatic Osteosarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:38.170462|2017-02-18 18:14:38.170462
NCT00005624|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-09-21|||August 1997||1997-08-01|September 2012|2012-09-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||CI-994 in Treating Patients With Advanced Myeloma|A Multicenter Phase 2 Study of Oral N-Acetyl Dinaline (CI-994) in the Treatment of Patients With Advanced Myeloma|Completed||Phase 2|6|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:38.522541|2017-02-18 18:14:38.522541
NCT00005623|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-03-25|||December 1999||1999-12-01|December 2003|2003-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer|A Phase III, Randomized, Multicenter, Placebo-Controlled, Double-Blind Clinical Trial to Study the Efficacy and Safety of CyPat (Cyproterone Acetate [CA]) for the Treatment of Hot Flashes Following Surgical or Chemical Castration of Prostate Cancer Patients and Its Impact on the Quality of Life in These Patients|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:38.638444|2017-02-18 18:14:38.638444
NCT00005622|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-10-24|||May 1996||1996-05-01|October 2012|2012-10-01|July 2009|Actual|2009-07-01|September 2005|Actual|2005-09-01||Interventional|||Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders|Allogeneic Bone Marrow Transplantation Using Closely Matched Related and Unrelated Donors|Completed||Phase 2|72|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:38.734742|2017-02-18 18:14:38.734742
NCT00005619|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2011-02-18|||February 2000||2000-02-01|February 2011|2011-02-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Observational|||Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia|Detection of Hairy Cell Leukemia Minimal Residual Disease: Detection by Flow Cytometry|Completed||N/A|16|Actual|Northwestern University|||1||f||||||||||||||2017-02-18 18:14:38.854533|2017-02-18 18:14:38.854533
NCT00005618|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-20|||February 2000||2000-02-01|October 2001|2001-10-01|March 2004|Actual|2004-03-01|||||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia|Phase II Study of Arsenic Trioxide, NSC 706363, in Relapsed of Refractory Chronic Myelogenous Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:38.946248|2017-02-18 18:14:38.946248
NCT00005617|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2015-10-28|||July 1997||1997-07-01|July 2012|2012-07-01||||June 2002|Actual|2002-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma|A Phase I Trial Testing Mart-1 Peptide Immunization in Malignant Melanoma|Completed||Phase 1|||Jonsson Comprehensive Cancer Center||6|||f||||t||||||||||2017-02-18 18:14:39.042421|2017-02-18 18:14:39.042421
NCT00005616|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-18|||September 1999||1999-09-01|June 2013|2013-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer|A Phase I Single Dose-Escalation Study of BIBH-1 in Patients With Colorectal Cancer Scheduled for Surgical Resection|Completed||Phase 1|12|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:14:39.168423|2017-02-18 18:14:39.168423
NCT00005615|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-09-21|||July 1997||1997-07-01|September 2012|2012-09-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa|The Florida Melanoma Trial: A Phase I/II Trial of Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa in the Treatment of Advanced Stage III Melanoma: Study Site & Coordinating Center|Completed||Phase 1/Phase 2|24|Actual|H. Lee Moffitt Cancer Center and Research Institute||1|||f||||f||||||||||2017-02-18 18:14:39.269344|2017-02-18 18:14:39.269344
NCT00005614|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-09-21|||August 1999||1999-08-01|September 2012|2012-09-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Management of Metastatic Breast Cancer in Frail Patients|Management of Metastatic Breast Cancer in Frail Patients|Withdrawn||Phase 2|0|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||no accrual|f||||f||||||||||2017-02-18 18:14:39.379009|2017-02-18 18:14:39.379009
NCT00005613|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-03|||March 1996||1996-03-01|June 2013|2013-06-01|June 2010|Actual|2010-06-01|October 2006|Actual|2006-10-01||Interventional|CBV||Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease|A Prospective, Comparative Trial of Allogeneic Versus Autologous Stem Cell Transplantation for High Risk Lymphoma|Completed||Phase 2|147|Actual|H. Lee Moffitt Cancer Center and Research Institute||2|||f||||f||||||||||2017-02-18 18:14:39.480048|2017-02-18 18:14:39.480048
NCT00005221|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2012-05-15|||April 1988||1988-04-01|May 2012|2012-05-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Analysis of Longitudinal Cardiopulmonary Data||Completed||N/A|60000|Actual|Brigham and Women's Hospital|||1||f||||||||||||||2017-02-18 18:15:20.060205|2017-02-18 18:15:20.060205
NCT00005612|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-09-24|||August 1999||1999-08-01|September 2012|2012-09-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|ETC||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer|A Phase I/II Study of Intensive-Dose Etoposide, Topotecan and Carboplatin (ETC) Followed by Autologous Stem Cell Rescue in Chemosensitive Ovarian Cancer Patients With Either Minimal Residual Disease or at First Relapse|Terminated||Phase 1/Phase 2|3|Actual|H. Lee Moffitt Cancer Center and Research Institute||1||Low accrual|f||||f||||||||||2017-02-18 18:14:39.603577|2017-02-18 18:14:39.603577
NCT00005611|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2008-07-23||||||August 2000|2000-08-01||||||||Interventional|||BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment|Phase I Study of BMS-188797 in Patients With Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:39.713339|2017-02-18 18:14:39.713339
NCT00005610|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2016-07-12|||September 2000||2000-09-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung|Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung|Completed||Phase 2|28|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:14:39.798676|2017-02-18 18:14:39.798676
NCT00005609|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-08-14|||April 2000||2000-04-01|September 2009|2009-09-01|February 2004|Actual|2004-02-01|||||Interventional|||Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia|Rituximab for Waldenstrom's Macroglobulinemia (WM): A Phase II Pilot Study for Untreated or Previously Treated Patients|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:39.923993|2017-02-18 18:14:39.923993
NCT00005608|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-05-31||2011-02-18|February 2000||2000-02-01|May 2012|2012-05-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer|Orzel (UFT+Leucovorin) as First-Line Therapy for Metastatic Breast Cancer|Terminated||Phase 2|||Northwestern University||||Drug was pulled from the market.|f||||||||||||||2017-02-18 18:14:40.115132|2017-02-18 18:14:40.115132
NCT00005607|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-12-18|||February 2000||2000-02-01|July 2000|2000-07-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus|A Phase II Study of CPT-11 and 5-FU/LCV in Patients With Previously Untreated Gastric Adenocarcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:40.209577|2017-02-18 18:14:40.209577
NCT00005606|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-05-31||2011-02-16|February 2000||2000-02-01|May 2012|2012-05-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation|Adoptive Immunotherapy of Epstein Barr Virus Induced Lymhoproliferative Disease. A Comparison of Allogeneic and Autologous Lymphocyte Responses ex Vivo and Use of Highly Selected Reactive Cells as an Alternative to Chemotherapy in Vivo.|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:14:40.306854|2017-02-18 18:14:40.306854
NCT00005605|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2011-02-18|||February 2000||2000-02-01|February 2011|2011-02-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Observational|||Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer|Does Tamoxifen Prevent the Skeletal and Cardiovascular Morbidity of Chemotherapy in Premenopausal Women?|Completed||N/A|79|Actual|Northwestern University|||2||f||||||||||||||2017-02-18 18:14:40.403901|2017-02-18 18:14:40.403901
NCT00005604|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-01-31|||March 2000||2000-03-01|January 2013|2013-01-01||||July 2003|Actual|2003-07-01||Interventional|||Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors|Phase I Trial of Twice Weekly IV IL-12 Plus Low-Dose Subcutaneous IL-2 in Patients With Advanced Malignancies|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:40.49636|2017-02-18 18:14:40.49636
NCT00005603|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2014-02-18|||March 2000||2000-03-01|February 2014|2014-02-01||||September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia|ALinC 17: Protocol for Patients With Newly Diagnosed High Risk Acute Lymphoblastic Leukemia (ALL) - Evaluation of the Augmented BFM Regimen: A Phase III Study|Completed||Phase 3|276|Actual|Children's Oncology Group|||||f||||t||||||||||2017-02-18 18:14:40.60074|2017-02-18 18:14:40.60074
NCT00005602|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2014-02-19|||February 2001||2001-02-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas|Phase I Study of Concurrent Cereport and Carboplatin With Radiation Therapy for Children With Newly-Diagnosed Brain Stem Gliomas|Completed||Phase 1|13|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 18:14:40.736223|2017-02-18 18:14:40.736223
NCT00005601|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2016-12-05|||October 2000||2000-10-01|December 2016|2016-12-01|February 2008|Actual|2008-02-01|July 2003|Actual|2003-07-01||Interventional|||Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|A Phase II Trial of Cisplatinum, Cytosine Arabinoside, Dexamethasone (DHAP) With Rituxan in Patients With Relapsed CD20+ B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|58|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:14:41.16873|2017-02-18 18:14:41.16873
NCT00005600|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-11-05|||November 1997||1997-11-01|December 2005|2005-12-01||||||||Interventional|||Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer|Optimum Drainage of the Axilla After Lymph Node Dissection: A Randomized Prospective Study|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:41.325629|2017-02-18 18:14:41.325629
NCT00005599|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-20|||February 2000||2000-02-01|August 2004|2004-08-01|August 2004|Actual|2004-08-01|||||Interventional|||Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer|Phase II Trail of Bryostatin-1 and Paclitaxel in Patients With Advanced Esophageal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:41.413413|2017-02-18 18:14:41.413413
NCT00005598|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-12-19|||October 2000||2000-10-01|December 2012|2012-12-01|March 2002|Actual|2002-03-01|December 2001|Actual|2001-12-01||Interventional|||Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome|A Phase II Trial of 5-Azacytidine (NSC #102816) and Ethyol (Amifostine) in the Treatment of Adults With Myelodysplastic Syndromes|Completed||Phase 2|||University of Michigan Cancer Center|||||f||||t||||||||||2017-02-18 18:14:41.512663|2017-02-18 18:14:41.512663
NCT00005220|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||April 1988||1988-04-01|June 2000|2000-06-01|January 1999||1999-01-01|||||Observational|||Postmenopausal Progestins, MI and Stroke||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:20.145343|2017-02-18 18:15:20.145343
NCT00005597|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-01-02|||April 2000||2000-04-01|January 2013|2013-01-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors|Phase II Study of Temozolomide in Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)|Completed||Phase 2|25|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:14:41.610776|2017-02-18 18:14:41.610776
NCT00005596|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2016-05-11|||April 2000||2000-04-01|May 2016|2016-05-01|July 2007|Actual|2007-07-01|July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia|ALinC 17: Protocol for Patients With Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL): A Phase III Study|Completed||Phase 3|1076|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 18:14:41.844565|2017-02-18 18:14:41.844565
NCT00005595|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-06-07||2011-02-18|June 2000||2000-06-01|June 2012|2012-06-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease|Multicenter Phase II Trial of Arsenic Trioxide in Relapsed and Refractory Hodgkin's Disease|Terminated||Phase 2|2|Actual|Northwestern University||||Unable to accrue subjects in a timely fashion.|f||||t||||||||||2017-02-18 18:14:42.137286|2017-02-18 18:14:42.137286
NCT00005594|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2010-12-30|||July 2000||2000-07-01|December 2010|2010-12-01||||December 2000|Actual|2000-12-01||Interventional|||ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas|Phase II Trial of ISIS 2503, an Antisense Inhibitor of H-Ras, in Patients With Advanced Pancreatic Cancer|Completed||Phase 2|4|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 18:14:42.249364|2017-02-18 18:14:42.249364
NCT00005593|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2010-06-09|||September 1998||1998-09-01|June 2010|2010-06-01|March 2003|Actual|2003-03-01|April 2002|Actual|2002-04-01||Interventional|||Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome|Phase I Study of Fludarabine, Carboplatin, and Topotecan for Patients With Relapsed/Refractory Acute Leukemia and Advanced Myelodysplastic Syndromes|Completed||Phase 1|31|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:14:42.36041|2017-02-18 18:14:42.36041
NCT00005592|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2015-10-20|||November 1999||1999-11-01|October 2015|2015-10-01|November 2005|Actual|2005-11-01|March 2002|Actual|2002-03-01||Interventional|||Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|A Multicenter, Open-Label, Trial to Evaluate the Efficacy and Safety of IDEC-Y2B8 Radioimmunotherapy of Relapsed or Refractory Low-Grade or Follicular Transformed B-Cell Non-Hodgkin's Lymphoma|Completed||Phase 2|23|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 18:14:42.476773|2017-02-18 18:14:42.476773
NCT00005591|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-12-11|||October 1999||1999-10-01|April 2007|2007-04-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas|Phase II Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody C225 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer|Withdrawn||Phase 2|0|Actual|University of Alabama at Birmingham|||||f||||t||||||||||2017-02-18 18:14:42.593328|2017-02-18 18:14:42.593328
NCT00005590|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-08-01|||August 1999||1999-08-01|July 2002|2002-07-01|September 2005|Actual|2005-09-01|||||Interventional|||Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma|A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:42.691442|2017-02-18 18:14:42.691442
NCT00005589|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-09-16|||October 1999||1999-10-01|March 2007|2007-03-01|April 2013|Actual|2013-04-01|||||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|Randomized Study of Rituximab (Mabthera) in Patients With Relapsed Follicular Lymphoma Prior to High-Dose Therapy as In Vivo Purging and to Maintain Remission Following High-Dose Therapy|Completed||Phase 3|460|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:42.816313|2017-02-18 18:14:42.816313
NCT00005588|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-12-18|||January 1999||1999-01-01|June 2000|2000-06-01|December 2004|Actual|2004-12-01|||||Interventional|||Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer|Standardization of Breast Radiotherapy: Trial A - A Randomized Comparison of Fractionation Regimens After Local Excision or Mastectomy in Women With Early Stage Breast Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:43.307691|2017-02-18 18:14:43.307691
NCT00005587|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-12-18|||January 1999||1999-01-01|July 2001|2001-07-01|June 2004|Actual|2004-06-01|||||Interventional|||Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer|Standardization of Breast Radiotherapy: Trial B - A Randomized Comparison of Fractionation Regimens After Local Excision or Mastectomy in Women With Early Stage Breast Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:43.427444|2017-02-18 18:14:43.427444
NCT00005586|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-12-17|||October 1997||1997-10-01|March 2007|2007-03-01||||||||Interventional|||Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed|A UKCCCR Study of Adjuvant Chemotherapy for Colorectal Cancer|Completed||Phase 3|2500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:43.553669|2017-02-18 18:14:43.553669
NCT00005585|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-07|||April 2000||2000-04-01|June 2013|2013-06-01||||July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia|ALINC #17 Treatment for Patients With Low Risk Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Phase III Study|Completed||Phase 3|838|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 18:14:43.657504|2017-02-18 18:14:43.657504
NCT00005584|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2016-02-03|||October 1998||1998-10-01|February 2016|2016-02-01||||May 2004|Actual|2004-05-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma|Prospective Controlled Trial in Clinical Stages I-II Supradiaphragmatic Hodgkin's Disease: Evaluation of Treatment Efficacy, (Long Term) Toxicity and Quality of Life in Two Different Prognostic Subgroups|Active, not recruiting||Phase 3|1649|Actual|European Organisation for Research and Treatment of Cancer - EORTC||3|||f||||||||||||||2017-02-18 18:14:43.956132|2017-02-18 18:14:43.956132
NCT00005583|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-08-01|||January 2000||2000-01-01|November 2006|2006-11-01|July 2010|Actual|2010-07-01|||||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer|A Randomized Trial of Adjuvant Treatment With Radiation Plus Chemotherapy Versus Radiation Alone in High Risk Endometrial Carcinoma|Completed||Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:44.196485|2017-02-18 18:14:44.196485
NCT00005581|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-12-17|||June 2000||2000-06-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer|Epirubicin Plus Paclitaxel Versus Cyclophosphamide, Epirubicin and 5-Fluorouracil as Adjuvant Treatment of Node Positive Breast Cancer Patients: A Controlled Randomized Phase III Study|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:44.33533|2017-02-18 18:14:44.33533
NCT00005580|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2010-02-23|||September 1998||1998-09-01|February 2010|2010-02-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma|Phase I Study of Bryostatin 1 (NSC 339555) and Fludarabine in Patients With Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin's Lymphoma|Completed||Phase 1|54|Actual|Virginia Commonwealth University||8|||f||||f||||||||||2017-02-18 18:14:44.450812|2017-02-18 18:14:44.450812
NCT00005579|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-06-25|||June 1998||1998-06-01|November 2002|2002-11-01|February 2003|Actual|2003-02-01|||||Interventional|||Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia|Phase II Trial of Dolastin 10 in Indolent Lymphoma and Chronic Lymphocytic Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:14:44.558264|2017-02-18 18:14:44.558264
NCT00005578|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2014-07-23|||March 1997||1997-03-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease|Advanced Stage Hodgkins Disease - A Pediatric Oncology Group Phase III Study|Completed||Phase 3|219|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:14:44.665009|2017-02-18 18:14:44.665009
NCT00005577|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-02-04|||August 1996||1996-08-01|December 2002|2002-12-01||||September 2002|Actual|2002-09-01||Interventional|||Gemcitabine in Treating Children With Refractory Solid Tumors|A PEDIATRIC PHASE I STUDY OF GEMCITABINE (NSC# 613327) IN SOLID TUMORS|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:44.859319|2017-02-18 18:14:44.859319
NCT00005576|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-01-15|||January 2001||2001-01-01|January 2013|2013-01-01||||March 2002|Actual|2002-03-01||Interventional|||Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma|A PHASE I STUDY OF CHIMERIC HUMAN/MURINE ANTI-GD2 MONOCLONAL ANTIBODY (ch14.18) WITH GM-CSF AND INTERLEUKIN-2 (IL-2) IN CHILDREN WITH NEUROBLASTOMA IMMEDIATELY POST AUTOLOGOUS BMT OR PBSC RESCUE|Completed||Phase 1|6|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:14:44.977004|2017-02-18 18:14:44.977004
NCT00005575|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-01|2010-01-12|||January 1999||1999-01-01|January 2010|2010-01-01|December 2002||2002-12-01|||||Interventional|||Treatment of Non-Cardiac Chest Pain With Imipramine or Cognitive-Behavioral Therapy|Psychophysiological Interactions in Non-Cardiac Chest Pain|Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:14:45.092734|2017-02-18 18:14:45.092734
NCT00005574|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2008-03-03|||February 2000||2000-02-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||Gentamicin Treatment of Muscular Dystrophy|Gentamicin Treatment of Patients With Muscular Dystrophy Due to Nonsense Mutations in Dystrophin|Completed||Phase 1|4||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:45.182142|2017-02-18 18:14:45.182142
NCT00005572|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-28|2008-07-31||||||June 2003|2003-06-01||||||||Observational|||A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection|Study of Pathogen-Specific Immune Responses and General Immune Competence in Opportunistic Infections|Completed||N/A|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:14:45.533817|2017-02-18 18:14:45.533817
NCT00005571|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-25|2008-03-03|||April 2000||2000-04-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis|A Randomized, Third-Party-Blind, Placebo-Controlled Pilot Study of the Effect of h5G1.1-mAb on Dermatomyositis Patients|Completed||Phase 2|17||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:45.63971|2017-02-18 18:14:45.63971
NCT00005570|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-22|2008-03-03|||April 2000||2000-04-01|April 2000|2000-04-01|July 2000||2000-07-01|||||Observational|||An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers|An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:45.73928|2017-02-18 18:14:45.73928
NCT00005569|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-22|2008-03-03|||April 2000||2000-04-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Interventional|||Effects of Topical SLPI on Skin Wounds|Effects of Topical Anti-Inflammatory Agents on Cutaneous Wound Healing|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:14:45.831251|2017-02-18 18:14:45.831251
NCT00005567|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-22|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||Parental Knowledge and Beliefs About Infant Sleep Position||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:45.917825|2017-02-18 18:14:45.917825
NCT00005566|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-22|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Cognitive Aspects of Adolescent Suicide||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:14:45.990398|2017-02-18 18:14:45.990398
NCT00005565|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||August 1997||1997-08-01|January 2008|2008-01-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Observational|||Mechanisms of Low Levels of Apolipoprotein B||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:46.075237|2017-02-18 18:14:46.075237
NCT00005564|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1997||1997-07-01|July 2004|2004-07-01|June 2002|Actual|2002-06-01|||||Observational|||Impact of Adult Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:46.156908|2017-02-18 18:14:46.156908
NCT00005563|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1999||1999-07-01|September 2002|2002-09-01|June 2001|Actual|2001-06-01|||||Observational|||Multicenter Asthma Research Collaboration||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:46.242177|2017-02-18 18:14:46.242177
NCT00005562|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-03-12|||September 1999||1999-09-01|March 2014|2014-03-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Coronary Artery Calcium, Exercise Tests, and CHD Outcome||Completed||N/A|||The Cooper Institute|||||f||||||||||||||2017-02-18 18:14:46.31732|2017-02-18 18:14:46.31732
NCT00005557|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-10-31|||April 1999||1999-04-01|October 2016|2016-10-01|April 2023|Anticipated|2023-04-01|April 2022|Anticipated|2022-04-01||Observational|||Epidemiology of Sleep-Disordered Breathing in Adults|Epidemiology of Sleep-Disordered Breathing in Adults|Enrolling by invitation||N/A|1545|Actual|University of Wisconsin, Madison|||1||f||||f||||||Samples With DNA|"~     Blood~   "|Undecided||2017-02-18 18:14:46.572733|2017-02-18 18:14:46.572733
NCT00005556|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||May 1997||1997-05-01|August 2004|2004-08-01|April 2003|Actual|2003-04-01|||||Observational|||Retention of Bone Marrow Donors in a National Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:46.684383|2017-02-18 18:14:46.684383
NCT00005555|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-07|||May 1998||1998-05-01|January 2016|2016-01-01|April 2003||2003-04-01|||||Interventional|||Dose Response to Exercise and Cardiovascular Health||Completed||N/A|||University of Florida|||||f||||||||||||||2017-02-18 18:14:46.759176|2017-02-18 18:14:46.759176
NCT00005554|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||February 1999||1999-02-01|December 2004|2004-12-01|January 2004|Actual|2004-01-01|||||Observational|||Biobehavioral Predictors of Coronary Angioplasty Outcome||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:46.837426|2017-02-18 18:14:46.837426
NCT00005553|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-08|||May 1998||1998-05-01|October 2005|2005-10-01|April 2004||2004-04-01|||||Observational|||Prospective Assessment After Pediatric Cardiac Ablation (PAPCA)||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 18:14:46.910689|2017-02-18 18:14:46.910689
NCT00005552|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||January 1999||1999-01-01|August 2004|2004-08-01|December 2001|Actual|2001-12-01|||||Observational|||Isocyanate Dermal Exposures in Autobody Shops||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:46.990594|2017-02-18 18:14:46.990594
NCT00005551|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1999||1999-04-01|August 2004|2004-08-01|March 2002|Actual|2002-03-01|||||Observational|||Sleep Apnea in a Non-Clinical Population||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:47.069788|2017-02-18 18:14:47.069788
NCT00005550|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-08-08|||January 1999||1999-01-01|August 2014|2014-08-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Observational|||Endotoxin and Bronchial Inflammation in Asthma||Completed||N/A|||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 18:14:47.141035|2017-02-18 18:14:47.141035
NCT00005549|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-03-13|||January 1999||1999-01-01|March 2014|2014-03-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Observational|||Isocyanate Antigens and T Cells That Cause Asthma||Completed||N/A|||Yale University|||||f||||||||||||||2017-02-18 18:14:47.220873|2017-02-18 18:14:47.220873
NCT00005548|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1999||1999-04-01|January 2005|2005-01-01|March 2001|Actual|2001-03-01|||||Observational|||Green Tea Consumption and Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:47.305279|2017-02-18 18:14:47.305279
NCT00005547|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1999||1999-04-01|January 2005|2005-01-01|June 2003|Actual|2003-06-01|||||Observational|||Infection and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:47.386885|2017-02-18 18:14:47.386885
NCT00005546|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||January 1999||1999-01-01|December 2004|2004-12-01|December 2004|Actual|2004-12-01|||||Observational|||Molecular Genetic Epidemiology of Three Cardiac Defects -SCOR in Pediatric Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:47.459896|2017-02-18 18:14:47.459896
NCT00005545|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-12-10|||December 1998||1998-12-01|December 2013|2013-12-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Arterial Endothelial Function--An Epidemiologic Study|Arterial Endothelial Function--An Epidemiologic Study|Completed||N/A|600|Actual|University of Iowa|||1||f||||||||||Samples With DNA|"~     Stored plasma and DNA samples~   "|||2017-02-18 18:14:47.526095|2017-02-18 18:14:47.526095
NCT00005544|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||February 1999||1999-02-01|May 2005|2005-05-01|January 2005|Actual|2005-01-01|||||Observational|||Community Based Study of Adult Onset Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:47.609557|2017-02-18 18:14:47.609557
NCT00005543|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-29|||April 1999||1999-04-01|December 2015|2015-12-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Observational|||Genetic Epidemiology of Venous Thromboembolism||Completed||N/A|3135|Actual|Mayo Clinic|||1||f||||||||||||||2017-02-18 18:14:47.680787|2017-02-18 18:14:47.680787
NCT00005542|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||May 1999||1999-05-01|October 2005|2005-10-01|April 2005|Actual|2005-04-01|||||Observational|||Sarcoid Genetic Analysis (SAGA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:47.752191|2017-02-18 18:14:47.752191
NCT00005541|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-13|||January 2000||2000-01-01|April 2009|2009-04-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Hemochromatosis and Iron Overload Screening Study (HEIRS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:47.832882|2017-02-18 18:14:47.832882
NCT00005540|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||July 1999||1999-07-01|November 2002|2002-11-01|May 2002||2002-05-01|||||Observational|||Physical Fitness and Cardiovascular Mortality in Firefighters||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:47.911153|2017-02-18 18:14:47.911153
NCT00005539|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-05|||February 1999||1999-02-01|February 2016|2016-02-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Observational|WESCID||Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes|Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes|Completed||N/A|||University of Wisconsin, Madison|||1||f||||||||||||||2017-02-18 18:14:47.97434|2017-02-18 18:14:47.97434
NCT00005538|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1987||1987-07-01|August 2004|2004-08-01|June 2000|Actual|2000-06-01|||||Observational|||CHD Risk, Behavioral Stress and Reproductive Hormones||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:48.057472|2017-02-18 18:14:48.057472
NCT00005537|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1997||1997-07-01|August 2004|2004-08-01|June 2002|Actual|2002-06-01|||||Observational|||Genetics of Airway Responsiveness and Lung Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:48.138785|2017-02-18 18:14:48.138785
NCT00005536|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1997||1997-07-01|March 2005|2005-03-01|June 2003|Actual|2003-06-01|||||Observational|||Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:48.218204|2017-02-18 18:14:48.218204
NCT00005535|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|October 2002|2002-10-01|August 2000|Actual|2000-08-01|||||Observational|||Gene Mapping for Quantitative Traits||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:48.292947|2017-02-18 18:14:48.292947
NCT00005520|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-01-15|||February 1997||1997-02-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|January 2008|Actual|2008-01-01||Observational|GERA||Genetic Epidemiology of Responses to Antihypertensives|Genetic Epidemiology of Responses to Antihypertensives|Completed||N/A|1200|Actual|Mayo Clinic|||4||f||||f||||||Samples With DNA|"~     Serum, plasma, buffy coat, urine.~   "|||2017-02-18 18:14:49.385284|2017-02-18 18:14:49.385284
NCT00005519|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1998||1998-09-01|August 2004|2004-08-01|August 2001|Actual|2001-08-01|||||Observational|||Prospective Study of Diet and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:52.540551|2017-02-18 18:14:52.540551
NCT00005518|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||June 1998||1998-06-01|August 2004|2004-08-01|August 2003|Actual|2003-08-01|||||Observational|||Epidemiology and Immunology of Hemophilia A Inhibitors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:52.60712|2017-02-18 18:14:52.60712
NCT00005517|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||August 1998||1998-08-01|November 2005|2005-11-01|June 2004|Actual|2004-06-01|||||Observational|||Community Surveillance of Congestive Heart Failure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:52.669486|2017-02-18 18:14:52.669486
NCT00005516|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1998||1998-07-01|March 2005|2005-03-01|June 2002|Actual|2002-06-01|||||Observational|||Epidemiology of Sleep Disordered Breathing in Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:52.746356|2017-02-18 18:14:52.746356
NCT00005515|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||September 1998||1998-09-01|July 2005|2005-07-01|August 2003||2003-08-01|||||Observational|||Mutations, Hormone Therapy (HRT) and Venous Thromboembolism||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:14:52.812801|2017-02-18 18:14:52.812801
NCT00005514|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-03-18|||August 1998||1998-08-01|March 2013|2013-03-01|January 2009|Actual|2009-01-01|January 2009|Actual|2009-01-01||Observational|||Dietary Patterns and Risk of Cardiovascular Disease||Completed||N/A|120000|Actual|Harvard School of Public Health|||1||f||||||||||Samples With DNA|"~     Plasma and buffy coat~   "|||2017-02-18 18:14:52.886085|2017-02-18 18:14:52.886085
NCT00005513|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1998||1998-09-01|August 2004|2004-08-01|July 2002|Actual|2002-07-01|||||Observational|||Framingham Nutrition Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:52.964652|2017-02-18 18:14:52.964652
NCT00005512|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-29|||August 1998||1998-08-01|February 2016|2016-02-01|July 2002||2002-07-01|||||Observational|||Genetic Epidemiology--Development of Cardiovascular Risk||Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-02-18 18:14:53.030028|2017-02-18 18:14:53.030028
NCT00005511|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-19|||September 1998||1998-09-01|January 2016|2016-01-01||||August 2003|Actual|2003-08-01||Observational|||SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea||Completed||N/A|||University of Pennsylvania|||||f||||||||||||||2017-02-18 18:14:53.1085|2017-02-18 18:14:53.1085
NCT00005510|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1998||1998-04-01|November 2001|2001-11-01|March 1999|Actual|1999-03-01|||||Observational|||Strong Heart Study Analyses Obesity and Lipoproteins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:53.185071|2017-02-18 18:14:53.185071
NCT00005509|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||April 1998||1998-04-01|December 2004|2004-12-01|March 2002|Actual|2002-03-01|||||Observational|||Cardiovascular Risk Factors in a Cohort of Latina Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:53.246066|2017-02-18 18:14:53.246066
NCT00005508|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1998||1998-08-01|August 2004|2004-08-01|June 2003|Actual|2003-06-01|||||Observational|||Determinants of Coronary Disease in High Risk Families||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:53.315306|2017-02-18 18:14:53.315306
NCT00005507|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||March 1998||1998-03-01|April 2002|2002-04-01|March 2000|Actual|2000-03-01|||||Observational|||Race and the Use of Cardiovascular Surgical Procedures||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:53.385924|2017-02-18 18:14:53.385924
NCT00005506|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||January 1998||1998-01-01|April 2004|2004-04-01|June 2000|Actual|2000-06-01|||||Observational|||Vascular Disease--Structure/Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:53.454206|2017-02-18 18:14:53.454206
NCT00005505|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||December 1997||1997-12-01|August 2004|2004-08-01|November 2002|Actual|2002-11-01|||||Observational|||Neighborhood Environments and Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:53.803971|2017-02-18 18:14:53.803971
NCT00005504|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-13|||February 1998||1998-02-01|May 2016|2016-05-01|December 2006||2006-12-01|||||Observational|LITE||Epidemiology of Venous Thrombosis and Pulmonary Embolism|Longitudinal Investigation of Thromboembolism Etiology|Active, not recruiting||N/A|21680|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples With DNA|"~     DNA, serum, plasma~   "|||2017-02-18 18:14:53.885519|2017-02-18 18:14:53.885519
NCT00005503|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1997||1997-09-01|October 2002|2002-10-01|August 1999|Actual|1999-08-01|||||Observational|||Epidemiology of Cardiac Development in Youth||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:53.967161|2017-02-18 18:14:53.967161
NCT00005502|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-05-13|||October 2002||2002-10-01|May 2013|2013-05-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|||Coronary Disease Morbidity and Mortality in a Population|Coronary Disease Morbidity and Mortality in a Population|Completed||N/A|5476|Actual|Mayo Clinic|||1||f||||f||||||Samples Without DNA|"~     plasma, serum and white blood cells are stored for future research projects~   "|||2017-02-18 18:14:54.037536|2017-02-18 18:14:54.037536
NCT00005501|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1998||1998-09-01|December 2000|2000-12-01|August 2000|Actual|2000-08-01|||||Observational|||Hypertensive Treatment and Epidemiological Analyses||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.144967|2017-02-18 18:14:54.144967
NCT00005500|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2008-01-25|||September 1992||1992-09-01|January 2008|2008-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Observational|||Collaborative Studies on the Genetics of Asthma (CSGA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.218581|2017-02-18 18:14:54.218581
NCT00005499|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1998||1998-07-01|August 2004|2004-08-01|June 2001|Actual|2001-06-01|||||Observational|||Congestive Heart Failure Trends in the Elderly 1970-94||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.300582|2017-02-18 18:14:54.300582
NCT00005498|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||May 1998||1998-05-01|August 2004|2004-08-01|October 2001|Actual|2001-10-01|||||Observational|||Do Hostility and Stress Predict Cardiovascular Mortality in MRFIT?||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:54.368842|2017-02-18 18:14:54.368842
NCT00005487|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||January 1999||1999-01-01|April 2012|2012-04-01|June 2009|Actual|2009-06-01|August 2015|Anticipated|2015-08-01||Observational|||Multi-Ethnic Study of Atherosclerosis (MESA)|Multi-Ethnic Study of Atherosclerosis (MESA)|Unknown status|Active, not recruiting|N/A|6000|Anticipated|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||||||2017-02-18 18:14:55.110113|2017-02-18 18:14:55.110113
NCT00005486|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1997||1997-07-01|December 2005|2005-12-01|June 2003|Actual|2003-06-01|||||Observational|||Lymphangioleiomyomatosis (LAM) Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:55.256667|2017-02-18 18:14:55.256667
NCT00005485|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-27|||September 2000||2000-09-01|April 2016|2016-04-01||||||||Observational|JHS||Jackson Heart Study (JHS) of Cardiovascular Diseases in African Americans|Environmental and Genetic Factors That Influence Cardiovascular Disease in African Americans|Active, not recruiting||N/A|5306|Actual|National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||t||||||Samples With DNA|"~     Serum, plasma, urine, DNA~   "|Yes||2017-02-18 18:14:55.3321|2017-02-18 18:14:55.3321
NCT00005484|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1992||1992-04-01|March 2004|2004-03-01|March 1997|Actual|1997-03-01|||||Observational|||Predictors of Hospital-Based Care in Asthma||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:55.443721|2017-02-18 18:14:55.443721
NCT00005483|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-06|||December 1994||1994-12-01|January 2016|2016-01-01|July 1999||1999-07-01|||||Observational|||Plasma Homocysteine Distribution in the United States||Completed||N/A|||Tufts University|||||f||||||||||||||2017-02-18 18:14:55.511308|2017-02-18 18:14:55.511308
NCT00005482|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||September 1995||1995-09-01|June 2000|2000-06-01|March 1999||1999-03-01|||||Observational|||Homocyst(e)Ine, Vitamin Status, and CVD Risk||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:14:55.576522|2017-02-18 18:14:55.576522
NCT00005481|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1996||1996-09-01|July 2004|2004-07-01|July 2002|Actual|2002-07-01|||||Observational|||Epidemiology of Impaired Coagulant Balance in Diabetes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:55.643447|2017-02-18 18:14:55.643447
NCT00005480|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1996||1996-09-01|October 2001|2001-10-01|August 1998|Actual|1998-08-01|||||Observational|||Cardiovascular Disease Knowledge/Morbidity--Socioeconomic Cohort Outcomes||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:55.981722|2017-02-18 18:14:55.981722
NCT00005479|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-23|||September 1996||1996-09-01|December 2015|2015-12-01|September 2009|Actual|2009-09-01|August 2001|Actual|2001-08-01||Observational|||Diabetes, Lipoproteins and Accelerated Vascular Disease|Measures of Postprandial Lipoproteins Are Not Associated With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus|Completed||N/A|164|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 18:14:56.046789|2017-02-18 18:14:56.046789
NCT00005478|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1996||1996-09-01|March 2004|2004-03-01|September 1998|Actual|1998-09-01|||||Observational|||Precursors of CVD Risk Factors--Project Heartbeat||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.134876|2017-02-18 18:14:56.134876
NCT00005477|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-08|||September 1996||1996-09-01|April 2002|2002-04-01|August 1998||1998-08-01|||||Observational|||Hispanic and White Women's Cardiovascular Health||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 18:14:56.21025|2017-02-18 18:14:56.21025
NCT00005476|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||September 1996||1996-09-01|May 2009|2009-05-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Observational|||Sociodemographic Regulation of Cardiovascular Function and Structure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.276266|2017-02-18 18:14:56.276266
NCT00005475|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||August 1996||1996-08-01|May 2009|2009-05-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Longitudinal Study of Asthma From Birth to Adulthood||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.356558|2017-02-18 18:14:56.356558
NCT00005474|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-04-13|||September 1996||1996-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Markers and Mechanisms of Macrovascular Disease in IDDM||Completed||N/A|1063|Actual|Medical University of South Carolina|||1||f||||||||||Samples Without DNA|"~     Both DNA samples as well as plasma, serum and urine samples were collected from the~     DCCT/EDIC cohort.~   "|||2017-02-18 18:14:56.454268|2017-02-18 18:14:56.454268
NCT00005473|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1996||1996-07-01|September 2002|2002-09-01|June 2001|Actual|2001-06-01|||||Observational|||Cardiovascular Disease Trends 1980-91--A Gender Specific Perspective||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.543369|2017-02-18 18:14:56.543369
NCT00005472|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1996||1996-09-01|August 2004|2004-08-01|August 1998|Actual|1998-08-01|||||Observational|||Job Strain, Ambulatory Blood Pressure and Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.618162|2017-02-18 18:14:56.618162
NCT00005471|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1996||1996-09-01|March 2005|2005-03-01|January 2001|Actual|2001-01-01|||||Observational|||Anxiety and Cardiovascular Autonomic Control||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.700958|2017-02-18 18:14:56.700958
NCT00005470|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1996||1996-09-01|August 2004|2004-08-01|August 2002|Actual|2002-08-01|||||Observational|||Divergence of Blood Pressure By Race in Adolescent Girls||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.7722|2017-02-18 18:14:56.7722
NCT00005469|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1990||1990-09-01|May 2000|2000-05-01|November 1996|Actual|1996-11-01|||||Observational|||Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.840592|2017-02-18 18:14:56.840592
NCT00005468|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1990||1990-07-01|June 2000|2000-06-01|December 1992|Actual|1992-12-01|||||Observational|||Lipid Variability--Influence of Stress||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.906418|2017-02-18 18:14:56.906418
NCT00005467|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||January 1990||1990-01-01|May 2000|2000-05-01|December 1992|Actual|1992-12-01|||||Observational|||Indices of Severity and Prognosis for Sickle Cell Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:56.971417|2017-02-18 18:14:56.971417
NCT00005466|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1991||1991-08-01|May 2000|2000-05-01|July 1995|Actual|1995-07-01|||||Observational|||Stroke and MI in Users of Estrogen/Progestogen||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:14:57.046819|2017-02-18 18:14:57.046819
NCT00005393|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-02|||August 1996||1996-08-01|December 2015|2015-12-01|May 2020|Anticipated|2020-05-01|May 2020|Anticipated|2020-05-01||Observational|||Epidemiology: Oxidative Stress and Early Atherosclerosis|Epidemiology: Oxidative Stress and Early Atherosclerosis|Active, not recruiting||N/A|5115|Actual|University of Minnesota - Clinical and Translational Science Institute|||1||f||||f||||||Samples With DNA|"~     blood and urine samples and DNA~   "|||2017-02-18 18:15:03.068204|2017-02-18 18:15:03.068204
NCT00005392|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||September 1995||1995-09-01|July 2005|2005-07-01|July 2000|Actual|2000-07-01|||||Observational|||Epidemiology of Venous Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:03.155093|2017-02-18 18:15:03.155093
NCT00005391|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-08-05|||September 1995||1995-09-01|January 2014|2014-01-01|May 2010|Actual|2010-05-01|||||Observational|||Pediatric Cardiomyopathy Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:03.229454|2017-02-18 18:15:03.229454
NCT00005390|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1996||1996-08-01|August 2004|2004-08-01|July 2001|Actual|2001-07-01|||||Observational|||Family Process, Adherence, and Child Asthma Outcome||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:03.308056|2017-02-18 18:15:03.308056
NCT00005389|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||September 1995||1995-09-01|April 2001|2001-04-01|August 1998||1998-08-01|||||Observational|||Effect of Drug Therapy on Reinfarction Risk in Women||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:03.380644|2017-02-18 18:15:03.380644
NCT00005388|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1995||1995-09-01|April 2004|2004-04-01|March 2004|Actual|2004-03-01|||||Observational|||Visceral Fat, Metabolic Rate, and CHD Risk in Young Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:03.733867|2017-02-18 18:15:03.733867
NCT00005387|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-11|||September 1995||1995-09-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Genetics of Hypertension in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:03.803058|2017-02-18 18:15:03.803058
NCT00005386|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-26|||September 1995||1995-09-01|August 2004|2004-08-01|August 1998||1998-08-01|||||Observational|||Biobehavioral Determinants of Obesity in Black Women||Completed||N/A|||University of Memphis|||||f||||||||||||||2017-02-18 18:15:03.881102|2017-02-18 18:15:03.881102
NCT00005385|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1994||1994-09-01|October 2005|2005-10-01|July 1999|Actual|1999-07-01|||||Observational|||Seasonal Variation of Blood Cholesterol Levels||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:03.964244|2017-02-18 18:15:03.964244
NCT00005384|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||January 1995||1995-01-01|August 2004|2004-08-01|December 2002|Actual|2002-12-01|||||Observational|||Diet/Activity of Mexican American and Anglo Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.040092|2017-02-18 18:15:04.040092
NCT00005383|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||January 1995||1995-01-01|September 2002|2002-09-01|December 1999|Actual|1999-12-01|||||Observational|||Anger and Cardiovascular Risk in Urban Youth||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.110405|2017-02-18 18:15:04.110405
NCT00005382|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1995||1995-07-01|November 2001|2001-11-01|May 1998|Actual|1998-05-01|||||Observational|||Sources of Variability in Peak Expiratory Flow||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.183754|2017-02-18 18:15:04.183754
NCT00005381|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||April 1994||1994-04-01|June 2001|2001-06-01|February 2000||2000-02-01|||||Observational|||Prevalence of Sleep Apnea in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.248653|2017-02-18 18:15:04.248653
NCT00005380|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1993||1993-09-01|March 2005|2005-03-01|August 1998|Actual|1998-08-01|||||Observational|||Insulin, Androgen, and Risk in African-American Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.315149|2017-02-18 18:15:04.315149
NCT00005379|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-28|||August 1994||1994-08-01|December 2015|2015-12-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Observational|||Tuberculosis in a Multiethnic Inner City Population|Tuberculosis in a Multiethnic Inner City Population|Completed||N/A|||New York University School of Medicine|||3||f||||||||||||||2017-02-18 18:15:04.406793|2017-02-18 18:15:04.406793
NCT00005378|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1994||1994-07-01|November 2001|2001-11-01|May 1998|Actual|1998-05-01|||||Observational|||Impact of Sleep Disordered Breathing in Older Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.508215|2017-02-18 18:15:04.508215
NCT00005377|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2009-05-01|||July 1994||1994-07-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Molecular Epidemiology of Essential Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.577144|2017-02-18 18:15:04.577144
NCT00005376|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1993||1993-09-01|November 2001|2001-11-01|August 1998|Actual|1998-08-01|||||Observational|||Premature Birth and Its Sequelae in Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.65652|2017-02-18 18:15:04.65652
NCT00005375|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2008-01-25|||September 1993||1993-09-01|January 2008|2008-01-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Smoking Onset in a Biethnic Population||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.730518|2017-02-18 18:15:04.730518
NCT00005374|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||January 1994||1994-01-01|March 2005|2005-03-01|May 2004||2004-05-01|||||Observational|||Genetics of the Metabolic Syndrome in Japanese Americans||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:04.812339|2017-02-18 18:15:04.812339
NCT00005373|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1992||1992-09-01|July 2000|2000-07-01|August 1998|Actual|1998-08-01|||||Observational|||Racial Differences in the Coronary Microcirculation||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:04.897598|2017-02-18 18:15:04.897598
NCT00005372|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-15|||January 1994||1994-01-01|January 2016|2016-01-01|February 2005||2005-02-01|||||Observational|||Intimal Thickening and Antioxidants in Hispanics and Anglos (Los Angeles Atherosclerosis Study)||Completed||N/A|||University of Southern California|||||f||||||||||||||2017-02-18 18:15:04.970815|2017-02-18 18:15:04.970815
NCT00005371|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1993||1993-04-01|March 2005|2005-03-01|March 1995|Actual|1995-03-01|||||Observational|||Epidemiology of Acute Phase Protein and CHD||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.046231|2017-02-18 18:15:05.046231
NCT00005370|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1993||1993-04-01|November 2001|2001-11-01|March 1999|Actual|1999-03-01|||||Observational|||Longitudinal Study of Cortisol and Pulmonary Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:05.117995|2017-02-18 18:15:05.117995
NCT00005323|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||December 1991||1991-12-01|October 2001|2001-10-01|November 1996|Actual|1996-11-01|||||Observational|||Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology and Diseases in Infants and Children||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:08.183523|2017-02-18 18:15:08.183523
NCT00005322|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-09-27|||January 1990||1990-01-01|August 2004|2004-08-01|December 1998|Actual|1998-12-01|||||Observational|||Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:08.251886|2017-02-18 18:15:08.251886
NCT00005321|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-11|||September 1988||1988-09-01|August 2000|2000-08-01|August 1999|Actual|1999-08-01|||||Observational|||Epidemiology of Sleep Disordered Breathing - SCOR in Cardiopulmonary Disorders of Sleep||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:08.323672|2017-02-18 18:15:08.323672
NCT00005320|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-09-27|||September 1988||1988-09-01|March 2005|2005-03-01|August 1998|Actual|1998-08-01|||||Observational|||Regulation of Pharyngeal Muscle Contraction - SCOR in Cardiopulmonary Disorders of Sleep||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:08.389983|2017-02-18 18:15:08.389983
NCT00005319|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1985||1985-09-01|May 2002|2002-05-01|December 1996|Actual|1996-12-01|||||Observational|||Epidemiologic Studies of Blood Use in the United States - SCOR in Transfusion Medicine||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:08.46002|2017-02-18 18:15:08.46002
NCT00005318|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-06-22|||January 1994||1994-01-01|June 2016|2016-06-01|November 2004||2004-11-01|||||Observational|||ARDS - Clinical Epidemiology and the Role of the Inflammatory Response - SCOR in Acute Lung Injury||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:15:08.520369|2017-02-18 18:15:08.520369
NCT00005317|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-11|||December 1986||1986-12-01|May 2000|2000-05-01|November 1996|Actual|1996-11-01|||||Observational|||Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:08.851041|2017-02-18 18:15:08.851041
NCT00005316|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||December 1985||1985-12-01|August 2001|2001-08-01|November 1995|Actual|1995-11-01|||||Observational|||White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:08.944653|2017-02-18 18:15:08.944653
NCT00005315|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-03-07|||September 1993||1993-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Psychosocial Factors and Cardiovascular Disease|Psychosocial Factors and Cardiovascular Disease|Completed||N/A|||Columbia University|||||f||||f||||||||||2017-02-18 18:15:09.019755|2017-02-18 18:15:09.019755
NCT00005314|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-03-12|||July 1986||1986-07-01|February 2015|2015-02-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Behavioral Factors in Coronary Heart Disease||Completed||N/A|694|Actual|Duke University|||1||f||||f||||||Samples With DNA|"~     Urine and plasma samples and extracted DNA are retained~   "|||2017-02-18 18:15:09.115474|2017-02-18 18:15:09.115474
NCT00005313|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-12-09|||April 2001||2001-04-01|December 2014|2014-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Observational|||Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia|Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia|Completed||N/A|450|Actual|University of Washington|||1||f||||f||||||||||2017-02-18 18:15:09.228116|2017-02-18 18:15:09.228116
NCT00005312|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||January 1990||1990-01-01|July 2004|2004-07-01|August 2002||2002-08-01|||||Observational|||International Programs Collaborative Studies Coordinating Center||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:09.340661|2017-02-18 18:15:09.340661
NCT00005311|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1993||1993-09-01|June 2000|2000-06-01|March 1996||1996-03-01|||||Observational|||Hypertension in Minorities Database-Workshop and Publication||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:09.418615|2017-02-18 18:15:09.418615
NCT00005309|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-05|||July 1990||1990-07-01|February 2016|2016-02-01|March 1995||1995-03-01|||||Observational|||Prospective Study of HIV Infection in Hemophiliacs||Completed||N/A|||Bloodworks (Puget Sound Blood Center)|||||f||||||||||||||2017-02-18 18:15:09.499735|2017-02-18 18:15:09.499735
NCT00005308|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1990||1990-04-01|November 2001|2001-11-01|March 1995|Actual|1995-03-01|||||Observational|||Anemia and Surgery: Indications For Transfusion||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:09.574285|2017-02-18 18:15:09.574285
NCT00005307|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1989||1989-04-01|May 2000|2000-05-01|March 1991|Actual|1991-03-01|||||Observational|||Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:09.639454|2017-02-18 18:15:09.639454
NCT00005306|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-13|||March 1988||1988-03-01|August 2004|2004-08-01|September 2001||2001-09-01|||||Observational|||Natural History of Post-transfusion Non-A, Non-B Hepatitis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:09.70969|2017-02-18 18:15:09.70969
NCT00005305|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-06-13|||September 1987||1987-09-01|June 2016|2016-06-01|September 1991|Actual|1991-09-01|September 1991|Actual|1991-09-01||Observational|||Hepatitis Delta Infections in Hemophiliacs|Prevalence and Consequences of Hepatitis Delta Virus Infection in Hemophiliacs|Completed||N/A|61|Actual|University of North Carolina, Chapel Hill|||1||f||||f||||||||No||2017-02-18 18:15:09.784702|2017-02-18 18:15:09.784702
NCT00005304|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-08|||September 1986||1986-09-01|December 2015|2015-12-01|September 1991||1991-09-01|||||Observational|||Delta Hepatitis and Liver Disease in Hemophiliacs||Completed||N/A|||Baylor College of Medicine|||||f||||||||||||||2017-02-18 18:15:09.885921|2017-02-18 18:15:09.885921
NCT00005303|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1986||1986-09-01|December 2001|2001-12-01|September 1995||1995-09-01|||||Observational|||Effectiveness of AIDS Antibody Screening||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:09.958201|2017-02-18 18:15:09.958201
NCT00005302|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1985||1985-04-01|May 2000|2000-05-01|June 1992|Actual|1992-06-01|||||Observational|||Drug Etiology of Aplastic Anemia and Related Dyscrasias||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.032864|2017-02-18 18:15:10.032864
NCT00005301|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-14|||September 1984||1984-09-01|August 2001|2001-08-01|February 1998||1998-02-01|||||Observational|||Transfusion Safety Study (TSS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.111436|2017-02-18 18:15:10.111436
NCT00005299|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-10-26|||August 1990||1990-08-01|October 2016|2016-10-01|March 2008|Actual|2008-03-01|March 2008|Actual|2008-03-01||Observational|||Familial Aggregation and Natural History of Sleep Apnea||Completed||N/A|726|Actual|Brigham and Women's Hospital|||1||f||||||||||Samples With DNA|"~     Samples stored deidentified~   "|||2017-02-18 18:15:10.300362|2017-02-18 18:15:10.300362
NCT00005298|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1990||1990-07-01|June 2000|2000-06-01|June 1993|Actual|1993-06-01|||||Observational|||Inflammation, Autonomic Dysfunction and Airway Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.408317|2017-02-18 18:15:10.408317
NCT00005297|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||April 1990||1990-04-01|March 2005|2005-03-01|June 1997|Actual|1997-06-01|||||Observational|||Age-related Prevalence of Sleep Respiratory Disturbances||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.485869|2017-02-18 18:15:10.485869
NCT00005296|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||January 1990||1990-01-01|August 2000|2000-08-01|December 1994||1994-12-01|||||Observational|||Sleep Apnea: Age Effects On Prevalence and Natural History||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.571712|2017-02-18 18:15:10.571712
NCT00005295|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||July 1989||1989-07-01|January 2016|2016-01-01|June 1995||1995-06-01|||||Observational|||Idiopathic Pulmonary Fibrosis: a Case-control Study||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-02-18 18:15:10.644647|2017-02-18 18:15:10.644647
NCT00005294|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1989||1989-07-01|April 2000|2000-04-01|June 1995|Actual|1995-06-01|||||Observational|||Developmental Sequelae of Severe Chronic Lung Disorders||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.723495|2017-02-18 18:15:10.723495
NCT00005293|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||December 1988||1988-12-01|April 2000|2000-04-01|November 1990|Actual|1990-11-01|||||Observational|||Antecedents of Bronchopulmonary Dysplasia||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.798814|2017-02-18 18:15:10.798814
NCT00005292|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-24|||September 1988||1988-09-01|August 2004|2004-08-01|November 1999||1999-11-01|||||Observational|||Alpha1-antitrypsin Deficiency Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.865952|2017-02-18 18:15:10.865952
NCT00005291|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1988||1988-07-01|June 2000|2000-06-01|April 2003|Actual|2003-04-01|||||Observational|||Clinical Epidemiology of Asthma in An HMO||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:10.948929|2017-02-18 18:15:10.948929
NCT00005290|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||April 1988||1988-04-01|January 2016|2016-01-01|June 1997||1997-06-01|||||Observational|||Epidemiology of Interstitial Lung Disease||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-02-18 18:15:11.018023|2017-02-18 18:15:11.018023
NCT00005289|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2008-07-23|||July 1987||1987-07-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Observational|||Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.084105|2017-02-18 18:15:11.084105
NCT00005288|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2017-01-13|||December 1986||1986-12-01|April 2001|2001-04-01|November 1991|Actual|1991-11-01|||||Observational|||Epidemiology and Pulmonary Response To Organic Dust Exposure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.16678|2017-02-18 18:15:11.16678
NCT00005287|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-08|||July 1986||1986-07-01|January 2016|2016-01-01|June 1989||1989-06-01|||||Observational|||Late Sequelae of Bronchopulmonary Dysplasia||Completed||N/A|||Stanford University|||||f||||||||||||||2017-02-18 18:15:11.249903|2017-02-18 18:15:11.249903
NCT00005286|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||April 1986||1986-04-01|January 2016|2016-01-01|March 1989||1989-03-01|||||Observational|||Epidemiology of Sleep Apnea Syndrome||Completed||N/A|||University of New Mexico|||||f||||||||||||||2017-02-18 18:15:11.315953|2017-02-18 18:15:11.315953
NCT00005285|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1985||1985-07-01|April 2001|2001-04-01|November 1996|Actual|1996-11-01|||||Observational|||Effect of Maternal Smoking On Neonatal Lung Function||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.385946|2017-02-18 18:15:11.385946
NCT00005284|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||January 1985||1985-01-01|August 2004|2004-08-01|March 2002|Actual|2002-03-01|||||Observational|||Epidemiology of Airway Responsiveness||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.464152|2017-02-18 18:15:11.464152
NCT00005283|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1983||1983-07-01|May 2000|2000-05-01|June 1990|Actual|1990-06-01|||||Observational|||Risk Factors For Asthma in Laboratory Animal Allergy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.54214|2017-02-18 18:15:11.54214
NCT00005282|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||December 1981||1981-12-01|April 2001|2001-04-01|November 1997|Actual|1997-11-01|||||Observational|||Prospective Evaluation of Airways Reactivity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.609087|2017-02-18 18:15:11.609087
NCT00005281|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1977||1977-09-01|April 2001|2001-04-01|November 1998|Actual|1998-11-01|||||Observational|||Early Risk Predictors For Chronic Pulmonary Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.688093|2017-02-18 18:15:11.688093
NCT00005280|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||June 1972||1972-06-01|March 2005|2005-03-01|November 1991|Actual|1991-11-01|||||Observational|||Specialized Center of Research in Occupational and Immunologic Lung Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.769437|2017-02-18 18:15:11.769437
NCT00005279|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||June 1971||1971-06-01|May 2002|2002-05-01|November 1997|Actual|1997-11-01|||||Observational|||Tucson Epidemiology Study of Chronic Obstructive Lung Diseases||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:11.996223|2017-02-18 18:15:11.996223
NCT00005278|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-14|||July 1989||1989-07-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Observational|||Retrovirus Epidemiology Donor Study I (REDS I)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:12.165493|2017-02-18 18:15:12.165493
NCT00005277|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1977||1977-09-01|August 2004|2004-08-01|December 2000||2000-12-01|||||Observational|||Cooperative Study of The Clinical Course of Sickle Cell Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:12.258276|2017-02-18 18:15:12.258276
NCT00005276|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-24|||June 1995||1995-06-01|December 2005|2005-12-01|March 2003||2003-03-01|||||Observational|||A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:12.336218|2017-02-18 18:15:12.336218
NCT00005275|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2013-05-19|||September 1994||1994-09-01|May 2013|2013-05-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Observational|SHHS||Sleep Heart Health Study (SHHS) Data Coordinating Center|The Sleep Heart Health Study (SHHS) Was a Multi-site Prospective Cohort Study to Investigate Obstructive Sleep Apnea (OSA) and Other Sleep-disordered Breathing (SDB) as Risk Factors for Cardiovascular Diseases and Hypertension|Completed||N/A|6441|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||f||||||||||2017-02-18 18:15:12.412314|2017-02-18 18:15:12.412314
NCT00005274|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-13|||May 1989||1989-05-01|October 2005|2005-10-01|March 2003||2003-03-01|||||Observational|||Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:12.524563|2017-02-18 18:15:12.524563
NCT00005273|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1987||1987-09-01|March 2005|2005-03-01|May 1997|Actual|1997-05-01|||||Observational|||Pulmonary Complications of HIV Infection Study (PACS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:15.608742|2017-02-18 18:15:15.608742
NCT00005272|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-26|||September 1990||1990-09-01|May 2000|2000-05-01|September 1992||1992-09-01|||||Observational|||Smoking and Body Weight: Analysis of HHANES||Completed||N/A|||University of Memphis|||||f||||||||||||||2017-02-18 18:15:15.699391|2017-02-18 18:15:15.699391
NCT00005271|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-11|||July 1995||1995-07-01|January 2016|2016-01-01|May 2015|Actual|2015-05-01|August 2009|Actual|2009-08-01||Observational|||INTERMAP: International Population Study on Macronutrients and BP|INTERMAP: International Population Study on Macronutrients and BP|Completed||N/A|4680|Actual|Northwestern University|||1||f||||f||||||Samples Without DNA|"~     24 hour urine collection among all participants~   "|||2017-02-18 18:15:15.770502|2017-02-18 18:15:15.770502
NCT00005270|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-09-01|||September 1995||1995-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Family Blood Pressure Program - SAPPHIRe Network||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:15.851285|2017-02-18 18:15:15.851285
NCT00005269|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2008-08-20|||September 1995||1995-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Family Blood Pressure Program - GENOA||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:15.926008|2017-02-18 18:15:15.926008
NCT00005268|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-08-05|||September 1995||1995-09-01|August 2008|2008-08-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Family Blood Pressure Program - GenNet Network||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:16.00708|2017-02-18 18:15:16.00708
NCT00005267|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-10-06|||September 1995||1995-09-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Family Blood Pressure Program - HyperGEN||Completed||N/A|3604|Actual|University of Alabama at Birmingham|||1||f||||||||||Samples With DNA|"~     Tissue suitable for DNA extraction~   "|||2017-02-18 18:15:16.091267|2017-02-18 18:15:16.091267
NCT00005266|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1990||1990-09-01|May 2000|2000-05-01|September 1992|Actual|1992-09-01|||||Observational|||Cardiovascular Disease Mortality in The NAS-NRC Twin Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:16.18523|2017-02-18 18:15:16.18523
NCT00005265|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1990||1990-09-01|November 2001|2001-11-01|May 1992|Actual|1992-05-01|||||Observational|||Natural History of Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:16.252604|2017-02-18 18:15:16.252604
NCT00005264|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1990||1990-09-01|October 2002|2002-10-01|September 1996|Actual|1996-09-01|||||Observational|||Pediatric Epidemiology of Cardiovascular Disease Risk Factors (Project Heartbeat)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:16.312921|2017-02-18 18:15:16.312921
NCT00005263|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-22|||July 1990||1990-07-01|December 2015|2015-12-01|November 1995|Actual|1995-11-01|November 1995|Actual|1995-11-01||Observational|||Postprandial Lipoproteins and Atherosclerosis|Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Newly Diagnosed Exercise-induced Myocardial Ischemia in Middle-aged Men and Women|Completed||N/A|205|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 18:15:16.461692|2017-02-18 18:15:16.461692
NCT00005262|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1990||1990-07-01|May 2000|2000-05-01|June 1996|Actual|1996-06-01|||||Observational|||Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:16.741578|2017-02-18 18:15:16.741578
NCT00005261|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-19|||July 1990||1990-07-01|January 2016|2016-01-01|June 1993||1993-06-01|||||Observational|||Urinary Kallikrein and Hypertension: A Prospective Study||Completed||N/A|||University of Utah|||||f||||||||||||||2017-02-18 18:15:16.81979|2017-02-18 18:15:16.81979
NCT00005260|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1990||1990-07-01|July 2005|2005-07-01|August 2002|Actual|2002-08-01|||||Observational|||Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:16.889987|2017-02-18 18:15:16.889987
NCT00005259|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-10-28|||July 1990||1990-07-01|October 2016|2016-10-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Observational|||Polyunsaturated Fats and Risk of Primary Cardiac Arrest||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:16.987082|2017-02-18 18:15:16.987082
NCT00005258|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||June 1990||1990-06-01|November 2001|2001-11-01|May 1993|Actual|1993-05-01|||||Observational|||Family Study of Congenital Cardiovascular Malformations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.06753|2017-02-18 18:15:17.06753
NCT00005257|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||May 1990||1990-05-01|March 2005|2005-03-01|April 1992|Actual|1992-04-01|||||Observational|||Diet and Plasma Cholesterol - Secular Trend Analysis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.14015|2017-02-18 18:15:17.14015
NCT00005256|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||May 1990||1990-05-01|April 2000|2000-04-01|August 1996|Actual|1996-08-01|||||Observational|||Coronary Screening in a High Risk Subset||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.213648|2017-02-18 18:15:17.213648
NCT00005255|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||May 1990||1990-05-01|May 2000|2000-05-01|April 1995|Actual|1995-04-01|||||Observational|||Ischemic Heart Disease Incidence and Indices of Body-fat Distribution||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.286885|2017-02-18 18:15:17.286885
NCT00005254|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||April 1990||1990-04-01|June 2000|2000-06-01|March 1995|Actual|1995-03-01|||||Observational|||Natural History of Peripheral Arterial Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:17.361403|2017-02-18 18:15:17.361403
NCT00005245|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-04|||June 1989||1989-06-01|February 2016|2016-02-01|May 1993|Actual|1993-05-01|May 1993|Actual|1993-05-01||Observational|||Community Structure and Cardiovascular Mortality Trends|Community Structure and Cardiovascular Mortality Trends|Completed||N/A|||University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 18:15:17.998971|2017-02-18 18:15:17.998971
NCT00005244|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||April 1989||1989-04-01|March 2005|2005-03-01|March 1991|Actual|1991-03-01|||||Observational|||Anger Expression, Self-focus and Coronary Heart Disease Risk Factors||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:18.077395|2017-02-18 18:15:18.077395
NCT00005243|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||April 1989||1989-04-01|December 2005|2005-12-01|August 2004|Actual|2004-08-01|||||Observational|||Triggers of Ventricular Arrhythmias (TOVA) Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:18.145428|2017-02-18 18:15:18.145428
NCT00005242|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||April 1989||1989-04-01|February 2016|2016-02-01|June 1994||1994-06-01|||||Observational|||Childhood Passive Smoking: Cohort Study of Cardiac Risk||Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-02-18 18:15:18.229398|2017-02-18 18:15:18.229398
NCT00005241|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1989||1989-04-01|June 2001|2001-06-01|December 1999|Actual|1999-12-01|||||Observational|||Myocardial Infarction and Current Oral Contraceptive Use||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:18.302305|2017-02-18 18:15:18.302305
NCT00005240|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-22|||October 1989||1989-10-01|December 2015|2015-12-01|December 1992|Actual|1992-12-01|June 1991|Actual|1991-06-01||Observational|||Epidemiology of Hypertensive Emergency|Correlates of Nonadherence to Hypertension Treatment in an Inner-City Minority Population|Completed||N/A|210|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 18:15:18.373319|2017-02-18 18:15:18.373319
NCT00005239|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||January 1989||1989-01-01|June 2004|2004-06-01|December 1991|Actual|1991-12-01|||||Observational|||Genetic Epidemiology of Coronary Heart Disease Risk in Women Twins||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:18.467464|2017-02-18 18:15:18.467464
NCT00005238|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-21|||December 1988||1988-12-01|December 2004|2004-12-01|December 2001||2001-12-01|||||Observational|||Antecedents of Hypertension: Role of Race and Stress||Completed||N/A|||Augusta University|||||f||||||||||||||2017-02-18 18:15:18.539714|2017-02-18 18:15:18.539714
NCT00005237|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||December 1988||1988-12-01|May 2000|2000-05-01|November 1993|Actual|1993-11-01|||||Observational|||Epidemiology of Symptomatic Arrhythmias||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:18.896087|2017-02-18 18:15:18.896087
NCT00005236|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||December 1988||1988-12-01|April 2000|2000-04-01|November 1994|Actual|1994-11-01|||||Observational|||Atherosclerosis and Omega-3 Fatty Acids in Alaskan Natives||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:18.968654|2017-02-18 18:15:18.968654
NCT00005235|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-22|||December 1988||1988-12-01|December 2015|2015-12-01|September 1993|Actual|1993-09-01|September 1993|Actual|1993-09-01||Observational|||Heart Rate Variability and Sudden Cardiac Death|The Ability of Several Short-term Measures of RR Variability to Predict Mortality After Myocardial Infarction|Completed||N/A|715|Actual|Columbia University|||1||f||||f||||||||||2017-02-18 18:15:19.036678|2017-02-18 18:15:19.036678
NCT00005234|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1988||1988-09-01|April 2000|2000-04-01|August 1993|Actual|1993-08-01|||||Observational|||Cardiovascular Disease in Black Versus White Physicians||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.130724|2017-02-18 18:15:19.130724
NCT00005233|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1988||1988-09-01|July 2002|2002-07-01|August 1992|Actual|1992-08-01|||||Observational|||Patterns of Fatty Acids in Framingham Offspring||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.197679|2017-02-18 18:15:19.197679
NCT00005232|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||August 1988||1988-08-01|June 2000|2000-06-01|July 1993|Actual|1993-07-01|||||Observational|||Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.259576|2017-02-18 18:15:19.259576
NCT00005231|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1988||1988-07-01|June 2000|2000-06-01|June 1991|Actual|1991-06-01|||||Observational|||Development, Testing, and Validation of A Protocol To Assess Cardiovascular Reactivity in Human Populations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.334253|2017-02-18 18:15:19.334253
NCT00005230|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1988||1988-07-01|December 2004|2004-12-01|June 2003|Actual|2003-06-01|||||Observational|||Epidemiology of Carotid Disease in Elderly Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.408191|2017-02-18 18:15:19.408191
NCT00005229|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1988||1988-07-01|December 2001|2001-12-01|June 1993|Actual|1993-06-01|||||Observational|||HIV-Associated Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.483745|2017-02-18 18:15:19.483745
NCT00005228|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1988||1988-07-01|December 2001|2001-12-01|June 1993|Actual|1993-06-01|||||Observational|||AIDS-Associated Heart Disease -- Incidence and Etiology||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.555046|2017-02-18 18:15:19.555046
NCT00005227|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1988||1988-07-01|March 2005|2005-03-01|June 1993|Actual|1993-06-01|||||Observational|||AIDS-Associated Cardiomyopathy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.632599|2017-02-18 18:15:19.632599
NCT00005226|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-24|||July 1988||1988-07-01|February 2016|2016-02-01|June 1992||1992-06-01|||||Observational|||Epidemiology of Plasma Fatty Acids and Atherosclerosis||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:15:19.71064|2017-02-18 18:15:19.71064
NCT00005225|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-19|||April 1988||1988-04-01|January 2016|2016-01-01|March 1991||1991-03-01|||||Observational|||Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease||Completed||N/A|||University of Utah|||||f||||||||||||||2017-02-18 18:15:19.778711|2017-02-18 18:15:19.778711
NCT00005224|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||April 1988||1988-04-01|March 2005|2005-03-01|March 1990|Actual|1990-03-01|||||Observational|||Gender Response To Coronary Risk||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.856507|2017-02-18 18:15:19.856507
NCT00005223|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1988||1988-04-01|April 2001|2001-04-01|March 1993|Actual|1993-03-01|||||Observational|||Epidemiology of APO- and Lipoproteins in Elderly Women||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:19.927585|2017-02-18 18:15:19.927585
NCT00005211|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-11|||October 1987||1987-10-01|November 2001|2001-11-01|September 1990|Actual|1990-09-01|||||Observational|||Cardiovascular Mortality Among Tunnel and Bridge Workers Exposed To Carbon Monoxide||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:20.902712|2017-02-18 18:15:20.902712
NCT00005210|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||September 1987||1987-09-01|June 2000|2000-06-01|September 1992|Actual|1992-09-01|||||Observational|||Sex Steroids, Obesity and Lipids in Adolescent Females||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:20.975085|2017-02-18 18:15:20.975085
NCT00005209|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||August 1987||1987-08-01|January 2008|2008-01-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Observational|||Genetic Epidemiology of Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:21.045492|2017-02-18 18:15:21.045492
NCT00005208|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||September 1987||1987-09-01|May 2000|2000-05-01|July 1992|Actual|1992-07-01|||||Observational|||Regulation of Placental Vascular Reactivity in Pregnancy-induced Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:21.127324|2017-02-18 18:15:21.127324
NCT00005207|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1987||1987-09-01|May 2000|2000-05-01|July 1992|Actual|1992-07-01|||||Observational|||Renin and Prorenin in Pregnancy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:21.200058|2017-02-18 18:15:21.200058
NCT00005206|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1987||1987-09-01|April 2002|2002-04-01|August 1991|Actual|1991-08-01|||||Observational|||Calcium Intake, Metabolism, and Gestational Blood Pressure||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:21.275431|2017-02-18 18:15:21.275431
NCT00005205|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-07|||August 1987||1987-08-01|March 2016|2016-03-01|July 2003||2003-07-01|||||Observational|||Incidence of Diabetes and Cardiovascular Disease in Mexican Americans|Incidence of Diabetes and Cardiovascular Disease in Mexican Americans|Completed||N/A|||The University of Texas Health Science Center at San Antonio|||||f||||f||||||||No||2017-02-18 18:15:21.346337|2017-02-18 18:15:21.346337
NCT00005204|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||August 1987||1987-08-01|November 2001|2001-11-01|July 1989|Actual|1989-07-01|||||Observational|||Blood Pressure and Diurnal Variation in Sodium, Potassium, and Water Excretion||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:21.454523|2017-02-18 18:15:21.454523
NCT00005203|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-08|||July 1987||1987-07-01|August 2004|2004-08-01|June 1992||1992-06-01|||||Observational|||Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia||Completed||N/A|||University of Washington|||||f||||||||||||||2017-02-18 18:15:21.516259|2017-02-18 18:15:21.516259
NCT00005202|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1987||1987-07-01|May 2000|2000-05-01|June 1992|Actual|1992-06-01|||||Observational|||Identifying High Risk Patients With Syncope||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:21.594735|2017-02-18 18:15:21.594735
NCT00005201|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1987||1987-07-01|May 2000|2000-05-01|June 1992|Actual|1992-06-01|||||Observational|||Idiopathic Dilated Cardiomyopathy||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:21.677785|2017-02-18 18:15:21.677785
NCT00005200|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1987||1987-07-01|April 2000|2000-04-01|June 1991|Actual|1991-06-01|||||Observational|||Adolescent Blood Pressure Variation and Ventricular Mass||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:21.745559|2017-02-18 18:15:21.745559
NCT00005199|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||June 1987||1987-06-01|May 2000|2000-05-01|November 1994||1994-11-01|||||Observational|||Balloon Valvuloplasty Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.098613|2017-02-18 18:15:22.098613
NCT00005198|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1987||1987-04-01|August 2001|2001-08-01|March 1998|Actual|1998-03-01|||||Observational|||Survival After Myocardial Infarction in A Biethnic Texas Community (Corpus Christi Heart Project)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.175028|2017-02-18 18:15:22.175028
NCT00005197|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||December 1986||1986-12-01|May 2000|2000-05-01|November 1991|Actual|1991-11-01|||||Observational|||Predictors of Perioperative Cardiac Morbidity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.247359|2017-02-18 18:15:22.247359
NCT00005196|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||December 1986||1986-12-01|May 2009|2009-05-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Observational|||Worcester Heart Attack Community Surveillance Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.332066|2017-02-18 18:15:22.332066
NCT00005195|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||September 1986||1986-09-01|September 2002|2002-09-01|August 1991|Actual|1991-08-01|||||Observational|||Catheter Ablation Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.432756|2017-02-18 18:15:22.432756
NCT00005194|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1986||1986-09-01|June 2000|2000-06-01|August 1991|Actual|1991-08-01|||||Observational|||Insulin and Biogenic Amines in Cardiovascular Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.513592|2017-02-18 18:15:22.513592
NCT00005193|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1986||1986-09-01|September 2002|2002-09-01|August 1990|Actual|1990-08-01|||||Observational|||Prospective Study of Diabetes-related Vascular Disease in Oklahoma Indians||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.587933|2017-02-18 18:15:22.587933
NCT00005192|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-14|||July 1986||1986-07-01|January 2016|2016-01-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Psychophysiology of Cardiovascular Reactivity||Completed||N/A|||University of Miami|||||f||||||||||||||2017-02-18 18:15:22.657892|2017-02-18 18:15:22.657892
NCT00005191|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1986||1986-07-01|April 2002|2002-04-01|March 2001|Actual|2001-03-01|||||Observational|||Clinical Course of Coronary Artery Disease Among Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.750168|2017-02-18 18:15:22.750168
NCT00005190|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1986||1986-07-01|October 2001|2001-10-01|December 1998|Actual|1998-12-01|||||Observational|||Reproduction and Survival After Cardiac Defect Repair||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.826919|2017-02-18 18:15:22.826919
NCT00005189|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1986||1986-07-01|November 2002|2002-11-01|April 1999|Actual|1999-04-01|||||Observational|||Carotid Atherosclerosis Follow-up Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.904049|2017-02-18 18:15:22.904049
NCT00005188|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||July 1986||1986-07-01|August 2004|2004-08-01|June 1991|Actual|1991-06-01|||||Observational|||Quantitative Genetic Analysis of Lipid Research Clinic Family Data||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:22.978872|2017-02-18 18:15:22.978872
NCT00005182|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-03-30|||December 1985||1985-12-01|March 2013|2013-03-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||Health Professionals Follow-up Study||Completed||N/A|50000|Actual|Harvard School of Public Health|||1||f||||||||||Samples With DNA|"~     plasma, RBC, WBC~   "|||2017-02-18 18:15:23.445085|2017-02-18 18:15:23.445085
NCT00005181|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-02-24|||July 2000||2000-07-01|February 2014|2014-02-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Observational|||Blood Pressure Control in Juveniles - Longitudinal Study||Completed||N/A|||Indiana University|||||f||||||||||||||2017-02-18 18:15:23.577499|2017-02-18 18:15:23.577499
NCT00005180|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1985||1985-09-01|May 2000|2000-05-01|June 1995|Actual|1995-06-01|||||Observational|||End-organ Pathology in Childhood Essential Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:23.664285|2017-02-18 18:15:23.664285
NCT00005179|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-21|||September 1985||1985-09-01|April 2000|2000-04-01|June 1990||1990-06-01|||||Observational|||Diet, Exercise and Cardiovascular Health Among Ethnic Children||Completed||N/A|||Augusta University|||||f||||||||||||||2017-02-18 18:15:23.732245|2017-02-18 18:15:23.732245
NCT00005178|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-12-21|||September 1985||1985-09-01|December 2000|2000-12-01|August 1991||1991-08-01|||||Observational|||Study of Children's Activity and Nutrition (SCAN)||Completed||N/A|||Augusta University|||||f||||||||||||||2017-02-18 18:15:23.806532|2017-02-18 18:15:23.806532
NCT00005177|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1985||1985-09-01|June 2000|2000-06-01|November 1996|Actual|1996-11-01|||||Observational|||Reno Diet Heart Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:23.902524|2017-02-18 18:15:23.902524
NCT00005176|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-10-20|||August 1985||1985-08-01|October 2015|2015-10-01|April 2013|Actual|2013-04-01|April 2013|Actual|2013-04-01||Observational|LQTS||Long QT Syndrome-Population Genetics and Cardiac Studies|Long QT Syndrome-Population Genetics and Cardiac Studies|Completed||N/A|2125|Actual|University of Rochester|||1||f||||f||||||Samples With DNA|"~     DNA~   "|||2017-02-18 18:15:23.975761|2017-02-18 18:15:23.975761
NCT00005175|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1985||1985-07-01|May 2000|2000-05-01|June 1990|Actual|1990-06-01|||||Observational|||Coronary Heart Disease Risk Factors in Upwardly Mobile Blacks and Whites||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.095997|2017-02-18 18:15:24.095997
NCT00005174|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1985||1985-07-01|July 2000|2000-07-01|June 1990|Actual|1990-06-01|||||Observational|||Western Collaborative Group Study (WCGS): 25-Year Follow-up of Cardiovascular Disease Morbidity and Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.162876|2017-02-18 18:15:24.162876
NCT00005173|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1985||1985-04-01|July 2000|2000-07-01|April 1989|Actual|1989-04-01|||||Observational|||Myocardial Infarction and Past Oral Contraceptive Use||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.233552|2017-02-18 18:15:24.233552
NCT00005172|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||December 1984||1984-12-01|August 2004|2004-08-01|April 1997|Actual|1997-04-01|||||Observational|||Socioeconomic Status, John Henryism and Hypertension Risk in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.307161|2017-02-18 18:15:24.307161
NCT00005171|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||December 1984||1984-12-01|June 2000|2000-06-01|March 1993|Actual|1993-03-01|||||Observational|||Cardiovascular Risk Factors in United States Adolescents and Adults||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.378444|2017-02-18 18:15:24.378444
NCT00005170|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||December 1984||1984-12-01|April 2000|2000-04-01|February 1993|Actual|1993-02-01|||||Observational|||Ambulatory Blood Pressure and Behavior||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.450483|2017-02-18 18:15:24.450483
NCT00005169|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||September 1984||1984-09-01|October 2002|2002-10-01|June 2000||2000-06-01|||||Observational|||Lifestyle and Chronic Disease in College Alumni (Harvard Alumni Health Study)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.536916|2017-02-18 18:15:24.536916
NCT00005168|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||August 1984||1984-08-01|May 2000|2000-05-01|December 1991|Actual|1991-12-01|||||Observational|||Hyperapo B and Coronary Heart Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.6251|2017-02-18 18:15:24.6251
NCT00005167|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||July 1984||1984-07-01|April 2000|2000-04-01|December 1991|Actual|1991-12-01|||||Observational|||Diet Modification and Blood Pressure in Young People||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.695768|2017-02-18 18:15:24.695768
NCT00005166|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||April 1984||1984-04-01|May 2000|2000-05-01|March 1996|Actual|1996-03-01|||||Observational|||Sodium Transport: Genetics and Hypertension||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.764589|2017-02-18 18:15:24.764589
NCT00005165|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||January 1984||1984-01-01|April 2000|2000-04-01|March 1995|Actual|1995-03-01|||||Observational|||Charleston Heart Study - Predictors of Coronary Disease in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.844525|2017-02-18 18:15:24.844525
NCT00005164|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1983||1983-09-01|June 2000|2000-06-01|August 1991|Actual|1991-08-01|||||Observational|||Insulin Resistance and Blood Pressure Regulation in Blacks||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:24.921633|2017-02-18 18:15:24.921633
NCT00005163|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1983||1983-09-01|May 2000|2000-05-01|May 1989|Actual|1989-05-01|||||Observational|||Validation and Field Test for Risk Appraisal Instruments||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:25.004309|2017-02-18 18:15:25.004309
NCT00005162|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||August 1983||1983-08-01|May 2000|2000-05-01|November 1996|Actual|1996-11-01|||||Observational|||Epidemiology of Decline in Heart Disease Mortality||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:25.082122|2017-02-18 18:15:25.082122
NCT00005161|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-04|||August 1983||1983-08-01|March 2016|2016-03-01|July 1993||1993-07-01|||||Observational|||Longitudinal Twin Study - Cohort Study of Blood Pressure||Completed||N/A|||Virginia Commonwealth University|||||f||||||||||||||2017-02-18 18:15:25.160119|2017-02-18 18:15:25.160119
NCT00005160|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-12|||April 1983||1983-04-01|January 2016|2016-01-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Observational|||Epidemiology of Cardiovascular Risk Factors in Women (Healthy Women Study)|Epidemiology of Cardiovascular Risk Factors in Women (Healthy Women Study)|Completed||N/A|532|Actual|University of Pittsburgh|||1||f||||t||||||Samples Without DNA|"~     Plasma and serum samples from baseline and follow up exams stored at -80 degrees Celsius in~     the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh.~   "|||2017-02-18 18:15:25.23803|2017-02-18 18:15:25.23803
NCT00005154|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2009-04-13|||July 1981||1981-07-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||National Health and Nutrition Examination Survey IV (NHANES (IV)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:25.995923|2017-02-18 18:15:25.995923
NCT00005153|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||December 1980||1980-12-01|October 2001|2001-10-01|November 1998|Actual|1998-11-01|||||Observational|||Etiologic Risk Factors of Cardiovascular Malformations||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:26.073727|2017-02-18 18:15:26.073727
NCT00005152|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-07|||August 1980||1980-08-01|January 2016|2016-01-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Observational|||Nurses' Health Study (Cardiovascular Component)|Nurses' Health Study (Cardiovascular Component)|Completed||N/A|121700|Actual|Brigham and Women's Hospital|||1||f||||f||||||||||2017-02-18 18:15:26.156118|2017-02-18 18:15:26.156118
NCT00005151|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||August 1980||1980-08-01|July 2000|2000-07-01|July 1997|Actual|1997-07-01|||||Observational|||Pawtucket Heart Health Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:26.283505|2017-02-18 18:15:26.283505
NCT00005150|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-24|||July 1980||1980-07-01|February 2016|2016-02-01|June 1993||1993-06-01|||||Observational|||Minnesota Heart Health Program||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:15:26.382068|2017-02-18 18:15:26.382068
NCT00005149|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-19|||February 1980||1980-02-01|January 2016|2016-01-01|November 1992||1992-11-01|||||Observational|||Genetic and Environmental Determinants of Hypertension||Completed||N/A|||University of Utah|||||f||||||||||||||2017-02-18 18:15:26.495501|2017-02-18 18:15:26.495501
NCT00005148|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1979||1979-09-01|April 2000|2000-04-01|August 1991|Actual|1991-08-01|||||Observational|||Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:26.583427|2017-02-18 18:15:26.583427
NCT00005147|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1979||1979-09-01|April 2000|2000-04-01|June 1991|Actual|1991-06-01|||||Observational|||Epidemiology of Atherosclerosis||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:26.676046|2017-02-18 18:15:26.676046
NCT00005146|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-07|||May 1979||1979-05-01|March 2016|2016-03-01|August 2002|Actual|2002-08-01|||||Observational|||Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)|Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)|Completed||N/A|||The University of Texas Health Science Center at San Antonio|||||f||||f||||||||No||2017-02-18 18:15:26.764004|2017-02-18 18:15:26.764004
NCT00005145|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-03|||April 1979||1979-04-01|February 2016|2016-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Observational|MHS||Minnesota Heart Survey - Risk Factor Survey|Study of Trends in Cardiovascular Risk Factors in an Urban Population.|Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||1||f||||||||||||||2017-02-18 18:15:26.90061|2017-02-18 18:15:26.90061
NCT00005144|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||August 1978||1978-08-01|April 2000|2000-04-01|June 1991|Actual|1991-06-01|||||Observational|||Coronary-Prone Behavior and Cardiovascular Reactivity||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:27.031409|2017-02-18 18:15:27.031409
NCT00005143|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2005-06-23|||July 1978||1978-07-01|March 2005|2005-03-01|February 1998||1998-02-01|||||Observational|||Stanford Five-City Multifactor Risk Reduction Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:27.119537|2017-02-18 18:15:27.119537
NCT00005142|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-26|||July 1978||1978-07-01|June 2000|2000-06-01|March 1990|Actual|1990-03-01|||||Observational|||Etiology and Prevalence of Peripheral Arterial Disease||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:27.21617|2017-02-18 18:15:27.21617
NCT00005141|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||September 1977||1977-09-01|June 2000|2000-06-01|May 1997|Actual|1997-05-01|||||Observational|||Minneapolis Children's Blood Pressure Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:27.290055|2017-02-18 18:15:27.290055
NCT00005140|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-02-17|||September 1977||1977-09-01|January 2008|2008-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Observational|||Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:27.370832|2017-02-18 18:15:27.370832
NCT00005139|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-01-19|||July 1977||1977-07-01|January 2016|2016-01-01|December 1991||1991-12-01|||||Observational|||Characterization Of Coronary Prone Pedigrees||Completed||N/A|||University of Utah|||||f||||||||||||||2017-02-18 18:15:27.481361|2017-02-18 18:15:27.481361
NCT00005138|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||June 1976||1976-06-01|May 2000|2000-05-01|June 1989|Actual|1989-06-01|||||Observational|||High Blood Pressure in the Young||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:27.566578|2017-02-18 18:15:27.566578
NCT00005137|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-05-27|||July 1992||1992-07-01|May 2014|2014-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|HERITAGE||Heritage Study--Genetics, Exercise and Risk Factors|Health, Risk Factors, Exercise Training, and Genetics|Completed||N/A|||Washington University School of Medicine|||||f||||||||||||||2017-02-18 18:15:27.645637|2017-02-18 18:15:27.645637
NCT00005136|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2014-03-14|||June 1992||1992-06-01|March 2014|2014-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Observational|||Family Heart Study (FHS)||Completed||N/A|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:15:27.783634|2017-02-18 18:15:27.783634
NCT00005135|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-08-05|||September 1991||1991-09-01|April 2009|2009-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Observational|||Insulin Resistance Atherosclerosis Study (IRAS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:27.893208|2017-02-18 18:15:27.893208
NCT00005134|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-28|||September 1988||1988-09-01|May 2009|2009-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Observational|||Strong Heart Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:28.002328|2017-02-18 18:15:28.002328
NCT00005133|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-10-24|||June 1988||1988-06-01|May 2009|2009-05-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Observational|||Cardiovascular Health Study (CHS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:28.077293|2017-02-18 18:15:28.077293
NCT00005132|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-13|||September 1985||1985-09-01|January 2006|2006-01-01|March 2000||2000-03-01|||||Observational|||National Growth and Health Study (NGHS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:28.154355|2017-02-18 18:15:28.154355
NCT00005130|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-12|||January 1984||1984-01-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Coronary Artery Risk Development in Young Adults (CARDIA)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||1||f||||||||||||||2017-02-18 18:15:28.341433|2017-02-18 18:15:28.341433
NCT00005129|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-12-05|||June 1972||1972-06-01|December 2016|2016-12-01|November 2019|Anticipated|2019-11-01|November 2019|Anticipated|2019-11-01||Observational|||Bogalusa Heart Study||Active, not recruiting||N/A|12000|Actual|Tulane University|||1||f||||f||||||Samples With DNA|"~     Blood samples collected at screening for biochemical cardiovascular risk factors, as well as~     genomic and DNA methylation analyses.~   "|Yes|Biolink|2017-02-18 18:15:28.427886|2017-02-18 18:15:28.427886
NCT00005128|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-13|||July 1972||1972-07-01|April 2004|2004-04-01|December 1994||1994-12-01|||||Observational|||Lipid Research Clinics Population Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:28.686824|2017-02-18 18:15:28.686824
NCT00005127|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-05-12|||June 1971||1971-06-01|July 2000|2000-07-01|November 1991|Actual|1991-11-01|||||Observational|||Muscatine Heart Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:29.067789|2017-02-18 18:15:29.067789
NCT00005126|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-07-11|||April 1989||1989-04-01|May 2000|2000-05-01|March 1991|Actual|1991-03-01|||||Observational|||Vietnam Era Twin (VET) Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:29.186157|2017-02-18 18:15:29.186157
NCT00005125|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2015-06-02|||July 1970||1970-07-01|June 2001|2001-06-01|September 1988||1988-09-01|||||Observational|||NAS-NRC Twin Registry||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:29.26594|2017-02-18 18:15:29.26594
NCT00005124|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1969||1969-07-01|May 2000|2000-05-01|November 1998|Actual|1998-11-01|||||Observational|||National Heart, Lung, and Blood Institute Twin Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:29.37756|2017-02-18 18:15:29.37756
NCT00005123|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-13|||July 1965||1965-07-01|September 2004|2004-09-01|September 2002||2002-09-01|||||Observational|||Honolulu Heart Program||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:29.464443|2017-02-18 18:15:29.464443
NCT00005122|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-03-15|||July 1958||1958-07-01|June 2000|2000-06-01|August 1995|Actual|1995-08-01|||||Observational|||Evans County Studies||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:29.64213|2017-02-18 18:15:29.64213
NCT00005121|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-25|2016-04-13|||July 1948||1948-07-01|April 2009|2009-04-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Observational|||Framingham Heart Study||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:15:29.786531|2017-02-18 18:15:29.786531
NCT00005120|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-20|2005-06-23|||April 2000||2000-04-01|June 2001|2001-06-01||||||||Interventional|||The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|A Phase IB Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV-Positive Patients With No Previous Antiretroviral Therapy|Unknown status|Active, not recruiting|Phase 1|16||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:29.856315|2017-02-18 18:15:29.856315
NCT00005119|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-19|2010-03-01|||May 2000||2000-05-01|March 2010|2010-03-01|October 2003||2003-10-01|||||Interventional|||Altered Calcium and Vitamin D in PMDD or Severe PMS|Altered Calcium And Vitamin D Metabolism in PMDD|Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:15:29.961863|2017-02-18 18:15:29.961863
NCT00005118|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-07|2005-06-23||||||July 2001|2001-07-01||||||||Interventional|||The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment|A Multicenter, Open-Label, 24-Week Study to Evaluate the Efficacy and Safety of Indinavir Sulfate 800 Mg and Ritonavir 200 Mg b.i.d. Plus 2 NRTIs b.i.d. in HIV-1 Infected Individuals Who Require Early Treatment Intervention|Unknown status|Active, not recruiting|Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:30.060953|2017-02-18 18:15:30.060953
NCT00005117|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-18|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Effect of Pravastatin on Endothelial Dysfunction Following a Single High Fat Meal||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:30.228288|2017-02-18 18:15:30.228288
NCT00005116|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-13|2010-03-01||||||March 2010|2010-03-01||||||||Interventional|||Depression In Juvenile Diabetics||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:15:30.311188|2017-02-18 18:15:30.311188
NCT00005113|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-14|2012-03-12|||July 1999||1999-07-01|March 2012|2012-03-01|March 2006|Actual|2006-03-01|July 2004|Actual|2004-07-01||Interventional|||A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant|An Open-Label, Comparative Study of the Effect of Sirolimus Versus Standard Treatment on Clinical Outcomes and Histologic Progression of Allograft Nephropathy in High Risk Pediatric Renal Transplant Patients|Terminated||Phase 3|102|Actual|Boston Children’s Hospital||2||Inability to meet the accrual target of 213.|f||||t||||||||||2017-02-18 18:15:30.391853|2017-02-18 18:15:30.391853
NCT00005112|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-15|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Growth Hormone Use in Cystic Fibrosis - a Multicenter Study||Completed||Phase 3|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:30.515197|2017-02-18 18:15:30.515197
NCT00005111|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-13|2008-03-03|||April 2000||2000-04-01|March 2000|2000-03-01|March 2001||2001-03-01|||||Observational|||PET Scans in Normal Volunteers and Patients With Fabry Disease|(18)Fluorodeoxyglucose Positron Emission Tomography in Patients With Fabry Disease|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:30.607218|2017-02-18 18:15:30.607218
NCT00005110|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-13|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis||Suspended||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:30.689473|2017-02-18 18:15:30.689473
NCT00005108|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-11|2008-03-03|||April 2000||2000-04-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls|Effects of Hormone Therapy on Vascular Inflammation and Compliance|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:30.772081|2017-02-18 18:15:30.772081
NCT00005107|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-11|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia||Unknown status|Recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:30.872342|2017-02-18 18:15:30.872342
NCT00005106|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2005-06-23|||September 1999||1999-09-01|November 2000|2000-11-01||||||||Interventional|||A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients|A 96-Week, Randomized, Open-Label, Multicenter Trial to Evaluate the Safety and Tolerability of the Antiretroviral Activity of Stavudine (40mg BID) Plus Lamivudine (150mg BID) Plus Nelfinavir (1250mg BID) Versus Abacavir (300mg BID) Plus Combivir (3TC 150mg/ZDV 300mg BID) Versus Combivir (3TC 150mg/ZDV 300mg BID) Plus Nelfinavir (1250mg BID) in HIV-1 Infected Subjects|Completed||Phase 4|230||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:30.957744|2017-02-18 18:15:30.957744
NCT00005105|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2005-06-23|||January 1997||1997-01-01|December 2003|2003-12-01||||||||Observational|||Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation||Unknown status|Recruiting|N/A|75||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:31.08094|2017-02-18 18:15:31.08094
NCT00005104|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2005-06-23|||January 2000||2000-01-01|December 2003|2003-12-01||||||||Interventional|||Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome||Completed||N/A|99||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:31.162992|2017-02-18 18:15:31.162992
NCT00005103|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2005-06-23|||November 2000||2000-11-01|December 2003|2003-12-01||||||||Observational|||Study of the Pathogenesis of Porphyria Cutanea Tarda||Completed||N/A|120||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:31.251557|2017-02-18 18:15:31.251557
NCT00005102|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2005-06-23|||January 1995||1995-01-01|December 2003|2003-12-01||||||||Observational|||Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome|Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome|Unknown status|Recruiting|N/A|11||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:31.324193|2017-02-18 18:15:31.324193
NCT00005101|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2005-06-23|||February 1998||1998-02-01|December 2003|2003-12-01||||||||Observational|||Study of Low Bone Mass in Premenopausal or Perimenopausal Women||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:31.401685|2017-02-18 18:15:31.401685
NCT00005100|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2005-06-23|||September 1999||1999-09-01|December 2003|2003-12-01||||||||Observational|||Measurement of Outcome of Surgical Treatment in Patients With Acromegaly||Unknown status|Recruiting|N/A|165||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:31.478228|2017-02-18 18:15:31.478228
NCT00005098|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2005-06-23|||March 1999||1999-03-01|May 2002|2002-05-01||||||||Observational|||Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency||Terminated||N/A|160||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:15:31.55549|2017-02-18 18:15:31.55549
NCT00005097|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-04-17|||August 1999||1999-08-01|April 2014|2014-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Green Tea Extract in Treating Patients With Actinic Keratosis|A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Polyphenon E Against Various Endpoints of Actinic Keratosis Pathobiology|Terminated||Phase 2|88|Actual|University of California, Irvine||1||terminated due to the low conditional power for a positive study|f||||t||||||||||2017-02-18 18:15:31.645635|2017-02-18 18:15:31.645635
NCT00005096|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2008-07-23|||December 1999||1999-12-01|January 2002|2002-01-01||||||||Interventional|||Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer|Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:31.75513|2017-02-18 18:15:31.75513
NCT00005095|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2016-09-29|||March 2000||2000-03-01|September 2016|2016-09-01||||December 2020|Anticipated|2020-12-01||Observational|||Specimen and Data Study for Ovarian Cancer Early Detection and Prevention|Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study|Recruiting||N/A|6000|Anticipated|Northwestern University|||1||f||||t||||||Samples With DNA|"~     Subjects blood and other specimens are collected their follow-up clinic appointments.~   "|||2017-02-18 18:15:31.921255|2017-02-18 18:15:31.921255
NCT00005094|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-04-11|||March 2000||2000-03-01|April 2013|2013-04-01||||April 2006|Actual|2006-04-01||Interventional|||Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps|Prevention of Sporadic Colorectal Adenomas With Celecoxib|Completed||Phase 3|1170|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:15:32.04022|2017-02-18 18:15:32.04022
NCT00005093|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-08-08|||December 1999||1999-12-01|August 2012|2012-08-01|May 2001|Actual|2001-05-01|||||Interventional|||Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer|A Randomized Double-Blind, Placebo-Controlled, Multicenter Study of CI-994 Capsules Plus Gemcitabine Infusion Versus Placebo Capsules Plus Gemcitabine Infusion as Second-Line Treatment of Patients With Advanced Nonsmall Cell Lung Cancer|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 18:15:32.156067|2017-02-18 18:15:32.156067
NCT00005092|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-07-27|||March 1999||1999-03-01|July 2012|2012-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|A Phase I Study of Photochemically Treated Donor T-Cell Supplements in HLA Haplotype Mismatched Hematopoietic Stem Cell Transplantation|Completed||Phase 1|7|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:15:32.272312|2017-02-18 18:15:32.272312
NCT00005091|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-07-09|||February 1999||1999-02-01|January 2008|2008-01-01|August 2003|Actual|2003-08-01|||||Interventional|||DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Stage IIIb or Stage IV Non-Small Cell Lung Cancer as First Line Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:32.421696|2017-02-18 18:15:32.421696
NCT00005090|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-01-22|||April 2000||2000-04-01|January 2013|2013-01-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease|A Randomized Phase III Trial Comparing Early High Dose Chemotherapy and an Autologous Stem Cell Transplant to Conventional Dose ABVD Chemotherapy for Patients With Advanced Stage Poor Prognosis Hodgkin's Disease as Defined by the International Prognostic Factors Project on Advanced Hodgkin's Disease|Terminated||Phase 3|11|Actual|Southwest Oncology Group||2||poor accrual|f||||t||||||||||2017-02-18 18:15:32.530204|2017-02-18 18:15:32.530204
NCT00005010|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-28|2013-01-23||||||January 2013|2013-01-01|March 2004|Actual|2004-03-01|||||Interventional|||Prevention of Kidney Transplant Rejection|An Interventional Trial in Established Chronic Renal Allograft Rejection|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||t||||||||||2017-02-18 18:15:49.844922|2017-02-18 18:15:49.844922
NCT00005089|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2017-01-12|||April 2000||2000-04-01|January 2017|2017-01-01|April 2014|Actual|2014-04-01|November 2004|Actual|2004-11-01||Interventional|||S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma|Evaluation of CHOP Plus Rituximab Plus Involved Field Radiotherapy for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High-Risk Localized Aggressive Histologies of Non-Hodgkin's Lymphoma|Completed||Phase 2|71|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:15:35.680036|2017-02-18 18:15:35.680036
NCT00005088|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-11-18|||April 2000||2000-04-01|November 2013|2013-11-01||||January 2002|Actual|2002-01-01||Interventional|||Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer|A Phase II Trial of Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:15:35.888927|2017-02-18 18:15:35.888927
NCT00005087|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2015-11-14|||March 2000||2000-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|November 2004|Actual|2004-11-01||Interventional|||Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer|Phase II Study of Paclitaxel and Cisplatin in Combination With Split Course Concomitant Hyperfractionated Re-Irradiation in Patients With Recurrent Squamous Cell Cancer of the Head and Neck|Completed||Phase 2|105|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:15:36.531345|2017-02-18 18:15:36.531345
NCT00005086|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-09-04|||August 1999||1999-08-01|September 2013|2013-09-01|April 2005|Actual|2005-04-01|August 2002|Actual|2002-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer|"A Phase II Trial of Sequential Doublets Chemotherapy in Patients With Locally Advanced or Metastatic Bladder Cancer"|Completed||Phase 2|6|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:15:37.182872|2017-02-18 18:15:37.182872
NCT00005085|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-02-08|||February 2000||2000-02-01|December 2002|2002-12-01||||June 2002|Actual|2002-06-01||Interventional|||Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer|A Phase II Study of Rebeccamycin Analogue NSC 655649 in Patients With Metastatic Colorectal Cancer (IMT Codes 23988, 23989, 23993)|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:15:37.296168|2017-02-18 18:15:37.296168
NCT00005084|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-12-17|||February 1999||1999-02-01|February 2008|2008-02-01||||||||Interventional|||Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma|Pediatric Low Grade Astrocytoma: Treatment Guidance|Unknown status|Active, not recruiting|Phase 2|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:37.405673|2017-02-18 18:15:37.405673
NCT00005083|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-10-02|||March 1998||1998-03-01|October 2012|2012-10-01||||||||Interventional|||Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors|Defining Functional Tissue in Brain Tumors With Integrated Neuroimaging (Pilot Study)|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||||no participants enrolled|f||||||||||||||2017-02-18 18:15:37.499209|2017-02-18 18:15:37.499209
NCT00005082|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-01-07|||November 1998||1998-11-01|January 2013|2013-01-01||||November 2000|Actual|2000-11-01||Interventional|||Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma|Magnetic Resonance Correlates of Glioma Tumor Burden|Completed||N/A|1|Actual|Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:15:37.577352|2017-02-18 18:15:37.577352
NCT00005081|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-08-20|||August 2000||2000-08-01|February 2013|2013-02-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma|Phase II Trial of BCNU Plus O6-Benzylguanine in the Treatment of Patients With Recurrent or Progressive Cerebral Anaplastic Gliomas|Completed||Phase 2|||Duke University|||||f||||||||||||||2017-02-18 18:15:37.66503|2017-02-18 18:15:37.66503
NCT00005080|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-01-15|||May 2000||2000-05-01|January 2013|2013-01-01||||January 2006|Actual|2006-01-01||Interventional|||506U78 in Treating Patients With Lymphoma|A Phase II Study of 506U78 in Patients With Previously Systemically Untreated Cutaneous T-cell Lymphoma (CTCL) or With Refractory or Relapsed Non-cutaneous Peripheral T-cell Lymphoma (PTCL)|Completed||Phase 2|74|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:15:37.757553|2017-02-18 18:15:37.757553
NCT00005079|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-05-14|||January 1999||1999-01-01|April 2003|2003-04-01|October 2004|Actual|2004-10-01|||||Interventional|||Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer|Timing of Breast Cancer Surgery, Menstrual Cycle and Prognosis|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:37.859692|2017-02-18 18:15:37.859692
NCT00005078|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2015-06-03|||March 2000||2000-03-01|June 2015|2015-06-01|July 2012|Actual|2012-07-01|July 2012|Actual|2012-07-01||Interventional|||Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors|Phase I Dose Escalation Study of Tirapazamine (NSC 130181) in Combination With Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors|Completed||Phase 1|44|Actual|City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:15:37.943705|2017-02-18 18:15:37.943705
NCT00005077|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2010-01-04|||February 2000||2000-02-01|January 2010|2010-01-01||||||||Interventional|||Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction|Phase I Study of Oxaliplatin in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction (Summary Last Modified 04/2000)|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:15:38.036723|2017-02-18 18:15:38.036723
NCT00005076|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-04-10|||October 1999||1999-10-01|April 2013|2013-04-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer|Phase II Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody Cetuximab in Combination With Chemotherapy in Patients With Advanced Colorectal Carcinoma|Completed||Phase 2|110|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 18:15:38.12808|2017-02-18 18:15:38.12808
NCT00005075|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-11-05|||July 1999||1999-07-01|May 2009|2009-05-01||||||||Interventional|||Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer|Evaluation of the Ablatherm High Intensity Focused Ultrasound Device After Failed Radiation Therapy for Localized Prostate Cancer|Terminated||Phase 3|||National Cancer Institute (NCI)||||Withdrawn because Ablatherm devices were not available anymore at trial centers|f||||||||||||||2017-02-18 18:15:38.225014|2017-02-18 18:15:38.225014
NCT00004992|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-17|2011-02-03|||July 1996||1996-07-01|February 2011|2011-02-01|April 2001||2001-04-01|||||Interventional|||Diabetes Prevention Program||Completed||N/A|3819||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 18:15:51.944806|2017-02-18 18:15:51.944806
NCT00005074|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2010-11-07|||January 2000||2000-01-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma|A Phase II Study of Flavopiridol (HMR 1275; NSC 649890) in Patients With Untreated or Relapsed Mantle Cell Lymphoma|Completed||Phase 2|||Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:15:38.305012|2017-02-18 18:15:38.305012
NCT00005073|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-04-30|||September 1999||1999-09-01|April 2013|2013-04-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms|A Randomized Double-Blind Placebo Controlled Phase III Trial Evaluating Zoledronate Plus Standard Therapy Versus Placebo Plus Standard Therapy in Patients With Recurrent Carcinoma of the Prostate Who Are Asymptomatic With Castrate Levels of Testosterone and Have Rising PSA Levels Without Radiologically-Evident Metastatic Disease|Terminated||Phase 3|544|Actual|Novartis|||||f||||||||||||||2017-02-18 18:15:38.401382|2017-02-18 18:15:38.401382
NCT00005072|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-07-25|||November 2000||2000-11-01|July 2014|2014-07-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer|Phase I/II Study Evaluating the Safety and Efficacy of Leuvectin Immunotherapy for the Treatment of Locally Recurrent Prostate Cancer Following Radiation Therapy (Summary Last Updated: 02/2001)|Terminated||Phase 1/Phase 2|25|Actual|Vical||1||Development in prostate cancer indication halted|f||||f||||||||||2017-02-18 18:15:38.770934|2017-02-18 18:15:38.770934
NCT00005071|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-11-05|||October 1998||1998-10-01|June 2007|2007-06-01||||||||Interventional|||Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer|A Pilot Study Leading to a Randomized Trial Comparing Outcomes in Patients With Suspected Lung Cancer Investigated in the Conventional Locally (LO) Based (BA) Chest Clinic Compared With a Centralized 2 Stop Pathway (LOBA 2STOP)|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:38.883172|2017-02-18 18:15:38.883172
NCT00005070|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer|A Phase II Trial of 6-Hydroxymethylacylfulvene (HMAF; MGI-114) in Patients With Advanced Cervical Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:15:38.983802|2017-02-18 18:15:38.983802
NCT00005069|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer|Phase II Trial of Arsenic Trioxide (NSC #706363) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:15:39.069077|2017-02-18 18:15:39.069077
NCT00005068|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2011-08-02|||January 2000||2000-01-01|August 2011|2011-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Study of Oxaliplatin, CPT-11, 5-FU and Leucovorin in Patients With Solid Tumors|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:15:39.177776|2017-02-18 18:15:39.177776
NCT00005067|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-01-15|||February 2000||2000-02-01|January 2013|2013-01-01||||January 2007|Actual|2007-01-01||Interventional|||Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer|A Phase I Trial of Photodynamic Therapy With Lutetium Texaphyrin in Patients With Locally Recurrent Prostate Carcinoma|Terminated||Phase 1|24|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:15:39.276776|2017-02-18 18:15:39.276776
NCT00005066|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-09-04|||June 2000||2000-06-01|September 2013|2013-09-01|October 2002|Actual|2002-10-01|September 2001|Actual|2001-09-01||Interventional|||O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma|A Phase II Trial of O6-Benzylguanine (NSC 637037) and BCNU (Carmustine) in Patients With Advanced Soft Tissue Sarcoma|Completed||Phase 2|12|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:15:39.401157|2017-02-18 18:15:39.401157
NCT00005065|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-06-03|||January 2000||2000-01-01|June 2013|2013-06-01||||December 2003|Actual|2003-12-01||Interventional|||Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer|A Phase I Study of Induction Carboplatin / Paclitaxel Chemotherapy, Pre-operative Radiotherapy With Gadolinium Texaphyrin (Gd-Tex), and Surgical Resection in Stage IIIA (N2) Non-small Cell Lung Carcinoma.|Completed||Phase 1|12|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:15:39.52121|2017-02-18 18:15:39.52121
NCT00005064|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-01-22|||February 2000||2000-02-01|January 2013|2013-01-01||||October 2002|Actual|2002-10-01||Interventional|||PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome|Phase I Study of PS-341 in Acute Myeloid Leukemias, Myelodysplastic Syndromes and Chronic Myeloid Leukemia in Blast Phase|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:15:39.63307|2017-02-18 18:15:39.63307
NCT00005062|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-03-12|||September 1999||1999-09-01|March 2014|2014-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission|A Phase III Trial Comparing High Versus Standard Dose of Prophylactic Cranial Irradiation (PCI) in Limited Small Cell Lung Cancer Complete Responders|Completed||Phase 3|||Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 18:15:39.746816|2017-02-18 18:15:39.746816
NCT00005061|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-07-17|||December 1999||1999-12-01|July 2012|2012-07-01||||June 2001|Actual|2001-06-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors|A Phase I, Open Label Multiple Dose, Safety and Pharmacokinetic Study of Intravenously Administered Humanized Anti-VEGF Monoclonal Antibody (HuMV833) to Patients With Relapsed or Refractory Solid Tumors|Completed||Phase 1|20|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:15:39.954347|2017-02-18 18:15:39.954347
NCT00005060|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-05-14|||November 1999||1999-11-01|May 2012|2012-05-01|March 2006|Actual|2006-03-01|November 2005|Actual|2005-11-01||Interventional|||Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer|A Phase III Trial of Preoperative vs. Postoperative Chemotherapy With Taxotere-Cisplatin-5FU (TCF) in Patients With Locally Advanced Operable Gastric Carcinoma|Completed||Phase 3|240|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 18:15:40.066355|2017-02-18 18:15:40.066355
NCT00005059|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2016-07-12|||January 2000||2000-01-01|July 2016|2016-07-01|April 2006|Actual|2006-04-01|July 2003|Actual|2003-07-01||Interventional|||Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer|A Phase II Study of Carboplatin and Paclitaxel in Elderly Patients With Metastatic or Recurrent Unresectable Non-Small Cell Lung Cancer|Completed||Phase 2|51|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:15:40.176273|2017-02-18 18:15:40.176273
NCT00005058|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-11-05|||August 1997||1997-08-01|April 2005|2005-04-01||||||||Interventional|||Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer|A Direct Comparison of Contrast Enhanced Power Doppler Ultrasound in Primary Breast Cancer and Axillary Nodal Status With Histopathological Variables and Clinical Outcome|Unknown status|Active, not recruiting|N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:40.309239|2017-02-18 18:15:40.309239
NCT00005057|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2015-04-28|||March 2000||2000-03-01|December 2002|2002-12-01||||||||Interventional|||Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma|A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination With Escalating Doses of Ganciclovir in Patients With Cutaneous Metastatic Malignant Melanoma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:40.396078|2017-02-18 18:15:40.396078
NCT00005056|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-06-25|||March 1999||1999-03-01|June 2006|2006-06-01|July 2006|Actual|2006-07-01|||||Interventional|||Bryostatin 1 In Treating Patients With Progressive Kidney Cancer|A Phase II Trial of Bryostatin-1 in Hypernephroma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:40.4875|2017-02-18 18:15:40.4875
NCT00005055|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-09-20|||January 2000||2000-01-01|September 2012|2012-09-01||||March 2001|Actual|2001-03-01||Interventional|||Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer|Open Label Phase II Study on Glufosfamide Administered as a 60 Minute Infusion Every 3 Weeks in Advanced Non Small Cell Lung Cancer|Completed||Phase 2|39|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:15:40.581002|2017-02-18 18:15:40.581002
NCT00005054|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-09-19|||May 1998||1998-05-01|January 2001|2001-01-01||||||||Interventional|||Temozolomide in Treating Women With Advanced Breast Cancer|Phase II Trial of Temodal 4 Hourly in Progressive Breast Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:40.675447|2017-02-18 18:15:40.675447
NCT00005053|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-09-20|||December 1999||1999-12-01|September 2012|2012-09-01||||March 2001|Actual|2001-03-01||Interventional|||Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer|Open Label Phase II Study on Glufosfamide Administered as a 60 Minute Infusion Every 3 Weeks in Advanced Pancreatic Cancer|Completed||Phase 2|35|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:15:40.761931|2017-02-18 18:15:40.761931
NCT00005052|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2009-02-06|||December 1999||1999-12-01|January 2006|2006-01-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Primary Stage II Melanoma|Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination: Post-Operative Adjuvant Ganglioside GM2-KLH/QS-21 (BMS-248479) Vaccination Treatment After Resection of Primary Cutaneous Melanoma Thicker Than 1.5mm (AJCC/UICC Stage II, T3-T4N0M0), a 2-Arm Multicenter Randomized Phase III Trial vs. Observation|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:40.871805|2017-02-18 18:15:40.871805
NCT00005051|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-11-08|||August 1999||1999-08-01|December 2003|2003-12-01||||March 2003|Actual|2003-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer|Phase II Study of First-Line Therapy of Ovarian Cancer With Sequential Regimens: Cisplatin-Prolonged Oral Topotecan (C-PORT) Followed by Paclitaxel/Carboplatin (PC)|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:15:41.310378|2017-02-18 18:15:41.310378
NCT00005050|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2011-03-25|||August 1999||1999-08-01|March 2011|2011-03-01||||June 2001|Actual|2001-06-01||Interventional|||Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer|A Phase I/II Study of Eniluracil Plus Oral 5-Fluorouracil Combined With Oxaliplatin (FOX-E) in Patients With Previously-Treated Colorectal Cancer|Completed||Phase 1/Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:15:41.417374|2017-02-18 18:15:41.417374
NCT00005049|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2011-04-04|||May 1997||1997-05-01|April 2011|2011-04-01||||November 2006|Actual|2006-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer|Pilot Study of Intraperitoneal (IP) Therapy With Cisplatin or Carboplatin and Floxuridine (FUdR) as Consolidation for Ovarian and Gastrointestinal Malignancies|Completed||Phase 2|45|Actual|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:15:41.509194|2017-02-18 18:15:41.509194
NCT00005048|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-11-08|||April 1997||1997-04-01|November 2000|2000-11-01||||August 2000|Actual|2000-08-01||Interventional|||Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|Safety and Efficacy of One Hour Weekly Taxol Infusion and Estramustine in Hormone Refractory Prostate Cancer|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:15:41.613968|2017-02-18 18:15:41.613968
NCT00005047|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2011-07-21|||September 1998||1998-09-01|June 2011|2011-06-01||||||||Interventional|||4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer|MVAC (Methotrexate, Vinblastine, Adriamycin, and Cisplatin) in Organ-Confined Bladder Cancer Based on p53 Status|Unknown status|Active, not recruiting|Phase 3|800|Anticipated|Southwest Oncology Group|||||f||||t||||||||||2017-02-18 18:15:41.713488|2017-02-18 18:15:41.713488
NCT00005046|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-05-24|||April 2000||2000-04-01|July 2008|2008-07-01||||January 2007|Actual|2007-01-01||Interventional|||Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer|A Phase I Open Label Assessment of the Safety and Pharmacokinetics of Intraperitoneal PACLIMER Microspheres (Polilactofate/Paclitaxel) in Patients With Ovarian Cancer|Completed||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:15:41.888|2017-02-18 18:15:41.888
NCT00005045|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-06-20|||March 2000||2000-03-01|December 2005|2005-12-01|June 2004|Actual|2004-06-01|||||Interventional|||Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer|Phase II Study of Carboxyamidotriazole (CAI, NSC #609974) in Patients With Advanced Renal Cell Carcinoma Refractory to Immunotherapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:41.989154|2017-02-18 18:15:41.989154
NCT00004991|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-18|2017-01-24|||March 14, 2000||2000-03-14|August 31, 2009|2009-08-31||||August 31, 2009|Actual|2009-08-31||Observational|||Study of Brain Activity During Speech Production and Speech Perception|Brain Activation During Developmental Speech Production and Speech Perception|Completed||N/A|411||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:52.041386|2017-02-18 18:15:52.041386
NCT00005044|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2015-11-14|||February 2000||2000-02-01|November 2015|2015-11-01||||May 2018|Anticipated|2018-05-01||Interventional|||Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer|A Phase III Trial to Evaluate the Duration of Neoadjuvant Total Androgen Suppression (TAS) and Radiation Therapy (RT) in Intermediate-Risk Prostate Cancer|Active, not recruiting||Phase 3|1579|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:15:42.155503|2017-02-18 18:15:42.155503
NCT00005042|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-08-28|||January 2000||2000-01-01|August 2014|2014-08-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma|A Multicenter, Open-Label, Phase II Study of SU5416 in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|||AIDS Malignancy Consortium|||||f||||f||||||||||2017-02-18 18:15:42.545825|2017-02-18 18:15:42.545825
NCT00005041|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-11-08|||September 1999||1999-09-01|November 2000|2000-11-01||||May 2000|Actual|2000-05-01||Interventional|||R115777 in Treating Patients With Relapsed Small Cell Lung Cancer|A Phase II Study to Determine the Antitumor Activity of Farnesyltransferase Inhibitor R115777 in Subjects With Relapsed Small Cell Lung Cancer|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:15:42.634672|2017-02-18 18:15:42.634672
NCT00005040|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-06-18|||January 2000||2000-01-01|June 2013|2013-06-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma|Phase II Study of Arsenic Trioxide (NSC #706363) in Relapsed and Refractory Intermediate and High-Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:15:42.722193|2017-02-18 18:15:42.722193
NCT00005039|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-01-23|||January 2000||2000-01-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)|A Phase II Randomized Trial of Recombinant Fowlpox and Recombinant Vaccinia Virus Expressing PSA in Patients With Adenocarcinoma of the Prostate|Terminated||Phase 2|86|Actual|National Cancer Institute (NCI)||2||Administratively complete.|f||||||||||||||2017-02-18 18:15:42.815935|2017-02-18 18:15:42.815935
NCT00005038|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-09-19|||June 1999||1999-06-01|June 2001|2001-06-01||||||||Interventional|||Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer|A Randomized Phase II Study to Evaluate the Efficacy of Combined Immunotherapy With Subcutaneous Interleukin-2 and Maxamine in Patients With Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:42.926992|2017-02-18 18:15:42.926992
NCT00005037|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-05-05|||January 2000||2000-01-01|May 2014|2014-05-01|April 2008|Actual|2008-04-01|October 2002|Actual|2002-10-01||Interventional|||Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer|Temozolomide in the Treatment of Advanced Non-Small Cell Lung Carcinoma: Phase II Evaluation in Previously Treated and Chemo-Naive Patients|Completed||Phase 2|51|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-02-18 18:15:43.279346|2017-02-18 18:15:43.279346
NCT00005036|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-05-01|||November 1999||1999-11-01|May 2013|2013-05-01||||December 2006|Actual|2006-12-01||Interventional|||Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|A Randomized Phase III Equivalence Trial of Irinotecan (CPT-11) Versus Oxaliplatin (OXAL)/5-Fluorouracil (5-FU)/Leucovorin (CF) in Patients With Advanced Colorectal Carcinoma Previously Treated With 5-FU|Completed||Phase 3|560|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:15:43.392481|2017-02-18 18:15:43.392481
NCT00005035|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-01-30|||December 1999||1999-12-01|February 2002|2002-02-01|March 2004|Actual|2004-03-01|||||Interventional|||Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer|A Phase II Study of Oxaliplatin in Patients With Advanced Carcinoma of the Head and Neck|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:43.5243|2017-02-18 18:15:43.5243
NCT00005033|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-06-20|||December 1999||1999-12-01|August 2004|2004-08-01|August 2004|Actual|2004-08-01|||||Interventional|||Trastuzumab in Treating Patients With Recurrent Osteosarcoma|Phase II Study of Recombinant Humanized Monoclonal Antibody Against HER2 for the Treatment of Recurrent Osteosarcoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:43.637049|2017-02-18 18:15:43.637049
NCT00005032|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-02-08|||April 2000||2000-04-01|February 2013|2013-02-01|September 2001|Actual|2001-09-01|January 2001|Actual|2001-01-01||Interventional|||Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer|A Phase I/II Study of G3139, a BCL-2 Antisense Oligonucleotide, Combined With Paclitaxel for the Treatment of Recurrent Small Cell Lung Cancer|Completed||Phase 1/Phase 2|12|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:15:43.736504|2017-02-18 18:15:43.736504
NCT00005031|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-05-24|||August 2000||2000-08-01|March 2008|2008-03-01||||October 2004|Actual|2004-10-01||Interventional|||Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer|A Phase II Evaluation of MGI-114 in the Treatment of Recurrent or Persistent Endometrial Carcinoma|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:15:43.869298|2017-02-18 18:15:43.869298
NCT00005030|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-10-05|||June 2000||2000-06-01|October 2012|2012-10-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver|A Phase IB Study of Oral Administration of SCH 66336 Preoperatively in Patients With Colorectal Carcinoma Metastatic to the Liver Scheduled for Exploratory Laparotomy and/or Resection|Withdrawn||Phase 1|0|Actual|M.D. Anderson Cancer Center||2||No enrollment.|f||||f||||||||||2017-02-18 18:15:44.030146|2017-02-18 18:15:44.030146
NCT00005029|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-04-10|||February 2000||2000-02-01|July 2004|2004-07-01||||January 2004||2004-01-01||Interventional|||Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer|Phase II Evaluation of Three-Day Topotecan (NSC 609699) in Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:15:44.163122|2017-02-18 18:15:44.163122
NCT00005028|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-02-08|||May 2000||2000-05-01|November 2005|2005-11-01||||July 2006|Actual|2006-07-01||Interventional|||Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer|Phase II Study of Weekly Paclitaxel and Bryostatin-1 in Hormone Refractory Prostate Cancer|Completed||Phase 2|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:15:44.358467|2017-02-18 18:15:44.358467
NCT00005027|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-04-03|||June 2000||2000-06-01|April 2013|2013-04-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer|A Phase II Study of Rebeccamycin Analog in Renal Cell Cancer|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:15:44.470548|2017-02-18 18:15:44.470548
NCT00005026|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-05-24|||February 2000||2000-02-01|July 2008|2008-07-01||||January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer|A Phase I Feasibility Trial of Carboplatin and Topotecan Followed by Carboplatin and Paclitaxel (Sequential Doublets) in Patients With Previously Untreated Epithelial Ovarian Carcinoma and Primary Peritoneal Carcinoma|Completed||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:15:44.568662|2017-02-18 18:15:44.568662
NCT00005025|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-11-05|||June 2000||2000-06-01|March 2003|2003-03-01||||||||Interventional|||Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer|A Phase II Trial of In Vivo Gene Therapy With the Herpes Simplex Thymidine Kinase for the Treatment of Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:44.710076|2017-02-18 18:15:44.710076
NCT00005024|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-01-03||||||June 2007|2007-06-01||||||||Interventional|||Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease|A Double-blind, Multicenter, Parallel Study Comparing the Efficacy and Safety of Kytril Tablets With Placebo, in the Prevention of Nausea and Vomiting During the Days Following Administration of IV Cyclophosphamide-based or Carboplatin-based Chemotherapy in Patients With Malignant Disease|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:44.802564|2017-02-18 18:15:44.802564
NCT00005023|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2012-12-12|||March 1999||1999-03-01|December 2012|2012-12-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer|A Phase I Vaccine Trial of a HER-2/Neu Peptide Incorporated Into PLG Microspheres in Patients With Advanced Stage HER2-Expressing Cancers|Completed||Phase 1|||University of Washington|||||f||||||||||||||2017-02-18 18:15:44.887966|2017-02-18 18:15:44.887966
NCT00005022|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-10-31|||February 1998||1998-02-01|October 2013|2013-10-01|June 2010|Actual|2010-06-01|October 2002|Actual|2002-10-01||Interventional|||Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer|A Phase I/II Escalation Study of Thoracic Irradiation With Concurrent Chemotherapy for Patients With Limited Small Cell Lung Cancer|Completed||Phase 1|64|Actual|Radiation Therapy Oncology Group||6|||f||||t||||||||||2017-02-18 18:15:45.205396|2017-02-18 18:15:45.205396
NCT00005021|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-07-10|||July 1996||1996-07-01|July 2013|2013-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma|Phase I Evaluation of Topotecan in Combination With Paclitaxel and Carboplatin|Completed||Phase 1|17|Actual|Fox Chase Cancer Center||1|||f||||t||||||||||2017-02-18 18:15:48.604114|2017-02-18 18:15:48.604114
NCT00005020|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2010-03-24||||||December 2004|2004-12-01||||||||Observational|||Observing Patients With Early HIV Infection|An Observational Study of Viral and Immune Dynamics in Subjects With Acute HIV Infection: A Study of the UCSD Acute/Early HIV Infection (AEHIV) Clinical Studies Unit|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:15:48.706079|2017-02-18 18:15:48.706079
NCT00005018|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-04|2005-06-23|||July 1999||1999-07-01|August 2000|2000-08-01|October 2000||2000-10-01|||||Interventional|||Safety and Effectiveness of a Combination Anti-HIV Drug Treatment|A Phase IV 48-Week, Randomized, Open-Label, Multicenter Trial of Abacavir (300mg BID)/Efavirenz (600mg QD)/Didanosine (400mg QD) +/- Hydroxyurea (500mg BID) in HIV-1 Infected Subjects Failing Initial Therapy With 3TC/ZDV (or d4T) +/- Protease Inhibitor(s)|Completed||Phase 4|150||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:48.787394|2017-02-18 18:15:48.787394
NCT00005017|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-03|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment|A Phase IV, Open-Label, Randomized Study to Compare the Efficacy and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) for 96 Weeks in the Treatment of HIV-1 Infected Subjects Who Are Antiretroviral Therapy Naive|Unknown status|Active, not recruiting|Phase 4|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:48.892932|2017-02-18 18:15:48.892932
NCT00005016|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-04|2008-03-03|||March 2000||2000-03-01|March 2000|2000-03-01|February 2001||2001-02-01|||||Observational|||Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly|The Experiences and Needs of Parents Continuing a Pregnancy Following Abnormal Prenatal Results: The Case of Holoprosencephaly|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:49.25662|2017-02-18 18:15:49.25662
NCT00005015|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-31|2005-11-17||||||November 2000|2000-11-01|September 2000||2000-09-01|||||Interventional|||Treatment of Depression in Youth With Bipolar Disorders|Fluoxetine for the Treatment of Major Depression in Youth With Bipolar Disorder _|Terminated||Phase 3|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:15:49.344366|2017-02-18 18:15:49.344366
NCT00005014|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-31|2014-04-16|||October 1997||1997-10-01|August 2010|2010-08-01|February 2001||2001-02-01|||||Interventional|||Treatment of Autism in Children and Adolescents|Placebo-Controlled Study of Risperidone for the Treatment of Children and Adolescents With Autism and Negative Behavioral Symptoms|Completed||Phase 3|101|Actual|National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:15:49.428032|2017-02-18 18:15:49.428032
NCT00005013|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-31|2014-04-07|||December 1998||1998-12-01|March 2006|2006-03-01|July 2001|Actual|2001-07-01|||||Interventional|||Treatment of Major Depression With St. John's Wort (Hypericum)|A Placebo Controlled Clinical Trial of a Standardized Extract of Hypericum Perforatum in Major Depressive Disorder|Completed||N/A|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:15:49.529625|2017-02-18 18:15:49.529625
NCT00005012|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-29|2005-06-23|||March 2000||2000-03-01|August 2000|2000-08-01|September 2000||2000-09-01|||||Interventional|||Safety and Effectiveness of PEG-Intron in HIV-Infected Patients|Antiviral Activity and Tolerability of PEG-Intron in HIV-Infected Subjects Failing HAART|Completed||Phase 2|250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:49.6405|2017-02-18 18:15:49.6405
NCT00005011|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-29|2017-01-24|||March 28, 2000||2000-03-28|October 28, 2016|2016-10-28|October 28, 2016||2016-10-28|||||Observational|||Combined Hormone Replacement in Menstrually-Related Mood Disorders|The Treatment of Menstrually-Related Mood Disorders With Continuous Gonadal Steroid Replacement|Completed||N/A|22|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:49.75208|2017-02-18 18:15:49.75208
NCT00005009|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-28|2017-02-14|||February 1998||1998-02-01|February 2017|2017-02-01|June 16, 2001|Actual|2001-06-16|June 16, 2001|Actual|2001-06-16||Interventional|||Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients|Evaluation of the Safety and Immunogenicity of Varivax® (Live-Attenuated Varicella-Zoster Virus Vaccine) in Pediatric Renal Transplant Recipients|Terminated||Phase 1|7|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1||Slow enrollment|f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 18:15:49.948359|2017-02-18 18:15:49.948359
NCT00005007|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-24|2007-12-19|||June 2000||2000-06-01|December 2007|2007-12-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Etanercept for Wegener's Granulomatosis|Wegener's Granulomatosis Etanercept Trial (WGET)|Completed||Phase 2/Phase 3|181||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||||||||||||||||2017-02-18 18:15:50.090574|2017-02-18 18:15:50.090574
NCT00005006|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-24|2015-08-17|||September 1987||1987-09-01|August 2015|2015-08-01|December 2006|Actual|2006-12-01|February 2003|Actual|2003-02-01||Interventional|||Parathyroid Hormone (PTH) With Alendronate for Osteoporosis|Cyclical vs Daily Continuous PTH in Combination With Alendronate vs Alendronate Alone|Completed||Phase 2|140|Actual|Helen Hayes Hospital||3|||f||||f||||||||||2017-02-18 18:15:50.208886|2017-02-18 18:15:50.208886
NCT00005005|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-24|2013-02-04|||October 1999||1999-10-01|February 2013|2013-02-01|November 2007|Actual|2007-11-01|November 2007|Actual|2007-11-01||Interventional|||PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis|Clinical Trial of Parathyroid Hormone (PTH) and Alendronate in Combination in the Treatment of Osteoporosis|Completed||Phase 2|238|Actual|University of California, San Francisco||4|||f||||||||||||||2017-02-18 18:15:50.332238|2017-02-18 18:15:50.332238
NCT00005004|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-23|2008-03-03|||March 2000||2000-03-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Observational|||Brain Processing of Language Meanings|Investigations in Discourse Processes|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:50.456187|2017-02-18 18:15:50.456187
NCT00005003|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-23|2008-03-03|||March 2000||2000-03-01|April 2006|2006-04-01|April 2006||2006-04-01|||||Observational|||Genetic Component of Handedness|Mapping the Genetic Component of Hand-Use Preference|Completed||N/A|1400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:50.5369|2017-02-18 18:15:50.5369
NCT00005002|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-21|2005-06-23||||||August 2001|2001-08-01||||||||Interventional|||Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)|A Randomized, Double-Blind, Adjuvant-Controlled, Multicenter Study to Compare the Virologic and Immunologic Effect of Highly Active Antiretroviral Therapy (HAART) Plus Remune Versus HAART Plus Incomplete Freund's Adjuvant (IFA) in Antiretroviral-Naive Patients Infected With Human Immunodeficiency Virus Type 1 (HIV-1)|Unknown status|Active, not recruiting|Phase 3|688||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:50.613995|2017-02-18 18:15:50.613995
NCT00005001|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-21|2005-06-23||||||March 2001|2001-03-01||||||||Interventional|||Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)|A Pilot, Phase II, Double-Blind Study to Assess the Virologic Effect of Remune Versus Incomplete Freund's Adjuvant (IFA) in Patients Who Are Infected With Human Immunodeficiency Virus Type I (HIV-1), Have a Plasma HIV-1 RNA Level Less Than 50 Copies/Ml, Are Receiving Highly Active Antiretroviral Therapy (HAART), and Who Subsequently Discontinue Their HAART Regimen|Completed||Phase 2|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:50.904836|2017-02-18 18:15:50.904836
NCT00005000|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-21|2005-06-23|||December 1999||1999-12-01|July 2002|2002-07-01||||||||Interventional|||Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs|A Randomized, Open-Label, Study of Nelfinavir or Efavirenz in HIV-1 Infected, Antiretroviral Naive Patients|Unknown status|Active, not recruiting|Phase 4|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:50.987101|2017-02-18 18:15:50.987101
NCT00004999|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-21|2005-06-23|||August 1999||1999-08-01|March 2001|2001-03-01||||||||Interventional|||Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients|A Randomized, Double-Blind, Placebo-Controlled Study of AG1549 in Combination With Viracept (Nelfinavir Mesylate) and Combivir (Zidovudine + Lamivudine) in Treatment-Naive HIV-Infected Patients|Suspended||Phase 2|350||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:51.084177|2017-02-18 18:15:51.084177
NCT00004998|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-21|2005-06-23|||November 1999||1999-11-01|March 2001|2001-03-01||||||||Interventional|||Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients|A Phase II, Open-Label Study of AG1549 in Combination With Other Antiretroviral Agents in Treatment-Naive HIV-Infected Patients|Suspended||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:51.494883|2017-02-18 18:15:51.494883
NCT00004997|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-22|2008-03-03|||April 1998||1998-04-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Leucovorin for the Treatment of 5 q Minus Syndrome|The Experimental Treatment of Transfusion Dependent 5q Minus Syndrome With Leucovorin|Completed||Phase 2|14||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:51.589391|2017-02-18 18:15:51.589391
NCT00004996|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-22|2017-01-24|||March 20, 2000||2000-03-20|April 22, 2015|2015-04-22|April 22, 2015||2015-04-22|||||Observational|||Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections|Langherhans' Cell Function and Inflammatory Responses in Skin of Volunteers Using the Suction Blister Technique|Completed||N/A|90|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:51.68079|2017-02-18 18:15:51.68079
NCT00004994|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-22|2008-03-03|||October 1999||1999-10-01|October 2004|2004-10-01|October 2004||2004-10-01|||||Observational|||Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant|A Study Comparing Quality of Life in Patients Undergoing a Non-Myeloablative Versus a Myeloablative Peripheral Blood Stem Cell Transplant for Hematological Diseases|Completed||N/A|106||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:51.774752|2017-02-18 18:15:51.774752
NCT00004993|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-17|2010-03-01|||August 1999||1999-08-01|March 2010|2010-03-01|August 2001||2001-08-01|||||Interventional|||Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis|Can PTH Reverse Glucocorticoid-induced Osteoporosis|Completed||Phase 2|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:15:51.854704|2017-02-18 18:15:51.854704
NCT00004990|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-18|2008-03-03|||March 2000||2000-03-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis|Pulse Dexamethasone in Focal Segmental Glomerulosclerosis|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:52.12089|2017-02-18 18:15:52.12089
NCT00004988|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-18|2008-03-03|||March 2000||2000-03-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria|A Phase I Trial of a Live, Genetically Modified Salmonella Typhimurium (VNP20009) for the Treatment of Cancer by Intravenous Administration|Completed||Phase 1|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:15:52.216216|2017-02-18 18:15:52.216216
NCT00004987|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-16|2005-06-23|||October 1999||1999-10-01|June 2001|2001-06-01||||||||Interventional|||Treatment of Advanced AIDS Patients With Dextrin Sulfate|Intraperitoneal Dextrin Sulfate in Patients With Advanced HIV Disease: A Phase I Trial|Unknown status|Active, not recruiting|Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:52.305028|2017-02-18 18:15:52.305028
NCT00004986|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-16|2005-06-23|||February 2000||2000-02-01|August 2000|2000-08-01||||||||Interventional|||Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients|Open Label, Multi-Center Evaluation of Nitazoxanide for the Treatment of Cryptosporidiosis in Subjects With AIDS in the United States|Terminated||Phase 3|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:52.386767|2017-02-18 18:15:52.386767
NCT00004985|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-15|2005-06-23|||January 2000||2000-01-01|March 2001|2001-03-01||||||||Interventional|||Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy|A Phase II, Single-Blind, Randomized, Placebo-Controlled Study of Capravirine (AG1549) in Combination With Viracept and Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Subjects Who Failed an Initial Nonnucleoside Reverse Transcriptase Inhibitor Containing Regimen|Completed||Phase 2|75||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:52.480611|2017-02-18 18:15:52.480611
NCT00004984|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-13|2010-01-14|||February 1994||1994-02-01|January 2010|2010-01-01|June 2003||2003-06-01|||||Interventional|||The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)||Completed||Phase 3|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||||||||||||||||2017-02-18 18:15:52.599903|2017-02-18 18:15:52.599903
NCT00004983|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-13|2010-02-12|||September 1999||1999-09-01|February 2010|2010-02-01|December 2006|Actual|2006-12-01|November 2006|Actual|2006-11-01||Interventional|||Education and Group Support for Diabetic Hispanics||Completed||N/A|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:15:52.710982|2017-02-18 18:15:52.710982
NCT00004982|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-13|2010-01-12|||December 1998||1998-12-01|January 2010|2010-01-01|November 2002||2002-11-01|||||Interventional|||Combination Iron Chelation Therapy||Completed||Phase 1|||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||f||||||||||||||2017-02-18 18:15:52.810435|2017-02-18 18:15:52.810435
NCT00004981|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-13|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)|A Phase IIIB Randomized, Multicenter Study of the Efficacy and Safety of Combivir 1 Tablet Po Bid Plus Ziagen 300mg Po Bid Versus an Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg Combination Tablet Po Bid, Administered for 24 Weeks in Subjects With HIV-1 Infection|Unknown status|Active, not recruiting|Phase 3|230||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:15:52.900916|2017-02-18 18:15:52.900916
NCT00004980|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-10|2013-08-05|2008-11-25||December 1999||1999-12-01|August 2013|2013-08-01|June 2005|Actual|2005-06-01|January 2005|Actual|2005-01-01||Interventional|||"Repetitive Transcranial Magnetic Stimulation for Voices"|"Repetitive Transcranial Magnetic Stimulation of Speech Processing Brain Areas in Schizophrenic Patients Who Hear Voices"|Completed||Phase 2|50|Actual|Yale University||2|||f||||t||||||||||2017-02-18 18:15:53.011185|2017-02-18 18:15:53.011185
NCT00004979|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2014-01-03||||||January 2001|2001-01-01|September 2000|Actual|2000-09-01|||||Interventional|||Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors|Phase I/II Study of Oral Topotecan and Intravenous Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (Phases I and II) and Other Advanced Solid Tumors (Phase I Only)|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:53.475045|2017-02-18 18:15:53.475045
NCT00004978|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-10|2013-05-01|2011-01-20||March 2000||2000-03-01|October 2012|2012-10-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|ESPRIT||An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy|A Randomized, Open-Label, Phase III, International Study of Subcutaneous Recombinant IL-2 in Patients With HIV-1 Infection and CD4+ Cell Counts 300/mm^3 or Greater: Evaluation of Subcutaneous Proleukin in a Randomized International Trial|Completed||Phase 3|4150|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||||2017-02-18 18:15:53.579513|2017-02-18 18:15:53.579513
NCT00004941|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||July 1996||1996-07-01|April 2000|2000-04-01|July 1996||1996-07-01|||||Interventional|||Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease||Completed||Phase 3|94||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:15:55.604774|2017-02-18 18:15:55.604774
NCT00004940|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||May 1996||1996-05-01|April 2000|2000-04-01|September 2001||2001-09-01|||||Interventional|||Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria||Completed||Phase 3|50||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:15:55.690951|2017-02-18 18:15:55.690951
NCT00004939|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1996||1996-08-01|December 2001|2001-12-01|August 1996||1996-08-01|||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy||Completed||Phase 3|34||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:15:55.767647|2017-02-18 18:15:55.767647
NCT00004938|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2006-06-08|||August 1996||1996-08-01|April 2000|2000-04-01|August 1996||1996-08-01|||||Interventional|||Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis||Completed||Phase 2|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:15:55.850976|2017-02-18 18:15:55.850976
NCT00004937|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-07-10|||October 1999||1999-10-01|July 2012|2012-07-01||||May 2000|Actual|2000-05-01||Interventional|||Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme|Open Label Phase II Study on XR5000 Administered as a 5 Day Infusion in Patients With Glioblastoma Multiforme|Completed||Phase 2|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:15:55.934112|2017-02-18 18:15:55.934112
NCT00004936|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-01-25|||April 2000||2000-04-01|January 2013|2013-01-01|October 2002|Actual|2002-10-01|May 2001|Actual|2001-05-01||Interventional|ACRIN 6651||MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients|Role of Radiology in the Pretreatment Evaluation of Invasive Cervical Cancer|Completed||N/A|||American College of Radiology Imaging Network|||||f||||t||||||||||2017-02-18 18:15:56.019867|2017-02-18 18:15:56.019867
NCT00004935|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2016-09-30|||August 1999||1999-08-01|September 2016|2016-09-01|June 2018|Anticipated|2018-06-01|May 2013|Actual|2013-05-01||Interventional|||Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2|Randomized Phase III Trial of Herceptin® Followed by Chemotherapy Plus Herceptin® Versus the Combination of Herceptin® and Chemotherapy as Palliative Treatment in Patients With HER2- Overexpressing Advanced/Metastatic Breast Cancer.|Active, not recruiting||Phase 3|175|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 18:15:56.388741|2017-02-18 18:15:56.388741
NCT00004934|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-02-01|||August 1999||1999-08-01|May 2003|2003-05-01|May 2003|Actual|2003-05-01|||||Interventional|||Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer|A Randomized Trial of Paclitaxel/Epirubicin/Carboplatin Combination (TEC) Versus Paclitaxel/Carboplatin (TC) in the Treatment of Women With Advanced Ovarian Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:56.512244|2017-02-18 18:15:56.512244
NCT00004933|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2016-07-01|||January 2000||2000-01-01|July 2016|2016-07-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa|A Phase III Study of Interferon-Refractory Patients With BCR/ABL(+) Chronic Myelogenous Leukemia (CML) Treated With Homoharringtonine (NSC #141633) vs. Hydroxyurea|Terminated||Phase 3|5|Actual|Alliance for Clinical Trials in Oncology||2||Poor accrual|f||||t||||||||||2017-02-18 18:15:56.627507|2017-02-18 18:15:56.627507
NCT00004932|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2014-02-20|||January 2002||2002-01-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||STI571 in Treating Patients With Recurrent Leukemia|A Phase I Study of STI571 in Ph+ Leukemia|Completed||Phase 1|31|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 18:15:56.888135|2017-02-18 18:15:56.888135
NCT00004931|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-01-10|||February 2000||2000-02-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer|A Clinical Trial Comparing 5-Fluorouracil (5-FU) Plus Leucovorin (LV) and Oxaliplatin With 5-FU Plus LV for the Treatment of Patients With Stages II and III Carcinoma of the Colon|Completed||Phase 3|2472|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:15:57.248868|2017-02-18 18:15:57.248868
NCT00004930|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-06-18|||July 1999||1999-07-01|June 2013|2013-06-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases|Phase I and Clinical Pharmacologic Study of Inhaled Doxorubicin in Adults With Advanced Solid Tumors Affecting the Lungs|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:15:57.36647|2017-02-18 18:15:57.36647
NCT00004929|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-01-30|||September 1999||1999-09-01|January 2013|2013-01-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer|Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21: A Trial Examining the Immunogenicity of Glycosylated MUC-2-KLH Peptide Conjugate Vaccine|Completed||Phase 1|15|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:15:57.461127|2017-02-18 18:15:57.461127
NCT00004928|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-06-18|||October 1999||1999-10-01|June 2013|2013-06-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer|A Phase I Study of 1,25 Dihydroxy-Vitamin D3 (Calcitriol) in Patients With Prostate Cancer|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:15:57.570085|2017-02-18 18:15:57.570085
NCT00004927|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2017-01-27|||July 1999||1999-07-01|January 2017|2017-01-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy|Phase I Study of BMS-247550 Given Every Three Weeks in Patients With Advanced Malignancies|Completed||Phase 1|||R-Pharm|||||f||||||||||||||2017-02-18 18:15:57.66056|2017-02-18 18:15:57.66056
NCT00004926|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-05-29|||October 1999||1999-10-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|August 2002|Actual|2002-08-01||Interventional|||ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy|A Phase I Study of Oral ILX23-7553 in Patients With Solid Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:57.755407|2017-02-18 18:15:57.755407
NCT00004925|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-06-18|||August 1999||1999-08-01|June 2013|2013-06-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer|Phase I/II Study of TLC D-99 Plus Herceptin as First or Second Line Therapy for Patients With Locally Advanced Inflammatory or Metastatic Breast Cancer|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:15:57.939734|2017-02-18 18:15:57.939734
NCT00004924|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2009-08-21|||March 1999||1999-03-01|August 2009|2009-08-01|February 2006|Actual|2006-02-01|||||Interventional|||Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer|Phase II Trial of Irinotecan Plus Paclitaxel in Patients With Advanced Nonsmall Cell Lung Cancer|Completed||Phase 2|28|Actual|Yale University|||||f||||f||||||||||2017-02-18 18:15:58.031179|2017-02-18 18:15:58.031179
NCT00004923|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2009-08-21|||April 1999||1999-04-01|August 2009|2009-08-01|May 2006|Actual|2006-05-01|||||Interventional|||Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors|Dose Escalation Trial of Docetaxel Plus Irinotecan in Patients With Advanced Cancer|Completed||Phase 1/Phase 2|47|Actual|Yale University|||||f||||f||||||||||2017-02-18 18:15:58.123704|2017-02-18 18:15:58.123704
NCT00004922|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-06-18|||June 1999||1999-06-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors|A Phase II Clinical Trial of Irinotecan (CPT-11) in Patients With Advanced High Grade Neuroendocrine Tumors|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:15:58.210146|2017-02-18 18:15:58.210146
NCT00004842|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||October 1998||1998-10-01|December 1998|1998-12-01||||||||Interventional|||Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis||Unknown status|Active, not recruiting|Phase 1|50||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:13.113946|2017-02-18 18:16:13.113946
NCT00004921|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-09-16|||September 1998||1998-09-01|July 2002|2002-07-01|September 2007|Actual|2007-09-01|||||Interventional|||High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery|A Randomized Phase III Trial of Sequential High Dose Chemotherapy or Standard Chemotherapy for Optimally Debulked FIGO Stage III and IV Ovarian Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:15:58.30532|2017-02-18 18:15:58.30532
NCT00004920|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-07-17|||November 1999||1999-11-01|July 2012|2012-07-01||||January 2003|Actual|2003-01-01||Interventional|||Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura|Phase III Study of Tomudex and Cisplatin Versus Cisplatin in Malignant Pleural Mesothelioma|Completed||Phase 3|256|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:15:58.421808|2017-02-18 18:15:58.421808
NCT00004919|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-07-01|||December 1999||1999-12-01|July 2013|2013-07-01||||March 2003|Actual|2003-03-01||Interventional|||Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy|A Trial of Irinotecan and Cisplatin in Children With Refractory Solid Tumors|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:15:58.748273|2017-02-18 18:15:58.748273
NCT00004918|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-01-04|||December 1999||1999-12-01|January 2013|2013-01-01||||December 2007|Actual|2007-12-01||Interventional|||Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome|A Phase I/II Study of PR1 (NSC 698102) Human Leukemia Peptide Vaccine With Montanide ISA 51 (NSC 675756) or Montanide ISA 51 VG (NSC 737063) Adjuvant|Completed||Phase 1/Phase 2|69|Anticipated|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:15:58.865509|2017-02-18 18:15:58.865509
NCT00004917|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2016-12-30|||June 2000||2000-06-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|November 2007|Actual|2007-11-01||Interventional|||Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer|A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:15:59.006174|2017-02-18 18:15:59.006174
NCT00004916|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-31||2011-07-01|February 1999||1999-02-01|May 2012|2012-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|Phase I/II Study of Mesna, Ifosfamide, Teniposide and Weekly Taxol (MITTen) in Relapsed Lymphoma|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:15:59.436463|2017-02-18 18:15:59.436463
NCT00004915|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-31||2011-02-16|November 1998||1998-11-01|May 2012|2012-05-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer|Phase II Study of Raloxifene in Recurrent Endometrial Cancer|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:15:59.534222|2017-02-18 18:15:59.534222
NCT00004914|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-31||2011-04-08|January 2000||2000-01-01|May 2012|2012-05-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue|A Phase II Trial of Progressive Resistance Training (PRT) Plus Procrit for the Treatment of Anemia-Related Fatigue in Cancer Patients|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:15:59.630976|2017-02-18 18:15:59.630976
NCT00004913|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-31|||January 2000||2000-01-01|May 2012|2012-05-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I Study of Docetaxel Plus 5-FU, Cisplatin and Leucovorin in Patients With Advanced Solid Tumors|Completed||Phase 1|||Northwestern University|||||f||||||||||||||2017-02-18 18:15:59.726141|2017-02-18 18:15:59.726141
NCT00004912|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-17||2011-02-18|January 2000||2000-01-01|May 2012|2012-05-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss|Phase II Trial of Progressive Resistance Training With Megestrol Acetate for the Treatment of Cancer-Related Weight Loss|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:15:59.814319|2017-02-18 18:15:59.814319
NCT00004911|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-31||2011-02-18|January 2000||2000-01-01|May 2012|2012-05-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction|A Pilot Phase I/II Trial of Enteral Wallstents for Colonic Obstruction in the Setting of Malignancy|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:15:59.909971|2017-02-18 18:15:59.909971
NCT00004910|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-31||2011-02-18|January 2000||2000-01-01|May 2012|2012-05-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction|A Pilot Phase I/II Trial of Enteral Wallstents for Duodenal Obstruction in the Setting of Malignancy|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:00.022317|2017-02-18 18:16:00.022317
NCT00004909|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2011-02-18|||November 1999||1999-11-01|February 2011|2011-02-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Observational|||Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer|The Impact of Oral Chemotherapy on Quality of Life in Patients With Recurrent Epithelial Ovarian Cancer|Completed||N/A|40|Actual|Northwestern University|||2||f||||t||||||||||2017-02-18 18:16:00.125547|2017-02-18 18:16:00.125547
NCT00004908|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2011-08-25||2011-08-23|November 1999||1999-11-01|August 2011|2011-08-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma|Autologous Blood Stem Cell Transplantation in Patients With Hodgkin's Disease and Non-Hodgkin's Lymphoma With High-Dose Cyclophosphamide, Total Body Irradiation and Involved-Field Radiation Therapy|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:00.226488|2017-02-18 18:16:00.226488
NCT00004907|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma|High-Dose Chemoradiotherapy With Stem Cell Allogeneic Cellular Rescue in Patients With Relapsed or Refractory Hematologic Malignancy - A Phase I/II Study|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:00.418111|2017-02-18 18:16:00.418111
NCT00004906|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-05-29|||October 1999||1999-10-01|November 2007|2007-11-01|June 2001|Actual|2001-06-01|||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer|A Phase II Multi-Institution Study of Docetaxel and Doxorubicin as Induction Therapy Followed by Sequential High Dose Chemotherapy and CD 34+ Selected Stem Cell Support for Women With Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:00.527262|2017-02-18 18:16:00.527262
NCT00004905|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-05-29|||October 1999||1999-10-01|February 2001|2001-02-01|September 2004|Actual|2004-09-01|||||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia|Pilot Study of Intensive Chemotherapy Followed by Peripheral Blood Stem Cell Harvesting for Autotransplantation of Adults With Chronic Myelogenous Leukemia and High Risk Acute Leukemia|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:00.634887|2017-02-18 18:16:00.634887
NCT00004904|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-31|||October 1999||1999-10-01|May 2012|2012-05-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Stem Cell Transplantation in Treating Patients With Hematologic Cancer|"Phase I Study of T Cell Depleted (TCD) Partially Matched Related Donor (PMRD) Hematopoietic Stem Cell Transplantation for High Risk Hematologic Diseases Using Intense Pre and Post Transplant Immunosuppression and Megadose CD34 Veto Cells"|Completed||Phase 1|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:00.731386|2017-02-18 18:16:00.731386
NCT00004903|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2014-01-03|||October 1999||1999-10-01|June 2001|2001-06-01||||||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase II Study of High Dose Late Intensification Therapy in Patients With Chemotherapy Sensitive Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:00.842655|2017-02-18 18:16:00.842655
NCT00004902|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-17||2011-02-16|January 1998||1998-01-01|May 2012|2012-05-01|November 1999|Actual|1999-11-01|November 1999|Actual|1999-11-01||Interventional|||Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma|Phase II Pilot Evaluation of Infusional 8 Cl-cAMP in the Treatment of Relapsed or Refractory Multiple Myeloma|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:00.936212|2017-02-18 18:16:00.936212
NCT00004901|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-06-25|||October 1999||1999-10-01|August 2000|2000-08-01|July 2004|Actual|2004-07-01|||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer|A Phase I Study of Concomitant Chemoradiotherapy With 776C85, 5-FU and Hydroxyurea for Patients With Poor Prognosis Oral Cancer|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:01.050107|2017-02-18 18:16:01.050107
NCT00004900|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-05-29|||October 1999||1999-10-01|October 2007|2007-10-01|August 2004|Actual|2004-08-01|||||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer|A Phase II Pilot Study of Sequential High Dose Chemotherapy and CD 34+ Selected Stem Cell Support Without Conventional-Dose Induction Chemotherapy for Women With Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:01.154196|2017-02-18 18:16:01.154196
NCT00004899|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Autologous Bone Marrow Transplantation for Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome - A Phase II Pilot Study|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:01.26719|2017-02-18 18:16:01.26719
NCT00004898|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia|Dose Escalation of VP-16 With Cyclophosphamide and Total Body Irradiation as Preparative Regimen for Autologous Transplantation for High-Grade Lymphoma and Acute Lymphoblastic Leukemia|Completed||Phase 1/Phase 2|6|Actual|Northwestern University|||||f||||t||||||||||2017-02-18 18:16:01.7751|2017-02-18 18:16:01.7751
NCT00004897|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-06-08||2011-05-25|October 1999||1999-10-01|June 2012|2012-06-01|November 2007|Actual|2007-11-01|July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer|PFL-Alpha Chemotherapy Followed by Surgery or FHX for Early Stage Esophageal Cancer - A Pilot Project|Terminated||Phase 2|||Northwestern University||||Institutional Review Board requested termination - all patients deceased and no new accrual.|f||||||||||||||2017-02-18 18:16:01.885604|2017-02-18 18:16:01.885604
NCT00004896|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Phase II Study of High-Dose Busulfan and Cyclophosphamide Followed by Allogeneic Bone Marrow Transplantation for Patients With Acute Myelogenous Leukemia|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:01.99785|2017-02-18 18:16:01.99785
NCT00004895|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery|Octreotide for Palliation of Inoperable Bowel Obstruction: A Phase II Study|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:02.115124|2017-02-18 18:16:02.115124
NCT00004893|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2016-07-15|||December 1999||1999-12-01|July 2016|2016-07-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer|Evaluation of Novel Therapeutic Agents Against Breast Cancer: An Innovative Randomized Phase II Trial Design|Completed||Phase 2|5|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:16:02.222302|2017-02-18 18:16:02.222302
NCT00004892|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2009-02-06|||April 2000||2000-04-01|February 2007|2007-02-01||||||||Interventional|||O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma|Phase I GLIADEL and Continuous Infusion of Intravenous O6-Benzylguanine Trial in Patients With Recurrent Malignant Glioma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:05.41355|2017-02-18 18:16:05.41355
NCT00004840|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||May 1998||1998-05-01|October 1998|1998-10-01|June 1998||1998-06-01|||||Interventional|||Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants||Completed||N/A|996||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:13.199376|2017-02-18 18:16:13.199376
NCT00004891|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2015-12-21|||September 1999||1999-09-01|December 2015|2015-12-01||||March 2007|Actual|2007-03-01||Interventional|||PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery|Prospective Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Multimodality Management of Locally Advanced Primary Rectal Cancer|Completed||N/A|149|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:16:05.524232|2017-02-18 18:16:05.524232
NCT00004890|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-03-25|||December 2000||2000-12-01|January 2008|2008-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer|Phase IB Open-Label Rising-Dose Study of Biomed 101 in Patients Treated With Interleukin-2 for Malignancy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:05.652077|2017-02-18 18:16:05.652077
NCT00004889|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2015-09-30|||December 1999||1999-12-01|July 2012|2012-07-01|July 2005|Actual|2005-07-01|January 2002|Actual|2002-01-01||Interventional|||Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia|Phase II Study of Rituximab (Rituxan, Mabthera) in Waldenstrom's Macroglobulinemia|Completed||Phase 2|8|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 18:16:05.750104|2017-02-18 18:16:05.750104
NCT00004888|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2014-05-07|2011-06-21||January 2001||2001-01-01|December 2012|2012-12-01|May 2009|Actual|2009-05-01|April 2008|Actual|2008-04-01||Interventional|||Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer|A Safety and Efficacy Study of Doxil and Taxotere ± Herceptin in Advanced Breast Cancer|Completed||Phase 2|84|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:16:05.887416|2017-02-18 18:16:05.887416
NCT00004887|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-09-19|||January 1999||1999-01-01|March 2000|2000-03-01||||||||Interventional|||Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery|A Randomized Phase III Comparative Study of Paclitaxel With Carboplatin Versus Mitomycin, Ifosfamide, Cisplatin (MIC) Chemotherapy in Inoperable Advanced Stage Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:06.730486|2017-02-18 18:16:06.730486
NCT00004886|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-09-20|||December 1999||1999-12-01|September 2012|2012-09-01||||June 2002|Actual|2002-06-01||Interventional|||MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors|Phase I Study to Determine the Safety of MS-209 in Combination With Docetaxel in Patients With a Solid Progressive Tumor|Completed||Phase 1|30|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:16:06.82324|2017-02-18 18:16:06.82324
NCT00004885|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-09-20|||July 1999||1999-07-01|September 2012|2012-09-01||||July 2001|Actual|2001-07-01||Interventional|||Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer|CPT-11 in Combination With Weekly 24 Hour Infusion 5-FU Plus Folinic Acid Relative to Weekly 24 Hour Infusion 5-FU Plus Folinic Acid Alone in Patients With Advanced Colorectal Cancer|Completed||Phase 3|430|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:16:06.928871|2017-02-18 18:16:06.928871
NCT00004884|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-09-20|||July 1999||1999-07-01|September 2012|2012-09-01||||March 2001|Actual|2001-03-01||Interventional|||Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer|Randomized Phase II Study of Docetaxel/Gemcitabine vs. Docetaxel/Cisplatin in Metastatic or Locoregionally Advanced Pancreatic Carcinoma|Completed||Phase 2|96|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:16:07.110857|2017-02-18 18:16:07.110857
NCT00004883|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-01-15|||February 2000||2000-02-01|January 2013|2013-01-01||||August 2005|Actual|2005-08-01||Interventional|||Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2|A Phase II Trial of Trastuzumab (Herceptin) for Advanced Stage (IIIB, IV), HER2 Overexpressing, Non-Small Cell Lung Cancer|Completed||Phase 2|84|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:16:07.231304|2017-02-18 18:16:07.231304
NCT00004881|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-06-25|||April 2000||2000-04-01|February 2001|2001-02-01|May 2004|Actual|2004-05-01|||||Interventional|||Vaccine Therapy in Treating Patients With Advanced Cancer|Phase I Bridging Trial of TG4010 as Antigen-Specific Immunotherapy in Patients With MUC-1 Positive Advanced Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:07.35312|2017-02-18 18:16:07.35312
NCT00004880|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2015-10-01|||June 1997||1997-06-01|July 2012|2012-07-01||||April 2001|Actual|2001-04-01||Interventional|||Vaccine Therapy in Treating Patients With Advanced Kidney Cancer|A Phase I Pilot Trial of a Multi-Antigen Loaded Dendritic Cell Vaccine for the Treatment of Advanced Renal Cell Carcinoma|Completed||Phase 1|14|Actual|Jonsson Comprehensive Cancer Center|||||f||||f||||||||||2017-02-18 18:16:07.439146|2017-02-18 18:16:07.439146
NCT00004879|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-01-07|||April 2000||2000-04-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer|An Open Label, Multiple Dose, Dose-Rising Clinical Trial of the Safety of ABX-EGF in Patients With Renal, Prostate, Pancreatic, Non-Small-Cell Lung, Colorectal, or Esophageal Cancer|Completed||Phase 1|||Jonsson Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:16:07.54132|2017-02-18 18:16:07.54132
NCT00004878|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-07-27||||||July 2012|2012-07-01||||||||Interventional|||Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia|A Study to Determine the Safety and Efficacy of Using CD8-High Density Microparticles (CD8-HDM) to Deplete CD8+ Cells From Donor Lymphocyte Infusion in Order to Reduce Graft-versus-Host Disease (GvHD) Without Compromising an Anti-Leukemia Effect in Patients With Chronic Myeloid Leukemia Given HLA-Identical Sibling Peripheral Blood Stem Cell Transplants After Non-Myeloablative Conditioning|Withdrawn||Phase 2|0|Actual|Jonsson Comprehensive Cancer Center||||study never opened|f||||||||||||||2017-02-18 18:16:07.625507|2017-02-18 18:16:07.625507
NCT00004877|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2009-12-02|||July 1999||1999-07-01|December 2009|2009-12-01||||April 2001|Actual|2001-04-01||Interventional|||BMS-214662 in Treating Patients With Advanced Solid Tumors|Phase I Study of BMS-214662 Oral Dosing in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:07.714029|2017-02-18 18:16:07.714029
NCT00004876|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-08-23|||August 1999||1999-08-01|November 2011|2011-11-01||||||||Interventional|||Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer|A Randomized Study Comparing Carboplatin and Thalidomide With Carboplatin Alone in Patients With Stage Ic - IV Ovarian Cancer|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:07.795604|2017-02-18 18:16:07.795604
NCT00004875|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2011-02-18|||July 1996||1996-07-01|February 2011|2011-02-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Observational|||Heparin or Enoxaparin in Patients With Cancer|Release of TFPI by Anticoagulants in Cancer Patients by Standard or LMW Heparin|Completed||N/A|6|Actual|Northwestern University|||2||f||||t||||||||||2017-02-18 18:16:07.896676|2017-02-18 18:16:07.896676
NCT00004874|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-04-17|||November 1998||1998-11-01|April 2013|2013-04-01|November 2012|Actual|2012-11-01|April 2002|Actual|2002-04-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|Expanded Access Study of Iodine-131 Anti-B1 Antibody for Relapsed/Refractory Low-Grade and Transformed Low-Grade Non-Hodgkin's Lymphoma|Terminated||Phase 3|31|Actual|University of Nebraska||1||lack of FDA approval|f||||||||||||||2017-02-18 18:16:08.285458|2017-02-18 18:16:08.285458
NCT00004873|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-14|||August 1999||1999-08-01|May 2012|2012-05-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer|Taxotere-Cisplatin-5FU (TCF) Versus Taxotere-Cisplatin (TC) Versus Epirubicin-Cisplatin-5FU (ECF) as Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial|Completed||Phase 2|||Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:16:08.383804|2017-02-18 18:16:08.383804
NCT00004872|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2015-09-30|||March 2000||2000-03-01|September 2015|2015-09-01||||||||Interventional|||Endostatin in Treating Patients With Advanced Refractory Solid Tumors|Phase I Study of Endostatin in Advanced Cancer Patients|Completed||Phase 1|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:16:08.487845|2017-02-18 18:16:08.487845
NCT00004871|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2010-03-09|||May 2000||2000-05-01|March 2010|2010-03-01||||||||Interventional|||Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome|Phase I, Dose De-Escalation to Minimal Effective Pharmacologic Dose Trial of Sodium Phenylbutyrate (PB, NSC 657802) in Combination With 5-Azacytidine (5-AZA, NSC 102816) in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:16:08.772952|2017-02-18 18:16:08.772952
NCT00004870|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-02-19|||June 2000||2000-06-01|February 2013|2013-02-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer|A Phase I/II, Pharmacokinetic, and Biologic Correlative Study of G3139, NSC # 683428 (Phosphorothioate Antisense Oligonucleotide Directed to Bcl-2) and Irinotecan in Patients With Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 18:16:08.866053|2017-02-18 18:16:08.866053
NCT00004868|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2008-11-22|||February 2000||2000-02-01|March 2003|2003-03-01||||||||Interventional|||SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy|A Phase I/II Trial of SU5416 in Patients With Recurrent High Grade Astrocytomas or Mixed Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:08.97582|2017-02-18 18:16:08.97582
NCT00004867|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2017-01-20|||November 1999||1999-11-01|January 2017|2017-01-01|January 2009|Actual|2009-01-01|July 2005|Actual|2005-07-01||Interventional|||Positron Emission Tomography in Determining Stage of Esophageal Cancer|The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Carcinoma of the Thoracic Esophagus|Completed||N/A|235|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:16:09.088303|2017-02-18 18:16:09.088303
NCT00004866|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-05-15|||January 2000||2000-01-01|May 2012|2012-05-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Advanced or Recurrent Squamous Cell Cancer of the Cervix|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:16:09.24955|2017-02-18 18:16:09.24955
NCT00004865|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2009-03-06|||November 1999||1999-11-01|March 2009|2009-03-01||||January 2002|Actual|2002-01-01||Interventional|||Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy|Phase II Study of Cetuximab Anti-Epidermal Growth Factor Receptor (EGFr) Antibody in Combination With Chemotherapy in Patients With Metastatic or Recurrent Squamous Cell Head and Neck Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:09.345938|2017-02-18 18:16:09.345938
NCT00004864|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2011-12-29|||July 1999||1999-07-01|July 2008|2008-07-01||||||||Interventional|||Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors|A Phase I Open-Label Safety Study of Escalating Doses of Taxotere in Combination With Escalating Doses of GEM231 in Patients With Refractory Solid Tumors|Completed||Phase 1|||Montefiore Medical Center|||||f||||||||||||||2017-02-18 18:16:09.448747|2017-02-18 18:16:09.448747
NCT00004863|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2010-10-25|||July 1999||1999-07-01|October 2010|2010-10-01||||||||Interventional|||Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors|A Phase I Open-Label Safety Study of Escalating Doses of Taxol in Combination With Escalating Doses of GEM231 in Patients With Refractory Solid Tumors|Completed||Phase 1|||Montefiore Medical Center|||||f||||||||||||||2017-02-18 18:16:09.537606|2017-02-18 18:16:09.537606
NCT00004862|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-01-31|||October 1999||1999-10-01|May 2002|2002-05-01||||December 2001|Actual|2001-12-01||Interventional|||Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia|A Phase I Study of G3139 (NSC 683428) in Combination With Salvage Chemotherapy for Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL)|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:16:09.623415|2017-02-18 18:16:09.623415
NCT00004861|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2012-08-08|||October 1999||1999-10-01|August 2012|2012-08-01|September 2001|Actual|2001-09-01|||||Interventional|||Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of CI-994 Capsules Plus Gemcitabine Infusion Versus Placebo Capsules Plus Gemcitabine Infusion in the Treatment of Patients With Advanced Pancreatic Cancer|Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-02-18 18:16:09.725732|2017-02-18 18:16:09.725732
NCT00004860|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-08-22|||June 2000||2000-06-01|August 2013|2013-08-01||||October 2005|Actual|2005-10-01||Interventional|||Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer|A Phase II Study of ORZEL (UFT + Leucovorin) in Elderly (at Least 75 Years Old) Patients With Colorectal Cancer|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:16:09.83897|2017-02-18 18:16:09.83897
NCT00004859|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2014-05-29|2012-02-16||January 2000||2000-01-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|December 2009|Actual|2009-12-01||Interventional|||Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer|A Randomized Phase III Trial of Carboplatin, Paclitaxel and Thoracic Radiotherapy, With or Without Thalidomide, in Patients With Stage III Non-Small Cell Lung Cancer (NSCLC)|Terminated||Phase 3|589|Actual|National Cancer Institute (NCI)||2||Trial was stopped early for futility|f||||t||||||||||2017-02-18 18:16:09.99867|2017-02-18 18:16:09.99867
NCT00004858|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-09-19|||March 2000||2000-03-01|July 2007|2007-07-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma|A Phase I Study of B43-Genistein Immunoconjugate in Recurrent B-Lineage Acute Lymphoblastic Leukemia and Non Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:11.207946|2017-02-18 18:16:11.207946
NCT00004857|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2016-07-01|||January 2000||2000-01-01|July 2016|2016-07-01|February 2010|Actual|2010-02-01|March 2003|Actual|2003-03-01||Interventional|||Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia|A Phase II Study of Fludarabine Induction Followed by CAMPATH-1H Consolidation in Untreated Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|86|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:16:11.319907|2017-02-18 18:16:11.319907
NCT00004856|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-07|2013-05-01|||July 2002||2002-07-01|May 2013|2013-05-01||||July 2002|Actual|2002-07-01||Interventional|||Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium|A Phase II Trial of Trastuzumab (Herceptin; NSC #688097, IND #6667) in Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma|Terminated||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 18:16:11.487946|2017-02-18 18:16:11.487946
NCT00004855|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-29|2012-05-17||||||May 2012|2012-05-01|April 2005|Actual|2005-04-01|||||Interventional|||Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs|A Randomized, Open-Label, Pilot Treatment Trial Evaluating Cellular Dynamics and Immune Restoration in Treatment-Naive HIV-Infected Subjects Receiving Either the Protease Inhibitor LPV/r or the Nucleoside Analogue Reverse Transcriptase Inhibitors d4T/3TC/Abacavir With the Non-Nucleoside Reverse Transcriptase Inhibitor Nevirapine|Completed||N/A|55||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:16:11.595952|2017-02-18 18:16:11.595952
NCT00004854|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-08|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure||Completed||Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:11.71776|2017-02-18 18:16:11.71776
NCT00004853|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-04|2017-01-24|||March 3, 2000||2000-03-03|January 27, 2016|2016-01-27|May 20, 2009|Actual|2009-05-20|May 20, 2009|Actual|2009-05-20||Interventional|||Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy|A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults With Sarcoma Treated With Dose-Intensive Chemotherapy|Completed||Phase 1|29|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 18:16:11.798183|2017-02-18 18:16:11.798183
NCT00004852|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-02|2005-06-23|||September 1999||1999-09-01|August 2000|2000-08-01||||||||Interventional|||Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs|A Phase II/III 48-Week, Randomized, Double-Blind, Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lamivudine 300mg Once Daily Vs. Lamivudine 150mg BID in Combination With Zidovudine 300mg BID and Efavirenz 600mg Once Daily in Antiretroviral-Naive Adults With HIV-1 Infection|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:16:11.909035|2017-02-18 18:16:11.909035
NCT00004851|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-02|2008-03-03|||April 1999||1999-04-01|March 2000|2000-03-01|May 2001||2001-05-01|||||Observational|||Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies|Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies|Completed||N/A|1||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:12.335264|2017-02-18 18:16:12.335264
NCT00004850|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-02|2017-01-24|||April 25, 1991||1991-04-25|November 10, 2016|2016-11-10||||||||Observational|||Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection|Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:12.428647|2017-02-18 18:16:12.428647
NCT00004848|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-02|2008-03-03|||July 1981||1981-07-01|July 1999|1999-07-01|May 2000||2000-05-01|||||Observational|||A Controlled Prospective Study of Transfusion-Associated Hepatitis|A Controlled Prospective Study of Transfusion-Associated Hepatitis|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:12.54147|2017-02-18 18:16:12.54147
NCT00004847|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-02|2017-01-24|||February 29, 2000||2000-02-29|January 6, 2017|2017-01-06||||||||Observational|||Diagnosis of Pheochromocytoma|Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma|Recruiting||N/A|2400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:12.630673|2017-02-18 18:16:12.630673
NCT00004846|ClinicalTrials.gov processed this data on February 17, 2017|2000-03-02|2008-03-03|||December 1999||1999-12-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV|Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV|Completed||N/A|30000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:12.744302|2017-02-18 18:16:12.744302
NCT00004845|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-28|2009-12-10||||||June 2009|2009-06-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)|A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease|Completed||Phase 2/Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:16:12.829986|2017-02-18 18:16:12.829986
NCT00004844|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||July 1998||1998-07-01|January 1999|1999-01-01||||||||Interventional|||Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease||Unknown status|Active, not recruiting|N/A|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:12.960589|2017-02-18 18:16:12.960589
NCT00004843|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1994||1994-06-01|December 1998|1998-12-01||||||||Interventional|||A Randomized Study of Surgery Vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism||Unknown status|Active, not recruiting|N/A|100||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:13.037208|2017-02-18 18:16:13.037208
NCT00004834|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2013-02-20|||May 1998||1998-05-01|February 2013|2013-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder||Completed||N/A|326||Northwell Health|||||f||||||||||||||2017-02-18 18:16:13.361178|2017-02-18 18:16:13.361178
NCT00004833|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-04-06|||July 1995||1995-07-01|September 2002|2002-09-01|November 2002||2002-11-01|||||Interventional|||Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome||Terminated||N/A|170||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:13.448523|2017-02-18 18:16:13.448523
NCT00004832|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||August 1994||1994-08-01|July 1998|1998-07-01|June 1998||1998-06-01|||||Interventional|||Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome||Completed||N/A|26||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:13.526723|2017-02-18 18:16:13.526723
NCT00004831|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||October 1996||1996-10-01|August 1998|1998-08-01|July 1998||1998-07-01|||||Interventional|||Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria||Completed||N/A|20||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:13.61081|2017-02-18 18:16:13.61081
NCT00004829|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||June 1995||1995-06-01|June 1998|1998-06-01|May 1998||1998-05-01|||||Interventional|||Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis||Completed||Phase 3|200||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:13.68985|2017-02-18 18:16:13.68985
NCT00004828|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||December 1994||1994-12-01|June 1998|1998-06-01|December 1997||1997-12-01|||||Interventional|||Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure||Completed||Phase 1|28||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:13.783313|2017-02-18 18:16:13.783313
NCT00004827|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||March 1996||1996-03-01|May 1998|1998-05-01|June 2002||2002-06-01|||||Interventional|||Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa||Completed||N/A|46||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:13.872849|2017-02-18 18:16:13.872849
NCT00004826|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||October 1993||1993-10-01|May 1998|1998-05-01|November 1997||1997-11-01|||||Interventional|||Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease||Completed||N/A|60||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:13.95803|2017-02-18 18:16:13.95803
NCT00004825|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||May 1998||1998-05-01|July 1998|1998-07-01|May 1998||1998-05-01|||||Interventional|||Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism||Completed||N/A|10||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:14.037926|2017-02-18 18:16:14.037926
NCT00004817|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||February 1991||1991-02-01|December 2001|2001-12-01||||||||Interventional|||Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures||Completed||Phase 3|385||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.118473|2017-02-18 18:16:14.118473
NCT00004816|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||July 1995||1995-07-01|December 2001|2001-12-01||||||||Interventional|||A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis||Completed||Phase 1|25||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.201717|2017-02-18 18:16:14.201717
NCT00004815|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||May 1992||1992-05-01|July 2004|2004-07-01||||||||Interventional|||Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome||Completed||N/A|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.289324|2017-02-18 18:16:14.289324
NCT00004814|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||October 1991||1991-10-01|January 1997|1997-01-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis||Completed||Phase 3|250||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.372329|2017-02-18 18:16:14.372329
NCT00004812|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||July 1995||1995-07-01|December 2001|2001-12-01||||||||Interventional|||Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord Injury||Completed||Phase 2|26||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.446979|2017-02-18 18:16:14.446979
NCT00004811|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2006-06-08|||March 1985||1985-03-01|December 2001|2001-12-01||||||||Interventional|||Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis||Completed||Phase 1/Phase 2|7||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.527014|2017-02-18 18:16:14.527014
NCT00004810|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1996||1996-06-01|December 2001|2001-12-01||||||||Interventional|||Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis||Completed||Phase 2|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.624397|2017-02-18 18:16:14.624397
NCT00004809|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1992||1992-06-01|December 2001|2001-12-01||||||||Interventional|||Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia||Completed||Phase 1|5||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.710354|2017-02-18 18:16:14.710354
NCT00004808|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2006-06-08|||September 1991||1991-09-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis||Completed||Phase 2|78||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.7889|2017-02-18 18:16:14.7889
NCT00004807|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||January 1995||1995-01-01|December 1998|1998-12-01||||||||Interventional|||Study of the Pathogenesis of Rett Syndrome||Completed||N/A|120||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:14.871046|2017-02-18 18:16:14.871046
NCT00004806|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2011-03-29|||June 1995||1995-06-01|March 2011|2011-03-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis||Completed||Phase 1|9||University of Alabama at Birmingham|||||f||||f||||||||||2017-02-18 18:16:14.957782|2017-02-18 18:16:14.957782
NCT00004805|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||September 1991||1991-09-01|February 2001|2001-02-01|August 1997||1997-08-01|||||Interventional|||Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death||Completed||N/A|500||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.0391|2017-02-18 18:16:15.0391
NCT00004804|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|February 1997|1997-02-01||||||||Interventional|||Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C||Completed||Phase 3|57||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.118091|2017-02-18 18:16:15.118091
NCT00004802|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1992||1992-06-01|January 1998|1998-01-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders||Completed||Phase 3|64||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.198722|2017-02-18 18:16:15.198722
NCT00004801|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||March 1992||1992-03-01|January 1998|1998-01-01||||||||Interventional|||Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency||Completed||Phase 1/Phase 2|3||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.285536|2017-02-18 18:16:15.285536
NCT00004800|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||September 1992||1992-09-01|February 1998|1998-02-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines||Completed||Phase 3|13250||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.367747|2017-02-18 18:16:15.367747
NCT00004799|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||April 1991||1991-04-01|January 1997|1997-01-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines||Completed||Phase 3|10000||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.454344|2017-02-18 18:16:15.454344
NCT00004797|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1995||1995-08-01|December 2001|2001-12-01||||||||Interventional|||Pilot Study of Fructose for Sickle Cell Crisis||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.532302|2017-02-18 18:16:15.532302
NCT00004796|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||November 1994||1994-11-01|February 1998|1998-02-01|February 1997||1997-02-01|||||Interventional|||Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis||Completed||Phase 2|16||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.622993|2017-02-18 18:16:15.622993
NCT00004795|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1994||1994-08-01|December 2001|2001-12-01||||||||Interventional|||Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus||Completed||Phase 2/Phase 3|190||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.698288|2017-02-18 18:16:15.698288
NCT00004794|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||March 1995||1995-03-01|January 1998|1998-01-01||||||||Interventional|||Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis||Completed||Phase 2|90||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.779224|2017-02-18 18:16:15.779224
NCT00004793|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1995||1995-06-01|December 2001|2001-12-01||||||||Observational|||Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal Children||Completed||N/A|4||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:15.855319|2017-02-18 18:16:15.855319
NCT00004791|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1995||1995-08-01|December 2001|2001-12-01||||||||Observational|||Study of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents With Epidermolysis Bullosa||Completed||N/A|15||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.187737|2017-02-18 18:16:16.187737
NCT00004789|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||July 1993||1993-07-01|December 2001|2001-12-01||||||||Interventional|||Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria||Completed||Phase 1/Phase 2|59||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.259318|2017-02-18 18:16:16.259318
NCT00004788|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||May 1988||1988-05-01|December 2001|2001-12-01||||||||Observational|||Study of Nutritional Factors in Porphyria||Completed||N/A|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.355502|2017-02-18 18:16:16.355502
NCT00004787|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||December 1994||1994-12-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.428165|2017-02-18 18:16:16.428165
NCT00004786|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||December 1995||1995-12-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis||Completed||Phase 3|200||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.514639|2017-02-18 18:16:16.514639
NCT00004785|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||November 1995||1995-11-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia||Completed||Phase 3|54||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.597049|2017-02-18 18:16:16.597049
NCT00004784|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||January 1994||1994-01-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis||Completed||Phase 3|315||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.677162|2017-02-18 18:16:16.677162
NCT00004781|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||September 1989||1989-09-01|February 1997|1997-02-01||||||||Observational|||Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups||Completed||N/A|250||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.762071|2017-02-18 18:16:16.762071
NCT00004779|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||January 1993||1993-01-01|December 2001|2001-12-01||||||||Interventional|||Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis||Completed||Phase 1|12||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.841815|2017-02-18 18:16:16.841815
NCT00004778|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery||Completed||Phase 3|1090||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.916353|2017-02-18 18:16:16.916353
NCT00004776|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||November 1993||1993-11-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome||Completed||Phase 3|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:16.997598|2017-02-18 18:16:16.997598
NCT00004773|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1995||1995-08-01|January 1997|1997-01-01|June 1997||1997-06-01|||||Observational|||Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome||Completed||N/A|95||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.080878|2017-02-18 18:16:17.080878
NCT00004772|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||September 1992||1992-09-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy||Completed||Phase 3|90||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.167239|2017-02-18 18:16:17.167239
NCT00004769|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2013-01-25|||December 1993||1993-12-01|January 2013|2013-01-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Observational|||Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy|Myotonic Dystrophy:Muscle Wasting and Altered Metabolism|Completed||N/A|130|Actual|University of Rochester|||4||f||||f||||||||||2017-02-18 18:16:17.409005|2017-02-18 18:16:17.409005
NCT00004767|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||January 1985||1985-01-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.500723|2017-02-18 18:16:17.500723
NCT00004763|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||January 1993||1993-01-01|December 2001|2001-12-01||||||||Interventional|||Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism||Completed||Phase 2|45||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.584085|2017-02-18 18:16:17.584085
NCT00004762|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||December 1994||1994-12-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis||Completed||Phase 2|5||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.669091|2017-02-18 18:16:17.669091
NCT00004761|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||September 1986||1986-09-01|July 2004|2004-07-01||||||||Observational|||Establishment of the National Epidermolysis Bullosa Registry||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.743717|2017-02-18 18:16:17.743717
NCT00004760|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||May 1995||1995-05-01|April 1998|1998-04-01|December 1997||1997-12-01|||||Interventional|||Study of Axial Mobility Exercises in Parkinson Disease||Completed||N/A|80||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.832386|2017-02-18 18:16:17.832386
NCT00004759|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2008-09-08|||December 1991||1991-12-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury|Phase III Randomized, Double-Blind Study of Methylprednisolone by 24- Versus 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury|Completed||Phase 3|497||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:17.916997|2017-02-18 18:16:17.916997
NCT00004758|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||November 1993||1993-11-01|December 2001|2001-12-01||||||||Interventional|||Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment||Completed||Phase 2|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.013041|2017-02-18 18:16:18.013041
NCT00004757|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1992||1992-08-01|January 1998|1998-01-01||||||||Interventional|||Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth||Completed||Phase 3|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.112188|2017-02-18 18:16:18.112188
NCT00004756|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||December 1994||1994-12-01|December 2001|2001-12-01||||||||Interventional|||Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus|Randomized Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus|Completed||N/A|150||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.202035|2017-02-18 18:16:18.202035
NCT00004755|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||September 1995||1995-09-01|January 1998|1998-01-01||||||||Interventional|||Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil|Phase II Randomized Study of Allopurinol Versus Glucantime Versus Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil|Completed||Phase 2|375||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.279247|2017-02-18 18:16:18.279247
NCT00004754|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|December 2001|2001-12-01||||||||Interventional|||Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension||Completed||Phase 4|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.385192|2017-02-18 18:16:18.385192
NCT00004753|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|December 2001|2001-12-01||||||||Observational|||Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease||Completed||N/A|90||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.462254|2017-02-18 18:16:18.462254
NCT00004751|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||October 1991||1991-10-01|February 1997|1997-02-01||||||||Interventional|||Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy Alone for Spastic Diplegia||Unknown status|Active, not recruiting|Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.535695|2017-02-18 18:16:18.535695
NCT00004748|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||November 1989||1989-11-01|December 2001|2001-12-01||||||||Interventional|||Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis|Phase III Randomized, Double-Blind, Placebo-Controlled Study of Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis|Completed||Phase 3|90||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.616157|2017-02-18 18:16:18.616157
NCT00004747|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||July 1995||1995-07-01|December 2001|2001-12-01||||||||Interventional|||Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis||Completed||Phase 2|170||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.699193|2017-02-18 18:16:18.699193
NCT00004744|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2008-09-08|||February 1993||1993-02-01|September 2008|2008-09-01||||September 1998|Actual|1998-09-01||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis||Completed||Phase 3|76||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.776701|2017-02-18 18:16:18.776701
NCT00004740|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||February 1995||1995-02-01|January 1998|1998-01-01||||||||Interventional|||Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users||Unknown status|Active, not recruiting|N/A|300||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:18.861035|2017-02-18 18:16:18.861035
NCT00004739|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-29|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||The Metabolic Effects of Protease Inhibitors in HIV Infected Children||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:18.945796|2017-02-18 18:16:18.945796
NCT00004738|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-26|2017-01-24|||February 24, 2000||2000-02-24|October 5, 2016|2016-10-05||||||||Observational|||Genetic Analysis of the Chiari I Malformation|Genetic Analysis of the Chiari I Malformation|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:19.025005|2017-02-18 18:16:19.025005
NCT00004686|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||February 1994||1994-02-01|March 1999|1999-03-01|September 1999||1999-09-01|||||Interventional|||Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis||Completed||Phase 2|300||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:22.084477|2017-02-18 18:16:22.084477
NCT00004736|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2008-09-10||||||June 2003|2003-06-01||||||||Interventional|||Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis|Viral and Immune Dynamics in HIV-Infected Patients With Tuberculosis|Completed||Phase 1|44||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:16:19.131428|2017-02-18 18:16:19.131428
NCT00004735|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2013-10-04|||February 2000||2000-02-01|October 2013|2013-10-01|September 2006|Actual|2006-09-01|||||Interventional|||The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV|The Effects of Highly Active Antiretroviral Therapy (HAART) on the Recovery of Immune Function in HIV-Infected Children and Young Adults|Completed||N/A|81|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:16:19.24985|2017-02-18 18:16:19.24985
NCT00004734|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2005-06-23|||September 1996||1996-09-01|April 2004|2004-04-01|February 2004||2004-02-01|||||Interventional|||Vitamin Therapy for Prevention of Stroke|Vitamin Intervention for Stroke Prevention|Completed||Phase 3|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:16:19.381873|2017-02-18 18:16:19.381873
NCT00004733|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2005-06-23|||January 1998||1998-01-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Timing of Levodopa Treatment in Parkinson's Disease|Earlier Versus Later L-Dopa in Parkinson's Disease|Completed||Phase 3|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:16:19.474629|2017-02-18 18:16:19.474629
NCT00004732|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2016-01-04|2013-09-26||December 2000||2000-12-01|October 2015|2015-10-01|December 2016|Anticipated|2016-12-01|February 2011|Actual|2011-02-01||Interventional|CREST||Carotid Revascularization Endarterectomy Versus Stenting Trial|Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)|Active, not recruiting||Phase 3|2502|Actual|Rutgers, The State University of New Jersey||2|||f||||t||||||||||2017-02-18 18:16:19.571938|2017-02-18 18:16:19.571938
NCT00004731|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2005-06-23|||September 1998||1998-09-01|December 2003|2003-12-01|October 2003||2003-10-01|||||Interventional|||Parkinson's Disease Treatment With Coenzyme Q10|Effects of Coenzyme Q10 in Early Parkinson's Disease|Completed||Phase 2|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:16:20.74022|2017-02-18 18:16:20.74022
NCT00004730|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2011-10-26|||August 1998||1998-08-01|October 2011|2011-10-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Magnesium Sulfate For Brain Injury|Magnesium Sulfate for Neuroprotection After Brain Trauma|Completed||Phase 3|||University of Washington|||||f||||t||||||||||2017-02-18 18:16:20.831391|2017-02-18 18:16:20.831391
NCT00004729|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2006-12-21|||July 1997||1997-07-01|December 2006|2006-12-01||||||||Interventional|||Ketogenic Diet for Child Epilepsy and Seizure Control|Efficacy of the Ketogenic Diet -- a Blinded Study|Completed||N/A|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:16:20.932718|2017-02-18 18:16:20.932718
NCT00004728|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2006-06-05||||||June 2006|2006-06-01|July 2003||2003-07-01|||||Interventional|||Aspirin Or Warfarin To Prevent Stroke|Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study|Terminated||Phase 3|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:16:21.025568|2017-02-18 18:16:21.025568
NCT00004727|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-25|2005-06-23||||||June 2003|2003-06-01||||||||Interventional|||Antiplatelet Therapy to Prevent Stroke in African Americans|African American Antiplatelet Stroke Prevention Study|Completed||Phase 4|||National Institute of Neurological Disorders and Stroke (NINDS)|||||f||||||||||||||2017-02-18 18:16:21.116982|2017-02-18 18:16:21.116982
NCT00004705|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||September 1996||1996-09-01|March 1999|1999-03-01|January 1999||1999-01-01|||||Interventional|||Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis||Completed||N/A|||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.215212|2017-02-18 18:16:21.215212
NCT00004700|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||August 1995||1995-08-01|March 1999|1999-03-01|January 1999||1999-01-01|||||Interventional|||Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism||Completed||Phase 2|16||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.300246|2017-02-18 18:16:21.300246
NCT00004699|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||August 1995||1995-08-01|March 1999|1999-03-01|January 1999||1999-01-01|||||Interventional|||Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism||Completed||N/A|8||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.384231|2017-02-18 18:16:21.384231
NCT00004697|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||November 1997||1997-11-01|March 1999|1999-03-01|March 1999||1999-03-01|||||Interventional|||Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition||Completed||N/A|15||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.469723|2017-02-18 18:16:21.469723
NCT00004696|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||August 1994||1994-08-01|May 1999|1999-05-01|July 1998||1998-07-01|||||Interventional|||Study of Morphine in Postoperative Infants to Allow Normal Ventilation||Completed||N/A|100||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.557485|2017-02-18 18:16:21.557485
NCT00004695|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||September 1997||1997-09-01|May 1999|1999-05-01|March 2000||2000-03-01|||||Interventional|||Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency||Completed||N/A|48||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.641109|2017-02-18 18:16:21.641109
NCT00004694|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||January 1994||1994-01-01|April 1999|1999-04-01|September 1998||1998-09-01|||||Interventional|||Study of Heparin Prophylaxis of Hereditary Angioedema Exacerbations||Completed||N/A|24||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.721886|2017-02-18 18:16:21.721886
NCT00004690|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||September 1996||1996-09-01|March 1999|1999-03-01|September 1998||1998-09-01|||||Interventional|||Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis||Completed||Phase 3|90||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.802281|2017-02-18 18:16:21.802281
NCT00004689|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||January 1991||1991-01-01|February 1999|1999-02-01|September 1998||1998-09-01|||||Interventional|||Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease||Completed||Phase 2|50||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.887342|2017-02-18 18:16:21.887342
NCT00004688|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||August 1996||1996-08-01|March 1999|1999-03-01|July 1998||1998-07-01|||||Interventional|||Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms||Completed||Phase 2|35||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:21.989001|2017-02-18 18:16:21.989001
NCT00004685|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||January 1998||1998-01-01|March 1999|1999-03-01|September 2000||2000-09-01|||||Interventional|||Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy||Completed||N/A|90||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:22.165646|2017-02-18 18:16:22.165646
NCT00004682|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2015-03-24|||March 1995||1995-03-01|March 1999|1999-03-01|March 1999||1999-03-01|||||Interventional|||Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis||Terminated||N/A|100||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:22.246119|2017-02-18 18:16:22.246119
NCT00004670|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||October 1994||1994-10-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Pallidotomy for Parkinson Disease||Completed||Phase 2|60||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:22.331009|2017-02-18 18:16:22.331009
NCT00004669|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1996||1996-06-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia||Completed||Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:22.418614|2017-02-18 18:16:22.418614
NCT00004667|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||October 1993||1993-10-01|December 2001|2001-12-01||||||||Interventional|||Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease||Completed||Phase 1|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:22.507064|2017-02-18 18:16:22.507064
NCT00004665|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1995||1995-06-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:22.599674|2017-02-18 18:16:22.599674
NCT00004664|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1995||1995-06-01|December 2001|2001-12-01||||||||Interventional|||Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting||Completed||N/A|69||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:22.675973|2017-02-18 18:16:22.675973
NCT00004663|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||February 1994||1994-02-01|July 2004|2004-07-01||||||||Observational|||Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus||Completed||N/A|480||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:22.758642|2017-02-18 18:16:22.758642
NCT00004662|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||March 1996||1996-03-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus||Completed||Phase 3|300||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:22.840076|2017-02-18 18:16:22.840076
NCT00004661|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||May 1993||1993-05-01|December 2001|2001-12-01||||||||Observational|||Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:22.930028|2017-02-18 18:16:22.930028
NCT00004660|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||June 1993||1993-06-01|January 1999|1999-01-01||||||||Interventional|||Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy||Unknown status|Active, not recruiting|Phase 2|42||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.00517|2017-02-18 18:16:23.00517
NCT00004659|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||November 1994||1994-11-01|March 1999|1999-03-01||||||||Interventional|||Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors||Unknown status|Active, not recruiting|Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.091282|2017-02-18 18:16:23.091282
NCT00004658|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||March 1995||1995-03-01|December 2001|2001-12-01||||||||Interventional|||Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity||Completed||Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.17104|2017-02-18 18:16:23.17104
NCT00004656|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||May 1993||1993-05-01|February 1999|1999-02-01||||||||Interventional|||Nutritional Aspects of Rett Syndrome||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.255501|2017-02-18 18:16:23.255501
NCT00004654|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||January 1996||1996-01-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia||Completed||Phase 3|60||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.324917|2017-02-18 18:16:23.324917
NCT00004652|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||February 1993||1993-02-01|December 2001|2001-12-01||||||||Interventional|||Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome||Completed||Phase 2|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.396988|2017-02-18 18:16:23.396988
NCT00004650|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||August 1993||1993-08-01|June 1999|1999-06-01||||||||Interventional|||Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss||Completed||Phase 3|150||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.48633|2017-02-18 18:16:23.48633
NCT00004649|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||May 1995||1995-05-01|December 2001|2001-12-01||||||||Observational|||Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.593112|2017-02-18 18:16:23.593112
NCT00004648|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||May 1996||1996-05-01|December 2001|2001-12-01||||||||Observational|||Studies of Hereditary Hemorrhagic Telangiectasia|Studies of Hereditary Hemorrhagic Telangiectasia: Screening Methods for Pulmonary Arteriovenous Malformations; Prevalence of Pulmonary and Cerebral Arteriovenous Malformations; Prevalence of Cardiac Valve Abnormalities; and Identification of Modifier Genes|Completed||N/A|65||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.662838|2017-02-18 18:16:23.662838
NCT00004647|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||March 1993||1993-03-01|March 1999|1999-03-01|February 1999||1999-02-01|||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy||Completed||Phase 3|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.729202|2017-02-18 18:16:23.729202
NCT00004646|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||April 1995||1995-04-01|December 2001|2001-12-01||||||||Interventional|||Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy||Completed||Phase 3|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.81343|2017-02-18 18:16:23.81343
NCT00004645|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||January 1995||1995-01-01|March 1999|1999-03-01||||||||Interventional|||Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone||Unknown status|Active, not recruiting|Phase 3|22||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.896664|2017-02-18 18:16:23.896664
NCT00004644|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||February 1995||1995-02-01|March 1999|1999-03-01||||||||Interventional|||Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection||Completed||Phase 1/Phase 2|25||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:23.98378|2017-02-18 18:16:23.98378
NCT00004642|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2005-06-23|||February 1995||1995-02-01|March 1999|1999-03-01||||||||Interventional|||Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease|Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease|Completed||Phase 1/Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:24.141578|2017-02-18 18:16:24.141578
NCT00004641|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-24|2008-09-08|||May 1993||1993-05-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosis|Randomized, Double-Blind Study of Timolol (A Nonselective Beta-Adrenergic Blocker) vs Placebo to Prevent Complications of Hepatic Portal Hypertension in Patients With Cirrhosis|Completed||Phase 2|212||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:24.22267|2017-02-18 18:16:24.22267
NCT00004640|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-17|2012-06-19|||May 1998||1998-05-01|June 2012|2012-06-01|October 2008|Actual|2008-10-01|May 2008|Actual|2008-05-01||Interventional|||"Clinical Trials to Enhance Elders' Oral Health (TEETH)"|Trials to Enhance Elders' Teeth and Oral Health|Completed||Phase 3|1101|Anticipated|University of Washington||1|||f||||t||||||||||2017-02-18 18:16:24.398508|2017-02-18 18:16:24.398508
NCT00004639|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-17|2011-09-16|||February 1996||1996-02-01|June 2011|2011-06-01|April 2007|Actual|2007-04-01|March 2006|Actual|2006-03-01||Interventional|||Cleft Palate Surgery and Speech Development|Velopharyngeal Function for Speech After Palatal Surgery|Completed||Phase 2|475|Actual|University of Florida||1|||f||||t||||||||||2017-02-18 18:16:24.487281|2017-02-18 18:16:24.487281
NCT00004638|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-23|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Immunologic Aspects of the Pathogenesis of Chronic Sinusitis in Children||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:24.585915|2017-02-18 18:16:24.585915
NCT00004637|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-23|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Double-Blind, Placebo-Controlled Trial of Vitamin E as Add-on Therapy for Children With Epilepsy||Completed||Phase 4|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:24.657919|2017-02-18 18:16:24.657919
NCT00004635|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-19|2012-08-13|2012-03-30||February 2000||2000-02-01|August 2012|2012-08-01|March 2010|Actual|2010-03-01|March 2010|Actual|2010-03-01||Interventional|||Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer|A Double Blinded Randomized Crossover Phase III Study of Oral Thalidomide Versus Placebo in Patients With Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation|Completed||Phase 3|159|Actual|National Institutes of Health Clinical Center (CC)|A total of 159 participants were accrued beginning in March 2000 until January 2005. Accrual rates were less than anticipated and the study was closed to further entry by the Independent Data Safety and Monitoring Board for the NCI CCR.|2|||f||||f||||||||||2017-02-18 18:16:24.749352|2017-02-18 18:16:24.749352
NCT00004604|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-02-21|||February 1997||1997-02-01|February 2013|2013-02-01|July 2002|Actual|2002-07-01|June 2001|Actual|2001-06-01||Interventional|||Biological Therapy in Treating Patients With Metastatic Cancer|A Phase I Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous Human Cultured Dendritic Cells in Patients With Metastatic Malignancies Expressing Carcinoembryonic Antigen|Completed||Phase 1|24|Actual|Duke University||1|||f||||f||||||||||2017-02-18 18:16:29.080672|2017-02-18 18:16:29.080672
NCT00004585|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-15|2005-06-23|||October 1999||1999-10-01|November 2000|2000-11-01||||||||Interventional|||A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults|A Phase IV, Open-Label, Multicenter Study of the Efficacy and Safety of Quadruple Combination Antiretroviral Therapy With Combivir (Lamivudine 150mg/Zidovudine 300mg) BID, Ziagen (Abacavir) 300mg BID, and Sustiva (Efavirenz) 600mg QD for 24 Weeks, Followed by the Triple Nucleoside Combination Tablet (Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg) BID Plus Sustiva (Efavirenz) 600mg QD for 24 Weeks in HIV-Infected Adults|Completed||Phase 4|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:16:29.491783|2017-02-18 18:16:29.491783
NCT00004584|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-10|2011-04-28||2011-04-13|December 1999||1999-12-01|April 2011|2011-04-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment|Safety and Antiviral Efficacy of a Novel HIV-1 Protease Inhibitor, BMS-232632, in Combination Regimen(s) as Compared to a Reference Combination Regimen(s) in Antiretroviral-Experienced HIV-Infected Subjects|Completed||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:16:29.596879|2017-02-18 18:16:29.596879
NCT00004583|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19|||March 1999||1999-03-01|February 2009|2009-02-01||||||||Interventional|||A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy|A Randomized, Double-Blind, Phase III Study of ABT-378/Ritonavir Plus Stavudine and Lamivudine vs Nelfinavir Plus Stavudine and Lamivudine in Antiretroviral Naive HIV-Infected Subjects|Completed||Phase 3|660||Abbott|||||f||||||||||||||2017-02-18 18:16:29.735051|2017-02-18 18:16:29.735051
NCT00004582|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2000|2000-08-01||||||||Interventional|||ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past|A Phase II Study of ABT-378/Ritonavir and Efavirenz in Multiple Protease Inhibitor-Experienced Subjects|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:16:29.914645|2017-02-18 18:16:29.914645
NCT00004581|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment|A Randomized, Open-Label, Phase III Study of ABT-378/Ritonavir in Combination With Nevirapine and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) vs. Investigator Selected Protease Inhibitor(s) in Combination With Nevirapine and Two NRTIs in Antiretroviral-Experienced HIV-Infected Subjects|Completed||Phase 3|300||Abbott|||||f||||||||||||||2017-02-18 18:16:30.010731|2017-02-18 18:16:30.010731
NCT00004580|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors|Phase I/II Study of ABT-378/Ritonavir in Protease Inhibitor Experienced HIV-Infected Patients|Completed||Phase 1|||Abbott|||||f||||||||||||||2017-02-18 18:16:30.296167|2017-02-18 18:16:30.296167
NCT00004579|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||April 1998||1998-04-01|June 2003|2003-06-01||||||||Interventional|||A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection|A Phase I, Dose-Ranging Trial of the Pasteur Merieux Connaught (PMC) Oligomeric HIV-1 gp160MN/LAI-2 Vaccine Alone or Primed With Live Recombinant ALVAC-HIV (vCP205) in HIV Seronegative Adults|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:16:30.380142|2017-02-18 18:16:30.380142
NCT00004578|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-04-02|||November 1997||1997-11-01|April 2008|2008-04-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects|Phase I/II Study of ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naive HIV-Infected Patients|Completed||Phase 1/Phase 2|100|Actual|Abbott||2|||f||||f||||||||||2017-02-18 18:16:30.672685|2017-02-18 18:16:30.672685
NCT00004577|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-18|2017-01-24|||February 17, 2000||2000-02-17|October 5, 2016|2016-10-05||||||||Observational|||Study of New Magnetic Resonance Imaging Methods of the Brain|Characterization of Brain Morphology and Activity Using Functional and Anatomical MRI Contrast|Recruiting||N/A|650|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:30.80606|2017-02-18 18:16:30.80606
NCT00004576|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-17|2008-03-03|||February 2000||2000-02-01|February 2000|2000-02-01|August 2000||2000-08-01|||||Interventional|||Study of LY300164 for the Treatment of Parkinson's Disease|AMPA Receptor Blockade With LY300164 in the Treatment of Parkinson's Disease|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:30.919634|2017-02-18 18:16:30.919634
NCT00004575|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-17|2008-03-03|||February 2000||2000-02-01|October 2001|2001-10-01|October 2001||2001-10-01|||||Interventional|||Effects of Miconazole on Blood Flow|Investigation of Miconazole as an Inhibitor of Endothelium-Derived Hyperpolarizing Factor|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:31.003139|2017-02-18 18:16:31.003139
NCT00004574|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-17|2008-03-03|||February 2000||2000-02-01|December 1999|1999-12-01|May 2001||2001-05-01|||||Observational|||Vitamin Replacement in Abetalipoproteinemia|Vitamin Replacement in Abetalipoproteinemia|Completed||N/A|1||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:31.088821|2017-02-18 18:16:31.088821
NCT00004573|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-18|2005-06-23||||||November 2001|2001-11-01||||||||Interventional|||Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:31.179744|2017-02-18 18:16:31.179744
NCT00004572|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-16|2005-06-23||||||April 2000|2000-04-01||||||||Observational|||Identification and Therapy Efficacy of Type 2 Diabetes in Hispanic Patients||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:31.268989|2017-02-18 18:16:31.268989
NCT00004571|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-15|2017-01-24|||February 11, 2000||2000-02-11|December 2, 2016|2016-12-02||||||||Observational|||Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers|Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers With 3.0 Tesla MRI and Magnetoencephalography|Recruiting||N/A|2920|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:31.353051|2017-02-18 18:16:31.353051
NCT00004570|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-14|2017-01-24|||February 8, 2000||2000-02-08|August 31, 2016|2016-08-31||||||||Observational|||Hereditary Deficits in Auditory Processing Leading to Language Impairment|Identification of Hereditary Auditory Temporal Processing Deficits|Completed||N/A|875|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:31.453606|2017-02-18 18:16:31.453606
NCT00004569|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-12|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Incorporating Flow Limitation Into the Diagnosis and Quantification of Sleep Disordered Breathing||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:31.559839|2017-02-18 18:16:31.559839
NCT00004568|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-11|2017-02-04|||February 4, 2000||2000-02-04|January 23, 2017|2017-01-23||||||||Observational|||Study of Inherited Neurological Disorders|Clinical and Molecular Manifestations of Inherited Neurological Disorders|Recruiting||N/A|2500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:31.628763|2017-02-18 18:16:31.628763
NCT00004567|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-11|2008-03-03|||February 2000||2000-02-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes|A Randomized Trial Comparing Methotrexate Versus Mycophenolate Mofetil for Remission Maintenance in Wegener's Granulomatosis and Related Vasculitides|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:31.735237|2017-02-18 18:16:31.735237
NCT00004566|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-11|2008-03-03|||February 2000||2000-02-01|May 2004|2004-05-01|May 2004||2004-05-01|||||Observational|||Study of Fetal Swallowing|Pilot Study: Ultrasonic Evaluation of the Development of the Fetal Upper Aerodigestive Tract: Establishing Clinical Indicators of Deglutitive Function|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:31.830112|2017-02-18 18:16:31.830112
NCT00004565|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-11|2017-01-24|||February 8, 2000||2000-02-08|May 4, 2012|2012-05-04|May 4, 2012||2012-05-04|||||Observational|||Susceptibility to Breast Cancer|Susceptibility to Breast Cancer|Completed||N/A|49|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:31.924496|2017-02-18 18:16:31.924496
NCT00004564|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-11|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:32.017369|2017-02-18 18:16:32.017369
NCT00004563|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-09|2015-03-05|2015-02-19||August 1999||1999-08-01|March 2015|2015-03-01|May 2013|Actual|2013-05-01|May 2013|Actual|2013-05-01||Interventional|SLS||Scleroderma Lung Disease|Cyclophosphamide Versus Placebo in Scleroderma Lung Study|Completed||Phase 3|158|Actual|The University of Texas Health Science Center, Houston||2|||f||||f||||||||||2017-02-18 18:16:32.102091|2017-02-18 18:16:32.102091
NCT00004562|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-09|2014-04-03|2010-05-07||September 1999||1999-09-01|April 2014|2014-04-01|June 2011|Actual|2011-06-01|March 2010|Actual|2010-03-01||Interventional|OAT||Occluded Artery Trial (OAT)|Occluded Artery Trial (OAT) - Randomized Comparative Effectiveness Trial of PCI and Medical Therapy Only Post MI|Completed||Phase 3|2201|Actual|New York University School of Medicine||2|||f||||t||||||||||2017-02-18 18:16:32.45737|2017-02-18 18:16:32.45737
NCT00004561|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-09|2016-05-12|||June 1997||1997-06-01|August 2004|2004-08-01|May 2003|Actual|2003-05-01|||||Interventional|||Treatment of Hypertension With Two Exercise Intensities||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:16:33.2782|2017-02-18 18:16:33.2782
NCT00004560|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-09|2016-04-13|||September 1999||1999-09-01|November 2005|2005-11-01|February 2004||2004-02-01|||||Interventional|||Public Access Defibrillation (PAD) Community Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:16:33.34996|2017-02-18 18:16:33.34996
NCT00004557|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-08|2008-03-03|||January 1992||1992-01-01|February 1999|1999-02-01|April 2000||2000-04-01|||||Observational|||Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders|Models of Disordered Knowledge and Memory Systems in Dementia and Related Disorders|Completed||N/A|650||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:33.67906|2017-02-18 18:16:33.67906
NCT00004556|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-08|2017-01-24|||September 27, 1991||1991-09-27|June 9, 2016|2016-06-09||||||||Observational|||The Effects of Dextroamphetamine on Brain Function|Mechanisms of Individual Variation of Dextroamphetamine Effects in Normal Human Subjects|Completed||N/A|108|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:33.770946|2017-02-18 18:16:33.770946
NCT00004554|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-04|2015-10-02|||January 2000||2000-01-01|September 2013|2013-09-01|February 2006|Actual|2006-02-01|August 2005|Actual|2005-08-01||Interventional|||Sertraline for Alcohol Dependence and Depression|Sertraline for Alcohol Dependence and Depression|Completed||Phase 4|171|Actual|University of Pennsylvania||4|||f||||f||||||||||2017-02-18 18:16:33.862443|2017-02-18 18:16:33.862443
NCT00004553|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-04|2008-03-03|||February 2000||2000-02-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Electromyography to Diagnose Neuromuscular Disorders|Diagnosis of Neuromuscular Disorders With Specialized Electromyographic Studies|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:33.979115|2017-02-18 18:16:33.979115
NCT00004552|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-03|2015-06-30||||||June 2015|2015-06-01|December 2002||2002-12-01|||||Interventional|||Acamprosate Treatment: Mechanisms of Action|Etiology and Treatment of Alcohol Dependence|Completed||Phase 2|120||Yale University|||||f||||||||||||||2017-02-18 18:16:34.275079|2017-02-18 18:16:34.275079
NCT00004551|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-03|2010-09-28|||February 1999||1999-02-01|September 2010|2010-09-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)|Mood Management Training for Alcohol Dependent Smokers|Completed||Phase 4|144|Actual|Mayo Clinic|||||f||||||||||||||2017-02-18 18:16:34.346702|2017-02-18 18:16:34.346702
NCT00004550|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-03|2017-01-24|||January 28, 2000||2000-01-28|April 21, 2008|2008-04-21|April 21, 2008||2008-04-21|||||Observational|||Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions|The Evaluation and Follow-up of Patients With Obsessive-Compulsive Disorder and OC Spectrum Disorders|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:34.435918|2017-02-18 18:16:34.435918
NCT00004549|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-03|2008-03-03|||January 2000||2000-01-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty|MRI Detection of Vascular Inflammation in Patients Undergoing Peripheral Angioplasty|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:16:34.517671|2017-02-18 18:16:34.517671
NCT00004547|ClinicalTrials.gov processed this data on February 17, 2017|2000-02-03|2015-10-19|2011-08-30||January 2000||2000-01-01|September 2015|2015-09-01|August 2009|Actual|2009-08-01|August 2009|Actual|2009-08-01||Interventional|||Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy|Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis|Completed||Phase 2|188|Actual|National Institutes of Health Clinical Center (CC)||3|||f||||f||||||||||2017-02-18 18:16:34.615882|2017-02-18 18:16:34.615882
NCT00004533|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2005-06-23|||August 1999||1999-08-01|February 2001|2001-02-01||||||||Interventional|||Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis||Unknown status|Active, not recruiting|Phase 1|19||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:35.363434|2017-02-18 18:16:35.363434
NCT00004500|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2012-05-01|2012-04-02||March 2000||2000-03-01|May 2012|2012-05-01|November 2004|Actual|2004-11-01|November 2002|Actual|2002-11-01||Interventional|||Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome|A Multicenter, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Bronchoalveolar Lavage With Lucinactant to Standard Care for the Treatment of the Meconium Aspriation Syndrome (MAS) in Newborn Infants|Terminated||Phase 3|69|Actual|Windtree Therapeutics|Early termination led to a small number of subjects analyzed. Results should be interpreted with caution.|2||Slow enrollment and administrative reasons|f||||t||||||||||2017-02-18 18:16:35.444966|2017-02-18 18:16:35.444966
NCT00004498|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||July 1998||1998-07-01|February 2000|2000-02-01|September 2000||2000-09-01|||||Interventional|||Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency||Terminated||Phase 1|21||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:35.962723|2017-02-18 18:16:35.962723
NCT00004497|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|September 1999|1999-09-01|September 2000||2000-09-01|||||Interventional|||Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension||Completed||Phase 3|||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:36.034051|2017-02-18 18:16:36.034051
NCT00004496|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||February 1999||1999-02-01|August 1999|1999-08-01|September 2003||2003-09-01|||||Interventional|||Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure||Completed||Phase 1|45|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:36.126829|2017-02-18 18:16:36.126829
NCT00004495|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||June 1999||1999-06-01|August 1999|1999-08-01|September 2000||2000-09-01|||||Interventional|||Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis||Completed||N/A|84|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:36.214222|2017-02-18 18:16:36.214222
NCT00004494|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2013-03-07|||September 1998||1998-09-01|August 1999|1999-08-01||||||||Interventional|||Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis||Unknown status|Recruiting|Phase 1|18|Anticipated|Stony Brook University|||||f||||||||||||||2017-02-18 18:16:36.304101|2017-02-18 18:16:36.304101
NCT00004493|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1998||1998-09-01|May 2000|2000-05-01|September 2003||2003-09-01|||||Interventional|||Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia||Completed||Phase 2|75|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:36.588615|2017-02-18 18:16:36.588615
NCT00004492|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||October 1999||1999-10-01|January 2001|2001-01-01|September 2001||2001-09-01|||||Interventional|||Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia||Completed||Phase 1/Phase 2|20|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:36.666431|2017-02-18 18:16:36.666431
NCT00004490|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|April 2000|2000-04-01|September 2002||2002-09-01|||||Interventional|||Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic Acidosis||Completed||Phase 3|45||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:36.763811|2017-02-18 18:16:36.763811
NCT00004489|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|January 2000|2000-01-01|September 2002||2002-09-01|||||Interventional|||Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis||Completed||N/A|60|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:36.862898|2017-02-18 18:16:36.862898
NCT00004488|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|March 2000|2000-03-01|September 2002||2002-09-01|||||Interventional|||Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease||Completed||Phase 2|82|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:36.959037|2017-02-18 18:16:36.959037
NCT00004487|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||May 1999||1999-05-01|April 2001|2001-04-01||||||||Interventional|||Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux||Unknown status|Active, not recruiting|Phase 3|60||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:37.056545|2017-02-18 18:16:37.056545
NCT00004486|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1998||1998-09-01|December 2000|2000-12-01|December 2002||2002-12-01|||||Interventional|||Randomized Study of Fluoxetine in Children and Adolescents With Autism||Completed||N/A|45||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:37.135009|2017-02-18 18:16:37.135009
NCT00004485|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2008-09-08|||December 1999||1999-12-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Bone Marrow Transplantation in Treating Children With Sickle Cell Disease|Phase I/II Study of Induction of Stable Mixed Chimerism After Bone Marrow Transplantation From HLA-Identical Donors in Children With Sickle Cell Disease|Completed||Phase 1/Phase 2|50||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:37.222513|2017-02-18 18:16:37.222513
NCT00004483|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-09-27|||January 2002||2002-01-01|September 2005|2005-09-01||||||||Observational|||NF2 Natural History Consortium||Unknown status|Active, not recruiting|N/A|100||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:37.317357|2017-02-18 18:16:37.317357
NCT00004482|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2010-09-08|||December 1999||1999-12-01|September 2010|2010-09-01|July 2006|Actual|2006-07-01|July 2005|Actual|2005-07-01||Interventional|||Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis||Completed||Phase 2|40||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:16:37.430213|2017-02-18 18:16:37.430213
NCT00004481|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1999||1999-11-01|January 2004|2004-01-01||||||||Observational|||Genetic Study of Sitosterolemia||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:37.51853|2017-02-18 18:16:37.51853
NCT00004480|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||July 1999||1999-07-01|July 2004|2004-07-01||||||||Interventional|||Study of Botulinum Toxin in Patients With Primary Hyperhidrosis||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:37.694527|2017-02-18 18:16:37.694527
NCT00004479|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||March 1999||1999-03-01|July 2004|2004-07-01||||||||Interventional|||Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:37.781289|2017-02-18 18:16:37.781289
NCT00004478|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2008-09-17|||March 1999||1999-03-01|September 2008|2008-09-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Droxidopa in Treating Patients With Neurogenic Hypotension|Study of Droxidopa in Patients With Neurologic Hypotension|Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:37.871663|2017-02-18 18:16:37.871663
NCT00004475|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2006-09-05|||December 1998||1998-12-01|September 2006|2006-09-01||||||||Observational|||Genetic Linkage Study for Hereditary Pancreatitis||Unknown status|Recruiting|N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:37.96341|2017-02-18 18:16:37.96341
NCT00004474|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2008-10-01|||September 1998||1998-09-01|October 2008|2008-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia|Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia|Completed||Phase 3|224||Office of Rare Diseases (ORD)||2|||f||||t||||||||||2017-02-18 18:16:38.044235|2017-02-18 18:16:38.044235
NCT00004471|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2011-03-28|||August 1995||1995-08-01|March 2011|2011-03-01||||May 2001|Actual|2001-05-01||Interventional|||Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer||Completed||Phase 1|9||University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 18:16:38.350027|2017-02-18 18:16:38.350027
NCT00004468|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1998||1998-10-01|July 2004|2004-07-01||||||||Interventional|||Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis||Completed||N/A|500||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:38.431252|2017-02-18 18:16:38.431252
NCT00004467|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2010-01-12|||June 1998||1998-06-01|January 2010|2010-01-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen||Completed||Phase 3|173|Actual|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|||||t||||t||||||||||2017-02-18 18:16:38.509995|2017-02-18 18:16:38.509995
NCT00004466|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1998||1998-10-01|June 2000|2000-06-01|December 1999||1999-12-01|||||Interventional|||Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome||Completed||N/A|30||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:38.650649|2017-02-18 18:16:38.650649
NCT00004465|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||July 1998||1998-07-01|October 2003|2003-10-01||||||||Interventional|||Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome||Completed||Phase 3|204||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:38.747555|2017-02-18 18:16:38.747555
NCT00004464|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2007-03-28|||February 1996||1996-02-01|March 2007|2007-03-01||||||||Interventional|||Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria||Unknown status|Active, not recruiting|N/A|25||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:38.872117|2017-02-18 18:16:38.872117
NCT00004458|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||May 1997||1997-05-01|October 2003|2003-10-01||||||||Observational|||Longitudinal and Biological Study of Childhood Disintegrative Disorder||Terminated||N/A|220||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:38.970258|2017-02-18 18:16:38.970258
NCT00004454|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1996||1996-10-01|October 2003|2003-10-01||||||||Interventional|||Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome)||Completed||Phase 1/Phase 2|2||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:39.136402|2017-02-18 18:16:39.136402
NCT00004451|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-11-29|||March 1998||1998-03-01|November 2005|2005-11-01||||||||Interventional|||Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients||Completed||N/A|120||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:16:39.222545|2017-02-18 18:16:39.222545
NCT00004450|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||August 1998||1998-08-01|January 2001|2001-01-01|November 2000||2000-11-01|||||Interventional|||Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy||Completed||N/A|60||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:39.316205|2017-02-18 18:16:39.316205
NCT00004449|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-05-26|||May 1998||1998-05-01|May 2015|2015-05-01|April 2006|Actual|2006-04-01|September 2004|Actual|2004-09-01||Interventional|||Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children With Autism|Randomized Study of Intensive One-on-one Behavioral Treatment Versus Individualized Parent Training in Preschool Aged Children With Autism|Completed||N/A|102|Actual|University of California, Los Angeles||1|||f||||f||||||||||2017-02-18 18:16:39.404783|2017-02-18 18:16:39.404783
NCT00004448|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2008-09-08|||November 1997||1997-11-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy||Completed||Phase 2|123||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:39.502051|2017-02-18 18:16:39.502051
NCT00004446|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||April 1998||1998-04-01|March 2005|2005-03-01||||||||Interventional|||Study of Fluoxetine in Patients With Depersonalization Disorder||Completed||N/A|80||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:16:39.584572|2017-02-18 18:16:39.584572
NCT00004445|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2013-07-31|||September 1996||1996-09-01|July 2013|2013-07-01||||September 2009|Actual|2009-09-01||Interventional|||Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries||Completed||N/A|17|Actual|Case Western Reserve University||1|||f||||||||||||||2017-02-18 18:16:39.673246|2017-02-18 18:16:39.673246
NCT00004444|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||November 1994||1994-11-01|February 2001|2001-02-01|January 2001||2001-01-01|||||Interventional|||Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis||Completed||N/A|24||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:39.778585|2017-02-18 18:16:39.778585
NCT00004443|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||October 1998||1998-10-01|April 2000|2000-04-01|September 2006||2006-09-01|||||Interventional|||Study of NTBC for Tyrosinemia I||Completed||N/A|20|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:39.867916|2017-02-18 18:16:39.867916
NCT00004442|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24||||||November 2000|2000-11-01|April 1999||1999-04-01|||||Interventional|||Study of Bile Acids in Patients With Peroxisomal Disorders||Terminated||N/A|25|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:39.954312|2017-02-18 18:16:39.954312
NCT00004441|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|July 1998|1998-07-01|September 2001||2001-09-01|||||Interventional|||Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis||Completed||N/A|39|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.042529|2017-02-18 18:16:40.042529
NCT00004440|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||August 1996||1996-08-01|April 2000|2000-04-01|June 1999||1999-06-01|||||Interventional|||Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis||Completed||N/A|75||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.141396|2017-02-18 18:16:40.141396
NCT00004438|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|June 1998|1998-06-01|September 2002||2002-09-01|||||Interventional|||Leuprolide in Treating Adults With Hypogonadotropism|Study of Leuprolide in Adults With Hypogonadotropism|Completed||N/A|45|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.218447|2017-02-18 18:16:40.218447
NCT00004437|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||October 1999||1999-10-01|January 2001|2001-01-01|October 2000||2000-10-01|||||Interventional|||Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2||Completed||Phase 2|||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.314833|2017-02-18 18:16:40.314833
NCT00004436|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||July 1993||1993-07-01|August 2000|2000-08-01|June 2000||2000-06-01|||||Interventional|||Randomized Study of Hormonal Regulation of Infantile Hemangioma||Completed||N/A|30||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.397093|2017-02-18 18:16:40.397093
NCT00004433|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||December 1994||1994-12-01|March 2000|2000-03-01|September 2002||2002-09-01|||||Interventional|||Randomized Study of Pergolide in Children With Tourette Syndrome||Completed||N/A|74||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.476333|2017-02-18 18:16:40.476333
NCT00004431|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||June 1998||1998-06-01|April 2000|2000-04-01|September 1999||1999-09-01|||||Interventional|||Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia||Completed||N/A|30|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.560711|2017-02-18 18:16:40.560711
NCT00004430|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1994||1994-09-01|August 2000|2000-08-01|September 1998||1998-09-01|||||Interventional|||Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization||Completed||N/A|150|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.644306|2017-02-18 18:16:40.644306
NCT00004429|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||December 1999||1999-12-01|October 2007|2007-10-01|February 2005|Actual|2005-02-01|||||Interventional|||Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis||Completed||N/A|25|Actual|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.752643|2017-02-18 18:16:40.752643
NCT00004428|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|January 2000|2000-01-01|October 1999||1999-10-01|||||Interventional|||Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis||Completed||Phase 1|35||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.839031|2017-02-18 18:16:40.839031
NCT00004426|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-25|||August 1994||1994-08-01|January 2000|2000-01-01|September 1998||1998-09-01|||||Interventional|||Leuprolide in Determining the Cause of Gonadotropin Deficiency|Study of Gonadotropin Releasing Hormone Agonist Test Using Leuprolide Acetate in Patients With Gonadotropin Deficiency|Completed||N/A|90|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:40.911566|2017-02-18 18:16:40.911566
NCT00004424|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||July 1996||1996-07-01|April 2000|2000-04-01|March 2000||2000-03-01|||||Interventional|||Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy||Completed||N/A|120||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.000759|2017-02-18 18:16:41.000759
NCT00004423|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||December 1995||1995-12-01|January 2000|2000-01-01|March 1998||1998-03-01|||||Interventional|||Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease||Completed||N/A|80||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.091826|2017-02-18 18:16:41.091826
NCT00004422|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||August 1997||1997-08-01|June 2000|2000-06-01|September 2002||2002-09-01|||||Interventional|||Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection||Completed||Phase 3|174||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.167907|2017-02-18 18:16:41.167907
NCT00004421|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|March 2000|2000-03-01|September 2000||2000-09-01|||||Interventional|||Deep Brain Stimulation in Treating Patients With Dystonia|Phase II/III Study of Deep Brain Stimulation in Patients With Dystonia|Completed||Phase 2/Phase 3|15|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.254132|2017-02-18 18:16:41.254132
NCT00004420|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1994||1994-09-01|January 2000|2000-01-01|August 1999||1999-08-01|||||Interventional|||Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis||Completed||N/A|50||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.344711|2017-02-18 18:16:41.344711
NCT00004419|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||April 1998||1998-04-01|June 1999|1999-06-01|September 2000||2000-09-01|||||Interventional|||Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance||Completed||N/A|18|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.428761|2017-02-18 18:16:41.428761
NCT00004418|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2014-09-17|||April 1998||1998-04-01|September 2014|2014-09-01|November 2014|Anticipated|2014-11-01|November 2014|Anticipated|2014-11-01||Interventional|||Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy|Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy|Suspended||Phase 2/Phase 3|30|Anticipated|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||1||No funding and moved to expanded access|f||||t||||||||||2017-02-18 18:16:41.526359|2017-02-18 18:16:41.526359
NCT00004416|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||January 1997||1997-01-01|April 2001|2001-04-01|March 2002||2002-03-01|||||Interventional|||Randomized Study of Botulinum Toxin Type A for Achalasia||Completed||N/A|56||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.639929|2017-02-18 18:16:41.639929
NCT00004415|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-04-06|||May 1991||1991-05-01|September 2002|2002-09-01|September 2000||2000-09-01|||||Interventional|||Study of Combined Intercostal and Diaphragm Pacing for Artificial Respiration in Quadriplegic Patients||Terminated||N/A|5||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.713782|2017-02-18 18:16:41.713782
NCT00004414|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1997||1997-09-01|May 1999|1999-05-01|June 2002||2002-06-01|||||Interventional|||Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis||Completed||N/A|252||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:41.781661|2017-02-18 18:16:41.781661
NCT00004412|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-18|2013-07-22||September 1997||1997-09-01|March 2015|2015-03-01|February 2005|Actual|2005-02-01|December 2002|Actual|2002-12-01||Interventional|||Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers|Phase II Trial of Arginine Butyrate for Treatment of Refractory Leg Ulcers in Sickle Cell Disease or Beta Thalassemia|Completed||Phase 2|23|Actual|Boston University||3|||f||||f||||||||||2017-02-18 18:16:41.87427|2017-02-18 18:16:41.87427
NCT00004410|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||June 1998||1998-06-01|August 1998|1998-08-01|March 2002||2002-03-01|||||Interventional|||Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants||Completed||N/A|50|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:42.491177|2017-02-18 18:16:42.491177
NCT00004409|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||August 1995||1995-08-01|May 2001|2001-05-01|April 2004||2004-04-01|||||Interventional|||Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease||Completed||Phase 2|36|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:42.57743|2017-02-18 18:16:42.57743
NCT00004408|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2012-03-05|||November 1997||1997-11-01|March 2012|2012-03-01|November 1999|Actual|1999-11-01|||||Interventional|||Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease||Completed||Phase 3|300||Mast Therapeutics, Inc.|||||f||||||||||||||2017-02-18 18:16:42.663493|2017-02-18 18:16:42.663493
NCT00004407|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||February 1998||1998-02-01|January 2001|2001-01-01|March 2000||2000-03-01|||||Interventional|||Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy||Terminated||N/A|75||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:42.747034|2017-02-18 18:16:42.747034
NCT00004406|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||October 1999||1999-10-01|January 2000|2000-01-01|July 2004||2004-07-01|||||Interventional|||Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis||Completed||N/A|36|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:43.02599|2017-02-18 18:16:43.02599
NCT00004404|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||April 1997||1997-04-01|May 1998|1998-05-01|September 2002||2002-09-01|||||Interventional|||Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes||Completed||N/A|20|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:43.113398|2017-02-18 18:16:43.113398
NCT00004403|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||May 2000||2000-05-01|January 2001|2001-01-01|March 2002||2002-03-01|||||Interventional|||Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis||Completed||N/A|120||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:43.210333|2017-02-18 18:16:43.210333
NCT00004402|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||November 1999||1999-11-01|January 2001|2001-01-01|June 2000||2000-06-01|||||Interventional|||Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis||Completed||Phase 3|30||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:43.30549|2017-02-18 18:16:43.30549
NCT00004401|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||January 1998||1998-01-01|March 2000|2000-03-01|June 1998||1998-06-01|||||Interventional|||Study of Human Botulism Immunoglobulin in Infants With Botulism||Completed||N/A|120|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:43.38931|2017-02-18 18:16:43.38931
NCT00004400|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||April 1997||1997-04-01|May 1998|1998-05-01|September 2001||2001-09-01|||||Interventional|||Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women||Completed||Phase 2|56|Anticipated|FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:43.487507|2017-02-18 18:16:43.487507
NCT00004399|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2015-03-24|||September 1995||1995-09-01|January 2001|2001-01-01|August 2000||2000-08-01|||||Interventional|||Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia||Completed||N/A|2000||FDA Office of Orphan Products Development|||||f||||||||||||||2017-02-18 18:16:43.584611|2017-02-18 18:16:43.584611
NCT00004398|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1998||1998-01-01|June 2000|2000-06-01|May 2000||2000-05-01|||||Interventional|||Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria||Completed||Phase 1|24||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:43.67173|2017-02-18 18:16:43.67173
NCT00004397|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1998||1998-01-01|June 2000|2000-06-01|May 2000||2000-05-01|||||Interventional|||Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria||Completed||Phase 1|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:43.769193|2017-02-18 18:16:43.769193
NCT00004396|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1997||1997-09-01|December 2003|2003-12-01||||||||Interventional|||Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias||Completed||Phase 2|32||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:43.854225|2017-02-18 18:16:43.854225
NCT00004393|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||July 1997||1997-07-01|March 2001|2001-03-01|September 2000||2000-09-01|||||Interventional|||Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome||Completed||Phase 2|50||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:43.945264|2017-02-18 18:16:43.945264
NCT00004392|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||May 1994||1994-05-01|January 2000|2000-01-01|August 1999||1999-08-01|||||Observational|||Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)||Completed||N/A|900||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.030966|2017-02-18 18:16:44.030966
NCT00004390|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||February 1995||1995-02-01|February 2000|2000-02-01||||||||Interventional|||Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia||Completed||Phase 3|120||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.125243|2017-02-18 18:16:44.125243
NCT00004387|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1996||1996-01-01|July 2000|2000-07-01||||||||Interventional|||Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease||Completed||Phase 2|34||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.217722|2017-02-18 18:16:44.217722
NCT00004386|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1995||1995-10-01|January 2000|2000-01-01||||||||Interventional|||Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency||Terminated||Phase 1|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.307574|2017-02-18 18:16:44.307574
NCT00004382|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2008-09-08|||December 1999||1999-12-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns||Completed||Phase 2|80||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.388354|2017-02-18 18:16:44.388354
NCT00004381|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||December 1999||1999-12-01|October 2003|2003-10-01||||||||Interventional|||Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia||Completed||Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.468555|2017-02-18 18:16:44.468555
NCT00004380|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||December 1991||1991-12-01|July 2004|2004-07-01|December 1997||1997-12-01|||||Interventional|||Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis||Completed||Phase 2|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.560892|2017-02-18 18:16:44.560892
NCT00004378|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1995||1995-01-01|April 2002|2002-04-01||||||||Interventional|||Stem Cell Transplantation (SCT) for Genetic Diseases||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:44.647607|2017-02-18 18:16:44.647607
NCT00004376|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1994||1994-09-01|March 2001|2001-03-01|June 2000||2000-06-01|||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder||Completed||Phase 3|35||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.740069|2017-02-18 18:16:44.740069
NCT00004375|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1991||1991-09-01|January 2004|2004-01-01||||||||Interventional|||Ultraviolet Light Therapy for Systemic Lupus Erythematosus||Unknown status|Recruiting|Phase 2|20||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:44.820142|2017-02-18 18:16:44.820142
NCT00004374|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1979||1979-01-01|December 2003|2003-12-01||||||||Observational|||Study of Systemic Amyloidosis Presentation and Prognosis|Study of Systemic Amyloidosis Presentation and Prognosis|Unknown status|Recruiting|N/A|100||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:44.910561|2017-02-18 18:16:44.910561
NCT00004373|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||March 1997||1997-03-01|May 2003|2003-05-01|March 2001||2001-03-01|||||Interventional|||Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety||Completed||Phase 2|80||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:44.994483|2017-02-18 18:16:44.994483
NCT00004368|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||May 1990||1990-05-01|October 2003|2003-10-01||||||||Interventional|||Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis||Unknown status|Active, not recruiting|Phase 1|15||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:45.107201|2017-02-18 18:16:45.107201
NCT00004367|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||May 2000||2000-05-01|December 2003|2003-12-01||||||||Interventional|||Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia||Completed||N/A|165||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:45.188197|2017-02-18 18:16:45.188197
NCT00004366|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||August 1995||1995-08-01|June 2000|2000-06-01|May 2000||2000-05-01|||||Interventional|||Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:45.270493|2017-02-18 18:16:45.270493
NCT00004365|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1995||1995-09-01|December 2003|2003-12-01|February 2000||2000-02-01|||||Observational|||Study of Pituitary Size and Function in Familial Dwarfism of Sindh||Completed||N/A|4||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:45.347316|2017-02-18 18:16:45.347316
NCT00004361|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||July 1995||1995-07-01|January 2001|2001-01-01||||||||Observational|||Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects||Completed||N/A|150||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:45.581488|2017-02-18 18:16:45.581488
NCT00004360|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1995||1995-09-01|December 1999|1999-12-01||||||||Observational|||Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus||Completed||N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:45.66301|2017-02-18 18:16:45.66301
NCT00004359|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||February 1996||1996-02-01|January 2000|2000-01-01||||||||Interventional|||Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita||Completed||Phase 2|10||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:45.740653|2017-02-18 18:16:45.740653
NCT00004358|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1992||1992-11-01|December 2003|2003-12-01||||||||Interventional|||Phase II Study of Calcitonin for Tumoral Calcinosis||Completed||Phase 2|9||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:45.813639|2017-02-18 18:16:45.813639
NCT00004357|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2011-07-20|||September 1997||1997-09-01|July 2011|2011-07-01|February 2008|Actual|2008-02-01|December 2005|Actual|2005-12-01||Interventional|||Absorption of Corticosteroids in Children With Juvenile Dermatomyositis|Phase II Study of Prednisolone/Methylprednisolone Absorption in Children With Juvenile Dermatomyositis|Completed||Phase 2|6|Actual|Northwestern University||1|||f||||f||||||||||2017-02-18 18:16:45.898491|2017-02-18 18:16:45.898491
NCT00004356|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||February 1995||1995-02-01|December 2001|2001-12-01|October 2000||2000-10-01|||||Observational|||Study of Homocysteine Metabolism in Homocystinuria||Completed||N/A|60||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:45.997884|2017-02-18 18:16:45.997884
NCT00004354|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||June 1999||1999-06-01|May 2002|2002-05-01||||||||Observational|||Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:46.072917|2017-02-18 18:16:46.072917
NCT00004353|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2008-07-09|||December 1978||1978-12-01|April 2002|2002-04-01||||||||Observational|||Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia||Completed||N/A|35|Anticipated|National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:46.237724|2017-02-18 18:16:46.237724
NCT00004351|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1999||1999-09-01|October 2003|2003-10-01||||||||Observational|||Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes||Completed||N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:46.320691|2017-02-18 18:16:46.320691
NCT00004350|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|December 1999|1999-12-01||||||||Observational|||Evaluation of Fanconi Syndrome and Cystinosis||Completed||N/A|12||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:46.411703|2017-02-18 18:16:46.411703
NCT00004348|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1995||1995-09-01|January 2000|2000-01-01||||||||Observational|||Study of Protein Translocation in Patients With Beta-Oxidation Disorders||Unknown status|Active, not recruiting|N/A|20||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:46.480562|2017-02-18 18:16:46.480562
NCT00004347|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1995||1995-11-01|December 2003|2003-12-01||||||||Interventional|||Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome|The Effects of Dietary Cholesterol in the Smith-Lemli-Opitz Syndrome|Unknown status|Recruiting|Phase 2|5||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:46.559798|2017-02-18 18:16:46.559798
NCT00004346|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1996||1996-01-01|December 2003|2003-12-01||||||||Interventional|||Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis|Effects of Diet and Medication in Patients With Cerebrotendinous Xanthomatosis (CTX)|Unknown status|Recruiting|Phase 2|5||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:46.655281|2017-02-18 18:16:46.655281
NCT00004345|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|July 2002|2002-07-01||||||||Observational|||Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome||Terminated||N/A|100||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:46.748282|2017-02-18 18:16:46.748282
NCT00004344|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1997||1997-01-01|February 2000|2000-02-01||||||||Observational|||Purification of Testis-Stimulating Factor in Precocious Puberty||Completed||N/A|4||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:46.840229|2017-02-18 18:16:46.840229
NCT00004343|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|December 2003|2003-12-01||||||||Observational|||Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome||Unknown status|Active, not recruiting|N/A|40||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:46.927373|2017-02-18 18:16:46.927373
NCT00004342|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||June 1994||1994-06-01|December 2003|2003-12-01||||||||Observational|||International Registry for Severe Chronic Neutropenia||Unknown status|Recruiting|N/A|1000||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:47.006376|2017-02-18 18:16:47.006376
NCT00004341|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||July 1995||1995-07-01|October 2003|2003-10-01||||||||Observational|||Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders||Unknown status|Active, not recruiting|N/A|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:47.099736|2017-02-18 18:16:47.099736
NCT00004340|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||June 1995||1995-06-01|April 2002|2002-04-01||||||||Interventional|||Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis||Completed||Phase 2|109||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:47.191277|2017-02-18 18:16:47.191277
NCT00004339|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2006-05-08|||January 1994||1994-01-01|December 2003|2003-12-01||||||||Interventional|||Study of Tetrathiomolybdate in Patients With Wilson Disease||Completed||Phase 3|90||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:47.283794|2017-02-18 18:16:47.283794
NCT00004338|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1993||1993-10-01|December 2003|2003-12-01||||||||Interventional|||Study of Zinc for Wilson Disease||Completed||Phase 4|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:47.376048|2017-02-18 18:16:47.376048
NCT00004336|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1995||1995-10-01|April 2002|2002-04-01||||||||Observational|||Pilot Study of Familial Nonsyndromal Mondini Dysplasia||Completed||N/A|2||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:47.463059|2017-02-18 18:16:47.463059
NCT00004335|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||April 1993||1993-04-01|December 2003|2003-12-01||||||||Observational|||Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:47.545063|2017-02-18 18:16:47.545063
NCT00004328|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||December 1992||1992-12-01|May 2000|2000-05-01||||||||Interventional|||Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I||Completed||Phase 2|1||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:51.079339|2017-02-18 18:16:51.079339
NCT00004327|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1995||1995-01-01|June 2000|2000-06-01||||||||Interventional|||Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia||Completed||Phase 2|8||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:51.169926|2017-02-18 18:16:51.169926
NCT00004326|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||August 1994||1994-08-01|April 2002|2002-04-01||||||||Observational|||Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome||Completed||N/A|12||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:51.251128|2017-02-18 18:16:51.251128
NCT00004325|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||December 1988||1988-12-01|January 2004|2004-01-01||||||||Observational|||Study of the Neurobiology of Tourette Syndrome and Related Disorders||Completed||N/A|200||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:51.340177|2017-02-18 18:16:51.340177
NCT00004324|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||December 1989||1989-12-01|January 2004|2004-01-01||||||||Observational|||Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents||Completed||N/A|90||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:51.431962|2017-02-18 18:16:51.431962
NCT00004323|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||February 1995||1995-02-01|April 2002|2002-04-01||||||||Interventional|||Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia||Completed||Phase 2|10||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:51.516774|2017-02-18 18:16:51.516774
NCT00004317|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2009-05-13|||July 2000||2000-07-01|May 2009|2009-05-01|December 2030|Anticipated|2030-12-01|December 2030|Anticipated|2030-12-01||Interventional|||Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis|Phase IV Randomized Study of Pyrimethamine, Sulfadiazine, and Leucovorin Calcium for Congenital Toxoplasmosis|Recruiting||Phase 4|600|Anticipated|Office of Rare Diseases (ORD)||2|||f||||t||||||||||2017-02-18 18:16:51.61868|2017-02-18 18:16:51.61868
NCT00004316|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2008-09-08|||June 1995||1995-06-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis||Completed||Phase 1/Phase 2|139||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:52.009416|2017-02-18 18:16:52.009416
NCT00004315|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1995||1995-11-01|April 2002|2002-04-01||||||||Interventional|||Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease||Unknown status|Active, not recruiting|Phase 2|20||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:52.093211|2017-02-18 18:16:52.093211
NCT00004314|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||February 1996||1996-02-01|January 2000|2000-01-01||||||||Interventional|||Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease||Completed||Phase 2|2||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:52.183964|2017-02-18 18:16:52.183964
NCT00004313|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||August 1995||1995-08-01|January 2000|2000-01-01||||||||Interventional|||Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency||Completed||Phase 3|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:52.273358|2017-02-18 18:16:52.273358
NCT00004312|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|December 2003|2003-12-01||||||||Observational|||Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis||Completed||N/A|400||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:52.354912|2017-02-18 18:16:52.354912
NCT00004311|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||July 1989||1989-07-01|May 2000|2000-05-01|January 1996||1996-01-01|||||Interventional|||Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome||Completed||Phase 2|||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:52.439081|2017-02-18 18:16:52.439081
NCT00004310|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1999||1999-10-01|December 2003|2003-12-01||||||||Interventional|||Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder||Unknown status|Active, not recruiting|Phase 2|76||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:52.525361|2017-02-18 18:16:52.525361
NCT00004307|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||December 1999||1999-12-01|December 2003|2003-12-01||||||||Interventional|||Study of Treatment and Metabolism in Patients With Urea Cycle Disorders|Therapeutic and Metabolic Studies of Urea Cycle Disorders: Part A: Nitrogen Flux and Ureagenesis; Part B (Closed): Phase I Adenovirus Vector-Mediated Gene Therapy for Ornithine Transcarbamylase Deficiency|Unknown status|Recruiting|Phase 1|66||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:52.624286|2017-02-18 18:16:52.624286
NCT00004306|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2012-03-05|||November 1999||1999-11-01|March 2012|2012-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Observational|||Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)|Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)|Completed||N/A|18|Actual|Office of Rare Diseases (ORD)|||1||f||||f||||||Samples With DNA|"~     DNA from blood and skin and muscle biopsy samples.~   "|||2017-02-18 18:16:52.716743|2017-02-18 18:16:52.716743
NCT00004305|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||January 1998||1998-01-01|April 2002|2002-04-01||||||||Observational|||Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis||Completed||N/A|105||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:52.801125|2017-02-18 18:16:52.801125
NCT00004300|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2010-10-05||||||March 2006|2006-03-01||||||||Interventional|||Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis|Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis|Suspended||Phase 2|40||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:52.885469|2017-02-18 18:16:52.885469
NCT00004297|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1995||1995-11-01|December 2001|2001-12-01|February 1999||1999-02-01|||||Interventional|||Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus||Completed||Phase 3|210||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:52.980007|2017-02-18 18:16:52.980007
NCT00004296|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1995||1995-09-01|January 2000|2000-01-01||||||||Observational|||Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients||Completed||N/A|1000||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.065326|2017-02-18 18:16:53.065326
NCT00004294|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1999||1999-11-01|December 2003|2003-12-01||||||||Interventional|||Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease||Completed||Phase 1|15||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:53.142027|2017-02-18 18:16:53.142027
NCT00004293|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1999||1999-11-01|December 2003|2003-12-01||||||||Interventional|||Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease||Unknown status|Recruiting|Phase 2|24||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:53.225416|2017-02-18 18:16:53.225416
NCT00004288|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||May 1996||1996-05-01|January 2000|2000-01-01|December 1999||1999-12-01|||||Interventional|||Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis||Completed||Phase 2|4||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.311238|2017-02-18 18:16:53.311238
NCT00004287|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||November 1995||1995-11-01|January 2000|2000-01-01||||||||Interventional|||Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis||Completed||Phase 1|14||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.387167|2017-02-18 18:16:53.387167
NCT00004286|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||February 1996||1996-02-01|January 2000|2000-01-01|November 1999||1999-11-01|||||Interventional|||Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy||Completed||Phase 3|120||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.471007|2017-02-18 18:16:53.471007
NCT00004285|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||October 1992||1992-10-01|July 2002|2002-07-01|December 2001||2001-12-01|||||Interventional|||Phase II Randomized Study of Standard Vs High Amount of Hemodialysis Using Low Vs High Flux Dialyzer Membranes for End Stage Renal Disease||Completed||Phase 2|900||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.5514|2017-02-18 18:16:53.5514
NCT00004284|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||April 1995||1995-04-01|June 2000|2000-06-01||||||||Interventional|||Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria||Completed||Phase 3|300||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.635055|2017-02-18 18:16:53.635055
NCT00004278|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||December 1991||1991-12-01|July 2000|2000-07-01||||||||Interventional|||Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection||Completed||Phase 3|130||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.735129|2017-02-18 18:16:53.735129
NCT00004276|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||September 1990||1990-09-01|December 2001|2001-12-01|June 1999||1999-06-01|||||Interventional|||Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections||Completed||Phase 2|50||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.820999|2017-02-18 18:16:53.820999
NCT00004275|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2008-09-08|||October 1999||1999-10-01|September 2008|2008-09-01||||August 2007|Actual|2007-08-01||Interventional|||Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome|Phase II Randomized Study of Oxandrolone vs Placebo for Growth Hormone-Treated Girls With Turner's Syndrome|Completed||Phase 2|80||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:53.911244|2017-02-18 18:16:53.911244
NCT00004274|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||February 1990||1990-02-01|October 2003|2003-10-01||||||||Interventional|||Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome|Controlled Study of Estrogen Effects on Cognitive and Social Function in Girls With Turner's Syndrome|Completed||N/A|260||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:54.005979|2017-02-18 18:16:54.005979
NCT00004268|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||April 2001||2001-04-01|April 2002|2002-04-01||||||||Interventional|||Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension||Completed||Phase 2|300||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:16:54.096869|2017-02-18 18:16:54.096869
NCT00004266|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-18|2005-06-23|||August 1993||1993-08-01|December 2001|2001-12-01|July 1999||1999-07-01|||||Interventional|||Study of Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes at High Risk of Kidney or Heart Disease|Randomized Study of Antihypertensives and Antilipemics in American Indians With Non-Insulin-Dependent Diabetes Mellitus at High Risk of Developing Nephropathy and Cardiovascular Disease|Completed||N/A|160||Office of Rare Diseases (ORD)|||||f||||||||||||||2017-02-18 18:16:54.46279|2017-02-18 18:16:54.46279
NCT00004265|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-12-03|||February 1999||1999-02-01|August 2000|2000-08-01||||||||Interventional|||Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer|Phase II Study of Weekly Paclitaxel as Second-Line Therapy in Patients With Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:54.550584|2017-02-18 18:16:54.550584
NCT00004264|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-12-03|||July 1997||1997-07-01|August 2000|2000-08-01||||||||Interventional|||Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer|Phase I/II Trial of Amifostine, High-Dose Cisplatin and Docetaxel in Patients With Advanced Lung Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:54.646927|2017-02-18 18:16:54.646927
NCT00004263|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-07-27|||December 1999||1999-12-01|July 2012|2012-07-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome|Phase I Study of UCN-01 and Cytarabine (ARA-C) in Patients With Acute Myelogenous Leukemia, and Myelodysplastic Syndromes|Completed||Phase 1|16|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:16:54.744212|2017-02-18 18:16:54.744212
NCT00004262|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-06-03|||November 1999||1999-11-01|June 2013|2013-06-01||||May 2005|Actual|2005-05-01||Interventional|||Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme|PHASE I TRIAL OF GADOLINIUM TEXAPHYRIN (PCI -0120) AS A RADIOSENSITIZER DURING STEREOTACTIC RADIOSURGERY BOOST FOR GLIOBLASTOMA MULTIFORME|Completed||Phase 1|12|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:16:54.866261|2017-02-18 18:16:54.866261
NCT00004261|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2016-05-20|||December 1999||1999-12-01|May 2016|2016-05-01||||June 2002||2002-06-01||Interventional|||EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma|A Phase I Trial of the Hypoxia Detection Agent EF5 (NSC 684681) in Patients With Cervix and Breast and Prostate Carcinomas, and High Grade Soft Tissue Sarcomas|Terminated||Phase 1|||University Health Network, Toronto||||Lack of patient accrual|f||||||||||||||2017-02-18 18:16:54.979864|2017-02-18 18:16:54.979864
NCT00004260|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2011-08-02|||October 1999||1999-10-01|August 2011|2011-08-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma|Phase I Study of Interleukin-12 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:16:55.100511|2017-02-18 18:16:55.100511
NCT00004259|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2016-09-28|||June 2000||2000-06-01|September 2016|2016-09-01||||March 2020|Anticipated|2020-03-01||Interventional|||Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas|A Phase III Randomized Study (Phase I Closed) of Radiation Therapy and Temozolomide Versus Radiation Therapy and Nitrosourea for Anaplastic Astrocytoma And Mixed Anaplastic Oligoastrocytoma (Astrocytoma Dominant)|Active, not recruiting||Phase 3|230|Actual|Radiation Therapy Oncology Group||5|||f||||t||||||||||2017-02-18 18:16:55.223572|2017-02-18 18:16:55.223572
NCT00004258|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2014-09-16|||December 1999||1999-12-01|September 2014|2014-09-01|September 2001|Actual|2001-09-01|August 2001|Actual|2001-08-01||Interventional|||EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer|A Phase I Trial of EMD 121974 in Patients With Advanced or Metastatic Cancer|Completed||Phase 1|40|Anticipated|Indiana University||1|||f||||||||||||||2017-02-18 18:16:55.456208|2017-02-18 18:16:55.456208
NCT00004257|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-03-25|||January 2000||2000-01-01|December 2007|2007-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer|A Phase I Study of Oxaliplatin in Combination With Continuous Infusion 5-Fluorouracil and Radiation in Esophageal Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:55.576391|2017-02-18 18:16:55.576391
NCT00004256|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-11-05|||October 1997||1997-10-01|August 2006|2006-08-01|July 2006|Actual|2006-07-01|||||Interventional|||Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer|Randomised Phase II Study of GM-CSF to Reduce Severity of Mucositis Caused by Accelerated Radiotherapy of Laryngeal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:55.676695|2017-02-18 18:16:55.676695
NCT00004255|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-07-09|||March 2000||2000-03-01|February 2002|2002-02-01|May 2003|Actual|2003-05-01|||||Interventional|||Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation|A Multi-Center, Open Label, Randomized, Active Controlled Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Processed Unrelated Bone Marrow in Patients With Acute or Chronic Leukemia|Completed||Phase 2/Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:55.769172|2017-02-18 18:16:55.769172
NCT00004254|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-07-17|||November 1999||1999-11-01|July 2012|2012-07-01||||June 2001|Actual|2001-06-01||Interventional|||Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed|Phase II Study on Tomusex in Malignant Mesothelioma|Completed||Phase 2|25|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:16:55.896858|2017-02-18 18:16:55.896858
NCT00004253|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-12-17|||March 2000||2000-03-01|November 2002|2002-11-01||||||||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery|A Phase II Study of 3-Dimensional Conformal Hyperfractionation Radiation Therapy (3D-CHRT) With Dose Escalation and Amifostine Mucosal Protection for Patients With Favorable Prognosis Inoperable Stage II-IIIA/B Non-Small Cell Lung Cancer (NSCLC) Receiving Paclitaxel and Carboplatin|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:56.000839|2017-02-18 18:16:56.000839
NCT00004252|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-09-10|||November 1999||1999-11-01|September 2012|2012-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer|A Randomized, Open-Label, Multicenter Phase III Study of 5-FU/Leucovorin With or Without Concomitant SU5416 in Patients With Metastatic Colorectal Cancer|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 18:16:56.099642|2017-02-18 18:16:56.099642
NCT00004251|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-09-20|||January 2000||2000-01-01|July 2012|2012-07-01|January 2011|Actual|2011-01-01|September 2002|Actual|2002-09-01||Interventional|||Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer|A Phase II Study of Letrozole in Patients With Advanced or Recurrent Endometrial Cancer|Completed||Phase 2|33|Actual|Canadian Cancer Trials Group||1|||f||||||||||||||2017-02-18 18:16:56.222711|2017-02-18 18:16:56.222711
NCT00004250|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-01-15|||August 1999||1999-08-01|January 2013|2013-01-01||||June 2007|Actual|2007-06-01||Interventional|||Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery|A Phase II Trial of Isolated Limb Infusion With Melphalan and Dactinomycin for Regional Melanoma and Soft Tissue Sarcoma of the Extremity|Completed||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:16:56.332607|2017-02-18 18:16:56.332607
NCT00004249|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-06-18|||August 1998||1998-08-01|June 2013|2013-06-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy|Immunization Using Polysialic Acid-KLH or N-Propionylated Polysialic Acid-KLH Conjugate Plus the Immunological Adjuvant QS-21 in Patients With Small Cell Lung Cancer Who Have Achieved a Major Response to Initial Therapy|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:16:56.434793|2017-02-18 18:16:56.434793
NCT00004248|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2011-03-03|||July 1999||1999-07-01|March 2011|2011-03-01|May 2001|Actual|2001-05-01|June 2000|Actual|2000-06-01||Interventional|||Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery|A Low Dose Schedule of Adriamycin and Protracted Infusion of Recombinant Interleukin-2: A Phase II Study of Immunotherapy in Unresectable Hepatocellular Carcinoma|Completed||Phase 2|24|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:16:56.531604|2017-02-18 18:16:56.531604
NCT00004246|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-07-27|||May 2000||2000-05-01|July 2012|2012-07-01|December 2002|Actual|2002-12-01|February 2001|Actual|2001-02-01||Interventional|||Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx|A Phase I Study of Fludarabine With Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 1|16|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:16:56.639746|2017-02-18 18:16:56.639746
NCT00004229|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-02-08|||October 1999||1999-10-01|December 2002|2002-12-01||||October 2002|Actual|2002-10-01||Interventional|||Endostatin in Treating Patients With Advanced Solid Tumors|A Phase I Surrogate Endpoint Trial of Human Recombinant Endostatin in Patients With Advanced Solid Tumors Amenable to Biopsy|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:16:58.812599|2017-02-18 18:16:58.812599
NCT00004245|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-01-17|||August 1999||1999-08-01|January 2013|2013-01-01||||September 2004|Actual|2004-09-01||Interventional|||Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia|A Phase I Study of Salicylate for Adult Patients With Advanced Myelodysplastic Disorders or Acute Myelogenous Leukemia|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:16:56.750937|2017-02-18 18:16:56.750937
NCT00004244|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-03-19|||March 2000||2000-03-01|June 2005|2005-06-01|September 2008|Actual|2008-09-01|July 2005|Actual|2005-07-01||Interventional|||Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma|Phase I Trial of rhIL-12 and rHuIFN-a2b in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:16:57.111722|2017-02-18 18:16:57.111722
NCT00004243|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2010-01-11|||March 2000||2000-03-01|January 2010|2010-01-01||||||||Interventional|||Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor|A Phase I Study of Oxaliplatin in Combination With Docetaxel (Taxotere) Metastatic/Recurrent Solid Tumors|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:16:57.220126|2017-02-18 18:16:57.220126
NCT00004242|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-02-08|||October 1999||1999-10-01|July 2002|2002-07-01||||December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors|Phase I Study of Oxaliplatin in Combination With 5-Fluorouracil and Gemcitabine in Patients With Solid Tumors|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:16:57.309596|2017-02-18 18:16:57.309596
NCT00004241|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-02-06|||October 1999||1999-10-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma|A Phase I Trial of Weekly 17-Allylamino-17 Demethoxygeldanamycin|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:16:57.421545|2017-02-18 18:16:57.421545
NCT00004239|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2016-07-01|||December 1999||1999-12-01|July 2016|2016-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment|A Phase I Study of Compound 506U78 (NSC #686673) in Patients With Hematologic Malignancies and Renal or Hepatic Impairment|Terminated||Phase 1|10|Actual|Alliance for Clinical Trials in Oncology||1||poor accrual|f||||f||||||||||2017-02-18 18:16:57.544078|2017-02-18 18:16:57.544078
NCT00004238|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-06-18|||July 1999||1999-07-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase II Study of 10-Propargyl-10-Deazaaminopterin (PDX) in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:16:57.655266|2017-02-18 18:16:57.655266
NCT00004237|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-11-05|||October 1998||1998-10-01|May 2005|2005-05-01|September 2005|Actual|2005-09-01|||||Interventional|||Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer|A Randomized Phase II Trial of Navelbine/Epirubicin Versus Navelbine/Mitozantrone Versus Cyclophosphamide/Adriamycin as Preoperative Chemotherapy in Patients With > or = 3cm Diameter Early Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:57.75543|2017-02-18 18:16:57.75543
NCT00004236|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2014-06-23|||August 1998||1998-08-01|December 2000|2000-12-01||||||||Interventional|||Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer|A Phase II Study of Caelyx in the Treatment of Advanced Gastric Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:16:57.847368|2017-02-18 18:16:57.847368
NCT00004235|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2016-07-12|||January 2000||2000-01-01|July 2016|2016-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach|A Phase II Study of Taxotere and Irinotecan (CPT-11) in Patients With Advanced Adenocarcinoma of the Lower Esophagus, Esophagogastric Junction, and Gastric Cardia|Completed||Phase 2|47|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:16:57.934249|2017-02-18 18:16:57.934249
NCT00004234|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2016-11-25|||August 1999||1999-08-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|March 2005|Actual|2005-03-01||Interventional|||Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx|A Comparison of Acute Oral Mucositis Between Morning and Afternoon Radiotherapy in Patients Receiving Radiation Treatment for Cancer of the Head and Neck|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-02-18 18:16:58.076888|2017-02-18 18:16:58.076888
NCT00004233|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2011-07-21|||February 2001||2001-02-01|May 2010|2010-05-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach|A Phase II Study of PN-401, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach|Completed||Phase 2|65|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:16:58.206563|2017-02-18 18:16:58.206563
NCT00004232|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-05-31|||October 1999||1999-10-01|May 2012|2012-05-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Augmenting Bone Marrow With CD34 Enriched Peripheral Blood Hematopoietic Stem Cells for Allogeneic Transplantation of Hematologic Malignancies|Completed||Phase 1|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:58.445261|2017-02-18 18:16:58.445261
NCT00004231|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Interventional|||Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma|Phase II Study of Multimodality Therapy in Mantle Cell Lymphoma|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:16:58.580529|2017-02-18 18:16:58.580529
NCT00004230|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation|Phase III Study of Captopril in Patients Undergoing Autologous Bone Marrow/Stem Cell Transplantation|Completed||Phase 3|35|Actual|Northwestern University|||||f||||t||||||||||2017-02-18 18:16:58.695178|2017-02-18 18:16:58.695178
NCT00003703|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-25|||January 1999||1999-01-01|September 2002|2002-09-01|March 2004|Actual|2004-03-01|||||Interventional|||Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I and Pharmacokinetics Study of SarCNU in Patients With Advanced Cancers|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:26.912559|2017-02-18 18:18:26.912559
NCT00004228|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2016-12-01|2013-10-08||June 2000||2000-06-01|November 2016|2016-11-01||||August 2008|Actual|2008-08-01||Interventional|||Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma|Randomized Phase III Study for the Treatment of Newly Diagnosed Disseminated Lymphoblastic Lymphoma or Localized Lymphoblastic Lymphoma|Active, not recruiting||Phase 3|393|Actual|Children's Oncology Group||7|||f||||t||||||||||2017-02-18 18:16:58.942547|2017-02-18 18:16:58.942547
NCT00004227|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2014-02-05|||April 1999||1999-04-01|November 2012|2012-11-01|May 2008|Actual|2008-05-01|March 2007|Actual|2007-03-01||Interventional|||Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx|Randomized Phase III Trial to Compare Radiation Therapy Alone With Radiation Therapy and Concomitant Anti-EGFr Antibody (C225) for Locally Advanced Squamous Cell Carcinomas of the Head and Neck|Terminated||Phase 3|32|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 18:17:02.209395|2017-02-18 18:17:02.209395
NCT00004226|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-12-03|||May 2000||2000-05-01|July 2004|2004-07-01||||||||Interventional|||Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy|Phase I/II Study of High Dose Limited Volume Postoperative Reirradiation in Recurrent or Second Primary Carcinoma of the Head and Neck|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:02.341941|2017-02-18 18:17:02.341941
NCT00004225|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2010-07-03|||January 2000||2000-01-01|April 2004|2004-04-01||||||||Interventional|||Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer|Phase I Pilot Trial of Adenovirus p53 and Radiotherapy on Nonsmall Cell Lung Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:02.431762|2017-02-18 18:17:02.431762
NCT00004224|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-08-23|||January 1999||1999-01-01|April 2008|2008-04-01|March 2008|Actual|2008-03-01|||||Interventional|||Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma|SIOP Study of Combined Modality Treatment in Childhood Ependymoma|Completed||Phase 2|65|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:02.520342|2017-02-18 18:17:02.520342
NCT00004223|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2010-01-26|||December 1999||1999-12-01|January 2010|2010-01-01||||October 2002|Actual|2002-10-01||Interventional|||Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer|Phase II Trial of Gemcitabine and Docetaxel in Advanced Carcinoma of the Urothelium|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:17:02.62887|2017-02-18 18:17:02.62887
NCT00004221|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2016-03-17|||November 1999||1999-11-01|March 2016|2016-03-01||||March 2010|Actual|2010-03-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer|A Phase II Trial Using Multiple Cycles of High Dose Sequential Carboplatin, Paclitaxel and Topotecan With Peripheral Blood Stem Cell (PBSC) Support as Initial Chemotherapy in Patients With Optimally Debulked Stage III Ovarian and Primary Peritoneal Carcinoma|Terminated||Phase 2|12|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:17:03.071705|2017-02-18 18:17:03.071705
NCT00004220|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2010-01-11|||October 1999||1999-10-01|January 2010|2010-01-01||||||||Interventional|||Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer|A Phase I Study of Oxaliplatin in Combination With Gemcitabine|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:17:03.218644|2017-02-18 18:17:03.218644
NCT00004219|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-08-01||||||June 2007|2007-06-01||||||||Interventional|||Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma|A Study to Investigate the Efficacy and Tolerability of Two Dose Levels of Lerisetron Compared With Granisetron in Patients Receiving Radiotherapy for Stage I Seminoma|Unknown status|Active, not recruiting|Phase 3|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:03.303262|2017-02-18 18:17:03.303262
NCT00004218|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-12-17|||October 1999||1999-10-01|January 2006|2006-01-01|July 2007|Actual|2007-07-01|||||Interventional|||Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia|Chronic Lymphocytic Leukemia Trial 4: A Randomized Comparison of Chlorambucil, Fludarabine and Fludarabine Plus Cyclophosphamide|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:03.394497|2017-02-18 18:17:03.394497
NCT00004217|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2015-03-05|||February 2000||2000-02-01|March 2015|2015-03-01|March 2006|Actual|2006-03-01|May 2001|Actual|2001-05-01||Interventional|||S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase II Study of Daunomycin and ARA-C Given by Continuous IV Infusion With PSC-833 for Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) in Patients of Age 56 or Older|Completed||Phase 2|55|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-02-18 18:17:03.585526|2017-02-18 18:17:03.585526
NCT00004216|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-07-17|||August 1999||1999-08-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy|A Phase I Trial of a Live, Genetically Modified Salmonella Typhimurium (VNP20009) for the Treatment of Cancer by Intratumoral Injection|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:03.952254|2017-02-18 18:17:03.952254
NCT00004215|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-06-18|||August 1999||1999-08-01|June 2013|2013-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia|"Clinical Protocol for a Phase II Study of Leridistim (SC-70935) in Adult Patients (Age>55) With Acute Myeloid Leukemia (AML) Receiving Chemotherapy With the Cytarabine and Daunorubicin 7+3 Regimen"|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:04.045217|2017-02-18 18:17:04.045217
NCT00004213|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-07-17|||May 1998||1998-05-01|December 2007|2007-12-01|January 2008|Actual|2008-01-01|||||Interventional|||3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors|An Open Label, Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP) in Cancer Patients Using a Single Daily Dose for Five Days|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:04.148347|2017-02-18 18:17:04.148347
NCT00004212|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2012-05-15|||September 1999||1999-09-01|May 2012|2012-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas|A Phase I Dose Escalation Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Pediatric Patients With Advanced Solid Tumors and Lymphomas|Completed||Phase 1|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:17:04.245444|2017-02-18 18:17:04.245444
NCT00004211|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-03-19|||July 1999||1999-07-01|January 2005|2005-01-01|January 2002|Actual|2002-01-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer|A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With RNA Encoding Prostate Specific Antigen, PSA|Completed||Phase 1/Phase 2|17|Actual|Duke University|||||f||||||||||||||2017-02-18 18:17:04.357076|2017-02-18 18:17:04.357076
NCT00004210|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2014-10-23|||February 2000||2000-02-01|July 2009|2009-07-01|June 2011|Actual|2011-06-01|June 2011|Actual|2011-06-01||Interventional|||Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer|Outcomes in Education and Counseling for HNPCC Testing|Completed||N/A|900|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:04.467456|2017-02-18 18:17:04.467456
NCT00004209|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-08-06|||May 1998||1998-05-01|June 2007|2007-06-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Randomized Study of MVP 3 Versus 6 Cycles in Advanced Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:04.580227|2017-02-18 18:17:04.580227
NCT00004208|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2015-03-10|||August 2000||2000-08-01|March 2015|2015-03-01|October 2011|Actual|2011-10-01|October 2006|Actual|2006-10-01||Interventional|||Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome|Antithymocyte Globulin (ATG) and Cyclosporine (CSA) to Treat Patients With Myelodysplastic Syndrome (MDS). A Randomized Trial Comparing ATG + CSA With Best Supportive Care|Completed||Phase 3|86|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 18:17:04.678204|2017-02-18 18:17:04.678204
NCT00004207|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2014-06-23|||December 1997||1997-12-01|July 2000|2000-07-01||||||||Interventional|||Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer|A Phase I Study to Determine the Maximum Tolerated Dose of Daunoxome as Therapy for the Treatment of Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:04.801701|2017-02-18 18:17:04.801701
NCT00004206|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2014-06-23|||September 1999||1999-09-01|July 2002|2002-07-01||||||||Interventional|||Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer|Phase II Study of Oxaliplatin and 5 Fluorouracil in the Treatment of Advanced Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:05.099878|2017-02-18 18:17:05.099878
NCT00004205|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2016-08-05|||March 1998||1998-03-01|August 2016|2016-08-01||||December 2008|Actual|2008-12-01||Interventional|BIG 1-98||Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer|A Phase III Study to Evaluate Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors|Active, not recruiting||Phase 3|8028|Actual|International Breast Cancer Study Group||4|||f||||t||||||||||2017-02-18 18:17:05.201012|2017-02-18 18:17:05.201012
NCT00004204|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2014-01-03|||February 2000||2000-02-01|April 2006|2006-04-01||||||||Interventional|||Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma|A Phase II Study of Temozolomide in the Treatment of Recurrent Malignant Gliomas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:05.342439|2017-02-18 18:17:05.342439
NCT00004203|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-09-04|||February 2000||2000-02-01|September 2013|2013-09-01|April 2005|Actual|2005-04-01|February 2002|Actual|2002-02-01||Interventional|||Oxaliplatin in Treating Patients With Metastatic Bladder Cancer|A Phase II Study of Oxaliplatin in Urothelial Cancer|Completed||Phase 2|20|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:17:05.484401|2017-02-18 18:17:05.484401
NCT00004202|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-05-08|||October 1998||1998-10-01|May 2013|2013-05-01||||||||Interventional|||Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer|A Phase II Study of Induction Chemotherapy With Paclitaxel and Carboplatin Followed by Radiation Therapy With RSR13 for Locally Advanced Inoperable Non-Small Cell Lung Cancer|Completed||Phase 2|||Spectrum Pharmaceuticals, Inc|||||f||||||||||||||2017-02-18 18:17:05.607823|2017-02-18 18:17:05.607823
NCT00004201|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-02-01||||||June 2007|2007-06-01|August 2004|Actual|2004-08-01|||||Interventional|||Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer|A Randomized Phase II Trial of Cisplatin or Carboplatin With Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:05.722338|2017-02-18 18:17:05.722338
NCT00004200|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2012-08-07|||October 1999||1999-10-01|August 2012|2012-08-01||||January 2002|Actual|2002-01-01||Interventional|||Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Randomized Double-Blind, Placebo-Controlled Phase II Study of the Matrix Metalloprotease Inhibitor Prinomastat in Combination With Temozolomide Following Radiation Therapy in Patients Having Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|||Pfizer|||||f||||||||||||||2017-02-18 18:17:05.807993|2017-02-18 18:17:05.807993
NCT00004199|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2012-08-07|||March 1999||1999-03-01|August 2012|2012-08-01||||July 2001|Actual|2001-07-01||Interventional|||Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Matrix Metalloprotease Inhibitor Prinomastat (AG3340) in Combination With Gemcitabine and Cisplatin in Patients Having Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 18:17:05.903273|2017-02-18 18:17:05.903273
NCT00004198|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2010-06-23|||June 1999||1999-06-01|June 2010|2010-06-01|November 2003|Actual|2003-11-01|January 2002|Actual|2002-01-01||Interventional|||Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma|A Phase II Trial to Evaluate the Rate of Immune Response Using Idiotype Immunotherapies Produced by Molecular Biological Means for Treatment of Indolent B Cell Lymphoma|Completed||Phase 2|||University of Nebraska|||||f||||f||||||||||2017-02-18 18:17:06.000302|2017-02-18 18:17:06.000302
NCT00004197|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2010-06-23|||June 1999||1999-06-01|June 2010|2010-06-01|November 2003|Actual|2003-11-01|January 2002|Actual|2002-01-01||Interventional|||Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma|A Phase II Trial to Evaluate the Rate of Immune Response Using Idiotype Immunotherapies Produced by Molecular Biological Means for Treatment of Aggressive B Cell Lymphoma|Completed||Phase 2|||University of Nebraska|||||f||||||||||||||2017-02-18 18:17:06.096972|2017-02-18 18:17:06.096972
NCT00002696|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-01|||October 1995||1995-10-01|April 2008|2008-04-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Stage III Breast Cancer|MULTIMODALITY TREATMENT STRATEGY FOR STAGE III BREAST CANCER|Suspended||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:14.849728|2017-02-18 18:21:14.849728
NCT00004196|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2014-01-16|||October 1999||1999-10-01|April 2013|2013-04-01|November 2007|Actual|2007-11-01|October 2004|Actual|2004-10-01||Interventional|||Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis|A Multicenter Trial of Adjuvant Interferon Alfa-2b for Melanoma Patients With Early Lymph Node Metastasis Detected by Lymphatic Mapping and Sentinel Lymph Node Biopsy|Completed||Phase 3|3000|Anticipated|University of Alabama at Birmingham||5|||f||||t||||||||||2017-02-18 18:17:06.203703|2017-02-18 18:17:06.203703
NCT00004195|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2015-06-12|||September 1998||1998-09-01|June 2015|2015-06-01|May 2001|Actual|2001-05-01|October 1999|Actual|1999-10-01||Interventional|||Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer|Evaluation of Dihydropyrimidine Dehydrogenase (DPD) Activity in Surgically Resected Primary and Metastatic Colorectal Cancer After 48 hr Pretreatment With Eniluracil|Completed||Phase 2|28|Actual|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 18:17:06.316769|2017-02-18 18:17:06.316769
NCT00004194|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-12-17||||||April 2000|2000-04-01||||||||Interventional|||Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease|A Phase I-II Study for the Treatment of Steroid Resistant GVHD With Fludarabine|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:06.416738|2017-02-18 18:17:06.416738
NCT00004193|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-04-10|||January 1999||1999-01-01|April 2013|2013-04-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer|Phase II Trial of ISIS 2503, an Antisense Inhibitor of H-ras, in Patients With Advanced Colorectal Cancer|Terminated||Phase 2|25|Anticipated|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 18:17:06.494379|2017-02-18 18:17:06.494379
NCT00004192|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2010-06-23|||May 2000||2000-05-01|June 2010|2010-06-01|March 2001|Actual|2001-03-01|February 2001|Actual|2001-02-01||Interventional|||Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma|A Randomized, Multicenter, Open-Label Study of Single Dose Filgrastim-SD/01 Versus Daily Filgrastim Following ESHAP Chemotherapy for Non-Hodgkin's Lymphoma|Completed||Phase 2|60|Anticipated|University of Nebraska|||||f||||||||||||||2017-02-18 18:17:06.598083|2017-02-18 18:17:06.598083
NCT00004190|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2016-07-12|||October 1999||1999-10-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|April 2003|Actual|2003-04-01||Interventional|||Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer|A Phase I(Limited)/Phase II Study of Oxaliplatin (OXAL) and Gemcitabine (GEMZAR) in Patients With Metastatic Pancreatic Carcinoma|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:17:06.701155|2017-02-18 18:17:06.701155
NCT00004189|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-02-08|||October 1999||1999-10-01|September 2003|2003-09-01||||July 2003|Actual|2003-07-01||Interventional|||Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer|A Phase I and Pharmacokinetic Study of Sequences of NSC 655649 (Rebeccamycin Analogue) and Cisplatin Without and With Granulocyte Colony-Stimulating Factor Support Every 21 Days|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:06.823908|2017-02-18 18:17:06.823908
NCT00004188|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-05-16|||February 2001||2001-02-01|May 2013|2013-05-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma|A Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplant Following Dose Intensive Induction Therapy for High Risk Neuroblastoma|Completed||Phase 3|495|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:17:06.943575|2017-02-18 18:17:06.943575
NCT00004187|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2012-05-14|||June 1999||1999-06-01|May 2012|2012-05-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer|A Phase I-II Study of Capecitabine and Oxaliplatin in Chemotherapy-Naive and Thymidylate Synthase Inhibitor Pretreated Advanced or Metastatic Colorectal Cancer|Completed||Phase 1/Phase 2|||Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:17:07.313011|2017-02-18 18:17:07.313011
NCT00004186|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-04-10|||December 1996||1996-12-01|April 2013|2013-04-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer|Phase I/IIA Study of Sequential Ifosfamide and Topotecan in Patients With Small Cell Lung Cancer|Completed||Phase 1/Phase 2|55|Anticipated|University of Alabama at Birmingham|||||f||||t||||||||||2017-02-18 18:17:07.411631|2017-02-18 18:17:07.411631
NCT00004184|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-04-11|||August 1998||1998-08-01|March 2013|2013-03-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma|A Phase I/II Trial of a Human Anti-Idiotypic Monoclonal Antibody Vaccine (4B5) Which Mimics the GD2 Antigen, in Patients With Melanoma|Completed||Phase 1/Phase 2|50|Anticipated|University of Alabama at Birmingham||2|||||||t||||||||||2017-02-18 18:17:07.517247|2017-02-18 18:17:07.517247
NCT00004183|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2016-07-12|||November 2000||2000-11-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|December 2003|Actual|2003-12-01||Interventional|||Capecitabine in Treating Patients With Malignant Mesothelioma|Capecitabine (Xeloda) in Malignant Mesothelioma: A Phase II Study|Completed||Phase 2|27|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:17:07.619198|2017-02-18 18:17:07.619198
NCT00004182|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer|Phase II Study for the Evaluation of CPT-11 (Irinotecan, Camptosar) in Patients With Metastatic or Recurrent Breast Cancer|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:07.992817|2017-02-18 18:17:07.992817
NCT00004181|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia|Allogeneic Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in the Chronic Phase or Multiple Myeloma|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:08.088332|2017-02-18 18:17:08.088332
NCT00004180|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2017-02-09|||October 1999||1999-10-01|February 2017|2017-02-01|May 2015|Actual|2015-05-01|March 2006|Actual|2006-03-01||Interventional|||Rosiglitazone in Treating Patients With Liposarcoma|Phase II Clinical Trial of Rosiglitazone, a Full-Agonist Ligand for the Peroxisome Proliferator-Activated Receptor Gamma (PPAR), as Differentiation Therapy for Patients With Liposarcoma|Completed||Phase 2|32|Actual|Dana-Farber Cancer Institute||4|||f||||f||||||||No||2017-02-18 18:17:08.187208|2017-02-18 18:17:08.187208
NCT00004179|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2016-02-03|||May 1999||1999-05-01|February 2016|2016-02-01||||April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|Chimeric Anti-CD20 Monoclonal Antibody (Mabthera) in Remission Induction and Maintenance Treatment of Relapsed Follicular Non-Hodgkin's Lymphoma: A Phase III Randomized Clinical Trial - Intergroup Collaborative Study|Active, not recruiting||Phase 3|475|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:08.307327|2017-02-18 18:17:08.307327
NCT00004178|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2011-06-09|||April 1998||1998-04-01|May 2006|2006-05-01|December 2001|Actual|2001-12-01|December 2000|Actual|2000-12-01||Interventional|||Gene Therapy in Treating Patients With Cancer|Phase I Study of T Cells Modified With Chimeric AntiCEA Immunoglobulin-T Cell Receptors (IgTCR) in Adenocarcinoma|Completed||Phase 1|||Roger Williams Medical Center|||||f||||||||||||||2017-02-18 18:17:08.695568|2017-02-18 18:17:08.695568
NCT00004177|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2011-06-21|||August 1999||1999-08-01|June 2011|2011-06-01||||May 2002|Actual|2002-05-01||Interventional|||Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer|Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 in Advanced Ovarian Cancer Using Autologous Peripheral Blood Stem Cell Rescue (PBSCR) to Control Myelotoxicity|Completed||Phase 1/Phase 2|15|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||||||||||||2017-02-18 18:17:08.802637|2017-02-18 18:17:08.802637
NCT00004176|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2013-05-14|||October 1998||1998-10-01|May 2013|2013-05-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|A Phase II Evaluation of Ethyol as an Esophageal Mucosal Protectant in the Treatment of Limited Disease Small Cell Lung Cancer With Chemotherapy and Twice-Daily Radiation|Completed||Phase 2|34|Actual|Washington University School of Medicine|||||f||||f||||||||||2017-02-18 18:17:08.904906|2017-02-18 18:17:08.904906
NCT00004175|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-31||2011-07-01|November 1998||1998-11-01|May 2012|2012-05-01|June 2005|Actual|2005-06-01|September 2004|Actual|2004-09-01||Interventional|||Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer|Phase II Study of Taxotere, Doxorubicin and Cyclophosphamide (TAC) Primary Therapy in Stage III Breast Cancer|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:09.002008|2017-02-18 18:17:09.002008
NCT00004174|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-07-09|||October 1999||1999-10-01|July 2013|2013-07-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer|High Dose Paclitaxel Added to Cyclophosphamide and Thiotepa Followed by Autologous Stem Cell Rescue: A Phase I Trial in Advanced Breast Cancer|Completed||Phase 1|30|Actual|Northwestern University||1|||f||||t||||||||||2017-02-18 18:17:09.098974|2017-02-18 18:17:09.098974
NCT00004173|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-05-14|||October 1999||1999-10-01|July 2003|2003-07-01||||||||Interventional|||Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer|A Phase I Study of Oxaliplatin in Combination With Paclitaxel|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:09.209641|2017-02-18 18:17:09.209641
NCT00004172|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer|Peripheral Stem Cell Transplantation Protocol for Patients With Previously Treated Advanced Breast Cancer - A Phase II Pilot Study|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:09.292998|2017-02-18 18:17:09.292998
NCT00004171|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-06-08||2011-02-16|October 1999||1999-10-01|June 2012|2012-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma|Autologous Blood Stem Cell Transplantation in Patients With Hodgkin's Disease and Non-Hodgkin's Lymphoma Who Have Had Prior Radiation Therapy|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:09.387041|2017-02-18 18:17:09.387041
NCT00004169|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-06-21||2011-07-01|November 1993||1993-11-01|June 2012|2012-06-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease|High-Dose Chemoradiotherapy With Stem Cell Support in Patients With Relapsed or Refractory Hodgkin's Disease|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:09.477578|2017-02-18 18:17:09.477578
NCT00004166|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-31||2011-02-18|October 1999||1999-10-01|May 2012|2012-05-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy|Amifostine as a Toxicity Protectant in Ovarian Cancer in Chemotherapy Treated Patients: A Pilot Phase III Randomized Controlled Trial|Completed||Phase 3|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:09.571323|2017-02-18 18:17:09.571323
NCT00004165|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-31||2011-02-16|October 1999||1999-10-01|May 2012|2012-05-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|Stem Cell Transplant as Standard Therapy for Symptomatic Multiple Myeloma|Completed||Phase 3|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:09.661441|2017-02-18 18:17:09.661441
NCT00004164|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-02-06|||August 1999||1999-08-01|September 2000|2000-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx|A Phase II Trial of Docetaxel, Cisplatin, 5-FU, and Leucovorin for Carcinoma of the Nasopharnyx|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:09.876924|2017-02-18 18:17:09.876924
NCT00004163|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-02-06|||January 1999||1999-01-01|December 2001|2001-12-01||||||||Interventional|||Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer|Herceptin In Patients With Advanced or Metastatic Salivary Gland Carcinomas|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:09.967471|2017-02-18 18:17:09.967471
NCT00004162|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-04-10|||June 1997||1997-06-01|April 2013|2013-04-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma|Phase I Trial of Liposomal Doxorubicin (Doxil) Based Combination Chemotherapy Regimen in AIDS-Associated Non-Hodgkin's Lymphoma|Completed||Phase 1|48|Anticipated|University of Alabama at Birmingham||8|||f||||t||||||||||2017-02-18 18:17:10.066648|2017-02-18 18:17:10.066648
NCT00004161|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-04-10|||June 1997||1997-06-01|April 2013|2013-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Fenretinide in Treating Patients With Leukoplakia of the Mouth|A Randomized, Double Blind, Placebo-Controlled Phase II Clinical Trial of N(4-Hydroxy-phenyl)Retinamide (Fenretinide, 4HPR) in Oral Leukoplakia|Completed||Phase 2|30|Anticipated|University of Alabama at Birmingham||2|||f||||t||||||||||2017-02-18 18:17:10.207001|2017-02-18 18:17:10.207001
NCT00004160|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-11-25|||February 2000||2000-02-01|October 2005|2005-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed|Sequential and Concomitant Chemoradiotherapy With Gemcitabine-Based Chemotherapy for Inoperable Stage IIIa and IIIb Non-Small Cell Lung Cancer: A Phase I/IIa Study|Completed||Phase 1/Phase 2|72|Actual|University of Alabama at Birmingham||5|||f||||t||||||||||2017-02-18 18:17:10.316858|2017-02-18 18:17:10.316858
NCT00004159|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-11-18|||February 2000||2000-02-01|March 2013|2013-03-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor|Biweekly Gemcitabine and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer and Solid Tumors: A Phase I/IIa Study|Terminated||Phase 1/Phase 2|54|Actual|University of Alabama at Birmingham|||||f||||||||||||||2017-02-18 18:17:10.436707|2017-02-18 18:17:10.436707
NCT00004158|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2010-09-17|||June 1999||1999-06-01|September 2010|2010-09-01|January 2006|Actual|2006-01-01|||||Interventional|||Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase I/II Study of Targeted Radiotherapy Using Holmium-166-DOTMP With Melphalan and Peripheral Blood Stem Cell Transplantation for Treatment of Multiple Myeloma|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:10.537071|2017-02-18 18:17:10.537071
NCT00004157|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2010-03-31|||August 2000||2000-08-01|March 2010|2010-03-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors|Combination of Interleukin 11 (Neumega) With G-CSF to Mobilize Autologous Peripheral Blood Stem Cells (PBSC)|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:10.625962|2017-02-18 18:17:10.625962
NCT00004156|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-10-29|||May 1999||1999-05-01|October 2013|2013-10-01||||June 2008|Actual|2008-06-01||Interventional|||Vaccine Therapy in Treating Patients With Breast Cancer|Vaccination of High Risk Breast Cancer Patients With MUC-1 (Glycosylated) Keyhole Limpet Hemocyanin Conjugates Plus the Immunological Adjuvant QS21|Completed||Phase 1|45|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:17:10.728595|2017-02-18 18:17:10.728595
NCT00004154|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2016-06-16|||June 2000||2000-06-01|October 2012|2012-10-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer|Randomized Chemoprevention Trial With 4-HPR (Fenretinide) in Superficial Bladder Cancer|Completed||Phase 3|111|Actual|M.D. Anderson Cancer Center||2|||f||||t||||||||||2017-02-18 18:17:11.041587|2017-02-18 18:17:11.041587
NCT00004153|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-09-04|||June 1998||1998-06-01|September 2013|2013-09-01|January 2005|Actual|2005-01-01|March 2004|Actual|2004-03-01||Interventional|||Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma|Sensitive RT-PCR Analysis for Melanoma Markers From Lymph Nodes and Peripheral Blood in Patients With Melanoma|Completed||N/A|106|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:17:11.163992|2017-02-18 18:17:11.163992
NCT00004152|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-01-15|||February 1999||1999-02-01|January 2013|2013-01-01||||December 2002|Actual|2002-12-01||Interventional|||PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma|A Pilot Study to Compare 18F-Fluorodeoxyglucose Positron Emission Tomography (PET) Scanning in Addition to CT Scanning With CT Scanning Alone in the Pre-Operative Evaluation of Patients With Stage III and IV Melanoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:11.26686|2017-02-18 18:17:11.26686
NCT00004151|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-09-20|||September 1999||1999-09-01|September 2012|2012-09-01||||November 2000|Actual|2000-11-01||Interventional|||Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer|Open Label Phase II Study on XR5000 Administered as a 5 Day Infusion in Advanced Non Small Cell Lung Cancer|Completed||Phase 2|15|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:11.370131|2017-02-18 18:17:11.370131
NCT00004150|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-11-05|||March 1999||1999-03-01|February 2001|2001-02-01|April 2007|Actual|2007-04-01|||||Interventional|||High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer|Pan-European Trials in Adjuvant Colon Cancer (PETACC-2): Randomized Phase III Intergroup Trial of High-Dose Infusional 5-FU (+ or - Folinic Acid) Versus Standard Bolus 5-FU/Folinic Acid|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:11.486927|2017-02-18 18:17:11.486927
NCT00004149|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-07-07|||September 1999||1999-09-01|July 2004|2004-07-01||||||||Interventional|||Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy|A Phase II Trial of Arsenic Trioxide in Advanced Hormone-Refractory Prostate Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:11.706897|2017-02-18 18:17:11.706897
NCT00004148|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-02-08|||October 1999||1999-10-01|June 2006|2006-06-01||||April 2006|Actual|2006-04-01||Interventional|||Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma|A Phase I Trial of Intra Lesional RV-B7.1 Vaccine in the Treatment of Malignant Melanoma|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:11.802748|2017-02-18 18:17:11.802748
NCT00004147|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-20|||July 2000||2000-07-01|May 2003|2003-05-01|November 2006|Actual|2006-11-01|||||Interventional|||COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors|A Phase I/II Study of Col-3 Administered on a Continuous Daily Oral Schedule in Patients With Recurrent High-Grade Astrocytoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:11.907818|2017-02-18 18:17:11.907818
NCT00004146|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2015-05-05|2015-03-13||March 2000||2000-03-01|April 2015|2015-04-01|January 2010|Actual|2010-01-01|January 2010|Actual|2010-01-01||Interventional|||Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM|Phase II Clinical and Pharmacologic Study of Radiation Therapy and CAI (Carboxy-Amido Triazole) in Adults With Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|55|Actual|National Cancer Institute (NCI)||1|||f||||t||||||||||2017-02-18 18:17:12.015716|2017-02-18 18:17:12.015716
NCT00004145|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2014-03-06|||November 1998||1998-11-01|March 2014|2014-03-01|August 2011|Actual|2011-08-01|November 2003|Actual|2003-11-01||Interventional|||Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Allogeneic Peripheral Blood Stem Cell Transplantation Using a Non-Myeloablative Preparative Regimen for Patients With Hematologic Malignancies|Completed||Phase 2|16|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:17:12.363235|2017-02-18 18:17:12.363235
NCT00004144|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2014-04-22|||May 2000||2000-05-01|April 2014|2014-04-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer|Phase I Study of Bryostatin 1 and Gemcitabine (Gemzar)|Completed||Phase 1|36|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 18:17:12.480021|2017-02-18 18:17:12.480021
NCT00004143|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2014-11-19|2013-09-06||September 1999||1999-09-01|November 2014|2014-11-01|June 2009|Actual|2009-06-01|May 2008|Actual|2008-05-01||Interventional|||Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes|Allogeneic Mixed Chimerism Stem Cell Transplantation Utilizing In Vivo and In Vitro Campath for Hemoglobinopathies and Bone Marrow Failure Syndromes|Completed||Phase 2|2|Actual|Duke University|Small number of subjects analyzed|2|||f||||t||||||||||2017-02-18 18:17:12.58545|2017-02-18 18:17:12.58545
NCT00004142|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-07-27|||September 1999||1999-09-01|July 2012|2012-07-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver|Phase II Study of Radiofrequency Ablation of Colorectal Cancer Liver Metastases Combined With Post-Ablation Hepatic Arterial Infusion of Floxuridine Alternating With 5-Fluorouracil|Completed||Phase 2|40|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:17:12.869177|2017-02-18 18:17:12.869177
NCT00004141|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-09-04|||August 1998||1998-08-01|September 2013|2013-09-01|April 2006|Actual|2006-04-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma|Phase II Study of Outpatient CDDP and DTIC Followed by GM-CSF, IFN-a2b, and IL-2 in Patients With Advanced Melanoma|Completed||Phase 2|46|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:17:12.992582|2017-02-18 18:17:12.992582
NCT00004139|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2016-07-19|||September 1999||1999-09-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|July 2004|Actual|2004-07-01||Interventional|||Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Phase II Randomized Trial of Gemcitabine/Docetaxel and Gemcitabine/Irinotecan in Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|80|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:17:13.118989|2017-02-18 18:17:13.118989
NCT00004138|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2016-07-12|||September 1999||1999-09-01|July 2016|2016-07-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Positron Emission Tomography for Detecting Non-small Cell Lung Cancer|The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma|Completed||N/A|303|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:17:13.374774|2017-02-18 18:17:13.374774
NCT00004137|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-02-12|||October 1999||1999-10-01|February 2013|2013-02-01|November 2008|Actual|2008-11-01|March 2004|Actual|2004-03-01||Interventional|||S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Paclitaxel, Carboplatin and Topotecan With G-CSF in Untreated Patients With Extensive Small Cell Lung Cancer|Completed||Phase 2|88|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:17:13.536735|2017-02-18 18:17:13.536735
NCT00004136|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-07-27|||November 1999||1999-11-01|July 2012|2012-07-01|January 2006|Actual|2006-01-01|April 2000|Actual|2000-04-01||Interventional|||Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer|A Phase II Study of Radiofrequency Ablation of Unresectable Liver Tumors|Completed||Phase 2|59|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:17:13.711796|2017-02-18 18:17:13.711796
NCT00004135|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2014-03-06|||February 1999||1999-02-01|March 2014|2014-03-01|August 2007|Actual|2007-08-01|October 2004|Actual|2004-10-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer|Allogeneic Stem Cell Transplantation of Renal Cell Cancer and Metastatic Melanoma After Non-Myeloablative Chemotherapy|Completed||Phase 2|19|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:17:13.832727|2017-02-18 18:17:13.832727
NCT00004132|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-25|||January 2000||2000-01-01|June 2007|2007-06-01|May 2004|Actual|2004-05-01|||||Interventional|||Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer|A Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Patients With Hematologic Malignancies Undergoing Total Body Irradiation (TBI) and High-Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell (PBPC) Transplantation|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:13.952111|2017-02-18 18:17:13.952111
NCT00004129|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-09-16|||September 1999||1999-09-01|April 2008|2008-04-01||||||||Interventional|||Phosphorus 32 in Treating Patients With Glioblastoma Multiforme|Phase I/II Study of Interstitial Colloidal 32P for the Treatment of Recurrent Malignant Central Nervous System Tumors and Primary Central Nervous System Tumors With Poor Prognostic Factors|Unknown status|Recruiting|Phase 1|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:14.060702|2017-02-18 18:17:14.060702
NCT00004128|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-12-22|||September 1999||1999-09-01|April 2008|2008-04-01||||January 2008|Anticipated|2008-01-01||Interventional|||Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia|The Value of High Dose Versus Standard Dose ARA-C During Induction and of IL-2 After Intensive Consolidation/Autologous Stem Cell Transplantation in Patients (Age 15-60 Years) With Acute Myelogenous Leukemia. A Randomized Phase II Trial of the EORTC and the GIMEMA-ALWP|Unknown status|Active, not recruiting|Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:14.151368|2017-02-18 18:17:14.151368
NCT00004127|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-02-08|||February 2000||2000-02-01|February 2013|2013-02-01|August 2003|Actual|2003-08-01|October 2002|Actual|2002-10-01||Interventional|||Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach|A Phase II Study of Oxaliplatin in Combination With Fluorouracil and Leucovorin in Carcinoma of the Esophagus and Gastric Cardia|Completed||Phase 2|35|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:17:14.26008|2017-02-18 18:17:14.26008
NCT00004126|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-02-08|||November 1999||1999-11-01|February 2013|2013-02-01|August 2003|Actual|2003-08-01|January 2001|Actual|2001-01-01||Interventional|||Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer|A Phase II Study of Oxaliplatin in Combination With Paclitaxel in Non-Small Cell Lung Cancer|Completed||Phase 2|38|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:17:14.401017|2017-02-18 18:17:14.401017
NCT00004125|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2010-01-28|||October 1999||1999-10-01|January 2010|2010-01-01||||May 2007|Actual|2007-05-01||Interventional|||Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes|A Phase III Study of Doxorubicin-Cyclophosphamide Therapy Followed by Paclitaxel or Docetaxel Given Weekly or Every 3 Weeks in Patients With Axillary Node-Positive Breast Cancer|Completed||Phase 3|||Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-02-18 18:17:14.535218|2017-02-18 18:17:14.535218
NCT00004124|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-10-03|||October 1999||1999-10-01|October 2012|2012-10-01||||June 2017|Anticipated|2017-06-01||Interventional|||S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer|Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High-Risk Prostate Cancer Patients Following Radical Prostatectomy|Terminated||Phase 3|983|Actual|Southwest Oncology Group||2||Permanently Closed Due to Safety Issue|f||||t||||||||||2017-02-18 18:17:17.693016|2017-02-18 18:17:17.693016
NCT00004123|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-07-27|||July 1997||1997-07-01|July 2012|2012-07-01|October 2009|Actual|2009-10-01|July 2001|Actual|2001-07-01||Interventional|||Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma|A Phase I Study of Preoperative Chemoradiation and Intraoperative Radiation Therapy in the Treatment of Retroperitoneal Sarcoma|Completed||Phase 1|36|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:17:18.333241|2017-02-18 18:17:18.333241
NCT00004122|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-01-31|||July 1999||1999-07-01|January 2013|2013-01-01||||April 2001|Actual|2001-04-01||Interventional|||BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer|A National Phase II Trial of Intron (Interferon-alfa 2b) Plus BCG for Treatment of Superficial Bladder Cancer|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:17:18.455726|2017-02-18 18:17:18.455726
NCT00004115|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-09-16|||December 1998||1998-12-01|April 2003|2003-04-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy|Multicenter Randomized Survival Study of Monoclonal Antibody Radioimmunotherapy: A Multinational Study in Patients With Ovarian Carcinoma Using the HMFG1 Antibody Labeled With 90Yttrium|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:18.550054|2017-02-18 18:17:18.550054
NCT00004114|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2015-09-30||||||July 2012|2012-07-01||||||||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer|Non-Myeloablative Chemotherapy Followed by Unrelated Allogeneic Stem Cell Transplantation in Patients With Advanced Hematologic Malignancies: A Pilot Study|Withdrawn||Phase 1|0|Actual|Jonsson Comprehensive Cancer Center||||Study never opened|f||||||||||||||2017-02-18 18:17:18.636064|2017-02-18 18:17:18.636064
NCT00004113|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-18|||June 1999||1999-06-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Temozolomide in Treating Patients With Recurrent Malignant Glioma|A Phase II Study of Temozolomide (SCH 52365, Temodal(R)) for the Treatment of Recurrent Malignant Glioma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:18.729922|2017-02-18 18:17:18.729922
NCT00004112|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2010-04-13|||September 1999||1999-09-01|April 2010|2010-04-01|March 2003|Actual|2003-03-01|December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma|A Phase III Randomized Trial of CHOP Chemotherapy Plus Rituxan (IDEC-C2B8) Versus CHOP Chemotherapy Alone for Newly Diagnosed, Previously Untreated, Aggressive Non-Hodgkin's Lymphoma|Completed||Phase 3|||University of Nebraska|||||f||||f||||||||||2017-02-18 18:17:18.826519|2017-02-18 18:17:18.826519
NCT00004110|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-10-30|||August 1999||1999-08-01|October 2013|2013-10-01||||September 2004|Actual|2004-09-01||Interventional|||Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma|Monoclonal Antibody 3F8 and Oral Etoposide for the Treatment of Neuroblastoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:18.92364|2017-02-18 18:17:18.92364
NCT00004109|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-08-01|||March 1998||1998-03-01|August 2012|2012-08-01|April 2011|Actual|2011-04-01|September 2001|Actual|2001-09-01||Interventional|||Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma|A Phase I Study of Preoperative Concurrent Chemoradiation for High-Risk Extremity and Trunk Soft Tissue Sarcomas|Completed||Phase 1|30|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:17:19.017429|2017-02-18 18:17:19.017429
NCT00004108|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-15|||September 1999||1999-09-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||DX-8951f in Treating Patients With Liver Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Hepatocellular Carcinoma|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:17:19.139104|2017-02-18 18:17:19.139104
NCT00004107|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-06-21|||February 1998||1998-02-01|June 2011|2011-06-01||||May 2001|Actual|2001-05-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia|Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With High-Dose 90Y-Labeled Humanized LL2 Anti-CD-22 Antibody and Peripheral Blood Stem Cell Rescue|Completed||Phase 1/Phase 2|18|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||||||||||||2017-02-18 18:17:19.236643|2017-02-18 18:17:19.236643
NCT00004106|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-31||2011-07-01|May 1998||1998-05-01|May 2012|2012-05-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome|Phase II Trial of Temozolomide for the Treatment of Mycosis Fungoides and the Sezary Syndrome|Terminated||Phase 2|29|Actual|Northwestern University||1||Per Data Monitoring Committee given the poor/inadequate accrual.|f||||||||||||||2017-02-18 18:17:19.600174|2017-02-18 18:17:19.600174
NCT00004105|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-03-25|||September 1998||1998-09-01|March 2011|2011-03-01||||April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I/II Study of Paclitaxel, Estramustine Phosphate, and Vinorelbine (PaclEVin)|Completed||Phase 1/Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:17:19.70303|2017-02-18 18:17:19.70303
NCT00004104|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2016-03-30|||June 1998||1998-06-01|March 2016|2016-03-01||||July 2000|Actual|2000-07-01||Interventional|||Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma|Phase II Trial of the Effects of Interferon Alfa-2b on the Immunogenicity of a Polyvalent Melanoma Antigen Vaccine in Patients With Stage III Malignant Melanoma|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:17:19.807599|2017-02-18 18:17:19.807599
NCT00004103|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-04-05|||July 1998||1998-07-01|April 2011|2011-04-01|June 2009|Actual|2009-06-01|March 2007|Actual|2007-03-01||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer|A Phase II Study of Systemic Therapy With CPT-11 (Camptosar HCl) and Cisplatin in Patients With Advanced Gastric Cancer to be Followed by Surgical Resection and Postoperative Intraperitoneal Chemotherapy|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:17:19.903085|2017-02-18 18:17:19.903085
NCT00004102|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-03-25|||January 1999||1999-01-01|March 2011|2011-03-01||||November 2001|Actual|2001-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|A Phase II Trial of Eloxatin in Combination With 5-Fluorouracil and Leucovorin in Patients With Advanced Colorectal Carcinoma|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:17:20.011072|2017-02-18 18:17:20.011072
NCT00004101|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-02-08|||November 1999||1999-11-01|May 2001|2001-05-01||||June 2005|Actual|2005-06-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma|Phase I Trial of Humanized 1D10 Monoclonal Antibody (Hu1D10) In Patients With Relapsed Non-Hodgkin's Lymphoma (NHL)|Completed||Phase 1|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:20.115215|2017-02-18 18:17:20.115215
NCT00004100|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-12-17|||November 1998||1998-11-01|June 2008|2008-06-01||||||||Interventional|||Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Gemcitabine and Vinorelbine vs Standard Chemotherapy Containing Cisplatin for Stage IIIB/IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:20.227581|2017-02-18 18:17:20.227581
NCT00004099|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-09-20|||July 1999||1999-07-01|September 2012|2012-09-01||||February 2004|Actual|2004-02-01||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer|Randomized Phase III Study of Preoperative Chemotherapy Followed by Surgery Versus Surgery Alone in Locally Advanced Gastric Cancer (cT3 and cT4NxM0)|Terminated||Phase 3|144|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:17:20.355396|2017-02-18 18:17:20.355396
NCT00004097|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-09-19|||August 1999||1999-08-01|October 2001|2001-10-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer|A Phase I Study of Concomitant Chemoradiotherapy With Gemcitabine, Paclitaxel, and 5-FU for Patients With Advanced and/or Recurrent Cancer of the Head and Neck|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:20.473822|2017-02-18 18:17:20.473822
NCT00004096|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-31||2011-01-28|August 1999||1999-08-01|May 2012|2012-05-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase I/II Study of Carboplatin and Navelbine for Advanced Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:17:20.569226|2017-02-18 18:17:20.569226
NCT00004095|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-01-28|||August 1999||1999-08-01|January 2011|2011-01-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors|Phase I Trial of Irinotecan (CPT-11) and Gemcitabine in Patients With Solid Tumors|Completed||Phase 1|||Northwestern University|||||f||||||||||||||2017-02-18 18:17:20.677937|2017-02-18 18:17:20.677937
NCT00004094|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2014-01-03|||August 1999||1999-08-01|December 2002|2002-12-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx|A Phase II Study of Induction Chemotherapy Followed by Concomitant Paclitaxel (1 Hour Infusion), Fluorouracil, Hydroxyurea and Hyperfractionated Radiotherapy for Advanced Oral, Pharynx and Larynx Cancer|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:20.788514|2017-02-18 18:17:20.788514
NCT00004093|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-31||2011-05-25|August 1999||1999-08-01|May 2012|2012-05-01|March 2002|Actual|2002-03-01|February 2002|Actual|2002-02-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer|A Phase I-II Study of Induction Chemotherapy With Carboplatin and Gemcitabine, Followed by Chemoradiotherapy With Paclitaxel and Vinorelbine for Patients With Locally Advanced Non-Small Cell Lung Cancer|Terminated||Phase 1/Phase 2|36|Actual|Northwestern University||1||Original Principal Investigator left the institution.|f||||||||||||||2017-02-18 18:17:20.901635|2017-02-18 18:17:20.901635
NCT00004092|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2015-07-07|2015-07-07||May 1999||1999-05-01|July 2015|2015-07-01|December 2013|Actual|2013-12-01|December 2013|Actual|2013-12-01||Interventional|||Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer|Randomized Phase II Study of Adriamycin/Cytoxan/Taxol (ACT) vs. Cytoxan, Thiotepa, Carboplatin (STAMP V) in Patients With High-Risk Primary Breast Cancer|Completed||Phase 2|72|Actual|City of Hope Medical Center||2|||f||||||||||||||2017-02-18 18:17:21.023163|2017-02-18 18:17:21.023163
NCT00004091|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-01-27|||August 1999||1999-08-01|January 2011|2011-01-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Observational|||Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results|Development of Antibody-Based Diagnostic Markers for Abnormal Cervical Cells|Completed||N/A|100|Anticipated|Northwestern University|||1||f||||||||||||||2017-02-18 18:17:21.654083|2017-02-18 18:17:21.654083
NCT00004090|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-07-09|||August 1999||1999-08-01|January 2011|2011-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors|Gemcitabine (10 mg/m2/Min) and Cisplatin: A Phase I Study|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:21.751421|2017-02-18 18:17:21.751421
NCT00004089|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-07-09|||August 1999||1999-08-01|January 2011|2011-01-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer|A Multicenter Phase II Study of Intensified Concomitant Chemoradiotherapy for Patients With Anaplastic Thyroid Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:21.845734|2017-02-18 18:17:21.845734
NCT00004088|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2016-07-27|||April 1999||1999-04-01|July 2016|2016-07-01||||February 2017|Anticipated|2017-02-01||Interventional|||Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma|Sequential High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Peripheral Blood Progenitor Cell Rescue, Interferon/Thalidomide and Pamidronate for Patients With Multiple Myeloma|Active, not recruiting||Phase 2|70|Anticipated|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 18:17:22.206111|2017-02-18 18:17:22.206111
NCT00004087|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-06-21|||March 1997||1997-03-01|June 2011|2011-06-01||||May 2001|Actual|2001-05-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer|Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 in Advanced Metastatic Colorectal Cancer and Pancreatic Cancers Using Autologous Peripheral Blood Stem Cell Rescue (PBSCR) to Control Myelotoxicity|Completed||Phase 1/Phase 2|15|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||f||||||||||2017-02-18 18:17:22.326183|2017-02-18 18:17:22.326183
NCT00004086|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-06-06|||June 1997||1997-06-01|December 2001|2001-12-01||||||||Interventional|||Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer|A Phase I Trial of a Combined Regimen of Chemotherapy and 90Y-Labeled, Humanized LL2 (Anti-CD22) Antibody With Peripheral Stem Cell Rescue for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:22.434396|2017-02-18 18:17:22.434396
NCT00004085|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-06-21|||May 1998||1998-05-01|June 2011|2011-06-01||||May 2002|Actual|2002-05-01||Interventional|||Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer|Phase I/II Trial of High-Dose Radioimmunotherapy With a 90Y-Humanized MN-14 Anti-Carcinoembryonic Antigen (CEA) Antibody for the Treatment of Stage IV Breast Cancer|Completed||Phase 1/Phase 2|15|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||||||||||||2017-02-18 18:17:22.53057|2017-02-18 18:17:22.53057
NCT00004084|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-06-21|||April 1998||1998-04-01|June 2011|2011-06-01||||May 2002|Actual|2002-05-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia|Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immu-LL2: Treatment With 90Y-hLL2 IgG|Completed||Phase 1/Phase 2|21|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology||1|||f||||||||||||||2017-02-18 18:17:22.635508|2017-02-18 18:17:22.635508
NCT00004083|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-03-25|||February 1999||1999-02-01|March 2011|2011-03-01||||December 1999|Actual|1999-12-01||Interventional|||Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer|A Phase II Pilot Study of SPI-77 (Stealth Liposomal Cisplatin) in Patients With Recurrent Platinum-Sensitive Ovarian Cancer|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:17:22.76146|2017-02-18 18:17:22.76146
NCT00004082|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-25|||July 1999||1999-07-01|November 2010|2010-11-01|December 2010|Actual|2010-12-01|September 2003|Actual|2003-09-01||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors|A Phase I Study of Docetaxel (Taxotere), Carboplatin, and Gemcitabine (DoCaGem) as First-Line Therapy for Patients With High-Risk Epithelial Tumors of Mullerian Origin|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:22.85407|2017-02-18 18:17:22.85407
NCT00004081|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-08-09|||July 1999||1999-07-01|August 2012|2012-08-01|March 2003|Actual|2003-03-01|January 2002|Actual|2002-01-01||Interventional|||Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer|A Phase II Trial of Weekly, Low-Dose Docetaxel (Taxotere) in Patients With Platinum-Resistant Epithelial Ovarian or Primary Peritoneal Serous Cancer|Completed||Phase 2|30|Actual|Dana-Farber Cancer Institute|||||f||||f||||||||||2017-02-18 18:17:22.952236|2017-02-18 18:17:22.952236
NCT00004080|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-02-06|||December 1999||1999-12-01|August 2001|2001-08-01||||||||Interventional|||Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors|Assessment of the Safety and Transduction Efficiency of SCH58500, An Adenoviral Vector p53 Delivery System, to Patients With Recurrent Malignant Brain Tumors|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:23.0623|2017-02-18 18:17:23.0623
NCT00004079|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-01-31|||August 1999||1999-08-01|January 2013|2013-01-01||||September 2005|Actual|2005-09-01||Interventional|||Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors|A Phase I Trial of Sarcosinamide Nitrosourea (SarCNU) in Patients With Solid Tumors|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:23.140169|2017-02-18 18:17:23.140169
NCT00004078|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-13|||October 1999||1999-10-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||Irinotecan in Treating Children With Refractory Solid Tumors|Phase II Trial of Irinotecan in Children With Refractory Solid Tumors|Completed||Phase 2|181|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:17:23.452987|2017-02-18 18:17:23.452987
NCT00004077|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-12-18|||May 1996||1996-05-01|January 2001|2001-01-01|July 2005|Actual|2005-07-01|||||Interventional|||Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer|A Study of Paclitaxel, Cisplatin and Ifosfamide as Induction Therapy in the Treatment of Patients Relapsing After BEP Chemotherapy for Metastatic Germ Cell Tumors|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:23.569665|2017-02-18 18:17:23.569665
NCT00004076|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-12-18|||June 1999||1999-06-01|November 2000|2000-11-01||||||||Interventional|||PNU 166148 in Treating Patients With Metastatic Solid Tumors|A Phase I Study to Evaluate MAG-CPT (PNU 166148) Given as One Single Intravenous Administration Every 4 Weeks in Patients With Advanced Solid Tumors|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:23.670143|2017-02-18 18:17:23.670143
NCT00004075|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-08-02|||August 1999||1999-08-01|August 2011|2011-08-01|January 2007|Actual|2007-01-01|January 2007|Actual|2007-01-01||Interventional|||17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery|A Phase I Trial of 17-Allylaminogeldanamycin (17-AAG) in Solid Tumor and Lymphoma Patients|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:17:23.747974|2017-02-18 18:17:23.747974
NCT00004074|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-02-27|||August 1999||1999-08-01|February 2013|2013-02-01||||February 2009|Actual|2009-02-01||Interventional|||Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu|A Phase I Trial of Herceptin and Interleukin-12|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:23.84619|2017-02-18 18:17:23.84619
NCT00004073|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-01|||December 1999||1999-12-01|May 2012|2012-05-01|June 2004|Actual|2004-06-01|May 2003|Actual|2003-05-01||Interventional|||Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|Phase II Study of Suramin and Concurrent Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme|Completed||Phase 2|54|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:17:23.993965|2017-02-18 18:17:23.993965
NCT00004072|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2010-06-09|||September 1999||1999-09-01|June 2010|2010-06-01|September 2004|Actual|2004-09-01|August 2004|Actual|2004-08-01||Interventional|||O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma|Phase II Trial of O6-Benzylguanine (NSC 637037) and BCNU in Patients With Multiple Myeloma|Completed||Phase 2|17|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:17:24.103104|2017-02-18 18:17:24.103104
NCT00004071|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-09-10|||August 1999||1999-08-01|September 2012|2012-09-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer|A Randomized, Open-Label Phase II/III Study of SU101 Plus Mitoxantrone/Prednisone Compared to Mitoxantrone/Prednisone Alone in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2/Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 18:17:24.215072|2017-02-18 18:17:24.215072
NCT00004070|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-02-06|||July 1999||1999-07-01|January 2001|2001-01-01||||||||Interventional|||Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer|A Multi-Center, Open-Label, Multiple Administration, Rising Dose Study of the Safety, Tolerability, and Efficacy of IL-12 Gene Medicine in Patients With Unresectable or Recurrent/Refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Unknown status|Active, not recruiting|Phase 1/Phase 2|34|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:24.314867|2017-02-18 18:17:24.314867
NCT00004068|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-10-03|||March 1999||1999-03-01|October 2011|2011-10-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor|Treatment of Newly Diagnosed High-Grade Gliomas in Patients Ages Greater Than or Equal to 3 and Less Than or Equal to 21 Years With a Phase II Irinotecan Window Followed by Radiation Therapy and Temozolomide|Completed||Phase 2|53|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-02-18 18:17:24.417072|2017-02-18 18:17:24.417072
NCT00004067|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2016-03-22|||February 2000||2000-02-01|March 2016|2016-03-01|March 2020|Anticipated|2020-03-01|March 2005|Actual|2005-03-01||Interventional|||Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2|A Randomized Trial Comparing the Safety and Efficacy of Adriamycin and Cyclophosphamide Followed by Taxol (AC-T) to That of Adriamycin and Cyclophosphamide Followed by Taxol Plus Herceptin (AC-T+H) in Node-Positive Breast Cancer Patients Who Have Tumors That Overexpress HER2|Active, not recruiting||Phase 3|2130|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 18:17:24.530785|2017-02-18 18:17:24.530785
NCT00004066|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-03-06|||June 1999||1999-06-01|March 2013|2013-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma|A Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma|Completed||Phase 2|82|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:24.813221|2017-02-18 18:17:24.813221
NCT00004065|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-20|||July 1999||1999-07-01|June 2013|2013-06-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer|A Phase I Trial of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AAG, NSC #330507) Daily X 5 in Patients With Advanced Cancer Therapeutic Protocol|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:24.906127|2017-02-18 18:17:24.906127
NCT00004064|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-11-05|||November 1998||1998-11-01|June 2007|2007-06-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase IIB Study of the Safety and Efficacy of OVAREX MabB43.13 in Ovarian Cancer Patients With an Elevated Serum CA 125 But Without Other Evidence of Disease|Unknown status|Active, not recruiting|Phase 2|102|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:25.277129|2017-02-18 18:17:25.277129
NCT00004063|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-04-29|||August 1999||1999-08-01|December 2008|2008-12-01||||November 2011|Anticipated|2011-11-01||Interventional|||Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer|A Phase I-II Clinical Trial of Cisplatin (Platinol) Followed by Gemcitabine HCl (Gemzar) in Combination With Mild, Fever-Range Whole Body Hyperthermia (LL-WBH) at 40C in Patients With Advanced Malignancies|Unknown status|Recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:25.388902|2017-02-18 18:17:25.388902
NCT00004062|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-12-18|||July 1999||1999-07-01|May 2004|2004-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer|Restoration of Radioiodine Uptake in Thyroid Carcinoma: A Clinical Trial|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:25.498477|2017-02-18 18:17:25.498477
NCT00004061|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-25|||May 1999||1999-05-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|May 2003|Actual|2003-05-01||Interventional|||Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer|A Randomized Double-Blind, Placebo-Controlled Trial of Recombinant Human Keratinocyte Growth Factor (rHuKGF) in Patients With Hematologic Malignancies Undergoing Total Body Irradiation (TBI) and High-Dose Chemotherapy With Autologous Peripheral Blood|Completed||Phase 2|111|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:25.593915|2017-02-18 18:17:25.593915
NCT00004060|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-15|||July 1999||1999-07-01|May 2012|2012-05-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Advanced Ovarian, Tubal, or Peritoneal Cancer Refractory to Platinum, Taxane and Topotecan|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:17:25.704545|2017-02-18 18:17:25.704545
NCT00004059|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-20|||July 1999||1999-07-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors|A Phase I Study of the Cyclin-Dependent Kinase (CDK)/Protein Kinase C (PKC) Inhibitor UCN-01 (NSC 638850) in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:25.799875|2017-02-18 18:17:25.799875
NCT00004058|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2010-01-25|||December 1998||1998-12-01|January 2010|2010-01-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder|Phase I Study of 12-O-tetradecanoylphorbol-13-acetate (TPA) in Patients With Refractory Hematologic Malignancies/Bone Marrow Disorders|Terminated||Phase 1|||Rutgers, The State University of New Jersey||||At this time it is felt that we will not gain further information from an additional patients.|f||||t||||||||||2017-02-18 18:17:25.887962|2017-02-18 18:17:25.887962
NCT00004057|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-20|||December 1998||1998-12-01|June 2013|2013-06-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas|A Phase I and Pharmacokinetic Study Evaluating the Safety, Tolerability, and Maximally Tolerated Dose of Combination Therapy With Paclitaxel and L-778,123 in Patients With Recurrent or Refractory Solid Malignancies|Completed||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:25.986011|2017-02-18 18:17:25.986011
NCT00004056|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2014-07-24|||October 1999||1999-10-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|October 2002|Actual|2002-10-01||Interventional|||Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia|Treatment of Newly Diagnosed Childhood AML Using a Timed-Sequential Remission Induction and Consolidation Followed by Single Dose Melphalan With Peripheral Stem Cell Rescue: A POG Pilot Study|Completed||Phase 1|35|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:17:26.078204|2017-02-18 18:17:26.078204
NCT00004055|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2016-07-12|||November 1999||1999-11-01|July 2016|2016-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer|Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer|Completed||Phase 2|38|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:17:26.227919|2017-02-18 18:17:26.227919
NCT00004054|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2014-12-24|2014-12-24||January 2000||2000-01-01|December 2014|2014-12-01|November 2013|Actual|2013-11-01|April 2010|Actual|2010-04-01||Interventional||All eligible patients|Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer|A Phase III Protocol of Androgen Suppression (AS) and Radiation Therapy (RT) vs AS and RT Followed by Chemotherapy With Paclitaxel, Estramustine, and Etoposide (TEE) for Localized, High-Risk, Prostate Cancer|Completed||Phase 3|397|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:17:26.369264|2017-02-18 18:17:26.369264
NCT00004052|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-06-24|||March 1999||1999-03-01|June 2013|2013-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia|Phase II, Multicenter Vaccination of Patients With Chronic Myelogenous Leukemia With a Multivalent Tumor Specific Breakpoint Peptide Vaccine|Completed||Phase 2|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:26.922897|2017-02-18 18:17:26.922897
NCT00004051|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-12-18|||August 1998||1998-08-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|July 2001|Actual|2001-07-01||Interventional|||Irinotecan in Treating Patients With Advanced Solid Tumors|A Phase I Study to Evaluate Orally Administered Irinotecan HCL (CPT-11) Given as a Powder-Filled Capsule Formulation Daily for 14 Days Every Three Weeks in Patients With Advanced Solid Tumors|Completed||Phase 1|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:27.01448|2017-02-18 18:17:27.01448
NCT00004050|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2014-07-25|||June 1999||1999-06-01|July 2014|2014-07-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer|Phase II Study Evaluating the Safety and Efficacy of Neoadjuvant Leuvectin Immunotherapy for the Treatment of Prostate Cancer|Terminated||Phase 2|13|Actual|Vical||1||Development in prostate cancer indication halted|f||||f||||||||||2017-02-18 18:17:27.100819|2017-02-18 18:17:27.100819
NCT00004049|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2008-07-23|||April 1999||1999-04-01|May 2001|2001-05-01||||||||Interventional|||SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors|A Phase I and Pharmacokinetic Study of SR-45023A Administered Once Every 7 Days|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:27.209864|2017-02-18 18:17:27.209864
NCT00004048|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-06-21|||September 1998||1998-09-01|June 2011|2011-06-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer|Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 Alone or Combined With Doxorubicin and Peripheral Blood Stem Cell Rescue (PBSCR) in Medullary Thyroid Cancer (MTC) Grant Application Title: Radioimmunotherapy of MTC With Y-90 Humanized MN14 Anti-CEA Mab and Doxorubicin|Completed||Phase 1/Phase 2|30|Anticipated|Garden State Cancer Center at the Center for Molecular Medicine and Immunology|||||f||||||||||||||2017-02-18 18:17:27.29225|2017-02-18 18:17:27.29225
NCT00004047|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-15|||June 1999||1999-06-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Chemotherapy in Treating Patients Who Have Hematologic Cancer|A Phase I Study of Intravenous DX-8951f in Patients With Advanced Myelodysplastic Syndromes, Refractory Acute Leukemia, Refractory or Transformed Chronic Lymphocytic Leukemia, and Chronic Myelogenous Leukemia in Blastic Phase|Completed||Phase 1|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:17:27.393438|2017-02-18 18:17:27.393438
NCT00004046|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2012-05-15|||June 1999||1999-06-01|May 2012|2012-05-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Chemotherapy in Treating Women With Metastatic Breast Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Metastatic Adenocarcinoma of the Breast|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:17:27.500216|2017-02-18 18:17:27.500216
NCT00004045|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-15|||June 1999||1999-06-01|May 2012|2012-05-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Chemotherapy in Treating Patients With Prostate Cancer|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2|||Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:17:27.602111|2017-02-18 18:17:27.602111
NCT00004043|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2012-05-24|||February 1999||1999-02-01|September 2009|2009-09-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer|Phase II Study of Pulse Calcitriol in Patients With Rising PSA After Definitive Treatment for Prostate Cancer|Completed||Phase 2|25|Actual|OHSU Knight Cancer Institute||1|||f||||t||||||||||2017-02-18 18:17:27.71381|2017-02-18 18:17:27.71381
NCT00004042|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-07-17|||November 1998||1998-11-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|July 2001|Actual|2001-07-01||Interventional|||Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer|A Phase I Dose-Escalation Study of BIBH-1 in Patients With Advanced or Metastatic Fibroblast Activation Protein-Positive Cancer|Completed||Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:27.80988|2017-02-18 18:17:27.80988
NCT00004041|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-02-06|||March 1999||1999-03-01|December 2002|2002-12-01||||||||Interventional|||Gene Therapy in Treating Patients With Recurrent Malignant Gliomas|Phase I Trial of Adenovirus-Mediated Wild-Type P53 Gene Therapy for Malignant Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:27.904731|2017-02-18 18:17:27.904731
NCT00004040|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2015-08-17|||June 1998||1998-06-01|August 2015|2015-08-01|June 1999|Actual|1999-06-01|June 1999|Actual|1999-06-01||Interventional|||Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy|Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma Whose Disease Has Been Controlled With Chemotherapy: Rituximab Anti-CD20 Monoclonal Antibody or Interferon Alpha 2-b as Maintenance Therapy|Withdrawn||Phase 2|0|Actual|Hoag Memorial Hospital Presbyterian||||no patient accruals|f||||f||||||||||2017-02-18 18:17:27.998731|2017-02-18 18:17:27.998731
NCT00004039|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2015-08-17|||June 1998||1998-06-01|August 2015|2015-08-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma|Phase II Trials of CHOP Chemotherapy and Interferon Alpha or Rituximab Anti-CD20 Monoclonal Antibody as Initial Treatment of Patients With Stage III and IV High-Risk Indolent B-Cell Lymphoma and Intermediate Grade B-Cell Lymphoma|Withdrawn||Phase 2|0|Actual|Hoag Memorial Hospital Presbyterian||||No patient accruals|f||||f||||||||||2017-02-18 18:17:28.107783|2017-02-18 18:17:28.107783
NCT00004038|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-02-06|||January 1999||1999-01-01|June 2001|2001-06-01||||May 2001|Actual|2001-05-01||Interventional|||Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer|Pilot Study of p53 Intralesional Gene Therapy With Chemotherapy in Breast Cancer|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:28.210731|2017-02-18 18:17:28.210731
NCT00004037|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-04-10|||June 1998||1998-06-01|May 2003|2003-05-01||||April 2003|Actual|2003-04-01||Interventional|||Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer|Evaluation of Docetaxel in Recurrent, Platinum Resistant, Refractory and Paclitaxel Refractory Ovarian Cancer and Primary Peritoneal Carcinoma|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:17:28.321334|2017-02-18 18:17:28.321334
NCT00004036|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-12-18|||November 1997||1997-11-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer|Phase I Trial of High Dose Chemotherapy Using Amifostine for In-Vivo Protection of GM-CSF Primed Progenitor Cells|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:28.745266|2017-02-18 18:17:28.745266
NCT00004033|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-03-25|||September 1998||1998-09-01|March 2011|2011-03-01||||May 2001|Actual|2001-05-01||Interventional|||Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma|Phase II Clinical Study of a Liposome Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally in Patients With Malignant Pleural Mesothelioma|Completed||Phase 2|30|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:17:28.850887|2017-02-18 18:17:28.850887
NCT00004032|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-01-22|||October 1997||1997-10-01|January 2013|2013-01-01||||April 2004|Actual|2004-04-01||Interventional|||Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer|Intraperitoneal (IP) Autologous Therapeutic Tumor Vaccine AUT-OV-ALVAC-h.B7.1 Plus IP rIFN-gamma for Patients With Ovarian Cancer. A Pilot Study|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:28.95576|2017-02-18 18:17:28.95576
NCT00004031|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-05-22|||July 1997||1997-07-01|May 2013|2013-05-01||||July 2010|Actual|2010-07-01||Interventional|||SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma|SWOG-9704 A Randomized Phase III Trial Comparing Early High Dose Chemoradiotherapy and an Autologous Stem Cell Transplant to Conventional Dose CHOP Chemotherapy Plus Rituximab for CD20+ B Cell Lymphomas (With Possible Late Autologous Stem Cell Transplant) for Patients With Diffuse Aggressive Non-Hodgkin's Lymphoma in the High-Intermediate and High Risk International Classification Prognostic Groups|Completed||Phase 3|397|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:17:29.088435|2017-02-18 18:17:29.088435
NCT00004030|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2011-03-22|||March 1996||1996-03-01|January 2001|2001-01-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin|A Phase I/II Study of the Pharmacokinetics, Tolerability and Safety of Administration of VX-853 to Patients Receiving Single Agent Therapy With Doxorubicin HCI|Completed||Phase 1/Phase 2|45|Anticipated|Georgetown University|||||f||||f||||||||||2017-02-18 18:17:29.237871|2017-02-18 18:17:29.237871
NCT00004029|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2013-02-08|||December 1996||1996-12-01|June 2006|2006-06-01||||May 2006|Actual|2006-05-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer|A PHASE I TRIAL OF RECOMBINANT VACCINIA VIRUS THAT EXPRESSES PSA IN PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE|Completed||Phase 1|46|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:29.325597|2017-02-18 18:17:29.325597
NCT00004028|ClinicalTrials.gov processed this data on February 17, 2017|1999-12-10|2009-02-06|||September 1996||1996-09-01|January 1999|1999-01-01||||||||Interventional|||Carmustine in Treating Patients With Recurrent Malignant Glioma|PHASE I, OPEN LABEL, MULTICENTER DOSE ESCALATION STUDY OF GLIADEL IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:29.432145|2017-02-18 18:17:29.432145
NCT00004026|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||December 1998||1998-12-01|June 2007|2007-06-01||||||||Interventional|||CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy|A Phase II Study of CT-2584 Mesylate in Patients With Hormone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:29.545188|2017-02-18 18:17:29.545188
NCT00004025|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||March 1999||1999-03-01|July 2002|2002-07-01||||||||Interventional|||Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma|Phase I/II Trial of the Safety, Immunogenicity, and Efficacy of Autologous Dendritic Cells Transduced With Adenoviruses Encoding the MART-1 and gp100 Melanoma Antigens Administered With or Without Low Dose Recombinant Interleukin-2 (rIL-2) in Patients With Stage IV Melanoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:29.648003|2017-02-18 18:17:29.648003
NCT00004024|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||June 1997||1997-06-01|April 2013|2013-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma|Immunotherapy for Malignant Glioma - Phase II Trial of Autologous Cancer Antigen Specific Immunotherapy|Completed||Phase 2|60|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:17:29.745778|2017-02-18 18:17:29.745778
NCT00004022|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||June 1997||1997-06-01|April 2013|2013-04-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma|Immunotherapy for Malignant Melanoma - Phase II Trial of Autologous Cancer Antigen Specific Immunotherapy|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 18:17:29.853442|2017-02-18 18:17:29.853442
NCT00004017|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||February 2000||2000-02-01|March 2003|2003-03-01||||||||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma|Phase II Open-Label, Non-Randomized, Multicenter Study of Interstitial 131I-chTNT-1/B for the Treatment of Newly Diagnosed or Recurrent Malignant Glioma|Completed||Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:29.963203|2017-02-18 18:17:29.963203
NCT00004016|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-05|||April 1999||1999-04-01|June 2013|2013-06-01||||||||Interventional|||Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors|Phase I Trial of Immunotherapy With Adenovirus-Interferon- Gamma (TG1041) in Patients With Malignant Melanoma|Completed||Phase 1|||University of Rochester|||||f||||||||||||||2017-02-18 18:17:30.075284|2017-02-18 18:17:30.075284
NCT00004015|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-17|||June 2002||2002-06-01|July 2012|2012-07-01||||July 2003|Actual|2003-07-01||Interventional|||Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery|Postoperative Treatment of Glioblastoma With BNCT at the Petten Irradiation Facility|Completed||Phase 1|36|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:30.169593|2017-02-18 18:17:30.169593
NCT00004014|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-08-13|||April 1999||1999-04-01|August 2010|2010-08-01|November 2001|Actual|2001-11-01|January 2000|Actual|2000-01-01||Interventional|||Liposomal Doxorubicin in Treating Patients With Prostate Cancer|Liposome-Encapsulated Doxorubicin (LED) in Hormone Refractory Prostate Carcinoma, Phase II|Completed||Phase 2|10|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:17:30.299738|2017-02-18 18:17:30.299738
NCT00004013|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-31|||January 1999||1999-01-01|March 2010|2010-03-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer|Treatment of Refractory Stage IV Metastatic Breast Cancer With Weekly Paclitaxel or Weekly Paclitaxel and Herceptin Following Autologous/Syngeneic Stem Cell Transplant|Completed||Phase 2|60|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:30.39805|2017-02-18 18:17:30.39805
NCT00004012|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||December 1998||1998-12-01|June 2013|2013-06-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Trial of Oral Capecitabine in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:30.489698|2017-02-18 18:17:30.489698
NCT00004011|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-30|||October 1999||1999-10-01|January 2013|2013-01-01|November 2012|Actual|2012-11-01|May 2005|Actual|2005-05-01||Interventional|||S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer|A Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|354|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:17:30.595909|2017-02-18 18:17:30.595909
NCT00004010|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-25|||October 1999||1999-10-01|February 2014|2014-02-01|June 2008|Actual|2008-06-01|October 2003|Actual|2003-10-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease|Pilot Study for the Treatment of Children With Newly Diagnosed Advanced Stage Hodgkin's Disease: Upfront Dose Intensive Chemotherapy|Completed||Phase 2|99|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:17:31.089821|2017-02-18 18:17:31.089821
NCT00004009|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||June 1999||1999-06-01|August 2000|2000-08-01||||||||Interventional|||R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia|A Phase I Study to Determine Biological Endpoints of Up to 21 Day Dosing of the Farnesyltransferase Inhibitor R115777 (IND# 52,302) for Refractory and Relapsed Adult Leukemias (Summary Last Modified 9/1999)|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:31.26729|2017-02-18 18:17:31.26729
NCT00004008|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||July 1999||1999-07-01|November 1999|1999-11-01|May 2003|Actual|2003-05-01|||||Interventional|||Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer|A Phase II Trial of Bryostatin 1 in Ovarian Cancer Administered by Weekly 24 Hour Intravenous Infusion|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:31.551584|2017-02-18 18:17:31.551584
NCT00004006|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-10-03|||November 1997||1997-11-01|October 2011|2011-10-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma|Treatment for Extrachoroidal or Metastatic Retinoblastoma|Completed||Phase 2|4|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-02-18 18:17:31.650938|2017-02-18 18:17:31.650938
NCT00004005|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-10-03|||September 1998||1998-09-01|October 2011|2011-10-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin|Irinotecan and 5-Fluorouracil/Leucovorin for Patients With Colorectal Carcinoma and Other Refractory Tumors|Completed||Phase 2|12|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-02-18 18:17:31.751642|2017-02-18 18:17:31.751642
NCT00004004|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||July 1999||1999-07-01|May 2007|2007-05-01|August 2003|Actual|2003-08-01|||||Interventional|||Procarbazine in Treating Patients With Recurrent Brain Tumor|A Phase I/II Study of Oral Procarbazine in the Treatment of Recurrent High Grade Astrocytomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:31.863632|2017-02-18 18:17:31.863632
NCT00004003|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||April 1999||1999-04-01|April 2013|2013-04-01|August 2003|Actual|2003-08-01|November 2001|Actual|2001-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery|A Study of Gemcitabine, Cisplatin, and 5-Fluorouracil in the Treatment of Advanced Pancreatic Cancer|Completed||Phase 2|30|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:17:31.975144|2017-02-18 18:17:31.975144
NCT00004002|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-08|||July 1999||1999-07-01|September 2005|2005-09-01||||October 2001|Actual|2001-10-01||Interventional|||PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma|Phase I Trial of PS-341 in Advanced Cancers|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:17:32.072458|2017-02-18 18:17:32.072458
NCT00004001|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-21|||October 1999||1999-10-01|February 2014|2014-02-01|January 2007|Actual|2007-01-01|July 2006|Actual|2006-07-01||Interventional|||S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy|Docetaxel and Estramustine Versus Mitoxantrone and Prednisone for Advanced, Hormone Refractory Prostate Cancer|Completed||Phase 3|770|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:17:32.201351|2017-02-18 18:17:32.201351
NCT00003998|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||October 1998||1998-10-01|October 2007|2007-10-01|December 2004|Actual|2004-12-01|||||Interventional|||Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer|A Randomized, Prospective Phase III Comparison of Paclitaxel-Carboplatin Versus Docetaxel-Carboplatin as First Line Chemotherapy in Stage Ic-IV Epithelial Ovarian Cancer|Completed||Phase 3|1050|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:32.354711|2017-02-18 18:17:32.354711
NCT00003997|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||July 1999||1999-07-01|January 2001|2001-01-01||||October 2000|Actual|2000-10-01||Interventional|||6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia|Phase I Study of MGI-114 (NSC#683863) in Patients With Refractory Myelodysplastic Syndromes, Acute Leukemia and Chronic Myelogenous Leukemia in Blastic Phase (CML-BP)|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:32.458064|2017-02-18 18:17:32.458064
NCT00003996|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-05|||May 1999||1999-05-01|December 2016|2016-12-01|May 2008|Actual|2008-05-01|August 2001|Actual|2001-08-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase II Trial of Pre-irradiation Chemotherapy With BCNU, Cisplatin and Oral Etoposide Combined With Radiation Therapy in the Treatment of Grade 4 Astrocytoma (Glioblastoma)|Completed||Phase 2|93|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:17:32.572779|2017-02-18 18:17:32.572779
NCT00003995|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||September 1999||1999-09-01|June 2007|2007-06-01||||March 2006|Actual|2006-03-01||Interventional|||Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2|Phase II and Pharmacokinetic Study of CPT-11 and Trastuzumab (RhuMab HER2, Herceptin) in Advanced Colo-Rectal Cancer With p185 HER 2 Overexpression|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:32.758285|2017-02-18 18:17:32.758285
NCT00003994|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-13|||March 1999||1999-03-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer|Intergroup Protocol for Treatment of Children With Hepatoblastoma|Completed||Phase 3|277|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 18:17:32.885897|2017-02-18 18:17:32.885897
NCT00003993|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-04-28|||September 1999||1999-09-01|May 2006|2006-05-01||||July 2008|Actual|2008-07-01||Interventional|||Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma|A Phase lb Trial of the Combination of Bryostatin-1 and Low Dose Interleukin-2: Evaluation of the Functional and Molecular Status of Human Monocytes as Antigen Presenting Cells|Completed||Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:17:33.027909|2017-02-18 18:17:33.027909
NCT00003992|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-31|||August 1999||1999-08-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|January 2007|Actual|2007-01-01||Interventional|||Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2|Pilot Trial of Paclitaxel-Herceptin Adjuvant Therapy for Early Stage Breast Cancer|Completed||Phase 2|200|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:17:33.127137|2017-02-18 18:17:33.127137
NCT00003991|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||July 1998||1998-07-01|December 2011|2011-12-01|August 2011|Actual|2011-08-01|||||Interventional|||Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia|Multi-Center, Randomized Open-Label Study to Evaluate the Safety and Efficacy of Immunotherapy With Subcutaneous Maxamine (Histamine Dihydrochloride) Plus Proleukin (Interleukin-2) Versus No Treatment (Standard of Care) in Patients With Acute Myeloid Leukemia in First or Subsequent Complete Remission (CR)|Completed||Phase 3|360|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:33.289581|2017-02-18 18:17:33.289581
NCT00003989|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||June 1998||1998-06-01|July 2012|2012-07-01||||||||Interventional|||ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma|Phase II Trial With ISIS 3521/CGP 64128A in Patients With Malignant Melanoma and Non Small Cell Lung Cancer|Completed||Phase 2|50|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:33.598033|2017-02-18 18:17:33.598033
NCT00003985|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||September 1998||1998-09-01|July 2012|2012-07-01||||||||Interventional|||KRN7000 in Treating Patients With Solid Tumors|Phase I Study of KRN7000 in Patients With Solid Tumor Treated With a Weekly Intravenous Administration Schedule|Withdrawn||Phase 1|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:33.712469|2017-02-18 18:17:33.712469
NCT00003984|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||February 1999||1999-02-01|July 2012|2012-07-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome|Phase II Trial With a Recombinant Humanized Anti-CD33 Monoclonal Antibody (HuM195) in Patients With High Risk Primary Myelodysplastic Syndromes|Withdrawn||Phase 2|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:33.827642|2017-02-18 18:17:33.827642
NCT00003982|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||June 1997||1997-06-01|July 2012|2012-07-01||||||||Interventional|||MEN-10755 in Treating Patients With Solid Tumors|Phase I Study to Determine the Safety of MEN-10755 (BMS-195615) in Patients With a Solid Tumor on a Short I.V. Infusion Given Once Every Week for 3 Consecutive Weeks, Followed by One Week's Rest|Completed||Phase 1|30|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:33.957979|2017-02-18 18:17:33.957979
NCT00003981|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||April 1998||1998-04-01|July 2012|2012-07-01||||||||Interventional|||E7070 in Treating Patients With Solid Tumors|Phase I Study to Determine the Safety of E7070 in Patients With a Solid Tumor as a Single IV Infusion Weekly X 4, Repeated Every 6 Weeks|Completed||Phase 1|30|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:34.074091|2017-02-18 18:17:34.074091
NCT00003980|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||February 1999||1999-02-01|July 2012|2012-07-01||||||||Interventional|||BIBX 1382 in Treating Patients With Solid Tumors|Phase I and Pharmacokinetics Study to Determine the Safety of BIBX 1382 in Patients With a Solid Tumor on a Continuous Daily Oral Administration Schedule and After Single Oral and Intravenous Doses|Suspended||Phase 1|80|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:34.186447|2017-02-18 18:17:34.186447
NCT00003979|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||April 1999||1999-04-01|July 2012|2012-07-01||||||||Interventional|||CHS 828 in Treating Patients With Solid Tumors|Phase I and Pharmacokinetics Study to Determine the Safety of CHS 828 in Patients With a Solid Tumor on a Single Oral Dose Repeated Every 3 Weeks|Withdrawn||Phase 1|0|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:34.303309|2017-02-18 18:17:34.303309
NCT00003977|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||November 1999||1999-11-01|December 2003|2003-12-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer|A Phase I Study of Immunization With Alternating Human Papillomavirus E7 Lipopeptide Epitope Vaccine and Dendritic Cells Presenting the E7 Epitope for the Treatment of Recurrent or Persistent Cervical Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:37.440025|2017-02-18 18:17:37.440025
NCT00003976|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||March 1998||1998-03-01|July 2012|2012-07-01||||||||Interventional|||E7070 in Treating Patients With Solid Tumors|Phase I Study to Determine the Safety of E7070 in Patients With a Solid Tumor on a Single IV Infusion Repeated Every 3 Weeks|Completed||Phase 1|30|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:37.524421|2017-02-18 18:17:37.524421
NCT00003974|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-03|||August 1997||1997-08-01|March 2011|2011-03-01|November 2000|Actual|2000-11-01|June 1998|Actual|1998-06-01||Interventional|||Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma|An Evaluation of the Immunological Parameters Associated With a Skin-Test and Immunization of Lung and Mesothelioma Cancer Patients With Autologous Lung Tumor Associated Antigen: Characterization of the Patients' Cytolytic and Helper T Cell Reactivity for Identification of the Specific Antigen(s): A Pilot Study|Completed||Phase 1|20|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:17:37.636822|2017-02-18 18:17:37.636822
NCT00003972|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-31|||July 1998||1998-07-01|March 2010|2010-03-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer|A Phase III Study of High-Dose Chemotherapy Using Busulfan, Melphalan and Thiotepa Versus Cyclophosphamide,Thiotepa, Carboplatin Followed by Autologous Stem Cell Transplantation in Patients With High-Risk Primary Stage II or III (Non-Inflammatory) Breast Cancer|Completed||Phase 3|280|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:37.728974|2017-02-18 18:17:37.728974
NCT00003970|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-23|||January 1999||1999-01-01|January 2013|2013-01-01||||October 2003|Actual|2003-10-01||Interventional|||Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma|A Phase I Clinical Trial to Investigate the Correlation Between UGT1A1 Genotype and Irinotecan (CPT-11) Pharmacokinetics and Toxicity in Cancer Patients|Completed||Phase 1|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:37.8233|2017-02-18 18:17:37.8233
NCT00003969|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||August 1998||1998-08-01|December 2000|2000-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Geldanamycin Analogue in Treating Patients With Advanced Cancer|A Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino-17-Demethoxygeldanamycin (17-AAG) (NSC 330507) Via Intravenous Administration in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:37.94492|2017-02-18 18:17:37.94492
NCT00003968|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||June 1999||1999-06-01|January 2004|2004-01-01||||December 2003|Actual|2003-12-01||Interventional|||Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer|Phase II Study of Bryostatin-1 in Metastatic Renal Cell Carcinoma(Summary Last Modified 8/1999)|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:38.038664|2017-02-18 18:17:38.038664
NCT00003967|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-24|||September 1999||1999-09-01|March 2008|2008-03-01||||April 2006|Actual|2006-04-01||Interventional|||Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer|A Phase I Study of Sequential Prolonged Oral Topotecan (IND# 58,131) and Prolonged Oral Etoposide as Second Line Therapy in Ovarian, Peritoneal or Tubal Carcinoma|Completed||Phase 1|24|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:17:38.421175|2017-02-18 18:17:38.421175
NCT00003966|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-19|||April 2000||2000-04-01|January 2017|2017-01-01|April 2006|Actual|2006-04-01|February 2006|Actual|2006-02-01||Interventional|||Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation|Defibrotide for Hematopoietic Stem Cell Transplant Patients With Severe Hepatic Venocclusive Disease: A Phase I/II Study to Determine the Minimal Effective Dose|Completed||Phase 2|151|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 18:17:38.521586|2017-02-18 18:17:38.521586
NCT00003963|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-09-30|||May 1999||1999-05-01|July 2012|2012-07-01|February 2005|Actual|2005-02-01|September 2003|Actual|2003-09-01||Interventional|||Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation|Treatment of B-Cell NHL Relapsing After Transplant With a Rituxan Vinorelbine Combination|Completed||Phase 2|14|Actual|Jonsson Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:17:38.655285|2017-02-18 18:17:38.655285
NCT00003962|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-01|||April 1998||1998-04-01|May 2014|2014-05-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Dose Finding Study of Toxicity and Immunomodulatory Effects of Interleukin-2 Following Allogeneic Bone Marrow Transplantation in Patients at High Risk for Relapse|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:17:38.775769|2017-02-18 18:17:38.775769
NCT00002971|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-12-13|||April 1997||1997-04-01|March 2003|2003-03-01||||||||Interventional|||O(6)-Benzylguanine in Treating Patients With Malignant Glioma|A Phase I Trial of Pre-Surgical O6-Benzylguanine in the Treatment of Patients With Malignant Glioma|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:30.177552|2017-02-18 18:20:30.177552
NCT00003961|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-04-16|||April 1999||1999-04-01|April 2014|2014-04-01|December 2007|Actual|2007-12-01|December 2007|Actual|2007-12-01||Interventional|||Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome|Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) After T-Lymphocyte Depleted Allogeneic BMT for Myelodysplastic Syndromes|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:17:38.878913|2017-02-18 18:17:38.878913
NCT00003960|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-01|||April 1998||1998-04-01|May 2014|2014-05-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Matched Unrelated and Haploidentical Bone Marrow Transplantation for Hematologic Malignancies|Completed||Phase 2|36|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:17:38.971852|2017-02-18 18:17:38.971852
NCT00003959|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-15|||June 1999||1999-06-01|January 2013|2013-01-01||||December 2001|Actual|2001-12-01||Interventional|||Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome|Vaccination of Patients With Myelodysplastic Syndrome Against Mutated RAS Proteins: A Pilot Trial|Completed||Phase 1|1|Actual|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:39.077511|2017-02-18 18:17:39.077511
NCT00003958|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-13|||September 2002||2002-09-01|June 2013|2013-06-01||||October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma|Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma|Completed||Phase 3|702|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:17:39.175078|2017-02-18 18:17:39.175078
NCT00003957|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-16|||December 1998||1998-12-01|April 2013|2013-04-01|August 2001|Actual|2001-08-01|September 2000|Actual|2000-09-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|A Phase II Trial of Multiple Cycles of Sequential High Dose Chemotherapy for Patients With Chemotherapy Sensitive Relapsed Non-Hodgkin's Lymphoma|Completed||Phase 2|3|Actual|Fox Chase Cancer Center|||||f||||||||||||||2017-02-18 18:17:39.307306|2017-02-18 18:17:39.307306
NCT00003956|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-02|||April 1999||1999-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|January 2001|Actual|2001-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I Study of Continuous Oral Administration of SCH 66336 and 5-Fluorouracil/Leucovorin (5FU/LV) in Patients With Advanced Cancer|Completed||Phase 1|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:39.404296|2017-02-18 18:17:39.404296
NCT00003955|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-12|||September 1999||1999-09-01|February 2014|2014-02-01|October 2009|Actual|2009-10-01|January 2005|Actual|2005-01-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma|"A Phase II Up-Front Window Study of Irinotecan (CPT-11) Followed by Multimodal, Multiagent, Therapy for Selected Children and Adolescents With Newly Diagnosed Stage 4/Clinical Group IV Rhabdomyosarcoma: An IRS-V Study"|Completed||Phase 2|77|Actual|Children's Oncology Group|||||f||||||||||||||2017-02-18 18:17:39.518364|2017-02-18 18:17:39.518364
NCT00003954|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-05-16|||March 1999||1999-03-01|May 2016|2016-05-01||||December 2002|Actual|2002-12-01||Interventional|||Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma|Allogeneic Stem Cell Transplantation For Multiple Myeloma: A Two Step Approach To Reduce Toxicity Involving High Dose Melphalan and Autologous Stem Cell Transplant Followed By PBSC Allografting After Low Dose TBI|Active, not recruiting||Phase 1/Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 18:17:40.144453|2017-02-18 18:17:40.144453
NCT00003953|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-25|||February 1999||1999-02-01|January 2013|2013-01-01|January 2013|Actual|2013-01-01|November 2001|Actual|2001-11-01||Interventional|||Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer|A Phase II Study of Preoperative Dose-Dense Chemotherapy With Sequential Doxorubicin and Docetaxel for Initial Treatment of Operable and Inoperable Stage II-IIIB Breast Cancer|Completed||Phase 2|39|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:17:40.289454|2017-02-18 18:17:40.289454
NCT00003951|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-15|||June 1999||1999-06-01|May 2012|2012-05-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas|A Phase II Study of Intravenous DX-8951f Administered Daily for Five Days Every Three Weeks to Patients With Metastatic Carcinoma of the Pancreas|Completed||Phase 2|37|Anticipated|Daiichi Sankyo Inc.|||||f||||||||||||||2017-02-18 18:17:40.416604|2017-02-18 18:17:40.416604
NCT00003950|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-03-06|||January 2000||2000-01-01|March 2014|2014-03-01|January 2005|Actual|2005-01-01|December 2001|Actual|2001-12-01||Interventional|||Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer|A Phase II Trial of Irinotecan (CPT-11) and Cyclosporine in Patients With 5-FU Refractory Advanced Colorectal Cancer|Completed||Phase 2|16|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:17:40.515522|2017-02-18 18:17:40.515522
NCT00003946|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-07|||August 1999||1999-08-01|July 2004|2004-07-01||||June 2003|Actual|2003-06-01||Interventional|||Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer|Phase II Study of Danazol in Advanced or Recurrent Endometrial Cancer|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:17:40.655705|2017-02-18 18:17:40.655705
NCT00003945|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-24|||June 1999||1999-06-01|September 2004|2004-09-01||||January 2007|Actual|2007-01-01||Interventional|||Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer|A Randomized Phase III Study of Cisplatin Versus Cisplatin Plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix|Completed||Phase 3|400|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:17:40.823646|2017-02-18 18:17:40.823646
NCT00003944|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-16|||August 1998||1998-08-01|April 2013|2013-04-01|February 2003|Actual|2003-02-01|December 1999|Actual|1999-12-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Trial Using Multiple Cycles of High Dose Sequential Carboplatin, Paclitaxel and Topotecan With Peripheral Blood Stem Cell (PBSC) Support as Initial Chemotherapy in Patients With Suboptimally Debulked Stage III or IV Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma|Completed||Phase 2|3|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-02-18 18:17:40.926177|2017-02-18 18:17:40.926177
NCT00003943|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-16|||September 1998||1998-09-01|April 2013|2013-04-01|February 2003|Actual|2003-02-01|November 2000|Actual|2000-11-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.|A Phase II Trial of High Dose Paclitaxel, Carboplatin and Topotecan With Peripheral Blood Stem Cell Support in Extensive Stage Small Cell Cancer|Completed||Phase 2|3|Actual|Fox Chase Cancer Center||1|||f||||f||||||||||2017-02-18 18:17:41.022421|2017-02-18 18:17:41.022421
NCT00003942|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||November 1998||1998-11-01|August 2000|2000-08-01||||||||Interventional|||Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma|A Phase I/II Study of the Safety and Feasibility of REVM10 or REVM10/ANTISENSE POL 1 Transduced Hematopoietic Stem Cells (HSC) in HIV-1 Related Non-Hodgkin's Lymphoma Patients Already Being Treated With High Dose Chemotherapy and Peripheral Blood Stem Cell Support|Unknown status|Active, not recruiting|Phase 1/Phase 2|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:41.125015|2017-02-18 18:17:41.125015
NCT00003941|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||April 1999||1999-04-01|September 2012|2012-09-01||||June 2007|Actual|2007-06-01||Interventional|||Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer|A Randomized Phase III Study of Sequential High-Dose Cisplatinum/Etoposide/Ifosfamide Plus Stem Cell Support Versus BEP in Patients With Poor Prognosis Germ Cell Cancer|Completed||Phase 3|222|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:41.232385|2017-02-18 18:17:41.232385
NCT00003939|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20||||||September 2012|2012-09-01||||November 2000|Actual|2000-11-01||Interventional|||Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma|Phase II Study on ET-743 in Advanced Soft Tissue Sarcomas of the Adult|Completed||Phase 2|132|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:41.6632|2017-02-18 18:17:41.6632
NCT00003938|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||June 1999||1999-06-01|September 2012|2012-09-01||||May 2003|Actual|2003-05-01||Interventional|||Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients|A Strategic Study to Determine the Optimal Moment to Initiate Systemic Antifungal Therapy With Ambisome in Granulocytopenic Cancer Patients With Unexplained Fever Refractory to Empirical Antibacterials|Completed||Phase 3|115|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:41.768173|2017-02-18 18:17:41.768173
NCT00003937|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-04|||September 1999||1999-09-01|August 2014|2014-08-01|June 2008|Actual|2008-06-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma|Protocol for Patients With Newly-Diagnosed Non-Metastatic Osteosarcoma - A POG/CCG Pilot Intergroup Study|Completed||Phase 3|253|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 18:17:41.937977|2017-02-18 18:17:41.937977
NCT00003936|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-04-09|||June 1999||1999-06-01|April 2014|2014-04-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease|Phase II Clinical Evaluation of Bryostatin 1 in Patients With Hodgkin's Disease|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:17:42.238447|2017-02-18 18:17:42.238447
NCT00003935|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-25|||September 1999||1999-09-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|October 2003|Actual|2003-10-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma|Treatment of Children With Diffuse Intrinsic Brain Stem Glioma With Standard Dose Irradiation and Vincristine Plus Oral VP-16, A POG Pilot Study|Completed||Phase 1|31|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:17:42.345185|2017-02-18 18:17:42.345185
NCT00003934|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-04|||June 1999||1999-06-01|June 2013|2013-06-01||||November 2006|Actual|2006-11-01||Interventional|||Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia|Phase III Randomized Study of Concurrent Tretinoin and Chemotherapy With or Without Arsenic Trioxide (AS2O3) (NSC # 706363) as Initial Consolidation Therapy Followed by Maintenance Therapy With Intermittent Tretinoin Versus Intermittent Tretinoin Plus Mercaptopurine and Methotrexate for Patients With Untreated Acute Promyelocytic Leukemia|Completed||Phase 3|420|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:17:42.588796|2017-02-18 18:17:42.588796
NCT00003933|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-06|||April 1999||1999-04-01|August 2014|2014-08-01||||April 2006|Actual|2006-04-01||Interventional|||Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia|The Incidence and Prognostic Significance of P16 INK4A/ P15 INK4B Gene Alterations in Children With Relapsed ALL Treated on CCG-1941|Completed||N/A|||Children's Oncology Group|||||f||||f||||||||||2017-02-18 18:17:42.727932|2017-02-18 18:17:42.727932
NCT00003931|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||February 1999||1999-02-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia|Assessment of the Partial Tandem Duplication of ALL1 (MLL) in Patients With Acute Myeloid Leukemia- A CALGB Leukemia Tissue Bank Project|Completed||N/A|9769|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     blood or bone marrow samples~   "|||2017-02-18 18:17:42.861366|2017-02-18 18:17:42.861366
NCT00003930|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-13|||September 1999||1999-09-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|July 2003|Actual|2003-07-01||Interventional|||Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer|A Phase I/II Trial in Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and Bid Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy|Completed||Phase 1/Phase 2|84|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:17:43.28192|2017-02-18 18:17:43.28192
NCT00003929|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-16|||June 1998||1998-06-01|March 2012|2012-03-01||||March 2000|Actual|2000-03-01||Interventional|||Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma|Combined Modality Therapy of AIDS-Related and Immunocompetent Primary CNS Lymphoma (PCL) Using Filgrastim (G-CSF)|Withdrawn||Phase 2|0|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:17:43.647944|2017-02-18 18:17:43.647944
NCT00003928|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-09|||January 1999||1999-01-01|June 2010|2010-06-01|April 2006|Actual|2006-04-01|February 2005|Actual|2005-02-01||Interventional|||Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Utilizing Gemcitabine and Cisplatinum in Patients With Renal Cell Carcinoma|Completed||Phase 2|32|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:17:43.760979|2017-02-18 18:17:43.760979
NCT00003927|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-27|||March 1999||1999-03-01|July 2016|2016-07-01||||March 2017|Anticipated|2017-03-01||Interventional|||Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer|High-Dose Infusional Taxol, Amifostine, Doxorubicin, and Cyclophosphamide Followed by Stem Cell Rescue for High Risk Primary and Responsive Metastatic Breast Cancer|Active, not recruiting||N/A|15|Anticipated|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 18:17:43.860504|2017-02-18 18:17:43.860504
NCT00003926|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-08-20|||November 1998||1998-11-01|August 2010|2010-08-01|August 2003|Actual|2003-08-01|August 2002|Actual|2002-08-01||Interventional|||Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors|A Phase I Study of the Chemoprotectant Amifostine With Autologous Stem Cell Transplantation for High Risk or Relapsed Pediatric Solid Tumors and Brain Tumors|Terminated||Phase 1|13|Actual|Masonic Cancer Center, University of Minnesota||2||Withdrawn due to slow accrual|f||||t||||||||||2017-02-18 18:17:43.975988|2017-02-18 18:17:43.975988
NCT00003925|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-05|||May 1998||1998-05-01|April 2013|2013-04-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Combination Chemotherapy In Treating Patients With Advanced Cancer|Phase I Study of Gemcitabine (Gemzar) and UFT/Leucovorin|Completed||Phase 1|36|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:17:44.112068|2017-02-18 18:17:44.112068
NCT00003924|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-06|||October 1995||1995-10-01|May 2007|2007-05-01||||||||Interventional|||Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma|A European Randomized Multicenter Study of Interferon Alfa-2b Versus No Treatment After Intensive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Relapsing Lymphoma Patients (Non-Hodgkin Lymphomas and Hodgkin's Disease)|Unknown status|Active, not recruiting|Phase 3|360|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:44.210508|2017-02-18 18:17:44.210508
NCT00003923|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-01|||March 1999||1999-03-01|March 2013|2013-03-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas|Phase II Study of Photodynamic Therapy With PHOTOFRIN (Porfimer Sodium) for Injection in Patients With Malignant Bile Duct Obstruction|Completed||Phase 2|4|Actual|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:17:44.317962|2017-02-18 18:17:44.317962
NCT00003920|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-06|||April 1996||1996-04-01|November 2000|2000-11-01||||||||Interventional|||Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer|Pharmacokinetic/Dosimetry/MTNTD Study of 111In/90Y-2IT-BAD-m170 for Therapy in Metastatic Breast Cancer Patients With Post Therapy Support of Autologous Pretherapy Apheresed Peripheral Blood Stem Cells and Cyclosporin A Given for Suppression of HAMA Response|Unknown status|Active, not recruiting|Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:44.415596|2017-02-18 18:17:44.415596
NCT00003917|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-08|||March 1999||1999-03-01|January 2014|2014-01-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer|An Open Label, Multicenter, Randomized, Phase III Comparator Study of Oral Topotecan Versus Intravenous Topotecan for Second Line Therapy in Patients With Small Cell Lung Cancer Who Have Relapsed Greater Than or Equal to 90 Days After Completion of First Line Therapy|Completed||Phase 3|4|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:17:44.509403|2017-02-18 18:17:44.509403
NCT00003916|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||April 1999||1999-04-01|September 2012|2012-09-01||||December 2001|Actual|2001-12-01||Interventional|||Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma|Focal Fractionated Conformal Stereotactic Boost Following Conventional Radiotherapy of High Grade Gliomas: A Randomized Phase III Study|Completed||Phase 3|25|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:44.669725|2017-02-18 18:17:44.669725
NCT00003915|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-02-25|||May 1999||1999-05-01|February 2016|2016-02-01|February 2017|Anticipated|2017-02-01|February 2017|Anticipated|2017-02-01||Interventional|||Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer|Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Definitive Local Treatment|Active, not recruiting||Phase 2|63|Actual|University of Massachusetts, Worcester||1|||f||||t||||||||||2017-02-18 18:17:44.782064|2017-02-18 18:17:44.782064
NCT00003914|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-05-10|||August 1999||1999-08-01|May 2011|2011-05-01|May 2009|Actual|2009-05-01|August 2002|Actual|2002-08-01||Interventional|||Dolastatin 10 in Treating Patients With Advanced Kidney Cancer|Phase II Study of Dolastatin-10 in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|30|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 18:17:44.899608|2017-02-18 18:17:44.899608
NCT00003913|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-31|||December 1998||1998-12-01|March 2010|2010-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease|A Multicenter Study of Unrelated Umbilical Cord Blood as an Alternate Source of Stem Cells for Transplantation|Completed||Phase 2|390|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:45.002759|2017-02-18 18:17:45.002759
NCT00003912|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||June 1998||1998-06-01|December 2000|2000-12-01|October 2009|Actual|2009-10-01|||||Interventional|||Chemotherapy in Treating Children With Liver Cancer|Liver Tumour Studies - Hepatoblastoma and Hepatocellular Carcinoma|Completed||Phase 3|260|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:45.130508|2017-02-18 18:17:45.130508
NCT00003911|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-30|||July 1999||1999-07-01|January 2013|2013-01-01|August 2007|Actual|2007-08-01|August 2002|Actual|2002-08-01||Interventional|||S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases|A Phase II Pilot Study of Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases|Terminated||Phase 2|2|Actual|Southwest Oncology Group||1||Poor accrual|f||||f||||||||||2017-02-18 18:17:45.253524|2017-02-18 18:17:45.253524
NCT00003910|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-06|2012-10-16||July 1999||1999-07-01|October 2012|2012-10-01|March 2012|Actual|2012-03-01|December 2010|Actual|2010-12-01||Interventional|||Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia|A Phase II Study of Initial Treatment With Methotrexate in Large Granular Lymphocytic (LGL) Leukemia|Terminated||Phase 2|59|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 18:17:45.691951|2017-02-18 18:17:45.691951
NCT00003909|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-15|||August 1999||1999-08-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma|A Phase I Study of Motexafin Gadolinium (Xcytrin, NSC 695238) and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:17:46.186607|2017-02-18 18:17:46.186607
NCT00003908|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-17|||November 1999||1999-11-01|April 2013|2013-04-01|January 2007|Actual|2007-01-01|June 2004|Actual|2004-06-01||Interventional|||S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Evaluation of the Combination of Docetaxel (Taxotere)/ Carboplatin in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Completed||Phase 2|68|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:17:46.32096|2017-02-18 18:17:46.32096
NCT00003907|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-12|2013-01-07||August 1999||1999-08-01|February 2013|2013-02-01|August 2012|Actual|2012-08-01|May 2011|Actual|2011-05-01||Interventional|||Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver|Chemoembolization in Hepatocellular Carcinoma or Neuroendocrine Hepatic Metastases: A Phase II Multi-Center Trial|Completed||Phase 2|50|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 18:17:46.55681|2017-02-18 18:17:46.55681
NCT00003906|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-05|||May 1999||1999-05-01|October 2015|2015-10-01|August 2012|Actual|2012-08-01|December 2005|Actual|2005-12-01||Interventional|||Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women|Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer|Completed||Phase 3|19747|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 18:17:47.14371|2017-02-18 18:17:47.14371
NCT00003903|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-10-14|||July 1999||1999-07-01|October 2013|2013-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer|An Evaluation of the Effect of Androgen Ablation on Bone Resorption in Prostate Cancer Patients|Completed||N/A|150|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 18:17:51.057412|2017-02-18 18:17:51.057412
NCT00003902|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||March 1999||1999-03-01|May 2012|2012-05-01|September 2005|Actual|2005-09-01|December 2004|Actual|2004-12-01||Interventional|||Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement|Phase I/II of Capecitabine and Vinorelbine in Elderly Patients (At Least 65 Years) With Metastatic Breast Cancer With or Without Bone Involvement|Completed||Phase 1/Phase 2|110|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:17:51.161882|2017-02-18 18:17:51.161882
NCT00003901|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-22|2016-12-22||July 1999||1999-07-01|December 2016|2016-12-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery|A Prospective Study of the Prognostic Significance of Occult Metastases in the Patient With Resectable Non-Small Cell Lung Carcinoma|Completed||Phase 3|1310|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:17:51.274696|2017-02-18 18:17:51.274696
NCT00003900|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||October 1999||1999-10-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer|A Phase II Study of Irinotecan (CPT-11) and Docetaxel (Taxotere) in Patients With Recurrent Non-Small Cell Lung Cancer|Completed||Phase 2|48|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:17:52.176024|2017-02-18 18:17:52.176024
NCT00003899|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-10-03|||January 1999||1999-01-01|September 2010|2010-09-01|November 2001|Actual|2001-11-01|||||Interventional|||Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors|High-Dose Consolidation With Escalating Doses of Melphalan and Thiotepa for Stage IV Breast Cancer|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:52.315711|2017-02-18 18:17:52.315711
NCT00003898|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-02-25|||January 1999||1999-01-01|February 2011|2011-02-01|January 2004|Actual|2004-01-01|June 2003|Actual|2003-06-01||Interventional|||Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation|The Use of Supplemental Oral Glutamine (GLN) to Decrease Morbidity in Patients Undergoing Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Study|Completed||Phase 2|120|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:17:52.415908|2017-02-18 18:17:52.415908
NCT00003897|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-07-22|||May 1999||1999-05-01|July 2015|2015-07-01|December 2006|Actual|2006-12-01|March 2001|Actual|2001-03-01||Interventional|||Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma|Phase I Trial of Immunization Using Particle-Mediated Transfer of Genes for GP-100 and GM-CSF Into Uninvolved Skin of Patients With Melanoma (Summary Last Modified 7/1999)|Completed||Phase 1|18|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:17:52.506612|2017-02-18 18:17:52.506612
NCT00003896|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-02|2012-10-30||September 1999||1999-09-01|January 2013|2013-01-01|February 2008|Actual|2008-02-01|February 2008|Actual|2008-02-01||Interventional|||S9912 Combination Chemo in Stage III Ovarian Cancer,|Phase II Evaluation of Intravenous Paclitaxel, Intraperitoneal Cisplatin, Intravenous Liposomal Doxorubicin and Intraperitoneal Paclitaxel in Women With Optimally-Debulked Stage III Epithelial Ovarian Cancer|Completed||Phase 2|68|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:17:52.606317|2017-02-18 18:17:52.606317
NCT00003895|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-28|||April 1999||1999-04-01|November 2013|2013-11-01||||September 2013|Actual|2013-09-01||Interventional|||Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma|A Randomized Phase II Trial to Determine the Immune Response to a Mutated gp100 Melanoma Peptide (209-2M) Vaccine in HLA-A2 Positive Patients With a &gt;1mm Melanoma on Initial Biopsy|Completed||Phase 2|26|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:17:53.133004|2017-02-18 18:17:53.133004
NCT00003894|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-03|||March 1999||1999-03-01|March 2011|2011-03-01|June 2002|Actual|2002-06-01|January 2000|Actual|2000-01-01||Interventional|||Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant|Thalidomide vs. Placebo for Steroid Dependent or Refractory Chronic Graft vs. Host Disease (cGVHD) IND #42782|Completed||Phase 2|36|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:17:53.24642|2017-02-18 18:17:53.24642
NCT00003893|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||July 1998||1998-07-01|November 2001|2001-11-01|April 2006|Actual|2006-04-01|||||Interventional|||Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer|Sequencing of Chemotherapy and Radiotherapy in Adjuvant Breast Cancer|Completed||Phase 3|2250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:53.614186|2017-02-18 18:17:53.614186
NCT00003892|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||February 1999||1999-02-01|July 2012|2012-07-01|September 2008|Actual|2008-09-01|October 2000|Actual|2000-10-01||Interventional|||ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer|Phase II Study of CGP 69846A (ISIS 5132) in Recurrent Epithelial Ovarian Cancer|Completed||Phase 2|22|Actual|Canadian Cancer Trials Group||1|||f||||f||||||||||2017-02-18 18:17:53.712504|2017-02-18 18:17:53.712504
NCT00003891|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2010-11-07|||February 1999||1999-02-01|March 2010|2010-03-01|September 2009|Actual|2009-09-01|||||Interventional|||Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors|A Phase I Study of NX211 Given as an IV Infusion Days 1, 2 and 3 Every 3 Weeks in Patients With Solid Tumors|Completed||Phase 1|25|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:17:53.900901|2017-02-18 18:17:53.900901
NCT00003890|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2010-11-07|||February 1999||1999-02-01|March 2010|2010-03-01|September 2008|Actual|2008-09-01|||||Interventional|||MG98 in Treating Patients With Advanced Solid Tumors|A Phase I Study of MG98 Given as a 2 Hour Twice Weekly IV Infusion in Patients With Advanced Cancer|Completed||Phase 1|20|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:17:53.997656|2017-02-18 18:17:53.997656
NCT00003888|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-07-16|||April 1999||1999-04-01|July 2015|2015-07-01|March 2015|Actual|2015-03-01|March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer|A Randomized Phase III Multicenter Trial of Neoadjuvant Docetaxel (Taxotere) Plus Cisplatin Plus 5-Fluorouracil Versus Neoadjuvant Cisplatin Plus 5-Fluorouracil in Patients With Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|359|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:17:54.090407|2017-02-18 18:17:54.090407
NCT00003887|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-11-28|||August 1998||1998-08-01|November 2011|2011-11-01|February 2003|Actual|2003-02-01|||||Interventional|||Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation|Donor Lymphocyte Infusion (DLI) as Adoptive Immunotherapy for Relapse Malignancies After Allogeneic Hematopoietic Transplantation|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:54.249886|2017-02-18 18:17:54.249886
NCT00003885|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||November 1997||1997-11-01|June 2000|2000-06-01||||||||Interventional|||Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma|Phase II Study of Arsenic Trioxide in Relapsed/Refractory Acute Leukemia and Blast Crisis of Chronic Myeloid Leukemia|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:54.358333|2017-02-18 18:17:54.358333
NCT00003884|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-20|||August 1998||1998-08-01|February 2013|2013-02-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zoledronate (4 and 8 mg) Administered Intravenously as an Adjuvant to Anticancer Therapy to Patients With Any Cancer With Bone Metastases Other Than Breast Cancer, Multiple Myeloma or Prostate Cancer|Completed||Phase 3|600|Anticipated|Novartis|||||f||||||||||||||2017-02-18 18:17:54.464473|2017-02-18 18:17:54.464473
NCT00003883|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-31|||October 1998||1998-10-01|March 2010|2010-03-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation|A Randomized, Comparative Study of Itraconazole Versus Fluconazole for Prevention of Aspergillus Infections in Peripheral Blood Stem Cell and Marrow Transplant Recipients|Completed||Phase 3|578|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:54.616059|2017-02-18 18:17:54.616059
NCT00003882|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-03|||March 1999||1999-03-01|March 2011|2011-03-01|September 2000|Actual|2000-09-01|April 2000|Actual|2000-04-01||Interventional|||Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors|Phase I Dose Finding Study of Anhydrovinblastine Administered as a 1-Hour Infusion Every 3 Weeks to Patients With Advanced Solid Tumors|Completed||Phase 1|10|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:17:54.726836|2017-02-18 18:17:54.726836
NCT00003881|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||May 1999||1999-05-01|March 2004|2004-03-01|July 2004|Actual|2004-07-01|||||Interventional|||Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer|Phase II Pilot Trial of Carboplatin, Paclitaxel, and Herceptin in HER2/Neu (+) Advanced NSCLC|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:54.828504|2017-02-18 18:17:54.828504
NCT00003880|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-04-15|||February 1999||1999-02-01|April 2015|2015-04-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer|A Phase II/III Trial of Chemotherapy Alone Versus Chemotherapy Plus SCH 58500 in Newly Diagnosed Stage III Ovarian and Primary Peritoneal Cancer Patients With Greater Than or Equal to 0.5 cm and Less Than or Equal to 2 cm Residual Disease Following Surgery|Terminated||Phase 2/Phase 3|132|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:17:54.989999|2017-02-18 18:17:54.989999
NCT00003878|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||April 2002||2002-04-01|July 2003|2003-07-01|April 2003|Actual|2003-04-01|||||Interventional|||Carmustine Implants in Treating Patients With Brain Metastases|The Treatment of One or Two Supratentorial Brain Metastases With Surgical Resection and BCNU-Polymer Wafers|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:55.075712|2017-02-18 18:17:55.075712
NCT00003877|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-03|||September 1998||1998-09-01|March 2011|2011-03-01|December 2000|Actual|2000-12-01|February 2000|Actual|2000-02-01||Interventional|||Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer|A Phase I/II Study in Metastatic Breast Cancer Patients Infused With Stromagen and Isolated, Mobilized, Autologous Peripheral Blood CD34+ Progenitor Cells After High-Dose Chemotherapy|Completed||Phase 1/Phase 2|30|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:17:55.166375|2017-02-18 18:17:55.166375
NCT00003876|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||April 1999||1999-04-01|May 2001|2001-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma|A Phase I Study of Concurrent Multi-modality Treatment for Patients With Relapsed Malignant Glioma Using Permanent I-125 Interstitial Seeds and Dose Escalation of Gliadel 3.85% Carmustine (BCNU) Polymer Wafers|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:55.264079|2017-02-18 18:17:55.264079
NCT00003875|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-08-04|||November 1998||1998-11-01|August 2015|2015-08-01||||April 2012|Actual|2012-04-01||Interventional|||Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia|Treatment of Acute Myelogenous Leukemia With Busulfan and Etoposide Followed by Autologous or Syngeneic Stem Cell Rescue and Low-Dose Interleukin 2 (IL-2) Immunotherapy|Completed||Phase 2|62|Actual|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 18:17:55.352778|2017-02-18 18:17:55.352778
NCT00003874|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-11-28|||February 1999||1999-02-01|November 2011|2011-11-01|September 2001||2001-09-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia|A Phase I/II Study of Combined Enrichment of CD34+ Cells and Depletion of B-Cells From Peripheral Blood Stem Cell Components for Patients With B-Lymphoid Malignancies|Completed||Phase 1/Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:55.734424|2017-02-18 18:17:55.734424
NCT00003873|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-23|||April 1999||1999-04-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer|Phase III Trial Comparing a 28 Day Schedule of Daily Oral 5-FU Plus Eniluracil to Protracted Intravenous Infusion in Previously Untreated Patients With Advanced Colorectal Cancer|Completed||Phase 3|950|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:17:55.827677|2017-02-18 18:17:55.827677
NCT00003871|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||August 1999||1999-08-01|January 2010|2010-01-01||||June 2002|Actual|2002-06-01||Interventional|||PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer|Phase II Randomized Study of Vaccine Treatment of Advanced Prostate Cancer|Completed||Phase 2|60|Anticipated|Eastern Cooperative Oncology Group|||||||||f||||||||||2017-02-18 18:17:55.949024|2017-02-18 18:17:55.949024
NCT00003870|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-31|||February 1999||1999-02-01|March 2010|2010-03-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia|Radiolabeled BC8 (Anti-CD45) Antibody Combined With Cyclophosphamide and Total Body Irradiation Followed by HLA-matched Related or Unrelated Stem Cell Transplantation as Treatment for Advanced Acute Lymphocytic Leukemia|Completed||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:56.06255|2017-02-18 18:17:56.06255
NCT00003869|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-02|2010-11-24||April 1999||1999-04-01|December 2012|2012-12-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer|Phase III Randomized, Double-Blind Study of CAI and Placebo in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)|Completed||Phase 3|186|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:17:56.177929|2017-02-18 18:17:56.177929
NCT00003868|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-08-20|||February 1999||1999-02-01|August 2010|2010-08-01|March 2005|Actual|2005-03-01|March 2005|Actual|2005-03-01||Interventional|||Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia|Radiolabeled BC8 (Anti-CD45) Antibody Combined With Cyclophosphamide and Total Body Irradiation Followed by HLA-matched Related or Unrelated Stem Cell Transplantation as Treatment for Advanced Acute Myeloid Leukemia and Myelodysplastic Syndrome|Completed||Phase 2|40|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:17:57.384423|2017-02-18 18:17:57.384423
NCT00003867|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||March 1999||1999-03-01|April 2007|2007-04-01||||||||Interventional|||Irinotecan and Capecitabine in Treating Patients With Solid Tumors|Phase I Clinical Study of Every Three Week Irinotecan With Oral Capecitabine Given Twice Daily for Two Weeks Out of Three in Patients With Gastrointestinal and Other Solid Malignancies|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:57.490906|2017-02-18 18:17:57.490906
NCT00003865|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||July 1999||1999-07-01|December 2003|2003-12-01||||||||Interventional|||Toremifene in Treating Patients With Ovarian Cancer|Phase II Study of Two Dose Levels of Toremifene in the Treatment of Chemotherapy-Resistant Papillary Carcinoma of the Ovary|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:57.585914|2017-02-18 18:17:57.585914
NCT00003864|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||July 1999||1999-07-01|August 2013|2013-08-01||||January 2004|Actual|2004-01-01||Interventional|||Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus|A Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:17:57.681827|2017-02-18 18:17:57.681827
NCT00003863|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||June 1999||1999-06-01|July 2016|2016-07-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Observational|||Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma|Genetic Changes in Diffuse Aggressive Non-Hodgkin's Lymphoma|Completed||N/A|391|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     Tissue samples~   "|||2017-02-18 18:17:57.856356|2017-02-18 18:17:57.856356
NCT00003862|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-17|||November 1999||1999-11-01|September 2003|2003-09-01||||November 2004|Actual|2004-11-01||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer|A Phase II Trial of Preoperative Chemotherapy and Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Stomach|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:17:58.043499|2017-02-18 18:17:58.043499
NCT00003861|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-05-04|||April 1999||1999-04-01|May 2016|2016-05-01||||January 2100|Anticipated|2100-01-01||Observational|||Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia|Molecular Genetic Features of Acute Leukemia|Active, not recruiting||N/A|840|Anticipated|Alliance for Clinical Trials in Oncology|||1||f||||||||||Samples With DNA|"~     Tissue, Blood~   "|||2017-02-18 18:17:58.459846|2017-02-18 18:17:58.459846
NCT00003860|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||September 1998||1998-09-01|December 1999|1999-12-01||||||||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer|Intensive Chemotherapy With Peripheral Blood Stem Cell Support for Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:58.617212|2017-02-18 18:17:58.617212
NCT00003859|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||April 1992||1992-04-01|April 2009|2009-04-01|April 2003|Actual|2003-04-01|||||Interventional|||Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS|Trial of Chemotherapy Utilizing Carboplatin, Vincristine, Cyclophosphamide and Etoposide for the Treatment of Central Nervous System Primitive Neurectodermal Tumors of Childhood|Completed||Phase 3|230|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:58.735638|2017-02-18 18:17:58.735638
NCT00003858|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12||||||July 2016|2016-07-01||||||||Interventional|||Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence|A Phase II Trial of Adjuvant Mitoxantrone (NSC #301739) for High Risk Patients Following Radical Prostatectomy|Withdrawn||Phase 2|0|Actual|Alliance for Clinical Trials in Oncology||1||The study was not activated.|f||||||||||||||2017-02-18 18:17:58.828784|2017-02-18 18:17:58.828784
NCT00003857|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-14|||December 1999||1999-12-01|November 2015|2015-11-01||||February 2004|Actual|2004-02-01||Interventional|||Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ|Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus Radiation Therapy for Good Risk Duct Carcinoma In-Situ (DCIS) of the Female Breast|Active, not recruiting||Phase 3|636|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:17:58.939191|2017-02-18 18:17:58.939191
NCT00003856|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||October 1998||1998-10-01|January 2001|2001-01-01||||||||Interventional|||Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy|A Multicenter, Multi-National, Open-Label, Single Group, Single and Multiple Dose Study of Foscan-Mediated Photodynamic Therapy (PDT) for the Palliative Treatment of Recurrent, Refractory or Second Primary Squamous Cell Carcinomas of the Head and Neck in Patients Considered to be Incurable With Surgery or Radiotherapy|Unknown status|Active, not recruiting|Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:17:59.791445|2017-02-18 18:17:59.791445
NCT00003855|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||April 1999||1999-04-01|July 2016|2016-07-01|February 2011|Actual|2011-02-01|August 2007|Actual|2007-08-01||Interventional|||Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer|A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node|Completed||Phase 3|605|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:17:59.898575|2017-02-18 18:17:59.898575
NCT00003854|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||April 1999||1999-04-01|July 2016|2016-07-01|July 2011|Actual|2011-07-01|August 2006|Actual|2006-08-01||Interventional|||Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer|A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer|Completed||Phase 3|4590|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:00.189753|2017-02-18 18:18:00.189753
NCT00003853|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-09|||April 1999||1999-04-01|May 2011|2011-05-01|August 2001|Actual|2001-08-01|August 2000|Actual|2000-08-01||Interventional|||4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis|Phase II Trial of 4'-IODO-4'-Deoxydoxorubicin in Primary Amyloidosis (AL)|Completed||Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:00.516495|2017-02-18 18:18:00.516495
NCT00003852|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-22|||March 1998||1998-03-01|June 2016|2016-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors|Phase II Study of Intensive Chemotherapy With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin Resistant Germ Cell Tumors|Terminated||Phase 2|45|Anticipated|UNICANCER||||lack of patient inclusion|f||||||||||||||2017-02-18 18:18:00.620489|2017-02-18 18:18:00.620489
NCT00003851|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-13|||March 1999||1999-03-01|February 2013|2013-02-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer|Evaluation of Intensive Pancreatic Proteolytic Enzyme Therapy With Ancillary Nutritional Support Versus Gemcitabine Chemotherapy in the Treatment of Inoperable Pancreatic Adenocarcinoma|Terminated||N/A|90|Anticipated|Columbia University||2||Approval lapse|f||||f||||||||||2017-02-18 18:18:00.740023|2017-02-18 18:18:00.740023
NCT00003850|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||April 1999||1999-04-01|January 2001|2001-01-01||||June 2003|Actual|2003-06-01||Interventional|||Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer|A Phase II Study of Thalidomide in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|47|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:00.852031|2017-02-18 18:18:00.852031
NCT00003849|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||July 1999||1999-07-01|July 2016|2016-07-01|February 2008|Actual|2008-02-01|February 2005|Actual|2005-02-01||Interventional|||Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease|A Phase II Trial of C2B8 in Patients With Asymptomatic CD20+ B-Cell Follicular Small Cleaved Low-Grade Non-Hodgkin's Lymphoma or Relapsed CD20+ Hodgkin's Disease|Completed||Phase 2|39|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:00.960601|2017-02-18 18:18:00.960601
NCT00003847|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-04|||December 1998||1998-12-01|September 2013|2013-09-01||||February 2001|Actual|2001-02-01||Interventional|||VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer|A Phase II Study of the Safety, Efficacy and Pharmacokinetics of VX-710 in Combination With Doxorubicin and Vincristine in Patients With Small Cell Lung Cancer (SCLC)|Terminated||Phase 2|36|Actual|Vertex Pharmaceuticals Incorporated||1|||f||||||||||||||2017-02-18 18:18:01.090432|2017-02-18 18:18:01.090432
NCT00003846|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-25|||July 1999||1999-07-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|October 2004|Actual|2004-10-01||Interventional|||Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors|Treatment of High Risk Central Nervous System Embryonal Tumors With Conventional Radiotherapy and Intensive Consolidation Chemotherapy With Peripheral Blood Progenitor Cell (PBSC) Support|Completed||Phase 2|25|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:18:01.211993|2017-02-18 18:18:01.211993
NCT00003843|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-02-13|||October 1998||1998-10-01|September 2013|2013-09-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Observational|||Irinotecan in Treating Patients With Colorectal Cancer|UGT1A1 Polymorphism in Patients With Colorectal Cancer Treated With CPT-11 (Irinotecan)|Terminated||Phase 2|28|Anticipated|California Cancer Consortium||||Study terminated due to poor accrual|||||||||||||||2017-02-18 18:18:01.569257|2017-02-18 18:18:01.569257
NCT00003842|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||March 1999||1999-03-01|June 1999|1999-06-01||||||||Interventional|||IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma|A Phase I Study of a Recombinant Chimeric Protein Composed of Circularly Permuted IL-4 and a Mutated Form of the Pseudomonas Exotoxin Termed IL-4(38-37)-PE38KDEL (IL-4 Toxin) for the Treatment of Recurrent Malignant Astrocytoma|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:01.6778|2017-02-18 18:18:01.6778
NCT00003840|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-17|||October 2000||2000-10-01|June 2013|2013-06-01|July 2005|Actual|2005-07-01|September 2002|Actual|2002-09-01||Interventional|||DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia|A Phase I Study of DTGM Fusion Protein (IND BB#8153) in Relapsed and Refractory Adult Acute Myeloid Leukemia (AML)|Completed||Phase 1/Phase 2|||Wake Forest University Health Sciences|||||||||||||||||||2017-02-18 18:18:01.787277|2017-02-18 18:18:01.787277
NCT00003838|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-24|||February 22, 1999||1999-02-22|August 10, 2016|2016-08-10|December 31, 2017|Anticipated|2017-12-31|December 31, 2017|Anticipated|2017-12-31||Interventional|||Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow|Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients With Debilitating Hematologic Diseases|Recruiting||Phase 2|214|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:18:01.897977|2017-02-18 18:18:01.897977
NCT00003837|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-18|||September 1999||1999-09-01|December 2005|2005-12-01|November 2007|Actual|2007-11-01|||||Interventional|||506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma|Compound 506U78 (NSC 686673) in Patients With Relapsed or Refractory T-Cell ALL or T-Cell Lymphoblastic Lymphoma|Completed||N/A|25|Anticipated|National Cancer Institute (NCI)|||||||||||||||||||2017-02-18 18:18:02.011736|2017-02-18 18:18:02.011736
NCT00003835|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-10-07|||May 1999||1999-05-01|October 2013|2013-10-01||||August 2007|Actual|2007-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III Colon Cancer|Phase III Intergroup Trial of Irinotecan (CPT-11) (NSC# 616348) Plus Fluorouracil/Leucovorin (5-FU/LV) Versus Fluorouracil/Leucovorin Alone After Curative Resection for Patients With Stage III Colon Cancer|Completed||Phase 3|1260|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:18:02.117212|2017-02-18 18:18:02.117212
NCT00003834|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||March 1999||1999-03-01|July 2016|2016-07-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer|A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum (Per 04/99 Amendment) Old Title: A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum Confined to the Liver|Completed||Phase 2|44|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:18:02.230253|2017-02-18 18:18:02.230253
NCT00003833|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||February 1999||1999-02-01|July 2016|2016-07-01|August 2006|Actual|2006-08-01|August 2006|Actual|2006-08-01||Observational|||Genetic Study in Patients With Stage II or Stage III Colon Cancer|The Clinical and Pathological Significance of Allelic Imbalance of 8p in Patients With Colorectal Cancer|Completed||N/A|598|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     Normal and tumor tissue~   "|||2017-02-18 18:18:02.371391|2017-02-18 18:18:02.371391
NCT00003832|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-24|||July 1999||1999-07-01|January 2013|2013-01-01||||June 2002|Actual|2002-06-01||Interventional|||Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer|Cell Kinetic Study of Bromodeoxyuridine (BrdU) in Prostate Cancer|Completed||Phase 2|75|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:02.537886|2017-02-18 18:18:02.537886
NCT00003831|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||July 1999||1999-07-01|July 2016|2016-07-01|January 2011|Actual|2011-01-01|March 2006|Actual|2006-03-01||Interventional|||Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer|Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma|Completed||Phase 3|1023|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:18:02.656648|2017-02-18 18:18:02.656648
NCT00003830|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-03-06|||May 1999||1999-05-01|March 2014|2014-03-01|February 2014|Actual|2014-02-01|September 2010|Actual|2010-09-01||Interventional|||Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer|A Randomized, Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer Patients|Completed||Phase 3|5611|Actual|NSABP Foundation Inc||2|||f||||t||||||||||2017-02-18 18:18:02.848143|2017-02-18 18:18:02.848143
NCT00003829|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-05|||August 1999||1999-08-01|December 2016|2016-12-01|October 2008|Actual|2008-10-01|May 2001|Actual|2001-05-01||Interventional|||Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia|A Phase II Study of Alternating Cycles of Fludarabine and Cyclophosphamide in Previously Untreated Patients With B-cell CLL|Completed||Phase 2|34|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:03.053466|2017-02-18 18:18:03.053466
NCT00003828|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-20|||May 1999||1999-05-01|August 2012|2012-08-01|March 2004|Actual|2004-03-01|December 2001|Actual|2001-12-01||Interventional|||S9804: Vinorelbine in Treating Patients With Stage IV Melanoma|Evaluation of Vinorelbine Tartrate (Navelbine) in Patients With Disseminated Malignant Melanoma and One Prior Systemic Therapy|Completed||Phase 2|24|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:18:03.181168|2017-02-18 18:18:03.181168
NCT00003827|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||January 1999||1999-01-01|July 2007|2007-07-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome|Treatment of Poor Risk Myelodysplasia With the Combination of Amifostine, Topotecan and ARA-C: A Phase II Study|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:03.495201|2017-02-18 18:18:03.495201
NCT00003825|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-09|||June 1999||1999-06-01|August 2013|2013-08-01||||April 2006|Actual|2006-04-01||Interventional|||Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy|Phase III Study of Pentosanpolysulfate (PPS) in Treatment of GI Tract Sequelae of Radiotherapy|Completed||Phase 3|174|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:18:03.603786|2017-02-18 18:18:03.603786
NCT00003824|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-07|||April 1999||1999-04-01|March 2012|2012-03-01|January 2007|Actual|2007-01-01|July 2001|Actual|2001-07-01||Interventional|||S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer|The Effect of Fluoroquinolones on the Disease-Free Interval in Patients With Stage Ta Transitional Cell Carcinoma of the Bladder|Terminated||Phase 3|114|Actual|Southwest Oncology Group||2||Permanently Closed Due to Poor Accrual|f||||t||||||||||2017-02-18 18:18:04.223811|2017-02-18 18:18:04.223811
NCT00003822|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|March 2001|2001-03-01||||||||Interventional|||SR-45023A in Treating Patients With Advanced Solid Tumors|A Phase I and Pharmacokinetic Study of SR-45023A During a 14-Day Treatment Schedule|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:04.464913|2017-02-18 18:18:04.464913
NCT00003821|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||January 1998||1998-01-01|July 2000|2000-07-01||||||||Interventional|||Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer|Phase II Trial of Aminopterin in Patients With Persistent or Recurrent Endometrial Carcinoma|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:04.547967|2017-02-18 18:18:04.547967
NCT00003820|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-05|||January 1999||1999-01-01|June 2012|2012-06-01|August 2008|Actual|2008-08-01|August 2008|Actual|2008-08-01||Interventional|||Rituximab in Treating Patients With Hodgkin's Lymphoma|Phase II Trial to Evaluate the Efficacy of Anti-CD20 Antibody in Patients With Lymphocyte Predominant Hodgkin's Disease|Completed||Phase 2|39|Actual|Stanford University||1|||f||||f||||||||||2017-02-18 18:18:04.653553|2017-02-18 18:18:04.653553
NCT00003819|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-18|||June 1998||1998-06-01|March 2013|2013-03-01|March 2009|Actual|2009-03-01|March 2009|Actual|2009-03-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer|Vaccination of Prostate Cancer Patients With Thompson-Friedenreich [TF(c)]-KLH Conjugate Plus the Immunological Adjuvant QS21: A Trial Comparing TF(c)-KLH Doses|Completed||Phase 1|21|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:18:04.751094|2017-02-18 18:18:04.751094
NCT00003817|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-13|||October 1999||1999-10-01|October 2015|2015-10-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy|A Randomized Phase II Trial of Acupressure and Acustimulation Wrist Bands for the Prevention of Chemotherapy-Induced Nausea and Vomiting|Completed||Phase 2|700|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 18:18:04.853973|2017-02-18 18:18:04.853973
NCT00003816|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-02-02|||October 1998||1998-10-01|February 2017|2017-02-01|April 2017||2017-04-01|April 2017|Anticipated|2017-04-01||Interventional|||Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer|Allogeneic Blood or Marrow Transplantation for Hematologic Malignancy and Aplastic Anemia|Active, not recruiting||Phase 2/Phase 3|362|Actual|Roswell Park Cancer Institute||9|||f||||t||||||||||2017-02-18 18:18:04.950473|2017-02-18 18:18:04.950473
NCT00003815|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||June 1994||1994-06-01|July 2001|2001-07-01||||||||Interventional|||Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma|A Randomised Study of High Dose Chemotherapy/Radiotherapy and Autologous Bone Marrow Transplantation in Patients With High Grade Malignant Non-Hodgkin's Lymphoma (Kiel Classification) According to Prognostic Groups|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:05.079415|2017-02-18 18:18:05.079415
NCT00003814|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||February 1999||1999-02-01|May 2007|2007-05-01|May 2007|Actual|2007-05-01|||||Interventional|||Eflornithine in Treating Patients With Bladder Cancer|Phase III Randomized, Double-Blind Study of DFMO vs. Placebo in Low Grade Superficial Bladder Cancer|Completed||Phase 3|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:05.190319|2017-02-18 18:18:05.190319
NCT00003812|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|||March 1999||1999-03-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|June 2004|Actual|2004-06-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|Topotecan/Paclitaxel Induction Followed by Consolidation Chemoradiotherapy for Limited Stage Small Cell Lung Cancer: A Phase II Study|Completed||Phase 2|75|Actual|Alliance for Clinical Trials in Oncology||1|||f||||||||||||||2017-02-18 18:18:05.452263|2017-02-18 18:18:05.452263
NCT00003811|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-03|||April 2000||2000-04-01|July 2013|2013-07-01|September 2007|Actual|2007-09-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors|High-Dose Cisplatin, Etoposide and Bleomycin (HD-PEB) Combined With Amifostine in Children With High-Risk Malignant Germ Cell Tumors - A POG Pilot Study|Completed||Phase 2|27|Actual|Children's Oncology Group|||||f||||||||||||||2017-02-18 18:18:05.609149|2017-02-18 18:18:05.609149
NCT00003810|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||April 1999||1999-04-01|August 2013|2013-08-01||||May 2002|Actual|2002-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas|A Phase II Study of Gemcitabine and Docetaxel in Pancreatic Adenocarcinoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:18:05.814891|2017-02-18 18:18:05.814891
NCT00003809|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||June 1999||1999-06-01|August 2013|2013-08-01||||September 2004|Actual|2004-09-01||Interventional|||Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|Randomized, Double Blind, Placebo Controlled Phase III Evaluation of Cisplatin + Placebo Versus Cisplatin + C225 a Mouse/Human Monoclonal Antibody to the Epidermal Growth Factor Receptor, in Patients With Metastatic and/or Recurrent Squamous Cell Cancer of the Head and Neck|Completed||Phase 3|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:18:05.919778|2017-02-18 18:18:05.919778
NCT00003808|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||May 1999||1999-05-01|August 2013|2013-08-01||||September 2002|Actual|2002-09-01||Interventional|||Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia|Phase II Study of Theophylline in Chronic Lymphocytic Leukemia|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:18:09.112675|2017-02-18 18:18:09.112675
NCT00003805|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||November 1997||1997-11-01|September 2012|2012-09-01||||June 2000|Actual|2000-06-01||Interventional|||Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count|Vancomycin Versus Placebo in Persistently Febrile Granulocytopenic Patients Given Piperacillin/Tazobactam|Completed||Phase 3|859|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:18:09.359374|2017-02-18 18:18:09.359374
NCT00003804|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-06-23|||July 1993||1993-07-01|April 2012|2012-04-01||||||||Interventional|||Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor|Nephroblastoma Clinical Trial and Study|Unknown status|Active, not recruiting|Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:09.783918|2017-02-18 18:18:09.783918
NCT00003803|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-17|||February 1999||1999-02-01|July 2012|2012-07-01||||March 2003|Actual|2003-03-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed|A Randomized Phase III Study Comparing Induction Chemotherapy to Daily Low Dose Cisplatin Both Combined With High Dose Radiotherapy Using Concomitant Boost Technique in Patients With Inoperable Non-Small Cell Lung Cancer Stage I, II, and Low Volume Stage III|Terminated||Phase 3|158|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:18:09.940288|2017-02-18 18:18:09.940288
NCT00003802|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-12-12|||February 1999||1999-02-01|December 2012|2012-12-01|October 2002|Actual|2002-10-01|||||Interventional|||Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma|A Phase II Trial of Pyrazoloacridine (NSC 366140, IND 36325) in Metastatic Cutaneous and Ocular Melanoma|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:18:10.070692|2017-02-18 18:18:10.070692
NCT00003801|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-08-19||||||February 2000|2000-02-01||||||||Interventional|||Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma|Intergroup Rhabdomyosarcoma Study Group: Late Effects After Treatment for Rhabdomyosarcoma|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:10.184165|2017-02-18 18:18:10.184165
NCT00003800|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-30|||May 1999||1999-05-01|November 2012|2012-11-01||||December 2004|Actual|2004-12-01||Interventional|||Diagnostic Study of Patients With Stage I Testicular Cancer|Correlation of Histopathology, Immunohistochemistry and Quantitative Radiology With Outcome in Early Stage Nonseminomatous Germ Cell Tumor|Unknown status|Active, not recruiting|N/A|76|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 18:18:10.262542|2017-02-18 18:18:10.262542
NCT00003799|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-09|||May 1999||1999-05-01|January 2013|2013-01-01||||September 2003|Actual|2003-09-01||Interventional|||Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer|Phase I Study of Preoperative Radiation Therapy With Concurrent Protracted Continuous Infusion 5-FU and Dose Escalating Oxaliplatin Followed by Surgery, 5-FU, and Leucovorin for Locally Advanced (T3 and T4) Rectal Adenocarcinoma|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:10.376952|2017-02-18 18:18:10.376952
NCT00003798|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-13|||April 2000||2000-04-01|November 2012|2012-11-01||||||||Interventional|||Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery|Phase I Study Involving Gadolinium Texaphyrin (NSC 695238) in Patients With Pancreatic and Periampullary Adenocarcinoma Receiving Radiotherapy for Unresectable Disease|Completed||Phase 1|45|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:18:10.487417|2017-02-18 18:18:10.487417
NCT00003797|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||March 1999||1999-03-01|December 2002|2002-12-01||||||||Interventional|||Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas|Herceptin (NSC #688097) and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/NEU|Unknown status|Active, not recruiting|Phase 2|41|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:10.582553|2017-02-18 18:18:10.582553
NCT00003796|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||May 1999||1999-05-01|March 2003|2003-03-01||||December 2003|Actual|2003-12-01||Interventional|||Irofulven in Treating Patients With Metastatic Breast Cancer|Phase II Study of MGI-114 in Patients With Metastatic Breast Cancer|Completed||Phase 2|32|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:10.686143|2017-02-18 18:18:10.686143
NCT00003795|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-24|||April 1999||1999-04-01|March 2009|2009-03-01||||March 2002|Actual|2002-03-01||Observational|||Quality of Life in Survivors of Gynecologic Cancer|Quality of Life of Gynecologic Cancer Survivors|Completed||N/A|311|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:18:10.787772|2017-02-18 18:18:10.787772
NCT00003794|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-07|||April 1999||1999-04-01|November 2005|2005-11-01||||July 2005|Actual|2005-07-01||Observational|||Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer|Quality of Life in Ovarian Germ Cell Cancer Survivors|Terminated||N/A|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:18:10.908111|2017-02-18 18:18:10.908111
NCT00003793|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-04|||December 1998||1998-12-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|December 2005|Actual|2005-12-01||Observational|||Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma|Clinical and Biological Predictors of Therapy-Related Leukemia|Completed||N/A|294|Actual|Children's Oncology Group|||2||f||||f||||||Samples With DNA|"~     blood~   "|||2017-02-18 18:18:11.274524|2017-02-18 18:18:11.274524
NCT00003792|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||April 1999||1999-04-01|October 2006|2006-10-01|October 2006|Actual|2006-10-01|||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Dendritic Cell Immunotherapy of Metastatic Melanoma - A Phase I Trial|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:11.489979|2017-02-18 18:18:11.489979
NCT00003790|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-05|||February 1995||1995-02-01|August 2014|2014-08-01|September 2006|Actual|2006-09-01|April 2002|Actual|2002-04-01||Observational|||Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome|Detection of Minimal Residual Disease in Children Receiving Therapy for AML or MDS|Completed||N/A|496|Actual|Children's Oncology Group|||||f||||f||||||||||2017-02-18 18:18:11.582726|2017-02-18 18:18:11.582726
NCT00003789|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-15|||March 1999||1999-03-01|June 2013|2013-06-01||||January 2004|Actual|2004-01-01||Interventional|||Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg|A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion and Melphalan With and Without Tumor Necrosis Factor in Patients With Localized Advanced Extremity Melanoma|Completed||Phase 3|216|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:18:11.732485|2017-02-18 18:18:11.732485
NCT00003788|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||April 1998||1998-04-01|September 2003|2003-09-01||||||||Interventional|||Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas|Prospective Clinical Trials in the Use of Photodynamic Therapy (PDT) for the Treatment of Malignant Supratentorial Brain Tumors|Unknown status|Active, not recruiting|Phase 3|270|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:11.857162|2017-02-18 18:18:11.857162
NCT00003787|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||March 1995||1995-03-01|May 2014|2014-05-01|July 2016|Anticipated|2016-07-01|March 2007|Actual|2007-03-01||Observational|||Women's Healthy Eating and Living Study|Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study|Unknown status|Active, not recruiting|Phase 3|3000|Anticipated|University of California, San Diego|||2||f||||t||||||Samples With DNA|"~     Serum, plasma, buffy coat, RBC, DNA at five time periods~   "|||2017-02-18 18:18:11.963523|2017-02-18 18:18:11.963523
NCT00003786|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-03-06|||April 1999||1999-04-01|March 2014|2014-03-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer|A Phase II Trial of MGI-114 (NSC# 683863) Administered as a 5-Minute Infusion Daily for Five Days Every 4 Weeks in Patients With Previously Untreated Advanced Colorectal Cancer|Withdrawn||Phase 2|0|Actual|University of Chicago||1||NO participants|f||||f||||||||||2017-02-18 18:18:12.102511|2017-02-18 18:18:12.102511
NCT00003784|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-23|||May 1999||1999-05-01|January 2013|2013-01-01||||January 2003|Actual|2003-01-01||Interventional|||S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Pilot Trial of CHOP Followed by Iodine-131-Labeled Monoclonal Anti-B1 Antibody for Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas|Completed||Phase 2|102|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:18:12.241474|2017-02-18 18:18:12.241474
NCT00003783|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-24|||March 1999||1999-03-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia|ALinC 17: Continuous Intensification for Very High Risk Acute Lymphocytic Leukemia (A.L.L.): A Pediatric Oncology Group Pilot Study|Completed||Phase 2|36|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:18:12.43961|2017-02-18 18:18:12.43961
NCT00003782|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-11|2012-08-24||March 1999||1999-03-01|January 2013|2013-01-01|December 2012|Actual|2012-12-01|December 2008|Actual|2008-12-01||Interventional|||Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes|A Three-Arm Randomized Trial to Compare Adjuvant Adriamycin and Cyclophosphamide Followed by Taxotere (AC-T); Adriamycin and Taxotere (AT); and Adriamycin, Taxotere, and Cyclophosphamide (ATC) in Breast Cancer Patients With Positive Axillary Lymph Nodes|Completed||Phase 3|5351|Actual|NSABP Foundation Inc||3|||f||||t||||||||||2017-02-18 18:18:12.920421|2017-02-18 18:18:12.920421
NCT00003781|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-24|||December 1998||1998-12-01|May 2012|2012-05-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Docetaxel in Treating Patients With Stage IV Prostate Cancer|Phase II Study of Weekly Docetaxel (Taxotere) in Hormone Refractory Metastatic Prostate Cancer|Completed||Phase 2|25|Actual|OHSU Knight Cancer Institute|||||f||||t||||||||||2017-02-18 18:18:13.718812|2017-02-18 18:18:13.718812
NCT00003780|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||December 1998||1998-12-01|May 2007|2007-05-01||||||||Interventional|||Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas|An Open Label Randomized Trial Comparing the Safety and Efficacy of Systemic Chemotherapy (Gemcitabine) to Immunotherapy (CYTOIMPLANT - Intra Tumor Implants of Allogeneic Peripheral Blood Mononuclear Cells Sensitized Against Patient Alloantigens by Mixed Lymphocyte Culture) as First Line Therapy for Patients With Unresectable Locally Advanced, and Metastatic Pancreatic Cancer|Unknown status|Active, not recruiting|Phase 2|150|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:13.830663|2017-02-18 18:18:13.830663
NCT00003779|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-16|||November 1998||1998-11-01|May 2013|2013-05-01|June 2010|Actual|2010-06-01|June 2001|Actual|2001-06-01||Interventional|||Biological Therapy in Treating Patients With Bladder Cancer|A Prospective Randomized Trial for the Comparison of Two BCG Strains (Bacille Calmette-Guerin) in the Prophylaxis of Papollary Bladder Tumors Stage Ta and T1 and Treatment of Carcinoma in Situ|Completed||Phase 3|40|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 18:18:13.928491|2017-02-18 18:18:13.928491
NCT00003778|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||April 1999||1999-04-01|September 2000|2000-09-01||||July 2000|Actual|2000-07-01||Interventional|||Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma|Phase II Trial of Dolastatin-10 in Patients With Previously Untreated Recurrent/Metastatic Sarcoma|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:14.051152|2017-02-18 18:18:14.051152
NCT00003777|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||December 1998||1998-12-01|November 2002|2002-11-01||||||||Interventional|||Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer|A Pilot Study of Combined Modality Therapy for Recurrent Head and Neck Carcinoma|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:14.17258|2017-02-18 18:18:14.17258
NCT00003776|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||December 1998||1998-12-01|June 2013|2013-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma|A Phase II Window Study of Trimetrexate With Simultaneous Leucovorin Protection in the Treatment of Newly Diagnosed Patients With Metastatic Osteosarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:14.26838|2017-02-18 18:18:14.26838
NCT00003775|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-12|||December 1998||1998-12-01|September 2012|2012-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse|A Phase II Open Label Study of SU101 for Patients With Anaplastic Astrocytoma in First Relapse|Completed||Phase 2|60|Actual|Pfizer|||||f||||||||||||||2017-02-18 18:18:14.366013|2017-02-18 18:18:14.366013
NCT00003773|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||February 1999||1999-02-01|May 2014|2014-05-01|August 2001|Actual|2001-08-01|July 2000|Actual|2000-07-01||Interventional|||IM-862 in Treating Patients With Recurrent Ovarian Cancer|Phase I Study of Escalating Doses of IM-862 in Patients With Ovarian Cancer|Completed||Phase 1|43|Actual|University of Southern California|||||f||||t||||||||||2017-02-18 18:18:14.489355|2017-02-18 18:18:14.489355
NCT00003772|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-24|||January 1999||1999-01-01|August 2012|2012-08-01|February 2003|Actual|2003-02-01|August 2001|Actual|2001-08-01||Observational|||Quality-of-Life Assessment in Patients With Ovarian Cancer|An International Field Study of the Reliability and Validity of a Disease-Specific Questionnaire Module (the QLQ-OV28) in Assessing the Quality of Life of Patients With Ovarian Cancer|Completed||N/A|372|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||1||f||||f||||||||||2017-02-18 18:18:14.600937|2017-02-18 18:18:14.600937
NCT00003771|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||September 1997||1997-09-01|July 2001|2001-07-01|February 2004|Actual|2004-02-01|||||Interventional|||Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer|Protocol for Randomized Clinical Study Concerning Hormonal Replacement Therapy (HRT) After Previous Radical Breast Cancer Treatment|Completed||Phase 3|1300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:14.712055|2017-02-18 18:18:14.712055
NCT00003769|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-09-09|||February 1999||1999-02-01|September 2014|2014-09-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer|A Phase II Trial of Perillyl Alcohol in Patients With Resectable Pancreatic Cancer|Completed||Phase 2|||Indiana University|||||f||||||||||||||2017-02-18 18:18:14.822|2017-02-18 18:18:14.822
NCT00003768|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-01-06|||September 1998||1998-09-01|January 2014|2014-01-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors|A Phase I Pharmacokinetic Study of Single Dose Intravenous CA4P in Patients With Advanced Cancer|Completed||Phase 1|25|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:18:14.919073|2017-02-18 18:18:14.919073
NCT00003766|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-03-05|||October 1999||1999-10-01|March 2014|2014-03-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery|Determination of Optimal O6-Benzylguanine Dose to Achieve O6-Alkylguanine-DNA Alkyltransferase Depletion in Patients With Surgically Resectable Solid Tumors|Completed||Phase 1|25|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:18:15.008214|2017-02-18 18:18:15.008214
NCT00003765|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||May 1999||1999-05-01|October 2007|2007-10-01||||March 2006|Actual|2006-03-01||Interventional|||O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors|A Trial of 06-BG and BCNU in Children With CNS Tumors|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:15.116059|2017-02-18 18:18:15.116059
NCT00003764|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||December 1999||1999-12-01|January 2010|2010-01-01||||November 2005|Actual|2005-11-01||Interventional|||Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia|Phase III Randomized Trial of Fludarabine and Cyclophosphamide Versus Fludarabine for Previously Untreated Chronic Lymphocytic Leukemia|Completed||Phase 3|280|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-02-18 18:18:15.582144|2017-02-18 18:18:15.582144
NCT00003763|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||January 1999||1999-01-01|April 1999|1999-04-01||||||||Interventional|||Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer|A Study to Determine the Ability of Folate Conjugates to Target Folate Receptors in Ovarian Cancer Tumors|Completed||N/A|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:15.925179|2017-02-18 18:18:15.925179
NCT00003762|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2016-07-12|||February 1999||1999-02-01|July 2016|2016-07-01|May 2008|Actual|2008-05-01|February 2003|Actual|2003-02-01||Interventional|||Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Randomized Phase II Study of Docetaxel and Gemcitabine for Stage IIIB/IV Non-Small Cell Lung Cancer|Completed||Phase 2|106|Actual|Alliance for Clinical Trials in Oncology||3|||f||||t||||||||||2017-02-18 18:18:16.048046|2017-02-18 18:18:16.048046
NCT00003761|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-02-13|||March 3, 1999|Actual|1999-03-03|February 2017|2017-02-01|October 19, 2001|Actual|2001-10-19|April 20, 2001|Actual|2001-04-20||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Breast Cancer|A Phase I Trial of Recombinant Vaccinia Virus That Expresses DF3/MUC1 in Patients With Metastatic Adenocarcinoma of the Breast|Completed||Phase 1|20|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 18:18:16.183093|2017-02-18 18:18:16.183093
NCT00003760|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-07|||November 1998||1998-11-01|August 2012|2012-08-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer|A Phase II Trial of MGI 114 in Patients With Advanced Pancreatic Adenocarcinoma|Completed||Phase 2|3|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:18:16.288483|2017-02-18 18:18:16.288483
NCT00003759|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-30|||November 1998||1998-11-01|November 2002|2002-11-01|November 2002|Actual|2002-11-01|||||Interventional|||AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer|Intravesical Treatment of Superficial Bladder Cancer Characterized on the Basis of the Tumor Markers p53 and pRb|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:16.388452|2017-02-18 18:18:16.388452
NCT00003758|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||December 1998||1998-12-01|January 2001|2001-01-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia|Treatment of Relapsed Acute Myelogenous Leukemia Consisting of Intermediate Dose Cytosine Arabinoside (ARA-C) Plus Interspaced Continuous Infusion Idarubicin, Followed by Continuous Infusion of Low-Dose ARA-C, A Phase II Study by the EORTC-LCG|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:16.48751|2017-02-18 18:18:16.48751
NCT00003757|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||February 1998||1998-02-01|May 2012|2012-05-01|July 2007|Actual|2007-07-01|July 2002|Actual|2002-07-01||Interventional|||Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy|Rituximab (IDEC-C2B8, Mabthera) in Patients With Hairy Cell Leukemia Relapsing After Treatment With 2-Chlorodeoxyadenosine (CDA)|Completed||Phase 2|25|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:18:16.608415|2017-02-18 18:18:16.608415
NCT00003755|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||October 1998||1998-10-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor|Phase I Study of R031-7453, a Novell Cell Cycle Inhibitor, Administered as Escalating Oral Doses in Adults With Solid Tumors: 4-Day Schedule|Completed||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:16.725102|2017-02-18 18:18:16.725102
NCT00003754|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||September 1998||1998-09-01|June 2013|2013-06-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers|A Phase II Study of Thalidomide and Cyclophosphamide in Patients With Recurrent or Refractory Malignancies|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:16.821626|2017-02-18 18:18:16.821626
NCT00003753|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||September 1998||1998-09-01|June 2013|2013-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer|A Phase I-II Study of Hepatic Arterial Therapy Via Pump (Protocol D97-063) With Floxuridine (FUDR) and Dexamethasone (DEX) in Combination With Intravenous Irinotecan as Adjuvant Treatment After Resection of Hepatic Metastases From Colorectal Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:16.918135|2017-02-18 18:18:16.918135
NCT00003752|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-29|||October 1998||1998-10-01|May 2007|2007-05-01|March 2003|Actual|2003-03-01|||||Interventional|||Bexarotene in Treating Patients With Metastatic Breast Cancer|A Multicenter Phase II Evaluation of Targretin (Bexarotene) Capsules in Patients With Advanced Breast Cancer|Completed||Phase 2|180|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:17.012769|2017-02-18 18:18:17.012769
NCT00003751|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-01|||March 1999||1999-03-01|May 2012|2012-05-01|July 2005|Actual|2005-07-01|June 2004|Actual|2004-06-01||Interventional|||Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma|Phase II Study of Penicillamine and Reduction of Copper for Angiosuppressive Therapy of Adults With Newly Diagnosed Glioblastoma|Completed||Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:18:17.154749|2017-02-18 18:18:17.154749
NCT00003750|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-06|||October 2001||2001-10-01|August 2014|2014-08-01|September 2005|Actual|2005-09-01|January 2005|Actual|2005-01-01||Interventional|||Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors|A Phase I/IB Intergroup Trial of the HU14.18-IL2 Fusion Protein in Children With Refractory Neuroblastoma and Other GD2 Positive Tumors|Completed||Phase 1|28|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:18:17.271274|2017-02-18 18:18:17.271274
NCT00003749|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||April 1998||1998-04-01|April 1999|1999-04-01|December 2008|Actual|2008-12-01|||||Interventional|||Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer|A Randomised Trial of Lymphadenectomy and of Adjuvant External Beam Radiotherapy in the Treatment of Endometrial Cancer|Completed||Phase 3|2300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:17.451018|2017-02-18 18:18:17.451018
NCT00003748|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-28|||August 1998||1998-08-01|July 2012|2012-07-01|January 2005|Actual|2005-01-01|June 2000|Actual|2000-06-01||Interventional|||Irinotecan in Treating Patients With Esophageal or Stomach Cancer|Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia|Completed||Phase 2|40|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 18:18:17.545977|2017-02-18 18:18:17.545977
NCT00003747|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||October 1998||1998-10-01|March 2001|2001-03-01||||||||Interventional|||Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma|Phase I (Tumour Site Specific) Study of Carboplatin and Temozolomide in Patients With Advanced Melanoma|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:17.977341|2017-02-18 18:18:17.977341
NCT00003746|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||September 1998||1998-09-01|May 2012|2012-05-01|November 2010|Actual|2010-11-01|November 2005|Actual|2005-11-01||Interventional|||Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia|Daily Versus Weekly Administration of 2-Chlorodeoxyadenosine (CDA) in Patients With Hairy Cell Leukemia|Completed||Phase 3|100|Actual|Swiss Group for Clinical Cancer Research||2|||f||||t||||||||||2017-02-18 18:18:18.074456|2017-02-18 18:18:18.074456
NCT00003745|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||May 1999||1999-05-01|April 2003|2003-04-01||||June 2003|Actual|2003-06-01||Interventional|||Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas|A Phase II Study of Continuous 21 Day Infusion of Topotecan (NSC # 609699) in Children With Relapsed Solid Tumors|Completed||Phase 2|125|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:18.228435|2017-02-18 18:18:18.228435
NCT00003744|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-17|||November 1998||1998-11-01|January 2017|2017-01-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery|Gemcitabine for Advanced Salivary Cancer: A Phase II Study|Completed||Phase 2|16|Actual|Dana-Farber Cancer Institute||2|||f||||t||||||||No||2017-02-18 18:18:18.646736|2017-02-18 18:18:18.646736
NCT00003743|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||March 1997||1997-03-01|May 2007|2007-05-01||||||||Interventional|||Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation|Multicenter Observer-Blind Randomized Phase II Parallel Study Comparing Three Doses of Subcutaneous Interleukin 2 After Megatherapy and Peripheral Stem Cell Reinfusion in Stage 4 Neuroblastoma in Patients Over 1 Year of Age|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:18.770816|2017-02-18 18:18:18.770816
NCT00003742|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||October 1998||1998-10-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors|Phase I Trial of Paclitaxel, Cisplatin, and Irinotecan in Patients With Advanced Solid Tumor Malignancies|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:18.857298|2017-02-18 18:18:18.857298
NCT00003741|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||February 1999||1999-02-01|March 2005|2005-03-01|December 2007|Actual|2007-12-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma|HeFi-1 Antibody Therapy in Ki-1 and Hodgkin's Lymphomas, a Phase I Study|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:18.947711|2017-02-18 18:18:18.947711
NCT00003740|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||October 1998||1998-10-01|June 2013|2013-06-01|September 2002|Actual|2002-09-01|September 2002|Actual|2002-09-01||Interventional|||Trastuzumab in Treating Patients With Prostate Cancer|Phase II Study of Herceptin (Recombinant Humanized Anti-p185HER2 Monoclonal Antibody) for the Treatment of Androgen Independent Prostate Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:19.030973|2017-02-18 18:18:19.030973
NCT00003739|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-12|||March 1999||1999-03-01|February 2014|2014-02-01|September 2006|Actual|2006-09-01|December 2002|Actual|2002-12-01||Interventional|||Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy|Randomized Comparison Between Antibiotics Alone and Antibiotics Plus Granulocyte-Colony Stimulating Factor in Pediatric Patients With Chemotherapy Induced Febrile Neutropenia|Completed||Phase 3|67|Actual|Children's Oncology Group|||||f||||t||||||||||2017-02-18 18:18:19.131688|2017-02-18 18:18:19.131688
NCT00003737|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||January 1999||1999-01-01|June 2013|2013-06-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Interventional|||Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma|A Pharmacokinetic-Guided Phase II Trial of the Rebeccamycin Analog NSC# 655649 in Pediatric Patients With Relapsed/Refractory Neuroblastoma|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:22.5488|2017-02-18 18:18:22.5488
NCT00003736|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||June 1999||1999-06-01|June 2007|2007-06-01||||||||Interventional|||MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer|Pilot Study: High Risk Breast Cancer Screening Pilot Study|Unknown status|Active, not recruiting|N/A|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:22.659092|2017-02-18 18:18:22.659092
NCT00003735|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||December 1998||1998-12-01|July 2014|2014-07-01|September 2006|Actual|2006-09-01|November 2002|Actual|2002-11-01||Interventional|||Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia|A Phase II Study of Oral Topotecan in Children With Relapsed Acute Leukemia|Completed||Phase 2|11|Actual|Children's Oncology Group||2|||f||||||||||||||2017-02-18 18:18:22.772481|2017-02-18 18:18:22.772481
NCT00003734|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-20|||December 1998||1998-12-01|December 2011|2011-12-01||||||||Interventional|||Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer|A Randomised Comparison of Short and Protracted Neoadjuvant Hormonal Therapy Prior to Radiation Therapy of High Risk Localized Prostate Cancer|Unknown status|Active, not recruiting|Phase 3|276|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:22.929938|2017-02-18 18:18:22.929938
NCT00003733|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||December 1997||1997-12-01|December 2000|2000-12-01||||||||Interventional|||Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer|A Phase II Study of Sequential Carboplatin, Paclitaxel and Hycamtin in Patients With Previously Untreated Advanced Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:23.04014|2017-02-18 18:18:23.04014
NCT00003732|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-09|||September 1998||1998-09-01|July 2002|2002-07-01|September 2005|Actual|2005-09-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer|A Phase I/II Study to Determine the Maximum Tolerated Doses of Oral Topotecan, Carboplatin and Paclitaxel Administered Every 21 Days to Patients With Epithelial Ovarian Cancer Stages IIb, IIc, III and IV|Completed||Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:23.188965|2017-02-18 18:18:23.188965
NCT00003731|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||December 1998||1998-12-01|September 2012|2012-09-01||||January 2001|Actual|2001-01-01||Interventional|||Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors|First Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors, a Phase II Trial|Completed||Phase 2|39|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:18:23.280518|2017-02-18 18:18:23.280518
NCT00003730|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||December 1998||1998-12-01|June 2012|2012-06-01||||November 2004|Actual|2004-11-01||Interventional|||Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer|A Multicenter Randomized Trial, With Direct Individual Benefit, to Determine the Optimal Circadian Time of Vinorelbine Administration Combined With Chronomodulated Infusion of 5-Fluorouracil in Previously Treated Patients With Metastatic Breast Cancer|Completed||N/A|80|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:18:23.680798|2017-02-18 18:18:23.680798
NCT00003729|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||December 1998||1998-12-01|September 2012|2012-09-01||||April 2002|Actual|2002-04-01||Interventional|||Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia|Phase II Study of Fludarabine + Idarubicin + Aracytine in Refractory or Relapsed ALL in Children|Terminated||Phase 2|13|Actual|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:18:23.800763|2017-02-18 18:18:23.800763
NCT00003728|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-01-20|||December 1998||1998-12-01|June 2009|2009-06-01||||May 2008|Anticipated|2008-05-01||Interventional|||Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma|The Value of Dexamethasone Versus Prednisolone During Induction and Maintenance Therapy of Prolonged Versus Conventional Duration of L-Asparaginase Therapy During Consolidation and Late Intensification, and of Corticosteroid + VCR Pulses During Maintenance in Acute Lymphoblastic Leukemia and Lymphoblastic Non-Hodgkin Lymphoma of Childhood|Unknown status|Active, not recruiting|Phase 3|1500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:23.931502|2017-02-18 18:18:23.931502
NCT00003727|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-09-23|||March 1999||1999-03-01|September 2009|2009-09-01|February 2008|Actual|2008-02-01|March 2005|Actual|2005-03-01||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia|Autotransplantation for Chronic Myelogenous Leukemia (CML) Followed by Immunotherapy With Ex-Vivo Expanded Autologous T Cells|Completed||Phase 2|22|Anticipated|University of Maryland|||||f||||||||||||||2017-02-18 18:18:24.077858|2017-02-18 18:18:24.077858
NCT00003726|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-27|2013-05-16||November 1998||1998-11-01|June 2016|2016-06-01|July 2001|Actual|2001-07-01|July 2001|Actual|2001-07-01||Interventional|||Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer|A Phase I/II Study of Recombinant Desulfato Hirudin, Lepirudin (Refludan) in Small Cell Lung Cancer Patients Previously Treated With Chemotherapy|Terminated||Phase 1/Phase 2|1|Actual|Dartmouth-Hitchcock Medical Center|The funding of the trial was discontinued and therefore only one participant was enrolled to the trial and experienced no adverse events.|1||Study funding was dropped.|f||||t||||||||||2017-02-18 18:18:24.185258|2017-02-18 18:18:24.185258
NCT00003725|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||December 1996||1996-12-01|May 2007|2007-05-01||||||||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer|Phase III Randomized Study of a Single Adjunctive Instillation of Intravesical AD 32 (N-Trifluoroacetyladriamycin-14-valerate) Versus No Adjunctive Therapy Immediately Following Transurethral Resection in Patients With Multiple Superficial (Ta/T1) Bladder Tumors|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:24.390704|2017-02-18 18:18:24.390704
NCT00003724|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-11|||February 1999||1999-02-01|July 2016|2016-07-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases|Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases|Completed||Phase 3|530|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:18:24.545047|2017-02-18 18:18:24.545047
NCT00003723|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-05|||February 1999||1999-02-01|October 2012|2012-10-01|December 2007|Actual|2007-12-01|June 2007|Actual|2007-06-01||Interventional|||S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery|Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma|Completed||Phase 2|57|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:18:24.970396|2017-02-18 18:18:24.970396
NCT00003721|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-27|||November 1998||1998-11-01|June 2012|2012-06-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I, Pharmacologic and Biologic Study of Col-3 (NSC683551) Administered on a 28-Day Oral Dosing Schedule in Patients With Advanced Solid Tumors|Completed||Phase 1|33|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:18:25.175431|2017-02-18 18:18:25.175431
NCT00003720|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-22|||July 1998||1998-07-01|August 2012|2012-08-01||||||||Interventional|||SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma|A Multicenter, Dose Escalating Study in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma|Completed||Phase 1|||Pfizer|||||f||||||||||||||2017-02-18 18:18:25.257758|2017-02-18 18:18:25.257758
NCT00003719|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||July 1997||1997-07-01|August 2001|2001-08-01||||||||Interventional|||Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma|Phase II Evaluation of Irinotecan (CPT-11) in Previously Treated Advanced Sarcomas|Unknown status|Active, not recruiting|Phase 2|27|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:25.347357|2017-02-18 18:18:25.347357
NCT00003718|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||September 1998||1998-09-01|August 2001|2001-08-01||||||||Interventional|||Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma|Phase II Evaluation of Temodal (Temozolomide, Schering) in Previously Treated Advanced Sarcomas|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:25.441834|2017-02-18 18:18:25.441834
NCT00003717|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||October 1998||1998-10-01|August 2001|2001-08-01||||||||Interventional|||Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer|A Phase II Trial of Weekly Paclitaxel Plus Oral Estramustine in Patients With Hormone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|17|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:25.535336|2017-02-18 18:18:25.535336
NCT00003716|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-17|||March 1998||1998-03-01|June 2002|2002-06-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy|Phase II Trial of Rituximab in Patients With B-Cell Lymphoproliferative Disorders Associated With Pharmacologic Immunosuppression|Unknown status|Active, not recruiting|Phase 2|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:25.634496|2017-02-18 18:18:25.634496
NCT00003715|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-12-02|||December 1998||1998-12-01|December 2015|2015-12-01||||||||Interventional|||Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma|A Prospective, Randomized, Open-Label, Comparative Clinical Trial in Post-Surgical Melanoma Patients With Either DNP-Modified Autologous Tumor Vaccine or Interferon Alpha-2b|Terminated||Phase 2|425|Anticipated|AVAX Technologies||||"Terminated: recruiting or enrolling participants has halted prematurely and will not resume;~   participants are no longer being examined or treated"|f||||||||||||||2017-02-18 18:18:25.728194|2017-02-18 18:18:25.728194
NCT00003714|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-02-20||||||February 2012|2012-02-01||||||||Interventional|||Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer|Phase II Trial of Pyrazoloacridine (PZA) in Previously Untreated Hepatocellular Carcinoma (HCC) Patients|Withdrawn||Phase 2|0|Actual|M.D. Anderson Cancer Center||1||Withdrawn|f||||f||||||||||2017-02-18 18:18:25.841902|2017-02-18 18:18:25.841902
NCT00003713|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1997||1997-08-01|May 2001|2001-05-01||||||||Interventional|||Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors|A Phase I, Pharmacokinetic, and Treatment Duration and Escalation Study of Intravenous Intoplicine Administered as a 5 to 21-Day Continuous Infusion Every 4 Weeks|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:25.953319|2017-02-18 18:18:25.953319
NCT00003712|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-07|||January 2001||2001-01-01|August 2012|2012-08-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||CCI-779 in Treating Patients With Advanced Solid Tumors|A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous CCI-779 Given Once Daily for 5 Days Every 2 Weeks to Patients With Advanced Solid Tumors|Completed||Phase 1|15|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:18:26.046332|2017-02-18 18:18:26.046332
NCT00003711|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-29|||September 1997||1997-09-01|April 2000|2000-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors|A Phase I Trial of LY231514 With Irinotecan Administered Intravenously Every 21 Days in Patients With Metastatic Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:26.14891|2017-02-18 18:18:26.14891
NCT00003710|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-07|||August 1998||1998-08-01|June 2012|2012-06-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors|Phase I and Pharmacokinetic Study of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Solid Tumors|Completed||Phase 1|12|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:18:26.232751|2017-02-18 18:18:26.232751
NCT00003709|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-07|||October 1998||1998-10-01|August 2012|2012-08-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Chemotherapy in Treating Patients With Advanced Solid Tumors|Phase I and Pharmacokinetic Study of FB-642 Administered Orally on a Weekly Schedule to Patients With Advanced Solid Tumors|Completed||Phase 1|25|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:18:26.317312|2017-02-18 18:18:26.317312
NCT00003708|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-07|||July 1998||1998-07-01|August 2012|2012-08-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Chemotherapy in Treating Patients With Advanced Solid Tumors|A Phase I Study of Cyclic Oral Administration of SCH 52365 for 21 of 28 Days in Patients With Advanced Solid Malignancies|Completed||Phase 1|32|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:18:26.412249|2017-02-18 18:18:26.412249
NCT00003707|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-26|||October 1998||1998-10-01|June 2012|2012-06-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I, Maximum Tolerated Dose (MTD) Trial to Determine the Safety and Pharmacokinetics of Chronic Oral Administration of Farnesyl Transferase Inhibitor R115777 in Combination With Gemcitabine in Subjects With Advanced Incurable Cancer|Completed||Phase 1|22|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:18:26.507804|2017-02-18 18:18:26.507804
NCT00003706|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-26|||April 1998||1998-04-01|June 2012|2012-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function|A Phase I Pharmacokinetic Trial of LY231514 Administered Intravenously Every 3 Weeks in Advanced Cancer Patients With Varying Degrees of Renal Function|Completed||Phase 1|50|Actual|The University of Texas Health Science Center at San Antonio||1|||f||||t||||||||||2017-02-18 18:18:26.59797|2017-02-18 18:18:26.59797
NCT00003705|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||November 1997||1997-11-01|August 2007|2007-08-01||||||||Interventional|||BMS-184476 in Treating Patients With Advanced Solid Tumors|Phase I Study of BMS-184476 in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:26.689554|2017-02-18 18:18:26.689554
NCT00003704|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||April 1999||1999-04-01|July 2016|2016-07-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer|Phase I Study of Oral Capecitabine (Xeloda) as a Radiation Enhancer in Locally Unresectable, Residual, or Recurrent Colorectal Cancer Localized in the Pelvis|Completed||Phase 1|51|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:26.784488|2017-02-18 18:18:26.784488
NCT00003702|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-02-09|||June 1999||1999-06-01|February 2016|2016-02-01||||July 2010|Actual|2010-07-01||Interventional|||Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia|"A Randomized Phase III Trial of Weekly Parenteral Methotrexate Versus Pulsed Dactinomycin as Primary Management for Low Risk Gestational Trophoblastic Neoplasia"|Completed||Phase 3|240|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-02-18 18:18:27.008385|2017-02-18 18:18:27.008385
NCT00003701|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-02|||March 1999||1999-03-01|February 2009|2009-02-01||||August 2001|Actual|2001-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Bladder Cancer|A Phase III Randomized Trial of Either M-VAC or Paclitaxel + Carboplatin as Postoperative Adjuvant Therapy in Patients With Muscle-Invasive Transitional Cell Carcinoma of the Bladder at High-Risk for Relapse|Completed||Phase 3|490|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:27.125664|2017-02-18 18:18:27.125664
NCT00003700|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||January 1999||1999-01-01|July 2016|2016-07-01|January 2010|Actual|2010-01-01|February 2004|Actual|2004-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia|Phase II Study in Adults With Untreated Acute Lymphoblastic Leukemia Testing Increased Doses of Daunorubicin During Induction, and Cytarabine During Consolidation, Followed by High-Dose Methotrexate and Intrathecal Methotrexate in Place of Cranial Irradiation|Completed||Phase 2|163|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:27.503881|2017-02-18 18:18:27.503881
NCT00003698|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||July 1998||1998-07-01|February 2008|2008-02-01|December 2003|Actual|2003-12-01|||||Interventional|||Chemotherapy in Treating Patients With Solid Tumors|A Phase I Trial of Combretastatin A4 Phosphate in Patients With Solid Tumours Given by Weekly Intravenous Infusion|Completed||Phase 1|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:27.684379|2017-02-18 18:18:27.684379
NCT00003697|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||October 1995||1995-10-01|June 2009|2009-06-01|December 1998|Actual|1998-12-01|||||Interventional|||Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors|A Phase I Trial of 5, 6 Dimethyl Xanthenone - 4 - Acetic Acid (DMXAA) in Solid Tumors|Completed||Phase 1|3|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:27.771447|2017-02-18 18:18:27.771447
NCT00003696|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||October 1998||1998-10-01|November 2001|2001-11-01||||||||Interventional|||Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer|Phase III Study of Cyclophosphamide, Doxorubicin and Etoposide Compared to Carboplatin and Taxol in Patients With Extensive Disease Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:27.858217|2017-02-18 18:18:27.858217
NCT00003695|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||May 1998||1998-05-01|May 2007|2007-05-01|January 2001|Actual|2001-01-01|||||Interventional|||Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer|A Randomised Trial of Interval Debulking Surgery in Epithelial Ovarian Cancer Suboptimally Debulked at Primary Surgery|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:27.953358|2017-02-18 18:18:27.953358
NCT00003694|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-04|||March 1999||1999-03-01|June 2013|2013-06-01||||August 2003|Actual|2003-08-01||Interventional|||Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase|A Phase II Study of Newly Diagnosed Patients With BCR/ABL (+) Chronic Myelogenous Leukemia Treated With Combined Homoharringtonine (NSC #141633) and Low-Dose Cytarabine|Completed||Phase 2|60|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:28.038359|2017-02-18 18:18:28.038359
NCT00003693|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-01|||March 1999||1999-03-01|August 2012|2012-08-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia|Phase I Study of Dolastatin-10 in Acute Leukemias, Myelodysplastic Syndromes and Chronic Myeloid Leukemia in Blast Phase|Completed||Phase 1|30|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:18:28.157726|2017-02-18 18:18:28.157726
NCT00003692|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|||December 1998||1998-12-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer|Video-Assisted Lobectomy for Peripheral (no Greater Than 3 cm), N0, Non-Small Cell Lung Cancer: A Phase II Feasibility Study|Completed||Phase 2|128|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:28.271774|2017-02-18 18:18:28.271774
NCT00003691|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-08|||December 1998||1998-12-01|September 2010|2010-09-01||||June 2004|Actual|2004-06-01||Interventional|||Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer|A Randomized Study of Doxorubicin Plus Cisplatin Versus Doxorubicin Plus Cisplatin Plus 3-Hour Paclitaxel With G-CSF Support in Patients With Primary Stage III & IV or Recurrent Endometrial Carcinoma|Completed||Phase 3|240|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:18:28.504689|2017-02-18 18:18:28.504689
NCT00003690|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-08-02|||December 1998||1998-12-01|August 2011|2011-08-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors|Phase I Study of Flavopiridol in Combination With Cisplatin in Patients With Advanced Malignancies|Completed||Phase 1|48|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 18:18:28.685979|2017-02-18 18:18:28.685979
NCT00003688|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-07|||October 1999||1999-10-01|December 2003|2003-12-01||||September 2006|Actual|2006-09-01||Interventional|||Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia|Pulse Actinomycin-D as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Neoplasia|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:18:28.782753|2017-02-18 18:18:28.782753
NCT00003687|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-25|||December 1998||1998-12-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|September 2001|Actual|2001-09-01||Interventional|||Treatment for Chronic Pain in Patients With Advanced Cancer|A Phase III Double-Blind Equivalence Study of Two Different Formulations of Slow-Release Morphine Followed by a Randomization Between Dextromethorphan or Placebo Plus Statex SR for Chronic Cancer Pain Relief in Terminally Ill Patients|Completed||Phase 3|||Canadian Cancer Trials Group|||||f||||t||||||||Undecided||2017-02-18 18:18:28.910357|2017-02-18 18:18:28.910357
NCT00003686|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-30|||August 1998||1998-08-01|January 2012|2012-01-01|November 1999|Actual|1999-11-01|October 1999|Actual|1999-10-01||Interventional|||Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids|A Double Blind Phase III Study of Oral Pilocarpine for Opioid-Induced Dry Mouth|Terminated||Phase 3|4|Actual|Canadian Cancer Trials Group||2||Terminated due to poor accrual.|f||||t||||||||||2017-02-18 18:18:29.023294|2017-02-18 18:18:29.023294
NCT00003685|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-07|||December 1998||1998-12-01|March 2010|2010-03-01|February 2009|Actual|2009-02-01|||||Interventional|||Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer|A Phase III Trial of Single Versus Fractionated Thoracic Radiation for Palliation of Symptoms in Patients With Non-Small Cell Lung Cancer|Completed||Phase 3|210|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:18:29.133314|2017-02-18 18:18:29.133314
NCT00003684|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-11|||March 1998||1998-03-01|March 2010|2010-03-01|December 2008|Actual|2008-12-01|||||Interventional|||Theophylline in Treating Cancer Patients With Shortness of Breath|A Phase III Double-Blind Study of Theophylline Versus Placebo for the Treatment of Dyspnea in Cancer Patients|Completed||Phase 3|60|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:18:29.243342|2017-02-18 18:18:29.243342
NCT00003683|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||March 1998||1998-03-01|May 2002|2002-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer|Treatment of Sarcomatous Kidney Cancer That is Metastatic in Adults With Doxorubicin and Ifosfamide. Phase II Study|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:29.332874|2017-02-18 18:18:29.332874
NCT00003682|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-22|||October 1998||1998-10-01|June 2016|2016-06-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer|Treatment of Metastatic Prostate Cancer That is Hormone-Independent: Evaluation of the Role of Chemotherapy on the Quality of Life of Patients. Phase II Study|Terminated||Phase 3|160|Anticipated|UNICANCER||||lack of inclusions|f||||||||||||||2017-02-18 18:18:29.428976|2017-02-18 18:18:29.428976
NCT00003681|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-05-09|||August 1998||1998-08-01|July 2000|2000-07-01||||||||Interventional|||Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome|Phase II Multicenter Study of Amifostine in Patients With Myelodysplastic Syndromes at Relatively Low Risk of Developing Acute Leukemia|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:29.805523|2017-02-18 18:18:29.805523
NCT00003680|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||November 1998||1998-11-01|May 2007|2007-05-01||||||||Interventional|||Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer|A Randomised Comparative Trial of Highly Intensive Chemotherapy With Stem Cell Support vs. Relatively Intensive Chemotherapy (CMF 8 Cycles) in Breast Cancer Patients Node Positive Surgery, Having Received Primary Medical Therapy With an Anthracycline Regimen|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:29.917746|2017-02-18 18:18:29.917746
NCT00003679|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||November 1998||1998-11-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer|A Randomised Comparative Trial of Adriamycin + Taxotere vs. Adriamycin + Cyclophosphamide as Primary Medical Therapy for Patients With Potentially Operable Breast Cancer Greater Than or Equal to 3 cm Diameter, Locally Advanced, or Inflammatory Disease|Unknown status|Active, not recruiting|Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:30.029314|2017-02-18 18:18:30.029314
NCT00003678|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||May 1991||1991-05-01|March 2007|2007-03-01||||||||Interventional|||Tamoxifen in Treating Women With Breast Cancer|A Large, Uniquely Simple, Randomised Study to Assess Much More Reliably the Balance of Benefits and Risks of Prolonging Adjuvant Tamoxifen Treatment in Early Breast Cancer|Unknown status|Active, not recruiting|Phase 3|20000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:30.120956|2017-02-18 18:18:30.120956
NCT00003677|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||March 1999||1999-03-01|July 2012|2012-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer|Phase II Study of Dolastatin 10 (NSC# 376128) Administered Intravenously Every 21 Days to Patients With Metastatic Pancreatic Adenocarcinoma|Completed||Phase 2|9|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:18:30.22473|2017-02-18 18:18:30.22473
NCT00003675|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|||March 1999||1999-03-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|January 2002|Actual|2002-01-01||Interventional|||Topotecan in Treating Patients With Myelodysplastic Syndrome|A Randomized Phase II Trial of Oral Topotecan Given Twice a Day for 5 Days or Once a Day for 10 Days to Patients With Myelodysplastic Syndromes (MDS)|Completed||Phase 2|100|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:18:30.338827|2017-02-18 18:18:30.338827
NCT00003674|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||December 1998||1998-12-01|July 2016|2016-07-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer|Phase III Double-Blind Trial Comparing Low-Molecular Weight Heparin (LMWH) Versus Placebo in Patients With Advanced Cancer|Completed||Phase 3|141|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:18:30.526861|2017-02-18 18:18:30.526861
NCT00003673|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-21|||March 1998||1998-03-01|August 2012|2012-08-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse|A Study of the Safety of CMA-676 in Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) in First Relapse|Completed||Phase 2|55|Anticipated|Pfizer|||||f||||||||||||||2017-02-18 18:18:30.679439|2017-02-18 18:18:30.679439
NCT00003671|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-24|||December 1998||1998-12-01|July 2014|2014-07-01|February 2009|Actual|2009-02-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia|Protocol for Patients With Newly Diagnosed Better Risk Acute Lymphoblastic Leukemia (ALL): A POG Pilot Study|Completed||Phase 2|59|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:18:30.802081|2017-02-18 18:18:30.802081
NCT00003670|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-06|||October 1998||1998-10-01|April 2008|2008-04-01|January 2001|Actual|2001-01-01|||||Interventional|||Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer|Phase II Study of LY353381-HC1 Administered to Women With Refractory Ovarian Cancer|Completed||Phase 2|||Eli Lilly and Company|||||f||||||||||||||2017-02-18 18:18:31.01127|2017-02-18 18:18:31.01127
NCT00003669|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-06|||November 1998||1998-11-01|April 2008|2008-04-01|April 2001|Actual|2001-04-01|||||Interventional|||Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer|Phase II Nonrandomized Study of LY353381-HC1 in Patients With Recurrent or Advanced Endometrial Cancer|Completed||Phase 2|||Eli Lilly and Company|||||f||||||||||||||2017-02-18 18:18:31.100107|2017-02-18 18:18:31.100107
NCT00003667|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||September 1998||1998-09-01|June 2013|2013-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma|Randomized Phase II Study of Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane With and Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:31.195234|2017-02-18 18:18:31.195234
NCT00003666|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|||November 1998||1998-11-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|September 2004|Actual|2004-09-01||Interventional|||Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer|Phase II Trial of 6-Hydroxymethylacylfulvene (HMAF; MGI-114) in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer|Completed||Phase 2|36|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:31.292123|2017-02-18 18:18:31.292123
NCT00003665|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-27|||April 1999||1999-04-01|February 2013|2013-02-01|November 2002|Actual|2002-11-01|October 2002|Actual|2002-10-01||Interventional|||Vaccine Therapy in Treating Patients With Stage IV Melanoma|Phase I Trial of a Dendritic Cell Vaccine for Melanoma|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||3|||f||||||||||||||2017-02-18 18:18:31.456682|2017-02-18 18:18:31.456682
NCT00003664|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||October 1998||1998-10-01|September 2000|2000-09-01||||||||Interventional|||Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically|Combination Chemobiotherapy With Gemcitabine, 5-Fluorouracil, Interleukin-2 and Alpha Interferon in Patients With Metastatic or Unresectable Renal Cell Cancer. A Phase II Study|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:31.572851|2017-02-18 18:18:31.572851
NCT00003663|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-08-17|||June 1998||1998-06-01|August 2015|2015-08-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma|Rituximab Anti-CD20 Monoclonal Antibody and Dexamethasone in the Treatment of Relapsed Indolent Lymphoma|Withdrawn||Phase 2|0|Actual|Hoag Memorial Hospital Presbyterian||||no patient accrual|f||||f||||||||||2017-02-18 18:18:31.672831|2017-02-18 18:18:31.672831
NCT00003662|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-03|||August 1998||1998-08-01|March 2011|2011-03-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases|A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Adults and Children With Bone Marrow Failure Syndromes or Inherited Metabolic or Hematologic Diseases|Completed||Phase 2|90|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:18:31.780764|2017-02-18 18:18:31.780764
NCT00003661|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-03|||June 1998||1998-06-01|March 2011|2011-03-01|March 2006|Actual|2006-03-01|November 1999|Actual|1999-11-01||Interventional|||Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer|A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Children and Adults With Hematologic Malignancies|Completed||Phase 2|3|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:18:31.895841|2017-02-18 18:18:31.895841
NCT00003659|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-28|2012-11-28||September 1998||1998-09-01|November 2012|2012-11-01|May 2009|Actual|2009-05-01|May 2009|Actual|2009-05-01||Interventional|||Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia|A Phase II Study of Fludarabine Induction With Sequential High Dose Cyclophosphamide and Rituximab as Consolidation Therapy for Previously Untreated Patients With Intermediate and High-Risk Chronic Lymphocytic Leukemia|Completed||Phase 2|39|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:18:32.038638|2017-02-18 18:18:32.038638
NCT00003658|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||September 1998||1998-09-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers|A Phase I-II Study of Pentostatin With Cyclophosphamide for Previously Treated Patients With Intermediate and High-Risk Chronic Lymphocytic Leukemia|Completed||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:32.297649|2017-02-18 18:18:32.297649
NCT00003657|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-19|||July 1998||1998-07-01|January 2017|2017-01-01|June 2002|Actual|2002-06-01|November 2000|Actual|2000-11-01||Interventional|||High-dose ICE With Amifostine|High Dose Ifosfamide, Carboplatin and Etoposide With Amifostine Chemoprotection|Completed||Phase 2|24|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 18:18:32.410716|2017-02-18 18:18:32.410716
NCT00003656|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-02-14|||January 1999|Actual|1999-01-01|February 2017|2017-02-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|||Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer|Phase II Trial of Atragen and Interferon Alfa-2b in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|26|Actual|Weill Medical College of Cornell University||1|||f||||||||||||||2017-02-18 18:18:32.556404|2017-02-18 18:18:32.556404
NCT00003654|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||September 1997||1997-09-01|December 2006|2006-12-01||||||||Interventional|||Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer|Diagnostic Study of Patent Blue V Dye to Identify Sentinel Lymph Nodes in Patients With Stage I or IIA Breast Cancer|Unknown status|Active, not recruiting|N/A|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:32.663627|2017-02-18 18:18:32.663627
NCT00003653|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-25|||January 1999||1999-01-01|August 2012|2012-08-01|January 2013|Actual|2013-01-01|May 2010|Actual|2010-05-01||Interventional|||Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer|A Phase III Randomized Trial Comparing Intermittent Versus Continuous Androgen Suppression for Patients With Prostate-Specific-Antigen Progression in the Clinical Absence of Distant Metastases Following Radiotherapy for Prostate Cancer|Completed||Phase 3|1386|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:18:32.749408|2017-02-18 18:18:32.749408
NCT00003652|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||January 1999||1999-01-01|May 2005|2005-05-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer|Intensification Therapy for Locally Advanced Epidermoid Cancer of the Anal Canal - Phase III Intergroup Study|Unknown status|Active, not recruiting|Phase 3|350|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:33.162739|2017-02-18 18:18:33.162739
NCT00003650|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-01-20|||June 1998||1998-06-01|March 2001|2001-03-01||||||||Interventional|||Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma|Phase III Study of Combination Chemotherapy in Children With T Cell and Pre-B Cell Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:33.329081|2017-02-18 18:18:33.329081
NCT00003649|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||November 1998||1998-11-01|February 2002|2002-02-01||||||||Interventional|||Gene Therapy in Treating Patients With Non-Small Cell Lung Cancer That Cannot Be Surgically Removed|Phase I Pilot Trial of Adenovirus p53 in Bronchioloalveolar Cell Lung Carcinoma (BAC) Administered by Bronchoalveolar Lavage|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:33.443454|2017-02-18 18:18:33.443454
NCT00003648|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||July 1998||1998-07-01|July 2016|2016-07-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Observational|||Genetic Study of Patients and Families With a History of Colorectal Cancer|The Familial Colorectal Neoplasia Collaborative Group|Completed||N/A|1500|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     blood and tumor samples~   "|||2017-02-18 18:18:33.545997|2017-02-18 18:18:33.545997
NCT00003647|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||July 1998||1998-07-01|July 2008|2008-07-01|September 2002|Actual|2002-09-01|||||Interventional|||Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma|Phase III Randomized Study of Dacarbazine With or Without Allovectin-7 in Patients With Metastatic Melanoma|Completed||Phase 3|||Vical|||||f||||t||||||||||2017-02-18 18:18:33.669042|2017-02-18 18:18:33.669042
NCT00003646|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-07-05|||August 1998||1998-08-01|July 2011|2011-07-01|May 2002|Actual|2002-05-01|March 2002|Actual|2002-03-01||Interventional|||Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma|Phase II Study of Allovectin-7 as an Immunotherapeutic Agent in Patients With Stages III and IV Melanoma|Completed||Phase 2|78|Actual|Vical||1|||f||||t||||||||||2017-02-18 18:18:33.830923|2017-02-18 18:18:33.830923
NCT00003645|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-13|||June 1999||1999-06-01|July 2016|2016-07-01||||June 2018|Anticipated|2018-06-01||Interventional|||Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence|A Phase III Randomized Prospective Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence|Active, not recruiting||Phase 3|496|Anticipated|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:18:33.943596|2017-02-18 18:18:33.943596
NCT00003644|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-03-17|||October 1998||1998-10-01|March 2016|2016-03-01||||March 2010|Actual|2010-03-01||Interventional|||Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer|A Randomized Phase III Trial of IV Carboplatin (AUC 6) and Paclitaxel 175 mg/m2 Q 21 Days x 3 Courses Plus Low Dose Paclitaxel 40 mg/m2/wk Versus IV Carboplatin (AUC 6) and Paclitaxel 175 mg/m2 Q 21 Days x 3 Courses Plus Observation in Patients With Early Stage Ovarian Carcinoma|Completed||Phase 3|571|Actual|Gynecologic Oncology Group||2|||f||||t||||||||||2017-02-18 18:18:34.081677|2017-02-18 18:18:34.081677
NCT00003643|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-05|||October 1998||1998-10-01|March 2012|2012-03-01||||||||Interventional|||Combination Chemotherapy in Treating Men With Germ Cell Cancer|Randomized Phase II/III Study of Taxol/Paclitaxel-BEP Versus BEP in Patients With Intermediate Prognosis Germ Cell Cancer|Unknown status|Active, not recruiting|Phase 2/Phase 3|498|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:18:34.391011|2017-02-18 18:18:34.391011
NCT00003642|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-05|||October 1998||1998-10-01|March 2012|2012-03-01||||July 2001|Actual|2001-07-01||Interventional|||Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer|A Phase II Feasibility Study of Combined Accelerated External Radiation and Chemotherapy With 5FU and CDDP Following Transurethral Resection in Patients With Muscle Invasive Transitional Carcinoma of the Bladder - T2-T3, N0, M0 (UICC 1992)|Terminated||Phase 2|43|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:18:34.552201|2017-02-18 18:18:34.552201
NCT00003641|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-03-31|2016-02-02||December 1998||1998-12-01|March 2016|2016-03-01|October 2025|Anticipated|2025-10-01|January 2015|Actual|2015-01-01||Interventional||All randomized patients|High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma|Phase III Randomized Study of Four Weeks of High Dose Interferon Alfa-2b in Stage T2bN0, T3a-bN0, T4a-bN0, and T1-4, N1a,2a (Microscopic) Melanoma|Terminated||Phase 3|1150|Actual|Eastern Cooperative Oncology Group||2||"The third interim analysis showed that there was no evidence of benefit from treatment with~   interferon."|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy|2017-02-18 18:18:34.674251|2017-02-18 18:18:34.674251
NCT00003640|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-05|||September 1998||1998-09-01|March 2012|2012-03-01||||November 2000|Actual|2000-11-01||Interventional|||Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer|A Feasibility Study of Thorough Transurethral Resection (TURB) and Escalated Dose M-VAC Chemotherapy as Primary Treatment of T2-T3a, N0-Nx, M0 Transitional Cell Carcinoma of the Bladder, With the Intention of Bladder Preservation|Terminated||Phase 2|73|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:18:39.366346|2017-02-18 18:18:39.366346
NCT00003639|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||November 1993||1993-11-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma|Randomised Controlled Trial of CID (Chlorambucil, Idarubicin, Dexamethasone) Versus CD (Chlorambucil, Dexamethasone) for Induction of Remission in Low Grade Non-Hodgkin's Lymphoma (Kiel Classification) Followed by Randomised Controlled Assessment of Standard Dose Interferon Versus Low Dose Interferon Versus No Further Therapy as Maintenance Treatment After Remission Induction|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:39.47064|2017-02-18 18:18:39.47064
NCT00003638|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-25|||January 1999||1999-01-01|December 2008|2008-12-01|December 2008|Actual|2008-12-01|January 2007|Actual|2007-01-01||Interventional|||Vaccine Therapy in Treating Women With Metastatic Breast Cancer|A Multi-Center Phase III Randomized, Controlled Study of Theratope Vaccine for Metastatic Breast Cancer|Completed||Phase 3|950|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:39.576369|2017-02-18 18:18:39.576369
NCT00003637|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||September 1998||1998-09-01|January 2006|2006-01-01||||||||Interventional|||Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx|Standard Radiotherapy Versus Concurrent Chemo-Radiotherapy Followed by Adjuvant Chemotherapy for Locally Advanced (Non-Metastatic) Nasopharyngeal Cancer|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:39.68759|2017-02-18 18:18:39.68759
NCT00003536|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer|Phase II Randomized Study of Methotrexate With or Without Antineoplaston A10 Capsules in Women With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:58.297162|2017-02-18 18:18:58.297162
NCT00003636|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-08-04|||September 1998||1998-09-01|August 2013|2013-08-01||||January 2009|Actual|2009-01-01||Interventional|||Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer|A Randomized Phase III Study Comparing Upfront Debulking Surgery Versus Neo-Adjuvant Chemotherapy in Patients With Stage IIIC or IV Epithelial Ovarian Carcinoma|Completed||Phase 3|704|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:18:39.787539|2017-02-18 18:18:39.787539
NCT00003635|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-17|||January 1999||1999-01-01|January 2002|2002-01-01|March 2004|Actual|2004-03-01|||||Interventional|||506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents|A Multicenter Study to Assess the Efficacy of 506U78 in Patients With Chronic Lymphocytic Leukemia Who Are Refractory to Fludarabine and Alkylator Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:39.983111|2017-02-18 18:18:39.983111
NCT00003634|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||April 1998||1998-04-01|May 2007|2007-05-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy|A Double-Blind Placebo Controlled Trial of Intravenous OvaRex MAb-B43.13 as Post Chemotherapy Consolidation for Ovarian Tubal and Peritoneal Carcinoma|Unknown status|Active, not recruiting|Phase 2|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:40.096239|2017-02-18 18:18:40.096239
NCT00003633|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||August 1998||1998-08-01|March 2005|2005-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer|Treatment of Prostate Cancer by Induction of Alternate Cell Death Pathways: A Phase I Trial of Docetaxel, Estramustine, Mitoxantrone and Prednisone|Unknown status|Active, not recruiting|Phase 1|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:40.223824|2017-02-18 18:18:40.223824
NCT00003632|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-15|||September 1998||1998-09-01|January 2013|2013-01-01||||July 2005|Actual|2005-07-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma|A Phase II Study of Intensive Methotrexate and Cytarabine Followed by High Dose Beam Chemotherapy With Autologous Peripheral Blood Progenitor Cell Transplantation in Patients With Newly Diagnosed Primary Central Nervous System Lymphoma|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:40.321871|2017-02-18 18:18:40.321871
NCT00003631|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-12-17|2015-12-17||August 1998||1998-08-01|December 2015|2015-12-01||||April 2010|Actual|2010-04-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma|High-Dose Chemo-Radiotherapy for Patients With Primary Refractory and Relapsed Hodgkin's Disease|Completed||Phase 2|118|Actual|Memorial Sloan Kettering Cancer Center||3|||f||||||||||||||2017-02-18 18:18:40.432748|2017-02-18 18:18:40.432748
NCT00003630|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||August 1998||1998-08-01|June 2013|2013-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Arsenic Trioxide in Treating Patients With Advanced Solid Tumors|Phase I Study of Arsenic Trioxide|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:40.927184|2017-02-18 18:18:40.927184
NCT00003627|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||October 1998||1998-10-01|January 2001|2001-01-01||||||||Interventional|||Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx|Phase III Randomized Study of Radiotherapy With or Without Cisplatin and Fluorouracil for Locally Advanced, Nonresectable Squamous Cell Cancer of the Oropharynx or Hypopharynx|Unknown status|Active, not recruiting|Phase 3|160|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:41.01497|2017-02-18 18:18:41.01497
NCT00003626|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||October 1998||1998-10-01|April 2013|2013-04-01|May 2000|Actual|2000-05-01|December 1999|Actual|1999-12-01||Interventional|||Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy|Phase II Evaluation of Dolastatin-10 in Patients With Hormone Refractory Prostate Cancer|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:18:41.388075|2017-02-18 18:18:41.388075
NCT00003625|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-25|||December 1998||1998-12-01|July 2014|2014-07-01|April 2006|Actual|2006-04-01|February 2001|Actual|2001-02-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma|Vincristine, Etoposide and Cyclosporine A in Concert With Standard Dose Radiation Therapy in Diffuse Intrinsic Brain Stem Glioma - A Phase I Study of Dose Escalation of Vincristine|Completed||Phase 1|7|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:18:41.494761|2017-02-18 18:18:41.494761
NCT00003624|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-10|||December 1998||1998-12-01|May 2006|2006-05-01||||January 2004|Actual|2004-01-01||Interventional|||Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer|A Limited Access Trial Using Amifostine for Protection Against Cisplatin and 3-Hour Paclitaxel-Induced Neurotoxicity|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:18:41.691393|2017-02-18 18:18:41.691393
NCT00003623|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||October 1999||1999-10-01|July 2016|2016-07-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer|Megadose Vitamins as Chemoprevention of Transitional Cell Carcinoma of the Bladder|Completed||Phase 3|21|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:18:41.803997|2017-02-18 18:18:41.803997
NCT00003622|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-02-26|||January 1999||1999-01-01|May 2008|2008-05-01||||May 2008|Actual|2008-05-01||Interventional|||Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy|Phase II Study of Vinorelbine With Paclitaxel in the Treatment of Hormone-Refractory Prostate Cancer|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:41.931125|2017-02-18 18:18:41.931125
NCT00003621|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||February 1999||1999-02-01|July 2016|2016-07-01|July 2005|Actual|2005-07-01|February 2005|Actual|2005-02-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma|Phase II Trial of Pre-Irradiation Chemotherapy With BCNU, Cisplatin and Oral Etoposide Combined With Radiation Therapy in the Treatment of Grade 3 Astrocytoma (Anaplastic Astrocytoma)|Completed||Phase 2|29|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:42.026214|2017-02-18 18:18:42.026214
NCT00003620|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-16|||June 1999||1999-06-01|January 2013|2013-01-01||||June 2006|Actual|2006-06-01||Interventional|||Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia|A PHASE II STUDY OF FLAVOPIRIDOL (NSC # 649890) IN PATIENTS WITH PREVIOUSLY TREATED BCELL CHRONIC LYMPHOCYTIC LEUKEMIA|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:42.168015|2017-02-18 18:18:42.168015
NCT00003619|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||February 1998||1998-02-01|February 2008|2008-02-01|April 2004|Actual|2004-04-01|||||Interventional|||Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia|A Phase I/II Combination Study of Topotecan, Fludarabine, Cytosine Arabinoside and G-CSF (T-FLAG) Induction Therapy in Patients With Poor Prognosis AML, MDS and Relapsed/Refractory ALL Followed by Maintenance of Either PBSC Transplant or 13 Cis-Retinoic Acid|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:42.273523|2017-02-18 18:18:42.273523
NCT00003617|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||March 1995||1995-03-01|April 2009|2009-04-01||||||||Interventional|||Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach|Protocol for a Randomised Trial of Observation Versus Chlorambucil After Anti-Helicobacter Therapy in Low Grade Gastric Lymphoma|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:42.381101|2017-02-18 18:18:42.381101
NCT00003616|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-12-13|||September 1998||1998-09-01|May 2006|2006-05-01||||||||Interventional|||Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma|Phase I/II Trial of Irinotecan (CPT-11) in Patients With Recurrent Malignant Glioma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:42.516179|2017-02-18 18:18:42.516179
NCT00003615|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||March 1999||1999-03-01|January 2010|2010-01-01||||August 2006|Actual|2006-08-01||Interventional|||Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Study of DAB 389 IL-2, an Interleukin-2 Fusion Toxin, for Previously Treated Stage II, III, and IV Follicular Low-Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|77|Anticipated|Eastern Cooperative Oncology Group|||||||||f||||||||||2017-02-18 18:18:42.822624|2017-02-18 18:18:42.822624
NCT00003614|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-08-22|||December 1998||1998-12-01|August 2013|2013-08-01||||April 2005|Actual|2005-04-01||Interventional|||Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer|Phase II Study of Weekly Paclitaxel by 1-HR Infusion Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:18:42.934826|2017-02-18 18:18:42.934826
NCT00003613|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-10|||April 1999||1999-04-01|January 2013|2013-01-01||||May 2006|Actual|2006-05-01||Interventional|||O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma|Phase I Trial of O6 Benzylguanine and BCNU in Cutaneous T-cell Lymphoma|Terminated||Phase 1|20|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:43.053989|2017-02-18 18:18:43.053989
NCT00003612|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||April 1999||1999-04-01|July 2016|2016-07-01||||December 2005|Actual|2005-12-01||Interventional|||Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer|Randomized Phase II Trial of Paclitaxel, Carboplatin and rhuMAb Her-2 (Herceptin) as First-Line Chemotherapy in Patients With Metastatic Breast Cancer Who Overexpress Her-2|Active, not recruiting||Phase 2|92|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:18:43.165656|2017-02-18 18:18:43.165656
NCT00003611|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||May 2000||2000-05-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|February 2003|Actual|2003-02-01||Interventional|||Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation|Chemoprevention Trial of Acitretin Versus Placebo in Solid Organ Transplant Recipients With Multiple Prior Treated Skin Cancers|Completed||N/A|129|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:18:43.331405|2017-02-18 18:18:43.331405
NCT00003610|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||October 1998||1998-10-01|July 2016|2016-07-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy|Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis|Completed||Phase 3|18|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:18:43.451546|2017-02-18 18:18:43.451546
NCT00003607|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-22|||December 1997||1997-12-01|June 2016|2016-06-01|January 2015|Actual|2015-01-01|December 2002|Actual|2002-12-01||Interventional|||Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer|Phase III Randomized Study of Radiotherapy to the Prostate With or Without Radiotherapy to the Pelvis in Patients With Stage I, II, or III Adenocarcinoma of the Prostate|Completed||Phase 3|450|Anticipated|UNICANCER|||||f||||||||||||||2017-02-18 18:18:43.571068|2017-02-18 18:18:43.571068
NCT00003606|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||March 1998||1998-03-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer|Phase III Randomized Study of Cisplatin and Etoposide With or Without Epirubicin and Cyclophosphamide for Extensive Stage Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|216|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:43.938939|2017-02-18 18:18:43.938939
NCT00003605|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-08-17|||May 1998||1998-05-01|August 2015|2015-08-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma|Rituximab Anti-CD20 Monoclonal Antibody Plus Oral Cyclophosphamide as Initial Treatment of Indolent Lymphoma|Withdrawn||Phase 2|0|Actual|Hoag Memorial Hospital Presbyterian||||no patient accrual|f||||f||||||||||2017-02-18 18:18:44.037062|2017-02-18 18:18:44.037062
NCT00003604|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||October 1997||1997-10-01|September 2000|2000-09-01||||||||Interventional|||Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery|A Multi-Center Adjuvant Trial of Outpatient Moderate-Dose Bolus Interleukin-2 for Renal Cancer|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:44.139618|2017-02-18 18:18:44.139618
NCT00003603|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||March 1998||1998-03-01|February 2001|2001-02-01||||||||Interventional|||Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma|A Randomised Study Comparing CIDEX (CCNU, Oral Idarubicin and Dexamethasone) With Melphalan and Prednisolone in Relapsed Multiple Myeloma|Unknown status|Active, not recruiting|Phase 3|660|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:44.233059|2017-02-18 18:18:44.233059
NCT00003602|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||March 1998||1998-03-01|January 2001|2001-01-01||||||||Interventional|||Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia|A Randomised Study Comparing an Oral Regimen (Idarubicin and Etoposide) With an Intravenous Regimen (MAE) for Consolidation in Patients Over 55 Years With Acute Myeloid Leukaemia in First Complete Remission|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:44.33972|2017-02-18 18:18:44.33972
NCT00003601|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||September 1998||1998-09-01|March 2008|2008-03-01||||March 2000|Actual|2000-03-01||Interventional|||Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome|A Phase II Double-Blind Study of Topical Tretinoin With or Without Oral 4-HPR (Fenretinide) in Patients With the Dysplastic Nevus Syndrome|Completed||Phase 2|38|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:44.431256|2017-02-18 18:18:44.431256
NCT00003600|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||December 1998||1998-12-01|July 2016|2016-07-01|January 2010|Actual|2010-01-01|December 2001|Actual|2001-12-01||Interventional|||Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy|A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy|Completed||Phase 3|344|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:18:44.521825|2017-02-18 18:18:44.521825
NCT00003599|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-02-17||||||February 2012|2012-02-01||||||||Interventional|||Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer|A Randomized Study of the Effect of Alpha-tocopherol (AT) on 13-cis-retinoic Acid (13-cRA) Toxicity in a Preliminary Chemoprevention Trial in Former and Current Smokers|Withdrawn||Phase 3|0|Actual|M.D. Anderson Cancer Center||2||Withdrawn study.|f||||f||||||||||2017-02-18 18:18:44.646619|2017-02-18 18:18:44.646619
NCT00003598|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-20|||January 1999||1999-01-01|September 2010|2010-09-01|November 2009|Actual|2009-11-01|March 2001|Actual|2001-03-01||Interventional|IRB 1996-0189||UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia|Retinoids and Intermediate Biomarkers for CIN II and III: Pilot Trial|Completed||N/A|180|Anticipated|University of Michigan Cancer Center|||||f||||t||||||||||2017-02-18 18:18:44.755202|2017-02-18 18:18:44.755202
NCT00003597|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||November 1998||1998-11-01|July 2014|2014-07-01|September 2005|Actual|2005-09-01|October 2004|Actual|2004-10-01||Interventional|||Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors|A Phase I Study of Thrombopoietin (rhTPO) Plus G-CSF in Children Receiving Ifosfamide, Carboplatin, and Etoposide (I.C.E.) Chemotherapy for Recurrent or Refractory Solid Tumors|Completed||Phase 1|16|Actual|Children's Oncology Group||2|||f||||||||||||||2017-02-18 18:18:44.853448|2017-02-18 18:18:44.853448
NCT00003596|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-30|||October 1998||1998-10-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2005|Actual|2005-10-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer|A Phase III Randomized Study of 5-Fluorouracil, Mitomycin-C, and Radiotherapy Versus 5-Fluorouracil, Cisplatin, and Radiotherapy in Carcinoma of the Anal Canal|Completed||Phase 3|682|Actual|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:18:45.026287|2017-02-18 18:18:45.026287
NCT00003595|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||January 1999||1999-01-01|May 2007|2007-05-01||||April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma|Randomized Trial of CHOP Chemotherapy With or Without Rituximab (Chimeric Anti-CD20 Antibody) for HIV-Associated Non-Hodgkin's Lymphoma|Completed||Phase 3|120|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:18:46.006006|2017-02-18 18:18:46.006006
NCT00003594|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||October 1998||1998-10-01|July 2016|2016-07-01|October 2004|Actual|2004-10-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum|Completed||Phase 3|1691|Actual|Alliance for Clinical Trials in Oncology||3|||f||||f||||||||||2017-02-18 18:18:46.226303|2017-02-18 18:18:46.226303
NCT00003593|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-26|||June 1999||1999-06-01|June 2013|2013-06-01|April 2012|Actual|2012-04-01|March 2007|Actual|2007-03-01||Interventional|||Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome|Treatment of Children With Down Syndrome (DS) and Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Transient Myeloproliferative Disorder (TMD): A Phase III Group-Wide Study|Completed||Phase 3|254|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:18:49.854051|2017-02-18 18:18:49.854051
NCT00003592|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-01-28|||September 1998||1998-09-01|January 2009|2009-01-01||||August 2000|Actual|2000-08-01||Interventional|||Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer|Phase III Randomized Trial of Methotrexate vs. Paclitaxel in Cisplatin-Ineligible Patients With Advanced Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|230|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:50.505998|2017-02-18 18:18:50.505998
NCT00003591|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-11|||November 1998||1998-11-01|November 2013|2013-11-01|October 2005|Actual|2005-10-01|June 2001|Actual|2001-06-01||Interventional|||Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer|A Phase II Trial of External Irradiation (50.4 GY) and Weekly Paclitaxel (Taxol) for Non-Metastatic, Unresectable Pancreatic Cancer|Completed||Phase 2|122|Actual|Radiation Therapy Oncology Group||1|||f||||t||||||||||2017-02-18 18:18:50.620656|2017-02-18 18:18:50.620656
NCT00003590|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-04-20|2011-11-07||November 1998||1998-11-01|April 2016|2016-04-01|July 2011|Actual|2011-07-01|December 2008|Actual|2008-12-01||Interventional|||S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma|Phase II Study of Hydroxyurea for Unresectable Meningioma|Completed||Phase 2|29|Actual|Southwest Oncology Group|Early termination leading to fewer than expected subjects analyzed. With 28 eligible patients estimate of response probability can be estimated to within +/- 19%.|1|||f||||f||||||||||2017-02-18 18:18:51.260299|2017-02-18 18:18:51.260299
NCT00003589|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-05|||August 1998||1998-08-01|March 2012|2012-03-01||||July 2000|Actual|2000-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer|Randomized Study With New Combination Chemotherapies in Advanced Non-Small Cell Lung Cancer|Completed||Phase 3|450|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:18:51.726515|2017-02-18 18:18:51.726515
NCT00003588|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||September 1998||1998-09-01|June 2002|2002-06-01||||March 2002|Actual|2002-03-01||Interventional|||Gene Therapy in Treating Patients With Ovarian Cancer|A Phase I Study of Ad-p53 (NSC# 683550) for Patients With Platinum- and Paclitaxel-Resistant Epithelial Ovarian Cancer|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:52.139301|2017-02-18 18:18:52.139301
NCT00002639|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||July 1995||1995-07-01|February 2001|2001-02-01|May 2004|Actual|2004-05-01|||||Interventional|||Suramin in Treating Patients With Recurrent Primary Brain Tumors|ANALYSIS OF THE EFFICACY OF SURAMIN IN RECURRENT MALIGNANT PRIMARY BRAIN TUMORS|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:23.551879|2017-02-18 18:21:23.551879
NCT00003587|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-05|||October 1998||1998-10-01|October 2012|2012-10-01|January 2007|Actual|2007-01-01|January 2001|Actual|2001-01-01||Interventional|||S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Randomized Phase II Trial of Carboplatin/Gemcitabine Followed By Paclitaxel or Cisplatin/Vinorelbine Followed by Docetaxel in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|204|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:18:52.245834|2017-02-18 18:18:52.245834
NCT00003585|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-09|||August 1996||1996-08-01|December 2013|2013-12-01|August 2002|Actual|2002-08-01|August 2001|Actual|2001-08-01||Interventional|||Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer|A Phase I/II Pilot Study of a Novel Four Drug Regimen for the Treatment of Advanced Renal Cell Carcinoma: FUNIL-cRA|Completed||Phase 1/Phase 2|35|Anticipated|University of New Mexico|||||f||||f||||||||||2017-02-18 18:18:52.46365|2017-02-18 18:18:52.46365
NCT00003584|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-05-10|||July 1998||1998-07-01|May 2016|2016-05-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer|A Phase II Trial of Combination Vinorelbine-Estramustine With or Without Prednisone for High Risk and Recurrent, Advanced and Metastatic Renal Cell Carcinoma|Completed||Phase 2|35|Anticipated|University of New Mexico|||||f||||||||||||||2017-02-18 18:18:52.562757|2017-02-18 18:18:52.562757
NCT00003583|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||June 1997||1997-06-01|May 2006|2006-05-01||||||||Interventional|||Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer|A Phase II Trial Using Amifostine as a Chemo/Radio Protective Agent in the Treatment of Limited Stage Small-Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:52.658003|2017-02-18 18:18:52.658003
NCT00003582|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-14|||May 1988||1988-05-01|December 2016|2016-12-01|December 1996|Actual|1996-12-01|December 1996|Actual|1996-12-01||Interventional|||Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer|Phase I/II Study to Evaluate Combined Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) and Amifostine (WR 2721, Ethyol) in Stage III and IV Inoperable Head and Neck Carcinomas|Completed||Phase 1/Phase 2|36|Anticipated|University of Miami|||||f||||||||||||||2017-02-18 18:18:52.762181|2017-02-18 18:18:52.762181
NCT00003580|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||June 1998||1998-06-01|May 2006|2006-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer|Phase II Study - Efficacy of Amifostine in Alleviating Toxicity Associated With Targeted Supradose Cisplatin and Concomitant Radiation Therapy (RADPLAT) in Head and Neck Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:52.871417|2017-02-18 18:18:52.871417
NCT00003578|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||January 1993||1993-01-01|May 2007|2007-05-01||||||||Interventional|||High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma|A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL|Unknown status|Active, not recruiting|Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:52.969598|2017-02-18 18:18:52.969598
NCT00003577|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||March 1996||1996-03-01|February 2001|2001-02-01|September 2008|Actual|2008-09-01|||||Interventional|||Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer|National Breast Cancer Study of Epirubicin + CMF v Classical CMF Adjuvant Therapy|Completed||Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:53.163257|2017-02-18 18:18:53.163257
NCT00003576|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||January 1997||1997-01-01|April 2007|2007-04-01|August 2005|Actual|2005-08-01|||||Interventional|||Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery|Surgery and Adjuvant Radiotherapy Versus Concurrent Chemo-Radiotherapy for Resectable (Non-Metastatic) Stage III/IV Head and Neck Squamous Cell Cancer|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:53.267761|2017-02-18 18:18:53.267761
NCT00003575|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||January 1999||1999-01-01|October 2002|2002-10-01||||April 2002|Actual|2002-04-01||Interventional|||Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma|A Randomized Pre-Phase II Trial of Interleukin-2, Interleukin-12, or No Additional Therapy Following Response to Ifosfamide/Etoposide Chemotherapy for Refractory HIV-Associated Non-Hodgkin's Lymphoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:53.378269|2017-02-18 18:18:53.378269
NCT00003574|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||April 1999||1999-04-01|November 2000|2000-11-01|June 2004|Actual|2004-06-01|||||Interventional|||Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors|A Multi-Center, Open-Label Clinical Study to Evaluate the Safety and Performance of the Proxima GliaSite RTS, a Radiation Delivery System, in Patients With Recurrent Malignant Brain Tumors Undergoing Surgical Resection|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:53.503631|2017-02-18 18:18:53.503631
NCT00003573|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-24|||November 1998||1998-11-01|July 2014|2014-07-01|March 2008|Actual|2008-03-01|October 2007|Actual|2007-10-01||Interventional|||Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma|A Phase I/II Feasibility Study of Oral Etoposide Given Concurrently With Radiotherapy Followed With Dose Intensive Adjuvant Chemotherapy for Children With Newly Diagnosed High Stage Medulloblastoma|Completed||Phase 2|53|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:18:53.621523|2017-02-18 18:18:53.621523
NCT00003572|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-01|||August 1998||1998-08-01|May 2014|2014-05-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers|Non-Myeloablative Allogeneic Bone Marrow Transplant for Hematologic Malignancies|Completed||Phase 2|20|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:18:53.854624|2017-02-18 18:18:53.854624
NCT00003571|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||August 1998||1998-08-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|January 2006|Actual|2006-01-01||Observational|||Gene Testing in Patients With Colon Cancer|Tumor Replication Error (RER) Status and Outcome in a Colon Cancer Adjuvant Chemotherapy Trial|Completed||N/A|300|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     Samples of tumor and normal tissue~   "|||2017-02-18 18:18:54.24316|2017-02-18 18:18:54.24316
NCT00003569|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-30|||March 1998||1998-03-01|January 2013|2013-01-01||||June 2003|Actual|2003-06-01||Observational|||Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel|Phase I Trial of Escalating Doses of BNP7787 in Patients With Solid Tumors Undergoing Treatment With Cisplatin and Taxol|Completed||Phase 1|2|Actual|Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:18:54.400037|2017-02-18 18:18:54.400037
NCT00003568|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||November 1998||1998-11-01|November 2005|2005-11-01|December 2005|Actual|2005-12-01|||||Interventional|||Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma|A Randomized Phase II Trial of a Mutated gp100 Melanoma Peptide (g209-217(210M) With Hight Dose Interleukin-2 (IL-2) in HLA-A2.1+Patients With Metastatic Melanoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:54.502753|2017-02-18 18:18:54.502753
NCT00003567|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-09|||May 1999||1999-05-01|June 2010|2010-06-01|February 2007|Actual|2007-02-01|January 2007|Actual|2007-01-01||Interventional|||Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma|Mutant MGMT Gene Transfer Into Human Hematopoietic Progenitors to Protect Hematopoiesis During O6-Benzylguanine (BG, NSC 637037) and Carmustine Followed by Temozolomide Therapy of Advanced Solid Tumors|Terminated||Phase 1|8|Actual|Case Comprehensive Cancer Center||1||slow accrual|f||||t||||||||||2017-02-18 18:18:54.606405|2017-02-18 18:18:54.606405
NCT00003566|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||September 1998||1998-09-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer|Pre-Resection Minimally Invasive Surgical Restaging of Stage III (Mediastinal Node Positive) Non-Small Cell Lung Cancer (NSCLC)|Completed||N/A|75|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:54.718574|2017-02-18 18:18:54.718574
NCT00003565|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||September 1998||1998-09-01|July 2016|2016-07-01|January 2008|Actual|2008-01-01|January 2006|Actual|2006-01-01||Interventional|||Docetaxel in Treating Patients With Solid Tumors|A Study of Population Pharmacokinetics of Docetaxel (Taxotere) in Caucasian and African-American Cancer Patients|Completed||Phase 2|109|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:18:54.901987|2017-02-18 18:18:54.901987
NCT00003564|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-02-17||||||February 2012|2012-02-01||||||||Interventional|||Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas|Phase III Randomized Evaluation of 13-Cis-Retinoic Acid (cRA) Plus Procarbazine Versus Procarbazine Alone in the Treatment of Patients With Recurrent Primary Malignant Gliomas|Withdrawn||Phase 3|0|Actual|M.D. Anderson Cancer Center||2||Study withdrawn.|f||||f||||||||||2017-02-18 18:18:55.105565|2017-02-18 18:18:55.105565
NCT00003563|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-10-29|||August 1998||1998-08-01|June 2008|2008-06-01|June 2005|Actual|2005-06-01|September 2001|Actual|2001-09-01||Interventional|||Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases|Phase III Randomized Trial of Gadolinium Texaphyrin (PCI-0120) Injection as a Radiation Sensitizer in Patients Receiving Whole Brain Radiation Therapy for the Treatment of Brain Metastases|Completed||Phase 3|430|Anticipated|Pharmacyclics LLC.||2|||||||||||||||||2017-02-18 18:18:55.213074|2017-02-18 18:18:55.213074
NCT00003562|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||July 1998||1998-07-01|March 2001|2001-03-01||||||||Interventional|||Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|A Phase II Study of Non-Small Cell Cancer of the Lung Utilizing Low-Dose Weekly Therapy of Taxotere and Carboplatin|Unknown status|Active, not recruiting|Phase 2|38|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:55.368613|2017-02-18 18:18:55.368613
NCT00003561|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-07-19|||February 1998||1998-02-01|April 2011|2011-04-01|August 2010|Actual|2010-08-01|October 2001|Actual|2001-10-01||Interventional|||Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia|Granulocyte-Macrophage Colony Stimulating Factor (Rhu-GM-CSF) With Interferon-Alpha (IFN-alpha) for Chronic Myeloid Leukemia|Terminated||Phase 2|48|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:18:55.460778|2017-02-18 18:18:55.460778
NCT00003560|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||May 1998||1998-05-01|September 2003|2003-09-01||||||||Interventional|||Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|A Phase II Study of Docetaxel and Carboplatin for Suboptimally Debulked Stage III or Stage IV Ovarian and Fallopian Tube Carcinoma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:55.551136|2017-02-18 18:18:55.551136
NCT00003558|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-06|||August 1998||1998-08-01|February 2003|2003-02-01||||||||Interventional|||Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin|A Randomized Phase III Trial of Paclitaxel, Carboplatin and Etoposide Vs. 5-Fluorouracil and Folinic Acid in the Treatment of Patients With Adenocarcinoma of Unknown Primary Site|Unknown status|Active, not recruiting|Phase 3|140|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:55.642918|2017-02-18 18:18:55.642918
NCT00003557|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-03-05|||January 1999||1999-01-01|March 2014|2014-03-01|August 2003|Actual|2003-08-01|June 2000|Actual|2000-06-01||Interventional|||Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer|A Phase II Trial of Dolastatin-10 (NSC 376128) Administered as an IV Bolus Every 3 Weeks in Patients With Hepatobiliary Cancer|Completed||Phase 2|16|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:18:55.749087|2017-02-18 18:18:55.749087
NCT00003556|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-07|||January 1999||1999-01-01|February 2013|2013-02-01||||May 2001|Actual|2001-05-01||Interventional|||Vaccine Therapy in Treating Patients With Melanoma|Phase Ib Trial of Intratumoral Injection of a Recombinant Canarypox Virus Encoding Human B7.1 (ALVAC-hB7.1) or a Combination of ALVAC-hB7.1 and a Recombinant Canarypox Virus Encoding Human Interleukin 12 (ALVAC-hIL-12) in Patients With Surgically Incurable Melanoma|Completed||Phase 1|15|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:55.873572|2017-02-18 18:18:55.873572
NCT00003555|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||July 1998||1998-07-01|May 2006|2006-05-01|May 2003|Actual|2003-05-01|||||Interventional|||Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors|Use of Weekly One Hour Paclitaxel Infusion With Dose Escalation for Recurrent and Resistant Cancers, Using Amifostine as a Cytoprotector|Completed||Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:55.980861|2017-02-18 18:18:55.980861
NCT00003554|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-17|||November 1998||1998-11-01|March 2008|2008-03-01|April 2004|Actual|2004-04-01|||||Interventional|||Rituximab in Treating Patients With Multiple Myeloma|Rituxan in the Management of Multiple Myeloma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:56.079155|2017-02-18 18:18:56.079155
NCT00003553|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-06-23|||January 1999||1999-01-01|June 2009|2009-06-01||||December 2009|Anticipated|2009-12-01||Interventional|||Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer|A Phase II Study of HLA-Matched Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation for Metastatic Renal Cell Carcinoma Followed by Allogeneic T-Cell Infusion as Adoptive Immunotherapy|Unknown status|Recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)||6|||f||||||||||||||2017-02-18 18:18:56.186217|2017-02-18 18:18:56.186217
NCT00003552|ClinicalTrials.gov processed this data on February 17, 2017|2007-03-01|2015-04-27|||January 1999||1999-01-01|December 2001|2001-12-01|October 2002|Actual|2002-10-01|||||Interventional|||Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma|Phase I/II Study of HLA-Matched Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation Followed by Allogeneic T-cell Infusion as Adoptive Immunotherapy in Patients With Metastatic Melanoma|Terminated||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:56.313032|2017-02-18 18:18:56.313032
NCT00003551|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||August 1998||1998-08-01|July 2000|2000-07-01|September 2004|Actual|2004-09-01|||||Interventional|||Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer|A Phase II Study of 9-Amino-20(S)-Camptothecin (9-AC) (NSC 603071) and Evaluation of Drug Resistance in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:56.411433|2017-02-18 18:18:56.411433
NCT00003549|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-05|||October 1998||1998-10-01|October 2012|2012-10-01|January 2003|Actual|2003-01-01|September 2001|Actual|2001-09-01||Interventional|||S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer|A Phase II Trial of Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma)|Completed||Phase 2|80|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:18:56.497729|2017-02-18 18:18:56.497729
NCT00003548|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2011-03-25|||August 1998||1998-08-01|March 2011|2011-03-01||||December 2001|Actual|2001-12-01||Interventional|||Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity|Phase I Study of Intraperitoneal Administration of 9-Amino-20(S)-Camptothecin to Patients With Cancer Predominantly Confined to the Peritoneal Cavity|Completed||Phase 1|20|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:18:56.66357|2017-02-18 18:18:56.66357
NCT00003546|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|||September 1998||1998-09-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|December 2003|Actual|2003-12-01||Interventional|||Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer|Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas|Completed||Phase 2|43|Actual|Alliance for Clinical Trials in Oncology||1|||f||||||||||||||2017-02-18 18:18:56.761722|2017-02-18 18:18:56.761722
NCT00003545|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||August 1998||1998-08-01|April 2007|2007-04-01||||March 2007|Actual|2007-03-01||Interventional|||506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma|A Phase II Study of 506U78 in Patients With Refractory or Relapsed T-Lineage Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphomas (LBL)|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:57.216941|2017-02-18 18:18:57.216941
NCT00003544|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||June 1998||1998-06-01|June 2013|2013-06-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Irinotecan in Treating Patients With Metastatic Colorectal Cancer|A Phase II Trial of Preoperative Irinotecan (CPT-11) in Patients With High-Risk Resectable Metastatic Colorectal Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:57.458214|2017-02-18 18:18:57.458214
NCT00003543|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||June 1998||1998-06-01|June 2013|2013-06-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer|Phase I Study of Combination Immunochemotherapy in Patients With Advanced Colorectal Carcinoma|Completed||Phase 1|18|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:57.558484|2017-02-18 18:18:57.558484
NCT00003542|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||May 1998||1998-05-01|June 2013|2013-06-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Interferon Alfa in Treating Patients With Advanced Kidney Cancer|Phase I/II Study of Subcutaneous Administration of Pegylated-Interferon Alpha-2A (RO 25-8310) in Previously Untreated Patients With Locally Advanced or Metastatic Renal Cell Carcinoma|Completed||Phase 1/Phase 2|58|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:57.658789|2017-02-18 18:18:57.658789
NCT00003541|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||June 1998||1998-06-01|June 2013|2013-06-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma|High Dose Combined Modality Therapy With Peripheral Blood Progenitor Cell Transplantation as Primary Treatment for Patients With Mantle Cell Lymphoma|Completed||Phase 1/Phase 2|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:57.757583|2017-02-18 18:18:57.757583
NCT00003540|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||June 1998||1998-06-01|June 2013|2013-06-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel|Phase II Study of Gemcitabine in the Treatment of Patients With Metastatic Breast Cancer Previously Treated With Adriamycin and Taxol|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:57.862804|2017-02-18 18:18:57.862804
NCT00003539|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||April 1998||1998-04-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer|Phase II Study of Weekly 1-Hour Paclitaxel (Taxol) Plus Recombinant Humanized Anti-p185HER2 Monoclonal Antibody (Herceptin) in the Treatment of Patients With Metastatic Breast Cancer|Completed||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:18:57.96221|2017-02-18 18:18:57.96221
NCT00003538|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-01|||March 1997||1997-03-01|May 2014|2014-05-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation|Stem Cell Augmented, Elutriated Grafts for Allogeneic Bone Marrow Transplantation|Completed||N/A|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:18:58.062626|2017-02-18 18:18:58.062626
NCT00003537|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-06-09|||April 1995||1995-04-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Anaplastic Astrocytoma|Unknown status|Recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:58.184467|2017-02-18 18:18:58.184467
NCT00003535|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-07-14|||August 1993||1993-08-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma|Phase II Study of Antineoplastons A10 and AS2-1 in Children With High Grade Glioma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:58.39135|2017-02-18 18:18:58.39135
NCT00003534|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:58.487261|2017-02-18 18:18:58.487261
NCT00003533|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:58.568433|2017-02-18 18:18:58.568433
NCT00003532|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Carcinoma of the Ovary|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:58.663863|2017-02-18 18:18:58.663863
NCT00003531|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-01-21|||April 1996||1996-04-01|October 2008|2008-10-01||||January 2008|Anticipated|2008-01-01||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Adenocarcinoma of the Pancreas|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:58.751497|2017-02-18 18:18:58.751497
NCT00003530|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Primary Liver Cancer|Phase II Study of Antineoplaston A10 in Patients With Primary Liver Cancer|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:58.845506|2017-02-18 18:18:58.845506
NCT00003528|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-15|||September 1998||1998-09-01|January 2013|2013-01-01||||June 2002|Actual|2002-06-01||Interventional|||Raltitrexed in Treating Children With Refractory Acute Leukemia|A Phase I Trial of Tomudex in Children With Leukemia|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:58.932754|2017-02-18 18:18:58.932754
NCT00003526|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-10-24|||March 1996||1996-03-01|October 2008|2008-10-01||||February 2008|Anticipated|2008-02-01||Interventional|||Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Adenocarcinoma of Unknown Primary|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:18:59.043566|2017-02-18 18:18:59.043566
NCT00003525|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Uterine Cervix and/or Vulva|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:59.14066|2017-02-18 18:18:59.14066
NCT00003524|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stomach Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Adenocarcinoma of the Stomach|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:59.23289|2017-02-18 18:18:59.23289
NCT00003523|ClinicalTrials.gov processed this data on February 17, 2017|2000-09-11|2013-06-20|||January 1999||1999-01-01|June 2005|2005-06-01|October 2007|Actual|2007-10-01|||||Interventional|||Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum|Evaluation of Aminocamptothecin (9-AC, NSC #603071) in Recurrent, Platinum Resistant and Refractory Ovarian Cancer and Primary Peritoneal Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:59.317753|2017-02-18 18:18:59.317753
NCT00003522|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Small Intestine|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:59.542057|2017-02-18 18:18:59.542057
NCT00003521|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Soft Tissue Sarcoma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:59.622918|2017-02-18 18:18:59.622918
NCT00003520|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Kidney|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:18:59.709819|2017-02-18 18:18:59.709819
NCT00003519|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-27|||August 1998||1998-08-01|January 2010|2010-01-01||||January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy in Treating Women With Breast Cancer|Phase III Study of Adriamycin/Taxotere Versus Adriamycin/Cytoxan for the Adjuvant Treatment of Node Positive or High Risk Node Negative Breast Cancer|Completed||Phase 3|2778|Anticipated|Eastern Cooperative Oncology Group|||||||||t||||||||||2017-02-18 18:18:59.798671|2017-02-18 18:18:59.798671
NCT00003518|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||January 1999||1999-01-01|January 2010|2010-01-01||||July 2002|Actual|2002-07-01||Interventional|||Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors|Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors|Completed||Phase 2|44|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:19:03.030786|2017-02-18 18:19:03.030786
NCT00003517|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer|Phase II Study of Antineoplastons A10 and AS2-1 Capsules With Total Androgen Blockade in Patients With Stage III or IV Adenocarcinoma of the Prostate|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:03.144931|2017-02-18 18:19:03.144931
NCT00003516|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer|Phase II Study of Antineoplaston A10 and AS2-1 Capsules In Patients With Incurable, Stage C or D Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:03.245034|2017-02-18 18:19:03.245034
NCT00003515|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Primitive Neuroectodermal Tumor Outside the Central Nervous System|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:03.333214|2017-02-18 18:19:03.333214
NCT00003514|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Metastatic or Incurable Neuroendocrine Tumors|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:03.697418|2017-02-18 18:19:03.697418
NCT00003513|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Neuroblastoma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:03.792067|2017-02-18 18:19:03.792067
NCT00003512|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-11-16|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Macroglobulinemia of Waldenstrom|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:03.88243|2017-02-18 18:19:03.88243
NCT00003511|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-01-21|||April 1996||1996-04-01|October 2008|2008-10-01||||January 2008|Anticipated|2008-01-01||Interventional|||Antineoplaston Therapy in Treating Patients With Multiple Myeloma|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Multiple Myeloma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:03.969151|2017-02-18 18:19:03.969151
NCT00003509|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-05-23|||March 1996||1996-03-01|May 2009|2009-05-01||||February 2005|Actual|2005-02-01||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Melanoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Malignant Melanoma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:04.075951|2017-02-18 18:19:04.075951
NCT00003508|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||March 1996||1996-03-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Mesothelioma|Terminated||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1||Withdrawn due to slow enrollment|f||||||||||||||2017-02-18 18:19:04.173633|2017-02-18 18:19:04.173633
NCT00003505|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09||||||October 2006|2006-10-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Primary Central Nervous System Lymphoma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:04.27094|2017-02-18 18:19:04.27094
NCT00003502|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Stage II, III, or IV Mantle Cell Lymphoma|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:04.363521|2017-02-18 18:19:04.363521
NCT00003501|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Refractory High-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma, High Grade|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:04.455619|2017-02-18 18:19:04.455619
NCT00003500|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Refractory or Recurrent Intermediate-Grade Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma, Intermediate Grade|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:04.541472|2017-02-18 18:19:04.541472
NCT00003499|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-08-12|||March 1996||1996-03-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma|Phase II Study of Antineoplaston A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma Low Grade|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:04.629797|2017-02-18 18:19:04.629797
NCT00003498|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-01-21|||December 1996||1996-12-01|October 2008|2008-10-01||||January 2008|Anticipated|2008-01-01||Interventional|||Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:04.728082|2017-02-18 18:19:04.728082
NCT00003497|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 Capsules In Patients With Non Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:04.826883|2017-02-18 18:19:04.826883
NCT00003496|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Small Cell Carcinoma of the Lung|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:04.922834|2017-02-18 18:19:04.922834
NCT00003495|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Squamos Cell Carcinoma of the Lung|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:05.009484|2017-02-18 18:19:05.009484
NCT00003494|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Bronchial Alveolar Carcinoma of the Lung|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:05.094879|2017-02-18 18:19:05.094879
NCT00003493|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-17|||November 1998||1998-11-01|August 2001|2001-08-01|April 2004|Actual|2004-04-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Multiple Myeloma|Phase II Trial of Doxil, Vincristine and Decadron in Multiple Myeloma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:05.174035|2017-02-18 18:19:05.174035
NCT00003492|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-01-21|||April 1996||1996-04-01|October 2008|2008-10-01||||January 2008|Anticipated|2008-01-01||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Large Cell, Undifferentiated Or Poorly Differentiated Stage IV Carcinoma of the Lung|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:05.268865|2017-02-18 18:19:05.268865
NCT00003491|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Adenocarcinoma of the Lung|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:05.370884|2017-02-18 18:19:05.370884
NCT00003490|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||October 1998||1998-10-01|March 2001|2001-03-01|August 2003|Actual|2003-08-01|||||Interventional|||Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma|Phase II to Treat Multiple Myeloma Patients With Cytoxan and Vincristine After Cycling Myeloma Cells With rHuGM-CSF|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:05.460549|2017-02-18 18:19:05.460549
NCT00003489|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|July 2004|2004-07-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Head and Neck|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:05.55612|2017-02-18 18:19:05.55612
NCT00003487|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||May 1996||1996-05-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Adenocarcinoma of the Esophagus|Terminated||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1||Withdrawn due to slow enrollment|f||||||||||||||2017-02-18 18:19:05.929088|2017-02-18 18:19:05.929088
NCT00003486|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Colon Cancer|Phase II Study of Antineoplastons A10 and AS2-1 Capsules in Patients With Adenocarcinoma of the Colon|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:06.038769|2017-02-18 18:19:06.038769
NCT00003485|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Adenocarcinoma of the Colon|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:06.120077|2017-02-18 18:19:06.120077
NCT00003484|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-04-22|||September 1997||1997-09-01|April 2015|2015-04-01|March 2010|Actual|2010-03-01|November 2003|Actual|2003-11-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors|Phase I Study of Anti-Tenascin Monoclonal Antibody I-Labeled 81C6 Via Surgically Created Cystic Resection Cavity in the Treatment of Patients With Primary Brain Tumors After External Beam Radiotherapy|Completed||Phase 1|21|Actual|Duke University||1|||f||||||||||||||2017-02-18 18:19:06.20321|2017-02-18 18:19:06.20321
NCT00003483|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-28|2016-12-28||June 1998||1998-06-01|December 2016|2016-12-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Antineoplaston Therapy in Treating Patients With Meningioma|Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Meningioma|Terminated||Phase 2|3|Actual|Burzynski Research Institute||1||Slow accrual|f||||f||||||||No||2017-02-18 18:19:06.314557|2017-02-18 18:19:06.314557
NCT00003479|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-28|2016-12-28||July 1966||1966-07-01|December 2016|2016-12-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|||Antineoplaston Therapy in Treating Patients With Ependymoma|Phase II Study of Antineoplastons A10 and AS2-1 Infusions in Patients With Ependymoma|Terminated||Phase 2|9|Actual|Burzynski Research Institute||1||Slow accrual|f||||f||||||||No||2017-02-18 18:19:06.553657|2017-02-18 18:19:06.553657
NCT00003478|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||October 1997||1997-10-01|February 2013|2013-02-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors|Phase I Study of Intra-Tumoral, Radiolabeled, Anti-Tenascin Monoclonal Antibody 81C6 in the Treatment of Patients With Malignant Primary Brain Tumors|Completed||Phase 1/Phase 2|10|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:19:06.852572|2017-02-18 18:19:06.852572
NCT00003477|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-10-25|2016-08-04||June 1996||1996-06-01|October 2016|2016-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Interventional|VPG||Antineoplaston Therapy in Treating Children With Visual Pathway Glioma|Phase II Study of Antineoplastons A10 and AS2-1 Infusions in Children With Visual Pathway Glioma|Completed||Phase 2|12|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:06.960953|2017-02-18 18:19:06.960953
NCT00003476|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-06-09|||March 1996||1996-03-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors|Phase II Study of Antineoplastons A10 and AS2-1 in Children With Primary Malignant Brain Tumors|Unknown status|Recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:07.271107|2017-02-18 18:19:07.271107
NCT00003410|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||July 1998||1998-07-01|May 2006|2006-05-01|June 2004|Actual|2004-06-01|||||Interventional|||Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas|Pilot Trial of Gadolium Texaphyrin for Magnetic Resonance Imaging-Guided Resection of High Grade Gliomas|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:16.518256|2017-02-18 18:19:16.518256
NCT00003475|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-10-26|2016-10-26||February 1996||1996-02-01|October 2016|2016-10-01|May 2011|Actual|2011-05-01|May 2011|Actual|2011-05-01||Interventional|||Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Primary Malignant Brain Tumors|Completed||Phase 2|40|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:07.374439|2017-02-18 18:19:07.374439
NCT00003473|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-14|2016-08-24||March 1996||1996-03-01|December 2016|2016-12-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Mixed Glioma|Completed||Phase 2|20|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:07.674372|2017-02-18 18:19:07.674372
NCT00003472|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-07-14|||May 1996||1996-05-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Oligodendroglioma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:07.965171|2017-02-18 18:19:07.965171
NCT00003471|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Low Grade Astrocytoma|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:08.055795|2017-02-18 18:19:08.055795
NCT00003470|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-28|2016-10-25||March 1996||1996-03-01|December 2016|2016-12-01|December 2009|Actual|2009-12-01|December 2008|Actual|2008-12-01||Interventional|AA||Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma|Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients With Anaplastic Astrocytoma|Completed||Phase 2|27|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:08.148675|2017-02-18 18:19:08.148675
NCT00003469|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-07-14|||February 1996||1996-02-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System|Phase II Study of Antineoplastons A10 and AS2-1 in Children With Rhabdoid Tumor of the Central Nervous System|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:08.724375|2017-02-18 18:19:08.724375
NCT00003468|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-10|2016-09-22||July 1996||1996-07-01|November 2016|2016-11-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma|Phase II Study of Antineoplastons A10 and AS2-1 in Children With Low Grade Astrocytoma|Completed||Phase 2|11|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:08.823283|2017-02-18 18:19:08.823283
NCT00003467|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-19|||January 1998||1998-01-01|October 2009|2009-10-01|February 2004|Actual|2004-02-01|||||Interventional|||Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma|Phase II Treatment of Adults With Recurrent Supratentorial Low Grade Glioma With Gliadel Wafers|Completed||Phase 2|68|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:19:09.152906|2017-02-18 18:19:09.152906
NCT00003466|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-07|||March 1998||1998-03-01|February 2013|2013-02-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|||Temozolomide in Treating Patients With Progressive Low-Grade Glioma|Phase II Treatment of Adults and Children With Progressive Low Grade Gliomas With Temodal|Completed||Phase 2|100|Anticipated|Duke University|||||f||||f||||||||||2017-02-18 18:19:09.250493|2017-02-18 18:19:09.250493
NCT00003465|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-19|||March 1998||1998-03-01|October 2009|2009-10-01|February 2001|Actual|2001-02-01|||||Interventional|||Temozolomide in Treating Patients With Anaplastic Oligodendroglioma|Phase II Treatment of Adults With Newly Diagnosed, Progressive or Recurrent Primary Malignant Anaplastic Oligodendroglioma With Temodal|Completed||Phase 2|60|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:19:09.360705|2017-02-18 18:19:09.360705
NCT00003464|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-19|||September 1997||1997-09-01|October 2009|2009-10-01|August 2003|Actual|2003-08-01|||||Interventional|||Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme|Phase II Treatment of Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme With Temodal|Completed||Phase 2|50|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:19:09.453524|2017-02-18 18:19:09.453524
NCT00003463|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||July 1998||1998-07-01|February 2013|2013-02-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas|Phase I Treatment of Adults With Recurrent Supratentorial High Grade Glioma With Gliadel Wafers Plus Irinotecan (CPT-11)|Completed||Phase 1|||Duke University|||||f||||||||||||||2017-02-18 18:19:09.553505|2017-02-18 18:19:09.553505
NCT00003462|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||April 1998||1998-04-01|February 2013|2013-02-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors|Phase I Study of Intrathecal Spartaject-Busulfan in Patients With Neoplastic Meningitis|Completed||Phase 1|20|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:19:09.659024|2017-02-18 18:19:09.659024
NCT00003461|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-20|||February 1998||1998-02-01|February 2013|2013-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors|Phase I Study of At-Labeled Anti-Tenascin Human/Mouse Chimeric Monoclonal Antibody 81C6 (ch81C6) Via Surgically Created Cystic Resection Cavity in the Treatment of Patients With Primary or Metastatic Brain Tumors|Completed||Phase 1/Phase 2|||Duke University||1|||f||||||||||||||2017-02-18 18:19:09.758114|2017-02-18 18:19:09.758114
NCT00003460|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-10|2016-09-22||April 1996||1996-04-01|November 2016|2016-11-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|PNET||Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors|Phase II Study of Antineoplastons A10 and AS2-1 In Children With Primitive Neuroectodermal Tumors|Completed||Phase 2|13|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:09.867163|2017-02-18 18:19:09.867163
NCT00003459|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-08-18|2016-05-25||March 1996||1996-03-01|August 2016|2016-08-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Antineoplaston Therapy in Treating Patients With Brain Stem Glioma|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Brain Stem Glioma|Completed||Phase 2|40|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:10.182854|2017-02-18 18:19:10.182854
NCT00003458|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-22|2016-09-22||September 1996||1996-09-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Antineoplaston Therapy in Treating Children With Brain Tumors|Phase II Study of Antineoplastons A10 and AS2-1 in Children With Brain Tumors|Completed||Phase 2|34|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:10.518854|2017-02-18 18:19:10.518854
NCT00003457|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-28|2016-10-25||July 1996||1996-07-01|December 2016|2016-12-01|February 2012|Actual|2012-02-01|February 2012|Actual|2012-02-01||Interventional|||Antineoplaston Therapy in Treating Patients With Brain Tumors|Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Brain Tumors.|Completed||Phase 2|40|Actual|Burzynski Research Institute||1|||f||||f||||||||No||2017-02-18 18:19:10.831697|2017-02-18 18:19:10.831697
NCT00003456|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||November 1998||1998-11-01|July 2004|2004-07-01||||||||Interventional|||Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Glioblastoma Multiforme|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:11.143482|2017-02-18 18:19:11.143482
NCT00003455|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09||||||December 2006|2006-12-01||||||||Interventional|||Antineoplaston Therapy in Treating Women With Advanced Breast Cancer|Phase II Study of Oral Antineoplastons A10 and AS2-1 in Women With Advanced Breast Cancer|Withdrawn||Phase 2|0|Actual|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:11.224239|2017-02-18 18:19:11.224239
NCT00003454|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||August 1998||1998-08-01|April 2004|2004-04-01||||||||Interventional|||Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Breast|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:11.580024|2017-02-18 18:19:11.580024
NCT00003453|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-06-09|||August 1996||1996-08-01|June 2009|2009-06-01||||December 2011|Anticipated|2011-12-01||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Adrenal Gland|Unknown status|Recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:11.665838|2017-02-18 18:19:11.665838
NCT00003452|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-10-22|||May 1996||1996-05-01|October 2008|2008-10-01||||August 2005|Anticipated|2005-08-01||Interventional|||Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer or Stage IV Newly Diagnosed, Incurable Bladder Cancer|Phase II Study of Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:11.759919|2017-02-18 18:19:11.759919
NCT00003451|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-31|||August 1998||1998-08-01|July 2007|2007-07-01||||December 2001|Actual|2001-12-01||Interventional|||Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer|Phase I Trial of Interleukin-12 Followed by Interferon-Alpha|Completed||Phase 1|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:11.855887|2017-02-18 18:19:11.855887
NCT00003450|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||September 1998||1998-09-01|June 2002|2002-06-01||||||||Interventional|||Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer|Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Patients With Advanced Recurrent or Persistent Ovarian Cancer|Unknown status|Active, not recruiting|Phase 1|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:11.976366|2017-02-18 18:19:11.976366
NCT00003449|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||May 1998||1998-05-01|May 2014|2014-05-01|February 2004|Actual|2004-02-01|June 2002|Actual|2002-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer|Phase II Study of Weekly Paclitaxel and Gemcitabine in Platinum-Resistant Ovarian Cancer|Completed||Phase 2|35|Actual|University of Southern California|||||f||||t||||||||||2017-02-18 18:19:12.06098|2017-02-18 18:19:12.06098
NCT00003447|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||July 1998||1998-07-01|September 2007|2007-09-01||||||||Interventional|||Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Vinorelbine Versus Gemcitabine Versus Gemcitabine and Vinorelbine in Elderly Patients With Stage IIIB-IV Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|630|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:12.164059|2017-02-18 18:19:12.164059
NCT00003446|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||December 1997||1997-12-01|September 2001|2001-09-01|August 2005|Actual|2005-08-01|||||Interventional|||Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer|Phase II Trial of Trimetrexate (Neutrexin), 5-Fluorouracil and Leucovorin in Metastatic Colorectal Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:12.265337|2017-02-18 18:19:12.265337
NCT00003445|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||December 1997||1997-12-01|September 2001|2001-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Docetaxel in Treating Patients With Advanced Cancer of the Cervix|Neoadjuvant Chemotherapy With Docetaxel in Advanced Cervical Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:12.375425|2017-02-18 18:19:12.375425
NCT00003444|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||October 1998||1998-10-01|January 2010|2010-01-01||||September 2003|Actual|2003-09-01||Interventional|||Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin|A Prospective Randomized Phase III Clinical Trial Assessing the Role of Post-Operative Radiotherapy Plus Adjuvant Interferon Alpha-2b in Patients With Cervical, Axillary, and Inguinal Nodal Metastasis From Cutaneous Melanoma|Completed||Phase 3|167|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-02-18 18:19:12.464589|2017-02-18 18:19:12.464589
NCT00003443|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||July 1998||1998-07-01|June 2013|2013-06-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer|A Phase II Trial of Bryostatin-1 In Patients With Metastatic or Recurrent Squamos Cell Carcinoma of the Head and Neck|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:12.58|2017-02-18 18:19:12.58
NCT00003441|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||August 1998||1998-08-01|July 2012|2012-07-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Irofulven in Treating Patients With Metastatic Colorectal Cancer|Phase II Study of MGI-114 (NSC# 683863) Administered Intravenously for Five Days Every 28 Days to Patients With Metastatic Colorectal Cancer|Completed||Phase 2|26|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:19:12.6809|2017-02-18 18:19:12.6809
NCT00003250|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-04-09|||May 1998||1998-05-01|April 2014|2014-04-01|December 2008|Actual|2008-12-01|December 2008|Actual|2008-12-01||Interventional|||Fenretinide in Treating Patients With Solid Tumors|Phase I Evaluation of Fenretinide (NSC# 374551)|Completed||Phase 1|31|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 18:19:44.837532|2017-02-18 18:19:44.837532
NCT00003440|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-03|||July 1998||1998-07-01|June 2013|2013-06-01||||July 2004|Actual|2004-07-01||Interventional|||Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic|A Phase III Study of Paclitaxel Via Weekly 1 Hour Infusion Versus Standard 3 Hour Infusion Every 3 Weeks With Herceptin (Trastuzumab) (NSC #688097) in the Treatment of Patients With/Without HER-2/Neu-Overexpressing Metastatic Breast Cancer|Completed||Phase 3|580|Actual|National Cancer Institute (NCI)||6|||f||||||||||||||2017-02-18 18:19:12.798248|2017-02-18 18:19:12.798248
NCT00003439|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-06|||August 1998||1998-08-01|April 2007|2007-04-01||||May 2001|Actual|2001-05-01||Interventional|||Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer|A Phase I Dose-Escalating Study of Recombinant Human Interleukin-12 (NSC # 672423) Administered by Intraperitoneal Infusion in Refractory Advanced Stage Ovarian Cancer and Other Abdominal Carcinomatosis|Completed||Phase 1|36|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:12.92417|2017-02-18 18:19:12.92417
NCT00003437|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||January 1997||1997-01-01|February 2003|2003-02-01||||||||Interventional|||Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia|Medical Research Council Working Party on Leukaemia in Children UK National Lymphoblastic Leukaemia (ALL) Trial|Unknown status|Active, not recruiting|Phase 3|1800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:13.030009|2017-02-18 18:19:13.030009
NCT00003436|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||July 1998||1998-07-01|December 2000|2000-12-01|December 2005|Actual|2005-12-01|||||Interventional|||Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia|Medical Research Council Working Party on Leukaemia in Childhood Acute Myeloid Leukaemia Trial 12|Completed||Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:13.144324|2017-02-18 18:19:13.144324
NCT00003435|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-06|||May 1998||1998-05-01|December 2000|2000-12-01||||||||Interventional|||Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer|A Pilot Study Involving Administration of Combination Anti-Retroviral Therapy and Transplantation of HLA-Matched Sibling Peripheral Blood Stem Cells or Partially HLA-Matched Unrelated Umbilical Cord Blood In Adults With HIV Infection and Hematologic Malignancies|Withdrawn||Phase 1|0|Actual|Duke University|||||f||||||||||||||2017-02-18 18:19:13.26551|2017-02-18 18:19:13.26551
NCT00003434|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-07|||June 1998||1998-06-01|February 2014|2014-02-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer|A Pilot Study of Active Immunotherapy With Carcinoembryonic Antigen Peptide-Pulsed, Autologous Human Cultured Dendritic Cells in Patients With Resected, Stage I, II and III Pancreatic Adenocarcinoma Expressing Carcinoembryonic Antigen|Terminated||Phase 1|8|Actual|Duke University||1|||f||||f||||||||||2017-02-18 18:19:13.371991|2017-02-18 18:19:13.371991
NCT00003433|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||June 1998||1998-06-01|November 2002|2002-11-01|August 2003|Actual|2003-08-01|||||Interventional|||Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer|A Phase I/II Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous, Cultured Dendritic Cells After Complete Resection of Hepatic Metastases of Colorectal Carcinoma|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:13.473954|2017-02-18 18:19:13.473954
NCT00003432|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||June 1998||1998-06-01|November 2013|2013-11-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Immunotherapy in Treating Patients With Metastatic Breast Cancer|A Phase I/II Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous Cultured Dendritic Cells for Patients With Breast Cancer Who Achieve a Complete Response After High Dose Chemotherapy and Stem Cell Support|Terminated||Phase 1/Phase 2|4|Actual|Duke University||1||low accrual|f||||f||||||||||2017-02-18 18:19:13.568042|2017-02-18 18:19:13.568042
NCT00003431|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-04|||June 1998||1998-06-01|March 2013|2013-03-01|May 2001|Actual|2001-05-01|||||Interventional|||Flt3L in Treating Patients With Metastatic Colorectal Cancer|Pilot Study of FLT3 Ligand Prior to Resection of Hepatic Metastases of Colorectal Cancer|Completed||Phase 1|||Duke University|||||f||||||||||||||2017-02-18 18:19:13.678469|2017-02-18 18:19:13.678469
NCT00003430|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors|A Pharmacokinetic Study Evaluating the Safety, Tolerability and Maximally Tolerated Dose of 7-Day Continuous Infusions of L-778,123 in Patients With Recurrent of Refractory Solid Malignancies|Completed||Phase 1|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:13.788351|2017-02-18 18:19:13.788351
NCT00003429|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-12-17|||May 1998||1998-05-01|December 2015|2015-12-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery|A Pilot Study of 18F-Flourodeoxyglucose Positron Emission Tomography in the Diagnosis of Primary and Recurrent Cervical Cancer|Completed||N/A|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:13.874474|2017-02-18 18:19:13.874474
NCT00003428|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||May 1998||1998-05-01|June 2013|2013-06-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Hormone Therapy in Treating Women With Breast Cancer|Phase II Randomized Double-Blind Evaluation of Two Dose Levels of LY353381 Hydrochloride Administered to Women With Locally Advanced or Metastatic Breast Cancer|Completed||Phase 2|114|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:13.974297|2017-02-18 18:19:13.974297
NCT00003427|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer|Phase I Study to Evaluate the Combination Chemotherapy Regimen of Oxaliplatin Plus Irinotecan in Previously Treated Patients With Metastatic Gastrointestinal Cancer|Completed||Phase 1|36|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:14.063506|2017-02-18 18:19:14.063506
NCT00003426|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||April 1998||1998-04-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer|A Phase I Trial of Combined Modality Gemcitabine Plus Radiation Therapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:14.176255|2017-02-18 18:19:14.176255
NCT00003425|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-25|||December 1997||1997-12-01|April 2013|2013-04-01||||July 2002|Actual|2002-07-01||Interventional|||Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect|Phase I/II Study of Escalating Dose Melphalan With Autologous Pluripotent Hematopoietic Stem Cell Support and Amifostine Cytoprotection in Cancer Patients|Completed||Phase 1/Phase 2|25|Anticipated|University of Kentucky||1|||f||||t||||||||||2017-02-18 18:19:14.273937|2017-02-18 18:19:14.273937
NCT00003424|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||April 1997||1997-04-01|August 2009|2009-08-01|August 2009|Actual|2009-08-01|June 2000|Actual|2000-06-01||Interventional|||Tamoxifen in Treating Patients With Primary Liver Cancer|Randomised Trial of Tamoxifen Versus Placebo for the Treatment of Inoperable Hepatocellular Carcinoma|Completed||Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:14.419156|2017-02-18 18:19:14.419156
NCT00003423|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||May 1995||1995-05-01|April 2001|2001-04-01||||||||Interventional|||Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma T Cell Protocol|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:14.512656|2017-02-18 18:19:14.512656
NCT00003422|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||January 1998||1998-01-01|March 2007|2007-03-01|June 2010|Actual|2010-06-01|||||Interventional|||Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed|A Randomised Trial Comparing Pre-Operative Radiotherapy and Selective Post-Operative Chemoradiotherapy in Rectal Cancer|Completed||Phase 3|1800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:14.608597|2017-02-18 18:19:14.608597
NCT00003421|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||June 1998||1998-06-01|May 2007|2007-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease|A UKLG Randomised Trial of Initial Chemotherapy for Advanced Stage Hodgkins Disease|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:14.721891|2017-02-18 18:19:14.721891
NCT00003420|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||July 1997||1997-07-01|December 2002|2002-12-01|April 2010|Actual|2010-04-01|||||Interventional|||CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy|A Study of CT Scan Frequency in Patients With Stage I Testicular Teratoma|Completed||N/A|900|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:14.821544|2017-02-18 18:19:14.821544
NCT00003419|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||June 1998||1998-06-01|November 2001|2001-11-01||||||||Interventional|||Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma|Treatment of HIV-Related Kaposi's Sarcoma and Stage I-III Slow-Proliferative Disease With Highly Active Antiretroviral Therapy (HAART)|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:14.911045|2017-02-18 18:19:14.911045
NCT00003418|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||February 1998||1998-02-01|March 2008|2008-03-01||||||||Interventional|||Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer|Randomized Double-Blind Trial in Postmenopausal Women With Primary Breast Cancer Who Have Received Adjuvant Tamoxifen for 2-3 Years, Comparing Subsequent Adjuvant Exemestane Treatment With Further Tamoxifen|Unknown status|Active, not recruiting|Phase 3|4400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:15.009378|2017-02-18 18:19:15.009378
NCT00003417|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-14|||September 1998||1998-09-01|November 2015|2015-11-01||||May 2004|Actual|2004-05-01||Interventional|||Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme|Phase I/II Radiation Dose Escalation Study Applying Conformal Radiation Therapy in Supratentorial Glioblastoma Multiforme|Completed||Phase 1/Phase 2|40|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:19:15.124055|2017-02-18 18:19:15.124055
NCT00003416|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-03-05|||September 1998||1998-09-01|March 2015|2015-03-01|January 2004|Actual|2004-01-01|August 2000|Actual|2000-08-01||Interventional|||S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia|S9805, Phase II Study of Tandem High Dose Melphalan Supported by Peripheral Blood Stem Cell Support in Waldenstrom's Macroglobulinemia (WM)|Completed||Phase 2|9|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:19:15.763132|2017-02-18 18:19:15.763132
NCT00003415|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-30|||September 1998||1998-09-01|July 2000|2000-07-01|November 2002|Actual|2002-11-01|||||Interventional|||Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome|Phase I/II Study of Combined Treatment With Amifostine (Ethyol) and Topotecan (Hycamtin MS) in Patients With Myelodysplastic Syndrome|Completed||Phase 1/Phase 2|26|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:15.993048|2017-02-18 18:19:15.993048
NCT00003414|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-07-16|||October 1997||1997-10-01|July 2015|2015-07-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease|Randomized Trial of Autologous GVHD for Refractory Lymphoma|Completed||Phase 3|50|Anticipated|Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:19:16.100565|2017-02-18 18:19:16.100565
NCT00003413|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-09-23|||September 1998||1998-09-01|September 2009|2009-09-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer|High Dose Chemotherapy With Stem Cell Rescue in Recently Diagnosed Patients With Advanced (Stage III and IV) Ovarian Cancer With > 1 cm Residual Disease After Debulking Surgery|Completed||Phase 2|32|Anticipated|University of Maryland|||||f||||||||||||||2017-02-18 18:19:16.211413|2017-02-18 18:19:16.211413
NCT00003412|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||June 1998||1998-06-01|October 2001|2001-10-01||||||||Interventional|||Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation|Phase I Study of Post Transplant rhIL-12 High Dose Cyclophosphamide, Thiotepa, and Carboplatin in the Treatment of Metastatic Breast Carcinoma|Unknown status|Active, not recruiting|Phase 1|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:16.318168|2017-02-18 18:19:16.318168
NCT00003411|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-01-15|||November 1998||1998-11-01|January 2016|2016-01-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer|Phase I Dose Escalation and Pharmacokinetics Study of the Radiosensitizer, Gadolinium Texaphyrin (Gd-Tex, NSC 695238) With Concurrent Radiotherapy in Advanced Biliary Tree and Pancreatic Cancers|Completed||Phase 1|||University of Pittsburgh|||||f||||t||||||||||2017-02-18 18:19:16.415911|2017-02-18 18:19:16.415911
NCT00003409|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||July 1998||1998-07-01|June 2007|2007-06-01||||||||Interventional|||Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme|A Phase I Dose Escalating Study of the Safety and Tolerability of Gadolinium Texaphyrin as a Radiation Sensitizer in Patients With Primary Glioblastoma Multiforme|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:16.60998|2017-02-18 18:19:16.60998
NCT00003408|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-25|||April 1998||1998-04-01|April 2003|2003-04-01|March 2000|Actual|2000-03-01|||||Interventional|||Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer|Cytokine-Based Immunotherapy Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:16.711198|2017-02-18 18:19:16.711198
NCT00003407|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-05-09|||April 1998||1998-04-01|May 2006|2006-05-01||||||||Interventional|||Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia|Protocol for Treatment of Newly Diagnosed High Risk And Relapsed Acute Myeloid Leukemia and Blastic Crisis Chronic Myelogenous Leukemia With Ethyol and High-Dose Cytarabine + Mitoxantron Followed by Maintenance Phase Using Low-Dose ARA-C, rhGM-CSF, Pentoxifylline, Ciprofloxacin and Decadron|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:16.835614|2017-02-18 18:19:16.835614
NCT00003406|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-25|||October 1997||1997-10-01|July 2007|2007-07-01|March 2000|Actual|2000-03-01|||||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer|A Phase I-II Intensive-Dose Ifosfamide, Carboplatin and Taxotere (IC-T) Combination Chemotherapy Followed by Autologous Stem Cell Rescue for Patients With Refractory Malignancies|Completed||Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:16.945313|2017-02-18 18:19:16.945313
NCT00003405|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||April 1998||1998-04-01|February 2001|2001-02-01||||||||Interventional|||Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia|Treatment Protocol for Patients With Standard Risk Acute Myelogenous Leukemia and Its Variants: Induction Using High-Dose Cytarabine, Mitoxantrone and Ethyol; Consolidation With Cytarabine and Idarubicin and Maintenance With 13 Cis Retinoic Acid and Alpha Interferon|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:17.050349|2017-02-18 18:19:17.050349
NCT00003404|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-25|||January 1998||1998-01-01|October 2015|2015-10-01|December 2019|Anticipated|2019-12-01|December 2019|Anticipated|2019-12-01||Interventional|||Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast|A Prospective Study of Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors|Active, not recruiting||Phase 2|50|Anticipated|Dartmouth-Hitchcock Medical Center||1|||f||||t||||||||||2017-02-18 18:19:17.145769|2017-02-18 18:19:17.145769
NCT00003403|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-22|||August 1999||1999-08-01|February 2001|2001-02-01||||||||Interventional|||GPX-100 in Treating Patients With Solid Tumors|Phase I Safety and Efficacy Study of an Intravenous Formulation of the Anthracycline Analog, GPX-100, in the Treatment of Metastatic Breast Cancer|Completed||Phase 1|||Gem Pharmaceuticals|||||f||||||||||||||2017-02-18 18:19:17.245714|2017-02-18 18:19:17.245714
NCT00003402|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-09-23|||January 1999||1999-01-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|Autologous Transplantation With and High Dose BCNU and Melphalan Followed by Consolidation With DCEP Plus Taxol/Cisplatin in Patients With Poor Prognosis Low Grade Non-Hodgkin's Lymphoma and Chronic Lymphocyte Leukemia, Who Have Received < or = 12 Months of Standard Therapy|Completed||Phase 2|35|Anticipated|University of Maryland|||||f||||||||||||||2017-02-18 18:19:17.33348|2017-02-18 18:19:17.33348
NCT00003401|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||January 1999||1999-01-01|January 2001|2001-01-01||||||||Interventional|||Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma|Autologous Transplantation With Gemcitabine and High Dose BCNU Plus Melphalan Followed by Consolidation With DCEP Plus Gemcitabine and Taxol/Cisplatin in Patients With Multiple Myeloma and >12 Months of Standard Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:17.445373|2017-02-18 18:19:17.445373
NCT00003400|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-02-26|||September 1998||1998-09-01|June 2000|2000-06-01||||||||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer|High Dose Chemotherapy With Stem Cell Rescue Followed By Consolidation Treatment in Patients With Metastatic Hormone-Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:17.553617|2017-02-18 18:19:17.553617
NCT00003399|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||September 1998||1998-09-01|January 2001|2001-01-01||||||||Interventional|||Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma|Autologous Transplantation With High Dose BCNU and Melphalan Followed by Consolidation With DCEP and Taxol/Cisplatin in Patients With Multiple Myeloma and < or = 12 Months of Standard Therapy|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:17.657213|2017-02-18 18:19:17.657213
NCT00003398|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-09-23|||September 1998||1998-09-01|September 2009|2009-09-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Hematologic Cancer|Evaluation of Allogeneic Marrow Transplants Depleted of T-Cells by CD34+ Selection in Patients Undergoing Transplantation With an Unrelated Matched or 1 Antigen Mismatched Donor or a 1 Antigen Mismatched Related Donor|Completed||Phase 4|45|Anticipated|University of Maryland|||||f||||||||||||||2017-02-18 18:19:17.769561|2017-02-18 18:19:17.769561
NCT00003397|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-09-23|||September 1998||1998-09-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma|Autologous Stem Cell Transplantation for Poor Prognosis, Relapsed, or Refractory Intermediate-High Grade B-Cell Lymphoma Using Gemcitabine Plus High Dose BCNU and Melphalan Followed by Anti-CD20 Moab (IDEC C2B8, Rituximab, Rituxan) and Consolidative Chemotherapy|Completed||Phase 2|25|Anticipated|University of Maryland|||||f||||||||||||||2017-02-18 18:19:17.886694|2017-02-18 18:19:17.886694
NCT00003092|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||September 1997||1997-09-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|March 2006|Actual|2006-03-01||Interventional|||Paclitaxel in Treating Older Patients With Solid Tumors|Clinical Pharmacology of Paclitaxel in Relation to Patient Age|Completed||Phase 3|120|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:20:12.827795|2017-02-18 18:20:12.827795
NCT00003396|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-09-23|||September 1998||1998-09-01|September 2009|2009-09-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Evaluation of Allogeneic Peripheral Blood Stem Cell Transplants From a Related Donor Without Graft-Versus-Host Prophylaxis in Patients With High Risk of Relapse|Completed||Phase 2|42|Anticipated|University of Maryland|||||f||||||||||||||2017-02-18 18:19:18.081252|2017-02-18 18:19:18.081252
NCT00003395|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer|Dose-Ranging Study of Arsenic Trioxide in Advanced Hematologic Cancers|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:18.191023|2017-02-18 18:19:18.191023
NCT00003394|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||April 1998||1998-04-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer|Phase I/II Study of Weekly Intravenous Estramustine Phosphate in Combination With Paclitaxel and Carboplatin in Patients With Advanced Prostate Cancer|Completed||Phase 1/Phase 2|18|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:18.293602|2017-02-18 18:19:18.293602
NCT00003392|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-02-19|||September 1997||1997-09-01|February 2012|2012-02-01|January 2003|Actual|2003-01-01|August 2002|Actual|2002-08-01||Interventional|||High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer|Multiple Cycles of High Dose Chemotherapy Supported With Filgrastim and Peripheral Blood Progenitor Cells in Patients With Metastatic Breast Cancer|Completed||Phase 2|61|Actual|UNC Lineberger Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:19:18.390883|2017-02-18 18:19:18.390883
NCT00003391|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-10-09|||June 1998||1998-06-01|October 2009|2009-10-01||||||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy|Phase I Trial of Monoclonal Antibody muJ591 in Patients With Hormone-Independent Prostate Cancer|Completed||Phase 1|30|Anticipated|Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 18:19:18.512329|2017-02-18 18:19:18.512329
NCT00003390|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||June 1998||1998-06-01|May 2000|2000-05-01|August 2004|Actual|2004-08-01|||||Interventional|||6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer|A Phase II Trial of 6-Hydroxymethylacylfulvene (MGI-114) in Patients With Advanced Renal Cell Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:18.606296|2017-02-18 18:19:18.606296
NCT00003389|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-09-25|2015-08-05||April 1999||1999-04-01|September 2015|2015-09-01|May 2016|Anticipated|2016-05-01|September 2011|Actual|2011-09-01||Interventional||Eligible patients are included in the primary analysis.|Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma|A Randomized Phase III Trial of ABVD Versus Stanford V (+/-) Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease|Active, not recruiting||Phase 3|854|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-02-18 18:19:18.715551|2017-02-18 18:19:18.715551
NCT00003388|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||February 1999||1999-02-01|January 2010|2010-01-01||||April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma|A Phase II Study of Doxil (Liposomal Doxorubicin), Cyclophosphamide, Vincristine and Prednisone for AIDS-Related Systemic Lymphoma|Completed||Phase 2|38|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:19:23.661747|2017-02-18 18:19:23.661747
NCT00003387|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|||July 1998||1998-07-01|July 2016|2016-07-01|April 2009|Actual|2009-04-01|May 2007|Actual|2007-05-01||Interventional|||Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery|Concurrent Carboplatin, Paclitaxel, and Radiation Therapy Versus Induction Carboplatin and Paclitaxel Followed by Concurrent Carboplatin, Paclitaxel and Radiation Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer: A Phase III Trial|Completed||Phase 3|366|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:19:23.766729|2017-02-18 18:19:23.766729
NCT00003386|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-10|||July 1999||1999-07-01|December 2008|2008-12-01||||April 2001|Actual|2001-04-01||Interventional|||Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer|Treatment of Ovarian Carcinoma With DNP-Modified Autologous Tumor Vaccine|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:24.215498|2017-02-18 18:19:24.215498
NCT00003385|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-24|||March 1999||1999-03-01|September 2003|2003-09-01||||January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer|A Phase I Study of Paclitaxel, Carboplatin, and Increasing Doses of Doxil in Untreated Ovarian, Peritoneal, and Tubal Carcinoma|Completed||Phase 1|48|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:24.381125|2017-02-18 18:19:24.381125
NCT00003384|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-05-27|||September 1998||1998-09-01|May 2015|2015-05-01||||January 2011|Actual|2011-01-01||Interventional|||Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer|Expression of the MN Protein in Atypical Glandular Cells of Undetermined Significance (Agus or Agcus) As a Potential Diagnostic Biomarker of Cervical Dysplasia/Neoplasia|Completed||N/A|684|Actual|Gynecologic Oncology Group||1|||f||||||||||||||2017-02-18 18:19:24.484434|2017-02-18 18:19:24.484434
NCT00003382|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-07|||May 1998||1998-05-01|May 2006|2006-05-01||||April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer|A Phase I Study of Gemcitabine/Topotecan in Combination in Refractory Ovarian Cancer or Cancer of the Fallopian Tube|Terminated||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:24.594712|2017-02-18 18:19:24.594712
NCT00003381|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||July 1998||1998-07-01|July 2016|2016-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Observational|||Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]|Quality of Life and Cost Analysis of a Prospective Randomized Phase III Trial Comparing Trimodality Therapy to Surgery Alone for Esophageal Cancer [Companion to CALGB-9781]|Terminated||N/A|56|Actual|Alliance for Clinical Trials in Oncology|||1|companion study to CALGB-9781 which closed administratively due to poor accrual|f||||f||||||||||2017-02-18 18:19:24.706084|2017-02-18 18:19:24.706084
NCT00003380|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-07|||May 1998||1998-05-01|October 2002|2002-10-01||||July 2002|Actual|2002-07-01||Interventional|||Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer|A Phase I Study of Liposomal Doxorubicin (Doxil) and Prolonged Etoposide As Second Line Therapy in Ovarian, Tubal and Peritoneal Carcinoma|Terminated||Phase 1|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:24.833061|2017-02-18 18:19:24.833061
NCT00003379|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-24|||November 1999||1999-11-01|November 2004|2004-11-01||||January 2007|Actual|2007-01-01||Interventional|||Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer|A Phase I/II Study Of Whole Pelvic Radiation Therapy With Concomitant Paclitaxel and Cisplatin Chemotherapy in Patients With Cervical Carcinoma (Stages I-IV) Limited to the Pelvis|Completed||Phase 1/Phase 2|40|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:24.993019|2017-02-18 18:19:24.993019
NCT00003378|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-08|||August 1998||1998-08-01|December 2011|2011-12-01||||February 2000|Actual|2000-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer|A Phase I Feasibility Trial of Carboplatin, Paclitaxel, and Gemcitabine in Patients With Previously Untreated Epithelial Ovarian Carcinoma and Primary Peritoneal Carcinoma|Terminated||Phase 1|45|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:25.214186|2017-02-18 18:19:25.214186
NCT00003377|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-12-27|2012-11-23||November 1999||1999-11-01|December 2012|2012-12-01|July 2009|Actual|2009-07-01|July 2009|Actual|2009-07-01||Interventional|||Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix|A Phase I Study of Extended Field Radiation Therapy With Concomitant Paclitaxel and Cisplatin Chemotherapy in Patients Cervical Carcinoma Metastatic to the Para-Aortic Lymph Nodes|Completed||Phase 1|29|Actual|Gynecologic Oncology Group||1|||f||||t||||||||||2017-02-18 18:19:25.581899|2017-02-18 18:19:25.581899
NCT00003376|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||September 1998||1998-09-01|January 2010|2010-01-01||||September 2005|Actual|2005-09-01||Interventional|||Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium|Phase III Trial of Methotrexate, Vinblastine, Doxorubicin and Cisplatin vs Carboplatin and Paclitaxel in Advanced Carcinoma of the Urothelium|Completed||Phase 3|330|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-02-18 18:19:26.873497|2017-02-18 18:19:26.873497
NCT00003375|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-09-28|||October 1998||1998-10-01|September 2016|2016-09-01||||August 2005|Actual|2005-08-01||Interventional|||Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma|A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase II Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma|Active, not recruiting||Phase 2/Phase 3|370|Actual|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-02-18 18:19:27.034863|2017-02-18 18:19:27.034863
NCT00003372|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-07|||December 1997||1997-12-01|November 2010|2010-11-01|December 2009||2009-12-01|||||Interventional|||Topotecan in Treating Patients With Recurrent Brain Tumors|A Phase II Study of Topotecan in Patients With Anaplastic Oligodendroglioma or Anaplastic Mixed Oligoastrocytoma|Completed||Phase 2|30|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:19:27.14668|2017-02-18 18:19:27.14668
NCT00003370|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||August 1998||1998-08-01|May 2006|2006-05-01||||March 2006|Actual|2006-03-01||Interventional|||Irofulven in Treating Children With Recurrent or Refractory Solid Tumors|A Trial of MGI 114 in Children With Solid Tumors: A Pediatric Oncology Group Phase I Cooperative Agreement Study|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:27.244738|2017-02-18 18:19:27.244738
NCT00003369|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-13|||August 1998||1998-08-01|June 2012|2012-06-01|July 2004|Actual|2004-07-01|October 2003|Actual|2003-10-01||Interventional|||S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer|Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer|Completed||Phase 2|56|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:19:27.485682|2017-02-18 18:19:27.485682
NCT00003368|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-19|||June 1998||1998-06-01|July 2006|2006-07-01|July 2006|Actual|2006-07-01|||||Interventional|||Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis|Phase I Study of Irinotecan for Patients With Abnormal Liver or Renal Function or With Prior Pelvic Radiation Therapy|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:27.889072|2017-02-18 18:19:27.889072
NCT00003367|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Diet and PSA Levels in Patients With Prostate Cancer|The Effect of a Low Fat Diet, High in Soy, Fruits, Vegetables, Green Tea, Vitamin E and Fiber on the PSA in Patients With Prostate Cancer|Completed||Phase 3|154|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:28.033957|2017-02-18 18:19:28.033957
NCT00003365|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-01-26|||August 1996||1996-08-01|January 2011|2011-01-01|July 2006|Actual|2006-07-01|July 2006|Actual|2006-07-01||Interventional|||Sulindac and Plant Compounds in Preventing Colon Cancer|The Effect of Plant Phenolic Compounds on Human Colon Epithelial Cells|Terminated||N/A|||Rutgers, The State University of New Jersey||||Study completed|f||||f||||||||||2017-02-18 18:19:28.12263|2017-02-18 18:19:28.12263
NCT00003364|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||January 1993||1993-01-01|May 2007|2007-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer|A Randomised Study of Timing of Thoracic Irradiation in Small Cell Lung Cancer (Study 8)|Completed||Phase 3|398|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:28.215663|2017-02-18 18:19:28.215663
NCT00003362|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||May 1998||1998-05-01|June 2013|2013-06-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma|Pilot Trial of Multi-Epitope Melanoma Peptide Vaccine Using GM-CSF, Montanide and QS-21 as Adjuvants|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:28.327813|2017-02-18 18:19:28.327813
NCT00003361|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||April 1998||1998-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|September 2003|Actual|2003-09-01||Interventional|||Decitabine in Treating Patients With Myelodysplastic Syndrome|Phase II Study With Decitabine (5-aza-2'-Deoxycytidine, DAC) in Myelodysplastic Syndromes|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:28.421672|2017-02-18 18:19:28.421672
NCT00003360|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-15|||April 1998||1998-04-01|January 2013|2013-01-01||||August 2000|Actual|2000-08-01||Interventional|||Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer|Phase I Study of 131I-Labeled Humanized Antibody A33 in Patients With Advanced Colorectal Carcinoma|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:28.514592|2017-02-18 18:19:28.514592
NCT00003359|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||April 1998||1998-04-01|June 2013|2013-06-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||T138067 Sodium in Treating Patients With Advanced Refractory Cancer|Phase I Dose Escalation Study to Evaluate the Safety of T138067-Sodium in Patients With Advanced Refractory Cancer|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:28.615814|2017-02-18 18:19:28.615814
NCT00003358|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-15|||January 1998||1998-01-01|January 2013|2013-01-01||||January 2001|Actual|2001-01-01||Interventional|||Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer|Phase I Trial Intraperitoneal Cisplatin With Intraperitoneal Gemcitabine in Patients With Epithelial Ovarian Carcinoma|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:28.701813|2017-02-18 18:19:28.701813
NCT00003357|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-12-11|||January 1998||1998-01-01|December 2012|2012-12-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease|Vaccination of High Risk Breast Cancer Patients Lacking Identifiable Disease With GM2-KLH Conjugate Plus the Immunological Adjuvant QS21|Completed||Phase 1|9|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:28.79349|2017-02-18 18:19:28.79349
NCT00003356|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-10-14|||November 1997||1997-11-01|October 2013|2013-10-01|May 2002|Actual|2002-05-01|May 2002|Actual|2002-05-01||Interventional|||Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma|A Phase II Study of Rituxan and IL-2 in Patients With Low Grade or Follicular B-Cell Lymphoma|Completed||Phase 1/Phase 2|58|Anticipated|University of Rochester|||||f||||||||||||||2017-02-18 18:19:28.879801|2017-02-18 18:19:28.879801
NCT00003354|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||July 1996||1996-07-01|January 2001|2001-01-01|December 2009|Actual|2009-12-01|||||Interventional|||Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer|Conventional Versus Laparoscopic-Assisted Surgery in Colorectal Cancer|Completed||Phase 3|1200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:28.977168|2017-02-18 18:19:28.977168
NCT00003353|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||July 1998||1998-07-01|August 2013|2013-08-01||||December 2002|Actual|2002-12-01||Interventional|||High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis|A Phase II Study of High-Dose Melphalan With Hematopoietic Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:19:29.087391|2017-02-18 18:19:29.087391
NCT00003352|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-12-10|||June 1998||1998-06-01|December 2012|2012-12-01|December 2002|Actual|2002-12-01|September 2000|Actual|2000-09-01||Interventional|||Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer|A Phase II Study in Patients With Metastatic or Locally Advanced Breast Cancer to Evaluate the Worth of the Combination of Adriamycin (Doxorubicin), Taxotere (Docetaxel), and Cyclophosphamide (ATC)|Completed||Phase 2|89|Actual|NSABP Foundation Inc||1|||f||||t||||||||||2017-02-18 18:19:29.205484|2017-02-18 18:19:29.205484
NCT00003351|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||August 1998||1998-08-01|July 2016|2016-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer|Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer|Completed||Phase 2|104|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:19:29.580479|2017-02-18 18:19:29.580479
NCT00003350|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-09|||March 1999||1999-03-01|January 2013|2013-01-01||||March 2007|Actual|2007-03-01||Interventional|||Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma|Phase III Study of Paclitaxel Versus Liposomal Doxorubicin for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma|Completed||Phase 3|240|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:19:29.904435|2017-02-18 18:19:29.904435
NCT00003348|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||May 1998||1998-05-01|February 2013|2013-02-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain|Phase I Trial of BCNU Plus O6-Benzylguanine in the Treatment of Patients With Recurrent, Persistent or Progressive Cerebral Anaplastic Gliomas|Completed||Phase 1|56|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:19:30.021257|2017-02-18 18:19:30.021257
NCT00003346|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||November 1997||1997-11-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma|Phase I-II Trial of High-Dose Acetaminophen With Carmustine in Patients With Metastatic Melanoma|Completed||Phase 2|80|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:30.115998|2017-02-18 18:19:30.115998
NCT00003345|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||October 1997||1997-10-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer|Phase II Trial of Cisplatin and Irinotecan in Patients With Suboptimally Debulked, Incompletely Responding Ovarian Cancer|Completed||Phase 2|35|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:30.207957|2017-02-18 18:19:30.207957
NCT00003344|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-04-26|||August 1998||1998-08-01|April 2012|2012-04-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer|Phase I-II Study of Weekly CPT-11 and Radiation Therapy for Unresectable or Locally Recurrent Large Bowel Cancer|Completed||Phase 1/Phase 2|49|Anticipated|Medical University of South Carolina|||||f||||t||||||||||2017-02-18 18:19:30.306141|2017-02-18 18:19:30.306141
NCT00003343|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-07|||March 1998||1998-03-01|August 2012|2012-08-01||||January 2001|Actual|2001-01-01||Interventional|||Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer|A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Matrix Metalloprotease Inhibitor AG3340 in Combination With Mitoxantrone and Prednisone With Provision for Subsequent Change in Therapy in Patients Having Hormone-Refractory Prostate Cancer|Completed||Phase 3|525|Anticipated|Pfizer|||||f||||||||||||||2017-02-18 18:19:30.404384|2017-02-18 18:19:30.404384
NCT00003342|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-02|||December 1997||1997-12-01|July 2013|2013-07-01|July 2007|Actual|2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer|Phase I Trial of Dose-Dense Gemcitabine, Doxorubicin, Then Paclitaxel Plus Carboplatin In Patients With Transitional Cell Carcinoma of the Urothelium and Impaired Renal Function|Completed||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:30.50707|2017-02-18 18:19:30.50707
NCT00003341|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||December 1997||1997-12-01|July 2013|2013-07-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy|The Effects of Procrit (Epoetin Alfa) on Hemoglobin Symptom Distress and Quality of Life During Chemotherapy in Lymphoma Patients With Mild to Moderate Anemia A Multicenter Trial|Completed||Phase 3|275|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:30.607498|2017-02-18 18:19:30.607498
NCT00003340|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-01|||November 1997||1997-11-01|May 2014|2014-05-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia|A Phase II Study of Cyclophosphamide Followed by Topotecan in Patients With Refractory or Relapsed Acute Myelogenous Leukemia|Completed||Phase 2|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:19:30.72622|2017-02-18 18:19:30.72622
NCT00003339|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||November 1998||1998-11-01|May 2014|2014-05-01|September 2004|Actual|2004-09-01|November 1999|Actual|1999-11-01||Interventional|||Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma|A Randomized Phase II Trial of a Vaccine Combining Tyrosinase/gp100 Peptides Emulsified With Montanide ISA 51 With and Without Interleukin-12 for Patients With Resected Stages III and IV Melanoma|Completed||Phase 2|48|Actual|University of Southern California|||||f||||t||||||||||2017-02-18 18:19:30.813348|2017-02-18 18:19:30.813348
NCT00003338|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||March 1997||1997-03-01|December 2001|2001-12-01||||||||Interventional|||Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma|The Utility of LymphoScan Imaging in the Dectection of Residual Tumor After Chemotherapy and/or Radiotherapy in Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2/Phase 3|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:30.911585|2017-02-18 18:19:30.911585
NCT00003337|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||March 1997||1997-03-01|December 2001|2001-12-01||||||||Interventional|||Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma|The Utility of LymphoScan Imaging in the Localization and Staging of Patients With Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 3|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:31.026548|2017-02-18 18:19:31.026548
NCT00003336|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-10|||January 1998||1998-01-01|June 2010|2010-06-01|February 2006|Actual|2006-02-01|December 2005|Actual|2005-12-01||Interventional|||Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions|A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With Severe Aplastic Anemia, Inborn Errors in Metabolism, or Inherited Hematologic Stem Cell Disorders|Completed||Phase 2|6|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:19:31.130464|2017-02-18 18:19:31.130464
NCT00003335|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-14|||January 1998||1998-01-01|March 2012|2012-03-01|January 2012|Actual|2012-01-01|November 2007|Actual|2007-11-01||Interventional|||Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer|A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With High Risk Hematologic Malignancies|Completed||Phase 2|44|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:19:31.243586|2017-02-18 18:19:31.243586
NCT00003334|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-03-10|||March 1997||1997-03-01|March 2016|2016-03-01||||December 2001|Actual|2001-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract|Phase II Study of Doxil and Paclitaxel in Patients With Endometrial, Tubal, and Sarcomas of Gynecologic Origin|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:19:31.361861|2017-02-18 18:19:31.361861
NCT00003332|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-25|||July 1997||1997-07-01|March 2011|2011-03-01||||October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer|Phase I/II Study of Induction Chemotherapy With Gemcitabine and Cisplatin Followed by Combined Chemo-radiation and/or Surgical Resection for Locally Advanced Pancreatic Cancer|Completed||Phase 1/Phase 2|36|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:19:31.478065|2017-02-18 18:19:31.478065
NCT00003331|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-25|||January 1998||1998-01-01|March 2011|2011-03-01||||November 2001|Actual|2001-11-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer|A Phase I Study of Low Dose Continuous Infusion Topotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Malignancies|Completed||Phase 1|30|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:19:31.573276|2017-02-18 18:19:31.573276
NCT00003330|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||July 1998||1998-07-01|May 2001|2001-05-01||||April 2002|Actual|2002-04-01||Interventional|||Interleukin-12 in Treating Patients With Advanced Cancer|Phase I Clinical Trials of IV rhIL-12 With or Without a Test-Dose in Patients With Advanced Malignancies (rhIL-12 NSC# 672423)|Completed||Phase 1|54|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:31.676338|2017-02-18 18:19:31.676338
NCT00003329|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-02|||January 1998||1998-01-01|March 2008|2008-03-01||||December 2007|Actual|2007-12-01||Observational|||Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer|ECOG Laboratory Study: Mapping Interactive Cancer Susceptibility Loci|Completed||N/A|4000|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:19:31.77404|2017-02-18 18:19:31.77404
NCT00003328|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-05-20|||December 1997||1997-12-01|May 2010|2010-05-01||||||||Interventional|||Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer|A Phase III Double-Blind, Randomised, Placebo-Controlled Study of Porfiromycin When Used as an Adjuvant to Radiation Therapy in Patients With Head and Neck Cancer|Completed||Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:31.8872|2017-02-18 18:19:31.8872
NCT00003327|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||September 1997||1997-09-01|November 2001|2001-11-01||||||||Interventional|||Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer|A Phase II Trial of Paclitaxel (TAXOL) Administered as a Weekly One Hour Infusion in Previously Treated Patients With Advanced Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:31.983692|2017-02-18 18:19:31.983692
NCT00003326|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||September 1997||1997-09-01|April 2001|2001-04-01||||||||Interventional|||Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus|A Phase II Trial of Paclitaxel (TAXOL) Administered as a Weekly One Hour Infusion in Patients With Advanced Esophageal Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:32.090168|2017-02-18 18:19:32.090168
NCT00003325|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-05-27|||December 1999||1999-12-01|May 2015|2015-05-01||||July 2013|Actual|2013-07-01||Interventional|||Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva|Intraoperative Lymphatic Mapping in Patients With Stage I and II Squamous Carcinoma of the Vulva|Completed||Phase 3|515|Actual|Gynecologic Oncology Group||1|||f||||f||||||||||2017-02-18 18:19:32.335327|2017-02-18 18:19:32.335327
NCT00003324|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-09-30|||December 1997||1997-12-01|July 2012|2012-07-01||||July 2006|Actual|2006-07-01||Interventional|||Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases|Prognostic Factors Associated With Successful Omission of Whole Brain Radiotherapy in Patients With 4 or Less Cerebral Metastases Treated With Focal Radiation or Surgery|Completed||N/A|61|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:19:32.517395|2017-02-18 18:19:32.517395
NCT00003323|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||May 1998||1998-05-01|July 2016|2016-07-01|March 2010|Actual|2010-03-01|May 2002|Actual|2002-05-01||Interventional|||Hormone Therapy in Treating Patients With Prostate Cancer|A Phase II Trial of Potency-Sparing Hormonal Therapy in Patients With Elevated Serum PSA After Radiation Therapy or Radical Prostatectomy for Prostate Cancer|Completed||Phase 2|101|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:19:32.651189|2017-02-18 18:19:32.651189
NCT00003322|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-24|||March 1998||1998-03-01|August 2012|2012-08-01||||January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer|A Phase III Randomized Trial of Intravenous Paclitaxel and Cisplatin Versus Intravenous Paclitaxel, Intraperitoneal Cisplatin and Intraperitoneal Paclitaxel in Patients With Optimal Stage III Epithelial Ovarian Carcinoma or Primary Peritoneal Carcinoma|Completed||Phase 3|384|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:33.021292|2017-02-18 18:19:33.021292
NCT00003321|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-11|||February 1998||1998-02-01|June 2013|2013-06-01||||August 2001|Actual|2001-08-01||Observational|||Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus|An International Field Study of the Reliability and Validity of the EORTC-QLQ-C30 and a Disease Specific Questionnaire Module (the EORTC OES-24) in Assessing the Quality of Life of Patients With Oesophageal Cancer|Completed||N/A|370|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:19:33.221916|2017-02-18 18:19:33.221916
NCT00003320|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-28|||March 1997||1997-03-01|July 2012|2012-07-01||||August 2006|Actual|2006-08-01||Interventional|||Radiation Therapy Following Surgery to Remove Brain Metastases|Pilot Study of Adjuvant Fractionated Stereotactic Radiotherapy Following Surgical Removal of Cerebral Metastases|Completed||N/A|20|Actual|Jonsson Comprehensive Cancer Center|||||f||||t||||||||||2017-02-18 18:19:33.33163|2017-02-18 18:19:33.33163
NCT00003317|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||May 1998||1998-05-01|July 2016|2016-07-01|August 2005|Actual|2005-08-01|June 2005|Actual|2005-06-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer|A Phase III Study of Surgical Resection and Chemotherapy (Paclitaxel and Carboplatin) With or Without Adjuvant Radiotherapy for Resected Stage IIIA Non-Small Cell Lung Cancer|Completed||Phase 3|480|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:19:33.432087|2017-02-18 18:19:33.432087
NCT00003316|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-04-10|||August 1998||1998-08-01|May 2004|2004-05-01||||April 2004|Actual|2004-04-01||Interventional|||Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus|Evaluation of Gemcitabine in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:33.578566|2017-02-18 18:19:33.578566
NCT00003315|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||July 1997||1997-07-01|May 2007|2007-05-01|December 1997|Actual|1997-12-01|||||Interventional|||Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection|Supplementary Protocol for Patients With Invasive Fungal Infection, Entered Into AML 11, AML 12 and UKALL XII (Or Their Successors)|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:33.724002|2017-02-18 18:19:33.724002
NCT00003313|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-11-19|||September 1998||1998-09-01|November 2014|2014-11-01|June 2010|Actual|2010-06-01|July 2002|Actual|2002-07-01||Interventional|||Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer|A Phase III Randomized Study of Amifostine Mucosal Protection for Patients With Favorable Performance Inoperable Stage II-III A/B Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Induction and Concurrent Hyperfractionated Radiotherapy With Paclitaxel and Carboplatin|Completed||Phase 3|243|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:19:33.843057|2017-02-18 18:19:33.843057
NCT00003312|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-23|||September 1998||1998-09-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|January 2004|Actual|2004-01-01||Interventional|||Brachytherapy in Treating Patients With Prostate Cancer|Phase II Trial of Transrectal Ultrasound Guided Permanent Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate|Completed||Phase 2|95|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:19:34.349349|2017-02-18 18:19:34.349349
NCT00003311|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-05|||March 1999||1999-03-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma|Phase II CCOP Trial of High Dose Methotrexate/ARA-C and HCVAD for Newly Diagnosed Nodular and Diffuse Mantle Cell Lymphoma and Their Blastic Variants|Completed||Phase 2|19|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:19:37.698421|2017-02-18 18:19:37.698421
NCT00003309|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||July 1998||1998-07-01|January 2010|2010-01-01||||March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer|"A Phase II Trial of Preradiation Multiagent Chemotherapy for Adults With Poor Risk Medulloblastoma, PNET, and Disseminated Ependymoma"|Completed||Phase 2|33|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:19:37.810259|2017-02-18 18:19:37.810259
NCT00003308|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||July 1998||1998-07-01|August 2013|2013-08-01||||September 2004|Actual|2004-09-01||Interventional|||Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma|A Phase II Trial of Radiosurgery for 1 to 3 Newly Diagnosed Brain Metastases From Renal Cell, Melanoma and Sarcoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:19:37.928264|2017-02-18 18:19:37.928264
NCT00003249|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-06|||May 1998||1998-05-01|February 2013|2013-02-01||||December 2001|Actual|2001-12-01||Interventional|||Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers|A Phase I Investigation of Carboxyamido-triazole (CAI) Modulated by Ketoconozole In Patients With Advanced Malignancies|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:44.934269|2017-02-18 18:19:44.934269
NCT00003307|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-12|||March 1998||1998-03-01|May 2006|2006-05-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer|A Phase II Open Label Trial of Amifostine Plus Fractionated Radiotherapy for Primary Prostate Adenocarcinoma (T1a-T3b, NoMo, PSA>10 ng/ml) to Estimate Acute Grade 2 Genitourinary and Gastrointestinal Toxicity|Completed||Phase 2|25|Anticipated|University of Arizona|||||f||||||||||||||2017-02-18 18:19:38.303218|2017-02-18 18:19:38.303218
NCT00003305|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||July 1997||1997-07-01|August 2008|2008-08-01|September 2007|Actual|2007-09-01|||||Interventional|||Aminopterin in Treating Patients With Refractory Leukemia|A Phase II Trial of Aminopterin in Adults and Children With Refractory Acute Leukemia Grant Application Title: A Phase II Trial of Aminopterin in Acute Leukemia|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:38.402961|2017-02-18 18:19:38.402961
NCT00003304|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-05|||April 1998||1998-04-01|March 2012|2012-03-01||||March 2000|Actual|2000-03-01||Interventional|||Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors|Second Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors After PCV-Chemotherapy|Completed||Phase 2|29|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:19:38.516428|2017-02-18 18:19:38.516428
NCT00003302|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-05-09|||May 1998||1998-05-01|February 2006|2006-02-01||||||||Interventional|||MRI to Detect Breast Tumors in Women|Breast MRI Protocol|Unknown status|Active, not recruiting|N/A|1500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:38.649846|2017-02-18 18:19:38.649846
NCT00003301|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||July 1998||1998-07-01|September 2005|2005-09-01|April 2004|Actual|2004-04-01|||||Interventional|||Irinotecan in Treating Patients With Recurrent Malignant Glioma|A Dose Finding and Safety/Efficacy Trial of CPT-11 (Irinotecan) in Patients With Recurrent Malignant Gliomas|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:38.754607|2017-02-18 18:19:38.754607
NCT00003299|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|||April 1998||1998-04-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|June 2005|Actual|2005-06-01||Interventional|||Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer|A Randomized Phase III Study Comparing Etoposide and Cisplatin With Etoposide, Cisplatin and Paclitaxel in Patients With Extensive Small Cell Lung Cancer|Completed||Phase 3|587|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:19:38.862083|2017-02-18 18:19:38.862083
NCT00003298|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-06-22|2015-06-02||February 1999||1999-02-01|June 2015|2015-06-01|May 2011|Actual|2011-05-01|February 2010|Actual|2010-02-01||Interventional||Eligible and treated in step 1|Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer|A Phase II Trial of Neoadjuvant Paclitaxel - Cisplatin Chemotherapy, Surgery and Adjuvant Radiation Therapy and 5-FU/Leucovorin for Gastric Cancer|Completed||Phase 2|39|Actual|Eastern Cooperative Oncology Group||1|||f||||f||||||||||2017-02-18 18:19:39.004225|2017-02-18 18:19:39.004225
NCT00003297|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-22|||December 1997||1997-12-01|September 2000|2000-09-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer|Phase I/II Study of High Dose Topotecan, Mitoxantrone and Thiotepa (TMT) Followed by Autologous Stem Cell Transplant in Patients With Recurrent Platinum Resistant Ovarian Cancer|Completed||Phase 1/Phase 2|50|Anticipated|Georgetown University|||||f||||f||||||||||2017-02-18 18:19:39.740322|2017-02-18 18:19:39.740322
NCT00003296|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||January 1998||1998-01-01|September 2000|2000-09-01||||||||Interventional|||Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer|Phase II Study of TLC D-99 for Hepatobiliary Carcinomas|Unknown status|Active, not recruiting|Phase 2|26|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:39.835763|2017-02-18 18:19:39.835763
NCT00003294|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-03|||May 1997||1997-05-01|March 2011|2011-03-01|May 2004|Actual|2004-05-01|April 1999|Actual|1999-04-01||Interventional|||Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer|Initial Clinical Evaluation of the Combination of Paclitaxel and Carboplatin With Modulation of Toxicity With GCSF and Amifostine|Completed||Phase 1|24|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:19:39.92787|2017-02-18 18:19:39.92787
NCT00003293|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-10|||February 1998||1998-02-01|September 2012|2012-09-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme|A Phase III Randomized Study of SU101 Versus Procarbazine for Patients With Glioblastoma Multiforme in First Relapse|Completed||Phase 3|||Pfizer|||||f||||||||||||||2017-02-18 18:19:40.031117|2017-02-18 18:19:40.031117
NCT00003292|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-07|||July 1998||1998-07-01|November 2013|2013-11-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||S9624 Ifosfamide in Treating Patients With Meningeal Tumors|S9624: Phase II Study of Ifosfamide in Patients With Aggressive Meningeal Tumors|Terminated||Phase 2|7|Actual|Southwest Oncology Group||1||lack of accrual|f||||t||||||||||2017-02-18 18:19:40.16666|2017-02-18 18:19:40.16666
NCT00003291|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-07|||March 1998||1998-03-01|August 2014|2014-08-01||||March 2006|Actual|2006-03-01||Observational|||Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia|Molecular Genetic Lesions and Clinical Outcome in Pediatric ALL Patients|Completed||N/A|200|Anticipated|Children's Oncology Group|||||f||||f||||||||||2017-02-18 18:19:40.341358|2017-02-18 18:19:40.341358
NCT00003290|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||January 1998||1998-01-01|July 2001|2001-07-01|August 2004|Actual|2004-08-01|||||Interventional|||Radiation Therapy in Treating Patients With Prostate Cancer|A Randomised Trial of High Dose Therapy in Localised Cancer of the Prostate Using Conformal Radiotherapy Techniques|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:40.439398|2017-02-18 18:19:40.439398
NCT00003289|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-08-05|||June 1998||1998-06-01|August 2010|2010-08-01||||||||Interventional|||UCN-01 in Treating Patients With Advanced Cancer|A Phase I and Pharmacologic Study of UCN-01 (NSC638850)|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:19:40.560405|2017-02-18 18:19:40.560405
NCT00003288|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||August 1998||1998-08-01|April 2000|2000-04-01||||June 2003|Actual|2003-06-01||Interventional|||Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors|A Trial of Tirapazamine and Cyclophosphamide in Children With Refractory Solid Tumors|Completed||Phase 1|12|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:40.655157|2017-02-18 18:19:40.655157
NCT00002972|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||January 1997||1997-01-01|June 2012|2012-06-01||||August 2002|Actual|2002-08-01||Interventional|||Paclitaxel in Treating Patients With Lung Cancer|Phase II Study on TAXOL in Bronchioalveolar Carcinoma|Completed||Phase 2|25|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:30.065425|2017-02-18 18:20:30.065425
NCT00003287|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||March 1998||1998-03-01|June 2012|2012-06-01||||March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer|First Line Infusional 5-Fluorouracil, Folinic Acid and Oxaliplatin for Metastatic Colorectal Cancer or Loco-Regional Recurrency - Role of Chronomodulated Delivery Upon Survival - A Multicenter Randomized Phase III Trial|Completed||Phase 3|554|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:19:40.778684|2017-02-18 18:19:40.778684
NCT00003284|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||January 1998||1998-01-01|June 2000|2000-06-01||||||||Interventional|||High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer|Tandem Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) After High Dose Paclitaxel Followed by Ifosfamide, Carboplatin, and Etoposide (ICE) for the Treatment of Lung Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:40.924565|2017-02-18 18:19:40.924565
NCT00003283|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||July 1998||1998-07-01|January 2010|2010-01-01||||September 2003|Actual|2003-09-01||Interventional|||Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma|Phase II Study of Octreotide Treatment of Advanced, Recurrent Thymoma|Completed||Phase 2|38|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:19:41.097489|2017-02-18 18:19:41.097489
NCT00003282|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-15|||March 1998||1998-03-01|January 2013|2013-01-01||||May 2005|Actual|2005-05-01||Interventional|||EF5 in Treating Patients With Solid Tumors|Phase I Trial of EF5, an Agent for the Detection of Hypoxia|Completed||Phase 1|50|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:41.43784|2017-02-18 18:19:41.43784
NCT00003281|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||April 1998||1998-04-01|July 2016|2016-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer|Phase II Trial of Topotecan and Paclitaxel in Previously Treated Patients With Relapsed Small Cell Lung Cancer|Completed||Phase 2|84|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:19:41.546736|2017-02-18 18:19:41.546736
NCT00003280|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||January 1998||1998-01-01|May 2012|2012-05-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma|A Randomized, Phase III Trial to Determine the Effect of Consolidation With Rituximab (IDEC C2B8-Mabthera) in Patients With CD20+ Follicular or Mantle Cell Lymphoma Having Received Induction Therapy With Rituximab Weekly x 4|Completed||Phase 3|240|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:19:41.688277|2017-02-18 18:19:41.688277
NCT00003279|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-05|||March 1998||1998-03-01|March 2012|2012-03-01||||January 2000|Actual|2000-01-01||Interventional|SILVA||Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer|The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG|Completed||Phase 3|500|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:19:41.807335|2017-02-18 18:19:41.807335
NCT00003278|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||March 1998||1998-03-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma|Primary Central Nervous System Non-Hodgkins's Lymphoma (PCNSL): A Phase II Clinical Trial of Radiation Therapy and High Dose Corticosteroids for Elderly Patients (70 Years of Age and Older)|Completed||Phase 2|28|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:19:42.019664|2017-02-18 18:19:42.019664
NCT00003276|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||March 1998||1998-03-01|July 2016|2016-07-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer|A Phase II Study of CPT-11 in Patients With Advanced Gallbladder or Bile Duct Tumors|Completed||Phase 2|40|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:19:42.158889|2017-02-18 18:19:42.158889
NCT00003274|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||March 1998||1998-03-01|May 2014|2014-05-01|November 2002|Actual|2002-11-01|September 2001|Actual|2001-09-01||Interventional|||Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery|A Randomized Phase II Trial of a Vaccine Combining Tyrosinase /gp100 Peptides Emulsified With Montanide ISA 51 Alone or With a Block Co-Polymer CRL 1005 or With GM-CSF for Patients With Resected Stages IIA and IIB Melanoma Grant Application Title: MART-1/gp100 Immune Responses to a Melanoma Vaccine|Completed||Phase 2|48|Actual|University of Southern California|||||f||||t||||||||||2017-02-18 18:19:42.297604|2017-02-18 18:19:42.297604
NCT00003273|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-30|||November 1997||1997-11-01|November 2015|2015-11-01||||||||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor|Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa, Etoposide and Carboplatin) and Autologous Stem Cell Rescue|Withdrawn||Phase 2|0|Actual|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:19:42.395884|2017-02-18 18:19:42.395884
NCT00003270|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-27|||September 1997||1997-09-01|June 2016|2016-06-01||||August 2017|Anticipated|2017-08-01||Interventional|||Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer|Cord Blood Transplantation for Hematologic Malignancies and Bone Marrow Failure Syndromes|Active, not recruiting||Phase 2|20|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:19:42.519109|2017-02-18 18:19:42.519109
NCT00003269|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-01-06|||February 1998||1998-02-01|January 2011|2011-01-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors|A Phase II, Open-Label, Trial Evaluating the Efficacy of Amifostine in Patients With Cancers Receiving Outpatient Dose-intensive Cyclophosphamide, Etoposide, and Cisplatin (DICEP) Chemotherapy|Completed||Phase 2|20|Actual|Scripps Health||1|||f||||f||||||||||2017-02-18 18:19:42.643766|2017-02-18 18:19:42.643766
NCT00003268|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-01|||January 1998||1998-01-01|October 2003|2003-10-01|December 2003|Actual|2003-12-01|||||Interventional|||Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia|A Phase I Study of Cytosine Arabinoside, Idarubicin, and Amifostine as Induction Therapy for Patients With Newly Diagnosed Acute Myeloid Leukemia|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:42.76182|2017-02-18 18:19:42.76182
NCT00003267|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||February 1998||1998-02-01|July 2012|2012-07-01||||July 2000|Actual|2000-07-01||Interventional|||Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer|A Randomized Phase III Trial for Evaluation of Usefulness of Pelvic Drains After Radical Hysterectomy and Node Dissection (RHND)|Completed||Phase 3|214|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:19:42.860757|2017-02-18 18:19:42.860757
NCT00003266|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-06|||June 1999||1999-06-01|March 2008|2008-03-01||||May 2002|Actual|2002-05-01||Interventional|||Methylphenidate in Treating Patients With Melanoma|Double-Blind Randomized Trial of Methylphenidate for Alleviation of Fatigue and Lethargy Associated With Interferon Alpha 2b|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:42.986984|2017-02-18 18:19:42.986984
NCT00003264|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-16|||October 1997||1997-10-01|April 2013|2013-04-01|June 2002|Actual|2002-06-01|February 2002|Actual|2002-02-01||Interventional|||Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer|Phase II Evaluation of Weekly Cisplatin and Gemcitabine in the Treatment of Advanced (Recurrent or Metastatic) Carcinoma of the Head and Neck|Completed||Phase 2|22|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-02-18 18:19:43.131206|2017-02-18 18:19:43.131206
NCT00003263|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-16|||August 1996||1996-08-01|April 2013|2013-04-01|November 2000|Actual|2000-11-01|December 1999|Actual|1999-12-01||Interventional|||Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma|Phase I Combined Modality Protocol for Malignant Mesothelioma: Cisplatin & rIFN-alpha-2b Followed by Surgical Resection (Debulking), and Post-Op Concurrent Chemoradiotherapy With Cisplatin, +/- rIFN-alpha-2b|Completed||Phase 1|6|Actual|Fox Chase Cancer Center||1|||f||||||||||||||2017-02-18 18:19:43.234011|2017-02-18 18:19:43.234011
NCT00003262|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||May 1997||1997-05-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection|"Prospective Non Randomized Study With Chemotherapy in Patients With Hodgkin's Disease and HIV Infection: Stanford V Regimen For Low Risk Patients, EBVP Regimen For High Risk Patients"|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:43.345303|2017-02-18 18:19:43.345303
NCT00003261|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||May 1997||1997-05-01|October 2001|2001-10-01||||||||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma|Treatment of HIV-Related Primary Central Nervous System Lymphoma (HIV-PCNSL): A Phase II Trial With Neoadjuvant Chemotherapy (High-Dose Methotrexate (MTX) Plus High-Dose Zidovudine) and Radiotherapy|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:43.45509|2017-02-18 18:19:43.45509
NCT00003260|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-01-10|||January 1998||1998-01-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer|Multicentre Phase III Comparing To Therapeutic Sequence: Folfiri Following of Folfox6 (Group A) and Folfox6 Following Of (Group B) For Metastatic Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|109|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:43.812266|2017-02-18 18:19:43.812266
NCT00003259|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||October 1997||1997-10-01|May 2012|2012-05-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Vinorelbine in Treating Patients With Metastatic Prostate Cancer|Master Protocol for Metastatic Hormone-Resistant Prostatic Carcinoma Phase II Trials Protocol 4: Vinorelbine|Completed||Phase 2|40|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:19:43.905999|2017-02-18 18:19:43.905999
NCT00003257|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||January 1998||1998-01-01|April 2000|2000-04-01||||||||Interventional|||Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer|A Phase II, Multicenter, Open Label Study to Evaluate Effectiveness and Safety of AdCMV-p53 Administered by Intra-Tumoral Injections in 39 Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)|Unknown status|Active, not recruiting|Phase 2|39|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:44.011516|2017-02-18 18:19:44.011516
NCT00003256|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||May 1998||1998-05-01|January 2013|2013-01-01|April 2004|Actual|2004-04-01|July 2002|Actual|2002-07-01||Interventional|||Flavopiridol in Treating Patients With Recurrent Prostate Cancer|A Phase II Trial of Flavopiridol in Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:44.120373|2017-02-18 18:19:44.120373
NCT00003255|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-11|||November 1999||1999-11-01|July 2016|2016-07-01|December 2006|Actual|2006-12-01|December 2006|Actual|2006-12-01||Interventional|||Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia|Phase II Study of Continuous Infusion Carboplatin and Topotecan in the Treamtment of Relapsed Acute Myelogenous Leukemia (AML)|Completed||Phase 2|38|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:19:44.232005|2017-02-18 18:19:44.232005
NCT00003254|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-06|||April 1998||1998-04-01|March 2012|2012-03-01|October 2003|Actual|2003-10-01|November 2002|Actual|2002-11-01||Interventional|||SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil|A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer|Completed||Phase 2|75|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:19:44.332127|2017-02-18 18:19:44.332127
NCT00003253|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||July 1997||1997-07-01|May 2006|2006-05-01||||||||Interventional|||Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer|Assessment of the Predictive Value of the Extreme Drug Resistance (EDR) Assay in Patients Receiving Paclitaxel for Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:44.538727|2017-02-18 18:19:44.538727
NCT00003252|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-25|||December 1997||1997-12-01|April 2000|2000-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy|A Phase IV Open Label Study of the Effects of a Five Minute Infusion Time for Ethyol (Amifostine) in Patients Undergoing Chemotherapy|Completed||Phase 4|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:44.641749|2017-02-18 18:19:44.641749
NCT00003251|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||December 1997||1997-12-01|June 2000|2000-06-01||||||||Interventional|||Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer|A Pilot Study of Amifostine and Concomitant Cisplatin, Paclitaxel and Radiotherapy in Previously Irradiated, Recurrent Head and Neck Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|46|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:44.72601|2017-02-18 18:19:44.72601
NCT00003248|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|||March 1998||1998-03-01|July 2016|2016-07-01|June 2010|Actual|2010-06-01|April 2003|Actual|2003-04-01||Interventional|||Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia|A Randomized Phase II Study of Concurrent Fludarabine + Chimeric Anti-CD20 Monoclonal Antibody IDEC-C2B8 (Rituximab) [NSC# 687451] Induction Followed By Rituximab Consolidation In Untreated Patients With B-Cell Chronic Lymphocytic Leukemia|Completed||Phase 2|104|Actual|Alliance for Clinical Trials in Oncology||2|||f||||||||||||||2017-02-18 18:19:45.066071|2017-02-18 18:19:45.066071
NCT00003245|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-05|||February 1998||1998-02-01|October 2012|2012-10-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma|Phase II Study of Irinotecan for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma|Completed||Phase 2|50|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:19:45.226653|2017-02-18 18:19:45.226653
NCT00003243|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-09|||January 1998||1998-01-01|March 2010|2010-03-01||||||||Interventional|||Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer|A Phase I Trial of Combined Chemotherapy and Donor Lymphocyte Infusion for Aggressive Hematologic Malignancies in Relapse After Allogeneic Bone Marrow Transplantation|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:19:45.319757|2017-02-18 18:19:45.319757
NCT00003242|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||February 1998||1998-02-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors|An Open-Label, Non-Randomized Phase I Study of the Protein Kinase C Inhibitor Bryostatin-1 Administered in Combination With Paclitaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:45.412763|2017-02-18 18:19:45.412763
NCT00003241|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||May 1998||1998-05-01|April 2000|2000-04-01|September 2004|Actual|2004-09-01|||||Interventional|||Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors|Phase II Study of Phenylacetate in Pediatric Patients With Central Nervous System Tumors|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:45.506355|2017-02-18 18:19:45.506355
NCT00003240|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||October 1995||1995-10-01|May 2007|2007-05-01||||||||Interventional|||Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer|A Major Randomised Trial to Determine the Value of Cisplatin-Based Chemotherapy For All Patients With Non-Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|1800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:45.602183|2017-02-18 18:19:45.602183
NCT00003239|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||March 1998||1998-03-01|July 2012|2012-07-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia|Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Alpha Interferon (IFN-A), Low-Dose Cytosine Arabinoside (ARA-C), and Homoharringtonine (HHT)|Completed||Phase 2|90|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:19:45.698905|2017-02-18 18:19:45.698905
NCT00003238|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-15|||February 1998||1998-02-01|August 2013|2013-08-01||||October 2001|Actual|2001-10-01||Interventional|||Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy|A Phase II Trial of Perillyl Alcohol (NSC 641066) Administered Daily In Patients With Metastatic Androgen Independent Prostate Cancer|Completed||Phase 2|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:19:45.822115|2017-02-18 18:19:45.822115
NCT00003237|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||March 1998||1998-03-01|January 2010|2010-01-01||||October 2003|Actual|2003-10-01||Interventional|||Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach|Phase II Trial of Post-Operative Adjuvant Paclitaxel + Cisplatin in Patients With Adenocarcinoma of the Esophagus, Gastro-Esophageal Junction or Cardia|Completed||Phase 2|55|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:19:45.92049|2017-02-18 18:19:45.92049
NCT00003236|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||May 1998||1998-05-01|August 2013|2013-08-01||||June 2002|Actual|2002-06-01||Interventional|||Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer|Randomized Phase II Study of Human C-raf Kinase Antisense Oligonucleotide Isis 5132 (CGP 69846A) or Human Pkc-Alpha Antisence Oligonucleotide ISIS 3521 (CGP 64128A) in Women With Previously Treated Matastatic Breast Cancer|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:19:46.067214|2017-02-18 18:19:46.067214
NCT00003235|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||April 1998||1998-04-01|January 2010|2010-01-01||||August 2006|Actual|2006-08-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed|A Phase III Trial of Induction Paclitaxel and Carboplatin Followed By Standard Radiotherapy (64 Gy/7 Weeks) vs. Hyperfractionated Accelerated Radiotherapy (HART 57.6 Gy/2.5 Weeks) For Patients With Unresectable Stage IIIA and IIIB Non-Small Cell Lung Cancer|Completed||Phase 3|294|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-02-18 18:19:46.163352|2017-02-18 18:19:46.163352
NCT00003234|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-25|||May 1998||1998-05-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|March 2006|Actual|2006-03-01||Interventional|||Vinorelbine in Treating Children With Recurrent or Refractory Cancers|A Phase II Study of Navelbine (Vinorelbine) In Children With Recurrent Or Refractory Malignancies|Completed||Phase 2|50|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 18:19:46.267563|2017-02-18 18:19:46.267563
NCT00003232|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-07|||November 1997||1997-11-01|November 2010|2010-11-01|February 2009|Actual|2009-02-01|February 2009|Actual|2009-02-01||Interventional|||Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer|Randomized Placebo-Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone Alone in Patients With Hormone Refractory Metastatic Prostate Cancer and Pain|Completed||Phase 3|204|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:19:46.909179|2017-02-18 18:19:46.909179
NCT00003231|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||April 1997||1997-04-01|May 2012|2012-05-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer|Preoperative Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2)|Completed||Phase 2|40|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:19:47.046858|2017-02-18 18:19:47.046858
NCT00003230|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||January 1998||1998-01-01|May 2012|2012-05-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia|Paclitaxol (Taxol) for Refractory or Relapsed Acute Leukemia in Elderly Patients, and Blast Crisis of Chronic Myelogenous Leukemia: A Multicenter Phase I/II Study|Completed||Phase 1/Phase 2|33|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:19:47.158711|2017-02-18 18:19:47.158711
NCT00003229|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-22|||July 1997||1997-07-01|March 2013|2013-03-01|February 2005|Actual|2005-02-01|April 2000|Actual|2000-04-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal|A Phase I-II Trial of Antigen-Pulsed Autologous Dendritic Cells for Induction of Anti-Tumor Immunity in Patients Completing Lymphadenectomy for Metastatic Melanoma|Completed||Phase 1/Phase 2|||Duke University|||||f||||||||||||||2017-02-18 18:19:47.262007|2017-02-18 18:19:47.262007
NCT00003225|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-09-30|||July 1997||1997-07-01|July 2012|2012-07-01|June 2001|Actual|2001-06-01|March 2000|Actual|2000-03-01||Interventional|||Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer|Phase I/II Trial to Evaluate Ethyol as a Protective Agent for Irinotecan (CPT-11) Toxicities in Patients With Advanced Colorectal Cancer|Completed||Phase 1/Phase 2|23|Actual|Jonsson Comprehensive Cancer Center||1|||f||||f||||||||||2017-02-18 18:19:47.36513|2017-02-18 18:19:47.36513
NCT00003224|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-11-18|2013-01-22||February 1996||1996-02-01|November 2014|2014-11-01||||August 2000|Actual|2000-08-01||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With a Synthetic Melanoma Peptide in Patients With High Risk Melanoma|Completed||Phase 1|22|Actual|University of Virginia||6|||f||||t||||||||||2017-02-18 18:19:47.491101|2017-02-18 18:19:47.491101
NCT00003223|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-20|||December 1997||1997-12-01|July 2012|2012-07-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth|A Single Arm, Phase II Study to Determine the Safety and Efficacy of 4-HPRN-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia|Terminated||Phase 2|5|Actual|Southwest Oncology Group||1||Closed due to poor accrual.|f||||f||||||||||2017-02-18 18:19:48.252194|2017-02-18 18:19:48.252194
NCT00003222|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-12-18|2013-01-22||April 1998||1998-04-01|December 2014|2014-12-01||||September 2003|Actual|2003-09-01||Interventional|||Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma|Phase II Trial for the Evaluation of the Efficacy of Vaccination With Synthetic Melanoma Peptides Either Pulsed on Dendritic Cells, or Administered With GM-CSF-in-Adjuvant, Plus Administration of Sustemic IL-2, in Patients With Advanced Melanoma.|Completed||Phase 2|40|Actual|University of Virginia||2|||f||||t||||||||||2017-02-18 18:19:48.372249|2017-02-18 18:19:48.372249
NCT00003220|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||February 1998||1998-02-01|April 2013|2013-04-01|June 2001|Actual|2001-06-01|November 2000|Actual|2000-11-01||Interventional|||Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer|Phase II Study of Bryostatin 1 in Patients With Metastatic Colo-Rectal Adenocarcinoma|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:19:48.865675|2017-02-18 18:19:48.865675
NCT00003219|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-08|||May 1998||1998-05-01|October 2012|2012-10-01|May 1998|Actual|1998-05-01|May 1998|Actual|1998-05-01||Interventional|||Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer|A Phase II Trial of Perillyl Alcohol (NSC 641066) Administered Daily in Patients With Metastatic Breast Cancer|Completed||Phase 2|||University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:19:48.958055|2017-02-18 18:19:48.958055
NCT00003217|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||March 1998||1998-03-01|July 2014|2014-07-01|September 2006|Actual|2006-09-01|October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia|A Pilot Study of Dose Intensification of Methotrexate and Cyclophosphamide in Patients With Advanced-Stage (III/IV) Small Non-Cleaved Non-Hodgkins Lymphoma and B-Cell All- A Limited Institution Phase III Pilot Study|Completed||Phase 1|20|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:19:49.122128|2017-02-18 18:19:49.122128
NCT00003216|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-18|||July 1998||1998-07-01|November 2013|2013-11-01||||October 2005|Actual|2005-10-01||Interventional|||Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas|A Phase III Study of Pre and Post Chemoradiation 5-FU vs. Pre and Post Chemoradiation Gemcitabine for Postoperative Adjuvant Treatment of Resected Pancreatic Adenocarcinoma|Completed||Phase 3|518|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:19:49.264878|2017-02-18 18:19:49.264878
NCT00003215|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||April 1997||1997-04-01|May 2012|2012-05-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma|Standard Chemotherapy (CHOP Regimen) Versus Sequential High-Dose Chemotherapy With Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas and Poor Prognostic Factors: A Randomized Phase III Study (MISTRAL)|Completed||Phase 3|400|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:19:52.464644|2017-02-18 18:19:52.464644
NCT00003214|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||July 1996||1996-07-01|May 2012|2012-05-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer|Randomized Trial on Chemosensitivity Testing in Advanced Primary Ovarian Carcinoma (Phase III)|Completed||Phase 3|300|Anticipated|Swiss Group for Clinical Cancer Research|||||f||||||||||||||2017-02-18 18:19:52.592489|2017-02-18 18:19:52.592489
NCT00003213|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||May 1996||1996-05-01|July 2012|2012-07-01|August 1999|Actual|1999-08-01|April 1999|Actual|1999-04-01||Interventional|||Drugs to Reduce the Side Effects of Chemotherapy|A Randomized, Double-Blind Trial to Compare the Clinical Efficacy and Safety of Granisetron vs. Metoclopramide Combined to Dexamethasone in the Prophylaxis of Chemotherapy-Induced Delayed Emesis|Completed||Phase 3|267|Actual|Swiss Group for Clinical Cancer Research||2|||f||||f||||||||||2017-02-18 18:19:52.69982|2017-02-18 18:19:52.69982
NCT00003212|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-01-19|||January 1998||1998-01-01|January 2012|2012-01-01||||November 2001|Actual|2001-11-01||Interventional|||Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma|Randomized Phase III Trial of Two Investigational Schedules of Ifosfamide vs. Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma|Completed||Phase 3|780|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:19:52.829388|2017-02-18 18:19:52.829388
NCT00003211|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-06|||October 1996||1996-10-01|November 2012|2012-11-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor|Treatment of Newly Diagnosed Medulloblastoma and Supratentorial PNET in Patients At Least 3 Years With a Phase II Topotecan Window (High-Risk Patients Only), Risk-Adapted Radiation Therapy, and Dose-Intensive Chemotherapy With Peripheral Blood Stem Cell Support|Completed||Phase 2|94|Actual|St. Jude Children's Research Hospital||2|||f||||f||||||||||2017-02-18 18:19:52.951012|2017-02-18 18:19:52.951012
NCT00003210|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-04-14|||February 1998||1998-02-01|January 2013|2013-01-01|November 2003|Actual|2003-11-01|November 2003|Actual|2003-11-01||Interventional|||Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease|A Phase II Study of Recombinant Human Interleukin-12 (rhIL-12) for the Treatment of Relapsed Lymphoma and Hodgkin's Disease|Completed||Phase 2|105|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:53.081987|2017-02-18 18:19:53.081987
NCT00003209|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||December 1997||1997-12-01|July 2012|2012-07-01||||December 1999|Actual|1999-12-01||Interventional|||Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer|A Randomized Phase III Study of Chemotherapy and Radiotherapy Versus Radiotherapy Alone as Adjuvant Treatment to Patients With Node Positive Stages IB or IIA Cervix Cancer|Completed||Phase 3|700|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:19:53.481028|2017-02-18 18:19:53.481028
NCT00003207|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-11|||March 1998||1998-03-01|April 2013|2013-04-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers|Phase I Study on Doxil and SDZ PSC 833 in the Treatment of AIDS-Associated Kaposi's Sarcoma and Other Advanced Malignancies|Completed||Phase 1|14|Actual|Washington University School of Medicine||1|||f||||f||||||||||2017-02-18 18:19:53.58589|2017-02-18 18:19:53.58589
NCT00003206|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||April 1998||1998-04-01|August 2013|2013-08-01||||July 2001|Actual|2001-07-01||Interventional|||Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer|A Phase II Trial of Carboplatin Plus Paclitaxel in the Treatment of Locally Recurrent or Metastatic Nasopharyngeal Carcinoma|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:19:53.695245|2017-02-18 18:19:53.695245
NCT00003205|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-28|||April 1998||1998-04-01|December 2002|2002-12-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Bryostatin 1 in Treating Patients With Stage IV Breast Cancer|A Phase II Trial of Bryostatin-1 for the Treatment of Stage IV Breast Cancer|Completed||Phase 2|||University of Colorado, Denver|||||f||||t||||||||||2017-02-18 18:19:53.810718|2017-02-18 18:19:53.810718
NCT00003204|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2013-02-26|||March 1998||1998-03-01|February 2013|2013-02-01||||May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma|Randomized Phase III Study in Low Grade Lymphoma Comparing Maintenance Anti-CD20 Antibody Versus Observation Following Induction Therapy|Completed||Phase 3|515|Actual|National Cancer Institute (NCI)||4|||f||||||||||||||2017-02-18 18:19:53.911046|2017-02-18 18:19:53.911046
NCT00003203|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||March 1998||1998-03-01|August 2013|2013-08-01|March 2012|Actual|2012-03-01|October 2007|Actual|2007-10-01||Interventional|||Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors|An Intergroup Pilot Study of Concurrent Carboplatin, Vincristine and Radiotherapy Followed by Adjuvant Chemotherapy in Patients With Newly Diagnosed High-Risk Central Nervous System Embryonal Tumors|Completed||Phase 2|168|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:19:54.052389|2017-02-18 18:19:54.052389
NCT00003202|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-18|||January 1998||1998-01-01|July 2012|2012-07-01|July 2006|Actual|2006-07-01|April 2002|Actual|2002-04-01||Interventional|||Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer|Alternating Phase I/II Trials of Twice-Weekly Infusion Gemcitabine (2'2'-Difluoro-2'-Deoxycytidine) and Concurrent Thoracic Radiation Alone - Or Following 2 Cycles of Cisplatin/Gemcitabine Induction Chemotherapy for the Treatment of Stage IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)|Completed||Phase 1/Phase 2|40|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 18:19:54.233896|2017-02-18 18:19:54.233896
NCT00003200|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-17|||October 1995||1995-10-01|January 2017|2017-01-01|June 2008|Actual|2008-06-01|October 2006|Actual|2006-10-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck|Taxotere Plus Concurrent Radiotherapy After Induction Chemotherapy for Squamous Cell Carcinoma of the Head and Neck (TAXT-XRT)|Completed||Phase 1|22|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 18:19:54.333483|2017-02-18 18:19:54.333483
NCT00003199|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-07-08|||November 1997||1997-11-01|July 2011|2011-07-01||||December 2009|Actual|2009-12-01||Interventional|||Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer|A Phase II Trial for Patients With Inflammatory (Stage IIIB) and Responsive Metastatic Stage IV Breast Cancer Using Busulfan, Melphalan and Thiotepa Followed by Autologous or Syngeneic PBSC Rescue and 12 Weeks of Post-Engraftment Immunotherapy With Low-Dose IL-2 and GM-CSF|Completed||Phase 2|70|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||f||||||||||2017-02-18 18:19:54.458019|2017-02-18 18:19:54.458019
NCT00003198|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||November 1997||1997-11-01|June 2013|2013-06-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors|A Phase I Dose-Escalation Study of Topotecan and Ifosfamide in Patients With Refractory Non-Hematologic Malignancies.|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:54.587458|2017-02-18 18:19:54.587458
NCT00003197|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||December 1997||1997-12-01|June 2013|2013-06-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Green Tea Extract in Treating Patients With Advanced Solid Tumors|Phase I Evaluation of Green Tea Extract in Adults With Advanced Solid Tumors|Completed||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:54.681603|2017-02-18 18:19:54.681603
NCT00003111|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-23|||April 1997||1997-04-01|August 2009|2009-08-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer|Phase II Clinical and Laboratory Study of Irinotecan/Cisplatin Chemotherapy Followed by Surgery in Stage III NSCLC|Completed||Phase 2|10|Actual|Yale University|||||f||||f||||||||||2017-02-18 18:20:10.288329|2017-02-18 18:20:10.288329
NCT00003196|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-10-24|||September 1997||1997-09-01|October 2016|2016-10-01||||April 2002|Actual|2002-04-01||Interventional|||Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma|Induction of Mixed Hematopoietic Chimerism in Older Patients With B-Cell Malignancies and in Selected Other Diseases, Using Low Dose TBI , PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil to be Followed by Donor Lymphocyte Infusion: A Pilot Study.|Active, not recruiting||N/A|63|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:19:54.763702|2017-02-18 18:19:54.763702
NCT00003195|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-11-15|||December 1997||1997-12-01|November 2011|2011-11-01|November 2000|Actual|2000-11-01|||||Interventional|||Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma|A Phase II Study of Total Marrow Irradiation, Busulfan, and Alpha-Interferon Followed by Allogeneic Peripheral Blood Stem Cell or Marrow Transplantation for Treatment of Patients With Advanced Multiple Myeloma.|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:19:54.905801|2017-02-18 18:19:54.905801
NCT00003194|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2009-02-06|||July 1997||1997-07-01|March 2003|2003-03-01||||||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors|A Phase I Study of Thiotepa in Combination With Carboplatin and Topotecan With Peripheral Blood Progenitor Cell Support for the Treatment of Children With Recurrent or Refractory Solid Tumors.|Unknown status|Active, not recruiting|Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:54.992209|2017-02-18 18:19:54.992209
NCT00003193|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-12-05|||January 1998||1998-01-01|December 2012|2012-12-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Phase I/II Study of Escalating Doses of Taxol Used Concurrently With Ethyol and Accelerated Hyperfractionated Radiotherapy in the Treatment of Stage III and IV Carcinoma of the Head and Neck|Completed||Phase 1/Phase 2|37|Anticipated|Massachusetts General Hospital||1|||f||||||||||||||2017-02-18 18:19:55.345572|2017-02-18 18:19:55.345572
NCT00003192|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-04|||March 1998||1998-03-01|September 2013|2013-09-01|August 2003|Actual|2003-08-01|February 2002|Actual|2002-02-01||Interventional|||Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus|A Phase II Trial of 9-Aminocamptothecin (NSC 603071) Administered as a 120-Hour Continuous Infusion in Patients With Previously Untreated Gastric Cancer|Completed||Phase 2|15|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:19:55.468127|2017-02-18 18:19:55.468127
NCT00003191|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-06|||March 1998||1998-03-01|August 2006|2006-08-01||||March 2005|Actual|2005-03-01||Interventional|||Fenretinide in Treating Children With Solid Tumors|A Phase I Study of Fenretinide (NSC #374551) in Children With High Risk Solid Tumors|Completed||Phase 1|18|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:55.58709|2017-02-18 18:19:55.58709
NCT00003190|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-03|||January 1998||1998-01-01|June 2013|2013-06-01||||August 2002|Actual|2002-08-01||Interventional|||Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia|Phase III Study of MDR Modulation With PSC-833 (NSC #648265) Followed by Immunotherapy With rIL-2 (NSC #373364) vs. No Further Therapy in Previously Untreated Patients With AML &gt;60 Years|Completed||Phase 3|640|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:19:55.720457|2017-02-18 18:19:55.720457
NCT00003187|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2010-02-23|||May 1995||1995-05-01|February 2010|2010-02-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma|The Unrelated Donor Marrow Transplantation Trial|Completed||Phase 2/Phase 3|19|Actual|Virginia Commonwealth University|||||f||||f||||||||||2017-02-18 18:19:55.845393|2017-02-18 18:19:55.845393
NCT00003186|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||April 1997||1997-04-01|February 2013|2013-02-01||||March 2005|Actual|2005-03-01||Interventional|||Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer|Dynamic In Vivo Lymphography and Sentinel Node Biopsy in Colorectal Cancer: A Feasibility Study|Completed||N/A|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:19:55.965677|2017-02-18 18:19:55.965677
NCT00003185|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||August 1997||1997-08-01|December 2008|2008-12-01|July 1998|Actual|1998-07-01|||||Interventional|||Biological Therapy in Treating Patients With Glioblastoma Multiforme|Adoptive Immunotherapy of Glioblastoma Multiforme With Tumor-Sensitized, Ex Vivo Activated T Lymphocytes|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:56.06535|2017-02-18 18:19:56.06535
NCT00003184|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-02|||August 1996||1996-08-01|November 2000|2000-11-01|July 2003|Actual|2003-07-01|||||Interventional|||Vaccine Therapy in Treating Women With Metastatic Breast Cancer|Phase I Trial Using a CD80-Modified Allogeneic Breast Cancer Cell Line to Vaccinate HLA-A2-Positive Women With Breast Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:56.175943|2017-02-18 18:19:56.175943
NCT00003183|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||March 1997||1997-03-01|April 2001|2001-04-01||||||||Interventional|||Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer|A Phase I/II Trial Using Weekly Mitoxantrone Chemotherapy and G-CSF for the Treatment of Metastatic Hormone Refractory Prostate Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|64|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:56.273837|2017-02-18 18:19:56.273837
NCT00003182|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||March 1997||1997-03-01|July 2000|2000-07-01||||||||Interventional|||Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck|A Phase I/II Study Using Cisplatin and Gemcitabine (Gemzar) for Advanced Head and Neck Cancer (Squamous Cell Carcinoma)|Unknown status|Active, not recruiting|Phase 1/Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:56.365692|2017-02-18 18:19:56.365692
NCT00003181|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||May 1997||1997-05-01|May 2001|2001-05-01||||||||Interventional|||Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer|A Phase II Study Using Low Dose Subcutaneous IL-2, Vinblastine and GM-CSF in the Treatment of Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|35|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:56.472505|2017-02-18 18:19:56.472505
NCT00003110|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-10|||July 1997||1997-07-01|June 2010|2010-06-01|December 2002|Actual|2002-12-01|August 2001|Actual|2001-08-01||Interventional|||Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma|A Phase II Trial of 72-Hour Continuous Infusion Bleomycin as Salvage Therapy in AIDS-Related and Immunocompetent Non-Hodgkin's Lymphoma|Completed||Phase 2|5|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:20:10.393535|2017-02-18 18:20:10.393535
NCT00003179|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-07|||November 1998||1998-11-01|July 2006|2006-07-01||||February 2006|Actual|2006-02-01||Interventional|||Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer|A Two-Part Study of the Treatment of Atypical Endometrial Hyperplasia: Part A: A Prospective Study of Immediate Hysterectomy; Part B: A Randomized Phase II Study of Medroxyprogesterone Acetate Versus Depoprovera|Terminated||Phase 2|360|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:56.569081|2017-02-18 18:19:56.569081
NCT00003178|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2014-07-24|||March 1998||1998-03-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|December 2004|Actual|2004-12-01||Interventional|||Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia|Idarubicin and Cladribine in Recurrent and Refractory Acute Myeloid Leukemia: A POG Phase II Study|Completed||Phase 2|120|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 18:19:56.7078|2017-02-18 18:19:56.7078
NCT00003176|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-12-13|||January 1998||1998-01-01|January 2007|2007-01-01||||||||Interventional|||Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma|A Phase II Trial of Temozolomide and BCNU for Anaplastic Gliomas|Unknown status|Active, not recruiting|Phase 2|82|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:57.333786|2017-02-18 18:19:57.333786
NCT00003175|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||December 1997||1997-12-01|February 2010|2010-02-01|March 2009|Actual|2009-03-01|||||Interventional|||Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer|A Phase II Study of Continuous 5-Fluorouracil (5-FU) in Recurrent Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urinary Tract|Completed||Phase 2|45|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:57.440558|2017-02-18 18:19:57.440558
NCT00003174|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-04-22|||May 1998||1998-05-01|April 2014|2014-04-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia|Phase I Clinical Evaluation of Bryostatin 1 in Combination With 2-CdA in Patients With Relapsed CLL|Completed||Phase 1|80|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:19:57.600388|2017-02-18 18:19:57.600388
NCT00003173|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-06|||September 1997||1997-09-01|March 2013|2013-03-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors|High-Dose Thiotepa With Autologous Stem Cell Rescue in Patients With Malignancies Refractory to Conventional Chemotherapy|Completed||Phase 2|36|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:19:57.704835|2017-02-18 18:19:57.704835
NCT00003172|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||December 1997||1997-12-01|September 2002|2002-09-01|September 2004|Actual|2004-09-01|||||Interventional|||Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer|Randomized Phase II Trial of Either 5-Fluorouracil, Recombinant Alfa-2a-Interferon and Intravenous Hydroxyurea With Filgrastim Support (FHIG) or Doxorubicin/Docetaxel (Dd) in Patients With Advanced Gastric Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:57.814289|2017-02-18 18:19:57.814289
NCT00003171|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||May 1998||1998-05-01|April 2013|2013-04-01|June 2003|Actual|2003-06-01|July 1999|Actual|1999-07-01||Interventional|||Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome|Phase II Clinical Evaluation of Bryostatin 1 in Patients With Myelodysplastic Syndrome|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:19:57.944343|2017-02-18 18:19:57.944343
NCT00003170|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-13|||February 1998||1998-02-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|May 2003|Actual|2003-05-01||Interventional|||Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer|Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy|Completed||Phase 3|129|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:19:58.043619|2017-02-18 18:19:58.043619
NCT00003167|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-22|||May 1998||1998-05-01|January 2013|2013-01-01||||December 2002|Actual|2002-12-01||Interventional|||Gene Therapy in Treating Patients With Advanced Bladder Cancer|A Phase I Trial of Intravesical Ad-p53 Treatment in Locally Advanced and Metastatic Bladder Cancer|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:58.175086|2017-02-18 18:19:58.175086
NCT00003166|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-10|||May 1998||1998-05-01|January 2013|2013-01-01||||July 2001|Actual|2001-07-01||Interventional|||Bryostatin and Vincristine in B-Cell Malignancies|A Phase I Trial of Combination Bryostatin 1 (NSC 339555) and Vincristine in B-Cell Malignancies|Completed||Phase 1|18|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:19:58.281775|2017-02-18 18:19:58.281775
NCT00003165|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||December 1997||1997-12-01|April 2010|2010-04-01||||||||Interventional|||Doxorubicin in Treating Women With Advanced Breast Cancer|A Phase II Trial of PK1 in Women With Advanced Breast Cancer|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:58.39627|2017-02-18 18:19:58.39627
NCT00003163|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||September 1997||1997-09-01|October 2002|2002-10-01||||||||Interventional|||Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers|Myeloblative Therapy With Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma and B-Cell Malignancies|Unknown status|Active, not recruiting|Phase 2|10|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:58.497962|2017-02-18 18:19:58.497962
NCT00003162|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-14|||February 1998||1998-02-01|November 2015|2015-11-01||||July 2003|Actual|2003-07-01||Interventional|||Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer|Randomized Trial of Palliative Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life|Completed||Phase 3|949|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:19:58.618692|2017-02-18 18:19:58.618692
NCT00003160|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-04-19|||September 1997||1997-09-01|January 2001|2001-01-01||||||||Interventional|||Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum|A Phase II Trial of Paclitaxel (Taxol) Administered as a Weekly One Hour Infusion in Patients With Taxol/Platinum-Refractory Stage III and IV Ovarian Cancer|Unknown status|Active, not recruiting|Phase 2|100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:59.236061|2017-02-18 18:19:59.236061
NCT00003159|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||August 1997||1997-08-01|May 2005|2005-05-01|June 2007|Actual|2007-06-01|||||Interventional|||Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer|Randomized Trial of Surgical Resection With or Without Pre-Operative Chemotherapy in Patients With Operable Non-Small Cell Lung Cancer (NSCLC) of Any Stage|Completed||Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:19:59.34188|2017-02-18 18:19:59.34188
NCT00003158|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-20|||February 1998||1998-02-01|July 2012|2012-07-01|December 2007|Actual|2007-12-01|December 2002|Actual|2002-12-01||Interventional|||S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer|A Phase II Trial of Concurrent Carboplatin/VP-16 and Radiation Followed by Paclitaxel (Taxol) for Poor-Risk Stage III Non-Small Cell Lung Cancer|Completed||Phase 2|96|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:19:59.451199|2017-02-18 18:19:59.451199
NCT00003157|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||February 1998||1998-02-01|July 2016|2016-07-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach|A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer|Completed||Phase 1|26|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:19:59.645023|2017-02-18 18:19:59.645023
NCT00003156|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-06|2013-04-10|||June 1998||1998-06-01|January 2006|2006-01-01||||October 2005|Actual|2005-10-01||Interventional|||Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus|Evaluation of Topotecan in the Treatment of Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:19:59.783926|2017-02-18 18:19:59.783926
NCT00003154|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-09|||January 1998||1998-01-01|June 2010|2010-06-01|June 2001|Actual|2001-06-01|April 2001|Actual|2001-04-01||Interventional|||Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer|Phase II Trial of 9-Aminocamptothecin (9-AC) Colloidal Dispersion (CD) 120-Hour Continuous Intravenous Infusion in Advanced Non-Small Cell Lung Cancer|Completed||Phase 2|19|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:19:59.916152|2017-02-18 18:19:59.916152
NCT00003153|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-25|||February 1998||1998-02-01|July 2004|2004-07-01||||February 2007|Actual|2007-02-01||Interventional|||Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation|Phase II Study of Salvage Cellular Immunotherapy for Patients With Persistent or Recurrent Multiple Myeloma After Allogeneic Bone Marrow Transplantation From an HLA-Matched Sibling Donor|Completed||Phase 2|22|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:00.01295|2017-02-18 18:20:00.01295
NCT00003152|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||March 1997||1997-03-01|June 2012|2012-06-01||||November 1999|Actual|1999-11-01||Interventional|||Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma|Marrow-Ablative Chemo-Radiotherapy and Autologous Stem Cell Transplantation Followed by Interferon-Alpha Maintenance Treatment Versus Interferon-Alpha Maintenance Treatment Alone After a Chemotherapy-Induced Remission in Patients With Stages III or IV Follicular Non-Hodgkin's Lymphoma. A Prospective, Randomized, Phase III Clinical Trial.|Terminated||Phase 3|469|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||low accrual|f||||||||||||||2017-02-18 18:20:00.106078|2017-02-18 18:20:00.106078
NCT00003151|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||September 1997||1997-09-01|June 2012|2012-06-01||||October 1998|Actual|1998-10-01||Interventional|||Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma|A Phase II Clinical Trial of Anti-Helicobacter Pylori Treatment in Endoscopically Diagnosed Low-Grade Localized Gastric Lymphoma|Completed||Phase 2|96|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:00.213452|2017-02-18 18:20:00.213452
NCT00003150|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||December 1997||1997-12-01|August 2010|2010-08-01|September 2006|Actual|2006-09-01|||||Interventional|||Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma|Phase III Trial of CHOP Versus CHOP and Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8) in Older Patients With Diffuse Mixed, Diffuse Large Cell and Immunoblastic Large Cell Histology Non-Hodgkin's Lymphoma|Completed||Phase 3|630|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:00.344759|2017-02-18 18:20:00.344759
NCT00003149|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||December 1997||1997-12-01|March 2009|2009-03-01|September 2006|Actual|2006-09-01|||||Interventional|||Interleukin-12 in Treating Patients With Multiple Myeloma|Phase II of Interleukin-12 for Plateau Phase Multiple Myeloma|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:00.549669|2017-02-18 18:20:00.549669
NCT00003148|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||October 1997||1997-10-01|June 2012|2012-06-01||||April 2001|Actual|2001-04-01||Interventional|||Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia|Phase II Study of the Efficacy of rH Interleukin-2 in Patients With Slowly Progressing Acute Myelogenous Leukemia (AML) and With Limited Bone Marrow Blastosis After Autologous Stem Cell Transplantation or Chemotherapy|Completed||Phase 2|86|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:00.643656|2017-02-18 18:20:00.643656
NCT00003147|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2013-02-04|||February 1998||1998-02-01|May 2000|2000-05-01||||June 2003|Actual|2003-06-01||Interventional|||Gene Therapy in Treating Patients With Cancer of The Liver|Phase I Study of Percutaneous Injections of Adeno-Virus p53 Construct (ADENO-p53) for Hepatocellular Carcinoma|Terminated||Phase 1|30|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:20:00.739828|2017-02-18 18:20:00.739828
NCT00003146|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-06-21|||November 1997||1997-11-01|June 2011|2011-06-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma|A Phase II Trial of Thiotepa, Busulfan, and Melphalan Followed by Autologous or Syngeneic Marrow or Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma|Completed||Phase 2|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:20:00.837512|2017-02-18 18:20:00.837512
NCT00003145|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-04|||August 1997||1997-08-01|January 2017|2017-01-01||||March 2005|Actual|2005-03-01||Interventional|||Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia|Induction of Mixed Hematopoietic Chimerism Using Fludarabine, Low Dose TBI , PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil to be Followed by Donor Lymphocyte Infusion In Patients With Chronic Myeloid Leukemia in Chronic and Accelerated Phases: A Multi-center Study|Active, not recruiting||Phase 2|18|Actual|Fred Hutchinson Cancer Research Center||1|||f||||t||||||||||2017-02-18 18:20:00.9246|2017-02-18 18:20:00.9246
NCT00003144|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-25|||August 1997||1997-08-01|March 2011|2011-03-01||||April 2001|Actual|2001-04-01||Interventional|||Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors|Phase I Study of Amifostine (Ethyol) as a Cytoprotector of Gemcitabine/Cisplatin Combination|Completed||Phase 1|44|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:20:01.053993|2017-02-18 18:20:01.053993
NCT00003143|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-03|||November 1997||1997-11-01|October 2012|2012-10-01||||December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation|A Randomized Study of Ethyol (Amifostine) With Platinum Based Salvage Chemotherapy in Patients With Lymphoma Undergoing Autologous Stem Cell Transplantation|Completed||Phase 2|20|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:01.41334|2017-02-18 18:20:01.41334
NCT00003141|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-03-27|||March 1998||1998-03-01|March 2014|2014-03-01|October 2011|Actual|2011-10-01|December 2007|Actual|2007-12-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors|A Pilot Study of Intensive Chemotherapy With Peripheral Stem Cell Support for Infants With Malignant Brain Tumors|Completed||Phase 1|94|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:01.538844|2017-02-18 18:20:01.538844
NCT00003140|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-09-18|||August 1998||1998-08-01|March 2012|2012-03-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Letrozole After Tamoxifen in Treating Women With Breast Cancer|A Phase III Randomized Double Blind Study of Letrozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen|Completed||Phase 3|5187|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:20:01.789149|2017-02-18 18:20:01.789149
NCT00003139|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-14|||March 1998||1998-03-01|November 2015|2015-11-01|October 2002|Actual|2002-10-01|January 2001|Actual|2001-01-01||Interventional|||Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer|A Phase III Study to Test the Efficacy of the Prophylactic Use of Oral Pilocarpine to Reduce Hyposalivation and Mucositis Associated With Curative Radiation Therapy in Head and Neck Cancer Patients|Completed||Phase 3|249|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:02.027692|2017-02-18 18:20:02.027692
NCT00003138|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-06|2013-09-11||December 1997||1997-12-01|October 2015|2015-10-01|May 2014|Actual|2014-05-01|August 2008|Actual|2008-08-01||Interventional||All patients with complete data are included.|Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes|Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes|Completed||Phase 3|118|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:02.429975|2017-02-18 18:20:02.429975
NCT00003137|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||December 1997||1997-12-01|July 2016|2016-07-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Irinotecan in Treating Patients With Advanced Cancer of the Stomach|A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53|Completed||Phase 2|70|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:20:03.135294|2017-02-18 18:20:03.135294
NCT00003136|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||December 1996||1996-12-01|February 2013|2013-02-01|October 2001|Actual|2001-10-01|December 2000|Actual|2000-12-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer|A Phase I/II Dose Escalation Trial of Carboplatin With Amifostine Pretreatment to Augment High Dose Cyclophosphamide With Autologous Peripheral Blood Stem Cell Support for the Treatment of Patients With Epithelial Ovarian Cancer|Completed||Phase 1/Phase 2|11|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:20:03.271586|2017-02-18 18:20:03.271586
NCT00003135|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-04-29|||November 1997||1997-11-01|December 2008|2008-12-01||||September 2009|Anticipated|2009-09-01||Interventional|||Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer|A Phase I-II Trial of Mild Whole-Body Hyperthermia Combined With Liposomal Doxorubicin/5-Fluorouracil in Patients With Advanced Malignancy|Unknown status|Recruiting|Phase 2|34|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:03.382318|2017-02-18 18:20:03.382318
NCT00003134|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-05|||January 1998||1998-01-01|December 2016|2016-12-01|January 2009|Actual|2009-01-01|October 2001|Actual|2001-10-01||Interventional|||Irinotecan in Treating Patients With Recurrent Glioma|A Phase II Trial of Irinotecan in Recurrent Glioma|Completed||Phase 2|64|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:20:03.484249|2017-02-18 18:20:03.484249
NCT00003133|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-26|||September 1997||1997-09-01|June 2013|2013-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer|Sequential Gemcitabine, Doxorubicin, Then Paclitaxel Plus Cisplatin Adjuvant Chemotherapy After Complete Resection of Locally Advanced Transitional Cell Carcinoma of the Urothelium|Completed||Phase 1|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:03.611428|2017-02-18 18:20:03.611428
NCT00003132|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-08|||January 1998||1998-01-01|November 2009|2009-11-01||||November 2001|Actual|2001-11-01||Interventional|||Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer|Phase I Study of Bryostatin-1 (NSC 339555) and Cisplatin in Advanced Malignancies|Completed||Phase 1|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:20:03.702513|2017-02-18 18:20:03.702513
NCT00003131|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-21|||February 1997||1997-02-01|August 2012|2012-08-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse|A Study of the Efficacy and Safety of CMA-676 as Single Agent Treatment of Patients With Acute Myeloid Leukemia (AML) in First Relapse|Completed||Phase 2|55|Anticipated|Pfizer|||||f||||||||||||||2017-02-18 18:20:03.79804|2017-02-18 18:20:03.79804
NCT00003130|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-15|||November 1997||1997-11-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|January 2002|Actual|2002-01-01||Interventional|||Paclitaxel in Treating Women With Recurrent Solid Tumors|Prospective Evaluation of Body Surface Area (BSA) as a Determinant of Paclitaxel Pharmacokinetics/Pharmacodynamics in Women With Solid Tumors|Completed||Phase 2|32|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:20:06.94183|2017-02-18 18:20:06.94183
NCT00003129|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-06-06|||July 1998||1998-07-01|January 2002|2002-01-01||||November 2002|Actual|2002-11-01||Interventional|||Chemotherapy in Treating Patients With Early-Stage Bladder Cancer|Phase II Study of Intravesical Therapy With AD 32 in Patients With Papillary Urothelial Carcinoma or Carcinoma in Situ (CIS) Refractory to Prior Therapy With Bacillus Calmette-Guerin|Completed||Phase 2|75|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:07.077925|2017-02-18 18:20:07.077925
NCT00003128|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-08|||November 1997||1997-11-01|May 2004|2004-05-01||||February 2007|Actual|2007-02-01||Interventional|||Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus|A Phase III Trial of Ifosfamide (NSC #109274) Versus Ifosfamide Plus Paclitaxel (NSC #125973) in Patients With Advanced, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus|Completed||Phase 3|166|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:20:07.178571|2017-02-18 18:20:07.178571
NCT00003127|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-13|||February 1998||1998-02-01|June 2012|2012-06-01|July 2004|Actual|2004-07-01|April 2003|Actual|2003-04-01||Interventional|||S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer|Phase II Trial of Paclitaxel and Carboplatin With Amifostine in Advanced Recurrent or Refractory Endometrial Adenocarcinoma|Completed||Phase 2|57|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:20:07.296894|2017-02-18 18:20:07.296894
NCT00003126|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-02|||June 1997||1997-06-01|January 2017|2017-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer|A Randomized Controlled Phase III Adjuvant Trial of High-Dose Bolus IL-2 in Patients With High-Risk Renal Cell Carcinoma|Completed||Phase 3|69|Actual|Loyola University||2|||f||||t||||||||No|There is no plan to share individual participant data|2017-02-18 18:20:07.795517|2017-02-18 18:20:07.795517
NCT00003125|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-22|||January 1998||1998-01-01|May 2007|2007-05-01|November 2004|Actual|2004-11-01|November 2004|Actual|2004-11-01||Interventional|||Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors|A Pilot Study of Sequential Vaccinations With ALVAC-CEA and Vaccinia-CEA With the Addition of IL-2 and GM-CSF in Patients With CEA Expressing Tumors|Completed||Phase 2|24|Anticipated|Georgetown University|||||f||||f||||||||||2017-02-18 18:20:07.937293|2017-02-18 18:20:07.937293
NCT00003124|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||May 1997||1997-05-01|December 2002|2002-12-01|January 2007|Actual|2007-01-01|||||Interventional|||Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer|Phase II Trial of Maximal Androgen Deprivation Followed by Conformal External Beam Radiotherapy With Continued Androgen Deprivation for Clinically Localized Prostate Cancer|Completed||Phase 2|105|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:08.038343|2017-02-18 18:20:08.038343
NCT00003123|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||August 1997||1997-08-01|January 2004|2004-01-01||||||||Interventional|||Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome|A Phase II Trial of Ethyol (Amifostine) in Adult Patients With Advanced Myelodysplastic Syndromes|Unknown status|Active, not recruiting|Phase 2|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:08.13852|2017-02-18 18:20:08.13852
NCT00003122|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-23|||December 1994||1994-12-01|July 2007|2007-07-01||||||||Interventional|||Surgery in Treating Patients With Neuroblastoma|Phase II Trial of Surgery as the Only Treatment for INSS Stage 2A & 2B Neuroblastoma|Unknown status|Recruiting|Phase 2|210|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:08.245465|2017-02-18 18:20:08.245465
NCT00003120|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-10-07|||November 1997||1997-11-01|October 2014|2014-10-01|November 2012|Actual|2012-11-01|June 2003|Actual|2003-06-01||Interventional|||S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission|Phase III Randomized Trial of 12 Months vs. 3 Months of Paclitaxel in Patients With Advanced Ovarian Cancer Who Attain a Clinically Defined Complete Response (CR) Following Platinum/Paclitaxel-Based Chemotherapy|Completed||Phase 3|308|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:08.426471|2017-02-18 18:20:08.426471
NCT00003119|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-02-29|||March 1998||1998-03-01|February 2016|2016-02-01||||March 2006|Actual|2006-03-01||Interventional|||Surgery in Treating Children With Neuroblastoma|Primary Surgical Therapy for Biologically Defined Low-Risk Neuroblastoma: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study|Active, not recruiting||Phase 3|968|Actual|Children's Oncology Group||2|||f||||f||||||||||2017-02-18 18:20:08.926584|2017-02-18 18:20:08.926584
NCT00003118|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||October 1997||1997-10-01|June 2016|2016-06-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus|A Prospective Randomized Phase III Trial Comparing Trimodality Therapy (Cisplatin, 5-FU, Radiotherapy, and Surgery) to Surgery Alone for Esophageal Cancer|Completed||Phase 3|56|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:20:09.298802|2017-02-18 18:20:09.298802
NCT00003117|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-28|||October 1997||1997-10-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|December 2004|Actual|2004-12-01||Interventional|||Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer|Single-Agent Versus Combination Chemotherapy in Advanced NSCLC: A CALGB Randomized Trial of Efficacy, Quality of Life, and Cost-Effectiveness|Completed||Phase 3|584|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:20:09.450443|2017-02-18 18:20:09.450443
NCT00003116|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-09|||May 1997||1997-05-01|June 2010|2010-06-01|June 2009|Actual|2009-06-01|March 2006|Actual|2006-03-01||Interventional|||High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer|Allogeneic Peripheral Blood Progenitor Cell Transplantation Using Histocompatible Sibling-Matched Donor Cells After High-Dose Busulfan/Cyclophosphamide as Therapy for Hematologic Malignancies|Completed||Phase 2|66|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:20:09.86192|2017-02-18 18:20:09.86192
NCT00003115|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-02-22|||June 1996||1996-06-01|February 2011|2011-02-01|February 2004|Actual|2004-02-01|January 2003|Actual|2003-01-01||Interventional|||Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy|Spinal Effects of Epidural Hydromorphone|Completed||Phase 3|40|Anticipated|Roswell Park Cancer Institute|||||f||||t||||||||||2017-02-18 18:20:09.982567|2017-02-18 18:20:09.982567
NCT00003114|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-09|||July 1997||1997-07-01|June 2010|2010-06-01|February 2003|Actual|2003-02-01|June 2002|Actual|2002-06-01||Interventional|||Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease|Oral Combination Chemotherapy in the Treatment of AIDS-Associated Hodgkin's Disease|Completed||Phase 2|5|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:20:10.071665|2017-02-18 18:20:10.071665
NCT00003113|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-01-13|||July 1997||1997-07-01|January 2011|2011-01-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas|Oral Combination Chemotherapy in Conjunction With G-CSF in the Treatment of Elderly Patients With Intermediate and High Grade Non-Hodgkin's Lymphoma|Terminated||Phase 2|6|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:20:10.175555|2017-02-18 18:20:10.175555
NCT00003109|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-16|||December 1997||1997-12-01|April 2013|2013-04-01|January 2001|Actual|2001-01-01|October 2000|Actual|2000-10-01||Interventional|||Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors|Phase I Pharmacokinetic and Pharmacodynamic Trial of Irinotecan in Combination With Tomudex in Patients With Refractory Solid Malignancies|Completed||Phase 1|39|Actual|Fox Chase Cancer Center|||||f||||f||||||||||2017-02-18 18:20:10.503561|2017-02-18 18:20:10.503561
NCT00003108|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-17|||October 1997||1997-10-01|July 2004|2004-07-01|October 2007|Actual|2007-10-01|||||Interventional|||Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer|A Phase I Study of Bryostatin and Cisplatin in Patients With Advanced Cancer|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:10.602628|2017-02-18 18:20:10.602628
NCT00003107|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-09-09|||October 1997||1997-10-01|September 2014|2014-09-01||||||||Interventional|||Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors|A Phase I Trial of Recombinant Human Interleukin-12 After High-Dose Therapy and Autologous Hematopoietic Stem Cell Support|Completed||Phase 1|||Indiana University|||||f||||||||||||||2017-02-18 18:20:10.703022|2017-02-18 18:20:10.703022
NCT00003105|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-02|||September 1997||1997-09-01|July 2013|2013-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer|Phase I/II Trial of Sequential Doxorubicin/Gemcitabine (AG) and Ifosfamide, Paclitaxel, and Cisplatin (ITP) Chemotherapy (AG-ITP) in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium|Completed||Phase 1/Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:10.825307|2017-02-18 18:20:10.825307
NCT00003104|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||June 1997||1997-06-01|June 2013|2013-06-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer|A Phase II Study Using High Dose Three Dimensional Conformal Radiation Therapy in Intermediate Prognostic Risk Patients With Adenocarcinoma of the Prostate|Completed||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:10.931672|2017-02-18 18:20:10.931672
NCT00003103|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||August 1997||1997-08-01|July 2013|2013-07-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Chemotherapy in Treating Patients With Solid Tumors|A Phase I/IIA Dose-Escalating Trial of BCL-2 Antisense (G3139) Treatment for Patients With Androgen-Independent Prostate Cancer or Other Advanced Solid Tumor Malignancies|Completed||Phase 1/Phase 2|57|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:11.020282|2017-02-18 18:20:11.020282
NCT00003102|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-12-02|||July 1997||1997-07-01|December 2009|2009-12-01||||August 2000|Actual|2000-08-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer|Phase I/II Study of 131-I-Labeled Chimeric Antibody G250 (131-I-cG250) in Patients With Advanced Renal Carcinoma|Completed||Phase 1/Phase 2|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:11.134573|2017-02-18 18:20:11.134573
NCT00003101|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||August 1997||1997-08-01|June 2013|2013-06-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma|A Phase II Trial of Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma|Completed||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:11.22881|2017-02-18 18:20:11.22881
NCT00003100|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||October 1996||1996-10-01|June 2000|2000-06-01||||||||Interventional|||Dietary Soy Isoflavones for the Prevention of Cancer|Metabolic Fate and Plasma Kinetics of Dietary Soy Isoflavones|Unknown status|Active, not recruiting|N/A|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:11.33946|2017-02-18 18:20:11.33946
NCT00003099|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||May 1996||1996-05-01|July 2012|2012-07-01|January 2003|Actual|2003-01-01|June 2000|Actual|2000-06-01||Interventional|||Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer|Phase II Clinical Trial of N-(4-hydroxyphenyl) Retinamide (4-HPR) and Tamoxifen in Breast Neoplasia, Administration During the Period Between the Diagnostic Core Biopsy and Definitive Surgery|Completed||Phase 2|52|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:11.429062|2017-02-18 18:20:11.429062
NCT00003098|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-01-29|||August 1997||1997-08-01|January 2016|2016-01-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Diet and Estrogen Metabolism in Postmenopausal Women|Diet and Estrogen Metabolism in Postmenopausal Women|Completed||N/A|12|Actual|Jonsson Comprehensive Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:11.554426|2017-02-18 18:20:11.554426
NCT00003097|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||April 1989||1989-04-01|October 2007|2007-10-01||||||||Interventional|||Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer|Skin Cancer Prophylaxis by Low-Fat Dietary Intervention|Unknown status|Active, not recruiting|Phase 2|175|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:11.665064|2017-02-18 18:20:11.665064
NCT00003096|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-05|||December 1996||1996-12-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|March 2006|Actual|2006-03-01||Observational|||Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors|Molecular Biology of Pediatric Brain Tumors|Completed||N/A|88|Actual|Children's Oncology Group|||||f||||f||||||||||2017-02-18 18:20:11.763442|2017-02-18 18:20:11.763442
NCT00003095|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-23|||November 1997||1997-11-01|October 2015|2015-10-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Observational|||S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer|S9719: Clonal Hematopoiesis as a Marker of Genetic Damage Following Adjuvant Chemotherapy for Breast Cancer: Pilot Study to Evaluate Incidence. Ancillary to S9623|Completed||N/A|26|Actual|Southwest Oncology Group|||2||f||||f||||||Samples With DNA|"~     tissue and blood~   "|||2017-02-18 18:20:11.913846|2017-02-18 18:20:11.913846
NCT00003094|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-19|||October 1997||1997-10-01|August 2007|2007-08-01||||||||Interventional|||Carotenoid Rich Diet in Treating Cervical Dysplasia|Carotenoid-Rich Diet Trial to Reverse CIN II|Withdrawn||Phase 2|0|Actual|University of California, San Diego||||Study was halted prematurely, prior to enrollment of first participant|f||||||||||||||2017-02-18 18:20:12.343343|2017-02-18 18:20:12.343343
NCT00003093|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-31|||March 1988||1988-03-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy in Treating Children With Neuroblastoma|Treatment for Infants and Children With Intermediate Risk Neuroblastoma: A Phase III Intergroup CCG/POG Study|Completed||Phase 3|573|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:12.451074|2017-02-18 18:20:12.451074
NCT00003091|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-05-10|||January 1996||1996-01-01|May 2011|2011-05-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma|Treatment of Metastatic Renal Cell Carcinoma and Melanoma With Subsequential High-Dose Subcutaneous Interferon Alfa-2b and High-Dose Bolus and Continuous Intravenous Interleukin-2|Completed||Phase 2|40|Anticipated|Hoag Memorial Hospital Presbyterian||1|||f||||f||||||||||2017-02-18 18:20:12.965974|2017-02-18 18:20:12.965974
NCT00003090|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||January 1996||1996-01-01|July 2000|2000-07-01||||||||Interventional|||Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer|Phase II Trial of Bolus Interleukin-2 in Previously Treated Lung Cancer|Unknown status|Active, not recruiting|Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:13.066817|2017-02-18 18:20:13.066817
NCT00003089|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09|||July 1997||1997-07-01|May 2006|2006-05-01|February 2004|Actual|2004-02-01|||||Interventional|||Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer|A Phase II Trial of Induction Paclitaxel Plus Carboplatin Followed by Thoracic Radiation Therapy With Concurrent Weekly Low-Dose Paclitaxel and Twice Weekly Amifostine for Patients With Unresectable Locally Advanced or Partially Resected Non-Small Cell Lung Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:13.151718|2017-02-18 18:20:13.151718
NCT00003088|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||September 1997||1997-09-01|July 2016|2016-07-01|June 2003|Actual|2003-06-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Breast Cancer|A Randomized Phase III Trial of Sequential Chemotherapy Using Doxorubicin, Paclitaxel, and Cyclophosphamide or Concurrent Doxorubicin and Cyclophosphamide Followed by Paclitaxel at 14 or 21 Day Intervals in Women With Node Positive Stage II/IIIA Breast Cancer|Completed||Phase 3|2005|Actual|Alliance for Clinical Trials in Oncology||4|||f||||t||||||||||2017-02-18 18:20:13.245985|2017-02-18 18:20:13.245985
NCT00003087|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||August 1997||1997-08-01|June 2013|2013-06-01|February 2005|Actual|2005-02-01|February 2005|Actual|2005-02-01||Interventional|||Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus|Phase II Trial of Preoperative Combined Modality Therapy for Localized Esophageal Carcinoma: Cisplatin-Paclitaxel Followed by Radiation Therapy With Concurrent Cisplatin and Paclitaxel|Completed||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:13.395923|2017-02-18 18:20:13.395923
NCT00003086|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||March 1997||1997-03-01|December 2006|2006-12-01||||||||Interventional|||Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer|Phase I/II Study of Samarium 153 as Part of a Double (Sequential) Autologous Bone Marrow Transplant (ABMT) for Patients With Stage IV Breast Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|12|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:13.494605|2017-02-18 18:20:13.494605
NCT00003085|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||September 1996||1996-09-01|May 2014|2014-05-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer|Minimal Access Surgery for Pancreas Cancer: A Phase II Trial Study I: Staging of Pancreas Cancer|Terminated||Phase 2|28|Actual|University of Southern California||||Insufficient Accrual|f||||t||||||||||2017-02-18 18:20:13.597396|2017-02-18 18:20:13.597396
NCT00003084|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||December 1997||1997-12-01|July 2012|2012-07-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer|A Randomized Phase II Trial of Taxol/VP-16/Estramustine vs. Ketoconazole/Doxorubicin/Vinblastine/Estramustine in Androgen Independent Prostate Cancer|Completed||Phase 2|75|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:13.684452|2017-02-18 18:20:13.684452
NCT00003082|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-12|||December 1997||1997-12-01|May 2007|2007-05-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer|A Phase IA Trial of Combined Murine IgG Monoclonal Anti-Transferrin Receptor Antibodies E2.3 and A27.15 in Cancer Patients|Completed||Phase 1|27|Anticipated|University of Arizona|||||f||||||||||||||2017-02-18 18:20:13.82781|2017-02-18 18:20:13.82781
NCT00003081|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-16|||March 1998||1998-03-01|September 2010|2010-09-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma|A Phase I Trial of Busulfan, Thiotepa and Melphalan Followed by Autologous or Syngeneic Peripheral Blood Stem Cell Transplantation and Followed by Total Marrow (Skeletal) Irradiation (TMI) in Patients With High-Risk Ewing's Sarcoma, PNET or Rhabdomyosarcoma|Completed||Phase 1|16|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:20:13.938208|2017-02-18 18:20:13.938208
NCT00003080|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-13|||September 1996||1996-09-01|September 2010|2010-09-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer|A Phase I Trial of Sequential High Dose Chemotherapy Regimens Followed by Autologous or Syngeneic Peripheral Blood Stem Cell (PBSC) Rescue in Patients With Persistent Stage III/IV Ovarian Cancer|Completed||Phase 1|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:20:14.040639|2017-02-18 18:20:14.040639
NCT00003079|ClinicalTrials.gov processed this data on February 17, 2017|2000-05-02|2010-02-15|||September 1997||1997-09-01|February 2010|2010-02-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma|Phase I Study of Bryostatin 1 (NSC 339555) and High-Dose 1-Beta-D-Arabinofuranosylcytosine (HiDAC) in Patients With Refractory Leukemia|Completed||Phase 1|30|Actual|Virginia Commonwealth University||5|||f||||f||||||||||2017-02-18 18:20:14.130058|2017-02-18 18:20:14.130058
NCT00003078|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-08|||October 1997||1997-10-01|April 2011|2011-04-01||||November 2005|Actual|2005-11-01||Interventional|||Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix|A Randomized Comparison of Radiation vs Radiation Plus Weekly Cisplatin vs Radiation Plus PVI (Protracted Venous Infusion) 5-FU in Patients With Stage II-B, III-B, and IV-A Carcinoma of the Cervix With Negative Paraaortic Nodes|Completed||Phase 3|870|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:20:14.221753|2017-02-18 18:20:14.221753
NCT00003077|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||October 1995||1995-10-01|July 2016|2016-07-01|November 2004|Actual|2004-11-01|July 2004|Actual|2004-07-01||Interventional|||Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss|Phase I/II Trial of Omega-3 Fatty Acids for Cancer Cachexia|Completed||Phase 1/Phase 2|63|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:20:14.641857|2017-02-18 18:20:14.641857
NCT00003076|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-12-18|||October 1995||1995-10-01|December 2012|2012-12-01|October 2005|Actual|2005-10-01|June 2002|Actual|2002-06-01||Interventional|||Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus|Phase IIb Chemoprevention Trial of Difluoromethylornithine (DFMO) in Human Subjects With Intestinal-type Barrett's Esophagus|Completed||Phase 2|152|Anticipated|University of Michigan Cancer Center|||||f||||||||||||||2017-02-18 18:20:14.758291|2017-02-18 18:20:14.758291
NCT00003075|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||September 1992||1992-09-01|July 2012|2012-07-01|May 2001|Actual|2001-05-01|September 2000|Actual|2000-09-01||Interventional|||Fenretinide in Treating Patients With Cervical Neoplasia|A Randomized Double-Blind Study of N-(4-hydroxyphenyl) Retinamide (4-HPR) Versus Placebo in Patients With Cervical Intraepithelial Neoplasia (CIN) Grade 2-3|Completed||Phase 3|39|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:14.851929|2017-02-18 18:20:14.851929
NCT00003073|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-22|||February 1997||1997-02-01|April 2002|2002-04-01||||||||Interventional|||Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors|A Phase I Dose Escalation Study of Intrathecal DepoFoam Encapsulated Cytarabine (DTC 101) in Pediatric Patients With Advanced Meningeal Malignancies|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:14.96917|2017-02-18 18:20:14.96917
NCT00003072|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-19|||May 1997||1997-05-01|September 2012|2012-09-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer|Amifostine (Ethyol) as a Protectant in Metastatic Ovarian and Non-Small Cell Lung Cancer in Paclitaxel/Carboplatin-Treated Patients: A Comparative Trial|Completed||Phase 2|80|Anticipated|University of California, San Francisco|||||f||||||||||||||2017-02-18 18:20:15.068202|2017-02-18 18:20:15.068202
NCT00003070|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-04|||September 2000||2000-09-01|August 2014|2014-08-01|March 2007|Actual|2007-03-01|July 2003|Actual|2003-07-01||Interventional|||Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer|Afterload Reduction Therapy for Late Anthracycline Cardiotoxicity: A Pediatric Oncology Group Cancer Control Study|Completed||Phase 3|13|Actual|Children's Oncology Group||8|||f||||t||||||||||2017-02-18 18:20:15.166604|2017-02-18 18:20:15.166604
NCT00003068|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-30|||June 1997||1997-06-01|May 2006|2006-05-01|November 2002|Actual|2002-11-01|||||Interventional|||High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer|An Out Patient Dose Escalation Trial of High Dose Mitoxantrone, Thiotepa and Cyclophosphamide Plus Autologous Blood Cell Rescue and Amifostine Cytoprotection|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:15.354686|2017-02-18 18:20:15.354686
NCT00003067|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||July 1997||1997-07-01|October 2008|2008-10-01||||||||Interventional|||Biological Therapy in Treating Patients With Primary or Advanced Glioma|Intracavitary Interleukin-2 (IL-2) and Lymphokine-Activated Killer (LAK) Cell Therapy for Malignant Gliomas|Suspended||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:15.445766|2017-02-18 18:20:15.445766
NCT00003066|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||February 1997||1997-02-01|December 2006|2006-12-01||||||||Interventional|||Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer|Phase II Evaluation of Docetaxel Combined With Estramustine Phosphate in Patients With Metastatic Breast Cancer|Unknown status|Active, not recruiting|Phase 2|40|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:15.550234|2017-02-18 18:20:15.550234
NCT00003065|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||January 1997||1997-01-01|September 2003|2003-09-01|February 2004|Actual|2004-02-01|||||Interventional|||Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix|Phase II Investigation of Topotecan and Taxol in Patients With Recurrent/Metastatic Cancer of the Cervix|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:15.642194|2017-02-18 18:20:15.642194
NCT00003064|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||January 1997||1997-01-01|December 2002|2002-12-01||||||||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer|Phase I-II Study of Tandem Cycles of High Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Support in Women With Persistent, Refractory or Recurrent Advanced (Stage III or IV), Epithelial Ovarian Cancer|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:15.740826|2017-02-18 18:20:15.740826
NCT00003063|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||November 1991||1991-11-01|November 2005|2005-11-01||||||||Interventional|||Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer|Adjuvant Chemoimmunotherapy for Colorectal Cancer|Unknown status|Active, not recruiting|Phase 3|1050|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:15.846023|2017-02-18 18:20:15.846023
NCT00003062|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||July 1997||1997-07-01|June 2012|2012-06-01||||January 2002|Actual|2002-01-01||Interventional|||Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer|A Phase II Study of TEMOZOLOMIDE in Advanced Non-Small Cell Lung Cancer With and Without Brain Metastases|Completed||Phase 2|70|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:16.029082|2017-02-18 18:20:16.029082
NCT00003061|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||July 1997||1997-07-01|June 2012|2012-06-01||||March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma|Evaluating the MBVP Chemotherapy Schedule Followed by Consolidating Radiotherapy in Non-AIDS Related Primary Central Nervous System Lymphoma (NAPCL)|Completed||Phase 2|50|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:16.132751|2017-02-18 18:20:16.132751
NCT00003060|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||March 1995||1995-03-01|June 2002|2002-06-01||||||||Interventional|||Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma|Pilot Study for Matched-Related Allogeneic Bone Marrow Transplantation for Metastatic Malignant Melanoma|Unknown status|Active, not recruiting|Phase 1|6|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:16.243925|2017-02-18 18:20:16.243925
NCT00003058|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-02-09|||June 1997||1997-06-01|February 2017|2017-02-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Troglitazone in Treating Patients With Liposarcoma|Phase II Clinical Trial of TROGLITAZONE, a Ligand for the Peroxisome Proliferator-Activated Receptor Gamma (PPAR), as Antineoplastic Differentiation Therapy for Patients With Malignant Liposarcoma|Completed||Phase 2|85|Actual|Dana-Farber Cancer Institute||1|||f||||t||||||||No||2017-02-18 18:20:16.340795|2017-02-18 18:20:16.340795
NCT00003057|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-05-09|||November 1996||1996-11-01|January 2009|2009-01-01||||May 2000|Actual|2000-05-01||Interventional|||Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer|Randomized Trial of High-Dose Versus Conventional Dose Octreotide Acetate Versus Loperamide in the Treatment of Chemotherpay-Related Diarrhea in Patients With Colorectal Cancer|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:16.468002|2017-02-18 18:20:16.468002
NCT00003056|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-06-26|||April 1997||1997-04-01|May 2013|2013-05-01|June 2003||2003-06-01|June 2003||2003-06-01||Interventional|||Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation|Peripheral Blood Stem Cell Transplantation in Patients With Advanced Malignancies Eligible for Allogeneic Transplantation From Matched Related Donors: A Randomized Study of Cyclosporine/Methotrexate or Cyclosporine/T-Cell Depletion (CD34 Cell Selection) for GVHD Prophylaxis|Terminated||Phase 3|105|Actual|Baxalta US Inc.||2||Interim analysis indicated study should be terminated|||||t||||||||||2017-02-18 18:20:16.591964|2017-02-18 18:20:16.591964
NCT00003055|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||June 1997||1997-06-01|June 2013|2013-06-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer|Phase II Trial of Cisplatin and Irinotecan in Patients With Advanced Esophageal Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:16.765027|2017-02-18 18:20:16.765027
NCT00003054|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-10|||August 1997||1997-08-01|May 2003|2003-05-01||||April 2003||2003-04-01||Interventional|||Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus|Evaluation of Paclitaxel (Taxol) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:20:16.861516|2017-02-18 18:20:16.861516
NCT00003053|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||January 1994||1994-01-01|January 2008|2008-01-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed|Adjuvant Treatment of Non Small Cell Lung Cancer|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:17.02671|2017-02-18 18:20:17.02671
NCT00003052|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||July 1997||1997-07-01|November 2006|2006-11-01|June 2010|Actual|2010-06-01|||||Interventional|||Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma|Randomized Study Comparing Neoadjuvant Chemotherapy Etoposide + Ifosfamide + Adriamycin (EIA) Combined With Regional Hyperthermia (RHT) Versus Neoadjuvant Chemotherapy Alone in the Treatment of High-Risk Soft Tissue Sarcomas in Adults|Completed||Phase 3|340|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:17.480292|2017-02-18 18:20:17.480292
NCT00003050|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||April 1997||1997-04-01|May 2014|2014-05-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer|Weekly Paclitaxel During Radiation Therapy for Locally Advanced Breat Cancer|Completed||Phase 2|46|Actual|University of Southern California|||||f||||t||||||||||2017-02-18 18:20:17.600615|2017-02-18 18:20:17.600615
NCT00003049|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-20|||May 1997||1997-05-01|May 2011|2011-05-01|July 2007|Actual|2007-07-01|August 2005|Actual|2005-08-01||Interventional|||Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas|A Prospective, Randomized Trial of Extended Lymphadenectomy in the Management of Resectable Pancreatic Cancer|Completed||Phase 3|100|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 18:20:17.71223|2017-02-18 18:20:17.71223
NCT00003048|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||May 1997||1997-05-01|July 2012|2012-07-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Amifostine in Treating Patients With Myelodysplastic Syndrome|Phase II Study of Intravenous Amifostine in Myelodysplastic Syndrome|Completed||Phase 2|12|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:20:17.810219|2017-02-18 18:20:17.810219
NCT00003046|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||August 1997||1997-08-01|July 2012|2012-07-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Interleukin-12 in Treating Patients With Cancer in the Abdomen|Phase I Study of Intraperitoneal Recombinant Human Interleukin-12 (rhIL-12) in Patients With Peritoneal Carcinomatosis, Associated With Mullerian and Gastrointestinal Carcinomas|Completed||Phase 1|29|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:20:17.948378|2017-02-18 18:20:17.948378
NCT00003045|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||April 1997||1997-04-01|November 2002|2002-11-01||||||||Interventional|||Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer|A Phase II Trial of Hyperthermia and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate|Unknown status|Active, not recruiting|Phase 2|65|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:18.076328|2017-02-18 18:20:18.076328
NCT00003044|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||September 1996||1996-09-01|April 2000|2000-04-01||||||||Interventional|||Chemotherapy in Treating Patients With Liver Cancer|A Two-Stage Phase II Safety and Efficacy Study of IntraDose (Cisplatin/Epinephrine) Injectable Gel (MPI 5010) Administered to Patients With Unresectable Primary Hepatocellular Carcinoma|Unknown status|Active, not recruiting|Phase 2|55|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:18.176382|2017-02-18 18:20:18.176382
NCT00003042|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-09-16|||May 1997||1997-05-01|September 2016|2016-09-01||||September 2017|Anticipated|2017-09-01||Interventional|||Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer|Dose-Intense Chemotherapy and Stem Cell Rescue in the Treatment of Inflammatory Breast Carcinoma|Active, not recruiting||Phase 2|60|Anticipated|City of Hope Medical Center||2|||f||||||||||||||2017-02-18 18:20:18.273941|2017-02-18 18:20:18.273941
NCT00003041|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-30|||July 1997||1997-07-01|January 2002|2002-01-01|January 2002|Actual|2002-01-01|||||Interventional|||Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer|Phase II Evaluation of Pyrazoloacridine (NSC #366140) in Patients With Metastatic Breast Cancer|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:18.402331|2017-02-18 18:20:18.402331
NCT00003040|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-13|||September 1997||1997-09-01|June 2012|2012-06-01|December 2007|Actual|2007-12-01|February 2007|Actual|2007-02-01||Interventional|||S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx|A Phase II Study to Evaluate Transoral CO2 Laser Supraglottic Laryngectomy and Irradiation in Stage I, II and III Squamous Cell Carcinoma of the Supraglottic Larynx|Terminated||Phase 2|42|Actual|Southwest Oncology Group||1||Poor accrual|f||||f||||||||||2017-02-18 18:20:18.506297|2017-02-18 18:20:18.506297
NCT00003039|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||September 1997||1997-09-01|April 2000|2000-04-01||||April 2000|Actual|2000-04-01||Interventional|||Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma|A Phase II Trial of Flavopiridol (NSC 649890) Administered as a 72-Hour Continuous Infusion Every 2 Weeks in Patients With Previously Treated Intermediate and High Grade Non-Hodgkin's Lymphoma Including Mantle Cell Lymphoma|Completed||Phase 2|40|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:18.649473|2017-02-18 18:20:18.649473
NCT00003038|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-08-02|||October 1997||1997-10-01|August 2011|2011-08-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors|A Phase I Trial of Suramin With Sequential Doxorubicin in Patients With Advanced Solid Tumors|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:20:18.775896|2017-02-18 18:20:18.775896
NCT00003037|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||April 1997||1997-04-01|June 2013|2013-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer|Phase I/II Trial of the Combination of Docetaxel, Gemcitabine and Cisplatin (DGP) as Induction Chemotherapy in Patients With Stage III Non-Small Cell Lung Cancer|Completed||Phase 1/Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:18.877664|2017-02-18 18:20:18.877664
NCT00003035|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-22|||March 1997||1997-03-01|December 2006|2006-12-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer|A Pilot Trial Comparing Doxorubicin and Paclitaxel Induced Apoptosis in Locally Advanced Breast Cancer|Completed||Phase 2|40|Anticipated|Georgetown University|||||f||||f||||||||||2017-02-18 18:20:18.981814|2017-02-18 18:20:18.981814
NCT00003034|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||May 1997||1997-05-01|October 2007|2007-10-01||||February 2008|Anticipated|2008-02-01||Interventional|||ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen|ONCONASE Plus Doxorubicin Versus Doxorubicin For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:20:19.074648|2017-02-18 18:20:19.074648
NCT00003032|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-07|||April 1997||1997-04-01|November 2010|2010-11-01|December 2008|Actual|2008-12-01|||||Interventional|||High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer|A Randomized Trial of High-Dose Chemotherapy and Autologous Stem Cell Therapy Versus Standard Therapy in Women With Metastatic Breast Cancer Who Have Responded to Anthracycline or Taxane-Based Induction Chemotherapy|Completed||Phase 3|192|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:20:19.200076|2017-02-18 18:20:19.200076
NCT00003031|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||June 1997||1997-06-01|June 2012|2012-06-01||||October 2000|Actual|2000-10-01||Interventional|||Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis|An Open Randomised Comparative Multicentre Study of the Efficacy, Safety and Toleration of Voriconazole Versus Amphotericin-B in the Treatment of Acute Invasive Aspergillosis in Immunocompromised Patients|Completed||Phase 3|212|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:19.319227|2017-02-18 18:20:19.319227
NCT00003029|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||May 1997||1997-05-01|June 2012|2012-06-01||||July 2003|Actual|2003-07-01||Interventional|||Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas|Infusional 5-Fluorouracil With or Without Cisplatin and With or Without Chronomodulation Against Locally-Advanced or Metastatic Pancreatic Cancer. A Multicenter Randomized Phase III Trial.|Completed||Phase 3|200|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:19.552679|2017-02-18 18:20:19.552679
NCT00003028|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||April 1997||1997-04-01|June 2012|2012-06-01||||||||Interventional|||MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors|Phase I Study to Determine the Safety of MEN-10755 (BMS-195615) in Patients With a Solid Tumor on a Short I.V. Infusion Given Once Every 3 Weeks|Completed||Phase 1|5|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:19.661276|2017-02-18 18:20:19.661276
NCT00003027|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-28|||October 1997||1997-10-01|January 2010|2010-01-01||||July 2007|Actual|2007-07-01||Interventional|||Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma|A Randomized Phase III Trial of Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, IL-2 and Interferon A-2B Versus Cisplatin, Vinblastine, Dacarbazine Alone in Patients With Metastatic Malignant Melanoma|Completed||Phase 3|482|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-02-18 18:20:19.799016|2017-02-18 18:20:19.799016
NCT00003026|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||April 1997||1997-04-01|June 2012|2012-06-01||||September 2001|Actual|2001-09-01||Interventional|||Hormone Therapy in Treating Patients With Advanced Prostate Cancer|Long Term Adjuvant Hormonal Treatment With LHRH Analogue Versus No Further Treatment in Locally Advanced Prostatic Carcinoma Treated by External Irradiation and a Six Months Combined Androgen Blockade - A Phase III Study|Completed||Phase 3|966|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:22.958005|2017-02-18 18:20:22.958005
NCT00003025|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||March 1997||1997-03-01|July 2013|2013-07-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer|A Phase I Pilot Trial of Immunotherapy With Autologous Tumor-Derived gp96 Heat Shock Protein - Peptide Complex (HSPPC-96) in Patients With Resected Pancreatic Adenocarcinoma|Completed||Phase 1|16|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:23.074177|2017-02-18 18:20:23.074177
NCT00003023|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-17|||March 1997||1997-03-01|January 2013|2013-01-01||||January 2005|Actual|2005-01-01||Interventional|||Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer|Phase I Trial of A1G4 Anti-Idiotypic Monoclonal Antibody With Bacille-Calmette-Guerin (BCG) Adjuvant in High Risk Patients With GD2 Positive Tumors|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:23.158411|2017-02-18 18:20:23.158411
NCT00003022|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||April 1997||1997-04-01|July 2013|2013-07-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer|Phase I Study of Intrathecal 131-I-3F8 Monoclonal Antibody in Patients With GD2 Positive Leptomeningeal Neoplasms|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:23.248871|2017-02-18 18:20:23.248871
NCT00003021|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-02|||August 1997||1997-08-01|November 2012|2012-11-01|November 2002|Actual|2002-11-01|November 2002|Actual|2002-11-01||Interventional|||Bizelesin in Treating Patients With Advanced Cancer|A Phase I Trial of Bizelesin (NSC 615291) Using a Single Bolus Infusion Given Every Twenty-eight (28) Days in Patients With Advanced Cancer|Completed||Phase 1|||The University of Texas Health Science Center at San Antonio|||||f||||||||||||||2017-02-18 18:20:23.352736|2017-02-18 18:20:23.352736
NCT00003020|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||September 1997||1997-09-01|February 2013|2013-02-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases|Protocol for a Phase I Study of Intrathecal LMB-7 (Single-Chain Immunotoxin Constructed From Monoclonal Antibody B3-Pseudomonas Exotoxin PE 38) [IND 5863, NSC 658931] in the Treatment of Patients With Leptomeningeal Neoplasms|Completed||Phase 1|24|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:20:23.514426|2017-02-18 18:20:23.514426
NCT00003019|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2014-07-24|||August 1997||1997-08-01|July 2014|2014-07-01|September 2006|Actual|2006-09-01|July 2003|Actual|2003-07-01||Interventional|||Vinblastine and Methotrexate in Treating Children With Desmoid Tumors|Vinblastine and Methotrexate in Children With Desmoid Tumor (Aggressive Fibromatosis) Which is Recurrent or Not Amenable to Surgical Resection or Irradiation - A Pediatric Oncology Group Phase II Study|Completed||Phase 2|28|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:23.825208|2017-02-18 18:20:23.825208
NCT00003018|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-02|||September 1997||1997-09-01|January 2013|2013-01-01|January 2007|Actual|2007-01-01|January 2002|Actual|2002-01-01||Interventional|||S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer|A Phase II Trial of Infusional 5-Fluorouracil (5-FU), Calcium Leucovorin (LV), Mitomycin-C (Mito-C), and Dipyridamole (D) in Patients With Locally Advanced Unresected Pancreatic Adenocarcinoma|Completed||Phase 2|54|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:24.000373|2017-02-18 18:20:24.000373
NCT00003017|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||July 1997||1997-07-01|July 2004|2004-07-01|August 2005|Actual|2005-08-01|||||Interventional|||Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix|Phase II Clinical Trial of Interleukin-12 in Patients With Advanced, Recurrent or Inoperable Carcinoma of the Cervix|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:24.220932|2017-02-18 18:20:24.220932
NCT00003016|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||October 1995||1995-10-01|October 2002|2002-10-01||||||||Interventional|||Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer|Reliable Assessment of the Efficacy and Safety of Prolonging the Use of Adjuvant Tamoxifen: A Large, Simple, Randomised Study|Unknown status|Active, not recruiting|Phase 3|20000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:24.318901|2017-02-18 18:20:24.318901
NCT00003015|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||January 1997||1997-01-01|January 2001|2001-01-01||||||||Interventional|||Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma|Ultimate Low Grade Glioma Study|Unknown status|Active, not recruiting|Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:24.413802|2017-02-18 18:20:24.413802
NCT00003014|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||April 1998||1998-04-01|March 2011|2011-03-01|July 2005|Actual|2005-07-01|||||Interventional|||Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer|Carboplatin in the Adjuvant Treatment of Stage I Seminoma: A Radomized Comparison of Single Agent Carboplatin With Radiotherapy in the Adjuvant Treatment of Stage I Seminoma of the Testis, Following Orchidectomy|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:24.522769|2017-02-18 18:20:24.522769
NCT00003013|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||October 1996||1996-10-01|June 2000|2000-06-01|March 2009|Actual|2009-03-01|||||Interventional|||Chemotherapy Plus Surgery in Treating Women With Breast Cancer|European Cooperative Study of Chemotherapy and Surgery Comparing Adjuvant Doxorubicin Followed by CMF vs. Adjuvant Doxorubicin/Paclitaxel Followed by CMF vs. Primary Doxorubicin/Paclitaxel Followed by CMF in Women With Operable Breast Cancer and T>2 cm|Completed||Phase 3|450|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:24.949619|2017-02-18 18:20:24.949619
NCT00003012|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||October 1996||1996-10-01|November 2008|2008-11-01||||||||Interventional|||Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer|A Prospective Randomized Comparison of CMF Versus Sequential Epirubicin Followed by SMF as Adjuvant Chemotherapy for Women With Early Breast Cancer|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:25.099938|2017-02-18 18:20:25.099938
NCT00003011|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-30|||March 1997||1997-03-01|January 2012|2012-01-01|December 2008|Actual|2008-12-01|January 2001|Actual|2001-01-01||Interventional|||Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer|A Phase III Study of Marimastat in Patients With Small Cell Lung Cancer Following a Response to First Line Chemotherapy|Completed||Phase 3|555|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:20:25.220439|2017-02-18 18:20:25.220439
NCT00003010|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||September 1997||1997-09-01|January 2010|2010-01-01||||December 2004|Actual|2004-12-01||Interventional|||Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy|A Randomized Phase III Trial of Marimastat Versus Placebo in Patients With Metastatic Breast Cancer Who Have Responding or Stable Disease After Induction Chemotherapy|Completed||Phase 3|334|Anticipated|Eastern Cooperative Oncology Group|||||f||||t||||||||||2017-02-18 18:20:25.37868|2017-02-18 18:20:25.37868
NCT00003009|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||February 1996||1996-02-01|May 2014|2014-05-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer|A Phase I Study of Inhalation of Interleukin-2 (IL-2) in Patients With Metastatic or Unresectable Cancer|Terminated||Phase 1|16|Actual|University of Southern California||||Insufficient Accrual|f||||t||||||||||2017-02-18 18:20:25.503386|2017-02-18 18:20:25.503386
NCT00003008|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||June 1997||1997-06-01|January 2010|2010-01-01||||June 2006|Actual|2006-06-01||Interventional|||Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma|Pilot Study to Evaluate the Potential Interactions Between Paclitaxel and Protease Inhibitors in Patients With AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|33|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:20:25.590826|2017-02-18 18:20:25.590826
NCT00003007|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||July 1996||1996-07-01|September 2002|2002-09-01|January 2004|Actual|2004-01-01|||||Interventional|||Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma|Interferon Maintenance in Advanced Multiple Myeloma After Using High-Dose Melphalan as Myeloablative Chemotherapy: A Pilot Study|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:25.691365|2017-02-18 18:20:25.691365
NCT00003006|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-28|||May 1997||1997-05-01|June 2016|2016-06-01|June 2010|Actual|2010-06-01|March 2002|Actual|2002-03-01||Observational|||Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer|Detection of Occult Micrometastases in Patients With Clinical Stage I NSCLC: A Prospective Analysis|Completed||N/A|501|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     Patients enrolled onto CALGB 9761 will have, at the time of thoracotomy (or video assisted~     lobectomy) and pulmonary resection, samples of bone marrow, primary tumor, and intrathoracic~     lymph nodes harvested.~   "|||2017-02-18 18:20:25.79464|2017-02-18 18:20:25.79464
NCT00003005|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-12|||December 1997||1997-12-01|June 2000|2000-06-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia|A Phase I Study of Cordycepin (NSC 63984) Plus 2'-Deoxycoformycin (NSC 218321) in Patients With Refractory TdT-Positive Leukemia|Completed||Phase 1|14|Actual|Boston Medical Center||1|||f||||t||||||||||2017-02-18 18:20:25.915926|2017-02-18 18:20:25.915926
NCT00003004|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||July 1997||1997-07-01|June 2013|2013-06-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors|An Open-Label, Non-Randomized Phase I Study of the Protein Kinase C Inhibitor Flavopiridol Administered in Combination With Paclitaxel in Patients With Advanced Solid Tumors|Completed||Phase 1|73|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:26.029395|2017-02-18 18:20:26.029395
NCT00003003|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-01|||September 1996||1996-09-01|June 2000|2000-06-01|August 2000|Actual|2000-08-01|August 2000|Actual|2000-08-01||Interventional|||Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia|A Pilot Clinical Trial of Mitomycin C Modulation of Multidrug Resistance Proteins and a Phase I Evaluation of Mitomycin C and Mitoxantrone in Patients With Acute Myelogenous Leukemia|Completed||Phase 1|29|Anticipated|Dartmouth-Hitchcock Medical Center|||||f||||t||||||||||2017-02-18 18:20:26.115132|2017-02-18 18:20:26.115132
NCT00003002|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-12-12|||April 1996||1996-04-01|December 2012|2012-12-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer|A Phase I Study of a HER-2/Neu Peptide Based Vaccine With GM-CSF as an Adjuvant in Patients With Advanced Stage HER-2/Neu Expressing Cancers|Completed||Phase 1|60|Actual|University of Washington||1|||f||||||||||||||2017-02-18 18:20:26.214771|2017-02-18 18:20:26.214771
NCT00003001|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||April 1997||1997-04-01|April 2002|2002-04-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer|Phase I/II Study of 5-Fluorouracil/Folinic Acid/Gemcitabine in Patients With Advanced Colorectal Carcinoma|Unknown status|Active, not recruiting|Phase 1/Phase 2|63|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:26.30889|2017-02-18 18:20:26.30889
NCT00003000|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-12|||May 1992||1992-05-01|October 2015|2015-10-01|June 2001|Actual|2001-06-01|January 2001|Actual|2001-01-01||Observational|||Morphine for the Treatment of Pain in Patients With Breast Cancer|Peripheral Effects of Opioid Analgesia in Patients Undergoing Axillary Node Dissection|Completed||N/A|18|Anticipated|Roswell Park Cancer Institute|||1||f||||t||||||||||2017-02-18 18:20:26.397345|2017-02-18 18:20:26.397345
NCT00002999|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-05-22||||||May 2015|2015-05-01||||||||Interventional|||S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx|S9715, Study of Patients With Advanced Nasopharyngeal Cancers Treated With Chemo-Radiotherapy, Phase II|Withdrawn||Phase 2|0|Actual|Southwest Oncology Group|||||f||||f||||||||||2017-02-18 18:20:26.483084|2017-02-18 18:20:26.483084
NCT00002998|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||August 1997||1997-08-01|July 2016|2016-07-01|May 2006|Actual|2006-05-01|April 2005|Actual|2005-04-01||Interventional|||Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer|Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer|Completed||Phase 2|59|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:20:26.571034|2017-02-18 18:20:26.571034
NCT00002997|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||August 1997||1997-08-01|March 2004|2004-03-01||||||||Interventional|||Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer|Phase II Trial of Cryoablation for Treatment of Unresectable Colorectal Hepatic Metastases|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:26.698072|2017-02-18 18:20:26.698072
NCT00002996|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-26|||February 1998||1998-02-01|January 2010|2010-01-01||||April 2006|Actual|2006-04-01||Interventional|||Flecainide in Treating Patients With Chronic Neuropathic Pain|Flecainide for the Treatment of Chronic Neuropathic Pain: A Phase II Trial|Completed||Phase 2|20|Anticipated|Eastern Cooperative Oncology Group|||||f||||f||||||||||2017-02-18 18:20:26.849638|2017-02-18 18:20:26.849638
NCT00002995|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-12|||August 1997||1997-08-01|February 2014|2014-02-01|January 2011|Actual|2011-01-01|September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma|Actinomycin D and Vincristine With or Without Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Rhabdomyosarcoma or Undifferentiated Sarcoma: IRS-V Protocol|Completed||Phase 3|483|Actual|Children's Oncology Group|||||f||||t||||||||||2017-02-18 18:20:27.160504|2017-02-18 18:20:27.160504
NCT00002994|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-27|||July 1997||1997-07-01|June 2016|2016-06-01|April 2002|Actual|2002-04-01|March 2000|Actual|2000-03-01||Interventional|||Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors|A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors|Completed||Phase 1|355|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:20:27.525974|2017-02-18 18:20:27.525974
NCT00002993|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-08|||August 1997||1997-08-01|May 2006|2006-05-01||||January 2000|Actual|2000-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus|Evaluation of Mitomycin, Doxorubicin and Cisplatin in the Treatment of Recurrent or Advanced Uterine Sarcomas|Terminated||Phase 2|30|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:20:27.6896|2017-02-18 18:20:27.6896
NCT00002990|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-11|||March 1997||1997-03-01|June 2013|2013-06-01||||April 2005|Actual|2005-04-01||Interventional|||Surgery and BCG in Treating Patients With Bladder Cancer|Comparative Study of Intravesical BCG Standard Dose Long-Term Maintenance Versus BCG 1/3 Dose Long-Term Maintenance Versus BCG Standard Dose Short-Term Maintenance Versus BCG 1/3 Dose Short-Term Maintenance in Intermediate and High Risk Ta, T1 Papillary Carcinoma of the Urinary Bladder|Completed||Phase 3|1288|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:27.845833|2017-02-18 18:20:27.845833
NCT00002989|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||March 1997||1997-03-01|July 2007|2007-07-01||||||||Interventional|||Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome|A Randomized Phase III Study to Assess Intensification of the Conditioning Regimen for Allogenic Stem Cell Transplantation (ALLO-SCT) for Leukemia or Myelodysplastic Syndrome With a High Risk of Relapse|Unknown status|Active, not recruiting|Phase 3|207|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:27.988407|2017-02-18 18:20:27.988407
NCT00002988|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-19|||April 1997||1997-04-01|February 2013|2013-02-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma|Phase I Treatment of Adults With Primary Malignant Glioma With Irinotecan (CPT-11) (NSC #6616348) Plus BCNU (NSC #409962)|Completed||Phase 1|36|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:20:28.114753|2017-02-18 18:20:28.114753
NCT00002987|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||January 1997||1997-01-01|March 2005|2005-03-01||||||||Interventional|||Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease|"Minimal Initial Therapy (MIT) for Early Supradiaphragmatic Hodgkin's Disease: A Multicenter Randomized Trial of Short Neoadjuvant Chemotherapy (VAPEC-B) Plus Involved Field Radiotherapy (MIT) Versus Mantle Radiotherapy"|Unknown status|Active, not recruiting|Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:28.211616|2017-02-18 18:20:28.211616
NCT00002986|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||February 1997||1997-02-01|February 2013|2013-02-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Chemotherapy in Treating Patients With Recurrent Malignant Glioma|Phase I Treatment of Adults With Primary Malignant Glioma With Topotecan (NSC #609699) Plus BCNU (NSC #409962)|Completed||Phase 1|36|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:20:28.327707|2017-02-18 18:20:28.327707
NCT00002985|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-01|||November 1996||1996-11-01|February 2013|2013-02-01||||January 2007|Actual|2007-01-01||Interventional|||Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma|Double-Blind Randomized Evaluation of Clinical Benefits of DOXIL in Patients With AIDS-Related Kaposi's Sarcoma Treated With DOXIL or DaunoXome|Completed||Phase 3|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:20:28.418784|2017-02-18 18:20:28.418784
NCT00002984|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-22|||March 1997||1997-03-01|May 2012|2012-05-01|January 2007|Actual|2007-01-01|May 2006|Actual|2006-05-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus|Paclitaxel Combined With 5-FU and Cisplatin Concomitant With Radiotherapy in the Management of Locally Advanced or Metastatic Esophageal Cancer (Adenocarcinoma and Squamous Histologies) - A Phase I/Modified Phase II Trial|Completed||Phase 1/Phase 2|26|Actual|UNC Lineberger Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:20:28.515649|2017-02-18 18:20:28.515649
NCT00002982|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||January 1997||1997-01-01|July 2013|2013-07-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma|A Phase II Trial of ICE Chemotherapy Followed by High Dose BEAM Chemotherapy With Autologous Peripheral Blood Progenitor Cell Transplantation in Patients >= 60 Years Old With Refractory or Relapsed Intermediate Grade Non-Hodgkin's Lymphoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:28.898452|2017-02-18 18:20:28.898452
NCT00002981|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-02-02|||January 1997||1997-01-01|February 2017|2017-02-01|April 2018|Anticipated|2018-04-01|April 2018|Anticipated|2018-04-01||Interventional|||PET Scan in Treating Patients With Metastatic Prostate Cancer|11C-Methionine and 2-18F-Fluoro-2-Deoxy-D-Glucose PET Imaging in Patients With Progressive Prostate Cancer|Active, not recruiting||N/A|173|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:20:29.009866|2017-02-18 18:20:29.009866
NCT00002980|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-13|||May 1997||1997-05-01|May 2007|2007-05-01||||||||Interventional|||Decitabine in Treating Patients With Melanoma or Other Advanced Cancer|A Phase I Study of the Biologic and Clinical Effects of 5-AZA-2'Deoxycytidine (DAC) in Patients With Advanced Malignancies|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:29.142281|2017-02-18 18:20:29.142281
NCT00002977|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-13|||January 1997||1997-01-01|September 2010|2010-09-01||||November 2001|Actual|2001-11-01||Interventional|||Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission|A Phase I Trial of Melphalan and Thiotepa Followed by Autologous or Syngeneic Peripheral Blood Stem Cell (PBSC) Rescue in Patients With a Complete Response Following Standard Therapy for Stage III/IV Epithelial Ovarian Cancer|Completed||Phase 1|45|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:20:29.268644|2017-02-18 18:20:29.268644
NCT00002976|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-10|||June 1997||1997-06-01|April 2003|2003-04-01||||July 2006|Actual|2006-07-01||Interventional|||Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer|A Randomized Double-Blinded Trial of Estrogen Replacement Therapy Versus Placebo in Women With Stage I or II Endometrial Adenocarcinoma|Terminated||Phase 3|2108|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:20:29.38582|2017-02-18 18:20:29.38582
NCT00002975|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-02|2013-06-28||February 1997||1997-02-01|August 2013|2013-08-01|April 2010|Actual|2010-04-01|April 2009|Actual|2009-04-01||Interventional||Treated Patients|Photodynamic Therapy in Treating Patients With Skin Cancer|A Phase II Trial of 4-5 Hour and 18-24 Hour Applications of 20% Topical ALA for Photodynamic Therapy of Cutaneous Carcinomas and Actinic Keratoses|Completed||Phase 2|180|Actual|Roswell Park Cancer Institute|Study was activated prior to RPCI putting a system in place to centralize data entry and data management. Data entry was done by PI's staff. PI died and left incomplete data. Efficay and safety data were not analyzed.|1|||f||||t||||||||||2017-02-18 18:20:29.666671|2017-02-18 18:20:29.666671
NCT00002974|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-09-30|||July 1996||1996-07-01|May 2011|2011-05-01|April 2003|Actual|2003-04-01|July 2001|Actual|2001-07-01||Interventional|||Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma|A Phase II Study of Whole Blood Hyperthermia and Ice Chemotherapy in Sarcoma Patients|Completed||Phase 2|34|Anticipated|University of Wisconsin, Madison|||||f||||f||||||||||2017-02-18 18:20:29.872936|2017-02-18 18:20:29.872936
NCT00002973|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-09-30|||December 1995||1995-12-01|September 2015|2015-09-01|December 2000|Actual|2000-12-01|May 2000|Actual|2000-05-01||Interventional|||Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma|Phase II Evaluation of IV Melphalan (L-PAM) and Whole Body Hyperthermia (WBH) for Malignant Melanoma|Completed||Phase 2|34|Anticipated|University of Wisconsin, Madison|||||f||||||||||||||2017-02-18 18:20:29.969401|2017-02-18 18:20:29.969401
NCT00002970|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||June 1997||1997-06-01|July 2013|2013-07-01||||January 2005|Actual|2005-01-01||Interventional|||506U78 in Treating Patients With Refractory Hematologic Cancer|A Phase II Study of Compound 506U78 in Patients With Refractory T-Cell Malignancies-POG/CCG Intergroup Study|Completed||Phase 2|148|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:30.279066|2017-02-18 18:20:30.279066
NCT00002969|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-20|||May 1997||1997-05-01|July 2012|2012-07-01|January 2007|Actual|2007-01-01|January 2004|Actual|2004-01-01||Interventional|||S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer|Phase II Trial of Paclitaxel by 96-Hour Infusion in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)|Completed||Phase 2|60|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:30.404832|2017-02-18 18:20:30.404832
NCT00002968|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-04|||May 1997||1997-05-01|June 2013|2013-06-01||||July 2003|Actual|2003-07-01||Interventional|||Edrecolomab in Treating Patients With Stage II Colon Cancer|Phase III Randomized Study of Adjuvant Immunotherapy With Monoclonal Antibody 17-1A Versus No Adjuvant Therapy Following Resection for State II (Modified Astler-Coller B2) Adenocarcinoma of the Colon|Completed||Phase 3|2100|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:20:30.594944|2017-02-18 18:20:30.594944
NCT00002967|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||May 1997||1997-05-01|June 2012|2012-06-01|March 2006|Actual|2006-03-01|||||Interventional|||Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer|A Clinical Trial to Evaluate the Benefit of Adding Octreotide (SMS 201-995 PA LAR) to Tamoxifen Alone or to Tamoxifen and Chemotherapy in Patients With Axillary Node-Negative, Estrogen-Receptor-Positive, Primary Invasive Breast Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:30.714788|2017-02-18 18:20:30.714788
NCT00002965|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||January 1997||1997-01-01|July 2012|2012-07-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas|Phase II Study to Evaluate the Efficacy of Recombinant Interferon-Alpha in the Treatment of Recurrent Unresectable Meningiomas and Malignant Meningiomas|Completed||Phase 2|16|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:30.902001|2017-02-18 18:20:30.902001
NCT00002964|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||February 1995||1995-02-01|February 2013|2013-02-01||||April 2004|Actual|2004-04-01||Interventional|||Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer|Pilot Study for the Diagnosis of Head and Neck Cancer: Photofrin and Visible Light|Completed||Phase 2|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:20:31.014058|2017-02-18 18:20:31.014058
NCT00002963|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-30|||November 1993||1993-11-01|January 2013|2013-01-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Photodynamic Therapy in Treating Patients With Skin Cancer|Cutaneous Absorption and Intralesional Penetration of Topical Amino-Levulinic Acid in Basal Cell Carcinoma and Squamous Cell Carcinoma as Measured by In Situ Fluorescence and Intensified Video Fluorescence Microscopy|Completed||Phase 2|||Roswell Park Cancer Institute|||||||||t||||||||||2017-02-18 18:20:31.099688|2017-02-18 18:20:31.099688
NCT00002961|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-10-14|||October 1995||1995-10-01|October 2013|2013-10-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia|Randomized Trial of Busulfan or Total Body Irradiation Conditioning Regimens for Children With Acute Lymphoblastic Leukemia|Terminated||Phase 3|43|Actual|Children's Hospital of Philadelphia||2||poor accrual|f||||f||||||||||2017-02-18 18:20:31.455501|2017-02-18 18:20:31.455501
NCT00002960|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-02-03|||June 1999||1999-06-01|February 2016|2016-02-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)|A Phase I Study in Patients With Peritoneal Carcinomatosis Using SCH 58500 (rAd/p53) Administered by Single Intraperitoneal Instillation|Completed||Phase 1|59|Actual|Merck Sharp & Dohme Corp.|||||f||||||||||||||2017-02-18 18:20:31.606063|2017-02-18 18:20:31.606063
NCT00002956|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-03-18|||November 1996||1996-11-01|November 2012|2012-11-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants|A Phase I Pilot Trial to Evaluate the Toxicity of Allogeneic Epstein-Barr Virus Specific T-Lymphocytes for the Treatment of EBV-Associated Lymphoproliferative Diseases in Organ Transplant Recipients|Withdrawn||Phase 1|0|Actual|University of Alabama at Birmingham||1|||f||||t||||||||||2017-02-18 18:20:31.705294|2017-02-18 18:20:31.705294
NCT00002955|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||August 1995||1995-08-01|May 2014|2014-05-01|June 2006|Actual|2006-06-01|May 2000|Actual|2000-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas|Modulation of 5-Fluorouracil With Trimetrexate and Leucovorin in Advanced Pancreatic Cancer|Completed||Phase 2|21|Actual|University of Southern California|||||f||||t||||||||||2017-02-18 18:20:31.822143|2017-02-18 18:20:31.822143
NCT00002953|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||December 1996||1996-12-01|December 2005|2005-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer|A Radomized Trial of Epirubicin & Cyclophosphamide vs. Epirubicin & Paclitaxel in the Treatment of Women With Metastatic Breast Cancer|Completed||Phase 3|704|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:31.93232|2017-02-18 18:20:31.93232
NCT00002952|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-04|||January 1997||1997-01-01|September 2013|2013-09-01|November 2002|Actual|2002-11-01|August 2002|Actual|2002-08-01||Interventional|||Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma|Phase I/II Study of Immunization With MAGE-3 Peptide-Pulsed Autologous PBMC Plus rhIL-12 in Patients With Metastatic Melanoma|Completed||Phase 1/Phase 2|20|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:20:32.060647|2017-02-18 18:20:32.060647
NCT00002951|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-04|||June 1996||1996-06-01|September 2013|2013-09-01|July 2006|Actual|2006-07-01|June 2004|Actual|2004-06-01||Interventional|||Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer|Hyperfractionated Radiotherapy With Concomitant Fluorouracil and Hydroxurea for Intermediate Stage Cancer of the Head and Neck|Completed||Phase 2|53|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:20:32.179287|2017-02-18 18:20:32.179287
NCT00002950|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||September 1996||1996-09-01|October 2001|2001-10-01||||||||Interventional|||Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer|Phase I/II Study of Topotecan (SKF 104864) With Recombinant GM-CSF (Sargramostim) Used as a Priming Agent in Advanced Malignancies|Unknown status|Active, not recruiting|Phase 1/Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:32.304309|2017-02-18 18:20:32.304309
NCT00002949|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-04|||July 1996||1996-07-01|September 2013|2013-09-01|May 2001|Actual|2001-05-01|November 2000|Actual|2000-11-01||Interventional|||Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis|Phase I Study of Concomitant Chemoradiotherapy With Vinorelbine and Paclitaxel in Patients With Advanced Pelvic Malignancies|Completed||Phase 1|33|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:20:32.39204|2017-02-18 18:20:32.39204
NCT00002948|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-01|||October 1996||1996-10-01|July 2014|2014-07-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer|A Phase I Study of High Dose Topotecan With Filgrastim and Peripheral Blood Stem Cell Support for Patients With Refractory Malignancies|Terminated||Phase 1|||Yale University|||||f||||f||||||||||2017-02-18 18:20:32.512461|2017-02-18 18:20:32.512461
NCT00002947|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-01|||October 1996||1996-10-01|July 2014|2014-07-01|August 2004|Actual|2004-08-01|August 2004|Actual|2004-08-01||Interventional|||Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer|A Phase I Study of [111In-DTPA-D-Phe]-Octreotide in Patients With Refractory Malignancies Expressing Somatostatin Receptors|Terminated||Phase 1|35|Anticipated|Yale University|||||f||||f||||||||||2017-02-18 18:20:32.605947|2017-02-18 18:20:32.605947
NCT00002946|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||October 1997||1997-10-01|January 2013|2013-01-01||||April 2002|Actual|2002-04-01||Interventional|||Penclomedine in Treating Patients With Solid Tumors or Lymphoma|A Phase I Trial of Oral Penclomedine|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:32.71753|2017-02-18 18:20:32.71753
NCT00002945|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-04-12|||December 1996||1996-12-01|April 2012|2012-04-01|August 2011|Actual|2011-08-01|August 2001|Actual|2001-08-01||Interventional|||High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia|High-Dose Cytarabine and Idarubicin Induction, High Dose Etoposide and Cyclophosphamide Intensification, Autologous Stem Cell Transplantation and Interleukin-2 Immune Modulation in Previously Untreated De Novo and Secondary Adult Myeloid Leukemia|Completed||Phase 3|61|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:20:32.843396|2017-02-18 18:20:32.843396
NCT00002944|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-06|||April 1997||1997-04-01|September 2013|2013-09-01|April 2012|Actual|2012-04-01|February 2006|Actual|2006-02-01||Interventional|||Combination Chemotherapy in Treating Children With Progressive Brain Tumors|Chemotherapy for Progressive Low Grade Astrocytoma in Children Less Than Ten Years Old|Completed||Phase 3|428|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:32.964392|2017-02-18 18:20:32.964392
NCT00002943|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-18|||February 1993||1993-02-01|July 2012|2012-07-01|August 2007|Actual|2007-08-01|October 2003|Actual|2003-10-01||Interventional|||Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer|High Dose Carboplatin, Etoposide, Cyclophosphamide and Autologous Bone Marrow Transplantation for Relapsed and Refractory Germ Cell Cancer: A Phase II Pilot Study|Completed||Phase 2|11|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 18:20:33.359729|2017-02-18 18:20:33.359729
NCT00002942|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-18|||June 1996||1996-06-01|July 2012|2012-07-01|December 2003|Actual|2003-12-01|January 2000|Actual|2000-01-01||Interventional|||Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer|Randomized Phase III Trial of G-CSF Primed Autologous Bone Marrow Versus Peripheral Blood Progenitor Cells (PBPC) as Hematopoietic Support for High-Dose Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) Therapy in Poor Prognosis Breast Cancer|Completed||Phase 3|136|Actual|Wake Forest University Health Sciences||2|||f||||f||||||||||2017-02-18 18:20:33.467089|2017-02-18 18:20:33.467089
NCT00002941|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-31|||April 1998||1998-04-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma|A Pilot Study of Peripheral Blood Stem Cell Transplantation (PBSCT) After Preparative Therapy Consisting of Cyclophosphamide, BCNU, and Etoposide (CBV) for Recurrent and Primarily Refractory Hodgkin's and Non-Hodgkin's Lymphoma|Completed||Phase 2|69|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:33.580944|2017-02-18 18:20:33.580944
NCT00002940|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-18|||October 1996||1996-10-01|June 2002|2002-06-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS|Hydroxyurea Treatment of EBV-Associated Primary CNS Lymphoma in Children and Adults With AIDS|Completed||Phase 2|||St. Jude Children's Research Hospital|||||f||||f||||||||||2017-02-18 18:20:37.181439|2017-02-18 18:20:37.181439
NCT00002939|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-04|||November 1996||1996-11-01|September 2013|2013-09-01|April 2002|Actual|2002-04-01|February 2001|Actual|2001-02-01||Interventional|||Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer|A Phase I Trial of Dose Escalated Irinotecan (CPT-11) With Paclitaxel in Patients With Metastatic or Recurrent Malignancies|Completed||Phase 1|21|Actual|University of Chicago||1|||f||||f||||||||||2017-02-18 18:20:37.300307|2017-02-18 18:20:37.300307
NCT00002938|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||May 1997||1997-05-01|July 2016|2016-07-01|January 2010|Actual|2010-01-01|February 2005|Actual|2005-02-01||Interventional|||Surgery in Treating Patients With Prostate Cancer|The Role of Salvage Prostatectomy for Radiation Failure in Prostate Carcinoma: A Phase II Trial|Completed||Phase 2|49|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:20:37.421524|2017-02-18 18:20:37.421524
NCT00002937|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-04|||June 1996||1996-06-01|January 2010|2010-01-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer|A Phase II Randomized Study of Paclitaxel Versus Paclitaxel + PSC833 for Advanced Breast Cancer (Recurring Less Than 6 Months Since Adjuvant or as Second Line for Advanced Disease|Completed||Phase 2|70|Anticipated|City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:20:37.598189|2017-02-18 18:20:37.598189
NCT00002936|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-01|||July 1996||1996-07-01|February 2013|2013-02-01||||January 2007|Actual|2007-01-01||Interventional|||Altretamine and Etoposide in Treating Patients With HIV-Related Cancer|Hexamethylamine and VP-16 an Oral Regimin for HIV Malignancies: A Phase I/II Trial|Completed||Phase 1|||Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:20:37.788962|2017-02-18 18:20:37.788962
NCT00002935|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-12-22|||October 1995||1995-10-01|December 2011|2011-12-01|September 2007|Actual|2007-09-01|August 2006|Actual|2006-08-01||Interventional|||Photodynamic Therapy in Treating Patients With Early Esophageal Cancer|A Phase II Study of the Safety and Efficacy of Photodynamic Therapy in Carcinoma in Situ of the Esophagus|Completed||Phase 2|30|Actual|Roswell Park Cancer Institute||1|||f||||t||||||||||2017-02-18 18:20:37.883497|2017-02-18 18:20:37.883497
NCT00002934|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-06|||April 1997||1997-04-01|October 2015|2015-10-01|October 2012|Actual|2012-10-01|December 2007|Actual|2007-12-01||Interventional|||Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ|Local Excision Alone for Selected Patients With DCIS of the Breast|Terminated||Phase 2|711|Actual|Eastern Cooperative Oncology Group||1||"This study was terminated when the accrual goal for the low/intermediate grade stratum was~   reached. The high grade stratum was closed due to slow accrual."|f||||f||||||||||2017-02-18 18:20:37.984059|2017-02-18 18:20:37.984059
NCT00002933|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-09|||September 1996||1996-09-01|June 2010|2010-06-01|January 2001|Actual|2001-01-01|July 2000|Actual|2000-07-01||Interventional|||Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer|CWRU 1296: Biochemical and Pharmacokinetic Predictors of Colon Cancer Response to a Topoisomerase I Directed Treatment With Irinotecan|Completed||Phase 2|21|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:20:38.417108|2017-02-18 18:20:38.417108
NCT00002932|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-11-19|||May 1997||1997-05-01|November 2014|2014-11-01|March 2005|Actual|2005-03-01|March 2001|Actual|2001-03-01||Interventional|||Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck|Phase II Multi-Institutional Trial of Targeted Supradose Cisplatin Chemoradiation for Stage IV Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|60|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:20:38.531723|2017-02-18 18:20:38.531723
NCT00002931|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-04|2016-11-04||February 1997||1997-02-01|November 2016|2016-11-01|December 2014|Actual|2014-12-01|December 2014|Actual|2014-12-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer|Tandem High-Dose Chemotherapy With Autologous Stem Cell Rescue for Poor-Prognosis Germ Cell Cancer|Completed||Phase 2|48|Actual|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 18:20:38.652372|2017-02-18 18:20:38.652372
NCT00002930|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-17|||December 1996||1996-12-01|January 2013|2013-01-01||||October 2002|Actual|2002-10-01||Interventional|||PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery|Whole-Body 18F-Fluorodeoxyglucose Positron Emission Tomography to Measure the Response to Induction Chemotherapy of Potentially Resectable Lung and Esophageal Carcinomas|Completed||Phase 2/Phase 3|75|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:39.080268|2017-02-18 18:20:39.080268
NCT00002928|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||January 1997||1997-01-01|June 2013|2013-06-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer|A Phase II Trial of Paclitaxel Administered Weekly in Patients With Advanced Ovarian Cancer|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:39.186912|2017-02-18 18:20:39.186912
NCT00002926|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-05-26|||December 1996||1996-12-01|May 2001|2001-05-01||||||||Interventional|||Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia|Autologous Peripheral Blood Stem Cell Transplantation (PSCT) Versus a Second Intensive Consolidation Course After a Common Induction and Consolidation Course in Patients With Bad Prognosis Myelodysplastic Syndromes (MDS) and Acute Myelogenous Leukemia Secondary (SAML) to MDS of More Acute Than 6 Months Duration|Unknown status|Active, not recruiting|Phase 3|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:39.288061|2017-02-18 18:20:39.288061
NCT00002925|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-29|||February 1997||1997-02-01|March 2011|2011-03-01|June 2010|Actual|2010-06-01|November 2003|Actual|2003-11-01||Interventional|||Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia|Phase I Study of MDR Modulation With PSC-833 (NSC# 648265) With a Pilot Study of Cytogenetic Risk-Adapted Consolidation Followed by a Phase II Pilot Study of Immunotherapy With RIL-2 (NSC # 373364) in Previously Untreated Patients With AML< 60 Years|Completed||Phase 1/Phase 2|410|Actual|National Cancer Institute (NCI)||2|||f||||f||||||||||2017-02-18 18:20:39.432182|2017-02-18 18:20:39.432182
NCT00002924|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||January 1997||1997-01-01|July 2016|2016-07-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Observational|||Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy|Androgen Receptor Mutations in Hormone Refractory Prostate Cancer|Completed||N/A|184|Actual|Alliance for Clinical Trials in Oncology|||1||f||||f||||||Samples With DNA|"~     Bone marrow biopsies were obtained from 164 patients enrolled on CALGB 9583 and from 20~     patients enrolled on CALGB chemotherapy trials (CALGB 9480, 9680, 9780).~   "|||2017-02-18 18:20:39.592311|2017-02-18 18:20:39.592311
NCT00002923|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-04-24|||May 1997||1997-05-01|April 2014|2014-04-01|October 2000|Actual|2000-10-01|January 2000|Actual|2000-01-01||Interventional|||KRN5500 in Treating Patients With Metastatic Solid Tumors|Phase I Evaluation of KRN5500 (NSC650426)|Completed||Phase 1|27|Anticipated|Barbara Ann Karmanos Cancer Institute||1|||f||||t||||||||||2017-02-18 18:20:40.01746|2017-02-18 18:20:40.01746
NCT00002922|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-28|||January 1997||1997-01-01|August 2013|2013-08-01||||September 2001|Actual|2001-09-01||Interventional|||Paclitaxel in Treating Patients With Advanced Head and Neck Cancer|Phase II Evaluation of Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 2|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:20:40.129037|2017-02-18 18:20:40.129037
NCT00002921|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-03|||March 1997||1997-03-01|October 2012|2012-10-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery|Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II|Terminated||Phase 2|13|Actual|Southwest Oncology Group||1||Permanently Closed Due to Lack of Accrual|f||||f||||||||||2017-02-18 18:20:40.25915|2017-02-18 18:20:40.25915
NCT00002920|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-30|||March 1997||1997-03-01|October 2012|2012-10-01|December 2009|Actual|2009-12-01|December 2006|Actual|2006-12-01||Interventional|||S9630, Medroxyprogesterone in Treating Women With Breast Cancer|A Randomized Comparison Of Medroxyprogesterone Acetate (MA) And Observation For Prevention Of Endometrial Pathology In Postmenopausal Breast Cancer Patients Treated With Tamoxifen, Phase III|Completed||Phase 3|313|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:40.458488|2017-02-18 18:20:40.458488
NCT00002919|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||November 1996||1996-11-01|July 2013|2013-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer|PHASE II TRIAL OF THE COMBINATION OF TRANSURETHRAL RESECTION AND NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH INVASIVE UROTHELIAL TRACT TUMORS SELECTED BY STAGE AND P53 NUCLEAR EXPRESSION|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:40.704047|2017-02-18 18:20:40.704047
NCT00002917|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-14|||November 1996||1996-11-01|January 2001|2001-01-01|May 2004|Actual|2004-05-01|||||Interventional|||Paclitaxel in Treating Patients With Early-Stage Bladder Cancer|A PHASE I/II INSTITUTIONAL STUDY OF INTRAVESICAL TAXOL (PACLITAXEL) INSTILLATION FOR THE TREATMENT OF SUPERFICIAL BLADDER CANCER|Completed||Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:40.802146|2017-02-18 18:20:40.802146
NCT00002916|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||November 1996||1996-11-01|June 2012|2012-06-01||||||||Interventional|||Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer|A Phase II Trial in Patients With Early Cervical Cancer to Study The Safety and The Immunological Effects of Vaccination With TA-HPV, A Live Recombinant Vaccinia Virus Expressing The Human Papilloma Virus 16 and 18 E6 and E7 Proteins|Completed||Phase 2|44|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:40.897349|2017-02-18 18:20:40.897349
NCT00002915|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-08-05|||December 1996||1996-12-01|August 2010|2010-08-01||||||||Interventional|||Penclomedine in Treating Patients With Advanced Solid Tumors|A PHASE I AND PHARMACOLOGICAL STUDY OF PENCLOMEDINE (NSC#338720, IND#43409) ADMINISTERED DAILY BY MOUTH FOR FIVE CONSECUTIVE DAYS IN PATIENTS WITH ADVANCED SOLID TUMOR MALIGNANCIES|Completed||Phase 1|||Sidney Kimmel Comprehensive Cancer Center|||||f||||||||||||||2017-02-18 18:20:41.026373|2017-02-18 18:20:41.026373
NCT00002914|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-25|||May 1997||1997-05-01|January 2010|2010-01-01|March 2004|Actual|2004-03-01|June 2001|Actual|2001-06-01||Interventional|||Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract|PHASE II STUDY OF PIRITREXIM IN ADVANCED CARCINOMA OF THE UROTHELIUM|Completed||Phase 2|40|Anticipated|Eastern Cooperative Oncology Group|||||||||f||||||||||2017-02-18 18:20:41.117516|2017-02-18 18:20:41.117516
NCT00002913|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-23|||December 1996||1996-12-01|January 2013|2013-01-01||||July 2007|Actual|2007-07-01||Interventional|||Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer|PHASE I STUDY OF PACLITAXEL COMBINED WITH TOPOTECAN AND CISPLATIN AND G-CSF IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED OVARIAN EPITHELIAL MALIGNANCIES|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:41.245684|2017-02-18 18:20:41.245684
NCT00002912|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-31|||January 1997||1997-01-01|August 2010|2010-08-01||||March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia|A PHASE I COOPERATIVE AGREEMENT PEDIATRIC TRIAL OF MITOXANTRONE, ETOPOSIDE AND PSC-833 (PSC-ME) THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY ACUTE LEUKEMIA|Completed||Phase 1|3|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:41.3679|2017-02-18 18:20:41.3679
NCT00002911|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||December 1996||1996-12-01|May 2007|2007-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer|A PHASE III, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MARIMASTAT IN PATIENTS WITH MINIMAL DISEASE STAGE III NON-SMALL CELL LUNG CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:41.521825|2017-02-18 18:20:41.521825
NCT00002909|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||February 1997||1997-02-01|February 2001|2001-02-01||||October 2000|Actual|2000-10-01||Interventional|||Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma|A PHASE I CLINICAL AND PHARMACOLOGIC EVALUATION OF PHENYLBUTYRATE IN PATIENTS WITH REFRACTORY SOLID TUMORS: STUDY OF CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE ON A THREE TIMES DAILY SCHEDULE|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:41.926005|2017-02-18 18:20:41.926005
NCT00002908|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||December 1996||1996-12-01|April 2013|2013-04-01|November 2001|Actual|2001-11-01|February 2000|Actual|2000-02-01||Interventional|||Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia|PHASE II CLINICAL EVALUATION OF BRYOSTATIN 1 IN PATIENTS WITH RELAPSED NON-HODGKIN'S LYMPHOMA AND CLL|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:20:42.038524|2017-02-18 18:20:42.038524
NCT00002907|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||January 1997||1997-01-01|April 2013|2013-04-01|November 2000|Actual|2000-11-01|January 1999|Actual|1999-01-01||Interventional|||Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma|PHASE II CLINICAL EVALUATION OF BRYOSTATIN 1 IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA|Completed||Phase 2|||Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:20:42.139897|2017-02-18 18:20:42.139897
NCT00002905|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||June 1995||1995-06-01|September 2011|2011-09-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma|PROSPECTIVE NON-RANDOMIZED STUDY WITH CHEMOTHERAPY FOR RELAPSED OR REFRACTORY HIV-RELATED NON-HODGKIN'S LYMPHOMA: VMP REGIMEN FOR RELAPSED PATIENTS, CDE REGIMEN FOR REFRACTORY PATIENTS|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:42.240994|2017-02-18 18:20:42.240994
NCT00002904|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||February 1996||1996-02-01|June 2012|2012-06-01||||||||Interventional|||Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors|PHASE I CLINICAL AND PHARMACOKINETIC STUDY TO DETERMINE THE SAFETY OF ECTEINASCIDIN-743 (ET-743) ADMINISTERED AS A SINGLE INTRAVENOUS INFUSION OVER 60 MINUTES EVERY 21 DAYS IN PATIENTS WITH SOLID TUMORS|Completed||Phase 1|40|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:42.339922|2017-02-18 18:20:42.339922
NCT00002903|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||July 1995||1995-07-01|June 2012|2012-06-01||||||||Interventional|||Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer|PHASE II TRIAL WITH DOCETAXEL IN PATIENTS WITH RELAPSING GERM CELL CANCER|Completed||Phase 2|25|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:42.484671|2017-02-18 18:20:42.484671
NCT00002902|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2008-07-23|||April 1997||1997-04-01|July 2002|2002-07-01||||||||Interventional|||Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors|PHASE I TRIAL OF IRINOTECAN AND TOMUDEX IN COMBINATION ON AN EVERY THREE WEEK SCHEDULE|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:42.637629|2017-02-18 18:20:42.637629
NCT00002901|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-11|||December 1996||1996-12-01|January 2010|2010-01-01||||||||Interventional|||Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function|PHASE I STUDY OF TAXOTERE IN PATIENTS WITH ADVANCED MALIGNANCIES AND VARYING DEGREES OF LIVER DYSFUNCTION|Completed||Phase 1|||City of Hope Medical Center|||||f||||||||||||||2017-02-18 18:20:42.721896|2017-02-18 18:20:42.721896
NCT00002900|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-15|||February 1997||1997-02-01|October 2015|2015-10-01||||March 2008|Actual|2008-03-01||Observational|||SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial|A STUDY OF THE LATE CARDIAC EFFECTS OF TWO DIFFERENT ADJUVANT CHEMOTHERAPY REGIMENTS IN WOMEN WITH NODE NEGATIVE BREAST CANCER TREATED ON SWOG-8897|Completed||N/A|180|Actual|Southwest Oncology Group|||1||f||||||||||||||2017-02-18 18:20:42.831922|2017-02-18 18:20:42.831922
NCT00002899|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||November 1996||1996-11-01|June 2012|2012-06-01||||November 2007|Actual|2007-11-01||Interventional|||Adjuvant Radiation Therapy in Treating Patients With Brain Metastases|Phase III Trial on Convergent Beam Irradiation of Cerebral Metastases|Terminated||Phase 3|340|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC||||Low accrual|f||||||||||||||2017-02-18 18:20:43.028752|2017-02-18 18:20:43.028752
NCT00002898|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||January 1995||1995-01-01|May 1999|1999-05-01|December 2009|Actual|2009-12-01|||||Interventional|||Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma|MMT 95 Study For Rhabdomyosarcoma and Other Malignant Soft Tissue Tumors of Childhood|Completed||Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:43.166458|2017-02-18 18:20:43.166458
NCT00002897|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||July 1992||1992-07-01|May 2007|2007-05-01|June 2001|Actual|2001-06-01|||||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus|RANDOMIZED STUDY OF PREOPERATIVE CHEMOTHERAPY VERSUS SURGERY ALONE IN ESOPHAGUS CANCER|Completed||Phase 3|240|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:43.271337|2017-02-18 18:20:43.271337
NCT00002896|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||September 1993||1993-09-01|February 2008|2008-02-01||||||||Interventional|||Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer|RANDOMIZED TRIAL OF CONCOMITANT PREOPERATIVE RADIO-CHEMOTHERAPY WITH OR WITHOUT POSTOPERATIVE CHEMOTHERAPY IN LOCALLY ADVANCED RECTAL CARCINOMA|Unknown status|Active, not recruiting|Phase 3|774|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:43.360949|2017-02-18 18:20:43.360949
NCT00002895|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-03|||June 1996||1996-06-01|September 2005|2005-09-01|October 2010|Actual|2010-10-01|||||Interventional|||Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer|A Randomised Trial in Relapsed Ovarian Cancer: Early Treatment Based on CA 125 Levels Alone Vs. Delayed Treatment Based On Conventional Clinical Indicators|Completed||Phase 3|1400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:43.456008|2017-02-18 18:20:43.456008
NCT00002894|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||March 1996||1996-03-01|February 2001|2001-02-01|June 2003|Actual|2003-06-01|||||Interventional|||Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer|A RANDOMISED TRIAL OF PACLITAXEL (TAXOL) IN COMBINATION WITH PLATINUM CHEMOTHERAPY VS. CONVENTIONAL PLATINUM-BASED CHEMOTHERAPY IN THE TREATMENT OF WOMEN WITH RELAPSED OVARIAN CANCER|Completed||Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:43.565137|2017-02-18 18:20:43.565137
NCT00002893|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||June 1995||1995-06-01|May 2007|2007-05-01||||||||Interventional|||Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer|CHEMOTHERAPY CHOICES IN ADVANCED COLORECTAL CANCER: A RANDOMISED TRIAL COMPARING 2 DURATIONS AND 3 SYSTEMIC CHEMOTHERAPY REGIMENS IN THE PALLIATIVE TREATMENT OF ADVANCED COLORECTAL CANCER|Unknown status|Active, not recruiting|Phase 3|900|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:43.653421|2017-02-18 18:20:43.653421
NCT00002892|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||October 1995||1995-10-01|May 2007|2007-05-01|December 2001|Actual|2001-12-01|||||Interventional|||Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma|A RANDOMISED STUDY OF OBSERVATION VERSUS ADJUVANT LOW DOSE EXTENDED DURATION INTERFERON ALPHA-2A IN COMPLETELY RESECTED HIGH RISK MALIGNANT MELANOMA|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:43.756421|2017-02-18 18:20:43.756421
NCT00002890|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||October 1996||1996-10-01|June 2013|2013-06-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia|PHASE I DOSE-ESCALATION TRIAL OF YTTRIUM-90-LABELED HuM195 (HUMANIZED ANTI-CD33) IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:43.869085|2017-02-18 18:20:43.869085
NCT00002889|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-27|||May 1997||1997-05-01|June 2016|2016-06-01|June 2009|Actual|2009-06-01|January 2004|Actual|2004-01-01||Interventional|||Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer|PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY|Completed||Phase 2|180|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:20:43.958498|2017-02-18 18:20:43.958498
NCT00002888|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||March 1997||1997-03-01|May 2007|2007-05-01|August 2004|Actual|2004-08-01|||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer|A RANDOMIZED PHASE III EVALUATION OF PACLITAXEL + G-CSF + CISPLATIN VERSUS CISPLATIN + 5-FU IN ADVANCED HEAD AND NECK CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:44.336982|2017-02-18 18:20:44.336982
NCT00002887|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||July 1995||1995-07-01|October 2001|2001-10-01||||||||Interventional|||Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer|PHASE I TRIAL OF HYDROXYUREA FOR SALVAGE OF INCURABLE NON-SMALL CELL LUNG CANCER|Unknown status|Active, not recruiting|Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:44.517577|2017-02-18 18:20:44.517577
NCT00002884|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-06|||March 1996||1996-03-01|May 2007|2007-05-01||||||||Interventional|||Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus|A PROSPECTIVE RANDOMISED NON SURGICAL TREATMENT OF OESOPHAGEAL CANCER WITH COMBINED CHEMOTHERAPY AND EXTERNAL BEAM IRRADIATION WITH VS WITHOUT HIGH-DOSE BRACHYTHERAPY|Unknown status|Active, not recruiting|Phase 3|326|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:44.605059|2017-02-18 18:20:44.605059
NCT00002883|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||October 1996||1996-10-01|April 2001|2001-04-01||||||||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus|A PROSPECTIVE RANDOMISED TRIAL OF INDUCTION CHEMOTHERAPY WITH 5-FU CONTINUOUS IV INFUSION AND CISPLATIN VERSUS SURGERY IN RESECTABLE ADENOCARCINOMA OF THE LOW THIRD OF THE ESOPHAGUS AND CARDIOESOPHAGEAL JUNCTION|Unknown status|Active, not recruiting|Phase 3|250|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:44.705769|2017-02-18 18:20:44.705769
NCT00002882|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-12-12|||November 1995||1995-11-01|December 2011|2011-12-01|April 2006|Actual|2006-04-01|August 2003|Actual|2003-08-01||Interventional|||Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma|Adjuvant Therapy for Melanoma Patients With Regional Lymph Node Metastases With Interferon Alfa-2B vs. Biochemotherapy Using Cisplatin + Vinblastine + DTIC + Interferon Plus IL-2|Completed||Phase 3|140|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 18:20:44.804284|2017-02-18 18:20:44.804284
NCT00002881|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-06|||October 1996||1996-10-01|May 2007|2007-05-01||||April 1998|Actual|1998-04-01||Interventional|||Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer|PHASE III TRIAL OF ORCHIECTOMY/LHRH ANALOG + FLUTAMIDE + SURAMIN + HYDROCORTISONE VS ORCHIECTOMY/LHRH ANALOG + FLUTAMIDE IN PATIENTS WITH METASTATIC PROSTATE CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:44.93552|2017-02-18 18:20:44.93552
NCT00002880|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-27|||November 1996||1996-11-01|June 2016|2016-06-01|January 2008|Actual|2008-01-01|January 2001|Actual|2001-01-01||Interventional|||Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma|PHASE II STUDY OF ORAL ETOPOSIDE WITH PHARMACODYNAMIC MODELING IN RELAPSED NON-HODGKIN'S LYMPHOMA (IWF GRADES A-H)|Completed||Phase 2|53|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:20:45.061161|2017-02-18 18:20:45.061161
NCT00002879|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-05|||November 1996||1996-11-01|December 2016|2016-12-01|December 2008|Actual|2008-12-01|April 2005|Actual|2005-04-01||Interventional|||Cladribine in Patients With Mantle Cell Lymphoma|A PHASE II TRIAL OF 2-CDA IN PREVIOUSLY TREATED OR UNTREATED PATIENTS WITH MANTLE CELL LYMPHOMA (MCL)|Completed||Phase 2|51|Actual|Alliance for Clinical Trials in Oncology||1|||f||||t||||||||||2017-02-18 18:20:45.177144|2017-02-18 18:20:45.177144
NCT00002878|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-28|||March 1997||1997-03-01|August 2013|2013-08-01||||April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma|A PHASE III STUDY OF PSC-833 IN COMBINATION WITH VINCRISTINE, DOXORUBICIN AND DEXAMETHASONE (PSC-833/VAD) VERSUS VAD ALONE IN PATIENTS WITH RELAPSING OR REFRACTORY MULTIPLE MYELOMA|Completed||Phase 3|||Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:20:45.324395|2017-02-18 18:20:45.324395
NCT00002876|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-05-10|||October 1991||1991-10-01|May 2011|2011-05-01|January 2005|Actual|2005-01-01|April 1998|Actual|1998-04-01||Interventional|||Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas|A PHASE II TRIAL OF ETOPOSIDE AND CISPLATIN IN THE TREATMENT OF RECURRENT EPENDYMOMAS|Completed||Phase 2|35|Anticipated|Mayo Clinic|||||f||||||||||||||2017-02-18 18:20:45.483531|2017-02-18 18:20:45.483531
NCT00002875|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-31|||December 1996||1996-12-01|July 2014|2014-07-01|January 2011|Actual|2011-01-01|February 2006|Actual|2006-02-01||Interventional|||Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma|Phase III Prospective Randomized Study of Craniospinal RT Followed by One of Two Adjuvant Chemotherapy Regimens (CCNU, CDDP, VCR OR CPM, CDDP, VCR) for Newly-Diagnosed Average Risk MedulloblastomaMEDULLOBLASTOMA|Completed||Phase 3|421|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:45.637135|2017-02-18 18:20:45.637135
NCT00002874|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-09-28|||February 1998||1998-02-01|September 2016|2016-09-01||||December 2016|Anticipated|2016-12-01||Interventional|||Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer|A PHASE III TRIAL OF RADIATION THERAPY WITH OR WITHOUT CASODEX IN PATIENTS WITH PSA ELEVATION FOLLOWING RADICAL PROSTATECTOMY FOR pT3N0 CARCINOMA OF THE PROSTATE|Active, not recruiting||Phase 3|840|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:45.823235|2017-02-18 18:20:45.823235
NCT00002873|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-17|||May 1997||1997-05-01|February 2008|2008-02-01||||June 2007|Actual|2007-06-01||Interventional|||Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer|A PHASE I/II TRIAL TO EVALUATE BRACHYTHERAPY AS THE SOLE METHOD OF RADIATION THERAPY FOR STAGE I AND II BREAST CARCINOMA|Completed||Phase 1/Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:20:46.191905|2017-02-18 18:20:46.191905
NCT00002872|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-28|||November 1996||1996-11-01|August 2013|2013-08-01||||February 2003|Actual|2003-02-01||Interventional|||Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions|A PROSPECTIVE RANDOMIZED TRIAL OF BLEOMYCIN VS. DOXYCYCLINE VS. TALC FOR THE INTRAPLEURAL TREATMENT OF MALIGNANT PLEURAL EFFUSIONS|Completed||Phase 3|480|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:20:46.837477|2017-02-18 18:20:46.837477
NCT00002870|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-12-14|||December 1994||1994-12-01|December 2014|2014-12-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer|A RANDOMIZED, MULTI-CENTRE PHASE III TRIAL TO EVALUATE THE ROLE OF INTENSIFIED THERAPY WITH AUTOLOGOUS TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN ADVANCED OR METASTATIC BREAST CANCER RESPONDING TO INDUCTION CHEMOTHERAPY|Completed||Phase 3|180|Anticipated|UNICANCER|||||f||||t||||||||||2017-02-18 18:20:46.929011|2017-02-18 18:20:46.929011
NCT00002869|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||April 1995||1995-04-01|February 2008|2008-02-01||||||||Interventional|||Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia|PROSPECTIVE RANDOMISED STUDY TO COMPARE LOW-DOSE INTERFERON-ALPHA-n1 (WELLFERON) +/- HYDROXYUREA VS HIGH-DOSE INTERFERON-ALPHA-n1 (WELLFERON) +/- HYDROXYUREA IN PATIENTS WITH NEWLY DIAGONISED CHRONIC PHASE CHRONIC MYELOID LEUKAEMIA|Unknown status|Active, not recruiting|Phase 3|800|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:47.092471|2017-02-18 18:20:47.092471
NCT00002868|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-02-09|||January 1996||1996-01-01|June 2005|2005-06-01||||March 2004|Actual|2004-03-01||Interventional|||Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia|PROSPECTIVE RANDOMISED STUDY TO COMPARE INTERFERON-ALPHA-n1 (WELLFERON) VS 'IDAC' CHEMOTHERAPY AND AUTOGRAFTING FOLLOWED BY INTERFERON ALPHA-n1 (WELLFERON) IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA|Completed||Phase 3|744|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:20:47.201563|2017-02-18 18:20:47.201563
NCT00002866|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-07|||August 1996||1996-08-01|November 2010|2010-11-01|December 2009|Actual|2009-12-01|||||Interventional|||Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer|A PHASE I/II STUDY OF DOCETAXEL AND EPIRUBICIN AS FIRST LINE THERAPY FOR METASTATIC BREAST CANCER|Completed||Phase 1|50|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:20:47.308548|2017-02-18 18:20:47.308548
NCT00002865|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-12|||April 1995||1995-04-01|September 2015|2015-09-01|August 2001|Actual|2001-08-01|June 2000|Actual|2000-06-01||Interventional|||High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia|HIGH INTENSITY, BRIEF DURATION CHEMOTHERAPY FOR RELAPSED OR REFRACTORY ALL: A PHASE II STUDY OF A MULTIDRUG REGIMEN|Completed||Phase 2|25|Actual|Wake Forest University Health Sciences||1|||f||||f||||||||||2017-02-18 18:20:47.40577|2017-02-18 18:20:47.40577
NCT00002844|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||March 1991||1991-03-01|July 2012|2012-07-01|June 2002|Actual|2002-06-01|July 2000|Actual|2000-07-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia|Bone Marrow Transplantation for Chronic Lymphocytic Leukemia|Completed||Phase 2|49|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:20:53.34255|2017-02-18 18:20:53.34255
NCT00002864|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||August 1996||1996-08-01|September 2011|2011-09-01|April 2010|Actual|2010-04-01|October 2007|Actual|2007-10-01||Interventional|||Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer|A RANDOMIZED TRIAL OF ANTIESTROGEN THERAPY VERSUS COMBINED ANTIESTROGEN AND OCTREOTIDE LAR THERAPY IN THE ADJUVANT TREATMENT OF BREAST CANCER IN POST-MENOPAUSAL WOMEN|Completed||Phase 3|667|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:20:47.527187|2017-02-18 18:20:47.527187
NCT00002863|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||June 1996||1996-06-01|May 2014|2014-05-01|July 2000|Actual|2000-07-01|July 2000|Actual|2000-07-01||Interventional|||Cryosurgery in Treating Patients With Soft Tissue Sarcoma|PHASE I FEASIBILITY TRIAL OF CRYOSURGICAL ABLATION OF SOFT TISSUE SARCOMAS OF THE EXTREMETY|Terminated||Phase 1|19|Actual|University of Southern California||1||Insufficient Accrual|f||||t||||||||||2017-02-18 18:20:47.674357|2017-02-18 18:20:47.674357
NCT00002862|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||October 1996||1996-10-01|September 2000|2000-09-01||||April 2001|Actual|2001-04-01||Interventional|||Perillyl Alcohol in Treating Patients With Refractory Cancer|A PHASE I STUDY OF PERILLYL ALCOHOL IN PATIENTS WITH REFRACTORY MALIGNANCIES (NSC #641066)|Completed||Phase 1|25|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:47.780482|2017-02-18 18:20:47.780482
NCT00002860|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-01-11|||November 1996||1996-11-01|January 2012|2012-01-01|December 2010|Actual|2010-12-01|December 2006|Actual|2006-12-01||Interventional|||SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma|A Phase II Trial of Complete Surgical Resection For Stage IV Melanoma -- Surgical Resection With Biological Evaluation and Clinical Follow-Up|Completed||Phase 2|77|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:20:47.899174|2017-02-18 18:20:47.899174
NCT00002858|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||March 1993||1993-03-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer|PHASE III STUDY COMPARING TWO DOSES OF INDUCTION CHEMOTHERAPY FOLLOWED BY ALTERNATION OF CHEMOTHERAPY AND RADIOTHERAPY IN LIMITED SMALL CELL LUNG CANCER|Unknown status|Active, not recruiting|Phase 3|280|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:48.193494|2017-02-18 18:20:48.193494
NCT00002855|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||August 1996||1996-08-01|July 2012|2012-07-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer|A Phase 3 Trial of Androgen Ablation Alone vs. Chemo/Hormonal Therapy as Initial Treatment of Unresectable/Metastatic Adenocarcinoma of the Prostate|Completed||Phase 3|306|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:48.296348|2017-02-18 18:20:48.296348
NCT00002854|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-08-24|||December 1994||1994-12-01|August 2015|2015-08-01|August 2015|Actual|2015-08-01|August 2015|Actual|2015-08-01||Interventional|||High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer|PHASE I PILOT STUDY OF SEQUENTIAL HIGH DOSE CYCLES OF CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE AND IFOSFAMIDE, CARBOPLATIN AND TAXOL WITH AUTOLOGOUS STEM CELL SUPPORT|Completed||Phase 1|33|Actual|City of Hope Medical Center||1|||f||||t||||||||||2017-02-18 18:20:48.427566|2017-02-18 18:20:48.427566
NCT00002852|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-02|||October 1996||1996-10-01|July 2013|2013-07-01||||July 2004|Actual|2004-07-01||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer|A PHASE III STUDY OF ADJUVANT CHEMOTHERAPY AFTER RESECTION FOR PATIENTS WITH T2N0 STAGE I NON-SMALL CELL CARCINOMA OF THE LUNG|Completed||Phase 3|500|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:20:48.544859|2017-02-18 18:20:48.544859
NCT00002851|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-01-28|||July 1996||1996-07-01|December 2004|2004-12-01||||||||Interventional|||Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed|PHASE III RANDOMISED TRIAL INVESTIGATING THE ROLE OF INTERNAL MAMMARY AND MEDIAL SUPRACLAVICULAR (IM-MS) LYMPH NODE CHAIN IRRADIATION IN STAGE I-III BREAST CANCER|Unknown status|Active, not recruiting|Phase 3|4000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:48.659084|2017-02-18 18:20:48.659084
NCT00002850|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-13|2014-07-10||March 1997||1997-03-01|October 2015|2015-10-01|January 2012|Actual|2012-01-01|April 2011|Actual|2011-04-01||Interventional||Patients with symptomatic and untreated MM receiving chemotherapy without an active infection during the 7 days prior to initiation of chemotherapy and off antibiotics for the prior 7 days were eligable for this study. They were required to receive myelosuppressive and/or immunosuppressive chemotherapy, and were randomized on a 1:1 basis.|Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy|Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma|Completed||Phase 3|212|Actual|University of Rochester||3|||f||||t||||||||||2017-02-18 18:20:51.780993|2017-02-18 18:20:51.780993
NCT00002849|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-03-05|||November 1996||1996-11-01|March 2015|2015-03-01|July 2000|Actual|2000-07-01|December 1998|Actual|1998-12-01||Interventional|||S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis|Phase II Study of Dexamethasone/Alpha-Interferon in AL Amyloidosis|Completed||Phase 2|93|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:52.798523|2017-02-18 18:20:52.798523
NCT00002848|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-04|||April 1997||1997-04-01|March 2013|2013-03-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Group Therapy Compared With Educational Materials in Patients With Prostate Cancer|SUPPORTIVE-EXPRESSIVE GROUP THERAPY FOR MEN WITH PRIMARY PROSTATE CANCER|Completed||N/A|480|Anticipated|University of Rochester|||||f||||f||||||||||2017-02-18 18:20:52.964392|2017-02-18 18:20:52.964392
NCT00002847|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||September 1995||1995-09-01|December 2003|2003-12-01||||||||Interventional|||Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer|TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON ALPHA|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:53.065612|2017-02-18 18:20:53.065612
NCT00002846|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||September 1995||1995-09-01|December 2003|2003-12-01||||||||Interventional|||Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer|TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH LOW-DOSE INTRAVENOUS RECOMBINANT INTERLEUKIN-2|Unknown status|Active, not recruiting|Phase 2|14|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:53.154789|2017-02-18 18:20:53.154789
NCT00002845|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||September 1995||1995-09-01|May 2000|2000-05-01||||||||Interventional|||Interleukin-2 in Treating Patients With Metastatic Melanoma|TREATMENT OF METASTATIC MELANOMA WITH RECOMBINANT INTERLEUKIN-2|Unknown status|Active, not recruiting|Phase 2|20|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:53.249486|2017-02-18 18:20:53.249486
NCT00002842|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-06-03|||September 1994||1994-09-01|June 2015|2015-06-01|May 2014|Actual|2014-05-01|May 2014|Actual|2014-05-01||Interventional|||Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer|Hepatic Resection Followed by Concurrent Adjuvant Portal Vein Infusion of Fluorodeoxyuridine and Systemic 5-Fluorouracil and Folinic Acid for Metastatic Colorectal Carcinoma|Completed||Phase 2|49|Actual|City of Hope Medical Center||1|||f||||||||||||||2017-02-18 18:20:53.474385|2017-02-18 18:20:53.474385
NCT00002840|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-06|||August 1996||1996-08-01|July 2012|2012-07-01||||March 2002|Actual|2002-03-01||Interventional|||Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma|PHASE III STUDY OF ADJUVANT PROCARBAZINE, CCNU AND VINCRISTINE CHEMOTHERAPY IN PATIENTS WITH HIGHLY ANAPLASTIC OLIGODENDROGLIOMA|Completed||Phase 3|350|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:53.602456|2017-02-18 18:20:53.602456
NCT00002839|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-07|||July 1996||1996-07-01|January 2013|2013-01-01||||May 2004|Actual|2004-05-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx|PHASE II STUDY ON LARYNX PRESERVATION COMPARING INDUCTION CHEMOTHERAPY AND RADIOTHERAPY VERSUS ALTERNATING CHEMO-RADIOTHERAPY IN RESECTABLE HYPOPHARYNX AND LARYNX CANCERS|Completed||Phase 3|564|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:20:53.753642|2017-02-18 18:20:53.753642
NCT00002838|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||December 1995||1995-12-01|July 2012|2012-07-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia|Phase I/II Pilot Study of Allogeneic Peripheral Blood Stem Cell Infusion For Patients With High Risk Chronic Lymphocytic Leukemia|Completed||Phase 1/Phase 2|13|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:20:53.872574|2017-02-18 18:20:53.872574
NCT00002837|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||September 1995||1995-09-01|July 2012|2012-07-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer|Phase I-II Study of Dose Intense Doxorubicin, Paclitaxel And Cyclophosphamide With Peripheral Blood Progenitor Cells (PBPC) And Cytokine Support In Patients With Metastatic Breast Cancer|Completed||Phase 1/Phase 2|21|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:20:53.996344|2017-02-18 18:20:53.996344
NCT00002836|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||May 1995||1995-05-01|July 2012|2012-07-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer|A Phase III Randomized Comparison of High Dose Chemotherapy G-CSF To G-CSF For Mobilization of Peripheral Blood Stem Cells For Autologous Transplantation For Patients With Responsive Metastatic Breast Cancer Or High Risk Stage II-III Patients|Completed||Phase 3|184|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:54.135137|2017-02-18 18:20:54.135137
NCT00002835|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||July 1995||1995-07-01|July 2012|2012-07-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Lymphoma|A Randomized Prospective Study of Early Intensification Versus Alternating Triple Therapy for Patients With Poor Prognosis Lymphoma|Completed||Phase 3|116|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:54.270977|2017-02-18 18:20:54.270977
NCT00002833|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||October 1994||1994-10-01|July 2012|2012-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia|Use of G-CSF Stimulated HLA-Identical Allogeneic Peripheral Blood Stem Cells for Patients With High Risk Acute Myelogenous Leukemia or CML in Blast Crisis|Completed||Phase 2|53|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:20:54.697159|2017-02-18 18:20:54.697159
NCT00002832|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||August 1995||1995-08-01|July 2012|2012-07-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia|Phase I/II Trial of Decitabine and Allogeneic Peripheral Blood Stem Cells Transplantation for Treatment of Relapse Post Allogeneic Bone Marrow Transplantation|Completed||Phase 1/Phase 2|14|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:20:54.84116|2017-02-18 18:20:54.84116
NCT00002831|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||July 1994||1994-07-01|July 2012|2012-07-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia|A Phase I/II Study of High-Dose Deoxyazacytidine, Busulfan, and Cyclophosphamide With Allogeneic Stem Cell Transplantation for Hematologic Malignancies|Completed||Phase 1/Phase 2|24|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:20:54.969869|2017-02-18 18:20:54.969869
NCT00002829|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-26|||February 1994||1994-02-01|July 2012|2012-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Lymphoma|Autologous and Allogeneic Bone Marrow Transplantation for Low Grade Lymphoma|Completed||Phase 2|45|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:20:55.096709|2017-02-18 18:20:55.096709
NCT00002828|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||April 1995||1995-04-01|June 2013|2013-06-01|November 2001|Actual|2001-11-01|November 2001|Actual|2001-11-01||Interventional|||Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer|PHASE I TRIAL OF SEQUENTIAL TOMUDEX AND 5-FLUOROURACIL IN SUBJECTS WITH ADVANCED COLORECTAL CARCINOMA|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:55.238075|2017-02-18 18:20:55.238075
NCT00002827|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-22|||October 1996||1996-10-01|August 2013|2013-08-01|June 2008|Actual|2008-06-01|October 2004|Actual|2004-10-01||Interventional|||Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease|RESPONSE DEPENDENT TREATMENT OF STAGES IA, IIA AND IIIA HODGKIN'S DISEASE WITH DBVE AND LOW DOSE INVOLVED FIELD IRRADIATION WITH OR WITHOUT ZINECARD: A PEDIATRIC ONCOLOGY GROUP PHASE III STUDY|Completed||Phase 3|294|Actual|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:55.331654|2017-02-18 18:20:55.331654
NCT00002826|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-28|||June 1997||1997-06-01|August 2013|2013-08-01||||November 2003|Actual|2003-11-01||Interventional|||Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer|A PILOT PHASE II TRIAL OF PSC 833 MODULATION OF MULTIDRUG RESISTANCE TO PACLITAXEL IN THE TREATMENT OF METASTATIC CARCINOMA OF THE BREAST|Completed||Phase 2|36|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:20:55.513509|2017-02-18 18:20:55.513509
NCT00002825|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||January 1997||1997-01-01|May 2006|2006-05-01||||December 2004|Actual|2004-12-01||Interventional|||Docetaxel in Treating Children With Recurrent Solid Tumors|A PHASE II STUDY OF DOCETAXEL (TAXOTERE) (NSC# 628503) IN CHILDREN WITH RECURRENT SOLID TUMORS|Completed||Phase 2|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:20:55.623706|2017-02-18 18:20:55.623706
NCT00002824|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||February 1996||1996-02-01|July 2000|2000-07-01||||||||Interventional|||Gene Therapy in Treating Patients With Primary Brain Tumors|A PHASE I TRIAL OF HSV-TK ADENOVIRUS GENE THERAPY FOR PRIMARY BRAIN TUMORS|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:55.771408|2017-02-18 18:20:55.771408
NCT00002823|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-26|||February 1995||1995-02-01|April 2011|2011-04-01||||January 2001|Actual|2001-01-01||Interventional|||Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer|A LARGE-SCALE TRIAL EVALUATING ADJUVANT CHEMOTHERAPY AFTER CURATIVE RESECTION OF NON-SMALL CELL LUNG CANCER|Completed||Phase 3|3300|Anticipated|Gustave Roussy, Cancer Campus, Grand Paris|||||f||||||||||||||2017-02-18 18:20:55.870098|2017-02-18 18:20:55.870098
NCT00002822|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||March 1996||1996-03-01|December 2000|2000-12-01|November 2005|Actual|2005-11-01|||||Interventional|||Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer|RANDOMISED CLINICAL TRIAL OF IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE WITH MID-CYCLE VINCRISTINE (VICE) VERSUS STANDARD PRACTICE CHEMOTHERAPY IN PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER (SCLC) AND GOOD PERFORMANCE STATUS|Completed||Phase 3|400|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:56.095509|2017-02-18 18:20:56.095509
NCT00002819|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-10|||November 1996||1996-11-01|May 2007|2007-05-01||||February 2000|Actual|2000-02-01||Interventional|||Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer|A RANDOMIZED, CONTROLLED TRIAL OF SALVAGE THERAPY WITH PACLITAXEL AND CARBOPLATIN VERSU SALVAGE THERAPY WITH STEM CELL SUPPORTED HIGH-DOSE CARBOPLATIN, MITOXANTRONE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH PERSISTENT LOW VOLUME OVARIAN CANCER AND RESPONSE TO PRIMARY THERAPY|Terminated||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:20:56.199049|2017-02-18 18:20:56.199049
NCT00002818|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2015-12-10|||February 1995||1995-02-01|December 2015|2015-12-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies|Phase I and Clinical Pharmacokinetic De-Escalation Study of 2'-Deoxycitidine Administered as a Continuous Infusion in Conjunction With a Continuous Infusion of High-Dose ARA-C in Patients With Refractory Acute Myelogenous Leukemia|Completed||Phase 1|15|Actual|Virginia Commonwealth University||1|||f||||f||||||||||2017-02-18 18:20:56.62011|2017-02-18 18:20:56.62011
NCT00002817|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-09|||April 1996||1996-04-01|May 2002|2002-05-01||||||||Interventional|||Vaccine Therapy in Treating Patients With Metastatic Melanoma|INTRALESIONAL IMMUNOTHERAPY WITH A VACCINIA/GM-CSF RECOMBINANT VIRUS IN PATIENTS WITH METASTATIC MELANOMA|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:56.730401|2017-02-18 18:20:56.730401
NCT00002816|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-21|||December 1996||1996-12-01|August 2013|2013-08-01|April 2006|Actual|2006-04-01|November 2002|Actual|2002-11-01||Interventional|||Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia|EXTRAMEDULLARY RELAPSE AND OCCULT BONE MARROW INVOLVEMENT IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE III GROUP-WIDE STUDY|Completed||Phase 3|120|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:20:56.823403|2017-02-18 18:20:56.823403
NCT00002814|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-10-26|||August 1996||1996-08-01|October 2011|2011-10-01|December 2001|Actual|2001-12-01|April 2001|Actual|2001-04-01||Interventional|||Combination Chemotherapy for Patients With Brain Cancer|A Phase II Trial of Paclitaxel and Topotecan With Filgrastim in Patients With Recurrent or Refractory Glioblastoma Multiforme or Anaplastic Astrocytoma|Completed||Phase 2|20|Actual|Dartmouth-Hitchcock Medical Center|||||f||||t||||||||||2017-02-18 18:20:57.111305|2017-02-18 18:20:57.111305
NCT00002813|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-24|||August 1997||1997-08-01|March 2008|2008-03-01||||October 2004|Actual|2004-10-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer|A LIMITED ACCESS PHASE II TRIAL OF CISPLATIN AND NAVELBINE (VINORELBINE) IN ADVANCED AND RECURRENT SQUAMOUS CELL CARCINOMA OF THE CERVIX|Completed||Phase 2|62|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:20:57.204938|2017-02-18 18:20:57.204938
NCT00002812|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-23|||September 1996||1996-09-01|August 2013|2013-08-01||||March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia|Treatment of Patients With Acute Lymphoblastic Leukemia With Unfavorable Features: A Phase III Group-wide Study|Completed||Phase 3|2078|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 18:20:57.309598|2017-02-18 18:20:57.309598
NCT00002811|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||July 1996||1996-07-01|May 2007|2007-05-01||||||||Interventional|||T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum|A RANDOMIZED, DOUBLE BLIND, MULTI-CENTER CLINICAL STUDY TO TEST THE SAFETY AND EFFICACY OF T4N5 LIPOSOME LOTION ON PATIENTS WITH XERODERMA PIGMENTOSUM IN THE PROTECTION AGAINST ACTINIC KERATOSES|Unknown status|Active, not recruiting|Phase 3|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:57.521901|2017-02-18 18:20:57.521901
NCT00002810|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-30|||May 1996||1996-05-01|September 2010|2010-09-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis|Autologous Peripheral Blood Stem Cell Transplantation With High Dose Melphalan For Treatment Of Primary Amyloidosis (AL)|Completed||Phase 2|||Temple University|||||f||||||||||||||2017-02-18 18:20:57.627307|2017-02-18 18:20:57.627307
NCT00002809|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-30|||August 1996||1996-08-01|September 2010|2010-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer|Unrelated Bone Marrow Transplantation With Cyclophosphamide and Total Body Irradiation For Hematologic Malignancies and Bone Marrow Failure States|Completed||Phase 2|10|Anticipated|Temple University|||||f||||||||||||||2017-02-18 18:20:57.734934|2017-02-18 18:20:57.734934
NCT00002807|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-25|||July 1996||1996-07-01|April 2012|2012-04-01|December 2009|Actual|2009-12-01|March 2007|Actual|2007-03-01||Interventional|||Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery|A Phase III Randomized Trial Comparing TAH BSO Versus TAH BSO Plus Adjuvant Pelvic Irradiation in Intermediate Risk Carcinoma of the Endometrium|Completed||Phase 3|116|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:20:57.849128|2017-02-18 18:20:57.849128
NCT00002806|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||July 1996||1996-07-01|July 2016|2016-07-01|July 2004|Actual|2004-07-01|January 2003|Actual|2003-01-01||Interventional|||Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma|PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS|Completed||Phase 2|43|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:20:57.994567|2017-02-18 18:20:57.994567
NCT00002805|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||August 1997||1997-08-01|July 2014|2014-07-01|June 2008|Actual|2008-06-01|May 2001|Actual|2001-05-01||Interventional|||Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome|Acute Myeloid Leukemia Salvage Therapy for Patients in First Relapse or Who Fail to Achieve an Initial Remission or Who Develop AML as a Second Malignant Neoplasm|Completed||Phase 2|115|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:58.126261|2017-02-18 18:20:58.126261
NCT00002804|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-24|||September 1996||1996-09-01|July 2014|2014-07-01|April 2006|Actual|2006-04-01|June 2000|Actual|2000-06-01||Interventional|||Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma|Phase II Study of Neoadjuvant Vincristine, Ifosfamide, Doxorubicin, and AND G-CSF in Children With Advanced Stage Non-Rhabdomyosarcoma Soft Tissue Sarcomas|Completed||Phase 2|43|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:20:58.295218|2017-02-18 18:20:58.295218
NCT00002803|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||July 1995||1995-07-01|April 2008|2008-04-01|February 2002|Actual|2002-02-01|||||Interventional|||Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma|COOPERATIVE MULTICENTER TRIAL FOR THE TREATMENT OF INFANTS WITH NEUROBLASTOMA|Completed||Phase 2|44|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:58.433604|2017-02-18 18:20:58.433604
NCT00002802|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||July 1990||1990-07-01|May 2007|2007-05-01|September 2003|Actual|2003-09-01|||||Interventional|||Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma|PHASE III MULTICENTRE TRIAL OF TREATMENT OF NEUROBLASTOMA IN CHILDREN AND ADOLESCENTS|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:58.531687|2017-02-18 18:20:58.531687
NCT00002801|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||April 1996||1996-04-01|December 2009|2009-12-01|December 2009|Actual|2009-12-01|December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer|PHASE I TRIAL OF POST-OPERATIVE COMBINED ORAL UFT PLUS LEUCOVORIN AND RADIATION THERAPY FOR RECTAL CANCER|Completed||Phase 1|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:58.637687|2017-02-18 18:20:58.637687
NCT00002800|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||July 1996||1996-07-01|July 2013|2013-07-01|March 2003|Actual|2003-03-01|March 2003|Actual|2003-03-01||Interventional|||Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome|PHASE II STUDY OF HIGH DOSE CYTARABINE COMBINED WITH A SINGLE HIGH DOSE OF IDARUBICIN FOR NEWLY DIAGNOSED PATIENTS WITH AML: THE AML-3 PROTOCOL|Completed||Phase 2|60|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:20:58.738888|2017-02-18 18:20:58.738888
NCT00002798|ClinicalTrials.gov processed this data on February 17, 2017|2000-11-24|2013-01-15|||August 1996||1996-08-01|January 2013|2013-01-01||||September 2006|Actual|2006-09-01||Interventional|||Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome|A PHASE III STUDY IN CHILDREN WITH UNTREATED ACUTE MYELOGENOUS LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)|Completed||Phase 3|880|Actual|National Cancer Institute (NCI)||5|||f||||||||||||||2017-02-18 18:20:58.837271|2017-02-18 18:20:58.837271
NCT00002796|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-31|||May 1997||1997-05-01|January 2013|2013-01-01||||December 2004|Actual|2004-12-01||Interventional|||Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer|Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate, Indomethacin and Recombinant Human Interferon-Gamma in Advanced Colorectal Cancer|Terminated||Phase 1/Phase 2|46|Actual|National Cancer Institute (NCI)||1||Administratively complete.|f||||||||||||||2017-02-18 18:20:59.26119|2017-02-18 18:20:59.26119
NCT00002794|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-10-03|||February 1996||1996-02-01|October 2011|2011-10-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Carboplatin Plus Vincristine in Treating Children With Retinoblastoma|Evaluation of Chemotherapy as Initial Treatment for Retinoblastoma|Completed||Phase 2|25|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-02-18 18:20:59.382661|2017-02-18 18:20:59.382661
NCT00002793|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||January 1991||1991-01-01|May 2007|2007-05-01||||||||Interventional|||Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer|PALLIATIVE LOCAL CHEMOTHERAPY FOR NON-RESECTABLE LIVER METASTASES FROM COLORECTAL CARCINOMA, A RANDOMISED PHASE III STUDY|Unknown status|Active, not recruiting|Phase 3|336|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:20:59.480488|2017-02-18 18:20:59.480488
NCT00002792|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-31|||June 1996||1996-06-01|March 2010|2010-03-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders|ALLOGENEIC MARROW OR PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA WITH MYELOFIBROSIS|Completed||Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:20:59.579574|2017-02-18 18:20:59.579574
NCT00002791|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-23|||February 1997||1997-02-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|May 2002|Actual|2002-05-01||Interventional|||Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma|A PHASE II STUDY OF NEOADJUVANT CHEMOTHERAPY AND RADIATION THERAPY IN THE MANAGEMENT OF HIGH-RISK, HIGH-GRADE, SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND BODY WALL|Completed||Phase 2|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:20:59.689283|2017-02-18 18:20:59.689283
NCT00002790|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-03-04|||March 1996||1996-03-01|March 2015|2015-03-01||||||||Interventional|||Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant|A PHASE I/II STUDY OF RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH METHOTREXATE (MTX) AND CYCLOSPORINE (CPS) IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FROM RELATED DONORS MISMATCHED FOR ONE HLA ANTIGEN IN THE DIRECTION OF GRAFT-VERSUS-HOST DISEASE (GVHD)|Withdrawn||Phase 1/Phase 2|0|Actual|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:00.037634|2017-02-18 18:21:00.037634
NCT00002773|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09|||May 1996||1996-05-01|April 2007|2007-04-01|April 2004|Actual|2004-04-01|||||Interventional|||Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer|A CLINICAL TRIAL FOR PANCREAS CANCER USING ACTIVE INTRALYMPHATIC IMMUNOTHERAPY WITH INTERFERON-TREATED PANCREAS CANCER TISSUE CULTURE CELLS, GMCSF, AND LOW-DOSE CYCLOPHOSPHAMIDE|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:02.0288|2017-02-18 18:21:02.0288
NCT00002789|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-29|||May 1996||1996-05-01|March 2010|2010-03-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia|A PHASE III RANDOMIZED STUDY COMPARING G-CSF MOBILIZED PERIPHERAL BLOOD STEM CELLS WITH MARROW AS THE SOURCE OF STEM CELLS FOR ALLOGENEIC TRANSPLANTS FROM HLA IDENTICAL, RELATED DONORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA|Completed||Phase 3|100|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:00.149529|2017-02-18 18:21:00.149529
NCT00002788|ClinicalTrials.gov processed this data on February 17, 2017|2000-08-03|2010-09-13|||October 1995||1995-10-01|September 2010|2010-09-01|September 2002||2002-09-01|||||Interventional|||High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia|A PILOT STUDY OF TOTAL BODY IRRADIATION AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION WITH CD34 SELECTED PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA|Completed||Phase 1|15|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:00.257448|2017-02-18 18:21:00.257448
NCT00002787|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-05-02|||March 1996||1996-03-01|May 2016|2016-05-01||||December 2002|Actual|2002-12-01||Interventional|||Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation|Phase I Trial of Post Transplant Immunization With Autologous Myeloma Idiotype-KLH/GM-CSF In Myeloma Patients Following Autologous or Allogeneic Marrow or Stem Cell Transplantation|Active, not recruiting||Phase 1|40|Anticipated|Fred Hutchinson Cancer Research Center||1|||f||||||||||||||2017-02-18 18:21:00.358588|2017-02-18 18:21:00.358588
NCT00002786|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-05-06|||October 1995||1995-10-01|May 2010|2010-05-01|March 2006|Actual|2006-03-01|||||Interventional|||Biological Therapy in Treating Patients With Metastatic Melanoma|PHASE I STUDY TO EVALUATE THE SAFETY OF CELLULAR ADOPTIVE IMMUNOTHERAPY USING GENETICALLY MODIFIED AND UNMODIFIED AUTOLOGOUS CD8+ TYROSINASE-SPECIFIC T CELLS FOR PATIENTS WITH METASTATIC MELANOMA|Completed||Phase 1/Phase 2|20|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:00.473418|2017-02-18 18:21:00.473418
NCT00002785|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||July 1996||1996-07-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|August 2000|Actual|2000-08-01||Interventional|||Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia|Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Infants Less Than 1 Year of Age.|Completed||Phase 2|||Children's Oncology Group|||||f||||t||||||||||2017-02-18 18:21:00.571313|2017-02-18 18:21:00.571313
NCT00002784|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||June 1996||1996-06-01|July 2012|2012-07-01|December 2011|Actual|2011-12-01|August 2011|Actual|2011-08-01||Interventional|15-95||High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer|Randomized Trial of High-dose Epirubicin and Cyclophosphamide x 3 Supported by Peripheral Blood Progenitor Cells Versus Anthracycline and Cyclophosphamide x 4 Followed by Cyclophosphamide, Methotrexate, and 5-fluorouracil x 3 as Adjuvant Treatment for High Risk Operable Stage ii and Stage Iii Breast Cancer in Premenopausal and Young Postmenopausal (Less Than or Equal to 65 Yrs) Patients.|Completed||Phase 3|344|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-02-18 18:21:00.737483|2017-02-18 18:21:00.737483
NCT00002783|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||May 1996||1996-05-01|July 2013|2013-07-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer|A PHASE II TRIAL OF NEOADJUVANT CISPLATIN-FLUOROURACIL CHEMOTHERAPY, SURGERY, AND INTRAPERITONEAL (IP) FLOXURIDINE (FUdR) PLUS LEUCOVORIN IN PATIENTS WITH GASTRIC CANCER|Completed||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:00.880245|2017-02-18 18:21:00.880245
NCT00002781|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||April 1996||1996-04-01|April 2000|2000-04-01||||||||Interventional|||Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma|PROCEDURES FOR BNCT PHASE-I STUDY OF MELANOMA IN THE EXTREMITIES|Unknown status|Active, not recruiting|Phase 1|15|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:00.981765|2017-02-18 18:21:00.981765
NCT00002780|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||May 1996||1996-05-01|February 2001|2001-02-01||||||||Interventional|||Biological Therapy in Treating Women With Metastatic Breast Cancer|INFUSION OF ACTIVATED T CELLS AND LOW DOSE INTERLEUKIN 2 COMBINED WITH PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR THE TREATMENT OF WOMEN WITH METASTATIC BREAST CANCER: PHASE I/II|Unknown status|Active, not recruiting|Phase 1/Phase 2|60|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:01.0683|2017-02-18 18:21:01.0683
NCT00002779|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-14|||February 1998||1998-02-01|December 2016|2016-12-01|June 2015|Actual|2015-06-01|July 2000|Actual|2000-07-01||Interventional|||Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma|PHASE II TRIAL OF FLUDARABINE AND SANDOSTATIN FOR RELAPSED LOW-GRADE NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|34|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:21:01.160925|2017-02-18 18:21:01.160925
NCT00002778|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-07-19|||February 1995||1995-02-01|April 2011|2011-04-01|July 2010|Actual|2010-07-01|February 2005|Actual|2005-02-01||Interventional|||Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia|GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (Rhu-GM-CSF) FOR REDUCTION OF LEUKEMIC RELAPSE AFTER T-LYMPHOCYTE DEPLETED ALLOGENEIC BMT FOR CHRONIC MYELOID LEUKEMIA|Terminated||Phase 2|40|Anticipated|Sidney Kimmel Comprehensive Cancer Center||||subject accrual and data analysis is completed.|f||||||||||||||2017-02-18 18:21:01.289709|2017-02-18 18:21:01.289709
NCT00002777|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||May 1996||1996-05-01|June 2012|2012-06-01||||December 2002|Actual|2002-12-01||Interventional|||Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer|RANDOMIZED PHASE II STUDY IN FIRST LINE HORMONAL TREATMENT FOR METASTATIC BREAST CANCER WITH EXEMESTANE OR TAMOXIFEN IN POSTMENOPAUSAL PATIENTS|Completed||Phase 3|342|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:01.393477|2017-02-18 18:21:01.393477
NCT00002775|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||February 1998||1998-02-01|April 2000|2000-04-01||||||||Interventional|||Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer|PHASE I/II STUDY OF DOCETAXEL (TAXOTERE) AND ESTRAMUSTINE COMBINATION CHEMOTHERAPY IN PATIENTS WITH PROSTATE CANCER|Unknown status|Active, not recruiting|Phase 1/Phase 2|37|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:01.540993|2017-02-18 18:21:01.540993
NCT00002774|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2014-06-19|||June 1996||1996-06-01|June 2014|2014-06-01|June 2005|Actual|2005-06-01|June 2000|Actual|2000-06-01||Interventional|||Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer|Randomized Phase 2 Trial of Tirapazamine and the Role of Tumor Hypoxia in Advanced Squamous Head and Neck Cancer|Completed||Phase 2|63|Actual|Stanford University||2|||f||||||||||||||2017-02-18 18:21:01.625733|2017-02-18 18:21:01.625733
NCT00002772|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-22|||July 1996||1996-07-01|January 2013|2013-01-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer|A Comparison of Intensive Sequential Chemotherapy Using Doxorubicin Plus Paclitaxel Plus Cyclophosphamide With High Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Support for Primary Breast Cancer in Women With 4-9 Involved Axillary Lymph Nodes|Terminated||Phase 3|602|Actual|Southwest Oncology Group||2||poor accrual|f||||t||||||||||2017-02-18 18:21:02.134405|2017-02-18 18:21:02.134405
NCT00002771|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-01|||January 1995||1995-01-01|July 2000|2000-07-01||||||||Interventional|||Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia|PROSPECTIVE CONTROLLED STUDY FOR THE OPTIMIZATION OF THERAPY IN CHRONIC MYELOID LEUKEMIA (CML): MULTICENTRIC STUDY FOR THE EVALUATION OF INTERFERON ALPHA VS ALLOGENIC BM TRANSPLANTATION WITH CHEMOTHERAPY IN CML|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:02.284716|2017-02-18 18:21:02.284716
NCT00002768|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-27|||June 1996||1996-06-01|June 2016|2016-06-01|March 2009|Actual|2009-03-01|February 2003|Actual|2003-02-01||Interventional|||Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission|AUTOLOGOUS STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN SECOND REMISSION: A PHASE II STUDY|Completed||Phase 2|51|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:21:02.389553|2017-02-18 18:21:02.389553
NCT00002767|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-03|||January 1996||1996-01-01|May 2007|2007-05-01||||||||Interventional|||Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma|PHASE III TRIAL OF MELACINE PLUS INTERFERON ALFA-2B VERSUS INTERFERON ALFA-2B IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMA|Unknown status|Active, not recruiting|Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:02.537216|2017-02-18 18:21:02.537216
NCT00002766|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-01-25|2015-12-17||March 1996||1996-03-01|January 2016|2016-01-01|September 2011|Actual|2011-09-01|September 2011|Actual|2011-09-01||Interventional|||Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma|"A Phase III Trial Comparing ARA-C/High-Dose Mitoxantrone (ALL-2') to A Standard Vincristine/Prednisone Based Regimen ('L-20') as Induction Therapy For Adult Patients With Acute Lymphoblastic Leukemia (ALL): The ALL-4 Protocol"|Completed||Phase 3|170|Actual|Memorial Sloan Kettering Cancer Center||2|||f||||||||||||||2017-02-18 18:21:02.669152|2017-02-18 18:21:02.669152
NCT00002765|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-04-28|||April 1996||1996-04-01|March 2003|2003-03-01||||||||Interventional|||Immunotoxin in Treating Patients With Leukemia or Lymphoma|PHASE I STUDY OF ANTI-TAC(Fv)-PE38 (LMB-2), A RECOMBINANT SINGLE-CHAIN IMMUNOTOXIN FOR TREATMENT OF TAC-EXPRESSING MALIGNANCIES|Completed||Phase 1|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:03.280357|2017-02-18 18:21:03.280357
NCT00002764|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||April 1996||1996-04-01|July 2012|2012-07-01||||November 2000|Actual|2000-11-01||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma|METASTASECTOMY AND CHEMOTHERAPY FOR LUNG METASTASES FROM SOFT TISSUE SARCOMA: A RANDOMIZED PHASE III STUDY (AN INTERGROUP STUDY WITH THE SCANDINAVIAN SARCOMA GROUP)|Completed||Phase 3|340|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:03.379234|2017-02-18 18:21:03.379234
NCT00002763|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-11-15|||April 1996||1996-04-01|November 2011|2011-11-01||||||||Interventional|||High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma|POST-OPERATIVE ADJUVANT INTERFERON-ALFA-2B (INTRON-A) TREATMENT AFTER RESECTION OF THICK PRIMARY MELANOMA AND/OR REGIONAL LYMPHNODE METASTASES 'INTERMEDIATE-HIGH DOSE' VS INTERMEDIATE-LOW DOSE' IFN-ALFA VS OBSERVATION: A 3-ARM MULTICENTER RANDOMIZED PHASE III TRIAL|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:03.480243|2017-02-18 18:21:03.480243
NCT00002762|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-11|||June 1996||1996-06-01|July 2016|2016-07-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Observational|||Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer|MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER|Completed||N/A|1118|Actual|Alliance for Clinical Trials in Oncology|||1||f||||t||||||||||2017-02-18 18:21:03.649185|2017-02-18 18:21:03.649185
NCT00002761|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-16|||February 1996||1996-02-01|November 2012|2012-11-01|October 2007|Actual|2007-10-01|February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia|CAMP-010: PHASE I/II STUDY OF IN VIVO PURGING FOLLOWED BY HIGH DOSE CHEMOTHERAPY, AUTOLOGOUS HEMATOPOIETIC STEM CELL INFUSION AND IMMUNOTHERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA|Withdrawn||Phase 1/Phase 2|0|Actual|Columbia University||||PI left institution|f||||||||||||||2017-02-18 18:21:03.889316|2017-02-18 18:21:03.889316
NCT00002760|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-27|||August 1996||1996-08-01|June 2016|2016-06-01|April 2009|Actual|2009-04-01|March 2004|Actual|2004-03-01||Interventional|||Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer|A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER|Completed||Phase 3|260|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:21:03.976757|2017-02-18 18:21:03.976757
NCT00002759|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||June 1996||1996-06-01|May 2006|2006-05-01||||April 2002|Actual|2002-04-01||Interventional|||Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma|A PHASE I STUDY OF IRINOTECAN (CPT-11) WITH PHARMACOKINETIC MODULATION BY CYCLOSPORINE A AND PHENOBARBITAL|Completed||Phase 1|3|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:04.099206|2017-02-18 18:21:04.099206
NCT00002757|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||June 2001||2001-06-01|July 2014|2014-07-01|October 2009|Actual|2009-10-01|October 2003|Actual|2003-10-01||Interventional|||TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma|FAB LMB 96 -- Treatment of Mature B-CELL Lymphoma/Leukemia: A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study|Completed||Phase 3|1148|Actual|Children's Oncology Group||3|||f||||t||||||||||2017-02-18 18:21:04.209156|2017-02-18 18:21:04.209156
NCT00002756|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-12|||June 1996||1996-06-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|September 2007|Actual|2007-09-01||Interventional|||Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia|Induction Intensification in Infant ALL: A Children's Oncology Group Study|Completed||Phase 2|221|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:21:04.360357|2017-02-18 18:21:04.360357
NCT00002755|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||November 1995||1995-11-01|May 2007|2007-05-01|June 1999|Actual|1999-06-01|||||Interventional|||Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer|PROSPECTIVE RANDOMISED EVALUATION OF HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL BLOOD PROGENITOR SUPPORT IN PATIENTS WITH HIGH RISK BREAST CANCER|Completed||Phase 3|600|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:07.564389|2017-02-18 18:21:07.564389
NCT00002754|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||February 1993||1993-02-01|February 2013|2013-02-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors|PHASE I STUDY OF MONOCLONAL ANTIBODY FRAGMENT 131I MEL-14 F(AB')2 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT MELANOMA AND OTHER BRAIN TUMORS|Completed||Phase 1|6|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:21:07.950511|2017-02-18 18:21:07.950511
NCT00002753|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||November 1991||1991-11-01|February 2013|2013-02-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas|PROTOCOL FOR A PHASE I STUDY OF INTRACYSTIC ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 IN THE TREATMENT OF PATIENTS WITH RECURRENT CYSTIC GLIOMAS|Completed||Phase 1|6|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:21:08.05438|2017-02-18 18:21:08.05438
NCT00002752|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-15|||February 1993||1993-02-01|February 2013|2013-02-01|March 2010|Actual|2010-03-01|January 2003|Actual|2003-01-01||Interventional|||Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers|PHASE I STUDY OF ANTI-TENASCIN MONOCLONAL ANTIBODY 131I 81C6 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT BRAIN TUMORS|Completed||Phase 1/Phase 2|||Duke University|||||f||||||||||||||2017-02-18 18:21:08.163816|2017-02-18 18:21:08.163816
NCT00002751|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-19|||July 1989||1989-07-01|October 2009|2009-10-01|May 2004|Actual|2004-05-01|||||Interventional|||Monoclonal Antibody Therapy in Treating Patients With Brain Metastases|PROTOCOL FOR A PHASE I STUDY OF INTRATHECAL MONOCLONAL ANTIBODY FRAGMENT 131I Me1-14 F(ab')2 IN PATIENTS WITH NEOPLASMS METASTATIC TO THE LEPTOMENINGES|Completed||Phase 1/Phase 2|6|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:21:08.273274|2017-02-18 18:21:08.273274
NCT00002750|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-15|||December 1992||1992-12-01|February 2013|2013-02-01|May 2001|Actual|2001-05-01|May 2001|Actual|2001-05-01||Interventional|||Melphalan in Patients With Neoplastic Meningitis|Phase I of Intrathecal Melphalan in Patients With Recurrent Neoplastic Meningitis|Completed||Phase 1|6|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:21:08.371566|2017-02-18 18:21:08.371566
NCT00002749|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-10-12|||February 1993||1993-02-01|October 2009|2009-10-01|March 2000|Actual|2000-03-01|||||Interventional|||Carboplatin in Patients With Progressive Gliomas|PHASE II STUDY OF CARBOPLATIN (CBDCA) IN THE TREATMENT OF CHILDREN AND ADULTS WITH PROGRESSIVE LOW GRADE GLIOMAS|Completed||Phase 2|25|Anticipated|Duke University|||||f||||||||||||||2017-02-18 18:21:08.480579|2017-02-18 18:21:08.480579
NCT00002748|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-10-03|||December 1991||1991-12-01|October 2011|2011-10-01|August 2007|Actual|2007-08-01|August 2007|Actual|2007-08-01||Interventional|||Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma|Phase I Study of Cytokine-Gene Modified Autologous or Partially Matched Allogeneic Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma|Completed||Phase 1|38|Actual|St. Jude Children's Research Hospital|||||f||||||||||||||2017-02-18 18:21:08.592907|2017-02-18 18:21:08.592907
NCT00002747|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||September 1992||1992-09-01|May 2007|2007-05-01||||||||Interventional|||Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer|RANDOMIZED TRIAL OF NEOADJUVANT CHEMOTHERAPY AND SURGERY +/- RADIOTHERAPY VERSUS SURGEERY +/- RADIOTHERAPY IN OPERABLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY|Unknown status|Active, not recruiting|Phase 3|240|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:08.689039|2017-02-18 18:21:08.689039
NCT00002746|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-12-12|||January 1996||1996-01-01|December 2012|2012-12-01|April 2004|Actual|2004-04-01|April 2004|Actual|2004-04-01||Interventional|||Interleukin-2 in Treating Patients With Myelodysplastic Syndrome|A PHASE I TRIAL OF SUBCUTANEOUS, OUTPATIENT INTERLEUKIN-2 FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)|Completed||Phase 1|24|Actual|University of Washington||1|||f||||||||||||||2017-02-18 18:21:08.777558|2017-02-18 18:21:08.777558
NCT00002745|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||April 1996||1996-04-01|January 2013|2013-01-01|January 2008|Actual|2008-01-01|April 2003|Actual|2003-04-01||Interventional|||Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma|PHASE II STUDY OF 9-AMINOCAMPTOTHECIN (9-AC/DMA, NSC# 603071) IN PREVIOUSLY TREATED HODGKIN'S DISEASE AND NON-HODGKIN'S LYMPHOMA: IWF GRADES A-H|Completed||Phase 2|37|Actual|National Cancer Institute (NCI)||1|||f||||f||||||||||2017-02-18 18:21:08.869169|2017-02-18 18:21:08.869169
NCT00002744|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-02-07|||May 1996||1996-05-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|March 2007|Actual|2007-03-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia|Randomized Comparisons of Oral Mercaptopurine vs Oral Thioguanine and IT Methotrexate vs ITT for Standard Risk Acute Lymphoblastic Leukemia|Completed||Phase 3|1970|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 18:21:08.987731|2017-02-18 18:21:08.987731
NCT00002742|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-25|||January 1996||1996-01-01|July 2007|2007-07-01|September 2007|Actual|2007-09-01|||||Interventional|||Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer|A PROSPECTIVE RANDOMIZED, DOUBLE-BLIND, COMPARATIVE, MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF NYSTATIN AND AMPHOTERICIN B FOR EMPIRIC ANTIFUNGAL TREATMENT IN NEUTROPENIC PATIENTS|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:09.185447|2017-02-18 18:21:09.185447
NCT00002740|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||May 1996||1996-05-01|July 2014|2014-07-01|September 2005|Actual|2005-09-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma|Phase I Pilot Study of Multiple Cycles of High Dose Chemotherapy With Peripheral Blood Stem Cell Infusions In Advanced Stage Neuroblastoma|Completed||Phase 1|30|Anticipated|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:21:09.614603|2017-02-18 18:21:09.614603
NCT00002738|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-06|||January 1996||1996-01-01|March 2013|2013-03-01|June 2006|Actual|2006-06-01|June 2006|Actual|2006-06-01||Interventional|||Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma|Phase II Trial of Trimetrexate and Leucovorin in The Treatment of Recurrent Childhood Acute Lymphoblastic Leukemia|Completed||Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:09.750771|2017-02-18 18:21:09.750771
NCT00002737|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-10|||March 1996||1996-03-01|July 2012|2012-07-01||||January 2001|Actual|2001-01-01||Interventional|||Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer|A RANDOMIZED PHASE II TRIAL OF INTERFERON ALPHA-2A WITH AND WITHOUT 13-CIS RETINOIC ACID IN PATIENTS WITH PROGRESSIVE MEASURABLE METASTATIC RENAL CELL CARCINOMA. Amendment Protocol: Extension to a Randomized Phase III Trial|Completed||Phase 3|320|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:09.84253|2017-02-18 18:21:09.84253
NCT00002735|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-09-28|||April 1996||1996-04-01|September 2015|2015-09-01|March 2005|Actual|2005-03-01|April 2004|Actual|2004-04-01||Interventional|||SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue|Induction Chemotherapy Followed By Chemoradiation For Organ Preservation In Patients With Advanced Resectable Cancer Of The Hypopharynx And Base Of Tongue, Phase II|Terminated||Phase 2|68|Actual|Southwest Oncology Group||1||Terminated due to poor accrual.|f||||t||||||||||2017-02-18 18:21:09.972233|2017-02-18 18:21:09.972233
NCT00002734|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||March 1996||1996-03-01|February 2001|2001-02-01||||April 2001|Actual|2001-04-01||Interventional|||Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer|PHASE I STUDY OF INTERFERON ENHANCED INTRAPERITONEAL RADIOIMMUNO-CHEMOTHERAPY FOR OVARIAN CANCER|Completed||Phase 1|30|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:10.12152|2017-02-18 18:21:10.12152
NCT00002733|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-05-10|||January 1996||1996-01-01|May 2011|2011-05-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Biological Therapy in Treating Patients With Metastatic Cancer|ALPHA INTERFERON, TUMOR INFILTRATING LYMPHOCYTES, AND INTERLEUKIN-2 IN THE TREATMENT OF CANCER|Completed||Phase 2|30|Anticipated|Hoag Memorial Hospital Presbyterian|||||f||||||||||||||2017-02-18 18:21:10.238975|2017-02-18 18:21:10.238975
NCT00002730|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-01-30|||June 1996||1996-06-01|January 2017|2017-01-01||||||||Interventional|||Chemotherapy in Treating Children With Neuroblastoma|PILOT STUDY OF BUTHIONINE SULFOXIMINE (BSO) IN COMBINATION WITH MELPHALAN FOR HIGH RISK NEUROBLASTOMA PATIENTS|Completed||Phase 1|||Children's Hospital Los Angeles|||||f||||||||||||||2017-02-18 18:21:10.340804|2017-02-18 18:21:10.340804
NCT00002727|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-30|||April 1996||1996-04-01|December 2016|2016-12-01|December 2016|Actual|2016-12-01|October 2005|Actual|2005-10-01||Interventional|||Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord|A RANDOMIZED STUDY OF HYPERFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN T2 SQUAMOUS CELL CARCINOMA OF THE VOCAL CORD|Completed||Phase 3|250|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:10.438878|2017-02-18 18:21:10.438878
NCT00002725|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||August 1996||1996-08-01|October 2000|2000-10-01||||April 2000|Actual|2000-04-01||Interventional|||Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma|PHASE II EVALUATION OF BRYOSTATIN-1 (NSC 339555) IN NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|35|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:11.053088|2017-02-18 18:21:11.053088
NCT00002723|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-27|||January 1996||1996-01-01|February 2013|2013-02-01|March 2008|Actual|2008-03-01|August 2002|Actual|2002-08-01||Interventional|||Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer|A PHASE III STUDY OF THREE DIFFERENT DOSES OF SURAMIN (NSC #34936) ADMINISTERED WITH A FIXED DOSING SCHEDULE IN PATIENTS WITH ADVANCED PROSTATE CANCER|Completed||Phase 3|390|Actual|National Cancer Institute (NCI)||3|||f||||t||||||||||2017-02-18 18:21:11.172988|2017-02-18 18:21:11.172988
NCT00002722|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-02|||January 1996||1996-01-01|March 2012|2012-03-01||||August 1999|Actual|1999-08-01||Interventional|||High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer|RANDOMIZED PHASE II STUDY OF A WEEKLY 24H-INFUSION OF HIGH-DOSE 5-FU PLUS OR MINUS FOLINIC ACID (HD-FU/FA) VERSUS HD-FU/FA PLUS BIWEEKLY CISPLATIN VERSUS FAMTX (5-FU/ADRIAMYCIN/METHOTREXATE) IN ADVANCED GASTRIC CANCER, AN EORTC/AIO INTERGROUP TRIAL|Completed||Phase 2|135|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:11.330245|2017-02-18 18:21:11.330245
NCT00002721|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-20|||March 1995||1995-03-01|May 2014|2014-05-01|June 2013|Actual|2013-06-01|June 2013|Actual|2013-06-01||Interventional|||Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer|A PHASE I TRIAL OF ESTRAMUSTINE PHOSPHATE AND DOXORUBICIN IN HORMONE REFRACTORY METASTATIC PROSTATE CANCER|Completed||Phase 1|18|Actual|University of New Mexico||1|||f||||f||||||||||2017-02-18 18:21:11.422063|2017-02-18 18:21:11.422063
NCT00002720|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||December 1995||1995-12-01|August 2000|2000-08-01|December 2012|Actual|2012-12-01|||||Interventional|||Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer|QUADRANTECTOMY PLUS AXILLARY DISSECTION VERSUS QUADRANTECTOMY ALONE IN MAMMOGRAPHIC STAGE T1N0 BREAST CANCER PATIENTS AGED OVER 65 YEARS|Completed||Phase 3|642|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:11.531707|2017-02-18 18:21:11.531707
NCT00002719|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||December 1995||1995-12-01|June 2012|2012-06-01||||November 2001|Actual|2001-11-01||Interventional|||Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia|RANDOMIZED PHASE III STUDY TO EVALUATE THE VALUE OF rHuG-CSF IN INDUCTION AND OF AN ORAL SCHEDULE AS CONSOLIDATION TREATMENT IN ELDERLY PATIENTS WITH ACUTE MYELOGENOUS LEUMEKIA (AML-13 PROTOCOL)|Completed||Phase 3|500|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:11.626789|2017-02-18 18:21:11.626789
NCT00002718|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-12-21|||November 1995||1995-11-01|December 2015|2015-12-01|October 2008|Actual|2008-10-01|January 2004|Actual|2004-01-01||Interventional|||T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia|A Phase II Trial of T-Cell Depleted Marrow Grafts Combined With Infusions of G-CSF Stimulated, CD34 Ceprate Stem Cell Column Selected, E-Rosette Depleted Peripheral Blood Progenitor Cells Derived From HLA Haplotype Matched Related Donors for Patients With Leukemia Lacking an HLA-Matched Related or Unrelated Donor|Completed||Phase 2|31|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:21:11.73636|2017-02-18 18:21:11.73636
NCT00002717|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-24|||March 1996||1996-03-01|January 2010|2010-01-01||||October 2007|Actual|2007-10-01||Interventional|||Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer|A Phase III Randomized Trial of Cisplatin (NSC #119875) With Paclitaxel (NSC #125973) Administered by Either 24 Hour Infusion or 96 Hour Infusion in Patients With Selected Stage III and Stage IV Epithelial Ovarian Cancer and Primary Peritoneal Carcinoma|Completed||Phase 3|324|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:21:11.871835|2017-02-18 18:21:11.871835
NCT00002716|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||January 1996||1996-01-01|July 2016|2016-07-01|August 2006|Actual|2006-08-01|March 2006|Actual|2006-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer|PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER|Completed||Phase 3|135|Actual|Alliance for Clinical Trials in Oncology||2|||f||||f||||||||||2017-02-18 18:21:12.035027|2017-02-18 18:21:12.035027
NCT00002715|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-07-01|||April 1989||1989-04-01|June 2009|2009-06-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma|A PHASE II PILOT STUDY OF SHORT TERM (12 WEEK) COMBINATION CHEMOTHERAPY (STANFORD V) IN UNFAVORABLE HODGKIN'S DISEASE|Unknown status|Active, not recruiting|Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:12.177104|2017-02-18 18:21:12.177104
NCT00002714|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-14|||April 1995||1995-04-01|September 2001|2001-09-01|September 2001|Actual|2001-09-01|||||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease|A PHASE II TRIAL OF EIGHT-WEEK STANFORD V CHEMOTHERAPY PLUS MODIFIED INVOLVED FIELD RADIOTHERAPY IN FAVORABLE, LIMITED STAGE HODGKIN'S DISEASE|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:12.289727|2017-02-18 18:21:12.289727
NCT00002711|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||October 1995||1995-10-01|July 2013|2013-07-01|October 2000|Actual|2000-10-01|October 2000|Actual|2000-10-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus|A PHASE I TRIAL OF COMBINED MODALITY THERAPY FOR LOCALIZED ESOPHAGEAL CANCER: CISPLATIN-PACLITAXEL FOLLOWED BY RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ESCALATING DOSES OF PACLITAXEL|Completed||Phase 1|24|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:12.378452|2017-02-18 18:21:12.378452
NCT00002708|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-18|||January 1996||1996-01-01|November 2013|2013-11-01|December 2004|Actual|2004-12-01|January 2002|Actual|2002-01-01||Interventional|||Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases|A PHASE III TRIAL COMPARING WHOLE BRAIN IRRADIATION WITH VERSUS WITHOUT STEREOTACTIC RADIOSURGERY BOOST FOR PATIENTS WITH ONE TO THREE UNRESECTED BRAIN METASTASES|Completed||Phase 3|333|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:12.490552|2017-02-18 18:21:12.490552
NCT00002707|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-02-02|||December 1995||1995-12-01|February 2010|2010-02-01|February 2010|Actual|2010-02-01|June 2002|Actual|2002-06-01||Interventional|||Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed|A RANDOMIZED TRIAL COMPARING PREOPERATIVE DOXORUBICIN (ADRIAMYCIN)/CYCLOPHOSPHAMIDE (AC) TO PREOPERATIVE AC FOLLOWED BY PREOPERATIVE DOCETAXEL (TAXOTERE) AND TO PREOPERATIVE AC FOLLOWED BY POSTOPERATIVE DOCETAXEL IN PATIENTS WITH OPERABLE CARCINOMA OF THE BREAST|Completed||Phase 3|2411|Actual|NSABP Foundation Inc||3|||f||||t||||||||||2017-02-18 18:21:13.134235|2017-02-18 18:21:13.134235
NCT00002706|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-05-27|||April 1996||1996-04-01|May 2015|2015-05-01||||March 2010|Actual|2010-03-01||Interventional|||Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus|A Phase III Randomized Clinical Trial of Laparoscopic Pelvic and Para-Aortic Node Sampling With Vaginal Hysterectomy and BSO Versus Open Laparotomy With Pelvic and Para-Aortic Node Sampling and Abdominal Hysterectomy and BSO in Endometrial Adenocarcinoma and Uterine Sarcoma, Clinical Stage I, IIA, Grade I, II, III|Completed||Phase 3|2616|Actual|Gynecologic Oncology Group||2|||f||||||||||||||2017-02-18 18:21:13.423742|2017-02-18 18:21:13.423742
NCT00002705|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-31|||April 1996||1996-04-01|May 2001|2001-05-01||||January 2001|Actual|2001-01-01||Interventional|||Topotecan in Treating Children With Refractory Leukemia|TOPOTECAN FOR CHILDREN WITH REFRACTORY LEUKEMIA, A PEDIATRIC ONCOLOGY GROUP PHASE I COOPERATIVE AGREEMENT STUDY|Completed||Phase 1|3|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:13.535067|2017-02-18 18:21:13.535067
NCT00002704|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-31|||January 1996||1996-01-01|November 2007|2007-11-01||||June 2004|Actual|2004-06-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia|TREATMENT OF ISOLATED CNS RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA -- A PEDIATRIC ONCOLOGY GROUP-WIDE PHASE II STUDY|Completed||Phase 2|156|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:13.68149|2017-02-18 18:21:13.68149
NCT00002703|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||January 1996||1996-01-01|April 2012|2012-04-01|September 2005|Actual|2005-09-01|||||Interventional|||Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer|A PHASE III TRIAL EMPLOYING CONFORMAL PHOTONS WITH PROTON BOOST IN EARLY STAGE PROSTATE CANCER: CONVENTIONAL DOSE COMPARED TO HIGH DOSE IRRADIATION|Completed||Phase 3|390|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:13.886223|2017-02-18 18:21:13.886223
NCT00002702|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-23|||September 1992||1992-09-01|February 2011|2011-02-01||||||||Interventional|||Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx|Multicentre Randomised Trial of Inductive and Adjuvant Perilymphatically Injected Proleukin (rlL-2) in The Treatment of Operable Primary Squamous Cell Carcinoma of The Oral Cavity and Oropharynx|Unknown status|Recruiting|Phase 3|260|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:13.985322|2017-02-18 18:21:13.985322
NCT00002701|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||October 1995||1995-10-01|November 2006|2006-11-01||||||||Interventional|||Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia|INDUCTION WITH ALL-TRANS RETINOIC ACID IN COMBINATION WITH IDARUBICIN AND INTENSIVE CONSOLIDATION FOLLOWED BY BONE MARROW TRANSPLANTATION OR A RANDOMIZED MAINTENANCE TREATMENT DEPENDING UPON THE AMOUNT OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:14.108565|2017-02-18 18:21:14.108565
NCT00002700|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-11|||August 1995||1995-08-01|June 2013|2013-06-01||||March 2004|Actual|2004-03-01||Interventional|||Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia|A RANDOMIZED PHASE III TRIAL COMPARING DEXAMETHASONE WITH PREDNISONE IN INDUCTION TREATMENT AND BONE MARROW TRANSPLANTATION WITH INTENSIVE MAINTENANCE TREATMENT IN ADOLESCENT AND ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL-4)|Completed||Phase 3|392|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:14.560427|2017-02-18 18:21:14.560427
NCT00002697|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||September 1995||1995-09-01|July 2013|2013-07-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma|HIGH DOSE CHEMORADIOTHERAPY WITH PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION FOR PATIENTS WITH PRIMARY REFRACTORY, RELAPSED AND POOR PROGNOSIS NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:14.739768|2017-02-18 18:21:14.739768
NCT00002695|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-09-24|||January 1996||1996-01-01|January 2002|2002-01-01||||||||Observational|||Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck|CLINICAL EFFICACY OF MOLECULAR ANALYSIS OF SURGICAL MARGINS AND REGIONAL LYMPH NODES IN MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA|Unknown status|Active, not recruiting|N/A|530|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:14.946705|2017-02-18 18:21:14.946705
NCT00002693|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-08-02|||October 1995||1995-10-01|August 2011|2011-08-01|April 2006|Actual|2006-04-01|April 2006|Actual|2006-04-01||Interventional|||Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia|PHASE I STUDY OF CONTINUOUS INFUSION CARBOPLATIN AND TOPOTECAN IN THE TREATMENT OF RELAPSED ACUTE LEUKEMIA AND BLAST CRISIS CHRONIC MYELOGENOUS LEUKEMIA|Completed||Phase 1|||Mayo Clinic|||||f||||t||||||||||2017-02-18 18:21:15.049517|2017-02-18 18:21:15.049517
NCT00002692|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||December 1994||1994-12-01|May 2007|2007-05-01||||||||Interventional|||Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver|A RANDOMISED TRIAL OF INTRAVENOUS VERSUS INTRAHEPATIC ARTERIAL 5-FU AND LEUCOVORIN FOR COLORECTAL LIVER METASTASES|Unknown status|Active, not recruiting|Phase 3|312|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:15.158785|2017-02-18 18:21:15.158785
NCT00002691|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||August 1995||1995-08-01|June 2013|2013-06-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|||Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma|LSA5 PROTOCOL FOR THE TREATMENT OF ADVANCED PEDIATRIC AND ADOLESCENT NON-HODGKIN'S LYMPHOMA (NHL)|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:15.265306|2017-02-18 18:21:15.265306
NCT00002689|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-17|||September 1995||1995-09-01|June 2007|2007-06-01|June 2007|Actual|2007-06-01|||||Interventional|||Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer|Phase II Interstitial Colloidal 32P Integrated in The Treatment of Non-Resectable Pancreatic Cancer|Completed||Phase 2|48|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:15.364263|2017-02-18 18:21:15.364263
NCT00002688|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||February 1995||1995-02-01|May 2007|2007-05-01||||||||Interventional|||Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia|AML-MVPCYA: ADDITION OF CYCLOSPORIN A TO THE COMBINATION OF MITOXANTRONE AND ETOPOSIDE (VP 16,213) TO OVERCOME RESISTANCE TO CHEMOTHERAPY IN REFRACTORY AML: A RANDOMIZED PHASE II STUDY|Unknown status|Active, not recruiting|Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:15.467628|2017-02-18 18:21:15.467628
NCT00002687|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-30|||February 1995||1995-02-01|November 2012|2012-11-01|July 2003|Actual|2003-07-01|July 2003|Actual|2003-07-01||Interventional|||Interleukin-2 in Treating Patients With Mycosis Fungoides|Phase 1 Trial of Subcutaneous [SC]; Outpatient Interleukin-2 for Patients With Advanced Mycosis Fungoides [Stage IIb, III, IV]|Completed||Phase 1|30|Anticipated|University of Washington|||||f||||||||||||||2017-02-18 18:21:15.580064|2017-02-18 18:21:15.580064
NCT00002684|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-02|||May 1995||1995-05-01|July 2013|2013-07-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer|Phase II Trial of Paclitaxel, Cisplatin and Ifosfamide in Patients With Advanced Urothelial Tumors|Completed||Phase 2|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:15.669458|2017-02-18 18:21:15.669458
NCT00002682|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||August 1995||1995-08-01|July 2012|2012-07-01|October 2001|Actual|2001-10-01|October 2001|Actual|2001-10-01||Interventional|||Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach|CURRENT PRACTICE STUDY OF ANTIBIOTIC TREATMENT OF GASTRIC MALT LYMPHOMA|Completed||Phase 2|5|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:21:15.765814|2017-02-18 18:21:15.765814
NCT00002681|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-06-09|||July 1995||1995-07-01|June 2011|2011-06-01|December 2003|Actual|2003-12-01|September 2003|Actual|2003-09-01||Interventional|||Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma|Humanized Anti-Tac Antibody Therapy In Hodgkin's Disease, A Phase Ib/II Trial|Completed||Phase 1/Phase 2|25|Anticipated|Roger Williams Medical Center|||||f||||||||||||||2017-02-18 18:21:15.885145|2017-02-18 18:21:15.885145
NCT00002680|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-23|||February 1994||1994-02-01|August 2009|2009-08-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer|Phase II Trial of Sequential High-Dose Alkylating Agents in Metastatic Breast Cancer|Completed||Phase 2|40|Actual|Yale University|||||f||||f||||||||||2017-02-18 18:21:15.986074|2017-02-18 18:21:15.986074
NCT00002679|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-08-24|||February 1994||1994-02-01|August 2009|2009-08-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer|Sequential Adjuvant Chemotherapy With Doxorubicin, Taxol, and Cyclophosphamide for Stage II or III Resectable Breast Cancer With Four or More Involved Axillary Lymph Nodes|Completed||Phase 2|89|Actual|Yale University|||||f||||f||||||||||2017-02-18 18:21:16.095569|2017-02-18 18:21:16.095569
NCT00002678|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||May 1995||1995-05-01|September 2011|2011-09-01|December 2009|Actual|2009-12-01|December 2003|Actual|2003-12-01||Interventional|||Combination Chemotherapy in Treating Patients With Multiple Myeloma|A COMPARATIVE STUDY OF DEXAMETHASONE VERSUS PREDNISONE (BOTH IN COMBINATION WITH MELPHALAN) AS INDUCTION THERAPY IN UNTREATED SYMPTOMATIC MYELOMA WITH AN ADDITIONAL ASSESSMENT OF DEXAMETHASONE VERSUS NO ADDITIONAL TREATMENT AS MAINTENANCE THERAPY IN NON-PROGRESSING PATIENTS|Completed||Phase 3|595|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:21:16.19719|2017-02-18 18:21:16.19719
NCT00002677|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||August 1995||1995-08-01|April 2001|2001-04-01||||January 2004|Actual|2004-01-01||Interventional|||Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors|PHASE I STUDY OF THE ORALLY ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS|Completed||Phase 1|24|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:16.36545|2017-02-18 18:21:16.36545
NCT00002676|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||July 1995||1995-07-01|July 2016|2016-07-01|October 2006|Actual|2006-10-01|October 2006|Actual|2006-10-01||Interventional|||Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma|PHASE II TRIAL OF CHEMOTHERAPY PLUS RADIOTHERAPY FOR MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM NON-HODGKIN'S LYMPHOMA (PCNSL)|Completed||Phase 2|36|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:21:16.468372|2017-02-18 18:21:16.468372
NCT00002675|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-26|||May 1995||1995-05-01|June 2013|2013-06-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Chemotherapy in Treating Patients With Retinoblastoma|A TRIAL OF ADJUVANT CHEMOTHERAPY IN PATIENTS WITH INTRAOCULAR RETINOBLASTOMA|Completed||Phase 2|50|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:16.616843|2017-02-18 18:21:16.616843
NCT00002674|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-31|||October 1994||1994-10-01|March 2010|2010-03-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia|CYTOREDUCTIVE CHEMOTHERAPY WITH MITOXANTRONE, CYTOSINE ARABINOSIDE AND ETOPOSIDE FOLLOWED BY RECOMBINANT HUMAN G-CSF FOR MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:16.713713|2017-02-18 18:21:16.713713
NCT00002673|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-15|||June 1995||1995-06-01|June 2010|2010-06-01|February 2002|Actual|2002-02-01|||||Interventional|||Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation|A PHASE II STUDY OF CELLULAR ADOPTIVE IMMUNOTHERAPY AS PROPHYLAXIS FOR CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:16.812202|2017-02-18 18:21:16.812202
NCT00002671|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-08|||December 1995||1995-12-01|May 2006|2006-05-01||||February 2001|Actual|2001-02-01||Interventional|||Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer|PHASE II STUDY OF 9-20-S-AMINO-CAMPTOTHECIN (9-AC) AS SECOND LINE THERAPY IN ADVANCED OVARIAN CARCINOMA|Completed||Phase 2|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:21:16.914885|2017-02-18 18:21:16.914885
NCT00002670|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-23|||September 1995||1995-09-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|July 2002|Actual|2002-07-01||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery|Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy For Resectable High Risk Squamous Cell Carcinoma of the Head and Neck|Completed||Phase 3|459|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:17.010973|2017-02-18 18:21:17.010973
NCT00002669|ClinicalTrials.gov processed this data on February 17, 2017|2000-06-02|2012-06-29|||June 1995||1995-06-01|June 2012|2012-06-01||||August 2002|Actual|2002-08-01||Interventional|||Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma|TREATMENT OF METASTATIC MELANOMA WITH DTIC, CDDP AND IFN ALPHA WITH OR WITHOUT IL-2: A RANDOMIZED PHASE III TRIAL|Completed||Phase 2|90|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:17.146833|2017-02-18 18:21:17.146833
NCT00002668|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-30|||October 1995||1995-10-01|November 2012|2012-11-01|September 1998|Actual|1998-09-01|September 1998|Actual|1998-09-01||Interventional|||Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer|PATIENT SKILLS FOR CANCER PAIN CONTROL IN PATIENTS WITH METASTATIC BREAST OR PROSTATE CANCER|Terminated||N/A|13|Actual|Eastern Cooperative Oncology Group||2||Slow accrual|f||||f||||||||||2017-02-18 18:21:17.261088|2017-02-18 18:21:17.261088
NCT00002667|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-02-23|||July 1995||1995-07-01|May 2006|2006-05-01||||||||Interventional|||Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer|EARLY DETECTION OF SECOND PRIMARY LUNG CANCERS BY SPUTUM CYTOLOGY IMMUNOSTAINING|Unknown status|Active, not recruiting|N/A|1100|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:17.377057|2017-02-18 18:21:17.377057
NCT00002665|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-03-05|||July 1995||1995-07-01|March 2015|2015-03-01|December 2003|Actual|2003-12-01|December 2001|Actual|2001-12-01||Interventional|||SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia|TREATMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: PHASE II TRIALS OF AN INDUCTION REGIMEN INCLUDING PEG-L-ASPARAGINASE, WITH OR WITHOUT PIXY, IN PREVIOUSLY UNTREATED PATIENTS, FOLLOWED BY ALLOGENEIC BONE MARROW TRANSPLANTATION OR FURTHER CHEMOTHERAPY IN FIRST COMPLETE REMISSION|Completed||Phase 2|50|Anticipated|Southwest Oncology Group||1|||f||||||||||||||2017-02-18 18:21:17.47709|2017-02-18 18:21:17.47709
NCT00002664|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||July 1995||1995-07-01|February 2001|2001-02-01||||||||Interventional|||Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer|PHASE II STUDY OF MONOCLONAL ANTIBODY 17-1A WITH GM-CSF IN TREATMENT OF 5-FU RESISTANT COLORECTAL CANCER|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:17.982866|2017-02-18 18:21:17.982866
NCT00002663|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-22|||March 1995||1995-03-01|December 2016|2016-12-01|December 2017|Anticipated|2017-12-01|March 2017|Anticipated|2017-03-01||Interventional|||Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies|An Evaluation of the Toxicity and Therapeutic Effects of Epstein-Barr Virus-Immune T-Lymphocytes Derived From a Normal HLA-Compatible or Haplotype-Matched Donor in the Treatment of EBV-Associated Lymphoproliferative Diseases or Malignancies and Patients With Detectable Circulating Levels of EBV DNA Who Are at High Risk for EBV-Associated Lymphoproliferative Diseases|Recruiting||Phase 1/Phase 2|84|Anticipated|Atara Biotherapeutics||1|||t||||||||||||||2017-02-18 18:21:18.080354|2017-02-18 18:21:18.080354
NCT00002662|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-01|||August 1994||1994-08-01|April 2004|2004-04-01|June 2004|Actual|2004-06-01|||||Interventional|||Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer|PHASE III COMPARISON OF TAXOTERE (DOCETAXEL) AND TAXOL (PACLITAXEL) IN PATIENTS WITH ADVANCED BREAST CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:18.224475|2017-02-18 18:21:18.224475
NCT00002659|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||May 1995||1995-05-01|May 2007|2007-05-01||||||||Interventional|||Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer|A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF CISPLATIN/EPINEPHRINE INJECTABLE GEL (PRODUCT MPI 5010) WHEN ADMINISTERED INTRATUMORALLY FOR ACHIEVEMENT OF TREATMENT GOALS IN RECURRENT OR REFRACTORY SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK|Unknown status|Active, not recruiting|Phase 3|120|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:18.363933|2017-02-18 18:21:18.363933
NCT00002658|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||January 1994||1994-01-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia|ACUTE MYELOID LEUKAEMIA TRIAL 12|Unknown status|Active, not recruiting|Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:18.490681|2017-02-18 18:21:18.490681
NCT00002657|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-22|||May 1995||1995-05-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|November 2003|Actual|2003-11-01||Interventional|||SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant|Phase II Trial of Sequential Modification of Immunosuppression, Interferon Alpha, and Promace-Cytabom For Treatment of Post-Cardiac Transplant Lymphoproliferation.|Completed||Phase 2|20|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:21:18.609573|2017-02-18 18:21:18.609573
NCT00002656|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-25|||October 1995||1995-10-01|April 2013|2013-04-01|February 2008|Actual|2008-02-01|December 2001|Actual|2001-12-01||Interventional|||Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer|PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA|Completed||Phase 2|20|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||f||||||||||2017-02-18 18:21:18.860716|2017-02-18 18:21:18.860716
NCT00002655|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-19|||March 1995||1995-03-01|July 2013|2013-07-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases|Cryosurgical Destruction of Surgically Incurable Liver Tumors|Completed||Phase 2|||University of Colorado, Denver|||||f||||t||||||||||2017-02-18 18:21:18.958448|2017-02-18 18:21:18.958448
NCT00002654|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-03-06|||April 1994||1994-04-01|March 2013|2013-03-01|July 2000|Actual|2000-07-01|March 1999|Actual|1999-03-01||Interventional|||Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer|Phase III Study of Hyperfractionated Radiation Therapy With or Without Simultaneaous Application of CIS-Platinum in Patients With Moderately Advanced to Advanced Cancers of the Head and Neck|Completed||Phase 3|224|Actual|Swiss Group for Clinical Cancer Research|||||f||||f||||||||||2017-02-18 18:21:19.044748|2017-02-18 18:21:19.044748
NCT00002653|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||September 1993||1993-09-01|October 2002|2002-10-01||||||||Interventional|||Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma|VIIITH MYELOMATOSIS TRIAL: A RANDOMISED TRIAL OF TREATMENT FOR INDUCING FIRST PLATEAU PHASE ABCM VS 3 COURSES OF ABCM FOLLOWED BY ORAL WEEKLY CYCLOPHOSPHAMIDE|Unknown status|Active, not recruiting|Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:19.141548|2017-02-18 18:21:19.141548
NCT00002652|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-01|||May 1995||1995-05-01|April 2002|2002-04-01|February 2004|Actual|2004-02-01|||||Interventional|||Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease|A PHASE II PILOT STUDY OF SURAMIN IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA AND PATIENTS WITH CASTLEMAN'S DISEASE|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:19.24264|2017-02-18 18:21:19.24264
NCT00002651|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-23|||May 1995||1995-05-01|April 2009|2009-04-01||||June 2013|Anticipated|2013-06-01||Interventional|||Hormone Therapy in Treating Men With Stage IV Prostate Cancer|Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer, Phase III|Unknown status|Recruiting|Phase 3|1512|Anticipated|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:21:19.33242|2017-02-18 18:21:19.33242
NCT00002650|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-06|||April 1995||1995-04-01|May 2007|2007-05-01||||||||Interventional|||High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed|PHASE II DOUBLE-BLIND CHEMOPREVENTION TRIAL OF HIGH DOSE FOLIC ACID VERSUS PLACEBO IN PATIENTS WITH RESECTED COLORECTAL POLYPS|Unknown status|Active, not recruiting|Phase 2|80|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:19.462257|2017-02-18 18:21:19.462257
NCT00002649|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-27|||May 1995||1995-05-01|February 2013|2013-02-01||||November 2006|Actual|2006-11-01||Interventional|||Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma|Total Body Irradiation, Etoposide, Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation Followed by Randomization to Therapy With Interleukin-2 Versus Observation for Patients With Non-Hodgkin's Lymphoma|Completed||Phase 3|206|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:21:19.555444|2017-02-18 18:21:19.555444
NCT00002647|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||May 1994||1994-05-01|June 2009|2009-06-01||||||||Interventional|||Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors|Photodynamic Therapy For Childhood Brain Tumors, A Phase I Study|Unknown status|Recruiting|Phase 1|24|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:19.670556|2017-02-18 18:21:19.670556
NCT00002646|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-01-04|||October 1995||1995-10-01|October 2010|2010-10-01||||February 2004|Actual|2004-02-01||Interventional|||Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer|PHASE III DOUBLE-BLIND, PLACEBO-CONTROLLED, PROSPECTIVE RANDOMIZED COMPARISON OF ADJUVANT THERAPY WITH TAMOXIFEN VS. TAMOXIFEN AND FENRETINIDE IN POSTMENOPAUSAL WOMEN WITH INVOLVED AXILLARY LYMPH NODES AND POSITIVE RECEPTORS|Completed||Phase 3|1500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:19.852127|2017-02-18 18:21:19.852127
NCT00002644|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||January 1994||1994-01-01|July 2011|2011-07-01|May 2011|Actual|2011-05-01|||||Interventional|||Tamoxifen for the Prevention of Breast Cancer in High-Risk Women|INTERNATIONAL BREAST CANCER INTERVENTION STUDY: A MULTICENTRE TRIAL OF TAMOXIFEN TO PREVENT BREAST CANCER|Completed||Phase 3|7000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:20.024684|2017-02-18 18:21:20.024684
NCT00002643|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-31|||April 1995||1995-04-01|March 2007|2007-03-01||||June 2003|Actual|2003-06-01||Interventional|||Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor|INTENSIVE THERAPY WITH GROWTH FACTOR SUPPORT FOR PATIENTS WITH EWING'S TUMOR METASTATIC AT DIAGNOSIS: A PEDIATRIC ONCOLOGY GROUP PHASE II STUDY|Completed||Phase 2|130|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:20.119628|2017-02-18 18:21:20.119628
NCT00002642|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-05|||April 1995||1995-04-01|October 2012|2012-10-01|July 2004|Actual|2004-07-01|January 2001|Actual|2001-01-01||Interventional|||SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer|Induction Chemoradiotherapy Followed by Surgical Resection for Non-small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors): A Phase II Trial|Completed||Phase 2|116|Actual|Southwest Oncology Group||1|||f||||t||||||||||2017-02-18 18:21:23.266417|2017-02-18 18:21:23.266417
NCT00002641|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-08-07|||February 1995||1995-02-01|July 2002|2002-07-01|June 2012|Actual|2012-06-01|February 2006|Actual|2006-02-01||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma|RANDOMISED TRIAL OF ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE DOXORUBICIN, IFOSFAMIDE AND LENOGRASTIM IN HIGH GRADE SOFT TISSUE SARCOMA|Completed||Phase 3|350|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:23.396353|2017-02-18 18:21:23.396353
NCT00002638|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09|||March 1995||1995-03-01|September 2002|2002-09-01|March 2005|Actual|2005-03-01|||||Interventional|||Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia|HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR CHILDREN WITH RELAPSED ACUTE LYMPHOCYTIC LEUKEMIA|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:23.648563|2017-02-18 18:21:23.648563
NCT00002637|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||January 1995||1995-01-01|June 2013|2013-06-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||Biological Therapy in Treating Patients With Prostate Cancer|PHASE I/II STUDY OF IMMUNIZATION WITH MHC CLASS I MATCHED ALLOGENEIC HUMAN PROSTATIC CARCINOMA CELLS ENGINEERED TO SECRETE INTERLEUKIN-2 AND INTERFERON-GAMMA|Completed||Phase 1/Phase 2|25|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:23.743931|2017-02-18 18:21:23.743931
NCT00002635|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-24|||May 1995||1995-05-01|March 2001|2001-03-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Aminocamptothecin in Treating Patients With T-cell Lymphoma|PHASE II TRIAL OF 9-AMINOCAMPTOTHECIN IN ADVANCED CUTANEOUS T CELL LYMPHOMA|Completed||Phase 2|12|Actual|Yale University||1|||f||||f||||||||||2017-02-18 18:21:24.102887|2017-02-18 18:21:24.102887
NCT00002634|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||February 1995||1995-02-01|July 2013|2013-07-01|September 2004|Actual|2004-09-01|September 2004|Actual|2004-09-01||Interventional|||Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma|N7: EVALUATION OF MAXIMAL CHEMOTHERAPY DOSE INTENSITY PLUS MONOCLONAL ANTIBODY 3F8 IN THE TREATMENT OF NEUROBLASTOMA|Completed||Phase 2|45|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:24.199314|2017-02-18 18:21:24.199314
NCT00002633|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-31|||March 1995||1995-03-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer|Phase III Randomized Trial Comparing Total Androgen Blockade Versus Total Androgen Blockade Plus Pelvic Irradiation in Clinical Stage T3-4, N0, M0 Adenocarcinoma of the Prostate|Completed||Phase 3|361|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:21:24.314677|2017-02-18 18:21:24.314677
NCT00002632|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-28|||March 1995||1995-03-01|August 2013|2013-08-01||||May 2002|Actual|2002-05-01||Interventional|||Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer|PHASE II TRIAL OF TAXOL IN ADVANCED OR METASTATIC SALIVARY GLAND MALIGNANCIES|Completed||Phase 2|32|Anticipated|Eastern Cooperative Oncology Group|||||f||||||||||||||2017-02-18 18:21:24.472182|2017-02-18 18:21:24.472182
NCT00002631|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-18|||June 1995||1995-06-01|November 2013|2013-11-01||||September 1999|Actual|1999-09-01||Interventional|||Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus|A PHASE III INTERGROUP RANDOMIZED COMPARISON OF COMBINED MODALITY THERAPY FOR CARCINOMA OF THE ESOPHAGUS: HIGH-DOSE VS CONVENTIONAL-DOSE RADIATION THERAPY|Completed||Phase 3|298|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:21:24.609759|2017-02-18 18:21:24.609759
NCT00002630|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-05-10|||June 1993||1993-06-01|May 2011|2011-05-01|May 2001|Actual|2001-05-01|February 1999|Actual|1999-02-01||Interventional|||High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse|HIGH-DOSE MELPHALAN CHEMOTHERAPY AND TOTAL BODY RADIATION WITH PERIPHERAL BLOOD STEM-CELL RECONSTITUTION FOR PATIENTS WITH RELAPSING MULTIPLE MYELOMA|Completed||Phase 2|50|Anticipated|Mayo Clinic|||||f||||t||||||||||2017-02-18 18:21:24.741987|2017-02-18 18:21:24.741987
NCT00002628|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-09|||November 1994||1994-11-01|April 2000|2000-04-01||||||||Interventional|||Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer|PHASE I/II TRIAL OF THE ADDITION OF TAXOL TO THE HIGH DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL SUPPORT IN PATIENTS WITH BREAST CANCER|Unknown status|Active, not recruiting|Phase 1/Phase 2|50|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:24.849251|2017-02-18 18:21:24.849251
NCT00002627|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-09|||November 1994||1994-11-01|July 2000|2000-07-01||||||||Interventional|||Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer|PHASE I/II TRIAL OF THE ADDITION OF TAXOL TO HIGH DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL SUPPORT IN PATIENTS WITH HIGH RISK STAGE II AND III BREAST CANCER|Unknown status|Active, not recruiting|Phase 1/Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:24.943432|2017-02-18 18:21:24.943432
NCT00002625|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||March 1995||1995-03-01|January 2013|2013-01-01|September 2000|Actual|2000-09-01|April 2000|Actual|2000-04-01||Interventional|||Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma|PHASE I STUDY OF TOPOTECAN AND THORACIC RADIATION|Completed||Phase 1|5|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:25.036042|2017-02-18 18:21:25.036042
NCT00002624|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-12|||December 1994||1994-12-01|July 2016|2016-07-01|August 2005|Actual|2005-08-01|April 2005|Actual|2005-04-01||Interventional|||Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function|VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY|Completed||Phase 2|66|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:21:25.14457|2017-02-18 18:21:25.14457
NCT00002623|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||December 1994||1994-12-01|June 2012|2012-06-01||||December 2002|Actual|2002-12-01||Interventional|||Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer|RANDOMIZED TRIAL OF SURGERY VERSUS RADIOTHERAPY IN PATIENTS WITH STAGE IIIa NON-SMALL CELL LUNG CANCER AFTER A RESPONSE TO INDUCTION-CHEMOTHERAPY|Completed||Phase 3|640|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:25.268767|2017-02-18 18:21:25.268767
NCT00002622|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-27|||December 1994||1994-12-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|March 2005|Actual|2005-03-01||Interventional|||Talc in Treating Patients With Malignant Pleural Effusion|Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study|Completed||Phase 3|501|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:21:25.674734|2017-02-18 18:21:25.674734
NCT00002621|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||December 1994||1994-12-01|July 2014|2014-07-01|September 2005|Actual|2005-09-01|July 2002|Actual|2002-07-01||Interventional|||Interferon Alfa in Treating Children With HIV-Related Cancer|A Phase II Study of Alpha Interferon (alphaIFN) In HIV-Related Malignancies - A Pediatric Oncology Group Wide Study|Completed||Phase 2|8|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:21:26.041676|2017-02-18 18:21:26.041676
NCT00002620|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||November 1994||1994-11-01|June 2012|2012-06-01||||June 2000|Actual|2000-06-01||Interventional|||Radiation Therapy in Treating Patients With Brain Cancer|EFFECT OF DIBROMODULCITOL PLUS BCNU ON FREE INTERVAL AND SURVIVAL OF PATIENTS WITH SUPRATENTORIAL MALIGNANT BRAIN GLIOMAS, A PHASE III TYPE STUDY|Completed||Phase 3|212|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:26.179573|2017-02-18 18:21:26.179573
NCT00002619|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-08|||September 1994||1994-09-01|June 2000|2000-06-01||||April 2000|Actual|2000-04-01||Interventional|||Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors|A TRIAL OF INTENSIVE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RECONSTITUTION FOR PATIENTS BETWEEN SIX AND SIXTY YEARS OF AGE, WITH NON-PROGRESSIVE GLIOBLASTOMA MULTIFORME OR DIFFUSE INTRINSIC BRAINSTEM TUMORS, FOLLOWING INITIAL LOCAL-FIELD IRRADIATION|Completed||Phase 2|60|Anticipated|New York University School of Medicine|||||f||||||||||||||2017-02-18 18:21:26.299025|2017-02-18 18:21:26.299025
NCT00002618|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||December 1994||1994-12-01|July 2014|2014-07-01|September 2006|Actual|2006-09-01|September 2000|Actual|2000-09-01||Interventional|||Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma|A Phase III Study of Large Cell Lymphomas in Children and Adolescents: Comparison of APO vs APO + IDMTX/HDARA-C and Continuous vs Bolus Infusion of Doxorubicin|Completed||Phase 3|242|Anticipated|Children's Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:26.401016|2017-02-18 18:21:26.401016
NCT00002616|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||February 1995||1995-02-01|September 2000|2000-09-01||||||||Interventional|||Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer|A PILOT TRIAL OF INTERLEUKIN-2 WITH G-CSF AS PRIMING THERAPY FOR PERIPHERAL BLOOD STEM CELL HARVESTING IN PATIENTS WITH ADVANCED BREAST CANCER: STAMP V HIGH DOSE CHEMOTHERAPY, STEM CELL INFUSION AND POST-INFUSION G-CSF AND INTERLEUKIN-2|Unknown status|Active, not recruiting|Phase 1|36|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:26.549469|2017-02-18 18:21:26.549469
NCT00002615|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||June 1994||1994-06-01|August 2001|2001-08-01|December 2003|Actual|2003-12-01|||||Interventional|||Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer|A RANDOMISED, CONTROLLED TRIAL OF PRE- AND POST-OPERATIVE CHEMOTHERAPY IN PATIENTS WITH OPERABLE GASTRIC CANCER|Completed||Phase 3|500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:26.644096|2017-02-18 18:21:26.644096
NCT00002611|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||July 1995||1995-07-01|July 2014|2014-07-01|August 2003|Actual|2003-08-01|June 2002|Actual|2002-06-01||Interventional|||Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer|NATIONAL WILMS TUMOR STUDY-5 -- THERAPEUTIC TRIAL AND BIOLOGY STUDY|Completed||Phase 3|3031|Actual|Children's Oncology Group||9|||f||||t||||||||||2017-02-18 18:21:26.751318|2017-02-18 18:21:26.751318
NCT00002610|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||January 1996||1996-01-01|July 2014|2014-07-01|February 2006|Actual|2006-02-01|June 2002|Actual|2002-06-01||Interventional|||Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors|National Wilms Tumor Study-5 -- Treatment of Relapsed Patients, A National Wilms Tumor Study Group Phase III Study|Completed||Phase 3|203|Actual|Children's Oncology Group||4|||f||||t||||||||||2017-02-18 18:21:27.437181|2017-02-18 18:21:27.437181
NCT00002609|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||August 1994||1994-08-01|June 2013|2013-06-01|February 2003|Actual|2003-02-01|February 2003|Actual|2003-02-01||Interventional|||Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission|PHASE II TRIAL OF POST-REMISSION THERAPY WITH HuM195 AND CYTOTOXIC CHEMOTHERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA|Completed||Phase 2|40|Actual|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:27.823306|2017-02-18 18:21:27.823306
NCT00002608|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09|||May 1994||1994-05-01|May 2005|2005-05-01|April 2005|Actual|2005-04-01|||||Interventional|||Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors|Cisplatin, Doxorubicin and Tamoxifen in the Treatment of Incurable Soft Tissue and Endocrine Malignancies|Completed||Phase 2|30|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:27.909635|2017-02-18 18:21:27.909635
NCT00002604|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-07-07|||January 1996||1996-01-01|July 2010|2010-07-01|February 2004|Actual|2004-02-01|July 2000|Actual|2000-07-01||Interventional|||O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors|Phase I Trial of O6 Benzylguanine and BCNU; A Biochemical Modulation Trial Based Upon Depletion of O6 Alkylguanine DNA Alkyltransferase Directed DNA Repair|Completed||Phase 1|28|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:21:28.01634|2017-02-18 18:21:28.01634
NCT00002602|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-03-26|||May 1994||1994-05-01|March 2015|2015-03-01|November 2013|Actual|2013-11-01|March 2004|Actual|2004-03-01||Interventional|||Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer|A PHASE I/II DOSE ESCALATION STUDY USING THREE DIMENSIONAL CONFORMAL RADIATION THERAPY FOR ADENOCARCINOMA OF THE PROSTATE|Completed||Phase 1/Phase 2|1084|Actual|Radiation Therapy Oncology Group||3|||f||||t||||||||||2017-02-18 18:21:28.118159|2017-02-18 18:21:28.118159
NCT00002601|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-21|2016-11-21||September 1994||1994-09-01|November 2016|2016-11-01|September 2014|Actual|2014-09-01|September 2014|Actual|2014-09-01||Interventional|||Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma|High-Dose Doxorubicin and Ifosfamide Followed by Melphalan and Cisplatin for Patients With High-Risk and Recurrent Sarcoma|Completed||Phase 2|13|Actual|City of Hope Medical Center||1|||f||||f||||||||||2017-02-18 18:21:28.757174|2017-02-18 18:21:28.757174
NCT00002600|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-04-23|||September 1994||1994-09-01|September 2001|2001-09-01||||||||Interventional|||Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer|A PHASE I TRIAL OF HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE MARROW AND PERIPHERAL BLOOD PROGENITOR CELL RESCUE IN PATIENTS WITH PLATINUM-SENSITIVE, CHEMOTHERAPY-RESPONSIVE EPITHELIAL OVARIAN CARCINOMA|Completed||Phase 1|18|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:29.115002|2017-02-18 18:21:29.115002
NCT00002599|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-18|||September 1994||1994-09-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma|MYELOMA VII MEDICAL RESEARCH COUNCIL WORKING PARTY ON LEUKEMIA IN ADULTS: MYELOMATOSIS THERAPY TRIAL|Unknown status|Active, not recruiting|Phase 3|750|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:29.216418|2017-02-18 18:21:29.216418
NCT00002581|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||June 1993||1993-06-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer|PROTOCOL FOR THE SCOTTISH POSTMENOPAUSAL CHEMO-ENDOCRINE TRIAL|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:32.400314|2017-02-18 18:21:32.400314
NCT00002598|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||June 1994||1994-06-01|June 2013|2013-06-01|June 2004|Actual|2004-06-01|June 2004|Actual|2004-06-01||Interventional|||Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia|A PHASE II STUDY OF MITOXANTRONE AND HIGH-DOSE ARA-C FOLLOWED BY INTENSIVE CONSOLIDATION WITH CYCLOPHOSPHAMIDE AND ETOPOSIDE FOR MYELOID BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA (CML)|Completed||Phase 2|30|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:29.324227|2017-02-18 18:21:29.324227
NCT00002597|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-14|||October 1994||1994-10-01|November 2015|2015-11-01||||July 2011|Actual|2011-07-01||Interventional|||Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer|A PHASE III TRIAL OF THE STUDY OF ENDOCRINE THERAPY USED AS A CYTOREDUCTIVE AND CYTOSTATIC AGENT PRIOR TO RADIATION THERAPY IN GOOD PROGNOSIS LOCALLY CONFINED ADENOCARCINOMA OF THE PROSTATE|Completed||Phase 3|2028|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:29.432884|2017-02-18 18:21:29.432884
NCT00002596|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||September 1994||1994-09-01|October 2003|2003-10-01|July 2006|Actual|2006-07-01|||||Interventional|||Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors|RANDOMIZED MULTIINSTITUTIONAL PHASE III TRIAL OF BEP AND HIGH DOSE CHEMOTHERAPY VERSUS BEP ALONE IN PREVIOUSLY UNTREATED PATIENTS WITH POOR RISK GERM CELL TUMORS|Completed||Phase 3|270|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:30.074764|2017-02-18 18:21:30.074764
NCT00002595|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09|||July 1991||1991-07-01|August 2010|2010-08-01|September 2010|Actual|2010-09-01|May 2003|Actual|2003-05-01||Interventional|||Toremifene in Treating Patients With Desmoid Tumors|PHASE II STUDY OF THE SAFETY AND EFFICACY OF TOREMIFENE IN THE THERAPY OF DESMOID TUMORS|Completed||Phase 2|72|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:30.348607|2017-02-18 18:21:30.348607
NCT00002594|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||September 1994||1994-09-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|September 2003|Actual|2003-09-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors|Dose-Intensive Melphalan and Cyclophosphamide With Autologous Bone Marrow Rescue for Recurrent Medulloblastoma and Germ Cell Tumors|Completed||Phase 2|31|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:21:30.446433|2017-02-18 18:21:30.446433
NCT00002593|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-02|||December 1994||1994-12-01|January 2013|2013-01-01|March 2005|Actual|2005-03-01|December 1999|Actual|1999-12-01||Interventional|||S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed|Phase III Randomized Trial of 5-FU/Leucovorin/Levamisole Versus 5-FU Continuous Infusion/Levamisole as Adjuvant Therapy for High-Risk Resectable Colon Cancer|Completed||Phase 3|1135|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:30.692982|2017-02-18 18:21:30.692982
NCT00002592|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-01-13|||June 1993||1993-06-01|January 2015|2015-01-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia|AUTOLOGOUS BONE MARROW TRANSPLANTATION USING C-MYB (LR-3001) ANTISENSE OLIGODEOXYNUCLEOTIDE TREATED BONE MARROW IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC OR ACCELERATED PHASE|Completed||Phase 2|40|Anticipated|Abramson Cancer Center of the University of Pennsylvania|||||f||||||||||||||2017-02-18 18:21:30.89434|2017-02-18 18:21:30.89434
NCT00002590|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-07-23|||July 1994||1994-07-01|July 2014|2014-07-01|March 2007|Actual|2007-03-01|March 2001|Actual|2001-03-01||Interventional|||Combination Chemotherapy in Treating Children With Lymphoma|A Pilot Study For The Treatment of Newly-Diagnosed Disseminated Anaplastic Large Cell Ki-1 Lymphoma and T-Large Cell Lymphoma|Completed||Phase 2|221|Actual|Children's Oncology Group||1|||f||||t||||||||||2017-02-18 18:21:31.004559|2017-02-18 18:21:31.004559
NCT00002589|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||July 1994||1994-07-01|December 2005|2005-12-01||||||||Interventional|||Lymphocyte Therapy in Treating Patients With Kidney Cancer|Adjuvant Autolymphocyte Therapy (ALT) For Patients With Non-Metastatic Renal Cell Carcinoma|Unknown status|Active, not recruiting|Phase 2|90|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:31.197715|2017-02-18 18:21:31.197715
NCT00002588|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-09|||August 1994||1994-08-01|June 2010|2010-06-01|January 2001|Actual|2001-01-01|July 2000|Actual|2000-07-01||Interventional|||Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia|Phase I Trial of Sequential Topotecan(NSC 609699)and Etoposide for Patients With Relapsed, Refractory,or High Risk Acute Myeloid or Lymphoid Leukemia|Completed||Phase 1|30|Actual|Case Comprehensive Cancer Center||1|||f||||t||||||||||2017-02-18 18:21:31.295921|2017-02-18 18:21:31.295921
NCT00002587|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-31|||September 1994||1994-09-01|April 2001|2001-04-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors|A PHASE I STUDY OF PROLONGED LOW-DOSE TOPOTECAN INFUSION COMBINED WITH PACLITAXEL (TAXOL)|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:31.397484|2017-02-18 18:21:31.397484
NCT00002586|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-05-05|||January 1993||1993-01-01|May 2014|2014-05-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|13-Cis||13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer|ASSESSMENT OF INTERMEDIATE ENDPOINT BIOMARKERS TO 13-CIS RETINOIC ACID WITH OR WITHOUT ALPHA TOCOPHEROL OR OBSERVATION|Completed||Phase 2|96|Actual|University of Colorado, Denver||3|||f||||t||||||||||2017-02-18 18:21:31.502347|2017-02-18 18:21:31.502347
NCT00002585|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-03-09|||February 1994||1994-02-01|March 2012|2012-03-01|January 2001|Actual|2001-01-01|October 1999|Actual|1999-10-01||Interventional|||Pyrazoloacridine in Treating Women With Metastatic Breast Cancer|PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE IN PATIENTS WITH METASTATIC BREAST CANCER|Completed||Phase 2|20|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||f||||||||||2017-02-18 18:21:31.619652|2017-02-18 18:21:31.619652
NCT00002583|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||July 1994||1994-07-01|March 2012|2012-03-01|December 2009|Actual|2009-12-01|December 2003|Actual|2003-12-01||Interventional|||Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed|A PHASE III PROSPECTIVE RANDOMIZED STUDY OF ADJUVANT CHEMOTHERAPY WITH VINORELBINE AND CISPLATIN IN COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER WITH COMPANION TUMOUR MARKER EVALUATION|Completed||Phase 3|482|Actual|Canadian Cancer Trials Group||2|||f||||||||||||||2017-02-18 18:21:31.712035|2017-02-18 18:21:31.712035
NCT00002582|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-01|||June 1993||1993-06-01|May 2007|2007-05-01|April 2007|Actual|2007-04-01|||||Interventional|||Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer|UKCCCR RANDOMISED TRIAL OF ADJUVANT ENDOCRINE THERAPY AND CHEMOTHERAPY IN WOMEN WITH EARLY BREAST CANCER, THE ADJUVANT BREAST CANCER (ABC) TRIAL|Completed||Phase 3|6000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:32.271872|2017-02-18 18:21:32.271872
NCT00002580|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||June 1993||1993-06-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer|PROTOCOL FOR THE SCOTTISH PREMENOPAUSAL CHEMO-ENDOCRINE TRIAL|Completed||Phase 3|1000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:32.51511|2017-02-18 18:21:32.51511
NCT00002579|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||March 1993||1993-03-01|May 2007|2007-05-01||||||||Interventional|||Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer|PROTOCOL FOR THE SCOTTISH CHEMO-ENDOCRINE TRIAL D|Completed||Phase 3|2000|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:32.631632|2017-02-18 18:21:32.631632
NCT00002578|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-05|||August 1994||1994-08-01|October 2015|2015-10-01||||January 2007|Actual|2007-01-01||Interventional|||Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma|Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome|Completed||Phase 2|35|Anticipated|Roswell Park Cancer Institute|||||f||||||||||||||2017-02-18 18:21:32.748474|2017-02-18 18:21:32.748474
NCT00002577|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-18|||July 1995||1995-07-01|November 2013|2013-11-01||||January 2003|Actual|2003-01-01||Interventional|||Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer|A PHASE I/II DOSE ESCALATION STUDY USING THREE DIMENSIONAL CONFORMAL RADIATION THERAPY POST INDUCTION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED INOPERABLE, NON-SMALL CELL LUNG CANCER|Completed||Phase 1/Phase 2|36|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:21:32.866904|2017-02-18 18:21:32.866904
NCT00002576|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-06|||November 1992||1992-11-01|May 2007|2007-05-01|January 2001|Actual|2001-01-01|||||Interventional|||Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma|A RANDOMIZED PROSPECTIVE TRIAL OF CHOP VERSUS MCOP IN ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH GRADE NON-HODGKIN'S LYMPHOMA (AGED 65 YEARS AND OVER)|Completed||Phase 3|200|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:33.22261|2017-02-18 18:21:33.22261
NCT00002575|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-15|||August 1994||1994-08-01|July 2016|2016-07-01|November 2009|Actual|2009-11-01|May 2004|Actual|2004-05-01||Interventional|||Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer|A PHASE III PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC-ASSISTED COLECTOMY VERSUS OPEN COLECTOMY FOR COLON CANCER|Completed||Phase 3|810|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:21:33.323887|2017-02-18 18:21:33.323887
NCT00002574|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-04|||September 1994||1994-09-01|October 2001|2001-10-01||||June 2001|Actual|2001-06-01||Interventional|||Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia|PHASE II STUDY OF SIMULTANEOUS HOMOHARRINGTONINE (NSC 141633) AND ALPHA INTERFERON (IFN-A) THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA (CML)|Completed||Phase 2|87|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:33.656634|2017-02-18 18:21:33.656634
NCT00002572|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-28|||November 1994||1994-11-01|July 2000|2000-07-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors|Intracavitary Allogenic Cytotoxic T Lymphocytes and Human Recombinant Interleukin-2 Therapy for Recurrent Primary Brain Tumors|Completed||Phase 1|10|Anticipated|University of Colorado, Denver|||||f||||||||||||||2017-02-18 18:21:36.858503|2017-02-18 18:21:36.858503
NCT00002571|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-01-22|||June 1994||1994-06-01|January 2013|2013-01-01|July 2011|Actual|2011-07-01|November 2003|Actual|2003-11-01||Interventional|||SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma|Study of Promace-Cytabom With Trimethoprim Sulfamethoxazole, Zidovudine (AZT), and Granulocyte Colony Stimulating Factor (G-CSF) in Patients With AIDS-Related Lymphoma, Phase II|Completed||Phase 2|52|Actual|Southwest Oncology Group||1|||f||||f||||||||||2017-02-18 18:21:36.966053|2017-02-18 18:21:36.966053
NCT00002570|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-25|||July 1994||1994-07-01|September 2011|2011-09-01|February 2009|Actual|2009-02-01|November 2000|Actual|2000-11-01||Interventional|||Immediate Compared With Delayed Chemotherapy in Treating Patients With Advanced Colorectal Cancer Without Signs or Symptoms of Disease|A PHASE III STUDY OF IMMEDIATE VERSUS DELAYED CHEMOTHERAPY FOR ASYMPTOMATIC ADVANCED COLORECTAL CANCER|Completed||Phase 3|67|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||||2017-02-18 18:21:37.168905|2017-02-18 18:21:37.168905
NCT00002569|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-14|||July 1994||1994-07-01|November 2015|2015-11-01||||February 2005|Actual|2005-02-01||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma|Phase III Intergroup Randomized Comparison of Radiation Alone vs. Pre-Radiation Chemotherapy for Pure and Mixed Anaplastic Oligodendrogliomas|Completed||Phase 3|299|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:37.588337|2017-02-18 18:21:37.588337
NCT00002568|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-08|||June 1994||1994-06-01|May 2010|2010-05-01||||December 2004|Actual|2004-12-01||Interventional|||Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer|A PHASE III RANDOMIZED STUDY OF CISPLATIN (NSC #119875) AND TAXOL (PACLITAXEL) (NSC #125973) WITH INTERVAL SECONDARY CYTOREDUCTION VERSUS CISPLATIN AND PACLITAXEL IN PATIENTS WITH SUBOPTIMAL STAGE III & IV EPITHELIAL OVARIAN CARCINOMA|Completed||Phase 3|470|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:21:37.825454|2017-02-18 18:21:37.825454
NCT00002567|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||March 1994||1994-03-01|June 2013|2013-06-01|November 2000|Actual|2000-11-01|November 2000|Actual|2000-11-01||Interventional|||High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission|PHASE II STUDY EVALUATING AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION FOR ACUTE LEUKEMIAS|Completed||Phase 2|45|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:37.990149|2017-02-18 18:21:37.990149
NCT00002566|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-11-02|||February 1994||1994-02-01|May 2007|2007-05-01||||||||Interventional|||Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors|INTERNATIONAL RANDOMIZED STUDY FOR THE SALVAGE TREATMENT OF GERM CELL TUMOURS|Unknown status|Active, not recruiting|Phase 3|280|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:38.096774|2017-02-18 18:21:38.096774
NCT00002565|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-05|||May 1994||1994-05-01|October 2012|2012-10-01|February 2007|Actual|2007-02-01|February 2007|Actual|2007-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma|"RANDOMIZED COMPARISON OF ALTERNATING TRIPLE THERAPY (ATT) VERUS CHOP IN PATIENTS WITH INTERMEDIATE GRADE LYMPHOMAS AND IMMUNOBLASTIC LYMPHOMAS WITH INTERNATIONAL INDEX 2-5"|Completed||Phase 3|61|Actual|M.D. Anderson Cancer Center||2|||f||||f||||||||||2017-02-18 18:21:38.207939|2017-02-18 18:21:38.207939
NCT00002564|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||April 1994||1994-04-01|February 2010|2010-02-01|December 2006|Actual|2006-12-01|||||Interventional|||Nutrition Intervention in Treating Women With Breast Cancer|A CLINICAL TRIAL TO DETERMINE THE EFFICACY OF A DIETARY FAT REDUCTION PROGRAM PROVIDED IN ADDITION TO SYSTEMIC ADJUVANT THERAPY IN THE MANAGEMENT OF PATIENTS WITH PRIMARY INVASIVE BREAST CANCER|Completed||Phase 3|2500|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:38.330561|2017-02-18 18:21:38.330561
NCT00002563|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-08|||April 1994||1994-04-01|April 2013|2013-04-01|May 2005|Actual|2005-05-01|September 2003|Actual|2003-09-01||Observational|||SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease|Health Status and Quality of Life in Patients With Early Stage Hodgkin's Disease: A Companion Study to SWOG-9133|Completed||N/A|263|Actual|Southwest Oncology Group|||1||f||||t||||||||||2017-02-18 18:21:38.526003|2017-02-18 18:21:38.526003
NCT00002562|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-19|||March 1994||1994-03-01|December 2005|2005-12-01|August 2004|Actual|2004-08-01|||||Interventional|||Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer|EVALUATION OF PACLITAXEL (TAXOL) IN PERSISTENT OR RECURRENT NON-SQUAMOUS CELL CARCINOMA OF THE CERVIX AND VAGINA|Completed||Phase 2|25|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:38.83312|2017-02-18 18:21:38.83312
NCT00002561|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-11-25|||January 1994||1994-01-01|January 2012|2012-01-01|January 2012|Actual|2012-01-01|December 2010|Actual|2010-12-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease|A PHASE III STUDY OF RADIOTHERAPY OR ABVD PLUS RADIOTHERAPY VERSUS ABVD ALONE IN THE TREATMENT OF EARLY STAGE HODGKIN'S DISEASE|Completed||Phase 3|405|Actual|Canadian Cancer Trials Group||2|||f||||t||||||||Undecided||2017-02-18 18:21:38.99818|2017-02-18 18:21:38.99818
NCT00002560|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-27|||February 1994||1994-02-01|June 2013|2013-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma|PHASE II TRIAL OF MONOCLONAL ANTIBODY 3F8 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FOR NEUROBLASTOMA|Completed||Phase 2|40|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:39.16251|2017-02-18 18:21:39.16251
NCT00002559|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-01|||January 1994||1994-01-01|July 2013|2013-07-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin|PHASE I/II TRIAL OF TAXOL, IFOSFAMIDE, AND CISPLATIN FOR CISPLATIN-RESISTANT GERM CELL TUMOR PATIENTS WITH FAVORABLE PROGNOSTIC FEATURES|Completed||Phase 1/Phase 2|43|Anticipated|Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:39.265408|2017-02-18 18:21:39.265408
NCT00002558|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-04-11|2015-12-21||January 1994||1994-01-01|April 2016|2016-04-01|April 2009|Actual|2009-04-01|April 2009|Actual|2009-04-01||Interventional|||Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors|PHASE I/II TRIAL OF SEQUENTIAL TAXOL/IFOSFAMIDE AND DOSEINTENSIVE CARBOPLATIN/ETOPOSIDE WITH STEM CELL SUPPORT IN CISPLATIN-RESISTANT GERM CELL TUMOR PATIENTS WITH UNFAVORABLE PROGNOSTIC FEATURES|Completed||Phase 1/Phase 2|108|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:21:39.367891|2017-02-18 18:21:39.367891
NCT00002557|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||June 1993||1993-06-01|August 2000|2000-08-01||||||||Interventional|||Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides|PROTOCOL FOR THE MANAGEMENT OF MYCOSIS FUNGOIDES AND THE SEZARY SYNDROME|Unknown status|Active, not recruiting|Phase 2|3|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:39.865432|2017-02-18 18:21:39.865432
NCT00002556|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-30|||July 1994||1994-07-01|May 2013|2013-05-01||||January 2006|Actual|2006-01-01||Interventional|||Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma|The Treatment of Multiple Myeloma Utilizing VBMCP Chemotherapy Alternating With High-Dose Cyclophosphamide and Alpha2b-Interferon Versus VBMCP: A Phase III Study for Previously Untreated Multiple Myeloma|Completed||Phase 3|312|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:21:39.972003|2017-02-18 18:21:39.972003
NCT00002555|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-06-29|||February 1994||1994-02-01|June 2012|2012-06-01||||October 2000|Actual|2000-10-01||Interventional|||High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer|A PHASE III RANDOMIZED STUDY ON POSTOPERATIVE RADIO- AND CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CARCINOMAS|Completed||Phase 3|338|Anticipated|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:40.113777|2017-02-18 18:21:40.113777
NCT00002554|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-03-29|||November 1993||1993-11-01|March 2010|2010-03-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse|RADIOLABELED BC8 (ANTI-CD45) ANTIBODY COMBINED WITH BUSULFAN AND CYCLOPHOSPHAMIDE AS TREATMENT FOR ACUTE MYELOGENOUS LEUKEMIA IN FIRST OR SECOND REMISSION OR UNTREATED FIRST RELAPSE FOLLOWED BY HLA-IDENTICAL RELATED MARROW TRANSPLANTATION|Completed||Phase 2|30|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:40.241278|2017-02-18 18:21:40.241278
NCT00002553|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-11-28|||August 1990||1990-08-01|November 2011|2011-11-01|June 2003|Actual|2003-06-01|||||Interventional|||Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer|TREATMENT OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES USING MARROW TRANSPLANTATION FROM UNRELATED DONORS MATCHED FOR HLA OR INCOMPATIBLE FOR ONE HLA LOCUS ANTIGEN|Completed||Phase 2|50|Anticipated|Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:40.339131|2017-02-18 18:21:40.339131
NCT00002552|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-05|||October 1993||1993-10-01|April 2013|2013-04-01|October 2003|Actual|2003-10-01|September 2001|Actual|2001-09-01||Interventional|||Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma|AUTOLOGOUS, ALLOGENEIC, OR SYNGENEIC BONE MARROW TRANSPLANTATION IN HODGKIN'S DISEASE, NON-HODGKIN'S LYMPHOMA, AND MULTIPLE MYELOMA|Completed||Phase 2|40|Anticipated|Barbara Ann Karmanos Cancer Institute|||||f||||t||||||||||2017-02-18 18:21:40.45093|2017-02-18 18:21:40.45093
NCT00002551|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||March 1994||1994-03-01|April 2013|2013-04-01|October 2008|Actual|2008-10-01|August 2006|Actual|2006-08-01||Interventional|||SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed|Postoperative Evaluation of 5-FU by Bolus Injection vs. 5-FU by Prolonged Venous Infusion Prior to and Following Combined Prolonged Venous Infusion Plus Pelvic XRT vs. Bolus 5-FU Plus Leucovorin Plus Levamisole Prior to and Following Combined Pelvic XRT Plus Bolus 5-FU Plus Leucovorin in Patients With Rectal Cancer, Phase III|Completed||Phase 3|1917|Actual|Southwest Oncology Group||3|||f||||t||||||||||2017-02-18 18:21:40.565038|2017-02-18 18:21:40.565038
NCT00002550|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-11-14|||March 1994||1994-03-01|November 2015|2015-11-01|November 2013|Actual|2013-11-01|June 2004|Actual|2004-06-01||Interventional|||Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer|A Phase III Comparison Between Concurrent Chemotherapy Plus Radiotherapy and Concurrent Chemotherapy Plus Radiotherapy Followed by Surgical Resection for Stage IIIA (N2) Non-Small Cell Lung Cancer|Completed||Phase 3|429|Actual|Radiation Therapy Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:40.998931|2017-02-18 18:21:40.998931
NCT00002549|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-12-22|||November 1993||1993-11-01|December 2009|2009-12-01||||||||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia|RANDOMIZED PHASE III STUDY OF INDUCTION (ICE VS MICE VS DCE) AND INTENSIVE CONSOLIDATION (IDIA VS NOVIA VS DIA) FOLLOWED BY BONE MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA: AML 10 PROTOCOL|Unknown status|Active, not recruiting|Phase 3|1520|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:41.1503|2017-02-18 18:21:41.1503
NCT00002548|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-03-05|||January 1994||1994-01-01|March 2015|2015-03-01|November 2006|Actual|2006-11-01|October 2003|Actual|2003-10-01||Interventional|||SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma|Standard Dose Versus Myeloablative Therapy for Previously Untreated Symptomatic Multiple Myeloma, A Phase III Intergroup Study|Completed||Phase 3|899|Actual|Southwest Oncology Group||4|||f||||t||||||||||2017-02-18 18:21:41.350014|2017-02-18 18:21:41.350014
NCT00002547|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-08-06|||August 1987||1987-08-01|August 2012|2012-08-01|October 2003|Actual|2003-10-01|October 2003|Actual|2003-10-01||Interventional|||Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome|ALLOGENEIC AND SYNGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE NON-LYMPHOCYTIC LEUKEMIA|Completed||Phase 2|280|Actual|Barbara Ann Karmanos Cancer Institute||1|||f||||||||||||||2017-02-18 18:21:41.541703|2017-02-18 18:21:41.541703
NCT00002546|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-02-10|||December 1993||1993-12-01|February 2016|2016-02-01||||September 2007|Actual|2007-09-01||Interventional|||Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus|A Phase III Randomized Study of Accelerated Hyperfractionated Whole Abdominal Radiotherapy (AHWAR) Versus Combination Ifosfamide-Mesna With Cisplatin in Optimally Debulked Stage I, II, III, or IV Carcinosarcoma (CS) of The Uterus|Completed||Phase 3|216|Anticipated|Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:21:41.663876|2017-02-18 18:21:41.663876
NCT00002545|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-09|||February 1994||1994-02-01|August 2013|2013-08-01||||December 2004|Actual|2004-12-01||Interventional|||Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme|A PHASE III TRIAL COMPARING THE USE OF RADIOSURGERY FOLLOWED BY CONVENTIONAL RADIOTHERAPY WITH BCNU TO CONVENTIONAL RADIOTHERAPY WITH BCNU FOR SUPRATENTORIAL GLIOBLASTOMA MULTIFORME|Completed||Phase 3|200|Anticipated|Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:21:41.852791|2017-02-18 18:21:41.852791
NCT00002544|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-01|||May 1993||1993-05-01|April 2001|2001-04-01|November 2002|Actual|2002-11-01|||||Interventional|||Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer|MITOXANTRONE (N) VS. 5-FLUOROURACIL, EPIRUBICIN AND CYCLOPHOSPHAMIDE AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC BREAST CANCER AND AN UNFAVORABLE PROGNOSIS|Completed||Phase 3|300|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:42.519759|2017-02-18 18:21:42.519759
NCT00002543|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-17|||February 1995||1995-02-01|May 2007|2007-05-01|October 2004|Actual|2004-10-01|||||Interventional|||Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors|GALLIUM NITRATE FOR THE TREATMENT OF MALIGNANT TUMORS, A PHASE I STUDY|Completed||Phase 1|3|Anticipated|National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:42.625256|2017-02-18 18:21:42.625256
NCT00002542|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-03-21|||July 1993||1993-07-01|January 2011|2011-01-01|January 2011|Actual|2011-01-01|January 2011|Actual|2011-01-01||Interventional|||Tamoxifen in Treating Women With High-Risk Breast Cancer|DOUBLE-BLIND RANDOMIZED TRIAL OF TAMOXIFEN VERSUS PLACEBO IN PATIENTS WITH NODE POSITIVE BREAST CANCER WHO HAVE COMPLETED CMF, CEF OR AC ADJUVANT CHEMOTHERAPY|Completed||Phase 3|800|Anticipated|Canadian Cancer Trials Group|||||f||||||||||||||2017-02-18 18:21:42.730073|2017-02-18 18:21:42.730073
NCT00002540|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2017-02-10|2013-08-30||November 1993||1993-11-01|February 2017|2017-02-01||||May 2012|Actual|2012-05-01||Interventional|||Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)|Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial|Active, not recruiting||N/A|76685|Actual|National Cancer Institute (NCI)||2|||f||||||||||||||2017-02-18 18:21:42.898264|2017-02-18 18:21:42.898264
NCT00002539|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||August 1993||1993-08-01|September 2012|2012-09-01||||October 2002|Actual|2002-10-01||Interventional|||Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma|A RANDOMISED TRIAL OF CHEMOTHERAPY WITH OR WITHOUT GRANULOCYTE COLONY-STIMULATING FACTOR IN OPERABLE OSTEOSARCOMA|Completed||Phase 3|214|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:43.579993|2017-02-18 18:21:43.579993
NCT00002538|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-19|||September 1993||1993-09-01|August 2013|2013-08-01||||March 2010|Actual|2010-03-01||Interventional|||Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers|LAPAROSCOPIC STAGING IN PATIENTS WITH INCOMPLETELY STAGED CANCERS OF THE OVARY|Completed||Phase 2|||Gynecologic Oncology Group|||||f||||t||||||||||2017-02-18 18:21:43.711942|2017-02-18 18:21:43.711942
NCT00002537|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-08|||September 1993||1993-09-01|May 2006|2006-05-01||||March 2006|Actual|2006-03-01||Interventional|||Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer|A PHASE I STUDY OF PROLONGED LOW-DOSE TOPOTECAN INFUSION COMBINED WITH CHEST IRRADIATION|Completed||Phase 1|20|Actual|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:43.821038|2017-02-18 18:21:43.821038
NCT00002536|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-08|||December 1996||1996-12-01|March 2008|2008-03-01||||August 2007|Actual|2007-08-01||Interventional|||Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer|TREATMENT OF PATIENTS WITH SUBOPTIMAL ('BULKY') STAGE IB CARCINOMA OF THE CERVIX: A RANDOMIZED COMPARISON OF RADICAL HYSTERECTOMY AND PELVIC AND PARA-AORTIC LYMPHADENECTOMY WITH OR WITHOUT NEOADJUVANT VINCRISTINE AND CISPLATIN CHEMOTHERAPY, PHASE III|Completed||Phase 3|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:21:43.929736|2017-02-18 18:21:43.929736
NCT00002535|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-25|||July 1993||1993-07-01|August 2000|2000-08-01|July 2004|Actual|2004-07-01|||||Interventional|||Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma|TUMOR INFILTRATING LYMPHOCYTE THERAPY FOR ADVANCED MELANOMA USING IMMUNOMODULATION, A PHASE II STUDY|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:44.057493|2017-02-18 18:21:44.057493
NCT00002534|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||May 1993||1993-05-01|June 2013|2013-06-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission|A RANDOMIZED TRIAL OF UNMODIFIED VERSUS T-CELL DEPLETED ALLOGENEIC HLA-IDENTICAL BONE MARROW TRANSPLANTATION FOR THE TREATMENT OF ACUTE LEUKEMIAS|Completed||Phase 3|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:44.141152|2017-02-18 18:21:44.141152
NCT00002533|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-14|||February 1993||1993-02-01|December 2016|2016-12-01|August 2006|Actual|2006-08-01|June 2006|Actual|2006-06-01||Interventional|||Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer|A PHASE II/III PILOT STUDY OF THE EFFECTS OF PROPHYLACTIC FLUCONAZOLE THERAPY ON MUCOSITIS IN PATIENTS UNDERGOING RADIATION TREATMENT FOR HEAD AND NECK CANCER|Completed||Phase 2/Phase 3|||University of Miami|||||f||||t||||||||||2017-02-18 18:21:44.247983|2017-02-18 18:21:44.247983
NCT00002532|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-06|||January 1993||1993-01-01|March 2002|2002-03-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia|TREATMENT OF ADULT PATIENTS WITH RELAPSING ACUTE LYMPHOCYTIC LEUKEMIA, A MULTICENTER TRIAL|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:44.359302|2017-02-18 18:21:44.359302
NCT00002531|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||January 1993||1993-01-01|December 2006|2006-12-01||||||||Interventional|||Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia|MULTICENTRE TRIAL OF INTENSIFIED THERAPY FOR ADULT ALL (O5/93)|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:44.446873|2017-02-18 18:21:44.446873
NCT00002529|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||May 1993||1993-05-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|August 2010|Actual|2010-08-01||Interventional|12-93||Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer|Adjuvant Therapy for Post/Perimenopausal Patients With Node Positive Breast Cancer Who Are Suitable for Endocrine Therapy Alone.|Completed||Phase 3|452|Actual|International Breast Cancer Study Group||6|||f||||t||||||||||2017-02-18 18:21:44.55195|2017-02-18 18:21:44.55195
NCT00002528|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-04-03|||May 1993||1993-05-01|July 2012|2012-07-01|August 2010|Actual|2010-08-01|December 2002|Actual|2002-12-01||Interventional|10-93||Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer|Surgical Therapy With or Without Axillary Node Clearance for Breast Cancer in the Elderly Who Receive Adjuvant Therapy With Tamoxifen.|Completed||Phase 3|473|Actual|International Breast Cancer Study Group||2|||f||||t||||||||||2017-02-18 18:21:44.774673|2017-02-18 18:21:44.774673
NCT00002527|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-01|||May 1993||1993-05-01|July 2016|2016-07-01|January 2006|Actual|2006-01-01|March 2003|Actual|2003-03-01||Interventional|||Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed|Colorectal Adenoma Chemoprevention Trial Using Aspirin: A Phase III Study|Completed||Phase 3|635|Actual|Alliance for Clinical Trials in Oncology||2|||f||||t||||||||||2017-02-18 18:21:44.920559|2017-02-18 18:21:44.920559
NCT00002526|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-14|||January 1993||1993-01-01|May 2012|2012-05-01|September 1995|Actual|1995-09-01|September 1995|Actual|1995-09-01||Interventional|||Chemotherapy in Treating Patients With Advanced Sarcoma|Continuous 5 Days Infusion of High Dose Ifosfamide and Adriamycin in Patients With Advanced Sarcoma|Completed||Phase 2|20|Actual|Swiss Group for Clinical Cancer Research||1|||f||||t||||||||||2017-02-18 18:21:45.279388|2017-02-18 18:21:45.279388
NCT00002525|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-07-19|2016-04-08||August 1993||1993-08-01|July 2016|2016-07-01|April 2015|Actual|2015-04-01|February 2015|Actual|2015-02-01||Interventional||The primary analysis population for the study was all randomized patients with Duke's B3 and C disease.|Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed|Phase III Intergroup Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection, Followed by 5-FU/Leucovorin for Patients With Colon Cancer|Terminated||Phase 3|859|Actual|Eastern Cooperative Oncology Group||2||The study was stopped before reaching its accrual goal due to slow accrual|f||||t||||||||Yes|Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.|2017-02-18 18:21:45.382677|2017-02-18 18:21:45.382677
NCT00002524|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-07-27|||June 1993||1993-06-01|July 2012|2012-07-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma|Pilot Study in AIDS-Related Lymphomas|Completed||Phase 2|46|Actual|M.D. Anderson Cancer Center||3|||f||||f||||||||||2017-02-18 18:21:45.949166|2017-02-18 18:21:45.949166
NCT00002523|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-09-01|||April 1993||1993-04-01|September 2016|2016-09-01|January 2016|Actual|2016-01-01|March 2003|Actual|2003-03-01||Interventional|||Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed|FOUR ARMS PHASE III CLINICAL TRIAL FOR T3-T4 RESECTABLE RECTAL CANCER COMPARING PRE-OPERATIVE PELVIC IRRADIATION TO PRE-OPERATIVE IRRADIATION COMBINED WITH FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT POST-OPERATIVE ADJUVANT CHEMOTHERAPY|Completed||Phase 3|1011|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:46.117929|2017-02-18 18:21:46.117929
NCT00002522|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-30|||February 1993||1993-02-01|September 2010|2010-09-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma|HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN (CEP) WITH RESCUE BY AUTOLOGOUS BONE MARROW OR AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN'S DISEASE|Completed||Phase 2|||Temple University|||||f||||||||||||||2017-02-18 18:21:46.261948|2017-02-18 18:21:46.261948
NCT00002521|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-30|||February 1993||1993-02-01|September 2010|2010-09-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma|HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN (CEP) WITH RESCUE BY AUTOLOGOUS BONE MARROW OR AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA (INTERMEDIATE AND HIGH-GRADE HISTOLOGIES)|Completed||Phase 2|||Temple University|||||f||||||||||||||2017-02-18 18:21:46.359359|2017-02-18 18:21:46.359359
NCT00002520|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2015-10-06|||June 1992||1992-06-01|October 2015|2015-10-01||||February 2002|Actual|2002-02-01||Interventional|||Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer|Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings|Completed||N/A|434|Actual|Eastern Cooperative Oncology Group||2|||f||||f||||||||||2017-02-18 18:21:46.466802|2017-02-18 18:21:46.466802
NCT00002519|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-01|||January 1997||1997-01-01|April 2011|2011-04-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer|PH I Continuous Infusion Taxol in Combination With Thoracic Radiation Therapy in Untreated Locally Advanced Non-Small Cell Lung Cancer|Completed||Phase 1|6|Actual|National Cancer Institute (NCI)|||||f||||t||||||||||2017-02-18 18:21:46.617333|2017-02-18 18:21:46.617333
NCT00002517|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-06-19|||March 1993||1993-03-01|December 2002|2002-12-01||||May 2010|Actual|2010-05-01||Interventional|||Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome|IDA VS MTZ IN INDUCTION AND INTENSIFICATION TREATMENT OF AML OR MDS IN CHILDREN, A PHASE III RANDOMIZED STUDY|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:46.7172|2017-02-18 18:21:46.7172
NCT00002516|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||July 1992||1992-07-01|January 2010|2010-01-01||||||||Interventional|||Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma|EUROPEAN INTERGROUP COOPERATIVE EWING'S SARCOMA STUDY [EICESS 92]|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:46.849445|2017-02-18 18:21:46.849445
NCT00002515|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-20|||October 1992||1992-10-01|June 2013|2013-06-01|April 2005|Actual|2005-04-01|April 2005|Actual|2005-04-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer|Myeloablative Chemotherapy With Bone Marrow Rescue For Rare Poor-Prognosis Cancers|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:46.967098|2017-02-18 18:21:46.967098
NCT00002514|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-11-21|||April 1993||1993-04-01|August 2007|2007-08-01||||December 2006|Actual|2006-12-01||Interventional|||Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission|Phase III Randomized Trial of Autologous and Allogeneic Stem Cell Transplantation Versus Intensive Conventional Chemotherapy in Acute Lymphoblastic Leukemia in First Remission|Completed||Phase 3|1929|Actual|Eastern Cooperative Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:47.075233|2017-02-18 18:21:47.075233
NCT00002511|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-10-15|||December 1992||1992-12-01|October 2012|2012-10-01||||December 2001|Actual|2001-12-01||Interventional|||Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer|PHASE III STUDY OF POST-OPERATIVE EXTERNAL RADIOTHERAPY IN PATHOLOGICAL STAGE T3 N0 PROSTATIC CARCINOMA|Completed||Phase 3|1005|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:47.3048|2017-02-18 18:21:47.3048
NCT00002510|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-30|||April 1992||1992-04-01|September 2010|2010-09-01|June 2001|Actual|2001-06-01|June 2001|Actual|2001-06-01||Interventional|||Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma|HIGH-DOSE CHEMORADIOTHERAPY FOLLOWED BY RESCUE WITH MOBILIZED AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH LOW-GRADE, TRANSFORMED, OR FOLLICULAR LARGE CELL NON-HODGKIN'S LYMPHOMA|Completed||Phase 1/Phase 2|||Temple University|||||f||||||||||||||2017-02-18 18:21:47.399034|2017-02-18 18:21:47.399034
NCT00002509|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-30|||November 1991||1991-11-01|September 2010|2010-09-01|December 2003|Actual|2003-12-01|December 2003|Actual|2003-12-01||Interventional|||High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer|HIGH-DOSE CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CARBOPLATIN FOLLOWED BY RESCUE WITH AUTOLOGOUS BONE MARROW AND AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH POOR PROGNOSIS BREAST CANCER|Completed||Phase 1/Phase 2|||Temple University|||||f||||||||||||||2017-02-18 18:21:47.495027|2017-02-18 18:21:47.495027
NCT00002508|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2010-09-30|||November 1990||1990-11-01|September 2010|2010-09-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors|INTENSIVE CHEMOTHERAPY FOR RELAPSED OR REFRACTORY GERM CELL TUMORS EMPLOYING HIGH-DOSE CARBOPLATIN, ETOPOSIDE, AND THIOTEPA WITH AUTOLOGOUS BONE MARROW RESCUE FOR PATIENTS 15 TO 60 YEARS OF AGE|Completed||Phase 1/Phase 2|||Temple University|||||f||||||||||||||2017-02-18 18:21:47.605782|2017-02-18 18:21:47.605782
NCT00002507|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-24|||November 1992||1992-11-01|June 2000|2000-06-01|October 2002|Actual|2002-10-01|October 2002|Actual|2002-10-01||Interventional|||Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer|RADIATION WITH MITOMYCIN C OR PORFIROMYCIN IN THE TREATMENT OF CANCER OF THE HEAD AND NECK AREA|Completed||Phase 3|||Yale University|||||f||||||||||||||2017-02-18 18:21:47.718319|2017-02-18 18:21:47.718319
NCT00002506|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-05-10|||August 1992||1992-08-01|May 2011|2011-05-01|February 1999|Actual|1999-02-01|January 1996|Actual|1996-01-01||Interventional|||Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer|ALPHA INTERFERON AND CIS-RETINOIC ACID FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS|Completed||Phase 2|||Hoag Memorial Hospital Presbyterian|||||f||||f||||||||||2017-02-18 18:21:47.829069|2017-02-18 18:21:47.829069
NCT00002505|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-05-10|||August 1992||1992-08-01|May 2011|2011-05-01|May 2006|Actual|2006-05-01|August 2002|Actual|2002-08-01||Interventional|||Tumor Cell Vaccine in Treating Patients With Advanced Cancer|RANDOMIZED PHASE II TRIAL OF AUTOLOGOUS TUMOR CELL VACCINE|Completed||Phase 2|||Hoag Memorial Hospital Presbyterian|||||f||||f||||||||||2017-02-18 18:21:48.018022|2017-02-18 18:21:48.018022
NCT00002504|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-05-10|||August 1992||1992-08-01|May 2011|2011-05-01|February 1999|Actual|1999-02-01|February 1998|Actual|1998-02-01||Interventional|||Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer|OUTPATIENT SUBCUTANEOUS IL-2 AND ALPHA INTERFERON IN THE MANAGEMENT OF METASTATIC CANCER|Completed||Phase 2|||Hoag Memorial Hospital Presbyterian|||||f||||f||||||||||2017-02-18 18:21:48.130748|2017-02-18 18:21:48.130748
NCT00002503|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||October 1992||1992-10-01|September 2012|2012-09-01||||November 2000|Actual|2000-11-01||Interventional|||Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases|A PROSPECTIVE MULTICENTER RANDOMIZED STUDY COMPARING STRONTIUM-89 CHLORIDE AND PALLIATIVE LOCAL FIELD RADIOTHERAPY IN PATIENTS WITH HORMONAL ESCAPED ADVANCED PROSTATIC CANCER|Completed||Phase 3|204|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:48.246558|2017-02-18 18:21:48.246558
NCT00002502|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-26|||July 1992||1992-07-01|June 2013|2013-06-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome|BUSULFAN AND CYCLOPHOSPHAMIDE FOR CYTOREDUCTION OF PATIENTS WITH ACUTE AND CHRONIC LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES UNDERGOING ALLOGENEIC BONE MARROW TRANSPLANTATION WHO CANNOT BE TREATED WITH TOTAL BODY IRRADIATION|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:48.56625|2017-02-18 18:21:48.56625
NCT00002501|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-30|||October 1992||1992-10-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|July 2001|Actual|2001-07-01||Interventional|||Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma|PHASE II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS RECOMBINANT HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR (rhG-CSF) IN THE TREATMENT OF FOLLICULAR LOW-GRADE NON-HODGKIN'S LYMPHOMA|Completed||Phase 2|29|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:21:48.699232|2017-02-18 18:21:48.699232
NCT00002499|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-19|||January 1990||1990-01-01|May 2000|2000-05-01||||||||Interventional|||Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia|TREATMENT OF ALL IN FIRST BONE MARROW RELAPSE AFTER BFM PROTOCOLS|Unknown status|Active, not recruiting|Phase 2/Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:48.836634|2017-02-18 18:21:48.836634
NCT00002498|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||July 1992||1992-07-01|May 2000|2000-05-01||||||||Interventional|||Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer|CMF AND MITOXANTRONE IN ELDERLY PATIENTS WITH ADVANCED BREAST CANCER, A RANDOMIZED PHASE II STUDY|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:48.948826|2017-02-18 18:21:48.948826
NCT00002496|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-01-23|||August 1992||1992-08-01|January 2014|2014-01-01|November 2013|Actual|2013-11-01|August 2002|Actual|2002-08-01||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx|PHASE III TRIAL TO PRESERVE THE LARYNX: INDUCTION CHEMOTHERAPY AND RADIATION THERAPY VERSUS CONCOMITANT CHEMOTHERAPY AND RADIATION THERAPY VERSUS RADIATION THERAPY|Completed||Phase 3|||Radiation Therapy Oncology Group|||||f||||t||||||||||2017-02-18 18:21:49.05002|2017-02-18 18:21:49.05002
NCT00002495|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-10-04|||September 1992||1992-09-01|October 2016|2016-10-01|December 2016|Anticipated|2016-12-01|November 2000|Actual|2000-11-01||Interventional|||SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease|Randomized Trial of Subtotal Nodal Irradiation Versus Doxorubicin, Vinblastine and Subtotal Nodal Irradiation for Stage I-IIA Hodgkin's Disease|Active, not recruiting||Phase 3|348|Actual|Southwest Oncology Group||2|||f||||t||||||||||2017-02-18 18:21:49.187244|2017-02-18 18:21:49.187244
NCT00002494|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-06-30|||May 1992||1992-05-01|June 2016|2016-06-01|January 2006|Actual|2006-01-01|March 2004|Actual|2004-03-01||Interventional|||Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia|HIGH INTENSITY, BRIEF DURATION CHEMOTHERAPY FOR DIFFUSE SMALL NONCLEAVED CELL LYMPHOMA AND THE L-3 SUBTYPE OF ALL: A PILOT STUDY OF A MULTIDRUG REGIMEN|Completed||Phase 2|134|Actual|Alliance for Clinical Trials in Oncology||1|||f||||f||||||||||2017-02-18 18:21:49.343393|2017-02-18 18:21:49.343393
NCT00002493|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-12|||May 1992||1992-05-01|February 2014|2014-02-01||||April 2001|Actual|2001-04-01||Interventional|||Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer|WHOLE ABDOMINAL RADIOTHERAPY VERSUS CIRCADIAN-TIMED COMBINATION DOXORUBICIN-CISPLATIN CHEMOTHERAPY IN ADVANCED ENDOMETRIAL CARCINOMA -- PHASE III|Completed||Phase 3|||Gynecologic Oncology Group|||||f||||t||||||||||2017-02-18 18:21:49.510782|2017-02-18 18:21:49.510782
NCT00002492|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-12-14|||November 1991||1991-11-01|December 2016|2016-12-01|February 2000|Actual|2000-02-01|February 2000|Actual|2000-02-01||Interventional|||Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma|CLINICAL AND PHARMACOLOGICAL STUDY OF CHEMOTHERAPY IN SOFT TISSUE SARCOMA|Completed||Phase 2|||University of Miami|||||f||||||||||||||2017-02-18 18:21:49.700726|2017-02-18 18:21:49.700726
NCT00002490|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||September 1991||1991-09-01|June 2001|2001-06-01||||||||Interventional|||Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer|A RANDOMIZED TRIAL OF RADICAL RADIOTHERAPY IN pT1G3 NXM0 BLADDER CANCER|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:49.801303|2017-02-18 18:21:49.801303
NCT00002489|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||October 1991||1991-10-01|June 2013|2013-06-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors|PROTOCOL FOR THE TREATMENT OF MALIGNANT NON-TESTICULAR GERM CELL TUMORS|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:49.909556|2017-02-18 18:21:49.909556
NCT00002488|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||December 1991||1991-12-01|April 2000|2000-04-01||||||||Interventional|||Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy|INTENSIFICATION WITH HIGH DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CISPLATIN FOR INTERMEDIATE OR HIGH GRADE LYMPHOMA PATIENTS WHO FAILED PRIMARY COMBINATION CHEMOTHERAPY|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:50.018675|2017-02-18 18:21:50.018675
NCT00002487|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-09-16|||July 1991||1991-07-01|April 2000|2000-04-01||||||||Interventional|||Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer|INTRAPERITONEAL METHOTREXATE AND DIPYRIDAMOLE AS SALVAGE TREATMENT FOR ADVANCED OVARIAN CARCINOMA|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:50.114161|2017-02-18 18:21:50.114161
NCT00002485|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2014-02-12|||February 1992||1992-02-01|February 2014|2014-02-01|September 2005|Actual|2005-09-01|July 2003|Actual|2003-07-01||Observational|||Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer|Barriers to Patient Enrollment Onto Frontline Therapeutic Clinical Trials and Development of Intervention Strategies to Increase the Proportion of Enrollment|Completed||N/A|359|Actual|Children's Oncology Group|||2||f||||||||||||||2017-02-18 18:21:50.202378|2017-02-18 18:21:50.202378
NCT00002484|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-10-31|||October 1991||1991-10-01|October 2013|2013-10-01||||July 2008|Actual|2008-07-01||Interventional|||Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer|A PHASE I TRIAL OF DOSE ESCALATION OF EXTERNAL BEAM RADIATION THERAPY USING CONFORMAL 3-DIMENSIONAL TREATMENT PLANNING FOR NON-SMALL CELL LUNG CANCER|Completed||Phase 1|104|Actual|Memorial Sloan Kettering Cancer Center||1|||f||||||||||||||2017-02-18 18:21:50.354995|2017-02-18 18:21:50.354995
NCT00002482|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||June 1991||1991-06-01|July 2007|2007-07-01||||||||Interventional|||Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer|A PHASE I-II TRIAL OF MUROMONAB (OKT-3) WITH LOW-DOSE CYCLOPHOSPHAMIDE|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:50.461416|2017-02-18 18:21:50.461416
NCT00002433|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS|Activation of Alveolar Macrophages by Aerosolized r-metHuIFN-Gamma (IFN-Gamma) in Patients With AIDS|Completed||N/A|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:59.148682|2017-02-18 18:21:59.148682
NCT00002481|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||March 1990||1990-03-01|May 2001|2001-05-01||||||||Interventional|||Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Phase II Study of High-Dose Cytarabine, Cisplatin, and Dexamethasone Followed By Cyclophosphamide, Etoposide, Total Body Irradiation, and Autologous Bone Marrow Rescue in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:50.558442|2017-02-18 18:21:50.558442
NCT00002480|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-24|||February 1991||1991-02-01|June 2013|2013-06-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Radiation Therapy in Treating Patients With Prostate Cancer|Phase I Study of 3-Dimensional Conformal Radiotherapy in Patients With Locally Advanced (Stage T2c and T3) Adenocarcinoma of the Prostate|Completed||Phase 1|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:50.65082|2017-02-18 18:21:50.65082
NCT00002479|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-05-17||2011-02-16|October 1991||1991-10-01|May 2012|2012-05-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome|Phase II Trial of Tretinoin (TRA) in Patients With Mycosis Fungoides/Sezary Syndrome|Completed||Phase 2|||Northwestern University|||||f||||t||||||||||2017-02-18 18:21:50.738875|2017-02-18 18:21:50.738875
NCT00002478|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-07|||June 1993||1993-06-01|November 2000|2000-11-01||||October 2003|Actual|2003-10-01||Interventional|||Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer|Phase II Study of Prolonged Oral VP-16 for Advanced Ovarian Epithelial and Cervical Cancer|Terminated||Phase 2|||Gynecologic Oncology Group|||||f||||||||||||||2017-02-18 18:21:50.833093|2017-02-18 18:21:50.833093
NCT00002477|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-12-17|||April 1991||1991-04-01|July 2007|2007-07-01||||||||Interventional|||Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer|Phase III Randomized Study of Adjuvant Therapy With a Platinum-Containing Regimen (e.g., CBDCA or CAP: CTX/DOX/CDDP) vs No Adjuvant Therapy in Patients With Fully Resected Early Stage Ovarian Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:51.059195|2017-02-18 18:21:51.059195
NCT00002476|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-01|||January 1990||1990-01-01|March 2010|2010-03-01|January 2010|Actual|2010-01-01|||||Interventional|||Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer|Phase III Randomized Study of Radiotherapy Alone vs With Concurrent Chemotherapy With MTX or VBMF (VCR/BLEO/MTX/5-FU) vs Subsequent Chemotherapy vs Concurrent and Subsequent Chemotherapy in Patients With Advanced Head and Neck Cancer|Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:51.16432|2017-02-18 18:21:51.16432
NCT00002475|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-07-09|||April 1991||1991-04-01|November 2008|2008-11-01|June 2009|Actual|2009-06-01|December 2007|Actual|2007-12-01||Interventional|||Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer|A Trial of Active Intralymphatic Immunotherapy With Interferon-Treated Cells and Cyclophosphamide|Completed||Phase 2|40|Anticipated|National Cancer Institute (NCI)||1|||f||||||||||||||2017-02-18 18:21:51.271327|2017-02-18 18:21:51.271327
NCT00002474|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-29|||February 1991||1991-02-01|March 2003|2003-03-01|October 2005|Actual|2005-10-01|||||Interventional|||Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer|Phase II Study of High Dose Cyclophosphamide, Mitoxantrone, and Carboplatin With Autologous Bone Marrow Transplantation in Refractory or Relapsed Ovarian Carcinoma|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:51.38576|2017-02-18 18:21:51.38576
NCT00002473|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-11|||March 1992||1992-03-01|June 2013|2013-06-01||||February 2011|Actual|2011-02-01||Interventional|||Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer|A Prospective Randomized Phase III Study Comparing Radical Surgery to Elective Kidney Sparing Surgery for Low Stage Renal Cell Carcinoma|Completed||Phase 3|||European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:51.691024|2017-02-18 18:21:51.691024
NCT00002472|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-03-14|||March 1991||1991-03-01|March 2011|2011-03-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors|Phase II Pre-Irradiation Chemotherapy for Central Nervous System Germ Cell Malignancies|Completed||Phase 2|||Mayo Clinic|||||f||||||||||||||2017-02-18 18:21:51.786588|2017-02-18 18:21:51.786588
NCT00002471|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-19|||February 1990||1990-02-01|June 2013|2013-06-01|January 2003|Actual|2003-01-01|January 2003|Actual|2003-01-01||Interventional|||Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma|Phase II Trial of Intensive, Short-Course Combination Chemotherapy in the Treatment of Newly Diagnosed Patients With Poor-Risk Nonlymphoblastic Lymphoma and Acute B-Lymphoblastic Leukemia and in Patients With Recurrent Non-Hodgkin's Lymphoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:51.893569|2017-02-18 18:21:51.893569
NCT00002470|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-05-14|||September 1990||1990-09-01|December 2003|2003-12-01|January 2004|Actual|2004-01-01|||||Interventional|||Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors|A Phase II Study of Protracted Infusional 5-Fluorouracil Plus Alpha Interferon for Advanced Metastatic Carcinoid|Completed||Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:52.008377|2017-02-18 18:21:52.008377
NCT00002466|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-19|||May 1990||1990-05-01|June 2013|2013-06-01|May 2005|Actual|2005-05-01|May 2005|Actual|2005-05-01||Interventional|||Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer|Phase II Study of Cyclophosphamide, Doxorubicin, Vincristine, Etoposide, and Ifosfamide, Followed by Resection and Radiotherapy in Patients With Peripheral Primitive Neuroectodermal Tumors or Ewing's Sarcoma|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:52.113864|2017-02-18 18:21:52.113864
NCT00002465|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-11-05|||December 1987||1987-12-01|July 2007|2007-07-01||||||||Interventional|||High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma|Phase I/II Study of High-Dose Megestrol in Breast or Endometrial Carcinoma or Mesothelioma|Unknown status|Active, not recruiting|Phase 1/Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:52.211619|2017-02-18 18:21:52.211619
NCT00002463|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-02-14|||February 1989||1989-02-01|February 2013|2013-02-01|January 2008|Actual|2008-01-01|January 2007|Actual|2007-01-01||Interventional|||Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors|Phase II Study of Methotrexate, Mechlorethamine, Vincristine, Prednisone, and Procarbazine (MMOPP) as Primary Therapy in Infants or Young Children With Primitive Neuroectodermal Tumors or High-Grade Astrocytoma|Completed||Phase 2|4|Actual|M.D. Anderson Cancer Center||1|||f||||f||||||||||2017-02-18 18:21:52.304248|2017-02-18 18:21:52.304248
NCT00002462|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2016-02-03|||September 1989||1989-09-01|February 2016|2016-02-01||||May 2000|Actual|2000-05-01||Interventional|||RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease|Phase III Randomized Trial of Adjuvant Involved-Field Radiotherapy vs No Adjuvant Therapy Following Remission Induction With MOPP/ABV Hybrid Chemotherapy in Patients With Stage III/IV Hodgkin's Disease|Active, not recruiting||Phase 3|615|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:55.483361|2017-02-18 18:21:55.483361
NCT00002461|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2009-02-06|||April 1988||1988-04-01|October 2006|2006-10-01||||||||Interventional|||Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma|Phase II Study of Intensive Carmustine and Etoposide With Cisplatin or Cyclophosphamide, Followed By Rescue With Autologous Bone Marrow Treated In Vitro With Etoposide and/or Peripheral Blood Stem Cells Mobilized With Filgrastim (G-CSF) or Sargramostim (GM-CSF) With or Without Radiotherapy in Patients With Resistant Hodgkin's Disease or Non-Hodgkin's Lymphoma|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:55.641887|2017-02-18 18:21:55.641887
NCT00002460|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-06|||September 1987||1987-09-01|December 2006|2006-12-01||||||||Interventional|||Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer|Phase III Randomized Study of Adjuvant Therapy With Tamoxifen vs Endocrine Ablation vs Tamoxifen Plus Endocrine Ablation vs No Adjuvant Therapy in Patients Under Age 50 With Operable Breast Cancer|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:55.753126|2017-02-18 18:21:55.753126
NCT00002459|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2012-09-20|||April 1988||1988-04-01|September 2012|2012-09-01||||August 2001|Actual|2001-08-01||Interventional|||Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus|Phase III Randomized Study of Adjuvant Pelvic Radiotherapy Versus Observation Alone in Patients With Completely Resected, Stage I or II, High-Grade Uterine Sarcoma|Completed||Phase 3|224|Actual|European Organisation for Research and Treatment of Cancer - EORTC|||||f||||||||||||||2017-02-18 18:21:56.171115|2017-02-18 18:21:56.171115
NCT00002458|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-06-04|||November 1987||1987-11-01|June 2013|2013-06-01|September 2001|Actual|2001-09-01|September 2001|Actual|2001-09-01||Interventional|||Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission|Phase II Study of Adjuvant Therapy With Antiganglioside GD2-Specific Mouse Monoclonal Antibody 3F8 for Metastatic Neuroblastoma in Second Remission|Completed||Phase 2|||Memorial Sloan Kettering Cancer Center|||||f||||||||||||||2017-02-18 18:21:56.308696|2017-02-18 18:21:56.308696
NCT00002456|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-11-28|||May 1986||1986-05-01|November 2011|2011-11-01|April 2002|Actual|2002-04-01|||||Interventional|||Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation|Postgrafting Methotrexate and Cyclosporine for the Prevention of Graft-Versus-Host Disease|Completed||Phase 3|||Fred Hutchinson Cancer Research Center|||||f||||||||||||||2017-02-18 18:21:56.412432|2017-02-18 18:21:56.412432
NCT00002455|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2013-08-06|||April 1971||1971-04-01|November 1998|1998-11-01||||||||Interventional|||Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma|Immunotherapy of Colon Cancer With Autologous Perchloric Soluble Tumors Extracts|Unknown status|Active, not recruiting|Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:56.521524|2017-02-18 18:21:56.521524
NCT00002454|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-01|2011-07-23|||December 1971||1971-12-01|January 2002|2002-01-01||||||||Interventional|||Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx|Phase II Study of Immunotherapy With Autogenous Papilloma Vaccine in Patients With Recurrent Juvenile Papilloma of the Larynx|Unknown status|Active, not recruiting|Phase 2|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:21:56.631729|2017-02-18 18:21:56.631729
NCT00002453|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-24|2005-06-23|||December 1999||1999-12-01|May 2000|2000-05-01||||||||Interventional|||A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection|An Open-Label, Multicenter, Compassionate Access Study of the Safety of Tenofovir Disoproxil Fumarate Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients|Completed||N/A|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:56.731741|2017-02-18 18:21:56.731741
NCT00002452|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2005-06-23||||||February 2000|2000-02-01||||||||Interventional|||A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir|A Multicenter, Open-Label, Pilot Study to Evaluate the Safety and Activity of L-756423/Indinavir Sulfate, 800/400 Mg b.i.d. in Combination With Two nRTIs in HIV-Infected Patients Who Failed an Indinavir Containing Regimen|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:56.82413|2017-02-18 18:21:56.82413
NCT00002451|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2005-06-23||||||July 2002|2002-07-01||||||||Interventional|||Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs|A Multicenter, Open-Label, 24-Week Pilot Study to Evaluate the Safety and Activity of Indinavir Sulfate 1200 Mg q.d. and Ritonavir 200 Mg q.d. in Combination With Stavudine and Lamivudine in Treatment Naive HIV-1 Infected Patients|Unknown status|Active, not recruiting|Phase 2|8||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:56.92583|2017-02-18 18:21:56.92583
NCT00002450|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2005-06-23||||||July 2000|2000-07-01||||||||Interventional|||Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients|A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Tenofovir Disoproxil Fumarate in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients|Completed||Phase 3|600||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:57.02303|2017-02-18 18:21:57.02303
NCT00002449|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||August 1999||1999-08-01|July 2001|2001-07-01||||||||Interventional|||Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy|A Bridging Dose-Escalation Study of the Safety, Pharmacokinetic Properties, and Immunologic Effect of Subcutaneous L2-7001 (Recombinant Human Interleukin-2) in Patients Infected With HIV With CD4+ T-Cell Counts of 300 to 500 Cells/mm3 and Viral Burden Under 10,000 Copies/Ml on Active Antiretroviral Therapy (ART)|Unknown status|Active, not recruiting|Phase 1|212||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:57.170864|2017-02-18 18:21:57.170864
NCT00002432|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1990|1990-07-01||||||||Interventional|||A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|An Open Study of Foscarnet Treatment of CMV-Retinitis in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:59.233945|2017-02-18 18:21:59.233945
NCT00002448|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||October 1999||1999-10-01|January 2001|2001-01-01||||||||Interventional|||A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients|Evaluation of Immune Reconstitution in HIV Infected Patients Treated With Fortovase (Saquinavir) SGC QD Plus Ritonavir QD Plus 2 NRTIs Vs Efavirenz QD Plus 2 NRTIs|Completed||Phase 3|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:57.273421|2017-02-18 18:21:57.273421
NCT00002447|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||October 1999||1999-10-01|January 2001|2001-01-01||||||||Interventional|||A Study to Compare Two Anti-HIV Drug Combinations|An Open Label, Randomized, Multicenter Study to Evaluate Fortovase (Saquinavir) SGC QD, Norvir (Ritonavir) QD Plus Two NRTIs Vs Sustiva (Efavirenz) QD Plus Two NRTIs in HIV Infected Patients|Completed||Phase 3|146||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:57.372587|2017-02-18 18:21:57.372587
NCT00002446|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||August 1998||1998-08-01|February 2000|2000-02-01||||||||Interventional|||Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients|Randomized, Controlled Trial of SCH 56592 Oral Suspension Versus Fluconazole Suspension in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients|Completed||Phase 3|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:57.785252|2017-02-18 18:21:57.785252
NCT00002445|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 2001|2001-06-01||||||||Interventional|||Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients|A Phase III Randomized Placebo Controlled and Double Blinded Study of IM862 for Patients With Muco-Cutaneous AIDS Associated Kaposi's Sarcoma|Completed||Phase 3|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:57.909644|2017-02-18 18:21:57.909644
NCT00002444|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||October 1995||1995-10-01|February 1996|1996-02-01|February 1996||1996-02-01|||||Interventional|||A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea|Phase I/II Open Label Evaluation of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients|Completed||Phase 1|28||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.053679|2017-02-18 18:21:58.053679
NCT00002443|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1996|1996-09-01|January 1996||1996-01-01|||||Interventional|||The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|Twelve-Month Study in HIV-1 Seropositive Retroviral-Naive Patients to Compare the Safety and Efficacy of MK-639 and Zidovudine (AZT) Administered Concomitantly to MK-639 Alone and Zidovudine (AZT) Alone|Completed||N/A|780||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.139609|2017-02-18 18:21:58.139609
NCT00002442|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||June 1999||1999-06-01|August 2000|2000-08-01||||||||Interventional|||A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs|A Phase II, Open-Label, Randomized Study of the Efficacy and Safety of Epivir 150 Mg BID Versus Epivir 300 Mg Once-Daily When Administered for 24 Weeks in Combination With FDA-Approved Dosage Regimens of Zerit and Either Crixivan or Viracept in Subjects With HIV-1 Infection|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.20974|2017-02-18 18:21:58.20974
NCT00002441|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 2000|2000-01-01||||||||Interventional|||Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection|A Phase III Trial to Determine the Efficacy of Bivalent AIDSVAX B/B Vaccine in Adults at Risk of Sexually Transmitted HIV-1 Infection in North America|Completed||Phase 3|5000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.320099|2017-02-18 18:21:58.320099
NCT00002440|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|An Open-Label, Phase II Trial to Evaluate the Steady-State Pharmacokinetics, Safety, and Efficacy of 1592U89 in Combination With Selected HIV-1 Protease Inhibitors in Antiretroviral-Naive, HIV-1-Infected Patients.|Completed||Phase 2|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.494345|2017-02-18 18:21:58.494345
NCT00002439|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma|Randomized Phase III Vehicle Controlled Trial of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.595817|2017-02-18 18:21:58.595817
NCT00002438|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients|Randomized Study Comparing Itraconazole to Placebo in the Prevention of Histoplasmosis in Patients With Human Immunodeficiency Virus Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.677915|2017-02-18 18:21:58.677915
NCT00002437|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1994|1994-11-01||||||||Interventional|||The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|A Phase II/III Study of the Safety and Efficacy of 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) for the Treatment of Peripheral Cytomegalovirus Retinitis in Patients With AIDS|Completed||Phase 2|48||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.76476|2017-02-18 18:21:58.76476
NCT00002436|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1994|1994-05-01||||||||Interventional|||The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT|A Randomized Lamivudine (3TC)/Dideoxycytidine (ddC) Double-Blind Multicenter Trial (With Open-Label AZT) to Evaluate the Safety and Efficacy of Low Dose 3TC Administered Concurrently With AZT Versus High Dose 3TC Administered Concurrently With AZT Versus ddC Administered Concurrently With AZT in the Treatment of HIV-1 Infected, AZT-Experienced (>= 24 Weeks) Patients With CD4 Counts of 100-300 Cells/mm3|Completed||Phase 3|325||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.861116|2017-02-18 18:21:58.861116
NCT00002435|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1998|1998-02-01||||||||Interventional|||A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients|Study of the Activity of Thymic Humoral Factor (THF Gamma 2) on HIV Load in HIV-Positive Individuals With CD4+ Cell Counts in the Range of 200-500 Cells/mm3|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:58.967248|2017-02-18 18:21:58.967248
NCT00002434|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1994|1994-01-01||||||||Interventional|||A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)|A Study of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:59.060719|2017-02-18 18:21:59.060719
NCT00002431|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1993|1993-11-01||||||||Interventional|||The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients|A Multi-Center Trial to Evaluate the Safety and Effectiveness of Peridex Dosed Twice or Three Times Daily for Preventing or Delaying the Occurrence of Lesions Due to Oral Candidiasis in HIV-Positive Individuals|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:59.31628|2017-02-18 18:21:59.31628
NCT00002430|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 2000|2000-02-01||||||||Interventional|||A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations|A Multicenter, Open-Label, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate/d4T/3TC Versus Indinavir Sulfate/Nelfinavir Mesylate/d4T/3TC in HIV-Infected Individuals|Completed||N/A|220||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:59.410989|2017-02-18 18:21:59.410989
NCT00002429|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-28||2011-04-13|July 1999||1999-07-01|April 2011|2011-04-01|January 2001|Actual|2001-01-01|January 2001|Actual|2001-01-01||Interventional|||Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen|Evaluation of HIV RNA Suppression Produced by a Triple Combination Regimen Containing an Enteric Coated Formulation of Didanosine (ddI EC) Administered Once Daily Compared to a Reference Combination Regimen|Completed||Phase 3|500||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:21:59.816578|2017-02-18 18:21:59.816578
NCT00002428|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects|A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:21:59.948839|2017-02-18 18:21:59.948839
NCT00002427|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||May 1999||1999-05-01|August 2000|2000-08-01||||||||Interventional|||Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults|A Phase I/II Study of the Safety and Antiretroviral Activity of Nine Hydroxyurea Regimens in Combination With ddI and d4T in Subjects With HIV Infection|Completed||Phase 1|225||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:00.05412|2017-02-18 18:22:00.05412
NCT00002426|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of Adefovir Dipivoxil as Intensification Therapy in Combination With Highly Active Antiretroviral Therapy (HAART) in HIV Infected Patients With HIV-1 RNA > 50 and <= 400 Copies/Ml|Completed||N/A|390||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:00.178316|2017-02-18 18:22:00.178316
NCT00002425|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1996|1996-12-01||||||||Interventional|||The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs|A Multicenter, Open-Label Study of the Safety and Activity of Saquinavir Soft Gelatin Capsule Formulation (Saquinavir SGC) in Combination With Other Antiretroviral Drugs|Completed||Phase 4|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:00.321194|2017-02-18 18:22:00.321194
NCT00002424|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine|A Multicenter, Double-Blind, Randomized Pilot Study to Compare the Safety and Activity of L-756423/Indinavir, 1600/800 Mg Qd or 800/400 Mg Bid Versus Indinavir, 800 Mg q8h, All in Combination With Stavudine and Lamivudine|Suspended||Phase 2|186||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:00.418702|2017-02-18 18:22:00.418702
NCT00002423|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||March 1999||1999-03-01|December 1999|1999-12-01||||||||Interventional|||A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir|A Phase II, Open-Label Trial for Treatment of HIV Infection in Subjects Who Have Failed Initial Combination Therapy With Regimens Containing Indinavir or Nelfinavir: Combination Therapy With 3TC (150 Mg BID), Abacavir (300 Mg BID) and Amprenavir (1200 Mg BID) Plus Either Nelfinavir (1250 Mg BID) or Indinavir (800 Mg TID) for 48 Weeks|Completed||Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:00.528871|2017-02-18 18:22:00.528871
NCT00002422|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-06-24||||||April 2002|2002-04-01||||||||Interventional|||A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy|A Phase I/II, Open-Label Study of the Safety, Tolerance, Pharmacokinetics, Drug-Interaction and Anti-HIV Activity of Intramuscularly Administered Alpha-Epi-Br (HE2000) in HIV-Infected Patients on Salvage Therapy|Completed||Phase 1|42||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:00.627326|2017-02-18 18:22:00.627326
NCT00002420|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-13||||||August 2008|2008-08-01||||||||Interventional|||The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors|A Phase II, 24-Week, Open-Label Study Designed to Evaluate the Pharmacokinetics, Safety, Tolerability, and Efficacy of Novel Combination Therapy With Videx (Didanosine), Zerit (Stavudine), Rescriptor (Delavirdine Mesylate), and MKC-442 (With or Without Hydroxyurea) for the Treatment of HIV-1- Infected Patients Who Failed Previous Protease Inhibitor Treatment|Terminated||Phase 2|25||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:00.719696|2017-02-18 18:22:00.719696
NCT00002419|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment|A Phase II, 24-Week, Open-Label Study Designed to Evaluate the Safety, Tolerability, and Efficacy of Novel Quadruple-Combination Therapy With Preveon (Adefovir Dipivoxil; Bis-POM PMEA), Abacavir (1592U89), Sustiva (Efavirenz; DMP-266), and Amprenavir (141W94) for the Treatment of HIV-1 Infection in Patients Who Have Failed Previous Protease Inhibitor Treatment|Completed||Phase 2|25||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:00.817411|2017-02-18 18:22:00.817411
NCT00002405|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Amprenavir in HIV-Infected Patients|Amprenavir (141W94) Open Label Protocol for Subjects With HIV-1 Infection Who Have Experienced Treatment Failure or Are Intolerant to Previous Protease Inhibitor Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:02.590692|2017-02-18 18:22:02.590692
NCT00002418|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-13||||||March 2000|2000-03-01||||||||Interventional|||The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors|A Phase II, 24-Week, Open-Label Study Designed to Evaluate the Pharmacokinetics, Safety, Tolerability, and Efficacy of Novel Combination Therapy With Videx (Didanosine), Zerit (Stavudine), Viramune (Nevirapine), and MKC-442 (With or Without Hydroxyurea) for the Treatment of HIV-1 Infection in Non-Nucleoside Reverse Transcriptase Inhibitor Naive Patients Who Failed Previous Protease Inhibitor Treatment|Terminated||Phase 2|25||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:00.91526|2017-02-18 18:22:00.91526
NCT00002417|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications|An Open-Label Study to Evaluate the Safety and Tolerance of Amprenavir (141W94) Combination Therapy in Protease Inhibitor Experienced Subjects Who Are Intolerant (Hyperlipidemia With or Without Lipodystrophy) But Not Failing Their Current Protease Inhibitor Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.026286|2017-02-18 18:22:01.026286
NCT00002416|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 2000|2000-03-01||||||||Interventional|||Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination|A Randomized, Open-Label Equivalence Study of FTC Versus Lamivudine in Patients on a Stable Triple Antiretroviral Therapy Regimen Containing Lamivudine, Stavudine or Zidovudine, and a Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor|Completed||Phase 3|390||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.112833|2017-02-18 18:22:01.112833
NCT00002415|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients|A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Antiviral Activity of the Addition of PMPA Prodrug to Combination Antiretroviral Regimens in Treatment-Experienced HIV-Infected Patients|Completed||Phase 2|175||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.202021|2017-02-18 18:22:01.202021
NCT00002414|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia|Randomized, Double-Blind, Parallel Group, Placebo Controlled, Tolerability, Safety and Pilot Efficacy Study of CPI-1189 in HIV Infected Individuals With Cognitive and Motor Impairment|Unknown status|Active, not recruiting|Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.312126|2017-02-18 18:22:01.312126
NCT00002413|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of MKC-442 in HIV-Positive Patients|An Open Label Study of MKC-442 in at Least Triple Drug Combination in Patients Previously Treated With Nucleoside Reverse Transcriptase and Protease Inhibitors and Who Are Naive to Non-Nucleoside Reverse Transcriptase Inhibitors|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.407212|2017-02-18 18:22:01.407212
NCT00002412|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of MKC-442 in Combination With Other Anti-HIV Drugs|A Randomized, Double-Blind Study of MKC-442 Combined With Stavudine, Didanosine, and Hydroxyurea in HIV-Infected Patients Who Are Protease Inhibitor Experienced and Non-Nucleoside Reverse Transcriptase Inhibitor Naive|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.481613|2017-02-18 18:22:01.481613
NCT00002411|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-13||2011-04-13|March 1998||1998-03-01|April 2011|2011-04-01|September 1999|Actual|1999-09-01|September 1999|Actual|1999-09-01||Interventional|||A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs|A Randomized Study of the Long-Term Suppression of Plasma HIV RNA Levels by Triple Combination Regimens in Treatment Naive Subjects|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:01.584262|2017-02-18 18:22:01.584262
NCT00002410|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients|A Phase III, Multicenter, Randomized, Open-Label Study to Compare Antiretroviral Activity and Tolerability of Three Different Combination Regimens (DMP 266 + Indinavir, DMP 266 + Zidovudine + Lamivudine, Indinavir + Zidovudine + Lamivudine) in HIV-Infected Patients|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.723176|2017-02-18 18:22:01.723176
NCT00002409|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||The Effect of Teaching HIV-Infected Patients About HIV and Treatment|A Phase IIIB, Open-Label, Randomized Study of the Effect of an Education Intervention on Virological Outcomes, Adherence, Immunological Outcome, and Health Outcomes in HIV-Infected Subjects From Under-Represented Populations Treated With Triple Nucleoside Therapy (Combivir, Lamivudine 150 Mg/Zidovudine 300 Mg PO BID Plus Abacavir 300 Mg PO BID) for Twenty-Four Weeks|Completed||Phase 3|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.844489|2017-02-18 18:22:01.844489
NCT00002408|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients|A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients|Completed||Phase 3|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:01.965156|2017-02-18 18:22:01.965156
NCT00002407|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs|A Randomized Open-Label Strategic Study to Evaluate the Safety and Efficacy of 3 Different Convergent and Divergent Drug Combination Therapies in Anti-Retroviral Naive HIV-1 Infected Patients With CD4+ Counts Above 200/mm3|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:02.365615|2017-02-18 18:22:02.365615
NCT00002406|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients|A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulphate, 800 Mg q 8h Versus 1,200 Mg q 12h in HIV-Infected Individuals Having Plasma Viral RNA Less Than 400 Copies/Ml, on Concomitant Therapy With 2 Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTI)|Completed||Phase 3|350||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:02.463521|2017-02-18 18:22:02.463521
NCT00002404|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-01-24||||||June 1999|1999-06-01||||||||Interventional|||The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients|The Effect of Treatment With Valacyclovir 500 mg BID on the Detection of HIV From Genital HSV Lesions in HIV-Infected Patients: A Double-Blind Crossover Study|Completed||N/A|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:02.67814|2017-02-18 18:22:02.67814
NCT00002403|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients|A Phase I/II Multiple Dose Study to Evaluate the Safety, Pharmacokinetic Profile and Virologic/Immunologic Activity of Zintevir (AR177) in HIV-1 Patients|Completed||Phase 1|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:02.767764|2017-02-18 18:22:02.767764
NCT00002402|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1998|1998-08-01||||||||Interventional|||A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines|Phase I/II Trial to Evaluate the Safety and Immunogenicity of AIDSVAX B/B and B/E Vaccines in the United States|Completed||Phase 1|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:02.859798|2017-02-18 18:22:02.859798
NCT00002401|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1999|1999-01-01||||||||Interventional|||A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients|An Open-Label Randomized Study of Delavirdine Mesylate (DLV, Rescriptor) in Triple and Quadruple Combinations With Zidovudine (ZDV), Indinavir (IDV), and Lamivudine (3TC) in HIV-1 Infected Individuals|Completed||N/A|160||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:02.962429|2017-02-18 18:22:02.962429
NCT00002400|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1999|1999-01-01||||||||Interventional|||A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients|An Open-Label Randomized Study of Delavirdine Mesylate (Rescriptor) in Combination With Zidovudine (Retrovir) and Two Doses of Indinavir (Crixivan) Versus Zidovudine, Lamivudine (Epivir), and Indinavir in HIV-1-Infected Individuals|Completed||N/A|45||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.051841|2017-02-18 18:22:03.051841
NCT00002399|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1999|1999-01-01||||||||Interventional|||A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients|A Multicenter, Randomized, Double-Blind, Phase II Study to Evaluate the Safety, Tolerance and Efficacy of Multiple Doses of SCH 56592 Versus Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients|Completed||Phase 2|500||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.159125|2017-02-18 18:22:03.159125
NCT00002398|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations|A Randomized, Open-Label Expanded Access Program to Evaluate the Safety of Preveon (Adefovir Dipivoxil) at Two Dose Levels When Used in Combination With Other Antiretroviral Agents for the Treatment of Patients With HIV Infection Who Have Failed Other Antiretroviral Therapy and Have Limited Treatment Options|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.316543|2017-02-18 18:22:03.316543
NCT00002397|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease|An Exploratory Study of Fortovase (Saquinavir) Soft Gelatin Capsules (SGC) Plus d4T and 3TC or Fortovase (Saquinavir) SGC Plus Nelfinavir and d4T in Patients With HIV-1 Associated Nephropathy|Completed||Phase 3|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.405384|2017-02-18 18:22:03.405384
NCT00002396|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients|A Phase I/II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance, Pharmacokinetics, and Antiviral Activity of 9-[2-(R)-[[Bis[[(Isopropoxycarbonyl)- Oxy]Methoxy]Phosphinoyl]Methoxy]Propyl]Adenine Fumarate (PMPA Prodrug) in HIV-Infected Patients|Unknown status|Active, not recruiting|Phase 1|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.494835|2017-02-18 18:22:03.494835
NCT00002395|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 2000|2000-07-01||||||||Interventional|||Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)|An Open, Comparative Phase II Study of Immediate Versus Delayed Treatment With Topotecan HCl Given as a Continuous 21-Day Infusion Every 28 Days to Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy|Completed||Phase 2|54||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.581231|2017-02-18 18:22:03.581231
NCT00002394|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment|A Four-Week, Open-Label, Non-Randomized, Multicenter, Dose-Finding, Pilot Study to Evaluate the Safety and Efficacy of Two Daily Doses of Lamisil (1500 Mg and 2000 Mg), Administered for a Maximum of 4 Weeks in HIV-Positive Subjects With Oral Mucosal Candidiasis Not Having Responded to a Minimum of 200 Mg Fluconazole Monotherapy|Completed||N/A|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.678493|2017-02-18 18:22:03.678493
NCT00002393|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study of Indinavir Taken With or Without DMP 266|A Phase III, Double-Blind, Placebo-Controlled, Multicenter Study to Determine the Effectiveness and Tolerability of the Combination of DMP 266 and Indinavir Versus Indinavir in HIV-Infected Patients Receiving Nucleoside Analogue (NRTI) Therapy|Completed||Phase 3|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.779381|2017-02-18 18:22:03.779381
NCT00002392|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART|A Study to Investigate the Potential of Thalidomide Treatment to Enhance Immune Responses in HIV-Infected Individuals Who Are Receiving Highly Active Antiretroviral Therapy.|Completed||N/A|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.885021|2017-02-18 18:22:03.885021
NCT00002391|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs|A Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety and Efficacy of the Combination of 1592U89/Zidovudine (ZDV)/Lamivudine (3TC) Versus the Combination of Zidovudine (ZDV)/Lamivudine (3TC) in HIV-1 Therapy-Experienced Pediatric Patients.|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:03.983626|2017-02-18 18:22:03.983626
NCT00002390|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients|A Phase II Randomized, Blinded, Dose-Ranging Multicenter Study to Evaluate the Safety and Efficacy of Different Regimens of 1592U89 Monotherapy Upon Selected Immunological and Virological Markers of HIV-1 Infection in Antiretroviral Therapy-Naive Patients|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.10716|2017-02-18 18:22:04.10716
NCT00002389|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs|A Randomized, Double-Blind, Parallel-Group, Multicenter Trial to Evaluate the Safety and Efficacy of 1592U89 in Combination With Lamivudine (3TC) and Zidovudine (ZDV) Versus 3TC/ZDV in HIV-1-Infected, Antiretroviral Therapy-Naive Subjects With CD4+ Counts >= 100 Cells/mm3|Completed||Phase 3|210||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.208169|2017-02-18 18:22:04.208169
NCT00002388|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of 1592U89 in HIV-Infected Patients|A Study to Evaluate the Single-Dose and Steady-State Pharmacokinetics/Dynamics of 1592U89 and Its Active Moiety, 1144U88 5'-Triphosphate (1144U88-TP) Following Six Different Dosing Regimens of 1592U89 in HIV-1 Infected Subjects|Completed||Phase 1|48||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.324819|2017-02-18 18:22:04.324819
NCT00002387|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz|A Multicenter, Open, Randomized, Forty-Eight-Week, Pilot Study to Evaluate the Activity, Safety, and Pharmacokinetics of Indinavir Sulfate, 1200 Mg q 12h and DMP 266, 300 Mg q 12h Versus Indinavir Sulfate, 1000 Mg q 8h and DMP 266, 600 Mg q.h.s.|Completed||N/A|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.432033|2017-02-18 18:22:04.432033
NCT00002386|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia|A Multiclinic, Open Pilot Study to Investigate the Effect of Combination Antiretroviral Therapy Including Indinavir Sulfate on Coagulation Factors, on Platelet Aggregation, and on Factor VIII/IX Half-Life in HIV-1 Seropositive Patients With Hemophilia A or B|Completed||Phase 4|55||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.540124|2017-02-18 18:22:04.540124
NCT00002385|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients|Multicenter, Rising, Multiple-Dose, Placebo-Controlled, Dose-Response Study to Evaluate the Safety, Tolerability, and Anti-Viral Activity of 4 Weeks of Treatment With 200-800 Mg Fozivudine Tidoxil in Patients With HIV-1 Infection (MF4314).|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.646319|2017-02-18 18:22:04.646319
NCT00002384|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.737432|2017-02-18 18:22:04.737432
NCT00002383|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients|A Randomized, Parallel, Open-Label Study Comparing Saquinavir (Hard Gelatin Formulation, 600 Mg Tid) to Saquinavir Soft Gelatin Formulation [(400 Mg, 800 Mg, 1200 Mg) Tid} x 4 Weeks in HIV Infected Patients|Completed||Phase 1|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.826147|2017-02-18 18:22:04.826147
NCT00002382|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1997|1997-06-01||||||||Interventional|||A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients|An Open Label International Compassionate Treatment Program for the Use of Saquinavir (R0 31-8959) Either As Monotherapy or in Combination With Other Anti-Retroviral Drugs in Patients With Proven HIV Infection|Completed||Phase 3|4000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:04.937363|2017-02-18 18:22:04.937363
NCT00002381|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine|An Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (Viramune) and Nelfinavir (Viracept) and the Efficacy of This Combination Therapy in HIV-1 Infected Adults Treated With Stavudine [d4T] (Zerit)|Completed||Phase 1|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:05.037877|2017-02-18 18:22:05.037877
NCT00002380|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children|A Phase I/II Pharmacokinetic and Safety Study of Saquinavir Soft Gelatin Capsules and Pediatric Pellet Formulations in Combination With Nucleoside Antiretroviral Agents With or Without Nelfinavir, in HIV-Infected Infants and Children|Completed||Phase 1|28||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:05.128785|2017-02-18 18:22:05.128785
NCT00002379|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1998|1998-10-01||||||||Interventional|||The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs|A Phase II, Stratified, Randomized, Open-Label, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil and Indinavir in Combination With Zidovudine, Lamivudine, or Stavudine for the Treatment of Therapy Naive HIV-Infected Patients With CD4 Cell Counts >= 100 Cells/mm3 and HIV-1 RNA Copy Numbers >= 5,000 Copies/Ml|Completed||Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:05.221489|2017-02-18 18:22:05.221489
NCT00002378|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients|A Randomized Phase IIIB Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) TID Regimen in Combination With Two NRTIs Versus Saquinavir Soft Gel Capsule (SGC) BID Regimen in Combination With Two NRTIs Versus Saquinavir Soft Gel Capsule (SGC) BID Plus Nelfinavir BID Plus a NRTI in HIV-1 Infected Patients|Completed||Phase 3|825||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:05.330062|2017-02-18 18:22:05.330062
NCT00002377|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-07-01||||||July 2005|2005-07-01||||||||Interventional|||A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes||Completed||Phase 3|||Hoffmann-La Roche|||||||||||||||||||2017-02-18 18:22:05.814573|2017-02-18 18:22:05.814573
NCT00002376|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients|A Randomized Controlled Clinical Study to Determine If the Addition of HIV RNA Viral Load Is an Effective Tool in Determining Treatment Regimens for HIV-Infected Patients|Completed||Phase 4|540||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:05.9262|2017-02-18 18:22:05.9262
NCT00002375|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 2000|2000-02-01||||||||Interventional|||Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients|A Multicenter, 24-Week Study of the Safety, Pharmacokinetics, and Activity of the Coadministration of Indinavir and Nelfinavir in HIV-1 Seropositive Patients|Completed||N/A|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:06.020026|2017-02-18 18:22:06.020026
NCT00002374|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients|A Phase IIIB Open-Label Trial Replacing Saquinavir HGC (Ro 31-8959) With Saquinavir SGC (Ro 31-8959) in Combination With Other Antiretroviral Drugs in Patients With HIV-1 Infection|Completed||Phase 3|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:06.118126|2017-02-18 18:22:06.118126
NCT00002373|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients|A Phase I/II Trial to Evaluate the Tolerability, Anti-CMV Activity and Pharmacokinetics of 1263W94 Following Multiple Oral Administration of Escalating Doses in HIV-Infected Patients With Asymptomatic CMV Shedding|Completed||Phase 1|56||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:06.225491|2017-02-18 18:22:06.225491
NCT00002372|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of 141W94 in Combination With Other Anti-HIV Drugs|A Phase I/II Screening Trial to Identify Potential Partner Compounds to Use in Combination With 141W94|Completed||Phase 1|48||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:06.327797|2017-02-18 18:22:06.327797
NCT00002371|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-28||2011-04-13|June 1996||1996-06-01|April 2011|2011-04-01|December 1997|Actual|1997-12-01|December 1997|Actual|1997-12-01||Interventional|||The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine|A Randomized Double-Blind Study of Safety, Virologic and Immunological Effects of Stavudine Plus Lamivudine (3TC) Versus Zidovudine Plus Lamivudine in HIV-Infected Subjects Following At Least Six Months of Zidovudine Therapy|Completed||Phase 3|80||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:06.44251|2017-02-18 18:22:06.44251
NCT00002370|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||Study of Itraconazole in Patients With Advanced HIV Infection|Pharmacokinetics Study of Intravenous Itraconazole Followed by Oral Dosing at 200 Mg Twice Daily in Patients With Advanced HIV Infection|Completed||N/A|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:06.571526|2017-02-18 18:22:06.571526
NCT00002369|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|An Open Label, Randomized, Comparative Study of Zerit (d4T) + Epivir (3TC) + Crixivan Versus Retrovir (AZT) + Epivir (3TC) + Crixivan in HIV-Infected, Antiretroviral Naive Subjects With CD4 Cell Counts of 200 - 700 Cells/mm3 and HIV RNA Baseline Copy Number of >= 10,000 Copies/ml|Completed||N/A|200||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:06.667177|2017-02-18 18:22:06.667177
NCT00002368|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs|An International, Double Blind, Randomized, Phase III Study to Evaluate the Tolerance, Safety, and Effectiveness of Viramune (Nevirapine) in Preventing Clinical AIDS Progression Events or Death When Used in Combination With Lamivudine (3TC) and Stable (>= 4 Weeks) Background Nucleoside Therapy|Completed||Phase 3|2000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:06.791552|2017-02-18 18:22:06.791552
NCT00002367|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs|An Open-Label, Non-Comparative Study of Saquinavir-SGC in Combination With Zidovudine (AZT) and Lamivudine (3TC) in the Treatment of HIV-1 Infected Patients With No Previous Anti-Retroviral Drug Therapy|Completed||Phase 3|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:06.956086|2017-02-18 18:22:06.956086
NCT00002366|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma|A Phase II Safety and Activity Study of Ritonavir in the Treatment of HIV-Associated Cutaneous Kaposi's Sarcoma|Completed||Phase 2|||Abbott|||||f||||||||||||||2017-02-18 18:22:07.058039|2017-02-18 18:22:07.058039
NCT00002365|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study of LXR015-1 in HIV-Infected Patients|A Randomized, Parallel, Open-Label Phase I Study of LXR015-1 in HIV-Infected Patients|Completed||Phase 1|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:07.15216|2017-02-18 18:22:07.15216
NCT00002364|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1997|1997-04-01||||||||Interventional|||A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs|An Exploratory Study of the Antiretroviral Activity of 1592U89 When Administered in Combination With Other Specific Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in NRTI Experienced Patients|Completed||Phase 2|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:07.252969|2017-02-18 18:22:07.252969
NCT00002363|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients|Study of the Safety and Effects of Two Doses of SPC3, Administered Daily Intravenously in HIV-1 Seropositive Patients|Completed||Phase 1|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:07.359646|2017-02-18 18:22:07.359646
NCT00002362|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||August 1999||1999-08-01|March 2000|2000-03-01||||||||Interventional|||A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|A Randomized, Open-Label Superiority Trial Comparing Emtricitabine to Abacavir Within a Triple Drug Combination in Antiretroviral-Drug Naive HIV-1 Infected Patients|Suspended||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:07.440372|2017-02-18 18:22:07.440372
NCT00002361|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 2000|2000-02-01||||||||Interventional|||Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors|A Multicenter, Open-Label, 24-Week Study to Evaluate the Safety and Activity of Indinavir Sulfate 800 Mg b.i.d. in Combination With Ritonavir 200 Mg b.i.d. and Two NRTIs in HIV-1 Infected Patients Who Failed PI Therapy|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:07.528611|2017-02-18 18:22:07.528611
NCT00002360|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-13|||March 1999||1999-03-01|April 2011|2011-04-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||A Study Comparing Two Forms of Didanosine in HIV-infected Patients|Pivotal Bioequivalence Study of Videx Chewable/Dispersible Buffered Tablets and an Encapsulated Enteric Coated Bead Formulation of Didanosine in HIV-Infected Subjects|Completed||Phase 1|30||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:07.619417|2017-02-18 18:22:07.619417
NCT00002359|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1997|1997-06-01||||||||Interventional|||A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega|A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Regardless of Concomitant HIV Therapies|Completed||Phase 3|3000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:07.706233|2017-02-18 18:22:07.706233
NCT00002358|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV|Open-Label BV-araU Treatment of Pediatric HIV-Infected Patients With Cutaneous, Visceral, or Ocular Varicella-Zoster Viral Disease Who Have Failed or Are Intolerant of Standard Therapy|Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:07.923573|2017-02-18 18:22:07.923573
NCT00002357|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1997|1997-05-01||||||||Interventional|||The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms|A Multicenter, Randomized, Double-Blinded, Dose-Escalation Study Evaluating the Safety and Antiretroviral Activity of HBY 097 Versus HBY 097 Plus AZT in Patients With Asymptomatic or Mildly Symptomatic HIV Infection|Completed||Phase 2|144||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:08.023396|2017-02-18 18:22:08.023396
NCT00002356|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes|An Open-Label Study of the Safety and Efficacy of Intravitreal ISIS 2922 in Acquired Immune Deficiency Syndrome (AIDS) Patients With Cytomegalovirus Retinitis (NOTE: Restricted to Patients Who Rollover From Another Controlled ISIS 2922 Trial)|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:08.115006|2017-02-18 18:22:08.115006
NCT00002355|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes|A Randomized Comparison of Immediate Versus Delayed Treatment With Intravitreal Injections of ISIS 2922 in Patients With Peripheral Cytomegalovirus (CMV) Retinitis|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:08.222044|2017-02-18 18:22:08.222044
NCT00002354|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients|One Year Study in HIV-1 Seropositive, AZT-Experienced Patients to Evaluate the Safety and Efficacy of MK-639 Administered Concomitantly With Stavudine (d4T)|Completed||N/A|540||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:08.313693|2017-02-18 18:22:08.313693
NCT00002353|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects|A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:08.396002|2017-02-18 18:22:08.396002
NCT00002352|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of Lobucavir in Patients With AIDS|Pilot Study of the Antiviral Activity of Multiple Doses of Oral Lobucavir in AIDS Patients|Completed||N/A|30||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:08.473867|2017-02-18 18:22:08.473867
NCT00002351|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1995|1995-10-01||||||||Interventional|||A Study of L-735,524 in HIV-Positive Children and Adolescents|An Open-Labeled, Multiple Dose, Multicenter Study to Investigate the Safety, Tolerability, and Plasma Concentration Profile of L-735,524 Capsules in HIV-Seropositive Older Children and Adolescent Patients|Completed||Phase 1|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:08.576408|2017-02-18 18:22:08.576408
NCT00002350|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients|A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients|Completed||Phase 1|16||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:08.666737|2017-02-18 18:22:08.666737
NCT00002349|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-13|||January 1995||1995-01-01|April 2011|2011-04-01|May 1999|Actual|1999-05-01|May 1999|Actual|1999-05-01||Interventional|||A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.|A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.|Completed||N/A|40||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:08.75212|2017-02-18 18:22:08.75212
NCT00002348|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma|Phase II Evaluation of Mitoguazone Dihydrochloride in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma Associated With Acquired Immunodeficiency Syndrome|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:11.838661|2017-02-18 18:22:11.838661
NCT00002347|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1995|1995-06-01||||||||Interventional|||The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection|A Master Protocol to Evaluate the Safety and Efficacy of Multi-Drug Combination Antiretroviral Therapy for the Treatment of HIV Infection: Retrovir/HIVID/Nevirapine and Retrovir/HIVID/Invirase|Completed||Phase 2|225||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:11.925166|2017-02-18 18:22:11.925166
NCT00002346|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1995|1995-03-01||||||||Interventional|||The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients|A Phase I/II Study of Safety, Tolerance, Pharmacokinetics, and Anti-HIV Activity of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA) and Placebo in HIV-Infected Patients|Completed||Phase 1|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:12.021599|2017-02-18 18:22:12.021599
NCT00002345|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||The Safety and Effectiveness of Megace in HIV-Infected Women|Phase IV Study on the Safety and Efficacy of Megace Oral Suspension in HIV-Positive Females|Completed||Phase 4|40||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:12.112423|2017-02-18 18:22:12.112423
NCT00002344|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Azithromycin in HIV-Infected Patients|Double-Blind Crossover Study Assessing the Dose Proportionality of Azithromycin Tablets in HIV-Infected Subjects|Completed||Phase 1|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:12.200698|2017-02-18 18:22:12.200698
NCT00002343|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1997|1997-06-01||||||||Interventional|||A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS|An Open-Label Randomized Pharmacokinetic/Pharmacodynamic Study of Mycobutin (Rifabutin) or Rifabutin in Combination With Myambutol (Ethambutol) for Prophylaxis of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts <= 100 Cells/mm3|Completed||Phase 4|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:12.278531|2017-02-18 18:22:12.278531
NCT00002342|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Tecogalan Sodium|A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Twice Weekly for 21 Days|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:12.371186|2017-02-18 18:22:12.371186
NCT00002341|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole|An Open-Label Extension Study of Maintenance Therapy in HIV-Positive Subjects With Fluconazole-Refractory Oropharyngeal Candidiasis Who Have Responded to Itraconazole Oral Solution|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:12.459976|2017-02-18 18:22:12.459976
NCT00002340|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX|A Randomized, Open-Label Trial of High Dose Atovaquone Versus Low Dose Atovaquone Versus Aerosolized Pentamidine for Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With HIV Infection Who Are Intolerant of TMP/SMX|Completed||Phase 3|615||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:12.556733|2017-02-18 18:22:12.556733
NCT00002339|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems|An Open Multicenter Trial of Fluconazole Oral Suspension in the Treatment of Esophageal Candidiasis in Immunocompromised Patients|Completed||Phase 3|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:12.658951|2017-02-18 18:22:12.658951
NCT00002338|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||The Safety and Effectiveness of 935U83 in HIV-Infected Patients|A Phase I Trial to Evaluate the Safety, Tolerance, and Pharmacokinetics of 935U83 After Multiple Dosing in Patients With HIV Infection|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:12.748017|2017-02-18 18:22:12.748017
NCT00002337|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease|A Phase I Safety and Tolerability Study of Four Doses of OPC-8212 (Vesnarinone) in Advanced HIV Disease|Completed||Phase 1|56||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:13.113876|2017-02-18 18:22:13.113876
NCT00002336|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-01-15|||November 1992||1992-11-01|February 2009|2009-02-01|November 1994|Actual|1994-11-01|November 1994|Actual|1994-11-01||Interventional|||The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients|A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Clarithromycin for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients With CD4 Counts <= 100 Cells/mm3|Completed||N/A|||Abbott|||||f||||||||||||||2017-02-18 18:22:13.213388|2017-02-18 18:22:13.213388
NCT00002335|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||The Safety and Effectiveness of 524W91|A Phase I, Randomized, Single-Dose, Placebo-Controlled Trial to Evaluate the Safety and Pharmacokinetics of 524W91|Completed||Phase 1|18||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:13.324193|2017-02-18 18:22:13.324193
NCT00002334|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1996|1996-09-01||||||||Interventional|||A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment|A Randomized, Multicenter, Double-Blind, Phase III, Parallel Study of Zidovudine (AZT) Alone Versus AZT Plus Zalcitabine (Dideoxycytidine; ddC) Versus AZT Plus Saquinavir Mesylate (Ro 31-8959 ; HIV Proteinase Inhibitor) Versus AZT Plus ddC Plus Ro 31-8959 in Previously Untreated or Minimally Pretreated HIV-Infected Patients With CD4 Lymphocyte Counts From 50 to <= 350 Cells/mm3|Completed||Phase 3|3000||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:13.416112|2017-02-18 18:22:13.416112
NCT00002333|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine|A Randomized, Double-Blind, Multicenter, Parallel Study of Ro 31-8959 (Saquinavir; HIV Proteinase Inhibitor) Alone, HIVID (Dideoxycytidine; Zalcitabine, ddC) Alone, and Both in Combination, as Treatment for Advanced HIV Infection (CD4 50-300 Cells/mm3) in Patients Discontinuing or Unable to Take Retrovir (Zidovudine; AZT) Therapy|Completed||Phase 2|900||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:13.547071|2017-02-18 18:22:13.547071
NCT00002332|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1995|1995-12-01||||||||Interventional|||A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs|Double-Blind Study of the Effect of Timunox (Thymopentin) on Lymphoproliferative Responses and Virus Load in HIV-Infected Subjects Receiving Nucleoside Analog Antiretroviral Therapy|Completed||Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:13.695304|2017-02-18 18:22:13.695304
NCT00002331|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-01-15|||January 1994||1994-01-01|February 2009|2009-02-01|March 1995|Actual|1995-03-01|March 1995|Actual|1995-03-01||Interventional|||The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS|A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC (dMAC) in Patients With AIDS|Completed||N/A|||Abbott|||||f||||||||||||||2017-02-18 18:22:13.783249|2017-02-18 18:22:13.783249
NCT00002330|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|A Randomized Study Comparing the Safety and Efficacy of Three Doses of Oral Ganciclovir to Intravenous Ganciclovir for the Maintenance Treatment of Cytomegalovirus Retinitis in People With AIDS|Completed||N/A|280||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:13.886005|2017-02-18 18:22:13.886005
NCT00002329|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1995|1995-05-01||||||||Interventional|||A Study of MDL 28,574A in HIV-Infected Patients|A Randomized, Placebo-Controlled, Double-Blind, Single and Multiple Oral Dose-Tolerance Study of Oral MDL 28,574A Solution in HIV-Positive Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:14.009427|2017-02-18 18:22:14.009427
NCT00002328|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs|Oral/Intravenous Azithromycin in the Treatment of Cryptosporidiosis in Patients Whose Disease Has Not Been Controlled by Conventional Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:14.096769|2017-02-18 18:22:14.096769
NCT00002327|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients|A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Condyloma Acuminatum in Patients With HIV Infection|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:14.169596|2017-02-18 18:22:14.169596
NCT00002326|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1995|1995-10-01||||||||Interventional|||The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients|A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of Combination Zidovudine (AZT) and 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA; Adefovir) Treatment in HIV-Infected Patients|Completed||Phase 1|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:14.551362|2017-02-18 18:22:14.551362
NCT00002325|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common|A Double-Blind, Placebo-Controlled Study of Fluconazole in the Prevention of Active Coccidioidomycosis and Other Systemic Fungal Infections in HIV-Infected Patients Living in the Coccidioidal Endemic Area|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:14.636444|2017-02-18 18:22:14.636444
NCT00002324|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease|A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Activity, Safety, and Tolerance of 1) 400 Mg Nevirapine in Combination With 500-600 Mg Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 3-24 Months of Prior Zidovudine Therapy and 200-500 CD4 Cells/mm3 and 2) 400 Mg Nevirapine Versus Nevirapine Placebo in Asymptomatic HIV-1 Nucleoside Naive Patients With 200-500 CD4 Cells/mm3|Completed||Phase 2|250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:14.722866|2017-02-18 18:22:14.722866
NCT00002323|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell|A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cells/mm3|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:14.842608|2017-02-18 18:22:14.842608
NCT00002322|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1996|1996-11-01||||||||Interventional|||A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients|Randomized, Double-Blind, Placebo-Controlled Comparative Dose-Response Study of Two Doses of Atevirdine Mesylate (U-87201E) in Combination With Fixed Doses of Zidovudine (AZT) in HIV+ Patients|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:14.927004|2017-02-18 18:22:14.927004
NCT00002321|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1994|1994-10-01||||||||Interventional|||A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis|A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.034038|2017-02-18 18:22:15.034038
NCT00002320|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-12-08||||||May 1994|1994-05-01||||||||Interventional|||A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past|A Randomized, Double-Blind Multicenter Trial to Compare the Safety and Efficacy of Lamivudine (3TC; GR109714X) Monotherapy Versus Zidovudine (AZT) Monotherapy Versus 3TC Administered With AZT in the Treatment of HIV-1 Infected Patients Who Are AZT Naive (< 4 Weeks) With CD4 Cell Counts of 200-500 Cells/mm3|Completed||Phase 3|320||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.12114|2017-02-18 18:22:15.12114
NCT00002108|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1995|1995-11-01||||||||Interventional|||3TC (Lamivudine; GR109714X) Open-Label Program|3TC (Lamivudine; GR109714X) Open-Label Program|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.154555|2017-02-18 18:22:40.154555
NCT00002319|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma|Open Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.251907|2017-02-18 18:22:15.251907
NCT00002318|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma|Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Adriamycin, Bleomycin, and Vincristine (ABV) in the Treatment of Severe AIDS-Related Kaposi's Sarcoma|Unknown status|Active, not recruiting|Phase 3|225||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.387397|2017-02-18 18:22:15.387397
NCT00002317|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1993|1993-07-01||||||||Interventional|||A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia|A Study of Neutrexin (Trimetrexate Glucuronate) With Leucovorin Protection for Pediatric Patients (Ages 2-12) With Pneumocystis Carinii Pneumonia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.509511|2017-02-18 18:22:15.509511
NCT00002316|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1994|1994-12-01||||||||Interventional|||The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis|Phase I Study to Evaluate the Safety and Tolerance of RMP-7 Administered With Amphotericin B to Patients With HIV Infection and Cryptococcal Meningitis|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.601893|2017-02-18 18:22:15.601893
NCT00002315|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1994|1994-05-01||||||||Interventional|||A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems|A Double-Blind, Multicenter Study Comparing Oral 882C87 With Oral Acyclovir for Treatment of Localized Herpes Zoster in Immunocompromised Patients|Completed||Phase 3|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.703729|2017-02-18 18:22:15.703729
NCT00002314|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1993|1993-12-01||||||||Interventional|||A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma|A Phase II Study of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV-Related Kaposi's Sarcoma|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.816065|2017-02-18 18:22:15.816065
NCT00002313|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||A Study of Nystatin in HIV-Infected Patients|Extended Maintenance Protocol for Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection (NOTE: Continuation Study Intended Only for Patients Who Have Completed FDA 103B)|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.884895|2017-02-18 18:22:15.884895
NCT00002312|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine|Open-Label Escalating Multiple-Dose Study of the Safety, Tolerance, and Pharmacokinetics of Oral U-90152 in HIV-1 Infected Males and Females With CD4 Counts of 200 - 500 Cells/mm3 Who Are Maintained on a Stable Dose of Zidovudine (AZT)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:15.973188|2017-02-18 18:22:15.973188
NCT00002311|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1993|1993-05-01||||||||Interventional|||The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients|A Phase I-II Dose Escalation Study to Examine the Safety of Four Doses of Wobenzym in HIV Seropositive Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:16.060435|2017-02-18 18:22:16.060435
NCT00002310|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1993|1993-09-01||||||||Interventional|||SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir|A Pilot Study to Determine the Safety and Efficacy of Topically Applied SP-303T in Patients With Acquired Immunodeficiency Syndrome and Concomitant Herpes Simplex Virus (HSV) Infection Unresponsive to Acyclovir|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:16.135339|2017-02-18 18:22:16.135339
NCT00002309|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients|A Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of Azithromycin as Prophylaxis Against the Development of Mycobacterium Avium Complex Disease in HIV-Infected People|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:16.216979|2017-02-18 18:22:16.216979
NCT00002308|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-08-04||||||August 2011|2011-08-01|November 1991|Actual|1991-11-01|||||Interventional|||A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs|A Randomized Blinded Evaluation of Two Doses of Stavudine (2',3'-Didehydro-2',3'-Dideoxythymidine; d4T) to Make Treatment Available to Severely Immunocompromised Patients With HIV Infection Who Have Failed or Are Intolerant of Alternative Antiretroviral Therapy|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:16.302974|2017-02-18 18:22:16.302974
NCT00002307|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-08-04||||||August 2011|2011-08-01|December 1994|Actual|1994-12-01|||||Interventional|||A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients|A Double-Blind Comparison of Zidovudine (AZT) Versus Stavudine (d4T; BMY 27857) for the Treatment of Patients With HIV Infection Who Have Absolute CD4 Lymphocyte Counts Between 50 and 500 Cells/mm3|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:16.391411|2017-02-18 18:22:16.391411
NCT00002306|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B|Multi-Center Evaluation of Fluconazole (UK-49,858) as Treatment for Acute Cryptococcal Meningitis in Patients Who Have Failed to Respond or Have Experienced Unacceptable Toxicity During Treatment With Amphotericin B|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:16.794077|2017-02-18 18:22:16.794077
NCT00002305|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis|Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:16.890816|2017-02-18 18:22:16.890816
NCT00002304|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems|A Randomized Comparative Multicenter Trial of Fluconazole and Ketoconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.020753|2017-02-18 18:22:17.020753
NCT00002303|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are Anemic|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in Patients With AIDS or Advanced ARC and Anemia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.156868|2017-02-18 18:22:17.156868
NCT00002302|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.242482|2017-02-18 18:22:17.242482
NCT00002301|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1991|1991-03-01||||||||Interventional|||A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir|Foscarnet Treatment of Cytomegalovirus (CMV) Retinitis in AIDS Patients Not Eligible for Ganciclovir Therapy and Ganciclovir Treatment Failures|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.340001|2017-02-18 18:22:17.340001
NCT00002300|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition|Phase II-III Randomized Double-Blind Study Comparing Megestrol Acetate at 100, 400, and 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia|Completed||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:17.430418|2017-02-18 18:22:17.430418
NCT00002299|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1990|1990-04-01||||||||Interventional|||The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS|Combination Therapy With 9-(1,3-Dihydroxy-2-Propoxymethyl) Guanine (DHPG) and Interferon Beta for the Prevention of Relapse of Cytomegalovirus Retinitis in Patients With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.5341|2017-02-18 18:22:17.5341
NCT00002298|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1998|1998-03-01||||||||Interventional|||The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection|Long-Term Efficacy and Tolerance of Oral Ribavirin Compared to Placebo as a Preventative in Early Stages of Human Immunodeficiency Virus Infection - United States|Terminated||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.643927|2017-02-18 18:22:17.643927
NCT00002297|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Study of Isoprinosine in Patients With Lymph Node Disease|A Multi-Center Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine (Inosiplex) in Patients With Unexplained Generalized Lymphadenopathy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.717246|2017-02-18 18:22:17.717246
NCT00002296|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease|A Multi-Center Randomized Double-Blind Placebo-Controlled Study to Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.795314|2017-02-18 18:22:17.795314
NCT00002295|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Study of Isoprinosine in Patients With Severe AIDS|A Double-Blind Placebo-Controlled Study to Investigate the Action of Isoprinosine (Inosiplex) in Patients With Severe Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.876054|2017-02-18 18:22:17.876054
NCT00002294|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS|Double Blind Placebo Controlled Study of Fluconazole (UK-49,858) for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:17.980231|2017-02-18 18:22:17.980231
NCT00002293|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes|Nystatin Pastille for the Prophylaxis of Oral Candidiasis in Patients With AIDS or AIDS Related Syndromes|Completed||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:18.071685|2017-02-18 18:22:18.071685
NCT00002292|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS|Inhaled Versus Intravenous Pentamidine in Pneumocystis Carinii Pneumonia in the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.182062|2017-02-18 18:22:18.182062
NCT00002291|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1989|1989-10-01||||||||Interventional|||The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before|A Double-Blind Group Comparative Study To Evaluate the Safety and Effectiveness of Three Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.273117|2017-02-18 18:22:18.273117
NCT00002290|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection|A Multi-Center, Double-Blind Trial to Evaluate the Safety and Efficacy of Concurrent Retrovir (Zidovudine) and Zovirax (Acyclovir) Therapy in Patients With Early Symptomatic Human Immunodeficiency Virus (HIV) Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.373556|2017-02-18 18:22:18.373556
NCT00002289|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients|Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.469788|2017-02-18 18:22:18.469788
NCT00002288|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System|Safety and Efficacy of Retrovir in HIV Infected Patients Having Neuropsychological Impairments|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.546159|2017-02-18 18:22:18.546159
NCT00002287|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus|A Placebo-Controlled Trial to Evaluate Retrovir in Preventing Infection With the Human Immunodeficiency Virus (HIV) in Health Care Workers After Accidental Exposure|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.626361|2017-02-18 18:22:18.626361
NCT00002286|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients|Retrovir Capsules in the Treatment of Psoriasis in HIV Antibody Positive Patients: A Pilot Study|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.711194|2017-02-18 18:22:18.711194
NCT00002285|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDS|A Phase I/II Pilot Trial To Evaluate Zidovudine (AZT) and T Lymphocyte Transfer in the Treatment of Human Immunodeficiency Virus Type-III (HIV) Infection in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.811964|2017-02-18 18:22:18.811964
NCT00002284|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant|A Pilot Study To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients Receiving a Bone Marrow Transplant|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.889321|2017-02-18 18:22:18.889321
NCT00002283|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS|Randomized Prospective Study of Dapsone Versus Trimethoprim-Sulfamethoxazole in the Treatment of First Episode Pneumocystis Carinii Pneumonia in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:18.961696|2017-02-18 18:22:18.961696
NCT00002282|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS|A Randomized Multicenter Study of the Efficacy, Safety, and Toleration of Fluconazole or Clotrimazole Troches in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:19.040393|2017-02-18 18:22:19.040393
NCT00002281|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex|An Open Label Phase I/II Study of Recombinant Granulocyte Colony-Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With AIDS or ARC|Completed||N/A|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:19.131441|2017-02-18 18:22:19.131441
NCT00002280|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-08-04||||||August 2011|2011-08-01|November 1994|Actual|1994-11-01|||||Interventional|||A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine|An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Children With Acquired Immunodeficiency Syndrome (AIDS) Who Have Demonstrated Significant Deterioration or Intolerance to Zidovudine (Retrovir)|Completed||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:19.214141|2017-02-18 18:22:19.214141
NCT00002279|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1991|1991-10-01||||||||Interventional|||A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)|Dideoxycytidine (Ro 24-2027). An Open-Label, Safety Study of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine (AZT) Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:19.318462|2017-02-18 18:22:19.318462
NCT00002278|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1990|1990-07-01||||||||Interventional|||A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS|28 Day Protocol for the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:19.410712|2017-02-18 18:22:19.410712
NCT00002277|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1993|1993-12-01||||||||Interventional|||A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections|Fluconazole Versus Amphotericin B: A Prospective, Randomized, Multicenter Study for Therapy of Fungal Infection|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:19.487636|2017-02-18 18:22:19.487636
NCT00002276|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1990|1990-06-01||||||||Interventional|||The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia|Study of Bleeding Tendency, Platelet Function, and Pharmacokinetics of Azidothymidine (AZT) and Motrin (Ibuprofen) in HIV-Infected Hemophiliacs|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:19.565822|2017-02-18 18:22:19.565822
NCT00002275|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)|Lipid-Based Parenteral Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome and Pneumocystis Carinii Pneumonia. A Comparison of Two Lipid Formulations|Completed||N/A|||Abbott|||||f||||||||||||||2017-02-18 18:22:19.649816|2017-02-18 18:22:19.649816
NCT00002274|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine|An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) Exhibiting Significant Deterioration While Taking Zidovudine (Retrovir)|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:19.997086|2017-02-18 18:22:19.997086
NCT00002273|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS|Double-Blind, Placebo-Controlled Study of Intravenous Ganciclovir (DHPG) for Cytomegalovirus Colitis in Patients With Acquired Immune Deficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.099362|2017-02-18 18:22:20.099362
NCT00002272|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1990|1990-09-01||||||||Interventional|||An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies|An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.186179|2017-02-18 18:22:20.186179
NCT00002271|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1991|1991-06-01||||||||Interventional|||An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects|An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.276517|2017-02-18 18:22:20.276517
NCT00002270|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1991|1991-03-01||||||||Interventional|||A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection|A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.355717|2017-02-18 18:22:20.355717
NCT00002269|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen|A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.447297|2017-02-18 18:22:20.447297
NCT00002268|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1991|1991-12-01||||||||Interventional|||A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria|A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.529063|2017-02-18 18:22:20.529063
NCT00002267|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1992|1992-03-01||||||||Interventional|||Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial|Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial|Completed||N/A|750||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.61621|2017-02-18 18:22:20.61621
NCT00002266|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1990|1990-12-01||||||||Interventional|||An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients|An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.74563|2017-02-18 18:22:20.74563
NCT00002265|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1994|1994-02-01||||||||Interventional|||An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492|An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.829404|2017-02-18 18:22:20.829404
NCT00002264|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea|Efficacy of Cow's Milk Immune Globulin in the Treatment of Chronic Intestinal Cryptosporidiosis in Patients With AIDS|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:20.923645|2017-02-18 18:22:20.923645
NCT00002263|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine|A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.004737|2017-02-18 18:22:21.004737
NCT00002262|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1988|1988-12-01||||||||Interventional|||A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma|A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.0875|2017-02-18 18:22:21.0875
NCT00002261|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-09-24||||||September 2007|2007-09-01||||||||Interventional|||A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers|A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers|Completed||Phase 1|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:21.165072|2017-02-18 18:22:21.165072
NCT00002260|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1992|1992-03-01||||||||Interventional|||An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects|An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.254517|2017-02-18 18:22:21.254517
NCT00002259|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma|Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.339695|2017-02-18 18:22:21.339695
NCT00002258|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1992|1992-11-01||||||||Interventional|||A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia|A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.420575|2017-02-18 18:22:21.420575
NCT00000523|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2005-06-23|||April 1986||1986-04-01|January 2000|2000-01-01||||||||Interventional|||Optimal Exercise Regimens for Persons at Increased Risk||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:00.612921|2017-02-18 18:26:00.612921
NCT00002257|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1992|1992-07-01||||||||Interventional|||A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS|A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS|Completed||N/A|150||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.500666|2017-02-18 18:22:21.500666
NCT00002256|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1994|1994-08-01||||||||Interventional|||Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.|Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.598909|2017-02-18 18:22:21.598909
NCT00002255|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1991|1991-01-01||||||||Interventional|||An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)|An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.675723|2017-02-18 18:22:21.675723
NCT00002254|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1991|1991-05-01||||||||Interventional|||A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)|A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.76957|2017-02-18 18:22:21.76957
NCT00002253|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1992|1992-08-01||||||||Interventional|||"A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either Responders or Non-Responders in a Prior Placebo-Controlled Double-Blind Sandostatin Study."|"A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either Responders or Non-Responders in a Prior Placebo-Controlled Double-Blind Sandostatin Study."|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.856721|2017-02-18 18:22:21.856721
NCT00002252|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1992|1992-08-01||||||||Interventional|||A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea|A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:21.95552|2017-02-18 18:22:21.95552
NCT00002251|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1991|1991-05-01||||||||Interventional|||A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir|A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir|Completed||N/A|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.059188|2017-02-18 18:22:22.059188
NCT00002250|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura|A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.140053|2017-02-18 18:22:22.140053
NCT00002249|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1991|1991-09-01||||||||Interventional|||A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection|A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.218535|2017-02-18 18:22:22.218535
NCT00002248|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1993|1993-04-01||||||||Interventional|||A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients|A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.299459|2017-02-18 18:22:22.299459
NCT00002247|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy|A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy|Completed||N/A|225||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.392511|2017-02-18 18:22:22.392511
NCT00002246|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-28||2011-04-13|October 1997||1997-10-01|April 2011|2011-04-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex|A Pilot Open Label, Multicenter Study to Evaluate the Role of Stavudine (d4T) in the Treatment of AIDS Dementia Complex|Completed||Phase 3|20||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:22.511199|2017-02-18 18:22:22.511199
NCT00002245|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||April 1999||1999-04-01|August 2000|2000-08-01||||||||Interventional|||A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients|Effect of Amprenavir on Carbohydrate and Lipid Metabolism in Patients With HIV Infection|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.60931|2017-02-18 18:22:22.60931
NCT00002244|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 2001|2001-03-01||||||||Interventional|||A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease|A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pivotal Clinical Study Evaluating the Safety and Efficacy of WF10 (TCDO) Intravenous Solution in the Management of Patients With Late-Stage HIV Disease|Completed||Phase 3|240||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.706713|2017-02-18 18:22:22.706713
NCT00002243|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 2000|2000-07-01||||||||Interventional|||A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment|A Phase 1B Dose-Range Study to Evaluate the Safety, Pharmacokinetics, and Effects of (+)-Calanolide A on Surrogate Markers in HIV-Positive Patients With No Previous Antiretroviral Therapy|Completed||Phase 1|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.816515|2017-02-18 18:22:22.816515
NCT00002241|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 2001|2001-07-01||||||||Interventional|||Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily|A Multicenter, Open-Label, 24-Week Pilot Study to Evaluate the Safety and Efficacy of Indinavir Sulfate 800 Mg b.i.d. in Combination With Ritonavir 100 Mg/d4T/3TC b.i.d. in HIV-Infected Individuals|Unknown status|Active, not recruiting|Phase 2|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:22.907399|2017-02-18 18:22:22.907399
NCT00002240|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-28||2011-04-13|March 1999||1999-03-01|April 2011|2011-04-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Interventional|||Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs|Evaluation of the Safety and Antiviral Efficacy of a Novel HIV-1 Protease Inhibitor, BMS-232632, Alone and in Combination With d4T and ddI as Compared to a Reference Combination Regimen|Completed||Phase 2|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:23.005685|2017-02-18 18:22:23.005685
NCT00002239|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-11-14|||May 1999||1999-05-01|November 2005|2005-11-01||||||||Interventional|||A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults|A Controlled Phase 2 Trial Assessing Three Doses of T-20 in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-1 Infected Adults|Completed||Phase 2|68||Hoffmann-La Roche|||||||||||||||||||2017-02-18 18:22:23.121538|2017-02-18 18:22:23.121538
NCT00002238|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1991|1991-04-01||||||||Interventional|||Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen|Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:23.218573|2017-02-18 18:22:23.218573
NCT00002237|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1999|1999-09-01||||||||Interventional|||A Study of Peldesine (BCX-34) in HIV-Infected Patients|Phase I Placebo-Controlled Study of Oral BCX-34 (Peldesine) in HIV-Infected Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:23.594272|2017-02-18 18:22:23.594272
NCT00002236|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients|An Open-Label, Parallel Group, Pilot Study of Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of BID and TID Regimens of Delavirdine Mesylate, Zidovudine, and Indinavir Sulfate in HIV-1 Infected Individuals|Completed||N/A|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:23.681895|2017-02-18 18:22:23.681895
NCT00002235|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 2000|2000-03-01||||||||Interventional|||A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors|A Phase II, 48-Week, Open-Label Study Designed to Evaluate the Safety, Tolerability, and Efficacy of a Simplified Dosing Regimen of Viracept (Nelfinavir Mesylate) 1250 Mg BID, Crixivan (Indinavir Sulfate) 1200mg q12h, and Sustiva (Efavirenz; DMP-266) 600 Mg q24h for the Treatment of HIV-1 Infection in Non-Nucleoside Reverse Transcriptase Inhibitor and Protease Inhibitor Naive Patients|Completed||Phase 2|6||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:23.7785|2017-02-18 18:22:23.7785
NCT00002234|ClinicalTrials.gov processed this data on February 17, 2017|2001-08-30|2005-06-23||||||November 2004|2004-11-01||||||||Interventional|||Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients|A Phase II, 48 Week, Open-Label Study Designed to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of a Simplified Dosing Regimen of Preveon (Adefovir Dipivoxil; bis-POM PMEA), Videx (Didanosine; ddI), Sustiva (Efavirenz; DMP-266), and Epivir (Lamivudine; 3TC) Administered Once Daily for the Treatment of HIV-1 Infection|Completed||Phase 2|25||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:23.88674|2017-02-18 18:22:23.88674
NCT00002233|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Study of a Combination of Four Drugs in Patients With Recent HIV Infection|A Phase II, 48-Week, Uncontrolled, Open-Label Study Designed to Evaluate the Safety and Efficacy of Quadruple Antiretroviral Therapy (EPIVIR, Abacavir, Amprenavir, and Indinavir) in Subjects Acutely Infected With HIV-1|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:23.981956|2017-02-18 18:22:23.981956
NCT00002232|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Study of GENEVAX-HIV, a Possible Vaccine|GENEVAX-HIV (APL 400-003), a Candidate DNA Vaccine: A Pilot Study of GENEVAX-HIV Given by Intramuscular or Intradermal Administration in HIV Seronegative Volunteers|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:24.074244|2017-02-18 18:22:24.074244
NCT00002231|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 2000|2000-05-01||||||||Interventional|||Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers|GENEVAX-HIV (APL 400-003), a Candidate DNA Vaccine: A Pilot Dose Escalation Study of GENEVAX-HIV Delivered Intramuscularly Using the Biojector 2000 in HIV Seronegative Volunteers|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:24.171958|2017-02-18 18:22:24.171958
NCT00002230|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients|A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients|Completed||Phase 3|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:24.279705|2017-02-18 18:22:24.279705
NCT00002229|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients|A Phase IV, Non-Comparative Study to Evaluate FORTOVASE (Saquinavir) Soft Gel Capsule (SGC) TID Regimen in Combination With Two NRTI's in HIV-1 Infected Women and Men|Completed||Phase 4|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:24.382595|2017-02-18 18:22:24.382595
NCT00002228|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of T-20 in HIV-Positive Adults|A Phase II Evaluation of the Safety, Plasma Pharmacokinetics, and Antiviral Activity of T-20 Administered to HIV-1 Positive Adults By Continuous Subcutaneous Infusion or Subcutaneous Injection|Completed||Phase 2|78||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:24.509431|2017-02-18 18:22:24.509431
NCT00002227|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs|A Phase II, Open-Label, Multicenter Study to Characterize the Effectiveness and Safety of Efavirenz in Combination With Stavudine and Lamivudine in Antiretroviral Therapy-Naive HIV-Infected Patients|Completed||Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:24.620831|2017-02-18 18:22:24.620831
NCT00002226|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 2000|2000-06-01||||||||Interventional|||Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma|A Multicenter, Dose Escalating Study in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma|Completed||N/A|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:24.721504|2017-02-18 18:22:24.721504
NCT00002225|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Efavirenz in Combination With Stavudine and Didanosine|A Phase II, Open-Label, Multicenter Study to Characterize the Effectiveness and Safety of Efavirenz in Combination With Stavudine and Didanosine in Antiretroviral Therapy-Naive HIV-Infected Patients|Completed||Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:24.820463|2017-02-18 18:22:24.820463
NCT00002224|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-13||2011-04-13|March 1999||1999-03-01|April 2011|2011-04-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)|Comparison of HIV RNA Suppression Produced by Triple Regimens Containing Either Didanosine Enteric Coated or Didanosine Formulations Each Administered Once Daily|Completed||Phase 3|120||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:24.92122|2017-02-18 18:22:24.92122
NCT00002223|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients|Ritonavir (ABT-538)/Indinavir Combination Treatment in HIV-Infected Patients Previously Receiving Indinavir 800 mg TID|Completed||N/A|||Abbott|||||f||||||||||||||2017-02-18 18:22:25.049722|2017-02-18 18:22:25.049722
NCT00002222|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS|An Open Label Study of the Safety and Tolerability of Valganciclovir, an Oral Prodrug of Ganciclovir, for the Treatment of Cytomegalovirus Retinitis in Subjects With AIDS|Completed||N/A|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.141116|2017-02-18 18:22:25.141116
NCT00002221|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 2003|2003-06-01||||||||Interventional|||Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma|High Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation for HIV Lymphomas: A Phase IIA Study of Comparative Marking Using a Ribozyme Gene and a Neutral Gene|Completed||Phase 2|5||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.236844|2017-02-18 18:22:25.236844
NCT00002220|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir|Multi-Center, Open-Label Study of the Effect of Indinavir, Efavirenz, and Adefovir Dipivoxil Combination Therapy in Patients Who Have Failed Nelfinavir|Completed||Phase 3|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.340865|2017-02-18 18:22:25.340865
NCT00002219|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children|A Phase I/II, Open-Label, Multi-Center Study of the Pharmacokinetics, Safety, Tolerance and Activity of Two Dose Levels of Adefovir Dipivoxil (ADF) and Nelfinavir When Added to Antiretroviral Therapy for the Treatment of HIV-Infected Pediatric Patients|Unknown status|Active, not recruiting|Phase 2|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.445258|2017-02-18 18:22:25.445258
NCT00002218|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients|A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.535299|2017-02-18 18:22:25.535299
NCT00002217|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs|Combivir, 1592U89, 141W94 Triple Antiretroviral, Experienced Patient Trial|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.613666|2017-02-18 18:22:25.613666
NCT00002216|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment|A Comparison of a Four-Drug Regimen Comprised of 141W94, 1592U89, and Combivir With a Three-Drug Regimen Comprised of Nelfinavir and Combivir in Antiretroviral-Naive HIV-Infected Patients.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.701581|2017-02-18 18:22:25.701581
NCT00002215|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive|A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.800647|2017-02-18 18:22:25.800647
NCT00002214|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||Phase I Trial of S-1153 in Patients With HIV Infection|Phase I Trial of S-1153 in Patients With HIV Infection|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.890961|2017-02-18 18:22:25.890961
NCT00002213|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1998|1998-03-01||||||||Interventional|||The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors|A Phase II Study Evaluating the Safety and Antiviral Activity of Combination Therapy With 1592U89, 141W94 and DMP 266 in HIV-1 Infected Subjects With Detectable HIV-1 Plasma RNA Despite Treatment With a Protease Inhibitor Containing Regimen|Completed||Phase 2|80||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:25.969861|2017-02-18 18:22:25.969861
NCT00002212|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma|Phase II Evaluation of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|27||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.062304|2017-02-18 18:22:26.062304
NCT00002211|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Interventional|||Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients|An Open-Label Randomized Study of Delavirdine Mesylate (DLV, Rescriptor) Plus Nelfinavir (NFV), Didanosine (ddI), and Stavudine (d4T) in Triple and Quadruple Treatment Regimens in HIV-1 Infected Individuals|Completed||N/A|160||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.142371|2017-02-18 18:22:26.142371
NCT00002210|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1998|1998-01-01||||||||Interventional|||A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies|Phase II Study of the Safety, Tolerance, Pharmacokinetics, and Antiviral Effect of Delavirdine Mesylate (Rescriptor), in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1-Infected Neonates, Infants, and Children|Completed||Phase 2|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.301721|2017-02-18 18:22:26.301721
NCT00002209|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1999|1999-12-01||||||||Interventional|||Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy|Multiple Ascending Dose Pharmacokinetics of CPI-1189 (LU 02-584) in Fasted, HIV Infected, Male Volunteers on Combined Reverse Transcriptase and Protease Inhibitor Therapy|Completed||Phase 1|48||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.384308|2017-02-18 18:22:26.384308
NCT00002208|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 2003|2003-02-01||||||||Interventional|||A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC|A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC|Completed||Phase 3|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.463706|2017-02-18 18:22:26.463706
NCT00002207|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-13||2011-04-13|February 2004||2004-02-01|April 2011|2011-04-01|February 2004|Actual|2004-02-01|February 2004|Actual|2004-02-01||Interventional|||A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients|A Randomized, Double-Blind Study of the Antiviral Activity of Once-Daily and Twice-Daily Dosing of Didanosine in Combination With Twice-Daily Dosing of Stavudine in HIV-Infected Subjects|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:26.573298|2017-02-18 18:22:26.573298
NCT00002206|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs|A Phase I/II, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance, Pharmacokinetics, and Anti-HIV Activity of 60 Mg Daily Dose of Adefovir Dipivoxil in HIV-Infected Patients Naive to Anti-Retroviral Therapy|Completed||Phase 1|45||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.682575|2017-02-18 18:22:26.682575
NCT00002205|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen|An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.766399|2017-02-18 18:22:26.766399
NCT00002204|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults|A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults|Completed||Phase 1|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.847904|2017-02-18 18:22:26.847904
NCT00002203|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Two Anti-HIV Drug Combinations|A Randomized, Multicenter Study of Epivir 150 Mg Bid, Retrovir 200 Mg Tid and a Protease Inhibitor Vs 3TC 150 Mg/ZDV 300 Mg Fixed Dose Tablet Given Bid With a Protease Inhibitor in HIV-Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:26.933242|2017-02-18 18:22:26.933242
NCT00002202|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Comparison of 141W94 and Indinavir in HIV-Infected Patients|A Phase III Trial to Compare the Safety and Antiviral Efficacy of 141W94 With Indinavir in Combination With Nucleoside Reverse Transcriptase Inhibitor (NRTI) Therapy, in NRTI-Experienced, Protease Inhibitor (PI)-Naive, HIV-1-Infected Patients.|Completed||Phase 3|460||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:27.027597|2017-02-18 18:22:27.027597
NCT00002201|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients|Safety and Efficacy of Ritonavir (ABT-538) in Combination With Nelfinavir in HIV-Infected Subjects.|Completed||N/A|||Abbott|||||f||||||||||||||2017-02-18 18:22:30.10536|2017-02-18 18:22:30.10536
NCT00002200|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Study of 1592U89 in HIV-Infected Adults|A 1592U89 Open-Label Protocol for Adult Patients With HIV-1 Infection.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.186753|2017-02-18 18:22:30.186753
NCT00002199|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.|A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.|Completed||Phase 3|550||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.269318|2017-02-18 18:22:30.269318
NCT00002198|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients|A Study to Investigate Whether There is a Pharmacokinetic Interaction Between 1592U89 and Ethanol Following Their Co-Administration to HIV-Infected Subjects.|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.355322|2017-02-18 18:22:30.355322
NCT00002197|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Study of 1592U89 in HIV-Infected Children|1592U89 Open-Label Protocol for Pediatric Patients With HIV Infection.|Completed||N/A|250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.436873|2017-02-18 18:22:30.436873
NCT00002196|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study of CI-1012 in HIV-Infected Patients|A Phase I Multiple Oral, Rising-Dose, Tolerance and Pharmacokinetic Trial of CI-1012 in HIV-1-Infected Volunteers.|Completed||Phase 1|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.526106|2017-02-18 18:22:30.526106
NCT00002195|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients|A Phase III Trial to Evaluate the Safety and Antiviral Efficacy of 141W94 in Combination With Retrovir and Epivir Compared to Retrovir and Epivir Alone in Patients With HIV Infection.|Completed||Phase 3|290||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.615361|2017-02-18 18:22:30.615361
NCT00002194|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.|An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.|Completed||Phase 1|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.707196|2017-02-18 18:22:30.707196
NCT00002193|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors|A Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Safety and Efficacy of 141W94 Plus Current Nucleoside Therapy Versus Current Nucleoside Therapy Alone in Protease-Naive, HIV-Infected Children|Completed||Phase 3|210||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.799157|2017-02-18 18:22:30.799157
NCT00002192|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.|Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:30.88398|2017-02-18 18:22:30.88398
NCT00002191|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis|A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:31.250135|2017-02-18 18:22:31.250135
NCT00002190|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients|A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients|Completed||Phase 2|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:31.353877|2017-02-18 18:22:31.353877
NCT00002189|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1998|1998-06-01||||||||Interventional|||Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals|Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:31.447401|2017-02-18 18:22:31.447401
NCT00002188|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma|Phase II Evaluation of Oral ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma.|Completed||Phase 2|27||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:31.544424|2017-02-18 18:22:31.544424
NCT00002187|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis|A Randomized Comparison of Two Dosage Schedules of Intravitreal ISIS 2922 for Patients With Advanced Cytomegalovirus Retinitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:31.620343|2017-02-18 18:22:31.620343
NCT00002186|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1998|1998-02-01||||||||Interventional|||Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)|Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)|Completed||N/A|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:31.734999|2017-02-18 18:22:31.734999
NCT00002185|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3|A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3|Completed||Phase 2|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:31.862603|2017-02-18 18:22:31.862603
NCT00002184|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1998|1998-10-01||||||||Interventional|||A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient|A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 100/mm3 and HIV-1 RNA Copy Numbers >= 5,000 Copies/Ml and Prior RTI Therapy But No Prior PI Therapy|Completed||Phase 2|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:31.953571|2017-02-18 18:22:31.953571
NCT00002183|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection|A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection|Completed||Phase 1|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:32.062252|2017-02-18 18:22:32.062252
NCT00002182|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study of Megestrol Acetate in HIV-Infected Children|Megestrol Acetate For Failure To Thrive In Pediatric HIV|Completed||N/A|25||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:32.150042|2017-02-18 18:22:32.150042
NCT00002181|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1997|1997-11-01||||||||Interventional|||Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS|Open-Label Study of Cidofovir Gel for Acyclovir-Unresponsive Mucocutaneous Herpes Simplex Disease in Patients With AIDS.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:32.229282|2017-02-18 18:22:32.229282
NCT00002180|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1999|1999-09-01||||||||Interventional|||A Study of PMPA in HIV-Infected Patients|A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance, and Pharmacokinetics, and Antiviral Activity of 9-[(R)-2-(Phosphonomethoxy)Propyl] Adenine (PMPA) in HIV-Infected Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:32.330594|2017-02-18 18:22:32.330594
NCT00002179|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection|A Multiclinic, Open Study to Evaluate the Ability of the Combination of Indinavir, Zidovudine and Lamivudine to Result in Sustained Suppression of HIV-1 in Asymptomatic HIV-1 Seropositive Patients|Completed||Phase 4|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:32.414316|2017-02-18 18:22:32.414316
NCT00002178|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients|A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients|Completed||Phase 3|375||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:32.536934|2017-02-18 18:22:32.536934
NCT00002177|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-13|||May 1997||1997-05-01|April 2011|2011-04-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection|A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection|Completed||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:32.628123|2017-02-18 18:22:32.628123
NCT00002176|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-04-13|||May 1997||1997-05-01|April 2011|2011-04-01|March 2000|Actual|2000-03-01|March 2000|Actual|2000-03-01||Interventional|||A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection|A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:32.984313|2017-02-18 18:22:32.984313
NCT00002175|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1999|1999-01-01||||||||Interventional|||Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.|Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.|Completed||Phase 1|46||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.073186|2017-02-18 18:22:33.073186
NCT00002174|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients|Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients|Completed||N/A|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.146053|2017-02-18 18:22:33.146053
NCT00002173|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1998|1998-06-01||||||||Interventional|||An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.|An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.240081|2017-02-18 18:22:33.240081
NCT00002172|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1995|1995-06-01||||||||Interventional|||An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml|An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.31445|2017-02-18 18:22:33.31445
NCT00002171|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Study of Viracept in HIV-Positive Women|A Phase II, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Viracept in Combination With Antiretroviral Therapy in HIV Positive Women With <= 1 Month of Prior Treatment With d4T and/or 3TC|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.384645|2017-02-18 18:22:33.384645
NCT00002170|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)|A Pilot, Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Disseminated Mycobacterium Avium Complex Disease (MAC) in AIDS Patients Who Are Receiving Standard Acute Treatment for This Opportunistic Infection|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.479881|2017-02-18 18:22:33.479881
NCT00002169|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis|A Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Cytomegalovirus (CMV) Retinitis in AIDS Patients Who Are Receiving Standard Induction and Maintenance Therapy for This Infection|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.57268|2017-02-18 18:22:33.57268
NCT00002168|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients|An Open Label, Randomized, Comparative Study of Zerit (d4T) + Videx (ddI) + Crixivan Versus Retrovir (AZT) + Epivir (3TC) + Crixivan in HIV-Infected, Antiretroviral Naive Subjects With CD4 Cell Counts of 200 - 700/mm3 and HIV RNA Baseline Copy Number of >= 10,000 Copies/ml|Completed||N/A|200||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:33.661036|2017-02-18 18:22:33.661036
NCT00002167|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.|Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.|Completed||Phase 2|78||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.772491|2017-02-18 18:22:33.772491
NCT00002166|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Interventional|||An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease|An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.867874|2017-02-18 18:22:33.867874
NCT00002165|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1996|1996-10-01||||||||Interventional|||Viracept Expanded Access Program|Viracept Expanded Access Program|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:33.950888|2017-02-18 18:22:33.950888
NCT00002164|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants|Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants|Completed||Phase 1|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.036566|2017-02-18 18:22:34.036566
NCT00002163|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex|A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.126187|2017-02-18 18:22:34.126187
NCT00002162|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs|A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs|Completed||Phase 2|140||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.230924|2017-02-18 18:22:34.230924
NCT00002161|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1997|1997-05-01||||||||Interventional|||A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3|A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3|Completed||N/A|400||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.361512|2017-02-18 18:22:34.361512
NCT00002160|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1998|1998-03-01||||||||Interventional|||A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain|A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain|Completed||Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.470625|2017-02-18 18:22:34.470625
NCT00002159|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1997|1997-12-01||||||||Interventional|||A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis|A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis|Completed||Phase 3|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.600393|2017-02-18 18:22:34.600393
NCT00002158|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-07-09||||||July 2007|2007-07-01||||||||Interventional|||A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis|Open-Label Compassionate Use of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients|Unknown status|Active, not recruiting|N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.710356|2017-02-18 18:22:34.710356
NCT00002157|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome|Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.793582|2017-02-18 18:22:34.793582
NCT00002156|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1998|1998-12-01||||||||Interventional|||A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )|A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )|Completed||Phase 2|194||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:34.870639|2017-02-18 18:22:34.870639
NCT00002155|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1996|1996-06-01||||||||Interventional|||A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC|A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC|Completed||N/A|600||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.239784|2017-02-18 18:22:35.239784
NCT00002154|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia|Parallel Group, Placebo-Controlled, Tolerability and Safety Study of Thioctic Acid and Deprenyl in HIV Dementia|Completed||Phase 2|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.334338|2017-02-18 18:22:35.334338
NCT00002153|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1999|1999-05-01||||||||Interventional|||Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders|Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders|Completed||Phase 1|25||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.423117|2017-02-18 18:22:35.423117
NCT00002152|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study of WF 10 IV Solution in Patients With Advanced HIV Disease|Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of WF 10 IV Solution ( TCDO ) in the Management of Patients With Advanced HIV Disease|Completed||Phase 2|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.507164|2017-02-18 18:22:35.507164
NCT00002151|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients|A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients|Completed||Phase 2|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.590449|2017-02-18 18:22:35.590449
NCT00002150|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients|A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients|Completed||Phase 2|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.697742|2017-02-18 18:22:35.697742
NCT00002149|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1997|1997-09-01||||||||Interventional|||Acupuncture and Herbal Treatment of Chronic HIV Sinusitis|Acupuncture and Herbal Treatment of Chronic HIV Sinusitis|Completed||N/A|40||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.802774|2017-02-18 18:22:35.802774
NCT00002148|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia|Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia|Completed||Phase 1|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.891712|2017-02-18 18:22:35.891712
NCT00002147|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.|Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:35.980205|2017-02-18 18:22:35.980205
NCT00002146|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1997|1997-01-01||||||||Interventional|||Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study|Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study|Completed||Phase 4|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.078435|2017-02-18 18:22:36.078435
NCT00002145|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease|Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease|Completed||Phase 3|145||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.164862|2017-02-18 18:22:36.164862
NCT00002144|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment|The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment|Completed||Phase 1|12||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.276722|2017-02-18 18:22:36.276722
NCT00002143|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Interventional|||Treatment of Psoriasis Using Acitretin in HIV-Positive Patients|Treatment of Psoriasis Using Acitretin in HIV-Positive Patients|Completed||Phase 3|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.38674|2017-02-18 18:22:36.38674
NCT00002142|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1995|1995-10-01||||||||Interventional|||An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS|An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS|Completed||N/A|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.47727|2017-02-18 18:22:36.47727
NCT00002141|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23|||July 1994||1994-07-01|October 1994|1994-10-01||||||||Interventional|||A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89|A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89|Completed||Phase 1|18||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.577114|2017-02-18 18:22:36.577114
NCT00002140|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients|A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.665248|2017-02-18 18:22:36.665248
NCT00002139|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.|Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.785271|2017-02-18 18:22:36.785271
NCT00002138|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.|A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.866974|2017-02-18 18:22:36.866974
NCT00002137|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4|A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:36.945102|2017-02-18 18:22:36.945102
NCT00002136|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days|A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.035982|2017-02-18 18:22:37.035982
NCT00002135|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1995|1995-11-01||||||||Interventional|||An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access|An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.12864|2017-02-18 18:22:37.12864
NCT00002134|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis|A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis|Completed||N/A|450||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.2156|2017-02-18 18:22:37.2156
NCT00002133|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.|An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.324167|2017-02-18 18:22:37.324167
NCT00002132|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.|Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.428975|2017-02-18 18:22:37.428975
NCT00002131|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma|A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma|Completed||Phase 2|28||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.528152|2017-02-18 18:22:37.528152
NCT00002130|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons|A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.62563|2017-02-18 18:22:37.62563
NCT00002129|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3|A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3|Completed||Phase 1|36||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.706388|2017-02-18 18:22:37.706388
NCT00002128|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1994|1994-07-01||||||||Interventional|||Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients|Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients|Completed||Phase 1|15||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.790976|2017-02-18 18:22:37.790976
NCT00002127|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome|A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome|Completed||Phase 2|75||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.879262|2017-02-18 18:22:37.879262
NCT00002126|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.|A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection|Completed||Phase 2|250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:37.982613|2017-02-18 18:22:37.982613
NCT00002125|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1997|1997-06-01||||||||Interventional|||A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)|A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)|Completed||Phase 4|112||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:38.083096|2017-02-18 18:22:38.083096
NCT00002124|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1997|1997-07-01||||||||Interventional|||A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3|A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3|Completed||Phase 3|1250||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:38.439155|2017-02-18 18:22:38.439155
NCT00002123|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1996|1996-11-01||||||||Interventional|||A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3|A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:38.642461|2017-02-18 18:22:38.642461
NCT00002107|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1995|1995-03-01||||||||Interventional|||A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients|A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.241578|2017-02-18 18:22:40.241578
NCT00002122|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients|A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients|Completed||Phase 3|720||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:38.819939|2017-02-18 18:22:38.819939
NCT00002121|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea|Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:38.924189|2017-02-18 18:22:38.924189
NCT00002120|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia|Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia|Completed||Phase 1|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.009341|2017-02-18 18:22:39.009341
NCT00002119|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection|A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.095289|2017-02-18 18:22:39.095289
NCT00002118|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1997|1997-08-01||||||||Interventional|||An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies|An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies|Completed||N/A|600||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.180982|2017-02-18 18:22:39.180982
NCT00002117|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection|A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection|Completed||Phase 3|528||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.288931|2017-02-18 18:22:39.288931
NCT00002116|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1995|1995-12-01||||||||Interventional|||A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS|A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS|Completed||Phase 1|30||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.408003|2017-02-18 18:22:39.408003
NCT00002115|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1995|1995-11-01||||||||Interventional|||A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.|A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.|Completed||Phase 1|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.512823|2017-02-18 18:22:39.512823
NCT00002114|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1994|1994-01-01|January 1994||1994-01-01|||||Interventional|||A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides|A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides|Completed||Phase 2|125||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.600714|2017-02-18 18:22:39.600714
NCT00002113|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.|A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.|Completed||N/A|64||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.669559|2017-02-18 18:22:39.669559
NCT00002112|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome|Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.759712|2017-02-18 18:22:39.759712
NCT00002111|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1995|1995-05-01||||||||Interventional|||A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.|A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.|Completed||Phase 1|32||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.845968|2017-02-18 18:22:39.845968
NCT00002110|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1995|1995-10-01||||||||Interventional|||A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease|A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease|Completed||Phase 2|300||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:39.930656|2017-02-18 18:22:39.930656
NCT00002109|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy|Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT/ddI or AZT/ddC) Anti-Retroviral Therapy|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.023049|2017-02-18 18:22:40.023049
NCT00002106|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1994|1994-05-01||||||||Interventional|||A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3|A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3|Completed||Phase 2|104||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.328454|2017-02-18 18:22:40.328454
NCT00002105|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1996|1996-01-01||||||||Interventional|||Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma|Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma|Completed||Phase 3|220||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.424515|2017-02-18 18:22:40.424515
NCT00002104|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV|Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.523457|2017-02-18 18:22:40.523457
NCT00002103|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1994|1994-01-01||||||||Interventional|||A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia|A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.624334|2017-02-18 18:22:40.624334
NCT00002102|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1994|1994-01-01||||||||Interventional|||A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.|A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.725126|2017-02-18 18:22:40.725126
NCT00002101|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1999|1999-06-01||||||||Interventional|||A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo|A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo|Completed||Phase 3|450||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.819482|2017-02-18 18:22:40.819482
NCT00002100|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||Phase I/II Study of Curdlan Sulfate|Phase I/II Study of Curdlan Sulfate|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:40.956659|2017-02-18 18:22:40.956659
NCT00002099|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1994|1994-07-01||||||||Interventional|||Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients|Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients|Unknown status|Active, not recruiting|Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:41.055708|2017-02-18 18:22:41.055708
NCT00002098|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1995|1995-03-01||||||||Interventional|||Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients|Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients|Completed||Phase 1|50||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:41.144581|2017-02-18 18:22:41.144581
NCT00002097|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.|A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:41.234533|2017-02-18 18:22:41.234533
NCT00002096|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1993|1993-11-01||||||||Interventional|||A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine|A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine|Completed||Phase 1|24||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:41.31636|2017-02-18 18:22:41.31636
NCT00002095|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1993|1993-11-01||||||||Interventional|||A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus|A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus|Completed||N/A|700||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:41.406834|2017-02-18 18:22:41.406834
NCT00002094|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1993|1993-02-01||||||||Interventional|||Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E|Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:41.780759|2017-02-18 18:22:41.780759
NCT00002093|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.|A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:41.865757|2017-02-18 18:22:41.865757
NCT00002092|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection|A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:41.978249|2017-02-18 18:22:41.978249
NCT00002091|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1993|1993-10-01||||||||Interventional|||An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent|An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.075799|2017-02-18 18:22:42.075799
NCT00002090|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)|An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.160724|2017-02-18 18:22:42.160724
NCT00002089|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy|An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.246128|2017-02-18 18:22:42.246128
NCT00002088|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1996|1996-03-01||||||||Interventional|||Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial|Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial|Completed||Phase 2|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.345724|2017-02-18 18:22:42.345724
NCT00002087|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1994|1994-04-01||||||||Interventional|||Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals|Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.435639|2017-02-18 18:22:42.435639
NCT00002086|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1993|1993-10-01||||||||Interventional|||A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection|A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection|Completed||Phase 2|256||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.530143|2017-02-18 18:22:42.530143
NCT00002085|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1998|1998-07-01||||||||Interventional|||A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy|A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.637364|2017-02-18 18:22:42.637364
NCT00002084|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients|A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.723573|2017-02-18 18:22:42.723573
NCT00002083|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS|Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.860576|2017-02-18 18:22:42.860576
NCT00002082|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study|Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:42.947018|2017-02-18 18:22:42.947018
NCT00002081|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1992|1992-06-01||||||||Interventional|||Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease|Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.033154|2017-02-18 18:22:43.033154
NCT00002080|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2003|2003-04-01||||||||Interventional|||Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study|Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.134104|2017-02-18 18:22:43.134104
NCT00002079|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)|Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.221534|2017-02-18 18:22:43.221534
NCT00002078|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1993|1993-11-01||||||||Interventional|||Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection|Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.320406|2017-02-18 18:22:43.320406
NCT00002077|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.418768|2017-02-18 18:22:43.418768
NCT00002076|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.499256|2017-02-18 18:22:43.499256
NCT00002075|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.594185|2017-02-18 18:22:43.594185
NCT00002074|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1990|1990-05-01||||||||Interventional|||Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome|Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.67622|2017-02-18 18:22:43.67622
NCT00002073|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.791727|2017-02-18 18:22:43.791727
NCT00002072|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.86746|2017-02-18 18:22:43.86746
NCT00002071|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:43.939121|2017-02-18 18:22:43.939121
NCT00002070|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1991|1991-05-01||||||||Interventional|||Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis|Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis|Completed||Phase 3|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.018618|2017-02-18 18:22:44.018618
NCT00002069|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1989|1989-07-01||||||||Interventional|||A Study of DTC in Patients With AIDS and AIDS Related Complex|A Study of DTC in Patients With AIDS and AIDS Related Complex|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.1094|2017-02-18 18:22:44.1094
NCT00002068|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.276924|2017-02-18 18:22:44.276924
NCT00002067|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia|Phase III Randomized Double-Blind Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia|Completed||Phase 3|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:44.369934|2017-02-18 18:22:44.369934
NCT00002066|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1989|1989-11-01||||||||Interventional|||Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.466688|2017-02-18 18:22:44.466688
NCT00002065|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Depot Disulfiram for AIDS and ARC|Depot Disulfiram for AIDS and ARC|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.550056|2017-02-18 18:22:44.550056
NCT00002064|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse|Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.628849|2017-02-18 18:22:44.628849
NCT00002063|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)|Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.712213|2017-02-18 18:22:44.712213
NCT00002062|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1991|1991-10-01||||||||Interventional|||"Open-Label Compassionate Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients"|"Open-Label Compassionate Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients"|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.799617|2017-02-18 18:22:44.799617
NCT00002061|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy|A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.875665|2017-02-18 18:22:44.875665
NCT00002060|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)|A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:44.978408|2017-02-18 18:22:44.978408
NCT00002059|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1989|1989-06-01||||||||Interventional|||A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers|A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:45.068505|2017-02-18 18:22:45.068505
NCT00002058|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1990|1990-12-01||||||||Interventional|||A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease|A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.160021|2017-02-18 18:22:48.160021
NCT00002057|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC|Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC|Completed||N/A|||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:48.250469|2017-02-18 18:22:48.250469
NCT00002056|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS|A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.341964|2017-02-18 18:22:48.341964
NCT00002055|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP|A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.424211|2017-02-18 18:22:48.424211
NCT00002054|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1989|1989-10-01||||||||Interventional|||A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients|A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.509361|2017-02-18 18:22:48.509361
NCT00002053|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1989|1989-10-01||||||||Interventional|||A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP|A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.594904|2017-02-18 18:22:48.594904
NCT00002052|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients|Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.681759|2017-02-18 18:22:48.681759
NCT00002051|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1989|1989-11-01||||||||Interventional|||Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.773971|2017-02-18 18:22:48.773971
NCT00002050|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.850394|2017-02-18 18:22:48.850394
NCT00002049|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1989|1989-08-01||||||||Interventional|||Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:48.931402|2017-02-18 18:22:48.931402
NCT00002048|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)|The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:49.010955|2017-02-18 18:22:49.010955
NCT00002047|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1990|1990-05-01||||||||Interventional|||Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure|Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:49.383838|2017-02-18 18:22:49.383838
NCT00002046|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1990|1990-05-01||||||||Interventional|||A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC|A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:49.460765|2017-02-18 18:22:49.460765
NCT00002045|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Prospective Double-Blind Study of Retrovir in Early HIV Infection|A Prospective Double-Blind Study of Retrovir in Early HIV Infection|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:49.557206|2017-02-18 18:22:49.557206
NCT00002044|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases|A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:49.635328|2017-02-18 18:22:49.635328
NCT00002043|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)|Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:49.716922|2017-02-18 18:22:49.716922
NCT00002042|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1989|1989-12-01||||||||Interventional|||A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia|A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:49.797178|2017-02-18 18:22:49.797178
NCT00002041|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-10-01||||||October 2007|2007-10-01||||||||Interventional|||Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients|Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:49.891946|2017-02-18 18:22:49.891946
NCT00002040|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:49.978636|2017-02-18 18:22:49.978636
NCT00002039|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1991|1991-03-01||||||||Interventional|||An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients|An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:50.064552|2017-02-18 18:22:50.064552
NCT00002038|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1996|1996-06-01||||||||Interventional|||Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy|Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:50.154693|2017-02-18 18:22:50.154693
NCT00002037|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1991|1991-05-01||||||||Interventional|||Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study|Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study|Completed||N/A|15||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:50.241948|2017-02-18 18:22:50.241948
NCT00002036|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)|Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)|Completed||Phase 1|12||Abbott|||||f||||||||||||||2017-02-18 18:22:50.338258|2017-02-18 18:22:50.338258
NCT00002035|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-08-04||||||August 2011|2011-08-01|April 1992|Actual|1992-04-01|||||Interventional|||Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine|Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine|Completed||N/A|300||Bristol-Myers Squibb|||||||||||||||||||2017-02-18 18:22:50.423907|2017-02-18 18:22:50.423907
NCT00002034|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1992|1992-01-01||||||||Interventional|||A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS|A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS|Completed||N/A|100||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:50.550192|2017-02-18 18:22:50.550192
NCT00002033|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1991|1991-02-01||||||||Interventional|||A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease|A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:50.635096|2017-02-18 18:22:50.635096
NCT00002032|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1992|1992-01-01||||||||Interventional|||Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial|Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial|Completed||N/A|750||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:50.728004|2017-02-18 18:22:50.728004
NCT00002031|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1990|1990-02-01||||||||Interventional|||Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)|Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:50.839938|2017-02-18 18:22:50.839938
NCT00002030|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1989|1989-11-01||||||||Interventional|||An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients|An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:50.916427|2017-02-18 18:22:50.916427
NCT00002029|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-19||||||February 2009|2009-02-01||||||||Interventional|||Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent|Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent|Completed||N/A|||Abbott|||||f||||||||||||||2017-02-18 18:22:51.263046|2017-02-18 18:22:51.263046
NCT00002028|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-08-15||||||August 2007|2007-08-01||||||||Interventional|||A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)|A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)|Completed||N/A|||Bristol-Myers Squibb|||||f||||||||||||||2017-02-18 18:22:51.349271|2017-02-18 18:22:51.349271
NCT00002027|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1990|1990-06-01||||||||Interventional|||Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)|Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:51.442885|2017-02-18 18:22:51.442885
NCT00002026|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1990|1990-05-01||||||||Interventional|||Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)|Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:51.531723|2017-02-18 18:22:51.531723
NCT00002025|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient|Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:51.617673|2017-02-18 18:22:51.617673
NCT00002024|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1989|1989-09-01||||||||Interventional|||Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections|Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:51.696712|2017-02-18 18:22:51.696712
NCT00002023|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2|An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:51.789953|2017-02-18 18:22:51.789953
NCT00002022|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1991|1991-02-01||||||||Interventional|||Treatment Program for Anemia in AIDS Patients|Treatment Program for Anemia in AIDS Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:51.873569|2017-02-18 18:22:51.873569
NCT00002021|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1990|1990-10-01||||||||Interventional|||An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies|An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:51.949256|2017-02-18 18:22:51.949256
NCT00002020|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1992|1992-02-01||||||||Interventional|||Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC|Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARC|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.033554|2017-02-18 18:22:52.033554
NCT00002019|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1999|1999-11-01||||||||Interventional|||Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome|Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.127269|2017-02-18 18:22:52.127269
NCT00002018|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects|Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects|Completed||N/A|60||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.315695|2017-02-18 18:22:52.315695
NCT00002017|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2|Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.391049|2017-02-18 18:22:52.391049
NCT00002016|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1993|1993-04-01||||||||Interventional|||A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis|A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.480641|2017-02-18 18:22:52.480641
NCT00002015|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children|An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children|Completed||N/A|20||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.580091|2017-02-18 18:22:52.580091
NCT00002014|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1991|1991-08-01||||||||Interventional|||A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)|A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.672846|2017-02-18 18:22:52.672846
NCT00002013|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1990|1990-12-01||||||||Interventional|||A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients|A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.761043|2017-02-18 18:22:52.761043
NCT00002012|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1993|1993-03-01||||||||Interventional|||Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients|Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients|Completed||N/A|45||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.847727|2017-02-18 18:22:52.847727
NCT00002011|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1990|1990-07-01||||||||Interventional|||The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex|The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:52.934053|2017-02-18 18:22:52.934053
NCT00002010|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1992|1992-02-01||||||||Interventional|||Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis|Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.022011|2017-02-18 18:22:53.022011
NCT00002009|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1988|1988-06-01||||||||Interventional|||A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia|A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.104631|2017-02-18 18:22:53.104631
NCT00002008|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1989|1989-01-01||||||||Interventional|||An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia|An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.183125|2017-02-18 18:22:53.183125
NCT00002007|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia|A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.265436|2017-02-18 18:22:53.265436
NCT00002006|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility|A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.357772|2017-02-18 18:22:53.357772
NCT00002005|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex|A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.435574|2017-02-18 18:22:53.435574
NCT00002004|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1990|1990-01-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex|A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.506699|2017-02-18 18:22:53.506699
NCT00002003|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1992|1992-03-01||||||||Interventional|||Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas|Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.596107|2017-02-18 18:22:53.596107
NCT00002002|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1992|1992-07-01||||||||Interventional|||A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome|A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.678336|2017-02-18 18:22:53.678336
NCT00002001|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 1991|1991-09-01||||||||Interventional|||The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease|The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.755099|2017-02-18 18:22:53.755099
NCT00002000|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1996|1996-04-01||||||||Interventional|||A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients|A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:53.8392|2017-02-18 18:22:53.8392
NCT00001999|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1993|1993-04-01||||||||Interventional|||A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS|A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.227218|2017-02-18 18:22:54.227218
NCT00001998|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1992|1992-11-01||||||||Interventional|||Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)|Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.316664|2017-02-18 18:22:54.316664
NCT00001997|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1991|1991-07-01||||||||Interventional|||Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals|Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.400625|2017-02-18 18:22:54.400625
NCT00001996|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||May 1992|1992-05-01||||||||Interventional|||A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole|A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.487262|2017-02-18 18:22:54.487262
NCT00001995|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1992|1992-11-01||||||||Interventional|||A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS|A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS|Completed||N/A|200||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.605601|2017-02-18 18:22:54.605601
NCT00001994|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1992|1992-03-01||||||||Interventional|||A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine|A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.717164|2017-02-18 18:22:54.717164
NCT00001993|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1992|1992-02-01||||||||Interventional|||Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3|Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3|Completed||Phase 2|120||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.823737|2017-02-18 18:22:54.823737
NCT00001992|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 1992|1992-08-01||||||||Interventional|||A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers|A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers|Completed||Phase 1|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.909418|2017-02-18 18:22:54.909418
NCT00001991|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2003|2003-04-01||||||||Interventional|||A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia|A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:54.98996|2017-02-18 18:22:54.98996
NCT00001990|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1993|1993-04-01||||||||Interventional|||An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine|An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine|Completed||N/A|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:55.073483|2017-02-18 18:22:55.073483
NCT00001989|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1992|1992-10-01||||||||Interventional|||A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin|A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin|Completed||Phase 2|||NIH AIDS Clinical Trials Information Service|||||f||||||||||||||2017-02-18 18:22:55.151339|2017-02-18 18:22:55.151339
NCT00001987|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2017-01-24|||January 30, 1976||1976-01-30|January 12, 2017|2017-01-12||||||||Observational|||Genetic Studies of Insulin and Diabetes|Natural History of Disorders of Insulin Resistance|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:55.245916|2017-02-18 18:22:55.245916
NCT00001986|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2008-03-03|||January 2000||2000-01-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||1-Octanol to Treat Essential Tremor|Double-Blind, Placebo-Controlled, Single-Dose Trial of 1-Octanol in Essential Tremor|Completed||Phase 1|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:55.351917|2017-02-18 18:22:55.351917
NCT00001985|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-26|2008-03-04|||January 2000||2000-01-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus|Multi-Center Study to Determine Whether CD 152 Gene Polymorphisms Associated With Susceptibility to Type-1-Diabetes Mellitus (T1DM) Correspond With Abnormalities in T Cell Function|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:55.438373|2017-02-18 18:22:55.438373
NCT00001984|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-26|2016-09-22|2010-09-13||November 1999||1999-11-01|September 2016|2016-09-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys|Tolerance Induction Following Human Renal Transplantation Using Treatment With a Humanized Monoclonal Antibody Against CD52 (Campath-1H)|Completed||Phase 2|5|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 18:22:55.522247|2017-02-18 18:22:55.522247
NCT00001983|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-26|2008-03-03|||January 2000||2000-01-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||Eligibility Screening for National Institute of Dental and Craniofacial Research Studies|Screening Protocol to Evaluate Patients for Approved Studies|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:55.936197|2017-02-18 18:22:55.936197
NCT00001982|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2008-03-03|||June 1993||1993-06-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Observational|||History of Hepatitis C in Volunteer Blood Donors|Natural History of Chronic Hepatitis C Among Volunteer Blood Donors|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.010068|2017-02-18 18:22:56.010068
NCT00001981|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2017-01-24|||April 15, 1985||1985-04-15|June 21, 2016|2016-06-21||||||||Observational|||The Treatment and Natural History of Acromegaly|Acromegaly Treatment and Natural History|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.084798|2017-02-18 18:22:56.084798
NCT00001979|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-20|2017-01-24|||April 13, 1992||1992-04-13|August 25, 2016|2016-08-25||||||||Observational|||Immune System Related Kidney Disease|Studies of Immunologically-Mediated Kidney Diseases|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.178832|2017-02-18 18:22:56.178832
NCT00001978|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-20|2017-01-24|||August 24, 1989||1989-08-24|January 4, 2017|2017-01-04||||||||Observational|||Determination of Kidney Function|Determination of Glomerular Filtration Rate, Effective Renal Plasma Flow and Glomerular Capillary Wall Permselectivity|Recruiting||N/A|9999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.285546|2017-02-18 18:22:56.285546
NCT00001977|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-20|2008-03-03|||January 2000||2000-01-01|January 2000|2000-01-01|April 2001||2001-04-01|||||Observational|||The Effect of Acetylcholine on Memory and Attention|Cholinergic Modulation of Human Memory and Attention: Functional Neuroimaging Studies|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.395645|2017-02-18 18:22:56.395645
NCT00001976|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-20|2008-03-03|||January 2000||2000-01-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection|CMV Real-Time PCR Versus PP65 Antigenemia in Diagnosing Cytomegalovirus Disease in Hematopoietic Stem Cell Transplant Patients|Completed||N/A|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.487331|2017-02-18 18:22:56.487331
NCT00001975|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-20|2017-02-02|||January 18, 2000||2000-01-18|January 24, 2017|2017-01-24||||||||Observational|||Study of Skin Tumors in Tuberous Sclerosis|Cutaneous Tumorigenesis in Patients With Tuberous Sclerosis|Recruiting||N/A|130|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.574253|2017-02-18 18:22:56.574253
NCT00001973|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2017-01-24|||December 18, 1996||1996-12-18|December 12, 2008|2008-12-12|December 12, 2008||2008-12-12|||||Observational|||Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome|Studies on Tissues From Patients With Fibrous Dysplasia of Bone/McCune-Albright Syndrome and Other Disorders of Calcified Tissues|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.679692|2017-02-18 18:22:56.679692
NCT00001972|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||September 1994||1994-09-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||PET Scan of Brain Metabolism in Relation to Age and Disease|Positron Emission Tomography Imaging of Human Brain Phospholipid Metabolism in Relation to Age and Disease|Completed||N/A|123||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.753782|2017-02-18 18:22:56.753782
NCT00001971|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2017-01-24|||September 9, 1991||1991-09-09|January 3, 2017|2017-01-03||||||||Observational|||Evaluation of Patients With Liver Disease|Evaluation of Patients With Liver Disease|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.840873|2017-02-18 18:22:56.840873
NCT00001969|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2017-01-24|||December 30, 1999||1999-12-30|January 19, 2007|2007-01-19|January 19, 2007||2007-01-19|||||Observational|||Heart Disease Risk Factors in Major Depression|Factors in Susceptibility to Ischemic Heart Disease in Major Depression: Documentation of Insulin Resistance in Patients With Major Depression Utilizing the Hyperinsulinemic Euglycemic Glucose Clamp|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:56.946396|2017-02-18 18:22:56.946396
NCT00001968|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||January 2000||2000-01-01|December 1999|1999-12-01|November 2000||2000-11-01|||||Interventional|||Once-Daily Drug Regimen for HIV-Infected Patients|A Pilot Study of Once-Daily Therapy With Amprenavir, Ritonavir, Lamivudine and Abacavir in HIV-Infected, Antiretroviral-Naive Patients|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:57.043378|2017-02-18 18:22:57.043378
NCT00001967|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Interventional|||Intermittent Versus Continuous Medication in the Treatment of HIV|Immunologic and Virologic Studies of Intermittent Versus Continuous HAART in the Treatment of HIV Disease|Completed||Phase 4|123||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:57.136772|2017-02-18 18:22:57.136772
NCT00001966|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||January 2000||2000-01-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome|A Pilot Study of Mind-Body Therapy for Chronic Pain in Ehlers-Danlos Syndrome|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:57.220244|2017-02-18 18:22:57.220244
NCT00001965|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|November 1999|1999-11-01|February 2001||2001-02-01|||||Interventional|||Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)|Double Blind Placebo Controlled Study of Cyclosporin A in Patients With Left Ventricular Hypertrophy Caused by Sarcomeric Gene Mutations|Completed||Phase 2|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:57.302481|2017-02-18 18:22:57.302481
NCT00001964|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2017-01-24|||December 1, 1999||1999-12-01|May 6, 2016|2016-05-06|May 12, 2015|Actual|2015-05-12|December 9, 2003|Actual|2003-12-09||Interventional|||Combination Therapy of Severe Aplastic Anemia|Treatment of Severe Aplastic Anemia With Combined Immunosuppression: Antithymocyte Globulin (ATG) and Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF)|Completed||Phase 2|104|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:22:57.390433|2017-02-18 18:22:57.390433
NCT00001963|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects|Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects|Completed||Phase 1|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:57.498055|2017-02-18 18:22:57.498055
NCT00001901|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|March 2005|2005-03-01|March 2005||2005-03-01|||||Interventional|||Etanercept to Treat Wegener's Granulomatosis|Phase I/II Trial of TNFR:Fc (Etanercept) in Patients With Wegener's Granulomatosis|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:03.720628|2017-02-18 18:23:03.720628
NCT00001962|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2015-04-28|2011-04-20||November 1999||1999-11-01|April 2015|2015-04-01|September 2010|Actual|2010-09-01|August 2009|Actual|2009-08-01||Interventional|||A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure|A Pilot Study of Recombinant Humanized Anti-Interleukin (IL-2) Receptor Antibody (Daclizumab) in Patients With Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia|Terminated||Phase 2|100|Actual|National Institutes of Health Clinical Center (CC)||1||DSMB recommended closing the study and publishing the results|f||||t||||||||||2017-02-18 18:22:57.611736|2017-02-18 18:22:57.611736
NCT00001961|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Interventional|||MRI Evaluation of Chest Pain|MRI Evaluation of Chest Pain Compatible With Myocardial Ischemia|Completed||Phase 2|360||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:58.203967|2017-02-18 18:22:58.203967
NCT00001960|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart Muscle|Controlled Cross-Over Study of DDD Pacemaker Therapy in Symptomatic Children With Obstructive Hypertrophic Cardiomyopathy|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:58.293958|2017-02-18 18:22:58.293958
NCT00001959|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2014-05-16|2010-06-16||December 1999||1999-12-01|April 2012|2012-04-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Interventional|||Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)|Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study|Completed||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)|No control group, measurement imprecision, results may not applicable to all patients with FSGS, needs histologic evidence to support our findings, Optimal dosage needs to be identified.|1|||f||||f||||||||||2017-02-18 18:22:58.388755|2017-02-18 18:22:58.388755
NCT00001958|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|February 2002|2002-02-01|February 2002||2002-02-01|||||Interventional|||Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)|Effect of Hydroxyurea on the Level of Ineffective Erythropoiesis, Transfusion Requirement, and Fetal Hemoglobin Synthesis in Patients With Beta-Thalassemia-Intermedia|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:58.720992|2017-02-18 18:22:58.720992
NCT00001957|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||Testing a Possible Cause of Reduced Ability of Children to Process Speech in Noise|TEOAE Suppression in Children With Auditory Processing Difficulty|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:58.811454|2017-02-18 18:22:58.811454
NCT00001956|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2006-06-29|||January 2000||2000-01-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Influence of Genetics in Pain Sensitivity||Completed||Phase 2|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:58.892848|2017-02-18 18:22:58.892848
NCT00001955|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)|The Role of Cytokines as Inflammatory Mediators in Painful Temporomandibular Joints|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:58.976832|2017-02-18 18:22:58.976832
NCT00001954|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Etanercept Therapy for Sjogren's Syndrome|Etanercept Therapy for Sjogren's Syndrome|Completed||Phase 2|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:59.069248|2017-02-18 18:22:59.069248
NCT00001953|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers|Basal and Stimulated Somatostatin Plasma Levels in Patients With Primary Sjogren's Syndrome and in Control Subjects|Completed||N/A|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:59.167662|2017-02-18 18:22:59.167662
NCT00001952|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Observational|||Using a Narcotic to Enhance the Numbing Effect of the Local Anesthetic Lidocaine on Inflamed Molar Teeth|Analgesic Effects of Peripherally Administered Opioids in a Clinical Model of Chronic Inflammation|Completed||N/A|275||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:59.453466|2017-02-18 18:22:59.453466
NCT00001951|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2007-02-24|||December 1999||1999-12-01|October 2006|2006-10-01|October 2006||2006-10-01|||||Interventional|||Hormone Replacement in Young Women With Premature Ovarian Failure|Hormone Replacement in Young Women With Premature Ovarian Failure|Completed||Phase 2|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:59.537779|2017-02-18 18:22:59.537779
NCT00001950|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2017-01-24|||December 14, 1999||1999-12-14|May 23, 2012|2012-05-23|May 23, 2012||2012-05-23|||||Observational|||The Development of Categorization|The Development of Categorization|Completed||N/A|219|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:59.626707|2017-02-18 18:22:59.626707
NCT00001948|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|February 2002|2002-02-01|February 2002||2002-02-01|||||Observational|||A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy|A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:59.72669|2017-02-18 18:22:59.72669
NCT00001946|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Interventional|||Comparison of Magnetic Resonance Angiography and Standard Angiography in Diagnosing Atherosclerosis|A Comparison of Contrast Enhanced Magnetic Resonance Angiography (MRA) and Conventional Angiography in the Diagnosis of Atherosclerotic Disease: A Pilot Study|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:59.820125|2017-02-18 18:22:59.820125
NCT00001944|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|December 2000|2000-12-01|June 2001||2001-06-01|||||Interventional|||Vinorelbine and XR9576 to Treat Cancer|A Clinical Trial of the P-Glycoprotein Antagonist, XR9576, in Combination With Vinorelbine in Patients With Cancer: Analysis of the Interaction Between XR9576 and Vinorelbine|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:22:59.905859|2017-02-18 18:22:59.905859
NCT00001252|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-14|||July 5, 1990||1990-07-05|January 27, 2017|2017-01-27||||||||Observational|||Human Movement Database|A Rigid Body Database on Human Movement|Recruiting||N/A|999999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:12.847615|2017-02-18 18:24:12.847615
NCT00001941|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2012-08-13|2012-04-23||December 1999||1999-12-01|August 2012|2012-08-01|February 2011|Actual|2011-02-01|February 2011|Actual|2011-02-01||Interventional|||Anti-Tac for Treatment of Leukemia|A Phase I/II Study of the Efficacy and Toxicity of Humanized Anti-Tac (Zenapax(Trademark)) in the Therapy of Tac-Expressing Adult T-Cell Leukemia|Completed||Phase 1/Phase 2|34|Actual|National Institutes of Health Clinical Center (CC)|Study was closed to accrual since the cessation of the production of daclizumab.|5|||f||||f||||||||||2017-02-18 18:22:59.995888|2017-02-18 18:22:59.995888
NCT00001940|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||December 1999||1999-12-01|November 2000|2000-11-01|July 2001||2001-07-01|||||Interventional|||Voriconazole to Treat Fungal Infections|An Open Label, Non-Comparative, Multi-Center Phase III Trial of the Efficacy, Safety, and Toleration of Extended Voriconazole in the Treatment of Invasive Fungal Infections|Completed||Phase 3|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:00.445546|2017-02-18 18:23:00.445546
NCT00001938|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2017-01-24|||November 16, 1999||1999-11-16|September 23, 2016|2016-09-23||||||||Observational|||A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)|A Pilot Study of Proteomic Evaluation of Epithelial Ovarian Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile Associated With Relapse|Completed||N/A|26|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:00.531845|2017-02-18 18:23:00.531845
NCT00001937|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2008-03-03|||November 1999||1999-11-01|November 1999|1999-11-01|December 2000||2000-12-01|||||Interventional|||Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients|A Phase III, Randomized, Double-Blind, Comparative Trial of FK463 Versus Fluconazole for Prophylaxis of Fungal Infections in Patients Undergoing a Hematopoetic Stem Cell Transplant|Completed||Phase 3|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:00.6325|2017-02-18 18:23:00.6325
NCT00001936|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 28, 1999||1999-09-28|August 18, 2009|2009-08-18||||August 18, 2009|Actual|2009-08-18||Observational|||Electrical Muscle Stimulation to Aid Swallowing in Dysphagia|Feasibility of Neuromuscular Stimulation for Laryngeal Elevation During Swallowing|Completed||N/A|155||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:00.735097|2017-02-18 18:23:00.735097
NCT00001934|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2011-08-04|||September 1999||1999-09-01|August 2011|2011-08-01|September 2008|Actual|2008-09-01|August 2005|Actual|2005-08-01||Interventional|||Zenapax to Treat Multiple Sclerosis|Effect of the Humanized Monoclonal Antibody Against the Interleukin-2 Receptor Alpha Subunit (IL-2R-Alpha; Zenapax(Registered Trademark)) on Inflammatory Activity in the CNS in MS in a Baseline-to-Treatment, Cross-Over, MRI-Controlled Single Center Phase I/II Trial|Completed||Phase 2|22|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:00.823318|2017-02-18 18:23:00.823318
NCT00001933|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Nefiracetam in the Treatment of Alzheimer's Disease|Nefiracetam Therapy of Alzheimer's Type Dementia|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:00.922938|2017-02-18 18:23:00.922938
NCT00001932|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 21, 1999||1999-06-21|August 15, 2007|2007-08-15|August 15, 2007||2007-08-15|||||Observational|||Serotonin Receptors in Seizure Disorders|PET Imaging of Serotonin Receptors in Seizure Disorders|Completed||N/A|95||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.016609|2017-02-18 18:23:01.016609
NCT00001931|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2008-03-03|||May 1999||1999-05-01|June 2000|2000-06-01|January 2001||2001-01-01|||||Interventional|||Treatment of Parkinson's Disease With a Transdermal Skin Patch|Transdermal Application of Dopamine Agonist N-0923 in Parkinson's Disease|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.101482|2017-02-18 18:23:01.101482
NCT00001930|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2000|2000-04-01|February 2001||2001-02-01|||||Interventional|||Treatment of Huntington's Chorea With Amantadine|NMDA-Receptor Blockade in Huntington's Chorea|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.197508|2017-02-18 18:23:01.197508
NCT00001929|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||Treatment of Parkinson's Disease With Eliprodil|NMDA-Receptor Blockade With Eliprodil in Parkinson's Disease|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.292477|2017-02-18 18:23:01.292477
NCT00001928|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|March 1999|1999-03-01|July 2000||2000-07-01|||||Observational|||Intravenous Levodopa for the Diagnosis of Parkinson's Disease|Intravenous Levodopa in Parkinsonism|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.384308|2017-02-18 18:23:01.384308
NCT00001927|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 22, 1999||1999-02-22|May 4, 2011|2011-05-04|May 4, 2011||2011-05-04|||||Observational|||Study of Abnormal Blood Clotting in Children With Stroke|Study of Abnormal Acquired and Genetic Coagulation Factors in Children With Porencephaly and Stroke|Completed||N/A|130|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.472158|2017-02-18 18:23:01.472158
NCT00001926|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||The Connection Between Areas in the Brain of Blind Patients|Connectivity of Occipital and Somatosensory Cortical Areas in Blind Subjects|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.551294|2017-02-18 18:23:01.551294
NCT00001925|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Effect of Alcohol on Tremors|Effect of Alcohol on Physiologic and Pathologic Tremors|Completed||Phase 2|23||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.647701|2017-02-18 18:23:01.647701
NCT00001923|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1998||1998-12-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Transcranial Magnetic Stimulation for the Treatment of Phantom Pain|Phantom Pain: A Therapeutic Trial Using Transcranial Magnetic Stimulation|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.738622|2017-02-18 18:23:01.738622
NCT00001922|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||November 5, 1998||1998-11-05|September 14, 2009|2009-09-14||||September 14, 2009|Actual|2009-09-14||Observational|||Sensory Function in Idiopathic Voice Disorders|Sensory Function in Idiopathic Voice Disorders|Completed||N/A|370||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.832189|2017-02-18 18:23:01.832189
NCT00001172|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 26, 1980||1980-08-26|August 6, 2008|2008-08-06|August 6, 2008||2008-08-06|||||Observational|||Visual Stimulus and Eye Movement|Visual Motor Coordination in Man|Completed||N/A|225||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.257199|2017-02-18 18:24:20.257199
NCT00001921|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 20, 1999||1999-09-20|June 3, 2016|2016-06-03||||||||Observational|||Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings|Integrating EEG/MEG and fMRI: Activity Correlation Between Frontal and Temporal Lobe Structures in Schizophrenic Patients, Their Siblings and Unrelated Normal Volunteers|Enrolling by invitation||N/A|1344|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:01.922791|2017-02-18 18:23:01.922791
NCT00001920|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 30, 1999||1999-08-30|June 2, 2010|2010-06-02|June 2, 2010||2010-06-02|||||Observational|||Eye Blink Response in Healthy Volunteers and Adults With Schizophrenia|Investigation of Brain Function During Eyeblink Responding in Normal Volunteers and Patients With Schizophrenia (A Study of Behavior and Evoked Potentials)|Completed||N/A|112|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.028784|2017-02-18 18:23:02.028784
NCT00001919|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1999||1999-09-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects|Serotonin Transporter Availability and Mood State in Normal Volunteers Taking Hypericum Perforatum (St. John's Wort)|Completed||N/A|13||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.109656|2017-02-18 18:23:02.109656
NCT00001918|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|June 1999|1999-06-01|August 2000||2000-08-01|||||Observational|||L-5-HTP-Related EMS|L-5-Hydroxy-Tryptophan-Related Eosinophilia-Myalgia Syndrome (EMS): Clinical Patient Evaluation|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.194091|2017-02-18 18:23:02.194091
NCT00001917|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Brain Imaging in Elderly People and Individuals With Alzheimer's Disease|M2 Receptor Measurements in Aging and in Alzheimer's Disease|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.275173|2017-02-18 18:23:02.275173
NCT00001916|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 1999|1999-02-01|August 2000||2000-08-01|||||Observational|||Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in Depression|Bone Biopsy for Histomorphometry and Analysis of Bone Marrow Derived Osteoblast and Osteoclast Progenitors to Explore Mechanisms of Decreased Bone Mineral Density in Depression|Completed||N/A|17||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.354606|2017-02-18 18:23:02.354606
NCT00001915|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation|Cortical Correlates of Subtle Motor Signs in Attention-Deficit/Hyperactivity Disorder and Healthy Controls|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.441165|2017-02-18 18:23:02.441165
NCT00001913|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1998||1998-10-01|October 2003|2003-10-01|October 2003||2003-10-01|||||Observational|||The Impact of Familiarity and Emotional Attachment on the Visual Processing of Faces|The Impact of Familiarity and Emotional Attachment on the Visual Processing of Faces|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.519466|2017-02-18 18:23:02.519466
NCT00001912|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 10, 1999||1999-08-10|April 4, 2012|2012-04-04|April 4, 2012||2012-04-04|||||Observational|||Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis|Analysis of the Occurrence of Perilesional Edema and Seizures in Patients With Inactive Cysticercosis|Completed||N/A|6|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.602796|2017-02-18 18:23:02.602796
NCT00001911|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Interventional|||Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections|Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.693821|2017-02-18 18:23:02.693821
NCT00001910|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Observational|||Mechanisms of Allergen Immunotherapy|Immunologic Mechanism of Allergen Immunotherapy|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.822471|2017-02-18 18:23:02.822471
NCT00001909|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|May 1999|1999-05-01|May 2000||2000-05-01|||||Interventional|||Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma|Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.907026|2017-02-18 18:23:02.907026
NCT00001908|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1999||1999-06-01|July 2001|2001-07-01|July 2001||2001-07-01|||||Observational|||T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma|T Cell Cytokine Changes During IL-4 Receptor Treatment for Asthma|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:02.990268|2017-02-18 18:23:02.990268
NCT00001906|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2000|2000-04-01|May 2001||2001-05-01|||||Interventional|||Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants|Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:03.346153|2017-02-18 18:23:03.346153
NCT00001905|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I|Interferon Gamma Administration in Leukocyte Adhesion Deficiency Type I|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:03.446847|2017-02-18 18:23:03.446847
NCT00001904|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|January 2000|2000-01-01|September 2000||2000-09-01|||||Observational|||Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness|Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:03.535664|2017-02-18 18:23:03.535664
NCT00001903|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|March 2000|2000-03-01|May 2001||2001-05-01|||||Interventional|||Prevention of RSV Infections in Bone Marrow Transplant Recipients|Prevention of RSV Infections in Bone Marrow Transplant Recipients|Completed||Phase 4|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:03.627209|2017-02-18 18:23:03.627209
NCT00000149|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||October 1993||1993-10-01|June 2002|2002-06-01||||||||Interventional|||Collaborative Initial Glaucoma Treatment Study (CIGTS)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.895795|2017-02-18 18:26:23.895795
NCT00001899|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 16, 1998||1998-12-16|April 8, 2013|2013-04-08|April 8, 2013||2013-04-08|||||Observational|||Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy|Immunologic and Virologic Characterization of HIV-Infected Patients After Cessation of Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:03.819249|2017-02-18 18:23:03.819249
NCT00001898|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 29, 1999||1999-06-29|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Observational|||Microarray Analysis for Human Genetic Disease|Microarray Analysis for Human Genetic Disease|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:03.906949|2017-02-18 18:23:03.906949
NCT00001895|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1999||1999-08-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Electromechanical Mapping to Evaluate Heart Muscle|Evaluation of Electromechanical Endocardial Mapping for Assessment of Myocardial Ischemia and Viability|Completed||Phase 3|71||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:03.999824|2017-02-18 18:23:03.999824
NCT00001894|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2006-07-03|||August 1999||1999-08-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Interventional|||A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy|A Randomized Prospective Comparison of DDD Chamber Pacing and Percutaneous Transluminal Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Associated With Severe Drug-Refractory Symptoms|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.103089|2017-02-18 18:23:04.103089
NCT00001893|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 17, 1999||1999-08-17|June 13, 2008|2008-06-13||||December 31, 2002|Actual|2002-12-31||Interventional|||Study of TNFR:Fc (Enbrel) in the Treatment of Asthma|A Clinical Trial of TNFR:Fc in a Segmental Allergen Challenge Model of Asthma|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.202529|2017-02-18 18:23:04.202529
NCT00001891|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|March 2000|2000-03-01|March 2001||2001-03-01|||||Interventional|||Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle|Assessment of Myocardial Viability Utilizing Myocardial Contrast Echocardiography|Completed||Phase 3|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.316207|2017-02-18 18:23:04.316207
NCT00001890|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|May 2000|2000-05-01|March 2001||2001-03-01|||||Interventional|||Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections|Immunomodulatory Effects of Hormone Therapy in Postmenopausal Women With Chronic Chlamydia Pneumoniae or Cytomegalovirus Infection|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.424069|2017-02-18 18:23:04.424069
NCT00001889|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|March 2001||2001-03-01|||||Interventional|||Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease|Comparison of Myocardial Contrast Echo With Dobutamine Echo in Diagnosis of Coronary Artery Disease|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.515987|2017-02-18 18:23:04.515987
NCT00001888|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-04|||March 30, 1999||1999-03-30|September 14, 2016|2016-09-14||||||||Observational|||Sample Collections From the Airways of Asthmatic Patients|Asthma Sample Collection Protocol|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.60847|2017-02-18 18:23:04.60847
NCT00001887|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|February 2001||2001-02-01|||||Observational|||Factors Involved in Asthma and Airway Inflammation|The Role of a Novel Aminopeptidase-Like Protein in Asthma|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.718031|2017-02-18 18:23:04.718031
NCT00001886|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|March 2001||2001-03-01|||||Interventional|||Real Time 3-Dimensional Stress Echocardiography|Real Time 3-Dimensional Stress Echocardiography|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.800645|2017-02-18 18:23:04.800645
NCT00001885|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 21, 1999||1999-03-21|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis|Pulmonary Fibrosis Associated With Rheumatoid Arthritis: Identification of Genetic Polymorphisms|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.887682|2017-02-18 18:23:04.887682
NCT00001884|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 21, 1999||1999-03-21|December 28, 2007|2007-12-28|December 28, 2007||2007-12-28|||||Observational|||Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis|Specimen Procurement for Individuals With Pulmonary Fibrosis Associated With Rheumatoid Arthritis|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:04.985441|2017-02-18 18:23:04.985441
NCT00001883|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||March 1999||1999-03-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||Quality Control of Cardiopulmonary Exercise Equipment|Quality Control of P-CCMB Cardiopulmonary Exercise Equipment|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.078589|2017-02-18 18:23:05.078589
NCT00001881|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|April 2001||2001-04-01|||||Observational|||Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease|Clinical Manifestations of Mutations in Genes Linked to Familial Cardiomyopathy|Completed||N/A|9999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.157533|2017-02-18 18:23:05.157533
NCT00001880|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-03|2017-01-24|||March 11, 1999||1999-03-11|August 30, 2016|2016-08-30||||||||Observational|||Stem Cell Transplantation for Metastatic Solid Tumors|Exploratory Study of Non-Myeloablative Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusions for Metastatic Neoplasms Refractory to Standard Therapy|Completed||N/A|84|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.238649|2017-02-18 18:23:05.238649
NCT00001879|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2000|2000-02-01|March 2001||2001-03-01|||||Observational|||Collections of Blood and Stool Samples in Patients With Acute Hepatitis|Collection of Blood and Stool Samples in Patients With Acute Hepatitis|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.343954|2017-02-18 18:23:05.343954
NCT00001858|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 8, 1999||1999-06-08|May 30, 2014|2014-05-30|May 30, 2014||2014-05-30|||||Observational|||Monitoring for Tolerance to Kidney or Combined Kidney-Pancreas Transplants|Monitoring for Donor-Specific Hyporesponsiveness Following Renal and Pancreatic Allotransplantation|Completed||N/A|294|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.326087|2017-02-18 18:23:07.326087
NCT00001878|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts|Contribution of Insulin-Like Growth Factor-I (IGF-I) and Its Binding Protein (IGFBP3) to Increased Left Ventricular Mass in Familial Hypertrophic Cardiomyopathy Caused by Distinct Sarcomeric Mutations|Completed||N/A|175||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.431158|2017-02-18 18:23:05.431158
NCT00001877|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|May 2004|2004-05-01|May 2004||2004-05-01|||||Interventional|||Treatment of Pulmonary Sarcoidosis With Pentoxifylline|Treatment of Pulmonary Sarcoidosis With Pentoxifylline|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.51853|2017-02-18 18:23:05.51853
NCT00001876|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 25, 1999||1999-02-25|July 19, 2016|2016-07-19||||||||Observational|||Lung Disease Associated With Rheumatoid Arthritis|Pulmonary Fibrosis Associated With Rheumatoid Arthritis: Definition of the Natural History of Disease|Completed||N/A|132|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.609141|2017-02-18 18:23:05.609141
NCT00001874|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 22, 1999||1999-02-22|August 3, 2009|2009-08-03|August 3, 2009|Actual|2009-08-03|August 3, 2009|Actual|2009-08-03||Observational|||Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy|Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.706198|2017-02-18 18:23:05.706198
NCT00001873|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 22, 1999||1999-02-22|July 8, 2016|2016-07-08|December 28, 2007|Actual|2007-12-28|December 28, 2007|Actual|2007-12-28||Interventional|||The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers|Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine|Completed||Phase 2|102|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:05.796003|2017-02-18 18:23:05.796003
NCT00001872|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 2, 1999||1999-02-02|April 15, 2016|2016-04-15||||||||Observational|||Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease|Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease|Recruiting||N/A|40|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:05.911657|2017-02-18 18:23:05.911657
NCT00001871|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|December 1999|1999-12-01|March 2001||2001-03-01|||||Observational|||Study of Muscle Abnormalities in Patients With Specific Genetic Mutations|An Exploratory Study of Skeletal Muscle Abnormalities in Patients With Mutations in Alpha-Tropomyosin and PABP2 Genes|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.014084|2017-02-18 18:23:06.014084
NCT00001870|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Study of the Effects of Vitamin C on Patients With Type 2 Diabetes|An Exploratory Study of the Effects of Oral Vitamin C Administration on Insulin Sensitivity and Vascular Reactivity in Subjects With Type 2 Diabetes|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.097664|2017-02-18 18:23:06.097664
NCT00001869|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1998||1998-12-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)|Lymphangioleiomyomatosis (LAM) Registry|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.185342|2017-02-18 18:23:06.185342
NCT00001867|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1999||1999-09-01|September 1999|1999-09-01|September 2000||2000-09-01|||||Observational|||Effect of Pregnancy on Uveitis|Effect of Pregnancy on Uveitis|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.475909|2017-02-18 18:23:06.475909
NCT00001866|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1999||1999-08-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Eye Muscle Surgery to Treat Congenital Nystagmus|Horizontal Rectus Tenotomy in the Treatment of Congenital Nystagmus|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.559277|2017-02-18 18:23:06.559277
NCT00001865|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||HAT in Eye Complications of Behcet's Disease|A Study to Investigate the Safety and Efficacy of HAT to Treat the Ocular Complications Related to Behcet's Disease|Completed||Phase 2|26||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.641282|2017-02-18 18:23:06.641282
NCT00001864|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Amblyopia (Lazy Eye) Treatment Study|Amblyopia Treatment Study|Completed||Phase 3|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.725866|2017-02-18 18:23:06.725866
NCT00001863|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Interventional|||Leflunomide to Treat Uveitis|Pilot Study of Leflunomide for the Treatment of Uveitis|Completed||Phase 2|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.813801|2017-02-18 18:23:06.813801
NCT00001862|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Interventional|||TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis|The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.90161|2017-02-18 18:23:06.90161
NCT00001861|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 29, 1999||1999-01-29|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Screening for Studies on Nystagmus and Strabismus|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Nystagmus or Strabismus|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:06.990735|2017-02-18 18:23:06.990735
NCT00001860|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1999||1999-08-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Sandostatin LAR Depot vs. Surgery for Treating Acromegaly|Sandostatin LAR vs. Surgery in Acromegalics With Macroadenoma|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.072304|2017-02-18 18:23:07.072304
NCT00001859|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 4, 1999||1999-06-04|May 30, 2014|2014-05-30|May 30, 2014||2014-05-30|||||Observational|||Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant|Screening Protocol for Patients Needing a Kidney, Kidney-Pancreas, or Islet Cell Transplant|Completed||N/A|621|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.232405|2017-02-18 18:23:07.232405
NCT00001857|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Interventional|||Study Comparing the Safety of BG9588 (Anti-CD40L Antibody) Against Standard Treatment in Kidney Transplantation|A Multicenter, Open-Label, Study to Determine the Safety of BG9588 (Anti-CD40L Antibody) Therapy Compared to Standard Treatment in Renal Allograft Transplantation|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.410322|2017-02-18 18:23:07.410322
NCT00001856|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 17, 1999||1999-05-17|May 30, 2014|2014-05-30|May 30, 2014||2014-05-30|||||Observational|||Live Donors for Kidney Transplants|Live Donor Renal Donation for Allotransplantation|Completed||N/A|260|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.494224|2017-02-18 18:23:07.494224
NCT00001854|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 12, 1999||1999-02-12|January 15, 2008|2008-01-15|January 15, 2008|Actual|2008-01-15|October 10, 2007|Actual|2007-10-10||Interventional|||Long-Term Therapy With Ribavirin for Chronic Hepatitis C|Long-Term Therapy With Ribavirin for Chronic Hepatitis C|Completed||Phase 4|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.571361|2017-02-18 18:23:07.571361
NCT00001853|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 6, 1998||1998-10-06|January 4, 2017|2017-01-04||||||||Observational|||Diabetes and Heart Disease Risk in Blacks|Diabetes and Heart Disease Risk in Blacks|Recruiting||N/A|1132|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.690322|2017-02-18 18:23:07.690322
NCT00001852|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 8, 1999||1999-04-08|December 29, 2016|2016-12-29||||||||Observational|||Natural History of Salivary Gland Dysfunction and Sj(SqrRoot)(Delta)Gren s Syndrome|Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome|Completed||N/A|560|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.787145|2017-02-18 18:23:07.787145
NCT00001851|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 15, 1998||1998-12-15|June 26, 2009|2009-06-26|April 30, 2002|Actual|2002-04-30|April 30, 2002|Actual|2002-04-30||Observational|||Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome|Evaluation and Treatment to Improve Bone Quality and Prevent Fractures by the Percutaneous Replacement of Diseased Tissue in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.885894|2017-02-18 18:23:07.885894
NCT00001850|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-14|||May 4, 1999||1999-05-04|January 26, 2017|2017-01-26||||||||Observational|||Evaluation of Women With Endocrine and Reproductive-Related Conditions|Evaluation of Women and Men With Endocrine and Reproductive-Related Conditions|Recruiting||N/A|900|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:07.967149|2017-02-18 18:23:07.967149
NCT00001849|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 25, 1999||1999-02-25|December 28, 2016|2016-12-28|December 31, 2019|Anticipated|2019-12-31|December 31, 2019|Anticipated|2019-12-31||Interventional|||New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome|New Imaging Modalities in the Evaluation of Patients With Ectopic Cushing's Syndrome|Recruiting||Phase 1/Phase 2|202|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:08.061882|2017-02-18 18:23:08.061882
NCT00001848|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2016-09-21|||November 1998||1998-11-01|September 2016|2016-09-01|January 2006||2006-01-01|||||Interventional|||The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis|The Safety and Effectiveness of Surgery With or Without Raloxifene (Evista (Trademark), Lilly) for the Treatment of Pelvic Pain Caused by Endometriosis|Completed||Phase 2|612||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:08.174616|2017-02-18 18:23:08.174616
NCT00001846|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-10|||August 26, 1999||1999-08-26|November 22, 2016|2016-11-22||||||||Observational|||Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use|Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:08.26245|2017-02-18 18:23:08.26245
NCT00001845|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1999||1999-09-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)|MR Perfusion Imaging in Hypercapnia: Development of Technical Protocols|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:08.357877|2017-02-18 18:23:08.357877
NCT00001844|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 8, 1999||1999-09-08|September 7, 2012|2012-09-07|September 7, 2012||2012-09-07|||||Observational|||Study of New Magnetic Resonance Methods|Functional and Metabolic Imaging Using Magnetic Resonance at 3.0 Tesla|Terminated||N/A|99|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:11.437858|2017-02-18 18:23:11.437858
NCT00001842|ClinicalTrials.gov processed this data on February 17, 2017|2007-07-31|2008-03-03|||July 1999||1999-07-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||G-CSF for Granulocyte Donation|Kinetics of Intravenous G-CSF-Induced Granulocyte Mobilization in Healthy Apheresis Donors|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:11.515415|2017-02-18 18:23:11.515415
NCT00001841|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Observational|||Magnetic Resonance Angiography (MRA) for the Diagnosis of Atherosclerosis|Contrast Enhanced Resonance Angiography (MRA) in the Diagnosis of Atherosclerotic Disease: A Pilot Technical Development Study|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:11.595806|2017-02-18 18:23:11.595806
NCT00001840|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1999||1999-02-01|January 2001|2001-01-01|July 2001||2001-07-01|||||Observational|||Evaluation of Treated and Untreated Stroke|Evaluation of Treated and Untreated Stroke|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:11.669832|2017-02-18 18:23:11.669832
NCT00001839|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1998||1998-12-01|December 1998|1998-12-01|May 2000||2000-05-01|||||Interventional|||A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome|A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome|Completed||Phase 2|182||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:11.752206|2017-02-18 18:23:11.752206
NCT00001837|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1998||1998-11-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Observational|||Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients|Sonographic Evaluation of the Effects of Raloxifene on the Uterus and Ovaries in Premenopausal Patients at High Risk for Developing Breast Cancer|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:11.835462|2017-02-18 18:23:11.835462
NCT00001836|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1998||1998-10-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography|Detection of Coronary Artery Calcification: Comparison of Volumetric and Electron Beam Computed Tomography|Completed||N/A|213||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:11.914545|2017-02-18 18:23:11.914545
NCT00001835|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1999||1999-09-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||Oxaliplatin in Cancer Patients With Impaired Kidney Function|A Phase I Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:11.990395|2017-02-18 18:23:11.990395
NCT00001832|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2012-12-19|2012-11-07||August 1999||1999-08-01|December 2012|2012-12-01|May 2010|Actual|2010-05-01|May 2010|Actual|2010-05-01||Interventional|||Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma|Treatment of Patients With Metastatic Melanoma Using Cloned Lymphocytes Following the Administration of a Non-Myeloablative But Lymphocyte Depleting Regimen|Completed||Phase 2|170|Actual|National Institutes of Health Clinical Center (CC)||15|||f||||t||||||||||2017-02-18 18:23:12.102999|2017-02-18 18:23:12.102999
NCT00001830|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 20, 1999||1999-07-20|May 19, 2015|2015-05-19|May 19, 2015|Actual|2015-05-19|||||Interventional|||Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants|Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation|Completed||Phase 1|110|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:16.299819|2017-02-18 18:23:16.299819
NCT00001827|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 26, 1999||1999-07-26|January 25, 2013|2013-01-25|January 25, 2013|Actual|2013-01-25|December 17, 2007|Actual|2007-12-17||Interventional|||p53 Vaccine for Ovarian Cancer|Vaccine Therapy With Tumor Specific p53 Peptides in Adult Patients With Low Burden Adenocarcinoma of the Ovary|Terminated||Phase 2|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:16.398436|2017-02-18 18:23:16.398436
NCT00001826|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1999||1999-07-01|May 2006|2006-05-01|May 2006||2006-05-01|||||Observational|||Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor|A Long-Term Observational Study of Immunologic Reconstitution in HIV-1 Infected Children Who Are Receiving Combination Protease Inhibitor and Reverse Transcriptase Inhibitors|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:16.507357|2017-02-18 18:23:16.507357
NCT00001823|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-08|||June 24, 1999||1999-06-24|February 6, 2017|2017-02-06||||||||Observational|||Evaluation for NCI Surgery Branch Clinical Studies|Evaluation for NCI Surgery Branch Clinical Research Protocols|Recruiting||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:16.609875|2017-02-18 18:23:16.609875
NCT00001818|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1999||1999-06-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Combination Drug Treatment of Pediatric HIV Infection|A Pilot Study of Hydroxyurea in Combination With Stavudine, Didanosine and Efavirenz in Pediatric Patients With HIV-1 Infection|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:16.719197|2017-02-18 18:23:16.719197
NCT00001816|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1999||1999-05-01|May 2000|2000-05-01|February 2001||2001-02-01|||||Observational|||The Impact of Starbright World on Children Being Treated at the NIH|The Impact of Starbright World on Children Being Treated at the NIH|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:16.819495|2017-02-18 18:23:16.819495
NCT00001814|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|February 2000|2000-02-01|January 2001||2001-01-01|||||Observational|||Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples|Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:16.899105|2017-02-18 18:23:16.899105
NCT00001813|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 26, 1999||1999-04-26|January 11, 2017|2017-01-11||||||||Observational|||Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy|Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy|Recruiting||N/A|700|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:16.975724|2017-02-18 18:23:16.975724
NCT00001812|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2000|2000-04-01|August 2000||2000-08-01|||||Interventional|||A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2|A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2|Completed||Phase 3|84||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.080748|2017-02-18 18:23:17.080748
NCT00001810|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1999||1999-04-01|April 2000|2000-04-01|October 2000||2000-10-01|||||Interventional|||An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections|An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections|Completed||Phase 3|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.172997|2017-02-18 18:23:17.172997
NCT00001807|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 15, 1999||1999-04-15|September 23, 2016|2016-09-23||||||||Observational|||(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy|(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy|Active, not recruiting||N/A|50|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.272721|2017-02-18 18:23:17.272721
NCT00001806|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-27|||April 3, 1999||1999-04-03|January 4, 2017|2017-01-04|November 4, 2017|Anticipated|2017-11-04|November 4, 2017|Anticipated|2017-11-04||Interventional|||Methods in Education for Breast Cancer Genetics|Methods in Education for Breast Cancer Genetics|Active, not recruiting||Phase 3|170|Anticipated|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 18:23:17.377101|2017-02-18 18:23:17.377101
NCT00001686|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 3, 1997||1997-12-03|December 8, 2016|2016-12-08||||||||Observational|||Evaluation, Treatment, and Natural History of Children With Cancer|Treatment of Children With Cancer|Enrolling by invitation||N/A|378|Actual|National Institutes of Health Clinical Center (CC)|||1||f||||||||||||||2017-02-18 18:23:26.621792|2017-02-18 18:23:26.621792
NCT00001805|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1999||1999-03-01|March 2000|2000-03-01|June 2000||2000-06-01|||||Interventional|||A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab|A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.49881|2017-02-18 18:23:17.49881
NCT00001803|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 26, 1999||1999-02-26|October 27, 2016|2016-10-27||||||||Observational|||Von Hippel-Lindau Disease Genetic Epidemiology Study|Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study|Active, not recruiting||N/A|546|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.599325|2017-02-18 18:23:17.599325
NCT00001797|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1999||1999-01-01|December 1999|1999-12-01|September 2000||2000-09-01|||||Interventional|||Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis|Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis|Completed||Phase 2|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.691451|2017-02-18 18:23:17.691451
NCT00001790|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1998||1998-10-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Interventional|||Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia|Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.777527|2017-02-18 18:23:17.777527
NCT00001789|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1999||1999-06-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Interventional|||BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis|An Open-Label, Multiple-Dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BG9588 (Anti-CD40L Antibody) in Subjects With Proliferative Lupus Glomerulonephritis (SLE-GN)|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.874268|2017-02-18 18:23:17.874268
NCT00001788|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 10, 1998||1998-10-10|November 28, 2016|2016-11-28||||||||Observational|||Genetic Basis of Primary Immunodeficiencies|Molecular Basis of Primary Immunodeficiencies|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:17.961946|2017-02-18 18:23:17.961946
NCT00001785|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|September 2004|2004-09-01|September 2004||2004-09-01|||||Interventional|||Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)|Combined Virological and Immunological Evaluation of Treatment of Patients With Early HTLV-1-Associated Myelopathy With Recombinant Human Interferon Beta-1a|Completed||Phase 2|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:18.159844|2017-02-18 18:23:18.159844
NCT00001784|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Mexiletine for the Treatment of Focal Dystonia|Mexiletine for the Treatment of Focal Dystonia|Completed||Phase 2|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:18.253412|2017-02-18 18:23:18.253412
NCT00001783|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical Therapy|Neuroanatomical and Neurophysiological Basis of Motor Recovery Associated With Treatment of Recent Stroke Using Amphetamine and Physical Therapy|Completed||Phase 2|34||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:18.537261|2017-02-18 18:23:18.537261
NCT00001782|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1998||1998-03-01|November 1999|1999-11-01|December 2000||2000-12-01|||||Observational|||Areas of Brain Responsible for Understanding American Sign Language|Hemispheric Lateralization of Language Receptive Function in the Deaf and in Hearing Individuals Who Learned ASL as First Language|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:18.629961|2017-02-18 18:23:18.629961
NCT00001781|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)|Open-Label Baseline vs. Treatment Trial Evaluating the Safety, Tolerability and Effect on MRI Lesion and Immunology Parameters of CGP 77116 in Patients With Multiple Sclerosis Mark|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:18.722601|2017-02-18 18:23:18.722601
NCT00001780|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Magnetic Stimulation of the Human Nervous System|Stimulation of the Human Central and Peripheral Nervous System With a Magnetic Stimulator|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:18.808875|2017-02-18 18:23:18.808875
NCT00001778|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-27|||December 23, 1997||1997-12-23|January 19, 2017|2017-01-19||||||||Observational|||Evaluation of Patients With HAM/TSP|Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:18.891262|2017-02-18 18:23:18.891262
NCT00001777|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1997||1997-12-01|November 1998|1998-11-01|May 2000||2000-05-01|||||Interventional|||Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD)|A Controlled, Randomized, Double-Blind Trial of Sertraline in Patients With Frontal Lobe Dementia (FLD)|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:18.990192|2017-02-18 18:23:18.990192
NCT00001776|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|December 2003|2003-12-01|December 2003||2003-12-01|||||Observational|||Effects of Brain Stimulation on Learning and Reasoning|Can Stimulation of Frontal Cortical Regions Facilitate Performance on Tests of Procedural Implicit Learning and Analogical Reasoning?|Completed||N/A|122||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:19.077027|2017-02-18 18:23:19.077027
NCT00001774|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Observational|||Vasodilation in Patients With Fabry's Disease|An Investigation of Endothelium-Derived Vasodilation in Patients With Fabry's Disease|Completed||N/A|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:19.165874|2017-02-18 18:23:19.165874
NCT00001772|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|August 2000|2000-08-01|July 2001||2001-07-01|||||Observational|||Evaluation of Patients With Rapid Cycling Bipolar Disorder (RCBD)|Evaluation of Patients With Rapid Cycling Bipolar Disorder|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:19.260506|2017-02-18 18:23:19.260506
NCT00001771|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1998||1998-05-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers|I-123 Beta-CIT SPECT Studies of Dopamine and Serotonin Transporters in Neuropsychiatric Patients and Normal Volunteers|Completed||N/A|112||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:19.345672|2017-02-18 18:23:19.345672
NCT00001770|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1998||1998-03-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)|The Phenomenology and Biophysiology of Progestin-Induced Dysphoria|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:19.433029|2017-02-18 18:23:19.433029
NCT00001768|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|December 1999|1999-12-01|June 2000||2000-06-01|||||Interventional|||Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)|Childhood Onset Psychiatric Disorders: A Placebo Controlled Double-Blind Crossover Trial of Intravenous Immunoglobulin (IVIg)|Completed||Phase 3|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:19.514245|2017-02-18 18:23:19.514245
NCT00001766|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1998||1998-08-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Drug Interactions Among Anti-HIV Agents|Pharmacokinetic Interactions Between Ritonavir, Amprenavir and Efavirenz and Nelfinavir, Amprenavir, and Efavirenz in People Infected With HIV|Completed||Phase 1|22||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:19.611725|2017-02-18 18:23:19.611725
NCT00001765|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Interventional|||Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease|Low Intensity Preparative Regimen Followed by HLA-Matched, Mobilized Peripheral Blood Stem Cell Transplantation for Chronic Granulomatous Disease|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:19.708548|2017-02-18 18:23:19.708548
NCT00001764|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions|Mycophenolate Mofetil in the Treatment of Wegener's Granulomatosis and Related Vasculitides|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.010207|2017-02-18 18:23:20.010207
NCT00001763|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|April 1999|1999-04-01|March 2000||2000-03-01|||||Interventional|||Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection|Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.104128|2017-02-18 18:23:20.104128
NCT00001762|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 23, 1998||1998-02-23|July 26, 2013|2013-07-26|July 26, 2013||2013-07-26|||||Observational|||Magnetic Resonance Imaging of the Face and Bones|Magnetic Resonance Imaging to Study Avascular Necrosis in HIV-Infected Subjects|Completed||N/A|532|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.205828|2017-02-18 18:23:20.205828
NCT00001761|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|January 1999|1999-01-01|April 2000||2000-04-01|||||Interventional|||Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis|Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.296052|2017-02-18 18:23:20.296052
NCT00001760|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2007-12-12|||January 1998||1998-01-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals|Determination of Cytokine Production Patterns in the Skin of Patients With Systemic Mastocytosis and Atopic Dermatitis Using the Suction Blister Technique|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.391862|2017-02-18 18:23:20.391862
NCT00001759|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1997||1997-12-01|February 2000|2000-02-01|January 2001||2001-01-01|||||Observational|||Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography|Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography|Completed||N/A|95||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.479056|2017-02-18 18:23:20.479056
NCT00001758|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz|Continued Salvage Anti-Retroviral Therapy With Abacavir, Amprenavir, and Efavirenz|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.564169|2017-02-18 18:23:20.564169
NCT00001757|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|December 1999|1999-12-01|July 2000||2000-07-01|||||Interventional|||An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections|An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections|Completed||Phase 3|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.660232|2017-02-18 18:23:20.660232
NCT00001756|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||November 5, 1997||1997-11-05|September 8, 2016|2016-09-08||||||||Observational|||Study of Mast Cell Precursors|The Characterization of CD34+ Derived Mast Cell Precursors Mobilized by Administration of Granulocyte Colony Stimulating Factor and Plerixafor|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.749288|2017-02-18 18:23:20.749288
NCT00001754|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|June 2000|2000-06-01|May 2001||2001-05-01|||||Observational|||Study of Skeletal Disorders and Short Stature|Clinical and Molecular Manifestations of Human Skeletal Dysplasias and Short Stature|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.857816|2017-02-18 18:23:20.857816
NCT00001753|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|August 1999|1999-08-01|November 2000||2000-11-01|||||Interventional|||Study of the Effects of Temperature on Metabolism in Human Muscle|Study of Temperature Effects on Skeletal Muscle Aerobic Energy Metabolism|Completed||Phase 1|17||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:20.949343|2017-02-18 18:23:20.949343
NCT00000601|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||July 1995||1995-07-01|February 2005|2005-02-01|June 2000|Actual|2000-06-01|||||Interventional|||Postmenopausal Hormone Therapy in Unstable Angina||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:49.292793|2017-02-18 18:25:49.292793
NCT00001752|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|August 1999|1999-08-01|July 2000||2000-07-01|||||Interventional|||Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women|Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.029125|2017-02-18 18:23:21.029125
NCT00001750|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1998||1998-09-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||Comparing Treatments for Multiple Myeloma|Randomized Trial of Autologous Transplantation With Filgrastim Versus Stem Cell Factor/Filgrastim-Primed CD34-Enriched Peripheral Blood Cells for Multiple Myeloma|Completed||Phase 2|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.13808|2017-02-18 18:23:21.13808
NCT00001749|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Interventional|||Medical Treatment for Diamond Blackfan Anemia|Treatment of Diamond Blackfan Anemia With Antithymocyte Globulin and Cyclosporine A|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.429903|2017-02-18 18:23:21.429903
NCT00001748|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|August 1999|1999-08-01|May 2000||2000-05-01|||||Interventional|||HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies|HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies|Completed||Phase 1|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.536144|2017-02-18 18:23:21.536144
NCT00001747|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1998||1998-05-01|May 2000|2000-05-01|March 2001||2001-03-01|||||Observational|||Racial Differences in Control of Blood Vessel Tone and Blood Flow|Racial Differences in Flow Mediated Vasodilator Function|Completed||N/A|108||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.632976|2017-02-18 18:23:21.632976
NCT00001746|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||April 1998||1998-04-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Screening for Inherited Heart Disease|Evaluation of Patients With Known or Suspected Inherited Heart Disease (Screening Protocol)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.717215|2017-02-18 18:23:21.717215
NCT00001742|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Observational|||The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients|The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.80085|2017-02-18 18:23:21.80085
NCT00001741|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Interventional|||Study of Inherited Changes of Receptors Located on Blood Vessels|Study of Vascular Responsiveness in Subjects With Polymorphisms of the Angiotensin II Type I Receptor Gene|Completed||Phase 1|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.888779|2017-02-18 18:23:21.888779
NCT00001740|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Observational|||Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional Echocardiography|Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional Echocardiography|Completed||N/A|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:21.981323|2017-02-18 18:23:21.981323
NCT00001738|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1998||1998-08-01|August 1999|1999-08-01|June 2000||2000-06-01|||||Observational|||Vascular Endothelial Growth Factor (VEGF) in Uveitis|A Pilot Study to Demonstrate the Presence of Vascular Endothelial Growth Factor (VEGF) in Uveitic Cystoid Macular Edema|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.066494|2017-02-18 18:23:22.066494
NCT00001737|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1998||1998-05-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Interventional|||Cyclosporin Implant to Treat Uveitis|A Pilot Study of a Sustained-Release Cyclosporine A Implant for Uveitis|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.152184|2017-02-18 18:23:22.152184
NCT00001736|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1998||1998-05-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Interventional|||New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis|Safety and Efficacy Trial of a Proposed NDA Formulation of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis|Completed||Phase 1|51||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.242799|2017-02-18 18:23:22.242799
NCT00001735|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|March 2000|2000-03-01|October 2000||2000-10-01|||||Interventional|||Gene Therapy for Gyrate Atrophy|Phase I Study in the Safety and Efficacy of Transduced Keratinocytes for Possible Treatment of Gyrate Atrophy|Completed||Phase 1|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.330592|2017-02-18 18:23:22.330592
NCT00001734|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 23, 1998||1998-03-23|October 3, 2008|2008-10-03|October 3, 2008||2008-10-03|||||Observational|||Screening for NEI Clinical Studies|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Ocular Inflammatory or Immunologic Diseases|Completed||N/A|3000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.419152|2017-02-18 18:23:22.419152
NCT00001733|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 6, 1998||1998-03-06|July 2, 2008|2008-07-02|July 2, 2008||2008-07-02|||||Observational|||Screening for Studies on Retinovascular Diseases|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.496037|2017-02-18 18:23:22.496037
NCT00001732|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 25, 1998||1998-02-25|May 20, 2008|2008-05-20|May 20, 2008||2008-05-20|||||Observational|||Screening for Studies on Inherited Eye Diseases|Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Inherited Ophthalmic Diseases|Completed||N/A|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.573126|2017-02-18 18:23:22.573126
NCT00001731|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|October 1999|1999-10-01|October 2000||2000-10-01|||||Interventional|||Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops|A Double-Masked, Randomized, Vehicle-Controlled Pilot Study of the Treatment of Keratoconjunctivitis Sicca With Topical Cyclosporin A 0.1% Emulsion|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.651447|2017-02-18 18:23:22.651447
NCT00001666|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy|Drug Refractory Partial Epilepsy, A Therapeutic Trial With Transcranial Magnetic Stimulation|Completed||N/A|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.07095|2017-02-18 18:23:28.07095
NCT00001730|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1997||1997-12-01|November 1999|1999-11-01|April 2000||2000-04-01|||||Interventional|||Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.|A Dosimetry Study of Radioiodine (131-I) Uptake Following the Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal|Completed||Phase 4|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.745401|2017-02-18 18:23:22.745401
NCT00001729|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Interventional|||Combination Drug Therapy for Patients With Hepatitis C|Combination of Alpha Interferon With Long Term Ribavirin Therapy for Patients With Chronic Hepatitis C|Completed||Phase 3|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:22.843124|2017-02-18 18:23:22.843124
NCT00001728|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 24, 1998||1998-08-24|May 2, 2011|2011-05-02|May 2, 2011|Actual|2011-05-02|August 19, 2007|Actual|2007-08-19||Interventional|||Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome|A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome|Completed||Phase 2|40|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:22.937793|2017-02-18 18:23:22.937793
NCT00001727|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 24, 1998||1998-08-24|July 19, 2016|2016-07-19||||||||Observational|||Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome|Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:23.030013|2017-02-18 18:23:23.030013
NCT00001726|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 19, 1998||1998-06-19|August 3, 2009|2009-08-03|August 3, 2009|Actual|2009-08-03|August 3, 2009|Actual|2009-08-03||Observational|||Study of the Composition of Dental Plaque|Spatial Organization of Viridans Streptococci in Oral Biofilms|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:23.217298|2017-02-18 18:23:23.217298
NCT00001725|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1997||1997-12-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain|Clinical Trials in Orofacial Neuralgias|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:23.295877|2017-02-18 18:23:23.295877
NCT00001724|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Local Flurbiprofen to Treat Pain Following Wisdom Tooth Extraction|Evaluation of the Analgesic Effects of Locally Applied Flurbiprofen and Bupivacaine in the Oral Surgery Model|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:23.387846|2017-02-18 18:23:23.387846
NCT00001723|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2012-11-15|2012-10-11||May 1998||1998-05-01|November 2012|2012-11-01|October 2011|Actual|2011-10-01|October 2011|Actual|2011-10-01||Interventional|||Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases|Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents With Obesity-Related Comorbid Conditions|Completed||Phase 2|200|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||t||||||||||2017-02-18 18:23:23.476588|2017-02-18 18:23:23.476588
NCT00001722|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Fat Tissue Microperfusion to Measure Leptin Secretion and Its Relations With Fat Breakdown in Humans|Adipose Tissue Microperfusion to Assess Leptin Secretion and Its Relations With Lipolysis in Humans|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.143328|2017-02-18 18:23:24.143328
NCT00001721|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 19, 1998||1998-03-19|September 2, 2016|2016-09-02||||||||Observational|||Study of Smith-Lemli-Opitz Syndrome|Clinical and Basic Investigations Into Smith-Lemli-Opitz Syndrome|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.22776|2017-02-18 18:23:24.22776
NCT00001720|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2016-09-21|||March 1998||1998-03-01|September 2016|2016-09-01|June 2003||2003-06-01|||||Interventional|||Treatment of Childhood Osteoporosis With Alendronate (Fosamax)|Alendronate Versus Placebo for Idiopathic Juvenile Osteoporosis|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.336561|2017-02-18 18:23:24.336561
NCT00001719|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1998||1998-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Magnetic Resonance Imaging of Blood Flow in the Liver and Abdomen|Examination of the Hemodynamics of the Portal Venous System in Normal Volunteers Using Magnetic Resonance Imaging|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.423993|2017-02-18 18:23:24.423993
NCT00001718|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Interventional|||Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia|Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.516128|2017-02-18 18:23:24.516128
NCT00001717|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|June 1999|1999-06-01|July 2000||2000-07-01|||||Observational|||Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent|Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent|Completed||N/A|225||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.600018|2017-02-18 18:23:24.600018
NCT00001716|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Interventional|||Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia|Physiologic Effects of Inhaled Nitric Oxide, Nitroglycerin, and Placebo in Study Subjects With Sickle Cell Anemia|Completed||Phase 2|58||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.676223|2017-02-18 18:23:24.676223
NCT00001715|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 21, 1998||1998-04-21|October 6, 2016|2016-10-06||||||||Observational|||Evaluation of Patients With Blood Disorders|Evaluation of Hematologic Patients - Training Protocol|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.779843|2017-02-18 18:23:24.779843
NCT00001714|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1998||1998-03-01|February 2001|2001-02-01|July 2001||2001-07-01|||||Observational|||Magnetization Transfer Quantitation and Characterization for Clinical Scanners|Magnetization Transfer Quantitation and Characterization for Clinical Scanners|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.885987|2017-02-18 18:23:24.885987
NCT00001713|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Treatment for Blood Clots in the Veins of the Legs|Treatment of Acute Deep Vein Thrombosis of the Lower Extremity With Intraclot, Pulse-Sprayed Recombinant Tissue Plasminogen Activator, Plus Heparin and Warfarin: A Pilot Study|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:24.973376|2017-02-18 18:23:24.973376
NCT00001712|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1998||1998-02-01|October 2005|2005-10-01|October 2005||2005-10-01|||||Observational|||Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan|Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan|Completed||N/A|3400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:25.07207|2017-02-18 18:23:25.07207
NCT00001711|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 28, 1997||1997-10-28|October 6, 2016|2016-10-06||||||||Observational|||Magnetic Resonance Imaging (MRI) Ofl Volunteers|Volunteer Scanning on MR|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:25.349178|2017-02-18 18:23:25.349178
NCT00001705|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1998||1998-07-01|July 2000|2000-07-01|June 2001||2001-06-01|||||Interventional|||Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence|Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence|Completed||Phase 2|141||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:25.446877|2017-02-18 18:23:25.446877
NCT00001703|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2014-07-16|2011-05-17||August 1998||1998-08-01|July 2014|2014-07-01|November 2008|Actual|2008-11-01|November 2008|Actual|2008-11-01||Interventional|||Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma|Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)|Patients were enrolled to Arm A only due to poor accrual and the lack of peptide vaccine.|1||Due to poor accrual and lack of peptide vaccine|f||||f||||||||||2017-02-18 18:23:25.536843|2017-02-18 18:23:25.536843
NCT00001702|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 29, 1998||1998-07-29|October 6, 2009|2009-10-06||||June 6, 2007|Actual|2007-06-06||Observational|||Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection|Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:25.825093|2017-02-18 18:23:25.825093
NCT00001701|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 29, 1998||1998-07-29|October 6, 2009|2009-10-06||||June 21, 2007|Actual|2007-06-21||Observational|||Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection|Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:25.907783|2017-02-18 18:23:25.907783
NCT00001699|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|June 1999|1999-06-01|March 2000||2000-03-01|||||Observational|||A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers|A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers|Completed||N/A|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:25.991232|2017-02-18 18:23:25.991232
NCT00001698|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR|Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR|Completed||Phase 2|57||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.07778|2017-02-18 18:23:26.07778
NCT00001696|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Interventional|||A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor|A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.167001|2017-02-18 18:23:26.167001
NCT00001695|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1998||1998-04-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials|Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials|Completed||N/A|125||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.254883|2017-02-18 18:23:26.254883
NCT00001693|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1998||1998-03-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers|Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.333433|2017-02-18 18:23:26.333433
NCT00001689|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1998||1998-01-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia|A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia|Completed||Phase 1|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.432947|2017-02-18 18:23:26.432947
NCT00001688|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1998||1998-01-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine|A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine|Completed||Phase 2|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.526687|2017-02-18 18:23:26.526687
NCT00001685|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1997||1997-11-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Interventional|||Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase|Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase|Completed||Phase 2|114||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.724479|2017-02-18 18:23:26.724479
NCT00001683|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer|A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer|Completed||Phase 1|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.815088|2017-02-18 18:23:26.815088
NCT00001681|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Observational|||A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations|A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.906605|2017-02-18 18:23:26.906605
NCT00001680|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1997||1997-10-01|September 2000|2000-09-01|July 2001||2001-07-01|||||Interventional|||A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus|A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus|Completed||Phase 2|17||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:26.991551|2017-02-18 18:23:26.991551
NCT00001679|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1998||1998-08-01|August 1999|1999-08-01|June 2000||2000-06-01|||||Observational|||Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients|Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients|Completed||N/A|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.094191|2017-02-18 18:23:27.094191
NCT00001678|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 7, 1998||1998-07-07|June 20, 2014|2014-06-20|June 20, 2014||2014-06-20|||||Observational|||Genetics of Rheumatoid Arthritis|Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium|Completed||N/A|39|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.192859|2017-02-18 18:23:27.192859
NCT00001677|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1998||1998-06-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Interventional|||Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy|Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.287261|2017-02-18 18:23:27.287261
NCT00001676|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1998||1998-01-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Interventional|||Cyclophosphamide and Fludarabine to Treat Lupus Nephritis|Combination of Cyclophosphamide and Fludarabine for Lupus Nephritis: Tolerance, Toxicity, Efficacy and Effects on B and T Lymphocyte Regeneration|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.389739|2017-02-18 18:23:27.389739
NCT00001675|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 23, 1998||1998-01-23|December 23, 2015|2015-12-23|December 23, 2015||2015-12-23|||||Observational|||The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and Nonalcoholics|Functional Neuroanatomy of Positive and Negative Affect in Alcoholics and Non-Alcoholics|Completed||N/A|1194|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.48099|2017-02-18 18:23:27.48099
NCT00001673|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 2, 1997||1997-10-02|December 15, 2015|2015-12-15|December 15, 2015||2015-12-15|||||Observational|||Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Screening Evaluation for NIAAA Protocols|Completed||N/A|2220|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.571699|2017-02-18 18:23:27.571699
NCT00001672|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|August 1999|1999-08-01|March 2000||2000-03-01|||||Observational|||Language Localization Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Epilepsy|Language Localization Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Epilepsy|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.658429|2017-02-18 18:23:27.658429
NCT00001671|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 9, 1997||1997-09-09|December 15, 2008|2008-12-15|December 15, 2008||2008-12-15|||||Observational|||The Classification and Cause of Leukodystrophies of Unknown Cause|The Nosology and Etiology of Leukodystrophies of Unknown Cause|Completed||N/A|400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.735434|2017-02-18 18:23:27.735434
NCT00001669|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|April 1999|1999-04-01|April 2000||2000-04-01|||||Interventional|||A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients|A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients|Completed||Phase 2|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.827619|2017-02-18 18:23:27.827619
NCT00001668|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1997||1997-04-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Observational|||Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors|Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.920845|2017-02-18 18:23:27.920845
NCT00001667|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|February 1999|1999-02-01|April 2000||2000-04-01|||||Observational|||Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases|Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:27.995193|2017-02-18 18:23:27.995193
NCT00001665|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1997||1997-01-01|December 1999|1999-12-01|September 2000||2000-09-01|||||Observational|||Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease|Can Subthreshold Transcranial Magnetic Stimulation (rTMS) to Motor Cortex and/or to Supplementary Motor Area (SMA) Improve Performance of Complex Motor Sequences in Parkinson's Disease?|Completed||N/A|12||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.153303|2017-02-18 18:23:28.153303
NCT00001664|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 4, 1996||1996-12-04|September 7, 2011|2011-09-07|September 7, 2011||2011-09-07|||||Observational|||Sleep Disorders of Patients With Diseases of the Nervous System|Training Protocol for Various Sleep Disorders in Patients With Neurological Disorders|Completed||N/A|83|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.231524|2017-02-18 18:23:28.231524
NCT00001663|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1997||1997-01-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation|Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.308965|2017-02-18 18:23:28.308965
NCT00001662|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Treatment of Alzheimer's Disease With CX516 (Ampalex)|Tolerability and Primary Efficacy of CX516 in Alzheimer's Disease|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.38801|2017-02-18 18:23:28.38801
NCT00001661|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Mechanisms of Human Plasticity in the Human System|Mechanisms of Plasticity in the Human Motor System|Completed||N/A|260||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.468584|2017-02-18 18:23:28.468584
NCT00001659|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Consequences of Conjugal Bereavement in Adults|Conjugal Bereavement in Older Adults: Biological, Functional, and Psychological Consequences|Completed||N/A|210||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.550417|2017-02-18 18:23:28.550417
NCT00001658|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|August 2000|2000-08-01|June 2001||2001-06-01|||||Interventional|||Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections|A Placebo Controlled Trial of Amoxicillin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections|Completed||Phase 4|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.629011|2017-02-18 18:23:28.629011
NCT00001657|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1997||1997-06-01|August 1999|1999-08-01|May 2000||2000-05-01|||||Observational|||Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Chronic Posttraumatic Stress Disorder (PTSD)|Controlled Studies of Repetitive Transcranial Magnetic Stimulation (rTMS) in Chronic Posttraumatic Stress Disorder (PTSD)|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:28.841679|2017-02-18 18:23:28.841679
NCT00001656|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2011-03-11|2011-03-02||June 1997||1997-06-01|March 2011|2011-03-01|June 2008|Actual|2008-06-01|June 2008|Actual|2008-06-01||Interventional|||Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders|Childhood Onset Psychotic Disorders: Characterization and Treatment With Atypical Neuroleptics|Completed||Phase 4|25|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:23:28.931602|2017-02-18 18:23:28.931602
NCT00001654|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||The Role of Emotion in the Development of Psychopathology|The Role of Emotion in the Development of Psychopathology|Completed||N/A|1200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:29.71354|2017-02-18 18:23:29.71354
NCT00001652|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Observational|||The Evaluation and Follow-up of Patients With Bipolar Disorder|The Evaluation and Naturalistic Follow-up of Patients With Bipolar Disorder|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:29.793996|2017-02-18 18:23:29.793996
NCT00001651|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 18, 1997||1997-09-18|October 11, 2016|2016-10-11||||||||Observational|||Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients|Studies of Lymphocyte Kinetics Using Stable Isotopes|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:29.870901|2017-02-18 18:23:29.870901
NCT00001650|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 19, 1997||1997-09-19|May 13, 2011|2011-05-13|May 13, 2011||2011-05-13|||||Observational|||Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients|Studies of Lymphocyte Kinetics Using Bromodeoxyuridine|Completed||N/A|56|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:29.967946|2017-02-18 18:23:29.967946
NCT00001649|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Valaciclovir to Prevent Transmission of Herpes Simplex Virus|A Randomized, Double-Blind, Placebo-Controlled Evaluation of Valaciclovir for the Prevention of Herpes Simplex Virus Transmission in Heterosexual Couples|Completed||Phase 3|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:30.253842|2017-02-18 18:23:30.253842
NCT00001648|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 20, 1997||1997-08-20|April 13, 2010|2010-04-13|April 13, 2010||2010-04-13|||||Observational|||Structure of the Herpes Simplex Virus Receptor|Polymorphism of the Herpes Simplex Virus Receptor|Completed||N/A|60|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:30.345041|2017-02-18 18:23:30.345041
NCT00001647|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||White Blood Cell Infusions to Treat HIV Infection|Effects of Repeated Infusions of Adoptively Transferred Syngeneic Lymphocytes on the Immune Systems of HIV-1 Infected Identical Twins|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:30.430733|2017-02-18 18:23:30.430733
NCT00001646|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|September 1999|1999-09-01|August 2000||2000-08-01|||||Interventional|||Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis|Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis|Completed||Phase 3|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:30.543484|2017-02-18 18:23:30.543484
NCT00001645|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 19, 1997||1997-03-19|August 24, 2016|2016-08-24||||||||Observational|||Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection|Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:30.653851|2017-02-18 18:23:30.653851
NCT00001644|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 3, 1997||1997-03-03|February 17, 2010|2010-02-17|February 17, 2010|Actual|2010-02-17|February 17, 2010|Actual|2010-02-17||Interventional|||Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection|Use of Combination Antiviral Therapy to Delineate the Identity and Longevity of Persistent Reservoirs of HIV-1 Infection and Replication|Completed||Phase 1|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:30.766315|2017-02-18 18:23:30.766315
NCT00001643|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 29, 1997||1997-08-29|August 31, 2009|2009-08-31||||August 31, 2009|Actual|2009-08-31||Observational|||Gene Analysis of Parkinson's Disease|Gene Analysis in Parkinson's Disease|Completed||N/A|320||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:30.877171|2017-02-18 18:23:30.877171
NCT00001642|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-06|2008-03-03|||May 1997||1997-05-01|May 1999|1999-05-01|March 2000||2000-03-01|||||Observational|||Positional Cloning of the Gene(s) Responsible for Alagille Syndrome|Positional Cloning of the Gene(s) Responsible for Alagille Syndrome|Completed||N/A|225||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:30.970788|2017-02-18 18:23:30.970788
NCT00001641|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Study of Heritable Connective Tissue Disorders|Clinical and Molecular Manifestations of Heritable Connective Tissue Disorders|Completed||N/A|900||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:31.07149|2017-02-18 18:23:31.07149
NCT00001640|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 11, 1997||1997-02-11|February 10, 2009|2009-02-10|February 10, 2009||2009-02-10|||||Observational|||Genetic Analysis of Parkinson's Disease|Genetic Analysis of Parkinson's Disease|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:31.156521|2017-02-18 18:23:31.156521
NCT00001639|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|October 1999|1999-10-01|October 2000||2000-10-01|||||Observational|||Evaluation of Patients With Unresolved Chromosome Abnormalities|Evaluation of Patients With Unresolved Chromosome Aberrations|Completed||N/A|263||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:31.248883|2017-02-18 18:23:31.248883
NCT00001638|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 29, 1997||1997-09-29|August 4, 2009|2009-08-04|August 3, 2009|Actual|2009-08-03|August 3, 2009|Actual|2009-08-03||Observational|||Magnetic Resonance Imaging of the Blood Vessels of the Heart|Cardiovascular Magnetic Resonance Imaging|Completed||N/A|99999999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:31.325899|2017-02-18 18:23:31.325899
NCT00001637|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 29, 1997||1997-09-29|December 28, 2016|2016-12-28|December 28, 2016|Actual|2016-12-28|July 28, 2008|Actual|2008-07-28||Interventional|||Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults|Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults|Completed||Phase 2|28|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:31.416256|2017-02-18 18:23:31.416256
NCT00001633|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|December 1999|1999-12-01|December 2000||2000-12-01|||||Interventional|||Safety and Effectiveness of Coronary Magnetic Resonance Angiography (CMRA) Imaging|A Phase II Feasibility Study of the Safety and Efficacy of Coronary Magnetic Resonance Angiography (CMRA) Imaging|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:31.517527|2017-02-18 18:23:31.517527
NCT00001632|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease|Myocardial Ultrasonic Tissue Characterization in Patients With a Genetic Predisposition for the Development of Hypertrophic Cardiomyopathy|Completed||N/A|195||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:31.804958|2017-02-18 18:23:31.804958
NCT00001631|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Interventional|||Study of Blood Flow in Heart Muscle|Study of Myocardial Perfusion by MRI|Completed||Phase 2|249||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:31.900234|2017-02-18 18:23:31.900234
NCT00001630|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 21, 1997||1997-07-21|March 21, 2011|2011-03-21|June 11, 2009|Actual|2009-06-11|||||Interventional|||Treatment of Autoimmune Thrombocytopenia (AITP)|High-Dose Cyclophosphamide With CD34+ Selected Autologous Hematopoietic Cell Support for Treatment of Refractory Chronic Autoimmune Thrombocytopenia|Completed||Phase 1|29|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:31.998758|2017-02-18 18:23:31.998758
NCT00001629|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|June 1999|1999-06-01|September 2000||2000-09-01|||||Interventional|||The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function|The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function|Completed||Phase 3|49||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:32.105014|2017-02-18 18:23:32.105014
NCT00001628|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|June 1999|1999-06-01|September 2000||2000-09-01|||||Interventional|||The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function|The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function|Completed||Phase 3|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:32.215321|2017-02-18 18:23:32.215321
NCT00001627|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 4, 1997||1997-06-04|December 16, 2016|2016-12-16||||||||Observational|||Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes|Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes|Completed||N/A|154|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:32.308218|2017-02-18 18:23:32.308218
NCT00001626|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 2, 1997||1997-05-02|October 11, 2016|2016-10-11|March 3, 2008|Actual|2008-03-03|September 30, 2002|Actual|2002-09-30||Interventional|||Comparing Therapies for the Treatment of Severe Aplastic Anemia|A Randomized Trial of Antithymocyte Globulin and Cyclosporine Versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia|Completed||Phase 3|33|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 18:23:32.405661|2017-02-18 18:23:32.405661
NCT00001625|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 3, 1997||1997-04-03|April 11, 2007|2007-04-11|April 11, 2007||2007-04-11|||||Observational|||Methods for Measuring Insulin Sensitivity|Methods for Assessing Insulin Sensitivity In Vivo|Completed||N/A|480||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:32.522656|2017-02-18 18:23:32.522656
NCT00000148|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-06-02|||April 1988||1988-04-01|October 2003|2003-10-01||||||||Interventional|||Advanced Glaucoma Intervention Study (AGIS)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.971471|2017-02-18 18:26:23.971471
NCT00001624|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|February 1999|1999-02-01|March 2000||2000-03-01|||||Interventional|||Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation|Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation|Completed||Phase 1|16||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:32.6127|2017-02-18 18:23:32.6127
NCT00001623|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 27, 1997||1997-03-27|August 18, 2016|2016-08-18|January 31, 2008|Actual|2008-01-31|January 31, 2008|Actual|2008-01-31||Interventional|||Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia|HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies|Completed||N/A|41|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:32.711582|2017-02-18 18:23:32.711582
NCT00001622|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|January 2000|2000-01-01|March 2001||2001-03-01|||||Interventional|||Study of the Response of Human Small Blood Vessels|Study of the Relation Between In Vivo and In Vitro Response of Human Small Vessels|Completed||Phase 1|87||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:32.812493|2017-02-18 18:23:32.812493
NCT00001621|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 7, 1997||1997-01-07|November 22, 2016|2016-11-22||||||||Observational|||Evaluation and Treatment of Patients With Lung Disease Not Participating in Research|Evaluation and Treatment of Pulmonary Patients Not Participating in Research (Training Protocol)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:32.900378|2017-02-18 18:23:32.900378
NCT00001620|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 6, 1996||1996-12-06|September 22, 2016|2016-09-22||||||||Observational|||Screening for Hematology Branch Protocols|Screening Protocol for Subjects Being Evaluated for Hematology Branch Protocols|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:32.995554|2017-02-18 18:23:32.995554
NCT00001619|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||November 5, 1996||1996-11-05|July 20, 2011|2011-07-20|July 20, 2011||2011-07-20|||||Observational|||Magnetic Resonance Imaging at Different Levels of Magnetic Intensity|Magnetic Resonance at 1.5 and 3 Tesla|Completed||N/A|497|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.108657|2017-02-18 18:23:33.108657
NCT00001618|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||November 15, 1996||1996-11-15|November 22, 2016|2016-11-22||||||||Observational|||Segmental Bronchoalveolar Lavage|Bronchoscopy in Patients With Pulmonary Diseases and Research Volunteers|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.189876|2017-02-18 18:23:33.189876
NCT00001617|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|November 1999|1999-11-01|August 2000||2000-08-01|||||Observational|||Test of QLS Device to Detect Early Cataracts|Feasibility Study - Use of Quasielastic Light Scattering (QLS) Device in a Study of the Human Lens and Lens Opacities|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.288357|2017-02-18 18:23:33.288357
NCT00001615|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|May 1999|1999-05-01|May 2000||2000-05-01|||||Interventional|||Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration|Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration|Completed||Phase 1|180||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.496296|2017-02-18 18:23:33.496296
NCT00001614|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Interventional|||The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis|The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis|Completed||Phase 1|13||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.583975|2017-02-18 18:23:33.583975
NCT00001613|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Cataract Surgery to Obtain Human Lens Material for the Study of Nuclear Cataracts|Use of Human Lens Material for the Study of Nuclear Cataracts|Completed||N/A|96||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.66457|2017-02-18 18:23:33.66457
NCT00001612|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|May 1999|1999-05-01|August 2000||2000-08-01|||||Observational|||Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)|Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)|Completed||N/A|170||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.739474|2017-02-18 18:23:33.739474
NCT00001611|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Observational|||Immune Activity Against CVM Retinitis|Efficacy of Elevated CD4 Cell Counts on CMV Retinitis|Completed||N/A|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.832327|2017-02-18 18:23:33.832327
NCT00001610|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Normal Human Electro-Oculogram|Normal Human Electro-Oculogram|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:33.917429|2017-02-18 18:23:33.917429
NCT00001609|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1996||1996-10-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Studies of Families With Hereditary Cataracts|Clinical and Molecular Studies in Families With Congenital or Hereditary Cataracts|Completed||N/A|1200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.009172|2017-02-18 18:23:34.009172
NCT00001606|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 8, 1997||1997-09-08|April 7, 2015|2015-04-07|April 7, 2015||2015-04-07|||||Observational|||Genetic Analysis of Human Hereditary Hearing Impairment|Genetic Analysis of Human Hereditary Hearing Impairment|Terminated||N/A|404|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.086626|2017-02-18 18:23:34.086626
NCT00001605|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|April 2000|2000-04-01|April 2001||2001-04-01|||||Interventional|||Vaccination for Middle Ear Infection|Phase I Study to Evaluate the Safety and Immunogenicity of a Nontypeable Haemophilus Influenzae Vaccine for Otitis Media|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.178354|2017-02-18 18:23:34.178354
NCT00001604|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 7, 1997||1997-01-07|October 28, 2016|2016-10-28||||||||Observational|||Genetic Linkage Studies of Stuttering|Genetic Studies of Stuttering|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.275191|2017-02-18 18:23:34.275191
NCT00001457|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1995||1995-09-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Lamivudine for Chronic Hepatitis B|Lamivudine for Chronic Hepatitis B|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.300289|2017-02-18 18:23:51.300289
NCT00001603|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Observational|||The Effects of Upper Airway and Digestive Tract Tumors on the Immune System|A Pilot Study of Immunoregulatory Factor Expression and Immune Responses in Patients With Squamous Cell Carcinoma or Papilloma of the Upper Aerodigestive Tract|Completed||N/A|93||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.381025|2017-02-18 18:23:34.381025
NCT00001602|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1996||1996-10-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Observational|||Genetic Factors Related to Stuttering|Genetic Linkage Analysis in Developmental Stuttering: Gene Mapping in Extended Kindreds and Candidate Gene Analyses|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.470528|2017-02-18 18:23:34.470528
NCT00001601|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||Evaluation and Treatment of Oral Soft Tissue Diseases|Patient Evaluation and Treatment of Oral Soft Tissue Diseases According to Generally Available, Standard Procedures and Therapeutic Modalities|Completed||N/A|999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.558399|2017-02-18 18:23:34.558399
NCT00001600|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1997||1997-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Diagnosis and Evaluation of Patients Needing Third Molar (Wisdom Tooth) Extraction and Patients With Chronic Facial Pain|Diagnosis and Evaluation of Patients in Need of Third Molar Removal or Suffering From Chronic Facial Pain|Completed||N/A|4000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.658307|2017-02-18 18:23:34.658307
NCT00001599|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Pilot Study of Thalidomide to Treat Sjogren's Syndrome|Pilot Study of Thalidomide for Sjogren's Syndrome|Completed||Phase 2|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.735503|2017-02-18 18:23:34.735503
NCT00001598|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1997||1997-05-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||DHEA Treatment for Sjogren's Syndrome|Dehydroepiandrosterone (DHEA) Treatment for Sjogren's Syndrome|Completed||Phase 2|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.837346|2017-02-18 18:23:34.837346
NCT00001597|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Pain Measurement in Healthy Volunteers|Pain Measurement in Healthy Volunteers|Completed||N/A|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:34.933354|2017-02-18 18:23:34.933354
NCT00001596|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2015-10-05|2011-12-12||September 2005||2005-09-01|October 2015|2015-10-01|September 2020|Anticipated|2020-09-01|September 2009|Actual|2009-09-01||Interventional|||Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome|Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome|Active, not recruiting||Phase 2|35|Actual|National Institutes of Health Clinical Center (CC)|Study enrollment progressed more slowly than anticipated (spanning >3 years instead of one). The Data Safety and Monitoring Board performed an interim analysis one year after 30 subjects enrolled and directed the study to stop due to futility.|2|||f||||t||||||||||2017-02-18 18:23:35.011846|2017-02-18 18:23:35.011846
NCT00001595|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-11|||February 13, 1997||1997-02-13|November 8, 2016|2016-11-08||||||||Observational|||An Investigation of Pituitary Tumors and Related Hypothalmic Disorders|A Clinical and Genetic Investigation of Pituitary and HYPOTHALAMIC Tumors and Related Disorders|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:35.622993|2017-02-18 18:23:35.622993
NCT00001594|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-10|||January 13, 1997||1997-01-13|October 19, 2016|2016-10-19||||||||Observational|||Evaluation and Intervention for the Effects of Osteogenesis Imperfecta|Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:35.723606|2017-02-18 18:23:35.723606
NCT00001591|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy|Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy|Completed||N/A|450||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:38.842799|2017-02-18 18:23:38.842799
NCT00001589|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1997||1997-04-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors|Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:38.973149|2017-02-18 18:23:38.973149
NCT00001587|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1997||1997-09-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Interventional|||A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver|A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:39.058166|2017-02-18 18:23:39.058166
NCT00001586|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-03-19|2012-12-18||September 1997||1997-09-01|March 2013|2013-03-01|November 2011|Actual|2011-11-01|November 2011|Actual|2011-11-01||Interventional|||Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis|Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis|Completed||Phase 2|105|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||f||||||||||2017-02-18 18:23:39.153346|2017-02-18 18:23:39.153346
NCT00001584|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Observational|||Determination of HIV-1 Production by the Prostate|Determination of HIV-1 Production by the Prostate|Completed||N/A|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:39.883619|2017-02-18 18:23:39.883619
NCT00001582|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 8, 1997||1997-07-08|September 23, 2016|2016-09-23||||||||Observational|||Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer|Collection of Blood, Bone Marrow and Tissue Samples for the Investigation of the Human Immune Response, Lymphoma Biology and HTLV-1 Infection|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:39.960595|2017-02-18 18:23:39.960595
NCT00001580|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1997||1997-06-01|March 2003|2003-03-01|March 2003||2003-03-01|||||Observational|||Tissue Acquisition for Molecular Diagnostics|Tissue Acquisition for Molecular Diagnostics|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:40.074243|2017-02-18 18:23:40.074243
NCT00001579|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2006-07-14|||June 1997||1997-06-01|May 2000|2000-05-01|March 2001||2001-03-01|||||Interventional|||A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors|A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:40.425673|2017-02-18 18:23:40.425673
NCT00001577|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1997||1997-06-01|April 1999|1999-04-01|March 2000||2000-03-01|||||Interventional|||Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity|Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:40.512207|2017-02-18 18:23:40.512207
NCT00001576|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1997||1997-07-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver|A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver|Completed||Phase 1|28||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:40.601642|2017-02-18 18:23:40.601642
NCT00001575|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2015-10-30|2015-05-14||April 1997||1997-04-01|October 2015|2015-10-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Interventional|||Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia||Completed||Phase 1/Phase 2|87|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 18:23:40.700096|2017-02-18 18:23:40.700096
NCT00001574|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 14, 1997||1997-03-14|August 3, 2016|2016-08-03||||||||Observational|||A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors|A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors|Completed||N/A|40|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:41.132037|2017-02-18 18:23:41.132037
NCT00001573|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1997||1997-03-01|February 2000|2000-02-01|May 2000||2000-05-01|||||Interventional|||A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy|A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:41.22977|2017-02-18 18:23:41.22977
NCT00001572|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 30, 1997||1997-01-30|November 2, 2010|2010-11-02|November 2, 2010|Actual|2010-11-02|July 31, 1999|Actual|1999-07-31||Interventional|||Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype|Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype|Completed||Phase 1|21|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:41.318781|2017-02-18 18:23:41.318781
NCT00001571|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Observational|||A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines|A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:41.411178|2017-02-18 18:23:41.411178
NCT00001570|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Interventional|||A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer|A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer|Completed||Phase 1|46||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:41.494819|2017-02-18 18:23:41.494819
NCT00001569|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1997||1997-01-01|December 2002|2002-12-01|December 2002||2002-12-01|||||Interventional|||Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis|Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis|Completed||Phase 1|74||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:41.580285|2017-02-18 18:23:41.580285
NCT00001568|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1997||1997-02-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities|Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities|Completed||Phase 2|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:41.671696|2017-02-18 18:23:41.671696
NCT00001567|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1997||1997-01-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia|A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia|Completed||Phase 2|56||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:41.753448|2017-02-18 18:23:41.753448
NCT00001566|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2012-06-12|2012-03-28||December 1996||1996-12-01|June 2012|2012-06-01|September 2008|Actual|2008-09-01|September 2008|Actual|2008-09-01||Interventional|||A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas|A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas|Completed||Phase 2|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||f||||||||||2017-02-18 18:23:41.847369|2017-02-18 18:23:41.847369
NCT00001565|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1996||1996-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy|Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy|Completed||Phase 1|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:42.667551|2017-02-18 18:23:42.667551
NCT00000555|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||August 1996||1996-08-01|August 2005|2005-08-01|May 2003|Actual|2003-05-01|||||Interventional|||Women's Angiographic Vitamin and Estrogen Trial (WAVE)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:57.497059|2017-02-18 18:25:57.497059
NCT00001564|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 23, 1996||1996-12-23|September 4, 2014|2014-09-04|October 25, 2007|Actual|2007-10-25|October 25, 2007|Actual|2007-10-25||Interventional|||A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas|A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas|Completed||Phase 2|30|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:42.765513|2017-02-18 18:23:42.765513
NCT00001563|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 10, 1996||1996-12-10|July 28, 2016|2016-07-28|May 5, 2005|Actual|2005-05-05|May 5, 2005|Actual|2005-05-05||Interventional|||EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma|EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma|Completed||Phase 2|39|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:42.873821|2017-02-18 18:23:42.873821
NCT00001561|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2007-09-21|||November 1996||1996-11-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Interventional|||Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation|Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation|Completed||Phase 3|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.002016|2017-02-18 18:23:43.002016
NCT00001560|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 24, 1996||1996-12-24|October 31, 2011|2011-10-31|October 31, 2011||2011-10-31|||||Observational|||Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers|Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers|Completed||N/A|24|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.112905|2017-02-18 18:23:43.112905
NCT00001554|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|May 1999|1999-05-01|June 2000||2000-06-01|||||Interventional|||Infrared Camera for Brain Mapping During Surgery|Intraoperative Infrared Functional Brain Mapping|Completed||Phase 1|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.199985|2017-02-18 18:23:43.199985
NCT00001553|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1996||1996-05-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Observational|||Motor Changes Associated With Recovery From Stroke After Therapy|Functional Changes Associated With Recovery of Motor Function in Chronic Ischemic Subcortical Stroke After a Therapeutic Intervention|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.290548|2017-02-18 18:23:43.290548
NCT00001552|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 22, 1996||1996-05-22|November 13, 2009|2009-11-13||||November 13, 2009|Actual|2009-11-13||Observational|||Characteristics of Idiopathic Familial Voice Disorders|Characteristics of Idiopathic Familial Voice Disorders|Completed||N/A|270||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.376836|2017-02-18 18:23:43.376836
NCT00001551|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 22, 1996||1996-05-22|November 13, 2009|2009-11-13||||November 13, 2009|Actual|2009-11-13||Observational|||Characteristics of Idiopathic Familial Speech Disorders|Characteristics of Idiopathic Familial Speech Disorders|Completed||N/A|375||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.464161|2017-02-18 18:23:43.464161
NCT00001550|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2006-07-13|||April 1996||1996-04-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Interventional|||Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)|The Efficacy of High-Dose Intravenous Immunoglobulin Therapy in Patients With Stiff-Man Syndrome: A Double-Blind, Placebo-Controlled Trial|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.55407|2017-02-18 18:23:43.55407
NCT00001549|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1995||1995-10-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Diagnosis and Natural History Study of Patients With Neurological Conditions|Diagnosis and Natural History Protocol for Patients With Neurological Conditions|Completed||N/A|600||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.651706|2017-02-18 18:23:43.651706
NCT00001548|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 22, 1996||1996-08-22|September 29, 2015|2015-09-29|September 29, 2015||2015-09-29|||||Observational|||Genetics of Obsessive-Compulsive Disorder|Genetics of Obsessive-Compulsive Disorder: A Collaborative Study|Completed||N/A|1067|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.73245|2017-02-18 18:23:43.73245
NCT00001547|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Neuropsychiatric Effects of Interferon-Alpha and Ribavirin|A Magnetic Resonance Spectroscopy Study of Neuropsychiatric Effects Associated With Cytokines|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.841809|2017-02-18 18:23:43.841809
NCT00001546|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1996||1996-05-01|April 1999|1999-04-01|June 2000||2000-06-01|||||Observational|||Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers|Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers|Completed||N/A|38||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:43.927988|2017-02-18 18:23:43.927988
NCT00001545|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2006-07-12|||May 1996||1996-05-01|July 2006|2006-07-01|July 2006||2006-07-01|||||Interventional|||Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders|Evaluation of rTMS in the Treatment of Mood Disorders|Completed||Phase 2|91||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.008666|2017-02-18 18:23:44.008666
NCT00001544|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Genetic Aspects of Neurologic and Psychiatric Disorders|Genetic Aspects of Neurologic and Psychiatric Disorders|Completed||N/A|1227||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.10566|2017-02-18 18:23:44.10566
NCT00001543|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1996||1996-03-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Dynamics of Leptin and Endocrine Function|Dynamics of Leptin and Endocrine Function|Completed||N/A|230||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.189396|2017-02-18 18:23:44.189396
NCT00001542|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1996||1996-07-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Fluconazole Prophylaxis of Thrush in AIDS|Fluconazole Prophylaxis of Thrush in AIDS|Completed||Phase 4|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.275667|2017-02-18 18:23:44.275667
NCT00001277|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 1, 1991||1991-03-01|September 14, 2016|2016-09-14||||||||Observational|||Studies of Elevated Parathyroid Activity|Studies of Hyperparathyroidism and Related Disorders|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.651467|2017-02-18 18:24:09.651467
NCT00001541|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|January 2003|2003-01-01|January 2003||2003-01-01|||||Observational|||Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis|Analysis of Bronchial and Bronchoalveolar Lavage Fluid and Bronchial Mucosal Biopsies in Patients With Wegener's Granulomatosis|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.365553|2017-02-18 18:23:44.365553
NCT00001540|ClinicalTrials.gov processed this data on February 17, 2017|2000-04-01|2008-03-03|||April 1996||1996-04-01|February 1999|1999-02-01|March 2000||2000-03-01|||||Observational|||The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo|The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo|Completed||N/A|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.445975|2017-02-18 18:23:44.445975
NCT00001539|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 22, 1996||1996-03-22|August 18, 2016|2016-08-18||||||||Observational|||Evaluation of Lyme Disease: Clinical, Microbiological and Immunological Characteristics|A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Chronic Lyme Infection and Selected Control Populations|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.524557|2017-02-18 18:23:44.524557
NCT00001538|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1996||1996-03-01|February 2000|2000-02-01|April 2001||2001-04-01|||||Interventional|||Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers|Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers|Completed||Phase 1|41||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.626984|2017-02-18 18:23:44.626984
NCT00001536|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1996||1996-08-01|August 1999|1999-08-01|July 2000||2000-07-01|||||Observational|||Issues Surrounding Prenatal Genetic Testing for Achondroplasia|Issues Surrounding Prenatal Genetic Testing for Achondroplasia|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.71398|2017-02-18 18:23:44.71398
NCT00001535|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-02-07|||March 1996||1996-03-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Twins Study of Gene Therapy for HIV Infection|Gene Therapy for AIDS Using Retroviral Mediated Gene Transfer to Deliver HIV-1 Anti-Sense TAR and Transdominant Rev Protein Genes to Syngeneic Lymphocytes in HIV-1 Infected Identical Twins|Completed||Phase 1|48||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.791982|2017-02-18 18:23:44.791982
NCT00001534|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1996||1996-09-01|April 2003|2003-04-01|April 2003||2003-04-01|||||Observational|||Long Term Effects of Enalapril and Losartan on Genetic Heart Disease|Double-Blind, Placebo-Controlled Study of the Long Term Effects of Angiotensin Converting Enzyme Inhibition (Enalapril) and Angiotensin II Receptor Blockade (Losartan) on Genetically-Induced Left Ventricular Hypertrophy in Non-Obstructive HCM|Completed||N/A|112||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.889135|2017-02-18 18:23:44.889135
NCT00001533|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2006-07-14|||September 1996||1996-09-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Interventional|||Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine|Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:44.990018|2017-02-18 18:23:44.990018
NCT00001532|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 6, 1996||1996-06-06|December 16, 2016|2016-12-16||||||||Observational|||Role of Genetic Factors in the Development of Lung Disease|Role of Genetic Factors in the Pathogenesis of Lung Disease|Recruiting||N/A|3600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:45.100369|2017-02-18 18:23:45.100369
NCT00001531|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|August 1999|1999-08-01|September 2000||2000-09-01|||||Observational|||Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction|Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction|Completed||N/A|355||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:45.211829|2017-02-18 18:23:45.211829
NCT00001530|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|April 1999|1999-04-01|May 2000||2000-05-01|||||Observational|||Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy|Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:45.295612|2017-02-18 18:23:45.295612
NCT00001529|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 12, 1996||1996-03-12|December 7, 2016|2016-12-07|May 1, 2030|Anticipated|2030-05-01|May 1, 2026|Anticipated|2026-05-01||Interventional|||Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives|Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections From Healthy Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation|Recruiting||Phase 1|99999999|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:45.645898|2017-02-18 18:23:45.645898
NCT00001528|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1996||1996-02-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Observational|||Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease|Post-Stress Left Ventricular Contractile Dysfunction: Does It Represent Persistent Myocardial Ischemia or Stunning?|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:45.762103|2017-02-18 18:23:45.762103
NCT00001527|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1995||1995-11-01|November 1999|1999-11-01|September 2000||2000-09-01|||||Observational|||Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension|Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:45.839277|2017-02-18 18:23:45.839277
NCT00001526|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 4, 1996||1996-06-04|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Interventional|||ANTI-TAC THERAPY FOR UVEITIS|Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis With Humanized Anti-Tac Antibody Therapy|Completed||Phase 1|15||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:45.930374|2017-02-18 18:23:45.930374
NCT00001524|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|December 2004|2004-12-01|December 2004||2004-12-01|||||Interventional|||Thalidomide to Treat Oral Lesions in HIV-Infected Patients|Evaluation of a TNF-Alpha Modulator for the Treatment of Oral Lesions in HIV/AIDS Patients|Completed||Phase 2|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.029923|2017-02-18 18:23:46.029923
NCT00001523|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1996||1996-05-01|June 1999|1999-06-01|March 2000||2000-03-01|||||Observational|||Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation|Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.126433|2017-02-18 18:23:46.126433
NCT00001522|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 4, 1996||1996-06-04|November 17, 2016|2016-11-17||||||||Observational|||Metabolic Differences of Overweight Children and Children of Overweight Parents|Population Differences in the Insulin Sensitivity, Resting Energy Expenditure, and Body Composition of Overweight Children and Children of Overweight Parents|Active, not recruiting||N/A|246|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.202936|2017-02-18 18:23:46.202936
NCT00001521|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 2, 1996||1996-02-02|January 11, 2017|2017-01-11|January 11, 2017|Actual|2017-01-11|||||Interventional|||Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia|An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children With Congenital Adrenal Hyperplasia|Completed||Phase 1|62|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:46.315452|2017-02-18 18:23:46.315452
NCT00001520|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1996||1996-09-01|September 1999|1999-09-01|August 2000||2000-08-01|||||Interventional|||The Early Reversibility of Rocuronium After Different Doses of Neostigmine|The Early Reversibility of Rocuronium After Different Doses of Neostigmine|Completed||Phase 4|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.416492|2017-02-18 18:23:46.416492
NCT00001519|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1996||1996-06-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Observational|||Oxygen Uptake Kinetics During Recovery From Maximal and Submaximal Exercise|Oxygen Uptake Kinetics During Recovery From Maximal and Submaximal Exercise|Completed||N/A|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.537128|2017-02-18 18:23:46.537128
NCT00001518|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1996||1996-01-01|December 1999|1999-12-01|November 2000||2000-11-01|||||Observational|||A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters|A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters|Completed||N/A|132||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.613067|2017-02-18 18:23:46.613067
NCT00001516|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1996||1996-01-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||Evaluating the Personal Computer as a Treatment Activity in Occupational Therapy|Linking Occupational Therapy Process and Patient Performance: The Personal Computer Activity in Occupational Interventions|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.69931|2017-02-18 18:23:46.69931
NCT00001515|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1995||1995-12-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Interventional|||Diagnostic Effectiveness of Virtual Bronchoscopy|Diagnostic Efficacy of Virtual Bronchoscopy|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.783431|2017-02-18 18:23:46.783431
NCT00001512|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 9, 1996||1996-09-09|March 5, 2010|2010-03-05|March 5, 2010|Actual|2010-03-05|March 5, 2010|Actual|2010-03-05||Interventional|||Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines|Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines|Completed||Phase 1|42|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:46.882523|2017-02-18 18:23:46.882523
NCT00001509|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1996||1996-07-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Interventional|||A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor|A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:46.979417|2017-02-18 18:23:46.979417
NCT00001507|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 12, 1996||1996-07-12|June 20, 2014|2014-06-20|June 20, 2014|Actual|2014-06-20|June 30, 1998|Actual|1998-06-30||Interventional|||Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer|A Multi-Center Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide With Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer|Completed||Phase 1|107|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:47.087397|2017-02-18 18:23:47.087397
NCT00001506|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 10, 1996||1996-06-10|December 21, 2016|2016-12-21||||||||Observational|||Evaluation and Treatment of Patients With Dermatologic Diseases|Evaluation and Treatment of Subjects With Dermatologic Diseases|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.185953|2017-02-18 18:23:47.185953
NCT00001505|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 3, 1996||1996-06-03|November 8, 2016|2016-11-08||||||||Observational|||The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases|The Acquisition of Blood and Skin Samples From Patient Volunteers to Support Research Activities on Dermatologic and Other Diseases|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.29125|2017-02-18 18:23:47.29125
NCT00001504|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1996||1996-05-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients|A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients|Completed||Phase 1|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.393294|2017-02-18 18:23:47.393294
NCT00001503|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 1, 1996||1996-05-01|November 9, 2016|2016-11-09||||||||Observational|||Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease|Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols|Enrolling by invitation||N/A|981|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.479672|2017-02-18 18:23:47.479672
NCT00001502|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|February 2000|2000-02-01|March 2000||2000-03-01|||||Interventional|||A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors|Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.562712|2017-02-18 18:23:47.562712
NCT00001500|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1996||1996-04-01|July 2004|2004-07-01|July 2004||2004-07-01|||||Observational|||Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits|Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits|Completed||N/A|4500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.653864|2017-02-18 18:23:47.653864
NCT00001499|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1996||1996-03-01|March 2000|2000-03-01|June 2000||2000-06-01|||||Interventional|||Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer|Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.750334|2017-02-18 18:23:47.750334
NCT00001498|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1996||1996-02-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer|A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer|Completed||Phase 2|55||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.842888|2017-02-18 18:23:47.842888
NCT00001497|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1995||1995-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Observational|||Assessment of Attentional Functioning in Children With HIV-1 Infection|Assessment of Attentional Functioning in Children With HIV-1 Infection|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:47.948653|2017-02-18 18:23:47.948653
NCT00001496|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1996||1996-01-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer|Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.040472|2017-02-18 18:23:48.040472
NCT00001495|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1995||1995-11-01|September 1999|1999-09-01|October 2000||2000-10-01|||||Interventional|||A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors|A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.11732|2017-02-18 18:23:48.11732
NCT00001493|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1995||1995-10-01|August 1999|1999-08-01|June 2000||2000-06-01|||||Interventional|||Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer|Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cance|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.208644|2017-02-18 18:23:48.208644
NCT00001491|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 11, 1995||1995-05-11|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Analysis of the Nervous System in Patients With Fabry's Disease|The Natural History and Pathogenesis of Fabry Disease|Completed||N/A|325||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.302288|2017-02-18 18:23:48.302288
NCT00001489|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1994||1994-10-01|August 1999|1999-08-01|August 2000||2000-08-01|||||Observational|||Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism|The Effect of Vigabatrin on Cerebral Blood Flow and Glucose Metabolism|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.399149|2017-02-18 18:23:48.399149
NCT00001487|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|April 2004|2004-04-01|April 2004||2004-04-01|||||Interventional|||Treatment of Mid-Life-Related Mood Disorders|Dehydroepiandrosterone Treatment of Mid-Life-Related Mood Disorders in Women and Men|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.494087|2017-02-18 18:23:48.494087
NCT00001486|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 30, 1995||1995-06-30|September 22, 2016|2016-09-22||||||||Observational|||Genetic Study of Schizophrenia|A Neurobiological Investigation of Patients With Schizophrenia Spectrum Disorders and Their Siblings|Recruiting||N/A|6150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.592674|2017-02-18 18:23:48.592674
NCT00001485|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|August 1999|1999-08-01|April 2000||2000-04-01|||||Observational|||Effects of Season on Melatonin Secretion in Healthy Men and Women and Patients With Seasonal Affective Disorder|Gender Differences in the Effects of Season on Patterns of Nocturnal Melatonin Secretion in Healthy Volunteers and Patients With Seasonal Affective Disorder (SAD)|Completed||N/A|116||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.69898|2017-02-18 18:23:48.69898
NCT00001483|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Interventional|||Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression|Acute Efficacy of Bupropion, Sertraline, and Venlafaxine as Adjuvant Treatment to Mood Stabilizers in Bipolar Depression: A Randomized, Double-Blind, Comparative Study|Completed||Phase 2|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.792796|2017-02-18 18:23:48.792796
NCT00001482|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1995||1995-05-01|June 2000|2000-06-01|May 2001||2001-05-01|||||Interventional|||New Drugs in the Treatment of Mood Disorders|Evaluation of Lamotrigine (Lamictal® (Registered Trademark)) Monotherapy and Gabapentin (Neurontin® (Registered Trademark)) Monotherapy in the Treatment of Mood Disorders|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:48.898339|2017-02-18 18:23:48.898339
NCT00001481|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 31, 1995||1995-03-31|November 25, 2016|2016-11-25||||||||Observational|||The Role of Hormones in Postpartum Mood Disorders|An Endocrine Model for Postpartum Mood Disorders|Recruiting||N/A|80|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.00136|2017-02-18 18:23:49.00136
NCT00001480|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 21, 1995||1995-03-21|March 31, 2007|2007-03-31|March 31, 2007||2007-03-31|||||Observational|||The Evaluation and Follow-up of Individuals With Memory Disorder|The Evaluation and Follow-up of Patients With Memory Disorder and Normal Controls|Completed||N/A|750||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.115222|2017-02-18 18:23:49.115222
NCT00001479|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1995||1995-01-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Observational|||Study of the Hypothalmic-Pituitary-Adrenal (HPA) Axis and Its Role in Major Depression|Intensively Sampled Dynamics of ACTH and Cortisol Affective Disorders|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.215244|2017-02-18 18:23:49.215244
NCT00001478|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1994||1994-10-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Observational|||Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders|Regional Cerebral Blood Flow Correlates of Spontaneous and Drug-Induced Clinical Changes in Mood Disorders|Completed||N/A|170||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.303646|2017-02-18 18:23:49.303646
NCT00001477|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1995||1995-08-01|February 2000|2000-02-01|October 2000||2000-10-01|||||Observational|||Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy|Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.384515|2017-02-18 18:23:49.384515
NCT00001476|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 1, 1995||1995-06-01|December 13, 2010|2010-12-13|December 13, 2010|Actual|2010-12-13|December 13, 2010|Actual|2010-12-13||Interventional|||Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up|Gene Therapy Approach for Chronic Granulomatous Disease|Completed||Phase 1|14|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:49.469016|2017-02-18 18:23:49.469016
NCT00001475|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist|A Randomized Trial of Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist in Patients With HIV-1 Infection|Completed||Phase 2|85||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.561991|2017-02-18 18:23:49.561991
NCT00001474|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1995||1995-05-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients|Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients|Completed||Phase 2|36||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.660316|2017-02-18 18:23:49.660316
NCT00001473|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides|A Staged Therapeutic Approach Using Cyclophosphamide and Methotrexate in the Treatment of Wegener's Granulomatosis and Related Vasculitides|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.758709|2017-02-18 18:23:49.758709
NCT00001471|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||November 21, 1994||1994-11-21|December 5, 2016|2016-12-05||||||||Observational|||Tissue Biopsy and Imaging Studies in HIV-Infected Patients|Virologic and Immunologic Evaluation of Lymph Node, Tonsillar, and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid|Recruiting||N/A|635|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.852058|2017-02-18 18:23:49.852058
NCT00001469|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 14, 1995||1995-07-14|September 26, 2016|2016-09-26||||||||Observational|||Genetic Analysis of Hereditary Prostate Cancer|Genetic Analysis of Hereditary Prostate Cancer|Completed||N/A|70000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:49.964937|2017-02-18 18:23:49.964937
NCT00001468|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|February 2000|2000-02-01|February 2001||2001-02-01|||||Observational|||Outcomes of Education and Counseling for BRCA1 Testing|Outcomes of Education and Counseling for BRCA1 or BRCA2 Testing|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:50.351184|2017-02-18 18:23:50.351184
NCT00001467|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 31, 1995||1995-01-31|April 8, 2016|2016-04-08||||||||Observational|||Genetic Analysis of Immune Disorders|Genetic Analysis of Immune Disorders|Enrolling by invitation||N/A|3155|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:50.442382|2017-02-18 18:23:50.442382
NCT00001466|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1994||1994-10-01|September 1999|1999-09-01|October 2000||2000-10-01|||||Observational|||Study of Clinical and Molecular Manifestations of Genetic Disorders|Clinical and Molecular Manifestations of Six Categories of Genetic Disorders|Completed||N/A|1200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:50.54486|2017-02-18 18:23:50.54486
NCT00001465|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 25, 1995||1995-09-25|December 16, 2016|2016-12-16||||||||Observational|||Study of the Disease Process of Lymphangioleiomyomatosis|Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:50.628066|2017-02-18 18:23:50.628066
NCT00001464|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 28, 1995||1995-07-28|November 3, 2016|2016-11-03|July 10, 2007|Actual|2007-07-10|July 10, 2007|Actual|2007-07-10||Interventional|||Effect of High Levels of Oxygen and Smoking on the Lungs in Human Volunteers|Effect of Hypoxia and Smoking on Oxidation of Proteins and Nucleic Acids in Human Volunteers|Completed||Phase 1|77|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:50.739337|2017-02-18 18:23:50.739337
NCT00001462|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1995||1995-05-01|August 1999|1999-08-01|April 2000||2000-04-01|||||Observational|||Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals|Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:50.843327|2017-02-18 18:23:50.843327
NCT00001461|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|April 2000|2000-04-01|April 2001||2001-04-01|||||Observational|||Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme|Investigation of the Interaction Between the Vascular Endothelium and Angiotensin-Converting Enzyme|Completed||N/A|209||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:50.932578|2017-02-18 18:23:50.932578
NCT00001460|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||January 1995||1995-01-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||Evaluation and Treatment of Heart Disease in Patients Not Participating in Research|Evaluation and Therapy of Heart Disease in Patients Not Participating in Research (Teaching Protocol)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.020775|2017-02-18 18:23:51.020775
NCT00001459|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1995||1995-01-01|January 2000|2000-01-01|March 2001||2001-03-01|||||Observational|||Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers|Tomographic Myocardial Wall Motion Analysis in Patients With Myocardial Ischemia and in Normal Subjects|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.110905|2017-02-18 18:23:51.110905
NCT00001458|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 6, 1995||1995-01-06|April 29, 2016|2016-04-29||||||||Observational|||Evaluation of Patients With Heart Disease Not Eligible for Research Protocols|Diagnosis and Treatment of Patients With Heart and Vascular Disease (Training Protocol)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.197442|2017-02-18 18:23:51.197442
NCT00001456|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 20, 1995||1995-09-20|September 26, 2016|2016-09-26||||||||Observational|||Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome|Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.394369|2017-02-18 18:23:51.394369
NCT00001455|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|June 1999|1999-06-01|June 2000||2000-06-01|||||Observational|||Iron Overload in African Americans|Iron Overload in African Americans|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.504459|2017-02-18 18:23:51.504459
NCT00001454|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 21, 1995||1995-04-21|July 27, 2015|2015-07-27|July 27, 2015||2015-07-27|||||Observational|||Hormonal Effects on the Uterus and Endometrium|Endometrial Mediators of Gonadal Steroid Action|Completed||N/A|129|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.589907|2017-02-18 18:23:51.589907
NCT00001453|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 10, 1995||1995-04-10|October 20, 2014|2014-10-20|October 20, 2014||2014-10-20|||||Observational|||Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome|Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome|Completed||N/A|98|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.677723|2017-02-18 18:23:51.677723
NCT00001452|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-01|||January 23, 1995||1995-01-23|January 18, 2017|2017-01-18||||||||Observational|||Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex|Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.76798|2017-02-18 18:23:51.76798
NCT00001451|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 14, 1995||1995-03-14|February 1, 2011|2011-02-01|February 1, 2011||2011-02-01|||||Observational|||Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)|Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)|Completed||N/A|57|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.867971|2017-02-18 18:23:51.867971
NCT00001450|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1995||1995-09-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Interventional|||Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC|Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC|Completed||Phase 2|58||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:51.945637|2017-02-18 18:23:51.945637
NCT00001449|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1995||1995-09-01|September 1999|1999-09-01|April 2000||2000-04-01|||||Interventional|||A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients|A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.039595|2017-02-18 18:23:52.039595
NCT00001448|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1995||1995-08-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Observational|||The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection|The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.124991|2017-02-18 18:23:52.124991
NCT00001446|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1995||1995-09-01|August 2000|2000-08-01|July 2001||2001-07-01|||||Interventional|||A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer|A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer|Completed||Phase 2|64||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.20758|2017-02-18 18:23:52.20758
NCT00001445|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1995||1995-08-01|August 2000|2000-08-01|July 2001||2001-07-01|||||Interventional|||Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection|Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection|Completed||Phase 1|32||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.3046|2017-02-18 18:23:52.3046
NCT00001444|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1995||1995-08-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Interventional|||A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms|A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms|Completed||Phase 1|51||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.393976|2017-02-18 18:23:52.393976
NCT00001443|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1995||1995-07-01|March 2000|2000-03-01|October 2000||2000-10-01|||||Interventional|||A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection|A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection|Completed||Phase 1|63||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.48799|2017-02-18 18:23:52.48799
NCT00001442|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1995||1995-07-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Interventional|||A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer|A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer|Completed||Phase 1|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.58667|2017-02-18 18:23:52.58667
NCT00001440|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-13|2008-03-03|||July 1995||1995-07-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy|Pilot Study of Autologous T Cells and/or IL-2 for the Enhancement of Immune Reconstitution After Dose-Intensive Chemotherapy for Breast Cancer|Completed||Phase 1|51||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.679774|2017-02-18 18:23:52.679774
NCT00001439|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Interventional|||A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant|A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant|Completed||Phase 1|255||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.774827|2017-02-18 18:23:52.774827
NCT00001438|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes|A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.868196|2017-02-18 18:23:52.868196
NCT00001437|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 1999|1999-05-01|March 2000||2000-03-01|||||Interventional|||Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis|Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:52.962471|2017-02-18 18:23:52.962471
NCT00001436|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1995||1995-05-01|April 2000|2000-04-01|September 2000||2000-09-01|||||Interventional|||A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma|A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma|Completed||Phase 1|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.069509|2017-02-18 18:23:53.069509
NCT00001435|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1995||1995-04-01|February 2000|2000-02-01|December 2000||2000-12-01|||||Observational|||Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children|Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children|Completed||N/A|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.161705|2017-02-18 18:23:53.161705
NCT00001432|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Observational|||The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies|The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.243234|2017-02-18 18:23:53.243234
NCT00001431|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1995||1995-02-01|November 2000|2000-11-01|November 2000||2000-11-01|||||Interventional|||A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas|A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas|Completed||Phase 1|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.332883|2017-02-18 18:23:53.332883
NCT00001430|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1995||1995-02-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas|A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas|Completed||Phase 2|49||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.422936|2017-02-18 18:23:53.422936
NCT00001428|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1995||1995-02-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer|A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer|Completed||Phase 2|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.514956|2017-02-18 18:23:53.514956
NCT00001427|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1995||1995-01-01|January 2000|2000-01-01|April 2000||2000-04-01|||||Interventional|||A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin|A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin|Completed||Phase 2|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.603698|2017-02-18 18:23:53.603698
NCT00001426|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 3, 1995||1995-02-03|November 7, 2013|2013-11-07|November 7, 2013|Actual|2013-11-07|October 15, 2007|Actual|2007-10-15||Interventional|||A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer|A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer|Completed||Phase 2|47|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:53.690285|2017-02-18 18:23:53.690285
NCT00001424|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1994||1994-11-01|October 1999|1999-10-01|August 2000||2000-08-01|||||Observational|||Evaluation and Natural History of Children With Cancer and AIDS|Evaluation and Natural History of Children With Cancer and AIDS|Completed||N/A|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.784625|2017-02-18 18:23:53.784625
NCT00001422|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Interventional|||A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis|A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.866192|2017-02-18 18:23:53.866192
NCT00001421|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1995||1995-06-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Interventional|||Methimazole to Treat Polymyositis and Dermatomyositis|A Pilot Study of the Role of Methimazole in Patients With Polymyositis and Dermatomyositis|Completed||Phase 2|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:53.9571|2017-02-18 18:23:53.9571
NCT00001420|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1995||1995-03-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Observational|||Study of Psoriatic Arthritis|Studies of the Pathogenesis and Natural History of Psoriatic Arthritis|Completed||N/A|999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.046666|2017-02-18 18:23:54.046666
NCT00001418|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1994||1994-07-01|August 2004|2004-08-01|August 2004||2004-08-01|||||Observational|||PET Scan in Patients With Neurocardiologic Disorders|Positron Emission Tomographic (PET) Scanning of Sympathetic Innervation and Function in Patients With Neurocardiologic Disorders|Completed||N/A|335||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.128002|2017-02-18 18:23:54.128002
NCT00001276|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 29, 1991||1991-01-29|September 14, 2016|2016-09-14||||||||Observational|||Diagnosing and Treating Low Blood Sugar Levels|Fasting Hypoglycemia: Diagnosis and Treatment|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.758415|2017-02-18 18:24:09.758415
NCT00001417|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1994||1994-06-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Direct Injection of Alcohol for the Treatment of Spinal Tumors|Study of the Efficacy of Direct Intratumoral Injection of Absolute Ethanol in Treating Symptomatic Spinal Tumors|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.203649|2017-02-18 18:23:54.203649
NCT00001416|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2016-09-21|||December 1993||1993-12-01|September 2016|2016-09-01|November 2000||2000-11-01|||||Interventional|||Bone Response to Enzyme Replacement in Gaucher's Disease|Skeletal Responses to Macrophage-Targeted Glucocerebrosidase in Patients With Type 1 Gaucher's Disease|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.29236|2017-02-18 18:23:54.29236
NCT00001415|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1994||1994-05-01|April 1999|1999-04-01|July 2000||2000-07-01|||||Observational|||Glucocorticoid Effects on Cellular Cytokine Release|Glucocorticoid Effects on Cellular Cytokine Release|Completed||N/A|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.379799|2017-02-18 18:23:54.379799
NCT00001414|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1994||1994-04-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Observational|||Mapping Personality Traits to Genes|Mapping Personality Traits to Genes|Completed||N/A|2400||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.465682|2017-02-18 18:23:54.465682
NCT00001413|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 6, 1994||1994-04-06|January 19, 2007|2007-01-19|January 19, 2007||2007-01-19|||||Observational|||Bone Mineral Density in Women With Major Depression|Bone Mineral Density in Patients With Major Depression With Melancholic and Atypical Features: Relation to Stress-System Neurohormonal Function|Completed||N/A|585||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.539358|2017-02-18 18:23:54.539358
NCT00001412|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1993||1993-12-01|November 2001|2001-11-01|November 2001||2001-11-01|||||Observational|||Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement|The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.618696|2017-02-18 18:23:54.618696
NCT00001410|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1993||1993-10-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Interventional|||PEG-Glucocerebrosidase for the Treatment of Gaucher Disease|A Phase I and II Study of PEG-Glucocerebrosidase in Patients With Type 1 or Type 3 Gaucher Disease|Completed||Phase 1|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.707406|2017-02-18 18:23:54.707406
NCT00001409|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1994||1994-09-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications|A Phase I/II Pilot Study of the Safety of the Adoptive Transfer of Syngeneic Gene-Modified Cytotoxic T Lymphocytes in HIV Infected Identical Twins|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.78851|2017-02-18 18:23:54.78851
NCT00001408|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 14, 1994||1994-09-14|June 25, 2009|2009-06-25|October 1, 1995|Actual|1995-10-01|October 1, 1995|Actual|1995-10-01||Observational|||Role of T-Cells in Asthma|Cytokine Expression in Allergic Asthma|Completed||N/A|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.876828|2017-02-18 18:23:54.876828
NCT00001407|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1994||1994-05-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Interventional|||Interferon Gamma for Drug Resistant Tuberculosis|Treatment of Multiply Drug Resistant Tuberculosis With Interferon Gamma: A Phase I/II Dose Escalation Trial|Completed||Phase 2|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:54.949309|2017-02-18 18:23:54.949309
NCT00001406|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 10, 1994||1994-02-10|July 22, 2016|2016-07-22||||||||Observational|||Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia|Eosinophil Activation and Function in Parasitic Infections and Other Conditions With Increased Tissue or Peripheral Blood Eosinophilia in Humans|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:55.037825|2017-02-18 18:23:55.037825
NCT00001405|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-01|||February 9, 1994||1994-02-09|September 20, 2016|2016-09-20||||||||Observational|||Use of G-CSF to Obtain Blood Cell Precursors|Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells,Mononuclear Cells and Granulocytes|Recruiting||N/A|450|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:55.13334|2017-02-18 18:23:55.13334
NCT00001404|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 18, 1994||1994-08-18|January 7, 2016|2016-01-07|January 7, 2016||2016-01-07|||||Observational|||Phenotype and Etiology of Pallister-Hall Syndrome|Genetic and Clinical Studies of Congenital Anomaly Syndromes|Completed||N/A|1170|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:55.240475|2017-02-18 18:23:55.240475
NCT00001403|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 18, 1994||1994-04-18|December 6, 2016|2016-12-06||||||||Observational|||Study of Proteus Syndrome and Related Congenital Disorders|The Phenotype and Etiology of Proteus Syndrome and Related Overgrowth Disorders|Recruiting||N/A|1500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:55.334681|2017-02-18 18:23:55.334681
NCT00001402|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1994||1994-01-01|December 1999|1999-12-01|March 2001||2001-03-01|||||Interventional|||PET Scan to Determine Areas of Blood Flow and Activity in the Hearts of Patients With Heart Disease Taking Beta-Blockers|Assessment of Metabolic Function and Perfusion Using Positron Emission Tomography: An Analysis of Patients With Congestive Cardiomyopathy Before and After Beta-Blockers|Completed||Phase 2|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:55.433295|2017-02-18 18:23:55.433295
NCT00001400|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||December 1993||1993-12-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||Outpatient Evaluation of Patients With Known or Suspected Heart Disease|Outpatient Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:55.783395|2017-02-18 18:23:55.783395
NCT00001399|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 3, 1993||1993-12-03|February 11, 2009|2009-02-11|February 11, 2009||2009-02-11|||||Interventional|||Gene Therapy for the Treatment of Fanconi's Anemia Type C|Retroviral Mediated Gene Transfer of the Fanconi Anemia Complementation Group C Gene to Hematopoietic Progenitors of Group C Patients|Completed||Phase 1|9||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:55.86209|2017-02-18 18:23:55.86209
NCT00001251|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-07|2013-08-16|||November 1989||1989-11-01|November 2003|2003-11-01|November 2003||2003-11-01|||||Interventional|||Phase I Study of Intrathecal Mafosfamide|Phase I Study of Intrathecal Mafosfamide|Completed||Phase 1|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:12.968691|2017-02-18 18:24:12.968691
NCT00001398|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1993||1993-10-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Stem Cell Factor Medication for Aplastic Anemia|A Phase I/II Trial of Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) in Patients Diagnosed With Acquired Aplastic Anemia|Completed||Phase 1|40||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:55.952933|2017-02-18 18:23:55.952933
NCT00001397|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 19, 1993||1993-10-19|November 10, 2016|2016-11-10||||||||Observational|||Evaluation, Treatment, and Training for Patients With Blood Disorders|Evaluation, Treatment and Training Protocol for Patients With Bone Marrow Failure States, Isolated or Multilineage Cytopenias, Metastatic Solid Tumors, or Hematologic Malignancies|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.0404|2017-02-18 18:23:56.0404
NCT00001396|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 6, 1993||1993-10-06|July 23, 2008|2008-07-23|July 23, 2008||2008-07-23|||||Interventional|||Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop...|Obstructive Hypertrophic Cardiomyopathy (HCM) in Children: Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:23:56.146634|2017-02-18 18:23:56.146634
NCT00001395|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1994||1994-03-01|March 1999|1999-03-01|August 2000||2000-08-01|||||Observational|||Long Term Follow-Up of Diabetic Retinopathy|Long Term Follow-Up of Diabetic Retinopathy|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.234076|2017-02-18 18:23:56.234076
NCT00001394|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1994||1994-08-01|July 2005|2005-07-01|July 2005||2005-07-01|||||Observational|||Using X-Ray Dye to Locate Hidden Parathyroid Tumors|Use of Hypocalcemic Intraarterial Infusion Into the Thyroid/Parathyroid Bed to Localize Occult Parathyroid Adenomas|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.31765|2017-02-18 18:23:56.31765
NCT00001393|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 18, 1994||1994-04-18|December 7, 2016|2016-12-07||||||||Observational|||Genetic Markers for Focal Segmental Glomerulosclerosis|Genetic Markers for Focal Segmental Glomerulosclerosis|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.403976|2017-02-18 18:23:56.403976
NCT00001392|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 7, 1994||1994-04-07|December 7, 2016|2016-12-07||||||||Observational|||Pathogenesis of Glomerulosclerosis|Pathogenesis of Glomerulosclerosis|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.521794|2017-02-18 18:23:56.521794
NCT00001391|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 3, 1994||1994-08-03|October 4, 2010|2010-10-04|October 4, 2010||2010-10-04|||||Observational|||Bone Regeneration Using Bone Marrow Stromal Cells|Bone Regeneration Using Bone Marrow Stromal Cells|Completed||N/A|54|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.629855|2017-02-18 18:23:56.629855
NCT00001390|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 22, 1993||1993-10-22|December 2, 2016|2016-12-02||||||||Observational|||Salivary Evaluation in Healthy Volunteers|Salivary Evaluation in Healthy Volunteers|Recruiting||N/A|250|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.717908|2017-02-18 18:23:56.717908
NCT00001387|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1994||1994-09-01|August 1999|1999-08-01|July 2000||2000-07-01|||||Interventional|||Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy|Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy|Completed||Phase 1|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.820945|2017-02-18 18:23:56.820945
NCT00001386|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1994||1994-06-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection|Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection|Completed||Phase 1|31||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:56.916684|2017-02-18 18:23:56.916684
NCT00001385|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1994||1994-05-01|May 1999|1999-05-01|April 2000||2000-04-01|||||Observational|||Positron Emission Tomography in Patients With Breast Cancer|Positron Emission Tomography in Patients With Breast Cancer|Completed||N/A|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.008871|2017-02-18 18:23:57.008871
NCT00001384|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1994||1994-05-01|April 2000|2000-04-01|February 2001||2001-02-01|||||Interventional|||A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients|A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients|Completed||Phase 2|35||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.092734|2017-02-18 18:23:57.092734
NCT00001383|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1994||1994-03-01|March 2000|2000-03-01|January 2001||2001-01-01|||||Interventional|||A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833|A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833|Completed||Phase 1|52||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.187095|2017-02-18 18:23:57.187095
NCT00001382|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1994||1994-03-01|March 2000|2000-03-01|March 2000||2000-03-01|||||Interventional|||A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate|A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate|Completed||Phase 1|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.291246|2017-02-18 18:23:57.291246
NCT00001381|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1994||1994-03-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder|A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder|Completed||Phase 1|18||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.375268|2017-02-18 18:23:57.375268
NCT00001254|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 22, 1990||1990-05-22|February 25, 2016|2016-02-25||||||||Observational|||Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome|Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome|Completed||N/A|273|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:12.613527|2017-02-18 18:24:12.613527
NCT00001379|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 9, 1994||1994-02-09|October 18, 2016|2016-10-18|February 1, 2022|Anticipated|2022-02-01|February 1, 2020|Anticipated|2020-02-01||Interventional|||Treatment and Natural History Study of Lymphomatoid Granulomatosis|Treatment and Natural History Study of Lymphomatoid Granulomatosis|Suspended||Phase 2|87|Actual|National Institutes of Health Clinical Center (CC)||2|||f||||||||||||||2017-02-18 18:23:57.469508|2017-02-18 18:23:57.469508
NCT00001378|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1994||1994-01-01|November 1999|1999-11-01|November 2000||2000-11-01|||||Interventional|||A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer|A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer|Completed||Phase 1|75||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.592381|2017-02-18 18:23:57.592381
NCT00001377|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1993||1993-12-01|December 1999|1999-12-01|December 2000||2000-12-01|||||Observational|||Familial Prostate Cancer|Familial Prostate Cancer|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.688984|2017-02-18 18:23:57.688984
NCT00001376|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1994||1994-08-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Observational|||Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status|Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status|Completed||N/A|209||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.77731|2017-02-18 18:23:57.77731
NCT00001375|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1994||1994-08-01|August 1999|1999-08-01|June 2000||2000-06-01|||||Observational|||The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis|The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.86614|2017-02-18 18:23:57.86614
NCT00001373|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-14|||March 8, 1994||1994-03-08|January 26, 2017|2017-01-26||||||||Observational|||Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics|Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:57.961992|2017-02-18 18:23:57.961992
NCT00001372|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-08|||February 1, 1994||1994-02-01|February 6, 2017|2017-02-06||||||||Observational|||Study of Systemic Lupus Erythematosus|Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.074347|2017-02-18 18:23:58.074347
NCT00001371|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1993||1993-12-01|December 1999|1999-12-01|December 2000||2000-12-01|||||Observational|||A Pilot Study of Topical Antiflammin-2 for Psoriasis|A Pilot Study of Topical Antiflammin-2 for Psoriasis|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.185214|2017-02-18 18:23:58.185214
NCT00001368|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1993||1993-10-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Interventional|||Potential Risk Factors for Stroke|Cytokine and Leukocyte Activation Profile as a Risk Factor for Cerebral Vascular Disease and Stroke|Completed||Phase 1|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.266929|2017-02-18 18:23:58.266929
NCT00001367|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 20, 1993||1993-08-20|October 21, 2016|2016-10-21||||||||Observational|||Diagnosis and History Study of Patients With Different Neurological Conditions|Diagnosis and Natural History Protocol for Patients With Different Neurological Conditions|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.356831|2017-02-18 18:23:58.356831
NCT00001366|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1993||1993-08-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Observational|||Mapping the Areas of the Brain Associated With Language in Children With Epilepsy|MRI-Based Functional Language Mapping in Children With Epilepsy|Completed||N/A|230||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.467779|2017-02-18 18:23:58.467779
NCT00001365|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2006-07-12|||July 1993||1993-07-01|July 2000|2000-07-01|June 2001||2001-06-01|||||Interventional|||Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System|NMDA Receptor Antagonist Treatment of Neurodegenerative Disease|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.547488|2017-02-18 18:23:58.547488
NCT00001364|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 2, 1993||1993-06-02|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities|Evaluation and Treatment of Patients With Spinal Vascular Abnormalities|Completed||N/A|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.635512|2017-02-18 18:23:58.635512
NCT00001363|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1993||1993-01-01|May 2000|2000-05-01|March 2001||2001-03-01|||||Observational|||PET Scan to Map the Areas of the Brain Involved in Planning|Functional Brain Mapping of Planning Activities With [015] Water PET Blood Flow Technique|Completed||N/A|230||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.717986|2017-02-18 18:23:58.717986
NCT00001362|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1992||1992-12-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders|Structural and Functional Imaging of Neurologically Impaired Patients and Normal Volunteers With 1.5 and 3.0 Tesla MRI|Completed||N/A|830||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.795596|2017-02-18 18:23:58.795596
NCT00001361|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1992||1992-10-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Magnetic Resonance Imaging Studies of Motor and Thought Processes|Central Nervous System Motor and Cognitive Processes: Nuclear Magnetic Resonance Imaging at 1.5 to 4 Tesla|Completed||N/A|610||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.872954|2017-02-18 18:23:58.872954
NCT00001360|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 2, 1993||1993-07-02|April 19, 2016|2016-04-19||||||||Observational|||Studies of Blood Flow to the Brain During Thought|Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory|Recruiting||N/A|4100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:58.969238|2017-02-18 18:23:58.969238
NCT00001359|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1993||1993-04-01|January 2006|2006-01-01|January 2006||2006-01-01|||||Interventional|||Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)|A Trial of Prophylaxis for the PANDAS Subgroup|Completed||Phase 2|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.080957|2017-02-18 18:23:59.080957
NCT00000554|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-04-03|||May 2001||2001-05-01|April 2014|2014-04-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Women's Ischemia Syndrome Evaluation (WISE)||Completed||Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:25:57.585183|2017-02-18 18:25:57.585183
NCT00001357|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1993||1993-08-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients|Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.173568|2017-02-18 18:23:59.173568
NCT00001356|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1993||1993-05-01|May 2002|2002-05-01|May 2002||2002-05-01|||||Observational|||Characteristics of Mast Cells in Mastocytosis|Culture and Characteristics of Mastocytosis Mast Cells|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.26956|2017-02-18 18:23:59.26956
NCT00001355|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 9, 1993||1993-04-09|December 2, 2016|2016-12-02||||||||Observational|||Detection and Characterization of Host Defense Defects|Detection and Characterization of Host Defense Defects|Recruiting||N/A|3000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.35406|2017-02-18 18:23:59.35406
NCT00001354|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1993||1993-03-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Interventional|||Interleukin-2 Therapy for HIV Infection - Supplemental Procedures|A Randomized Trial of Interleukin-2 Therapy in HIV-Infected Patients|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.4578|2017-02-18 18:23:59.4578
NCT00001353|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1993||1993-03-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs|A Study of the Safety and Survival of the Adoptive Transfer of Genetically Marked Syngeneic Lymphocytes in HIV-Infected Identical Twins|Completed||N/A|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.549694|2017-02-18 18:23:59.549694
NCT00001352|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 10, 1993||1993-03-10|August 1, 2016|2016-08-01||||||||Observational|||Evaluation and Follow-up of Patients With Cryptococcosis|Cryptococcosis in Previously Healthy Adults|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.708104|2017-02-18 18:23:59.708104
NCT00001351|ClinicalTrials.gov processed this data on February 17, 2017|2006-07-12|2017-01-24|||February 5, 1993||1993-02-05|September 19, 2016|2016-09-19||||||||Observational|||Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders|Evaluation and Long Term Follow Up of Patients With Acute or Chronic Inflammatory Disorders|Enrolling by invitation||N/A|291|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.808941|2017-02-18 18:23:59.808941
NCT00001350|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 18, 1992||1992-12-18|October 17, 2016|2016-10-17||||||||Observational|||Study of Autoimmune Lymphoproliferative Syndrome (ALPS)|Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated With an Expansion of CD4-8-/TCR Alpha/Beta+ T Cells|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:23:59.9055|2017-02-18 18:23:59.9055
NCT00001349|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 15, 1992||1992-12-15|May 23, 2016|2016-05-23||||||||Observational|||Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies|Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies|Recruiting||N/A|300|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.016579|2017-02-18 18:24:00.016579
NCT00001347|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1993||1993-06-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Study of Usher Syndromes, Type 1 and Type 2|Usher Syndrome - Clinical and Molecular Studies|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.116624|2017-02-18 18:24:00.116624
NCT00001346|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1992||1992-11-01|February 2000|2000-02-01|October 2000||2000-10-01|||||Observational|||Diabetic Retinopathy and Visual Function Study|Diabetic Retinopathy and Visual Function Study|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.204238|2017-02-18 18:24:00.204238
NCT00001345|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 19, 1993||1993-04-19|September 29, 2016|2016-09-29||||||||Observational|||Studies of Inherited Diseases of Metabolism|Family Studies in Metabolic Diseases and Mineral Metabolism|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.310639|2017-02-18 18:24:00.310639
NCT00001344|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1993||1993-03-01|March 2000|2000-03-01|February 2001||2001-02-01|||||Interventional|||Dextromethorphan Versus Placebo for Neuropathic Pain|Dextromethorphan Versus Placebo for Neuropathic Pain|Completed||Phase 2|129||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.422438|2017-02-18 18:24:00.422438
NCT00001343|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||December 11, 1992||1992-12-11|October 10, 2007|2007-10-10|October 10, 2007||2007-10-10|||||Interventional|||The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome|The Relative Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate, GH Binding Protein, IGF-I, and Cognitive Function in Growth Hormone-Treated Girls With Turner Syndrome|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.513801|2017-02-18 18:24:00.513801
NCT00001342|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1992||1992-11-01|October 1999|1999-10-01|April 2001||2001-04-01|||||Observational|||Study of Glycogen Storage Disease and Associated Disorders|A Study of Collateral Disorders of Glycogen Storage Disease|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.602463|2017-02-18 18:24:00.602463
NCT00001341|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1993||1993-09-01|August 2000|2000-08-01|June 2001||2001-06-01|||||Interventional|||A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease|A Phase I Trial of ZD1694 (TOMUDEX® (Registered Trademark)), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.686001|2017-02-18 18:24:00.686001
NCT00001339|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1993||1993-08-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection|A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection|Completed||Phase 2|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:00.780273|2017-02-18 18:24:00.780273
NCT00001253|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1990||1990-05-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Interventional|||The Effects of Estrogen on Cognition in Girls With Turner Syndrome|Estrogen Effects on Cognition in Girls With Turner Syndrome|Completed||Phase 2|950||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:12.736102|2017-02-18 18:24:12.736102
NCT00001338|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1993||1993-06-01|April 2000|2000-04-01|January 2001||2001-01-01|||||Interventional|||A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer|A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer|Completed||Phase 3|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:03.910912|2017-02-18 18:24:03.910912
NCT00001337|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-16|||April 30, 1993||1993-04-30|January 6, 2017|2017-01-06|March 31, 2022|Anticipated|2022-03-31|March 31, 2019|Anticipated|2019-03-31||Interventional|||Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma|Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Adults and Children With Previously Untreated Patients With Aggressive Non-Hodgkin's Lymphoma|Recruiting||Phase 2|348|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:24:04.016157|2017-02-18 18:24:04.016157
NCT00001336|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1993||1993-04-01|February 2003|2003-02-01|February 2003||2003-02-01|||||Observational|||In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients|In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients|Completed||N/A|1000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:04.142193|2017-02-18 18:24:04.142193
NCT00001335|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1993||1993-04-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Interventional|||New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma|New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma|Completed||Phase 2|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:04.225053|2017-02-18 18:24:04.225053
NCT00001333|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1993||1993-02-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||Phase I Study of Intrathecal Topotecan|Phase I Study of Intrathecal Topotecan|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:04.316908|2017-02-18 18:24:04.316908
NCT00001332|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1992||1992-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis|Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis|Completed||Phase 1|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:04.623738|2017-02-18 18:24:04.623738
NCT00001331|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||May 1993||1993-05-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Genetic and Family Studies of Inherited Muscle Diseases|Genetic and Family Studies of Inherited Muscle Diseases|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:04.706032|2017-02-18 18:24:04.706032
NCT00001330|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1992||1992-11-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Observational|||Study of Silicone-Associated Connective Tissue Diseases|Epidemiologic, Immunologic, and Immunogenetic Factors in Silicone-Associated Connective Tissue Diseases|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:04.789731|2017-02-18 18:24:04.789731
NCT00001329|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1992||1992-09-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Observational|||Study of Norepinephrine Levels and Sympathetic Nervous System Activity|Plasma Catecholamine Kinetics|Completed||N/A|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:04.873195|2017-02-18 18:24:04.873195
NCT00001328|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 21, 1992||1992-08-21|April 30, 2010|2010-04-30|April 30, 2010|Actual|2010-04-30|April 30, 2010|Actual|2010-04-30||Interventional|||Gene Therapy for the Treatment of Brain Tumors|Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction With the Thymidine Kinase Gene and Intravenous Ganciclovir|Completed||Phase 1|15|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:24:04.954005|2017-02-18 18:24:04.954005
NCT00001327|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 29, 1992||1992-07-29|March 31, 2011|2011-03-31|March 31, 2011||2011-03-31|||||Observational|||Establishing the Physiology of Syringomyelia|Establishing the Physiology of Syringomyelia|Completed||N/A|120|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:05.049465|2017-02-18 18:24:05.049465
NCT00001325|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1992||1992-04-01|June 2004|2004-06-01|June 2004||2004-06-01|||||Observational|||Metabolic Abnormalities in Children With Epilepsy|Natural History of Metabolic Abnormalities in Children With Epilepsy|Completed||N/A|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:05.128488|2017-02-18 18:24:05.128488
NCT00001324|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1992||1992-03-01|March 2000|2000-03-01|July 2001||2001-07-01|||||Observational|||PET Scan to Study Brain Control of Human Movement|CNS Control of Human Movement: H215O PET Studies|Completed||N/A|510||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:05.476456|2017-02-18 18:24:05.476456
NCT00001323|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1992||1992-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia|Neuropsychiatric Evaluation of Normal Subjects and Psychiatric and Neurologic Contrast Groups|Completed||N/A|810||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:05.565506|2017-02-18 18:24:05.565506
NCT00001322|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-14|||April 25, 1992||1992-04-25|January 24, 2017|2017-01-24||||||||Observational|||The Effects of Reproductive Hormones on Mood and Behavior|The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism With and Without Estrogen and Progesterone Replacement|Recruiting||N/A|150|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:05.643132|2017-02-18 18:24:05.643132
NCT00001320|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1991||1991-10-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients|I-123 Iodobenzamide (IBZM) SPECT Studies of D2 Receptor Distribution and Function in Patients With Schizophrenia and Normal Volunteers|Completed||N/A|265||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:05.749716|2017-02-18 18:24:05.749716
NCT00001319|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1992||1992-09-01|July 2003|2003-07-01|July 2003||2003-07-01|||||Observational|||Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts|Evaluation of the Epidemiology, Clinical Manifestations, Etiologies, and Immunology of Human Immunodeficiency Virus (HIV) Negative CD4 T Lymphocyte Deficient Patients|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:05.833722|2017-02-18 18:24:05.833722
NCT00001318|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1992||1992-08-01|August 1999|1999-08-01|November 2000||2000-11-01|||||Interventional|||Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma|Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:05.926794|2017-02-18 18:24:05.926794
NCT00001317|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1992||1992-05-01|May 2000|2000-05-01|July 2001||2001-07-01|||||Interventional|||A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood|A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood|Completed||Phase 4|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.018228|2017-02-18 18:24:06.018228
NCT00001316|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 18, 1992||1992-03-18|July 5, 2016|2016-07-05||||||||Observational|||Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals|A Study of Viral Burden in Peripheral Blood Versus Lymphoid and Bone Marrow Tissue in HIV-Infected Individuals|Recruiting||N/A|400|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.106796|2017-02-18 18:24:06.106796
NCT00001314|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1992||1992-05-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Observational|||Investigation of Heart Function in Patients With Heart Valve Defects|Investigation of Myocardial Contractile Reserve by Dobutamine Stress Transesophageal Echocardiography in Aortic and Mitral Regurgitation|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.219645|2017-02-18 18:24:06.219645
NCT00001313|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 10, 1992||1992-05-10|January 6, 2009|2009-01-06|January 6, 2009||2009-01-06|||||Observational|||Evaluation of Patients With Known or Suspected Heart Disease|Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.305787|2017-02-18 18:24:06.305787
NCT00001311|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1992||1992-04-01|March 2000|2000-03-01|February 2001||2001-02-01|||||Interventional|||Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients|Evaluation of the Efficacy of a Surface Modified Intraocular Lens in Reducing Post-Operative Inflammatory Signs Following Extracapsular Surgery in Uveitis Patients With Cataracts|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.383019|2017-02-18 18:24:06.383019
NCT00001310|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 5, 1992||1992-03-05|September 16, 2015|2015-09-16|September 16, 2015||2015-09-16|||||Observational|||Tissue Studies of Human Eye Diseases|Immunopathology and Molecular Pathology of Ocular Diseases in Humans|Terminated||N/A|3797|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.470044|2017-02-18 18:24:06.470044
NCT00001309|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 25, 1991||1991-10-25|May 20, 2016|2016-05-20||||||||Observational|||The Body's Affect on Vitamin C|Pharmacokinetics and Biodistribution of Ascorbic Acid in Healthy Human Subjects|Recruiting||N/A|50|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.571142|2017-02-18 18:24:06.571142
NCT00001308|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 28, 1992||1992-04-28|October 6, 2016|2016-10-06|October 6, 2016||2016-10-06|||||Observational|||Central Mechanisms in Speech Motor Control Studied With H215O PET|Multimodal Studies of Language Production and Comprehension in Normal Volunteers and Patients With Neurologically-Based Language Impairments|Terminated||N/A|1163|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.681879|2017-02-18 18:24:06.681879
NCT00001307|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1992||1992-08-01|August 2005|2005-08-01|August 2005||2005-08-01|||||Observational|||Positron Emission Tomography to Measure Pain and Pain Control|Somatosensory Studies of Pain and Pain Control Measured With Oxygen-15 Water Positron Emission Tomography and Functional MRI in Normals and Patients With Neuropathic or Chronic Pain Conditions|Completed||N/A|273||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.771509|2017-02-18 18:24:06.771509
NCT00001306|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 10, 1992||1992-07-10|December 12, 2011|2011-12-12|December 12, 2011||2011-12-12|||||Observational|||Steroid Therapy in Autoimmune Premature Ovarian Failure|Autoimmune Premature Ovarian Failure: A Controlled Trial of Alternate-Day Prednisone Therapy|Completed||N/A|33|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:06.855962|2017-02-18 18:24:06.855962
NCT00001305|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||November 5, 1991||1991-11-05|May 10, 2016|2016-05-10|March 31, 2017|Anticipated|2017-03-31|March 31, 2017|Anticipated|2017-03-31||Interventional|||Growth Hormone Therapy in Osteogenesis Imperfecta|Studies of Growth Deficiency and Growth Hormone Treatment in Children With Osteogenesis Imperfecta Types III and IV|Active, not recruiting||Phase 3|52|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:24:06.939435|2017-02-18 18:24:06.939435
NCT00001304|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2015-11-10|2015-03-12||October 1991||1991-10-01|November 2015|2015-11-01|April 2014|Actual|2014-04-01|March 2014|Actual|2014-03-01||Interventional|||Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34|Treatment of Hypoparathyroidism With Synthetic Human Parathyroid Hormone 1-34|Completed||Phase 2|27|Actual|National Institutes of Health Clinical Center (CC)|Study reported here was the primary long-term study for adults with hypoparathyroidism. Subsequent studies included additional patients.|2|||f||||t||||||||||2017-02-18 18:24:07.046147|2017-02-18 18:24:07.046147
NCT00001303|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 4, 1992||1992-04-04|July 22, 2016|2016-07-22|March 21, 2007|Actual|2007-03-21|March 21, 2007|Actual|2007-03-21||Interventional|||Effects of Endotoxin in Normal Human Volunteers|The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers|Completed||Phase 1|198|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:24:07.663875|2017-02-18 18:24:07.663875
NCT00001302|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1992||1992-09-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833|A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833|Completed||Phase 1|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:07.75567|2017-02-18 18:24:07.75567
NCT00001301|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1992||1992-08-01|June 1999|1999-06-01|April 2000||2000-04-01|||||Observational|||Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors|Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors|Completed||N/A|107||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:07.839811|2017-02-18 18:24:07.839811
NCT00001275|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-02-09|||May 12, 1991||1991-05-12|February 8, 2017|2017-02-08|February 8, 2017||2017-02-08|||||Observational|||Ovarian Follicle Function in Patients With Primary Ovarian Failure|Ovarian Follicle Function in Patients With Primary Ovarian Insufficiency|Completed||N/A|1134|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.856231|2017-02-18 18:24:09.856231
NCT00001300|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1992||1992-06-01|April 2000|2000-04-01|March 2001||2001-03-01|||||Interventional|||A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma|A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma|Completed||Phase 3|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.189564|2017-02-18 18:24:08.189564
NCT00001298|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1992||1992-03-01|February 2000|2000-02-01|January 2001||2001-01-01|||||Interventional|||A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction|A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction|Completed||Phase 1|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.280421|2017-02-18 18:24:08.280421
NCT00001296|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1992||1992-02-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma|A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma|Completed||Phase 3|122||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.36978|2017-02-18 18:24:08.36978
NCT00001295|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 29, 1992||1992-01-29|August 23, 2016|2016-08-23|August 23, 2016||2016-08-23|||||Observational|||Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease|Continuing Treatment for Children and Adults in the Center for Cancer Research|Completed||N/A|2145|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.468686|2017-02-18 18:24:08.468686
NCT00001294|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1992||1992-01-01|April 2005|2005-04-01|April 2005||2005-04-01|||||Observational|||Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens|Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.556241|2017-02-18 18:24:08.556241
NCT00001292|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||February 1992||1992-02-01|April 2000|2000-04-01|April 2001||2001-04-01|||||Observational|||Study of Scaling Disorders and Other Inherited Skin Diseases|Clinical and Genetic Studies of the Scaling Disorders and Other Selected Genodermatoses|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.637212|2017-02-18 18:24:08.637212
NCT00001291|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||December 1991||1991-12-01|December 1999|1999-12-01|January 2001||2001-01-01|||||Observational|||Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions|Investigations of Blood, Synovial Tissue and Synovial Fluids From Patients With Rheumatoid Arthritis and Related Conditions|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.717856|2017-02-18 18:24:08.717856
NCT00001289|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 23, 1991||1991-09-23|March 3, 2008|2008-03-03|March 3, 2008||2008-03-03|||||Observational|||Effects of Enzyme Replacement in Gaucher's Disease|Clinical and Biochemical Effects of Macrophage-Targeted Glucocerebrosidase on Neurological Involvement in Neuronopathic Gaucher's Disease|Completed||N/A|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.803549|2017-02-18 18:24:08.803549
NCT00001288|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1991||1991-05-01|June 2003|2003-06-01|June 2003||2003-06-01|||||Observational|||Brain Blood Flow Studies of Language and Memory|Cerebral Blood Flow Studies of Language and Memory|Completed||N/A|303||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.880738|2017-02-18 18:24:08.880738
NCT00001287|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1990||1990-12-01|February 2000|2000-02-01|January 2001||2001-01-01|||||Interventional|||Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)|The Efficacy of High-Dose Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)|Completed||Phase 2|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:08.970622|2017-02-18 18:24:08.970622
NCT00001285|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1991||1991-08-01|October 1999|1999-10-01|June 2000||2000-06-01|||||Observational|||Effects of Sex Hormones on Circadian Rhythm in Men and Women|Chronobiologic Effects of Gonadal Steroid Manipulations in Volunteer Subjects|Completed||N/A|73||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.069151|2017-02-18 18:24:09.069151
NCT00001284|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 9, 1991||1991-05-09|March 11, 2016|2016-03-11||||||||Observational|||Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers|Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers With 1.5 Tesla MRI|Completed||N/A|2802|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.154231|2017-02-18 18:24:09.154231
NCT00001282|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1991||1991-07-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients|A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients|Completed||Phase 2|73||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.258964|2017-02-18 18:24:09.258964
NCT00001281|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 17, 1991||1991-05-17|October 21, 2016|2016-10-21||||||||Observational|||Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons|Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Reproductive Fluids in HIV-Infected and HIV-Uninfected Volunteers|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.364651|2017-02-18 18:24:09.364651
NCT00001280|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1991||1991-01-01|February 2000|2000-02-01|March 2001||2001-03-01|||||Interventional|||Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease|Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.477142|2017-02-18 18:24:09.477142
NCT00001278|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1991||1991-05-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Observational|||Study of Eye Tissue for Sarcoidosis|Immunologic Assay of Conjunctiva and Lacrimal Gland for Sarcoidosis|Completed||N/A|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.572574|2017-02-18 18:24:09.572574
NCT00001272|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1991||1991-09-01|June 1999|1999-06-01|May 2000||2000-05-01|||||Interventional|||A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients|A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients|Completed||Phase 1|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:09.95174|2017-02-18 18:24:09.95174
NCT00001271|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1991||1991-07-01|June 2000|2000-06-01|April 2001||2001-04-01|||||Interventional|||A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma|A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma|Completed||Phase 1|24||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:10.033876|2017-02-18 18:24:10.033876
NCT00001270|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1991||1991-06-01|May 1999|1999-05-01|March 2000||2000-03-01|||||Interventional|||Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma|Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma|Completed||Phase 1|85||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:10.126095|2017-02-18 18:24:10.126095
NCT00001269|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1991||1991-05-01|April 2000|2000-04-01|February 2001||2001-02-01|||||Interventional|||Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer|Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer|Completed||Phase 1|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:10.220002|2017-02-18 18:24:10.220002
NCT00001267|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1990||1990-10-01|August 1999|1999-08-01|April 2000||2000-04-01|||||Interventional|||A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine|A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine|Completed||Phase 3|42||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:10.319959|2017-02-18 18:24:10.319959
NCT00001266|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1990||1990-10-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma|A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma|Completed||Phase 2|70||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:10.414627|2017-02-18 18:24:10.414627
NCT00001265|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 6, 1991||1991-08-06|November 23, 2016|2016-11-23||||||||Observational|||Study and Treatment of Inflammatory Muscle Diseases|Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:10.504596|2017-02-18 18:24:10.504596
NCT00001262|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2015-09-29|2014-08-05||June 1990||1990-06-01|September 2015|2015-09-01|July 2013|Actual|2013-07-01|July 2012|Actual|2012-07-01||Interventional|||Copper Histidine Therapy for Menkes Diseases|Early Copper Histidine Therapy in Menkes Disease|Completed||Phase 1/Phase 2|60|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||t||||||||||2017-02-18 18:24:10.619843|2017-02-18 18:24:10.619843
NCT00001261|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1990||1990-05-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Interventional|||Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies|The Efficacy of High-Dose Intravenous Immunoglobulin in Patients With Inflammatory Myopathies: A Three Month Randomized Trial With Option for Cross-Over|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:11.653429|2017-02-18 18:24:11.653429
NCT00001260|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 29, 1990||1990-05-29|December 21, 2016|2016-12-21||||||||Observational|||Brain Tissue Collection for Neuropathological Studies|Brain Procurement for the Human Brain Collection Core|Recruiting||N/A|2500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:11.739386|2017-02-18 18:24:11.739386
NCT00001259|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 9, 1990||1990-03-09|May 23, 2016|2016-05-23||||||||Observational|||A Treatment Study for Premenstrual Syndrome (PMS)|The Treatment of Menstrually-Related Mood Disorders With the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)|Recruiting||N/A|100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:11.838855|2017-02-18 18:24:11.838855
NCT00001258|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 26, 1989||1989-10-26|October 31, 2016|2016-10-31||||||||Observational|||Studies of Frontal Lobe Brain Functioning in Schizophrenia|Studies of Frontal Lobe Function During Cognitive Stimulation as Measured With Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Patients With Neuropsychiatric Disorders|Recruiting||N/A|1070|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:11.938749|2017-02-18 18:24:11.938749
NCT00001257|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 24, 1990||1990-04-24|July 22, 2016|2016-07-22||||||||Observational|||Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses|Comparison of Inflammatory Responses in Normal Volunteers and Patients With Abnormal Phagocyte Function Using the Suction Blister Technique|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:12.317124|2017-02-18 18:24:12.317124
NCT00001256|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1990||1990-03-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Interventional|||Steroids and Methotrexate to Treat Systemic Vasculitis|An Open Trial of the Efficacy of Glucocorticoids and Methotrexate (MTX) in the Treatment of Systemic Vasculitis|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:12.423016|2017-02-18 18:24:12.423016
NCT00001255|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1990||1990-09-01|July 2002|2002-07-01|July 2002||2002-07-01|||||Observational|||Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study|Treatment of Severe Combined Immunodeficiency Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency With Autologous Lymphocytes of CD34+ Cells Transduced With a Human ADA Gene: A Natural History Study|Completed||N/A|10||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:12.519139|2017-02-18 18:24:12.519139
NCT00001250|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1989||1989-12-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial|Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial|Completed||Phase 2|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:13.059156|2017-02-18 18:24:13.059156
NCT00001249|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1989||1989-12-01|November 1999|1999-11-01|October 2000||2000-10-01|||||Interventional|||Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac|Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac|Completed||Phase 1|30||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:13.373234|2017-02-18 18:24:13.373234
NCT00001248|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 13, 1989||1989-03-13|November 30, 2016|2016-11-30||||||||Observational|||Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)|Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI)|Recruiting||N/A|1100|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:13.463259|2017-02-18 18:24:13.463259
NCT00001247|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 13, 1989||1989-09-13|November 30, 2016|2016-11-30||||||||Observational|||Inpatient Evaluation of Adults With Schizophrenia|Inpatient Evaluation of Neuropsychiatric Patients|Recruiting||N/A|600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:13.572277|2017-02-18 18:24:13.572277
NCT00001246|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 10, 1989||1989-01-10|January 3, 2017|2017-01-03||||||||Observational|||Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers|Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers|Recruiting||N/A|6000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:13.669055|2017-02-18 18:24:13.669055
NCT00001245|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2009-08-24|||August 1989||1989-08-01|May 2009|2009-05-01||||May 2009|Actual|2009-05-01||Observational|||Study of Patients With Strongyloides Stercoralis Infection|Study of Patients With Known or Suspected Infection With Strongyloides Stercoralis|Completed||N/A|650||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:13.785209|2017-02-18 18:24:13.785209
NCT00001244|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 14, 1989||1989-09-14|November 21, 2016|2016-11-21||||||||Observational|||Immune Regulation in Patients With Common Variable Immunodeficiency and Related Syndromes|Studies of Immune Regulation in Patients With Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:13.867314|2017-02-18 18:24:13.867314
NCT00001243|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1989||1989-02-01|December 2005|2005-12-01|December 2005||2005-12-01|||||Observational|||Effects of HIV on the Development and Function of Bone Marrow Cells|Effects of Infection With the Human Immunodeficiency Virus on the Development and Function of Bone Marrow Cells|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:13.980192|2017-02-18 18:24:13.980192
NCT00001242|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||September 29, 1989||1989-09-29|November 25, 2016|2016-11-25||||||||Observational|||Resistance to Vitamin D or Parathyroid Hormone|Studies of States With Resistance to Vitamin D and Parathyroid Hormone|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.061129|2017-02-18 18:24:14.061129
NCT00001241|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 27, 1989||1989-01-27|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Observational|||Treatment of Zollinger-Ellison Syndrome|Medical Therapy of Zollinger-Ellison Syndrome|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.170162|2017-02-18 18:24:14.170162
NCT00001240|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||January 1989||1989-01-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Observational|||Evaluating Patients With Abnormal Levels of Gastric Acid|Diagnostic Evaluation of Patients With Suspected Abnormalities of Gastric Secretion|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.260294|2017-02-18 18:24:14.260294
NCT00001239|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1989||1989-07-01|April 2000|2000-04-01|January 2001||2001-01-01|||||Interventional|||Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer|Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.34004|2017-02-18 18:24:14.34004
NCT00001238|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 20, 1989||1989-04-20|December 27, 2016|2016-12-27||||||||Observational|||Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders|Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders|Recruiting||N/A|5000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.43744|2017-02-18 18:24:14.43744
NCT00001237|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1989||1989-03-01|January 2000|2000-01-01|April 2000||2000-04-01|||||Interventional|||Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas|Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas|Completed||Phase 2|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.544116|2017-02-18 18:24:14.544116
NCT00001235|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1988||1988-02-01|February 2004|2004-02-01|February 2004||2004-02-01|||||Observational|||Genetic Studies in Alzheimer's Disease|Biochemical and Genetic Studies in Familial Alzheimer's Disease|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.641402|2017-02-18 18:24:14.641402
NCT00001234|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1988||1988-01-01|April 2002|2002-04-01|April 2002||2002-04-01|||||Interventional|||Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells|Retroviral-Mediated Transfer and Expression of Glucocerebrosidase and Ceramidtrihexosidase (a-Galactosidase A) cDNA's in Human Hematopoietic Progenitor Cells|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.730638|2017-02-18 18:24:14.730638
NCT00001233|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1988||1988-12-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Observational|||Study of Children at Risk for Disruptive Behavior Disorders|A Longitudinal Study of Children at Risk for Disruptive Behavior Disorders: Transitions From Early Childhood to Middle Childhood and Adolescence|Completed||N/A|900||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.815865|2017-02-18 18:24:14.815865
NCT00001232|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1988||1988-07-01|July 1999|1999-07-01|June 2000||2000-06-01|||||Observational|||The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders|Pituitary Gonadotropin Response to GnRH Stimulation in Menstrual, Climacteric and, Menopause-Related Mood and Behavioral Disorders|Completed||N/A|140||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.895912|2017-02-18 18:24:14.895912
NCT00001231|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 12, 1988||1988-07-12|April 4, 2016|2016-04-04||||||||Observational|||Perimenopause-Related Mood and Behavioral Disorders|The Evaluation of Women With Perimenopause-Related Mood and Behavioral Disorders|Recruiting||N/A|1900|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:14.990766|2017-02-18 18:24:14.990766
NCT00001230|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 6, 1988||1988-05-06|November 15, 2016|2016-11-15||||||||Observational|||Host Response to Infection and Treatment in Filarial Diseases|Host Response to Infection and Treatment in the Filarial Diseases of Humans|Recruiting||N/A|500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.095719|2017-02-18 18:24:15.095719
NCT00001229|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1988||1988-10-01|November 1999|1999-11-01|January 2001||2001-01-01|||||Observational|||Diagnosis and Treatment of Pheochromocytoma|Diagnosis and Treatment of Pheochromocytoma|Completed||N/A|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.20636|2017-02-18 18:24:15.20636
NCT00001228|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 25, 1988||1988-10-25|September 6, 2007|2007-09-06|September 6, 2007||2007-09-06|||||Interventional|||Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer|Evaluation of Treatment With Interferon, Octreotide, or Their Combination in Patients With Zollinger-Ellison Syndrome and Progressive Metastatic Non-B Islet Cell Neoplasm|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.288708|2017-02-18 18:24:15.288708
NCT00001226|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1987||1987-12-01|March 2002|2002-03-01|March 2002||2002-03-01|||||Observational|||Lipoprotein Metabolism in Normal Volunteers and Patients With Abnormal Levels of Lipoproteins|Lipoprotein Metabolism in Normal Volunteers and Dyslipoproteinemic Patients (Stable Isotopes)|Completed||N/A|90||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.378383|2017-02-18 18:24:15.378383
NCT00001225|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1987||1987-04-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Family Studies of Inherited Heart Disease|Family Studies of Hypertrophic Cardiomyopathy|Completed||N/A|5880||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.468253|2017-02-18 18:24:15.468253
NCT00001224|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1987||1987-07-01|September 2002|2002-09-01|September 2002||2002-09-01|||||Observational|||Analysis of Eye Tissue|Immunologic Analysis of Intra-Ocular Tissue|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.549108|2017-02-18 18:24:15.549108
NCT00001223|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 18, 1987||1987-02-18|May 5, 2016|2016-05-05||||||||Observational|||Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders|Diagnosis and Treatment of Patients With Cystic Fibrosis and Other Disorders of the Respiratory System and Pancreas|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.632597|2017-02-18 18:24:15.632597
NCT00001221|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1987||1987-09-01|September 2003|2003-09-01|September 2003||2003-09-01|||||Interventional|||Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome|A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome|Completed||Phase 2|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.737493|2017-02-18 18:24:15.737493
NCT00001220|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1987||1987-10-01|November 2005|2005-11-01|November 2005||2005-11-01|||||Observational|||Ultrasound and Videofluoroscopy for Diagnosing Swallowing Disorders|Comparison of Ultrasound and Videofluoroscopic Imaging Techniques in Diagnosing Oropharyngeal Dysphagia in Neurologically Impaired Subjects|Completed||N/A|750||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.830633|2017-02-18 18:24:15.830633
NCT00001219|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 18, 1987||1987-06-18|May 3, 2016|2016-05-03||||||||Observational|||Comparing Magnetic Resonance Imaging/Spectroscopy Techniques|Magnetic Resonance Imaging at 1.5 and 3.0 Tesla|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:15.915754|2017-02-18 18:24:15.915754
NCT00001218|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1987||1987-02-01|January 2000|2000-01-01|January 2001||2001-01-01|||||Observational|||Development of Normative Ultrasound Databases of Tongue Surface Configuration|Development of Normative Ultrasound Databases of Tongue Surface Configuration|Completed||N/A|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.026868|2017-02-18 18:24:16.026868
NCT00001217|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1987||1987-05-01|January 2000|2000-01-01|December 2000||2000-12-01|||||Interventional|||Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study|Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study|Completed||Phase 3|260||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.108432|2017-02-18 18:24:16.108432
NCT00001216|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1986||1986-02-01|December 1999|1999-12-01|February 2001||2001-02-01|||||Observational|||Non-Invasive Electrical Stimulation of the Human Brain|Non-Invasive Stimulation of the Human Central Nervous System (Digitimer)|Completed||N/A|175||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.190584|2017-02-18 18:24:16.190584
NCT00001215|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 16, 1986||1986-05-16|September 26, 2016|2016-09-26||||||||Observational|||Genetic Studies of Lysosomal Storage Disorders|Studies of Genetic Heterogeneity in Patients With Lysosomal Storage Disorders|Enrolling by invitation||N/A|424|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.268286|2017-02-18 18:24:16.268286
NCT00001214|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 30, 1986||1986-04-30|August 25, 2016|2016-08-25||||||||Observational|||Collection of Blood From Patients With Pancytopenia|Lymphocytapheresis of Patients With Pancytopenia|Completed||N/A|38|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.37229|2017-02-18 18:24:16.37229
NCT00001174|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 4, 1980||1980-08-04|January 10, 2017|2017-01-10||||||||Observational|||Evaluation of the Genetics of Bipolar Disorder|Bipolar Genetics: A Collaborative Study|Recruiting||N/A|4000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.065036|2017-02-18 18:24:20.065036
NCT00001213|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2014-06-20|2014-06-20||April 1986||1986-04-01|June 2014|2014-06-01|July 2013|Actual|2013-07-01|July 2013|Actual|2013-07-01||Interventional|||Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis|Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis|Completed||Phase 2|328|Actual|National Institutes of Health Clinical Center (CC)|Due to the progressive nature of the drug's development, this protocol reflects the culmination of cysteamine studies performed at NIH. The combined analyses of the data is presented and not the data or analyses of one individual protocol.|1|||f||||f||||||||||2017-02-18 18:24:16.461709|2017-02-18 18:24:16.461709
NCT00001212|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-04-08|||November 1986||1986-11-01|April 2008|2008-04-01|September 2004||2004-09-01|||||Interventional|||Drug Therapy in Lupus Nephropathy|Immunosuppressive Drug Therapy in Membranous Lupus Nephropathy|Completed||Phase 2|45||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.742723|2017-02-18 18:24:16.742723
NCT00001211|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1986||1986-01-01|February 2000|2000-02-01|December 2000||2000-12-01|||||Observational|||Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects|Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects|Completed||N/A|160||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.831168|2017-02-18 18:24:16.831168
NCT00001210|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1986||1986-11-01|October 1999|1999-10-01|September 2000||2000-09-01|||||Observational|||Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines|Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines|Completed||N/A|60||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.907576|2017-02-18 18:24:16.907576
NCT00001209|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1986||1986-10-01|September 1999|1999-09-01|August 2000||2000-08-01|||||Interventional|||A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors|A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors|Completed||Phase 1|120||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:16.990543|2017-02-18 18:24:16.990543
NCT00001208|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||November 21, 1985||1985-11-21|October 25, 2016|2016-10-25|October 30, 2019|Anticipated|2019-10-30|||||Interventional|||Botulinum Toxin for the Treatment of Involuntary Movement Disorders|A Training Protocol for the Use of Botulinum Toxin in the Treatment of Neurological Disorders|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:24:17.347071|2017-02-18 18:24:17.347071
NCT00001206|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||June 5, 1985||1985-06-05|December 4, 2015|2015-12-04||||||||Observational|||Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)|Biological Markers in Childhood Psychiatric Disorders|Completed||N/A|347|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:17.457076|2017-02-18 18:24:17.457076
NCT00001205|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||July 22, 1985||1985-07-22|November 17, 2016|2016-11-17||||||||Observational|||Treatment of Patients With Cysticercosis With Praziquantel or Albendazole|Treatment of Cysticercosis Including Neurocysticercosis With Praziquantel, Albendazole and Other Novel Treatment Modalities|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:17.555734|2017-02-18 18:24:17.555734
NCT00001204|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 28, 1985||1985-05-28|March 7, 2016|2016-03-07||||||||Observational|||Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers|Cardiovascular Evaluation of Homozygous Familial Hypercholesterolemia|Completed||N/A|73|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:17.670901|2017-02-18 18:24:17.670901
NCT00001203|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||April 22, 1985||1985-04-22|November 9, 2015|2015-11-09|November 9, 2015||2015-11-09|||||Observational|||Deferoxamine for the Treatment of Hemochromatosis|Clinical Course of Patients With Transfusional Hemochromatosis on Deferoxamine|Completed||N/A|151|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:17.764495|2017-02-18 18:24:17.764495
NCT00001202|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1985||1985-01-01|January 2004|2004-01-01|January 2004||2004-01-01|||||Interventional|||Treatment of Boys With Precocious Puberty|Spironolactone and Testolactone Treatment of Boys With Familial Isosexual Precocious Puberty|Completed||Phase 2|80||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:17.865161|2017-02-18 18:24:17.865161
NCT00001201|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1984||1984-10-01|November 2002|2002-11-01|November 2002||2002-11-01|||||Observational|||Evaluation of Neuromuscular Disease|Evaluation of Neuromuscular Diseases|Completed||N/A|1500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:17.959045|2017-02-18 18:24:17.959045
NCT00001198|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 19, 1984||1984-03-19|August 29, 2016|2016-08-29||||||||Observational|||Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia|Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients|Recruiting||N/A|1975|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.042064|2017-02-18 18:24:18.042064
NCT00001197|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 7, 1984||1984-02-07|May 18, 2015|2015-05-18|May 18, 2015|Actual|2015-05-18|December 21, 2003|Actual|2003-12-21||Interventional|||Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia|Effect of Hydroxyurea on Fetal Hemoglobin Synthesis in Patients With Sickle Cell Anemia|Completed||Phase 2|41|Actual|National Institutes of Health Clinical Center (CC)||1|||f||||||||||||||2017-02-18 18:24:18.147805|2017-02-18 18:24:18.147805
NCT00001196|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 23, 1984||1984-03-23|September 29, 2015|2015-09-29|September 29, 2015||2015-09-29|||||Observational|||Evaluation of Salivary Gland Dysfunction|Evaluation of Salivary Gland Dysfunction|Terminated||N/A|1740|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.253068|2017-02-18 18:24:18.253068
NCT00001195|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 28, 1984||1984-08-28|October 20, 2014|2014-10-20|October 20, 2014||2014-10-20|||||Observational|||Endocrine Studies of Healthy Children|Endocrine Studies of Healthy Children|Completed||N/A|1247|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.362815|2017-02-18 18:24:18.362815
NCT00001194|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1984||1984-04-01|March 2000|2000-03-01|February 2001||2001-02-01|||||Observational|||NMR Scanning on Patients|NMR Scanning on Patients|Completed||N/A|99999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.446911|2017-02-18 18:24:18.446911
NCT00001173|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1980||1980-06-01|June 1999|1999-06-01|June 2000||2000-06-01|||||Observational|||Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization|Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization|Completed||N/A|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.171164|2017-02-18 18:24:20.171164
NCT00001193|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1984||1984-11-01|August 1999|1999-08-01|September 2000||2000-09-01|||||Interventional|||A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer|A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer|Completed||Phase 2|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.520717|2017-02-18 18:24:18.520717
NCT00001192|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||October 18, 1983||1983-10-18|December 20, 2006|2006-12-20|December 20, 2006||2006-12-20|||||Observational|||Neuropsychological Evaluation of Psychiatric and Neurological Patients|Neuropsychological Evaluation of Psychiatric and Neurological Patients|Completed||N/A|4300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.610449|2017-02-18 18:24:18.610449
NCT00001191|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 3, 1983||1983-02-03|December 10, 2007|2007-12-10|December 10, 2007||2007-12-10|||||Interventional|||The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid|The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid|Completed||Phase 2|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.702954|2017-02-18 18:24:18.702954
NCT00001190|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1983||1983-11-01|October 2001|2001-10-01|October 2001||2001-10-01|||||Interventional|||Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature|A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.804657|2017-02-18 18:24:18.804657
NCT00001189|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1983||1983-12-01|May 2000|2000-05-01|April 2001||2001-04-01|||||Interventional|||The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors|The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors|Completed||Phase 2|150||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.892521|2017-02-18 18:24:18.892521
NCT00001188|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1983||1983-12-01|November 1999|1999-11-01|September 2000||2000-09-01|||||Interventional|||The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities|The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:18.986899|2017-02-18 18:24:18.986899
NCT00001186|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||February 8, 1983||1983-02-08|December 8, 2016|2016-12-08||||||||Observational|||Psychological Benefits of a Normalized Camping Experience for Children With Cancer|Psychological Benefits of a Normalized Camping Experience for Children With Cancer|Recruiting||N/A|9999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.071369|2017-02-18 18:24:19.071369
NCT00001185|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1982||1982-06-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Observational|||"Study of Post-Polio Syndrome"|Post-Polio Motor Neuron Disease: Clinical, Virological, and Immunological Studies|Completed||N/A|360||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.177689|2017-02-18 18:24:19.177689
NCT00001184|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||November 12, 1982||1982-11-12|December 15, 2016|2016-12-15||||||||Observational|||Immune Regulation in Ulcerative Colitis or Crohn s Disease|Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut|Recruiting||N/A|1000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.258907|2017-02-18 18:24:19.258907
NCT00001183|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 11, 1982||1982-03-11|November 22, 2016|2016-11-22||||||||Observational|||Evaluation of the Causes and Disease Processes of Chronic Lung Disease|Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.371138|2017-02-18 18:24:19.371138
NCT00001182|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||April 1982||1982-04-01|June 2002|2002-06-01|June 2002||2002-06-01|||||Interventional|||Evaluation of Patients With Unusual Diagnostic or Treatment Considerations|General Dental Diagnostic and Therapeutic Study: A Pilot Program for Evaluating the Research Potential of Referred Subjects|Completed||N/A|300||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.469475|2017-02-18 18:24:19.469475
NCT00001181|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1982||1982-10-01|May 2003|2003-05-01|May 2003||2003-05-01|||||Interventional|||Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty|Testolactone Treatment of Girls With LHRH Analog-Resistant Precocious Puberty Due to Autonomous, Non-Neoplastic Ovarian Estrogen Secretion|Completed||Phase 2|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.550378|2017-02-18 18:24:19.550378
NCT00001180|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||March 1982||1982-03-01|June 2005|2005-06-01|June 2005||2005-06-01|||||Observational|||Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency|Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency|Completed||N/A|2250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.653574|2017-02-18 18:24:19.653574
NCT00001178|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 19, 1981||1981-01-19|December 17, 2012|2012-12-17|December 17, 2012||2012-12-17|||||Observational|||Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders|Regional Cerebral Utilization of Glucose in Patients With a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders|Terminated||N/A|597|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.748612|2017-02-18 18:24:19.748612
NCT00001177|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 24, 1981||1981-08-24|April 21, 2016|2016-04-21||||||||Observational|||Study of Premenstrual Syndrome and Premenstrual Dysphoria|The Evaluation of Women With Menstrually Regulated Mood and Behavioral Disorders|Recruiting||N/A|1600|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.851789|2017-02-18 18:24:19.851789
NCT00001176|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||May 1981||1981-05-01|December 2001|2001-12-01|December 2001||2001-12-01|||||Observational|||Effects of Salt Intake on the Nervous Systems of Patients With Salt-Sensitive High Blood Pressure|The Function of Dopaminergic and Noradrenergic Systems in Salt-Sensitive Hypertension: The Effects of Changes in Sodium Intake|Completed||N/A|110||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:19.970796|2017-02-18 18:24:19.970796
NCT00001171|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1979||1979-07-01|September 2005|2005-09-01|September 2005||2005-09-01|||||Observational|||Evaluation of Factors in Human Brain Tumors|Evaluation of Biological, Immunological and Therapeutic Parameters in Brain Tumor Patients|Completed||N/A|800||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.350229|2017-02-18 18:24:20.350229
NCT00001170|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1979||1979-10-01|February 2005|2005-02-01|February 2005||2005-02-01|||||Observational|||Study of the Psychological Development of Children of Parents With and Without Affective Disorders|Affective Disorders and Affective Development: A Study of Child Rearing and Child Development in Normal Families and Families With Affective Disorders|Completed||N/A|1045||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.431649|2017-02-18 18:24:20.431649
NCT00001169|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||December 1979||1979-12-01|February 2000|2000-02-01|February 2001||2001-02-01|||||Observational|||Clinical Investigation of Infections Due to Leishmanial Parasites|Clinical Investigation of Infections Due to Leishmanial Parasites|Completed||N/A|250||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.510018|2017-02-18 18:24:20.510018
NCT00001168|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||August 6, 1979||1979-08-06|March 7, 2016|2016-03-07||||||||Observational|||Evaluation of Lipoproteins|Teaching Protocol for the Evaluation of Plasma Lipoproteins|Recruiting||N/A|2000|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.590221|2017-02-18 18:24:20.590221
NCT00001167|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||August 1979||1979-08-01|November 2004|2004-11-01|November 2004||2004-11-01|||||Observational|||Ultrasound Evaluation of Tongue Movements in Speech and Swallowing|Exploration of the Diagnostic Capabilities of Ultrasound of the Oropharynx and Larynx|Completed||N/A|570||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.691757|2017-02-18 18:24:20.691757
NCT00001166|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||January 1978||1978-01-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Gyrate Atrophy of the Choroid and Retina|The Diagnosis, Pathogenesis and Treatment of Gyrate Atrophy of the Choroid and Retina|Completed||N/A|65||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.776648|2017-02-18 18:24:20.776648
NCT00001165|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||September 1978||1978-09-01|August 2003|2003-08-01|August 2003||2003-08-01|||||Interventional|||Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas|Evaluation of Chemotherapy With Streptozotocin Combined With 5-Fluorouracil and Adriamycin in Patients With Zollinger-Ellison Syndrome and Metastatic Non-Beta-Islet Cell Neoplasm|Completed||Phase 2|999||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.856645|2017-02-18 18:24:20.856645
NCT00001164|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||July 1978||1978-07-01|June 2000|2000-06-01|June 2000||2000-06-01|||||Observational|||Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers|Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:20.944396|2017-02-18 18:24:20.944396
NCT00001163|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 20, 1978||1978-03-20|September 23, 2016|2016-09-23||||||||Observational|||Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer|Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer|Recruiting||N/A|7500|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:21.028069|2017-02-18 18:24:21.028069
NCT00001162|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||May 23, 1977||1977-05-23|June 28, 2016|2016-06-28||||||||Observational|||Parasitic Infections of the Gastrointestinal Tract|Study of Patients With Parasitic Infections of the Gastrointestinal Tract|Recruiting||N/A|200|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:21.343387|2017-02-18 18:24:21.343387
NCT00001161|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||July 1977||1977-07-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Observational|||Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens|Anomalies of the Anterior Chamber, Angle, Iris, Cornea and Lens With or Without Glaucoma or Ocular Hypertension|Completed||N/A|100||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:21.456142|2017-02-18 18:24:21.456142
NCT00001160|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-28|||May 31, 1977||1977-05-31|September 14, 2016|2016-09-14||||||||Observational|||Studies on Tumors of the Thyroid|Studies on Thyroid Nodules and Thyroid Cancer|Recruiting||N/A|99999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:21.551093|2017-02-18 18:24:21.551093
NCT00001159|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-28|||January 14, 1977||1977-01-14|November 7, 2016|2016-11-07||||||||Observational|||Evaluation of Patients With Thyroid Disorders|Evaluation of Patients With Thyroid Function Disorders|Recruiting||N/A|99999999|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:21.662827|2017-02-18 18:24:21.662827
NCT00001158|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-04|||April 1977||1977-04-01|April 1999|1999-04-01|March 2000||2000-03-01|||||Observational|||Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System|Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System|Completed||N/A|||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:21.774755|2017-02-18 18:24:21.774755
NCT00001156|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||January 23, 1976||1976-01-23|February 1, 2010|2010-02-01|February 1, 2010||2010-02-01|||||Observational|||Assessment of Patients With Multiple Sclerosis (MS)|Combined Clinical, Immunological and Virological Assessment of Patients With Multiple Sclerosis (MS)|Completed||N/A|1388|Actual|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:21.854895|2017-02-18 18:24:21.854895
NCT00001155|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||February 1976||1976-02-01|February 2002|2002-02-01|February 2002||2002-02-01|||||Interventional|||Treatment of Wegener's Granulomatosis With Cyclophosphamide|Treatment of Wegener's Granulomatosis With Cyclophosphamide|Completed||Phase 2|200||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:21.934661|2017-02-18 18:24:21.934661
NCT00001154|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2017-01-24|||March 3, 1976||1976-03-03|October 24, 2016|2016-10-24||||||||Observational|||Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins|Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients|Recruiting||N/A|900|Anticipated|National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.027768|2017-02-18 18:24:22.027768
NCT00001153|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1976||1976-06-01|May 1999|1999-05-01|May 2000||2000-05-01|||||Observational|||Visual Function and Ocular Pigmentation in Albinism|Visual Function and Ocular Pigmentation in Albinism|Completed||N/A|130||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.131672|2017-02-18 18:24:22.131672
NCT00001152|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||June 1976||1976-06-01|May 1998|1998-05-01|June 2000||2000-06-01|||||Observational|||Pigment Dispersion Syndrome With and Without Glaucoma|Pigment Dispersion Syndrome With and Without Glaucoma|Completed||N/A|175||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.225642|2017-02-18 18:24:22.225642
NCT00001151|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-11-21|2010-11-12||March 1976||1976-03-01|June 2013|2013-06-01|October 2009|Actual|2009-10-01|October 2009|Actual|2009-10-01||Interventional|||Studies With 1,25-Dihydroxycholecalciferol|Studies With 1,25-Dihydroxycholecalciferol|Terminated||Phase 2|6|Actual|National Institutes of Health Clinical Center (CC)||1||Terminated because of lack of drug supply|f||||f||||||||||2017-02-18 18:24:22.304312|2017-02-18 18:24:22.304312
NCT00001150|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1976||1976-10-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers|Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers|Completed||N/A|2000||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.510207|2017-02-18 18:24:22.510207
NCT00001149|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||November 1975||1975-11-01|January 2002|2002-01-01|January 2002||2002-01-01|||||Observational|||Monitoring Patients With Uncontrolled Epilepsy|Monitoring of Seizures, EEG and Serum Antiepileptic Drug Concentrations in Patients With Uncontrolled Epilepsy|Completed||N/A|900||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.58852|2017-02-18 18:24:22.58852
NCT00001148|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|January 2005|2005-01-01|January 2005||2005-01-01|||||Observational|||Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor|Detection of Glioblastoma or Anaplastic Astrocytoma Cells in the Circulation During Surgical Resection|Completed||N/A|25||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.668724|2017-02-18 18:24:22.668724
NCT00001147|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|March 2004|2004-03-01|March 2004||2004-03-01|||||Observational|||Blood Sampling for Neurochemical and Genetic Testing|Blood Sampling for Neurochemical and Genetic Testing|Completed||N/A|500||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.751116|2017-02-18 18:24:22.751116
NCT00001146|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|August 2002|2002-08-01|August 2002||2002-08-01|||||Interventional|||Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial|Omega-3 Fatty Acids in the Treatment of Major Depression and Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial|Completed||Phase 2|240||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.836242|2017-02-18 18:24:22.836242
NCT00001145|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|October 2003|2003-10-01|October 2003||2003-10-01|||||Interventional|||Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome|Study of Immune Responses and Safety of Recombinant CD40 Ligand in Patients With X-Linked Hyper IgM Syndrome|Completed||Phase 2|5||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:22.926859|2017-02-18 18:24:22.926859
NCT00001144|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-10-06|||October 1999||1999-10-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Interventional|||Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia|Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Chronic Phase CML|Completed||Phase 2|50||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:23.01829|2017-02-18 18:24:23.01829
NCT00001143|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|October 2002|2002-10-01|October 2002||2002-10-01|||||Observational|||Development of the Eye Motor System During the First 7 Months of Life in Infants With and Without a Family History of Cross-Eye|Ocular Motor Development During the First Seven Months of Life in Infants With and Without a Family History of Strabismus|Completed||N/A|20||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:23.386557|2017-02-18 18:24:23.386557
NCT00001142|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2008-03-03|||October 1999||1999-10-01|October 2000|2000-10-01|December 2000||2000-12-01|||||Observational|||Metabolism and Body Shape of Healthy Children and Children With Chronic Infections|Metabolism and Body Composition of Healthy Children and Children With Chronic Infections|Completed||N/A|185||National Institutes of Health Clinical Center (CC)|||||f||||||||||||||2017-02-18 18:24:23.676911|2017-02-18 18:24:23.676911
NCT00001137|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-28|2013-12-05|||January 2000||2000-01-01|December 2013|2013-12-01|November 2013|Actual|2013-11-01|November 2013|Actual|2013-11-01||Observational|||Long-Term Data Collection From Participants in Adult AIDS Clinical Trials|Adult AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) Protocol|Completed||N/A|5982|Actual|AIDS Clinical Trials Group|||1||f||||||||||||||2017-02-18 18:24:23.765756|2017-02-18 18:24:23.765756
NCT00001136|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-25|2012-05-11||||||May 2012|2012-05-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine|A Multi-Centered Phase 1 Trial to Evaluate the Memory Responses to a Single Boosting Vaccination With ALVAC-HIV vCP205 in Volunteers Who Have Previously Received Poxvirus-Based Vaccines|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:23.973715|2017-02-18 18:24:23.973715
NCT00001135|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-23|2012-03-30||||||March 2012|2012-03-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants|A Phase III Randomized, Double-Blinded Study of Nevirapine for the Prevention of Maternal-Fetal Transmission in Pregnant HIV-Infected Women|Completed||Phase 3|2009||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:24.083951|2017-02-18 18:24:24.083951
NCT00001133|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2012-05-21||||||May 2012|2012-05-01|August 2006|Actual|2006-08-01|||||Interventional|||Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir|A Phase I/II, Randomized, Open-Label Study of the Safety and Pharmacokinetics of Indinavir + Ritonavir Therapy in HIV-Infected Subjects Failing Amprenavir, Nelfinavir, Saquinavir, or Nelfinavir/Saquinavir Combination Therapy|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:24:24.214508|2017-02-18 18:24:24.214508
NCT00001132|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2008-09-08|||November 1999||1999-11-01|June 2003|2003-06-01|April 2001||2001-04-01|||||Interventional|||Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination|A Pilot Study of Early Treatment Intensification of Antiretroviral Therapy|Completed||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:24.348297|2017-02-18 18:24:24.348297
NCT00001131|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2015-05-14|||May 2004||2004-05-01|September 2013|2013-09-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Interventional|||Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients|Procedure for Initiation, Administration, and Discontinuation of Interleukin-2 (IL-2) Therapy in Conjunction With Highly Active Antiretroviral Therapy|Completed||N/A|42|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:24:24.495023|2017-02-18 18:24:24.495023
NCT00001130|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2008-09-08||||||January 2005|2005-01-01||||||||Observational|||Identifying Emergency Room Patients Who Have Recently Been Infected With HIV|Increasing Identification of Patients With Primary HIV Infection (PHI) Through a Questionnaire Intervention in an Emergency Department (ED) Setting|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:24.616082|2017-02-18 18:24:24.616082
NCT00001129|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2013-09-28||||||September 2013|2013-09-01|June 2003|Actual|2003-06-01|||||Interventional|||A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly|Adherence Strategies Using a Medication Manager and an Electronic Medication Reminder System for HIV-Infected Patients Receiving HAART|Completed||N/A|1248||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:24.696709|2017-02-18 18:24:24.696709
NCT00001128|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2016-12-13||||||June 2003|2003-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Treatment of Chronic Cryptosporidiosis in AIDS Patients|A Pilot, Proof-of-Concept, Dose-Escalating Trial of Recombinant Human Interleukin-12 (rhIL-12) Versus Placebo Along With Paromomycin and Azithromycin for Chronic Cryptosporidiosis in AIDS|Terminated||N/A|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:24.817333|2017-02-18 18:24:24.817333
NCT00001127|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Study of a Flu Vaccine in Children|Study of the Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in a Community-Based, Non-Randomized, Open-Label Trial in Children to Assess Safety and Herd Immunity for the Control of Epidemic Influenza|Completed||Phase 3|15000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:24.912187|2017-02-18 18:24:24.912187
NCT00001126|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)|A Phase I/II Evaluation of Cidofovir Therapy For Recurrent Laryngeal Papillomatosis in Children|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:24.995616|2017-02-18 18:24:24.995616
NCT00001125|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2014-10-28||||||October 2014|2014-10-01|March 2004|Actual|2004-03-01|||||Interventional|||Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox|Use of a Live-Attenuated Varicella-Zoster Virus (VZV) Vaccine to Boost Immunity to VZV in HIV-Infected Children Previously Infected With Varicella|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:24:25.096619|2017-02-18 18:24:25.096619
NCT00001123|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome|A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome|Completed||N/A|130||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:25.218441|2017-02-18 18:24:25.218441
NCT00001122|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-01||||||January 2005|2005-01-01||||October 2003|Actual|2003-10-01||Interventional|||A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly|A Phase II, Randomized, Open-Label Study of Maximally Assisted Therapy (MAT) Compared to Self-Administered Therapy (SAT) for the Treatment of HIV Infection in Antiretroviral Naive Subjects With CD4 Greater Than or Equal to 200 Cells/mm3|Completed||Phase 2|74||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:25.303087|2017-02-18 18:24:25.303087
NCT00001121|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-09-11|||August 1999||1999-08-01|June 2003|2003-06-01||||||||Observational|||A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1|Evaluation of Virologic, Immunologic, and Clinical Parameters of Participants in HIVNET 014 Who Become Infected With HIV-1|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:25.402837|2017-02-18 18:24:25.402837
NCT00001120|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-09-11||||||May 2006|2006-05-01||||||||Observational|||A Study of Patients With AIDS Syndrome|Oncogenic Viral Pathogenesis and Cancer Risk Factors Among Patients With the Acquired Immunodeficiency Syndrome: A Prospective Cohort Study|Completed||N/A|5000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:25.506178|2017-02-18 18:24:25.506178
NCT00001119|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-01|||October 1999||1999-10-01|January 2005|2005-01-01||||June 2004|Actual|2004-06-01||Interventional|||Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV|A Study of the Effects of Combination Antiretroviral Therapy in Acute HIV-1 Infection With an Emphasis on Immunological Responses|Completed||N/A|288||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:25.617447|2017-02-18 18:24:25.617447
NCT00001118|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|December 2002|Actual|2002-12-01|||||Interventional|||Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children|A Phase I/II Study of T-20, a Fusion Inhibitor, in HIV-1 Infected Children|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:25.724145|2017-02-18 18:24:25.724145
NCT00001117|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-30||||||June 2003|2003-06-01||||||||Observational|||A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection|Dynamics of Hepatitis C Infection in Subjects With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Receiving Highly Active Antiretroviral Therapy (HAART)|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:25.840602|2017-02-18 18:24:25.840602
NCT00001116|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|June 2000|Actual|2000-06-01|||||Interventional|||A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients|Effect of Recombinant Human Soluble Tumor Necrosis Factor Receptor (TNFR:Fc) on Interleukin-6 (IL-6), Tumor Necrosis Factor-Alpha (TNF-alpha) and Markers of Immune Activation in HIV-Infected Subjects|Completed||N/A|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:25.958417|2017-02-18 18:24:25.958417
NCT00001115|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-10-27||||||June 1998|1998-06-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood|A Pilot Study to Determine the Effect of Acyclovir Treatment for Herpes Simplex Virus (HSV) Infection on Peripheral Blood HIV Viral Load.|Completed||N/A|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:26.062817|2017-02-18 18:24:26.062817
NCT00001114|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|March 2000|Actual|2000-03-01|||||Interventional|||The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma|A Randomized Phase II Trial to Determine the Safety, Tolerance, and Efficacy of Two Doses of Interferon Alfa-2b Combined With Didanosine in Patients With Kaposi's Sarcoma|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:26.248977|2017-02-18 18:24:26.248977
NCT00001113|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|March 1990|Actual|1990-03-01|||||Interventional|||A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma|A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:26.361389|2017-02-18 18:24:26.361389
NCT00001112|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|April 1993|Actual|1993-04-01|||||Interventional|||The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine|A Phase I Study To Determine the Safety of the Optimal Monocyte Activating Administration Schedule of Subcutaneous Human Recombinant Interferon-gamma in ZDV-Treated Patients With AIDS|Completed||Phase 1|5||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:26.472201|2017-02-18 18:24:26.472201
NCT00001111|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||June 1995|Actual|1995-06-01||Interventional|||A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children|Pharmacokinetics, Safety, Tolerance, and Activity of Nevirapine (BI-RG-587) Alone and in Combination With AZT in Mildly to Moderately Symptomatic HIV-1 Infected Children|Completed||N/A|35||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:26.583892|2017-02-18 18:24:26.583892
NCT00001110|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26|||August 1999||1999-08-01|July 2013|2013-07-01|April 2003|Actual|2003-04-01|||||Interventional|||Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients|Effect of Highly Active Antiretroviral Therapy (HAART) on Viral Burden and Immune Function in the Lungs of HIV-Infected Subjects|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:26.694944|2017-02-18 18:24:26.694944
NCT00001109|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-29||||||October 2004|2004-10-01||||||||Observational|||A Blood Test to Look at Cells of the Immune System in Healthy Children|Mononuclear Cell Phenotyping in Normal Children|Completed||N/A|630||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:26.78579|2017-02-18 18:24:26.78579
NCT00001108|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|June 2000|Actual|2000-06-01|||||Interventional|||A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses|Multi-Drug Antiretroviral Therapy for Heavily Pretreated Pediatric AIDS Patients: A Phase I Proof of Concept Trial|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:29.950704|2017-02-18 18:24:29.950704
NCT00001107|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants|Invasive Fungal Infection in Liver Transplant Recipients: A Randomized Double-Blind Trial Comparing AmBisome and Fluconazole in the High Risk Group and an Observational Cohort Study in the Low Risk|Completed||Phase 4|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:30.065614|2017-02-18 18:24:30.065614
NCT00001106|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-06-02||||||March 2012|2012-03-01|March 1994|Actual|1994-03-01|||||Interventional|||A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children|A Phase I Trial To Evaluate Zidovudine (ZDV) in HIV-1 Infected Pregnant Women and Their Offspring|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:30.14806|2017-02-18 18:24:30.14806
NCT00001105|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|March 1996|Actual|1996-03-01|||||Interventional|||The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV|A Phase I Clinical Trial to Study the Toxicity, Pharmacokinetics, and Efficacy of Human Monoclonal Antibody, F105, for Treating Human Immunodeficiency Virus Infection.|Completed||Phase 1|8||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:30.250281|2017-02-18 18:24:30.250281
NCT00001104|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia|A Placebo Controlled Trial To Evaluate Zidovudine (ZDV) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Hemophilic Patients|Completed||Phase 3|538||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:30.347268|2017-02-18 18:24:30.347268
NCT00001103|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-28||||||May 2006|2006-05-01||||||||Observational|||HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs|Cerebrospinal Fluid Human Immunodeficiency Virus-1 (HIV-1) and Cognitive Function in Individuals Receiving Potent Antiretroviral Therapy|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:30.479595|2017-02-18 18:24:30.479595
NCT00001102|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-04-16||||||April 2014|2014-04-01|June 2006|Actual|2006-06-01|||||Observational|||The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients|Metabolic Consequences of Highly Active Antiretroviral Therapy (HAART) in HIV-Positive Individuals|Completed||N/A|460||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:30.879486|2017-02-18 18:24:30.879486
NCT00001101|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-08-26||||||March 2010|2010-03-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease|Completed||Phase 3|194||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:30.986708|2017-02-18 18:24:30.986708
NCT00001100|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.|A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.|Completed||Phase 3|130||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:31.082926|2017-02-18 18:24:31.082926
NCT00001097|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-04-23|||December 1997||1997-12-01|November 2005|2005-11-01||||||||Observational|||Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems|Establishment and Maintenance of Long-Term Undetectable Plasma HIV-1 RNA: Correlation With Immunologic Reconstitution and Viral Dynamics|Completed||N/A|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:31.172478|2017-02-18 18:24:31.172478
NCT00001096|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|March 2000|Actual|2000-03-01|||||Interventional|||A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:31.314785|2017-02-18 18:24:31.314785
NCT00001095|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|October 1999|Actual|1999-10-01|||||Interventional|||A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir|A Phase II Study of 1) Amprenavir (141W94/VX478) Plus 3TC Plus ZDV (or d4T) or 2) IDV Plus NVP Plus 3TC Plus d4T in Subjects Previously Treated With Amprenavir and 3) Other Treatment Regimens (Observational ARM) in Subjects Previously Treated With Amprenavir|Completed||Phase 2|94||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:31.42145|2017-02-18 18:24:31.42145
NCT00001094|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-03-05||||||March 2015|2015-03-01||||||||Interventional|||A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients|A Phase II, Randomized, Controlled, Open-Label Trial of Combination Therapy With Nelfinavir (NFV) and Saquinavir (SQV)Sgc With Delavirdine (DLV) or 3TC/ZDV Versus Nelfinavir (NFV) and 3TC/ZDV in Subjects With HIV Infection and > 5,000 HIV RNA Copies/ML|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:31.534054|2017-02-18 18:24:31.534054
NCT00001093|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-26|||October 1999||1999-10-01|October 2012|2012-10-01|June 2007|Actual|2007-06-01|||||Observational|||Outcomes of Anti-HIV Therapy During Early HIV Infection|Outcomes of Antiretroviral Therapy During Primary HIV Infection|Completed||N/A|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:31.642035|2017-02-18 18:24:31.642035
NCT00001092|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-10-21|||October 1999||1999-10-01|October 2015|2015-10-01|October 2008|Actual|2008-10-01|October 2008|Actual|2008-10-01||Observational|||The Biology of HIV Transmission|The Determinants of the Biology of HIV Transmission to Determine the Immunologic and Virologic Characteristics of Those Who May Have Transmitted HIV to Another Individual|Completed||N/A|20|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood, genital fluids, and saliva collection~   "|||2017-02-18 18:24:31.729444|2017-02-18 18:24:31.729444
NCT00001091|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|October 2000|Actual|2000-10-01|||||Interventional|||Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens|A Phase II Rolling Arm Master Protocol (PRAM) of Novel Antiretroviral Therapy in Stable Experienced HIV-Infected Children. PRAM-2: A Phase I/II Randomized, Multicenter Protocol Comparing Four Antiretroviral Regimens Containing Combinations of Protease Inhibitors, NRTIs and an NNRTI|Completed||Phase 1|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:31.828699|2017-02-18 18:24:31.828699
NCT00001090|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|October 1999|Actual|1999-10-01|||||Interventional|||A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers|A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205, Combined With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Healthy, HIV-1 Uninfected Volunteers|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:32.250116|2017-02-18 18:24:32.250116
NCT00001089|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 2003|2003-02-01||||||||Observational|||A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients|Human Immunodeficiency Virus (HIV) and Cytomegalovirus (CMV) Viral Burden and Development of CMV End-Organ Disease: A Prospective Study in HIV-Infected Individuals.|Completed||N/A|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:32.351682|2017-02-18 18:24:32.351682
NCT00001088|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-09-26|||July 1997||1997-07-01|September 2008|2008-09-01|February 2001|Actual|2001-02-01|February 2001|Actual|2001-02-01||Interventional|||A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:32.47474|2017-02-18 18:24:32.47474
NCT00001087|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|July 2000|Actual|2000-07-01|||||Interventional|||The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs|Comparison of the Virologic Efficacy of Nelfinavir and/or DMP 266 (Efavirenz, EFV) in Combination With One or Two New Nucleoside Analogs in Nucleoside Experienced Subjects: A Roll-Over Study to ACTG 302/303|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:32.585067|2017-02-18 18:24:32.585067
NCT00000553|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-08|||September 1994||1994-09-01|March 2005|2005-03-01|February 2001||2001-02-01|||||Interventional|||HDL-Atherosclerosis Treatment Study (HATS)||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-02-18 18:25:57.682245|2017-02-18 18:25:57.682245
NCT00001086|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|September 1999|Actual|1999-09-01|||||Interventional|||A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients|A Randomized, Phase II, Placebo Controlled Trial of Abacavir (ABC, 1592U89) in Combination With Open-Label Indinavir Sulfate (IDV) and Efavirenz (EFV, DMP-266) in HIV-Infected Subjects With Nucleoside Analog Experience: A Rollover Study for ACTG 320|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:32.71277|2017-02-18 18:24:32.71277
NCT00001085|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|September 1998|Actual|1998-09-01|||||Interventional|||A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients|A Randomized, Double-Blind, Phase II Study of 141W94 (VX-478) Monotherapy vs. 141W94 (VX-478) Plus ZDV Plus 3TC in HIV Infected Individuals|Completed||Phase 2|94||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:32.878108|2017-02-18 18:24:32.878108
NCT00001084|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|December 1997|Actual|1997-12-01|||||Interventional|||A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients|A Prospective Randomized Double-Blind Trial of Three Maintenance Regimens for HIV-Infected Subjects Receiving Induction Therapy With Zidovudine, Lamivudine and Indinavir|Completed||Phase 2|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:33.001805|2017-02-18 18:24:33.001805
NCT00001083|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|June 2001|Actual|2001-06-01|||||Interventional|||Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs|A Phase II Rolling Arm Master Protocol (PRAM) of Novel Antiretroviral Therapy in Stable Experienced HIV- Infected Children; PRAM-1: ZDV+3TC vs. d4T+Ritonavir vs. ZDV+3TC+Ritonavir; PRAM-1, Step 2: d4T+Nevirapine+Ritonavir; PRAM-1, Step 3: d4T+Indinavir vs. ZDV+3TC+Indinavir|Completed||Phase 2|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:33.166984|2017-02-18 18:24:33.166984
NCT00001082|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28|||December 1996||1996-12-01|September 2013|2013-09-01|August 1999|Actual|1999-08-01|January 1999|Actual|1999-01-01||Interventional|||The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients|A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil (Bis-POM PMEA) in Prolonging Survival of HIV-Infected Individuals With a CD4+ Cell Count of <= 100/mm3 or With a CD4+ Cell Count Both > 100 and <= 200/mm3 and a Nadir CD4+ Cell Count of <= 50/mm3|Completed||Phase 3|505|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:24:33.33422|2017-02-18 18:24:33.33422
NCT00001081|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|September 1998|Actual|1998-09-01|||||Interventional|||A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium|A Phase II/III Placebo-Controlled Study of Nitazoxanide (NTZ) For Persons With AIDS and Cryptosporidiosis|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:33.465761|2017-02-18 18:24:33.465761
NCT00001080|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01||||||||Interventional|||Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals|Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||||as of 4/23/97|f||||||||||||||2017-02-18 18:24:33.552938|2017-02-18 18:24:33.552938
NCT00001079|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|December 2002|Actual|2002-12-01|||||Interventional|||A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss|Double-Blind Randomized Comparison Phase II Trial of Megestrol Acetate and Testosterone Enanthate in Combination Versus Megestrol Acetate Plus Testosterone Enanthate Placebo in Human Immunodeficiency Virus (HIV)-Associated Wasting.|Completed||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:33.641367|2017-02-18 18:24:33.641367
NCT00001078|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-01||||||July 2005|2005-07-01||||May 2005|Actual|2005-05-01||Interventional|||A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications|An Observational Study of the Rate of Opportunistic Infection Events in HIV-Infected Children Who Have Demonstrated Immunologic Reconstitution and Who Have Discontinued OI Prophylaxis|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:33.753462|2017-02-18 18:24:33.753462
NCT00001077|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28|||June 1996||1996-06-01|September 2013|2013-09-01|April 1998|Actual|1998-04-01|April 1998|Actual|1998-04-01||Observational|||A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements|An Open-Label, Randomized, Three-Arm, Comparative Trial of a Caloric Supplement With Peptides and Medium-Chain Triglycerides Versus a Caloric Supplement With Whole Protein and Long-Chain Triglycerides Versus No Caloric Supplement for the Prevention of Weight Loss in Individuals With AIDS Who Take a Daily Multivitamin and Mineral Supplement|Completed||N/A|536|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||||||||Samples With DNA|"~     Blood collection~   "|||2017-02-18 18:24:34.176836|2017-02-18 18:24:34.176836
NCT00001076|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|December 1997|Actual|1997-12-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules|Completed||Phase 1|34||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:34.302707|2017-02-18 18:24:34.302707
NCT00001075|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-13||||||February 2012|2012-02-01|July 2007|Actual|2007-07-01|||||Interventional|||The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients|A Pilot Study to Evaluate the Immunologic Consequences of a Highly Active Antiretroviral Therapy Regimen (HAART) Consisting of Ritonavir (ABT-538), Zidovudine (AZT), and Lamivudine (3TC) in Moderately Advanced HIV-1 Disease|Completed||N/A|55||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:34.41701|2017-02-18 18:24:34.41701
NCT00001074|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|January 2000|Actual|2000-01-01|||||Interventional|||The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients|A Phase I/II Dosing Study of the Safety and Antiretroviral Activity of Hydroxyurea Alone and in Combination With ddI Compared With ddI Alone in Subjects With HIV Infection|Completed||Phase 1|140||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:34.527892|2017-02-18 18:24:34.527892
NCT00001073|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|March 2001|Actual|2001-03-01|||||Interventional|||Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors|A Randomized Phase III Trial of Oral Isotretinoin Versus Observation for Low-Grade Squamous Intraepithelial Lesions in HIV-Infected Women|Completed||Phase 3|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:34.65064|2017-02-18 18:24:34.65064
NCT00001072|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|January 1999|Actual|1999-01-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|140||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:34.792763|2017-02-18 18:24:34.792763
NCT00001071|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|October 1998|Actual|1998-10-01|||||Interventional|||A Study of Stem Cells and Filgrastim|A Pilot Study of Stem Cell Mobilization and Harvesting From the Peripheral Blood Using Filgrastim|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:34.902181|2017-02-18 18:24:34.902181
NCT00001070|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-12-28||||||December 2012|2012-12-01||||||||Interventional|||The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients|A Dose Escalation Study to Evaluate Tolerance and Antiviral Effect of Oral Vitamin C in Two Groups of HIV-Infected Adults|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:35.00839|2017-02-18 18:24:35.00839
NCT00001069|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 2003|2003-01-01||||||||Observational|||A Study of Two Methods of Determining When to Begin or Change Anti-HIV Treatment|A Randomized Study of the Clinical Effects of Initiating or Changing Antiretroviral Therapy Based on Plasma HIV RNA Quantitation Compared With Initiating or Changing Therapy Based on Current Clinical Practice Alone|Terminated||N/A|1100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:35.081584|2017-02-18 18:24:35.081584
NCT00001068|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|October 1998|Actual|1998-10-01|||||Interventional|||A Study of Disease Progression and Anti-HIV Treatments|Influence of Risk Status for Disease Progression on the Response to Antiretroviral Interventions: A Follow-up Study to ACTG 175|Completed||Phase 2|210||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:35.196014|2017-02-18 18:24:35.196014
NCT00001067|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|November 1997|Actual|1997-11-01|||||Interventional|||The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs|A Phase II Randomized Study of the Virologic and Immunologic Effects of Zidovudine Plus Lamivudine (3TC) Versus d4T Versus Zidovudine Plus d4T in HIV-Infected Patients With CD4 Cell Counts Between 300-600/mm3 and No Previous Nucleoside Experience|Completed||Phase 2|105||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:35.333841|2017-02-18 18:24:35.333841
NCT00001066|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-01||||||March 2011|2011-03-01||||January 2001|Actual|2001-01-01||Interventional|||A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children|A Randomized Comparative Study of Combined Zidovudine-Lamivudine (3TC) vs. the Better of ddI Monotherapy vs. Zidovudine Plus Ddl in Symptomatic HIV-1 Infected Children|Completed||Phase 2|740||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:35.461193|2017-02-18 18:24:35.461193
NCT00001065|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|April 1998|Actual|1998-04-01|||||Interventional|||A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole|A Phase II Trial of Amphotericin B Oral Suspension for Fluconazole-Resistant Oral Candidiasis in HIV-Infected Patients|Completed||Phase 2|70||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:35.665492|2017-02-18 18:24:35.665492
NCT00001064|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-12-13||||||April 1995|1995-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3|A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3|Terminated||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:35.7889|2017-02-18 18:24:35.7889
NCT00001063|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-13||||||April 2012|2012-04-01|November 1997|Actual|1997-11-01|||||Interventional|||The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks|A Phase II Randomized Study of the Virologic and Immunologic Effects of d4T vs Zidovudine Plus d4T vs Zidovudine Plus Ddl in HIV-Infected Patients With CD4 Cell Counts Between 300-600/mm3 and Greater Than 12 Weeks Zidovudine Experience|Completed||Phase 2|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:35.870504|2017-02-18 18:24:35.870504
NCT00001062|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|January 1998|Actual|1998-01-01|||||Interventional|||A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes|A Phase I Study of a Fixed-Schedule Regimen of Alternating Oral and Intravenous Ganciclovir for Treatment of Cytomegalovirus Retinitis|Completed||Phase 1|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:36.002305|2017-02-18 18:24:36.002305
NCT00001061|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|March 1998|Actual|1998-03-01|||||Interventional|||Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS|A Phase II, Double-Masked, Randomized, Placebo-Controlled Evaluation of Standard Therapy vs. Standard Therapy Combined With Human Monoclonal Anti-Cytomegalovirus Antibody (MSL 109) in the Therapy of AIDS Patients With Cytomegalovirus (CMV) Retinitis|Completed||Phase 2|167||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:36.368287|2017-02-18 18:24:36.368287
NCT00001060|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-05-03||||||May 2013|2013-05-01|June 2002|Actual|2002-06-01|||||Interventional|||A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons|A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:36.498752|2017-02-18 18:24:36.498752
NCT00001033|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|July 1997|Actual|1997-07-01|||||Interventional|||The Treatment of Tuberculosis in HIV-Infected Patients|The Treatment of Pulmonary Mycobacterium Tuberculosis in HIV Infection|Completed||Phase 3|650||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:39.712766|2017-02-18 18:24:39.712766
NCT00001059|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-13||||||April 2012|2012-04-01|August 1998|Actual|1998-08-01|||||Interventional|||Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS|Comparison Study of Liposomal Doxorubicin With or Without Bleomycin and Vincristine for the Treatment of Advanced AIDS-Associated Kaposi's Sarcoma|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:36.598301|2017-02-18 18:24:36.598301
NCT00001058|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|January 1999|Actual|1999-01-01|||||Interventional|||A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS|A Phase II/III Prospective, Multicenter, Randomized, Controlled Trial Comparing the Safety and Efficacy of Three Clarithromycin-Containing Combination Drug Regimens for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Disease in Persons With AIDS|Completed||Phase 2|246||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:36.718875|2017-02-18 18:24:36.718875
NCT00001057|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1995|Actual|1995-05-01|||||Interventional|||The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients|A Phase II Randomized, Double-Blind, Placebo-Controlled Trial of the Virologic Effect of Two Different Nucleoside Treatment Strategies (Zidovudine Versus Zidovudine in Combination With Didanosine) for HIV Infection in Subjects With CD4+ Counts >= 550 Cells/mm3|Completed||Phase 2|105||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:36.867742|2017-02-18 18:24:36.867742
NCT00001056|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|October 1994|Actual|1994-10-01|||||Interventional|||A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose|A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose|Completed||Phase 1|25|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:36.980419|2017-02-18 18:24:36.980419
NCT00001055|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|November 1997|Actual|1997-11-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|76||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.095901|2017-02-18 18:24:37.095901
NCT00001054|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|January 2001|Actual|2001-01-01|||||Interventional|||The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children|A Phase I Trial to Evaluate the Pharmacokinetics, Safety, and Tolerance of Valacyclovir HCl in HIV-1 Infected Children With Herpes Simplex Infections or Varicella/Zoster Infections|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.204757|2017-02-18 18:24:37.204757
NCT00001053|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|March 1996|Actual|1996-03-01|||||Interventional|||A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects|A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects|Completed||Phase 1|36|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.300802|2017-02-18 18:24:37.300802
NCT00001052|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|September 1997|Actual|1997-09-01|||||Interventional|||A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults|Completed||Phase 1|110|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.398967|2017-02-18 18:24:37.398967
NCT00001050|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1994|1994-03-01||||||||Observational|||Study of Women Who Have AIDS|Women's AIDS Cohort Study (WACS)|Terminated||N/A|1250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.501443|2017-02-18 18:24:37.501443
NCT00001049|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|June 1998|Actual|1998-06-01|||||Interventional|||A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV|A Phase I Evaluation of the Safety and Toxicity of Zidovudine and Didanosine in Combination in HIV-Infected or Exposed Infants and a Phase II Study of the Effect of Didanosine vs. Combination Therapy With Zidovudine and Didanosine on HIV-1 RNA in Infants With HIV Infection|Completed||Phase 1|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.578451|2017-02-18 18:24:37.578451
NCT00001048|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|April 1997|Actual|1997-04-01|||||Interventional|||Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients|A Phase II Multicenter Study Comparing Antiretroviral Therapy Alone to Antiretroviral Therapy Plus Cytosine Arabinoside (Cytarabine; Ara-C) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in Human Immunodeficiency Virus (HIV)-Infected Subjects|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.734074|2017-02-18 18:24:37.734074
NCT00001047|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|August 1996|Actual|1996-08-01|||||Interventional|||Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS|An Open-Label, Randomized Trial of Four Treatment Regimens for Patients With Disseminated Mycobacterium Avium Complex Disease and Acquired Immunodeficiency Syndrome (AIDS)|Completed||Phase 3|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.865635|2017-02-18 18:24:37.865635
NCT00001046|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01||||||||Interventional|||Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)|Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:37.989948|2017-02-18 18:24:37.989948
NCT00001045|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1998|Actual|1998-10-01|||||Interventional|||Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease|A Double-Blinded, Randomized Trial Comparing Zidovudine (AZT) Versus AZT Plus Didanosine (ddI) Versus AZT Plus ddI Plus Nevirapine in Asymptomatic Patients on AZT Monotherapy Who Develop a Mutation at Codon 215 of HIV Reverse Transcriptase in Serum/Plasma Viral RNA|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:38.100559|2017-02-18 18:24:38.100559
NCT00001044|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|May 1995|Actual|1995-05-01|||||Interventional|||A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.|Completed||Phase 1|80|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:38.270361|2017-02-18 18:24:38.270361
NCT00001043|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|May 1997|Actual|1997-05-01|||||Interventional|||A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules|A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules|Completed||Phase 1|20|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:38.372337|2017-02-18 18:24:38.372337
NCT00001042|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|March 1996|Actual|1996-03-01|||||Interventional|||A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals|A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals|Completed||Phase 1|112|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:38.479541|2017-02-18 18:24:38.479541
NCT00001041|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|July 1998|Actual|1998-07-01|||||Interventional|||Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)|Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:38.587814|2017-02-18 18:24:38.587814
NCT00001040|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||May 1994|Actual|1994-05-01||Interventional|||Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC|Double-Blind, Randomized, Phase II Study of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (Dideoxycytidine; ddC) Versus Ro 31-8959 Plus AZT Plus ddC|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:38.690029|2017-02-18 18:24:38.690029
NCT00001039|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-29||||||October 2012|2012-10-01|June 2002|Actual|2002-06-01|||||Interventional|||Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients|The Effect of Therapy on the Tissue Burden of Disseminated MAC Infection as Measured by Quantitative Bone Marrow Culture and Correlation With Quantitative Blood Culture in HIV-Infected Patients|Completed||Phase 2|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:38.795024|2017-02-18 18:24:38.795024
NCT00001038|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||May 1996|Actual|1996-05-01||Interventional|||A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients|A Randomized, Double-Blind Trial of Valacyclovir Hydrochloride (BW 256U87) Prophylaxis for Opportunistic Cytomegalovirus End-Organ Disease in Patients With Advanced HIV Infection (< 100 CD4+ Lymphocytes)|Completed||Phase 3|1200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:38.896343|2017-02-18 18:24:38.896343
NCT00001037|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|May 1995|Actual|1995-05-01|||||Interventional|||A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules|A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules|Completed||Phase 1|22|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:39.020153|2017-02-18 18:24:39.020153
NCT00001036|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-29||||||October 1996|1996-10-01||||||||Interventional|||The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection|Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine and Thymosin Alpha 1 in HIV-Positive, Asymptomatic and Symptomatic Individuals|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:39.117085|2017-02-18 18:24:39.117085
NCT00001035|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|September 1996|Actual|1996-09-01|||||Interventional|||The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections|A Phase I Pilot Study of the Safety and Efficacy of Interferon Alfa-2b (IFN Alfa-2b) in Combination With Nucleoside Analog Therapy in Patients With Combined Hepatitis C (HCV) and Advanced Human Immunodeficiency Virus (HIV) Infections|Completed||Phase 1|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:39.215281|2017-02-18 18:24:39.215281
NCT00001034|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|August 1995|Actual|1995-08-01|||||Interventional|||The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV|A Randomized, Comparative, Placebo-Controlled Trial of the Safety and Efficacy of Oral Ganciclovir for Prophylaxis of Cytomegalovirus (CMV) Retinal and Gastrointestinal Mucosal Disease in HIV-Infected Individuals With Severe Immunosuppression|Completed||Phase 2|850||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:39.326657|2017-02-18 18:24:39.326657
NCT00001032|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|April 1995|Actual|1995-04-01|||||Interventional|||A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT|A Phase II Study to Evaluate Pharmacokinetics, Safety, Tolerance and Activity of Dideoxycytidine (ddC) Administered in Combination With Zidovudine (AZT) in Stable, AZT-Treated Pediatric Patients With HIV Infection|Completed||Phase 2|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:39.848948|2017-02-18 18:24:39.848948
NCT00001031|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|December 1997|Actual|1997-12-01|||||Interventional|||A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults|A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults|Completed||Phase 2|296|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:40.019865|2017-02-18 18:24:40.019865
NCT00001030|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-06-02||||||March 2012|2012-03-01|June 1996|Actual|1996-06-01|||||Interventional|||The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients|A Prospective, Randomized, Comparative Study of the Safety and Efficacy of Clarithromycin Versus Rifabutin Versus the Combination of Clarithromycin Plus Rifabutin for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia or Disseminated MAC Disease in HIV-Infected Patients With CD4 Lymphocyte Counts <= 100 Cells/mm3|Completed||Phase 3|1100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:40.165507|2017-02-18 18:24:40.165507
NCT00001029|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|May 1993|Actual|1993-05-01|||||Interventional|||A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past|A Randomized, Double-Blind, Three-Arm Study Comparing Combination to Monthly Alternating Nucleoside Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3) With a Prior History of Nucleoside Therapy|Completed||Phase 2|654||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:40.34229|2017-02-18 18:24:40.34229
NCT00001028|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1994|Actual|1994-06-01|||||Interventional|||A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides|A Randomized, Comparative, Prospective Study of Monthly Aerosolized Pentamidine and Thrice Weekly Dapsone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant to Trimethoprim and/or Sulfonamides|Completed||Phase 3|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:40.505467|2017-02-18 18:24:40.505467
NCT00001027|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole|A Phase I/II Trial of Parenteral Pentamidine for PCP Prophylaxis in HIV-Infected Children Who Are Intolerant to Oral Trimethoprim-Sulfamethoxazole|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:40.627619|2017-02-18 18:24:40.627619
NCT00001026|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|December 1994|Actual|1994-12-01|||||Interventional|||A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals|A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:40.743097|2017-02-18 18:24:40.743097
NCT00001025|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1995|Actual|1995-05-01|||||Interventional|||Evaluation of Patients Who Have Not Had Success With Zidovudine|A Study to Evaluate the Short-Term Clinical and Virologic Significance of Zidovudine Resistance|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:40.851472|2017-02-18 18:24:40.851472
NCT00001024|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|June 2002|Actual|2002-06-01|||||Interventional|||The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS|A Multicenter, Open-Label Study of Viral Burden in Peripheral Blood Versus Lymphoid Tissue Before and After Antiretroviral Therapy in HIV-Infected Individuals Without AIDS (NOTE: One Arm Receives no Treatment)|Completed||N/A|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:40.98006|2017-02-18 18:24:40.98006
NCT00001023|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-29||||||October 2012|2012-10-01|July 1998|Actual|1998-07-01|||||Interventional|||The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients|Evaluation of the Safety, Tolerance and Pharmacokinetics of Rifabutin/Clarithromycin Combination and Rifabutin/Azithromycin Combination in HIV-Infected Patients|Completed||N/A|91||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:41.103376|2017-02-18 18:24:41.103376
NCT00001022|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|December 1995|Actual|1995-12-01|||||Interventional|||A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients|A Randomized, Comparative Trial of Zidovudine (AZT) Versus AZT Plus Didanosine (ddI) Versus AZT Plus Dideoxycytidine (ddC) in HIV-Infected Patients|Completed||Phase 3|1200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:41.218915|2017-02-18 18:24:41.218915
NCT00001021|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)|A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)|Completed||Phase 1|57||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:41.343137|2017-02-18 18:24:41.343137
NCT00000800|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|October 1998|Actual|1998-10-01|||||Interventional|||Methadone Effects on Zidovudine (ZDV, AZT) Disposition|Methadone Effects on Zidovudine (ZDV, AZT) Disposition|Completed||Phase 1|15||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:22.831172|2017-02-18 18:25:22.831172
NCT00001020|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|February 1995|Actual|1995-02-01|||||Interventional|||A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)|A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)|Completed||Phase 1|28||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:41.440468|2017-02-18 18:24:41.440468
NCT00001019|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-29||||||October 2012|2012-10-01||||||||Interventional|||Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant|A Phase I Clinical Trial to Evaluate:Part A. The Safety and Immunogenicity of Two Dose Levels of SF-2 gp120 (CHO) With or Without MTP-PE Adjuvant in the MF59 Emulsion Part B. The Safety and Immunogenicity of Five Monthly Doses of 50 mcg gp120 Protein in MF59 Emulsion (Without MTP-PE) Versus the Emulsion Control|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:41.54213|2017-02-18 18:24:41.54213
NCT00001018|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1992|1992-10-01||||||||Interventional|||A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea|Blinded, Placebo-Controlled, Single-Dose Pharmacokinetics and Dose Escalation, Efficacy, and Safety Study of Letrazuril for AIDS-Related Cryptosporidial Diarrhea|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:41.634627|2017-02-18 18:24:41.634627
NCT00001017|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||September 2002|2002-09-01||||July 1991|Actual|1991-07-01||Interventional|||Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS|Comparison of Fluconazole (UK-49,858) and Amphotericin B for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome|Completed||Phase 3|330||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:41.723697|2017-02-18 18:24:41.723697
NCT00001016|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-09-26||||||July 1993|1993-07-01|August 2007|Actual|2007-08-01|||||Interventional|||A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies|A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:41.917454|2017-02-18 18:24:41.917454
NCT00001015|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1990|Actual|1990-06-01|||||Interventional|||A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems|A Multicenter Phase I Clinical Trial of Ribavirin in the Treatment of Patients With AIDS and Advanced AIDS Related Illnesses|Completed||Phase 1|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:42.014445|2017-02-18 18:24:42.014445
NCT00001014|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1991|Actual|1991-09-01|||||Interventional|||Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS|A Randomized, Comparative, Double-Blind Trial of Trimetrexate (CI-898) With Leucovorin Calcium Rescue Versus Trimethoprim / Sulfamethoxazole for Moderately Severe Pneumocystis Carinii Pneumonia in Patients With AIDS|Completed||Phase 3|302||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:42.1137|2017-02-18 18:24:42.1137
NCT00001013|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1991|Actual|1991-09-01|||||Interventional|||Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS|A Randomized, Comparative, Double-Blind Trial of Trimetrexate (CI-898) With Leucovorin Calcium Rescue Versus Trimethoprim / Sulfamethoxazole for Moderately Severe Pneumocystis Carinii Pneumonia in Patients With AIDS|Completed||Phase 3|364||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:42.215919|2017-02-18 18:24:42.215919
NCT00001012|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||September 2002|2002-09-01||||||||Interventional|||A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes|An Open Label, Multiple Dose Ranging Trial of AL721 in Patients With Persistent Generalized Lymphadenopathy and Symptomatic HIV Infection|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:42.336367|2017-02-18 18:24:42.336367
NCT00001011|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex|The Safety and Efficacy of Zidovudine in the Treatment of Patients With Early AIDS Related Complex|Completed||Phase 3|538||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:42.431767|2017-02-18 18:24:42.431767
NCT00001010|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|October 1990|Actual|1990-10-01|||||Interventional|||A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients|An Uncontrolled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Zidovudine (AZT) and Acyclovir (ACV) Given Concomitantly to Patients With Human Immunodeficiency Virus Infection|Completed||Phase 1|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:45.555755|2017-02-18 18:24:45.555755
NCT00001009|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|April 1990|Actual|1990-04-01|||||Interventional|||A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)|A Phase I/II Dose Ranging Trial of Oral Dextran Sulfate (UA001) in HIV Infected Individuals and in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS Related Complex (ARC)|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:45.661348|2017-02-18 18:24:45.661348
NCT00001008|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||August 1991|1991-08-01||||March 1991|Actual|1991-03-01||Interventional|||A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)|Pharmacokinetic Study of the Interaction of Azidothymidine and Methadone in Patients With AIDS and ARC|Completed||N/A|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:45.764179|2017-02-18 18:24:45.764179
NCT00001007|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-11||||||January 2003|2003-01-01||||||||Interventional|||A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth|A Multicenter Phase I Trial To Evaluate the Safety and Pharmacokinetics of Intravenous and Oral Zidovudine in Infants With Perinatal Human Immunodeficiency Virus (HIV) Exposure|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:45.859343|2017-02-18 18:24:45.859343
NCT00001006|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|March 1993|Actual|1993-03-01|||||Interventional|||A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)|A Phase One Study of AS-101 in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:45.963861|2017-02-18 18:24:45.963861
NCT00001005|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-25||||||April 2012|2012-04-01|February 1995|Actual|1995-02-01|||||Interventional|||A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes|Interleukin-2 Augmentation of Specific Anti-HIV Immune Responses: Phase I Trial of the Combination of 3'-Azido-3'-Deoxythymidine (Zidovudine) and Recombinant Interleukin-2 in Patients With Asymptomatic HIV Infection Associated With Lymphadenopathy (Walter Reed Stage II)|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:46.063528|2017-02-18 18:24:46.063528
NCT00001004|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|February 1990|Actual|1990-02-01|||||Interventional|||A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex|A Randomized Multicenter Phase II Trial of Recombinant Tumor Necrosis Factor and Recombinant Human Interferon-gamma in Patients With AIDS Related Complex|Completed||Phase 2|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:46.174995|2017-02-18 18:24:46.174995
NCT00001003|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|January 1992|Actual|1992-01-01|||||Interventional|||A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia|Aerosols in the Treatment of Pneumocystis Carinii Pneumonia: A Nested Study Quantitating the Delivery of Aerosolized Pentamidine for Prophylaxis of PCP in Protocols ACTG 021 and ACTG 081|Completed||N/A|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:46.283416|2017-02-18 18:24:46.283416
NCT00001002|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1991|Actual|1991-06-01|||||Interventional|||A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time|Intermittent Foscarnet Therapy for Human Immunodeficiency Virus Infection in Patients Receiving Long-Term Zidovudine Therapy|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:46.668063|2017-02-18 18:24:46.668063
NCT00001001|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||A Study of Zidovudine in HIV-Infected Patients With Liver Disease|A Clinical Study Examining the Pharmacokinetics and Bioavailability of Azidothymidine (AZT, Zidovudine) in Patients With Human Immunodeficiency Virus (HIV) Infection and Hepatic Disease|Completed||N/A|39||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:46.77774|2017-02-18 18:24:46.77774
NCT00001000|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-18||||||October 2012|2012-10-01|January 1990|Actual|1990-01-01|||||Interventional|||A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection|Immunologic Effect After Single Dose Atvogen in Healthy Volunteers and Asymptomatic HIV-Infected Patients|Completed||N/A|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:46.887658|2017-02-18 18:24:46.887658
NCT00000999|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|March 1989|Actual|1989-03-01|||||Interventional|||The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC|A Multicenter Uncontrolled Trial To Evaluate the Long Term Safety and Tolerance of Zidovudine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS and Advanced ARC|Completed||Phase 1|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:46.978795|2017-02-18 18:24:46.978795
NCT00000998|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-12-17||||||December 2012|2012-12-01|April 1989|Actual|1989-04-01|||||Interventional|||A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP|Evaluation of Escalating Doses of Intravenous Trimetrexate as Therapy for Previously Untreated Pneumocystis Carinii Pneumonia in AIDS Patients With Subsequent Comparison of Intravenous and Oral Pharmacokinetics|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:47.114316|2017-02-18 18:24:47.114316
NCT00000997|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|December 1988|Actual|1988-12-01|||||Interventional|||A Study of Dideoxycytidine in HIV-Infected Patients|Pharmacokinetics and Bioavailability of Dideoxycytidine in Patients With Human Immunodeficiency Virus Infection|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:47.216488|2017-02-18 18:24:47.216488
NCT00000996|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|June 1990|Actual|1990-06-01|||||Interventional|||A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma|Phase II Study of Weekly Doxorubicin Treatment of AIDS Associated Kaposi's Sarcoma|Completed||Phase 2|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:47.315515|2017-02-18 18:24:47.315515
NCT00000995|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-15||||||February 2012|2012-02-01|February 1990|Actual|1990-02-01|||||Interventional|||A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection|Phase I Studies of the Combination of AZT and DHPG (Ganciclovir) in Patients With AIDS and Cytomegalovirus Infection|Completed||N/A|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:47.423761|2017-02-18 18:24:47.423761
NCT00000994|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-15||||||February 2012|2012-02-01|May 1990|Actual|1990-05-01|||||Interventional|||A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma|A Placebo-Controlled Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS-Associated Kaposi's Sarcoma|Completed||Phase 3|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:47.551493|2017-02-18 18:24:47.551493
NCT00000993|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-11-04||||||April 1991|1991-04-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|||A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus|An Open Protocol for the Use of Zidovudine for Prophylactic Treatment of Individuals After Accidental Massive Exposure to the Human Immunodeficiency Virus (HIV)|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:47.677187|2017-02-18 18:24:47.677187
NCT00000992|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-05-15||||||March 2012|2012-03-01|June 1992|Actual|1992-06-01|||||Interventional|||A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS|Pilot Study to Determine the Feasibility of Itraconazole for Suppression of Relapse of Disseminated Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:47.77679|2017-02-18 18:24:47.77679
NCT00000991|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|April 1994|Actual|1994-04-01|||||Interventional|||A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients|A Randomized Trial of Three Anti-Pneumocystis Agents Plus Zidovudine for the Primary Prevention of Serious Infections in Patients With Advanced HIV Infection|Completed||Phase 3|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:47.890564|2017-02-18 18:24:47.890564
NCT00000990|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1992|Actual|1992-09-01|||||Interventional|||The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms|A Multicenter Placebo-Controlled Trial To Evaluate the Safety and Efficacy of Oral Zidovudine in the Treatment of Children Infected With Human Immunodeficiency Virus With Mild to Moderate Symptoms (Including LIP)|Completed||Phase 2|224||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:48.024208|2017-02-18 18:24:48.024208
NCT00000989|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|July 1992|Actual|1992-07-01|||||Interventional|||The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS|A Controlled, Randomized Phase II Study of the Safety and Efficacy of Combined Therapy With Ganciclovir and Granulocyte-Macrophage Colony Stimulating Factor Versus Ganciclovir Alone for the Treatment of Sight-Threatening Cytomegalovirus Retinitis in AIDS Patients|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:48.436358|2017-02-18 18:24:48.436358
NCT00000988|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-25||||||December 1994|1994-12-01||||||||Interventional|||A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex|A Phase I Safety and Pharmacokinetics Study of BMY-27857 (2',3'-Didehydro-3'-Deoxythymidine) Administered Twice Daily to Patients With AIDS or AIDS Related Complex|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:48.546432|2017-02-18 18:24:48.546432
NCT00000987|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|April 1992|Actual|1992-04-01|||||Interventional|||A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS|A Phase I Study of Combination Chemotherapy (Adriamycin, Bleomycin, and Vincristine) and Azidothymidine in the Treatment of AIDS Related Kaposi's Sarcoma|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:48.723753|2017-02-18 18:24:48.723753
NCT00000986|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-25||||||April 2012|2012-04-01|January 1994|Actual|1994-01-01|||||Interventional|||The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex|A Safety, Tolerance, and Immunological Study of a Combination of Recombinant Interleukin 2 and Zidovudine in Patients With AIDS or AIDS Related Complex|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:48.837059|2017-02-18 18:24:48.837059
NCT00000985|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|October 1990|Actual|1990-10-01|||||Interventional|||Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir|Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Infection in Patients With the Acquired Immunodeficiency Syndrome: A Randomized Multicenter Study of Foscarnet Versus Vidarabine|Completed||Phase 3|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:48.949323|2017-02-18 18:24:48.949323
NCT00000984|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1996|1996-10-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection|A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:49.059702|2017-02-18 18:24:49.059702
NCT00000983|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|December 1994|Actual|1994-12-01|||||Interventional|||The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children|A Randomized Blinded Trial To Evaluate the Safety and Tolerance of High Versus Low Dose Zidovudine Administered to Children With Human Immunodeficiency Virus|Completed||Phase 2|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:49.17394|2017-02-18 18:24:49.17394
NCT00000982|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||October 1996|1996-10-01||||September 1996|Actual|1996-09-01||Interventional|||A Study of Azidothymidine in HIV-Infected Children|A Randomized Trial To Evaluate the Impact of Maintaining Steady-State Concentrations of Azidothymidine (AZT) Versus an Intermittent Schedule of AZT Delivery in Children With Symptomatic HIV Infection|Completed||Phase 2|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:49.334551|2017-02-18 18:24:49.334551
NCT00000981|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-12-17||||||December 2012|2012-12-01|February 1993|Actual|1993-02-01|||||Interventional|||The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS|Efficacy and Safety of Oral FIAC in AIDS Patients With Cytomegalovirus Infection: A Dose Ranging Study|Completed||Phase 2|78||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:49.448187|2017-02-18 18:24:49.448187
NCT00000980|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1990|1990-10-01||||||||Interventional|||A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea|Single-Blind Efficacy Evaluation of Intravenous Spiramycin in Subjects With AIDS-Related Cryptosporidial Diarrhea|Completed||Phase 1|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:49.559484|2017-02-18 18:24:49.559484
NCT00000979|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||January 2003|2003-01-01||||October 1992|Actual|1992-10-01||Interventional|||Comparison of ddI Versus Zidovudine in HIV-Infected Patients|Comparison of 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine in Therapy of Patients With HIV Infection|Completed||Phase 2|1500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:49.674434|2017-02-18 18:24:49.674434
NCT00000978|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-06||||||August 1992|1992-08-01||||||||Interventional|||A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)|An Open-Label, Randomized, Dose-Finding, Multicenter Trial of Dideoxycytidine (ddC) Administered Concurrently With Zidovudine (AZT) in the Treatment of AIDS or Advanced ARC|Completed||Phase 1|68||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:49.861515|2017-02-18 18:24:49.861515
NCT00000964|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|October 1990|Actual|1990-10-01|||||Interventional|||The Effect of Stomach Acid on Foscarnet|The Effect of Increasing Gastric pH Upon the Bioavailability of Orally Administered Phosphonoformic Acid (Foscarnet)|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:51.673089|2017-02-18 18:24:51.673089
NCT00000977|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|May 1993|Actual|1993-05-01|||||Interventional|||Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity|Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity|Completed||Phase 1|52||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:49.957092|2017-02-18 18:24:49.957092
NCT00000976|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-05||||||December 1994|1994-12-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex|A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:50.065023|2017-02-18 18:24:50.065023
NCT00000975|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1994|Actual|1994-09-01|||||Interventional|||A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS|Pilot Study To Determine the Feasibility of Itraconazole for Primary Treatment and Suppression of Relapse of Disseminated Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome|Completed||Phase 2|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:50.17677|2017-02-18 18:24:50.17677
NCT00000974|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia|A Phase I Study of the Safety, Tolerance, and Study of the Pharmacokinetics of Aerosolized Pentamidine and Parenteral Pentamidine in Children With HIV Infection and Suspected Pneumocystis Carinii Pneumonia|Completed||Phase 1|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:50.291025|2017-02-18 18:24:50.291025
NCT00000973|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|March 1995|Actual|1995-03-01|||||Interventional|||A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients|Pyrimethamine Pharmacokinetics in HIV Positive Patients Seropositive for Toxoplasma Gondii|Completed||Phase 1|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:50.39826|2017-02-18 18:24:50.39826
NCT00000972|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|April 1992|Actual|1992-04-01|||||Interventional|||A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59|A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59|Completed||Phase 1|64|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:50.510081|2017-02-18 18:24:50.510081
NCT00000971|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-31||||||October 1996|1996-10-01||||||||Interventional|||The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS|A Phase I/II Dose-Ranging, Pharmacokinetic, Drug Interaction, Safety and Preliminary Efficacy Study of Oral Clarithromycin Granules for Suspension, in Combination With Zidovudine or Dideoxyinosine, in the Treatment of Disseminated Mycobacterium Avium Complex Infections in Pediatric Patients With AIDS|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:50.620642|2017-02-18 18:24:50.620642
NCT00000970|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|June 1993|Actual|1993-06-01|||||Interventional|||A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir|A Phase I Open-Labeled Study of Long Term Combined or Alternating Foscarnet/Ganciclovir Maintenance Therapy for AIDS Patients With CMV Retinitis After Ganciclovir Induction Therapy|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:50.732248|2017-02-18 18:24:50.732248
NCT00000969|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|September 1992|Actual|1992-09-01|||||Interventional|||A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy|A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy|Completed||N/A|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:51.116989|2017-02-18 18:24:51.116989
NCT00000968|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|August 1993|Actual|1993-08-01|||||Interventional|||A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)|A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)|Completed||Phase 1|60|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:51.238057|2017-02-18 18:24:51.238057
NCT00000967|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children|Safety and Tolerance of Zidovudine and Interferon-Alpha in HIV-Infected Children|Completed||Phase 1|52||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:51.34356|2017-02-18 18:24:51.34356
NCT00000966|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-25||||||October 1994|1994-10-01||||||||Interventional|||A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS|A Dose-Escalation, Phase I/II Study of Oral Azithromycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS|Completed||Phase 1|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:51.461245|2017-02-18 18:24:51.461245
NCT00000965|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-25||||||February 2011|2011-02-01||||August 1993|Actual|1993-08-01||Interventional|||The Effects of Zidovudine on the Blood of HIV-Infected Patients|Pharmacokinetics of Total Phosphorylated Zidovudine in Mononuclear Cells From HIV-Infected Patients|Completed||N/A|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:51.572852|2017-02-18 18:24:51.572852
NCT00000529|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-11-01|||May 1992||1992-05-01|August 2001|2001-08-01|November 1995||1995-11-01|||||Interventional|||Tamoxifen Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:00.021082|2017-02-18 18:26:00.021082
NCT00000963|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1995|Actual|1995-09-01|||||Interventional|||A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine|A Randomized Comparative Trial of Two Doses of 2',3'-Dideoxyinosine (ddI) in Children With Symptomatic HIV Infection Who Are Either Unresponsive to Zidovudine and/or Who Are Intolerant to Zidovudine|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:51.780905|2017-02-18 18:24:51.780905
NCT00000962|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-01||||||December 1994|1994-12-01||||||||Interventional|||The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients|An Open Label, Staggered Rising Dose Cohort Study Assessing Safety, Tolerance, and Activity of BI-RG-587 in Patients With HIV Infection (CD4+ Cell Count < 400 Cells/mm3)|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:51.938802|2017-02-18 18:24:51.938802
NCT00000961|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||March 1998|1998-03-01||||May 1991|Actual|1991-05-01||Interventional|||The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants|A Phase II Study to Evaluate the Safety, Tolerance and Efficacy of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HIVIG) and of Zidovudine (ZDV) in Infants With Documented HIV Infections|Terminated||Phase 2|112||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:52.040374|2017-02-18 18:24:52.040374
NCT00000960|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-05-15||||||March 2012|2012-03-01|June 1994|Actual|1994-06-01|||||Interventional|||The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants|A Phase III Randomized Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerance of Oral Zidovudine (AZT) in Pregnant HIV Infected Women and Their Infants|Completed||Phase 3|1496||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:52.15393|2017-02-18 18:24:52.15393
NCT00000959|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|June 1996|Actual|1996-06-01|||||Interventional|||Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection|Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection|Completed||N/A|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:52.332335|2017-02-18 18:24:52.332335
NCT00000958|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|September 1995|Actual|1995-09-01|||||Interventional|||A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)|A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)|Completed||Phase 1|8||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:52.458725|2017-02-18 18:24:52.458725
NCT00000957|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|August 1993|Actual|1993-08-01|||||Interventional|||A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules|A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:52.559284|2017-02-18 18:24:52.559284
NCT00000956|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|March 1993|Actual|1993-03-01|||||Interventional|||A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|Completed||Phase 1|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:52.658124|2017-02-18 18:24:52.658124
NCT00000955|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|December 1992|Actual|1992-12-01|December 1992|Actual|1992-12-01||Interventional|||Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection|Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection|Completed||N/A|864|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:24:52.758324|2017-02-18 18:24:52.758324
NCT00000954|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma|Phase I/II Study of Combination Chemotherapy (Adriamycin, Bleomycin, +/- Vincristine) and Dideoxyinosine (ddI) or Dideoxycytidine (ddC) in the Treatment of AIDS-Related Kaposi's Sarcoma|Completed||Phase 1|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:52.902518|2017-02-18 18:24:52.902518
NCT00000953|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-25||||||February 2011|2011-02-01||||September 1996|Actual|1996-09-01||Interventional|||Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients|Evaluation of Brovavir ( BV-ara-U; SQ 32,756 ) Versus Acyclovir in the Treatment of Localized Herpes Zoster in HIV-Infected Patients|Completed||Phase 2|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:53.015302|2017-02-18 18:24:53.015302
NCT00000952|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-10-28||||||October 2014|2014-10-01|January 2004|Actual|2004-01-01|||||Interventional|||A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children|A Phase I/II Study of Ritonavir Therapy in HIV-1 Infected Infants and Children|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:53.152822|2017-02-18 18:24:53.152822
NCT00000951|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|May 2002|Actual|2002-05-01|||||Interventional|||A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush|A Phase IV Randomized Study of the Use of Fluconazole as Chronic Suppressive Therapy Versus Episodic Therapy in HIV Positive Subjects With Recurrent Oropharyngeal Candidiasis|Completed||Phase 4|948||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:53.267608|2017-02-18 18:24:53.267608
NCT00000950|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-01||||||March 2011|2011-03-01||||May 2002|Actual|2002-05-01||Interventional|||Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis|Pharmacokinetics of Antituberculosis Agents in HIV-Infected Persons With Tuberculosis|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:53.678726|2017-02-18 18:24:53.678726
NCT00000949|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|July 2000|Actual|2000-07-01|||||Interventional|||A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3|A Randomized, Open-Label, Study of the Impact of Two Doses of Subcutaneous Recombinant IL-2 (Proleukin) on Viral Burden and CD4+ Cell Count in Patients With HIV-1 Infection and CD4+ Cell Counts Greater Than or Equal to 300/mm3|Completed||Phase 3|460||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:53.796549|2017-02-18 18:24:53.796549
NCT00000948|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-02-01|||February 1998||1998-02-01|February 2013|2013-02-01||||March 2000|Actual|2000-03-01||Interventional|||Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3|A Randomized, Open Label Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Plus Antiretroviral Therapy vs. Antiretroviral Therapy Alone in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3|Completed||Phase 2|72||National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:24:53.908772|2017-02-18 18:24:53.908772
NCT00000947|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|July 2000|Actual|2000-07-01|||||Interventional|||A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients|A Randomized, Double-Blind, Placebo-Controlled Trial of Prophylaxis for Disseminated Mycobacterium Avium Complex Disease and Bacterial Pneumonia Versus Deferred Prophylaxis in HIV-Infected Patients Who Experience Rebound in CD4+ Cell Count Due to Active Antiretroviral Therapy|Completed||N/A|850||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:54.024193|2017-02-18 18:24:54.024193
NCT00000946|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|March 2001|Actual|2001-03-01|||||Interventional|||A Study to Test the Safety of Three Experimental HIV Vaccines|"A Phase I Trial to Evaluate the HIV-1 SF-2 Recombinant p24 Subunit Vaccine [Chiron Vaccines] Administered as a Novel Boost in Prime-Boost Vaccination Regimens With ALVAC-HIV vCP205 [Pasteur Merieux Connaught] and HIV-1 SF-2 rgp120 in MF59 [Chiron Vaccines]"|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:54.149481|2017-02-18 18:24:54.149481
NCT00000945|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|March 2001|Actual|2001-03-01|||||Interventional|||A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients|A Pilot Study of the Effect of Cidofovir for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in Subjects With Acquired Immunodeficiency Syndrome (AIDS)|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:54.257334|2017-02-18 18:24:54.257334
NCT00000944|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|March 2003|Actual|2003-03-01|||||Interventional|||A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants|A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Indinavir Co-Administered With Lamivudine (3TC) and Zidovudine (ZDV) in HIV-1-Infected Pregnant Women During Gestation and Post Partum, and in Their Infants Post Maternal Dosing|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:24:54.384599|2017-02-18 18:24:54.384599
NCT00000943|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328|A Controlled, Pilot Study of the Immunogenicity of Remune in HIV-Infected Subjects Receiving Either Highly Active Antiretroviral Therapy (HAART) Alone or HAART and Interleukin-2 (IL-2): A Nested Substudy of ACTG 328|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:54.495884|2017-02-18 18:24:54.495884
NCT00000942|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies|A Phase III Randomized, Double-Blinded Study of Nevirapine for the Prevention of Maternal-Fetal Transmission in Pregnant HIV-Infected Women|Completed||Phase 3|1244||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:54.602026|2017-02-18 18:24:54.602026
NCT00000941|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|March 2002|Actual|2002-03-01|||||Interventional|||A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood|Evaluation of Potential Pharmacokinetic Interactions Between Protease Inhibitors and Lipid Lowering Agents|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:54.705118|2017-02-18 18:24:54.705118
NCT00000940|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-01-05|||May 1999||1999-05-01|January 2016|2016-01-01|October 2006|Actual|2006-10-01|||||Interventional|||Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV|A Phase II Trial to Evaluate the Safety and Efficacy of Induction Treatment With Lamivudine Plus Stavudine Plus Abacavir Plus Amprenavir/Ritonavir Followed by Supervised Treatment Interruption in Subjects With Acute HIV Infection or Recent Seroconversion|Completed||Phase 2|121|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:24:54.828523|2017-02-18 18:24:54.828523
NCT00000939|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|January 2000|Actual|2000-01-01|||||Interventional|||A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible|Phase II Randomized, Open-Label Study of Maintenance of HIV RNA Suppression After Switching to ddI/d4T/HU vs. ddI/d4T/EFV vs. Continuing the Pre-Entry Protease Inhibitor Regimen|Completed||Phase 2|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:54.954196|2017-02-18 18:24:54.954196
NCT00000938|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease|A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease|Completed||Phase 3|66||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:55.079901|2017-02-18 18:24:55.079901
NCT00000937|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-08-26||||||November 2005|2005-11-01|November 2005||2005-11-01|||||Interventional|||Study and Treatment of Post Lyme Disease (STOP-LD)|Study and Treatment of Post Lyme Disease (STOP-LD)|Completed||Phase 3|55||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:55.166114|2017-02-18 18:24:55.166114
NCT00000936|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2017-01-10|||November 1999||1999-11-01|January 2017|2017-01-01|March 2004|Actual|2004-03-01|||||Interventional|||A Study To Test An Anti-Rejection Therapy After Kidney Transplantation|Controlled Trial of Induction Therapy in Renal Transplantation|Terminated||Phase 3|292|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 18:24:55.25009|2017-02-18 18:24:55.25009
NCT00000935|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2017-01-10||||||January 2017|2017-01-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens|Evaluation of Intravenous Gamma Globulin (IVIG) As an Agent to Lower Allosensitization and Improve Allograft Survival in Highly-Sensitized Adult End-Stage Renal Disease (ESRD) Patients (IG02)|Completed||Phase 3|100|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||t||||||||Yes|Participant level data and additional relevant materials are available to the public in the Immunology Database and Analysis Portal (ImmPort). ImmPort is a long-term archive of clinical and mechanistic data from DAIT-funded grants and contracts.|2017-02-18 18:24:55.360112|2017-02-18 18:24:55.360112
NCT00000933|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|July 2000|Actual|2000-07-01|||||Observational|||Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048|Effects of Prophylaxis for Disseminated Mycobacterium Avium Complex (MAC) Disease With Azithromycin Versus Deferred Prophylaxis on Carriage of Antibiotic-Resistant Streptococcus Pneumoniae: A Substudy of the CR-MAC Protocol (CPCRA 048)|Completed||N/A|326||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:55.470426|2017-02-18 18:24:55.470426
NCT00000932|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-04-14|||March 1999||1999-03-01|April 2014|2014-04-01|September 2006|Actual|2006-09-01|September 2006|Actual|2006-09-01||Observational|||A Study of the Long-Term Outcomes of HIV-Positive Patients|A Prospective Study of Long-Term Clinical, Virologic, and Immunologic Outcomes in HIV-Infected Individuals|Completed||N/A|3669|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||3||f||||||||||||||2017-02-18 18:24:55.58861|2017-02-18 18:24:55.58861
NCT00000931|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-09-08||||||November 2006|2006-11-01||||||||Interventional|||HIV Prevention Counseling for Men Who Have Sex With Men|A Randomized Clinical Trial of the Efficacy of a Behavioral Intervention to Prevent Acquisition of HIV Among Men Who Have Sex With Men|Completed||Phase 3|4350||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:55.783777|2017-02-18 18:24:55.783777
NCT00000930|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-11-04||||||October 2012|2012-10-01|May 2008|Actual|2008-05-01|May 2008|Actual|2008-05-01||Observational|||A Study of HIV in Newly Infected Individuals|Infected Participants Protocol: Evaluation of Natural History of HIV Infection in Newly HIV-Infected Persons in HIVNET Target Populations|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     Specimens appropriate for clinical and laboratory assessments and necessary for evaluation~     of study outcome measures~   "|||2017-02-18 18:24:55.886014|2017-02-18 18:24:55.886014
NCT00000929|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|July 1999|Actual|1999-07-01|||||Interventional|||A Study of the Effects of Advantage 24 on the Rectum|Phase I Rectal Microbicide Study|Completed||Phase 1|70||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||t||||||||||2017-02-18 18:24:56.012246|2017-02-18 18:24:56.012246
NCT00000928|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-11-04||||||October 2012|2012-10-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Interventional|||Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples|Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples|Completed||Phase 1|90|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:24:56.117288|2017-02-18 18:24:56.117288
NCT00000927|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-01-08||||||March 1999|1999-03-01||||||||Interventional|||A Study of BufferGel in Women|Phase I Vaginal Microbicide Study of BufferGel|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:56.221328|2017-02-18 18:24:56.221328
NCT00000926|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|February 2001|Actual|2001-02-01|||||Interventional|||A Study of Nonoxynol-9 (N-9) and HIV Infection|Phase III Nonoxynol-9 and HIV Infection|Completed||Phase 3|4400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:56.309187|2017-02-18 18:24:56.309187
NCT00000925|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26|||May 1999||1999-05-01|July 2013|2013-07-01||||June 2003|Actual|2003-06-01||Interventional|||A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss|Evaluation of High Protein Supplementation in HIV-1-Positive Subjects With Stable Weight Loss|Completed||Phase 2|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:56.416633|2017-02-18 18:24:56.416633
NCT00000924|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|June 2001|Actual|2001-06-01|||||Interventional|||A Study to Compare Two Different Anti-HIV Drug Regimens|A Phase II Randomized, Multicenter Protocol Evaluating Two Antiretroviral Regimens Containing Combinations of Protease Inhibitors, NRTIs, and an NNRTI|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:56.530608|2017-02-18 18:24:56.530608
NCT00000923|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|August 2004|Actual|2004-08-01|||||Interventional|||Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328|Treatment Rollover for Subjects Formerly on ACTG 328 With Subcutaneous Interleukin-2 (IL-2) in Combination With Highly Active Antiretroviral Therapy (HAART)|Completed||N/A|110||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:56.670146|2017-02-18 18:24:56.670146
NCT00000922|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-04-16||||||April 2014|2014-04-01|June 2006|Actual|2006-06-01|January 2003|Actual|2003-01-01||Interventional|||A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)|A Randomized, Open-Label Study of the Long-Term Effectiveness of Three Initial Highly Active Antiretroviral Therapy (HAART) Strategies in HAART-Niave, HIV-Infected Persons|Completed||N/A|1710||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:57.064964|2017-02-18 18:24:57.064964
NCT00000921|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-22|||August 1996||1996-08-01|June 2003|2003-06-01||||June 2002|Actual|2002-06-01||Interventional|||The Effects of Prednisone on HIV Levels and the Immune System|A Phase II, Randomized, Placebo-Controlled Study of the Immunologic and Virologic Effects of Prednisone on HIV-1 Infection|Completed||Phase 2|118||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:57.214421|2017-02-18 18:24:57.214421
NCT00000920|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|April 2003|Actual|2003-04-01|||||Interventional|||Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns|A Phase I Trial of the Safety and Pharmacokinetics of Fortovase (Saquinavir-SGC) Co-Administered With Low Dose (Ritonavir) RTV, ZDV and 3TC in HIV Seropositive Pregnant Women During Gestation and Postpartum, and in Their Infant's Post-Maternal Dosing|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:24:57.3381|2017-02-18 18:24:57.3381
NCT00000919|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-06-05||||||June 2012|2012-06-01|November 2002|Actual|2002-11-01|||||Interventional|||A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection|Study of Protease Inhibitor and/or Non-Nucleoside Reverse Transcriptase Inhibitor With Dual Nucleosides in Initial Therapy of HIV Infection|Completed||N/A|900||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:57.481842|2017-02-18 18:24:57.481842
NCT00000918|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|February 2002|Actual|2002-02-01|||||Interventional|||A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure|A Phase II, Randomized, Open-Label Comparative Trial of Salvage Antiretroviral Therapies for HIV-Infected Individuals With Virological Evidence of Nelfinavir Treatment Failure as Reflected by Plasma HIV RNA Concentration of >= 1,000 Copies/ml|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:57.701932|2017-02-18 18:24:57.701932
NCT00000917|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-30|||September 1997||1997-09-01|June 2003|2003-06-01||||||||Observational|||Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants|Establishment of a Cord Blood Bank for Gene Therapy in HIV-Infected Infants|Terminated||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:57.864826|2017-02-18 18:24:57.864826
NCT00000916|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|August 2004|Actual|2004-08-01|||||Interventional|||A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood|A Phase II, Randomized Study of the Safety and Efficacy of Hydroxyurea in Subjects on Potent Antiretroviral Therapy With Less Than 200 Copies/ml of HIV RNA in the Plasma|Completed||Phase 2|399||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:57.959422|2017-02-18 18:24:57.959422
NCT00000915|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1999|1999-03-01||||||||Interventional|||An HIV Vaccine Preparedness Study|HIV Vaccine Preparedness Study|Completed||N/A|4892||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:58.118472|2017-02-18 18:24:58.118472
NCT00000914|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-26||||||March 2012|2012-03-01|June 2000|Actual|2000-06-01|||||Interventional|||A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks|A Randomized Study of the Virologic Efficacy of Different Antiretroviral (AR) Treatment Strategies in HIV-Infected Individuals With Detectable Plasma HIV RNA Measurements After at Least 16 Weeks on Their Initial Protease Inhibitor-Containing AR Regimens|Completed||N/A|800||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:58.236793|2017-02-18 18:24:58.236793
NCT00000913|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-26||||||March 2012|2012-03-01|April 2001|Actual|2001-04-01|||||Interventional|||A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children|A Randomized Trial of Two Saquinavir-Containing Combination Treatment Regimens in Children With HIV Infection|Completed||Phase 2|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:58.351676|2017-02-18 18:24:58.351676
NCT00000912|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-06-02||||||July 2013|2013-07-01|May 2000|Actual|2000-05-01|||||Interventional|||A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients|A Phase II, Randomized Trial of Amprenavir as Part of Dual Protease Inhibitor Regimens (Placebo-Controlled) in Combination With Abacavir, Efavirenz, and Adefovir Dipivoxil Versus Amprenavir Alone in HIV-Infected Subjects With Prior Exposure to Approved Protease Inhibitors and Loss of Virologic Suppression as Reflected by a Plasma HIV-1 RNA Concentration >= 1,000 Copies/ml|Completed||Phase 2|475||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:58.480891|2017-02-18 18:24:58.480891
NCT00000911|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-10-21|||October 1999||1999-10-01|October 2015|2015-10-01|June 2007|Actual|2007-06-01|June 2007|Actual|2007-06-01||Observational|||A Study to Monitor Patients With Primary or Early HIV Infection|An Observational Study of Subjects With Primary HIV Infection: A Study of the UCSD Acute/Early HIV Infection (AEHIV) Clinical Studies Unit|Completed||N/A|1500|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood, lymph node tissue, CSF, and semen or vaginal secretion specimens~   "|||2017-02-18 18:24:58.637924|2017-02-18 18:24:58.637924
NCT00000910|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-10-04||||||October 2013|2013-10-01|June 2004|Actual|2004-06-01|||||Observational|||A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies|Medical Chart Abstraction of HIV-Infected Pregnant Women and Their Infants Receiving Care or Consultation at Study Sites|Completed||N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:58.725405|2017-02-18 18:24:58.725405
NCT00000909|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|June 2004|Actual|2004-06-01|||||Interventional|||A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy|A Randomized, Open Label Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Alone vs No Therapy in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3 Who Do Not Wish to Receive Treatment With Antiretroviral Therapy|Completed||Phase 2|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:58.805918|2017-02-18 18:24:58.805918
NCT00000908|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 2003|2003-02-01||||||||Observational|||A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts|Impact of Discontinuing PCP Prophylaxis in Subjects Receiving Antiretroviral Therapies Who Have Had Increases in CD4 Counts to > 200 Cells/mm3|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:58.974723|2017-02-18 18:24:58.974723
NCT00000907|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-29||||||June 2003|2003-06-01||||||||Observational|||A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients|A Study of Discontinuing Maintenance Therapy in Subjects With Disseminated Mycobacterium Avium Complex (DMAC)|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:59.103424|2017-02-18 18:24:59.103424
NCT00000906|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|September 2000|Actual|2000-09-01|||||Interventional|||Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients|The Effect of HIV Protease Inhibitors on the Stereospecific Metabolism of Methadone in HIV-Infected Subjects|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:59.204259|2017-02-18 18:24:59.204259
NCT00000905|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-28||||||June 2003|2003-06-01||||||||Observational|||A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy|Discontinuation of Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Immune Reconstitution by Potent Antiretroviral Therapy: Safety, Virology, and Immunology Profiles|Completed||N/A|75||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:24:59.307649|2017-02-18 18:24:59.307649
NCT00000904|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|August 1999|Actual|1999-08-01|||||Interventional|||Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults|A Phase I Trial to Compare the Safety and Immunogenicity of the Live Recombinant Canarypox ALVAC-HIV Vaccines, vCP205, vCP1433, and vCP1452, in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:02.504053|2017-02-18 18:25:02.504053
NCT00000903|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|July 2001|Actual|2001-07-01|||||Interventional|||Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen|A Phase III Randomized, Controlled Trial of Efavirenz (EFV) or Nelfinavir (NFV) in Combination With Fixed-Dose Combination Lamivudine/Zidovudine (3TC/ZDV) and Indinavir (IDV) in HIV-Infected Subjects With Less Than or Equal to 200 CD4 Cells/mm3 or Greater Than or Equal to 80,000 HIV RNA Copies/ml in Plasma|Completed||Phase 3|444||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:02.613015|2017-02-18 18:25:02.613015
NCT00000902|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-09-30||||||October 2012|2012-10-01|April 2002|Actual|2002-04-01|||||Interventional|||A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment|RAD-1: A Phase I/II Antiretroviral Management Algorithm for Pediatric Subjects of Four-Drug Combination Therapies Based on Prior Antiretroviral Experience|Completed||Phase 1|217||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:02.759922|2017-02-18 18:25:02.759922
NCT00000901|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|October 2000|Actual|2000-10-01|||||Interventional|||Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children|A Multicenter, Open-Labeled, 96-Week Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Indinavir in Combination With Stavudine and Lamivudine in Pediatric Patients With HIV-1 Infection|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:03.204464|2017-02-18 18:25:03.204464
NCT00000900|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1999|1999-04-01||||||||Observational|||The Effects of Illnesses on HIV Levels in the Body|The Impact of Intercurrent Illness on HIV Viral Load|Completed||N/A|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:03.329119|2017-02-18 18:25:03.329119
NCT00000899|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|October 2001|Actual|2001-10-01|||||Interventional|||A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients|Effect of Cytoreductive Chemotherapy Combined With Highly Active Antiretroviral Therapy on Lymph Node HIV DNA in HIV-Infected Subjects|Completed||Phase 1|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:03.431457|2017-02-18 18:25:03.431457
NCT00000898|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|May 2000|Actual|2000-05-01|||||Interventional|||The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir|A Prototype Study to Test the Effect of Staggered Dosing on the Pharmacokinetic Interactions Between Paired Combinations of Nelfinavir (NFV), Ritonavir (RTV), and Soft Gelatin Capsule of Saquinavir (SQVsgc)|Completed||N/A|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:03.542884|2017-02-18 18:25:03.542884
NCT00000897|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-01||||||March 2011|2011-03-01||||October 2005|Actual|2005-10-01||Interventional|||A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women|The Effect of Oral and Injectable Contraceptives (Norethindrone/Ethinyl Estradiol, Medroxyprogesterone Acetate) and Gender on Plasma and Intracellular Zidovudine Pharmacokinetics|Completed||N/A|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:03.659129|2017-02-18 18:25:03.659129
NCT00000896|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|October 2000|Actual|2000-10-01|||||Interventional|||A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients|A Randomized Controlled Trial to Compare the Efficacy of a Four Drug Antiretroviral Regimen Alone or in Combination With GM-CSF or IL-12 Administered to HIV-1 Infected Subjects as Measured by the Characteristics of Viral Decay|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:03.980824|2017-02-18 18:25:03.980824
NCT00000895|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01|August 2001|Actual|2001-08-01|||||Interventional|||A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection|Pathogenesis of MAC Disease in Advanced HIV-1-Infected Subjects and the Impact of Highly-Active Antiretroviral Treatment (HAART) on Immune Functions Relevant for MAC and Other Opportunistic Infections|Completed||N/A|85||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:04.079523|2017-02-18 18:25:04.079523
NCT00000894|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-22||||||June 2003|2003-06-01||||June 2000|Actual|2000-06-01||Interventional|||Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis|Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)|Completed||Phase 4|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:04.426865|2017-02-18 18:25:04.426865
NCT00000893|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-06-02|||October 1997||1997-10-01|June 2015|2015-06-01|December 2002|Actual|2002-12-01|||||Interventional|||Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children|A Phase I/II, Open-Label, AUC-Controlled Study to Determine the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in Children|Completed||Phase 1|103|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:25:04.52724|2017-02-18 18:25:04.52724
NCT00000892|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|August 1999|Actual|1999-08-01|||||Interventional|||A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir|Activity of the Soft Gelatin Capsule of Saquinavir (SQVsgc) in Combination With Ritonavir or Nelfinavir and Combinations of Delavirdine and/or Adefovir Dipivoxil in HIV-Infected Subjects With Prior Indinavir Use and Viral Loads From 2,000 to 200,000 Copies HIV RNA/ml|Completed||N/A|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:04.661388|2017-02-18 18:25:04.661388
NCT00000891|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|May 2004|Actual|2004-05-01|||||Interventional|||Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315|Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315|Completed||Phase 2|34||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:05.081539|2017-02-18 18:25:05.081539
NCT00000890|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01||||||||Observational|||A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients|Effect of Highly Active Antiretroviral Therapy (HAART) on Lean Body Mass|Completed||N/A|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:05.194193|2017-02-18 18:25:05.194193
NCT00000889|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-11-07|||October 1997||1997-10-01|April 2014|2014-04-01|December 1999|Actual|1999-12-01|December 1999|Actual|1999-12-01||Interventional|||A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3|A Randomized, Open-Label, Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Plus Antiretroviral Therapy vs. Antiretroviral Therapy Alone in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3|Completed||Phase 2|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:05.31816|2017-02-18 18:25:05.31816
NCT00000888|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|April 2001|Actual|2001-04-01|||||Interventional|||Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies|A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Ritonavir Co-Administered With Lamivudine (3TC) and Zidovudine (ZDV) in HIV-1-Infected Pregnant Women and Their Infants|Completed||Phase 1|14||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:05.429873|2017-02-18 18:25:05.429873
NCT00000887|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants|A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Nelfinavir (Viracept) Co-Administered With Zidovudine (ZDV) and Lamivudine (3TC) in HIV Infected Pregnant Women and Their Infants|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:05.553584|2017-02-18 18:25:05.553584
NCT00000886|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-10||||||May 2012|2012-05-01|April 1999|Actual|1999-04-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)|A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)|Completed||Phase 1|24|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:05.664459|2017-02-18 18:25:05.664459
NCT00000885|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-08-15||||||August 2012|2012-08-01|June 2003|Actual|2003-06-01|||||Interventional|||Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320|A Phase II Study of the Prolongation of Virologic Success (ACTG 372A) and Options for Virologic Failure (ACTG B/C/D) in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320|Completed||Phase 2|440||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:05.774877|2017-02-18 18:25:05.774877
NCT00000884|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|October 2000|Actual|2000-10-01|||||Interventional|||A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers|A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|84|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||7|||f||||||||||||||2017-02-18 18:25:05.940797|2017-02-18 18:25:05.940797
NCT00000883|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-24|||October 1997||1997-10-01|October 2012|2012-10-01|April 2007|Actual|2007-04-01|||||Interventional|||Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy|Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Complications In Subjects With Past CD4 Cells/mm3 Below 50 Who Increased CD4 Cells/mm3 to Above 100 on HAART|Completed||N/A|636||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:06.070186|2017-02-18 18:25:06.070186
NCT00000882|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01||||May 1999|Actual|1999-05-01||Interventional|||Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects|Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:06.213425|2017-02-18 18:25:06.213425
NCT00000881|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-16||||||February 2012|2012-02-01||||||||Interventional|||A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease|A Phase I/II Study of Cidofovir for HIV-Infected Children With Invasive CMV (Cytomegalovirus) Disease|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:06.346083|2017-02-18 18:25:06.346083
NCT00000880|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|May 2000|Actual|2000-05-01|||||Interventional|||A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease|Phase II Study of Cyclosporin (Neoral) in Immune Activation and HIV Expression in Early HIV Disease|Completed||Phase 2|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:06.437906|2017-02-18 18:25:06.437906
NCT00000528|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-15|||September 1986||1986-09-01|December 2005|2005-12-01|June 1998|Actual|1998-06-01|||||Interventional|||Trials of Hypertension Prevention (TOHP)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:00.108503|2017-02-18 18:26:00.108503
NCT00000879|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|April 2005|Actual|2005-04-01|||||Interventional|||A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers|A Phase I/II Study to Evaluate the Safety and Immunogenicity of ALVAC HIV Vaccines Alone and With AIDSVAX B/B in Children Born to HIV-Infected Mothers|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:25:06.552604|2017-02-18 18:25:06.552604
NCT00000878|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|October 2001|Actual|2001-10-01|||||Interventional|||A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants|A Phase I/II, Open-Label Study to Evaluate the Safety, Tolerance and Pharmacokinetics of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Infected Pregnant Women and Their Infants|Completed||Phase 1|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:06.944746|2017-02-18 18:25:06.944746
NCT00000877|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|October 2000|Actual|2000-10-01|||||Interventional|||Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults|Steady-State Pharmacokinetic Interaction Study of Indinavir and Rifabutin|Completed||Phase 1|31||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:07.064842|2017-02-18 18:25:07.064842
NCT00000876|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|November 2006|Actual|2006-11-01|||||Interventional|||Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children|Phase I/II Trial of CD4-IgG2 in HIV-Infected Children|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:25:07.178311|2017-02-18 18:25:07.178311
NCT00000875|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-12-13||||||April 2003|2003-04-01|April 2003|Actual|2003-04-01|April 2003|Actual|2003-04-01||Interventional|||Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection|Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection|Terminated||N/A|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:07.293354|2017-02-18 18:25:07.293354
NCT00000874|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28|||August 1997||1997-08-01|September 2013|2013-09-01|March 1999|Actual|1999-03-01|January 1999|Actual|1999-01-01||Observational|||A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART|A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART|Completed||N/A|148|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||4||f||||||||||Samples With DNA|"~     Blood collection~   "|||2017-02-18 18:25:07.391685|2017-02-18 18:25:07.391685
NCT00000873|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-10-04||||||October 2013|2013-10-01|September 2005|Actual|2005-09-01|||||Interventional|||A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants|A Randomized, Double-Blind, Controlled Study of an Increased Caloric Density Infant Formula and Its Effect on Growth and Nutritional Status in HIV-Infected Infants|Completed||N/A|2400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:07.519943|2017-02-18 18:25:07.519943
NCT00000872|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|January 2005|Actual|2005-01-01|||||Interventional|||Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection|Early Intensive Antiretroviral Combination Therapy in HIV-1 Infected Infants and Children|Completed||Phase 2|55|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:07.704225|2017-02-18 18:25:07.704225
NCT00000871|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|January 2000|Actual|2000-01-01|||||Interventional|||A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers|A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers|Completed||Phase 2|420||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:07.848072|2017-02-18 18:25:07.848072
NCT00000870|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|March 2007|Actual|2007-03-01|||||Interventional|||A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone|A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone|Completed||Phase 2|200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:07.977139|2017-02-18 18:25:07.977139
NCT00000869|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|May 2001|Actual|2001-05-01|||||Interventional|||A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies|A Phase III Randomized, Blinded Study of Nevirapine for the Prevention of Maternal-Fetal Transmission in Pregnant HIV-Infected Women|Completed||Phase 3|2009||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:08.115055|2017-02-18 18:25:08.115055
NCT00000868|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|May 2000|Actual|2000-05-01|||||Interventional|||A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers|A Phase I Safety and Immunogenicity Trial of Orally Administered Live Attenuated Recombinant Salmonella Typhi CVD 908 Delta-asd (pW57-asd+) Expressing HIV-1 LAI gp120 (VVG 203) and Parenterally Administered HIV-1 MN rgp120 in Alum in HIV-1-Uninfected Volunteers|Completed||Phase 1|27||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:08.291798|2017-02-18 18:25:08.291798
NCT00000867|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-06-07|||December 1996||1996-12-01|June 2013|2013-06-01|July 2001|Actual|2001-07-01|||||Interventional|||A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)|A Phase II, Randomized, Double Blind, Placebo-Controlled Trial of Memantine for AIDS Dementia Complex (ADC) as Concurrent Treatment With Antiretroviral Therapy|Completed||Phase 2|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:08.389825|2017-02-18 18:25:08.389825
NCT00000840|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2000|2000-04-01||||||||Observational|||A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA|A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA|Completed||N/A|70||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:11.796746|2017-02-18 18:25:11.796746
NCT00000866|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|July 1999|Actual|1999-07-01|||||Interventional|||A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.|Completed||N/A|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:08.503734|2017-02-18 18:25:08.503734
NCT00000865|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-14||||||February 2012|2012-02-01|April 1998|Actual|1998-04-01|||||Interventional|||The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children|A Phase I Safety and Pharmacokinetic Study of 1592U89 Alone and In Combination With Other Antiretroviral Agents in Infants and Children With HIV Infection|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:08.599737|2017-02-18 18:25:08.599737
NCT00000864|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|January 2001|Actual|2001-01-01|||||Interventional|||A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women|Phase I Study of Safety, Tolerance, and Pharmacokinetics of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy In Neonates Born to HIV-1 Infected Women|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:25:08.707394|2017-02-18 18:25:08.707394
NCT00000863|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|July 1998|Actual|1998-07-01|||||Interventional|||A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients|A Phase II Study of WR 6026 for Pneumocystis Carinii Pneumonia in People With HIV Infection|Completed||Phase 2|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:08.819197|2017-02-18 18:25:08.819197
NCT00000862|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|November 2003|Actual|2003-11-01|||||Interventional|||A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women|A Phase I Trial of the Pharmacokinetics and Tolerance of Oral Zidovudine Administered to HIV-1 Infected Pregnant Women During Labor and Delivery|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:08.926051|2017-02-18 18:25:08.926051
NCT00000861|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|March 1997|Actual|1997-03-01|||||Interventional|||The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients|A Randomized Trial of Immediate Versus Deferred Indinavir in Addition to Background Antiretroviral Therapy in HIV-Infected Patients With CD4+ Cell Counts Between 200 and 500/mm3 and Plasma HIV RNA Levels >= 10,000 Copies/ml|Completed||N/A|1900||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:09.302697|2017-02-18 18:25:09.302697
NCT00000860|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 1999|1999-07-01||||||||Observational|||The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients|Effects of Treatment for MAC Infection on Cytokine Expression in HIV-Infected Persons.|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:09.416343|2017-02-18 18:25:09.416343
NCT00000859|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|December 2001|Actual|2001-12-01|||||Interventional|||A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3|A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3|Completed||N/A|1300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:09.523877|2017-02-18 18:25:09.523877
NCT00000858|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Observational|||Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections|Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections|Completed||N/A|350||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:09.665138|2017-02-18 18:25:09.665138
NCT00000857|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-06-02||||||May 2012|2012-05-01|June 2001|Actual|2001-06-01|||||Interventional|||A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3|A Phase I, Double-Blind, Randomized, Placebo-Controlled Trial of Recombinant Human Interleukin-12 (rhIL-12) in HIV-Infected Subjects With Less Than 50 CD4+ T Cells and Subjects With 300-500 CD4+ T Cells|Completed||Phase 1|65||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:09.753162|2017-02-18 18:25:09.753162
NCT00000856|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-29||||||May 2012|2012-05-01||||||||Interventional|||A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.|A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:09.86694|2017-02-18 18:25:09.86694
NCT00000855|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 2000|Actual|2000-02-01|||||Interventional|||A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.|The Safety, Tolerance, and Pharmacokinetics of Zidovudine in Premature Infants Exposed to HIV.|Completed||N/A|35||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:09.971046|2017-02-18 18:25:09.971046
NCT00000854|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-13||||||February 2012|2012-02-01|May 2003|Actual|2003-05-01|||||Interventional|||A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss|A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Trial of Nandrolone Decanoate in Women With HIV-Associated Weight Loss|Completed||Phase 1|38||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:10.124345|2017-02-18 18:25:10.124345
NCT00000839|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||August 2004|2004-08-01|June 2001|Actual|2001-06-01|||||Interventional|||A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women|A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:11.888987|2017-02-18 18:25:11.888987
NCT00000853|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|January 1999|Actual|1999-01-01|||||Interventional|||A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults|A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults|Completed||Phase 1|37|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:10.250373|2017-02-18 18:25:10.250373
NCT00000852|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 1998|1998-11-01||||||||Interventional|||A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection|A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:10.355499|2017-02-18 18:25:10.355499
NCT00000851|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|October 1998|Actual|1998-10-01|||||Interventional|||Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children|Trial of Stavudine (d4T) Plus Didanosine (ddI) in Children on Long-Term Stavudine Monotherapy, and Stavudine Versus Stavudine Plus Didanosine in Children on Long-Term Zidovudine Monotherapy: A Rollover Protocol for ACTG 240 Participants and Children Receiving Prescription Zidovudine|Completed||Phase 2|198||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:10.45265|2017-02-18 18:25:10.45265
NCT00000850|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|December 2003|Actual|2003-12-01|||||Interventional|||The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy|The Effects of GM-CSF on Plasma HIV-1 RNA and Chemokine Receptor Expression in HIV-1 Infected Subjects Receiving Concomitant Potent Antiretroviral Therapy|Completed||Phase 2|108||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:10.590492|2017-02-18 18:25:10.590492
NCT00000849|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|March 2001|Actual|2001-03-01|||||Interventional|||A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children|Phase I/II Trial of Recombinant Interleukin-2 In Symptomatic Human Immunodeficiency Virus-Infected Children|Completed||Phase 1|27||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:10.733358|2017-02-18 18:25:10.733358
NCT00000848|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-13||||||February 2012|2012-02-01|October 1998|Actual|1998-10-01|||||Interventional|||The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year|The Antiviral Effect of Switching From Hard Capsule Saquinavir (SQVhc) to the Soft Gelatin Capsule of Saquinavir (SQVsc) Versus Switching to Indinavir (IDV) After 1 Year of Saquinavir Use|Completed||Phase 2|144|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:10.844752|2017-02-18 18:25:10.844752
NCT00000847|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|May 1999|Actual|1999-05-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:10.957527|2017-02-18 18:25:10.957527
NCT00000846|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.|A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:11.082511|2017-02-18 18:25:11.082511
NCT00000845|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects|A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:11.173734|2017-02-18 18:25:11.173734
NCT00000844|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|June 2002|Actual|2002-06-01|||||Interventional|||A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3|A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3|Completed||N/A|560||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:11.268236|2017-02-18 18:25:11.268236
NCT00000843|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 1998|1998-04-01||||||||Interventional|||The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children|A Phase IA Single Dose Pharmacokinetics and Safety Study of the Oral Antiviral Compound, 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA) (Adefovir Dipivoxil) in Children With HIV-1 Infection|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:11.387127|2017-02-18 18:25:11.387127
NCT00000842|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-09||||||May 2012|2012-05-01|February 1999|Actual|1999-02-01|||||Interventional|||A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy|A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy|Completed||Phase 2|270||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:11.506658|2017-02-18 18:25:11.506658
NCT00000841|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|June 1997|Actual|1997-06-01|||||Interventional|||A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months|A Randomized, Double-Blind, Phase III Study of Indinavir Sulfate With Open-Label Zidovudine (AZT) and Lamivudine (3TC) in Subjects With HIV Infection With CD4 Cell Counts <= 200 Cells/mm3 and >= 6 Months of Prior AZT Experience|Completed||Phase 3|1750||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:11.617605|2017-02-18 18:25:11.617605
NCT00000527|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-09|||August 1986||1986-08-01|December 2013|2013-12-01|November 1998|Actual|1998-11-01|November 1998|Actual|1998-11-01||Interventional|||Recurrent Carotid Stenosis||Completed||Phase 2|||Emory University|||||f||||||||||||||2017-02-18 18:26:00.231776|2017-02-18 18:26:00.231776
NCT00000838|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|March 1998|Actual|1998-03-01|||||Interventional|||Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine|A Phase II, Randomized Study of the Antiviral Activity and Resistance Interactions of Lamivudine (3TC) in Combination With Zidovudine (AZT), Stavudine (d4T), or Didanosine (ddI) Versus Monotherapy With ddI or d4T in HIV-Infected Individuals With 200 - 600 CD4+ Cells/mm3 and No Previous Nucleoside Experience|Completed||Phase 2|256||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:12.291787|2017-02-18 18:25:12.291787
NCT00000837|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-02-11||||||February 2015|2015-02-01|November 2005|Actual|2005-11-01|||||Interventional|||A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children|Phase I/II Study of the Safety and Immunogenicity of Live-Attenuated Varicella Vaccine (Varivax) in HIV-Infected Children|Completed||Phase 1|127||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:25:12.544039|2017-02-18 18:25:12.544039
NCT00000836|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-24||||||October 2012|2012-10-01|August 1998|Actual|1998-08-01|||||Interventional|||A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)|A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:12.681725|2017-02-18 18:25:12.681725
NCT00000835|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01||||||||Observational|||A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:12.785686|2017-02-18 18:25:12.785686
NCT00000834|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|June 2002|Actual|2002-06-01|||||Interventional|||A Phase I Study of Methotrexate for HIV Infection|A Phase I Study of Methotrexate for HIV Infection|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:12.857803|2017-02-18 18:25:12.857803
NCT00000833|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|July 1998|Actual|1998-07-01|||||Interventional|||A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.|A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:12.977704|2017-02-18 18:25:12.977704
NCT00000832|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|January 1998|Actual|1998-01-01|||||Interventional|||A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers|A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|30|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:13.121704|2017-02-18 18:25:13.121704
NCT00000831|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|May 1998|Actual|1998-05-01|||||Interventional|||Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy|Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy|Completed||Phase 2|280||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:13.235738|2017-02-18 18:25:13.235738
NCT00000830|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 1998|1998-03-01||||||||Observational|||Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.|Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.|Completed||N/A|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:13.401899|2017-02-18 18:25:13.401899
NCT00000829|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|October 1999|Actual|1999-10-01|||||Interventional|||A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants|A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:25:13.498237|2017-02-18 18:25:13.498237
NCT00000828|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1997|1997-10-01||||||||Observational|||Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine|Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:13.681004|2017-02-18 18:25:13.681004
NCT00000827|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|April 1998|Actual|1998-04-01|||||Interventional|||A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children|A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children|Completed||Phase 1|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:13.803473|2017-02-18 18:25:13.803473
NCT00000826|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-01||||||May 2012|2012-05-01|May 1999|Actual|1999-05-01|||||Interventional|||Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites|Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:13.944564|2017-02-18 18:25:13.944564
NCT00000825|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-04-08|||May 1998||1998-05-01|April 2014|2014-04-01||||March 2000|Actual|2000-03-01||Interventional|||The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3|A Randomized, Open-Label Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Plus Antiretroviral Therapy vs. Antiretroviral Therapy Alone in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3|Completed||Phase 2|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:14.05069|2017-02-18 18:25:14.05069
NCT00000824|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-12-13||||||April 1995|1995-04-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients|A Pilot Study of HIV Specific Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients With CD4+ T Cells 100-350 Cells/mm3|Terminated||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:14.136825|2017-02-18 18:25:14.136825
NCT00000823|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-07-26||||||July 2013|2013-07-01|February 2000|Actual|2000-02-01|||||Interventional|||A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection|A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection|Completed||Phase 2|85||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:14.216638|2017-02-18 18:25:14.216638
NCT00000822|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-08||||||May 2012|2012-05-01|May 1999|Actual|1999-05-01|||||Interventional|||A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells|A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells|Completed||Phase 1|46||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:14.4081|2017-02-18 18:25:14.4081
NCT00000821|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-11-01||||||October 2012|2012-10-01|March 2002|Actual|2002-03-01|||||Interventional|||Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients|Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients|Completed||Phase 1|78||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:14.513601|2017-02-18 18:25:14.513601
NCT00000820|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-24||||||April 2012|2012-04-01|March 2002|Actual|2002-03-01|||||Interventional|||A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy|A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy|Completed||Phase 2|104||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:14.604499|2017-02-18 18:25:14.604499
NCT00000819|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-13||||||April 2012|2012-04-01|September 1996|Actual|1996-09-01|||||Interventional|||A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)|A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)|Completed||Phase 2|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:14.715165|2017-02-18 18:25:14.715165
NCT00000818|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-28||||||May 1996|1996-05-01||||||||Interventional|||Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.|Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:14.825671|2017-02-18 18:25:14.825671
NCT00000817|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28|||November 1994||1994-11-01|September 2013|2013-09-01|May 1997|Actual|1997-05-01|||||Interventional|||The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients|The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients|Completed||N/A|260|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||1|||f||||||||||||||2017-02-18 18:25:14.925265|2017-02-18 18:25:14.925265
NCT00000816|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-13||||||April 2012|2012-04-01|September 1996|Actual|1996-09-01|||||Interventional|||Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis|Gradual Initiation of Trimethoprim/Sulfamethoxazole as Primary Pneumocystis Carinii Pneumonia Prophylaxis|Completed||Phase 4|370||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:15.054016|2017-02-18 18:25:15.054016
NCT00000815|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|August 2001|Actual|2001-08-01|||||Interventional|||A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group|A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group|Completed||Phase 2|270|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)||2|||f||||||||||||||2017-02-18 18:25:18.19504|2017-02-18 18:25:18.19504
NCT00000814|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|November 1998|Actual|1998-11-01|||||Interventional|||A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease|A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease|Completed||Phase 1|390||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:18.35954|2017-02-18 18:25:18.35954
NCT00000813|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01|June 1995|Actual|1995-06-01|||||Interventional|||A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers|A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers|Completed||Phase 1|28||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:18.803714|2017-02-18 18:25:18.803714
NCT00000812|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|July 2000|Actual|2000-07-01|||||Interventional|||A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection|A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:18.903078|2017-02-18 18:25:18.903078
NCT00000811|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|November 2001|Actual|2001-11-01|||||Interventional|||A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children|A Randomized, Phase II/III, Double-Blind, Two-Armed Study of Micronized Atovaquone and Azithromycin (AT/AZ) as Compared to Trimethoprim-Sulfamethoxazole (TMP/SMX) in the Prevention of Serious Bacterial Infections When Used in Children Aged 3 Months to 19 Years With HIV Infection|Completed||Phase 2|690||National Institute of Allergy and Infectious Diseases (NIAID)|||||||||||||||||||2017-02-18 18:25:19.031047|2017-02-18 18:25:19.031047
NCT00000810|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|January 1996|Actual|1996-01-01|||||Interventional|||Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)|Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)|Completed||Phase 1|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:19.21943|2017-02-18 18:25:19.21943
NCT00000809|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-16||||||May 2012|2012-05-01||||||||Interventional|||Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women|A Phase I Trial of the Safety and Immunogenicity of MN rsgp120/HIV-1 With the Adjuvants QS-21 and Alum Compared to MN rsgp120/HIV-1 and QS-21 in Infants Born to HIV-Infected Women|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:19.360863|2017-02-18 18:25:19.360863
NCT00000808|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1998|Actual|1998-09-01|||||Interventional|||A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers|A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers|Completed||Phase 1|49||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:19.437999|2017-02-18 18:25:19.437999
NCT00000807|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|July 2000|Actual|2000-07-01|||||Interventional|||Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy|Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy|Completed||Phase 2|41||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:19.553194|2017-02-18 18:25:19.553194
NCT00000806|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||February 1995|1995-02-01||||||||Interventional|||A Phase I Randomized Dose/Formulation Comparison Study of SC-52151|A Phase I Randomized Dose/Formulation Comparison Study of SC-52151|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:19.670018|2017-02-18 18:25:19.670018
NCT00000805|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|March 1998|Actual|1998-03-01|||||Interventional|||A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease|A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:19.760813|2017-02-18 18:25:19.760813
NCT00000725|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma|A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:20.156992|2017-02-18 18:25:20.156992
NCT00000724|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-12-18||||||December 2012|2012-12-01|July 2004|Actual|2004-07-01|||||Interventional|||A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia|A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:20.261425|2017-02-18 18:25:20.261425
NCT00000723|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-29||||||May 2012|2012-05-01|March 1990|Actual|1990-03-01|||||Interventional|||The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer|Chemotherapy, Radiotherapy, and Azidothymidine for AIDS-Related Primary CNS Lymphoma|Terminated||N/A|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:20.3682|2017-02-18 18:25:20.3682
NCT00000722|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1991|Actual|1991-06-01|||||Interventional|||Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy|Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy|Completed||N/A|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:20.481727|2017-02-18 18:25:20.481727
NCT00000721|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|March 1991|Actual|1991-03-01|||||Interventional|||An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive|An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive|Completed||Phase 1|85||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:20.592585|2017-02-18 18:25:20.592585
NCT00000720|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|April 1993|Actual|1993-04-01|||||Interventional|||A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine|A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine|Completed||Phase 3|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:20.70625|2017-02-18 18:25:20.70625
NCT00000719|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease|A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease|Completed||N/A|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:20.882242|2017-02-18 18:25:20.882242
NCT00000718|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1991|Actual|1991-09-01|||||Interventional|||A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC|A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC|Completed||N/A|112||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:20.992323|2017-02-18 18:25:20.992323
NCT00000526|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-05|||August 1986||1986-08-01|August 2004|2004-08-01|March 1998||1998-03-01|||||Interventional|||Cardiac Arrhythmia Suppression Trial (CAST)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:00.322789|2017-02-18 18:26:00.322789
NCT00000717|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-18||||||October 2012|2012-10-01|November 1991|Actual|1991-11-01|||||Interventional|||The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS|The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS|Completed||N/A|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.099429|2017-02-18 18:25:21.099429
NCT00000716|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||May 1990|1990-05-01||||January 1991|Actual|1991-01-01||Interventional|||A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection|A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection|Completed||Phase 2|70||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.208349|2017-02-18 18:25:21.208349
NCT00000715|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1991|Actual|1991-09-01|||||Interventional|||A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS|A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Pneumonia in AIDS|Completed||Phase 3|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.319123|2017-02-18 18:25:21.319123
NCT00000714|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|July 2004|Actual|2004-07-01|||||Interventional|||An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies|An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.430842|2017-02-18 18:25:21.430842
NCT00000713|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1992|Actual|1992-10-01|||||Interventional|||A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects|A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.549633|2017-02-18 18:25:21.549633
NCT00000712|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|November 1994|Actual|1994-11-01|||||Interventional|||A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3|A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3|Completed||Phase 2|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.642484|2017-02-18 18:25:21.642484
NCT00000711|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-25||||||April 2012|2012-04-01|May 1990|Actual|1990-05-01|||||Interventional|||Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC|Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.751294|2017-02-18 18:25:21.751294
NCT00000710|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex|A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex|Completed||Phase 1|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.856362|2017-02-18 18:25:21.856362
NCT00000709|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts|An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts|Completed||Phase 3|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:21.950558|2017-02-18 18:25:21.950558
NCT00000804|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-12-13||||||April 2003|2003-04-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)|A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)|Withdrawn||N/A|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:22.060239|2017-02-18 18:25:22.060239
NCT00000803|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|March 1997|Actual|1997-03-01|||||Interventional|||A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy|A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy|Completed||Phase 2|471||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:22.130604|2017-02-18 18:25:22.130604
NCT00000802|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|July 1997|Actual|1997-07-01|||||Interventional|||A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides|A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides|Completed||Phase 3|700||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:22.556981|2017-02-18 18:25:22.556981
NCT00000801|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-31||||||October 2012|2012-10-01|April 1998|Actual|1998-04-01|||||Interventional|||Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma|Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma|Completed||Phase 2|33||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:22.715179|2017-02-18 18:25:22.715179
NCT00000525|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-09-18|||July 1986||1986-07-01|September 2013|2013-09-01||||September 1989|Actual|1989-09-01||Interventional|||Diuretics, Hypertension, and Arrhythmias Clinical Trial||Completed||Phase 3|233|Actual|University of California, San Francisco|||||f||||||||||||||2017-02-18 18:26:00.433807|2017-02-18 18:26:00.433807
NCT00000799|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-31||||||October 2012|2012-10-01|April 1996|Actual|1996-04-01|||||Interventional|||HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol|HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:22.938116|2017-02-18 18:25:22.938116
NCT00000798|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects|A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:23.054138|2017-02-18 18:25:23.054138
NCT00000797|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-30|||August 2004||2004-08-01|October 2012|2012-10-01||||November 2005|Actual|2005-11-01||Observational|||Women's Interagency HIV Study (WIHS)|Women's Interagency HIV Study (WIHS)|Unknown status|Recruiting|N/A|4176|Anticipated|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Blood and bodily fluid collection~   "|||2017-02-18 18:25:23.161335|2017-02-18 18:25:23.161335
NCT00000796|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1998|Actual|1998-10-01|||||Interventional|||A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.|A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.|Completed||N/A|525||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:23.274861|2017-02-18 18:25:23.274861
NCT00000795|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-09-08||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects|A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects|Completed||Phase 1|28||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:23.416034|2017-02-18 18:25:23.416034
NCT00000794|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|April 1998|Actual|1998-04-01|||||Interventional|||Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis|Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis|Completed||Phase 2|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:23.508304|2017-02-18 18:25:23.508304
NCT00000793|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|October 1997|Actual|1997-10-01|||||Interventional|||A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection|A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection|Completed||Phase 2|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:23.634204|2017-02-18 18:25:23.634204
NCT00000792|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|January 1995|Actual|1995-01-01|||||Interventional|||A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects|A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:23.78627|2017-02-18 18:25:23.78627
NCT00000791|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-02||||||April 2012|2012-04-01|July 1995|Actual|1995-07-01|||||Interventional|||A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV|A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV|Completed||Phase 2|210||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:23.897399|2017-02-18 18:25:23.897399
NCT00000790|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1998|Actual|1998-10-01|||||Interventional|||Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection|Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection|Completed||Phase 2|164||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:24.02842|2017-02-18 18:25:24.02842
NCT00000789|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|July 1998|Actual|1998-07-01|||||Interventional|||A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection|A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection|Completed||Phase 2|230||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:24.176768|2017-02-18 18:25:24.176768
NCT00000788|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|June 1994|Actual|1994-06-01|||||Interventional|||A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone|A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:24.337255|2017-02-18 18:25:24.337255
NCT00000787|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2003|2003-04-01||||||||Interventional|||Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study|Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study|Completed||N/A|1000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:24.447215|2017-02-18 18:25:24.447215
NCT00000785|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28|||August 1992||1992-08-01|September 2013|2013-09-01|June 1994|Actual|1994-06-01|June 1994|Actual|1994-06-01||Observational|||A Registry of Tuberculosis Cases in the CPCRA|A Registry of Tuberculosis Cases in the CPCRA|Completed||N/A|1509|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||Samples With DNA|"~     Any sample that can be used to test for M.tuberculosis~   "|||2017-02-18 18:25:24.536472|2017-02-18 18:25:24.536472
NCT00000784|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28|||October 1994||1994-10-01|September 2013|2013-09-01|September 1996|Actual|1996-09-01|September 1996|Actual|1996-09-01||Observational|||A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols|A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols|Completed||N/A|557|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||1||f||||||||||||||2017-02-18 18:25:24.643216|2017-02-18 18:25:24.643216
NCT00000783|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-10-05|||June 1994||1994-06-01|October 2012|2012-10-01||||November 1999|Actual|1999-11-01||Observational|||Heterosexual HIV Transmission Study (HATS)|Heterosexual HIV Transmission Study (HATS)|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||2||f||||||||||Samples With DNA|"~     Seminal and cervico-vaginal fluids will be collected as well as blood and urine samples.~   "|||2017-02-18 18:25:24.745603|2017-02-18 18:25:24.745603
NCT00000782|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|October 1996|Actual|1996-10-01|||||Interventional|||A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen|A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:25.137623|2017-02-18 18:25:25.137623
NCT00000781|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)|A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)|Completed||Phase 2|1292||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:25.249562|2017-02-18 18:25:25.249562
NCT00000780|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 2003|2003-03-01||||||||Observational|||"A Pre-Enrollment Protocol for HIV-Infected Adolescents"|"A Pre-Enrollment Protocol for HIV-Infected Adolescents"|Completed||N/A|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:25.468517|2017-02-18 18:25:25.468517
NCT00000779|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|September 1996|Actual|1996-09-01|||||Interventional|||A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3|A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3|Completed||Phase 1|130||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:25.618937|2017-02-18 18:25:25.618937
NCT00000778|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-06||||||June 1995|1995-06-01||||||||Interventional|||A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin|A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin|Completed||Phase 1|44||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:25.737129|2017-02-18 18:25:25.737129
NCT00000777|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|July 1998|Actual|1998-07-01|||||Interventional|||Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)|Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:25.85611|2017-02-18 18:25:25.85611
NCT00000776|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||Dexamethasone in Cryptococcal Meningitis|Dexamethasone in Cryptococcal Meningitis|Completed||Phase 2|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:25.955126|2017-02-18 18:25:25.955126
NCT00000775|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 2002|2002-10-01||||||||Interventional|||A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)|A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)|Completed||Phase 1|40||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:26.069716|2017-02-18 18:25:26.069716
NCT00000774|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|January 1999|Actual|1999-01-01|||||Interventional|||A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers|A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers|Completed||Phase 1|156|Actual|National Institute of Allergy and Infectious Diseases (NIAID)||4|||f||||||||||||||2017-02-18 18:25:26.180058|2017-02-18 18:25:26.180058
NCT00000773|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children|Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:26.337972|2017-02-18 18:25:26.337972
NCT00000772|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals|A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals|Completed||Phase 1|15||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:26.446008|2017-02-18 18:25:26.446008
NCT00000771|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3|A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3|Completed||Phase 2|68||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:26.5592|2017-02-18 18:25:26.5592
NCT00000770|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|November 1994|Actual|1994-11-01|||||Interventional|||A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine|A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine|Completed||Phase 2|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:26.676622|2017-02-18 18:25:26.676622
NCT00000769|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|April 1998|Actual|1998-04-01|||||Interventional|||A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma|A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:26.845301|2017-02-18 18:25:26.845301
NCT00000768|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|August 1998|Actual|1998-08-01|||||Interventional|||A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients|A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:26.957528|2017-02-18 18:25:26.957528
NCT00000767|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|July 1996|Actual|1996-07-01|||||Interventional|||A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)|A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.067658|2017-02-18 18:25:27.067658
NCT00000766|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||September 1995|Actual|1995-09-01||Interventional|||CMV Retinitis Retreatment Trial|CMV Retinitis Retreatment Trial|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.178907|2017-02-18 18:25:27.178907
NCT00000765|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|June 2002|Actual|2002-06-01|||||Interventional|||Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)|Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)|Completed||N/A|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.289284|2017-02-18 18:25:27.289284
NCT00000764|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|July 1996|Actual|1996-07-01|||||Interventional|||Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.|Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.|Completed||Phase 1|98||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.400477|2017-02-18 18:25:27.400477
NCT00000763|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|February 1997|Actual|1997-02-01|||||Interventional|||A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma|A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.493465|2017-02-18 18:25:27.493465
NCT00000762|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|February 1996|Actual|1996-02-01|||||Interventional|||A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection|A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection|Completed||Phase 1|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.600268|2017-02-18 18:25:27.600268
NCT00000761|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|October 1997|Actual|1997-10-01|||||Interventional|||Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children|Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.737142|2017-02-18 18:25:27.737142
NCT00000760|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-31||||||November 1998|1998-11-01||||||||Interventional|||A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection|A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection|Completed||Phase 1|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.830975|2017-02-18 18:25:27.830975
NCT00000759|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||June 1998|1998-06-01||||||||Observational|||Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials|Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials|Completed||N/A|675||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:27.936698|2017-02-18 18:25:27.936698
NCT00000758|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|April 1998|Actual|1998-04-01|||||Interventional|||A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women|A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women|Completed||Phase 3|158||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:28.298861|2017-02-18 18:25:28.298861
NCT00000757|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|October 1992|Actual|1992-10-01|||||Interventional|||A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:28.440466|2017-02-18 18:25:28.440466
NCT00000756|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|June 2002|Actual|2002-06-01|||||Interventional|||Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3|Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3|Completed||Phase 1|15||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:28.558402|2017-02-18 18:25:28.558402
NCT00000755|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|March 1993|Actual|1993-03-01|||||Interventional|||A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3|A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3|Completed||Phase 1|168||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:28.663242|2017-02-18 18:25:28.663242
NCT00000603|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-12|||September 1996||1996-09-01|January 2008|2008-01-01|October 2007|Actual|2007-10-01|October 2007|Actual|2007-10-01||Interventional|||Cord Blood Stem Cell Transplantation Study (COBLT)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:49.120845|2017-02-18 18:25:49.120845
NCT00000754|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3|A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:28.78285|2017-02-18 18:25:28.78285
NCT00000753|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC|A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:28.905345|2017-02-18 18:25:28.905345
NCT00000752|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-05-14||||||October 2012|2012-10-01|February 1993|Actual|1993-02-01|||||Interventional|||Preventing Frequent Sinus Infections in HIV-Infected Patients|Management of HIV-Infected Patients at Risk of Recurrent Purulent Sinusitis: Role of Anti-Inflammatory, Antibacterial, and Decongestant Prophylaxis|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:29.025293|2017-02-18 18:25:29.025293
NCT00000751|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-09-26||||||May 2006|2006-05-01|August 2007|Actual|2007-08-01|||||Interventional|||A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)|A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)|Completed||Phase 3|1600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:29.150165|2017-02-18 18:25:29.150165
NCT00000750|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection|A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection|Completed||Phase 3|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:29.33407|2017-02-18 18:25:29.33407
NCT00000749|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-29||||||October 2012|2012-10-01||||||||Interventional|||A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months|Completed||Phase 1|14||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:29.499433|2017-02-18 18:25:29.499433
NCT00000748|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|November 1996|Actual|1996-11-01|||||Interventional|||A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients|A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients|Completed||Phase 3|2500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:29.592948|2017-02-18 18:25:29.592948
NCT00000747|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-28||||||February 2011|2011-02-01||||December 1994|Actual|1994-12-01||Interventional|||An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3|An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3|Completed||Phase 2|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:29.728819|2017-02-18 18:25:29.728819
NCT00000746|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|July 1994|Actual|1994-07-01|||||Interventional|||A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines|A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:29.829637|2017-02-18 18:25:29.829637
NCT00000745|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-23||||||May 2012|2012-05-01|May 1991|Actual|1991-05-01|||||Interventional|||A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160|Completed||Phase 1|72||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:29.933537|2017-02-18 18:25:29.933537
NCT00000744|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|December 1995|Actual|1995-12-01|||||Interventional|||A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women|A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women|Completed||N/A|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:30.042386|2017-02-18 18:25:30.042386
NCT00000743|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|May 1995|Actual|1995-05-01|||||Interventional|||A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons|A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons|Completed||Phase 1|64||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:30.159066|2017-02-18 18:25:30.159066
NCT00000742|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|October 1993|Actual|1993-10-01|||||Interventional|||A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)|A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)|Completed||Phase 1|15||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:30.26366|2017-02-18 18:25:30.26366
NCT00000741|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-24||||||October 2012|2012-10-01||||||||Interventional|||The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS|A Controlled Randomized Trial to Study the Efficacy of Adjunctive Methylprednisolone for the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Pediatric AIDS Patients|Withdrawn||Phase 3|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:30.371457|2017-02-18 18:25:30.371457
NCT00000740|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|September 1993|Actual|1993-09-01|||||Interventional|||Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects|Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects|Completed||Phase 1|44||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:30.466942|2017-02-18 18:25:30.466942
NCT00000739|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|June 1998|Actual|1998-06-01|||||Interventional|||Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection|Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection|Completed||Phase 1|96||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:30.569995|2017-02-18 18:25:30.569995
NCT00000738|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|June 1994|Actual|1994-06-01|||||Interventional|||Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1|Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:30.782054|2017-02-18 18:25:30.782054
NCT00000737|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-22||||||January 1994|1994-01-01||||||||Interventional|||A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome|A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome|Completed||Phase 1|56||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:30.896583|2017-02-18 18:25:30.896583
NCT00000736|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals|Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals|Completed||Phase 3|3200||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:31.00394|2017-02-18 18:25:31.00394
NCT00000735|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC|A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:31.143926|2017-02-18 18:25:31.143926
NCT00000734|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine|Evaluation of the Interaction Between High Dose Trimethoprim/Sulfamethoxazole and Zidovudine|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:34.256373|2017-02-18 18:25:34.256373
NCT00000733|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|October 1991|Actual|1991-10-01|||||Interventional|||Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients|Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients|Completed||Phase 1|42||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:34.390818|2017-02-18 18:25:34.390818
NCT00000732|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine|Evaluation of the Interaction Between Low Dose Trimethoprim/Sulfamethoxazole and Zidovudine|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:34.501203|2017-02-18 18:25:34.501203
NCT00000731|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|May 1990|Actual|1990-05-01|||||Interventional|||Evaluation of the Interaction Between Acetaminophen and Zidovudine|Evaluation of the Interaction Between Acetaminophen and Zidovudine|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:34.598142|2017-02-18 18:25:34.598142
NCT00000730|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-29||||||May 2012|2012-05-01|March 1989|Actual|1989-03-01|||||Interventional|||Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients|A Randomized, Comparative Trial of Trimetrexate With Leucovorin Rescue Versus Standard Anti-Pneumocystis Therapy Versus Standard Anti-Pneumocystis Therapy With High Dose Steroids for AIDS Patients With Pneumocystis Pneumonia Who Appear to Be Refractory to Conventional Drugs|Terminated||Phase 3|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:34.698791|2017-02-18 18:25:34.698791
NCT00000729|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1992|Actual|1992-06-01|||||Interventional|||A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease|A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease|Completed||Phase 1|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:34.799339|2017-02-18 18:25:34.799339
NCT00000728|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-24||||||April 2012|2012-04-01|April 1990|Actual|1990-04-01|||||Interventional|||Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy|Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:34.905311|2017-02-18 18:25:34.905311
NCT00000727|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|August 1991|Actual|1991-08-01|||||Interventional|||A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)|A Controlled Comparative Trial of Trimethoprim - Sulfamethoxazole Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)|Completed||Phase 3|322||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:35.00307|2017-02-18 18:25:35.00307
NCT00000726|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|February 1992|Actual|1992-02-01|||||Interventional|||Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome|Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome|Completed||Phase 1|53||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:35.124898|2017-02-18 18:25:35.124898
NCT00000708|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||July 1991|1991-07-01||||July 1991|Actual|1991-07-01||Interventional|||Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis|Completed||N/A|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:35.319928|2017-02-18 18:25:35.319928
NCT00000707|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|June 1991|Actual|1991-06-01|||||Interventional|||Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms|Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms|Completed||N/A|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:35.631708|2017-02-18 18:25:35.631708
NCT00000706|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|December 1988|Actual|1988-12-01|||||Interventional|||Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine|Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:35.732646|2017-02-18 18:25:35.732646
NCT00000705|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-08-04||||||August 2014|2014-08-01|March 1989|Actual|1989-03-01|||||Interventional|||Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia|A Phase I Trial to Evaluate Azidothymidine (AZT) in the Treatment of HIV Infections in Patients With Hemophilia|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:35.843357|2017-02-18 18:25:35.843357
NCT00000704|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|April 1990|Actual|1990-04-01|||||Interventional|||A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.|A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.|Completed||Phase 1|64||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:35.95223|2017-02-18 18:25:35.95223
NCT00000703|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|March 1990|Actual|1990-03-01|||||Interventional|||Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members|Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members|Completed||N/A|45||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.053518|2017-02-18 18:25:36.053518
NCT00000702|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-15||||||February 2012|2012-02-01|August 1990|Actual|1990-08-01|||||Interventional|||A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection|A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection|Completed||Phase 3|315||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.181286|2017-02-18 18:25:36.181286
NCT00000701|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC)|A Phase I Evaluation of Azidothymidine (AZT) in Children With Acquired Immune Deficiency Syndrome (AIDS) or AIDS Related Complex (ARC)|Completed||Phase 1|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.306813|2017-02-18 18:25:36.306813
NCT00000700|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-02-15||||||February 2012|2012-02-01|May 1990|Actual|1990-05-01|||||Interventional|||A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP|A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP|Completed||Phase 3|482||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.411053|2017-02-18 18:25:36.411053
NCT00000699|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-25||||||April 2003|2003-04-01||||||||Interventional|||A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients|A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.543461|2017-02-18 18:25:36.543461
NCT00000698|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-09-26||||||April 1992|1992-04-01|August 2007|Actual|2007-08-01|||||Interventional|||A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis|A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis|Completed||Phase 3|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.638487|2017-02-18 18:25:36.638487
NCT00000697|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-29||||||May 2012|2012-05-01||||||||Interventional|||A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir|A Phase II Randomized Controlled Trial of Immediate Versus Delayed Foscarnet Therapy in AIDS Patients With Non-Immediately Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due to Myelosuppression|Withdrawn||Phase 2|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.728254|2017-02-18 18:25:36.728254
NCT00000696|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|November 1993|Actual|1993-11-01|||||Interventional|||A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease|A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.827099|2017-02-18 18:25:36.827099
NCT00000524|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||July 1986||1986-07-01|November 2013|2013-11-01|March 1994|Actual|1994-03-01|||||Interventional|||Myocarditis Treatment Trial||Completed||Phase 2|||University of Utah|||||f||||||||||||||2017-02-18 18:26:00.525987|2017-02-18 18:26:00.525987
NCT00000695|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|July 1991|Actual|1991-07-01|||||Interventional|||Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma|Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma|Completed||Phase 1|36||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:36.939474|2017-02-18 18:25:36.939474
NCT00000694|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|August 1992|Actual|1992-08-01|||||Interventional|||A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma|A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:37.05074|2017-02-18 18:25:37.05074
NCT00000693|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|March 1992|Actual|1992-03-01|||||Interventional|||Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS|Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS|Completed||N/A|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:37.160832|2017-02-18 18:25:37.160832
NCT00000692|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||March 2003|2003-03-01||||||||Interventional|||Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex|Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:37.260798|2017-02-18 18:25:37.260798
NCT00000691|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|August 1992|Actual|1992-08-01|||||Interventional|||A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure|A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure|Completed||Phase 2|156||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:37.638456|2017-02-18 18:25:37.638456
NCT00000690|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|October 1989|Actual|1989-10-01|||||Interventional|||Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers|Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:37.756063|2017-02-18 18:25:37.756063
NCT00000689|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|March 1991|Actual|1991-03-01|||||Interventional|||Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma|Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:37.859956|2017-02-18 18:25:37.859956
NCT00000688|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||October 1990|1990-10-01||||February 1995|Actual|1995-02-01||Interventional|||A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS|A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS|Completed||Phase 3|180||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:37.971901|2017-02-18 18:25:37.971901
NCT00000687|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|July 1993|Actual|1993-07-01|||||Interventional|||Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma|Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma|Completed||Phase 2|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.094517|2017-02-18 18:25:38.094517
NCT00000686|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-25||||||May 1999|1999-05-01||||||||Interventional|||A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT|A Phase I Safety Study of BMY-27857 (2',3'-Dideoxy-2',3'-Didehydrothymidine [d4T]) Administered Four Times Daily to AZT-Intolerant Patients With AIDS or AIDS-Related Complex|Terminated||Phase 1|35||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.217557|2017-02-18 18:25:38.217557
NCT00000685|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1990|Actual|1990-02-01|||||Interventional|||A Study of Zidovudine in HIV-Infected Patients With Kidney Problems|Evaluation of Zidovudine Pharmacokinetics in Patients With Human Immunodeficiency Virus and Varying Degrees of Renal Insufficiency|Withdrawn||Phase 1|0|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.310555|2017-02-18 18:25:38.310555
NCT00000684|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|April 1991|Actual|1991-04-01|||||Interventional|||Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals|Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals|Completed||N/A|10||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.427394|2017-02-18 18:25:38.427394
NCT00000683|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|June 1993|Actual|1993-06-01|||||Interventional|||A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus|A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus|Completed||Phase 1|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.529693|2017-02-18 18:25:38.529693
NCT00000682|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1992|Actual|1992-09-01|||||Interventional|||A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002|A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002|Completed||Phase 3|120||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.636824|2017-02-18 18:25:38.636824
NCT00000681|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|October 1993|Actual|1993-10-01|||||Interventional|||A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma|A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.751499|2017-02-18 18:25:38.751499
NCT00000680|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|April 1993|Actual|1993-04-01|||||Interventional|||A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC|A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.878743|2017-02-18 18:25:38.878743
NCT00000679|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||December 1994|1994-12-01||||February 1994|Actual|1994-02-01||Interventional|||(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC|(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC|Completed||Phase 2|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:38.987765|2017-02-18 18:25:38.987765
NCT00000678|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||September 1992|1992-09-01||||July 1992|Actual|1992-07-01||Interventional|||Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.|Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.|Completed||Phase 2|320||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:39.117528|2017-02-18 18:25:39.117528
NCT00000677|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||December 1994|1994-12-01||||||||Interventional|||SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy|SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy|Completed||Phase 1|50||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:39.241996|2017-02-18 18:25:39.241996
NCT00000676|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|November 1993|Actual|1993-11-01|||||Interventional|||Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)|Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)|Completed||Phase 3|500||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:39.378833|2017-02-18 18:25:39.378833
NCT00000675|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||January 1991|1991-01-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex|A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex|Completed||Phase 1|60||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:39.508638|2017-02-18 18:25:39.508638
NCT00000674|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|August 1992|Actual|1992-08-01|||||Interventional|||A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS|A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS|Completed||N/A|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:39.602195|2017-02-18 18:25:39.602195
NCT00000673|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1993|Actual|1993-05-01|||||Interventional|||A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy|A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy|Completed||Phase 1|38||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:39.714046|2017-02-18 18:25:39.714046
NCT00000672|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||October 1994|1994-10-01||||February 1993|Actual|1993-02-01||Interventional|||An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex|An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex|Completed||Phase 2|660||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:39.82288|2017-02-18 18:25:39.82288
NCT00000671|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||August 1992|1992-08-01||||March 1992|Actual|1992-03-01||Interventional|||A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment|A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment|Completed||Phase 2|750||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:40.269025|2017-02-18 18:25:40.269025
NCT00000670|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|July 1989|Actual|1989-07-01|||||Interventional|||Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks|Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks|Completed||N/A|16||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:40.453116|2017-02-18 18:25:40.453116
NCT00000669|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-25||||||October 1996|1996-10-01||||||||Interventional|||A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection|A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection|Completed||Phase 1|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:40.561497|2017-02-18 18:25:40.561497
NCT00000668|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-15||||||March 2012|2012-03-01|February 1995|Actual|1995-02-01|||||Interventional|||A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir|A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir|Completed||Phase 1|48||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:40.664335|2017-02-18 18:25:40.664335
NCT00000667|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-21||||||May 2012|2012-05-01|July 1993|Actual|1993-07-01|||||Interventional|||A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells|A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells|Completed||Phase 1|20||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:40.7661|2017-02-18 18:25:40.7661
NCT00000666|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-26||||||October 2012|2012-10-01|March 1992|Actual|1992-03-01|||||Interventional|||A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection|A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection|Completed||N/A|600||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:40.868402|2017-02-18 18:25:40.868402
NCT00000665|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||December 1994|1994-12-01||||April 1992|Actual|1992-04-01||Interventional|||Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component|Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component|Completed||N/A|240||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:40.976751|2017-02-18 18:25:40.976751
NCT00000664|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-01||||||December 1994|1994-12-01||||||||Interventional|||Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals|Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals|Completed||Phase 1|26||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.078002|2017-02-18 18:25:41.078002
NCT00000663|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 1996|1996-10-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection|A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection|Completed||Phase 1|18||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.179478|2017-02-18 18:25:41.179478
NCT00000662|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-10-27||||||April 1992|1992-04-01|May 1993|Actual|1993-05-01|May 1993|Actual|1993-05-01||Interventional|||A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease|A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease|Completed||N/A|||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.288202|2017-02-18 18:25:41.288202
NCT00000661|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-08-01||||||December 1994|1994-12-01||||||||Interventional|||The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient|The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient|Completed||Phase 1|8||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.390091|2017-02-18 18:25:41.390091
NCT00000660|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|July 1992|Actual|1992-07-01|||||Interventional|||Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma|Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma|Completed||Phase 1|24||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.489882|2017-02-18 18:25:41.489882
NCT00000659|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-03-11||||||July 1990|1990-07-01||||July 1990|Actual|1990-07-01||Interventional|||A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)|A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)|Terminated||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.598092|2017-02-18 18:25:41.598092
NCT00000658|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-26||||||April 2012|2012-04-01|February 1996|Actual|1996-02-01|||||Interventional|||A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma|A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma|Completed||Phase 3|250||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.703971|2017-02-18 18:25:41.703971
NCT00000657|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|September 1992|Actual|1992-09-01|||||Interventional|||Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex|Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex|Completed||Phase 2|80||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.830713|2017-02-18 18:25:41.830713
NCT00000656|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|November 1993|Actual|1993-11-01|||||Interventional|||A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease|A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease|Completed||Phase 1|116||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:41.947612|2017-02-18 18:25:41.947612
NCT00000655|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-25||||||February 2011|2011-02-01||||January 1992|Actual|1992-01-01||Interventional|||A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients|A Randomized, Double-Blind Study of 566C80 Versus Septra (Trimethoprim/Sulfamethoxazole) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients|Completed||Phase 2|300||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:42.060725|2017-02-18 18:25:42.060725
NCT00000654|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-12-17||||||December 2012|2012-12-01|February 1993|Actual|1993-02-01|||||Interventional|||The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU|The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU|Completed||Phase 2|78||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:42.183434|2017-02-18 18:25:42.183434
NCT00000653|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|June 1995|Actual|1995-06-01|||||Interventional|||A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT|A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT|Completed||Phase 2|140||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:42.275539|2017-02-18 18:25:42.275539
NCT00000652|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-31||||||October 2012|2012-10-01|November 1995|Actual|1995-11-01|||||Interventional|||A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection|A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection|Completed||Phase 1|85||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:42.410762|2017-02-18 18:25:42.410762
NCT00000651|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-28||||||March 2012|2012-03-01|May 1993|Actual|1993-05-01|||||Interventional|||A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy|A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy|Completed||Phase 3|750||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:42.500031|2017-02-18 18:25:42.500031
NCT00000650|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients|An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients|Completed||N/A|12||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:42.906078|2017-02-18 18:25:42.906078
NCT00000649|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-29||||||June 1993|1993-06-01||||||||Interventional|||An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)|An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:42.998876|2017-02-18 18:25:42.998876
NCT00000648|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-10-24||||||October 2012|2012-10-01|February 1996|Actual|1996-02-01|||||Interventional|||A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals|A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals|Completed||N/A|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.103911|2017-02-18 18:25:43.103911
NCT00000647|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|December 1994|Actual|1994-12-01|||||Interventional|||An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection|An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection|Completed||N/A|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.252997|2017-02-18 18:25:43.252997
NCT00000646|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|March 1993|Actual|1993-03-01|||||Interventional|||Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS|Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS|Completed||Phase 1|54||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.351401|2017-02-18 18:25:43.351401
NCT00000645|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|October 1994|Actual|1994-10-01|||||Interventional|||A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes|A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes|Completed||Phase 1|32||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.446999|2017-02-18 18:25:43.446999
NCT00000644|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-24||||||February 2011|2011-02-01||||November 1997|Actual|1997-11-01||Interventional|||A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS|A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS|Completed||Phase 2|100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.542415|2017-02-18 18:25:43.542415
NCT00000643|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|May 1994|Actual|1994-05-01|||||Interventional|||Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients|Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients|Completed||Phase 2|150||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.639997|2017-02-18 18:25:43.639997
NCT00000642|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||October 2003|2003-10-01||||||||Interventional|||A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns|A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns|Completed||Phase 1|30||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.770284|2017-02-18 18:25:43.770284
NCT00000641|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|December 1994|Actual|1994-12-01|||||Interventional|||A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.|A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.|Completed||Phase 2|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.862112|2017-02-18 18:25:43.862112
NCT00000602|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-09-15|||April 1994||1994-04-01|October 2005|2005-10-01|March 1997|Actual|1997-03-01|||||Interventional|||Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:49.20783|2017-02-18 18:25:49.20783
NCT00000640|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1994|Actual|1994-09-01|||||Interventional|||A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS|A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Trimethoprim / Sulfamethoxazole in the Treatment of Mild-to-Moderate PCP in Patients With AIDS|Completed||Phase 3|290||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:43.981193|2017-02-18 18:25:43.981193
NCT00000639|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1997|Actual|1997-09-01|||||Interventional|||A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis|A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis|Completed||N/A|400||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:44.126623|2017-02-18 18:25:44.126623
NCT00000638|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1999|Actual|1999-09-01|||||Interventional|||Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection|Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection|Completed||N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:44.26819|2017-02-18 18:25:44.26819
NCT00000637|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|September 1996|Actual|1996-09-01|||||Interventional|||A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children|A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children|Completed||Phase 3|819||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:44.460414|2017-02-18 18:25:44.460414
NCT00000636|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-09-28||||||September 2013|2013-09-01|October 1997|Actual|1997-10-01|||||Interventional|||Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection|Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection|Completed||N/A|2000||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:44.65556|2017-02-18 18:25:44.65556
NCT00000635|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-29||||||March 2012|2012-03-01|April 1992|Actual|1992-04-01|||||Interventional|||Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine|Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine|Completed||N/A|25||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:44.777412|2017-02-18 18:25:44.777412
NCT00000634|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-25||||||February 2011|2011-02-01||||June 1995|Actual|1995-06-01||Interventional|||A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children|A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children|Completed||N/A|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:44.884144|2017-02-18 18:25:44.884144
NCT00000633|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-17||||||May 2012|2012-05-01|October 1998|Actual|1998-10-01|||||Interventional|||A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals|A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals|Completed||Phase 1|55||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:44.97801|2017-02-18 18:25:44.97801
NCT00000632|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-04-27||||||April 2012|2012-04-01|May 1992|Actual|1992-05-01|||||Interventional|||A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59|A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59|Completed||Phase 1|14|Actual|National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:45.081538|2017-02-18 18:25:45.081538
NCT00000631|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|December 1992|Actual|1992-12-01|||||Interventional|||A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)|A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)|Completed||Phase 1|13||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:45.178976|2017-02-18 18:25:45.178976
NCT00000630|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|December 1992|Actual|1992-12-01|||||Interventional|||Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)|Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)|Completed||Phase 1|35||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:45.282563|2017-02-18 18:25:45.282563
NCT00000629|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-29||||||October 2003|2003-10-01||||||||Interventional|||The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.|The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.|Completed||Phase 1|6||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:45.379223|2017-02-18 18:25:45.379223
NCT00000628|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-07-29||||||October 1994|1994-10-01||||||||Interventional|||A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine|A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine|Completed||Phase 1|27||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:45.469801|2017-02-18 18:25:45.469801
NCT00000627|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|November 1994|Actual|1994-11-01|||||Interventional|||Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome|Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome|Completed||N/A|90||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:45.574044|2017-02-18 18:25:45.574044
NCT00000626|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-05-22||||||May 2012|2012-05-01|February 1999|Actual|1999-02-01|||||Interventional|||Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease|Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease|Completed||Phase 2|27||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:45.960565|2017-02-18 18:25:45.960565
NCT00000625|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-03-30||||||March 2012|2012-03-01|November 1995|Actual|1995-11-01|||||Interventional|||A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3|A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3|Completed||Phase 2|2100||National Institute of Allergy and Infectious Diseases (NIAID)|||||f||||||||||||||2017-02-18 18:25:46.08523|2017-02-18 18:25:46.08523
NCT00000623|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-03-03|||July 2000||2000-07-01|July 2006|2006-07-01|July 2006|Actual|2006-07-01|||||Observational|||Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)|Thalassemia Clinical Research Network (TCRN)|Completed||N/A|1000|Anticipated|New England Research Institutes|||||f||||||||||||||2017-02-18 18:25:46.282797|2017-02-18 18:25:46.282797
NCT00000622|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2006-08-24|||September 1999||1999-09-01|August 2006|2006-08-01||||||||Interventional|||Childhood Asthma Research and Education (CARE) Network|Childhood Asthma Research and Education (CARE) Network|Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:46.404484|2017-02-18 18:25:46.404484
NCT00000621|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2008-01-15|||September 1999||1999-09-01|January 2008|2008-01-01|December 2004|Actual|2004-12-01|December 2004|Actual|2004-12-01||Interventional|||Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:46.510098|2017-02-18 18:25:46.510098
NCT00000620|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-11-21|2014-09-05||September 1999||1999-09-01|November 2014|2014-11-01|December 2012|Actual|2012-12-01|June 2009|Actual|2009-06-01||Interventional|ACCORD||Action to Control Cardiovascular Risk in Diabetes (ACCORD)|Action to Control Cardiovascular Risk in Diabetes (ACCORD)|Completed||Phase 3|10251|Actual|National Heart, Lung, and Blood Institute (NHLBI)||6|||f||||t||||||||||2017-02-18 18:25:46.59566|2017-02-18 18:25:46.59566
NCT00000619|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||April 2001||2001-04-01|January 2008|2008-01-01|March 2006|Actual|2006-03-01|March 2006|Actual|2006-03-01||Interventional|||Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:47.566203|2017-02-18 18:25:47.566203
NCT00000617|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-11-04|||September 1998||1998-09-01|May 2005|2005-05-01|November 2005|Actual|2005-11-01|||||Interventional|||Azithromycin and Coronary Events Study (ACES)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:47.633782|2017-02-18 18:25:47.633782
NCT00000616|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||September 1998||1998-09-01|November 2005|2005-11-01|August 2004|Actual|2004-08-01|||||Interventional|||PREMIER: Lifestyle Interventions for Blood Pressure Control||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:47.708267|2017-02-18 18:25:47.708267
NCT00000615|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2006-10-02|||August 1999||1999-08-01|April 2005|2005-04-01|November 2006||2006-11-01|||||Interventional|||Girls Health Enrichment Multi-Site Studies (GEMS)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:47.790498|2017-02-18 18:25:47.790498
NCT00000614|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-15|||September 1998||1998-09-01|September 2005|2005-09-01|August 2004|Actual|2004-08-01|||||Interventional|||Prevention of Recurrent Venous Thromboembolism (PREVENT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:47.867324|2017-02-18 18:25:47.867324
NCT00000613|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-26|||April 1997||1997-04-01|December 2005|2005-12-01|December 2004|Actual|2004-12-01|||||Interventional|||CVD Risk and Health in Postmenopausal Phytoestrogen Users||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:47.951445|2017-02-18 18:25:47.951445
NCT00000612|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-12|||January 1996||1996-01-01|November 2000|2000-11-01|December 1998|Actual|1998-12-01|||||Interventional|||Soy Estrogen Alternative Study (SEA)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:48.029801|2017-02-18 18:25:48.029801
NCT00000611|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-14||||||January 2006|2006-01-01||||March 2005|Actual|2005-03-01||Interventional|||Women's Health Initiative (WHI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:48.109107|2017-02-18 18:25:48.109107
NCT00000610|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||April 1998||1998-04-01|March 2005|2005-03-01|November 2003||2003-11-01|||||Interventional|||Magnesium in Coronaries (MAGIC)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:48.433231|2017-02-18 18:25:48.433231
NCT00000609|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-12|||May 1997||1997-05-01|November 2005|2005-11-01|April 2005|Actual|2005-04-01|||||Interventional|||Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:48.590857|2017-02-18 18:25:48.590857
NCT00000608|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-28|||February 1997||1997-02-01|January 2008|2008-01-01|July 2002|Actual|2002-07-01|July 2002|Actual|2002-07-01||Interventional|||Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:48.676799|2017-02-18 18:25:48.676799
NCT00000607|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-12-22|||October 1997||1997-10-01|December 2015|2015-12-01|March 1999|Actual|1999-03-01|March 1999|Actual|1999-03-01||Interventional|||Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH)|The REMATCH Trial: Rationale, Design, and End Points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure|Completed||Phase 3|129|Actual|Columbia University||2|||f||||f||||||||||2017-02-18 18:25:48.760978|2017-02-18 18:25:48.760978
NCT00000606|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||December 1996||1996-12-01|April 2009|2009-04-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||National Emphysema Treatment Trial (NETT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:48.874476|2017-02-18 18:25:48.874476
NCT00000605|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||August 1996||1996-08-01|April 2005|2005-04-01|July 2002|Actual|2002-07-01|||||Interventional|||Estrogen and Graft Atherosclerosis Research Trial (EAGER)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:48.96617|2017-02-18 18:25:48.96617
NCT00000604|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-12-11|||January 1994||1994-01-01|December 2015|2015-12-01|December 1996||1996-12-01|||||Interventional|||Influence of CPB Temperature on CABG Morbidity||Completed||Phase 2|||Baystate Medical Center|||||f||||||||||||||2017-02-18 18:25:49.045033|2017-02-18 18:25:49.045033
NCT00000600|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-12|||June 1995||1995-06-01|October 2006|2006-10-01|May 2000|Actual|2000-05-01|||||Interventional|||Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up|Antioxidants and Prevention of Early Atherosclerosis|Terminated||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:49.375694|2017-02-18 18:25:49.375694
NCT00000599|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-12|||June 1980||1980-06-01|May 2000|2000-05-01|November 1994|Actual|1994-11-01|||||Interventional|||Cholesterol-Lowering Atherosclerosis Study (CLAS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:49.465361|2017-02-18 18:25:49.465361
NCT00000598|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-01-08|||August 1991||1991-08-01|March 2005|2005-03-01|August 1996||1996-08-01|||||Interventional|||Diet and Exercise for Elevated Risk (DEER)||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-02-18 18:25:49.555405|2017-02-18 18:25:49.555405
NCT00000597|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||March 1982||1982-03-01|May 2000|2000-05-01|December 1988|Actual|1988-12-01|||||Interventional|||Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:52.628923|2017-02-18 18:25:52.628923
NCT00000596|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||June 1978||1978-06-01|February 2002|2002-02-01|January 1983|Actual|1983-01-01|||||Interventional|||Diffuse Fibrotic Lung Disease||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:52.724639|2017-02-18 18:25:52.724639
NCT00000595|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||January 1978||1978-01-01|May 2000|2000-05-01|September 1994|Actual|1994-09-01|||||Interventional|||Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:52.801917|2017-02-18 18:25:52.801917
NCT00000594|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2012-04-26|||November 1971||1971-11-01|April 2012|2012-04-01|November 1976|Actual|1976-11-01|||||Interventional|||NHLBI Type II Coronary Intervention Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:52.884379|2017-02-18 18:25:52.884379
NCT00000593|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||November 1994||1994-11-01|December 2005|2005-12-01|March 2001|Actual|2001-03-01|||||Interventional|||Viral Activation Transfusion Study (VATS)||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:52.9783|2017-02-18 18:25:52.9783
NCT00000592|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-12-21|||July 1994||1994-07-01|November 2005|2005-11-01|August 2000||2000-08-01|||||Interventional|||Stroke Prevention in Sickle Cell Anemia (STOP 1)||Completed||Phase 3|||Augusta University|||||f||||||||||||||2017-02-18 18:25:53.055997|2017-02-18 18:25:53.055997
NCT00000591|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-14|||November 1993||1993-11-01|November 2005|2005-11-01|February 2005||2005-02-01|||||Interventional|||T-Cell Depletion in Unrelated Donor Marrow Transplantation||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:53.134311|2017-02-18 18:25:53.134311
NCT00000590|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||September 1991||1991-09-01|March 2005|2005-03-01|December 1996||1996-12-01|||||Interventional|||Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:53.215943|2017-02-18 18:25:53.215943
NCT00000589|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-11-04|||August 1989||1989-08-01|May 2000|2000-05-01|July 1997|Actual|1997-07-01|||||Interventional|||Trial to Reduce Alloimmunization to Platelets (TRAP)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:53.310012|2017-02-18 18:25:53.310012
NCT00000588|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-02-10|||June 1989||1989-06-01|February 2002|2002-02-01||||||||Interventional|||Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone||Completed||Phase 2|||Case Western Reserve University|||||f||||||||||||||2017-02-18 18:25:53.404216|2017-02-18 18:25:53.404216
NCT00000587|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2006-01-03|||September 1988||1988-09-01|December 2005|2005-12-01||||||||Interventional|||Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:53.481389|2017-02-18 18:25:53.481389
NCT00000586|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||January 1992||1992-01-01|January 2009|2009-01-01|June 1994|Actual|1994-06-01|June 1994|Actual|1994-06-01||Interventional|||Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)|Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)|Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:53.554782|2017-02-18 18:25:53.554782
NCT00000585|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-24|||August 1983||1983-08-01|October 1994|1994-10-01|October 1994||1994-10-01|||||Interventional|||Penicillin Prophylaxis in Sickle Cell Disease (PROPS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:53.913682|2017-02-18 18:25:53.913682
NCT00000584|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||July 1983||1983-07-01|December 2005|2005-12-01|June 1988|Actual|1988-06-01|||||Interventional|||Transfusion-Transmitted Cytomegalovirus Prevention in Neonates||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:54.000559|2017-02-18 18:25:54.000559
NCT00000583|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||November 1978||1978-11-01|April 2012|2012-04-01|June 1980|Actual|1980-06-01|||||Interventional|||Hepatitis B Vaccine Clinical Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:54.082022|2017-02-18 18:25:54.082022
NCT00000582|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2012-04-26|||July 1978||1978-07-01|April 2012|2012-04-01|July 1979|Actual|1979-07-01|||||Interventional|||Cooperative Study of Factor VIII Inhibitors||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:54.160641|2017-02-18 18:25:54.160641
NCT00000581|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||September 1976||1976-09-01|January 2000|2000-01-01|September 1981|Actual|1981-09-01|||||Interventional|||Granulocyte Transfusion Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:54.250379|2017-02-18 18:25:54.250379
NCT00000580|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||November 1975||1975-11-01|January 2000|2000-01-01|June 1986|Actual|1986-06-01|||||Interventional|||Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:54.325978|2017-02-18 18:25:54.325978
NCT00000579|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-22|||September 1994||1994-09-01|August 2006|2006-08-01|July 2004|Actual|2004-07-01|||||Interventional|||Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)|Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)|Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:54.403969|2017-02-18 18:25:54.403969
NCT00000578|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||April 1994||1994-04-01|February 2005|2005-02-01|October 2000|Actual|2000-10-01|||||Interventional|||NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:54.564855|2017-02-18 18:25:54.564855
NCT00000577|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2017-01-12|||September 1993||1993-09-01|August 2006|2006-08-01|July 2008||2008-07-01|||||Interventional|||Asthma Clinical Research Network (ACRN)|Asthma Clinical Research Network (ACRN)|Withdrawn||Phase 3|0|Actual|Milton S. Hershey Medical Center||||"Record is an ACRN grant summary & not reflective of an individual trial. All ACTs conducted by~   ACRN were individually registered on the PRS."|f||||||||||||||2017-02-18 18:25:54.650825|2017-02-18 18:25:54.650825
NCT00000576|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||June 1993||1993-06-01|May 2001|2001-05-01|April 1999|Actual|1999-04-01|||||Interventional|||Inhaled Beclomethasone to Prevent Chronic Lung Disease||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:54.775715|2017-02-18 18:25:54.775715
NCT00000575|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-02-20|2013-10-16||September 1991||1991-09-01|February 2014|2014-02-01|March 2012|Actual|2012-03-01|October 1999|Actual|1999-10-01||Interventional|CAMP||Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)|Childhood Asthma Management Program|Completed||Phase 3|1041|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-02-18 18:25:54.861915|2017-02-18 18:25:54.861915
NCT00000574|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-01-28|||September 1990||1990-09-01|January 2016|2016-01-01|July 1995||1995-07-01|||||Interventional|||Ibuprofen in Sepsis Study||Completed||Phase 3|||Vanderbilt University|||||f||||||||||||||2017-02-18 18:25:55.52874|2017-02-18 18:25:55.52874
NCT00000573|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-12|||January 1990||1990-01-01|April 2002|2002-04-01|November 2005|Actual|2005-11-01|||||Interventional|||Emphysema: Physiologic Effects of Nutritional Support||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:55.609781|2017-02-18 18:25:55.609781
NCT00000572|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-04-08|||June 1987||1987-06-01|April 2015|2015-04-01|January 1993|Actual|1993-01-01|April 1991|Actual|1991-04-01||Interventional|||Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome|Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome|Completed||Phase 3|40|Actual|Intermountain Health Care, Inc.||2|||f||||f||||||||||2017-02-18 18:25:55.682298|2017-02-18 18:25:55.682298
NCT00000571|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-12-28|||February 1986||1986-02-01|April 2001|2001-04-01||||||||Interventional|||Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease||Completed||Phase 3|||McGill University|||||f||||||||||||||2017-02-18 18:25:55.783116|2017-02-18 18:25:55.783116
NCT00000570|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-12|||January 1986||1986-01-01|January 2000|2000-01-01|June 1990|Actual|1990-06-01|||||Interventional|||Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:55.858287|2017-02-18 18:25:55.858287
NCT00000569|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-10-25|||September 1993||1993-09-01|October 2016|2016-10-01|May 1999|Actual|1999-05-01|May 1999|Actual|1999-05-01||Interventional|LHSII||Lung Health Study II|The Chronic Obstructive Pulmonary Disease Early Intervention Trial|Completed||Phase 3|1116|Actual|University of Minnesota - Clinical and Translational Science Institute||2|||f||||t||||||||No||2017-02-18 18:25:56.215879|2017-02-18 18:25:56.215879
NCT00000568|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||September 1984||1984-09-01|August 2005|2005-08-01|January 2005||2005-01-01|||||Interventional|||Lung Health Study (LHS) I and III||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:56.330078|2017-02-18 18:25:56.330078
NCT00000567|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||August 1984||1984-08-01|December 2005|2005-12-01||||||||Interventional|||High Frequency Ventilation in Premature Infants (HIFI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:56.439639|2017-02-18 18:25:56.439639
NCT00000566|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-14|||September 1983||1983-09-01|June 2002|2002-06-01|December 1989||1989-12-01|||||Interventional|||Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:56.516035|2017-02-18 18:25:56.516035
NCT00000565|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||November 1976||1976-11-01|May 2002|2002-05-01||||||||Interventional|||Clinical Study of Intermittent Positive Pressure Breathing (IPPB)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:56.601973|2017-02-18 18:25:56.601973
NCT00000564|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2005-06-23|||July 1976||1976-07-01|May 2002|2002-05-01||||||||Interventional|||Nocturnal Oxygen Therapy||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:56.694992|2017-02-18 18:25:56.694992
NCT00000563|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2012-04-26|||June 1976||1976-06-01|April 2012|2012-04-01|August 1983|Actual|1983-08-01|||||Interventional|||Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:56.777643|2017-02-18 18:25:56.777643
NCT00000562|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||June 1974||1974-06-01|January 2000|2000-01-01|November 1979|Actual|1979-11-01|||||Interventional|||Extracorporeal Support for Respiratory Insufficiency (ECMO)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:56.866813|2017-02-18 18:25:56.866813
NCT00000561|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-22|||June 1995||1995-06-01|May 2005|2005-05-01|May 2002||2002-05-01|||||Interventional|||Mode Selection Trial in Sinus Node Dysfunction (MOST)||Completed||Phase 3|||Mt. Sinai Medical Center, Miami|||||f||||||||||||||2017-02-18 18:25:56.942741|2017-02-18 18:25:56.942741
NCT00000560|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-12|||June 1994||1994-06-01|April 2005|2005-04-01|September 1999||1999-09-01|||||Interventional|||Beta-Blocker Evaluation in Survival Trial (BEST)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:57.028633|2017-02-18 18:25:57.028633
NCT00000559|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||March 1995||1995-03-01|May 2005|2005-05-01|August 2001|Actual|2001-08-01|||||Interventional|||Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:57.11588|2017-02-18 18:25:57.11588
NCT00000558|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||November 1995||1995-11-01|January 2008|2008-01-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:57.210073|2017-02-18 18:25:57.210073
NCT00000557|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-12|||September 1995||1995-09-01|January 2008|2008-01-01|September 2005|Actual|2005-09-01|September 2005|Actual|2005-09-01||Interventional|||Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:57.303544|2017-02-18 18:25:57.303544
NCT00000556|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-24|||March 1995||1995-03-01|November 2005|2005-11-01|September 2002||2002-09-01|||||Interventional|||Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:57.399512|2017-02-18 18:25:57.399512
NCT00000552|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-03-03|||September 1994||1994-09-01|March 2014|2014-03-01|December 2005|Actual|2005-12-01|December 2005|Actual|2005-12-01||Interventional|||Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.||Completed||Phase 3|||New England Research Institutes|||||f||||||||||||||2017-02-18 18:25:57.767447|2017-02-18 18:25:57.767447
NCT00000551|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-24|||September 1994||1994-09-01|August 2007|2007-08-01|September 2002||2002-09-01|||||Interventional|||Activity Counseling Trial (ACT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:57.859056|2017-02-18 18:25:57.859056
NCT00000550|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-03-03|||August 1994||1994-08-01|March 2014|2014-03-01|May 2000|Actual|2000-05-01|May 2000|Actual|2000-05-01||Interventional|||Rapid Early Action for Coronary Treatment (REACT)||Completed||Phase 3|||New England Research Institutes|||||f||||||||||||||2017-02-18 18:25:57.939829|2017-02-18 18:25:57.939829
NCT00000549|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-15|||August 1994||1994-08-01|December 2005|2005-12-01|July 2000|Actual|2000-07-01|||||Interventional|||Estrogen Replacement and Atherosclerosis (ERA) in Older Women||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:58.021084|2017-02-18 18:25:58.021084
NCT00000548|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-03-03|||March 2000||2000-03-01|March 2015|2015-03-01|February 2006|Actual|2006-02-01|||||Interventional|||Inhaled NO in Prevention of Chronic Lung Disease||Completed||Phase 3|||University of California, San Francisco|||||f||||||||||||||2017-02-18 18:25:58.104799|2017-02-18 18:25:58.104799
NCT00000547|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||April 1994||1994-04-01|December 2005|2005-12-01|February 2001|Actual|2001-02-01|||||Interventional|||Enalapril After Anthracycline Cardiotoxicity||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:58.181865|2017-02-18 18:25:58.181865
NCT00000546|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||March 1994||1994-03-01|October 2005|2005-10-01|May 2005|Actual|2005-05-01|||||Interventional|||Stress Reduction and Atherosclerotic CVD in Blacks||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:58.267133|2017-02-18 18:25:58.267133
NCT00000545|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-28|||September 1993||1993-09-01|December 2005|2005-12-01|July 2002|Actual|2002-07-01|||||Interventional|||PATHWAYS--FULL SCALE STUDY|PATHWAYS--FULL SCALE STUDY|Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:58.348669|2017-02-18 18:25:58.348669
NCT00000544|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-11-04|||August 1993||1993-08-01|October 2005|2005-10-01|July 1997|Actual|1997-07-01|||||Interventional|||Dietary Approaches to Stop Hypertension (DASH)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:58.431462|2017-02-18 18:25:58.431462
NCT00000543|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-12|||August 1993||1993-08-01|April 2002|2002-04-01|July 1999|Actual|1999-07-01|||||Interventional|||Oral Calcium in Pregnant Women With Hypertension||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:58.514873|2017-02-18 18:25:58.514873
NCT00000542|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-28|||August 1993||1993-08-01|February 2009|2009-02-01|March 2002|Actual|2002-03-01|March 2002|Actual|2002-03-01||Interventional|||Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:58.588856|2017-02-18 18:25:58.588856
NCT00000541|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-01-07|||May 1993||1993-05-01|January 2016|2016-01-01|July 2005|Actual|2005-07-01|July 2005|Actual|2005-07-01||Interventional|WAFACS||Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)|Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)|Completed||Phase 2|||Brigham and Women's Hospital|||||f||||t||||||||||2017-02-18 18:25:58.690747|2017-02-18 18:25:58.690747
NCT00000540|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-11-04|||December 1992||1992-12-01|August 2004|2004-08-01|December 1998|Actual|1998-12-01|||||Interventional|||Coronary Artery Bypass Graft (CABG) Patch Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:58.791158|2017-02-18 18:25:58.791158
NCT00000539|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||September 1992||1992-09-01|January 2006|2006-01-01|March 1999|Actual|1999-03-01|||||Interventional|||Arterial Disease Multifactorial Intervention Trial (ADMIT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:59.13802|2017-02-18 18:25:59.13802
NCT00000538|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-08-11|||September 1992||1992-09-01|August 2014|2014-08-01|May 1995|Actual|1995-05-01|May 1995|Actual|1995-05-01||Interventional|||Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA)||Completed||Phase 3|189|Actual|University of North Carolina, Chapel Hill|||||f||||||||||||||2017-02-18 18:25:59.220126|2017-02-18 18:25:59.220126
NCT00000537|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2008-07-23|||July 1992||1992-07-01|July 2008|2008-07-01|July 2008|Actual|2008-07-01|July 2008|Actual|2008-07-01||Interventional|||Stress Reduction & CVD Morbidity and Mortality in Blacks||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:59.309645|2017-02-18 18:25:59.309645
NCT00000536|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-24|||July 1992||1992-07-01|February 2016|2016-02-01|June 1997||1997-06-01|||||Interventional|||Sodium Sensitivity in African Americans||Completed||Phase 2|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:25:59.389127|2017-02-18 18:25:59.389127
NCT00000535|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-11-04|||April 1992||1992-04-01|October 2002|2002-10-01|March 1997|Actual|1997-03-01|||||Interventional|||Trial of Nonpharmacologic Interventions in Elderly (TONE)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:59.462887|2017-02-18 18:25:59.462887
NCT00000534|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2017-01-25|||March 1991||1991-03-01|January 2017|2017-01-01|June 2000||2000-06-01|||||Interventional|||Calcium for Pre-Eclampsia Prevention (CPEP)||Completed||Phase 3|||Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|||||f||||||||||||||2017-02-18 18:25:59.553418|2017-02-18 18:25:59.553418
NCT00000533|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-12-28|||February 1992||1992-02-01|March 2005|2005-03-01|December 1996||1996-12-01|||||Interventional|||Montreal Heart Attack Readjustment Trial (M-HART)|Montreal Heart Attack Readjustment Trial (M-HART)|Completed||Phase 3|||McGill University|||||f||||||||||||||2017-02-18 18:25:59.639872|2017-02-18 18:25:59.639872
NCT00000532|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-12|||February 1992||1992-02-01|April 2002|2002-04-01|January 2000|Actual|2000-01-01|||||Interventional|||Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:59.720006|2017-02-18 18:25:59.720006
NCT00000531|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-12|||September 1992||1992-09-01|May 2005|2005-05-01|August 2002||2002-08-01|||||Interventional|||Antiarrhythmics Versus Implantable Defibrillators (AVID)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:59.80096|2017-02-18 18:25:59.80096
NCT00000530|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-14|||September 1992||1992-09-01|August 2004|2004-08-01|June 1998||1998-06-01|||||Interventional|||Raynaud's Treatment Study (RTS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:25:59.91211|2017-02-18 18:25:59.91211
NCT00000522|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-24|||August 1985||1985-08-01|February 2016|2016-02-01|May 1994||1994-05-01|||||Interventional|||Treatment of Mild Hypertension Study (TOMHS)||Completed||Phase 2|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:26:00.69715|2017-02-18 18:26:00.69715
NCT00000521|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-05-27|||August 1985||1985-08-01|May 2014|2014-05-01|December 1990|Actual|1990-12-01|July 1990|Actual|1990-07-01||Interventional|||Sodium-Potassium Blood Pressure Trial in Children|Sodium-Potassium Blood Pressure Trial in Children|Completed||Phase 4|285|Actual|University of Minnesota - Clinical and Translational Science Institute||1|||f||||||||||||||2017-02-18 18:26:00.793863|2017-02-18 18:26:00.793863
NCT00000520|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-12|||July 1985||1985-07-01|April 2012|2012-04-01|November 1989|Actual|1989-11-01|||||Interventional|||Prevention of Coronary Aneurysms in Kawasaki Syndrome||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:00.872981|2017-02-18 18:26:00.872981
NCT00000519|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-06-25|||July 1982||1982-07-01|June 2013|2013-06-01||||||||Interventional|||Exercise Training and Plasma Lipoproteins in Man||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-02-18 18:26:01.163184|2017-02-18 18:26:01.163184
NCT00000518|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-01-19|||July 1985||1985-07-01|January 2016|2016-01-01|December 1992||1992-12-01|||||Interventional|||Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)||Completed||Phase 3|||University of Utah|||||f||||||||||||||2017-02-18 18:26:01.261537|2017-02-18 18:26:01.261537
NCT00000517|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-04-09|||July 1985||1985-07-01|April 2014|2014-04-01|June 1991|Actual|1991-06-01|June 1991|Actual|1991-06-01||Interventional|||Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)||Completed||Phase 3|||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 18:26:01.356173|2017-02-18 18:26:01.356173
NCT00000516|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-14|||July 1985||1985-07-01|April 2012|2012-04-01|May 1990|Actual|1990-05-01|||||Interventional|||Studies of Left Ventricular Dysfunction (SOLVD)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:01.444808|2017-02-18 18:26:01.444808
NCT00000515|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||July 1984||1984-07-01|February 2005|2005-02-01|September 1992|Actual|1992-09-01|||||Interventional|||Randomized Trial of Dietary Intervention Therapy in Obese Hypertensives (DITOH)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:01.549226|2017-02-18 18:26:01.549226
NCT00000514|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-14|||June 1984||1984-06-01|January 2005|2005-01-01|October 1996||1996-10-01|||||Interventional|||Systolic Hypertension in the Elderly Program (SHEP)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:01.634917|2017-02-18 18:26:01.634917
NCT00000513|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||April 1984||1984-04-01|April 2012|2012-04-01|November 1994|Actual|1994-11-01|||||Interventional|||Trial of Antihypertensive Intervention Management||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:01.735875|2017-02-18 18:26:01.735875
NCT00000512|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-12-01|||January 1984||1984-01-01|December 2015|2015-12-01|August 1989|Actual|1989-08-01|August 1989|Actual|1989-08-01||Interventional|FATS||Familial Atherosclerosis Treatment Study|Familial Atherosclerosis Treatment Study|Completed||Phase 3|146|Actual|University of Washington||3|||f||||t||||||||||2017-02-18 18:26:01.831887|2017-02-18 18:26:01.831887
NCT00000511|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-12|||December 1983||1983-12-01|December 2013|2013-12-01|November 1994|Actual|1994-11-01|November 1994|Actual|1994-11-01||Interventional|||Polyunsaturates and KCL to Control Mild Hypertension||Completed||Phase 2|||Brigham and Women's Hospital||1|||f||||||||||||||2017-02-18 18:26:01.94987|2017-02-18 18:26:01.94987
NCT00000510|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||September 1983||1983-09-01|March 2005|2005-03-01|September 1988|Actual|1988-09-01|||||Interventional|||Platelet-Inhibitor Drug Trial in Coronary Angioplasty||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:02.054807|2017-02-18 18:26:02.054807
NCT00000509|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2005-06-23|||September 1983||1983-09-01|January 2000|2000-01-01||||||||Interventional|||Potassium and Sodium to Control Blood Pressure in Hypertensives||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:02.126462|2017-02-18 18:26:02.126462
NCT00000508|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-01-08|||September 1983||1983-09-01|March 1993|1993-03-01|March 1993||1993-03-01|||||Interventional|||Stanford Coronary Risk Intervention Project (SCRIP)||Completed||Phase 3|||Stanford University|||||f||||||||||||||2017-02-18 18:26:02.19319|2017-02-18 18:26:02.19319
NCT00000507|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-08|||August 1983||1983-08-01|October 1994|1994-10-01|October 1994||1994-10-01|||||Interventional|||Intravenous Streptokinase in Acute Myocardial Infarction||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-02-18 18:26:02.273656|2017-02-18 18:26:02.273656
NCT00000506|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||May 1983||1983-05-01|January 2000|2000-01-01|April 1988|Actual|1988-04-01|||||Interventional|||Cardiovascular System in Obesity: Effect of Treatment||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:02.347096|2017-02-18 18:26:02.347096
NCT00000505|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-15|||April 1983||1983-04-01|July 2000|2000-07-01|December 1990|Actual|1990-12-01|||||Interventional|||Thrombolysis in Myocardial Infarction (TIMI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:02.424606|2017-02-18 18:26:02.424606
NCT00000504|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2012-04-26|||September 1982||1982-09-01|April 2012|2012-04-01|September 1985|Actual|1985-09-01|||||Interventional|||Cardiac Arrhythmia Pilot Study (CAPS)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:02.531801|2017-02-18 18:26:02.531801
NCT00000503|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||August 1982||1982-08-01|January 2000|2000-01-01|October 1987|Actual|1987-10-01|||||Interventional|||Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:02.835845|2017-02-18 18:26:02.835845
NCT00000502|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||September 1981||1981-09-01|May 2000|2000-05-01|June 1985|Actual|1985-06-01|||||Interventional|||Evaluation of SC-V Versus Conventional CPR||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:02.919776|2017-02-18 18:26:02.919776
NCT00000501|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||September 1981||1981-09-01|April 2012|2012-04-01|August 1986|Actual|1986-08-01|||||Interventional|||Hypertension Prevention Trial (HPT) Feasibility Study||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:02.995443|2017-02-18 18:26:02.995443
NCT00000500|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-01-24|||September 1981||1981-09-01|January 2014|2014-01-01|December 1996|Actual|1996-12-01|December 1995|Actual|1995-12-01||Interventional|||Physicians' Health Study||Completed||Phase 3|||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 18:26:03.079482|2017-02-18 18:26:03.079482
NCT00000499|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||September 1980||1980-09-01|April 2012|2012-04-01|May 1983|Actual|1983-05-01|||||Interventional|||Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:03.45127|2017-02-18 18:26:03.45127
NCT00000498|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-25|||April 1980||1980-04-01|January 2000|2000-01-01|March 1983|Actual|1983-03-01|||||Interventional|||Control of Hypertension by Non-Pharmacologic Means||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:03.540748|2017-02-18 18:26:03.540748
NCT00000497|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2015-04-14|||January 1980||1980-01-01|January 2000|2000-01-01|September 1994|Actual|1994-09-01|||||Interventional|||Dietary Intervention Study for Hypertension (DISH)||Completed||Phase 3|||University of Mississippi Medical Center|||||f||||||||||||||2017-02-18 18:26:03.625815|2017-02-18 18:26:03.625815
NCT00000496|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||December 1979||1979-12-01|April 2012|2012-04-01|December 1982|Actual|1982-12-01|||||Interventional|||Platelet Drug Trial in Coronary Disease Progression||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:03.712793|2017-02-18 18:26:03.712793
NCT00000495|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2014-11-21|||December 1978||1978-12-01|January 2000|2000-01-01||||||||Interventional|||Prevention of Hypertension: A Randomized Trial||Completed||Phase 3|||Northwestern University|||||f||||||||||||||2017-02-18 18:26:03.782327|2017-02-18 18:26:03.782327
NCT00000494|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-12|||September 1978||1978-09-01|April 2012|2012-04-01|March 1982|Actual|1982-03-01|||||Interventional|||Management of Patent Ductus in Premature Infants||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:03.862875|2017-02-18 18:26:03.862875
NCT00000493|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||September 1977||1977-09-01|December 1985|1985-12-01|December 1985|Actual|1985-12-01|||||Interventional|||Multicenter Investigation of Limitation of Infarct Size (MILIS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:03.947383|2017-02-18 18:26:03.947383
NCT00000492|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||September 1977||1977-09-01|October 1981|1981-10-01|October 1981|Actual|1981-10-01|||||Interventional|||Beta-Blocker Heart Attack Trial (BHAT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:04.051698|2017-02-18 18:26:04.051698
NCT00000491|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-24|||October 1974||1974-10-01|April 2012|2012-04-01|August 1979|Actual|1979-08-01|||||Interventional|||Aspirin-Myocardial Infarction Study (AMIS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:04.160325|2017-02-18 18:26:04.160325
NCT00000490|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-24|||June 1973||1973-06-01|February 2016|2016-02-01|December 1997||1997-12-01|||||Interventional|||Program on Surgical Control of Hyperlipidemias (POSCH)||Completed||Phase 3|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:26:04.272422|2017-02-18 18:26:04.272422
NCT00000489|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-16|||June 1973||1973-06-01|December 2005|2005-12-01|December 1996||1996-12-01|||||Interventional|||Coronary Artery Surgery Study (CASS)||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-02-18 18:26:04.385298|2017-02-18 18:26:04.385298
NCT00000488|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-13|||June 1973||1973-06-01|April 2012|2012-04-01|October 1989|Actual|1989-10-01|||||Interventional|||Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:04.503058|2017-02-18 18:26:04.503058
NCT00000487|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-24|||June 1972||1972-06-01|February 2016|2016-02-01|July 1998||1998-07-01|||||Interventional|||Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)||Completed||Phase 3|||University of Minnesota - Clinical and Translational Science Institute|||||f||||||||||||||2017-02-18 18:26:04.607893|2017-02-18 18:26:04.607893
NCT00000486|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||January 1972||1972-01-01|January 2000|2000-01-01|January 1980|Actual|1980-01-01|||||Interventional|||Unstable Angina Pectoris Trial||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:04.743816|2017-02-18 18:26:04.743816
NCT00000485|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||May 1971||1971-05-01|December 2005|2005-12-01|May 1982|Actual|1982-05-01|||||Interventional|||Hypertension Detection and Follow-up Program (HDFP)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:04.829549|2017-02-18 18:26:04.829549
NCT00000484|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||April 1966||1966-04-01|January 2000|2000-01-01|January 1979|Actual|1979-01-01|||||Interventional|||Treatment of Hypertension||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:04.943848|2017-02-18 18:26:04.943848
NCT00000483|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||June 1981||1981-06-01|April 2004|2004-04-01|March 1985|Actual|1985-03-01|||||Interventional|||Coronary Drug Project Mortality Surveillance||Completed||N/A|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:05.028437|2017-02-18 18:26:05.028437
NCT00000482|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-11-25|||April 1965||1965-04-01|July 2004|2004-07-01|March 1985|Actual|1985-03-01|||||Interventional|||Coronary Drug Project||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:05.116638|2017-02-18 18:26:05.116638
NCT00000481|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2017-02-13|||September 1991||1991-09-01|February 2017|2017-02-01|January 1996||1996-01-01|||||Interventional|||Women's Health Trial: Feasibility Study in Minority Populations||Completed||Phase 3|||National Cancer Institute (NCI)|||||f||||||||||||||2017-02-18 18:26:05.211318|2017-02-18 18:26:05.211318
NCT00000480|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2017-01-13|||September 1991||1991-09-01|August 2004|2004-08-01|September 1996|Actual|1996-09-01|||||Interventional|||Multicenter Unsustained Tachycardia Trial (MUSTT)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:05.29796|2017-02-18 18:26:05.29796
NCT00000479|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2012-06-12|2011-12-05||September 1992||1992-09-01|June 2012|2012-06-01|February 2005|Actual|2005-02-01|March 2004|Actual|2004-03-01||Interventional|WHS||Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer|Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women|Completed||Phase 3|39876|Actual|Brigham and Women's Hospital||4|||f||||t||||||||||2017-02-18 18:26:05.389185|2017-02-18 18:26:05.389185
NCT00000478|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-24|||November 1990||1990-11-01|February 2002|2002-02-01|June 1997||1997-06-01|||||Interventional|||Asymptomatic Cardiac Ischemia Pilot (ACIP) Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.015278|2017-02-18 18:26:06.015278
NCT00000477|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||July 1990||1990-07-01|June 1992|1992-06-01|June 1992|Actual|1992-06-01|||||Interventional|||Cholesterol Reduction in Seniors Program (CRISP)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.109732|2017-02-18 18:26:06.109732
NCT00000476|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||June 1990||1990-06-01|November 2005|2005-11-01|June 1998|Actual|1998-06-01|||||Interventional|||Digitalis Investigation Group (DIG)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.194685|2017-02-18 18:26:06.194685
NCT00000475|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||April 1990||1990-04-01|December 2005|2005-12-01|March 1995|Actual|1995-03-01|||||Interventional|||Prevention of Early Readmission in Elderly Congestive Heart Failure Patients||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.277119|2017-02-18 18:26:06.277119
NCT00000474|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-11|||September 1989||1989-09-01|June 2001|2001-06-01|September 1994|Actual|1994-09-01|||||Interventional|||Prevention and Treatment of Hypertension Study (PATHS)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.358984|2017-02-18 18:26:06.358984
NCT00000473|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-12|||July 1989||1989-07-01|April 2012|2012-04-01|June 1994|Actual|1994-06-01|||||Interventional|||Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.428685|2017-02-18 18:26:06.428685
NCT00000472|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-15|||April 1989||1989-04-01|July 2000|2000-07-01|June 1995|Actual|1995-06-01|||||Interventional|||Thrombolysis in Myocardial Ischemia Trial (TIMI III)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.511515|2017-02-18 18:26:06.511515
NCT00000471|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-12-12|||April 1989||1989-04-01|January 2000|2000-01-01|March 1993|Actual|1993-03-01|||||Interventional|||Lifestyle Heart Trial||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.612112|2017-02-18 18:26:06.612112
NCT00000470|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-07-28|||December 1988||1988-12-01|July 2016|2016-07-01|October 1993|Actual|1993-10-01|February 1992|Actual|1992-02-01||Interventional|BCAS||Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest|Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest|Completed||Phase 3|171|Actual|Boston Children’s Hospital||2|||f||||t||||||||No|Not required when trial was performed in 1988-92|2017-02-18 18:26:06.699606|2017-02-18 18:26:06.699606
NCT00000469|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-12|||May 1988||1988-05-01|April 2000|2000-04-01|August 1998|Actual|1998-08-01|||||Interventional|||Asymptomatic Carotid Artery Plaque Study (ACAPS)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.789108|2017-02-18 18:26:06.789108
NCT00000468|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-08|||April 1988||1988-04-01|June 2001|2001-06-01|March 1992||1992-03-01|||||Interventional|||Myocardial Infarction Triage and Intervention Project (MITI)||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-02-18 18:26:06.873651|2017-02-18 18:26:06.873651
NCT00000467|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||September 1987||1987-09-01|January 2008|2008-01-01|March 1991|Actual|1991-03-01|March 1991|Actual|1991-03-01||Interventional|||Child and Adolescent Trial for Cardiovascular Health (CATCH)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:06.961828|2017-02-18 18:26:06.961828
NCT00000466|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-12|||September 1987||1987-09-01|July 2005|2005-07-01|October 2000|Actual|2000-10-01|||||Interventional|||Postmenopausal Estrogen/Progestin Interventions (PEPI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:07.062098|2017-02-18 18:26:07.062098
NCT00000465|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-02-17|||June 1987||1987-06-01|September 2002|2002-09-01|August 1998|Actual|1998-08-01|||||Interventional|||Emory Angioplasty Versus Surgery Trial (EAST)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:07.154235|2017-02-18 18:26:07.154235
NCT00000464|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2013-07-26|||April 1987||1987-04-01|July 2013|2013-07-01||||December 1992|Actual|1992-12-01||Interventional|||Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)||Completed||Phase 3|||University of Washington|||||f||||||||||||||2017-02-18 18:26:07.229982|2017-02-18 18:26:07.229982
NCT00000463|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-04-12|||April 1987||1987-04-01|August 2004|2004-08-01|December 1998||1998-12-01|||||Interventional|||Post Coronary Artery Bypass Graft (CABG) Study||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:07.325525|2017-02-18 18:26:07.325525
NCT00000462|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-12|||April 1987||1987-04-01|March 2005|2005-03-01|November 2004||2004-11-01|||||Interventional|||Bypass Angioplasty Revascularization Investigation (BARI)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:07.412854|2017-02-18 18:26:07.412854
NCT00000461|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-03-15|||December 1986||1986-12-01|March 2005|2005-03-01|November 1992|Actual|1992-11-01|||||Interventional|||Harvard Atherosclerosis Reversibility Project (HARP)||Completed||Phase 2|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:07.772782|2017-02-18 18:26:07.772782
NCT00000460|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-01-05|||December 1986||1986-12-01|November 2013|2013-11-01|March 1991|Actual|1991-03-01|March 1991|Actual|1991-03-01||Observational|||Training Levels Comparison Trial|Training Levels Comparison (TLC) Trial in Patients With Coronary Heart Disease|Withdrawn||Phase 2|0|Actual|University of Alabama at Birmingham|||2|due to lack of enrollment|f||||||||||||||2017-02-18 18:26:07.870576|2017-02-18 18:26:07.870576
NCT00000459|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-27|2016-05-04|||December 1986||1986-12-01|March 2005|2005-03-01|January 1999|Actual|1999-01-01|||||Interventional|||Dietary Intervention Study in Children (DISC)||Completed||Phase 3|||National Heart, Lung, and Blood Institute (NHLBI)|||||f||||||||||||||2017-02-18 18:26:07.97774|2017-02-18 18:26:07.97774
NCT00000458|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01|January 2002||2002-01-01|||||Interventional|||Sertraline and Cognitive Therapy in Depressed Alcoholics|Sertraline and Cognitive Therapy in Depressed Alcoholics|Completed||Phase 2|100||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:26:08.073192|2017-02-18 18:26:08.073192
NCT00000457|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-10-18|||June 1998||1998-06-01|October 2013|2013-10-01|August 2007|Actual|2007-08-01|April 2002|Actual|2002-04-01||Interventional|||Pharmacologic Relapse Prevention for Alcoholic Smokers|Pharmacologic Relapse Prevention for Alcoholic Smokers|Completed||Phase 2|195|Actual|Mayo Clinic||2|||f||||f||||||||||2017-02-18 18:26:08.156817|2017-02-18 18:26:08.156817
NCT00000456|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-10-01|||September 1992||1992-09-01|October 2010|2010-10-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Behavioral Therapy Plus Naltrexone for Alcoholism|Comparison of Cognitive Behavioral Therapy and Motivational Enhancement Therapy Plus Naltrexone for Alcoholism|Completed||Phase 4|160|Actual|Medical University of South Carolina||2|||f||||||||||||||2017-02-18 18:26:08.290328|2017-02-18 18:26:08.290328
NCT00000455|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-06-17||||||June 2011|2011-06-01|September 2002||2002-09-01|||||Interventional|||Naltrexone for Early Problem Drinkers|Targeted Naltrexone for Early Problem Drinkers|Completed||Phase 4|160||UConn Health|||||f||||f||||||||||2017-02-18 18:26:08.400873|2017-02-18 18:26:08.400873
NCT00000454|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-05-18||||||May 2010|2010-05-01|August 2002||2002-08-01|||||Interventional|||Smoking Cessation in Alcoholism Treatment|Field Study of Smoking Cessation in Alcoholism Treatment|Completed||Phase 4|112||Yale University|||||f||||f||||||||||2017-02-18 18:26:08.492714|2017-02-18 18:26:08.492714
NCT00000452|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 2004|2004-11-01|January 2003||2003-01-01|||||Interventional|||Naltrexone Treatment of Alcohol Dependence||Completed||Phase 4|240||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:26:08.580563|2017-02-18 18:26:08.580563
NCT00000451|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-01-28|||January 2003||2003-01-01|January 2013|2013-01-01|November 2005|Actual|2005-11-01|August 2005|Actual|2005-08-01||Interventional|||Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)|Naltrexone and SSRI Therapy for Alcohol Dependence in Alaska Natives|Completed||Phase 2|198|Actual|Yale University||2|||f||||||||||||||2017-02-18 18:26:08.869431|2017-02-18 18:26:08.869431
NCT00000450|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-07-21||||||July 2010|2010-07-01|April 2002||2002-04-01|||||Interventional|||Naltrexone Maintenance Treatment of Alcoholism|Nalmefene Maintenance Treatment of Alcoholism|Completed||Phase 4|184||The Scripps Research Institute|||||f||||||||||||||2017-02-18 18:26:08.980515|2017-02-18 18:26:08.980515
NCT00000449|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01|March 2000||2000-03-01|||||Interventional|||Behavior and Naltrexone Treatment for Alcoholics|Coping, Exposure, and Naltrexone Treatment With Alcoholics|Completed||Phase 4|160||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:26:09.072263|2017-02-18 18:26:09.072263
NCT00000448|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-05-06|||October 1995||1995-10-01|May 2014|2014-05-01|December 2000|Actual|2000-12-01|December 2000|Actual|2000-12-01||Interventional|||Naltrexone Treatment for Alcoholic Women|Naltrexone: Consummatory Behaviors in Alcoholic Women|Completed||Phase 4|160|Actual|Yale University||2|||f||||f||||||||||2017-02-18 18:26:09.155724|2017-02-18 18:26:09.155724
NCT00000447|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-09-30|||September 1998||1998-09-01|September 2010|2010-09-01|May 2003|Actual|2003-05-01|||||Interventional|||Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)|Behavioral/Pharmacological Treatments for Alcohol-Nicotine Dependence|Completed||Phase 4|200||The University of Texas Health Science Center, Houston|||||f||||||||||||||2017-02-18 18:26:09.276205|2017-02-18 18:26:09.276205
NCT00000446|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||April 2004|2004-04-01|December 2000||2000-12-01|||||Interventional|||Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder|Sertraline Treatment in Comorbid Post-Traumatic Stress Disorder and Alcoholism|Completed||Phase 2|||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:26:09.363229|2017-02-18 18:26:09.363229
NCT00000445|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||July 2003|2003-07-01|September 2002||2002-09-01|||||Interventional|||Use of Naltrexone in a Clinical Setting|Effectiveness of Naltrexone in a Community Setting|Completed||Phase 4|300||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:26:09.447912|2017-02-18 18:26:09.447912
NCT00000444|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-02-10|||September 1997||1997-09-01|January 2008|2008-01-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)|Timing of Smoking Intervention in Alcohol Treatment|Completed||Phase 4|500||Minneapolis Veterans Affairs Medical Center|||||f||||||||||||||2017-02-18 18:26:09.530492|2017-02-18 18:26:09.530492
NCT00000443|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01|April 2000||2000-04-01|||||Interventional|||Ondansetron Treatment for Alcoholism|Pharmacological Treatment for Alcoholism|Completed||Phase 2|||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:26:09.611872|2017-02-18 18:26:09.611872
NCT00000442|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2011-06-17||||||June 2011|2011-06-01|December 2002||2002-12-01|||||Interventional|||Naltrexone for Relapse Prevention|Etiology and Treatment of Alcohol Dependence|Completed||Phase 4|57||UConn Health|||||f||||||||||||||2017-02-18 18:26:09.696319|2017-02-18 18:26:09.696319
NCT00000441|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||August 2002|2002-08-01|December 2000||2000-12-01|||||Interventional|||Drug Therapy for Alcohol Detoxification|Carbamazepine and Lorazepam in Outpatient Detoxification|Completed||Phase 4|||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:26:09.782164|2017-02-18 18:26:09.782164
NCT00000440|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-06-23||||||November 2004|2004-11-01|September 2002||2002-09-01|||||Interventional|||Sertraline and Naltrexone for Alcohol Dependence|Sertraline and Naltrexone for Alcohol Dependents|Completed||Phase 2|124||National Institute on Alcohol Abuse and Alcoholism (NIAAA)|||||f||||||||||||||2017-02-18 18:26:09.858435|2017-02-18 18:26:09.858435
NCT00000439|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2009-02-24|||October 2000||2000-10-01|February 2009|2009-02-01|August 2003|Actual|2003-08-01|August 2003|Actual|2003-08-01||Interventional|||Drug Treatment for Alcoholics With Bipolar Disorder|Efficacy of Valproate Maintenance in Bipolar Alcoholics|Completed||Phase 2|72|Actual|National Institute on Alcohol Abuse and Alcoholism (NIAAA)||1|||f||||f||||||||||2017-02-18 18:26:09.937315|2017-02-18 18:26:09.937315
NCT00000438|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-05-13||||||May 2010|2010-05-01|March 2003||2003-03-01|||||Interventional|||Naltrexone Treatment for Alcoholism|Naltrexone Treatment for Alcoholism: Predicting Outcome|Completed||Phase 4|192||Johns Hopkins University|||||f||||f||||||||||2017-02-18 18:26:10.063712|2017-02-18 18:26:10.063712
NCT00000437|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2010-07-21||||||July 2010|2010-07-01|December 2003|Actual|2003-12-01|||||Interventional|||Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)|Nalmefene in Nicotine and Alcohol Dependence|Completed||Phase 4|166||The Scripps Research Institute|||||f||||||||||||||2017-02-18 18:26:10.148429|2017-02-18 18:26:10.148429
NCT00000436|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-29|2007-01-02|||July 1993||1993-07-01|March 2001|2001-03-01|June 2000||2000-06-01|||||Interventional|||Improving Functional Recovery After Hip Fracture|Self-Efficacy and High-Intensity Strength Training to Improve Postoperative Rehabilitation of Hip Fracture Patients|Completed||Phase 3|200||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:26:10.232481|2017-02-18 18:26:10.232481
NCT00000435|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2007-07-30|||September 1999||1999-09-01|July 2007|2007-07-01|September 2004||2004-09-01|||||Interventional|||dnaJ Peptide for Relieving Rheumatoid Arthritis|A Clinical Trial of Shared Epitope Peptides in Rheumatoid Arthritis (RA)|Completed||Phase 2|160|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||2|||||||||||||||||2017-02-18 18:26:10.339451|2017-02-18 18:26:10.339451
NCT00000434|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-21|2007-12-20|||December 1983||1983-12-01|December 2007|2007-12-01|September 2003|Actual|2003-09-01|September 2003|Actual|2003-09-01||Interventional|||Impact of Exercise on Older Persons With Osteoarthritis|Impact of Exercise on Older Persons With Osteoarthritis (OA)|Completed||Phase 2|217|Actual|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)||1|||f||||f||||||||||2017-02-18 18:26:10.461917|2017-02-18 18:26:10.461917
NCT00000433|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2007-01-02|||October 1999||1999-10-01|February 2003|2003-02-01|March 2002||2002-03-01|||||Interventional|||Blocking Tumor Necrosis Factor in Ankylosing Spondylitis|Anti-Tumor Necrosis Factor (TNFR:Fc) in Ankylosing Spondylitis|Completed||Phase 2|42||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:26:10.569362|2017-02-18 18:26:10.569362
NCT00000432|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2013-12-23|||April 1997||1997-04-01|December 2013|2013-12-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Lyme Disease Prevention Program|A Controlled Trial of a Primary and Secondary Program for Lyme Disease|Completed||Phase 3|20000||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 18:26:10.660588|2017-02-18 18:26:10.660588
NCT00000431|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2013-05-08|||January 2005||2005-01-01|March 2009|2009-03-01|March 2011|Actual|2011-03-01|July 2008|Actual|2008-07-01||Interventional|||Preliminary Testing of New Treatment for Chronic Leg Wounds|Phase I Trial to Evaluate the Safety of Platelet Derived Growth Factor B (PDGF-B) and a Limb Compression Bandage in Venous Leg Ulcers|Completed||Phase 1|24|Actual|University of Pennsylvania||1|||f||||t||||||||||2017-02-18 18:26:10.749827|2017-02-18 18:26:10.749827
NCT00000430|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2007-01-02|||October 1999||1999-10-01|February 2004|2004-02-01|September 2004||2004-09-01|||||Interventional|||Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis|Clinical Trial of Continuous Low-Dose Hormone Replacement Therapy Combined With Alendronate in Postmenopausal Women With Low Bone Density|Terminated||Phase 3|240||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:26:10.875539|2017-02-18 18:26:10.875539
NCT00000429|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2013-07-31|||June 1996||1996-06-01|July 2013|2013-07-01|May 2001||2001-05-01|||||Interventional|||Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis|Calcium Supplementation for Bone Mineralization in Juvenile Rheumatoid Arthritis (JRA)|Completed||Phase 2|192||Children's Hospital Medical Center, Cincinnati|||||f||||||||||||||2017-02-18 18:26:10.971353|2017-02-18 18:26:10.971353
NCT00000428|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2013-07-31|||September 2000||2000-09-01|July 2013|2013-07-01|March 2004|Actual|2004-03-01|March 2004|Actual|2004-03-01||Interventional|||Combining N-of-1 Trials to Assess Fibromyalgia Treatments|Combining N-of-1 Trials to Assess Fibromyalgia Therapies|Completed||Phase 4|58|Actual|Tufts Medical Center||1|||f||||t||||||||||2017-02-18 18:26:11.060207|2017-02-18 18:26:11.060207
NCT00000427|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2013-12-06|||September 1999||1999-09-01|December 2013|2013-12-01|October 2005|Actual|2005-10-01|October 2005|Actual|2005-10-01||Interventional|||Effects of Parathyroid Hormone in Men With Osteoporosis|Anabolic Actions of Parathyroid Hormone in Osteoporotic Men|Completed||Phase 3|81||Massachusetts General Hospital|||||f||||||||||||||2017-02-18 18:26:11.195871|2017-02-18 18:26:11.195871
NCT00000426|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-06-27|||January 1995||1995-01-01|June 2013|2013-06-01|June 2000||2000-06-01|||||Interventional|||Treatment of Calcium Deficiency in Young Women|Treatment of Calcium Deficiency in Young Women|Completed||Phase 2|150||Creighton University|||||f||||||||||||||2017-02-18 18:26:11.307712|2017-02-18 18:26:11.307712
NCT00000425|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-04-30|||July 1996||1996-07-01|April 2013|2013-04-01|April 2001||2001-04-01|||||Interventional|||Toward Better Outcomes in Osteoarthritis|Toward Better Outcomes in Osteoarthritis (OA): Finding the Appropriate Role for Nonsteroidal Anti-inflammatory Drugs (NSAIDs)|Completed||Phase 3|900||Stanford University|||||f||||||||||||||2017-02-18 18:26:11.418918|2017-02-18 18:26:11.418918
NCT00000424|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2006-12-28|||July 1995||1995-07-01|March 2001|2001-03-01|June 2001||2001-06-01|||||Interventional|||Tidal Lavage in Knee Osteoarthritis|Tidal Lavage vs. Sham Lavage in Knee Osteoarthritis (OA)|Completed||Phase 2|180||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:26:11.530616|2017-02-18 18:26:11.530616
NCT00000423|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-12-03|||September 1996||1996-09-01|March 2001|2001-03-01|February 2001||2001-02-01|||||Interventional|||Support, Health, and Fibromyalgia|Social Support and Health in Fibromyalgia|Completed||Phase 2|600||San Diego State University|||||f||||||||||||||2017-02-18 18:26:11.715632|2017-02-18 18:26:11.715632
NCT00000422|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-10-29|||July 1998||1998-07-01|October 2013|2013-10-01|May 2004|Actual|2004-05-01|May 2004|Actual|2004-05-01||Interventional|||Tailored Treatments of Fibromyalgia|Subgroups of FMS: Symptoms, Beliefs and Tailored Treatments|Completed||Phase 2/Phase 3|312||University of Washington|||||f||||||||||||||2017-02-18 18:26:11.803846|2017-02-18 18:26:11.803846
NCT00000421|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2016-03-02|||September 1997||1997-09-01|March 2016|2016-03-01|August 2003|Actual|2003-08-01|August 2002|Actual|2002-08-01||Interventional|SACS-SLE||Serologically Active, Clinically Stable Systemic Lupus Erythematosus|Serologically Active, Clinically Stable Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|154|Actual|New York University School of Medicine||2|||f||||f||||||||||2017-02-18 18:26:11.906218|2017-02-18 18:26:11.906218
NCT00000420|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-05-01|||June 1997||1997-06-01|May 2013|2013-05-01|August 2003||2003-08-01|||||Interventional|||Safety of Estrogens in Lupus: Birth Control Pills|Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Oral Contraceptives|Completed||Phase 3|350||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:26:12.024669|2017-02-18 18:26:12.024669
NCT00000419|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-05-01|||April 1996||1996-04-01|May 2013|2013-05-01|August 2002||2002-08-01|||||Interventional|||Safety of Estrogens in Lupus: Hormone Replacement Therapy|Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Hormone Replacement Therapy|Terminated||Phase 3|350||New York University School of Medicine|||||||||||||||||||2017-02-18 18:26:12.138669|2017-02-18 18:26:12.138669
NCT00000418|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-06-04|||September 1977||1977-09-01|June 1999|1999-06-01|March 2001||2001-03-01|||||Interventional|||Psychosocial Treatment for Acute Low Back Pain|Psychosocial Intervention for Acute Low Back Pain (ALBP)|Completed||Phase 2|211||Indiana University|||||f||||||||||||||2017-02-18 18:26:12.24856|2017-02-18 18:26:12.24856
NCT00000417|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-12-23|||April 1997||1997-04-01|December 2013|2013-12-01|March 2001|Actual|2001-03-01|March 2001|Actual|2001-03-01||Interventional|||Psychoeducational Approach to Improve Health in Lupus|A Randomized Controlled Trial of a Psychoeducational Intervention to Improve Outcomes in Systemic Lupus Erythematosus (SLE)|Completed||Phase 2|150||Brigham and Women's Hospital|||||f||||||||||||||2017-02-18 18:26:12.354223|2017-02-18 18:26:12.354223
NCT00000416|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-07-31|||September 1997||1997-09-01|July 2013|2013-07-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Prevention of Arthritis-Related Work Disability|Prevention of Arthritis-Related Work Disability: A Trial of Job Retention Services Provided to Employed Persons With Arthritis|Completed||N/A|242|Actual|Boston University||2|||f||||f||||||||||2017-02-18 18:26:12.449239|2017-02-18 18:26:12.449239
NCT00000415|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-06-03|||April 1998||1998-04-01|June 2013|2013-06-01|March 2003|Actual|2003-03-01|February 2003|Actual|2003-02-01||Interventional|||Physical Activity, Calcium, and Bone in Children|Calcium Modifies Bone Response to Activity in Children|Completed||Phase 2|224||South Dakota State University|||||f||||||||||||||2017-02-18 18:26:12.559384|2017-02-18 18:26:12.559384
NCT00000414|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-06-19|||July 1996||1996-07-01|November 2004|2004-11-01|April 2001|Actual|2001-04-01|April 2001|Actual|2001-04-01||Interventional|||Patient Education in Rheumatoid Arthritis and Osteoarthritis|Patient Education Strategies for Better Outcomes in Rheumatoid Arthritis (RA) and Osteoarthritis (OA)|Completed||N/A|1200|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 18:26:15.681166|2017-02-18 18:26:15.681166
NCT00000413|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2006-12-28|||July 1998||1998-07-01|February 2003|2003-02-01|June 2002||2002-06-01|||||Interventional|||Osteoporosis Prevention in Preadolescent Girls|Osteoporosis Prevention in Preadolescent Girls|Completed||Phase 2|340||National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|||||f||||||||||||||2017-02-18 18:26:15.808705|2017-02-18 18:26:15.808705
NCT00000412|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2015-07-02|||September 1997||1997-09-01|July 2015|2015-07-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Osteoporosis Prevention After Heart Transplant|Prevention of Osteoporosis After Cardiac Transplantation|Completed||Phase 3|149|Actual|Columbia University||2|||f||||||||||||||2017-02-18 18:26:15.898396|2017-02-18 18:26:15.898396
NCT00000411|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2015-08-03|||March 2000||2000-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|||Spine Patient Outcomes Research Trial (SPORT): Spinal Stenosis|Spine Patient Outcomes Research Trial (SPORT): A Multicenter Trial for Spinal Stenosis (SpS)|Completed||Phase 4|289|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 18:26:16.017821|2017-02-18 18:26:16.017821
NCT00000410|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2015-08-03|||March 2000||2000-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SPORT||Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation|Spine Patient Outcomes Research Trial (SPORT): A Multicenter Randomized Trial for Intervertebral Disc Herniation (IDH)|Completed||Phase 4|501|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 18:26:16.156955|2017-02-18 18:26:16.156955
NCT00000409|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2015-08-03|||March 2000||2000-03-01|August 2015|2015-08-01|April 2015|Actual|2015-04-01|April 2015|Actual|2015-04-01||Interventional|SPORT||Spine Patient Outcomes Research Trial (SPORT): Degenerative Spondylolisthesis With Spinal Stenosis|Spine Patient Outcomes Research Trial (SPORT): A Multicenter Randomized Trial for Degenerative Spondylolisthesis (DS) With Spinal Stenosis (SpS) at L4/L5 Level.|Completed||Phase 4|304|Actual|Dartmouth-Hitchcock Medical Center||2|||f||||t||||||||||2017-02-18 18:26:16.297809|2017-02-18 18:26:16.297809
NCT00000408|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-04-30|||February 1998||1998-02-01|February 2003|2003-02-01|February 2002|Actual|2002-02-01|February 2002|Actual|2002-02-01||Interventional|||Low Back Pain Patient Education Evaluation|Evaluation of a Low Back Pain Patient Education Program|Completed||N/A|580|Actual|Stanford University||2|||f||||f||||||||||2017-02-18 18:26:16.430356|2017-02-18 18:26:16.430356
NCT00000407|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2016-01-05|||January 1997||1997-01-01|September 2015|2015-09-01|December 2001||2001-12-01|||||Interventional|||Improving Vocational Outcomes in Arthritis|Improving Vocational Outcomes in Arthritis|Completed||Phase 2|326|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-02-18 18:26:16.817874|2017-02-18 18:26:16.817874
NCT00000406|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-04-29|||September 1977||1977-09-01|April 2013|2013-04-01|November 2006|Actual|2006-11-01|November 2006|Actual|2006-11-01||Interventional|||Effects of Strength Training on Knee Osteoarthritis|Effects of Strength Training on Knee Osteoarthritis (OA)|Completed||Phase 2|280||Indiana University|||||f||||||||||||||2017-02-18 18:26:16.931301|2017-02-18 18:26:16.931301
NCT00000405|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2016-06-07|||September 1998||1998-09-01|June 2016|2016-06-01|November 2008|Actual|2008-11-01|June 2008|Actual|2008-06-01||Interventional|||Effects of Jumping on Growing Bones|The Effects of Jumping on Growing Bones|Completed||Phase 2|200||Oregon State University|||||f||||||||||||||2017-02-18 18:26:17.026841|2017-02-18 18:26:17.026841
NCT00000404|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-04-29|||April 1997||1997-04-01|April 2013|2013-04-01|March 2001||2001-03-01|||||Interventional|||Effects of Comprehensive Care for Knee OA|Effects of Comprehensive Care for Knee Osteoarthritis (OA)|Completed||Phase 2|300||Indiana University|||||f||||||||||||||2017-02-18 18:26:17.12955|2017-02-18 18:26:17.12955
NCT00000403|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-04-29|||September 1996||1996-09-01|April 2013|2013-04-01|July 2001||2001-07-01|||||Interventional|||Doxycycline and OA Progression|Effect of Doxycycline on Osteoarthritis (OA) Progression|Completed||Phase 3|432||Indiana University|||||||||||||||||||2017-02-18 18:26:17.229509|2017-02-18 18:26:17.229509
NCT00000402|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-05-21|||August 1991||1991-08-01|May 2013|2013-05-01|December 2001||2001-12-01|||||Interventional|||Calcium and Bone Mass in Young Females|Long Term Effects of Calcium on Bone Mass in Young Females|Completed||Phase 2|354||Ohio State University|||||f||||||||||||||2017-02-18 18:26:17.340607|2017-02-18 18:26:17.340607
NCT00000401|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-05-28|||July 1999||1999-07-01|May 2013|2013-05-01|August 2005|Actual|2005-08-01|August 2005|Actual|2005-08-01||Interventional|||Oral Collagen for Rheumatoid Arthritis|Open Label Multicenter Induction of CII Tolerance in Patients With Rheumatoid Arthritis|Completed||Phase 2|110|Actual|University of Tennessee||2|||t||||t||||||||||2017-02-18 18:26:17.45251|2017-02-18 18:26:17.45251
NCT00000400|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-12-06|||August 1999||1999-08-01|December 2013|2013-12-01|June 2006|Actual|2006-06-01|April 2006|Actual|2006-04-01||Interventional|||Alendronate and/or Parathyroid Hormone for Osteoporosis|Bone Formation-Resorption Coupling and Osteoporosis|Completed||Phase 2|176|Actual|Massachusetts General Hospital||3|||f||||t||||||||||2017-02-18 18:26:17.573697|2017-02-18 18:26:17.573697
NCT00000399|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-05-17|||August 1995||1995-08-01|May 2013|2013-05-01|January 2001||2001-01-01|||||Interventional|||Bone Estrogen Strength Training|Bone Estrogen Strength Training (BEST)|Completed||Phase 2|300||University of Arizona|||||f||||||||||||||2017-02-18 18:26:17.702774|2017-02-18 18:26:17.702774
NCT00000398|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-11-26|||July 1996||1996-07-01|June 2000|2000-06-01|June 2000||2000-06-01|||||Interventional|||Behavioral Treatment of Fibromyalgia|Behavioral Treatment of Fibromyalgia|Completed||Phase 2|180||Ohio University|||||f||||||||||||||2017-02-18 18:26:17.796153|2017-02-18 18:26:17.796153
NCT00000397|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2014-07-18|||July 1999||1999-07-01|December 2005|2005-12-01|September 2004|Actual|2004-09-01|||||Interventional|||Behavioral Insomnia Therapy for Fibromyalgia|Behavioral Insomnia Therapy for Fibromyalgia Patients|Completed||N/A|106|Actual|Duke University|||||f||||||||||||||2017-02-18 18:26:17.883351|2017-02-18 18:26:17.883351
NCT00000396|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-06-08|||September 1997||1997-09-01|June 2013|2013-06-01|October 2002|Actual|2002-10-01|March 2001|Actual|2001-03-01||Interventional|||Arthritis Patient Education for Urban African Americans|Evaluating/Reinforcing Arthritis Patient Education for Urban African Americans|Completed||N/A|90|Actual|University of Michigan||1|||f||||f||||||||||2017-02-18 18:26:17.975772|2017-02-18 18:26:17.975772
NCT00000395|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2016-12-14|||September 1996||1996-09-01|June 2013|2013-06-01|August 2002|Actual|2002-08-01|August 2002|Actual|2002-08-01||Interventional|||Antifolate Effectiveness in Arthritis|Mechanisms of Antifolate Efficacy in Arthritis|Completed||Phase 2|40|Actual|University of Alabama at Birmingham||2|||f||||||||||||||2017-02-18 18:26:18.079986|2017-02-18 18:26:18.079986
NCT00000394|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2013-05-14|||May 1999||1999-05-01|June 2000|2000-06-01|January 2002||2002-01-01|||||Interventional|||Acupuncture for Carpal Tunnel Syndrome|A Controlled Trial of Acupuncture for Carpal Tunnel Syndrome|Completed||Phase 2|144||George Washington University|||||f||||||||||||||2017-02-18 18:26:18.193407|2017-02-18 18:26:18.193407
NCT00000393|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2015-02-26|||January 1988||1988-01-01|April 2002|2002-04-01||||January 1990|Actual|1990-01-01||Interventional|||A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).||Completed||Phase 1|6|Actual|National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:26:18.266114|2017-02-18 18:26:18.266114
NCT00000392|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2015-07-29|2015-07-17||January 1990||1990-01-01|October 2013|2013-10-01|August 1996|Actual|1996-08-01|August 1996|Actual|1996-08-01||Interventional|||Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.|Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.|Completed||Phase 2|215|Actual|National Institute of Mental Health (NIMH)||2|||f||||||||||||||2017-02-18 18:26:18.360434|2017-02-18 18:26:18.360434
NCT00000391|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2015-03-02|||January 1988||1988-01-01|April 2002|2002-04-01||||January 1990|Actual|1990-01-01||Interventional|||A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.||Completed||Phase 1|30|Actual|National Institute of Mental Health (NIMH)||1|||f||||||||||||||2017-02-18 18:26:18.774979|2017-02-18 18:26:18.774979
NCT00000390|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-17|2015-04-22||||||April 2000|2000-04-01||||||||Interventional|||Antidepressant Treatment of AIDS Related Depression.||Completed||Phase 2|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:26:18.860673|2017-02-18 18:26:18.860673
NCT00000389|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-06-13|||October 1996||1996-10-01|November 2005|2005-11-01|November 1999||1999-11-01|||||Interventional|||Treatment for Anxiety in Children|Research Unit on Pediatric Psychopharmacology Anxiety Treatment Study|Completed||Phase 3|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:26:19.216694|2017-02-18 18:26:19.216694
NCT00000388|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-09-28|||September 1998||1998-09-01|September 2015|2015-09-01|November 1999||1999-11-01|||||Interventional|MTA||Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)|Multimodal Treatment Study of Children With ADHD|Completed||Phase 4|||New York University School of Medicine|||||f||||||||||||||2017-02-18 18:26:19.314014|2017-02-18 18:26:19.314014
NCT00000387|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2007-12-26|||April 1998||1998-04-01|December 2007|2007-12-01|January 2005|Actual|2005-01-01|January 2005|Actual|2005-01-01||Interventional|FamCent||Self-Management Therapy for Youth With Schizophrenia|Self-Management Therapy for Youth With Schizophrenia|Completed||Phase 3|40|Actual|National Institute of Mental Health (NIMH)||2|||f||||f||||||||||2017-02-18 18:26:19.434444|2017-02-18 18:26:19.434444
NCT00000386|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2008-02-08|||December 1998||1998-12-01|February 2008|2008-02-01|November 2003||2003-11-01|||||Interventional|||Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)|Behavior Therapy for Childhood OCD|Completed||Phase 3|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:26:19.545403|2017-02-18 18:26:19.545403
NCT00000385|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-11-25|||September 1997||1997-09-01|November 2013|2013-11-01|June 2005|Actual|2005-06-01|December 2003|Actual|2003-12-01||Interventional|||Long-Term Lithium Treatment for Aggressive Conduct Disorder|Long-Term Lithium for Aggressive Conduct Disorder|Completed||Phase 3|59|Actual|Drexel University||2|||f||||f||||||||||2017-02-18 18:26:19.637501|2017-02-18 18:26:19.637501
NCT00000384|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2016-08-19|||May 1997||1997-05-01|November 2005|2005-11-01|April 2002||2002-04-01|||||Interventional|||Treatment of Obsessive-Compulsive Disorder (OCD) in Children|Treatment of Pediatric Obsessive-Compulsive Disorder|Completed||Phase 3|||University of Pennsylvania|||||f||||||||||||||2017-02-18 18:26:19.754415|2017-02-18 18:26:19.754415
NCT00000383|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-03-27|||September 1997||1997-09-01|March 2015|2015-03-01|September 2002|Actual|2002-09-01|September 2001|Actual|2001-09-01||Interventional|||Treatment of Post-Traumatic Stress Disorder (PTSD) in Sexually Abused Children|Treatment of PTSD in Sexually Abused Children|Completed||N/A|229|Actual|Allegheny Singer Research Institute||2|||f||||t||||||||||2017-02-18 18:26:19.855896|2017-02-18 18:26:19.855896
NCT00000382|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-11-05|||July 1998||1998-07-01|November 2013|2013-11-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Preventing Child Abuse in Infants|Preventive Intervention for Maltreated Infants|Completed||Phase 3|||University of Rochester|||||f||||t||||||||||2017-02-18 18:26:19.978173|2017-02-18 18:26:19.978173
NCT00000381|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-01-07|||June 1997||1997-06-01|December 2005|2005-12-01|May 2003|Actual|2003-05-01|May 2003|Actual|2003-05-01||Interventional|||Fluoxetine for Anxious Children||Completed||Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:26:20.064399|2017-02-18 18:26:20.064399
NCT00000380|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-12-01|||June 1996||1996-06-01|December 2015|2015-12-01|July 2007||2007-07-01|July 2007|Actual|2007-07-01||Interventional|||Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances|Age-Related Sleep Impairment - Treatment w/GHRH|Completed||N/A|||University of Washington||2|||f||||||||||||||2017-02-18 18:26:20.176123|2017-02-18 18:26:20.176123
NCT00000379|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-02-19|||January 1999||1999-01-01|February 2014|2014-02-01|December 2003||2003-12-01|||||Interventional|||Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)|Treatment of Outcomes of Fluoxetine vs EMDR in PTSD|Completed||Phase 3|||Boston University|||||f||||||||||||||2017-02-18 18:26:20.289758|2017-02-18 18:26:20.289758
NCT00000378|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-10-06|2015-04-02||July 1997||1997-07-01|September 2008|2008-09-01|June 2002|Actual|2002-06-01|June 2002|Actual|2002-06-01||Interventional|||Antidepressant Treatment of Melancholia in Late Life|Antidepressant Treatment of Melancholia in Late :Ife|Completed||Phase 4|110|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 18:26:20.398487|2017-02-18 18:26:20.398487
NCT00000377|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-06-20|||March 1989||1989-03-01|June 2013|2013-06-01|April 2000|Actual|2000-04-01|April 2000|Actual|2000-04-01||Interventional|||Preventing the Return of Depression in Elderly Patients|Maintenance Therapies in Late-Life Depression|Completed||N/A|||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:26:20.81395|2017-02-18 18:26:20.81395
NCT00000376|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2015-10-09|||March 1996||1996-03-01|December 2005|2005-12-01|February 1999||1999-02-01|||||Interventional|||Cognitive and Drug Therapy for Drug-Resistant Depression||Completed||N/A|||University of Pennsylvania|||||f||||||||||||||2017-02-18 18:26:20.909511|2017-02-18 18:26:20.909511
NCT00000375|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2005-12-19|||February 1997||1997-02-01|December 2005|2005-12-01||||||||Interventional|||Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder|Continuation ECT Vs Pharmacotherapy--Efficacy And Safety|Completed||Phase 4|||National Institute of Mental Health (NIMH)|||||f||||||||||||||2017-02-18 18:26:20.997989|2017-02-18 18:26:20.997989
NCT00000374|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-01-12|||September 1998||1998-09-01|January 2012|2012-01-01|May 2007|Actual|2007-05-01|May 2007|Actual|2007-05-01||Interventional|||Treatment for First-Episode Schizophrenia|Preventing Morbidity in First-Episode Schizophrenia|Completed||Phase 4|125|Actual|Northwell Health||1|||f||||t||||||||||2017-02-18 18:26:21.088866|2017-02-18 18:26:21.088866
NCT00000373|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-11-26|||September 1992||1992-09-01|November 2013|2013-11-01|July 2003|Actual|2003-07-01|January 2003|Actual|2003-01-01||Interventional|||Treatment of Obsessive-Compulsive Disorder|Neurobiology/Treatment of Obsessive-Compulsive Disorder|Completed||Phase 4|74|Actual|University of Florida||2|||f||||f||||||||||2017-02-18 18:26:21.195279|2017-02-18 18:26:21.195279
NCT00000372|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-06-11|||March 1998||1998-03-01|June 2014|2014-06-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||Glycine and D-Cycloserine in Schizophrenia|A Placebo Controlled Trial of Glycine Added to Clozapine in Schizophrenia|Withdrawn||Phase 3|0|Actual|Massachusetts General Hospital||3||"Pairing D-Cycloserine with Clozapine was found to worsen negative side effects in patients~   with Schizophrenia, so the study was suspended."|f||||||||||||||2017-02-18 18:26:21.31282|2017-02-18 18:26:21.31282
NCT00000371|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-09-03|2014-08-11||August 1996||1996-08-01|September 2014|2014-09-01|April 2002|Actual|2002-04-01|April 2002|Actual|2002-04-01||Interventional|||Trial of D-Cycloserine in Schizophrenia|A Six Month, Placebo-Controlled Trial of D-Cycloserine Co-Administered With Conventional Antipsychotics in Schizophrenia Patients|Completed||Phase 3|60|Actual|Massachusetts General Hospital|A biased sample may have been produced by restricting the analysis to patients with prominent negative symptoms receiving conventional agents (less compliant with study medication). Additionally, Adverse Event data was lost for the study.|2|||f||||||||||||||2017-02-18 18:26:21.423142|2017-02-18 18:26:21.423142
NCT00000370|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-08-05|||May 1998||1998-05-01|August 2013|2013-08-01|February 2003||2003-02-01|||||Interventional|||Treatment of Social Phobia|Treatment of Social Phobia: Mediators And Moderators|Completed||N/A|||Boston University|||||f||||||||||||||2017-02-18 18:26:21.787387|2017-02-18 18:26:21.787387
NCT00000369|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-06-21|||June 1997||1997-06-01|February 2008|2008-02-01|December 2002|Actual|2002-12-01|||||Interventional|||Maintenance Therapies in Bipolar Disorders||Completed||Phase 3|||University of Pittsburgh|||||f||||||||||||||2017-02-18 18:26:21.888692|2017-02-18 18:26:21.888692
NCT00000368|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2014-03-17|||February 1999||1999-02-01|March 2014|2014-03-01|July 2004|Actual|2004-07-01|July 2004|Actual|2004-07-01||Interventional|||Treatment of Panic Disorder: Long Term Strategies|Treatment of Panic Disorder: Long Term Strategies|Completed||Phase 3|379|Actual|New York State Psychiatric Institute|||||f||||t||||||||||2017-02-18 18:26:21.977094|2017-02-18 18:26:21.977094
NCT00000367|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2013-10-25|||September 1998||1998-09-01|October 2013|2013-10-01|August 2003||2003-08-01|||||Interventional|||Prevention of Suicide in the Elderly||Completed||N/A|||Weill Medical College of Cornell University|||||f||||||||||||||2017-02-18 18:26:22.089877|2017-02-18 18:26:22.089877
NCT00000363|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2006-04-21||||||April 2006|2006-04-01|June 2001||2001-06-01|||||Interventional|||Acute Otitis Media: Adjuvant Therapy to Improve Outcome||Completed||Phase 3|||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-02-18 18:26:22.178221|2017-02-18 18:26:22.178221
NCT00000362|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2006-04-21||||||April 2006|2006-04-01|January 2006||2006-01-01|||||Interventional|||Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects||Terminated||Phase 3|600||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-02-18 18:26:22.265809|2017-02-18 18:26:22.265809
NCT00000361|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2006-04-21|||March 1998||1998-03-01|April 2006|2006-04-01|November 2002||2002-11-01|||||Interventional|||Autoimmunity in Inner Ear Disease||Terminated||Phase 3|||National Institute on Deafness and Other Communication Disorders (NIDCD)|||||f||||||||||||||2017-02-18 18:26:22.342577|2017-02-18 18:26:22.342577
NCT00000359|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-02|2012-07-25|||October 1998||1998-10-01|July 2012|2012-07-01|June 2003|Actual|2003-06-01|June 2003|Actual|2003-06-01||Interventional|||Treatments for Benign Paroxysmal Positional Vertigo (BPPV)|Treatments for Benign Paroxysmal Positional Vertigo (BPPV)|Completed||Phase 2|150|Actual|Baylor College of Medicine||5|||f||||f||||||||||2017-02-18 18:26:22.69625|2017-02-18 18:26:22.69625
NCT00000358|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11||||||December 2002|2002-12-01||||||||Interventional|||Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7|Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:22.810782|2017-02-18 18:26:22.810782
NCT00000161|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||August 1993||1993-08-01|September 2001|2001-09-01||||||||Interventional|||Randomized Trials of Vitamin Supplements and Eye Disease||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:22.895646|2017-02-18 18:26:22.895646
NCT00000160|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-06-01|||January 1972||1972-01-01|October 2003|2003-10-01||||||||Interventional|||Diabetic Retinopathy Study (DRS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:22.980696|2017-02-18 18:26:22.980696
NCT00000159|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||August 1983||1983-08-01|October 1999|1999-10-01||||||||Interventional|||Sorbinil Retinopathy Trial (SRT)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.059469|2017-02-18 18:26:23.059469
NCT00000158|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||February 1979||1979-02-01|June 2002|2002-06-01||||||||Interventional|||Macular Photocoagulation Study (MPS)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.1413|2017-02-18 18:26:23.1413
NCT00000157|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||April 1982||1982-04-01|September 2009|2009-09-01|January 1988|Actual|1988-01-01|||||Interventional|||Randomized Trial of Aspirin and Cataracts in U.S. Physicians||Terminated||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.235369|2017-02-18 18:26:23.235369
NCT00000156|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-06-02|||July 1995||1995-07-01|October 2003|2003-10-01||||||||Interventional|||The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.31594|2017-02-18 18:26:23.31594
NCT00000155|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||June 1995||1995-06-01|November 2001|2001-11-01||||||||Observational|||The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study||Unknown status|Active, not recruiting|N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.408621|2017-02-18 18:26:23.408621
NCT00000154|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||October 1976||1976-10-01|October 1999|1999-10-01||||||||Interventional|||Diabetic Retinopathy Vitrectomy Study (DRVS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.503924|2017-02-18 18:26:23.503924
NCT00000153|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||December 1984||1984-12-01|October 1999|1999-10-01||||||||Interventional|||Krypton-Argon Regression of Neovascularization Study (KARNS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.585685|2017-02-18 18:26:23.585685
NCT00000152|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||April 1982||1982-04-01|September 2001|2001-09-01||||||||Interventional|||Randomized Trial of Beta-Carotene and Macular Degeneration||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.65937|2017-02-18 18:26:23.65937
NCT00000151|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-09-01|||December 1979||1979-12-01|October 2003|2003-10-01||||||||Interventional|||Early Treatment Diabetic Retinopathy Study (ETDRS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.742698|2017-02-18 18:26:23.742698
NCT00000150|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||January 1999||1999-01-01|September 2009|2009-09-01|September 2001||2001-09-01|||||Interventional|||Submacular Surgery Trials (SST)|Submacular Surgery Trials (SST)|Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:23.824144|2017-02-18 18:26:23.824144
NCT00000147|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-05-26|||July 1988||1988-07-01|October 1999|1999-10-01||||||||Interventional|||Longitudinal Optic Neuritis Study (LONS)||Unknown status|Active, not recruiting|N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:24.070266|2017-02-18 18:26:24.070266
NCT00000146|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-06-02|||July 1988||1988-07-01|October 2003|2003-10-01||||||||Interventional|||Optic Neuritis Treatment Trial (ONTT)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:24.179762|2017-02-18 18:26:24.179762
NCT00000145|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-01-21|||September 1990||1990-09-01|January 2009|2009-01-01|December 2006|Actual|2006-12-01|October 2001|Actual|2001-10-01||Interventional|||Age-Related Eye Disease Study (AREDS)|Age-Related Eye Disease Study (AREDS)|Completed||Phase 3|4757|Actual|National Eye Institute (NEI)||4|||f||||t||||||||||2017-02-18 18:26:24.295292|2017-02-18 18:26:24.295292
NCT00000144|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-06-02|||January 1984||1984-01-01|October 2003|2003-10-01||||||||Interventional|||Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:24.412632|2017-02-18 18:26:24.412632
NCT00000143|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2016-02-18|2015-07-01||May 1997||1997-05-01|July 2015|2015-07-01|June 2000|Actual|2000-06-01|June 2000|Actual|2000-06-01||Interventional|GCCRT||Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)|Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)|Completed||Phase 3|61|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||Yes||2017-02-18 18:26:24.492429|2017-02-18 18:26:24.492429
NCT00000142|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2015-10-14|2015-06-02||April 1994||1994-04-01|July 2015|2015-07-01|February 1996|Actual|1996-02-01|February 1996|Actual|1996-02-01||Interventional|HPCRT||Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)|Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)|Completed||Phase 2/Phase 3|64|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-02-18 18:26:24.857432|2017-02-18 18:26:24.857432
NCT00000140|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||September 1985||1985-09-01|October 1999|1999-10-01||||||||Interventional|||The Silicone Study||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:25.267803|2017-02-18 18:26:25.267803
NCT00000139|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2010-03-23|||October 1992||1992-10-01|September 2009|2009-09-01||||||||Interventional|||Herpetic Eye Disease Study (HEDS) II||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:25.341841|2017-02-18 18:26:25.341841
NCT00000357|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||June 1992||1992-06-01|December 1993|1993-12-01|October 1993|Actual|1993-10-01|August 1993|Actual|1993-08-01||Interventional|||Buprenorphine Maintenance for Opiate Dependence - 6|Buprenorphine Maintenance for Opiate Dependence|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:25.443466|2017-02-18 18:26:25.443466
NCT00000356|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||June 1991||1991-06-01|February 1992|1992-02-01|October 1992|Actual|1992-10-01|August 1992|Actual|1992-08-01||Interventional|||Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5|Pharmacokinetics of LAAM in Methadone Patients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:25.523857|2017-02-18 18:26:25.523857
NCT00000355|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||November 1994||1994-11-01|May 1995|1995-05-01|March 1996|Actual|1996-03-01|January 1996|Actual|1996-01-01||Interventional|||Effects of Buprenorphine and Naloxone in Opiate Addicts - 4|Effects of Buprenophine and Naloxone in Opiate Addicts|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:25.606604|2017-02-18 18:26:25.606604
NCT00000354|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||July 1996||1996-07-01|July 1996|1996-07-01|December 1997|Actual|1997-12-01|September 1997|Actual|1997-09-01||Interventional|||Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3|Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:25.686476|2017-02-18 18:26:25.686476
NCT00000138|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||May 1989||1989-05-01|September 2009|2009-09-01||||||||Interventional|||Herpetic Eye Disease Study (HEDS) I||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:25.761986|2017-02-18 18:26:25.761986
NCT00000137|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||May 1986||1986-05-01|September 2009|2009-09-01|September 1989|Actual|1989-09-01|||||Interventional|||Collaborative Corneal Transplantation Studies (CCTS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:25.839058|2017-02-18 18:26:25.839058
NCT00000353|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-17|||October 1996||1996-10-01|December 2002|2002-12-01|October 1997|Actual|1997-10-01|September 1997|Actual|1997-09-01||Interventional|||Trial of Buprenorphine/Naloxone for Opiate Dependence - 2|Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:25.905231|2017-02-18 18:26:25.905231
NCT00000352|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||December 1996||1996-12-01|August 1997|1997-08-01|April 1998|Actual|1998-04-01|February 1998|Actual|1998-02-01||Interventional|||Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1|Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:25.985761|2017-02-18 18:26:25.985761
NCT00000351|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-10||||||December 2002|2002-12-01||||||||Observational|||Cognitive Correlates of Substance Abuse, Part 2 - 16|Cognitive Correlates of Substance Abuse, Part 2|Unknown status|Active, not recruiting|Phase 4|43||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:26.063456|2017-02-18 18:26:26.063456
NCT00000350|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-10|||March 1999||1999-03-01|March 1999|1999-03-01||||||||Interventional|||Effects of Stimulant Dependence on Human Striatal Dopamine System - 15|Effects of Stimulant Dependence on Human Striatal Dopamine System|Unknown status|Active, not recruiting|Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:26.135272|2017-02-18 18:26:26.135272
NCT00000349|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-10||||||December 2002|2002-12-01||||||||Interventional|||Infusion Laboratory: Protocol 5 (Flupenthixol) - 14|Infusion Laboratory: Protocol 5 (Flupenthixol)|Unknown status|Active, not recruiting|Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:26.496144|2017-02-18 18:26:26.496144
NCT00000348|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-10||||||December 2002|2002-12-01||||||||Interventional|||Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13|Infusion Laboratory: Protocol 4 (Dihydrexidine)|Unknown status|Active, not recruiting|Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:26.596502|2017-02-18 18:26:26.596502
NCT00000347|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||July 1997||1997-07-01|March 1998|1998-03-01|September 1998|Actual|1998-09-01|August 1998|Actual|1998-08-01||Interventional|||Risperidone for Treatment of Cocaine Dependence in Outpatients - 12|Risperidone for Treatment of Cocaine Dependence in Outpatients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:26.686484|2017-02-18 18:26:26.686484
NCT00000346|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-10||||||December 2002|2002-12-01||||||||Interventional|||Cognitive Correlates of Substance Abuse - 11|Cognitive Correlates of Substance Abuse, Part 1|Unknown status|Active, not recruiting|Phase 4|80||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:26.771859|2017-02-18 18:26:26.771859
NCT00000345|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||April 1996||1996-04-01|September 1997|1997-09-01||||||||Interventional|||Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10|Evaluation of Lofexidine for Treatment of Opiate Withdrawal|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:26.854019|2017-02-18 18:26:26.854019
NCT00000344|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11||||||August 2008|2008-08-01|August 2000|Actual|2000-08-01|||||Interventional|||Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9|Trial of Buprenorphine/Naloxone for Treatment of Opiate Dependence|Completed||Phase 2|40||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:26.941577|2017-02-18 18:26:26.941577
NCT00000343|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||April 1996||1996-04-01|April 1996|1996-04-01||||||||Interventional|||Brain Changes in Stimulant Dependent Subjects - 8|Brain Changes in Stimulant Dependent Subjects|Completed||Phase 4|90||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:27.034757|2017-02-18 18:26:27.034757
NCT00000342|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-13|||July 1996||1996-07-01|June 1997|1997-06-01|September 1997|Actual|1997-09-01|August 1997|Actual|1997-08-01||Interventional|||Risperidone for the Treatment of Cocaine Dependence - 7|Risperidone for the Treatment of Cocaine Dependence|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:27.124758|2017-02-18 18:26:27.124758
NCT00000341|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||August 1996||1996-08-01|August 2008|2008-08-01|August 2000|Actual|2000-08-01|||||Interventional|||Evaluation of Liquid vs. Tablet Buprenorphine - 6|Pharmacokinetics and Bioavailability of Liquid vs Tablet Buprenorphine|Completed||Phase 2|1||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:27.209441|2017-02-18 18:26:27.209441
NCT00000340|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||June 1996||1996-06-01|August 2008|2008-08-01||||||||Interventional|||Pemoline in the Treatment of Stimulant Dependence - 5|Pemoline in the Treatment of Stimulant Dependence|Withdrawn||Phase 2|0|Actual|National Institute on Drug Abuse (NIDA)||||Study was never funded.|f||||||||||||||2017-02-18 18:26:27.301329|2017-02-18 18:26:27.301329
NCT00000339|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-10|||June 1996||1996-06-01|June 1996|1996-06-01||||||||Interventional|||Infusion Laboratory: Protocol 3 (Risperidone) - 4|Infusion Laboratory: Protocol 3 (Risperidone)|Unknown status|Active, not recruiting|Phase 1|13||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:27.385041|2017-02-18 18:26:27.385041
NCT00000338|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-10|||March 1996||1996-03-01|March 1996|1996-03-01||||||||Interventional|||Infusion Laboratory: Protocol 2 (Lisuride) - 3|Infusion Laboratory: Protocol 2 (Lisuride)|Unknown status|Active, not recruiting|Phase 1|2||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:27.489828|2017-02-18 18:26:27.489828
NCT00000337|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||November 1994||1994-11-01|August 1996|1996-08-01||||||||Interventional|||Infusion Laboratory: Protocol 1 - Selegeline - 2|Infusion Laboratory: Protocol 1 - Selegeline|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:27.575569|2017-02-18 18:26:27.575569
NCT00000336|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-13|||January 1995||1995-01-01|January 1996|1996-01-01|March 1996|Actual|1996-03-01|February 1996|Actual|1996-02-01||Interventional|||Selegiline in Outpatient Treatment for Cocaine Dependence - 1|Safety and Efficacy of Selegiline in Outpatient Treatment for Cocaine|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:27.671605|2017-02-18 18:26:27.671605
NCT00000335|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-30|||September 30, 1995|Actual|1995-09-30|December 2002|2002-12-01|May 20, 1996|Actual|1996-05-20|March 20, 1996|Actual|1996-03-20||Interventional|||Activity Monitoring Assessment of Opiate Withdrawal - 4|Activity Monitoring Assessment of Opiate Withdrawal|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:27.757592|2017-02-18 18:26:27.757592
NCT00000136|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2015-09-22|2015-06-22||March 1990||1990-03-01|July 2015|2015-07-01|October 1991|Actual|1991-10-01|October 1991|Actual|1991-10-01||Interventional|FGCRT||Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)|Foscarnet-Ganciclovir CMV Retinitis Trial|Completed||Phase 3|234|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-02-18 18:26:27.853186|2017-02-18 18:26:27.853186
NCT00000135|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2015-10-14|2015-06-12||September 1995||1995-09-01|July 2015|2015-07-01|August 1996|Actual|1996-08-01|August 1996|Actual|1996-08-01||Interventional|MACRT||Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)|Monoclonal Antibody CMV Retinitis Trial (MACRT)|Completed||Phase 2/Phase 3|209|Actual|Johns Hopkins Bloomberg School of Public Health||2|||f||||t||||||||||2017-02-18 18:26:28.220584|2017-02-18 18:26:28.220584
NCT00000134|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2015-08-11|2015-06-15||December 1992||1992-12-01|August 2015|2015-08-01|March 1995|Actual|1995-03-01|March 1995|Actual|1995-03-01||Interventional|CRRT||Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)|Cytomegalovirus Retinitis Retreatment Trial|Completed||Phase 3|279|Actual|Johns Hopkins Bloomberg School of Public Health||3|||f||||t||||||||||2017-02-18 18:26:28.570007|2017-02-18 18:26:28.570007
NCT00000133|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2014-02-03|||January 1986||1986-01-01|October 2003|2003-10-01|August 2003|Actual|2003-08-01|||||Interventional|||Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity||Completed||N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:29.002922|2017-02-18 18:26:29.002922
NCT00000132|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||October 1992||1992-10-01|October 2001|2001-10-01||||||||Interventional|||Early Manifest Glaucoma Trial (EMGT)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:29.130307|2017-02-18 18:26:29.130307
NCT00000131|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||August 1988||1988-08-01|September 2009|2009-09-01|February 1994|Actual|1994-02-01|||||Interventional|||Central Vein Occlusion Study (CVOS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:29.223323|2017-02-18 18:26:29.223323
NCT00000130|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||February 1990||1990-02-01|September 2009|2009-09-01|January 1995|Actual|1995-01-01|||||Interventional|||Endophthalmitis Vitrectomy Study (EVS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:29.30312|2017-02-18 18:26:29.30312
NCT00000129|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||April 1981||1981-04-01|September 2009|2009-09-01|October 1983|Actual|1983-10-01|||||Interventional|||Prospective Evaluation of Radial Keratotomy (PERK) Study||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:29.38729|2017-02-18 18:26:29.38729
NCT00000128|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||June 1996||1996-06-01|June 2002|2002-06-01||||||||Interventional|||A Trial of Bifocals in Myopic Children With Esophoria||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:29.464668|2017-02-18 18:26:29.464668
NCT00000127|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2010-03-23|||October 1992||1992-10-01|September 2009|2009-09-01|October 1994|Actual|1994-10-01|||||Interventional|||Ischemic Optic Neuropathy Decompression Trial (IONDT)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:29.540398|2017-02-18 18:26:29.540398
NCT00000126|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-05-25|||October 1994||1994-10-01|October 2003|2003-10-01||||||||Observational|||Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)||Unknown status|Active, not recruiting|N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:29.629685|2017-02-18 18:26:29.629685
NCT00000125|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2016-12-15|2015-03-06||February 1994||1994-02-01|December 2016|2016-12-01|March 2020|Anticipated|2020-03-01|June 2002|Actual|2002-06-01||Interventional|OHTS|1636 ocular hypertensive patients were randomized to either close observation or ocular hypertensive medication.|Ocular Hypertension Treatment Study (OHTS)|Ocular Hypertension Treatment Study (OHTS)|Active, not recruiting||Phase 3|1636|Actual|Washington University School of Medicine||2|||f||||t||||||||||2017-02-18 18:26:29.739345|2017-02-18 18:26:29.739345
NCT00000334|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-30|||December 1, 2002|Actual|2002-12-01|December 2002|2002-12-01|January 15, 2005|Actual|2005-01-15|November 1, 2004|Actual|2004-11-01||Interventional|||Comparison of Buprenorphine and Methadone - 3|Pharmacological Comparison of Buprenorphine and Methadone|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:30.169258|2017-02-18 18:26:30.169258
NCT00000333|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-06-02||||||December 2002|2002-12-01||||||||Interventional|||Evaluation of Benztropine for Cocaine Craving - 2|Evaluation of Efficacy of Benztropine for Cocaine Craving|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:30.25422|2017-02-18 18:26:30.25422
NCT00000332|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-06-02||||||December 2002|2002-12-01||||||||Interventional|||High Dose Nimodipine Treatment Adjunct - 1|High Dose Nimodipine Pharmacotherapy Adjunct|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:30.359046|2017-02-18 18:26:30.359046
NCT00000331|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-06-02|||December 2002||2002-12-01|December 2013|2013-12-01|December 2002|Actual|2002-12-01|December 2002|Actual|2002-12-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3|Terminated||Phase 2|0||University of Colorado, Denver||2|||f||||||||||||||2017-02-18 18:26:30.465769|2017-02-18 18:26:30.465769
NCT00000330|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-06-02|||October 1999||1999-10-01|December 2013|2013-12-01|November 1999|Actual|1999-11-01|November 1999|Actual|1999-11-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2|Terminated||Phase 2|0||University of Colorado, Denver|||||f||||||||||||||2017-02-18 18:26:30.58189|2017-02-18 18:26:30.58189
NCT00000329|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-06-02|||April 1999||1999-04-01|December 2013|2013-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1|Completed||Phase 2|0||University of Colorado, Denver|||||f||||||||||||||2017-02-18 18:26:30.677903|2017-02-18 18:26:30.677903
NCT00000328|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05|||July 1997||1997-07-01|December 2013|2013-12-01|August 1997|Actual|1997-08-01|August 1997|Actual|1997-08-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III|Completed||Phase 2|0||University of Colorado, Denver|||||f||||||||||||||2017-02-18 18:26:30.787647|2017-02-18 18:26:30.787647
NCT00000327|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||June 1997||1997-06-01|December 2013|2013-12-01|August 1997|Actual|1997-08-01|August 1997|Actual|1997-08-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2)|Completed||Phase 2|0||University of Colorado, Denver|||||f||||||||||||||2017-02-18 18:26:30.883215|2017-02-18 18:26:30.883215
NCT00000326|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||April 1997||1997-04-01|March 2014|2014-03-01|August 1997|Actual|1997-08-01|August 1997|Actual|1997-08-01||Interventional|||Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1|Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1(1)|Completed||Phase 2|0||University of Colorado, Denver|||||f||||||||||||||2017-02-18 18:26:30.988254|2017-02-18 18:26:30.988254
NCT00000124|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2006-06-01|||November 1986||1986-11-01|June 2002|2002-06-01||||||||Interventional|||Collaborative Ocular Melanoma Study (COMS)||Unknown status|Active, not recruiting|Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:31.093062|2017-02-18 18:26:31.093062
NCT00000123|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||January 1978||1978-01-01|September 2009|2009-09-01|February 1979|Actual|1979-02-01|||||Interventional|||The Berkeley Orthokeratology Study||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:31.174368|2017-02-18 18:26:31.174368
NCT00000122|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||September 1985||1985-09-01|September 2009|2009-09-01|June 1988|Actual|1988-06-01|||||Interventional|||Fluorouracil Filtering Surgery Study (FFSS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:31.524792|2017-02-18 18:26:31.524792
NCT00000121|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||March 1984||1984-03-01|September 2009|2009-09-01|May 1989|Actual|1989-05-01|||||Interventional|||The Prism Adaptation Study (PAS)||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:31.602889|2017-02-18 18:26:31.602889
NCT00000120|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||January 1985||1985-01-01|September 2009|2009-09-01||||||||Interventional|||Clinical Trial of Eye Prophylaxis in the Newborn||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:31.686596|2017-02-18 18:26:31.686596
NCT00000119|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||March 1994||1994-03-01|September 1999|1999-09-01||||||||Interventional|||Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis||Unknown status|Active, not recruiting|Phase 2|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:31.781986|2017-02-18 18:26:31.781986
NCT00000118|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||October 1992||1992-10-01|September 2009|2009-09-01|December 1993|Actual|1993-12-01|||||Interventional|||Ganciclovir Implant Study for Cytomegalovirus Retinitis||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:31.871575|2017-02-18 18:26:31.871575
NCT00000117|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||August 1995||1995-08-01|September 2009|2009-09-01|December 1997|Actual|1997-12-01|||||Interventional|||Intravenous Immunoglobulin Therapy in Optic Neuritis||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:31.960283|2017-02-18 18:26:31.960283
NCT00000116|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||May 1996||1996-05-01|September 2009|2009-09-01|September 1997||1997-09-01|||||Interventional|||Randomized Trial for Retinitis Pigmentosa|Randomized Trial for Retinitis Pigmentosa|Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:32.05914|2017-02-18 18:26:32.05914
NCT00000115|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||December 1990||1990-12-01|September 2009|2009-09-01|June 1994|Actual|1994-06-01|||||Interventional|||Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema||Completed||Phase 2|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:32.157555|2017-02-18 18:26:32.157555
NCT00000114|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||May 1984||1984-05-01|September 2009|2009-09-01|June 1987|Actual|1987-06-01|||||Interventional|||Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:32.23691|2017-02-18 18:26:32.23691
NCT00000113|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2016-04-14|||September 1997||1997-09-01|April 2016|2016-04-01|September 2013|Actual|2013-09-01|October 2001|Actual|2001-10-01||Interventional|||Correction of Myopia Evaluation Trial (COMET)|Correction of Myopia Evaluation Trial (COMET)|Completed||Phase 3|469|Actual|Stony Brook University||2|||f||||t||||||||||2017-02-18 18:26:32.31977|2017-02-18 18:26:32.31977
NCT00000112|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Prevalence of Carbohydrate Intolerance in Lean and Obese Children||Unknown status|Recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:26:32.430447|2017-02-18 18:26:32.430447
NCT00000111|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2005-06-23||||||September 2000|2000-09-01||||||||Interventional|||Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites||Unknown status|Active, not recruiting|Phase 1|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:26:32.499432|2017-02-18 18:26:32.499432
NCT00000110|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Influence of Diet and Endurance Running on Intramuscular Lipids Measured at 4.1 TESLA||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:26:32.573433|2017-02-18 18:26:32.573433
NCT00000108|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2005-06-23||||||December 2003|2003-12-01||||||||Interventional|||Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:26:32.647999|2017-02-18 18:26:32.647999
NCT00000107|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Body Water Content in Cyanotic Congenital Heart Disease||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:26:32.723077|2017-02-18 18:26:32.723077
NCT00000106|ClinicalTrials.gov processed this data on February 17, 2017|2000-01-18|2005-06-23||||||November 2000|2000-11-01||||||||Interventional|||41.8 Degree Centigrade Whole Body Hyperthermia for the Treatment of Rheumatoid Diseases||Unknown status|Active, not recruiting|N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:26:32.803952|2017-02-18 18:26:32.803952
NCT00000105|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2012-11-06|||July 2002||2002-07-01|November 2012|2012-11-01|March 2012|Actual|2012-03-01|March 2012|Actual|2012-03-01||Observational|||Vaccination With Tetanus and KLH to Assess Immune Responses.|Vaccination With Tetanus Toxoid and Keyhole Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses|Terminated||N/A|112|Actual|Masonic Cancer Center, University of Minnesota|||3|Replaced by another study.|f||||t||||||Samples With DNA|"~     analysis of blood samples before and 4 weeks postvaccination~   "|||2017-02-18 18:26:32.893412|2017-02-18 18:26:32.893412
NCT00000104|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2005-06-23||||||December 2003|2003-12-01||||||||Observational|||Does Lead Burden Alter Neuropsychological Development?||Completed||N/A|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:26:33.016714|2017-02-18 18:26:33.016714
NCT00000102|ClinicalTrials.gov processed this data on February 17, 2017|1999-11-03|2005-06-23||||||January 2004|2004-01-01||||||||Interventional|||Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets||Completed||Phase 1/Phase 2|||National Center for Research Resources (NCRR)|||||f||||||||||||||2017-02-18 18:26:33.110097|2017-02-18 18:26:33.110097
NCT00000325|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11||||||December 2002|2002-12-01|December 2001||2001-12-01|||||Interventional|||Psychostimulant Abuse - Novel Treatment Approaches - 1|Psychostimulant Abuse - Novel Treatment Approaches|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:33.196219|2017-02-18 18:26:33.196219
NCT00000324|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||March 1997||1997-03-01|August 2005|2005-08-01|April 2001||2001-04-01|||||Interventional|||Tryptophan and Behavior Therapy for Cocaine Abuse - 1|Tryptophan and Behavior Therapy for Cocaine Abuse|Completed||Phase 2|200||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 18:26:33.269926|2017-02-18 18:26:33.269926
NCT00000323|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||July 1996||1996-07-01|May 2004|2004-05-01|December 1998||1998-12-01|||||Observational|||Therapeutic Potential of Kappa-Opioids Against Cocaine - 1|Therapeutic Potential of Kappa-Opioids Against Cocaine|Completed||Phase 1|10||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:33.368439|2017-02-18 18:26:33.368439
NCT00000322|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||April 1997||1997-04-01|April 1997|1997-04-01|December 2001||2001-12-01|||||Interventional|||Tyrosine for Methamphetamine Dependence - 1|Tyrosine for Methamphetamine Dependence|Completed||Phase 2|89||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:33.457137|2017-02-18 18:26:33.457137
NCT00000321|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||October 1996||1996-10-01|October 1996|1996-10-01|December 2001||2001-12-01|||||Interventional|||Methamphetamine Abuse Treatment in Patients With AIDS - 1|Methamphetamine Abuse Pharmacology in Patients With AIDS|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:33.553535|2017-02-18 18:26:33.553535
NCT00000320|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||October 1997||1997-10-01|January 2009|2009-01-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1|Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution|Completed||Phase 1/Phase 2|120|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 18:26:33.662764|2017-02-18 18:26:33.662764
NCT00000319|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||June 1996||1996-06-01|June 1996|1996-06-01||||||||Interventional|||Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2|Buprenorphine Maintenance Dose Schedule and Treatment Setting|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:33.775974|2017-02-18 18:26:33.775974
NCT00000318|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||December 1994||1994-12-01|December 2008|2008-12-01|August 2007|Actual|2007-08-01|March 2004|Actual|2004-03-01||Interventional|||Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1|Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot|Completed||Phase 2|202|Actual|National Institute on Drug Abuse (NIDA)||2|||f||||f||||||||||2017-02-18 18:26:33.86517|2017-02-18 18:26:33.86517
NCT00000317|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2012-10-24|||August 1996||1996-08-01|October 2012|2012-10-01|July 1999|Actual|1999-07-01|July 1999|Actual|1999-07-01||Interventional|||Early Phase II Trials for Cocaine Medication Development - 1|Early Phase II Trials for Cocaine Medication Development|Completed||Phase 2|31|Actual|New York State Psychiatric Institute||2|||f||||f||||||||||2017-02-18 18:26:33.969856|2017-02-18 18:26:33.969856
NCT00000316|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||August 1996||1996-08-01|August 1996|1996-08-01|December 2001||2001-12-01|||||Interventional|||Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2|Human Dopamine Transported Imaging in Cocaine Abuse: 2|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:34.083021|2017-02-18 18:26:34.083021
NCT00000315|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||November 1996||1996-11-01|November 1996|1996-11-01|December 2001||2001-12-01|||||Interventional|||Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1|Human Dopamine Transported Imaging in Cocaine Abuse: 1|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:34.172253|2017-02-18 18:26:34.172253
NCT00000314|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-17|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||M-CPP and Fenfluramine in Cocaine Addicts - 3|To Study Predictive Values of M-CPP and Fenfluramine in Cocaine Addicts|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:34.264403|2017-02-18 18:26:34.264403
NCT00000313|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11||||||December 2002|2002-12-01||||||||Interventional|||Predictive Values of Serotonergic Alterations for Outcome - 2|Predictive Values of Serotonergic Alterations for Outcome|Terminated||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:34.350355|2017-02-18 18:26:34.350355
NCT00000312|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23||||||December 2002|2002-12-01||||||||Interventional|||Alterations in Serotonergic Functions in Cocaine Addicts - 1|Alterations in Serotonergic Functions in Cocaine Addicts|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:34.436737|2017-02-18 18:26:34.436737
NCT00000311|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2008-10-27|||September 1999||1999-09-01|October 2008|2008-10-01||||||||Interventional|||Combining Behavioral Treatment With Agonist Maintenance - 1|Combining Behavioral Treatment With Agonist Maintenance|Unknown status|Active, not recruiting|Phase 3|168||National Institute on Drug Abuse (NIDA)||2|||f||||||||||||||2017-02-18 18:26:34.528579|2017-02-18 18:26:34.528579
NCT00000310|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-13|||January 1996||1996-01-01|January 1996|1996-01-01|March 1996|Actual|1996-03-01|March 1996|Actual|1996-03-01||Interventional|||Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2|Serotonin/Dopamine Antagonism of Cocaine Effect|Terminated||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:34.628968|2017-02-18 18:26:34.628968
NCT00000309|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-07-23|||August 1994||1994-08-01|July 2015|2015-07-01|January 2000|Actual|2000-01-01|January 2000|Actual|2000-01-01||Interventional|||Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1|Serotonin/Dopamine Antagonism of Cocaine Effect|Terminated||Phase 2|0||Butler Hospital||||Unable to recruit adequate number of subjects|f||||||||||||||2017-02-18 18:26:34.723852|2017-02-18 18:26:34.723852
NCT00000308|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||September 1995||1995-09-01|October 2016|2016-10-01|September 2000|Actual|2000-09-01|September 2000|Actual|2000-09-01||Interventional|||Dextroamphetamine-Cocaine Behavioral Intervention - 5|D-amphetamine-Cocaine Behavioral Intervention|Completed||Phase 2|54|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 18:26:34.817916|2017-02-18 18:26:34.817916
NCT00000307|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||April 2003||2003-04-01|October 2016|2016-10-01|April 2007|Actual|2007-04-01|April 2007|Actual|2007-04-01||Interventional|||Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4|Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||t||||||||||2017-02-18 18:26:34.929143|2017-02-18 18:26:34.929143
NCT00000306|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||September 1994||1994-09-01|October 2016|2016-10-01|September 2001||2001-09-01|||||Interventional|||Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3|Dextroamphetamine as an Adjunct in Cocaine/Opiate Dependent Patients|Completed||Phase 2|140||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:35.098838|2017-02-18 18:26:35.098838
NCT00000305|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2012-05-17||||||May 2012|2012-05-01||||||||Interventional|||Amphetamine Cocaine Interaction Study - 2|Amphetamine Cocaine Interaction Study|Terminated||Phase 1|0||The University of Texas Health Science Center, Houston||||Original P.I. left the institution|f||||t||||||||||2017-02-18 18:26:35.198831|2017-02-18 18:26:35.198831
NCT00000304|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||August 1997||1997-08-01|October 2016|2016-10-01|August 2001|Actual|2001-08-01|August 2001|Actual|2001-08-01||Interventional|||Dextroamphetamine as an Adjunct in Cocaine Treatment - 1|Dextroamphetamine as an Adjunct in Cocaine Treatment|Completed||Phase 2|120|Actual|National Institute on Drug Abuse (NIDA)||3|||f||||t||||||||||2017-02-18 18:26:35.278471|2017-02-18 18:26:35.278471
NCT00000303|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-07-07|||October 1997||1997-10-01|July 2016|2016-07-01||||May 1999|Actual|1999-05-01||Interventional|||Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6|Rapid Evaluation of Cocaine Pharmacotherapies (Baclofen)|Completed||Phase 2|0||University of California, Los Angeles|||||f||||||||||||||2017-02-18 18:26:35.386619|2017-02-18 18:26:35.386619
NCT00000302|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-11-03||||||December 2002|2002-12-01||||||||Interventional|||Study Comparing Liquid and Tablet Buprenorphine Formulations - 5|Expanded Steady-State Pharmacokinetic Study, Comparing Liquid and Tablet Buprenorphine Formulations|Completed||Phase 3|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:35.485223|2017-02-18 18:26:35.485223
NCT00000301|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-07-07|||March 1996||1996-03-01|July 2016|2016-07-01||||June 1998|Actual|1998-06-01||Interventional|||Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4|Rapid Evaluation of Cocaine Pharmacotherapies (Amantadine)|Completed||Phase 2|0||University of California, Los Angeles|||||f||||||||||||||2017-02-18 18:26:35.572295|2017-02-18 18:26:35.572295
NCT00000300|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-11-03|||March 1995||1995-03-01|March 1995|1995-03-01||||||||Interventional|||Feasibility Study of Take-Home LAAM Medication - 3|Feasibility Study of Take-Home LAAM Medication|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:35.672667|2017-02-18 18:26:35.672667
NCT00000299|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-01-27|||October 2008||2008-10-01|January 2016|2016-01-01|November 2009|Actual|2009-11-01|November 2009|Actual|2009-11-01||Interventional|||Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2|Rapid Opiate Detoxification & Naltrexone Induction Using Bup.|Completed||Phase 2|12|Actual|University of California, Los Angeles||2|||f||||||||||||||2017-02-18 18:26:35.761088|2017-02-18 18:26:35.761088
NCT00000298|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||August 1995||1995-08-01|January 1996|1996-01-01||||||||Interventional|||Buprenorphine Combination Tablet Feasibility - 1|Buprenorphine Combination Tablet Feasibility|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:35.868062|2017-02-18 18:26:35.868062
NCT00000297|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||October 1998||1998-10-01|October 1998|1998-10-01|December 2001||2001-12-01|||||Interventional|||Effects of Labetalol on Nicotine Administration in Humans - 14|Effects of Labetalol on Nicotine Administration in Humans|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:35.953668|2017-02-18 18:26:35.953668
NCT00000296|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||November 1997||1997-11-01|February 1999|1999-02-01|December 2001||2001-12-01|||||Interventional|||Role of Metabolites in Nicotine Dependence (4) - 13|Role of Metabolites in Nicotine Dependence (4)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:36.037225|2017-02-18 18:26:36.037225
NCT00000295|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||April 1999||1999-04-01|April 1999|1999-04-01|December 2001||2001-12-01|||||Interventional|||Progesterone Treatment in Female Smokers - 12|Progesterone Treatment in Female Smokers|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.133939|2017-02-18 18:26:39.133939
NCT00000294|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||September 1998||1998-09-01|March 1999|1999-03-01|December 2001||2001-12-01|||||Interventional|||Effects of Carvedilol on Cocaine Use in Humans - 11|Effects of Carvedilol on Cocaine Use in Humans|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.241978|2017-02-18 18:26:39.241978
NCT00000293|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||January 1999||1999-01-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10|Effect of Nefazodone on Relapse in Females With Cocaine Abuse|Completed||Phase 3|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.333371|2017-02-18 18:26:39.333371
NCT00000292|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||April 1996||1996-04-01|April 1996|1996-04-01|December 2001||2001-12-01|||||Interventional|||Acute Withdrawal From Smoked Cocaine - 9|Acute Withdrawal From Smoked Cocaine|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.424785|2017-02-18 18:26:39.424785
NCT00000291|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||October 1997||1997-10-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Effects of Labetalol on Human Cocaine Use - 8|Effects of Labetalol on Human Cocaine Use|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.511093|2017-02-18 18:26:39.511093
NCT00000290|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||May 1997||1997-05-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Stress Hormones and Human Cocaine Use - 7|Stress Hormones and Human Cocaine Use|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.603404|2017-02-18 18:26:39.603404
NCT00000289|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||May 1998||1998-05-01|December 1998|1998-12-01|December 2001||2001-12-01|||||Interventional|||Role of Metabolites in Nicotine Dependence (3) - 6|Role of Metabolites in Nicotine Dependence (3)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.696387|2017-02-18 18:26:39.696387
NCT00000288|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||December 1995||1995-12-01|November 2016|2016-11-01|December 2002||2002-12-01|||||Interventional|||Role of Metabolites in Nicotine Dependence (2) - 5|Role of Metabolites in Nicotine Dependence (2)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.781585|2017-02-18 18:26:39.781585
NCT00000287|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||February 1995||1995-02-01|October 2016|2016-10-01|December 2001|Actual|2001-12-01|December 2001|Actual|2001-12-01||Observational|||Relapse Patterns in Female Cocaine Users - 4|Relapse Patterns in Female Cocaine Users|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.886619|2017-02-18 18:26:39.886619
NCT00000286|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||December 1996||1996-12-01|October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3|Effects of Nefazodone on Treatment of Female Cocaine Abusers|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:39.970178|2017-02-18 18:26:39.970178
NCT00000285|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||May 1996||1996-05-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Effects of Phenytoin on Cocaine Use in Humans - 2|Effects of Phenytoin on Cocaine Use in Humans|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:40.078095|2017-02-18 18:26:40.078095
NCT00000284|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||February 1995||1995-02-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Role of Metabolites in Nicotine Dependence (1) - 1|Role of Metabolites in Nicotine Dependence (1)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:40.18763|2017-02-18 18:26:40.18763
NCT00000282|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-12-13|||September 1994||1994-09-01|December 2016|2016-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Pemoline for Cocaine Abuse - 7|Pemoline for Cocaine Abuse|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-02-18 18:26:40.557476|2017-02-18 18:26:40.557476
NCT00000281|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-12-13|||September 1994||1994-09-01|December 2016|2016-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Pharmacotherapy for Schizophrenic Drug Users - 6|Pharmacotherapy for Schizophrenic Drug Users|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-02-18 18:26:40.652465|2017-02-18 18:26:40.652465
NCT00000280|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Glutaminergic Agents for Cocaine Abuse - 5|Glutaminergic Agents for Cocaine Abuse|Completed||Phase 1|0||Yale University|||||f||||||||||||||2017-02-18 18:26:40.746287|2017-02-18 18:26:40.746287
NCT00000279|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Novel Medications for Opiate Detoxification - 4|Novel Medications for Opiate Detoxification|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-02-18 18:26:40.831462|2017-02-18 18:26:40.831462
NCT00000278|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Disulfiram for Cocaine-Alcohol Abuse - 3|Disulfiram for Cocaine-Alcohol Abuse|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-02-18 18:26:40.923392|2017-02-18 18:26:40.923392
NCT00000277|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2002|2002-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Mazindol for Cocaine Abuse - 2|Mazindol for Cocaine Abuse|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-02-18 18:26:41.019633|2017-02-18 18:26:41.019633
NCT00000276|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-07-24|||September 1994||1994-09-01|December 2008|2008-12-01|August 1999|Actual|1999-08-01|August 1999|Actual|1999-08-01||Interventional|||Dopamine Reuptake Inhibitors of Cocaine Abuse - 1|Dopamine Reuptake Inhibitors of Cocaine Abuse|Terminated||Phase 1|0||Yale University|||||f||||||||||||||2017-02-18 18:26:41.116443|2017-02-18 18:26:41.116443
NCT00000275|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||November 1996||1996-11-01|November 2016|2016-11-01|March 1998||1998-03-01|||||Interventional|||Cocaine Abuse and ADHD - 10|Cocaine Abuse and ADHD|Completed||Phase 2|16||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:41.202901|2017-02-18 18:26:41.202901
NCT00000274|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||March 1997||1997-03-01|November 2016|2016-11-01|May 1999||1999-05-01|||||Interventional|||Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9|Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics|Completed||Phase 2|60||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:41.294712|2017-02-18 18:26:41.294712
NCT00000253|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||November 1994||1994-11-01|May 2015|2015-05-01|March 1996|Actual|1996-03-01|March 1996|Actual|1996-03-01||Interventional|||Effects of Nitrous Oxide: A Dose-Response Analysis - 5|Effects of Nitrous Oxide: A Dose-Response Analysis|Completed||N/A|16|Actual|University of Chicago||4|||f||||||||||||||2017-02-18 18:26:43.644944|2017-02-18 18:26:43.644944
NCT00000273|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-11-04|||August 1995||1995-08-01|November 2013|2013-11-01|November 2005|Actual|2005-11-01|November 2005|Actual|2005-11-01||Interventional|||A Laboratory Model for Heroin Abuse Medications - 8|A Laboratory Model for Heroin Abuse Medications|Completed||Phase 2|37|Anticipated|New York State Psychiatric Institute||1|||f||||t||||||||||2017-02-18 18:26:41.385189|2017-02-18 18:26:41.385189
NCT00000272|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||March 1995||1995-03-01|March 1995|1995-03-01||||||||Interventional|||New Approaches to Cocaine Abuse Medications (B) - 7|New Approaches to Cocaine Abuse Medications (B)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:41.491814|2017-02-18 18:26:41.491814
NCT00000271|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||January 1995||1995-01-01|January 1995|1995-01-01||||||||Interventional|||New Approaches to Cocaine Abuse Medications (A) - 6|New Approaches to Cocaine Abuse Medications (A)|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:41.58188|2017-02-18 18:26:41.58188
NCT00000270|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||May 1995||1995-05-01|May 1996|1996-05-01||||||||Interventional|||Brain Imaging: Cocaine Effects & Medication Development - 5|Brain Imaging: Cocaine Effects & Medication Development|Completed||Phase 4|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:41.661788|2017-02-18 18:26:41.661788
NCT00000269|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||October 1995||1995-10-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Pergolide Treatment for Substance Abusers - 4|Pergolide Treatment for Substance Abusers|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:41.746126|2017-02-18 18:26:41.746126
NCT00000268|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||May 1995||1995-05-01|November 2016|2016-11-01|November 1998||1998-11-01|||||Interventional|||Cocaine Abuse and Attention Deficit Disorder - 3|Cocaine Abuse and Attention Deficit Disorder|Completed||N/A|32||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 18:26:41.825719|2017-02-18 18:26:41.825719
NCT00000267|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11||||||October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||Risperidone Treatment in Dually-Diagnosed Individuals - 2|Risperidone Treatment in Dually-Diagnosed Individuals|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:41.913881|2017-02-18 18:26:41.913881
NCT00000266|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||August 1994||1994-08-01|October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1|Flupenthixol Treatment in Schizophrenic Cocaine Abusers|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:42.007449|2017-02-18 18:26:42.007449
NCT00000265|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||July 1997||1997-07-01|May 2015|2015-05-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Observational|||Subjective Effects of Nitrous Oxide in Dental Patients - 17|Subjective Effects of Nitrous Oxide in Dental Patients|Completed||Phase 2|46|Actual|University of Chicago|||3||f||||||||||||||2017-02-18 18:26:42.1019|2017-02-18 18:26:42.1019
NCT00000264|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||September 1997||1997-09-01|May 2015|2015-05-01|October 1999|Actual|1999-10-01|October 1999|Actual|1999-10-01||Interventional|||Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16|Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide|Completed||N/A|8|Actual|University of Chicago||3|||f||||||||||||||2017-02-18 18:26:42.193242|2017-02-18 18:26:42.193242
NCT00000263|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||January 1997||1997-01-01|May 2015|2015-05-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||Effects of Combined Alcohol and Nitrous Oxide Intake - 15|Effects of Combined Alcohol and Nitrous Oxide Intake|Completed||N/A|11|Actual|University of Chicago||3|||f||||||||||||||2017-02-18 18:26:42.300234|2017-02-18 18:26:42.300234
NCT00000262|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||November 1996||1996-11-01|May 2015|2015-05-01|February 1999|Actual|1999-02-01|February 1999|Actual|1999-02-01||Interventional|||Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14|Effects of Combined Sevoflurane and Nitrous Oxide Inhalation|Completed||N/A|20|Actual|University of Chicago||3|||f||||||||||||||2017-02-18 18:26:42.403186|2017-02-18 18:26:42.403186
NCT00000261|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||November 1997||1997-11-01|May 2015|2015-05-01|October 1998|Actual|1998-10-01|October 1998|Actual|1998-10-01||Interventional|||Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13|Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide|Completed||Phase 2|14|Actual|University of Chicago||1|||f||||||||||||||2017-02-18 18:26:42.780597|2017-02-18 18:26:42.780597
NCT00000260|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||June 1997||1997-06-01|May 2015|2015-05-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12|Effects of Behavioral Contingencies on Effects of Nitrous Oxide|Completed||N/A|18|Actual|University of Chicago|||||f||||||||||||||2017-02-18 18:26:42.884598|2017-02-18 18:26:42.884598
NCT00000259|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||August 1996||1996-08-01|May 2015|2015-05-01|November 1997|Actual|1997-11-01|November 1997|Actual|1997-11-01||Interventional|||Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11|Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations|Completed||N/A|12|Actual|University of Chicago||5|||f||||||||||||||2017-02-18 18:26:42.976197|2017-02-18 18:26:42.976197
NCT00000258|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||April 1996||1996-04-01|May 2015|2015-05-01|November 1997|Actual|1997-11-01|November 1997|Actual|1997-11-01||Interventional|||Role of Instructions in Nitrous Oxide Effects and Choice - 10|Role of Instructions in Nitrous Oxide Effects and Choice|Completed||N/A|22|Actual|University of Chicago||2|||f||||||||||||||2017-02-18 18:26:43.089947|2017-02-18 18:26:43.089947
NCT00000257|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||September 1995||1995-09-01|May 2015|2015-05-01|April 1997|Actual|1997-04-01|April 1997|Actual|1997-04-01||Interventional|||Effects of Alcohol History on Effects of Nitrous Oxide - 9|Effects of Alcohol History on Effects of Nitrous Oxide|Completed||N/A|19|Actual|University of Chicago||2|||f||||||||||||||2017-02-18 18:26:43.196659|2017-02-18 18:26:43.196659
NCT00000256|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||August 1995||1995-08-01|May 2015|2015-05-01|November 1996|Actual|1996-11-01|November 1996|Actual|1996-11-01||Interventional|||Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8|Reinforcing Effects of Brief Exposures to Nitrous Oxide|Completed||N/A|11|Actual|University of Chicago||4|||f||||||||||||||2017-02-18 18:26:43.301846|2017-02-18 18:26:43.301846
NCT00000255|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||April 1995||1995-04-01|May 2015|2015-05-01|May 1996|Actual|1996-05-01|May 1996|Actual|1996-05-01||Interventional|||Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7|Differential Acute Tolerance Development to Effects of Nitrous Oxide|Completed||Phase 2|10|Actual|University of Chicago||5|||f||||||||||||||2017-02-18 18:26:43.418903|2017-02-18 18:26:43.418903
NCT00000254|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||January 1995||1995-01-01|May 2015|2015-05-01|September 1995|Actual|1995-09-01|September 1995|Actual|1995-09-01||Interventional|||Isoflurane at Subanesthetic Concentrations - 6|Isoflurane at Subanesthetic Concentrations|Completed||Phase 2|10|Actual|University of Chicago||4|||f||||||||||||||2017-02-18 18:26:43.52527|2017-02-18 18:26:43.52527
NCT00000252|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||June 1994||1994-06-01|May 2015|2015-05-01|June 1996|Actual|1996-06-01|June 1996|Actual|1996-06-01||Interventional|||Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4|Lack of Acute Tolerance Development to Effects of Nitrous Oxide|Completed||Phase 2|11|Actual|University of Chicago||5|||f||||||||||||||2017-02-18 18:26:43.759088|2017-02-18 18:26:43.759088
NCT00000251|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-11-30|||April 1994||1994-04-01|November 2015|2015-11-01|January 1996|Actual|1996-01-01|January 1996|Actual|1996-01-01||Interventional|||Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3|Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide|Completed||Phase 2|10|Actual|University of Chicago||6|||f||||||||||||||2017-02-18 18:26:43.872241|2017-02-18 18:26:43.872241
NCT00000250|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||December 1993||1993-12-01|May 2015|2015-05-01|May 1995|Actual|1995-05-01|May 1995|Actual|1995-05-01||Interventional|||Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2|Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide|Completed||Phase 2|12|Actual|University of Chicago||2|||f||||||||||||||2017-02-18 18:26:43.993933|2017-02-18 18:26:43.993933
NCT00000249|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||September 1993||1993-09-01|May 2015|2015-05-01|June 1995|Actual|1995-06-01|June 1995|Actual|1995-06-01||Interventional|||Effects of Subanesthetic Concentrations of Nitrous Oxide - 1|Effects of Subanesthetic Concentrations of Nitrous Oxide|Completed||Phase 2|10|Actual|University of Chicago||4|||f||||||||||||||2017-02-18 18:26:44.103542|2017-02-18 18:26:44.103542
NCT00000248|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2012-09-11|||February 1996||1996-02-01|May 1997|1997-05-01||||||||Interventional|||Dose Response Trial of Pergolide for Cocaine Dependence - 1|Dose Response Trial of Pergolide for Cocaine Dependence|Completed||Phase 3|0||Medical University of South Carolina|||||f||||||||||||||2017-02-18 18:26:44.215043|2017-02-18 18:26:44.215043
NCT00000246|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-09-06|||January 1993||1993-01-01|September 2016|2016-09-01|December 1994|Actual|1994-12-01|December 1994|Actual|1994-12-01||Interventional|||Rapid Benzodiazepine Detoxification Using Flumazenil - 1|Rapid Benzodiazepine Detoxification Using Flumazenil|Completed||Phase 2|10|Actual|Yale University|||||f||||||||||||||2017-02-18 18:26:44.326021|2017-02-18 18:26:44.326021
NCT00000245|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||May 1994||1994-05-01|November 2016|2016-11-01|December 2001||2001-12-01|||||Interventional|||Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1|Evaluation of a Desipramine Ceiling in Cocaine Abuse|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:44.423415|2017-02-18 18:26:44.423415
NCT00000244|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||August 1994||1994-08-01|May 2015|2015-05-01|March 1997|Actual|1997-03-01|March 1997|Actual|1997-03-01||Interventional|||Effects of Dynorphin 1-13 on Heroin Addiction - 1|Effects of Dynorphin 1-13 on Heroin Addiction|Completed||Phase 2|0||University of Minnesota - Clinical and Translational Science Institute|||||f||||t||||||||||2017-02-18 18:26:44.5156|2017-02-18 18:26:44.5156
NCT00000243|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||September 2002||2002-09-01|November 2016|2016-11-01|January 2004||2004-01-01|||||Interventional|||Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone|Transitioning Patients From Methadone to Buprenorphine/Naloxone for Treating Opioid Dependence|Terminated||N/A|16||National Institute on Drug Abuse (NIDA)|||||||||||||||||||2017-02-18 18:26:44.622645|2017-02-18 18:26:44.622645
NCT00000242|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-10-08|||October 1992||1992-10-01|July 1996|1996-07-01||||||||Interventional|||Carbamazepine Treatment of Cocaine Dependence - 1|Carbamazepine Treatment of Cocaine Dependence|Completed||Phase 2|0||Medical University of South Carolina|||||f||||||||||||||2017-02-18 18:26:44.727071|2017-02-18 18:26:44.727071
NCT00000241|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||February 1994||1994-02-01|October 2016|2016-10-01|May 1996||1996-05-01|||||Interventional|||Flupenthixol Decanoate in Methamphetamine Smoking - 1|Flupenthixol Decanoate in Methamphetamine Smoking|Completed||Phase 2|58||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:44.830458|2017-02-18 18:26:44.830458
NCT00000240|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-06-02|||April 1999||1999-04-01|April 1999|1999-04-01||||||||Interventional|||Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22|Combined Buprenorphine and Behavioral Treatment Without Contingent Reinforcement|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-02-18 18:26:44.923336|2017-02-18 18:26:44.923336
NCT00000239|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16||||||December 2002|2002-12-01||||||||Interventional|||Buprenorphine Pharmacology Related to Addiction Treatment - 21|Buprenorphine Pharmacology Related to Addiction Treatment|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:45.00791|2017-02-18 18:26:45.00791
NCT00000238|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2008-11-19|||August 1997||1997-08-01|November 2008|2008-11-01||||||||Interventional|||Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20|Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:45.105825|2017-02-18 18:26:45.105825
NCT00000237|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||May 1997||1997-05-01|May 1997|1997-05-01||||||||Interventional|||Buprenorphine Detoxification - BBDVI - 19|Buprenorphine Detoxification - BBDVI|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:45.187207|2017-02-18 18:26:45.187207
NCT00000236|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16||||||December 2002|2002-12-01||||||||Interventional|||Buprenorphine Pharmacology Related to Addiction Treatment - 18|Buprenorphine Pharmacology Related to Addiction Treatment|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:45.272614|2017-02-18 18:26:45.272614
NCT00000235|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16||||||December 2002|2002-12-01||||||||Interventional|||Alternate Day Buprenorphine Administration, Phase XII - 17|Alternate Day Buprenorphine Administration, Phase XII|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:45.359763|2017-02-18 18:26:45.359763
NCT00000234|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05||||||December 2002|2002-12-01||||||||Interventional|||Alternate Day Buprenorphine Administration, Phase XI - 16|Alternate Day Buprenorphine Administration, Phase XI|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-02-18 18:26:45.445151|2017-02-18 18:26:45.445151
NCT00000233|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||May 1993||1993-05-01|September 1995|1995-09-01||||||||Interventional|||Alternate Day Buprenorphine Administration, Phase X - 15|Alternate Day Buprenorphine Administration, Phase X|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:45.525013|2017-02-18 18:26:45.525013
NCT00000232|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05|||March 1992||1992-03-01|April 1994|1994-04-01||||||||Interventional|||Alternate Day Buprenorphine Administration, Phase IX - 14|Alternate Day Buprenorphine Administration, Phase IX|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-02-18 18:26:45.608542|2017-02-18 18:26:45.608542
NCT00000231|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||February 1992||1992-02-01|March 1994|1994-03-01||||||||Interventional|||Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13|Buprenorphine Detoxification With Two Types of Treatment. BBD IV|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:45.695356|2017-02-18 18:26:45.695356
NCT00000230|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05|||January 1995||1995-01-01|August 1996|1996-08-01||||||||Interventional|||Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12|Buprenorphine Detoxification With Two Types of Treatment. BBD III|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-02-18 18:26:46.064287|2017-02-18 18:26:46.064287
NCT00000229|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05|||October 1995||1995-10-01|September 1996|1996-09-01||||||||Interventional|||Buprenorphine Detox With Two Types of Treatment. BBD II - 11|Buprenorphine Detox With Two Types of Treatment. BBD II|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-02-18 18:26:46.145876|2017-02-18 18:26:46.145876
NCT00000228|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||August 1994||1994-08-01|July 1996|1996-07-01||||||||Interventional|||Buprenorphine Detox With Two Types of Treatment. BBD I - 10|Buprenorphine Detox With Two Types of Treatment. BBD I|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:46.235171|2017-02-18 18:26:46.235171
NCT00000227|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05|||August 1994||1994-08-01|July 1996|1996-07-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase VIII - 9|Alternate-Day Buprenorphine Administration. Phase VIII|Completed||Phase 2|0||University of Vermont|||||f||||||||||||||2017-02-18 18:26:46.325103|2017-02-18 18:26:46.325103
NCT00000226|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||November 1994||1994-11-01|July 1996|1996-07-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase VII - 8|Alternate-Day Buprenorphine Administration. Phase VII|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:46.418718|2017-02-18 18:26:46.418718
NCT00000225|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||December 1992||1992-12-01|June 2004|2004-06-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase VI - 7|Alternate-Day Buprenorphine Administration. Phase VI|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:46.511625|2017-02-18 18:26:46.511625
NCT00000224|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||February 1993||1993-02-01|April 1996|1996-04-01||||||||Interventional|||Alternate-Day Buprenorphine. Phase V - 6|Alternate-Day Buprenorphine. Phase V|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:46.601165|2017-02-18 18:26:46.601165
NCT00000223|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||June 1993||1993-06-01|September 1994|1994-09-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase IV - 5|Alternate-Day Buprenorphine Administration. Phase IV|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:46.703773|2017-02-18 18:26:46.703773
NCT00000222|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||July 1992||1992-07-01|December 1993|1993-12-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase II - 4|Alternate-Day Buprenorphine Administration. Phase II|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:46.785973|2017-02-18 18:26:46.785973
NCT00000221|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||April 1992||1992-04-01|November 1993|1993-11-01||||||||Interventional|||Alternate-Day Buprenorphine Administration. Phase I - 3|Alternate-Day Buprenorphine Administration. Phase I|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:46.868508|2017-02-18 18:26:46.868508
NCT00000220|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-06-23|||June 1991||1991-06-01|September 1991|1991-09-01|July 2001||2001-07-01|||||Interventional|||Gradual Vs. Rapid Buprenorphine Detoxification - 2|Gradual Vs. Rapid Buprenorphine Detoxification|Completed||Phase 1|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:46.954534|2017-02-18 18:26:46.954534
NCT00000219|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05|||December 1991||1991-12-01|April 1992|1992-04-01|July 2001||2001-07-01|||||Interventional|||Buprenorphine Dose Alteration Study - 1|Buprenorphine Dose Alteration Study|Completed||Phase 1|0||University of Vermont|||||f||||||||||||||2017-02-18 18:26:47.044218|2017-02-18 18:26:47.044218
NCT00000218|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11||||||October 2016|2016-10-01|June 2005|Actual|2005-06-01|||||Interventional|||Pharmacotherapy and Intensive Treatment - 2|Pharmacotherapy and Intensive Treatment|Completed||Phase 4|353||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:47.134143|2017-02-18 18:26:47.134143
NCT00000217|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-04-15|||September 1990||1990-09-01|April 2015|2015-04-01||||October 1996|Actual|1996-10-01||Interventional|||Pharmacotherapy and Intensive Treatment of Drug Abuse - 1|Pharmacotherapy and Intensive Treatment of Drug Abuse|Completed||Phase 2|||University of Kansas Medical Center|||||f||||||||||||||2017-02-18 18:26:47.22279|2017-02-18 18:26:47.22279
NCT00000216|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16||||||December 2002|2002-12-01||||||||Interventional|||Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1|Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts|Completed||Phase 3|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:47.326878|2017-02-18 18:26:47.326878
NCT00000215|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11||||||October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||IV Cocaine Abuse: A Laboratory Model - 4|IV Cocaine Abuse: A Laboratory Model|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:47.415163|2017-02-18 18:26:47.415163
NCT00000214|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-08-27|||January 1992||1992-01-01|December 2012|2012-12-01|January 1993|Actual|1993-01-01|January 1993|Actual|1993-01-01||Interventional|||IV Cocaine Abuse: A Laboratory Model - 3|IV Cocaine Abuse: A Laboratory Model|Completed||Phase 2|0||New York State Psychiatric Institute|||||f||||||||||||||2017-02-18 18:26:47.507038|2017-02-18 18:26:47.507038
NCT00000213|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-08-27|||April 1990||1990-04-01|December 2012|2012-12-01|April 1991|Actual|1991-04-01|April 1991|Actual|1991-04-01||Interventional|||IV Cocaine Abuse: A Laboratory Model - 2|IV Cocaine Abuse: A Laboratory Model|Completed||Phase 2|0||New York State Psychiatric Institute|||||f||||||||||||||2017-02-18 18:26:47.603875|2017-02-18 18:26:47.603875
NCT00000212|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-08-27|||July 1987||1987-07-01|December 2012|2012-12-01|July 1988|Actual|1988-07-01|July 1988|Actual|1988-07-01||Interventional|||IV Cocaine Abuse: A Laboratory Model - 1|IV Cocaine Abuse: A Laboratory Model|Completed||Phase 2|0||New York State Psychiatric Institute|||||f||||||||||||||2017-02-18 18:26:47.707251|2017-02-18 18:26:47.707251
NCT00000211|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||September 1989||1989-09-01|December 2002|2002-12-01|February 1996|Actual|1996-02-01|February 1996|Actual|1996-02-01||Interventional|||Treatment Efficacy for Drug Abuse and AIDS Prevention - 2|Treatment Efficacy for Drug Abuse and AIDS Prevention|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:47.802443|2017-02-18 18:26:47.802443
NCT00000210|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||September 1989||1989-09-01|December 2002|2002-12-01|February 1996|Actual|1996-02-01|February 1996|Actual|1996-02-01||Interventional|||Treatment Efficacy for Drug Abuse and AIDS Prevention - 1|Treatment Efficacy for Drug Abuse and AIDS Prevention|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:47.88746|2017-02-18 18:26:47.88746
NCT00000209|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||November 1992||1992-11-01|September 1994|1994-09-01||||||||Interventional|||Buprenorphine Dosing Interval - 5|Buprenorphine Dosing Interval|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:47.977258|2017-02-18 18:26:47.977258
NCT00000208|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2005-08-16|||February 1992||1992-02-01|September 1993|1993-09-01||||||||Interventional|||Methadone/Buprenorphine Cross-Over Study - 4|Methadone/Buprenorphine Cross-Over Study|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:48.061974|2017-02-18 18:26:48.061974
NCT00000207|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-07-07|||May 1992||1992-05-01|July 2016|2016-07-01||||April 1997|Actual|1997-04-01||Interventional|||Multicenter Clinical Trial of Buprenorphine - 3|Multicenter Clinical Trial of Buprenorphine|Completed||Phase 3|0||University of California, Los Angeles|||||f||||||||||||||2017-02-18 18:26:48.152422|2017-02-18 18:26:48.152422
NCT00000206|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-11-03|||April 1991||1991-04-01|November 2016|2016-11-01||||August 2005|Actual|2005-08-01||Interventional|||Clinical Rescue Protocol - 2|Clinical Rescue Protocol|Completed||Phase 2|0||University of California, Los Angeles|||||f||||||||||||||2017-02-18 18:26:48.258761|2017-02-18 18:26:48.258761
NCT00000205|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-07-07|||October 1990||1990-10-01|July 2016|2016-07-01|September 1993|Actual|1993-09-01|March 1993|Actual|1993-03-01||Interventional|||Buprenorphine Maintenance Protocol - 1|Buprenorphine Maintenance Protocol|Completed||Phase 3|0||University of California, Los Angeles|||||f||||||||||||||2017-02-18 18:26:48.348559|2017-02-18 18:26:48.348559
NCT00000204|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-07-24|||August 1988||1988-08-01|August 2005|2005-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Buprenorphine Maintenance for Opioid Addicts - 3|Buprenorphine Maintenance for Opioid Addicts|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-02-18 18:26:48.444738|2017-02-18 18:26:48.444738
NCT00000203|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-07-24|||August 1988||1988-08-01|August 2005|2005-08-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Buprenorphine Maintenance for Opioid Addicts - 2|Buprenorphine Maintenance for Opioid Addicts|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-02-18 18:26:48.539474|2017-02-18 18:26:48.539474
NCT00000202|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2013-07-24|||August 1988||1988-08-01|December 2002|2002-12-01|May 2006|Actual|2006-05-01|May 2006|Actual|2006-05-01||Interventional|||Buprenorphine Maintenance for Opioid Addicts - 1|Buprenorphine Maintenance for Opioid Addicts|Completed||Phase 2|0||Yale University|||||f||||||||||||||2017-02-18 18:26:48.637417|2017-02-18 18:26:48.637417
NCT00000201|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11||||||October 2016|2016-10-01|December 2001||2001-12-01|||||Interventional|||Pharmacological Modulation of Cocaine Effects - 1|Pharmacological Modulation of Cocaine Effects|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||||||||||||2017-02-18 18:26:48.732215|2017-02-18 18:26:48.732215
NCT00000200|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||January 1997||1997-01-01|October 2016|2016-10-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Cocaine Effects in Humans: Physiology and Behavior - 1|Cocaine Effects in Humans: Physiology and Behavior|Completed||Phase 2|19|Actual|National Institute on Drug Abuse (NIDA)||1|||f||||t||||||||||2017-02-18 18:26:48.822882|2017-02-18 18:26:48.822882
NCT00000199|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-10-07||||||July 2013|2013-07-01||||||||Interventional|||Piracetam for Treatment of Cocaine Addiction, Phase II - 4|Piracetam for Treatment of Cocaine Addiction, Phase II|Withdrawn||Phase 1|0|Actual|University of Pennsylvania|||||f||||||||||||||2017-02-18 18:26:48.921625|2017-02-18 18:26:48.921625
NCT00000198|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-10-05|||October 1996||1996-10-01|December 2013|2013-12-01|October 1997|Actual|1997-10-01|October 1997|Actual|1997-10-01||Interventional|||Piracetam for Treatment of Cocaine Addiction - 3|Piracetam for Treatment of Cocaine Addiction|Completed||Phase 1|0||University of Pennsylvania|||||||||||||||||||2017-02-18 18:26:49.046856|2017-02-18 18:26:49.046856
NCT00000197|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2017-01-11|||January 1987||1987-01-01|October 2016|2016-10-01|January 2002|Actual|2002-01-01|January 2002|Actual|2002-01-01||Interventional|||Propranolol for Treatment of Cocaine Addiction - 2|Propranolol for Treatment of Cocaine Addiction|Completed||Phase 2|0||National Institute on Drug Abuse (NIDA)|||||f||||f||||||||||2017-02-18 18:26:49.142679|2017-02-18 18:26:49.142679
NCT00000196|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-06-02|||January 1993||1993-01-01|September 2013|2013-09-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 5 - 5|Neurobiology of Opioid Dependence: 5|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-02-18 18:26:49.237706|2017-02-18 18:26:49.237706
NCT00000195|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05|||January 1993||1993-01-01|August 2015|2015-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 4 - 4|Neurobiology of Opioid Dependence: 4|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-02-18 18:26:49.322099|2017-02-18 18:26:49.322099
NCT00000194|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2016-05-05|||January 1993||1993-01-01|August 2015|2015-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 3 - 3|Neurobiology of Opioid Dependence: 3|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-02-18 18:26:49.416853|2017-02-18 18:26:49.416853
NCT00000193|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-08-05|||January 1993||1993-01-01|August 2015|2015-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 2 - 2|Neurobiology of Opioid Dependence: 2|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-02-18 18:26:49.501696|2017-02-18 18:26:49.501696
NCT00000192|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-08-05|||January 1993||1993-01-01|August 2015|2015-08-01|January 1998|Actual|1998-01-01|January 1998|Actual|1998-01-01||Interventional|||Neurobiology of Opioid Dependence: 1 - 1|Neurobiology of Opioid Dependence: 1|Withdrawn||Phase 2|0|Actual|Yale University|||||f||||||||||||||2017-02-18 18:26:49.588149|2017-02-18 18:26:49.588149
NCT00000191|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||January 1991||1991-01-01|May 2015|2015-05-01|February 1994|Actual|1994-02-01|February 1994|Actual|1994-02-01||Interventional|||Carbamazepine Treatment for Cocaine Dependence - 5|Carbamazepine Treatment for Cocaine Dependence|Completed||Phase 2|0||University of Pennsylvania|||||f||||||||||||||2017-02-18 18:26:49.679438|2017-02-18 18:26:49.679438
NCT00000190|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||January 1991||1991-01-01|May 2015|2015-05-01|February 1992|Actual|1992-02-01|February 1992|Actual|1992-02-01||Interventional|||Cocaine in Parotid Saliva, Blood and Urine - 4|Cocaine in Parotid Saliva, Blood and Urine|Completed||Phase 1|0||University of Pennsylvania|||||f||||||||||||||2017-02-18 18:26:49.774577|2017-02-18 18:26:49.774577
NCT00000189|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||January 1990||1990-01-01|May 2015|2015-05-01|February 1991|Actual|1991-02-01|February 1991|Actual|1991-02-01||Interventional|||Gepirone vs Placebo in Treatment of Cocaine Dependence - 3|Gepirone vs Placebo in Treatment of Cocaine Dependence|Completed||Phase 2|41|Actual|University of Pennsylvania||1|||f||||||||||||||2017-02-18 18:26:49.866118|2017-02-18 18:26:49.866118
NCT00000188|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||September 1994||1994-09-01|May 2015|2015-05-01|October 1995|Actual|1995-10-01|October 1995|Actual|1995-10-01||Interventional|||Selegiline in Treatment of Cocaine Dependence - 2|Selegiline in Treatment of Cocaine Dependence|Completed||Phase 2|50|Actual|University of Pennsylvania||1|||f||||||||||||||2017-02-18 18:26:49.953207|2017-02-18 18:26:49.953207
NCT00000187|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-20|2015-05-26|||July 1992||1992-07-01|May 2015|2015-05-01||||June 1994|Actual|1994-06-01||Interventional|||Ritanserin in Treatment of Cocaine Dependence - 1|Ritanserin in Treatment of Cocaine Dependence|Completed||Phase 2|80|Actual|University of Pennsylvania||1|||f||||||||||||||2017-02-18 18:26:50.309711|2017-02-18 18:26:50.309711
NCT00000180|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2009-12-10||||||February 2005|2005-02-01|June 2005|Actual|2005-06-01|June 2005|Actual|2005-06-01||Interventional|||AIT-082 Phase 1B Study||Completed||Phase 1|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:50.411033|2017-02-18 18:26:50.411033
NCT00000179|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2005-06-23||||||March 2005|2005-03-01||||||||Interventional|||Agitation in Alzheimer's Disease||Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:50.504995|2017-02-18 18:26:50.504995
NCT00000178|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2005-06-23||||||February 2005|2005-02-01||||||||Interventional|||Multicenter Trial of Prednisone in Alzheimer's Disease|Multicenter Trial of Prednisone in Alzheimer's Disease|Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:50.616162|2017-02-18 18:26:50.616162
NCT00000177|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2009-12-10|||October 1995||1995-10-01|September 2009|2009-09-01|January 1999|Actual|1999-01-01|January 1999|Actual|1999-01-01||Interventional|||Estrogen Hormone Protocol||Completed||Phase 3|120||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:50.723789|2017-02-18 18:26:50.723789
NCT00000176|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2010-11-03||||||November 2010|2010-11-01|September 2007|Actual|2007-09-01|September 2007|Actual|2007-09-01||Interventional|||Alzheimer's Disease Prevention Trial|Alzheimer's Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimer's Disease and Loss of Memory in Women.|Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:50.843137|2017-02-18 18:26:50.843137
NCT00000175|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2009-12-10||||||March 2004|2004-03-01|June 2005|Anticipated|2005-06-01|June 2005|Anticipated|2005-06-01||Interventional|||The Effects of Sex Hormones on Cognition and Mood in Older Adults||Terminated||N/A|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:50.970735|2017-02-18 18:26:50.970735
NCT00000174|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2005-12-08||||||January 2000|2000-01-01||||||||Interventional|||Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)||Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:51.080015|2017-02-18 18:26:51.080015
NCT00000173|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2009-12-10|||March 1999||1999-03-01|June 2009|2009-06-01|January 2004|Actual|2004-01-01|January 2004|Actual|2004-01-01||Interventional|||Memory Impairment Study (Mild Cognitive Impairment Study)|A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin E and Donepezil HCL (Aricept) to Delay Clinical Progression From Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD)|Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:51.190585|2017-02-18 18:26:51.190585
NCT00000172|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2005-06-23||||||November 2002|2002-11-01||||||||Interventional|||Evaluation of Galantamine in the Treatment of Alzheimer's Disease|Placebo Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy Under a Slow-Titration Regimen|Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:51.377617|2017-02-18 18:26:51.377617
NCT00000171|ClinicalTrials.gov processed this data on February 17, 2017|1999-10-29|2005-06-23||||||March 2005|2005-03-01||||||||Interventional|||Study of Melatonin: Sleep Problems in Alzheimer's Disease||Completed||Phase 3|||National Institute on Aging (NIA)|||||f||||||||||||||2017-02-18 18:26:51.531411|2017-02-18 18:26:51.531411
NCT00000170|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2014-03-05|||April 1999||1999-04-01|March 2014|2014-03-01|August 2013|Actual|2013-08-01|November 2001|Actual|2001-11-01||Interventional|||Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia|Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia|Completed||Phase 3|419|Actual|Jaeb Center for Health Research||2|||f||||t||||||||||2017-02-18 18:26:51.660987|2017-02-18 18:26:51.660987
NCT00000169|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||April 1999||1999-04-01|June 2001|2001-06-01||||||||Observational|||The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study||Unknown status|Recruiting|N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:51.797607|2017-02-18 18:26:51.797607
NCT00000168|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2015-06-10|||August 1998||1998-08-01|June 2015|2015-06-01|August 2013|Actual|2013-08-01|August 2013|Actual|2013-08-01||Observational|LSOCA||Longitudinal Study of Ocular Complications of AIDS (LSOCA)|Studies of Ocular Complications of AIDS (SOCA)|Completed||N/A|2392|Actual|Johns Hopkins Bloomberg School of Public Health|||1||f||||t||||||Samples With DNA|"~     Laboratory studies will include hematology serum chemistry and lymphocyte subset analysis~     for all patients. The amount of blood for hematology, serum chemistry, and lymphocyte subset~     analysis is restricted to no more than a total of 17 mL per draw. Data existing on HIV viral~     load analysis at the clinic will be collected. If HIV data are not available from medical~     records within the visit time window, blood should be collected for local HIV viral load~     determination.~   "|||2017-02-18 18:26:51.878167|2017-02-18 18:26:51.878167
NCT00000167|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2010-03-23|||May 1999||1999-05-01|December 2007|2007-12-01|June 2006|Actual|2006-06-01|||||Interventional|CAPT||Complications of Age-Related Macular Degeneration Prevention Trial|Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)|Completed||Phase 3|1052|Actual|National Eye Institute (NEI)||1|||f||||t||||||||||2017-02-18 18:26:52.00625|2017-02-18 18:26:52.00625
NCT00000163|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2009-09-16|||December 1997||1997-12-01|September 2009|2009-09-01|July 2000||2000-07-01|||||Observational|||Congenital Esotropia Observational Study (CEOS)||Completed||N/A|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:52.131905|2017-02-18 18:26:52.131905
NCT00000162|ClinicalTrials.gov processed this data on February 17, 2017|1999-09-23|2005-06-23|||July 1977||1977-07-01|October 1999|1999-10-01||||||||Interventional|||Branch Vein Occlusion Study||Completed||Phase 3|||National Eye Institute (NEI)|||||f||||||||||||||2017-02-18 18:26:52.198074|2017-02-18 18:26:52.198074
